TY - JOUR AD - Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. AN - 7662979 AU - Wellmann, A. AU - Otsuki, T. AU - Vogelbruch, M. AU - Clark, H. M. AU - Jaffe, E. S. AU - Raffeld, M. DA - Sep 15 DP - NLM ET - 1995/09/15 IS - 6 LA - eng N1 - Wellmann, A Otsuki, T Vogelbruch, M Clark, H M Jaffe, E S Raffeld, M Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1995 Sep 15;86(6):2321-8. PY - 1995 SN - 0006-4971 (Print) 0006-4971 SP - 2321-8 ST - Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease T2 - Blood TI - Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease VL - 86 ID - 102 ER - TY - JOUR AD - Department of Cell Biology, Neurobiology and Anatomy, Loyola University Chicago Medical Center, Maywood, IL 60153, USA. AN - 8562514 AU - Schluns, K. S. AU - Grutkoski, P. S. AU - Cook, J. E. AU - Engelmann, G. L. AU - Le, P. T. DA - Oct DO - 10.1093/intimm/7.10.1681 DP - NLM ET - 1995/10/01 IS - 10 LA - eng N1 - Schluns, K S Grutkoski, P S Cook, J E Engelmann, G L Le, P T AR34808/AR/NIAMS NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. England Int Immunol. 1995 Oct;7(10):1681-90. doi: 10.1093/intimm/7.10.1681. PY - 1995 SN - 0953-8178 (Print) 0953-8178 SP - 1681-90 ST - Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors T2 - Int Immunol TI - Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors VL - 7 ID - 103 ER - TY - JOUR AD - Department of Pathology and Cytology, Karolinska Institute and Hospital, Stockholm, Sweden. AN - 7579458 AU - Elmberger, P. G. AU - Lozano, M. D. AU - Weisenburger, D. D. AU - Sanger, W. AU - Chan, W. C. DA - Nov 1 DP - NLM ET - 1995/11/01 IS - 9 LA - eng N1 - Elmberger, P G Lozano, M D Weisenburger, D D Sanger, W Chan, W C CA36727/CA/NCI NIH HHS/United States Journal Article Research Support, U.S. Gov't, P.H.S. United States Blood. 1995 Nov 1;86(9):3517-21. PY - 1995 SN - 0006-4971 (Print) 0006-4971 SP - 3517-21 ST - Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions T2 - Blood TI - Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions VL - 86 ID - 104 ER - TY - JOUR AD - Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622, USA. AN - 7588209 AU - King, A. P. AU - Carter-Su, C. DA - Nov DO - 10.1210/endo.136.11.7588209 DP - NLM ET - 1995/11/01 IS - 11 LA - eng N1 - King, A P Carter-Su, C DK-48283/DK/NIDDK NIH HHS/United States GM-08322/GM/NIGMS NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Endocrinology. 1995 Nov;136(11):4796-803. doi: 10.1210/endo.136.11.7588209. PY - 1995 SN - 0013-7227 (Print) 0013-7227 SP - 4796-803 ST - Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts T2 - Endocrinology TI - Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts VL - 136 ID - 105 ER - TY - JOUR AD - Department of Pathology and CIGH/CNRS, CHU Purpan, Toulouse, France. AN - 8547653 AU - Lamant, L. AU - Meggetto, F. AU - al Saati, T. AU - Brugières, L. AU - de Paillerets, B. B. AU - Dastugue, N. AU - Bernheim, A. AU - Rubie, H. AU - Terrier-Lacombe, M. J. AU - Robert, A. AU - Rigal, F. AU - Schlaifer, D. AU - Shiuta, M. AU - Mori, S. AU - Delsol, G. DA - Jan 1 DP - NLM ET - 1996/01/01 IS - 1 LA - eng N1 - Lamant, L Meggetto, F al Saati, T Brugières, L de Paillerets, B B Dastugue, N Bernheim, A Rubie, H Terrier-Lacombe, M J Robert, A Rigal, F Schlaifer, D Shiuta, M Mori, S Delsol, G Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1996 Jan 1;87(1):284-91. PY - 1996 SN - 0006-4971 (Print) 0006-4971 SP - 284-91 ST - High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining T2 - Blood TI - High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining VL - 87 ID - 106 ER - TY - JOUR AD - Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. AN - 8781434 AU - Sarris, A. H. AU - Luthra, R. AU - Papadimitracopoulou, V. AU - Waasdorp, M. AU - Dimopoulos, M. A. AU - McBride, J. A. AU - Cabanillas, F. AU - Duvic, M. AU - Deisseroth, A. AU - Morris, S. W. AU - Pugh, W. C. DA - Sep 1 DP - NLM ET - 1996/09/01 IS - 5 LA - eng N1 - Sarris, A H Luthra, R Papadimitracopoulou, V Waasdorp, M Dimopoulos, M A McBride, J A Cabanillas, F Duvic, M Deisseroth, A Morris, S W Pugh, W C CA-01702/CA/NCI NIH HHS/United States CA-69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 1996 Sep 1;88(5):1771-9. PY - 1996 SN - 0006-4971 (Print) 0006-4971 SP - 1771-9 ST - Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis T2 - Blood TI - Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis VL - 88 ID - 107 ER - TY - JOUR AD - Department of Internal Medicine I, University of Saarland, Homburg/Saar, Germany. AN - 9209648 AU - Trümper, L. AU - Daus, H. AU - Merz, H. AU - von Bonin, F. AU - Loftin, U. AU - Cochlovius, C. AU - Möller, P. AU - Feller, A. C. AU - Pfreundschuh, M. DP - NLM ET - 1997/01/01 LA - eng N1 - Trümper, L Daus, H Merz, H von Bonin, F Loftin, U Cochlovius, C Möller, P Feller, A C Pfreundschuh, M Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't England Ann Oncol. 1997;8 Suppl 2:83-7. PY - 1997 SN - 0923-7534 (Print) 0923-7534 SP - 83-7 ST - NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis T2 - Ann Oncol TI - NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis VL - 8 Suppl 2 ID - 108 ER - TY - JOUR AD - University Department of Cellular Science, John Radcliffe Hospital, Oxford, UK. AN - 9028963 AU - Pulford, K. AU - Lamant, L. AU - Morris, S. W. AU - Butler, L. H. AU - Wood, K. M. AU - Stroud, D. AU - Delsol, G. AU - Mason, D. Y. DA - Feb 15 DP - NLM ET - 1997/02/15 IS - 4 LA - eng N1 - Pulford, K Lamant, L Morris, S W Butler, L H Wood, K M Stroud, D Delsol, G Mason, D Y Wellcome Trust/United Kingdom Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1997 Feb 15;89(4):1394-404. PY - 1997 SN - 0006-4971 (Print) 0006-4971 SP - 1394-404 ST - Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 T2 - Blood TI - Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 VL - 89 ID - 109 ER - TY - JOUR AD - Department of Pathology, CHU Purpan, Toulouse, France. AN - 9057627 AU - Delsol, G. AU - Lamant, L. AU - Mariamé, B. AU - Pulford, K. AU - Dastugue, N. AU - Brousset, P. AU - Rigal-Huguet, F. AU - al Saati, T. AU - Cerretti, D. P. AU - Morris, S. W. AU - Mason, D. Y. DA - Mar 1 DP - NLM ET - 1997/03/01 IS - 5 LA - eng N1 - Delsol, G Lamant, L Mariamé, B Pulford, K Dastugue, N Brousset, P Rigal-Huguet, F al Saati, T Cerretti, D P Morris, S W Mason, D Y CA 01702/CA/NCI NIH HHS/United States CA 21765/CA/NCI NIH HHS/United States CA 69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 1997 Mar 1;89(5):1483-90. PY - 1997 SN - 0006-4971 (Print) 0006-4971 SP - 1483-90 ST - A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation T2 - Blood TI - A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation VL - 89 ID - 110 ER - TY - JOUR AD - Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. AN - 9220028 AU - Sharif, T. R. AU - Luo, W. AU - Sharif, M. DA - Jun 20 DO - 10.1016/s0303-7207(97)00080-4 DP - NLM ET - 1997/06/20 IS - 1-2 LA - eng N1 - Sharif, T R Luo, W Sharif, M CA21765/CA/NCI NIH HHS/United States CA71756/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Ireland Mol Cell Endocrinol. 1997 Jun 20;130(1-2):119-30. doi: 10.1016/s0303-7207(97)00080-4. PY - 1997 SN - 0303-7207 (Print) 0303-7207 SP - 119-30 ST - Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway T2 - Mol Cell Endocrinol TI - Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway VL - 130 ID - 111 ER - TY - JOUR AD - Department of Pathology, University of Leuven, Belgium. AN - 9250148 AU - Pittaluga, S. AU - Wlodarska, I. AU - Pulford, K. AU - Campo, E. AU - Morris, S. W. AU - Van den Berghe, H. AU - De Wolf-Peeters, C. C2 - PMC1858018 DA - Aug DP - NLM ET - 1997/08/01 IS - 2 LA - eng N1 - 1525-2191 Pittaluga, S Wlodarska, I Pulford, K Campo, E Morris, S W Van den Berghe, H De Wolf-Peeters, C CA01702/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Am J Pathol. 1997 Aug;151(2):343-51. PY - 1997 SN - 0002-9440 (Print) 0002-9440 SP - 343-51 ST - The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements T2 - Am J Pathol TI - The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements VL - 151 ID - 112 ER - TY - JOUR AD - Department of Medicine, Biological Chemistry and Pharmacology, University of California, Irvine 92697, USA. AN - 9333017 AU - Kornmann, M. AU - Ishiwata, T. AU - Beger, H. G. AU - Korc, M. DA - Sep 18 DO - 10.1038/sj.onc.1201307 DP - NLM ET - 1997/10/23 IS - 12 LA - eng N1 - Kornmann, M Ishiwata, T Beger, H G Korc, M DK-44948/DK/NIDDK NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. England Oncogene. 1997 Sep 18;15(12):1417-24. doi: 10.1038/sj.onc.1201307. PY - 1997 SN - 0950-9232 (Print) 0950-9232 SP - 1417-24 ST - Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions T2 - Oncogene TI - Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions VL - 15 ID - 113 ER - TY - JOUR AD - Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QR, United Kingdom. AN - 9486982 AU - Dib, K. AU - Whitehead, J. P. AU - Humphreys, P. J. AU - Soos, M. A. AU - Baynes, K. C. AU - Kumar, S. AU - Harvey, T. AU - O'Rahilly, S. C2 - PMC508663 DA - Mar 1 DO - 10.1172/jci119884 DP - NLM ET - 1998/04/16 IS - 5 LA - eng N1 - Dib, K Whitehead, J P Humphreys, P J Soos, M A Baynes, K C Kumar, S Harvey, T O'Rahilly, S Wellcome Trust/United Kingdom Journal Article Research Support, Non-U.S. Gov't J Clin Invest. 1998 Mar 1;101(5):1111-20. doi: 10.1172/JCI119884. PY - 1998 SN - 0021-9738 (Print) 0021-9738 SP - 1111-20 ST - Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance T2 - J Clin Invest TI - Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance VL - 101 ID - 114 ER - TY - JOUR AD - Service de Neuropédiatrie and INSERM CRI 97-01, Hôpital Robert-Debré, Paris, France. AN - 9603224 AU - Gressens, P. AU - Marret, S. AU - Martin, J. L. AU - Laquerrière, A. AU - Lombet, A. AU - Evrard, P. DA - Jun DO - 10.1046/j.1471-4159.1998.70062574.x DP - NLM ET - 1998/05/29 IS - 6 LA - eng N1 - Gressens, P Marret, S Martin, J L Laquerrière, A Lombet, A Evrard, P Journal Article Research Support, Non-U.S. Gov't England J Neurochem. 1998 Jun;70(6):2574-84. doi: 10.1046/j.1471-4159.1998.70062574.x. PY - 1998 SN - 0022-3042 (Print) 0022-3042 SP - 2574-84 ST - Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies T2 - J Neurochem TI - Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies VL - 70 ID - 115 ER - TY - JOUR AD - Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. AN - 9607929 AU - Zhang, Y. Y. AU - Vik, T. A. AU - Ryder, J. W. AU - Srour, E. F. AU - Jacks, T. AU - Shannon, K. AU - Clapp, D. W. C2 - PMC2212307 DA - Jun 1 DO - 10.1084/jem.187.11.1893 DP - NLM ET - 1998/06/10 IS - 11 LA - eng N1 - 1540-9538 Zhang, Y Y Vik, T A Ryder, J W Srour, E F Jacks, T Shannon, K Clapp, D W P50DK49218/DK/NIDDK NIH HHS/United States R29 CA-74177-01/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. J Exp Med. 1998 Jun 1;187(11):1893-902. doi: 10.1084/jem.187.11.1893. PY - 1998 SN - 0022-1007 (Print) 0022-1007 SP - 1893-902 ST - Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines T2 - J Exp Med TI - Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines VL - 187 ID - 116 ER - TY - JOUR AD - Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA. AN - 9660487 AU - Fleming, T. P. AU - Song, Z. AU - Andley, U. P. DA - Jul DP - NLM ET - 1998/07/11 IS - 8 LA - eng N1 - Fleming, T P Song, Z Andley, U P EY02687/EY/NEI NIH HHS/United States R01-EY05681/EY/NEI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1387-98. PY - 1998 SN - 0146-0404 (Print) 0146-0404 SP - 1387-98 ST - Expression of growth control and differentiation genes in human lens epithelial cells with extended life span T2 - Invest Ophthalmol Vis Sci TI - Expression of growth control and differentiation genes in human lens epithelial cells with extended life span VL - 39 ID - 117 ER - TY - JOUR AD - Division of Endocrinology, Diabetes and Metabolism, Departments of Medicine, Biological Chemistry and Pharmacology, University of California, Irvine, California, USA. AN - 10220513 AU - Kleeff, J. AU - Maruyama, H. AU - Ishiwata, T. AU - Sawhney, H. AU - Friess, H. AU - Büchler, M. W. AU - Korc, M. DA - May DO - 10.1016/s0016-5085(99)70024-7 DP - NLM ET - 1999/04/30 IS - 5 LA - eng N1 - Kleeff, J Maruyama, H Ishiwata, T Sawhney, H Friess, H Büchler, M W Korc, M CA-40162/CA/NCI NIH HHS/United States CA-75059/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Gastroenterology. 1999 May;116(5):1202-16. doi: 10.1016/s0016-5085(99)70024-7. PY - 1999 SN - 0016-5085 (Print) 0016-5085 SP - 1202-16 ST - Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo T2 - Gastroenterology TI - Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo VL - 116 ID - 118 ER - TY - JOUR AN - 10450759 AU - Hernández, F. AU - López, O. AU - Estivill, C. AU - Baiget, M. AU - Pujol, R. M. AU - Bordes, R. AU - Nomdedéu, J. F. DA - Aug DO - 10.1038/sj.leu.2401475 DP - NLM ET - 1999/08/18 IS - 8 LA - eng N1 - Hernández, F López, O Estivill, C Baiget, M Pujol, R M Bordes, R Nomdedéu, J F Letter Research Support, Non-U.S. Gov't England Leukemia. 1999 Aug;13(8):1291-2. doi: 10.1038/sj.leu.2401475. PY - 1999 SN - 0887-6924 (Print) 0887-6924 SP - 1291-2 ST - NPM/ALK rearrangements in indolent cutaneous lesions T2 - Leukemia TI - NPM/ALK rearrangements in indolent cutaneous lesions VL - 13 ID - 119 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA. AN - 10555007 AU - Cataldo, K. A. AU - Jalal, S. M. AU - Law, M. E. AU - Ansell, S. M. AU - Inwards, D. J. AU - Fine, M. AU - Arber, D. A. AU - Pulford, K. A. AU - Strickler, J. G. DA - Nov DO - 10.1097/00000478-199911000-00009 DP - NLM ET - 1999/11/11 IS - 11 LA - eng N1 - Cataldo, K A Jalal, S M Law, M E Ansell, S M Inwards, D J Fine, M Arber, D A Pulford, K A Strickler, J G Clinical Trial Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 1999 Nov;23(11):1386-92. doi: 10.1097/00000478-199911000-00009. PY - 1999 SN - 0147-5185 (Print) 0147-5185 SP - 1386-92 ST - Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue T2 - Am J Surg Pathol TI - Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue VL - 23 ID - 120 ER - TY - JOUR AD - Institute of Hematology, University of Perugia, Perugia, Italy. AN - 10552961 AU - Falini, B. AU - Pulford, K. AU - Pucciarini, A. AU - Carbone, A. AU - De Wolf-Peeters, C. AU - Cordell, J. AU - Fizzotti, M. AU - Santucci, A. AU - Pelicci, P. G. AU - Pileri, S. AU - Campo, E. AU - Ott, G. AU - Delsol, G. AU - Mason, D. Y. DA - Nov 15 DP - NLM ET - 1999/11/24 IS - 10 LA - eng N1 - Falini, B Pulford, K Pucciarini, A Carbone, A De Wolf-Peeters, C Cordell, J Fizzotti, M Santucci, A Pelicci, P G Pileri, S Campo, E Ott, G Delsol, G Mason, D Y Journal Article Research Support, Non-U.S. Gov't United States Blood. 1999 Nov 15;94(10):3509-15. PY - 1999 SN - 0006-4971 (Print) 0006-4971 SP - 3509-15 ST - Lymphomas expressing ALK fusion protein(s) other than NPM-ALK T2 - Blood TI - Lymphomas expressing ALK fusion protein(s) other than NPM-ALK VL - 94 ID - 121 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan. AN - 10646854 AU - Misawa, A. AU - Hosoi, H. AU - Arimoto, A. AU - Shikata, T. AU - Akioka, S. AU - Matsumura, T. AU - Houghton, P. J. AU - Sawada, T. DA - Jan 1 DP - NLM ET - 2000/01/26 IS - 1 LA - eng N1 - Misawa, A Hosoi, H Arimoto, A Shikata, T Akioka, S Matsumura, T Houghton, P J Sawada, T CA23099/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Cancer Res. 2000 Jan 1;60(1):64-9. PY - 2000 SN - 0008-5472 (Print) 0008-5472 SP - 64-9 ST - N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells T2 - Cancer Res TI - N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells VL - 60 ID - 122 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, University of Tennessee, College of Medicine, Memphis, TN 38105-2794, USA. AN - 10706887 AU - Ma, Z. AU - Cools, J. AU - Marynen, P. AU - Cui, X. AU - Siebert, R. AU - Gesk, S. AU - Schlegelberger, B. AU - Peeters, B. AU - De Wolf-Peeters, C. AU - Wlodarska, I. AU - Morris, S. W. DA - Mar 15 DP - NLM ET - 2000/03/09 IS - 6 LA - eng N1 - Ma, Z Cools, J Marynen, P Cui, X Siebert, R Gesk, S Schlegelberger, B Peeters, B De Wolf-Peeters, C Wlodarska, I Morris, S W CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 2000 Mar 15;95(6):2144-9. PY - 2000 SN - 0006-4971 (Print) 0006-4971 SP - 2144-9 ST - Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis T2 - Blood TI - Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis VL - 95 ID - 123 ER - TY - JOUR AD - Carcinogenesis and Developmental Therapeutics Program, College of Veterinary Medicine, University of Tennessee, Knoxville 37909-1071, USA. AN - 10771023 AU - Schuller, H. M. AU - Jull, B. A. AU - Sheppard, B. J. AU - Plummer, H. K. DA - Mar 30 DO - 10.1016/s0014-2999(00)00094-7 DP - NLM ET - 2000/04/20 IS - 1-3 LA - eng N1 - Schuller, H M Jull, B A Sheppard, B J Plummer, H K CA51211/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Netherlands Eur J Pharmacol. 2000 Mar 30;393(1-3):265-77. doi: 10.1016/s0014-2999(00)00094-7. PY - 2000 SN - 0014-2999 (Print) 0014-2999 SP - 265-77 ST - Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders T2 - Eur J Pharmacol TI - Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders VL - 393 ID - 124 ER - TY - JOUR AD - Department of Pathology, Centre Hospitalo-Universitaire Purpan, Toulouse, France. AN - 10793082 AU - Lamant, L. AU - Pulford, K. AU - Bischof, D. AU - Morris, S. W. AU - Mason, D. Y. AU - Delsol, G. AU - Mariamé, B. C2 - PMC1876934 DA - May DO - 10.1016/s0002-9440(10)65042-0 DP - NLM ET - 2000/05/04 IS - 5 LA - eng N1 - 1525-2191 Lamant, L Pulford, K Bischof, D Morris, S W Mason, D Y Delsol, G Mariamé, B P30 CA021765/CA/NCI NIH HHS/United States R01 CA069129/CA/NCI NIH HHS/United States CA 21765/CA/NCI NIH HHS/United States CA 69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Am J Pathol. 2000 May;156(5):1711-21. doi: 10.1016/S0002-9440(10)65042-0. PY - 2000 SN - 0002-9440 (Print) 0002-9440 SP - 1711-21 ST - Expression of the ALK tyrosine kinase gene in neuroblastoma T2 - Am J Pathol TI - Expression of the ALK tyrosine kinase gene in neuroblastoma VL - 156 ID - 125 ER - TY - JOUR AD - Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK. AN - 10886208 AU - Haralambieva, E. AU - Pulford, K. A. AU - Lamant, L. AU - Pileri, S. AU - Roncador, G. AU - Gatter, K. C. AU - Delsol, G. AU - Mason, D. Y. DA - Jun DO - 10.1046/j.1365-2141.2000.02045.x DP - NLM ET - 2000/07/11 IS - 3 LA - eng N1 - Haralambieva, E Pulford, K A Lamant, L Pileri, S Roncador, G Gatter, K C Delsol, G Mason, D Y Journal Article Research Support, Non-U.S. Gov't England Br J Haematol. 2000 Jun;109(3):584-91. doi: 10.1046/j.1365-2141.2000.02045.x. PY - 2000 SN - 0007-1048 (Print) 0007-1048 SP - 584-91 ST - Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas T2 - Br J Haematol TI - Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas VL - 109 ID - 126 ER - TY - JOUR AD - Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands. AN - 10911802 AU - ten Berge, R. L. AU - Oudejans, J. J. AU - Ossenkoppele, G. J. AU - Pulford, K. AU - Willemze, R. AU - Falini, B. AU - Chott, A. AU - Meijer, C. J. C2 - PMC1731216 DA - Jun DO - 10.1136/jcp.53.6.445 DP - NLM ET - 2000/07/27 IS - 6 LA - eng N1 - 1472-4146 ten Berge, R L Oudejans, J J Ossenkoppele, G J Pulford, K Willemze, R Falini, B Chott, A Meijer, C J Journal Article J Clin Pathol. 2000 Jun;53(6):445-50. doi: 10.1136/jcp.53.6.445. PY - 2000 SN - 0021-9746 (Print) 0021-9746 SP - 445-50 ST - ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination T2 - J Clin Pathol TI - ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination VL - 53 ID - 127 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. AN - 10934142 AU - Lawrence, B. AU - Perez-Atayde, A. AU - Hibbard, M. K. AU - Rubin, B. P. AU - Dal Cin, P. AU - Pinkus, J. L. AU - Pinkus, G. S. AU - Xiao, S. AU - Yi, E. S. AU - Fletcher, C. D. AU - Fletcher, J. A. C2 - PMC1850130 DA - Aug DO - 10.1016/s0002-9440(10)64550-6 DP - NLM ET - 2000/08/10 IS - 2 LA - eng N1 - 1525-2191 Lawrence, B Perez-Atayde, A Hibbard, M K Rubin, B P Dal Cin, P Pinkus, J L Pinkus, G S Xiao, S Yi, E S Fletcher, C D Fletcher, J A Journal Article Am J Pathol. 2000 Aug;157(2):377-84. doi: 10.1016/S0002-9440(10)64550-6. PY - 2000 SN - 0002-9440 (Print) 0002-9440 SP - 377-84 ST - TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors T2 - Am J Pathol TI - TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors VL - 157 ID - 128 ER - TY - JOUR AD - Service of Pathologic Anatomy and Haematopathology, Institute of Hematology and Clinical Oncology "L. & A. Seràgnoli", Bologna University, Policlinico S. Orsola, Bologna, Italy. AN - 10980638 AU - Piccaluga, P. P. AU - Ascani, S. AU - Fraternali Orcioni, G. AU - Piccioli, M. AU - Pileri, A., Jr. AU - Falini, B. AU - Pileri, S. DA - Sep DP - NLM ET - 2000/09/12 IS - 9 LA - eng N1 - Piccaluga, P P Ascani, S Fraternali Orcioni, G Piccioli, M Pileri, A Jr Falini, B Pileri, S Case Reports Journal Article Research Support, Non-U.S. Gov't Italy Haematologica. 2000 Sep;85(9):978-81. PY - 2000 SN - 0390-6078 (Print) 0390-6078 SP - 978-81 ST - Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction T2 - Haematologica TI - Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction VL - 85 ID - 129 ER - TY - JOUR AD - DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig. AN - 10994999 AU - Drexler, H. G. AU - Gignac, S. M. AU - von Wasielewski, R. AU - Werner, M. AU - Dirks, W. G. DA - Sep DO - 10.1038/sj.leu.2401878 DP - NLM ET - 2000/09/20 IS - 9 LA - eng N1 - Drexler, H G Gignac, S M von Wasielewski, R Werner, M Dirks, W G Journal Article Research Support, Non-U.S. Gov't Review England Leukemia. 2000 Sep;14(9):1533-59. doi: 10.1038/sj.leu.2401878. PY - 2000 SN - 0887-6924 (Print) 0887-6924 SP - 1533-59 ST - Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas T2 - Leukemia TI - Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas VL - 14 ID - 130 ER - TY - JOUR AD - Institute for Cell, Animal and Population Biology, Ashworth Laboratories, The University of Edinburgh, Edinburgh, Scotland. AN - 11110670 AU - Falcone, F. H. AU - Haas, H. AU - Gibbs, B. F. DA - Dec 15 DP - NLM ET - 2000/12/09 IS - 13 LA - eng N1 - Falcone, F H Haas, H Gibbs, B F Journal Article Research Support, Non-U.S. Gov't Review United States Blood. 2000 Dec 15;96(13):4028-38. PY - 2000 SN - 0006-4971 (Print) 0006-4971 SP - 4028-38 ST - The human basophil: a new appreciation of its role in immune responses T2 - Blood TI - The human basophil: a new appreciation of its role in immune responses VL - 96 ID - 131 ER - TY - JOUR AD - Laboratory for Molecular Carcinogenesis, MGC-Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL, Leiden, Netherlands. AN - 11152962 AU - Vertegaal, A. C. AU - Kuiperij, H. B. AU - Yamaoka, S. AU - Courtois, G. AU - van der Eb, A. J. AU - Zantema, A. DA - Dec DO - 10.1016/s0898-6568(00)00133-9 DP - NLM ET - 2001/01/12 IS - 11-12 LA - eng N1 - Vertegaal, A C Kuiperij, H B Yamaoka, S Courtois, G van der Eb, A J Zantema, A Journal Article Research Support, Non-U.S. Gov't England Cell Signal. 2000 Dec;12(11-12):759-68. doi: 10.1016/s0898-6568(00)00133-9. PY - 2000 SN - 0898-6568 (Print) 0898-6568 SP - 759-68 ST - Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells T2 - Cell Signal TI - Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells VL - 12 ID - 132 ER - TY - JOUR AD - Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA. jarbise@emory.edu AN - 11174372 AU - Arbiser, J. L. AU - Weiss, S. W. AU - Arbiser, Z. K. AU - Bravo, F. AU - Govindajaran, B. AU - Caceres-Rios, H. AU - Cotsonis, G. AU - Recavarren, S. AU - Swerlick, R. A. AU - Cohen, C. DA - Feb DO - 10.1067/mjd.2000.111632 DP - NLM ET - 2001/02/15 IS - 2 LA - eng N1 - Arbiser, J L Weiss, S W Arbiser, Z K Bravo, F Govindajaran, B Caceres-Rios, H Cotsonis, G Recavarren, S Swerlick, R A Cohen, C KO8 AR02030/AR/NIAMS NIH HHS/United States P30 AR 42687/AR/NIAMS NIH HHS/United States R03AR44947/AR/NIAMS NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States J Am Acad Dermatol. 2001 Feb;44(2):193-7. doi: 10.1067/mjd.2000.111632. PY - 2001 SN - 0190-9622 (Print) 0190-9622 SP - 193-7 ST - Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy T2 - J Am Acad Dermatol TI - Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy VL - 44 ID - 133 ER - TY - JOUR AD - Department of Pediatric Laboratory Medicine, Hospital for Sick Children and University of Toronto, Ontario, Canada. AN - 11178628 AU - Sherman, C. G. AU - Zielenska, M. AU - Lorenzana, A. N. AU - Pulford, K. A. AU - Mason, D. Y. AU - Hutchison, R. E. AU - Thorner, P. S. DA - Mar-Apr DO - 10.1007/s100240010139 DP - NLM ET - 2001/02/15 IS - 2 LA - eng N1 - Sherman, C G Zielenska, M Lorenzana, A N Pulford, K A Mason, D Y Hutchison, R E Thorner, P S Journal Article Research Support, Non-U.S. Gov't United States Pediatr Dev Pathol. 2001 Mar-Apr;4(2):129-37. doi: 10.1007/s100240010139. PY - 2001 SN - 1093-5266 (Print) 1093-5266 SP - 129-37 ST - Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation T2 - Pediatr Dev Pathol TI - Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation VL - 4 ID - 134 ER - TY - JOUR AD - Department of Pathology and Groupe d'Etude des Lymphomes Malins CNRS/UPR2163 CHU Purpan, 31300 Toulouse, France. AN - 11215285 AU - Greenland, C. AU - Dastugue, N. AU - Touriol, C. AU - Lamant, L. AU - Delsol, G. AU - Brousset, P. C2 - PMC1731343 DA - Feb DO - 10.1136/jcp.54.2.152 DP - NLM ET - 2001/02/24 IS - 2 LA - eng N1 - 1472-4146 Greenland, C Dastugue, N Touriol, C Lamant, L Delsol, G Brousset, P Case Reports Journal Article Research Support, Non-U.S. Gov't J Clin Pathol. 2001 Feb;54(2):152-4. doi: 10.1136/jcp.54.2.152. PY - 2001 SN - 0021-9746 (Print) 0021-9746 SP - 152-4 ST - Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene T2 - J Clin Pathol TI - Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene VL - 54 ID - 135 ER - TY - JOUR AD - Department of Medical Biology, Faculty of Medicine, Pécs University, Hungary. AN - 11299726 AU - Fábián, Z. AU - Töröcsik, B. AU - Kiss, K. AU - Csatary, L. K. AU - Bodey, B. AU - Tigyi, J. AU - Csatary, C. AU - Szeberényi, J. DA - Jan-Feb DP - NLM ET - 2001/04/13 IS - 1a LA - eng N1 - Fábián, Z Töröcsik, B Kiss, K Csatary, L K Bodey, B Tigyi, J Csatary, C Szeberényi, J Journal Article Greece Anticancer Res. 2001 Jan-Feb;21(1A):125-35. PY - 2001 SN - 0250-7005 (Print) 0250-7005 SP - 125-35 ST - Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells T2 - Anticancer Res TI - Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells VL - 21 ID - 136 ER - TY - JOUR AD - Laboratory of Osteoblast Biology and Pathology, INSERM U 349, Affiliated CNRS, Lariboisière Hospital, 75475 Cedex 10 Paris, France. AN - 11395480 AU - Haÿ, E. AU - Lemonnier, J. AU - Fromigué, O. AU - Marie, P. J. DA - Aug 3 DO - 10.1074/jbc.M011265200 DP - NLM ET - 2001/06/08 IS - 31 LA - eng N1 - Haÿ, E Lemonnier, J Fromigué, O Marie, P J Journal Article Research Support, Non-U.S. Gov't United States J Biol Chem. 2001 Aug 3;276(31):29028-36. doi: 10.1074/jbc.M011265200. Epub 2001 Jun 6. PY - 2001 SN - 0021-9258 (Print) 0021-9258 SP - 29028-36 ST - Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway T2 - J Biol Chem TI - Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway VL - 276 ID - 137 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. AN - 11380391 AU - Morris, S. W. AU - Xue, L. AU - Ma, Z. AU - Kinney, M. C. DA - May DO - 10.1046/j.1365-2141.2001.02574.x DP - NLM ET - 2001/06/14 IS - 2 LA - eng N1 - Morris, S W Xue, L Ma, Z Kinney, M C CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States CA76301/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review England Br J Haematol. 2001 May;113(2):275-95. doi: 10.1046/j.1365-2141.2001.02574.x. PY - 2001 SN - 0007-1048 (Print) 0007-1048 SP - 275-95 ST - Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma T2 - Br J Haematol TI - Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma VL - 113 ID - 138 ER - TY - JOUR AD - Department of Pathology, Center for Human Molecular Genetics, 983135 University of Nebraska Medical Center, Omaha, NE 68198, USA. jbridge@unmc.edu AN - 11485898 AU - Bridge, J. A. AU - Kanamori, M. AU - Ma, Z. AU - Pickering, D. AU - Hill, D. A. AU - Lydiatt, W. AU - Lui, M. Y. AU - Colleoni, G. W. AU - Antonescu, C. R. AU - Ladanyi, M. AU - Morris, S. W. C2 - PMC1850566 DA - Aug DO - 10.1016/s0002-9440(10)61711-7 DP - NLM ET - 2001/08/04 IS - 2 LA - eng N1 - 1525-2191 Bridge, J A Kanamori, M Ma, Z Pickering, D Hill, D A Lydiatt, W Lui, M Y Colleoni, G W Antonescu, C R Ladanyi, M Morris, S W R01 CA069129/CA/NCI NIH HHS/United States CA21765/CA/NCI NIH HHS/United States P30 CA021765/CA/NCI NIH HHS/United States P30 CA036727/CA/NCI NIH HHS/United States P30 CA36727/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Am J Pathol. 2001 Aug;159(2):411-5. doi: 10.1016/S0002-9440(10)61711-7. PY - 2001 SN - 0002-9440 (Print) 0002-9440 SP - 411-5 ST - Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor T2 - Am J Pathol TI - Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor VL - 159 ID - 139 ER - TY - JOUR AD - Section of Pediatric Hematology/Oncology, Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO 80262, USA. AN - 11493472 AU - Meech, S. J. AU - McGavran, L. AU - Odom, L. F. AU - Liang, X. AU - Meltesen, L. AU - Gump, J. AU - Wei, Q. AU - Carlsen, S. AU - Hunger, S. P. DA - Aug 15 DO - 10.1182/blood.v98.4.1209 DP - NLM ET - 2001/08/09 IS - 4 LA - eng N1 - Meech, S J McGavran, L Odom, L F Liang, X Meltesen, L Gump, J Wei, Q Carlsen, S Hunger, S P CA 46934/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 2001 Aug 15;98(4):1209-16. doi: 10.1182/blood.v98.4.1209. PY - 2001 SN - 0006-4971 (Print) 0006-4971 SP - 1209-16 ST - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion T2 - Blood TI - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion VL - 98 ID - 140 ER - TY - JOUR AD - Department of Cell Metabolism, National Institute of Haematology and Immunology, Budapest, Hungary. AN - 11583024 AU - Kolonics, A. AU - Apáti, A. AU - Nahajevszky, S. AU - Gáti, R. AU - Brózik, A. AU - Magócsi, M. DO - 10.1163/15685590152492936 DP - NLM ET - 2001/10/05 IS - 2 LA - eng N1 - Kolonics, A Apáti, A Nahajevszky, S Gáti, R Brózik, A Magócsi, M Journal Article Research Support, Non-U.S. Gov't Netherlands Haematologia (Budap). 2001;31(2):125-38. doi: 10.1163/15685590152492936. PY - 2001 SN - 0017-6559 (Print) 0017-6559 SP - 125-38 ST - Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia T2 - Haematologia (Budap) TI - Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia VL - 31 ID - 141 ER - TY - JOUR AD - Lauren V. Ackerman Division of Surgical Pathology, Washington University School of Medicine, St. Louis, Missouri, USA. AN - 11684952 AU - Cook, J. R. AU - Dehner, L. P. AU - Collins, M. H. AU - Ma, Z. AU - Morris, S. W. AU - Coffin, C. M. AU - Hill, D. A. DA - Nov DO - 10.1097/00000478-200111000-00003 DP - NLM ET - 2001/10/31 IS - 11 LA - eng N1 - Cook, J R Dehner, L P Collins, M H Ma, Z Morris, S W Coffin, C M Hill, D A CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Am J Surg Pathol. 2001 Nov;25(11):1364-71. doi: 10.1097/00000478-200111000-00003. PY - 2001 SN - 0147-5185 (Print) 0147-5185 SP - 1364-71 ST - Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study T2 - Am J Surg Pathol TI - Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study VL - 25 ID - 142 ER - TY - JOUR AD - Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada. mmayne@cc.umanitoba.ca AN - 11689646 AU - Mayne, M. AU - Cheadle, C. AU - Soldan, S. S. AU - Cermelli, C. AU - Yamano, Y. AU - Akhyani, N. AU - Nagel, J. E. AU - Taub, D. D. AU - Becker, K. G. AU - Jacobson, S. C2 - PMC114751 DA - Dec DO - 10.1128/jvi.75.23.11641-11650.2001 DP - NLM ET - 2001/11/02 IS - 23 LA - eng N1 - 1098-5514 Mayne, M Cheadle, C Soldan, S S Cermelli, C Yamano, Y Akhyani, N Nagel, J E Taub, D D Becker, K G Jacobson, S Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. J Virol. 2001 Dec;75(23):11641-50. doi: 10.1128/JVI.75.23.11641-11650.2001. PY - 2001 SN - 0022-538X (Print) 0022-538x SP - 11641-50 ST - Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms T2 - J Virol TI - Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms VL - 75 ID - 143 ER - TY - JOUR AD - Department of Lymphoma-Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. AN - 11697652 AU - Herling, M. AU - Rassidakis, G. Z. AU - Viviani, S. AU - Bonfante, V. AU - Giardini, R. AU - Gianni, M. AU - Morris, S. W. AU - Cabanillas, F. AU - Medeiros, L. J. AU - Sarris, A. H. DA - Sep-Oct DO - 10.3109/10428190109097716 DP - NLM ET - 2001/11/08 IS - 5 LA - eng N1 - Herling, M Rassidakis, G Z Viviani, S Bonfante, V Giardini, R Gianni, M Morris, S W Cabanillas, F Medeiros, L J Sarris, A H Journal Article United States Leuk Lymphoma. 2001 Sep-Oct;42(5):969-79. doi: 10.3109/10428190109097716. PY - 2001 SN - 1042-8194 (Print) 1026-8022 SP - 969-79 ST - Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients T2 - Leuk Lymphoma TI - Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients VL - 42 ID - 144 ER - TY - JOUR AD - Department of Pathology, BC Research Institute for Children's and Women's Health, Vancouver, British Columbia, V6H 3V4. AN - 11751416 AU - Tognon, C. AU - Garnett, M. AU - Kenward, E. AU - Kay, R. AU - Morrison, K. AU - Sorensen, P. H. DA - Dec 15 DP - NLM ET - 2001/12/26 IS - 24 LA - eng N1 - Tognon, C Garnett, M Kenward, E Kay, R Morrison, K Sorensen, P H U01-CA88199/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Cancer Res. 2001 Dec 15;61(24):8909-16. PY - 2001 SN - 0008-5472 (Print) 0008-5472 SP - 8909-16 ST - The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation T2 - Cancer Res TI - The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation VL - 61 ID - 145 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. d.w.hommes@amc.uva.nl AN - 11781274 AU - Hommes, D. AU - van den Blink, B. AU - Plasse, T. AU - Bartelsman, J. AU - Xu, C. AU - Macpherson, B. AU - Tytgat, G. AU - Peppelenbosch, M. AU - Van Deventer, S. DA - Jan DO - 10.1053/gast.2002.30770 DP - NLM ET - 2002/01/10 IS - 1 LA - eng N1 - Hommes, Daan van den Blink, Bernt Plasse, Terry Bartelsman, Joep Xu, Cuiping Macpherson, Bret Tytgat, Guido Peppelenbosch, Mailkel Van Deventer, Sander Clinical Trial Journal Article Randomized Controlled Trial United States Gastroenterology. 2002 Jan;122(1):7-14. doi: 10.1053/gast.2002.30770. PY - 2002 SN - 0016-5085 (Print) 0016-5085 SP - 7-14 ST - Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease T2 - Gastroenterology TI - Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease VL - 122 ID - 146 ER - TY - JOUR AD - Department of Pathology, University of Colorado School of Medicine, Denver, USA. AN - 11863224 AU - Liang, X. AU - Golitz, L. E. AU - Smoller, B. R. AU - Meech, S. J. AU - Odom, L. F. AU - Williams, S. A. AU - Ryder, J. W. DA - Feb DO - 10.1309/trw0-kxwv-qwg0-9xdf DP - NLM ET - 2002/02/28 IS - 2 LA - eng N1 - Liang, Xiayuan Golitz, Loren E Smoller, Bruce R Meech, Sandra J Odom, Lorrie F Williams, Sara A Ryder, John W Comparative Study Journal Article England Am J Clin Pathol. 2002 Feb;117(2):276-82. doi: 10.1309/trw0-kxwv-qwg0-9xdf. PY - 2002 SN - 0002-9173 (Print) 0002-9173 SP - 276-82 ST - Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma T2 - Am J Clin Pathol TI - Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma VL - 117 ID - 147 ER - TY - JOUR AD - Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA. AN - 12060576 AU - Kerby, G. S. AU - Cottin, V. AU - Accurso, F. J. AU - Hoffmann, F. AU - Chan, E. D. AU - Fadok, V. A. AU - Riches, D. W. DA - Jul DO - 10.1152/ajplung.00263.2001 DP - NLM ET - 2002/06/13 IS - 1 LA - eng N1 - Kerby, Gwendolyn S Cottin, Vincent Accurso, Frank J Hoffmann, Fukun Chan, Edward D Fadok, Valerie A Riches, David W H HL-65326/HL/NHLBI NIH HHS/United States MO1-RR00069/RR/NCRR NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Am J Physiol Lung Cell Mol Physiol. 2002 Jul;283(1):L188-97. doi: 10.1152/ajplung.00263.2001. PY - 2002 SN - 1040-0605 (Print) 1040-0605 SP - L188-97 ST - Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis T2 - Am J Physiol Lung Cell Mol Physiol TI - Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis VL - 283 ID - 148 ER - TY - JOUR AD - Department of Experimental Medicine, University of L'Aquila, Via Vetoio, Coppito II, 67100 L'Aquila, Italy. AN - 12186945 AU - Mauro, A. AU - Ciccarelli, C. AU - De Cesaris, P. AU - Scoglio, A. AU - Bouché, M. AU - Molinaro, M. AU - Aquino, A. AU - Zani, B. M. DA - Sep 15 DO - 10.1242/jcs.00037 DP - NLM ET - 2002/08/21 IS - Pt 18 LA - eng N1 - Mauro, Annunziata Ciccarelli, Carmela De Cesaris, Paola Scoglio, Arianna Bouché, Marina Molinaro, Mario Aquino, Angelo Zani, Bianca Maria Journal Article Research Support, Non-U.S. Gov't England J Cell Sci. 2002 Sep 15;115(Pt 18):3587-99. doi: 10.1242/jcs.00037. PY - 2002 SN - 0021-9533 (Print) 0021-9533 SP - 3587-99 ST - PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells T2 - J Cell Sci TI - PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells VL - 115 ID - 149 ER - TY - JOUR AD - Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996, USA. hmsch@utk.edu AN - 12494489 AU - Schuller, H. M. AU - Plummer, H. K., 3rd AU - Jull, B. A. DA - Jan DO - 10.1002/ar.a.10019 DP - NLM ET - 2002/12/21 IS - 1 LA - eng N1 - Schuller, Hildegard M Plummer, Howard K 3rd Jull, Brian A Journal Article Review United States Anat Rec A Discov Mol Cell Evol Biol. 2003 Jan;270(1):51-8. doi: 10.1002/ar.a.10019. PY - 2003 SN - 1552-4884 (Print) 1552-4884 SP - 51-8 ST - Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells T2 - Anat Rec A Discov Mol Cell Evol Biol TI - Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells VL - 270 ID - 150 ER - TY - JOUR AD - Division of Hematology-Medical Oncology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. AN - 12512384 AU - Beeram, M. AU - Patnaik, A. DA - Oct DO - 10.1016/s0889-8588(02)00054-0 DP - NLM ET - 2003/01/07 IS - 5 LA - eng N1 - Beeram, Muralidhar Patnaik, Amita Journal Article Review United States Hematol Oncol Clin North Am. 2002 Oct;16(5):1089-100. doi: 10.1016/s0889-8588(02)00054-0. PY - 2002 SN - 0889-8588 (Print) 0889-8588 SP - 1089-100 ST - Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics T2 - Hematol Oncol Clin North Am TI - Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics VL - 16 ID - 151 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA. AN - 12661011 AU - Ma, Z. AU - Hill, D. A. AU - Collins, M. H. AU - Morris, S. W. AU - Sumegi, J. AU - Zhou, M. AU - Zuppan, C. AU - Bridge, J. A. DA - May DO - 10.1002/gcc.10177 DP - NLM ET - 2003/03/28 IS - 1 LA - eng N1 - Ma, Zhigui Hill, D Ashley Collins, Margaret H Morris, Stephan W Sumegi, Janos Zhou, Ming Zuppan, Craig Bridge, Julia A CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States P30 CA36727/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Genes Chromosomes Cancer. 2003 May;37(1):98-105. doi: 10.1002/gcc.10177. PY - 2003 SN - 1045-2257 (Print) 1045-2257 SP - 98-105 ST - Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor T2 - Genes Chromosomes Cancer TI - Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor VL - 37 ID - 152 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. AN - 12709419 AU - Calabrese, C. AU - Frank, A. AU - Maclean, K. AU - Gilbertson, R. DA - Jul 4 DO - 10.1074/jbc.M211600200 DP - NLM ET - 2003/04/24 IS - 27 LA - eng N1 - Calabrese, Christopher Frank, Adrian Maclean, Kirsteen Gilbertson, Richard CA 21765/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States J Biol Chem. 2003 Jul 4;278(27):24951-9. doi: 10.1074/jbc.M211600200. Epub 2003 Apr 22. PY - 2003 SN - 0021-9258 (Print) 0021-9258 SP - 24951-9 ST - Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM T2 - J Biol Chem TI - Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM VL - 278 ID - 153 ER - TY - JOUR AD - Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. AN - 12713619 AU - Yamamoto, H. AU - Oda, Y. AU - Saito, T. AU - Sakamoto, A. AU - Miyajima, K. AU - Tamiya, S. AU - Tsuneyoshi, M. DA - May DO - 10.1046/j.1365-2559.2003.01611.x DP - NLM ET - 2003/04/26 IS - 5 LA - eng N1 - Yamamoto, H Oda, Y Saito, T Sakamoto, A Miyajima, K Tamiya, S Tsuneyoshi, M Journal Article Research Support, Non-U.S. Gov't England Histopathology. 2003 May;42(5):431-9. doi: 10.1046/j.1365-2559.2003.01611.x. PY - 2003 SN - 0309-0167 (Print) 0309-0167 SP - 431-9 ST - p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours T2 - Histopathology TI - p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours VL - 42 ID - 154 ER - TY - JOUR AD - Department of Plastic and Reconstructive Surgery, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4, Sakamoto, Nagasaki 852-8523, Japan. AN - 12787120 AU - Daian, T. AU - Ohtsuru, A. AU - Rogounovitch, T. AU - Ishihara, H. AU - Hirano, A. AU - Akiyama-Uchida, Y. AU - Saenko, V. AU - Fujii, T. AU - Yamashita, S. DA - Jun DO - 10.1046/j.1523-1747.2003.12143.x DP - NLM ET - 2003/06/06 IS - 6 LA - eng N1 - Daian, Takehiro Ohtsuru, Akira Rogounovitch, Tatiana Ishihara, Hiroshi Hirano, Akiyoshi Akiyama-Uchida, Yuri Saenko, Vladimir Fujii, Tohru Yamashita, Shunichi Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2003 Jun;120(6):956-62. doi: 10.1046/j.1523-1747.2003.12143.x. PY - 2003 SN - 0022-202X (Print) 0022-202x SP - 956-62 ST - Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts T2 - J Invest Dermatol TI - Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts VL - 120 ID - 155 ER - TY - JOUR AD - Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, , Japan. AN - 12787312 AU - Hisaoka, M. AU - Shimajiri, S. AU - Matsuki, Y. AU - Meis-Kindblom, J. M. AU - Kindblom, L. G. AU - Li, X. Q. AU - Wang, J. AU - Hashimoto, H. DA - Jun DO - 10.1046/j.1440-1827.2003.01484.x DP - NLM ET - 2003/06/06 IS - 6 LA - eng N1 - Hisaoka, Masanori Shimajiri, Shohei Matsuki, Yasumasa Meis-Kindblom, Jeanne M Kindblom, Lars-Gunnar Li, Xiao-Qiu Wang, Jian Hashimoto, Hiroshi Journal Article Research Support, Non-U.S. Gov't Australia Pathol Int. 2003 Jun;53(6):376-81. doi: 10.1046/j.1440-1827.2003.01484.x. PY - 2003 SN - 1320-5463 (Print) 1320-5463 SP - 376-81 ST - Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype T2 - Pathol Int TI - Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype VL - 53 ID - 156 ER - TY - JOUR AD - Department of Pathology, St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA. mihaela.onciu@stjude.org AN - 12816858 AU - Onciu, M. AU - Behm, F. G. AU - Downing, J. R. AU - Shurtleff, S. A. AU - Raimondi, S. C. AU - Ma, Z. AU - Morris, S. W. AU - Kennedy, W. AU - Jones, S. C. AU - Sandlund, J. T. DA - Oct 1 DO - 10.1182/blood-2003-04-1095 DP - NLM ET - 2003/06/21 IS - 7 LA - eng N1 - Onciu, Mihaela Behm, Frederick G Downing, James R Shurtleff, Sheila A Raimondi, Susana C Ma, Zhigui Morris, Stephan W Kennedy, Wren Jones, Sandra C Sandlund, John T CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 2003 Oct 1;102(7):2642-4. doi: 10.1182/blood-2003-04-1095. Epub 2003 Jun 19. PY - 2003 SN - 0006-4971 (Print) 0006-4971 SP - 2642-4 ST - ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases T2 - Blood TI - ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases VL - 102 ID - 157 ER - TY - JOUR AD - Department of Pathology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA. AN - 12894500 AU - Paner, G. P. AU - Silberman, S. AU - Hartman, G. AU - Micetich, K. C. AU - Aranha, G. V. AU - Alkan, S. DA - May-Jun DP - NLM ET - 2003/08/05 IS - 3b LA - eng N1 - Paner, Gladell P Silberman, Simone Hartman, Grace Micetich, Kenneth C Aranha, Gerard V Alkan, Serhan Journal Article Greece Anticancer Res. 2003 May-Jun;23(3B):2253-60. PY - 2003 SN - 0250-7005 (Print) 0250-7005 SP - 2253-60 ST - Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors T2 - Anticancer Res TI - Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors VL - 23 ID - 158 ER - TY - JOUR AD - Departments of Surgery, Sections of Cardiac and Vascular Surgery, Washington University School of Medicine, 9901 Wohl Hospital, 4960 Children's Place, St. Louis, MO 63110, USA. AN - 12928630 AU - Absi, T. S. AU - Sundt, T. M., 3rd AU - Tung, W. S. AU - Moon, M. AU - Lee, J. K. AU - Damiano, R. R., Jr. AU - Thompson, R. W. DA - Aug DO - 10.1016/s0022-5223(02)73576-9 DP - NLM ET - 2003/08/21 IS - 2 LA - eng N1 - Absi, Tarek S Sundt, Thoralf M 3rd Tung, William S Moon, Marc Lee, Jason K Damiano, Ralph R Jr Thompson, Robert W HL 64332/HL/NHLBI NIH HHS/United States HL 64333/HL/NHLBI NIH HHS/United States Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S. Validation Study United States J Thorac Cardiovasc Surg. 2003 Aug;126(2):344-57; discission 357. doi: 10.1016/s0022-5223(02)73576-9. PY - 2003 SN - 0022-5223 (Print) 0022-5223 SP - 344-57; discission 357 ST - Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease T2 - J Thorac Cardiovasc Surg TI - Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease VL - 126 ID - 159 ER - TY - JOUR AD - Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China. AN - 12930919 AU - Liu, E. AU - Law, H. K. AU - Lau, Y. L. DA - Dec DO - 10.1203/01.Pdr.0000088067.04673.1b DP - NLM ET - 2003/08/22 IS - 6 LA - eng N1 - Liu, Enmei Law, Helen K W Lau, Yu-Lung Journal Article Research Support, Non-U.S. Gov't United States Pediatr Res. 2003 Dec;54(6):919-25. doi: 10.1203/01.PDR.0000088067.04673.1B. Epub 2003 Aug 20. PY - 2003 SN - 0031-3998 (Print) 0031-3998 SP - 919-25 ST - Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways T2 - Pediatr Res TI - Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways VL - 54 ID - 160 ER - TY - JOUR AD - Center for Human Genetics, Catholic University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. Maria.Debiec-Rychter@med.kuleuven.ac.be AN - 12937132 AU - Debiec-Rychter, M. AU - Croes, R. AU - De Vos, R. AU - Marynen, P. AU - Roskams, T. AU - Hagemeijer, A. AU - Lombaerts, R. AU - Sciot, R. C2 - PMC1868245 DA - Sep DO - 10.1016/s0002-9440(10)63451-7 DP - NLM ET - 2003/08/26 IS - 3 LA - eng N1 - 1525-2191 Debiec-Rychter, Maria Croes, Romaric De Vos, Rita Marynen, Peter Roskams, Tania Hagemeijer, Anne Lombaerts, Rita Sciot, Raf Case Reports Journal Article Research Support, Non-U.S. Gov't Am J Pathol. 2003 Sep;163(3):913-22. doi: 10.1016/S0002-9440(10)63451-7. PY - 2003 SN - 0002-9440 (Print) 0002-9440 SP - 913-22 ST - Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor T2 - Am J Pathol TI - Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor VL - 163 ID - 161 ER - TY - JOUR AD - Dept of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy. secchier@mail.umbi.umd.edu AN - 12969966 AU - Secchiero, P. AU - Melloni, E. AU - Heikinheimo, M. AU - Mannisto, S. AU - Di Pietro, R. AU - Iacone, A. AU - Zauli, G. DA - Jan 15 DO - 10.1182/blood-2003-06-2137 DP - NLM ET - 2003/09/13 IS - 2 LA - eng N1 - Secchiero, Paola Melloni, Elisabetta Heikinheimo, Markku Mannisto, Susanna Di Pietro, Roberta Iacone, Antonio Zauli, Giorgio Journal Article Research Support, Non-U.S. Gov't United States Blood. 2004 Jan 15;103(2):517-22. doi: 10.1182/blood-2003-06-2137. Epub 2003 Sep 11. PY - 2004 SN - 0006-4971 (Print) 0006-4971 SP - 517-22 ST - TRAIL regulates normal erythroid maturation through an ERK-dependent pathway T2 - Blood TI - TRAIL regulates normal erythroid maturation through an ERK-dependent pathway VL - 103 ID - 162 ER - TY - JOUR AD - Dept of Pathology, St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA. AN - 14560573 AU - Onciu, M. AU - Behm, F. G. AU - Raimondi, S. C. AU - Moore, S. AU - Harwood, E. L. AU - Pui, C. H. AU - Sandlund, J. T. DA - Oct DO - 10.1309/wh8p-nu9p-k4rr-v852 DP - NLM ET - 2003/10/17 IS - 4 LA - eng N1 - Onciu, Mihaela Behm, Frederick G Raimondi, Susana C Moore, Sheila Harwood, Emma L Pui, Ching-Hon Sandlund, John T CA-21765/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review England Am J Clin Pathol. 2003 Oct;120(4):617-25. doi: 10.1309/WH8P-NU9P-K4RR-V852. PY - 2003 SN - 0002-9173 (Print) 0002-9173 SP - 617-25 ST - ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature T2 - Am J Clin Pathol TI - ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature VL - 120 ID - 163 ER - TY - JOUR AD - Department of Biological Sciences and the Center for Gene Structure and Function, Hunter College of the City University of New York, Graduate Center of the City University of New York, New York, New York 10021, USA. AN - 14635193 AU - Nie, K. AU - Henderson, A. DA - Dec 15 DO - 10.1002/jcb.10704 DP - NLM ET - 2003/11/25 IS - 6 LA - eng N1 - Nie, K Henderson, A RR-03037/RR/NCRR NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States J Cell Biochem. 2003 Dec 15;90(6):1197-206. doi: 10.1002/jcb.10704. PY - 2003 SN - 0730-2312 (Print) 0730-2312 SP - 1197-206 ST - MAP kinase activation in cells exposed to a 60 Hz electromagnetic field T2 - J Cell Biochem TI - MAP kinase activation in cells exposed to a 60 Hz electromagnetic field VL - 90 ID - 164 ER - TY - JOUR AD - Gonda Department of Cell and Molecular Biology, House Ear Institute, University of Southern California, Los Angeles, CA 90057, USA. AN - 14993593 AU - Watanabe, T. AU - Jono, H. AU - Han, J. AU - Lim, D. J. AU - Li, J. D. C2 - PMC373502 DA - Mar 9 DO - 10.1073/pnas.0400557101 DP - NLM ET - 2004/03/03 IS - 10 LA - eng N1 - 1091-6490 Watanabe, Takahiro Jono, Hirofumi Han, Jiahuai Lim, David J Li, Jian-Dong DC005843/DC/NIDCD NIH HHS/United States R01 DC004562/DC/NIDCD NIH HHS/United States R01 DC005843/DC/NIDCD NIH HHS/United States R01 HL070293/HL/NHLBI NIH HHS/United States HL070293/HL/NHLBI NIH HHS/United States DC004562/DC/NIDCD NIH HHS/United States Journal Article Research Support, U.S. Gov't, P.H.S. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3563-8. doi: 10.1073/pnas.0400557101. Epub 2004 Mar 1. PY - 2004 SN - 0027-8424 (Print) 0027-8424 SP - 3563-8 ST - Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha T2 - Proc Natl Acad Sci U S A TI - Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha VL - 101 ID - 165 ER - TY - JOUR AD - Ludwig Institute for Cancer Research, Melbourne, Australia. AN - 15000491 AU - Hirokawa, Y. AU - Tikoo, A. AU - Huynh, J. AU - Utermark, T. AU - Hanemann, C. O. AU - Giovannini, M. AU - Xiao, G. H. AU - Testa, J. R. AU - Wood, J. AU - Maruta, H. DA - Jan-Feb DO - 10.1097/00130404-200401000-00006 DP - NLM ET - 2004/03/06 IS - 1 LA - eng N1 - Hirokawa, Yumiko Tikoo, Anjali Huynh, John Utermark, Tamara Hanemann, C Oliver Giovannini, Marco Xiao, Guang-Hui Testa, Joseph R Wood, John Maruta, Hiroshi CA45745/CA/NCI NIH HHS/United States Journal Article Research Support, U.S. Gov't, P.H.S. United States Cancer J. 2004 Jan-Feb;10(1):20-6. doi: 10.1097/00130404-200401000-00006. PY - 2004 SN - 1528-9117 (Print) 1528-9117 SP - 20-6 ST - A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor T2 - Cancer J TI - A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor VL - 10 ID - 166 ER - TY - JOUR AD - Department of Pathology, University of Colorado School of Medicine, Denver, USA. AN - 15080301 AU - Liang, X. AU - Meech, S. J. AU - Odom, L. F. AU - Bitter, M. A. AU - Ryder, J. W. AU - Hunger, S. P. AU - Lovell, M. A. AU - Meltesen, L. AU - Wei, Q. AU - Williams, S. A. AU - Hutchinson, R. N. AU - McGavran, L. DA - Apr DO - 10.1309/tle8-fn6e-yf0n-jgp7 DP - NLM ET - 2004/04/15 IS - 4 LA - eng N1 - Liang, Xiayuan Meech, Sandra J Odom, Lorrie F Bitter, Mitchell A Ryder, John W Hunger, Stephen P Lovell, Mark A Meltesen, Lynn Wei, Qi Williams, Sara A Hutchinson, Rebecca N McGavran, Loris Comparative Study Journal Article England Am J Clin Pathol. 2004 Apr;121(4):496-506. doi: 10.1309/TLE8-FN6E-YF0N-JGP7. PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 496-506 ST - Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma T2 - Am J Clin Pathol TI - Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma VL - 121 ID - 167 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, University of Cincinnati, 231 Albert Sabin Way, P.O. Box 670529, Cincinnati, OH 45267 0529, USA. yuri.nikiforov@uc.edu AN - 15145515 AU - Nikiforova, M. N. AU - Ciampi, R. AU - Salvatore, G. AU - Santoro, M. AU - Gandhi, M. AU - Knauf, J. A. AU - Thomas, G. A. AU - Jeremiah, S. AU - Bogdanova, T. I. AU - Tronko, M. D. AU - Fagin, J. A. AU - Nikiforov, Y. E. DA - Jun 8 DO - 10.1016/j.canlet.2003.12.004 DP - NLM ET - 2004/05/18 IS - 1 LA - eng N1 - Nikiforova, Marina N Ciampi, Raffaele Salvatore, Giuliana Santoro, Massimo Gandhi, Manoj Knauf, Jeffrey A Thomas, Gerry A Jeremiah, Stephen Bogdanova, Tatyana I Tronko, Mykola D Fagin, James A Nikiforov, Yuri E CA50706/CA/NCI NIH HHS/United States M01 RR08084/RR/NCRR NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Ireland Cancer Lett. 2004 Jun 8;209(1):1-6. doi: 10.1016/j.canlet.2003.12.004. PY - 2004 SN - 0304-3835 (Print) 0304-3835 SP - 1-6 ST - Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas T2 - Cancer Lett TI - Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas VL - 209 ID - 168 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA. AN - 15151211 AU - Nascimento, A. F. AU - Pinkus, J. L. AU - Pinkus, G. S. DA - May DO - 10.1309/gq2r-lndw-lb9w-y6uu DP - NLM ET - 2004/05/21 IS - 5 LA - eng N1 - Nascimento, Alessandra F Pinkus, Jack L Pinkus, Geraldine S Journal Article England Am J Clin Pathol. 2004 May;121(5):709-17. doi: 10.1309/GQ2R-LNDW-LB9W-Y6UU. PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 709-17 ST - Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms T2 - Am J Clin Pathol TI - Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms VL - 121 ID - 169 ER - TY - JOUR AD - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. AN - 15166029 AU - Brown, P. AU - Meshinchi, S. AU - Levis, M. AU - Alonzo, T. A. AU - Gerbing, R. AU - Lange, B. AU - Arceci, R. AU - Small, D. DA - Sep 15 DO - 10.1182/blood-2004-03-1034 DP - NLM ET - 2004/05/29 IS - 6 LA - eng N1 - Brown, Patrick Meshinchi, Soheil Levis, Mark Alonzo, Todd A Gerbing, Robert Lange, Beverly Arceci, Robert Small, Donald CA095600/CA/NCI NIH HHS/United States CA102624/CA/NCI NIH HHS/United States CA60441/CA/NCI NIH HHS/United States CA70970/CA/NCI NIH HHS/United States CA90668/CA/NCI NIH HHS/United States CA91177/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. PY - 2004 SN - 0006-4971 (Print) 0006-4971 SP - 1841-9 ST - Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition T2 - Blood TI - Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition VL - 104 ID - 170 ER - TY - JOUR AD - Department of Pediatrics, Pediatric Nephrology Unit, Karolinska University Hospital-Huddinge, Stockholm, Sweden. ming.chen@klinvet.ki.se AN - 15195252 AU - Chen, M. AU - Bao, W. AU - Aizman, R. AU - Huang, P. AU - Aspevall, O. AU - Gustafsson, L. E. AU - Ceccatelli, S. AU - Celsi, G. DA - Jul 1 DO - 10.1086/421243 DP - NLM ET - 2004/06/15 IS - 1 LA - eng N1 - Chen, Ming Bao, Wenjie Aizman, Roman Huang, Ping Aspevall, Olle Gustafsson, Lars E Ceccatelli, Sandra Celsi, Gianni Journal Article Research Support, Non-U.S. Gov't United States J Infect Dis. 2004 Jul 1;190(1):127-35. doi: 10.1086/421243. Epub 2004 Jun 2. PY - 2004 SN - 0022-1899 (Print) 0022-1899 SP - 127-35 ST - Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1 T2 - J Infect Dis TI - Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1 VL - 190 ID - 171 ER - TY - JOUR AD - Departments of Dermatology and Faculty of Medicine, University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan. simazuk-tky@umin.ac.jp AN - 15214912 AU - Sasaki, K. AU - Sugaya, M. AU - Fujita, H. AU - Takeuchi, K. AU - Torii, H. AU - Asahina, A. AU - Tamaki, K. DA - Jun DO - 10.1111/j.1365-2133.2004.05987.x DP - NLM ET - 2004/06/25 IS - 6 LA - eng N1 - Sasaki, K Sugaya, M Fujita, H Takeuchi, K Torii, H Asahina, A Tamaki, K Case Reports Journal Article England Br J Dermatol. 2004 Jun;150(6):1202-7. doi: 10.1111/j.1365-2133.2004.05987.x. PY - 2004 SN - 0007-0963 (Print) 0007-0963 SP - 1202-7 ST - A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation T2 - Br J Dermatol TI - A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation VL - 150 ID - 172 ER - TY - JOUR AD - Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA. ofer.levy@childrens.harvard.edu AN - 15383597 AU - Levy, O. AU - Zarember, K. A. AU - Roy, R. M. AU - Cywes, C. AU - Godowski, P. J. AU - Wessels, M. R. DA - Oct 1 DO - 10.4049/jimmunol.173.7.4627 DP - NLM ET - 2004/09/24 IS - 7 LA - eng N1 - Levy, Ofer Zarember, Kol A Roy, Rene M Cywes, Colette Godowski, Paul J Wessels, Michael R KO8AI50583/AI/NIAID NIH HHS/United States N01AI25495/AI/NIAID NIH HHS/United States Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States J Immunol. 2004 Oct 1;173(7):4627-34. doi: 10.4049/jimmunol.173.7.4627. PY - 2004 SN - 0022-1767 (Print) 0022-1767 SP - 4627-34 ST - Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848 T2 - J Immunol TI - Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848 VL - 173 ID - 173 ER - TY - JOUR AD - Department of Pathology, Buffalo General Hospital, The State University of New York, Buffalo, NY, USA. AN - 15475930 AU - Kansal, R. AU - Sait, S. N. AU - Block, A. W. AU - Ward, P. M. AU - Kelly, F. L. AU - Cheney, R. T. AU - Czuczman, M. AU - Brecher, M. L. AU - Barcos, M. DA - Feb DO - 10.1038/modpathol.3800299 DP - NLM ET - 2004/10/12 IS - 2 LA - eng N1 - Kansal, Rina Sait, Sheila N J Block, AnneMarie W Ward, Pamela M Kelly, Felicity L R Cheney, Richard T Czuczman, Myron Brecher, Martin L Barcos, Maurice Comparative Study Journal Article United States Mod Pathol. 2005 Feb;18(2):235-43. doi: 10.1038/modpathol.3800299. PY - 2005 SN - 0893-3952 (Print) 0893-3952 SP - 235-43 ST - Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology T2 - Mod Pathol TI - Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology VL - 18 ID - 174 ER - TY - JOUR AD - Department of Neuropathology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany. AN - 15517309 AU - Knobbe, C. B. AU - Reifenberger, J. AU - Reifenberger, G. DA - Dec DO - 10.1007/s00401-004-0929-9 DP - NLM ET - 2004/11/02 IS - 6 LA - eng N1 - Knobbe, Christiane B Reifenberger, Julia Reifenberger, Guido Journal Article Research Support, Non-U.S. Gov't Germany Acta Neuropathol. 2004 Dec;108(6):467-70. doi: 10.1007/s00401-004-0929-9. Epub 2004 Oct 28. PY - 2004 SN - 0001-6322 (Print) 0001-6322 SP - 467-70 ST - Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas T2 - Acta Neuropathol TI - Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas VL - 108 ID - 175 ER - TY - JOUR AD - Unità Citoistopatologia, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, Rome. AN - 15539382 AU - Branca, M. AU - Ciotti, M. AU - Santini, D. AU - Bonito, L. D. AU - Benedetto, A. AU - Giorgi, C. AU - Paba, P. AU - Favalli, C. AU - Costa, S. AU - Agarossi, A. AU - Alderisio, M. AU - Syrjänen, K. DA - Dec DO - 10.1309/vqxf-t880-jxc7-qd2w DP - NLM ET - 2004/11/13 IS - 6 LA - eng N1 - Branca, Margherita Ciotti, Marco Santini, Donatella Bonito, Luigi Di Benedetto, Arrigo Giorgi, Colomba Paba, Pierpaolo Favalli, Carterio Costa, Silvano Agarossi, Alberto Alderisio, Mauro Syrjänen, Kari HPV-Pathogen ISS Study Group Journal Article Research Support, Non-U.S. Gov't England Am J Clin Pathol. 2004 Dec;122(6):902-11. doi: 10.1309/VQXF-T880-JXC7-QD2W. PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 902-11 ST - Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer T2 - Am J Clin Pathol TI - Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer VL - 122 ID - 176 ER - TY - JOUR AD - The Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. AN - 15547749 AU - Miao, J. AU - Kusafuka, T. AU - Fukuzawa, M. DA - Dec DP - NLM ET - 2004/11/18 IS - 6 LA - eng N1 - Miao, Jiangyong Kusafuka, Takeshi Fukuzawa, Masahiro Journal Article Greece Oncol Rep. 2004 Dec;12(6):1269-72. PY - 2004 SN - 1021-335X (Print) 1021-335x SP - 1269-72 ST - Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms T2 - Oncol Rep TI - Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms VL - 12 ID - 177 ER - TY - JOUR AD - Department of Clinical Chemistry-Biochemistry, School of Medicine, University of Crete and University Hospital of Heraklion, 71110 Heraklion, Crete, Greece. christoforidou@hotmail.com AN - 15575964 AU - Christoforidou, A. V. AU - Papadaki, H. A. AU - Margioris, A. N. AU - Eliopoulos, G. D. AU - Tsatsanis, C. C2 - PMC539294 DA - Dec 3 DO - 10.1186/1476-4598-3-34 DP - NLM ET - 2004/12/04 IS - 1 LA - eng N1 - 1476-4598 Christoforidou, Anna V Papadaki, Helen A Margioris, Andrew N Eliopoulos, George D Tsatsanis, Christos Journal Article Research Support, Non-U.S. Gov't Mol Cancer. 2004 Dec 3;3(1):34. doi: 10.1186/1476-4598-3-34. PY - 2004 SN - 1476-4598 SP - 34 ST - Expression of the Tpl2/Cot oncogene in human T-cell neoplasias T2 - Mol Cancer TI - Expression of the Tpl2/Cot oncogene in human T-cell neoplasias VL - 3 ID - 178 ER - TY - JOUR AD - Department of Pathology and Microbiology, The Aga Khan University, Medical Centre, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan. AN - 15648604 AU - Noorali, S. AU - Pervez, S. AU - Yaqoob, N. AU - Moatter, T. AU - Nasir, M. I. AU - Haroon, S. AU - Hodges, E. AU - Smith, J. L. DO - 10.1016/j.prp.2004.08.004 DP - NLM ET - 2005/01/15 IS - 10 LA - eng N1 - Noorali, Samina Pervez, Shahid Yaqoob, Nausheen Moatter, Tariq Nasir, Muhammad Israr Haroon, Sarwat Hodges, Elizabeth Smith, John Lewis Journal Article Germany Pathol Res Pract. 2004;200(10):669-79. doi: 10.1016/j.prp.2004.08.004. PY - 2004 SN - 0344-0338 (Print) 0344-0338 SP - 669-79 ST - Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients T2 - Pathol Res Pract TI - Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients VL - 200 ID - 179 ER - TY - JOUR AD - Department of Pediatric Dentistry, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden. AN - 15664665 AU - Brunius, G. AU - Domeij, H. AU - Gustavsson, A. AU - Yucel-Lindberg, T. DA - Mar 30 DO - 10.1016/j.regpep.2004.09.005 DP - NLM ET - 2005/01/25 IS - 3 LA - eng N1 - Brunius, Gustaf Domeij, Helena Gustavsson, Agneta Yucel-Lindberg, Tülay Journal Article Research Support, Non-U.S. Gov't Netherlands Regul Pept. 2005 Mar 30;126(3):183-8. doi: 10.1016/j.regpep.2004.09.005. PY - 2005 SN - 0167-0115 (Print) 0167-0115 SP - 183-8 ST - Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha T2 - Regul Pept TI - Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha VL - 126 ID - 180 ER - TY - JOUR AD - Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama 700-8530, Japan. AN - 15684480 AU - Motoki, T. AU - Takami, Y. AU - Yagi, Y. AU - Tai, A. AU - Yamamoto, I. AU - Gohda, E. DA - Feb DO - 10.1248/bpb.28.260 DP - NLM ET - 2005/02/03 IS - 2 LA - eng N1 - Motoki, Takahiro Takami, Yoichiro Yagi, Yasuyuki Tai, Akihiro Yamamoto, Itaru Gohda, Eiichi Comparative Study Journal Article Japan Biol Pharm Bull. 2005 Feb;28(2):260-6. doi: 10.1248/bpb.28.260. PY - 2005 SN - 0918-6158 (Print) 0918-6158 SP - 260-6 ST - Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin T2 - Biol Pharm Bull TI - Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin VL - 28 ID - 181 ER - TY - JOUR AD - Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium. AN - 15713800 AU - De Keersmaecker, K. AU - Graux, C. AU - Odero, M. D. AU - Mentens, N. AU - Somers, R. AU - Maertens, J. AU - Wlodarska, I. AU - Vandenberghe, P. AU - Hagemeijer, A. AU - Marynen, P. AU - Cools, J. DA - Jun 15 DO - 10.1182/blood-2004-12-4897 DP - NLM ET - 2005/02/17 IS - 12 LA - eng N1 - De Keersmaecker, Kim Graux, Carlos Odero, Maria D Mentens, Nicole Somers, Riet Maertens, Johan Wlodarska, Iwona Vandenberghe, Peter Hagemeijer, Anne Marynen, Peter Cools, Jan Case Reports Journal Article Research Support, Non-U.S. Gov't United States Blood. 2005 Jun 15;105(12):4849-52. doi: 10.1182/blood-2004-12-4897. Epub 2005 Feb 15. PY - 2005 SN - 0006-4971 (Print) 0006-4971 SP - 4849-52 ST - Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32) T2 - Blood TI - Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32) VL - 105 ID - 182 ER - TY - JOUR AD - Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Westmead, New South Wales 2145, Australia. linda_bendall@wmi.usyd.edu.au AN - 15833862 AU - Bendall, L. J. AU - Baraz, R. AU - Juarez, J. AU - Shen, W. AU - Bradstock, K. F. DA - Apr 15 DO - 10.1158/0008-5472.Can-04-3402 DP - NLM ET - 2005/04/19 IS - 8 LA - eng N1 - Bendall, Linda J Baraz, Rana Juarez, Julius Shen, Wei Bradstock, Kenneth F Journal Article Research Support, Non-U.S. Gov't United States Cancer Res. 2005 Apr 15;65(8):3290-8. doi: 10.1158/0008-5472.CAN-04-3402. PY - 2005 SN - 0008-5472 (Print) 0008-5472 SP - 3290-8 ST - Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia T2 - Cancer Res TI - Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia VL - 65 ID - 183 ER - TY - JOUR AD - Division of Metabolism, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, ROC. AN - 15876154 AU - Liu, R. T. AU - Chou, F. F. AU - Wang, C. H. AU - Lin, C. L. AU - Chao, F. P. AU - Chung, J. C. AU - Huang, C. C. AU - Wang, P. W. AU - Cheng, J. T. DA - Apr DO - 10.1089/thy.2005.15.326 DP - NLM ET - 2005/05/07 IS - 4 LA - eng N1 - Liu, Rue-Tsuan Chou, Fong-Fu Wang, Chih-Hui Lin, Chang-Lin Chao, Fang-Ping Chung, Jui-Chen Huang, Chao-Cheng Wang, Pei-Wen Cheng, Jiin-Tsuey Journal Article Research Support, Non-U.S. Gov't United States Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326. PY - 2005 SN - 1050-7256 (Print) 1050-7256 SP - 326-35 ST - Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese T2 - Thyroid TI - Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese VL - 15 ID - 184 ER - TY - JOUR AD - Department of Pathology, University of Hong Kong, Queen Mary Hospital, Hong Kong. AN - 15917418 AU - Wong, C. W. AU - Fan, Y. S. AU - Chan, T. L. AU - Chan, A. S. AU - Ho, L. C. AU - Ma, T. K. AU - Yuen, S. T. AU - Leung, S. Y. C2 - PMC1770697 DA - Jun DO - 10.1136/jcp.2004.022509 DP - NLM ET - 2005/05/27 IS - 6 LA - eng N1 - 1472-4146 Wong, C W Fan, Y S Chan, T L Chan, A S W Ho, L C Ma, T K F Yuen, S T Leung, S Y Cancer Genome Project Wellcome Trust/United Kingdom Journal Article Research Support, Non-U.S. Gov't Review J Clin Pathol. 2005 Jun;58(6):640-4. doi: 10.1136/jcp.2004.022509. PY - 2005 SN - 0021-9746 (Print) 0021-9746 SP - 640-4 ST - BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs T2 - J Clin Pathol TI - BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs VL - 58 ID - 185 ER - TY - JOUR AD - Department of Cytology, General Hospital of Chania, Crete, Greece. AN - 15933425 AU - Tamiolakis, D. AU - Papadopoulos, N. AU - Venizelos, J. AU - Kakagia, D. AU - Nikolaidou, S. AU - Bolioti, S. AU - Kouskoukis, C. DA - Jun DO - 10.1159/000085475 DP - NLM ET - 2005/06/04 IS - 6-7 LA - eng N1 - Tamiolakis, Demetrio Papadopoulos, Nikolaos Venizelos, John Kakagia, Despoina Nikolaidou, Sylvia Bolioti, Sophia Kouskoukis, Constantinos Case Reports Journal Article Switzerland Onkologie. 2005 Jun;28(6-7):356-8. doi: 10.1159/000085475. Epub 2005 Jun 2. PY - 2005 SN - 0378-584X (Print) 0378-584x SP - 356-8 ST - ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma T2 - Onkologie TI - ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma VL - 28 ID - 186 ER - TY - JOUR AD - Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37332, USA. mary.ann.thompson@vanderbilt.edu AN - 15948116 AU - Thompson, M. A. AU - Stumph, J. AU - Henrickson, S. E. AU - Rosenwald, A. AU - Wang, Q. AU - Olson, S. AU - Brandt, S. J. AU - Roberts, J. AU - Zhang, X. AU - Shyr, Y. AU - Kinney, M. C. DA - May DO - 10.1016/j.humpath.2005.03.004 DP - NLM ET - 2005/06/11 IS - 5 LA - eng N1 - Thompson, Mary Ann Stumph, Jennifer Henrickson, Sarah E Rosenwald, Andreas Wang, Qifu Olson, Sandy Brandt, Stephen J Roberts, Jeremy Zhang, Xueqiong Shyr, Yu Kinney, Marsha C T32 GM007753/GM/NIGMS NIH HHS/United States Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2005 May;36(5):494-504. doi: 10.1016/j.humpath.2005.03.004. PY - 2005 SN - 0046-8177 (Print) 0046-8177 SP - 494-504 ST - Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas T2 - Hum Pathol TI - Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas VL - 36 ID - 187 ER - TY - JOUR AD - Growth Factor Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan. AN - 15972965 AU - Osajima-Hakomori, Y. AU - Miyake, I. AU - Ohira, M. AU - Nakagawara, A. AU - Nakagawa, A. AU - Sakai, R. C2 - PMC1603453 DA - Jul DO - 10.1016/s0002-9440(10)62966-5 DP - NLM ET - 2005/06/24 IS - 1 LA - eng N1 - 1525-2191 Osajima-Hakomori, Yuko Miyake, Izumi Ohira, Miki Nakagawara, Akira Nakagawa, Atsuko Sakai, Ryuichi Journal Article Research Support, Non-U.S. Gov't Am J Pathol. 2005 Jul;167(1):213-22. doi: 10.1016/S0002-9440(10)62966-5. PY - 2005 SN - 0002-9440 (Print) 0002-9440 SP - 213-22 ST - Biological role of anaplastic lymphoma kinase in neuroblastoma T2 - Am J Pathol TI - Biological role of anaplastic lymphoma kinase in neuroblastoma VL - 167 ID - 188 ER - TY - JOUR AD - Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. m.vandijk@pathol.umcn.nl AN - 16096402 AU - van Dijk, M. C. AU - Bernsen, M. R. AU - Ruiter, D. J. DA - Sep DO - 10.1097/01.pas.0000157749.18591.9e DP - NLM ET - 2005/08/13 IS - 9 LA - eng N1 - van Dijk, Marcory C R F Bernsen, Monique R Ruiter, Dirk J Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 2005 Sep;29(9):1145-51. doi: 10.1097/01.pas.0000157749.18591.9e. PY - 2005 SN - 0147-5185 (Print) 0147-5185 SP - 1145-51 ST - Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma T2 - Am J Surg Pathol TI - Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma VL - 29 ID - 189 ER - TY - JOUR AD - Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. AN - 16116481 AU - Gee, M. F. AU - Tsuchida, R. AU - Eichler-Jonsson, C. AU - Das, B. AU - Baruchel, S. AU - Malkin, D. DA - Dec 1 DO - 10.1038/sj.onc.1208939 DP - NLM ET - 2005/08/24 IS - 54 LA - eng N1 - Gee, Matthew F W Tsuchida, Rika Eichler-Jonsson, Claudia Das, Bikul Baruchel, Sylvain Malkin, David Comparative Study Journal Article Research Support, Non-U.S. Gov't England Oncogene. 2005 Dec 1;24(54):8025-37. doi: 10.1038/sj.onc.1208939. PY - 2005 SN - 0950-9232 (Print) 0950-9232 SP - 8025-37 ST - Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid T2 - Oncogene TI - Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid VL - 24 ID - 190 ER - TY - JOUR AD - Wilmer Eye Institute, Department of Otolaryngology/Head and Neck Surgery, Division of Head and Neck Cancer Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. AN - 16123397 AU - Goldenberg-Cohen, N. AU - Cohen, Y. AU - Rosenbaum, E. AU - Herscovici, Z. AU - Chowers, I. AU - Weinberger, D. AU - Pe'er, J. AU - Sidransky, D. DA - Sep DO - 10.1167/iovs.04-1449 DP - NLM ET - 2005/08/27 IS - 9 LA - eng N1 - Goldenberg-Cohen, Nitza Cohen, Yoram Rosenbaum, Eli Herscovici, Zvi Chowers, Itay Weinberger, Dov Pe'er, Jacob Sidransky, David Journal Article Research Support, Non-U.S. Gov't United States Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3027-30. doi: 10.1167/iovs.04-1449. PY - 2005 SN - 0146-0404 (Print) 0146-0404 SP - 3027-30 ST - T1799A BRAF mutations in conjunctival melanocytic lesions T2 - Invest Ophthalmol Vis Sci TI - T1799A BRAF mutations in conjunctival melanocytic lesions VL - 46 ID - 191 ER - TY - JOUR AD - Department of Biological Sciences, Institute of Cell Biology and Biosystem Technology, Rostock, Germany. thilo.papp@biologie.uni-rostock.de AN - 16179867 AU - Papp, T. AU - Schipper, H. AU - Kumar, K. AU - Schiffmann, D. AU - Zimmermann, R. DA - Oct DO - 10.1097/00008390-200510000-00008 DP - NLM ET - 2005/09/24 IS - 5 LA - eng N1 - Papp, Thilo Schipper, Holger Kumar, Krishan Schiffmann, Dietmar Zimmermann, Regina Journal Article Research Support, Non-U.S. Gov't England Melanoma Res. 2005 Oct;15(5):401-7. doi: 10.1097/00008390-200510000-00008. PY - 2005 SN - 0960-8931 (Print) 0960-8931 SP - 401-7 ST - Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi T2 - Melanoma Res TI - Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi VL - 15 ID - 192 ER - TY - JOUR AD - Department of Clinical Laboratory Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, Japan. a-hishi@dokkyomed.ac.jp AN - 16187918 AU - Hishinuma, A. AU - Fukata, S. AU - Kakudo, K. AU - Murata, Y. AU - Ieiri, T. DA - Sep DO - 10.1089/thy.2005.15.1079 DP - NLM ET - 2005/09/29 IS - 9 LA - eng N1 - Hishinuma, Akira Fukata, Shuji Kakudo, Kennichi Murata, Yoshiharu Ieiri, Tamio Journal Article United States Thyroid. 2005 Sep;15(9):1079-84. doi: 10.1089/thy.2005.15.1079. PY - 2005 SN - 1050-7256 (Print) 1050-7256 SP - 1079-84 ST - High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations T2 - Thyroid TI - High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations VL - 15 ID - 193 ER - TY - JOUR AD - Department of Neurology, Johns Hopkins University School of Medicine, MD 21205, USA. AN - 16230398 AU - Li, Y. AU - Lal, B. AU - Kwon, S. AU - Fan, X. AU - Saldanha, U. AU - Reznik, T. E. AU - Kuchner, E. B. AU - Eberhart, C. AU - Laterra, J. AU - Abounader, R. DA - Oct 15 DO - 10.1158/0008-5472.Can-05-1946 DP - NLM ET - 2005/10/19 IS - 20 LA - eng N1 - Li, Yunqing Lal, Bachchu Kwon, Sherwin Fan, Xing Saldanha, Usha Reznik, Thomas E Kuchner, Eric B Eberhart, Charles Laterra, John Abounader, Roger NS 43987/NS/NINDS NIH HHS/United States R01 NS032148/NS/NINDS NIH HHS/United States R01 NS045209/NS/NINDS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. United States Cancer Res. 2005 Oct 15;65(20):9355-62. doi: 10.1158/0008-5472.CAN-05-1946. PY - 2005 SN - 0008-5472 (Print) 0008-5472 SP - 9355-62 ST - The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy T2 - Cancer Res TI - The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy VL - 65 ID - 194 ER - TY - JOUR AD - Clinical Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, USA. AN - 16287957 AU - Sweet, K. AU - Willis, J. AU - Zhou, X. P. AU - Gallione, C. AU - Sawada, T. AU - Alhopuro, P. AU - Khoo, S. K. AU - Patocs, A. AU - Martin, C. AU - Bridgeman, S. AU - Heinz, J. AU - Pilarski, R. AU - Lehtonen, R. AU - Prior, T. W. AU - Frebourg, T. AU - Teh, B. T. AU - Marchuk, D. A. AU - Aaltonen, L. A. AU - Eng, C. DA - Nov 16 DO - 10.1001/jama.294.19.2465 DP - NLM ET - 2005/11/17 IS - 19 LA - eng N1 - 1538-3598 Sweet, Kevin Willis, Joseph Zhou, Xiao-Ping Gallione, Carol Sawada, Takeshi Alhopuro, Pia Khoo, Sok Kean Patocs, Attila Martin, Cossette Bridgeman, Scott Heinz, John Pilarski, Robert Lehtonen, Rainer Prior, Thomas W Frebourg, Thierry Teh, Bin Tean Marchuk, Douglas A Aaltonen, Lauri A Eng, Charis Journal Article Research Support, Non-U.S. Gov't United States JAMA. 2005 Nov 16;294(19):2465-73. doi: 10.1001/jama.294.19.2465. PY - 2005 SN - 0098-7484 SP - 2465-73 ST - Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis T2 - Jama TI - Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis VL - 294 ID - 195 ER - TY - JOUR AD - Laboratory of Oncology, Department of Experimental and Laboratory Medicine, G. Gaslini Institute, Genoa, Italy. irmaairoldi@ospedale-gaslini.ge.it AN - 16397027 AU - Airoldi, I. AU - Raffaghello, L. AU - Piovan, E. AU - Cocco, C. AU - Carlini, B. AU - Amadori, A. AU - Corrias, M. V. AU - Pistoia, V. DA - Jan 1 DO - 10.1158/1078-0432.Ccr-05-1376 DP - NLM ET - 2006/01/07 IS - 1 LA - eng N1 - Airoldi, Irma Raffaghello, Lizzia Piovan, Erich Cocco, Claudia Carlini, Barbara Amadori, Alberto Corrias, Maria Valeria Pistoia, Vito Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2006 Jan 1;12(1):77-82. doi: 10.1158/1078-0432.CCR-05-1376. PY - 2006 SN - 1078-0432 (Print) 1078-0432 SP - 77-82 ST - CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications T2 - Clin Cancer Res TI - CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications VL - 12 ID - 196 ER - TY - JOUR AD - Department of Dermatology, Columbia University Medical Center, New York, NY 10032, USA. AN - 16421887 AU - Lee, D. A. AU - Cohen, J. A. AU - Twaddell, W. S. AU - Palacios, G. AU - Gill, M. AU - Levit, E. AU - Halperin, A. J. AU - Mones, J. AU - Busam, K. J. AU - Silvers, D. N. AU - Celebi, J. T. DA - Feb 15 DO - 10.1002/cncr.21686 DP - NLM ET - 2006/01/20 IS - 4 LA - eng N1 - Lee, David A Cohen, Jason A Twaddell, William S Palacios, Gustavo Gill, Melissa Levit, Eyal Halperin, Alan J Mones, Joan Busam, Klaus J Silvers, David N Celebi, Julide Tok K08 AR050273/AR/NIAMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Cancer. 2006 Feb 15;106(4):907-13. doi: 10.1002/cncr.21686. PY - 2006 SN - 0008-543X (Print) 0008-543x SP - 907-13 ST - Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma T2 - Cancer TI - Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma VL - 106 ID - 197 ER - TY - JOUR AD - Comprehensive Cancer Center and Cancer Research Institute, University of California, San Francisco, CA 94115, USA. AN - 16439621 AU - Rodriguez-Viciana, P. AU - Tetsu, O. AU - Tidyman, W. E. AU - Estep, A. L. AU - Conger, B. A. AU - Cruz, M. S. AU - McCormick, F. AU - Rauen, K. A. DA - Mar 3 DO - 10.1126/science.1124642 DP - NLM ET - 2006/01/28 IS - 5765 LA - eng N1 - 1095-9203 Rodriguez-Viciana, Pablo Tetsu, Osamu Tidyman, William E Estep, Anne L Conger, Brenda A Cruz, Molly Santa McCormick, Frank Rauen, Katherine A HD048502/HD/NICHD NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Science. 2006 Mar 3;311(5765):1287-90. doi: 10.1126/science.1124642. Epub 2006 Jan 26. PY - 2006 SN - 0036-8075 SP - 1287-90 ST - Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome T2 - Science TI - Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome VL - 311 ID - 198 ER - TY - JOUR AD - Academisch Ziekenhuis, Vrije Universiteit Brussel, Department of Dermatology, Belgium. AN - 16445780 AU - De Raeve, L. E. AU - Claes, A. AU - Ruiter, D. J. AU - van Muijen, G. N. AU - Roseeuw, D. AU - van Kempen, L. C. DA - Mar DO - 10.1111/j.1365-2133.2005.07055.x DP - NLM ET - 2006/02/01 IS - 3 LA - eng N1 - De Raeve, L E Claes, A Ruiter, D J van Muijen, G N P Roseeuw, D van Kempen, L C L T Journal Article Research Support, Non-U.S. Gov't England Br J Dermatol. 2006 Mar;154(3):485-92. doi: 10.1111/j.1365-2133.2005.07055.x. PY - 2006 SN - 0007-0963 (Print) 0007-0963 SP - 485-92 ST - Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage T2 - Br J Dermatol TI - Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage VL - 154 ID - 199 ER - TY - JOUR AD - Section of Endocrinology and Metabolism, University of Illinois College of Medicine, Chicago, Illinois 60612, USA. bcollins@uic.edu AN - 16487015 AU - Collins, B. J. AU - Schneider, A. B. AU - Prinz, R. A. AU - Xu, X. DA - Jan DO - 10.1089/thy.2006.16.61 DP - NLM ET - 2006/02/21 IS - 1 LA - eng N1 - Collins, Barbara J Schneider, Arthur B Prinz, Richard A Xu, Xiulong R01 CA21518/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Thyroid. 2006 Jan;16(1):61-6. doi: 10.1089/thy.2006.16.61. PY - 2006 SN - 1050-7256 (Print) 1050-7256 SP - 61-6 ST - Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure T2 - Thyroid TI - Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure VL - 16 ID - 200 ER - TY - JOUR AD - Department of Experimental Medicine, II University of Naples, Via De Crecchio 7, 80138 Naples, Italy. AN - 16584185 AU - Galdiero, S. AU - Vitiello, M. AU - Amodeo, P. AU - D'Isanto, M. AU - Cantisani, M. AU - Pedone, C. AU - Galdiero, M. DA - Apr 11 DO - 10.1021/bi052262p DP - NLM ET - 2006/04/06 IS - 14 LA - eng N1 - Galdiero, Stefania Vitiello, Mariateresa Amodeo, Pietro D'Isanto, Marina Cantisani, Marco Pedone, Carlo Galdiero, Massimiliano Journal Article Research Support, Non-U.S. Gov't United States Biochemistry. 2006 Apr 11;45(14):4491-501. doi: 10.1021/bi052262p. PY - 2006 SN - 0006-2960 (Print) 0006-2960 SP - 4491-501 ST - Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae T2 - Biochemistry TI - Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae VL - 45 ID - 201 ER - TY - JOUR AD - Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan. AN - 16691193 AU - Ichii-Nakato, N. AU - Takata, M. AU - Takayanagi, S. AU - Takashima, S. AU - Lin, J. AU - Murata, H. AU - Fujimoto, A. AU - Hatta, N. AU - Saida, T. DA - Sep DO - 10.1038/sj.jid.5700366 DP - NLM ET - 2006/05/13 IS - 9 LA - eng N1 - Ichii-Nakato, Nami Takata, Minoru Takayanagi, Shuko Takashima, Shiho Lin, Jingrong Murata, Hiroshi Fujimoto, Akihide Hatta, Naohito Saida, Toshiaki Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2006 Sep;126(9):2111-8. doi: 10.1038/sj.jid.5700366. Epub 2006 May 11. PY - 2006 SN - 0022-202X (Print) 0022-202x SP - 2111-8 ST - High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi T2 - J Invest Dermatol TI - High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi VL - 126 ID - 202 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI 48109-0602, USA. dfullen@med.umich.edu AN - 16799476 AU - Fullen, D. R. AU - Poynter, J. N. AU - Lowe, L. AU - Su, L. D. AU - Elder, J. T. AU - Nair, R. P. AU - Johnson, T. M. AU - Gruber, S. B. DA - Oct DO - 10.1038/modpathol.3800653 DP - NLM ET - 2006/06/27 IS - 10 LA - eng N1 - Fullen, Douglas R Poynter, Jenny N Lowe, Lori Su, Lyndon D Elder, James T Nair, Rajan P Johnson, Timothy M Gruber, Stephen B T32 HG00040/HG/NHGRI NIH HHS/United States U01 CA83180/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. United States Mod Pathol. 2006 Oct;19(10):1324-32. doi: 10.1038/modpathol.3800653. Epub 2006 Jun 23. PY - 2006 SN - 0893-3952 (Print) 0893-3952 SP - 1324-32 ST - BRAF and NRAS mutations in spitzoid melanocytic lesions T2 - Mod Pathol TI - BRAF and NRAS mutations in spitzoid melanocytic lesions VL - 19 ID - 203 ER - TY - JOUR AD - Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA. landim@mail.nih.gov AN - 16809487 AU - Landi, M. T. AU - Bauer, J. AU - Pfeiffer, R. M. AU - Elder, D. E. AU - Hulley, B. AU - Minghetti, P. AU - Calista, D. AU - Kanetsky, P. A. AU - Pinkel, D. AU - Bastian, B. C. DA - Jul 28 DO - 10.1126/science.1127515 DP - NLM ET - 2006/07/01 IS - 5786 LA - eng N1 - 1095-9203 Landi, Maria Teresa Bauer, Jürgen Pfeiffer, Ruth M Elder, David E Hulley, Benjamin Minghetti, Paola Calista, Donato Kanetsky, Peter A Pinkel, Daniel Bastian, Boris C K07 CA80700/CA/NCI NIH HHS/United States P01 CA025874-25-A1/CA/NCI NIH HHS/United States R01 CA5558/CA/NCI NIH HHS/United States R01 CA94963/CA/NCI NIH HHS/United States R33 CA95300/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Science. 2006 Jul 28;313(5786):521-2. doi: 10.1126/science.1127515. Epub 2006 Jun 29. PY - 2006 SN - 0036-8075 SP - 521-2 ST - MC1R germline variants confer risk for BRAF-mutant melanoma T2 - Science TI - MC1R germline variants confer risk for BRAF-mutant melanoma VL - 313 ID - 204 ER - TY - JOUR AD - Division of Oncology, The Children's Hospital of Philadelphia; Philadelphia, PA, USA. vincent.dam@jefferson.edu AN - 16822308 AU - Dam, V. AU - Morgan, B. T. AU - Mazanek, P. AU - Hogarty, M. D. C2 - PMC1533846 DA - Jul 5 DO - 10.1186/1471-2407-6-177 DP - NLM ET - 2006/07/11 LA - eng N1 - 1471-2407 Dam, Vincent Morgan, Brian T Mazanek, Pavel Hogarty, Michael D P01 CA097323/CA/NCI NIH HHS/United States CA97323/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't BMC Cancer. 2006 Jul 5;6:177. doi: 10.1186/1471-2407-6-177. PY - 2006 SN - 1471-2407 SP - 177 ST - Mutations in PIK3CA are infrequent in neuroblastoma T2 - BMC Cancer TI - Mutations in PIK3CA are infrequent in neuroblastoma VL - 6 ID - 205 ER - TY - JOUR AD - Amgen Inc., Thousand Oaks, CA 91320-1799, USA. sross@amgen.com AN - 16945013 AU - Ross, S. AU - Chen, T. AU - Yu, V. AU - Tudor, Y. AU - Zhang, D. AU - Liu, L. AU - Tamayo, N. AU - Dominguez, C. AU - Powers, D. DA - Aug DO - 10.1089/adt.2006.4.397 DP - NLM ET - 2006/09/02 IS - 4 LA - eng N1 - Ross, Sandra Chen, Teresa Yu, Violeta Tudor, Yanyan Zhang, Dawei Liu, Longbin Tamayo, Nuria Dominguez, Celia Powers, David Journal Article United States Assay Drug Dev Technol. 2006 Aug;4(4):397-409. doi: 10.1089/adt.2006.4.397. PY - 2006 SN - 1540-658X (Print) 1540-658x SP - 397-409 ST - High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays T2 - Assay Drug Dev Technol TI - High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays VL - 4 ID - 206 ER - TY - JOUR AD - Biospectrum Life Science Institute, Gunpo City, Gyunggi Do, Republic of Korea. AN - 16959273 AU - Lee, J. AU - Jung, E. AU - Lee, J. AU - Huh, S. AU - Hwang, C. H. AU - Lee, H. Y. AU - Kim, E. J. AU - Cheon, J. M. AU - Hyun, C. G. AU - Kim, Y. S. AU - Park, D. DA - Nov 25 DO - 10.1016/j.lfs.2006.08.008 DP - NLM ET - 2006/09/09 IS - 26 LA - eng N1 - Lee, Jongsung Jung, Eunsun Lee, Jiyoung Huh, Sungran Hwang, Cheng-Hwan Lee, Hwa-Young Kim, Eun-Jung Cheon, Ji-Min Hyun, Chang Gu Kim, Yeong Shik Park, Deokhoon Journal Article Research Support, Non-U.S. Gov't Netherlands Life Sci. 2006 Nov 25;79(26):2480-5. doi: 10.1016/j.lfs.2006.08.008. Epub 2006 Aug 17. PY - 2006 SN - 0024-3205 (Print) 0024-3205 SP - 2480-5 ST - Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1) T2 - Life Sci TI - Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1) VL - 79 ID - 207 ER - TY - JOUR AD - Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. hidetaka@surgpath.med.kyushu-u.ac.jp AN - 16984614 AU - Yamamoto, H. AU - Kohashi, K. AU - Oda, Y. AU - Tamiya, S. AU - Takahashi, Y. AU - Kinoshita, Y. AU - Ishizawa, S. AU - Kubota, M. AU - Tsuneyoshi, M. DA - Oct DO - 10.1111/j.1440-1827.2006.02012.x DP - NLM ET - 2006/09/21 IS - 10 LA - eng N1 - Yamamoto, Hidetaka Kohashi, Kenichi Oda, Yoshinao Tamiya, Sadafumi Takahashi, Yukiko Kinoshita, Yoshiaki Ishizawa, Shin Kubota, Masayuki Tsuneyoshi, Masazumi Evaluation Study Journal Article Australia Pathol Int. 2006 Oct;56(10):584-90. doi: 10.1111/j.1440-1827.2006.02012.x. PY - 2006 SN - 1320-5463 (Print) 1320-5463 SP - 584-90 ST - Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene T2 - Pathol Int TI - Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene VL - 56 ID - 208 ER - TY - JOUR AD - Department of Molecular Oncology, John Wayne Cancer Institute at Saint Johns Hospital, Santa Monica, CA 90404, USA. AN - 17060774 AU - Kim, J. AU - Giuliano, A. E. AU - Turner, R. R. AU - Gaffney, R. E. AU - Umetani, N. AU - Kitago, M. AU - Elashoff, D. AU - Hoon, D. S. C2 - PMC1856588 DA - Nov DO - 10.1097/01.sla.0000224751.80858.13 DP - NLM ET - 2006/10/25 IS - 5 LA - eng N1 - 1528-1140 Kim, Joseph Giuliano, Armando E Turner, Roderick R Gaffney, Robyn E Umetani, Naoyuki Kitago, Minoru Elashoff, David Hoon, Dave S B P01 CA012582/CA/NCI NIH HHS/United States P01 CA029605/CA/NCI NIH HHS/United States CA29605/CA/NCI NIH HHS/United States P01 CA12582/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Ann Surg. 2006 Nov;244(5):799-804. doi: 10.1097/01.sla.0000224751.80858.13. PY - 2006 SN - 0003-4932 (Print) 0003-4932 SP - 799-804 ST - Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma T2 - Ann Surg TI - Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma VL - 244 ID - 209 ER - TY - JOUR AD - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555-0647, USA. AN - 17122129 AU - Pladzyk, A. AU - Reddy, A. B. AU - Yadav, U. C. AU - Tammali, R. AU - Ramana, K. V. AU - Srivastava, S. K. DA - Dec DO - 10.1167/iovs.06-0469 DP - NLM ET - 2006/11/24 IS - 12 LA - eng N1 - Pladzyk, Agnieszka Reddy, Aramati B M Yadav, Umesh C S Tammali, Ravinder Ramana, Kota V Srivastava, Satish K DK36118/DK/NIDDK NIH HHS/United States EY01677/EY/NEI NIH HHS/United States GM71036/GM/NIGMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural United States Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5395-403. doi: 10.1167/iovs.06-0469. PY - 2006 SN - 0146-0404 (Print) 0146-0404 SP - 5395-403 ST - Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells T2 - Invest Ophthalmol Vis Sci TI - Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells VL - 47 ID - 210 ER - TY - JOUR AD - Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC, 88040-900, Brazil. AN - 17333127 AU - Posser, T. AU - de Aguiar, C. B. AU - Garcez, R. C. AU - Rossi, F. M. AU - Oliveira, C. S. AU - Trentin, A. G. AU - Neto, V. M. AU - Leal, R. B. DA - Jun DO - 10.1007/s00204-007-0177-6 DP - NLM ET - 2007/03/03 IS - 6 LA - eng N1 - Posser, Thaís de Aguiar, Cláudia B N Mendes Garcez, Ricardo C Rossi, Francesco M Oliveira, Camila S Trentin, Andréa G Neto, Vivaldo Moura Leal, Rodrigo B Journal Article Research Support, Non-U.S. Gov't Germany Arch Toxicol. 2007 Jun;81(6):407-14. doi: 10.1007/s00204-007-0177-6. Epub 2007 Feb 28. PY - 2007 SN - 0340-5761 (Print) 0340-5761 SP - 407-14 ST - Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2 T2 - Arch Toxicol TI - Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2 VL - 81 ID - 211 ER - TY - JOUR AD - Department of Pediatrics, University of California, 513 Parnassus Avenue, Room HSE-302, San Francisco, California 94143, USA. AN - 17384584 AU - Schubbert, S. AU - Shannon, K. AU - Bollag, G. DA - Apr DO - 10.1038/nrc2109 DP - NLM ET - 2007/03/27 IS - 4 LA - eng N1 - Schubbert, Suzanne Shannon, Kevin Bollag, Gideon Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review England Nat Rev Cancer. 2007 Apr;7(4):295-308. doi: 10.1038/nrc2109. PY - 2007 SN - 1474-175X (Print) 1474-175x SP - 295-308 ST - Hyperactive Ras in developmental disorders and cancer T2 - Nat Rev Cancer TI - Hyperactive Ras in developmental disorders and cancer VL - 7 ID - 212 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, University Hospital of Essen, Essen, Germany. AN - 17464312 AU - Sheu, S. Y. AU - Schwertheim, S. AU - Worm, K. AU - Grabellus, F. AU - Schmid, K. W. DA - Jul DO - 10.1038/modpathol.3800797 DP - NLM ET - 2007/04/28 IS - 7 LA - eng N1 - Sheu, Sien-Yi Schwertheim, Suzan Worm, Karl Grabellus, Florian Schmid, Kurt Werner Journal Article United States Mod Pathol. 2007 Jul;20(7):779-87. doi: 10.1038/modpathol.3800797. Epub 2007 Apr 27. PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 779-87 ST - Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements T2 - Mod Pathol TI - Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements VL - 20 ID - 213 ER - TY - JOUR AD - Department of Pathology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. AN - 17464320 AU - Li, C. AU - Takino, H. AU - Eimoto, T. AU - Ishida, T. AU - Inagaki, A. AU - Ueda, R. AU - Suzuki, R. AU - Yoshino, T. AU - Nakagawa, A. AU - Nakamura, S. AU - Inagaki, H. DA - Jun DO - 10.1038/modpathol.3800781 DP - NLM ET - 2007/04/28 IS - 6 LA - eng N1 - Li, Chunmei Takino, Hisashi Eimoto, Tadaaki Ishida, Takashi Inagaki, Atsushi Ueda, Ryuzo Suzuki, Ritsuro Yoshino, Tadashi Nakagawa, Atsuko Nakamura, Shigeo Inagaki, Hiroshi Journal Article Research Support, Non-U.S. Gov't United States Mod Pathol. 2007 Jun;20(6):648-55. doi: 10.1038/modpathol.3800781. Epub 2007 Apr 20. PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 648-55 ST - Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma T2 - Mod Pathol TI - Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma VL - 20 ID - 214 ER - TY - JOUR AD - Brody School of Medicine at East Carolina University, Department of Microbiology & Immunology, Greenville, NC 27834, USA. AN - 17465719 AU - Lambert, P. J. AU - Shahrier, A. Z. AU - Whitman, A. G. AU - Dyson, O. F. AU - Reber, A. J. AU - McCubrey, J. A. AU - Akula, S. M. DA - May DO - 10.1517/14728222.11.5.589 DP - NLM ET - 2007/05/01 IS - 5 LA - eng N1 - 1744-7631 Lambert, Phelps J Shahrier, Aniqa Z Whitman, Audy G Dyson, Ossie F Reber, Adrian J McCubrey, James A Akula, Shaw M Journal Article Review England Expert Opin Ther Targets. 2007 May;11(5):589-99. doi: 10.1517/14728222.11.5.589. PY - 2007 SN - 1472-8222 SP - 589-99 ST - Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis T2 - Expert Opin Ther Targets TI - Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis VL - 11 ID - 215 ER - TY - JOUR AD - Department of Pediatrics, Asahikawa Medical College, Asahikawa, Japan. AN - 17483702 AU - Makita, Y. AU - Narumi, Y. AU - Yoshida, M. AU - Niihori, T. AU - Kure, S. AU - Fujieda, K. AU - Matsubara, Y. AU - Aoki, Y. DA - May DO - 10.1097/MPH.0b013e3180547136 DP - NLM ET - 2007/05/08 IS - 5 LA - eng N1 - Makita, Yoshio Narumi, Yoko Yoshida, Makoto Niihori, Tetsuya Kure, Shigeo Fujieda, Kenji Matsubara, Yoichi Aoki, Yoko Case Reports Journal Article Research Support, Non-U.S. Gov't United States J Pediatr Hematol Oncol. 2007 May;29(5):287-90. doi: 10.1097/MPH.0b013e3180547136. PY - 2007 SN - 1077-4114 (Print) 1077-4114 SP - 287-90 ST - Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene T2 - J Pediatr Hematol Oncol TI - Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene VL - 29 ID - 216 ER - TY - JOUR AD - Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. james_indsto@wmi.usyd.edu.au AN - 17518771 AU - Indsto, J. O. AU - Kumar, S. AU - Wang, L. AU - Crotty, K. A. AU - Arbuckle, S. M. AU - Mann, G. J. DA - Jun DO - 10.1111/j.1600-0560.2006.00646.x DP - NLM ET - 2007/05/24 IS - 6 LA - eng N1 - Indsto, James O Kumar, Swapna Wang, Lixiang Crotty, Kerry A Arbuckle, Susan M Mann, Graham J Journal Article Research Support, Non-U.S. Gov't United States J Cutan Pathol. 2007 Jun;34(6):448-55. doi: 10.1111/j.1600-0560.2006.00646.x. PY - 2007 SN - 0303-6987 (Print) 0303-6987 SP - 448-55 ST - Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions T2 - J Cutan Pathol TI - Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions VL - 34 ID - 217 ER - TY - JOUR AD - Division of Medical Genetics, A.I. duPont Hospital for Children/Nemours Childrens' Clinic, Wilmington, DE 19899, USA. kgripp@nemours.org AN - 17551924 AU - Gripp, K. W. AU - Lin, A. E. AU - Nicholson, L. AU - Allen, W. AU - Cramer, A. AU - Jones, K. L. AU - Kutz, W. AU - Peck, D. AU - Rebolledo, M. A. AU - Wheeler, P. G. AU - Wilson, W. AU - Al-Rahawan, M. M. AU - Stabley, D. L. AU - Sol-Church, K. DA - Jul 1 DO - 10.1002/ajmg.a.31815 DP - NLM ET - 2007/06/07 IS - 13 LA - eng N1 - Gripp, Karen W Lin, Angela E Nicholson, Linda Allen, William Cramer, Andrea Jones, Kenneth L Kutz, Wendy Peck, Dawn Rebolledo, Michael A Wheeler, Patricia G Wilson, William Al-Rahawan, Mohamad M Stabley, Deborah L Sol-Church, Katia P30 RR 020173-01/RR/NCRR NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Am J Med Genet A. 2007 Jul 1;143A(13):1472-80. doi: 10.1002/ajmg.a.31815. PY - 2007 SN - 1552-4825 (Print) 1552-4825 SP - 1472-80 ST - Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome T2 - Am J Med Genet A TI - Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome VL - 143a ID - 218 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Germany. AN - 17584027 AU - Flotho, C. AU - Kratz, C. AU - Niemeyer, C. M. DA - Jun DO - 10.2174/138945007780830773 DP - NLM ET - 2007/06/23 IS - 6 LA - eng N1 - 1873-5592 Flotho, Christian Kratz, Christian Niemeyer, Charlotte M Journal Article Review United Arab Emirates Curr Drug Targets. 2007 Jun;8(6):715-25. doi: 10.2174/138945007780830773. PY - 2007 SN - 1389-4501 SP - 715-25 ST - Targeting RAS signaling pathways in juvenile myelomonocytic leukemia T2 - Curr Drug Targets TI - Targeting RAS signaling pathways in juvenile myelomonocytic leukemia VL - 8 ID - 219 ER - TY - JOUR AD - Department of Biochemistry, Virginia Commonwealth University, Richmond, VA 23298, USA. stgrant@hsc.vcu.edu AN - 17584030 AU - Grant, S. AU - Dent, P. DA - Jun DO - 10.2174/138945007780830764 DP - NLM ET - 2007/06/23 IS - 6 LA - eng N1 - 1873-5592 Grant, Steven Dent, Paul CA-100866/CA/NCI NIH HHS/United States CA-63753/CA/NCI NIH HHS/United States CA-93738/CA/NCI NIH HHS/United States CA88906/CA/NCI NIH HHS/United States DK52825/DK/NIDDK NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review United Arab Emirates Curr Drug Targets. 2007 Jun;8(6):751-9. doi: 10.2174/138945007780830764. PY - 2007 SN - 1389-4501 SP - 751-9 ST - Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias T2 - Curr Drug Targets TI - Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias VL - 8 ID - 220 ER - TY - JOUR AD - Department of Pediatrics, Faculty of Pediatrics, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. AN - 17617806 AU - Hung, C. H. AU - Suen, J. L. AU - Hua, Y. M. AU - Chiang, W. AU - Chang, H. C. AU - Chen, C. N. AU - Jong, Y. J. DA - Aug DO - 10.1111/j.1399-3038.2007.00535.x DP - NLM ET - 2007/07/10 IS - 5 LA - eng N1 - Hung, Chih-Hsing Suen, Jau-Ling Hua, Yi-Ming Chiang, Wen Chang, Hui-Chiu Chen, Chun-Nan Jong, Yuh-Jyh Journal Article Research Support, Non-U.S. Gov't England Pediatr Allergy Immunol. 2007 Aug;18(5):378-84. doi: 10.1111/j.1399-3038.2007.00535.x. PY - 2007 SN - 0905-6157 (Print) 0905-6157 SP - 378-84 ST - Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes T2 - Pediatr Allergy Immunol TI - Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes VL - 18 ID - 221 ER - TY - JOUR AD - Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA. AN - 17643094 AU - Tavora, F. AU - Shilo, K. AU - Ozbudak, I. H. AU - Przybocki, J. M. AU - Wang, G. AU - Travis, W. D. AU - Franks, T. J. DA - Sep DO - 10.1038/modpathol.3800938 DP - NLM ET - 2007/07/24 IS - 9 LA - eng N1 - Tavora, Fabio Shilo, Konstantin Ozbudak, Irem H Przybocki, Jean M Wang, Guanghua Travis, William D Franks, Teri J Journal Article United States Mod Pathol. 2007 Sep;20(9):995-9. doi: 10.1038/modpathol.3800938. Epub 2007 Jul 20. PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 995-9 ST - Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases T2 - Mod Pathol TI - Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases VL - 20 ID - 222 ER - TY - JOUR AD - Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. AN - 17661820 AU - Lee, S. T. AU - Ki, C. S. AU - Lee, H. J. DA - Aug DO - 10.1111/j.1399-0004.2007.00839.x DP - NLM ET - 2007/07/31 IS - 2 LA - eng N1 - Lee, S-T Ki, C-S Lee, H J Journal Article Research Support, Non-U.S. Gov't Denmark Clin Genet. 2007 Aug;72(2):150-5. doi: 10.1111/j.1399-0004.2007.00839.x. PY - 2007 SN - 0009-9163 (Print) 0009-9163 SP - 150-5 ST - Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome T2 - Clin Genet TI - Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome VL - 72 ID - 223 ER - TY - JOUR AD - Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Polish Mother's Memorial Hospital-Research Institute, Rzgowska Street No. 281/289, 93-338 Lodz, Poland. AN - 17693984 AU - Brzeziańska, E. AU - Pastuszak-Lewandoska, D. AU - Wojciechowska, K. AU - Migdalska-Sek, M. AU - Cyniak-Magierska, A. AU - Nawrot, E. AU - Lewiński, A. DA - Aug DP - NLM ET - 2007/08/19 IS - 4 LA - eng N1 - Brzeziańska, Ewa Pastuszak-Lewandoska, Dorota Wojciechowska, Katarzyna Migdalska-Sek, Monika Cyniak-Magierska, Anna Nawrot, Ewa Lewiński, Andrzej Journal Article Sweden Neuro Endocrinol Lett. 2007 Aug;28(4):351-9. PY - 2007 SN - 0172-780X (Print) 0172-780x SP - 351-9 ST - Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population T2 - Neuro Endocrinol Lett TI - Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population VL - 28 ID - 224 ER - TY - JOUR AD - Department of Genetics, AP-HP, Hôpital Robert Debré, Paris, France. AN - 17704260 AU - Nava, C. AU - Hanna, N. AU - Michot, C. AU - Pereira, S. AU - Pouvreau, N. AU - Niihori, T. AU - Aoki, Y. AU - Matsubara, Y. AU - Arveiler, B. AU - Lacombe, D. AU - Pasmant, E. AU - Parfait, B. AU - Baumann, C. AU - Héron, D. AU - Sigaudy, S. AU - Toutain, A. AU - Rio, M. AU - Goldenberg, A. AU - Leheup, B. AU - Verloes, A. AU - Cavé, H. C2 - PMC2652823 DA - Dec DO - 10.1136/jmg.2007.050450 DP - NLM ET - 2007/08/21 IS - 12 LA - eng N1 - 1468-6244 Nava, Caroline Hanna, Nadine Michot, Caroline Pereira, Sabrina Pouvreau, Nathalie Niihori, Tetsuya Aoki, Yoko Matsubara, Yoichi Arveiler, Benoit Lacombe, Didier Pasmant, Eric Parfait, Béatrice Baumann, Clarisse Héron, Delphine Sigaudy, Sabine Toutain, Annick Rio, Marlène Goldenberg, Alice Leheup, Bruno Verloes, Alain Cavé, Hélène Journal Article Research Support, Non-U.S. Gov't J Med Genet. 2007 Dec;44(12):763-71. doi: 10.1136/jmg.2007.050450. Epub 2007 Aug 17. PY - 2007 SN - 0022-2593 (Print) 0022-2593 SP - 763-71 ST - Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome T2 - J Med Genet TI - Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome VL - 44 ID - 225 ER - TY - JOUR AD - Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. leelsn@cuhk.edu.hk AN - 17712756 AU - Lee, N. AU - Wong, C. K. AU - Chan, P. K. AU - Lun, S. W. AU - Lui, G. AU - Wong, B. AU - Hui, D. S. AU - Lam, C. W. AU - Cockram, C. S. AU - Choi, K. W. AU - Yeung, A. C. AU - Tang, J. W. AU - Sung, J. J. DA - Sep 15 DO - 10.1086/520981 DP - NLM ET - 2007/08/23 IS - 6 LA - eng N1 - 1537-6591 Lee, N Wong, C K Chan, P K S Lun, S W M Lui, G Wong, B Hui, D S C Lam, C W K Cockram, C S Choi, K W Yeung, A C M Tang, J W Sung, J J Y Journal Article Research Support, Non-U.S. Gov't United States Clin Infect Dis. 2007 Sep 15;45(6):723-31. doi: 10.1086/520981. Epub 2007 Aug 8. PY - 2007 SN - 1058-4838 SP - 723-31 ST - Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection T2 - Clin Infect Dis TI - Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection VL - 45 ID - 226 ER - TY - JOUR AD - Department of Pathology, University of Yamanashi, Chuo, Yamanashi 409-3898, Japan. ktetsuo@yamanashi.ac.jp AN - 17714762 AU - Kondo, T. AU - Nakazawa, T. AU - Murata, S. AU - Kurebayashi, J. AU - Ezzat, S. AU - Asa, S. L. AU - Katoh, R. DA - Dec DO - 10.1016/j.humpath.2007.04.014 DP - NLM ET - 2007/08/24 IS - 12 LA - eng N1 - Kondo, Tetsuo Nakazawa, Tadao Murata, Shin-ichi Kurebayashi, Junichi Ezzat, Shereen Asa, Sylvia L Katoh, Ryohei Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2007 Dec;38(12):1810-8. doi: 10.1016/j.humpath.2007.04.014. Epub 2007 Aug 21. PY - 2007 SN - 0046-8177 (Print) 0046-8177 SP - 1810-8 ST - Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas T2 - Hum Pathol TI - Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas VL - 38 ID - 227 ER - TY - JOUR AD - Department of Pathology, Penn State University, Hershey, PA 16802, USA. AN - 17889677 AU - Alsop, S. AU - Sanger, W. G. AU - Elenitoba-Johnson, K. S. AU - Lim, M. S. DA - Oct DO - 10.1016/j.humpath.2007.05.018 DP - NLM ET - 2007/09/25 IS - 10 LA - eng N1 - Alsop, Skylar Sanger, Warren G Elenitoba-Johnson, Kojo S J Lim, Megan S Case Reports Journal Article United States Hum Pathol. 2007 Oct;38(10):1576-80. doi: 10.1016/j.humpath.2007.05.018. PY - 2007 SN - 0046-8177 (Print) 0046-8177 SP - 1576-80 ST - Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma T2 - Hum Pathol TI - Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma VL - 38 ID - 228 ER - TY - JOUR AD - Department of Medicine, Children's Hospital Boston, MA, USA. katherine.janeway@childrens.harvard.edu AN - 17909012 AU - Janeway, K. A. AU - Liegl, B. AU - Harlow, A. AU - Le, C. AU - Perez-Atayde, A. AU - Kozakewich, H. AU - Corless, C. L. AU - Heinrich, M. C. AU - Fletcher, J. A. DA - Oct 1 DO - 10.1158/0008-5472.Can-07-1938 DP - NLM ET - 2007/10/03 IS - 19 LA - eng N1 - Janeway, Katherine A Liegl, Bernadette Harlow, Amy Le, Claudia Perez-Atayde, Antonio Kozakewich, Harry Corless, Christopher L Heinrich, Michael C Fletcher, Jonathan A 1P50CA12703-01/CA/NCI NIH HHS/United States 5732HL007574.25/HL/NHLBI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. United States Cancer Res. 2007 Oct 1;67(19):9084-8. doi: 10.1158/0008-5472.CAN-07-1938. PY - 2007 SN - 0008-5472 (Print) 0008-5472 SP - 9084-8 ST - Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors T2 - Cancer Res TI - Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors VL - 67 ID - 229 ER - TY - JOUR AD - Division of Hematology-Oncology, Department of Pediatrics, University of Southern California, USA. AN - 17909043 AU - Peng, H. AU - Sohara, Y. AU - Moats, R. A. AU - Nelson, M. D., Jr. AU - Groshen, S. G. AU - Ye, W. AU - Reynolds, C. P. AU - DeClerck, Y. A. DA - Oct 1 DO - 10.1158/0008-5472.Can-06-4508 DP - NLM ET - 2007/10/03 IS - 19 LA - eng N1 - Peng, Hongjun Sohara, Yasuyoshi Moats, Rex A Nelson, Marvin D Jr Groshen, Susan G Ye, Wei Reynolds, C Patrick DeClerck, Yves A CA81403/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural United States Cancer Res. 2007 Oct 1;67(19):9346-55. doi: 10.1158/0008-5472.CAN-06-4508. PY - 2007 SN - 0008-5472 (Print) 0008-5472 SP - 9346-55 ST - The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation T2 - Cancer Res TI - The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation VL - 67 ID - 230 ER - TY - JOUR AD - Department of Paediatric Oncology, Royal Liverpool Children's NHS Trust, Liverpool, UK. AN - 17914741 AU - Rannan-Eliya, Y. F. AU - Pulford, K. AU - Johnson, R. AU - Peart, I. AU - Kokai, G. AU - Baillie, C. AU - Ait-Tahar, K. AU - Pizer, B. DA - Apr DO - 10.1002/pbc.21357 DP - NLM ET - 2007/10/05 IS - 4 LA - eng N1 - 1545-5017 Rannan-Eliya, Yi Fan Pulford, Karen Johnson, Rob Peart, Ian Kokai, George Baillie, Colin Ait-Tahar, Kamel Pizer, Barry Case Reports Journal Article United States Pediatr Blood Cancer. 2008 Apr;50(4):879-81. doi: 10.1002/pbc.21357. PY - 2008 SN - 1545-5009 SP - 879-81 ST - Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration T2 - Pediatr Blood Cancer TI - Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration VL - 50 ID - 231 ER - TY - JOUR AD - Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210, USA. AN - 18004977 AU - Knostman, K. A. AU - Venkateswaran, A. AU - Zimmerman, B. AU - Capen, C. C. AU - Jhiang, S. M. DA - Dec DO - 10.1089/thy.2007.0224 DP - NLM ET - 2007/11/17 IS - 12 LA - eng N1 - Knostman, Katherine A B Venkateswaran, Anjli Zimmerman, Bevin Capen, Charles C Jhiang, Sissy M 1 R01 EB001876-01/EB/NIBIB NIH HHS/United States T32 RR07073/RR/NCRR NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Thyroid. 2007 Dec;17(12):1181-8. doi: 10.1089/thy.2007.0224. PY - 2007 SN - 1050-7256 (Print) 1050-7256 SP - 1181-8 ST - Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression T2 - Thyroid TI - Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression VL - 17 ID - 232 ER - TY - JOUR AD - Division of Medical Genetics, A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. AN - 18025929 AU - Quezada, E. AU - Gripp, K. W. DA - Dec DO - 10.1097/MOP.0b013e3282f161dc DP - NLM ET - 2007/11/21 IS - 6 LA - eng N1 - Quezada, Emilio Gripp, Karen W Journal Article United States Curr Opin Pediatr. 2007 Dec;19(6):636-44. doi: 10.1097/MOP.0b013e3282f161dc. PY - 2007 SN - 1040-8703 (Print) 1040-8703 SP - 636-44 ST - Costello syndrome and related disorders T2 - Curr Opin Pediatr TI - Costello syndrome and related disorders VL - 19 ID - 233 ER - TY - JOUR AD - Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA. AN - 18032947 AU - Wu, J. AU - Rosenbaum, E. AU - Begum, S. AU - Westra, W. H. DA - Dec DO - 10.1097/DAD.0b013e3181584950 DP - NLM ET - 2007/11/23 IS - 6 LA - eng N1 - 1533-0311 Wu, Julie Rosenbaum, Eli Begum, Shanaz Westra, William H Journal Article United States Am J Dermatopathol. 2007 Dec;29(6):534-7. doi: 10.1097/DAD.0b013e3181584950. PY - 2007 SN - 0193-1091 SP - 534-7 ST - Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis T2 - Am J Dermatopathol TI - Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis VL - 29 ID - 234 ER - TY - JOUR AD - Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan. AN - 18089783 AU - Liao, Y. H. AU - Hsu, S. M. AU - Huang, P. H. DA - Dec 15 DO - 10.1158/0008-5472.Can-07-1930 DP - NLM ET - 2007/12/20 IS - 24 LA - eng N1 - 1538-7445 Liao, Yi-Hua Hsu, Su-Ming Huang, Pei-Hsin Journal Article Research Support, Non-U.S. Gov't United States Cancer Res. 2007 Dec 15;67(24):11547-56. doi: 10.1158/0008-5472.CAN-07-1930. PY - 2007 SN - 0008-5472 SP - 11547-56 ST - ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma T2 - Cancer Res TI - ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma VL - 67 ID - 235 ER - TY - JOUR AD - Abteilung Klinische Pharmakologie, Ruhr-Universitaet Bochum, Bochum, Germany. david.diaz-carballo@rub.de AN - 18194446 AU - Díaz-Carballo, D. AU - Malak, S. AU - Bardenheuer, W. AU - Freistuehler, M. AU - Reusch, H. P. C2 - PMC3828876 DA - Dec DO - 10.1111/j.1582-4934.2008.00232.x DP - NLM ET - 2008/01/16 IS - 6b LA - eng N1 - 1582-4934 Díaz-Carballo, D Malak, S Bardenheuer, W Freistuehler, M Reusch, H P Journal Article Research Support, Non-U.S. Gov't J Cell Mol Med. 2008 Dec;12(6B):2598-608. doi: 10.1111/j.1582-4934.2008.00232.x. PY - 2008 SN - 1582-1838 (Print) 1582-1838 SP - 2598-608 ST - Cytotoxic activity of nemorosone in neuroblastoma cells T2 - J Cell Mol Med TI - Cytotoxic activity of nemorosone in neuroblastoma cells VL - 12 ID - 236 ER - TY - JOUR AD - Department of Plastic and Reconstructive Surgery, University Sapienza, Rome, Italy. AN - 18201759 AU - Scuderi, N. AU - Onesti, M. G. AU - Bistoni, G. AU - Ceccarelli, S. AU - Rotolo, S. AU - Angeloni, A. AU - Marchese, C. DA - Apr DO - 10.1016/j.biomaterials.2007.12.024 DP - NLM ET - 2008/01/19 IS - 11 LA - eng N1 - Scuderi, Nicolò Onesti, Maria G Bistoni, Giovanni Ceccarelli, Simona Rotolo, Sabrina Angeloni, Antonio Marchese, Cinzia Case Reports Journal Article Research Support, Non-U.S. Gov't Netherlands Biomaterials. 2008 Apr;29(11):1620-9. doi: 10.1016/j.biomaterials.2007.12.024. Epub 2008 Jan 16. PY - 2008 SN - 0142-9612 (Print) 0142-9612 SP - 1620-9 ST - The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold T2 - Biomaterials TI - The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold VL - 29 ID - 237 ER - TY - JOUR AD - Section for Pathology, The Gade Institute, University of Bergen, Haukeland University Hospital, Bergen, Norway. lars.akslen@gades.uib.no AN - 18227705 AU - Akslen, L. A. AU - Puntervoll, H. AU - Bachmann, I. M. AU - Straume, O. AU - Vuhahula, E. AU - Kumar, R. AU - Molven, A. DA - Feb DO - 10.1097/CMR.0b013e3282f32517 DP - NLM ET - 2008/01/30 IS - 1 LA - eng N1 - Akslen, Lars A Puntervoll, Hanne Bachmann, Ingeborg M Straume, Oddbjørn Vuhahula, Edda Kumar, Rajiv Molven, Anders Journal Article Research Support, Non-U.S. Gov't England Melanoma Res. 2008 Feb;18(1):29-35. doi: 10.1097/CMR.0b013e3282f32517. PY - 2008 SN - 0960-8931 (Print) 0960-8931 SP - 29-35 ST - Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma T2 - Melanoma Res TI - Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma VL - 18 ID - 238 ER - TY - JOUR AD - Department of Vascular Biology, Boston Children's Hospital, Boston, Massachusetts, USA. Paul.Beaudry@CalgaryHealthRegion.ca AN - 18245671 AU - Beaudry, P. AU - Nilsson, M. AU - Rioth, M. AU - Prox, D. AU - Poon, D. AU - Xu, L. AU - Zweidler-Mckay, P. AU - Ryan, A. AU - Folkman, J. AU - Ryeom, S. AU - Heymach, J. DA - Feb DO - 10.1158/1535-7163.Mct-07-0568 DP - NLM ET - 2008/02/05 IS - 2 LA - eng N1 - Beaudry, Paul Nilsson, Monique Rioth, Matthew Prox, Daniela Poon, David Xu, Lanwei Zweidler-Mckay, Patrick Ryan, Anderson Folkman, Judah Ryeom, Sandra Heymach, John P20 CA090578/CA/NCI NIH HHS/United States Howard Hughes Medical Institute/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Mol Cancer Ther. 2008 Feb;7(2):418-24. doi: 10.1158/1535-7163.MCT-07-0568. Epub 2008 Feb 1. PY - 2008 SN - 1535-7163 (Print) 1535-7163 SP - 418-24 ST - Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium T2 - Mol Cancer Ther TI - Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium VL - 7 ID - 239 ER - TY - JOUR AD - Metabolic and Endocrine Disorders, Radboud University Medical Centre, Nijmegen, The Netherlands. c.noordam@cukz.umcn.nl AN - 18174700 AU - Noordam, K. DO - 10.1159/000110468 DP - NLM ET - 2008/02/07 LA - eng N1 - 1423-0046 Noordam, Kees Journal Article Review Switzerland Horm Res. 2007;68 Suppl 5:24-7. doi: 10.1159/000110468. Epub 2007 Dec 10. PY - 2007 SN - 0301-0163 SP - 24-7 ST - Expanding the genetic spectrum of Noonan syndrome T2 - Horm Res TI - Expanding the genetic spectrum of Noonan syndrome VL - 68 Suppl 5 ID - 240 ER - TY - JOUR AD - Institut de Physiologie et Biologie Cellulaires, EA 3813, Université de Poitiers, Poitiers 86000, France. AN - 18287965 AU - Mok, E. AU - Constantin, B. AU - Favreau, F. AU - Neveux, N. AU - Magaud, C. AU - Delwail, A. AU - Hankard, R. DA - Mar DO - 10.1203/PDR.0b013e318163a259 DP - NLM ET - 2008/02/22 IS - 3 LA - eng N1 - Mok, Elise Constantin, Bruno Favreau, Frédéric Neveux, Nathalie Magaud, Christophe Delwail, Adriana Hankard, Régis Journal Article Research Support, Non-U.S. Gov't United States Pediatr Res. 2008 Mar;63(3):268-73. doi: 10.1203/PDR.0b013e318163a259. PY - 2008 SN - 0031-3998 (Print) 0031-3998 SP - 268-73 ST - l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice T2 - Pediatr Res TI - l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice VL - 63 ID - 241 ER - TY - JOUR AD - Orthopedic Surgery Service, Memorial Sloan-Kettering Cancer Center, Weil Medical College of Cornell University, New York, New York, USA. AN - 18338812 AU - Kubo, T. AU - Piperdi, S. AU - Rosenblum, J. AU - Antonescu, C. R. AU - Chen, W. AU - Kim, H. S. AU - Huvos, A. G. AU - Sowers, R. AU - Meyers, P. A. AU - Healey, J. H. AU - Gorlick, R. DA - May 15 DO - 10.1002/cncr.23437 DP - NLM ET - 2008/03/15 IS - 10 LA - eng N1 - Kubo, Tadahiko Piperdi, Sajida Rosenblum, Jeremy Antonescu, Cristina R Chen, Wen Kim, Han-Soo Huvos, Andrew G Sowers, Rebecca Meyers, Paul A Healey, John H Gorlick, Richard Journal Article United States Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437. PY - 2008 SN - 0008-543X (Print) 0008-543x SP - 2119-29 ST - Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma T2 - Cancer TI - Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma VL - 112 ID - 242 ER - TY - JOUR AD - Department of Academic Haematology, Cardiff University, Heath Park, Cardiff, UK. AN - 18373709 AU - Al Shaer, L. AU - Walsby, E. AU - Gilkes, A. AU - Tonks, A. AU - Walsh, V. AU - Mills, K. AU - Burnett, A. AU - Rowntree, C. DA - May DO - 10.1111/j.1365-2141.2008.07053.x DP - NLM ET - 2008/04/01 IS - 4 LA - eng N1 - 1365-2141 Al Shaer, Laila Walsby, Elisabeth Gilkes, Amanda Tonks, Amanda Walsh, Valerie Mills, Ken Burnett, Alan Rowntree, Clare Journal Article Multicenter Study England Br J Haematol. 2008 May;141(4):483-93. doi: 10.1111/j.1365-2141.2008.07053.x. Epub 2008 Mar 27. PY - 2008 SN - 0007-1048 SP - 483-93 ST - Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling T2 - Br J Haematol TI - Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling VL - 141 ID - 243 ER - TY - JOUR AD - Université Paris XI-IFR54, UPRES EA 3535 Pharmacology and New Treatment in Cancers, Institut Gustave Roussy, Villejuif, France. geoerger@igr.fr AN - 18386816 AU - Geoerger, B. AU - Gaspar, N. AU - Opolon, P. AU - Morizet, J. AU - Devanz, P. AU - Lecluse, Y. AU - Valent, A. AU - Lacroix, L. AU - Grill, J. AU - Vassal, G. DA - Jul 1 DO - 10.1002/ijc.23488 DP - NLM ET - 2008/04/05 IS - 1 LA - eng N1 - 1097-0215 Geoerger, Birgit Gaspar, Nathalie Opolon, Paule Morizet, Jackie Devanz, Pauline Lecluse, Yann Valent, Alexander Lacroix, Ludovic Grill, Jacques Vassal, Gilles Journal Article Research Support, Non-U.S. Gov't United States Int J Cancer. 2008 Jul 1;123(1):209-16. doi: 10.1002/ijc.23488. PY - 2008 SN - 0020-7136 SP - 209-16 ST - EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts T2 - Int J Cancer TI - EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts VL - 123 ID - 244 ER - TY - JOUR AD - Unidad de Investigación, Hospital Universitario Reina Sofía, Córdoba, Spain. nuria.barbarroja.exts@juntadeandalucia.es AN - 18445086 AU - Barbarroja, N. AU - Siendones, E. AU - Torres, L. A. AU - Luque, M. J. AU - Martinez, J. M. AU - Dorado, G. AU - Velasco, F. AU - Torres, A. AU - López-Pedrera, C. DA - Jul DO - 10.1111/j.1365-2141.2008.07154.x DP - NLM ET - 2008/05/01 IS - 1 LA - eng N1 - 1365-2141 Barbarroja, Nuria Siendones, Emilio Torres, Luis Arístides Luque, Maria Jose Martinez, Julio Manuel Dorado, Gabriel Velasco, Francisco Torres, Antonio López-Pedrera, Chary Journal Article Research Support, Non-U.S. Gov't England Br J Haematol. 2008 Jul;142(1):27-35. doi: 10.1111/j.1365-2141.2008.07154.x. Epub 2008 Apr 28. PY - 2008 SN - 0007-1048 SP - 27-35 ST - MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia T2 - Br J Haematol TI - MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia VL - 142 ID - 245 ER - TY - JOUR AD - Departments of Medical Oncology and Pathology and Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. AN - 18550829 AU - Tarn, C. AU - Rink, L. AU - Merkel, E. AU - Flieder, D. AU - Pathak, H. AU - Koumbi, D. AU - Testa, J. R. AU - Eisenberg, B. AU - von Mehren, M. AU - Godwin, A. K. C2 - PMC2448846 DA - Jun 17 DO - 10.1073/pnas.0803383105 DP - NLM ET - 2008/06/14 IS - 24 LA - eng N1 - 1091-6490 Tarn, Chi Rink, Lori Merkel, Erin Flieder, Douglas Pathak, Harsh Koumbi, Daphne Testa, Joseph R Eisenberg, Burton von Mehren, Margaret Godwin, Andrew K P30 CA06927/CA/NCI NIH HHS/United States CA009035-31/CA/NCI NIH HHS/United States CA106588/CA/NCI NIH HHS/United States R01 CA077429/CA/NCI NIH HHS/United States R01 CA106588/CA/NCI NIH HHS/United States 5P30CA06927-44/CA/NCI NIH HHS/United States CA77429/CA/NCI NIH HHS/United States P30 CA006927/CA/NCI NIH HHS/United States T32 CA009035/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92. doi: 10.1073/pnas.0803383105. Epub 2008 Jun 11. PY - 2008 SN - 0027-8424 (Print) 0027-8424 SP - 8387-92 ST - Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors T2 - Proc Natl Acad Sci U S A TI - Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors VL - 105 ID - 246 ER - TY - JOUR AD - Department of Pathology, Virginia Mason Medical Center, Seattle, WA, USA. AN - 18587320 AU - Assaad, A. AU - Voeghtly, L. AU - Hunt, J. L. DA - Sep DO - 10.1038/modpathol.2008.122 DP - NLM ET - 2008/07/01 IS - 9 LA - eng N1 - 1530-0285 Assaad, Adel Voeghtly, Laura Hunt, Jennifer L Journal Article United States Mod Pathol. 2008 Sep;21(9):1176-82. doi: 10.1038/modpathol.2008.122. Epub 2008 Jun 27. PY - 2008 SN - 0893-3952 SP - 1176-82 ST - Thyroidectomies from patients with history of therapeutic radiation during childhood and adolescence have a unique mutational profile T2 - Mod Pathol TI - Thyroidectomies from patients with history of therapeutic radiation during childhood and adolescence have a unique mutational profile VL - 21 ID - 247 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. AN - 18615679 AU - Agaram, N. P. AU - Wong, G. C. AU - Guo, T. AU - Maki, R. G. AU - Singer, S. AU - Dematteo, R. P. AU - Besmer, P. AU - Antonescu, C. R. C2 - PMC2902874 C6 - NIHMS216366 DA - Oct DO - 10.1002/gcc.20589 DP - NLM ET - 2008/07/11 IS - 10 LA - eng N1 - 1098-2264 Agaram, Narasimhan P Wong, Grace C Guo, Tianhua Maki, Robert G Singer, Samuel Dematteo, Ronald P Besmer, Peter Antonescu, Cristina R HL/DK55748/DK/NIDDK NIH HHS/United States R01 CA102774/CA/NCI NIH HHS/United States P01CA47179/CA/NCI NIH HHS/United States CA102613/CA/NCI NIH HHS/United States P01 CA047179-15A29002/CA/NCI NIH HHS/United States R01 CA102613/CA/NCI NIH HHS/United States R01 DK055748/DK/NIDDK NIH HHS/United States CA102774/CA/NCI NIH HHS/United States P01 CA047179/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Genes Chromosomes Cancer. 2008 Oct;47(10):853-9. doi: 10.1002/gcc.20589. PY - 2008 SN - 1045-2257 (Print) 1045-2257 SP - 853-9 ST - Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors T2 - Genes Chromosomes Cancer TI - Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors VL - 47 ID - 248 ER - TY - JOUR AD - Department of Internal Medicine, Hematology Division, University Medical School of Patras, Patras, Greece. lagadin@med.upatras.gr AN - 18650843 AU - Lagadinou, E. D. AU - Ziros, P. G. AU - Tsopra, O. A. AU - Dimas, K. AU - Kokkinou, D. AU - Thanopoulou, E. AU - Karakantza, M. AU - Pantazis, P. AU - Spyridonidis, A. AU - Zoumbos, N. C. DA - Oct DO - 10.1038/leu.2008.192 DP - NLM ET - 2008/07/25 IS - 10 LA - eng N1 - 1476-5551 Lagadinou, E D Ziros, P G Tsopra, O A Dimas, K Kokkinou, D Thanopoulou, E Karakantza, M Pantazis, P Spyridonidis, A Zoumbos, N C Journal Article England Leukemia. 2008 Oct;22(10):1899-908. doi: 10.1038/leu.2008.192. Epub 2008 Jul 24. PY - 2008 SN - 0887-6924 SP - 1899-908 ST - c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia T2 - Leukemia TI - c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia VL - 22 ID - 249 ER - TY - JOUR AD - Department of Molecular Neuroscience, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, London, UK. n.potter@ion.ucl.ac.uk AN - 18670637 AU - Potter, N. AU - Karakoula, A. AU - Phipps, K. P. AU - Harkness, W. AU - Hayward, R. AU - Thompson, D. N. AU - Jacques, T. S. AU - Harding, B. AU - Thomas, D. G. AU - Palmer, R. W. AU - Rees, J. AU - Darling, J. AU - Warr, T. J. C2 - PMC2481566 DA - Aug DO - 10.1593/neo.07914 DP - NLM ET - 2008/08/02 IS - 8 LA - eng N1 - 1476-5586 Potter, Nicola Karakoula, Aikaterini Phipps, Kim P Harkness, William Hayward, Richard Thompson, Dominic N P Jacques, Thomas S Harding, Brian Thomas, David G T Palmer, Rodger W Rees, Jeremy Darling, John Warr, Tracy J Journal Article Research Support, Non-U.S. Gov't Neoplasia. 2008 Aug;10(8):757-72. doi: 10.1593/neo.07914. PY - 2008 SN - 1522-8002 (Print) 1476-5586 SP - 757-72 ST - Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma T2 - Neoplasia TI - Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma VL - 10 ID - 250 ER - TY - JOUR AD - Centro de Investigação de Patobiologia Molecular, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal. AN - 18710471 AU - Espadinha, C. AU - Santos, J. R. AU - Sobrinho, L. G. AU - Bugalho, M. J. DA - Apr DO - 10.1111/j.1365-2265.2008.03376.x DP - NLM ET - 2008/08/20 IS - 4 LA - eng N1 - 1365-2265 Espadinha, Carla Santos, Jorge Rosa Sobrinho, Luís G Bugalho, Maria João Comparative Study Journal Article England Clin Endocrinol (Oxf). 2009 Apr;70(4):629-35. doi: 10.1111/j.1365-2265.2008.03376.x. Epub 2008 Aug 15. PY - 2009 SN - 0300-0664 SP - 629-35 ST - Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency T2 - Clin Endocrinol (Oxf) TI - Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency VL - 70 ID - 251 ER - TY - JOUR AD - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. ebar1@jhmi.edu AN - 18716556 AU - Bar, E. E. AU - Lin, A. AU - Tihan, T. AU - Burger, P. C. AU - Eberhart, C. G. DA - Sep DO - 10.1097/NEN.0b013e3181845622 DP - NLM ET - 2008/08/22 IS - 9 LA - eng N1 - Bar, Eli E Lin, Alex Tihan, Tarik Burger, Peter C Eberhart, Charles G Journal Article Research Support, Non-U.S. Gov't England J Neuropathol Exp Neurol. 2008 Sep;67(9):878-87. doi: 10.1097/NEN.0b013e3181845622. PY - 2008 SN - 0022-3069 (Print) 0022-3069 SP - 878-87 ST - Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma T2 - J Neuropathol Exp Neurol TI - Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma VL - 67 ID - 252 ER - TY - JOUR AD - IRIBHM, Université Libre de Bruxelles, Brussels, Belgium. vdetours@ulb.ac.be AN - 18769217 AU - Detours, V. AU - Versteyhe, S. AU - Dumont, J. E. AU - Maenhaut, C. DA - Oct DO - 10.1097/MED.0b013e32830eb874 DP - NLM ET - 2008/09/05 IS - 5 LA - eng N1 - 1752-2978 Detours, Vincent Versteyhe, Soetkin Dumont, Jacques E Maenhaut, Carine Journal Article Research Support, Non-U.S. Gov't Review England Curr Opin Endocrinol Diabetes Obes. 2008 Oct;15(5):440-5. doi: 10.1097/MED.0b013e32830eb874. PY - 2008 SN - 1752-296x SP - 440-5 ST - Gene expression profiles of post-Chernobyl thyroid cancers T2 - Curr Opin Endocrinol Diabetes Obes TI - Gene expression profiles of post-Chernobyl thyroid cancers VL - 15 ID - 253 ER - TY - JOUR AD - Department of Pathology, A. I. DuPont Hospital for Children, Wilmington, DE, USA. dcorao@nemours.org AN - 18788887 AU - Corao, D. A. AU - Biegel, J. A. AU - Coffin, C. M. AU - Barr, F. G. AU - Wainwright, L. M. AU - Ernst, L. M. AU - Choi, J. K. AU - Zhang, P. J. AU - Pawel, B. R. DA - Jul-Aug DO - 10.2350/08-03-0434.1 DP - NLM ET - 2008/09/16 IS - 4 LA - eng N1 - Corao, Diana A Biegel, Jaclyn A Coffin, Cheryl M Barr, Frederic G Wainwright, Luanne M Ernst, Linda M Choi, John K Zhang, Paul J Pawel, Bruce R Journal Article United States Pediatr Dev Pathol. 2009 Jul-Aug;12(4):275-83. doi: 10.2350/08-03-0434.1. PY - 2009 SN - 1093-5266 (Print) 1093-5266 SP - 275-83 ST - ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status T2 - Pediatr Dev Pathol TI - ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status VL - 12 ID - 254 ER - TY - JOUR AD - School of Pharmacy, China Medical University, Taichung, Taiwan. AN - 18822283 AU - Chen, J. T. AU - Fong, Y. C. AU - Li, T. M. AU - Liu, J. F. AU - Hsu, C. W. AU - Chang, C. S. AU - Tang, C. H. DA - Nov 12 DO - 10.1016/j.ejphar.2008.08.036 DP - NLM ET - 2008/09/30 IS - 1-3 LA - eng N1 - Chen, Jung-Tsan Fong, Yi-Chin Li, Te-Mao Liu, Ju-Fang Hsu, Che-Wei Chang, Chih-Shiang Tang, Chih-Hsin Journal Article Research Support, Non-U.S. Gov't Netherlands Eur J Pharmacol. 2008 Nov 12;597(1-3):19-26. doi: 10.1016/j.ejphar.2008.08.036. Epub 2008 Sep 16. PY - 2008 SN - 0014-2999 (Print) 0014-2999 SP - 19-26 ST - DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells T2 - Eur J Pharmacol TI - DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells VL - 597 ID - 255 ER - TY - JOUR AD - Molecular Cytogenetics, Section of Molecular Carcinogenesis, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. AN - 18839394 AU - Gilbert, D. C. AU - Chandler, I. AU - McIntyre, A. AU - Goddard, N. C. AU - Gabe, R. AU - Huddart, R. A. AU - Shipley, J. DA - Jan DO - 10.1002/path.2436 DP - NLM ET - 2008/10/08 IS - 1 LA - eng N1 - 1096-9896 Gilbert, D C Chandler, I McIntyre, A Goddard, N C Gabe, R Huddart, R A Shipley, J MC_U122861331/Medical Research Council/United Kingdom Journal Article Research Support, Non-U.S. Gov't England J Pathol. 2009 Jan;217(1):94-102. doi: 10.1002/path.2436. PY - 2009 SN - 0022-3417 SP - 94-102 ST - Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents T2 - J Pathol TI - Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents VL - 217 ID - 256 ER - TY - JOUR AD - Division of Infection & Immunity, FBLS, University of Glasgow, Glasgow, UK. AN - 18985043 AU - Janssen, C. S. AU - Sibbett, R. AU - Henriquez, F. L. AU - McKay, I. C. AU - Kemp, E. G. AU - Roberts, F. C2 - PMC2584949 DA - Nov 18 DO - 10.1038/sj.bjc.6604731 DP - NLM ET - 2008/11/06 IS - 10 LA - eng N1 - 1532-1827 Janssen, C S Sibbett, R Henriquez, F L McKay, I C Kemp, E G Roberts, F Journal Article Research Support, Non-U.S. Gov't Br J Cancer. 2008 Nov 18;99(10):1673-7. doi: 10.1038/sj.bjc.6604731. Epub 2008 Nov 4. PY - 2008 SN - 0007-0920 (Print) 0007-0920 SP - 1673-7 ST - The T1799A point mutation is present in posterior uveal melanoma T2 - Br J Cancer TI - The T1799A point mutation is present in posterior uveal melanoma VL - 99 ID - 257 ER - TY - JOUR AD - Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. AN - 19016743 AU - Sievert, A. J. AU - Jackson, E. M. AU - Gai, X. AU - Hakonarson, H. AU - Judkins, A. R. AU - Resnick, A. C. AU - Sutton, L. N. AU - Storm, P. B. AU - Shaikh, T. H. AU - Biegel, J. A. C2 - PMC2850204 C6 - NIHMS184143 DA - Jul DO - 10.1111/j.1750-3639.2008.00225.x DP - NLM ET - 2008/11/20 IS - 3 LA - eng N1 - 1750-3639 Sievert, Angela J Jackson, Eric M Gai, Xiaowu Hakonarson, Hakon Judkins, Alexander R Resnick, Adam C Sutton, Leslie N Storm, Phillip B Shaikh, Tamim H Biegel, Jaclyn A GM081519/GM/NIGMS NIH HHS/United States CA133173/CA/NCI NIH HHS/United States R21 CA133173/CA/NCI NIH HHS/United States R01 GM081519/GM/NIGMS NIH HHS/United States R21 CA133173-01/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Brain Pathol. 2009 Jul;19(3):449-58. doi: 10.1111/j.1750-3639.2008.00225.x. Epub 2008 Oct 21. PY - 2009 SN - 1015-6305 (Print) 1015-6305 SP - 449-58 ST - Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene T2 - Brain Pathol TI - Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene VL - 19 ID - 258 ER - TY - JOUR AD - Appareil Digestif Environnement Nutrition EA4311, Institute for Biomedical Research, IFRMP23, Rouen University and Rouen University Hospital, Rouen, France. AN - 19022976 AU - Lecleire, S. AU - Hassan, A. AU - Marion-Letellier, R. AU - Antonietti, M. AU - Savoye, G. AU - Bôle-Feysot, C. AU - Lerebours, E. AU - Ducrotté, P. AU - Déchelotte, P. AU - Coëffier, M. DA - Dec DO - 10.3945/jn.108.099127 DP - NLM ET - 2008/11/22 IS - 12 LA - eng N1 - 1541-6100 Lecleire, Stéphane Hassan, Aktham Marion-Letellier, Rachel Antonietti, Michel Savoye, Guillaume Bôle-Feysot, Christine Lerebours, Eric Ducrotté, Philippe Déchelotte, Pierre Coëffier, Moïse Journal Article Research Support, Non-U.S. Gov't United States J Nutr. 2008 Dec;138(12):2481-6. doi: 10.3945/jn.108.099127. PY - 2008 SN - 0022-3166 SP - 2481-6 ST - Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways T2 - J Nutr TI - Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways VL - 138 ID - 259 ER - TY - JOUR AD - Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, PR China. AN - 19082454 AU - Hu, K. AU - Gan, Y. H. AU - Li, S. L. AU - Gao, Y. AU - Wu, D. C. AU - Wang, C. Y. AU - Yu, G. Y. DA - Jan DP - NLM ET - 2008/12/17 IS - 1 LA - eng N1 - Hu, Kai Gan, Ye-Hua Li, Sheng-Lin Gao, Yan Wu, Deng-Cheng Wang, Cun-Yu Yu, Guang-Yan Journal Article Research Support, Non-U.S. Gov't Greece Oncol Rep. 2009 Jan;21(1):137-43. PY - 2009 SN - 1021-335X (Print) 1021-335x SP - 137-43 ST - Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma T2 - Oncol Rep TI - Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma VL - 21 ID - 260 ER - TY - JOUR AD - CHU Clermont-Ferrand, Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, Hôtel-Dieu, France. AN - 19131793 AU - Merlin, E. AU - Chabrier, S. AU - Verkarre, V. AU - Cramer, E. AU - Delabesse, E. AU - Stéphan, J. L. DA - Dec DO - 10.1097/MPH.0b013e31818a959a DP - NLM ET - 2009/01/10 IS - 12 LA - eng N1 - 1536-3678 Merlin, Etienne Chabrier, Stéphane Verkarre, Virginie Cramer, Elisabeth Delabesse, Eric Stéphan, Jean-Louis Case Reports Journal Article United States J Pediatr Hematol Oncol. 2008 Dec;30(12):963-7. doi: 10.1097/MPH.0b013e31818a959a. PY - 2008 SN - 1077-4114 SP - 963-7 ST - Primary leptomeningeal ALK+ lymphoma in a 13-year-old child T2 - J Pediatr Hematol Oncol TI - Primary leptomeningeal ALK+ lymphoma in a 13-year-old child VL - 30 ID - 261 ER - TY - JOUR AD - IRCCS-CSS, San Giovanni Rotondo and CSS-Mendel Institute, 00198 Rome, Italy. AN - 19142971 AU - Bottillo, I. AU - Ahlquist, T. AU - Brekke, H. AU - Danielsen, S. A. AU - van den Berg, E. AU - Mertens, F. AU - Lothe, R. A. AU - Dallapiccola, B. DA - Apr DO - 10.1002/path.2494 DP - NLM ET - 2009/01/15 IS - 5 LA - eng N1 - 1096-9896 Bottillo, Irene Ahlquist, Terje Brekke, Helge Danielsen, Stine A van den Berg, Eva Mertens, Fredrik Lothe, Ragnhild A Dallapiccola, Bruno Journal Article England J Pathol. 2009 Apr;217(5):693-701. doi: 10.1002/path.2494. PY - 2009 SN - 0022-3417 SP - 693-701 ST - Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours T2 - J Pathol TI - Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours VL - 217 ID - 262 ER - TY - JOUR AD - Melanoma Genetics, Department of Experimental Oncology, Immunotherapy of Human Tumors Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. AN - 19158841 AU - Daniotti, M. AU - Ferrari, A. AU - Frigerio, S. AU - Casieri, P. AU - Miselli, F. AU - Zucca, E. AU - Collini, P. AU - Della Torre, G. AU - Manoukian, S. AU - Peissel, B. AU - Bono, A. AU - Santinami, M. AU - Parmiani, G. AU - Rivoltini, L. AU - Pilotti, S. AU - Rodolfo, M. DA - Jul DO - 10.1038/jid.2008.422 DP - NLM ET - 2009/01/23 IS - 7 LA - eng N1 - 1523-1747 Daniotti, Maria Ferrari, Andrea Frigerio, Simona Casieri, Paola Miselli, Francesca Zucca, Elisa Collini, Paola Della Torre, Gabriella Manoukian, Siranoush Peissel, Bernard Bono, Aldo Santinami, Mario Parmiani, Giorgio Rivoltini, Licia Pilotti, Silvana Rodolfo, Monica Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2009 Jul;129(7):1759-68. doi: 10.1038/jid.2008.422. Epub 2009 Jan 22. PY - 2009 SN - 0022-202x SP - 1759-68 ST - Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT T2 - J Invest Dermatol TI - Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT VL - 129 ID - 263 ER - TY - JOUR AD - Institut National de la Santé et de la Recherche Médicale, UMR 664, Lyon F-69372, France. AN - 19208736 AU - Durand, S. AU - Ferraro-Peyret, C. AU - Joufre, M. AU - Chave, A. AU - Borson-Chazot, F. AU - Selmi-Ruby, S. AU - Rousset, B. DA - Jun DO - 10.1677/erc-08-0081 DP - NLM ET - 2009/02/12 IS - 2 LA - eng N1 - Durand, Stéphanie Ferraro-Peyret, Carole Joufre, Mireille Chave, Annie Borson-Chazot, Françoise Selmi-Ruby, Samia Rousset, Bernard Journal Article Research Support, Non-U.S. Gov't England Endocr Relat Cancer. 2009 Jun;16(2):467-81. doi: 10.1677/ERC-08-0081. Epub 2009 Feb 10. PY - 2009 SN - 1351-0088 (Print) 1351-0088 SP - 467-81 ST - Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features T2 - Endocr Relat Cancer TI - Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features VL - 16 ID - 264 ER - TY - JOUR AD - Childrens Hospital, University of Lübeck Medical School, Ratzeburger Allee 160, 23538 Lübeck, Germany. AN - 19215806 AU - Härtel, C. AU - Rupp, J. AU - Iblher, P. AU - Puzik, A. AU - Osthues, I. AU - Schultz, C. AU - Müller-Steinhardt, M. DO - 10.1016/j.imbio.2008.08.003 DP - NLM ET - 2009/02/14 IS - 3 LA - eng N1 - 1878-3279 Härtel, Christoph Rupp, Jan Iblher, Peter Puzik, Alexander Osthues, Ines Schultz, Christian Müller-Steinhardt, Michael Journal Article Research Support, Non-U.S. Gov't Netherlands Immunobiology. 2009;214(3):235-43. doi: 10.1016/j.imbio.2008.08.003. Epub 2008 Oct 11. PY - 2009 SN - 0171-2985 SP - 235-43 ST - Immunomodulatory effects of Sanglifehrin A in the innate and acquired immune response of neonatal whole blood cells T2 - Immunobiology TI - Immunomodulatory effects of Sanglifehrin A in the innate and acquired immune response of neonatal whole blood cells VL - 214 ID - 265 ER - TY - JOUR AD - Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. alexj@usp.br AN - 19258709 AU - Jorge, A. A. AU - Malaquias, A. C. AU - Arnhold, I. J. AU - Mendonca, B. B. DO - 10.1159/000201106 DP - NLM ET - 2009/03/05 IS - 4 LA - eng N1 - 1423-0046 Jorge, Alexander A L Malaquias, Alexsandra C Arnhold, Ivo J P Mendonca, Berenice B Journal Article Research Support, Non-U.S. Gov't Review Switzerland Horm Res. 2009;71(4):185-93. doi: 10.1159/000201106. Epub 2009 Mar 4. PY - 2009 SN - 0301-0163 SP - 185-93 ST - Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway T2 - Horm Res TI - Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway VL - 71 ID - 266 ER - TY - JOUR AD - Department of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo, Japan. tago-mg@pha.keio.ac.jp AN - 19289461 AU - Funakoshi-Tago, M. AU - Tago, K. AU - Sumi, K. AU - Abe, M. AU - Aizu-Yokota, E. AU - Oshio, T. AU - Sonoda, Y. AU - Kasahara, T. C2 - PMC2675997 DA - May 8 DO - 10.1074/jbc.M808879200 DP - NLM ET - 2009/03/18 IS - 19 LA - eng N1 - 1083-351x Funakoshi-Tago, Megumi Tago, Kenji Sumi, Kazuya Abe, Miyuki Aizu-Yokota, Eriko Oshio, Tomoyuki Sonoda, Yoshiko Kasahara, Tadashi Journal Article Research Support, Non-U.S. Gov't J Biol Chem. 2009 May 8;284(19):12680-90. doi: 10.1074/jbc.M808879200. Epub 2009 Mar 16. PY - 2009 SN - 0021-9258 (Print) 0021-9258 SP - 12680-90 ST - The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice T2 - J Biol Chem TI - The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice VL - 284 ID - 267 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA. AN - 19289593 AU - Buxton, D. AU - Bacchi, C. E. AU - Gualco, G. AU - Weiss, L. M. AU - Zuppan, C. W. AU - Rowsell, E. H. AU - Huang, Q. AU - Wang, J. DA - Apr DO - 10.1309/ajcpe68hzxcgwtkk DP - NLM ET - 2009/03/18 IS - 4 LA - eng N1 - 1943-7722 Buxton, Daniel Bacchi, Carlos E Gualco, Gabriela Weiss, Lawrence M Zuppan, Craig W Rowsell, Edward H Huang, Qin Wang, Jun Journal Article England Am J Clin Pathol. 2009 Apr;131(4):574-9. doi: 10.1309/AJCPE68HZXCGWTKK. PY - 2009 SN - 0002-9173 SP - 574-9 ST - Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases T2 - Am J Clin Pathol TI - Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases VL - 131 ID - 268 ER - TY - JOUR AD - MRC Human Genetics Unit and The University of Edinburgh Institute for Genetics and Molecular Medicine, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. AN - 19376813 AU - Anastasaki, C. AU - Estep, A. L. AU - Marais, R. AU - Rauen, K. A. AU - Patton, E. E. C2 - PMC2701326 DA - Jul 15 DO - 10.1093/hmg/ddp186 DP - NLM ET - 2009/04/21 IS - 14 LA - eng N1 - 1460-2083 Anastasaki, Corina Estep, Anne L Marais, Richard Rauen, Katherine A Patton, E Elizabeth G120/875/Medical Research Council/United Kingdom MC_PC_U127585840/Medical Research Council/United Kingdom HD048502/HD/NICHD NIH HHS/United States MC_U127585840/Medical Research Council/United Kingdom Wellcome Trust/United Kingdom Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Hum Mol Genet. 2009 Jul 15;18(14):2543-54. doi: 10.1093/hmg/ddp186. Epub 2009 Apr 17. PY - 2009 SN - 0964-6906 (Print) 0964-6906 SP - 2543-54 ST - Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors T2 - Hum Mol Genet TI - Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors VL - 18 ID - 269 ER - TY - JOUR AD - Service de Génétique & CNRS FRE 2939, Institut Gustave Roussy, Villejuif, France. AN - 19383316 AU - Kannengiesser, C. AU - Spatz, A. AU - Michiels, S. AU - Eychène, A. AU - Dessen, P. AU - Lazar, V. AU - Winnepenninckx, V. AU - Lesueur, F. AU - Druillennec, S. AU - Robert, C. AU - van den Oord, J. J. AU - Sarasin, A. AU - Bressac-de Paillerets, B. C2 - PMC5543835 DA - Apr DO - 10.1016/j.molonc.2008.01.002 DP - NLM ET - 2009/04/23 IS - 4 LA - eng N1 - 1878-0261 Kannengiesser, Caroline Spatz, Alain Michiels, Stefan Eychène, Alain Dessen, Philippe Lazar, Vladimir Winnepenninckx, Véronique Lesueur, Fabienne Druillennec, Sabine Robert, Caroline van den Oord, Joost J Sarasin, Alain Bressac-de Paillerets, Brigitte EORTC Melanoma group Journal Article Research Support, Non-U.S. Gov't Mol Oncol. 2008 Apr;1(4):425-30. doi: 10.1016/j.molonc.2008.01.002. Epub 2008 Jan 12. PY - 2008 SN - 1574-7891 (Print) 1574-7891 SP - 425-30 ST - Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas T2 - Mol Oncol TI - Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas VL - 1 ID - 270 ER - TY - JOUR AD - Department of Human Genetics, Catholic University Leuven, Leuven, Belgium. AN - 19410195 AU - Brems, H. AU - Beert, E. AU - de Ravel, T. AU - Legius, E. DA - May DO - 10.1016/s1470-2045(09)70033-6 DP - NLM ET - 2009/05/05 IS - 5 LA - eng N1 - 1474-5488 Brems, Hilde Beert, Eline de Ravel, Thomy Legius, Eric Journal Article Review England Lancet Oncol. 2009 May;10(5):508-15. doi: 10.1016/S1470-2045(09)70033-6. PY - 2009 SN - 1470-2045 SP - 508-15 ST - Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 T2 - Lancet Oncol TI - Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 VL - 10 ID - 271 ER - TY - JOUR AD - Department of Dermatology, Eberhard Karls University, Tübingen, Germany. AN - 19493000 AU - Bauer, J. AU - Weng, J. AU - Kebebew, E. AU - Soares, P. AU - Trovisco, V. AU - Bastian, B. C. C2 - PMC2862686 C6 - NIHMS178610 DA - Jun DO - 10.1111/j.1600-0625.2008.00827.x DP - NLM ET - 2009/06/06 IS - 6 LA - eng N1 - 1600-0625 Bauer, Jürgen Weng, Julie Kebebew, Electron Soares, Paula Trovisco, Vitor Bastian, Boris C P01 CA025874/CA/NCI NIH HHS/United States P01 CA025874-25A10020/CA/NCI NIH HHS/United States Comparative Study Journal Article Research Support, Non-U.S. Gov't Exp Dermatol. 2009 Jun;18(6):548-52. doi: 10.1111/j.1600-0625.2008.00827.x. PY - 2009 SN - 0906-6705 (Print) 0906-6705 SP - 548-52 ST - Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer T2 - Exp Dermatol TI - Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer VL - 18 ID - 272 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, Justus-Liebig University, Giessen, Germany. AN - 19545284 AU - Damm-Welk, C. AU - Klapper, W. AU - Oschlies, I. AU - Gesk, S. AU - Röttgers, S. AU - Bradtke, J. AU - Siebert, R. AU - Reiter, A. AU - Woessmann, W. DA - Aug DO - 10.1111/j.1365-2141.2009.07754.x DP - NLM ET - 2009/06/24 IS - 3 LA - eng N1 - 1365-2141 Damm-Welk, Christine Klapper, Wolfram Oschlies, Ilske Gesk, Stefan Röttgers, Silja Bradtke, Jutta Siebert, Reiner Reiter, Alfred Woessmann, Willi Journal Article England Br J Haematol. 2009 Aug;146(3):306-9. doi: 10.1111/j.1365-2141.2009.07754.x. Epub 2009 May 26. PY - 2009 SN - 0007-1048 SP - 306-9 ST - Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation T2 - Br J Haematol TI - Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation VL - 146 ID - 273 ER - TY - JOUR AD - James Graham Brown Cancer Center, University of Louisville, KY 40202, USA. AN - 19588509 AU - Wysoczynski, M. AU - Shin, D. M. AU - Kucia, M. AU - Ratajczak, M. Z. C2 - PMC4021846 C6 - NIHMS578205 DA - Jan 15 DO - 10.1002/ijc.24732 DP - NLM ET - 2009/07/10 IS - 2 LA - eng N1 - 1097-0215 Wysoczynski, Marcin Shin, Dong-Myung Kucia, Magda Ratajczak, Mariusz Z R01 CA106281/CA/NCI NIH HHS/United States R01 CA106281-05/CA/NCI NIH HHS/United States R01 DK074720/DK/NIDDK NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Int J Cancer. 2010 Jan 15;126(2):371-81. doi: 10.1002/ijc.24732. PY - 2010 SN - 0020-7136 (Print) 0020-7136 SP - 371-81 ST - Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications T2 - Int J Cancer TI - Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications VL - 126 ID - 274 ER - TY - JOUR AD - Department of Pediatrics and Human Genetics, Montreal Children's Hospital, McGill University Health Center, Montreal H3Z 2Z3, Canada. nada.jabado@mcgill.ca AN - 19603027 AU - Jacob, K. AU - Albrecht, S. AU - Sollier, C. AU - Faury, D. AU - Sader, E. AU - Montpetit, A. AU - Serre, D. AU - Hauser, P. AU - Garami, M. AU - Bognar, L. AU - Hanzely, Z. AU - Montes, J. L. AU - Atkinson, J. AU - Farmer, J. P. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. AU - Jabado, N. C2 - PMC2736806 DA - Aug 18 DO - 10.1038/sj.bjc.6605179 DP - NLM ET - 2009/07/16 IS - 4 LA - eng N1 - 1532-1827 Jacob, K Albrecht, S Sollier, C Faury, D Sader, E Montpetit, A Serre, D Hauser, P Garami, M Bognar, L Hanzely, Z Montes, J L Atkinson, J Farmer, J-P Bouffet, E Hawkins, C Tabori, U Jabado, N Journal Article Research Support, Non-U.S. Gov't Br J Cancer. 2009 Aug 18;101(4):722-33. doi: 10.1038/sj.bjc.6605179. Epub 2009 Jul 14. PY - 2009 SN - 0007-0920 (Print) 0007-0920 SP - 722-33 ST - Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours T2 - Br J Cancer TI - Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours VL - 101 ID - 275 ER - TY - JOUR AD - Senckenberg Institute for Pathology, University of Frankfurt, Medical School, Frankfurt/Main, Germany. AN - 19657361 AU - Eckerle, S. AU - Brune, V. AU - Döring, C. AU - Tiacci, E. AU - Bohle, V. AU - Sundström, C. AU - Kodet, R. AU - Paulli, M. AU - Falini, B. AU - Klapper, W. AU - Chaubert, A. B. AU - Willenbrock, K. AU - Metzler, D. AU - Bräuninger, A. AU - Küppers, R. AU - Hansmann, M. L. DA - Nov DO - 10.1038/leu.2009.161 DP - NLM ET - 2009/08/07 IS - 11 LA - eng N1 - 1476-5551 Eckerle, S Brune, V Döring, C Tiacci, E Bohle, V Sundström, C Kodet, R Paulli, M Falini, B Klapper, W Chaubert, A B Willenbrock, K Metzler, D Bräuninger, A Küppers, R Hansmann, M-L Journal Article Research Support, Non-U.S. Gov't England Leukemia. 2009 Nov;23(11):2129-38. doi: 10.1038/leu.2009.161. Epub 2009 Aug 6. PY - 2009 SN - 0887-6924 SP - 2129-38 ST - Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma T2 - Leukemia TI - Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma VL - 23 ID - 276 ER - TY - JOUR AD - Discovery Biology, Inflammation Research, Pfizer Global Research and Development, Chesterfield, Missouri 63017, USA. heidi.r.hope@pfizer.com AN - 19720877 AU - Hope, H. R. AU - Anderson, G. D. AU - Burnette, B. L. AU - Compton, R. P. AU - Devraj, R. V. AU - Hirsch, J. L. AU - Keith, R. H. AU - Li, X. AU - Mbalaviele, G. AU - Messing, D. M. AU - Saabye, M. J. AU - Schindler, J. F. AU - Selness, S. R. AU - Stillwell, L. I. AU - Webb, E. G. AU - Zhang, J. AU - Monahan, J. B. DA - Dec DO - 10.1124/jpet.109.158329 DP - NLM ET - 2009/09/02 IS - 3 LA - eng N1 - 1521-0103 Hope, Heidi R Anderson, Gary D Burnette, Barry L Compton, Robert P Devraj, Rajesh V Hirsch, Jeffrey L Keith, Robert H Li, Xiong Mbalaviele, Gabriel Messing, Dean M Saabye, Matthew J Schindler, John F Selness, Shaun R Stillwell, Loreen I Webb, Elizabeth G Zhang, Jian Monahan, Joseph B Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States J Pharmacol Exp Ther. 2009 Dec;331(3):882-95. doi: 10.1124/jpet.109.158329. Epub 2009 Aug 31. PY - 2009 SN - 0022-3565 SP - 882-95 ST - Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation T2 - J Pharmacol Exp Ther TI - Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation VL - 331 ID - 277 ER - TY - JOUR AD - Department of Human Genetics, Catholic University Leuven, Leuven, Belgium. AN - 19738042 AU - Brems, H. AU - Park, C. AU - Maertens, O. AU - Pemov, A. AU - Messiaen, L. AU - Upadhyaya, M. AU - Claes, K. AU - Beert, E. AU - Peeters, K. AU - Mautner, V. AU - Sloan, J. L. AU - Yao, L. AU - Lee, C. C. AU - Sciot, R. AU - De Smet, L. AU - Legius, E. AU - Stewart, D. R. C2 - PMC2747722 C6 - NIHMS135382 DA - Sep 15 DO - 10.1158/0008-5472.Can-09-1752 DP - NLM ET - 2009/09/10 IS - 18 LA - eng N1 - 1538-7445 Brems, Hilde Park, Caroline Maertens, Ophélia Pemov, Alexander Messiaen, Ludwine Upadhyaya, Meena Claes, Kathleen Beert, Eline Peeters, Kristel Mautner, Victor Sloan, Jennifer L Yao, Lawrence Lee, Chyi-Chia Richard Sciot, Raf De Smet, Luc Legius, Eric Stewart, Douglas R Z01 HG200329-03/Intramural NIH HHS/United States Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Cancer Res. 2009 Sep 15;69(18):7393-401. doi: 10.1158/0008-5472.CAN-09-1752. Epub 2009 Sep 8. PY - 2009 SN - 0008-5472 (Print) 0008-5472 SP - 7393-401 ST - Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association T2 - Cancer Res TI - Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association VL - 69 ID - 278 ER - TY - JOUR AD - Department of Clinical Pathology, Cleveland Clinic, Cleveland, Ohio, USA. AN - 19738460 AU - Jakubowski, M. AU - Hunt, J. L. DA - Nov DO - 10.1097/PAS.0b013e3181b7c7ae DP - NLM ET - 2009/09/10 IS - 11 LA - eng N1 - 1532-0979 Jakubowski, Maureen Hunt, Jennifer L Journal Article United States Am J Surg Pathol. 2009 Nov;33(11):1590-3. doi: 10.1097/PAS.0b013e3181b7c7ae. PY - 2009 SN - 0147-5185 SP - 1590-3 ST - BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns T2 - Am J Surg Pathol TI - BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns VL - 33 ID - 279 ER - TY - JOUR AD - Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan. AN - 19765597 AU - Chen, Y. J. AU - Tsai, Y. M. AU - Kuo, C. D. AU - Ku, K. L. AU - Shie, H. S. AU - Liao, H. F. DA - Oct 21 DO - 10.1016/j.lfs.2009.09.003 DP - NLM ET - 2009/09/22 IS - 17-18 LA - eng N1 - 1879-0631 Chen, Yu-Jen Tsai, Yin-Meng Kuo, Cheng-Deng Ku, Kuo-Lung Shie, Huei-Sian Liao, Hui-Fen Journal Article Research Support, Non-U.S. Gov't Netherlands Life Sci. 2009 Oct 21;85(17-18):642-51. doi: 10.1016/j.lfs.2009.09.003. Epub 2009 Sep 16. PY - 2009 SN - 0024-3205 SP - 642-51 ST - Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect T2 - Life Sci TI - Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect VL - 85 ID - 280 ER - TY - JOUR AD - Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea. AN - 19816090 AU - Kim, J. H. AU - Kim, J. H. AU - Kim, D. H. AU - Cho, C. S. AU - Jun, H. O. AU - Yu, Y. S. AU - Kim, K. W. DO - 10.1159/000243766 DP - NLM ET - 2009/10/10 IS - 5-6 LA - eng N1 - 1423-0380 Kim, Jeong Hun Kim, Jin Hyoung Kim, Dong Hun Cho, Chang Sik Jun, Hyoung-Oh Yu, Young Suk Kim, Kyu-Won Journal Article Research Support, Non-U.S. Gov't United States Tumour Biol. 2009;30(5-6):233-41. doi: 10.1159/000243766. Epub 2009 Oct 7. PY - 2009 SN - 1010-4283 SP - 233-41 ST - Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation T2 - Tumour Biol TI - Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation VL - 30 ID - 281 ER - TY - JOUR AD - Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, London E1 2AT, UK. j.epstein@qmul.ac.uk AN - 19878610 AU - Epstein, J. AU - Docena, G. AU - MacDonald, T. T. AU - Sanderson, I. R. DA - Mar DO - 10.1017/s0007114509992510 DP - NLM ET - 2009/11/03 IS - 6 LA - eng N1 - 1475-2662 Epstein, Jenny Docena, Guillermo MacDonald, Thomas T Sanderson, Ian R Journal Article Research Support, Non-U.S. Gov't England Br J Nutr. 2010 Mar;103(6):824-32. doi: 10.1017/S0007114509992510. Epub 2009 Nov 2. PY - 2010 SN - 0007-1145 SP - 824-32 ST - Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease T2 - Br J Nutr TI - Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease VL - 103 ID - 282 ER - TY - JOUR AD - Department of Anatomy and Cell Biology, RWTH Aachen University, Germany. lbrandenburg@ukaachen.de AN - 19879657 AU - Brandenburg, L. O. AU - Varoga, D. AU - Nicolaeva, N. AU - Leib, S. L. AU - Podschun, R. AU - Wruck, C. J. AU - Wilms, H. AU - Lucius, R. AU - Pufe, T. DA - Dec 10 DO - 10.1016/j.jneuroim.2009.10.004 DP - NLM ET - 2009/11/03 IS - 1-2 LA - eng N1 - 1872-8421 Brandenburg, Lars-Ove Varoga, Deike Nicolaeva, Nicoletta Leib, Stephen L Podschun, Rainer Wruck, Christoph J Wilms, Henrik Lucius, Ralph Pufe, Thomas Journal Article Research Support, Non-U.S. Gov't Netherlands J Neuroimmunol. 2009 Dec 10;217(1-2):55-64. doi: 10.1016/j.jneuroim.2009.10.004. Epub 2009 Oct 30. PY - 2009 SN - 0165-5728 SP - 55-64 ST - Expression and regulation of antimicrobial peptide rCRAMP after bacterial infection in primary rat meningeal cells T2 - J Neuroimmunol TI - Expression and regulation of antimicrobial peptide rCRAMP after bacterial infection in primary rat meningeal cells VL - 217 ID - 283 ER - TY - JOUR AD - Endocrinology Division, Department of Internal and Specialistic Medicine, University of Catania Medical School, Garibaldi-Nesima Hospital, Catania, Italy. gabriellapellegriti@hotmail.com AN - 19893009 AU - Pellegriti, G. AU - De Vathaire, F. AU - Scollo, C. AU - Attard, M. AU - Giordano, C. AU - Arena, S. AU - Dardanoni, G. AU - Frasca, F. AU - Malandrino, P. AU - Vermiglio, F. AU - Previtera, D. M. AU - D'Azzò, G. AU - Trimarchi, F. AU - Vigneri, R. DA - Nov 18 DO - 10.1093/jnci/djp354 DP - NLM ET - 2009/11/07 IS - 22 LA - eng N1 - 1460-2105 Pellegriti, Gabriella De Vathaire, Florent Scollo, Claudia Attard, Marco Giordano, Carla Arena, Salvatore Dardanoni, Gabriella Frasca, Francesco Malandrino, Pasqualino Vermiglio, Francesco Previtera, Domenico Massimo D'Azzò, Girolamo Trimarchi, Francesco Vigneri, Riccardo Journal Article Research Support, Non-U.S. Gov't United States J Natl Cancer Inst. 2009 Nov 18;101(22):1575-83. doi: 10.1093/jnci/djp354. Epub 2009 Nov 5. PY - 2009 SN - 0027-8874 SP - 1575-83 ST - Papillary thyroid cancer incidence in the volcanic area of Sicily T2 - J Natl Cancer Inst TI - Papillary thyroid cancer incidence in the volcanic area of Sicily VL - 101 ID - 284 ER - TY - JOUR AD - Boston University School of Medicine, Boston, MA, USA. AN - 19919630 AU - Nguyen, L. P. AU - Emley, A. AU - Wajapeyee, N. AU - Green, M. R. AU - Mahalingam, M. C2 - PMC2921125 C6 - HHMIMS221883 DA - Mar DO - 10.1111/j.1365-2133.2009.09558.x DP - NLM ET - 2009/11/19 IS - 3 LA - eng N1 - 1365-2133 Nguyen, L P Emley, A Wajapeyee, N Green, M R Mahalingam, M Howard Hughes Medical Institute/United States Journal Article Br J Dermatol. 2010 Mar;162(3):677-80. doi: 10.1111/j.1365-2133.2009.09558.x. Epub 2009 Nov 16. PY - 2010 SN - 0007-0963 (Print) 0007-0963 SP - 677-80 ST - BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi T2 - Br J Dermatol TI - BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi VL - 162 ID - 285 ER - TY - JOUR AD - Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI 48109-1078, USA. AN - 19922767 AU - Shiozawa, Y. AU - Pedersen, E. A. AU - Taichman, R. S. C2 - PMC2815170 C6 - NIHMS159568 DA - Feb DO - 10.1016/j.exphem.2009.11.002 DP - NLM ET - 2009/11/20 IS - 2 LA - eng N1 - 1873-2399 Shiozawa, Yusuke Pedersen, Elisabeth A Taichman, Russell S P01 CA093900-01A20001/CA/NCI NIH HHS/United States P30 AR046024-01A1S10002/AR/NIAMS NIH HHS/United States P30 AR046024/AR/NIAMS NIH HHS/United States P01 CA093900-06A18687/CA/NCI NIH HHS/United States P01 CA093900/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Exp Hematol. 2010 Feb;38(2):132-40. doi: 10.1016/j.exphem.2009.11.002. Epub 2009 Nov 14. PY - 2010 SN - 0301-472X (Print) 0301-472x SP - 132-40 ST - GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche T2 - Exp Hematol TI - GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche VL - 38 ID - 286 ER - TY - JOUR AD - Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. AN - 19924296 AU - MacConaill, L. E. AU - Campbell, C. D. AU - Kehoe, S. M. AU - Bass, A. J. AU - Hatton, C. AU - Niu, L. AU - Davis, M. AU - Yao, K. AU - Hanna, M. AU - Mondal, C. AU - Luongo, L. AU - Emery, C. M. AU - Baker, A. C. AU - Philips, J. AU - Goff, D. J. AU - Fiorentino, M. AU - Rubin, M. A. AU - Polyak, K. AU - Chan, J. AU - Wang, Y. AU - Fletcher, J. A. AU - Santagata, S. AU - Corso, G. AU - Roviello, F. AU - Shivdasani, R. AU - Kieran, M. W. AU - Ligon, K. L. AU - Stiles, C. D. AU - Hahn, W. C. AU - Meyerson, M. L. AU - Garraway, L. A. C2 - PMC2774511 consultant for and/or receives sponsored research from Novartis, Inc. None of these relationships constitute a conflict of interest for this work. This does not alter his adherence to all PLoS ONE policies on data sharing and materials. DA - Nov 18 DO - 10.1371/journal.pone.0007887 DP - NLM ET - 2009/11/20 IS - 11 LA - eng N1 - 1932-6203 MacConaill, Laura E Campbell, Catarina D Kehoe, Sarah M Bass, Adam J Hatton, Charles Niu, Lili Davis, Matt Yao, Keluo Hanna, Megan Mondal, Chandrani Luongo, Lauren Emery, Caroline M Baker, Alissa C Philips, Juliet Goff, Deborah J Fiorentino, Michelangelo Rubin, Mark A Polyak, Kornelia Chan, Jennifer Wang, Yuexiang Fletcher, Jonathan A Santagata, Sandro Corso, Gianni Roviello, Franco Shivdasani, Ramesh Kieran, Mark W Ligon, Keith L Stiles, Charles D Hahn, William C Meyerson, Matthew L Garraway, Levi A K08 CA134931/CA/NCI NIH HHS/United States R21 CA126674/CA/NCI NIH HHS/United States K08CA134931/CA/NCI NIH HHS/United States R21CA126674/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't PLoS One. 2009 Nov 18;4(11):e7887. doi: 10.1371/journal.pone.0007887. PY - 2009 SN - 1932-6203 SP - e7887 ST - Profiling critical cancer gene mutations in clinical tumor samples T2 - PLoS One TI - Profiling critical cancer gene mutations in clinical tumor samples VL - 4 ID - 287 ER - TY - JOUR AD - Clinical Pharmacology, Hoffman-La Roche, Nutley, New Jersey 07110, USA. lucy.lee@roche.com AN - 19934286 AU - Lee, L. AU - Niu, H. AU - Rueger, R. AU - Igawa, Y. AU - Deutsch, J. AU - Ishii, N. AU - Mu, S. AU - Sakamoto, Y. AU - Busse-Reid, R. AU - Gimmi, C. AU - Goelzer, P. AU - De Schepper, S. AU - Yoshimura, Y. AU - Barrett, J. AU - Ishikawa, Y. AU - Weissgerber, G. AU - Peck, R. DA - Dec 1 DO - 10.1158/1078-0432.Ccr-09-1696 DP - NLM ET - 2009/11/26 IS - 23 LA - eng N1 - Lee, Lucy Niu, Huifeng Rueger, Ruediger Igawa, Yuriko Deutsch, Jonathan Ishii, Nobuya Mu, Song Sakamoto, Yuuichiro Busse-Reid, Rachel Gimmi, Claude Goelzer, Petra De Schepper, Stefanie Yoshimura, Yashushi Barrett, Joanne Ishikawa, Yuji Weissgerber, Georges Peck, Richard Journal Article Randomized Controlled Trial United States Clin Cancer Res. 2009 Dec 1;15(23):7368-74. doi: 10.1158/1078-0432.CCR-09-1696. Epub 2009 Nov 24. PY - 2009 SN - 1078-0432 (Print) 1078-0432 SP - 7368-74 ST - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker T2 - Clin Cancer Res TI - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker VL - 15 ID - 288 ER - TY - JOUR AD - INSERM, U.563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. AN - 19951975 AU - Lamant, L. AU - Pileri, S. AU - Sabattini, E. AU - Brugières, L. AU - Jaffe, E. S. AU - Delsol, G. C2 - PMC2833075 DA - Mar DO - 10.3324/haematol.2009.015024 DP - NLM ET - 2009/12/03 IS - 3 LA - eng N1 - 1592-8721 Lamant, Laurence Pileri, Stefano Sabattini, Elena Brugières, Laurence Jaffe, Elaine S Delsol, Georges Intramural NIH HHS/United States Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Haematologica. 2010 Mar;95(3):449-55. doi: 10.3324/haematol.2009.015024. Epub 2009 Nov 30. PY - 2010 SN - 0390-6078 (Print) 0390-6078 SP - 449-55 ST - Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases T2 - Haematologica TI - Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases VL - 95 ID - 289 ER - TY - JOUR AD - Oncosurgery, Geneva UniversityHospital, Geneva, Switzerland. arnaud.roth@sim.hcuge.ch AN - 20008640 AU - Roth, A. D. AU - Tejpar, S. AU - Delorenzi, M. AU - Yan, P. AU - Fiocca, R. AU - Klingbiel, D. AU - Dietrich, D. AU - Biesmans, B. AU - Bodoky, G. AU - Barone, C. AU - Aranda, E. AU - Nordlinger, B. AU - Cisar, L. AU - Labianca, R. AU - Cunningham, D. AU - Van Cutsem, E. AU - Bosman, F. DA - Jan 20 DO - 10.1200/jco.2009.23.3452 DP - NLM ET - 2009/12/17 IS - 3 LA - eng N1 - 1527-7755 Roth, Arnaud D Tejpar, Sabine Delorenzi, Mauro Yan, Pu Fiocca, Roberto Klingbiel, Dirk Dietrich, Daniel Biesmans, Bart Bodoky, György Barone, Carlo Aranda, Enrique Nordlinger, Bernard Cisar, Laura Labianca, Roberto Cunningham, David Van Cutsem, Eric Bosman, Fred Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States J Clin Oncol. 2010 Jan 20;28(3):466-74. doi: 10.1200/JCO.2009.23.3452. Epub 2009 Dec 14. PY - 2010 SN - 0732-183x SP - 466-74 ST - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial T2 - J Clin Oncol TI - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial VL - 28 ID - 290 ER - TY - JOUR AD - 1Department of Pathology, Institut Bergonié, Bordeaux, France. AN - 20023270 AU - Hostein, I. AU - Faur, N. AU - Primois, C. AU - Boury, F. AU - Denard, J. AU - Emile, J. F. AU - Bringuier, P. P. AU - Scoazec, J. Y. AU - Coindre, J. M. DA - Jan DO - 10.1309/ajcppckga2qgbj1r DP - NLM ET - 2009/12/22 IS - 1 LA - eng N1 - 1943-7722 Hostein, Isabelle Faur, Nicolas Primois, Charlotte Boury, Frédérique Denard, Jérome Emile, Jean-François Bringuier, Pierre-Paul Scoazec, Jean-Yves Coindre, Jean-Michel Comparative Study Journal Article Research Support, Non-U.S. Gov't England Am J Clin Pathol. 2010 Jan;133(1):141-8. doi: 10.1309/AJCPPCKGA2QGBJ1R. PY - 2010 SN - 0002-9173 SP - 141-8 ST - BRAF mutation status in gastrointestinal stromal tumors T2 - Am J Clin Pathol TI - BRAF mutation status in gastrointestinal stromal tumors VL - 133 ID - 291 ER - TY - JOUR AD - Instituto Universitario de Oncología del Principado de Asturias (IUOPA), c/Julian Claveria, Oviedo, Spain. AN - 20025643 AU - Casado-Zapico, S. AU - Rodriguez-Blanco, J. AU - García-Santos, G. AU - Martín, V. AU - Sánchez-Sánchez, A. M. AU - Antolín, I. AU - Rodriguez, C. DA - Jan DO - 10.1111/j.1600-079X.2009.00727.x DP - NLM ET - 2009/12/23 IS - 1 LA - eng N1 - 1600-079x Casado-Zapico, Sara Rodriguez-Blanco, Jezabel García-Santos, Guillermo Martín, Vanesa Sánchez-Sánchez, Ana M Antolín, Isaac Rodriguez, Carmen Journal Article Research Support, Non-U.S. Gov't England J Pineal Res. 2010 Jan;48(1):72-80. doi: 10.1111/j.1600-079X.2009.00727.x. PY - 2010 SN - 0742-3098 SP - 72-80 ST - Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway T2 - J Pineal Res TI - Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway VL - 48 ID - 292 ER - TY - JOUR AD - Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran. Hematology, Oncology and BMT Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran. Hematology, Oncology and BMT Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran; Department of Molecular Medicine, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran; Department of Molecular Medicine, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mhghahremani@tums.ac.ir. AN - 20164150 AU - Mandegary, A. AU - Hosseini, R. AU - Ghaffari, S. H. AU - Alimoghaddam, K. AU - Rostami, S. AU - Ghavamzadeh, A. AU - Ghahremani, M. H. DA - Sep DO - 10.1093/annonc/mdq034 DP - NLM ET - 2010/02/19 IS - 9 LA - eng N1 - 1569-8041 Mandegary, A Hosseini, R Ghaffari, S H Alimoghaddam, K Rostami, S Ghavamzadeh, A Ghahremani, M H Journal Article Research Support, Non-U.S. Gov't England Ann Oncol. 2010 Sep;21(9):1884-1890. doi: 10.1093/annonc/mdq034. Epub 2010 Feb 17. PY - 2010 SN - 0923-7534 SP - 1884-1890 ST - The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide T2 - Ann Oncol TI - The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide VL - 21 ID - 293 ER - TY - JOUR AN - 20169312 AU - Ando, K. AU - Tamada, Y. AU - Shimizu, K. AU - Akita, Y. AU - Watanabe, D. AU - Nakamura, S. AU - Hara, K. AU - Matsumoto, Y. DA - Mar DO - 10.2340/00015555-0775 DP - NLM ET - 2010/02/20 IS - 2 LA - eng N1 - 1651-2057 Ando, Kazuha Tamada, Yasuhiko Shimizu, Kazuyuki Akita, Yoichi Watanabe, Daisuke Nakamura, Shigeru Hara, Kazuo Matsumoto, Yoshinari Case Reports Letter Sweden Acta Derm Venereol. 2010 Mar;90(2):198-200. doi: 10.2340/00015555-0775. PY - 2010 SN - 0001-5555 SP - 198-200 ST - ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation T2 - Acta Derm Venereol TI - ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation VL - 90 ID - 294 ER - TY - JOUR AD - Department of Pathology, Chinese PLA General Hospital, Beijing, China. shihuaiyin@sina.com AN - 20350216 AU - Shi, H. AU - Li, Y. AU - Wei, L. AU - Sun, L. DA - Apr DO - 10.3109/00313021003631312 DP - NLM ET - 2010/03/31 IS - 3 LA - eng N1 - 1465-3931 Shi, Huaiyin Li, Yan Wei, Lixin Sun, Lu Journal Article England Pathology. 2010 Apr;42(3):235-41. doi: 10.3109/00313021003631312. PY - 2010 SN - 0031-3025 SP - 235-41 ST - Primary colorectal inflammatory myofibroblastic tumour: a clinicopathological and immunohistochemical study of seven cases T2 - Pathology TI - Primary colorectal inflammatory myofibroblastic tumour: a clinicopathological and immunohistochemical study of seven cases VL - 42 ID - 295 ER - TY - JOUR AD - Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. stefano.caramuta@ki.se AN - 20357817 AU - Caramuta, S. AU - Egyházi, S. AU - Rodolfo, M. AU - Witten, D. AU - Hansson, J. AU - Larsson, C. AU - Lui, W. O. DA - Aug DO - 10.1038/jid.2010.63 DP - NLM ET - 2010/04/02 IS - 8 LA - eng N1 - 1523-1747 Caramuta, Stefano Egyházi, Suzanne Rodolfo, Monica Witten, Daniela Hansson, Johan Larsson, Catharina Lui, Weng-Onn Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2010 Aug;130(8):2062-70. doi: 10.1038/jid.2010.63. Epub 2010 Apr 1. PY - 2010 SN - 0022-202x SP - 2062-70 ST - MicroRNA expression profiles associated with mutational status and survival in malignant melanoma T2 - J Invest Dermatol TI - MicroRNA expression profiles associated with mutational status and survival in malignant melanoma VL - 130 ID - 296 ER - TY - JOUR AD - Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. AN - 20398663 AU - Munitz, A. AU - Cole, E. T. AU - Beichler, A. AU - Groschwitz, K. AU - Ahrens, R. AU - Steinbrecher, K. AU - Willson, T. AU - Han, X. AU - Denson, L. AU - Rothenberg, M. E. AU - Hogan, S. P. C2 - PMC3423916 C6 - NIHMS197647 DA - Aug DO - 10.1053/j.gastro.2010.04.006 DP - NLM ET - 2010/04/20 IS - 2 LA - eng N1 - 1528-0012 Munitz, Ariel Cole, Eric T Beichler, Amanda Groschwitz, Katherine Ahrens, Richard Steinbrecher, Kris Willson, Tara Han, Xiaonan Denson, Lee Rothenberg, Marc E Hogan, Simon P R01 AI073553-01A1/AI/NIAID NIH HHS/United States P01 HL076383/HL/NHLBI NIH HHS/United States R01 AI073553-01/AI/NIAID NIH HHS/United States P01 HL-076383/HL/NHLBI NIH HHS/United States R01 AI057803/AI/NIAID NIH HHS/United States R01 AI073553/AI/NIAID NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Gastroenterology. 2010 Aug;139(2):530-41. doi: 10.1053/j.gastro.2010.04.006. Epub 2010 Apr 14. PY - 2010 SN - 0016-5085 (Print) 0016-5085 SP - 530-41 ST - Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis T2 - Gastroenterology TI - Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis VL - 139 ID - 297 ER - TY - JOUR AD - Division of Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University , Kaohsiung, Taiwan. AN - 20406109 AU - Chou, C. K. AU - Chen, R. F. AU - Chou, F. F. AU - Chang, H. W. AU - Chen, Y. J. AU - Lee, Y. F. AU - Yang, K. D. AU - Cheng, J. T. AU - Huang, C. C. AU - Liu, R. T. DA - May DO - 10.1089/thy.2009.0027 DP - NLM ET - 2010/04/22 IS - 5 LA - eng N1 - 1557-9077 Chou, Chen-Kai Chen, Rong-Fu Chou, Fong-Fu Chang, Hsueh-Wen Chen, Yi-Ju Lee, Ya-Fang Yang, Kuender D Cheng, Jiin-Tsuey Huang, Chao-Cheng Liu, Rue-Tsuan Journal Article Research Support, Non-U.S. Gov't United States Thyroid. 2010 May;20(5):489-94. doi: 10.1089/thy.2009.0027. PY - 2010 SN - 1050-7256 SP - 489-94 ST - miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation T2 - Thyroid TI - miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation VL - 20 ID - 298 ER - TY - JOUR AD - Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom. AN - 20416888 AU - Ghorbel, M. T. AU - Cherif, M. AU - Jenkins, E. AU - Mokhtari, A. AU - Kenny, D. AU - Angelini, G. D. AU - Caputo, M. C2 - PMC2951593 C6 - UKMS32141 DA - Aug DO - 10.1016/j.jtcvs.2009.12.055 DP - NLM ET - 2010/04/27 IS - 2 LA - eng N1 - 1097-685x Ghorbel, Mohamed T Cherif, Myriam Jenkins, Emma Mokhtari, Amir Kenny, Damien Angelini, Gianni D Caputo, Massimo PG/03/125/16132/British Heart Foundation/United Kingdom PG/2001046/12839/British Heart Foundation/United Kingdom Comparative Study Journal Article Research Support, Non-U.S. Gov't J Thorac Cardiovasc Surg. 2010 Aug;140(2):337-345.e26. doi: 10.1016/j.jtcvs.2009.12.055. Epub 2010 Apr 22. PY - 2010 SN - 0022-5223 (Print) 0022-5223 SP - 337-345.e26 ST - Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression T2 - J Thorac Cardiovasc Surg TI - Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression VL - 140 ID - 299 ER - TY - JOUR AD - Department of Medical Sciences, University of Milan and Endocrine Unit, Fondazione Policlinico IRCCS, Milan. AN - 20447069 AU - Muzza, M. AU - Degl'Innocenti, D. AU - Colombo, C. AU - Perrino, M. AU - Ravasi, E. AU - Rossi, S. AU - Cirello, V. AU - Beck-Peccoz, P. AU - Borrello, M. G. AU - Fugazzola, L. DA - May DO - 10.1111/j.1365-2265.2009.03699.x DP - NLM ET - 2010/05/08 IS - 5 LA - eng N1 - 1365-2265 Muzza, Marina Degl'Innocenti, Debora Colombo, Carla Perrino, Michela Ravasi, Elena Rossi, Stefania Cirello, Valentina Beck-Peccoz, Paolo Borrello, Maria Grazia Fugazzola, Laura Journal Article Research Support, Non-U.S. Gov't England Clin Endocrinol (Oxf). 2010 May;72(5):702-8. doi: 10.1111/j.1365-2265.2009.03699.x. PY - 2010 SN - 0300-0664 SP - 702-8 ST - The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies T2 - Clin Endocrinol (Oxf) TI - The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies VL - 72 ID - 300 ER - TY - JOUR AD - Gastrointestinal Cancer Research Laboratory, Baylor University Medical Center, Dallas, TX, USA. AN - 20473912 AU - Goel, A. AU - Nguyen, T. P. AU - Leung, H. C. AU - Nagasaka, T. AU - Rhees, J. AU - Hotchkiss, E. AU - Arnold, M. AU - Banerji, P. AU - Koi, M. AU - Kwok, C. T. AU - Packham, D. AU - Lipton, L. AU - Boland, C. R. AU - Ward, R. L. AU - Hitchins, M. P. C2 - PMC3794437 C6 - NIHMS517877 DA - Feb 15 DO - 10.1002/ijc.25422 DP - NLM ET - 2010/05/18 IS - 4 LA - eng N1 - 1097-0215 Goel, Ajay Nguyen, Thuy-Phuong Leung, Hon-Chiu E Nagasaka, Takeshi Rhees, Jennifer Hotchkiss, Erin Arnold, Mildred Banerji, Pia Koi, Minoru Kwok, Chau-To Packham, Deborah Lipton, Lara Boland, C Richard Ward, Robyn L Hitchins, Megan P R01 CA072851/CA/NCI NIH HHS/United States R01 CA 72851/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Int J Cancer. 2011 Feb 15;128(4):869-78. doi: 10.1002/ijc.25422. PY - 2011 SN - 0020-7136 (Print) 0020-7136 SP - 869-78 ST - De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one T2 - Int J Cancer TI - De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one VL - 128 ID - 301 ER - TY - JOUR AD - Pediatric Oncology Branch National Cancer Institute National Institutes of Health, Bethesda, Maryland 20892, USA. kimsuyou@mail.nih.gov AN - 20485167 AU - Kim, S. Y. AU - Janeway, K. AU - Pappo, A. C2 - PMC2949288 C6 - NIHMS237419 DA - Jul DO - 10.1097/CCO.0b013e32833aaae7 DP - NLM ET - 2010/05/21 IS - 4 LA - eng N1 - 1531-703x Kim, Su Y Janeway, Katherine Pappo, Alberto ZIA BC011196-01/Intramural NIH HHS/United States Journal Article Review Curr Opin Oncol. 2010 Jul;22(4):347-50. doi: 10.1097/CCO.0b013e32833aaae7. PY - 2010 SN - 1040-8746 (Print) 1040-8746 SP - 347-50 ST - Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches T2 - Curr Opin Oncol TI - Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches VL - 22 ID - 302 ER - TY - JOUR AD - Second Division, Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu 431-3192, Japan. AN - 20501680 AU - Iino, K. AU - Oki, Y. AU - Yamashita, M. AU - Matsushita, F. AU - Hayashi, C. AU - Yogo, K. AU - Nishizawa, S. AU - Yamada, S. AU - Maekawa, M. AU - Sasano, H. AU - Nakamura, H. DA - Aug DO - 10.1210/jc.2009-2716 DP - NLM ET - 2010/05/27 IS - 8 LA - eng N1 - 1945-7197 Iino, Kazumi Oki, Yutaka Yamashita, Miho Matsushita, Fumie Hayashi, Chiga Yogo, Kosuke Nishizawa, Shigeru Yamada, Shozo Maekawa, Masato Sasano, Hironobu Nakamura, Hirotoshi Journal Article United States J Clin Endocrinol Metab. 2010 Aug;95(8):4003-11. doi: 10.1210/jc.2009-2716. Epub 2010 May 25. PY - 2010 SN - 0021-972x SP - 4003-11 ST - Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenoma T2 - J Clin Endocrinol Metab TI - Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenoma VL - 95 ID - 303 ER - TY - JOUR AD - EA2216 Immunology and Pathology and Institut Fédératif de Recherche 148, Université de Bretagne Occidentale, Brest, France. AN - 20516366 AU - Séïté, J. F. AU - Cornec, D. AU - Renaudineau, Y. AU - Youinou, P. AU - Mageed, R. A. AU - Hillion, S. DA - Sep 9 DO - 10.1182/blood-2009-12-261461 DP - NLM ET - 2010/06/03 IS - 10 LA - eng N1 - 1528-0020 Séïté, Jean-François Cornec, Divi Renaudineau, Yves Youinou, Pierre Mageed, Rizgar A Hillion, Sophie Journal Article United States Blood. 2010 Sep 9;116(10):1698-704. doi: 10.1182/blood-2009-12-261461. Epub 2010 Jun 1. PY - 2010 SN - 0006-4971 SP - 1698-704 ST - IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes T2 - Blood TI - IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes VL - 116 ID - 304 ER - TY - JOUR AD - Texas Children's Cancer Center, Department of Pediatrics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. AN - 20562916 AU - Shang, X. AU - Vasudevan, S. A. AU - Yu, Y. AU - Ge, N. AU - Ludwig, A. D. AU - Wesson, C. L. AU - Wang, K. AU - Burlingame, S. M. AU - Zhao, Y. J. AU - Rao, P. H. AU - Lu, X. AU - Russell, H. V. AU - Okcu, M. F. AU - Hicks, M. J. AU - Shohet, J. M. AU - Donehower, L. A. AU - Nuchtern, J. G. AU - Yang, J. C2 - PMC7580258 C6 - NIHMS1638028 DA - Sep 2 DO - 10.1038/onc.2010.244 DP - NLM ET - 2010/06/22 IS - 35 LA - eng N1 - 1476-5594 Shang, X Vasudevan, S A Yu, Y Ge, N Ludwig, A D Wesson, C L Wang, K Burlingame, S M Zhao, Y-J Rao, P H Lu, X Russell, H V Okcu, M F Hicks, M J Shohet, J M Donehower, L A Nuchtern, J G Yang, J F32 CA113059/CA/NCI NIH HHS/United States 1F32CA113059-01A1/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Oncogene. 2010 Sep 2;29(35):4938-46. doi: 10.1038/onc.2010.244. Epub 2010 Jun 21. PY - 2010 SN - 0950-9232 (Print) 0950-9232 SP - 4938-46 ST - Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma T2 - Oncogene TI - Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma VL - 29 ID - 305 ER - TY - JOUR AD - The Airway Mucus Institute, Yonsei University College of Medicine, Seoul, South Korea. AN - 20564234 AU - Moon, U. Y. AU - Kim, C. H. AU - Choi, J. Y. AU - Kim, Y. J. AU - Choi, Y. H. AU - Yoon, H. G. AU - Kim, H. AU - Yoon, J. H. DA - Aug 15 DO - 10.1002/jcb.22655 DP - NLM ET - 2010/06/22 IS - 6 LA - eng N1 - 1097-4644 Moon, Uk Yeol Kim, Chang-Hoon Choi, Jae Young Kim, Yoon-Ju Choi, Yeon Ho Yoon, Ho-Geun Kim, Hyeyoung Yoon, Joo-Heon Journal Article Research Support, Non-U.S. Gov't United States J Cell Biochem. 2010 Aug 15;110(6):1386-98. doi: 10.1002/jcb.22655. PY - 2010 SN - 0730-2312 SP - 1386-98 ST - AP2alpha is essential for MUC8 gene expression in human airway epithelial cells T2 - J Cell Biochem TI - AP2alpha is essential for MUC8 gene expression in human airway epithelial cells VL - 110 ID - 306 ER - TY - JOUR AD - Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan. AN - 20615395 AU - Lu, D. Y. AU - Leung, Y. M. AU - Cheung, C. W. AU - Chen, Y. R. AU - Wong, K. L. DA - Oct 15 DO - 10.1016/j.bcp.2010.06.046 DP - NLM ET - 2010/07/10 IS - 8 LA - eng N1 - 1873-2968 Lu, Dah-Yuu Leung, Yuk-Man Cheung, Chi-Wai Chen, Yun-Ru Wong, Kar-Lok Journal Article Research Support, Non-U.S. Gov't England Biochem Pharmacol. 2010 Oct 15;80(8):1201-9. doi: 10.1016/j.bcp.2010.06.046. Epub 2010 Jul 6. PY - 2010 SN - 0006-2952 SP - 1201-9 ST - Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells T2 - Biochem Pharmacol TI - Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells VL - 80 ID - 307 ER - TY - JOUR AD - Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera, Università di Padova, Padova, Italy. AN - 20658615 AU - Mussolin, L. AU - Pillon, M. AU - Bonato, P. AU - Leszl, A. AU - Franceschetto, G. AU - Di Meglio, A. AU - d'Amore, E. S. AU - Sainati, L. AU - Rosolen, A. DA - Sep DO - 10.1002/pbc.22550 DP - NLM ET - 2010/07/27 IS - 3 LA - eng N1 - 1545-5017 Mussolin, Lara Pillon, Marta Bonato, Paola Leszl, Anna Franceschetto, Genny Di Meglio, Annamaria d'Amore, Emanuele S G Sainati, Laura Rosolen, Angelo Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Pediatr Blood Cancer. 2010 Sep;55(3):446-51. doi: 10.1002/pbc.22550. PY - 2010 SN - 1545-5009 SP - 446-51 ST - Cytogenetic analysis of pediatric anaplastic large cell lymphoma T2 - Pediatr Blood Cancer TI - Cytogenetic analysis of pediatric anaplastic large cell lymphoma VL - 55 ID - 308 ER - TY - JOUR AD - Department of Physiology and Biophysics, Georgetown University, Washington, DC 20057, USA. AN - 20676138 AU - Lu, C. AU - Everhart, L. AU - Tilan, J. AU - Kuo, L. AU - Sun, C. C. AU - Munivenkatappa, R. B. AU - Jönsson-Rylander, A. C. AU - Sun, J. AU - Kuan-Celarier, A. AU - Li, L. AU - Abe, K. AU - Zukowska, Z. AU - Toretsky, J. A. AU - Kitlinska, J. C2 - PMC2955165 C6 - NIHMS215233 DA - Oct 14 DO - 10.1038/onc.2010.301 DP - NLM ET - 2010/08/03 IS - 41 LA - eng N1 - 1476-5594 Lu, C Everhart, L Tilan, J Kuo, L Sun, C-C J Munivenkatappa, R B Jönsson-Rylander, A-C Sun, J Kuan-Celarier, A Li, L Abe, K Zukowska, Z Toretsky, J A Kitlinska, J R01 CA123211-05/CA/NCI NIH HHS/United States R01 CA123211-01/CA/NCI NIH HHS/United States R01 CA123211-03/CA/NCI NIH HHS/United States R01 CA123211-04/CA/NCI NIH HHS/United States 1R01CA123211-01/CA/NCI NIH HHS/United States R01 CA123211/CA/NCI NIH HHS/United States R01 CA123211-02/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Oncogene. 2010 Oct 14;29(41):5630-42. doi: 10.1038/onc.2010.301. Epub 2010 Aug 2. PY - 2010 SN - 0950-9232 (Print) 0950-9232 SP - 5630-42 ST - Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy T2 - Oncogene TI - Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy VL - 29 ID - 309 ER - TY - JOUR AD - Departments of Surgery, University of Texas Medical Branch, Galveston, Texas, USA. AN - 20716917 AU - Baregamian, N. AU - Song, J. AU - Bailey, C. E. AU - Papaconstantinou, J. AU - Evers, B. M. AU - Chung, D. H. C2 - PMC2835918 DA - Nov-Dec DO - 10.4161/oxim.2.5.9541 DP - NLM ET - 2010/08/19 IS - 5 LA - eng N1 - 1942-0994 Baregamian, Naira Song, Jun Bailey, C Eric Papaconstantinou, John Evers, B Mark Chung, Dai H P01 DK035608/DK/NIDDK NIH HHS/United States R01 DK48498/DK/NIDDK NIH HHS/United States T32 DK007639/DK/NIDDK NIH HHS/United States P01 DK35608/DK/NIDDK NIH HHS/United States R01 DK61470/DK/NIDDK NIH HHS/United States R01 DK061470/DK/NIDDK NIH HHS/United States P30 AG024832/AG/NIA NIH HHS/United States R01 DK048498/DK/NIDDK NIH HHS/United States T32 DK07639/DK/NIDDK NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Oxid Med Cell Longev. 2009 Nov-Dec;2(5):297-306. doi: 10.4161/oxim.2.5.9541. PY - 2009 SN - 1942-0900 (Print) 1942-0994 SP - 297-306 ST - Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis T2 - Oxid Med Cell Longev TI - Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis VL - 2 ID - 310 ER - TY - JOUR AD - Centre for Infectious Disease and Centre for Academic Surgery, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK. AN - 20731675 AU - Docena, G. AU - Rovedatti, L. AU - Kruidenier, L. AU - Fanning, A. AU - Leakey, N. A. AU - Knowles, C. H. AU - Lee, K. AU - Shanahan, F. AU - Nally, K. AU - McLean, P. G. AU - Di Sabatino, A. AU - MacDonald, T. T. C2 - PMC2990936 DA - Oct DO - 10.1111/j.1365-2249.2010.04203.x DP - NLM ET - 2010/08/25 IS - 1 LA - eng N1 - 1365-2249 Docena, G Rovedatti, L Kruidenier, L Fanning, A Leakey, N A B Knowles, C H Lee, K Shanahan, F Nally, K McLean, P G Di Sabatino, A MacDonald, T T Journal Article Research Support, Non-U.S. Gov't Clin Exp Immunol. 2010 Oct;162(1):108-15. doi: 10.1111/j.1365-2249.2010.04203.x. Epub 2010 Aug 20. PY - 2010 SN - 0009-9104 (Print) 0009-9104 SP - 108-15 ST - Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease T2 - Clin Exp Immunol TI - Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease VL - 162 ID - 311 ER - TY - JOUR AD - Department of Dermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. AN - 20732960 AU - Nardone, B. AU - Nicholson, K. AU - Newman, M. AU - Guitart, J. AU - Gerami, P. AU - Talarico, N. AU - Yang, X. J. AU - Rademaker, A. AU - West, D. P. AU - Lacouture, M. E. DA - Sep 1 DO - 10.1158/1078-0432.Ccr-10-0421 DP - NLM ET - 2010/08/25 IS - 17 LA - eng N1 - Nardone, Beatrice Nicholson, Kimberly Newman, Marissa Guitart, Joan Gerami, Pedram Talarico, Nicholas Yang, Ximing J Rademaker, Alfred West, Dennis P Lacouture, Mario E Journal Article Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2010 Sep 1;16(17):4452-60. doi: 10.1158/1078-0432.CCR-10-0421. Epub 2010 Aug 23. PY - 2010 SN - 1078-0432 (Print) 1078-0432 SP - 4452-60 ST - Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients T2 - Clin Cancer Res TI - Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients VL - 16 ID - 312 ER - TY - JOUR AD - Greenwood Genetic Center, Greenwood, SC 29646, USA. AN - 20735442 AU - Champion, K. J. AU - Bunag, C. AU - Estep, A. L. AU - Jones, J. R. AU - Bolt, C. H. AU - Rogers, R. C. AU - Rauen, K. A. AU - Everman, D. B. DA - May DO - 10.1111/j.1399-0004.2010.01495.x DP - NLM ET - 2010/08/26 IS - 5 LA - eng N1 - 1399-0004 Champion, K J Bunag, C Estep, A L Jones, J R Bolt, C H Rogers, R C Rauen, K A Everman, D B HD048502/HD/NICHD NIH HHS/United States UL1 RR024131/RR/NCRR NIH HHS/United States Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Denmark Clin Genet. 2011 May;79(5):468-74. doi: 10.1111/j.1399-0004.2010.01495.x. PY - 2011 SN - 0009-9163 SP - 468-74 ST - Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome T2 - Clin Genet TI - Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome VL - 79 ID - 313 ER - TY - JOUR AD - Department of Neonatology, University of Heidelberg, Medical School, Heidelberg, Germany. lutz.koch@med.uni-heidelberg.de AN - 20798552 AU - Koch, L. AU - Fritzsching, B. AU - Frommhold, D. AU - Poeschl, J. DO - 10.1159/000313967 DP - NLM ET - 2010/08/28 IS - 2 LA - eng N1 - 1661-7819 Koch, Lutz Fritzsching, Benedikt Frommhold, David Poeschl, Johannes Journal Article Switzerland Neonatology. 2011;99(2):140-5. doi: 10.1159/000313967. Epub 2010 Aug 27. PY - 2011 SN - 1661-7800 SP - 140-5 ST - Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK T2 - Neonatology TI - Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK VL - 99 ID - 314 ER - TY - JOUR AD - Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand. AN - 20854070 AU - Jovanovic, L. AU - Delahunt, B. AU - McIver, B. AU - Eberhardt, N. L. AU - Bhattacharya, A. AU - Lea, R. AU - Grebe, S. K. DO - 10.3109/00313025.2010.508780 DP - NLM ET - 2010/09/22 IS - 6 LA - eng N1 - 1465-3931 Jovanovic, Lidija Delahunt, Brett McIver, Bryan Eberhardt, Norman L Bhattacharya, Alokananda Lea, Rod Grebe, Stefan K G CA80117/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't England Pathology. 2010;42(6):524-33. doi: 10.3109/00313025.2010.508780. PY - 2010 SN - 0031-3025 SP - 524-33 ST - Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma T2 - Pathology TI - Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma VL - 42 ID - 315 ER - TY - JOUR AD - Department of Pathology, University of Virginia Health System, Charlottesville, VA 22908, USA. es7yj@virginia.edu AN - 20924280 AU - Woodford, R. L. AU - Nikiforov, Y. E. AU - Hunt, J. L. AU - Bellizzi, A. M. AU - Zhang, X. AU - Mills, S. E. AU - Stelow, E. B. DA - Nov DO - 10.1097/PAS.0b013e3181f2d820 DP - NLM ET - 2010/10/07 IS - 11 LA - eng N1 - 1532-0979 Woodford, Randall Lyndon Nikiforov, Yuri E Hunt, Jennifer L Bellizzi, Andrew M Zhang, Xiaotang Mills, Stacey E Stelow, Edward B Journal Article United States Am J Surg Pathol. 2010 Nov;34(11):1582-90. doi: 10.1097/PAS.0b013e3181f2d820. PY - 2010 SN - 0147-5185 SP - 1582-90 ST - Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases T2 - Am J Surg Pathol TI - Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases VL - 34 ID - 316 ER - TY - JOUR AD - 1Department of Pathology and Cytology, Division of Clinical Cytology, Karolinska University Hospital, Solna 17176, Sweden. vitalijs.svjatoha@karolinska.se AN - 20944096 AU - Sviatoha, V. AU - Tani, E. AU - Ghaderi, M. AU - Kleina, R. AU - Skoog, L. DA - Sep DP - NLM ET - 2010/10/15 IS - 9 LA - eng N1 - 1791-7530 Sviatoha, Vitali Tani, Edneia Ghaderi, Mehran Kleina, Regina Skoog, Lambert Journal Article Research Support, Non-U.S. Gov't Greece Anticancer Res. 2010 Sep;30(9):3267-72. PY - 2010 SN - 0250-7005 SP - 3267-72 ST - Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas T2 - Anticancer Res TI - Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas VL - 30 ID - 317 ER - TY - JOUR AD - Department of Dermatology and Pediatrics, Oregon Health and Science University, Portland, USA. dsiegel@mcw.edu AN - 21062266 AU - Siegel, D. H. AU - McKenzie, J. AU - Frieden, I. J. AU - Rauen, K. A. C2 - PMC4063552 C6 - NIHMS252247 DA - Mar DO - 10.1111/j.1365-2133.2010.10122.x DP - NLM ET - 2010/11/11 IS - 3 LA - eng N1 - 1365-2133 Siegel, D H McKenzie, J Frieden, I J Rauen, K A K23 HD048502/HD/NICHD NIH HHS/United States K23 HD048502-01/HD/NICHD NIH HHS/United States HD048502/HD/NICHD NIH HHS/United States UL1 RR02414001/RR/NCRR NIH HHS/United States UL1 RR024140/RR/NCRR NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Br J Dermatol. 2011 Mar;164(3):521-9. doi: 10.1111/j.1365-2133.2010.10122.x. Epub 2011 Jan 28. PY - 2011 SN - 0007-0963 (Print) 0007-0963 SP - 521-9 ST - Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome T2 - Br J Dermatol TI - Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome VL - 164 ID - 318 ER - TY - JOUR AD - Department of Surgical and Molecular Pathology, National Institute of Oncology, Budapest, Hungary. vereczkey.ildiko@oncol.hu AN - 21136228 AU - Vereczkey, I. AU - Serester, O. AU - Dobos, J. AU - Gallai, M. AU - Szakács, O. AU - Szentirmay, Z. AU - Tóth, E. DA - Sep DO - 10.1007/s12253-010-9345-8 DP - NLM ET - 2010/12/08 IS - 3 LA - eng N1 - 1532-2807 Vereczkey, Ildikó Serester, Orsolya Dobos, Judit Gallai, Mónika Szakács, Orsolya Szentirmay, Zoltán Tóth, Erika Comparative Study Journal Article Research Support, Non-U.S. Gov't Netherlands Pathol Oncol Res. 2011 Sep;17(3):551-9. doi: 10.1007/s12253-010-9345-8. Epub 2010 Dec 7. PY - 2011 SN - 1219-4956 SP - 551-9 ST - Molecular characterization of 103 ovarian serous and mucinous tumors T2 - Pathol Oncol Res TI - Molecular characterization of 103 ovarian serous and mucinous tumors VL - 17 ID - 319 ER - TY - JOUR AD - Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumor Research Centre, Toronto, Ontario, Canada. AN - 21151472 AU - Kongkham, P. N. AU - Onvani, S. AU - Smith, C. A. AU - Rutka, J. T. C2 - PMC3000458 DA - Dec 1 DO - 10.1593/tlo.10121 DP - NLM ET - 2010/12/15 IS - 6 LA - eng N1 - 1936-5233 Kongkham, Paul N Onvani, Sara Smith, Christian A Rutka, James T Journal Article Transl Oncol. 2010 Dec 1;3(6):336-43. doi: 10.1593/tlo.10121. PY - 2010 SN - 1936-5233 SP - 336-43 ST - Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma T2 - Transl Oncol TI - Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma VL - 3 ID - 320 ER - TY - JOUR AD - Laboratoire de Biologie des Cancers, Equipe Micro-organismes et Facteurs Oncogènes, Faculté de Médecine et de Pharmacie, Fez, Morocco. AN - 21161938 AU - Bennani, B. AU - Gilles, S. AU - Fina, F. AU - Nanni, I. AU - Ibrahimi, S. A. AU - Riffi, A. A. AU - Nejjari, C. AU - Benajeh, D. A. AU - El Abkari, M. AU - Martin, P. M. AU - Ouafik, L. DA - Oct-Dec DP - NLM ET - 2010/12/17 IS - 4 LA - eng N1 - 1724-6008 Bennani, Bahia Gilles, Sophie Fina, Frederic Nanni, Isabelle Ibrahimi, Sidi Adil Riffi, Afaf Amarti Nejjari, Chakib Benajeh, Dafr-Allah El Abkari, Mohammed Martin, Pierre-Marie Ouafik, L'Houcine Journal Article United States Int J Biol Markers. 2010 Oct-Dec;25(4):179-84. PY - 2010 SN - 0393-6155 SP - 179-84 ST - Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer T2 - Int J Biol Markers TI - Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer VL - 25 ID - 321 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. AN - 21164297 AU - Mariño-Enríquez, A. AU - Wang, W. L. AU - Roy, A. AU - Lopez-Terrada, D. AU - Lazar, A. J. AU - Fletcher, C. D. AU - Coffin, C. M. AU - Hornick, J. L. DA - Jan DO - 10.1097/PAS.0b013e318200cfd5 DP - NLM ET - 2010/12/18 IS - 1 LA - eng N1 - 1532-0979 Mariño-Enríquez, Adrián Wang, Wei-Lien Roy, Angshumoy Lopez-Terrada, Dolores Lazar, Alexander J F Fletcher, Christopher D M Coffin, Cheryl M Hornick, Jason L Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 2011 Jan;35(1):135-44. doi: 10.1097/PAS.0b013e318200cfd5. PY - 2011 SN - 0147-5185 SP - 135-44 ST - Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK T2 - Am J Surg Pathol TI - Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK VL - 35 ID - 322 ER - TY - JOUR AD - Department of Pathology, Griffith Medical School, Gold Coast, Queensland, Gold Coast QLD 4222, Australia. AN - 21167555 AU - Smith, R. A. AU - Salajegheh, A. AU - Weinstein, S. AU - Nassiri, M. AU - Lam, A. K. DA - Apr DO - 10.1016/j.humpath.2009.09.023 DP - NLM ET - 2010/12/21 IS - 4 LA - eng N1 - 1532-8392 Smith, Robert Anthony Salajegheh, Ali Weinstein, Stephen Nassiri, Mohammad Lam, Alfred King-Yin Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2011 Apr;42(4):500-6. doi: 10.1016/j.humpath.2009.09.023. Epub 2010 Dec 16. PY - 2011 SN - 0046-8177 SP - 500-6 ST - Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant T2 - Hum Pathol TI - Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant VL - 42 ID - 323 ER - TY - JOUR AD - Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, China. AN - 22430133 AU - Xu, J. AU - He, J. AU - Yang, H. AU - Luo, X. AU - Liang, Z. AU - Chen, J. AU - Cai, Z. AU - Xu, J. AU - Ren-Heidenreich, L. DO - 10.3233/cbm-2012-0233 DP - NLM ET - 2011/01/01 IS - 2 LA - eng N1 - 1875-8592 Xu, Jianping He, Jiaying Yang, Huiyi Luo, Xiaodi Liang, Zhangmin Chen, Jiaxin Cai, Zhiping Xu, Jiasen Ren-Heidenreich, Lifen Journal Article Research Support, Non-U.S. Gov't Netherlands Cancer Biomark. 2011-2012;10(2):63-9. doi: 10.3233/CBM-2012-0233. PY - 2011 SN - 1574-0153 SP - 63-9 ST - Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer T2 - Cancer Biomark TI - Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer VL - 10 ID - 324 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., FC8.2057, Box 0455, Houston, TX 77030, USA. AN - 21216929 AU - Janku, F. AU - Tsimberidou, A. M. AU - Garrido-Laguna, I. AU - Wang, X. AU - Luthra, R. AU - Hong, D. S. AU - Naing, A. AU - Falchook, G. S. AU - Moroney, J. W. AU - Piha-Paul, S. A. AU - Wheler, J. J. AU - Moulder, S. L. AU - Fu, S. AU - Kurzrock, R. C2 - PMC3072168 C6 - NIHMS263540 the subject of this manuscript. DA - Mar DO - 10.1158/1535-7163.Mct-10-0994 DP - NLM ET - 2011/01/11 IS - 3 LA - eng N1 - 1538-8514 Janku, Filip Tsimberidou, Apostolia M Garrido-Laguna, Ignacio Wang, Xuemei Luthra, Rajyalakshmi Hong, David S Naing, Aung Falchook, Gerald S Moroney, John W Piha-Paul, Sarina A Wheler, Jennifer J Moulder, Stacy L Fu, Siqing Kurzrock, Razelle P30 CA016672/CA/NCI NIH HHS/United States UL1 RR024148/RR/NCRR NIH HHS/United States UL1 RR024148-04/RR/NCRR NIH HHS/United States RR024148/RR/NCRR NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. PY - 2011 SN - 1535-7163 (Print) 1535-7163 SP - 558-65 ST - PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors T2 - Mol Cancer Ther TI - PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors VL - 10 ID - 325 ER - TY - JOUR AD - Department of Pediatrics and the Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. lohm@itsa.ucsf.edu AN - 21239819 AU - Loh, M. L. DO - 10.1182/asheducation-2010.1.357 DP - NLM ET - 2011/01/18 LA - eng N1 - 1520-4383 Loh, Mignon L Journal Article Research Support, Non-U.S. Gov't Review United States Hematology Am Soc Hematol Educ Program. 2010;2010:357-62. doi: 10.1182/asheducation-2010.1.357. PY - 2010 SN - 1520-4383 SP - 357-62 ST - Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia T2 - Hematology Am Soc Hematol Educ Program TI - Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia VL - 2010 ID - 326 ER - TY - JOUR AD - Rady Children's Hospital San Diego and the University of California, San Diego, California 92123, USA. AN - 21255872 AU - Tom, W. L. AU - Hsu, J. W. AU - Eichenfield, L. F. AU - Friedlander, S. F. DA - Mar DO - 10.1016/j.jaad.2009.12.063 DP - NLM ET - 2011/01/25 IS - 3 LA - eng N1 - 1097-6787 Tom, Wynnis L Hsu, Jessica W Eichenfield, Lawrence F Friedlander, Sheila Fallon Case Reports Journal Article Review United States J Am Acad Dermatol. 2011 Mar;64(3):559-72. doi: 10.1016/j.jaad.2009.12.063. Epub 2011 Jan 20. PY - 2011 SN - 0190-9622 SP - 559-72 ST - Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children T2 - J Am Acad Dermatol TI - Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children VL - 64 ID - 327 ER - TY - JOUR AD - Department of Cancer Genetics, Royal College of Surgeons in Ireland, York House, York Street, Dublin 2, Ireland. AN - 21266077 AU - Tivnan, A. AU - Tracey, L. AU - Buckley, P. G. AU - Alcock, L. C. AU - Davidoff, A. M. AU - Stallings, R. L. C2 - PMC3038978 DA - Jan 25 DO - 10.1186/1471-2407-11-33 DP - NLM ET - 2011/01/27 LA - eng N1 - 1471-2407 Tivnan, Amanda Tracey, Lorraine Buckley, Patrick G Alcock, Leah C Davidoff, Andrew M Stallings, Raymond L 5R01CA127496/CA/NCI NIH HHS/United States CA23099/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33. PY - 2011 SN - 1471-2407 SP - 33 ST - MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma T2 - BMC Cancer TI - MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma VL - 11 ID - 328 ER - TY - JOUR AD - Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA. erik_sampson@urmc.rochester.edu AN - 21308771 AU - Sampson, E. R. AU - Martin, B. A. AU - Morris, A. E. AU - Xie, C. AU - Schwarz, E. M. AU - O'Keefe, R. J. AU - Rosier, R. N. DA - Jun DO - 10.1002/jbmr.336 DP - NLM ET - 2011/02/11 IS - 6 LA - eng N1 - 1523-4681 Sampson, Erik R Martin, Brad A Morris, Aimee E Xie, Chao Schwarz, Edward M O'Keefe, Regis J Rosier, Randy N Journal Article Research Support, Non-U.S. Gov't United States J Bone Miner Res. 2011 Jun;26(6):1283-94. doi: 10.1002/jbmr.336. PY - 2011 SN - 0884-0431 SP - 1283-94 ST - The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model T2 - J Bone Miner Res TI - The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model VL - 26 ID - 329 ER - TY - JOUR AD - Department of Pediatrics, Laboratory of Hematology-Oncology, University of Padova, Padova, Italy. martina.pigazzi@unipd.it AN - 21325296 AU - Pigazzi, M. AU - Manara, E. AU - Beghin, A. AU - Baron, E. AU - Tregnago, C. AU - Basso, G. DA - Feb 15 DO - 10.1158/1078-0432.Ccr-10-0886 DP - NLM ET - 2011/02/18 IS - 4 LA - eng N1 - Pigazzi, Martina Manara, Elena Beghin, Alessandra Baron, Emma Tregnago, Claudia Basso, Giuseppe Journal Article Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2011 Feb 15;17(4):742-52. doi: 10.1158/1078-0432.CCR-10-0886. PY - 2011 SN - 1078-0432 (Print) 1078-0432 SP - 742-52 ST - ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia T2 - Clin Cancer Res TI - ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia VL - 17 ID - 330 ER - TY - JOUR AD - Department of Dermatology, No 1 Hospital of China Medical University, Shenyang, Liaoning, China. AN - 21326296 AU - Qi, R. Q. AU - He, L. AU - Zheng, S. AU - Hong, Y. AU - Ma, L. AU - Zhang, S. AU - Zhao, L. AU - Guo, X. AU - Wang, Y. AU - Yu, J. Y. AU - Fu, L. AU - Zhang, W. AU - Long, T. AU - Zhang, C. AU - Chen, G. AU - Lin, J. AU - Wang, C. AU - Zhou, L. AU - Mi, Q. AU - Weiland, M. AU - Chen, J. Z. AU - McHenga, S. S. AU - Wang, Y. K. AU - McHepange, U. AU - Wang, Z. AU - Chen, H. D. AU - Gao, X. H. DA - May DO - 10.1038/jid.2010.405 DP - NLM ET - 2011/02/18 IS - 5 LA - eng N1 - 1523-1747 Qi, Rui-Qun He, Li Zheng, Song Hong, Yuxiao Ma, Lei Zhang, Shifa Zhao, Liping Guo, Xinjian Wang, Yong Yu, Jiang-Yun Fu, Lan Zhang, Wei Long, Tingfeng Zhang, Chao Chen, Guohong Lin, Junping Wang, Chengliang Zhou, Li Mi, Qingsheng Weiland, Matthew Chen, John Z S McHenga, S S Salum Wang, Ya-Kun McHepange, Uwesu Wang, Zhimin Chen, Hong-Duo Gao, Xing-Hua Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2011 May;131(5):1129-38. doi: 10.1038/jid.2010.405. Epub 2011 Feb 17. PY - 2011 SN - 0022-202x SP - 1129-38 ST - BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han T2 - J Invest Dermatol TI - BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han VL - 131 ID - 331 ER - TY - JOUR AD - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. michal.grzmil@fmi.ch AN - 21406405 AU - Grzmil, M. AU - Morin, P., Jr. AU - Lino, M. M. AU - Merlo, A. AU - Frank, S. AU - Wang, Y. AU - Moncayo, G. AU - Hemmings, B. A. DA - Mar 15 DO - 10.1158/0008-5472.Can-10-3112 DP - NLM ET - 2011/03/17 IS - 6 LA - eng N1 - 1538-7445 Grzmil, Michal Morin, Pier Jr Lino, Maria Maddalena Merlo, Adrian Frank, Stephan Wang, Yuhua Moncayo, Gerald Hemmings, Brian A Journal Article Research Support, Non-U.S. Gov't United States Cancer Res. 2011 Mar 15;71(6):2392-402. doi: 10.1158/0008-5472.CAN-10-3112. Epub 2011 Mar 14. PY - 2011 SN - 0008-5472 SP - 2392-402 ST - MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma T2 - Cancer Res TI - MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma VL - 71 ID - 332 ER - TY - JOUR AD - Department of Cleft Lip and Palate, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China. AN - 21430505 AU - Wu, D. AU - Wang, M. AU - Wang, X. AU - Yin, N. AU - Song, T. AU - Li, H. AU - Yu, J. AU - Wang, D. M. AU - Zhao, Z. DA - Jun DO - 10.1097/DAD.0b013e3181fb5bc7 DP - NLM ET - 2011/03/25 IS - 4 LA - eng N1 - 1533-0311 Wu, Di Wang, Mei Wang, Xingang Yin, Ningbei Song, Tao Li, Haidong Yu, Jun Wang, Duen-Mei Zhao, Zhenmin Journal Article United States Am J Dermatopathol. 2011 Jun;33(4):341-4. doi: 10.1097/DAD.0b013e3181fb5bc7. PY - 2011 SN - 0193-1091 SP - 341-4 ST - Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population T2 - Am J Dermatopathol TI - Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population VL - 33 ID - 333 ER - TY - JOUR AD - Division of Pathological Anatomy, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy. Daniela.massi@UNIFI.IT AN - 21496703 AU - Massi, D. AU - Cesinaro, A. M. AU - Tomasini, C. AU - Paglierani, M. AU - Bettelli, S. AU - Dal Maso, L. AU - Simi, L. AU - Salvianti, F. AU - Pinzani, P. AU - Orlando, C. AU - De Giorgi, V. AU - Lukic, S. AU - Maiorana, A. AU - Santucci, M. AU - Canzonieri, V. DA - May DO - 10.1016/j.jaad.2010.05.043 DP - NLM ET - 2011/04/19 IS - 5 LA - eng N1 - 1097-6787 Massi, Daniela Cesinaro, Anna Maria Tomasini, Carlo Paglierani, Milena Bettelli, Stefania Dal Maso, Luigino Simi, Lisa Salvianti, Francesca Pinzani, Pamela Orlando, Claudio De Giorgi, Vincenzo Lukic, Silvana Maiorana, Antonio Santucci, Marco Canzonieri, Vincenzo Journal Article Research Support, Non-U.S. Gov't United States J Am Acad Dermatol. 2011 May;64(5):919-35. doi: 10.1016/j.jaad.2010.05.043. PY - 2011 SN - 0190-9622 SP - 919-35 ST - Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis T2 - J Am Acad Dermatol TI - Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis VL - 64 ID - 334 ER - TY - JOUR AD - University of North Carolina, 170 Manning Drive, Chapel Hill, NC 27599-730, USA. Bert_oneil@med.unc.edu AN - 21519015 AU - O'Neil, B. H. AU - Goff, L. W. AU - Kauh, J. S. AU - Strosberg, J. R. AU - Bekaii-Saab, T. S. AU - Lee, R. M. AU - Kazi, A. AU - Moore, D. T. AU - Learoyd, M. AU - Lush, R. M. AU - Sebti, S. M. AU - Sullivan, D. M. C2 - PMC3107750 found at the end of this article. DA - Jun 10 DO - 10.1200/jco.2010.33.9432 DP - NLM ET - 2011/04/27 IS - 17 LA - eng N1 - 1527-7755 O'Neil, Bert H Goff, Laura W Kauh, John Sae Wook Strosberg, Jonathan R Bekaii-Saab, Tanios S Lee, Ruey-Min Kazi, Aslamuzzaman Moore, Dominic T Learoyd, Maria Lush, Richard M Sebti, Said M Sullivan, Daniel M N01CM62208/CA/NCI NIH HHS/United States K23 CA118431/CA/NCI NIH HHS/United States 5K23CA118431/CA/NCI NIH HHS/United States P30 CA076292/CA/NCI NIH HHS/United States UL1 RR024975/RR/NCRR NIH HHS/United States UL1 RR024975-01/RR/NCRR NIH HHS/United States Clinical Trial, Phase II Journal Article Research Support, N.I.H., Extramural J Clin Oncol. 2011 Jun 10;29(17):2350-6. doi: 10.1200/JCO.2010.33.9432. Epub 2011 Apr 25. PY - 2011 SN - 0732-183X (Print) 0732-183x SP - 2350-6 ST - Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma T2 - J Clin Oncol TI - Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma VL - 29 ID - 335 ER - TY - JOUR AD - Department of Surgery, Section of Endocrine Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. AN - 21537871 AU - Yip, L. AU - Kelly, L. AU - Shuai, Y. AU - Armstrong, M. J. AU - Nikiforov, Y. E. AU - Carty, S. E. AU - Nikiforova, M. N. C2 - PMC4157306 C6 - NIHMS538551 DA - Jul DO - 10.1245/s10434-011-1733-0 DP - NLM ET - 2011/05/04 IS - 7 LA - eng N1 - 1534-4681 Yip, Linwah Kelly, Lindsey Shuai, Yongli Armstrong, Michaele J Nikiforov, Yuri E Carty, Sally E Nikiforova, Marina N P30 AG024827/AG/NIA NIH HHS/United States R01 CA088041/CA/NCI NIH HHS/United States R01 CA88041/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Ann Surg Oncol. 2011 Jul;18(7):2035-41. doi: 10.1245/s10434-011-1733-0. Epub 2011 May 3. PY - 2011 SN - 1068-9265 (Print) 1068-9265 SP - 2035-41 ST - MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma T2 - Ann Surg Oncol TI - MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma VL - 18 ID - 336 ER - TY - JOUR AD - Department of Pathology, Yale University, New Haven, Connecticut 06520, USA. AN - 21568726 AU - Adeniran, A. J. AU - Theoharis, C. AU - Hui, P. AU - Prasad, M. L. AU - Hammers, L. AU - Carling, T. AU - Udelsman, R. AU - Chhieng, D. C. DA - Jul DO - 10.1089/thy.2011.0021 DP - NLM ET - 2011/05/17 IS - 7 LA - eng N1 - 1557-9077 Adeniran, Adebowale J Theoharis, Constantine Hui, Pei Prasad, Manju L Hammers, Lynwood Carling, Tobias Udelsman, Robert Chhieng, David C Journal Article United States Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021. Epub 2011 May 13. PY - 2011 SN - 1050-7256 SP - 717-23 ST - Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study T2 - Thyroid TI - Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study VL - 21 ID - 337 ER - TY - JOUR AD - Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. AN - 21569090 AU - Yun, J. AU - Lee, J. AU - Jang, J. AU - Lee, E. J. AU - Jang, K. T. AU - Kim, J. H. AU - Kim, K. M. DA - Jun DO - 10.1111/j.1600-0463.2011.02737.x DP - NLM ET - 2011/05/17 IS - 6 LA - eng N1 - 1600-0463 Yun, Jina Lee, Jeeyun Jang, Jiryeon Lee, Eui Jin Jang, Kee Taek Kim, Jung Han Kim, Kyoung-Mee Journal Article Denmark APMIS. 2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24. PY - 2011 SN - 0903-4641 SP - 330-5 ST - KIT amplification and gene mutations in acral/mucosal melanoma in Korea T2 - Apmis TI - KIT amplification and gene mutations in acral/mucosal melanoma in Korea VL - 119 ID - 338 ER - TY - JOUR AD - Department of Pediatric Oncology-Hematology, Erasmus MC- Sophia Children's Hospital, Dr. Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands. f.duijkers@erasmusmc.nl AN - 21625996 AU - Duijkers, F. A. AU - Gaal, J. AU - Meijerink, J. P. AU - Admiraal, P. AU - Pieters, R. AU - de Krijger, R. R. AU - van Noesel, M. M. C2 - PMC3219872 DA - Oct DO - 10.1007/s13402-011-0048-2 DP - NLM ET - 2011/06/01 IS - 5 LA - eng N1 - 2211-3436 Duijkers, Floor A M Gaal, José Meijerink, Jules P P Admiraal, Pieter Pieters, Rob de Krijger, Ronald R van Noesel, Max M Journal Article Research Support, Non-U.S. Gov't Cell Oncol (Dordr). 2011 Oct;34(5):409-17. doi: 10.1007/s13402-011-0048-2. Epub 2011 May 31. PY - 2011 SN - 2211-3428 (Print) 2211-3428 SP - 409-17 ST - Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels T2 - Cell Oncol (Dordr) TI - Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels VL - 34 ID - 339 ER - TY - JOUR AD - Paediatric Oncology, Institute of Cancer Research, Sutton, United Kingdom. AN - 21659463 AU - Bielen, A. AU - Perryman, L. AU - Box, G. M. AU - Valenti, M. AU - de Haven Brandon, A. AU - Martins, V. AU - Jury, A. AU - Popov, S. AU - Gowan, S. AU - Jeay, S. AU - Raynaud, F. I. AU - Hofmann, F. AU - Hargrave, D. AU - Eccles, S. A. AU - Jones, C. C2 - PMC3160488 C6 - UKMS35725 DA - Aug DO - 10.1158/1535-7163.Mct-11-0205 DP - NLM ET - 2011/06/11 IS - 8 LA - eng N1 - 1538-8514 Bielen, Aleksandra Perryman, Lara Box, Gary M Valenti, Melanie de Haven Brandon, Alexis Martins, Vanessa Jury, Alexa Popov, Sergey Gowan, Sharon Jeay, Sebastien Raynaud, Florence I Hofmann, Francesco Hargrave, Darren Eccles, Suzanne A Jones, Chris C13468/A6718/Cancer Research UK/United Kingdom C309/A8274/Cancer Research UK/United Kingdom A11736/Cancer Research UK/United Kingdom 11566/Cancer Research UK/United Kingdom A6718/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Mol Cancer Ther. 2011 Aug;10(8):1407-18. doi: 10.1158/1535-7163.MCT-11-0205. Epub 2011 Jun 9. PY - 2011 SN - 1535-7163 (Print) 1535-7163 SP - 1407-18 ST - Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β T2 - Mol Cancer Ther TI - Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β VL - 10 ID - 340 ER - TY - JOUR AD - Division of Ophthalmology, 455 Hospital, PLA, Shanghai, PR China. AN - 21769948 AU - Min, H. AU - Ghatnekar, G. S. AU - Ghatnekar, A. V. AU - You, X. AU - Bu, M. AU - Guo, X. AU - Bu, S. AU - Shen, B. AU - Huang, Q. DA - Jul DO - 10.1002/mc.20825 DP - NLM ET - 2011/07/20 IS - 7 LA - eng N1 - 1098-2744 Min, Hongbo Ghatnekar, Gautam S Ghatnekar, Angela V You, Xiaohong Bu, Min Guo, Xinyi Bu, Shizhong Shen, Bo Huang, Qin Journal Article Research Support, Non-U.S. Gov't United States Mol Carcinog. 2012 Jul;51(7):576-85. doi: 10.1002/mc.20825. Epub 2011 Jul 18. PY - 2012 SN - 0899-1987 SP - 576-85 ST - 2-Methoxyestradiol induced Bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation T2 - Mol Carcinog TI - 2-Methoxyestradiol induced Bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation VL - 51 ID - 341 ER - TY - JOUR AD - INSERM ERI-21/EA4319, University of Nice Sophia Antipolis, 06107 Nice, France. AN - 21778212 AU - Lassalle, S. AU - Hofman, V. AU - Ilie, M. AU - Bonnetaud, C. AU - Puisségur, M. P. AU - Brest, P. AU - Loubatier, C. AU - Guevara, N. AU - Bordone, O. AU - Cardinaud, B. AU - Lebrigand, K. AU - Rios, G. AU - Santini, J. AU - Franc, B. AU - Mari, B. AU - Al Ghuzlan, A. AU - Vielh, P. AU - Barbry, P. AU - Hofman, P. DA - Oct DO - 10.1530/erc-10-0283 DP - NLM ET - 2011/07/23 IS - 5 LA - eng N1 - 1479-6821 Lassalle, Sandra Hofman, Véronique Ilie, Marius Bonnetaud, Christelle Puisségur, Marie-Pierre Brest, Patrick Loubatier, Céline Guevara, Nicolas Bordone, Olivier Cardinaud, Bruno Lebrigand, Kévin Rios, Géraldine Santini, Joseph Franc, Brigitte Mari, Bernard Al Ghuzlan, Abir Vielh, Philippe Barbry, Pascal Hofman, Paul Journal Article Research Support, Non-U.S. Gov't England Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct. PY - 2011 SN - 1351-0088 SP - 579-94 ST - Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? T2 - Endocr Relat Cancer TI - Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? VL - 18 ID - 342 ER - TY - JOUR AD - Department of Neuropathology, University of Bonn, Germany. AN - 21817898 AU - Setty, P. AU - Gessi, M. AU - Waha, A. AU - Hammes, J. AU - El-Maarri, O. AU - Pietsch, T. AU - Waha, A. DA - Sep DO - 10.1097/PDM.0b013e3182143817 DP - NLM ET - 2011/08/06 IS - 3 LA - eng N1 - 1533-4066 Setty, Prashanth Gessi, Marco Waha, Anke Hammes, Jennifer El-Maarri, Osman Pietsch, Torsten Waha, Andreas Journal Article United States Diagn Mol Pathol. 2011 Sep;20(3):148-57. doi: 10.1097/PDM.0b013e3182143817. PY - 2011 SN - 1052-9551 SP - 148-57 ST - Sensitive determination of BRAF copy number in clinical samples by pyrosequencing T2 - Diagn Mol Pathol TI - Sensitive determination of BRAF copy number in clinical samples by pyrosequencing VL - 20 ID - 343 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. AN - 21829508 AU - Janku, F. AU - Lee, J. J. AU - Tsimberidou, A. M. AU - Hong, D. S. AU - Naing, A. AU - Falchook, G. S. AU - Fu, S. AU - Luthra, R. AU - Garrido-Laguna, I. AU - Kurzrock, R. C2 - PMC3146490 DO - 10.1371/journal.pone.0022769 DP - NLM ET - 2011/08/11 IS - 7 LA - eng N1 - 1932-6203 Janku, Filip Lee, J Jack Tsimberidou, Apostolia M Hong, David S Naing, Aung Falchook, Gerald S Fu, Siqing Luthra, Rajyalakshmi Garrido-Laguna, Ignacio Kurzrock, Razelle UL1 RR024148/RR/NCRR NIH HHS/United States RR024148/RR/NCRR NIH HHS/United States Journal Article Research Support, N.I.H., Extramural PLoS One. 2011;6(7):e22769. doi: 10.1371/journal.pone.0022769. Epub 2011 Jul 29. PY - 2011 SN - 1932-6203 SP - e22769 ST - PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers T2 - PLoS One TI - PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers VL - 6 ID - 344 ER - TY - JOUR AD - Division of Endocrine and Minimally Invasive Surgery, Department of Surgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA. AN - 21879273 AU - Buitrago, D. AU - Keutgen, X. M. AU - Crowley, M. AU - Filicori, F. AU - Aldailami, H. AU - Hoda, R. AU - Liu, Y. F. AU - Hoda, R. S. AU - Scognamiglio, T. AU - Jin, M. AU - Fahey, T. J., 3rd AU - Zarnegar, R. DA - Mar DO - 10.1245/s10434-011-2029-0 DP - NLM ET - 2011/09/01 IS - 3 LA - eng N1 - 1534-4681 Buitrago, D Keutgen, X M Crowley, M Filicori, F Aldailami, H Hoda, R Liu, Yi-Fang Hoda, R S Scognamiglio, T Jin, M Fahey, T J 3rd Zarnegar, R Journal Article United States Ann Surg Oncol. 2012 Mar;19(3):973-80. doi: 10.1245/s10434-011-2029-0. Epub 2011 Aug 31. PY - 2012 SN - 1068-9265 SP - 973-80 ST - Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma T2 - Ann Surg Oncol TI - Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma VL - 19 ID - 345 ER - TY - JOUR AD - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. AN - 21884820 AU - Tian, Y. AU - Rich, B. E. AU - Vena, N. AU - Craig, J. M. AU - Macconaill, L. E. AU - Rajaram, V. AU - Goldman, S. AU - Taha, H. AU - Mahmoud, M. AU - Ozek, M. AU - Sav, A. AU - Longtine, J. A. AU - Lindeman, N. I. AU - Garraway, L. A. AU - Ligon, A. H. AU - Stiles, C. D. AU - Santagata, S. AU - Chan, J. A. AU - Kieran, M. W. AU - Ligon, K. L. C2 - PMC3194058 DA - Nov DO - 10.1016/j.jmoldx.2011.07.002 DP - NLM ET - 2011/09/03 IS - 6 LA - eng N1 - 1943-7811 Tian, Yongji Rich, Benjamin E Vena, Natalie Craig, Justin M Macconaill, Laura E Rajaram, Veena Goldman, Stewart Taha, Hala Mahmoud, Madeha Ozek, Memet Sav, Aydin Longtine, Janina A Lindeman, Neal I Garraway, Levi A Ligon, Azra H Stiles, Charles D Santagata, Sandro Chan, Jennifer A Kieran, Mark W Ligon, Keith L Journal Article Research Support, Non-U.S. Gov't J Mol Diagn. 2011 Nov;13(6):669-77. doi: 10.1016/j.jmoldx.2011.07.002. Epub 2011 Aug 30. PY - 2011 SN - 1525-1578 (Print) 1525-1578 SP - 669-77 ST - Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas T2 - J Mol Diagn TI - Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas VL - 13 ID - 346 ER - TY - JOUR AD - Dipartimento di Chirurgia, Università di Pisa, Pisa, Italy. AN - 21909080 AU - Torregrossa, L. AU - Giannini, R. AU - Borrelli, N. AU - Sensi, E. AU - Melillo, R. M. AU - Leocata, P. AU - Materazzi, G. AU - Miccoli, P. AU - Santoro, M. AU - Basolo, F. DA - Jan DO - 10.1038/modpathol.2011.140 DP - NLM ET - 2011/09/13 IS - 1 LA - eng N1 - 1530-0285 Torregrossa, Liborio Giannini, Riccardo Borrelli, Nicla Sensi, Elisa Melillo, Rosa Marina Leocata, Pietro Materazzi, Gabriele Miccoli, Paolo Santoro, Massimo Basolo, Fulvio Journal Article Research Support, Non-U.S. Gov't United States Mod Pathol. 2012 Jan;25(1):46-55. doi: 10.1038/modpathol.2011.140. Epub 2011 Sep 9. PY - 2012 SN - 0893-3952 SP - 46-55 ST - CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas T2 - Mod Pathol TI - CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas VL - 25 ID - 347 ER - TY - JOUR AD - Department of Pathology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea. AN - 21940108 AU - Kwon, M. J. AU - Choi, Y. L. AU - Sung, K. W. AU - Kang, S. Y. AU - Park, S. M. AU - Choi, S. Y. AU - Kim, J. S. AU - Suh, Y. L. DA - Oct 15 DO - 10.1016/j.prp.2011.07.011 DP - NLM ET - 2011/09/24 IS - 10 LA - eng N1 - 1618-0631 Kwon, Mi Jung Choi, Yoon-La Sung, Ki Woong Kang, So Young Park, Sang Mo Choi, Song-Yi Kim, Jung-Sun Suh, Yeon-Lim Journal Article Research Support, Non-U.S. Gov't Germany Pathol Res Pract. 2011 Oct 15;207(10):634-9. doi: 10.1016/j.prp.2011.07.011. Epub 2011 Sep 21. PY - 2011 SN - 0344-0338 SP - 634-9 ST - Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors T2 - Pathol Res Pract TI - Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors VL - 207 ID - 348 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China. AN - 21946058 AU - Zhang, S. AU - Guo, W. AU - Ren, T. T. AU - Lu, X. C. AU - Tang, G. Q. AU - Zhao, F. L. DA - Jan DO - 10.1097/CAD.0b013e32834bfd68 DP - NLM ET - 2011/09/29 IS - 1 LA - eng N1 - 1473-5741 Zhang, Shuai Guo, Wei Ren, Ting-Ting Lu, Xin-Chang Tang, Guo-Qing Zhao, Fu-Long Journal Article Research Support, Non-U.S. Gov't England Anticancer Drugs. 2012 Jan;23(1):108-18. doi: 10.1097/CAD.0b013e32834bfd68. PY - 2012 SN - 0959-4973 SP - 108-18 ST - Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase T2 - Anticancer Drugs TI - Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase VL - 23 ID - 349 ER - TY - JOUR AD - University of California, San Francisco, San Francisco, CA 94158, USA. AN - 22038996 AU - Nicolaides, T. P. AU - Li, H. AU - Solomon, D. A. AU - Hariono, S. AU - Hashizume, R. AU - Barkovich, K. AU - Baker, S. J. AU - Paugh, B. S. AU - Jones, C. AU - Forshew, T. AU - Hindley, G. F. AU - Hodgson, J. G. AU - Kim, J. S. AU - Rowitch, D. H. AU - Weiss, W. A. AU - Waldman, T. A. AU - James, C. D. C2 - PMC3638050 C6 - NIHMS334979 constituting conflicts) at the time of submission. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-11-1456 DP - NLM ET - 2011/11/01 IS - 24 LA - eng N1 - Nicolaides, Theodore P Li, Huifang Solomon, David A Hariono, Sujatmi Hashizume, Rintaro Barkovich, Krister Baker, Suzanne J Paugh, Barbara S Jones, Chris Forshew, Tim Hindley, Guy F Hodgson, J Graeme Kim, Jung-Sik Rowitch, David H Weiss, William A Waldman, Todd A James, C David K08 NS065268/NS/NINDS NIH HHS/United States R01 CA135554/CA/NCI NIH HHS/United States R01 CA159467/CA/NCI NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States P01 CA096832/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Clin Cancer Res. 2011 Dec 15;17(24):7595-604. doi: 10.1158/1078-0432.CCR-11-1456. Epub 2011 Oct 28. PY - 2011 SN - 1078-0432 (Print) 1078-0432 SP - 7595-604 ST - Targeted therapy for BRAFV600E malignant astrocytoma T2 - Clin Cancer Res TI - Targeted therapy for BRAFV600E malignant astrocytoma VL - 17 ID - 350 ER - TY - JOUR AD - Department of Anatomy and Developmental Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 22076433 AU - Sugiyama, N. AU - Kohno, M. AU - Yokoyama, T. DA - Apr DO - 10.1093/ndt/gfr550 DP - NLM ET - 2011/11/15 IS - 4 LA - eng N1 - 1460-2385 Sugiyama, Noriyuki Kohno, Michiaki Yokoyama, Takahiko Journal Article Research Support, Non-U.S. Gov't England Nephrol Dial Transplant. 2012 Apr;27(4):1351-8. doi: 10.1093/ndt/gfr550. Epub 2011 Nov 9. PY - 2012 SN - 0931-0509 SP - 1351-8 ST - Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model T2 - Nephrol Dial Transplant TI - Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model VL - 27 ID - 351 ER - TY - JOUR AD - Department of Pathology, Anschutz Medical Campus, University of Colorado, Denver, CO 80045, USA. bk.demasters@ucdenver.edu AN - 22082607 AU - Kleinschmidt-DeMasters, B. K. AU - Birks, D. K. AU - Aisner, D. L. AU - Hankinson, T. C. AU - Rosenblum, M. K. DA - Dec DO - 10.1097/PAS.0b013e3182382a3f DP - NLM ET - 2011/11/16 IS - 12 LA - eng N1 - 1532-0979 Kleinschmidt-DeMasters, B K Birks, Diane K Aisner, Dara L Hankinson, Todd C Rosenblum, Marc K Case Reports Journal Article United States Am J Surg Pathol. 2011 Dec;35(12):1894-901. doi: 10.1097/PAS.0b013e3182382a3f. PY - 2011 SN - 0147-5185 SP - 1894-901 ST - Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization T2 - Am J Surg Pathol TI - Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization VL - 35 ID - 352 ER - TY - JOUR AN - 22092579 AU - Passeron, T. AU - Lacour, J. P. AU - Allegra, M. AU - Ségalen, C. AU - Deville, A. AU - Thyss, A. AU - Giacchero, D. AU - Ortonne, J. P. AU - Bertolotto, C. AU - Ballotti, R. AU - Bahadoran, P. DA - Dec DO - 10.1111/j.1600-0625.2011.01385.x DP - NLM ET - 2011/11/19 IS - 12 LA - eng N1 - 1600-0625 Passeron, Thierry Lacour, Jean-Philippe Allegra, Maryline Ségalen, Coralie Deville, Anne Thyss, Antoine Giacchero, Damien Ortonne, Jean-Paul Bertolotto, Corine Ballotti, Robert Bahadoran, Philippe Case Reports Letter Research Support, Non-U.S. Gov't Denmark Exp Dermatol. 2011 Dec;20(12):1030-2. doi: 10.1111/j.1600-0625.2011.01385.x. PY - 2011 SN - 0906-6705 SP - 1030-2 ST - Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? T2 - Exp Dermatol TI - Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? VL - 20 ID - 353 ER - TY - JOUR AD - Department of Dermatology and Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road TBRC, 2nd Floor, Suite C2010, Milwaukee, WI 53226, USA. dsiegel@mcw.edu AN - 22098123 AU - Siegel, D. H. AU - Mann, J. A. AU - Krol, A. L. AU - Rauen, K. A. C2 - PMC4063554 C6 - NIHMS339752 DA - Mar DO - 10.1111/j.1365-2133.2011.10744.x DP - NLM ET - 2011/11/22 IS - 3 LA - eng N1 - 1365-2133 Siegel, D H Mann, J A Krol, A L Rauen, K A K23 HD048502/HD/NICHD NIH HHS/United States K23 HD048502-01/HD/NICHD NIH HHS/United States UL1 RR024140/RR/NCRR NIH HHS/United States HD048502/HD/NICHD NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Br J Dermatol. 2012 Mar;166(3):601-7. doi: 10.1111/j.1365-2133.2011.10744.x. PY - 2012 SN - 0007-0963 (Print) 0007-0963 SP - 601-7 ST - Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development T2 - Br J Dermatol TI - Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development VL - 166 ID - 354 ER - TY - JOUR AD - Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. AN - 22142829 AU - Shukla, N. AU - Ameur, N. AU - Yilmaz, I. AU - Nafa, K. AU - Lau, C. Y. AU - Marchetti, A. AU - Borsu, L. AU - Barr, F. G. AU - Ladanyi, M. C2 - PMC3271129 C6 - NIHMS342183 DA - Feb 1 DO - 10.1158/1078-0432.Ccr-11-2056 DP - NLM ET - 2011/12/07 IS - 3 LA - eng N1 - 1078-0432 Shukla, Neerav Ameur, Nabahet Yilmaz, Ismail Nafa, Khedoudja Lau, Chyau-Yueh Marchetti, Angela Borsu, Laetitia Barr, Frederic G Ladanyi, Marc P01 CA106450/CA/NCI NIH HHS/United States P01 CA106450-05/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Clin Cancer Res. 2012 Feb 1;18(3):748-57. doi: 10.1158/1078-0432.CCR-11-2056. Epub 2011 Dec 5. PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 748-57 ST - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways T2 - Clin Cancer Res TI - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways VL - 18 ID - 355 ER - TY - JOUR AD - Department of Pediatrics, Pediatric Oncology Institute (Grupo de Apoio ao Adolescente e à Criança com Câncer), Federal University of São Paulo, São Paulo, SP 04023-062, Brazil. francine.tesser@yahoo.com.br AN - 22154052 AU - Tesser-Gamba, F. AU - Petrilli, A. S. AU - de Seixas Alves, M. T. AU - Filho, R. J. AU - Juliano, Y. AU - Toledo, S. R. DA - Jul DO - 10.1016/j.humpath.2011.08.003 DP - NLM ET - 2011/12/14 IS - 7 LA - eng N1 - 1532-8392 Tesser-Gamba, Francine Petrilli, Antonio Sergio de Seixas Alves, Maria Teresa Filho, Reynaldo Jesus Garcia Juliano, Yara Toledo, Sílvia Regina Caminada Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2012 Jul;43(7):994-1002. doi: 10.1016/j.humpath.2011.08.003. Epub 2011 Dec 9. PY - 2012 SN - 0046-8177 SP - 994-1002 ST - MAPK7 and MAP2K4 as prognostic markers in osteosarcoma T2 - Hum Pathol TI - MAPK7 and MAP2K4 as prognostic markers in osteosarcoma VL - 43 ID - 356 ER - TY - JOUR AD - ARUP Institute for Clinical and Experimental Pathology®, ARUP Laboratories, Inc., and Department of Pathology, University of Utah, Salt Lake City, Utah, USA. AN - 22156469 AU - Smith, G. D. AU - Zhou, L. AU - Rowe, L. R. AU - Jarboe, E. A. AU - Collins, B. T. AU - Bentz, J. S. AU - Wittwer, C. T. AU - Chadwick, B. E. DO - 10.1159/000333453 DP - NLM ET - 2011/12/14 IS - 6 LA - eng N1 - Smith, G Denice Zhou, Luming Rowe, Leslie R Jarboe, Elke A Collins, Brian T Bentz, Joel S Wittwer, Carl T Chadwick, Barbara E Journal Article Research Support, Non-U.S. Gov't Switzerland Acta Cytol. 2011;55(6):576-83. doi: 10.1159/000333453. Epub 2011 Dec 9. PY - 2011 SN - 0001-5547 (Print) 0001-5547 SP - 576-83 ST - Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens T2 - Acta Cytol TI - Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens VL - 55 ID - 357 ER - TY - JOUR AD - Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. AN - 22157620 AU - Lin, A. AU - Rodriguez, F. J. AU - Karajannis, M. A. AU - Williams, S. C. AU - Legault, G. AU - Zagzag, D. AU - Burger, P. C. AU - Allen, J. C. AU - Eberhart, C. G. AU - Bar, E. E. C2 - PMC4629834 C6 - NIHMS729483 DA - Jan DO - 10.1097/NEN.0b013e31823f2cb0 DP - NLM ET - 2011/12/14 IS - 1 LA - eng N1 - 1554-6578 Lin, Alex Rodriguez, Fausto J Karajannis, Matthias A Williams, Susan C Legault, Genevieve Zagzag, David Burger, Peter C Allen, Jeffrey C Eberhart, Charles G Bar, Eli E P30 CA006973/CA/NCI NIH HHS/United States Comparative Study Journal Article Research Support, Non-U.S. Gov't J Neuropathol Exp Neurol. 2012 Jan;71(1):66-72. doi: 10.1097/NEN.0b013e31823f2cb0. PY - 2012 SN - 0022-3069 (Print) 0022-3069 SP - 66-72 ST - BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants T2 - J Neuropathol Exp Neurol TI - BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants VL - 71 ID - 358 ER - TY - JOUR AD - Department of Orthopaedics, Second Affiliated Hospital, Shandong University, 247 Beiyuan Da Street, Jinan 250033, PR China. AN - 22179790 AU - Si, H. AU - Peng, C. AU - Li, J. AU - Wang, X. AU - Zhai, L. AU - Li, X. AU - Li, J. C2 - PMC3584577 DA - Apr DO - 10.3892/ijo.2011.1303 DP - NLM ET - 2011/12/20 IS - 4 LA - eng N1 - 1791-2423 Si, Haipeng Peng, Changliang Li, Jingjing Wang, Xiqian Zhai, Lianwen Li, Xiaofeng Li, Jianmin Journal Article Research Support, Non-U.S. Gov't Int J Oncol. 2012 Apr;40(4):1291-7. doi: 10.3892/ijo.2011.1303. Epub 2011 Dec 15. PY - 2012 SN - 1019-6439 (Print) 1019-6439 SP - 1291-7 ST - RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro T2 - Int J Oncol TI - RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro VL - 40 ID - 359 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI, USA. AN - 22179823 AU - McDonnell, S. R. AU - Hwang, S. R. AU - Basrur, V. AU - Conlon, K. P. AU - Fermin, D. AU - Wey, E. AU - Murga-Zamalloa, C. AU - Zeng, Z. AU - Zu, Y. AU - Elenitoba-Johnson, K. S. AU - Lim, M. S. C2 - PMC4244868 C6 - NIHMS643434 DA - Aug 9 DO - 10.1038/onc.2011.542 DP - NLM ET - 2011/12/20 IS - 32 LA - eng N1 - 1476-5594 McDonnell, S R P Hwang, S R Basrur, V Conlon, K P Fermin, D Wey, E Murga-Zamalloa, C Zeng, Z Zu, Y Elenitoba-Johnson, K S J Lim, M S R01 CA140806/CA/NCI NIH HHS/United States R01 CA136905/CA/NCI NIH HHS/United States 5R01CA140806-02/CA/NCI NIH HHS/United States R01DE119249/DE/NIDCR NIH HHS/United States R01CA136905/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Oncogene. 2012 Aug 9;31(32):3733-40. doi: 10.1038/onc.2011.542. Epub 2011 Dec 19. PY - 2012 SN - 0950-9232 (Print) 0950-9232 SP - 3733-40 ST - NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis T2 - Oncogene TI - NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis VL - 31 ID - 360 ER - TY - JOUR AD - Section of Cytopathology, University of Pisa and Pisa University Hospital, Pisa, Italy. i.marchetti@ao-pisa.toscana.it AN - 22181337 AU - Marchetti, I. AU - Iervasi, G. AU - Mazzanti, C. M. AU - Lessi, F. AU - Tomei, S. AU - Naccarato, A. G. AU - Aretini, P. AU - Alberti, B. AU - Di Coscio, G. AU - Bevilacqua, G. DA - Mar DO - 10.1089/thy.2011.0107 DP - NLM ET - 2011/12/21 IS - 3 LA - eng N1 - 1557-9077 Marchetti, Ivo Iervasi, Giorgio Mazzanti, Chiara Maria Lessi, Francesca Tomei, Sara Naccarato, Antonio Giuseppe Aretini, Paolo Alberti, Baldassare Di Coscio, Giancarlo Bevilacqua, Generoso Journal Article United States Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19. PY - 2012 SN - 1050-7256 SP - 292-8 ST - Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis T2 - Thyroid TI - Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis VL - 22 ID - 361 ER - TY - JOUR AD - Department of Surgery, Haeundae Paik Hospital, Inje University College of Medicine, 1435 Jwa-dong, Haeundae-gu, Busan, 612-030, Korea. su.jin.kim.md@gmail.com AN - 22190222 AU - Kim, S. J. AU - Lee, K. E. AU - Myong, J. P. AU - Park, J. H. AU - Jeon, Y. K. AU - Min, H. S. AU - Park, S. Y. AU - Jung, K. C. AU - Koo do, H. AU - Youn, Y. K. DA - Feb DO - 10.1007/s00268-011-1383-1 DP - NLM ET - 2011/12/23 IS - 2 LA - eng N1 - 1432-2323 Kim, Su-jin Lee, Kyu Eun Myong, Jun Pyo Park, Jeong-hwan Jeon, Yoon Kyung Min, Hye Sook Park, So Yeon Jung, Kyeong Cheon Koo, Do Hoon Youn, Yeo-Kyu Journal Article United States World J Surg. 2012 Feb;36(2):310-7. doi: 10.1007/s00268-011-1383-1. PY - 2012 SN - 0364-2313 SP - 310-7 ST - BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer T2 - World J Surg TI - BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer VL - 36 ID - 362 ER - TY - JOUR AD - Translational Oncopathology, IRCSS A.O.U. San Martino-IST, National Cancer Research Institute, L.go R. Benzi 10, 16132 Genoa, Italy. AN - 22192458 AU - Del Grosso, F. AU - De Mariano, M. AU - Passoni, L. AU - Luksch, R. AU - Tonini, G. P. AU - Longo, L. C2 - PMC3267831 DA - Dec 22 DO - 10.1186/1471-2407-11-525 DP - NLM ET - 2011/12/24 LA - eng N1 - 1471-2407 Del Grosso, Federica De Mariano, Marilena Passoni, Lorena Luksch, Roberto Tonini, Gian Paolo Longo, Luca Journal Article Research Support, Non-U.S. Gov't BMC Cancer. 2011 Dec 22;11:525. doi: 10.1186/1471-2407-11-525. PY - 2011 SN - 1471-2407 SP - 525 ST - Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines T2 - BMC Cancer TI - Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines VL - 11 ID - 363 ER - TY - JOUR AD - Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. kaladym@ccf.org AN - 22228154 AU - Kalady, M. F. AU - Dejulius, K. L. AU - Sanchez, J. A. AU - Jarrar, A. AU - Liu, X. AU - Manilich, E. AU - Skacel, M. AU - Church, J. M. DA - Feb DO - 10.1097/DCR.0b013e31823c08b3 DP - NLM ET - 2012/01/10 IS - 2 LA - eng N1 - 1530-0358 Kalady, Matthew F Dejulius, Kathryn L Sanchez, Julian A Jarrar, Awad Liu, Xiuli Manilich, Elena Skacel, Marek Church, James M Journal Article United States Dis Colon Rectum. 2012 Feb;55(2):128-33. doi: 10.1097/DCR.0b013e31823c08b3. PY - 2012 SN - 0012-3706 SP - 128-33 ST - BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis T2 - Dis Colon Rectum TI - BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis VL - 55 ID - 364 ER - TY - JOUR AD - Division of Medical Genetics, Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA. kgripp@nemours.org AN - 22261753 AU - Gripp, K. W. AU - Lin, A. E. DA - Mar DO - 10.1038/gim.0b013e31822dd91f DP - NLM ET - 2012/01/21 IS - 3 LA - eng N1 - 1530-0366 Gripp, Karen W Lin, Angela E Case Reports Journal Article Review United States Genet Med. 2012 Mar;14(3):285-92. doi: 10.1038/gim.0b013e31822dd91f. PY - 2012 SN - 1098-3600 SP - 285-92 ST - Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations T2 - Genet Med TI - Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations VL - 14 ID - 365 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics, START Center, San Antonio, Texas 78229, USA. AN - 22261800 AU - Shimizu, T. AU - Tolcher, A. W. AU - Papadopoulos, K. P. AU - Beeram, M. AU - Rasco, D. W. AU - Smith, L. S. AU - Gunn, S. AU - Smetzer, L. AU - Mays, T. A. AU - Kaiser, B. AU - Wick, M. J. AU - Alvarez, C. AU - Cavazos, A. AU - Mangold, G. L. AU - Patnaik, A. DA - Apr 15 DO - 10.1158/1078-0432.Ccr-11-2381 DP - NLM ET - 2012/01/21 IS - 8 LA - eng N1 - Shimizu, Toshio Tolcher, Anthony W Papadopoulos, Kyriakos P Beeram, Muralidhar Rasco, Drew W Smith, Lon S Gunn, Shelly Smetzer, Leslie Mays, Theresa A Kaiser, Brianne Wick, Michael J Alvarez, Cathy Cavazos, Aracely Mangold, Gina L Patnaik, Amita Journal Article United States Clin Cancer Res. 2012 Apr 15;18(8):2316-25. doi: 10.1158/1078-0432.CCR-11-2381. Epub 2012 Jan 19. PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 2316-25 ST - The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer T2 - Clin Cancer Res TI - The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer VL - 18 ID - 366 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. AN - 22266870 AU - Carpenter, E. L. AU - Haglund, E. A. AU - Mace, E. M. AU - Deng, D. AU - Martinez, D. AU - Wood, A. C. AU - Chow, A. K. AU - Weiser, D. A. AU - Belcastro, L. T. AU - Winter, C. AU - Bresler, S. C. AU - Vigny, M. AU - Mazot, P. AU - Asgharzadeh, S. AU - Seeger, R. C. AU - Zhao, H. AU - Guo, R. AU - Christensen, J. G. AU - Orange, J. S. AU - Pawel, B. R. AU - Lemmon, M. A. AU - Mossé, Y. P. C2 - PMC3730824 C6 - NIHMS470414 DA - Nov 15 DO - 10.1038/onc.2011.647 DP - NLM ET - 2012/01/24 IS - 46 LA - eng N1 - 1476-5594 Carpenter, E L Haglund, E A Mace, E M Deng, D Martinez, D Wood, A C Chow, A K Weiser, D A Belcastro, L T Winter, C Bresler, S C Vigny, M Mazot, P Asgharzadeh, S Seeger, R C Zhao, H Guo, R Christensen, J G Orange, J S Pawel, B R Lemmon, M A Mossé, Y P 2R01 CA60104-16/CA/NCI NIH HHS/United States R01-CA140198/CA/NCI NIH HHS/United States T32-GM008275/GM/NIGMS NIH HHS/United States T32 CA009615/CA/NCI NIH HHS/United States 2R01 CA60104-16S1/CA/NCI NIH HHS/United States T32 GM008275/GM/NIGMS NIH HHS/United States R01 CA140198/CA/NCI NIH HHS/United States R01 CA060104/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Oncogene. 2012 Nov 15;31(46):4859-67. doi: 10.1038/onc.2011.647. Epub 2012 Jan 23. PY - 2012 SN - 0950-9232 (Print) 0950-9232 SP - 4859-67 ST - Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma T2 - Oncogene TI - Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma VL - 31 ID - 367 ER - TY - JOUR AD - Pediatric Onco-Hematology Clinic, University Hospital Padova, Padova, Italy. paolo.bonvini@unipd.it AN - 22289917 AU - Bonvini, P. AU - Zorzi, E. AU - Mussolin, L. AU - Pillon, M. AU - Romualdi, C. AU - Peron, M. AU - d'Amore, E. S. AU - Lamant, L. AU - Rosolen, A. DA - Jun DO - 10.1038/leu.2011.367 DP - NLM ET - 2012/02/01 IS - 6 LA - eng N1 - 1476-5551 Bonvini, P Zorzi, E Mussolin, L Pillon, M Romualdi, C Peron, M d'Amore, E S G Lamant, L Rosolen, A Journal Article Research Support, Non-U.S. Gov't England Leukemia. 2012 Jun;26(6):1375-82. doi: 10.1038/leu.2011.367. Epub 2012 Jan 6. PY - 2012 SN - 0887-6924 SP - 1375-82 ST - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas T2 - Leukemia TI - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas VL - 26 ID - 368 ER - TY - JOUR AD - Biomaterials and Tissue Engineering Research Unit, School of AMME, The University of Sydney, Sydney, Australia. AN - 22296271 AU - Lu, Z. AU - Wang, G. AU - Dunstan, C. R. AU - Zreiqat, H. DA - Sep 1 DO - 10.1089/scd.2011.0589 DP - NLM ET - 2012/02/03 IS - 13 LA - eng N1 - 1557-8534 Lu, ZuFu Wang, Guocheng Dunstan, Colin R Zreiqat, Hala Journal Article Research Support, Non-U.S. Gov't United States Stem Cells Dev. 2012 Sep 1;21(13):2420-9. doi: 10.1089/scd.2011.0589. Epub 2012 Mar 6. PY - 2012 SN - 1547-3287 SP - 2420-9 ST - Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation T2 - Stem Cells Dev TI - Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation VL - 21 ID - 369 ER - TY - JOUR AD - Department of Pathology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. laueran@ohsu.edu AN - 22317887 AU - Chakrapani, A. AU - Warrick, A. AU - Nelson, D. AU - Beadling, C. AU - Corless, C. L. DA - Jul DO - 10.1097/DAD.0b013e31823931b4 DP - NLM ET - 2012/02/10 IS - 5 LA - eng N1 - 1533-0311 Chakrapani, Andrea Warrick, Andrea Nelson, Dylan Beadling, Carol Corless, Christopher L Journal Article United States Am J Dermatopathol. 2012 Jul;34(5):533-5. doi: 10.1097/DAD.0b013e31823931b4. PY - 2012 SN - 0193-1091 SP - 533-5 ST - BRAF and KRAS mutations in sporadic glomus tumors T2 - Am J Dermatopathol TI - BRAF and KRAS mutations in sporadic glomus tumors VL - 34 ID - 370 ER - TY - JOUR AD - Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-Osaka 577-8502, Japan. AN - 22326785 AU - Tsubaki, M. AU - Satou, T. AU - Itoh, T. AU - Imano, M. AU - Ogaki, M. AU - Yanae, M. AU - Nishida, S. DA - Mar 15 DO - 10.1016/j.taap.2012.01.024 DP - NLM ET - 2012/02/14 IS - 3 LA - eng N1 - 1096-0333 Tsubaki, Masanobu Satou, Takao Itoh, Tatsuki Imano, Motohiro Ogaki, Mitsuhiko Yanae, Masashi Nishida, Shozo Journal Article United States Toxicol Appl Pharmacol. 2012 Mar 15;259(3):402-10. doi: 10.1016/j.taap.2012.01.024. Epub 2012 Feb 3. PY - 2012 SN - 0041-008x SP - 402-10 ST - Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway T2 - Toxicol Appl Pharmacol TI - Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway VL - 259 ID - 371 ER - TY - JOUR AD - Medical and Scientific Affairs, Roche Molecular Systems, Inc, 4300 Hacienda Dr, Pleasanton, CA 94588, USA. AN - 22332713 AU - Anderson, S. AU - Bloom, K. J. AU - Vallera, D. U. AU - Rueschoff, J. AU - Meldrum, C. AU - Schilling, R. AU - Kovach, B. AU - Lee, J. R. AU - Ochoa, P. AU - Langland, R. AU - Halait, H. AU - Lawrence, H. J. AU - Dugan, M. C. DA - Nov DO - 10.5858/arpa.2011-0505-OA DP - NLM ET - 2012/02/16 IS - 11 LA - eng N1 - 1543-2165 Anderson, Steven Bloom, Kenneth J Vallera, Dino U Rueschoff, Josef Meldrum, Cliff Schilling, Robert Kovach, Barbara Lee, Ju Ruey-Jiuan Ochoa, Pam Langland, Rachel Halait, Harkanwal Lawrence, H Jeffrey Dugan, Michael C Clinical Trial, Phase II Clinical Trial, Phase III Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Arch Pathol Lab Med. 2012 Nov;136(11):1385-91. doi: 10.5858/arpa.2011-0505-OA. Epub 2012 Feb 14. PY - 2012 SN - 0003-9985 SP - 1385-91 ST - Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma T2 - Arch Pathol Lab Med TI - Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma VL - 136 ID - 372 ER - TY - JOUR AD - Department of Pathology, Nanfang Hospital affiliated to Southern Medical University, Guangzhou 510515 Guangdong, China. AN - 22365399 AU - Li, H. L. AU - Huang, X. P. AU - Zhou, X. H. AU - Ji, T. H. AU - Wu, Z. Q. AU - Wang, Z. Q. AU - Jiang, H. Y. AU - Liu, F. R. AU - Zhao, T. DA - Dec DO - 10.3967/0895-3988.2011.06.007 DP - NLM ET - 2012/03/01 IS - 6 LA - eng N1 - Li, Hui Ling Huang, Xue Ping Zhou, Xin Hua Ji, Tian Hai Wu, Zi Qing Wang, Zhi Qiang Jiang, Hui Yong Liu, Fan Rong Zhao, Tong Journal Article Research Support, Non-U.S. Gov't China Biomed Environ Sci. 2011 Dec;24(6):630-41. doi: 10.3967/0895-3988.2011.06.007. PY - 2011 SN - 0895-3988 (Print) 0895-3988 SP - 630-41 ST - Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma T2 - Biomed Environ Sci TI - Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma VL - 24 ID - 373 ER - TY - JOUR AD - Department of Endocrinology, Acibadem Maslak Hospital, Buyukdere Cad. No: 40, Maslak, Istanbul, Turkey. neslihandr@hotmail.com AN - 22426956 AU - Kurtulmus, N. AU - Duren, M. AU - Ince, U. AU - Cengiz Yakicier, M. AU - Peker, O. AU - Aydın, O. AU - Altiok, E. AU - Giray, S. AU - Azizlerli, H. DA - Oct DO - 10.1007/s12020-012-9651-x DP - NLM ET - 2012/03/20 IS - 2 LA - eng N1 - 1559-0100 Kurtulmus, Neslihan Duren, Mete Ince, Umit Cengiz Yakicier, M Peker, Onder Aydın, Ozlem Altiok, Ender Giray, Serdar Azizlerli, Halil Journal Article United States Endocrine. 2012 Oct;42(2):404-10. doi: 10.1007/s12020-012-9651-x. Epub 2012 Mar 17. PY - 2012 SN - 1355-008x SP - 404-10 ST - BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness T2 - Endocrine TI - BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness VL - 42 ID - 374 ER - TY - JOUR AD - Soochow University Affiliated Children's Hospital, Suzhou, China. AN - 22443189 AU - Zhu, G. AU - Ge, X. AU - Zhu, J. AU - Wei, Y. AU - Wang, J. DA - Dec DO - 10.3109/15513815.2012.659401 DP - NLM ET - 2012/03/27 IS - 6 LA - eng N1 - 1551-3823 Zhu, Guoji Ge, Xuhua Zhu, Jie Wei, Yan Wang, Jian Journal Article Research Support, Non-U.S. Gov't England Fetal Pediatr Pathol. 2012 Dec;31(6):365-73. doi: 10.3109/15513815.2012.659401. Epub 2012 Mar 23. PY - 2012 SN - 1551-3815 SP - 365-73 ST - Impaired cytokine production and decreased TLR2-mediated signaling in mouse infant macrophages T2 - Fetal Pediatr Pathol TI - Impaired cytokine production and decreased TLR2-mediated signaling in mouse infant macrophages VL - 31 ID - 375 ER - TY - JOUR AD - Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. AN - 22471241 AU - Jung, C. K. AU - Im, S. Y. AU - Kang, Y. J. AU - Lee, H. AU - Jung, E. S. AU - Kang, C. S. AU - Bae, J. S. AU - Choi, Y. J. DA - Aug DO - 10.1089/thy.2011.0123 DP - NLM ET - 2012/04/05 IS - 8 LA - eng N1 - 1557-9077 Jung, Chan-Kwon Im, So-Young Kang, Yeo-Ju Lee, Hyoungnam Jung, Eun-Sun Kang, Chang-Suk Bae, Ja-Seong Choi, Yeong-Jin Journal Article United States Thyroid. 2012 Aug;22(8):791-7. doi: 10.1089/thy.2011.0123. Epub 2012 Apr 3. PY - 2012 SN - 1050-7256 SP - 791-7 ST - Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma T2 - Thyroid TI - Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma VL - 22 ID - 376 ER - TY - JOUR AD - Department of Ophthalmology, Summa Health System, Akron, Ohio, USA. dedwar39@jhmi.edu AN - 22480745 AU - Edward, D. P. AU - Morales, J. AU - Bouhenni, R. A. AU - Patil, J. AU - Edward, P. R. AU - Cummings, T. J. AU - Chaudhry, I. A. AU - Alkatan, H. DA - Jul DO - 10.1016/j.ophtha.2012.01.027 DP - NLM ET - 2012/04/07 IS - 7 LA - eng N1 - 1549-4713 Edward, Deepak P Morales, Jose Bouhenni, Rachida A Patil, Jayaprakash Edward, Priya R Cummings, Thomas J Chaudhry, Imtiaz A Alkatan, Hind Journal Article Research Support, Non-U.S. Gov't United States Ophthalmology. 2012 Jul;119(7):1485-94. doi: 10.1016/j.ophtha.2012.01.027. Epub 2012 Apr 4. PY - 2012 SN - 0161-6420 SP - 1485-94 ST - Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights T2 - Ophthalmology TI - Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights VL - 119 ID - 377 ER - TY - JOUR AD - Department of Laboratory Diagnostics, Division of Molecular Diagnostics, University Hospital Center Zagrab, Croatia. AN - 22489692 AU - Rako, I. AU - Jakic-Razumovic, J. AU - Katalinic, D. AU - Sertic, J. AU - Plestina, S. DO - 10.4149/neo_2012_049 DP - NLM ET - 2012/04/12 IS - 4 LA - eng N1 - Rako, I Jakic-Razumovic, J Katalinic, D Sertic, J Plestina, S Journal Article Research Support, Non-U.S. Gov't Slovakia Neoplasma. 2012;59(4):376-83. doi: 10.4149/neo_2012_049. PY - 2012 SN - 0028-2685 (Print) 0028-2685 SP - 376-83 ST - Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients T2 - Neoplasma TI - Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients VL - 59 ID - 378 ER - TY - JOUR AD - Department of Pathology, University of Kentucky, MS-155, 800 Rose Street, Lexington, KY 40536, USA. craig.horbinski@uky.edu AN - 22492957 AU - Horbinski, C. AU - Nikiforova, M. N. AU - Hagenkord, J. M. AU - Hamilton, R. L. AU - Pollack, I. F. C2 - PMC3367847 DA - Jun DO - 10.1093/neuonc/nos077 DP - NLM ET - 2012/04/12 IS - 6 LA - eng N1 - 1523-5866 Horbinski, Craig Nikiforova, Marina N Hagenkord, Jill M Hamilton, Ronald L Pollack, Ian F K08 CA155764/CA/NCI NIH HHS/United States K08 CA155764-01A1/CA/NCI NIH HHS/United States R01NS37704/NS/NINDS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Neuro Oncol. 2012 Jun;14(6):777-89. doi: 10.1093/neuonc/nos077. Epub 2012 Apr 5. PY - 2012 SN - 1522-8517 (Print) 1522-8517 SP - 777-89 ST - Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas T2 - Neuro Oncol TI - Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas VL - 14 ID - 379 ER - TY - JOUR AD - Department of Nuclear Medicine, Virgen de las Nieves University Hospital, Granada, Spain. marisacgarre@gmail.com AN - 22504197 AU - Cañadas-Garre, M. AU - Becerra-Massare, P. AU - López de la Torre-Casares, M. AU - Villar-del Moral, J. AU - Céspedes-Mas, S. AU - Vílchez-Joya, R. AU - Muros-de Fuentes, T. AU - García-Calvente, C. AU - Piédrola-Maroto, G. AU - López-Nevot, M. A. AU - Montes-Ramírez, R. AU - Llamas-Elvira, J. M. DA - May DO - 10.1097/SLA.0b013e31824e8d70 DP - NLM ET - 2012/04/17 IS - 5 LA - eng N1 - 1528-1140 Cañadas-Garre, Marisa Becerra-Massare, Patricia López de la Torre-Casares, Martín Villar-del Moral, Jesús Céspedes-Mas, Susana Vílchez-Joya, Ricardo Muros-de Fuentes, Teresa García-Calvente, Carlos Piédrola-Maroto, Gonzalo López-Nevot, Miguel A Montes-Ramírez, Rosa Llamas-Elvira, José M Journal Article Research Support, Non-U.S. Gov't United States Ann Surg. 2012 May;255(5):986-92. doi: 10.1097/SLA.0b013e31824e8d70. PY - 2012 SN - 0003-4932 SP - 986-92 ST - Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients T2 - Ann Surg TI - Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients VL - 255 ID - 380 ER - TY - JOUR AD - Department of Pediatric Intensive Care, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands. AN - 22506067 AU - de Jong, P. R. AU - Schadenberg, A. W. AU - van den Broek, T. AU - Beekman, J. M. AU - van Wijk, F. AU - Coffer, P. J. AU - Prakken, B. J. AU - Jansen, N. J. C2 - PMC3323636 DO - 10.1371/journal.pone.0035070 DP - NLM ET - 2012/04/17 IS - 4 LA - eng N1 - 1932-6203 de Jong, Petrus R Schadenberg, Alvin W L van den Broek, Theo Beekman, Jeffrey M van Wijk, Femke Coffer, Paul J Prakken, Berent J Jansen, Nicolaas J G Journal Article Research Support, Non-U.S. Gov't PLoS One. 2012;7(4):e35070. doi: 10.1371/journal.pone.0035070. Epub 2012 Apr 10. PY - 2012 SN - 1932-6203 SP - e35070 ST - STAT3 regulates monocyte TNF-alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass T2 - PLoS One TI - STAT3 regulates monocyte TNF-alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass VL - 7 ID - 381 ER - TY - JOUR AD - Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4006, Australia. c.rosty@uq.edu.au AN - 22510757 AU - Rosty, C. AU - Buchanan, D. D. AU - Walsh, M. D. AU - Pearson, S. A. AU - Pavluk, E. AU - Walters, R. J. AU - Clendenning, M. AU - Spring, K. J. AU - Jenkins, M. A. AU - Win, A. K. AU - Hopper, J. L. AU - Sweet, K. AU - Frankel, W. L. AU - Aronson, M. AU - Gallinger, S. AU - Goldblatt, J. AU - Woodall, S. AU - Arnold, J. AU - Walker, N. I. AU - Jass, J. R. AU - Parry, S. AU - Young, J. P. C2 - PMC3354022 C6 - NIHMS361343 respect to this work. DA - Jun DO - 10.1097/PAS.0b013e31824e133f DP - NLM ET - 2012/04/19 IS - 6 LA - eng N1 - 1532-0979 Rosty, Christophe Buchanan, Daniel D Walsh, Michael D Pearson, Sally-Ann Pavluk, Erika Walters, Rhiannon J Clendenning, Mark Spring, Kevin J Jenkins, Mark A Win, Aung K Hopper, John L Sweet, Kevin Frankel, Wendy L Aronson, Melyssa Gallinger, Steve Goldblatt, Jack Woodall, Sonja Arnold, Julie Walker, Neal I Jass, Jeremy R Parry, Susan Young, Joanne P R01 CA123010/CA/NCI NIH HHS/United States R01 CA123010-01A1/CA/NCI NIH HHS/United States U01 CA097735/CA/NCI NIH HHS/United States 1R01CA123010/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Am J Surg Pathol. 2012 Jun;36(6):876-82. doi: 10.1097/PAS.0b013e31824e133f. PY - 2012 SN - 0147-5185 (Print) 0147-5185 SP - 876-82 ST - Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics T2 - Am J Surg Pathol TI - Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics VL - 36 ID - 382 ER - TY - JOUR AD - Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland. hanna.pelttari@kolumbus.fi AN - 22515292 AU - Pelttari, H. AU - Schalin-Jäntti, C. AU - Arola, J. AU - Löyttyniemi, E. AU - Knuutila, S. AU - Välimäki, M. J. DA - May DO - 10.1111/j.1600-0463.2011.02844.x DP - NLM ET - 2012/04/21 IS - 5 LA - eng N1 - 1600-0463 Pelttari, Hanna Schalin-Jäntti, Camilla Arola, Johanna Löyttyniemi, Eliisa Knuutila, Sakari Välimäki, Matti J Journal Article Research Support, Non-U.S. Gov't Denmark APMIS. 2012 May;120(5):380-6. doi: 10.1111/j.1600-0463.2011.02844.x. Epub 2011 Nov 25. PY - 2012 SN - 0903-4641 SP - 380-6 ST - BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients T2 - Apmis TI - BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients VL - 120 ID - 383 ER - TY - JOUR AD - Cell Signaling Technology, Inc., Danvers, Massachusetts 01923, USA. AN - 22570254 AU - Ren, H. AU - Tan, Z. P. AU - Zhu, X. AU - Crosby, K. AU - Haack, H. AU - Ren, J. M. AU - Beausoleil, S. AU - Moritz, A. AU - Innocenti, G. AU - Rush, J. AU - Zhang, Y. AU - Zhou, X. M. AU - Gu, T. L. AU - Yang, Y. F. AU - Comb, M. J. DA - Jul 1 DO - 10.1158/0008-5472.Can-11-3931 DP - NLM ET - 2012/05/10 IS - 13 LA - eng N1 - 1538-7445 Ren, Hong Tan, Zhi-Ping Zhu, Xin Crosby, Katherine Haack, Herbert Ren, Jian-Min Beausoleil, Sean Moritz, Albrecht Innocenti, Gregory Rush, John Zhang, Yi Zhou, Xin-Min Gu, Ting-Lei Yang, Yi-Feng Comb, Michael J Journal Article Research Support, Non-U.S. Gov't United States Cancer Res. 2012 Jul 1;72(13):3312-23. doi: 10.1158/0008-5472.CAN-11-3931. Epub 2012 May 8. PY - 2012 SN - 0008-5472 SP - 3312-23 ST - Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer T2 - Cancer Res TI - Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer VL - 72 ID - 384 ER - TY - JOUR AD - Department of Pediatrics, University of California, San Francisco, CA 94143, USA. AN - 22586120 AU - Huillard, E. AU - Hashizume, R. AU - Phillips, J. J. AU - Griveau, A. AU - Ihrie, R. A. AU - Aoki, Y. AU - Nicolaides, T. AU - Perry, A. AU - Waldman, T. AU - McMahon, M. AU - Weiss, W. A. AU - Petritsch, C. AU - James, C. D. AU - Rowitch, D. H. C2 - PMC3365162 DA - May 29 DO - 10.1073/pnas.1117255109 DP - NLM ET - 2012/05/16 IS - 22 LA - eng N1 - 1091-6490 Huillard, Emmanuelle Hashizume, Rintaro Phillips, Joanna J Griveau, Amélie Ihrie, Rebecca A Aoki, Yasuyuki Nicolaides, Theodore Perry, Arie Waldman, Todd McMahon, Martin Weiss, William A Petritsch, Claudia James, C David Rowitch, David H R01 NS040511/NS/NINDS NIH HHS/United States K08 NS063456/NS/NINDS NIH HHS/United States P30 CA016672/CA/NCI NIH HHS/United States 1R01CA164746/CA/NCI NIH HHS/United States K08 NS065268/NS/NINDS NIH HHS/United States R01 CA131261/CA/NCI NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States R01 NS057727/NS/NINDS NIH HHS/United States R01 CA159467/CA/NCI NIH HHS/United States R01 CA164746/CA/NCI NIH HHS/United States R01CA131261/CA/NCI NIH HHS/United States 5K08NS063456/NS/NINDS NIH HHS/United States K08NS065268/NS/NINDS NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States Howard Hughes Medical Institute/United States 2R01NS057727-05/NS/NINDS NIH HHS/United States CA097257/CA/NCI NIH HHS/United States R01CA159467/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Proc Natl Acad Sci U S A. 2012 May 29;109(22):8710-5. doi: 10.1073/pnas.1117255109. Epub 2012 May 14. PY - 2012 SN - 0027-8424 (Print) 0027-8424 SP - 8710-5 ST - Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy T2 - Proc Natl Acad Sci U S A TI - Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy VL - 109 ID - 385 ER - TY - JOUR AD - Department of Pediatrics, UCSF Helen Diller Family Comprehensive Cancer Center, and UCSF Benioff Children's Hospital, UCSF Medical Center, University of California, San Francisco, CA 94143-0106, USA. matthayk@peds.ucsf.edu AN - 22589483 AU - Matthay, K. K. AU - George, R. E. AU - Yu, A. L. C2 - PMC3382042 C6 - NIHMS366101 DA - May 15 DO - 10.1158/1078-0432.Ccr-11-1939 DP - NLM ET - 2012/05/17 IS - 10 LA - eng N1 - 1078-0432 Matthay, Katherine K George, Rani E Yu, Alice L P01 CA081403/CA/NCI NIH HHS/United States R21 CA097758-01A1/CA/NCI NIH HHS/United States P01 CA81403/CA/NCI NIH HHS/United States R01 CA148688-03/CA/NCI NIH HHS/United States P01 CA081403-13/CA/NCI NIH HHS/United States R01 CA148688/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Clin Cancer Res. 2012 May 15;18(10):2740-53. doi: 10.1158/1078-0432.CCR-11-1939. PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 2740-53 ST - Promising therapeutic targets in neuroblastoma T2 - Clin Cancer Res TI - Promising therapeutic targets in neuroblastoma VL - 18 ID - 386 ER - TY - JOUR AD - Department of Biological Sciences, CIRPeB and IBB CNR, University of Naples "Federico II," Napoli, Italy. AN - 22654515 AU - Cantisani, M. AU - Vitiello, M. AU - Falanga, A. AU - Finamore, E. AU - Galdiero, M. AU - Galdiero, S. C2 - PMC3363952 DO - 10.2147/ijn.S30467 DP - NLM ET - 2012/06/02 LA - eng N1 - 1178-2013 Cantisani, Marco Vitiello, Mariateresa Falanga, Annarita Finamore, Emiliana Galdiero, Marilena Galdiero, Stefania Journal Article Research Support, Non-U.S. Gov't Int J Nanomedicine. 2012;7:2361-71. doi: 10.2147/IJN.S30467. Epub 2012 May 11. PY - 2012 SN - 1176-9114 (Print) 1176-9114 SP - 2361-71 ST - Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity T2 - Int J Nanomedicine TI - Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity VL - 7 ID - 387 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. AN - 22658521 AU - Wang, X. AU - Krishnan, C. AU - Nguyen, E. P. AU - Meyer, K. J. AU - Oliveira, J. L. AU - Yang, P. AU - Yi, E. S. AU - Erickson-Johnson, M. R. AU - Yaszemski, M. J. AU - Maran, A. AU - Oliveira, A. M. DA - Nov DO - 10.1016/j.humpath.2012.02.014 DP - NLM ET - 2012/06/05 IS - 11 LA - eng N1 - 1532-8392 Wang, Xiaoke Krishnan, Chandra Nguyen, Edward P Meyer, Kevin J Oliveira, Jennifer L Yang, Ping Yi, Eunhee S Erickson-Johnson, Michele R Yaszemski, Michael J Maran, Avudaiappan Oliveira, Andre M Case Reports Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2012 Nov;43(11):2047-52. doi: 10.1016/j.humpath.2012.02.014. Epub 2012 Jun 1. PY - 2012 SN - 0046-8177 SP - 2047-52 ST - Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor T2 - Hum Pathol TI - Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor VL - 43 ID - 388 ER - TY - JOUR AD - Department of Dermatology, University of Regensburg, Regensburg, Germany. AN - 22683711 AU - Groesser, L. AU - Herschberger, E. AU - Ruetten, A. AU - Ruivenkamp, C. AU - Lopriore, E. AU - Zutt, M. AU - Langmann, T. AU - Singer, S. AU - Klingseisen, L. AU - Schneider-Brachert, W. AU - Toll, A. AU - Real, F. X. AU - Landthaler, M. AU - Hafner, C. DA - Jun 10 DO - 10.1038/ng.2316 DP - NLM ET - 2012/06/12 IS - 7 LA - eng N1 - 1546-1718 Groesser, Leopold Herschberger, Eva Ruetten, Arno Ruivenkamp, Claudia Lopriore, Enrico Zutt, Markus Langmann, Thomas Singer, Sebastian Klingseisen, Laura Schneider-Brachert, Wulf Toll, Agusti Real, Francisco X Landthaler, Michael Hafner, Christian Journal Article Research Support, Non-U.S. Gov't United States Nat Genet. 2012 Jun 10;44(7):783-7. doi: 10.1038/ng.2316. PY - 2012 SN - 1061-4036 SP - 783-7 ST - Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome T2 - Nat Genet TI - Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome VL - 44 ID - 389 ER - TY - JOUR AD - Department of Experimental Medicine, University of Rome, Rome, Italy. AN - 22702340 AU - Ulisse, S. AU - Baldini, E. AU - Sorrenti, S. AU - Barollo, S. AU - Prinzi, N. AU - Catania, A. AU - Nesca, A. AU - Gnessi, L. AU - Pelizzo, M. R. AU - Mian, C. AU - De Vito, C. AU - Calvanese, A. AU - Palermo, S. AU - Persechino, S. AU - De Antoni, E. AU - D'Armiento, M. DA - Nov DO - 10.1111/j.1365-2265.2012.04465.x DP - NLM ET - 2012/06/19 IS - 5 LA - eng N1 - 1365-2265 Ulisse, Salvatore Baldini, Enke Sorrenti, Salvatore Barollo, Susi Prinzi, Natalie Catania, Antonio Nesca, Angela Gnessi, Lucio Pelizzo, Maria R Mian, Caterina De Vito, Corrado Calvanese, Anna Palermo, Silvio Persechino, Severino De Antoni, Enrico D'Armiento, Massimino Journal Article Research Support, Non-U.S. Gov't England Clin Endocrinol (Oxf). 2012 Nov;77(5):780-6. doi: 10.1111/j.1365-2265.2012.04465.x. PY - 2012 SN - 0300-0664 SP - 780-6 ST - In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval T2 - Clin Endocrinol (Oxf) TI - In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval VL - 77 ID - 390 ER - TY - JOUR AD - Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy. AN - 22713244 AU - Buontempo, F. AU - Chiarini, F. AU - Bressanin, D. AU - Tabellini, G. AU - Melchionda, F. AU - Pession, A. AU - Fini, M. AU - Neri, L. M. AU - McCubrey, J. A. AU - Martelli, A. M. DA - Jul 1 DO - 10.4161/cc.20859 DP - NLM ET - 2012/06/21 IS - 13 LA - eng N1 - 1551-4005 Buontempo, Francesca Chiarini, Francesca Bressanin, Daniela Tabellini, Giovanna Melchionda, Fraia Pession, Andrea Fini, Milena Neri, Luca M McCubrey, James A Martelli, Alberto M Journal Article Research Support, Non-U.S. Gov't United States Cell Cycle. 2012 Jul 1;11(13):2467-75. doi: 10.4161/cc.20859. Epub 2012 Jul 1. PY - 2012 SN - 1551-4005 SP - 2467-75 ST - Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a T2 - Cell Cycle TI - Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a VL - 11 ID - 391 ER - TY - JOUR AD - Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. AN - 22749438 AU - Sugiura, Y. AU - Hiramatsu, K. AU - Hamauzu, R. AU - Motoki, T. AU - Miyazaki, M. AU - Uto, H. AU - Tsubouchi, H. AU - Tanaka, S. AU - Gohda, E. DA - Oct DO - 10.1016/j.cyto.2012.06.007 DP - NLM ET - 2012/07/04 IS - 1 LA - eng N1 - 1096-0023 Sugiura, Yoshihiro Hiramatsu, Kaori Hamauzu, Reimi Motoki, Takahiro Miyazaki, Masahiro Uto, Hirofumi Tsubouchi, Hirohito Tanaka, Satoshi Gohda, Eiichi Journal Article Research Support, Non-U.S. Gov't England Cytokine. 2012 Oct;60(1):205-11. doi: 10.1016/j.cyto.2012.06.007. Epub 2012 Jun 30. PY - 2012 SN - 1043-4666 SP - 205-11 ST - Mitogen-activated protein kinases-dependent induction of hepatocyte growth factor production in human dermal fibroblasts by the antibiotic polymyxin B T2 - Cytokine TI - Mitogen-activated protein kinases-dependent induction of hepatocyte growth factor production in human dermal fibroblasts by the antibiotic polymyxin B VL - 60 ID - 392 ER - TY - JOUR AD - Department of Pathology, Gülhane Military Medical Academy and School of Medicine, Ankara, Turkey. bkurt@gata.edu.tr AN - 22767446 AU - Kurt, B. AU - Yalçın, S. AU - Alagöz, E. AU - Karslıoğlu, Y. AU - Yigit, N. AU - Günal, A. AU - Deveci, M. S. DA - Sep DO - 10.1007/s12022-012-9218-7 DP - NLM ET - 2012/07/07 IS - 3 LA - eng N1 - 1559-0097 Kurt, Bülent Yalçın, Serap Alagöz, Engin Karslıoğlu, Yıldırım Yigit, Nuri Günal, Armağan Deveci, M Salih Journal Article Research Support, Non-U.S. Gov't United States Endocr Pathol. 2012 Sep;23(3):135-40. doi: 10.1007/s12022-012-9218-7. PY - 2012 SN - 1046-3976 SP - 135-40 ST - The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas T2 - Endocr Pathol TI - The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas VL - 23 ID - 393 ER - TY - JOUR AD - Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. ioschlies@path.uni-kiel.de AN - 22773605 AU - Oschlies, I. AU - Lisfeld, J. AU - Lamant, L. AU - Nakazawa, A. AU - d'Amore, E. S. AU - Hansson, U. AU - Hebeda, K. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Müllauer, L. AU - Tinguely, M. AU - Stücker, M. AU - Ledeley, M. C. AU - Siebert, R. AU - Reiter, A. AU - Brugières, L. AU - Klapper, W. AU - Woessmann, W. C2 - PMC3533659 DA - Jan DO - 10.3324/haematol.2012.065664 DP - NLM ET - 2012/07/10 IS - 1 LA - eng N1 - 1592-8721 Oschlies, Ilske Lisfeld, Jasmin Lamant, Laurence Nakazawa, Atsuko d'Amore, Emanuele S G Hansson, Ulrika Hebeda, Konnie Simonitsch-Klupp, Ingrid Maldyk, Jadwiga Müllauer, Leonhard Tinguely, Marianne Stücker, Markus Ledeley, Marie-Cecile Siebert, Reiner Reiter, Alfred Brugières, Laurence Klapper, Wolfram Woessmann, Wilhelm Case Reports Journal Article Multicenter Study Research Support, Non-U.S. Gov't Review Haematologica. 2013 Jan;98(1):50-6. doi: 10.3324/haematol.2012.065664. Epub 2012 Jul 6. PY - 2013 SN - 0390-6078 (Print) 0390-6078 SP - 50-6 ST - ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study T2 - Haematologica TI - ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study VL - 98 ID - 394 ER - TY - JOUR AD - Thyroid Section, Endocrine Division, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Porto Alegre, RS, Brazil. AN - 22823995 AU - Romitti, M. AU - Wajner, S. M. AU - Zennig, N. AU - Goemann, I. M. AU - Bueno, A. L. AU - Meyer, E. L. AU - Maia, A. L. DA - Sep DO - 10.1089/thy.2012.0031 DP - NLM ET - 2012/07/25 IS - 9 LA - eng N1 - 1557-9077 Romitti, Mírian Wajner, Simone Magagnin Zennig, Nadja Goemann, Iuri Martin Bueno, Ana Laura Meyer, Erika L Souza Maia, Ana Luiza Journal Article Research Support, Non-U.S. Gov't United States Thyroid. 2012 Sep;22(9):897-904. doi: 10.1089/thy.2012.0031. Epub 2012 Jul 23. PY - 2012 SN - 1050-7256 SP - 897-904 ST - Increased type 3 deiodinase expression in papillary thyroid carcinoma T2 - Thyroid TI - Increased type 3 deiodinase expression in papillary thyroid carcinoma VL - 22 ID - 395 ER - TY - JOUR AD - Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College, No. 2 Fuxue Lane, Wenzhou, Zhejiang, China. AN - 22855362 AU - Zhou, Y. L. AU - Liu, C. AU - Dai, X. X. AU - Zhang, X. H. AU - Wang, O. C. DA - Dec DO - 10.1007/s12032-012-0315-8 DP - NLM ET - 2012/08/03 IS - 5 LA - eng N1 - 1559-131x Zhou, Yi-Li Liu, Chao Dai, Xuan-xuan Zhang, Xiao-Hua Wang, Ou-Chen Journal Article Research Support, Non-U.S. Gov't United States Med Oncol. 2012 Dec;29(5):3360-6. doi: 10.1007/s12032-012-0315-8. Epub 2012 Aug 2. PY - 2012 SN - 1357-0560 SP - 3360-6 ST - Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas T2 - Med Oncol TI - Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas VL - 29 ID - 396 ER - TY - JOUR AD - University of Alabama, Birmingham, Birmingham, AL 35233, USA. AN - 22934706 AU - Megison, M. L. AU - Gillory, L. A. AU - Beierle, E. A. C2 - PMC3710698 C6 - NIHMS487768 DA - May DO - 10.2174/1871520611313040005 DP - NLM ET - 2012/09/01 IS - 4 LA - eng N1 - 1875-5992 Megison, Michael L Gillory, Lauren A Beierle, Elizabeth A K08 CA118178/CA/NCI NIH HHS/United States T32 CA091078/CA/NCI NIH HHS/United States CA118178/CA/NCI NIH HHS/United States CA91078/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Review Anticancer Agents Med Chem. 2013 May;13(4):563-75. doi: 10.2174/1871520611313040005. PY - 2013 SN - 1871-5206 (Print) 1871-5206 SP - 563-75 ST - Cell survival signaling in neuroblastoma T2 - Anticancer Agents Med Chem TI - Cell survival signaling in neuroblastoma VL - 13 ID - 397 ER - TY - JOUR AD - Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. AN - 22964613 AU - Kwak, J. Y. AU - Han, K. H. AU - Yoon, J. H. AU - Kim, E. K. AU - Moon, H. J. AU - Kim, Y. L. AU - Park, S. J. AU - Choi, J. R. DA - Summer DP - NLM ET - 2012/09/12 IS - 3 LA - eng N1 - 1550-8080 Kwak, Jin Young Han, Kyung Hwa Yoon, Jung Hyun Kim, Eun-Kyung Moon, Hee Jung Kim, Yoo-Li Park, Seo-Jin Choi, Jong Rak Journal Article Research Support, Non-U.S. Gov't United States Ann Clin Lab Sci. 2012 Summer;42(3):258-65. PY - 2012 SN - 0091-7370 SP - 258-65 ST - BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR T2 - Ann Clin Lab Sci TI - BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR VL - 42 ID - 398 ER - TY - JOUR AD - Department of Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation, Minami-ku, Hiroshima, Japan. AN - 23050789 AU - Hamatani, K. AU - Mukai, M. AU - Takahashi, K. AU - Hayashi, Y. AU - Nakachi, K. AU - Kusunoki, Y. C2 - PMC3487115 DA - Nov DO - 10.1089/thy.2011.0511 DP - NLM ET - 2012/10/12 IS - 11 LA - eng N1 - 1557-9077 Hamatani, Kiyohiro Mukai, Mayumi Takahashi, Keiko Hayashi, Yuzo Nakachi, Kei Kusunoki, Yoichiro Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Thyroid. 2012 Nov;22(11):1153-9. doi: 10.1089/thy.2011.0511. Epub 2012 Oct 10. PY - 2012 SN - 1050-7256 (Print) 1050-7256 SP - 1153-9 ST - Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors T2 - Thyroid TI - Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors VL - 22 ID - 399 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. AN - 23051629 AU - Karram, S. AU - Novy, M. AU - Saroufim, M. AU - Loya, A. AU - Taraif, S. AU - Houreih, M. A. AU - Rauscher, B. AU - Habib, R. H. AU - Oberkanins, C. AU - Khalifeh, I. DA - Jun DO - 10.1097/DAD.0b013e31826db181 DP - NLM ET - 2012/10/12 IS - 4 LA - eng N1 - 1533-0311 Karram, Sarah Novy, Michael Saroufim, Maya Loya, Asif Taraif, Suad Houreih, Mohammad A Rauscher, Bettina Habib, Robert H Oberkanins, Christian Khalifeh, Ibrahim Journal Article Multicenter Study United States Am J Dermatopathol. 2013 Jun;35(4):412-8. doi: 10.1097/DAD.0b013e31826db181. PY - 2013 SN - 0193-1091 SP - 412-8 ST - Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure T2 - Am J Dermatopathol TI - Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure VL - 35 ID - 400 ER - TY - JOUR AD - Departments of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. AN - 23052255 AU - Suehara, Y. AU - Arcila, M. AU - Wang, L. AU - Hasanovic, A. AU - Ang, D. AU - Ito, T. AU - Kimura, Y. AU - Drilon, A. AU - Guha, U. AU - Rusch, V. AU - Kris, M. G. AU - Zakowski, M. F. AU - Rizvi, N. AU - Khanin, R. AU - Ladanyi, M. C2 - PMC4234119 C6 - NIHMS641462 DA - Dec 15 DO - 10.1158/1078-0432.Ccr-12-0838 DP - NLM ET - 2012/10/12 IS - 24 LA - eng N1 - Suehara, Yoshiyuki Arcila, Maria Wang, Lu Hasanovic, Adnan Ang, Daphne Ito, Tatsuo Kimura, Yuki Drilon, Alexander Guha, Udayan Rusch, Valerie Kris, Mark G Zakowski, Maureen F Rizvi, Naiyer Khanin, Raya Ladanyi, Marc P01 CA129243/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Clin Cancer Res. 2012 Dec 15;18(24):6599-608. doi: 10.1158/1078-0432.CCR-12-0838. Epub 2012 Oct 10. PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 6599-608 ST - Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions T2 - Clin Cancer Res TI - Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions VL - 18 ID - 401 ER - TY - JOUR AD - Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria. AN - 23064464 AU - Laimer, D. AU - Dolznig, H. AU - Kollmann, K. AU - Vesely, P. W. AU - Schlederer, M. AU - Merkel, O. AU - Schiefer, A. I. AU - Hassler, M. R. AU - Heider, S. AU - Amenitsch, L. AU - Thallinger, C. AU - Staber, P. B. AU - Simonitsch-Klupp, I. AU - Artaker, M. AU - Lagger, S. AU - Turner, S. D. AU - Pileri, S. AU - Piccaluga, P. P. AU - Valent, P. AU - Messana, K. AU - Landra, I. AU - Weichhart, T. AU - Knapp, S. AU - Shehata, M. AU - Todaro, M. AU - Sexl, V. AU - Höfler, G. AU - Piva, R. AU - Medico, E. AU - Ruggeri, B. A. AU - Cheng, M. AU - Eferl, R. AU - Egger, G. AU - Penninger, J. M. AU - Jaeger, U. AU - Moriggl, R. AU - Inghirami, G. AU - Kenner, L. DA - Nov DO - 10.1038/nm.2966 DP - NLM ET - 2012/10/16 IS - 11 LA - eng N1 - 1546-170x Laimer, Daniela Dolznig, Helmut Kollmann, Karoline Vesely, Paul W Schlederer, Michaela Merkel, Olaf Schiefer, Ana-Iris Hassler, Melanie R Heider, Susi Amenitsch, Lena Thallinger, Christiane Staber, Philipp B Simonitsch-Klupp, Ingrid Artaker, Matthias Lagger, Sabine Turner, Suzanne D Pileri, Stefano Piccaluga, Pier Paolo Valent, Peter Messana, Katia Landra, Indira Weichhart, Thomas Knapp, Sylvia Shehata, Medhat Todaro, Maria Sexl, Veronika Höfler, Gerald Piva, Roberto Medico, Enzo Ruggeri, Bruce A Cheng, Mangeng Eferl, Robert Egger, Gerda Penninger, Josef M Jaeger, Ulrich Moriggl, Richard Inghirami, Giorgio Kenner, Lukas 092809/Wellcome Trust/United Kingdom F 3013/Austrian Science Fund FWF/Austria Journal Article Research Support, Non-U.S. Gov't United States Nat Med. 2012 Nov;18(11):1699-704. doi: 10.1038/nm.2966. Epub 2012 Oct 14. PY - 2012 SN - 1078-8956 SP - 1699-704 ST - PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas T2 - Nat Med TI - PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas VL - 18 ID - 402 ER - TY - JOUR AD - Anna Meyer Children's Hospital, Florence, Italy. ambuccoliero@unifi.it AN - 23073165 AU - Buccoliero, A. M. AU - Castiglione, F. AU - Degl'innocenti, D. R. AU - Moncini, D. AU - Spacca, B. AU - Giordano, F. AU - Genitori, L. AU - Taddei, G. L. DA - Mar-Apr DO - 10.5414/np300500 DP - NLM ET - 2012/10/18 IS - 2 LA - eng N1 - Buccoliero, Anna Maria Castiglione, Francesca Degl'innocenti, Duccio Rossi Moncini, Daniela Spacca, Barbara Giordano, Flavio Genitori, Lorenzo Taddei, Gian Luigi Case Reports Journal Article Germany Clin Neuropathol. 2013 Mar-Apr;32(2):107-13. doi: 10.5414/NP300500. PY - 2013 SN - 0722-5091 (Print) 0722-5091 SP - 107-13 ST - Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases T2 - Clin Neuropathol TI - Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases VL - 32 ID - 403 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK. AN - 23077088 AU - Al-Shehhi, H. AU - Konn, Z. J. AU - Schwab, C. J. AU - Erhorn, A. AU - Barber, K. E. AU - Wright, S. L. AU - Gabriel, A. S. AU - Harrison, C. J. AU - Moorman, A. V. DA - Feb DO - 10.1002/gcc.22021 DP - NLM ET - 2012/10/19 IS - 2 LA - eng N1 - 1098-2264 Al-Shehhi, Halima Konn, Zoe J Schwab, Claire J Erhorn, Amy Barber, Kerry E Wright, Sarah L Gabriel, Alem S Harrison, Christine J Moorman, Anthony V Journal Article Research Support, Non-U.S. Gov't United States Genes Chromosomes Cancer. 2013 Feb;52(2):202-13. doi: 10.1002/gcc.22021. Epub 2012 Oct 18. PY - 2013 SN - 1045-2257 SP - 202-13 ST - Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia T2 - Genes Chromosomes Cancer TI - Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia VL - 52 ID - 404 ER - TY - JOUR AD - Department of Chemical Biology, Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. AN - 23085756 AU - Martino, J. J. AU - Wall, B. A. AU - Mastrantoni, E. AU - Wilimczyk, B. J. AU - La Cava, S. N. AU - Degenhardt, K. AU - White, E. AU - Chen, S. C2 - PMC3910169 C6 - NIHMS549991 DA - Sep 12 DO - 10.1038/onc.2012.471 DP - NLM ET - 2012/10/23 IS - 37 LA - eng N1 - 1476-5594 Martino, J J Wall, B A Mastrantoni, E Wilimczyk, B J La Cava, S N Degenhardt, K White, E Chen, S P30 CA072720/CA/NCI NIH HHS/United States R01 CA108720/CA/NCI NIH HHS/United States R01CA108720/CA/NCI NIH HHS/United States R01 CA074077/CA/NCI NIH HHS/United States R01 CA130893/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Oncogene. 2013 Sep 12;32(37):4366-76. doi: 10.1038/onc.2012.471. Epub 2012 Oct 22. PY - 2013 SN - 0950-9232 (Print) 0950-9232 SP - 4366-76 ST - Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells T2 - Oncogene TI - Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells VL - 32 ID - 405 ER - TY - JOUR AD - Department of Pathology, The University of Colorado Health Sciences Center, 12605 E. 16th Avenue, Room 3026, MS F768, Aurora, CO 80045, USA. AN - 23096133 AU - Schmidt, Y. AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Lillehei, K. O. AU - Damek, D. C2 - PMC4617340 C6 - NIHMS730193 DA - Jan DO - 10.1007/s11060-012-0991-4 DP - NLM ET - 2012/10/26 IS - 1 LA - eng N1 - 1573-7373 Schmidt, Yao Kleinschmidt-DeMasters, B K Aisner, Dara L Lillehei, Kevin O Damek, Denise P30 CA046934/CA/NCI NIH HHS/United States Case Reports Journal Article J Neurooncol. 2013 Jan;111(1):59-69. doi: 10.1007/s11060-012-0991-4. Epub 2012 Oct 25. PY - 2013 SN - 0167-594X (Print) 0167-594x SP - 59-69 ST - Anaplastic PXA in adults: case series with clinicopathologic and molecular features T2 - J Neurooncol TI - Anaplastic PXA in adults: case series with clinicopathologic and molecular features VL - 111 ID - 406 ER - TY - JOUR AD - Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu and Fundació Sant Joan de Déu, Barcelona, Spain. AN - 23108190 AU - Casalà, C. AU - Gil-Guiñón, E. AU - Ordóñez, J. L. AU - Miguel-Queralt, S. AU - Rodríguez, E. AU - Galván, P. AU - Lavarino, C. AU - Munell, F. AU - de Alava, E. AU - Mora, J. AU - de Torres, C. DA - Feb DO - 10.1093/carcin/bgs338 DP - NLM ET - 2012/10/31 IS - 2 LA - eng N1 - 1460-2180 Casalà, Carla Gil-Guiñón, Estel Ordóñez, José Luis Miguel-Queralt, Solange Rodríguez, Eva Galván, Patricia Lavarino, Cinzia Munell, Francina de Alava, Enrique Mora, Jaume de Torres, Carmen Journal Article Research Support, Non-U.S. Gov't England Carcinogenesis. 2013 Feb;34(2):268-76. doi: 10.1093/carcin/bgs338. Epub 2012 Oct 29. PY - 2013 SN - 0143-3334 SP - 268-76 ST - The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis T2 - Carcinogenesis TI - The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis VL - 34 ID - 407 ER - TY - JOUR AD - Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA. Martin.Belinsky@fccc.edu AN - 23109135 AU - Belinsky, M. G. AU - Rink, L. AU - Flieder, D. B. AU - Jahromi, M. S. AU - Schiffman, J. D. AU - Godwin, A. K. AU - Mehren, Mv C2 - PMC3564228 C6 - NIHMS430867 DA - Feb DO - 10.1002/gcc.22023 DP - NLM ET - 2012/10/31 IS - 2 LA - eng N1 - 1098-2264 Belinsky, Martin G Rink, Lori Flieder, Douglas B Jahromi, Mona S Schiffman, Joshua D Godwin, Andrew K Mehren, Margaret von R21 CA150831-02/CA/NCI NIH HHS/United States R21 CA150381/CA/NCI NIH HHS/United States UL1 TR000001/TR/NCATS NIH HHS/United States R01 CA106588/CA/NCI NIH HHS/United States P30 CA006927/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Genes Chromosomes Cancer. 2013 Feb;52(2):214-24. doi: 10.1002/gcc.22023. Epub 2012 Oct 29. PY - 2013 SN - 1045-2257 (Print) 1045-2257 SP - 214-24 ST - Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors T2 - Genes Chromosomes Cancer TI - Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors VL - 52 ID - 408 ER - TY - JOUR AD - Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. nakano_masahito@kurume-u.ac.jp AN - 23147476 AU - Nakano, M. AU - Tanaka, M. AU - Kuromatsu, R. AU - Nagamatsu, H. AU - Sakata, K. AU - Matsugaki, S. AU - Kajiwara, M. AU - Fukuizumi, K. AU - Tajiri, N. AU - Matsukuma, N. AU - Sakai, T. AU - Ono, N. AU - Yano, Y. AU - Koga, H. AU - Kurogi, J. AU - Takata, A. AU - Sumie, S. AU - Satani, M. AU - Yamada, S. AU - Niizeki, T. AU - Aino, H. AU - Iwamoto, H. AU - Torimura, T. AU - Sata, M. DO - 10.1159/000342650 DP - NLM ET - 2012/11/14 IS - 2 LA - eng N1 - 1423-0232 Nakano, Masahito Tanaka, Masatoshi Kuromatsu, Ryoko Nagamatsu, Hiroaki Sakata, Kenji Matsugaki, Satoru Kajiwara, Masahiko Fukuizumi, Kunitaka Tajiri, Nobuyoshi Matsukuma, Norito Sakai, Terufumi Ono, Noriyuki Yano, Yoichi Koga, Hironori Kurogi, Junichi Takata, Akio Sumie, Shuji Satani, Manabu Yamada, Shingo Niizeki, Takashi Aino, Hajime Iwamoto, Hideki Torimura, Takuji Sata, Michio Journal Article Switzerland Oncology. 2013;84(2):108-14. doi: 10.1159/000342650. Epub 2012 Nov 9. PY - 2013 SN - 0030-2414 SP - 108-14 ST - Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma T2 - Oncology TI - Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma VL - 84 ID - 409 ER - TY - JOUR AD - Pediatric Oncology Experimental Therapeutics Investigators Consortium (POETIC) Laboratory for Pre-Clinical and Drug Discovery Studies, University of Calgary, Calgary, AB, Canada. AN - 23176524 AU - Jayanthan, A. AU - Cooper, T. M. AU - Hoeksema, K. A. AU - Lotfi, S. AU - Woldum, E. AU - Lewis, V. A. AU - Narendran, A. DA - Jul DO - 10.3109/10428194.2012.752079 DP - NLM ET - 2012/11/28 IS - 7 LA - eng N1 - 1029-2403 Jayanthan, Aarthi Cooper, Todd M Hoeksema, Kimberley A Lotfi, Shamim Woldum, Evan Lewis, Victor A Narendran, Aru Canadian Institutes of Health Research/Canada Journal Article Research Support, Non-U.S. Gov't United States Leuk Lymphoma. 2013 Jul;54(7):1505-16. doi: 10.3109/10428194.2012.752079. Epub 2012 Dec 29. PY - 2013 SN - 1026-8022 SP - 1505-16 ST - Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells T2 - Leuk Lymphoma TI - Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells VL - 54 ID - 410 ER - TY - JOUR AD - Departments of Anatomic Pathology and Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan. AN - 23209032 AU - Endo, M. AU - Yamamoto, H. AU - Setsu, N. AU - Kohashi, K. AU - Takahashi, Y. AU - Ishii, T. AU - Iida, K. AU - Matsumoto, Y. AU - Hakozaki, M. AU - Aoki, M. AU - Iwasaki, H. AU - Dobashi, Y. AU - Nishiyama, K. AU - Iwamoto, Y. AU - Oda, Y. DA - Jan 15 DO - 10.1158/1078-0432.Ccr-12-1067 DP - NLM ET - 2012/12/05 IS - 2 LA - eng N1 - Endo, Makoto Yamamoto, Hidetaka Setsu, Nokitaka Kohashi, Kenichi Takahashi, Yusuke Ishii, Takeaki Iida, Kei-ichiro Matsumoto, Yoshihiro Hakozaki, Michiyuki Aoki, Mikiko Iwasaki, Hiroshi Dobashi, Yoh Nishiyama, Kenichi Iwamoto, Yukihide Oda, Yoshinao Journal Article Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2013 Jan 15;19(2):450-61. doi: 10.1158/1078-0432.CCR-12-1067. Epub 2012 Dec 3. PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 450-61 ST - Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors T2 - Clin Cancer Res TI - Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors VL - 19 ID - 411 ER - TY - JOUR AD - Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA. AN - 23221337 AU - Chang, T. AU - Krisman, K. AU - Theobald, E. H. AU - Xu, J. AU - Akutagawa, J. AU - Lauchle, J. O. AU - Kogan, S. AU - Braun, B. S. AU - Shannon, K. C2 - PMC3533281 DA - Jan DO - 10.1172/jci63193 DP - NLM ET - 2012/12/12 IS - 1 LA - eng N1 - 1558-8238 Chang, Tiffany Krisman, Kimberly Theobald, Emily Harding Xu, Jin Akutagawa, Jon Lauchle, Jennifer O Kogan, Scott Braun, Benjamin S Shannon, Kevin R37 CA072614/CA/NCI NIH HHS/United States R37 CA72614/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Clin Invest. 2013 Jan;123(1):335-9. doi: 10.1172/JCI63193. Epub 2012 Dec 10. PY - 2013 SN - 0021-9738 (Print) 0021-9738 SP - 335-9 ST - Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice T2 - J Clin Invest TI - Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice VL - 123 ID - 412 ER - TY - JOUR AD - Children’s Hospital Medical Center, Division of Experimental Hematology and Cancer Biology, 3333 Burnet Ave., M.L.C. 7013, Cincinnati, Ohio 45229, USA. AN - 23221341 AU - Jessen, W. J. AU - Miller, S. J. AU - Jousma, E. AU - Wu, J. AU - Rizvi, T. A. AU - Brundage, M. E. AU - Eaves, D. AU - Widemann, B. AU - Kim, M. O. AU - Dombi, E. AU - Sabo, J. AU - Hardiman Dudley, A. AU - Niwa-Kawakita, M. AU - Page, G. P. AU - Giovannini, M. AU - Aronow, B. J. AU - Cripe, T. P. AU - Ratner, N. C2 - PMC3533264 DA - Jan DO - 10.1172/jci60578 DP - NLM ET - 2012/12/12 IS - 1 LA - eng N1 - 1558-8238 Jessen, Walter J Miller, Shyra J Jousma, Edwin Wu, Jianqiang Rizvi, Tilat A Brundage, Meghan E Eaves, David Widemann, Brigitte Kim, Mi-Ok Dombi, Eva Sabo, Jessica Hardiman Dudley, Atira Niwa-Kawakita, Michiko Page, Grier P Giovannini, Marco Aronow, Bruce J Cripe, Timothy P Ratner, Nancy R01 NS028840/NS/NINDS NIH HHS/United States UL1 TR000077/TR/NCATS NIH HHS/United States P50-NS05753/NS/NINDS NIH HHS/United States R01-NS28840/NS/NINDS NIH HHS/United States Clinical Trial Journal Article Research Support, American Recovery and Reinvestment Act Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. J Clin Invest. 2013 Jan;123(1):340-7. doi: 10.1172/JCI60578. Epub 2012 Dec 10. PY - 2013 SN - 0021-9738 (Print) 0021-9738 SP - 340-7 ST - MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors T2 - J Clin Invest TI - MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors VL - 123 ID - 413 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. fjanku@mdanderson.org AN - 23248156 AU - Janku, F. AU - Wheler, J. J. AU - Naing, A. AU - Stepanek, V. M. AU - Falchook, G. S. AU - Fu, S. AU - Garrido-Laguna, I. AU - Tsimberidou, A. M. AU - Piha-Paul, S. A. AU - Moulder, S. L. AU - Lee, J. J. AU - Luthra, R. AU - Hong, D. S. AU - Kurzrock, R. C2 - PMC3681495 support from GlaxoSmithKline, Novartis, Merck, and Bayer. DA - Dec DO - 10.18632/oncotarget.716 DP - NLM ET - 2012/12/19 IS - 12 LA - eng N1 - 1949-2553 Janku, Filip Wheler, Jennifer J Naing, Aung Stepanek, Vanda M Falchook, Gerald S Fu, Siqing Garrido-Laguna, Ignacio Tsimberidou, Apostolia M Piha-Paul, Sarina A Moulder, Stacy L Lee, Jack J Luthra, Rajyalakshmi Hong, David S Kurzrock, Razelle P30 CA016672/CA/NCI NIH HHS/United States Journal Article Oncotarget. 2012 Dec;3(12):1566-75. doi: 10.18632/oncotarget.716. PY - 2012 SN - 1949-2553 SP - 1566-75 ST - PIK3CA mutations in advanced cancers: characteristics and outcomes T2 - Oncotarget TI - PIK3CA mutations in advanced cancers: characteristics and outcomes VL - 3 ID - 414 ER - TY - JOUR AD - Pulmonology Department, Maltepe University Hospital, Istanbul, Turkey. nessariman@yahoo.com AN - 23254266 AU - Sarıman, N. AU - Levent, E. AU - Yener, N. A. AU - Orki, A. AU - Saygı, A. DA - Mar DO - 10.1016/j.lungcan.2012.11.014 DP - NLM ET - 2012/12/21 IS - 3 LA - eng N1 - 1872-8332 Sarıman, Nesrin Levent, Ender Yener, Neşe Arzu Orki, Alpay Saygı, Attila Case Reports Journal Article Ireland Lung Cancer. 2013 Mar;79(3):321-3. doi: 10.1016/j.lungcan.2012.11.014. Epub 2012 Dec 14. PY - 2013 SN - 0169-5002 SP - 321-3 ST - Lung cancer and pregnancy T2 - Lung Cancer TI - Lung cancer and pregnancy VL - 79 ID - 415 ER - TY - JOUR AD - UMR 911, INSERM, Marseille, France; Medecine School, Aix-Marseille University, Marseille, France. AN - 23278243 AU - Colin, C. AU - Padovani, L. AU - Chappé, C. AU - Mercurio, S. AU - Scavarda, D. AU - Loundou, A. AU - Frassineti, F. AU - André, N. AU - Bouvier, C. AU - Korshunov, A. AU - Lena, G. AU - Figarella-Branger, D. DA - Oct DO - 10.1111/nan.12013 DP - NLM ET - 2013/01/03 IS - 6 LA - eng N1 - 1365-2990 Colin, C Padovani, L Chappé, C Mercurio, S Scavarda, D Loundou, A Frassineti, F André, N Bouvier, C Korshunov, A Lena, G Figarella-Branger, D Journal Article Research Support, Non-U.S. Gov't England Neuropathol Appl Neurobiol. 2013 Oct;39(6):693-705. doi: 10.1111/nan.12013. PY - 2013 SN - 0305-1846 SP - 693-705 ST - Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution T2 - Neuropathol Appl Neurobiol TI - Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution VL - 39 ID - 416 ER - TY - JOUR AD - Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan. akyoshid@ncc.go.jp AN - 23307059 AU - Yoshida, A. AU - Shibata, T. AU - Wakai, S. AU - Ushiku, T. AU - Tsuta, K. AU - Fukayama, M. AU - Makimoto, A. AU - Furuta, K. AU - Tsuda, H. DA - Jun DO - 10.1038/modpathol.2012.222 DP - NLM ET - 2013/01/12 IS - 6 LA - eng N1 - 1530-0285 Yoshida, Akihiko Shibata, Tatsuhiro Wakai, Susumu Ushiku, Tetsuo Tsuta, Koji Fukayama, Masashi Makimoto, Atsushi Furuta, Koh Tsuda, Hitoshi Journal Article Research Support, Non-U.S. Gov't United States Mod Pathol. 2013 Jun;26(6):772-81. doi: 10.1038/modpathol.2012.222. Epub 2013 Jan 11. PY - 2013 SN - 0893-3952 SP - 772-81 ST - Anaplastic lymphoma kinase status in rhabdomyosarcomas T2 - Mod Pathol TI - Anaplastic lymphoma kinase status in rhabdomyosarcomas VL - 26 ID - 417 ER - TY - JOUR AD - Department of Medical Biology, Medical Faculty, Uludag University, Bursa, Turkey. btunca@uludag.edu.tr AN - 23322277 AU - Tunca, B. AU - Tezcan, G. AU - Cecener, G. AU - Egeli, U. AU - Zorluoglu, A. AU - Yilmazlar, T. AU - Ak, S. AU - Yerci, O. AU - Ozturk, E. AU - Umut, G. AU - Evrensel, T. DA - Apr DO - 10.1007/s00432-013-1372-x DP - NLM ET - 2013/01/17 IS - 4 LA - eng N1 - 1432-1335 Tunca, Berrin Tezcan, Gulcin Cecener, Gulsah Egeli, Unal Zorluoglu, Abdullah Yilmazlar, Tuncay Ak, Secil Yerci, Omer Ozturk, Ersin Umut, Gorkem Evrensel, Turkkan Comparative Study Journal Article Research Support, Non-U.S. Gov't Germany J Cancer Res Clin Oncol. 2013 Apr;139(4):691-702. doi: 10.1007/s00432-013-1372-x. Epub 2013 Jan 16. PY - 2013 SN - 0171-5216 SP - 691-702 ST - Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients T2 - J Cancer Res Clin Oncol TI - Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients VL - 139 ID - 418 ER - TY - JOUR AD - Department of Transplantation, Polish-American Institute of Pediatrics, Jagiellonian University School of Medicine, Cracow, Poland. AN - 23328666 AU - Miekus, K. AU - Lukasiewicz, E. AU - Jarocha, D. AU - Sekula, M. AU - Drabik, G. AU - Majka, M. C2 - PMC3563987 DA - Jan 17 DO - 10.1038/cddis.2012.199 DP - NLM ET - 2013/01/19 IS - 1 LA - eng N1 - 2041-4889 Miekus, K Lukasiewicz, E Jarocha, D Sekula, M Drabik, G Majka, M Journal Article Research Support, Non-U.S. Gov't Cell Death Dis. 2013 Jan 17;4(1):e459. doi: 10.1038/cddis.2012.199. PY - 2013 SP - e459 ST - The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation T2 - Cell Death Dis TI - The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation VL - 4 ID - 419 ER - TY - JOUR AD - Clinical Research Division, Institut Gustave Roussy, Villejuif Cedex, France. gilles.vassal@igr.fr AN - 23329813 AU - Vassal, G. AU - Geoerger, B. AU - Morland, B. DA - Mar 15 DO - 10.1158/1078-0432.Ccr-12-2551 DP - NLM ET - 2013/01/19 IS - 6 LA - eng N1 - Vassal, Gilles Geoerger, Birgit Morland, Bruce Journal Article United States Clin Cancer Res. 2013 Mar 15;19(6):1315-25. doi: 10.1158/1078-0432.CCR-12-2551. Epub 2013 Jan 17. PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 1315-25 ST - Is the European pediatric medicine regulation working for children and adolescents with cancer? T2 - Clin Cancer Res TI - Is the European pediatric medicine regulation working for children and adolescents with cancer? VL - 19 ID - 420 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, 1000 Welch Rd, Suite 300, Palo Alto, CA 94304-1812, USA. mlink@stanford.edu AN - 23341511 AU - Link, M. P. DA - Mar 1 DO - 10.1200/jco.2012.48.0293 DP - NLM ET - 2013/01/24 IS - 7 LA - eng N1 - 1527-7755 Link, Michael P Address United States J Clin Oncol. 2013 Mar 1;31(7):825-32. doi: 10.1200/JCO.2012.48.0293. Epub 2013 Jan 22. PY - 2013 SN - 0732-183x SP - 825-32 ST - Collaborating to conquer cancer: lessons from our children T2 - J Clin Oncol TI - Collaborating to conquer cancer: lessons from our children VL - 31 ID - 421 ER - TY - JOUR AD - University of Colorado Denver, Denver, CO, USA. srush@chmca.org AN - 23358987 AU - Rush, S. AU - Foreman, N. AU - Liu, A. DA - Apr 1 DO - 10.1200/jco.2012.44.1568 DP - NLM ET - 2013/01/30 IS - 10 LA - eng N1 - 1527-7755 Rush, Sarah Foreman, Nicholas Liu, Arthur Case Reports Journal Article United States J Clin Oncol. 2013 Apr 1;31(10):e159-60. doi: 10.1200/JCO.2012.44.1568. Epub 2013 Jan 28. PY - 2013 SN - 0732-183x SP - e159-60 ST - Brainstem ganglioglioma successfully treated with vemurafenib T2 - J Clin Oncol TI - Brainstem ganglioglioma successfully treated with vemurafenib VL - 31 ID - 422 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. AN - 23436219 AU - Leeman-Neill, R. J. AU - Brenner, A. V. AU - Little, M. P. AU - Bogdanova, T. I. AU - Hatch, M. AU - Zurnadzy, L. Y. AU - Mabuchi, K. AU - Tronko, M. D. AU - Nikiforov, Y. E. C2 - PMC3648615 C6 - NIHMS416400 DA - May 15 DO - 10.1002/cncr.27893 DP - NLM ET - 2013/02/26 IS - 10 LA - eng N1 - 1097-0142 Leeman-Neill, Rebecca J Brenner, Alina V Little, Mark P Bogdanova, Tetiana I Hatch, Maureen Zurnadzy, Liudmyla Y Mabuchi, Kiyohiko Tronko, Mykola D Nikiforov, Yuri E R01 CA088041/CA/NCI NIH HHS/United States R01 CA88041/CA/NCI NIH HHS/United States Intramural NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Cancer. 2013 May 15;119(10):1792-9. doi: 10.1002/cncr.27893. Epub 2013 Feb 21. PY - 2013 SN - 0008-543X (Print) 0008-543x SP - 1792-9 ST - RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics T2 - Cancer TI - RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics VL - 119 ID - 423 ER - TY - JOUR AD - ENT Department, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. ignafernandez@yahoo.it AN - 23482475 AU - Fernandez, I. J. AU - Piccin, O. AU - Sciascia, S. AU - Cavicchi, O. AU - Repaci, A. AU - Vicennati, V. AU - Fiorentino, M. DA - Jun DO - 10.1177/0194599813481942 DP - NLM ET - 2013/03/14 IS - 6 LA - eng N1 - 1097-6817 Fernandez, Ignacio J Piccin, Ottavio Sciascia, Silvia Cavicchi, Ottavio Repaci, Andrea Vicennati, Valentina Fiorentino, Michelangelo Comparative Study Journal Article England Otolaryngol Head Neck Surg. 2013 Jun;148(6):919-25. doi: 10.1177/0194599813481942. Epub 2013 Mar 12. PY - 2013 SN - 0194-5998 SP - 919-25 ST - Clinical significance of BRAF mutation in thyroid papillary cancer T2 - Otolaryngol Head Neck Surg TI - Clinical significance of BRAF mutation in thyroid papillary cancer VL - 148 ID - 424 ER - TY - JOUR AD - Terry Fox Lab, British Columbia Cancer Agency, Vancouver, BC, Canada. yxing@bccrc.ca AN - 23522913 AU - Xing, Y. AU - Hogge, D. E. DA - Jun DO - 10.1016/j.leukres.2013.03.003 DP - NLM ET - 2013/03/26 IS - 6 LA - eng N1 - 1873-5835 Xing, Yan Hogge, Donna E Journal Article England Leuk Res. 2013 Jun;37(6):697-704. doi: 10.1016/j.leukres.2013.03.003. Epub 2013 Mar 21. PY - 2013 SN - 0145-2126 SP - 697-704 ST - Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors T2 - Leuk Res TI - Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors VL - 37 ID - 425 ER - TY - JOUR AD - Department of Pathology, The University of Colorado Health Sciences Center, Aurora, CO 80045, USA. bk.demasters@ucdenver.edu). AN - 23552385 AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Birks, D. K. AU - Foreman, N. K. C2 - PMC4610349 C6 - NIHMS726045 DA - May DO - 10.1097/PAS.0b013e31827f9c5e DP - NLM ET - 2013/04/05 IS - 5 LA - eng N1 - 1532-0979 Kleinschmidt-DeMasters, Bette Kay Aisner, Dara L Birks, Diane K Foreman, Nicholas K P30 CA046934/CA/NCI NIH HHS/United States Journal Article Am J Surg Pathol. 2013 May;37(5):685-98. doi: 10.1097/PAS.0b013e31827f9c5e. PY - 2013 SN - 0147-5185 (Print) 0147-5185 SP - 685-98 ST - Epithelioid GBMs show a high percentage of BRAF V600E mutation T2 - Am J Surg Pathol TI - Epithelioid GBMs show a high percentage of BRAF V600E mutation VL - 37 ID - 426 ER - TY - JOUR AD - Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, Nashville, TN 37232-6307, USA. jeff.sosman@vanderbilt.edu AN - 23569304 AU - Trunzer, K. AU - Pavlick, A. C. AU - Schuchter, L. AU - Gonzalez, R. AU - McArthur, G. A. AU - Hutson, T. E. AU - Moschos, S. J. AU - Flaherty, K. T. AU - Kim, K. B. AU - Weber, J. S. AU - Hersey, P. AU - Long, G. V. AU - Lawrence, D. AU - Ott, P. A. AU - Amaravadi, R. K. AU - Lewis, K. D. AU - Puzanov, I. AU - Lo, R. S. AU - Koehler, A. AU - Kockx, M. AU - Spleiss, O. AU - Schell-Steven, A. AU - Gilbert, H. N. AU - Cockey, L. AU - Bollag, G. AU - Lee, R. J. AU - Joe, A. K. AU - Sosman, J. A. AU - Ribas, A. DA - May 10 DO - 10.1200/jco.2012.44.7888 DP - NLM ET - 2013/04/10 IS - 14 LA - eng N1 - 1527-7755 Trunzer, Kerstin Pavlick, Anna C Schuchter, Lynn Gonzalez, Rene McArthur, Grant A Hutson, Thomas E Moschos, Stergios J Flaherty, Keith T Kim, Kevin B Weber, Jeffrey S Hersey, Peter Long, Georgina V Lawrence, Donald Ott, Patrick A Amaravadi, Ravi K Lewis, Karl D Puzanov, Igor Lo, Roger S Koehler, Astrid Kockx, Mark Spleiss, Olivia Schell-Steven, Annette Gilbert, Houston N Cockey, Louise Bollag, Gideon Lee, Richard J Joe, Andrew K Sosman, Jeffrey A Ribas, Antoni Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't United States J Clin Oncol. 2013 May 10;31(14):1767-74. doi: 10.1200/JCO.2012.44.7888. Epub 2013 Apr 8. PY - 2013 SN - 0732-183x SP - 1767-74 ST - Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma T2 - J Clin Oncol TI - Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma VL - 31 ID - 427 ER - TY - JOUR AD - Department of Experimental Medicine, University of Genoa, Genoa, Italy. AN - 23579276 AU - Marengo, B. AU - De Ciucis, C. G. AU - Ricciarelli, R. AU - Furfaro, A. L. AU - Colla, R. AU - Canepa, E. AU - Traverso, N. AU - Marinari, U. M. AU - Pronzato, M. A. AU - Domenicotti, C. C2 - PMC3641341 DA - Apr 11 DO - 10.1038/cddis.2013.118 DP - NLM ET - 2013/04/13 IS - 4 LA - eng N1 - 2041-4889 Marengo, B De Ciucis, C G Ricciarelli, R Furfaro, A L Colla, R Canepa, E Traverso, N Marinari, U M Pronzato, M A Domenicotti, C Journal Article Cell Death Dis. 2013 Apr 11;4(4):e589. doi: 10.1038/cddis.2013.118. PY - 2013 SP - e589 ST - p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment T2 - Cell Death Dis TI - p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment VL - 4 ID - 428 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: mosse@chop.edu. AN - 23598171 AU - Mossé, Y. P. AU - Lim, M. S. AU - Voss, S. D. AU - Wilner, K. AU - Ruffner, K. AU - Laliberte, J. AU - Rolland, D. AU - Balis, F. M. AU - Maris, J. M. AU - Weigel, B. J. AU - Ingle, A. M. AU - Ahern, C. AU - Adamson, P. C. AU - Blaney, S. M. C2 - PMC3730818 C6 - NIHMS476957 company. The other authors declare that they have no conflicts of interest. DA - May DO - 10.1016/s1470-2045(13)70095-0 DP - NLM ET - 2013/04/20 IS - 6 LA - eng N1 - 1474-5488 Mossé, Yael P Lim, Megan S Voss, Stephan D Wilner, Keith Ruffner, Katherine Laliberte, Julie Rolland, Delphine Balis, Frank M Maris, John M Weigel, Brenda J Ingle, Ashish M Ahern, Charlotte Adamson, Peter C Blaney, Susan M U01 CA097452/CA/NCI NIH HHS/United States U10 CA098413/CA/NCI NIH HHS/United States P30 CA016520/CA/NCI NIH HHS/United States U10 CA098543/CA/NCI NIH HHS/United States R01 CA140198/CA/NCI NIH HHS/United States UM1 CA097452/CA/NCI NIH HHS/United States Clinical Trial, Phase I Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Lancet Oncol. 2013 May;14(6):472-80. doi: 10.1016/S1470-2045(13)70095-0. Epub 2013 Apr 16. PY - 2013 SN - 1470-2045 (Print) 1470-2045 SP - 472-80 ST - Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study T2 - Lancet Oncol TI - Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study VL - 14 ID - 429 ER - TY - JOUR AD - Department of Genetics, Saint Savvas Hospital, Athens, Greece. AN - 23612919 AU - Dimitriadis, E. AU - Alexiou, G. A. AU - Tsotsou, P. AU - Simeonidi, E. AU - Stefanaki, K. AU - Patereli, A. AU - Prodromou, N. AU - Pandis, N. DA - Jul DO - 10.1007/s11060-013-1131-5 DP - NLM ET - 2013/04/25 IS - 3 LA - eng N1 - 1573-7373 Dimitriadis, Efthymios Alexiou, George A Tsotsou, Panagiota Simeonidi, Efthymia Stefanaki, Kalliopi Patereli, Amalia Prodromou, Neofytos Pandis, Nikolaos Journal Article United States J Neurooncol. 2013 Jul;113(3):353-8. doi: 10.1007/s11060-013-1131-5. Epub 2013 Apr 24. PY - 2013 SN - 0167-594x SP - 353-8 ST - BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors T2 - J Neurooncol TI - BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors VL - 113 ID - 430 ER - TY - JOUR AD - Arkansas Children's Nutrition Center, Little Rock, AR 72202, USA. AN - 23632636 AU - Saben, J. AU - Zhong, Y. AU - Gomez-Acevedo, H. AU - Thakali, K. M. AU - Borengasser, S. J. AU - Andres, A. AU - Shankar, K. C2 - PMC4116409 DA - Jul 1 DO - 10.1152/ajpendo.00076.2013 DP - NLM ET - 2013/05/02 IS - 1 LA - eng N1 - 1522-1555 Saben, Jessica Zhong, Ying Gomez-Acevedo, Horacio Thakali, Keshari M Borengasser, Sarah J Andres, Aline Shankar, Kartik R01 DK084225/DK/NIDDK NIH HHS/United States KL2-TR-000063/TR/NCATS NIH HHS/United States R01-DK084225/DK/NIDDK NIH HHS/United States UL1-TR-000039/TR/NCATS NIH HHS/United States Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E1-14. doi: 10.1152/ajpendo.00076.2013. Epub 2013 Apr 30. PY - 2013 SN - 0193-1849 (Print) 0193-1849 SP - E1-14 ST - Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity T2 - Am J Physiol Endocrinol Metab TI - Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity VL - 305 ID - 431 ER - TY - JOUR AD - Department of Food Science, Dairy Technology, University of Copenhagen, Faculty of Science, Frederiksberg C, Denmark. dcha@life.ku.dk AN - 23660296 AU - Chatterton, D. E. AU - Nguyen, D. N. AU - Bering, S. B. AU - Sangild, P. T. DA - Aug DO - 10.1016/j.biocel.2013.04.028 DP - NLM ET - 2013/05/11 IS - 8 LA - eng N1 - 1878-5875 Chatterton, Dereck E W Nguyen, Duc Ninh Bering, Stine Brandt Sangild, Per Torp Journal Article Research Support, Non-U.S. Gov't Review Netherlands Int J Biochem Cell Biol. 2013 Aug;45(8):1730-47. doi: 10.1016/j.biocel.2013.04.028. Epub 2013 May 6. PY - 2013 SN - 1357-2725 SP - 1730-47 ST - Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns T2 - Int J Biochem Cell Biol TI - Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns VL - 45 ID - 432 ER - TY - JOUR AD - National Specialist Ophthalmic Pathology Service, Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK. hardeep.mudhar@sth.nhs.uk AN - 23685997 AU - Mudhar, H. S. AU - Doherty, R. AU - Salawu, A. AU - Sisley, K. AU - Rennie, I. G. DA - Jul DO - 10.1136/bjophthalmol-2013-303291 DP - NLM ET - 2013/05/21 IS - 7 LA - eng N1 - 1468-2079 Mudhar, Hardeep Singh Doherty, Rachel Salawu, Abdulazeez Sisley, Karen Rennie, Ian G Journal Article Research Support, Non-U.S. Gov't England Br J Ophthalmol. 2013 Jul;97(7):924-8. doi: 10.1136/bjophthalmol-2013-303291. Epub 2013 May 17. PY - 2013 SN - 0007-1161 SP - 924-8 ST - Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations T2 - Br J Ophthalmol TI - Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations VL - 97 ID - 433 ER - TY - JOUR AD - Department of Laboratory Medicine, Chosun University Medical School, Gwangju, Korea. AN - 23690118 AU - Kang, S. H. AU - Pyo, J. Y. AU - Yang, S. W. AU - Hong, S. W. DA - Jun DO - 10.1309/ajcpn3ulh6ywbhph DP - NLM ET - 2013/05/22 IS - 6 LA - eng N1 - 1943-7722 Kang, Seong-Ho Pyo, Ju Yeon Yang, Seok-Woo Hong, Soon Won Comparative Study Journal Article Research Support, Non-U.S. Gov't England Am J Clin Pathol. 2013 Jun;139(6):759-64. doi: 10.1309/AJCPN3ULH6YWBHPH. PY - 2013 SN - 0002-9173 SP - 759-64 ST - Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR T2 - Am J Clin Pathol TI - Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR VL - 139 ID - 434 ER - TY - JOUR AD - Department of Dermatology, Bispebjerg Hospital, University of Copenhagen , Denmark. AN - 23697875 AU - Kamstrup, M. R. AU - Biskup, E. AU - Gjerdrum, L. M. AU - Ralfkiaer, E. AU - Niazi, O. AU - Gniadecki, R. DA - Mar DO - 10.3109/10428194.2013.807510 DP - NLM ET - 2013/05/24 IS - 3 LA - eng N1 - 1029-2403 Kamstrup, Maria Rørbæk Biskup, Edyta Gjerdrum, Lise Mette Rahbek Ralfkiaer, Elizabeth Niazi, Omid Gniadecki, Robert Journal Article United States Leuk Lymphoma. 2014 Mar;55(3):639-44. doi: 10.3109/10428194.2013.807510. Epub 2013 Aug 5. PY - 2014 SN - 1026-8022 SP - 639-44 ST - The importance of Notch signaling in peripheral T-cell lymphomas T2 - Leuk Lymphoma TI - The importance of Notch signaling in peripheral T-cell lymphomas VL - 55 ID - 435 ER - TY - JOUR AD - Cell Biology Program, The Hospital for Sick Children, TMDT East Tower #12-314, 101 College St., Toronto, Ontario, M5G 1L7; Canada. dkaplan@sickkids.ca. AN - 23701117 AU - Vojvodic, M. AU - Hansford, L. M. AU - Morozova, O. AU - Blakely, K. M. AU - Taylor, P. AU - Fathers, K. E. AU - Moffat, J. AU - Marra, M. AU - Smith, K. M. AU - Moran, M. F. AU - Kaplan, D. R. DA - Dec DO - 10.2174/15701638113109990001 DP - NLM ET - 2013/05/25 IS - 4 LA - eng N1 - 1875-6220 Vojvodic, Miliana Hansford, Loen M Morozova, Olena Blakely, Kim M Taylor, Paul Fathers, Kelly E Moffat, Jason Marra, Marco Smith, Kristen M Moran, Michael F Kaplan, David R Journal Article Research Support, Non-U.S. Gov't United Arab Emirates Curr Drug Discov Technol. 2013 Dec;10(4):283-304. doi: 10.2174/15701638113109990001. PY - 2013 SN - 1570-1638 SP - 283-304 ST - A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines T2 - Curr Drug Discov Technol TI - A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines VL - 10 ID - 436 ER - TY - JOUR AD - From the Department of Hematology/Oncology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN; Division of Hematology Oncology, Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. AN - 23714564 AU - Ferguson, M. AU - Hingorani, P. AU - Gupta, A. A. DO - 10.14694/EdBook_AM.2013.33.420 DP - NLM ET - 2013/05/30 LA - eng N1 - 1548-8756 Ferguson, Michael Hingorani, Pooja Gupta, Abha A Journal Article Review United States Am Soc Clin Oncol Educ Book. 2013:420-4. doi: 10.14694/EdBook_AM.2013.33.420. PY - 2013 SN - 1548-8748 SP - 420-4 ST - Emerging molecular-targeted therapies in early-phase clinical trials and preclinical models T2 - Am Soc Clin Oncol Educ Book TI - Emerging molecular-targeted therapies in early-phase clinical trials and preclinical models ID - 437 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. AN - 23730215 AU - Shi, B. AU - Vishwamitra, D. AU - Granda, J. G. AU - Whitton, T. AU - Shi, P. AU - Amin, H. M. C2 - PMC3664999 DA - Jun DO - 10.1593/neo.122012 DP - NLM ET - 2013/06/05 IS - 6 LA - eng N1 - 1476-5586 Shi, Bin Vishwamitra, Deeksha Granda, J Gabrielle Whitton, Thomas Shi, Ping Amin, Hesham M R01 CA151533/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Neoplasia. 2013 Jun;15(6):669-83. doi: 10.1593/neo.122012. PY - 2013 SN - 1522-8002 (Print) 1476-5586 SP - 669-83 ST - Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor T2 - Neoplasia TI - Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor VL - 15 ID - 438 ER - TY - JOUR AD - Department of Neurology and Neurological Surgery, University of Washington, Seattle, WA 98109, USA. chambemc@u.washington.edu AN - 23756728 AU - Chamberlain, M. C. DA - Sep DO - 10.1007/s11060-013-1176-5 DP - NLM ET - 2013/06/13 IS - 2 LA - eng N1 - 1573-7373 Chamberlain, Marc C Case Reports Journal Article United States J Neurooncol. 2013 Sep;114(2):237-40. doi: 10.1007/s11060-013-1176-5. Epub 2013 Jun 12. PY - 2013 SN - 0167-594x SP - 237-40 ST - Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series T2 - J Neurooncol TI - Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series VL - 114 ID - 439 ER - TY - JOUR AD - *Department of Pathology, American University of Beirut Medical Center, Beirut, Lebanon; †Department of Internal Medicine, Outcomes Research Unit, American University of Beirut Medical Center, Beirut, Lebanon; ‡Department of Pathology, Saad Specialist Hospital, Al Khobar, Kingdom of Saudi Arabia; §Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; ¶Department of Pathology, Tishreen University, Lattakia, Syrian Arab Republic; ‖Department of Pathology, Dhahran Health Center, Dhahran, Kingdom of Saudi Arabia; **Department of Pathology, King Fahd Specialist Hospital, Dammam, Kingdom of Saudi Arabia; ††Department of Pathology, King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia; and ‡‡ViennaLab Diagnostics GmbH, Vienna, Austria. AN - 23782679 AU - Saroufim, M. AU - Habib, R. AU - Karram, S. AU - Youssef Massad, C. AU - Taraif, S. AU - Loya, A. AU - Houreih, M. A. AU - Sheikh, S. S. AU - Amr, S. S. AU - Satti, M. AU - Oberkanins, C. AU - Khalifeh, I. DA - Jan DO - 10.1097/DAD.0b013e318293f355 DP - NLM ET - 2013/06/21 IS - 1 LA - eng N1 - 1533-0311 Saroufim, Maya Habib, Robert Karram, Sarah Youssef Massad, Cleo Taraif, Suad Loya, Asif Houreih, Mohammad Adib Sheikh, Salwa S Amr, Samir S Satti, Mohamed Oberkanins, Christian Khalifeh, Ibrahim Journal Article Research Support, Non-U.S. Gov't United States Am J Dermatopathol. 2014 Jan;36(1):68-73. doi: 10.1097/DAD.0b013e318293f355. PY - 2014 SN - 0193-1091 SP - 68-73 ST - BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions T2 - Am J Dermatopathol TI - BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions VL - 36 ID - 440 ER - TY - JOUR AD - Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan. AN - 23792105 AU - Chang, Y. S. AU - Lin, I. L. AU - Yeh, K. T. AU - Chang, J. G. DA - Oct DO - 10.1016/j.clinbiochem.2013.06.005 DP - NLM ET - 2013/06/25 IS - 15 LA - eng N1 - 1873-2933 Chang, Ya-Sian Lin, I-Ling Yeh, Kun-Tu Chang, Jan-Gowth Journal Article Research Support, Non-U.S. Gov't United States Clin Biochem. 2013 Oct;46(15):1572-7. doi: 10.1016/j.clinbiochem.2013.06.005. Epub 2013 Jun 20. PY - 2013 SN - 0009-9120 SP - 1572-7 ST - Rapid detection of K-, N-, H-RAS, and BRAF hotspot mutations in thyroid cancer using the multiplex primer extension T2 - Clin Biochem TI - Rapid detection of K-, N-, H-RAS, and BRAF hotspot mutations in thyroid cancer using the multiplex primer extension VL - 46 ID - 441 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore. AN - 23801497 AU - Yan, B. AU - Lim, M. AU - Zhou, L. AU - Kuick, C. H. AU - Leong, M. Y. AU - Yong, K. J. AU - Aung, L. AU - Salto-Tellez, M. AU - Chang, K. T. DA - Nov DO - 10.1136/jclinpath-2012-201375 DP - NLM ET - 2013/06/27 IS - 11 LA - eng N1 - 1472-4146 Yan, Benedict Lim, Malcolm Zhou, Lihan Kuick, Chik Hong Leong, May Ying Yong, Kol Jia Aung, Lele Salto-Tellez, Manuel Chang, Kenneth T E Journal Article England J Clin Pathol. 2013 Nov;66(11):985-91. doi: 10.1136/jclinpath-2012-201375. Epub 2013 Jun 25. PY - 2013 SN - 0021-9746 SP - 985-91 ST - Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas T2 - J Clin Pathol TI - Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas VL - 66 ID - 442 ER - TY - JOUR AD - Adis R & D Insight, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand. dru@adis.com AN - 23846731 AU - Wright, C. J. AU - McCormack, P. L. DA - Jul DO - 10.1007/s40265-013-0096-1 DP - NLM ET - 2013/07/13 IS - 11 LA - eng N1 - 1179-1950 Wright, Cameron J M McCormack, Paul L Journal Article New Zealand Drugs. 2013 Jul;73(11):1245-54. doi: 10.1007/s40265-013-0096-1. PY - 2013 SN - 0012-6667 SP - 1245-54 ST - Trametinib: first global approval T2 - Drugs TI - Trametinib: first global approval VL - 73 ID - 443 ER - TY - JOUR AD - Department of Medical Oncology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. AN - 23867124 AU - van Gaal, J. C. AU - Roeffen, M. H. AU - Flucke, U. E. AU - van der Laak, J. A. AU - van der Heijden, G. AU - de Bont, E. S. AU - Suurmeijer, A. J. AU - Versleijen-Jonkers, Y. M. AU - van der Graaf, W. T. DA - Nov DO - 10.1016/j.ejca.2013.06.022 DP - NLM ET - 2013/07/23 IS - 16 LA - eng N1 - 1879-0852 van Gaal, J Carlijn Roeffen, Melissa H S Flucke, Uta E van der Laak, Jeroen A W M van der Heijden, Gwen de Bont, Eveline S J M Suurmeijer, Albert J H Versleijen-Jonkers, Yvonne M H van der Graaf, Winette T A Journal Article Multicenter Study Research Support, Non-U.S. Gov't England Eur J Cancer. 2013 Nov;49(16):3462-70. doi: 10.1016/j.ejca.2013.06.022. Epub 2013 Jul 15. PY - 2013 SN - 0959-8049 SP - 3462-70 ST - Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice T2 - Eur J Cancer TI - Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice VL - 49 ID - 444 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, University Hospital of Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, NW, Germany. AN - 23871289 AU - Reis, H. AU - Hager, T. AU - Wohlschlaeger, J. AU - Bauer, S. AU - Katenkamp, K. AU - Katenkamp, D. AU - Baba, H. A. DA - Oct DO - 10.1016/j.humpath.2013.04.018 DP - NLM ET - 2013/07/23 IS - 10 LA - eng N1 - 1532-8392 Reis, Henning Hager, Thomas Wohlschlaeger, Jeremias Bauer, Sebastian Katenkamp, Kathrin Katenkamp, Detlef Baba, Hideo-Andreas Journal Article United States Hum Pathol. 2013 Oct;44(10):2266-74. doi: 10.1016/j.humpath.2013.04.018. Epub 2013 Jul 17. PY - 2013 SN - 0046-8177 SP - 2266-74 ST - Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma T2 - Hum Pathol TI - Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma VL - 44 ID - 445 ER - TY - JOUR AN - 23883275 AU - Kang, S. Y. AU - Ahn, S. AU - Lee, S. M. AU - Jeong, J. Y. AU - Sung, J. Y. AU - Oh, Y. L. AU - Kim, K. M. C2 - PMC3751688 DA - Jul 24 DO - 10.1186/1746-1596-8-121 DP - NLM ET - 2013/07/26 LA - eng N1 - 1746-1596 Kang, So Young Ahn, Soomin Lee, Sun-Mi Jeong, Ji Yun Sung, Ji-Youn Oh, Young Lyun Kim, Kyoung-Mee Journal Article Research Support, Non-U.S. Gov't Diagn Pathol. 2013 Jul 24;8:121. doi: 10.1186/1746-1596-8-121. PY - 2013 SN - 1746-1596 SP - 121 ST - Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas T2 - Diagn Pathol TI - Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas VL - 8 ID - 446 ER - TY - JOUR AD - Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore. AN - 23888996 AU - Yan, J. AU - Jiang, N. AU - Huang, G. AU - Tay, J. L. AU - Lin, B. AU - Bi, C. AU - Koh, G. S. AU - Li, Z. AU - Tan, J. AU - Chung, T. H. AU - Lu, Y. AU - Ariffin, H. AU - Kham, S. K. AU - Yeoh, A. E. AU - Chng, W. J. DA - Oct DO - 10.1111/bjh.12489 DP - NLM ET - 2013/07/31 IS - 1 LA - eng N1 - 1365-2141 Yan, Junli Jiang, Nan Huang, Gaofeng Tay, Jim L-S Lin, Baohong Bi, Chonglei Koh, Grace S Li, Zhenhua Tan, Joy Chung, Tae-Hoon Lu, Yi Ariffin, Hany Kham, Shirley K Y Yeoh, Allen E J Chng, Wee-Joo Journal Article Research Support, Non-U.S. Gov't England Br J Haematol. 2013 Oct;163(1):93-103. doi: 10.1111/bjh.12489. Epub 2013 Jul 25. PY - 2013 SN - 0007-1048 SP - 93-103 ST - Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia T2 - Br J Haematol TI - Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia VL - 163 ID - 447 ER - TY - JOUR AD - Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. AN - 23890088 AU - Botton, T. AU - Yeh, I. AU - Nelson, T. AU - Vemula, S. S. AU - Sparatta, A. AU - Garrido, M. C. AU - Allegra, M. AU - Rocchi, S. AU - Bahadoran, P. AU - McCalmont, T. H. AU - LeBoit, P. E. AU - Burton, E. A. AU - Bollag, G. AU - Ballotti, R. AU - Bastian, B. C. C2 - PMC3808507 C6 - NIHMS512581 DA - Nov DO - 10.1111/pcmr.12148 DP - NLM ET - 2013/07/31 IS - 6 LA - eng N1 - 1755-148x Botton, Thomas Yeh, Iwei Nelson, Tyrrell Vemula, Swapna S Sparatta, Alyssa Garrido, Maria C Allegra, Maryline Rocchi, Stephane Bahadoran, Philippe McCalmont, Timothy H LeBoit, Philip E Burton, Elizabeth A Bollag, Gideon Ballotti, Robert Bastian, Boris C P01 CA025874/CA/NCI NIH HHS/United States R01 CA131524/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Pigment Cell Melanoma Res. 2013 Nov;26(6):845-51. doi: 10.1111/pcmr.12148. Epub 2013 Aug 19. PY - 2013 SN - 1755-1471 (Print) 1755-1471 SP - 845-51 ST - Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy T2 - Pigment Cell Melanoma Res TI - Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy VL - 26 ID - 448 ER - TY - JOUR AD - Authors' Affiliations: Divisions of Clinical Studies, Cancer Therapeutics, and Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey; Histopathology Department, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and Department of Neuropathology, University of Bonn, Bonn, Germany. AN - 23918606 AU - Renshaw, J. AU - Taylor, K. R. AU - Bishop, R. AU - Valenti, M. AU - De Haven Brandon, A. AU - Gowan, S. AU - Eccles, S. A. AU - Ruddle, R. R. AU - Johnson, L. D. AU - Raynaud, F. I. AU - Selfe, J. L. AU - Thway, K. AU - Pietsch, T. AU - Pearson, A. D. AU - Shipley, J. C2 - PMC3818134 C6 - EMS54323 DA - Nov 1 DO - 10.1158/1078-0432.Ccr-13-0850 DP - NLM ET - 2013/08/07 IS - 21 LA - eng N1 - Renshaw, Jane Taylor, Kathryn R Bishop, Ryan Valenti, Melanie De Haven Brandon, Alexis Gowan, Sharon Eccles, Suzanne A Ruddle, Ruth R Johnson, Louise D Raynaud, Florence I Selfe, Joanna L Thway, Khin Pietsch, Torsten Pearson, Andrew D Shipley, Janet C5066/A10399/Cancer Research UK/United Kingdom A11566/Cancer Research UK/United Kingdom C309/A11566/Cancer Research UK/United Kingdom A10399/Cancer Research UK/United Kingdom 11566/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Clin Cancer Res. 2013 Nov 1;19(21):5940-51. doi: 10.1158/1078-0432.CCR-13-0850. Epub 2013 Aug 5. PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 5940-51 ST - Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo T2 - Clin Cancer Res TI - Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo VL - 19 ID - 449 ER - TY - JOUR AD - Department of Pediatrics and Child Neurology, Oita University Faculty of Medicine, Oita, Japan. AN - 23950000 AU - Sekiguchi, K. AU - Maeda, T. AU - Suenobu, S. AU - Kunisaki, N. AU - Shimizu, M. AU - Kiyota, K. AU - Handa, Y. S. AU - Akiyoshi, K. AU - Korematsu, S. AU - Aoki, Y. AU - Matsubara, Y. AU - Izumi, T. DA - Oct DO - 10.1002/ajmg.a.36107 DP - NLM ET - 2013/08/21 IS - 10 LA - eng N1 - 1552-4833 Sekiguchi, Kazuhito Maeda, Tomoki Suenobu, So-ichi Kunisaki, Nobutaka Shimizu, Miki Kiyota, Kyoko Handa, Yo-suke Akiyoshi, Kensuke Korematsu, Seigo Aoki, Yoko Matsubara, Yoichi Izumi, Tatsuro Case Reports Journal Article United States Am J Med Genet A. 2013 Oct;161A(10):2600-3. doi: 10.1002/ajmg.a.36107. Epub 2013 Aug 15. PY - 2013 SN - 1552-4825 SP - 2600-3 ST - A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation T2 - Am J Med Genet A TI - A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation VL - 161a ID - 450 ER - TY - JOUR AD - Viral Disease Division, Animal and Plant Quarantine Agency , Anyang-Si, Gyeonggi-Do , Republic of Korea. AN - 23952478 AU - Lee, J. AU - Shin, Y. K. AU - Song, J. Y. AU - Lee, K. W. DA - Jan DO - 10.3109/09553002.2013.835502 DP - NLM ET - 2013/08/21 IS - 1 LA - eng N1 - 1362-3095 Lee, Jienny Shin, Yeun-Kyung Song, Jae-Young Lee, Kyung-Woo Journal Article Research Support, Non-U.S. Gov't England Int J Radiat Biol. 2014 Jan;90(1):20-8. doi: 10.3109/09553002.2013.835502. Epub 2013 Sep 13. PY - 2014 SN - 0955-3002 SP - 20-8 ST - Protective mechanism of morin against ultraviolet B-induced cellular senescence in human keratinocyte stem cells T2 - Int J Radiat Biol TI - Protective mechanism of morin against ultraviolet B-induced cellular senescence in human keratinocyte stem cells VL - 90 ID - 451 ER - TY - JOUR AD - Departamento de Biología de Sistemas, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universidad de Alcalá, 28871 Alcalá de Henares, Spain. AN - 23958494 AU - Hernández-Breijo, B. AU - Monserrat, J. AU - Román, I. D. AU - González-Rodríguez, Á AU - Fernández-Moreno, M. D. AU - Lobo, M. V. AU - Valverde Á, M. AU - Gisbert, J. P. AU - Guijarro, L. G. DA - Nov 1 DO - 10.1016/j.taap.2013.07.024 DP - NLM ET - 2013/08/21 IS - 3 LA - eng N1 - 1096-0333 Hernández-Breijo, Borja Monserrat, Jorge Román, Irene D González-Rodríguez, Águeda Fernández-Moreno, Ma Dolores Lobo, M Val T Valverde, Ángela M Gisbert, Javier P Guijarro, Luis G Journal Article Research Support, Non-U.S. Gov't United States Toxicol Appl Pharmacol. 2013 Nov 1;272(3):568-78. doi: 10.1016/j.taap.2013.07.024. Epub 2013 Aug 16. PY - 2013 SN - 0041-008x SP - 568-78 ST - Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1 T2 - Toxicol Appl Pharmacol TI - Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1 VL - 272 ID - 452 ER - TY - JOUR AD - Dept. Life Sciences, University of Siena, Via. A. Moro 2, Siena 53100, Italy. AN - 23965518 AU - Monti, M. AU - Terzuoli, E. AU - Ziche, M. AU - Morbidelli, L. DA - Oct DO - 10.1016/j.phrs.2013.08.003 DP - NLM ET - 2013/08/24 LA - eng N1 - 1096-1186 Monti, Martina Terzuoli, Erika Ziche, Marina Morbidelli, Lucia Journal Article Research Support, Non-U.S. Gov't Netherlands Pharmacol Res. 2013 Oct;76:171-81. doi: 10.1016/j.phrs.2013.08.003. Epub 2013 Aug 18. PY - 2013 SN - 1043-6618 SP - 171-81 ST - The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis T2 - Pharmacol Res TI - The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis VL - 76 ID - 453 ER - TY - JOUR AD - Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. marco.gessi@ukb.uni-bonn.de AN - 23965740 AU - Gessi, M. AU - Zur Mühlen, A. AU - Hammes, J. AU - Waha, A. AU - Denkhaus, D. AU - Pietsch, T. DA - Sep DO - 10.1097/NEN.0b013e3182a033a0 DP - NLM ET - 2013/08/24 IS - 9 LA - eng N1 - 1554-6578 Gessi, Marco Zur Mühlen, Anja Hammes, Jennifer Waha, Andreas Denkhaus, Dorota Pietsch, Torsten Journal Article England J Neuropathol Exp Neurol. 2013 Sep;72(9):807-15. doi: 10.1097/NEN.0b013e3182a033a0. PY - 2013 SN - 0022-3069 SP - 807-15 ST - Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas T2 - J Neuropathol Exp Neurol TI - Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas VL - 72 ID - 454 ER - TY - JOUR AD - IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Dr Roberto Frias s/n, 4200-465 Porto, Portugal. AN - 23966419 AU - Boaventura, P. AU - Pereira, D. AU - Celestino, R. AU - Mendes, A. AU - Nakasawa, T. AU - Teixeira-Gomes, J. AU - Sobrinho-Simões, M. AU - Soares, P. DA - Nov DO - 10.1530/eje-13-0543 DP - NLM ET - 2013/08/24 IS - 5 LA - eng N1 - 1479-683x Boaventura, Paula Pereira, Dina Celestino, Ricardo Mendes, Adélia Nakasawa, Tadao Teixeira-Gomes, José Sobrinho-Simões, Manuel Soares, Paula Journal Article Research Support, Non-U.S. Gov't England Eur J Endocrinol. 2013 Oct 3;169(5):673-9. doi: 10.1530/EJE-13-0543. Print 2013 Nov. PY - 2013 SN - 0804-4643 SP - 673-9 ST - Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment T2 - Eur J Endocrinol TI - Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment VL - 169 ID - 455 ER - TY - JOUR AD - Inserm, U900, Paris, France ; Institut Curie, Centre de Recherche, Paris, France ; Mines ParisTech, Fontainebleau, France. AN - 23991058 AU - Boeva, V. AU - Jouannet, S. AU - Daveau, R. AU - Combaret, V. AU - Pierre-Eugène, C. AU - Cazes, A. AU - Louis-Brennetot, C. AU - Schleiermacher, G. AU - Ferrand, S. AU - Pierron, G. AU - Lermine, A. AU - Rio Frio, T. AU - Raynal, V. AU - Vassal, G. AU - Barillot, E. AU - Delattre, O. AU - Janoueix-Lerosey, I. C2 - PMC3753337 DO - 10.1371/journal.pone.0072182 DP - NLM ET - 2013/08/31 IS - 8 LA - eng N1 - 1932-6203 Boeva, Valentina Jouannet, Stéphanie Daveau, Romain Combaret, Valérie Pierre-Eugène, Cécile Cazes, Alex Louis-Brennetot, Caroline Schleiermacher, Gudrun Ferrand, Sandrine Pierron, Gaëlle Lermine, Alban Rio Frio, Thomas Raynal, Virginie Vassal, Gilles Barillot, Emmanuel Delattre, Olivier Janoueix-Lerosey, Isabelle Journal Article Research Support, Non-U.S. Gov't PLoS One. 2013 Aug 26;8(8):e72182. doi: 10.1371/journal.pone.0072182. eCollection 2013. PY - 2013 SN - 1932-6203 SP - e72182 ST - Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis T2 - PLoS One TI - Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis VL - 8 ID - 456 ER - TY - JOUR AD - Division of Endocrinology, Department of Pediatrics, Children's Hospital of, Pittsburgh of UPMC, Pittsburgh, PA, United States. Electronic address: melissa.buryk@chp.edu. AN - 23993207 AU - Buryk, M. A. AU - Monaco, S. E. AU - Witchel, S. F. AU - Mehta, D. K. AU - Gurtunca, N. AU - Nikiforov, Y. E. AU - Simons, J. P. DA - Oct DO - 10.1016/j.ijporl.2013.07.029 DP - NLM ET - 2013/09/03 IS - 10 LA - eng N1 - 1872-8464 Buryk, Melissa A Monaco, Sara E Witchel, Selma F Mehta, Deepak K Gurtunca, Nursen Nikiforov, Yuri E Simons, Jeffrey P Journal Article Ireland Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1697-700. doi: 10.1016/j.ijporl.2013.07.029. Epub 2013 Aug 9. PY - 2013 SN - 0165-5876 SP - 1697-700 ST - Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules T2 - Int J Pediatr Otorhinolaryngol TI - Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules VL - 77 ID - 457 ER - TY - JOUR AD - Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland; AN - 24004669 AU - Boi, M. AU - Rinaldi, A. AU - Kwee, I. AU - Bonetti, P. AU - Todaro, M. AU - Tabbò, F. AU - Piva, R. AU - Rancoita, P. M. AU - Matolcsy, A. AU - Timar, B. AU - Tousseyn, T. AU - Rodríguez-Pinilla, S. M. AU - Piris, M. A. AU - Beà, S. AU - Campo, E. AU - Bhagat, G. AU - Swerdlow, S. H. AU - Rosenwald, A. AU - Ponzoni, M. AU - Young, K. H. AU - Piccaluga, P. P. AU - Dummer, R. AU - Pileri, S. AU - Zucca, E. AU - Inghirami, G. AU - Bertoni, F. DA - Oct 10 DO - 10.1182/blood-2013-04-497933 DP - NLM ET - 2013/09/06 IS - 15 LA - eng N1 - 1528-0020 Boi, Michela Rinaldi, Andrea Kwee, Ivo Bonetti, Paola Todaro, Maria Tabbò, Fabrizio Piva, Roberto Rancoita, Paola M V Matolcsy, András Timar, Botond Tousseyn, Thomas Rodríguez-Pinilla, Socorro Maria Piris, Miguel A Beà, Sílvia Campo, Elias Bhagat, Govind Swerdlow, Steven H Rosenwald, Andreas Ponzoni, Maurilio Young, Ken H Piccaluga, Pier Paolo Dummer, Reinhard Pileri, Stefano Zucca, Emanuele Inghirami, Giorgio Bertoni, Francesco Journal Article Research Support, Non-U.S. Gov't United States Blood. 2013 Oct 10;122(15):2683-93. doi: 10.1182/blood-2013-04-497933. Epub 2013 Sep 4. PY - 2013 SN - 0006-4971 SP - 2683-93 ST - PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma T2 - Blood TI - PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma VL - 122 ID - 458 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco2Department of Otolaryngology-Head and Neck Surgery, Northwestern University, Chicago, Illinois. AN - 24030686 AU - Gouveia, C. AU - Can, N. T. AU - Bostrom, A. AU - Grenert, J. P. AU - van Zante, A. AU - Orloff, L. A. DA - Nov DO - 10.1001/jamaoto.2013.4501 DP - NLM ET - 2013/09/14 IS - 11 LA - eng N1 - 2168-619x Gouveia, Christopher Can, Nhu Thuy Bostrom, Alan Grenert, James P van Zante, Annemieke Orloff, Lisa A Comparative Study Journal Article United States JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1164-70. doi: 10.1001/jamaoto.2013.4501. PY - 2013 SN - 2168-6181 SP - 1164-70 ST - Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience T2 - JAMA Otolaryngol Head Neck Surg TI - Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience VL - 139 ID - 459 ER - TY - JOUR AD - Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria. Electronic address: guido.gualdoni@meduniwien.ac.at. AN - 24035785 AU - Gualdoni, G. A. AU - Kovarik, J. J. AU - Hofer, J. AU - Dose, F. AU - Pignitter, M. AU - Doberer, D. AU - Steinberger, P. AU - Somoza, V. AU - Wolzt, M. AU - Zlabinger, G. J. DA - Jan DO - 10.1016/j.bbagen.2013.09.009 DP - NLM ET - 2013/09/17 IS - 1 LA - eng N1 - Gualdoni, Guido A Kovarik, Johannes J Hofer, Johannes Dose, Franziska Pignitter, Marc Doberer, Daniel Steinberger, Peter Somoza, Veronika Wolzt, Michael Zlabinger, Gerhard J Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Netherlands Biochim Biophys Acta. 2014 Jan;1840(1):95-105. doi: 10.1016/j.bbagen.2013.09.009. Epub 2013 Sep 12. PY - 2014 SN - 0006-3002 (Print) 0006-3002 SP - 95-105 ST - Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation T2 - Biochim Biophys Acta TI - Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation VL - 1840 ID - 460 ER - TY - JOUR AD - Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. AN - 24057326 AU - Cykowski, M. D. AU - Allen, R. A. AU - Kanaly, A. C. AU - Fung, K. M. AU - Marshall, R. AU - Perry, A. AU - Stolzenberg, E. D. AU - Dunn, S. T. DA - Dec DO - 10.1007/s11060-013-1249-5 DP - NLM ET - 2013/09/24 IS - 3 LA - eng N1 - 1573-7373 Cykowski, Matthew D Allen, Richard A Kanaly, Angela C Fung, Kar-Ming Marshall, Roxanne Perry, Arie Stolzenberg, Ethan D Dunn, S Terence Journal Article Research Support, Non-U.S. Gov't United States J Neurooncol. 2013 Dec;115(3):477-86. doi: 10.1007/s11060-013-1249-5. Epub 2013 Sep 21. PY - 2013 SN - 0167-594x SP - 477-86 ST - The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features T2 - J Neurooncol TI - The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features VL - 115 ID - 461 ER - TY - JOUR AD - Department of Psychiatry, University of California San Francisco, San Francisco, California, USA. AN - 24101678 AU - Adviento, B. AU - Corbin, I. L. AU - Widjaja, F. AU - Desachy, G. AU - Enrique, N. AU - Rosser, T. AU - Risi, S. AU - Marco, E. J. AU - Hendren, R. L. AU - Bearden, C. E. AU - Rauen, K. A. AU - Weiss, L. A. C2 - PMC4230531 C6 - NIHMS597979 DA - Jan DO - 10.1136/jmedgenet-2013-101951 DP - NLM ET - 2013/10/09 IS - 1 LA - eng N1 - 1468-6244 Adviento, Brigid Corbin, Iris L Widjaja, Felicia Desachy, Guillaume Enrique, Nicole Rosser, Tena Risi, Susan Marco, Elysa J Hendren, Robert L Bearden, Carrie E Rauen, Katherine A Weiss, Lauren A 1DP2OD007449/OD/NIH HHS/United States DP2 OD007449/OD/NIH HHS/United States R34 MH089299/MH/NIMH NIH HHS/United States R34 MH089299-01/MH/NIMH NIH HHS/United States R01 AR062165/AR/NIAMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Med Genet. 2014 Jan;51(1):10-20. doi: 10.1136/jmedgenet-2013-101951. Epub 2013 Oct 7. PY - 2014 SN - 0022-2593 (Print) 0022-2593 SP - 10-20 ST - Autism traits in the RASopathies T2 - J Med Genet TI - Autism traits in the RASopathies VL - 51 ID - 462 ER - TY - JOUR AD - Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université Pierre et Marie Curie-Paris VI, Paris, France. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Medical Oncology, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Maxillofacial and Plastic Surgery, Hôpital Necker, APHP, Paris, France. Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH, Paris, France. Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Pathology, Hôpital Trousseau, APHP, Paris, France. Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH, Paris, France; Laboratory for Epigenetics and Environment, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory of Pharmacology-Genetics, Hôpital Saint-Louis, APHP, Paris, France. Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université René Descartes-Paris V, Paris, France; Department of Dermatology, Hôpital Cochin, APHP, Paris, France. Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Dermatology, Hôpital Tenon, APHP, Paris, France. Electronic address: sarah.guegan@tnn.aphp.fr. AN - 24129063 AU - Charbel, C. AU - Fontaine, R. H. AU - Malouf, G. G. AU - Picard, A. AU - Kadlub, N. AU - El-Murr, N. AU - How-Kit, A. AU - Su, X. AU - Coulomb-L'Hermine, A. AU - Tost, J. AU - Mourah, S. AU - Aractingi, S. AU - Guégan, S. DA - Apr DO - 10.1038/jid.2013.429 DP - NLM ET - 2013/10/17 IS - 4 LA - eng N1 - 1523-1747 Charbel, Christelle Fontaine, Romain H Malouf, Gabriel G Picard, Arnaud Kadlub, Natacha El-Murr, Nizar How-Kit, Alexandre Su, Xiaoping Coulomb-L'Hermine, Aurore Tost, Jorg Mourah, Samia Aractingi, Selim Guégan, Sarah P30 CA016672/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2014 Apr;134(4):1067-1074. doi: 10.1038/jid.2013.429. Epub 2013 Oct 15. PY - 2014 SN - 0022-202x SP - 1067-1074 ST - NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi T2 - J Invest Dermatol TI - NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi VL - 134 ID - 463 ER - TY - JOUR AD - Authors' Affiliations: Center for Childhood Cancer & Blood Diseases, Nationwide Children's Hospital; Center for Biostatistics, The Ohio State University, Columbus, Ohio; Institut of Pathology, Department Neuropathology, Ruprecht-Karls University and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; and Astrazeneca Ltd., Oncology iMed, Macclesfield, United Kingdom. AN - 24132923 AU - Bid, H. K. AU - Kibler, A. AU - Phelps, D. A. AU - Manap, S. AU - Xiao, L. AU - Lin, J. AU - Capper, D. AU - Oswald, D. AU - Geier, B. AU - DeWire, M. AU - Smith, P. D. AU - Kurmasheva, R. T. AU - Mo, X. AU - Fernandez, S. AU - Houghton, P. J. C2 - PMC4086218 C6 - NIHMS532794 DA - Dec 15 DO - 10.1158/1078-0432.Ccr-13-0842 DP - NLM ET - 2013/10/18 IS - 24 LA - eng N1 - Bid, Hemant K Kibler, Aaron Phelps, Doris A Manap, Sagymbek Xiao, Linlin Lin, Jiayuh Capper, David Oswald, Duane Geier, Brian DeWire, Mariko Smith, Paul D Kurmasheva, Raushan T Mo, Xiaokui Fernandez, Soledad Houghton, Peter J CA165995/CA/NCI NIH HHS/United States P01 CA165995/CA/NCI NIH HHS/United States N01-CM42216/CM/NCI NIH HHS/United States R01 CA169368/CA/NCI NIH HHS/United States P30 CA016058/CA/NCI NIH HHS/United States N01CM42216/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Clin Cancer Res. 2013 Dec 15;19(24):6716-29. doi: 10.1158/1078-0432.CCR-13-0842. Epub 2013 Oct 16. PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 6716-29 ST - Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma T2 - Clin Cancer Res TI - Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma VL - 19 ID - 464 ER - TY - JOUR AN - 24156711 AU - Cizmarova, M. AU - Kostalova, L. AU - Pribilincova, Z. AU - Lasabova, Z. AU - Hlavata, A. AU - Kovacs, L. AU - Ilencikova, D. DA - Oct DO - 10.4149/endo_2013_04_217 DP - NLM ET - 2013/10/26 IS - 4 LA - eng N1 - Cizmarova, M Kostalova, L Pribilincova, Z Lasabova, Z Hlavata, A Kovacs, L Ilencikova, D Journal Article Research Support, Non-U.S. Gov't Review Germany Endocr Regul. 2013 Oct;47(4):217-22. doi: 10.4149/endo_2013_04_217. PY - 2013 SN - 1210-0668 (Print) 1210-0668 SP - 217-22 ST - Rasopathies - dysmorphic syndromes with short stature and risk of malignancy T2 - Endocr Regul TI - Rasopathies - dysmorphic syndromes with short stature and risk of malignancy VL - 47 ID - 465 ER - TY - JOUR AD - Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California, Davis, California; AN - 24163071 AU - den Hartigh, L. J. AU - Altman, R. AU - Norman, J. E. AU - Rutledge, J. C. C2 - PMC3920150 DA - Jan 1 DO - 10.1152/ajpheart.00137.2013 DP - NLM ET - 2013/10/29 IS - 1 LA - eng N1 - 1522-1539 den Hartigh, Laura J Altman, Robin Norman, Jennifer E Rutledge, John C U24 DK092993/DK/NIDDK NIH HHS/United States R01-HL-055667/HL/NHLBI NIH HHS/United States T32-GM08799/GM/NIGMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H109-20. doi: 10.1152/ajpheart.00137.2013. Epub 2013 Oct 25. PY - 2014 SN - 0363-6135 (Print) 0363-6135 SP - H109-20 ST - Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB T2 - Am J Physiol Heart Circ Physiol TI - Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB VL - 306 ID - 466 ER - TY - JOUR AD - German Cancer Consortium (DKTK), Germany. AN - 24166094 AU - Schulte, J. H. AU - Schulte, S. AU - Heukamp, L. C. AU - Astrahantseff, K. AU - Stephan, H. AU - Fischer, M. AU - Schramm, A. AU - Eggert, A. DA - Nov DO - 10.1055/s-0033-1357132 DP - NLM ET - 2013/10/30 IS - 6 LA - eng N1 - 1439-3824 Schulte, J H Schulte, S Heukamp, L C Astrahantseff, K Stephan, H Fischer, M Schramm, A Eggert, A Journal Article Research Support, Non-U.S. Gov't Review Germany Klin Padiatr. 2013 Nov;225(6):303-8. doi: 10.1055/s-0033-1357132. Epub 2013 Oct 28. PY - 2013 SN - 0300-8630 SP - 303-8 ST - Targeted Therapy for Neuroblastoma: ALK Inhibitors T2 - Klin Padiatr TI - Targeted Therapy for Neuroblastoma: ALK Inhibitors VL - 225 ID - 467 ER - TY - JOUR AD - Corresponding Author: Ulrike Stein, PhD, Experimental and Clinical Research Center, Charité University Medicine Berlin and the Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany. ustein@mdc-berlin.de. AN - 24220141 AU - Hagemann, C. AU - Fuchs, S. AU - Monoranu, C. M. AU - Herrmann, P. AU - Smith, J. AU - Hohmann, T. AU - Grabiec, U. AU - Kessler, A. F. AU - Dehghani, F. AU - Löhr, M. AU - Ernestus, R. I. AU - Vince, G. H. AU - Stein, U. C2 - PMC3829600 DA - Dec DO - 10.1093/neuonc/not136 DP - NLM ET - 2013/11/14 IS - 12 LA - eng N1 - 1523-5866 Hagemann, Carsten Fuchs, Steffen Monoranu, Camelia M Herrmann, Pia Smith, Janice Hohmann, Tim Grabiec, Urszula Kessler, Almuth F Dehghani, Faramarz Löhr, Mario Ernestus, Ralf-Ingo Vince, Giles H Stein, Ulrike Journal Article Neuro Oncol. 2013 Dec;15(12):1696-709. doi: 10.1093/neuonc/not136. Epub 2013 Nov 11. PY - 2013 SN - 1522-8517 (Print) 1522-8517 SP - 1696-709 ST - Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis T2 - Neuro Oncol TI - Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis VL - 15 ID - 468 ER - TY - JOUR AD - Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China. AN - 24293393 AU - Yi, B. AU - Yang, J. AU - Wang, L. DA - Apr DO - 10.1007/s13277-013-1422-7 DP - NLM ET - 2013/12/03 IS - 4 LA - eng N1 - 1423-0380 Yi, Bin Yang, Jixin Wang, Lizhong Journal Article United States Tumour Biol. 2014 Apr;35(4):3229-35. doi: 10.1007/s13277-013-1422-7. Epub 2013 Nov 30. PY - 2014 SN - 1010-4283 SP - 3229-35 ST - The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line T2 - Tumour Biol TI - The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line VL - 35 ID - 469 ER - TY - JOUR AD - Non-Hodgkin Lymphoma-Berlin-Frankfurt-Münster Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany; AN - 24297868 AU - Damm-Welk, C. AU - Mussolin, L. AU - Zimmermann, M. AU - Pillon, M. AU - Klapper, W. AU - Oschlies, I. AU - d'Amore, E. S. AU - Reiter, A. AU - Woessmann, W. AU - Rosolen, A. DA - Jan 16 DO - 10.1182/blood-2013-09-526202 DP - NLM ET - 2013/12/04 IS - 3 LA - eng N1 - 1528-0020 Damm-Welk, Christine Mussolin, Lara Zimmermann, Martin Pillon, Marta Klapper, Wolfram Oschlies, Ilske d'Amore, Emanuele S G Reiter, Alfred Woessmann, Wilhelm Rosolen, Angelo Clinical Trial Journal Article Research Support, Non-U.S. Gov't United States Blood. 2014 Jan 16;123(3):334-7. doi: 10.1182/blood-2013-09-526202. Epub 2013 Dec 2. PY - 2014 SN - 0006-4971 SP - 334-7 ST - Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma T2 - Blood TI - Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma VL - 123 ID - 470 ER - TY - JOUR AD - Department of Thyroid and Breast Surgery, West China Hospital, Sichuan University, Chengdu, China. AN - 24301760 AU - Gong, R. X. AU - Gong, Y. P. AU - Yang, J. AU - Wei, T. AU - Li-Ling, J. AU - Zhu, J. Q. DA - Oct 24 DO - 10.4238/2013.October.24.11 DP - NLM ET - 2013/12/05 IS - 4 LA - eng N1 - 1676-5680 Gong, R X Gong, Y P Yang, J Wei, T Li-Ling, J Zhu, J Q Journal Article Research Support, Non-U.S. Gov't Brazil Genet Mol Res. 2013 Oct 24;12(4):4990-7. doi: 10.4238/2013.October.24.11. PY - 2013 SN - 1676-5680 SP - 4990-7 ST - Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography T2 - Genet Mol Res TI - Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography VL - 12 ID - 471 ER - TY - JOUR AN - 24321241 AU - Aisner, D. L. AU - Newell, K. L. AU - Pollack, A. G. AU - Kleinschmidt-Demasters, B. K. AU - Steinberg, G. K. AU - Smyth, L. T. AU - Vogel, H. C2 - PMC4594433 DA - Mar-Apr DO - 10.5414/np300679 DP - NLM ET - 2013/12/11 IS - 2 LA - eng N1 - Aisner, Dara L Newell, Kathy L Pollack, Ania G Kleinschmidt-Demasters, Bette K Steinberg, Gary K Smyth, Lawrence T Vogel, Hannes Journal Article Clin Neuropathol. 2014 Mar-Apr;33(2):112-21. doi: 10.5414/NP300679. PY - 2014 SN - 0722-5091 (Print) 0722-5091 SP - 112-21 ST - Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases T2 - Clin Neuropathol TI - Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases VL - 33 ID - 472 ER - TY - JOUR AD - Department of Medical Biochemistry and Genetics and MediCity Research Laboratories, University of Turku, Finland; Turku Doctoral Programme of Molecular Medicine, Turku, Finland. AN - 24374844 AU - Kurppa, K. J. AU - Catón, J. AU - Morgan, P. R. AU - Ristimäki, A. AU - Ruhin, B. AU - Kellokoski, J. AU - Elenius, K. AU - Heikinheimo, K. C2 - PMC4255689 DA - Apr DO - 10.1002/path.4317 DP - NLM ET - 2014/01/01 IS - 5 LA - eng N1 - 1096-9896 Kurppa, Kari J Catón, Javier Morgan, Peter R Ristimäki, Ari Ruhin, Blandine Kellokoski, Jari Elenius, Klaus Heikinheimo, Kristiina Department of Health/United Kingdom Journal Article Research Support, Non-U.S. Gov't J Pathol. 2014 Apr;232(5):492-8. doi: 10.1002/path.4317. Epub 2014 Jan 31. PY - 2014 SN - 0022-3417 (Print) 0022-3417 SP - 492-8 ST - High frequency of BRAF V600E mutations in ameloblastoma T2 - J Pathol TI - High frequency of BRAF V600E mutations in ameloblastoma VL - 232 ID - 473 ER - TY - JOUR AD - Department of Orthopedics, Tongji Hospital of Tongji University, Shanghai, 200065, China, meijiong005@sina.com. AN - 24375110 AU - Mei, J. AU - Zhu, X. AU - Wang, Z. AU - Wang, Z. DA - May DO - 10.1007/s12013-013-9781-7 DP - NLM ET - 2014/01/01 IS - 1 LA - eng N1 - 1559-0283 Mei, Jiong Zhu, Xiaozhong Wang, Zhiyuan Wang, Zheren Journal Article Research Support, Non-U.S. Gov't United States Cell Biochem Biophys. 2014 May;69(1):151-6. doi: 10.1007/s12013-013-9781-7. PY - 2014 SN - 1085-9195 SP - 151-6 ST - VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment T2 - Cell Biochem Biophys TI - VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment VL - 69 ID - 474 ER - TY - JOUR AD - Pediatric and Adolescent Oncology Department, Gustave Roussy, Villejuif, France. AN - 24375920 AU - Bautista, F. AU - Paci, A. AU - Minard-Colin, V. AU - Dufour, C. AU - Grill, J. AU - Lacroix, L. AU - Varlet, P. AU - Valteau-Couanet, D. AU - Geoerger, B. DA - Jun DO - 10.1002/pbc.24891 DP - NLM ET - 2014/01/01 IS - 6 LA - eng N1 - 1545-5017 Bautista, Francisco Paci, Angelo Minard-Colin, Veronique Dufour, Christelle Grill, Jacques Lacroix, Ludovic Varlet, Pascale Valteau-Couanet, Dominique Geoerger, Birgit Case Reports Journal Article United States Pediatr Blood Cancer. 2014 Jun;61(6):1101-3. doi: 10.1002/pbc.24891. Epub 2013 Dec 3. PY - 2014 SN - 1545-5009 SP - 1101-3 ST - Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas T2 - Pediatr Blood Cancer TI - Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas VL - 61 ID - 475 ER - TY - JOUR AD - Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan. AN - 27508178 AU - Hsu, C. H. AU - Shen, Y. C. AU - Shao, Y. Y. AU - Hsu, C. AU - Cheng, A. L. C2 - PMC4918267 DO - 10.2147/jhc.S45040 DP - NLM ET - 2014/01/01 LA - eng N1 - 2253-5969 Hsu, Chih-Hung Shen, Ying-Chun Shao, Yu-Yun Hsu, Chiun Cheng, Ann-Lii Journal Article Review J Hepatocell Carcinoma. 2014 Jun 12;1:85-99. doi: 10.2147/JHC.S45040. eCollection 2014. PY - 2014 SN - 2253-5969 (Print) 2253-5969 SP - 85-99 ST - Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives T2 - J Hepatocell Carcinoma TI - Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives VL - 1 ID - 476 ER - TY - JOUR AD - Departments of *Dermatology ‡Preventive Medicine §Robert H. Lurie Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL †Department of Dermatopathology, Memorial Sloan-Kettering Cancer Center, New York, NY. AN - 24451276 AU - Yazdan, P. AU - Cooper, C. AU - Sholl, L. M. AU - Busam, K. AU - Rademaker, A. AU - Weitner, B. B. AU - Obregon, R. AU - Guitart, J. AU - Gerami, P. DA - May DO - 10.1097/pas.0000000000000160 DP - NLM ET - 2014/01/24 IS - 5 LA - eng N1 - 1532-0979 Yazdan, Pedram Cooper, Chelsea Sholl, Lauren Meldi Busam, Klaus Rademaker, Alfred Weitner, Bing Bing Obregon, Roxana Guitart, Joan Gerami, Pedram Comparative Study Historical Article Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 2014 May;38(5):638-45. doi: 10.1097/PAS.0000000000000160. PY - 2014 SN - 0147-5185 SP - 638-45 ST - Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression T2 - Am J Surg Pathol TI - Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression VL - 38 ID - 477 ER - TY - JOUR AD - Department of Medical Oncology, Erciyes University Faculty of Medicine, Turkey E-mail : veliberk@gmail.com. AN - 24460304 AU - Berk, V. AU - Kaplan, M. A. AU - Tonyali, O. AU - Buyukberber, S. AU - Balakan, O. AU - Ozkan, M. AU - Demirci, U. AU - Ozturk, T. AU - Bilici, A. AU - Tastekin, D. AU - Ozdemir, N. AU - Unal, O. U. AU - Oflazoglu, U. AU - Turkmen, E. AU - Erdogan, B. AU - Uyeturk, U. AU - Oksuzoglu, B. AU - Cinkir, H. Y. AU - Yasar, N. AU - Gumus, M. DO - 10.7314/apjcp.2013.14.12.7367 DP - NLM ET - 2014/01/28 IS - 12 LA - eng N1 - 2476-762x Berk, Veli Kaplan, Mehmet Ali Tonyali, Onder Buyukberber, Suleyman Balakan, Ozan Ozkan, Metin Demirci, Umut Ozturk, Turkan Bilici, Ahmet Tastekin, Didem Ozdemir, Nuriye Unal, Olcun Umit Oflazoglu, Utku Turkmen, Esma Erdogan, Bulent Uyeturk, Ummugul Oksuzoglu, Berna Cinkir, Havva Yesil Yasar, Nurgul Gumus, Mahmut Journal Article Multicenter Study Thailand Asian Pac J Cancer Prev. 2013;14(12):7367-9. doi: 10.7314/apjcp.2013.14.12.7367. PY - 2013 SN - 1513-7368 SP - 7367-9 ST - Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology T2 - Asian Pac J Cancer Prev TI - Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology VL - 14 ID - 478 ER - TY - JOUR AD - Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. AN - 24463458 AU - Rizos, H. AU - Menzies, A. M. AU - Pupo, G. M. AU - Carlino, M. S. AU - Fung, C. AU - Hyman, J. AU - Haydu, L. E. AU - Mijatov, B. AU - Becker, T. M. AU - Boyd, S. C. AU - Howle, J. AU - Saw, R. AU - Thompson, J. F. AU - Kefford, R. F. AU - Scolyer, R. A. AU - Long, G. V. DA - Apr 1 DO - 10.1158/1078-0432.Ccr-13-3122 DP - NLM ET - 2014/01/28 IS - 7 LA - eng N1 - Rizos, Helen Menzies, Alexander M Pupo, Gulietta M Carlino, Matteo S Fung, Carina Hyman, Jessica Haydu, Lauren E Mijatov, Branka Becker, Therese M Boyd, Suzanah C Howle, Julie Saw, Robyn Thompson, John F Kefford, Richard F Scolyer, Richard A Long, Georgina V Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2014 Apr 1;20(7):1965-77. doi: 10.1158/1078-0432.CCR-13-3122. Epub 2014 Jan 24. PY - 2014 SN - 1078-0432 (Print) 1078-0432 SP - 1965-77 ST - BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact T2 - Clin Cancer Res TI - BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact VL - 20 ID - 479 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. AN - 24469048 AU - Bunda, S. AU - Qin, K. AU - Kommaraju, K. AU - Heir, P. AU - Ohh, M. DA - Feb 5 DO - 10.1038/onc.2013.596 DP - NLM ET - 2014/01/29 IS - 6 LA - eng N1 - 1476-5594 Bunda, S Qin, K Kommaraju, K Heir, P Ohh, M MOP119356/Canadian Institutes of Health Research/Canada Journal Article Research Support, Non-U.S. Gov't England Oncogene. 2015 Feb 5;34(6):789-97. doi: 10.1038/onc.2013.596. Epub 2014 Jan 27. PY - 2015 SN - 0950-9232 SP - 789-97 ST - Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway T2 - Oncogene TI - Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway VL - 34 ID - 480 ER - TY - JOUR AN - 24471189 AU - Estrozi, B. AU - Machado, J. AU - Rodriguez, R. AU - Bacchi, C. E. DA - Jan DO - 10.1097/pdm.0b013e318298c1d9 DP - NLM ET - 2014/01/29 IS - 1 LA - eng N1 - 1533-4058 Estrozi, Bruna Machado, Juliana Rodriguez, Rubens Bacchi, Carlos E Journal Article United States Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):57-64. doi: 10.1097/pdm.0b013e318298c1d9. PY - 2014 SN - 1533-4058 SP - 57-64 ST - Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults T2 - Appl Immunohistochem Mol Morphol TI - Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults VL - 22 ID - 481 ER - TY - JOUR AD - Department of Pediatrics, Pediatrics Oncology Institute-GRAACC (Grupo de Apoio ao Adolescente e à Criança com Câncer), UNIFESP (Federal University of São Paulo), Rua Botucatu, no 743, Floor 8 - Genetics Laboratory, Vila Clementino, São Paulo, SP, 04023-062, Brazil, gabi.rampazzo@gmail.com. AN - 24532263 AU - Cruz, G. R. AU - Dias Oliveira, I. AU - Moraes, L. AU - Del Giudice Paniago, M. AU - de Seixas Alves, M. T. AU - Capellano, A. M. AU - Saba-Silva, N. AU - Cavalheiro, S. AU - Cerutti, J. M. AU - Toledo, S. R. DA - Apr DO - 10.1007/s11060-014-1398-1 DP - NLM ET - 2014/02/18 IS - 2 LA - eng N1 - 1573-7373 Cruz, Gabriela Rampazzo Dias Oliveira, Indhira Moraes, Laís Del Giudice Paniago, Mário de Seixas Alves, Maria Teresa Capellano, Andrea Maria Saba-Silva, Nasjla Cavalheiro, Sérgio Cerutti, Janete Maria Toledo, Silvia Regina Caminada Journal Article Research Support, Non-U.S. Gov't United States J Neurooncol. 2014 Apr;117(2):235-42. doi: 10.1007/s11060-014-1398-1. Epub 2014 Feb 17. PY - 2014 SN - 0167-594x SP - 235-42 ST - Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas T2 - J Neurooncol TI - Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas VL - 117 ID - 482 ER - TY - JOUR AD - 1 Prince Henry's Institute of Medical Research , Clayton, Australia . AN - 24559275 AU - Mond, M. AU - Alexiadis, M. AU - Eriksson, N. AU - Davis, M. J. AU - Muscat, G. E. AU - Fuller, P. J. AU - Gilfillan, C. DA - Jun DO - 10.1089/thy.2013.0509 DP - NLM ET - 2014/02/25 IS - 6 LA - eng N1 - 1557-9077 Mond, Michael Alexiadis, Maria Eriksson, Natalie Davis, Melissa J Muscat, George E O Fuller, Peter J Gilfillan, Christopher Journal Article Research Support, Non-U.S. Gov't United States Thyroid. 2014 Jun;24(6):1000-11. doi: 10.1089/thy.2013.0509. Epub 2014 May 19. PY - 2014 SN - 1050-7256 SP - 1000-11 ST - Nuclear receptor expression in human differentiated thyroid tumors T2 - Thyroid TI - Nuclear receptor expression in human differentiated thyroid tumors VL - 24 ID - 483 ER - TY - JOUR AD - Columbia University College of Physicians and Surgeons, New York, New York. AN - 24602192 AU - West, E. S. AU - Williams, V. L. AU - Morelli, J. G. DA - Jan-Feb DO - 10.1111/pde.12316 DP - NLM ET - 2014/03/08 IS - 1 LA - eng N1 - 1525-1470 West, Emily S Williams, Victoria L Morelli, Joseph G Case Reports Journal Article United States Pediatr Dermatol. 2015 Jan-Feb;32(1):153-4. doi: 10.1111/pde.12316. Epub 2014 Mar 6. PY - 2015 SN - 0736-8046 SP - 153-4 ST - Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma T2 - Pediatr Dermatol TI - Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma VL - 32 ID - 484 ER - TY - JOUR AD - Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea. Department of Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Electronic address: ejseo@amc.seoul.kr. AN - 24613277 AU - Lim, J. H. AU - Jang, S. AU - Park, C. J. AU - Cho, Y. U. AU - Lee, J. H. AU - Lee, K. H. AU - Lee, J. O. AU - Shin, J. Y. AU - Kim, J. I. AU - Huh, J. AU - Seo, E. J. DA - Jan-Feb DO - 10.1016/j.cancergen.2013.12.003 DP - NLM ET - 2014/03/13 IS - 1-2 LA - eng N1 - Lim, Ji-Hun Jang, Seongsoo Park, Chan-Jeoung Cho, Young-Uk Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Jin-Ok Shin, Jong-Yeon Kim, Jong-Il Huh, Jooryung Seo, Eul-Ju Case Reports Journal Article Review United States Cancer Genet. 2014 Jan-Feb;207(1-2):40-5. doi: 10.1016/j.cancergen.2013.12.003. Epub 2014 Jan 21. PY - 2014 SN - 2210-7762 (Print) SP - 40-5 ST - RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia T2 - Cancer Genet TI - RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia VL - 207 ID - 485 ER - TY - JOUR AD - Translational Genomics Research Institute, 445 N. Fifth St, Phoenix, AZ, 85004, USA, mdemeure@tgen.org. AN - 24633422 AU - Demeure, M. J. AU - Aziz, M. AU - Rosenberg, R. AU - Gurley, S. D. AU - Bussey, K. J. AU - Carpten, J. D. DA - Jun DO - 10.1007/s00268-014-2485-3 DP - NLM ET - 2014/03/19 IS - 6 LA - eng N1 - 1432-2323 Demeure, Michael J Aziz, Meraj Rosenberg, Richard Gurley, Steven D Bussey, Kimberly J Carpten, John D Case Reports Journal Article United States World J Surg. 2014 Jun;38(6):1296-305. doi: 10.1007/s00268-014-2485-3. PY - 2014 SN - 0364-2313 SP - 1296-305 ST - Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target T2 - World J Surg TI - Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target VL - 38 ID - 486 ER - TY - JOUR AD - Division of Cancer Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, U.K. AN - 24641191 AU - Pourreyron, C. AU - Chen, M. AU - McGrath, J. A. AU - Salas-Alanis, J. C. AU - South, A. P. AU - Leigh, I. M. DA - Jun DO - 10.1111/bjd.12715 DP - NLM ET - 2014/03/20 IS - 6 LA - eng N1 - 1365-2133 Pourreyron, C Chen, M McGrath, J A Salas-Alanis, J C South, A P Leigh, I M 13044/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't England Br J Dermatol. 2014 Jun;170(6):1256-65. doi: 10.1111/bjd.12715. PY - 2014 SN - 0007-0963 SP - 1256-65 ST - High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion T2 - Br J Dermatol TI - High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion VL - 170 ID - 487 ER - TY - JOUR AD - Departments of *Pathology ∥Urology ¶Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD †Department of Pathology, University of South Carolina School of Medicine-Greenville, Greenville, SC ‡Department of Pathology, Brigham and Women's Hospital, Boston, MA §Departments of Pathology/Microbiology, Pediatrics and Orthopedic Surgery, University of Nebraska Medical Center, Omaha, NE. AN - 24698962 AU - Smith, N. E. AU - Deyrup, A. T. AU - Mariño-Enriquez, A. AU - Fletcher, J. A. AU - Bridge, J. A. AU - Illei, P. B. AU - Netto, G. J. AU - Argani, P. C2 - PMC4352307 C6 - NIHMS664075 DA - Jun DO - 10.1097/pas.0000000000000179 DP - NLM ET - 2014/04/05 IS - 6 LA - eng N1 - 1532-0979 Smith, Nathaniel E Deyrup, Andrea T Mariño-Enriquez, Adrian Fletcher, Jonathan A Bridge, Julia A Illei, Peter B Netto, George J Argani, Pedram P30 CA006973/CA/NCI NIH HHS/United States Case Reports Journal Article Am J Surg Pathol. 2014 Jun;38(6):858-63. doi: 10.1097/PAS.0000000000000179. PY - 2014 SN - 0147-5185 (Print) 0147-5185 SP - 858-63 ST - VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? T2 - Am J Surg Pathol TI - VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? VL - 38 ID - 488 ER - TY - JOUR AD - *Department of Pathology §Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY †Dermatopathologie Friedrichshafen, Friedrichshafen, Germany ‡Department of Dermatology, Medical University Graz, Graz, Austria. AN - 24698967 AU - Busam, K. J. AU - Kutzner, H. AU - Cerroni, L. AU - Wiesner, T. C2 - PMC5042334 C6 - NIHMS708433 DA - Jul DO - 10.1097/pas.0000000000000187 DP - NLM ET - 2014/04/05 IS - 7 LA - eng N1 - 1532-0979 Busam, Klaus J Kutzner, Heinz Cerroni, Lorenzo Wiesner, Thomas P30 CA008748/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Am J Surg Pathol. 2014 Jul;38(7):925-33. doi: 10.1097/PAS.0000000000000187. PY - 2014 SN - 0147-5185 (Print) 0147-5185 SP - 925-33 ST - Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions T2 - Am J Surg Pathol TI - Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions VL - 38 ID - 489 ER - TY - JOUR AD - Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. AN - 24720374 AU - Go, H. AU - Jeon, Y. K. AU - Huh, J. AU - Choi, S. J. AU - Choi, Y. D. AU - Cha, H. J. AU - Kim, H. J. AU - Park, G. AU - Min, S. AU - Kim, J. E. DA - Aug DO - 10.1111/his.12416 DP - NLM ET - 2014/04/12 IS - 2 LA - eng N1 - 1365-2559 Go, Heounjeong Jeon, Yoon Kyung Huh, Jooryung Choi, Suk Jin Choi, Yoo-Duk Cha, Hee Jeong Kim, Hyun-Jung Park, Gyeongsin Min, Sookee Kim, Ji Eun Journal Article Research Support, Non-U.S. Gov't England Histopathology. 2014 Aug;65(2):261-72. doi: 10.1111/his.12416. Epub 2014 May 12. PY - 2014 SN - 0309-0167 SP - 261-72 ST - Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms T2 - Histopathology TI - Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms VL - 65 ID - 490 ER - TY - JOUR AD - Surgical Clinic II, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Trieste, Italy. Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto-IRCCS, Padova, Italy. Endocrinology Unit, Department of Medicine, University of Padova, Padova, Italy. Department of Imaging, Nuclear Medicine, PET/CT Centre, Radiology, Neuroradiology, Medical Physics, Santa Maria della Misericordia Hospital, Rovigo, Italy. Electronic address: domenico.rubello@libero.it. AN - 24721322 AU - Pelizzo, M. R. AU - Dobrinja, C. AU - Casal Ide, E. AU - Zane, M. AU - Lora, O. AU - Toniato, A. AU - Mian, C. AU - Barollo, S. AU - Izuzquiza, M. AU - Guerrini, J. AU - De Manzini, N. AU - Merante Boschin, I. AU - Rubello, D. DA - May DO - 10.1016/j.biopha.2014.03.008 DP - NLM ET - 2014/04/12 IS - 4 LA - eng N1 - 1950-6007 Pelizzo, M R Dobrinja, C Casal Ide, E Zane, M Lora, O Toniato, A Mian, C Barollo, S Izuzquiza, M Guerrini, J De Manzini, N Merante Boschin, I Rubello, D Journal Article France Biomed Pharmacother. 2014 May;68(4):413-7. doi: 10.1016/j.biopha.2014.03.008. Epub 2014 Mar 18. PY - 2014 SN - 0753-3322 SP - 413-7 ST - The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma T2 - Biomed Pharmacother TI - The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma VL - 68 ID - 491 ER - TY - JOUR AD - Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Electronic address: revita@naver.com. Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Electronic address: soonwonh@yuhs.ac. AN - 24745617 AU - Kim, Y. H. AU - Choi, S. E. AU - Yoon, S. O. AU - Hong, S. W. DA - Jul DO - 10.1016/j.humpath.2014.02.025 DP - NLM ET - 2014/04/22 IS - 7 LA - eng N1 - 1532-8392 Kim, Yon Hee Choi, Sung-Eun Yoon, Sun Och Hong, Soon Won Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2014 Jul;45(7):1483-8. doi: 10.1016/j.humpath.2014.02.025. Epub 2014 Mar 14. PY - 2014 SN - 0046-8177 SP - 1483-8 ST - A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma T2 - Hum Pathol TI - A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma VL - 45 ID - 492 ER - TY - JOUR AD - Department of Neurosurgery, University Hospital Münster, Münster, Germany; Institute of Neuropathology, University Hospital Münster, Münster, Germany. AN - 24750136 AU - Brokinkel, B. AU - Peetz-Dienhart, S. AU - Ligges, S. AU - Brentrup, A. AU - Stummer, W. AU - Paulus, W. AU - Hasselblatt, M. DA - Feb DO - 10.1111/nan.12145 DP - NLM ET - 2014/04/23 IS - 2 LA - eng N1 - 1365-2990 Brokinkel, Benjamin Peetz-Dienhart, Susanne Ligges, Sandra Brentrup, Angela Stummer, Walter Paulus, Werner Hasselblatt, Martin Comparative Study Journal Article Research Support, Non-U.S. Gov't England Neuropathol Appl Neurobiol. 2015 Feb;41(2):258-61. doi: 10.1111/nan.12145. PY - 2015 SN - 0305-1846 SP - 258-61 ST - A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive. [corrected] T2 - Neuropathol Appl Neurobiol TI - A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive. [corrected] VL - 41 ID - 493 ER - TY - JOUR AD - *Department of Pathology, King Fahd University Hospital, University of Dammam, Dammam, Kingdom of Saudi Arabia; and †Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia. AN - 24752216 AU - A, A. LSayyah AU - AlHumidi, A. DA - Jan DO - 10.1097/dad.0000000000000063 DP - NLM ET - 2014/04/23 IS - 1 LA - eng N1 - 1533-0311 ALSayyah, Ahmed AlHumidi, Ahmed Case Reports Journal Article United States Am J Dermatopathol. 2015 Jan;37(1):e12-4. doi: 10.1097/DAD.0000000000000063. PY - 2015 SN - 0193-1091 SP - e12-4 ST - A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case T2 - Am J Dermatopathol TI - A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case VL - 37 ID - 494 ER - TY - JOUR AD - 1 Department of Genetics, King Faisal Specialist Hospital and Research Centre , Riyadh, Saudi Arabia . AN - 24798740 AU - Zou, M. AU - Baitei, E. Y. AU - Alzahrani, A. S. AU - BinHumaid, F. S. AU - Alkhafaji, D. AU - Al-Rijjal, R. A. AU - Meyer, B. F. AU - Shi, Y. C2 - PMC4106383 DA - Aug DO - 10.1089/thy.2013.0610 DP - NLM ET - 2014/05/07 IS - 8 LA - eng N1 - 1557-9077 Zou, Minjing Baitei, Essa Y Alzahrani, Ali S BinHumaid, Faisal S Alkhafaji, Dania Al-Rijjal, Roua A Meyer, Brian F Shi, Yufei Journal Article Research Support, Non-U.S. Gov't Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10. PY - 2014 SN - 1050-7256 (Print) 1050-7256 SP - 1256-66 ST - Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma T2 - Thyroid TI - Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma VL - 24 ID - 495 ER - TY - JOUR AD - Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA 52242. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan. Division of Medical Microbiology, Lund University, SE-223 62 Lund, Sweden. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093 a1varki@ucsd.edu vnizet@ucsd.edu. AN - 24799499 AU - Ali, S. R. AU - Fong, J. J. AU - Carlin, A. F. AU - Busch, T. D. AU - Linden, R. AU - Angata, T. AU - Areschoug, T. AU - Parast, M. AU - Varki, N. AU - Murray, J. AU - Nizet, V. AU - Varki, A. C2 - PMC4042635 DA - Jun 2 DO - 10.1084/jem.20131853 DP - NLM ET - 2014/05/07 IS - 6 LA - eng N1 - 1540-9538 Ali, Syed Raza Fong, Jerry J Carlin, Aaron F Busch, Tamara D Linden, Rebecka Angata, Takashi Areschoug, Thomas Parast, Mana Varki, Nissi Murray, Jeffrey Nizet, Victor Varki, Ajit P01 HL107150/HL/NHLBI NIH HHS/United States T32 AI007036/AI/NIAID NIH HHS/United States P01HL107150/HL/NHLBI NIH HHS/United States AI057153/AI/NIAID NIH HHS/United States U54 AI057153/AI/NIAID NIH HHS/United States Journal Article Research Support, N.I.H., Extramural J Exp Med. 2014 Jun 2;211(6):1231-42. doi: 10.1084/jem.20131853. Epub 2014 May 5. PY - 2014 SN - 0022-1007 (Print) 0022-1007 SP - 1231-42 ST - Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus T2 - J Exp Med TI - Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus VL - 211 ID - 496 ER - TY - JOUR AD - NYU Comprehensive Neurofibromatosis Center, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (M.A.K., G.L., A.M., J.C.A.); Division of Oncology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (M.J.F., A.J.S.); Department of Radiology, NYU Langone Medical Center, New York, New York (S.S.M., M.C.B.); The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (K.J.C.); Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Langone Medical Center, New York, New York (J.H.W., D.H.H.); Division of Biostatistics, Department of Population Health and The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (J.D.G., T.H.); Department of Neurosurgery, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (A.C.R); Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); German Cancer Research Center and University Hospital, Heidelberg, Germany (D.T.W.J., A.K., S.M.P.); Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland (C.G.E.); Division of Neuropathology, Department of Pathology, Department of Neurosurgery and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (D.Z.). AN - 24803676 AU - Karajannis, M. A. AU - Legault, G. AU - Fisher, M. J. AU - Milla, S. S. AU - Cohen, K. J. AU - Wisoff, J. H. AU - Harter, D. H. AU - Goldberg, J. D. AU - Hochman, T. AU - Merkelson, A. AU - Bloom, M. C. AU - Sievert, A. J. AU - Resnick, A. C. AU - Dhall, G. AU - Jones, D. T. AU - Korshunov, A. AU - Pfister, S. M. AU - Eberhart, C. G. AU - Zagzag, D. AU - Allen, J. C. C2 - PMC4165419 DA - Oct DO - 10.1093/neuonc/nou059 DP - NLM ET - 2014/05/08 IS - 10 LA - eng N1 - 1523-5866 Karajannis, Matthias A Legault, Geneviève Fisher, Michael J Milla, Sarah S Cohen, Kenneth J Wisoff, Jeffrey H Harter, David H Goldberg, Judith D Hochman, Tsivia Merkelson, Amanda Bloom, Michael C Sievert, Angela J Resnick, Adam C Dhall, Girish Jones, David T W Korshunov, Andrey Pfister, Stefan M Eberhart, Charles G Zagzag, David Allen, Jeffrey C 5P30CA016087/CA/NCI NIH HHS/United States P30 CA016087/CA/NCI NIH HHS/United States UL1TR000038/TR/NCATS NIH HHS/United States UL1 TR000003/TR/NCATS NIH HHS/United States UL1TR000003/TR/NCATS NIH HHS/United States Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Neuro Oncol. 2014 Oct;16(10):1408-16. doi: 10.1093/neuonc/nou059. Epub 2014 May 6. PY - 2014 SN - 1522-8517 (Print) 1522-8517 SP - 1408-16 ST - Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas T2 - Neuro Oncol TI - Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas VL - 16 ID - 497 ER - TY - JOUR AD - Authors' Affiliations: Departments of Pediatrics, Jean.Mulcahy-Levy@childrenscolorado.org. Authors' Affiliations: Departments of Pediatrics. Neurosurgery. Pharmacology, and. Radiology, University of Colorado Denver, Aurora, Colorado. AN - 24823863 AU - Levy, J. M. AU - Thompson, J. C. AU - Griesinger, A. M. AU - Amani, V. AU - Donson, A. M. AU - Birks, D. K. AU - Morgan, M. J. AU - Mirsky, D. M. AU - Handler, M. H. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC4090283 C6 - NIHMS596029 DA - Jul DO - 10.1158/2159-8290.Cd-14-0049 DP - NLM ET - 2014/05/16 IS - 7 LA - eng N1 - 2159-8290 Levy, Jean M Mulcahy Thompson, Joshua C Griesinger, Andrea M Amani, Vladimir Donson, Andrew M Birks, Diane K Morgan, Michael J Mirsky, David M Handler, Michael H Foreman, Nicholas K Thorburn, Andrew L40 CA154111/CA/NCI NIH HHS/United States R01CA150925/CA/NCI NIH HHS/United States R01 CA150925/CA/NCI NIH HHS/United States CA111421/CA/NCI NIH HHS/United States P30CA046934/CA/NCI NIH HHS/United States UL1 RR025780/RR/NCRR NIH HHS/United States P30 CA046934/CA/NCI NIH HHS/United States K12 HD068372/HD/NICHD NIH HHS/United States UL1 TR001082/TR/NCATS NIH HHS/United States R01 CA111421/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer Discov. 2014 Jul;4(7):773-80. doi: 10.1158/2159-8290.CD-14-0049. Epub 2014 May 13. PY - 2014 SN - 2159-8274 (Print) 2159-8274 SP - 773-80 ST - Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors T2 - Cancer Discov TI - Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors VL - 4 ID - 498 ER - TY - JOUR AD - Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. AN - 24832869 AU - Scorsone, K. AU - Zhang, L. AU - Woodfield, S. E. AU - Hicks, J. AU - Zage, P. E. DA - Oct DO - 10.1007/s10637-014-0107-4 DP - NLM ET - 2014/05/17 IS - 5 LA - eng N1 - 1573-0646 Scorsone, Kathy Zhang, Linna Woodfield, Sarah E Hicks, John Zage, Peter E Journal Article Research Support, Non-U.S. Gov't United States Invest New Drugs. 2014 Oct;32(5):815-24. doi: 10.1007/s10637-014-0107-4. Epub 2014 May 16. PY - 2014 SN - 0167-6997 SP - 815-24 ST - The novel kinase inhibitor EMD1214063 is effective against neuroblastoma T2 - Invest New Drugs TI - The novel kinase inhibitor EMD1214063 is effective against neuroblastoma VL - 32 ID - 499 ER - TY - JOUR AD - From the Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA. AN - 24857135 AU - Kieran, M. W. DO - 10.14694/EdBook_AM.2014.34.e436 DP - NLM ET - 2014/05/27 LA - eng N1 - 1548-8756 Kieran, Mark W Journal Article Research Support, Non-U.S. Gov't Review United States Am Soc Clin Oncol Educ Book. 2014:e436-40. doi: 10.14694/EdBook_AM.2014.34.e436. PY - 2014 SN - 1548-8748 SP - e436-40 ST - Targeting BRAF in pediatric brain tumors T2 - Am Soc Clin Oncol Educ Book TI - Targeting BRAF in pediatric brain tumors ID - 500 ER - TY - JOUR AD - Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China. Electronic address: liangweiguo@tom.com. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. Electronic address: jiake.xu@uwa.edu.au. AN - 24857985 AU - Liang, W. AU - Fang, D. AU - Ye, D. AU - Zou, L. AU - Shen, Y. AU - Dai, L. AU - Xu, J. DA - Jul 11 DO - 10.1016/j.bbrc.2014.05.042 DP - NLM ET - 2014/05/27 IS - 4 LA - eng N1 - 1090-2104 Liang, Weiguo Fang, Dejian Ye, Dongping Zou, Longqiang Shen, Yan Dai, Libing Xu, Jiake Journal Article Research Support, Non-U.S. Gov't United States Biochem Biophys Res Commun. 2014 Jul 11;449(4):466-70. doi: 10.1016/j.bbrc.2014.05.042. Epub 2014 May 21. PY - 2014 SN - 0006-291x SP - 466-70 ST - Differential expression of extracellular-signal-regulated kinase 5 (ERK5) in normal and degenerated human nucleus pulposus tissues and cells T2 - Biochem Biophys Res Commun TI - Differential expression of extracellular-signal-regulated kinase 5 (ERK5) in normal and degenerated human nucleus pulposus tissues and cells VL - 449 ID - 501 ER - TY - JOUR AD - Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Pathological Anatomy, University of Pisa, Pisa, Italy. AN - 24913568 AU - Proietti, A. AU - Borrelli, N. AU - Giannini, R. AU - Romani, R. AU - Di Coscio, G. AU - Quilici, F. AU - Rago, T. AU - Miccoli, P. AU - Vitti, P. AU - Basolo, F. DA - Oct DO - 10.1002/cncy.21454 DP - NLM ET - 2014/06/11 IS - 10 LA - eng N1 - 1934-6638 Proietti, Agnese Borrelli, Nicla Giannini, Riccardo Romani, Rossana Di Coscio, Giancarlo Quilici, Francesca Rago, Teresa Miccoli, Paolo Vitti, Paolo Basolo, Fulvio Journal Article United States Cancer Cytopathol. 2014 Oct;122(10):751-9. doi: 10.1002/cncy.21454. Epub 2014 Jun 9. PY - 2014 SN - 1934-662x SP - 751-9 ST - Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas T2 - Cancer Cytopathol TI - Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas VL - 122 ID - 502 ER - TY - JOUR AD - aInstitute of Molecular Biology and Biophysics bBioLink Ltd, Novosibirsk cN.N.Blokhin Russian Cancer Research Center, Moscow, Russia dBioron GmbH, Ludwigshafen eInstitute of Pathology fDepartment of Dermatology, University Hospital Erlangen, Erlangen, Germany. AN - 24922189 AU - Pisareva, E. AU - Gutkina, N. AU - Kovalenko, S. AU - Kuehnapfel, S. AU - Hartmann, A. AU - Heinzerling, L. AU - Schneider-Stock, R. AU - Lyubchenko, L. AU - Shamanin, V. A. DA - Aug DO - 10.1097/cmr.0000000000000090 DP - NLM ET - 2014/06/13 IS - 4 LA - eng N1 - 1473-5636 Pisareva, Ekaterina Gutkina, Nadezhda Kovalenko, Sergei Kuehnapfel, Sarah Hartmann, Arndt Heinzerling, Lucie Schneider-Stock, Regine Lyubchenko, Lyudmila Shamanin, Vladimir A Journal Article Research Support, Non-U.S. Gov't England Melanoma Res. 2014 Aug;24(4):322-31. doi: 10.1097/CMR.0000000000000090. PY - 2014 SN - 0960-8931 SP - 322-31 ST - Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma T2 - Melanoma Res TI - Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma VL - 24 ID - 503 ER - TY - JOUR AD - Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany. Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany. AN - 24941214 AU - Choukair, D. AU - Hügel, U. AU - Sander, A. AU - Uhlmann, L. AU - Tönshoff, B. DA - Sep DO - 10.1038/pr.2014.84 DP - NLM ET - 2014/06/19 IS - 3 LA - eng N1 - 1530-0447 Choukair, Daniela Hügel, Ulrike Sander, Anja Uhlmann, Lorenz Tönshoff, Burkhard Journal Article Research Support, Non-U.S. Gov't United States Pediatr Res. 2014 Sep;76(3):245-51. doi: 10.1038/pr.2014.84. Epub 2014 Jun 18. PY - 2014 SN - 0031-3998 SP - 245-51 ST - Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes T2 - Pediatr Res TI - Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes VL - 76 ID - 504 ER - TY - JOUR AD - Department of Pediatrics, Yamagata University Faculty of Medicine, Yamagata, Japan; Department of Immunology, Yamagata University Faculty of Medicine, Yamagata, Japan. AN - 24965693 AU - Onoda, T. AU - Kanno, M. AU - Sato, H. AU - Takahashi, N. AU - Izumino, H. AU - Ohta, H. AU - Emura, T. AU - Katoh, H. AU - Ohizumi, H. AU - Ohtake, H. AU - Asao, H. AU - Dehner, L. P. AU - Hill, A. D. AU - Hayasaka, K. AU - Mitsui, T. DA - Oct DO - 10.1002/gcc.22199 DP - NLM ET - 2014/06/27 IS - 10 LA - eng N1 - 1098-2264 Onoda, Tadashi Kanno, Miyako Sato, Hiroko Takahashi, Noriyuki Izumino, Hiroko Ohta, Hiroshi Emura, Takaki Katoh, Hirohisa Ohizumi, Hiroyuki Ohtake, Hiroya Asao, Hironobu Dehner, Louis P Hill, Ashley D Hayasaka, Kiyoshi Mitsui, Tetsuo Case Reports Journal Article Research Support, Non-U.S. Gov't United States Genes Chromosomes Cancer. 2014 Oct;53(10):865-74. doi: 10.1002/gcc.22199. Epub 2014 Jun 26. PY - 2014 SN - 1045-2257 SP - 865-74 ST - Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor T2 - Genes Chromosomes Cancer TI - Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor VL - 53 ID - 505 ER - TY - JOUR AD - 1 Institute of Pathology, Lille University Hospital , Lille, France . AN - 25012490 AU - Renaud, F. AU - Gnemmi, V. AU - Devos, P. AU - Aubert, S. AU - Crépin, M. AU - Coppin, L. AU - Ramdane, N. AU - Bouchindhomme, B. AU - d'Herbomez, M. AU - Van Seuningen, I. AU - Do Cao, C. AU - Pattou, F. AU - Carnaille, B. AU - Pigny, P. AU - Wémeau, J. L. AU - Leteurtre, E. DA - Sep DO - 10.1089/thy.2013.0594 DP - NLM ET - 2014/07/12 IS - 9 LA - eng N1 - 1557-9077 Renaud, Florence Gnemmi, Viviane Devos, Patrick Aubert, Sébastien Crépin, Michel Coppin, Lucie Ramdane, Nassima Bouchindhomme, Brigitte d'Herbomez, Michelle Van Seuningen, Isabelle Do Cao, Christine Pattou, François Carnaille, Bruno Pigny, Pascal Wémeau, Jean-Louis Leteurtre, Emmanuelle Journal Article United States Thyroid. 2014 Sep;24(9):1375-84. doi: 10.1089/thy.2013.0594. Epub 2014 Aug 1. PY - 2014 SN - 1050-7256 SP - 1375-84 ST - MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse T2 - Thyroid TI - MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse VL - 24 ID - 506 ER - TY - JOUR AD - Orthopaedic Research & Biotechnology Unit, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. E-mail address for J. El-Hoss: jel-hoss@ccia.unsw.edu.au. E-mail address for T. Cheng: tegan.cheng@sydney.edu.au. E-mail address for E.C. Carpenter: carpie@doctors.org.uk. E-mail address for K. Sullivan: kates3@live.com. E-mail address for N. Deo: nikita.deo@sydney.edu.au. E-mail address for K. Mikulec: kathy.mikulec@health.nsw.gov.au. E-mail address for D.G. Little: david.little@health.nsw.gov.au. E-mail address for A. Schindeler: aaron.schindeler@sydney.edu.au. AN - 25031379 AU - El-Hoss, J. AU - Cheng, T. AU - Carpenter, E. C. AU - Sullivan, K. AU - Deo, N. AU - Mikulec, K. AU - Little, D. G. AU - Schindeler, A. DA - Jul 16 DO - 10.2106/jbjs.M.00862 DP - NLM ET - 2014/07/18 IS - 14 LA - eng N1 - 1535-1386 El-Hoss, J Cheng, T Carpenter, E C Sullivan, K Deo, N Mikulec, K Little, D G Schindeler, A Journal Article United States J Bone Joint Surg Am. 2014 Jul 16;96(14):e117. doi: 10.2106/JBJS.M.00862. PY - 2014 SN - 0021-9355 SP - e117 ST - A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis T2 - J Bone Joint Surg Am TI - A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis VL - 96 ID - 507 ER - TY - JOUR AD - Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, PO-Box 2040, 3000 CA, Rotterdam, The Netherlands. AN - 25035100 AU - Dubbink, H. J. AU - Bakels, H. AU - Post, E. AU - Zwarthoff, E. C. AU - Verdijk, R. M. DA - Nov DO - 10.1007/s11060-014-1553-8 DP - NLM ET - 2014/07/19 IS - 2 LA - eng N1 - 1573-7373 Dubbink, Hendrikus J Bakels, Hannah Post, Edward Zwarthoff, Ellen C Verdijk, Robert M Journal Article United States J Neurooncol. 2014 Nov;120(2):267-72. doi: 10.1007/s11060-014-1553-8. Epub 2014 Jul 18. PY - 2014 SN - 0167-594x SP - 267-72 ST - TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors T2 - J Neurooncol TI - TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors VL - 120 ID - 508 ER - TY - JOUR AD - Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. AN - 25043591 AU - de la Croix Ndong, J. AU - Stevens, D. M. AU - Vignaux, G. AU - Uppuganti, S. AU - Perrien, D. S. AU - Yang, X. AU - Nyman, J. S. AU - Harth, E. AU - Elefteriou, F. C2 - PMC4280331 C6 - NIHMS638051 DA - Jan DO - 10.1002/jbmr.2316 DP - NLM ET - 2014/07/22 IS - 1 LA - eng N1 - 1523-4681 de la Croix Ndong, Jean Stevens, David M Vignaux, Guillaume Uppuganti, Sasidhar Perrien, Daniel S Yang, Xiangli Nyman, Jeffry S Harth, Eva Elefteriou, Florent R01 AR055966/AR/NIAMS NIH HHS/United States S10 RR027631/RR/NCRR NIH HHS/United States T32 GM007628/GM/NIGMS NIH HHS/United States 5R01 AR055966/AR/NIAMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Bone Miner Res. 2015 Jan;30(1):55-63. doi: 10.1002/jbmr.2316. PY - 2015 SN - 0884-0431 (Print) 0884-0431 SP - 55-63 ST - Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice T2 - J Bone Miner Res TI - Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice VL - 30 ID - 509 ER - TY - JOUR AD - Department of Medical Genetics, Ajou University School of Medicine, Suwon, Republic of Korea. Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea. Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea. AN - 25109740 AU - Park, G. H. AU - Lee, S. J. AU - Yim, H. AU - Han, J. H. AU - Kim, H. J. AU - Sohn, Y. B. AU - Ko, J. M. AU - Jeong, S. Y. C2 - PMC4148385 DA - Oct DO - 10.3892/or.2014.3379 DP - NLM ET - 2014/08/12 IS - 4 LA - eng N1 - 1791-2431 Park, Gun-Hoo Lee, Su-Jin Yim, Hyunee Han, Jae-Ho Kim, Hyon J Sohn, Young-Bae Ko, Jung Min Jeong, Seon-Yong UL1 TR001425/TR/NCATS NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Oncol Rep. 2014 Oct;32(4):1347-54. doi: 10.3892/or.2014.3379. Epub 2014 Aug 4. PY - 2014 SN - 1021-335X (Print) 1021-335x SP - 1347-54 ST - TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions T2 - Oncol Rep TI - TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions VL - 32 ID - 510 ER - TY - JOUR AD - *Department of Pathology †Department of Pediatric Hematology-Oncology, Institute of Pediatrics, University of Debrecen Clinical Centre, Debrecen, Hungary. AN - 25118810 AU - Méhes, G. AU - Irsai, G. AU - Bedekovics, J. AU - Beke, L. AU - Fazakas, F. AU - Rózsa, T. AU - Kiss, C. DA - Dec DO - 10.1097/pas.0000000000000304 DP - NLM ET - 2014/08/15 IS - 12 LA - eng N1 - 1532-0979 Méhes, Gábor Irsai, Gábor Bedekovics, Judit Beke, Lívia Fazakas, Ferenc Rózsa, Tímea Kiss, Csongor Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 2014 Dec;38(12):1644-8. doi: 10.1097/PAS.0000000000000304. PY - 2014 SN - 0147-5185 SP - 1644-8 ST - Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry T2 - Am J Surg Pathol TI - Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry VL - 38 ID - 511 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. From the Department of Pathology, UT Health-Department of Pathology and Laboratory medicine, Houston, Texas, United States of America. Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Pediatric Hematology/Oncology/BMT, Levine Children's Hospital/Levine Cancer Institute, Charlotte, North Carolina, United States of America. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Center for Personalized Cancer Therapy and Division of Hematology & Oncology, University of California San Diego - Moores Cancer Center, La Jolla, California, United States of America. AN - 25119929 AU - Jiang, Y. AU - Subbiah, V. AU - Janku, F. AU - Ludwig, J. A. AU - Naing, A. AU - Benjamin, R. S. AU - Brown, R. E. AU - Anderson, P. AU - Kurzrock, R. C2 - PMC4131855 DO - 10.1371/journal.pone.0093676 DP - NLM ET - 2014/08/15 IS - 8 LA - eng N1 - 1932-6203 Jiang, Yunyun Subbiah, Vivek Janku, Filip Ludwig, Joseph A Naing, Aung Benjamin, Robert S Brown, Robert E Anderson, Pete Kurzrock, Razelle CA 016672/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't PLoS One. 2014 Aug 13;9(8):e93676. doi: 10.1371/journal.pone.0093676. eCollection 2014. PY - 2014 SN - 1932-6203 SP - e93676 ST - Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors T2 - PLoS One TI - Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors VL - 9 ID - 512 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. Electronic address: kppatel@mdanderson.org. AN - 25128227 AU - Mehrotra, M. AU - Medeiros, L. J. AU - Luthra, R. AU - Sargent, R. L. AU - Yao, H. AU - Barkoh, B. A. AU - Singh, R. AU - Patel, K. P. DA - Oct DO - 10.1016/j.humpath.2014.06.012 DP - NLM ET - 2014/08/17 IS - 10 LA - eng N1 - 1532-8392 Mehrotra, Meenakshi Medeiros, L Jeffrey Luthra, Rajyalakshmi Sargent, Rachel L Yao, Hui Barkoh, Bedia A Singh, Rajesh Patel, Keyur P Journal Article United States Hum Pathol. 2014 Oct;45(10):1995-2005. doi: 10.1016/j.humpath.2014.06.012. Epub 2014 Jun 30. PY - 2014 SN - 0046-8177 SP - 1995-2005 ST - Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma T2 - Hum Pathol TI - Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma VL - 45 ID - 513 ER - TY - JOUR AD - Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA. McGovern Institute, Massachusetts Institute of Technology, Boston, MA, USA. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Georgetown University, Washington, DC, USA. 1] Department of Nursing, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA [2] Department of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA. Department of Pathology and Neuropathology, Medical University of Gdańsk, Gdańsk, Poland. Department of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA. AN - 25132261 AU - Czarnecka, M. AU - Trinh, E. AU - Lu, C. AU - Kuan-Celarier, A. AU - Galli, S. AU - Hong, S. H. AU - Tilan, J. U. AU - Talisman, N. AU - Izycka-Swieszewska, E. AU - Tsuei, J. AU - Yang, C. AU - Martin, S. AU - Horton, M. AU - Christian, D. AU - Everhart, L. AU - Maheswaran, I. AU - Kitlinska, J. C2 - PMC4333135 C6 - NIHMS607462 DA - Jun 11 DO - 10.1038/onc.2014.253 DP - NLM ET - 2014/08/19 IS - 24 LA - eng N1 - 1476-5594 Czarnecka, M Trinh, E Lu, C Kuan-Celarier, A Galli, S Hong, S-H Tilan, J U Talisman, N Izycka-Swieszewska, E Tsuei, J Yang, C Martin, S Horton, M Christian, D Everhart, L Maheswaran, I Kitlinska, J 1R01CA123211/CA/NCI NIH HHS/United States P30-CA051008/CA/NCI NIH HHS/United States UL1 RR031975/RR/NCRR NIH HHS/United States UL1 TR000101/TR/NCATS NIH HHS/United States UL1RR031975/RR/NCRR NIH HHS/United States P30 CA051008/CA/NCI NIH HHS/United States R03 CA178809/CA/NCI NIH HHS/United States 1R03CA178809/CA/NCI NIH HHS/United States UL1TR000101/TR/NCATS NIH HHS/United States R01 CA123211/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Oncogene. 2015 Jun 11;34(24):3131-43. doi: 10.1038/onc.2014.253. Epub 2014 Aug 18. PY - 2015 SN - 0950-9232 (Print) 0950-9232 SP - 3131-43 ST - Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance T2 - Oncogene TI - Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance VL - 34 ID - 514 ER - TY - JOUR AD - Aix Marseille Univ, CRO2, 13284 Marseille, France. sebastien.salas@ap-hm.fr. AN - 25146150 AU - Salas, S. AU - Jiguet-Jiglaire, C. AU - Campion, L. AU - Bartoli, C. AU - Frassineti, F. AU - Deville, J. L. AU - Maues De Paula, A. AU - Forest, F. AU - Jézéquel, P. AU - Gentet, J. C. AU - Bouvier, C. C2 - PMC4150966 DA - Aug 20 DO - 10.1186/1471-2407-14-606 DP - NLM ET - 2014/08/26 LA - eng N1 - 1471-2407 Salas, Sébastien Jiguet-Jiglaire, Carine Campion, Loic Bartoli, Catherine Frassineti, Frédéric Deville, Jean-Laurent Maues De Paula, André Forest, Fabien Jézéquel, Pascal Gentet, Jean-Claude Bouvier, Corinne Journal Article Research Support, Non-U.S. Gov't BMC Cancer. 2014 Aug 20;14:606. doi: 10.1186/1471-2407-14-606. PY - 2014 SN - 1471-2407 SP - 606 ST - Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma T2 - BMC Cancer TI - Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma VL - 14 ID - 515 ER - TY - JOUR AD - Department of Experimental Medicine, Second University of Naples, 80138 Naples, Italy. Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, 80138 Naples, Italy. Department of Veterinary Medicine and Animal Reproduction, Federico II University, 80138 Naples, Italy. Unit of General and Geriatric Surgery, School of Medicine, Second University of Naples, 80137 Naples, Italy. AN - 25197428 AU - Monda, M. AU - Messina, G. AU - Scognamiglio, I. AU - Lombardi, A. AU - Martin, G. A. AU - Sperlongano, P. AU - Porcelli, M. AU - Caraglia, M. AU - Stiuso, P. C2 - PMC4147268 DO - 10.1155/2014/131024 DP - NLM ET - 2014/09/10 LA - eng N1 - 1942-0994 Monda, Marcellino Orcid: 0000-0002-7184-218x Messina, Giovanni Orcid: 0000-0002-0011-867x Scognamiglio, Ilaria Lombardi, Angela Martin, Giuseppe A Sperlongano, Pasquale Porcelli, Marina Caraglia, Michele Stiuso, Paola Orcid: 0000-0001-5096-7488 Journal Article Oxid Med Cell Longev. 2014;2014:131024. doi: 10.1155/2014/131024. Epub 2014 Aug 13. PY - 2014 SN - 1942-0900 (Print) 1942-0994 SP - 131024 ST - Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress T2 - Oxid Med Cell Longev TI - Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress VL - 2014 ID - 516 ER - TY - JOUR AD - The Genome Institute, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, USA. The Genome Institute, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Genetics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Siteman Cancer Center, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Cytogenetics, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Genetics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Siteman Cancer Center, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: alberto.pappo@stjude.org. Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: armita.bahrami@stjude.org. AN - 25268584 AU - Lu, C. AU - Zhang, J. AU - Nagahawatte, P. AU - Easton, J. AU - Lee, S. AU - Liu, Z. AU - Ding, L. AU - Wyczalkowski, M. A. AU - Valentine, M. AU - Navid, F. AU - Mulder, H. AU - Tatevossian, R. G. AU - Dalton, J. AU - Davenport, J. AU - Yin, Z. AU - Edmonson, M. AU - Rusch, M. AU - Wu, G. AU - Li, Y. AU - Parker, M. AU - Hedlund, E. AU - Shurtleff, S. AU - Raimondi, S. AU - Bhavin, V. AU - Donald, Y. AU - Mardis, E. R. AU - Wilson, R. K. AU - Evans, W. E. AU - Ellison, D. W. AU - Pounds, S. AU - Dyer, M. AU - Downing, J. R. AU - Pappo, A. AU - Bahrami, A. C2 - PMC4340976 DA - Mar DO - 10.1038/jid.2014.425 DP - NLM ET - 2014/10/01 IS - 3 LA - eng N1 - 1523-1747 Lu, Charles Zhang, Jinghui Nagahawatte, Panduka Easton, John Lee, Seungjae Liu, Zhifa Ding, Li Wyczalkowski, Matthew A Valentine, Marcus Navid, Fariba Mulder, Heather Tatevossian, Ruth G Dalton, James Davenport, James Yin, Zhirong Edmonson, Michael Rusch, Michael Wu, Gang Li, Yongjin Parker, Matthew Hedlund, Erin Shurtleff, Sheila Raimondi, Susana Bhavin, Vadodaria Donald, Yergeau Mardis, Elaine R Wilson, Richard K Evans, William E Ellison, David W Pounds, Stanley Dyer, Michael Downing, James R Pappo, Alberto Bahrami, Armita R01 EY018599/EY/NEI NIH HHS/United States CA168875/CA/NCI NIH HHS/United States CA21765/CA/NCI NIH HHS/United States R01 EY014867/EY/NEI NIH HHS/United States R01 CA168875/CA/NCI NIH HHS/United States R01 CA180006/CA/NCI NIH HHS/United States P30 CA021765/CA/NCI NIH HHS/United States Howard Hughes Medical Institute/United States EY018599/EY/NEI NIH HHS/United States EY014867/EY/NEI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Invest Dermatol. 2015 Mar;135(3):816-823. doi: 10.1038/jid.2014.425. Epub 2014 Sep 30. PY - 2015 SN - 0022-202X (Print) 0022-202x SP - 816-823 ST - The genomic landscape of childhood and adolescent melanoma T2 - J Invest Dermatol TI - The genomic landscape of childhood and adolescent melanoma VL - 135 ID - 517 ER - TY - JOUR AD - Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of the Ukraine, Kiev, Ukraine. Institute of Radiation Protection, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Bundeswehr Institute of Radiobiology, Munich, Germany. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, MD, USA. AN - 25284583 AU - Selmansberger, M. AU - Feuchtinger, A. AU - Zurnadzhy, L. AU - Michna, A. AU - Kaiser, J. C. AU - Abend, M. AU - Brenner, A. AU - Bogdanova, T. AU - Walch, A. AU - Unger, K. AU - Zitzelsberger, H. AU - Hess, J. DA - Jul 23 DO - 10.1038/onc.2014.311 DP - NLM ET - 2014/10/07 IS - 30 LA - eng N1 - 1476-5594 Selmansberger, M Feuchtinger, A Zurnadzhy, L Michna, A Kaiser, J C Abend, M Brenner, A Bogdanova, T Walch, A Unger, K Zitzelsberger, H Hess, J Journal Article Research Support, Non-U.S. Gov't England Oncogene. 2015 Jul 23;34(30):3917-25. doi: 10.1038/onc.2014.311. Epub 2014 Oct 6. PY - 2015 SN - 0950-9232 SP - 3917-25 ST - CLIP2 as radiation biomarker in papillary thyroid carcinoma T2 - Oncogene TI - CLIP2 as radiation biomarker in papillary thyroid carcinoma VL - 34 ID - 518 ER - TY - JOUR AD - Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. douglas.b.johnson@vanderbilt.edu. Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. AN - 25287827 AU - Johnson, D. B. AU - Flaherty, K. T. AU - Weber, J. S. AU - Infante, J. R. AU - Kim, K. B. AU - Kefford, R. F. AU - Hamid, O. AU - Schuchter, L. AU - Cebon, J. AU - Sharfman, W. H. AU - McWilliams, R. R. AU - Sznol, M. AU - Lawrence, D. P. AU - Gibney, G. T. AU - Burris, H. A., 3rd AU - Falchook, G. S. AU - Algazi, A. AU - Lewis, K. AU - Long, G. V. AU - Patel, K. AU - Ibrahim, N. AU - Sun, P. AU - Little, S. AU - Cunningham, E. AU - Sosman, J. A. AU - Daud, A. AU - Gonzalez, R. C2 - PMC4226803 online at www.jco.org. Author contributions are found at the end of this article. DA - Nov 20 DO - 10.1200/jco.2014.57.3535 DP - NLM ET - 2014/10/08 IS - 33 LA - eng N1 - 1527-7755 Johnson, Douglas B Flaherty, Keith T Weber, Jeffrey S Infante, Jeffrey R Kim, Kevin B Kefford, Richard F Hamid, Omid Schuchter, Lynn Cebon, Jonathan Sharfman, William H McWilliams, Robert R Sznol, Mario Lawrence, Donald P Gibney, Geoffrey T Burris, Howard A 3rd Falchook, Gerald S Algazi, Alain Lewis, Karl Long, Georgina V Patel, Kiran Ibrahim, Nageatte Sun, Peng Little, Shonda Cunningham, Elizabeth Sosman, Jeffrey A Daud, Adil Gonzalez, Rene K12 CA090625/CA/NCI NIH HHS/United States P30 CA015083/CA/NCI NIH HHS/United States Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't J Clin Oncol. 2014 Nov 20;32(33):3697-704. doi: 10.1200/JCO.2014.57.3535. Epub 2014 Oct 6. PY - 2014 SN - 0732-183X (Print) 0732-183x SP - 3697-704 ST - Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor T2 - J Clin Oncol TI - Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor VL - 32 ID - 519 ER - TY - JOUR AD - Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. Clinical Biochemistry Unit, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. Laboratory of Molecular Pathology, UO Pathological Anatomy III, Pisa, Italy. Unit of Mechanisms of Cancer, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. Clinical and Descriptive Epidemiology Unit, Institute for Study and Cancer Prevention (ISPO), Florence, Italy. Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. Dermatopathology Section, SM Annunziata Hospital, Florence, Italy. Unit of Medical Oncology, Division of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. AN - 25341653 AU - Massi, D. AU - Simi, L. AU - Sensi, E. AU - Baroni, G. AU - Xue, G. AU - Scatena, C. AU - Caldarella, A. AU - Pinzani, P. AU - Fontanini, G. AU - Carobbio, A. AU - Urso, C. AU - Mandalà, M. DA - Apr DO - 10.1038/modpathol.2014.137 DP - NLM ET - 2014/10/25 IS - 4 LA - eng N1 - 1530-0285 Massi, Daniela Simi, Lisa Sensi, Elisa Baroni, Gianna Xue, Gongda Scatena, Cristian Caldarella, Adele Pinzani, Pamela Fontanini, Gabriella Carobbio, Alessandra Urso, Carmelo Mandalà, Mario Journal Article Research Support, Non-U.S. Gov't United States Mod Pathol. 2015 Apr;28(4):487-97. doi: 10.1038/modpathol.2014.137. Epub 2014 Oct 24. PY - 2015 SN - 0893-3952 SP - 487-97 ST - Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma T2 - Mod Pathol TI - Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma VL - 28 ID - 520 ER - TY - JOUR AD - 1 The First Affiliated Hospital of Chongqing Medical University , Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing, People's Republic of China . AN - 25343528 AU - Ye, Z. AU - Wang, C. AU - Tang, J. AU - Zhou, Y. AU - Bai, L. AU - Liu, Y. AU - Kijlstra, A. AU - Yang, P. DA - Apr DO - 10.1089/jir.2014.0042 DP - NLM ET - 2014/10/25 IS - 4 LA - eng N1 - 1557-7465 Ye, Zi Wang, Chaokui Tang, Jihong Zhou, Yan Bai, Lin Liu, Yunjia Kijlstra, Aize Yang, Peizeng Journal Article Research Support, Non-U.S. Gov't United States J Interferon Cytokine Res. 2015 Apr;35(4):265-72. doi: 10.1089/jir.2014.0042. Epub 2014 Oct 24. PY - 2015 SN - 1079-9907 SP - 265-72 ST - Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment T2 - J Interferon Cytokine Res TI - Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment VL - 35 ID - 521 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics LLC, San Antonio. Electronic address: atolcher@start.stoh.com. Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. South Texas Accelerated Research Therapeutics LLC, San Antonio. GlaxoSmithKline, Collegeville. Pharmaceutical Companies of Johnson and Johnson, Greater Philadelphia Area. Novartis, East Hanover, USA. AN - 25344362 AU - Tolcher, A. W. AU - Bendell, J. C. AU - Papadopoulos, K. P. AU - Burris, H. A., 3rd AU - Patnaik, A. AU - Jones, S. F. AU - Rasco, D. AU - Cox, D. S. AU - Durante, M. AU - Bellew, K. M. AU - Park, J. AU - Le, N. T. AU - Infante, J. R. DA - Jan DO - 10.1093/annonc/mdu482 DP - NLM ET - 2014/10/26 IS - 1 LA - eng N1 - 1569-8041 Tolcher, A W Bendell, J C Papadopoulos, K P Burris, H A 3rd Patnaik, A Jones, S F Rasco, D Cox, D S Durante, M Bellew, K M Park, J Le, N T Infante, J R Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't England Ann Oncol. 2015 Jan;26(1):58-64. doi: 10.1093/annonc/mdu482. Epub 2014 Oct 24. PY - 2015 SN - 0923-7534 SP - 58-64 ST - A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors T2 - Ann Oncol TI - A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors VL - 26 ID - 522 ER - TY - JOUR AD - Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea. AN - 25346165 AU - Lee, D. AU - Cho, Y. H. AU - Kang, S. Y. AU - Yoon, N. AU - Sung, C. O. AU - Suh, Y. L. DA - Mar DO - 10.1002/jso.23822 DP - NLM ET - 2014/10/28 IS - 3 LA - eng N1 - 1096-9098 Lee, Dakeun Cho, Young Hye Kang, So Young Yoon, Nara Sung, Chang Ohk Suh, Yeon-Lim Journal Article Research Support, Non-U.S. Gov't United States J Surg Oncol. 2015 Mar;111(3):359-64. doi: 10.1002/jso.23822. Epub 2014 Oct 24. PY - 2015 SN - 0022-4790 SP - 359-64 ST - BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas T2 - J Surg Oncol TI - BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas VL - 111 ID - 523 ER - TY - JOUR AD - Departments of *Pathology, †Dermatology, and ‡Plastic and Reconstructive Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea; and §Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. AN - 25365497 AU - Seo, A. N. AU - Lee, S. J. AU - Choi, Y. H. AU - Chung, H. Y. AU - Huh, J. AU - Yoon, G. S. DA - May DO - 10.1097/dad.0000000000000219 DP - NLM ET - 2014/11/05 IS - 5 LA - eng N1 - 1533-0311 Seo, An Na Lee, Seok-Jong Choi, Yoon Hyuk Chung, Ho Yun Huh, Jooryung Yoon, Ghil Suk Case Reports Journal Article United States Am J Dermatopathol. 2015 May;37(5):398-400. doi: 10.1097/DAD.0000000000000219. PY - 2015 SN - 0193-1091 SP - 398-400 ST - Congenital primary cutaneous anaplastic large-cell lymphoma: a case report T2 - Am J Dermatopathol TI - Congenital primary cutaneous anaplastic large-cell lymphoma: a case report VL - 37 ID - 524 ER - TY - JOUR AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, P.R. China. AN - 25369801 AU - Zhang, Z. AU - Nie, F. AU - Chen, X. AU - Qin, Z. AU - Kang, C. AU - Chen, B. AU - Ma, J. AU - Pan, B. AU - Ma, Y. C2 - PMC4262479 DA - Feb DO - 10.3892/mmr.2014.2827 DP - NLM ET - 2014/11/06 IS - 2 LA - eng N1 - 1791-3004 Zhang, Zhe Nie, Fangfei Chen, Xinlei Qin, Zelian Kang, Chunfu Chen, Bin Ma, Jianxun Pan, Bolin Ma, Yongguang Journal Article Research Support, Non-U.S. Gov't Mol Med Rep. 2015 Feb;11(2):857-64. doi: 10.3892/mmr.2014.2827. Epub 2014 Oct 31. PY - 2015 SN - 1791-2997 (Print) 1791-2997 SP - 857-64 ST - Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1 T2 - Mol Med Rep TI - Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1 VL - 11 ID - 525 ER - TY - JOUR AD - Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy. AN - 25382612 AU - Antonelli, M. AU - Badiali, M. AU - Moi, L. AU - Buttarelli, F. R. AU - Baldi, C. AU - Massimino, M. AU - Sanson, M. AU - Giangaspero, F. DA - Apr DO - 10.1002/pbc.25272 DP - NLM ET - 2014/11/11 IS - 4 LA - eng N1 - 1545-5017 Antonelli, Manila Badiali, Manuela Moi, Loredana Buttarelli, Francesca R Baldi, Caterina Massimino, Maura Sanson, Marc Giangaspero, Felice Journal Article Research Support, Non-U.S. Gov't United States Pediatr Blood Cancer. 2015 Apr;62(4):724-7. doi: 10.1002/pbc.25272. Epub 2014 Nov 8. PY - 2015 SN - 1545-5009 SP - 724-7 ST - KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis T2 - Pediatr Blood Cancer TI - KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis VL - 62 ID - 526 ER - TY - JOUR AD - *Department of Laboratory Medicine and Pathology ∥Division of Hematology, Mayo Clinic, Rochester, MN †Department of Pathology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China ‡Department of Hematology-Oncology, National University Cancer Institute of Singapore §Cancer Science Institute of Singapore, National University Cancer Institute of Singapore, Singapore, Singapore ¶Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton, NY. AN - 25390351 AU - Xing, X. AU - Flotte, T. J. AU - Law, M. E. AU - Blahnik, A. J. AU - Chng, W. J. AU - Huang, G. AU - Knudson, R. A. AU - Ketterling, R. P. AU - Porcher, J. C. AU - Ansell, S. M. AU - Sidhu, J. AU - Dogan, A. AU - Feldman, A. L. C2 - PMC4427553 C6 - NIHMS598418 DA - Sep DO - 10.1097/pai.0000000000000118 DP - NLM ET - 2014/11/13 IS - 8 LA - eng N1 - 1533-4058 Xing, Xiaoming Flotte, Thomas J Law, Mark E Blahnik, Anthony J Chng, Wee-Joo Huang, Gaofeng Knudson, Ryan A Ketterling, Rhett P Porcher, Julie C Ansell, Stephen M Sidhu, Jagmohan Dogan, Ahmet Feldman, Andrew L P30 CA086862/CA/NCI NIH HHS/United States P50 CA097274/CA/NCI NIH HHS/United States R01 CA177734/CA/NCI NIH HHS/United States P50 CA97274/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):580-9. doi: 10.1097/PAI.0000000000000118. PY - 2015 SN - 1541-2016 (Print) 1533-4058 SP - 580-9 ST - Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma T2 - Appl Immunohistochem Mol Morphol TI - Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma VL - 23 ID - 527 ER - TY - JOUR AD - Division of Pediatric Oncology, Alberta Children's Hospital and POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada (Y.R., A.J., X.L., R.A., A.N.); Department of Biological Sciences, University of Lethbridge, Lethbridge, Canada (A.K., O.K.); Department of Pathology, Yokohama City University School of Medicine and Division of Diagnostic Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan (Y.N.); Department of Pathology and Laboratory Medicine, Alberta Children's Hospital and Calgary Laboratory Services, Calgary, Canada (J.R.W., A.P.); Department of Neurology, Alberta Children's Hospital, Calgary, Canada (A.K.). AN - 25395461 AU - Ruan, Y. AU - Kovalchuk, A. AU - Jayanthan, A. AU - Lun, X. AU - Nagashima, Y. AU - Kovalchuk, O. AU - Wright, J. R., Jr. AU - Pinto, A. AU - Kirton, A. AU - Anderson, R. AU - Narendran, A. C2 - PMC4483116 DA - Jun DO - 10.1093/neuonc/nou310 DP - NLM ET - 2014/11/15 IS - 6 LA - eng N1 - 1523-5866 Ruan, Yibing Kovalchuk, Anna Jayanthan, Aarthi Lun, Xueqing Nagashima, Yoji Kovalchuk, Olga Wright, James R Jr Pinto, Alfredo Kirton, Adam Anderson, Ronald Narendran, Aru Journal Article Research Support, Non-U.S. Gov't Neuro Oncol. 2015 Jun;17(6):822-31. doi: 10.1093/neuonc/nou310. Epub 2014 Nov 12. PY - 2015 SN - 1522-8517 (Print) 1522-8517 SP - 822-31 ST - Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy T2 - Neuro Oncol TI - Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy VL - 17 ID - 528 ER - TY - JOUR AD - The authors' affiliations are listed in the Appendix. AN - 25399551 AU - Robert, C. AU - Karaszewska, B. AU - Schachter, J. AU - Rutkowski, P. AU - Mackiewicz, A. AU - Stroiakovski, D. AU - Lichinitser, M. AU - Dummer, R. AU - Grange, F. AU - Mortier, L. AU - Chiarion-Sileni, V. AU - Drucis, K. AU - Krajsova, I. AU - Hauschild, A. AU - Lorigan, P. AU - Wolter, P. AU - Long, G. V. AU - Flaherty, K. AU - Nathan, P. AU - Ribas, A. AU - Martin, A. M. AU - Sun, P. AU - Crist, W. AU - Legos, J. AU - Rubin, S. D. AU - Little, S. M. AU - Schadendorf, D. DA - Jan 1 DO - 10.1056/NEJMoa1412690 DP - NLM ET - 2014/11/18 IS - 1 LA - eng N1 - 1533-4406 Robert, Caroline Karaszewska, Boguslawa Schachter, Jacob Rutkowski, Piotr Mackiewicz, Andrzej Stroiakovski, Daniil Lichinitser, Michael Dummer, Reinhard Grange, Florent Mortier, Laurent Chiarion-Sileni, Vanna Drucis, Kamil Krajsova, Ivana Hauschild, Axel Lorigan, Paul Wolter, Pascal Long, Georgina V Flaherty, Keith Nathan, Paul Ribas, Antoni Martin, Anne-Marie Sun, Peng Crist, Wendy Legos, Jeff Rubin, Stephen D Little, Shonda M Schadendorf, Dirk Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't United States N Engl J Med. 2015 Jan 1;372(1):30-9. doi: 10.1056/NEJMoa1412690. Epub 2014 Nov 16. PY - 2015 SN - 0028-4793 SP - 30-9 ST - Improved overall survival in melanoma with combined dabrafenib and trametinib T2 - N Engl J Med TI - Improved overall survival in melanoma with combined dabrafenib and trametinib VL - 372 ID - 529 ER - TY - JOUR AD - The authors' affiliations are listed in the Appendix. AN - 25399552 AU - Robert, C. AU - Long, G. V. AU - Brady, B. AU - Dutriaux, C. AU - Maio, M. AU - Mortier, L. AU - Hassel, J. C. AU - Rutkowski, P. AU - McNeil, C. AU - Kalinka-Warzocha, E. AU - Savage, K. J. AU - Hernberg, M. M. AU - Lebbé, C. AU - Charles, J. AU - Mihalcioiu, C. AU - Chiarion-Sileni, V. AU - Mauch, C. AU - Cognetti, F. AU - Arance, A. AU - Schmidt, H. AU - Schadendorf, D. AU - Gogas, H. AU - Lundgren-Eriksson, L. AU - Horak, C. AU - Sharkey, B. AU - Waxman, I. M. AU - Atkinson, V. AU - Ascierto, P. A. DA - Jan 22 DO - 10.1056/NEJMoa1412082 DP - NLM ET - 2014/11/18 IS - 4 LA - eng N1 - 1533-4406 Robert, Caroline Long, Georgina V Brady, Benjamin Dutriaux, Caroline Maio, Michele Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela M Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Cognetti, Francesco Arance, Ana Schmidt, Henrik Schadendorf, Dirk Gogas, Helen Lundgren-Eriksson, Lotta Horak, Christine Sharkey, Brian Waxman, Ian M Atkinson, Victoria Ascierto, Paolo A Clinical Trial, Phase III Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16. PY - 2015 SN - 0028-4793 SP - 320-30 ST - Nivolumab in previously untreated melanoma without BRAF mutation T2 - N Engl J Med TI - Nivolumab in previously untreated melanoma without BRAF mutation VL - 372 ID - 530 ER - TY - JOUR AD - Department of Pathology. Department of Internal Medicine. Department of Pathology junarplus@chol.com. Department of Nuclear Medicine. Department of Pathology Biomedical Sciences, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea. AN - 25403583 AU - Won, J. K. AU - Keam, B. AU - Koh, J. AU - Cho, H. J. AU - Jeon, Y. K. AU - Kim, T. M. AU - Lee, S. H. AU - Lee, D. S. AU - Kim, D. W. AU - Chung, D. H. DA - Feb DO - 10.1093/annonc/mdu530 DP - NLM ET - 2014/11/19 IS - 2 LA - eng N1 - 1569-8041 Won, J K Keam, B Koh, J Cho, H J Jeon, Y K Kim, T M Lee, S H Lee, D S Kim, D W Chung, D H Comparative Study Journal Article Research Support, Non-U.S. Gov't England Ann Oncol. 2015 Feb;26(2):348-54. doi: 10.1093/annonc/mdu530. Epub 2014 Nov 17. PY - 2015 SN - 0923-7534 SP - 348-54 ST - Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor T2 - Ann Oncol TI - Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor VL - 26 ID - 531 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. AN - 25404214 AU - Pulitzer, M. AU - Ogunrinade, O. AU - Lin, O. AU - Steinherz, P. C2 - PMC5108361 C6 - NIHMS819955 DA - Mar DO - 10.1111/cup.12446 DP - NLM ET - 2014/11/19 IS - 3 LA - eng N1 - 1600-0560 Pulitzer, Melissa Ogunrinade, Olakunle Lin, Oscar Steinherz, Peter P30 CA008748/CA/NCI NIH HHS/United States Case Reports Journal Article J Cutan Pathol. 2015 Mar;42(3):182-7. doi: 10.1111/cup.12446. Epub 2015 Feb 5. PY - 2015 SN - 0303-6987 (Print) 0303-6987 SP - 182-7 ST - ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient T2 - J Cutan Pathol TI - ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient VL - 42 ID - 532 ER - TY - JOUR AD - Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Department of Radiology, Konyang University Hospital, Konyang University College of Medicine, Seoul, Korea. Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Biostatistics Collaboration Unit, Medical Research Center, Yonsei University College of Medicine, Seoul, Korea. Department of Pathology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea docjin@yuhs.ac. AN - 25404749 AU - Seo, J. Y. AU - Choi, J. R. AU - Moon, H. J. AU - Kim, E. K. AU - Han, K. H. AU - Kim, H. AU - Kwak, J. Y. DA - May DO - 10.1177/0003489414560433 DP - NLM ET - 2014/11/19 IS - 5 LA - eng N1 - Seo, Jae Young Choi, Jong Rak Moon, Hee Jung Kim, Eun-Kyung Han, Kyung Hwa Kim, Hyunki Kwak, Jin Young Journal Article Research Support, Non-U.S. Gov't United States Ann Otol Rhinol Laryngol. 2015 May;124(5):392-9. doi: 10.1177/0003489414560433. Epub 2014 Nov 17. PY - 2015 SN - 0003-4894 (Print) 0003-4894 SP - 392-9 ST - Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma T2 - Ann Otol Rhinol Laryngol TI - Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma VL - 124 ID - 533 ER - TY - JOUR AD - Department of General Pediatrics, Acute Lymphoblastic Leukemia-Berlin-Frankfurt-Münster Study Group, and. Department of Children's Pathology, University Hospital Schleswig-Holstein, Kiel, Germany; and. II. Medical Clinic and Institute of Tumor Biology, University Hospital Eppendorf, Hamburg, Germany. AN - 25428221 AU - Krause, S. AU - Pfeiffer, C. AU - Strube, S. AU - Alsadeq, A. AU - Fedders, H. AU - Vokuhl, C. AU - Loges, S. AU - Waizenegger, J. AU - Ben-Batalla, I. AU - Cario, G. AU - Möricke, A. AU - Stanulla, M. AU - Schrappe, M. AU - Schewe, D. M. DA - Jan 29 DO - 10.1182/blood-2014-06-583062 DP - NLM ET - 2014/11/28 IS - 5 LA - eng N1 - 1528-0020 Krause, Sarah Pfeiffer, Christian Strube, Susanne Alsadeq, Ameera Fedders, Henning Vokuhl, Christian Loges, Sonja Waizenegger, Jonas Ben-Batalla, Isabel Cario, Gunnar Möricke, Anja Stanulla, Martin Schrappe, Martin Schewe, Denis M Journal Article Research Support, Non-U.S. Gov't United States Blood. 2015 Jan 29;125(5):820-30. doi: 10.1182/blood-2014-06-583062. Epub 2014 Nov 26. PY - 2015 SN - 0006-4971 SP - 820-30 ST - Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) T2 - Blood TI - Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) VL - 125 ID - 534 ER - TY - JOUR AD - University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Electronic address: martina.sanlorenzo@hotmail.it. University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California. University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria. Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria. AN - 25440439 AU - Sanlorenzo, M. AU - Choudhry, A. AU - Vujic, I. AU - Posch, C. AU - Chong, K. AU - Johnston, K. AU - Meier, M. AU - Osella-Abate, S. AU - Quaglino, P. AU - Daud, A. AU - Algazi, A. AU - Rappersberger, K. AU - Ortiz-Urda, S. C2 - PMC4254519 C6 - NIHMS627049 DA - Dec DO - 10.1016/j.jaad.2014.09.002 DP - NLM ET - 2014/12/03 IS - 6 LA - eng N1 - 1097-6787 Sanlorenzo, Martina Choudhry, Aditi Vujic, Igor Posch, Christian Chong, Kim Johnston, Katia Meier, Melissa Osella-Abate, Simona Quaglino, Pietro Daud, Adil Algazi, Alain Rappersberger, Klemens Ortiz-Urda, Susana K08 CA155035/CA/NCI NIH HHS/United States UL1 TR000004/TR/NCATS NIH HHS/United States K08CA155035/CA/NCI NIH HHS/United States Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Am Acad Dermatol. 2014 Dec;71(6):1102-1109.e1. doi: 10.1016/j.jaad.2014.09.002. Epub 2014 Oct 16. PY - 2014 SN - 0190-9622 (Print) 0190-9622 SP - 1102-1109.e1 ST - Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma T2 - J Am Acad Dermatol TI - Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma VL - 71 ID - 535 ER - TY - JOUR AD - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Pathology, Penn State Hershey Medical Center, Hershey, PA, 17033 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Departments of Pathology, Massachusetts General Hospital, Boston, MA, 02114 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Medical Genetics, National Taiwan University Hospital, Taipei, 100, Taiwan. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Electronic address: mlin36@jhmi.edu. AN - 25456393 AU - Chen, G. AU - Dudley, J. AU - Tseng, L. H. AU - Smith, K. AU - Gurda, G. T. AU - Gocke, C. D. AU - Eshleman, J. R. AU - Lin, M. T. DA - Jan DO - 10.1016/j.humpath.2014.09.014 DP - NLM ET - 2014/12/03 IS - 1 LA - eng N1 - 1532-8392 Chen, Guoli Dudley, Jonathan Tseng, Li-Hui Smith, Kirstin Gurda, Grzegorz T Gocke, Christopher D Eshleman, James R Lin, Ming-Tseh Journal Article United States Hum Pathol. 2015 Jan;46(1):113-9. doi: 10.1016/j.humpath.2014.09.014. Epub 2014 Oct 7. PY - 2015 SN - 0046-8177 SP - 113-9 ST - Lymph node metastases of melanoma: challenges for BRAF mutation detection T2 - Hum Pathol TI - Lymph node metastases of melanoma: challenges for BRAF mutation detection VL - 46 ID - 536 ER - TY - JOUR AD - Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Department of Pathology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Internal Medicine, Division of Endocrinology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Pathology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Electronic address: hkim1967@gmail.com. AN - 25468810 AU - Jung, Y. Y. AU - Yoo, J. H. AU - Park, E. S. AU - Kim, M. K. AU - Lee, T. J. AU - Cho, B. Y. AU - Chung, Y. J. AU - Kang, K. H. AU - Ahn, H. Y. AU - Kim, H. S. DA - Feb DO - 10.1016/j.prp.2014.10.005 DP - NLM ET - 2014/12/04 IS - 2 LA - eng N1 - 1618-0631 Jung, Yoon Yang Yoo, Jae Hyung Park, Eon Sub Kim, Mi Kyung Lee, Tae Jin Cho, Bo Youn Chung, Yun Jae Kang, Kyung Ho Ahn, Hwa Young Kim, Hee Sung Comparative Study Evaluation Study Journal Article Research Support, Non-U.S. Gov't Germany Pathol Res Pract. 2015 Feb;211(2):162-70. doi: 10.1016/j.prp.2014.10.005. Epub 2014 Oct 27. PY - 2015 SN - 0344-0338 SP - 162-70 ST - Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma T2 - Pathol Res Pract TI - Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma VL - 211 ID - 537 ER - TY - JOUR AD - Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. mariachiara.pelleri2@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. allison.piovesan2@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. maria.caracausi2@unibo.it. Research Laboratory Stem Cells, U.O.C. Immunohematology-Transfusion Medicine and Laboratory of Hematology, Santo Spirito's Hospital, Via del Circuito, 65100, Pescara, Italy. annacberardi@yahoo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. lorenza.vitale@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. pierluigi.strippoli@unibo.it. Interdepartmental Center for Cancer Research Giorgio Prodi (CIRC), S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, BO, Italy. pierluigi.strippoli@unibo.it. AN - 25476127 AU - Pelleri, M. C. AU - Piovesan, A. AU - Caracausi, M. AU - Berardi, A. C. AU - Vitale, L. AU - Strippoli, P. C2 - PMC4304173 DA - Dec 5 DO - 10.1186/s12920-014-0063-z DP - NLM ET - 2014/12/06 LA - eng N1 - 1755-8794 Pelleri, Maria Chiara Piovesan, Allison Caracausi, Maria Berardi, Anna Concetta Vitale, Lorenza Strippoli, Pierluigi Comparative Study Journal Article Research Support, Non-U.S. Gov't BMC Med Genomics. 2014 Dec 5;7:63. doi: 10.1186/s12920-014-0063-z. PY - 2014 SN - 1755-8794 SP - 63 ST - Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS) T2 - BMC Med Genomics TI - Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS) VL - 7 ID - 538 ER - TY - JOUR AD - Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland. Department of Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Department of Nuclear Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland. Clinical Trials Unit, Kantonsspital St. Gallen, St. Gallen, Switzerland. Cancer Registry Eastern Switzerland, St. Gallen, Switzerland. Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Electronic address: martina.broglie@kssg.ch. AN - 25482468 AU - Niederer-Wüst, S. M. AU - Jochum, W. AU - Förbs, D. AU - Brändle, M. AU - Bilz, S. AU - Clerici, T. AU - Oettli, R. AU - Müller, J. AU - Haile, S. R. AU - Ess, S. AU - Stoeckli, S. J. AU - Broglie, M. A. DA - Jan DO - 10.1016/j.surg.2014.07.015 DP - NLM ET - 2014/12/09 IS - 1 LA - eng N1 - 1532-7361 Niederer-Wüst, Séverine M Jochum, Wolfram Förbs, Diana Brändle, Michael Bilz, Stefan Clerici, Thomas Oettli, René Müller, Joachim Haile, Sarah R Ess, Silvia Stoeckli, Sandro J Broglie, Martina A Journal Article Research Support, Non-U.S. Gov't United States Surgery. 2015 Jan;157(1):119-25. doi: 10.1016/j.surg.2014.07.015. PY - 2015 SN - 0039-6060 SP - 119-25 ST - Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer T2 - Surgery TI - Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer VL - 157 ID - 539 ER - TY - JOUR AD - a Nuffield Department of Orthopaedics; Rheumatology and Musculoskeletal Sciences ; Kennedy Institute of Rheumatology; University of Oxford ; Oxford , UK. AN - 25482829 AU - Giblin, S. P. AU - Midwood, K. S. C2 - PMC4422809 DO - 10.4161/19336918.2014.987587 DP - NLM ET - 2014/12/09 IS - 1-2 LA - eng N1 - 1933-6926 Giblin, Sean P Midwood, Kim S 20003/ARC_/Arthritis Research UK/United Kingdom 20003/VAC_/Versus Arthritis/United Kingdom Journal Article Research Support, Non-U.S. Gov't Review Cell Adh Migr. 2015;9(1-2):48-82. doi: 10.4161/19336918.2014.987587. PY - 2015 SN - 1933-6918 (Print) 1933-6918 SP - 48-82 ST - Tenascin-C: Form versus function T2 - Cell Adh Migr TI - Tenascin-C: Form versus function VL - 9 ID - 540 ER - TY - JOUR AD - a Department of Pediatrics ; University of Colorado Denver ; Aurora , CO USA. AN - 25484091 AU - Mulcahy Levy, J. M. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC4502777 DO - 10.4161/auto.36138 DP - NLM ET - 2014/12/09 IS - 11 LA - eng N1 - 1554-8635 Mulcahy Levy, Jean M Foreman, Nicholas K Thorburn, Andrew R01CA150925/CA/NCI NIH HHS/United States R01 CA150925/CA/NCI NIH HHS/United States CA111421/CA/NCI NIH HHS/United States P30CA046934/CA/NCI NIH HHS/United States UL1 RR025780/RR/NCRR NIH HHS/United States P30 CA046934/CA/NCI NIH HHS/United States K12 HD068372/HD/NICHD NIH HHS/United States UL1 TR001082/TR/NCATS NIH HHS/United States R01 CA111421/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Autophagy. 2014;10(11):2077-8. doi: 10.4161/auto.36138. PY - 2014 SN - 1554-8627 (Print) 1554-8627 SP - 2077-8 ST - Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors T2 - Autophagy TI - Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors VL - 10 ID - 541 ER - TY - JOUR AD - 1 Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. AN - 25490715 AU - Salgado, C. M. AU - Basu, D. AU - Nikiforova, M. AU - Bauer, B. S. AU - Johnson, D. AU - Rundell, V. AU - Grunwaldt, L. J. AU - Reyes-Múgica, M. DA - Jan-Feb DO - 10.2350/14-10-1566-oa.1 DP - NLM ET - 2014/12/10 IS - 1 LA - eng N1 - Salgado, Cláudia M Basu, Dipanjan Nikiforova, Marina Bauer, Bruce S Johnson, Donald Rundell, Veronica Grunwaldt, Lorelei J Reyes-Múgica, Miguel Journal Article Research Support, Non-U.S. Gov't United States Pediatr Dev Pathol. 2015 Jan-Feb;18(1):1-9. doi: 10.2350/14-10-1566-OA.1. Epub 2014 Dec 9. PY - 2015 SN - 1093-5266 (Print) 1093-5266 SP - 1-9 ST - BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi T2 - Pediatr Dev Pathol TI - BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi VL - 18 ID - 542 ER - TY - JOUR AD - Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia. Cancer Center, University of New Mexico, Albuquerque, New Mexico. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. Center for Childhood Cancer, Nationwide Children's Hospital, Columbus, Ohio. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatrics, University of California at San Francisco, San Francisco, California. University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado. CTEP/NCI, Bethesda, Maryland. Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia. rlock@ccia.unsw.edu.au. AN - 25504635 AU - Suryani, S. AU - Bracken, L. S. AU - Harvey, R. C. AU - Sia, K. C. AU - Carol, H. AU - Chen, I. M. AU - Evans, K. AU - Dietrich, P. A. AU - Roberts, K. G. AU - Kurmasheva, R. T. AU - Billups, C. A. AU - Mullighan, C. G. AU - Willman, C. L. AU - Loh, M. L. AU - Hunger, S. P. AU - Houghton, P. J. AU - Smith, M. A. AU - Lock, R. B. C2 - PMC4326541 C6 - NIHMS646510 Novartis to discuss the possible role of JAK inhibition in childhood leukemia. The remaining authors disclose no potential conflicts of interest. DA - Feb DO - 10.1158/1535-7163.Mct-14-0647 DP - NLM ET - 2014/12/17 IS - 2 LA - eng N1 - 1538-8514 Suryani, Santi Bracken, Lauryn S Harvey, Richard C Sia, Keith C S Carol, Hernan Chen, I-Ming Evans, Kathryn Dietrich, Philipp A Roberts, Kathryn G Kurmasheva, Raushan T Billups, Catherine A Mullighan, Charles G Willman, Cheryl L Loh, Mignon L Hunger, Stephen P Houghton, Peter J Smith, Malcolm A Lock, Richard B CA98543/CA/NCI NIH HHS/United States CA114766/CA/NCI NIH HHS/United States U10 CA098413/CA/NCI NIH HHS/United States U24 CA114766/CA/NCI NIH HHS/United States N0I-CM-91001-03/CM/NCI NIH HHS/United States N01 CM042216/CM/NCI NIH HHS/United States U01 CA157937/CA/NCI NIH HHS/United States U10 CA098543/CA/NCI NIH HHS/United States N01CM42216/CA/NCI NIH HHS/United States CA98413/CA/NCI NIH HHS/United States U10 CA180886/CA/NCI NIH HHS/United States N0I-CM-42216/CM/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Mol Cancer Ther. 2015 Feb;14(2):364-74. doi: 10.1158/1535-7163.MCT-14-0647. Epub 2014 Dec 10. PY - 2015 SN - 1535-7163 (Print) 1535-7163 SP - 364-74 ST - Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia T2 - Mol Cancer Ther TI - Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia VL - 14 ID - 543 ER - TY - JOUR AD - From the Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands (IV, KvdH, CMHAS, GMJMR, AzH, E-JMS, VJLW); GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands (KvdH, AzH, E-JMS, VJLW); Department of Clinical Pathology, Atrium Medical Centre Parkstad, Heerlen, The Netherlands (RC); Department of Pathology, St. Laurentius ziekenhuis, Roermond, The Netherlands (APW); and Laboratory of Translational Cell & Tissue Research and Department of Pathology, University Hospital, KULeuven, Leuven, Belgium (JJvdO). AN - 25526463 AU - Verlinden, I. AU - van den Hurk, K. AU - Clarijs, R. AU - Willig, A. P. AU - Stallinga, C. M. AU - Roemen, G. M. AU - van den Oord, J. J. AU - zur Hausen, A. AU - Speel, E. J. AU - Winnepenninckx, V. J. C2 - PMC4603111 DA - Dec DO - 10.1097/md.0000000000000285 DP - NLM ET - 2014/12/20 IS - 28 LA - eng N1 - 1536-5964 Verlinden, Ivana van den Hurk, Karin Clarijs, Ruud Willig, Arjan P Stallinga, Cecile M H A Roemen, Guido M J M van den Oord, Joost J zur Hausen, Axel Speel, Ernst-Jan M Winnepenninckx, Véronique J L Journal Article Multicenter Study Research Support, Non-U.S. Gov't Medicine (Baltimore). 2014 Dec;93(28):e285. doi: 10.1097/MD.0000000000000285. PY - 2014 SN - 0025-7974 (Print) 0025-7974 SP - e285 ST - BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article T2 - Medicine (Baltimore) TI - BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article VL - 93 ID - 544 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. AN - 25585684 AU - Leng, R. AU - Liao, G. AU - Wang, H. AU - Kuang, J. AU - Tang, L. DA - Feb DO - 10.1007/s12032-014-0329-5 DP - NLM ET - 2015/01/15 IS - 2 LA - eng N1 - 1559-131x Leng, Ruobing Liao, Gang Wang, Haixia Kuang, Jun Tang, Liangdan Journal Article Research Support, Non-U.S. Gov't United States Med Oncol. 2015 Feb;32(2):329. doi: 10.1007/s12032-014-0329-5. Epub 2015 Jan 14. PY - 2015 SN - 1357-0560 SP - 329 ST - Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome T2 - Med Oncol TI - Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome VL - 32 ID - 545 ER - TY - JOUR AD - Service d'Oncologie Médicale, Centre Eugene Marquis, Rennes, France. Brittany Melanoma Network, GRoupe Ouest Mélanome (GROUM), Rennes, France. Gene Expression and Oncogenesis Team, Institut de Génétique et Developement de Rennes, CNRS UMR6290, Rennes, France. CHU Pontchaillou, Université Européenne de Bretagne, Rennes, France. CHU Pontchaillou, Service de Génétique Moléculaire et Génomique des Cancers, Rennes, France. SFR Biosit UMS CNRS 3480/US INSERM 018, Rennes, France. Service d'Anatomopathologie, CHU Pontchaillou, Rennes, France. Laboratoire d'Anatomopathologie Atalante, Rennes, France. Centre d'Investigations Cliniques et Unité de Pharmacologie et de Pharmaco-épidémiologie, Rennes, France. CHU Pontchaillou, Service de Dermatologie, Rennes, France. AN - 25623140 AU - Pracht, M. AU - Mogha, A. AU - Lespagnol, A. AU - Fautrel, A. AU - Mouchet, N. AU - Le Gall, F. AU - Paumier, V. AU - Lefeuvre-Plesse, C. AU - Rioux-Leclerc, N. AU - Mosser, J. AU - Oger, E. AU - Adamski, H. AU - Galibert, M. D. AU - Lesimple, T. DA - Aug DO - 10.1111/jdv.12910 DP - NLM ET - 2015/01/28 IS - 8 LA - eng N1 - 1468-3083 Pracht, M Mogha, A Lespagnol, A Fautrel, A Mouchet, N Le Gall, F Paumier, V Lefeuvre-Plesse, C Rioux-Leclerc, N Mosser, J Oger, E Adamski, H Galibert, M-D Lesimple, T Journal Article Research Support, Non-U.S. Gov't England J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1530-8. doi: 10.1111/jdv.12910. Epub 2015 Jan 26. PY - 2015 SN - 0926-9959 SP - 1530-8 ST - Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma T2 - J Eur Acad Dermatol Venereol TI - Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma VL - 29 ID - 546 ER - TY - JOUR AD - Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. City of Hope Comprehensive Cancer Center, Duarte, CA, USA. City of Hope Comprehensive Cancer Center, Duarte, CA, USA lxue@coh.org. AN - 25633507 AU - Xue, D. AU - Li, X. AU - Ren, Y. AU - Liu, Q. AU - Yen, Y. AU - Xue, L. DA - Jun DO - 10.1177/1066896915568993 DP - NLM ET - 2015/01/31 IS - 4 LA - eng N1 - 1940-2465 Xue, Dan Li, Xiuzhen Ren, Yunqing Liu, Qi Yen, Yun Xue, Lijun Case Reports Journal Article Research Support, Non-U.S. Gov't United States Int J Surg Pathol. 2015 Jun;23(4):333-5. doi: 10.1177/1066896915568993. Epub 2015 Jan 29. PY - 2015 SN - 1066-8969 SP - 333-5 ST - Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule T2 - Int J Surg Pathol TI - Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule VL - 23 ID - 547 ER - TY - JOUR AD - Division of Cancer Treatment and Diagnosis, National Cancer Institute, 31 Center Drive, Bldg 31, Rm 3A44, Bethesda, MD, 20892, USA. AN - 25637165 AU - Do, K. AU - Speranza, G. AU - Bishop, R. AU - Khin, S. AU - Rubinstein, L. AU - Kinders, R. J. AU - Datiles, M. AU - Eugeni, M. AU - Lam, M. H. AU - Doyle, L. A. AU - Doroshow, J. H. AU - Kummar, S. DA - Jun DO - 10.1007/s10637-015-0212-z DP - NLM ET - 2015/02/01 IS - 3 LA - eng N1 - 1573-0646 Do, Khanh Speranza, Giovanna Bishop, Rachel Khin, Sonny Rubinstein, Larry Kinders, Robert J Datiles, Manuel Eugeni, Michelle Lam, Michael H Doyle, L Austin Doroshow, James H Kummar, Shivaani N01-CM-2011-00032/CM/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Invest New Drugs. 2015 Jun;33(3):720-8. doi: 10.1007/s10637-015-0212-z. Epub 2015 Feb 1. PY - 2015 SN - 0167-6997 SP - 720-8 ST - Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer T2 - Invest New Drugs TI - Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer VL - 33 ID - 548 ER - TY - JOUR AD - Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Division of Hematology, Oncology, and Blood & Bone Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, CA, USA. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. The Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Division of Pediatric Oncology, Johns Hopkins University, Baltimore, MD, USA. AN - 25638158 AU - Weingart, M. F. AU - Roth, J. J. AU - Hutt-Cabezas, M. AU - Busse, T. M. AU - Kaur, H. AU - Price, A. AU - Maynard, R. AU - Rubens, J. AU - Taylor, I. AU - Mao, X. G. AU - Xu, J. AU - Kuwahara, Y. AU - Allen, S. J. AU - Erdreich-Epstein, A. AU - Weissman, B. E. AU - Orr, B. A. AU - Eberhart, C. G. AU - Biegel, J. A. AU - Raabe, E. H. C2 - PMC4413645 DA - Feb 20 DO - 10.18632/oncotarget.3078 DP - NLM ET - 2015/02/02 IS - 5 LA - eng N1 - 1949-2553 Weingart, Melanie F Roth, Jacquelyn J Hutt-Cabezas, Marianne Busse, Tracy M Kaur, Harpreet Price, Antoinette Maynard, Rachael Rubens, Jeffrey Taylor, Isabella Mao, Xing-Gang Xu, Jingying Kuwahara, Yasumichi Allen, Sariah J Erdreich-Epstein, Anat Weissman, Bernard E Orr, Brent A Eberhart, Charles G Biegel, Jaclyn A Raabe, Eric H P30 CA006973/CA/NCI NIH HHS/United States R01 CA046274/CA/NCI NIH HHS/United States R01 CA091048/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Feb 20;6(5):3165-77. doi: 10.18632/oncotarget.3078. PY - 2015 SN - 1949-2553 SP - 3165-77 ST - Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target T2 - Oncotarget TI - Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target VL - 6 ID - 549 ER - TY - JOUR AD - Comprehensive Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China. AN - 25643922 AU - Zhu, L. AU - Dissanayaka, W. L. AU - Green, D. W. AU - Zhang, C. C2 - PMC6495676 DA - Apr DO - 10.1111/cpr.12172 DP - NLM ET - 2015/02/04 IS - 2 LA - eng N1 - 1365-2184 Zhu, Lifang Dissanayaka, Waruna Lakmal Green, David William Zhang, Chengfei Journal Article Research Support, Non-U.S. Gov't Cell Prolif. 2015 Apr;48(2):231-8. doi: 10.1111/cpr.12172. Epub 2015 Feb 3. PY - 2015 SN - 0960-7722 (Print) 0960-7722 SP - 231-8 ST - Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells T2 - Cell Prolif TI - Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells VL - 48 ID - 550 ER - TY - JOUR AD - Drug Development Unit, Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom. Drug Development Unit, Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom. udai.banerji@icr.ac.uk. AN - 25649020 AU - Rafii, S. AU - Roda, D. AU - Geuna, E. AU - Jimenez, B. AU - Rihawi, K. AU - Capelan, M. AU - Yap, T. A. AU - Molife, L. R. AU - Kaye, S. B. AU - de Bono, J. S. AU - Banerji, U. C2 - PMC4401558 C6 - EMS62092 DA - Apr 15 DO - 10.1158/1078-0432.Ccr-14-2424 DP - NLM ET - 2015/02/05 IS - 8 LA - eng N1 - Rafii, Saeed Roda, Desamparados Geuna, Elena Jimenez, Begona Rihawi, Karim Capelan, Marta Yap, Timothy A Molife, L Rhoda Kaye, Stanley B de Bono, Johann S Banerji, Udai G0502133/Medical Research Council/United Kingdom A15573/Cancer Research UK/United Kingdom A11566/Cancer Research UK/United Kingdom MARBRC-2012-1/Department of Health/United Kingdom C347/A15403/Cancer Research UK/United Kingdom C309/A11566/Cancer Research UK/United Kingdom 11566/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Clin Cancer Res. 2015 Apr 15;21(8):1869-76. doi: 10.1158/1078-0432.CCR-14-2424. Epub 2015 Feb 3. PY - 2015 SN - 1078-0432 (Print) 1078-0432 SP - 1869-76 ST - Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials T2 - Clin Cancer Res TI - Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials VL - 21 ID - 551 ER - TY - JOUR AD - Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. AN - 25651238 AU - Carrera, C. AU - Puig-Butillè, J. A. AU - Tell-Marti, G. AU - García, A. AU - Badenas, C. AU - Alós, L. AU - Puig, S. AU - Malvehy, J. DA - May DO - 10.1001/jamadermatol.2014.4115 DP - NLM ET - 2015/02/05 IS - 5 LA - eng N1 - 2168-6084 Carrera, Cristina Puig-Butillè, Joan A Tell-Marti, Gemma García, Adriana Badenas, Celia Alós, Llucia Puig, Susana Malvehy, Josep Case Reports Journal Article Research Support, Non-U.S. Gov't United States JAMA Dermatol. 2015 May;151(5):544-8. doi: 10.1001/jamadermatol.2014.4115. PY - 2015 SN - 2168-6068 SP - 544-8 ST - Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma T2 - JAMA Dermatol TI - Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma VL - 151 ID - 552 ER - TY - JOUR AD - Centre Léon-Bérard, Laboratoire de Recherche Translationnelle, 28 rue Laennec, 69373, Lyon Cedex 08, France. AN - 25653133 AU - Combaret, V. AU - Iacono, I. AU - Bellini, A. AU - Bréjon, S. AU - Bernard, V. AU - Marabelle, A. AU - Coze, C. AU - Pierron, G. AU - Lapouble, E. AU - Schleiermacher, G. AU - Blay, J. Y. C2 - PMC4402069 DA - Apr DO - 10.1002/cam4.414 DP - NLM ET - 2015/02/06 IS - 4 LA - eng N1 - 2045-7634 Combaret, Valérie Iacono, Isabelle Bellini, Angela Bréjon, Stéphanie Bernard, Virginie Marabelle, Aurélien Coze, Carole Pierron, Gaelle Lapouble, Eve Schleiermacher, Gudrun Blay, Jean Yves Journal Article Research Support, Non-U.S. Gov't Cancer Med. 2015 Apr;4(4):540-50. doi: 10.1002/cam4.414. Epub 2015 Feb 4. PY - 2015 SN - 2045-7634 (Print) 2045-7634 SP - 540-50 ST - Detection of tumor ALK status in neuroblastoma patients using peripheral blood T2 - Cancer Med TI - Detection of tumor ALK status in neuroblastoma patients using peripheral blood VL - 4 ID - 553 ER - TY - JOUR AD - Department of Histopathology, Bristol Royal Infirmary, Bristol, UK. AN - 25659413 AU - Wong, N. A. AU - Wingate, J. AU - Gradhand, E. DA - Sep DO - 10.1111/his.12667 DP - NLM ET - 2015/02/11 IS - 3 LA - eng N1 - 1365-2559 Wong, Newton A C S Wingate, Jenny Gradhand, Elise Journal Article Research Support, Non-U.S. Gov't England Histopathology. 2015 Sep;67(3):378-85. doi: 10.1111/his.12667. Epub 2015 Mar 17. PY - 2015 SN - 0309-0167 SP - 378-85 ST - An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours T2 - Histopathology TI - An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours VL - 67 ID - 554 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 25682942 AU - Ouchi, K. AU - Miyachi, M. AU - Tsuma, Y. AU - Tsuchiya, K. AU - Iehara, T. AU - Konishi, E. AU - Yanagisawa, A. AU - Hosoi, H. DA - May DO - 10.1002/pbc.25424 DP - NLM ET - 2015/02/17 IS - 5 LA - eng N1 - 1545-5017 Ouchi, Kazutaka Miyachi, Mitsuru Tsuma, Yusuke Tsuchiya, Kunihiko Iehara, Tomoko Konishi, Eiichi Yanagisawa, Akio Hosoi, Hajime Case Reports Journal Article Research Support, Non-U.S. Gov't United States Pediatr Blood Cancer. 2015 May;62(5):909-11. doi: 10.1002/pbc.25424. Epub 2015 Feb 14. PY - 2015 SN - 1545-5009 SP - 909-11 ST - FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor T2 - Pediatr Blood Cancer TI - FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor VL - 62 ID - 555 ER - TY - JOUR AD - Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA. Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Orthopaedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115, USA. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: arin.greene@childrens.harvard.edu. AN - 25728774 AU - Couto, J. A. AU - Vivero, M. P. AU - Kozakewich, H. P. AU - Taghinia, A. H. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. C2 - PMC4375628 DA - Mar 5 DO - 10.1016/j.ajhg.2015.01.007 DP - NLM ET - 2015/03/03 IS - 3 LA - eng N1 - 1537-6605 Couto, Javier A Vivero, Matthew P Kozakewich, Harry P W Taghinia, Amir H Mulliken, John B Warman, Matthew L Greene, Arin K R01 AR064231/AR/NIAMS NIH HHS/United States R21 HD081004/HD/NICHD NIH HHS/United States R01-AR064231/AR/NIAMS NIH HHS/United States R21-HD081004/HD/NICHD NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Am J Hum Genet. 2015 Mar 5;96(3):480-6. doi: 10.1016/j.ajhg.2015.01.007. Epub 2015 Feb 26. PY - 2015 SN - 0002-9297 (Print) 0002-9297 SP - 480-6 ST - A somatic MAP3K3 mutation is associated with verrucous venous malformation T2 - Am J Hum Genet TI - A somatic MAP3K3 mutation is associated with verrucous venous malformation VL - 96 ID - 556 ER - TY - JOUR AD - Department of Dermatology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. Research and Education Network, Westmead Hospital, Westmead, Australia. Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Westmead, Australia. Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Faculty of Medicine, University of Western Sydney, Sydney, Australia. Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Department of Dermatology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: pablo.fernandezpenas@sydney.edu.au. AN - 25748298 AU - Anforth, R. AU - Menzies, A. AU - Byth, K. AU - Carlos, G. AU - Chou, S. AU - Sharma, R. AU - Scolyer, R. A. AU - Kefford, R. AU - Long, G. V. AU - Fernandez-Peñas, P. DA - May DO - 10.1016/j.jaad.2015.01.018 DP - NLM ET - 2015/03/10 IS - 5 LA - eng N1 - 1097-6787 Anforth, Rachael Menzies, Alexander Byth, Karen Carlos, Giuliana Chou, Shaun Sharma, Raghwa Scolyer, Richard A Kefford, Richard Long, Georgina V Fernandez-Peñas, Pablo Journal Article United States J Am Acad Dermatol. 2015 May;72(5):809-15.e1. doi: 10.1016/j.jaad.2015.01.018. Epub 2015 Mar 3. PY - 2015 SN - 0190-9622 SP - 809-15.e1 ST - Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy T2 - J Am Acad Dermatol TI - Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy VL - 72 ID - 557 ER - TY - JOUR AD - Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College People's Republic of China. Department of Pathology, Xuanwu Hospital, Capital Medical University People's Republic of China. AN - 25755776 AU - Lu, J. AU - Gao, J. AU - Zhang, J. AU - Sun, J. AU - Wu, H. AU - Shi, X. AU - Teng, L. AU - Liang, Z. C2 - PMC4348874 DP - NLM ET - 2015/03/11 IS - 1 LA - eng N1 - 1936-2625 Lu, Junliang Gao, Jie Zhang, Jing Sun, Jian Wu, Huanwen Shi, Xiaohua Teng, Lianghong Liang, Zhiyong Journal Article Int J Clin Exp Pathol. 2015 Jan 1;8(1):793-9. eCollection 2015. PY - 2015 SN - 1936-2625 SP - 793-9 ST - Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma T2 - Int J Clin Exp Pathol TI - Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma VL - 8 ID - 558 ER - TY - JOUR AD - Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. Oncology Research Center of Mercogliano (CROM), Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale", IRCCS, Naples, Italy. Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Pharmacy Department, University of Genoa, Genoa, Italy. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA, USA. AN - 25762618 AU - Casini, N. AU - Forte, I. M. AU - Mastrogiovanni, G. AU - Pentimalli, F. AU - Angelucci, A. AU - Festuccia, C. AU - Tomei, V. AU - Ceccherini, E. AU - Di Marzo, D. AU - Schenone, S. AU - Botta, M. AU - Giordano, A. AU - Indovina, P. C2 - PMC4494948 DA - May 20 DO - 10.18632/oncotarget.3043 DP - NLM ET - 2015/03/13 IS - 14 LA - eng N1 - 1949-2553 Casini, Nadia Forte, Iris Maria Mastrogiovanni, Gianmarco Pentimalli, Francesca Angelucci, Adriano Festuccia, Claudio Tomei, Valentina Ceccherini, Elisa Di Marzo, Domenico Schenone, Silvia Botta, Maurizio Giordano, Antonio Indovina, Paola Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 May 20;6(14):12421-35. doi: 10.18632/oncotarget.3043. PY - 2015 SN - 1949-2553 SP - 12421-35 ST - SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation T2 - Oncotarget TI - SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation VL - 6 ID - 559 ER - TY - JOUR AD - Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan. Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Surgery, National Taiwan University Hospital, Hsin-Chu Branch, Hisn-Chu, Taiwan. Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: chiayu@ntu.edu.tw. AN - 25767048 AU - Sheen, Y. S. AU - Liao, Y. H. AU - Liau, J. Y. AU - Lin, M. H. AU - Hsieh, Y. C. AU - Jee, S. H. AU - Chu, C. Y. DA - Feb DO - 10.1016/j.jfma.2015.02.001 DP - NLM ET - 2015/03/15 IS - 2 LA - eng N1 - Sheen, Yi-Shuan Liao, Yi-Hua Liau, Jau-Yu Lin, Ming-Hsien Hsieh, Yi-Chun Jee, Shiou-Hwa Chu, Chia-Yu Journal Article Research Support, Non-U.S. Gov't Singapore J Formos Med Assoc. 2016 Feb;115(2):121-7. doi: 10.1016/j.jfma.2015.02.001. Epub 2015 Mar 10. PY - 2016 SN - 0929-6646 (Print) 0929-6646 SP - 121-7 ST - Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan T2 - J Formos Med Assoc TI - Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan VL - 115 ID - 560 ER - TY - JOUR AD - Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China ; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Department of Orthopedics, General Hospital of Tianjin Medical University, Tianjin, People's Republic of China. Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA. Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center and Sino-US Joint Laboratory for Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center and Sino-US Joint Laboratory for Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China. Department of Biochemistry, Medical Center, Rush University, Chicago, IL, USA. Department of Colorectal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China. Research Center for Bioengineering and Sensing Technology, University of Science and Technology Beijing, Beijing, People's Republic of China. Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City, UT, USA. Department of General Surgery, The First People's Hospital of Shunde affiliated to Southern Medical University, Foshan, Guangdong, People's Republic of China. Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China. AN - 25792811 AU - Niu, N. K. AU - Wang, Z. L. AU - Pan, S. T. AU - Ding, H. Q. AU - Au, G. H. AU - He, Z. X. AU - Zhou, Z. W. AU - Xiao, G. AU - Yang, Y. X. AU - Zhang, X. AU - Yang, T. AU - Chen, X. W. AU - Qiu, J. X. AU - Zhou, S. F. C2 - PMC4362906 DO - 10.2147/dddt.S74197 DP - NLM ET - 2015/03/21 LA - eng N1 - 1177-8881 Niu, Ning-Kui Wang, Zi-Li Pan, Shu-Ting Ding, Hui-Qiang Au, Giang H T He, Zhi-Xu Zhou, Zhi-Wei Xiao, Guozhi Yang, Yin-Xue Zhang, Xueji Yang, Tianxin Chen, Xiao-Wu Qiu, Jia-Xuan Zhou, Shu-Feng Journal Article Drug Des Devel Ther. 2015 Mar 12;9:1555-84. doi: 10.2147/DDDT.S74197. eCollection 2015. PY - 2015 SN - 1177-8881 SP - 1555-84 ST - Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway T2 - Drug Des Devel Ther TI - Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway VL - 9 ID - 561 ER - TY - JOUR AD - Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Department of Pathology and Medical Biology, Pathology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Department of Neurosurgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. AN - 25799134 AU - Sie, M. AU - den Dunnen, W. F. AU - Lourens, H. J. AU - Meeuwsen-de Boer, T. G. AU - Scherpen, F. J. AU - Zomerman, W. W. AU - Kampen, K. R. AU - Hoving, E. W. AU - de Bont, E. S. C2 - PMC4370756 DO - 10.1371/journal.pone.0122555 DP - NLM ET - 2015/03/24 IS - 3 LA - eng N1 - 1932-6203 Sie, Mariska den Dunnen, Wilfred F A Lourens, Harm Jan Meeuwsen-de Boer, Tiny G J Scherpen, Frank J G Zomerman, Walderik W Kampen, Kim R Hoving, Eelco W de Bont, Eveline S J M Journal Article Research Support, Non-U.S. Gov't PLoS One. 2015 Mar 23;10(3):e0122555. doi: 10.1371/journal.pone.0122555. eCollection 2015. PY - 2015 SN - 1932-6203 SP - e0122555 ST - Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma T2 - PLoS One TI - Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma VL - 10 ID - 562 ER - TY - JOUR AD - Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Germany. Kids Cancer Center, Sydneys Children's Hospital, Children's Cancer Institute, Lowy Cancer Centre, University of New South Wales, Sydney, Australia. Unité Inserm U830, Centre de Recherche, Institut Curie, Paris, France. Biotherapy Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Oncology Discovery Research and Early Development, Johnson & Johnson, Beerse, Belgium. VP Oncology, Xcovery LLC, West Palm Beach, Florida. Department of Pediatric Oncology and Haematology, Ghent University Hospital, Ghent, Belgium. Center for Human Genetics, K.U. Leuven-VIB, Leuven, Belgium. Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Germany. German Cancer Consortium (DKTK), Germany. Translational Neuro-Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany. Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany. Oncology Discovery Biology, Janssen Research & Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium. Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. franki.speleman@ugent.be. AN - 25805801 AU - Lambertz, I. AU - Kumps, C. AU - Claeys, S. AU - Lindner, S. AU - Beckers, A. AU - Janssens, E. AU - Carter, D. R. AU - Cazes, A. AU - Cheung, B. B. AU - De Mariano, M. AU - De Bondt, A. AU - De Brouwer, S. AU - Delattre, O. AU - Gibbons, J. AU - Janoueix-Lerosey, I. AU - Laureys, G. AU - Liang, C. AU - Marchall, G. M. AU - Porcu, M. AU - Takita, J. AU - Trujillo, D. C. AU - Van Den Wyngaert, I. AU - Van Roy, N. AU - Van Goethem, A. AU - Van Maerken, T. AU - Zabrocki, P. AU - Cools, J. AU - Schulte, J. H. AU - Vialard, J. AU - Speleman, F. AU - De Preter, K. DA - Jul 15 DO - 10.1158/1078-0432.Ccr-14-2024 DP - NLM ET - 2015/03/26 IS - 14 LA - eng N1 - Lambertz, Irina Kumps, Candy Claeys, Shana Lindner, Sven Beckers, Anneleen Janssens, Els Carter, Daniel R Cazes, Alex Cheung, Belamy B De Mariano, Marilena De Bondt, An De Brouwer, Sara Delattre, Olivier Gibbons, Jay Janoueix-Lerosey, Isabelle Laureys, Geneviève Liang, Chris Marchall, Glenn M Porcu, Michael Takita, Junko Trujillo, David Camacho Van Den Wyngaert, Ilse Van Roy, Nadine Van Goethem, Alan Van Maerken, Tom Zabrocki, Piotr Cools, Jan Schulte, Johannes H Vialard, Jorge Speleman, Frank De Preter, Katleen 1F31CA142311-01/CA/NCI NIH HHS/United States 5T32CA059366-15/CA/NCI NIH HHS/United States P30 CA43703/CA/NCI NIH HHS/United States R01CA102074/CA/NCI NIH HHS/United States R01CA134878/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2015 Jul 15;21(14):3327-39. doi: 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24. PY - 2015 SN - 1078-0432 (Print) 1078-0432 SP - 3327-39 ST - Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment T2 - Clin Cancer Res TI - Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment VL - 21 ID - 563 ER - TY - JOUR AD - Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK; Current address: Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK. Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK. Beatson Institute for Cancer Research, Glasgow, UK. GOSgene, UCL Institute of Child Health, London, UK. Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK. Department of Veterans Affairs, Vanderbilt University Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK; Pediatric Dermatology, Great Ormond St Hospital, London, UK. Electronic address: v.kinsler@ucl.ac.uk. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK. Electronic address: p.adams@beatson.gla.ac.uk. AN - 25815427 AU - Pawlikowski, J. S. AU - Brock, C. AU - Chen, S. C. AU - Al-Olabi, L. AU - Nixon, C. AU - McGregor, F. AU - Paine, S. AU - Chanudet, E. AU - Lambie, W. AU - Holmes, W. M. AU - Mullin, J. M. AU - Richmond, A. AU - Wu, H. AU - Blyth, K. AU - King, A. AU - Kinsler, V. A. AU - Adams, P. D. C2 - PMC4539947 C6 - NIHMS674239 DA - Aug DO - 10.1038/jid.2015.114 DP - NLM ET - 2015/03/31 IS - 8 LA - eng N1 - 1523-1747 Pawlikowski, Jeffrey S Brock, Claire Chen, Sheau-Chiann Al-Olabi, Lara Nixon, Colin McGregor, Fiona Paine, Simon Chanudet, Estelle Lambie, Wendy Holmes, William M Mullin, James M Richmond, Ann Wu, Hong Blyth, Karen King, Ayala Kinsler, Veronica A Adams, Peter D R01-CA116021/CA/NCI NIH HHS/United States I01 BX002301/BX/BLRD VA/United States C10652/A16566/Cancer Research UK/United Kingdom T32HL007751/HL/NHLBI NIH HHS/United States T32 HL007751/HL/NHLBI NIH HHS/United States Department of Health/United Kingdom R01 CA129334/CA/NCI NIH HHS/United States MR/M000605/1/Medical Research Council/United Kingdom R01 CA116021/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. J Invest Dermatol. 2015 Aug;135(8):2093-2101. doi: 10.1038/jid.2015.114. Epub 2015 Mar 27. PY - 2015 SN - 0022-202X (Print) 0022-202x SP - 2093-2101 ST - Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling T2 - J Invest Dermatol TI - Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling VL - 135 ID - 564 ER - TY - JOUR AD - Department of Pediatric Oncology and Hematology, Hôpital Mère-Enfant, Nantes, France. 1] Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France [2] Paris Sud University, Le Kremlin-Bicêtre, France. Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France. Department of Pediatric Oncology and Hematology, Hôpital Estaing, Clermont-Ferrand, France. Department of Pediatric Hematology, IHOP, Lyon, France. Department of Pediatric Oncology and Hematology, Hôpital Pellegrin, Bordeaux, France. Department of Pediatric Hematology, Hôpital Robert Debré, Paris, France. Department of Pediatric Oncology and Hematology, Hôpital Hautepierre, Strasbourg, France. Department of Pathology, Hôpital Purpan, Toulouse, France. Department of Pediatric Hematology, Hôpital La Timone, Marseille, France. Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. AN - 25822227 AU - Strullu, M. AU - Thomas, C. AU - Le Deley, M. C. AU - Chevance, A. AU - Kanold, J. AU - Bertrand, Y. AU - Jubert, C. AU - Dalle, J. H. AU - Paillard, C. AU - Baruchel, A. AU - Lamant, L. AU - Michel, G. AU - Brugières, L. DA - Jun DO - 10.1038/bmt.2015.57 DP - NLM ET - 2015/03/31 IS - 6 LA - eng N1 - 1476-5365 Strullu, M Thomas, C Le Deley, M-C Chevance, A Kanold, J Bertrand, Y Jubert, C Dalle, J-H Paillard, C Baruchel, A Lamant, L Michel, G Brugières, L Journal Article Multicenter Study England Bone Marrow Transplant. 2015 Jun;50(6):795-801. doi: 10.1038/bmt.2015.57. Epub 2015 Mar 30. PY - 2015 SN - 0268-3369 SP - 795-801 ST - Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC T2 - Bone Marrow Transplant TI - Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC VL - 50 ID - 565 ER - TY - JOUR AD - Department of Internal Medicine and Medical Specialties, University of Rome "Sapienza", 00161, Rome, Italy. Department of Health Sciences, University of Catanzaro "Magna Graecia", Campus "S. Venuta", Viale Europa, 88100, Catanzaro, Italy. Institute of Medical Genetics, University Hospital "S. Maria della Misericordia", 33100, Udine, Italy. Department of Surgical Sciences, University of Rome "Sapienza", 00161, Rome, Italy. Department of Radiological, Oncological and Pathological Sciences, University of Rome "Sapienza", 00161, Rome, Italy. Department of Health Sciences, University of Catanzaro "Magna Graecia", Campus "S. Venuta", Viale Europa, 88100, Catanzaro, Italy. d.russo@unicz.it. AN - 25837309 AU - Sponziello, M. AU - Verrienti, A. AU - Rosignolo, F. AU - De Rose, R. F. AU - Pecce, V. AU - Maggisano, V. AU - Durante, C. AU - Bulotta, S. AU - Damante, G. AU - Giacomelli, L. AU - Di Gioia, C. R. AU - Filetti, S. AU - Russo, D. AU - Celano, M. DA - Nov DO - 10.1007/s12020-015-0586-x DP - NLM ET - 2015/04/04 IS - 2 LA - eng N1 - 1559-0100 Sponziello, Marialuisa Verrienti, Antonella Rosignolo, Francesca De Rose, Roberta Francesca Pecce, Valeria Maggisano, Valentina Durante, Cosimo Bulotta, Stefania Damante, Giuseppe Giacomelli, Laura Di Gioia, Cira Rosaria Tiziana Filetti, Sebastiano Russo, Diego Celano, Marilena Journal Article Research Support, Non-U.S. Gov't United States Endocrine. 2015 Nov;50(2):434-41. doi: 10.1007/s12020-015-0586-x. Epub 2015 Apr 3. PY - 2015 SN - 1355-008x SP - 434-41 ST - PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells T2 - Endocrine TI - PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells VL - 50 ID - 566 ER - TY - JOUR AD - From the Departments of Biochemistry and Molecular Biology. From the Departments of Biochemistry and Molecular Biology, Dermatology, and Obstetrics and Gynecology and the Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201 reckert@umaryland.edu. AN - 25851901 AU - Saha, K. AU - Eckert, R. L. C2 - PMC4505598 DA - May 22 DO - 10.1074/jbc.M115.642868 DP - NLM ET - 2015/04/09 IS - 21 LA - eng N1 - 1083-351x Saha, Kamalika Eckert, Richard L R21 AR065266/AR/NIAMS NIH HHS/United States R01 CA131074/CA/NCI NIH HHS/United States R01 CA131064/CA/NCI NIH HHS/United States R01CA131064/CA/NCI NIH HHS/United States R21AR065266/AR/NIAMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Biol Chem. 2015 May 22;290(21):13521-30. doi: 10.1074/jbc.M115.642868. Epub 2015 Apr 7. PY - 2015 SN - 0021-9258 (Print) 0021-9258 SP - 13521-30 ST - Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression T2 - J Biol Chem TI - Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression VL - 290 ID - 567 ER - TY - JOUR AD - Medical Oncology Department, Institut Català d'Oncologia de Girona, Girona, Spain. jrubio@iconcologia.net. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. jrubio@iconcologia.net. Faculty of Medicine, University of Girona (UdG), Girona, Catalonia, Spain. jrubio@iconcologia.net. Medical Oncology Department, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Spain. jborras@grupsagessa.com. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. jborras@grupsagessa.com. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. jborras@grupsagessa.com. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. jborras@grupsagessa.com. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. mccarmonagarcia22@gmail.com. Epidemiology Unit and Girona Cancer Registry (UERC), Oncology Coordination Plan Department of Health Government of Catalonia, Girona, Spain. mccarmonagarcia22@gmail.com. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. aameijide@grupsagessa.com. Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. AGonzalezV@santpau.cat. Faculty of Medicine, University of Girona (UdG), Girona, Catalonia, Spain. rortizduran.girona.ics@gencat.cat. Department of Pathology, University Hospital Josep Trueta, Girona, Spain. rortizduran.girona.ics@gencat.cat. Department of Pathology, University Hospital Verge de la Cinta, Institut d'Investigació Sanitària Pere Virgili (IISPV), Fundació Dr. Ferran (FF), Tortosa, Spain. rbosch.ebre.ics@gencat.cat. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. friu@grupsagessa.com. Department of Pathology, University Hospital Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. friu@grupsagessa.com. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. dparada@grupsagessa.com. Department of Pathology, University Hospital Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. dparada@grupsagessa.com. Department of Pathology, Hospital Santa Tecla, Tarragona, Spain. emc@xarxatecla.cat. Department of Pathology, Clinica Girona, Girona, Spain. pmiroap@clinicagirona.cat. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. jsirvent.hj23.ics@gencat.cat. Department of Pathology, University Hospital Joan XXIII, Tarragona, Spain. jsirvent.hj23.ics@gencat.cat. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. jgalceran@grupsagessa.com. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. jgalceran@grupsagessa.com. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. rmarcos@iconcologia.net. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. rmarcos@iconcologia.net. Epidemiology Unit and Girona Cancer Registry (UERC), Oncology Coordination Plan Department of Health Government of Catalonia, Girona, Spain. rmarcos@iconcologia.net. AN - 25885906 AU - Rubió-Casadevall, J. AU - Borràs, J. L. AU - Carmona-García, M. C. AU - Ameijide, A. AU - Gonzalez-Vidal, A. AU - Ortiz, M. R. AU - Bosch, R. AU - Riu, F. AU - Parada, D. AU - Martí, E. AU - Miró, J. AU - Sirvent, J. J. AU - Galceran, J. AU - Marcos-Gragera, R. C2 - PMC4336765 DA - Feb 13 DO - 10.1186/s12957-015-0474-0 DP - NLM ET - 2015/04/18 LA - eng N1 - 1477-7819 Rubió-Casadevall, Jordi Borràs, Joan Lluis Carmona-García, Maria Carme Ameijide, Alberto Gonzalez-Vidal, Allan Ortiz, Maria Rosa Bosch, Ramon Riu, Francesc Parada, David Martí, Esther Miró, Josefina Sirvent, Juan Jose Galceran, Jaume Marcos-Gragera, Rafael Journal Article Research Support, Non-U.S. Gov't World J Surg Oncol. 2015 Feb 13;13:47. doi: 10.1186/s12957-015-0474-0. PY - 2015 SN - 1477-7819 SP - 47 ST - Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study T2 - World J Surg Oncol TI - Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study VL - 13 ID - 568 ER - TY - JOUR AD - Department of Dermatology, Southwest Hospital, Third Military Medical University, Chongqing, China. Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China. Department of Dermatology and Allergy, Technische Universita et Muenchen, Munich, Germany. AN - 25912722 AU - Song, Z. AU - Deng, X. AU - Chen, W. AU - Xu, J. AU - Chen, S. AU - Zhong, H. AU - Hao, F. DA - Nov DO - 10.1111/jdv.13172 DP - NLM ET - 2015/04/29 IS - 11 LA - eng N1 - 1468-3083 Song, Z Deng, X Chen, W Xu, J Chen, S Zhong, H Hao, F Journal Article Research Support, Non-U.S. Gov't England J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2169-76. doi: 10.1111/jdv.13172. Epub 2015 Apr 24. PY - 2015 SN - 0926-9959 SP - 2169-76 ST - Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis T2 - J Eur Acad Dermatol Venereol TI - Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis VL - 29 ID - 569 ER - TY - JOUR AD - Department of Pathology, Istituto Giannina Gaslini, Genova, Italy. Department of Hematology-Oncology, Istituto Giannina Gaslini, Genova, Italy. U.O.C. Bioterapie IRCSS A.O.U. San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. Neuroblastoma Laboratory, Onco/Hematology Laboratory, SDB Department, University of Padova, Pediatric Research Institute, Fondazione Città della Speranza, Padova, Italy. Department of Pediatrics, University of Padova, Padova, Italy. Department of Pediatric Oncology, National Cancer Institute, Milano, Italy. Department of Pediatric Hematology and Oncology, ARNAS Civico Di Cristina Benfratelli Hospital, Palermo, Italy. Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", University of Bologna Sant'Orsola-Malpighi Hospital, Bologna, Italy. Department of Pediatric Hematology-Oncology, IRCCS, Ospedale Bambino Gesù, Rome, Italy. Department of Epidemiology and Biostatistics, Istituto Giannina Gaslini, Genova, Italy. AN - 25925003 AU - Mazzocco, K. AU - Defferrari, R. AU - Sementa, A. R. AU - Garaventa, A. AU - Longo, L. AU - De Mariano, M. AU - Esposito, M. R. AU - Negri, F. AU - Ircolò, D. AU - Viscardi, E. AU - Luksch, R. AU - D'Angelo, P. AU - Prete, A. AU - Castellano, A. AU - Massirio, P. AU - Erminio, G. AU - Gigliotti, A. R. AU - Tonini, G. P. AU - Conte, M. DA - Oct DO - 10.1002/pbc.25552 DP - NLM ET - 2015/05/01 IS - 10 LA - eng N1 - 1545-5017 Mazzocco, Katia Defferrari, Raffaella Sementa, Angela Rita Garaventa, Alberto Longo, Luca De Mariano, Marilena Esposito, Maria Rosaria Negri, Francesca Ircolò, Davide Viscardi, Elisabetta Luksch, Roberto D'Angelo, Paolo Prete, Arcangelo Castellano, Aurora Massirio, Paolo Erminio, Giovanni Gigliotti, Anna Rita Tonini, Gian Paolo Conte, Massimo Journal Article Research Support, Non-U.S. Gov't United States Pediatr Blood Cancer. 2015 Oct;62(10):1725-32. doi: 10.1002/pbc.25552. Epub 2015 Apr 29. PY - 2015 SN - 1545-5009 SP - 1725-32 ST - Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group T2 - Pediatr Blood Cancer TI - Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group VL - 62 ID - 570 ER - TY - JOUR AD - Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A. Michallon, and Université Joseph Fourier, INSERM U823, Institut Albert Bonniot, Grenoble, France SLantuejoul@chu-grenoble.fr. Service d'Anatomie Pathologique, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. Département de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, INSERM S1147, Paris, France. Service d'Anatomie et de Cytologie Pathologiques, Registre MESONAT, CHU Côte de Nacre, U1086 INSERM-UCBN "Cancers et Préventions", Caen, France. Laboratoire de Pathologie Clinique et Expérimentale et Biobanque, Hôpital Pasteur, Centre Hospitalo-Universitaire de Nice, Université de Nice Sophia Antipolis, Nice, France. Service d'Anatomie Pathologique, Service de Biologie des Tumeurs, CHU Haut-Levêque, Pessac, France. Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU de Lille, Lille, France. Laboratoire d'Anatomie Pathologique, Hôpital Nord, Marseille, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Central, Nancy, France. Service d'Anatomie et Cytologie Pathologiques, Hôpital de la Croix Rousse, Lyon, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpitaux universitaire Paris centre, Paris, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Louis Pradel, Bron, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Tenon, Paris, France. Service d'Anatomie Pathologique, Centre Jean Perrin, Clermont-Ferrand, France. Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A. Michallon, and Université Joseph Fourier, INSERM U823, Institut Albert Bonniot, Grenoble, France. AN - 25929957 AU - Lantuejoul, S. AU - Rouquette, I. AU - Blons, H. AU - Le Stang, N. AU - Ilie, M. AU - Begueret, H. AU - Grégoire, V. AU - Hofman, P. AU - Gros, A. AU - Garcia, S. AU - Monhoven, N. AU - Devouassoux-Shisheboran, M. AU - Mansuet-Lupo, A. AU - Thivolet, F. AU - Antoine, M. AU - Vignaud, J. M. AU - Penault-Llorca, F. AU - Galateau-Sallé, F. AU - McLeer-Florin, A. DA - Jul DO - 10.1183/09031936.00119914 DP - NLM ET - 2015/05/02 IS - 1 LA - eng N1 - 1399-3003 Lantuejoul, Sylvie Rouquette, Isabelle Blons, Hélène Le Stang, Nolwenn Ilie, Marius Begueret, Hugues Grégoire, Valerie Hofman, Paul Gros, Audrey Garcia, Stephane Monhoven, Nathalie Devouassoux-Shisheboran, Mojgan Mansuet-Lupo, Audrey Thivolet, Françoise Antoine, Martine Vignaud, Jean-Michel Penault-Llorca, Frederique Galateau-Sallé, Françoise McLeer-Florin, Anne Journal Article Multicenter Study Research Support, Non-U.S. Gov't England Eur Respir J. 2015 Jul;46(1):207-18. doi: 10.1183/09031936.00119914. Epub 2015 Apr 30. PY - 2015 SN - 0903-1936 SP - 207-18 ST - French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas T2 - Eur Respir J TI - French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas VL - 46 ID - 571 ER - TY - JOUR AD - 1 Clinic of Pediatric Surgery, Martin-Luther-University Halle-Wittenberg - Halle, Halle - Germany. AN - 25983099 AU - Höhne, S. AU - Milzsch, M. AU - Adams, J. AU - Kunze, C. AU - Finke, R. DA - May-Jun DO - 10.5301/tj.5000353 DP - NLM ET - 2015/05/20 IS - 3 LA - eng N1 - 2038-2529 Höhne, Sven Milzsch, Monika Adams, Johannes Kunze, Christian Finke, Rainer Case Reports Journal Article Review United States Tumori. 2015 May-Jun;101(3):249-56. doi: 10.5301/tj.5000353. Epub 2015 May 12. PY - 2015 SN - 0300-8916 SP - 249-56 ST - Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-year-old child T2 - Tumori TI - Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-year-old child VL - 101 ID - 572 ER - TY - JOUR AD - Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada M5S1A1. Department of Pathology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China. Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8. Chula GenePRO Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Chula GenePRO Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada M5S1A1; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Electronic address: paul.thorner@sickkids.ca. AN - 26014474 AU - Chami, R. AU - Yin, M. AU - Marrano, P. AU - Teerapakpinyo, C. AU - Shuangshoti, S. AU - Thorner, P. S. DA - Aug DO - 10.1016/j.humpath.2015.03.019 DP - NLM ET - 2015/05/28 IS - 8 LA - eng N1 - 1532-8392 Chami, Rose Yin, Minzhi Marrano, Paula Teerapakpinyo, Chinachote Shuangshoti, Shanop Thorner, Paul Scott Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2015 Aug;46(8):1153-61. doi: 10.1016/j.humpath.2015.03.019. Epub 2015 Apr 21. PY - 2015 SN - 0046-8177 SP - 1153-61 ST - BRAF mutations in pediatric metanephric tumors T2 - Hum Pathol TI - BRAF mutations in pediatric metanephric tumors VL - 46 ID - 573 ER - TY - JOUR AD - Departments of Pediatrics, University of California San Francisco, San Francisco, CA, USA. Departments of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. Departments of Neurology, University of California San Francisco, San Francisco, CA, USA. Departments of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. AN - 26023796 AU - Yao, T. W. AU - Zhang, J. AU - Prados, M. AU - Weiss, W. A. AU - James, C. D. AU - Nicolaides, T. C2 - PMC4673141 DA - Sep 8 DO - 10.18632/oncotarget.4014 DP - NLM ET - 2015/05/30 IS - 26 LA - eng N1 - 1949-2553 Yao, Tsun-Wen Zhang, Jie Prados, Michael Weiss, William A James, C David Nicolaides, Theodore U54 CA163155/CA/NCI NIH HHS/United States K08 NS065268/NS/NINDS NIH HHS/United States U01 CA176287/CA/NCI NIH HHS/United States U54CA163155/CA/NCI NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States U01 U01CA176287/CA/NCI NIH HHS/United States P30 CA082103/CA/NCI NIH HHS/United States R01NS080619/NS/NINDS NIH HHS/United States P30 CA060553/CA/NCI NIH HHS/United States K08NS065268/NS/NINDS NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States P50CA097257/CA/NCI NIH HHS/United States P30CA82103/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Oncotarget. 2015 Sep 8;6(26):21993-2005. doi: 10.18632/oncotarget.4014. PY - 2015 SN - 1949-2553 SP - 21993-2005 ST - EGFR blockade prevents glioma escape from BRAFV600E targeted therapy T2 - Oncotarget TI - EGFR blockade prevents glioma escape from BRAFV600E targeted therapy VL - 6 ID - 574 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, USA. Département de BioPathologie, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH-8091 Zurich, Switzerland. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. AN - 26061100 AU - Lee, S. AU - Barnhill, R. L. AU - Dummer, R. AU - Dalton, J. AU - Wu, J. AU - Pappo, A. AU - Bahrami, A. C2 - PMC4462090 DA - Jun 10 DO - 10.1038/srep11200 DP - NLM ET - 2015/06/11 LA - eng N1 - 2045-2322 Lee, Seungjae Barnhill, Raymond L Dummer, Reinhard Dalton, James Wu, Jianrong Pappo, Alberto Bahrami, Armita P30 CA021765/CA/NCI NIH HHS/United States P30CA021765/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PY - 2015 SN - 2045-2322 SP - 11200 ST - TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms T2 - Sci Rep TI - TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms VL - 5 ID - 575 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. AN - 26075701 AU - Rodrigues, L. N. AU - Correa, G. B. AU - Diniz, M. G. AU - Galvão, C. F. AU - Gomes, C. C. AU - Gomez, R. S. DA - Sep DO - 10.1111/jop.12337 DP - NLM ET - 2015/06/16 IS - 8 LA - eng N1 - 1600-0714 Rodrigues, Leonardo Nogueira Correa, GefterThiago Batista Diniz, Marina Gonçalves Galvão, Clarice Ferreira Gomes, Carolina Cavaliéri Gomez, Ricardo Santiago Journal Article Research Support, Non-U.S. Gov't Denmark J Oral Pathol Med. 2015 Sep;44(8):634-7. doi: 10.1111/jop.12337. Epub 2015 Jun 15. PY - 2015 SN - 0904-2512 SP - 634-7 ST - BRAF V600E and loss of heterozygosity assessment in benign oralneural tumours T2 - J Oral Pathol Med TI - BRAF V600E and loss of heterozygosity assessment in benign oralneural tumours VL - 44 ID - 576 ER - TY - JOUR AD - Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Department of Dermatology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Department of Dermatology, Medical School, Instituto i+12, Universidad Complutense, Hospital Universitario 12 de Octubre, Madrid, Spain. Department of Pathology, Hospital Virgen Macarena, Sevilla, Spain. Department of Pathology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jrperalto@salud.madrid.org. AN - 26083553 AU - Riveiro-Falkenbach, E. AU - Villanueva, C. A. AU - Garrido, M. C. AU - Ruano, Y. AU - García-Martín, R. M. AU - Godoy, E. AU - Ortiz-Romero, P. L. AU - Ríos-Martín, J. J. AU - Santos-Briz, A. AU - Rodríguez-Peralto, J. L. DA - Dec DO - 10.1038/jid.2015.229 DP - NLM ET - 2015/06/18 IS - 12 LA - eng N1 - 1523-1747 Riveiro-Falkenbach, Erica Villanueva, Cándida A Garrido, María C Ruano, Yolanda García-Martín, Rosa M Godoy, Elena Ortiz-Romero, Pablo L Ríos-Martín, Juan J Santos-Briz, Angel Rodríguez-Peralto, José L Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2015 Dec;135(12):3078-3085. doi: 10.1038/jid.2015.229. Epub 2015 Jun 17. PY - 2015 SN - 0022-202x SP - 3078-3085 ST - Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors T2 - J Invest Dermatol TI - Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors VL - 135 ID - 577 ER - TY - JOUR AD - Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. Université Paul-Sabatier, Toulouse, France. Department of Dermatology, Larrey Hospital, CHU de Toulouse, Toulouse, France. Department of Biopathology, Institut Bergonié, Bordeaux, France. AN - 26100036 AU - Leguellec, S. AU - Tournier, E. AU - Karanian, M. AU - Brousset, P. AU - Mazereeuw, J. AU - Coindre, J. M. AU - Lamant, L. DA - Jan DO - 10.1111/his.12759 DP - NLM ET - 2015/06/24 IS - 2 LA - eng N1 - 1365-2559 Leguellec, Sophie Tournier, Emilie Karanian, Marie Brousset, Pierre Mazereeuw, Juliette Coindre, Jean-Michel Lamant, Laurence Case Reports Journal Article England Histopathology. 2016 Jan;68(2):297-302. doi: 10.1111/his.12759. Epub 2015 Aug 7. PY - 2016 SN - 0309-0167 SP - 297-302 ST - Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases T2 - Histopathology TI - Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases VL - 68 ID - 578 ER - TY - JOUR AD - University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: aribas@mednet.ucla.edu. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. University of Zürich, Zürich, Switzerland. University Hospital Essen, Essen, Germany. The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Gustave Roussy and Paris-Sud University, Villejuif, France. Dana-Farber Cancer Institute, Boston, MA, USA. Sheba Medical Center, Tel Hashomer, Israel. New York University Cancer Institute, New York, NY, USA. University of Colorado Denver, Aurora, CO, USA. University of Arizona Cancer Center, Tucson, AZ, USA. Netherlands Cancer Institute, Amsterdam, Netherlands. Beverly Hills Cancer Center, Beverly Hills, CA, USA. Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Duke Cancer Institute, Durham, NC, USA. Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. University Medical Center, Mainz, Germany. Universitätsklinikum Tübingen, Tübingen, Germany. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. University of North Carolina, Chapel Hill, NC, USA. University of Pittsburgh, Pittsburgh, PA, USA. Memorial Sloan Kettering Cancer Center, New York, NY, USA. Merck & Co, Kenilworth, NJ, USA. University of California, San Francisco, San Francisco, CA, USA. AN - 26115796 AU - Ribas, A. AU - Puzanov, I. AU - Dummer, R. AU - Schadendorf, D. AU - Hamid, O. AU - Robert, C. AU - Hodi, F. S. AU - Schachter, J. AU - Pavlick, A. C. AU - Lewis, K. D. AU - Cranmer, L. D. AU - Blank, C. U. AU - O'Day, S. J. AU - Ascierto, P. A. AU - Salama, A. K. AU - Margolin, K. A. AU - Loquai, C. AU - Eigentler, T. K. AU - Gangadhar, T. C. AU - Carlino, M. S. AU - Agarwala, S. S. AU - Moschos, S. J. AU - Sosman, J. A. AU - Goldinger, S. M. AU - Shapira-Frommer, R. AU - Gonzalez, R. AU - Kirkwood, J. M. AU - Wolchok, J. D. AU - Eggermont, A. AU - Li, X. N. AU - Zhou, W. AU - Zernhelt, A. M. AU - Lis, J. AU - Ebbinghaus, S. AU - Kang, S. P. AU - Daud, A. DA - Aug DO - 10.1016/s1470-2045(15)00083-2 DP - NLM ET - 2015/06/28 IS - 8 LA - eng N1 - 1474-5488 Ribas, Antoni Puzanov, Igor Dummer, Reinhard Schadendorf, Dirk Hamid, Omid Robert, Caroline Hodi, F Stephen Schachter, Jacob Pavlick, Anna C Lewis, Karl D Cranmer, Lee D Blank, Christian U O'Day, Steven J Ascierto, Paolo A Salama, April K S Margolin, Kim A Loquai, Carmen Eigentler, Thomas K Gangadhar, Tara C Carlino, Matteo S Agarwala, Sanjiv S Moschos, Stergios J Sosman, Jeffrey A Goldinger, Simone M Shapira-Frommer, Ronnie Gonzalez, Rene Kirkwood, John M Wolchok, Jedd D Eggermont, Alexander Li, Xiaoyun Nicole Zhou, Wei Zernhelt, Adriane M Lis, Joy Ebbinghaus, Scot Kang, S Peter Daud, Adil P30 CA016086/CA/NCI NIH HHS/United States Clinical Trial, Phase II Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't England Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. PY - 2015 SN - 1470-2045 SP - 908-18 ST - Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial T2 - Lancet Oncol TI - Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial VL - 16 ID - 579 ER - TY - JOUR AD - Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tübingen, Calwerstr. 3, 72076, Tübingen, Germany. Department of Pathology, University of Tübingen, Tübingen, Germany. Pediatric Oncology, University Childrens Hospital, University of Tübingen, Tübingen, Germany. Department of Neurosurgery, University of Tuebingen, Tübingen, Germany. Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tübingen, Calwerstr. 3, 72076, Tübingen, Germany. jens.schittenhelm@med.uni-tuebingen.de. AN - 26115961 AU - Gierke, M. AU - Sperveslage, J. AU - Schwab, D. AU - Beschorner, R. AU - Ebinger, M. AU - Schuhmann, M. U. AU - Schittenhelm, J. DA - Jan DO - 10.1007/s00432-015-2006-2 DP - NLM ET - 2015/06/28 IS - 1 LA - eng N1 - 1432-1335 Gierke, Midea Sperveslage, Jan Schwab, David Beschorner, Rudi Ebinger, Martin Schuhmann, Martin U Schittenhelm, Jens Journal Article Research Support, Non-U.S. Gov't Germany J Cancer Res Clin Oncol. 2016 Jan;142(1):89-100. doi: 10.1007/s00432-015-2006-2. Epub 2015 Jun 27. PY - 2016 SN - 0171-5216 SP - 89-100 ST - Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification T2 - J Cancer Res Clin Oncol TI - Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification VL - 142 ID - 580 ER - TY - JOUR AD - Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. ICGEX Platform, Institut Curie, Paris, France. 1] ICGEX Platform, Institut Curie, Paris, France. [2] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. Unité de Génétique Somatique, Institut Curie, Paris, France. Centre Léon-Bérard, Laboratoire de Recherche Translationnelle Lyon, Lyon, France. Département de Pédiatrie, Institut Curie, Paris, France. Princess Margaret Cancer Centre, University Health Network; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA. Department of Biostatistics, University of Florida, Children's Oncology Group (COG), Gainesville, Florida, USA. 1] The Ohio State University College of Medicine, Columbus, Ohio, USA. [2] Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA. 1] Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA. [2] Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA. [3] Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA. Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA. Translational Cancer Therapeutics Laboratory, Cancer Research UK, London, UK. 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. 1] Department of Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. [2] German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. [3] Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany. [4] Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany. Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA. 1] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. [2] Département de Pédiatrie, Institut Curie, Paris, France. [3] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. AN - 26121087 AU - Eleveld, T. F. AU - Oldridge, D. A. AU - Bernard, V. AU - Koster, J. AU - Colmet Daage, L. AU - Diskin, S. J. AU - Schild, L. AU - Bentahar, N. B. AU - Bellini, A. AU - Chicard, M. AU - Lapouble, E. AU - Combaret, V. AU - Legoix-Né, P. AU - Michon, J. AU - Pugh, T. J. AU - Hart, L. S. AU - Rader, J. AU - Attiyeh, E. F. AU - Wei, J. S. AU - Zhang, S. AU - Naranjo, A. AU - Gastier-Foster, J. M. AU - Hogarty, M. D. AU - Asgharzadeh, S. AU - Smith, M. A. AU - Guidry Auvil, J. M. AU - Watkins, T. B. AU - Zwijnenburg, D. A. AU - Ebus, M. E. AU - van Sluis, P. AU - Hakkert, A. AU - van Wezel, E. AU - van der Schoot, C. E. AU - Westerhout, E. M. AU - Schulte, J. H. AU - Tytgat, G. A. AU - Dolman, M. E. AU - Janoueix-Lerosey, I. AU - Gerhard, D. S. AU - Caron, H. N. AU - Delattre, O. AU - Khan, J. AU - Versteeg, R. AU - Schleiermacher, G. AU - Molenaar, J. J. AU - Maris, J. M. C2 - PMC4775079 C6 - NIHMS757254 DA - Aug DO - 10.1038/ng.3333 DP - NLM ET - 2015/06/30 IS - 8 LA - eng N1 - 1546-1718 Eleveld, Thomas F Oldridge, Derek A Bernard, Virginie Koster, Jan Colmet Daage, Léo Diskin, Sharon J Schild, Linda Bentahar, Nadia Bessoltane Bellini, Angela Chicard, Mathieu Lapouble, Eve Combaret, Valérie Legoix-Né, Patricia Michon, Jean Pugh, Trevor J Hart, Lori S Rader, JulieAnn Attiyeh, Edward F Wei, Jun S Zhang, Shile Naranjo, Arlene Gastier-Foster, Julie M Hogarty, Michael D Asgharzadeh, Shahab Smith, Malcolm A Guidry Auvil, Jaime M Watkins, Thomas B K Zwijnenburg, Danny A Ebus, Marli E van Sluis, Peter Hakkert, Anne van Wezel, Esther van der Schoot, C Ellen Westerhout, Ellen M Schulte, Johannes H Tytgat, Godelieve A Dolman, M Emmy M Janoueix-Lerosey, Isabelle Gerhard, Daniela S Caron, Huib N Delattre, Olivier Khan, Javed Versteeg, Rogier Schleiermacher, Gudrun Molenaar, Jan J Maris, John M CA98543/CA/NCI NIH HHS/United States F30 CA192831/CA/NCI NIH HHS/United States RC1 MD004418/MD/NIMHD NIH HHS/United States U10 CA098413/CA/NCI NIH HHS/United States RC1MD004418/MD/NIMHD NIH HHS/United States HHSN261200800001E/PHS HHS/International U10 CA098543/CA/NCI NIH HHS/United States HHSN261200800001C/RC/CCR NIH HHS/United States CA98413/CA/NCI NIH HHS/United States T32 HG000046/HG/NHGRI NIH HHS/United States U10 CA180886/CA/NCI NIH HHS/United States HHSN261200800001E/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Nat Genet. 2015 Aug;47(8):864-71. doi: 10.1038/ng.3333. Epub 2015 Jun 29. PY - 2015 SN - 1061-4036 (Print) 1061-4036 SP - 864-71 ST - Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations T2 - Nat Genet TI - Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations VL - 47 ID - 581 ER - TY - JOUR AD - Paediatric Solid Tumour Biology and Therapeutics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Paediatric Solid Tumour Biology and Therapeutics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Louis.Chesler@icr.ac.uk. AN - 26122839 AU - Tucker, E. R. AU - Danielson, L. S. AU - Innocenti, P. AU - Chesler, L. C2 - PMC4539575 C6 - EMS62962 DA - Jul 15 DO - 10.1158/0008-5472.Can-14-3817 DP - NLM ET - 2015/07/01 IS - 14 LA - eng N1 - 1538-7445 Tucker, Elizabeth R Danielson, Laura S Innocenti, Paolo Chesler, Louis A14610/Cancer Research UK/United Kingdom G1100386/Medical Research Council/United Kingdom Journal Article Research Support, Non-U.S. Gov't Review Cancer Res. 2015 Jul 15;75(14):2770-4. doi: 10.1158/0008-5472.CAN-14-3817. Epub 2015 Jun 29. PY - 2015 SN - 0008-5472 (Print) 0008-5472 SP - 2770-4 ST - Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic T2 - Cancer Res TI - Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic VL - 75 ID - 582 ER - TY - JOUR AD - Programa de Mestrado em Genética e Programa de Mestrado em Ciências Ambientais e Saúde, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil rcsilvaf@gmail.com. Programa de Mestrado em Genética e Programa de Mestrado em Ciências Ambientais e Saúde, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil. Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brasil. Hospital Araújo Jorge, Associação de Combate ao Câncer em Goiás, Goiânia, GO, Brasil. Departamento de Biologia, Universidade Estadual de Goiás, Morrinhos, GO, Brasil. AN - 26125698 AU - da Silva, R. C. AU - de Paula, H. S. AU - Leal, C. B. AU - Cunha, B. C. AU - de Paula, E. C. AU - Alencar, R. C. AU - Meneghini, A. J. AU - Silva, A. M. AU - Gontijo, A. P. AU - Wastowski, I. J. AU - Saddi, V. A. DA - May 12 DO - 10.4238/2015.May.12.9 DP - NLM ET - 2015/07/01 IS - 2 LA - eng N1 - 1676-5680 da Silva, R C de Paula, H S C Leal, C B Q S Cunha, B C R de Paula, E C Alencar, R C G Meneghini, A J Silva, A M T C Gontijo, A P Wastowski, I J Saddi, V A Journal Article Research Support, Non-U.S. Gov't Brazil Genet Mol Res. 2015 May 12;14(2):5065-75. doi: 10.4238/2015.May.12.9. PY - 2015 SN - 1676-5680 SP - 5065-75 ST - BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas T2 - Genet Mol Res TI - BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas VL - 14 ID - 583 ER - TY - JOUR AD - Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Cosenza, Italy. Department of Medicine-DIMED, University of Padova, Padova, Italy. Department of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy. Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Rome, Italy. Research Center, San Pietro Hospital-Fatebenefratelli, Rome, Italy. AN - 26131713 AU - Chimento, A. AU - Sirianni, R. AU - Casaburi, I. AU - Zolea, F. AU - Rizza, P. AU - Avena, P. AU - Malivindi, R. AU - De Luca, A. AU - Campana, C. AU - Martire, E. AU - Domanico, F. AU - Fallo, F. AU - Carpinelli, G. AU - Cerquetti, L. AU - Amendola, D. AU - Stigliano, A. AU - Pezzi, V. C2 - PMC4662484 DA - Aug 7 DO - 10.18632/oncotarget.4241 DP - NLM ET - 2015/07/02 IS - 22 LA - eng N1 - 1949-2553 Chimento, Adele Sirianni, Rosa Casaburi, Ivan Zolea, Fabiana Rizza, Pietro Avena, Paola Malivindi, Rocco De Luca, Arianna Campana, Carmela Martire, Emilia Domanico, Francesco Fallo, Francesco Carpinelli, Giulia Cerquetti, Lidia Amendola, Donatella Stigliano, Antonio Pezzi, Vincenzo Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Aug 7;6(22):19190-203. doi: 10.18632/oncotarget.4241. PY - 2015 SN - 1949-2553 SP - 19190-203 ST - GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo T2 - Oncotarget TI - GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo VL - 6 ID - 584 ER - TY - JOUR AD - Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Department of Pathology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Department of Pathology, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. AN - 26139079 AU - Lee, J. C. AU - Wu, J. M. AU - Liau, J. Y. AU - Huang, H. Y. AU - Lo, C. Y. AU - Jan, I. S. AU - Hornick, J. L. AU - Qian, X. DA - Aug DO - 10.1002/cncy.21558 DP - NLM ET - 2015/07/04 IS - 8 LA - eng N1 - 1934-6638 Lee, Jen-Chieh Wu, Jiann-Ming Liau, Jau-Yu Huang, Hsuan-Ying Lo, Cheng-Yu Jan, I-Shiow Hornick, Jason L Qian, Xiaohua Journal Article United States Cancer Cytopathol. 2015 Aug;123(8):495-504. doi: 10.1002/cncy.21558. Epub 2015 Jul 2. PY - 2015 SN - 1934-662x SP - 495-504 ST - Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis T2 - Cancer Cytopathol TI - Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis VL - 123 ID - 585 ER - TY - JOUR AD - Department of Anatomical Pathology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. Department of Medical Services, Electron Microscopy Laboratory, Institute of Pathology, Ministry of Public Health, Bangkok, Thailand. Department of Medical Oncology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. AN - 26179668 AU - Loharamtaweethong, K. AU - Puripat, N. AU - Aoonjai, N. AU - Sutepvarnon, A. AU - Bandidwattanawong, C. DA - Mar DO - 10.1111/his.12779 DP - NLM ET - 2015/07/17 IS - 4 LA - eng N1 - 1365-2559 Loharamtaweethong, Kongsak Puripat, Napaporn Aoonjai, Nadda Sutepvarnon, Apisada Bandidwattanawong, Chanyoot Case Reports Journal Article England Histopathology. 2016 Mar;68(4):603-7. doi: 10.1111/his.12779. Epub 2015 Sep 2. PY - 2016 SN - 0309-0167 SP - 603-7 ST - Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum T2 - Histopathology TI - Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum VL - 68 ID - 586 ER - TY - JOUR AD - *Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY Divisions of †Cardiology ‡Hematology-Oncology, All Children's Hospital, St Petersburg, FL. AN - 26181424 AU - Modak, S. AU - Asante-Korang, A. AU - Steinherz, L. J. AU - Grana, N. DA - Aug DO - 10.1097/mph.0000000000000364 DP - NLM ET - 2015/07/17 IS - 6 LA - eng N1 - 1536-3678 Modak, Shakeel Asante-Korang, Alfred Steinherz, Laurel J Grana, Nanette Case Reports Journal Article United States J Pediatr Hematol Oncol. 2015 Aug;37(6):e381-3. doi: 10.1097/MPH.0000000000000364. PY - 2015 SN - 1077-4114 SP - e381-3 ST - Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma T2 - J Pediatr Hematol Oncol TI - Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma VL - 37 ID - 587 ER - TY - JOUR AD - Inserm, U1078, Brest, F-29200, France. arnaud.uguen@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. arnaud.uguen@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. arnaud.uguen@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. matthieu.talagas@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. matthieu.talagas@chu-brest.fr. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. matthieu.talagas@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. sebastian.costa@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. laura.samaison@gmail.com. Université Européenne de Bretagne, Rennes, France. laura.samaison@gmail.com. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. laura.samaison@gmail.com. CHRU Brest, Laboratoire de Génétique Moléculaire et d'Histocompatibilité, Brest, F-29220, France. laure.paule@chu-brest.fr. Inserm, CIC1412, Brest, F-29200, France. zarrin.alavi@chu-brest.fr. Inserm, U1078, Brest, F-29200, France. marc.debraekeleer@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. marc.debraekeleer@chu-brest.fr. CHRU Brest, Laboratoire de Cytogénétique et Biologie de la Reproduction, Brest, F-29220, France. marc.debraekeleer@chu-brest.fr. Inserm, U1078, Brest, F-29200, France. cedric.lemarechal@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. cedric.lemarechal@chu-brest.fr. CHRU Brest, Laboratoire de Génétique Moléculaire et d'Histocompatibilité, Brest, F-29220, France. cedric.lemarechal@chu-brest.fr. Department of Molecular Genetics and Histocompatibily, University Hospital Morvan, 2, Avenue Foch 29609, Brest, France. cedric.lemarechal@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. pascale.marcorelles@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. pascale.marcorelles@chu-brest.fr. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. pascale.marcorelles@chu-brest.fr. Department of Pathology, University Hospital Morvan, 2, Avenue Foch 29609, Brest, France. pascale.marcorelles@chu-brest.fr. AN - 26204954 AU - Uguen, A. AU - Talagas, M. AU - Costa, S. AU - Samaison, L. AU - Paule, L. AU - Alavi, Z. AU - De Braekeleer, M. AU - Le Marechal, C. AU - Marcorelles, P. C2 - PMC4513673 DA - Jul 25 DO - 10.1186/s13000-015-0359-0 DP - NLM ET - 2015/07/25 LA - eng N1 - 1746-1596 Uguen, Arnaud Talagas, Matthieu Costa, Sebastian Samaison, Laura Paule, Laure Alavi, Zarrin De Braekeleer, Marc Le Marechal, Cédric Marcorelles, Pascale Journal Article Research Support, Non-U.S. Gov't Diagn Pathol. 2015 Jul 25;10:121. doi: 10.1186/s13000-015-0359-0. PY - 2015 SN - 1746-1596 SP - 121 ST - NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas T2 - Diagn Pathol TI - NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas VL - 10 ID - 588 ER - TY - JOUR AD - From the Bristol Genetics Laboratory, Pathology Sciences, Southmead Hospital, Bristol (CF, AP, CW, MG, MW); Brain Tumour Research Group, Institute of Clinical Neurosciences, Southmead Hospital (HPE, AS, CP, HRH, HW, KMK); Department of Paediatric Oncology, Bristol Royal Hospital for Children (SL); and Applied Statistics Group, University of the West of England (PW), Bristol, UK; and Department of Neuropathology, Institute of Pathology, University of Heidelberg and CCU Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. AN - 26222501 AU - Faulkner, C. AU - Ellis, H. P. AU - Shaw, A. AU - Penman, C. AU - Palmer, A. AU - Wragg, C. AU - Greenslade, M. AU - Haynes, H. R. AU - Williams, H. AU - Lowis, S. AU - White, P. AU - Williams, M. AU - Capper, D. AU - Kurian, K. M. C2 - PMC4554227 DA - Sep DO - 10.1097/nen.0000000000000226 DP - NLM ET - 2015/07/30 IS - 9 LA - eng N1 - 1554-6578 Faulkner, Claire Ellis, Hayley Patricia Shaw, Abigail Penman, Catherine Palmer, Abigail Wragg, Christopher Greenslade, Mark Haynes, Harry Russell Williams, Hannah Lowis, Stephen White, Paul Williams, Maggie Capper, David Kurian, Kathreena Mary Journal Article Research Support, Non-U.S. Gov't J Neuropathol Exp Neurol. 2015 Sep;74(9):867-72. doi: 10.1097/NEN.0000000000000226. PY - 2015 SN - 0022-3069 (Print) 0022-3069 SP - 867-72 ST - BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum T2 - J Neuropathol Exp Neurol TI - BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum VL - 74 ID - 589 ER - TY - JOUR AD - Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA. Electronic address: patild@ccf.org. Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA; Department of Molecular Genetics, Cleveland Clinic and Lerner Research Institute, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA. AN - 26297068 AU - Patil, D. T. AU - Rubin, B. P. DA - Sep DO - 10.1016/j.path.2015.05.006 DP - NLM ET - 2015/08/25 IS - 3 LA - eng N1 - 1875-9157 Patil, Deepa T Rubin, Brian P Journal Article Review United States Surg Pathol Clin. 2015 Sep;8(3):515-24. doi: 10.1016/j.path.2015.05.006. Epub 2015 Jul 7. PY - 2015 SN - 1875-9157 SP - 515-24 ST - Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? T2 - Surg Pathol Clin TI - Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? VL - 8 ID - 590 ER - TY - JOUR AD - Véronique Minard-Colin, Laurence Brugières, Anne Auperin, Marie-Cécile Le Deley, and Catherine Patte, Institut Gustave Roussy, Villejuif; Martine Raphael, Centre National de la Recherche Scientifique UMR 8126, Université Paris Sud; Elizabeth Macintyre, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, and Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris; Laurence Lamant, Institut Universitaire du Cancer Toulouse Oncopole and Université Paul-Sabatier, Toulouse, France; Alfred Reiter, Wilhelm Woessmann, and Christine Damm-Welk, Justus-Liebig-University Giessen, Giessen; Birgit Burkhardt, Children University Hospital, Münster; Martin Zimmerman, Medizinische Hochschule, Hannover; Wolfram Klapper, Christian-Albrechts-University Kiel, Kiel, Germany; Mitchell S. Cairo, New York Medical College, Valhalla, NY; Thomas G. Gross, National Cancer Institute, Bethesda, MD; John T. Sandlund, St Jude Children's Research Hospital and University of Tennessee Health Science Center, College of Medicine, Memphis, TN; Sherrie L. Perkins, University of Utah Health Sciences, Salt Lake City, UT; Denise Williams, Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom; Marta Pillon and Angelo Rosolen, University of Padova, Padova; Lara Mussolin, Istituto di Ricerca Pediatrico-Fondazione Cittàdella Speranza and University of Padua, Padua, Italy; Keizo Horibe, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; and Hélène A. Poirel, Center for Human Genetics, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Belgium, Brussels. Véronique Minard-Colin, Laurence Brugières, Anne Auperin, Marie-Cécile Le Deley, and Catherine Patte, Institut Gustave Roussy, Villejuif; Martine Raphael, Centre National de la Recherche Scientifique UMR 8126, Université Paris Sud; Elizabeth Macintyre, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, and Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris; Laurence Lamant, Institut Universitaire du Cancer Toulouse Oncopole and Université Paul-Sabatier, Toulouse, France; Alfred Reiter, Wilhelm Woessmann, and Christine Damm-Welk, Justus-Liebig-University Giessen, Giessen; Birgit Burkhardt, Children University Hospital, Münster; Martin Zimmerman, Medizinische Hochschule, Hannover; Wolfram Klapper, Christian-Albrechts-University Kiel, Kiel, Germany; Mitchell S. Cairo, New York Medical College, Valhalla, NY; Thomas G. Gross, National Cancer Institute, Bethesda, MD; John T. Sandlund, St Jude Children's Research Hospital and University of Tennessee Health Science Center, College of Medicine, Memphis, TN; Sherrie L. Perkins, University of Utah Health Sciences, Salt Lake City, UT; Denise Williams, Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom; Marta Pillon and Angelo Rosolen, University of Padova, Padova; Lara Mussolin, Istituto di Ricerca Pediatrico-Fondazione Cittàdella Speranza and University of Padua, Padua, Italy; Keizo Horibe, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; and Hélène A. Poirel, Center for Human Genetics, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Belgium, Brussels. catherine.patte@gustaveroussy.fr. AN - 26304908 AU - Minard-Colin, V. AU - Brugières, L. AU - Reiter, A. AU - Cairo, M. S. AU - Gross, T. G. AU - Woessmann, W. AU - Burkhardt, B. AU - Sandlund, J. T. AU - Williams, D. AU - Pillon, M. AU - Horibe, K. AU - Auperin, A. AU - Le Deley, M. C. AU - Zimmerman, M. AU - Perkins, S. L. AU - Raphael, M. AU - Lamant, L. AU - Klapper, W. AU - Mussolin, L. AU - Poirel, H. A. AU - Macintyre, E. AU - Damm-Welk, C. AU - Rosolen, A. AU - Patte, C. C2 - PMC4979194 online at www.jco.org. Author contributions are found at the end of this article. DA - Sep 20 DO - 10.1200/jco.2014.59.5827 DP - NLM ET - 2015/08/26 IS - 27 LA - eng N1 - 1527-7755 Minard-Colin, Véronique Brugières, Laurence Reiter, Alfred Cairo, Mitchell S Gross, Thomas G Woessmann, Wilhelm Burkhardt, Birgit Sandlund, John T Williams, Denise Pillon, Marta Horibe, Keizo Auperin, Anne Le Deley, Marie-Cécile Zimmerman, Martin Perkins, Sherrie L Raphael, Martine Lamant, Laurence Klapper, Wolfram Mussolin, Lara Poirel, Hélène A Macintyre, Elizabeth Damm-Welk, Christine Rosolen, Angelo Patte, Catherine Journal Article Review J Clin Oncol. 2015 Sep 20;33(27):2963-74. doi: 10.1200/JCO.2014.59.5827. Epub 2015 Aug 24. PY - 2015 SN - 0732-183X (Print) 0732-183x SP - 2963-74 ST - Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead T2 - J Clin Oncol TI - Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead VL - 33 ID - 591 ER - TY - JOUR AD - Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Department of Pediatrics, University of California School of Medicine, San Francisco, CA; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA; Division of Pediatric Hematology and Oncology, University of Utah, Salt Lake City, UT; Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN; and. Department of Microbiology, New York University Langone Medical Center, New York, NY. AN - 26324703 AU - Jones, C. L. AU - Gearheart, C. M. AU - Fosmire, S. AU - Delgado-Martin, C. AU - Evensen, N. A. AU - Bride, K. AU - Waanders, A. J. AU - Pais, F. AU - Wang, J. AU - Bhatla, T. AU - Bitterman, D. S. AU - de Rijk, S. R. AU - Bourgeois, W. AU - Dandekar, S. AU - Park, E. AU - Burleson, T. M. AU - Madhusoodhan, P. P. AU - Teachey, D. T. AU - Raetz, E. A. AU - Hermiston, M. L. AU - Müschen, M. AU - Loh, M. L. AU - Hunger, S. P. AU - Zhang, J. AU - Garabedian, M. J. AU - Porter, C. C. AU - Carroll, W. L. C2 - PMC4635116 DA - Nov 5 DO - 10.1182/blood-2015-04-639138 DP - NLM ET - 2015/09/02 IS - 19 LA - eng N1 - 1528-0020 Jones, Courtney L Gearheart, Christy M Fosmire, Susan Delgado-Martin, Cristina Evensen, Nikki A Bride, Karen Waanders, Angela J Pais, Faye Wang, Jinhua Bhatla, Teena Bitterman, Danielle S de Rijk, Simone R Bourgeois, Wallace Dandekar, Smita Park, Eugene Burleson, Tamara M Madhusoodhan, Pillai Pallavi Teachey, David T Raetz, Elizabeth A Hermiston, Michelle L Müschen, Markus Loh, Mignon L Hunger, Stephen P Zhang, Jinghui Garabedian, Michael J Porter, Christopher C Carroll, William L R01 CA172385/CA/NCI NIH HHS/United States P30 CA016087/CA/NCI NIH HHS/United States 101880/Wellcome Trust/United Kingdom 2P30CA016087-33/CA/NCI NIH HHS/United States T32 GM008497/GM/NIGMS NIH HHS/United States R01 CA157644/CA/NCI NIH HHS/United States T32 CA082086/CA/NCI NIH HHS/United States P30 CA046934/CA/NCI NIH HHS/United States T32 GM066704/GM/NIGMS NIH HHS/United States R01 CA140729/CA/NCI NIH HHS/United States 1R01 CA172385-01A1/CA/NCI NIH HHS/United States U10 CA180886/CA/NCI NIH HHS/United States Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Blood. 2015 Nov 5;126(19):2202-12. doi: 10.1182/blood-2015-04-639138. Epub 2015 Aug 31. PY - 2015 SN - 0006-4971 (Print) 0006-4971 SP - 2202-12 ST - MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia T2 - Blood TI - MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia VL - 126 ID - 592 ER - TY - JOUR AD - Inserm, UMR1037 CRCT, F-31000 Toulouse, France. Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France. CNRS, ERL5294 CRCT, F-31000 Toulouse, France. Phenotyping Service, INSERM-US006 ANEXPLO/CREFRE, Toulouse, France. Université Toulouse III - Paul Sabatier, Toulouse, France. INSERM/UPS - US006/CREFRE, Service d'Histopathologie, CHU Purpan, Toulouse, France. INSERM UMRS 1185, Faculté de Médecine Paris Sud, Le Kremlin-Bicêtre, France. Department of Pathology, IUCT, Toulouse, France. European Research Initiative on ALK-related malignancies (ERIA). Institut Necker Enfants-Malades, INSERM U1151-CNRS UMR 8253, Paris, France. AN - 26338968 AU - Mitou, G. AU - Frentzel, J. AU - Desquesnes, A. AU - Le Gonidec, S. AU - AlSaati, T. AU - Beau, I. AU - Lamant, L. AU - Meggetto, F. AU - Espinos, E. AU - Codogno, P. AU - Brousset, P. AU - Giuriato, S. C2 - PMC4745787 DA - Oct 6 DO - 10.18632/oncotarget.4999 DP - NLM ET - 2015/09/05 IS - 30 LA - eng N1 - 1949-2553 Mitou, Géraldine Frentzel, Julie Desquesnes, Aurore Le Gonidec, Sophie AlSaati, Talal Beau, Isabelle Lamant, Laurence Meggetto, Fabienne Espinos, Estelle Codogno, Patrice Brousset, Pierre Giuriato, Sylvie Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Oct 6;6(30):30149-64. doi: 10.18632/oncotarget.4999. PY - 2015 SN - 1949-2553 SP - 30149-64 ST - Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma T2 - Oncotarget TI - Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma VL - 6 ID - 593 ER - TY - JOUR AD - Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. teicherba@mail.nih.gov. Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. Molecular Pharmacology Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. AN - 26351324 AU - Teicher, B. A. AU - Polley, E. AU - Kunkel, M. AU - Evans, D. AU - Silvers, T. AU - Delosh, R. AU - Laudeman, J. AU - Ogle, C. AU - Reinhart, R. AU - Selby, M. AU - Connelly, J. AU - Harris, E. AU - Monks, A. AU - Morris, J. C2 - PMC4636476 C6 - NIHMS718413 to report. DA - Nov DO - 10.1158/1535-7163.Mct-15-0074 DP - NLM ET - 2015/09/10 IS - 11 LA - eng N1 - 1538-8514 Teicher, Beverly A Polley, Eric Kunkel, Mark Evans, David Silvers, Thomas Delosh, Rene Laudeman, Julie Ogle, Chad Reinhart, Russell Selby, Michael Connelly, John Harris, Erik Monks, Anne Morris, Joel HHSN261200800001C/RC/CCR NIH HHS/United States HHSN261200800001E/CA/NCI NIH HHS/United States Z99 CA999999/Intramural NIH HHS/United States HHSN261200800001E/PHS HHS/United States Journal Article Research Support, N.I.H., Extramural Mol Cancer Ther. 2015 Nov;14(11):2452-62. doi: 10.1158/1535-7163.MCT-15-0074. Epub 2015 Sep 8. PY - 2015 SN - 1535-7163 (Print) 1535-7163 SP - 2452-62 ST - Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression T2 - Mol Cancer Ther TI - Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression VL - 14 ID - 594 ER - TY - JOUR AD - Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (D.B., C.M.S., M.R.M.); Department of Plastic Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (L.J.G.); Department of Radiology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (A.P.); Division of Plastic and Reconstructive Surgery, NorthShore University HealthSystem, Northbrook, Illinois (B.S.B., D.J., V.R.); Division of Molecular Genomic Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (M.N.); Department of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (Y.K.); Department of Pediatrics, Weill Cornell Medical College, New York, New York (Y.K.). AN - 26354928 AU - Basu, D. AU - Salgado, C. M. AU - Bauer, B. S. AU - Johnson, D. AU - Rundell, V. AU - Nikiforova, M. AU - Khakoo, Y. AU - Gunwaldt, L. J. AU - Panigrahy, A. AU - Reyes-Múgica, M. C2 - PMC4799680 DA - Apr DO - 10.1093/neuonc/nov184 DP - NLM ET - 2015/09/12 IS - 4 LA - eng N1 - 1523-5866 Basu, Dipanjan Salgado, Cláudia M Bauer, Bruce S Johnson, Donald Rundell, Veronica Nikiforova, Marina Khakoo, Yasmin Gunwaldt, Lorelei J Panigrahy, Ashok Reyes-Múgica, Miguel P30 CA008748/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Neuro Oncol. 2016 Apr;18(4):528-37. doi: 10.1093/neuonc/nov184. Epub 2015 Sep 9. PY - 2016 SN - 1522-8517 (Print) 1522-8517 SP - 528-37 ST - Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway T2 - Neuro Oncol TI - Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway VL - 18 ID - 595 ER - TY - JOUR AD - Department of Pediatrics, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Dermatology, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Miyagi, Japan. AN - 26360803 AU - Watanabe, Y. AU - Shido, K. AU - Niihori, T. AU - Niizuma, H. AU - Katata, Y. AU - Iizuka, C. AU - Oba, D. AU - Moriya, K. AU - Saito-Nanjo, Y. AU - Onuma, M. AU - Rikiishi, T. AU - Sasahara, Y. AU - Watanabe, M. AU - Aiba, S. AU - Saito, R. AU - Sonoda, Y. AU - Tominaga, T. AU - Aoki, Y. AU - Kure, S. DA - Jan DO - 10.1002/ajmg.a.37376 DP - NLM ET - 2015/09/12 IS - 1 LA - eng N1 - 1552-4833 Watanabe, Yuko Shido, Kosuke Niihori, Tetsuya Niizuma, Hidetaka Katata, Yu Iizuka, Chie Oba, Daiju Moriya, Kunihiko Saito-Nanjo, Yuka Onuma, Masaei Rikiishi, Takeshi Sasahara, Yoji Watanabe, Mika Aiba, Setsuya Saito, Ryuta Sonoda, Yukihiko Tominaga, Teiji Aoki, Yoko Kure, Shigeo Journal Article Research Support, Non-U.S. Gov't United States Am J Med Genet A. 2016 Jan;170A(1):189-94. doi: 10.1002/ajmg.a.37376. Epub 2015 Sep 11. PY - 2016 SN - 1552-4825 SP - 189-94 ST - Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities T2 - Am J Med Genet A TI - Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities VL - 170a ID - 596 ER - TY - JOUR AD - 1 Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. 2 Department of Pathology, Texas Children's Hospital, Houston, TX, USA. 3 Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. 4 Department of Pediatric Medicine, Texas Children's Hospital, Houston, TX, USA. 5 Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX, USA. AN - 26366474 AU - Ballester, L. Y. AU - Sarabia, S. F. AU - Sayeed, H. AU - Patel, N. AU - Baalwa, J. AU - Athanassaki, I. AU - Hernandez, J. A. AU - Fang, E. AU - Quintanilla, N. M. AU - Roy, A. AU - López-Terrada, D. H. DA - Mar-Apr DO - 10.2350/15-05-1638-oa.1 DP - NLM ET - 2015/09/15 IS - 2 LA - eng N1 - Ballester, Leomar Y Sarabia, Stephen F Sayeed, Hadi Patel, Nimesh Baalwa, Joshua Athanassaki, Ioanna Hernandez, Jose A Fang, Erica Quintanilla, Norma M Roy, Angshumoy López-Terrada, Dolores H Journal Article United States Pediatr Dev Pathol. 2016 Mar-Apr;19(2):94-100. doi: 10.2350/15-05-1638-OA.1. Epub 2015 Sep 14. PY - 2016 SN - 1093-5266 (Print) 1093-5266 SP - 94-100 ST - Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions T2 - Pediatr Dev Pathol TI - Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions VL - 19 ID - 597 ER - TY - JOUR AD - Division of Experimental Medicine, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. Department of Experimental Pathology, Immunology and Microbiology, American University Of Beirut, Beirut, Lebanon. Departments of Pediatrics and Human Genetics, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. Division of Theoretical Bioinformatics, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Division of Pediatric Neurooncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany. McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada. Department of Neurosurgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary. Department of Neurosurgery, Montreal Children's Hospital and McGill University Health Centre, Montreal, Canada. Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom. Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Division of Pediatric Hematology-Oncology and The Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada. Department of Pathology, Montreal Children's Hospital and McGill University Health Centre, Montreal, Canada. Institute of Neuropathology, University Hospital Münster, Münster, Germany. AN - 26378811 AU - Fontebasso, A. M. AU - Shirinian, M. AU - Khuong-Quang, D. A. AU - Bechet, D. AU - Gayden, T. AU - Kool, M. AU - De Jay, N. AU - Jacob, K. AU - Gerges, N. AU - Hutter, B. AU - Şeker-Cin, H. AU - Witt, H. AU - Montpetit, A. AU - Brunet, S. AU - Lepage, P. AU - Bourret, G. AU - Klekner, A. AU - Bognár, L. AU - Hauser, P. AU - Garami, M. AU - Farmer, J. P. AU - Montes, J. L. AU - Atkinson, J. AU - Lambert, S. AU - Kwan, T. AU - Korshunov, A. AU - Tabori, U. AU - Collins, V. P. AU - Albrecht, S. AU - Faury, D. AU - Pfister, S. M. AU - Paulus, W. AU - Hasselblatt, M. AU - Jones, D. T. AU - Jabado, N. C2 - PMC4741644 DA - Oct 13 DO - 10.18632/oncotarget.5571 DP - NLM ET - 2015/09/18 IS - 31 LA - eng N1 - 1949-2553 Fontebasso, Adam M Shirinian, Margret Khuong-Quang, Dong-Anh Bechet, Denise Gayden, Tenzin Kool, Marcel De Jay, Nicolas Jacob, Karine Gerges, Noha Hutter, Barbara Şeker-Cin, Huriye Witt, Hendrik Montpetit, Alexandre Brunet, Sébastien Lepage, Pierre Bourret, Geneviève Klekner, Almos Bognár, László Hauser, Peter Garami, Miklós Farmer, Jean-Pierre Montes, Jose-Luis Atkinson, Jeffrey Lambert, Sally Kwan, Tony Korshunov, Andrey Tabori, Uri Collins, V Peter Albrecht, Steffen Faury, Damien Pfister, Stefan M Paulus, Werner Hasselblatt, Martin Jones, David T W Jabado, Nada Comparative Study Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Oct 13;6(31):31844-56. doi: 10.18632/oncotarget.5571. PY - 2015 SN - 1949-2553 SP - 31844-56 ST - Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age T2 - Oncotarget TI - Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age VL - 6 ID - 598 ER - TY - JOUR AD - POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. asingh@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. asingh@ucalgary.ca. POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. ruan@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. ruan@ucalgary.ca. Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. trippet1@MSKCC.org. POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. a.narendran@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. a.narendran@ucalgary.ca. AN - 26384788 AU - Singh, A. AU - Ruan, Y. AU - Tippett, T. AU - Narendran, A. C2 - PMC4575431 DA - Sep 18 DO - 10.1186/s13046-015-0222-x DP - NLM ET - 2015/09/20 IS - 1 LA - eng N1 - 1756-9966 Singh, Anjali Ruan, Yibing Tippett, Tanya Narendran, Aru Journal Article Research Support, Non-U.S. Gov't J Exp Clin Cancer Res. 2015 Sep 18;34(1):104. doi: 10.1186/s13046-015-0222-x. PY - 2015 SN - 0392-9078 (Print) 0392-9078 SP - 104 ST - Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells T2 - J Exp Clin Cancer Res TI - Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells VL - 34 ID - 599 ER - TY - JOUR AD - Valley Radiotherapy Associates, 1500 Rosecrans Avenue, Manhattan Beach, CA, 90266, USA. tinadasgupta2006@gmail.com. Department of Laboratory Medicine, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Radiation Oncology, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Pediatrics, University of California, San Francisco, San Francisco, CA, 94143, USA. Department of Neurology, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Radiotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. AN - 26384810 AU - Dasgupta, T. AU - Olow, A. K. AU - Yang, X. AU - Hashizume, R. AU - Nicolaides, T. P. AU - Tom, M. AU - Aoki, Y. AU - Berger, M. S. AU - Weiss, W. A. AU - Stalpers, L. J. AU - Prados, M. AU - James, C. D. AU - Mueller, S. AU - Haas-Kogan, D. A. C2 - PMC4907264 C6 - NIHMS792232 DA - Feb DO - 10.1007/s11060-015-1939-2 DP - NLM ET - 2015/09/20 IS - 3 LA - eng N1 - 1573-7373 Dasgupta, Tina Olow, Aleksandra K Yang, Xiaodong Hashizume, Rintaro Nicolaides, Theodore P Tom, Maxwell Aoki, Yasuyuki Berger, Mitchel S Weiss, William A Stalpers, Lukas J A Prados, Michael James, C David Mueller, Sabine Haas-Kogan, Daphne A R01 NS091620/NS/NINDS NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States R01 NS093079/NS/NINDS NIH HHS/United States R01NS091620/NS/NINDS NIH HHS/United States P30 CA060553/CA/NCI NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States NS080619/NS/NINDS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Neurooncol. 2016 Feb;126(3):385-93. doi: 10.1007/s11060-015-1939-2. Epub 2015 Sep 18. PY - 2016 SN - 0167-594X (Print) 0167-594x SP - 385-93 ST - Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma T2 - J Neurooncol TI - Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma VL - 126 ID - 600 ER - TY - JOUR AD - Department of Biology, University of Padova, Padova, Italy. Endocrinology Division, Department of Medicine, Hospital/University of Padova, Padova, Italy. Surgical Pathology & Cytopathology Unit, Department of Medicine, Hospital/University of Padova, Padova, Italy. Department of Clinical and Biotechnological Sciences, University of L'Aquila, L'Aquila, Italy. Neuromed Institute, Department of Neurological Sciences, University of L'Aquila, L'Aquila, Italy. Department of Radiotherapy, Istituto Oncologico del Veneto, IOV-IRCCS, Padova, Italy. Department of Molecular Medicine, University of Padova, Padova, Italy. AN - 26392334 AU - Occhi, G. AU - Barollo, S. AU - Regazzo, D. AU - Bertazza, L. AU - Galuppini, F. AU - Guzzardo, V. AU - Jaffrain-Rea, M. L. AU - Vianello, F. AU - Ciato, D. AU - Ceccato, F. AU - Watutantrige-Fernando, S. AU - Bisognin, A. AU - Bortoluzzi, S. AU - Pennelli, G. AU - Boscaro, M. AU - Scaroni, C. AU - Mian, C. C2 - PMC4741662 DA - Oct 13 DO - 10.18632/oncotarget.5194 DP - NLM ET - 2015/09/24 IS - 31 LA - eng N1 - 1949-2553 Occhi, Gianluca Barollo, Susi Regazzo, Daniela Bertazza, Loris Galuppini, Francesca Guzzardo, Vincenza Jaffrain-Rea, Marie Lise Vianello, Federica Ciato, Denis Ceccato, Filippo Watutantrige-Fernando, Sara Bisognin, Andrea Bortoluzzi, Stefania Pennelli, Gianmaria Boscaro, Marco Scaroni, Carla Mian, Caterina Comparative Study Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Oct 13;6(31):32104-14. doi: 10.18632/oncotarget.5194. PY - 2015 SN - 1949-2553 SP - 32104-14 ST - A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC T2 - Oncotarget TI - A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC VL - 6 ID - 601 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America. Department of Medicine, Division of Solid Tumors, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, United States of America; California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California, United States of America. Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, United States of America; California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California, United States of America. AN - 26402468 AU - Anderson, J. L. AU - Park, A. AU - Akiyama, R. AU - Tap, W. D. AU - Denny, C. T. AU - Federman, N. C2 - PMC4581723 DO - 10.1371/journal.pone.0133610 DP - NLM ET - 2015/09/25 IS - 9 LA - eng N1 - 1932-6203 Anderson, Jennifer L Park, Ann Akiyama, Ryan Tap, William D Denny, Christopher T Federman, Noah P30 AI028697/AI/NIAID NIH HHS/United States P30 CA016042/CA/NCI NIH HHS/United States UL1 TR000124/TR/NCATS NIH HHS/United States UL1TR000124/TR/NCATS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural PLoS One. 2015 Sep 24;10(9):e0133610. doi: 10.1371/journal.pone.0133610. eCollection 2015. PY - 2015 SN - 1932-6203 SP - e0133610 ST - Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas T2 - PLoS One TI - Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas VL - 10 ID - 602 ER - TY - JOUR AD - Department of Medical Oncology, Royal Marsden NHS Trust, London, UK. Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. Department of Oncologic Pathology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan. AN - 26414886 AU - Seifert, H. AU - Hirata, E. AU - Gore, M. AU - Khabra, K. AU - Messiou, C. AU - Larkin, J. AU - Sahai, E. C2 - PMC4737278 DA - Jan DO - 10.1111/pcmr.12424 DP - NLM ET - 2015/09/29 IS - 1 LA - eng N1 - 1755-148x Seifert, Heike Orcid: 0000-0003-3052-1651 Hirata, Eishu Gore, Martin Khabra, Komel Messiou, Christina Larkin, James Sahai, Erik Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Pigment Cell Melanoma Res. 2016 Jan;29(1):92-100. doi: 10.1111/pcmr.12424. Epub 2015 Nov 3. PY - 2016 SN - 1755-1471 (Print) 1755-1471 SP - 92-100 ST - Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases T2 - Pigment Cell Melanoma Res TI - Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases VL - 29 ID - 603 ER - TY - JOUR AD - Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark. Research Center, Danish Cancer Society, Copenhagen, Denmark. Research Unit, Section of General Practice, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark. Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. Division of Pathology, Department of Molecular and Clinical Medicine, Royal Liverpool University Hospital, Liverpool, England. Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark4Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. AN - 26425792 AU - Larsen, A. C. AU - Dahmcke, C. M. AU - Dahl, C. AU - Siersma, V. D. AU - Toft, P. B. AU - Coupland, S. E. AU - Prause, J. U. AU - Guldberg, P. AU - Heegaard, S. DA - Nov DO - 10.1001/jamaophthalmol.2015.3200 DP - NLM ET - 2015/10/02 IS - 11 LA - eng N1 - 2168-6173 Larsen, Ann-Cathrine Dahmcke, Christina M Dahl, Christina Siersma, Volkert D Toft, Peter B Coupland, Sarah E Prause, Jan U Guldberg, Per Heegaard, Steffen Journal Article Research Support, Non-U.S. Gov't United States JAMA Ophthalmol. 2015 Nov;133(11):1295-303. doi: 10.1001/jamaophthalmol.2015.3200. PY - 2015 SN - 2168-6165 SP - 1295-303 ST - A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations T2 - JAMA Ophthalmol TI - A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations VL - 133 ID - 604 ER - TY - JOUR AD - Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. francesca.megiorni@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. hdominici@tin.it. Department of Oncology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. hdominici@tin.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. simona.camero@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. o.mannarino@libero.it. Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. simona.ceccarelli@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. milena.paiano@uniroma1.it. Department of Paediatric Surgery, Alder Hey Children's NHS Foundation Trust; Academic Paediatric Surgery Unit, University of Liverpool, Eaton Road, L12 2AP, Liverpool, UK. paul.losty@liverpool.ac.uk. Department of Oncology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. barry.pizer@alderhey.nhs.uk. Department of Perinatal and Paediatric Pathology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. rajeev.shukla@alderhey.nhs.uk. Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. antonio.pizzuti@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. anna.clerico@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. carlo.dominici@uniroma1.it. AN - 26445453 AU - Megiorni, F. AU - McDowell, H. P. AU - Camero, S. AU - Mannarino, O. AU - Ceccarelli, S. AU - Paiano, M. AU - Losty, P. D. AU - Pizer, B. AU - Shukla, R. AU - Pizzuti, A. AU - Clerico, A. AU - Dominici, C. C2 - PMC4596370 DA - Oct 6 DO - 10.1186/s13046-015-0228-4 DP - NLM ET - 2015/10/09 LA - eng N1 - 1756-9966 Megiorni, Francesca McDowell, Heather P Camero, Simona Mannarino, Olga Ceccarelli, Simona Paiano, Milena Losty, Paul D Pizer, Barry Shukla, Rajeev Pizzuti, Antonio Clerico, Anna Dominici, Carlo Journal Article Research Support, Non-U.S. Gov't J Exp Clin Cancer Res. 2015 Oct 6;34:112. doi: 10.1186/s13046-015-0228-4. PY - 2015 SN - 0392-9078 (Print) 0392-9078 SP - 112 ST - Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition T2 - J Exp Clin Cancer Res TI - Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition VL - 34 ID - 605 ER - TY - JOUR AD - Department of Pathology, Kasturba Medical College, Mangalore, Manipal University, Manipal, India. AN - 26458652 AU - Sridevi, H. B. AU - Shanthala, P. R. AU - Raghuveer, C. V. AU - Prabhu, A. K. AU - Akbar, J. K. AU - Shivaprasad, G. S. AU - Suresh, P. K. AU - Navani, S. DA - Jul-Sep DO - 10.4103/0973-1482.139338 DP - NLM ET - 2015/10/16 IS - 3 LA - eng N1 - 1998-4138 Sridevi, H B Shanthala, P R Raghuveer, C V Prabhu, Ananth K Akbar, Jallaluddin K C Shivaprasad, G S Suresh, Pooja K Navani, Sanjay Case Reports Letter India J Cancer Res Ther. 2015 Jul-Sep;11(3):656. doi: 10.4103/0973-1482.139338. PY - 2015 SN - 1998-4138 SP - 656 ST - A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult T2 - J Cancer Res Ther TI - A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult VL - 11 ID - 606 ER - TY - JOUR AD - Melanoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. The Institute of Cancer Research, Division of Radiotherapy and Imaging, 123 Old Brompton Road, London SW7 3RP, UK. The Institute of Cancer Research, Division of Clinical Studies, 123 Old Brompton Road, London SW7 3RP, UK. Department of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK. AN - 26484413 AU - Wilkins, A. AU - Furness, A. AU - Corbett, R. W. AU - Bloomfield, A. AU - Porta, N. AU - Morris, S. AU - Ali, Z. AU - Larkin, J. AU - Harrington, K. C2 - PMC4815790 DA - Nov 3 DO - 10.1038/bjc.2015.357 DP - NLM ET - 2015/10/21 IS - 9 LA - eng N1 - 1532-1827 Wilkins, Anna Furness, Andrew Corbett, Richard W Bloomfield, Adam Porta, Nuria Morris, Stephen Ali, Zohra Larkin, James Harrington, Kevin C1491/A15955/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Br J Cancer. 2015 Nov 3;113(9):1275-81. doi: 10.1038/bjc.2015.357. Epub 2015 Oct 20. PY - 2015 SN - 0007-0920 (Print) 0007-0920 SP - 1275-81 ST - The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma T2 - Br J Cancer TI - The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma VL - 113 ID - 607 ER - TY - JOUR AD - Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Kanagawa, Japan. Research Center for Regenerative Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Kanagawa, Japan. AN - 26505752 AU - Hiyama, A. AU - Hiraishi, S. AU - Sakai, D. AU - Mochida, J. DA - May DO - 10.1002/jor.23085 DP - NLM ET - 2015/10/28 IS - 5 LA - eng N1 - 1554-527x Hiyama, Akihiko Hiraishi, Shunsuke Sakai, Daisuke Mochida, Joji Journal Article United States J Orthop Res. 2016 May;34(5):865-75. doi: 10.1002/jor.23085. Epub 2016 Jan 21. PY - 2016 SN - 0736-0266 SP - 865-75 ST - CCAAT/enhancer binding protein β regulates the expression of tumor necrosis factor-α in the nucleus pulposus cells T2 - J Orthop Res TI - CCAAT/enhancer binding protein β regulates the expression of tumor necrosis factor-α in the nucleus pulposus cells VL - 34 ID - 608 ER - TY - JOUR AD - Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul, Republic of Korea. Current address: Seegene Inc., Seoul, Korea. Department of Laboratory Medicine, Dankook University College of Medicine, Cheonan, Korea. Dankook University College of Health Sciences, Department of Biomedical Laboratory Science, Cheonan, Korea. College of Pharmacy, Medical Research Center, Chungbuk National University, Chungbuk, Korea. AN - 26516703 AU - Kim, M. S. AU - Kang, J. W. AU - Jeon, J. S. AU - Kim, J. K. AU - Kim, J. W. AU - Hong, J. AU - Yoon, D. Y. C2 - PMC4747366 DA - Dec 1 DO - 10.18632/oncotarget.5688 DP - NLM ET - 2015/10/31 IS - 38 LA - eng N1 - 1949-2553 Kim, Man Sub Kang, Jeong-Woo Jeon, Jae-Sik Kim, Jae Kyung Kim, Jong Wan Hong, Jintae Yoon, Do-Young Comparative Study Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Dec 1;6(38):40747-61. doi: 10.18632/oncotarget.5688. PY - 2015 SN - 1949-2553 SP - 40747-61 ST - IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production T2 - Oncotarget TI - IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production VL - 6 ID - 609 ER - TY - JOUR AD - Cancer Epigenetics Laboratory and School of Cellular & Molecular Medicine, University of Bristol, Bristol, UK. Department of Cellular Pathology, Southmead Hospital, Bristol, UK. Colorectal Cancer Laboratory, School of Cellular & Molecular Medicine, University of Bristol, Bristol, UK. The Kids Research Institute, The Children's Hospital at Westmead, Westmead, New South Wales, Australia. Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. AN - 26517508 AU - Vieira, G. C. AU - Chockalingam, S. AU - Melegh, Z. AU - Greenhough, A. AU - Malik, S. AU - Szemes, M. AU - Park, J. H. AU - Kaidi, A. AU - Zhou, L. AU - Catchpoole, D. AU - Morgan, R. AU - Bates, D. O. AU - Gabb, P. D. AU - Malik, K. C2 - PMC4741879 DA - Nov 24 DO - 10.18632/oncotarget.5548 DP - NLM ET - 2015/10/31 IS - 37 LA - eng N1 - 1949-2553 Vieira, Gabriella Cunha Chockalingam, S Melegh, Zsombor Greenhough, Alexander Malik, Sally Szemes, Marianna Park, Ji Hyun Kaidi, Abderrahmane Zhou, Li Catchpoole, Daniel Morgan, Rhys Bates, David O Gabb, Peter David Malik, Karim 11975/Cancer Research UK/United Kingdom 12743/Cancer Research UK/United Kingdom C20791/A12743/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't Oncotarget. 2015 Nov 24;6(37):40053-67. doi: 10.18632/oncotarget.5548. PY - 2015 SN - 1949-2553 SP - 40053-67 ST - LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma T2 - Oncotarget TI - LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma VL - 6 ID - 610 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. mosse@chop.edu. AN - 26554404 AU - Infarinato, N. R. AU - Park, J. H. AU - Krytska, K. AU - Ryles, H. T. AU - Sano, R. AU - Szigety, K. M. AU - Li, Y. AU - Zou, H. Y. AU - Lee, N. V. AU - Smeal, T. AU - Lemmon, M. A. AU - Mossé, Y. P. C2 - PMC4707106 C6 - NIHMS737610 NRF, JHP, KK, HTR, RS, KS, MAL and YPM. HYZ, NVL and TS are employees at Pfizer, Inc. Disclosure of Potential Conflicts of Interest Helen Y. Zou, Nathan V. Lee, and Tod Smeal are employees and shareholders of Pfizer, Inc. Yaël Mossé is an inventor on a patent filed by the Children’s Hospital of Philadelphia (WO/2009/103061 or PCT/US2009/034288: Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma). DA - Jan DO - 10.1158/2159-8290.Cd-15-1056 DP - NLM ET - 2015/11/12 IS - 1 LA - eng N1 - 2159-8290 Infarinato, Nicole R Park, Jin H Krytska, Kateryna Ryles, Hannah T Sano, Renata Szigety, Katherine M Li, Yimei Zou, Helen Y Lee, Nathan V Smeal, Tod Lemmon, Mark A Mossé, Yael P P30 CA016520/CA/NCI NIH HHS/United States R01 CA140198/CA/NCI NIH HHS/United States R01-CA140198/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Cancer Discov. 2016 Jan;6(1):96-107. doi: 10.1158/2159-8290.CD-15-1056. Epub 2015 Nov 10. PY - 2016 SN - 2159-8274 (Print) 2159-8274 SP - 96-107 ST - The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma T2 - Cancer Discov TI - The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma VL - 6 ID - 611 ER - TY - JOUR AD - *Programa de Pesquisa em Hemato-Oncologia Molecular, Laboratório de Hemato-oncologia Celular e Molecular, and Programa de Biologia Celular, Laboratório de Biologia Estrutural-Instituto Nacional de Câncer, Rio de Janeiro, Brazil; and Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom. *Programa de Pesquisa em Hemato-Oncologia Molecular, Laboratório de Hemato-oncologia Celular e Molecular, and Programa de Biologia Celular, Laboratório de Biologia Estrutural-Instituto Nacional de Câncer, Rio de Janeiro, Brazil; and Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom cklumb@inca.gov.br. AN - 26561567 AU - Ferreira, A. C. AU - de-Freitas-Junior, J. C. AU - Morgado-Díaz, J. A. AU - Ridley, A. J. AU - Klumb, C. E. DA - Apr DO - 10.1189/jlb.2A0415-162R DP - NLM ET - 2015/11/13 IS - 4 LA - eng N1 - 1938-3673 Ferreira, Ana Carolina dos Santos de-Freitas-Junior, Julio Cesar Madureira Morgado-Díaz, Jose Andres Ridley, Anne J Klumb, Claudete Esteves C6220/15961/Cancer Research UK/United Kingdom Journal Article Research Support, Non-U.S. Gov't United States J Leukoc Biol. 2016 Apr;99(4):569-78. doi: 10.1189/jlb.2A0415-162R. Epub 2015 Nov 11. PY - 2016 SN - 0741-5400 SP - 569-78 ST - Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration T2 - J Leukoc Biol TI - Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration VL - 99 ID - 612 ER - TY - JOUR AD - Rady Childrens Hospital, San Diego, CA (VW, JC, DM, HA); Foundation Medicine, Inc., Cambridge, MA (DP, TB, RY, JSR, VAM, PJS, SMA); Albany Medical College, Albany, NY (JSR). siraj@foundationmedicine.com. AN - 26563356 AU - Wong, V. AU - Pavlick, D. AU - Brennan, T. AU - Yelensky, R. AU - Crawford, J. AU - Ross, J. S. AU - Miller, V. A. AU - Malicki, D. AU - Stephens, P. J. AU - Ali, S. M. AU - Ahn, H. DA - Jan DO - 10.1093/jnci/djv307 DP - NLM ET - 2015/11/14 IS - 1 LA - eng N1 - 1460-2105 Wong, Victor Pavlick, Dean Brennan, Tim Yelensky, Roman Crawford, John Ross, Jeffrey S Miller, Vincent A Malicki, Denise Stephens, Philip J Ali, Siraj M Ahn, Hyunah Case Reports Letter United States J Natl Cancer Inst. 2015 Nov 12;108(1):djv307. doi: 10.1093/jnci/djv307. Print 2016 Jan. PY - 2016 SN - 0027-8874 ST - Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib T2 - J Natl Cancer Inst TI - Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib VL - 108 ID - 613 ER - TY - JOUR AD - Department of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. AN - 28174704 AU - Coulombe, G. AU - Rivard, N. C2 - PMC4980741 DA - Jan DO - 10.1016/j.jcmgh.2015.11.001 DP - NLM ET - 2015/11/14 IS - 1 LA - eng N1 - 2352-345x Coulombe, Geneviève Rivard, Nathalie Journal Article Review Cell Mol Gastroenterol Hepatol. 2015 Nov 14;2(1):11-21. doi: 10.1016/j.jcmgh.2015.11.001. eCollection 2016 Jan. PY - 2016 SN - 2352-345X (Print) 2352-345x SP - 11-21 ST - New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract T2 - Cell Mol Gastroenterol Hepatol TI - New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract VL - 2 ID - 614 ER - TY - JOUR AD - Nemours Center for Cancer and Blood Disorders, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, United States of America. Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Mississippi, University of Mississippi Medical Center, Jackson, MS, United States of America. AN - 26571493 AU - Sampson, V. B. AU - Vetter, N. S. AU - Kamara, D. F. AU - Collier, A. B. AU - Gresh, R. C. AU - Kolb, E. A. C2 - PMC4646493 DO - 10.1371/journal.pone.0142704 DP - NLM ET - 2015/11/17 IS - 11 LA - eng N1 - 1932-6203 Sampson, Valerie B Vetter, Nancy S Kamara, Davida F Collier, Anderson B Gresh, Renee C Kolb, E Anders P20 GM103464/GM/NIGMS NIH HHS/United States P30 GM114736/GM/NIGMS NIH HHS/United States P20GM103464/GM/NIGMS NIH HHS/United States P30GM114736/GM/NIGMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't PLoS One. 2015 Nov 16;10(11):e0142704. doi: 10.1371/journal.pone.0142704. eCollection 2015. PY - 2015 SN - 1932-6203 SP - e0142704 ST - Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways T2 - PLoS One TI - Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways VL - 10 ID - 615 ER - TY - JOUR AD - Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA Department of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA jw92@cumc.columbia.edu. AN - 26574555 AU - Munabi, N. C. AU - England, R. W. AU - Edwards, A. K. AU - Kitajewski, A. A. AU - Tan, Q. K. AU - Weinstein, A. AU - Kung, J. E. AU - Wilcox, M. AU - Kitajewski, J. K. AU - Shawber, C. J. AU - Wu, J. K. C2 - PMC4704871 DA - Jan DO - 10.5966/sctm.2015-0076 DP - NLM ET - 2015/11/18 IS - 1 LA - eng N1 - 2157-6580 Munabi, Naikhoba C O England, Ryan W Edwards, Andrew K Kitajewski, Alison A Tan, Qian Kun Weinstein, Andrew Kung, Justin E Wilcox, Maya Kitajewski, Jan K Shawber, Carrie J Wu, June K T35 5T35HL007616-34/HL/NHLBI NIH HHS/United States 1R01 HL112626/HL/NHLBI NIH HHS/United States 1R21 EB016515-01/EB/NIBIB NIH HHS/United States T35 HL007616/HL/NHLBI NIH HHS/United States K08 1K08 HL102068-01/HL/NHLBI NIH HHS/United States R01 HL119043/HL/NHLBI NIH HHS/United States R21 EB016515/EB/NIBIB NIH HHS/United States UL1 TR000040/TR/NCATS NIH HHS/United States R01 HL112626/HL/NHLBI NIH HHS/United States K08 HL102068/HL/NHLBI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Stem Cells Transl Med. 2016 Jan;5(1):45-55. doi: 10.5966/sctm.2015-0076. Epub 2015 Nov 16. PY - 2016 SN - 2157-6564 (Print) 2157-6564 SP - 45-55 ST - Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation T2 - Stem Cells Transl Med TI - Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation VL - 5 ID - 616 ER - TY - JOUR AD - Pediatric Department of Longhua Hospital, Shanghai University of TCM, Shanghai, 200126, China. Institute for TCM Pediatric, Shanghai TCM Academy, Shanghai, 200071, China. Pediatric Department of Longhua Hospital, Shanghai University of TCM, Shanghai, 200126, China. Xiaozhen@126.com. AN - 26590157 AU - Jiang, Y. H. AU - Yu, J. E. AU - Guo, A. H. AU - Li, X. AU - Lin, Y. AU - Jiang, Z. Y. AU - Xiao, Z. DA - Apr DO - 10.1007/s11418-015-0944-2 DP - NLM ET - 2015/11/22 IS - 2 LA - eng N1 - 1861-0293 Jiang, Yong-hong Yu, Jian-er Guo, Ai-hua Li, Xiao Lin, Yan Jiang, Zhi-yan Xiao, Zhen Journal Article Research Support, Non-U.S. Gov't Japan J Nat Med. 2016 Apr;70(2):145-51. doi: 10.1007/s11418-015-0944-2. Epub 2015 Nov 20. PY - 2016 SN - 1340-3443 SP - 145-51 ST - Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice T2 - J Nat Med TI - Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice VL - 70 ID - 617 ER - TY - JOUR AD - Université Paris-Sud 11, Vectorology and Anticancer Therapeutics, UMR 8203, Villejuif, France. CNRS, Vectorology and Anticancer Therapeutics, UMR 8203, Orsay, France. Gustave Roussy, Vectorology and Anticancer Therapeutics, UMR 8203, Villejuif, France. University Children's Hospital, Department of Pediatric Hematology and Oncology, Münster, Germany. PFEP (Plateforme d'évaluation préclinique), Gustave Roussy, Villejuif, France. Tribvn, Châtillon, France. Pathology Laboratory, Gustave Roussy, Villejuif, France. Department of Neuropathology, Sainte-Anne's Hospital, Paris, France. Paris Descartes University, Paris, France. Bayer Pharma Aktiengesellschaft, Berlin, Germany. AN - 26599335 AU - Daudigeos-Dubus, E. AU - Le Dret, L. AU - Lanvers-Kaminsky, C. AU - Bawa, O. AU - Opolon, P. AU - Vievard, A. AU - Villa, I. AU - Pagès, M. AU - Bosq, J. AU - Vassal, G. AU - Zopf, D. AU - Geoerger, B. C2 - PMC4658168 supported by Bayer Pharma Aktiengesellschaft. Co-author Dieter Zopf is employed by Bayer Pharma Aktiengesellschaft. Co-author Albane Vievard is employed by Tribvn. There are no patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials as detailed online in the guide for authors. All other authors have no conflict to interest to declare. DO - 10.1371/journal.pone.0142612 DP - NLM ET - 2015/11/26 IS - 11 LA - eng N1 - 1932-6203 Daudigeos-Dubus, Estelle Le Dret, Ludivine Lanvers-Kaminsky, Claudia Bawa, Olivia Opolon, Paule Vievard, Albane Villa, Irène Pagès, Mélanie Bosq, Jacques Vassal, Gilles Zopf, Dieter Geoerger, Birgit Journal Article Research Support, Non-U.S. Gov't PLoS One. 2015 Nov 23;10(11):e0142612. doi: 10.1371/journal.pone.0142612. eCollection 2015. PY - 2015 SN - 1932-6203 SP - e0142612 ST - Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models T2 - PLoS One TI - Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models VL - 10 ID - 618 ER - TY - JOUR AD - Clinical Oncology Research Institute, N. N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow, Russia. Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, Russia. Institute of Molecular Biology and Biophysics, Novosibirsk, Russia. AN - 26600396 AU - Lyubchenko, L. AU - Emelyanova, M. AU - Shamanin, V. AU - Demidov, L. AU - Zasedatelev, A. AU - Nasedkina, T. DO - 10.3233/cbm-150551 DP - NLM ET - 2015/11/26 IS - 1 LA - eng N1 - 1875-8592 Lyubchenko, Ludmila Emelyanova, Marina Shamanin, Vladimir Demidov, Lev Zasedatelev, Alexander Nasedkina, Tatyana Journal Article Research Support, Non-U.S. Gov't Netherlands Cancer Biomark. 2016;16(1):153-60. doi: 10.3233/CBM-150551. PY - 2016 SN - 1574-0153 SP - 153-60 ST - The \textit{BRAF} V600E mutation in single- institution study of Russian melanoma patients T2 - Cancer Biomark TI - The \textit{BRAF} V600E mutation in single- institution study of Russian melanoma patients VL - 16 ID - 619 ER - TY - JOUR AD - Laboratory of Morphology of Endocrine System, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. Department of Pathology, University of Pittsburgh School of Medicine, 3477 Euler Way, Pittsburgh, PA 15213, USA. Department of Fundamental and Applied Problems of Endocrinology, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 9609 Medical Center Drive, MSC 9778, Bethesda, MD 20892-9778, USA. Department of Dosimetry and Radiation Protection, State Institution 'National Research Center for Radiation Medicine of Academy of Medical Sciences of Ukraine', Melnikova Street 53, Kyiv 04050, Ukraine. Laboratory of Radiation Protection, State Institution 'National Research Centre for Radiation Medicine of Academy of Medical Sciences of Ukraine', Melnikova Street 53, Kyiv 04050, Ukraine. Department of Epidemiology and Biostatistics, University of California San Francisco, 3333 California Street, San Francisco, CA 94118-1944, USA. Department of Medical Consequences of the Chernobyl accident and International Cooperation, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. The Thyroid Center, Columbia University, 161 Fort Washington Avenue, New York, NY, 10032, USA. Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA. AN - 26625214 AU - Bogdanova, T. I. AU - Zurnadzhy, L. Y. AU - Nikiforov, Y. E. AU - Leeman-Neill, R. J. AU - Tronko, M. D. AU - Chanock, S. AU - Mabuchi, K. AU - Likhtarov, I. A. AU - Kovgan, L. M. AU - Drozdovitch, V. AU - Little, M. P. AU - Hatch, M. AU - Zablotska, L. B. AU - Shpak, V. M. AU - McConnell, R. J. AU - Brenner, A. V. C2 - PMC4705885 DA - Dec 1 DO - 10.1038/bjc.2015.372 DP - NLM ET - 2015/12/02 IS - 11 LA - eng N1 - 1532-1827 Bogdanova, Tetiana I Zurnadzhy, Liudmyla Yu Nikiforov, Yuri E Leeman-Neill, Rebecca J Tronko, Mykola D Chanock, Stephen Mabuchi, Kiyohiko Likhtarov, Ilya A Kovgan, Leonila M Drozdovitch, Vladimir Little, Mark P Hatch, Maureen Zablotska, Lydia B Shpak, Viktor M McConnell, Robert J Brenner, Alina V N01-CP-21178/CP/NCI NIH HHS/United States Intramural NIH HHS/United States CA132918/CA/NCI NIH HHS/United States R01 CA88041/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S. Br J Cancer. 2015 Dec 1;113(11):1556-64. doi: 10.1038/bjc.2015.372. Epub 2015 Dec 3. PY - 2015 SN - 0007-0920 (Print) 0007-0920 SP - 1556-64 ST - Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort T2 - Br J Cancer TI - Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort VL - 113 ID - 620 ER - TY - JOUR AD - Safety Assessment, GlaxoSmithKline, King of Prussia, Pennsylvania. Vet Path Services, Inc, Mason, Ohio. AN - 26626128 AU - Posobiec, L. M. AU - Vidal, J. D. AU - Hughes-Earle, A. AU - Laffan, S. B. AU - Hart, T. DA - Dec DO - 10.1002/bdrb.21165 DP - NLM ET - 2015/12/03 IS - 6 LA - eng N1 - 1542-9741 Posobiec, Lorraine M Vidal, Justin D Hughes-Earle, Angela Laffan, Susan B Hart, Timothy Journal Article United States Birth Defects Res B Dev Reprod Toxicol. 2015 Dec;104(6):244-52. doi: 10.1002/bdrb.21165. Epub 2015 Dec 1. PY - 2015 SN - 1542-9733 SP - 244-52 ST - Early Vaginal Opening in Juvenile Female Rats Given BRAF-Inhibitor Dabrafenib Is Not Associated with Early Physiologic Sexual Maturation T2 - Birth Defects Res B Dev Reprod Toxicol TI - Early Vaginal Opening in Juvenile Female Rats Given BRAF-Inhibitor Dabrafenib Is Not Associated with Early Physiologic Sexual Maturation VL - 104 ID - 621 ER - TY - JOUR AD - Department of Pathology, Faculty of Medicine, Ege University, Izmir, Turkey. AN - 26630683 AU - Yaman, B. AU - Kandiloğlu, G. AU - Akalin, T. DA - Feb DO - 10.1097/dad.0000000000000404 DP - NLM ET - 2015/12/03 IS - 2 LA - eng N1 - 1533-0311 Yaman, Banu Kandiloğlu, Gülşen Akalin, Taner Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Am J Dermatopathol. 2016 Feb;38(2):113-20. doi: 10.1097/DAD.0000000000000404. PY - 2016 SN - 0193-1091 SP - 113-20 ST - BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry T2 - Am J Dermatopathol TI - BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry VL - 38 ID - 622 ER - TY - JOUR AD - Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY. AN - 26637768 AU - Kobos, R. AU - Terry, W. DO - 10.1182/asheducation-2015.1.522 DP - NLM ET - 2015/12/08 LA - eng N1 - 1520-4383 Kobos, Rachel Terry, William Journal Article Review United States Hematology Am Soc Hematol Educ Program. 2015;2015:522-8. doi: 10.1182/asheducation-2015.1.522. PY - 2015 SN - 1520-4383 SP - 522-8 ST - Advances in therapies for non-Hodgkin lymphoma in children T2 - Hematology Am Soc Hematol Educ Program TI - Advances in therapies for non-Hodgkin lymphoma in children VL - 2015 ID - 623 ER - TY - JOUR AD - Department of Anatomical Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan. Department of Pathology, National Kyushu Cancer Center, Fukuoka, Japan. Department of Pathology, Faculty of Medicine, University of Miyazaki, Kiyotake, Japan. Department of Pathology, Saga Medical Centre Koseikan, Saga, Japan. AN - 26647767 AU - Yamamoto, H. AU - Yoshida, A. AU - Taguchi, K. AU - Kohashi, K. AU - Hatanaka, Y. AU - Yamashita, A. AU - Mori, D. AU - Oda, Y. DA - Jul DO - 10.1111/his.12910 DP - NLM ET - 2015/12/10 IS - 1 LA - eng N1 - 1365-2559 Yamamoto, Hidetaka Yoshida, Akihiko Taguchi, Kenichi Kohashi, Kenichi Hatanaka, Yui Yamashita, Atsushi Mori, Daisuke Oda, Yoshinao Journal Article England Histopathology. 2016 Jul;69(1):72-83. doi: 10.1111/his.12910. Epub 2016 Jan 19. PY - 2016 SN - 0309-0167 SP - 72-83 ST - ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours T2 - Histopathology TI - ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours VL - 69 ID - 624 ER - TY - JOUR AD - Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Service des Maladies du Sang, Centre François Magendie, Hôpital du Haut-Lévèque, Pessac, France. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Adult Hematology, Hôpital Saint Louis, Paris, France. Department of Hematology, Hôpital Hotel Dieu, Nantes, France. Department of Hematology, Hôpital Edouard Herriot, Lyon, France. Clinical Biomarkers, Merck KGaA, Darmstadt, Germany. Clinical Oncology, Early Development, EMD Serono, Billerica, MA, USA. Global Biostatistics, Hematologic Cancer and BMT, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD, USA. AN - 26657199 AU - Ravandi, F. AU - Pigneux, A. AU - DeAngelo, D. J. AU - Raffoux, E. AU - Delaunay, J. AU - Thomas, X. AU - Kadia, T. AU - Kantarjian, H. AU - Scheuenpflug, J. AU - Zhao, C. AU - Guo, W. AU - Smith, B. D. C2 - PMC4735070 of this study. JS is employed by Merck KGaA, Darmstadt, Germany. CZ and WG are employed by EMD Serono, Billerica, USA. AP has received honorarium for coordination of this study. The remaining authors have no conflict of interest. DA - Dec 11 DO - 10.1038/bcj.2015.103 DP - NLM ET - 2015/12/15 IS - 12 LA - eng N1 - 2044-5385 Ravandi, F Pigneux, A DeAngelo, D J Raffoux, E Delaunay, J Thomas, X Kadia, T Kantarjian, H Scheuenpflug, J Zhao, C Guo, W Smith, B D Clinical Trial Letter Research Support, Non-U.S. Gov't Blood Cancer J. 2015 Dec 11;5(12):e375. doi: 10.1038/bcj.2015.103. PY - 2015 SN - 2044-5385 SP - e375 ST - Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies T2 - Blood Cancer J TI - Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies VL - 5 ID - 625 ER - TY - JOUR AD - Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. Present address: Research Department of Pathology, Cancer Institute, University College London, 72 Huntley St, Camden Town, London, WC1E 6DD, UK. Present address: Department of Neuropathology, St Jude Children's Research Hospital, Memphis, TN, 38105, USA. Present address: Inivata Limited, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Developmental Biology and Cancer Programme, UCL-Institute of Child Health, University College London, London, WC1N 1EH, UK. Department of Neurosurgery, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Department of Oncology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. t.jacques@ich.ucl.ac.uk. Developmental Biology and Cancer Programme, UCL-Institute of Child Health, University College London, London, WC1N 1EH, UK. t.jacques@ich.ucl.ac.uk. Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. d.sheer@qmul.ac.uk. AN - 26682910 AU - Jones, T. A. AU - Jeyapalan, J. N. AU - Forshew, T. AU - Tatevossian, R. G. AU - Lawson, A. R. AU - Patel, S. N. AU - Doctor, G. T. AU - Mumin, M. A. AU - Picker, S. R. AU - Phipps, K. P. AU - Michalski, A. AU - Jacques, T. S. AU - Sheer, D. C2 - PMC4683939 DA - Dec 18 DO - 10.1186/s40478-015-0266-3 DP - NLM ET - 2015/12/20 LA - eng N1 - 2051-5960 Jones, Tania A Jeyapalan, Jennie N Forshew, Tim Tatevossian, Ruth G Lawson, Andrew R J Patel, Sheena N Doctor, Gabriel T Mumin, Muhammad A Picker, Simon R Phipps, Kim P Michalski, Antony Jacques, Thomas S Sheer, Denise Journal Article Research Support, Non-U.S. Gov't Acta Neuropathol Commun. 2015 Dec 18;3:86. doi: 10.1186/s40478-015-0266-3. PY - 2015 SN - 2051-5960 SP - 86 ST - Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways T2 - Acta Neuropathol Commun TI - Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways VL - 3 ID - 626 ER - TY - JOUR AD - Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Electronic address: marie.frugier-regairaz@ens-cachan.fr. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France; Sainte Justine University Hospital Center, University of Montréal, Montréal, Québec, Canada. Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. Histocytopathology Unit, Laboratory of Translational Research, Gustave Roussy, Villejuif, France. Research on Cell Growth, Tissue Repair and Regeneration (CRRET), Centre National de la Recherche Scientifique, University Paris-Est Créteil, Créteil, France. Department of Pathology, Bicêtre Hospital, Le Kremlin-Bicêtre, France. Department of Pediatrics, Shiga University of Medical Science, Otsu, Shiga, Japan. Histocytopathology Unit, Laboratory of Translational Research, Gustave Roussy, Villejuif, France; Department of Pathology and Biobank, Gustave Roussy, Villejuif, France. Department of Pediatrics, Gustave Roussy, Villejuif, France. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Electronic address: gilles.vassal@gustaveroussy.fr. AN - 26687816 AU - Regairaz, M. AU - Munier, F. AU - Sartelet, H. AU - Castaing, M. AU - Marty, V. AU - Renauleaud, C. AU - Doux, C. AU - Delbé, J. AU - Courty, J. AU - Fabre, M. AU - Ohta, S. AU - Vielh, P. AU - Michiels, S. AU - Valteau-Couanet, D. AU - Vassal, G. DA - Feb DO - 10.1016/j.ajpath.2015.10.016 DP - NLM ET - 2015/12/22 IS - 2 LA - eng N1 - 1525-2191 Regairaz, Marie Munier, Fabienne Sartelet, Hervé Castaing, Marine Marty, Virginie Renauleaud, Céline Doux, Camille Delbé, Jean Courty, José Fabre, Monique Ohta, Shigeru Vielh, Philippe Michiels, Stefan Valteau-Couanet, Dominique Vassal, Gilles Journal Article Research Support, Non-U.S. Gov't United States Am J Pathol. 2016 Feb;186(2):435-45. doi: 10.1016/j.ajpath.2015.10.016. Epub 2015 Dec 12. PY - 2016 SN - 0002-9440 SP - 435-45 ST - Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma T2 - Am J Pathol TI - Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma VL - 186 ID - 627 ER - TY - JOUR AD - University of Milan-Bicocca, Monza, Italy carlo.gambacorti@unimib.it. AN - 26736010 AU - Gambacorti-Passerini, C. AU - Mussolin, L. AU - Brugieres, L. DA - Jan 7 DO - 10.1056/NEJMc1511045 DP - NLM ET - 2016/01/07 IS - 1 LA - eng N1 - 1533-4406 Gambacorti-Passerini, Carlo Mussolin, Lara Brugieres, Laurence Case Reports Letter United States N Engl J Med. 2016 Jan 7;374(1):95-6. doi: 10.1056/NEJMc1511045. PY - 2016 SN - 0028-4793 SP - 95-6 ST - Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib T2 - N Engl J Med TI - Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib VL - 374 ID - 628 ER - TY - JOUR AD - Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba 6-3, Aramaki, Aoba-ku, Sendai 980-8578, Japan; Department of Pharmacology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. Electronic address: obaray@med.id.yamagata-u.ac.jp. Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba 6-3, Aramaki, Aoba-ku, Sendai 980-8578, Japan. Department of Physiology and Pharmacology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. The Vollum Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. Department of Urology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. Department of Pharmacology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. AN - 26739108 AU - Obara, Y. AU - Nagasawa, R. AU - Nemoto, W. AU - Pellegrino, M. J. AU - Takahashi, M. AU - Habecker, B. A. AU - Stork, P. J. S. AU - Ichiyanagi, O. AU - Ito, H. AU - Tomita, Y. AU - Ishii, K. AU - Nakahata, N. C2 - PMC6521842 C6 - NIHMS1026847 DA - Mar DO - 10.1016/j.cellsig.2015.12.016 DP - NLM ET - 2016/01/08 IS - 3 LA - eng N1 - 1873-3913 Obara, Yutaro Nagasawa, Ryusuke Nemoto, Wataru Pellegrino, Michael J Takahashi, Maho Habecker, Beth A Stork, Philip J S Ichiyanagi, Osamu Ito, Hiromi Tomita, Yoshihiko Ishii, Kuniaki Nakahata, Norimichi R01 HL068231/HL/NHLBI NIH HHS/United States R01 HL093056/HL/NHLBI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cell Signal. 2016 Mar;28(3):177-189. doi: 10.1016/j.cellsig.2015.12.016. Epub 2015 Dec 29. PY - 2016 SN - 0898-6568 (Print) 0898-6568 SP - 177-189 ST - ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells T2 - Cell Signal TI - ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells VL - 28 ID - 629 ER - TY - JOUR AD - Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada. Division of Oncology, University Children's Hospital of Zurich, Zurich, Switzerland. AN - 26764564 AU - Guerreiro Stucklin, A. S. AU - Tabori, U. AU - Grotzer, M. A. DA - Apr DO - 10.1055/s-0035-1570491 DP - NLM ET - 2016/01/15 IS - 2 LA - eng N1 - 1439-1899 Guerreiro Stucklin, Ana S Tabori, Uri Grotzer, Michael A Journal Article Review Germany Neuropediatrics. 2016 Apr;47(2):70-83. doi: 10.1055/s-0035-1570491. Epub 2016 Jan 14. PY - 2016 SN - 0174-304x SP - 70-83 ST - The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies T2 - Neuropediatrics TI - The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies VL - 47 ID - 630 ER - TY - JOUR AD - Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Anatomic Pathology, Bellaria Hospital, University of Bologna School of Medicine, Bologna, Italy. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Department of Surgery, Yale School of Medicine, New Haven, Connecticut. AN - 26784937 AU - Prasad, M. L. AU - Vyas, M. AU - Horne, M. J. AU - Virk, R. K. AU - Morotti, R. AU - Liu, Z. AU - Tallini, G. AU - Nikiforova, M. N. AU - Christison-Lagay, E. R. AU - Udelsman, R. AU - Dinauer, C. A. AU - Nikiforov, Y. E. DA - Apr 1 DO - 10.1002/cncr.29887 DP - NLM ET - 2016/01/20 IS - 7 LA - eng N1 - 1097-0142 Prasad, Manju L Vyas, Monika Horne, Matthew J Virk, Renu K Morotti, Raffaella Liu, Zongzhi Tallini, Giovanni Nikiforova, Marina N Christison-Lagay, Emily R Udelsman, Robert Dinauer, Catherine A Nikiforov, Yuri E Journal Article Research Support, Non-U.S. Gov't United States Cancer. 2016 Apr 1;122(7):1097-107. doi: 10.1002/cncr.29887. Epub 2016 Jan 19. PY - 2016 SN - 0008-543x SP - 1097-107 ST - NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States T2 - Cancer TI - NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States VL - 122 ID - 631 ER - TY - JOUR AD - Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Queensland University of Technology, Institute of Health and Biomedical Innovation, Brisbane, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Cancer Research UK Manchester Institute & University of Manchester, Manchester, UK. Anatomical Pathology, Sullivan Nicolaides Pathology, Taringa, Queensland, Australia. Anatomical Pathology, IQ Pathology, West End, Queensland, Australia. Anatomical Pathology, Queensland Medical Laboratory, Murarrie, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: David.Whiteman@qimrberghofer.edu.au. AN - 26807515 AU - Hacker, E. AU - Olsen, C. M. AU - Kvaskoff, M. AU - Pandeya, N. AU - Yeo, A. AU - Green, A. C. AU - Williamson, R. M. AU - Triscott, J. AU - Wood, D. AU - Mortimore, R. AU - Hayward, N. K. AU - Whiteman, D. C. DA - Apr DO - 10.1016/j.jid.2015.12.035 DP - NLM ET - 2016/01/26 IS - 4 LA - eng N1 - 1523-1747 Hacker, Elke Olsen, Catherine M Kvaskoff, Marina Pandeya, Nirmala Yeo, Abrey Green, Adèle C Williamson, Richard M Triscott, Joe Wood, Dominic Mortimore, Rohan Hayward, Nicholas K Whiteman, David C Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2016 Apr;136(4):829-837. doi: 10.1016/j.jid.2015.12.035. Epub 2016 Jan 22. PY - 2016 SN - 0022-202x SP - 829-837 ST - Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas T2 - J Invest Dermatol TI - Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas VL - 136 ID - 632 ER - TY - JOUR AD - Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan. Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan. Departments of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan. AN - 26816265 AU - Zenitani, M. AU - Nojiri, T. AU - Uehara, S. AU - Miura, K. AU - Hosoda, H. AU - Kimura, T. AU - Nakahata, K. AU - Miyazato, M. AU - Okuyama, H. AU - Kangawa, K. C2 - PMC4864809 DA - May DO - 10.1002/cam4.642 DP - NLM ET - 2016/01/28 IS - 5 LA - eng N1 - 2045-7634 Zenitani, Masahiro Nojiri, Takashi Uehara, Shuichiro Miura, Koichi Hosoda, Hiroshi Kimura, Toru Nakahata, Kengo Miyazato, Mikiya Okuyama, Hiroomi Kangawa, Kenji Journal Article Research Support, Non-U.S. Gov't Cancer Med. 2016 May;5(5):795-805. doi: 10.1002/cam4.642. Epub 2016 Jan 26. PY - 2016 SN - 2045-7634 SP - 795-805 ST - C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells T2 - Cancer Med TI - C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells VL - 5 ID - 633 ER - TY - JOUR AD - Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100730, People's Republic of China. AN - 26823846 AU - Sun, J. AU - Zhang, J. AU - Lu, J. AU - Gao, J. AU - Lu, T. AU - Ren, X. AU - Duan, H. AU - Liang, Z. C2 - PMC4713632 DP - NLM ET - 2016/01/30 IS - 11 LA - eng N1 - 1936-2625 Sun, Jian Zhang, Jing Lu, Junliang Gao, Jie Lu, Tao Ren, Xinyu Duan, Huanli Liang, Zhiyong Journal Article Int J Clin Exp Pathol. 2015 Nov 1;8(11):15072-8. eCollection 2015. PY - 2015 SN - 1936-2625 SP - 15072-8 ST - Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma T2 - Int J Clin Exp Pathol TI - Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma VL - 8 ID - 634 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Department of Internal Medicine, Division of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Electronic address: pair@upmc.edu. AN - 26826419 AU - Olevian, D. C. AU - Nikiforova, M. N. AU - Chiosea, S. AU - Sun, W. AU - Bahary, N. AU - Kuan, S. F. AU - Pai, R. K. DA - Mar DO - 10.1016/j.humpath.2015.11.004 DP - NLM ET - 2016/01/31 LA - eng N1 - 1532-8392 Olevian, Dane C Nikiforova, Marina N Chiosea, Simon Sun, Weijing Bahary, Nathan Kuan, Shih-Fan Pai, Reetesh K Comparative Study Journal Article United States Hum Pathol. 2016 Mar;49:124-34. doi: 10.1016/j.humpath.2015.11.004. Epub 2015 Nov 17. PY - 2016 SN - 0046-8177 SP - 124-34 ST - Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival T2 - Hum Pathol TI - Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival VL - 49 ID - 635 ER - TY - JOUR AD - Université de Poitiers, Équipe Récepteurs, Régulations et Cellules Tumorales (2RCT), Pôle Biologie Santé, Bât. B36/B37, UFR Sciences Fondamentales et Appliquées, 1 rue Georges Bonnet TSA, 51106 86073 Poitiers Cedex 9, France. Université de Rouen, INSERM U982, Equipe Neuropeptides, survie neuronale et plasticité cellulaire, IRIB, UFR Sciences et Techniques, Place E. Blondel, 76821 Mont-Saint-Aignan, France. INRS, Institut Armand-Frappier, 531 boul. des Prairies, Laval, QC H7V 1B7, Canada. Université de la Réunion, Stemcis c/o CYROI, 2, rue Maxime Rivière, 97490 Sainte Clotilde, France. Université de Poitiers, Équipe Récepteurs, Régulations et Cellules Tumorales (2RCT), Pôle Biologie Santé, Bât. B36/B37, UFR Sciences Fondamentales et Appliquées, 1 rue Georges Bonnet TSA, 51106 86073 Poitiers Cedex 9, France. Electronic address: corinne.chadeneau@univ-poitiers.fr. AN - 26826611 AU - de Boisvilliers, M. AU - Perrin, F. AU - Hebache, S. AU - Balandre, A. C. AU - Bensalma, S. AU - Garnier, A. AU - Vaudry, D. AU - Fournier, A. AU - Festy, F. AU - Muller, J. M. AU - Chadéneau, C. DA - Apr DO - 10.1016/j.peptides.2016.01.014 DP - NLM ET - 2016/01/31 LA - eng N1 - 1873-5169 de Boisvilliers, Madryssa Perrin, Florian Hebache, Salima Balandre, Annie-Claire Bensalma, Souheyla Garnier, Agnès Vaudry, David Fournier, Alain Festy, Franck Muller, Jean-Marc Chadéneau, Corinne Journal Article Research Support, Non-U.S. Gov't United States Peptides. 2016 Apr;78:30-41. doi: 10.1016/j.peptides.2016.01.014. Epub 2016 Jan 27. PY - 2016 SN - 0196-9781 SP - 30-41 ST - VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells T2 - Peptides TI - VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells VL - 78 ID - 636 ER - TY - JOUR AD - *Center for Cancer and Blood Disorders †Institute for Molecular Medicine Departments of ‡Neuro-Radiology §Pathology ∥Barrow's Neurologic Institute, Phoenix Children's Hospital, Phoenix, AZ. AN - 26886222 AU - Rosenfeld, A. AU - Etzl, M. AU - Lee, D. AU - Miller, J. AU - Carpenteri, D. AU - Shafron, D. AU - Kaplan, A. DA - Mar DO - 10.1097/mph.0000000000000457 DP - NLM ET - 2016/02/18 IS - 2 LA - eng N1 - 1536-3678 Rosenfeld, Amy Etzl, Michael Lee, David Miller, Jeffrey Carpenteri, David Shafron, David Kaplan, Allen Journal Article United States J Pediatr Hematol Oncol. 2016 Mar;38(2):e63-6. doi: 10.1097/MPH.0000000000000457. PY - 2016 SN - 1077-4114 SP - e63-6 ST - A Case Series Characterizing Pilomyxoid Astrocytomas in Childhood T2 - J Pediatr Hematol Oncol TI - A Case Series Characterizing Pilomyxoid Astrocytomas in Childhood VL - 38 ID - 637 ER - TY - JOUR AD - 1 Department of Endocrinology, Holycross Cancer Centre , Kielce, Poland . 2 Department of Molecular Diagnostics, Holycross Cancer Centre , Kielce, Poland . 3 Department of Surgical Pathology, Holycross Cancer Centre , Kielce, Poland . 4 Department of Surgical Pathology, Medical University of Silesia , Katowice, Poland . 5 Department of Probability Theory and Statistics Institute of Mathematics, Faculty of Mathematics and Natural Science, Jan Kochanowski University , Kielce, Poland . 6 Department of Clinical Oncology, Holycross Cancer Centre , Kielce, Poland . 7 Faculty of Health Sciences, Jan Kochanowski University , Kielce, Poland . 8 Department of Endocrinology and Nuclear Medicine, Military Institute of Medicine , Warsaw, Poland . AN - 26889698 AU - Kowalska, A. AU - Walczyk, A. AU - Kowalik, A. AU - Pałyga, I. AU - Trybek, T. AU - Kopczyński, J. AU - Kajor, M. AU - Chrapek, M. AU - Pięciak, L. AU - Chłopek, M. AU - Góźdź, S. AU - Kamiński, G. DA - Apr DO - 10.1089/thy.2015.0352 DP - NLM ET - 2016/02/19 IS - 4 LA - eng N1 - 1557-9077 Kowalska, Aldona Walczyk, Agnieszka Kowalik, Artur Pałyga, Iwona Trybek, Tomasz Kopczyński, Janusz Kajor, Maciej Chrapek, Magdalena Pięciak, Liliana Chłopek, Małgorzata Góźdź, Stanisław Kamiński, Grzegorz Journal Article United States Thyroid. 2016 Apr;26(4):543-51. doi: 10.1089/thy.2015.0352. Epub 2016 Feb 18. PY - 2016 SN - 1050-7256 SP - 543-51 ST - Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study T2 - Thyroid TI - Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study VL - 26 ID - 638 ER - TY - JOUR AD - Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address: jijulee@hanmail.net. AN - 26897385 AU - Lee, W. J. AU - Moon, I. J. AU - Lee, S. H. AU - Won, C. H. AU - Chang, S. E. AU - Choi, J. H. AU - Moon, K. C. AU - Park, C. S. AU - Huh, J. AU - Lee, M. W. DA - Jun DO - 10.1016/j.jaad.2015.12.053 DP - NLM ET - 2016/02/22 IS - 6 LA - eng N1 - 1097-6787 Lee, Woo Jin Moon, Ik Jun Lee, Sang Hyung Won, Chong Hyun Chang, Sung Eun Choi, Jee Ho Moon, Kee Chan Park, Chan-Sik Huh, Jooryung Lee, Mi Woo Journal Article United States J Am Acad Dermatol. 2016 Jun;74(6):1135-43. doi: 10.1016/j.jaad.2015.12.053. Epub 2016 Feb 17. PY - 2016 SN - 0190-9622 SP - 1135-43 ST - Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site T2 - J Am Acad Dermatol TI - Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site VL - 74 ID - 639 ER - TY - JOUR AD - From the Department of Pathology, MD Anderson Cancer Center, Houston, Texas (Dr Gertz); the Division of Molecular Genomic Pathology, University of Pittsburgh, Pennsylvania (Dr Nikiforov); the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison (Drs Lloyd and Rehrauer); and the School of Public Health, Louisiana State University, New Orleans (Dr McDaniel). Dr Gertz is now located at the Department of Pathology, OhioHealth Riverside Methodist Hospital, Columbus, Ohio. AN - 26910217 AU - Gertz, R. J. AU - Nikiforov, Y. AU - Rehrauer, W. AU - McDaniel, L. AU - Lloyd, R. V. DA - Feb DO - 10.5858/arpa.2014-0612-OA DP - NLM ET - 2016/02/26 IS - 2 LA - eng N1 - 1543-2165 Gertz, Ryan J Nikiforov, Yuri Rehrauer, William McDaniel, Lee Lloyd, Ricardo V P30 CA014520/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Arch Pathol Lab Med. 2016 Feb;140(2):134-9. doi: 10.5858/arpa.2014-0612-OA. PY - 2016 SN - 0003-9985 SP - 134-9 ST - Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population T2 - Arch Pathol Lab Med TI - Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population VL - 140 ID - 640 ER - TY - JOUR AD - Department of Pathology, Division of Molecular Histopathology, University of Cambridge, Cambridge, UK. European Research Initiative for ALK related Malignancies, Toulouse, France. Institut Universitaire de Cancérologie Oncopole, Toulouse, France. Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. Department of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. Département de Cancérologie de l'Enfant et l'Adolescent, Gustave Roussy, Villejuif, France. AN - 26913827 AU - Turner, S. D. AU - Lamant, L. AU - Kenner, L. AU - Brugières, L. DA - May DO - 10.1111/bjh.13958 DP - NLM ET - 2016/02/26 IS - 4 LA - eng N1 - 1365-2141 Turner, Suzanne D Lamant, Laurence Kenner, Lukas Brugières, Laurence Journal Article Review England Br J Haematol. 2016 May;173(4):560-72. doi: 10.1111/bjh.13958. Epub 2016 Feb 23. PY - 2016 SN - 0007-1048 SP - 560-72 ST - Anaplastic large cell lymphoma in paediatric and young adult patients T2 - Br J Haematol TI - Anaplastic large cell lymphoma in paediatric and young adult patients VL - 173 ID - 641 ER - TY - JOUR AD - Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA. AN - 26915300 AU - Kamionek, M. AU - Ahmadi Moghaddam, P. AU - Sakhdari, A. AU - Kovach, A. E. AU - Welch, M. AU - Meng, X. AU - Dresser, K. AU - Tomaszewicz, K. AU - Cosar, E. F. AU - Mark, E. J. AU - Fraire, A. E. AU - Hutchinson, L. DA - Sep DO - 10.1111/his.12955 DP - NLM ET - 2016/02/27 IS - 3 LA - eng N1 - 1365-2559 Kamionek, Michal Ahmadi Moghaddam, Parnian Sakhdari, Ali Kovach, Alexandra E Welch, Matthew Meng, Xiuling Dresser, Karen Tomaszewicz, Keith Cosar, Ediz F Mark, Eugene J Fraire, Armando E Hutchinson, Lloyd Journal Article England Histopathology. 2016 Sep;69(3):499-509. doi: 10.1111/his.12955. Epub 2016 Apr 29. PY - 2016 SN - 0309-0167 SP - 499-509 ST - Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease T2 - Histopathology TI - Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease VL - 69 ID - 642 ER - TY - JOUR AD - Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. woodfiel@bcm.edu. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. lxzhang@txch.org. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. kascorso@txch.org. Department of Neurobiology and Anatomy, The University of Texas Medical School, Houston, TX, USA. yin.liu@uth.tmc.edu. Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA. yin.liu@uth.tmc.edu. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. zage@bcm.edu. Texas Children's Cancer Center, Houston, TX, USA. zage@bcm.edu. AN - 26925841 AU - Woodfield, S. E. AU - Zhang, L. AU - Scorsone, K. A. AU - Liu, Y. AU - Zage, P. E. C2 - PMC4772351 DA - Mar 1 DO - 10.1186/s12885-016-2199-z DP - NLM ET - 2016/03/02 LA - eng N1 - 1471-2407 Woodfield, Sarah E Zhang, Linna Scorsone, Kathleen A Liu, Yin Zage, Peter E R01 CA166749/CA/NCI NIH HHS/United States R01 LM010022/LM/NLM NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't BMC Cancer. 2016 Mar 1;16:172. doi: 10.1186/s12885-016-2199-z. PY - 2016 SN - 1471-2407 SP - 172 ST - Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression T2 - BMC Cancer TI - Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression VL - 16 ID - 643 ER - TY - JOUR AD - Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. soojincha36@gmail.com. Interdisciplinary Program for Bioengineering of Graduate School, Seoul National University, Seoul, Republic of Korea. jeleedict@gmail.com. Genomic Medicine Institute, Seoul National University, Seoul, Republic of Korea. jongyeon.anna@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. medijiyeon@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. cantusprote@gmail.com. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. bhumsuk@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. bhumsuk@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. gabriel9@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. gabriel9@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. kimdw@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. kimdw@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. heo1013@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. heo1013@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. sehoon.lee119@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. sehoon.lee119@gmail.com. Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. sehoon.lee119@gmail.com. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. sehoon.lee119@gmail.com. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. jongil@snu.ac.kr. Genomic Medicine Institute, Seoul National University, Seoul, Republic of Korea. jongil@snu.ac.kr. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Republic of Korea. jongil@snu.ac.kr. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea. jongil@snu.ac.kr. AN - 26925973 AU - Cha, S. AU - Lee, J. AU - Shin, J. Y. AU - Kim, J. Y. AU - Sim, S. H. AU - Keam, B. AU - Kim, T. M. AU - Kim, D. W. AU - Heo, D. S. AU - Lee, S. H. AU - Kim, J. I. C2 - PMC4772349 DA - Feb 29 DO - 10.1186/s12885-016-2209-1 DP - NLM ET - 2016/03/02 LA - eng N1 - 1471-2407 Cha, Soojin Lee, Jeongeun Shin, Jong-Yeon Kim, Ji-Yeon Sim, Sung Hoon Keam, Bhumsuk Kim, Tae Min Kim, Dong-Wan Heo, Dae Seog Lee, Se-Hoon Kim, Jong-Il Journal Article Research Support, Non-U.S. Gov't BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1. PY - 2016 SN - 1471-2407 SP - 170 ST - Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis T2 - BMC Cancer TI - Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis VL - 16 ID - 644 ER - TY - JOUR AD - Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America. Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain. Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline R&D, Heidelberg, Germany. Department of Chemistry, University of Washington, Seattle, Washington, United States of America. Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. Drug Discovery, Medicines for Malaria Venture, Geneva, Switzerland. AN - 26934697 AU - Crowther, G. J. AU - Hillesland, H. K. AU - Keyloun, K. R. AU - Reid, M. C. AU - Lafuente-Monasterio, M. J. AU - Ghidelli-Disse, S. AU - Leonard, S. E. AU - He, P. AU - Jones, J. C. AU - Krahn, M. M. AU - Mo, J. S. AU - Dasari, K. S. AU - Fox, A. M. AU - Boesche, M. AU - El Bakkouri, M. AU - Rivas, K. L. AU - Leroy, D. AU - Hui, R. AU - Drewes, G. AU - Maly, D. J. AU - Van Voorhis, W. C. AU - Ojo, K. K. C2 - PMC4774911 GlaxoSmithKline (GSK), which partially funded this work (in the form of employee salaries) and hold patent WO 2006/134056 on the kinobeads technology used in this study. Cellzome/GSK does not offer any commercial services related to this technology. DL is an employee of the Medicines for Malaria Venture (MMV), which partially funded this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. DO - 10.1371/journal.pone.0149996 DP - NLM ET - 2016/03/05 IS - 3 LA - eng N1 - 1932-6203 Crowther, Gregory J Hillesland, Heidi K Keyloun, Katelyn R Reid, Molly C Lafuente-Monasterio, Maria Jose Ghidelli-Disse, Sonja Leonard, Stephen E He, Panqing Jones, Jackson C Krahn, Mallory M Mo, Jack S Dasari, Kartheek S Fox, Anna M W Boesche, Markus El Bakkouri, Majida Rivas, Kasey L Leroy, Didier Hui, Raymond Drewes, Gerard Maly, Dustin J Van Voorhis, Wesley C Ojo, Kayode K R01 GM086858/GM/NIGMS NIH HHS/United States F32CA174346/CA/NCI NIH HHS/United States R01AI1089441/AI/NIAID NIH HHS/United States R01GM086858/GM/NIGMS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't PLoS One. 2016 Mar 2;11(3):e0149996. doi: 10.1371/journal.pone.0149996. eCollection 2016. PY - 2016 SN - 1932-6203 SP - e0149996 ST - Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds T2 - PLoS One TI - Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds VL - 11 ID - 645 ER - TY - JOUR AD - Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. semen_yesil@yahoo.com.tr. Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Pathology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey. Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Pathology, University Health Network, Toronto, ON, Canada. ozgur.mete2@uhn.ca. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. ozgur.mete2@uhn.ca. Endocrine Oncology Site Group, Princess Margaret Cancer Center, Toronto, ON, Canada. ozgur.mete2@uhn.ca. AN - 26951110 AU - Onder, S. AU - Ozturk Sari, S. AU - Yegen, G. AU - Sormaz, I. C. AU - Yilmaz, I. AU - Poyrazoglu, S. AU - Sanlı, Y. AU - Giles Senyurek, Y. AU - Kapran, Y. AU - Mete, O. DA - Jun DO - 10.1007/s12022-016-9420-0 DP - NLM ET - 2016/03/10 IS - 2 LA - eng N1 - 1559-0097 Onder, Semen Ozturk Sari, Sule Yegen, Gulcin Sormaz, Ismail Cem Yilmaz, Ismail Poyrazoglu, Sukran Sanlı, Yasemin Giles Senyurek, Yasemin Kapran, Yersu Mete, Ozgur Journal Article United States Endocr Pathol. 2016 Jun;27(2):153-61. doi: 10.1007/s12022-016-9420-0. PY - 2016 SN - 1046-3976 SP - 153-61 ST - Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas T2 - Endocr Pathol TI - Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas VL - 27 ID - 646 ER - TY - JOUR AD - Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. ajdodgshun@gmail.com. Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia. ajdodgshun@gmail.com. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Longwood Ave, Boston, 02115, USA. Harvard Medical School, Boston, MA, USA. Department of Medical Oncology, Dana-Faber Cancer Institute, Boston, 02115, USA. Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. Department of Pathology, Boston Children's Hospital, Boston, MA, USA. Department of Pathology, Royal Children's Hospital, Melbourne, VIC, 3052, Australia. Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Department of Neurosurgery, Harvard Medical School, Boston, MA, USA. Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia. Broad Institute of MIT and Harvard, Cambridge, USA. Department of Pathology, Harvard Medical School, Boston, MA, USA. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, USA. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Longwood Ave, Boston, 02115, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Harvard Medical School, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Broad Institute of MIT and Harvard, Cambridge, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. AN - 26994902 AU - Dodgshun, A. J. AU - SantaCruz, N. AU - Hwang, J. AU - Ramkissoon, S. H. AU - Malkin, H. AU - Bergthold, G. AU - Manley, P. AU - Chi, S. AU - MacGregor, D. AU - Goumnerova, L. AU - Sullivan, M. AU - Ligon, K. AU - Beroukhim, R. AU - Herrington, B. AU - Kieran, M. W. AU - Hansford, J. R. AU - Bandopadhayay, P. DA - Jun DO - 10.1007/s11060-016-2109-x DP - NLM ET - 2016/03/21 IS - 2 LA - eng N1 - 1573-7373 Dodgshun, Andrew J SantaCruz, Nadine Hwang, Jaeho Ramkissoon, Shakti H Malkin, Hayley Bergthold, Guillaume Manley, Peter Chi, Susan MacGregor, Duncan Goumnerova, Liliana Sullivan, Michael Ligon, Keith Beroukhim, Rameen Herrington, Betty Kieran, Mark W Hansford, Jordan R Bandopadhayay, Pratiti Journal Article Research Support, Non-U.S. Gov't United States J Neurooncol. 2016 Jun;128(2):293-302. doi: 10.1007/s11060-016-2109-x. Epub 2016 Mar 19. PY - 2016 SN - 0167-594x SP - 293-302 ST - Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation T2 - J Neurooncol TI - Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation VL - 128 ID - 647 ER - TY - JOUR AD - Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. nmargaryan@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. agilgur@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. eseftor@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. chad-purnell@northwestern.edu. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. narva@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. argosain@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. m-hendrix@northwestern.edu. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. lstrizzi@luriechildrens.org. AN - 27011171 AU - Margaryan, N. V. AU - Gilgur, A. AU - Seftor, E. A. AU - Purnell, C. AU - Arva, N. C. AU - Gosain, A. K. AU - Hendrix, M. J. AU - Strizzi, L. C2 - PMC4813269 DA - Mar 22 DO - 10.3390/ijms17030418 DP - NLM ET - 2016/03/25 IS - 3 LA - eng N1 - 1422-0067 Margaryan, Naira V Gilgur, Alina Seftor, Elisabeth A Purnell, Chad Arva, Nicoleta C Gosain, Arun K Hendrix, Mary J C Strizzi, Luigi R01 CA121205/CA/NCI NIH HHS/United States R37 CA059702/CA/NCI NIH HHS/United States R01CA121205/CA/NCI NIH HHS/United States R37CA59702/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Int J Mol Sci. 2016 Mar 22;17(3):418. doi: 10.3390/ijms17030418. PY - 2016 SN - 1422-0067 SP - 418 ST - Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi T2 - Int J Mol Sci TI - Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi VL - 17 ID - 648 ER - TY - JOUR AD - Department of Neurosurgery; Department of Neuropathology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Spain. Department of Neurosurgery, Neurotraumatology, and Neurosurgery Research Unit; and. AN - 27015517 AU - Cicuendez, M. AU - Martinez-Saez, E. AU - Martinez-Ricarte, F. AU - Asanza, E. C. AU - Sahuquillo, J. DA - Jul DO - 10.3171/2016.1.Peds15558 DP - NLM ET - 2016/03/26 IS - 1 LA - eng N1 - 1933-0715 Cicuendez, Marta Martinez-Saez, Elena Martinez-Ricarte, Francisco Asanza, Esteban Cordero Sahuquillo, Juan Case Reports Journal Article United States J Neurosurg Pediatr. 2016 Jul;18(1):53-7. doi: 10.3171/2016.1.PEDS15558. Epub 2016 Mar 25. PY - 2016 SN - 1933-0707 SP - 53-7 ST - Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report T2 - J Neurosurg Pediatr TI - Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report VL - 18 ID - 649 ER - TY - JOUR AD - Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. pindovina@inwind.it. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. pindovina@inwind.it. Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. Oncology Research Center of Mercogliano (CROM), Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. AORN Dei Colli Monaldi UOC, Oncology, Naples, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. Pharmacy Department, University of Genoa, Genoa, Italy. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. giordano@temple.edu. AN - 27037775 AU - Indovina, P. AU - Casini, N. AU - Forte, I. M. AU - Garofano, T. AU - Cesari, D. AU - Iannuzzi, C. A. AU - Del Porro, L. AU - Pentimalli, F. AU - Napoliello, L. AU - Boffo, S. AU - Schenone, S. AU - Botta, M. AU - Giordano, A. DA - Jan DO - 10.1002/jcp.25397 DP - NLM ET - 2016/04/03 IS - 1 LA - eng N1 - 1097-4652 Indovina, Paola Casini, Nadia Forte, Iris Maria Garofano, Tiziana Cesari, Daniele Iannuzzi, Carmelina Antonella Del Porro, Leonardo Pentimalli, Francesca Napoliello, Luca Boffo, Silvia Schenone, Silvia Botta, Maurizio Giordano, Antonio Journal Article Research Support, Non-U.S. Gov't United States J Cell Physiol. 2017 Jan;232(1):129-35. doi: 10.1002/jcp.25397. Epub 2016 Apr 19. PY - 2017 SN - 0021-9541 SP - 129-35 ST - SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration T2 - J Cell Physiol TI - SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration VL - 232 ID - 650 ER - TY - JOUR AN - 27061517 AU - Printz, C. DA - Apr 15 DO - 10.1002/cncr.29999 DP - NLM ET - 2016/04/12 IS - 8 LA - eng N1 - 1097-0142 Printz, Carrie News United States Cancer. 2016 Apr 15;122(8):1148. doi: 10.1002/cncr.29999. PY - 2016 SN - 0008-543x SP - 1148 ST - Pediatric gliomas with CRAF fusions may require combination treatment T2 - Cancer TI - Pediatric gliomas with CRAF fusions may require combination treatment VL - 122 ID - 651 ER - TY - JOUR AD - Department of Medical Oncology, Gustave Roussy, Villejuif, France. Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Thoracic Oncology Unit, Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. Pneumology Department, University Hospital of Strasbourg, Strasbourg, France. Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Joan and Sanfor I Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Livon, Marseille, France. Acute Respiratory Medicine and Thoracic Oncology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. Department of Pulmonary Diseases, University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, Netherlands. Upper Aerodigestive Malignancies Division, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. College of Medicine, Yonsei University, Seoul, South Korea. Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. Adaptimmune LLC, Philadelphia, PA, USA. GlaxoSmithKline, Collegeville, Pennsylvania, PA, USA. Biothera, Eagan, MN, USA. Novartis Pharmaceuticals, King of Prussia, PA, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Novartis Pharmaceuticals, Morrisville, NC, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Bruce_Johnson@dfci.harvard.edu. AN - 27080216 AU - Planchard, D. AU - Kim, T. M. AU - Mazieres, J. AU - Quoix, E. AU - Riely, G. AU - Barlesi, F. AU - Souquet, P. J. AU - Smit, E. F. AU - Groen, H. J. AU - Kelly, R. J. AU - Cho, B. C. AU - Socinski, M. A. AU - Pandite, L. AU - Nase, C. AU - Ma, B. AU - D'Amelio, A., Jr. AU - Mookerjee, B. AU - Curtis, C. M., Jr. AU - Johnson, B. E. C2 - PMC5006181 C6 - NIHMS812215 Boehinger, Lilly, Bristol-Myers Squibb, AstraZeneca, MSD and Pierre Fabre. GR reports grants from GlaxoSmithKline and Novartis; consulting with Novartis; and employer receives research funding from Pfizer, Chugai/Roche and Millennium for support of research led by him. FB reports personal fees from GlaxoSmithKline and Novartis. P-J Souquet reports clinical trial for GlaxoSmithKline. HJMG reports payments to his institution from Roche, MSD, Pfizer and GlaxoSmithKline. LP at the time of the study, was an employee of GlaxoSmithKline. CN reports employment at GlaxoSmithKline at the time the study was conducted, former employment at Novartis and current employment at GlaxoSmithKline. B. Ma reports employment at GlaxoSmithKline at the time the study was conducted. AD, at the time of the study, was an employee of GlaxoSmithKline, is now an employee of Novartis. B Mookerjee, at the time of the study, was an employee of GlaxoSmithKline, is now an employee of Novartis; and owns stock in GlaxoSmithKline and Novartis. CMC was an employee of Novartis and GlaxoSmithKline. BEJ reports personal fees from AstraZeneca, Clovis Oncology, Novartis, Merck, Genentech; honoraria from Chugai Pharmaceuticals; received shares of post-market revenue for EGFR Genotyping patent. TMK, JM, EQ, EFS, RJK, BCC, and MAS report nothing to disclose. DA - May DO - 10.1016/s1470-2045(16)00077-2 DP - NLM ET - 2016/04/16 IS - 5 LA - eng N1 - 1474-5488 Planchard, David Kim, Tae Min Mazieres, Julien Quoix, Elisabeth Riely, Gregory Barlesi, Fabrice Souquet, Pierre-Jean Smit, Egbert F Groen, Harry J M Kelly, Ronan J Cho, B C Socinski, Mark A Pandite, Lini Nase, Christine Ma, Bo D'Amelio, Anthony Jr Mookerjee, Bijoyesh Curtis, C Martin Jr Johnson, Bruce E P30 CA008748/CA/NCI NIH HHS/United States P50 CA090578/CA/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Multicenter Study Research Support, Non-U.S. Gov't Lancet Oncol. 2016 May;17(5):642-50. doi: 10.1016/S1470-2045(16)00077-2. Epub 2016 Apr 11. PY - 2016 SN - 1470-2045 (Print) 1470-2045 SP - 642-50 ST - Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial T2 - Lancet Oncol TI - Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial VL - 17 ID - 652 ER - TY - JOUR AD - Department of Pathology, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. tatsuno-m@ncchd.go.jp. Department of Children's Cancer Center, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Pathology, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Clinical Laboratory Medicine, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Pathology, Tokai University School of Medicine, PO Box 259-1193, 143 Shimokasuya, Isehara-shi, Kanagawa, Japan. AN - 27094161 AU - Tatsuno, M. AU - Shioda, Y. AU - Iwafuchi, H. AU - Yamazaki, S. AU - Iijima, K. AU - Takahashi, C. AU - Ono, H. AU - Uchida, K. AU - Okamura, O. AU - Matubayashi, M. AU - Okuyama, T. AU - Matsumoto, K. AU - Yoshioka, T. AU - Nakazawa, A. C2 - PMC4837618 DA - Apr 19 DO - 10.1186/s13000-016-0489-z DP - NLM ET - 2016/04/21 LA - eng N1 - 1746-1596 Tatsuno, Michiko Shioda, Yoko Iwafuchi, Hideto Yamazaki, Shigeki Iijima, Kenta Takahashi, Chiaki Ono, Hiromi Uchida, Kiyono Okamura, Osamu Matubayashi, Mamoru Okuyama, Torayuki Matsumoto, Kimikazu Yoshioka, Takako Nakazawa, Atsuko Comparative Study Journal Article Research Support, Non-U.S. Gov't Diagn Pathol. 2016 Apr 19;11:39. doi: 10.1186/s13000-016-0489-z. PY - 2016 SN - 1746-1596 SP - 39 ST - BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay T2 - Diagn Pathol TI - BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay VL - 11 ID - 653 ER - TY - JOUR AD - St Paul's Eye Unit, Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK. Pathology Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Department of Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, California, USA. AN - 27098748 AU - Krishna, Y. AU - Kalirai, H. AU - Thornton, S. AU - Damato, B. E. AU - Heimann, H. AU - Coupland, S. E. DA - Jul DO - 10.1136/bjophthalmol-2015-308301 DP - NLM ET - 2016/04/22 IS - 7 LA - eng N1 - 1468-2079 Krishna, Yamini Kalirai, Helen Thornton, Sophie Damato, Bertil E Heimann, Heinrich Coupland, Sarah E Journal Article England Br J Ophthalmol. 2016 Jul;100(7):1012-1016. doi: 10.1136/bjophthalmol-2015-308301. Epub 2016 Apr 20. PY - 2016 SN - 0007-1161 SP - 1012-1016 ST - Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas T2 - Br J Ophthalmol TI - Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas VL - 100 ID - 654 ER - TY - JOUR AD - The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, DC; Center for Neuroscience and Behavior, Children's National Health System, Washington, DC. Electronic address: averyr@email.chop.edu. The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, DC. Division of Oncology, Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC; The Brain Tumor Institute, Children's National Health System, Washington, DC. AN - 27108842 AU - Avery, R. A. AU - Trimboli-Heidler, C. AU - Kilburn, L. B. C2 - PMC4912405 C6 - NIHMS780872 DA - Jun DO - 10.1016/j.jaapos.2016.01.012 DP - NLM ET - 2016/04/26 IS - 3 LA - eng N1 - 1528-3933 Avery, Robert A Trimboli-Heidler, Carmelina Kilburn, Lindsay B K23 EY022673/EY/NEI NIH HHS/United States Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J AAPOS. 2016 Jun;20(3):268-71. doi: 10.1016/j.jaapos.2016.01.012. Epub 2016 Apr 21. PY - 2016 SN - 1091-8531 (Print) 1091-8531 SP - 268-71 ST - Separation of outer retinal layers secondary to selumetinib T2 - J aapos TI - Separation of outer retinal layers secondary to selumetinib VL - 20 ID - 655 ER - TY - JOUR AD - Cytokines and Growth Factors Section, Biotherapeutics Group, National Institute for Biological Standards and Control , Potters Bar, United Kingdom . AN - 27119567 AU - Jia, H. AU - Dilger, P. AU - Bird, C. AU - Wadhwa, M. C2 - PMC4854210 DA - May DO - 10.1089/jir.2015.0091 DP - NLM ET - 2016/04/28 IS - 5 LA - eng N1 - 1557-7465 Jia, Haiyan Dilger, Paula Bird, Chris Wadhwa, Meenu Journal Article J Interferon Cytokine Res. 2016 May;36(5):302-16. doi: 10.1089/jir.2015.0091. Epub 2016 Jan 27. PY - 2016 SN - 1079-9907 (Print) 1079-9907 SP - 302-16 ST - IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs T2 - J Interferon Cytokine Res TI - IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs VL - 36 ID - 656 ER - TY - JOUR AD - GlaxoSmithKline, Collegeville, PA, USA. Sarah Cannon Research Institute, Nashville, TN, USA. Pinnacle Oncology Hematology, Scottsdale, AZ, USA. AN - 27136909 AU - Cox, D. S. AU - Allred, A. AU - Zhou, Y. AU - Infante, J. R. AU - Gordon, M. S. AU - Bendell, J. AU - Jones, S. AU - Burris, H., 3rd AU - Orford, K. DA - Jul DO - 10.1002/cpdd.152 DP - NLM ET - 2016/05/04 IS - 4 LA - eng N1 - 2160-7648 Cox, Donna S Allred, Alicia Zhou, YanYan Infante, Jeffrey R Gordon, Michael S Bendell, Johanna Jones, Suzanne Burris, Howard 3rd Orford, Keith Clinical Trial, Phase I Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't United States Clin Pharmacol Drug Dev. 2015 Jul;4(4):287-94. doi: 10.1002/cpdd.152. Epub 2014 Oct 27. PY - 2015 SN - 2160-763x SP - 287-94 ST - Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors T2 - Clin Pharmacol Drug Dev TI - Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors VL - 4 ID - 657 ER - TY - JOUR AD - Sarcoma Unit, Royal Marsden Hospital, London, UK. Clinical Cytogenetics, Royal Marsden Hospital, Sutton, Surrey, UK. Sarcoma Unit, Royal Marsden Hospital, London, UK. Electronic address: khin.thway@rmh.nhs.uk. AN - 27155927 AU - Vroobel, K. AU - Judson, I. AU - Dainton, M. AU - McCormick, A. AU - Fisher, C. AU - Thway, K. DA - Aug DO - 10.1016/j.prp.2016.04.007 DP - NLM ET - 2016/05/09 IS - 8 LA - eng N1 - 1618-0631 Vroobel, Katherine Judson, Ian Dainton, Melissa McCormick, Alison Fisher, Cyril Thway, Khin Case Reports Journal Article Germany Pathol Res Pract. 2016 Aug;212(8):743-6. doi: 10.1016/j.prp.2016.04.007. Epub 2016 Apr 26. PY - 2016 SN - 0344-0338 SP - 743-6 ST - ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male T2 - Pathol Res Pract TI - ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male VL - 212 ID - 658 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands. Netherlands Translational Research Center B.V., Oss, The Netherlands. The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. AN - 27174491 AU - Canté-Barrett, K. AU - Spijkers-Hagelstein, J. A. AU - Buijs-Gladdines, J. G. AU - Uitdehaag, J. C. AU - Smits, W. K. AU - van der Zwet, J. AU - Buijsman, R. C. AU - Zaman, G. J. AU - Pieters, R. AU - Meijerink, J. P. C2 - PMC5240021 Center B.V. The remaining authors declare no conflict of interests. DA - Sep DO - 10.1038/leu.2016.83 DP - NLM ET - 2016/05/14 IS - 9 LA - eng N1 - 1476-5551 Canté-Barrett, K Spijkers-Hagelstein, J A P Buijs-Gladdines, J G C A M Uitdehaag, J C M Smits, W K van der Zwet, J Buijsman, R C Zaman, G J R Pieters, R Meijerink, J P P Journal Article Leukemia. 2016 Sep;30(9):1832-43. doi: 10.1038/leu.2016.83. Epub 2016 Apr 22. PY - 2016 SN - 0887-6924 (Print) 0887-6924 SP - 1832-43 ST - MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia T2 - Leukemia TI - MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia VL - 30 ID - 659 ER - TY - JOUR AD - Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006; HistoPath Pathology, North Ryde, NSW, Australia 2113. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006. Electronic address: affgill@med.usyd.edu.au. AN - 27184481 AU - Wang, J. AU - Andrici, J. AU - Sioson, L. AU - Clarkson, A. AU - Sheen, A. AU - Farzin, M. AU - Toon, C. W. AU - Turchini, J. AU - Gill, A. J. DA - Sep DO - 10.1016/j.humpath.2016.04.018 DP - NLM ET - 2016/05/18 LA - eng N1 - 1532-8392 Wang, Jennifer Andrici, Juliana Sioson, Loretta Clarkson, Adele Sheen, Amy Farzin, Mahtab Toon, Christopher W Turchini, John Gill, Anthony J Journal Article Research Support, Non-U.S. Gov't United States Hum Pathol. 2016 Sep;55:83-90. doi: 10.1016/j.humpath.2016.04.018. Epub 2016 May 14. PY - 2016 SN - 0046-8177 SP - 83-90 ST - Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency T2 - Hum Pathol TI - Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency VL - 55 ID - 660 ER - TY - JOUR AD - Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Tumor Virus Molecular Biology Section, Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA. Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: jianyou@mail.med.upenn.edu. AN - 27212661 AU - Liu, W. AU - Yang, R. AU - Payne, A. S. AU - Schowalter, R. M. AU - Spurgeon, M. E. AU - Lambert, P. F. AU - Xu, X. AU - Buck, C. B. AU - You, J. C2 - PMC4900903 C6 - NIHMS783901 DA - Jun 8 DO - 10.1016/j.chom.2016.04.024 DP - NLM ET - 2016/05/24 IS - 6 LA - eng N1 - 1934-6069 Liu, Wei Yang, Ruifeng Payne, Aimee S Schowalter, Rachel M Spurgeon, Megan E Lambert, Paul F Xu, Xiaowei Buck, Christopher B You, Jianxin R01 CA142723/CA/NCI NIH HHS/United States R01 AR054593/AR/NIAMS NIH HHS/United States R01 CA187718/CA/NCI NIH HHS/United States T32 AI078985/AI/NIAID NIH HHS/United States P50 CA174523/CA/NCI NIH HHS/United States R01 CA148768/CA/NCI NIH HHS/United States R56 AR064220/AR/NIAMS NIH HHS/United States Journal Article Cell Host Microbe. 2016 Jun 8;19(6):775-87. doi: 10.1016/j.chom.2016.04.024. Epub 2016 May 19. PY - 2016 SN - 1931-3128 (Print) 1931-3128 SP - 775-87 ST - Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection T2 - Cell Host Microbe TI - Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection VL - 19 ID - 661 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois. AN - 27225638 AU - Cajaiba, M. M. AU - Jennings, L. J. AU - George, D. AU - Perlman, E. J. C2 - PMC4980203 C6 - NIHMS790500 DA - Oct DO - 10.1002/gcc.22382 DP - NLM ET - 2016/05/27 IS - 10 LA - eng N1 - 1098-2264 Cajaiba, Mariana M Jennings, Lawrence J George, David Perlman, Elizabeth J U10 CA098543/CA/NCI NIH HHS/United States U10 CA180886/CA/NCI NIH HHS/United States U10 CA180899/CA/NCI NIH HHS/United States U24 CA114766/CA/NCI NIH HHS/United States Case Reports Letter Research Support, N.I.H., Extramural Genes Chromosomes Cancer. 2016 Oct;55(10):814-7. doi: 10.1002/gcc.22382. Epub 2016 Jul 7. PY - 2016 SN - 1045-2257 (Print) 1045-2257 SP - 814-7 ST - Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript T2 - Genes Chromosomes Cancer TI - Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript VL - 55 ID - 662 ER - TY - JOUR AD - *Department of Pathology, Vancouver General Hospital §Genome Sciences Center ∥British Columbia Cancer Agency ¶British Columbia Children's Hospital #Department of Pathology, University of British Columbia, Vancouver, BC **Department of Pathology, Royal Alexandra Hospital, Edmonton, AB, Canada †Department of Pathology, King Abdulaziz Medical City, Riyadh, Saudi Arabia ‡Department of Pathology, Kuwait University, Kuwait. AN - 27259007 AU - Alassiri, A. H. AU - Ali, R. H. AU - Shen, Y. AU - Lum, A. AU - Strahlendorf, C. AU - Deyell, R. AU - Rassekh, R. AU - Sorensen, P. H. AU - Laskin, J. AU - Marra, M. AU - Yip, S. AU - Lee, C. H. AU - Ng, T. L. DA - Aug DO - 10.1097/pas.0000000000000677 DP - NLM ET - 2016/06/04 IS - 8 LA - eng N1 - 1532-0979 Alassiri, Ali H Ali, Rola H Shen, Yaoqing Lum, Amy Strahlendorf, Caron Deyell, Rebecca Rassekh, Rod Sorensen, Poul H Laskin, Janessa Marra, Marco Yip, Stephen Lee, Cheng-Han Ng, Tony L Case Reports Journal Article United States Am J Surg Pathol. 2016 Aug;40(8):1051-61. doi: 10.1097/PAS.0000000000000677. PY - 2016 SN - 0147-5185 SP - 1051-61 ST - ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors T2 - Am J Surg Pathol TI - ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors VL - 40 ID - 663 ER - TY - JOUR AD - Department of Neurosurgery, Eberhard-Karls University, Hoppe-Seyler Street 3, 72076, Tübingen, Germany. felix.behling@med.uni-tuebingen.de. Department of Neuropathology, Georg-August University, Robert-Koch-Street 40, 37075, Göttingen, Germany. Department of Neurosurgery, Eberhard-Karls University, Hoppe-Seyler Street 3, 72076, Tübingen, Germany. Department of Pathology, Eberhard-Karls University, Liebermeisterstr. 8, 72076, Tübingen, Germany. Department of Neuropathology, Hannover Medical School, Carl-Neuberg Street 1, 30625, Hannover, Germany. Department of Neurosurgery, Städtisches Klinikum Dresden-Friedrichstadt, Friedrichstr. 41, 01067, Dresden, Germany. Department of Neurosurgery, Georg-August University, Robert-Koch-Street 40, 37075, Göttingen, Germany. Department of Neuropathology, Eberhard-Karls University, Calwer Str. 3, 72076, Tübingen, Germany. AN - 27350555 AU - Behling, F. AU - Barrantes-Freer, A. AU - Skardelly, M. AU - Nieser, M. AU - Christians, A. AU - Stockhammer, F. AU - Rohde, V. AU - Tatagiba, M. AU - Hartmann, C. AU - Stadelmann, C. AU - Schittenhelm, J. C2 - PMC4924254 DA - Jun 27 DO - 10.1186/s13000-016-0506-2 DP - NLM ET - 2016/06/29 IS - 1 LA - eng N1 - 1746-1596 Behling, Felix Orcid: 0000-0002-1083-1276 Barrantes-Freer, Alonso Skardelly, Marco Nieser, Maike Christians, Arne Stockhammer, Florian Rohde, Veit Tatagiba, Marcos Hartmann, Christian Stadelmann, Christine Schittenhelm, Jens Journal Article Diagn Pathol. 2016 Jun 27;11(1):55. doi: 10.1186/s13000-016-0506-2. PY - 2016 SN - 1746-1596 SP - 55 ST - Frequency of BRAF V600E mutations in 969 central nervous system neoplasms T2 - Diagn Pathol TI - Frequency of BRAF V600E mutations in 969 central nervous system neoplasms VL - 11 ID - 664 ER - TY - JOUR AD - Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Research Center (MBC 03), PO Box 3354, Riyadh, 11211, Saudi Arabia. Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Research Center (MBC 03), PO Box 3354, Riyadh, 11211, Saudi Arabia. aliz@kfshrc.edu.sa. Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. aliz@kfshrc.edu.sa. AN - 27387551 AU - Murugan, A. K. AU - Qasem, E. AU - Al-Hindi, H. AU - Shi, Y. AU - Alzahrani, A. S. C2 - PMC4936197 DA - Jul 7 DO - 10.1186/s12967-016-0958-x DP - NLM ET - 2016/07/09 IS - 1 LA - eng N1 - 1479-5876 Murugan, Avaniyapuram Kannan Qasem, Ebtesam Al-Hindi, Hindi Shi, Yufei Alzahrani, Ali S Journal Article Research Support, Non-U.S. Gov't J Transl Med. 2016 Jul 7;14(1):204. doi: 10.1186/s12967-016-0958-x. PY - 2016 SN - 1479-5876 SP - 204 ST - Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer T2 - J Transl Med TI - Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer VL - 14 ID - 665 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio, TX, 78229, USA. Amita.Patnaik@start.stoh.com. South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio, TX, 78229, USA. Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA. GlaxoSmithKline, Research Triangle Park, NC, 27709, USA. Quinitles, 4820 Emperor Boulevard, Durham, NC, 27703, USA. MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA, 19426, USA. Teva Pharmaceuticals Industries, Ltd., 1090 Horsham Road, North Wales, PA, 19454, USA. GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA, USA. AN - 27392790 AU - Patnaik, A. AU - Tolcher, A. AU - Papadopoulos, K. P. AU - Beeram, M. AU - Rasco, D. AU - Werner, T. L. AU - Bauman, J. W. AU - Scheuber, A. AU - Cox, D. S. AU - Patel, B. R. AU - Zhou, Y. AU - Hamid, M. AU - Schramek, D. AU - Sharma, S. DA - Sep DO - 10.1007/s00280-016-3090-y DP - NLM ET - 2016/07/10 IS - 3 LA - eng N1 - 1432-0843 Patnaik, Amita Tolcher, Anthony Papadopoulos, Kyriakos P Beeram, Murali Rasco, Drew Werner, Theresa L Bauman, John W Scheuber, Anita Cox, Donna S Patel, Bela R Zhou, YanYan Hamid, Mohammed Schramek, Daniel Sharma, Sunil Clinical Trial, Phase I Journal Article Multicenter Study Germany Cancer Chemother Pharmacol. 2016 Sep;78(3):491-500. doi: 10.1007/s00280-016-3090-y. Epub 2016 Jul 8. PY - 2016 SN - 0344-5704 SP - 491-500 ST - Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours T2 - Cancer Chemother Pharmacol TI - Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours VL - 78 ID - 666 ER - TY - JOUR AD - Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: frodrig4@jhmi.edu. Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Cellular and Tissue Biology, National Autonomous University of Mexico (UNAM), Mexico City, Mexico. Division of Molecular Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. AN - 27444975 AU - Rodriguez, F. J. AU - Vizcaino, M. A. AU - Lin, M. T. C2 - PMC5397677 DA - Sep DO - 10.1016/j.jmoldx.2016.05.005 DP - NLM ET - 2016/07/23 IS - 5 LA - eng N1 - 1943-7811 Rodriguez, Fausto J Vizcaino, M Adelita Lin, Ming-Tseh P30 CA006973/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review J Mol Diagn. 2016 Sep;18(5):620-634. doi: 10.1016/j.jmoldx.2016.05.005. PY - 2016 SN - 1525-1578 (Print) 1525-1578 SP - 620-634 ST - Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults T2 - J Mol Diagn TI - Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults VL - 18 ID - 667 ER - TY - JOUR AD - Service de Génétique, C.H.U. de Poitiers, Centre de Référence Anomalies du Développement Ouest, Poitiers, France. EA 3808 Université de Poitiers, Poitiers, France. Service de Génétique et Biologie Moléculaires, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Bâtiment Jean Dausset, 3ème étage, 27 rue du Faubourg Saint Jacques, Paris, France. EA7331, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Pharmacie, Paris, France. Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Département de Génétique, INSERM UMR_S1131, Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne-Paris-Cité, Paris, France. Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Département de Génétique, INSERM UMR 1141, Université Paris Diderot, Sorbonne-Paris-Cité, Paris, France. Service de Génétique et Biologie Moléculaires, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Bâtiment Jean Dausset, 3ème étage, 27 rue du Faubourg Saint Jacques, Paris, France. eric.pasmant@gmail.com. EA7331, Université Paris Descartes, Sorbonne Paris Cité, Faculté de Pharmacie, Paris, France. eric.pasmant@gmail.com. AN - 27450488 AU - Gilbert-Dussardier, B. AU - Briand-Suleau, A. AU - Laurendeau, I. AU - Bilan, F. AU - Cavé, H. AU - Verloes, A. AU - Vidaud, M. AU - Vidaud, D. AU - Pasmant, E. C2 - PMC4957908 DA - Jul 22 DO - 10.1186/s13023-016-0479-y DP - NLM ET - 2016/07/28 IS - 1 LA - eng N1 - 1750-1172 Gilbert-Dussardier, Brigitte Briand-Suleau, Audrey Laurendeau, Ingrid Bilan, Frédéric Cavé, Hélène Verloes, Alain Vidaud, Michel Vidaud, Dominique Pasmant, Eric Letter Orphanet J Rare Dis. 2016 Jul 22;11(1):101. doi: 10.1186/s13023-016-0479-y. PY - 2016 SN - 1750-1172 SP - 101 ST - Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities T2 - Orphanet J Rare Dis TI - Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities VL - 11 ID - 668 ER - TY - JOUR AD - Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, 270 Dong An Road, Shanghai, 200032, China. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University and Shanghai Respiratory Research Institute, Shanghai, 200032, China. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China. Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, 270 Dong An Road, Shanghai, 200032, China. softtissuetumor@163.com. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. softtissuetumor@163.com. AN - 27460384 AU - Yu, L. AU - Liu, J. AU - Lao, I. W. AU - Luo, Z. AU - Wang, J. C2 - PMC4962498 DA - Jul 27 DO - 10.1186/s13000-016-0517-z DP - NLM ET - 2016/07/28 IS - 1 LA - eng N1 - 1746-1596 Yu, Lin Liu, Jinguo Lao, I Weng Luo, Zhiguo Wang, Jian Case Reports Journal Article Review Diagn Pathol. 2016 Jul 27;11(1):67. doi: 10.1186/s13000-016-0517-z. PY - 2016 SN - 1746-1596 SP - 67 ST - Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature T2 - Diagn Pathol TI - Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature VL - 11 ID - 669 ER - TY - JOUR AD - Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu 210093, P.R. China. Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China. Department of Respiratory Medicine, Nanjing Children's Hospital Affiliated with Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China. AN - 27460781 AU - Feng, Q. AU - Su, Z. AU - Song, S. AU - Χu, H. AU - Zhang, B. AU - Yi, L. AU - Tian, M. AU - Wang, H. C2 - PMC4990302 DA - Sep DO - 10.3892/ijmm.2016.2691 DP - NLM ET - 2016/07/28 IS - 3 LA - eng N1 - 1791-244x Feng, Qiuqin Su, Zhonglan Song, Shiyu Χu, Hui Zhang, Bin Yi, Long Tian, Man Wang, Hongwei Journal Article Int J Mol Med. 2016 Sep;38(3):812-22. doi: 10.3892/ijmm.2016.2691. Epub 2016 Jul 26. PY - 2016 SN - 1107-3756 (Print) 1107-3756 SP - 812-22 ST - Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation T2 - Int J Mol Med TI - Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation VL - 38 ID - 670 ER - TY - JOUR AD - Department of Cytology and Cytogenetic, University Hospital Merkur, Zagreb, Croatia. School of Medicine, University of Zagreb, Croatia. Department of Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia. Department of Clinical Chemistry and Laboratory Medicine, Merkur, University Hospital, Zagreb, Croatia. Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia. AN - 27468968 AU - Bogdanic, M. AU - Ostojic Kolonic, S. AU - Kaic, G. AU - Kardum Paro, M. M. AU - Lasan Trcic, R. AU - Kardum-Skelin, I. DA - Jan DO - 10.1002/dc.23542 DP - NLM ET - 2016/07/30 IS - 1 LA - eng N1 - 1097-0339 Bogdanic, Maja Ostojic Kolonic, Slobodanka Kaic, Gordana Kardum Paro, Mirjana Mariana Lasan Trcic, Ruzica Kardum-Skelin, Ika Case Reports Journal Article United States Diagn Cytopathol. 2017 Jan;45(1):51-54. doi: 10.1002/dc.23542. Epub 2016 Jul 29. PY - 2017 SN - 1097-0339 SP - 51-54 ST - Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation T2 - Diagn Cytopathol TI - Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation VL - 45 ID - 671 ER - TY - JOUR AD - a Division of Pediatric Oncology , Catholic University of Rome , Rome , Italy. AN - 27494648 AU - Rizzo, D. AU - Ruggiero, A. AU - Amato, M. AU - Maurizi, P. AU - Riccardi, R. DA - Dec DO - 10.1080/17425255.2016.1214710 DP - NLM ET - 2016/08/06 IS - 12 LA - eng N1 - 1744-7607 Rizzo, Daniela Ruggiero, Antonio Amato, Maria Maurizi, Palma Riccardi, Riccardo Journal Article Review England Expert Opin Drug Metab Toxicol. 2016 Dec;12(12):1397-1405. doi: 10.1080/17425255.2016.1214710. Epub 2016 Aug 5. PY - 2016 SN - 1742-5255 SP - 1397-1405 ST - BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities T2 - Expert Opin Drug Metab Toxicol TI - BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities VL - 12 ID - 672 ER - TY - JOUR AD - Department of Pediatrics, Yokohama City University, Yokohama, Japan. Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan. AN - 27494825 AU - Hayashi, A. AU - Tanoshima, R. AU - Tsujimoto, S. I. AU - Yanagimachi, M. AU - Takeuchi, M. AU - Sasaki, K. AU - Ikeda, J. AU - Kajiwara, R. AU - Ito, S. AU - Takahashi, H. C2 - PMC5022176 DA - Aug 5 DO - 10.1038/bcj.2016.52 DP - NLM ET - 2016/08/06 IS - 8 LA - eng N1 - 2044-5385 Hayashi, A Tanoshima, R Tsujimoto, S-I Yanagimachi, M Takeuchi, M Sasaki, K Ikeda, J Kajiwara, R Ito, S Takahashi, H Case Reports Journal Article Research Support, Non-U.S. Gov't Blood Cancer J. 2016 Aug 5;6(8):e456. doi: 10.1038/bcj.2016.52. PY - 2016 SN - 2044-5385 SP - e456 ST - Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene T2 - Blood Cancer J TI - Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene VL - 6 ID - 673 ER - TY - JOUR AN - 27563714 AU - Li, W. AU - Repnikova, E. DA - Apr 21 DO - 10.1182/blood-2016-01-695288 DP - NLM ET - 2016/08/27 IS - 16 LA - eng N1 - 1528-0020 Li, Weijie Repnikova, Elena Case Reports Journal Article United States Blood. 2016 Apr 21;127(16):2041. doi: 10.1182/blood-2016-01-695288. PY - 2016 SN - 0006-4971 SP - 2041 ST - ALK-positive anaplastic large-cell lymphoma with marked leukemoid reaction and hemophagocytic lymphohistiocytosis T2 - Blood TI - ALK-positive anaplastic large-cell lymphoma with marked leukemoid reaction and hemophagocytic lymphohistiocytosis VL - 127 ID - 674 ER - TY - JOUR AD - Alvaro Lassaletta, Cynthia E. Hawkins, Rahul Krishnatry, Matthew Mistry, Anthony Arnoldo, Vijay Ramaswamy, Annie Huang, Ute Bartels, Uri Tabori, and Eric Bouffet, The Hospital for Sick Children, Toronto; Katrin Scheinemann, McMaster Children's Hospital; Shayna M. Zelcer, Children's Hospital of Western Ontario, London; Gregory Russell Pond, Ontario Clinical Oncology Group, McMaster University, Hamilton; Daniel Keene and Donna L. Johnston, Children's Hospital of Eastern Ontario, Ottawa, Ontario; Juliette Hukin and Ken Poskitt, British Columbia Children's Hospital, Vancouver, British Columbia; Beverley A. Wilson, University of Alberta Hospital; Lucie Lafay-Cousin, Alberta Children's Hospital, Calgary; David D. Eisenstat, Stollery Children's Hospital, Edmonton; Alberta; Nada Jabado, McGill University; Anne Sophie Carret, Hospital Sainte Justine, Montreal; Valerie Larouche, Centre Hospitalier Universitaire de Québec, Québec, Québec; and David D. Eisenstat, Cancer Care Manitoba, Winnipeg, Manitoba, Canada. AN - 27573663 AU - Lassaletta, A. AU - Scheinemann, K. AU - Zelcer, S. M. AU - Hukin, J. AU - Wilson, B. A. AU - Jabado, N. AU - Carret, A. S. AU - Lafay-Cousin, L. AU - Larouche, V. AU - Hawkins, C. E. AU - Pond, G. R. AU - Poskitt, K. AU - Keene, D. AU - Johnston, D. L. AU - Eisenstat, D. D. AU - Krishnatry, R. AU - Mistry, M. AU - Arnoldo, A. AU - Ramaswamy, V. AU - Huang, A. AU - Bartels, U. AU - Tabori, U. AU - Bouffet, E. DA - Oct 10 DO - 10.1200/jco.2016.68.1585 DP - NLM ET - 2016/08/31 IS - 29 LA - eng N1 - 1527-7755 Lassaletta, Alvaro Scheinemann, Katrin Zelcer, Shayna M Hukin, Juliette Wilson, Beverley A Jabado, Nada Carret, Anne Sophie Lafay-Cousin, Lucie Larouche, Valerie Hawkins, Cynthia E Pond, Gregory Russell Poskitt, Ken Keene, Daniel Johnston, Donna L Eisenstat, David D Krishnatry, Rahul Mistry, Matthew Arnoldo, Anthony Ramaswamy, Vijay Huang, Annie Bartels, Ute Tabori, Uri Bouffet, Eric Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't United States J Clin Oncol. 2016 Oct 10;34(29):3537-3543. doi: 10.1200/JCO.2016.68.1585. PY - 2016 SN - 0732-183x SP - 3537-3543 ST - Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study T2 - J Clin Oncol TI - Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study VL - 34 ID - 675 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. AN - 27588400 AU - Kerstjens, M. AU - Driessen, E. M. AU - Willekes, M. AU - Pinhanços, S. S. AU - Schneider, P. AU - Pieters, R. AU - Stam, R. W. C2 - PMC5362448 DA - Feb 28 DO - 10.18632/oncotarget.11730 DP - NLM ET - 2016/09/03 IS - 9 LA - eng N1 - 1949-2553 Kerstjens, Mark Driessen, Emma M C Willekes, Merel Pinhanços, Sandra S Schneider, Pauline Pieters, Rob Stam, Ronald W Journal Article Oncotarget. 2017 Feb 28;8(9):14835-14846. doi: 10.18632/oncotarget.11730. PY - 2017 SN - 1949-2553 SP - 14835-14846 ST - MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations T2 - Oncotarget TI - MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations VL - 8 ID - 676 ER - TY - JOUR AD - Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon, Republic of Korea. Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon, Republic of Korea. Electronic address: iohan@inha.ac.kr. AN - 27609291 AU - Hwang, J. S. AU - Jung, E. H. AU - Kwon, M. Y. AU - Han, I. O. DA - Sep 15 DO - 10.1016/j.jneuroim.2016.08.001 DP - NLM ET - 2016/09/10 LA - eng N1 - 1872-8421 Hwang, Ji-Sun Jung, Eun-Hye Kwon, Mi-Youn Han, Inn-Oc Journal Article Netherlands J Neuroimmunol. 2016 Sep 15;298:165-71. doi: 10.1016/j.jneuroim.2016.08.001. Epub 2016 Aug 2. PY - 2016 SN - 0165-5728 SP - 165-71 ST - Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α T2 - J Neuroimmunol TI - Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α VL - 298 ID - 677 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. AN - 27611946 AU - Yao, T. W. AU - Zhang, J. AU - Prados, M. AU - Weiss, W. A. AU - James, C. D. AU - Nicolaides, T. C2 - PMC5352180 DA - Jan 3 DO - 10.18632/oncotarget.11882 DP - NLM ET - 2016/09/10 IS - 1 LA - eng N1 - 1949-2553 Yao, Tsun-Wen Zhang, Jie Prados, Michael Weiss, William A James, C David Nicolaides, Theodore U54 CA163155/CA/NCI NIH HHS/United States K08 NS065268/NS/NINDS NIH HHS/United States U01 CA176287/CA/NCI NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States P30 CA082103/CA/NCI NIH HHS/United States P30 CA060553/CA/NCI NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States Journal Article Oncotarget. 2017 Jan 3;8(1):583-595. doi: 10.18632/oncotarget.11882. PY - 2017 SN - 1949-2553 SP - 583-595 ST - Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas T2 - Oncotarget TI - Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas VL - 8 ID - 678 ER - TY - JOUR AD - Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Electronic address: bio-zcw@163.com. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China. First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Electronic address: yangqiuli@hotmail.com. AN - 27613090 AU - Zhang, Y. AU - Zeng, C. AU - Lu, S. AU - Qin, T. AU - Yang, L. AU - Chen, S. AU - Chen, J. AU - Li, Y. DA - Sep 30 DO - 10.1016/j.bbrc.2016.09.020 DP - NLM ET - 2016/09/11 IS - 4 LA - eng N1 - 1090-2104 Zhang, Yikai Zeng, Chengwu Lu, Shuai Qin, Tianyu Yang, Lijian Chen, Shaohua Chen, Jie Li, Yangqiu Journal Article Research Support, Non-U.S. Gov't United States Biochem Biophys Res Commun. 2016 Sep 30;478(4):1758-63. doi: 10.1016/j.bbrc.2016.09.020. Epub 2016 Sep 6. PY - 2016 SN - 0006-291x SP - 1758-63 ST - Identification of miR-125b targets involved in acute promyelocytic leukemia cell proliferation T2 - Biochem Biophys Res Commun TI - Identification of miR-125b targets involved in acute promyelocytic leukemia cell proliferation VL - 478 ID - 679 ER - TY - JOUR AD - Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan; Brain Research Unit, Innovation Center for Medical Redox Navigation, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: takahiro@npsych.med.kyushu-u.ac.jp. Department of Psychiatry, Saga University Faculty of Medicine, Saga 849-8501, Japan. Faculty of Medicine, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. AN - 27614570 AU - Sato-Kasai, M. AU - Kato, T. A. AU - Ohgidani, M. AU - Mizoguchi, Y. AU - Sagata, N. AU - Inamine, S. AU - Horikawa, H. AU - Hayakawa, K. AU - Shimokawa, N. AU - Kyuragi, S. AU - Seki, Y. AU - Monji, A. AU - Kanba, S. DA - Dec DO - 10.1016/j.schres.2016.08.022 DP - NLM ET - 2016/09/12 IS - 1-3 LA - eng N1 - 1573-2509 Sato-Kasai, Mina Kato, Takahiro A Ohgidani, Masahiro Mizoguchi, Yoshito Sagata, Noriaki Inamine, Shogo Horikawa, Hideki Hayakawa, Kohei Shimokawa, Norihiro Kyuragi, Sota Seki, Yoshihiro Monji, Akira Kanba, Shigenobu Journal Article Research Support, Non-U.S. Gov't Netherlands Schizophr Res. 2016 Dec;178(1-3):35-43. doi: 10.1016/j.schres.2016.08.022. Epub 2016 Sep 7. PY - 2016 SN - 0920-9964 SP - 35-43 ST - Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7 T2 - Schizophr Res TI - Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7 VL - 178 ID - 680 ER - TY - JOUR AD - Institut National de la Santé et de la Recherche Médicale (Inserm) U1053, Universitaire de Bordeaux, F-33076 Bordeaux, France. Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France. Service de Biologie des Tumeurs-Tumorothèque, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France. Service de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, F-33000 Bordeaux, France. Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, CEP 20550-013 Rio de Janeiro, Brazil. Plateforme de Vectorologie, Unité Mixte de Services (UMS TBM-Core), Centre National de la Recherche Scientifique (CNRS)- Institut National de la Santé et de la Recherche Médicale (Inserm)-Universitaire de Bordeaux, F-33076 Bordeaux, France. Biothérapies des Maladies Génétiques et Cancers, Institut National de la Santé et de la Recherche Médicale (Inserm), U1035, Universitaire de Bordeaux, F-33076 Bordeaux, France. AN - 27626696 AU - Mélard, P. AU - Idrissi, Y. AU - Andrique, L. AU - Poglio, S. AU - Prochazkova-Carlotti, M. AU - Berhouet, S. AU - Boucher, C. AU - Laharanne, E. AU - Chevret, E. AU - Pham-Ledard, A. AU - De Souza Góes, A. C. AU - Guyonnet-Duperat, V. AU - Bibeyran, A. AU - Moreau-Gaudry, F. AU - Vergier, B. AU - Beylot-Barry, M. AU - Merlio, J. P. AU - Cappellen, D. C2 - PMC5356586 DA - Oct 18 DO - 10.18632/oncotarget.11930 DP - NLM ET - 2016/09/15 IS - 42 LA - eng N1 - 1949-2553 Mélard, Pierre Idrissi, Yamina Andrique, Laetitia Poglio, Sandrine Prochazkova-Carlotti, Martina Berhouet, Sabine Boucher, Cécile Laharanne, Elodie Chevret, Edith Pham-Ledard, Anne De Souza Góes, Andréa Carla Guyonnet-Duperat, Véronique Bibeyran, Alice Moreau-Gaudry, François Vergier, Béatrice Beylot-Barry, Marie Merlio, Jean-Philippe Cappellen, David Journal Article Oncotarget. 2016 Oct 18;7(42):68734-68748. doi: 10.18632/oncotarget.11930. PY - 2016 SN - 1949-2553 SP - 68734-68748 ST - Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes T2 - Oncotarget TI - Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes VL - 7 ID - 681 ER - TY - JOUR AD - Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030; Department of Dermatology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Biostatistics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030; Department of Dermatology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Electronic address: vprieto@mdanderson.org. AN - 27666765 AU - Siroy, A. E. AU - Aung, P. P. AU - Torres-Cabala, C. A. AU - Tetzlaff, M. T. AU - Nagarajan, P. AU - Milton, D. R. AU - Curry, J. L. AU - Ivan, D. AU - Prieto, V. G. DA - Jan DO - 10.1016/j.humpath.2016.09.010 DP - NLM ET - 2016/09/27 LA - eng N1 - 1532-8392 Siroy, Alan E Aung, Phyu P Torres-Cabala, Carlos A Tetzlaff, Michael T Nagarajan, Priyadharsini Milton, Denái R Curry, Jonathan L Ivan, Doina Prieto, Victor G Journal Article United States Hum Pathol. 2017 Jan;59:48-54. doi: 10.1016/j.humpath.2016.09.010. Epub 2016 Sep 22. PY - 2017 SN - 0046-8177 SP - 48-54 ST - Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma T2 - Hum Pathol TI - Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma VL - 59 ID - 682 ER - TY - JOUR AD - Department of Medical Oncology, National Cancer Centre Singapore, Singapore. Department of Haematology-Oncology, National University Health System, Singapore. Divisions of Clinical Trials and Epidemiological Sciences. Oncologic Imaging, National Cancer Centre Singapore, Singapore. Cancer Science Institute of Singapore, National University of Singapore, Singapore. SingHealth Duke-NUS Radiological Sciences Academic Clinical Program, Singapore. Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, Singapore. Department of Pathology, Singapore General Hospital, Singapore, Singapore. Department of Medical Oncology, National Cancer Centre Singapore, Singapore choo.su.pin@singhealth.com.sg. AN - 27681866 AU - Tai, W. M. AU - Yong, W. P. AU - Lim, C. AU - Low, L. S. AU - Tham, C. K. AU - Koh, T. S. AU - Ng, Q. S. AU - Wang, W. W. AU - Wang, L. Z. AU - Hartano, S. AU - Thng, C. H. AU - Huynh, H. AU - Lim, K. T. AU - Toh, H. C. AU - Goh, B. C. AU - Choo, S. P. DA - Dec DO - 10.1093/annonc/mdw415 DP - NLM ET - 2016/09/30 IS - 12 LA - eng N1 - 1569-8041 Tai, W M Yong, W P Lim, C Low, L S Tham, C K Koh, T S Ng, Q S Wang, W W Wang, L Z Hartano, S Thng, C H Huynh, H Lim, K T Toh, H C Goh, B C Choo, S P Clinical Trial, Phase I Journal Article England Ann Oncol. 2016 Dec;27(12):2210-2215. doi: 10.1093/annonc/mdw415. Epub 2016 Sep 28. PY - 2016 SN - 0923-7534 SP - 2210-2215 ST - A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) T2 - Ann Oncol TI - A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) VL - 27 ID - 683 ER - TY - JOUR AD - People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China. Key Laboratory of Integrative Kidney Disease in Fujian Province, Fuzhou, Fujian, China. Fuzhou General Hospital of Nanjing Military District, Fuzhou, Fujian, China. Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China zjiandr@163.com. Key Laboratory of Integrative Kidney Disease in Fujian Province, Fuzhou, Fujian, China zjiandr@163.com. AN - 27706571 AU - Ai, S. AU - Lin, Y. Y. AU - Zheng, J. AU - Qiu, C. X. AU - Liu, Y. J. AU - Lin, X. DA - Aug 19 DO - 10.4238/gmr.15038131 DP - NLM ET - 2016/10/06 IS - 3 LA - eng N1 - 1676-5680 Ai, S Lin, Y Y Zheng, J Qiu, C X Liu, Y J Lin, X Journal Article Brazil Genet Mol Res. 2016 Aug 19;15(3). doi: 10.4238/gmr.15038131. PY - 2016 SN - 1676-5680 ST - Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy T2 - Genet Mol Res TI - Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy VL - 15 ID - 684 ER - TY - JOUR AD - Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Division of Pediatric Oncology, Shanghai Institute of Pediatric Research, Shanghai, China. AN - 27732954 AU - Chen, K. AU - Lv, F. AU - Xu, G. AU - Zhang, M. AU - Wu, Y. AU - Wu, Z. C2 - PMC5342791 DA - Nov 15 DO - 10.18632/oncotarget.12513 DP - NLM ET - 2016/10/13 IS - 46 LA - eng N1 - 1949-2553 Chen, Kai Lv, Fan Xu, Guofeng Zhang, Min Wu, Yeming Wu, Zhixiang Journal Article Oncotarget. 2016 Nov 15;7(46):75968-75980. doi: 10.18632/oncotarget.12513. PY - 2016 SN - 1949-2553 SP - 75968-75980 ST - Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma T2 - Oncotarget TI - Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma VL - 7 ID - 685 ER - TY - JOUR AD - *Department of Pathology, University of Colorado Denver, Aurora, CO †Department of Hematopathology, MD Anderson Cancer Center, Houston, TX §Department of Laboratory Medicine, University of Washington, Seattle, WA ∥Department of Pathology, City of Hope National Medical Center, Duarte ††Department of Pathology, University of California Davis, Sacramento ‡‡Department of Pathology, University of California San Diego, La Jolla, CA ¶Department of Pathology, University of Alabama at Birmingham, Birmingham, AL #Human Genetics Laboratory **Department of Biostatistics §§Department of Pathology and Microbiology, University of Nebraska Medical Center, NE ‡Department of Pathology, Peking University Health Science Center, Beijing, China. AN - 27740969 AU - Pan, Z. AU - Hu, S. AU - Li, M. AU - Zhou, Y. AU - Kim, Y. S. AU - Reddy, V. AU - Sanmann, J. N. AU - Smith, L. M. AU - Chen, M. AU - Gao, Z. AU - Wang, H. Y. AU - Yuan, J. DA - Jan DO - 10.1097/pas.0000000000000753 DP - NLM ET - 2016/10/16 IS - 1 LA - eng N1 - 1532-0979 Pan, Zenggang Hu, Shimin Li, Min Zhou, Yi Kim, Young S Reddy, Vishnu Sanmann, Jennifer N Smith, Lynette M Chen, Mingyi Gao, Zifen Wang, Huan-You Yuan, Ji Journal Article Review United States Am J Surg Pathol. 2017 Jan;41(1):25-38. doi: 10.1097/PAS.0000000000000753. PY - 2017 SN - 0147-5185 SP - 25-38 ST - ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature T2 - Am J Surg Pathol TI - ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature VL - 41 ID - 686 ER - TY - JOUR AD - The University of Texas MD Anderson Cancer Center, Houston, Tex., USA. AN - 27764830 AU - Subbiah, V. AU - Holmes, O. AU - Gowen, K. AU - Spritz, D. AU - Amini, B. AU - Wang, W. L. AU - Schrock, A. B. AU - Meric-Bernstam, F. AU - Zinner, R. AU - Piha-Paul, S. AU - Zarzour, M. AU - Elvin, J. A. AU - Erlich, R. L. AU - Stockman, D. L. AU - Vergilio, J. A. AU - Suh, J. H. AU - Stephens, P. J. AU - Miller, V. AU - Ross, J. S. AU - Ali, S. M. C2 - PMC5130597 C6 - NIHMS818564 DO - 10.1159/000449204 DP - NLM ET - 2016/10/21 IS - 6 LA - eng N1 - 1423-0232 Subbiah, Vivek Holmes, Oliver Gowen, Kyle Spritz, Daniel Amini, Behrang Wang, Wei-Lien Schrock, Alexa B Meric-Bernstam, Funda Zinner, Ralph Piha-Paul, Sarina Zarzour, Maria Elvin, Julia A Erlich, Rachel L Stockman, David L Vergilio, Jo-Anne Suh, James H Stephens, Philip J Miller, Vincent Ross, Jeffrey S Ali, Siraj M P30 CA016672/CA/NCI NIH HHS/United States UL1 TR000371/TR/NCATS NIH HHS/United States Case Reports Journal Article Oncology. 2016;91(6):348-353. doi: 10.1159/000449204. Epub 2016 Oct 21. PY - 2016 SN - 0030-2414 (Print) 0030-2414 SP - 348-353 ST - Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion T2 - Oncology TI - Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion VL - 91 ID - 687 ER - TY - JOUR AD - *Pediatric Hematology-Oncology-BMT, CancerCare Manitoba ‡Department of Pathology, University of Manitoba, Winnipeg, MB, Canada †Department of Pediatrics, King Fahd Hospital of the University and Medical College, University of Dammam, Dammam, Saudi Arabia. AN - 27271810 AU - Shash, H. AU - Stefanovici, C. AU - Phillips, S. AU - Cuvelier, G. D. DA - Nov DO - 10.1097/mph.0000000000000594 DP - NLM ET - 2016/10/22 IS - 8 LA - eng N1 - 1536-3678 Shash, Hwazen Stefanovici, Camelia Phillips, Susan Cuvelier, Geoffrey D E Case Reports Journal Article United States J Pediatr Hematol Oncol. 2016 Nov;38(8):642-645. doi: 10.1097/MPH.0000000000000594. PY - 2016 SN - 1077-4114 SP - 642-645 ST - Aggressive Metastatic Inflammatory Myofibroblastic Tumor After Allogeneic Stem Cell Transplant With Fatal Pulmonary Toxicity From Crizotinib T2 - J Pediatr Hematol Oncol TI - Aggressive Metastatic Inflammatory Myofibroblastic Tumor After Allogeneic Stem Cell Transplant With Fatal Pulmonary Toxicity From Crizotinib VL - 38 ID - 688 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Electronic address: mcajaiba@luriechildrens.org. AN - 27769870 AU - Marsden, L. AU - Jennings, L. J. AU - Gadd, S. AU - Yu, M. AU - Perlman, E. J. AU - Cajaiba, M. M. DA - Feb DO - 10.1016/j.humpath.2016.09.025 DP - NLM ET - 2016/10/23 LA - eng N1 - 1532-8392 Marsden, Lily Jennings, Lawrence J Gadd, Samantha Yu, Min Perlman, Elizabeth J Cajaiba, Mariana M Journal Article United States Hum Pathol. 2017 Feb;60:32-36. doi: 10.1016/j.humpath.2016.09.025. Epub 2016 Oct 18. PY - 2017 SN - 0046-8177 SP - 32-36 ST - BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors T2 - Hum Pathol TI - BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors VL - 60 ID - 689 ER - TY - JOUR AD - *Department of Dermatology, Feinberg School of Medicine †The Robert H. Lurie Cancer Center, Northwestern University, Chicago, IL. AN - 27776007 AU - Amin, S. M. AU - Haugh, A. M. AU - Lee, C. Y. AU - Zhang, B. AU - Bubley, J. A. AU - Merkel, E. A. AU - Verzì, A. E. AU - Gerami, P. DA - Apr DO - 10.1097/pas.0000000000000761 DP - NLM ET - 2016/10/25 IS - 4 LA - eng N1 - 1532-0979 Amin, Sapna M Haugh, Alexandra M Lee, Christina Y Zhang, Bin Bubley, Jeffrey A Merkel, Emily A Verzì, Anna Elisa Gerami, Pedram Comparative Study Journal Article United States Am J Surg Pathol. 2017 Apr;41(4):491-498. doi: 10.1097/PAS.0000000000000761. PY - 2017 SN - 0147-5185 SP - 491-498 ST - A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms T2 - Am J Surg Pathol TI - A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms VL - 41 ID - 690 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. School of Dentistry, Universidade Federal do Ceará-UFC, Ceará, Brazil. Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. rsgomez@ufmg.br. AN - 27084044 AU - Pereira, N. B. AU - Pereira, K. M. AU - Coura, B. P. AU - Diniz, M. G. AU - de Castro, W. H. AU - Gomes, C. C. AU - Gomez, R. S. DA - Nov DO - 10.1111/jop.12443 DP - NLM ET - 2016/10/27 IS - 10 LA - eng N1 - 1600-0714 Pereira, Núbia Braga Pereira, Karuza Maria Alves Coura, Bruna Pizziolo Diniz, Marina Gonçalves de Castro, Wagner Henriques Gomes, Carolina Cavalieri Gomez, Ricardo Santiago Journal Article Denmark J Oral Pathol Med. 2016 Nov;45(10):780-785. doi: 10.1111/jop.12443. Epub 2016 Apr 15. PY - 2016 SN - 0904-2512 SP - 780-785 ST - BRAFV600E mutation in the diagnosis of unicystic ameloblastoma T2 - J Oral Pathol Med TI - BRAFV600E mutation in the diagnosis of unicystic ameloblastoma VL - 45 ID - 691 ER - TY - JOUR AD - Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. The Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Electronic address: jbarredo@miami.edu. AN - 27626202 AU - Leclerc, G. M. AU - Zheng, S. AU - Leclerc, G. J. AU - DeSalvo, J. AU - Swords, R. T. AU - Barredo, J. C. DA - Nov DO - 10.1016/j.leukres.2016.09.007 DP - NLM ET - 2016/10/27 LA - eng N1 - 1873-5835 Leclerc, Gilles M Zheng, Shuhua Leclerc, Guy J DeSalvo, Joanna Swords, Ronan T Barredo, Julio C Journal Article Research Support, Non-U.S. Gov't England Leuk Res. 2016 Nov;50:1-10. doi: 10.1016/j.leukres.2016.09.007. Epub 2016 Sep 5. PY - 2016 SN - 0145-2126 SP - 1-10 ST - The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia T2 - Leuk Res TI - The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia VL - 50 ID - 692 ER - TY - JOUR AD - Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Division of Hematology-Oncology, Arthur and Sonia Labatt Brain Tumour Research Centre, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON M4N1X8, Canada. Department of Pathology and ARUP Laboratories, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA. Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Primary Children's Hospital/Intermountain Healthcare, Salt Lake City, UT 84113, USA. Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: rodney.stewart@hci.utah.edu. AN - 27783941 AU - Modzelewska, K. AU - Boer, E. F. AU - Mosbruger, T. L. AU - Picard, D. AU - Anderson, D. AU - Miles, R. R. AU - Kroll, M. AU - Oslund, W. AU - Pysher, T. J. AU - Schiffman, J. D. AU - Jensen, R. AU - Jette, C. A. AU - Huang, A. AU - Stewart, R. A. DA - Oct 25 DO - 10.1016/j.celrep.2016.09.081 DP - NLM ET - 2016/10/27 IS - 5 LA - eng N1 - 2211-1247 Modzelewska, Katarzyna Boer, Elena F Mosbruger, Timothy L Picard, Daniel Anderson, Daniela Miles, Rodney R Kroll, Mitchell Oslund, William Pysher, Theodore J Schiffman, Joshua D Jensen, Randy Jette, Cicely A Huang, Annie Stewart, Rodney A Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Cell Rep. 2016 Oct 25;17(5):1255-1264. doi: 10.1016/j.celrep.2016.09.081. PY - 2016 SP - 1255-1264 ST - MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells T2 - Cell Rep TI - MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells VL - 17 ID - 693 ER - TY - JOUR AD - Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: sarkar.chitra@gmail.com. AN - 27599148 AU - Kakkar, A. AU - Majumdar, A. AU - Kumar, A. AU - Tripathi, M. AU - Pathak, P. AU - Sharma, M. C. AU - Suri, V. AU - Tandon, V. AU - Chandra, S. P. AU - Sarkar, C. DA - Nov DO - 10.1016/j.eplepsyres.2016.08.028 DP - NLM ET - 2016/10/30 LA - eng N1 - 1872-6844 Kakkar, Aanchal Majumdar, Atreye Kumar, Anupam Tripathi, Manjari Pathak, Pankaj Sharma, Mehar C Suri, Vaishali Tandon, Vivek Chandra, Sarat P Sarkar, Chitra Journal Article Research Support, Non-U.S. Gov't Netherlands Epilepsy Res. 2016 Nov;127:141-151. doi: 10.1016/j.eplepsyres.2016.08.028. Epub 2016 Aug 28. PY - 2016 SN - 0920-1211 SP - 141-151 ST - Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) T2 - Epilepsy Res TI - Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) VL - 127 ID - 694 ER - TY - JOUR AD - Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California. Brain Tumor Research Center, University of California, San Francisco, Helen-Diller Cancer Diller Cancer Research Center, San Francisco, California. Department of Neurology, University of California, San Francisco, San Francisco, California. Department of Pediatrics, University of California, San Francisco, San Francisco, California. Department of Neurological Surgery, University of California, San Francisco, San Francisco, California. Department of Neurological Surgery, Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Radiotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Brain Tumor Research Center, University of California, San Francisco, Helen-Diller Cancer Diller Cancer Research Center, San Francisco, California. dhaas-kogan@lroc.harvard.edu. Department of Radiation Oncology, Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. AN - 27217440 AU - Olow, A. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Meyerowitz, J. AU - Weiss, W. AU - Resnick, A. C. AU - Waanders, A. J. AU - Stalpers, L. J. AU - Berger, M. S. AU - Gupta, N. AU - James, C. D. AU - Petritsch, C. K. AU - Haas-Kogan, D. A. C2 - PMC5093033 C6 - NIHMS791672 to report. DA - Nov 1 DO - 10.1158/1078-0432.Ccr-15-1101 DP - NLM ET - 2016/11/03 IS - 21 LA - eng N1 - Olow, Aleksandra Mueller, Sabine Yang, Xiaodong Hashizume, Rintaro Meyerowitz, Justin Weiss, William Resnick, Adam C Waanders, Angela J Stalpers, Lukas J A Berger, Mitchel S Gupta, Nalin James, C David Petritsch, Claudia K Haas-Kogan, Daphne A R01 NS091620/NS/NINDS NIH HHS/United States KL2 TR000143/TR/NCATS NIH HHS/United States T32 GM007618/GM/NIGMS NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States R21 NS099836/NS/NINDS NIH HHS/United States R01 NS093079/NS/NINDS NIH HHS/United States R01 CA164746/CA/NCI NIH HHS/United States P30 CA060553/CA/NCI NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States R01 NS085336/NS/NINDS NIH HHS/United States Journal Article Clin Cancer Res. 2016 Nov 1;22(21):5312-5321. doi: 10.1158/1078-0432.CCR-15-1101. Epub 2016 May 23. PY - 2016 SN - 1078-0432 (Print) 1078-0432 SP - 5312-5321 ST - BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas T2 - Clin Cancer Res TI - BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas VL - 22 ID - 695 ER - TY - JOUR AD - 1 Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, China . 2 Department of Gerontology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, China . 3 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital of Sun Yat-sen University , Guangzhou, China . 4 Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center , Guangzhou, China . AN - 27717302 AU - Hong, S. AU - Yu, S. AU - Li, J. AU - Yin, Y. AU - Liu, Y. AU - Zhang, Q. AU - Guan, H. AU - Li, Y. AU - Xiao, H. DA - Dec DO - 10.1089/thy.2015.0578 DP - NLM ET - 2016/11/03 IS - 12 LA - eng N1 - 1557-9077 Hong, Shubin Yu, Shuang Li, Jin Yin, Yali Liu, Yujie Zhang, Quan Guan, Hongyu Li, Yanbing Xiao, Haipeng Journal Article United States Thyroid. 2016 Dec;26(12):1733-1743. doi: 10.1089/thy.2015.0578. Epub 2016 Nov 2. PY - 2016 SN - 1050-7256 SP - 1733-1743 ST - MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway T2 - Thyroid TI - MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway VL - 26 ID - 696 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. AN - 27840956 AU - Otabe, O. AU - Kikuchi, K. AU - Tsuchiya, K. AU - Katsumi, Y. AU - Yagyu, S. AU - Miyachi, M. AU - Iehara, T. AU - Hosoi, H. DA - Jan DO - 10.3892/or.2016.5213 DP - NLM ET - 2016/11/15 IS - 1 LA - eng N1 - 1791-2431 Otabe, Osamu Kikuchi, Ken Tsuchiya, Kunihiko Katsumi, Yoshiki Yagyu, Shigeki Miyachi, Mitsuru Iehara, Tomoko Hosoi, Hajime Journal Article Greece Oncol Rep. 2017 Jan;37(1):98-104. doi: 10.3892/or.2016.5213. Epub 2016 Nov 2. PY - 2017 SN - 1021-335x SP - 98-104 ST - MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells T2 - Oncol Rep TI - MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells VL - 37 ID - 697 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Tarry Building, 300 E Superior, Chicago, IL, 60611, USA. Department of Neurology, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, HD400, San Francisco, CA, 94158, USA. Department of Pediatrics, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Theodore.Nicolaides@ucsf.edu. Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, HD400, San Francisco, CA, 94158, USA. Theodore.Nicolaides@ucsf.edu. AN - 27848137 AU - Zhang, J. AU - Yao, T. W. AU - Hashizume, R. AU - Hariono, S. AU - Barkovich, K. J. AU - Fan, Q. W. AU - Prados, M. AU - James, C. D. AU - Weiss, W. A. AU - Nicolaides, T. C2 - PMC5560871 C6 - NIHMS830203 DA - Feb DO - 10.1007/s11060-016-2333-4 DP - NLM ET - 2016/11/17 IS - 3 LA - eng N1 - 1573-7373 Zhang, Jie Yao, Tsun-Wen Hashizume, Rintaro Hariono, Sujatmi Barkovich, Krister J Fan, Qi-Wen Prados, Michael James, C David Weiss, William A Nicolaides, Theodore U54 CA163155/CA/NCI NIH HHS/United States K08 NS065268/NS/NINDS NIH HHS/United States U01 CA176287/CA/NCI NIH HHS/United States R01 NS080619/NS/NINDS NIH HHS/United States P30 CA082103/CA/NCI NIH HHS/United States R01 NS093079/NS/NINDS NIH HHS/United States P50 CA097257/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Neurooncol. 2017 Feb;131(3):495-505. doi: 10.1007/s11060-016-2333-4. Epub 2016 Nov 15. PY - 2017 SN - 0167-594X (Print) 0167-594x SP - 495-505 ST - Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas T2 - J Neurooncol TI - Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas VL - 131 ID - 698 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and. Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA. AN - 27879258 AU - Werner, M. T. AU - Zhao, C. AU - Zhang, Q. AU - Wasik, M. A. DA - Feb 16 DO - 10.1182/blood-2016-05-717793 DP - NLM ET - 2016/11/24 IS - 7 LA - eng N1 - 1528-0020 Werner, Michael T Orcid: 0000-0003-3976-0608 Zhao, Chen Zhang, Qian Wasik, Mariusz A Orcid: 0000-0002-1988-3670 Journal Article Review United States Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22. PY - 2017 SN - 0006-4971 SP - 823-831 ST - Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target T2 - Blood TI - Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target VL - 129 ID - 699 ER - TY - JOUR AD - Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom. Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Genetic Medicine, Central Parkway, Newcastle upon Tyne, NE1 3BZ, United Kingdom. Institut Curie, 75248 Paris cedex 05, France. Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA. AN - 27888620 AU - Chen, L. AU - Humphreys, A. AU - Turnbull, L. AU - Bellini, A. AU - Schleiermacher, G. AU - Salwen, H. AU - Cohn, S. L. AU - Bown, N. AU - Tweddle, D. A. C2 - PMC5349989 DA - Dec 27 DO - 10.18632/oncotarget.13541 DP - NLM ET - 2016/11/27 IS - 52 LA - eng N1 - 1949-2553 Chen, Lindi Humphreys, Angharad Turnbull, Lisa Bellini, Angela Schleiermacher, Gudrun Salwen, Helen Cohn, Susan L Bown, Nick Tweddle, Deborah A Journal Article Oncotarget. 2016 Dec 27;7(52):87301-87311. doi: 10.18632/oncotarget.13541. PY - 2016 SN - 1949-2553 SP - 87301-87311 ST - Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse T2 - Oncotarget TI - Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse VL - 7 ID - 700 ER - TY - JOUR AD - Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. AN - 27911979 AU - Kim, D. W. AU - Haydu, L. E. AU - Joon, A. Y. AU - Bassett, R. L., Jr. AU - Siroy, A. E. AU - Tetzlaff, M. T. AU - Routbort, M. J. AU - Amaria, R. N. AU - Wargo, J. A. AU - McQuade, J. L. AU - Kemnade, J. AU - Hwu, P. AU - Woodman, S. E. AU - Roszik, J. AU - Kim, K. B. AU - Gershenwald, J. E. AU - Lazar, A. J. AU - Davies, M. A. C2 - PMC5384865 C6 - NIHMS828172 DA - Apr 15 DO - 10.1002/cncr.30463 DP - NLM ET - 2016/12/03 IS - 8 LA - eng N1 - 1097-0142 Kim, Dae Won Haydu, Lauren E Joon, Aron Y Bassett, Roland L Jr Siroy, Alan E Tetzlaff, Michael T Routbort, Mark J Amaria, Rodabe N Wargo, Jennifer A McQuade, Jennifer L Kemnade, Jan Hwu, Patrick Woodman, Scott E Roszik, Jason Kim, Kevin B Gershenwald, Jeffrey E Lazar, Alexander J Davies, Michael A T32 CA163185/CA/NCI NIH HHS/United States R01 CA187076/CA/NCI NIH HHS/United States UL1 TR001863/TR/NCATS NIH HHS/United States R01 CA154710/CA/NCI NIH HHS/United States P50 CA093459/CA/NCI NIH HHS/United States T32 CA009666/CA/NCI NIH HHS/United States K08 CA160692/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer. 2017 Apr 15;123(8):1372-1381. doi: 10.1002/cncr.30463. Epub 2016 Dec 2. PY - 2017 SN - 0008-543X (Print) 0008-543x SP - 1372-1381 ST - Clinicopathological features and clinical outcomes associated with TP53 and BRAF(N)(on-)(V)(600) mutations in cutaneous melanoma patients T2 - Cancer TI - Clinicopathological features and clinical outcomes associated with TP53 and BRAF(N)(on-)(V)(600) mutations in cutaneous melanoma patients VL - 123 ID - 701 ER - TY - JOUR AD - Institute of Drug Metabolism and Pharmacokinetics, Merck KGaA, Grafing, Germany (H.S., F.K., E.W.); Central Analytics, Bio NMR and NMR Spectroscopy (A.M.) and Department of Clinical Pharmacology (A.J.), Merck KGaA, Darmstadt, Germany holger.scheible@merckgroup.com. Institute of Drug Metabolism and Pharmacokinetics, Merck KGaA, Grafing, Germany (H.S., F.K., E.W.); Central Analytics, Bio NMR and NMR Spectroscopy (A.M.) and Department of Clinical Pharmacology (A.J.), Merck KGaA, Darmstadt, Germany. AN - 27934635 AU - Scheible, H. AU - Kraetzer, F. AU - Marx, A. AU - Johne, A. AU - Wimmer, E. DA - Feb DO - 10.1124/dmd.116.072934 DP - NLM ET - 2016/12/10 IS - 2 LA - eng N1 - 1521-009x Scheible, Holger Kraetzer, Friedrich Marx, Andreas Johne, Andreas Wimmer, Elmar Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't United States Drug Metab Dispos. 2017 Feb;45(2):174-182. doi: 10.1124/dmd.116.072934. Epub 2016 Dec 1. PY - 2017 SN - 0090-9556 SP - 174-182 ST - Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors T2 - Drug Metab Dispos TI - Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors VL - 45 ID - 702 ER - TY - JOUR AD - Division of Pediatric Dermatology, Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Department of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, Minnesota. AN - 27981612 AU - Boull, C. AU - Hook, K. AU - Moertel, C. AU - Maguiness, S. DA - Jan DO - 10.1111/pde.13038 DP - NLM ET - 2016/12/17 IS - 1 LA - eng N1 - 1525-1470 Boull, Christina Hook, Kristen Moertel, Christopher Maguiness, Sheilagh Journal Article United States Pediatr Dermatol. 2017 Jan;34(1):90-94. doi: 10.1111/pde.13038. Epub 2016 Dec 16. PY - 2017 SN - 0736-8046 SP - 90-94 ST - Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors T2 - Pediatr Dermatol TI - Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors VL - 34 ID - 703 ER - TY - JOUR AD - Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, College of Stomatology, Chongqing Medical University, Chongqing, China. Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, College of Stomatology, Chongqing Medical University. Department of Preventive Dentistry, College of Stomatology, Chongqing Medical University. Department of Orthodontics, College of Stomatology, Chongqing Medical University. Key Laboratory of Clinical Laboratory Science, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University. AN - 27982724 AU - Jiang, L. AU - Song, J. AU - Hu, X. AU - Zhang, H. AU - Huang, E. AU - Zhang, Y. AU - Deng, F. AU - Wu, X. DA - May DO - 10.1902/jop.2016.160396 DP - NLM ET - 2016/12/17 IS - 5 LA - eng N1 - 1943-3670 Jiang, Lin Song, Jinlin Hu, Xiaolei Zhang, Hongmei Huang, Enyi Zhang, Yan Deng, Feng Wu, Xiaomian Journal Article Research Support, Non-U.S. Gov't United States J Periodontol. 2017 May;88(5):473-483. doi: 10.1902/jop.2016.160396. Epub 2016 Dec 16. PY - 2017 SN - 0022-3492 SP - 473-483 ST - The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats T2 - J Periodontol TI - The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats VL - 88 ID - 704 ER - TY - JOUR AD - Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Genomics Institute of the Novartis Research Foundation, San Diego, California. Novartis Institutes of Biomedical Research, Cambridge, Massachusetts. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. mosse@email.chop.edu. AN - 27986745 AU - Wood, A. C. AU - Krytska, K. AU - Ryles, H. T. AU - Infarinato, N. R. AU - Sano, R. AU - Hansel, T. D. AU - Hart, L. S. AU - King, F. J. AU - Smith, T. R. AU - Ainscow, E. AU - Grandinetti, K. B. AU - Tuntland, T. AU - Kim, S. AU - Caponigro, G. AU - He, Y. Q. AU - Krupa, S. AU - Li, N. AU - Harris, J. L. AU - Mossé, Y. P. C2 - PMC5457336 C6 - NIHMS837654 ALK mutations filed by the Children’s Hospital of Philadelphia (WO/2009/103061 or PCT/US2009/034288: Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma). A patent application has been filed on the combination of Ceritinib/Ribociclib for the treatment of neuroblastoma. FJK, TRS, EA, KBG, TT, SK, GC, YQH, SK, NL, JLH are Novartis employees. All other authors declare that they have no competing interests. DA - Jun 1 DO - 10.1158/1078-0432.Ccr-16-1114 DP - NLM ET - 2016/12/18 IS - 11 LA - eng N1 - Wood, Andrew C Krytska, Kateryna Ryles, Hannah T Infarinato, Nicole R Sano, Renata Hansel, Theodore D Hart, Lori S King, Frederick J Smith, Timothy R Ainscow, Edward Grandinetti, Kathryn B Tuntland, Tove Kim, Sunkyu Caponigro, Giordano He, You Qun Krupa, Shiva Li, Nanxin Harris, Jennifer L Mossé, Yaël P R01 CA140198/CA/NCI NIH HHS/United States Journal Article Clin Cancer Res. 2017 Jun 1;23(11):2856-2868. doi: 10.1158/1078-0432.CCR-16-1114. Epub 2016 Dec 16. PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 2856-2868 ST - Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma T2 - Clin Cancer Res TI - Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma VL - 23 ID - 705 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands. Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. Research Institute Children's Cancer Center Hamburg, Hamburg, Germany. Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Co-operative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Netherlands Translational Research Center, Oss, The Netherlands. AN - 27997540 AU - Li, Y. AU - Buijs-Gladdines, J. G. AU - Canté-Barrett, K. AU - Stubbs, A. P. AU - Vroegindeweij, E. M. AU - Smits, W. K. AU - van Marion, R. AU - Dinjens, W. N. AU - Horstmann, M. AU - Kuiper, R. P. AU - Buijsman, R. C. AU - Zaman, G. J. AU - van der Spek, P. J. AU - Pieters, R. AU - Meijerink, J. P. C2 - PMC5172551 Center B.V. The other authors have declared that no competing interests exist. DA - Dec DO - 10.1371/journal.pmed.1002200 DP - NLM ET - 2016/12/21 IS - 12 LA - eng N1 - 1549-1676 Li, Yunlei Buijs-Gladdines, Jessica G C A M Canté-Barrett, Kirsten Orcid: 0000-0003-0418-8445 Stubbs, Andrew P Vroegindeweij, Eric M Smits, Willem K van Marion, Ronald Dinjens, Winand N M Horstmann, Martin Kuiper, Roland P Buijsman, Rogier C Orcid: 0000-0002-2757-2899 Zaman, Guido J R van der Spek, Peter J Pieters, Rob Meijerink, Jules P P Journal Article PLoS Med. 2016 Dec 20;13(12):e1002200. doi: 10.1371/journal.pmed.1002200. eCollection 2016 Dec. PY - 2016 SN - 1549-1277 (Print) 1549-1277 SP - e1002200 ST - IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study T2 - PLoS Med TI - IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study VL - 13 ID - 706 ER - TY - JOUR AD - Clinical Cooperation Unit Pediatric Oncology (G340), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Center for Individualized Pediatric Oncology (ZIPO) and Section of Pediatric Brain Tumors, Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany. Division of Biostatistics (C060), German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology (G380), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ), Heidelberg, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. Division of Molecular Genetics (B060), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Current affiliation: AbbVie Deutschland GmbH & Co. KG, Medical Immunology, Wiesbaden, Germany. Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany. Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany. Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University and University Medical Centre, Freiburg, Germany. Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Heidelberg, Germany. AN - 28002790 AU - Selt, F. AU - Hohloch, J. AU - Hielscher, T. AU - Sahm, F. AU - Capper, D. AU - Korshunov, A. AU - Usta, D. AU - Brabetz, S. AU - Ridinger, J. AU - Ecker, J. AU - Oehme, I. AU - Gronych, J. AU - Marquardt, V. AU - Pauck, D. AU - Bächli, H. AU - Stiles, C. D. AU - von Deimling, A. AU - Remke, M. AU - Schuhmann, M. U. AU - Pfister, S. M. AU - Brummer, T. AU - Jones, D. T. AU - Witt, O. AU - Milde, T. C2 - PMC5355278 DA - Feb 14 DO - 10.18632/oncotarget.14004 DP - NLM ET - 2016/12/22 IS - 7 LA - eng N1 - 1949-2553 Selt, Florian Hohloch, Juliane Hielscher, Thomas Sahm, Felix Capper, David Korshunov, Andrey Usta, Diren Brabetz, Sebastian Ridinger, Johannes Ecker, Jonas Oehme, Ina Gronych, Jan Marquardt, Viktoria Pauck, David Bächli, Heidi Stiles, Charles D von Deimling, Andreas Remke, Marc Schuhmann, Martin U Pfister, Stefan M Brummer, Tilman Jones, David T W Witt, Olaf Milde, Till Journal Article Oncotarget. 2017 Feb 14;8(7):11460-11479. doi: 10.18632/oncotarget.14004. PY - 2017 SN - 1949-2553 SP - 11460-11479 ST - Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing T2 - Oncotarget TI - Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing VL - 8 ID - 707 ER - TY - JOUR AD - From the Center for Cancer Research, Pediatric Oncology Branch, Bethesda (E.D., A. Baldwin, L.J.M., P. Whitcomb, S.M., R.E., P. Wolters, J.T., J.G., A.J.S., A.G., B.C.W.) and the Cancer Therapy Evaluation Program, Shady Grove (A.L.D.), National Cancer Institute, and the National Heart, Lung, and Blood Institute (A. Brofferio), Bethesda, National Institutes of Health, and the Food and Drug Administration, Silver Spring (L.J.M., R.E.) - all in Maryland; the Division of Oncology, Children's Hospital of Philadelphia, and the Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (M.J.F., J.B.B.); Children's National Health System, Washington, DC (A.K.); and Cincinnati Children's Hospital, Cincinnati (B.W., L.E.A.-S., T.A.R., J.W., E.S., N.R.). AN - 28029918 AU - Dombi, E. AU - Baldwin, A. AU - Marcus, L. J. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Whitcomb, P. AU - Martin, S. AU - Aschbacher-Smith, L. E. AU - Rizvi, T. A. AU - Wu, J. AU - Ershler, R. AU - Wolters, P. AU - Therrien, J. AU - Glod, J. AU - Belasco, J. B. AU - Schorry, E. AU - Brofferio, A. AU - Starosta, A. J. AU - Gillespie, A. AU - Doyle, A. L. AU - Ratner, N. AU - Widemann, B. C. C2 - PMC5508592 C6 - NIHMS848283 DA - Dec 29 DO - 10.1056/NEJMoa1605943 DP - NLM ET - 2016/12/29 IS - 26 LA - eng N1 - 1533-4406 Dombi, Eva Baldwin, Andrea Marcus, Leigh J Fisher, Michael J Weiss, Brian Kim, AeRang Whitcomb, Patricia Martin, Staci Aschbacher-Smith, Lindsey E Rizvi, Tilat A Wu, Jianqiang Ershler, Rachel Wolters, Pamela Therrien, Janet Glod, John Belasco, Jean B Schorry, Elizabeth Brofferio, Alessandra Starosta, Amy J Gillespie, Andrea Doyle, Austin L Ratner, Nancy Widemann, Brigitte C R01 NS028840/NS/NINDS NIH HHS/United States R01 NS086219/NS/NINDS NIH HHS/United States Clinical Trial, Phase I Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't N Engl J Med. 2016 Dec 29;375(26):2550-2560. doi: 10.1056/NEJMoa1605943. PY - 2016 SN - 0028-4793 (Print) 0028-4793 SP - 2550-2560 ST - Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas T2 - N Engl J Med TI - Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas VL - 375 ID - 708 ER - TY - JOUR AD - Medicine and Dermatology, University of California, 1600 Divisadero Street Rm A 743, San Francisco, CA, 94143, USA. Adil.Daud@ucsf.edu. PAREXEL International, Chandigarh, India. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. AN - 28052762 AU - Daud, A. AU - Gill, J. AU - Kamra, S. AU - Chen, L. AU - Ahuja, A. C2 - PMC5209913 DA - Jan 4 DO - 10.1186/s13045-016-0369-8 DP - NLM ET - 2017/01/06 IS - 1 LA - eng N1 - 1756-8722 Daud, Adil Gill, Japinder Kamra, Sheily Chen, Lei Ahuja, Amit Comparative Study Journal Article J Hematol Oncol. 2017 Jan 4;10(1):3. doi: 10.1186/s13045-016-0369-8. PY - 2017 SN - 1756-8722 SP - 3 ST - Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients T2 - J Hematol Oncol TI - Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients VL - 10 ID - 709 ER - TY - JOUR AN - 28062673 DA - Jan DO - 10.1158/2159-8290.Cd-nb2016-140 DP - NLM ET - 2017/01/08 IS - 1 LA - eng N1 - 2159-8290 Congress United States Cancer Discov. 2017 Jan;7(1):OF5. doi: 10.1158/2159-8290.CD-NB2016-140. Epub 2016 Nov 9. PY - 2017 SN - 2159-8274 SP - Of5 ST - Dabrafenib Effective in Pediatric Glioma T2 - Cancer Discov TI - Dabrafenib Effective in Pediatric Glioma VL - 7 ID - 710 ER - TY - JOUR AD - 1 Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary , Calgary, Canada . 2 Divisions of Endocrinology and Nephrology, University of Leipzig , Leipzig, Germany . 3 Department of Pathology, University Hospital Halle , Halle, Germany . 4 Amedes MVZ wagnerstibbe für Laboratoriumsmedizin, Hämostaseologie, Humangenetik und Mikrobiologie , Hannover, Germany . 5 Zentrum für Nuklearmedizin und PET/CT , Bremen, Germany . 6 Radiologie Hoheluft , Hamburg, Germany . 7 Klinik Dr. Hancken , Stade, Germany . 8 Praxis für Nuklearmedizin , PET-CT Zentrum, Wiesbaden, Germany . 9 Praxis für Nuklearmedizin , Oldenburg, Germany . 10 Institut für Radiologie & Nuklearmedizin , Bremerhaven, Germany . 11 Endokrinologie & Diabetologie im Zentrum , Stuttgart, Germany . 12 Praxisgemeinschaft auf dem Meere , Lüneburg, Germany . 13 Radiologie und Nuklearmedizin in der Gottorpstraße , Oldenburg, Germany . 14 Radiologie Oldenburg, Praxis Stehen und Partner GbR , Oldenburg, Germany . 15 Amedes MVZ , Hamburg, Germany . 16 Nuklearmedizinische Praxis Dr.med.Klaushenke , Cloppenburg, Germany . 17 Endokrinologische Gemeinschaftspraxis , Zentrum für Hormon- und Stoffwechselstörungen, Frankfurt/Main, Germany . 18 Röntgenpraxis Georgstraße , Hannover, Germany . 19 Radiologisch-Nuklearmedizinische Gemeinschaftspraxis , Celle, Germany . 20 MVZ Westerwald GmbH , Dernbach, Germany . 21 Schilddrüsen- und Hormon-Praxis , Gera, Germany . 22 Diagnostisches Zentrum Göttingen, Gemeinschaftspraxis für Radiologie und Nuklearmedizin , Göttingen, Germany . 23 Schilddrüse Stuttgart, Fachärzte für Innere Medizin und Nuklearmedizinische Schilddrüsendiagnostik , Stuttgart, Germany . 24 MVZ wagnerstibbe für Gynäkologie, Reproduktionsmedizin, Zytologie, Pathologie und Innere Medizin GmbH , Einbeck, Germany . 25 Division of Endocrinology, Department of Medicine, and Departments of Oncology, and Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary , Calgary, Canada . AN - 28071986 AU - Eszlinger, M. AU - Böhme, K. AU - Ullmann, M. AU - Görke, F. AU - Siebolts, U. AU - Neumann, A. AU - Franzius, C. AU - Adam, S. AU - Molwitz, T. AU - Landvogt, C. AU - Amro, B. AU - Hach, A. AU - Feldmann, B. AU - Graf, D. AU - Wefer, A. AU - Niemann, R. AU - Bullmann, C. AU - Klaushenke, G. AU - Santen, R. AU - Tönshoff, G. AU - Ivancevic, V. AU - Kögler, A. AU - Bell, E. AU - Lorenz, B. AU - Kluge, G. AU - Hartenstein, C. AU - Ruschenburg, I. AU - Paschke, R. DA - Mar DO - 10.1089/thy.2016.0445 DP - NLM ET - 2017/01/11 IS - 3 LA - eng N1 - 1557-9077 Eszlinger, Markus Böhme, Katharina Ullmann, Maha Görke, Fabian Siebolts, Udo Neumann, Anna Franzius, Christiane Adam, Sabine Molwitz, Thomas Landvogt, Christian Amro, Bassam Hach, Anja Feldmann, Berit Graf, Dieter Wefer, Antje Niemann, Rainer Bullmann, Catharina Klaushenke, Günther Santen, Reinhard Tönshoff, Gregor Ivancevic, Velimir Kögler, Andreas Bell, Erhard Lorenz, Bernd Kluge, Gerald Hartenstein, Christoph Ruschenburg, Ilka Paschke, Ralf Journal Article United States Thyroid. 2017 Mar;27(3):402-411. doi: 10.1089/thy.2016.0445. Epub 2017 Feb 7. PY - 2017 SN - 1050-7256 SP - 402-411 ST - Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany T2 - Thyroid TI - Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany VL - 27 ID - 711 ER - TY - JOUR AD - Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Program in Molecular Pharmacology, Department of Medicine, and Center for Mechanism Based Therapeutics Memorial Sloan Kettering Cancer Center, New York, USA. Division of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, USA. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. Departments of Neurosurgery and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. AN - 28082416 AU - Sun, Y. AU - Alberta, J. A. AU - Pilarz, C. AU - Calligaris, D. AU - Chadwick, E. J. AU - Ramkissoon, S. H. AU - Ramkissoon, L. A. AU - Garcia, V. M. AU - Mazzola, E. AU - Goumnerova, L. AU - Kane, M. AU - Yao, Z. AU - Kieran, M. W. AU - Ligon, K. L. AU - Hahn, W. C. AU - Garraway, L. A. AU - Rosen, N. AU - Gray, N. S. AU - Agar, N. Y. AU - Buhrlage, S. J. AU - Segal, R. A. AU - Stiles, C. D. C2 - PMC5464455 DA - Jun 1 DO - 10.1093/neuonc/now261 DP - NLM ET - 2017/01/14 IS - 6 LA - eng N1 - 1523-5866 Sun, Yu Alberta, John A Pilarz, Catherine Calligaris, David Chadwick, Emily J Ramkissoon, Shakti H Ramkissoon, Lori A Garcia, Veronica Matia Mazzola, Emanuele Goumnerova, Liliana Kane, Michael Yao, Zhan Kieran, Mark W Ligon, Keith L Hahn, William C Garraway, Levi A Rosen, Neal Gray, Nathanael S Agar, Nathalie Y Buhrlage, Sara J Segal, Rosalind A Stiles, Charles D P01 CA142536/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States Journal Article Neuro Oncol. 2017 Jun 1;19(6):774-785. doi: 10.1093/neuonc/now261. PY - 2017 SN - 1522-8517 (Print) 1522-8517 SP - 774-785 ST - A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas T2 - Neuro Oncol TI - A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas VL - 19 ID - 712 ER - TY - JOUR AN - 28089105 AU - Burki, T. K. DA - Feb DO - 10.1016/s1470-2045(17)30009-8 DP - NLM ET - 2017/01/17 IS - 2 LA - eng N1 - 1474-5488 Burki, Talha Khan News England Lancet Oncol. 2017 Feb;18(2):e69. doi: 10.1016/S1470-2045(17)30009-8. Epub 2017 Jan 7. PY - 2017 SN - 1470-2045 SP - e69 ST - Selumetinib for children with plexiform neurofibromas T2 - Lancet Oncol TI - Selumetinib for children with plexiform neurofibromas VL - 18 ID - 713 ER - TY - JOUR AD - Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Cell and Gene Therapy, Novartis, Cambridge, Massachusetts. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. sar@mail.nih.gov. AN - 28093487 AU - Deniger, D. C. AU - Kwong, M. L. AU - Pasetto, A. AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Langhan, M. M. AU - Lee, C. R. AU - Rosenberg, S. A. C2 - PMC5245178 C6 - NIHMS827134 DA - Jan 15 DO - 10.1158/1078-0432.Ccr-16-0906 DP - NLM ET - 2017/01/18 IS - 2 LA - eng N1 - Deniger, Drew C Kwong, Mei Li M Pasetto, Anna Dudley, Mark E Wunderlich, John R Langhan, Michelle M Lee, Chyi-Chia Richard Rosenberg, Steven A Z01 BC010984-01/Intramural NIH HHS/United States Clinical Trial, Phase I Journal Article Clin Cancer Res. 2017 Jan 15;23(2):351-362. doi: 10.1158/1078-0432.CCR-16-0906. Epub 2016 Oct 7. PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 351-362 ST - A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma T2 - Clin Cancer Res TI - A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma VL - 23 ID - 714 ER - TY - JOUR AD - Department of Pediatrics, University of Colorado Denver, Aurora, United States. Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, United States. Department of Pathology, University of Colorado Denver, Aurora, United States. Department of Neurosurgery, University of Colorado Denver, Aurora, United States. Department of Pharmacology, University of Colorado Denver, Aurora, United States. Department of Radiology, University of Colorado Denver, Aurora, United States. AN - 28094001 AU - Mulcahy Levy, J. M. AU - Zahedi, S. AU - Griesinger, A. M. AU - Morin, A. AU - Davies, K. D. AU - Aisner, D. L. AU - Kleinschmidt-DeMasters, B. K. AU - Fitzwalter, B. E. AU - Goodall, M. L. AU - Thorburn, J. AU - Amani, V. AU - Donson, A. M. AU - Birks, D. K. AU - Mirsky, D. M. AU - Hankinson, T. C. AU - Handler, M. H. AU - Green, A. L. AU - Vibhakar, R. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC5241115 DA - Jan 17 DO - 10.7554/eLife.19671 DP - NLM ET - 2017/01/18 LA - eng N1 - 2050-084x Mulcahy Levy, Jean M Orcid: 0000-0002-3022-4246 Zahedi, Shadi Griesinger, Andrea M Morin, Andrew Davies, Kurtis D Aisner, Dara L Kleinschmidt-DeMasters, B K Fitzwalter, Brent E Goodall, Megan L Thorburn, Jacqueline Amani, Vladimir Donson, Andrew M Birks, Diane K Mirsky, David M Hankinson, Todd C Handler, Michael H Green, Adam L Vibhakar, Rajeev Foreman, Nicholas K Thorburn, Andrew R01 CA150925/CA/NCI NIH HHS/United States K08 CA193982/CA/NCI NIH HHS/United States P30 CA046934/CA/NCI NIH HHS/United States T32 GM007635/GM/NIGMS NIH HHS/United States K12 HD068372/HD/NICHD NIH HHS/United States R01 CA190170/CA/NCI NIH HHS/United States Journal Article Elife. 2017 Jan 17;6:e19671. doi: 10.7554/eLife.19671. PY - 2017 SN - 2050-084x ST - Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors T2 - Elife TI - Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors VL - 6 ID - 715 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905; Department of Pathology, The China-Japan Union Hospital of Jilin University, Changchun, Jilin Province 130033, China. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905. Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905. Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton, NY 13790. Department of Dermatology, Roger Williams Medical Center, Providence, RI 02908. Division of Hematology, Mayo Clinic, Rochester, MN 55905. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905. Electronic address: feldman.andrew@mayo.edu. AN - 28153507 AU - Wang, X. AU - Boddicker, R. L. AU - Dasari, S. AU - Sidhu, J. S. AU - Kadin, M. E. AU - Macon, W. R. AU - Ansell, S. M. AU - Ketterling, R. P. AU - Rech, K. L. AU - Feldman, A. L. C2 - PMC5518937 C6 - NIHMS876504 DA - Jun DO - 10.1016/j.humpath.2017.01.003 DP - NLM ET - 2017/02/06 LA - eng N1 - 1532-8392 Wang, Xueju Boddicker, Rebecca L Dasari, Surendra Sidhu, Jagmohan S Kadin, Marshall E Macon, William R Ansell, Stephen M Ketterling, Rhett P Rech, Karen L Feldman, Andrew L P30 CA015083/CA/NCI NIH HHS/United States P50 CA097274/CA/NCI NIH HHS/United States R01 CA177734/CA/NCI NIH HHS/United States UL1 TR000135/TR/NCATS NIH HHS/United States Journal Article Hum Pathol. 2017 Jun;64:19-27. doi: 10.1016/j.humpath.2017.01.003. Epub 2017 Jan 30. PY - 2017 SN - 0046-8177 (Print) 0046-8177 SP - 19-27 ST - Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping T2 - Hum Pathol TI - Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping VL - 64 ID - 716 ER - TY - JOUR AD - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. drilona@mskcc.org. Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milan, Italy. Chao Family Comprehensive Cancer Center, University of California, Irvine, California. Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, Florida. Samsung Medical Center, Seoul, Korea. Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. Massachusetts General Hospital, Boston, Massachusetts. The University of Texas MD Anderson Cancer Center, Houston, Texas. Georgetown Lombardi Comprehensive Cancer Center, Washington, DC. University of Colorado Cancer Center, Aurora, Colorado. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Nerviano Medical Sciences s.r.l, Milan, Italy. Ignyta, Inc., San Diego, California. AN - 28183697 AU - Drilon, A. AU - Siena, S. AU - Ou, S. I. AU - Patel, M. AU - Ahn, M. J. AU - Lee, J. AU - Bauer, T. M. AU - Farago, A. F. AU - Wheler, J. J. AU - Liu, S. V. AU - Doebele, R. AU - Giannetta, L. AU - Cerea, G. AU - Marrapese, G. AU - Schirru, M. AU - Amatu, A. AU - Bencardino, K. AU - Palmeri, L. AU - Sartore-Bianchi, A. AU - Vanzulli, A. AU - Cresta, S. AU - Damian, S. AU - Duca, M. AU - Ardini, E. AU - Li, G. AU - Christiansen, J. AU - Kowalski, K. AU - Johnson, A. D. AU - Patel, R. AU - Luo, D. AU - Chow-Maneval, E. AU - Hornby, Z. AU - Multani, P. S. AU - Shaw, A. T. AU - De Braud, F. G. C2 - PMC5380583 C6 - NIHMS848554 AbbVie, Intervention Insights, Merrimack Pharmaceuticals, Pharmamar SA, and Takeda. JW is currently employed by Novartis. RD has research agreements with Ignyta and Loxo and intellectual property royalties and/or licensing fees from Abbott Molecular and Ariad Pharmaceuticals. SS is an advisory board member of Amgen, Bayer, Eli Lilly, Merck, Novartis, Roche, and Sanofi. GL, JC, KK, AJ, RP, DL, ECM, ZH, and PM are employees of Ignyta. EA is an employee of Nerviano Medical Sciences. DA - Apr DO - 10.1158/2159-8290.Cd-16-1237 DP - NLM ET - 2017/02/12 IS - 4 LA - eng N1 - 2159-8290 Drilon, Alexander Siena, Salvatore Ou, Sai-Hong Ignatius Patel, Manish Ahn, Myung Ju Lee, Jeeyun Bauer, Todd M Farago, Anna F Wheler, Jennifer J Liu, Stephen V Doebele, Robert Giannetta, Laura Cerea, Giulio Marrapese, Giovanna Schirru, Michele Amatu, Alessio Bencardino, Katia Palmeri, Laura Sartore-Bianchi, Andrea Vanzulli, Angelo Cresta, Sara Damian, Silvia Duca, Matteo Ardini, Elena Li, Gang Christiansen, Jason Kowalski, Karey Johnson, Ann D Patel, Rupal Luo, David Chow-Maneval, Edna Hornby, Zachary Multani, Pratik S Shaw, Alice T De Braud, Filippo G P30 CA008748/CA/NCI NIH HHS/United States P50 CA058187/CA/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9. PY - 2017 SN - 2159-8274 (Print) 2159-8274 SP - 400-409 ST - Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) T2 - Cancer Discov TI - Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) VL - 7 ID - 717 ER - TY - JOUR AD - Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. AN - 28192645 AU - Zhao, L. AU - Dias-Santagata, D. AU - Sadow, P. M. AU - Faquin, W. C. DA - May DO - 10.1002/cncy.21839 DP - NLM ET - 2017/02/14 IS - 5 LA - eng N1 - 1934-6638 Zhao, Liena Dias-Santagata, Dora Sadow, Peter M Faquin, William C Comparative Study Journal Article United States Cancer Cytopathol. 2017 May;125(5):323-331. doi: 10.1002/cncy.21839. Epub 2017 Feb 13. PY - 2017 SN - 1934-662x SP - 323-331 ST - Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma T2 - Cancer Cytopathol TI - Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma VL - 125 ID - 718 ER - TY - JOUR AD - Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China. Basic Medical School, Wuhan University, Wuhan, China. Institute of Model Animal of Wuhan University, Wuhan, China. Medical Research Institute, School of Medicine, Wuhan University, Wuhan, China. College of Life Sciences, Wuhan University, Wuhan, China. Division of Cardiothoracic and Vascular Surgery, Heart-Lung Transplantation Center, Sino-Swiss Heart-Lung Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Biomedical Engineering Department, Huazhong University of Science and Technology, Wuhan, China. AN - 28218919 AU - Wang, P. X. AU - Ji, Y. X. AU - Zhang, X. J. AU - Zhao, L. P. AU - Yan, Z. Z. AU - Zhang, P. AU - Shen, L. J. AU - Yang, X. AU - Fang, J. AU - Tian, S. AU - Zhu, X. Y. AU - Gong, J. AU - Zhang, X. AU - Wei, Q. F. AU - Wang, Y. AU - Li, J. AU - Wan, L. AU - Xie, Q. AU - She, Z. G. AU - Wang, Z. AU - Huang, Z. AU - Li, H. DA - Apr DO - 10.1038/nm.4290 DP - NLM ET - 2017/02/22 IS - 4 LA - eng N1 - 1546-170x Wang, Pi-Xiao Ji, Yan-Xiao Zhang, Xiao-Jing Zhao, Ling-Ping Yan, Zhen-Zhen Zhang, Peng Shen, Li-Jun Yang, Xia Fang, Jing Tian, Song Zhu, Xue-Yong Gong, Jun Zhang, Xin Wei, Qiao-Fang Wang, Yong Li, Jing Wan, Lu Xie, Qingguo She, Zhi-Gang Wang, Zhihua Huang, Zan Li, Hongliang Journal Article United States Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20. PY - 2017 SN - 1078-8956 SP - 439-449 ST - Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates T2 - Nat Med TI - Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates VL - 23 ID - 719 ER - TY - JOUR AD - Department of Pathology, Texas Children's Hospital, Houston, TX, USA. Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA. Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA. Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA. AN - 28219109 AU - Ballester, L. Y. AU - Cantu, M. D. AU - Lim, K. P. H. AU - Sarabia, S. F. AU - Ferguson, L. S. AU - Renee Webb, C. AU - Allen, C. E. AU - McClain, K. L. AU - Mohila, C. A. AU - Punia, J. N. AU - Roy, A. AU - López-Terrada, D. H. AU - John Hicks, M. AU - Fisher, K. E. C2 - PMC6886693 C6 - NIHMS1060374 DA - Feb DO - 10.1002/hon.2388 DP - NLM ET - 2017/02/22 IS - 1 LA - eng N1 - 1099-1069 Ballester, Leomar Y Cantu, Miguel D Lim, Karen P H Sarabia, Stephen F Ferguson, Lizmery Suarez Renee Webb, C Allen, Carl E McClain, Kenneth L Mohila, Carrie A Punia, Jyotinder N Roy, Angshumoy López-Terrada, Dolores H John Hicks, M Fisher, Kevin E Orcid: 0000-0002-6179-0937 L30 CA189034/CA/NCI NIH HHS/United States P50 CA126752/CA/NCI NIH HHS/United States R01 CA154947/CA/NCI NIH HHS/United States T32 DK060445/DK/NIDDK NIH HHS/United States Journal Article Hematol Oncol. 2018 Feb;36(1):307-315. doi: 10.1002/hon.2388. Epub 2017 Feb 20. PY - 2018 SN - 0278-0232 (Print) 0278-0232 SP - 307-315 ST - The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis T2 - Hematol Oncol TI - The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis VL - 36 ID - 720 ER - TY - JOUR AD - Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. meredith.chuk@fda.hhs.gov. Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. AN - 28235882 AU - Chuk, M. K. AU - Chang, J. T. AU - Theoret, M. R. AU - Sampene, E. AU - He, K. AU - Weis, S. L. AU - Helms, W. S. AU - Jin, R. AU - Li, H. AU - Yu, J. AU - Zhao, H. AU - Zhao, L. AU - Paciga, M. AU - Schmiel, D. AU - Rawat, R. AU - Keegan, P. AU - Pazdur, R. DA - Oct 1 DO - 10.1158/1078-0432.Ccr-16-0663 DP - NLM ET - 2017/02/27 IS - 19 LA - eng N1 - Chuk, Meredith K Chang, Jennie T Theoret, Marc R Sampene, Emmanuel He, Kun Weis, Shawna L Helms, Whitney S Jin, Runyan Li, Hongshan Yu, Jingyu Zhao, Hong Zhao, Liang Paciga, Mark Schmiel, Deborah Rawat, Rashmi Keegan, Patricia Pazdur, Richard Clinical Trial, Phase I Journal Article Multicenter Study Randomized Controlled Trial United States Clin Cancer Res. 2017 Oct 1;23(19):5666-5670. doi: 10.1158/1078-0432.CCR-16-0663. Epub 2017 Feb 24. PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 5666-5670 ST - FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma T2 - Clin Cancer Res TI - FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma VL - 23 ID - 721 ER - TY - JOUR AD - Paediatric Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Genetics and Genomic Medicine, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Paediatric Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Developmental Biology and Cancer Programme, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. AN - 28253523 AU - Kinsler, V. A. AU - O'Hare, P. AU - Jacques, T. AU - Hargrave, D. AU - Slater, O. C2 - PMC5396107 conflict of interest. DA - Apr 11 DO - 10.1038/bjc.2017.49 DP - NLM ET - 2017/03/03 IS - 8 LA - eng N1 - 1532-1827 Kinsler, Veronica A O'Hare, Patricia Jacques, Thomas Hargrave, Darren Slater, Olga Case Reports Journal Article Br J Cancer. 2017 Apr 11;116(8):990-993. doi: 10.1038/bjc.2017.49. Epub 2017 Mar 2. PY - 2017 SN - 0007-0920 (Print) 0007-0920 SP - 990-993 ST - MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children T2 - Br J Cancer TI - MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children VL - 116 ID - 722 ER - TY - JOUR AD - Pathology Department Angers University Hospital Angers France. Genetics and Biochemistry Department Angers University Hospital Angers France. Pathology Department Angers University Hospital Angers France; INSERM UMR-1066, Micro- and Nanomedicine Biomimetics (MINT) Angers University Hospital Angers France. INSERM UMR-1066, Micro- and Nanomedicine Biomimetics (MINT) Angers University Hospital Angers France; Neurosurgery Department Angers University Hospital Angers France. AN - 28293477 AU - Breton, Q. AU - Plouhinec, H. AU - Prunier-Mirebeau, D. AU - Boisselier, B. AU - Michalak, S. AU - Menei, P. AU - Rousseau, A. C2 - PMC5346524 DA - Mar DO - 10.1002/brb3.641 DP - NLM ET - 2017/03/16 IS - 3 LA - eng N1 - 2162-3279 Breton, Quentin Orcid: 0000-0002-6327-678x Plouhinec, Hélène Prunier-Mirebeau, Delphine Boisselier, Blandine Michalak, Sophie Menei, Philippe Rousseau, Audrey Comparative Study Journal Article Brain Behav. 2017 Feb 10;7(3):e00641. doi: 10.1002/brb3.641. eCollection 2017 Mar. PY - 2017 SP - e00641 ST - BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors T2 - Brain Behav TI - BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors VL - 7 ID - 723 ER - TY - JOUR AD - Division of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. christoph.schmid@usz.ch. Division of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Competence Centre for Systems Physiology and Metabolic Diseases, Swiss Federal Institute of Technology (ETH) Zurich, 8093, Zurich, Switzerland. AN - 28316059 AU - Schmid, C. AU - Ghirlanda, C. AU - Niessen, M. C2 - PMC5532423 DA - Aug DO - 10.1007/s11010-017-2996-y DP - NLM ET - 2017/03/21 IS - 1-2 LA - eng N1 - 1573-4919 Schmid, Christoph Ghirlanda, Claudia Niessen, Markus Orcid: 0000-0003-4091-0597 Journal Article Mol Cell Biochem. 2017 Aug;432(1-2):41-54. doi: 10.1007/s11010-017-2996-y. Epub 2017 Mar 18. PY - 2017 SN - 0300-8177 (Print) 0300-8177 SP - 41-54 ST - Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase T2 - Mol Cell Biochem TI - Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase VL - 432 ID - 724 ER - TY - JOUR AD - University of California San Francisco, San Francisco, California; Boston Children's Hospital, Boston, Massachusetts; Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; St Jude Children's Research Hospital, Memphis, Tennessee; Lurie Children's Hospital, Chicago, Illinois; Children's National Medical Center, Washington, DC; Duke University Medical Center, Durham, North Carolina; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. AN - 28339824 AU - Banerjee, A. AU - Jakacki, R. I. AU - Onar-Thomas, A. AU - Wu, S. AU - Nicolaides, T. AU - Young Poussaint, T. AU - Fangusaro, J. AU - Phillips, J. AU - Perry, A. AU - Turner, D. AU - Prados, M. AU - Packer, R. J. AU - Qaddoumi, I. AU - Gururangan, S. AU - Pollack, I. F. AU - Goldman, S. AU - Doyle, L. A. AU - Stewart, C. F. AU - Boyett, J. M. AU - Kun, L. E. AU - Fouladi, M. C2 - PMC5570236 DA - Aug 1 DO - 10.1093/neuonc/now282 DP - NLM ET - 2017/03/25 IS - 8 LA - eng N1 - 1523-5866 Banerjee, Anuradha Jakacki, Regina I Onar-Thomas, Arzu Wu, Shengjie Nicolaides, Theodore Young Poussaint, Tina Fangusaro, Jason Phillips, Joanna Perry, Arie Turner, David Prados, Michael Packer, Roger J Qaddoumi, Ibrahim Gururangan, Sridharan Pollack, Ian F Goldman, Stewart Doyle, Lawrence A Stewart, Clinton F Boyett, James M Kun, Larry E Fouladi, Maryam U01 CA081457/CA/NCI NIH HHS/United States UM1 CA081457/CA/NCI NIH HHS/United States Clinical Trial, Phase I Journal Article Neuro Oncol. 2017 Aug 1;19(8):1135-1144. doi: 10.1093/neuonc/now282. PY - 2017 SN - 1522-8517 (Print) 1522-8517 SP - 1135-1144 ST - A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study T2 - Neuro Oncol TI - A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study VL - 19 ID - 725 ER - TY - JOUR AD - 1 Department of Radiation Medical Sciences, Atomic Bomb Disease Institute , Nagasaki University, Nagasaki, Japan . 2 Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan . 3 Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute , Nagasaki University, Nagasaki, Japan . 4 Department of Thyroid and Endocrinology, Fukushima Medical University , Fukushima, Japan . AN - 28351223 AU - Iyama, K. AU - Matsuse, M. AU - Mitsutake, N. AU - Rogounovitch, T. AU - Saenko, V. AU - Suzuki, K. AU - Ashizawa, M. AU - Ookouchi, C. AU - Suzuki, S. AU - Mizunuma, H. AU - Fukushima, T. AU - Suzuki, S. AU - Yamashita, S. DA - Jun DO - 10.1089/thy.2016.0673 DP - NLM ET - 2017/03/30 IS - 6 LA - eng N1 - 1557-9077 Iyama, Keita Matsuse, Michiko Mitsutake, Norisato Rogounovitch, Tatiana Saenko, Vladimir Suzuki, Keiji Ashizawa, Mai Ookouchi, Chiyo Suzuki, Satoshi Mizunuma, Hiroshi Fukushima, Toshihiko Suzuki, Shinichi Yamashita, Shunichi Journal Article United States Thyroid. 2017 Jun;27(6):811-818. doi: 10.1089/thy.2016.0673. Epub 2017 Apr 25. PY - 2017 SN - 1050-7256 SP - 811-818 ST - Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima T2 - Thyroid TI - Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima VL - 27 ID - 726 ER - TY - JOUR AD - Micro-Environnement et Renouvellement Cellulaire Intégré, MERCI UPRES EA 3829, Faculté de Médecine et Pharmacie, Université de Rouen, 76183 Rouen Cedex, France. Current address: Unité Inserm U1234/Université de Rouen/IRIB, Rouen, France. Service Immuno-Hémato-Oncologie Pédiatrique, CHU Charles Nicolle, 76031 ROUEN Cedex, France. AN - 28423696 AU - Abdoul-Azize, S. AU - Dubus, I. AU - Vannier, J. P. C2 - PMC5432339 DA - Apr 18 DO - 10.18632/oncotarget.16039 DP - NLM ET - 2017/04/21 IS - 16 LA - eng N1 - 1949-2553 Abdoul-Azize, Souleymane Dubus, Isabelle Vannier, Jean-Pierre Journal Article Oncotarget. 2017 Apr 18;8(16):27339-27352. doi: 10.18632/oncotarget.16039. PY - 2017 SN - 1949-2553 SP - 27339-27352 ST - Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation T2 - Oncotarget TI - Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation VL - 8 ID - 727 ER - TY - JOUR AD - Department of Pathology, Cork University Hospital, Cork, Ireland. Department of Medical Oncology, Cork University Hospital, Cork, Ireland. AN - 28424234 AU - O'Brien, O. AU - Lyons, T. AU - Murphy, S. AU - Feeley, L. AU - Power, D. AU - Heffron, Ccbb DA - Nov DO - 10.1136/jclinpath-2017-204367 DP - NLM ET - 2017/04/21 IS - 11 LA - eng N1 - 1472-4146 O'Brien, Odharnaith Orcid: 0000-0001-6119-1849 Lyons, Tomas Murphy, Sandra Feeley, Linda Power, Derek Heffron, Cynthia C B B Comparative Study Journal Article England J Clin Pathol. 2017 Nov;70(11):935-940. doi: 10.1136/jclinpath-2017-204367. Epub 2017 Apr 19. PY - 2017 SN - 0021-9746 SP - 935-940 ST - BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods T2 - J Clin Pathol TI - BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods VL - 70 ID - 728 ER - TY - JOUR AD - Paediatric Solid Tumour Biology and Therapeutics Team, Division of Clinical Studies and Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Clinical Pharmacodynamic Biomarker Team, Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Tumour Biology and Metastasis, Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, Surrey, UK. AN - 28432815 AU - Tucker, E. R. AU - Tall, J. R. AU - Danielson, L. S. AU - Gowan, S. AU - Jamin, Y. AU - Robinson, S. P. AU - Banerji, U. AU - Chesler, L. C2 - PMC5537911 DA - Aug DO - 10.1002/1878-0261.12069 DP - NLM ET - 2017/04/23 IS - 8 LA - eng N1 - 1878-0261 Tucker, Elizabeth R Tall, Jennifer R Danielson, Laura S Gowan, Sharon Jamin, Yann Robinson, Simon P Banerji, Udai Chesler, Louis G1100386/Medical Research Council/United Kingdom A14619/Cancer Research UK/United Kingdom Journal Article Mol Oncol. 2017 Aug;11(8):996-1006. doi: 10.1002/1878-0261.12069. Epub 2017 May 31. PY - 2017 SN - 1574-7891 (Print) 1574-7891 SP - 996-1006 ST - Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma T2 - Mol Oncol TI - Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma VL - 11 ID - 729 ER - TY - JOUR AD - Servicio de Endocrinología, Hospital Universitario de Basurto, Bilbao, España; Universidad del País Vasco (UPV-EHU), Bilbao, España. Electronic address: miguel.pajafano@osakidetza.net. Servicio de Anatomía Patológica, Hospital Universitario de Basurto, Bilbao, España. Servicio de Endocrinología, Hospital Universitario de Basurto, Bilbao, España. AN - 28440781 AU - Paja Fano, M. AU - Ugalde Olano, A. AU - Fuertes Thomas, E. AU - Oleaga Alday, A. DA - Feb DO - 10.1016/j.endinu.2016.12.004 DP - NLM ET - 2017/04/26 IS - 2 LA - eng spa N1 - 2530-0172 Paja Fano, Miguel Ugalde Olano, Aitziber Fuertes Thomas, Elena Oleaga Alday, Amelia Clinical Trial Comparative Study Journal Article Spain Endocrinol Diabetes Nutr. 2017 Feb;64(2):75-81. doi: 10.1016/j.endinu.2016.12.004. Epub 2017 Feb 10. OP - Detección inmunohistoquímica de la mutación BRAF V600E en el carcinoma papilar de tiroides. Evaluación frente a la reacción en cadena de la polimerasa en tiempo real. PY - 2017 SN - 2530-0164 SP - 75-81 ST - Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction T2 - Endocrinol Diabetes Nutr TI - Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction VL - 64 ID - 730 ER - TY - JOUR AD - Department of Surgical Pathology, Tata Memorial Hospital, Mumbai, India. Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey. Department of Pathology, Istanbul University, Capa School of Medicine, Istanbul, Turkey. AN - 28452074 AU - Rekhi, B. AU - Kosemehmetoglu, K. AU - Tezel, G. G. AU - Dervisoglu, S. DA - Aug DO - 10.1111/apm.12702 DP - NLM ET - 2017/04/30 IS - 8 LA - eng N1 - 1600-0463 Rekhi, Bharat Kosemehmetoglu, Kemal Tezel, Gaye Guler Dervisoglu, Sergulen Case Reports Journal Article Denmark APMIS. 2017 Aug;125(8):679-689. doi: 10.1111/apm.12702. Epub 2017 Apr 27. PY - 2017 SN - 0903-4641 SP - 679-689 ST - Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis T2 - Apmis TI - Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis VL - 125 ID - 731 ER - TY - JOUR AD - Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO. AN - 28475456 AU - Kim, D. W. AU - Tiseo, M. AU - Ahn, M. J. AU - Reckamp, K. L. AU - Hansen, K. H. AU - Kim, S. W. AU - Huber, R. M. AU - West, H. L. AU - Groen, H. J. M. AU - Hochmair, M. J. AU - Leighl, N. B. AU - Gettinger, S. N. AU - Langer, C. J. AU - Paz-Ares Rodríguez, L. G. AU - Smit, E. F. AU - Kim, E. S. AU - Reichmann, W. AU - Haluska, F. G. AU - Kerstein, D. AU - Camidge, D. R. DA - Aug 1 DO - 10.1200/jco.2016.71.5904 DP - NLM ET - 2017/05/06 IS - 22 LA - eng N1 - 1527-7755 Kim, Dong-Wan Tiseo, Marcello Ahn, Myung-Ju Reckamp, Karen L Hansen, Karin Holmskov Kim, Sang-We Huber, Rudolf M West, Howard L Groen, Harry J M Hochmair, Maximilian J Leighl, Natasha B Gettinger, Scott N Langer, Corey J Paz-Ares Rodríguez, Luis G Smit, Egbert F Kim, Edward S Reichmann, William Haluska, Frank G Kerstein, David Camidge, D Ross Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial United States J Clin Oncol. 2017 Aug 1;35(22):2490-2498. doi: 10.1200/JCO.2016.71.5904. Epub 2017 May 5. PY - 2017 SN - 0732-183x SP - 2490-2498 ST - Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial T2 - J Clin Oncol TI - Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial VL - 35 ID - 732 ER - TY - JOUR AD - Institute of Cellular Medicine and. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. Department of Cellular Pathology, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom. Internal Medicine Department, Hôtel-Dieu University Hopital, Nantes, France. Memorial Sloan Kettering Cancer Center, New York, NY. East Midlands Children's and Young Persons' Integrated Cancer Service, Leicester Children's Hospital, Leicester, United Kingdom. Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom. Rheumatology Department, North Bristol National Health Service Trust, Bristol, United Kingdom. Blackpool Teaching Hospitals National Health Service Foundation Trust, Blackpool, United Kingdom; and. Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX. AN - 28512190 AU - Milne, P. AU - Bigley, V. AU - Bacon, C. M. AU - Néel, A. AU - McGovern, N. AU - Bomken, S. AU - Haniffa, M. AU - Diamond, E. L. AU - Durham, B. H. AU - Visser, J. AU - Hunt, D. AU - Gunawardena, H. AU - Macheta, M. AU - McClain, K. L. AU - Allen, C. AU - Abdel-Wahab, O. AU - Collin, M. C2 - PMC5524529 DA - Jul 13 DO - 10.1182/blood-2016-12-757823 DP - NLM ET - 2017/05/18 IS - 2 LA - eng N1 - 1528-0020 Milne, Paul Bigley, Venetia Bacon, Chris M Néel, Antoine McGovern, Naomi Bomken, Simon Haniffa, Muzlifah Diamond, Eli L Durham, Benjamin H Visser, Johannes Hunt, David Gunawardena, Harsha Macheta, Mac McClain, Kenneth L Allen, Carl Abdel-Wahab, Omar Collin, Matthew R01 CA201247/CA/NCI NIH HHS/United States R01 CA154947/CA/NCI NIH HHS/United States WT_/Wellcome Trust/United Kingdom 101155/Z/13/Z/WT_/Wellcome Trust/United Kingdom C30484/A21025/CRUK_/Cancer Research UK/United Kingdom WT088555MA/WT_/Wellcome Trust/United Kingdom Journal Article Research Support, Non-U.S. Gov't Blood. 2017 Jul 13;130(2):167-175. doi: 10.1182/blood-2016-12-757823. Epub 2017 May 16. PY - 2017 SN - 0006-4971 (Print) 0006-4971 SP - 167-175 ST - Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults T2 - Blood TI - Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults VL - 130 ID - 733 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, Tübingen University Hospital, Tübingen, Germany. Hematopathology Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain. Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD. Department of Cellular Pathology, Barts and The London National Health Service Trust, London, United Kingdom. Pathology Department, Instituto Portugues de Oncología, Lisbon, Portugal. Department of Histopathology, Guy's and St Thomas' Hospitals, London, United Kingdom. Department of Pathology, All Wales Lymphoma Panel, University Hospital of Wales, Cardiff, United Kingdom. Institute of Pathology, University of Würzburg, Würzburg, Germany. Comprehensive Cancer Center Mainfranken, Würzburg, Germany. Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany; and. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. AN - 28533310 AU - Schmidt, J. AU - Ramis-Zaldivar, J. E. AU - Nadeu, F. AU - Gonzalez-Farre, B. AU - Navarro, A. AU - Egan, C. AU - Montes-Mojarro, I. A. AU - Marafioti, T. AU - Cabeçadas, J. AU - van der Walt, J. AU - Dojcinov, S. AU - Rosenwald, A. AU - Ott, G. AU - Bonzheim, I. AU - Fend, F. AU - Campo, E. AU - Jaffe, E. S. AU - Salaverria, I. AU - Quintanilla-Martinez, L. C2 - PMC5520474 DA - Jul 20 DO - 10.1182/blood-2017-03-776278 DP - NLM ET - 2017/05/24 IS - 3 LA - eng N1 - 1528-0020 Schmidt, Janine Ramis-Zaldivar, Joan Enric Orcid: 0000-0001-7108-7738 Nadeu, Ferran Orcid: 0000-0003-2910-9440 Gonzalez-Farre, Blanca Orcid: 0000-0002-1796-7248 Navarro, Alba Orcid: 0000-0002-4041-0974 Egan, Caoimhe Montes-Mojarro, Ivonne Aidee Marafioti, Teresa Cabeçadas, Jose van der Walt, Jon Dojcinov, Stefan Rosenwald, Andreas Ott, German Bonzheim, Irina Fend, Falko Campo, Elias Orcid: 0000-0001-9850-9793 Jaffe, Elaine S Salaverria, Itziar Orcid: 0000-0002-2427-9822 Quintanilla-Martinez, Leticia Orcid: 0000-0001-7156-5365 Journal Article Research Support, Non-U.S. Gov't Blood. 2017 Jul 20;130(3):323-327. doi: 10.1182/blood-2017-03-776278. Epub 2017 May 22. PY - 2017 SN - 0006-4971 (Print) 0006-4971 SP - 323-327 ST - Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation T2 - Blood TI - Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation VL - 130 ID - 734 ER - TY - JOUR AD - Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. AN - 28546523 AU - Lee, J. W. AU - Park, S. H. AU - Kang, H. J. AU - Park, K. D. AU - Shin, H. Y. AU - Ahn, H. S. C2 - PMC5912141 DA - Apr DO - 10.4143/crt.2016.577 DP - NLM ET - 2017/05/27 IS - 2 LA - eng N1 - 2005-9256 Lee, Ji Won Park, Sung Hye Kang, Hyoung Jin Park, Kyung Duk Shin, Hee Young Ahn, Hyo Seop Journal Article Cancer Res Treat. 2018 Apr;50(2):495-505. doi: 10.4143/crt.2016.577. Epub 2017 May 22. PY - 2018 SN - 1598-2998 (Print) 1598-2998 SP - 495-505 ST - ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor T2 - Cancer Res Treat TI - ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor VL - 50 ID - 735 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Department of Hematology, Affiliated Hospital of the University of Nantong, Jiangsu, China. Department of Pathology and Immunology, Baylor College of Medicine & Texas Children's Hospital, Houston, TX, USA. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. AN - 28557340 AU - Shi, W. AU - George, S. K. AU - George, B. AU - Curry, C. V. AU - Murzabdillaeva, A. AU - Alkan, S. AU - Amin, H. M. C2 - PMC5579389 DA - Sep DO - 10.1002/1878-0261.12088 DP - NLM ET - 2017/05/31 IS - 9 LA - eng N1 - 1878-0261 Shi, Wenyu George, Suraj Konnath George, Bhawana Curry, Choladda V Murzabdillaeva, Albina Alkan, Serhan Amin, Hesham M P30 CA125123/CA/NCI NIH HHS/United States R01 CA151533/CA/NCI NIH HHS/United States Journal Article Mol Oncol. 2017 Sep;11(9):1189-1207. doi: 10.1002/1878-0261.12088. Epub 2017 Jun 18. PY - 2017 SN - 1574-7891 (Print) 1574-7891 SP - 1189-1207 ST - TrkA is a binding partner of NPM-ALK that promotes the survival of ALK(+) T-cell lymphoma T2 - Mol Oncol TI - TrkA is a binding partner of NPM-ALK that promotes the survival of ALK(+) T-cell lymphoma VL - 11 ID - 736 ER - TY - JOUR AD - Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Nuclear Dynamics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. School of Physiology and Pharmacology, University of Bristol, Bristol, UK. Centre for Molecular Processing and School of Biosciences, University of Kent, Canterbury, UK. Institut für Medizinische Virologie, Klinikum der Goethe-Universität, Frankfurt am Main, Germany. Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Electronic address: K.T.A.Malik@bristol.ac.uk. AN - 28602975 AU - Kollareddy, M. AU - Sherrard, A. AU - Park, J. H. AU - Szemes, M. AU - Gallacher, K. AU - Melegh, Z. AU - Oltean, S. AU - Michaelis, M. AU - Cinatl, J., Jr. AU - Kaidi, A. AU - Malik, K. C2 - PMC5542135 DA - Sep 10 DO - 10.1016/j.canlet.2017.05.027 DP - NLM ET - 2017/06/13 LA - eng N1 - 1872-7980 Kollareddy, Madhu Sherrard, Alice Park, Ji Hyun Szemes, Marianna Gallacher, Kelli Melegh, Zsombor Oltean, Sebastian Michaelis, Martin Cinatl, Jindrich Jr Kaidi, Abderrahmane Malik, Karim A21046/Cancer Research UK/United Kingdom MR/N000013/1/Medical Research Council/United Kingdom WT107789AIA/Wellcome Trust/United Kingdom Journal Article Research Support, Non-U.S. Gov't Cancer Lett. 2017 Sep 10;403:74-85. doi: 10.1016/j.canlet.2017.05.027. Epub 2017 Jun 7. PY - 2017 SN - 0304-3835 (Print) 0304-3835 SP - 74-85 ST - The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis T2 - Cancer Lett TI - The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis VL - 403 ID - 737 ER - TY - JOUR AD - Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Osaka, Japan. Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan. AN - 28650561 AU - Ueda, K. AU - Yaoita, M. AU - Niihori, T. AU - Aoki, Y. AU - Okamoto, N. DA - Sep DO - 10.1002/ajmg.a.38337 DP - NLM ET - 2017/06/27 IS - 9 LA - eng N1 - 1552-4833 Ueda, Kimiko Orcid: 0000-0001-7032-4754 Yaoita, Masako Niihori, Tetsuya Aoki, Yoko Okamoto, Nobuhiko Orcid: 0000-0001-5415-656x Journal Article United States Am J Med Genet A. 2017 Sep;173(9):2346-2352. doi: 10.1002/ajmg.a.38337. Epub 2017 Jun 26. PY - 2017 SN - 1552-4825 SP - 2346-2352 ST - Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype T2 - Am J Med Genet A TI - Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype VL - 173 ID - 738 ER - TY - JOUR AD - Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Bioresource Research Center, Tokyo Medical and Dental University, Tokyo, Japan. Department of Oral Health Science Center, Tokyo Dental College, Tokyo, Japan. AN - 28658279 AU - Yukimori, A. AU - Oikawa, Y. AU - Morita, K. I. AU - Nguyen, C. T. K. AU - Harada, H. AU - Yamaguchi, S. AU - Kayamori, K. AU - Yamaguchi, A. AU - Ikeda, T. AU - Sakamoto, K. C2 - PMC5489209 DO - 10.1371/journal.pone.0180224 DP - NLM ET - 2017/06/29 IS - 6 LA - eng N1 - 1932-6203 Yukimori, Akane Oikawa, Yu Morita, Kei-Ichi Nguyen, Chi Thi Kim Harada, Hiroyuki Yamaguchi, Satoshi Kayamori, Kou Yamaguchi, Akira Ikeda, Tohru Sakamoto, Kei Journal Article PLoS One. 2017 Jun 28;12(6):e0180224. doi: 10.1371/journal.pone.0180224. eCollection 2017. PY - 2017 SN - 1932-6203 SP - e0180224 ST - Genetic basis of calcifying cystic odontogenic tumors T2 - PLoS One TI - Genetic basis of calcifying cystic odontogenic tumors VL - 12 ID - 739 ER - TY - JOUR AD - Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. AN - 28665943 AU - Jiang, X. N. AU - Yu, B. H. AU - Wang, W. G. AU - Zhou, X. Y. AU - Li, X. Q. C2 - PMC5493294 DO - 10.1371/journal.pone.0178416 DP - NLM ET - 2017/07/01 IS - 6 LA - eng N1 - 1932-6203 Jiang, Xiang-Nan Yu, Bao-Hua Wang, Wei-Ge Zhou, Xiao-Yan Li, Xiao-Qiu Journal Article Review PLoS One. 2017 Jun 30;12(6):e0178416. doi: 10.1371/journal.pone.0178416. eCollection 2017. PY - 2017 SN - 1932-6203 SP - e0178416 ST - Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature T2 - PLoS One TI - Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature VL - 12 ID - 740 ER - TY - JOUR AD - College of Medicine, University of Tennessee Health Science Center. Department of Neurosurgery, Le Bonheur Children's Hospital. Division of Neurosurgery, St. Jude Children's Research Hospital. Semmes-Murphey Neurologic & Spine Institute; and. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 28686121 AU - Lee, R. P. AU - Foster, K. A. AU - Lillard, J. C. AU - Klimo, P., Jr. AU - Ellison, D. W. AU - Orr, B. AU - Boop, F. A. C2 - PMC5839469 C6 - NIHMS1500030 DA - Sep DO - 10.3171/2017.4.Peds16668 DP - NLM ET - 2017/07/08 IS - 3 LA - eng N1 - 1933-0715 Lee, Ryan P Foster, Kimberly A Lillard, Jock C Klimo, Paul Jr Ellison, David W Orr, Brent Boop, Frederick A P01 CA096832/CA/NCI NIH HHS/United States Journal Article J Neurosurg Pediatr. 2017 Sep;20(3):247-255. doi: 10.3171/2017.4.PEDS16668. Epub 2017 Jul 7. PY - 2017 SN - 1933-0707 (Print) 1933-0707 SP - 247-255 ST - Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors T2 - J Neurosurg Pediatr TI - Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors VL - 20 ID - 741 ER - TY - JOUR AD - Department of Pathology, Chi-Mei Medical Center, Liouying, Taiwan. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Department of Pathology, Kaohsiung Medical University Hospital and School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, Taipei Medical University, Taipei, Taiwan; Department of Pathology, National Taiwan University, Taipei, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw. AN - 28693749 AU - Lee, Y. Y. AU - Takata, K. AU - Wang, R. C. AU - Yang, S. F. AU - Chuang, S. S. DA - Aug DO - 10.1016/j.pathol.2017.05.007 DP - NLM ET - 2017/07/12 IS - 5 LA - eng N1 - 1465-3931 Lee, Yi-Ying Takata, Katsuyoshi Wang, Ren-Ching Yang, Sheau-Fang Chuang, Shih-Sung Journal Article England Pathology. 2017 Aug;49(5):479-485. doi: 10.1016/j.pathol.2017.05.007. Epub 2017 Jul 8. PY - 2017 SN - 0031-3025 SP - 479-485 ST - Primary gastrointestinal anaplastic large cell lymphoma T2 - Pathology TI - Primary gastrointestinal anaplastic large cell lymphoma VL - 49 ID - 742 ER - TY - JOUR AD - Department of Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS. Department of Pathology and Laboratory Medicine, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS. AN - 28707818 AU - Le, T. AU - New, J. AU - Jones, J. W. AU - Usman, S. AU - Yalamanchali, S. AU - Tawfik, O. AU - Hoover, L. AU - Bruegger, D. E. AU - Thomas, S. M. C2 - PMC5827962 C6 - NIHMS944552 DA - Oct DO - 10.1002/alr.21987 DP - NLM ET - 2017/07/15 IS - 10 LA - eng N1 - 2042-6984 Le, Tran New, Jacob Jones, Joel W Usman, Shireen Yalamanchali, Sreeya Tawfik, Ossama Hoover, Larry Bruegger, Dan E Thomas, Sufi Mary P30 CA168524/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Int Forum Allergy Rhinol. 2017 Oct;7(10):973-979. doi: 10.1002/alr.21987. Epub 2017 Jul 14. PY - 2017 SN - 2042-6976 (Print) 2042-6976 SP - 973-979 ST - Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma T2 - Int Forum Allergy Rhinol TI - Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma VL - 7 ID - 743 ER - TY - JOUR AD - Department of Pathology, University of Texas Southwestern Medical Center Department of Pathology and Laboratory Medicine, Children's Health Department of Pediatrics, University of Texas Southwestern Medical Center Department of Pediatrics, Children's Health Department of Radiology, University of Texas Southwestern Medical Center Department of Radiology, Children's Health Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas AN - 28784858 AU - Drobysheva, A. AU - Klesse, L. J. AU - Bowers, D. C. AU - Rajaram, V. AU - Rakheja, D. AU - Timmons, C. F. AU - Wang, J. AU - Koral, K. AU - Gargan, L. AU - Ramos, E. AU - Park, J. Y. DA - Aug DO - 10.6004/jnccn.2017.0139 DP - NLM ET - 2017/08/09 IS - 8 LA - eng N1 - 1540-1413 Drobysheva, Anastasia Klesse, Laura J Bowers, Daniel C Rajaram, Veena Rakheja, Dinesh Timmons, Charles F Wang, Jason Koral, Korgun Gargan, Lynn Ramos, Erica Park, Jason Y Case Reports Journal Article United States J Natl Compr Canc Netw. 2017 Aug;15(8):978-982. doi: 10.6004/jnccn.2017.0139. PY - 2017 SN - 1540-1405 SP - 978-982 ST - Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas T2 - J Natl Compr Canc Netw TI - Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas VL - 15 ID - 744 ER - TY - JOUR AD - Yael P. Mossé, Megan S. Lim, Delphine Rolland, Elizabeth Fox, and Peter Adamson, University of Pennsylvania, Philadelphia, PA; Stephan D. Voss, Harvard Medical School, Boston, MA; Charles G. Minard and Susan M. Blaney, Baylor College of Medicine, Houston, TX; Keith Wilner, Pfizer Oncology, La Jolla, CA; and Brenda J. Weigel, University of Minnesota Cancer Center, Minneapolis, MN. AN - 28787259 AU - Mossé, Y. P. AU - Voss, S. D. AU - Lim, M. S. AU - Rolland, D. AU - Minard, C. G. AU - Fox, E. AU - Adamson, P. AU - Wilner, K. AU - Blaney, S. M. AU - Weigel, B. J. C2 - PMC5617123 DA - Oct 1 DO - 10.1200/jco.2017.73.4830 DP - NLM ET - 2017/08/09 IS - 28 LA - eng N1 - 1527-7755 Mossé, Yael P Voss, Stephan D Lim, Megan S Rolland, Delphine Minard, Charles G Fox, Elizabeth Adamson, Peter Wilner, Keith Blaney, Susan M Weigel, Brenda J U01 CA097452/CA/NCI NIH HHS/United States UM1 CA097452/CA/NCI NIH HHS/United States Clinical Trial, Phase I Clinical Trial, Phase II Journal Article J Clin Oncol. 2017 Oct 1;35(28):3215-3221. doi: 10.1200/JCO.2017.73.4830. Epub 2017 Aug 8. PY - 2017 SN - 0732-183X (Print) 0732-183x SP - 3215-3221 ST - Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study T2 - J Clin Oncol TI - Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study VL - 35 ID - 745 ER - TY - JOUR AD - Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Electronic address: rajivpat@med.umich.edu. AN - 28844540 AU - Udager, A. M. AU - Frisch, N. K. AU - Hong, L. J. AU - Stasenko, M. AU - Johnston, C. M. AU - Liu, J. R. AU - Chan, M. P. AU - Harms, P. W. AU - Fullen, D. R. AU - Orsini, A. AU - Thomas, D. G. AU - Lowe, L. AU - Patel, R. M. DA - Nov DO - 10.1016/j.ygyno.2017.08.023 DP - NLM ET - 2017/08/29 IS - 2 LA - eng N1 - 1095-6859 Udager, Aaron M Frisch, Nora K Hong, Linda J Stasenko, Marina Johnston, Carolyn M Liu, J Rebecca Chan, May P Harms, Paul W Fullen, Douglas R Orsini, Amy Thomas, Dafydd G Lowe, Lori Patel, Rajiv M Journal Article Research Support, Non-U.S. Gov't United States Gynecol Oncol. 2017 Nov;147(2):351-357. doi: 10.1016/j.ygyno.2017.08.023. Epub 2017 Aug 24. PY - 2017 SN - 0090-8258 SP - 351-357 ST - Gynecologic melanomas: A clinicopathologic and molecular analysis T2 - Gynecol Oncol TI - Gynecologic melanomas: A clinicopathologic and molecular analysis VL - 147 ID - 746 ER - TY - JOUR AD - Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. AN - 28879901 AU - Kakkar, A. AU - Majumdar, A. AU - Pathak, P. AU - Kumar, A. AU - Kumari, K. AU - Tripathi, M. AU - Sharma, M. C. AU - Suri, V. AU - Tandon, V. AU - Chandra, S. P. AU - Sarkar, C. DA - Sep-Oct DO - 10.4103/neuroindia.NI_207_17 DP - NLM ET - 2017/09/08 IS - 5 LA - eng N1 - Kakkar, Aanchal Majumdar, Atreye Pathak, Pankaj Kumar, Anupam Kumari, Kalpana Tripathi, Manjari Sharma, Mehar C Suri, Vaishali Tandon, Vivek Chandra, Sarat P Sarkar, Chitra Journal Article India Neurol India. 2017 Sep-Oct;65(5):1076-1082. doi: 10.4103/neuroindia.NI_207_17. PY - 2017 SN - 0028-3886 (Print) 0028-3886 SP - 1076-1082 ST - BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas T2 - Neurol India TI - BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas VL - 65 ID - 747 ER - TY - JOUR AD - From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). AN - 28891408 AU - Long, G. V. AU - Hauschild, A. AU - Santinami, M. AU - Atkinson, V. AU - Mandalà, M. AU - Chiarion-Sileni, V. AU - Larkin, J. AU - Nyakas, M. AU - Dutriaux, C. AU - Haydon, A. AU - Robert, C. AU - Mortier, L. AU - Schachter, J. AU - Schadendorf, D. AU - Lesimple, T. AU - Plummer, R. AU - Ji, R. AU - Zhang, P. AU - Mookerjee, B. AU - Legos, J. AU - Kefford, R. AU - Dummer, R. AU - Kirkwood, J. M. DA - Nov 9 DO - 10.1056/NEJMoa1708539 DP - NLM ET - 2017/09/12 IS - 19 LA - eng N1 - 1533-4406 Long, Georgina V Hauschild, Axel Santinami, Mario Atkinson, Victoria Mandalà, Mario Chiarion-Sileni, Vanna Larkin, James Nyakas, Marta Dutriaux, Caroline Haydon, Andrew Robert, Caroline Mortier, Laurent Schachter, Jacob Schadendorf, Dirk Lesimple, Thierry Plummer, Ruth Ji, Ran Zhang, Pingkuan Mookerjee, Bijoyesh Legos, Jeff Kefford, Richard Dummer, Reinhard Kirkwood, John M Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't United States N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10. PY - 2017 SN - 0028-4793 SP - 1813-1823 ST - Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma T2 - N Engl J Med TI - Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma VL - 377 ID - 748 ER - TY - JOUR AD - Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China. AN - 28892804 AU - Wang, P. AU - Lun, Y. AU - Fu, Y. AU - Wang, F. AU - Zhao, S. AU - Wang, Y. AU - Hou, X. DO - 10.1159/000477909 DP - NLM ET - 2017/09/12 IS - 10 LA - eng N1 - 2296-5262 Wang, Ping Lun, Yu Fu, Yudong Wang, Fei Zhao, Shihua Wang, Yangyang Hou, Xu Journal Article Netherlands Oncol Res Treat. 2017;40(10):586-592. doi: 10.1159/000477909. Epub 2017 Sep 12. PY - 2017 SN - 2296-5270 SP - 586-592 ST - Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation T2 - Oncol Res Treat TI - Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation VL - 40 ID - 749 ER - TY - JOUR AD - Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, PR China. Department of Respiratory Disease, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, PR China. Electronic address: qianyechang@163.com. Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, PR China. Electronic address: wsl@tongji.edu.cn. AN - 28923539 AU - Zhu, R. AU - Wang, Z. AU - Liang, P. AU - He, X. AU - Zhuang, X. AU - Huang, R. AU - Wang, M. AU - Wang, Q. AU - Qian, Y. AU - Wang, S. DA - Nov DO - 10.1016/j.actbio.2017.09.009 DP - NLM ET - 2017/09/20 LA - eng N1 - 1878-7568 Zhu, Rongrong Wang, Zhaoqi Liang, Peng He, Xiaolie Zhuang, Xizhen Huang, Ruiqi Wang, Mei Wang, Qigang Qian, Yechang Wang, Shilong Journal Article Research Support, Non-U.S. Gov't England Acta Biomater. 2017 Nov;63:163-180. doi: 10.1016/j.actbio.2017.09.009. Epub 2017 Sep 18. PY - 2017 SN - 1742-7061 SP - 163-180 ST - Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO(2)@LDH for anti-neuroblastoma therapy T2 - Acta Biomater TI - Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO(2)@LDH for anti-neuroblastoma therapy VL - 63 ID - 750 ER - TY - JOUR AD - Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven. Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Warsaw. Oncology Center, Warsaw, Poland. Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France. Medical Clinic III, University Hospital of Munich, Munich, Germany. Department of Oncology, University College London Hospital NHS Trust, London. Institute of Oncology, Leeds Teaching Hospitals National Health Service Trust, St. James's University Hospital, Leeds, UK. Department of Medical Oncology, CHU la Timone Boulevard J Moulin Marseille, Marseille. Aix Marseille University (AMU), Marseille, France. University Cancer Center, Dresden. Medical Department I, University Hospital Carl Gustav Carus, Dresden. Department of Haematology, Haemostasis and Oncology, Hannover Medical School, Hannover, Germany. The Christie NHS Foundation Trust, Manchester, UK. HELIOS Klinikum Berlin-Buch, Sarcoma Center Berlin-Brandenburg, Berlin, Germany. National Cancer Institute, Bratislava, Slovakia. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. The Institute of Cancer Research, London, UK. Department of Pathology, University Hospitals Leuven, Leuven. Department of Human Genetics, KU Leuven, Leuven. European Organization for Research and Treatment of Cancer, Brussels, Belgium. Department of Internal Medicine, West German Cancer Center, University Hospital, University of Duisburg-Essen, Duisburg, Germany. AN - 28950372 AU - Schöffski, P. AU - Wozniak, A. AU - Stacchiotti, S. AU - Rutkowski, P. AU - Blay, J. Y. AU - Lindner, L. H. AU - Strauss, S. J. AU - Anthoney, A. AU - Duffaud, F. AU - Richter, S. AU - Grünwald, V. AU - Leahy, M. G. AU - Reichardt, P. AU - Sufliarsky, J. AU - van der Graaf, W. T. AU - Sciot, R. AU - Debiec-Rychter, M. AU - van Cann, T. AU - Marréaud, S. AU - Lia, M. AU - Raveloarivahy, T. AU - Collette, L. AU - Bauer, S. C2 - PMC5834120 DA - Dec 1 DO - 10.1093/annonc/mdx527 DP - NLM ET - 2017/09/28 IS - 12 LA - eng N1 - 1569-8041 Schöffski, P Wozniak, A Stacchiotti, S Rutkowski, P Blay, J-Y Lindner, L H Strauss, S J Anthoney, A Duffaud, F Richter, S Grünwald, V Leahy, M G Reichardt, P Sufliarsky, J van der Graaf, W T Sciot, R Debiec-Rychter, M van Cann, T Marréaud, S Lia, M Raveloarivahy, T Collette, L Bauer, S Clinical Trial, Phase II Journal Article Multicenter Study Ann Oncol. 2017 Dec 1;28(12):3000-3008. doi: 10.1093/annonc/mdx527. PY - 2017 SN - 0923-7534 (Print) 0923-7534 SP - 3000-3008 ST - Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' T2 - Ann Oncol TI - Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' VL - 28 ID - 751 ER - TY - JOUR AD - The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: ohamid@theangelesclinic.org. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. University of Zürich, Zürich, Switzerland. Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. University of California, San Francisco, San Francisco, CA, USA. University Hospital Essen, Essen, Germany. Netherlands Cancer Institute, Amsterdam, The Netherlands. University of Arizona Cancer Center, Tucson, AZ, USA. Gustave Roussy and Paris-Sud University, Villejuif, France. New York University Cancer Institute, New York, NY, USA. University of Colorado Denver, Aurora, CO, USA. Dana-Farber Cancer Institute, Boston, MA, USA. Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Duke Cancer Institute, Durham, NC, USA. City of Hope, Duarte, CA, USA. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. Merck & Co., Inc., Kenilworth, NJ, USA. University of California Los Angeles, Los Angeles, CA, USA. AN - 28961465 AU - Hamid, O. AU - Puzanov, I. AU - Dummer, R. AU - Schachter, J. AU - Daud, A. AU - Schadendorf, D. AU - Blank, C. AU - Cranmer, L. D. AU - Robert, C. AU - Pavlick, A. C. AU - Gonzalez, R. AU - Hodi, F. S. AU - Ascierto, P. A. AU - Salama, A. K. S. AU - Margolin, K. A. AU - Gangadhar, T. C. AU - Wei, Z. AU - Ebbinghaus, S. AU - Ibrahim, N. AU - Ribas, A. DA - Nov DO - 10.1016/j.ejca.2017.07.022 DP - NLM ET - 2017/09/30 LA - eng N1 - 1879-0852 Hamid, Omid Puzanov, Igor Dummer, Reinhard Schachter, Jacob Daud, Adil Schadendorf, Dirk Blank, Christian Cranmer, Lee D Robert, Caroline Pavlick, Anna C Gonzalez, Rene Hodi, F Stephen Ascierto, Paolo A Salama, April K S Margolin, Kim A Gangadhar, Tara C Wei, Ziwen Ebbinghaus, Scot Ibrahim, Nageatte Ribas, Antoni Clinical Trial, Phase II Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't England Eur J Cancer. 2017 Nov;86:37-45. doi: 10.1016/j.ejca.2017.07.022. PY - 2017 SN - 0959-8049 SP - 37-45 ST - Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma T2 - Eur J Cancer TI - Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma VL - 86 ID - 752 ER - TY - JOUR AD - Departments of1Neurosurgery. 2Radiology, and. 3Pathology, Huashan Hospital, Fudan University; and. 4State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China. AN - 28984520 AU - Yue, Q. AU - Yu, Y. AU - Shi, Z. AU - Wang, Y. AU - Zhu, W. AU - Du, Z. AU - Yao, Z. AU - Chen, L. AU - Mao, Y. DA - Jul DO - 10.3171/2017.4.Jns163113 DP - NLM ET - 2017/10/07 IS - 1 LA - eng N1 - 1933-0693 Yue, Qi Yu, Yang Shi, Zhifeng Wang, Yongfei Zhu, Wei Du, Zunguo Yao, Zhenwei Chen, Liang Mao, Ying Journal Article Research Support, Non-U.S. Gov't United States J Neurosurg. 2018 Jul;129(1):27-34. doi: 10.3171/2017.4.JNS163113. Epub 2017 Oct 6. PY - 2018 SN - 0022-3085 SP - 27-34 ST - Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features T2 - J Neurosurg TI - Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features VL - 129 ID - 753 ER - TY - JOUR AD - Georgina V. Long, University of Sydney, and Royal North Shore Hospital; Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales; Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia; Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL; Jeffrey Infante, Tennessee Oncology; Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Adil Daud, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, University of Colorado, Denver, CO; Lynn Schuchter, University of Pennsylvania, Philadelphia, PA; William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD; Robert McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University, New Haven, CT; Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ; Jeffrey Weber, New York University Langone Medical Center, New York, NY; and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. AN - 28991513 AU - Long, G. V. AU - Eroglu, Z. AU - Infante, J. AU - Patel, S. AU - Daud, A. AU - Johnson, D. B. AU - Gonzalez, R. AU - Kefford, R. AU - Hamid, O. AU - Schuchter, L. AU - Cebon, J. AU - Sharfman, W. AU - McWilliams, R. AU - Sznol, M. AU - Redhu, S. AU - Gasal, E. AU - Mookerjee, B. AU - Weber, J. AU - Flaherty, K. T. DA - Mar 1 DO - 10.1200/jco.2017.74.1025 DP - NLM ET - 2017/10/11 IS - 7 LA - eng N1 - 1527-7755 Long, Georgina V Eroglu, Zeynep Infante, Jeffrey Patel, Sapna Daud, Adil Johnson, Douglas B Gonzalez, Rene Kefford, Richard Hamid, Omid Schuchter, Lynn Cebon, Jonathan Sharfman, William McWilliams, Robert Sznol, Mario Redhu, Suman Gasal, Eduard Mookerjee, Bijoyesh Weber, Jeffrey Flaherty, Keith T Clinical Trial, Phase II Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States J Clin Oncol. 2018 Mar 1;36(7):667-673. doi: 10.1200/JCO.2017.74.1025. Epub 2017 Oct 9. PY - 2018 SN - 0732-183x SP - 667-673 ST - Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib T2 - J Clin Oncol TI - Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib VL - 36 ID - 754 ER - TY - JOUR AD - Department of Translational Research & UMR1052, CRCL, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. INSERM U1218, Genetics and Biology of Sarcomas, Institut Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. University of Bordeaux, 146 Rue Léo Saignat, Bordeaux 33076, France. Department of Histopathology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Pathology, Institute Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Surgery, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Radiation Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Cancer Medicine, Gustave Roussy, 114 Rue Édouard-Vaillant, Villejuif Cedex 94805, France. Department of Surgery, Institute Curie, PSL Research University, 26 Rue d'Ulm, Paris Cedex 05 75248, France. Department of Medical Oncology, Institute Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. EMS Team, Centre Léon Bérard, 28 rue Laennec, Lyon 69008, France. AN - 29024938 AU - Dantas-Barbosa, C. AU - Lesluyes, T. AU - Loarer, F. L. AU - Chibon, F. AU - Treilleux, I. AU - Coindre, J. M. AU - Meeus, P. AU - Brahmi, M. AU - Bally, O. AU - Ray-Coquard, I. AU - Sunyach, M. P. AU - Cesne, A. L. AU - Mir, O. AU - Bonvalot, S. AU - Toulmonde, M. AU - Italiano, A. AU - Saintigny, P. AU - Jean-Denis, M. AU - Ducimetiere, F. AU - Ranchere, D. AU - El Sayadi, H. AU - Alberti, L. AU - Blay, J. Y. C2 - PMC5729471 DA - Dec 5 DO - 10.1038/bjc.2017.354 DP - NLM ET - 2017/10/13 IS - 12 LA - eng N1 - 1532-1827 Dantas-Barbosa, Carmela Lesluyes, Tom Loarer, François Le Chibon, Fréderic Treilleux, Isabelle Coindre, Jean-Michel Meeus, Pierre Brahmi, Mehdi Bally, Olivia Ray-Coquard, Isabelle Sunyach, Marie-Pierre Cesne, Axel Le Mir, Olivier Bonvalot, Sylvie Toulmonde, Maud Italiano, Antoine Saintigny, Pierre Jean-Denis, Myriam Ducimetiere, Francoise Ranchere, Dominique El Sayadi, Hiba Alberti, Laurent Blay, Jean-Yves Journal Article Br J Cancer. 2017 Dec 5;117(12):1787-1797. doi: 10.1038/bjc.2017.354. Epub 2017 Oct 12. PY - 2017 SN - 0007-0920 (Print) 0007-0920 SP - 1787-1797 ST - Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma T2 - Br J Cancer TI - Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma VL - 117 ID - 755 ER - TY - JOUR AD - Hematology Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Laboratory Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Hematology Department, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. Urology surgery Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, Hunan, China. Molecular Biology Research Center, School of Life Science, Central South University, Changsha, 410078, China. Hematology Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. xychenfp@qq.com. AN - 29051621 AU - Peng, M. AU - Li, Y. AU - Zhang, J. AU - Wu, Y. AU - Yang, X. AU - Lei, Y. AU - Ye, M. AU - Liu, J. AU - Han, X. AU - Kuang, Y. AU - Zhao, X. AU - Chen, F. C2 - PMC5648841 DA - Oct 19 DO - 10.1038/s41598-017-14099-0 DP - NLM ET - 2017/10/21 IS - 1 LA - eng N1 - 2045-2322 Peng, Minyuan Orcid: 0000-0001-8173-3457 Li, Yanming Zhang, Jian Wu, Yong Yang, Xiaoyang Lei, Ye Ye, Mao Liu, Jing Han, Xu Kuang, Yijin Zhao, Xielan Chen, Fangping Journal Article Sci Rep. 2017 Oct 19;7(1):13571. doi: 10.1038/s41598-017-14099-0. PY - 2017 SN - 2045-2322 SP - 13571 ST - Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation T2 - Sci Rep TI - Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation VL - 7 ID - 756 ER - TY - JOUR AD - Vivek Subbiah and Maria E. Cabanillas, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert J. Kreitman, National Institutes of Health, Bethesda, MD; Zev A. Wainberg, University of California Los Angeles, Los Angeles, CA; Jae Yong Cho, Yonsei University College of Medicine Gangnam Severance Hospital; Bhumsuk Keam, Seoul National University Hospital, Seoul, Republic of Korea; Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam; Jan H.M. Schellens, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands; Jean Charles Soria, Institut Gustave Roussy, University of Paris-Sud, and University of Paris-Saclay, Villejuif, France; Patrick Y. Wen, Dana-Farber Cancer Institute, Boston, MA; Christoph Zielinski, Comprehensive Cancer Center, Medical University Vienna; Vienna, Austria; and Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, and Fatima Rangwala, Novartis Oncology, East Hanover, NJ. AN - 29072975 AU - Subbiah, V. AU - Kreitman, R. J. AU - Wainberg, Z. A. AU - Cho, J. Y. AU - Schellens, J. H. M. AU - Soria, J. C. AU - Wen, P. Y. AU - Zielinski, C. AU - Cabanillas, M. E. AU - Urbanowitz, G. AU - Mookerjee, B. AU - Wang, D. AU - Rangwala, F. AU - Keam, B. C2 - PMC5791845 DA - Jan 1 DO - 10.1200/jco.2017.73.6785 DP - NLM ET - 2017/10/27 IS - 1 LA - eng N1 - 1527-7755 Subbiah, Vivek Kreitman, Robert J Wainberg, Zev A Cho, Jae Yong Schellens, Jan H M Soria, Jean Charles Wen, Patrick Y Zielinski, Christoph Cabanillas, Maria E Urbanowitz, Gladys Mookerjee, Bijoyesh Wang, Dazhe Rangwala, Fatima Keam, Bhumsuk P30 CA016042/CA/NCI NIH HHS/United States P30 CA016672/CA/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Clin Oncol. 2018 Jan 1;36(1):7-13. doi: 10.1200/JCO.2017.73.6785. Epub 2017 Oct 26. PY - 2018 SN - 0732-183X (Print) 0732-183x SP - 7-13 ST - Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer T2 - J Clin Oncol TI - Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer VL - 36 ID - 757 ER - TY - JOUR AD - 1 Division of Oncology, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania. 2 Asuragen, Inc. , Austin, Texas. 3 Division of Anatomic Pathology, Department of Pathology. 4 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania. 5 Department of Biostatistics and Epidemiology, University of Pennsylvania , Philadelphia, Pennsylvania. 6 Division of Pediatric Otolaryngology, Department of Pediatric Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 7 Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 8 Division of General Surgery, Department of Pediatric Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 9 Division of Endocrinology and Diabetes, Department of Pediatrics, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania. AN - 29108474 AU - Mostoufi-Moab, S. AU - Labourier, E. AU - Sullivan, L. AU - LiVolsi, V. AU - Li, Y. AU - Xiao, R. AU - Beaudenon-Huibregtse, S. AU - Kazahaya, K. AU - Adzick, N. S. AU - Baloch, Z. AU - Bauer, A. J. C2 - PMC5770125 DA - Jan DO - 10.1089/thy.2017.0059 DP - NLM ET - 2017/11/08 IS - 1 LA - eng N1 - 1557-9077 Mostoufi-Moab, Sogol Labourier, Emmanuel Sullivan, Lisa LiVolsi, Virginia Li, Yimei Xiao, Rui Beaudenon-Huibregtse, Sylvie Kazahaya, Ken Adzick, N Scott Baloch, Zubair Bauer, Andrew J K07 CA166177/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Thyroid. 2018 Jan;28(1):60-67. doi: 10.1089/thy.2017.0059. Epub 2017 Dec 11. PY - 2018 SN - 1050-7256 (Print) 1050-7256 SP - 60-67 ST - Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions T2 - Thyroid TI - Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions VL - 28 ID - 758 ER - TY - JOUR AD - Department of Ophthalmology, Palmetto Health/University of South Carolina, Richland. Department of Ophthalmology, Palmetto Health/University of South Carolina, Richland. Electronic address: keckkt@gmail.com. Department of Otolaryngology, Palmetto Health/University of South Carolina, Richland. Department of Pathology, Palmetto Health/University of South Carolina, Richland. AN - 29126970 AU - Walters, A. R. AU - Keck, K. M. AU - Simmons, O. AU - Williams, S. G. AU - Cross, S. AU - Patel, R. M. DA - Dec DO - 10.1016/j.jaapos.2017.06.025 DP - NLM ET - 2017/11/12 IS - 6 LA - eng N1 - 1528-3933 Walters, Alexander R Keck, Katie M Simmons, Oliver Williams, Sarah G Cross, Stephen Patel, Rakesh M Case Reports Journal Article United States J AAPOS. 2017 Dec;21(6):501-503. doi: 10.1016/j.jaapos.2017.06.025. Epub 2017 Nov 7. PY - 2017 SN - 1091-8531 SP - 501-503 ST - Malignant melanoma presenting as amelanotic caruncular lesion in a child T2 - J aapos TI - Malignant melanoma presenting as amelanotic caruncular lesion in a child VL - 21 ID - 759 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. State Institution V. P. Komisarenko Institute of Endocrinology and Metabolism of AMS of Ukraine, Kyiv, Ukraine. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Columbia University Medical Center, New York, NY. AN - 29165687 AU - Efanov, A. A. AU - Brenner, A. V. AU - Bogdanova, T. I. AU - Kelly, L. M. AU - Liu, P. AU - Little, M. P. AU - Wald, A. I. AU - Hatch, M. AU - Zurnadzy, L. Y. AU - Nikiforova, M. N. AU - Drozdovitch, V. AU - Leeman-Neill, R. AU - Mabuchi, K. AU - Tronko, M. D. AU - Chanock, S. J. AU - Nikiforov, Y. E. C2 - PMC6059206 DA - Apr 1 DO - 10.1093/jnci/djx209 DP - NLM ET - 2017/11/23 IS - 4 LA - eng N1 - 1460-2105 Efanov, Alexey A Brenner, Alina V Bogdanova, Tetiana I Kelly, Lindsey M Liu, Pengyuan Little, Mark P Wald, Abigail I Hatch, Maureen Zurnadzy, Liudmyla Y Nikiforova, Marina N Drozdovitch, Vladimir Leeman-Neill, Rebecca Mabuchi, Kiyohiko Tronko, Mykola D Chanock, Stephen J Nikiforov, Yuri E R01 CA088041/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural J Natl Cancer Inst. 2018 Apr 1;110(4):371-378. doi: 10.1093/jnci/djx209. PY - 2018 SN - 0027-8874 (Print) 0027-8874 SP - 371-378 ST - Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer T2 - J Natl Cancer Inst TI - Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer VL - 110 ID - 760 ER - TY - JOUR AD - Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Department of Preventive Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Division of Pathology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Centre for Oral Cancer Prevention Awareness and Research, Sree Balaji Dental College and Hospital, Bharat University, Chennai, Tamil Nadu, India. Division of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Division of Preventive Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. AN - 29199726 AU - Krishnamurthy, A. AU - Ramshankar, V. AU - Murherkar, K. AU - Vidyarani, S. AU - Raghunandhan, G. C. AU - Das, A. AU - Desai, P. B. AU - Albert, K. DA - Jan-Mar DO - 10.4103/ijc.IJC_182_17 DP - NLM ET - 2017/12/05 IS - 1 LA - eng N1 - 1998-4774 Krishnamurthy, A Ramshankar, V Murherkar, K Vidyarani, S Raghunandhan, G C Das, A Desai, P B Albert, K Journal Article India Indian J Cancer. 2017 Jan-Mar;54(1):372-378. doi: 10.4103/ijc.IJC_182_17. PY - 2017 SN - 0019-509x SP - 372-378 ST - Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature T2 - Indian J Cancer TI - Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature VL - 54 ID - 761 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology. Division of Radiology. Division of Pathology. Division of Neurosurgery, King Hussein Cancer Center, Amman, Jordan. Division of Hematology/Oncology. Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada. AN - 29200156 AU - Amayiri, N. AU - Swaidan, M. AU - Al-Hussaini, M. AU - Halalsheh, H. AU - Al-Nassan, A. AU - Musharbash, A. AU - Tabori, U. AU - Hawkins, C. AU - Bouffet, E. DA - Aug DO - 10.1097/mph.0000000000001032 DP - NLM ET - 2017/12/05 IS - 6 LA - eng N1 - 1536-3678 Amayiri, Nisreen Swaidan, Maisa Al-Hussaini, Maysa Halalsheh, Hadeel Al-Nassan, Anwar Musharbash, Awni Tabori, Uri Hawkins, Cynthia Bouffet, Eric Case Reports Journal Article United States J Pediatr Hematol Oncol. 2018 Aug;40(6):478-482. doi: 10.1097/MPH.0000000000001032. PY - 2018 SN - 1077-4114 SP - 478-482 ST - Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma T2 - J Pediatr Hematol Oncol TI - Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma VL - 40 ID - 762 ER - TY - JOUR AD - School of Medicine, University of Dublin, Trinity College, Dublin, Ireland. Conway Institute, University College Dublin, Belfield, Dublin, Ireland. School of Genetics and Microbiology, University of Dublin, Trinity College, Dublin, Ireland. Our Lady's Children's Hospital, Crumlin, Dublin, Ireland. AN - 29243812 AU - Kenny, C. AU - McDonagh, N. AU - Lazaro, A. AU - O'Meara, E. AU - Klinger, R. AU - O'Connor, D. AU - Roche, F. AU - Hokamp, K. AU - O'Sullivan, M. J. DA - Mar DO - 10.1002/path.5020 DP - NLM ET - 2017/12/16 IS - 3 LA - eng N1 - 1096-9896 Kenny, Colin Orcid: 0000-0001-8926-4413 McDonagh, Naomi Lazaro, Antonio O'Meara, Elaine Klinger, Rut O'Connor, Darran Roche, Fiona Hokamp, Karsten O'Sullivan, Maureen J Journal Article Research Support, Non-U.S. Gov't England J Pathol. 2018 Mar;244(3):334-345. doi: 10.1002/path.5020. Epub 2018 Jan 23. PY - 2018 SN - 0022-3417 SP - 334-345 ST - Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney T2 - J Pathol TI - Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney VL - 244 ID - 763 ER - TY - JOUR AD - Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, The Netherlands. Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands. Newcastle University, Northern Institute for Cancer Research, Wolfson Childhood Cancer Research Centre, Newcastle upon Tyne, United Kingdom. Departamento de Medicina Interna, Universidade Federal do Parana, Hospital de Clinicas de Curitiba, Curitiba, Brazil. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Hans.Koenen@radboudumc.nl. AN - 29248493 AU - Urbano, P. C. M. AU - Aguirre-Gamboa, R. AU - Ashikov, A. AU - van Heeswijk, B. AU - Krippner-Heidenreich, A. AU - Tijssen, H. AU - Li, Y. AU - Azevedo, V. F. AU - Smits, L. J. T. AU - Hoentjen, F. AU - Joosten, I. AU - Koenen, Hjpm DA - Aug DO - 10.1016/j.jaci.2017.11.024 DP - NLM ET - 2017/12/19 IS - 2 LA - eng N1 - 1097-6825 Urbano, Paulo C M Aguirre-Gamboa, Raúl Ashikov, Angel van Heeswijk, Bennie Krippner-Heidenreich, Anja Tijssen, Henk Li, Yang Azevedo, Valderilio F Smits, Lisa J T Hoentjen, Frank Joosten, Irma Koenen, Hans J P M Journal Article Research Support, Non-U.S. Gov't United States J Allergy Clin Immunol. 2018 Aug;142(2):517-529. doi: 10.1016/j.jaci.2017.11.024. Epub 2017 Dec 14. PY - 2018 SN - 0091-6749 SP - 517-529 ST - TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression T2 - J Allergy Clin Immunol TI - TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression VL - 142 ID - 764 ER - TY - JOUR AD - Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. Department of Integrative Neuroscience, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. Division of Biostatistics and Clinical Epidemiology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. AN - 29271010 AU - Hayashi, T. AU - Hayakawa, Y. AU - Koh, M. AU - Tomita, T. AU - Nagai, S. AU - Kashiwazaki, D. AU - Sugimori, M. AU - Origasa, H. AU - Kuroda, S. DA - Apr DO - 10.1111/neup.12446 DP - NLM ET - 2017/12/23 IS - 2 LA - eng N1 - 1440-1789 Hayashi, Tomohide Hayakawa, Yumiko Koh, Masaki Tomita, Takahiro Nagai, Shoichi Kashiwazaki, Daina Sugimori, Michiya Origasa, Hideki Kuroda, Satoshi Orcid: 0000-0003-1820-8793 Journal Article Australia Neuropathology. 2018 Apr;38(2):144-153. doi: 10.1111/neup.12446. Epub 2017 Dec 21. PY - 2018 SN - 0919-6544 SP - 144-153 ST - Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma T2 - Neuropathology TI - Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma VL - 38 ID - 765 ER - TY - JOUR AD - Department of Medicine, Division of Medical Oncology, Washington University School of Medicine Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Division of Neuropathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri AN - 29295876 AU - Johanns, T. M. AU - Ferguson, C. J. AU - Grierson, P. M. AU - Dahiya, S. AU - Ansstas, G. DA - Jan DO - 10.6004/jnccn.2017.7032 DP - NLM ET - 2018/01/04 IS - 1 LA - eng N1 - 1540-1413 Johanns, Tanner M Ferguson, Cole J Grierson, Patrick M Dahiya, Sonika Ansstas, George T32 HL007088/HL/NHLBI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States J Natl Compr Canc Netw. 2018 Jan;16(1):4-10. doi: 10.6004/jnccn.2017.7032. PY - 2018 SN - 1540-1405 SP - 4-10 ST - Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma T2 - J Natl Compr Canc Netw TI - Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma VL - 16 ID - 766 ER - TY - JOUR AD - From the Department of Genetic Medicine and Development, University of Geneva Medical School (S.I.N., X.B., S.E.A.), Service of Genetic Medicine, University Hospitals of Geneva (S.I.N., S.E.A.), and iGE3, Institute of Genetics and Genomics of Geneva (S.E.A.) - all in Geneva; the Department of Fundamental Neurobiology, Krembil Research Institute (S.V., M.T., I.R.), Toronto General Hospital Research Institute (E.B., N.K., P.V.D., J.E.F.), the Department of Pathology (T.-R.K.), the Division of Neurosurgery, Department of Surgery (V.M.P., T.K., H.A.-B., T.T., T.V., G.Z., M.T., I.R.), and the Joint Division of Medical Imaging, Department of Medical Imaging (V.M.P., T.K.), Toronto Western Hospital, University Health Network, the Department of Laboratory Medicine and Pathobiology, University of Toronto (E.B., N.K., P.V.D., T.-R.K., J.E.F.), and the Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research (E.B., N.K., P.V.D., J.E.F.) - all in Toronto; the Department of Molecular Medicine, AIV Institute, University of Eastern Finland (S.J., B.R.J., S.S., S.Y.-H., J.F.), and the Hemorrhagic Brain Pathology Research Group, Department of Neurosurgery and NeuroCenter (S.J., B.R.J., S.S., T.R., J.F.), and the Department of Pathology (T.R.), Kuopio University Hospital - all in Kuopio, Finland; and the Cardiovascular Research Institute and the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston (A.M.H., J.D.W.). AN - 29298116 AU - Nikolaev, S. I. AU - Vetiska, S. AU - Bonilla, X. AU - Boudreau, E. AU - Jauhiainen, S. AU - Rezai Jahromi, B. AU - Khyzha, N. AU - DiStefano, P. V. AU - Suutarinen, S. AU - Kiehl, T. R. AU - Mendes Pereira, V. AU - Herman, A. M. AU - Krings, T. AU - Andrade-Barazarte, H. AU - Tung, T. AU - Valiante, T. AU - Zadeh, G. AU - Tymianski, M. AU - Rauramaa, T. AU - Ylä-Herttuala, S. AU - Wythe, J. D. AU - Antonarakis, S. E. AU - Frösen, J. AU - Fish, J. E. AU - Radovanovic, I. DA - Jan 18 DO - 10.1056/NEJMoa1709449 DP - NLM ET - 2018/01/04 IS - 3 LA - eng N1 - 1533-4406 Nikolaev, Sergey I Vetiska, Sandra Bonilla, Ximena Boudreau, Emilie Jauhiainen, Suvi Rezai Jahromi, Behnam Khyzha, Nadiya DiStefano, Peter V Suutarinen, Santeri Kiehl, Tim-Rasmus Mendes Pereira, Vitor Herman, Alexander M Krings, Timo Andrade-Barazarte, Hugo Tung, Takyee Valiante, Taufik Zadeh, Gelareh Tymianski, Mike Rauramaa, Tuomas Ylä-Herttuala, Seppo Wythe, Joshua D Antonarakis, Stylianos E Frösen, Juhana Fish, Jason E Radovanovic, Ivan T32 HL007676/HL/NHLBI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States N Engl J Med. 2018 Jan 18;378(3):250-261. doi: 10.1056/NEJMoa1709449. Epub 2018 Jan 3. PY - 2018 SN - 0028-4793 SP - 250-261 ST - Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain T2 - N Engl J Med TI - Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain VL - 378 ID - 767 ER - TY - JOUR AD - Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore. Electron Microscopy Laboratory, Life Sciences Institute, National University of Singapore, Singapore. Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Centre for Biomedical & Life Sciences, Singapore Polytechnic, Singapore. AN - 29324904 AU - Too, I. H. K. AU - Bonne, I. AU - Tan, E. L. AU - Chu, J. J. H. AU - Alonso, S. C2 - PMC5764453 DA - Jan DO - 10.1371/journal.ppat.1006778 DP - NLM ET - 2018/01/13 IS - 1 LA - eng N1 - 1553-7374 Too, Issac Horng Khit Bonne, Isabelle Tan, Eng Lee Chu, Justin Jang Hann Alonso, Sylvie Journal Article Research Support, Non-U.S. Gov't PLoS Pathog. 2018 Jan 11;14(1):e1006778. doi: 10.1371/journal.ppat.1006778. eCollection 2018 Jan. PY - 2018 SN - 1553-7366 (Print) 1553-7366 SP - e1006778 ST - Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis T2 - PLoS Pathog TI - Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis VL - 14 ID - 768 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada. Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON, Canada. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. AN - 29327718 AU - Dickson, B. C. AU - Swanson, D. AU - Charames, G. S. AU - Fletcher, C. D. AU - Hornick, J. L. DA - May DO - 10.1038/modpathol.2017.191 DP - NLM ET - 2018/01/13 IS - 5 LA - eng N1 - 1530-0285 Dickson, Brendan C Orcid: 0000-0003-2269-6216 Swanson, David Charames, George S Fletcher, Christopher Dm Hornick, Jason L Journal Article Research Support, Non-U.S. Gov't United States Mod Pathol. 2018 May;31(5):753-762. doi: 10.1038/modpathol.2017.191. Epub 2018 Jan 12. PY - 2018 SN - 0893-3952 SP - 753-762 ST - Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases T2 - Mod Pathol TI - Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases VL - 31 ID - 769 ER - TY - JOUR AD - Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York, United States. Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, United States. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Department of Pathology, Weill-Cornell Medical Center, New York, New York, United States. AN - 29332123 AU - Francis, J. H. AU - Grossniklaus, H. E. AU - Habib, L. A. AU - Marr, B. AU - Abramson, D. H. AU - Busam, K. J. C2 - PMC6110167 DA - Jan 1 DO - 10.1167/iovs.17-22517 DP - NLM ET - 2018/01/15 IS - 1 LA - eng N1 - 1552-5783 Francis, Jasmine H Grossniklaus, Hans E Habib, Larissa A Marr, Brian Abramson, David H Busam, Klaus J P30 CA008748/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):117-121. doi: 10.1167/iovs.17-22517. PY - 2018 SN - 0146-0404 (Print) 0146-0404 SP - 117-121 ST - BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi T2 - Invest Ophthalmol Vis Sci TI - BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi VL - 59 ID - 770 ER - TY - JOUR AD - Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. Department of Pediatric Hematology and Oncology, Children's Teaching Hospital and St. Elizabeth University, Bratislava, Slovakia. Memorial Sloan Kettering Cancer Center, New York, New York. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Roche Innovation Center, New York, New York. Roche Products Limited, Welwyn Garden City, UK. Genentech, South San Francisco, California. AN - 29350463 AU - Chisholm, J. C. AU - Suvada, J. AU - Dunkel, I. J. AU - Casanova, M. AU - Zhang, W. AU - Ritchie, N. AU - Choi, Y. AU - Park, J. AU - Das Thakur, M. AU - Simko, S. AU - Wan Rachel Tam, N. AU - Ferrari, A. C2 - PMC5867229 C6 - NIHMS928012 DA - May DO - 10.1002/pbc.26947 DP - NLM ET - 2018/01/20 IS - 5 LA - eng N1 - 1545-5017 Chisholm, Julia C Orcid: 0000-0003-3479-7997 Suvada, Jozef Dunkel, Ira J Casanova, Michela Zhang, Weijiang Ritchie, Natasha Choi, YounJeong Park, Jane Das Thakur, Meghna Simko, Stephen Wan Rachel Tam, Nga Ferrari, Andrea Orcid: 0000-0002-4724-0517 P30 CA008748/CA/NCI NIH HHS/United States Clinical Trial, Phase I Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Pediatr Blood Cancer. 2018 May;65(5):e26947. doi: 10.1002/pbc.26947. Epub 2018 Jan 19. PY - 2018 SN - 1545-5009 (Print) 1545-5009 SP - e26947 ST - BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma T2 - Pediatr Blood Cancer TI - BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma VL - 65 ID - 771 ER - TY - JOUR AD - University of Milano Bicocca, San Gerardo Hospital, Monza, Italy. St Petersburg Medical University, St Petersburg, Russia. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong, China. Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. Department of Medical Oncology, Sun-Yat Sen University Cancer Center, Guangdong, China. National Kyushu Cancer Center, Fukuoka, Japan. National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Highlands Oncology Group, Fayetteville, Arkansas. Cancer Institute of Greenville Health System, Greenville, South Carolina. Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Oregon Health & Science University, Portland, Oregon. National Cancer Center Hospital, Tokyo, Japan. Washington University School of Medicine, St. Louis, Missouri. National Taiwan University Hospital, Taipei, Taiwan. Pfizer Oncology, Milan, Italy. Pfizer Oncology, La Jolla, California. Seoul National University Hospital, Seoul, South Korea. AN - 29352732 AU - Gambacorti-Passerini, C. AU - Orlov, S. AU - Zhang, L. AU - Braiteh, F. AU - Huang, H. AU - Esaki, T. AU - Horibe, K. AU - Ahn, J. S. AU - Beck, J. T. AU - Edenfield, W. J. AU - Shi, Y. AU - Taylor, M. AU - Tamura, K. AU - Van Tine, B. A. AU - Wu, S. J. AU - Paolini, J. AU - Selaru, P. AU - Kim, T. M. C2 - PMC5947833 DA - May DO - 10.1002/ajh.25043 DP - NLM ET - 2018/01/21 IS - 5 LA - eng N1 - 1096-8652 Gambacorti-Passerini, Carlo Orlov, Sergey Zhang, Li Braiteh, Fadi Huang, Huiqiang Esaki, Taito Horibe, Keizo Ahn, Jin-Seok Beck, Joseph T Edenfield, William Jeffrey Shi, Yuankai Orcid: 0000-0002-3342-4964 Taylor, Matthew Tamura, Kenji Orcid: 0000-0002-3514-9927 Van Tine, Brian A Wu, Shang-Ju Paolini, Jolanda Selaru, Paulina Kim, Tae Min Clinical Trial, Phase I Journal Article Multicenter Study Research Support, Non-U.S. Gov't Am J Hematol. 2018 May;93(5):607-614. doi: 10.1002/ajh.25043. Epub 2018 Feb 8. PY - 2018 SN - 0361-8609 (Print) 0361-8609 SP - 607-614 ST - Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study T2 - Am J Hematol TI - Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study VL - 93 ID - 772 ER - TY - JOUR AD - 1 University of Wisconsin Hospitals and Clinics, American Family Children's Hospital, Madison, WI, USA. 2 School of Pharmacy, University of Wisconsin, Madison, WI, USA. AN - 29357780 AU - Lubcke, N. AU - Van Camp, K. DA - Apr DO - 10.1177/1078155217752537 DP - NLM ET - 2018/01/24 IS - 3 LA - eng N1 - 1477-092x Lubcke, Nicole Van Camp, Kevin Case Reports Journal Article England J Oncol Pharm Pract. 2019 Apr;25(3):724-726. doi: 10.1177/1078155217752537. Epub 2018 Jan 22. PY - 2019 SN - 1078-1552 SP - 724-726 ST - Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma T2 - J Oncol Pharm Pract TI - Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma VL - 25 ID - 773 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Yale University School of Medicine, New Haven, Connecticut. Department of Radiation Oncology, Yale University School of Medicine, New Haven, Connecticut. Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. Department of Neurosurgery, Yale University School of Medicine. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. AN - 29380516 AU - Marks, A. M. AU - Bindra, R. S. AU - DiLuna, M. L. AU - Huttner, A. AU - Jairam, V. AU - Kahle, K. T. AU - Kieran, M. W. DA - May DO - 10.1002/pbc.26969 DP - NLM ET - 2018/01/31 IS - 5 LA - eng N1 - 1545-5017 Marks, Asher M Orcid: 0000-0002-9913-9912 Bindra, Ranjit S DiLuna, Michael L Huttner, Anita Jairam, Vikram Kahle, Kristopher T Kieran, Mark W Case Reports Journal Article United States Pediatr Blood Cancer. 2018 May;65(5):e26969. doi: 10.1002/pbc.26969. Epub 2018 Jan 30. PY - 2018 SN - 1545-5009 SP - e26969 ST - Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib T2 - Pediatr Blood Cancer TI - Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib VL - 65 ID - 774 ER - TY - JOUR AD - Department of Oncology, MS 260, Division of Neuro-Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Neurosurgery, LeBonheur Children's Hospital, Memphis, TN, USA. Department of Ophthalmology & Pediatrics, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Oncology, MS 260, Division of Neuro-Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. ibrahim.qaddoumi@stjude.org. AN - 29392423 AU - Upadhyaya, S. A. AU - Robinson, G. W. AU - Harreld, J. H. AU - Klimo, P. D., Jr. AU - Hoehn, M. E. AU - Orr, B. A. AU - Qaddoumi, I. A. C2 - PMC5857244 C6 - NIHMS939364 DA - Apr DO - 10.1007/s00381-018-3739-4 DP - NLM ET - 2018/02/03 IS - 4 LA - eng N1 - 1433-0350 Upadhyaya, Santhosh A Robinson, Giles W Harreld, Julie H Klimo, Paul D Jr Hoehn, Mary Ellen Orr, Brent A Qaddoumi, Ibrahim A P30 CA021765/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, N.I.H., Extramural Childs Nerv Syst. 2018 Apr;34(4):605-610. doi: 10.1007/s00381-018-3739-4. Epub 2018 Feb 1. PY - 2018 SN - 0256-7040 (Print) 0256-7040 SP - 605-610 ST - Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases T2 - Childs Nerv Syst TI - Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases VL - 34 ID - 775 ER - TY - JOUR AD - Medical Oncology Department, Centre Leon Berard, University Lyon I, Lyon, France. Electronic address: christelle.delafouchardiere@lyon.unicancer.fr. Pathology Department, Hospital Lyon-Sud, University Lyon I, Pierre-Bénite, France. Epidemiology, Pharmacology and Clinical Investigations, Mother Child Hospital, Bron; University Lyon I, Lyon, France. Biochemistry and Molecular Biology Department, Hospital Lyon-Sud, University Lyon I, Lyon, Pierre-Bénite, France. Department of General and Endocrine Surgery, University Hospital Lyon-Sud, Lyon, France. Department of Nuclear Medicine Centre Leon Berard, University Lyon I, Lyon, France. Endocrinology Department-INSERM, UMR 1052, University Lyon I, Lyon, France. Department of Nuclear Medicine, Hospital Louis Pradel, University Lyon I, Bron, France. AN - 29413688 AU - de la Fouchardière, C. AU - Decaussin-Petrucci, M. AU - Berthiller, J. AU - Descotes, F. AU - Lopez, J. AU - Lifante, J. C. AU - Peix, J. L. AU - Giraudet, A. L. AU - Delahaye, A. AU - Masson, S. AU - Bournaud-Salinas, C. AU - Borson Chazot, F. DA - Mar DO - 10.1016/j.ejca.2017.12.027 DP - NLM ET - 2018/02/08 LA - eng N1 - 1879-0852 de la Fouchardière, Christelle Decaussin-Petrucci, Myriam Berthiller, Julien Descotes, Françoise Lopez, Jonathan Lifante, Jean-Christophe Peix, Jean-Louis Giraudet, Anne-Laure Delahaye, Armelle Masson, Sandrine Bournaud-Salinas, Claire Borson Chazot, Françoise Journal Article Multicenter Study England Eur J Cancer. 2018 Mar;92:40-47. doi: 10.1016/j.ejca.2017.12.027. Epub 2018 Feb 3. PY - 2018 SN - 0959-8049 SP - 40-47 ST - Predictive factors of outcome in poorly differentiated thyroid carcinomas T2 - Eur J Cancer TI - Predictive factors of outcome in poorly differentiated thyroid carcinomas VL - 92 ID - 776 ER - TY - JOUR AD - Departments of Orthopedics. Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. AN - 29420337 AU - Qing, X. AU - Shao, Z. AU - Lv, X. AU - Pu, F. AU - Gao, F. AU - Liu, L. AU - Shi, D. C2 - PMC5882294 DA - Apr DO - 10.1097/cad.0000000000000602 DP - NLM ET - 2018/02/09 IS - 4 LA - eng N1 - 1473-5741 Qing, Xiangcheng Shao, Zengwu Lv, Xiao Pu, Feifei Gao, Feng Liu, Lei Shi, Deyao Journal Article Anticancer Drugs. 2018 Apr;29(4):341-352. doi: 10.1097/CAD.0000000000000602. PY - 2018 SN - 0959-4973 (Print) 0959-4973 SP - 341-352 ST - Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species T2 - Anticancer Drugs TI - Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species VL - 29 ID - 777 ER - TY - JOUR AD - Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. China. Outpatient Department, Qingdao No. 1 Sanitarium, Qingdao, Shandong, P.R. China. Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. China. AN - 29426375 AU - Jiang, J. AU - Song, X. AU - Yang, J. AU - Lei, K. AU - Ni, Y. AU - Zhou, F. AU - Sun, L. DA - Sep 14 DO - 10.3727/096504018x15179661552702 DP - NLM ET - 2018/02/11 IS - 8 LA - eng N1 - 1555-3906 Jiang, Jian Song, Xuewen Yang, Jing Lei, Ke Ni, Yongan Zhou, Fei Sun, Lirong Journal Article United States Oncol Res. 2018 Sep 14;26(8):1235-1243. doi: 10.3727/096504018X15179661552702. Epub 2018 Feb 9. PY - 2018 SN - 0965-0407 SP - 1235-1243 ST - Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a T2 - Oncol Res TI - Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a VL - 26 ID - 778 ER - TY - JOUR AD - Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science and. Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. Department of Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. Deparment of Pediatrics, Nakadori General Hospital, Akita, Japan; and. Department of Cellular Signaling, Graduate School of Medicine and. Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. AN - 29437595 AU - Murakami, N. AU - Okuno, Y. AU - Yoshida, K. AU - Shiraishi, Y. AU - Nagae, G. AU - Suzuki, K. AU - Narita, A. AU - Sakaguchi, H. AU - Kawashima, N. AU - Wang, X. AU - Xu, Y. AU - Chiba, K. AU - Tanaka, H. AU - Hama, A. AU - Sanada, M. AU - Ito, M. AU - Hirayama, M. AU - Watanabe, A. AU - Ueno, T. AU - Kojima, S. AU - Aburatani, H. AU - Mano, H. AU - Miyano, S. AU - Ogawa, S. AU - Takahashi, Y. AU - Muramatsu, H. DA - Apr 5 DO - 10.1182/blood-2017-07-798157 DP - NLM ET - 2018/02/14 IS - 14 LA - eng N1 - 1528-0020 Murakami, Norihiro Okuno, Yusuke Yoshida, Kenichi Shiraishi, Yuichi Nagae, Genta Suzuki, Kyogo Narita, Atsushi Sakaguchi, Hirotoshi Kawashima, Nozomu Wang, Xinan Xu, Yinyan Chiba, Kenichi Tanaka, Hiroko Hama, Asahito Sanada, Masashi Ito, Masafumi Hirayama, Masashi Watanabe, Arata Ueno, Toshihide Kojima, Seiji Aburatani, Hiroyuki Mano, Hiroyuki Miyano, Satoru Ogawa, Seishi Takahashi, Yoshiyuki Muramatsu, Hideki Journal Article Multicenter Study Research Support, Non-U.S. Gov't United States Blood. 2018 Apr 5;131(14):1576-1586. doi: 10.1182/blood-2017-07-798157. Epub 2018 Feb 2. PY - 2018 SN - 0006-4971 SP - 1576-1586 ST - Integrated molecular profiling of juvenile myelomonocytic leukemia T2 - Blood TI - Integrated molecular profiling of juvenile myelomonocytic leukemia VL - 131 ID - 779 ER - TY - JOUR AD - Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China. Eaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA 02114. Molecular Pathology Division, Massachusetts General Hospital, Boston, MA 02114. Division of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. Department of Neurology, Massachusetts General Hospital, Boston, MA 02114. Cancer Center, Massachusetts General Hospital, Boston, MA 02114. Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; jain@steele.mgh.harvard.edu lei@steele.mgh.harvard.edu. AN - 29440379 AU - Zhao, Y. AU - Liu, P. AU - Zhang, N. AU - Chen, J. AU - Landegger, L. D. AU - Wu, L. AU - Zhao, F. AU - Zhao, Y. AU - Zhang, Y. AU - Zhang, J. AU - Fujita, T. AU - Stemmer-Rachamimov, A. AU - Ferraro, G. B. AU - Liu, H. AU - Muzikansky, A. AU - Plotkin, S. R. AU - Stankovic, K. M. AU - Jain, R. K. AU - Xu, L. C2 - PMC5834719 DA - Feb 27 DO - 10.1073/pnas.1719966115 DP - NLM ET - 2018/02/15 IS - 9 LA - eng N1 - 1091-6490 Zhao, Yingchao Liu, Pinan Zhang, Na Chen, Jie Landegger, Lukas D Wu, Limeng Zhao, Fu Zhao, Yanxia Zhang, Yanling Zhang, Jing Fujita, Takeshi Stemmer-Rachamimov, Anat Ferraro, Gino B Liu, Hao Muzikansky, Alona Plotkin, Scott R Stankovic, Konstantina M Jain, Rakesh K Xu, Lei U01 CA224348/CA/NCI NIH HHS/United States R01 DC015824/DC/NIDCD NIH HHS/United States R01 CA129371/CA/NCI NIH HHS/United States R35 CA197743/CA/NCI NIH HHS/United States P01 CA080124/CA/NCI NIH HHS/United States R01 CA208205/CA/NCI NIH HHS/United States P50 CA165962/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2077-E2084. doi: 10.1073/pnas.1719966115. Epub 2018 Feb 9. PY - 2018 SN - 0027-8424 (Print) 0027-8424 SP - E2077-e2084 ST - Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models T2 - Proc Natl Acad Sci U S A TI - Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models VL - 115 ID - 780 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jmcquade@mdanderson.org. University of Texas MD Anderson Cancer Center, Houston, TX, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Vanderbilt University Medical Center, Nashville, TN, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. Genentech, San Francisco, CA, USA. University of California Los Angeles Medical Center, Los Angeles, CA, USA. Bristol-Myers Squibb, New York, NY, USA. Dana-Farber Cancer Institute, Boston, MA, USA. Memorial Sloan Kettering Cancer Center, New York, NY, USA. Northwestern University, Chicago, IL, USA. University Hospital Essen and German Cancer Consortium, Essen, Germany. Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. Massachusetts General Hospital Cancer Center, Boston, MA, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. AN - 29449192 AU - McQuade, J. L. AU - Daniel, C. R. AU - Hess, K. R. AU - Mak, C. AU - Wang, D. Y. AU - Rai, R. R. AU - Park, J. J. AU - Haydu, L. E. AU - Spencer, C. AU - Wongchenko, M. AU - Lane, S. AU - Lee, D. Y. AU - Kaper, M. AU - McKean, M. AU - Beckermann, K. E. AU - Rubinstein, S. M. AU - Rooney, I. AU - Musib, L. AU - Budha, N. AU - Hsu, J. AU - Nowicki, T. S. AU - Avila, A. AU - Haas, T. AU - Puligandla, M. AU - Lee, S. AU - Fang, S. AU - Wargo, J. A. AU - Gershenwald, J. E. AU - Lee, J. E. AU - Hwu, P. AU - Chapman, P. B. AU - Sosman, J. A. AU - Schadendorf, D. AU - Grob, J. J. AU - Flaherty, K. T. AU - Walker, D. AU - Yan, Y. AU - McKenna, E. AU - Legos, J. J. AU - Carlino, M. S. AU - Ribas, A. AU - Kirkwood, J. M. AU - Long, G. V. AU - Johnson, D. B. AU - Menzies, A. M. AU - Davies, M. A. C2 - PMC5840029 C6 - NIHMS944499 DA - Mar DO - 10.1016/s1470-2045(18)30078-0 DP - NLM ET - 2018/02/17 IS - 3 LA - eng N1 - 1474-5488 McQuade, Jennifer L Daniel, Carrie R Hess, Kenneth R Mak, Carmen Wang, Daniel Y Rai, Rajat R Park, John J Haydu, Lauren E Spencer, Christine Wongchenko, Matthew Lane, Stephen Lee, Dung-Yang Kaper, Mathilde McKean, Meredith Beckermann, Kathryn E Rubinstein, Samuel M Rooney, Isabelle Musib, Luna Budha, Nageshwar Hsu, Jessie Nowicki, Theodore S Avila, Alexandre Haas, Tomas Puligandla, Maneka Lee, Sandra Fang, Shenying Wargo, Jennifer A Gershenwald, Jeffrey E Lee, Jeffrey E Hwu, Patrick Chapman, Paul B Sosman, Jeffrey A Schadendorf, Dirk Grob, Jean-Jacques Flaherty, Keith T Walker, Dana Yan, Yibing McKenna, Edward Legos, Jeffrey J Carlino, Matteo S Ribas, Antoni Kirkwood, John M Long, Georgina V Johnson, Douglas B Menzies, Alexander M Davies, Michael A P30 CA016672/CA/NCI NIH HHS/United States K23 CA204726/CA/NCI NIH HHS/United States R35 CA197633/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States R01 CA187076/CA/NCI NIH HHS/United States T32 CA009666/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Lancet Oncol. 2018 Mar;19(3):310-322. doi: 10.1016/S1470-2045(18)30078-0. Epub 2018 Feb 12. PY - 2018 SN - 1470-2045 (Print) 1470-2045 SP - 310-322 ST - Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis T2 - Lancet Oncol TI - Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis VL - 19 ID - 781 ER - TY - JOUR AD - Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa, Italy. Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy. Department of Oncology, University and General Hospital, Udine, Italy. Department of Oncology, San Bortolo General Hospital, ULSS8 Berica, East District, Vicenza, Italy. Department of Medical Oncology, Hospital of Frosinone, Frosinone, Italy. Dipartimento di Oncologia Università Campus Bio-Medico di Roma, Rome, Italy. Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padova, Italy. Unit of Medical Oncology, Hospital Felice Lotti, Azienda Toscana Nord Ovest, Pontedera, Italy. Unit of Medical Oncology, Policlinico G. B. Rossi, Azienda Ospedaliera Integrata di Verona, Verona, Italy. Unit of Medical Oncology, Hospital San Giovanni Calibita Fatebenefratelli, Rome, Italy. Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy. Department of Oncology, Hospital San Raffaele IRCSS, Milan, Italy. Unit of Medical Oncology, Policlinico Sant'Orsola-Malpighi, Bologna, Italy. Department of Medical Oncology, Policlinico Umberto I Sapienza, University of Rome, Rome, Italy. Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Florence, Italy. AN - 29450468 AU - Cremolini, C. AU - Antoniotti, C. AU - Lonardi, S. AU - Aprile, G. AU - Bergamo, F. AU - Masi, G. AU - Grande, R. AU - Tonini, G. AU - Mescoli, C. AU - Cardellino, G. G. AU - Coltelli, L. AU - Salvatore, L. AU - Corsi, D. C. AU - Lupi, C. AU - Gemma, D. AU - Ronzoni, M. AU - Dell'Aquila, E. AU - Marmorino, F. AU - Di Fabio, F. AU - Mancini, M. L. AU - Marcucci, L. AU - Fontanini, G. AU - Zagonel, V. AU - Boni, L. AU - Falcone, A. C2 - PMC5885260 F. Hoffman–La Roche, Bayer, Sirtex, and Amgen. Dr Masi reported receiving personal fees from Amgen, F. Hoffman–La Roche, Bayer, Merk Serono, and Sirtex. Dr Tonini reported receiving personal fees from Novartis, F. Hoffman–La Roche, and Molteni. Dr Salvatore reported receiving personal fees from Servier, Bayer, and Sanofi. Dr Falcone reported receiving grants and personal fees from F. Hoffman–La Roche, Amgen, and Merck Serono as well as personal fees from Celgene, Bayer, and Sanofi Aventis. No other disclosures were reported. DA - Apr 1 DO - 10.1001/jamaoncol.2017.5314 DP - NLM ET - 2018/02/17 IS - 4 LA - eng N1 - 2374-2445 Cremolini, Chiara Antoniotti, Carlotta Lonardi, Sara Aprile, Giuseppe Bergamo, Francesca Masi, Gianluca Grande, Roberta Tonini, Giuseppe Mescoli, Claudia Cardellino, Giovanni Gerardo Coltelli, Luigi Salvatore, Lisa Corsi, Domenico Cristiano Lupi, Cristiana Gemma, Donatello Ronzoni, Monica Dell'Aquila, Emanuela Marmorino, Federica Di Fabio, Francesca Mancini, Maria Laura Marcucci, Lorenzo Fontanini, Gabriella Zagonel, Vittorina Boni, Luca Falcone, Alfredo Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial JAMA Oncol. 2018 Apr 1;4(4):529-536. doi: 10.1001/jamaoncol.2017.5314. PY - 2018 SN - 2374-2437 (Print) 2374-2437 SP - 529-536 ST - Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial T2 - JAMA Oncol TI - Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial VL - 4 ID - 782 ER - TY - JOUR AD - Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People's Republic of China; Department of Neurosurgery, Beijing Fengtai You'anmen Hospital, Beijing, People's Republic of China. Department of Neurosurgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Electronic address: mengguolu@sina.com. Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People's Republic of China. Department of Neurosurgery, Beijing Fengtai You'anmen Hospital, Beijing, People's Republic of China. Department of Neurosurgery, Jiangyin Hospital, Medical School of Southeast University, Jiangsu Province, People's Republic of China. Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China. AN - 29454117 AU - Lin, X. AU - Meng, G. AU - Liu, X. AU - Yu, T. AU - Bai, C. AU - Fei, X. AU - Deng, S. AU - Zhao, J. AU - Ren, S. AU - Zhang, J. AU - Wu, Z. AU - Wang, S. AU - Zhang, J. AU - Zhang, L. DA - May DO - 10.1016/j.wneu.2018.02.002 DP - NLM ET - 2018/02/18 LA - eng N1 - 1878-8769 Lin, Xiangjiang Meng, Guolu Liu, Xing Yu, Tengfei Bai, Chuanfeng Fei, Xiaobin Deng, Shengze Zhao, Jizong Ren, Shulin Zhang, Junting Wu, Zhen Wang, Shuo Zhang, Jianguo Zhang, Liwei Journal Article United States World Neurosurg. 2018 May;113:e247-e270. doi: 10.1016/j.wneu.2018.02.002. Epub 2018 Feb 14. PY - 2018 SN - 1878-8750 SP - e247-e270 ST - The Differentially Expressed Genes of Human Sporadic Cerebral Cavernous Malformations T2 - World Neurosurg TI - The Differentially Expressed Genes of Human Sporadic Cerebral Cavernous Malformations VL - 113 ID - 783 ER - TY - JOUR AD - Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. Department of Dermatology, Kyoto University Hospital, Kyoto, Japan. AN - 29498772 AU - Sugimoto, A. AU - Kataoka, T. R. AU - Ueshima, C. AU - Takei, Y. AU - Kitamura, K. AU - Hirata, M. AU - Nomura, T. AU - Haga, H. DA - Jun DO - 10.1111/exd.13523 DP - NLM ET - 2018/03/03 IS - 6 LA - eng N1 - 1600-0625 Sugimoto, Akihiko Orcid: 0000-0001-8160-0267 Kataoka, Tatsuki R Orcid: 0000-0003-3095-8976 Ueshima, Chiyuki Takei, Yusuke Kitamura, Kyohei Hirata, Masahiro Nomura, Takashi Haga, Hironori Journal Article Research Support, Non-U.S. Gov't Denmark Exp Dermatol. 2018 Jun;27(6):641-646. doi: 10.1111/exd.13523. PY - 2018 SN - 0906-6705 SP - 641-646 ST - SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis T2 - Exp Dermatol TI - SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis VL - 27 ID - 784 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Justus Liebig University Giessen, Giessen, Germany. Department of Internal Medicine, Stauferklinikum Schwaebisch Gmuend, Mutlangen, Germany. The Child and Youth Clinic, Department of Pediatric Hematology and Oncology, University Hospital Copenhagen, Copenhagen, Denmark. Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic. Department of Pediatric Hematology and Oncology, Eberhard Karls University Tuebingen, Tuebingen, Germany. Department of Pediatric Hematology and Oncology, University Hospital Ulm, Ulm, Germany. Children's Hospital Cottbus, Cottbus, Germany. AN - 29512859 AU - Ruf, S. AU - Hebart, H. AU - Hjalgrim, L. L. AU - Kabickova, E. AU - Lang, P. AU - Steinbach, D. AU - Schwabe, G. C. AU - Woessmann, W. DA - Jun DO - 10.1002/pbc.27003 DP - NLM ET - 2018/03/08 IS - 6 LA - eng N1 - 1545-5017 Ruf, Stephanie Orcid: 0000-0002-9555-7826 Hebart, Holger Hjalgrim, Lisa Lyngsie Kabickova, Edita Lang, Peter Steinbach, Daniel Schwabe, Georg C Woessmann, Wilhelm Case Reports Journal Article United States Pediatr Blood Cancer. 2018 Jun;65(6):e27003. doi: 10.1002/pbc.27003. Epub 2018 Mar 7. PY - 2018 SN - 1545-5009 SP - e27003 ST - CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series T2 - Pediatr Blood Cancer TI - CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series VL - 65 ID - 785 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennesssee. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 29512900 AU - Broniscer, A. AU - Jia, S. AU - Mandrell, B. AU - Hamideh, D. AU - Huang, J. AU - Onar-Thomas, A. AU - Gajjar, A. AU - Raimondi, S. C. AU - Tatevossian, R. G. AU - Stewart, C. F. C2 - PMC5980705 C6 - NIHMS942124 DA - Jul DO - 10.1002/pbc.27035 DP - NLM ET - 2018/03/08 IS - 7 LA - eng N1 - 1545-5017 Broniscer, Alberto Orcid: 0000-0001-9646-0463 Jia, Sujuan Mandrell, Belinda Hamideh, Dima Huang, Jie Onar-Thomas, Arzu Gajjar, Amar Raimondi, Susana C Tatevossian, Ruth G Stewart, Clinton F P30 CA021765/CA/NCI NIH HHS/United States Clinical Trial, Phase I Journal Article Research Support, N.I.H., Extramural Pediatr Blood Cancer. 2018 Jul;65(7):e27035. doi: 10.1002/pbc.27035. Epub 2018 Mar 7. PY - 2018 SN - 1545-5009 (Print) 1545-5009 SP - e27035 ST - Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma T2 - Pediatr Blood Cancer TI - Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma VL - 65 ID - 786 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, 510120, China. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China. zengmsh@sysucc.org.cn. Department of Otolaryngology-Head and Neck Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, 510120, China. hxming@mail.sysu.edu.cn. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. hxming@mail.sysu.edu.cn. AN - 29515111 AU - Yu, S. T. AU - Zhong, Q. AU - Chen, R. H. AU - Han, P. AU - Li, S. B. AU - Zhang, H. AU - Yuan, L. AU - Xia, T. L. AU - Zeng, M. S. AU - Huang, X. M. C2 - PMC5841418 DA - Mar 7 DO - 10.1038/s41419-018-0352-0 DP - NLM ET - 2018/03/09 IS - 3 LA - eng N1 - 2041-4889 Yu, Shi-Tong Zhong, Qian Chen, Ren-Hui Han, Ping Li, Shi-Bing Zhang, Hua Yuan, Li Xia, Tian-Liang Zeng, Mu-Sheng Orcid: 0000-0003-3509-5591 Huang, Xiao-Ming Journal Article Research Support, Non-U.S. Gov't Cell Death Dis. 2018 Mar 7;9(3):371. doi: 10.1038/s41419-018-0352-0. PY - 2018 SP - 371 ST - CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways T2 - Cell Death Dis TI - CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways VL - 9 ID - 787 ER - TY - JOUR AD - Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Herston, Queensland, Australia. Centre de recherche en Epidémiologie et Santé des Populations, Faculté de médecine-Université Paris-Sud, Faculté de médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France. Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK. Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. MEDLAB Pathology, Brisbane, Queensland, Australia. Princess Alexandra Hospital, Metro South Health, Brisbane, Queensland, Australia. IQ Pathology, West End, Queensland, Australia. Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Electronic address: David.Whiteman@qimrberghofer.edu.au. AN - 29524457 AU - Pandeya, N. AU - Kvaskoff, M. AU - Olsen, C. M. AU - Green, A. C. AU - Perry, S. AU - Baxter, C. AU - Davis, M. B. AU - Mortimore, R. AU - Westacott, L. AU - Wood, D. AU - Triscott, J. AU - Williamson, R. AU - Whiteman, D. C. DA - Aug DO - 10.1016/j.jid.2017.12.036 DP - NLM ET - 2018/03/11 IS - 8 LA - eng N1 - 1523-1747 Pandeya, Nirmala Kvaskoff, Marina Olsen, Catherine M Green, Adèle C Perry, Susan Baxter, Catherine Davis, Marcia B Mortimore, Rohan Westacott, Lorraine Wood, Dominic Triscott, Joe Williamson, Richard Whiteman, David C Comparative Study Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2018 Aug;138(8):1816-1824. doi: 10.1016/j.jid.2017.12.036. Epub 2018 Mar 7. PY - 2018 SN - 0022-202x SP - 1816-1824 ST - Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study T2 - J Invest Dermatol TI - Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study VL - 138 ID - 788 ER - TY - JOUR AD - a Melanoma Unit , Istituto Europeo di Oncologia , Milano , Italy. b Division of Biostatistics , Istituto Europeo di Oncologia , Milano , Italy. c Fertility Unit , Istituto Europeo di Oncologia , Milano , Italy. AN - 29526130 AU - Cocorocchio, E. AU - Pala, L. AU - Battaglia, A. AU - Gandini, S. AU - Peccatori, F. A. AU - Ferrucci, P. F. DA - Aug DO - 10.1080/0284186x.2018.1449251 DP - NLM ET - 2018/03/13 IS - 8 LA - eng N1 - 1651-226x Cocorocchio, Emilia Orcid: 0000-0003-1184-6426 Pala, Laura Orcid: 0000-0002-0111-9869 Battaglia, Angelo Orcid: 0000-0002-3715-624x Gandini, Sara Orcid: 0000-0002-1348-4548 Peccatori, Fedro Alessandro Orcid: 0000-0001-8227-8740 Ferrucci, Pier Francesco Orcid: 0000-0001-6255-5851 Case Reports Letter England Acta Oncol. 2018 Aug;57(8):1131-1133. doi: 10.1080/0284186X.2018.1449251. Epub 2018 Mar 11. PY - 2018 SN - 0284-186x SP - 1131-1133 ST - Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma T2 - Acta Oncol TI - Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma VL - 57 ID - 789 ER - TY - JOUR AD - Department of Orthopedic, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China. Department of Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China. AN - 29545891 AU - Bian, J. AU - Cao, D. AU - Shen, J. AU - Jiang, B. AU - Chen, D. AU - Bian, L. C2 - PMC5840919 DA - Apr DO - 10.3892/etm.2018.5842 DP - NLM ET - 2018/03/17 IS - 4 LA - eng N1 - 1792-1015 Bian, Jun Cao, Dan Shen, Jie Jiang, Bo Chen, Dan Bian, Lanzheng Journal Article Exp Ther Med. 2018 Apr;15(4):3617-3622. doi: 10.3892/etm.2018.5842. Epub 2018 Feb 7. PY - 2018 SN - 1792-0981 (Print) 1792-0981 SP - 3617-3622 ST - N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway T2 - Exp Ther Med TI - N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway VL - 15 ID - 790 ER - TY - JOUR AD - Department of Pediatrics, Faculty of Medicine and Dentistry, Cardiovascular Research Centre, University of Alberta, 87th Avenue and 112 Street, Edmonton, Alberta T6G 2S2, Canada. Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 308 Harvard Street S.E., Minneapolis, MN 55455, USA. Department of Medicine, Cardiovascular Research Centre, Faculty of Medicine and Dentistry, University of Alberta, 87th Avenue and 112 Street, Edmonton, Alberta T6G 2S2, Canada. Department of Integrative Biology and Physiology, Medical School, University of Minnesota, 2231 6th Street S.E. Minneapolis, MN 55455, USA. AN - 29566148 AU - Matsumura, N. AU - Zordoky, B. N. AU - Robertson, I. M. AU - Hamza, S. M. AU - Parajuli, N. AU - Soltys, C. M. AU - Beker, D. L. AU - Grant, M. K. AU - Razzoli, M. AU - Bartolomucci, A. AU - Dyck, J. R. B. C2 - PMC6054166 DA - Aug 1 DO - 10.1093/cvr/cvy064 DP - NLM ET - 2018/03/23 IS - 10 LA - eng N1 - 1755-3245 Matsumura, Nobutoshi Zordoky, Beshay N Robertson, Ian M Hamza, Shereen M Parajuli, Nirmal Soltys, Carrie-Lynn M Beker, Donna L Grant, Marianne K Razzoli, Maria Bartolomucci, Alessandro Dyck, Jason R B UL1 TR000114/TR/NCATS NIH HHS/United States MOP119336/CIHR/Canada Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cardiovasc Res. 2018 Aug 1;114(10):1350-1359. doi: 10.1093/cvr/cvy064. PY - 2018 SN - 0008-6363 (Print) 0008-6363 SP - 1350-1359 ST - Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes T2 - Cardiovasc Res TI - Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes VL - 114 ID - 791 ER - TY - JOUR AD - Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. German Rheumatism Research Centre, German Rheumatism Research Centre (DRFZ), A Leibniz Institute, 10117, Berlin, Germany. Medical Department I, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. The Scripps Research Institute, Jupiter, FL, 33458, USA. Department of Molecular Biotechnology and Health Sciences, Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy. NHL-BFM Study Centre and Department of Paediatric Haematology and Oncology, Justus-Liebig-University, Giessen, Germany. Department of Nephrology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. Department of Pathology, University of Cambridge, Cambridge, CB21QP, UK. Department of Medicine A, Albert-Schweitzer-Campus 1, University Hospital Münster, 48149, Münster, Germany. Cluster of Excellence EXC 1003, Cells in Motion, 48149, Münster, Germany. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. lukas.kenner@meduniwien.ac.at. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. lukas.kenner@meduniwien.ac.at. University of Veterinary Medicine, Vienna, Austria. lukas.kenner@meduniwien.ac.at. CBmed, Center for Biomarker Research in Medicine, 8010, Graz, Austria. lukas.kenner@meduniwien.ac.at. Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück-Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, 13125, Berlin, Germany. Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. stephan.mathas@charite.de. Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. stephan.mathas@charite.de. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. stephan.mathas@charite.de. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. stephan.mathas@charite.de. Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück-Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, 13125, Berlin, Germany. stephan.mathas@charite.de. AN - 29588546 AU - Schleussner, N. AU - Merkel, O. AU - Costanza, M. AU - Liang, H. C. AU - Hummel, F. AU - Romagnani, C. AU - Durek, P. AU - Anagnostopoulos, I. AU - Hummel, M. AU - Jöhrens, K. AU - Niedobitek, A. AU - Griffin, P. R. AU - Piva, R. AU - Sczakiel, H. L. AU - Woessmann, W. AU - Damm-Welk, C. AU - Hinze, C. AU - Stoiber, D. AU - Gillissen, B. AU - Turner, S. D. AU - Kaergel, E. AU - von Hoff, L. AU - Grau, M. AU - Lenz, G. AU - Dörken, B. AU - Scheidereit, C. AU - Kenner, L. AU - Janz, M. AU - Mathas, S. C2 - PMC6127090 DA - Sep DO - 10.1038/s41375-018-0045-9 DP - NLM ET - 2018/03/29 IS - 9 LA - eng N1 - 1476-5551 Schleussner, Nikolai Merkel, Olaf Costanza, Mariantonia Orcid: 0000-0002-8959-1083 Liang, Huan-Chang Hummel, Franziska Romagnani, Chiara Durek, Pawel Anagnostopoulos, Ioannis Hummel, Michael Jöhrens, Korinna Niedobitek, Antonia Griffin, Patrick R Piva, Roberto Sczakiel, Henrike L Woessmann, Wilhelm Damm-Welk, Christine Hinze, Christian Stoiber, Dagmar Gillissen, Bernd Turner, Suzanne D Kaergel, Eva von Hoff, Linda Grau, Michael Lenz, Georg Dörken, Bernd Scheidereit, Claus Kenner, Lukas Janz, Martin Mathas, Stephan Journal Article Research Support, Non-U.S. Gov't Leukemia. 2018 Sep;32(9):1994-2007. doi: 10.1038/s41375-018-0045-9. Epub 2018 Mar 28. PY - 2018 SN - 0887-6924 (Print) 0887-6924 SP - 1994-2007 ST - The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma T2 - Leukemia TI - The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma VL - 32 ID - 792 ER - TY - JOUR AD - Department of Pediatrics, Royal Hobart Hospital, Hobart, Australia. Department of Oncology, Royal Children's Hospital, Melbourne, Australia. Department of Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia. AN - 29603581 AU - Heath, J. A. AU - Campbell, M. A. AU - Thomas, A. AU - Solomon, B. DA - Jul DO - 10.1002/pbc.27055 DP - NLM ET - 2018/04/01 IS - 7 LA - eng N1 - 1545-5017 Heath, John A Orcid: 0000-0002-6243-0669 Campbell, Marty A Thomas, Alison Solomon, Ben Case Reports Letter United States Pediatr Blood Cancer. 2018 Jul;65(7):e27055. doi: 10.1002/pbc.27055. Epub 2018 Mar 30. PY - 2018 SN - 1545-5009 SP - e27055 ST - Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma T2 - Pediatr Blood Cancer TI - Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma VL - 65 ID - 793 ER - TY - JOUR AD - Department of Neurology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Department of Pathology, Johns Hopkins University; Department of Radiology and Radiological Science, Johns Hopkins Hospital; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. AN - 29632053 AU - Schreck, K. C. AU - Guajardo, A. AU - Lin, D. D. M. AU - Eberhart, C. G. AU - Grossman, S. A. DA - Apr DO - 10.6004/jnccn.2017.7052 DP - NLM ET - 2018/04/11 IS - 4 LA - eng N1 - 1540-1413 Schreck, Karisa C Guajardo, Andrew Lin, Doris D M Eberhart, Charles G Grossman, Stuart A Case Reports Journal Article United States J Natl Compr Canc Netw. 2018 Apr;16(4):343-347. doi: 10.6004/jnccn.2017.7052. PY - 2018 SN - 1540-1405 SP - 343-347 ST - Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors T2 - J Natl Compr Canc Netw TI - Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors VL - 16 ID - 794 ER - TY - JOUR AD - Department of Occupational and Environmental Health, School of Public Heath, China Medical University, PR China. Department of Occupational and Environmental Health, School of Public Heath, China Medical University, PR China. Electronic address: Jchen@cmu.edu.cn. AN - 29635194 AU - Gu, W. AU - Wang, Y. AU - Qiu, Z. AU - Dong, J. AU - Wang, Y. AU - Chen, J. DA - Sep 1 DO - 10.1016/j.scitotenv.2018.03.329 DP - NLM ET - 2018/04/11 LA - eng N1 - 1879-1026 Gu, Weijia Wang, Yi Qiu, Zhenmin Dong, Jing Wang, Yuan Chen, Jie Journal Article Netherlands Sci Total Environ. 2018 Sep 1;634:525-533. doi: 10.1016/j.scitotenv.2018.03.329. Epub 2018 Apr 7. PY - 2018 SN - 0048-9697 SP - 525-533 ST - Maternal exposure to nonylphenol during pregnancy and lactation induces microglial cell activation and pro-inflammatory cytokine production in offspring hippocampus T2 - Sci Total Environ TI - Maternal exposure to nonylphenol during pregnancy and lactation induces microglial cell activation and pro-inflammatory cytokine production in offspring hippocampus VL - 634 ID - 795 ER - TY - JOUR AD - Departement of Biopathology, Centre Leon Bérard, Lyon. Department of Pathology, Centre Hospitalier Universitaire de Québec-Université Laval. Department of Molecular Biology and Medical Biochemistry, Faculté de médecine de l'Université Laval, Québec City, QC, Canada. Centre George François Leclerc, Dijon. Department of Histopathology, University Hospitals of Toulouse, Toulouse. Pathology Laboratory of Auxerre, Auxerre, France. AN - 29635259 AU - Perron, E. AU - Pissaloux, D. AU - Charon Barra, C. AU - Karanian, M. AU - Lamant, L. AU - Parfait, S. AU - Alberti, L. AU - de la Fouchardière, A. DA - May DO - 10.1097/pas.0000000000000973 DP - NLM ET - 2018/04/11 IS - 5 LA - eng N1 - 1532-0979 Perron, Emilie Pissaloux, Daniel Charon Barra, Celine Karanian, Marie Lamant, Laurence Parfait, Sophie Alberti, Laurent de la Fouchardière, Arnaud Case Reports Journal Article Research Support, Non-U.S. Gov't United States Am J Surg Pathol. 2018 May;42(5):595-603. doi: 10.1097/PAS.0000000000000973. PY - 2018 SN - 0147-5185 SP - 595-603 ST - Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge T2 - Am J Surg Pathol TI - Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge VL - 42 ID - 796 ER - TY - JOUR AD - Department of Neurosurgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Department of Neurosurgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. mkanamori@med.tohoku.ac.jp. Department of Pediatrics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan. Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Japan. Department of Pathology, Tohoku University Hospital, Sendai, Miyagi, Japan. AN - 29666969 AU - Kajitani, T. AU - Kanamori, M. AU - Saito, R. AU - Watanabe, Y. AU - Suzuki, H. AU - Watanabe, M. AU - Kure, S. AU - Tominaga, T. DA - Apr DO - 10.1007/s10014-018-0316-1 DP - NLM ET - 2018/04/19 IS - 2 LA - eng N1 - 1861-387x Kajitani, Takumi Kanamori, Masayuki Saito, Ryuta Watanabe, Yuko Suzuki, Hiroyoshi Watanabe, Mika Kure, Shigeo Tominaga, Teiji Case Reports Journal Article Japan Brain Tumor Pathol. 2018 Apr;35(2):114-122. doi: 10.1007/s10014-018-0316-1. Epub 2018 Apr 17. PY - 2018 SN - 1433-7398 SP - 114-122 ST - Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia T2 - Brain Tumor Pathol TI - Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia VL - 35 ID - 797 ER - TY - JOUR AD - Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, New York. Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, New York. Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York. Department of Pathology, SUNY Upstate Medical University, Syracuse, New York. AN - 29697184 AU - Hudson, S. AU - Wang, D. AU - Middleton, F. AU - Nevaldine, B. H. AU - Naous, R. AU - Hutchison, R. E. DA - Aug DO - 10.1002/pbc.27094 DP - NLM ET - 2018/04/27 IS - 8 LA - eng N1 - 1545-5017 Hudson, Sandra Wang, Dongliang Middleton, Frank Nevaldine, Barbara H Naous, Rana Hutchison, Robert E Orcid: 0000-0002-1704-8006 Journal Article United States Pediatr Blood Cancer. 2018 Aug;65(8):e27094. doi: 10.1002/pbc.27094. Epub 2018 Apr 26. PY - 2018 SN - 1545-5009 SP - e27094 ST - Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes T2 - Pediatr Blood Cancer TI - Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes VL - 65 ID - 798 ER - TY - JOUR AD - Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 2100 Webster Street, Suite 326, San Francisco, CA, 94115, USA. Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 2100 Webster Street, Suite 326, San Francisco, CA, 94115, USA. KimKB@sutterhealth.org. AN - 29703161 AU - Vosoughi, E. AU - Lee, J. M. AU - Miller, J. R. AU - Nosrati, M. AU - Minor, D. R. AU - Abendroth, R. AU - Lee, J. W. AU - Andrews, B. T. AU - Leng, L. Z. AU - Wu, M. AU - Leong, S. P. AU - Kashani-Sabet, M. AU - Kim, K. B. C2 - PMC5924486 DA - Apr 27 DO - 10.1186/s12885-018-4374-x DP - NLM ET - 2018/04/29 IS - 1 LA - eng N1 - 1471-2407 Vosoughi, Elham Lee, Jee Min Miller, James R Nosrati, Mehdi Minor, David R Abendroth, Roy Lee, John W Andrews, Brian T Leng, Lewis Z Wu, Max Leong, Stanley P Kashani-Sabet, Mohammed Kim, Kevin B Orcid: 0000-0003-0694-0530 Journal Article BMC Cancer. 2018 Apr 27;18(1):490. doi: 10.1186/s12885-018-4374-x. PY - 2018 SN - 1471-2407 SP - 490 ST - Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies T2 - BMC Cancer TI - Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies VL - 18 ID - 799 ER - TY - JOUR AD - Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA. Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA. AN - 29719098 AU - John, T. D. AU - Naik, S. AU - Leung, K. AU - Sasa, G. AU - Martinez, C. AU - Krance, R. A. DA - Aug DO - 10.1111/petr.13210 DP - NLM ET - 2018/05/03 IS - 5 LA - eng N1 - 1399-3046 John, Tami D Orcid: 0000-0003-0632-3559 Naik, Swati Leung, Kathryn Sasa, Ghadir Martinez, Caridad Krance, Robert A Case Reports Denmark Pediatr Transplant. 2018 Aug;22(5):e13210. doi: 10.1111/petr.13210. Epub 2018 May 2. PY - 2018 SN - 1397-3142 SP - e13210 ST - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma T2 - Pediatr Transplant TI - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma VL - 22 ID - 800 ER - TY - JOUR AD - Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan. College of Health Professions, Ferris State University, Big Rapids, Michigan. Spectrum Health System, Helen DeVos Children's Hospital, Grand Rapids, Michigan. Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan. Genomics Core, Van Andel Research Institute, Grand Rapids, Michigan. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. Department of Pathology, Duke University Medical Center, Durham, North Carolina. Department Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina. Aix-Marseille Univ, CNRS, IBDM, Marseille, France. Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan. Matt.Steensma@vai.org. Michigan State University College of Human Medicine, Grand Rapids, Michigan. AN - 29720369 AU - Peacock, J. D. AU - Pridgeon, M. G. AU - Tovar, E. A. AU - Essenburg, C. J. AU - Bowman, M. AU - Madaj, Z. AU - Koeman, J. AU - Boguslawski, E. A. AU - Grit, J. AU - Dodd, R. D. AU - Khachaturov, V. AU - Cardona, D. M. AU - Chen, M. AU - Kirsch, D. G. AU - Maina, F. AU - Dono, R. AU - Winn, M. E. AU - Graveel, C. R. AU - Steensma, M. R. C2 - PMC6235171 C6 - NIHMS995301 DA - Jul 1 DO - 10.1158/0008-5472.Can-17-3167 DP - NLM ET - 2018/05/04 IS - 13 LA - eng N1 - 1538-7445 Peacock, Jacqueline D Pridgeon, Matthew G Tovar, Elizabeth A Essenburg, Curt J Bowman, Megan Madaj, Zachary Koeman, Julie Boguslawski, Elissa A Grit, Jamie Dodd, Rebecca D Khachaturov, Vadim Cardona, Diana M Chen, Mark Kirsch, David G Maina, Flavio Orcid: 0000-0001-6100-4695 Dono, Rosanna Winn, Mary E Graveel, Carrie R Steensma, Matthew R F30 CA206424/CA/NCI NIH HHS/United States P30 CA086862/CA/NCI NIH HHS/United States R35 CA197616/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Cancer Res. 2018 Jul 1;78(13):3672-3687. doi: 10.1158/0008-5472.CAN-17-3167. Epub 2018 May 2. PY - 2018 SN - 0008-5472 (Print) 0008-5472 SP - 3672-3687 ST - Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors T2 - Cancer Res TI - Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors VL - 78 ID - 801 ER - TY - JOUR AD - Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan. Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung, Taiwan. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan. Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan. Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. AN - 29766567 AU - Lu, K. H. AU - Su, S. C. AU - Lin, C. W. AU - Hsieh, Y. H. AU - Lin, Y. C. AU - Chien, M. H. AU - Reiter, R. J. AU - Yang, S. F. DA - Oct DO - 10.1111/jpi.12507 DP - NLM ET - 2018/05/17 IS - 3 LA - eng N1 - 1600-079x Lu, Ko-Hsiu Su, Shih-Chi Lin, Chiao-Wen Hsieh, Yi-Hsien Lin, Ya-Chiu Chien, Ming-Hsien Reiter, Russel J Yang, Shun-Fa Orcid: 0000-0002-0365-7927 CSH-2018-E-002-Y2/Chung Shan Medical University Hospital/ Journal Article England J Pineal Res. 2018 Oct;65(3):e12507. doi: 10.1111/jpi.12507. Epub 2018 May 28. PY - 2018 SN - 0742-3098 SP - e12507 ST - Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway T2 - J Pineal Res TI - Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway VL - 65 ID - 802 ER - TY - JOUR AD - 1 Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 2 Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 3 Department of Physics, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 4 Department of Chemistry and Biochemistry, Division of Hematology, Center for RNA Biology, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 5 Department of Pathology, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. AN - 29768105 AU - He, H. AU - Li, W. AU - Yan, P. AU - Bundschuh, R. AU - Killian, J. A. AU - Labanowska, J. AU - Brock, P. AU - Shen, R. AU - Heerema, N. A. AU - de la Chapelle, A. C2 - PMC5994666 DA - Jun DO - 10.1089/thy.2017.0258 DP - NLM ET - 2018/05/17 IS - 6 LA - eng N1 - 1557-9077 He, Huiling Li, Wei Yan, Pearlly Bundschuh, Ralf Killian, Jackson A Labanowska, Jadwiga Brock, Pamela Shen, Rulong Heerema, Nyla A de la Chapelle, Albert P30 CA016058/CA/NCI NIH HHS/United States P50 CA168505/CA/NCI NIH HHS/United States R50 CA211524/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Thyroid. 2018 Jun;28(6):748-754. doi: 10.1089/thy.2017.0258. Epub 2018 May 16. PY - 2018 SN - 1050-7256 (Print) 1050-7256 SP - 748-754 ST - Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma T2 - Thyroid TI - Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma VL - 28 ID - 803 ER - TY - JOUR AD - Department of Ophthalmology, Ningbo Eye Hospital, Ningbo, Zhejiang 315040, P.R. China. Ningbo Central Blood Center, Ningbo, Zhejiang 315040, P.R. China. Department of Ophthalmology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China. AN - 29845211 AU - Yi, Q. Y. AU - Bai, Z. S. AU - Cai, B. AU - Chen, N. AU - Chen, L. S. AU - Yuan, T. AU - Mao, J. H. C2 - PMC6072295 DA - Aug DO - 10.3892/or.2018.6454 DP - NLM ET - 2018/05/31 IS - 2 LA - eng N1 - 1791-2431 Yi, Quan-Yong Bai, Zhi-Sha Cai, Bin Chen, Nan Chen, Li-Shuang Yuan, Tao Mao, Jing-Hai Journal Article Oncol Rep. 2018 Aug;40(2):682-692. doi: 10.3892/or.2018.6454. Epub 2018 May 21. PY - 2018 SN - 1021-335X (Print) 1021-335x SP - 682-692 ST - HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK T2 - Oncol Rep TI - HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK VL - 40 ID - 804 ER - TY - JOUR AD - Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Computational Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. phil.potter@stjude.org. AN - 29855693 AU - Wierdl, M. AU - Tsurkan, L. AU - Chi, L. AU - Hatfield, M. J. AU - Tollemar, V. AU - Bradley, C. AU - Chen, X. AU - Qu, C. AU - Potter, P. M. C2 - PMC6054567 C6 - NIHMS971365 DA - Aug DO - 10.1007/s00280-018-3615-7 DP - NLM ET - 2018/06/02 IS - 2 LA - eng N1 - 1432-0843 Wierdl, Monika Tsurkan, Lyudmila Chi, Liying Hatfield, M Jason Tollemar, Viktor Bradley, Cori Chen, Xiang Qu, Chunxu Potter, Philip M Orcid: 0000-0001-8922-8535 P30 CA021765/CA/NCI NIH HHS/United States R25 CA023944/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer Chemother Pharmacol. 2018 Aug;82(2):251-263. doi: 10.1007/s00280-018-3615-7. Epub 2018 May 31. PY - 2018 SN - 0344-5704 (Print) 0344-5704 SP - 251-263 ST - Targeting ALK in pediatric RMS does not induce antitumor activity in vivo T2 - Cancer Chemother Pharmacol TI - Targeting ALK in pediatric RMS does not induce antitumor activity in vivo VL - 82 ID - 805 ER - TY - JOUR AD - Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pediatrics, Weill Cornell Medical College, New York, New York. Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. cpratil1@jhmi.edu. AN - 29880583 AU - Wang, J. AU - Yao, Z. AU - Jonsson, P. AU - Allen, A. N. AU - Qin, A. C. R. AU - Uddin, S. AU - Dunkel, I. J. AU - Petriccione, M. AU - Manova, K. AU - Haque, S. AU - Rosenblum, M. K. AU - Pisapia, D. J. AU - Rosen, N. AU - Taylor, B. S. AU - Pratilas, C. A. C2 - PMC6125191 C6 - NIHMS978289 advisory board of and has ownership interests in BeiGene and Kura. Neal Rosen is also on the scientific advisory board of Chugai and Astra-Zeneca. Ira J. Dunkel is a consultant to Apexigen, Bayer, Bristol-Myers Squibb, Celgene, Eisai, Ipsen and Pfizer. DA - Sep DO - 10.1158/2159-8290.Cd-17-1263 DP - NLM ET - 2018/06/09 IS - 9 LA - eng N1 - 2159-8290 Wang, Jiawan Yao, Zhan Jonsson, Philip Allen, Amy N Qin, Alice Can Ran Uddin, Sharmeen Dunkel, Ira J Orcid: 0000-0001-8091-6067 Petriccione, Mary Manova, Katia Haque, Sofia Rosenblum, Marc K Pisapia, David J Rosen, Neal Taylor, Barry S Pratilas, Christine A K08 CA127350/CA/NCI NIH HHS/United States R01 CA204749/CA/NCI NIH HHS/United States U54 OD020355/OD/NIH HHS/United States R35 CA210085/CA/NCI NIH HHS/United States P30 CA008748/CA/NCI NIH HHS/United States Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer Discov. 2018 Sep;8(9):1130-1141. doi: 10.1158/2159-8290.CD-17-1263. Epub 2018 Jun 7. PY - 2018 SN - 2159-8274 (Print) 2159-8274 SP - 1130-1141 ST - A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF(V600E)-Mutant Brain Tumor T2 - Cancer Discov TI - A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF(V600E)-Mutant Brain Tumor VL - 8 ID - 806 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. tasians@email.chop.edu. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. tasians@email.chop.edu. Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Department of Pediatrics, Division of Hematology and Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Division of Hematology-Oncology, San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, University of California, San Francisco, CA, USA. Department of Hematology, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. AN - 29884903 AU - Tasian, S. K. AU - Casas, J. A. AU - Posocco, D. AU - Gandre-Babbe, S. AU - Gagne, A. L. AU - Liang, G. AU - Loh, M. L. AU - Weiss, M. J. AU - French, D. L. AU - Chou, S. T. C2 - PMC6286697 C6 - NIHMS969005 to this work. DA - Jan DO - 10.1038/s41375-018-0169-y DP - NLM ET - 2018/06/10 IS - 1 LA - eng N1 - 1476-5551 Tasian, Sarah K Orcid: 0000-0003-1327-1662 Casas, Jessica A Posocco, David Gandre-Babbe, Shilpa Gagne, Alyssa L Liang, Ge Loh, Mignon L Weiss, Mitchell J French, Deborah L Chou, Stella T P30 DK090969/DK/NIDDK NIH HHS/United States K08 CA184418/CA/NCI NIH HHS/United States T32 HL007150/HL/NHLBI NIH HHS/United States U54 HD086984/HD/NICHD NIH HHS/United States RC2 HL101606/HL/NHLBI NIH HHS/United States R01 DK100854/DK/NIDDK NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Leukemia. 2019 Jan;33(1):181-190. doi: 10.1038/s41375-018-0169-y. Epub 2018 Jun 8. PY - 2019 SN - 0887-6924 (Print) 0887-6924 SP - 181-190 ST - Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells T2 - Leukemia TI - Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells VL - 33 ID - 807 ER - TY - JOUR AD - Department of Pathology & Dermatology, University of Virginia, Charlottesville, VA. Department of Pathology, University of Virginia, Charlottesville, VA. AN - 29905579 AU - Gru, A. A. AU - Voorhess, P. J. DA - Jul DO - 10.1097/dad.0000000000001061 DP - NLM ET - 2018/06/16 IS - 7 LA - eng N1 - 1533-0311 Gru, Alejandro A Voorhess, Patrick J Case Reports Journal Article United States Am J Dermatopathol. 2018 Jul;40(7):519-522. doi: 10.1097/DAD.0000000000001061. PY - 2018 SN - 0193-1091 SP - 519-522 ST - A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation T2 - Am J Dermatopathol TI - A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation VL - 40 ID - 808 ER - TY - JOUR AD - Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. Children's Hospital Affiliated to Zhengzhou University, 450018 Zhengzhou, China. Department of Pathology and Genetics, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. Childhood Cancer Research Unit, Department of Women's and Children's Health, and Pediatric Oncology Program Karolinska University Hospital, Stockholm 17176, Sweden. Institute of Molecular Biology, Umeå University, Umeå 90187, Sweden. Department of Oncology-Pathology, Karolinska Institutet, Stockholm 17176, Sweden. Department of Clinical Pathology, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Radiology, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatric Radiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatric Surgery, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatrics and Pathology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. AN - 29907598 AU - Guan, J. AU - Fransson, S. AU - Siaw, J. T. AU - Treis, D. AU - Van den Eynden, J. AU - Chand, D. AU - Umapathy, G. AU - Ruuth, K. AU - Svenberg, P. AU - Wessman, S. AU - Shamikh, A. AU - Jacobsson, H. AU - Gordon, L. AU - Stenman, J. AU - Svensson, P. J. AU - Hansson, M. AU - Larsson, E. AU - Martinsson, T. AU - Palmer, R. H. AU - Kogner, P. AU - Hallberg, B. C2 - PMC6071567 DA - Aug DO - 10.1101/mcs.a002550 DP - NLM ET - 2018/06/17 IS - 4 LA - eng N1 - 2373-2873 Guan, Jikui Orcid: 0000-0003-1723-0307 Fransson, Susanne Orcid: 0000-0002-9713-3074 Siaw, Joachim Tetteh Orcid: 0000-0002-1286-4485 Treis, Diana Van den Eynden, Jimmy Orcid: 0000-0003-0002-5614 Chand, Damini Umapathy, Ganesh Ruuth, Kristina Svenberg, Petter Wessman, Sandra Shamikh, Alia Jacobsson, Hans Gordon, Lena Stenman, Jakob Svensson, Pär-Johan Hansson, Magnus Larsson, Erik Martinsson, Tommy Orcid: 0000-0002-9403-3123 Palmer, Ruth H Orcid: 0000-0002-2735-8470 Kogner, Per Orcid: 0000-0002-2202-9694 Hallberg, Bengt Orcid: 0000-0003-2032-2616 Case Reports Journal Article Research Support, Non-U.S. Gov't Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4):a002550. doi: 10.1101/mcs.a002550. Print 2018 Aug. PY - 2018 SN - 2373-2873 ST - Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib T2 - Cold Spring Harb Mol Case Stud TI - Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib VL - 4 ID - 809 ER - TY - JOUR AD - Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China. Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Electronic address: buxingyaozz@yeah.net. AN - 29908894 AU - Wang, B. Q. AU - Yang, B. AU - Yang, H. C. AU - Wang, J. Y. AU - Hu, S. AU - Gao, Y. S. AU - Bu, X. Y. DA - Sep DO - 10.1016/j.brainresbull.2018.06.005 DP - NLM ET - 2018/06/18 LA - eng N1 - 1873-2747 Wang, Bang-Qing Yang, Bin Yang, Hua-Chao Wang, Jun-Yi Hu, Sen Gao, Yu-Shuai Bu, Xing-Yao Journal Article Research Support, Non-U.S. Gov't United States Brain Res Bull. 2018 Sep;142:96-106. doi: 10.1016/j.brainresbull.2018.06.005. Epub 2018 Jun 15. PY - 2018 SN - 0361-9230 SP - 96-106 ST - MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway T2 - Brain Res Bull TI - MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway VL - 142 ID - 810 ER - TY - JOUR AD - Department of Medicine, University of Padua, Padua, Italy; Istituto Oncologico Veneto, Padua, Italy. Department of Medicine, University of Padua, Padua, Italy. Istituto Oncologico Veneto, Padua, Italy. Unit of Dermatology, University of Padua, Padua, Italy. Unit of Plastic and Reconstructive Surgery, University of Padua, Padua, Italy. Department of Medicine, University of Padua, Padua, Italy; Veneto Tumor Registry, Veneto Region, Padua, Italy. Department of Dermatology, Medical University Graz, Graz, Austria. Department of Medicine, University of Padua, Padua, Italy. Electronic address: matteo.fassan@unipd.it. AN - 29920315 AU - Saraggi, D. AU - Salmaso, R. AU - Zamuner, C. AU - Munari, G. AU - Lanza, C. AU - Alaibac, M. S. AU - Bassetto, F. AU - Rugge, M. AU - Montesco, M. C. AU - Cerroni, L. AU - Fassan, M. DA - Oct DO - 10.1016/j.jaad.2018.06.018 DP - NLM ET - 2018/06/20 IS - 4 LA - eng N1 - 1097-6787 Saraggi, Deborah Salmaso, Roberto Zamuner, Carolina Munari, Giada Lanza, Cristiano Alaibac, Mauro Salvatore Bassetto, Franco Rugge, Massimo Montesco, Maria Cristina Cerroni, Lorenzo Fassan, Matteo Comparative Study Journal Article United States J Am Acad Dermatol. 2018 Oct;79(4):728-735. doi: 10.1016/j.jaad.2018.06.018. Epub 2018 Jun 18. PY - 2018 SN - 0190-9622 SP - 728-735 ST - Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions T2 - J Am Acad Dermatol TI - Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions VL - 79 ID - 811 ER - TY - JOUR AD - Regenerative Medicine Program, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. Central Animal Care Services, University of Manitoba, Winnipeg, Manitoba, Canada. Ottawa Bioinformatics Core Facility, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Department of Pathology, University of Manitoba and the Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada. Program in Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada. Department of Neurosurgery, University of Kansas, Kansas City, Kansas. The Arthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children, Toronto, Ontario, Canada. Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada. Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada. The Arthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children, Toronto, Ontario, Canada. Tamra.Ogilvie@umanitoba.ca vijay.ramaswamy@sickkids.ca. Division of Haematology/Oncology, University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. Program in Neuroscience and Mental Health and Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada. Regenerative Medicine Program, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. Tamra.Ogilvie@umanitoba.ca vijay.ramaswamy@sickkids.ca. AN - 29930101 AU - Liang, L. AU - Coudière-Morrison, L. AU - Tatari, N. AU - Stromecki, M. AU - Fresnoza, A. AU - Porter, C. J. AU - Del Bigio, M. R. AU - Hawkins, C. AU - Chan, J. A. AU - Ryken, T. C. AU - Taylor, M. D. AU - Ramaswamy, V. AU - Werbowetski-Ogilvie, T. E. DA - Aug 15 DO - 10.1158/0008-5472.Can-18-0027 DP - NLM ET - 2018/06/23 IS - 16 LA - eng N1 - 1538-7445 Liang, Lisa Coudière-Morrison, Ludivine Tatari, Nazanin Stromecki, Margaret Fresnoza, Agnes Porter, Christopher J Orcid: 0000-0001-8636-4515 Del Bigio, Marc R Hawkins, Cynthia Chan, Jennifer A Ryken, Timothy C Taylor, Michael D Ramaswamy, Vijay Werbowetski-Ogilvie, Tamra E CIHR/Canada Journal Article Research Support, Non-U.S. Gov't United States Cancer Res. 2018 Aug 15;78(16):4745-4759. doi: 10.1158/0008-5472.CAN-18-0027. Epub 2018 Jun 21. PY - 2018 SN - 0008-5472 SP - 4745-4759 ST - CD271(+) Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma T2 - Cancer Res TI - CD271(+) Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma VL - 78 ID - 812 ER - TY - JOUR AD - University Hospital of Wales, Department of Neurosurgery, Cardiff University, Heath Park, Cardiff, CF14 4XW, UK. Sharouffh@cardiff.ac.uk. University Hospital of Wales, Department of Neurosurgery, Cardiff University, Heath Park, Cardiff, CF14 4XW, UK. University Hospital of Wales, Cardiff, UK. AN - 29948137 AU - Sharouf, F. AU - Zaben, M. AU - Lammie, A. AU - Leach, P. AU - Bhatti, M. I. C2 - PMC6060827 DA - Aug DO - 10.1007/s00381-018-3851-5 DP - NLM ET - 2018/06/28 IS - 8 LA - eng N1 - 1433-0350 Sharouf, F Orcid: 0000-0002-3034-3392 Zaben, M Lammie, A Leach, P Bhatti, M I Case Reports Journal Article Review Childs Nerv Syst. 2018 Aug;34(8):1471-1477. doi: 10.1007/s00381-018-3851-5. Epub 2018 Jun 12. PY - 2018 SN - 0256-7040 (Print) 0256-7040 SP - 1471-1477 ST - Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update T2 - Childs Nerv Syst TI - Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update VL - 34 ID - 813 ER - TY - JOUR AD - Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; Department of Surgery, Department of Laboratory Medicine and Pathobiology, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. Institute of Neuropathology, University Hospital Zürich, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada; Department of Surgery, Department of Laboratory Medicine and Pathobiology, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. Paediatric Leukaemia Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland; Department of Oncology, University Children's Hospital Zürich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland. Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. Electronic address: martin.baumgartner@kispi.uzh.ch. AN - 29949765 AU - Santhana Kumar, K. AU - Neve, A. AU - Guerreiro Stucklin, A. S. AU - Kuzan-Fischer, C. M. AU - Rushing, E. J. AU - Taylor, M. D. AU - Tripolitsioti, D. AU - Behrmann, L. AU - Kirschenbaum, D. AU - Grotzer, M. A. AU - Baumgartner, M. DA - Jun 26 DO - 10.1016/j.celrep.2018.05.083 DP - NLM ET - 2018/06/28 IS - 13 LA - eng N1 - 2211-1247 Santhana Kumar, Karthiga Neve, Anuja Guerreiro Stucklin, Ana S Kuzan-Fischer, Claudia M Rushing, Elisabeth J Taylor, Michael D Tripolitsioti, Dimitra Behrmann, Lena Kirschenbaum, Daniel Grotzer, Michael A Baumgartner, Martin Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Cell Rep. 2018 Jun 26;23(13):3798-3812.e8. doi: 10.1016/j.celrep.2018.05.083. PY - 2018 SP - 3798-3812.e8 ST - TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma T2 - Cell Rep TI - TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma VL - 23 ID - 814 ER - TY - JOUR AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Department of Pathology, Seoul National University Hospital, Seoul, Korea. AN - 29950554 AU - Ock, C. Y. AU - Yoo, S. H. AU - Keam, B. AU - Kim, M. AU - Kim, T. M. AU - Jeon, Y. K. AU - Kim, D. W. AU - Chung, D. H. AU - Heo, D. S. C2 - PMC6718771 DA - Sep DO - 10.3904/kjim.2018.011 DP - NLM ET - 2018/06/29 IS - 5 LA - eng N1 - 2005-6648 Ock, Chan-Young Yoo, Shin-Hye Keam, Bhumsuk Kim, Miso Kim, Tae Min Jeon, Yoon Kyung Kim, Dong-Wan Chung, Doo Hyun Heo, Dae Seog Health Technology Assessment Programme/ HI17C2085/Ministry of Health and Welfare/ Journal Article Validation Study Korean J Intern Med. 2019 Sep;34(5):1116-1124. doi: 10.3904/kjim.2018.011. Epub 2018 Jun 29. PY - 2019 SN - 1226-3303 (Print) 1226-3303 SP - 1116-1124 ST - Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer T2 - Korean J Intern Med TI - Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer VL - 34 ID - 815 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University. Department of Nursing, Chang Gung University and Memorial Hospital. Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taoyuan, Taiwan. AN - 29952979 AU - Jaing, T. H. AU - Chang, T. Y. AU - Chen, S. H. AU - Wen, Y. C. AU - Chuang, W. Y. AU - Yang, C. P. C2 - PMC6039684 DA - Jun DO - 10.1097/md.0000000000011222 DP - NLM ET - 2018/06/29 IS - 26 LA - eng N1 - 1536-5964 Jaing, Tang-Her Chang, Tsung-Yen Chen, Shih-Hsiang Wen, Yu-Chuan Chuang, Wen-Yu Yang, Chao-Ping Case Reports Journal Article Medicine (Baltimore). 2018 Jun;97(26):e11222. doi: 10.1097/MD.0000000000011222. PY - 2018 SN - 0025-7974 (Print) 0025-7974 SP - e11222 ST - Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation: A case report T2 - Medicine (Baltimore) TI - Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation: A case report VL - 97 ID - 816 ER - TY - JOUR AD - Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA. yoheme@mail.nih.gov khanjav@mail.nih.gov. Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA. Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Bethesda, MD 20892, USA. Pathology/Histotechnology Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NIH, Frederick, MD 21702, USA. Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NIH, Frederick, MD 21701, USA. Collaborative Protein Technology Resource, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Systems Biology Center, National Heart Lung and Blood Institute, NIH, Bethesda, MD 20892, USA. AN - 29973406 AU - Yohe, M. E. AU - Gryder, B. E. AU - Shern, J. F. AU - Song, Y. K. AU - Chou, H. C. AU - Sindiri, S. AU - Mendoza, A. AU - Patidar, R. AU - Zhang, X. AU - Guha, R. AU - Butcher, D. AU - Isanogle, K. A. AU - Robinson, C. M. AU - Luo, X. AU - Chen, J. Q. AU - Walton, A. AU - Awasthi, P. AU - Edmondson, E. F. AU - Difilippantonio, S. AU - Wei, J. S. AU - Zhao, K. AU - Ferrer, M. AU - Thomas, C. J. AU - Khan, J. DA - Jul 4 DO - 10.1126/scitranslmed.aan4470 DP - NLM ET - 2018/07/06 IS - 448 LA - eng N1 - 1946-6242 Yohe, Marielle E Orcid: 0000-0001-5356-9426 Gryder, Berkley E Orcid: 0000-0003-0130-2302 Shern, Jack F Song, Young K Chou, Hsien-Chao Sindiri, Sivasish Mendoza, Arnulfo Patidar, Rajesh Zhang, Xiaohu Guha, Rajarashi Orcid: 0000-0001-7403-8819 Butcher, Donna Orcid: 0000-0002-2065-8067 Isanogle, Kristine A Robinson, Christina M Luo, Xiaoling Chen, Jin-Qiu Walton, Ashley Awasthi, Parirokh Orcid: 0000-0002-5831-9781 Edmondson, Elijah F Orcid: 0000-0002-6106-3705 Difilippantonio, Simone Wei, Jun S Orcid: 0000-0002-4812-0250 Zhao, Keji Ferrer, Marc Thomas, Craig J Khan, Javed Orcid: 0000-0002-5858-0488 HHSN261200800001E/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Sci Transl Med. 2018 Jul 4;10(448):eaan4470. doi: 10.1126/scitranslmed.aan4470. PY - 2018 SN - 1946-6234 ST - MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma T2 - Sci Transl Med TI - MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma VL - 10 ID - 817 ER - TY - JOUR AD - Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A basud@upmc.edu. Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A. Division of Plastic and Reconstructive Surgery, North Shore University Health System, Northbrook, IL, U.S.A. Department of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A. Department of Pediatrics, Weill Cornell Medical College, New York, NY, U.S.A. Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, U.S.A. AN - 29976629 AU - Basu, D. AU - Salgado, C. M. AU - Bauer, B. AU - Khakoo, Y. AU - Patel, J. R. AU - Hoehl, R. M. AU - Bertolini, D. M. AU - Zabec, J. AU - Brzozowski, M. R. AU - Reyes-Múgica, M. C2 - PMC6070711 DA - Jul-Aug DO - 10.21873/cgp.20082 DP - NLM ET - 2018/07/07 IS - 4 LA - eng N1 - 1790-6245 Basu, Dipanjan Salgado, Cláudia M Bauer, Bruce Khakoo, Yasmin Patel, Janki R Hoehl, Ryan M Bertolini, Dominique M Zabec, Joie Brzozowski, Morgan R Reyes-Múgica, Miguel P30 CA008748/CA/NCI NIH HHS/United States Journal Article Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):239-248. doi: 10.21873/cgp.20082. PY - 2018 SN - 1109-6535 (Print) 1109-6535 SP - 239-248 ST - The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis T2 - Cancer Genomics Proteomics TI - The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis VL - 15 ID - 818 ER - TY - JOUR AD - Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany; Cluster of Excellence "Cells in Motion", Westfälische Wilhelms-Universität, Münster, Germany. Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany. University of Tübingen, Interfaculty Institute for Cell Biology, Department of Immunology, Tübingen, Germany. Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany; Cluster of Excellence "Cells in Motion", Westfälische Wilhelms-Universität, Münster, Germany. Electronic address: ludwigs@uni-muenster.de. AN - 29990517 AU - Schräder, T. AU - Dudek, S. E. AU - Schreiber, A. AU - Ehrhardt, C. AU - Planz, O. AU - Ludwig, S. DA - Sep DO - 10.1016/j.antiviral.2018.07.006 DP - NLM ET - 2018/07/11 LA - eng N1 - 1872-9096 Schräder, Tobias Dudek, Sabine E Schreiber, André Ehrhardt, Christina Planz, Oliver Ludwig, Stephan Journal Article Research Support, Non-U.S. Gov't Netherlands Antiviral Res. 2018 Sep;157:80-92. doi: 10.1016/j.antiviral.2018.07.006. Epub 2018 Jul 7. PY - 2018 SN - 0166-3542 SP - 80-92 ST - The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression T2 - Antiviral Res TI - The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression VL - 157 ID - 819 ER - TY - JOUR AD - Departments of Pathology. Dermatopathology. Clinical Cancer Genomics Laboratory. Helen Diller Cancer Center, University of California, San Francisco. Orofacial Sciences, Pathology & Radiation Oncology. Department of Pathology, Zuckerberg San Francisco General Hospital, San Francisco, CA. AN - 30001233 AU - Cohen, J. N. AU - Yeh, I. AU - Jordan, R. C. AU - Wolsky, R. J. AU - Horvai, A. E. AU - McCalmont, T. H. AU - LeBoit, P. E. DA - Sep DO - 10.1097/pas.0000000000001122 DP - NLM ET - 2018/07/13 IS - 9 LA - eng N1 - 1532-0979 Cohen, Jarish N Yeh, Iwei Jordan, Richard C Wolsky, Rebecca J Horvai, Andrew E McCalmont, Timothy H LeBoit, Philip E Journal Article United States Am J Surg Pathol. 2018 Sep;42(9):1133-1142. doi: 10.1097/PAS.0000000000001122. PY - 2018 SN - 0147-5185 SP - 1133-1142 ST - Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions T2 - Am J Surg Pathol TI - Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions VL - 42 ID - 820 ER - TY - JOUR AD - Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address: pippa.corrie@addenbrookes.nhs.uk. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. Medical Oncology, Mount Vernon Hospital, Northwood, UK. Department of Medical Oncology, Christie Hospital, Manchester, UK. Royal Marsden Hospital NHS Trust, London, UK. Oncology Research, Broomfield Hospital, Chelmsford, UK. Oncology Department, Leicester Royal Infirmary, Leicester, UK. Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle upon Tyne, UK. Leeds Cancer Centre, St James's University Hospital, Leeds, UK. Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, UK. Cancer & Palliative Care, St. Helen's Hospital, St. Helens, UK. Oncology Department, Royal Surrey County Hospital, Guildford, UK. Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. Clinical Trials Unit, Beatson WOS Cancer Centre, Glasgow, UK. Department of Clinical Oncology, Norfolk & Norwich University Hospital, Norwich, UK. Guy's & St. Thomas' Hospital, Guy's Cancer Centre, London, UK. Velindre Cancer Centre, Cardiff, UK. Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK. St George's Hospital, Cancer Centre, London, UK. Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK. Cancer Centre, Ninewells Hospital, Dundee, UK. Royal Free Hospital, London, UK. Castle Hill Hospital, Cottingham, UK. Academic Unit of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK. CRUK and NIHR Southampton Experimental Cancer Medicine Centre, Southampton University Hospitals NHS Foundation Trust, Southampton, UK. Oncology Centre, Cheltenham General Hospital, Cheltenham, UK. Oncology Department, James Cook University Hospital, Middlesbrough, UK. Oncology Department, Poole Hospital, Dorset, UK. Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Department of Oncology, University of Oxford, Oxford, UK; Experimental Cancer Medicine Centre, Oxford, UK. Melanoma Focus, Cambridge, UK. Oxford NIHR Biomedical Research Centre, Oxford, UK. AN - 30010756 AU - Corrie, P. G. AU - Marshall, A. AU - Nathan, P. D. AU - Lorigan, P. AU - Gore, M. AU - Tahir, S. AU - Faust, G. AU - Kelly, C. G. AU - Marples, M. AU - Danson, S. J. AU - Marshall, E. AU - Houston, S. J. AU - Board, R. E. AU - Waterston, A. M. AU - Nobes, J. P. AU - Harries, M. AU - Kumar, S. AU - Goodman, A. AU - Dalgleish, A. AU - Martin-Clavijo, A. AU - Westwell, S. AU - Casasola, R. AU - Chao, D. AU - Maraveyas, A. AU - Patel, P. M. AU - Ottensmeier, C. H. AU - Farrugia, D. AU - Humphreys, A. AU - Eccles, B. AU - Young, G. AU - Barker, E. O. AU - Harman, C. AU - Weiss, M. AU - Myers, K. A. AU - Chhabra, A. AU - Rodwell, S. H. AU - Dunn, J. A. AU - Middleton, M. R. AU - Nathan, P. AU - Lorigan, P. AU - Dziewulski, P. AU - Holikova, S. AU - Panwar, U. AU - Tahir, S. AU - Faust, G. AU - Thomas, A. AU - Corrie, P. AU - Sirohi, B. AU - Kelly, C. AU - Middleton, M. AU - Marples, M. AU - Danson, S. AU - Lester, J. AU - Marshall, E. AU - Ajaz, M. AU - Houston, S. AU - Board, R. AU - Eaton, D. AU - Waterston, A. AU - Nobes, J. AU - Loo, S. AU - Gray, G. AU - Stubbings, H. AU - Gore, M. AU - Harries, M. AU - Kumar, S. AU - Goodman, A. AU - Dalgleish, A. AU - Martin-Clavijo, A. AU - Marsden, J. AU - Westwell, S. AU - Casasola, R. AU - Chao, D. AU - Maraveyas, A. AU - Marshall, E. AU - Patel, P. AU - Ottensmeier, C. AU - Farrugia, D. AU - Humphreys, A. AU - Eccles, B. AU - Dega, R. AU - Herbert, C. AU - Price, C. AU - Brunt, M. AU - Scott-Brown, M. AU - Hamilton, J. AU - Hayward, R. L. AU - Smyth, J. AU - Woodings, P. AU - Nayak, N. AU - Burrows, L. AU - Wolstenholme, V. AU - Wagstaff, J. AU - Nicolson, M. AU - Wilson, A. AU - Barlow, C. AU - Scrase, C. AU - Podd, T. AU - Gonzalez, M. AU - Stewart, J. AU - Highley, M. AU - Wolstenholme, V. AU - Grumett, S. AU - Goodman, A. AU - Talbot, T. AU - Nathan, K. AU - Coltart, R. AU - Gee, B. AU - Gore, M. AU - Farrugia, D. AU - Martin-Clavijo, A. AU - Marsden, J. AU - Price, C. AU - Farrugia, D. AU - Nathan, K. AU - Coltart, R. AU - Nathan, K. AU - Coltart, R. C2 - PMC6096737 DA - Aug 1 DO - 10.1093/annonc/mdy229 DP - NLM ET - 2018/07/17 IS - 8 LA - eng N1 - 1569-8041 Corrie, P G Marshall, A Nathan, P D Lorigan, P Gore, M Tahir, S Faust, G Kelly, C G Marples, M Danson, S J Marshall, E Houston, S J Board, R E Waterston, A M Nobes, J P Harries, M Kumar, S Goodman, A Dalgleish, A Martin-Clavijo, A Westwell, S Casasola, R Chao, D Maraveyas, A Patel, P M Ottensmeier, C H Farrugia, D Humphreys, A Eccles, B Young, G Barker, E O Harman, C Weiss, M Myers, K A Chhabra, A Rodwell, S H Dunn, J A Middleton, M R AVAST-M Investigators Nathan, Paul Lorigan, Paul Dziewulski, Peter Holikova, Sonja Panwar, Udaiveer Tahir, Saad Faust, Guy Thomas, Anne Corrie, Pippa Sirohi, Bhawna Kelly, Charles Middleton, Mark Marples, Maria Danson, Sarah Lester, James Marshall, Ernest Ajaz, Mazhar Houston, Stephen Board, Ruth Eaton, David Waterston, Ashita Nobes, Jenny Loo, Suat Gray, Gill Stubbings, Helen Gore, Martin Harries, Mark Kumar, Satish Goodman, Andrew Dalgleish, Angus Martin-Clavijo, Agustin Marsden, Jerry Westwell, Sarah Casasola, Richard Chao, David Maraveyas, Anthony Patel, Poulam Ottensmeier, Christian Farrugia, David Humphreys, Alison Eccles, Bryony Dega, Renata Herbert, Chris Price, Christopher Brunt, Murray Scott-Brown, Martin Hamilton, Joanna Hayward, Richard Larry Smyth, John Woodings, Pamela Nayak, Neena Burrows, Lorna Wolstenholme, Virginia Wagstaff, John Nicolson, Marianne Wilson, Andrew Barlow, Clare Scrase, Christopher Podd, Timothy Gonzalez, Michael Stewart, John Highley, Martin Grumett, Simon Talbot, Toby Nathan, Kannon Coltart, Robert Gee, Bruce 12130/CRUK_/Cancer Research UK/United Kingdom 8466/CRUK_/Cancer Research UK/United Kingdom C2195/A8466/CRUK_/Cancer Research UK/United Kingdom C7535/A6408/CRUK_/Cancer Research UK/United Kingdom Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Ann Oncol. 2018 Aug 1;29(8):1843-1852. doi: 10.1093/annonc/mdy229. PY - 2018 SN - 0923-7534 (Print) 0923-7534 SP - 1843-1852 ST - Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial T2 - Ann Oncol TI - Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial VL - 29 ID - 821 ER - TY - JOUR AD - Department of Stomatology, The Second Affiliated Hospital Of Xinjiang Medical University, Urumqi, China. 418617006@qq.com. AN - 30024628 AU - Xu, J. AU - Yang, Z. Y. AU - Chen, X. AU - Liu, X. DA - Jul DO - 10.26355/eurrev_201807_15435 DP - NLM ET - 2018/07/20 IS - 13 LA - eng N1 - 2284-0729 Xu, J Yang, Z-Y Chen, X Liu, X Journal Article Research Support, Non-U.S. Gov't Italy Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4363-4370. doi: 10.26355/eurrev_201807_15435. PY - 2018 SN - 1128-3602 SP - 4363-4370 ST - HMTH1 induces the metastasis and recurrence of the parotid adenoma by repairing DNA damage T2 - Eur Rev Med Pharmacol Sci TI - HMTH1 induces the metastasis and recurrence of the parotid adenoma by repairing DNA damage VL - 22 ID - 822 ER - TY - JOUR AD - University of Colorado, Denver, Colorado. MD Anderson Cancer Center, Houston, Texas. Ohio State University, Columbus, Ohio. Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Washington University School of Medicine, St. Louis, Missouri. University of North Carolina, Chapel Hill, North Carolina. University of Pittsburgh, Pittsburgh, Pennsylvania. Princess Margaret Hospital, Toronto, Canada. Colorado State University, Denver, Colorado. University of Texas at Austin Dell Medical School, LIVESTRONG Cancer Institutes, Austin, Texas. University of Colorado, Denver, Colorado. christopher.lieu@ucdenver.edu. AN - 30042150 AU - Krishnamurthy, A. AU - Dasari, A. AU - Noonan, A. M. AU - Mehnert, J. M. AU - Lockhart, A. C. AU - Leong, S. AU - Capasso, A. AU - Stein, M. N. AU - Sanoff, H. K. AU - Lee, J. J. AU - Hansen, A. AU - Malhotra, U. AU - Rippke, S. AU - Gustafson, D. L. AU - Pitts, T. M. AU - Ellison, K. AU - Davis, S. L. AU - Messersmith, W. A. AU - Eckhardt, S. G. AU - Lieu, C. H. C2 - PMC6139073 C6 - NIHMS1500544 Bayer AG and Merck & Co, Inc., Mark N. Stein: Merck Sharpe & Dohme Corp. DA - Sep 15 DO - 10.1158/0008-5472.Can-18-0316 DP - NLM ET - 2018/07/26 IS - 18 LA - eng N1 - 1538-7445 Krishnamurthy, Anuradha Dasari, Arvind Noonan, Anne M Mehnert, Janice M Lockhart, Albert C Leong, Stephen Capasso, Anna Stein, Mark N Sanoff, Hanna K Lee, James J Hansen, Aaron Malhotra, Usha Rippke, Sarah Gustafson, Daniel L Pitts, Todd M Ellison, Kim Davis, S Lindsey Messersmith, Wells A Eckhardt, S Gail Lieu, Christopher H UM1 CA186688/CA/NCI NIH HHS/United States P30 CA047904/CA/NCI NIH HHS/United States U01 CA099168/CA/NCI NIH HHS/United States K23 CA190849/CA/NCI NIH HHS/United States P30 CA016058/CA/NCI NIH HHS/United States Clinical Trial, Phase I Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer Res. 2018 Sep 15;78(18):5398-5407. doi: 10.1158/0008-5472.CAN-18-0316. Epub 2018 Jul 24. PY - 2018 SN - 0008-5472 (Print) 0008-5472 SP - 5398-5407 ST - Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer T2 - Cancer Res TI - Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer VL - 78 ID - 823 ER - TY - JOUR AD - State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China. Beijing Key Laboratory of Bio-feed Additives, China Agricultural University, Beijing, China. National Feed Engineering Technology Research Center, Beijing, China. Department of Animal Sciences, South Dakota State University, Brookings, SD, United States. Swine Nutrition and Production, West Central Research and Outreach Center, University of Minnesota, Morris, MN, United States. AN - 30057893 AU - Yu, H. AU - Ding, X. AU - Shang, L. AU - Zeng, X. AU - Liu, H. AU - Li, N. AU - Huang, S. AU - Wang, Y. AU - Wang, G. AU - Cai, S. AU - Chen, M. AU - Levesque, C. L. AU - Johnston, L. J. AU - Qiao, S. C2 - PMC6053529 DO - 10.3389/fcimb.2018.00242 DP - NLM ET - 2018/07/31 LA - eng N1 - 2235-2988 Yu, Haitao Ding, Xiuliang Shang, Lijun Zeng, Xiangfang Liu, Hongbin Li, Ning Huang, Shuo Wang, Yuming Wang, Gang Cai, Shuang Chen, Meixia Levesque, Crystal L Johnston, Lee J Qiao, Shiyan Journal Article Research Support, Non-U.S. Gov't Front Cell Infect Microbiol. 2018 Jul 13;8:242. doi: 10.3389/fcimb.2018.00242. eCollection 2018. PY - 2018 SN - 2235-2988 SP - 242 ST - Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells T2 - Front Cell Infect Microbiol TI - Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells VL - 8 ID - 824 ER - TY - JOUR AD - Department of Nephrology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Department of Transplantation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. AN - 30088539 AU - Chen, Y. AU - Zheng, Y. AU - Zhou, Z. AU - Wang, J. C2 - PMC6086549 DA - Aug 6 DO - 10.1590/1414-431x20187476 DP - NLM ET - 2018/08/09 IS - 10 LA - eng N1 - 1414-431x Chen, Yan Zheng, Yu Zhou, Zhihong Wang, Jinjun Journal Article Braz J Med Biol Res. 2018 Aug 6;51(10):e7476. doi: 10.1590/1414-431X20187476. PY - 2018 SN - 0100-879X (Print) 0100-879x SP - e7476 ST - Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways T2 - Braz J Med Biol Res TI - Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways VL - 51 ID - 825 ER - TY - JOUR AD - Division of Hemato-Oncology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada. Department of Radiology, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Department of Pathology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Hematology-Oncology Research Center, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Division of Neurosurgery, Department of Surgery, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada. Division of Neurosurgery, Department of Surgery, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Neurosurgery, Department of Pediatric Surgery, McGill University Health Center, Montreal, QC, Canada. Division of Child Neurology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada. s.perreault@umontreal.ca. AN - 30097824 AU - Kondyli, M. AU - Larouche, V. AU - Saint-Martin, C. AU - Ellezam, B. AU - Pouliot, L. AU - Sinnett, D. AU - Legault, G. AU - Crevier, L. AU - Weil, A. AU - Farmer, J. P. AU - Jabado, N. AU - Perreault, S. DA - Nov DO - 10.1007/s11060-018-2971-9 DP - NLM ET - 2018/08/12 IS - 2 LA - eng N1 - 1573-7373 Kondyli, Maria Larouche, Valérie Saint-Martin, Christine Ellezam, Benjamin Pouliot, Lauranne Sinnett, Daniel Legault, Geneviève Crevier, Louis Weil, Alex Farmer, Jean-Pierre Jabado, Nada Perreault, Sébastien Orcid: 0000-0002-4417-7698 Case Reports Journal Article United States J Neurooncol. 2018 Nov;140(2):435-444. doi: 10.1007/s11060-018-2971-9. Epub 2018 Aug 10. PY - 2018 SN - 0167-594x SP - 435-444 ST - Trametinib for progressive pediatric low-grade gliomas T2 - J Neurooncol TI - Trametinib for progressive pediatric low-grade gliomas VL - 140 ID - 826 ER - TY - JOUR AD - Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of General Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Otorhinolaryngology-Head and Neck Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Pathology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Radiology, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, South Korea. Department of Surgery (Busan Cancer Center), Pusan National University Hospital, Pusan National University College of Medicine, Busan, South Korea. AN - 30118506 AU - Kim, D. S. AU - Kim, D. W. AU - Heo, Y. J. AU - Baek, J. W. AU - Lee, Y. J. AU - Choo, H. J. AU - Park, Y. M. AU - Park, H. K. AU - Ha, T. K. AU - Kim, D. H. AU - Jung, S. J. AU - Park, J. S. AU - Ahn, K. J. AU - Baek, H. J. AU - Kang, T. C2 - PMC6097667 DO - 10.1371/journal.pone.0202687 DP - NLM ET - 2018/08/18 IS - 8 LA - eng N1 - 1932-6203 Kim, Da Som Kim, Dong Wook Orcid: 0000-0002-9826-1326 Heo, Young Jin Baek, Jin Wook Orcid: 0000-0003-4632-4951 Lee, Yoo Jin Choo, Hye Jung Park, Young Mi Park, Ha Kyoung Ha, Tae Kwun Orcid: 0000-0001-7980-3700 Kim, Do Hun Jung, Soo Jin Orcid: 0000-0002-9139-701x Park, Ji Sun Ahn, Ki Jung Orcid: 0000-0002-5163-0040 Baek, Hye Jin Orcid: 0000-0001-7349-2841 Kang, Taewoo Orcid: 0000-0002-6279-0904 Journal Article PLoS One. 2018 Aug 17;13(8):e0202687. doi: 10.1371/journal.pone.0202687. eCollection 2018. PY - 2018 SN - 1932-6203 SP - e0202687 ST - Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules T2 - PLoS One TI - Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules VL - 13 ID - 827 ER - TY - JOUR AD - Department of Orthopedic, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China (mainland). Department of Orthopedics, Taizhou Fourth People's Hospital, Taizhou, Jiangsu, China (mainland). AN - 30135419 AU - Zhou, Y. AU - Hu, J. C2 - PMC6118161 DA - Aug 23 DO - 10.12659/msm.909682 DP - NLM ET - 2018/08/24 LA - eng N1 - 1643-3750 Zhou, Yuelai Hu, Jinlong Journal Article Med Sci Monit. 2018 Aug 23;24:5874-5880. doi: 10.12659/MSM.909682. PY - 2018 SN - 1234-1010 (Print) 1234-1010 SP - 5874-5880 ST - Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway T2 - Med Sci Monit TI - Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway VL - 24 ID - 828 ER - TY - JOUR AD - Department of Pediatrics, Nagoya Medical Center, Nagoya 460-0001, Japan.masahiro.sekimizu@nnh.go.jp. AN - 30140094 AU - Sekimizu, M. AU - Osumi, T. AU - Fukano, R. AU - Koga, Y. AU - Kada, A. AU - Saito, A. M. AU - Mori, T. DA - Aug DO - 10.18926/amo/56184 DP - NLM ET - 2018/08/25 IS - 4 LA - eng N1 - Sekimizu, Masahiro Osumi, Tomoo Fukano, Reiji Koga, Yuhki Kada, Akiko Saito, Akiko M Mori, Tetsuya Clinical Trial Protocol Journal Article Japan Acta Med Okayama. 2018 Aug;72(4):431-436. doi: 10.18926/AMO/56184. PY - 2018 SN - 0386-300X (Print) 0386-300x SP - 431-436 ST - A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial T2 - Acta Med Okayama TI - A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial VL - 72 ID - 829 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Departments of Molecular and Cellular Biology and Pediatrics, BIO5 Institute, University of Arizona, Tucson, AZ 85721, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Integrated Biomedical Sciences, University of Tennessee Health Science Center, Memphis, TN 38105, USA. Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Preclinical Pharmacokinetics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. The McDonnell Genome Institute, Washington University, St. Louis, MO 63108, USA; Department of Genetics, Washington University, St. Louis, MO 63108, USA; Department of Medicine, Washington University, St. Louis, MO 63108, USA. The McDonnell Genome Institute, Washington University, St. Louis, MO 63108, USA; Department of Genetics, Washington University, St. Louis, MO 63108, USA; Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, MO 63108, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38105, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: michael.dyer@stjude.org. AN - 30146332 AU - Stewart, E. AU - McEvoy, J. AU - Wang, H. AU - Chen, X. AU - Honnell, V. AU - Ocarz, M. AU - Gordon, B. AU - Dapper, J. AU - Blankenship, K. AU - Yang, Y. AU - Li, Y. AU - Shaw, T. I. AU - Cho, J. H. AU - Wang, X. AU - Xu, B. AU - Gupta, P. AU - Fan, Y. AU - Liu, Y. AU - Rusch, M. AU - Griffiths, L. AU - Jeon, J. AU - Freeman, B. B., 3rd AU - Clay, M. R. AU - Pappo, A. AU - Easton, J. AU - Shurtleff, S. AU - Shelat, A. AU - Zhou, X. AU - Boggs, K. AU - Mulder, H. AU - Yergeau, D. AU - Bahrami, A. AU - Mardis, E. R. AU - Wilson, R. K. AU - Zhang, J. AU - Peng, J. AU - Downing, J. R. AU - Dyer, M. A. C2 - PMC6158019 C6 - NIHMS1504174 DA - Sep 10 DO - 10.1016/j.ccell.2018.07.012 DP - NLM ET - 2018/08/28 IS - 3 LA - eng N1 - 1878-3686 Stewart, Elizabeth McEvoy, Justina Wang, Hong Chen, Xiang Honnell, Victoria Ocarz, Monica Gordon, Brittney Dapper, Jason Blankenship, Kaley Yang, Yanling Li, Yuxin Shaw, Timothy I Cho, Ji-Hoon Wang, Xusheng Xu, Beisi Gupta, Pankaj Fan, Yiping Liu, Yu Rusch, Michael Griffiths, Lyra Jeon, Jongrye Freeman, Burgess B 3rd Clay, Michael R Pappo, Alberto Easton, John Shurtleff, Sheila Shelat, Anang Zhou, Xin Boggs, Kristy Mulder, Heather Yergeau, Donald Bahrami, Armita Mardis, Elaine R Wilson, Richard K Zhang, Jinghui Peng, Junmin Downing, James R Dyer, Michael A St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project R01 CA219686/CA/NCI NIH HHS/United States R01 EY018599/EY/NEI NIH HHS/United States R01 EY014867/EY/NEI NIH HHS/United States R01 CA168875/CA/NCI NIH HHS/United States Howard Hughes Medical Institute/United States P30 CA021765/CA/NCI NIH HHS/United States R01 AG047928/AG/NIA NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Cancer Cell. 2018 Sep 10;34(3):411-426.e19. doi: 10.1016/j.ccell.2018.07.012. Epub 2018 Aug 23. PY - 2018 SN - 1535-6108 (Print) 1535-6108 SP - 411-426.e19 ST - Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses T2 - Cancer Cell TI - Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses VL - 34 ID - 830 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, AP-HM, La Timone Children's Hospital, Marseille 13005, France. Department of Paediatric Neurology, AP-HM, La Timone Children's Hospital, Marseille 13005, France. Centre d'Essais Précoce en Cancérologie de Marseille, AP-HM, La Timone Children's Hospital, Marseille 13005, France. AN - 30174724 AU - Papalia, H. AU - Audic, F. AU - Rivière, G. R. AU - Verschuur, A. AU - André, N. C2 - PMC6113984 DO - 10.3332/ecancer.2018.862 DP - NLM ET - 2018/09/04 LA - eng N1 - 1754-6605 Papalia, Honoré Audic, Frédérique Rivière, Gabriel Revon Verschuur, Arnauld André, Nicolas Case Reports Ecancermedicalscience. 2018 Aug 28;12:862. doi: 10.3332/ecancer.2018.862. eCollection 2018. PY - 2018 SN - 1754-6605 (Print) 1754-6605 SP - 862 ST - Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas T2 - Ecancermedicalscience TI - Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas VL - 12 ID - 831 ER - TY - JOUR AD - Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Sydney Medical School, The University of Sydney, Sydney, Australia. Charles Perkins Centre, The University of Sydney, Sydney, Australia. QIMR Berghofer Medical Research Institute, Brisbane, Australia. Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia. Royal Prince Alfred Hospital, Camperdown, Australia. The University of the Highlands and Islands, Inverness, United Kingdom. Royal North Shore Hospital, New South Wales, Australia. Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, Camperdown, Australia. Macquarie University, North Ryde, Australia. Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia. AN - 30178487 AU - Wilmott, J. S. AU - Johansson, P. A. AU - Newell, F. AU - Waddell, N. AU - Ferguson, P. AU - Quek, C. AU - Patch, A. M. AU - Nones, K. AU - Shang, P. AU - Pritchard, A. L. AU - Kazakoff, S. AU - Holmes, O. AU - Leonard, C. AU - Wood, S. AU - Xu, Q. AU - Saw, R. P. M. AU - Spillane, A. J. AU - Stretch, J. R. AU - Shannon, K. F. AU - Kefford, R. F. AU - Menzies, A. M. AU - Long, G. V. AU - Thompson, J. F. AU - Pearson, J. V. AU - Mann, G. J. AU - Hayward, N. K. AU - Scolyer, R. A. DA - Mar 1 DO - 10.1002/ijc.31791 DP - NLM ET - 2018/09/05 IS - 5 LA - eng N1 - 1097-0215 Wilmott, James S Orcid: 0000-0002-6750-5244 Johansson, Peter A Newell, Felicity Waddell, Nicola Ferguson, Peter Quek, Camelia Patch, Ann-Marie Nones, Katia Shang, Ping Pritchard, Antonia L Kazakoff, Stephen Holmes, Oliver Leonard, Conrad Wood, Scott Xu, Qinying Saw, Robyn P M Spillane, Andrew J Stretch, Jonathan R Shannon, Kerwin F Kefford, Richard F Menzies, Alexander M Long, Georgina V Thompson, John F Pearson, John V Mann, Graham J Hayward, Nicholas K Scolyer, Richard A Journal Article Research Support, Non-U.S. Gov't United States Int J Cancer. 2019 Mar 1;144(5):1049-1060. doi: 10.1002/ijc.31791. Epub 2018 Nov 21. PY - 2019 SN - 0020-7136 SP - 1049-1060 ST - Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility T2 - Int J Cancer TI - Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility VL - 144 ID - 832 ER - TY - JOUR AD - Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. martin.sramek@mail.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. martin.sramek@mail.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. martin.sramek@mail.muni.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. jneradil@sci.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. jneradil@sci.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. jneradil@sci.muni.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. macigova@med.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. macigova@med.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. mudry.peter@fnbrno.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. polaskova.kristyna@fnbrno.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. polaskova.kristyna@fnbrno.cz. Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic. ondrej.slaby@ceitec.muni.cz. Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic. hana.noskova@ceitec.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. sterba.jaroslav@fnbrno.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. sterba.jaroslav@fnbrno.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. veselska@sci.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. veselska@sci.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. veselska@sci.muni.cz. AN - 30200486 AU - Sramek, M. AU - Neradil, J. AU - Macigova, P. AU - Mudry, P. AU - Polaskova, K. AU - Slaby, O. AU - Noskova, H. AU - Sterba, J. AU - Veselska, R. C2 - PMC6163232 DA - Sep 1 DO - 10.3390/ijms19092599 DP - NLM ET - 2018/09/12 IS - 9 LA - eng N1 - 1422-0067 Sramek, Martin Orcid: 0000-0002-4424-7967 Neradil, Jakub Macigova, Petra Orcid: 0000-0002-1545-0720 Mudry, Peter Polaskova, Kristyna Slaby, Ondrej Noskova, Hana Sterba, Jaroslav Veselska, Renata Orcid: 0000-0002-0048-9913 16-34083A/Ministerstvo Zdravotnictví Ceské Republiky/ 16-33209A/Ministerstvo Zdravotnictví Ceské Republiky/ LQ1605/Ministerstvo Školství, Mládeže a Tělovýchovy/ Journal Article Int J Mol Sci. 2018 Sep 1;19(9):2599. doi: 10.3390/ijms19092599. PY - 2018 SN - 1422-0067 ST - Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis T2 - Int J Mol Sci TI - Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis VL - 19 ID - 833 ER - TY - JOUR AD -, , , , , , , , , , , , and , The University of Texas MD Anderson Cancer Center, Houston, TX; and , Sarah Cannon Research Institute at HealthONE, Denver, CO. AN - 32913986 AU - Subbiah, V. AU - Sen, S. AU - Hess, K. R. AU - Janku, F. AU - Hong, D. S. AU - Khatua, S. AU - Karp, D. D. AU - Munoz, J. AU - Falchook, G. S. AU - Groisberg, R. AU - Tsimberidou, A. M. AU - Sherman, S. I. AU - Hwu, P. AU - Meric-Bernstam, F. C2 - PMC7446411 interpretation of the data; the writing of the article; and the decision to submit the article for publication.The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center. Vivek SubbiahConsulting or Advisory Role: MedImmune Research Funding: Novartis (Inst), GlaxoSmithKline (Inst), NanoCarrier (Inst), Northwest Biotherapeutics (Inst), Genentech (Inst), Berg Pharma (Inst), Bayer (Inst), Incyte (Inst), Fujifilm (Inst), PharmaMar (Inst), D3 Oncology Solutions (Inst), Pfizer (Inst), Amgen (Inst), AbbVie (Inst), Multivir (Inst), Blueprint Medicines (Inst), Loxo (Inst), Vegenics (Inst), Takeda (Inst), Alfasigma (Inst), Agensys (Inst), Idera (Inst), Boston Biomedical (Inst) Travel, Accommodations, Expenses: PharmaMar, BayerShiraj SenNo relationship to discloseKenneth R. HessNo relationship to discloseFilip JankuStock and Other Ownership Interests: Trovagene Consulting or Advisory Role: Deciphera, Trovagene, Novartis, Sequenom, Foundation Medicine, Guardant Health, Immunome Research Funding: Novartis, BioMed Valley Discoveries, Roche, Agios, Astellas Pharma, Deciphera, Symphony Evolution, Plexxikon, Piqur, Fujifilm Other Relationship: Bio-RadDavid S. HongStock and Other Ownership Interests: MolecularMatch, Oncorena Honoraria: Adaptimmune, Baxter, Merrimack, Bayer Consulting or Advisory Role: Baxter, Bayer, Guidepoint Global, Janssen Speakers' Bureau: Genentech, Janssen Oncology Research Funding: Novartis, Genentech, Eisai, AstraZeneca, Pfizer, miRNA Therapeutics, Amgen, Daiichi Sankyo, Merck, Mirati Therapeutics, Eli Lilly, Adaptimmune, AbbVie, Bayer, Bristol-Myers Squibb, Genmab, Ignyta, Infinity Pharmaceuticals, Kite Pharma, Kyowa Hakko Kirin, Loxo, MedImmune, Molecular Templates, Takeda Travel, Accommodations, Expenses: Loxo, miRNA Therapeutics Other Relationship: Oncorena, EisaiSoumen KhatuaNo relationship to discloseDaniel D. KarpConsulting or Advisory Role: Black Beret Life Sciences Research Funding: Phosplatin Therapeutics Travel, Accommodations, Expenses: Phosplatin TherapeuticsJavier MunozConsulting or Advisory Role: Kite Pharma, Pfizer, Pharmacyclics, Bayer, Alexion Pharmaceuticals, Bristol-Myers Squibb, Janssen, Seattle Genetics, Gilead Sciences, Kyowa Hakko Kirin Speakers' Bureau: Kite PharmaGerald S. FalchookEmployment: Sarah Cannon Research Institute, HealthONE Research Funding: Millennium, EMD Serono, Celgene, MedImmune, Genmab, Vegenics, Novartis, AstraZeneca, Incyte, ARMO BioSciences, Kolltan Pharmaceuticals, 3-V Biosciences, AbbVie, Aileron Therapeutics, DelMar Pharmaceuticals, eFFECTOR Therapeutics, Strategia Therapeutics, Fujifilm, Hutchison MediPharma, Regeneron, Biothera, Curegenix, Curis, Eli Lilly, Jounce Therapeutics, OncoMed, Precision Oncology, Syndax, Taiho Pharmaceutical, Tesaro, Takeda, BeiGene, Ignyta, Merck, Rgenix, Tarveda Therapeutics, Tocagen Patents, Royalties, Other Intellectual Property: Handbook of Targeted Cancer Therapy Travel, Accommodations, Expenses: Millennium, Sarah Cannon Research Institute, EMD Serono, Bristol-Myers SquibbRoman GroisbergNo relationship to discloseApostolia M. TsimberidouConsulting or Advisory Role: Roche Research Funding: EMD Serono (Inst), Baxter (Inst), Foundation Medicine (Inst), Onyx (Inst), Bayer (Inst), Boston Biomedical (Inst), Placon (Inst), IMMATICS (Inst), Karus Therapeutics (Inst), Stem Cells (Inst), OBI Pharma (Inst)Steven I. ShermanHonoraria: Genzyme, Eisai Consulting or Advisory Role: Eisai, Exelixis, Veracyte, Novo Nordisk, Bristol-Myers Squibb, Loxo, Genzyme, Ignyta, Novartis Research Funding: Genzyme Travel, Accommodations, Expenses: Eisai, Veracyte, IgnytaPatrick HwuStock and Other Ownership Interests: Immatics Consulting or Advisory Role: Dragonfly Therapeutics, GlaxoSmithKline, Immatics, Sanofi Research Funding: Genentech (Inst)Funda Meric-BernstamHonoraria: Sumitomo Group, Dialectica Consulting or Advisory Role: Genentech, Inflection Biosciences, Pieris Pharmaceuticals, Clearlight Diagnostics, Darwin Health, Samsung Bioepis, Spectrum Pharmaceuticals Research Funding: Novartis, AstraZeneca, Taiho Pharmaceutical, Genentech, Calithera Biosciences, Debiopharm Group, Bayer, Aileron Therapeutics, PUMA Biotechnology, CytomX Therapeutics, Jounce Therapeutics, Zymeworks, Curis, Pfizer, eFFECTOR Therapeutics, AbbVie DO - 10.1200/po.18.00189 DP - NLM ET - 2018/09/13 LA - eng N1 - 2473-4284 Subbiah, Vivek Sen, Shiraj Hess, Kenneth R Janku, Filip Hong, David S Khatua, Soumen Karp, Daniel D Munoz, Javier Falchook, Gerald S Groisberg, Roman Tsimberidou, Apostolia M Sherman, Steven I Hwu, Patrick Meric-Bernstam, Funda Journal Article JCO Precis Oncol. 2018 Sep 13;2:PO.18.00189. doi: 10.1200/PO.18.00189. eCollection 2018. PY - 2018 SN - 2473-4284 ST - Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies T2 - JCO Precis Oncol TI - Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies VL - 2 ID - 834 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan. Wayne State University School of Medicine, Detroit, Michigan. John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii. Department of Radiology, Children's Hospital of Michigan, Detroit, Michigan. Department of Pathology, Children's Hospital of Michigan, Detroit, Michigan. AN - 30251337 AU - Knight, T. AU - Shatara, M. AU - Carvalho, L. AU - Altinok, D. AU - Poulik, J. AU - Wang, Z. J. DA - Jan DO - 10.1002/pbc.27474 DP - NLM ET - 2018/09/27 IS - 1 LA - eng N1 - 1545-5017 Knight, Tristan Orcid: 0000-0002-7828-1522 Shatara, Margaret Carvalho, Lindsey Altinok, Deniz Poulik, Janet Wang, Zhihong Joanne Case Reports Letter United States Pediatr Blood Cancer. 2019 Jan;66(1):e27474. doi: 10.1002/pbc.27474. Epub 2018 Sep 24. PY - 2019 SN - 1545-5009 SP - e27474 ST - Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma T2 - Pediatr Blood Cancer TI - Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma VL - 66 ID - 835 ER - TY - JOUR AD - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona. Anaxomics Biotech, Barcelona. Hematology Department. Hematopathology Unit, Hospital Clinic, Barcelona. Hematology Department, University Hospital- IBSAL, and Institute of Molecular and Cellular Biology of Cancer, University of Salamanca, CIBERONC. Hematology Department, Hospital Clínico Universitario, Valencia. Hematology Department, Hospital Universitario Central de Asturias, Oviedo. Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, CIBERONC, Spain. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona dcolomer@clinic.cat. AN - 30262568 AU - Giménez, N. AU - Martínez-Trillos, A. AU - Montraveta, A. AU - Lopez-Guerra, M. AU - Rosich, L. AU - Nadeu, F. AU - Valero, J. G. AU - Aymerich, M. AU - Magnano, L. AU - Rozman, M. AU - Matutes, E. AU - Delgado, J. AU - Baumann, T. AU - Gine, E. AU - González, M. AU - Alcoceba, M. AU - Terol, M. J. AU - Navarro, B. AU - Colado, E. AU - Payer, A. R. AU - Puente, X. S. AU - López-Otín, C. AU - Lopez-Guillermo, A. AU - Campo, E. AU - Colomer, D. AU - Villamor, N. C2 - PMC6395334 DA - Mar DO - 10.3324/haematol.2018.196931 DP - NLM ET - 2018/09/29 IS - 3 LA - eng N1 - 1592-8721 Giménez, Neus Martínez-Trillos, Alejandra Montraveta, Arnau Lopez-Guerra, Mónica Rosich, Laia Nadeu, Ferran Valero, Juan G Aymerich, Marta Magnano, Laura Rozman, Maria Matutes, Estella Delgado, Julio Baumann, Tycho Gine, Eva González, Marcos Alcoceba, Miguel Terol, M José Navarro, Blanca Colado, Enrique Payer, Angel R Puente, Xose S López-Otín, Carlos Lopez-Guillermo, Armando Campo, Elias Colomer, Dolors Villamor, Neus Journal Article Research Support, Non-U.S. Gov't Haematologica. 2019 Mar;104(3):576-586. doi: 10.3324/haematol.2018.196931. Epub 2018 Sep 27. PY - 2019 SN - 0390-6078 (Print) 0390-6078 SP - 576-586 ST - Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia T2 - Haematologica TI - Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia VL - 104 ID - 836 ER - TY - JOUR AD - Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. AN - 30265855 AU - Maraka, S. AU - Janku, F. DA - Aug DP - NLM ET - 2018/09/29 IS - 141 LA - eng N1 - 1944-7930 Maraka, Stefania Janku, Filip Journal Article Research Support, Non-U.S. Gov't Review United States Discov Med. 2018 Aug;26(141):51-60. PY - 2018 SN - 1539-6509 SP - 51-60 ST - BRAF alterations in primary brain tumors T2 - Discov Med TI - BRAF alterations in primary brain tumors VL - 26 ID - 837 ER - TY - JOUR AD - Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany. Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. NCT Trial Center, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany. Division of Pediatric Neuro-oncology, DKFZ, German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. Division of Applied Bioinformatics, DKFZ, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. Dktk. Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany. National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany. Clinical Cooperation Unit Radiation Oncology, DKFZ, Heidelberg, Germany. Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany. DKFZ, Heidelberg, Germany. Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany. Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany. Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology, DKTK. Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKTK, DKFZ, Heidelberg, Germany. Department of Neurology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. AN - 30277538 AU - Wick, W. AU - Dettmer, S. AU - Berberich, A. AU - Kessler, T. AU - Karapanagiotou-Schenkel, I. AU - Wick, A. AU - Winkler, F. AU - Pfaff, E. AU - Brors, B. AU - Debus, J. AU - Unterberg, A. AU - Bendszus, M. AU - Herold-Mende, C. AU - Eisenmenger, A. AU - von Deimling, A. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Sahm, F. AU - Platten, M. C2 - PMC6303534 DA - Jan 1 DO - 10.1093/neuonc/noy161 DP - NLM ET - 2018/10/03 IS - 1 LA - eng N1 - 1523-5866 Wick, Wolfgang Dettmer, Susan Berberich, Anne Kessler, Tobias Karapanagiotou-Schenkel, Irini Wick, Antje Winkler, Frank Pfaff, Elke Brors, Benedikt Debus, Jürgen Unterberg, Andreas Bendszus, Martin Herold-Mende, Christel Eisenmenger, Andreas von Deimling, Andreas Jones, David T W Pfister, Stefan M Sahm, Felix Platten, Michael Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Neuro Oncol. 2019 Jan 1;21(1):95-105. doi: 10.1093/neuonc/noy161. PY - 2019 SN - 1522-8517 (Print) 1522-8517 SP - 95-105 ST - N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma T2 - Neuro Oncol TI - N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma VL - 21 ID - 838 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Nursing, National Tainan Institute of Nursing, Tainan, Taiwan. Department of Pathology and Laboratory Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, and National Defense Medical Center, Taipei, Taiwan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, School of Medicine, Taipei Medical University and National Taiwan University, Taipei, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw. AN - 30348505 AU - Wang, R. C. AU - Sakata, S. AU - Chen, B. J. AU - Chang, S. T. AU - Hsieh, P. P. AU - Yang, C. S. AU - Baba, S. AU - Takeuchi, K. AU - Chuang, S. S. DA - Dec DO - 10.1016/j.pathol.2018.08.008 DP - NLM ET - 2018/10/24 IS - 7 LA - eng N1 - 1465-3931 Wang, Ren Ching Sakata, Seiji Chen, Bo-Jung Chang, Sheng-Tsung Hsieh, Pin-Pen Yang, Chi-Shun Baba, Satoko Takeuchi, Kengo Chuang, Shih-Sung Journal Article England Pathology. 2018 Dec;50(7):718-724. doi: 10.1016/j.pathol.2018.08.008. Epub 2018 Oct 20. PY - 2018 SN - 0031-3025 SP - 718-724 ST - Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression T2 - Pathology TI - Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression VL - 50 ID - 839 ER - TY - JOUR AD - Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yonakano@ncc.go.jp. Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan. yonakano@ncc.go.jp. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Department of Neurosurgery, National Defense Medical College, Saitama, Japan. Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan. Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan. Department of Pathology, Osaka City General Hospital, Osaka, Japan. Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan. AN - 30350109 AU - Nakano, Y. AU - Tomiyama, A. AU - Kohno, T. AU - Yoshida, A. AU - Yamasaki, K. AU - Ozawa, T. AU - Fukuoka, K. AU - Fukushima, H. AU - Inoue, T. AU - Hara, J. AU - Sakamoto, H. AU - Ichimura, K. DA - Jan DO - 10.1007/s10014-018-0330-3 DP - NLM ET - 2018/10/24 IS - 1 LA - eng N1 - 1861-387x Nakano, Yoshiko Orcid: 0000-0001-5394-8194 Tomiyama, Arata Kohno, Takashi Yoshida, Akihiko Yamasaki, Kai Ozawa, Tatsuya Fukuoka, Kohei Fukushima, Hiroko Inoue, Takeshi Hara, Junichi Sakamoto, Hiroaki Ichimura, Koichi JP17ck0106168/Japan Agency for Medical Research and Development/ Case Reports Journal Article Review Japan Brain Tumor Pathol. 2019 Jan;36(1):14-19. doi: 10.1007/s10014-018-0330-3. Epub 2018 Oct 22. PY - 2019 SN - 1433-7398 SP - 14-19 ST - Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma T2 - Brain Tumor Pathol TI - Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma VL - 36 ID - 840 ER - TY - JOUR AD - Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ki, Tokyo, 104-0045, Japan. tkumamot@ncc.go.jp. Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ki, Tokyo, 104-0045, Japan. Department of Pediatrics, Nippon Medical School, Tokyo, Japan. Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. Department of Pathology, National Cancer Hospital, Tokyo, Japan. AN - 30361829 AU - Kumamoto, T. AU - Aoki, Y. AU - Sonoda, T. AU - Yamanishi, M. AU - Arakawa, A. AU - Sugiyama, M. AU - Shirakawa, N. AU - Ishimaru, S. AU - Saito, Y. AU - Maeshima, A. AU - Maeda, M. AU - Ogawa, C. DA - Feb DO - 10.1007/s12185-018-2553-9 DP - NLM ET - 2018/10/27 IS - 2 LA - eng N1 - 1865-3774 Kumamoto, Tadashi Orcid: 0000-0001-7325-5950 Aoki, Yuki Sonoda, Tomoko Yamanishi, Miho Arakawa, Ayumu Sugiyama, Masanaka Shirakawa, Nami Ishimaru, Sae Saito, Yoshimasa Maeshima, Akiko Maeda, Miho Ogawa, Chitose Case Reports Journal Article Japan Int J Hematol. 2019 Feb;109(2):228-232. doi: 10.1007/s12185-018-2553-9. Epub 2018 Oct 25. PY - 2019 SN - 0925-5710 SP - 228-232 ST - A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib T2 - Int J Hematol TI - A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib VL - 109 ID - 841 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Oncology Institute, Istanbul University. Division of Pediatric Hematology-Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. AN - 30376464 AU - Büyükkapu Bay, S. AU - Kebudi, R. AU - Zülfikar, B. DA - Feb DO - 10.1097/cmr.0000000000000537 DP - NLM ET - 2018/10/31 IS - 1 LA - eng N1 - 1473-5636 Büyükkapu Bay, Sema Kebudi, Rejin Zülfikar, Bülent Case Reports Journal Article England Melanoma Res. 2019 Feb;29(1):99-101. doi: 10.1097/CMR.0000000000000537. PY - 2019 SN - 0960-8931 SP - 99-101 ST - Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency T2 - Melanoma Res TI - Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency VL - 29 ID - 842 ER - TY - JOUR AD - Department of Hematology, West China Hospital of Sichuan University, China. Department of Human Sciences, Texas A&M University-Kingsville, Kingsville, TX 78363, USA. School of Medicine, University of Electronic Science and Technology of China, China. Department of Hematology, West China Hospital of Sichuan University, China. Electronic address: gongyuping@hotmail.com. AN - 30389549 AU - Guo, Y. AU - Li, Y. AU - Wang, F. F. AU - Xiang, B. AU - Huang, X. O. AU - Ma, H. B. AU - Gong, Y. P. DA - Jan DO - 10.1016/j.biocel.2018.10.008 DP - NLM ET - 2018/11/06 LA - eng N1 - 1878-5875 Guo, Yong Li, Yi Wang, Fang-Fang Xiang, Bing Huang, Xiao-Ou Ma, Hong-Bing Gong, Yu-Ping Journal Article Research Support, Non-U.S. Gov't Netherlands Int J Biochem Cell Biol. 2019 Jan;106:8-20. doi: 10.1016/j.biocel.2018.10.008. Epub 2018 Oct 30. PY - 2019 SN - 1357-2725 SP - 8-20 ST - The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway T2 - Int J Biochem Cell Biol TI - The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway VL - 106 ID - 843 ER - TY - JOUR AD - Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. Department of Medicine, Institute Gustave Roussy, Villejuif, France. Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. Department of Oncology, McGill University, Montreal, Quebec, Canada. Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. Department of Dermatology, University Hospital Cologne, Cologne, Germany. Division of Oncology, Regina Elena Institute, Rome, Italy. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Department of Dermatology, University Hospital Essen, Essen, Germany. German Cancer Consortium, Heidelberg, Germany. First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. AN - 30422243 AU - Ascierto, P. A. AU - Long, G. V. AU - Robert, C. AU - Brady, B. AU - Dutriaux, C. AU - Di Giacomo, A. M. AU - Mortier, L. AU - Hassel, J. C. AU - Rutkowski, P. AU - McNeil, C. AU - Kalinka-Warzocha, E. AU - Savage, K. J. AU - Hernberg, M. M. AU - Lebbé, C. AU - Charles, J. AU - Mihalcioiu, C. AU - Chiarion-Sileni, V. AU - Mauch, C. AU - Cognetti, F. AU - Ny, L. AU - Arance, A. AU - Svane, I. M. AU - Schadendorf, D. AU - Gogas, H. AU - Saci, A. AU - Jiang, J. AU - Rizzo, J. AU - Atkinson, V. C2 - PMC6439558 role with Bristol-Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Amgen, Array, Merck, Pierre-Fabre, Incyte, Genmab, Newlink Genetics, MedImmune, Syndax, and AstraZeneca and reported receiving institutional research funding from Bristol-Myers Squibb, Roche-Genentech, and Array. Dr Long reported receiving honoraria from Merck MSD, Roche, and Bristol-Myers Squibb and reported having a paid consulting role with Merck MSD, Roche, Bristol-Myers Squibb, Amgen, Novartis, and Pierre-Fabre. Dr Robert reported having a paid consulting role with Bristol-Myers Squibb, Merck, Roche, and Amgen and reported receiving honoraria from Bristol-Myers Squibb, Merck, GlaxoSmithKline, Roche, Novartis, and Amgen. Dr Brady reported being paid to participate in speakers’ bureaus for Bristol-Myers Squibb and Merck; reported having a paid consulting role with Merck and Novartis; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb. Dr Di Giacomo reported receiving honoraria from Bristol-Myers Squibb, Roche, and Merck Sharp & Dohme and reported being a consultant for Incyte, Pierre-Fabre, and GlaxoSmithKline. Dr Mortier reported receiving clinical trials funding from Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, and Roche and reported participating on an advisory board for Bristol-Myers Squibb. Dr Hassel reported having a paid consulting role with Merck and Amgen and reported receiving honoraria from Bristol-Myers Squibb, Merck, Novartis, Roche, and Pfizer. Dr Rutkowski reported receiving honoraria from Bristol-Myers Squibb, Roche, Novartis, Merck Sharp & Dohme, and GlaxoSmithKline; reported having a paid consulting role with Bristol-Myers Squibb, Roche, Merck Sharp & Dohme, and Amgen; reported being paid to participate in speakers’ bureaus for Novartis and Merck Sharp & Dohme; reported receiving institutional research funding from Bristol-Myers Squibb; and reported having travel or other expenses paid or reimbursed by Novartis. Dr McNeil and members of her department reported having travel or other expenses paid or reimbursed by Merck Sharp & Dohme and Bristol-Myers Squibb; reported participating on advisory boards for Bristol-Myers Squibb and Merck Sharp & Dohme; and reported receiving research funding from Merck Sharp & Dohme for her institution. Dr Kalinka-Warzocha reported receiving payments for trial procedures according to study protocol from Bristol-Myers Squibb; reported receiving honoraria from Bristol-Myers Squibb, Roche, Novartis, Merck Sharp & Dohme, and AstraZeneca; and reported having a paid consultant role with Bristol-Myers Squibb, Merck Sharp & Dohme, and AstraZeneca. Dr Savage reported receiving honoraria from Seattle Genetics, Bristol-Myers Squibb, Celgene, and Takeda; reported having a paid consulting role with Seattle Genetics, Merck, and Bristol-Myers Squibb; reported being paid to participate in a speakers’ bureau for Seattle Genetics; and reported receiving research funding from Roche. Dr Lebbé reported participating on advisory boards for Bristol-Myers Squibb, Merck Sharp & Dohme, Roche, GlaxoSmithKline, and Novartis and reported receiving travel expenses from Bristol-Myers Squibb and Merck Sharp & Dohme. Dr Mihalcioiu reporting having a paid consulting role with Bristol-Myers Squibb, Novartis, and Merck and reported having an issued US patent on circulatory cells. Dr Chiarion-Sileni reported having a paid consulting role with Bristol-Myers Squibb, Roche, GlaxoSmithKline, and Merck Sharp & Dohme; reported being paid to participate in a speakers’ bureau for Bristol-Myers Squibb, Roche, and GlaxoSmithKline; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb, Roche, GlaxoSmithKline, and Merck Sharp & Dohme. Dr Cognetti reported participating on an advisory board for Astellas Oncology. Dr Ny reported receiving clinical institutional funding from Merck Sharpe & Dohme and Syndax; reported receiving payment for participating in advisory boards with Bristol-Myers Squibb and Novartis; and reported having a consulting role with Bristol-Myers Squibb and AstraZeneca. Dr Arance reported having a paid consulting role with GlaxoSmithKline and Roche; reported being paid to participate in speakers’ bureaus for GlaxoSmithKline, Roche, and Bristol-Myers Squibb; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb. Dr Svane reported receiving honoraria from Bristol-Myers Squibb, Merck, and Roche; reported receiving clinical research funding from Bristol-Myers Squibb, Novartis, and Roche; and reported receiving payment for participation in scientific advisory boards from Bristol-Myers Squibb, GlaxoSmithKline, and Roche. Dr Schadendorf reported receiving honoraria from Merck Sharp & Dohme, Roche, Amgen, Novartis, and Bristol-Myers Squibb; reported having paid consulting roles and being a member of speakers’ bureaus with Merck Sharp & Dohme, Roche, Amgen, Novartis, Bristol-Myers Squibb, Pierre-Fabre, and Merck-Serono; reported having a paid consultant role with Incyte; and reported receiving research funding from Merck Sharp & Dohme and Bristol-Myers Squibb. Dr Gogas reported receiving personal fees from GlaxoSmithKline, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, and Amgen. Drs Saci, Jiang, and Rizzo reported being employed by Bristol-Myers Squibb. Dr Atkinson reported receiving honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; reported having a paid consulting role with Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; reported being paid to participate in speakers’ bureaus for Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis. No other disclosures were reported. DA - Feb 1 DO - 10.1001/jamaoncol.2018.4514 DP - NLM ET - 2018/11/14 IS - 2 LA - eng N1 - 2374-2445 Ascierto, Paolo A Long, Georgina V Robert, Caroline Brady, Benjamin Dutriaux, Caroline Di Giacomo, Anna Maria Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela M Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Cognetti, Francesco Ny, Lars Arance, Ana Svane, Inge Marie Schadendorf, Dirk Gogas, Helen Saci, Abdel Jiang, Joel Rizzo, Jasmine Atkinson, Victoria Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't JAMA Oncol. 2019 Feb 1;5(2):187-194. doi: 10.1001/jamaoncol.2018.4514. PY - 2019 SN - 2374-2437 (Print) 2374-2437 SP - 187-194 ST - Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial T2 - JAMA Oncol TI - Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial VL - 5 ID - 844 ER - TY - JOUR AD - Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy. Center for Life Nano Science at Sapienza, Italian Institute of Technology, 00161 Rome, Italy. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy. Department of Biochemical Sciences 'A. Rossi Fanelli', Sapienza University of Rome, 00161 Rome, Italy. Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. AN - 30483764 AU - Antonucci, L. AU - Di Magno, L. AU - D'Amico, D. AU - Manni, S. AU - Serrao, S. M. AU - Di Pastena, F. AU - Bordone, R. AU - Yurtsever, Z. N. AU - Caimano, M. AU - Petroni, M. AU - Giorgi, A. AU - Schininà, M. E. AU - Yates Iii, J. R. AU - Di Marcotullio, L. AU - De Smaele, E. AU - Checquolo, S. AU - Capalbo, C. AU - Agostinelli, E. AU - Maroder, M. AU - Coni, S. AU - Canettieri, G. C2 - PMC6317670 DA - Feb DO - 10.3892/ijo.2018.4638 DP - NLM ET - 2018/11/30 IS - 2 LA - eng N1 - 1791-2423 Antonucci, Laura Di Magno, Laura D'Amico, Davide Manni, Simona Serrao, Silvia Maria Di Pastena, Fiorella Bordone, Rosa Yurtsever, Zuleyha Nihan Caimano, Miriam Petroni, Marialaura Giorgi, Alessandra Schininà, Maria Eugenia Yates Iii, John R Di Marcotullio, Lucia De Smaele, Enrico Checquolo, Saula Capalbo, Carlo Agostinelli, Enzo Maroder, Marella Coni, Sonia Canettieri, Gianluca Journal Article Int J Oncol. 2019 Feb;54(2):505-514. doi: 10.3892/ijo.2018.4638. Epub 2018 Nov 19. PY - 2019 SN - 1019-6439 (Print) 1019-6439 SP - 505-514 ST - Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation T2 - Int J Oncol TI - Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation VL - 54 ID - 845 ER - TY - JOUR AD - Graduate School of Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: agemma@nms.ac.jp. National Cancer Center Hospital East, Kashiwa, Japan. St. Luke's International Hospital, Tokyo, Japan. Izumi Municipal Hospital, Osaka, Japan. Pfizer Japan Inc., Tokyo, Japan. Tokyo Medical University Hospital, Tokyo, Japan. AN - 30521972 AU - Gemma, A. AU - Kusumoto, M. AU - Kurihara, Y. AU - Masuda, N. AU - Banno, S. AU - Endo, Y. AU - Houzawa, H. AU - Ueno, N. AU - Ohki, E. AU - Yoshimura, A. DA - Apr DO - 10.1016/j.jtho.2018.11.022 DP - NLM ET - 2018/12/07 IS - 4 LA - eng N1 - 1556-1380 Gemma, Akihiko Kusumoto, Masahiko Kurihara, Yasuyuki Masuda, Noriyuki Banno, Shigeo Endo, Yutaka Houzawa, Hiroyuki Ueno, Naomi Ohki, Emiko Yoshimura, Akinobu Journal Article Research Support, Non-U.S. Gov't United States J Thorac Oncol. 2019 Apr;14(4):672-682. doi: 10.1016/j.jtho.2018.11.022. Epub 2018 Dec 3. PY - 2019 SN - 1556-0864 SP - 672-682 ST - Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib T2 - J Thorac Oncol TI - Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib VL - 14 ID - 846 ER - TY - JOUR AD - University of Cincinnati. Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Harvard Medical School. Broad Institute of MIT and Harvard, Boston, Massachusetts. Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital. Division of Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta. Emory University School of Medicine, Atlanta, Georgia, USA. AN - 30531227 AU - de Blank, P. AU - Bandopadhayay, P. AU - Haas-Kogan, D. AU - Fouladi, M. AU - Fangusaro, J. C2 - PMC6664811 C6 - NIHMS1037092 DA - Feb DO - 10.1097/mop.0000000000000717 DP - NLM ET - 2018/12/12 IS - 1 LA - eng N1 - 1531-698x de Blank, Peter Bandopadhayay, Pratiti Haas-Kogan, Daphne Fouladi, Maryam Fangusaro, Jason R01 NS091620/NS/NINDS NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Curr Opin Pediatr. 2019 Feb;31(1):21-27. doi: 10.1097/MOP.0000000000000717. PY - 2019 SN - 1040-8703 (Print) 1040-8703 SP - 21-27 ST - Management of pediatric low-grade glioma T2 - Curr Opin Pediatr TI - Management of pediatric low-grade glioma VL - 31 ID - 847 ER - TY - JOUR AD - Department of Pathology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. m.lastowska@ipczd.pl. Department of Experimental and Clinical Pathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, A. Pawińskiego 5 Street, 02-106, Warsaw, Poland. m.lastowska@ipczd.pl. Department of Pathology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. Clinic of Oncology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. Department of Experimental and Clinical Pathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, A. Pawińskiego 5 Street, 02-106, Warsaw, Poland. AN - 30523493 AU - Łastowska, M. AU - Trubicka, J. AU - Karkucińska-Więckowska, A. AU - Kaleta, M. AU - Tarasińska, M. AU - Perek-Polnik, M. AU - Sobocińska, A. A. AU - Dembowska-Bagińska, B. AU - Grajkowska, W. AU - Matyja, E. C2 - PMC6514113 DA - Jan DO - 10.1007/s10014-018-0331-2 DP - NLM ET - 2018/12/14 IS - 1 LA - eng N1 - 1861-387x Łastowska, Maria Orcid: 0000-0003-0632-6995 Trubicka, Joanna Karkucińska-Więckowska, Agnieszka Kaleta, Magdalena Tarasińska, Magdalena Perek-Polnik, Marta Sobocińska, Anna Antonina Dembowska-Bagińska, Bożenna Grajkowska, Wiesława Matyja, Ewa 2016/21/B/NZ2/01785/Narodowe Centrum Nauki/ 2016/23/B/NZ2/03064/Narodowe Centrum Nauki/ Journal Article Brain Tumor Pathol. 2019 Jan;36(1):1-6. doi: 10.1007/s10014-018-0331-2. Epub 2018 Dec 6. PY - 2019 SN - 1433-7398 (Print) 1433-7398 SP - 1-6 ST - Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors T2 - Brain Tumor Pathol TI - Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors VL - 36 ID - 848 ER - TY - JOUR AD - Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt, 34116 Istanbul, Turkey. Electronic address: ezgi.oztas@istanbul.edu.tr. Karadeniz Technical University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 61000 Trabzo, Turkey. Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt, 34116 Istanbul, Turkey. AN - 30550854 AU - Oztas, E. AU - Abudayyak, M. AU - Celiksoz, M. AU - Özhan, G. DA - Mar DO - 10.1016/j.tiv.2018.12.005 DP - NLM ET - 2018/12/15 LA - eng N1 - 1879-3177 Oztas, Ezgi Abudayyak, Mahmoud Celiksoz, Muzeyyen Özhan, Gül Journal Article England Toxicol In Vitro. 2019 Mar;55:101-107. doi: 10.1016/j.tiv.2018.12.005. Epub 2018 Dec 12. PY - 2019 SN - 0887-2333 SP - 101-107 ST - Inflammation and oxidative stress are key mediators in AKB48-induced neurotoxicity in vitro T2 - Toxicol In Vitro TI - Inflammation and oxidative stress are key mediators in AKB48-induced neurotoxicity in vitro VL - 55 ID - 849 ER - TY - JOUR AD - Department of Pediatric Internal Medicine, Cangzhou Central Hospital, Xihuan Middle Street, Yunhe District, Cangzhou city, Hebei Province 061000, China. Electronic address: ZhaoQiuJu_zqj083@163.com. The Orthopedics Department, Cangzhou People's Hospital, No. 7 Qingchi Road, Xinhua District, Cangzhou city, Heibei Province 061500, China. Department of Pediatric Internal Medicine, Cangzhou Central Hospital, Xihuan Middle Street, Yunhe District, Cangzhou city, Hebei Province 061000, China. AN - 30551418 AU - Zhao, Q. AU - Zhao, S. AU - Li, J. AU - Zhang, H. AU - Qian, C. AU - Wang, H. AU - Liu, J. AU - Zhao, Y. DA - Jan DO - 10.1016/j.biopha.2018.10.046 DP - NLM ET - 2018/12/16 LA - eng N1 - 1950-6007 Zhao, Qiuju Zhao, Shihao Li, Jinling Zhang, Huiwu Qian, Cheng Wang, He Liu, Jianjun Zhao, Yuqi Journal Article France Biomed Pharmacother. 2019 Jan;109:1640-1649. doi: 10.1016/j.biopha.2018.10.046. Epub 2018 Nov 16. PY - 2019 SN - 0753-3322 SP - 1640-1649 ST - TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway T2 - Biomed Pharmacother TI - TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway VL - 109 ID - 850 ER - TY - JOUR AD - Division of Pediatric Dermatology, Department of Dermatology, Stanford University School of Medicine, Stanford, California. Section of Dermatology, Division of Ambulatory and Adolescent Medicine, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Department of Genetics, Yale School of Medicine, New Haven, Connecticut. AN - 30566190 AU - Lekwuttikarn, R. AU - Lim, Y. H. AU - Admani, S. AU - Choate, K. A. AU - Teng, J. M. C. C2 - PMC7186908 C6 - NIHMS1558774 DA - Feb 1 DO - 10.1001/jamadermatol.2018.4653 DP - NLM ET - 2018/12/20 IS - 2 LA - eng N1 - 2168-6084 Lekwuttikarn, Ramrada Lim, Young H Admani, Shehla Choate, Keith A Teng, Joyce M C R01 AR071491/AR/NIAMS NIH HHS/United States T32 GM007205/GM/NIGMS NIH HHS/United States Case Reports Journal Article Research Support, N.I.H., Extramural JAMA Dermatol. 2019 Feb 1;155(2):256-257. doi: 10.1001/jamadermatol.2018.4653. PY - 2019 SN - 2168-6068 (Print) 2168-6068 SP - 256-257 ST - Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child T2 - JAMA Dermatol TI - Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child VL - 155 ID - 851 ER - TY - JOUR AD - Division of Hematology, Department of Medicine, University of Washington School of Medicine, 617 Eastlake Ave. East, P.O. Box CE3-300, Seattle, WA, 98109, USA. ashustov@uw.edu. Department of Laboratory Medicine, University of Washington School of Medicine, 825 Eastlake Ave. East, P.O. Box G7-800, Seattle, WA, 98109, USA. AN - 30596216 AU - Shustov, A. AU - Soma, L. DO - 10.1007/978-3-319-99716-2_6 DP - NLM ET - 2019/01/01 LA - eng N1 - Shustov, Andrei Soma, Lorinda Journal Article Review United States Cancer Treat Res. 2019;176:127-144. doi: 10.1007/978-3-319-99716-2_6. PY - 2019 SN - 0927-3042 (Print) 0927-3042 SP - 127-144 ST - Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management T2 - Cancer Treat Res TI - Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management VL - 176 ID - 852 ER - TY - JOUR AD - Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand. dru@adis.com. AN - 30604291 AU - Syed, Y. Y. DA - Jan DO - 10.1007/s40265-018-1041-0 DP - NLM ET - 2019/01/04 IS - 1 LA - eng N1 - 1179-1950 Syed, Yahiya Y Journal Article Review New Zealand Drugs. 2019 Jan;79(1):93-98. doi: 10.1007/s40265-018-1041-0. PY - 2019 SN - 0012-6667 SP - 93-98 ST - Lorlatinib: First Global Approval T2 - Drugs TI - Lorlatinib: First Global Approval VL - 79 ID - 853 ER - TY - JOUR AD - Department of Pediatric Surgery, Fujita Medical University, Toyoake, Japan - watanabe@fujita-hu.ac.jp. Department of Pediatric Surgery, Fujita Medical University, Toyoake, Japan. AN - 30605998 AU - Watanabe, S. AU - Suzuki, T. AU - Kondo, Y. AU - Naoe, A. AU - Uga, N. AU - Yasui, T. AU - Hara, F. AU - Tsuchiya, T. DA - Jan 2 DO - 10.23736/s0026-4946.18.05444-0 DP - NLM ET - 2019/01/05 LA - eng N1 - 1827-1715 Watanabe, Shunsuke Suzuki, Tatsuya Kondo, Yasuhiro Naoe, Atsuki Uga, Naoko Yasui, Toshihiro Hara, Fujio Tsuchiya, Tomonori Journal Article Italy Minerva Pediatr. 2019 Jan 2. doi: 10.23736/S0026-4946.18.05444-0. PY - 2019 SN - 0026-4946 ST - Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with vascular endothelial growth factor and platelet-derived growth factor receptor T2 - Minerva Pediatr TI - Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with vascular endothelial growth factor and platelet-derived growth factor receptor ID - 854 ER - TY - JOUR AD - Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. OrigiMed, Shanghai, China. Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address: cairuijun20@163.com. AN - 30642440 AU - Mai, S. AU - Xiong, G. AU - Diao, D. AU - Wang, W. AU - Zhou, Y. AU - Cai, R. DA - Feb DO - 10.1016/j.lungcan.2018.12.016 DP - NLM ET - 2019/01/16 LA - eng N1 - 1872-8332 Mai, Shijie Xiong, Gang Diao, Dingwei Wang, Wenjing Zhou, Yujie Cai, Ruijun Case Reports Journal Article Ireland Lung Cancer. 2019 Feb;128:101-104. doi: 10.1016/j.lungcan.2018.12.016. Epub 2018 Dec 17. PY - 2019 SN - 0169-5002 SP - 101-104 ST - Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor T2 - Lung Cancer TI - Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor VL - 128 ID - 855 ER - TY - JOUR AD - Department of Ophthalmology, The First People's Hospital of Shangqiu, Shangqiu, Henan 476100, P.R. China. Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China. AN - 30664191 AU - Guo, L. AU - Bai, Y. AU - Ji, S. AU - Ma, H. C2 - PMC6365030 DA - Mar DO - 10.3892/ijo.2019.4689 DP - NLM ET - 2019/01/22 IS - 3 LA - eng N1 - 1791-2423 Guo, Long Bai, Yu Ji, Shuzhe Ma, Hong Journal Article Int J Oncol. 2019 Mar;54(3):807-820. doi: 10.3892/ijo.2019.4689. Epub 2019 Jan 17. PY - 2019 SN - 1019-6439 (Print) 1019-6439 SP - 807-820 ST - MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway T2 - Int J Oncol TI - MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway VL - 54 ID - 856 ER - TY - JOUR AD - Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei 10002, Taiwan. Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei , 10002, Taiwan. AN - 30664316 AU - Huang, Y. L. AU - Chang, Y. L. AU - Chen, K. C. AU - Wu, C. T. DA - Feb DO - 10.1111/pin.12747 DP - NLM ET - 2019/01/22 IS - 2 LA - eng N1 - 1440-1827 Huang, Yen-Lin Chang, Yih-Leong Chen, Ke-Cheng Wu, Chen-Tu Case Reports Journal Article Australia Pathol Int. 2019 Feb;69(2):104-109. doi: 10.1111/pin.12747. Epub 2019 Jan 21. PY - 2019 SN - 1320-5463 SP - 104-109 ST - Mixed squamous cell and glandular papilloma of the lung: A case report of a novel mutation in the BRAF gene and coexistent HPV infection, possible relationship to ciliated muconodular papillary tumor T2 - Pathol Int TI - Mixed squamous cell and glandular papilloma of the lung: A case report of a novel mutation in the BRAF gene and coexistent HPV infection, possible relationship to ciliated muconodular papillary tumor VL - 69 ID - 857 ER - TY - JOUR AD - Division of Haematology/Oncology. Division of Endocrinology, The Hospital for Sick Children. Divison of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. AN - 30676433 AU - Egan, G. AU - Hamilton, J. AU - McKeown, T. AU - Bouffet, E. AU - Tabori, U. AU - Dirks, P. AU - Bartels, U. DA - May DO - 10.1097/mph.0000000000001427 DP - NLM ET - 2019/01/25 IS - 4 LA - eng N1 - 1536-3678 Egan, Grace Hamilton, Jill McKeown, Tara Bouffet, Eric Tabori, Uri Dirks, Peter Bartels, Ute Case Reports Journal Article United States J Pediatr Hematol Oncol. 2020 May;42(4):e248-e250. doi: 10.1097/MPH.0000000000001427. PY - 2020 SN - 1077-4114 SP - e248-e250 ST - Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings? T2 - J Pediatr Hematol Oncol TI - Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings? VL - 42 ID - 858 ER - TY - JOUR AD - Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, UK. European Research Initiative for ALK-related malignancies (www.erialcl.net), Cambridge, UK. Department of paediatric oncology, Addenbrooke's Hospital, Cambridge, UK. Division of Pediatric Hematology-Oncology, Children's Hospital of the Kings Daughter, Norfolk, Virginia, USA. AN - 30681723 AU - Larose, H. AU - Burke, G. A. A. AU - Lowe, E. J. AU - Turner, S. D. DA - Jun DO - 10.1111/bjh.15763 DP - NLM ET - 2019/01/27 IS - 6 LA - eng N1 - 1365-2141 Larose, Hugo Burke, G A Amos Lowe, Eric J Turner, Suzanne D Orcid: 0000-0002-8439-4507 Journal Article Research Support, Non-U.S. Gov't Review England Br J Haematol. 2019 Jun;185(6):1043-1054. doi: 10.1111/bjh.15763. Epub 2019 Jan 25. PY - 2019 SN - 0007-1048 SP - 1043-1054 ST - From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK T2 - Br J Haematol TI - From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK VL - 185 ID - 859 ER - TY - JOUR AD - Prinses Maxima Centrum, Center for Pediatric Oncology, Utrecht, the Netherlands. Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. AN - 30697903 AU - Brivio, E. AU - Zwaan, C. M. DA - May DO - 10.1002/pbc.27645 DP - NLM ET - 2019/01/31 IS - 5 LA - eng N1 - 1545-5017 Brivio, Erica Orcid: 0000-0001-5285-1702 Zwaan, C Michel Case Reports Journal Article United States Pediatr Blood Cancer. 2019 May;66(5):e27645. doi: 10.1002/pbc.27645. Epub 2019 Jan 29. PY - 2019 SN - 1545-5009 SP - e27645 ST - ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects T2 - Pediatr Blood Cancer TI - ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects VL - 66 ID - 860 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, University at Buffalo, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Department of Paediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France. AN - 30701541 AU - Barth, M. J. AU - Minard-Colin, V. DA - Jun DO - 10.1111/bjh.15783 DP - NLM ET - 2019/02/01 IS - 6 LA - eng N1 - 1365-2141 Barth, Matthew J Orcid: 0000-0001-5263-9509 Minard-Colin, Veronique Journal Article Review England Br J Haematol. 2019 Jun;185(6):1111-1124. doi: 10.1111/bjh.15783. Epub 2019 Jan 30. PY - 2019 SN - 0007-1048 SP - 1111-1124 ST - Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma T2 - Br J Haematol TI - Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma VL - 185 ID - 861 ER - TY - JOUR AD - Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: Andrew.colebatch@health.nsw.gov.au. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Queensland Institute of Medical Research, Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia; School of Cancer Medicine and Molecular Cancer Prevention Program, La Trobe University, Bundoora, Victoria, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Department of Melanoma and Surgical Oncology, Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. AN - 30772300 AU - Colebatch, A. J. AU - Ferguson, P. AU - Newell, F. AU - Kazakoff, S. H. AU - Witkowski, T. AU - Dobrovic, A. AU - Johansson, P. A. AU - Saw, R. P. M. AU - Stretch, J. R. AU - McArthur, G. A. AU - Long, G. V. AU - Thompson, J. F. AU - Pearson, J. V. AU - Mann, G. J. AU - Hayward, N. K. AU - Waddell, N. AU - Scolyer, R. A. AU - Wilmott, J. S. DA - Aug DO - 10.1016/j.jid.2018.12.033 DP - NLM ET - 2019/02/18 IS - 8 LA - eng N1 - 1523-1747 Colebatch, Andrew J Ferguson, Peter Newell, Felicity Kazakoff, Stephen H Witkowski, Tom Dobrovic, Alexander Johansson, Peter A Saw, Robyn P M Stretch, Jonathan R McArthur, Grant A Long, Georgina V Thompson, John F Pearson, John V Mann, Graham J Hayward, Nicholas K Waddell, Nicola Scolyer, Richard A Wilmott, James S Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2019 Aug;139(8):1762-1768. doi: 10.1016/j.jid.2018.12.033. Epub 2019 Feb 14. PY - 2019 SN - 0022-202x SP - 1762-1768 ST - Molecular Genomic Profiling of Melanocytic Nevi T2 - J Invest Dermatol TI - Molecular Genomic Profiling of Melanocytic Nevi VL - 139 ID - 862 ER - TY - JOUR AD - a Department of Oncology, Tongji Hospital, Tongji Medical College , Huazhong University of Science and Technology , Wuhan , China. b Biological Sciences, Faculty of Environmental and Life Sciences , University of Southampton , Southampton , UK. c Institute for Life Sciences , University of Southampton , Southampton , UK. d Ludwig Institute for Cancer Research Ltd., Nuffield Department of Clinical Medicine , University of Oxford , Oxford , UK. e Rutgers Cancer Institute of New Jersey , New Brunswick , NJ , USA. f Oncogene Biology Laboratory , The Francis Crick Institute , London , UK. g Centre for Pathology , St Mary's Hospital, Imperial College London , London , UK. AN - 30782064 AU - Wang, Y. AU - Xiong, H. AU - Liu, D. AU - Hill, C. AU - Ertay, A. AU - Li, J. AU - Zou, Y. AU - Miller, P. AU - White, E. AU - Downward, J. AU - Goldin, R. D. AU - Yuan, X. AU - Lu, X. C2 - PMC6517269 C6 - EMS80343 DA - May DO - 10.1080/15548627.2019.1569912 DP - NLM ET - 2019/02/21 IS - 5 LA - eng N1 - 1554-8635 Wang, Yihua Orcid: 0000-0001-5561-0648 Xiong, Hua Liu, Dian Hill, Charlotte Ertay, Ayse Li, Juanjuan Zou, Yanmei Miller, Paul Orcid: 0000-0002-5800-1220 White, Eileen Downward, Julian Orcid: 0000-0002-2331-4729 Goldin, Robert D Orcid: 0000-0001-5184-4519 Yuan, Xianglin Lu, Xin Orcid: 0000-0002-6587-1152 SBF002\1038/AMS_/Academy of Medical Sciences/United Kingdom FC001070/WT_/Wellcome Trust/United Kingdom R01 CA163591/CA/NCI NIH HHS/United States FC001070/CRUK_/Cancer Research UK/United Kingdom FC001070/MRC_/Medical Research Council/United Kingdom Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Autophagy. 2019 May;15(5):886-899. doi: 10.1080/15548627.2019.1569912. Epub 2019 Feb 20. PY - 2019 SN - 1554-8627 (Print) 1554-8627 SP - 886-899 ST - Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells T2 - Autophagy TI - Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells VL - 15 ID - 863 ER - TY - JOUR AD - Department of Pediatrics, Massachusetts General Hospital, Massachusetts, Boston. Dermatology Program, Boston Children's Hospital, Boston, Massachusetts. Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer Center and Blood Disorder Center, Boston, Massachusetts. AN - 30821092 AU - Song, H. AU - Zhong, C. S. AU - Kieran, M. W. AU - Chi, S. N. AU - Wright, K. D. AU - Huang, J. T. DA - Jun DO - 10.1002/pbc.27682 DP - NLM ET - 2019/03/02 IS - 6 LA - eng N1 - 1545-5017 Song, Hannah Orcid: 0000-0002-9999-4943 Zhong, Connie S Kieran, Mark W Chi, Susan N Wright, Karen D Huang, Jennifer T Journal Article United States Pediatr Blood Cancer. 2019 Jun;66(6):e27682. doi: 10.1002/pbc.27682. Epub 2019 Feb 28. PY - 2019 SN - 1545-5009 SP - e27682 ST - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study T2 - Pediatr Blood Cancer TI - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study VL - 66 ID - 864 ER - TY - JOUR AD - Department of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan. nozomim@gunma-u.ac.jp. Department of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan. Department of Pathology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan. Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan. Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Niigata, Japan. Department of Neurosurgery, Nishi-Niigata Chuo National Hospital, Niigata, Niigata, Japan. Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan. Department of Epileptology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Aichi, Japan. Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan. Department of Neurosurgery, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan. Department of Pathology, Hidaka Hospital, Takasaki, Gunma, Japan. Department of Diagnostic Pathology, Gunma University Hospital, Maebashi, Gunma, Japan. AN - 30825062 AU - Matsumura, N. AU - Nobusawa, S. AU - Ito, J. AU - Kakita, A. AU - Suzuki, H. AU - Fujii, Y. AU - Fukuda, M. AU - Iwasaki, M. AU - Nakasato, N. AU - Tominaga, T. AU - Natsume, A. AU - Mikami, Y. AU - Shinojima, N. AU - Yamazaki, T. AU - Nakazato, Y. AU - Hirato, J. AU - Yokoo, H. DA - May DO - 10.1007/s11060-019-03138-7 DP - NLM ET - 2019/03/03 IS - 1 LA - eng N1 - 1573-7373 Matsumura, Nozomi Orcid: 0000-0001-6592-6582 Nobusawa, Sumihito Ito, Junko Kakita, Akiyoshi Suzuki, Hiroyoshi Fujii, Yukihiko Fukuda, Masafumi Iwasaki, Masaki Nakasato, Nobukazu Tominaga, Teiji Natsume, Atsushi Mikami, Yoshiki Shinojima, Naoki Yamazaki, Tatsuya Nakazato, Yoichi Hirato, Junko Yokoo, Hideaki Journal Article United States J Neurooncol. 2019 May;143(1):27-33. doi: 10.1007/s11060-019-03138-7. Epub 2019 Mar 1. PY - 2019 SN - 0167-594x SP - 27-33 ST - Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors T2 - J Neurooncol TI - Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors VL - 143 ID - 865 ER - TY - JOUR AD - Children's Hospital of Nanjing Medical University Jiangsu China. Department of Musculoskeletal Tumor Shanghai Cancer Center Fudan University Shanghai China. AN - 30868057 AU - Xie, G. AU - Wu, H. AU - Cai, W. AU - Chen, M. AU - Huang, W. AU - Yan, W. AU - Chang, Y. C2 - PMC6396142 DA - Mar DO - 10.1002/2211-5463.12586 DP - NLM ET - 2019/03/15 IS - 3 LA - eng N1 - 2211-5463 Xie, Guojin Wu, Haiyan Cai, Weiluo Chen, Mo Huang, Wending Yan, Wangjun Chang, Yong Journal Article Research Support, Non-U.S. Gov't FEBS Open Bio. 2019 Jan 28;9(3):490-497. doi: 10.1002/2211-5463.12586. eCollection 2019 Mar. PY - 2019 SN - 2211-5463 (Print) 2211-5463 SP - 490-497 ST - RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway T2 - FEBS Open Bio TI - RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway VL - 9 ID - 866 ER - TY - JOUR AD - Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Laboratory of Cancer Biology, Institute of Clinical Science, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Radiotherapy, The Second People's Hospital of Anhui Province, Hefei, Anhui, China. Department of Medical Oncology, Xiasha Branch of Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Respiratory Medicine, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Electronic address: panhongming@zju.edu.cn. Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China; Laboratory of Cancer Biology, Institute of Clinical Science, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Electronic address: hanwd@zju.edu.cn. AN - 30879923 AU - Liu, Z. AU - Jiang, L. AU - Li, Y. AU - Xie, B. AU - Xie, J. AU - Wang, Z. AU - Zhou, X. AU - Jiang, H. AU - Fang, Y. AU - Pan, H. AU - Han, W. C2 - PMC6491942 DA - Apr DO - 10.1016/j.ebiom.2019.03.019 DP - NLM ET - 2019/03/19 LA - eng N1 - 2352-3964 Liu, Zhen Jiang, Liming Li, Yiran Xie, Binbin Xie, Jiansheng Wang, Zhanggui Zhou, Xiaoyun Jiang, Hanliang Fang, Yong Pan, Hongming Han, Weidong Journal Article EBioMedicine. 2019 Apr;42:326-339. doi: 10.1016/j.ebiom.2019.03.019. Epub 2019 Mar 15. PY - 2019 SN - 2352-3964 SP - 326-339 ST - Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway T2 - EBioMedicine TI - Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway VL - 42 ID - 867 ER - TY - JOUR AD - Division of Medical Oncology, University of Colorado, Denver, Colorado. Medical University of Gdańsk, Gdańsk, Poland. Lausanne University Hospital, Lausanne, Switzerland. State Key Laboratory of South China, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. F. Hoffmann-La Roche Ltd, Basel, Switzerland. University of Michigan, Ann Arbor, Michigan. University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. Royal North Shore Hospital, Sydney University, Sydney, Australia. European Institute of Oncology, Scientific Institute for Research and Healthcare, Milan, Italy. Severence Hospital, Seoul, Republic of Korea. Sun Yet-sen University Cancer Center, Guangdong, People's Republic of China. Grenoble University Hospital Center, La Tronche, France. Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: Ashaw1@partners.org. AN - 30902613 AU - Camidge, D. R. AU - Dziadziuszko, R. AU - Peters, S. AU - Mok, T. AU - Noe, J. AU - Nowicka, M. AU - Gadgeel, S. M. AU - Cheema, P. AU - Pavlakis, N. AU - de Marinis, F. AU - Cho, B. C. AU - Zhang, L. AU - Moro-Sibilot, D. AU - Liu, T. AU - Bordogna, W. AU - Balas, B. AU - Müller, B. AU - Shaw, A. T. DA - Jul DO - 10.1016/j.jtho.2019.03.007 DP - NLM ET - 2019/03/25 IS - 7 LA - eng N1 - 1556-1380 Camidge, D Ross Dziadziuszko, Rafal Peters, Solange Mok, Tony Noe, Johannes Nowicka, Malgorzata Gadgeel, Shirish M Cheema, Parneet Pavlakis, Nick de Marinis, Filippo Cho, Byoung Chul Zhang, Li Moro-Sibilot, Denis Liu, Ting Bordogna, Walter Balas, Bogdana Müller, Barbara Shaw, Alice T Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't United States J Thorac Oncol. 2019 Jul;14(7):1233-1243. doi: 10.1016/j.jtho.2019.03.007. Epub 2019 Mar 20. PY - 2019 SN - 1556-0864 SP - 1233-1243 ST - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study T2 - J Thorac Oncol TI - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study VL - 14 ID - 868 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Pediatrics, Uji Takeda Hospital, Kyoto, Japan. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: iehara@koto.kpu-m.ac.jp. Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 30904164 AU - Nakagawa, N. AU - Kikuchi, K. AU - Yagyu, S. AU - Miyachi, M. AU - Iehara, T. AU - Tajiri, T. AU - Sakai, T. AU - Hosoi, H. DA - May 7 DO - 10.1016/j.bbrc.2019.03.038 DP - NLM ET - 2019/03/25 IS - 3 LA - eng N1 - 1090-2104 Nakagawa, Norio Kikuchi, Ken Yagyu, Shigeki Miyachi, Mitsuru Iehara, Tomoko Tajiri, Tatsuro Sakai, Toshiyuki Hosoi, Hajime Journal Article Research Support, Non-U.S. Gov't United States Biochem Biophys Res Commun. 2019 May 7;512(3):524-530. doi: 10.1016/j.bbrc.2019.03.038. Epub 2019 Mar 21. PY - 2019 SN - 0006-291x SP - 524-530 ST - Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma T2 - Biochem Biophys Res Commun TI - Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma VL - 512 ID - 869 ER - TY - JOUR AD - Departamento de Biorregulação, Laboratório de Estudo da Tireoide, Instituto de Saúde e Ciência, Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil. Departamento de Anatomia Patológica e Citopatologia, Hospital São Rafael, Salvador, BA, Brasil. Departamento de Anatomia Patológica e Medicina Legal, Faculdade de Medicina da Bahia, Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil. Departamento de Medicina Nuclear, Hospital São Rafael, Salvador, BA, Brasil. Departamento de Cirurgia de Cabeça e Pescoço, Hospital São Rafael, Salvador, BA, Brasil. AN - 30916170 AU - Pessôa-Pereira, D. AU - Medeiros, Mfds AU - Lima, V. M. S. AU - Silva, J. C. D., Jr. AU - Cerqueira, T. L. O. AU - Silva, I. C. D. AU - Fonseca, L. E., Jr. AU - Sampaio, L. J. L. AU - Lima, C. R. A. AU - Ramos, H. E. DA - Mar-Apr DO - 10.20945/2359-3997000000120 DP - NLM ET - 2019/03/28 IS - 2 LA - eng N1 - 2359-4292 Pessôa-Pereira, Danielle Medeiros, Mateus Fernandes da Silva Lima, Virna Mendonça Sampaio Silva, Joaquim Custódio da Jr Cerqueira, Taíse Lima de Oliveira Silva, Igor Campos da Fonseca, Luciano Espinheira Jr Sampaio, Luiz José Lobão Lima, Cláudio Rogério Alves de Ramos, Helton Estrela Journal Article Brazil Arch Endocrinol Metab. 2019 Mar-Apr;63(2):97-106. doi: 10.20945/2359-3997000000120. Epub 2019 Mar 21. PY - 2019 SN - 2359-3997 SP - 97-106 ST - Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series T2 - Arch Endocrinol Metab TI - Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series VL - 63 ID - 870 ER - TY - JOUR AD - 1 Integrated Biostatistics and Bioinformatics Programme, Duke-NUS Medical School, Singapore. 2 Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore. 3 Centre for Computational Biology, Duke-NUS Medical School, Singapore. 4 Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore. 5 Department of Oral and Maxillofacial Surgery, National Dental Centre Singapore, Singapore. 6 Division of Surgical Oncology, National Cancer Centre Singapore, Singapore. 7 Cancer Science Institute of Singapore, National University of Singapore, Singapore. 8 Institute of Molecular and Cell Biology, Singapore. 9 Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore. 10 SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore. AN - 30917298 AU - Guan, P. AU - Wong, S. F. AU - Lim, J. Q. AU - Ng, C. C. Y. AU - Soong, P. L. AU - Sim, C. Q. X. AU - Ong, C. K. AU - Rajasegaran, V. AU - Myint, S. S. AU - Lee, J. Y. AU - Tan, H. K. AU - Iyer, N. G. AU - Soo, K. C. AU - Teh, B. T. AU - Tay, A. B. G. DA - Jun DO - 10.1177/0022034519837248 DP - NLM ET - 2019/03/28 IS - 6 LA - eng N1 - 1544-0591 Guan, P Wong, S F Lim, J Q Ng, C C Y Soong, P L Sim, C Q X Ong, C K Orcid: 0000-0001-6402-4288 Rajasegaran, V Myint, S S Lee, J Y Tan, H K Iyer, N G Soo, K C Teh, B T Orcid: 0000-0003-1514-1124 Tay, A B G Journal Article Research Support, Non-U.S. Gov't United States J Dent Res. 2019 Jun;98(6):652-658. doi: 10.1177/0022034519837248. Epub 2019 Mar 27. PY - 2019 SN - 0022-0345 SP - 652-658 ST - Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking T2 - J Dent Res TI - Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking VL - 98 ID - 871 ER - TY - JOUR AN - 30923800 AU - Burbidge, T. E. AU - Bastian, B. C. AU - Guo, D. AU - Li, H. AU - Morris, D. G. AU - Monzon, J. G. AU - Leung, G. AU - Yang, H. AU - Cheng, T. C2 - PMC6855935 DA - Nov 1 DO - 10.1093/jnci/djz048 DP - NLM ET - 2019/03/30 IS - 11 LA - eng N1 - 1460-2105 Burbidge, Toni E Bastian, Boris C Guo, Danny Li, Haocheng Morris, Don G Monzon, Jose G Leung, Gabriella Yang, Huiming Cheng, Tina R35 CA220481/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't J Natl Cancer Inst. 2019 Nov 1;111(11):1228-1231. doi: 10.1093/jnci/djz048. PY - 2019 SN - 0027-8874 (Print) 0027-8874 SP - 1228-1231 ST - Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations T2 - J Natl Cancer Inst TI - Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations VL - 111 ID - 872 ER - TY - JOUR AD - Pediatrics Department, Miguel Servet Children's Hospital, Isabel la Católica Avenue 1-3, 50009, Zaragoza, Spain. irenebaquedano.l@gmail.com. Clinical Genetics and Assisted Reproduction, Clinical Biochemistry Department, Miguel Servet Hospital, Padre Arrupe Street, 50009, Zaragoza, Spain. Neonatology Department, Miguel Servet Children's Hospital, Isabel la Católica Avenue 1-3, 50009, Zaragoza, Spain. AN - 30953504 AU - Baquedano Lobera, I. AU - Izquierdo Álvarez, S. AU - Oliván Del Cacho, M. J. C2 - PMC6449997 DA - Apr 5 DO - 10.1186/s12887-019-1463-1 DP - NLM ET - 2019/04/07 IS - 1 LA - eng N1 - 1471-2431 Baquedano Lobera, Irene Orcid: 0000-0002-8282-4630 Izquierdo Álvarez, Silvia Oliván Del Cacho, María Jesús Case Reports Journal Article BMC Pediatr. 2019 Apr 5;19(1):92. doi: 10.1186/s12887-019-1463-1. PY - 2019 SN - 1471-2431 SP - 92 ST - Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient T2 - BMC Pediatr TI - Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient VL - 19 ID - 873 ER - TY - JOUR AD - Institute of Nutritional Sciences, Justus-Liebig-University Giessen, Giessen, Germany. Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany. AN - 30984764 AU - Kuntz, S. AU - Rudloff, S. AU - Kunz, C. C2 - PMC6447651 DO - 10.3389/fnut.2019.00031 DP - NLM ET - 2019/04/16 LA - eng N1 - 2296-861x Kuntz, Sabine Rudloff, Silvia Kunz, Clemens Journal Article Front Nutr. 2019 Mar 28;6:31. doi: 10.3389/fnut.2019.00031. eCollection 2019. PY - 2019 SN - 2296-861X (Print) 2296-861x SP - 31 ST - Milk Oligosaccharides From Different Cattle Breeds Influence Growth-Related Characteristics of Intestinal Cells T2 - Front Nutr TI - Milk Oligosaccharides From Different Cattle Breeds Influence Growth-Related Characteristics of Intestinal Cells VL - 6 ID - 874 ER - TY - JOUR AD - 1Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India. 2Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. 3Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. AN - 30994389 AU - Biswas, A. AU - Devnani, B. AU - Agarwal, S. AU - Sharma, M. C. AU - Sharma, A. DA - Aug DO - 10.1089/jayao.2018.0158 DP - NLM ET - 2019/04/18 IS - 4 LA - eng N1 - 2156-535x Biswas, Ahitagni Devnani, Bharti Agarwal, Shipra Sharma, Mehar Chand Sharma, Atul Case Reports Journal Article United States J Adolesc Young Adult Oncol. 2019 Aug;8(4):469-476. doi: 10.1089/jayao.2018.0158. Epub 2019 Apr 17. PY - 2019 SN - 2156-5333 SP - 469-476 ST - Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case T2 - J Adolesc Young Adult Oncol TI - Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case VL - 8 ID - 875 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org diamone1@mskcc.org. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York. fjanku@mdanderson.org diamone1@mskcc.org. Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. AN - 31015311 AU - Janku, F. AU - Diamond, E. L. AU - Goodman, A. M. AU - Raghavan, V. K. AU - Barnes, T. G. AU - Kato, S. AU - Abdel-Wahab, O. AU - Durham, B. H. AU - Meric-Bernstam, F. AU - Kurzrock, R. C2 - PMC6548628 C6 - NIHMS1526992 BioMed Valley Discoveries, Plexxikon, Deciphera, Piqur, Symphogen, Bayer, FujiFilm Corporation and Upsher-Smith Laboratories; is on the Scientific Advisory Boards of IFM Therapeutics, Synlogic, Guardant Health and Deciphera; is a paid consultant for Trovagene and Immunomet; and has ownership interests in Trovagene. Dr. Razelle Kurzrock receives research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, and Guardant; consultant fees from Sequenom, LOXO, Actuate Therapeutics, and Genentech; and speaker fees from Roche. Dr. Kurzrock also has an ownership interest in CureMatch, Inc. DA - Jun DO - 10.1158/1535-7163.Mct-18-1244 DP - NLM ET - 2019/04/25 IS - 6 LA - eng N1 - 1538-8514 Janku, Filip Diamond, Eli L Goodman, Aaron M Raghavan, Vaijayanthi Kandadai Barnes, Tamara G Kato, Shumei Abdel-Wahab, Omar Durham, Benjamin H Meric-Bernstam, Funda Kurzrock, Razelle P30 CA008748/CA/NCI NIH HHS/United States P30 CA016672/CA/NCI NIH HHS/United States P30 CA023100/CA/NCI NIH HHS/United States R01 CA201247/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Mol Cancer Ther. 2019 Jun;18(6):1149-1157. doi: 10.1158/1535-7163.MCT-18-1244. Epub 2019 Apr 23. PY - 2019 SN - 1535-7163 (Print) 1535-7163 SP - 1149-1157 ST - Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis T2 - Mol Cancer Ther TI - Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis VL - 18 ID - 876 ER - TY - JOUR AD - Clinical Cancer Research Center, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. Genesmile Company, Nanjing, China. AN - 31021028 AU - Wang, Z. AU - Sun, K. AU - Jing, C. AU - Cao, H. AU - Ma, R. AU - Wu, J. C2 - PMC6642310 DA - Jul DO - 10.1002/jcla.22902 DP - NLM ET - 2019/04/26 IS - 6 LA - eng N1 - 1098-2825 Wang, Zhuo Orcid: 0000-0002-3920-4348 Sun, Kejing Jing, Changwen Cao, Haixia Ma, Rong Wu, Jianzhong BE2016795/Science Foundation of Jiangsu Province/ Comparative Study Journal Article J Clin Lab Anal. 2019 Jul;33(6):e22902. doi: 10.1002/jcla.22902. Epub 2019 Apr 25. PY - 2019 SN - 0887-8013 (Print) 0887-8013 SP - e22902 ST - Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma T2 - J Clin Lab Anal TI - Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma VL - 33 ID - 877 ER - TY - JOUR AD - Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey. AN - 31058533 AU - Tas, F. AU - Erturk, K. DA - Jul 23 DO - 10.4149/neo_2018_181006N740 DP - NLM ET - 2019/05/07 IS - 4 LA - eng N1 - Tas, F Erturk, K Journal Article Slovakia Neoplasma. 2019 Jul 23;66(4):631-636. doi: 10.4149/neo_2018_181006N740. Epub 2019 Apr 24. PY - 2019 SN - 0028-2685 (Print) 0028-2685 SP - 631-636 ST - Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients T2 - Neoplasma TI - Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients VL - 66 ID - 878 ER - TY - JOUR AD - Saint-Antoine Research Center, INSERM UMRS_938, Paris, France; Sorbonne Université, Paris, France. Saint-Antoine Research Center, INSERM UMRS_938, Paris, France; Université Paris-Descartes, Paris, France; AP-HP, Hôpital Cochin, Department of Dermatology, Paris, France. Université Paris-Descartes, Paris, France; AP-HP, Hôpital Necker-Enfants-Malades, Department of Maxillofacial and Plastic Surgery, Paris, France. AP-HP, Hôpital Necker-Enfants-Malades, Department of Pathology, Paris, France. Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH, Paris, France. Université Paris-Descartes, Paris, France; AP-HP, Hôpital Européen Georges-Pompidou, Department of Plastic Surgery, Paris, France. AP-HP, Hôpital Tenon, Department of Pathology, Paris, France. Saint-Antoine Research Center, INSERM UMRS_938, Paris, France; Université Paris-Descartes, Paris, France; AP-HP, Hôpital Cochin, Department of Dermatology, Paris, France. Electronic address: sarah.guegan.bart@gmail.com. AN - 31059696 AU - Rouillé, T. AU - Aractingi, S. AU - Kadlub, N. AU - Fraitag, S. AU - How-Kit, A. AU - Daunay, A. AU - Hivelin, M. AU - Moguelet, P. AU - Picard, A. AU - Fontaine, R. H. AU - Guégan, S. DA - Sep DO - 10.1016/j.jid.2019.03.1156 DP - NLM ET - 2019/05/07 IS - 9 LA - eng N1 - 1523-1747 Rouillé, Thomas Aractingi, Selim Kadlub, Natacha Fraitag, Sylvie How-Kit, Alexandre Daunay, Antoine Hivelin, Mikael Moguelet, Philippe Picard, Arnaud Fontaine, Romain H Guégan, Sarah Journal Article Research Support, Non-U.S. Gov't United States J Invest Dermatol. 2019 Sep;139(9):2004-2015.e13. doi: 10.1016/j.jid.2019.03.1156. Epub 2019 May 3. PY - 2019 SN - 0022-202x SP - 2004-2015.e13 ST - Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi T2 - J Invest Dermatol TI - Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi VL - 139 ID - 879 ER - TY - JOUR AD - Sydney Children's Hospital, Randwick, New South Wales, Australia. Children's Cancer Institute, Sydney, New South Wales, Australia. University of New South Wales, Sydney, New South Wales, Australia. Prince of Wales Hospital, Randwick, New South Wales, Australia. Canberra Hospital, Garran, Australian Capital Territory, Australia. Australian National University Medical School, Acton, Australian Capital Territory, Australia. St Vincent's Hospital, Darlinghurst, New South Wales, Australia. University of Auckland, Auckland, New Zealand. Perth Children's Hospital, Perth, Western Australia, Australia. Queensland Children's Hospital, South Brisbane, Queensland, Australia. Garvan Institute of Medical Research, Sydney, New South Wales, Australia. Altius Institute for Biomedical Sciences, Seattle, WA. Children's Medical Research Institute, Westmead New South Wales, Australia. AN - 32914017 AU - Trahair, T. AU - Gifford, A. J. AU - Fordham, A. AU - Mayoh, C. AU - Fadia, M. AU - Lukeis, R. AU - Wood, A. C. AU - Valvi, S. AU - Walker, R. D. AU - Blackburn, J. AU - Heyer, E. E. AU - Mercer, T. R. AU - Barbaric, D. AU - Marshall, G. M. AU - MacKenzie, K. L. C2 - PMC7446396 manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center. Toby TrahairStock and Other Ownership Interests: CSLAndrew C. WoodPatents, Royalties, Other Intellectual Property: PAT055863-US-PCT, inventor assigned to Genomics Institute of the Novartis Research Foundation involving combination inhibition of ALKTim R. MercerSpeakers’ Bureau: Oxford Nanopore Patents, Royalties, Other Intellectual Property: Inventor of two patents related to synthetic RNA and DNA controls for next-generation sequencingKaren L. MacKenzieResearch Funding: Komipharm (Inst) No other potential conflicts of interest were reported. DO - 10.1200/po.18.00297 DP - NLM ET - 2019/05/16 LA - eng N1 - 2473-4284 Trahair, Toby Gifford, Andrew J Fordham, Ashleigh Mayoh, Chelsea Fadia, Mitali Lukeis, Robyn Wood, Andrew C Valvi, Santosh Walker, Roderick D Blackburn, James Heyer, Erin E Mercer, Tim R Barbaric, Draga Marshall, Glenn M MacKenzie, Karen L Journal Article JCO Precis Oncol. 2019 May 16;3:PO.18.00297. doi: 10.1200/PO.18.00297. eCollection 2019. PY - 2019 SN - 2473-4284 ST - Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors T2 - JCO Precis Oncol TI - Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors VL - 3 ID - 880 ER - TY - JOUR AD - Department of Ophthalmology and Visual Science, Havener Eye Institute, The Ohio State University, Wexner Medical Center, 915 Olentangy River Rd, Ste 5000, Columbus, OH, 43212, USA. Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Wexner Medical Center, Columbus, OH, USA. Department of Ophthalmology and Visual Science, Havener Eye Institute, The Ohio State University, Wexner Medical Center, 915 Olentangy River Rd, Ste 5000, Columbus, OH, 43212, USA. colleen.cebulla@osumc.edu. AN - 31098752 AU - Kunkler, A. L. AU - Binkley, E. M. AU - Mantopoulos, D. AU - Hendershot, A. J. AU - Ohr, M. P. AU - Kendra, K. L. AU - Davidorf, F. H. AU - Cebulla, C. M. DA - Aug DO - 10.1007/s00417-019-04337-8 DP - NLM ET - 2019/05/18 IS - 8 LA - eng N1 - 1435-702x Kunkler, Anne L Binkley, Elaine M Mantopoulos, Dimosthenis Hendershot, Andrew J Ohr, Matthew P Kendra, Kari L Davidorf, Frederick H Cebulla, Colleen M K08EY022672/National Eye Institute/ 313310/Retina Research in Ophthalmology/ Journal Article Germany Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1771-1781. doi: 10.1007/s00417-019-04337-8. Epub 2019 May 16. PY - 2019 SN - 0721-832x SP - 1771-1781 ST - Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics T2 - Graefes Arch Clin Exp Ophthalmol TI - Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics VL - 257 ID - 881 ER - TY - JOUR AD - Department of Clinical Oncology, Odense University Hospital, Odense, Denmark. Electronic address: lars.bastholt@rsyd.dk. Center for Cancer Immune Therapy, Department of Oncology and Haematology, Copenhagen University Hospital, Herlev, Denmark. Department of Clinical Oncology, Odense University Hospital, Odense, Denmark. Center for Evidence-Based Medicine, University of Southern Denmark, Odense, Denmark. Department of Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. AN - 31108244 AU - Bastholt, L. AU - Svane, I. M. AU - Bjerregaard, J. K. AU - Herrstedt, J. AU - Hróbjartsson, A. AU - Schmidt, H. DA - Jul DO - 10.1016/j.ejca.2019.03.023 DP - NLM ET - 2019/05/21 LA - eng N1 - 1879-0852 Bastholt, Lars Svane, Inge Marie Bjerregaard, Jon Kroll Herrstedt, Jørn Hróbjartsson, Asbjørn Schmidt, Henrik Journal Article Multicenter Study Research Support, Non-U.S. Gov't England Eur J Cancer. 2019 Jul;115:61-67. doi: 10.1016/j.ejca.2019.03.023. Epub 2019 May 17. PY - 2019 SN - 0959-8049 SP - 61-67 ST - High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort T2 - Eur J Cancer TI - High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort VL - 115 ID - 882 ER - TY - JOUR AD - Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China. Department of Ophthalmology, The First People's Hospital of Changde City, Changde, Hunan 415000, P.R. China. AN - 31115482 AU - Zeng, Z. AU - Gao, Z. L. AU - Zhang, Z. P. AU - Jiang, H. B. AU - Yang, C. Q. AU - Yang, J. AU - Xia, X. B. C2 - PMC6559318 DA - Jul DO - 10.3892/ijmm.2019.4183 DP - NLM ET - 2019/05/23 IS - 1 LA - eng N1 - 1791-244x Zeng, Zhou Gao, Zhao-Lin Zhang, Zhi-Pei Jiang, Hai-Bo Yang, Chang-Quan Yang, Jie Xia, Xiao-Bo Journal Article Int J Mol Med. 2019 Jul;44(1):103-114. doi: 10.3892/ijmm.2019.4183. Epub 2019 May 8. PY - 2019 SN - 1107-3756 (Print) 1107-3756 SP - 103-114 ST - Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway T2 - Int J Mol Med TI - Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway VL - 44 ID - 883 ER - TY - JOUR AD - a Evidera, Inc , Bethesda , MD , USA. b Millennium Pharmaceuticals, Inc , Cambridge , MA , USA , a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. AN - 31125274 AU - Kawata, A. K. AU - Lenderking, W. R. AU - Eseyin, O. R. AU - Kerstein, D. AU - Huang, J. AU - Huang, H. AU - Zhang, P. AU - Lin, H. M. DA - Sep DO - 10.1080/13696998.2019.1624080 DP - NLM ET - 2019/05/28 IS - 9 LA - eng N1 - 1941-837x Kawata, Ariane K Lenderking, William R Eseyin, Olabimpe R Kerstein, David Huang, Joice Huang, Hui Zhang, Pingkuan Lin, Huamao M Orcid: 0000-0002-8399-8966 Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial England J Med Econ. 2019 Sep;22(9):924-935. doi: 10.1080/13696998.2019.1624080. Epub 2019 Jun 25. PY - 2019 SN - 1369-6998 SP - 924-935 ST - Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study T2 - J Med Econ TI - Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study VL - 22 ID - 884 ER - TY - JOUR AD - Department of Hematology, Oncology, and Stem Cell Transplantation, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, USA. Electronic address: jfangus@emory.edu. Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Radiology, Boston Children's Hospital, Boston, MA, USA. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Center for Cancer and Blood Disorders, University of California, San Francisco, San Francisco, CA, USA. Department of Neurology, Children's National Medical Center, Washington, DC, USA. Department of Haematology and Oncology, Children's National Medical Center, Washington, DC, USA. Department of Haematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA. Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Hematology and Oncology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Neurology, Stanford University Medical Center, Palo Alto, CA, USA. Department of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, CA, USA. Department of Hematology and Oncology, Texas Children's Hospital, Houston, TX, USA. Department of Hematology and Oncology, Duke University School of Medicine, Durham, NC, USA. Department of Pharmaceutical Science, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Pediatric Glioma Research Group, Hopp Children's Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Pediatric Neuro-Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Radiology, Children's National Medical Center, Washington, DC, USA. Department of Radiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA. Department of Radiology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Radiology, Children's Hospital Los Angeles, Los Angeles, CA, USA. Department of Radiology, Nationwide Children's Hospital, Columbus, OH, USA. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Radiology, Duke University School of Medicine, Durham, NC, USA. Department of Radiology, University of California, San Francisco, San Francisco, CA, USA. Department of Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Investigational Drug Branch, National Cancer Institute and Cancer Therapy Evaluation Program, Bethesda, MD, USA. Clinical Investigation Branch, National Cancer Institute and Cancer Therapy Evaluation Program, Bethesda, MD, USA. Department of Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Haematology and Oncology, Cincinnati Children's Hospital, Cincinnati, OH, USA. AN - 31151904 AU - Fangusaro, J. AU - Onar-Thomas, A. AU - Young Poussaint, T. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. AU - Banerjee, A. AU - Packer, R. J. AU - Kilburn, L. B. AU - Goldman, S. AU - Pollack, I. F. AU - Qaddoumi, I. AU - Jakacki, R. I. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. AU - Kreissman, S. G. AU - Stewart, C. F. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Vezina, G. AU - Stern, J. S. AU - Panigrahy, A. AU - Patay, Z. AU - Tamrazi, B. AU - Jones, J. Y. AU - Haque, S. S. AU - Enterline, D. S. AU - Cha, S. AU - Fisher, M. J. AU - Doyle, L. A. AU - Smith, M. AU - Dunkel, I. J. AU - Fouladi, M. C2 - PMC6628202 C6 - NIHMS1035573 AstraZeneca and was an employee of AstraZeneca from 9/2014–5/2017. RJP serves on a selumetinib plexiform neurofibroma Advisory Committee for AstraZeneca. MJF acted as an unpaid consultant for AstraZeneca and received travel reimbursement to participate in an Advisory Board meeting. All other authors declare no competing interests. DA - Jul DO - 10.1016/s1470-2045(19)30277-3 DP - NLM ET - 2019/06/04 IS - 7 LA - eng N1 - 1474-5488 Fangusaro, Jason Onar-Thomas, Arzu Young Poussaint, Tina Wu, Shengjie Ligon, Azra H Lindeman, Neal Banerjee, Anuradha Packer, Roger J Kilburn, Lindsay B Goldman, Stewart Pollack, Ian F Qaddoumi, Ibrahim Jakacki, Regina I Fisher, Paul G Dhall, Girish Baxter, Patricia Kreissman, Susan G Stewart, Clinton F Jones, David T W Pfister, Stefan M Vezina, Gilbert Stern, Jessica S Panigrahy, Ashok Patay, Zoltan Tamrazi, Benita Jones, Jeremy Y Haque, Sofia S Enterline, David S Cha, Soonmee Fisher, Michael J Doyle, Laurence Austin Smith, Malcolm Dunkel, Ira J Fouladi, Maryam P30 CA008748/CA/NCI NIH HHS/United States P30 CA021765/CA/NCI NIH HHS/United States UM1 CA081457/CA/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. PY - 2019 SN - 1470-2045 (Print) 1470-2045 SP - 1011-1022 ST - Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial T2 - Lancet Oncol TI - Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial VL - 20 ID - 885 ER - TY - JOUR AD - From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France; Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia; Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland; the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany; the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy; the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.); Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.); the University of California, Los Angeles, Los Angeles (A.R.); the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.); Novartis Pharma, Basel, Switzerland (P.B.); Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.); and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.). AN - 31166680 AU - Robert, C. AU - Grob, J. J. AU - Stroyakovskiy, D. AU - Karaszewska, B. AU - Hauschild, A. AU - Levchenko, E. AU - Chiarion Sileni, V. AU - Schachter, J. AU - Garbe, C. AU - Bondarenko, I. AU - Gogas, H. AU - Mandalá, M. AU - Haanen, Jbag AU - Lebbé, C. AU - Mackiewicz, A. AU - Rutkowski, P. AU - Nathan, P. D. AU - Ribas, A. AU - Davies, M. A. AU - Flaherty, K. T. AU - Burgess, P. AU - Tan, M. AU - Gasal, E. AU - Voi, M. AU - Schadendorf, D. AU - Long, G. V. DA - Aug 15 DO - 10.1056/NEJMoa1904059 DP - NLM ET - 2019/06/06 IS - 7 LA - eng N1 - 1533-4406 Robert, Caroline Grob, Jean J Stroyakovskiy, Daniil Karaszewska, Boguslawa Hauschild, Axel Levchenko, Evgeny Chiarion Sileni, Vanna Schachter, Jacob Garbe, Claus Bondarenko, Igor Gogas, Helen Mandalá, Mario Haanen, John B A G Lebbé, Celeste Mackiewicz, Andrzej Rutkowski, Piotr Nathan, Paul D Ribas, Antoni Davies, Michael A Flaherty, Keith T Burgess, Paul Tan, Monique Gasal, Eduard Voi, Maurizio Schadendorf, Dirk Long, Georgina V Clinical Trial, Phase III Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States N Engl J Med. 2019 Aug 15;381(7):626-636. doi: 10.1056/NEJMoa1904059. Epub 2019 Jun 4. PY - 2019 SN - 0028-4793 SP - 626-636 ST - Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma T2 - N Engl J Med TI - Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma VL - 381 ID - 886 ER - TY - JOUR AD - Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. paolo.ascierto@gmail.com. European Institute of Oncology IRCCS, Milan, Italy. pier.ferrucci@ieo.it. Auckland City Hospital, Auckland, New Zealand. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. Aarhus University Hospital, Aarhus, Denmark. Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. IRCCS San Martino-IST, Genova, Italy. Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. Herlev Hospital, University of Copenhagen, Herlev, Denmark. Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. Rambam Health Care Campus, Haifa, Israel. Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. Novartis, East Hanover, NJ, USA. Merck & Co., Inc., Kenilworth, NJ, USA. University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. aribas@mednet.ucla.edu. AN - 31171878 AU - Ascierto, P. A. AU - Ferrucci, P. F. AU - Fisher, R. AU - Del Vecchio, M. AU - Atkinson, V. AU - Schmidt, H. AU - Schachter, J. AU - Queirolo, P. AU - Long, G. V. AU - Di Giacomo, A. M. AU - Svane, I. M. AU - Lotem, M. AU - Bar-Sela, G. AU - Couture, F. AU - Mookerjee, B. AU - Ghori, R. AU - Ibrahim, N. AU - Moreno, B. H. AU - Ribas, A. DA - Jun DO - 10.1038/s41591-019-0448-9 DP - NLM ET - 2019/06/07 IS - 6 LA - eng N1 - 1546-170x Ascierto, Paolo Antonio Orcid: 0000-0002-8322-475x Ferrucci, Pier Francesco Fisher, Rosalie Del Vecchio, Michele Atkinson, Victoria Schmidt, Henrik Schachter, Jacob Queirolo, Paola Long, Georgina V Orcid: 0000-0001-8894-3545 Di Giacomo, Anna Maria Svane, Inge Marie Lotem, Michal Bar-Sela, Gil Couture, Felix Mookerjee, Bijoyesh Ghori, Razi Ibrahim, Nageatte Moreno, Blanca Homet Ribas, Antoni Orcid: 0000-0003-3669-8458 Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Nat Med. 2019 Jun;25(6):941-946. doi: 10.1038/s41591-019-0448-9. Epub 2019 Jun 6. PY - 2019 SN - 1078-8956 SP - 941-946 ST - Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma T2 - Nat Med TI - Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma VL - 25 ID - 887 ER - TY - JOUR AD - 1Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. 2Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 3Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. 4Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 5Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 6Department of Internal Medicine, Kuma Hospital, Kobe, Japan. 7Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan. 8Department of Surgery, Kuma Hospital, Kobe, Japan. 9Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. AN - 31286848 AU - Tanaka, A. AU - Matsuse, M. AU - Saenko, V. AU - Nakao, T. AU - Yamanouchi, K. AU - Sakimura, C. AU - Yano, H. AU - Nishihara, E. AU - Hirokawa, M. AU - Suzuki, K. AU - Miyauchi, A. AU - Eguchi, S. AU - Yoshiura, K. I. AU - Yamashita, S. AU - Nagayasu, T. AU - Mitsutake, N. DA - Aug DO - 10.1089/thy.2018.0695 DP - NLM ET - 2019/07/10 IS - 8 LA - eng N1 - 1557-9077 Tanaka, Aya Matsuse, Michiko Saenko, Vladimir Nakao, Tomoe Yamanouchi, Kosho Sakimura, Chika Yano, Hiroshi Nishihara, Eijun Hirokawa, Mitsuyoshi Suzuki, Keiji Miyauchi, Akira Eguchi, Susumu Yoshiura, Ko-Ichiro Yamashita, Shunichi Nagayasu, Takeshi Mitsutake, Norisato Journal Article Research Support, Non-U.S. Gov't United States Thyroid. 2019 Aug;29(8):1105-1114. doi: 10.1089/thy.2018.0695. Epub 2019 Aug 5. PY - 2019 SN - 1050-7256 SP - 1105-1114 ST - TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas T2 - Thyroid TI - TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas VL - 29 ID - 888 ER - TY - JOUR AD - Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Department of Pediatric Oncology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Division of Neurosurgery, Department of Surgical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Department of Radiation Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. sridhep@gmail.com. Department of Pathology (& Division of Molecular Pathology), Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. sridhep@gmail.com. AN - 31321520 AU - Kurani, H. AU - Gurav, M. AU - Shetty, O. AU - Chinnaswamy, G. AU - Moiyadi, A. AU - Gupta, T. AU - Jalali, R. AU - Epari, S. DA - Sep DO - 10.1007/s00381-019-04282-1 DP - NLM ET - 2019/07/20 IS - 9 LA - eng N1 - 1433-0350 Kurani, Hetakshi Gurav, Mamta Shetty, Omshree Chinnaswamy, Girish Moiyadi, Aliasagar Gupta, Tejpal Jalali, Rakesh Epari, Sridhar Orcid: 0000-0002-1038-5755 IEC-III/138/Terry Fox Foundation/International Journal Article Research Support, Non-U.S. Gov't Germany Childs Nerv Syst. 2019 Sep;35(9):1525-1536. doi: 10.1007/s00381-019-04282-1. Epub 2019 Jul 18. PY - 2019 SN - 0256-7040 SP - 1525-1536 ST - Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups T2 - Childs Nerv Syst TI - Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups VL - 35 ID - 889 ER - TY - JOUR AD - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Weill Cornell Medical College, New York, NY, USA. Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Loxo Oncology, South San Francisco, CA, USA. Department of Medical Affairs, Guardant Health Inc., Redwood City, CA, USA. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. drilona@mskcc.org. Weill Cornell Medical College, New York, NY, USA. drilona@mskcc.org. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scaltrim@mskcc.org. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scaltrim@mskcc.org. AN - 31406350 AU - Cocco, E. AU - Schram, A. M. AU - Kulick, A. AU - Misale, S. AU - Won, H. H. AU - Yaeger, R. AU - Razavi, P. AU - Ptashkin, R. AU - Hechtman, J. F. AU - Toska, E. AU - Cownie, J. AU - Somwar, R. AU - Shifman, S. AU - Mattar, M. AU - Selçuklu, S. D. AU - Samoila, A. AU - Guzman, S. AU - Tuch, B. B. AU - Ebata, K. AU - de Stanchina, E. AU - Nagy, R. J. AU - Lanman, R. B. AU - Houck-Loomis, B. AU - Patel, J. A. AU - Berger, M. F. AU - Ladanyi, M. AU - Hyman, D. M. AU - Drilon, A. AU - Scaltriti, M. C2 - PMC6736691 C6 - NIHMS1533563 DA - Sep DO - 10.1038/s41591-019-0542-z DP - NLM ET - 2019/08/14 IS - 9 LA - eng N1 - 1546-170x Cocco, Emiliano Schram, Alison M Kulick, Amanda Misale, Sandra Won, Helen H Yaeger, Rona Razavi, Pedram Ptashkin, Ryan Hechtman, Jaclyn F Toska, Eneda Cownie, James Somwar, Romel Shifman, Sophie Mattar, Marissa Selçuklu, S Duygu Samoila, Aliaksandra Guzman, Sean Tuch, Brian B Ebata, Kevin Orcid: 0000-0001-7166-7513 de Stanchina, Elisa Nagy, Rebecca J Lanman, Richard B Orcid: 0000-0001-8122-4329 Houck-Loomis, Brian Patel, Juber A Berger, Michael F Ladanyi, Marc Hyman, David M Orcid: 0000-0001-8150-9762 Drilon, Alexander Orcid: 0000-0001-6806-9061 Scaltriti, Maurizio Orcid: 0000-0002-5522-1447 P30 CA008748/CA/NCI NIH HHS/United States R01 CA226864/CA/NCI NIH HHS/United States T32 CA160001/CA/NCI NIH HHS/United States U54 OD020355/OD/NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Nat Med. 2019 Sep;25(9):1422-1427. doi: 10.1038/s41591-019-0542-z. Epub 2019 Aug 12. PY - 2019 SN - 1078-8956 (Print) 1078-8956 SP - 1422-1427 ST - Resistance to TRK inhibition mediated by convergent MAPK pathway activation T2 - Nat Med TI - Resistance to TRK inhibition mediated by convergent MAPK pathway activation VL - 25 ID - 890 ER - TY - JOUR AD - Institute of Animal Nutrition, Northeast Agricultural University, Harbin, 150030, P. R. China. asshan@neau.edu.cn. AN - 31432838 AU - Meng, Q. AU - Sun, S. AU - Luo, Z. AU - Shi, B. AU - Shan, A. AU - Cheng, B. DA - Sep 1 DO - 10.1039/c9fo00637k DP - NLM ET - 2019/08/23 IS - 9 LA - eng N1 - 2042-650x Meng, Qingwei Sun, Shishuai Luo, Zhang Shi, Baoming Shan, Anshan Orcid: 0000-0003-2830-7509 Cheng, Baojing Journal Article England Food Funct. 2019 Sep 1;10(9):5626-5643. doi: 10.1039/c9fo00637k. Epub 2019 Aug 21. PY - 2019 SN - 2042-6496 SP - 5626-5643 ST - Maternal dietary resveratrol alleviates weaning-associated diarrhea and intestinal inflammation in pig offspring by changing intestinal gene expression and microbiota T2 - Food Funct TI - Maternal dietary resveratrol alleviates weaning-associated diarrhea and intestinal inflammation in pig offspring by changing intestinal gene expression and microbiota VL - 10 ID - 891 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Experimental, Diagnostic and Specialty Medicine-Anatomic Pathology, University of Bologna School of Medicine, Bologna, Italy. AN - 31452453 AU - Xu, B. AU - Serrette, R. AU - Tuttle, R. M. AU - Alzumaili, B. AU - Ganly, I. AU - Katabi, N. AU - Tallini, G. AU - Ghossein, R. C2 - PMC6918873 DA - Dec DO - 10.1089/thy.2019.0328 DP - NLM ET - 2019/08/28 IS - 12 LA - eng N1 - 1557-9077 Xu, Bin Serrette, Rene Tuttle, R Michael Alzumaili, Bayan Ganly, Ian Katabi, Nora Tallini, Giovanni Ghossein, Ronald P30 CA008748/CA/NCI NIH HHS/United States P50 CA172012/CA/NCI NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Thyroid. 2019 Dec;29(12):1792-1803. doi: 10.1089/thy.2019.0328. Epub 2019 Oct 10. PY - 2019 SN - 1050-7256 (Print) 1050-7256 SP - 1792-1803 ST - How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features T2 - Thyroid TI - How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features VL - 29 ID - 892 ER - TY - JOUR AD - Pediatric Hematology/Oncology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. University Cancer Center of the University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany. Pediatric Hematology/Oncology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. claudia.paret@unimedizin-mainz.de. University Cancer Center of the University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany. claudia.paret@unimedizin-mainz.de. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. claudia.paret@unimedizin-mainz.de. Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK)-German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Section of Pediatric Neurosurgery, Department of Neurosurgery, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Neurological Institute (Edinger-Institute), Goethe-University Medical School, 60528 Frankfurt am Main, Germany. Frankfurt Cancer Institute (FCI), 60596 Frankfurt am Main, Germany. Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. Institute of Neuropathology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. Department of Neuroradiology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany. Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, 53127 Bonn, Germany. AN - 31480400 AU - Russo, A. AU - Paret, C. AU - Alt, F. AU - Burhenne, J. AU - Fresnais, M. AU - Wagner, W. AU - Glaser, M. AU - Bender, H. AU - Huprich, S. AU - Harter, P. N. AU - Filipski, K. AU - Lehmann, N. AU - Backes, N. AU - Roth, L. AU - Seidmann, L. AU - Sommer, C. AU - Brockmann, M. A. AU - Pietsch, T. AU - Neu, M. A. AU - Wingerter, A. AU - Faber, J. C2 - PMC6747232 DA - Aug 30 DO - 10.3390/ijms20174267 DP - NLM ET - 2019/09/05 IS - 17 LA - eng N1 - 1422-0067 Russo, Alexandra Paret, Claudia Orcid: 0000-0002-9094-1634 Alt, Francesca Burhenne, Jürgen Fresnais, Margaux Orcid: 0000-0002-9215-3033 Wagner, Wolfgang Glaser, Martin Bender, Hannah Huprich, Sabrina Harter, Patrick N Filipski, Katharina Lehmann, Nadine Orcid: 0000-0003-1897-3129 Backes, Nora Roth, Lea Seidmann, Larissa Sommer, Clemens Brockmann, Marc A Pietsch, Torsten Neu, Marie A Wingerter, Arthur Faber, Jörg Orcid: 0000-0002-5432-8234 Journal Article Int J Mol Sci. 2019 Aug 30;20(17):4267. doi: 10.3390/ijms20174267. PY - 2019 SN - 1422-0067 ST - Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor T2 - Int J Mol Sci TI - Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor VL - 20 ID - 893 ER - TY - JOUR AD - Departments of Computational Biology. Oncology. Pathology, St. Jude Children's Research Hospital, Memphis, TN. Departments of Pathology and Translational Research, Institut Curie, Paris, France. AN - 31498175 AU - Newman, S. AU - Pappo, A. AU - Raimondi, S. AU - Zhang, J. AU - Barnhill, R. AU - Bahrami, A. DA - Dec DO - 10.1097/pas.0000000000001362 DP - NLM ET - 2019/09/10 IS - 12 LA - eng N1 - 1532-0979 Newman, Scott Pappo, Alberto Raimondi, Susana Zhang, Jinghui Barnhill, Raymond Bahrami, Armita Journal Article United States Am J Surg Pathol. 2019 Dec;43(12):1631-1637. doi: 10.1097/PAS.0000000000001362. PY - 2019 SN - 0147-5185 SP - 1631-1637 ST - Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort T2 - Am J Surg Pathol TI - Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort VL - 43 ID - 894 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas. Pediatrics Neuro-oncology Program, MD Anderson Cancer Center, Houston, Texas. AN - 31502413 AU - Phadnis, S. S. AU - Chen, L. AU - Wang, W. L. AU - Migden, M. R. AU - Zaky, W. DA - Dec DO - 10.1002/pbc.27974 DP - NLM ET - 2019/09/11 IS - 12 LA - eng N1 - 1545-5017 Phadnis, Sheetal S Orcid: 0000-0002-6880-1408 Chen, Leon Wang, Wei-Lien Migden, Michael R Zaky, Wafik Case Reports Letter United States Pediatr Blood Cancer. 2019 Dec;66(12):e27974. doi: 10.1002/pbc.27974. Epub 2019 Sep 10. PY - 2019 SN - 1545-5009 SP - e27974 ST - Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy T2 - Pediatr Blood Cancer TI - Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy VL - 66 ID - 895 ER - TY - JOUR AD - Harvard Medical School, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. birgit.geoerger@gustaveroussy.fr. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, New York. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. UCL Great Ormond Street Institute of Child Health, Pediatric Oncology Unit, London, United Kingdom. Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona. Institut Curie, PSL Research University, Oncology Center SIREDO, Paris, France. CHU de Toulouse - Pôle Pédiatrique, Toulouse, France. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Cancer and Blood Disorder Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Children's Hospital of Orange County, Orange, California. The Hospital for Sick Children, University of Toronto, Department of Pediatrics, Toronto, Ontario. Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, and The Institute of Cancer Research, Sutton, United Kingdom. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. Novartis Pharma AG, Basel, Switzerland. AN - 31506385 AU - Kieran, M. W. AU - Geoerger, B. AU - Dunkel, I. J. AU - Broniscer, A. AU - Hargrave, D. AU - Hingorani, P. AU - Aerts, I. AU - Bertozzi, A. I. AU - Cohen, K. J. AU - Hummel, T. R. AU - Shen, V. AU - Bouffet, E. AU - Pratilas, C. A. AU - Pearson, A. D. J. AU - Tseng, L. AU - Nebot, N. AU - Green, S. AU - Russo, M. W. AU - Whitlock, J. A. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-17-3572 DP - NLM ET - 2019/09/12 IS - 24 LA - eng N1 - Kieran, Mark W Geoerger, Birgit Dunkel, Ira J Orcid: 0000-0001-8091-6067 Broniscer, Alberto Hargrave, Darren Orcid: 0000-0001-8219-9807 Hingorani, Pooja Aerts, Isabelle Bertozzi, Anne-Isabelle Cohen, Kenneth J Orcid: 0000-0001-9193-9344 Hummel, Trent R Shen, Violet Bouffet, Eric Pratilas, Christine A Pearson, Andrew D J Tseng, Lillian Orcid: 0000-0002-2833-1480 Nebot, Noelia Green, Steven Russo, Mark W Whitlock, James A DH_/Department of Health/United Kingdom P50 CA165962/CA/NCI NIH HHS/United States Clinical Trial Protocol Clinical Trial, Phase I Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2019 Dec 15;25(24):7294-7302. doi: 10.1158/1078-0432.CCR-17-3572. Epub 2019 Sep 10. PY - 2019 SN - 1078-0432 (Print) 1078-0432 SP - 7294-7302 ST - A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors T2 - Clin Cancer Res TI - A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors VL - 25 ID - 896 ER - TY - JOUR AD - Trousseau Hospital, Paris, France. Centre Hospitalier Universitaire R.-Poincaré, Garches, France. Centre Hospitalier Universitaire de Grenoble, Grenoble, France. Cambridge University Hospitals, Cambridge, United Kingdom. Medical University of Vienna, Vienna, Austria. Azienda Ospedaliero-Universitaria A. Meyer, Florence, Italy. Centre Hospitalier du Nord, Zgharta, Lebanon. Rafic Hariri University Hospital, Beirut, Lebanon. Newcastle University, Newcastle upon Tyne, United Kingdom. Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France. Université Paris-Saclay, Boulogne-Billancourt, France. Hôpital Sainte Marguerite, Marseille, France. Centre Hospitalier Universitaire Félix-Guyon (Saint-Denis), La Réunion, France. Comenius University Children's Hospital Limbova 1, Bratislava, Slovakia. Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Centre Hospitalier Universitaire de Rouen, Rouen, France. Centre Hospitalier Universitaire de Toulouse, Toulouse, France. Centre Hospitalier Universitaire d'Amiens, Amiens, France. Universitätsklinikum Frankfurt, Frankfurt am Main, Germany. Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium. University Hospital, Minsk, Belarus. Universitätsklinikum Münster Klinik für Kinder- und Jugendmedizin-Pädiatrische Hämatologie und Onkologie, Münster, Germany. Centre Hospitalier Universitaire de Poitiers, Poitiers, France. Centre Hospitalier Universitaire de Lille, Lille, France. Hôpital Mustapha, Mustapha, Algeria. Charité-University Medicine Berlin, Berlin, Germany. University Hospital Motol, Prague, Czech Republic. Hôpitaux Universitaires de Genève, Geneva, Switzerland. Schneider Children's Medical Center, Petah Tikva, Israel. The Edmond and Lily Safra Children's Hospital, Tel-Hahsomer, Israel. Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia. Centre Hospitalier Universitaire La Pitié-Salpêtrière-Charles Foix, Paris, France. Great Ormond Street Hospital, London, United Kingdom. Université Paris Sorbonne Cité, Paris, France. AN - 31513482 AU - Donadieu, J. AU - Larabi, I. A. AU - Tardieu, M. AU - Visser, J. AU - Hutter, C. AU - Sieni, E. AU - Kabbara, N. AU - Barkaoui, M. AU - Miron, J. AU - Chalard, F. AU - Milne, P. AU - Haroche, J. AU - Cohen, F. AU - Hélias-Rodzewicz, Z. AU - Simon, N. AU - Jehanne, M. AU - Kolenova, A. AU - Pagnier, A. AU - Aladjidi, N. AU - Schneider, P. AU - Plat, G. AU - Lutun, A. AU - Sonntagbauer, A. AU - Lehrnbecher, T. AU - Ferster, A. AU - Efremova, V. AU - Ahlmann, M. AU - Blanc, L. AU - Nicholson, J. AU - Lambilliote, A. AU - Boudiaf, H. AU - Lissat, A. AU - Svojgr, K. AU - Bernard, F. AU - Elitzur, S. AU - Golan, M. AU - Evseev, D. AU - Maschan, M. AU - Idbaih, A. AU - Slater, O. AU - Minkov, M. AU - Taly, V. AU - Collin, M. AU - Alvarez, J. C. AU - Emile, J. F. AU - Héritier, S. C2 - PMC6823889 DA - Nov 1 DO - 10.1200/jco.19.00456 DP - NLM ET - 2019/09/13 IS - 31 LA - eng N1 - 1527-7755 Donadieu, Jean Larabi, Islam Amine Tardieu, Mathilde Visser, Johannes Hutter, Caroline Sieni, Elena Kabbara, Nabil Barkaoui, Mohamed Miron, Jean Chalard, François Milne, Paul Haroche, Julien Cohen, Fleur Hélias-Rodzewicz, Zofia Simon, Nicolas Jehanne, Mathilde Kolenova, Alexandra Pagnier, Anne Aladjidi, Nathalie Schneider, Pascale Plat, Geneviève Lutun, Anne Sonntagbauer, Anne Lehrnbecher, Thomas Ferster, Alina Efremova, Viktoria Ahlmann, Martina Blanc, Laurence Nicholson, James Lambilliote, Anne Boudiaf, Houda Lissat, Andrej Svojgr, Karel Bernard, Fanette Elitzur, Sarah Golan, Michal Evseev, Dmitriy Maschan, Michael Idbaih, Ahmed Slater, Olga Minkov, Milen Taly, Valerie Collin, Matthew Alvarez, Jean-Claude Emile, Jean-François Héritier, Sébastien Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't J Clin Oncol. 2019 Nov 1;37(31):2857-2865. doi: 10.1200/JCO.19.00456. Epub 2019 Sep 12. PY - 2019 SN - 0732-183X (Print) 0732-183x SP - 2857-2865 ST - Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study T2 - J Clin Oncol TI - Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study VL - 37 ID - 897 ER - TY - JOUR AD - Department of Clinical Laboratory, Zhumadian Central Hospital, Zhumadian, 463100, China. Electronic address: guo_dfang3@163.com. Department of Clinical Laboratory, Zhumadian Central Hospital, Zhumadian, 463100, China. Deparment of Hematopathology, Zhumadian Central Hospital, Zhumadian, 463100, China. Deparment of Infectious Diseases, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471000, China. AN - 31521893 AU - Guo, D. AU - Zhang, A. AU - Huang, J. AU - Suo, M. AU - Zhong, Y. AU - Liang, Y. DA - Nov DO - 10.1016/j.biopha.2019.109399 DP - NLM ET - 2019/09/16 LA - eng N1 - 1950-6007 Guo, Dongfang Zhang, Airong Huang, Jing Suo, Meifang Zhong, Yaping Liang, Yile Journal Article France Biomed Pharmacother. 2019 Nov;119:109399. doi: 10.1016/j.biopha.2019.109399. Epub 2019 Sep 12. PY - 2019 SN - 0753-3322 SP - 109399 ST - Suppression of HSP70 inhibits the development of acute lymphoblastic leukemia via TAK1/Egr-1 T2 - Biomed Pharmacother TI - Suppression of HSP70 inhibits the development of acute lymphoblastic leukemia via TAK1/Egr-1 VL - 119 ID - 898 ER - TY - JOUR AD - Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan. Department of Pathology, Nippon Medical School Hospital, Tokyo, Japan. Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan. AN - 31533501 AU - Kure, S. AU - Ishino, K. AU - Kudo, M. AU - Wada, R. AU - Saito, M. AU - Nagaoka, R. AU - Sugitani, I. AU - Naito, Z. C2 - PMC6862924 DA - Nov DO - 10.1177/0300060519873481 DP - NLM ET - 2019/09/20 IS - 11 LA - eng N1 - 1473-2300 Kure, Shoko Orcid: 0000-0002-9536-9438 Ishino, Kousuke Orcid: 0000-0002-6862-9898 Kudo, Mitsuhiro Wada, Ryuichi Saito, Marie Nagaoka, Ryuta Sugitani, Iwao Naito, Zenya Clinical Trial Journal Article J Int Med Res. 2019 Nov;47(11):5560-5572. doi: 10.1177/0300060519873481. Epub 2019 Sep 18. PY - 2019 SN - 0300-0605 (Print) 0300-0605 SP - 5560-5572 ST - Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience T2 - J Int Med Res TI - Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience VL - 47 ID - 899 ER - TY - JOUR AD - Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey. Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Yeditep University, Istanbul, Turkey. Division of Medical Oncology, Umraniye Research and Training Hospital, Istanbul, Turkey. Department of Pathology, Faculty of Medicine, Marmara University, Istanbul, Turkey. Department of Radiology, Faculty of Medicine, Marmara University, Istanbul, Turkey. Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey. AN - 31615346 AU - Alan, O. AU - Kuzhan, O. AU - Koca, S. AU - Telli, T. A. AU - Basoglu, T. AU - Ercelep, O. AU - Filinte, D. AU - Sengul, Y. AU - Arikan, H. AU - Kaya, S. AU - Babacan, N. A. AU - Dane, F. AU - Yumuk, P. F. DA - Jun DO - 10.1177/1078155219879757 DP - NLM ET - 2019/10/17 IS - 4 LA - eng N1 - 1477-092x Alan, Ozkan Orcid: 0000-0002-6635-2012 Kuzhan, Okan Koca, Sinan Telli, Tugba Akin Orcid: 0000-0001-6535-6030 Basoglu, Tugba Ercelep, Ozlem Filinte, Deniz Sengul, Yildiz Arikan, Huseyin Kaya, Serap Babacan, Nalan Akgul Dane, Faysal Yumuk, Perran Fulden Case Reports Journal Article Review England J Oncol Pharm Pract. 2020 Jun;26(4):1011-1018. doi: 10.1177/1078155219879757. Epub 2019 Oct 15. PY - 2020 SN - 1078-1552 SP - 1011-1018 ST - How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature T2 - J Oncol Pharm Pract TI - How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature VL - 26 ID - 900 ER - TY - JOUR AD - Université de Lorraine, CNRS UMR7039 CRAN, Institut de Cancérologie de Lorraine, Service de Biopathologie, Vandoeuvre-lès- Nancy, France. Université de Lorraine, CNRS UMR7039 CRAN, Centre Hospitalier Régional Universitaire (CHRU), Hôpital d'enfants, Service d'Oncologie Pédiatrique, Vandoeuvre-lès-Nancy, France. Service d'Oncologie Pédiatrique, Institut Curie, Paris, France. Service de Neuropathologie, Centre Hospitalier St Anne, Paris, France. Université de Lorraine, INSERM UMRS954 NGERE, Service d'Anatomie Pathologique, CHRU Nancy, Vandoeuvre-lès- Nancy, France. AN - 31642744 AU - Merlin, M. S. AU - Gilson, P. AU - Rouyer, M. AU - Chastagner, P. AU - Doz, F. AU - Varlet, P. AU - Leroux, A. AU - Gauchotte, G. AU - Merlin, J. L. DA - Feb DO - 10.1080/08880018.2019.1679304 DP - NLM ET - 2019/10/24 IS - 1 LA - eng N1 - 1521-0669 Merlin, Marie-Sophie Gilson, Pauline Rouyer, Marie Chastagner, Pascal Doz, François Varlet, Pascale Leroux, Agnès Gauchotte, Guillaume Merlin, Jean-Louis Journal Article England Pediatr Hematol Oncol. 2020 Feb;37(1):29-40. doi: 10.1080/08880018.2019.1679304. Epub 2019 Oct 23. PY - 2020 SN - 0888-0018 SP - 29-40 ST - Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas T2 - Pediatr Hematol Oncol TI - Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas VL - 37 ID - 901 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA. Pediatric Neurosurgery, Children's Hospital of Michigan, Detroit, Michigan, USA. Department of Radiology, Children's Hospital of Michigan, Detroit, Michigan, USA. Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA, yankelevic@gmail.com. Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, yankelevic@gmail.com. AN - 31661699 AU - Gorsi, H. AU - Marupudi, N. I. AU - Sood, S. AU - Altinok, D. AU - Yankelevich, M. DO - 10.1159/000503639 DP - NLM ET - 2019/10/30 IS - 1 LA - eng N1 - 1423-0305 Gorsi, Hamza Marupudi, Neena I Sood, Sandeep Altinok, Deniz Yankelevich, Maxim Case Reports Switzerland Pediatr Neurosurg. 2020;55(1):51-53. doi: 10.1159/000503639. Epub 2019 Oct 29. PY - 2020 SN - 1016-2291 SP - 51-53 ST - Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib T2 - Pediatr Neurosurg TI - Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib VL - 55 ID - 902 ER - TY - JOUR AD - Department of Dermatology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany; The German Cancer Consortium, Heidelberg, Germany. Electronic address: dirk.schadendorf@uk-essen.de. Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Banchi di Sotto, 55, 53100, Siena, SI, Italy. N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Russian Academy of Medical Sciences, Kashirskoye Shosse 24, 115478, Moscow, Russian Federation. Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Centro Ospedaliero, 24129, Bergamo, BG, Italy. Dnipropetrovsk State Medical Academy, Volodymyra Vernadskoho St, 9, Dnipropetrovsk, 49044, Ukraine. Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Via Mariano Semmola, 53, 80131, Napoli, NA, Italy. Bristol Haematology and Oncology Centre, Horfield Rd, Avon, Bristol, BS2 8ED, United Kingdom. Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Collegium Maius, Fredry 10, 61-701, Poznań, Poland. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Wawelska 15 B, 00-001, Warsaw, Poland. Melanoma Translational Research Group, Melanoma Institute Australia, 40 Rocklands Rd, Wollstonecraft NSW, 2065, New South Wales, Australia. Genentech, Inc., 410 Allerton Ave, South San Francisco, CA, 94080, USA. University of Colorado Comprehensive Cancer Center, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA. AN - 31704549 AU - Schadendorf, D. AU - Di Giacomo, A. M. AU - Demidov, L. AU - Merelli, B. AU - Bondarenko, I. AU - Ascierto, P. A. AU - Herbert, C. AU - Mackiewicz, A. AU - Rutkowski, P. AU - Guminski, A. AU - Goodman, G. R. AU - Simmons, B. AU - Ye, C. AU - Hong, A. AU - Lewis, K. DA - Dec DO - 10.1016/j.ejca.2019.09.019 DP - NLM ET - 2019/11/11 LA - eng N1 - 1879-0852 Schadendorf, Dirk Di Giacomo, Anna Maria Demidov, Lev Merelli, Barbara Bondarenko, Igor Ascierto, Paolo A Herbert, Christopher Mackiewicz, Andrzej Rutkowski, Piotr Guminski, Alexander Goodman, Grant R Simmons, Brian Ye, Chenglin Hong, Agnes Lewis, Karl BRIM8 Investigators Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't England Eur J Cancer. 2019 Dec;123:155-161. doi: 10.1016/j.ejca.2019.09.019. Epub 2019 Nov 5. PY - 2019 SN - 0959-8049 SP - 155-161 ST - Health-related quality of life in patients with fully resected BRAF(V600) mutation-positive melanoma receiving adjuvant vemurafenib T2 - Eur J Cancer TI - Health-related quality of life in patients with fully resected BRAF(V600) mutation-positive melanoma receiving adjuvant vemurafenib VL - 123 ID - 904 ER - TY - JOUR AD - Department of Dermatology, Complejo Hospitalario de Navarra, Navarra, Spain. Department of Dermatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. AN - 31705590 AU - Martínez-de-Espronceda, I. AU - Bernabeu-Wittel, J. AU - Azcona, M. AU - Monserrat, M. T. DA - Jan DO - 10.1111/dth.13164 DP - NLM ET - 2019/11/11 IS - 1 LA - eng N1 - 1529-8019 Martínez-de-Espronceda, Inigo Orcid: 0000-0002-7211-3456 Bernabeu-Wittel, José Azcona, Maialen Monserrat, Maria-Teresa Letter United States Dermatol Ther. 2020 Jan;33(1):e13164. doi: 10.1111/dth.13164. Epub 2019 Nov 15. PY - 2020 SN - 1396-0296 SP - e13164 ST - Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient T2 - Dermatol Ther TI - Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient VL - 33 ID - 905 ER - TY - JOUR AD - Department of Pathology and Molecular Medicine, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Electronic address: alena.kalfusova@fnmotol.cz. Department of Oncology, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Department of Pathology and Molecular Medicine, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Department of Paediatric Haematology and Oncology, Charles University - 2nd Faculty of Medicine and University Hospital Motol, Czech Republic. AN - 31708372 AU - Kalfusova, A. AU - Linke, Z. AU - Kalinova, M. AU - Krskova, L. AU - Hilska, I. AU - Szabova, J. AU - Vicha, A. AU - Kodet, R. DA - Dec DO - 10.1016/j.prp.2019.152708 DP - NLM ET - 2019/11/12 IS - 12 LA - eng N1 - 1618-0631 Kalfusova, Alena Linke, Zdenek Kalinova, Marketa Krskova, Lenka Hilska, Irena Szabova, Jana Vicha, Ales Kodet, Roman Journal Article Germany Pathol Res Pract. 2019 Dec;215(12):152708. doi: 10.1016/j.prp.2019.152708. Epub 2019 Oct 29. PY - 2019 SN - 0344-0338 SP - 152708 ST - Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects T2 - Pathol Res Pract TI - Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects VL - 215 ID - 906 ER - TY - JOUR AD - Memorial Sloan Kettering Cancer Center, New York. Weill Cornell Medical College, New York, USA. AN - 31738426 AU - Drilon, A. C2 - PMC6859818 DA - Nov 1 DO - 10.1093/annonc/mdz282 DP - NLM ET - 2019/11/19 IS - Suppl_8 LA - eng N1 - 1569-8041 Drilon, A P30 CA008748/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Review Ann Oncol. 2019 Nov 1;30(Suppl_8):viii23-viii30. doi: 10.1093/annonc/mdz282. PY - 2019 SN - 0923-7534 (Print) 0923-7534 SP - viii23-viii30 ST - TRK inhibitors in TRK fusion-positive cancers T2 - Ann Oncol TI - TRK inhibitors in TRK fusion-positive cancers VL - 30 ID - 907 ER - TY - JOUR AD - Ta-Kuo Clinic, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: lms870088@gmail.com. Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Laboratory Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: pedhung@gmail.com. AN - 31759853 AU - Kuo, C. H. AU - Lee, M. S. AU - Kuo, H. F. AU - Lin, Y. C. AU - Hung, C. H. DA - Dec DO - 10.1016/j.jmii.2019.10.001 DP - NLM ET - 2019/11/25 IS - 6 LA - eng N1 - 1995-9133 Kuo, Chang-Hung Lee, Min-Sheng Kuo, Hsuan-Fu Lin, Yi-Ching Hung, Chih-Hsing Journal Article England J Microbiol Immunol Infect. 2019 Dec;52(6):872-879. doi: 10.1016/j.jmii.2019.10.001. Epub 2019 Nov 5. PY - 2019 SN - 1684-1182 SP - 872-879 ST - Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line T2 - J Microbiol Immunol Infect TI - Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line VL - 52 ID - 908 ER - TY - JOUR AD - Pediatric Oncology Unit, UCL Great Ormond Street Institute of Child Health, London, United Kingdom. darren.hargrave@nhs.net. Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Arthur and Sonia Labatt Brain Tumor Research Center, Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Division of Pediatric Oncology, Baltimore, Maryland. Department of Pediatrics, The Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Victoria, Australia. Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. Novartis Healthcare Pvt. Ltd., Hyderabad, India. Harvard Medical School, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. AN - 31811016 AU - Hargrave, D. R. AU - Bouffet, E. AU - Tabori, U. AU - Broniscer, A. AU - Cohen, K. J. AU - Hansford, J. R. AU - Geoerger, B. AU - Hingorani, P. AU - Dunkel, I. J. AU - Russo, M. W. AU - Tseng, L. AU - Dasgupta, K. AU - Gasal, E. AU - Whitlock, J. A. AU - Kieran, M. W. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-19-2177 DP - NLM ET - 2019/12/08 IS - 24 LA - eng N1 - Hargrave, Darren R Orcid: 0000-0001-8219-9807 Bouffet, Eric Tabori, Uri Broniscer, Alberto Cohen, Kenneth J Orcid: 0000-0001-9193-9344 Hansford, Jordan R Orcid: 0000-0001-7733-383x Geoerger, Birgit Hingorani, Pooja Dunkel, Ira J Orcid: 0000-0001-8091-6067 Russo, Mark W Tseng, Lillian Orcid: 0000-0002-2833-1480 Dasgupta, Kohinoor Gasal, Eduard Whitlock, James A Kieran, Mark W P50 CA165962/CA/NCI NIH HHS/United States Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States Clin Cancer Res. 2019 Dec 15;25(24):7303-7311. doi: 10.1158/1078-0432.CCR-19-2177. PY - 2019 SN - 1078-0432 (Print) 1078-0432 SP - 7303-7311 ST - Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study T2 - Clin Cancer Res TI - Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study VL - 25 ID - 909 ER - TY - JOUR AD - Department of Pathology, National University Health System, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology, National University Health System, Singapore, Singapore. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore. Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. AN - 31820133 AU - Tan, C. L. AU - Lian, D. W. Q. AU - Kuick, C. H. AU - Chan, Y. H. AU - Chang, K. T. E. DA - Jan DO - 10.1007/s10014-019-00356-9 DP - NLM ET - 2019/12/11 IS - 1 LA - eng N1 - 1861-387x Tan, C L Orcid: 0000-0002-1470-3175 Lian, D W Q Kuick, C H Chan, Y H Chang, K T E Journal Article Japan Brain Tumor Pathol. 2020 Jan;37(1):14-21. doi: 10.1007/s10014-019-00356-9. Epub 2019 Dec 9. PY - 2020 SN - 1433-7398 SP - 14-21 ST - Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall T2 - Brain Tumor Pathol TI - Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall VL - 37 ID - 910 ER - TY - JOUR AD - Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Department of Pediatric Neurology, University Medical Center Utrecht, Utrecht, The Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Department of Pediatrics, Medical University of Vienna, Vienna, Austria. Institute of Neurology, Medical University of Vienna, Vienna, Austria. Department of Neurology and Epileptology, Children's Memorial Health Institute, Warsaw, Poland. Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland. Department of Pathology, Children's Memorial Health Institute, Warsaw, Poland. Pathology Unit, Anna Meyer Children's Hospital, Florence, Italy. Department of Neurosurgery, Anna Meyer Children's Hospital, Florence, Italy. Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany. Department of Paediatric Neurology, Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic. Department of Pathology and Molecular Medicine, Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Center for Experimental and Molecular Medicine and Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Stichting Epilepsie Instellingen Nederland (SEIN), The Netherlands. AN - 31834371 AU - Bongaarts, A. AU - van Scheppingen, J. AU - Korotkov, A. AU - Mijnsbergen, C. AU - Anink, J. J. AU - Jansen, F. E. AU - Spliet, W. G. M. AU - den Dunnen, W. F. A. AU - Gruber, V. E. AU - Scholl, T. AU - Samueli, S. AU - Hainfellner, J. A. AU - Feucht, M. AU - Kotulska, K. AU - Jozwiak, S. AU - Grajkowska, W. AU - Buccoliero, A. M. AU - Caporalini, C. AU - Giordano, F. AU - Genitori, L. AU - Coras, R. AU - Blümcke, I. AU - Krsek, P. AU - Zamecnik, J. AU - Meijer, L. AU - Scicluna, B. P. AU - Schouten-van Meeteren, A. Y. N. AU - Mühlebner, A. AU - Mills, J. D. AU - Aronica, E. C2 - PMC6935755 DA - Jan 1 DO - 10.1093/brain/awz370 DP - NLM ET - 2019/12/14 IS - 1 LA - eng N1 - 1460-2156 Bongaarts, Anika van Scheppingen, Jackelien Korotkov, Anatoly Mijnsbergen, Caroline Anink, Jasper J Jansen, Floor E Spliet, Wim G M den Dunnen, Wilfred F A Gruber, Victoria E Scholl, Theresa Samueli, Sharon Hainfellner, Johannes A Feucht, Martha Kotulska, Katarzyna Jozwiak, Sergiusz Grajkowska, Wieslawa Buccoliero, Anna Maria Caporalini, Chiara Giordano, Flavio Genitori, Lorenzo Coras, Roland Blümcke, Ingmar Krsek, Pavel Zamecnik, Josef Meijer, Lisethe Scicluna, Brendon P Schouten-van Meeteren, Antoinette Y N Mühlebner, Angelika Mills, James D Aronica, Eleonora Journal Article Research Support, Non-U.S. Gov't Brain. 2020 Jan 1;143(1):131-149. doi: 10.1093/brain/awz370. PY - 2020 SN - 0006-8950 (Print) 0006-8950 SP - 131-149 ST - The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas T2 - Brain TI - The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas VL - 143 ID - 911 ER - TY - JOUR AD - Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. Mucosal Immunobiology and Vaccine Center (MIVAC), Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, SE-405 30, Gothenburg, Sweden. Turning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200, San Diego, California, 92121, United States. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. ruth.palmer@gu.se. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. bengt.hallberg@gu.se. AN - 31852910 AU - Cervantes-Madrid, D. AU - Szydzik, J. AU - Lind, D. E. AU - Borenäs, M. AU - Bemark, M. AU - Cui, J. AU - Palmer, R. H. AU - Hallberg, B. C2 - PMC6920469 Therapeutics. All other authors declare no potential conflict of interest. DA - Dec 18 DO - 10.1038/s41598-019-55060-7 DP - NLM ET - 2019/12/20 IS - 1 LA - eng N1 - 2045-2322 Cervantes-Madrid, Diana Orcid: 0000-0003-1071-1407 Szydzik, Joanna Lind, Dan Emil Orcid: 0000-0002-8299-5659 Borenäs, Marcus Bemark, Mats Orcid: 0000-0001-7416-9819 Cui, Jean Palmer, Ruth Helen Hallberg, Bengt Orcid: 0000-0003-2032-2616 Journal Article Research Support, Non-U.S. Gov't Sci Rep. 2019 Dec 18;9(1):19353. doi: 10.1038/s41598-019-55060-7. PY - 2019 SN - 2045-2322 SP - 19353 ST - Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells T2 - Sci Rep TI - Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells VL - 9 ID - 912 ER - TY - JOUR AD - Division of Child Neurology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada. s.perreault@umontreal.ca. Division of Hemato-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada. Department of Pathology, Hospital for Sick Children, Toronto, ON, Canada. CHU Sainte-Justine Research Center, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Pathology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Radiology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Pharmacology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Neuropsychology, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, QC, Canada. Division of Neurology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Departments of Oncology and Pediatrics, Alberta Children's Hospital, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada. Division of Child Neurology and Oncology, BC Children's Hospital, University of British Columbia, BC, Vancouver, British Columbia, Canada. Division of Hemato-Oncology, Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. Division of Hemato-Oncology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. AN - 31881853 AU - Perreault, S. AU - Larouche, V. AU - Tabori, U. AU - Hawkin, C. AU - Lippé, S. AU - Ellezam, B. AU - Décarie, J. C. AU - Théoret, Y. AU - Métras, MÉ AU - Sultan, S. AU - Cantin, É AU - Routhier, MÈ AU - Caru, M. AU - Legault, G. AU - Bouffet, É AU - Lafay-Cousin, L. AU - Hukin, J. AU - Erker, C. AU - Jabado, N. C2 - PMC6935133 DA - Dec 27 DO - 10.1186/s12885-019-6442-2 DP - NLM ET - 2019/12/29 IS - 1 LA - eng N1 - 1471-2407 Perreault, Sébastien Orcid: 0000-0002-4417-7698 Larouche, Valérie Tabori, Uri Hawkin, Cynthia Lippé, Sarah Ellezam, Benjamin Décarie, Jean-Claude Théoret, Yves Métras, Marie-Élaine Sultan, Serge Cantin, Édith Routhier, Marie-Ève Caru, Maxime Legault, Geneviève Bouffet, Éric Lafay-Cousin, Lucie Hukin, Juliette Erker, Craig Jabado, Nada 419196/CAPMC/CIHR/Canada Clinical Trial Protocol Clinical Trial, Phase II Journal Article Multicenter Study BMC Cancer. 2019 Dec 27;19(1):1250. doi: 10.1186/s12885-019-6442-2. PY - 2019 SN - 1471-2407 SP - 1250 ST - A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01 T2 - BMC Cancer TI - A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01 VL - 19 ID - 913 ER - TY - JOUR AD - Department of Child Health, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China; School of Public Health, Xiamen University, Xiamen, Fujian, China. School of Public Health, Xiamen University, Xiamen, Fujian, China. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China; Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, China; Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China. Fulgent Technologies Inc, Minhang District, Shanghai, China. Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Electronic address: chenjing8469899@126.com. Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; Division of Genetics and Genomics, Boston Children's Hospital, Department of Neurology, Harvard Medical School, Boston, MA, USA. Electronic address: yiping.shen@childrens.harvard.edu. AN - 31972311 AU - Chen, J. AU - Che, L. AU - Xu, C. AU - Zhao, S. AU - Yang, J. AU - Li, M. AU - Li, G. AU - Shen, Y. DA - Apr 5 DO - 10.1016/j.gene.2020.144369 DP - NLM ET - 2020/01/24 LA - eng N1 - 1879-0038 Chen, Jing Che, Lin Xu, Chao Zhao, Suzhou Yang, Jiangfei Li, Mengting Li, Guimei Shen, Yiping Case Reports Journal Article Netherlands Gene. 2020 Apr 5;733:144369. doi: 10.1016/j.gene.2020.144369. Epub 2020 Jan 20. PY - 2020 SN - 0378-1119 SP - 144369 ST - Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy T2 - Gene TI - Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy VL - 733 ID - 914 ER - TY - JOUR AD - University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: reinhard.dummer@usz.ch. Novartis Pharma, Basel, Switzerland. Novartis Institutes for BioMedical Research, Cambridge, MA, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane, QLD, Australia. Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Royal Marsden NHS Foundation Trust, London, UK. Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif, France. Macquarie University and Westmead Hospital, Sydney, NSW, Australia; Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. Melanoma Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. University Hospital Schleswig-Holstein, Kiel, Germany. University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. AN - 32007138 AU - Dummer, R. AU - Brase, J. C. AU - Garrett, J. AU - Campbell, C. D. AU - Gasal, E. AU - Squires, M. AU - Gusenleitner, D. AU - Santinami, M. AU - Atkinson, V. AU - Mandalà, M. AU - Chiarion-Sileni, V. AU - Flaherty, K. AU - Larkin, J. AU - Robert, C. AU - Kefford, R. AU - Kirkwood, J. M. AU - Hauschild, A. AU - Schadendorf, D. AU - Long, G. V. DA - Mar DO - 10.1016/s1470-2045(20)30062-0 DP - NLM ET - 2020/02/03 IS - 3 LA - eng N1 - 1474-5488 Dummer, Reinhard Brase, Jan C Garrett, James Campbell, Catarina D Gasal, Eduard Squires, Matthew Gusenleitner, Daniel Santinami, Mario Atkinson, Victoria Mandalà, Mario Chiarion-Sileni, Vanna Flaherty, Keith Larkin, James Robert, Caroline Kefford, Richard Kirkwood, John M Hauschild, Axel Schadendorf, Dirk Long, Georgina V Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't England Lancet Oncol. 2020 Mar;21(3):358-372. doi: 10.1016/S1470-2045(20)30062-0. Epub 2020 Jan 30. PY - 2020 SN - 1470-2045 SP - 358-372 ST - Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial T2 - Lancet Oncol TI - Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial VL - 21 ID - 915 ER - TY - JOUR AD - Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, United Kingdom. Pathology Department, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy. Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester, United Kingdom. SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL University, Paris, France. Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Department of Pediatric Oncology, Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France. Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Hematology and Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy. Paediatric Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center Amsterdam, Netherlands. Clinical Trials and Biostatistics Unit, IRCCS Istituto Oncologico Veneto, Padova, Italy. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Electronic address: andrea.ferrari@istitutotumori.mi.it. AN - 32007712 AU - Casanova, M. AU - Brennan, B. AU - Alaggio, R. AU - Kelsey, A. AU - Orbach, D. AU - van Noesel, M. M. AU - Corradini, N. AU - Minard-Colin, V. AU - Zanetti, I. AU - Bisogno, G. AU - Gallego, S. AU - Merks, J. H. M. AU - De Salvo, G. L. AU - Ferrari, A. DA - Mar DO - 10.1016/j.ejca.2019.12.021 DP - NLM ET - 2020/02/03 LA - eng N1 - 1879-0852 Casanova, Michela Brennan, Bernadette Alaggio, Rita Kelsey, Anna Orbach, Daniel van Noesel, Max M Corradini, Nadege Minard-Colin, Veronique Zanetti, Ilaria Bisogno, Gianni Gallego, Soledad Merks, Johannes H M De Salvo, Gian Luca Ferrari, Andrea Journal Article Multicenter Study England Eur J Cancer. 2020 Mar;127:123-129. doi: 10.1016/j.ejca.2019.12.021. Epub 2020 Jan 30. PY - 2020 SN - 0959-8049 SP - 123-129 ST - Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) T2 - Eur J Cancer TI - Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) VL - 127 ID - 916 ER - TY - JOUR AD - Laboratory of Molecular Nutrition and Immunity, Northeast Agricultural University, Harbin, P.R. China. AN - 32037545 AU - Dong, N. AU - Li, X. AU - Xue, C. AU - Zhang, L. AU - Wang, C. AU - Xu, X. AU - Shan, A. DA - Jul DO - 10.1002/jcp.29452 DP - NLM ET - 2020/02/11 IS - 7-8 LA - eng N1 - 1097-4652 Dong, Na Li, Xinran Orcid: 0000-0003-3840-728x Xue, Chenyu Zhang, Lei Wang, Chensi Xu, Xinyao Shan, Anshan CARS-35/Supported by the China Agriculture Research System/ 16XG14/Academic Backbone Project of Northeast Agricultural University/ LH2019C023/Heilongjiang Province Natural Science Foundation of Heilongjiang Province/ 31472104/National Natural Science Foundation of China/ 31672434/National Natural Science Foundation of China/ Journal Article United States J Cell Physiol. 2020 Jul;235(7-8):5525-5540. doi: 10.1002/jcp.29452. Epub 2020 Feb 9. PY - 2020 SN - 0021-9541 SP - 5525-5540 ST - Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway T2 - J Cell Physiol TI - Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway VL - 235 ID - 917 ER - TY - JOUR AD - 1Department of Neurosurgery, Hokkaido University School of Medicine, Kita-ku, Sapporo. 2Department of Surgical Pathology, Hokkaido University Hospital, Kita-ku, Sapporo; and. 3Department of Neurosurgery, Kashiwaba Neurosurgical Hospital, Toyohira-ku, Sapporo, Hokkaido, Japan. AN - 32059187 AU - Ishi, Y. AU - Yamaguchi, S. AU - Hatanaka, K. C. AU - Okamoto, M. AU - Motegi, H. AU - Kobayashi, H. AU - Terasaka, S. AU - Houkin, K. DA - Feb 14 DO - 10.3171/2019.12.Jns192155 DP - NLM ET - 2020/02/15 LA - eng N1 - 1933-0693 Ishi, Yukitomo Yamaguchi, Shigeru Hatanaka, Kanako C Okamoto, Michinari Motegi, Hiroaki Kobayashi, Hiroyuki Terasaka, Shunsuke Houkin, Kiyohiro Journal Article United States J Neurosurg. 2020 Feb 14:1-9. doi: 10.3171/2019.12.JNS192155. PY - 2020 SN - 0022-3085 SP - 1-9 ST - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients T2 - J Neurosurg TI - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients ID - 918 ER - TY - JOUR AD - Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland). AN - 32065117 AU - Xu, W. AU - Wang, Z. AU - Li, K. AU - Jin, R. C2 - PMC7043341 DA - Feb 17 DO - 10.12659/msm.921649 DP - NLM ET - 2020/02/18 LA - eng N1 - 1643-3750 Xu, Wenfu Wang, Zhujun Li, Kun Jin, Runming Journal Article Med Sci Monit. 2020 Feb 17;26:e921649. doi: 10.12659/MSM.921649. PY - 2020 SN - 1234-1010 (Print) 1234-1010 SP - e921649 ST - Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α T2 - Med Sci Monit TI - Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α VL - 26 ID - 919 ER - TY - JOUR AD - Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; and. Division of Bone Marrow Transplant and Immune Deficiency. Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, and. Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. AN - 32092141 AU - Lee, L. H. AU - Krupski, C. AU - Clark, J. AU - Wunderlich, M. AU - Lorsbach, R. B. AU - Grimley, M. S. AU - Burwinkel, M. AU - Nelson, A. AU - Kumar, A. R. C2 - PMC7042980 and Sobi for primary HLH therapy. The remaining authors declare no competing financial interests. DA - Feb 25 DO - 10.1182/bloodadvances.2019032367 DP - NLM ET - 2020/02/25 IS - 4 LA - eng N1 - 2473-9537 Lee, Lynn H Krupski, Christa Clark, Jason Wunderlich, Mark Lorsbach, Robert B Grimley, Michael S Burwinkel, Matthew Nelson, Adam Kumar, Ashish R L40 HL143713/HL/NHLBI NIH HHS/United States R50 CA211404/CA/NCI NIH HHS/United States S10 OD023410/OD/NIH HHS/United States Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Blood Adv. 2020 Feb 25;4(4):717-727. doi: 10.1182/bloodadvances.2019032367. PY - 2020 SN - 2473-9529 (Print) 2473-9529 SP - 717-727 ST - High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy T2 - Blood Adv TI - High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy VL - 4 ID - 920 ER - TY - JOUR AD - From the Pediatric Oncology Branch (A.M.G., P.L.W., E.D., P.W., S.M., M.C.R., D.C.P., A.C., J.T., O.K., J.G., B.C.W.) and the Clinical Pharmacology Program (C.J.P., W.D.F.), Center for Cancer Research, National Cancer Institute, and the Rehabilitation Medicine Department, Clinical Center (S.M.P), National Institutes of Health, Bethesda, the Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick (A.B., K.H.), the Cancer Therapy Evaluation Program (M.S., L.A.D.) and the Biostatistics and Data Management Section, Center for Cancer Research (S.M.S., D.J.V.), National Cancer Institute, National Institutes of Health, Shady Grove, and Johns Hopkins University School of Medicine, Baltimore (J.O.B.) - all in Maryland; Children's Hospital of Philadelphia, Philadelphia (M.J.F., A.C.S.); Cincinnati Children's Hospital, Cincinnati (B.W.); Children's National Hospital, Washington, DC (A.K., M.B.); and Indiana University School of Medicine, Indianapolis (D.W.C., C.Z.). AN - 32187457 AU - Gross, A. M. AU - Wolters, P. L. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Bornhorst, M. AU - Shah, A. C. AU - Martin, S. AU - Roderick, M. C. AU - Pichard, D. C. AU - Carbonell, A. AU - Paul, S. M. AU - Therrien, J. AU - Kapustina, O. AU - Heisey, K. AU - Clapp, D. W. AU - Zhang, C. AU - Peer, C. J. AU - Figg, W. D. AU - Smith, M. AU - Glod, J. AU - Blakeley, J. O. AU - Steinberg, S. M. AU - Venzon, D. J. AU - Doyle, L. A. AU - Widemann, B. C. C2 - PMC7305659 C6 - NIHMS1590456 DA - Apr 9 DO - 10.1056/NEJMoa1912735 DP - NLM ET - 2020/03/19 IS - 15 LA - eng N1 - 1533-4406 Gross, Andrea M Wolters, Pamela L Dombi, Eva Baldwin, Andrea Whitcomb, Patricia Fisher, Michael J Weiss, Brian Kim, AeRang Bornhorst, Miriam Shah, Amish C Martin, Staci Roderick, Marie C Pichard, Dominique C Carbonell, Amanda Paul, Scott M Therrien, Janet Kapustina, Oxana Heisey, Kara Clapp, D Wade Zhang, Chi Peer, Cody J Figg, William D Orcid: 0000-0003-2428-5613 Smith, Malcolm Glod, John Blakeley, Jaishri O Steinberg, Seth M Venzon, David J Doyle, L Austin Widemann, Brigitte C U54 CA196519/CA/NCI NIH HHS/United States Z99 CA999999/ImNIH/Intramural NIH HHS/United States U54 CA196519-04/US/United States/United States Clinical Trial, Phase II Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't N Engl J Med. 2020 Apr 9;382(15):1430-1442. doi: 10.1056/NEJMoa1912735. Epub 2020 Mar 18. PY - 2020 SN - 0028-4793 (Print) 0028-4793 SP - 1430-1442 ST - Selumetinib in Children with Inoperable Plexiform Neurofibromas T2 - N Engl J Med TI - Selumetinib in Children with Inoperable Plexiform Neurofibromas VL - 382 ID - 921 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Center for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. University Cancer Center (UCT), University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK)-German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Institute of Pathology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. AN - 32224911 AU - Beck, O. AU - Paret, C. AU - Russo, A. AU - Burhenne, J. AU - Fresnais, M. AU - Steimel, K. AU - Seidmann, L. AU - Wagner, D. C. AU - Vewinger, N. AU - Lehmann, N. AU - Sprang, M. AU - Backes, N. AU - Roth, L. AU - Neu, M. A. AU - Wingerter, A. AU - Henninger, N. AU - Malki, K. E. AU - Otto, H. AU - Alt, F. AU - Desuki, A. AU - Kindler, T. AU - Faber, J. C2 - PMC7225940 DA - Mar 26 DO - 10.3390/cancers12040793 DP - NLM ET - 2020/04/01 IS - 4 LA - eng N1 - 2072-6694 Beck, Olaf Paret, Claudia Orcid: 0000-0002-9094-1634 Russo, Alexandra Burhenne, Jürgen Fresnais, Margaux Steimel, Kevin Seidmann, Larissa Wagner, Daniel-Christoph Vewinger, Nadine Lehmann, Nadine Orcid: 0000-0003-1897-3129 Sprang, Maximilian Backes, Nora Roth, Lea Neu, Marie Astrid Wingerter, Arthur Henninger, Nicole Malki, Khalifa El Otto, Henrike Alt, Francesca Desuki, Alexander Kindler, Thomas Faber, Joerg KKH010/16/Children's Cancer Foundation Mainz/ KS01/18/Sophia Kallinowsky Foundation/ Journal Article Cancers (Basel). 2020 Mar 26;12(4):793. doi: 10.3390/cancers12040793. PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma T2 - Cancers (Basel) TI - Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma VL - 12 ID - 923 ER - TY - JOUR AD - Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21287, USA. Division of Pediatric Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. The Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. Center for Cancer and Blood Disorders, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, D.C. 20010, USA. AN - 32238401 AU - Obasaju, P. AU - Shahab, S. AU - Dunn, E. AU - Rhee, D. S. AU - Jiang, L. AU - Dome, J. S. AU - Friedman, A. D. AU - Argani, P. AU - Pratilas, C. A. C2 - PMC7133746 DA - Apr DO - 10.1101/mcs.a004820 DP - NLM ET - 2020/04/03 IS - 2 LA - eng N1 - 2373-2873 Obasaju, Patience Shahab, Shubin Dunn, Emily Rhee, Daniel S Jiang, LiQun Dome, Jeffrey S Friedman, Alan D Argani, Pedram Pratilas, Christine A Journal Article Cold Spring Harb Mol Case Stud. 2020 Apr 1;6(2):a004820. doi: 10.1101/mcs.a004820. Print 2020 Apr. PY - 2020 SN - 2373-2873 ST - BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition T2 - Cold Spring Harb Mol Case Stud TI - BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition VL - 6 ID - 924 ER - TY - JOUR AD - University of Texas Southwestern, Dallas, Texas, USA. Massachusetts General Hospital, Boston, Massachusetts, USA. Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Children's Tumor Foundation, New York, New York, USA. Keck School of Medicine of USC, Children's Hospital of Los Angeles, Los Angeles, California, USA. Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio. Boston Children's Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA. University of Utah, Salt Lake City, Utah, USA. NYU Langone Health, New York, New York, USA. AN - 32272491 AU - Klesse, L. J. AU - Jordan, J. T. AU - Radtke, H. B. AU - Rosser, T. AU - Schorry, E. AU - Ullrich, N. AU - Viskochil, D. AU - Knight, P. AU - Plotkin, S. R. AU - Yohay, K. C2 - PMC7356675 DA - Jul DO - 10.1634/theoncologist.2020-0069 DP - NLM ET - 2020/04/10 IS - 7 LA - eng N1 - 1549-490x Klesse, Laura J Orcid: 0000-0003-1323-7720 Jordan, Justin T Radtke, Heather B Rosser, Tena Schorry, Elizabeth Ullrich, Nicole Viskochil, David Knight, Pamela Plotkin, Scott R Yohay, Kaleb Orcid: 0000-0001-5560-3392 Journal Article Oncologist. 2020 Jul;25(7):e1109-e1116. doi: 10.1634/theoncologist.2020-0069. Epub 2020 Apr 22. PY - 2020 SN - 1083-7159 (Print) 1083-7159 SP - e1109-e1116 ST - The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities T2 - Oncologist TI - The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities VL - 25 ID - 925 ER - TY - JOUR AD - Department of Neurosciences, University of California and Rady Children's Hospital. Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego and Rady Children's Hospital, San Diego, CA. AN - 32398601 AU - Paul, M. R. AU - Pehlivan, K. C. AU - Milburn, M. AU - Yeh-Nayre, L. AU - Elster, J. AU - Crawford, J. R. DA - Nov DO - 10.1097/mph.0000000000001819 DP - NLM ET - 2020/05/14 IS - 8 LA - eng N1 - 1536-3678 Paul, Megan R Pehlivan, Katherine C Milburn, Mehrzad Yeh-Nayre, Lanipua Elster, Jennifer Crawford, John R Journal Article United States J Pediatr Hematol Oncol. 2020 Nov;42(8):e730-e737. doi: 10.1097/MPH.0000000000001819. PY - 2020 SN - 1077-4114 SP - e730-e737 ST - Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience T2 - J Pediatr Hematol Oncol TI - Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience VL - 42 ID - 926 ER - TY - JOUR AD - Departments of Dermatology. Pathology, Leiden University Medical Center, Leiden. Department of Dermatology, Academic Medical Center and Vrije University Medical Center, Amsterdam. Department of Dermatology, University Medical Center of Groningen, Groningen, The Netherlands. AN - 32412717 AU - Melchers, R. C. AU - Willemze, R. AU - van de Loo, M. AU - van Doorn, R. AU - Jansen, P. M. AU - Cleven, A. H. G. AU - Solleveld, N. AU - Bekkenk, M. W. AU - van Kester, M. S. AU - Diercks, G. F. H. AU - Vermeer, M. H. AU - Quint, K. D. DA - Jun DO - 10.1097/pas.0000000000001449 DP - NLM ET - 2020/05/16 IS - 6 LA - eng N1 - 1532-0979 Melchers, Rutger C Willemze, Rein van de Loo, Merel van Doorn, Remco Jansen, Patty M Cleven, Arjen H G Solleveld, Nienke Bekkenk, Marcel W van Kester, Marloes S Diercks, Gillis F H Vermeer, Maarten H Quint, Koen D Journal Article United States Am J Surg Pathol. 2020 Jun;44(6):776-781. doi: 10.1097/PAS.0000000000001449. PY - 2020 SN - 0147-5185 SP - 776-781 ST - Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma T2 - Am J Surg Pathol TI - Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma VL - 44 ID - 927 ER - TY - JOUR AD - Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp. Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp. AN - 32514929 AU - Kobayashi, M. AU - Ando, S. AU - Kawamata, T. AU - Makiyama, J. AU - Yokoyama, K. AU - Imai, Y. AU - Tojo, A. DA - Aug DO - 10.1007/s12185-020-02892-z DP - NLM ET - 2020/06/10 IS - 2 LA - eng N1 - 1865-3774 Kobayashi, Masayuki Ando, Shohei Kawamata, Toyotaka Makiyama, Junya Yokoyama, Kazuaki Imai, Yoichi Tojo, Arinobu Orcid: 0000-0001-9016-1948 Journal Article Japan Int J Hematol. 2020 Aug;112(2):185-192. doi: 10.1007/s12185-020-02892-z. Epub 2020 Jun 8. PY - 2020 SN - 0925-5710 SP - 185-192 ST - Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience T2 - Int J Hematol TI - Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience VL - 112 ID - 928 ER - TY - JOUR AD - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center. Department of Pediatrics, University of Cincinnati College of Medicine. Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. AN - 32520842 AU - Lazow, M. A. AU - Lawson, S. A. AU - Salloum, R. AU - Hummel, T. R. AU - Pillay Smiley, N. AU - DeWire-Schottmiller, M. D. AU - Fouladi, M. AU - de Blank, P. DA - Jun 9 DO - 10.1097/mph.0000000000001859 DP - NLM ET - 2020/06/11 LA - eng N1 - 1536-3678 Lazow, Margot A Lawson, Sarah A Salloum, Ralph Hummel, Trent R Pillay Smiley, Natasha DeWire-Schottmiller, Mariko D Fouladi, Maryam de Blank, Peter Journal Article United States J Pediatr Hematol Oncol. 2020 Jun 9. doi: 10.1097/MPH.0000000000001859. PY - 2020 SN - 1077-4114 ST - Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor T2 - J Pediatr Hematol Oncol TI - Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor ID - 929 ER - TY - JOUR AD - Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy. francescobaldo11@yahoo.it. Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy. Pharmacy and Clinical Pharmacology Unit, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. Department of Radiology, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. Department of Radiology, Institute for Maternal and Child Health, IRCCS Giannina Gaslini, Via Gerolamo Gaslini 5, 16147, Genova, Italy. Department of Pediatrics, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. AN - 32533336 AU - Baldo, F. AU - Grasso, A. G. AU - Cortellazzo Wiel, L. AU - Maestro, A. AU - Trojniak, M. P. AU - Murru, F. M. AU - Basso, L. AU - Magnolato, A. AU - Bruno, I. AU - Barbi, E. DA - Aug DO - 10.1007/s40272-020-00399-y DP - NLM ET - 2020/06/14 IS - 4 LA - eng N1 - 1179-2019 Baldo, Francesco Orcid: 0000-0002-7523-3154 Grasso, Antonio Giacomo Cortellazzo Wiel, Luisa Orcid: 0000-0003-0069-560x Maestro, Alessandra Trojniak, Marta Paulina Murru, Flora Maria Orcid: 0000-0001-8954-8889 Basso, Luca Orcid: 0000-0003-0289-8283 Magnolato, Andrea Orcid: 0000-0002-5099-6526 Bruno, Irene Orcid: 0000-0002-2437-6198 Barbi, Egidio Orcid: 0000-0002-6343-846x Journal Article Switzerland Paediatr Drugs. 2020 Aug;22(4):417-423. doi: 10.1007/s40272-020-00399-y. PY - 2020 SN - 1174-5878 SP - 417-423 ST - Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects T2 - Paediatr Drugs TI - Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects VL - 22 ID - 930 ER - TY - JOUR AD - Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom. European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, United Kingdom. Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, Vienna, Austria. Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, University Hospital Tübingen, Eberhard-Karls-University, Tübingen, Germany. Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA. Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY. Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. Department of Pediatric Hematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom. Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan. Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria. Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. Department of Pediatric, Adolescent, and Young Adult Oncology, Institute Curie Medical Centre, Paris, France. Department of Pediatric Oncology and Hematology, Sorbonne Université/Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Department of Pathology, (AP-HP), CHU Necker-Enfants Malades, Paris, France. Oncology Center SIREDO (Care, Innovation, Research for Cancer in Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris, France. INSERM U830 Transfer Department, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. Equipe Integrated Cancer Research Site (SiRIC) Recherche Translationelle en Oncologie Pédiatrique (RTOP), Institut Curie, Paris, France. Department of Pathology, Hematopathology Section, Universitätsklinikum Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany. School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China. Department of Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Department of Clinical Research, Gustave Roussy Cancer Center, Villejuif, France. Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria. Center for Biomarker Research in Medicine (CBmed) Vienna, Core-Lab2, Medical University of Vienna, Vienna, Austria. Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France; and. INSERM U1015, Université Paris-Saclay, Villejuif, France. AN - 32573700 AU - Prokoph, N. AU - Probst, N. A. AU - Lee, L. C. AU - Monahan, J. M. AU - Matthews, J. D. AU - Liang, H. C. AU - Bahnsen, K. AU - Montes-Mojarro, I. A. AU - Karaca-Atabay, E. AU - Sharma, G. G. AU - Malik, V. AU - Larose, H. AU - Forde, S. D. AU - Ducray, S. P. AU - Lobello, C. AU - Wang, Q. AU - Luan, S. L. AU - Pospíšilová, Š AU - Gambacorti-Passerini, C. AU - Burke, G. A. A. AU - Pervez, S. AU - Attarbaschi, A. AU - Janíková, A. AU - Pacquement, H. AU - Landman-Parker, J. AU - Lambilliotte, A. AU - Schleiermacher, G. AU - Klapper, W. AU - Jauch, R. AU - Woessmann, W. AU - Vassal, G. AU - Kenner, L. AU - Merkel, O. AU - Mologni, L. AU - Chiarle, R. AU - Brugières, L. AU - Geoerger, B. AU - Barbieri, I. AU - Turner, S. D. C2 - PMC7530646 interests. DA - Oct 1 DO - 10.1182/blood.2019003793 DP - NLM ET - 2020/06/24 IS - 14 LA - eng N1 - 1528-0020 Prokoph, Nina Probst, Nicola A Lee, Liam C Monahan, Jack M Matthews, Jamie D Liang, Huan-Chang Bahnsen, Klaas Montes-Mojarro, Ivonne A Karaca-Atabay, Elif Sharma, Geeta G Malik, Vikas Larose, Hugo Forde, Sorcha D Ducray, Stephen P Lobello, Cosimo Wang, Qi Luan, Shi-Lu Pospíšilová, Šárka Gambacorti-Passerini, Carlo Burke, G A Amos Pervez, Shahid Attarbaschi, Andishe Janíková, Andrea Pacquement, Hélène Landman-Parker, Judith Lambilliotte, Anne Schleiermacher, Gudrun Klapper, Wolfram Jauch, Ralf Woessmann, Wilhelm Vassal, Gilles Kenner, Lukas Merkel, Olaf Mologni, Luca Chiarle, Roberto Brugières, Laurence Geoerger, Birgit Barbieri, Isaia Turner, Suzanne D R01 CA196703/CA/NCI NIH HHS/United States Journal Article Blood. 2020 Oct 1;136(14):1657-1669. doi: 10.1182/blood.2019003793. PY - 2020 SN - 0006-4971 (Print) 0006-4971 SP - 1657-1669 ST - IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma T2 - Blood TI - IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma VL - 136 ID - 931 ER - TY - JOUR AD - University of Minnesota, Division of Pediatric Dermatology. University of Minnesota Medical School. Electronic address: gardeen@d.umn.edu. University of Toronto. Harvard Medical School. Washington School of Medicine in St Louis. Biostatistics Core, Masonic Cancer Center, University of Minnesota. Children's Hospital of Wisconsin - Milwaukee. Seattle Children's Hospital. Texas Children's Hospital. Children's Hospital Los Angeles. University of Minnesota Masonic Children's Hospital, Division of Pediatric Hematology and Oncology. Ann & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Dermatology. Dermatology Program, Boston Children's Hospital, Harvard Medical School. University of Toronto, Division of Pediatric Medicine Section of Dermatology. AN - 32682884 AU - Boull, C. L. AU - Gardeen, S. AU - Abdali, T. AU - Li, E. AU - Potts, J. AU - Rubin, N. AU - Carlberg, V. M. AU - Gupta, D. AU - Hunt, R. AU - Luu, M. AU - Maguiness, S. M. AU - Moertel, C. L. AU - Song, H. AU - Vivar, K. L. AU - Coughlin, C. AU - Huang, J. T. AU - Lara-Corrales, I. DA - Jul 16 DO - 10.1016/j.jaad.2020.07.044 DP - NLM ET - 2020/07/20 LA - eng N1 - 1097-6787 Boull, Christina L Gardeen, Samantha Abdali, Talal Li, Edward Potts, Jolee Rubin, Nathan Carlberg, Valerie M Gupta, Deepti Hunt, Raegan Luu, Minnelly Maguiness, Sheilagh M Moertel, Christopher L Song, Hannah Vivar, Karina L Coughlin, Carrie Huang, Jennifer T Lara-Corrales, Irene Journal Article United States J Am Acad Dermatol. 2020 Jul 16:S0190-9622(20)32213-1. doi: 10.1016/j.jaad.2020.07.044. PY - 2020 SN - 0190-9622 ST - Cutaneous Reactions in Children Treated with MEK Inhibitors, BRAF Inhibitors, or Combination Therapy: A Multi-Center Study T2 - J Am Acad Dermatol TI - Cutaneous Reactions in Children Treated with MEK Inhibitors, BRAF Inhibitors, or Combination Therapy: A Multi-Center Study ID - 932 ER - TY - JOUR AD - Department of Paediatric Oncology, Combined Military Hospital, Rawalpindi, Pakistan. Armed Forces Bone Marrow Transplant Centre, CMH Medical Complex, Rawalpindi, Pakistan. Medical Student at Army Medical College, Rawalpindi, Pakistan. AN - 32695536 AU - Khalil, S. AU - Ghafoor, T. AU - Raja, A. K. F. C2 - PMC7368202 DO - 10.1155/2020/6923103 DP - NLM ET - 2020/07/23 LA - eng N1 - 2090-6714 Khalil, Sumaira Ghafoor, Tariq Orcid: 0000-0003-1279-7160 Raja, Amna Kaneez Fatima Case Reports Case Rep Oncol Med. 2020 Jul 9;2020:6923103. doi: 10.1155/2020/6923103. eCollection 2020. PY - 2020 SN - 2090-6706 (Print) SP - 6923103 ST - Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib T2 - Case Rep Oncol Med TI - Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib VL - 2020 ID - 933 ER - TY - JOUR AD - Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, PO box 9600, 2300 RC Leiden, The Netherlands. Department of Medical Oncology, Maastricht University Medical Center, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands. Department of Medical Oncology, Zuyderland Medical Center, 6130 MB Sittard-Geleen, The Netherlands. Department of Medical Oncology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands. Department of Pediatric Oncology, Princess Máxima Center, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. Isala Oncology Center, Isala, 8000 GK Zwolle, The Netherlands. Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Department of Medical Oncology, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands. Department of Medical Oncology, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands. Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Department of Medical Oncology, Amphia Ziekenhuis, Langendijk 175, 4819 EV Breda, The Netherlands. Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3000 CA Rotterdam, The Netherlands. Department of Medical Oncology, Maxima Medical Center, de Run 4600, 5500 MB Veldhoven, The Netherlands. Department of Surgical Oncology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands. Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, PO box 9600, 2300 RC Leiden, The Netherlands. AN - 32726988 AU - van der Kooij, M. K. AU - Wetzels, Mjal AU - Aarts, M. J. B. AU - van den Berkmortel, Fwpj AU - Blank, C. U. AU - Boers-Sonderen, M. J. AU - Dierselhuis, M. P. AU - de Groot, J. W. B. AU - Hospers, G. A. P. AU - Piersma, D. AU - van Rijn, R. S. AU - Suijkerbuijk, K. P. M. AU - Ten Tije, A. J. AU - van der Veldt, A. A. M. AU - Vreugdenhil, G. AU - Wouters, Mwjm AU - Haanen, Jbag AU - van den Eertwegh, A. J. M. AU - Bastiaannet, E. AU - Kapiteijn, E. C2 - PMC7464956 DA - Jul 27 DO - 10.3390/cancers12082072 DP - NLM ET - 2020/07/31 IS - 8 LA - eng N1 - 2072-6694 van der Kooij, Monique K Orcid: 0000-0002-9764-5467 Wetzels, Marjolein J A L Aarts, Maureen J B van den Berkmortel, Franchette W P J Blank, Christian U Boers-Sonderen, Marye J Dierselhuis, Miranda P de Groot, Jan Willem B Hospers, Geke A P Piersma, Djura van Rijn, Rozemarijn S Suijkerbuijk, Karijn P M Orcid: 0000-0003-3604-5430 Ten Tije, Albert J van der Veldt, Astrid A M Vreugdenhil, Gerard Wouters, Michel W J M Orcid: 0000-0001-6173-0662 Haanen, John B A G van den Eertwegh, Alfonsus J M Bastiaannet, Esther Kapiteijn, Ellen Orcid: 0000-0002-4814-6426 836002002/The Netherlands Organization for Health Research and Development/ Journal Article Cancers (Basel). 2020 Jul 27;12(8):2072. doi: 10.3390/cancers12082072. PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response T2 - Cancers (Basel) TI - Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response VL - 12 ID - 934 ER - TY - JOUR AD - Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, MA, 02215-5450, USA. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. Department of Radiology, Boston Children's Hospital, Boston, USA. Department of Neurology, Boston Children's Hospital, Boston, USA. Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, MA, 02215-5450, USA. keek_yeo@dfci.harvard.edu. AN - 32780261 AU - Manoharan, N. AU - Choi, J. AU - Chordas, C. AU - Zimmerman, M. A. AU - Scully, J. AU - Clymer, J. AU - Filbin, M. AU - Ullrich, N. J. AU - Bandopadhayay, P. AU - Chi, S. N. AU - Yeo, K. K. DA - Sep DO - 10.1007/s11060-020-03592-8 DP - NLM ET - 2020/08/12 IS - 2 LA - eng N1 - 1573-7373 Manoharan, Neevika Choi, Jungwhan Chordas, Christine Zimmerman, Mary Ann Scully, Jacqueline Clymer, Jessica Filbin, Mariella Ullrich, Nicole J Bandopadhayay, Pratiti Chi, Susan N Yeo, Kee Kiat Orcid: 0000-0003-0713-6384 Journal Article United States J Neurooncol. 2020 Sep;149(2):253-262. doi: 10.1007/s11060-020-03592-8. Epub 2020 Aug 11. PY - 2020 SN - 0167-594x SP - 253-262 ST - Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma T2 - J Neurooncol TI - Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma VL - 149 ID - 935 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: vsubbiah@mdanderson.org. Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Medical Oncology Department, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France. Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, and University of Milano, Milan, Italy. Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Dipartimento di Oncologia, Istituto Nazionale dei Tumori, Milan, Italy. Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria. Third Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, CCS Salzburg, Salzburg, Austria. Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Department of Clinical Pharmacology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Berry Consultants, Austin, TX, USA; Department of Biostatistics, University of Kentucky, Lexington, KY, USA. Precision Medicine, Novartis Pharmaceuticals, East Hanover, NJ, USA. Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA. Global Drug Development, Novartis Pharma, Basel, Switzerland. Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. AN - 32818466 AU - Subbiah, V. AU - Lassen, U. AU - Élez, E. AU - Italiano, A. AU - Curigliano, G. AU - Javle, M. AU - de Braud, F. AU - Prager, G. W. AU - Greil, R. AU - Stein, A. AU - Fasolo, A. AU - Schellens, J. H. M. AU - Wen, P. Y. AU - Viele, K. AU - Boran, A. D. AU - Gasal, E. AU - Burgess, P. AU - Ilankumaran, P. AU - Wainberg, Z. A. DA - Sep DO - 10.1016/s1470-2045(20)30321-1 DP - NLM ET - 2020/08/21 IS - 9 LA - eng N1 - 1474-5488 Subbiah, Vivek Lassen, Ulrik Élez, Elena Italiano, Antoine Curigliano, Giuseppe Javle, Milind de Braud, Filippo Prager, Gerald W Greil, Richard Stein, Alexander Fasolo, Angelica Schellens, Jan H M Wen, Patrick Y Viele, Kert Boran, Aislyn D Gasal, Eduard Burgess, Paul Ilankumaran, Palanichamy Wainberg, Zev A UL1 TR000371/TR/NCATS NIH HHS/United States R01 CA242845/CA/NCI NIH HHS/United States Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. England Lancet Oncol. 2020 Sep;21(9):1234-1243. doi: 10.1016/S1470-2045(20)30321-1. Epub 2020 Aug 17. PY - 2020 SN - 1470-2045 SP - 1234-1243 ST - Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial T2 - Lancet Oncol TI - Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial VL - 21 ID - 936 ER - TY - JOUR AD - Departments of Diagnostic Pathology. Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Breast Surgery. Hematology. Rare Cancer Center, National Cancer Center Hospital. Breast and Medical Oncology. AN - 32826530 AU - Kashima, J. AU - Yoshida, M. AU - Jimbo, K. AU - Izutsu, K. AU - Ushiku, T. AU - Yonemori, K. AU - Yoshida, A. DA - Aug 20 DO - 10.1097/pas.0000000000001567 DP - NLM ET - 2020/08/23 LA - eng N1 - 1532-0979 Kashima, Jumpei Yoshida, Masayuki Jimbo, Kenjiro Izutsu, Koji Ushiku, Tetsuo Yonemori, Kan Yoshida, Akihiko Journal Article United States Am J Surg Pathol. 2020 Aug 20. doi: 10.1097/PAS.0000000000001567. PY - 2020 SN - 0147-5185 ST - ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology T2 - Am J Surg Pathol TI - ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology ID - 937 ER - TY - JOUR AD - The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA. AN - 32869334 AU - Young, T. K. AU - Gutierrez, D. AU - Criscito, M. C. AU - Kim, R. H. AU - Lakdawala, N. AU - Oza, V. S. DA - Sep 1 DO - 10.1111/pde.14306 DP - NLM ET - 2020/09/02 LA - eng N1 - 1525-1470 Young, Trevor K Orcid: 0000-0003-0215-9886 Gutierrez, Daniel Criscito, Maressa C Kim, Randie H Lakdawala, Nikita Orcid: 0000-0002-8122-6145 Oza, Vikash S Journal Article United States Pediatr Dermatol. 2020 Sep 1. doi: 10.1111/pde.14306. PY - 2020 SN - 0736-8046 ST - Dabrafenib-induced neutrophilic panniculitis in a child undergoing dual BRAF-MEK inhibitor therapy for glioblastoma multiforme T2 - Pediatr Dermatol TI - Dabrafenib-induced neutrophilic panniculitis in a child undergoing dual BRAF-MEK inhibitor therapy for glioblastoma multiforme ID - 938 ER - TY - JOUR AD - Arizona College of Osteopathic Medicine, Glendale, Arizona, USA. Departments of Pathology and Dermatology, Kaiser Permanente, Sunset Medical Center, Los Angeles, California, USA. AN - 32974961 AU - Jafri, Z. A. AU - Reddy, S. P. AU - Cassarino, D. S. DA - Sep 25 DO - 10.1111/cup.13883 DP - NLM ET - 2020/09/26 LA - eng N1 - 1600-0560 Jafri, Zainab A Orcid: 0000-0003-4369-6311 Reddy, Shivani P Orcid: 0000-0003-3295-8021 Cassarino, David S Case Reports United States J Cutan Pathol. 2020 Sep 25. doi: 10.1111/cup.13883. PY - 2020 SN - 0303-6987 ST - KRAS 117N positive Rosai-Dorfman with atypical features T2 - J Cutan Pathol TI - KRAS 117N positive Rosai-Dorfman with atypical features ID - 939 ER - TY - JOUR AD - Hopp Children's Cancer Center (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany. Institute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Würzburg, Germany. Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. Department of Pediatric Oncology/Hematology, Charité Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin and Berlin Institute of Health, Berlin, Germany. Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Neuropathology, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet Zu Berlin, and Berlin Institute of Health, Charité-Universitaetsmedizin Berlin, Berlin, Germany. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Berlin, Berlin, Germany. Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany. Hopp Children's Cancer Center (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. t.milde@kitz-heidelberg.de. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. t.milde@kitz-heidelberg.de. KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany. t.milde@kitz-heidelberg.de. AN - 33026636 AU - Selt, F. AU - van Tilburg, C. M. AU - Bison, B. AU - Sievers, P. AU - Harting, I. AU - Ecker, J. AU - Pajtler, K. W. AU - Sahm, F. AU - Bahr, A. AU - Simon, M. AU - Jones, D. T. W. AU - Well, L. AU - Mautner, V. F. AU - Capper, D. AU - Hernáiz Driever, P. AU - Gnekow, A. AU - Pfister, S. M. AU - Witt, O. AU - Milde, T. C2 - PMC7609413 DA - Sep DO - 10.1007/s11060-020-03640-3 DP - NLM ET - 2020/10/08 IS - 3 LA - eng N1 - 1573-7373 Selt, Florian Orcid: 0000-0001-9717-6712 van Tilburg, Cornelis M Bison, Brigitte Sievers, Philipp Harting, Inga Ecker, Jonas Pajtler, Kristian W Sahm, Felix Bahr, Annabelle Simon, Michèle Jones, David T W Well, Lennart Mautner, Victor-Felix Capper, David Hernáiz Driever, Pablo Gnekow, Astrid Pfister, Stefan M Witt, Olaf Milde, Till GN-000382/Brain Tumour Charity/ Journal Article J Neurooncol. 2020 Sep;149(3):499-510. doi: 10.1007/s11060-020-03640-3. Epub 2020 Oct 7. PY - 2020 SN - 0167-594X (Print) 0167-594x SP - 499-510 ST - Response to trametinib treatment in progressive pediatric low-grade glioma patients T2 - J Neurooncol TI - Response to trametinib treatment in progressive pediatric low-grade glioma patients VL - 149 ID - 940 ER - TY - JOUR AD - Cancer Research Center of Toulouse, INSERM U1037-Université Toulouse III-Paul Sabatier-CNRS ERL5294, F-31037 Toulouse, France. Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. Ligue Nationale Contre le Cancer, équipe labellisée 2016, F-31037 Toulouse, France. European Research Initiative on ALK-related malignancies (ERIA), Cambridge CB2 0QQ, UK. Merck Serono S.A., Department of Biotechnology Process Sciences, Route de Fenil 25, Z.I. B, 1804 Corsier-sur-Vevey, Switzerland. Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy. Pôle Technologique du CRCT-Plateau de Cytométrie et Tri cellulaire-INSERM U1037, F-31037 Toulouse, France. TRANSAUTOPHAGY: European Network for Multidisciplinary Research and Translation of Autophagy Knowledge, COST Action CA15138, 08193 Barcelona, Spain. AN - 33066037 AU - Sorrentino, D. AU - Frentzel, J. AU - Mitou, G. AU - Blasco, R. B. AU - Torossian, A. AU - Hoareau-Aveilla, C. AU - Pighi, C. AU - Farcé, M. AU - Meggetto, F. AU - Manenti, S. AU - Espinos, E. AU - Chiarle, R. AU - Giuriato, S. C2 - PMC7650725 DA - Oct 13 DO - 10.3390/cancers12102951 DP - NLM ET - 2020/10/18 IS - 10 LA - eng N1 - 2072-6694 Sorrentino, Domenico Frentzel, Julie Orcid: 0000-0002-2403-4526 Mitou, Géraldine Blasco, Rafael B Torossian, Avédis Hoareau-Aveilla, Coralie Pighi, Chiara Farcé, Manon Meggetto, Fabienne Orcid: 0000-0002-2610-0144 Manenti, Stéphane Espinos, Estelle Orcid: 0000-0002-5693-8941 Chiarle, Roberto Giuriato, Sylvie 675712/European Union's Horizon 2020 research and innovative Programme under the Marie Sklodowska-Curie grant agreement/ R12020BB/Ligue Contre le Cancer/ R15002BB/Fondation ARC pour la Recherche sur le Cancer/ R12004BB/Agence Nationale de la Recherche/ R01CA196703/CA/NCI NIH HHS/United States Journal Article Cancers (Basel). 2020 Oct 13;12(10):2951. doi: 10.3390/cancers12102951. PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells T2 - Cancers (Basel) TI - High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells VL - 12 ID - 941 ER - TY - JOUR AD - Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia. Electronic address: adithya.balasubramanian@austin.org.au. Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia. Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia; La Trobe University School of Cancer Medicine, 145 Studley Road Heidelberg, Victoria 3084, Australia; Department of Medicine, University of Melbourne, 145 Studley Road Heidelberg, Victoria 3084, Australia. Department of Radiology, Austin Health, 145 Studley Road Heidelberg, Victoria 3084, Australia; University of Melbourne, Parkville, Victoria 3010, Australia. AN - 33070910 AU - Balasubramanian, A. AU - Gunjur, A. AU - Gan, H. K. AU - Perchyonok, Y. AU - Cher, L. M. DA - Sep DO - 10.1016/j.jocn.2020.07.028 DP - NLM ET - 2020/10/20 LA - eng N1 - 1532-2653 Balasubramanian, Adithya Gunjur, Ashray Gan, Hui Kong Perchyonok, Yuliya Cher, Lawrence Myron Case Reports Scotland J Clin Neurosci. 2020 Sep;79:269-271. doi: 10.1016/j.jocn.2020.07.028. Epub 2020 Aug 26. PY - 2020 SN - 0967-5868 SP - 269-271 ST - Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma T2 - J Clin Neurosci TI - Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma VL - 79 ID - 942 ER - TY - JOUR AD - Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. emilyg@umn.edu. St Jude Children's Research Hospital, Memphis, TN, USA. Children's Oncology Group, Monrovia, CA, USA. Baylor College of Medicine, Houston, TX, USA. Mayo Clinic, Rochester, MN, USA. Dana Farber Cancer Institute, Boston, MA, USA. Pfizer, Inc, Bentonville, AR, USA. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. AN - 33095287 AU - Greengard, E. AU - Mosse, Y. P. AU - Liu, X. AU - Minard, C. G. AU - Reid, J. M. AU - Voss, S. AU - Wilner, K. AU - Fox, E. AU - Balis, F. AU - Blaney, S. M. AU - Adamson, P. C. AU - Weigel, B. J. DA - Dec DO - 10.1007/s00280-020-04171-4 DP - NLM ET - 2020/10/24 IS - 6 LA - eng N1 - 1432-0843 Greengard, Emily Orcid: 0000-0002-2963-5638 Mosse, Yael P Liu, Xiaowei Minard, Charles G Reid, Joel M Voss, Stephan Wilner, Keith Fox, Elizabeth Balis, Frank Blaney, Susan M Adamson, Peter C Weigel, Brenda J UM1 CA228823/CA/NCI NIH HHS/United States Um1ca228823/pep-ctn/ P30 CA015083/CA/NCI NIH HHS/United States Journal Article Germany Cancer Chemother Pharmacol. 2020 Dec;86(6):829-840. doi: 10.1007/s00280-020-04171-4. Epub 2020 Oct 23. PY - 2020 SN - 0344-5704 SP - 829-840 ST - Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212) T2 - Cancer Chemother Pharmacol TI - Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212) VL - 86 ID - 943 ER - TY - JOUR AD - Pediatric Oncology Branch, National Cancer Institute. Molecular Oncology Section, Pediatric Oncology Branch, CCR, NCI, NIH. Laboratory of Cellular and Molecular Biolgoy, National Cancer Institute. Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH. Division of Preclinical Innovation, NCATS, NIH. Frederick National Laboratory for Cancer Research, National Cancer Institute. Laboratory of Animal Science Program, Leidos Biomedical Research Inc.,Frederick National Laboratory for Cancer Research. Collaborative Protein Technology Resource, Laboratory of Cell Biology, NCI, NIH. Laboratory of Biochemistry and Molecular Biology, National Cancer Institute. Medical Oncology Branch, National Institutes of Health. National Center for Advancing Translational Sciences, National Institutes of Health. Limb / ppb, nichd / nih. Laboratory of Cell and Developmental Signaling, National Cancer Institute. Pediatric Oncology Branch, National Cancer Institute yoheme@mail.nih.gov. AN - 33158997 AU - Kowalczyk, J. T. AU - Wan, X. AU - Hernandez, E. R. AU - Luo, R. AU - Lyons, G. C. AU - Wilson, K. M. AU - Gallardo, D. C. AU - Isanogle, K. A. AU - Robinson, C. M. AU - Mendoza, A. AU - Heske, C. M. AU - Chen, J. Q. AU - Luo, X. AU - Kelly, A. E. AU - Difilippantonio, S. AU - Robey, R. W. AU - Thomas, C. J. AU - Sackett, D. L. AU - Morrison, D. K. AU - Randazzo, P. A. AU - Miller Jenkins, L. M. AU - Yohe, M. E. DA - Nov 6 DO - 10.1158/1535-7163.Mct-20-0525 DP - NLM ET - 2020/11/08 LA - eng N1 - 1538-8514 Kowalczyk, Joshua T Orcid: 0000-0002-2212-7809 Wan, Xiaolin Hernandez, Edjay R Luo, Ruibai Orcid: 0000-0002-1887-5636 Lyons, Gaelyn C Orcid: 0000-0002-8933-4693 Wilson, Kelli M Orcid: 0000-0003-2636-2766 Gallardo, Devorah C Isanogle, Kristine A Robinson, Christina M Mendoza, Arnulfo Heske, Christine M Chen, Jinqiu-Qiu Luo, Xiaoling Kelly, Alexander E Orcid: 0000-0002-3395-6012 Difilippantonio, Simone Robey, Robert W Thomas, Craig J Sackett, Dan L Morrison, Deborah K Randazzo, Paul A Orcid: 0000-0001-5349-0881 Miller Jenkins, Lisa M Yohe, Marielle E Orcid: 0000-0001-5356-9426 Journal Article United States Mol Cancer Ther. 2020 Nov 6:molcanther.0525.2020. doi: 10.1158/1535-7163.MCT-20-0525. PY - 2020 SN - 1535-7163 ST - Rigosertib induces mitotic arrest and apoptosis in RAS-driven rhabdomyosarcoma and neuroblastoma T2 - Mol Cancer Ther TI - Rigosertib induces mitotic arrest and apoptosis in RAS-driven rhabdomyosarcoma and neuroblastoma ID - 944 ER - TY - JOUR AD - Guangxi Medical University. Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. AN - 33181717 AU - Zhang, Z. AU - Liu, C. AU - Liang, T. AU - Yu, C. AU - Qin, Z. AU - Zhou, X. AU - Xue, J. AU - Zeng, H. AU - Lu, Z. AU - Xu, G. AU - Wang, Z. AU - Chen, J. AU - Jiang, J. AU - Zhan, X. C2 - PMC7668544 DA - Nov 13 DO - 10.1097/md.0000000000023251 DP - NLM ET - 2020/11/13 IS - 46 LA - eng N1 - 1536-5964 Zhang, Zide Liu, Chong Liang, Tuo Yu, Chaojie Qin, Zhaojie Zhou, Xin Xue, Jiang Zeng, Haopeng Lu, Zhaojun Xu, Guoyong Wang, Zequn Chen, Jiarui Jiang, Jie Zhan, Xinli Journal Article Medicine (Baltimore). 2020 Nov 13;99(46):e23251. doi: 10.1097/MD.0000000000023251. PY - 2020 SN - 0025-7974 (Print) 0025-7974 SP - e23251 ST - Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients T2 - Medicine (Baltimore) TI - Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients VL - 99 ID - 945 ER - TY - GEN AD - B.J. Weigel, Pediatric Hematology/Oncology, The University of Minnesota Masonic Children’s Hospital/Masonic Cancer Center, Minneapolis, MN, United States AU - Greengard, E. G. AU - Weigel, B. J. C1 - mk 1775 DB - Embase DO - 10.1007/978-3-030-51160-9_11 J2 - Pediatr. Oncol. LA - English M1 - (Greengard E.G., emilyg@umn.edu; Weigel B.J., weige007@umn.edu) Pediatric Hematology/Oncology, The University of Minnesota Masonic Children’s Hospital/Masonic Cancer Center, Minneapolis, MN, United States M3 - Chapter N1 - L633030313 2020-10-12 2020-11-05 PY - 2021 SN - 2191-0812 1613-5318 SP - 149-164 ST - Strategies for new agent development in pediatric sarcomas TI - Strategies for new agent development in pediatric sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633030313&from=export http://dx.doi.org/10.1007/978-3-030-51160-9_11 ID - 946 ER - TY - JOUR AD - S. Hou, Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China AU - Hou, S. AU - Xu, X. AU - Wang, Y. AU - Yang, Y. DB - Embase Medline DO - 10.1007/s12038-020-0016-y IS - 1 LA - English M3 - Article N1 - L2004390428 2020-03-16 2020-03-24 PY - 2020 SN - 0973-7138 0250-5991 ST - Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus T2 - Journal of Biosciences TI - Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004390428&from=export http://dx.doi.org/10.1007/s12038-020-0016-y VL - 45 ID - 947 ER - TY - JOUR AD - R. Zeiser, Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany AU - Hamarsheh, S. AU - Osswald, L. AU - Saller, B. S. AU - Unger, S. AU - De Feo, D. AU - Vinnakota, J. M. AU - Konantz, M. AU - Uhl, F. M. AU - Becker, H. AU - Lübbert, M. AU - Shoumariyeh, K. AU - Schürch, C. AU - Andrieux, G. AU - Venhoff, N. AU - Schmitt-Graeff, A. AU - Duquesne, S. AU - Pfeifer, D. AU - Cooper, M. A. AU - Lengerke, C. AU - Boerries, M. AU - Duyster, J. AU - Niemeyer, C. M. AU - Erlacher, M. AU - Blazar, B. R. AU - Becher, B. AU - Groß, O. AU - Brummer, T. AU - Zeiser, R. DB - Embase Medline DO - 10.1038/s41467-020-15497-1 IS - 1 LA - English M3 - Article N1 - L2004628006 2020-05-22 2020-05-26 PY - 2020 SN - 2041-1723 ST - Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation T2 - Nature Communications TI - Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004628006&from=export http://dx.doi.org/10.1038/s41467-020-15497-1 VL - 11 ID - 948 ER - TY - JOUR AD - S. Mueller, Department of Oncology and Children’s Research Center, University Children’s Hospital Zurich, Steinwiesstrasse 75, Zurich, Switzerland AU - Mueller, T. AU - Stucklin, A. S. G. AU - Postlmayr, A. AU - Metzger, S. AU - Gerber, N. AU - Kline, C. AU - Grotzer, M. AU - Nazarian, J. AU - Mueller, S. DB - Embase DO - 10.1007/s11940-020-00651-3 IS - 12 LA - English M3 - Review N1 - L2007249949 2020-11-16 PY - 2020 SN - 1534-3138 1092-8480 ST - Advances in Targeted Therapies for Pediatric Brain Tumors T2 - Current Treatment Options in Neurology TI - Advances in Targeted Therapies for Pediatric Brain Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007249949&from=export http://dx.doi.org/10.1007/s11940-020-00651-3 VL - 22 ID - 949 ER - TY - JOUR AD - Z.-F. Zhang, department of Gynecology, Affiliated, Hangzhou Hospital of Nanjing Medical University, 369 Kunpeng Road, Hangzhou, Zhejiang, China R.-C. Chian, department of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University, 818 Tianyuan East Road, Jiangning, Nanjing, Jiangsu, China AU - Zhang, D. AU - Wang, L. AU - Guo, H. L. AU - Zhang, Z. W. AU - Wang, C. AU - Chian, R. C. AU - Zhang, Z. F. DB - Embase Medline DO - 10.3892/ijmm.2020.4749 IS - 6 LA - English M3 - Article N1 - L2008424808 2020-11-04 PY - 2020 SN - 1791-244X 1107-3756 SP - 2078-2088 ST - MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway T2 - International Journal of Molecular Medicine TI - MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008424808&from=export http://dx.doi.org/10.3892/ijmm.2020.4749 VL - 46 ID - 950 ER - TY - JOUR AD - S.H. Swerdlow, Division of Hematopathology, Hill Building, Room 359, 3477 Euler Way, Pittsburgh, PA, United States AU - Barasch, N. J. K. AU - Liu, Y. C. AU - Ho, J. AU - Bailey, N. AU - Aggarwal, N. AU - Cook, J. R. AU - Swerdlow, S. H. DB - Embase Medline DO - 10.1016/j.humpath.2020.09.014 LA - English M3 - Article N1 - L2008478727 2020-11-10 PY - 2020 SN - 1532-8392 0046-8177 SP - 93-105 ST - The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma T2 - Human Pathology TI - The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008478727&from=export http://dx.doi.org/10.1016/j.humpath.2020.09.014 VL - 106 ID - 951 ER - TY - JOUR AU - Wu, Y. T. AU - Ma, S. Y. AU - Sun, W. Q. AU - Shen, W. W. AU - Zhu, H. T. AU - Zhang, Q. AU - Chen, H. F. DB - Medline DO - 10.1210/clinem/dgaa804 LA - English M3 - Article in Press N1 - L633342970 2020-11-11 PY - 2020 SN - 1945-7197 ST - TRIM65 promotes invasion of endometrial stromal cells by activating ERK1/2/C-myc signaling via ubiquitination of DUSP6 T2 - The Journal of clinical endocrinology and metabolism TI - TRIM65 promotes invasion of endometrial stromal cells by activating ERK1/2/C-myc signaling via ubiquitination of DUSP6 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633342970&from=export http://dx.doi.org/10.1210/clinem/dgaa804 ID - 952 ER - TY - JOUR AD - N. Galeotti, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology, University of Florence, Viale G. Pieraccini 6, Florence, Italy AU - Borgonetti, V. AU - Governa, P. AU - Biagi, M. AU - Pellati, F. AU - Galeotti, N. C2 - Extrasynthese(France) Indena(Italy) Sigma Aldrich(Italy) DB - Embase Medline DO - 10.1016/j.phymed.2020.153307 LA - English M3 - Article N1 - L2007546953 2020-08-26 2020-10-22 PY - 2020 SN - 1618-095X 0944-7113 ST - Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice T2 - Phytomedicine TI - Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007546953&from=export http://dx.doi.org/10.1016/j.phymed.2020.153307 VL - 78 ID - 953 ER - TY - JOUR AD - J. Zhu, Department of Epidemiology and Microbiology, Huadong Medical Institute of Biotechniques, 293 East Zhongshan Road, Nanjing, Jiangsu, China AU - Wang, Y. AU - Gong, D. AU - Yao, C. AU - Zheng, F. AU - Zhou, T. AU - Cao, Q. AU - Zhu, X. AU - Wang, M. AU - Zhu, J. DB - Embase Medline DO - 10.3892/mmr.2020.11500 IS - 5 LA - English M3 - Article N1 - L2007966264 2020-10-07 2020-10-30 PY - 2020 SN - 1791-3004 1791-2997 SP - 4125-4134 ST - Human monoclonal anti-TLR4 antibody negatively regulates lipopolysaccharide-induced inflammatory responses in mouse macrophages T2 - Molecular Medicine Reports TI - Human monoclonal anti-TLR4 antibody negatively regulates lipopolysaccharide-induced inflammatory responses in mouse macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007966264&from=export http://dx.doi.org/10.3892/mmr.2020.11500 VL - 22 ID - 954 ER - TY - JOUR AU - Kohn, L. AU - Ahn, T. AU - Cerrone, D. AU - Butte, M. DB - Embase DO - 10.1016/j.anai.2020.08.311 IS - 5 LA - English M3 - Conference Abstract N1 - L2008361758 2020-10-26 PY - 2020 SN - 1534-4436 1081-1206 SP - S94 ST - NOVEL VARIATION IN RASGRP1 CAUSES NEWBORN T CELL LYMPHOPENIA T2 - Annals of Allergy, Asthma and Immunology TI - NOVEL VARIATION IN RASGRP1 CAUSES NEWBORN T CELL LYMPHOPENIA UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008361758&from=export http://dx.doi.org/10.1016/j.anai.2020.08.311 VL - 125 ID - 955 ER - TY - JOUR AU - Wang, H. L. AU - Liang, N. AU - Huang, D. X. AU - Zhao, X. Y. AU - Dang, Q. Y. AU - Jiang, X. Y. AU - Xiao, R. AU - Yu, H. L. DB - Medline DO - 10.1016/j.placenta.2020.10.024 LA - English M3 - Article in Press N1 - L633369802 2020-11-16 PY - 2020 SN - 1532-3102 SP - 199-205 ST - The effects of high-density lipoprotein and oxidized high-density lipoprotein on forskolin-induced syncytialization of BeWo cells T2 - Placenta TI - The effects of high-density lipoprotein and oxidized high-density lipoprotein on forskolin-induced syncytialization of BeWo cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633369802&from=export http://dx.doi.org/10.1016/j.placenta.2020.10.024 VL - 103 ID - 957 ER - TY - JOUR AD - C.C. Wang, Department of Obstetrics and Gynaecology, Faculty of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, Hong Kong C.C. Wang, Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong SAR, Hong Kong AU - Man, G. C. W. AU - Wang, J. AU - Song, Y. AU - Wong, J. H. AU - Zhao, Y. AU - Lau, T. S. AU - Leung, K. T. AU - Chan, T. H. AU - Wang, H. AU - Kwong, J. AU - Ng, T. B. AU - Wang, C. C. DB - Embase Medline DO - 10.1186/s12885-020-07455-3 IS - 1 LA - English M3 - Article N1 - L633028090 2020-10-19 PY - 2020 SN - 1471-2407 ST - Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer T2 - BMC Cancer TI - Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633028090&from=export http://dx.doi.org/10.1186/s12885-020-07455-3 VL - 20 ID - 958 ER - TY - JOUR AD - A.C.D.M. Malinverni, Department of Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil A.C.D.M. Malinverni, Laboratory of Molecular and Experimental Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil AU - Salles, D. AU - Laviola, G. AU - Malinverni, A. C. D. M. AU - Stávale, J. N. DB - Embase Medline DO - 10.1177/0883073820937225 IS - 12 LA - English M3 - Review N1 - L2005644270 2020-07-29 PY - 2020 SN - 1708-8283 0883-0738 SP - 852-858 ST - Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics T2 - Journal of Child Neurology TI - Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005644270&from=export http://dx.doi.org/10.1177/0883073820937225 VL - 35 ID - 960 ER - TY - JOUR AD - M.-F. Heymann, Institut de Cancérologie de l'Ouest, Blvd Jacques Monod, Saint-Herblain, France AU - Heymann, M. F. AU - Lezot, F. AU - Heymann, D. DB - Embase Medline DO - 10.1016/j.bone.2020.115523 LA - English M3 - Article N1 - L2007034765 2020-07-22 2020-07-28 PY - 2020 SN - 8756-3282 ST - Bisphosphonates in common pediatric and adult bone sarcomas T2 - Bone TI - Bisphosphonates in common pediatric and adult bone sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007034765&from=export http://dx.doi.org/10.1016/j.bone.2020.115523 VL - 139 ID - 961 ER - TY - JOUR AD - C.-C. Li, Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan AU - Wang, S. C. AU - Sun, H. L. AU - Hsu, Y. H. AU - Liu, S. H. AU - Lii, C. K. AU - Tsai, C. H. AU - Liu, K. L. AU - Huang, C. S. AU - Li, C. C. DB - Embase Medline DO - 10.1016/j.bcp.2020.114152 LA - English M3 - Article N1 - L2007135341 2020-07-29 2020-09-03 PY - 2020 SN - 1873-2968 0006-2952 ST - α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition T2 - Biochemical Pharmacology TI - α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007135341&from=export http://dx.doi.org/10.1016/j.bcp.2020.114152 VL - 180 ID - 962 ER - TY - JOUR AD - C.C. McCuaig, CHU Sainte Justine Division of Dermatology in Pediatrics, University of Montreal, 3175 chemin Côte Sainte-Catherine, Montreal, QC, Canada AU - Caruana, M. AU - Hatami, A. AU - Marcoux, D. AU - Perreault, S. AU - McCuaig, C. C. DB - Embase DO - 10.1016/j.jdcr.2020.07.021 IS - 10 LA - English M3 - Article N1 - L2007877481 2020-09-25 2020-10-20 PY - 2020 SN - 2352-5126 SP - 1056-1058 ST - Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib T2 - JAAD Case Reports TI - Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007877481&from=export http://dx.doi.org/10.1016/j.jdcr.2020.07.021 VL - 6 ID - 963 ER - TY - JOUR AD - C. Koschmann, Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Medical School, 3520D MSRB 1, 1150 West Medical Center Drive, Ann Arbor, MI, United States AU - Miklja, Z. AU - Yadav, V. N. AU - Cartaxo, R. T. AU - Siada, R. AU - Thomas, C. C. AU - Cummings, J. R. AU - Mullan, B. AU - Stallard, S. AU - Paul, A. AU - Bruzek, A. K. AU - Wierzbicki, K. AU - Yang, T. AU - Garcia, T. AU - Wolfe, I. AU - Leonard, M. AU - Robertson, P. L. AU - Garton, H. J. L. AU - Wahl, D. R. AU - Parmar, H. AU - Sarkaria, J. N. AU - Kline, C. AU - Mueller, S. AU - Nicolaides, T. AU - Glasser, C. AU - Leary, S. E. S. AU - Venneti, S. AU - Kumar-Sinha, C. AU - Chinnaiyan, A. M. AU - Mody, R. AU - Pai, M. P. AU - Phoenix, T. N. AU - Marini, B. L. AU - Koschmann, C. C2 - Selleck DB - Embase Medline DO - 10.1172/JCI133310 IS - 10 LA - English M3 - Article N1 - L2008018740 2020-10-14 2020-11-16 PY - 2020 SN - 1558-8238 0021-9738 SP - 5313-5325 ST - Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma T2 - Journal of Clinical Investigation TI - Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008018740&from=export http://dx.doi.org/10.1172/JCI133310 VL - 130 ID - 964 ER - TY - JOUR AD - R.-F. Wang, NRT5503, 1450 Biggy St., Los Angeles, CA, United States G. Nie, Beiyitiao 11, Zhongguancun, Beijing, China AU - Zhu, M. AU - Deng, G. AU - Tan, P. AU - Xing, C. AU - Guan, C. AU - Jiang, C. AU - Zhang, Y. AU - Ning, B. AU - Li, C. AU - Yin, B. AU - Chen, K. AU - Zhao, Y. AU - Wang, H. Y. AU - Levine, B. AU - Nie, G. AU - Wang, R. F. DB - Embase Medline DO - 10.1172/JCI133283 IS - 10 LA - English M3 - Article N1 - L2008018743 2020-10-14 2020-11-16 PY - 2020 SN - 1558-8238 0021-9738 SP - 5349-5369 ST - Beclin 2 negatively regulates innate immune signaling and tumor development T2 - Journal of Clinical Investigation TI - Beclin 2 negatively regulates innate immune signaling and tumor development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008018743&from=export http://dx.doi.org/10.1172/JCI133283 VL - 130 ID - 965 ER - TY - JOUR AD - G. Liang, Pharmaceutical College, Guangxi Medical University, Nanning, China AU - Liao, Z. H. AU - Zhu, H. Q. AU - Chen, Y. Y. AU - Chen, R. L. AU - Fu, L. X. AU - Li, L. AU - Zhou, H. AU - Zhou, J. L. AU - Liang, G. C2 - hangzhou hetian(China) DB - Embase Medline DO - 10.1016/j.jep.2020.112852 LA - English M3 - Article N1 - L2005874196 2020-05-19 2020-05-27 PY - 2020 SN - 1872-7573 0378-8741 ST - The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways T2 - Journal of Ethnopharmacology TI - The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005874196&from=export http://dx.doi.org/10.1016/j.jep.2020.112852 VL - 259 ID - 968 ER - TY - JOUR AD - G. Kessler-Icekson, Felsenstein Medical Research Center, Beilinson Campus, Rabin Medical Center, Petach-Tikva, Israel AU - Nudelman, V. AU - Zahalka, M. A. AU - Nudelman, A. AU - Rephaeli, A. AU - Kessler-Icekson, G. DB - Embase Medline DO - 10.1016/j.ejphar.2020.173255 LA - English M3 - Article N1 - L2006928542 2020-07-17 2020-07-22 PY - 2020 SN - 1879-0712 0014-2999 ST - Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts T2 - European Journal of Pharmacology TI - Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006928542&from=export http://dx.doi.org/10.1016/j.ejphar.2020.173255 VL - 882 ID - 969 ER - TY - JOUR AD - R.J. Antaya, Department of Dermatology, Yale University School of Medicine, New Haven, CT, United States R.J. Antaya, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States AU - Sun, Q. AU - Antaya, R. J. DB - Embase Medline DO - 10.1111/pde.14276 IS - 5 LA - English M3 - Article N1 - L2005520939 2020-07-17 PY - 2020 SN - 1525-1470 0736-8046 SP - 970-971 ST - Treatment of MEK inhibitor-induced paronychia with doxycycline T2 - Pediatric Dermatology TI - Treatment of MEK inhibitor-induced paronychia with doxycycline UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005520939&from=export http://dx.doi.org/10.1111/pde.14276 VL - 37 ID - 970 ER - TY - JOUR AD - G. Decorti, Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Trieste, Italy AU - Lucafò, M. AU - Sicari, D. AU - Chicco, A. AU - Curci, D. AU - Bellazzo, A. AU - Di Silvestre, A. AU - Pegolo, C. AU - Autry, R. AU - Cecchin, E. AU - De Iudicibus, S. AU - Collavin, L. AU - Evans, W. AU - Decorti, G. AU - Stocco, G. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1007/s00280-020-04122-z IS - 3 LA - English M3 - Article N1 - L2005814660 2020-08-13 PY - 2020 SN - 1432-0843 0344-5704 SP - 361-374 ST - miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway T2 - Cancer Chemotherapy and Pharmacology TI - miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005814660&from=export http://dx.doi.org/10.1007/s00280-020-04122-z VL - 86 ID - 971 ER - TY - JOUR AD - B. Lecka-Czernik, Department of Orthopaedic Surgery, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States B. Lecka-Czernik, Department of Physiology and Pharmacology, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States B. Lecka-Czernik, Center for Diabetes and Endocrine Research, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States AU - Chougule, A. AU - Kolli, V. AU - Baroi, S. AU - Ebraheim, N. AU - Czernik, P. J. AU - Loh, Y. P. AU - Lecka-Czernik, B. DB - Embase DO - 10.1002/jbm4.10392 IS - 9 LA - English M3 - Article N1 - L2005838951 2020-08-17 2020-09-28 PY - 2020 SN - 2473-4039 ST - Nonenzymatic and Trophic Activities of Carboxypeptidase E Regulate Bone Mass and Bioenergetics of Skeletal Stem Cells in Mice T2 - JBMR Plus TI - Nonenzymatic and Trophic Activities of Carboxypeptidase E Regulate Bone Mass and Bioenergetics of Skeletal Stem Cells in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005838951&from=export http://dx.doi.org/10.1002/jbm4.10392 VL - 4 ID - 973 ER - TY - JOUR AD - Z. Chen, Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China J. Wang, Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China AU - Miao, R. AU - Lu, Y. AU - He, X. AU - Liu, X. AU - Chen, Z. AU - Wang, J. DB - Embase Medline DO - 10.1111/jcmm.15724 IS - 18 LA - English M3 - Article N1 - L2005862705 2020-08-19 PY - 2020 SN - 1582-1838 SP - 10946-10957 ST - Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway T2 - Journal of Cellular and Molecular Medicine TI - Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005862705&from=export http://dx.doi.org/10.1111/jcmm.15724 VL - 24 ID - 974 ER - TY - JOUR AD - E.A. Simons, Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, MS 8117, 12801 E 17th Avenue, Aurora, CO, United States AU - Simons, E. A. AU - Smith, D. E. AU - Gao, D. AU - Camidge, D. R. DB - Embase Medline DO - 10.1016/j.jtho.2020.04.020 IS - 9 LA - English M3 - Conference Paper N1 - L2006039396 2020-06-05 2020-10-05 PY - 2020 SN - 1556-1380 1556-0864 SP - 1425-1433 ST - Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences T2 - Journal of Thoracic Oncology TI - Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006039396&from=export http://dx.doi.org/10.1016/j.jtho.2020.04.020 VL - 15 ID - 975 ER - TY - JOUR AD - N. Rasool, Department of Ophthalmology, University of California San Francisco, 10 Koret Way, San Francisco, CA, United States AU - Mekonnen, B. AU - Richardson, Q. AU - Bhisitkul, J. M. AU - Diab, M. AU - Rasool, N. DB - Embase DO - 10.1016/j.ajoc.2020.100749 LA - English M3 - Article N1 - L2006071711 2020-06-05 2020-06-11 PY - 2020 SN - 2451-9936 ST - Bilateral optic disc pits in a pediatric patient with Cobb syndrome T2 - American Journal of Ophthalmology Case Reports TI - Bilateral optic disc pits in a pediatric patient with Cobb syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006071711&from=export http://dx.doi.org/10.1016/j.ajoc.2020.100749 VL - 19 ID - 976 ER - TY - JOUR AD - L. Zhang, Department of Nursing, First People's Hospital of Foshan, 81 North Lingnan Avenue, Chancheng, Foshan, Guangdong, China AU - Lyu, C. AU - Jiang, S. AU - Kong, M. AU - Chen, X. AU - Zhang, L. C2 - Merck AG Sigma Aldrich DB - Embase Medline DO - 10.3892/mmr.2020.11286 IS - 3 LA - English M3 - Article N1 - L2007066653 2020-10-13 2020-11-13 PY - 2020 SN - 1791-3004 1791-2997 SP - 2107-2114 ST - Vitamin D protects against necrotising enterocolitis in newborn mice by activating the ERK signalling pathway T2 - Molecular Medicine Reports TI - Vitamin D protects against necrotising enterocolitis in newborn mice by activating the ERK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007066653&from=export http://dx.doi.org/10.3892/mmr.2020.11286 VL - 22 ID - 977 ER - TY - JOUR AD - D. Orbach, SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France AU - Orbach, D. AU - Sparber-Sauer, M. AU - Laetsch, T. W. AU - Minard-Colin, V. AU - Bielack, S. S. AU - Casanova, M. AU - Corradini, N. AU - Koscielniak, E. AU - Scheer, M. AU - Hettmer, S. AU - Bisogno, G. AU - Hawkins, D. S. AU - Ferrari, A. DB - Embase Medline DO - 10.1016/j.ejca.2020.06.028 LA - English M3 - Article N1 - L2007396828 2020-08-13 2020-08-21 PY - 2020 SN - 1879-0852 0959-8049 SP - 183-192 ST - Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies T2 - European Journal of Cancer TI - Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007396828&from=export http://dx.doi.org/10.1016/j.ejca.2020.06.028 VL - 137 ID - 978 ER - TY - JOUR AD - B. Neven, Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris, France AU - Pincez, T. AU - Bruneau, J. AU - Berteloot, L. AU - Piekarski, E. AU - Thomas, C. AU - Marçais, A. AU - Trinquand, A. AU - Castelle, M. AU - Garcelon, N. AU - Plantaz, D. AU - Cheminant, M. AU - Moshous, D. AU - Molina, T. J. AU - Hermine, O. AU - Macintyre, E. AU - Fischer, A. AU - Blanche, S. AU - Suarez, F. AU - Neven, B. DB - Embase Medline DO - 10.3324/haematol.2019.230276 IS - 9 LA - English M3 - Letter N1 - L2007704596 2020-10-07 2020-10-22 PY - 2020 SN - 1592-8721 0390-6078 SP - E461-E464 ST - Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies T2 - Haematologica TI - Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007704596&from=export http://dx.doi.org/10.3324/haematol.2019.230276 VL - 105 ID - 980 ER - TY - JOUR AD - M. Yao, Department of Anesthesiology and Pain Research center, The Affiliated Hospital of Jiaxing University, Jiaxing, China AU - Wang, T. AU - Shen, H. AU - Deng, H. AU - Pan, H. AU - He, Q. AU - Ni, H. AU - Tao, J. AU - Liu, S. AU - Xu, L. AU - Yao, M. DB - Embase Medline DO - 10.1016/j.jprot.2020.103879 LA - English M3 - Article N1 - L2006893913 2020-07-09 2020-07-14 PY - 2020 SN - 1876-7737 1874-3919 ST - Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster T2 - Journal of Proteomics TI - Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006893913&from=export http://dx.doi.org/10.1016/j.jprot.2020.103879 VL - 225 ID - 981 ER - TY - JOUR AD - G. Pugliese, Department of Clinical and Molecular Medicine, La Sapienza University, Via di Grottarossa, 1035-1039, Rome, Italy AU - Menini, S. AU - Iacobini, C. AU - De Latouliere, L. AU - Manni, I. AU - Vitale, M. AU - Pilozzi, E. AU - Pesce, C. AU - Cappello, P. AU - Novelli, F. AU - Piaggio, G. AU - Pugliese, G. DB - Embase Medline DO - 10.1186/s13046-020-01665-0 IS - 1 LA - English M3 - Article N1 - L632557241 2020-08-25 2020-09-29 PY - 2020 SN - 1756-9966 ST - Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice T2 - Journal of Experimental and Clinical Cancer Research TI - Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632557241&from=export http://dx.doi.org/10.1186/s13046-020-01665-0 VL - 39 ID - 982 ER - TY - JOUR AD - J. Andrew Livingston, Department of Sarcoma Medical Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 0450, Houston, TX, United States AU - Dupuis, M. AU - Shen, Y. AU - Curcio, C. AU - Meis, J. M. AU - Wang, W. L. AU - Amini, B. AU - Rhines, L. AU - Reuther, J. AU - Roy, A. AU - Fisher, K. E. AU - Conley, A. P. AU - Andrew Livingston, J. DB - Embase DO - 10.1186/s13569-020-00136-6 IS - 1 LA - English M3 - Article N1 - L632556946 2020-08-26 2020-10-01 PY - 2020 SN - 2045-3329 ST - Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor T2 - Clinical Sarcoma Research TI - Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632556946&from=export http://dx.doi.org/10.1186/s13569-020-00136-6 VL - 10 ID - 983 ER - TY - JOUR AD - J.-Y. Lee, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea AU - Kim, S. H. AU - Suh, Y. AU - Ah, Y. M. AU - Jun, K. AU - Lee, J. Y. DB - Embase Medline DO - 10.1007/s00520-019-05204-2 IS - 8 LA - English M3 - Article N1 - L2003816692 2019-12-13 PY - 2020 SN - 1433-7339 0941-4355 SP - 3617-3626 ST - Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study T2 - Supportive Care in Cancer TI - Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003816692&from=export http://dx.doi.org/10.1007/s00520-019-05204-2 VL - 28 ID - 984 ER - TY - JOUR AD - N. Asher, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel G. Markel, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel G. Markel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel G. Markel, The Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel AU - Asher, N. AU - Ben-Betzalel, G. AU - Lev-Ari, S. AU - Shapira-Frommer, R. AU - Steinberg-Silman, Y. AU - Gochman, N. AU - Schachter, J. AU - Meirson, T. AU - Markel, G. DB - Embase DO - 10.3390/cancers12082329 IS - 8 LA - English M3 - Article N1 - L2004935923 2020-08-26 2020-10-05 PY - 2020 SN - 2072-6694 SP - 1-18 ST - Real world outcomes of ipilimumab and nivolumab in patients with metastatic melanoma T2 - Cancers TI - Real world outcomes of ipilimumab and nivolumab in patients with metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004935923&from=export http://dx.doi.org/10.3390/cancers12082329 VL - 12 ID - 986 ER - TY - JOUR AD - P. Juszczyński, Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland AU - Górniak, P. AU - Wasylecka-Juszczyńska, M. AU - Ługowska, I. AU - Rutkowski, P. AU - Polak, A. AU - Szydłowski, M. AU - Juszczyński, P. DB - Embase Medline DO - 10.1002/1878-0261.12695 IS - 8 LA - English M3 - Article N1 - L2004987594 2020-05-26 2020-09-30 PY - 2020 SN - 1878-0261 1574-7891 SP - 1817-1832 ST - BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells T2 - Molecular Oncology TI - BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004987594&from=export http://dx.doi.org/10.1002/1878-0261.12695 VL - 14 ID - 987 ER - TY - JOUR AD - Q. Liu, Department of Oral Pathology, Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China H. Sun, Department of Oral Pathology, Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China AU - Meng, L. AU - Zhao, Y. AU - Bu, W. AU - Li, X. AU - Liu, X. AU - Zhou, D. AU - Chen, Y. AU - Zheng, S. AU - Lin, Q. AU - Liu, Q. AU - Sun, H. DB - Embase Medline DO - 10.1111/cpr.12859 IS - 8 LA - English M3 - Article N1 - L2005436711 2020-07-14 2020-10-23 PY - 2020 SN - 1365-2184 0960-7722 ST - Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma T2 - Cell Proliferation TI - Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005436711&from=export http://dx.doi.org/10.1111/cpr.12859 VL - 53 ID - 989 ER - TY - JOUR AD - H. Tang, School of Public Health, Dongguan Key Laboratory of Environmental Medicine, Guangdong Medical University, China AU - Liu, X. AU - Zhao, X. AU - Wang, Y. AU - Hong, J. AU - Shi, M. AU - Pfaff, D. AU - Guo, L. AU - Tang, H. DB - Embase Medline DO - 10.1016/j.chemosphere.2020.126470 LA - English M3 - Article N1 - L2005460176 2020-04-20 2020-07-13 Concerns have been raised over the neurotoxicity of triphenyl phosphate (TPP), but there have been few studies of the neurotoxic effects of TPP on mammals and the underlying mechanisms. In this study, weaned male mice (C57/BL6) were used and exposed to 0, 50, or 150 mg/kg TPP daily by oral gavage for 30 days. The blood brain barrier (BBB) permeability of TPP and its metabolite diphenyl phosphate (DPP) in the brain, and TPP induced metabolomic and transcriptomic changes of the brain were investigated. The results showed that TPP and DPP can cross the BBB of mice. Histopathological examination of the brain revealed abnormalities in the hippocampus, cortex and thalamus, and mice treated with high doses showed a potential inflammation in the thalamus and hippocampus. Untargeted metabolomic results revealed that the changed level of glutamic acid, N-acetyl CoA metabolites, and organic acid in the brain of treated mice, suggest that amino acid and lipid metabolism was interfered. RNA-seq data indicated that neuronal transcription processes and cell apoptosis pathway (forkhead box (FOXO), and mitogen-activated protein kinase (MAPK) signaling pathways) were significantly affected by TPP exposure. RT-PCR showed proinflammation cytokine tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6)) levels were increased, while antioxidant genes including nuclear factor-E2-related factor 2 (Nrf2), heme oxygenase1 (HO-1) and superoxide dismutase (SOD1) decreased. These results suggest that TPP could cause a degree of neurotoxicity by inducing neuroinflammation and neuronal apoptosis, which are related to oxidative stress. The potential implications for neurophysiology and behavioral regulation cannot be ignored. PY - 2020 SN - 1879-1298 0045-6535 ST - Triphenyl phosphate permeates the blood brain barrier and induces neurotoxicity in mouse brain T2 - Chemosphere TI - Triphenyl phosphate permeates the blood brain barrier and induces neurotoxicity in mouse brain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005460176&from=export http://dx.doi.org/10.1016/j.chemosphere.2020.126470 VL - 252 ID - 990 ER - TY - JOUR AD - H. Zhang, Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, Guangdong, China F. Wei, Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China AU - Zhang, H. AU - Xu, H. AU - Zhang, R. AU - Zhao, X. AU - Liang, M. AU - Wei, F. C2 - Sigma Aldrich DB - Embase Medline DO - 10.1007/s00280-020-04115-y IS - 2 LA - English M3 - Article N1 - L2005633159 2020-07-29 PY - 2020 SN - 1432-0843 0344-5704 SP - 257-266 ST - Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells T2 - Cancer Chemotherapy and Pharmacology TI - Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005633159&from=export http://dx.doi.org/10.1007/s00280-020-04115-y VL - 86 ID - 991 ER - TY - JOUR AD - Y. Aoki, Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan AU - Katata, Y. AU - Inoue, S. I. AU - Asao, A. AU - Kobayashi, S. AU - Terui, H. AU - Inoue-Shibui, A. AU - Abe, T. AU - Niihori, T. AU - Aiba, S. AU - Ishii, N. AU - Kure, S. AU - Aoki, Y. C1 - pd 0325901 DB - Embase Medline DO - 10.1038/s41419-020-02845-8 IS - 8 LA - English M3 - Article N1 - L2005852584 2020-08-19 2020-08-25 PY - 2020 SN - 2041-4889 ST - Costello syndrome model mice with a Hras G12S/+ mutation are susceptible to develop house dust mite-induced atopic dermatitis T2 - Cell Death and Disease TI - Costello syndrome model mice with a Hras G12S/+ mutation are susceptible to develop house dust mite-induced atopic dermatitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005852584&from=export http://dx.doi.org/10.1038/s41419-020-02845-8 VL - 11 ID - 992 ER - TY - JOUR AD - T. Yang, Postal Address: No.56 Xinjian South Road, Taiyuan, Shanxi, China AU - Chen, J. AU - Dai, J. AU - Kang, Z. AU - Yang, T. AU - Zhao, Q. AU - Zheng, J. AU - Zhang, X. AU - Zhang, J. AU - Xu, J. AU - Sun, G. AU - Yang, L. AU - Yang, T. C1 - bms 754807 gsk 2126458 DB - Embase Medline DO - 10.1016/j.yexcr.2020.112060 IS - 1 LA - English M3 - Article N1 - L2005878448 2020-05-19 2020-05-26 PY - 2020 SN - 1090-2422 0014-4827 ST - A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer T2 - Experimental Cell Research TI - A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005878448&from=export http://dx.doi.org/10.1016/j.yexcr.2020.112060 VL - 393 ID - 993 ER - TY - JOUR AD - S.I. Labidi-Galy, Department of Oncology, Hôpitaux Universitaires de Genève, Rue Gabrielle Perret-Gentil 4, Geneva, Switzerland AU - Terzic, J. AU - Seipel, A. AU - Dubuisson, J. AU - Tille, J. C. AU - Tsantoulis, P. AU - Addeo, A. AU - Labidi-Galy, S. I. DB - Embase DO - 10.1016/j.gore.2020.100600 LA - English M3 - Article N1 - L2006786369 2020-07-06 2020-07-08 PY - 2020 SN - 2352-5789 ST - Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation T2 - Gynecologic Oncology Reports TI - Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006786369&from=export http://dx.doi.org/10.1016/j.gore.2020.100600 VL - 33 ID - 994 ER - TY - JOUR AD - L.Y. Li, Department of Gynecological Oncology, Jiangxi Medical College of Nanchang University, 318 Bayi Street, Nanchang, Jiangxi, China AU - Jiang, T. AU - Zhou, B. AU - Li, Y. M. AU - Yang, Q. Y. AU - Tu, K. J. AU - Li, L. Y. DB - Embase DO - 10.3892/ol.2020.11641 IS - 2 LA - English M3 - Article N1 - L2006816293 2020-07-28 2020-09-28 PY - 2020 SN - 1792-1082 1792-1074 SP - 1360-1368 ST - ALOX12B promotes carcinogenesis in cervical cancer by regulating the PI3K/ERK1 signaling pathway T2 - Oncology Letters TI - ALOX12B promotes carcinogenesis in cervical cancer by regulating the PI3K/ERK1 signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006816293&from=export http://dx.doi.org/10.3892/ol.2020.11641 VL - 20 ID - 995 ER - TY - JOUR AD - J. Fuchs, Department of Pediatric Surgery and Pediatric Urology, Children´s Hospital, University of Tuebingen, Hoppe-Seyler-Str. 03, Tuebingen, Germany AU - Fuchs, J. AU - Warmann, S. W. AU - Urla, C. AU - Schäfer, J. F. AU - Schmidt, A. DB - Embase Medline DO - 10.1016/j.sempedsurg.2020.150941 IS - 4 LA - English M3 - Article N1 - L2007302842 2020-08-07 2020-10-07 PY - 2020 SN - 1532-9453 1055-8586 ST - Management of benign liver tumors T2 - Seminars in Pediatric Surgery TI - Management of benign liver tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007302842&from=export http://dx.doi.org/10.1016/j.sempedsurg.2020.150941 VL - 29 ID - 996 ER - TY - JOUR AD - W. Woessmann, NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany AU - Damm-Welk, C. AU - Kutscher, N. AU - Zimmermann, M. AU - Attarbaschi, A. AU - Schieferstein, J. AU - Knörr, F. AU - Oschlies, I. AU - Klapper, W. AU - Woessmann, W. DB - Embase Medline DO - 10.3324/haematol.2019.232314 IS - 8 LA - English M3 - Article N1 - L2007360970 2020-08-18 PY - 2020 SN - 1592-8721 0390-6078 SP - 2141-2149 ST - Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma T2 - Haematologica TI - Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007360970&from=export http://dx.doi.org/10.3324/haematol.2019.232314 VL - 105 ID - 997 ER - TY - JOUR AD - T. Srivastava, Section of Nephrology, Children’s Mercy Hospital, University of Missouri, Kansas City, MO, United States AU - Srivastava, T. AU - Joshi, T. AU - Jiang, Y. AU - Heruth, D. P. AU - Rezaiekhaligh, M. H. AU - Novak, J. AU - Staggs, V. S. AU - Alon, U. S. AU - Garola, R. E. AU - El-Meanawy, A. AU - McCarthy, E. T. AU - Zhou, J. AU - Boinpelly, V. C. AU - Sharma, R. AU - Savin, V. J. AU - Sharma, M. DB - Embase Medline DO - 10.1152/ajprenal.00183.2020 IS - 2 LA - English M3 - Article N1 - L2007611645 2020-10-12 2020-11-12 PY - 2020 SN - 1522-1466 0363-6127 SP - F312-F322 ST - Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes T2 - American Journal of Physiology - Renal Physiology TI - Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007611645&from=export http://dx.doi.org/10.1152/ajprenal.00183.2020 VL - 319 ID - 998 ER - TY - JOUR AD - K. Shi, Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, China AU - Wu, C. AU - Shang, X. Q. AU - You, Z. P. AU - Jin, Q. F. AU - Zhang, Y. L. AU - Zhou, Y. AU - Zhang, Y. Z. AU - Shi, K. DB - Embase Medline DO - 10.1167/IOVS.61.10.2 IS - 10 LA - English M3 - Article N1 - L2007671884 2020-10-12 PY - 2020 SN - 1552-5783 0146-0404 ST - TRIM59 promotes retinoblastoma progression by activating the p38–MAPK signaling pathway T2 - Investigative Ophthalmology and Visual Science TI - TRIM59 promotes retinoblastoma progression by activating the p38–MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007671884&from=export http://dx.doi.org/10.1167/IOVS.61.10.2 VL - 61 ID - 999 ER - TY - JOUR AU - Moustafa, D. AU - Blundell, A. R. AU - Hawryluk, E. B. DB - Medline DO - 10.1097/MOP.0000000000000924 IS - 4 LA - English M3 - Article N1 - L632415902 2020-07-30 PY - 2020 SN - 1531-698X SP - 491-497 ST - Congenital melanocytic nevi T2 - Current opinion in pediatrics TI - Congenital melanocytic nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632415902&from=export http://dx.doi.org/10.1097/MOP.0000000000000924 VL - 32 ID - 1000 ER - TY - JOUR AD - Y. Ohmichi, Department of Anatomy, Aichi Medical University, 1-1 Yazakokarimta, Nagakute, Aichi, Japan AU - Ohmichi, Y. AU - Ohmichi, M. AU - Tashima, R. AU - Osuka, K. AU - Fukushige, K. AU - Kanikowska, D. AU - Fukazawa, Y. AU - Yawo, H. AU - Tsuda, M. AU - Naito, M. AU - Nakano, T. DB - Embase Medline DO - 10.1097/j.pain.0000000000001867 IS - 8 LA - English M3 - Article N1 - L632859884 2020-09-22 2020-09-24 PY - 2020 SN - 1872-6623 0304-3959 SP - 1808-1823 ST - Physical disuse contributes to widespread chronic mechanical hyperalgesia, tactile allodynia, and cold allodynia through neurogenic inflammation and spino-parabrachio-amygdaloid pathway activation T2 - Pain TI - Physical disuse contributes to widespread chronic mechanical hyperalgesia, tactile allodynia, and cold allodynia through neurogenic inflammation and spino-parabrachio-amygdaloid pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632859884&from=export http://dx.doi.org/10.1097/j.pain.0000000000001867 VL - 161 ID - 1001 ER - TY - JOUR AD - P. Li, Department of Gastric Surgery, Fujian Medical University Union Hospital, No.29 Xinquan Road, Fuzhou Fujian Province, China AU - Xie, J. W. AU - Huang, X. B. AU - Chen, Q. Y. AU - Ma, Y. B. AU - Zhao, Y. J. AU - Liu, L. C. AU - Wang, J. B. AU - Lin, J. X. AU - Lu, J. AU - Cao, L. L. AU - Lin, M. AU - Tu, R. H. AU - Zheng, C. H. AU - Huang, C. M. AU - Li, P. DB - Embase Medline DO - 10.1186/s12943-020-01223-4 IS - 1 LA - English M3 - Article N1 - L632298346 2020-08-17 2020-09-04 PY - 2020 SN - 1476-4598 ST - m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling T2 - Molecular Cancer TI - m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632298346&from=export http://dx.doi.org/10.1186/s12943-020-01223-4 VL - 19 ID - 1002 ER - TY - JOUR AD - W.-P. Lin, Department of Orthopedic Surgery, Second Affiliated Hospital, Fujian Medical University, Quanzhou, China AU - Chen, W. K. AU - Feng, L. J. AU - Liu, Q. D. AU - Ke, Q. F. AU - Cai, P. Y. AU - Zhang, P. R. AU - Cai, L. Q. AU - Huang, N. L. AU - Lin, W. P. DB - Embase Medline DO - 10.1186/s12974-020-01884-4 IS - 1 LA - English M3 - Article N1 - L632298509 2020-07-24 PY - 2020 SN - 1742-2094 ST - Inhibition of leucine-rich repeats and calponin homology domain containing 1 accelerates microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model T2 - Journal of Neuroinflammation TI - Inhibition of leucine-rich repeats and calponin homology domain containing 1 accelerates microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632298509&from=export http://dx.doi.org/10.1186/s12974-020-01884-4 VL - 17 ID - 1003 ER - TY - JOUR AD - K. Li, Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China AU - Wang, J. AU - Yao, W. AU - Li, K. DB - Embase DO - 10.1136/wjps-2020-000164 IS - 2 LA - English M3 - Review N1 - L632230666 2020-07-22 2020-07-24 PY - 2020 SN - 2516-5410 ST - Applications and prospects of targeted therapy for neuroblastoma T2 - World Journal of Pediatric Surgery TI - Applications and prospects of targeted therapy for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632230666&from=export http://dx.doi.org/10.1136/wjps-2020-000164 VL - 3 ID - 1004 ER - TY - JOUR AD - Z. Wang, Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China AU - Chen, Y. AU - Qin, C. AU - Cui, X. AU - Geng, W. AU - Xian, G. AU - Wang, Z. DB - Embase Medline DO - 10.1002/jcp.29506 IS - 7-8 LA - English M3 - Article N1 - L2004157603 2020-02-04 2020-05-01 PY - 2020 SN - 1097-4652 0021-9541 SP - 5711-5721 ST - miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2 T2 - Journal of Cellular Physiology TI - miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004157603&from=export http://dx.doi.org/10.1002/jcp.29506 VL - 235 ID - 1005 ER - TY - JOUR AD - W. Wang, Department of Obstetrics, Weifang Maternal and Child Health Hospital, Weifang, Shandong, China AU - Song, T. T. AU - Xu, F. AU - Wang, W. DB - Embase Medline DO - 10.1002/kjm2.12204 IS - 7 LA - English M3 - Article N1 - L2004463898 2020-03-27 PY - 2020 SN - 2410-8650 1607-551X SP - 501-507 ST - Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma T2 - Kaohsiung Journal of Medical Sciences TI - Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004463898&from=export http://dx.doi.org/10.1002/kjm2.12204 VL - 36 ID - 1007 ER - TY - JOUR AD - A. Lonetti, “Giorgio Prodi” Cancer Research Center, University of Bologna, S. Orsola-Malpighi Hospital, Via Massarenti 11, Bologna, Italy AU - Lonetti, A. AU - Indio, V. AU - Laginestra, M. A. AU - Tarantino, G. AU - Chiarini, F. AU - Astolfi, A. AU - Bertuccio, S. N. AU - Martelli, A. M. AU - Locatelli, F. AU - Pession, A. AU - Masetti, R. C1 - az 628(Selleck,United States) gw 5074(Tocris,United Kingdom) C2 - Selleck Tocris(United Kingdom) Selleck(United States) DB - Embase DO - 10.3390/cancers12071972 IS - 7 LA - English M3 - Article N1 - L2004735145 2020-07-24 2020-07-30 PY - 2020 SN - 2072-6694 SP - 1-18 ST - Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml T2 - Cancers TI - Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004735145&from=export http://dx.doi.org/10.3390/cancers12071972 VL - 12 ID - 1008 ER - TY - JOUR AD - V. Winnepenninckx, Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center (MUMC+), Maastricht, Netherlands AU - Hillen, L. M. AU - Geybels, M. S. AU - Spassova, I. AU - Becker, J. C. AU - Gambichler, T. AU - Garmyn, M. AU - zur Hausen, A. AU - van den Oord, J. AU - Winnepenninckx, V. DB - Embase Medline DO - 10.1002/2211-5463.12897 IS - 7 LA - English M3 - Article N1 - L2005154154 2020-06-10 2020-07-15 PY - 2020 SN - 2211-5463 SP - 1326-1341 ST - A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms T2 - FEBS Open Bio TI - A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005154154&from=export http://dx.doi.org/10.1002/2211-5463.12897 VL - 10 ID - 1009 ER - TY - JOUR AD - V. Ramaswamy, Department of Medical Biophysics and Pediatrics, University of Toronto, Toronto, ON, Canada AU - Cacciotti, C. AU - Fleming, A. AU - Ramaswamy, V. DB - Embase Medline DO - 10.1002/path.5457 IS - 3 LA - English M3 - Review N1 - L2005188464 2020-06-30 2020-07-09 PY - 2020 SN - 1096-9896 0022-3417 SP - 249-261 ST - Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy T2 - Journal of Pathology TI - Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005188464&from=export http://dx.doi.org/10.1002/path.5457 VL - 251 ID - 1010 ER - TY - JOUR AD - N.A. Vitanza, Division of Hematology/Oncology, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, 4800 Sand Point Way NE, M/S MB.8.501, PO Box 5371, Seattle, WA, United States AU - Crotty, E. E. AU - Leary, S. E. S. AU - Geyer, J. R. AU - Olson, J. M. AU - Millard, N. E. AU - Sato, A. A. AU - Ermoian, R. P. AU - Cole, B. L. AU - Lockwood, C. M. AU - Paulson, V. A. AU - Browd, S. R. AU - Ellenbogen, R. G. AU - Hauptman, J. S. AU - Lee, A. AU - Ojemann, J. G. AU - Vitanza, N. A. DB - Embase Medline DO - 10.1007/s11060-020-03558-w IS - 3 LA - English M3 - Article N1 - L2005272014 2020-07-06 PY - 2020 SN - 1573-7373 0167-594X SP - 607-617 ST - Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience T2 - Journal of Neuro-Oncology TI - Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005272014&from=export http://dx.doi.org/10.1007/s11060-020-03558-w VL - 148 ID - 1011 ER - TY - JOUR AD - Y. Jiang, Department of Joint Surgery, Huadu District People's Hospital, Southern Medical University, Guangzhou, Guangdong, China AU - Su, Z. AU - Yang, B. AU - Zeng, Z. AU - Zhu, S. AU - Wang, C. AU - Lei, S. AU - Jiang, Y. AU - Lin, L. DB - Embase DO - 10.3892/ol.2020.11544 IS - 1 LA - English M3 - Article N1 - L2006061124 2020-06-09 2020-07-07 PY - 2020 SN - 1792-1082 1792-1074 SP - 99-112 ST - Metastasis-associated gene MAPK15 promotes the migration and invasion of osteosarcoma cells via the c-Jun/MMPs pathway T2 - Oncology Letters TI - Metastasis-associated gene MAPK15 promotes the migration and invasion of osteosarcoma cells via the c-Jun/MMPs pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006061124&from=export http://dx.doi.org/10.3892/ol.2020.11544 VL - 20 ID - 1012 ER - TY - JOUR AD - J.A. Dyer, Department of Dermatology, University of Missouri School of Medicine, Columbia, MO, United States AU - Ladd, R. AU - Davis, M. AU - Dyer, J. A. DB - Embase Medline DO - 10.1016/j.clindermatol.2020.03.007 IS - 4 LA - English M3 - Article N1 - L2006141072 2020-06-15 2020-09-30 PY - 2020 SN - 1879-1131 0738-081X SP - 432-454 ST - Genodermatoses with malignant potential T2 - Clinics in Dermatology TI - Genodermatoses with malignant potential UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006141072&from=export http://dx.doi.org/10.1016/j.clindermatol.2020.03.007 VL - 38 ID - 1013 ER - TY - JOUR AD - K.-K. Park, Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, South Korea AU - Park, J. AU - Jang, K. M. AU - Park, K. K. DB - Embase Medline DO - 10.3390/ijms21124319 IS - 12 LA - English M3 - Article N1 - L2004569019 2020-07-24 2020-08-31 PY - 2020 SN - 1422-0067 1661-6596 SP - 1-14 ST - Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK channels and TLR4-mediated signaling pathways T2 - International Journal of Molecular Sciences TI - Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK channels and TLR4-mediated signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004569019&from=export http://dx.doi.org/10.3390/ijms21124319 VL - 21 ID - 1014 ER - TY - JOUR AD - M. Tolomeo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, via del Vespro 129, Palermo, Italy AU - Tolomeo, M. AU - Grimaudo, S. DB - Embase Medline DO - 10.3390/ijms21124308 IS - 12 LA - English M3 - Review N1 - L2004569095 2020-07-24 2020-09-08 PY - 2020 SN - 1422-0067 1661-6596 SP - 1-18 ST - The “janus” role of C/EBPs family members in cancer progression T2 - International Journal of Molecular Sciences TI - The “janus” role of C/EBPs family members in cancer progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004569095&from=export http://dx.doi.org/10.3390/ijms21124308 VL - 21 ID - 1015 ER - TY - JOUR AD - I. Yeh, Departments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, United States AU - Raghavan, S. S. AU - Peternel, S. AU - Mully, T. W. AU - North, J. P. AU - Pincus, L. B. AU - LeBoit, P. E. AU - McCalmont, T. H. AU - Bastian, B. C. AU - Yeh, I. DB - Embase Medline DO - 10.1038/s41379-019-0445-z IS - 6 LA - English M3 - Article N1 - L2004009773 2020-01-13 2020-07-02 PY - 2020 SN - 1530-0285 0893-3952 SP - 1122-1134 ST - Spitz melanoma is a distinct subset of spitzoid melanoma T2 - Modern Pathology TI - Spitz melanoma is a distinct subset of spitzoid melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004009773&from=export http://dx.doi.org/10.1038/s41379-019-0445-z VL - 33 ID - 1017 ER - TY - JOUR AD - F.J. Cubero, Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany AU - Cubero, F. J. AU - Mohamed, M. R. AU - Woitok, M. M. AU - Zhao, G. AU - Hatting, M. AU - Nevzorova, Y. A. AU - Chen, C. AU - Haybaeck, J. AU - de Bruin, A. AU - Avila, M. A. AU - Boekschoten, M. V. AU - Davis, R. J. AU - Trautwein, C. DB - Embase DO - 10.1002/hep4.1495 IS - 6 LA - English M3 - Article N1 - L2004655408 2020-04-24 2020-06-12 PY - 2020 SN - 2471-254X SP - 834-851 ST - Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma T2 - Hepatology Communications TI - Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004655408&from=export http://dx.doi.org/10.1002/hep4.1495 VL - 4 ID - 1018 ER - TY - JOUR AD - I. Andolfo, CEINGE, Biotecnologie Avanzate, Naples, Italy AU - Andolfo, I. AU - Lasorsa, V. A. AU - Manna, F. AU - Rosato, B. E. AU - Formicola, D. AU - Iolascon, A. AU - Capasso, M. DB - Embase Medline DO - 10.1111/jcmm.15297 IS - 11 LA - English M3 - Article N1 - L2004762958 2020-05-07 PY - 2020 SN - 1582-1838 SP - 6459-6471 ST - Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma T2 - Journal of Cellular and Molecular Medicine TI - Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004762958&from=export http://dx.doi.org/10.1111/jcmm.15297 VL - 24 ID - 1019 ER - TY - JOUR AD - A. Markham, Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, New Zealand AU - Markham, A. AU - Keam, S. J. DB - Embase Medline DO - 10.1007/s40265-020-01331-x IS - 9 LA - English M3 - Article N1 - L2005165467 2020-06-30 2020-07-03 PY - 2020 SN - 1179-1950 0012-6667 SP - 931-937 ST - Selumetinib: First Approval T2 - Drugs TI - Selumetinib: First Approval UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005165467&from=export http://dx.doi.org/10.1007/s40265-020-01331-x VL - 80 ID - 1020 ER - TY - JOUR AD - J. Wang, Department of Cardiology, Affiliated Hospital of Jining Medical University, No. 89 Guhuai Road, Jining City, Shandong Province, China AU - Huang, C. AU - Zhang, Y. AU - Qi, H. AU - Xu, X. AU - Yang, L. AU - Wang, J. DB - Embase Medline DO - 10.1042/BSR20194472 IS - 6 LA - English M3 - Article N1 - L2007257487 2020-10-13 PY - 2020 SN - 1573-4935 0144-8463 ST - Myc is involved in Genistein protecting against LPS-induced myocarditis in vitro through mediating MAPK/JNK signaling pathway T2 - Bioscience Reports TI - Myc is involved in Genistein protecting against LPS-induced myocarditis in vitro through mediating MAPK/JNK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007257487&from=export http://dx.doi.org/10.1042/BSR20194472 VL - 40 ID - 1021 ER - TY - JOUR AD - Y. Xiao, Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Xiao, Y. AU - Deng, T. AU - Wang, D. DB - Embase Medline IS - 3 LA - English M3 - Article N1 - L2007417767 2020-09-08 2020-10-27 PY - 2020 SN - 1107-0625 SP - 1607-1613 ST - Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway T2 - Journal of B.U.ON. TI - Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007417767&from=export VL - 25 ID - 1022 ER - TY - JOUR AD - R. Gruszka, Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Pomorska 251, Lodz, Poland AU - Gruszka, R. AU - Zakrzewski, K. AU - Liberski, P. P. AU - Zakrzewska, M. DB - Embase Medline DO - 10.5114/FN.2020.96734 IS - 2 LA - English M3 - Article N1 - L2007580907 2020-09-07 2020-09-09 PY - 2020 SN - 1509-572X 1641-4640 SP - 123-132 ST - MicroRNA interaction with MAPK and AKT pathways in paediatric brain tumours-Preliminary results and review of the literature T2 - Folia Neuropathologica TI - MicroRNA interaction with MAPK and AKT pathways in paediatric brain tumours-Preliminary results and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007580907&from=export http://dx.doi.org/10.5114/FN.2020.96734 VL - 58 ID - 1023 ER - TY - JOUR AD - S. Ahuja, Icahn School of Medicine, Mount Sinai Hospital AU - Ahuja, S. AU - Bryce, C. DB - Embase DO - 10.1093/jnen/nlaa036 IS - 6 LA - English M3 - Conference Abstract N1 - L632059648 2020-07-24 PY - 2020 SN - 1554-6578 SP - 673 ST - Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) with distinct clinical and molecular features in a cerebellar tonsils T2 - Journal of Neuropathology and Experimental Neurology TI - Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) with distinct clinical and molecular features in a cerebellar tonsils UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632059648&from=export http://dx.doi.org/10.1093/jnen/nlaa036 VL - 79 ID - 1025 ER - TY - JOUR AD - W. Zhang, Department of Pediatric Lymphoma, Beijing Boren Hospital, Beijing, China AU - Zhang, W. AU - Yang, J. AU - Hu, B. AU - Liu, Y. AU - Jin, L. AU - Zhu, Q. AU - Liu, Y. AU - Wang, S. AU - Zheng, Q. AU - Zhou, C. AU - Gao, Z. AU - Zhang, Y. DB - Embase DO - 10.1097/HS9.0000000000000404 LA - English M3 - Conference Abstract N1 - L632447018 2020-07-31 PY - 2020 SN - 2572-9241 SP - 562-563 ST - Early response observation in alk kinase inhibitors combined with/without vinblastine in pediatric refractory/relapsed ALK+ anaplastic large cell lymphoma T2 - HemaSphere TI - Early response observation in alk kinase inhibitors combined with/without vinblastine in pediatric refractory/relapsed ALK+ anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632447018&from=export http://dx.doi.org/10.1097/HS9.0000000000000404 VL - 4 ID - 1026 ER - TY - JOUR AD - B. Dong, Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China J. Kong, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China AU - Ma, H. AU - Dong, X. F. AU - Cao, X. R. AU - Hei, N. H. AU - Li, J. L. AU - Wang, Y. L. AU - Kong, J. AU - Dong, B. C1 - pd 98059 DB - Embase Medline DO - 10.1089/hum.2019.124 IS - 11-12 LA - English M3 - Article N1 - L632617196 2020-08-24 2020-10-23 PY - 2020 SN - 1557-7422 1043-0342 SP - 639-650 ST - Pro-Renin Receptor Overexpression Promotes Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice T2 - Human Gene Therapy TI - Pro-Renin Receptor Overexpression Promotes Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632617196&from=export http://dx.doi.org/10.1089/hum.2019.124 VL - 31 ID - 1027 ER - TY - JOUR AD - J. Terada, Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Japan AU - Shikano, K. AU - Ishiwata, T. AU - Saegusa, F. AU - Terada, J. AU - Sakayori, M. AU - Abe, M. AU - Kawasaki, T. AU - Ikari, J. AU - Kawata, N. AU - Tada, Y. AU - Tatsumi, K. DB - Embase DO - 10.21037/jtd-20-671 IS - 6 LA - English M3 - Article N1 - L632741494 2020-09-08 2020-10-02 PY - 2020 SN - 2077-6624 2072-1439 SP - 3057-3064 ST - Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy T2 - Journal of Thoracic Disease TI - Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632741494&from=export http://dx.doi.org/10.21037/jtd-20-671 VL - 12 ID - 1028 ER - TY - JOUR AD - Z. Liu, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China AU - Ji, J. AU - Liu, Z. AU - Hong, X. AU - Liu, Z. AU - Gao, J. AU - Liu, J. DB - Embase Medline DO - 10.1186/s12872-020-01529-7 IS - 1 LA - English M3 - Article N1 - L631834312 2020-06-02 2020-07-01 PY - 2020 SN - 1471-2261 ST - Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts T2 - BMC Cardiovascular Disorders TI - Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631834312&from=export http://dx.doi.org/10.1186/s12872-020-01529-7 VL - 20 ID - 1029 ER - TY - JOUR AD - S. Pilotto, Section of Oncology, Department of Medicine, University of Verona, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Verona, Italy AU - Trestini, I. AU - Sperduti, I. AU - Sposito, M. AU - Kadrija, D. AU - Drudi, A. AU - Avancini, A. AU - Tregnago, D. AU - Carbognin, L. AU - Bovo, C. AU - Santo, A. AU - Lanza, M. AU - D'Onofrio, M. AU - Tortora, G. AU - Bria, E. AU - Milella, M. AU - Pilotto, S. DB - Embase Medline DO - 10.1136/esmoopen-2020-000689 IS - 3 LA - English M3 - Article N1 - L631797800 2020-06-02 2020-06-05 PY - 2020 SN - 2059-7029 ST - Evaluation of nutritional status in non-small-cell lung cancer: Screening, assessment and correlation with treatment outcome T2 - ESMO Open TI - Evaluation of nutritional status in non-small-cell lung cancer: Screening, assessment and correlation with treatment outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631797800&from=export http://dx.doi.org/10.1136/esmoopen-2020-000689 VL - 5 ID - 1030 ER - TY - JOUR AU - Moore, C. AU - Palau, V. E. AU - Mahboob, R. AU - Lightner, J. AU - Stone, W. AU - Krishnan, K. DB - Medline DO - 10.1186/s12885-020-06947-6 IS - 1 LA - English M3 - Article N1 - L631779994 2020-05-25 PY - 2020 SN - 1471-2407 SP - 428 ST - Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells T2 - BMC cancer TI - Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631779994&from=export http://dx.doi.org/10.1186/s12885-020-06947-6 VL - 20 ID - 1031 ER - TY - JOUR AD - W.L. Shaib, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States AU - Zakka, K. AU - Nagy, R. AU - Drusbosky, L. AU - Akce, M. AU - Wu, C. AU - Alese, O. B. AU - El-Rayes, B. F. AU - Kasi, P. M. AU - Mody, K. AU - Starr, J. AU - Shaib, W. L. DB - Embase DO - 10.18632/oncotarget.27588 IS - 19 LA - English M3 - Article N1 - L632012639 2020-06-30 2020-07-14 PY - 2020 SN - 1949-2553 SP - 1749-1757 ST - Blood-based next-generation sequencing analysis of neuroendocrine neoplasms T2 - Oncotarget TI - Blood-based next-generation sequencing analysis of neuroendocrine neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632012639&from=export http://dx.doi.org/10.18632/oncotarget.27588 VL - 11 ID - 1032 ER - TY - JOUR AD - A. de la Fouchardière, Department of Biopathology, Centre Léon Bérard, Lyon, France AU - Houlier, A. AU - Pissaloux, D. AU - Masse, I. AU - Tirode, F. AU - Karanian, M. AU - Pincus, L. B. AU - McCalmont, T. H. AU - LeBoit, P. E. AU - Bastian, B. C. AU - Yeh, I. AU - de la Fouchardière, A. DB - Embase Medline DO - 10.1038/s41379-019-0384-8 IS - 5 LA - English M3 - Article N1 - L2003633707 2019-11-22 PY - 2020 SN - 1530-0285 0893-3952 SP - 846-857 ST - Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations T2 - Modern Pathology TI - Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003633707&from=export http://dx.doi.org/10.1038/s41379-019-0384-8 VL - 33 ID - 1033 ER - TY - JOUR AD - A. Gomez-Brouchet, Department of Pathology and Cytology, Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Paul Sabatier University Toulouse III, Toulouse, France AU - Brunac, A. C. AU - Laprie, A. AU - Castex, M. P. AU - Laurent, C. AU - Le Loarer, F. AU - Karanian, M. AU - Le Guellec, S. AU - Guillemot, D. AU - Pierron, G. AU - Gomez-Brouchet, A. DB - Embase Medline DO - 10.1002/pbc.28185 IS - 5 LA - English M3 - Letter N1 - L2004155918 2020-02-04 2020-04-10 PY - 2020 SN - 1545-5017 1545-5009 ST - The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript T2 - Pediatric Blood and Cancer TI - The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004155918&from=export http://dx.doi.org/10.1002/pbc.28185 VL - 67 ID - 1034 ER - TY - JOUR AD - D.A. Largaespada, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States AU - Williams, K. B. AU - Largaespada, D. A. C1 - pd 0325901 plx 3397 DB - Embase Medline DO - 10.3390/genes11050477 IS - 5 LA - English M3 - Review N1 - L2004246218 2020-05-06 2020-05-15 PY - 2020 SN - 2073-4425 ST - New model systems and the development of targeted therapies for the treatment of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors T2 - Genes TI - New model systems and the development of targeted therapies for the treatment of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004246218&from=export http://dx.doi.org/10.3390/genes11050477 VL - 11 ID - 1035 ER - TY - JOUR AD - E.V. Preobrazhenskaya, N.N. Petrov Institute of Oncology, St. Petersburg, Russian Federation AU - Preobrazhenskaya, E. V. AU - Iyevleva, A. G. AU - Suleymanova, A. M. AU - Tiurin, V. I. AU - Mitiushkina, N. V. AU - Bizin, I. V. AU - Ivanstov, A. O. AU - Gorustovich, O. A. AU - Shelekhova, K. V. AU - Kachanov, D. Y. AU - Varfolomeeva, S. R. AU - Roschin, V. Y. AU - Kazakova, A. N. AU - Litvinov, D. V. AU - Shamanskaya, T. V. AU - Savelov, N. A. AU - Suspitsin, E. N. AU - Imyanitov, E. N. DB - Embase Medline DO - 10.1002/pbc.28220 IS - 5 LA - English M3 - Article N1 - L2004277507 2020-02-25 2020-04-10 PY - 2020 SN - 1545-5017 1545-5009 ST - Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors T2 - Pediatric Blood and Cancer TI - Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004277507&from=export http://dx.doi.org/10.1002/pbc.28220 VL - 67 ID - 1036 ER - TY - JOUR AD - Y. Ma, Deparatment of Neonatology, The Affiliated Children Hospital of Xi'an Jiaotong University, Xi'an, China AU - Liu, H. AU - Lin, Z. AU - Ma, Y. DB - Embase Medline DO - 10.1016/j.biopha.2020.109943 LA - English M3 - Article N1 - L2005028410 2020-02-27 2020-03-04 PY - 2020 SN - 1950-6007 0753-3322 ST - Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation T2 - Biomedicine and Pharmacotherapy TI - Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005028410&from=export http://dx.doi.org/10.1016/j.biopha.2020.109943 VL - 125 ID - 1037 ER - TY - JOUR AD - A.R. Kirane, Division of Surgical Oncology, Department of Surgery, University of California, Davis Medical Center, 4501 X Street, Sacramento, CA, United States AU - Bateni, S. B. AU - Johns, A. J. AU - Gingrich, A. A. AU - Gholami, S. AU - Bold, R. J. AU - Canter, R. J. AU - Kirane, A. R. DB - Embase Medline DO - 10.21873/anticanres.14266 IS - 5 LA - English M3 - Article N1 - L2005797121 2020-05-15 2020-05-19 PY - 2020 SN - 1791-7530 0250-7005 SP - 2895-2903 ST - Elderly age is associated with more conservative treatment of invasive melanoma T2 - Anticancer Research TI - Elderly age is associated with more conservative treatment of invasive melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005797121&from=export http://dx.doi.org/10.21873/anticanres.14266 VL - 40 ID - 1038 ER - TY - JOUR AD - D. Deng, Department of Hematology, Kaifeng Children’s Hospital, Kaifeng, Henan, China AU - Deng, D. AU - Yang, S. AU - Wang, X. DB - Embase Medline DO - 10.1042/BSR20200723 IS - 5 LA - English M3 - Article N1 - L2006048610 2020-06-11 2020-06-16 PY - 2020 SN - 1573-4935 0144-8463 ST - Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells T2 - Bioscience Reports TI - Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006048610&from=export http://dx.doi.org/10.1042/BSR20200723 VL - 40 ID - 1039 ER - TY - JOUR AU - Kong, X. AU - Yang, M. AU - Guo, J. AU - Feng, Z. DB - Medline DO - 10.1097/MPG.0000000000002636 IS - 5 LA - English M3 - Article N1 - L630707984 2020-01-31 PY - 2020 SN - 1536-4801 SP - 645-651 ST - Effects of Bovine Lactoferrin on Rat Intestinal Epithelial Cells T2 - Journal of pediatric gastroenterology and nutrition TI - Effects of Bovine Lactoferrin on Rat Intestinal Epithelial Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630707984&from=export http://dx.doi.org/10.1097/MPG.0000000000002636 VL - 70 ID - 1040 ER - TY - JOUR AD - Y.-H. Zhang, Beijing Key Laboratory of Pediatric Hematology Oncology, National Discipline of Pediatrics, Ministry of Education, MOE Key Laboratory of Major Diseases in Children, Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, Nanlishi Road, Beijing, China AU - Yang, J. AU - Li, J. AU - Gu, W. Y. AU - Jin, L. AU - Duan, Y. L. AU - Huang, S. AU - Zhang, M. AU - Wang, X. S. AU - Liu, Y. AU - Zhou, C. J. AU - Gao, C. AU - Zheng, H. Y. AU - Zhang, Y. H. DB - Embase DO - 10.12998/WJCC.V8.I9.1685 IS - 9 LA - English M3 - Article N1 - L632109016 2020-07-08 2020-07-09 PY - 2020 SN - 2307-8960 SP - 1685-1692 ST - Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report T2 - World Journal of Clinical Cases TI - Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632109016&from=export http://dx.doi.org/10.12998/WJCC.V8.I9.1685 VL - 8 ID - 1041 ER - TY - JOUR AD - N. Li, Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Wang, S. AU - Chen, R. AU - Tang, Y. AU - Yu, Y. AU - Fang, Y. AU - Huang, H. AU - Wu, D. AU - Fang, H. AU - Bai, Y. AU - Sun, C. AU - Yu, A. AU - Fan, Q. AU - Gu, D. AU - Yi, X. AU - Li, N. DB - Embase DO - 10.3389/fonc.2020.00536 LA - English M3 - Article N1 - L631649634 2020-05-13 2020-05-15 PY - 2020 SN - 2234-943X ST - Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies T2 - Frontiers in Oncology TI - Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631649634&from=export http://dx.doi.org/10.3389/fonc.2020.00536 VL - 10 ID - 1042 ER - TY - JOUR AD - J.-B. Kim, Department of Pediatrics, Hangang Sacred Heart Hospital, Hallym University, 94-200 Yeong-deungpo-Dong, Yeongdeungpo-Ku, Seoul, South Korea AU - Cui, H. S. AU - Joo, S. Y. AU - Cho, Y. S. AU - Kim, J. B. AU - Seo, C. H. DB - Embase Medline DO - 10.1016/j.abb.2020.108322 LA - English M3 - Article N1 - L2005097748 2020-03-04 2020-03-10 PY - 2020 SN - 1096-0384 0003-9861 ST - CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts T2 - Archives of Biochemistry and Biophysics TI - CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005097748&from=export http://dx.doi.org/10.1016/j.abb.2020.108322 VL - 683 ID - 1043 ER - TY - JOUR AD - O. Lopez-Nunez, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, United States AU - Lopez-Nunez, O. AU - John, I. AU - Panasiti, R. N. AU - Ranganathan, S. AU - Santoro, L. AU - Grélaud, D. AU - Wu, T. AU - Buccoliero, A. M. AU - Casanova, M. AU - Alaggio, R. AU - Surrey, L. F. DB - Embase Medline DO - 10.1038/s41379-019-0406-6 IS - 4 LA - English M3 - Article N1 - L2003543687 2019-11-15 PY - 2020 SN - 1530-0285 0893-3952 SP - 576-590 ST - Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases T2 - Modern Pathology TI - Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003543687&from=export http://dx.doi.org/10.1038/s41379-019-0406-6 VL - 33 ID - 1045 ER - TY - JOUR AD - F. Barra, Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy AU - Barra, F. AU - Ferro Desideri, L. AU - Leone Roberti Maggiore, U. AU - Gaetano Vellone, V. AU - Maramai, M. AU - Scala, C. AU - Ferrero, S. DB - Embase DO - 10.22074/ijfs.2020.5876 IS - 1 LA - English M3 - Letter N1 - L2003928403 2020-03-11 2020-03-17 PY - 2020 SN - 2008-0778 2008-076X SP - 76-77 ST - Endometriosis classification and the role of tumor necrosis factor-alpha polymorphisms as a therapeutic target T2 - International Journal of Fertility and Sterility TI - Endometriosis classification and the role of tumor necrosis factor-alpha polymorphisms as a therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003928403&from=export http://dx.doi.org/10.22074/ijfs.2020.5876 VL - 14 ID - 1046 ER - TY - JOUR AD - Y. Zu, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Cancer Pathology Research Laboratory, Houston Methodist Research Institute, Houston, TX, United States AU - Zeng, Z. AU - Tung, C. H. AU - Zu, Y. C2 - Sigma Aldrich(United States) DB - Embase DO - 10.3390/cancers12040780 IS - 4 LA - English M3 - Article N1 - L2004111171 2020-04-13 2020-04-20 PY - 2020 SN - 2072-6694 ST - Aptamer-equipped protamine nanomedicine for precision lymphoma therapy T2 - Cancers TI - Aptamer-equipped protamine nanomedicine for precision lymphoma therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004111171&from=export http://dx.doi.org/10.3390/cancers12040780 VL - 12 ID - 1048 ER - TY - JOUR AD - J. Potratz, Department of Pediatric Hematology and Oncology, University Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany AU - Berning, P. AU - Hennemann, C. AU - Tulotta, C. AU - Schaefer, C. AU - Lechtape, B. AU - Hotfilder, M. AU - El Gourari, Y. AU - Jürgens, H. AU - Snaar-Jagalska, E. AU - Hempel, G. AU - Dirksen, U. AU - Potratz, J. C1 - bms 777607 DB - Embase DO - 10.3390/cancers12040904 IS - 4 LA - English M3 - Article N1 - L2004152861 2020-04-30 2020-05-08 PY - 2020 SN - 2072-6694 ST - The receptor tyrosine kinase RON and its isoforms as therapeutic targets in ewing sarcoma T2 - Cancers TI - The receptor tyrosine kinase RON and its isoforms as therapeutic targets in ewing sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004152861&from=export http://dx.doi.org/10.3390/cancers12040904 VL - 12 ID - 1049 ER - TY - JOUR AD - B. Shivanna, Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States AU - Menon, R. T. AU - Shrestha, A. K. AU - Barrios, R. AU - Reynolds, C. AU - Shivanna, B. DB - Embase Medline DO - 10.3390/ijms21072408 IS - 7 LA - English M3 - Article N1 - L2004197024 2020-04-29 2020-05-15 PY - 2020 SN - 1422-0067 1661-6596 ST - Tie-2 cre-mediated deficiency of extracellular signal-regulated kinase 2 potentiates experimental bronchopulmonary dysplasia-associated pulmonary hypertension in neonatal mice T2 - International Journal of Molecular Sciences TI - Tie-2 cre-mediated deficiency of extracellular signal-regulated kinase 2 potentiates experimental bronchopulmonary dysplasia-associated pulmonary hypertension in neonatal mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004197024&from=export http://dx.doi.org/10.3390/ijms21072408 VL - 21 ID - 1050 ER - TY - JOUR AD - B. Liu, Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, United States AU - Shi, Q. AU - Pei, F. AU - Silverman, G. A. AU - Pak, S. C. AU - Perlmutter, D. H. AU - Liu, B. AU - Bahar, I. DB - Embase Medline DO - 10.3390/ijms21082855 IS - 8 LA - English M3 - Article N1 - L2004241886 2020-05-08 2020-05-13 PY - 2020 SN - 1422-0067 1661-6596 ST - Mechanisms of action of autophagy modulators dissected by quantitative systems pharmacology analysis T2 - International Journal of Molecular Sciences TI - Mechanisms of action of autophagy modulators dissected by quantitative systems pharmacology analysis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004241886&from=export http://dx.doi.org/10.3390/ijms21082855 VL - 21 ID - 1051 ER - TY - JOUR AD - H. Nzwalo, Department of Biomedical Sciences and Medicine, Universidade do Algarve, Faro, Portugal AU - Espírito Santo, V. AU - Passos, J. AU - Nzwalo, H. AU - Carvalho, I. AU - Santos, F. AU - Martins, C. AU - Salgado, L. AU - Silva, C. AU - Vinhais, S. AU - Vilares, M. AU - Salgado, D. AU - Nunes, S. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1007/s11060-020-03443-6 IS - 2 LA - English M3 - Article N1 - L2004386158 2020-03-16 2020-04-23 PY - 2020 SN - 1573-7373 0167-594X SP - 459-463 ST - Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience T2 - Journal of Neuro-Oncology TI - Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004386158&from=export http://dx.doi.org/10.1007/s11060-020-03443-6 VL - 147 ID - 1052 ER - TY - JOUR AD - C.S. Moreno, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States AU - Li, Z. AU - Sun, C. AU - Tao, S. AU - Osunkoya, A. O. AU - Arnold, R. S. AU - Petros, J. A. AU - Zu, X. AU - Moreno, C. S. C2 - Cayman(United States) Selleck(United States) DB - Embase DO - 10.1016/j.tranon.2020.100751 IS - 4 LA - English M3 - Article N1 - L2005245595 2020-04-10 2020-04-14 PY - 2020 SN - 1936-5233 ST - The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression T2 - Translational Oncology TI - The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005245595&from=export http://dx.doi.org/10.1016/j.tranon.2020.100751 VL - 13 ID - 1053 ER - TY - JOUR AU - Delve, E. AU - Di Scipio, M. AU - Kandel, R. DB - Embase DO - 10.1016/j.joca.2020.02.170 LA - English M3 - Conference Abstract N1 - L2005478841 2020-04-10 PY - 2020 SN - 1522-9653 1063-4584 SP - S106 ST - Proteoglycan 4 expression by superficial zone chondrocytes is regulated in part by JNK and P38 in vitro T2 - Osteoarthritis and Cartilage TI - Proteoglycan 4 expression by superficial zone chondrocytes is regulated in part by JNK and P38 in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005478841&from=export http://dx.doi.org/10.1016/j.joca.2020.02.170 VL - 28 ID - 1054 ER - TY - JOUR AD - Y. Shi, Department of Pediatric Surgery, Xuzhou Children's Hospital, Xuzhou Medical University, 18 Sudibei Road, Xuzhou, Jiangsu, China AU - Li, Z. AU - Sun, Q. AU - Shi, Y. DB - Embase Medline DO - 10.23736/S0026-4946.17.04823-X IS - 2 LA - English M3 - Review N1 - L2006737238 2020-07-24 2020-08-26 PY - 2020 SN - 1827-1715 0026-4946 SP - 116-122 ST - Recent perspectives of molecular aberrations in pediatric high-grade glioma T2 - Minerva Pediatrica TI - Recent perspectives of molecular aberrations in pediatric high-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006737238&from=export http://dx.doi.org/10.23736/S0026-4946.17.04823-X VL - 72 ID - 1056 ER - TY - JOUR AU - Xu, W. F. AU - Wang, Z. J. AU - Li, K. AU - Shen, Y. Q. AU - Lu, K. AU - Lv, X. Y. AU - Wen, Y. X. AU - Jin, R. M. DB - Medline DO - 10.1007/s11596-020-2181-5 IS - 2 LA - English M3 - Article N1 - L631651985 2020-05-08 PY - 2020 SN - 2523-899X SP - 354-362 ST - Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells T2 - Current medical science TI - Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631651985&from=export http://dx.doi.org/10.1007/s11596-020-2181-5 VL - 40 ID - 1057 ER - TY - JOUR AD - R. Zeiser, Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Hugstetterstrasse 55, Freiburg, Germany AU - Mathew, N. R. AU - Vinnakota, J. M. AU - Apostolova, P. AU - Erny, D. AU - Hamarsheh, S. AU - Andrieux, G. AU - Kim, J. S. AU - Hanke, K. AU - Goldmann, T. AU - Chappell-Maor, L. AU - El-Khawanky, N. AU - Ihorst, G. AU - Schmidt, D. AU - Duyster, J. AU - Finke, J. AU - Blank, T. AU - Boerries, M. AU - Blazar, B. R. AU - Jung, S. AU - Prinz, M. AU - Zeiser, R. DB - Embase Medline DO - 10.1172/JCI130272 IS - 3 LA - English M3 - Article N1 - L2005136348 2020-03-16 2020-03-20 PY - 2020 SN - 1558-8238 0021-9738 SP - 1315-1329 ST - Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia T2 - Journal of Clinical Investigation TI - Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005136348&from=export http://dx.doi.org/10.1172/JCI130272 VL - 130 ID - 1058 ER - TY - JOUR AD - F. Le Loarer, Department of Pathology, Institut Bergonié, Bordeaux, France AU - Le Loarer, F. AU - Cleven, A. H. G. AU - Bouvier, C. AU - Castex, M. P. AU - Romagosa, C. AU - Moreau, A. AU - Salas, S. AU - Bonhomme, B. AU - Gomez-Brouchet, A. AU - Laurent, C. AU - Le Guellec, S. AU - Audard, V. AU - Giraud, A. AU - Ramos-Oliver, I. AU - Cleton-Jansen, A. M. AU - Savci-Heijink, D. C. AU - Kroon, H. M. AU - Baud, J. AU - Pissaloux, D. AU - Pierron, G. AU - Sherwood, A. AU - Coindre, J. M. AU - Bovée, J. V. M. G. AU - Larousserie, F. AU - Tirode, F. DB - Embase Medline DO - 10.1038/s41379-019-0323-8 IS - 3 LA - English M3 - Article N1 - L2002408720 2019-08-14 2020-03-19 PY - 2020 SN - 1530-0285 0893-3952 SP - 404-419 ST - A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation T2 - Modern Pathology TI - A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002408720&from=export http://dx.doi.org/10.1038/s41379-019-0323-8 VL - 33 ID - 1059 ER - TY - JOUR AD - K.W. Gripp, Al duPont Hospital for Children, Wilmington, DE, United States AU - Gripp, K. W. AU - Schill, L. AU - Schoyer, L. AU - Stronach, B. AU - Bennett, A. M. AU - Blaser, S. AU - Brown, A. AU - Burdine, R. AU - Burkitt-Wright, E. AU - Castel, P. AU - Darilek, S. AU - Dias, A. AU - Dyer, T. AU - Ellis, M. AU - Erickson, G. AU - Gelb, B. D. AU - Green, T. AU - Gross, A. AU - Ho, A. AU - Holder, J. L. AU - Inoue, S. I. AU - Jelin, A. C. AU - Kennedy, A. AU - Klein, R. AU - Kontaridis, M. I. AU - Magoulas, P. AU - McConnell, D. B. AU - McCormick, F. AU - Neel, B. G. AU - Prada, C. E. AU - Rauen, K. A. AU - Roberts, A. AU - Rodriguez-Viciana, P. AU - Rosen, N. AU - Rumbaugh, G. AU - Sablina, A. AU - Solman, M. AU - Tartaglia, M. AU - Thomas, A. AU - Timmer, W. C. AU - Venkatachalam, K. AU - Walsh, K. S. AU - Wolters, P. L. AU - Yi, J. S. AU - Zenker, M. AU - Ratner, N. C1 - bi 1701963 bi 2852 bi 3406 ci 1040 ly 294002 shp 099 DB - Embase Medline DO - 10.1002/ajmg.a.61434 IS - 3 LA - English M3 - Conference Paper N1 - L2003888070 2019-12-30 2020-03-04 PY - 2020 SN - 1552-4833 1552-4825 SP - 597-606 ST - The sixth international RASopathies symposium: Precision medicine—From promise to practice T2 - American Journal of Medical Genetics, Part A TI - The sixth international RASopathies symposium: Precision medicine—From promise to practice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003888070&from=export http://dx.doi.org/10.1002/ajmg.a.61434 VL - 182 ID - 1060 ER - TY - JOUR AD - L. Dalle Carbonare, Department of Medicine, University of Verona, Verona, Italy AU - Deiana, M. AU - Dalle Carbonare, L. AU - Serena, M. AU - Cheri, S. AU - Mutascio, S. AU - Gandini, A. AU - Innamorati, G. AU - Lorenzi, P. AU - Cumerlato, M. AU - Bertacco, J. AU - Antoniazzi, F. AU - Romanelli, M. G. AU - Mottes, M. AU - Zipeto, D. AU - Valenti, M. T. DB - Embase Medline DO - 10.3390/cells9030751 IS - 3 LA - English M3 - Article N1 - L2004079346 2020-04-10 2020-04-20 PY - 2020 SN - 2073-4409 ST - A potential role of RUNX2-RUNT domain in modulating the expression of genes involved in bone metastases: An in vitro study with melanoma cells T2 - Cells TI - A potential role of RUNX2-RUNT domain in modulating the expression of genes involved in bone metastases: An in vitro study with melanoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004079346&from=export http://dx.doi.org/10.3390/cells9030751 VL - 9 ID - 1061 ER - TY - JOUR AD - L. Heimfarth, Department of Physiology, Laboratory of Neuroscience and Pharmacological Assays (LANEF), Federal University of Sergipe, Av. Marechal Rondom, s/n, São Cristóvão, Brazil AU - Heimfarth, L. AU - Carvalho, A. M. S. AU - Quintans, J. D. S. S. AU - Pereira, E. W. M. AU - Lima, N. T. AU - Bezerra Carvalho, M. T. AU - Barreto, R. D. S. S. AU - Moreira, J. C. F. AU - da Silva-Júnior, E. F. AU - Schmitt, M. AU - Bourguignon, J. J. AU - de Aquino, T. M. AU - Araújo-Júnior, J. X. D. AU - Quintans-Júnior, L. J. DB - Embase Medline DO - 10.1016/j.neuint.2019.104647 LA - English M3 - Article N1 - L2004466204 2020-01-03 2020-02-18 PY - 2020 SN - 1872-9754 0197-0186 ST - Indole-3-guanylhydrazone hydrochloride mitigates long-term cognitive impairment in a neonatal sepsis model with involvement of MAPK and NFκB pathways T2 - Neurochemistry International TI - Indole-3-guanylhydrazone hydrochloride mitigates long-term cognitive impairment in a neonatal sepsis model with involvement of MAPK and NFκB pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004466204&from=export http://dx.doi.org/10.1016/j.neuint.2019.104647 VL - 134 ID - 1062 ER - TY - JOUR AD - S.A. Stewart, Washington University in St. Louis School of Medicine, BJC-IH ICCE Institute (Rm 7610), 660 South Euclid, Box 8228, St. Louis, MO, United States AU - Yao, Z. AU - Murali, B. AU - Ren, Q. AU - Luo, X. AU - Faget, D. V. AU - Cole, T. AU - Ricci, B. AU - Thotala, D. AU - Monahan, J. AU - Van Deursen, J. M. AU - Baker, D. AU - Faccio, R. AU - Schwarz, J. K. AU - Stewart, S. A. C1 - ati 450(Aclaris Therapeutics) cdd 111(Aclaris Therapeutics) C2 - Aclaris Therapeutics DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-2348 IS - 5 LA - English M3 - Article N1 - L2005424132 2020-04-07 2020-04-14 PY - 2020 SN - 1538-7445 0008-5472 SP - 1171-1182 ST - Therapy-induced senescence drives bone loss T2 - Cancer Research TI - Therapy-induced senescence drives bone loss UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005424132&from=export http://dx.doi.org/10.1158/0008-5472.CAN-19-2348 VL - 80 ID - 1063 ER - TY - JOUR AD - L.-S. Chang, Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's HospitalandTheOhioStateUniversityCollegeofMedicine, 700Children'sDrive, Columbus, OH, United States AU - Chang, L. S. AU - Oblinger, J. L. AU - Burns, S. S. AU - Huang, J. AU - Anderson, L. W. AU - Hollingshead, M. G. AU - Shen, R. AU - Pan, L. AU - Agarwal, G. AU - Ren, Y. AU - Roberts, R. D. AU - O'Keefe, B. R. AU - Douglas Kinghorn, A. AU - Collins, J. M. DB - Embase Medline DO - 10.1158/1535-7163.MCT-19-0809 IS - 3 LA - English M3 - Article N1 - L2005693370 2020-05-04 2020-07-07 PY - 2020 SN - 1538-8514 1535-7163 SP - 731-741 ST - Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas T2 - Molecular Cancer Therapeutics TI - Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005693370&from=export http://dx.doi.org/10.1158/1535-7163.MCT-19-0809 VL - 19 ID - 1064 ER - TY - JOUR AD - G.M. Brodeur, Children's Hospital of Philadelphia, University of Pennsylvania, CTRB Rm. 3018, Civic Center Boulevard, Philadelphia, PA, United States AU - MacFarland, S. P. AU - Naraparaju, K. AU - Iyer, R. AU - Guan, P. AU - Kolla, V. AU - Hu, Y. AU - Tan, K. AU - Brodeur, G. M. C1 - rxdx 101(ignyta) C2 - ignyta DB - Embase Medline DO - 10.1158/1535-7163.MCT-18-1044 IS - 3 LA - English M3 - Article N1 - L2005693386 2020-05-04 2020-07-02 PY - 2020 SN - 1538-8514 1535-7163 SP - 920-926 ST - Mechanisms of entrectinib resistance in a neuroblastoma xenograft model T2 - Molecular Cancer Therapeutics TI - Mechanisms of entrectinib resistance in a neuroblastoma xenograft model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005693386&from=export http://dx.doi.org/10.1158/1535-7163.MCT-18-1044 VL - 19 ID - 1065 ER - TY - JOUR AD - M.L.C. Policarpio-Nicolas, Cleveland Clinic, 9500 Euclid Avenue, Mail Code L25, Main Campus, Cleveland, OH, United States AU - Zarei, S. AU - Abdul-Karim, F. W. AU - Chase, D. M. AU - Astbury, C. AU - Policarpio-Nicolas, M. L. C. DB - Embase Medline DO - 10.1097/PGP.0000000000000588 IS - 2 LA - English M3 - Article N1 - L626348481 2019-02-18 PY - 2020 SN - 1538-7151 0277-1691 SP - 152-156 ST - Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: A case report T2 - International Journal of Gynecological Pathology TI - Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626348481&from=export http://dx.doi.org/10.1097/PGP.0000000000000588 VL - 39 ID - 1066 ER - TY - JOUR AD - V.-M. Kähäri, Department of Dermatology, University of Turku and Turku University Hospital, Hämeentie 11 TE6, Turku, Finland AU - Riihilä, P. AU - Viiklepp, K. AU - Nissinen, L. AU - Farshchian, M. AU - Kallajoki, M. AU - Kivisaari, A. AU - Meri, S. AU - Peltonen, J. AU - Peltonen, S. AU - Kähäri, V. M. DB - Embase Medline DO - 10.1111/bjd.18095 IS - 3 LA - English M3 - Article N1 - L628856681 2019-08-14 2020-03-12 PY - 2020 SN - 1365-2133 0007-0963 SP - 658-670 ST - Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma T2 - British Journal of Dermatology TI - Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628856681&from=export http://dx.doi.org/10.1111/bjd.18095 VL - 182 ID - 1067 ER - TY - JOUR AD - P. Chandra, Departments of Neurosurgery, AIIMS, New Delhi, India AU - Dixit, A. AU - Srivastava, A. AU - Sharma, D. AU - Tripathi, M. AU - Paul, D. AU - Lalwani, S. AU - Doddamani, R. AU - Sharma, M. AU - Banerjee, J. AU - Chandra, P. DB - Embase Medline DO - 10.4103/0028-3886.280649 IS - 2 LA - English M3 - Article N1 - L631872590 2020-06-02 2020-06-15 PY - 2020 SN - 1998-4022 0028-3886 SP - 307-313 ST - Integrated Genome-Wide DNA Methylation and RNAseq Analysis of Hippocampal Specimens Identifies Potential Candidate Genes and Aberrant Signalling Pathways in Patients with Hippocampal Sclerosis T2 - Neurology India TI - Integrated Genome-Wide DNA Methylation and RNAseq Analysis of Hippocampal Specimens Identifies Potential Candidate Genes and Aberrant Signalling Pathways in Patients with Hippocampal Sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631872590&from=export http://dx.doi.org/10.4103/0028-3886.280649 VL - 68 ID - 1069 ER - TY - JOUR AD - X. Shi, Shanghai, China AU - Shi, X. AU - Liu, A. AU - Wang, K. AU - Zhang, B. AU - Wang, J. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631879552 2020-06-02 PY - 2020 SN - 1530-0285 SP - 80-83 ST - Significance of NGS in diagnosis and therapy guidance of bone and soft tissue sarcomas T2 - Modern Pathology TI - Significance of NGS in diagnosis and therapy guidance of bone and soft tissue sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631879552&from=export VL - 33 ID - 1070 ER - TY - JOUR AD - D. Yim, Seoul National University, College of Medicine/Hospital, Seoul, South Korea AU - Yim, D. AU - Song, S. G. AU - Kim, S. AU - Park, S. Y. AU - Kim, T. M. AU - Park, S. H. AU - Jeon, Y. K. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631879679 2020-06-02 PY - 2020 SN - 1530-0285 SP - 1412 ST - Primary cns lymphoma of peripheral t-cell lineage: Clinicopathological analysis of 10 cases from a single institute T2 - Modern Pathology TI - Primary cns lymphoma of peripheral t-cell lineage: Clinicopathological analysis of 10 cases from a single institute UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631879679&from=export VL - 33 ID - 1071 ER - TY - JOUR AD - N. Maximova, Bone Marrow Transplant Unit, Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy AU - Maximova, N. AU - Maestro, A. AU - Zanon, D. AU - Marcuzzi, A. DB - Embase Medline DO - 10.1136/jitc-2019-000388 IS - 1 LA - English M3 - Article N1 - L630969054 2020-04-13 2020-04-29 PY - 2020 SN - 2051-1426 ST - Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration T2 - Journal for ImmunoTherapy of Cancer TI - Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630969054&from=export http://dx.doi.org/10.1136/jitc-2019-000388 VL - 8 ID - 1074 ER - TY - JOUR AD - J.-D. Li, Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, 100 Piedmont Avenue, Atlanta, GA, United States AU - Komatsu, K. AU - Nam, D. H. AU - Lee, J. Y. AU - Yoneda, G. AU - Yan, C. AU - Li, J. D. C1 - pd 98059(Enzo Life Sciences) C2 - Enzo Life Sciences Tocris DB - Embase Medline DO - 10.4049/jimmunol.1901299 IS - 4 LA - English M3 - Article N1 - L2004868454 2020-02-14 2020-02-24 PY - 2020 SN - 1550-6606 0022-1767 SP - 933-942 ST - Vinpocetine suppresses streptococcus pneumoniae-induced inflammation via inhibition of ERK1 by CYLD T2 - Journal of Immunology TI - Vinpocetine suppresses streptococcus pneumoniae-induced inflammation via inhibition of ERK1 by CYLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004868454&from=export http://dx.doi.org/10.4049/jimmunol.1901299 VL - 204 ID - 1075 ER - TY - JOUR AD - B. Izar, Columbia University Medical Center, Division of Hematology and Oncology, 1790 Broadway, New York, NY, United States AU - Melms, J. C. AU - Vallabhaneni, S. AU - Mills, C. E. AU - Yapp, C. AU - Chen, J. Y. AU - Morelli, E. AU - Waszyk, P. AU - Kumar, S. AU - Deming, D. AU - Moret, N. AU - Rodriguez, S. AU - Subramanian, K. AU - Rogava, M. AU - Cartwright, A. N. R. AU - Luoma, A. AU - Mei, S. AU - Brinker, T. J. AU - Miller, D. M. AU - Spektor, A. AU - Schadendorf, D. AU - Riggi, N. AU - Wucherpfennig, K. W. AU - Sorger, P. K. AU - Izar, B. C1 - cx 6258 DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-2330 IS - 4 LA - English M3 - Article N1 - L2004972326 2020-02-25 2020-03-04 PY - 2020 SN - 1538-7445 0008-5472 SP - 798-810 ST - Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity T2 - Cancer Research TI - Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004972326&from=export http://dx.doi.org/10.1158/0008-5472.CAN-19-2330 VL - 80 ID - 1076 ER - TY - JOUR AD - L. Bertero, Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy AU - Gambella, A. AU - Senetta, R. AU - Collemi, G. AU - Vallero, S. G. AU - Monticelli, M. AU - Cofano, F. AU - Zeppa, P. AU - Garbossa, D. AU - Pellerino, A. AU - Rudà, R. AU - Soffietti, R. AU - Fagioli, F. AU - Papotti, M. AU - Cassoni, P. AU - Bertero, L. DB - Embase Medline DO - 10.3390/ijms21030753 IS - 3 LA - English M3 - Review N1 - L2003652036 2020-02-03 2020-02-06 PY - 2020 SN - 1422-0067 1661-6596 ST - NTRK fusions in central nervous system tumors: A rare, but worthy target T2 - International Journal of Molecular Sciences TI - NTRK fusions in central nervous system tumors: A rare, but worthy target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003652036&from=export http://dx.doi.org/10.3390/ijms21030753 VL - 21 ID - 1078 ER - TY - JOUR AD - A. Schiattarella, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples, Italy AU - Riemma, G. AU - Laganà, A. S. AU - Schiattarella, A. AU - Garzon, S. AU - Cobellis, L. AU - Autiero, R. AU - Licciardi, F. AU - Della Corte, L. AU - La Verde, M. AU - De Franciscis, P. DB - Embase Medline DO - 10.3390/ijms21031114 IS - 3 LA - English M3 - Review N1 - L2003730714 2020-02-14 2020-02-19 PY - 2020 SN - 1422-0067 1661-6596 ST - Ion channels in the pathogenesis of endometriosis: A cutting-edge point of view T2 - International Journal of Molecular Sciences TI - Ion channels in the pathogenesis of endometriosis: A cutting-edge point of view UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003730714&from=export http://dx.doi.org/10.3390/ijms21031114 VL - 21 ID - 1079 ER - TY - JOUR AD - X.-C. Zhang, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China AU - Yin, K. AU - Feng, H. B. AU - Li, L. L. AU - Chen, Y. AU - Xie, Z. AU - Lv, Z. Y. AU - Guo, W. B. AU - Lu, D. X. AU - Yang, X. N. AU - Yan, W. Q. AU - Wu, Y. L. AU - Zhang, X. C. DB - Embase Medline DO - 10.1111/1759-7714.13271 IS - 2 LA - English M3 - Article N1 - L2003823817 2019-12-17 2020-02-24 PY - 2020 SN - 1759-7714 1759-7706 SP - 346-352 ST - Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma T2 - Thoracic Cancer TI - Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003823817&from=export http://dx.doi.org/10.1111/1759-7714.13271 VL - 11 ID - 1080 ER - TY - JOUR AD - H.-Y. Lin, Department of Pediatrics and Rare Disease Center, Mackay Memorial Hospital, Taipei, Taiwan AU - Lee, C. L. AU - Tan, L. T. H. C. AU - Lin, H. Y. AU - Hwu, W. L. AU - Lee, N. C. AU - Chien, Y. H. AU - Chuang, C. K. AU - Wu, M. H. AU - Wang, J. K. AU - Chu, S. Y. AU - Lin, J. L. AU - Lo, F. S. AU - Su, P. H. AU - Hsu, C. C. AU - Ko, Y. Y. AU - Chen, M. R. AU - Chiu, H. C. AU - Lin, S. P. DB - Embase Medline DO - 10.1002/ajmg.a.61429 IS - 2 LA - English M3 - Article N1 - L2003911388 2019-12-27 2020-01-23 PY - 2020 SN - 1552-4833 1552-4825 SP - 357-364 ST - Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan T2 - American Journal of Medical Genetics, Part A TI - Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003911388&from=export http://dx.doi.org/10.1002/ajmg.a.61429 VL - 182 ID - 1081 ER - TY - JOUR AD - E.-M. Domsa, Fourth Medical Clinic, 5th Department of Internal Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 18 Republicii Street, Cluj-Napoca, Romania AU - Domsa, E. M. AU - Berindan-Neagoe, I. AU - Para, I. AU - Munteanu, L. AU - Matei, D. AU - Andreica, V. DB - Embase Medline DO - 10.26402/jpp.2020.1.01 IS - 1 LA - English M3 - Review N1 - L2004325145 2020-05-15 2020-05-20 PY - 2020 SN - 1899-1505 0867-5910 SP - 1-12 ST - Celiac disease: A multi-faceted medical condition T2 - Journal of Physiology and Pharmacology TI - Celiac disease: A multi-faceted medical condition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004325145&from=export http://dx.doi.org/10.26402/jpp.2020.1.01 VL - 71 ID - 1082 ER - TY - JOUR AD - L. Ning, Department of Orthopaedics, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, 3 East Qingchun Road, Hangzhou, China AU - Ning, L. AU - Wan, S. AU - Jie, Z. AU - Xie, Z. AU - Li, X. AU - Pan, X. AU - Wan, X. AU - Chen, W. AU - Huang, H. AU - Wang, J. AU - Qin, A. AU - Fan, S. AU - Zhao, X. C1 - lycorine(Sigma Aldrich,United States) sb 203580(Selleck,United States) C2 - Selleck(United States) Sigma Aldrich(United States) DB - Embase Medline DO - 10.1097/BRS.0000000000003217 IS - 3 LA - English M3 - Article N1 - L629219707 2019-09-10 2020-01-31 PY - 2020 SN - 1528-1159 0362-2436 SP - E126-E139 ST - Lycorine Induces Apoptosis and G1 Phase Arrest through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo T2 - Spine TI - Lycorine Induces Apoptosis and G1 Phase Arrest through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629219707&from=export http://dx.doi.org/10.1097/BRS.0000000000003217 VL - 45 ID - 1083 ER - TY - JOUR AU - Saunders, I. M. AU - Goodman, A. M. AU - Kurzrock, R. DB - Medline DO - 10.1634/theoncologist.2019-0606 IS - 2 LA - English M3 - Article N1 - L630890069 2020-02-17 PY - 2020 SN - 1549-490X SP - e386-e390 ST - Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease T2 - The oncologist TI - Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630890069&from=export http://dx.doi.org/10.1634/theoncologist.2019-0606 VL - 25 ID - 1084 ER - TY - JOUR AD - H.-J. Jang, College of Korean Medicine and College of Pharmacy, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea AU - An, E. J. AU - Kim, Y. AU - Lee, S. H. AU - Choi, S. H. AU - Chung, W. S. AU - Jang, H. J. C2 - ChemFaces(China) DB - Embase Medline DO - 10.1016/j.bbrc.2019.10.190 IS - 1 LA - English M3 - Article N1 - L2003779876 2019-11-28 PY - 2020 SN - 1090-2104 0006-291X SP - 40-46 ST - Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell T2 - Biochemical and Biophysical Research Communications TI - Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003779876&from=export http://dx.doi.org/10.1016/j.bbrc.2019.10.190 VL - 522 ID - 1085 ER - TY - JOUR AD - Y. Liu, Center for Perinatal Research The Abigail Wexner Research Institute at Nationwide Children's Hospital, 575 Children's Cross Road, Columbus, OH, United States AU - Kirk, S. G. AU - Samavati, L. AU - Liu, Y. DB - Embase Medline DO - 10.1016/j.lfs.2019.117157 LA - English M3 - Article N1 - L2004284242 2019-12-20 2019-12-31 PY - 2020 SN - 1879-0631 0024-3205 ST - MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response T2 - Life Sciences TI - MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004284242&from=export http://dx.doi.org/10.1016/j.lfs.2019.117157 VL - 241 ID - 1086 ER - TY - JOUR AD - M. Good, Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, MO, United States AU - Nolan, L. S. AU - Parks, O. B. AU - Good, M. DB - Embase Medline DO - 10.3390/nu12010014 IS - 1 LA - English M3 - Review N1 - L2003390609 2020-01-06 2020-01-08 PY - 2020 SN - 2072-6643 ST - A review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis T2 - Nutrients TI - A review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003390609&from=export http://dx.doi.org/10.3390/nu12010014 VL - 12 ID - 1087 ER - TY - JOUR AD - J.A. Lake, Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, United States AU - Lake, J. A. AU - Donson, A. M. AU - Prince, E. AU - Davies, K. D. AU - Nellan, A. AU - Green, A. L. AU - Mulcahy Levy, J. AU - Dorris, K. AU - Vibhakar, R. AU - Hankinson, T. C. AU - Foreman, N. K. AU - Ewalt, M. D. AU - Kleinschmidt-DeMasters, B. K. AU - Hoffman, L. M. AU - Gilani, A. DB - Embase Medline DO - 10.1002/pbc.28028 IS - 1 LA - English M3 - Article N1 - L2003447825 2019-10-31 PY - 2020 SN - 1545-5017 1545-5009 ST - Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors T2 - Pediatric Blood and Cancer TI - Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003447825&from=export http://dx.doi.org/10.1002/pbc.28028 VL - 67 ID - 1088 ER - TY - JOUR AD - J.T. Seykora, Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States AU - Lee, V. AU - Gober, M. D. AU - Bashir, H. AU - O'Day, C. AU - Blair, I. A. AU - Mesaros, C. AU - Weng, L. AU - Huang, A. AU - Chen, A. AU - Tang, R. AU - Anagnos, V. AU - Li, J. AU - Roling, S. AU - Sagaityte, E. AU - Wang, A. AU - Lin, C. AU - Yeh, C. AU - Atillasoy, C. AU - Marshall, C. AU - Dentchev, T. AU - Ridky, T. AU - Seykora, J. T. DB - Embase Medline DO - 10.1111/exd.14038 IS - 1 LA - English M3 - Article N1 - L2003531501 2019-11-14 PY - 2020 SN - 1600-0625 0906-6705 SP - 29-38 ST - Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress T2 - Experimental Dermatology TI - Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003531501&from=export http://dx.doi.org/10.1111/exd.14038 VL - 29 ID - 1089 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Room 317, 950 West 28th Ave, Vancouver, British Columbia, Canada AU - Zhao, J. AU - Klausen, C. AU - Yi, Y. AU - Cheng, J. C. AU - Chang, H. M. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1016/j.cellsig.2019.109439 LA - English M3 - Article N1 - L2003556180 2019-11-01 2019-11-07 PY - 2020 SN - 1873-3913 0898-6568 ST - Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling T2 - Cellular Signalling TI - Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003556180&from=export http://dx.doi.org/10.1016/j.cellsig.2019.109439 VL - 65 ID - 1090 ER - TY - JOUR AD - Z. Li, Heart Center, Qingdao Women and Children’s Hospital, No. 6 Tongfu Road, Shibei District, Qingdao, China AU - Nie, N. AU - Bai, C. AU - Song, S. AU - Zhang, Y. AU - Wang, B. AU - Li, Z. C1 - sb 203580 sn 50 DB - Embase Medline DO - 10.1007/s11010-019-03651-3 IS - 1-2 LA - English M3 - Article N1 - L2003629974 2019-11-25 PY - 2020 SN - 1573-4919 0300-8177 SP - 83-91 ST - Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways T2 - Molecular and Cellular Biochemistry TI - Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003629974&from=export http://dx.doi.org/10.1007/s11010-019-03651-3 VL - 464 ID - 1091 ER - TY - JOUR AD - H.-T. Wang, Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan AU - Ho, W. C. AU - Hsu, C. C. AU - Huang, H. J. AU - Wang, H. T. AU - Lin, A. M. Y. C1 - azd 6244(Astra Zeneca,United Kingdom) C2 - Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1007/s12035-019-01758-8 IS - 1 LA - English M3 - Article N1 - L2003768719 2019-12-04 PY - 2020 SN - 1559-1182 0893-7648 SP - 88-95 ST - Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation T2 - Molecular Neurobiology TI - Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003768719&from=export http://dx.doi.org/10.1007/s12035-019-01758-8 VL - 57 ID - 1093 ER - TY - JOUR AD - B.A. Croker, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, United States AU - Speir, M. AU - Nowell, C. J. AU - Chen, A. A. AU - O’Donnell, J. A. AU - Shamie, I. S. AU - Lakin, P. R. AU - D’Cruz, A. A. AU - Braun, R. O. AU - Babon, J. J. AU - Lewis, R. S. AU - Bliss-Moreau, M. AU - Shlomovitz, I. AU - Wang, S. AU - Cengia, L. H. AU - Stoica, A. I. AU - Hakem, R. AU - Kelliher, M. A. AU - O’Reilly, L. A. AU - Patsiouras, H. AU - Lawlor, K. E. AU - Weller, E. AU - Lewis, N. E. AU - Roberts, A. W. AU - Gerlic, M. AU - Croker, B. A. DB - Embase Medline DO - 10.1038/s41590-019-0550-7 IS - 1 LA - English M3 - Article N1 - L2003855269 2019-12-23 2020-01-31 PY - 2020 SN - 1529-2916 1529-2908 SP - 54-64 ST - Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation T2 - Nature Immunology TI - Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003855269&from=export http://dx.doi.org/10.1038/s41590-019-0550-7 VL - 21 ID - 1095 ER - TY - JOUR AD - H. Zhang, Department of Orthopedics, Affiliated Jiangyin Hospital, Medical College of Southeast University, No. 163, Shoushan Road, Jiangyin, Jiangsu, China AU - Xu, X. AU - Cao, F. AU - Zhang, H. DB - Embase IS - 2 LA - English M3 - Article N1 - L2003914076 2020-03-06 2020-03-10 PY - 2020 SN - 1940-5901 SP - 407-416 ST - MiR-133b in predicting prognosis for patients with osteosarcoma, and its effect on apoptosis of osteosarcoma cells T2 - International Journal of Clinical and Experimental Medicine TI - MiR-133b in predicting prognosis for patients with osteosarcoma, and its effect on apoptosis of osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003914076&from=export VL - 13 ID - 1096 ER - TY - JOUR AD - L. Ou, College of Pharmacy, Shaanxi University of Chinese Medicine, Century Avenue, Xianyang, Shaanxi Province, China AU - Ou, L. AU - Gao, F. AU - Li, M. AU - Wei, P. DB - Embase IS - 2 LA - English M3 - Article N1 - L2003914077 2020-03-06 2020-03-10 PY - 2020 SN - 1940-5901 SP - 417-428 ST - Monotropein accelerates chondrocyte progression in osteoarthritis by alleviating TNF-α induced inflammatiothrough regulation of MAPK/NF-κB signaling pathway T2 - International Journal of Clinical and Experimental Medicine TI - Monotropein accelerates chondrocyte progression in osteoarthritis by alleviating TNF-α induced inflammatiothrough regulation of MAPK/NF-κB signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003914077&from=export VL - 13 ID - 1097 ER - TY - JOUR AD - K.A. Hodby, Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, United Kingdom AU - Hodby, K. A. AU - Marks, D. I. DB - Embase Medline DO - 10.1007/s11864-020-0712-8 IS - 3 LA - English M3 - Article N1 - L2004316868 2020-03-02 2020-03-04 PY - 2020 SN - 1534-6277 1527-2729 ST - Recent Advances in the Management of Acute Lymphoblastic Leukaemia T2 - Current Treatment Options in Oncology TI - Recent Advances in the Management of Acute Lymphoblastic Leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004316868&from=export http://dx.doi.org/10.1007/s11864-020-0712-8 VL - 21 ID - 1098 ER - TY - JOUR AD - M. Wang, Department of Radiation Therapy, Cangzhou Central Hospital, 16 Xinhua West Road, Cangzhou, Hebei, China AU - Wang, M. AU - Wang, L. AU - He, X. AU - Zhang, J. AU - Zhu, Z. AU - Zhang, M. AU - Li, X. DB - Embase Medline DO - 10.3892/ijo.2019.4929 IS - 1 LA - English M3 - Article N1 - L2004354222 2019-12-31 2020-01-06 PY - 2020 SN - 1791-2423 1019-6439 SP - 327-336 ST - IncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145/p70S6K1 and p53 pathway T2 - International Journal of Oncology TI - IncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145/p70S6K1 and p53 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004354222&from=export http://dx.doi.org/10.3892/ijo.2019.4929 VL - 56 ID - 1099 ER - TY - JOUR AD - E.E. Lepik, Clinical Hematologist, Oncology Department, Raisa Gorbacheva Memorial Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University, L. Tolstoy St. 6-8, St. Petersburg, Russian Federation AU - Lepik, E. E. AU - Kozlov, A. V. AU - Borzenkova, E. S. AU - Zalyalov, Y. R. AU - Lepik, K. V. AU - Kondakova, E. V. AU - Baykov, V. V. AU - Moiseev, I. S. AU - Schneider, T. V. AU - Mikhaylova, N. B. AU - Afanasyev, B. V. DB - Embase DO - 10.18620/ctt-1866-8836-2020-9-1-28-37 IS - 1 LA - English M3 - Article N1 - L2004467246 2020-07-13 PY - 2020 SN - 1866-8836 1867-416X SP - 28-37 ST - Treatment options for T-cell lymphomas: A single-center study T2 - Cellular Therapy and Transplantation TI - Treatment options for T-cell lymphomas: A single-center study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004467246&from=export http://dx.doi.org/10.18620/ctt-1866-8836-2020-9-1-28-37 VL - 9 ID - 1100 ER - TY - JOUR AD - R.W. Wong, WPI Nano Life Science Institute (WPI-nanolsi) & Unit Leader in Cell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan AU - Dewi, F. R. P. AU - Jiapaer, S. AU - Kobayashi, A. AU - Hazawa, M. AU - Ikliptikawati, D. K. AU - Hartono AU - Sabit, H. AU - Nakada, M. AU - Wong, R. W. DB - Embase Medline DO - 10.1080/15548627.2020.1741318 LA - English M3 - Article in Press N1 - L2004499374 2020-04-07 PY - 2020 SN - 1554-8635 1554-8627 ST - Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma T2 - Autophagy TI - Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004499374&from=export http://dx.doi.org/10.1080/15548627.2020.1741318 ID - 1101 ER - TY - JOUR AD - A.C. Simões-E-silva, Pediatric Branch, Interdisciplinary Laboratory of Medical Investigation, Faculty of Medicine, UFMG, Brazil AU - Gonzaga, A. L. A. C. P. AU - Palmeira, V. A. AU - Ri-Beiro, T. F. S. AU - Costa, L. B. AU - de Sá Rodrigues, K. E. AU - Simões-E-silva, A. C. C1 - a 779 pd 123319 txa 127(Tarix Pharmaceutical) C2 - Tarix Pharmaceutical DB - Embase Medline DO - 10.2174/1389450121666200210124217 IS - 9 LA - English M3 - Review N1 - L2004548832 2020-07-24 2020-09-08 PY - 2020 SN - 1873-5592 1389-4501 SP - 892-901 ST - ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: Potential role for pediatric tumors T2 - Current Drug Targets TI - ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: Potential role for pediatric tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004548832&from=export http://dx.doi.org/10.2174/1389450121666200210124217 VL - 21 ID - 1102 ER - TY - JOUR AD - M.-L. Kuo, Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan AU - Ma, J. AU - Chan, C. C. AU - Huang, W. C. AU - Kuo, M. L. C2 - Sigma Aldrich DB - Embase Medline DO - 10.7150/ijms.45400 IS - 10 LA - English M3 - Article N1 - L2004579276 2020-08-07 2020-09-07 PY - 2020 SN - 1449-1907 SP - 1464-1473 ST - Berberine inhibits pro-inflammatory cytokine-induced IL-6 and ccl11 production via modulation of stat6 pathway in human bronchial epithelial cells T2 - International Journal of Medical Sciences TI - Berberine inhibits pro-inflammatory cytokine-induced IL-6 and ccl11 production via modulation of stat6 pathway in human bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004579276&from=export http://dx.doi.org/10.7150/ijms.45400 VL - 17 ID - 1103 ER - TY - JOUR AD - P.-Y. Li, Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Wang, M. R. AU - Fang, D. AU - Di, M. P. AU - Guan, J. L. AU - Wang, G. AU - Liu, L. AU - Sheng, J. Q. AU - Tian, D. A. AU - Li, P. Y. DB - Embase Medline DO - 10.7150/ijms.45256 IS - 9 LA - English M3 - Article N1 - L2004579292 2020-08-07 2020-09-07 PY - 2020 SN - 1449-1907 SP - 1224-1234 ST - Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway T2 - International Journal of Medical Sciences TI - Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004579292&from=export http://dx.doi.org/10.7150/ijms.45256 VL - 17 ID - 1104 ER - TY - JOUR AD - M.D. Siegelin, Columbia University Medical Center, 630 W, 168th Street, P&S 15th–415, New York, NY, United States AU - Zhang, Y. AU - Nguyen, T. T. T. AU - Shang, E. AU - Mela, A. AU - Humala, N. AU - Mahajan, A. AU - Zhao, J. AU - Shu, C. AU - Torrini, C. AU - Sanchez-Quintero, M. J. AU - Kleiner, G. AU - Bianchetti, E. AU - Westhoff, M. A. AU - Quinzii, C. M. AU - Karpel-Massler, G. AU - Bruce, J. N. AU - Canoll, P. AU - Siegelin, M. D. DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-1389 IS - 1 LA - English M3 - Article N1 - L2004593613 2020-01-16 2020-01-23 PY - 2020 SN - 1538-7445 0008-5472 SP - 30-43 ST - MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma T2 - Cancer Research TI - MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004593613&from=export http://dx.doi.org/10.1158/0008-5472.CAN-19-1389 VL - 80 ID - 1105 ER - TY - JOUR AD - J. Xu, Shaoxing Second Hospital, 123 Yanan Road, Shaoxing, Zhejiang, China AU - Zheng, G. AU - Qiu, G. AU - Ge, M. AU - Meng, J. AU - Zhang, G. AU - Wang, J. AU - Huang, R. AU - Shu, Q. AU - Xu, J. DB - Embase Medline DO - 10.1155/2020/4370983 LA - English M3 - Article N1 - L2004858916 2020-02-14 2020-02-20 PY - 2020 SN - 1466-1861 0962-9351 ST - MiR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory Function T2 - Mediators of Inflammation TI - MiR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory Function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004858916&from=export http://dx.doi.org/10.1155/2020/4370983 VL - 2020 ID - 1107 ER - TY - JOUR AD - S. Naviglio, Dipartimento di Medicina di Precisione, Università Degli Studi della Campania Luigi Vanvitelli, Via L. De Crecchio 7, Naples, Italy AU - Sapio, L. AU - Nigro, E. AU - Ragone, A. AU - Salzillo, A. AU - Illiano, M. AU - Spina, A. AU - Polito, R. AU - Daniele, A. AU - Naviglio, S. DB - Embase DO - 10.1155/2020/7262479 LA - English M3 - Article N1 - L2004859118 2020-02-17 2020-02-24 PY - 2020 SN - 1687-8469 1687-8450 ST - AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells T2 - Journal of Oncology TI - AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004859118&from=export http://dx.doi.org/10.1155/2020/7262479 VL - 2020 ID - 1108 ER - TY - JOUR AD - Z. Xia, Department of Pharmacy, School & Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China AU - Tang, Z. AU - Lu, L. AU - Xia, Z. DB - Embase Medline DO - 10.2147/DDDT.S258811 LA - English M3 - Article N1 - L2005142445 2020-11-02 PY - 2020 SN - 1177-8881 SP - 3965-3976 ST - Anti-tumor xanthones from garcinia nujiangensis suppress proliferation, and induce apoptosis via parp, pi3k/akt/mtor, and mapk/erk signaling pathways in human ovarian cancers cells T2 - Drug Design, Development and Therapy TI - Anti-tumor xanthones from garcinia nujiangensis suppress proliferation, and induce apoptosis via parp, pi3k/akt/mtor, and mapk/erk signaling pathways in human ovarian cancers cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005142445&from=export http://dx.doi.org/10.2147/DDDT.S258811 VL - 14 ID - 1109 ER - TY - JOUR AD - W.-H. Qi, Department of Obstetrics and Gynaecology, Beijing Hospital, 1 Dongdan Dahua Road, Beijing, China AU - Wang, Y. AU - Shi, L. Y. AU - Qi, W. H. AU - Yang, J. AU - Qi, Y. C2 - Sigma(United States) DB - Embase DO - 10.5114/aoms.2017.71420 IS - 2 LA - English M3 - Article N1 - L2005265090 2020-03-24 2020-04-07 PY - 2020 SN - 1896-9151 1734-1922 SP - 428-435 ST - Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway T2 - Archives of Medical Science TI - Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005265090&from=export http://dx.doi.org/10.5114/aoms.2017.71420 VL - 16 ID - 1110 ER - TY - JOUR AD - J. Zhang, Department of Orthodontics, School of Stomatology, Shandong University, 44-1 Wenhua Xi road, Jinan, Shandong, China AU - Yuan, J. AU - Wang, X. AU - Ma, D. AU - Gao, H. AU - Zheng, D. AU - Zhang, J. C1 - pd 98059 DB - Embase Medline DO - 10.3892/mmr.2020.11021 IS - 5 LA - English M3 - Article N1 - L2005368189 2020-04-07 PY - 2020 SN - 1791-3004 1791-2997 SP - 2085-2094 ST - Resveratrol rescues TNF-α-induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway T2 - Molecular Medicine Reports TI - Resveratrol rescues TNF-α-induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005368189&from=export http://dx.doi.org/10.3892/mmr.2020.11021 VL - 21 ID - 1111 ER - TY - JOUR AD - H. Jin, Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Jiang, Y. AU - Wang, W. AU - Zheng, X. AU - Jin, H. C1 - aldara(3M) xt 311(BioXCell) C2 - 3M BioXCell DB - Embase Medline DO - 10.1155/2020/5980190 LA - English M3 - Article N1 - L2005487138 2020-04-13 2020-07-08 PY - 2020 SN - 2314-7156 2314-8861 ST - Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation T2 - Journal of Immunology Research TI - Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005487138&from=export http://dx.doi.org/10.1155/2020/5980190 VL - 2020 ID - 1112 ER - TY - JOUR AD - F.-M. Xie, Department of Neurosurgery, Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Shandong Academy of Medical Sciences, Taian, China AU - Yang, F. AU - Xing, W. W. AU - Shen, D. W. AU - Tong, M. F. AU - Xie, F. M. DB - Embase Medline DO - 10.26355/eurrev_202003_20691 IS - 6 LA - English M3 - Article N1 - L2005488263 2020-04-14 2020-04-20 PY - 2020 SN - 2284-0729 1128-3602 SP - 3245-3253 ST - Effect of miR-126 on intracranial aneurysms and its predictive value for rupture of aneurysms T2 - European Review for Medical and Pharmacological Sciences TI - Effect of miR-126 on intracranial aneurysms and its predictive value for rupture of aneurysms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005488263&from=export http://dx.doi.org/10.26355/eurrev_202003_20691 VL - 24 ID - 1113 ER - TY - JOUR AD - E. Rossi, Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, L.go A. Gemelli 8, Rome, Italy AU - Rossi, E. AU - Schinzari, G. AU - Maiorano, B. A. AU - Indellicati, G. AU - Di Stefani, A. AU - Pagliara, M. M. AU - Fragomeni, S. M. AU - De Luca, E. V. AU - Sammarco, M. G. AU - Garganese, G. AU - Galli, J. AU - Blasi, M. A. AU - Paludetti, G. AU - Scambia, G. AU - Peris, K. AU - Tortora, G. DB - Embase Medline DO - 10.1080/21645515.2020.1771986 LA - English M3 - Article N1 - L2005603058 2020-07-24 2020-07-29 PY - 2020 SN - 2164-554X 2164-5515 SP - 1-10 ST - Efficacy of immune checkpoint inhibitors in different types of melanoma T2 - Human Vaccines and Immunotherapeutics TI - Efficacy of immune checkpoint inhibitors in different types of melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005603058&from=export http://dx.doi.org/10.1080/21645515.2020.1771986 ID - 1114 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy AU - Demichelis, C. AU - Balestra, A. AU - Lapucci, C. AU - Zuppa, A. AU - Grisanti, S. G. AU - Prada, V. AU - Pesce, G. AU - Grasso, I. AU - Queirolo, P. AU - Schenone, A. AU - Benedetti, L. AU - Grandis, M. DB - Embase Medline DO - 10.1007/s10072-020-04604-1 LA - English M3 - Article in Press N1 - L2005828894 2020-08-17 PY - 2020 SN - 1590-3478 1590-1874 ST - Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature T2 - Neurological Sciences TI - Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005828894&from=export http://dx.doi.org/10.1007/s10072-020-04604-1 ID - 1115 ER - TY - JOUR AD - H. Zhang, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China AU - Zhao, Y. AU - Liu, X. L. AU - Huang, J. H. AU - Yin, A. J. AU - Zhang, H. DB - Embase Medline DO - 10.26355/eurrev_202005_21311 IS - 10 LA - English M3 - Review N1 - L2006023327 2020-06-05 2020-06-16 PY - 2020 SN - 2284-0729 1128-3602 SP - 5292-5302 ST - MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition T2 - European Review for Medical and Pharmacological Sciences TI - MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006023327&from=export http://dx.doi.org/10.26355/eurrev_202005_21311 VL - 24 ID - 1116 ER - TY - JOUR AD - J. Wu, NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China AU - Sun, Y. AU - Sun, Y. AU - Sun, Y. AU - Gao, L. AU - Gao, L. AU - Gao, L. AU - Hou, W. AU - Hou, W. AU - Hou, W. AU - Wu, J. AU - Wu, J. AU - Wu, J. DB - Embase Medline DO - 10.1155/2020/7532306 LA - English M3 - Article N1 - L2006163155 2020-07-06 2020-07-14 PY - 2020 SN - 2314-6141 2314-6133 ST - β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κ B Pathways in LPS-Exposed BV2 Cells T2 - BioMed Research International TI - β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κ B Pathways in LPS-Exposed BV2 Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006163155&from=export http://dx.doi.org/10.1155/2020/7532306 VL - 2020 ID - 1118 ER - TY - JOUR AD - M. Ruggieri, Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, AOU “Policlinico”, PO “G. Rodolico”, Via S. Sofia, 78, Catania, Italy AU - Ruggieri, M. AU - Polizzi, A. AU - Marceca, G. P. AU - Catanzaro, S. AU - Praticò, A. D. AU - Di Rocco, C. DB - Embase Medline DO - 10.1007/s00381-020-04758-5 LA - English M3 - Article in Press N1 - L2006718661 PY - 2020 SN - 1433-0350 0256-7040 ST - Introduction to phacomatoses (neurocutaneous disorders) in childhood T2 - Child's Nervous System TI - Introduction to phacomatoses (neurocutaneous disorders) in childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006718661&from=export http://dx.doi.org/10.1007/s00381-020-04758-5 ID - 1119 ER - TY - JOUR AD - R. Bale, Department of Radiology, Interventional Oncology-Microinvasive Therapy (SIP), Medical University of Innsbruck, Innsbruck, Austria AU - Hetzer, B. AU - Vogel, G. F. AU - Entenmann, A. AU - Heil, M. AU - Schullian, P. AU - Putzer, D. AU - Meister, B. AU - Crazzolara, R. AU - Kropshofer, G. AU - Salvador, C. AU - Straub, S. AU - Karall, D. AU - Niederwanger, C. AU - Cortina, G. AU - Janecke, A. AU - Freund-Unsinn, K. AU - Maurer, K. AU - Schweigmann, G. AU - Oberhuber, G. AU - Renz, O. AU - Schneeberger, S. AU - Müller, T. AU - Bale, R. DB - Embase Medline DO - 10.1080/02656736.2020.1822549 IS - 1 LA - English M3 - Article N1 - L2006760386 2020-09-28 2020-10-20 PY - 2020 SN - 1464-5157 0265-6736 SP - 1074-1081 ST - Stereotactic radiofrequency ablation of a variety of liver masses in children T2 - International Journal of Hyperthermia TI - Stereotactic radiofrequency ablation of a variety of liver masses in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006760386&from=export http://dx.doi.org/10.1080/02656736.2020.1822549 VL - 37 ID - 1120 ER - TY - JOUR AD - N.E. Berlow, Children's Cancer Therapy Development Institute, Beaverton, OR, United States AU - Berlow, N. E. AU - Grasso, C. S. AU - Quist, M. J. AU - Cheng, M. AU - Gandour-Edwards, R. AU - Hernandez, B. S. AU - Michalek, J. E. AU - Ryan, C. AU - Spellman, P. AU - Pal, R. AU - Million, L. S. AU - Renneker, M. AU - Keller, C. C1 - abt 737 DB - Embase DO - 10.1155/2020/6312480 LA - English M3 - Article N1 - L2006779560 2020-07-08 2020-07-13 PY - 2020 SN - 1369-1643 1357-714X ST - Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma T2 - Sarcoma TI - Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006779560&from=export http://dx.doi.org/10.1155/2020/6312480 VL - 2020 ID - 1121 ER - TY - JOUR AD - C. Luo, Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Chongqing Medical University, Chongqing, China X. Wu, Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China AU - Li, T. AU - Liu, N. AU - Gao, Y. AU - Quan, Z. AU - Hao, Y. AU - Yu, C. AU - Li, L. AU - Yuan, M. AU - Niu, L. AU - Luo, C. AU - Wu, X. DB - Embase Medline DO - 10.1038/s41416-020-01091-1 LA - English M3 - Article in Press N1 - L2006887774 2020-10-13 PY - 2020 SN - 1532-1827 0007-0920 ST - Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM T2 - British Journal of Cancer TI - Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006887774&from=export http://dx.doi.org/10.1038/s41416-020-01091-1 ID - 1122 ER - TY - JOUR AD - Q. He, Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China AU - Zhang, X. AU - Cheng, Y. AU - Zhou, Q. AU - Huang, H. AU - Dong, Y. AU - Yang, Y. AU - Zhao, M. AU - He, Q. DB - Embase Medline DO - 10.1155/2020/2153912 LA - English M3 - Review N1 - L2006929289 2020-07-17 2020-07-22 PY - 2020 SN - 1942-0994 1942-0900 ST - The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy T2 - Oxidative Medicine and Cellular Longevity TI - The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006929289&from=export http://dx.doi.org/10.1155/2020/2153912 VL - 2020 ID - 1124 ER - TY - JOUR AD - Y.-L. He, Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China AU - Huang, X. B. AU - Song, K. J. AU - Chen, G. B. AU - Liu, R. AU - Jiang, Z. F. AU - He, Y. L. DB - Embase Medline DO - 10.1080/15384047.2020.1824513 LA - English M3 - Article in Press N1 - L2006950162 2020-10-19 PY - 2020 SN - 1555-8576 1538-4047 ST - Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway T2 - Cancer Biology and Therapy TI - Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006950162&from=export http://dx.doi.org/10.1080/15384047.2020.1824513 ID - 1125 ER - TY - JOUR AD - A. Schindeler, Orthopaedic Research & Biotechnology Research Building, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, Australia AU - Bobyn, J. D. AU - Deo, N. AU - Little, D. G. AU - Schindeler, A. DB - Embase Medline DO - 10.1016/j.jos.2020.05.016 LA - English M3 - Article in Press N1 - L2007164129 2020-07-29 PY - 2020 SN - 1436-2023 0949-2658 ST - Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation T2 - Journal of Orthopaedic Science TI - Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007164129&from=export http://dx.doi.org/10.1016/j.jos.2020.05.016 ID - 1127 ER - TY - JOUR AD - H.A. Stephany, Department of Urology, University of California, Irvine, CA, United States AU - Kopelevich, A. AU - Holzman, S. A. AU - La, J. AU - Lai, H. A. AU - Torno, L. AU - Stephany, H. A. DB - Embase Medline DO - 10.1016/j.urology.2020.08.032 LA - English M3 - Article in Press N1 - L2007934681 2020-10-07 PY - 2020 SN - 1527-9995 0090-4295 ST - Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma T2 - Urology TI - Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007934681&from=export http://dx.doi.org/10.1016/j.urology.2020.08.032 ID - 1129 ER - TY - JOUR AD - Y.-P. Zhang, Department of Prenatal Diagnosis Center, Maternal and Child Health Care Hospital of Shandong Province, Key Laboratory of Birth Regulation and Control Technology of National Health and Family Planning Commission of China, Key Laboratory for Improving Birth Outcome Technique of Shandong Province, Jinan, China AU - Du, S. Y. AU - Huang, X. X. AU - Li, N. M. AU - Lv, C. Y. AU - Lv, C. H. AU - Wei, M. L. AU - Gao, Z. AU - Zhang, Y. P. DB - Embase Medline DO - 10.26355/eurrev_202010_23388 IS - 20 LA - English M3 - Article N1 - L2008501552 2020-11-13 PY - 2020 SN - 2284-0729 1128-3602 SP - 10383-10390 ST - MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4 T2 - European Review for Medical and Pharmacological Sciences TI - MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008501552&from=export http://dx.doi.org/10.26355/eurrev_202010_23388 VL - 24 ID - 1130 ER - TY - JOUR AD - M.A. Piris, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain AU - Pérez, C. AU - Mondéjar, R. AU - García-Díaz, N. AU - Cereceda, L. AU - León, A. AU - Montes, S. AU - Durán Vian, C. AU - Pérez Paredes, M. G. AU - González-Morán, A. AU - Alegre de Miguel, V. AU - Sanz Anquela, J. M. AU - Frias, J. AU - Limeres, M. A. AU - González, L. M. AU - Martín Dávila, F. AU - Beltrán, M. AU - Mollejo, M. AU - Méndez, J. R. AU - González, M. A. AU - González García, J. AU - López, R. AU - Gómez, A. AU - Izquierdo, F. AU - Ramos, R. AU - Camacho, C. AU - Rodriguez-Pinilla, S. M. AU - Martínez, N. AU - Vaqué, J. P. AU - Ortiz-Romero, P. L. AU - Piris, M. A. DB - Embase Medline DO - 10.1111/bjd.18098 IS - 1 LA - English M3 - Article N1 - L628873092 2019-08-16 2020-01-16 PY - 2020 SN - 1365-2133 0007-0963 SP - 147-155 ST - Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways T2 - British Journal of Dermatology TI - Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628873092&from=export http://dx.doi.org/10.1111/bjd.18098 VL - 182 ID - 1131 ER - TY - JOUR AD - Z.-F. Xiong, Division of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Li, Q. T. AU - Feng, Y. M. AU - Ke, Z. H. AU - Qiu, M. J. AU - He, X. X. AU - Wang, M. M. AU - Li, Y. N. AU - Xu, J. AU - Shi, L. L. AU - Xiong, Z. F. DB - Embase Medline DO - 10.1136/jim-2019-001073 IS - 1 LA - English M3 - Article N1 - L629015773 2019-08-28 2020-01-09 PY - 2020 SN - 1708-8267 1081-5589 SP - 68-74 ST - KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma T2 - Journal of Investigative Medicine TI - KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629015773&from=export http://dx.doi.org/10.1136/jim-2019-001073 VL - 68 ID - 1132 ER - TY - JOUR AD - Y. Li, Department of Orthopedic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China AU - Peng, Y. AU - Wu, S. AU - Li, Y. AU - Crane, J. L. C1 - l 235 DB - Embase Medline DO - 10.7150/thno.34126 IS - 1 LA - English M3 - Review N1 - L630442940 2020-01-22 2020-01-31 PY - 2020 SN - 1838-7640 SP - 426-436 ST - Type H blood vessels in bone modeling and remodeling T2 - Theranostics TI - Type H blood vessels in bone modeling and remodeling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630442940&from=export http://dx.doi.org/10.7150/thno.34126 VL - 10 ID - 1133 ER - TY - JOUR AD - C.-E. Zhang, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Lab of Respiratory Disease, Affiliated Cancer Hospital of Guangzhou Medical University, Guangdong, China AU - Chen, H. AU - Liang, L. AU - Xu, H. AU - Xu, J. AU - Yao, L. AU - Li, Y. AU - Tan, Y. AU - Li, X. AU - Huang, Q. AU - Yang, Z. AU - Wu, J. AU - Chen, J. AU - Huang, H. AU - Wang, X. AU - Zhang, C. E. AU - Liu, J. C1 - bilirubin(Sigma Aldrich,United States) C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.3233/JAD-190945 IS - 1 LA - English M3 - Article N1 - L630705745 2020-01-31 2020-02-05 PY - 2020 SN - 1875-8908 1387-2877 SP - 277-295 ST - Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life T2 - Journal of Alzheimer's Disease TI - Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630705745&from=export http://dx.doi.org/10.3233/JAD-190945 VL - 73 ID - 1134 ER - TY - JOUR AD - P. Zhang, Longgang E.N.T. Hospital, Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong, China AU - Liu, X. Y. AU - Zheng, C. B. AU - Wang, T. AU - Xu, J. AU - Zhang, M. AU - Gou, L. S. AU - Jin, L. AU - Qi, X. AU - Zeng, X. AU - Li, H. AU - Qiu, S. AU - Zhang, P. DB - Embase Medline DO - 10.1042/CS20190865 IS - 2 LA - English M3 - Article N1 - L630852136 2020-02-13 2020-02-19 PY - 2020 SN - 1470-8736 0143-5221 SP - 155-167 ST - SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer T2 - Clinical Science TI - SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630852136&from=export http://dx.doi.org/10.1042/CS20190865 VL - 134 ID - 1135 ER - TY - JOUR AD - T. Atik, Department of Pediatric Genetics, Ege University, School of Medicine, Izmir, Turkey AU - Atik, T. AU - Işik, E. DB - Embase IS - 2 LA - English M3 - Conference Abstract N1 - L631449685 2020-04-20 PY - 2020 SN - 2147-2092 SP - P21-P22 ST - Genetics of cutaneous vascular malformations and genetic counseling T2 - Gazi Medical Journal TI - Genetics of cutaneous vascular malformations and genetic counseling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631449685&from=export VL - 31 ID - 1137 ER - TY - JOUR AD - U. Demirsoy, Kocaeli Üniversitesi Tip Fakültesi Çocuk Onkoloji Bölümü, Turkey AU - Demirsoy, U. AU - Demirsoy, E. O. DB - Embase IS - 2 LA - English M3 - Conference Abstract N1 - L631449885 2020-04-20 PY - 2020 SN - 2147-2092 SP - P50 ST - Cafe-au-lait spots and hypopigmented macules: constitutional mismatch repair deficiency syndrome T2 - Gazi Medical Journal TI - Cafe-au-lait spots and hypopigmented macules: constitutional mismatch repair deficiency syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631449885&from=export VL - 31 ID - 1138 ER - TY - JOUR AD - J. Hu, Department and Institute of Infectious Diseases, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China AU - Hu, J. AU - Wang, H. AU - Li, X. AU - Liu, Y. AU - Mi, Y. AU - Kong, H. AU - Xi, D. AU - Yan, W. AU - Luo, X. AU - Ning, Q. AU - Wang, X. DB - Embase DO - 10.1007/s12072-020-10030-4 LA - English M3 - Conference Abstract N1 - L631553401 2020-04-28 PY - 2020 SN - 1936-0541 SP - S319 ST - Fibrinogen-like protein 2 exacerbates non-alcoholic steatohepatitis via interaction with TLR4 eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder T2 - Hepatology International TI - Fibrinogen-like protein 2 exacerbates non-alcoholic steatohepatitis via interaction with TLR4 eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631553401&from=export http://dx.doi.org/10.1007/s12072-020-10030-4 VL - 14 ID - 1139 ER - TY - JOUR AD - H.Y. Lu, BC Children's Hospital, University of British Columbia AU - Lu, H. Y. AU - Suresh, S. AU - McGonigle, L. AU - Luider, J. AU - Turvey, S. E. DB - Embase DO - 10.1007/s10875-019-00597-5 LA - English M3 - Conference Abstract N1 - L632157232 2020-07-24 PY - 2020 SN - 1573-2592 SP - S22 ST - Homozygosity for a novel CARD11 mutation causes severe combined immunodeficiency (SCID), inflammatory gastrointestinal disease, and complete abrogation of MALT1 activity T2 - Journal of Clinical Immunology TI - Homozygosity for a novel CARD11 mutation causes severe combined immunodeficiency (SCID), inflammatory gastrointestinal disease, and complete abrogation of MALT1 activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632157232&from=export http://dx.doi.org/10.1007/s10875-019-00597-5 VL - 39 ID - 1141 ER - TY - JOUR AD - S. Otsuki, Pediatrics, Stanford University, Stanford, CA, United States AU - Otsuki, S. AU - Saito, T. AU - Taylor, S. AU - Li, D. AU - Moonen, J. R. AU - Marciano, D. AU - Harper, R. AU - Cao, A. AU - Wang, L. AU - Roof, M. B. AU - Ariza, M. E. AU - Rabinovitch, M. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L632376362 2020-07-27 PY - 2020 SN - 1535-4970 ST - Human endogenous retrovirus k induces a pro-inflammatory and endothelial to mesenchymal phenotype in pulmonary artery endothelial cells T2 - American Journal of Respiratory and Critical Care Medicine TI - Human endogenous retrovirus k induces a pro-inflammatory and endothelial to mesenchymal phenotype in pulmonary artery endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632376362&from=export VL - 201 ID - 1142 ER - TY - JOUR AD - G.H.O. Coyne AU - Coyne, G. H. O. AU - Gross, A. M. AU - Dombi, E. AU - Tibery, C. AU - Carbonell, A. AU - Takebe, N. AU - Derdak, J. AU - Pichard, D. AU - Srivastava, A. K. AU - Herrick, W. AU - Parchment, R. E. AU - Martin, S. AU - Wolters, P. AU - Whitcomb, P. AU - Rubinstein, L. AU - Doroshow, J. H. AU - Chen, A. P. AU - Widemann, B. C. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3612 IS - 15 LA - English M3 - Conference Abstract N1 - L632807206 2020-09-15 PY - 2020 SN - 1527-7755 ST - Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) T2 - Journal of Clinical Oncology TI - Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632807206&from=export http://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3612 VL - 38 ID - 1143 ER - TY - JOUR AD - V. Moreno AU - Moreno, V. AU - Min Kim, T. AU - Young Rha, S. AU - Longo, F. AU - Sathornsumetee, S. AU - Zhang, S. AU - Hirschberg, Y. AU - Pramanik, B. AU - Wamil, B. D. AU - Kiss, I. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3520 IS - 15 LA - English M3 - Conference Abstract N1 - L632807446 2020-09-15 PY - 2020 SN - 1527-7755 ST - An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies (ASCEND-10) T2 - Journal of Clinical Oncology TI - An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies (ASCEND-10) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632807446&from=export http://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3520 VL - 38 ID - 1144 ER - TY - JOUR AD - F. Janku AU - Janku, F. AU - Elez, E. AU - Iyer, G. AU - Yamamoto, N. AU - Tan, D. S. W. AU - Stathis, A. AU - Stammberger, U. Z. M. AU - Evans, H. AU - Seroutou, A. AU - Mais, A. AU - Schuler, M. H. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3640 IS - 15 LA - English M3 - Conference Abstract N1 - L632809472 2020-09-15 PY - 2020 SN - 1527-7755 ST - Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations T2 - Journal of Clinical Oncology TI - Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632809472&from=export http://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3640 VL - 38 ID - 1145 ER - TY - JOUR AD - C.-X. Dong, Department of Hemangioma and Vascular Malformation Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, NO. 7 Weiwu Road, Zhengzhou, China AU - Li, M. M. AU - Dong, C. X. AU - Sun, B. AU - Lei, H. Z. AU - Wang, Y. L. AU - Gong, Y. B. AU - Sun, L. L. AU - Sun, Z. W. DB - Embase Medline DO - 10.1016/j.lfs.2019.116946 LA - English M3 - Article N1 - L2003715473 2019-11-13 2019-11-18 PY - 2019 SN - 1879-0631 0024-3205 ST - LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway T2 - Life Sciences TI - LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003715473&from=export http://dx.doi.org/10.1016/j.lfs.2019.116946 VL - 239 ID - 1147 ER - TY - JOUR AD - Y. Li, Department of Radiology, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, Jilin, China AU - Wang, Y. AU - Huang, H. AU - Li, Y. DB - Embase Medline DO - 10.1080/21691401.2019.1601099 IS - 1 LA - English M3 - Article N1 - L627279562 2019-05-14 PY - 2019 SN - 2169-141X 2169-1401 SP - 1458-1465 ST - Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP T2 - Artificial Cells, Nanomedicine and Biotechnology TI - Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627279562&from=export http://dx.doi.org/10.1080/21691401.2019.1601099 VL - 47 ID - 1148 ER - TY - JOUR AU - Li, Z. F. AU - Xu, W. W. AU - Li, J. D. AU - Tao, F. L. AU - Chen, J. X. AU - Xu, J. H. DB - Medline DO - 10.1177/0036850419891046 LA - English M3 - Article in Press N1 - L630034592 2019-12-11 PY - 2019 SN - 2047-7163 SP - 36850419891046 ST - Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis T2 - Science progress TI - Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630034592&from=export http://dx.doi.org/10.1177/0036850419891046 ID - 1149 ER - TY - JOUR AD - R. Beroukhim, Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA, United States AU - Reitman, Z. J. AU - Paolella, B. R. AU - Bergthold, G. AU - Pelton, K. AU - Becker, S. AU - Jones, R. AU - Sinai, C. E. AU - Malkin, H. AU - Huang, Y. AU - Grimmet, L. AU - Herbert, Z. T. AU - Sun, Y. AU - Weatherbee, J. L. AU - Alberta, J. A. AU - Daley, J. F. AU - Rozenblatt-Rosen, O. AU - Condurat, A. L. AU - Qian, K. AU - Khadka, P. AU - Segal, R. A. AU - Haas-Kogan, D. AU - Filbin, M. G. AU - Suva, M. L. AU - Regev, A. AU - Stiles, C. D. AU - Kieran, M. W. AU - Goumnerova, L. AU - Ligon, K. L. AU - Shalek, A. K. AU - Bandopadhayay, P. AU - Beroukhim, R. DB - Embase Medline DO - 10.1038/s41467-019-11493-2 IS - 1 LA - English M3 - Article N1 - L2002505294 2019-08-26 2019-08-29 PY - 2019 SN - 2041-1723 ST - Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells T2 - Nature Communications TI - Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002505294&from=export http://dx.doi.org/10.1038/s41467-019-11493-2 VL - 10 ID - 1150 ER - TY - JOUR AD - S. Liu, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Huang, X. AU - Ye, Q. AU - Chen, M. AU - Li, A. AU - Mi, W. AU - Fang, Y. AU - Zaytseva, Y. Y. AU - O’Connor, K. L. AU - Vander Kooi, C. W. AU - Liu, S. AU - She, Q. B. DB - Embase Medline DO - 10.1038/s41467-019-11580-4 IS - 1 LA - English M3 - Article N1 - L2002547532 2019-08-27 2019-09-02 PY - 2019 SN - 2041-1723 ST - N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals T2 - Nature Communications TI - N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002547532&from=export http://dx.doi.org/10.1038/s41467-019-11580-4 VL - 10 ID - 1151 ER - TY - JOUR AD - M.S. Brassesco, Departamento de Biologia, FFCLRP-USP, Av. Bandeirantes, 3900, Bairro Monte Alegre, Ribeirao Preto, SP, Brazil AU - Viera, G. M. AU - Salomao, K. B. AU - de Sousa, G. R. AU - Baroni, M. AU - Delsin, L. E. A. AU - Pezuk, J. A. AU - Brassesco, M. S. DB - Embase Medline DO - 10.1007/s12094-019-02104-z IS - 12 LA - English M3 - Review N1 - L2002703455 2019-09-10 PY - 2019 SN - 1699-3055 1699-048X SP - 1583-1623 ST - miRNA signatures in childhood sarcomas and their clinical implications T2 - Clinical and Translational Oncology TI - miRNA signatures in childhood sarcomas and their clinical implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002703455&from=export http://dx.doi.org/10.1007/s12094-019-02104-z VL - 21 ID - 1152 ER - TY - JOUR AD - B. Yuan, Laboratory of Pharmacology, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama, Japan AU - Yuan, B. AU - Shimada, R. AU - Xu, K. AU - Han, L. AU - Si, N. AU - Zhao, H. AU - Bian, B. AU - Hayashi, H. AU - Okazaki, M. AU - Takagi, N. C2 - Baoji Herbest(China) DB - Embase Medline DO - 10.1016/j.cbi.2019.108849 LA - English M3 - Article N1 - L2003366816 2019-10-18 2019-11-21 PY - 2019 SN - 1872-7786 0009-2797 ST - Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87 T2 - Chemico-Biological Interactions TI - Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003366816&from=export http://dx.doi.org/10.1016/j.cbi.2019.108849 VL - 314 ID - 1154 ER - TY - JOUR AD - Z. Yang, Department of Anesthesiology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Embryo Original Disease, Shanghai Municipal Key Clinical Specialty, Huashan Rd. 1961, Shanghai, China AU - Ji, C. AU - Ni, Q. AU - Chen, W. AU - Yang, Z. AU - Ma, D. DB - Embase Medline DO - 10.1016/j.neubiorev.2019.10.003 LA - English M3 - Review N1 - L2003666868 2019-11-07 2019-11-13 PY - 2019 SN - 1873-7528 0149-7634 SP - 883-896 ST - General anesthetic neurotoxicity in the young: Mechanism and prevention T2 - Neuroscience and Biobehavioral Reviews TI - General anesthetic neurotoxicity in the young: Mechanism and prevention UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003666868&from=export http://dx.doi.org/10.1016/j.neubiorev.2019.10.003 VL - 107 ID - 1155 ER - TY - JOUR AD - N. Takeda, Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan AU - Abe, H. AU - Takeda, N. AU - Isagawa, T. AU - Semba, H. AU - Nishimura, S. AU - Morioka, M. S. AU - Nakagama, Y. AU - Sato, T. AU - Soma, K. AU - Koyama, K. AU - Wake, M. AU - Katoh, M. AU - Asagiri, M. AU - Neugent, M. L. AU - Kim, J. W. AU - Stockmann, C. AU - Yonezawa, T. AU - Inuzuka, R. AU - Hirota, Y. AU - Maemura, K. AU - Yamashita, T. AU - Otsu, K. AU - Manabe, I. AU - Nagai, R. AU - Komuro, I. DB - Embase Medline DO - 10.1038/s41467-019-10859-w IS - 1 LA - English M3 - Article N1 - L628280196 2019-07-03 2019-07-16 PY - 2019 SN - 2041-1723 ST - Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M T2 - Nature Communications TI - Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628280196&from=export http://dx.doi.org/10.1038/s41467-019-10859-w VL - 10 ID - 1156 ER - TY - JOUR AD - A. Idbaih, Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France AU - Boisseau, W. AU - Euskirchen, P. AU - Mokhtari, K. AU - Dehais, C. AU - Touat, M. AU - Hoang-Xuan, K. AU - Sanson, M. AU - Capelle, L. AU - Nouet, A. AU - Karachi, C. AU - Bielle, F. AU - Guégan, J. AU - Marie, Y. AU - Martin-Duverneuil, N. AU - Taillandier, L. AU - Rousseau, A. AU - Delattre, J. Y. AU - Idbaih, A. C1 - campto CCNU vp16 DB - Embase Medline DO - 10.1634/theoncologist.2019-0223 IS - 12 LA - English M3 - Article N1 - L628861617 2019-08-14 2019-12-20 PY - 2019 SN - 1549-490X 1083-7159 SP - 1584-1592 ST - Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations T2 - Oncologist TI - Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628861617&from=export http://dx.doi.org/10.1634/theoncologist.2019-0223 VL - 24 ID - 1157 ER - TY - JOUR AD - R.I. Gafni, National Institute of Dental and Craniofacial Research, National Institutes of Health, United States AU - Gafni, R. I. AU - Zhadina, M. AU - Streit, J. AU - Collins, M. T. AU - Flippo, C. L. AU - Gottschalk, M. AU - Patel, D. AU - Nilubol, N. DB - Embase LA - English M3 - Conference Abstract N1 - L631807840 2020-05-26 PY - 2019 SN - 1523-4681 SP - 305 ST - Somatic HRAS variant in a parathyroid adenoma, squamous cell carcinoma, and endomyocardial membrane expands the phenotype of the cutaneous skeletal hypophosphatemia syndrome (CSHS) T2 - Journal of Bone and Mineral Research TI - Somatic HRAS variant in a parathyroid adenoma, squamous cell carcinoma, and endomyocardial membrane expands the phenotype of the cutaneous skeletal hypophosphatemia syndrome (CSHS) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631807840&from=export VL - 34 ID - 1159 ER - TY - JOUR AD - X. Shi, Department of Orthopedic Trauma and Hand and Foot Surgery, Jinan Central Hospital Affiliated to Shandong University, No. 105, Jiefang Road, Jinan City, Shandong Province, China AU - Liu, B. AU - Zhao, H. AU - Zhang, L. AU - Shi, X. DB - Embase Medline DO - 10.1186/s12885-019-6335-4 IS - 1 LA - English M3 - Article N1 - L629849750 2019-11-22 2019-11-26 PY - 2019 SN - 1471-2407 ST - Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway T2 - BMC Cancer TI - Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629849750&from=export http://dx.doi.org/10.1186/s12885-019-6335-4 VL - 19 ID - 1160 ER - TY - JOUR AD - P. Ding, Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China AU - Xue, L. P. AU - Lu, B. AU - Gao, B. B. AU - Shi, Y. Y. AU - Xu, J. Q. AU - Yang, R. AU - Xu, B. AU - Ding, P. DB - Embase Medline DO - 10.12659/MSM.916024 LA - English M3 - Article N1 - L2004761102 2020-02-05 2020-02-10 PY - 2019 SN - 1643-3750 1234-1010 SP - 8422-8429 ST - Overexpression of tripartite motif-containing 48 (TRIM48) inhibits growth of human glioblastoma cells by suppressing extracellular signal regulated kinase 1/2 (ERK1/2) pathway T2 - Medical Science Monitor TI - Overexpression of tripartite motif-containing 48 (TRIM48) inhibits growth of human glioblastoma cells by suppressing extracellular signal regulated kinase 1/2 (ERK1/2) pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004761102&from=export http://dx.doi.org/10.12659/MSM.916024 VL - 25 ID - 1161 ER - TY - JOUR AD - A. Stone, Department of Pediatrics, Division of Pulmonology, Oregon Health and Science University, Portland, OR, United States AU - Stone, A. AU - Friedman, D. N. AU - Kushner, B. H. AU - Wolden, S. AU - Modak, S. AU - LaQuaglia, M. P. AU - Costello, J. AU - Wu, X. AU - Cheung, N. K. AU - Sklar, C. A. DB - Embase Medline DO - 10.1002/pbc.27960 IS - 11 LA - English M3 - Article N1 - L2002476160 2019-08-21 2019-10-25 PY - 2019 SN - 1545-5017 1545-5009 ST - Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma T2 - Pediatric Blood and Cancer TI - Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002476160&from=export http://dx.doi.org/10.1002/pbc.27960 VL - 66 ID - 1162 ER - TY - JOUR AD - M. Kurpisz, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland AU - Malcher, A. AU - Jedrzejczak, P. AU - Stokowy, T. AU - Monem, S. AU - Nowicka-Bauer, K. AU - Zimna, A. AU - Czyzyk, A. AU - Maciejewska-Jeske, M. AU - Meczekalski, B. AU - Bednarek-Rajewska, K. AU - Wozniak, A. AU - Rozwadowska, N. AU - Kurpisz, M. DB - Embase Medline DO - 10.3390/ijms20215418 IS - 21 LA - English M3 - Article N1 - L2002894737 2019-11-07 2019-12-16 PY - 2019 SN - 1422-0067 1661-6596 ST - Novel mutations segregating with complete androgen insensitivity syndrome and their molecular characteristics T2 - International Journal of Molecular Sciences TI - Novel mutations segregating with complete androgen insensitivity syndrome and their molecular characteristics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002894737&from=export http://dx.doi.org/10.3390/ijms20215418 VL - 20 ID - 1163 ER - TY - JOUR AD - M. Cassina, Clinical Genetics Unit, Department of Women’s and Children’s Health, University of Padova, Padova, Italy AU - Cassina, M. AU - Frizziero, L. AU - Opocher, E. AU - Parrozzani, R. AU - Sorrentino, U. AU - Viscardi, E. AU - Miglionico, G. AU - Midena, E. AU - Clementi, M. AU - Trevisson, E. C1 - azd 6244 DB - Embase DO - 10.3390/cancers11111790 IS - 11 LA - English M3 - Review N1 - L2003245104 2019-11-22 2019-11-28 PY - 2019 SN - 2072-6694 ST - Optic pathway glioma in type 1 neurofibromatosis: Review of its pathogenesis, diagnostic assessment, and treatment recommendations T2 - Cancers TI - Optic pathway glioma in type 1 neurofibromatosis: Review of its pathogenesis, diagnostic assessment, and treatment recommendations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003245104&from=export http://dx.doi.org/10.3390/cancers11111790 VL - 11 ID - 1164 ER - TY - JOUR AD - S.L. George, Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom AU - George, S. L. AU - Izquierdo, E. AU - Campbell, J. AU - Koutroumanidou, E. AU - Proszek, P. AU - Jamal, S. AU - Hughes, D. AU - Yuan, L. AU - Marshall, L. V. AU - Carceller, F. AU - Chisholm, J. C. AU - Vaidya, S. AU - Mandeville, H. AU - Angelini, P. AU - Wasti, A. AU - Bexelius, T. AU - Thway, K. AU - Gatz, S. A. AU - Clarke, M. AU - Al-Lazikani, B. AU - Barone, G. AU - Anderson, J. AU - Tweddle, D. A. AU - Gonzalez, D. AU - Walker, B. A. AU - Barton, J. AU - Depani, S. AU - Eze, J. AU - Ahmed, S. W. AU - Moreno, L. AU - Pearson, A. AU - Shipley, J. AU - Jones, C. AU - Hargrave, D. AU - Jacques, T. S. AU - Hubank, M. AU - Chesler, L. DB - Embase Medline DO - 10.1016/j.ejca.2019.07.027 LA - English M3 - Article N1 - L2003393367 2019-10-23 2019-11-07 PY - 2019 SN - 1879-0852 0959-8049 SP - 224-235 ST - A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations T2 - European Journal of Cancer TI - A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003393367&from=export http://dx.doi.org/10.1016/j.ejca.2019.07.027 VL - 121 ID - 1165 ER - TY - JOUR AD - J. Jin, Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, China AU - Jin, J. AU - Xu, H. AU - Wu, R. AU - Gao, N. AU - Wu, N. AU - Li, S. AU - Niu, J. DB - Embase Medline DO - 10.1111/jcmm.14616 IS - 11 LA - English M3 - Article N1 - L2003430800 2019-11-01 2019-11-08 PY - 2019 SN - 1582-1838 SP - 7474-7489 ST - Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection T2 - Journal of Cellular and Molecular Medicine TI - Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003430800&from=export http://dx.doi.org/10.1111/jcmm.14616 VL - 23 ID - 1166 ER - TY - JOUR AD - G. Garcia-Manero AU - Garcia-Manero, G. AU - Navada, S. C. AU - Fenaux, P. AU - Zbyszewski, P. S. AU - Adesanya, A. R. AU - Azarnia, N. AU - Fruchtman, S. M. AU - Silverman, L. R. DB - Embase DO - 10.1182/blood-2019-132149 LA - English M3 - Conference Abstract N1 - L630315301 2019-12-31 PY - 2019 SN - 1528-0020 ST - Phase 3, multi-center, international, randomized, double-blind placebo controlled study of oral rigosertib + injectable azacitidine (AZA) versus injectable azacitidine in treatment-naive patients with higher-risk myelodysplastic syndrome (HR-MDS) T2 - Blood TI - Phase 3, multi-center, international, randomized, double-blind placebo controlled study of oral rigosertib + injectable azacitidine (AZA) versus injectable azacitidine in treatment-naive patients with higher-risk myelodysplastic syndrome (HR-MDS) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630315301&from=export http://dx.doi.org/10.1182/blood-2019-132149 VL - 134 ID - 1168 ER - TY - JOUR AD - X. Long AU - Long, X. AU - Man, C. AU - Narayanan, P. AU - Seashore, E. AU - Redell, M. DB - Embase DO - 10.1182/blood-2019-129074 LA - English M3 - Conference Abstract N1 - L630316813 2019-12-31 PY - 2019 SN - 1528-0020 ST - Inhibition of BMP-SMAD pathway reduces leukemic stemness in pediatric aml T2 - Blood TI - Inhibition of BMP-SMAD pathway reduces leukemic stemness in pediatric aml UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630316813&from=export http://dx.doi.org/10.1182/blood-2019-129074 VL - 134 ID - 1169 ER - TY - JOUR AD - K. Kudo AU - Kudo, K. AU - Kanezaki, R. AU - Kobayashi, A. AU - Sato, T. AU - Kamio, T. AU - Sasaki, S. AU - Masaru, I. AU - Imai, C. AU - Irie, M. AU - Sasahara, Y. AU - Ando, K. AU - Kakuda, H. AU - Doi, T. AU - Kawaguchi, H. AU - Kudo, K. AU - Kanegane, H. AU - Terui, K. AU - Toki, T. AU - Ito, E. DB - Embase DO - 10.1182/blood-2019-127536 LA - English M3 - Conference Abstract N1 - L630318538 2019-12-31 PY - 2019 SN - 1528-0020 ST - Brafv600e-positive precursors as molecular markers of bone marrow involvement in pediatric langerhans cell histiocytosis T2 - Blood TI - Brafv600e-positive precursors as molecular markers of bone marrow involvement in pediatric langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630318538&from=export http://dx.doi.org/10.1182/blood-2019-127536 VL - 134 ID - 1170 ER - TY - JOUR AD - L.M. Kuhn AU - Kuhn, L. M. AU - Schipp, C. AU - Hein, D. AU - Killing, B. AU - Qin, N. AU - Jepsen, V. H. AU - Ahlert, H. AU - Bartl, J. AU - Marquardt, V. AU - Pauck, D. AU - Völtzke, K. AU - Lim, J. AU - Leprivier, G. AU - Remke, M. AU - Bhatia, S. AU - Rosenbaum, T. AU - Borkhardt, A. AU - Fischer, U. DB - Embase DO - 10.1182/blood-2019-131406 LA - English M3 - Conference Abstract N1 - L630318720 2019-12-31 PY - 2019 SN - 1528-0020 ST - Investigation of new therapeutic compounds for juvenile myelomonocytic leukemia using induced pluripotent stem cells with stably activated ras pathway T2 - Blood TI - Investigation of new therapeutic compounds for juvenile myelomonocytic leukemia using induced pluripotent stem cells with stably activated ras pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630318720&from=export http://dx.doi.org/10.1182/blood-2019-131406 VL - 134 ID - 1171 ER - TY - JOUR AD - D. Bhojwani AU - Bhojwani, D. AU - Peterson, B. AU - Taraseviciute, A. AU - Pulsipher, M. A. AU - Wayne, A. S. AU - Sheard, M. AU - Allem, C. AU - Trampush, J. AU - Bansal, R. DB - Embase DO - 10.1182/blood-2019-127533 LA - English M3 - Conference Abstract N1 - L630319856 2019-12-31 PY - 2019 SN - 1528-0020 ST - Immunologic and brain bases of neurotoxicity associated with car t-cell therapy T2 - Blood TI - Immunologic and brain bases of neurotoxicity associated with car t-cell therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630319856&from=export http://dx.doi.org/10.1182/blood-2019-127533 VL - 134 ID - 1172 ER - TY - JOUR AD - N. Singh AU - Singh, N. AU - Frey, N. V. AU - Engels, B. AU - Barrett, D. M. AU - Shestova, O. AU - Ravikumar, P. AU - Shyu, A. AU - Highfill, S. AU - Zhao, L. AU - Peng, L. AU - Granda, B. AU - Ramones, M. AU - Lu, X. M. AU - Christian, D. A. AU - Perazzelli, J. AU - Lacey, S. F. AU - Roy, N. AU - Burkhardt, J. K. AU - Colomb, F. AU - Abdel-Mohsen, M. AU - Young, R. M. AU - Brogdon, J. AU - Grupp, S. AU - June, C. H. AU - Maude, S. L. AU - Gill, S. I. AU - Ruella, M. DB - Embase DO - 10.1182/blood-2019-131024 LA - English M3 - Conference Abstract N1 - L630320423 2019-12-31 PY - 2019 SN - 1528-0020 ST - Single chain variable fragment linker length regulates CAR biology and T cell efficacy T2 - Blood TI - Single chain variable fragment linker length regulates CAR biology and T cell efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630320423&from=export http://dx.doi.org/10.1182/blood-2019-131024 VL - 134 ID - 1173 ER - TY - JOUR AD - G. Robinson, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Robinson, G. AU - Desai, A. AU - Gauvain, K. AU - Basu, E. AU - Dorris, K. AU - Maese, L. AU - Sabnis, A. AU - Foster, J. AU - Shusterman, S. AU - Yoon, J. AU - Weiss, B. AU - Abdelbaki, M. AU - Farid-Kapadia, M. AU - Meneses-Lorente, G. AU - Cardenas, A. AU - Hutchinson, K. AU - Bergthold, G. AU - Maneval, E. C. AU - Fox, E. AU - Gajjar, A. DB - Embase DO - 10.1093/neuonc/noz175.774 LA - English M3 - Conference Abstract N1 - L631168490 2020-03-17 PY - 2019 SN - 1523-5866 SP - vi186 ST - Entrectinib in children and adolescents with recurrent or refractory solid tumors including primary CNS tumors T2 - Neuro-Oncology TI - Entrectinib in children and adolescents with recurrent or refractory solid tumors including primary CNS tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631168490&from=export http://dx.doi.org/10.1093/neuonc/noz175.774 VL - 21 ID - 1174 ER - TY - JOUR AD - B. Archambault, Duke University Medical Center, Durham, NC, United States AU - Archambault, B. AU - Landi, D. AU - Schroeder, K. DB - Embase DO - 10.1093/neuonc/noz175.854 LA - English M3 - Conference Abstract N1 - L631168740 2020-03-17 PY - 2019 SN - 1523-5866 SP - vi205 ST - Dose frequency modification of trametinib to mitigate severe rash and improve quality of life in pediatric low-grade glioma patients T2 - Neuro-Oncology TI - Dose frequency modification of trametinib to mitigate severe rash and improve quality of life in pediatric low-grade glioma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631168740&from=export http://dx.doi.org/10.1093/neuonc/noz175.854 VL - 21 ID - 1175 ER - TY - JOUR AD - L. Ge, Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing, China AU - Zhai, Y. AU - Wang, Y. AU - Rao, N. AU - Li, J. AU - Li, X. AU - Fang, T. AU - Zhao, Y. AU - Ge, L. DB - Embase DO - 10.3389/fphys.2019.01304 LA - English M3 - Article N1 - L629756827 2019-11-13 2019-11-15 PY - 2019 SN - 1664-042X ST - Activation and Biological Properties of Human β Defensin 4 in Stem Cells Derived From Human Exfoliated Deciduous Teeth T2 - Frontiers in Physiology TI - Activation and Biological Properties of Human β Defensin 4 in Stem Cells Derived From Human Exfoliated Deciduous Teeth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629756827&from=export http://dx.doi.org/10.3389/fphys.2019.01304 VL - 10 ID - 1177 ER - TY - JOUR AD - C. Bellido, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, Avenida de Córdoba s/n, Madrid, Spain AU - Bellido, C. AU - Barbero, P. AU - Forcén, L. AU - Blanco, M. AU - Alonso-Riaño, M. AU - Galindo, A. DB - Embase Medline DO - 10.1080/14767058.2018.1461830 IS - 19 LA - English M3 - Article N1 - L621755815 2018-04-25 2019-07-19 PY - 2019 SN - 1476-4954 1476-7058 SP - 3300-3302 ST - Lung adenocarcinoma during pregnancy: clinical case and literature review T2 - Journal of Maternal-Fetal and Neonatal Medicine TI - Lung adenocarcinoma during pregnancy: clinical case and literature review UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621755815&from=export http://dx.doi.org/10.1080/14767058.2018.1461830 VL - 32 ID - 1178 ER - TY - JOUR AD - W. Chen, Department of Toxicology, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, China AU - Chen, S. AU - Li, D. AU - Zhang, H. AU - Yu, D. AU - Chen, R. AU - Zhang, B. AU - Tan, Y. AU - Niu, Y. AU - Duan, H. AU - Mai, B. AU - Chen, S. AU - Yu, J. AU - Luan, T. AU - Chen, L. AU - Xing, X. AU - Li, Q. AU - Xiao, Y. AU - Dong, G. AU - Niu, Y. AU - Aschner, M. AU - Zhang, R. AU - Zheng, Y. AU - Chen, W. DB - Embase Medline DO - 10.1016/j.envint.2019.104943 LA - English M3 - Article N1 - L2002239205 2019-07-12 2019-07-19 PY - 2019 SN - 1873-6750 0160-4120 ST - The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure T2 - Environment International TI - The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002239205&from=export http://dx.doi.org/10.1016/j.envint.2019.104943 VL - 131 ID - 1179 ER - TY - JOUR AD - H. Pan, Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong An Road, Shanghai, China AU - Pan, H. AU - Pan, J. AU - Ji, L. AU - Song, S. AU - Lv, H. AU - Yang, Z. AU - Guo, Y. DB - Embase Medline DO - 10.1016/j.ijbiomac.2019.07.028 LA - English M3 - Article N1 - L2002311255 2019-07-22 2019-07-26 PY - 2019 SN - 1879-0003 0141-8130 SP - 125-134 ST - Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer T2 - International Journal of Biological Macromolecules TI - Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002311255&from=export http://dx.doi.org/10.1016/j.ijbiomac.2019.07.028 VL - 138 ID - 1180 ER - TY - JOUR AD - C. Zhou, University of Oklahoma Health Sciences Center, College of Medicine AU - Zhou, C. AU - Davis, D. AU - Haskell, H. AU - Levin, J. DB - Embase DO - 10.1016/j.jaad.2019.06.357 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643058 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB92 ST - MEK inhibitor-induced chronic paronychia T2 - Journal of the American Academy of Dermatology TI - MEK inhibitor-induced chronic paronychia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643058&from=export http://dx.doi.org/10.1016/j.jaad.2019.06.357 VL - 81 ID - 1181 ER - TY - JOUR AD - K. Mohr, Department of Dermatology and Dermatopathology, University of Arkansas for Medical Sciences, Little Rock, AR, United States AU - Mohr, K. AU - Gardner, J. AU - Kincannon, J. DB - Embase DO - 10.1016/j.jaad.2019.06.845 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643217 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB231 ST - Langerhans cell histiocytosis in pediatric patient responsive to vemurafenib after refractory to initial therapy and significant morbidity to salvage therapy T2 - Journal of the American Academy of Dermatology TI - Langerhans cell histiocytosis in pediatric patient responsive to vemurafenib after refractory to initial therapy and significant morbidity to salvage therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643217&from=export http://dx.doi.org/10.1016/j.jaad.2019.06.845 VL - 81 ID - 1182 ER - TY - JOUR AD - K.L. Gleghorn, Department of Dermatology, University of Texas Medical Branch, Galveston, TX, United States AU - Gleghorn, K. L. AU - Wagner, K. AU - Quian, Y. W. AU - Totman, K. AU - Goodwin, B. DB - Embase DO - 10.1016/j.jaad.2019.06.571 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643224 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB153 ST - A case of pediatric CD30+ primary cutaneous anaplastic large cell lymphoma T2 - Journal of the American Academy of Dermatology TI - A case of pediatric CD30+ primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643224&from=export http://dx.doi.org/10.1016/j.jaad.2019.06.571 VL - 81 ID - 1183 ER - TY - JOUR AD - E. Guo, Medstar Washington Hospital Center, Georgetown University Hospital, United States AU - Guo, E. AU - Dollani, L. AU - Marathe, K. AU - Norton, S. DB - Embase DO - 10.1016/j.jaad.2019.06.581 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643828 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB155 ST - A child with an unknown Noonan-like syndrome with CNS tumors, café-au-lait patches, pigmented axillary papules, punctate leukoderma, and cutaneous and gastric granular cell tumors T2 - Journal of the American Academy of Dermatology TI - A child with an unknown Noonan-like syndrome with CNS tumors, café-au-lait patches, pigmented axillary papules, punctate leukoderma, and cutaneous and gastric granular cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643828&from=export http://dx.doi.org/10.1016/j.jaad.2019.06.581 VL - 81 ID - 1184 ER - TY - JOUR C1 - braftovi(Fabre) mektovi(Fabre) C2 - Fabre DB - Embase DO - 10.18773/austprescr.2019.057 IS - 5 LA - English M3 - Note N1 - L2002733501 2019-10-22 2019-10-24 PY - 2019 SN - 1839-3942 0312-8008 SP - 168-169 ST - Binimetinib plus encorafenib for metastatic melanoma T2 - Australian Prescriber TI - Binimetinib plus encorafenib for metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002733501&from=export http://dx.doi.org/10.18773/austprescr.2019.057 VL - 42 ID - 1185 ER - TY - JOUR AD - A.R. Anvikar, Epidemiology and Clinical Research Division, ICMR-National Institute of Malaria Research, New Delhi, India AU - Ahmed, M. Z. AU - Bhardwaj, N. AU - Sharma, S. AU - Pande, V. AU - Anvikar, A. R. DB - Embase Medline DO - 10.3390/biom9100600 IS - 10 LA - English M3 - Article N1 - L2002777393 2019-10-23 2019-12-16 PY - 2019 SN - 2218-273X ST - Transcriptional modulation of the host immunity mediated by cytokines and transcriptional factors in plasmodium falciparum-infected patients of north-east India T2 - Biomolecules TI - Transcriptional modulation of the host immunity mediated by cytokines and transcriptional factors in plasmodium falciparum-infected patients of north-east India UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002777393&from=export http://dx.doi.org/10.3390/biom9100600 VL - 9 ID - 1186 ER - TY - JOUR AD - S.P. Singh, Division of Hematology & Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States AU - Bose, C. AU - Singh, S. P. AU - Igid, H. AU - Green, W. C. AU - Singhal, S. S. AU - Lee, J. AU - Palade, P. T. AU - Rajan, A. AU - Ball, S. AU - Tonk, V. AU - Hindle, A. AU - Tarbox, M. AU - Awasthi, S. C1 - azd 2461(Techne,United States) C2 - Sigma(United States) Techne(United States) DB - Embase DO - 10.3390/cancers11101556 IS - 10 LA - English M3 - Article N1 - L2002796111 2019-10-29 2019-11-05 PY - 2019 SN - 2072-6694 ST - Topical 2′-hydroxyflavanone for cutaneous melanoma T2 - Cancers TI - Topical 2′-hydroxyflavanone for cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002796111&from=export http://dx.doi.org/10.3390/cancers11101556 VL - 11 ID - 1187 ER - TY - JOUR AU - Guo, R. AU - Preeshagul, I. AU - Schoenfeld, A. AU - McCarthy, C. AU - Makhnin, A. AU - Plodkowski, A. AU - Ginsberg, M. AU - Davare, M. AU - Delasos, L. AU - Somwar, R. AU - Arcila, M. AU - Riely, G. AU - Rekhtman, N. AU - Ladanyi, M. AU - Kris, M. AU - Drilon, A. DB - Embase DO - 10.1016/j.jtho.2019.08.1201 IS - 10 LA - English M3 - Conference Abstract N1 - L2003405563 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S574-S575 ST - P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma T2 - Journal of Thoracic Oncology TI - P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003405563&from=export http://dx.doi.org/10.1016/j.jtho.2019.08.1201 VL - 14 ID - 1188 ER - TY - JOUR AU - Doebele, R. DB - Embase DO - 10.1016/j.jtho.2019.08.051 IS - 10 LA - English M3 - Conference Abstract N1 - L2003405943 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S2 ST - PL01.01 Tumor-Agnostic Biologically Driven Treatments: An Endless Dream? T2 - Journal of Thoracic Oncology TI - PL01.01 Tumor-Agnostic Biologically Driven Treatments: An Endless Dream? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003405943&from=export http://dx.doi.org/10.1016/j.jtho.2019.08.051 VL - 14 ID - 1189 ER - TY - JOUR AU - Ramirez, L. AU - Villota, A. G. AU - Parga, J. H. AU - Velasco, M. AU - Lòpez, J. DB - Embase DO - 10.1016/j.jtho.2019.08.1985 IS - 10 LA - English M3 - Conference Abstract N1 - L2003406901 2019-10-24 PY - 2019 SN - 1556-1380 1556-0864 SP - S915 ST - EP1.01-26 Non-Small Cellular Pulmon Cancer ALK Positive in Pediatrics T2 - Journal of Thoracic Oncology TI - EP1.01-26 Non-Small Cellular Pulmon Cancer ALK Positive in Pediatrics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003406901&from=export http://dx.doi.org/10.1016/j.jtho.2019.08.1985 VL - 14 ID - 1190 ER - TY - JOUR AU - Chen, H. AU - Ling, T. AU - Huang, Y. AU - Chen, J. AU - Su, S. DB - Embase DO - 10.1016/j.jtho.2019.08.1487 IS - 10 LA - English M3 - Conference Abstract N1 - L2003407279 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S699 ST - P2.03-40 Particle Matters Induce Carcinogenic Phenotype and Gene Expression Changes in Murine Pulmonary Progenitor Cells T2 - Journal of Thoracic Oncology TI - P2.03-40 Particle Matters Induce Carcinogenic Phenotype and Gene Expression Changes in Murine Pulmonary Progenitor Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003407279&from=export http://dx.doi.org/10.1016/j.jtho.2019.08.1487 VL - 14 ID - 1191 ER - TY - JOUR AD - B. Will, Department of Medicine (Oncology) & Department of Cell Biology Director, Stem Cell Pharmacodynamics Laboratory, Albert Einstein College of Medicine, Jack & Pearl Resnick Campus, 1300 Morris Park Avenue, Chanin Building, Room 401, Bronx, NY, United States AU - Bussel, J. AU - Kulasekararaj, A. AU - Cooper, N. AU - Verma, A. AU - Steidl, U. AU - Semple, J. W. AU - Will, B. DB - Embase Medline DO - 10.1053/j.seminhematol.2019.09.001 IS - 4 LA - English M3 - Review N1 - L2003801391 2019-11-27 2019-12-18 PY - 2019 SN - 1532-8686 0037-1963 SP - 262-278 ST - Mechanisms and therapeutic prospects of thrombopoietin receptor agonists T2 - Seminars in Hematology TI - Mechanisms and therapeutic prospects of thrombopoietin receptor agonists UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003801391&from=export http://dx.doi.org/10.1053/j.seminhematol.2019.09.001 VL - 56 ID - 1192 ER - TY - JOUR AU - Hazar, V. DB - Embase DO - 10.1016/S0145-2126(19)30236-X LA - English M3 - Conference Abstract N1 - L2004021042 2019-12-03 PY - 2019 SN - 1873-5835 0145-2126 SP - S17-S18 ST - Novel therapy for relapsed childhood acute lymphoblastic leukemia T2 - Leukemia Research TI - Novel therapy for relapsed childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004021042&from=export http://dx.doi.org/10.1016/S0145-2126(19)30236-X VL - 85 ID - 1193 ER - TY - JOUR AD - F. Guo, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, Cincinnati, OH, United States AU - Nguyen, P. AU - Chakrabarti, J. AU - Li, Y. AU - Kalim, K. W. AU - Zhang, M. AU - Zhang, L. AU - Zheng, Y. AU - Guo, F. C1 - casin(Cayman) C2 - Cayman Selleck Sigma Aldrich DB - Embase DO - 10.3389/fonc.2019.00958 LA - English M3 - Article N1 - L629580519 2019-10-25 2019-12-18 PY - 2019 SN - 2234-943X ST - Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma T2 - Frontiers in Oncology TI - Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629580519&from=export http://dx.doi.org/10.3389/fonc.2019.00958 VL - 9 ID - 1194 ER - TY - JOUR AD - C. Menicanti, IRCCS Cà Granda Foundation, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy AU - Menicanti, C. AU - Nuñez Hipólito, L. AU - Prieto Torres, L. AU - Alegría-Landa, V. AU - Requena, L. DB - Embase IS - 10 LA - English M3 - Conference Abstract N1 - L629610670 2019-10-22 PY - 2019 SN - 1533-0311 SP - e125 ST - Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome a non-previously described association T2 - American Journal of Dermatopathology TI - Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome a non-previously described association UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629610670&from=export VL - 41 ID - 1195 ER - TY - JOUR AD - S. Frankford, Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States AU - Frankford, S. AU - Reynolds, S. AU - Patel, A. AU - Mendonca-Torres, M. AU - Costello, J. AU - Bikas, A. AU - Burman, K. D. AU - Jensen, K. E. AU - Vasko, V. DB - Embase DO - 10.1089/thy.2019.29085.abstracts LA - English M3 - Conference Abstract N1 - L629777078 2019-11-12 PY - 2019 SN - 1557-9077 SP - A129 ST - Assessment of therapy-inducible molecular changes in patient-derived xenograft of thyroid cancer T2 - Thyroid TI - Assessment of therapy-inducible molecular changes in patient-derived xenograft of thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629777078&from=export http://dx.doi.org/10.1089/thy.2019.29085.abstracts VL - 29 ID - 1196 ER - TY - JOUR AD - C. Balbi, CardioCentro Ticino, Lugano, Italy AU - Balbi, C. AU - Bolis, S. AU - Barile, L. AU - Vassalli, G. DB - Embase DO - 10.1093/eurheartj/ehz748.0912 LA - English M3 - Conference Abstract N1 - L630047966 2019-12-13 PY - 2019 SN - 0195-668X SP - 1546 ST - Cardiac progenitor cell exosome-associated periostin triggers reentry of cardiomyocytes into cell cycle T2 - European Heart Journal TI - Cardiac progenitor cell exosome-associated periostin triggers reentry of cardiomyocytes into cell cycle UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630047966&from=export http://dx.doi.org/10.1093/eurheartj/ehz748.0912 VL - 40 ID - 1197 ER - TY - JOUR AD - Z.T. Al-Salama, Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, New Zealand AU - Al-Salama, Z. T. AU - Keam, S. J. DB - Embase Medline DO - 10.1007/s40265-019-01177-y IS - 13 LA - English M3 - Review N1 - L2002394094 2019-08-13 2019-09-20 PY - 2019 SN - 1179-1950 0012-6667 SP - 1477-1483 ST - Entrectinib: First Global Approval T2 - Drugs TI - Entrectinib: First Global Approval UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002394094&from=export http://dx.doi.org/10.1007/s40265-019-01177-y VL - 79 ID - 1198 ER - TY - JOUR AD - C. Zhang, Department of Pediatrics, Jining No.1 People's Hospital, Jining, China AU - Meng, J. AU - Chen, Y. AU - Zhang, C. DB - Embase Medline DO - 10.1002/jcb.28755 IS - 9 LA - English M3 - Article N1 - L627469652 2019-05-14 2019-08-01 PY - 2019 SN - 1097-4644 0730-2312 SP - 14928-14935 ST - Protective impacts of long noncoding RNA taurine-upregulated 1 against lipopolysaccharide-evoked injury in MRC-5 cells through inhibition of microRNA-127 T2 - Journal of Cellular Biochemistry TI - Protective impacts of long noncoding RNA taurine-upregulated 1 against lipopolysaccharide-evoked injury in MRC-5 cells through inhibition of microRNA-127 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627469652&from=export http://dx.doi.org/10.1002/jcb.28755 VL - 120 ID - 1200 ER - TY - JOUR AD - S. Yamaguchi, Department of Dermatology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan AU - Kaneshima, A. AU - Yamaguchi, S. AU - Miyagi, T. AU - Kariya, Y. AU - Awazawa, T. AU - Ohshiro, T. AU - Hyakuna, N. AU - Nakanishi, K. AU - Takahashi, K. DB - Embase Medline DO - 10.1111/1346-8138.14996 IS - 9 LA - English M3 - Article N1 - L628430775 2019-07-12 2019-09-11 PY - 2019 SN - 1346-8138 0385-2407 SP - 812-815 ST - Extracellular signal-regulated kinase activation of self-healing Langerhans cell histiocytosis: A case report T2 - Journal of Dermatology TI - Extracellular signal-regulated kinase activation of self-healing Langerhans cell histiocytosis: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628430775&from=export http://dx.doi.org/10.1111/1346-8138.14996 VL - 46 ID - 1201 ER - TY - JOUR AD - E.A. Tallant AU - Tallant, E. A. AU - Rahimi, O. AU - Varagic, J. AU - Westwood, B. M. AU - Gallagher, P. E. DB - Embase DO - 10.1161/hyp.74.suppl_1.P3006 LA - English M3 - Conference Abstract N1 - L629597945 2019-10-21 PY - 2019 SN - 1524-4563 ST - Angiotensin-(1-7) prevents doxorubicin-induced aortic dysfunction through anti-fibrotic mechanisms in juvenile male and female Sprague Dawley rats T2 - Hypertension TI - Angiotensin-(1-7) prevents doxorubicin-induced aortic dysfunction through anti-fibrotic mechanisms in juvenile male and female Sprague Dawley rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629597945&from=export http://dx.doi.org/10.1161/hyp.74.suppl_1.P3006 VL - 74 ID - 1203 ER - TY - JOUR AD - W. Yang, NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China AU - Xu, H. AU - Cheng, M. AU - Chi, X. AU - Liu, X. AU - Zhou, J. AU - Lin, T. AU - Yang, W. DB - Embase DO - 10.1128/JVI.00758-19 IS - 19 LA - English M3 - Article N1 - L629624943 2019-10-23 2019-10-31 PY - 2019 SN - 1098-5514 0022-538X ST - High-throughput screening identifies mixed-lineage kinase 3 as a key host regulatory factor in Zika virus infection T2 - Journal of Virology TI - High-throughput screening identifies mixed-lineage kinase 3 as a key host regulatory factor in Zika virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629624943&from=export http://dx.doi.org/10.1128/JVI.00758-19 VL - 93 ID - 1204 ER - TY - JOUR AD - Y. Lu, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China AU - Liu, N. W. AU - Huang, X. AU - Liu, S. AU - Lu, Y. DB - Embase Medline DO - 10.12659/MSM.918295 LA - English M3 - Article N1 - L2004761178 2020-02-04 2020-02-28 PY - 2019 SN - 1643-3750 1234-1010 SP - 6491-6503 ST - EXT1, regulated by miR-665, promotes cell apoptosis via ERK1/2 signaling pathway in acute lymphoblastic leukemia T2 - Medical Science Monitor TI - EXT1, regulated by miR-665, promotes cell apoptosis via ERK1/2 signaling pathway in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004761178&from=export http://dx.doi.org/10.12659/MSM.918295 VL - 25 ID - 1205 ER - TY - JOUR AD - C. Wang, Clinical and Translational Science Center, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Box 16, 1000 West Carson Street, Torrance, CA, United States AU - Jia, Y. AU - Lue, Y. AU - Swerdloff, R. S. AU - Lasky, J. L. AU - Panosyan, E. H. AU - Dai-Ju, J. AU - Wang, C. C2 - CPC Scientific(United States) Sigma(United States) DB - Embase Medline DO - 10.1016/j.yexmp.2019.104261 LA - English M3 - Article N1 - L2002083106 2019-06-13 2019-06-19 PY - 2019 SN - 1096-0945 0014-4800 SP - 42-50 ST - The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma T2 - Experimental and Molecular Pathology TI - The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002083106&from=export http://dx.doi.org/10.1016/j.yexmp.2019.104261 VL - 109 ID - 1206 ER - TY - JOUR AD - D.B. Johnson, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States AU - Johnson, D. B. AU - McDonnell, W. J. AU - Gonzalez-Ericsson, P. I. AU - Al-Rohil, R. N. AU - Mobley, B. C. AU - Salem, J. E. AU - Wang, D. Y. AU - Sanchez, V. AU - Wang, Y. AU - Chastain, C. A. AU - Barker, K. AU - Liang, Y. AU - Warren, S. AU - Beechem, J. M. AU - Menzies, A. M. AU - Tio, M. AU - Long, G. V. AU - Cohen, J. V. AU - Guidon, A. C. AU - O’Hare, M. AU - Chandra, S. AU - Chowdhary, A. AU - Lebrun-Vignes, B. AU - Goldinger, S. M. AU - Rushing, E. J. AU - Buchbinder, E. I. AU - Mallal, S. A. AU - Shi, C. AU - Xu, Y. AU - Moslehi, J. J. AU - Sanders, M. E. AU - Sosman, J. A. AU - Balko, J. M. DB - Embase Medline DO - 10.1038/s41591-019-0523-2 IS - 8 LA - English M3 - Article N1 - L2002413009 2019-08-14 2020-04-27 PY - 2019 SN - 1546-170X 1078-8956 SP - 1243-1250 ST - A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis T2 - Nature Medicine TI - A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002413009&from=export http://dx.doi.org/10.1038/s41591-019-0523-2 VL - 25 ID - 1207 ER - TY - JOUR DB - Embase DO - 10.1016/j.jaapos.2019.08.114 IS - 4 LA - English M3 - Conference Abstract N1 - L2003104613 2019-10-04 PY - 2019 SN - 1528-3933 1091-8531 SP - e32-e33 ST - Incidence of mitogen-activated protein kinase inhibitor-associated retinopathy in pediatric pateints T2 - Journal of AAPOS TI - Incidence of mitogen-activated protein kinase inhibitor-associated retinopathy in pediatric pateints UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003104613&from=export http://dx.doi.org/10.1016/j.jaapos.2019.08.114 VL - 23 ID - 1208 ER - TY - JOUR AD - M. Pereira, Department of Medicine Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, United States AU - Cheng, Y. AU - Pereira, M. AU - Raukar, N. AU - Reagan, J. L. AU - Queseneberry, M. AU - Goldberg, L. AU - Borgovan, T. AU - LaFrance, W. C. AU - Dooner, M. AU - Deregibus, M. AU - Camussi, G. AU - Ramratnam, B. AU - Quesenberry, P. DB - Embase Medline DO - 10.1002/jcp.28139 IS - 8 LA - English M3 - Article N1 - L625983492 2019-01-22 2019-05-14 PY - 2019 SN - 1097-4652 0021-9541 SP - 14377-14388 ST - Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles T2 - Journal of Cellular Physiology TI - Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625983492&from=export http://dx.doi.org/10.1002/jcp.28139 VL - 234 ID - 1209 ER - TY - JOUR AD - J. Lu, Department of Orthopaedics, The Central Hospital of Yongzhou, Yongzhou, China AU - Tang, H. AU - Tang, Z. AU - Jiang, Y. AU - Wei, W. AU - Lu, J. DB - Embase Medline DO - 10.1111/ajco.13165 IS - 4 LA - English M3 - Review N1 - L627827523 2019-05-30 2019-07-24 PY - 2019 SN - 1743-7563 1743-7555 SP - 218-224 ST - Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma T2 - Asia-Pacific Journal of Clinical Oncology TI - Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627827523&from=export http://dx.doi.org/10.1111/ajco.13165 VL - 15 ID - 1210 ER - TY - JOUR AD - G. Agabekyan, National Medical Research Centre for Neurosurgery n.a. N.N. Burdenko, Moscow, Russian Federation AU - Agabekyan, G. AU - Kobyakov, G. AU - Lodygina, K. AU - Kobyakov, N. AU - Absalyamova, O. AU - Ryzhova, M. AU - Inozemceva, M. AU - Poddubsky, A. DB - Embase DO - 10.1093/neuonc/noz126.300 LA - English M3 - Conference Abstract N1 - L631167679 2020-03-17 PY - 2019 SN - 1523-5866 SP - iii82 ST - Anaplastic pleomorphic xanthoastrocytoma: Literature review& case report T2 - Neuro-Oncology TI - Anaplastic pleomorphic xanthoastrocytoma: Literature review& case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631167679&from=export http://dx.doi.org/10.1093/neuonc/noz126.300 VL - 21 ID - 1212 ER - TY - JOUR AD - T. Chen, National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China AU - Tian, P. AU - Wang, Y. AU - Liu, H. AU - Yang, Y. AU - Wu, X. AU - Wei, H. AU - Chen, T. DB - Embase Medline DO - 10.3389/fcimb.2019.00275 LA - English M3 - Article N1 - L629221916 2019-09-20 2019-10-03 PY - 2019 SN - 2235-2988 ST - Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus T2 - Frontiers in Cellular and Infection Microbiology TI - Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629221916&from=export http://dx.doi.org/10.3389/fcimb.2019.00275 VL - 9 ID - 1213 ER - TY - JOUR AD - X. Ying, Department of Gynecology, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China AU - Li, Y. AU - Kong, C. AU - Wu, C. AU - Wang, Y. AU - Xu, B. AU - Liang, S. AU - Ying, X. DB - Embase Medline DO - 10.1042/BSR20181794 IS - 7 LA - English M3 - Article N1 - L2002402929 2019-08-01 2019-08-06 PY - 2019 SN - 1573-4935 0144-8463 ST - Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11 T2 - Bioscience Reports TI - Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002402929&from=export http://dx.doi.org/10.1042/BSR20181794 VL - 39 ID - 1214 ER - TY - JOUR AD - A. Forschner, Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Liebermeisterstr. 25, Tuebingen, Germany AU - Forschner, A. AU - Battke, F. AU - Hadaschik, D. AU - Schulze, M. AU - Weißgraeber, S. AU - Han, C. T. AU - Kopp, M. AU - Frick, M. AU - Klumpp, B. AU - Tietze, N. AU - Amaral, T. AU - Martus, P. AU - Sinnberg, T. AU - Eigentler, T. AU - Keim, U. AU - Garbe, C. AU - Döcker, D. AU - Biskup, S. DB - Embase Medline DO - 10.1186/s40425-019-0659-0 IS - 1 LA - English M3 - Article N1 - L628486221 2019-07-19 2019-07-24 PY - 2019 SN - 2051-1426 ST - Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - Results of a prospective biomarker study T2 - Journal for ImmunoTherapy of Cancer TI - Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - Results of a prospective biomarker study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628486221&from=export http://dx.doi.org/10.1186/s40425-019-0659-0 VL - 7 ID - 1215 ER - TY - JOUR AD - Y. Adachi, Department of Diagnostic Pathology, Toyooka Hospital, 1094 Tobera, Toyooka, Hyogo, Japan AU - Okumura, Y. AU - Adachi, Y. AU - Shirahase, T. AU - Nagashima, Y. AU - Tanaka, Y. AU - Taki, Y. AU - Watanabe, J. AU - Uegaki, M. AU - Sakatani, T. AU - Ikehara, S. DB - Embase DO - 10.3892/mco.2019.1848 IS - 1 LA - English M3 - Article N1 - L2002184730 2019-07-12 2019-07-17 PY - 2019 SN - 2049-9469 2049-9450 SP - 55-58 ST - Malignant rhabdoid tumour in an adult kidney: A case report T2 - Molecular and Clinical Oncology TI - Malignant rhabdoid tumour in an adult kidney: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002184730&from=export http://dx.doi.org/10.3892/mco.2019.1848 VL - 11 ID - 1216 ER - TY - JOUR AD - J.W. Tyner, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Mailcode KR-HEM, Portland, OR, United States AU - Nechiporuk, T. AU - Kurtz, S. E. AU - Nikolova, O. AU - Liu, T. AU - Jones, C. L. AU - D’alessandro, A. AU - Culp-Hill, R. AU - D’almeida, A. AU - Joshi, S. K. AU - Rosenberg, M. AU - Tognon, C. E. AU - Danilov, A. V. AU - Druker, B. J. AU - Chang, B. H. AU - McWeeney, S. K. AU - Tyner, J. W. DB - Embase Medline DO - 10.1158/2159-8290.CD-19-0125 IS - 7 LA - English M3 - Article N1 - L2002229750 2019-08-06 2019-08-08 PY - 2019 SN - 2159-8290 2159-8274 SP - 910-925 ST - The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells T2 - Cancer Discovery TI - The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002229750&from=export http://dx.doi.org/10.1158/2159-8290.CD-19-0125 VL - 9 ID - 1218 ER - TY - JOUR AD - D.J. Daniels, Department of Neurosurgery, Mayo Clinic, Rochester, MN, United States AU - Zhang, L. AU - Peterson, T. E. AU - Lu, V. M. AU - Parney, I. F. AU - Daniels, D. J. DB - Embase Medline DO - 10.1371/journal.pone.0220569 IS - 7 LA - English M3 - Article N1 - L2002481033 2019-08-09 2020-08-26 PY - 2019 SN - 1932-6203 ST - Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells T2 - PLoS ONE TI - Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002481033&from=export http://dx.doi.org/10.1371/journal.pone.0220569 VL - 14 ID - 1219 ER - TY - JOUR AD - J.M. Cerutti, Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil AU - Sisdelli, L. AU - Cordioli, M. I. C. V. AU - Vaisman, F. AU - Moraes, L. AU - Colozza-Gama, G. A. AU - Alves, P. A. G. AU - Araújo, M. L. AU - Alves, M. T. S. AU - Monte, O. AU - Longui, C. A. AU - Cury, A. N. AU - Carvalheira, G. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1002/pbc.27707 IS - 7 LA - English M3 - Article N1 - L626985467 2019-04-04 2019-06-03 PY - 2019 SN - 1545-5017 1545-5009 ST - AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma T2 - Pediatric Blood and Cancer TI - AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626985467&from=export http://dx.doi.org/10.1002/pbc.27707 VL - 66 ID - 1220 ER - TY - JOUR AD - H. Hakonarson, Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA, United States AU - Li, D. AU - March, M. E. AU - Gutierrez-Uzquiza, A. AU - Kao, C. AU - Seiler, C. AU - Pinto, E. AU - Matsuoka, L. S. AU - Battig, M. R. AU - Bhoj, E. J. AU - Wenger, T. L. AU - Tian, L. AU - Robinson, N. AU - Wang, T. AU - Liu, Y. AU - Weinstein, B. M. AU - Swift, M. AU - Jung, H. M. AU - Kaminski, C. N. AU - Chiavacci, R. AU - Perkins, J. A. AU - Levine, M. A. AU - Sleiman, P. M. A. AU - Hicks, P. J. AU - Strausbaugh, J. T. AU - Belasco, J. B. AU - Dori, Y. AU - Hakonarson, H. C1 - mekinist DB - Embase Medline DO - 10.1038/s41591-019-0479-2 IS - 7 LA - English M3 - Article N1 - L628408257 2019-07-11 2020-04-27 PY - 2019 SN - 1546-170X 1078-8956 SP - 1116-1122 ST - ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor T2 - Nature Medicine TI - ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628408257&from=export http://dx.doi.org/10.1038/s41591-019-0479-2 VL - 25 ID - 1221 ER - TY - JOUR AD - E. Cocco, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Cocco, E. AU - Kulick, A. AU - Misale, S. AU - Yaeger, R. AU - Razavi, P. AU - Won, H. H. AU - Ptashkin, R. AU - Hechtman, J. F. AU - Toska, E. AU - Cownie, J. AU - Somwar, R. AU - Shifman, S. AU - Mattar, M. AU - Selçuklu, S. D. AU - Samoila, A. AU - Guzman, S. AU - Tuch, B. B. AU - Ebata, K. AU - De Stanchina, E. AU - Nagy, R. J. AU - Lanman, R. B. AU - Berger, M. F. AU - Ladanyi, M. AU - Hyman, D. M. AU - Drilon, A. AU - Scaltriti, M. AU - Schram, A. M. DB - Embase DO - 10.1158/1538-7445.SABCS18-LB-118 IS - 13 LA - English M3 - Conference Abstract N1 - L628709858 2019-08-01 PY - 2019 SN - 1538-7445 ST - Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation T2 - Cancer Research TI - Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628709858&from=export http://dx.doi.org/10.1158/1538-7445.SABCS18-LB-118 VL - 79 ID - 1222 ER - TY - JOUR AD - G. Haebich, Princess of Wales Hospital, Bridgend, United Kingdom AU - Haebich, G. AU - Pilz, D. AU - Li, V. DB - Embase DO - 10.1111/bjd.17890 LA - English M3 - Conference Abstract N1 - L628868442 2019-08-14 PY - 2019 SN - 1365-2133 SP - 82 ST - A rare case of mutation-positive cardiofaciocutaneous syndrome with associated multiple epidermoid cysts T2 - British Journal of Dermatology TI - A rare case of mutation-positive cardiofaciocutaneous syndrome with associated multiple epidermoid cysts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628868442&from=export http://dx.doi.org/10.1111/bjd.17890 VL - 181 ID - 1223 ER - TY - JOUR AD - J.A. Hanna, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Hanna, J. A. AU - Langdon, C. G. AU - Garcia, M. R. AU - Finkelstein, D. AU - Rehg, J. E. AU - Hatley, M. E. DB - Embase DO - 10.1158/1538-7445.SABCS18-4631 IS - 13 LA - English M3 - Conference Abstract N1 - L628905989 2019-08-20 PY - 2019 SN - 1538-7445 ST - Modeling the vascular sarcoma spectrum with genetically engineered mice T2 - Cancer Research TI - Modeling the vascular sarcoma spectrum with genetically engineered mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628905989&from=export http://dx.doi.org/10.1158/1538-7445.SABCS18-4631 VL - 79 ID - 1224 ER - TY - JOUR AD - L.D. Trucco, Cancer Research UK Manchester Institute, Manchester, United Kingdom AU - Trucco, L. D. AU - Mundra, P. A. AU - Garcia-Martinez, P. AU - Hogan, K. AU - Dhomen, N. AU - Pavet, V. AU - Marais, R. DB - Embase DO - 10.1158/1538-7445.SABCS18-4653 IS - 13 LA - English M3 - Conference Abstract N1 - L628906990 2019-08-20 PY - 2019 SN - 1538-7445 ST - Melanocyte specific deletion of Map3k1 reveals its role in BRAFV600E-driven melanoma T2 - Cancer Research TI - Melanocyte specific deletion of Map3k1 reveals its role in BRAFV600E-driven melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628906990&from=export http://dx.doi.org/10.1158/1538-7445.SABCS18-4653 VL - 79 ID - 1225 ER - TY - JOUR AD - N. Alijaj, University Children's Hospital Zurich, Zurich, Switzerland AU - Alijaj, N. AU - Moutel, S. AU - Gray, M. AU - Roveri, M. AU - Manzella, G. AU - Wachtel, M. AU - Perez, F. AU - Schafer, B. AU - Bernasconi, M. DB - Embase DO - 10.1158/1538-7445.SABCS18-3116 IS - 13 LA - English M3 - Conference Abstract N1 - L628907233 2019-08-20 PY - 2019 SN - 1538-7445 ST - Targeting fibroblast growth factor receptors in rhabdomyosarcoma T2 - Cancer Research TI - Targeting fibroblast growth factor receptors in rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628907233&from=export http://dx.doi.org/10.1158/1538-7445.SABCS18-3116 VL - 79 ID - 1226 ER - TY - JOUR AU - Dong, J. AU - Jan, Y. J. AU - Cheng, J. AU - Zhang, R. Y. AU - Meng, M. AU - Smalley, M. AU - Chen, P. J. AU - Tang, X. AU - Tseng, P. AU - Bao, L. AU - Huang, T. Y. AU - Zhou, D. AU - Liu, Y. AU - Chai, X. AU - Zhang, H. AU - Zhou, A. AU - Agopian, V. G. AU - Posadas, E. M. AU - Shyue, J. J. AU - Jonas, S. J. AU - Weiss, P. S. AU - Li, M. AU - Zheng, G. AU - Yu, H. H. AU - Zhao, M. AU - Tseng, H. R. AU - Zhu, Y. DB - Medline DO - 10.1126/sciadv.aav9186 IS - 7 LA - English M3 - Article N1 - L629044121 2019-09-20 2020-05-11 PY - 2019 SN - 2375-2548 SP - eaav9186 ST - Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells T2 - Science advances TI - Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629044121&from=export http://dx.doi.org/10.1126/sciadv.aav9186 VL - 5 ID - 1227 ER - TY - JOUR AD - T.M. Martin, Ophthalmology, Oregon Health and Science University, Portland, OR, United States AU - Martin, T. M. AU - Ogle, K. AU - Stiefel, H. AU - Neff, T. AU - Albert, D. M. AU - Lee, M. J. AU - Planck, S. R. AU - Corless, C. AU - Rosenbaum, J. T. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L629938985 2019-11-29 PY - 2019 SN - 1552-5783 ST - Genetic mutations in archival ocular biopsies from histiocytic orbital disease lesions T2 - Investigative Ophthalmology and Visual Science TI - Genetic mutations in archival ocular biopsies from histiocytic orbital disease lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629938985&from=export VL - 60 ID - 1228 ER - TY - JOUR AD - J. Trka, CLIP - Childhood Leukaemia Investigation Prague, Czech Republic AU - Zaliova, M. AU - Stuchly, J. AU - Winkowska, L. AU - Musilova, A. AU - Fiser, K. AU - Slamova, M. AU - Starkova, J. AU - Vaskova, M. AU - Hrusak, O. AU - Sramkova, L. AU - Stary, J. AU - Zuna, J. AU - Trka, J. DB - Embase Medline DO - 10.3324/haematol.2018.204974 IS - 7 LA - English M3 - Article N1 - L2002200155 2019-08-22 2019-08-29 PY - 2019 SN - 1592-8721 0390-6078 SP - 1396-1406 ST - Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort T2 - Haematologica TI - Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002200155&from=export http://dx.doi.org/10.3324/haematol.2018.204974 VL - 104 ID - 1229 ER - TY - JOUR AD - M. Sakaguchi, Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-shi, Okayama, Japan AU - Chen, Y. AU - Sumardika, I. W. AU - Tomonobu, N. AU - Winarsa Ruma, I. M. AU - Kinoshita, R. AU - Kondo, E. AU - Inoue, Y. AU - Sato, H. AU - Yamauchi, A. AU - Murata, H. AU - Yamamoto, K. I. AU - Tomida, S. AU - Shien, K. AU - Yamamoto, H. AU - Soh, J. AU - Liu, M. AU - Futami, J. AU - Sasai, K. AU - Katayama, H. AU - Kubo, M. AU - Putranto, E. W. AU - Hibino, T. AU - Sun, B. AU - Nishibori, M. AU - Toyooka, S. AU - Sakaguchi, M. DB - Embase Medline DO - 10.1016/j.canlet.2019.03.023 LA - English M3 - Article N1 - L2001752201 2019-04-04 2019-04-09 PY - 2019 SN - 1872-7980 0304-3835 SP - 178-190 ST - Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion T2 - Cancer Letters TI - Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001752201&from=export http://dx.doi.org/10.1016/j.canlet.2019.03.023 VL - 452 ID - 1230 ER - TY - JOUR AD - C. Paret, Section of Pediatric Oncology, Children’s Hospital, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany AU - Vewinger, N. AU - Huprich, S. AU - Seidmann, L. AU - Russo, A. AU - Alt, F. AU - Bender, H. AU - Sommer, C. AU - Samuel, D. AU - Lehmann, N. AU - Backes, N. AU - Roth, L. AU - Harter, P. N. AU - Filipski, K. AU - Faber, J. AU - Paret, C. DB - Embase Medline DO - 10.3390/ijms20123027 IS - 12 LA - English M3 - Article N1 - L2002248285 2019-08-14 2019-08-21 PY - 2019 SN - 1422-0067 1661-6596 ST - Igf1r is a potential new therapeutic target for hgnet-bcor brain tumor patients T2 - International Journal of Molecular Sciences TI - Igf1r is a potential new therapeutic target for hgnet-bcor brain tumor patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002248285&from=export http://dx.doi.org/10.3390/ijms20123027 VL - 20 ID - 1231 ER - TY - JOUR AD - S.A. Mousa, The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, United States AU - Pastor, E. R. AU - Mousa, S. A. C1 - 131I MIBG ap 26113(Ariad) asp 3026(Astellas) azd 3463(Astra Zeneca) ch 5424802(Chugai) hu 1418k 322a i bet 151 jq 1 ldk 378(Novartis) mg 132 mln 8237 otx 015 pf 02341066(Pfizer) pf 06463922(Pfizer) unituxin x 396(Betta) C2 - Ariad Astellas Astra Zeneca Betta Chugai Novartis Pfizer DB - Embase Medline DO - 10.1016/j.critrevonc.2019.03.013 LA - English M3 - Review N1 - L2001782543 2019-04-09 2019-04-11 PY - 2019 SN - 1879-0461 1040-8428 SP - 38-43 ST - Current management of neuroblastoma and future direction T2 - Critical Reviews in Oncology/Hematology TI - Current management of neuroblastoma and future direction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001782543&from=export http://dx.doi.org/10.1016/j.critrevonc.2019.03.013 VL - 138 ID - 1232 ER - TY - JOUR AD - J. Luo, Department of Orthopedics, Henan Provincial People's Hospital, 7 Weiwu Road, Zhengzhou, Henan, China AU - Gao, S. AU - Wang, J. AU - Tian, S. AU - Luo, J. DB - Embase Medline DO - 10.3892/ijo.2019.4783 IS - 6 LA - English M3 - Article N1 - L2001865335 2019-05-14 PY - 2019 SN - 1791-2423 1019-6439 SP - 1921-1932 ST - MiR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16 T2 - International Journal of Oncology TI - MiR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001865335&from=export http://dx.doi.org/10.3892/ijo.2019.4783 VL - 54 ID - 1233 ER - TY - JOUR AD - R. Gruber, Department of Oral Biology, Medical University of Vienna, Austria, Sensengasse 2a, Vienna, Austria AU - Panahipour, L. AU - Kochergina, E. AU - Kreissl, A. AU - Haiden, N. AU - Gruber, R. DB - Embase DO - 10.1016/j.cytox.2019.100009 IS - 2 LA - English M3 - Article N1 - L2002307035 2019-07-19 2019-07-25 PY - 2019 SN - 2590-1532 ST - Milk modulates macrophage polarization in vitro T2 - Cytokine: X TI - Milk modulates macrophage polarization in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002307035&from=export http://dx.doi.org/10.1016/j.cytox.2019.100009 VL - 1 ID - 1234 ER - TY - JOUR AD - J. Tan, Center for Medical Genetics and School of Life Science, Central South University, Changsha, China AU - Cai, M. AU - Li, S. AU - Shuai, Y. AU - Li, J. AU - Tan, J. AU - Zeng, Q. DB - Embase Medline DO - 10.1002/jcp.27595 IS - 6 LA - English M3 - Article N1 - L624408565 2018-10-23 2019-05-14 PY - 2019 SN - 1097-4652 0021-9541 SP - 9184-9193 ST - Genome-wide CRISPR-Cas9 viability screen reveals genes involved in TNF-α-induced apoptosis of human umbilical vein endothelial cells T2 - Journal of Cellular Physiology TI - Genome-wide CRISPR-Cas9 viability screen reveals genes involved in TNF-α-induced apoptosis of human umbilical vein endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624408565&from=export http://dx.doi.org/10.1002/jcp.27595 VL - 234 ID - 1235 ER - TY - JOUR AD - C.C. Gomes, Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil AU - Coura, B. P. AU - Bernardes, V. F. AU - de Sousa, S. F. AU - França, J. A. AU - Pereira, N. B. AU - Pontes, H. A. R. AU - Batista, A. C. AU - da Cruz Perez, D. E. AU - Albuquerque Junior, R. L. C. AU - de Souza, L. B. AU - Martins, M. D. AU - Diniz, M. G. AU - Gomez, R. S. AU - Gomes, C. C. DB - Embase Medline DO - 10.1038/s41379-018-0194-4 IS - 6 LA - English M3 - Article N1 - L625984703 2019-01-22 2019-06-26 PY - 2019 SN - 1530-0285 0893-3952 SP - 799-806 ST - KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features T2 - Modern Pathology TI - KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625984703&from=export http://dx.doi.org/10.1038/s41379-018-0194-4 VL - 32 ID - 1236 ER - TY - JOUR AD - M.L. Metzger, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States AU - Metzger, M. L. AU - Mauz-Körholz, C. C1 - sb 1518 DB - Embase Medline DO - 10.1111/bjh.15789 IS - 6 LA - English M3 - Review N1 - L626328024 2019-02-16 2019-06-18 PY - 2019 SN - 1365-2141 0007-1048 SP - 1142-1157 ST - Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma T2 - British Journal of Haematology TI - Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626328024&from=export http://dx.doi.org/10.1111/bjh.15789 VL - 185 ID - 1238 ER - TY - JOUR AD - L.S. Sherman, Division of Neuroscience, Oregon National Primate Research Center, and Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, United States AU - Ferner, R. E. AU - Bakker, A. AU - Elgersma, Y. AU - Evans, D. G. R. AU - Giovannini, M. AU - Legius, E. AU - Lloyd, A. AU - Messiaen, L. M. AU - Plotkin, S. AU - Reilly, K. M. AU - Schindeler, A. AU - Smith, M. J. AU - Ullrich, N. J. AU - Widemann, B. AU - Sherman, L. S. C1 - azd 2014 mln 4924 pd 0325901 DB - Embase Medline DO - 10.1002/ajmg.a.61112 IS - 6 LA - English M3 - Conference Paper N1 - L626923732 2019-04-01 2019-05-15 PY - 2019 SN - 1552-4833 1552-4825 SP - 1098-1106 ST - From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis T2 - American Journal of Medical Genetics, Part A TI - From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626923732&from=export http://dx.doi.org/10.1002/ajmg.a.61112 VL - 179 ID - 1240 ER - TY - JOUR AD - K.A. Rauen, Department of Pediatics, Division of Genomic Medicine, University of California Davis, Sacramento, CA, United States AU - Rauen, K. A. AU - Alsaegh, A. AU - Ben-Shachar, S. AU - Berman, Y. AU - Blakeley, J. AU - Cordeiro, I. AU - Elgersma, Y. AU - Evans, D. G. AU - Fisher, M. J. AU - Frayling, I. M. AU - George, J. AU - Huson, S. M. AU - Kerr, B. AU - Khire, U. AU - Korf, B. AU - Legius, E. AU - Messiaen, L. AU - van Minkelen, R. AU - Nampoothiri, S. AU - Ngeow, J. AU - Parada, L. F. AU - Phadke, S. AU - Pillai, A. AU - Plotkin, S. R. AU - Puri, R. AU - Raji, A. AU - Ramesh, V. AU - Ratner, N. AU - Shankar, S. P. AU - Sharda, S. AU - Tambe, A. AU - Vikkula, M. AU - Widemann, B. C. AU - Wolkenstein, P. AU - Upadhyaya, M. DB - Embase Medline DO - 10.1002/ajmg.a.61125 IS - 6 LA - English M3 - Conference Paper N1 - L626924414 2019-04-01 2019-05-15 PY - 2019 SN - 1552-4833 1552-4825 SP - 1091-1097 ST - First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics T2 - American Journal of Medical Genetics, Part A TI - First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626924414&from=export http://dx.doi.org/10.1002/ajmg.a.61125 VL - 179 ID - 1241 ER - TY - JOUR AD - M. Kudek, Medical College of Wisconsin, Milwaukee, WI, United States AU - Kudek, M. AU - Knipstein, J. AU - Zimbric, K. AU - Schloemer, N. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305566 2019-05-14 PY - 2019 SN - 1545-5017 SP - S105-S106 ST - Mek-ing a plan to treat NF: Safe delivery of mek inhibitors for inoperable plexiform neurofibromas T2 - Pediatric Blood and Cancer TI - Mek-ing a plan to treat NF: Safe delivery of mek inhibitors for inoperable plexiform neurofibromas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305566&from=export http://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 1242 ER - TY - JOUR AD - M. Srinivas, Hackensack University Medical Center, Hackensack, NJ, United States AU - Srinivas, M. AU - Burton, A. AU - Bhattacharyya, P. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305601 2019-05-14 PY - 2019 SN - 1545-5017 SP - S78 ST - An 8-year old boy with localized anaplastic large cell lymphoma T2 - Pediatric Blood and Cancer TI - An 8-year old boy with localized anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305601&from=export http://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 1243 ER - TY - JOUR AD - M. Shatara, Children's Hospital of Michigan, Detroit, MI, United States AU - Shatara, M. AU - Knight, T. AU - Altinok, D. AU - Yankelevich, M. AU - Bhmabhani, K. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305696 2019-05-14 PY - 2019 SN - 1545-5017 SP - S112 ST - Mek inhibitor for pediatric low-grade gliomas (LGGS): A single-institution experience T2 - Pediatric Blood and Cancer TI - Mek inhibitor for pediatric low-grade gliomas (LGGS): A single-institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305696&from=export http://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 1244 ER - TY - JOUR AD - F. Mertens, Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden AU - Piarulli, G. AU - Puls, F. AU - Wängberg, B. AU - Fagman, H. AU - Hansson, M. AU - Nilsson, J. AU - Arbajian, E. AU - Mertens, F. DB - Embase Medline DO - 10.1111/his.13839 IS - 7 LA - English M3 - Article N1 - L627470005 2019-05-14 2019-05-21 PY - 2019 SN - 1365-2559 0309-0167 SP - 1098-1102 ST - Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour T2 - Histopathology TI - Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627470005&from=export http://dx.doi.org/10.1111/his.13839 VL - 74 ID - 1245 ER - TY - JOUR AD - F. Liu, Medical College of Xiamen University, Department of Basic Medical Sciences, Medical College, Xiamen University, Fujian Sheng, China AU - Fan, C. AU - Lin, B. AU - Huang, Z. AU - Cui, D. AU - Zhu, M. AU - Ma, Z. AU - Zhang, Y. AU - Liu, F. AU - Liu, Y. DB - Embase IS - 41 LA - English M3 - Article N1 - L628343593 2019-07-05 2019-07-10 PY - 2019 SN - 1949-2553 SP - 4192-4204 ST - MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4 T2 - Oncotarget TI - MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628343593&from=export VL - 10 ID - 1246 ER - TY - JOUR AD - K. Amaro Hosey, Clinical Pharmacology Service, Vall d'Hebron University Hospital, Barcelona, Spain AU - Amaro Hosey, K. AU - Danés Carreras, I. AU - Vendrell Bosch, L. AU - Cereza García, G. AU - RenedoMiró, B. AU - Alonso García, L. AU - Dapena Díaz, J. L. AU - Gros Subías, L. AU - Diogène Fadini, E. DB - Embase DO - 10.1007/s00228-019-02685-2 LA - English M3 - Conference Abstract N1 - L628798457 2019-08-08 PY - 2019 SN - 1432-1041 SP - S23 ST - Adverse reactions to drugs of special interest in a pediatric oncohematology service T2 - European Journal of Clinical Pharmacology TI - Adverse reactions to drugs of special interest in a pediatric oncohematology service UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628798457&from=export http://dx.doi.org/10.1007/s00228-019-02685-2 VL - 75 ID - 1247 ER - TY - JOUR AD - I. Müller, Institute of Pathology, University Hospital Tübingen, Eberhard-Karls- University of Tübingen, Tübingen, Germany AU - Müller, I. AU - Ramis-Zaldívar, J. AU - Schmidt, J. AU - Egan, C. AU - Gonzalez-Farre, B. AU - Salmeron-Villalobos, J. AU - Mattern, S. AU - Szablewski, V. AU - Dojcinov, S. AU - Chott, A. AU - Copie-Bergman, C. AU - Bonzheim, I. AU - Campo, E. AU - Fend, F. AU - Jaffe, E. S. AU - Salaverria, I. AU - Quintanilla De Fend, L. DB - Embase DO - 10.1002/hon.102_2629 LA - English M3 - Conference Abstract N1 - L628867684 2019-08-14 PY - 2019 SN - 1099-1069 SP - 144-145 ST - Genome wide-analysis of t(14;18)-negative follicular lymphoma T2 - Hematological Oncology TI - Genome wide-analysis of t(14;18)-negative follicular lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628867684&from=export http://dx.doi.org/10.1002/hon.102_2629 VL - 37 ID - 1248 ER - TY - JOUR AD - H. Ahlert, Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, University Hospital Dusseldorf, Dusseldorf, Germany AU - Ahlert, H. AU - Bhatia, S. AU - Sonnichsen, M. AU - Dienstbier, N. AU - Remke, M. AU - Fischer, U. AU - Hauer, J. AU - Borkhardt, A. DB - Embase LA - English M3 - Conference Abstract N1 - L629911706 2019-11-26 PY - 2019 SN - 2572-9241 SP - 762-763 ST - The clinical relevance of indirect myc inhibitors for personalized T-all treatment T2 - HemaSphere TI - The clinical relevance of indirect myc inhibitors for personalized T-all treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629911706&from=export VL - 3 ID - 1249 ER - TY - JOUR AD - K. Ishii, First Department of Internal Medicine, Division of Hematology and Oncology, Kansai Medical University, Osaka, Japan AU - Nakaya, A. AU - Ishii, K. AU - Fujita, S. AU - Satake, A. AU - Nakanishi, T. AU - Azuma, Y. AU - Tsubokura, Y. AU - Saito, R. AU - Konishi, A. AU - Hotta, M. AU - Yoshimura, H. AU - Ito, T. AU - Nomura, S. DB - Embase LA - English M3 - Conference Abstract N1 - L629911914 2019-11-26 PY - 2019 SN - 2572-9241 SP - 933 ST - Retrospective analysis of adolescent and young adult (AYA) with lymphoma in Japan T2 - HemaSphere TI - Retrospective analysis of adolescent and young adult (AYA) with lymphoma in Japan UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629911914&from=export VL - 3 ID - 1250 ER - TY - JOUR AD - X. Luo, Department of Hematology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China AU - Luo, X. AU - Xu, L. AU - Wu, X. AU - Tan, H. AU - Liu, L. DB - Embase DO - 10.1186/s12935-019-0850-x IS - 1 LA - English M3 - Article N1 - L627732111 2019-05-29 2019-06-03 PY - 2019 SN - 1475-2867 ST - Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation T2 - Cancer Cell International TI - Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627732111&from=export http://dx.doi.org/10.1186/s12935-019-0850-x VL - 19 ID - 1251 ER - TY - JOUR AD - C.S. Chim, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong AU - Li, Z. AU - Wong, K. Y. AU - Calin, G. A. AU - Chng, W. J. AU - Chan, G. C. F. AU - Chim, C. S. DB - Embase Medline DO - 10.1186/s13148-019-0669-2 IS - 1 LA - English M3 - Article N1 - L627530849 2019-05-16 2019-05-17 PY - 2019 SN - 1868-7083 1868-7075 ST - Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impact T2 - Clinical Epigenetics TI - Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impact UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627530849&from=export http://dx.doi.org/10.1186/s13148-019-0669-2 VL - 11 ID - 1252 ER - TY - JOUR AD - A. Branco, Departamento de Saúde, Universidade Estadual de Feira de Santana, Av. Transnordestina s/n, Feira de Santana, BA, Brazil AU - Reis, I. M. A. AU - Conceição, R. S. AU - Ferreira, R. S. AU - dos Santos, C. C. AU - da Silva, G. R. AU - de Mattos Oliveira, L. AU - Cassiano, D. S. A. AU - dos Santos Junior, M. C. AU - Botura, M. B. AU - da Silva, V. D. A. AU - Costa, S. L. AU - da Silva, T. M. S. AU - Vieira, I. J. C. AU - Braz-Filho, R. AU - Branco, A. DB - Embase Medline DO - 10.1016/j.bioorg.2019.02.023 LA - English M3 - Article N1 - L2001637033 2019-03-05 2019-03-08 PY - 2019 SN - 1090-2120 0045-2068 SP - 665-673 ST - Alkene lactones from Persea fulva (Lauraceae): Evaluation of their effects on tumor cell growth in vitro and molecular docking studies T2 - Bioorganic Chemistry TI - Alkene lactones from Persea fulva (Lauraceae): Evaluation of their effects on tumor cell growth in vitro and molecular docking studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001637033&from=export http://dx.doi.org/10.1016/j.bioorg.2019.02.023 VL - 86 ID - 1253 ER - TY - JOUR AD - M.J. Kwon, Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 22, Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea AU - Park, H. Y. AU - Kwon, M. J. AU - Kang, H. S. AU - Kim, Y. J. AU - Kim, N. Y. AU - Kim, M. J. AU - Min, K. W. AU - Choi, K. C. AU - Nam, E. S. AU - Cho, S. J. AU - Park, H. R. AU - Min, S. K. AU - Seo, J. AU - Choe, J. Y. AU - Lee, H. K. DB - Embase Medline DO - 10.1016/j.humpath.2019.02.007 LA - English M3 - Article N1 - L2001796467 2019-04-16 2019-04-18 PY - 2019 SN - 1532-8392 0046-8177 SP - 83-94 ST - Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets T2 - Human Pathology TI - Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001796467&from=export http://dx.doi.org/10.1016/j.humpath.2019.02.007 VL - 87 ID - 1254 ER - TY - JOUR AD - C. Li, Department of Pediatric Surgery, Maternal and Child Health Care, Hospital of Qujing, 371 Liaokuo South Road, Qujing, Yunnan, China AU - Yu, X. AU - Li, C. DB - Embase Medline DO - 10.3892/mmr.2019.10113 IS - 5 LA - English M3 - Article N1 - L2001807120 2019-04-17 2019-08-22 PY - 2019 SN - 1791-3004 1791-2997 SP - 4507-4513 ST - Protective effects of propofol on experimental neonatal acute lung injury T2 - Molecular Medicine Reports TI - Protective effects of propofol on experimental neonatal acute lung injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001807120&from=export http://dx.doi.org/10.3892/mmr.2019.10113 VL - 49 ID - 1255 ER - TY - JOUR AU - Wataya-Kaneda, M. AU - Nakamura, A. AU - Watanabe, Y. AU - Katayama, I. DB - Embase DO - 10.1016/j.jid.2019.03.630 IS - 5 LA - English M3 - Conference Abstract N1 - L2001808588 2019-04-16 PY - 2019 SN - 1523-1747 0022-202X SP - S95 ST - 554 Sirolimus gel effectively reduced neurofibromas in neurofibromatosis type 1 in a double-blind, placebo-controlled, randomized clinical trial T2 - Journal of Investigative Dermatology TI - 554 Sirolimus gel effectively reduced neurofibromas in neurofibromatosis type 1 in a double-blind, placebo-controlled, randomized clinical trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001808588&from=export http://dx.doi.org/10.1016/j.jid.2019.03.630 VL - 139 ID - 1256 ER - TY - JOUR AU - Chen, W. AU - Twaroski, K. AU - Pickett-Leonard, M. AU - Tolar, J. DB - Embase DO - 10.1016/j.jid.2019.03.215 IS - 5 LA - English M3 - Conference Abstract N1 - L2001808820 2019-04-16 PY - 2019 SN - 1523-1747 0022-202X SP - S24 ST - 139 Transforming growth factor-β1 secreted by dermal fibroblasts induces an epithelial-to-mesenchymal transition in recessive dystrophic epidermolysis bullosa squamous cell carcinoma T2 - Journal of Investigative Dermatology TI - 139 Transforming growth factor-β1 secreted by dermal fibroblasts induces an epithelial-to-mesenchymal transition in recessive dystrophic epidermolysis bullosa squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001808820&from=export http://dx.doi.org/10.1016/j.jid.2019.03.215 VL - 139 ID - 1257 ER - TY - JOUR AD - K.T.E. Chang, Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital, Singapore, Singapore AU - Chang, K. T. E. AU - Tay, A. Z. E. AU - Kuick, C. H. AU - Chen, H. AU - Algar, E. AU - Taubenheim, N. AU - Campbell, J. AU - Mechinaud, F. AU - Campbell, M. AU - Super, L. AU - Chantranuwat, C. AU - Yuen, S. T. AU - Chan, J. K. C. AU - Chow, C. W. DB - Embase Medline DO - 10.1038/s41379-018-0168-6 IS - 5 LA - English M3 - Article N1 - L625590795 2018-12-27 2019-05-14 PY - 2019 SN - 1530-0285 0893-3952 SP - 598-608 ST - ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion T2 - Modern Pathology TI - ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625590795&from=export http://dx.doi.org/10.1038/s41379-018-0168-6 VL - 32 ID - 1258 ER - TY - JOUR AD - A.B. Schrock, Foundation Medicine, Inc., Cambridge, MA, United States AU - Boussemart, L. AU - Nelson, A. AU - Wong, M. AU - Ross, J. S. AU - Sosman, J. AU - Mehnert, J. AU - Daniels, G. AU - Kendra, K. AU - Ali, S. M. AU - Miller, V. A. AU - Schrock, A. B. DB - Embase Medline DO - 10.1634/theoncologist.2018-0271 IS - 5 LA - English M3 - Review N1 - L626128153 2019-02-01 2019-05-28 PY - 2019 SN - 1549-490X 1083-7159 SP - 657-663 ST - Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing T2 - Oncologist TI - Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626128153&from=export http://dx.doi.org/10.1634/theoncologist.2018-0271 VL - 24 ID - 1259 ER - TY - JOUR AD - B. Hallberg, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden AU - Umapathy, G. AU - Mendoza-Garcia, P. AU - Hallberg, B. AU - Palmer, R. H. C1 - nvp tae 684 DB - Embase Medline DO - 10.1111/apm.12940 IS - 5 LA - English M3 - Review N1 - L627061362 2019-04-09 2019-06-17 PY - 2019 SN - 1600-0463 0903-4641 SP - 288-302 ST - Targeting anaplastic lymphoma kinase in neuroblastoma T2 - APMIS TI - Targeting anaplastic lymphoma kinase in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627061362&from=export http://dx.doi.org/10.1111/apm.12940 VL - 127 ID - 1261 ER - TY - JOUR AD - S.M. Krams, Surgery/Division of Abdominal Transplant, Stanford University, Stanford, CA, United States AU - Krams, S. M. AU - Arvedson, M. AU - Maloney, E. AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. D. AU - Esquivel, C. O. AU - Martinez, O. M. DB - Embase DO - 10.1111/petr.13441 LA - English M3 - Conference Abstract N1 - L627772922 2019-05-28 PY - 2019 SN - 1399-3046 ST - Characterization of genomic alterations in EBV+ PTLD T2 - Pediatric Transplantation TI - Characterization of genomic alterations in EBV+ PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627772922&from=export http://dx.doi.org/10.1111/petr.13441 VL - 23 ID - 1262 ER - TY - JOUR AU - Aftab, S. AU - Dattani, M. T. DB - Medline DO - 10.17458/per.vol16.2019.ad.pathogenesisrasopathies LA - English M3 - Article N1 - L627933403 2019-06-11 2019-06-14 PY - 2019 SN - 1565-4753 SP - 447-458 ST - Pathogenesis of Growth Failure in Rasopathies T2 - Pediatric endocrinology reviews : PER TI - Pathogenesis of Growth Failure in Rasopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627933403&from=export http://dx.doi.org/10.17458/per.vol16.2019.ad.pathogenesisrasopathies VL - 16 ID - 1263 ER - TY - JOUR AD - G.W. Robinson AU - Robinson, G. W. AU - Gajjar, A. J. AU - Gauvain, K. M. AU - Basu, E. M. AU - Macy, M. E. AU - Maese, L. D. AU - Sabnis, A. J. AU - Foster, J. H. AU - Shusterman, S. AU - Yoon, J. AU - Weiss, B. D. AU - Abdelbaki, M. AU - Farid-Kapadia, M. AU - Meneses-Lorente, G. AU - Cardenas, A. AU - Hutchinson, K. AU - Bergthold, G. AU - Maneval, E. C. AU - Fox, E. AU - Desai, A. V. DB - Embase DO - 10.1200/JCO.2019.37.15_suppl.10009 LA - English M3 - Conference Abstract N1 - L629361175 2019-09-24 PY - 2019 SN - 1527-7755 ST - Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors T2 - Journal of Clinical Oncology TI - Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629361175&from=export http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.10009 VL - 37 ID - 1264 ER - TY - JOUR AD - W. Akik, Research Institute, McGill University Health Centre, Montreal, QC, Canada AU - Akik, W. AU - Dauletbaev, N. AU - Lands, L. C. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L630354941 2020-01-01 PY - 2019 SN - 1535-4970 ST - Mechanisms underlying corticosteroid insensitivity induction by interleukin-17A in bronchial epithelial cells T2 - American Journal of Respiratory and Critical Care Medicine TI - Mechanisms underlying corticosteroid insensitivity induction by interleukin-17A in bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630354941&from=export VL - 199 ID - 1265 ER - TY - JOUR AD - L. Winnicka, NYU Winthrop University Hospital, Mineola, NY, United States AU - Winnicka, L. AU - Gour, A. C. AU - Spier, L. AU - Thomas, S. V. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L630355929 2020-01-01 PY - 2019 SN - 1535-4970 ST - An inflammatory myofibroblastic tumor masquerading as a bronchopulmonary sequestration T2 - American Journal of Respiratory and Critical Care Medicine TI - An inflammatory myofibroblastic tumor masquerading as a bronchopulmonary sequestration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630355929&from=export VL - 199 ID - 1266 ER - TY - JOUR AD - S. Chen, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, China AU - Wen, L. AU - Xu, Y. AU - Yao, L. AU - Wang, N. AU - Wang, Q. AU - Liu, T. AU - Pan, J. AU - Cen, J. AU - Zhou, H. AU - Miao, M. AU - Shao, Y. W. AU - Wang, X. AU - Wang, X. AU - Ruan, C. AU - Wu, D. AU - Chen, S. DB - Embase Medline DO - 10.3324/haematol.2018.205369 IS - 5 LA - English M3 - Letter N1 - L2002006551 2019-07-10 2019-07-15 PY - 2019 SN - 1592-8721 0390-6078 SP - e195-e199 ST - Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions T2 - Haematologica TI - Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002006551&from=export http://dx.doi.org/10.3324/haematol.2018.205369 VL - 104 ID - 1267 ER - TY - JOUR AD - V. Leventaki, Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States AU - Graetz, D. AU - Crews, K. R. AU - Azzato, E. M. AU - Singh, R. K. AU - Raimondi, S. AU - Mason, J. AU - Valentine, M. AU - Mullighan, C. G. AU - Holland, A. AU - Inaba, H. AU - Leventaki, V. DB - Embase Medline DO - 10.3324/haematol.2018.215103 IS - 5 LA - English M3 - Article N1 - L2002006557 2019-07-10 2019-07-15 PY - 2019 SN - 1592-8721 0390-6078 SP - e218-e221 ST - Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib T2 - Haematologica TI - Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002006557&from=export http://dx.doi.org/10.3324/haematol.2018.215103 VL - 104 ID - 1268 ER - TY - JOUR AD - A. Guo, Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Nantong, China AU - Zhang, Y. AU - Zhou, Y. AU - Chen, S. AU - Hu, Y. AU - Zhu, Z. AU - Wang, Y. AU - Du, N. AU - Song, T. AU - Yang, Y. AU - Guo, A. AU - Wang, Y. DB - Embase Medline DO - 10.1186/s12974-019-1468-6 IS - 1 LA - English M3 - Article N1 - L627186321 2019-05-14 PY - 2019 SN - 1742-2094 ST - Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury T2 - Journal of Neuroinflammation TI - Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627186321&from=export http://dx.doi.org/10.1186/s12974-019-1468-6 VL - 16 ID - 1269 ER - TY - JOUR AD - M.S. Lan, Louisiana State University Health Sciences Center, CSRB Box, 533 Bolivar St., New Orleans, LA, United States AU - Chen, C. AU - Breslin, M. B. AU - Guidry, J. J. AU - Lan, M. S. DB - Embase Medline DO - 10.1074/jbc.RA118.006761 IS - 14 LA - English M3 - Article N1 - L2001816090 2019-05-14 2020-04-07 PY - 2019 SN - 1083-351X 0021-9258 SP - 5456-5465 ST - 5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth T2 - Journal of Biological Chemistry TI - 5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001816090&from=export http://dx.doi.org/10.1074/jbc.RA118.006761 VL - 294 ID - 1270 ER - TY - JOUR AD - C.-Y. Cheng, Graduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine and Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, 261 Wen-Hwa 1st Road, Guishan Dist., Taoyuan City, Taiwan AU - Cheng, S. C. AU - Wu, Y. H. AU - Huang, W. C. AU - Pang, J. H. S. AU - Huang, T. H. AU - Cheng, C. Y. C1 - bay 11 7082(Enzo Life Sciences,United States) sp 600125(Enzo Life Sciences,United States) u 0126(Enzo Life Sciences,United States) C2 - Biotic Chemical(Taiwan) Enzo Life Sciences(United States) DB - Embase Medline DO - 10.1016/j.cyto.2019.01.001 LA - English M3 - Article N1 - L2001490388 2019-01-29 2019-02-06 PY - 2019 SN - 1096-0023 1043-4666 SP - 48-60 ST - Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells T2 - Cytokine TI - Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001490388&from=export http://dx.doi.org/10.1016/j.cyto.2019.01.001 VL - 116 ID - 1271 ER - TY - JOUR AD - A. Gácser, Department of Microbiology, University of Szeged Interdisciplinary Excellence Centre, Szeged, Hungary AU - Tóth, R. AU - Nosek, J. AU - Mora-Montes, H. M. AU - Gabaldon, T. AU - Bliss, J. M. AU - Nosanchuk, J. D. AU - Turner, S. A. AU - Butler, G. AU - Vágvölgyi, C. AU - Gácser, A. DB - Embase Medline DO - 10.1128/CMR.00111-18 IS - 2 LA - English M3 - Review N1 - L2001743919 2019-04-17 PY - 2019 SN - 1098-6618 0893-8512 ST - Candida parapsilosis: From genes to the bedside T2 - Clinical Microbiology Reviews TI - Candida parapsilosis: From genes to the bedside UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001743919&from=export http://dx.doi.org/10.1128/CMR.00111-18 VL - 32 ID - 1273 ER - TY - JOUR AD - W.S. Park, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea AU - Sung, D. K. AU - Chang, Y. S. AU - Sung, S. I. AU - Ahn, S. Y. AU - Park, W. S. DB - Embase DO - 10.3390/jcm8040533 IS - 4 LA - English M3 - Article N1 - L2002182741 2019-08-20 2019-08-22 PY - 2019 SN - 2077-0383 ST - Thrombin preconditioning of extracellular vesicles derived from mesenchymal stem cells accelerates cutaneous wound healing by boosting their biogenesis and enriching cargo content T2 - Journal of Clinical Medicine TI - Thrombin preconditioning of extracellular vesicles derived from mesenchymal stem cells accelerates cutaneous wound healing by boosting their biogenesis and enriching cargo content UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002182741&from=export http://dx.doi.org/10.3390/jcm8040533 VL - 8 ID - 1274 ER - TY - JOUR AD - X. Fang, Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China AU - Jie, Z. AU - Xie, Z. AU - Zhao, X. AU - Sun, X. AU - Yu, H. AU - Pan, X. AU - Shen, S. AU - Qin, A. AU - Fang, X. AU - Fan, S. DB - Embase Medline DO - 10.1002/jcp.27171 IS - 4 LA - English M3 - Article N1 - L623674344 2018-09-04 2019-01-11 PY - 2019 SN - 1097-4652 0021-9541 SP - 4167-4178 ST - Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB–AP1 complexes formation T2 - Journal of Cellular Physiology TI - Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB–AP1 complexes formation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623674344&from=export http://dx.doi.org/10.1002/jcp.27171 VL - 234 ID - 1275 ER - TY - JOUR AD - G. Mugundu, Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States AU - Farha, M. AU - Masson, E. AU - Tomkinson, H. AU - Mugundu, G. DB - Embase Medline DO - 10.1002/jcph.1351 IS - 4 LA - English M3 - Review N1 - L625410613 2018-12-17 2019-03-25 PY - 2019 SN - 1552-4604 0091-2700 SP - 463-471 ST - Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology T2 - Journal of Clinical Pharmacology TI - Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625410613&from=export http://dx.doi.org/10.1002/jcph.1351 VL - 59 ID - 1276 ER - TY - JOUR AD - K.M. Boycott, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada AU - Boycott, K. M. AU - Innes, A. M. DB - Embase Medline DO - 10.1002/ajmg.a.61063 IS - 4 LA - English M3 - Conference Paper N1 - L626328495 2019-02-16 2019-03-20 PY - 2019 SN - 1552-4833 1552-4825 SP - 674-746 ST - 39th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2018 Annual Meeting T2 - American Journal of Medical Genetics, Part A TI - 39th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2018 Annual Meeting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626328495&from=export http://dx.doi.org/10.1002/ajmg.a.61063 VL - 179 ID - 1277 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Policlinico San Martino, Genova, Italy AU - Demichelis, C. AU - Lapucci, C. AU - Zuppa, A. AU - Grisanti, S. AU - Genova, C. AU - Queirolo, P. AU - Schenone, A. AU - Grandis, M. AU - Benedetti, L. DB - Embase DO - 10.1111/jns.12312 LA - English M3 - Conference Abstract N1 - L627391002 2019-05-14 PY - 2019 SN - 1529-8027 SP - S18 ST - Neuromuscular complications following targeted therapy in cancer patients T2 - Journal of the Peripheral Nervous System TI - Neuromuscular complications following targeted therapy in cancer patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627391002&from=export http://dx.doi.org/10.1111/jns.12312 VL - 24 ID - 1279 ER - TY - JOUR AD - N. Manoharan, Dana Farber Cancer Institute/Boston Children's Cancer and Blood Disorder Center, Boston, MA, United States AU - Manoharan, N. AU - Choi, J. AU - Chordas, C. AU - Zimmerman, M. A. AU - Scully, J. AU - Clymer, J. AU - Ullrich, N. J. AU - Filbin, M. AU - Bandopadhayay, P. AU - Chi, S. AU - Yeo, K. K. DB - Embase DO - 10.1093/neuonc/noz036.155 LA - English M3 - Conference Abstract N1 - L628910984 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA101 ST - Trametinib for the treatment of recurrent/progressive pediatric low grade glioma: A single institution experience T2 - Neuro-Oncology TI - Trametinib for the treatment of recurrent/progressive pediatric low grade glioma: A single institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628910984&from=export http://dx.doi.org/10.1093/neuonc/noz036.155 VL - 21 ID - 1280 ER - TY - JOUR AD - P. Jain, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Jain, P. AU - Surrey, L. F. AU - Zhang, B. AU - Straka, J. AU - Zhao, X. AU - Storm, P. B. AU - Resnick, A. C. AU - Harding, B. N. AU - Li, M. M. AU - Buccoliero, A. M. AU - Santi, M. AU - Waanders, A. J. DB - Embase DO - 10.1093/neuonc/noz036.157 LA - English M3 - Conference Abstract N1 - L628911026 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA102 ST - The genetic landscape of dysembryoplastic neuroepithelial tumors T2 - Neuro-Oncology TI - The genetic landscape of dysembryoplastic neuroepithelial tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628911026&from=export http://dx.doi.org/10.1093/neuonc/noz036.157 VL - 21 ID - 1281 ER - TY - JOUR AD - J. Fangusaro, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, United States AU - Fangusaro, J. AU - Onar-Thomas, A. AU - Poussaint, T. Y. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. AU - Banerjee, A. AU - Packer, R. J. AU - Kilburn, L. B. AU - Goldman, S. AU - Pollack, I. F. AU - Jakacki, R. I. AU - Qaddoumi, I. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. AU - Kreissman, S. G. AU - Stewart, C. F. AU - Jones, D. T. W. AU - Pfster, S. M. AU - Vezina, G. AU - Stern, J. S. AU - Panigrahy, A. AU - Jones, B. V. AU - Patay, Z. AU - Tamrazi, B. AU - Jones, J. Y. AU - Haque, S. S. AU - Enterline, D. S. AU - Cha, S. AU - Fisher, M. J. AU - Doyle, A. AU - Smith, M. AU - Fouladi, M. AU - Dunkel, I. J. DB - Embase DO - 10.1093/neuonc/noz036.145 LA - English M3 - Conference Abstract N1 - L628912312 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA98-AA99 ST - A phase ii prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (PLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B T2 - Neuro-Oncology TI - A phase ii prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (PLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628912312&from=export http://dx.doi.org/10.1093/neuonc/noz036.145 VL - 21 ID - 1282 ER - TY - JOUR AD - Z. Reitman, Dana-Farber Cancer Institute, Boston, MA, United States AU - Reitman, Z. AU - Paolella, B. AU - Bergthold, G. AU - Pelton, K. AU - Becker, S. AU - Jones, R. AU - Sinai, C. AU - Malkin, H. AU - Huang, Y. AU - Grimmet, L. AU - Herbert, Z. AU - Sun, Y. AU - Weatherbee, J. AU - Qian, K. AU - Condurat, A. L. AU - Alberta, J. AU - Daley, J. AU - Rozenblatt-Rozen, O. AU - Segal, R. AU - Haas-Kogan, D. AU - Filbin, M. AU - Suva, M. AU - Regev, A. AU - Stiles, C. AU - Kieran, M. AU - Goumnerova, L. AU - Ligon, K. AU - Shalek, A. AU - Beroukhim, R. AU - Bandopadhayay, P. DB - Embase DO - 10.1093/neuonc/noz036.148 LA - English M3 - Conference Abstract N1 - L628912489 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA99 ST - Single cell RNA sequencing reveals mitogenic and progenitor gene programs in braf-rearranged pilocytic astrocytomas T2 - Neuro-Oncology TI - Single cell RNA sequencing reveals mitogenic and progenitor gene programs in braf-rearranged pilocytic astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628912489&from=export http://dx.doi.org/10.1093/neuonc/noz036.148 VL - 21 ID - 1283 ER - TY - JOUR AD - P. Hardy, Department of Pediatrics, Physiology and Pharmacology Research Center of CHU Sainte-Justine, 3175 Côte-Sainte-Catherine, Room 2714, Montréal, QC, Canada AU - Tabatabaei, S. N. AU - Derbali, R. M. AU - Yang, C. AU - Superstein, R. AU - Hamel, P. AU - Chain, J. L. AU - Hardy, P. C1 - mirvana(Life Technologies) C2 - alkeran(Canada) Life Technologies DB - Embase Medline DO - 10.1016/j.jconrel.2019.02.014 LA - English M3 - Article N1 - L2001603128 2019-02-26 2019-03-05 PY - 2019 SN - 1873-4995 0168-3659 SP - 177-185 ST - Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma T2 - Journal of Controlled Release TI - Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001603128&from=export http://dx.doi.org/10.1016/j.jconrel.2019.02.014 VL - 298 ID - 1284 ER - TY - JOUR AD - A. Xuan, Institute of Neuroscience, Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Lab. of Neurogenetics and Channelopathies of Guangdong Prov. and the Min. of Education of China, Guangzhou, China AU - Gong, Z. AU - Huang, J. AU - Xu, B. AU - Ou, Z. AU - Zhang, L. AU - Lin, X. AU - Ye, X. AU - Kong, X. AU - Long, D. AU - Sun, X. AU - He, X. AU - Xu, L. AU - Li, Q. AU - Xuan, A. C2 - Standard Laboratories(China) DB - Embase Medline DO - 10.1186/s12974-019-1450-3 IS - 1 LA - English M3 - Article N1 - L626758927 2019-03-22 2019-08-02 PY - 2019 SN - 1742-2094 ST - Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice T2 - Journal of Neuroinflammation TI - Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626758927&from=export http://dx.doi.org/10.1186/s12974-019-1450-3 VL - 16 ID - 1285 ER - TY - JOUR AD - J. Fanburg-Smith, Penn State Health Milton S. Hershey Medical Center, McLean, VA, United States AU - Fanburg-Smith, J. AU - Reinhard, H. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631813260 2020-05-26 PY - 2019 SN - 1530-0285 ST - Deep juvenile xanthogranuloma harbors BRAF V600E mutation similar to other histiocytic lesions T2 - Modern Pathology TI - Deep juvenile xanthogranuloma harbors BRAF V600E mutation similar to other histiocytic lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631813260&from=export VL - 32 ID - 1288 ER - TY - JOUR AD - P. Bandopadhayay, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Department of Pediatric Neuro-Oncology, 450 Brookline Ave, Boston, MA, United States AU - Clymer, J. AU - Bandopadhayay, P. DB - Embase Medline DO - 10.1093/neuonc/noy188 IS - 2 LA - English M3 - Editorial N1 - L626566412 2019-03-06 2019-03-07 PY - 2019 SN - 1523-5866 1522-8517 SP - 143-145 ST - Old meet new-the path to combination treatments in pediatric low-grade gliomas T2 - Neuro-Oncology TI - Old meet new-the path to combination treatments in pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626566412&from=export http://dx.doi.org/10.1093/neuonc/noy188 VL - 21 ID - 1290 ER - TY - JOUR AD - Y. Zhong, Department of hematology, Zhumadian Central Hospital, No. 747 Zhonghua Road, Zhumadian, Henan, China AU - Zhong, Y. AU - Zhang, Y. AU - Ma, D. AU - Ren, X. AU - Xu, C. AU - Wan, D. DB - Embase Medline DO - 10.1016/j.lfs.2018.12.011 LA - English M3 - Article N1 - L2001386093 2018-12-21 2019-04-08 PY - 2019 SN - 1879-0631 0024-3205 SP - 1-7 ST - Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2 T2 - Life Sciences TI - Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001386093&from=export http://dx.doi.org/10.1016/j.lfs.2018.12.011 VL - 218 ID - 1291 ER - TY - JOUR AU - Karunanithi, J. AU - Hong, K. C. AU - Yi, C. H. AU - Sittampalam, K. DB - Embase DO - 10.1016/j.pathol.2018.12.223 LA - English M3 - Conference Abstract N1 - L2001470507 2019-02-06 PY - 2019 SN - 1465-3931 0031-3025 SP - S86 ST - Inflammatory myofibroblastic tumour; a case report with a unique ROS1 fusion variant T2 - Pathology TI - Inflammatory myofibroblastic tumour; a case report with a unique ROS1 fusion variant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001470507&from=export http://dx.doi.org/10.1016/j.pathol.2018.12.223 VL - 51 ID - 1292 ER - TY - JOUR AD - J.D. Trobe, University of Michigan, 1000 Wall Street, Ann Arbor, MI, United States AU - Tuohy, M. AU - Robertson, P. L. AU - Rivas-Rodriguez, F. AU - Trobe, J. D. DB - Embase Medline DO - 10.3928/01913913-20190801-01 IS - 1 LA - English M3 - Article N1 - L2005919656 2020-06-02 2020-06-15 PY - 2019 SN - 1938-2405 0191-3913 SP - E79-E83 ST - Nystagmus in the diagnosis of Russell diencephalic syndrome T2 - Journal of Pediatric Ophthalmology and Strabismus TI - Nystagmus in the diagnosis of Russell diencephalic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005919656&from=export http://dx.doi.org/10.3928/01913913-20190801-01 VL - 56 ID - 1293 ER - TY - JOUR AD - W. Pan, Department of Pediatrics, The Second Hospital of Jilin University, Changchun, China AU - Xu, X. H. AU - Zhang, S. J. AU - Hu, Q. B. AU - Song, X. Y. AU - Pan, W. DB - Embase DO - 10.1002/jcb.27559 IS - 2 LA - English M3 - Article N1 - L624319485 2018-10-17 2018-12-28 PY - 2019 SN - 1097-4644 0730-2312 SP - 2594-2606 ST - Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway T2 - Journal of Cellular Biochemistry TI - Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624319485&from=export http://dx.doi.org/10.1002/jcb.27559 VL - 120 ID - 1294 ER - TY - JOUR AD - E. Wang AU - Wang, E. AU - Kim, D. W. AU - Mahipal, A. AU - Chen, D. T. AU - Cao, B. AU - Masawi, F. AU - Kim, R. D. DB - Embase LA - English M3 - Conference Abstract N1 - L627163334 2019-04-16 PY - 2019 SN - 1527-7755 ST - Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC) T2 - Journal of Clinical Oncology TI - Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627163334&from=export VL - 37 ID - 1295 ER - TY - JOUR AD - F. Meggetto, Inserm, UMR1037 CRCT, Toulouse, France AU - Hoareau-Aveilla, C. AU - Quelen, C. AU - Congras, A. AU - Caillet, N. AU - Labourdette, D. AU - Dozier, C. AU - Brousset, P. AU - Lamant, L. AU - Meggetto, F. C1 - pd 0332991 C2 - Sigma Aldrich(France) Selleck Chemicals(United States) DB - Embase Medline DO - 10.3324/haematol.2018.195131 IS - 2 LA - English M3 - Article N1 - L2001600606 2019-04-01 2019-04-03 PY - 2019 SN - 1592-8721 0390-6078 SP - 347-359 ST - miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells T2 - Haematologica TI - miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001600606&from=export http://dx.doi.org/10.3324/haematol.2018.195131 VL - 104 ID - 1297 ER - TY - JOUR AD - K. Prabhash, Department of Medical Oncology, TMH, Mumbai, India AU - Joshi, A. AU - Pande, N. AU - Noronha, V. AU - Patil, V. AU - Kumar, R. AU - Chougule, A. AU - Trivedi, V. AU - Janu, A. AU - Mahajan, A. AU - Prabhash, K. DB - Embase DO - 10.3332/ecancer.2019.900 LA - English M3 - Article N1 - L2002842544 2019-09-20 2019-09-25 PY - 2019 SN - 1754-6605 ST - ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes T2 - ecancermedicalscience TI - ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002842544&from=export http://dx.doi.org/10.3332/ecancer.2019.900 VL - 13 ID - 1298 ER - TY - JOUR AD - D.A. Solomon, Department of Pathology, University of California, San Francisco, CA, United States AU - López, G. Y. AU - Van Ziffle, J. AU - Onodera, C. AU - Grenert, J. P. AU - Yeh, I. AU - Bastian, B. C. AU - Clarke, J. AU - Oberheim Bush, N. A. AU - Taylor, J. AU - Chang, S. AU - Butowski, N. AU - Banerjee, A. AU - Mueller, S. AU - Kline, C. AU - Torkildson, J. AU - Samuel, D. AU - Siongco, A. AU - Raffel, C. AU - Gupta, N. AU - Kunwar, S. AU - Mummaneni, P. AU - Aghi, M. AU - Theodosopoulos, P. AU - Berger, M. AU - Phillips, J. J. AU - Pekmezci, M. AU - Tihan, T. AU - Bollen, A. W. AU - Perry, A. AU - Solomon, D. A. DB - Embase Medline DO - 10.1007/s00401-018-1906-z IS - 1 LA - English M3 - Article N1 - L623846105 2018-09-17 2019-01-31 PY - 2019 SN - 1432-0533 0001-6322 SP - 139-150 ST - The genetic landscape of gliomas arising after therapeutic radiation T2 - Acta Neuropathologica TI - The genetic landscape of gliomas arising after therapeutic radiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623846105&from=export http://dx.doi.org/10.1007/s00401-018-1906-z VL - 137 ID - 1301 ER - TY - JOUR AD - Y. Zhou, Department of Clinical Laboratory, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin's Clinical Research Center for Cancer, Tianjin, China AU - Liu, X. AU - Zhang, L. AU - Tong, Y. AU - Yu, M. AU - Wang, M. AU - Dong, D. AU - Shao, J. AU - Zhang, F. AU - Niu, R. AU - Zhou, Y. DB - Embase Medline DO - 10.1016/j.lfs.2018.11.057 LA - English M3 - Article N1 - L2001353236 2018-12-10 2018-12-11 PY - 2019 SN - 1879-0631 0024-3205 SP - 57-69 ST - MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα T2 - Life Sciences TI - MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001353236&from=export http://dx.doi.org/10.1016/j.lfs.2018.11.057 VL - 217 ID - 1302 ER - TY - JOUR AD - Y. Wei, Department of Gastrointestinal Surgery, Huzhou Central Hospital (Zhejiang University Huzhou Hospital), No. 198 Hongqi Road, Huzhou, China AU - Wei, Y. AU - Shao, J. AU - Wang, Y. AU - Shen, H. AU - Yu, S. AU - Zhang, J. AU - Yin, L. DB - Embase Medline DO - 10.1007/s11010-018-3382-0 IS - 1-2 LA - English M3 - Article N1 - L622664477 2018-06-26 2019-01-24 PY - 2019 SN - 1573-4919 0300-8177 SP - 159-166 ST - Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells T2 - Molecular and Cellular Biochemistry TI - Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622664477&from=export http://dx.doi.org/10.1007/s11010-018-3382-0 VL - 450 ID - 1303 ER - TY - JOUR AD - A. Bolhassani, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran AU - Naderi, N. AU - Yousefi, H. AU - Mollazadeh, S. AU - Seyed Mikaeili, A. AU - Keshavarz Norouzpour, M. AU - Jazebi, M. AU - Moazezi Nekooi Asl, S. S. AU - Namvar, A. AU - Azizi Saraji, A. AU - Agi, E. AU - Bolhassani, A. DB - Embase Medline DO - 10.1080/08880018.2019.1585503 IS - 1 LA - English M3 - Article N1 - L626831829 2019-03-26 2019-05-20 PY - 2019 SN - 1521-0669 0888-0018 SP - 28-39 ST - Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients T2 - Pediatric Hematology and Oncology TI - Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626831829&from=export http://dx.doi.org/10.1080/08880018.2019.1585503 VL - 36 ID - 1304 ER - TY - JOUR AD - T.L. Ng, University of Colorado, Division of Medical Oncology, 12801 E 17th Ave, 8122, 8th Floor, Aurora, CO, United States AU - Ng, T. L. AU - Yu, H. AU - Smith, D. E. AU - Boyle, T. A. AU - York, E. R. AU - Leedy, S. AU - Gao, D. AU - Aisner, D. L. AU - Van Bokhoven, A. AU - Heasley, L. E. AU - Hirsch, F. R. AU - Camidge, D. R. DB - Embase Medline DO - 10.1016/j.cllc.2018.09.001 IS - 1 LA - English M3 - Article N1 - L2001157576 2018-10-15 2019-01-03 Introduction: Preclinically, high epidermal growth factor receptor 1 (FGFR1) messenger RNA (FGFR1-MRNA) and FGFR1 amplification (FGFR1-AMP) predicted sensitivity to fibroblast growth factor receptor inhibitors in non–small-cell lung cancer and small-cell lung cancer cell lines. KRAS mutations did not preclude sensitivity. Patients and Methods: Metastatic EGFR- and ALK-negative lung cancers were screened for FGFR1-MRNA by in-situ hybridization (ISH) and FGFR1-AMP by silver in-situ hybridization (SISH). Patients with positive findings were offered ponatinib, a multi–kinase inhibitor of FGFR1-4. Differences in overall survival (OS) between cohorts were assessed by the log-rank test. Association of FGFR1 positivity with clinicopathologic features were assessed by Fisher exact test and Kruskal-Wallis rank sum test. Results: A total of 171 cases were prescreened: 9 (7.3%) of 123 SISH+; 53 (42.1%) of 126 ISH+; and 6 cases concordantly positive for SISH and ISH. SISH+ cases had fewer coincident KRAS mutations (P =.03) than SISH− cases, and ISH+ cases had worse OS (P =.020) than ISH− cases. Data distributions suggested a distinct higher positivity cut point for FGFR1 ISH (≥ 20%), occurring in 29 (23%) of 126 cases, was associated with small-cell lung cancer histology (P =.022), soft tissue metastases (P =.050) and shorter OS (P =.031). Four patients received ponatinib on study: All ISH+ by the initial cut point, 2 of 4 by higher cut point, 1 of 4 SISH+. Tolerability was poor. The best response for the 2 higher ISH cases was stable disease and progressive disease for the 2 lower ISH cases. Conclusion: Elevated FGFR1-MRNA is more common than FGFR1-AMP and associated with worse OS. Higher FGFR1 mRNA expression may be associated with a specific phenotype and is worthy of further exploration. Ponatinib's poor tolerance suggests further fibroblast growth factor receptor exploration in ISH+ cases should utilize more selective FGFR1 inhibitors. PY - 2019 SN - 1938-0690 1525-7304 SP - e39-e51 ST - Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib T2 - Clinical Lung Cancer TI - Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001157576&from=export http://dx.doi.org/10.1016/j.cllc.2018.09.001 VL - 20 ID - 1305 ER - TY - JOUR AD - R. Xue, Neonatal Ward of Department of Pediatrics, Jining No. 1 People's Hospital, No. 6 Jiankang Road, Jining, China AU - Quan, B. AU - Zhang, H. AU - Xue, R. DB - Embase Medline DO - 10.1016/j.lfs.2018.11.056 LA - English M3 - Article N1 - L2001335552 2018-12-07 2018-12-12 PY - 2019 SN - 1879-0631 0024-3205 SP - 271-278 ST - miR-141 alleviates LPS-induced inflammation injury in WI-38 fibroblasts by up-regulation of NOX2 T2 - Life Sciences TI - miR-141 alleviates LPS-induced inflammation injury in WI-38 fibroblasts by up-regulation of NOX2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001335552&from=export http://dx.doi.org/10.1016/j.lfs.2018.11.056 VL - 216 ID - 1306 ER - TY - JOUR AD - M. Wilhelm, Dept. of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, Biomedicum B7, Stockholm, Sweden AU - Marin Navarro, A. AU - Day, K. AU - Kogner, P. AU - Wilhelm, M. AU - Falk, A. DB - Embase Medline DO - 10.1016/j.scr.2018.11.017 LA - English M3 - Article N1 - L2001420602 2019-01-03 2019-01-11 PY - 2019 SN - 1876-7753 1873-5061 ST - Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation T2 - Stem Cell Research TI - Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001420602&from=export http://dx.doi.org/10.1016/j.scr.2018.11.017 VL - 34 ID - 1307 ER - TY - JOUR AD - H. Yu, Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, United States AU - Hsu, L. C. AU - Reddy, S. V. AU - Yilmaz, Ö AU - Yu, H. DB - Embase DO - 10.3390/cells8010017 IS - 1 LA - English M3 - Article N1 - L2001542516 2019-02-28 2019-03-01 PY - 2019 SN - 2073-4409 ST - Sphingosine-1-phosphate receptor 2 controls podosome components induced by RANKL affecting osteoclastogenesis and bone resorption T2 - Cells TI - Sphingosine-1-phosphate receptor 2 controls podosome components induced by RANKL affecting osteoclastogenesis and bone resorption UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001542516&from=export http://dx.doi.org/10.3390/cells8010017 VL - 8 ID - 1308 ER - TY - JOUR AD - L. Jiang, Department of Neurosurgery, Children’s Hospital of Chongqing Medical University, No 136 Zhongshan 2nd Road, YuZhong District, Chongqing, China AU - Zhou, Y. AU - Liang, P. AU - Ji, W. AU - Yu, Z. AU - Chen, H. AU - Jiang, L. DB - Embase DO - 10.2147/OTT.S176582 LA - English M3 - Article N1 - L2001574921 2019-03-22 2019-03-26 PY - 2019 SN - 1178-6930 SP - 1825-1839 ST - Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway T2 - OncoTargets and Therapy TI - Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001574921&from=export http://dx.doi.org/10.2147/OTT.S176582 VL - 12 ID - 1309 ER - TY - JOUR AD - S. Wang, Department of Rheumatology and Immune Disease, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China AU - Liu, K. AU - He, B. AU - Xu, J. AU - Li, Y. AU - Guo, C. AU - Cai, Q. AU - Wang, S. DB - Embase Medline DO - 10.12659/MSM.913005 LA - English M3 - Article N1 - L2001617890 2019-04-04 2019-05-14 PY - 2019 SN - 1643-3750 1234-1010 SP - 1459-1468 ST - MiR-483-5p targets MKNK1 to suppress wilms’ tumor cell proliferation and apoptosis in vitro and in vivo T2 - Medical Science Monitor TI - MiR-483-5p targets MKNK1 to suppress wilms’ tumor cell proliferation and apoptosis in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001617890&from=export http://dx.doi.org/10.12659/MSM.913005 VL - 25 ID - 1310 ER - TY - JOUR AD - Y. Wu, State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Cardiovascular Institute, Center of Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, North Lishi Road, Xicheng District, No. 167, Beijing, China AU - Gao, H. AU - Wu, D. AU - Zhang, E. AU - Liang, T. AU - Meng, X. AU - Chen, L. AU - Wu, Y. DB - Embase IS - 2 LA - English M3 - Article N1 - L2001628640 2019-04-03 2019-04-08 PY - 2019 SN - 1943-8141 SP - 911-930 ST - Phasic change and apoptosis regulation of jak2/stat3 pathway in a type 2 diabetic rat model T2 - American Journal of Translational Research TI - Phasic change and apoptosis regulation of jak2/stat3 pathway in a type 2 diabetic rat model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001628640&from=export VL - 11 ID - 1311 ER - TY - JOUR AD - X.-Q. Zhang, Department of Obstetrics and Gynecology, Xiamen Maternal and Child Health Hospital, Xiamen, China AU - Lin, L. P. AU - Niu, G. H. AU - Zhang, X. Q. DB - Embase Medline DO - 10.26355/eurrev_201902_17025 IS - 3 LA - English M3 - Article N1 - L2001635271 2019-03-06 2019-03-07 PY - 2019 SN - 2284-0729 1128-3602 SP - 1296-1304 ST - Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway T2 - European Review for Medical and Pharmacological Sciences TI - Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001635271&from=export http://dx.doi.org/10.26355/eurrev_201902_17025 VL - 23 ID - 1312 ER - TY - JOUR AD - G.-B. Sun, Endoscopy Center, Tianjin Fifth Central Hospital, Tianjin, China AU - Dou, G. X. AU - Zhang, J. N. AU - Wang, P. AU - Wa, J. L. AU - Sun, G. B. DB - Embase Medline DO - 10.12659/MSM.914248 LA - English M3 - Article N1 - L2001833947 2019-05-14 2019-09-04 PY - 2019 SN - 1643-3750 1234-1010 SP - 2141-2150 ST - Long intergenic non-protein-coding RNA 01138 accelerates tumor growth and invasion in gastric cancer by regulating miR-1273e T2 - Medical Science Monitor TI - Long intergenic non-protein-coding RNA 01138 accelerates tumor growth and invasion in gastric cancer by regulating miR-1273e UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001833947&from=export http://dx.doi.org/10.12659/MSM.914248 VL - 25 ID - 1313 ER - TY - JOUR AD - Y. Gao, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China AU - Gao, Y. AU - Qian, H. AU - Tang, X. AU - Du, X. AU - Wang, G. AU - Zhang, H. AU - Ye, F. AU - Liu, T. DB - Embase Medline DO - 10.2147/IJN.S200480 LA - English M3 - Article N1 - L2001899887 2019-05-20 2019-05-22 PY - 2019 SN - 1178-2013 1176-9114 SP - 2719-2731 ST - Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth T2 - International Journal of Nanomedicine TI - Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001899887&from=export http://dx.doi.org/10.2147/IJN.S200480 VL - 14 ID - 1314 ER - TY - JOUR AD - I. Maillard, Division of Hematology-Oncology, Department of Internal Medicine, University of Pennsylvania Perelman, School of Medicine, 421 Curie Boulevard, BRB-2/3, Philadelphia, PA, United States AU - Chung, J. AU - Radojcic, V. AU - Perkey, E. AU - Parnell, T. J. AU - Niknafs, Y. AU - Jin, X. AU - Friedman, A. AU - Labrecque, N. AU - Blazar, B. R. AU - Brennan, T. V. AU - Siebel, C. W. AU - Maillard, I. DB - Embase Medline DO - 10.4049/jimmunol.1900192 IS - 2 LA - English M3 - Article N1 - L2002312823 2019-07-23 2019-07-29 PY - 2019 SN - 1550-6606 0022-1767 SP - 557-568 ST - Early notch signals induce a pathogenic molecular signature during priming of alloantigen-specific conventional CD4+ T cells in graft-versus-host disease T2 - Journal of Immunology TI - Early notch signals induce a pathogenic molecular signature during priming of alloantigen-specific conventional CD4+ T cells in graft-versus-host disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002312823&from=export http://dx.doi.org/10.4049/jimmunol.1900192 VL - 203 ID - 1316 ER - TY - JOUR AD - K.-I. Lin, Department of Obstetrics and Gynecology, Chang Bing Show Chwan Memorial Hospital, No. 6 Lugong Road, Lugang Town, Changhua County, Taiwan AU - Yue, C. H. AU - Liu, J. Y. AU - Chi, C. S. AU - Hu, C. W. AU - Tan, K. T. AU - Huang, F. M. AU - Pan, Y. R. AU - Lin, K. I. AU - Lee, C. J. DB - Embase Medline DO - 10.21873/anticanres.13574 IS - 8 LA - English M3 - Article N1 - L2002603589 2019-08-21 2019-08-26 PY - 2019 SN - 1791-7530 0250-7005 SP - 4149-4164 ST - Myeloid Zinc Finger 1 (MZF1) maintains the mesenchymal phenotype by down-regulating IGF1R/p38 MAPK/ERα signaling pathway in high-level MZF1-expressing TNBC cells T2 - Anticancer Research TI - Myeloid Zinc Finger 1 (MZF1) maintains the mesenchymal phenotype by down-regulating IGF1R/p38 MAPK/ERα signaling pathway in high-level MZF1-expressing TNBC cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002603589&from=export http://dx.doi.org/10.21873/anticanres.13574 VL - 39 ID - 1319 ER - TY - JOUR AU - Sahoo, D. AU - Abdul Wazid, M. AU - Gupta, A. K. AU - Meena, J. P. AU - Seth, R. DB - Embase DO - 10.1016/j.phoj.2019.08.071 IS - 2 LA - English M3 - Conference Abstract N1 - L2002713668 2019-09-05 PY - 2019 SN - 2468-1245 SP - S26 ST - Diverse clinical profile of children with anaplastic large cell lymphoma: a tertiary centre experience T2 - Pediatric Hematology Oncology Journal TI - Diverse clinical profile of children with anaplastic large cell lymphoma: a tertiary centre experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002713668&from=export http://dx.doi.org/10.1016/j.phoj.2019.08.071 VL - 4 ID - 1320 ER - TY - JOUR AU - Nikila, R. AU - Shivani, P. AU - Kesavan, M. R. AU - Venkateswaran, V. S. AU - Indira, J. AU - Balasubramaniam, R. AU - Lakshman, V. AU - Ramya, U. AU - Revathi, R. DB - Embase DO - 10.1016/j.phoj.2019.08.081 IS - 2 LA - English M3 - Conference Abstract N1 - L2002713669 2019-09-05 PY - 2019 SN - 2468-1245 SP - S29 ST - Peripheral T cell lymphoma (PTCL) in children and adolescents – a single centre experience T2 - Pediatric Hematology Oncology Journal TI - Peripheral T cell lymphoma (PTCL) in children and adolescents – a single centre experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002713669&from=export http://dx.doi.org/10.1016/j.phoj.2019.08.081 VL - 4 ID - 1321 ER - TY - JOUR AD - S.Y. Ha, Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong AU - Ha, S. Y. AU - Cheuk, D. K. L. DB - Embase IS - 4 LA - English M3 - Article N1 - L2002854098 2019-11-15 2019-11-20 PY - 2019 SN - 2309-5393 1013-9923 SP - 216-226 ST - Paediatric haematology and oncology in Hong Kong: A quarter century of progress T2 - Hong Kong Journal of Paediatrics TI - Paediatric haematology and oncology in Hong Kong: A quarter century of progress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002854098&from=export VL - 24 ID - 1322 ER - TY - JOUR AD - Y. Zeng, Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China AU - Wu, Y. AU - Lu, X. AU - Shen, B. AU - Zeng, Y. DB - Embase Medline DO - 10.2174/1566523219666190716092203 IS - 4 LA - English M3 - Article N1 - L2003254318 2019-11-29 2019-12-04 PY - 2019 SN - 1875-5631 1566-5232 SP - 255-263 ST - The therapeutic potential and role of miRNA, IncRNA, and circRNA in osteoarthritis T2 - Current Gene Therapy TI - The therapeutic potential and role of miRNA, IncRNA, and circRNA in osteoarthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003254318&from=export http://dx.doi.org/10.2174/1566523219666190716092203 VL - 19 ID - 1323 ER - TY - JOUR AD - R. Vadde, Department of Biotechnology & Bioinformatics, Yogi Vemana University, Kadapa, Andhra Pradesh, India AU - Mallepalli, S. AU - Gupta, M. K. AU - Vadde, R. DB - Embase Medline DO - 10.2174/1389200221666191226102231 IS - 13 LA - English M3 - Review N1 - L2003853638 2020-03-24 2020-04-29 PY - 2019 SN - 1875-5453 1389-2002 SP - 1014-1022 ST - Neuroblastoma: An updated review on biology and treatment T2 - Current Drug Metabolism TI - Neuroblastoma: An updated review on biology and treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003853638&from=export http://dx.doi.org/10.2174/1389200221666191226102231 VL - 20 ID - 1324 ER - TY - JOUR AD - C. Lu, Department of Pediatrics, First Affiliated Hospital, Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, Zhejiang Province, China AU - Wang, K. AU - Zhou, A. AU - Ruan, M. AU - Jin, Z. AU - Lu, J. AU - Wang, Q. AU - Lu, C. DB - Embase IS - 9 LA - English M3 - Article N1 - L2004409880 2020-01-07 2020-01-09 PY - 2019 SN - 1943-8141 SP - 6159-6169 ST - Dehydrocostus lactone suppresses ox-LDL-induced attachment of monocytes to endothelial cells T2 - American Journal of Translational Research TI - Dehydrocostus lactone suppresses ox-LDL-induced attachment of monocytes to endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004409880&from=export VL - 11 ID - 1326 ER - TY - JOUR AD - H. Bian, Newborn Department, Yancheng Maternity and Child Health Care Hospital, Yancheng, Jiangsu Province, China AU - Cai, Z. AU - Liu, J. AU - Bian, H. AU - Cai, J. C2 - National Institute for Food and Drug Control(China) DB - Embase IS - 12 LA - English M3 - Article N1 - L2004518887 2020-01-23 2020-01-31 PY - 2019 SN - 1943-8141 SP - 7300-7309 ST - Albiflorin alleviates ovalbumin (OVA)-induced pulmonary inflammation in asthmatic mice T2 - American Journal of Translational Research TI - Albiflorin alleviates ovalbumin (OVA)-induced pulmonary inflammation in asthmatic mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004518887&from=export VL - 11 ID - 1327 ER - TY - JOUR AD - Y. Mareeva, 1 Samory Mashela Str, Moscow, Russian Federation AU - Zhukov, N. AU - Mareeva, Y. AU - Konovalov, D. AU - Druy, A. AU - Grachev, N. AU - Litvinov, D. DB - Embase DO - 10.1200/PO.19.00282 LA - English M3 - Article N1 - L2006156800 2020-06-30 2020-07-03 PY - 2019 SN - 2473-4284 ST - Potentially curative targeted therapy for undifferentiated high-grade sarcoma developing after malignant transformation of a BRAF V600E-mutated ameloblastic fibroma T2 - JCO Precision Oncology TI - Potentially curative targeted therapy for undifferentiated high-grade sarcoma developing after malignant transformation of a BRAF V600E-mutated ameloblastic fibroma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006156800&from=export http://dx.doi.org/10.1200/PO.19.00282 VL - 3 ID - 1328 ER - TY - JOUR AU - Nobre, L. AU - Zapotocky, M. AU - Ramaswamy, V. AU - Ryall, S. AU - Bennett, J. AU - Alderete, D. AU - Guill, J. B. AU - Baroni, L. AU - Bartels, U. AU - Bavle, A. AU - Bornhorst, M. AU - Boue, D. R. AU - Canete, A. AU - Chintagumpala, M. AU - Coven, S. L. AU - Cruz, O. AU - Dahiya, S. AU - Dirks, P. AU - Dunkel, I. J. AU - Eisenstat, D. AU - Conter, C. F. AU - Finch, E. AU - Finlay, J. L. AU - Frappaz, D. AU - Garre, M. L. AU - Gauvain, K. AU - Bechensteen, A. G. AU - Hansford, J. R. AU - Harting, I. AU - Hauser, P. AU - Hazrati, L. N. AU - Huang, A. AU - Injac, S. G. AU - Iurilli, V. AU - Karajannis, M. AU - Kaur, G. AU - Kyncl, M. AU - Krskova, L. AU - Laperriere, N. AU - Larouche, V. AU - Lassaletta, A. AU - Leary, S. AU - Lin, F. AU - Mascelli, S. AU - McKeown, T. AU - Milde, T. AU - la Madrid, A. M. AU - Morana, G. AU - Morse, H. AU - Mushtaq, N. AU - Osorio, D. S. AU - Packer, R. AU - Pavelka, Z. AU - Quiroga-Cantero, E. AU - Rutka, J. AU - Sabel, M. AU - Salgado, D. AU - Solano, P. AU - Sterba, J. AU - Su, J. AU - Sumerauer, D. AU - Taylor, M. D. AU - Toledano, H. AU - Tsang, D. S. AU - Fernandes, M. V. AU - van Landeghem, F. AU - van Tilburg, C. M. AU - Wilson, B. AU - Witt, O. AU - Zamecnik, J. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. DB - Embase DO - 10.1200/PO.19.00298 LA - English M3 - Conference Paper N1 - L2006710049 2020-07-06 PY - 2019 SN - 2473-4284 SP - 561-571 ST - Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition T2 - JCO Precision Oncology TI - Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006710049&from=export http://dx.doi.org/10.1200/PO.19.00298 VL - 3 ID - 1329 ER - TY - JOUR AD - A.A. Thomas, Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, United States AU - Thomas, A. A. AU - Tucker, S. M. AU - Nelson, C. J. AU - Nickerson, J. P. AU - Durham, S. R. AU - Homans, A. C. DB - Embase Medline DO - 10.1002/pbc.27465 IS - 1 LA - English M3 - Letter N1 - L624036022 2018-10-01 2019-10-31 PY - 2019 SN - 1545-5017 1545-5009 ST - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab T2 - Pediatric Blood and Cancer TI - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624036022&from=export http://dx.doi.org/10.1002/pbc.27465 VL - 66 ID - 1330 ER - TY - JOUR AD - K. Marshall, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom AU - Marshall, K. AU - O'Hare, P. AU - Hargrave, D. AU - Marshall, L. AU - Morland, B. AU - Hayden, J. AU - Murray, M. AU - Nicholson, J. AU - Pears, J. AU - Slater, O. AU - Bomken, S. AU - Collin, M. AU - Milne, P. AU - Nanduri, V. AU - Donadieu, J. AU - Visser, J. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283140 2018-12-05 PY - 2019 SN - 1545-5017 ST - Increasing number of children on long-term mapk inhibitors for refractory langerhans cell histiocytosis: Where do we go from here? T2 - Pediatric Blood and Cancer TI - Increasing number of children on long-term mapk inhibitors for refractory langerhans cell histiocytosis: Where do we go from here? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283140&from=export http://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 1331 ER - TY - JOUR AD - J. Picarsic, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States AU - Picarsic, J. AU - Alaggio, R. AU - Jaffe, R. AU - Diamond, E. L. AU - Durham, B. H. AU - Abdel-Wahab, O. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283420 2018-12-05 PY - 2019 SN - 1545-5017 ST - Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns T2 - Pediatric Blood and Cancer TI - Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283420&from=export http://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 1332 ER - TY - JOUR AD - M.L. Galluzzo, Pathology Department, Hospital Nacional de Pediatría Garrahan, Buenos Aires, Argentina AU - Galluzzo, M. L. AU - Roibón, N. G. AU - Felizzia, G. AU - La Rosa, C. S. AU - Buján, M. M. AU - Braier, J. AU - Durham, B. H. AU - Abdel-Wahab, O. AU - Diamond, E. L. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283699 2018-12-05 PY - 2019 SN - 1545-5017 ST - Progressive nodular histiocytosis. Report of a pediatric case T2 - Pediatric Blood and Cancer TI - Progressive nodular histiocytosis. Report of a pediatric case UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283699&from=export http://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 1333 ER - TY - JOUR AD - P. Kemps, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands AU - Kemps, P. AU - Zondag, T. AU - Steenwijk, E. AU - Verdijk, R. AU - Van Noesel, C. AU - Cleven, A. AU - Lang, V. AU - Egeler, M. AU - Solleveld-Westerink, N. AU - Van Eijk, R. AU - Van Wezel, T. AU - Beishuizen, A. AU - Van Laar, J. AU - Abla, O. AU - Van Den Bos, C. AU - Van Halteren, A. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283960 2018-12-05 PY - 2019 SN - 1545-5017 ST - Incidence and clinical correlations of somatic mapk pathway mutations in pediatric and adult langerhans cell histiocytosis T2 - Pediatric Blood and Cancer TI - Incidence and clinical correlations of somatic mapk pathway mutations in pediatric and adult langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283960&from=export http://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 1334 ER - TY - JOUR AD - J. Chen, Department of Breast Surgery, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, 399 Century Avenue, Nantong, Jiangsu, China AU - Li, Z. AU - Xu, W. AU - Ren, X. AU - Xu, J. AU - Chen, J. C2 - National Institutes for Food and Drug Control(China) DB - Embase Medline DO - 10.3892/mmr.2018.9682 IS - 1 LA - English M3 - Article N1 - L625809177 2019-01-11 2019-01-16 PY - 2019 SN - 1791-3004 1791-2997 SP - 205-212 ST - Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer T2 - Molecular Medicine Reports TI - Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625809177&from=export http://dx.doi.org/10.3892/mmr.2018.9682 VL - 19 ID - 1335 ER - TY - JOUR AD - R.D. Britt, Center for Perinatal Research, The Research Inst. at Nationwide Children’s Hospital, 575 Children’s Crossroad, Columbus, OH, United States AU - Britt, R. D. AU - Thompson, M. A. AU - Sasse, S. AU - Pabelick, C. M. AU - Gerber, A. N. AU - Prakash, Y. S. DB - Embase Medline DO - 10.1152/ajplung.00547.2017 IS - 1 LA - English M3 - Article N1 - L625901290 2019-01-17 2019-01-23 PY - 2019 SN - 1522-1504 1040-0605 SP - L71-L81 ST - Th1 cytokines tnf-α and ifn-γ promote corticosteroid resistance in developing human airway smooth muscle T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Th1 cytokines tnf-α and ifn-γ promote corticosteroid resistance in developing human airway smooth muscle UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625901290&from=export http://dx.doi.org/10.1152/ajplung.00547.2017 VL - 316 ID - 1336 ER - TY - JOUR AD - J.J. Bissler, Department of Pediatrics, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, TN, United States AU - Bissler, J. J. AU - Zadjali, F. AU - Bridges, D. AU - Astrinidis, A. AU - Barone, S. AU - Yao, Y. AU - Redd, J. R. AU - Siroky, B. J. AU - Wang, Y. AU - Finley, J. T. AU - Rusiniak, M. E. AU - Baumann, H. AU - Zahedi, K. AU - Gross, K. W. AU - Soleimani, M. DB - Embase Medline DO - 10.14814/phy2.13983 IS - 2 LA - English M3 - Article N1 - L626169781 2019-02-05 2019-02-06 PY - 2019 SN - 2051-817X ST - Tuberous sclerosis complex exhibits a new renal cystogenic mechanism T2 - Physiological Reports TI - Tuberous sclerosis complex exhibits a new renal cystogenic mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626169781&from=export http://dx.doi.org/10.14814/phy2.13983 VL - 7 ID - 1338 ER - TY - JOUR AD - Y. Zhu, Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, East Jianshe Road, Zhengzhou, China AU - Zhou, T. AU - Zhu, Y. DB - Embase Medline DO - 10.1007/s12031-019-01289-w LA - English M3 - Article in Press N1 - L626735133 2019-03-18 PY - 2019 SN - 1559-1166 0895-8696 ST - Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation T2 - Journal of Molecular Neuroscience TI - Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626735133&from=export http://dx.doi.org/10.1007/s12031-019-01289-w ID - 1339 ER - TY - JOUR AD - Z. Shen, Department of Oncology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China AU - Yu, W. AU - Tang, L. AU - Lin, F. AU - Yao, Y. AU - Shen, Z. DB - Embase DO - 10.3389/fonc.2019.00172 IS - JAN LA - English M3 - Article N1 - L626837748 2019-03-29 2019-04-01 PY - 2019 SN - 2234-943X ST - DGKZ acts as a potential oncogene in osteosarcoma proliferation through its possible interaction with ERK1/2 and MYC pathway T2 - Frontiers in Oncology TI - DGKZ acts as a potential oncogene in osteosarcoma proliferation through its possible interaction with ERK1/2 and MYC pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626837748&from=export http://dx.doi.org/10.3389/fonc.2019.00172 VL - 9 ID - 1340 ER - TY - JOUR AD - B.N. Porto, Laboratory of Clinical and Experimental Immunology, Infant Center, School of Medicine, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil AU - de Souza, G. F. AU - Muraro, S. P. AU - Santos, L. D. AU - Monteiro, A. P. T. AU - da Silva, A. G. AU - de Souza, A. P. D. AU - Stein, R. T. AU - Bozza, P. T. AU - Porto, B. N. DB - Embase Medline DO - 10.1007/s00011-019-01233-z LA - English M3 - Article in Press N1 - L627211626 2019-04-19 PY - 2019 SN - 1420-908X 1023-3830 ST - Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages T2 - Inflammation Research TI - Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627211626&from=export http://dx.doi.org/10.1007/s00011-019-01233-z ID - 1341 ER - TY - JOUR AD - C. Lechler, Department of Medicine II, Klinikum rechts Der Isar, Technische Universitat Munchen, Munich, Germany AU - Lechler, C. AU - Dong, S. AU - Rosner, T. AU - Manmadhan, S. AU - Kohnke-Ertel, B. AU - Steiger, K. AU - Schmid, R. M. AU - Ehmer, U. AU - Sage, J. DB - Embase DO - 10.1055/s-0038-1677213 IS - 1 LA - English M3 - Conference Abstract N1 - L627523866 2019-05-14 PY - 2019 SN - 1439-7803 SP - e63 ST - A targeted screen to identify relevant oncogenes in RAS activated liver cancer T2 - Zeitschrift fur Gastroenterologie TI - A targeted screen to identify relevant oncogenes in RAS activated liver cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627523866&from=export http://dx.doi.org/10.1055/s-0038-1677213 VL - 57 ID - 1342 ER - TY - JOUR AD - L. Palova-Jelinkova, SOTIO A.s., Prague, Czech Republic AU - Grohová, A. AU - Daóòvá, K. AU - Špíšek, R. AU - Palova-Jelinkova, L. DB - Embase Medline DO - 10.3389/fimmu.2019.00079 IS - FEB LA - English M3 - Article N1 - L627728458 2019-05-29 2019-06-03 PY - 2019 SN - 1664-3224 ST - Cell based therapy for type 1 diabetes: Should we take hyperglycemia into accout? T2 - Frontiers in Immunology TI - Cell based therapy for type 1 diabetes: Should we take hyperglycemia into accout? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627728458&from=export http://dx.doi.org/10.3389/fimmu.2019.00079 VL - 10 ID - 1343 ER - TY - JOUR AD - X. Lei, NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China AU - Xiao, X. AU - Qi, J. AU - Lei, X. AU - Wang, J. DB - Embase DO - 10.3389/fmicb.2019.00321 IS - FEB LA - English M3 - Review N1 - L627729215 2019-05-29 PY - 2019 SN - 1664-302X ST - Interactions between enteroviruses and the inflammasome: New insights into viral pathogenesis T2 - Frontiers in Microbiology TI - Interactions between enteroviruses and the inflammasome: New insights into viral pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627729215&from=export http://dx.doi.org/10.3389/fmicb.2019.00321 VL - 10 ID - 1344 ER - TY - JOUR AD - J. Roth, Institute of Immunology, University of Muenster, Münster, Germany AU - Holzinger, D. AU - Tenbrock, K. AU - Roth, J. DB - Embase Medline DO - 10.3389/fimmu.2019.00182 IS - FEB LA - English M3 - Review N1 - L627779955 2019-05-29 PY - 2019 SN - 1664-3224 ST - Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases T2 - Frontiers in Immunology TI - Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627779955&from=export http://dx.doi.org/10.3389/fimmu.2019.00182 VL - 10 ID - 1345 ER - TY - JOUR AD - M. Fujino, Division of Transplantation Immunology, Research Institute, National Center for Child Health and Development, Tokyo, Japan AU - Liu, C. AU - Zhu, P. AU - Fujino, M. AU - Zhu, S. AU - Ito, H. AU - Takahashi, K. AU - Nakajima, M. AU - Tanaka, T. AU - Zhuang, J. AU - Li, X. K. DB - Embase Medline DO - 10.1111/acer.14117 IS - 8 LA - English M3 - Article N1 - L628157974 2019-06-24 2019-08-19 PY - 2019 SN - 1530-0277 0145-6008 SP - 1651-1661 ST - 5-ALA/SFC Attenuated Binge Alcohol–Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats T2 - Alcoholism: Clinical and Experimental Research TI - 5-ALA/SFC Attenuated Binge Alcohol–Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628157974&from=export http://dx.doi.org/10.1111/acer.14117 VL - 43 ID - 1346 ER - TY - JOUR AD - Y.S. Choi, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States AU - Choi, Y. S. AU - Dobry, A. S. AU - Hawryluk, E. B. AU - Zakka, L. R. AU - Mihm, M. C. AU - Fisher, D. E. DB - Embase DO - 10.1111/pcmr.12747 IS - 1 LA - English M3 - Conference Abstract N1 - L628190744 2019-06-25 PY - 2019 SN - 1755-148X SP - 176 ST - Topical hapten-based immunotherapy and MEK-targeted local therapy regress congenital melanocytic nevi in NRASQ61R-driven preclinical models of human giant congenital nevi T2 - Pigment Cell and Melanoma Research TI - Topical hapten-based immunotherapy and MEK-targeted local therapy regress congenital melanocytic nevi in NRASQ61R-driven preclinical models of human giant congenital nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628190744&from=export http://dx.doi.org/10.1111/pcmr.12747 VL - 32 ID - 1347 ER - TY - JOUR AD - H.T. Michael, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Michael, H. T. AU - Day, C. P. AU - Sassano, A. AU - Liu, H. AU - Yang, H. AU - Lee, M. AU - Merlino, G. DB - Embase DO - 10.1111/pcmr.12747 IS - 1 LA - English M3 - Conference Abstract N1 - L628191062 2019-06-25 PY - 2019 SN - 1755-148X SP - 184 ST - Initiation and progression of BRAF/NRAS wildtype melanoma in a UV-induced mouse model of cutaneous melanoma T2 - Pigment Cell and Melanoma Research TI - Initiation and progression of BRAF/NRAS wildtype melanoma in a UV-induced mouse model of cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628191062&from=export http://dx.doi.org/10.1111/pcmr.12747 VL - 32 ID - 1348 ER - TY - JOUR AD - Y. Tsukamoto, Department of Pathology, Takarazuka City Hospital, Takarazuka, Japan AU - Masuda, Y. AU - Tsukamoto, Y. AU - Zenitani, M. AU - Oda, Y. AU - Kinoshita, I. AU - Kohashi, K. AU - Takemoto, J. AU - Hirota, S. AU - Shibata, A. AU - Koda, T. AU - Takeshima, Y. DB - Embase Medline DO - 10.1002/pbc.27902 IS - 10 LA - English M3 - Letter N1 - L628356142 2019-07-08 2019-09-03 PY - 2019 SN - 1545-5017 1545-5009 ST - A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion T2 - Pediatric Blood and Cancer TI - A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628356142&from=export http://dx.doi.org/10.1002/pbc.27902 VL - 66 ID - 1349 ER - TY - JOUR AD - W. Xu, Department of Orthopaedics, TongRen Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China AU - Li, Z. AU - Zhu, X. AU - Xu, R. AU - Wang, Y. AU - Hu, R. AU - Xu, W. C2 - MOLBASE(China) DB - Embase DO - 10.3389/fphar.2019.00599 IS - JUN LA - English M3 - Article N1 - L628533764 2019-07-24 2019-08-02 PY - 2019 SN - 1663-9812 ST - Deacylcynaropicrin inhibits RANKL-induced osteoclastogenesis by inhibiting NF-κB and MAPK and promoting M2 polarization of macrophages T2 - Frontiers in Pharmacology TI - Deacylcynaropicrin inhibits RANKL-induced osteoclastogenesis by inhibiting NF-κB and MAPK and promoting M2 polarization of macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628533764&from=export http://dx.doi.org/10.3389/fphar.2019.00599 VL - 10 ID - 1350 ER - TY - JOUR AD - L. Li, Department of Pathology, Capital Medical University, Beijing, China AU - Sun, J. AU - Xu, S. AU - Li, H. AU - Li, L. AU - Xu, Z. Q. D. DB - Embase Medline DO - 10.1155/2019/2716028 LA - English M3 - Article N1 - L628630661 2019-08-02 PY - 2019 SN - 1466-1861 0962-9351 ST - Galanin protects rat cortical astrocyte from oxidative stress: Involvement of GALR2 and PERK1/2 signal pathway T2 - Mediators of Inflammation TI - Galanin protects rat cortical astrocyte from oxidative stress: Involvement of GALR2 and PERK1/2 signal pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628630661&from=export http://dx.doi.org/10.1155/2019/2716028 VL - 2019 ID - 1351 ER - TY - JOUR AD - R.O. Dillman, AIVITA Biomedical, Inc., Irvine, CA, United States AU - Dillman, R. O. AU - Cornforth, A. N. AU - McClay, E. F. AU - Depriest, C. DB - Embase DO - 10.2217/mmt-2018-0010 IS - 2 LA - English M3 - Article N1 - L628983296 2019-08-27 2019-09-02 PY - 2019 SN - 2045-0893 2045-0885 ST - Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma T2 - Melanoma Management TI - Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628983296&from=export http://dx.doi.org/10.2217/mmt-2018-0010 VL - 6 ID - 1353 ER - TY - JOUR AD - Y. Capri, Dpt of Genetic CHU Robert Debre, Paris, France AU - Capri, Y. AU - Bourdeaut, F. AU - Dorfmuller, G. AU - El Maleh, M. AU - Vera, L. AU - Bourrat, E. AU - Cave, H. AU - Verloes, A. DB - Embase DO - 10.1038/s41431-018-0248-6 LA - English M3 - Conference Abstract N1 - L629480527 2019-10-08 PY - 2019 SN - 1476-5438 SP - 971 ST - Multiple glioma in Noonan syndrome: Report on a RAF1 mutated patient T2 - European Journal of Human Genetics TI - Multiple glioma in Noonan syndrome: Report on a RAF1 mutated patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629480527&from=export http://dx.doi.org/10.1038/s41431-018-0248-6 VL - 26 ID - 1354 ER - TY - JOUR AD - J. Chen, Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China AU - Wang, X. AU - Wang, X. AU - Li, W. AU - Zhang, Q. AU - Chen, J. AU - Chen, T. DB - Embase DO - 10.3389/fonc.2019.01105 IS - OCT LA - English M3 - Article N1 - L629729295 2019-11-12 2019-11-14 PY - 2019 SN - 2234-943X ST - Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma T2 - Frontiers in Oncology TI - Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629729295&from=export http://dx.doi.org/10.3389/fonc.2019.01105 VL - 9 ID - 1355 ER - TY - JOUR AD - A.K.L. Goey, Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands AU - Goey, A. K. L. AU - With, M. D. AU - Agema, B. C. AU - Hoop, E. O. D. AU - Singh, R. K. AU - Van Der Veldt, A. A. M. AU - Mathijssen, R. H. J. AU - Van Schaik, R. H. N. AU - Bins, S. DB - Embase Medline DO - 10.2217/pgs-2019-0101 IS - 18 LA - English M3 - Article N1 - L630253861 2019-12-27 2019-12-31 PY - 2019 SN - 1744-8042 1462-2416 SP - 1283-1290 ST - Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma T2 - Pharmacogenomics TI - Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630253861&from=export http://dx.doi.org/10.2217/pgs-2019-0101 VL - 20 ID - 1356 ER - TY - JOUR AD - G. Gao, Department of Orthopedics, Guizhou Provincial People's Hospital, No. 83, East Zhongshan Road, Guiyang Guizhou, China AU - Gao, G. AU - Tian, Z. AU - Zhu, H. Y. AU - Ouyang, X. Y. DB - Embase DO - 10.1186/s12935-018-0696-7 IS - 1 LA - English M3 - Article N1 - L625468031 2018-12-25 2019-01-03 PY - 2018 SN - 1475-2867 ST - MiRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma T2 - Cancer Cell International TI - MiRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625468031&from=export http://dx.doi.org/10.1186/s12935-018-0696-7 VL - 18 ID - 1357 ER - TY - JOUR AD - M.A. Davare, Division of Pediatric Hematology/Oncology, Department of Pediatrics, Pape Pediatric Research Institute, Oregon Health and Sciences University, Portland, OR, United States AU - Davare, M. A. AU - Henderson, J. J. AU - Agarwal, A. AU - Wagner, J. P. AU - Iyer, S. R. AU - Shah, N. AU - Woltjer, R. AU - Somwar, R. AU - Gilheeney, S. W. AU - DeCarvalo, A. AU - Mikkelson, T. AU - Van Meir, E. G. AU - Ladanyi, M. AU - Druker, B. J. C1 - pf 06463922 rxdx 101 xl 184 xl 880 DB - Embase Medline DO - 10.1158/1078-0432.CCR-18-1052 IS - 24 LA - English M3 - Article N1 - L625427861 2018-12-20 2018-12-27 PY - 2018 SN - 1557-3265 1078-0432 SP - 6471-6482 ST - Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma T2 - Clinical Cancer Research TI - Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625427861&from=export http://dx.doi.org/10.1158/1078-0432.CCR-18-1052 VL - 24 ID - 1358 ER - TY - JOUR AD - Q. Jiang, Department of Oncology, Second Clinical College, Harbin Medical University, Harbin, China AU - Li, L. AU - Huang, Y. AU - Gao, Y. AU - Shi, T. AU - Xu, Y. AU - Li, H. AU - Hyytiäinen, M. AU - Keski-Oja, J. AU - Jiang, Q. AU - Hu, Y. AU - Du, Z. DB - Embase Medline DO - 10.1186/s12885-018-5056-4 IS - 1 LA - English M3 - Article N1 - L625304121 2018-12-11 2018-12-13 PY - 2018 SN - 1471-2407 ST - EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence T2 - BMC Cancer TI - EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625304121&from=export http://dx.doi.org/10.1186/s12885-018-5056-4 VL - 18 ID - 1359 ER - TY - JOUR AD - J.A. Orellana, Departamento de Neurología, Escuela de Medicina and Centro Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile AU - Gómez, G. I. AU - Falcon, R. V. AU - Maturana, C. J. AU - Labra, V. C. AU - Salgado, N. AU - Rojas, C. A. AU - Oyarzun, J. E. AU - Cerpa, W. AU - Quintanilla, R. A. AU - Orellana, J. A. DB - Embase DO - 10.3389/fncel.2018.00472 LA - English M3 - Article N1 - L625557492 2018-12-28 2018-12-31 PY - 2018 SN - 1662-5102 ST - Heavy alcohol exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: Effects on neuroinflammation and astrocyte arborization T2 - Frontiers in Cellular Neuroscience TI - Heavy alcohol exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: Effects on neuroinflammation and astrocyte arborization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625557492&from=export http://dx.doi.org/10.3389/fncel.2018.00472 VL - 12 ID - 1360 ER - TY - JOUR AD - M. Xu, College of Food Science and Engineering, Jiangxi Agricultural University, 1101 Zhimin Avenue, Nanchang, China AU - Zhu, G. AU - Luo, J. AU - Du, H. AU - Jiang, Y. AU - Tu, Y. AU - Yao, Y. AU - Xu, M. DB - Embase Medline DO - 10.1016/j.ijbiomac.2018.08.058 LA - English M3 - Article N1 - L2001026816 2018-08-21 2019-01-11 PY - 2018 SN - 1879-0003 0141-8130 SP - 1-9 ST - Ovotransferrin enhances intestinal immune response in cyclophosphamide-induced immunosuppressed mice T2 - International Journal of Biological Macromolecules TI - Ovotransferrin enhances intestinal immune response in cyclophosphamide-induced immunosuppressed mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001026816&from=export http://dx.doi.org/10.1016/j.ijbiomac.2018.08.058 VL - 120 ID - 1361 ER - TY - JOUR AD - M. Minkov, Dept. Pediatrics, Neonatology and Adolescent Medicine, Juchgasse 25, Vienna, Austria AU - Minkov, M. DB - Embase IS - 4 LA - English M3 - Review N1 - L2001650688 2019-04-09 2019-04-11 PY - 2018 SN - 2008-4595 SP - 101-107 ST - The “rare” or “non-lch” histiocytic disorders in childhood: A brief overview T2 - Iranian Journal of Blood and Cancer TI - The “rare” or “non-lch” histiocytic disorders in childhood: A brief overview UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001650688&from=export VL - 10 ID - 1362 ER - TY - JOUR AD - R. Kapur, Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, United States AU - Hu, P. AU - Nebreda, A. R. AU - Hanenberg, H. AU - Kinnebrew, G. H. AU - Ivan, M. AU - Yoder, M. C. AU - Filippi, M. D. AU - Broxmeyer, H. E. AU - Kapur, R. C1 - sp 600125 DB - Embase Medline DO - 10.1038/s41467-018-05955-2 IS - 1 LA - English M3 - Article N1 - L623695254 2018-09-10 2018-09-11 PY - 2018 SN - 2041-1723 ST - P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim T2 - Nature Communications TI - P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623695254&from=export http://dx.doi.org/10.1038/s41467-018-05955-2 VL - 9 ID - 1363 ER - TY - JOUR AD - J.I. Geller, Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Bartlett, A. L. AU - Leslie, N. D. AU - Gupta, A. AU - Geller, J. I. DB - Embase Medline DO - 10.1002/pbc.27392 IS - 12 LA - English M3 - Article N1 - L623776406 2018-09-11 2019-05-29 PY - 2018 SN - 1545-5017 1545-5009 ST - Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma T2 - Pediatric Blood and Cancer TI - Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623776406&from=export http://dx.doi.org/10.1002/pbc.27392 VL - 65 ID - 1364 ER - TY - JOUR AD - Y.-Q. Zhang, Department of Neurosurgery, Yuquan Hospital, Tsinghua University, No. 5 Shijingshan Road, Shijingshan District, Beijing, China AU - Ma, X. L. AU - Shang, F. AU - Ni, W. AU - Zhu, J. AU - Luo, B. AU - Zhang, Y. Q. DB - Embase Medline DO - 10.1007/s00432-018-2745-y IS - 12 LA - English M3 - Article N1 - L623963235 2018-09-25 2018-12-20 PY - 2018 SN - 1432-1335 0171-5216 SP - 2351-2366 ST - MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1 T2 - Journal of Cancer Research and Clinical Oncology TI - MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623963235&from=export http://dx.doi.org/10.1007/s00432-018-2745-y VL - 144 ID - 1365 ER - TY - JOUR AD - L. Schoyer, RASopathies Network, Altadena, CA, United States AU - Rauen, K. A. AU - Schoyer, L. AU - Schill, L. AU - Stronach, B. AU - Albeck, J. AU - Andresen, B. S. AU - Cavé, H. AU - Ellis, M. AU - Fruchtman, S. M. AU - Gelb, B. D. AU - Gibson, C. C. AU - Gripp, K. AU - Hefner, E. AU - Huang, W. Y. C. AU - Itkin, M. AU - Kerr, B. AU - Linardic, C. M. AU - McMahon, M. AU - Oberlander, B. AU - Perlstein, E. AU - Ratner, N. AU - Rogers, L. AU - Schenck, A. AU - Shankar, S. AU - Shvartsman, S. AU - Stevenson, D. A. AU - Stites, E. C. AU - Stork, P. J. S. AU - Sun, C. AU - Therrien, M. AU - Ullian, E. M. AU - Widemann, B. C. AU - Yeh, E. AU - Zampino, G. AU - Zenker, M. AU - Timmer, W. AU - McCormick, F. DB - Embase Medline DO - 10.1002/ajmg.a.40632 IS - 12 LA - English M3 - Conference Paper N1 - L624319363 2018-10-17 2019-11-05 PY - 2018 SN - 1552-4833 1552-4825 SP - 2924-2929 ST - Proceedings of the fifth international RASopathies symposium: When development and cancer intersect T2 - American Journal of Medical Genetics, Part A TI - Proceedings of the fifth international RASopathies symposium: When development and cancer intersect UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624319363&from=export http://dx.doi.org/10.1002/ajmg.a.40632 VL - 176 ID - 1366 ER - TY - JOUR AD - A. Drilon, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Cocco, E. AU - Scaltriti, M. AU - Drilon, A. DB - Embase Medline DO - 10.1038/s41571-018-0113-0 IS - 12 LA - English M3 - Review N1 - L624458460 2018-10-25 2019-06-07 PY - 2018 SN - 1759-4782 1759-4774 SP - 731-747 ST - NTRK fusion-positive cancers and TRK inhibitor therapy T2 - Nature Reviews Clinical Oncology TI - NTRK fusion-positive cancers and TRK inhibitor therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624458460&from=export http://dx.doi.org/10.1038/s41571-018-0113-0 VL - 15 ID - 1367 ER - TY - JOUR AD - J.D. Spencer, Center for Clinical and Translational Research, The Research Institute at Nationwide Children's, Columbus, OH, United States AU - Schwartz, L. AU - Cohen, A. AU - Thomas, J. AU - Spencer, J. D. DB - Embase DO - 10.3390/vaccines6040076 IS - 4 LA - English M3 - Review N1 - L625466887 2018-12-25 2018-12-27 PY - 2018 SN - 2076-393X ST - The immunomodulatory and antimicrobial properties of the vertebrate ribonuclease a superfamily T2 - Vaccines TI - The immunomodulatory and antimicrobial properties of the vertebrate ribonuclease a superfamily UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625466887&from=export http://dx.doi.org/10.3390/vaccines6040076 VL - 6 ID - 1368 ER - TY - JOUR AD - Q. Xu, Department of Gynecology, Obstetrics and Gynecology, Hospital Affiliated to Nanjing Medical University, 123 Mochou Rd, Nanjing, China AU - Ma, H. AU - Shi, X. AU - Fu, Z. AU - Wu, X. AU - Huangfu, Y. AU - Xu, P. AU - Zeng, X. AU - Xu, J. AU - Ruan, H. AU - Xu, Q. DB - Embase DO - 10.21037/tcr.2018.10.16 IS - 6 LA - English M3 - Article N1 - L625775697 2019-01-11 PY - 2018 SN - 2219-6803 2218-676X SP - 1376-1383 ST - Potential roles of microRNA in levonorgestrel-treated uterine leiomyoma cells T2 - Translational Cancer Research TI - Potential roles of microRNA in levonorgestrel-treated uterine leiomyoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625775697&from=export http://dx.doi.org/10.21037/tcr.2018.10.16 VL - 7 ID - 1369 ER - TY - JOUR AD - C. Chen, Teaching and Research Section of Clinical Examination and Diagnosis, School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, China AU - Li, H. AU - Song, Y. H. AU - Du, Z. P. AU - Zhang, X. AU - An, C. X. AU - Hu, Y. AU - Tian, Y. AU - Wu, Z. AU - Wu, H. AU - Chen, C. DB - Embase DO - 10.21037/tcr.2018.12.18 IS - 6 LA - English M3 - Article N1 - L625778419 2019-01-11 PY - 2018 SN - 2219-6803 2218-676X SP - 1714-1727 ST - COPB2-shRNA suppresses cell growth and induces apoptosis of STAD SGC-7901 cells via inactivation of p38 MAPK/Smad2/Chk1/2 as an oncogene T2 - Translational Cancer Research TI - COPB2-shRNA suppresses cell growth and induces apoptosis of STAD SGC-7901 cells via inactivation of p38 MAPK/Smad2/Chk1/2 as an oncogene UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625778419&from=export http://dx.doi.org/10.21037/tcr.2018.12.18 VL - 7 ID - 1370 ER - TY - JOUR AD - Z. Xia, College of Veterinary Medicine, China Agricultural University, Beijing, China AU - Liu, Y. AU - Jia, Y. AU - Liu, C. AU - Ding, L. AU - Xia, Z. C2 - Beijing Shine Biology(China) DB - Embase Medline DO - 10.1186/s12864-018-5261-1 IS - 1 LA - English M3 - Article N1 - L625171786 2018-12-12 2020-07-28 PY - 2018 SN - 1471-2164 ST - RNA-Seq transcriptome analysis of breast muscle in Pekin ducks supplemented with the dietary probiotic Clostridium butyricum T2 - BMC Genomics TI - RNA-Seq transcriptome analysis of breast muscle in Pekin ducks supplemented with the dietary probiotic Clostridium butyricum UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625171786&from=export http://dx.doi.org/10.1186/s12864-018-5261-1 VL - 19 ID - 1371 ER - TY - JOUR AD - M. Prieto-Barrios, Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain AU - Prieto-Barrios, M. AU - Llamas-Martin, R. AU - Velasco-Tamariz, V. AU - Calleja-Algarra, A. AU - Ruano, Y. AU - Ortiz-Romero, P. L. AU - Rodriguez-Peralto, J. L. DB - Embase Medline DO - 10.1111/bjd.16435 IS - 5 LA - English M3 - Article N1 - L622065395 2018-05-14 2019-11-20 PY - 2018 SN - 1365-2133 0007-0963 SP - 1163-1167 ST - Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma T2 - British Journal of Dermatology TI - Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622065395&from=export http://dx.doi.org/10.1111/bjd.16435 VL - 179 ID - 1373 ER - TY - JOUR AD - Y. Luan, Central Research Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, China AU - Zhang, Z. AU - Sun, C. AU - Wang, J. AU - Jiang, W. AU - Xin, Q. AU - Luan, Y. DB - Embase Medline DO - 10.1111/jcmm.13843 IS - 11 LA - English M3 - Article N1 - L623776231 2018-09-11 2018-11-02 PY - 2018 SN - 1582-1838 SP - 5759-5763 ST - Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia T2 - Journal of Cellular and Molecular Medicine TI - Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623776231&from=export http://dx.doi.org/10.1111/jcmm.13843 VL - 22 ID - 1374 ER - TY - JOUR AD - Y. Tang, Department of Orthopedics, Children's Hospital Affiliated to Nanjing Medical University, 8 Jiangdong South Road, Nanjing, Jiangsu, China AU - Cao, D. AU - Pi, J. AU - Shan, Y. AU - Tang, Y. AU - Zhou, P. DB - Embase DO - 10.3892/etm.2018.6721 IS - 5 LA - English M3 - Article N1 - L624052373 2018-10-02 2018-10-05 PY - 2018 SN - 1792-1015 1792-0981 SP - 4283-4288 ST - Anti-inflammatory effect of resolvin D1 on LPS-treated MG-63 cells T2 - Experimental and Therapeutic Medicine TI - Anti-inflammatory effect of resolvin D1 on LPS-treated MG-63 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624052373&from=export http://dx.doi.org/10.3892/etm.2018.6721 VL - 16 ID - 1375 ER - TY - JOUR AD - I. Kazantsev, R.M.Gorbacheva Memorial Institute for Pediatric Oncology, Hematology and Transplantation, Pediatric Oncology, Saint-Petersburg, Russian Federation AU - Kazantsev, I. AU - Gevorgyan, A. AU - Jukhta, T. AU - Tolkunova, P. AU - Kozlov, A. AU - Andreeva, T. AU - Morozova, E. AU - Safonova, S. AU - Punanov, Y. AU - Zubarovskaya, L. AU - Afanasyev, B. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624178671 2018-10-11 PY - 2018 SN - 1545-5017 SP - S257-S258 ST - Combined chemo-and targeted therapy in primary resistant/relapsed neuroblastoma patients: A single-center experience T2 - Pediatric Blood and Cancer TI - Combined chemo-and targeted therapy in primary resistant/relapsed neuroblastoma patients: A single-center experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624178671&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1376 ER - TY - JOUR AD - J. Barredo, Univiersity of Miami Miller School of Medicine, Dept. of Pediatrics, Medicine and Biochmeistry and Molecular Biology, Miami, United States AU - Barredo, J. AU - Sun, G. AU - Shavab, A. AU - Li, B. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624178703 2018-10-11 PY - 2018 SN - 1545-5017 SP - S102 ST - Elucidating and targeting epigenetic metabolic stress response signatures in acute lymphoblastic leukemia (ALL) T2 - Pediatric Blood and Cancer TI - Elucidating and targeting epigenetic metabolic stress response signatures in acute lymphoblastic leukemia (ALL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624178703&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1377 ER - TY - JOUR AD - C. Willis, Royal Hospital for Children, Paediatric Oncology, Glasgow, United Kingdom AU - Willis, C. AU - Murphy, D. AU - Ronghe, M. AU - McIntosh, D. AU - Sastry, J. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179038 2018-10-11 PY - 2018 SN - 1545-5017 SP - S421 ST - A review of outcomes for paediatric patients with solid tumours treated with targeted therapies in the west of scotland T2 - Pediatric Blood and Cancer TI - A review of outcomes for paediatric patients with solid tumours treated with targeted therapies in the west of scotland UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179038&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1378 ER - TY - JOUR AD - B. Campbell, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada, Department of Haematology/Oncology, Toronto, Canada AU - Campbell, B. AU - Morgenstern, D. AU - Lipman, T. AU - Fabrizio, D. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179824 2018-10-11 PY - 2018 SN - 1545-5017 SP - S68 ST - Hypermutant pediatric high grade gliomas are driven by RAS/MAPK mutations and respond to mek inhibition T2 - Pediatric Blood and Cancer TI - Hypermutant pediatric high grade gliomas are driven by RAS/MAPK mutations and respond to mek inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179824&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1379 ER - TY - JOUR AD - M. Hiwatari, University of Tokyo, Cell Therapy and Transplantation Medicine, Tokyo, Japan AU - Hiwatari, M. AU - Watanabe, K. AU - Kimura, S. AU - Takita, J. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179926 2018-10-11 PY - 2018 SN - 1545-5017 SP - S252 ST - Synergistic activity of ALK and STAT3 inhibitors for the treatment of ALK mutated neuroblastoma cells T2 - Pediatric Blood and Cancer TI - Synergistic activity of ALK and STAT3 inhibitors for the treatment of ALK mutated neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179926&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1380 ER - TY - JOUR AD - A. Suleymanova, National Research Center of Pediatric Hematology, Oncology and Immunology Named after Dmitry Rogachev, Clinical Oncology, Moscow, Russian Federation AU - Suleymanova, A. AU - Imyanitov, E. AU - Roschin, V. AU - Shamanskaya, T. AU - Olshanskaya, Y. AU - Kazakova, A. AU - Mitiushkina, N. AU - Preobrazhenskaya, E. AU - Kachanov, D. AU - Varfolomeeva, S. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624180027 2018-10-11 PY - 2018 SN - 1545-5017 SP - S388 ST - Rapid response to crizotinib in 3-year-old boy with ros1-rearranged inflammatory myofibroblastic tumor of the stomach T2 - Pediatric Blood and Cancer TI - Rapid response to crizotinib in 3-year-old boy with ros1-rearranged inflammatory myofibroblastic tumor of the stomach UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624180027&from=export http://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 1381 ER - TY - JOUR AD - S.H. Adams, Arkansas Children’s Nutrition Center, 15 Children’s Way, 512-20B, Little Rock, AR, United States AU - Ono-Moore, K. D. AU - Blackburn, M. L. AU - Adams, S. H. DB - Embase Medline DO - 10.1152/ajpendo.00187.2018 IS - 5 LA - English M3 - Article N1 - L624975123 2018-11-21 2018-11-28 PY - 2018 SN - 1522-1555 0193-1849 SP - E780-E794 ST - Is palmitate truly proinflammatory? Experimental confounders and context-specificity T2 - American Journal of Physiology - Endocrinology and Metabolism TI - Is palmitate truly proinflammatory? Experimental confounders and context-specificity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624975123&from=export http://dx.doi.org/10.1152/ajpendo.00187.2018 VL - 315 ID - 1382 ER - TY - JOUR AD - P. Hu, Department of Pediatrics, First Affiliated Hospital, Anhui Medical University, No. 218 Ji-Xi Road, Hefei, China AU - Wu, Y. F. AU - Zhang, D. D. AU - Liu, S. Y. AU - Luo, H. H. AU - Jiang, G. M. AU - Xu, Y. AU - Wu, Y. AU - Wang, J. J. AU - Liu, F. F. AU - Samadli, S. AU - Wei, W. AU - Hu, B. AU - Hu, P. DB - Embase Medline DO - 10.1089/jir.2018.0051 IS - 11 LA - English M3 - Article N1 - L625122398 2018-11-28 2018-12-04 PY - 2018 SN - 1557-7465 1079-9907 SP - 500-509 ST - C-type natriuretic peptide dampens fibroblast growth factor-23 expression through MAPK signaling pathway in human mesangial cells T2 - Journal of Interferon and Cytokine Research TI - C-type natriuretic peptide dampens fibroblast growth factor-23 expression through MAPK signaling pathway in human mesangial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625122398&from=export http://dx.doi.org/10.1089/jir.2018.0051 VL - 38 ID - 1383 ER - TY - JOUR AD - C.-J. Chen, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan AU - Chen, W. Y. AU - Chang, C. Y. AU - Li, J. R. AU - Wang, J. D. AU - Wu, C. C. AU - Kuan, Y. H. AU - Liao, S. L. AU - Wang, W. Y. AU - Chen, C. J. DB - Embase Medline DO - 10.3390/ijms19113678 IS - 11 LA - English M3 - Article N1 - L625185235 2018-12-12 2019-02-28 PY - 2018 SN - 1422-0067 1661-6596 ST - Anti-inflammatory and neuroprotective effects of fungal immunomodulatory protein involving microglial inhibition T2 - International Journal of Molecular Sciences TI - Anti-inflammatory and neuroprotective effects of fungal immunomodulatory protein involving microglial inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625185235&from=export http://dx.doi.org/10.3390/ijms19113678 VL - 19 ID - 1384 ER - TY - JOUR AD - K. Watanabe, Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Japan AU - Watanabe, K. AU - Takita, J. DB - Embase DO - 10.1002/pbc.27514 LA - English M3 - Conference Abstract N1 - L625308364 2018-12-06 PY - 2018 SN - 1545-5017 SP - S13 ST - Novel therapeutic approaches to high-risk neuroblastoma targeting cancer metabolism T2 - Pediatric Blood and Cancer TI - Novel therapeutic approaches to high-risk neuroblastoma targeting cancer metabolism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625308364&from=export http://dx.doi.org/10.1002/pbc.27514 VL - 65 ID - 1385 ER - TY - JOUR AD - O.S. Eckstein, Texas Children's Cancer Center, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States AU - Eckstein, O. S. AU - Zinn, D. AU - Levy, C. F. AU - Henry, M. M. AU - Campbell, P. AU - Jordan, M. B. AU - Kumar, A. R. AU - Rodriguez-Galindo, C. AU - Hijiya, N. AU - Abla, O. AU - McClain, K. L. AU - Allen, C. E. DB - Embase DO - 10.1182/blood-2018-99-120393 LA - English M3 - Conference Abstract N1 - L626415138 2019-02-22 PY - 2018 SN - 0006-4971 ST - Clinical outcomes and molecular responses in children with langerhans cell histiocytosis treated with mapk pathway inhibitors T2 - Blood TI - Clinical outcomes and molecular responses in children with langerhans cell histiocytosis treated with mapk pathway inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626415138&from=export http://dx.doi.org/10.1182/blood-2018-99-120393 VL - 132 ID - 1386 ER - TY - JOUR AD - G.C. Sun, Pediatrics, University of Miami Leonard M Miller School of Med, Miami, FL, United States AU - Sun, G. C. AU - Shvab, A. C. AU - Li, B. C. AU - Beckedorff, F. C. AU - Leclerc, G. J. AU - Shiekhattar, R. AU - Barredo, J. C. DB - Embase DO - 10.1182/blood-2018-99-112678 LA - English M3 - Conference Abstract N1 - L626478939 2019-02-27 PY - 2018 SN - 0006-4971 ST - Acadesine elicits a rapid epigenetic reprograming of immediate early genes through the protein kinase D1 pathway in acute lymphoblastic leukemia cells undergoing energy/metabolic stress T2 - Blood TI - Acadesine elicits a rapid epigenetic reprograming of immediate early genes through the protein kinase D1 pathway in acute lymphoblastic leukemia cells undergoing energy/metabolic stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626478939&from=export http://dx.doi.org/10.1182/blood-2018-99-112678 VL - 132 ID - 1387 ER - TY - JOUR AD - H.-T. Lin, Institute of Medical Science, University of Tokyo, Tokyo, Japan AU - Lin, H. T. AU - Kubara, K. AU - Yamazaki, K. AU - Takagi, M. AU - Naruto, T. AU - Morio, T. AU - Okumura, T. AU - Otsu, M. DB - Embase DO - 10.1182/blood-2018-99-117889 LA - English M3 - Conference Abstract N1 - L626479309 2019-02-27 PY - 2018 SN - 0006-4971 ST - Enhanced selective inhibition of KRAS mutant hematopoietic progenitor cell expansion by MEK and Bcl-2 inhibition T2 - Blood TI - Enhanced selective inhibition of KRAS mutant hematopoietic progenitor cell expansion by MEK and Bcl-2 inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626479309&from=export http://dx.doi.org/10.1182/blood-2018-99-117889 VL - 132 ID - 1388 ER - TY - JOUR AD - M. Hiwatari, Department of Cell Therapy and Transplantation Medicine, Tokyo University Hospital, Tokyo, Japan AU - Hiwatari, M. AU - Watanabe, K. AU - Kubota, Y. AU - Kimura, S. AU - Takita, J. DB - Embase DO - 10.1182/blood-2018-99-111090 LA - English M3 - Conference Abstract N1 - L626530411 2019-03-04 PY - 2018 SN - 0006-4971 ST - Identification of novel pathways and small molecules able to down regulate oncogenes expression by compounds screening approaches in acute leukemia and neuroblastoma cells T2 - Blood TI - Identification of novel pathways and small molecules able to down regulate oncogenes expression by compounds screening approaches in acute leukemia and neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530411&from=export http://dx.doi.org/10.1182/blood-2018-99-111090 VL - 132 ID - 1389 ER - TY - JOUR AD - C. Mambet, Stefan S Nicolau Institute of Virology, MyeloAL Program, Bucharest, Romania AU - Mambet, C. AU - Defour, J. P. AU - Babosova, O. AU - Leroy, E. AU - Necula, L. AU - Stanca, O. AU - Tatic, A. AU - Coriu, D. AU - Belickova, M. AU - Kralova, B. AU - Lanikova, L. AU - Saussoy, P. AU - Havelange, V. AU - Diaconu, C. C. AU - Divoky, V. AU - Constantinescu, S. N. DB - Embase DO - 10.1182/blood-2018-99-117019 LA - English M3 - Conference Abstract N1 - L626530538 2019-03-04 PY - 2018 SN - 0006-4971 ST - JAK2 R1063H variant enhances V617F constitutive signaling and favors development of essential thrombocythemia with increased hemoglobin and neutrophils T2 - Blood TI - JAK2 R1063H variant enhances V617F constitutive signaling and favors development of essential thrombocythemia with increased hemoglobin and neutrophils UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530538&from=export http://dx.doi.org/10.1182/blood-2018-99-117019 VL - 132 ID - 1390 ER - TY - JOUR AD - M. Sekimizu, Department of Pediatrics, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan AU - Sekimizu, M. AU - Fukano, R. AU - Choi, I. AU - Kada, A. AU - Saito, A. AU - Asada, R. AU - Mori, T. AU - Nagai, H. DB - Embase DO - 10.1182/blood-2018-99-112708 LA - English M3 - Conference Abstract N1 - L626530588 2019-03-04 PY - 2018 SN - 0006-4971 ST - Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma T2 - Blood TI - Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530588&from=export http://dx.doi.org/10.1182/blood-2018-99-112708 VL - 132 ID - 1391 ER - TY - JOUR AD - E.J. Lowe, Children's Hospital of The King's Daughters, Norfolk, VA, United States AU - Lowe, E. J. AU - Reilly, A. AU - Bollard, C. M. AU - Barkauskas, D. A. AU - Buxton, A. B. AU - Hall, D. AU - Saguilig, L. AU - Sandlund, J. T. DB - Embase DO - 10.1182/blood-2018-99-118450 LA - English M3 - Conference Abstract N1 - L626530846 2019-03-04 PY - 2018 SN - 0006-4971 ST - Toxicity profile of brentuximab vedotin in combination with chemotherapy for newly diagnosed patients with ALK+ ALCL: A children's oncology group study ANHL12P1 T2 - Blood TI - Toxicity profile of brentuximab vedotin in combination with chemotherapy for newly diagnosed patients with ALK+ ALCL: A children's oncology group study ANHL12P1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530846&from=export http://dx.doi.org/10.1182/blood-2018-99-118450 VL - 132 ID - 1392 ER - TY - JOUR AD - L. Lee, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Lee, L. AU - Krupski, M. C. AU - Clark, J. AU - Lorsbach, R. B. AU - Grimley, M. AU - Burwinkel, M. AU - Nelson, A. S. AU - Kumar, A. R. DB - Embase DO - 10.1182/blood-2018-99-119383 LA - English M3 - Conference Abstract N1 - L626531107 2019-03-04 PY - 2018 SN - 0006-4971 ST - High-risk langerhans cell histiocytosis in infants exhibits malignant features in a xenograft model but responds durably to targeted therapy T2 - Blood TI - High-risk langerhans cell histiocytosis in infants exhibits malignant features in a xenograft model but responds durably to targeted therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626531107&from=export http://dx.doi.org/10.1182/blood-2018-99-119383 VL - 132 ID - 1393 ER - TY - JOUR AD - B.H. Chang, OHSU, Portland, OR, United States AU - Chang, B. H. AU - Leonard, J. AU - Wolf, J. AU - Degnin, M. AU - Lenz, K. AU - Wilmot, B. AU - Mullighan, C. G. AU - Loh, M. L. AU - Hunger, S. P. AU - Tyner, J. W. AU - Druker, B. J. DB - Embase DO - 10.1182/blood-2018-99-115706 LA - English M3 - Conference Abstract N1 - L626588637 2019-03-08 PY - 2018 SN - 0006-4971 ST - Significant in vivo sensitivity to aurora kinase inhibition in TCF3-HLF rearranged acute lymphoblastic leukemia T2 - Blood TI - Significant in vivo sensitivity to aurora kinase inhibition in TCF3-HLF rearranged acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626588637&from=export http://dx.doi.org/10.1182/blood-2018-99-115706 VL - 132 ID - 1394 ER - TY - JOUR AD - C. Fan, Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai, China AU - Fan, C. AU - Cai, X. AU - Zhang, F. AU - Hochstetler, C. AU - Chen, X. AU - Guo, F. AU - Tian, W. AU - Zheng, Y. DB - Embase DO - 10.1182/blood-2018-99-115225 LA - English M3 - Conference Abstract N1 - L626588687 2019-03-08 PY - 2018 SN - 0006-4971 ST - Precision assessment of on-and off-target effects of mtor kinase inhibitors in a mouse model T2 - Blood TI - Precision assessment of on-and off-target effects of mtor kinase inhibitors in a mouse model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626588687&from=export http://dx.doi.org/10.1182/blood-2018-99-115225 VL - 132 ID - 1395 ER - TY - JOUR AD - H.-D. Chae, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States AU - Chae, H. D. AU - Murphy, L. C. AU - Donato, M. AU - Lee, A. G. AU - Alejandro Sweet-Cordero, E. AU - Abidi, P. AU - Bittencourt, H. AU - Lacayo, N. J. AU - Van Houten Dahl, G. AU - Aftandilian, C. AU - Davis, K. L. AU - Huang, M. AU - Sumarsono, N. AU - Redell, M. AU - Fu, C. H. AU - Chen, I. M. L. AU - Alonzo, T. A. AU - Eklund, E. A. AU - Gotlib, J. R. AU - Khatri, P. AU - Hijiya, N. AU - Sakamoto, K. M. DB - Embase DO - 10.1182/blood-2018-99-119974 LA - English M3 - Conference Abstract N1 - L626671631 2019-03-12 PY - 2018 SN - 0006-4971 ST - Comparison of the transcriptomic signature of pediatric vs. adult CML and normal bone marrow stem cells T2 - Blood TI - Comparison of the transcriptomic signature of pediatric vs. adult CML and normal bone marrow stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626671631&from=export http://dx.doi.org/10.1182/blood-2018-99-119974 VL - 132 ID - 1396 ER - TY - JOUR AD - R. Chang, Department of Neurosurgery, Weill Cornell Medicine, New York, NY, United States AU - Chang, R. AU - Tosi, U. AU - Maachani, U. B. AU - Voronina, I. AU - Schweitzer, M. AU - Wu, L. AU - Souweidane, M. DB - Embase DO - 10.1093/neuonc/noy148 LA - English M3 - Conference Abstract N1 - L628633890 2019-07-26 PY - 2018 SN - 1523-5866 SP - vi209 ST - Dual therapy with PI3K inhibitor ZSTK-474 and mek inhibitor trametinib via convection-enhanced delivery in a genetically-engineered mouse model of diffuse intrinsic pontine glioma T2 - Neuro-Oncology TI - Dual therapy with PI3K inhibitor ZSTK-474 and mek inhibitor trametinib via convection-enhanced delivery in a genetically-engineered mouse model of diffuse intrinsic pontine glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628633890&from=export http://dx.doi.org/10.1093/neuonc/noy148 VL - 20 ID - 1397 ER - TY - JOUR AD - N. Pflederer, Creighton University, Omaha, NE, United States AU - Pflederer, N. AU - Gross, J. AU - Bridge, J. AU - Nguyen, C. AU - Ruma, T. DB - Embase DO - 10.1093/neuonc/noy148 LA - English M3 - Conference Abstract N1 - L628635129 2019-07-26 PY - 2018 SN - 1523-5866 SP - vi241 ST - Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: A rare entity T2 - Neuro-Oncology TI - Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: A rare entity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628635129&from=export http://dx.doi.org/10.1093/neuonc/noy148 VL - 20 ID - 1398 ER - TY - JOUR AD - X. Fu, School of Pharmacy, Ningxia Medical University, Yinchuan, China AU - Dong, L. AU - Yin, L. AU - Chen, R. AU - Zhang, Y. AU - Hua, S. AU - Quan, H. AU - Fu, X. C2 - Quality Control Chemicals(United States) DB - Embase Medline DO - 10.1016/j.gene.2018.06.057 LA - English M3 - Article N1 - L2000915604 2018-07-09 2018-10-05 PY - 2018 SN - 1879-0038 0378-1119 SP - 94-101 ST - Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells T2 - Gene TI - Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000915604&from=export http://dx.doi.org/10.1016/j.gene.2018.06.057 VL - 675 ID - 1399 ER - TY - JOUR AD - A. Schriefer, Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil AU - Sousa, R. AU - Andrade, V. M. AU - Bair, T. AU - Ettinger, N. A. AU - Guimarães, L. AU - Andrade, L. AU - Guimarães, L. H. AU - Machado, P. R. L. AU - Carvalho, E. M. AU - Wilson, M. E. AU - Schriefer, A. DB - Embase DO - 10.3389/fmicb.2018.02464 IS - OCT LA - English M3 - Article N1 - L624296268 2018-10-29 2018-10-31 PY - 2018 SN - 1664-302X ST - Early suppression of macrophage gene expression by Leishmania braziliensis T2 - Frontiers in Microbiology TI - Early suppression of macrophage gene expression by Leishmania braziliensis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624296268&from=export http://dx.doi.org/10.3389/fmicb.2018.02464 VL - 9 ID - 1400 ER - TY - JOUR AD - T.H. Tran, Division of Pediatric Hematology-Oncology, CHU Sainte-Justine, 3175 Cote Sainte-Catherine, Local A-435, Montreal, QC, Canada AU - Khan, M. AU - Siddiqi, R. AU - Tran, T. H. C1 - azd 2014 nvp bbt 594 DB - Embase Medline DO - 10.1053/j.seminhematol.2018.05.001 IS - 4 LA - English M3 - Review N1 - L2000884840 2018-06-29 2018-12-06 PY - 2018 SN - 1532-8686 0037-1963 SP - 235-241 ST - Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options T2 - Seminars in Hematology TI - Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000884840&from=export http://dx.doi.org/10.1053/j.seminhematol.2018.05.001 VL - 55 ID - 1401 ER - TY - JOUR AD - F. Locatelli, Department of Pediatric Haematology and Oncology IRCCS, Ospedale Pediatrico Bambino Gesú, Rome, Italy AU - Locatelli, F. AU - Mauz-Koerholz, C. AU - Neville, K. AU - Llort, A. AU - Beishuizen, A. AU - Daw, S. AU - Pillon, M. AU - Aladjidi, N. AU - Klingebiel, T. AU - Landman-Parker, J. AU - Medina-Sanson, A. AU - August, K. AU - Sachs, J. AU - Hoffman, K. AU - Kinley, J. AU - Song, S. AU - Song, G. AU - Zhang, S. AU - Suri, A. AU - Gore, L. DB - Embase Medline DO - 10.1016/S2352-3026(18)30153-4 IS - 10 LA - English M3 - Article N1 - L2001149306 2018-10-08 2018-10-11 PY - 2018 SN - 2352-3026 SP - e450-e461 ST - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study T2 - The Lancet Haematology TI - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001149306&from=export http://dx.doi.org/10.1016/S2352-3026(18)30153-4 VL - 5 ID - 1403 ER - TY - JOUR AD - B. Scholtz, Genomic Medicine and Bioinformatic Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary AU - Horváth, J. AU - Szabó, A. AU - Tar, I. AU - Dezső, B. AU - Kiss, C. AU - Márton, I. AU - Scholtz, B. DB - Embase Medline DO - 10.1007/s12253-017-0296-1 IS - 4 LA - English M3 - Article N1 - L618172318 2017-09-12 2018-11-21 PY - 2018 SN - 1532-2807 1219-4956 SP - 833-842 ST - Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer T2 - Pathology and Oncology Research TI - Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618172318&from=export http://dx.doi.org/10.1007/s12253-017-0296-1 VL - 24 ID - 1404 ER - TY - JOUR AD - P. Bhatia, Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Totadri, S. AU - Singh, M. AU - Trehan, A. AU - Varma, N. AU - Bhatia, P. DB - Embase DO - 10.1007/s12288-018-0997-y IS - 4 LA - English M3 - Review N1 - L623527756 2018-08-22 2018-10-25 PY - 2018 SN - 0974-0449 0971-4502 SP - 595-601 ST - Keeping PACE with Ph Positive to Ph-Like Detection in B-Lineage Acute Lymphoblastic Leukemia: A Practical and Cost Effective (PACE) Approach in a Resource Constrained Setting T2 - Indian Journal of Hematology and Blood Transfusion TI - Keeping PACE with Ph Positive to Ph-Like Detection in B-Lineage Acute Lymphoblastic Leukemia: A Practical and Cost Effective (PACE) Approach in a Resource Constrained Setting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623527756&from=export http://dx.doi.org/10.1007/s12288-018-0997-y VL - 34 ID - 1405 ER - TY - JOUR AD - X.-P. Li, Department of Pediatrics, First Hospital of Jilin University, Changchun, Jilin Province, China AU - Gu, Y. AU - Ma, L. J. AU - Bai, X. X. AU - Jie, J. AU - Zhang, X. F. AU - Chen, D. AU - Li, X. P. DB - Embase DO - 10.4103/1673-5374.238621 IS - 10 LA - English M3 - Article N1 - L623688913 2018-09-04 2018-09-07 PY - 2018 SN - 1876-7958 1673-5374 SP - 1842-1850 ST - Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity T2 - Neural Regeneration Research TI - Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623688913&from=export http://dx.doi.org/10.4103/1673-5374.238621 VL - 13 ID - 1406 ER - TY - JOUR AU - Li, N. AU - Nan, C. C. AU - Zhong, X. Y. AU - Weng, J. Q. AU - Fan, H. D. AU - Sun, H. P. AU - Tang, S. AU - Shi, L. AU - Huang, S. X. DB - Embase Medline DO - 10.1159/000493411 IS - 4 LA - English M3 - Article N1 - L624040053 2018-10-01 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1329-1341 ST - MiR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1 T2 - Cellular Physiology and Biochemistry TI - MiR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624040053&from=export http://dx.doi.org/10.1159/000493411 VL - 49 ID - 1407 ER - TY - JOUR AU - Falero-Perez, J. AU - Song, Y. S. AU - Zhao, Y. AU - Teixeira, L. AU - Sorenson, C. M. AU - Sheibani, N. DB - Embase Medline DO - 10.1371/journal.pone.0206756 IS - 10 LA - English M3 - Article N1 - L624584113 2018-11-16 2019-04-19 PY - 2018 SN - 1932-6203 ST - Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells T2 - PLoS ONE TI - Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624584113&from=export http://dx.doi.org/10.1371/journal.pone.0206756 VL - 13 ID - 1408 ER - TY - JOUR AD - L. Crinó, Medical Oncology Unit, Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (IRST)- IRCCS, Meldola, Italy AU - Crinó, L. AU - Ahn, M. J. AU - Han, J. Y. AU - Liu, X. AU - Ou, S. H. I. AU - Shaw, A. T. AU - Yang, P. C. AU - Shi, Y. K. AU - Lanzalone, S. AU - Polli, A. AU - Wilner, K. D. AU - Kim, D. W. DB - Embase DO - 10.1093/annonc/mdy292.020 LA - English M3 - Conference Abstract N1 - L628559028 2019-07-23 PY - 2018 SN - 1569-8041 SP - viii503-viii504 ST - Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) T2 - Annals of Oncology TI - Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628559028&from=export http://dx.doi.org/10.1093/annonc/mdy292.020 VL - 29 ID - 1409 ER - TY - JOUR AD - M. Kalinova, Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine Motol University Hospital, Prague, Czech Republic AU - Kalinova, M. AU - Krskova, L. AU - Mrhalova, M. AU - Kabickova, E. AU - Riha, P. AU - Kodet, R. DB - Embase DO - 10.1093/annonc/mdy286.006 LA - English M3 - Conference Abstract N1 - L628560315 2019-07-23 PY - 2018 SN - 1569-8041 SP - viii361 ST - ALK positive anaplastic large cell lymphoma: Molecular diagnosis and minimal residual disease monitoring T2 - Annals of Oncology TI - ALK positive anaplastic large cell lymphoma: Molecular diagnosis and minimal residual disease monitoring UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628560315&from=export http://dx.doi.org/10.1093/annonc/mdy286.006 VL - 29 ID - 1410 ER - TY - JOUR AD - A.W. Baqir, SUNY Downstate, United States AU - Baqir, A. W. AU - Gupta, R. AU - Dresner, L. AU - Zuretti, A. DB - Embase DO - 10.1093/ajcp/aqy090 LA - English M3 - Conference Abstract N1 - L629440950 2019-10-02 PY - 2018 SN - 1943-7722 SP - S21 ST - A pediatric primary anaplastic large cell lymphoma of the breast: Unusual presentation in an unexpected clinical setting T2 - American Journal of Clinical Pathology TI - A pediatric primary anaplastic large cell lymphoma of the breast: Unusual presentation in an unexpected clinical setting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629440950&from=export http://dx.doi.org/10.1093/ajcp/aqy090 VL - 150 ID - 1411 ER - TY - JOUR AD - S. Bakhshi, Department of Medical Oncology, Dr B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India AU - Patel, A. AU - Sharma, M. C. AU - Bakhshi, S. DB - Embase Medline DO - 10.1007/s12098-017-2585-9 IS - 9 LA - English M3 - Article N1 - L620625746 2018-02-15 2018-11-16 PY - 2018 SN - 0973-7693 0019-5456 SP - 782-784 ST - Outcome of Early Stage Pediatric Non-Lymphoblastic Non-Hodgkin Lymphoma T2 - Indian Journal of Pediatrics TI - Outcome of Early Stage Pediatric Non-Lymphoblastic Non-Hodgkin Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620625746&from=export http://dx.doi.org/10.1007/s12098-017-2585-9 VL - 85 ID - 1414 ER - TY - JOUR AD - J. Lu, Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, China AU - Wu, D. M. AU - Wang, Y. J. AU - Han, X. R. AU - Wen, X. AU - Wang, S. AU - Shen, M. AU - Fan, S. H. AU - Zhuang, J. AU - Zhang, Z. F. AU - Shan, Q. AU - Li, M. Q. AU - Hu, B. AU - Sun, C. H. AU - Lu, J. AU - Zheng, Y. L. DB - Embase Medline DO - 10.1002/jcp.26329 IS - 9 LA - English M3 - Article N1 - L621386526 2018-03-28 2018-06-08 PY - 2018 SN - 1097-4652 0021-9541 SP - 6689-6704 ST - LncRNA LINC00880 promotes cell proliferation, migration, and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma T2 - Journal of Cellular Physiology TI - LncRNA LINC00880 promotes cell proliferation, migration, and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621386526&from=export http://dx.doi.org/10.1002/jcp.26329 VL - 233 ID - 1415 ER - TY - JOUR AD - G. Kaur, Medical Biotechnology Laboratory, Department of Biotechnology, Guru Nanak Dev University, Amritsar, Punjab, India AU - Gupta, M. AU - Kaur, G. DB - Embase Medline DO - 10.1007/s12017-018-8497-7 IS - 3 LA - English M3 - Article N1 - L622411330 2018-06-06 PY - 2018 SN - 1559-1174 1535-1084 SP - 343-362 ST - Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation T2 - NeuroMolecular Medicine TI - Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622411330&from=export http://dx.doi.org/10.1007/s12017-018-8497-7 VL - 20 ID - 1416 ER - TY - JOUR AD - M. Pinter, Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria AU - Pinter, M. AU - Peck-Radosavljevic, M. C1 - fgf 401 DB - Embase Medline DO - 10.1111/apt.14913 IS - 6 LA - English M3 - Review N1 - L623244376 2018-08-01 2018-08-30 PY - 2018 SN - 1365-2036 0269-2813 SP - 598-609 ST - Review article: systemic treatment of hepatocellular carcinoma T2 - Alimentary Pharmacology and Therapeutics TI - Review article: systemic treatment of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623244376&from=export http://dx.doi.org/10.1111/apt.14913 VL - 48 ID - 1417 ER - TY - JOUR AD - A.O.S. El-Kadi, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada AU - Maayah, Z. H. AU - Zhang, T. AU - Forrest, M. L. AU - Alrushaid, S. AU - Doschak, M. R. AU - Davies, N. M. AU - El-Kadi, A. O. S. DB - Embase DO - 10.3390/pharmaceutics10030144 IS - 3 LA - English M3 - Article N1 - L623783787 2018-09-18 2018-09-24 PY - 2018 SN - 1999-4923 ST - DOX-vit D, a novel doxorubicin delivery approach, inhibits human osteosarcoma cell proliferation by inducing apoptosis while inhibiting akt and mTOR signaling pathways T2 - Pharmaceutics TI - DOX-vit D, a novel doxorubicin delivery approach, inhibits human osteosarcoma cell proliferation by inducing apoptosis while inhibiting akt and mTOR signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623783787&from=export http://dx.doi.org/10.3390/pharmaceutics10030144 VL - 10 ID - 1419 ER - TY - JOUR AD - A. Bhargava, Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, United States AU - Hagiwara, S. I. AU - Kaushal, E. AU - Paruthiyil, S. AU - Pasricha, P. J. AU - Hasdemir, B. AU - Bhargava, A. DB - Embase Medline DO - 10.1371/journal.pone.0203704 IS - 9 LA - English M3 - Article N1 - L623831956 2018-09-18 2018-09-20 PY - 2018 SN - 1932-6203 ST - Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia T2 - PLoS ONE TI - Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623831956&from=export http://dx.doi.org/10.1371/journal.pone.0203704 VL - 13 ID - 1420 ER - TY - JOUR AD - C.S. Venegas López, Hospital General de México, Dept. of Pathology, Ciudad De México, Mexico AU - Venegas López, C. S. AU - Pilar Eguía-Aguilar, M. D. AU - Pérezpeña-Díazconti, J. M. AU - García-Quintana, J. AU - Aguirre Hernández, J. AU - Valencia Mayoral, P. AU - Luna Hernández, A. DB - Embase DO - 10.1007/s00428-018-2422-1 LA - English M3 - Conference Abstract N1 - L623968534 2018-09-25 PY - 2018 SN - 1432-2307 SP - 310 ST - Differential expression of microRNAs in mesenchymal hamartoma and undifferentiated embryonal sarcoma T2 - Virchows Archiv TI - Differential expression of microRNAs in mesenchymal hamartoma and undifferentiated embryonal sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623968534&from=export http://dx.doi.org/10.1007/s00428-018-2422-1 VL - 473 ID - 1421 ER - TY - JOUR AD - L. Gabler, Department of Medicine I, Institute of Cancer Research, Medical University, Vienna, Austria AU - Gabler, L. AU - Gojo, J. AU - Lötsch, D. AU - Kirchhofer, D. AU - Van Schoonhoven, S. AU - Stojanovic, M. AU - Schmidt, H. M. AU - Ensle, D. AU - Czech, T. AU - Haberler, C. AU - Slavc, I. AU - Spiegl-Kreinecker, S. AU - Berger, W. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239666 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii290 ST - TERT promoter mutation-driven TERT activation is mediated by ETS1 in BRAF V600E mutated glioma T2 - Neuro-Oncology TI - TERT promoter mutation-driven TERT activation is mediated by ETS1 in BRAF V600E mutated glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239666&from=export http://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 1422 ER - TY - JOUR AD - A. Guerreiro Stücklin, PLGG Taskforce The Hospital for Sick Children, Toronto, ON, Canada AU - Guerreiro Stücklin, A. AU - Ryall, S. AU - Fukuoka, K. AU - Zapotocky, M. AU - Lassaletta, A. AU - Arnoldo, A. AU - Zhong, Y. AU - Kowalski, P. AU - Li, C. AU - Grotzer, M. AU - Taylor, M. AU - Tabori, U. AU - Hawkins, C. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239699 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii224 ST - Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life T2 - Neuro-Oncology TI - Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239699&from=export http://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 1423 ER - TY - JOUR AD - D. Loetsch, Institute of Cancer Research, Vienna, Vienna, Austria AU - Loetsch, D. AU - Gojo, J. AU - Kirchhofer, D. AU - Van Schoonhoven, S. AU - Pajtler, K. AU - Kool, M. AU - Haberler, C. AU - Czech, T. AU - Slavc, I. AU - Berger, W. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239757 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii224 ST - FGFR a novel target in malignant pediatric ependymoma T2 - Neuro-Oncology TI - FGFR a novel target in malignant pediatric ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239757&from=export http://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 1424 ER - TY - JOUR AD - R. Guiho, Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Institute of Child Health, London, United Kingdom AU - Guiho, R. AU - Apps, J. R. AU - Hong, Y. AU - Hargrave, D. AU - Brogan, P. AU - Jacques, T. S. AU - Martinez-Barbera, J. P. DB - Embase DO - 10.1159/000492307 LA - English M3 - Conference Abstract N1 - L630602135 2020-01-20 PY - 2018 SN - 1663-2826 SP - 58-59 ST - Identification of the MAPK/ERK pathway as a novel therapeutic target in adamantinomatous craniopharyngioma T2 - Hormone Research in Paediatrics TI - Identification of the MAPK/ERK pathway as a novel therapeutic target in adamantinomatous craniopharyngioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630602135&from=export http://dx.doi.org/10.1159/000492307 VL - 90 ID - 1426 ER - TY - JOUR AD - M. Umetani, Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, United States AU - Hiramitsu, S. AU - Ishikawa, T. AU - Lee, W. R. AU - Khan, T. AU - Crumbley, C. AU - Khwaja, N. AU - Zamanian, F. AU - Asghari, A. AU - Sen, M. AU - Zhang, Y. AU - Hawse, J. R. AU - Minna, J. D. AU - Umetani, M. DB - Embase DO - 10.3389/fendo.2018.00470 IS - AUG LA - English M3 - Article N1 - L623589424 2018-08-31 2018-09-05 PY - 2018 SN - 1664-2392 ST - Estrogen receptor beta-mediated modulation of lung cancer cell proliferation by 27-hydroxycholesterol T2 - Frontiers in Endocrinology TI - Estrogen receptor beta-mediated modulation of lung cancer cell proliferation by 27-hydroxycholesterol UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623589424&from=export http://dx.doi.org/10.3389/fendo.2018.00470 VL - 9 ID - 1428 ER - TY - JOUR AD - I. Murakami, Department of Pathology, Kochi Medical School, Kochi University, Kohasu, Okoh, Nankoku, Kochi, Japan AU - Murakami, I. AU - Wada, N. AU - Nakashima, J. AU - Iguchi, M. AU - Toi, M. AU - Hashida, Y. AU - Higuchi, T. AU - Daibata, M. AU - Matsushita, M. AU - Iwasaki, T. AU - Kuwamoto, S. AU - Horie, Y. AU - Nagata, K. AU - Hayashi, K. AU - Oka, T. AU - Yoshino, T. AU - Imamura, T. AU - Morimoto, A. AU - Imashuku, S. AU - Gogusev, J. AU - Jaubert, F. DB - Embase Medline DO - 10.1186/s12964-018-0261-y IS - 1 LA - English M3 - Review N1 - L623556902 2018-08-28 2018-08-30 PY - 2018 SN - 1478-811X ST - Merkel cell polyomavirus and Langerhans cell neoplasm T2 - Cell Communication and Signaling TI - Merkel cell polyomavirus and Langerhans cell neoplasm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623556902&from=export http://dx.doi.org/10.1186/s12964-018-0261-y VL - 16 ID - 1429 ER - TY - JOUR AD - B. Liu, School of Traditional Chinese Medicine, Southern Medical University, 1063 Shatai Road, Guangzhou, Guangdong, China AU - Fan, H. J. AU - Xie, Z. P. AU - Lu, Z. W. AU - Tan, Z. B. AU - Bi, Y. M. AU - Xie, L. P. AU - Wu, Y. T. AU - Zhang, W. T. AU - Liu-Kot, K. AU - Liu, B. AU - Zhou, Y. C. C2 - sanjiu medical and pharmaceutical(China) shanghai chemical reagent company(China) DB - Embase Medline DO - 10.1016/j.jep.2018.04.032 LA - English M3 - Article N1 - L2000730406 2018-05-17 2018-10-24 PY - 2018 SN - 1872-7573 0378-8741 SP - 1-10 ST - Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction T2 - Journal of Ethnopharmacology TI - Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000730406&from=export http://dx.doi.org/10.1016/j.jep.2018.04.032 VL - 222 ID - 1430 ER - TY - JOUR AD - D.S. Kaufman, Department of Medicine, Division of Regenerative Medicine, Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, United States AU - Li, Y. AU - Hermanson, D. L. AU - Moriarity, B. S. AU - Kaufman, D. S. DB - Embase Medline DO - 10.1016/j.stem.2018.06.002 IS - 2 LA - English M3 - Article N1 - L2000887071 2018-06-29 2018-11-27 PY - 2018 SN - 1875-9777 1934-5909 SP - 181-192.e5 ST - Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity T2 - Cell Stem Cell TI - Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000887071&from=export http://dx.doi.org/10.1016/j.stem.2018.06.002 VL - 23 ID - 1431 ER - TY - JOUR AD - K.C. Moon, Department of Pathology and Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, 103 Daehak-ro Jongno-gu, Seoul, South Korea AU - Park, J. H. AU - Lee, C. AU - Chang, M. S. AU - Kim, K. AU - Choi, S. AU - Lee, H. AU - Lee, H. S. AU - Moon, K. C. DB - Embase DO - 10.1016/j.tranon.2018.05.010 IS - 4 LA - English M3 - Article N1 - L2000863275 2018-06-21 2018-06-26 PY - 2018 SN - 1936-5233 SP - 962-970 ST - Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma T2 - Translational Oncology TI - Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000863275&from=export http://dx.doi.org/10.1016/j.tranon.2018.05.010 VL - 11 ID - 1432 ER - TY - JOUR AD - M.H. Alhagamhmad, Faculty of Medicine, University of Benghazi (Al-Arab Medical University), Benghazi, Libyan Arab Jamahiriya AU - Alhagamhmad, M. H. DB - Embase Medline DO - 10.1002/ncp.10004 IS - 4 LA - English M3 - Review N1 - L620248614 2018-01-23 2018-11-21 PY - 2018 SN - 1941-2452 0884-5336 SP - 483-492 ST - Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy T2 - Nutrition in Clinical Practice TI - Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620248614&from=export http://dx.doi.org/10.1002/ncp.10004 VL - 33 ID - 1433 ER - TY - JOUR AD - R. Jiang, Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China AU - Zhao, J. AU - Zhang, C. AU - Gao, Z. AU - Wu, H. AU - Gu, R. AU - Jiang, R. DB - Embase Medline DO - 10.1002/jcb.26671 IS - 8 LA - English M3 - Article N1 - L622321872 2018-05-31 2018-07-09 PY - 2018 SN - 1097-4644 0730-2312 SP - 6461-6469 ST - Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21 T2 - Journal of Cellular Biochemistry TI - Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622321872&from=export http://dx.doi.org/10.1002/jcb.26671 VL - 119 ID - 1435 ER - TY - JOUR AD - Z. Wang, Pediatric Orthopedic Department, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, 1678 Dongfang Road, Pudong, Shanghai, China AU - Cai, H. AU - Miao, M. AU - Wang, Z. DB - Embase DO - 10.3892/ol.2018.8927 IS - 2 LA - English M3 - Article N1 - L622921393 2018-07-11 2018-07-17 PY - 2018 SN - 1792-1082 1792-1074 SP - 2620-2628 ST - Mir-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting cadm1 T2 - Oncology Letters TI - Mir-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting cadm1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622921393&from=export http://dx.doi.org/10.3892/ol.2018.8927 VL - 16 ID - 1438 ER - TY - JOUR AD - R. Somech, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center; Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, 52621, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel AU - Somekh, I. AU - Marquardt, B. AU - Liu, Y. AU - Rohlfs, M. AU - Hollizeck, S. AU - Karakukcu, M. AU - Unal, E. AU - Yilmaz, E. AU - Patiroglu, T. AU - Cansever, M. AU - Frizinsky, S. AU - Vishnvenska-Dai, V. AU - Rechavi, E. AU - Stauber, T. AU - Simon, A. J. AU - Lev, A. AU - Klein, C. AU - Kotlarz, D. AU - Somech, R. DB - Embase Medline DO - 10.1007/s10875-018-0533-8 IS - 6 LA - English M3 - Article N1 - L623185246 2018-07-30 2018-09-25 PY - 2018 SN - 1573-2592 0271-9142 SP - 699-710 ST - Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma T2 - Journal of Clinical Immunology TI - Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623185246&from=export http://dx.doi.org/10.1007/s10875-018-0533-8 VL - 38 ID - 1439 ER - TY - JOUR AD - S.H. Ghaffari, Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran, Iran AU - Zekri, A. AU - Mesbahi, Y. AU - Boustanipour, E. AU - Sadr, Z. AU - Ghaffari, S. H. C1 - azd 1152 DB - Embase Medline DO - 10.1007/s12031-018-1118-y IS - 4 LA - English M3 - Article N1 - L623276979 2018-08-03 2018-11-21 PY - 2018 SN - 1559-1166 0895-8696 SP - 444-455 ST - The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA) T2 - Journal of Molecular Neuroscience TI - The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623276979&from=export http://dx.doi.org/10.1007/s12031-018-1118-y VL - 65 ID - 1440 ER - TY - JOUR AD - P. Lu, International Medical Center, Hebei Yanda Lu Daopei Hospital, Langfang, China AU - Zhang, Y. AU - Wang, F. AU - Chen, X. AU - Zhang, Y. AU - Wang, M. AU - Liu, H. AU - Cao, P. AU - Ma, X. AU - Wang, T. AU - Zhang, J. AU - Zhang, X. AU - Lu, P. AU - Liu, H. DB - Embase Medline DO - 10.1002/cncr.31586 IS - 16 LA - English M3 - Article N1 - L623638082 2018-08-31 2018-09-04 PY - 2018 SN - 1097-0142 0008-543X SP - 3329-3338 ST - CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia T2 - Cancer TI - CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623638082&from=export http://dx.doi.org/10.1002/cncr.31586 VL - 124 ID - 1441 ER - TY - JOUR AD - D.N. Meijles AU - Meijles, D. N. AU - Rostron, K. A. AU - Fuller, S. J. AU - Sugden, P. H. AU - Clerk, A. DB - Embase DO - 10.1161/res.123.suppl_1.491 LA - English M3 - Conference Abstract N1 - L628264720 2019-07-01 PY - 2018 SN - 1524-4571 ST - Cardiomyocyte braf promotes hypertrophy and is required for hypertrophic adaptation to hypertension in mice in vivo, but raf inhibitors have differential effects T2 - Circulation Research TI - Cardiomyocyte braf promotes hypertrophy and is required for hypertrophic adaptation to hypertension in mice in vivo, but raf inhibitors have differential effects UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628264720&from=export http://dx.doi.org/10.1161/res.123.suppl_1.491 VL - 123 ID - 1444 ER - TY - JOUR AD - A.P. Singh, Vanderbilt Univ Med. Cntr, Nashville, TN, United States AU - Singh, A. P. AU - Glennon, M. S. AU - Umbarkar, P. P. AU - Gupte, M. AU - Galindo, C. L. AU - Zhang, Q. AU - Force, T. AU - Becker, J. R. AU - Lal, H. DB - Embase DO - 10.1161/res.123.suppl_1.361 LA - English M3 - Conference Abstract N1 - L628264730 2019-07-01 PY - 2018 SN - 1524-4571 ST - Analysis of cardiotoxic mechanisms associated with tyrosine kinase inhibitor ponatinib T2 - Circulation Research TI - Analysis of cardiotoxic mechanisms associated with tyrosine kinase inhibitor ponatinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628264730&from=export http://dx.doi.org/10.1161/res.123.suppl_1.361 VL - 123 ID - 1445 ER - TY - JOUR AD - E. Santamaría, Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Irunlarrea, Pamplona, Spain AU - González-Morales, A. AU - Zabaleta, A. AU - Guruceaga, E. AU - Alonso, M. M. AU - García-Moure, M. AU - Fernández-Irigoyen, J. AU - Santamaría, E. C1 - dnx 2401 DB - Embase DO - 10.18632/oncotarget.25774 IS - 57 LA - English M3 - Article N1 - L623245969 2018-08-01 2018-08-03 PY - 2018 SN - 1949-2553 SP - 31045-31065 ST - Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection T2 - Oncotarget TI - Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623245969&from=export http://dx.doi.org/10.18632/oncotarget.25774 VL - 9 ID - 1446 ER - TY - JOUR AD - P.A.J. Henricks, Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, Utrecht, CG, Netherlands AU - Li, M. AU - van Esch, B. C. A. M. AU - Wagenaar, G. T. M. AU - Garssen, J. AU - Folkerts, G. AU - Henricks, P. A. J. DB - Embase Medline DO - 10.1016/j.ejphar.2018.05.003 LA - English M3 - Article N1 - L2000764967 2018-05-30 2018-10-23 PY - 2018 SN - 1879-0712 0014-2999 SP - 52-59 ST - Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells T2 - European Journal of Pharmacology TI - Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000764967&from=export http://dx.doi.org/10.1016/j.ejphar.2018.05.003 VL - 831 ID - 1447 ER - TY - JOUR AD - C.E. McCoach, Division of Medical Oncology, UCSF Helen Diller Comprehensive Cancer Center, 1600 Divisadero St, MS 1770, San Francisco, CA, United States AU - McCoach, C. E. AU - Le, A. T. AU - Gowan, K. AU - Jones, K. AU - Schubert, L. AU - Doak, A. AU - Estrada-Bernal, A. AU - Davies, K. D. AU - Merrick, D. T. AU - Bunn, P. A. AU - Purcell, W. T. AU - Dziadziuszko, R. AU - Varella-Garcia, M. AU - Aisner, D. L. AU - Camidge, D. R. AU - Doebele, R. C. DB - Embase Medline DO - 10.1158/1078-0432.CCR-17-2452 IS - 14 LA - English M3 - Article N1 - L623054788 2018-07-25 PY - 2018 SN - 1557-3265 1078-0432 SP - 3334-3347 ST - Resistance mechanisms to targeted therapies in ROS1þ and ALKþ non–small cell lung cancer T2 - Clinical Cancer Research TI - Resistance mechanisms to targeted therapies in ROS1þ and ALKþ non–small cell lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623054788&from=export http://dx.doi.org/10.1158/1078-0432.CCR-17-2452 VL - 24 ID - 1448 ER - TY - JOUR AD - T. Visalli, Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ, United States AU - Visalli, T. AU - Bower, N. AU - Kokate, T. AU - Andrews, P. A. DB - Embase Medline DO - 10.1016/j.yrtph.2018.05.009 LA - English M3 - Review N1 - L2000787373 2018-05-29 2018-12-27 PY - 2018 SN - 1096-0295 0273-2300 SP - 167-177 ST - Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials T2 - Regulatory Toxicology and Pharmacology TI - Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000787373&from=export http://dx.doi.org/10.1016/j.yrtph.2018.05.009 VL - 96 ID - 1450 ER - TY - JOUR AD - C. Li, Department of Interventional MRI, Shandong Medical Imaging Research Institute Affiliated to Shandong University, Jinan, Shandong, China AU - Liu, C. AU - Wang, L. AU - Qiu, H. AU - Dong, Q. AU - Feng, Y. AU - Li, D. AU - Li, C. AU - Fan, C. DB - Embase Medline DO - 10.1007/s11064-018-2547-2 IS - 7 LA - English M3 - Article N1 - L622315566 2018-05-30 2018-11-23 PY - 2018 SN - 1573-6903 0364-3190 SP - 1317-1327 ST - Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk T2 - Neurochemical Research TI - Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622315566&from=export http://dx.doi.org/10.1007/s11064-018-2547-2 VL - 43 ID - 1452 ER - TY - JOUR AD - I. Modlin, Department of Gastrointestinal Surgery, School of Medicine, Yale University, Connecticut, United States AU - Alvarez, M. J. AU - Subramaniam, P. S. AU - Tang, L. H. AU - Grunn, A. AU - Aburi, M. AU - Rieckhof, G. AU - Komissarova, E. V. AU - Hagan, E. A. AU - Bodei, L. AU - Clemons, P. A. AU - Dela Cruz, F. S. AU - Dhall, D. AU - Diolaiti, D. AU - Fraker, D. A. AU - Ghavami, A. AU - Kaemmerer, D. AU - Karan, C. AU - Kidd, M. AU - Kim, K. M. AU - Kim, H. C. AU - Kunju, L. P. AU - Langel, Ü AU - Li, Z. AU - Lee, J. AU - Li, H. AU - Livolsi, V. AU - Pfragner, R. AU - Rainey, A. R. AU - Realubit, R. B. AU - Remotti, H. AU - Regberg, J. AU - Roses, R. AU - Rustgi, A. AU - Sepulveda, A. R. AU - Serra, S. AU - Shi, C. AU - Yuan, X. AU - Barberis, M. AU - Bergamaschi, R. AU - Chinnaiyan, A. M. AU - Detre, T. AU - Ezzat, S. AU - Frilling, A. AU - Hommann, M. AU - Jaeger, D. AU - Kim, M. K. AU - Knudsen, B. S. AU - Kung, A. L. AU - Leahy, E. AU - Metz, D. C. AU - Milsom, J. W. AU - Park, Y. S. AU - Reidy-Lagunes, D. AU - Schreiber, S. AU - Washington, K. AU - Wiedenmann, B. AU - Modlin, I. AU - Califano, A. C1 - arq 197 azd 8055 cd 437 fk 866 i bet 151 ly 2183240 mk 2206 ms 27 275 pdx 101 pha 665752 su 11274 y 27632 DB - Embase Medline DO - 10.1038/s41588-018-0138-4 IS - 7 LA - English M3 - Article N1 - L622636890 2018-06-25 2018-07-17 PY - 2018 SN - 1546-1718 1061-4036 SP - 979-989 ST - A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors T2 - Nature Genetics TI - A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622636890&from=export http://dx.doi.org/10.1038/s41588-018-0138-4 VL - 50 ID - 1453 ER - TY - JOUR AD - Y. Balachandran, Transplant Immunology Laboratory, Division of Abdominal Transplant, Stanford University, Stanford, CA, United States AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. D. AU - Esquivel, C. O. AU - Krams, S. AU - Martinez, O. M. DB - Embase IS - 7 LA - English M3 - Conference Abstract N1 - L623701485 2018-09-05 PY - 2018 SN - 0041-1337 SP - S319 ST - Delineation of the viral and host cell genomic alterations in EBV-positive PTLD T2 - Transplantation TI - Delineation of the viral and host cell genomic alterations in EBV-positive PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623701485&from=export VL - 102 ID - 1454 ER - TY - JOUR AD - A. Agarwal, Department of Endocrine Surgery, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India AU - George, N. AU - Agarwal, A. AU - Kumari, N. AU - Agarwal, S. AU - Krisnani, N. AU - Gupta, S. DB - Embase DO - 10.4103/ijem.IJEM_441_17 IS - 4 LA - English M3 - Article N1 - L624425790 2018-10-23 2018-10-26 PY - 2018 SN - 2230-9500 2230-8210 SP - 505-510 ST - Mutational profile of papillary thyroid carcinoma in an endemic goiter region of North India T2 - Indian Journal of Endocrinology and Metabolism TI - Mutational profile of papillary thyroid carcinoma in an endemic goiter region of North India UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624425790&from=export http://dx.doi.org/10.4103/ijem.IJEM_441_17 VL - 22 ID - 1455 ER - TY - JOUR AD - C.-P. Chiang, Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan AU - Gao, H. W. AU - Tsai, W. C. AU - Perng, C. L. AU - Wang, W. M. AU - Chiang, C. P. DB - Embase Medline DO - 10.1684/ejd.2018.3359 IS - 4 LA - English M3 - Article N1 - L624877894 2019-01-11 2019-04-19 PY - 2018 SN - 1952-4013 1167-1122 SP - 509-518 ST - Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals T2 - European Journal of Dermatology TI - Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624877894&from=export http://dx.doi.org/10.1684/ejd.2018.3359 VL - 28 ID - 1456 ER - TY - JOUR AD - S. Ispasanie, Charité Universitätsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumour Pathology and Systems Biology, Berlin, Germany AU - Ispasanie, S. AU - Kistler, S. AU - Heberle, A. AU - Uhlitz, F. AU - Kasack, K. AU - Dittmar, G. AU - Blüthgen, N. AU - Thedieck, K. AU - Campbell, S. AU - Sers, C. DB - Embase DO - 10.1136/esmoopen-2018-EACR25.518 LA - English M3 - Conference Abstract N1 - L627974500 2019-06-11 PY - 2018 SN - 2059-7029 SP - A218-A219 ST - HDAC inhibitor resistance in colorectal cancer: RAS and amp; MYC-the partners in crime T2 - ESMO Open TI - HDAC inhibitor resistance in colorectal cancer: RAS and amp; MYC-the partners in crime UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627974500&from=export http://dx.doi.org/10.1136/esmoopen-2018-EACR25.518 VL - 3 ID - 1458 ER - TY - JOUR AD - E. Cordes, Western Michigan University School of Medicine, Kalamazoo, MI, United States AU - Cordes, E. AU - Barr, J. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.705 IS - 1 LA - English M3 - Conference Abstract N1 - L630752688 2020-02-04 PY - 2018 SN - 1098-4275 ST - Widening the differential: An adult case of hemophagocytic lymphohistiocytosis disguised as a fever of unknown origin T2 - Pediatrics TI - Widening the differential: An adult case of hemophagocytic lymphohistiocytosis disguised as a fever of unknown origin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752688&from=export http://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.705 VL - 142 ID - 1459 ER - TY - JOUR AD - J.M. Fischer, Uniformed Services University of the Health Sciences, Gaithersburg, MD, United States AU - Fischer, J. M. AU - Smith, B. AU - Waters, A. AU - Krishnamurthy, J. AU - Parekh, D. AU - Thiele, C. AU - Lieuw, K. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.609 IS - 1 LA - English M3 - Conference Abstract N1 - L630752770 2020-02-04 PY - 2018 SN - 1098-4275 ST - Development of a minimal residual disease assay for anaplastic lymphoma kinase mutations using digital droplet polymerase chain reaction T2 - Pediatrics TI - Development of a minimal residual disease assay for anaplastic lymphoma kinase mutations using digital droplet polymerase chain reaction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752770&from=export http://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.609 VL - 142 ID - 1460 ER - TY - JOUR AD - M. Nishitani, University of Chicago Medical Center, Chicago, IL, United States AU - Nishitani, M. AU - Dolan, P. AU - Gundeti, M. AU - Tonsgard, J. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.464 IS - 1 LA - English M3 - Conference Abstract N1 - L630752940 2020-02-04 PY - 2018 SN - 1098-4275 ST - Teen with neurofibromatosis type 1 presents with large scrotal mass and large tumor burden T2 - Pediatrics TI - Teen with neurofibromatosis type 1 presents with large scrotal mass and large tumor burden UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752940&from=export http://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.464 VL - 142 ID - 1461 ER - TY - JOUR DB - Embase IS - 1 LA - English M3 - Conference Review N1 - L630753127 2020-02-04 PY - 2018 SN - 1098-4275 ST - NCE Abstracts 2017 T2 - Pediatrics TI - NCE Abstracts 2017 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630753127&from=export VL - 142 ID - 1462 ER - TY - JOUR AD - Y. Yu, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China AU - Liu, J. AU - Qu, J. AU - Zhou, W. AU - Huang, Y. AU - Jia, L. AU - Huang, X. AU - Qian, Z. AU - Xia, J. AU - Yu, Y. DB - Embase Medline DO - 10.1016/j.ejmech.2018.05.015 LA - English M3 - Article N1 - L2000807242 2018-06-05 2020-10-07 PY - 2018 SN - 1768-3254 0223-5234 SP - 354-366 ST - Syntenin-targeted peptide blocker inhibits progression of cancer cells T2 - European Journal of Medicinal Chemistry TI - Syntenin-targeted peptide blocker inhibits progression of cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000807242&from=export http://dx.doi.org/10.1016/j.ejmech.2018.05.015 VL - 154 ID - 1463 ER - TY - JOUR AD - J.B. Kunz, Heidelberg University Children's Hospital, Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg, Germany AU - Cordas dos Santos, D. M. AU - Eilers, J. AU - Sosa Vizcaino, A. AU - Orlova, E. AU - Zimmermann, M. AU - Stanulla, M. AU - Schrappe, M. AU - Börner, K. AU - Grimm, D. AU - Muckenthaler, M. U. AU - Kulozik, A. E. AU - Kunz, J. B. DB - Embase Medline DO - 10.1186/s12885-018-4525-0 IS - 1 LA - English M3 - Article N1 - L622608485 2018-06-26 2019-02-14 PY - 2018 SN - 1471-2407 ST - MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-ΚB T2 - BMC Cancer TI - MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-ΚB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622608485&from=export http://dx.doi.org/10.1186/s12885-018-4525-0 VL - 18 ID - 1464 ER - TY - JOUR AD - D. Tang, Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA, United States AU - Yang, M. AU - Li, C. AU - Zhu, S. AU - Cao, L. AU - Kroemer, G. AU - Zeh, H. AU - Tang, D. AU - Kang, R. C2 - Selleck(United States) Sigma(United States) DB - Embase DO - 10.1080/2162402X.2018.1431086 IS - 6 LA - English M3 - Article N1 - L620741404 2018-02-22 2018-06-26 PY - 2018 SN - 2162-402X 2162-4011 ST - TFAM is a novel mediator of immunogenic cancer cell death T2 - OncoImmunology TI - TFAM is a novel mediator of immunogenic cancer cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620741404&from=export http://dx.doi.org/10.1080/2162402X.2018.1431086 VL - 7 ID - 1465 ER - TY - JOUR AD - G. Nuovo, GNOME Diagnostics, Powell, OH, United States AU - Tili, E. AU - Mezache, L. AU - Michaille, J. J. AU - Amann, V. AU - Williams, J. AU - Vandiver, P. AU - Quinonez, M. AU - Fadda, P. AU - Mikhail, A. AU - Nuovo, G. DB - Embase Medline DO - 10.1016/j.anndiagpath.2018.03.006 LA - English M3 - Article N1 - L2000609259 2018-04-13 2018-11-06 PY - 2018 SN - 1532-8198 1092-9134 SP - 103-109 ST - microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia T2 - Annals of Diagnostic Pathology TI - microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000609259&from=export http://dx.doi.org/10.1016/j.anndiagpath.2018.03.006 VL - 34 ID - 1466 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium AU - Schöffski, P. AU - Sufliarsky, J. AU - Gelderblom, H. AU - Blay, J. Y. AU - Strauss, S. J. AU - Stacchiotti, S. AU - Rutkowski, P. AU - Lindner, L. H. AU - Leahy, M. G. AU - Italiano, A. AU - Isambert, N. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Van Cann, T. AU - Marréaud, S. AU - Nzokirantevye, A. AU - Collette, S. AU - Wozniak, A. C1 - xalkori(Pfizer,United States) C2 - Pfizer(United States) DB - Embase Medline DO - 10.1016/S2213-2600(18)30116-4 IS - 6 LA - English M3 - Article N1 - L2000644913 2018-04-17 2018-06-01 PY - 2018 SN - 2213-2619 2213-2600 SP - 431-441 ST - Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial T2 - The Lancet Respiratory Medicine TI - Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000644913&from=export http://dx.doi.org/10.1016/S2213-2600(18)30116-4 VL - 6 ID - 1467 ER - TY - JOUR AD - D.S. Hong, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Kato, S. AU - Jardim, D. L. AU - Johnson, F. M. AU - Subbiah, V. AU - Piha-Paul, S. AU - Tsimberidou, A. M. AU - Falchook, G. S. AU - Karp, D. AU - Zinner, R. AU - Wheler, J. AU - Janku, F. AU - Fu, S. AU - Lim, J. A. AU - Bean, S. AU - Nguyen, L. AU - Urban, S. AU - Browne, E. AU - Meric-Bernstam, F. AU - Hong, D. S. DB - Embase Medline DO - 10.1007/s10637-017-0513-5 IS - 3 LA - English M3 - Article N1 - L618837426 2017-10-25 2018-05-29 PY - 2018 SN - 1573-0646 0167-6997 SP - 416-423 ST - Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer T2 - Investigational New Drugs TI - Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618837426&from=export http://dx.doi.org/10.1007/s10637-017-0513-5 VL - 36 ID - 1468 ER - TY - JOUR AD - P. Rossner, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic AU - Honkova, K. AU - Rossnerova, A. AU - Pavlikova, J. AU - Svecova, V. AU - Klema, J. AU - Topinka, J. AU - Milcova, A. AU - Libalova, H. AU - Choi, H. AU - Veleminsky, M. AU - Sram, R. J. AU - Rossner, P. DB - Embase Medline DO - 10.1002/em.22184 IS - 5 LA - English M3 - Article N1 - L621494697 2018-04-04 PY - 2018 SN - 1098-2280 0893-6692 SP - 401-415 ST - Gene expression profiling in healthy newborns from diverse localities of the Czech Republic T2 - Environmental and Molecular Mutagenesis TI - Gene expression profiling in healthy newborns from diverse localities of the Czech Republic UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621494697&from=export http://dx.doi.org/10.1002/em.22184 VL - 59 ID - 1470 ER - TY - JOUR AD - O. Eckstein, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States AU - Eckstein, O. AU - Zinn, D. AU - Visser, J. AU - Fein Levy, C. AU - Karras, N. AU - Henry, M. AU - Campbell, P. AU - Jordan, M. AU - Kumar, A. AU - Rodriguez-Galindo, C. AU - McClain, K. AU - Allen, C. DB - Embase DO - 10.1002/pbc.27057 LA - English M3 - Conference Abstract N1 - L621728488 2018-04-24 PY - 2018 SN - 1545-5017 SP - S238-S239 ST - Clinical outcomes with mapk inhibition in pediatric langerhans cell histiocytosis T2 - Pediatric Blood and Cancer TI - Clinical outcomes with mapk inhibition in pediatric langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621728488&from=export http://dx.doi.org/10.1002/pbc.27057 VL - 65 ID - 1471 ER - TY - JOUR AD - S. White, University of Illinois, College of Medicine at Peoria, Peoria, IL, United States AU - White, S. AU - Bach, S. AU - Chiang, J. AU - Lin, J. AU - Lucas, J. AU - Qaddoumi, I. AU - Aprahamian, C. AU - O'Suoji, C. AU - Libes, J. DB - Embase DO - 10.1002/pbc.27057 LA - English M3 - Conference Abstract N1 - L621728784 2018-04-24 PY - 2018 SN - 1545-5017 SP - S70 ST - Peritoneal dissemination of braf fusion positive high grade neuroepithelial tumors in a child with a ventriculo-peritoneal shunt placed for a braf-fusion positive low grade glioma T2 - Pediatric Blood and Cancer TI - Peritoneal dissemination of braf fusion positive high grade neuroepithelial tumors in a child with a ventriculo-peritoneal shunt placed for a braf-fusion positive low grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621728784&from=export http://dx.doi.org/10.1002/pbc.27057 VL - 65 ID - 1472 ER - TY - JOUR AD - Y. Balachandran, Abdominal Transplant, Stanford University, Stanford, United States AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. AU - Esquivel, C. AU - Krams, S. AU - Martinez, O. DB - Embase DO - 10.1111/ajt.14917 LA - English M3 - Conference Abstract N1 - L622280150 2018-05-29 PY - 2018 SN - 1600-6143 SP - 353-354 ST - Characterization of viral and host cell genomic alterations in EBV+ PTLD T2 - American Journal of Transplantation TI - Characterization of viral and host cell genomic alterations in EBV+ PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622280150&from=export http://dx.doi.org/10.1111/ajt.14917 VL - 18 ID - 1473 ER - TY - JOUR AD - J.L. Espirito, The US Oncology Network/McKesson Specialty Health, The Woodlands, TX, United States AU - Reynolds, C. AU - Masters, E. T. AU - Black-Shinn, J. AU - Boyd, M. AU - Mardekian, J. AU - Espirito, J. L. AU - Chioda, M. DB - Embase DO - 10.3390/jcm7060129 IS - 6 LA - English M3 - Article N1 - L622336783 2018-06-07 2018-06-12 PY - 2018 SN - 2077-0383 ST - Real-world use and outcomes of ALK-positive crizotinib-treated metastatic NSCLC in us community oncology practices: A retrospective observational study T2 - Journal of Clinical Medicine TI - Real-world use and outcomes of ALK-positive crizotinib-treated metastatic NSCLC in us community oncology practices: A retrospective observational study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622336783&from=export http://dx.doi.org/10.3390/jcm7060129 VL - 7 ID - 1474 ER - TY - JOUR AD - J. Luo, Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, United States AU - Luo, J. DB - Embase DO - 10.1111/acer.13748 LA - English M3 - Conference Abstract N1 - L622676155 2018-06-28 PY - 2018 SN - 1530-0277 SP - 305A ST - Alcohol and breast cancer stem cells T2 - Alcoholism: Clinical and Experimental Research TI - Alcohol and breast cancer stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622676155&from=export http://dx.doi.org/10.1111/acer.13748 VL - 42 ID - 1475 ER - TY - JOUR AD - N. Yepuri, SUNY Upstate Medical University, Syracuse, NY, United States AU - Yepuri, N. AU - Meng, Q. AU - Cooney, R. N. DB - Embase DO - 10.1097/SHK.0000000000001158 IS - 6 LA - English M3 - Conference Abstract N1 - L622687470 2018-06-28 PY - 2018 SN - 1540-0514 SP - 61-62 ST - Curcumin induced activation of aryl hydrocarbon receptor attenuates fermented formula induced injury in neonatal enterocytes T2 - Shock TI - Curcumin induced activation of aryl hydrocarbon receptor attenuates fermented formula induced injury in neonatal enterocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622687470&from=export http://dx.doi.org/10.1097/SHK.0000000000001158 VL - 49 ID - 1476 ER - TY - JOUR AD - C. Klopsch, Reference and Translation Center for Cardiac Stem Cell Therapy, Rostock University, Medical Center, Rostock, Germany AU - Klopsch, C. AU - Skorska, A. AU - Ludwig, M. AU - Lemcke, H. AU - Maass, G. AU - Gaebel, R. AU - Beyer, M. AU - Lux, C. AU - Toelk, A. AU - Müller, K. AU - Maschmeier, C. AU - Rohde, S. AU - Mela, P. AU - Müller-Hilke, B. AU - Jockenhoevel, S. AU - Vollmar, B. AU - Jaster, R. AU - David, R. AU - Steinhoff, G. C1 - epoetin alfa(Ortho,Germany) erypo(Ortho,Germany) C2 - Ortho(Germany) DB - Embase Medline DO - 10.1242/dmm.033282 IS - 6 LA - English M3 - Article N1 - L622727960 2018-07-02 2018-12-27 PY - 2018 SN - 1754-8411 1754-8403 ST - Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart T2 - DMM Disease Models and Mechanisms TI - Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622727960&from=export http://dx.doi.org/10.1242/dmm.033282 VL - 11 ID - 1477 ER - TY - JOUR AD - K. Waters, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Waters, K. AU - Rangan, K. AU - Margol, A. AU - Robison, N. AU - Dhall, G. AU - Evans, A. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098190 2018-07-25 PY - 2018 SN - 1523-5866 SP - i152 ST - Introduction of skin care guidelines for children and teens taking molecularly targeted agents T2 - Neuro-Oncology TI - Introduction of skin care guidelines for children and teens taking molecularly targeted agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098190&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1478 ER - TY - JOUR AD - C. Zhong, Harvard Medical School, Boston, MA, United States AU - Zhong, C. AU - Song, H. AU - Kieran, M. AU - Chi, S. AU - Wright, K. AU - Huang, J. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098233 2018-07-25 PY - 2018 SN - 1523-5866 SP - i163 ST - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study T2 - Neuro-Oncology TI - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098233&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1479 ER - TY - JOUR AD - S. Hederova, Department of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava, Slovakia AU - Hederova, S. AU - Mocna, A. AU - Husakova, K. AU - Kaiserova, E. AU - Makohusova, M. AU - Jakešova, S. AU - Rychly, B. AU - Kolenova, A. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098250 2018-07-25 PY - 2018 SN - 1523-5866 SP - i107-i108 ST - Low grade glioma, 16 years single center experience T2 - Neuro-Oncology TI - Low grade glioma, 16 years single center experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098250&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1480 ER - TY - JOUR AD - S. Toll, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Toll, S. AU - Cotter, J. AU - Judkins, A. AU - Tamrazi, B. AU - Biegel, J. AU - Patel, P. AU - Tran, H. N. AU - Cooper, R. AU - Margol, A. S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098295 2018-07-25 PY - 2018 SN - 1523-5866 SP - i98 ST - Sustained response of three pediatric BRAFV600E mutated high-grade gliomas with BRAF and MEK inhibitor therapy T2 - Neuro-Oncology TI - Sustained response of three pediatric BRAFV600E mutated high-grade gliomas with BRAF and MEK inhibitor therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098295&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1481 ER - TY - JOUR AD - M. Hemenway, Children's Hospital Colorado, Univ of Colorado, Aurora, CO, United States AU - Hemenway, M. AU - Waters, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098299 2018-07-25 PY - 2018 SN - 1523-5866 SP - i154 ST - Neurofibromatosis therapeutics: Pearls to treat the complex child T2 - Neuro-Oncology TI - Neurofibromatosis therapeutics: Pearls to treat the complex child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098299&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1482 ER - TY - JOUR AD - B. Weiss, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Weiss, B. AU - Plotkin, S. AU - Widemann, B. AU - Tonsgard, J. AU - Blakeley, J. AU - Allen, J. AU - Schorry, E. AU - Korf, B. AU - Rosser, T. AU - Goldman, S. AU - Vinks, A. AU - Cutter, G. AU - Dombi, E. AU - Ratner, N. AU - Packer, R. AU - Fisher, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098342 2018-07-25 PY - 2018 SN - 1523-5866 SP - i143 ST - NF106: Phase 2 trial of the MEK inhibitor PD-0325901 in adolescents and adults with nf1-related plexiform neurofibromas: An NF clinical trials consortium study T2 - Neuro-Oncology TI - NF106: Phase 2 trial of the MEK inhibitor PD-0325901 in adolescents and adults with nf1-related plexiform neurofibromas: An NF clinical trials consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098342&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1483 ER - TY - JOUR AD - A. Gross, National Institutes of Health, Bethesda, MD, United States AU - Gross, A. AU - Wolters, P. AU - Baldwin, A. AU - Dombi, E. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Blakeley, J. AU - Whitcomb, P. AU - Holmblad, M. AU - Maritin, S. AU - Roderick, M. C. AU - Paul, S. M. AU - Therrien, J. AU - Heisey, K. AU - Doyle, A. AU - Smith, M. AU - Glod, J. AU - Steinberg, S. AU - Widemann, B. C. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098363 2018-07-25 PY - 2018 SN - 1523-5866 SP - i143-i144 ST - Sprint: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) T2 - Neuro-Oncology TI - Sprint: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098363&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1484 ER - TY - JOUR AD - A. Bavle, Jimmy Everest Section of Pediatric Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States AU - Bavle, A. AU - Choudhry, F. AU - Gavula, T. AU - Shah, R. AU - Ruiz-Elizalde, A. AU - Taylor, A. AU - Gross, N. AU - Peterson, J. E. AU - Fung, K. M. AU - McNall-Knapp, R. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098386 2018-07-25 PY - 2018 SN - 1523-5866 SP - i144 ST - Safety and efficacy of trametinib in the management of children with rasopathies T2 - Neuro-Oncology TI - Safety and efficacy of trametinib in the management of children with rasopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098386&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1485 ER - TY - JOUR AD - L. Kilburn, Children's National Health System, Washington, DC, United States AU - Kilburn, L. AU - Kuhn, J. AU - Nazemi, K. AU - Molinaro, A. AU - Liang, W. AU - Banerjee, A. AU - Hwang, E. AU - Crawford, J. AU - Nicolaides, T. AU - Packer, R. AU - Nazarian, J. AU - Gupta, N. AU - Resnick, A. C. AU - Byron, S. AU - Berens, M. AU - Prados, M. AU - Mueller, S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098402 2018-07-25 PY - 2018 SN - 1523-5866 SP - i64 ST - PNOC-003: Precision medicine trial for children with diffuses intrinsic pontine glioma: Preliminary experience with multi-agent personalized therapy recommendations T2 - Neuro-Oncology TI - PNOC-003: Precision medicine trial for children with diffuses intrinsic pontine glioma: Preliminary experience with multi-agent personalized therapy recommendations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098402&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1486 ER - TY - JOUR AD - K.D. Wright, Dana-Farber Cancer Institute, Boston, MA, United States AU - Wright, K. D. AU - Zimmerman, M. A. AU - Fine, E. AU - Aspri, T. AU - Kieran, M. W. AU - Chi, S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098411 2018-07-25 PY - 2018 SN - 1523-5866 SP - i110 ST - Type II BRAF inhibitor TAK-580 shows promise for upcoming clinal trial as evidenced by single patient IND study T2 - Neuro-Oncology TI - Type II BRAF inhibitor TAK-580 shows promise for upcoming clinal trial as evidenced by single patient IND study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098411&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1487 ER - TY - JOUR AD - M. Meel, VU University Medical Center, Amsterdam, Netherlands AU - Meel, M. AU - Navarro, M. G. AU - De Gooijer, M. AU - Waranecki, P. AU - Petersen, N. AU - Van Vuurden, D. AU - Kaspers, G. AU - Hulleman, E. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098455 2018-07-25 PY - 2018 SN - 1523-5866 SP - i31 ST - Preclinical efficacy of combined inhibition of MEK and MELK in atypical teratoid/rhabdoid tumors T2 - Neuro-Oncology TI - Preclinical efficacy of combined inhibition of MEK and MELK in atypical teratoid/rhabdoid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098455&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1488 ER - TY - JOUR AD - P. O'Hare, Department of Paediatric Oncology, Great Ormond Street Hospital NHS Trust, London, United Kingdom AU - O'Hare, P. AU - Loka, T. AU - D'Arco, F. AU - Depani, S. AU - Michalski, A. AU - Slater, O. AU - Jorgensen, M. AU - Jacques, T. AU - Hargrave, D. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098647 2018-07-25 PY - 2018 SN - 1523-5866 SP - i113 ST - Clinical experience of BRAF and MEK inhibitor therapy in paediatric glioma T2 - Neuro-Oncology TI - Clinical experience of BRAF and MEK inhibitor therapy in paediatric glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098647&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1489 ER - TY - JOUR AD - N. Robison, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Robison, N. AU - Pauly, J. AU - Malvar, J. AU - Gruber-Filbin, M. AU - De Mola, R. L. AU - Dorris, K. AU - Bendel, A. AU - Bowers, D. AU - Bornhorst, M. AU - Gauvain, K. AU - Leary, S. AU - Diaz, P. AU - Tan, Y. J. AU - Margol, A. AU - Dhall, G. AU - Rosser, T. AU - Bandopadhayay, P. AU - Davidson, T. AU - Ullrich, N. AU - Borchert, M. AU - Nelson, M. AU - Sinai, C. AU - Ligon, K. AU - Sposto, R. AU - Kieran, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098662 2018-07-25 PY - 2018 SN - 1523-5866 SP - i114 ST - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS/RAF pathway-activated tumors T2 - Neuro-Oncology TI - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS/RAF pathway-activated tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098662&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1490 ER - TY - JOUR AD - E. Bouffet, University of Toronto Hospital for Sick Children, Toronto, ON, Canada AU - Bouffet, E. AU - Kieran, M. AU - Hargrave, D. AU - Roberts, S. AU - Aerts, I. AU - Broniscer, A. AU - Geoerger, B. AU - Dasgupta, K. AU - Tseng, L. AU - Russo, M. AU - Mookerjee, B. AU - Moertel, C. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098705 2018-07-25 PY - 2018 SN - 1523-5866 SP - i114 ST - Trametinib therapy in pediatric patients with low-grade gliomas (LGG) with BRAF gene fusion; A disease-specific cohort in the first pediatric testing of trametinib T2 - Neuro-Oncology TI - Trametinib therapy in pediatric patients with low-grade gliomas (LGG) with BRAF gene fusion; A disease-specific cohort in the first pediatric testing of trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098705&from=export http://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 1491 ER - TY - JOUR AD - M. Krumbholz, University Hospital Erlangen, Department of Pediatrics, Erlangen, Germany AU - Krumbholz, M. AU - Woessmann, W. AU - Zierk, J. AU - Seniuk, D. AU - Ceppi, P. AU - Zimmermann, M. AU - Singh, V. K. AU - Metzler, M. AU - Damm-Welk, C. DB - Embase DO - 10.18632/oncotarget.25489 IS - 41 LA - English M3 - Article N1 - L622363913 2018-06-04 2018-06-07 PY - 2018 SN - 1949-2553 SP - 26543-26555 ST - Characterization and diagnostic application of genomic NPMALK fusion sequences in anaplastic large-cell lymphoma T2 - Oncotarget TI - Characterization and diagnostic application of genomic NPMALK fusion sequences in anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622363913&from=export http://dx.doi.org/10.18632/oncotarget.25489 VL - 9 ID - 1493 ER - TY - JOUR AD - Y. Ebisuno, Immunology Unit, Takeda Pharmaceutical Company Limited, Pharmaceutical Research Division, 2-26-1, Muraoka-Higashi, Fujisawa, Japan AU - Gamo, K. AU - Okuzono, Y. AU - Yabuki, M. AU - Ochi, T. AU - Sugimura, K. AU - Sato, Y. AU - Sagara, M. AU - Hayashi, H. AU - Ishimura, Y. AU - Nishimoto, Y. AU - Murakawa, Y. AU - Shiokawa, Z. AU - Gotoh, M. AU - Miyazaki, T. AU - Ebisuno, Y. DB - Embase Medline DO - 10.1093/ibd/izy079 IS - 6 LA - English M3 - Article N1 - L622340107 2018-06-01 2018-06-07 PY - 2018 SN - 1536-4844 1078-0998 SP - 1251-1265 ST - Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated with Relapse after Anti-TNFα Treatment for Crohn's Disease T2 - Inflammatory Bowel Diseases TI - Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated with Relapse after Anti-TNFα Treatment for Crohn's Disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622340107&from=export http://dx.doi.org/10.1093/ibd/izy079 VL - 24 ID - 1494 ER - TY - JOUR AD - J.J. Yang, Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, United States AU - Zhang, Y. AU - Gao, Y. AU - Zhang, H. AU - Zhang, J. AU - He, F. AU - Hnízda, A. AU - Qian, M. AU - Liu, X. AU - Gocho, Y. AU - Pui, C. H. AU - Cheng, T. AU - Wang, Q. AU - Yang, J. J. AU - Zhu, X. AU - Liu, X. DB - Embase Medline DO - 10.1182/blood-2017-11-817510 IS - 20 LA - English M3 - Article N1 - L622326440 2018-06-05 2018-06-07 PY - 2018 SN - 1528-0020 0006-4971 SP - 2256-2261 ST - PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia T2 - Blood TI - PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622326440&from=export http://dx.doi.org/10.1182/blood-2017-11-817510 VL - 131 ID - 1495 ER - TY - JOUR AD - S. Grazioli, Pediatric Intensive Care Unit, Department of Pediatrics, University Hospital of Geneva, University of Geneva, Geneva, Switzerland AU - Grazioli, S. AU - Pugin, J. DB - Embase DO - 10.3389/fimmu.2018.00832 IS - MAY LA - English M3 - Review N1 - L622020029 2018-05-16 2018-05-29 PY - 2018 SN - 1664-3224 ST - Mitochondrial damage-associated molecular patterns: From inflammatory signaling to human diseases T2 - Frontiers in Immunology TI - Mitochondrial damage-associated molecular patterns: From inflammatory signaling to human diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622020029&from=export http://dx.doi.org/10.3389/fimmu.2018.00832 VL - 9 ID - 1496 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, Leuven, Belgium AU - Schöffski, P. AU - Wozniak, A. AU - Leahy, M. G. AU - Aamdal, S. AU - Rutkowski, P. AU - Bauer, S. AU - Richter, S. AU - Grünwald, V. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Geoerger, B. AU - Marréaud, S. AU - Collette, S. AU - Nzokirantevye, A. AU - Strauss, S. J. DB - Embase Medline DO - 10.1016/j.ejca.2018.02.011 LA - English M3 - Article N1 - L2000558478 2018-03-26 2018-04-03 PY - 2018 SN - 1879-0852 0959-8049 SP - 156-167 ST - The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ T2 - European Journal of Cancer TI - The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000558478&from=export http://dx.doi.org/10.1016/j.ejca.2018.02.011 VL - 94 ID - 1497 ER - TY - JOUR AD - R. Dummer, Department of Dermatology, Skin Cancer Center, University Hospital ZÜrich, ZÜrich, Switzerland AU - Dummer, R. AU - Ascierto, P. A. AU - Gogas, H. J. AU - Arance, A. AU - Mandala, M. AU - Liszkay, G. AU - Garbe, C. AU - Schadendorf, D. AU - Krajsova, I. AU - Gutzmer, R. AU - Chiarion-Sileni, V. AU - Dutriaux, C. AU - de Groot, J. W. B. AU - Yamazaki, N. AU - Loquai, C. AU - Moutouh-de Parseval, L. A. AU - Pickard, M. D. AU - Sandor, V. AU - Robert, C. AU - Flaherty, K. T. DB - Embase Medline DO - 10.1016/S1470-2045(18)30142-6 IS - 5 LA - English M3 - Article N1 - L2000563995 2018-03-28 2018-05-16 PY - 2018 SN - 1474-5488 1470-2045 SP - 603-615 ST - Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial T2 - The Lancet Oncology TI - Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000563995&from=export http://dx.doi.org/10.1016/S1470-2045(18)30142-6 VL - 19 ID - 1498 ER - TY - JOUR AU - Moreno, L. DB - Embase Medline DO - 10.1016/S1470-2045(18)30191-8 IS - 5 LA - English M3 - Note N1 - L2000612769 2018-04-04 2018-05-16 PY - 2018 SN - 1474-5488 1470-2045 SP - 594-595 ST - An active drug for TRK-positive paediatric solid tumours T2 - The Lancet Oncology TI - An active drug for TRK-positive paediatric solid tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000612769&from=export http://dx.doi.org/10.1016/S1470-2045(18)30191-8 VL - 19 ID - 1499 ER - TY - JOUR AU - Hammami, M. B. AU - Alsabbagh, M. E. Y. Y. DB - Embase DO - 10.1016/S0016-5085(18)33982-9 IS - 6 LA - English M3 - Conference Abstract N1 - L2000864498 2019-08-01 PY - 2018 SN - 1528-0012 0016-5085 SP - S-1205 ST - MAVYRET-INDUCED ACUTE LIVER INJURY IN A NON-CIRRHOTIC, NONHBV INFECTED PATIENT: A CASE REPORT T2 - Gastroenterology TI - MAVYRET-INDUCED ACUTE LIVER INJURY IN A NON-CIRRHOTIC, NONHBV INFECTED PATIENT: A CASE REPORT UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000864498&from=export http://dx.doi.org/10.1016/S0016-5085(18)33982-9 VL - 154 ID - 1500 ER - TY - JOUR AD - L. Zhao, Department of Dermatology, Jining No. 1 People's Hospital, Jining, Shandong, China AU - Liu, S. AU - Man, Y. AU - Zhao, L. DB - Embase Medline DO - 10.1016/j.biopha.2018.02.086 LA - English M3 - Article N1 - L620915284 2018-03-07 2018-09-18 PY - 2018 SN - 1950-6007 0753-3322 SP - 422-429 ST - Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells T2 - Biomedicine and Pharmacotherapy TI - Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620915284&from=export http://dx.doi.org/10.1016/j.biopha.2018.02.086 VL - 101 ID - 1503 ER - TY - JOUR AD - Y. Lee, Department of Dermatology, College of Medicine, Chung-Ang University, 102 Heukseok-ro, Seoul, South Korea AU - Na, J. AU - Bak, D. H. AU - Im, S. I. AU - Choi, H. AU - Hwang, J. H. AU - Kong, S. Y. AU - No, Y. A. AU - Lee, Y. AU - Kim, B. J. DB - Embase Medline DO - 10.3892/ijmm.2018.3483 IS - 5 LA - English M3 - Article N1 - L621003658 2018-03-09 2018-03-19 PY - 2018 SN - 1791-244X 1107-3756 SP - 3090-3098 ST - Anti-apoptotic effects of glycosaminoglycans via inhibition of ERK/AP-1 signaling in TNF-ααstimulated human dermal fibroblasts T2 - International Journal of Molecular Medicine TI - Anti-apoptotic effects of glycosaminoglycans via inhibition of ERK/AP-1 signaling in TNF-ααstimulated human dermal fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621003658&from=export http://dx.doi.org/10.3892/ijmm.2018.3483 VL - 41 ID - 1504 ER - TY - JOUR AD - X. Yin, Department of Cardiology, First Affiliated Hospital of Harbin Medical University, No. 199 Dazhi Street, Harbin, China AU - Chi, J. AU - Wang, L. AU - Zhang, X. AU - Fu, Y. AU - Liu, Y. AU - Chen, W. AU - Liu, W. AU - Shi, Z. AU - Yin, X. DB - Embase Medline DO - 10.1016/j.biochi.2018.02.017 LA - English M3 - Article N1 - L621032039 2018-03-13 2018-09-25 PY - 2018 SN - 6183-1638 0300-9084 SP - 55-62 ST - Cyclosporin A induces autophagy in cardiac fibroblasts through the NRP-2/WDFY-1 axis T2 - Biochimie TI - Cyclosporin A induces autophagy in cardiac fibroblasts through the NRP-2/WDFY-1 axis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621032039&from=export http://dx.doi.org/10.1016/j.biochi.2018.02.017 VL - 148 ID - 1505 ER - TY - JOUR AD - J.R. Apps, Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom AU - Apps, J. R. AU - Carreno, G. AU - Gonzalez-Meljem, J. M. AU - Haston, S. AU - Guiho, R. AU - Cooper, J. E. AU - Manshaei, S. AU - Jani, N. AU - Hölsken, A. AU - Pettorini, B. AU - Beynon, R. J. AU - Simpson, D. M. AU - Fraser, H. C. AU - Hong, Y. AU - Hallang, S. AU - Stone, T. J. AU - Virasami, A. AU - Donson, A. M. AU - Jones, D. AU - Aquilina, K. AU - Spoudeas, H. AU - Joshi, A. R. AU - Grundy, R. AU - Storer, L. C. D. AU - Korbonits, M. AU - Hilton, D. A. AU - Tossell, K. AU - Thavaraj, S. AU - Ungless, M. A. AU - Gil, J. AU - Buslei, R. AU - Hankinson, T. AU - Hargrave, D. AU - Goding, C. AU - Andoniadou, C. L. AU - Brogan, P. AU - Jacques, T. S. AU - Williams, H. J. AU - Martinez-Barbera, J. P. DB - Embase Medline DO - 10.1007/s00401-018-1830-2 IS - 5 LA - English M3 - Article N1 - L621250923 2018-03-20 2018-04-30 PY - 2018 SN - 1432-0533 0001-6322 SP - 757-777 ST - Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target T2 - Acta Neuropathologica TI - Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621250923&from=export http://dx.doi.org/10.1007/s00401-018-1830-2 VL - 135 ID - 1506 ER - TY - JOUR AD - V.P. Tolbert, Department of Pediatrics, UCSF Helen Diller Family Comprehensive Cancer Center, and UCSF Benioff Children’s Hospital, University of California, San Francisco, CA, United States AU - Tolbert, V. P. AU - Matthay, K. K. DB - Embase Medline DO - 10.1007/s00441-018-2821-2 IS - 2 LA - English M3 - Review N1 - L621402077 2018-03-30 2018-05-16 PY - 2018 SN - 1432-0878 0302-766X SP - 195-209 ST - Neuroblastoma: clinical and biological approach to risk stratification and treatment T2 - Cell and Tissue Research TI - Neuroblastoma: clinical and biological approach to risk stratification and treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621402077&from=export http://dx.doi.org/10.1007/s00441-018-2821-2 VL - 372 ID - 1507 ER - TY - JOUR AD - R. Buettner, Cologne Institute of Pathology, University Hospital Cologne, Kerpener Straße 62, Cologne, Germany AU - Gültekin, S. E. AU - Aziz, R. AU - Heydt, C. AU - Sengüven, B. AU - Zöller, J. AU - Safi, A. F. AU - Kreppel, M. AU - Buettner, R. DB - Embase Medline DO - 10.1007/s00428-018-2305-5 IS - 5 LA - English M3 - Article N1 - L621588408 2018-04-13 2018-06-05 PY - 2018 SN - 1432-2307 0945-6317 SP - 807-814 ST - The landscape of genetic alterations in ameloblastomas relates to clinical features T2 - Virchows Archiv TI - The landscape of genetic alterations in ameloblastomas relates to clinical features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621588408&from=export http://dx.doi.org/10.1007/s00428-018-2305-5 VL - 472 ID - 1508 ER - TY - JOUR AD - S. Geller, Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medicine, New York, NY, United States AU - Geller, S. AU - Canavan, T. N. AU - Pulitzer, M. AU - Moskowitz, A. J. AU - Myskowski, P. L. DB - Embase Medline DO - 10.1111/ijd.13804 IS - 5 LA - English M3 - Review N1 - L621613876 2018-04-16 2018-10-16 PY - 2018 SN - 1365-4632 0011-9059 SP - 515-520 ST - ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature T2 - International Journal of Dermatology TI - ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621613876&from=export http://dx.doi.org/10.1111/ijd.13804 VL - 57 ID - 1509 ER - TY - JOUR AD - J.P. Roose, Department of Anatomy, University of California San Francisco, San Francisco, CA, United States AU - Ksionda, O. AU - Mues, M. AU - Wandler, A. M. AU - Donker, L. AU - Tenhagen, M. AU - Jun, J. AU - Ducker, G. S. AU - Matlawska-Wasowska, K. AU - Shannon, K. AU - Shokat, K. M. AU - Roose, J. P. C1 - as 605240(Selleck) gdc 0941(Selleck) pd 0325901 C2 - Selleck DB - Embase Medline DO - 10.1371/journal.pone.0193849 IS - 5 LA - English M3 - Article N1 - L622278654 2018-06-01 2018-08-03 PY - 2018 SN - 1932-6203 ST - Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy T2 - PLoS ONE TI - Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622278654&from=export http://dx.doi.org/10.1371/journal.pone.0193849 VL - 13 ID - 1510 ER - TY - JOUR AD - D. Rakheja, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, United States AU - Chen, K. S. AU - Fustino, N. J. AU - Shukla, A. A. AU - Stroup, E. K. AU - Budhipramono, A. AU - Ateek, C. AU - Stuart, S. H. AU - Yamaguchi, K. AU - Kapur, P. AU - Frazier, A. L. AU - Lum, L. AU - Looijenga, L. H. J. AU - Laetsch, T. W. AU - Rakheja, D. AU - Amatruda, J. F. C2 - LC DB - Embase Medline DO - 10.1158/1535-7163.MCT-17-0137 IS - 5 LA - English M3 - Article N1 - L622326967 2018-06-06 2018-06-08 PY - 2018 SN - 1538-8514 1535-7163 SP - 1079-1089 ST - EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors T2 - Molecular Cancer Therapeutics TI - EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622326967&from=export http://dx.doi.org/10.1158/1535-7163.MCT-17-0137 VL - 17 ID - 1511 ER - TY - JOUR AD - H. Kang, Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States AU - Kang, H. AU - Jha, S. AU - Deng, Z. AU - Fratzl-Zelman, N. AU - Cabral, W. AU - Ivovic, A. AU - Meylan, F. AU - Hanson, E. AU - Lange, E. AU - Katz, J. AU - Roschger, P. AU - Klaushofer, K. AU - Cowen, E. AU - Siegel, R. AU - Bhattacharyya, T. AU - Marini, J. DB - Embase DO - 10.1007/s00223-018-0418-0 IS - 1 LA - English M3 - Conference Abstract N1 - L622359931 2018-06-04 PY - 2018 SN - 1432-0827 SP - S151 ST - Somatic activating mutations in MAP2K1 cause melorheostosis T2 - Calcified Tissue International TI - Somatic activating mutations in MAP2K1 cause melorheostosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622359931&from=export http://dx.doi.org/10.1007/s00223-018-0418-0 VL - 102 ID - 1512 ER - TY - JOUR AD - Y.M. Hosakote, University of Texas, Medical Branch at Galveston, United States AU - Hosakote, Y. M. AU - Rayavara, K. AU - Hallberg, L. M. AU - Ameredes, B. T. AU - Kurosky, A. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L623264266 2018-08-02 PY - 2018 SN - 1550-6606 ST - Antioxidant treatment ameliorates cigarette smoke and respiratory syncytial virus-induced inflammatory response by blocking HMGB1 release T2 - Journal of Immunology TI - Antioxidant treatment ameliorates cigarette smoke and respiratory syncytial virus-induced inflammatory response by blocking HMGB1 release UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623264266&from=export VL - 200 ID - 1513 ER - TY - JOUR AD - G.B. McCowage AU - McCowage, G. B. AU - Mueller, S. AU - Pratilas, C. A. AU - Hargrave, D. R. AU - Moertel, C. L. AU - Whitlock, J. AU - Fox, E. AU - Hingorani, P. AU - Russo, M. W. AU - Dasgupta, K. AU - Tseng, L. AU - Mookerjee, B. AU - Geoerger, B. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10504 IS - 15 LA - English M3 - Conference Abstract N1 - L625973254 2019-01-22 PY - 2018 SN - 1527-7755 ST - Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study T2 - Journal of Clinical Oncology TI - Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625973254&from=export http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10504 VL - 36 ID - 1514 ER - TY - JOUR AD - I.H. El Dika AU - El Dika, I. H. AU - Capanu, M. AU - Chou, J. F. AU - Harding, J. J. AU - Hrabovsky, A. D. AU - Do, R. K. G. AU - Shia, J. AU - Germino, J. AU - O'Reilly, E. M. AU - Abou-Alfa, G. K. DB - Embase DO - 10.1200/JCO.2018.36.15-suppl.4080 IS - 15 LA - English M3 - Conference Abstract N1 - L625973745 2019-02-26 PY - 2018 SN - 1527-7755 ST - Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S) T2 - Journal of Clinical Oncology TI - Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625973745&from=export http://dx.doi.org/10.1200/JCO.2018.36.15-suppl.4080 VL - 36 ID - 1515 ER - TY - JOUR AD - A. Vijay Desai AU - Vijay Desai, A. AU - Brodeur, G. M. AU - Foster, J. AU - Berg, S. L. AU - Basu, E. M. AU - Shusterman, S. AU - Sabnis, A. J. AU - Macy, M. AU - Yoon, J. AU - Gauvain, K. AU - Esquibel, V. AU - Maneval, E. C. AU - Multani, P. S. AU - Fox, E. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10536 IS - 15 LA - English M3 - Conference Abstract N1 - L625975930 2019-01-22 PY - 2018 SN - 1527-7755 ST - Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors T2 - Journal of Clinical Oncology TI - Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625975930&from=export http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10536 VL - 36 ID - 1516 ER - TY - JOUR AD - B. Geoerger AU - Geoerger, B. AU - Moertel, C. L. AU - Whitlock, J. AU - McCowage, G. B. AU - Kieran, M. W. AU - Broniscer, A. AU - Hargrave, D. R. AU - Hingorani, P. AU - Kilburn, L. B. AU - Mueller, S. AU - Tseng, L. AU - Nebot, N. AU - Dasgupta, K. AU - Russo, M. W. AU - Fox, E. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10537 IS - 15 LA - English M3 - Conference Abstract N1 - L625975949 2019-01-22 PY - 2018 SN - 1527-7755 ST - Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN) T2 - Journal of Clinical Oncology TI - Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625975949&from=export http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10537 VL - 36 ID - 1517 ER - TY - JOUR AD - J. Wyss, Paediatric Haematology and Oncology, London, United Kingdom AU - Wyss, J. AU - Slater, O. AU - Jacques, T. AU - Jorgensen, M. DB - Embase LA - English M3 - Conference Abstract N1 - L626848529 2019-03-26 PY - 2018 SN - 1424-3997 SP - 46S-47S ST - Disseminated isolated intracranial juvenile xanthogranuloma T2 - Swiss Medical Weekly TI - Disseminated isolated intracranial juvenile xanthogranuloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626848529&from=export VL - 147 ID - 1520 ER - TY - JOUR AD - R.D. Carvajal, Division of Hematology/ Oncology, Columbia University, Medical Center, New York, NY, United States AU - Carvajal, R. D. AU - Piperno-Neumann, S. AU - Kapiteijn, E. AU - Chapman, P. B. AU - Frank, S. AU - Joshua, A. M. AU - Piulats, J. M. AU - Wolter, P. AU - Cocquyt, V. AU - Chmielowski, B. AU - Evans, T. R. J. AU - Gastaud, L. AU - Linette, G. AU - Berking, C. AU - Schachter, J. AU - Rodrigues, M. J. AU - Shoushtari, A. N. AU - Clemett, D. AU - Ghiorghiu, D. AU - Mariani, G. AU - Spratt, S. AU - Lovick, S. AU - Barker, P. AU - Kilgour, E. AU - Lai, Z. AU - Schwartz, G. K. AU - Nathan, P. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1200/JCO.2017.74.1090 IS - 12 LA - English M3 - Conference Paper N1 - L621718128 2018-04-26 2019-08-27 PY - 2018 SN - 1527-7755 0732-183X SP - 1232-1239 ST - Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) T2 - Journal of Clinical Oncology TI - Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621718128&from=export http://dx.doi.org/10.1200/JCO.2017.74.1090 VL - 36 ID - 1521 ER - TY - JOUR AD - F. Rossi, Department of Women, Child and General and Specialist Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy AU - Punzo, F. AU - Manzo, I. AU - Tortora, C. AU - Pota, E. AU - D'Angelo, V. AU - Bellini, G. AU - Di Paola, A. AU - Verace, F. AU - Casale, F. AU - Rossi, F. C1 - jwh 133(Tocris,United States) C2 - Tocris(United States) DB - Embase DO - 10.18632/oncotarget.25052 IS - 30 LA - English M3 - Article N1 - L621802627 2018-04-30 2018-05-09 PY - 2018 SN - 1949-2553 SP - 21244-21258 ST - Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia T2 - Oncotarget TI - Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621802627&from=export http://dx.doi.org/10.18632/oncotarget.25052 VL - 9 ID - 1522 ER - TY - JOUR AD - S. Burdach, Department of Pediatrics and Children's Cancer Research Center, Kinderklinik München Schwabing, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Munich, Germany AU - Weidenbusch, B. AU - Richter, G. H. S. AU - Kesper, M. S. AU - Guggemoos, M. AU - Gall, K. AU - Prexler, C. AU - Kazantsev, I. AU - Sipol, A. AU - Lindner, L. AU - Nathrath, M. AU - Witt, O. AU - Specht, K. AU - Beitinger, F. AU - Knebel, C. AU - Hosie, S. AU - von Eisenhardt-Rothe, R. AU - Weichert, W. AU - Teichert-von Luettichau, I. AU - Burdach, S. DB - Embase DO - 10.18632/oncotarget.25087 IS - 29 LA - English M3 - Article N1 - L621732356 2018-04-24 2018-05-03 PY - 2018 SN - 1949-2553 SP - 20747-20760 ST - Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy T2 - Oncotarget TI - Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621732356&from=export http://dx.doi.org/10.18632/oncotarget.25087 VL - 9 ID - 1523 ER - TY - JOUR AD - R. de Cássia Viu Carrara, UNAERP, Avenida Costábile Romano, 2201, Ribeirania, Ribeirao Preto, Sao Paulo, Brazil AU - de Cássia Viu Carrara, R. AU - Fontes, A. M. AU - Abraham, K. J. AU - Orellana, M. D. AU - Haddad, S. K. AU - Palma, P. V. B. AU - Panepucci, R. A. AU - Zago, M. A. AU - Covas, D. T. DB - Embase Medline DO - 10.1007/s12094-017-1751-x IS - 4 LA - English M3 - Article N1 - L618299024 2017-09-21 2018-09-05 PY - 2018 SN - 1699-3055 1699-048X SP - 542-549 ST - Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls T2 - Clinical and Translational Oncology TI - Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618299024&from=export http://dx.doi.org/10.1007/s12094-017-1751-x VL - 20 ID - 1524 ER - TY - JOUR AD - L. Brugieres, Department of Oncology for Children and Adolescents, Gustave Roussy Caner Campus, Villejuif, France AU - Rigaud, C. AU - Abbou, S. AU - Minard-Colin, V. AU - Geoerger, B. AU - Scoazec, J. Y. AU - Vassal, G. AU - Jaff, N. AU - Heuberger, L. AU - Valteau-Couanet, D. AU - Brugieres, L. DB - Embase Medline DO - 10.1002/pbc.26902 IS - 4 LA - English M3 - Letter N1 - L619506835 2017-12-07 2018-03-01 PY - 2018 SN - 1545-5017 1545-5009 ST - Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma T2 - Pediatric Blood and Cancer TI - Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619506835&from=export http://dx.doi.org/10.1002/pbc.26902 VL - 65 ID - 1525 ER - TY - JOUR AD - Q. Chang, Department of Pathology, Peking University School of Basic Medical Science, Peking University Third Hospital, Peking Univeristy Health Science Center, Beijing, China AU - Li, Y. X. AU - Yu, Z. W. AU - Jiang, T. AU - Shao, L. W. AU - Liu, Y. AU - Li, N. AU - Wu, Y. F. AU - Zheng, C. AU - Wu, X. Y. AU - Zhang, M. AU - Zheng, D. F. AU - Qi, X. L. AU - Ding, M. AU - Zhang, J. AU - Chang, Q. DB - Embase Medline DO - 10.1111/cas.13515 IS - 4 LA - English M3 - Article N1 - L620773368 2018-02-26 2018-04-19 PY - 2018 SN - 1349-7006 1347-9032 SP - 1263-1275 ST - SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis T2 - Cancer Science TI - SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620773368&from=export http://dx.doi.org/10.1111/cas.13515 VL - 109 ID - 1526 ER - TY - JOUR AD - J.-H. Klusmann, University of Halle, Department of Pediatrics I, Pediatric Hematology and Oncology, Ernst-Grube-Str 40, Halle, Germany AU - Bhayadia, R. AU - Krowiorz, K. AU - Haetscher, N. AU - Jammal, R. AU - Emmrich, S. AU - Obulkasim, A. AU - Fiedler, J. AU - Schwarzer, A. AU - Rouhi, A. AU - Heuser, M. AU - Wingert, S. AU - Bothur, S. AU - Döhner, K. AU - Mätzig, T. AU - Ng, M. AU - Reinhardt, D. AU - Döhner, H. AU - Zwaan, C. M. AU - Van Den Heuvel Eibrink, M. AU - Heckl, D. AU - Fornerod, M. AU - Thum, T. AU - Humphries, R. K. AU - Rieger, M. A. AU - Kuchenbauer, F. AU - Klusmann, J. H. DB - Embase Medline DO - 10.1200/JCO.2017.75.2204 IS - 10 LA - English M3 - Article N1 - L621516143 2018-04-12 2018-05-09 PY - 2018 SN - 1527-7755 0732-183X SP - 1007-1016 ST - Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia T2 - Journal of Clinical Oncology TI - Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621516143&from=export http://dx.doi.org/10.1200/JCO.2017.75.2204 VL - 36 ID - 1528 ER - TY - JOUR AD - R. Atkar, Addenbrookes Hospital, Cambridge, United Kingdom AU - Atkar, R. AU - Holden, S. AU - Firth, H. AU - Burrows, N. AU - Gass, J. DB - Embase DO - 10.1111/pde.13555 LA - English M3 - Conference Abstract N1 - L622129876 2018-05-18 PY - 2018 SN - 1525-1470 SP - S12 ST - Cardiofaciocutaneous syndrome T2 - Pediatric Dermatology TI - Cardiofaciocutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622129876&from=export http://dx.doi.org/10.1111/pde.13555 VL - 35 ID - 1531 ER - TY - JOUR AD - S. Reif, Hadassah Medical Center, Jerusalem, Israel AU - Reif, S. AU - Golan-Gerstl, R. AU - Shiff, Y. E. DB - Embase LA - English M3 - Conference Abstract N1 - L622343934 2018-06-01 PY - 2018 SN - 1536-4801 SP - 961 ST - The biological function of milk-derived miRNAs T2 - Journal of Pediatric Gastroenterology and Nutrition TI - The biological function of milk-derived miRNAs UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622343934&from=export VL - 66 ID - 1532 ER - TY - JOUR AD - M. Yousef, Health Sciences, Brock Univsersity, St Catharines, ON, Canada AU - Yousef, M. AU - Hicks, N. J. AU - Boyd, T. AU - Tsiani, E. AU - MacNeil, A. J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622544928 2018-06-18 PY - 2018 SN - 1530-6860 ST - Inhibition of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.) T2 - FASEB Journal TI - Inhibition of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622544928&from=export VL - 32 ID - 1533 ER - TY - JOUR AD - L. Pulakat AU - Pulakat, L. AU - Belenchia, A. M. AU - Toedebusch, R. G. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622546233 2018-06-18 PY - 2018 SN - 1530-6860 ST - The novel cardio-oncology drug, NP-6A4, regulates the growth of multiple breast cancer cell lines through distinct cell-specific mechanisms T2 - FASEB Journal TI - The novel cardio-oncology drug, NP-6A4, regulates the growth of multiple breast cancer cell lines through distinct cell-specific mechanisms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622546233&from=export VL - 32 ID - 1534 ER - TY - JOUR AD - K. Manokaran, Department of Medical Laboratory Technology, School of Allied Health Sciences, Manipal Academy of Higher Education, Madhav Nagar, Near Tiger Circle, Manipal, Karnataka, India AU - Ma, H. AU - Li, D. AU - Rengarajan, T. AU - Manokaran, K. DB - Embase DO - 10.4103/pm.pm_418_17 IS - 55 LA - English M3 - Article N1 - L623742790 2018-09-07 2018-09-11 PY - 2018 SN - 0976-4062 0973-1296 SP - S237-S244 ST - Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways T2 - Pharmacognosy Magazine TI - Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623742790&from=export http://dx.doi.org/10.4103/pm.pm_418_17 VL - 14 ID - 1535 ER - TY - JOUR AD - S. Liang, Department of Physiology, Basic Medical School of Nanchang University, Nanchang, Jiangxi, China AU - Yi, Z. AU - Xie, L. AU - Zhou, C. AU - Yuan, H. AU - Ouyang, S. AU - Fang, Z. AU - Zhao, S. AU - Jia, T. AU - Zou, L. AU - Wang, S. AU - Xue, Y. AU - Wu, B. AU - Gao, Y. AU - Li, G. AU - Liu, S. AU - Xu, H. AU - Xu, C. AU - Zhang, C. AU - Liang, S. DB - Embase Medline DO - 10.1007/s11302-017-9594-z IS - 1 LA - English M3 - Article N1 - L619347888 2017-11-27 2018-04-03 PY - 2018 SN - 1573-9546 1573-9538 SP - 47-58 ST - P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2′,3′-dideoxycytidine T2 - Purinergic Signalling TI - P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2′,3′-dideoxycytidine UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619347888&from=export http://dx.doi.org/10.1007/s11302-017-9594-z VL - 14 ID - 1536 ER - TY - JOUR AD - Y. Zhang, Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital Affiliated Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, China AU - Tang, M. AU - Wang, W. AU - Cheng, L. AU - Jin, R. AU - Zhang, L. AU - Bian, W. AU - Zhang, Y. C2 - fusheng pharmaceutical(China) DB - Embase DO - 10.22038/ijbms.2018.19451.5153 IS - 3 LA - English M3 - Article N1 - L620400500 2018-02-02 2018-02-21 PY - 2018 SN - 2008-3874 2008-3866 SP - 309-317 ST - The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro T2 - Iranian Journal of Basic Medical Sciences TI - The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620400500&from=export http://dx.doi.org/10.22038/ijbms.2018.19451.5153 VL - 21 ID - 1538 ER - TY - JOUR AD - F. Wang, Department of Oncology, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan, Hubei, China AU - Fu, H. AU - Zhang, J. AU - Pan, T. AU - Ai, S. AU - Tang, L. AU - Wang, F. C2 - Selleck(United States) DB - Embase Medline DO - 10.3892/mmr.2018.8390 IS - 3 LA - English M3 - Article N1 - L620409122 2018-02-05 2018-02-06 PY - 2018 SN - 1791-3004 1791-2997 SP - 4581-4588 ST - MiR-378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c-RAF T2 - Molecular Medicine Reports TI - MiR-378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c-RAF UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620409122&from=export http://dx.doi.org/10.3892/mmr.2018.8390 VL - 17 ID - 1539 ER - TY - JOUR AU - Liu, Y. AU - Zhang, R. X. AU - Yuan, W. AU - Chen, H. Q. AU - Tian, D. D. AU - Li, H. AU - Jiang, X. AU - Deng, Z. L. AU - Wang, Y. DB - Embase Medline DO - 10.1159/000487784 IS - 5 LA - English M3 - Article N1 - L620990894 2018-03-08 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1759-1771 ST - Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression T2 - Cellular Physiology and Biochemistry TI - Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620990894&from=export http://dx.doi.org/10.1159/000487784 VL - 45 ID - 1540 ER - TY - JOUR AU - Shen, C. H. AU - Tung, S. Y. AU - Huang, W. S. AU - Lee, K. F. AU - Hsieh, Y. Y. AU - Hsieh, M. C. AU - Chen, C. N. AU - Kuo, H. C. DB - Embase Medline DO - 10.1159/000487968 IS - 5 LA - English M3 - Article N1 - L621207972 2018-03-19 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1915-1926 ST - Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes T2 - Cellular Physiology and Biochemistry TI - Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621207972&from=export http://dx.doi.org/10.1159/000487968 VL - 45 ID - 1541 ER - TY - JOUR AU - Bhat, T. AU - Rosman, I. S. AU - Coughlin, C. C. DB - Embase Medline DO - 10.1111/pde.13381 IS - 2 LA - English M3 - Letter N1 - L621392031 2018-03-29 2018-08-06 PY - 2018 SN - 1525-1470 0736-8046 SP - 287-288 ST - Comment on “Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib” T2 - Pediatric Dermatology TI - Comment on “Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib” UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621392031&from=export http://dx.doi.org/10.1111/pde.13381 VL - 35 ID - 1542 ER - TY - JOUR AD - J. Charron, Centre de recherche sur le cancer, Université Laval, CRCHU de Québec, L'Hôtel-Dieu de Québec, Québec, Canada AU - Aoidi, R. AU - Houde, N. AU - Landry-Truchon, K. AU - Holter, M. AU - Jacquet, K. AU - Charron, L. AU - Krishnaswami, S. R. AU - Yu, B. D. AU - Rauen, K. A. AU - Bisson, N. AU - Newbern, J. AU - Charron, J. DB - Embase Medline DO - 10.1242/dmm.031278 IS - 3 LA - English M3 - Review N1 - L621593226 2018-04-13 2018-10-19 PY - 2018 SN - 1754-8411 1754-8403 ST - Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome T2 - DMM Disease Models and Mechanisms TI - Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621593226&from=export http://dx.doi.org/10.1242/dmm.031278 VL - 11 ID - 1543 ER - TY - JOUR AD - N. Oishi, Mayo Clinic, Rochester, MN, United States AU - Oishi, N. AU - Boddicker, R. L. AU - Ansell, S. M. AU - Dasari, S. AU - Rech, K. AU - Feldman, A. DB - Embase DO - 10.1038/labinvest.2018.13 LA - English M3 - Conference Abstract N1 - L621622891 2018-04-16 PY - 2018 SN - 1530-0307 SP - 542-543 ST - PD-l1 expression correlates with genetic subtype and predicts outcome in anaplastic large cell lymphoma T2 - Laboratory Investigation TI - PD-l1 expression correlates with genetic subtype and predicts outcome in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621622891&from=export http://dx.doi.org/10.1038/labinvest.2018.13 VL - 98 ID - 1544 ER - TY - JOUR AD - N. Barasch, University of Pittsburgh Medical Center, Pittsburgh, PA, United States AU - Barasch, N. AU - Liu, Y. C. AU - Bailey, N. AU - Ho, J. AU - Swerdlow, S. H. DB - Embase DO - 10.1038/labinvest.2018.13 LA - English M3 - Conference Abstract N1 - L621623777 2018-04-16 PY - 2018 SN - 1530-0307 SP - 498 ST - Mutational and immunophenotypic landscape of primary cutaneous follicle center lymphoma T2 - Laboratory Investigation TI - Mutational and immunophenotypic landscape of primary cutaneous follicle center lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621623777&from=export http://dx.doi.org/10.1038/labinvest.2018.13 VL - 98 ID - 1545 ER - TY - JOUR AD - G. Nayyar, Pediatrics, New York Medical College, Valhalla, NY, United States AU - Nayyar, G. AU - Chu, Y. AU - Su, N. K. AU - Rosenblum, J. AU - Wong, H. C. AU - Lee, D. AU - Cairo, M. S. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L621900063 2018-05-02 PY - 2018 SN - 1523-6536 SP - S472-S473 ST - Combining dinutuximab with ALT-803 (IL-15 Superagonist) significantly improves the activity of ex vivo expanded natural killer cells against GD2+ pediatric solid tumors (ST) T2 - Biology of Blood and Marrow Transplantation TI - Combining dinutuximab with ALT-803 (IL-15 Superagonist) significantly improves the activity of ex vivo expanded natural killer cells against GD2+ pediatric solid tumors (ST) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621900063&from=export VL - 24 ID - 1546 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, and Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, Leuven, Belgium AU - Schöffski, P. AU - Wozniak, A. AU - Kasper, B. AU - Aamdal, S. AU - Leahy, M. G. AU - Rutkowski, P. AU - Bauer, S. AU - Gelderblom, H. AU - Italiano, A. AU - Lindner, L. H. AU - Hennig, I. AU - Strauss, S. AU - Zakotnik, B. AU - Anthoney, A. AU - Albiges, L. AU - Blay, J. Y. AU - Reichardt, P. AU - Sufliarsky, J. AU - van der Graaf, W. T. A. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Van Cann, T. AU - Marréaud, S. AU - Raveloarivahy, T. AU - Collette, S. AU - Stacchiotti, S. DB - Embase Medline DO - 10.1093/annonc/mdx774 IS - 3 LA - English M3 - Article N1 - L621930961 2018-05-04 2019-05-28 PY - 2018 SN - 1569-8041 0923-7534 SP - 758-765 ST - Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE' T2 - Annals of Oncology TI - Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE' UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621930961&from=export http://dx.doi.org/10.1093/annonc/mdx774 VL - 29 ID - 1547 ER - TY - JOUR AD - Y.-Y. Wu, Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan AU - Tsai, C. L. AU - Chiu, Y. M. AU - Lee, Y. J. AU - Hsieh, C. T. AU - Shieh, D. C. AU - Tsay, G. J. AU - Bau, D. T. AU - Wu, Y. Y. DB - Embase Medline DO - 10.1684/ecn.2018.0407 IS - 1 LA - English M3 - Article N1 - L622219698 2018-05-29 2018-09-28 PY - 2018 SN - 1952-4005 1148-5493 SP - 36-47 ST - Interleukin-32 plays an essential role in human calcified aortic valve cells T2 - European Cytokine Network TI - Interleukin-32 plays an essential role in human calcified aortic valve cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622219698&from=export http://dx.doi.org/10.1684/ecn.2018.0407 VL - 29 ID - 1548 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics Maternal and Child Health, University of Genova and Policlinico San Martino, Genova, Italy AU - Demichelis, C. AU - Lapucci, C. AU - Grisanti, S. AU - Genova, C. AU - Grossi, F. AU - Tanda, E. AU - Queirolo, P. AU - Benedetti, L. AU - Schenone, A. AU - Grandis, M. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622822418 2018-07-06 PY - 2018 SN - 2532-1900 SP - 67-68 ST - Neuromuscular complications following target therapy in cancer patients T2 - Acta Myologica TI - Neuromuscular complications following target therapy in cancer patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622822418&from=export VL - 37 ID - 1549 ER - TY - JOUR AD - C. Damm-Welk, NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany AU - Knörr, F. AU - Damm-Welk, C. AU - Ruf, S. AU - Singh, V. K. AU - Zimmermann, M. AU - Reiter, A. AU - Woessmann, W. DB - Embase Medline DO - 10.3324/haematol.2017.177972 IS - 3 LA - English M3 - Article N1 - L621006469 2018-03-09 2018-03-16 PY - 2018 SN - 1592-8721 0390-6078 SP - 477-485 ST - Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma T2 - Haematologica TI - Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621006469&from=export http://dx.doi.org/10.3324/haematol.2017.177972 VL - 103 ID - 1550 ER - TY - JOUR AD - L. Ma, School of Laboratory Medicine and Biotechnology, Institute of Molecular Immunology, Southern Medical University, Guangzhou, China AU - He, W. AU - Hu, S. AU - Du, X. AU - Wen, Q. AU - Zhong, X. P. AU - Zhou, X. AU - Zhou, C. AU - Xiong, W. AU - Gao, Y. AU - Zhang, S. AU - Wang, R. AU - Yang, J. AU - Ma, L. DB - Embase DO - 10.3389/fimmu.2018.00365 IS - FEB LA - English M3 - Article N1 - L620841695 2018-03-05 2018-03-08 PY - 2018 SN - 1664-3224 ST - Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis T2 - Frontiers in Immunology TI - Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620841695&from=export http://dx.doi.org/10.3389/fimmu.2018.00365 VL - 9 ID - 1552 ER - TY - JOUR AD - Y. Iijima-Yamashita, Department of Clinical Trials and Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi, Japan AU - Iijima-Yamashita, Y. AU - Mori, T. AU - Nakazawa, A. AU - Fukano, R. AU - Takimoto, T. AU - Tsurusawa, M. AU - Kobayashi, R. AU - Horibe, K. DB - Embase Medline DO - 10.1007/s12185-017-2338-6 IS - 2 LA - English M3 - Article N1 - L618784855 2017-10-23 2018-06-08 PY - 2018 SN - 1865-3774 0925-5710 SP - 244-250 ST - Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma T2 - International Journal of Hematology TI - Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618784855&from=export http://dx.doi.org/10.1007/s12185-017-2338-6 VL - 107 ID - 1553 ER - TY - JOUR AD - P.J. Houghton, Greehey Children's Cancer Research Institute, University of Texas Health Science Center, San Antonio, TX, United States AU - Bandyopadhyay, A. AU - Favours, E. AU - Phelps, D. A. AU - Pozo, V. D. AU - Ghilu, S. AU - Kurmashev, D. AU - Michalek, J. AU - Trevino, A. AU - Guttridge, D. AU - London, C. AU - Hirotani, K. AU - Zhang, L. AU - Kurmasheva, R. T. AU - Houghton, P. J. C1 - erlotinib(Daiichi Sankyo) patritumab(Daiichi Sankyo) C2 - Daiichi Sankyo DB - Embase Medline DO - 10.1002/pbc.26870 IS - 2 LA - English M3 - Article N1 - L618975757 2017-11-01 2018-01-02 PY - 2018 SN - 1545-5017 1545-5009 ST - Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models T2 - Pediatric Blood and Cancer TI - Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618975757&from=export http://dx.doi.org/10.1002/pbc.26870 VL - 65 ID - 1554 ER - TY - JOUR AD - X. Yan, Department of Anesthesiology, Shenzhen Bao'an Maternity and Child Health Hospital, NO.56 Yulv Road, Bao'an District, Shenzhen, China AU - Chen, H. AU - Wang, X. AU - Yan, X. AU - Cheng, X. AU - He, X. AU - Zheng, W. DB - Embase Medline DO - 10.1016/j.intimp.2017.11.038 LA - English M3 - Article N1 - L619591841 2017-12-15 2018-08-24 PY - 2018 SN - 1878-1705 1567-5769 SP - 69-76 ST - LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB T2 - International Immunopharmacology TI - LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619591841&from=export http://dx.doi.org/10.1016/j.intimp.2017.11.038 VL - 55 ID - 1555 ER - TY - JOUR AD - K. Huang, Department of Gastrointestinal Surgery, Jiangxi Provincial Cancer Hospital, No. 519, Beijing East Road, Nanchang, Jiangxi, China AU - Zhang, S. AU - Xiao, J. AU - Chai, Y. AU - Hong, Z. AU - Liu, Z. AU - Yuan, R. AU - Luo, Z. AU - Zhou, X. AU - Iii, D. E. L. P. AU - Huang, K. DB - Embase Medline DO - 10.1007/s10620-017-4884-4 IS - 2 LA - English M3 - Article N1 - L619860729 2017-12-25 2018-05-29 PY - 2018 SN - 1573-2568 0163-2116 SP - 395-402 ST - Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer T2 - Digestive Diseases and Sciences TI - Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619860729&from=export http://dx.doi.org/10.1007/s10620-017-4884-4 VL - 63 ID - 1556 ER - TY - JOUR AD - X. Wu, Department of Dermatology and Venereology, People's Hospital of Xinjiang, No. 91, Tianchi Road, Uygur Autonomous Region, Urumqi, Xinjiang, China AU - Wu, X. AU - Zhao, Z. AU - Ding, Y. AU - Xiang, F. AU - Kang, X. AU - Pu, X. DB - Embase Medline DO - 10.1097/MD.0000000000009928 IS - 7 LA - English M3 - Article N1 - L620853705 2018-03-01 2018-03-07 PY - 2018 SN - 1536-5964 0025-7974 ST - Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province T2 - Medicine (United States) TI - Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620853705&from=export http://dx.doi.org/10.1097/MD.0000000000009928 VL - 97 ID - 1557 ER - TY - JOUR AD - T. Loka, Oncology Trials Unit, United Kingdom AU - Loka, T. AU - Mahon, C. AU - O'Hare, P. O. AU - Hargrave, D. DB - Embase DO - 10.1111/bjd.16141 IS - 2 LA - English M3 - Conference Abstract N1 - L621486274 2018-04-04 PY - 2018 SN - 1365-2133 SP - e150-e151 ST - The cutaneous toxicities of BRAF and MEK inhibitor therapy in children T2 - British Journal of Dermatology TI - The cutaneous toxicities of BRAF and MEK inhibitor therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621486274&from=export http://dx.doi.org/10.1111/bjd.16141 VL - 178 ID - 1558 ER - TY - JOUR AD - V. Kon, Departments of Pediatrics, Vanderbilt University Medical Center, C-4204 Medical Center North, 1161 21st Avenue South, Nashville, TN, United States AU - Kaseda, R. AU - Tsuchida, Y. AU - Yang, H. C. AU - Yancey, P. G. AU - Zhong, J. AU - Tao, H. AU - Bian, A. AU - Fogo, A. B. AU - Linton, M. R. F. AU - Fazio, S. AU - Ikizler, T. A. AU - Kon, V. DB - Embase Medline DO - 10.1186/s12882-018-0814-8 IS - 1 LA - English M3 - Article N1 - L620339057 2018-02-07 2018-09-03 PY - 2018 SN - 1471-2369 ST - Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: Effects of liver X receptor agonism T2 - BMC Nephrology TI - Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: Effects of liver X receptor agonism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620339057&from=export http://dx.doi.org/10.1186/s12882-018-0814-8 VL - 19 ID - 1559 ER - TY - JOUR AD - S. Gong, Guangzhou Medical University, Digestive Department, Guangzhou Women and Children's Medical Center, No.9 Jinsui Road, Guangzhou, Guangdong, China AU - Cheng, Y. AU - Zhu, Y. AU - Xu, J. AU - Yang, M. AU - Chen, P. AU - Xu, W. AU - Zhao, J. AU - Geng, L. AU - Gong, S. DB - Embase Medline DO - 10.1186/s12943-017-0747-z IS - 1 LA - English M3 - Article N1 - L620329101 2018-01-31 2018-02-05 PY - 2018 SN - 1476-4598 ST - PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway T2 - Molecular Cancer TI - PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620329101&from=export http://dx.doi.org/10.1186/s12943-017-0747-z VL - 17 ID - 1560 ER - TY - JOUR AD - Y. Nagumo, Department of Urology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan AU - Nagumo, Y. AU - Maejima, A. AU - Toyoshima, Y. AU - Komiyama, M. AU - Yonemori, K. AU - Yoshida, A. AU - Fujimoto, H. DB - Embase DO - 10.1016/j.ijscr.2018.04.027 LA - English M3 - Article N1 - L2000752002 2018-05-18 2018-06-04 PY - 2018 SN - 2210-2612 SP - 1-4 ST - Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report T2 - International Journal of Surgery Case Reports TI - Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000752002&from=export http://dx.doi.org/10.1016/j.ijscr.2018.04.027 VL - 48 ID - 1561 ER - TY - JOUR AD - V. Keshari, Kushabhau Thakrey District Hospital, India AU - Keshari, V. AU - Tripathi, G. AU - Keshari, V. AU - Singh, J. DB - Embase DO - 10.1016/j.phoj.2018.11.032 IS - 3 LA - English M3 - Conference Abstract N1 - L2001337399 2018-12-06 PY - 2018 SN - 2468-1245 SP - S12 ST - RASopathies: Link Between Birth Defects and Cancer in children T2 - Pediatric Hematology Oncology Journal TI - RASopathies: Link Between Birth Defects and Cancer in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001337399&from=export http://dx.doi.org/10.1016/j.phoj.2018.11.032 VL - 3 ID - 1562 ER - TY - JOUR AD - J.M. Brandwein, Division of Hematology, Department of Medicine, University of Alberta, 11350-83 Ave., Suite 4-112 CSB, Edmonton, AB, Canada AU - Mohseni, M. AU - Uludag, H. AU - Brandwein, J. M. DB - Embase IS - 4 LA - English M3 - Review N1 - L2001995030 2019-06-11 PY - 2018 SN - 2160-1992 SP - 29-56 ST - Advances in biology of acute lymphoblastic leukemia (All) and therapeutic implications T2 - American Journal of Blood Research TI - Advances in biology of acute lymphoblastic leukemia (All) and therapeutic implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001995030&from=export VL - 8 ID - 1563 ER - TY - JOUR AD - W. Wang, Department of Physiology, Basic Medical College, Jiamusi University, 148 Xuefu Street, Jiamusi, Heilongjiang, China AU - Jia, L. AU - Li, F. AU - Shao, M. AU - Zhang, W. AU - Zhang, C. AU - Zhao, X. AU - Luan, H. AU - Qi, Y. AU - Zhang, P. AU - Liang, L. AU - Jia, X. AU - Zhang, K. AU - Lu, Y. AU - Yang, Z. AU - Zhu, X. AU - Zhang, Q. AU - Du, J. AU - Wang, W. DB - Embase DO - 10.3892/ol.2017.7391 IS - 1 LA - English M3 - Article N1 - L619453170 2017-12-05 2017-12-08 PY - 2018 SN - 1792-1082 1792-1074 SP - 1350-1356 ST - IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells T2 - Oncology Letters TI - IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619453170&from=export http://dx.doi.org/10.3892/ol.2017.7391 VL - 15 ID - 1564 ER - TY - JOUR AD - K. Yang, Institute of Cardiovascular Disease, Ruijin Hospital, Shanghai, China AU - Feng, D. AU - Wang, Y. AU - Liu, Y. AU - Wu, L. AU - Li, X. AU - Chen, Y. AU - Chen, Y. AU - Chen, Y. AU - Xu, C. AU - Yang, K. AU - Zhou, T. DB - Embase Medline DO - 10.1111/cei.13048 IS - 1 LA - English M3 - Article N1 - L619676722 2017-12-18 2017-12-20 PY - 2018 SN - 1365-2249 0009-9104 SP - 107-115 ST - DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury T2 - Clinical and Experimental Immunology TI - DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619676722&from=export http://dx.doi.org/10.1111/cei.13048 VL - 191 ID - 1565 ER - TY - JOUR AD - Y.-F. Wang, Department of Medical Laboratory Science and Biotechnology, Fooyin-University, Kaohsiung, Taiwan AU - Tsai, C. Y. AU - Chen, C. Y. AU - Chiou, Y. H. AU - Shyu, H. W. AU - Lin, K. H. AU - Chou, M. C. AU - Huang, M. H. AU - Wang, Y. F. DB - Embase DO - 10.3390/ijms19010016 IS - 1 LA - English M3 - Article N1 - L619950609 2018-01-04 2018-01-08 PY - 2018 SN - 1422-0067 1661-6596 ST - Epigallocatechin-3-gallate suppresses human herpesvirus 8 replication and induces ROS leading to apoptosis and autophagy in primary effusion lymphoma cells T2 - International Journal of Molecular Sciences TI - Epigallocatechin-3-gallate suppresses human herpesvirus 8 replication and induces ROS leading to apoptosis and autophagy in primary effusion lymphoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619950609&from=export http://dx.doi.org/10.3390/ijms19010016 VL - 19 ID - 1566 ER - TY - JOUR AD - M. Merad, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States AU - Hogstad, B. AU - Berres, M. L. AU - Chakraborty, R. AU - Tang, J. AU - Bigenwald, C. AU - Serasinghe, M. AU - Lim, K. P. H. AU - Lin, H. AU - Man, T. K. AU - Remark, R. AU - Baxter, S. AU - Kana, V. AU - Jordan, S. AU - Karoulia, Z. AU - Kwan, W. H. AU - Leboeuf, M. AU - Brandt, E. AU - Salmon, H. AU - McClain, K. AU - Poulikakos, P. AU - Chipuk, J. AU - Mulder, W. J. M. AU - Allen, C. E. AU - Merad, M. C1 - abt 263 gsk 1120212 DB - Embase Medline DO - 10.1084/jem.20161881 IS - 1 LA - English M3 - Article N1 - L620086797 2018-01-11 2018-01-12 PY - 2018 SN - 1540-9538 0022-1007 SP - 319-336 ST - RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions T2 - Journal of Experimental Medicine TI - RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620086797&from=export http://dx.doi.org/10.1084/jem.20161881 VL - 215 ID - 1567 ER - TY - JOUR AD - J.M. Cerutti, Departamento de Morfologia e Genética, Genetic Bases of Thyroid Tumors Laboratory, Disciplina de Genética, Universidade Federal de São Paulo, São Paulo, Brazil AU - Bastos, A. U. AU - De Jesus, A. C. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1530/EJE-17-0499 IS - 1 LA - English M3 - Article N1 - L620213047 2018-01-19 2018-01-22 PY - 2018 SN - 1479-683X 0804-4643 SP - 83-91 ST - ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population T2 - European Journal of Endocrinology TI - ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620213047&from=export http://dx.doi.org/10.1530/EJE-17-0499 VL - 178 ID - 1568 ER - TY - JOUR AU - Huang, H. I. AU - Chio, C. C. AU - Lin, J. Y. DB - Embase Medline DO - 10.1371/journal.pone.0191617 IS - 1 LA - English M3 - Article N1 - L620325723 2018-02-01 2018-02-06 PY - 2018 SN - 1932-6203 ST - Inhibition of EV71 by curcumin in intestinal epithelial cells T2 - PLoS ONE TI - Inhibition of EV71 by curcumin in intestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620325723&from=export http://dx.doi.org/10.1371/journal.pone.0191617 VL - 13 ID - 1569 ER - TY - JOUR AD - M. Higashi, Kyoto Prefectural University of Medicine, Kyoto, Japan AU - Higashi, M. AU - Kin, K. AU - Tajiri, T. DB - Embase DO - 10.1158/1535-7163.TARG-17-B091 IS - 1 LA - English M3 - Conference Abstract N1 - L620384280 2018-02-01 PY - 2018 SN - 1538-8514 ST - Disruption of cancer stemness by targeting the JNK-STAT3 pathway in neuroblastoma T2 - Molecular Cancer Therapeutics TI - Disruption of cancer stemness by targeting the JNK-STAT3 pathway in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620384280&from=export http://dx.doi.org/10.1158/1535-7163.TARG-17-B091 VL - 17 ID - 1570 ER - TY - JOUR AD - P. Zavattari, Unit of Biology and Genetics, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy AU - Antonelli, M. AU - Fadda, A. AU - Loi, E. AU - Moi, L. AU - Zavattari, C. AU - Sulas, P. AU - Gentilini, D. AU - Cameli, C. AU - Bacchelli, E. AU - Badiali, M. AU - Arcella, A. AU - Morra, I. AU - Giangaspero, F. AU - Zavattari, P. DB - Embase DO - 10.18632/oncotarget.24480 IS - 17 LA - English M3 - Article N1 - L621000120 2018-03-08 2018-03-14 PY - 2018 SN - 1949-2553 SP - 13807-13821 ST - Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas T2 - Oncotarget TI - Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621000120&from=export http://dx.doi.org/10.18632/oncotarget.24480 VL - 9 ID - 1571 ER - TY - JOUR AD - C. Boura, Université de Lorraine, CNRS, CRAN, Nancy, France AU - Gong, C. AU - Valduga, J. AU - Chateau, A. AU - Richard, M. AU - Pellegrin-Moïse, N. AU - Barberi-Heyob, M. AU - Chastagner, P. AU - Boura, C. C1 - mr 438 DB - Embase DO - 10.18632/oncotarget.24521 IS - 20 LA - English M3 - Article N1 - L621297233 2018-03-22 2018-04-03 PY - 2018 SN - 1949-2553 SP - 15312-15325 ST - Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1 T2 - Oncotarget TI - Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621297233&from=export http://dx.doi.org/10.18632/oncotarget.24521 VL - 9 ID - 1572 ER - TY - JOUR AD - K.T.E. Chang, Departments of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore AU - Hue, S. S. S. AU - Iyer, P. AU - Toh, L. H. W. AU - Jain, S. AU - Tan, E. E. K. AU - Sittampalam, K. AU - Lian, D. W. Q. AU - Chang, K. T. E. DB - Embase Medline DO - 10.1097/MPH.0000000000000839 IS - 2 LA - English M3 - Article N1 - L621403368 2018-03-30 2018-04-11 PY - 2018 SN - 1536-3678 1077-4114 SP - e103-e107 ST - Primary Bone Anaplastic Large Cell Lymphoma Masquerading as Ewing Sarcoma: Diagnosis by Anchored Multiplex PCR T2 - Journal of Pediatric Hematology/Oncology TI - Primary Bone Anaplastic Large Cell Lymphoma Masquerading as Ewing Sarcoma: Diagnosis by Anchored Multiplex PCR UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621403368&from=export http://dx.doi.org/10.1097/MPH.0000000000000839 VL - 40 ID - 1573 ER - TY - JOUR AD - M. Pawar, Department of Dermatology, Dr. Vasantrao Pawar Medical College, Hospital and Research Center, Nashik, Maharashtra, India AU - Shah, M. AU - Pawar, M. AU - Zawar, V. DB - Embase Medline DO - 10.15570/actaapa.2018.7 IS - 1 LA - English M3 - Article N1 - L621565699 2018-04-11 2018-10-11 PY - 2018 SN - 1581-2979 1318-4458 SP - 33-34 ST - A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma T2 - Acta Dermatovenerologica Alpina, Pannonica et Adriatica TI - A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621565699&from=export http://dx.doi.org/10.15570/actaapa.2018.7 VL - 27 ID - 1574 ER - TY - JOUR AD - A. Tomiyama, Div. Brain. Tumor. Transl. Res., Natl. Can. Ctr. Res. Inst., Japan AU - Tomiyama, A. AU - Nakano, Y. AU - Yamasaki, K. AU - Fukushima, H. AU - Inoue, T. AU - Kohno, T. AU - Yoshida, A. AU - Fukuoka, K. AU - Matsusaka, Y. AU - Hara, J. AU - Sakamoto, H. AU - Mori, K. AU - Ichimura, K. DB - Embase LA - English M3 - Conference Abstract N1 - L621976582 2018-05-08 PY - 2018 SN - 1349-7006 ST - The oncogenic role of a novel KLC1-ROS1 fusion gene identified in a pediatric low-grade glioma T2 - Cancer Science TI - The oncogenic role of a novel KLC1-ROS1 fusion gene identified in a pediatric low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621976582&from=export VL - 109 ID - 1575 ER - TY - JOUR AD - M.A. Tanino, Dept. Cancer. Pathol., Fac. of Med., Hokkaido Univ., Japan AU - Tanino, M. A. AU - Nanjo, H. AU - Tsuda, M. AU - Sugino, H. AU - Wang, R. AU - Ishida, Y. AU - Tanaka, S. DB - Embase LA - English M3 - Conference Abstract N1 - L621977428 2018-05-08 PY - 2018 SN - 1349-7006 SP - 1128 ST - Aanalysis of relationship between BRAF V600E mutation and expression for p16 in pleomorphic xanthoastrocytoma T2 - Cancer Science TI - Aanalysis of relationship between BRAF V600E mutation and expression for p16 in pleomorphic xanthoastrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621977428&from=export VL - 109 ID - 1576 ER - TY - JOUR AD - F. Casamenti, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy AU - Nardiello, P. AU - Pantano, D. AU - Lapucci, A. AU - Stefani, M. AU - Casamenti, F. DB - Embase Medline DO - 10.3233/JAD-171124 IS - 3 LA - English M3 - Article N1 - L622275486 2018-05-29 2018-05-31 PY - 2018 SN - 1875-8908 1387-2877 SP - 1161-1172 ST - Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition T2 - Journal of Alzheimer's Disease TI - Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622275486&from=export http://dx.doi.org/10.3233/JAD-171124 VL - 63 ID - 1577 ER - TY - JOUR AD - T. Loka, Great Ormond Street Hospital NHS Trust, Department of Paediatric Oncology, London, United Kingdom AU - Loka, T. AU - Hare, P. O. AU - Mahon, C. AU - Hargrave, D. DB - Embase DO - 10.1007/s00520-018-4193-2 IS - 2 LA - English M3 - Conference Abstract N1 - L622327645 2018-05-31 PY - 2018 SN - 1433-7339 SP - S67 ST - Cutaneous toxicity of BRAF and MEK inhibitor therapy in children T2 - Supportive Care in Cancer TI - Cutaneous toxicity of BRAF and MEK inhibitor therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622327645&from=export http://dx.doi.org/10.1007/s00520-018-4193-2 VL - 26 ID - 1578 ER - TY - JOUR AD - T.G. Muñoz, Microenvironment and Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain AU - Muñoz, T. G. AU - Di Giannatale, A. AU - Savini, C. AU - Garcia-Silva, S. AU - Benito-Martin, A. AU - Merino, C. AU - Peinado, H. DB - Embase DO - 10.1080/20013078.2018.1461450 LA - English M3 - Conference Abstract N1 - L622571939 2018-06-19 PY - 2018 SN - 2001-3078 SP - 232-233 ST - Use of tumour-secreted exosomes to define new biomarkers and targets to prevent malignant peripheral nerve-sheath tumour progression T2 - Journal of Extracellular Vesicles TI - Use of tumour-secreted exosomes to define new biomarkers and targets to prevent malignant peripheral nerve-sheath tumour progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622571939&from=export http://dx.doi.org/10.1080/20013078.2018.1461450 VL - 7 ID - 1579 ER - TY - JOUR AD - A.M. Andruska, Pulmonary and Critical Care, Stanford University Hospital, Stanford, CA, United States AU - Andruska, A. M. AU - Shafiq, M. AU - Ohgami, R. AU - Guo, H. H. AU - Sung, A. W. DB - Embase IS - MeetingAbstracts LA - English M3 - Conference Abstract N1 - L622965439 2018-07-16 PY - 2018 SN - 1535-4970 ST - A lung cyst in a sea of histiocytes: Systemic langerhans cell histiocytosis diagnosed via EBUS T2 - American Journal of Respiratory and Critical Care Medicine TI - A lung cyst in a sea of histiocytes: Systemic langerhans cell histiocytosis diagnosed via EBUS UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622965439&from=export VL - 197 ID - 1580 ER - TY - JOUR AD - B.D. Ross, Radiology, University of Michigan, Ann Arbor, MI, United States AU - Ross, B. D. AU - Galban, S. AU - Hoff, B. A. AU - Van Dort, M. AU - Espinoza, C. AU - Xu, X. AU - Hardie, W. D. DB - Embase IS - MeetingAbstracts LA - English M3 - Conference Abstract N1 - L622967362 2018-07-16 PY - 2018 SN - 1535-4970 ST - First-in-class MAPK/PI3K small molecule exhibits reversal of fibroproliferative disease T2 - American Journal of Respiratory and Critical Care Medicine TI - First-in-class MAPK/PI3K small molecule exhibits reversal of fibroproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622967362&from=export VL - 197 ID - 1581 ER - TY - GEN AD - S. Berger, Cancer Center Heilbronn-Franken, MOLIT Institute, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, Heilbronn, Germany AU - Berger, S. AU - Martens, U. M. AU - Bochum, S. C1 - loxo 101 C5 - 30069765 DB - Embase Medline DO - 10.1007/978-3-319-91442-8_10 J2 - Recent Results Cancer Res. LA - English M1 - (Berger S., stephanie.berger@slk-kliniken.de; Martens U.M., uwe.martens@slk-kliniken.de; Bochum S., sylvia.bochum@slk-kliniken.de) Cancer Center Heilbronn-Franken, MOLIT Institute, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, Heilbronn, Germany M3 - Chapter N1 - L623409430 2018-08-14 2018-08-21 PY - 2018 SN - 2197-6767 0080-0015 SP - 141-151 ST - Larotrectinib (LOXO-101) TI - Larotrectinib (LOXO-101) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623409430&from=export http://dx.doi.org/10.1007/978-3-319-91442-8_10 VL - 211 ID - 1582 ER - TY - JOUR AD - H. Kadara, Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon AU - Rahal, Z. AU - Abdulhai, F. AU - Kadara, H. AU - Saab, R. C1 - herceptin DB - Embase IS - 8 LA - English M3 - Review N1 - L623730829 2018-09-06 2018-09-10 PY - 2018 SN - 2156-6976 SP - 1356-1386 ST - Genomics of adult and pediatric solid tumors T2 - American Journal of Cancer Research TI - Genomics of adult and pediatric solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623730829&from=export VL - 8 ID - 1583 ER - TY - JOUR AD - M.B. Yaffe, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States AU - Dreaden, E. C. AU - Kong, Y. W. AU - Quadir, M. A. AU - Correa, S. AU - Suárez-López, L. AU - Barberio, A. E. AU - Hwang, M. K. AU - Shi, A. C. AU - Oberlton, B. AU - Gallagher, P. N. AU - Shopsowitz, K. E. AU - Elias, K. M. AU - Yaffe, M. B. AU - Hammond, P. T. C2 - LC Sigma Aldrich DB - Embase DO - 10.1002/btm2.10086 IS - 1 LA - English M3 - Article N1 - L623769866 2018-09-11 2018-09-13 PY - 2018 SN - 2380-6761 SP - 26-36 ST - RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors T2 - Bioengineering and Translational Medicine TI - RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623769866&from=export http://dx.doi.org/10.1002/btm2.10086 VL - 3 ID - 1584 ER - TY - JOUR AD - Y. Zhuang, Department of Orthopedics, Affiliated Jiangyin Hospital, Southeast University Medical College, Wuxi, China AU - Tian, Z. G. AU - Zhuang, Y. AU - Jin, Z. AU - Zhou, F. AU - Zhu, L. F. AU - Shen, P. C. DB - Embase Medline IS - 17 LA - English M3 - Article N1 - L623984826 2018-10-02 2018-10-04 PY - 2018 SN - 2284-0729 1128-3602 SP - 5460-5470 ST - MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways T2 - European Review for Medical and Pharmacological Sciences TI - MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623984826&from=export VL - 22 ID - 1586 ER - TY - JOUR AD - B. Dréno, Dermato-cancerology Department, CHU Nantes, Place Alexis Ricordeau, Nantes, France AU - Saint-Jean, M. AU - Knol, A. C. AU - Volteau, C. AU - Quéreux, G. AU - Peuvrel, L. AU - Brocard, A. AU - Pandolfino, M. C. AU - Saiagh, S. AU - Nguyen, J. M. AU - Bedane, C. AU - Basset-Seguin, N. AU - Khammari, A. AU - Dréno, B. C1 - azd 6244(Astra Zeneca) proleukin(Chiron,United States) C2 - Astra Zeneca Chiron(United States) DB - Embase Medline DO - 10.1155/2018/3530148 LA - English M3 - Article N1 - L624692383 2018-11-16 2019-01-24 PY - 2018 SN - 2314-7156 2314-8861 ST - Adoptive cell therapy with tumor-infiltrating lymphocytes in advanced melanoma patients T2 - Journal of Immunology Research TI - Adoptive cell therapy with tumor-infiltrating lymphocytes in advanced melanoma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624692383&from=export http://dx.doi.org/10.1155/2018/3530148 VL - 2018 ID - 1587 ER - TY - JOUR AD - P. Fan, Department of Plastic and Esthetic surgery, Xiangya Hospital of Central South University, Changsha, China AU - Fan, P. AU - Chen, S. AU - Li, Z. AU - Yang, X. AU - Lei, S. AU - Tan, W. DB - Embase IS - 11 LA - English M3 - Article N1 - L625290452 2018-12-11 2018-12-13 PY - 2018 SN - 1940-5901 SP - 12124-12132 ST - Gallic acid inhibits lps induced hypertrophic scar inflammation via toll-like receptor 4/nuclear factor-κb/peroxisome proliferator-activated receptor γ signaling T2 - International Journal of Clinical and Experimental Medicine TI - Gallic acid inhibits lps induced hypertrophic scar inflammation via toll-like receptor 4/nuclear factor-κb/peroxisome proliferator-activated receptor γ signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625290452&from=export VL - 11 ID - 1588 ER - TY - JOUR AD - Y. Liu, Department of Pediatrics, Tongji Hospital Affiliated, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Liu, Y. AU - Xu, S. Q. AU - Long, W. J. AU - Zhang, X. Y. AU - Lu, H. L. DB - Embase Medline DO - 10.26355/eurrev-201811-16428 IS - 22 LA - English M3 - Article N1 - L625358192 2018-12-11 2018-12-18 PY - 2018 SN - 2284-0729 1128-3602 SP - 7994-8003 ST - C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway T2 - European Review for Medical and Pharmacological Sciences TI - C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625358192&from=export http://dx.doi.org/10.26355/eurrev-201811-16428 VL - 22 ID - 1589 ER - TY - JOUR AD - T. Lv, Department of Hand and Foot Microsurgery, Liaoyang Central Hospital, Liaoyang, Liaoning, China AU - Lv, T. AU - Liu, Y. AU - Li, Z. AU - Huang, R. AU - Zhang, Z. AU - Li, J. DB - Embase Medline DO - 10.3233/CBM-170906 IS - 3 LA - English M3 - Article N1 - L625493375 2018-12-21 2019-04-10 PY - 2018 SN - 1875-8592 1574-0153 SP - 315-322 ST - MiR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor T2 - Cancer Biomarkers TI - MiR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625493375&from=export http://dx.doi.org/10.3233/CBM-170906 VL - 23 ID - 1590 ER - TY - JOUR AD - P.K. Mangat, American Society of Clinical Oncology, 2318 Mill Rd, Alexandria, VA, United States AU - Mangat, P. K. AU - Halabi, S. AU - Bruinooge, S. S. AU - Garrett-Mayer, E. AU - Alva, A. AU - Janeway, K. A. AU - Stella, P. J. AU - Voest, E. AU - Yost, K. J. AU - Perlmutter, J. AU - Pinto, N. AU - Kim, E. S. AU - Schilsky, R. L. DB - Embase DO - 10.1200/PO.18.00122 IS - 2 LA - English M3 - Article N1 - L626826794 2019-03-27 2019-03-29 PY - 2018 SN - 2473-4284 ST - Rationale and design of the targeted agent and profiling utilization registry study T2 - JCO Precision Oncology TI - Rationale and design of the targeted agent and profiling utilization registry study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626826794&from=export http://dx.doi.org/10.1200/PO.18.00122 ID - 1591 ER - TY - JOUR AD - J. Bylund, The Phagocyte Research Group, Netherlands Institute for Neuroscience, An Institute of the Royal Netherlands Academy of Arts and Sciences, University of Gothenburg, Gothenburg, Sweden AU - Sundqvist, M. AU - Christenson, K. AU - Björnsdottir, H. AU - Osla, V. AU - Karlsson, A. AU - Dahlgren, C. AU - Speert, D. P. AU - Fasth, A. AU - Brown, K. L. AU - Bylund, J. DB - Embase DO - 10.3389/fimmu.2017.01828 IS - DEC LA - English M3 - Article N1 - L619910119 2017-12-29 2018-01-03 PY - 2017 SN - 1664-3224 ST - Elevated mitochondrial reactive oxygen species and cellular redox imbalance in human NADPH-oxidase-deficient phagocytes T2 - Frontiers in Immunology TI - Elevated mitochondrial reactive oxygen species and cellular redox imbalance in human NADPH-oxidase-deficient phagocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619910119&from=export http://dx.doi.org/10.3389/fimmu.2017.01828 VL - 8 ID - 1593 ER - TY - JOUR AD - C. Chiaverini, Centre de référence des maladies rares de la peau et des muqueuses d'origine génétique, service de dermatologie, hôpital Archet 2, CHU de Nice, France AU - Chiaverini, C. DB - Embase Medline DO - 10.1016/S0151-9638(17)31063-3 LA - English French M3 - Article N1 - L619813455 2017-12-22 2018-08-17 PY - 2017 SN - 0151-9638 SP - IVS29-IVS39 ST - What's new in pediatric dermatology? T2 - Annales de Dermatologie et de Venereologie TI - What's new in pediatric dermatology? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619813455&from=export http://dx.doi.org/10.1016/S0151-9638(17)31063-3 VL - 144 ID - 1594 ER - TY - JOUR AD - C. Skurk, Department of Cardiology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany AU - Jenke, A. AU - Schur, R. AU - Röger, C. AU - Karadeniz, Z. AU - Grüger, M. AU - Holzhauser, L. AU - Savvatis, K. AU - Poller, W. AU - Schultheiss, H. P. AU - Landmesser, U. AU - Skurk, C. C1 - pd 098059 r 848 sp 600125 DB - Embase Medline DO - 10.14814/phy2.13523 IS - 24 LA - English M3 - Article N1 - L619927826 2017-12-28 2017-12-29 PY - 2017 SN - 2051-817X ST - Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice T2 - Physiological Reports TI - Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619927826&from=export http://dx.doi.org/10.14814/phy2.13523 VL - 5 ID - 1595 ER - TY - JOUR AD - J. Zhang, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin, China AU - Zhang, J. AU - Guo, Y. AU - Yang, W. AU - Chen, X. AU - Chao, L. AU - Chen, Y. AU - Zou, Y. AU - Zhu, X. AU - Zhang, Y. DB - Embase LA - English M3 - Conference Abstract N1 - L620310650 2018-01-26 PY - 2017 SN - 1528-0020 ST - Aberrant FLT3 transcription arised from polycomb repressive complex 2 inactivation indiactes a potential therapy target for pediatric T cell acute lymphoblastic leukemia T2 - Blood TI - Aberrant FLT3 transcription arised from polycomb repressive complex 2 inactivation indiactes a potential therapy target for pediatric T cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620310650&from=export VL - 130 ID - 1596 ER - TY - JOUR AD - R. Kebudi, Pediatric Hematology-Oncology, Istanbul University, Cerrahpasa Medical Faculty and Oncology Institute, Istanbul, Turkey AU - Kebudi, R. AU - Gorgun, O. AU - Dogan, O. DB - Embase LA - English M3 - Conference Abstract N1 - L620333990 2018-01-30 PY - 2017 SN - 1528-0020 ST - Aggresive lymphoma-leukemia presenting as a solitary bone tumor and mimicking ewing's sarcoma T2 - Blood TI - Aggresive lymphoma-leukemia presenting as a solitary bone tumor and mimicking ewing's sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620333990&from=export VL - 130 ID - 1597 ER - TY - JOUR AD - L. Brugières, Gustave Roussy, Villejuif, France AU - Brugières, L. AU - Houot, R. AU - Cozic, N. AU - De La Fouchardière, C. AU - Morschhauser, F. AU - Brice, P. AU - Laboure, N. A. AU - Auvrignon, A. AU - Aladjidi, N. AU - Kolb, B. AU - Blanc, L. AU - Pagnier, A. AU - Arfi-Rouche, J. AU - Cottereau, A. S. AU - Oukhatar, C. A. AU - Labouret, N. H. AU - Vassal, G. DB - Embase LA - English M3 - Conference Abstract N1 - L620334263 2018-01-30 PY - 2017 SN - 1528-0020 ST - Crizotinib in advanced ALK+ anaplastic large cell lymphoma in children and adults: Results of the ACS© phase II trial T2 - Blood TI - Crizotinib in advanced ALK+ anaplastic large cell lymphoma in children and adults: Results of the ACS© phase II trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334263&from=export VL - 130 ID - 1598 ER - TY - JOUR AD - D. Zinn, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States AU - Zinn, D. AU - Picarsic, J. AU - Chakraborty, R. AU - Lin, H. AU - Abhyankar, H. AU - Scull, B. AU - Shih, A. AU - Lim, K. P. H. AU - Eckstein, O. S. AU - Peters, T. L. AU - Olea, W. AU - Burke, T. AU - Ahmed, N. AU - Hicks, J. AU - Tran, B. AU - Jones, J. AU - Dauser, R. AU - Jeng, M. R. AU - Baiocchi, R. A. AU - Schiff, D. E. AU - Goldman, S. AU - Heym, K. M. AU - Wilson, H. AU - Carcamo, B. AU - Kumar, A. AU - Rodriguez-Galindo, C. AU - Whipple, N. AU - Campbell, P. AU - Murdoch, G. AU - Heales, S. AU - Malone, M. AU - Woltjer, R. AU - Quinn, J. AU - Orchard, P. AU - Kruer, M. AU - Jaffe, R. AU - Manz, M. G. AU - Lira, S. AU - Parsons, D. W. AU - Merad, M. AU - Man, T. K. AU - McClain, K. L. AU - Allen, C. E. DB - Embase LA - English M3 - Conference Abstract N1 - L620334442 2018-01-30 PY - 2017 SN - 1528-0020 ST - BRAF-V600E in peripheral mononuclear cells and microglia-like brain cells suggest hematopoietic origin of langerhans cell histiocytosis-associated neurodegeneration T2 - Blood TI - BRAF-V600E in peripheral mononuclear cells and microglia-like brain cells suggest hematopoietic origin of langerhans cell histiocytosis-associated neurodegeneration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334442&from=export VL - 130 ID - 1599 ER - TY - JOUR AD - K.P.H. Lim, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Missouri City, TX, United States AU - Lim, K. P. H. AU - Milne, P. AU - Poidinger, M. AU - Lin, H. AU - Duan, K. AU - Merad, M. AU - Newell, E. AU - Chakraborty, R. AU - Eckstein, O. S. AU - Zinn, D. AU - Abhyankar, H. AU - McClain, K. L. AU - Man, C. T. K. AU - Ginhoux, F. AU - Collin, M. P. AU - Allen, C. E. DB - Embase LA - English M3 - Conference Abstract N1 - L620334685 2018-01-30 PY - 2017 SN - 1528-0020 ST - Transcriptional profiles, lineage tracing with BRAF-V600E and HLA-DQB2 expression support a model of blood CD1c+ cells as precursors to LCH Lesion CD207+ Cells T2 - Blood TI - Transcriptional profiles, lineage tracing with BRAF-V600E and HLA-DQB2 expression support a model of blood CD1c+ cells as precursors to LCH Lesion CD207+ Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334685&from=export VL - 130 ID - 1600 ER - TY - JOUR AD - I. Somekh, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany AU - Somekh, I. AU - Marquardt, B. AU - Liu, Y. AU - Rohlfs, M. AU - Frizinsky, S. AU - Unal, E. AU - Kotlarz, D. AU - Somech, R. AU - Klein, C. DB - Embase LA - English M3 - Conference Abstract N1 - L620384866 2018-02-01 PY - 2017 SN - 1528-0020 ST - Novel mutations in RASGRP1 are associated with immune dysregulation and predispose to EBV-induced lymphoma T2 - Blood TI - Novel mutations in RASGRP1 are associated with immune dysregulation and predispose to EBV-induced lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620384866&from=export VL - 130 ID - 1601 ER - TY - JOUR AD - C. Fan, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, United States AU - Fan, C. AU - Zhao, C. AU - Zhang, F. AU - Cai, X. AU - Xu, L. AU - Lin, S. AU - Chen, X. AU - Guo, F. AU - Lu, R. Q. AU - Tian, W. AU - Zheng, Y. DB - Embase LA - English M3 - Conference Abstract N1 - L620385264 2018-02-01 PY - 2017 SN - 1528-0020 ST - Mtor restricts chromatin access and genomic activity to maintain hematopoietic stem cell quiescence and engraftment T2 - Blood TI - Mtor restricts chromatin access and genomic activity to maintain hematopoietic stem cell quiescence and engraftment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385264&from=export VL - 130 ID - 1603 ER - TY - JOUR AD - A.R. Oseghale, Vascular Biology Center, Augusta University, Augusta, GA, United States AU - Oseghale, A. R. AU - Johnson, M. M. AU - Zhu, X. AU - Nudelman, A. AU - Rephaeli, A. AU - Pace, B. S. DB - Embase LA - English M3 - Conference Abstract N1 - L620385380 2018-02-01 PY - 2017 SN - 1528-0020 ST - Novel conjugates of butyrate and δ-aminolevulinate increase γ-globin gene expression and fetal hemoglobin synthesis in erythroid progenitors T2 - Blood TI - Novel conjugates of butyrate and δ-aminolevulinate increase γ-globin gene expression and fetal hemoglobin synthesis in erythroid progenitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385380&from=export VL - 130 ID - 1604 ER - TY - JOUR AD - J. Hellmuth, Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, United States AU - Hellmuth, J. AU - Louissaint, A. AU - Szczepanowski, M. AU - Häbe, S. AU - Pastore, A. AU - Staiger, A. M. AU - Hartmann, S. AU - Kridel, R. AU - Ducar, M. D. AU - Koch, P. AU - Dreyling, M. AU - Hansmann, M. L. AU - Ott, G. AU - Rosenwald, A. AU - Gascoyne, R. D. AU - Weinstock, D. M. AU - Hiddemann, W. AU - Klapper, W. AU - Weigert, O. DB - Embase LA - English M3 - Conference Abstract N1 - L620385702 2018-02-01 PY - 2017 SN - 1528-0020 ST - The mutational landscape and immune microenvironment of primary intestinal follicular lymphoma (PIFL) T2 - Blood TI - The mutational landscape and immune microenvironment of primary intestinal follicular lymphoma (PIFL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385702&from=export VL - 130 ID - 1605 ER - TY - JOUR AD - J. Lee, Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA, United States AU - Lee, J. AU - Geng, H. AU - Chen, Z. AU - Xiao, G. AU - Cosgun, K. N. N. AU - Zammarchi, F. AU - Van Berkel, P. AU - Melnick, A. AU - Paietta, E. AU - Muschen, M. DB - Embase LA - English M3 - Conference Abstract N1 - L620385938 2018-02-01 PY - 2017 SN - 1528-0020 ST - CD25 enables oncogenic BCR-signaling and represents a therapeutic target in B cell malignancies T2 - Blood TI - CD25 enables oncogenic BCR-signaling and represents a therapeutic target in B cell malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385938&from=export VL - 130 ID - 1606 ER - TY - JOUR AD - S.H. Chu, Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States AU - Chu, S. H. AU - Song, E. J. AU - Chabon, J. AU - Minehart, J. AU - Feng, Z. AU - Ross, K. AU - Koche, R. AU - Krivtsov, A. V. AU - Armstrong, S. DB - Embase LA - English M3 - Conference Abstract N1 - L620386002 2018-02-01 PY - 2017 SN - 1528-0020 ST - Targeting the DNA damage response pathway in MLL-rearranged B-acute lymphoblastic leukemias T2 - Blood TI - Targeting the DNA damage response pathway in MLL-rearranged B-acute lymphoblastic leukemias UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620386002&from=export VL - 130 ID - 1607 ER - TY - JOUR AD - R.J. Leeman-Neill, VC14-236, Columbia University Medical Center, New York, NY, United States AU - Leeman-Neill, R. J. AU - Raciti, P. M. AU - Hsiao, S. J. AU - Vundavalli, M. AU - Alobeid, B. AU - Mansukhani, M. M. AU - Bhagat, G. DB - Embase LA - English M3 - Conference Abstract N1 - L620386166 2018-02-01 PY - 2017 SN - 1528-0020 ST - Molecular characterization of post-transplant plasmablastic lymphomas implicates RAS, TP53, and notch mutations and MYC deregulation in disease pathogenesis T2 - Blood TI - Molecular characterization of post-transplant plasmablastic lymphomas implicates RAS, TP53, and notch mutations and MYC deregulation in disease pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620386166&from=export VL - 130 ID - 1608 ER - TY - JOUR AD - Y.A. DeClerck, Children’s Hospital Los Angeles, 4650 Sunset Boulevard, MS#54, Los Angeles, CA, United States AU - Nakata, R. AU - Shimada, H. AU - Fernandez, G. E. AU - Fanter, R. AU - Fabbri, M. AU - Malvar, J. AU - Zimmermann, P. AU - DeClerck, Y. A. DB - Embase DO - 10.1080/20013078.2017.1332941 IS - 1 LA - English M3 - Article N1 - L620605866 2018-02-19 2018-02-26 PY - 2017 SN - 2001-3078 ST - Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells T2 - Journal of Extracellular Vesicles TI - Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620605866&from=export http://dx.doi.org/10.1080/20013078.2017.1332941 VL - 6 ID - 1609 ER - TY - JOUR AD - S. Bhattacharyya, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, OH, United States AU - Kong, F. AU - Liu, Z. AU - Jain, V. G. AU - Shima, K. AU - Suzuki, T. AU - Muglia, L. J. AU - Starczynowski, D. T. AU - Pasare, C. AU - Bhattacharyya, S. DB - Embase Medline DO - 10.4049/jimmunol.1700443 IS - 10 LA - English M3 - Article N1 - L619180893 2017-11-15 2017-11-23 PY - 2017 SN - 1550-6606 0022-1767 SP - 3654-3667 ST - Inhibition of IRAK1 ubiquitination determines glucocorticoid sensitivity for tlr9-induced inflammation in macrophages T2 - Journal of Immunology TI - Inhibition of IRAK1 ubiquitination determines glucocorticoid sensitivity for tlr9-induced inflammation in macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619180893&from=export http://dx.doi.org/10.4049/jimmunol.1700443 VL - 199 ID - 1610 ER - TY - JOUR AD - K. Kudo, Department of Pediatrics, Hirosaki University, Graduate School of Medicine, Hirosaki, Japan AU - Kudo, K. AU - Kanezaki, R. AU - Kobayashi, A. AU - Sato, T. AU - Kamio, T. AU - Sasaki, S. AU - Terui, K. AU - Sato, A. AU - Irie, M. AU - Sasahara, Y. AU - Imamura, M. AU - Imai, C. AU - Toki, T. AU - Ito, E. DB - Embase DO - 10.1002/pbc.26770 LA - English M3 - Conference Abstract N1 - L618304361 2017-09-21 PY - 2017 SN - 1545-5017 SP - S19 ST - Detection of somatic mutations by PCR-based next-generation sequencing from fixed clinical specimens in childhood LCH T2 - Pediatric Blood and Cancer TI - Detection of somatic mutations by PCR-based next-generation sequencing from fixed clinical specimens in childhood LCH UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618304361&from=export http://dx.doi.org/10.1002/pbc.26770 VL - 64 ID - 1611 ER - TY - JOUR AD - Y.-Y. Le, Key Laboratory of Food Safety Research, Chinese Academy of Sciences, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Shanghai, China AU - Yao, P. L. AU - Zhuo, S. AU - Mei, H. AU - Chen, X. F. AU - Li, N. AU - Zhu, T. F. AU - Chen, S. T. AU - Wang, J. M. AU - Hou, R. X. AU - Le, Y. Y. DB - Embase Medline DO - 10.1111/cns.12757 IS - 11 LA - English M3 - Article N1 - L618516238 2017-10-06 2018-07-23 PY - 2017 SN - 1755-5949 1755-5930 SP - 855-865 ST - Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ T2 - CNS Neuroscience and Therapeutics TI - Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618516238&from=export http://dx.doi.org/10.1111/cns.12757 VL - 23 ID - 1612 ER - TY - JOUR AD - F. Bautista, INSERM U1018, CESP, Univ. Paris-Sud, Univ. Paris-Saclay, Villejuif, France AU - Bautista, F. AU - Moreno, L. AU - Marshall, L. AU - Pearson, A. D. J. AU - Geoerger, B. AU - Paoletti, X. C1 - lde 225 ldk 378 lee 011 DB - Embase Medline DO - 10.1016/j.ejca.2017.09.015 LA - English M3 - Article N1 - L618790053 2017-10-26 2017-10-31 PY - 2017 SN - 1879-0852 0959-8049 SP - 275-284 ST - Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium T2 - European Journal of Cancer TI - Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618790053&from=export http://dx.doi.org/10.1016/j.ejca.2017.09.015 VL - 86 ID - 1614 ER - TY - JOUR AD - B. Lerman, Brookfield, WI, United States AU - Lerman, B. AU - Verbsky, J. AU - Routes, J. AU - Bausch-Jurken, M. DB - Embase IS - 5 LA - English M3 - Conference Abstract N1 - L619349013 2017-11-27 PY - 2017 SN - 1534-4436 SP - S77 ST - NOD2 compound heterozygous mutations in a patient with severe crohn's disease T2 - Annals of Allergy, Asthma and Immunology TI - NOD2 compound heterozygous mutations in a patient with severe crohn's disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619349013&from=export VL - 119 ID - 1615 ER - TY - JOUR AD - S. Joychan, St. Petersburg, FL, United States AU - Joychan, S. AU - Patel, B. AU - Mayer, J. AU - Sriaroon, P. DB - Embase IS - 5 LA - English M3 - Conference Abstract N1 - L619349028 2017-11-27 PY - 2017 SN - 1534-4436 SP - S29 ST - A case of anaphylaxis to methotrexate and successful desensitization T2 - Annals of Allergy, Asthma and Immunology TI - A case of anaphylaxis to methotrexate and successful desensitization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619349028&from=export VL - 119 ID - 1616 ER - TY - JOUR AD - M. Sugawa, Department of Hematology and Oncology, Saitama Children's Medical Center, Saitama, Japan AU - Sugawa, M. AU - Watanabe, K. AU - Arakawa, Y. AU - Noguchi, J. AU - Kawakami, R. AU - Yanagi, M. AU - Itabashi, T. AU - Sasaki, K. AU - Isobe, K. AU - Mori, M. AU - Kawashima, H. AU - Oguma, E. AU - Kishimoto, H. AU - Takita, J. AU - Koh, K. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619368583 2017-11-28 PY - 2017 SN - 1545-5017 SP - S40-S41 ST - Inflammatory myofibroblastic tumor of the liver with a remarkable response to crizotinib in a young child T2 - Pediatric Blood and Cancer TI - Inflammatory myofibroblastic tumor of the liver with a remarkable response to crizotinib in a young child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619368583&from=export http://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 1617 ER - TY - JOUR AD - Y. Nakano, National Cancer Center Research Institute, Division of Brain Tumor Translational Research, Tokyo, Japan AU - Nakano, Y. AU - Tomiyama, A. AU - Yamasaki, K. AU - Fukuoka, K. AU - Fukushima, H. AU - Inoue, T. AU - Kohno, T. AU - Yoshida, A. AU - Matsusaka, Y. AU - Hara, J. AU - Sakamoto, H. AU - Ichimura, K. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619369640 2017-11-28 PY - 2017 SN - 1545-5017 SP - S54-S55 ST - Novel oncogenic klc1-ros1 fusion in pediatric low grade glioma T2 - Pediatric Blood and Cancer TI - Novel oncogenic klc1-ros1 fusion in pediatric low grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619369640&from=export http://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 1619 ER - TY - JOUR AD - A. Arakawa, Department of Pediatric Oncology, National Cancer Center Hospital, Japan AU - Arakawa, A. AU - Yonemori, K. AU - Kumamoto, T. AU - Aoki, Y. AU - Sonoda, T. AU - Sugiyama, M. AU - Ishimaru, S. AU - Shirakawa, N. AU - Umeda, K. AU - Okajima, H. AU - Adachi, S. AU - Ogawa, C. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619370093 2017-11-28 PY - 2017 SN - 1545-5017 SP - S40 ST - Successful treatment of a highly aggressive abdominal cavity ALK-rearranged inflammatory myofibroblastic tumor with alectinib: A case report T2 - Pediatric Blood and Cancer TI - Successful treatment of a highly aggressive abdominal cavity ALK-rearranged inflammatory myofibroblastic tumor with alectinib: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619370093&from=export http://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 1620 ER - TY - JOUR AD - Y. Chu, New York Medical College, Valhalla, NY, United States AU - Chu, Y. AU - Su, N. K. AU - Rosenblum, J. AU - Wong, H. C. AU - Lee, D. A. AU - Cairo, M. S. DB - Embase DO - 10.1186/s40425-017-0288-4 LA - English M3 - Conference Abstract N1 - L619372141 2017-11-28 PY - 2017 SN - 2051-1426 ST - Significant enhancement of expanded natural killer cells against GD2 pediatric solid tumors (ST) in combination with ALT-803 (IL-15 superagonist) and dinutuximab T2 - Journal for ImmunoTherapy of Cancer TI - Significant enhancement of expanded natural killer cells against GD2 pediatric solid tumors (ST) in combination with ALT-803 (IL-15 superagonist) and dinutuximab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619372141&from=export http://dx.doi.org/10.1186/s40425-017-0288-4 VL - 5 ID - 1621 ER - TY - JOUR AD - J. Bleloch, University of Cape Town, Cape Town, South Africa AU - Bleloch, J. AU - Ballim, R. AU - Blanckenberg, A. AU - Mapolie, S. AU - Kimani, S. AU - Prince, S. DB - Embase DO - 10.1158/1538-7445.NEWFRONT17-B38 IS - 22 LA - English M3 - Conference Abstract N1 - L619752347 2017-12-20 PY - 2017 SN - 1538-7445 ST - A novel palladacycle complex with anti-cancer activity against breast cancer and melanomas also exhibits potent cytotoxicity in a range of sarcomas T2 - Cancer Research TI - A novel palladacycle complex with anti-cancer activity against breast cancer and melanomas also exhibits potent cytotoxicity in a range of sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619752347&from=export http://dx.doi.org/10.1158/1538-7445.NEWFRONT17-B38 VL - 77 ID - 1622 ER - TY - JOUR AD - P. Green, Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Green, P. AU - Schwartz, R. H. AU - Shell, J. AU - Allgauer, M. AU - Chong, D. AU - Kebebew, E. C2 - Genentech(United States) DB - Embase DO - 10.2217/ije-2017-0016 IS - 4 LA - English M3 - Article N1 - L619850504 2017-12-25 2018-01-08 PY - 2017 SN - 2045-0877 2045-0869 SP - 159-165 ST - Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer T2 - International Journal of Endocrine Oncology TI - Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619850504&from=export http://dx.doi.org/10.2217/ije-2017-0016 VL - 4 ID - 1623 ER - TY - JOUR AD - A. Thomas, University of Vermont Medical Center, Burlington, VT, United States AU - Thomas, A. AU - Tucker, S. AU - Nelson, C. AU - Nickerson, J. AU - Durham, S. AU - Homans, A. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619947536 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi216 ST - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab T2 - Neuro-Oncology TI - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619947536&from=export http://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 1624 ER - TY - JOUR AD - M. Kondyli, Division of Hematology/Oncology, CHU Sainte-Justine, Montreal, QC, Canada AU - Kondyli, M. AU - Ellezam, B. AU - Saint-Martin, C. AU - Farmer, J. P. AU - Crevier, L. AU - Perreault, S. AU - Jabado, N. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619947817 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi185-vi186 ST - Trametinib and dabrafenib for refractory/ inoperable pediatric low grade gliomas T2 - Neuro-Oncology TI - Trametinib and dabrafenib for refractory/ inoperable pediatric low grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619947817&from=export http://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 1625 ER - TY - JOUR AD - N. Robison, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Robison, N. AU - Pauly, J. AU - Malvar, J. AU - Filbin, M. AU - De Mola, R. L. AU - Dorris, K. AU - Bendel, A. AU - Bowers, D. AU - Bornhorst, M. AU - Gauvain, K. AU - Leary, S. AU - MacDonald, T. AU - Gardner, S. AU - Reddy, A. AU - Diaz, P. AU - Tan, Y. J. AU - Sinai, C. AU - Davidson, T. AU - Ullrich, N. AU - Margol, A. AU - Dhall, G. AU - Borchert, M. AU - Ligon, K. AU - Sposto, R. AU - Kieran, M. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619948205 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi189 ST - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS-RAF pathway-activated tumors: Initial report T2 - Neuro-Oncology TI - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS-RAF pathway-activated tumors: Initial report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619948205&from=export http://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 1626 ER - TY - JOUR AD - B. Yan, Gynecological Oncology, Hubei Maternal and Child Health Hospital, Wuhan, China AU - Yan, B. AU - Wu, X. DB - Embase DO - 10.1093/annonc/mdx663.019 LA - English M3 - Conference Abstract N1 - L620035907 2018-01-05 PY - 2017 SN - 1569-8041 SP - x91 ST - G-CSF induces production of Bv8 in murine bone marrow neutrophils and promotes tumor growth and angiogenesis of U14 murine cervical cancer cell line T2 - Annals of Oncology TI - G-CSF induces production of Bv8 in murine bone marrow neutrophils and promotes tumor growth and angiogenesis of U14 murine cervical cancer cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620035907&from=export http://dx.doi.org/10.1093/annonc/mdx663.019 VL - 28 ID - 1627 ER - TY - JOUR AD - S. Hong, Sun Yat-Sen University Cancer Center, Guangzhou, China AU - Hong, S. AU - Zhang, L. DB - Embase IS - 11 LA - English M3 - Conference Abstract N1 - L620147483 2018-01-12 PY - 2017 SN - 1556-1380 SP - S2392 ST - Evaluation of toxicity profile of ALK inhibitors in non-small cell lung cancer (NSCLC) T2 - Journal of Thoracic Oncology TI - Evaluation of toxicity profile of ALK inhibitors in non-small cell lung cancer (NSCLC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620147483&from=export VL - 12 ID - 1628 ER - TY - JOUR AD - M.J. Overman, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States AU - Schrock, A. B. AU - Devoe, C. E. AU - McWilliams, R. AU - Sun, J. AU - Aparicio, T. AU - Stephens, P. J. AU - Ross, J. S. AU - Wilson, R. AU - Miller, V. A. AU - Ali, S. M. AU - Overman, M. J. DB - Embase Medline DO - 10.1001/jamaoncol.2017.1051 IS - 11 LA - English M3 - Conference Paper N1 - L621081780 2018-03-13 2019-09-24 PY - 2017 SN - 2374-2445 2374-2437 SP - 1546-1553 ST - Genomic profiling of small-bowel adenocarcinoma T2 - JAMA Oncology TI - Genomic profiling of small-bowel adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621081780&from=export http://dx.doi.org/10.1001/jamaoncol.2017.1051 VL - 3 ID - 1629 ER - TY - JOUR AD - D. Usta, Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany AU - Usta, D. AU - Selt, F. AU - Hohloch, J. AU - Pusch, S. AU - Pfister, S. M. AU - Jones, D. T. W. AU - Brummer, T. AU - Witt, O. AU - Milde, T. DB - Embase DO - 10.1055/s-0037-1607404 IS - 6 LA - English M3 - Conference Abstract N1 - L627805151 2019-05-29 PY - 2017 SN - 1439-3824 ST - Development of a novel assay suitable for preclinical testing of MAPK inhibitors in low-grade glioma T2 - Klinische Padiatrie TI - Development of a novel assay suitable for preclinical testing of MAPK inhibitors in low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627805151&from=export http://dx.doi.org/10.1055/s-0037-1607404 VL - 229 ID - 1630 ER - TY - JOUR AD - D.M. Schewe, Department of Pediatrics, Christian-Albrechts University Kiel, University Medical Center Schleswig-Holstein, Kiel, Germany AU - Fedders, H. AU - Alsadeq, A. AU - Schmäh, J. AU - Vogiatzi, F. AU - Zimmermann, M. AU - Möricke, A. AU - Lenk, L. AU - zur Stadt, U. AU - Horstmann, M. A. AU - Pieters, R. AU - Schrappe, M. AU - Stanulla, M. AU - Cario, G. AU - Schewe, D. M. DB - Embase Medline DO - 10.3324/haematol.2017.169870 IS - 11 LA - English M3 - Letter N1 - L619078294 2017-11-08 2018-10-25 PY - 2017 SN - 1592-8721 0390-6078 SP - e438-e442 ST - The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia T2 - Haematologica TI - The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619078294&from=export http://dx.doi.org/10.3324/haematol.2017.169870 VL - 102 ID - 1631 ER - TY - JOUR AD - K.C. Kim, University of Arizona College of Medicine, 1656 E Mabel St, MRB-419, Tucson, AZ, United States AU - Kato, K. AU - Hanss, A. D. AU - Zemskova, M. A. AU - Morgan, N. E. AU - Kim, M. AU - Knox, K. S. AU - Lin, Y. AU - Lillehoj, E. P. AU - Kim, K. C. DB - Embase Medline DO - 10.1016/j.bbrc.2017.08.056 IS - 2 LA - English M3 - Article N1 - L617974839 2017-08-29 2017-09-13 PY - 2017 SN - 1090-2104 0006-291X SP - 231-235 ST - Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway T2 - Biochemical and Biophysical Research Communications TI - Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617974839&from=export http://dx.doi.org/10.1016/j.bbrc.2017.08.056 VL - 492 ID - 1632 ER - TY - JOUR AD - A.T.S. Wyse, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600-Anexo, CEP, Porto Alegre, RS, Brazil AU - Pierozan, P. AU - Biasibetti, H. AU - Schmitz, F. AU - Ávila, H. AU - Fernandes, C. G. AU - Pessoa-Pureur, R. AU - Wyse, A. T. S. DB - Embase Medline DO - 10.1007/s12035-016-0101-2 IS - 8 LA - English M3 - Article N1 - L612356929 2016-10-03 2018-08-10 PY - 2017 SN - 1559-1182 0893-7648 SP - 5752-5767 ST - Neurotoxicity of Methylmercury in Isolated Astrocytes and Neurons: the Cytoskeleton as a Main Target T2 - Molecular Neurobiology TI - Neurotoxicity of Methylmercury in Isolated Astrocytes and Neurons: the Cytoskeleton as a Main Target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612356929&from=export http://dx.doi.org/10.1007/s12035-016-0101-2 VL - 54 ID - 1633 ER - TY - JOUR AD - H.D. Davies, Department of Pediatrics, College of Medicine, University of Nebraska Medical Center, Omaha, NE, United States AU - Korir, M. L. AU - Manning, S. D. AU - Davies, H. D. DB - Embase Medline DO - 10.1128/CMR.00019-17 IS - 4 LA - English M3 - Review N1 - L617798022 2017-08-25 2017-08-29 PY - 2017 SN - 1098-6618 0893-8512 SP - 973-989 ST - Intrinsic maturational neonatal immune deficiencies and susceptibility to group B streptococcus infection T2 - Clinical Microbiology Reviews TI - Intrinsic maturational neonatal immune deficiencies and susceptibility to group B streptococcus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617798022&from=export http://dx.doi.org/10.1128/CMR.00019-17 VL - 30 ID - 1634 ER - TY - JOUR AD - C. Koschmann, Department of Pediatrics, Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital at the University of Michigan, 1500 E Medical Center Dr., Ann Arbor, MI, United States AU - Marini, B. L. AU - Benitez, L. L. AU - Zureick, A. H. AU - Salloum, R. AU - Gauthier, A. C. AU - Brown, J. AU - Wu, Y. M. AU - Robinson, D. R. AU - Kumar, C. AU - Lonigro, R. AU - Vats, P. AU - Cao, X. AU - Kasaian, K. AU - Anderson, B. AU - Mullan, B. AU - Chandler, B. AU - Linzey, J. R. AU - Camelo-Piragua, S. I. AU - Venneti, S. AU - McKeever, P. E. AU - McFadden, K. A. AU - Lieberman, A. P. AU - Brown, N. AU - Shao, L. AU - Leonard, M. A. S. AU - Junck, L. AU - McKean, E. AU - Maher, C. O. AU - Garton, H. J. L. AU - Muraszko, K. M. AU - Hervey-Jumper, S. AU - Mulcahy-Levy, J. M. AU - Green, A. AU - Hoffman, L. M. AU - Dorris, K. AU - Vitanza, N. A. AU - Wang, J. AU - Schwartz, J. AU - Lulla, R. AU - Smiley, N. P. AU - Bornhorst, M. AU - Haas-Kogan, D. A. AU - Robertson, P. L. AU - Chinnaiyan, A. M. AU - Mody, R. AU - Koschmann, C. DB - Embase Medline DO - 10.1016/j.trsl.2017.08.001 LA - English M3 - Article N1 - L618256912 2017-09-20 2020-10-08 PY - 2017 SN - 1878-1810 1931-5244 SP - 27.e1-27.e14 ST - Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors T2 - Translational Research TI - Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618256912&from=export http://dx.doi.org/10.1016/j.trsl.2017.08.001 VL - 188 ID - 1635 ER - TY - JOUR AD - M. Prieto Barrios, Dermatology, Hospital Universitario 12 De Octubre, Madrid, Spain AU - Prieto Barrios, M. AU - Llamas Martin, R. AU - Palencia Pérez, S. AU - Velasco Tamariz, V. AU - Yolanda, R. AU - Aragón De Miguel, R. AU - Calleja Algarra, A. AU - Gil De La Cruz, E. AU - Ortiz Romero, P. AU - Rodriguez Peralto, J. DB - Embase DO - 10.1016/j.jid.2017.07.214 IS - 10 LA - English M3 - Conference Abstract N1 - L618276579 2017-09-19 PY - 2017 SN - 1523-1747 SP - S229 ST - Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better understand cancer T2 - Journal of Investigative Dermatology TI - Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better understand cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618276579&from=export http://dx.doi.org/10.1016/j.jid.2017.07.214 VL - 137 ID - 1636 ER - TY - JOUR AD - S. Palencia Pérez, Hospital Universitario 12 De Octubre, Dermatology, Madrid, Spain AU - Palencia Pérez, S. AU - Prieto Barrios, M. AU - Llamas Martin, R. AU - Velasco Tamariz, V. AU - Calleja Algarra, A. AU - Aragón De Miguel, R. AU - Ruano, Y. AU - Postigo Llorente, C. AU - Rodríguez Peralto, J. L. AU - Ortiz Romero, P. L. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618778899 2017-10-23 PY - 2017 SN - 1525-1470 SP - S26 ST - Phacomatosis pigmentokeratotica: A case report of hras mosaicism T2 - Pediatric Dermatology TI - Phacomatosis pigmentokeratotica: A case report of hras mosaicism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618778899&from=export http://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 1638 ER - TY - JOUR AD - C. Vanden Eycken, KU Leuven, Dermatology, Leuven, Belgium AU - Vanden Eycken, C. AU - Morren, M. A. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779133 2017-10-23 PY - 2017 SN - 1525-1470 SP - S51 ST - Histiocytic disorders: An atypical clinical presentation and histopathology T2 - Pediatric Dermatology TI - Histiocytic disorders: An atypical clinical presentation and histopathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779133&from=export http://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 1639 ER - TY - JOUR AD - S. Janssens, University Hospital Leuven, Dermatologie, Leuven, Belgium AU - Janssens, S. AU - Morren, M. A. AU - Renard, M. AU - Hauben, E. AU - DeHaes, P. AU - Busschots, A. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779330 2017-10-23 PY - 2017 SN - 1525-1470 SP - S42 ST - A retrospective cohort study of cutaneous lymphoma diagnosed in children in the University Hospital in Leuven T2 - Pediatric Dermatology TI - A retrospective cohort study of cutaneous lymphoma diagnosed in children in the University Hospital in Leuven UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779330&from=export http://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 1640 ER - TY - JOUR AD - N. Kaparos, Pediatric Dermatology Unit, University Hospital CHUV, Lausanne, Switzerland AU - Kaparos, N. AU - Norrenberg, S. AU - Christen-Zaech, S. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779725 2017-10-23 PY - 2017 SN - 1525-1470 SP - S24 ST - Misdiagnosis of neurofibromatosis type 1 in patients with piebaldism T2 - Pediatric Dermatology TI - Misdiagnosis of neurofibromatosis type 1 in patients with piebaldism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779725&from=export http://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 1641 ER - TY - JOUR AD - D.M. Lopategui, University of Miami Miller School of Medicine, Miami, FL, United States AU - Lopategui, D. M. AU - Yechieli, R. AU - Ramasamy, R. DB - Embase DO - 10.21037/tau.2017.07.03 IS - 5 LA - English M3 - Review N1 - L618986267 2017-11-01 2017-11-06 PY - 2017 SN - 2223-4691 2223-4683 SP - 951-958 ST - Oncofertility in sarcoma patients T2 - Translational Andrology and Urology TI - Oncofertility in sarcoma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618986267&from=export http://dx.doi.org/10.21037/tau.2017.07.03 VL - 6 ID - 1642 ER - TY - JOUR AD - P. Macigova, Department of Experimental Biology, Masaryk University, University Hospital Brno, Brno, Czech Republic AU - Macigova, P. AU - Neradil, J. AU - Melicharkova, K. AU - Kyr, M. AU - Mudry, P. AU - Veselska, R. AU - Sterba, J. DB - Embase DO - 10.1093/annonc/mdx511 LA - English M3 - Conference Abstract N1 - L619416979 2017-11-30 PY - 2017 SN - 1569-8041 SP - vii19 ST - Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors T2 - Annals of Oncology TI - Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619416979&from=export http://dx.doi.org/10.1093/annonc/mdx511 VL - 28 ID - 1643 ER - TY - JOUR AD - E. Sabattini, Unit of Haemolymphopathology, Department of Hematology and Oncology, S. Orsola University Hospital, Bologna, Italy AU - Sabattini, E. AU - Agostinelli, C. AU - Bacci, F. AU - Sagramoso, C. DB - Embase LA - English M3 - Conference Abstract N1 - L620886556 2018-03-02 PY - 2017 SN - 1592-8721 SP - 212 ST - WHO 2016: What changes for lymphoid neoplasms T2 - Haematologica TI - WHO 2016: What changes for lymphoid neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620886556&from=export VL - 102 ID - 1644 ER - TY - JOUR AD - T. Loka, Haematology/Oncology Clinical Trials Research Office, Level 1, Barclay House, 37 Queens Square, London, United Kingdom AU - Loka, T. AU - O'Hare, P. AU - Mahon, C. DB - Embase DO - 10.1136/archdischild-2017-084620.68 LA - English M3 - Conference Abstract N1 - L620926116 2018-03-06 PY - 2017 SN - 1468-2044 ST - Single centre experience of cutaneous toxicity associated with braf and mek inhibitor treatment in children T2 - Archives of Disease in Childhood TI - Single centre experience of cutaneous toxicity associated with braf and mek inhibitor treatment in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620926116&from=export http://dx.doi.org/10.1136/archdischild-2017-084620.68 VL - 102 ID - 1645 ER - TY - JOUR AD - S. Ilangumaran, Department of Pediatrics, Immunology division, Faculty of Medicine and Health Sciences, University of Sherbrooke, 3001 North 12th avenue, Sherbrooke, QC, Canada AU - Gui, Y. AU - Khan, M. G. M. AU - Bobbala, D. AU - Dubois, C. AU - Ramanathan, S. AU - Saucier, C. AU - Ilangumaran, S. DB - Embase Medline DO - 10.3748/wjg.v23.i36.6639 IS - 36 LA - English M3 - Article N1 - L618521083 2017-10-06 2018-07-02 PY - 2017 SN - 2219-2840 1007-9327 SP - 6639-6649 ST - Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1 T2 - World Journal of Gastroenterology TI - Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618521083&from=export http://dx.doi.org/10.3748/wjg.v23.i36.6639 VL - 23 ID - 1646 ER - TY - JOUR AD - P. Ravanan, Apoptosis and Cell Survival Research Lab, Department of Biosciences, School of Biosciences and Technology, VIT University, Vellore, India AU - Chaudhari, N. AU - Talwar, P. AU - Lefebvre D’hellencourt, C. AU - Ravanan, P. C1 - t 0070907(Cayman) C2 - Cayman Sigma Aldrich DB - Embase DO - 10.3389/fnmol.2017.00310 LA - English M3 - Article N1 - L618882869 2017-11-01 2017-11-02 PY - 2017 SN - 1662-5099 ST - CDDO and ATRA instigate differentiation of IMR32 human neuroblastoma cells T2 - Frontiers in Molecular Neuroscience TI - CDDO and ATRA instigate differentiation of IMR32 human neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618882869&from=export http://dx.doi.org/10.3389/fnmol.2017.00310 VL - 10 ID - 1647 ER - TY - JOUR AD - M. S. Cairo, Department of Pediatrics, Professor of Pediatrics, Medicine, Pathology, Microbiology & Immunology and Cell Biology & Anatomy, Maria Fareri Children Hospital at Westchester Medical Center, New York Medical College, 40 Sunshine Cottage Rd., Skyline Office 1N-D12, Valhalla, NY, United States AU - Chu, Y. AU - Yahr, A. AU - Huang, B. AU - Ayello, J. AU - Barth, M. AU - S. Cairo, M. C1 - romidepsin(Celgene,United States) C2 - Celgene(United States) DB - Embase DO - 10.1080/2162402X.2017.1341031 IS - 9 LA - English M3 - Article N1 - L618078120 2017-09-06 2017-09-21 PY - 2017 SN - 2162-402X 2162-4011 ST - Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice T2 - OncoImmunology TI - Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618078120&from=export http://dx.doi.org/10.1080/2162402X.2017.1341031 VL - 6 ID - 1648 ER - TY - JOUR AD - T. Ohta, Department of Obstetrics and Gynecology, Yamagata University, School of Medicine, 2-2-2 Iidanishi, Yamagata, Japan AU - Matsumura, S. AU - Ohta, T. AU - Yamanouchi, K. AU - Liu, Z. AU - Sudo, T. AU - Kojimahara, T. AU - Seino, M. AU - Narumi, M. AU - Tsutsumi, S. AU - Takahashi, T. AU - Takahashi, K. AU - Kurachi, H. AU - Nagase, S. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1080/15384047.2016.1235656 IS - 9 LA - English M3 - Article N1 - L618516647 2017-10-06 2018-08-06 PY - 2017 SN - 1555-8576 1538-4047 SP - 730-739 ST - Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells T2 - Cancer Biology and Therapy TI - Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618516647&from=export http://dx.doi.org/10.1080/15384047.2016.1235656 VL - 18 ID - 1649 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Pathak, P. AU - Kumar, A. AU - Jha, P. AU - Purkait, S. AU - Faruq, M. AU - Suri, A. AU - Suri, V. AU - Sharma, M. C. AU - Sarkar, C. DB - Embase Medline DO - 10.1111/bpa.12444 IS - 5 LA - English M3 - Article N1 - L613998421 2017-01-11 2018-08-24 PY - 2017 SN - 1750-3639 1015-6305 SP - 580-589 ST - Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma T2 - Brain Pathology TI - Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613998421&from=export http://dx.doi.org/10.1111/bpa.12444 VL - 27 ID - 1650 ER - TY - JOUR AD - J. Luo, Department of Hematology, The Second Hospital of Hebei Medical University, Key Laboratory of Hematology, Shijiazhuang, Hebei, China AU - Zhang, X. AU - Yang, L. AU - Liu, X. AU - Nie, Z. AU - Wang, X. AU - Pan, Y. AU - Luo, J. C1 - lbh 589(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.1111/bjh.14739 IS - 5 LA - English M3 - Article N1 - L616106621 2017-05-16 2017-08-30 PY - 2017 SN - 1365-2141 0007-1048 SP - 728-738 ST - Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia T2 - British Journal of Haematology TI - Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616106621&from=export http://dx.doi.org/10.1111/bjh.14739 VL - 178 ID - 1651 ER - TY - JOUR AD - S. Sharif, Department of Pathobiology, University of Guelph, Guelph, ON, Canada AU - Kulkarni, R. R. AU - Villanueva, A. I. AU - Read, L. R. AU - Brisbin, J. T. AU - Bhaumik, S. K. AU - LaMarre, J. AU - Murali-Krishna, K. AU - Sharif, S. DB - Embase Medline DO - 10.1007/s00441-017-2631-y IS - 3 LA - English M3 - Article N1 - L616479770 2017-06-01 2017-09-13 PY - 2017 SN - 1432-0878 0302-766X SP - 541-554 ST - CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status T2 - Cell and Tissue Research TI - CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616479770&from=export http://dx.doi.org/10.1007/s00441-017-2631-y VL - 369 ID - 1652 ER - TY - JOUR AD - V.E. Torres, Div. of Nephrology, Mayo Clinic, 200 First St. SW, Rochester, MN, United States AU - Ye, H. AU - Wang, X. AU - Constans, M. M. AU - Sussman, C. R. AU - Chebib, F. T. AU - Irazabal, M. V. AU - Young, W. F. AU - Harris, P. C. AU - Kirschner, L. S. AU - Torres, V. E. DB - Embase Medline DO - 10.1152/ajprenal.00119.2017 IS - 3 LA - English M3 - Article N1 - L618213922 2017-09-13 2017-09-18 PY - 2017 SN - 1522-1466 0363-6127 SP - F677-F686 ST - The regulatory 1α subunit of protein kinase a modulates renal cystogenesis T2 - American Journal of Physiology - Renal Physiology TI - The regulatory 1α subunit of protein kinase a modulates renal cystogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618213922&from=export http://dx.doi.org/10.1152/ajprenal.00119.2017 VL - 313 ID - 1654 ER - TY - JOUR AD - H.T. Michael, National Cancer Institutes, Bethesda, MD, United States AU - Michael, H. T. AU - Day, C. P. AU - Sassano, A. AU - Michalowski, A. AU - Yang, H. AU - Lee, M. AU - Merlino, G. DB - Embase DO - 10.1111/pcmr.12622 IS - 5 LA - English M3 - Conference Abstract N1 - L618288214 2017-09-20 PY - 2017 SN - 1755-1471 SP - e42-e43 ST - GNAQ/GNA11 pathway mutations are involved in malignant transformation in a mouse model of UV-induced melanocytic lesion progression T2 - Pigment Cell and Melanoma Research TI - GNAQ/GNA11 pathway mutations are involved in malignant transformation in a mouse model of UV-induced melanocytic lesion progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618288214&from=export http://dx.doi.org/10.1111/pcmr.12622 VL - 30 ID - 1655 ER - TY - JOUR AD - R. Riedel, University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany AU - Riedel, R. AU - Plenker, D. AU - Michels, S. AU - Nogova, L. AU - Abdulla, D. AU - Scheffler, M. AU - Fischer, R. AU - Brandes, V. AU - Heukamp, L. C. AU - Scheel, A. H. AU - Büttner, R. AU - Sos, M. L. AU - Wolf, J. DB - Embase DO - 10.1159/000479566 LA - English M3 - Conference Abstract N1 - L618607510 2017-10-11 PY - 2017 SN - 2296-5262 SP - 173 ST - KIF5B-MET fusion genes are novel targets in NSCLC and show sensitivity to MET inhibition with crizotinib T2 - Oncology Research and Treatment TI - KIF5B-MET fusion genes are novel targets in NSCLC and show sensitivity to MET inhibition with crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618607510&from=export http://dx.doi.org/10.1159/000479566 VL - 40 ID - 1656 ER - TY - JOUR AD - J.H. Foster, Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, 6701 Fannin St., Houston, TX, United States AU - Greenwood, K. AU - Foster, J. H. DB - Embase Medline DO - 10.1358/DOT.2017.53.9.2693023 IS - 9 LA - English M3 - Article N1 - L620051629 2018-01-08 2018-01-11 PY - 2017 SN - 1699-4019 1699-3993 SP - 469-476 ST - Dinutuximab for the treatment of pediatric patients with neuroblastoma T2 - Drugs of Today TI - Dinutuximab for the treatment of pediatric patients with neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620051629&from=export http://dx.doi.org/10.1358/DOT.2017.53.9.2693023 VL - 53 ID - 1657 ER - TY - JOUR AD - M. Beidas, Microbiology, Kuwait University, Kuwait, Kuwait AU - Beidas, M. AU - Chehadeh, W. DB - Embase DO - 10.1093/ofid/ofx163.728 LA - English M3 - Conference Abstract N1 - L628004453 2019-06-13 PY - 2017 SN - 2328-8957 SP - S312 ST - Pcr array profiling of antiviral genes in human embryonic kidney cells expressing human coronavirus Oc43 structural and accessory proteins T2 - Open Forum Infectious Diseases TI - Pcr array profiling of antiviral genes in human embryonic kidney cells expressing human coronavirus Oc43 structural and accessory proteins UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628004453&from=export http://dx.doi.org/10.1093/ofid/ofx163.728 VL - 4 ID - 1658 ER - TY - JOUR AU - Olmo, I. G. AU - Carvalho, T. G. AU - Costa, V. V. AU - Alves-Silva, J. AU - Ferrari, C. Z. AU - Izidoro-Toledo, T. C. AU - da Silva, J. F. AU - Teixeira, A. L. AU - Souza, D. G. AU - Marques, J. T. AU - Teixeira, M. M. AU - Vieira, L. B. AU - Ribeiro, F. M. DB - Embase DO - 10.3389/fimmu.2017.01016 IS - AUG LA - English M3 - Article N1 - L617949510 2017-08-30 2017-09-04 PY - 2017 SN - 1664-3224 ST - Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors T2 - Frontiers in Immunology TI - Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617949510&from=export http://dx.doi.org/10.3389/fimmu.2017.01016 VL - 8 ID - 1659 ER - TY - JOUR AD - I. Brcic, Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, Graz, Austria AU - Szurian, K. AU - Till, H. AU - Amerstorfer, E. AU - Hinteregger, N. AU - Mischinger, H. J. AU - Liegl-Atzwanger, B. AU - Brcic, I. DB - Embase Medline DO - 10.3748/wjg.v23.i31.5817 IS - 31 LA - English M3 - Article N1 - L617954728 2017-08-29 2018-05-28 PY - 2017 SN - 2219-2840 1007-9327 SP - 5817-5822 ST - Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases T2 - World Journal of Gastroenterology TI - Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617954728&from=export http://dx.doi.org/10.3748/wjg.v23.i31.5817 VL - 23 ID - 1660 ER - TY - JOUR AD - L. Moreno, Paediatric Phase I-II Clinical Trials Unit, Paediatric Haematology & Oncology, Hospital Niño Jesus, Madrid, Spain AU - Moreno, L. AU - Caron, H. AU - Geoerger, B. AU - Eggert, A. AU - Schleiermacher, G. AU - Brock, P. AU - Valteau-Couanet, D. AU - Chesler, L. AU - Schulte, J. H. AU - De Preter, K. AU - Molenaar, J. AU - Schramm, A. AU - Eilers, M. AU - Van Maerken, T. AU - Johnsen, J. I. AU - Garrett, M. AU - George, S. L. AU - Tweddle, D. A. AU - Kogner, P. AU - Berthold, F. AU - Koster, J. AU - Barone, G. AU - Tucker, E. R. AU - Marshall, L. AU - Herold, R. AU - Sterba, J. AU - Norga, K. AU - Vassal, G. AU - Pearson, A. D. C1 - azd 7762 azd 8055 cct 137690 cct 244747 cct 245737 gsk 1324726a jq 1 ldk 378 lee 011 ly 2835219 mk 8776 mln 8237 sch 900776 ym 155 DB - Embase Medline DO - 10.1080/17460441.2017.1340269 IS - 8 LA - English M3 - Review N1 - L617310291 2017-07-18 2017-07-19 PY - 2017 SN - 1746-045X 1746-0441 SP - 801-811 ST - Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project T2 - Expert Opinion on Drug Discovery TI - Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617310291&from=export http://dx.doi.org/10.1080/17460441.2017.1340269 VL - 12 ID - 1661 ER - TY - JOUR AD - M.G. Bianchi, Department of Medicine and Surgery, University of Parma, Parma, Italy AU - Bianchi, M. G. AU - Allegri, M. AU - Chiu, M. AU - Costa, A. L. AU - Blosi, M. AU - Ortelli, S. AU - Bussolati, O. AU - Bergamaschi, E. DB - Embase DO - 10.3389/fimmu.2017.00866 IS - AUG LA - English M3 - Article N1 - L617629197 2017-08-11 2017-08-16 PY - 2017 SN - 1664-3224 ST - Lipopolysaccharide adsorbed to the bio-corona of TiO2 nanoparticles powerfully activates selected pro-inflammatory transduction pathways T2 - Frontiers in Immunology TI - Lipopolysaccharide adsorbed to the bio-corona of TiO2 nanoparticles powerfully activates selected pro-inflammatory transduction pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617629197&from=export http://dx.doi.org/10.3389/fimmu.2017.00866 VL - 8 ID - 1662 ER - TY - JOUR AD - S.-F. Yang, Institute of Medicine Chung Shan Medical University, Taichung, Taiwan AU - Chang, P. Y. AU - Hsieh, M. J. AU - Hsieh, Y. S. AU - Chen, P. N. AU - Yang, J. S. AU - Lo, F. C. AU - Yang, S. F. AU - Lu, K. H. DB - Embase Medline DO - 10.1002/tox.22380 IS - 8 LA - English M3 - Article N1 - L613545147 2016-12-09 2017-07-24 PY - 2017 SN - 1522-7278 1520-4081 SP - 2032-2040 ST - Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways T2 - Environmental Toxicology TI - Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613545147&from=export http://dx.doi.org/10.1002/tox.22380 VL - 32 ID - 1663 ER - TY - JOUR AD - H.B. Kim, Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States AU - Lee, E. AU - Hodgkinson, N. AU - Fawaz, R. AU - Vakili, K. AU - Kim, H. B. C1 - fk 506 DB - Embase Medline DO - 10.1111/petr.12904 IS - 5 LA - English M3 - Article N1 - L615408716 2017-04-20 2017-07-20 PY - 2017 SN - 1399-3046 1397-3142 ST - Multivisceral transplantation for abdominal tumors in children: A single center experience and review of the literature T2 - Pediatric Transplantation TI - Multivisceral transplantation for abdominal tumors in children: A single center experience and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615408716&from=export http://dx.doi.org/10.1111/petr.12904 VL - 21 ID - 1664 ER - TY - JOUR AD - M. Sadhukhan, Department of Pediatrics, Tunbridge Wells Hospital, Tonbridge Road, Royal Tunbridge Wells, United Kingdom AU - Sadhukhan, M. AU - Conry, B. AU - Bhaduri, B. C1 - gsk 116540(Glaxo SmithKline) C2 - Glaxo SmithKline DB - Embase Medline DO - 10.1007/s12098-017-2349-6 IS - 8 LA - English M3 - Letter N1 - L615667556 2017-05-01 2018-09-03 PY - 2017 SN - 0973-7693 0019-5456 SP - 645-646 ST - Extensive Retropharyngeal and Spinal Plexiform Neurofibromas in a Neonate with Type 1-Neurofibromatosis T2 - Indian Journal of Pediatrics TI - Extensive Retropharyngeal and Spinal Plexiform Neurofibromas in a Neonate with Type 1-Neurofibromatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615667556&from=export http://dx.doi.org/10.1007/s12098-017-2349-6 VL - 84 ID - 1665 ER - TY - JOUR AD - L. Hou, Beijing Institute of Biotechnology, Beijing, China AU - Zhang, Z. AU - Wang, B. AU - Wu, S. AU - Wen, Y. AU - Wang, X. AU - Song, X. AU - Zhang, J. AU - Hou, L. AU - Chen, W. C1 - pd169316 DB - Embase Medline DO - 10.1016/j.virol.2017.05.012 LA - English M3 - Article N1 - L616314341 2017-05-29 2017-06-02 PY - 2017 SN - 1096-0341 0042-6822 SP - 150-158 ST - PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71 T2 - Virology TI - PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616314341&from=export http://dx.doi.org/10.1016/j.virol.2017.05.012 VL - 508 ID - 1666 ER - TY - JOUR AD - B. Liu, Department of General Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China AU - Hu, K. AU - Huang, P. AU - Luo, H. AU - Yao, Z. AU - Wang, Q. AU - Xiong, Z. AU - Lin, J. AU - Huang, H. AU - Xu, S. AU - Zhang, P. AU - Liu, B. DB - Embase DO - 10.1002/2211-5463.12254 IS - 8 LA - English M3 - Article N1 - L616991417 2017-07-03 2017-08-10 PY - 2017 SN - 2211-5463 SP - 1144-1153 ST - Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells T2 - FEBS Open Bio TI - Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616991417&from=export http://dx.doi.org/10.1002/2211-5463.12254 VL - 7 ID - 1667 ER - TY - JOUR AD - A.D.J. Pearson, Paediatric Drug Development, Children and Young Peoplefs Unit, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom AU - Moreno, L. AU - Pearson, A. D. J. AU - Paoletti, X. AU - Jimenez, I. AU - Geoerger, B. AU - Kearns, P. R. AU - Zwaan, C. M. AU - Doz, F. AU - Baruchel, A. AU - Vormoor, J. AU - Casanova, M. AU - Pfister, S. M. AU - Morland, B. AU - Vassal, G. DB - Embase Medline DO - 10.1038/nrclinonc.2017.59 IS - 8 LA - English M3 - Review N1 - L617482634 2017-07-28 2017-08-01 PY - 2017 SN - 1759-4782 1759-4774 SP - 497-507 ST - Early phase clinical trials of anticancer agents in children and adolescents-an ITCC perspective T2 - Nature Reviews Clinical Oncology TI - Early phase clinical trials of anticancer agents in children and adolescents-an ITCC perspective UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617482634&from=export http://dx.doi.org/10.1038/nrclinonc.2017.59 VL - 14 ID - 1669 ER - TY - JOUR AD - M. Tanaka, Department of Pathology, Kanagawa Children's Medical Center, Mutsukawa 2-138-4, Minami-ku, Yokohama, Japan AU - Tanaka, M. AU - Kohashi, K. AU - Kushitani, K. AU - Yoshida, M. AU - Kurihara, S. AU - Kawashima, M. AU - Ueda, Y. AU - Souzaki, R. AU - Kinoshita, Y. AU - Oda, Y. AU - Takeshima, Y. AU - Hiyama, E. AU - Taguchi, T. AU - Tanaka, Y. DB - Embase Medline DO - 10.1016/j.humpath.2017.06.013 LA - English M3 - Article N1 - L618198379 2017-09-14 2017-09-19 PY - 2017 SN - 1532-8392 0046-8177 SP - 177-182 ST - Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions T2 - Human Pathology TI - Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618198379&from=export http://dx.doi.org/10.1016/j.humpath.2017.06.013 VL - 66 ID - 1672 ER - TY - JOUR AD - B. Wang, Monash University, Centre of Cardiovascular Research and Education in Therapeutics, SPHPM Melbourne, Australia AU - Wang, B. AU - Xu, T. T. AU - Cai, Y. AU - Huang, L. AU - Ma, Y. Y. AU - Vinh, N. AU - Min, S. D. AU - Wang, K. X. AU - Scammells, P. AU - Ju, S. H. DB - Embase DO - 10.1093/eurheartj/ehx502.P5274 LA - English M3 - Conference Abstract N1 - L621237161 2018-03-20 PY - 2017 SN - 1522-9645 SP - 1105 ST - VCP979, a novel p38MAPK inhibitor, attenuates inflammatory response and improve cardiac function post-myocardial infarction T2 - European Heart Journal TI - VCP979, a novel p38MAPK inhibitor, attenuates inflammatory response and improve cardiac function post-myocardial infarction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621237161&from=export http://dx.doi.org/10.1093/eurheartj/ehx502.P5274 VL - 38 ID - 1673 ER - TY - JOUR AD - J.-W. Zeng, Department of Physiology, Zunyi Medical College, No. 6 West Xuefu Road, Xinpu District, Zunyi, Guizhou, China AU - Liu, P. W. AU - Yue, M. X. AU - Zhou, R. AU - Niu, J. AU - Huang, D. J. AU - Xu, T. AU - Luo, P. AU - Liu, X. H. AU - Zeng, J. W. DB - Embase DO - 10.2147/JPR.S137131 LA - English M3 - Article N1 - L617515852 2017-08-04 2017-08-07 PY - 2017 SN - 1178-7090 SP - 1755-1767 ST - P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia T2 - Journal of Pain Research TI - P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617515852&from=export http://dx.doi.org/10.2147/JPR.S137131 VL - 10 ID - 1674 ER - TY - JOUR AD - V. Tisato, Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Via Fossato di Mortara 66, Ferrara, Italy AU - Tisato, V. AU - Voltan, R. AU - Gonelli, A. AU - Secchiero, P. AU - Zauli, G. C1 - abt 199 amg 232(Amgen) cgm 097(Novartis) ds 3032b(Daiichi Industry) hdm 201(Novartis) mi 77301(Labaz) mk 8242(Merck) rg 7112(Hoffmann La Roche) rg 7388 ro 5045337(Hoffmann La Roche) ro 5503781 sar 405838(Labaz) sch 900242(Merck) C2 - Amgen Daiichi Industry Hoffmann La Roche Labaz Merck Novartis DB - Embase Medline DO - 10.1186/s13045-017-0500-5 IS - 1 LA - English M3 - Review N1 - L617035749 2017-07-10 2017-07-11 PY - 2017 SN - 1756-8722 ST - MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer T2 - Journal of Hematology and Oncology TI - MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617035749&from=export http://dx.doi.org/10.1186/s13045-017-0500-5 VL - 10 ID - 1676 ER - TY - JOUR AD - L.B. Rapkin, Department of Pediatric Hematology/Oncology, Emory University School of Medicine, Children's Healthcare of Atlanta, Aflac Cancer & Blood Disorders Center, Atlanta, GA, United States AU - Carden, M. A. AU - Smith, S. AU - Meany, H. AU - Yin, H. AU - Alazraki, A. AU - Rapkin, L. B. DB - Embase DO - 10.1002/pbc.26402 IS - 7 LA - English M3 - Article N1 - L613956573 2017-01-09 2017-05-31 PY - 2017 SN - 1545-5017 1545-5009 ST - Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases T2 - Pediatric Blood and Cancer TI - Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613956573&from=export http://dx.doi.org/10.1002/pbc.26402 VL - 64 ID - 1677 ER - TY - JOUR AD - P. Fang, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States AU - Fang, P. AU - Jiang, W. AU - Allen, P. AU - Glitza, I. AU - Guha, N. AU - Hwu, P. AU - Ghia, A. AU - Phan, J. AU - Mahajan, A. AU - Tawbi, H. AU - Li, J. DB - Embase Medline DO - 10.1007/s11060-017-2470-4 IS - 3 LA - English M3 - Article N1 - L616187158 2017-05-19 2017-08-14 PY - 2017 SN - 1573-7373 0167-594X SP - 595-602 ST - Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma T2 - Journal of Neuro-Oncology TI - Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616187158&from=export http://dx.doi.org/10.1007/s11060-017-2470-4 VL - 133 ID - 1678 ER - TY - JOUR AD - Z. Yao, Department of Dermatology, Xinhua Hospital, Jiaotong University School of Medicine, Shanghai, China AU - Yu, X. AU - Zhang, J. AU - Xu, K. AU - Li, M. AU - Yao, Z. DB - Embase Medline DO - 10.1111/ced.13146 IS - 5 LA - English M3 - Article N1 - L616502133 2017-06-05 2017-06-26 PY - 2017 SN - 1365-2230 0307-6938 SP - 539-542 ST - Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma T2 - Clinical and Experimental Dermatology TI - Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616502133&from=export http://dx.doi.org/10.1111/ced.13146 VL - 42 ID - 1679 ER - TY - JOUR AD - K. Yang, Department of Joint Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, 195 Tongbai Road, Zhengzhou, Henan, China AU - Zhang, Z. R. AU - Gao, M. X. AU - Yang, K. DB - Embase DO - 10.3892/etm.2017.4547 IS - 1 LA - English M3 - Article N1 - L616852712 2017-06-22 2017-06-28 PY - 2017 SN - 1792-1015 1792-0981 SP - 805-812 ST - Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways T2 - Experimental and Therapeutic Medicine TI - Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616852712&from=export http://dx.doi.org/10.3892/etm.2017.4547 VL - 14 ID - 1680 ER - TY - JOUR AD - R. Gong, Blood Purification Center, Institute of Nephrology, First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, Zhengzhou, China AU - Wang, P. AU - Zhang, Y. AU - Wang, Y. AU - Brem, A. S. AU - Liu, Z. AU - Gong, R. C2 - Shanghai The First Biochemical and Pharmaceutical(China) DB - Embase Medline DO - 10.1542/peds.2016-2169 IS - 1 LA - English M3 - Article N1 - L617228570 2017-07-12 2017-07-18 PY - 2017 SN - 1098-4275 0031-4005 ST - Acquired resistance to corticotropin therapy in nephrotic syndrome: Role of de novo neutralizing antibody T2 - Pediatrics TI - Acquired resistance to corticotropin therapy in nephrotic syndrome: Role of de novo neutralizing antibody UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617228570&from=export http://dx.doi.org/10.1542/peds.2016-2169 VL - 140 ID - 1681 ER - TY - JOUR AD - L. Zubritsky, University of Cincinnati, United States AU - Zubritsky, L. AU - Schimdt, F. B. DB - Embase DO - 10.1111/pde.13196 LA - English M3 - Conference Abstract N1 - L617274519 2017-07-17 PY - 2017 SN - 1525-1470 SP - S161 ST - Eruptive nevi in a 9-year-old female patient with low grade glioma after initiation of dabrafenib, a selective BRAF inhibitor T2 - Pediatric Dermatology TI - Eruptive nevi in a 9-year-old female patient with low grade glioma after initiation of dabrafenib, a selective BRAF inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617274519&from=export http://dx.doi.org/10.1111/pde.13196 VL - 34 ID - 1682 ER - TY - JOUR AD - S.T. Ngu, Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, United Kingdom AU - Ngu, S. T. AU - French, P. AU - Jury, C. AU - Bilsland, D. AU - Hague, R. DB - Embase DO - 10.1111/bjd.15428 LA - English M3 - Conference Abstract N1 - L617313393 2017-07-18 PY - 2017 SN - 1365-2133 SP - 22 ST - Resolution of primary cutaneous anaplastic large cell lymphoma with rapamycin T2 - British Journal of Dermatology TI - Resolution of primary cutaneous anaplastic large cell lymphoma with rapamycin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617313393&from=export http://dx.doi.org/10.1111/bjd.15428 VL - 177 ID - 1683 ER - TY - JOUR AD - K.S. Kwatra, Department of Pathology, Christian Medical College and Hospital, Ludhiana, Punjab, India AU - Kwatra, K. S. AU - Paul, P. A. M. AU - Calton, N. AU - John, J. M. AU - Cotelingam, J. D. C1 - adriamycin DB - Embase DO - 10.4103/2278-330X.214575 IS - 3 LA - English M3 - Article N1 - L618346073 2017-09-25 2017-09-27 PY - 2017 SN - 2278-4306 2278-330X SP - 129-131 ST - Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile T2 - South Asian Journal of Cancer TI - Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618346073&from=export http://dx.doi.org/10.4103/2278-330X.214575 VL - 6 ID - 1684 ER - TY - JOUR AD - S.R. Punganuru, Texas Tech Univ. Health Sciences Ctr., Amarillo, TX, United States AU - Punganuru, S. R. AU - Madala, H. R. AU - Srivenugopal, K. S. DB - Embase DO - 10.1158/1538-7445.AM2017-185 IS - 13 LA - English M3 - Conference Abstract N1 - L618564890 2017-10-10 PY - 2017 SN - 1538-7445 ST - Development of a novel non-diuretic brain-penetrating ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models T2 - Cancer Research TI - Development of a novel non-diuretic brain-penetrating ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618564890&from=export http://dx.doi.org/10.1158/1538-7445.AM2017-185 VL - 77 ID - 1685 ER - TY - JOUR AD - S.S. Roy, UTHSCSA, San Antonio, TX, United States AU - Roy, S. S. AU - Shackleford, T. AU - Houghton, P. DB - Embase DO - 10.1158/1538-7445.AM2017-1431 IS - 13 LA - English M3 - Conference Abstract N1 - L618565149 2017-10-10 PY - 2017 SN - 1538-7445 ST - Therapeutic exploitation of mutant BRAF in childhood glioma T2 - Cancer Research TI - Therapeutic exploitation of mutant BRAF in childhood glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618565149&from=export http://dx.doi.org/10.1158/1538-7445.AM2017-1431 VL - 77 ID - 1686 ER - TY - JOUR AD - T.J. Shackleford, Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, TX, United States AU - Shackleford, T. J. AU - Hariharan, S. AU - Phelps, D. AU - Bid, H. AU - Zhong, H. AU - Houghton, P. DB - Embase DO - 10.1158/1538-7445.AM2017-5825 IS - 13 LA - English M3 - Conference Abstract N1 - L618566399 2017-10-10 PY - 2017 SN - 1538-7445 ST - Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines T2 - Cancer Research TI - Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618566399&from=export http://dx.doi.org/10.1158/1538-7445.AM2017-5825 VL - 77 ID - 1687 ER - TY - JOUR AD - E.D. Fleuren, Institute of Cancer Research, London, United Kingdom AU - Fleuren, E. D. AU - Vlenterie, M. AU - Van Der Graaf, W. AU - Hillebrandt-Roeffen, M. AU - Cebeci, S. AU - Van De Ven, A. AU - Flucke, U. AU - Wu, J. AU - Versleijen-Jonkers, Y. AU - Daly, R. DB - Embase DO - 10.1158/1538-7445.AM2017-5837 IS - 13 LA - English M3 - Conference Abstract N1 - L618566796 2017-10-10 PY - 2017 SN - 1538-7445 ST - Phosphoproteomic landscape of sarcoma: Novel subgroups and actionable targets T2 - Cancer Research TI - Phosphoproteomic landscape of sarcoma: Novel subgroups and actionable targets UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618566796&from=export http://dx.doi.org/10.1158/1538-7445.AM2017-5837 VL - 77 ID - 1688 ER - TY - JOUR AD - S.M. Fransson, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden AU - Fransson, S. M. AU - Javanmardi, N. AU - Sjoberg, R. M. AU - Kogner, P. AU - Martinsson, T. DB - Embase DO - 10.1158/1538-7445.AM2017-4876 IS - 13 LA - English M3 - Conference Abstract N1 - L618567217 2017-10-10 PY - 2017 SN - 1538-7445 ST - Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment T2 - Cancer Research TI - Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618567217&from=export http://dx.doi.org/10.1158/1538-7445.AM2017-4876 VL - 77 ID - 1689 ER - TY - JOUR AD - G.J. Walker, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD, Australia AU - Tonks, I. D. AU - Mukhopadhyay, P. AU - Schroder, W. A. AU - Sorolla, A. AU - Mould, A. W. AU - Handoko, H. Y. AU - Ferguson, B. AU - Muller, H. K. AU - Keith, P. AU - Hayward, N. K. AU - Walker, G. J. AU - Kay, G. F. DB - Embase Medline DO - 10.1038/onc.2016.511 IS - 26 LA - English M3 - Article N1 - L614424160 2017-02-20 2017-07-12 PY - 2017 SN - 1476-5594 0950-9232 SP - 3789-3795 ST - Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation T2 - Oncogene TI - Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614424160&from=export http://dx.doi.org/10.1038/onc.2016.511 VL - 36 ID - 1691 ER - TY - JOUR AD - J.R. Fangusaro AU - Fangusaro, J. R. AU - Onar-Thomas, A. AU - Young-Poussaint, T. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. I. AU - Banerjee, A. AU - Packer, R. AU - Kilburn, L. B. AU - Pollack, I. AU - Jakacki, R. AU - Qaddoumi, I. A. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. A. AU - Kreissman, S. G. AU - Doyle, L. A. AU - Smith, M. A. AU - Dunkel, I. J. AU - Fouladi, M. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617388927 2017-07-25 PY - 2017 SN - 0732-183X ST - A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study T2 - Journal of Clinical Oncology TI - A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617388927&from=export VL - 35 ID - 1692 ER - TY - JOUR AD - P.E. Zage AU - Zage, P. E. AU - Subramonian, D. AU - Mo, Q. AU - Huang, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617435606 2017-07-26 PY - 2017 SN - 0732-183X ST - Effects of the multikinase inhibitor regorafenib in neuroblastoma T2 - Journal of Clinical Oncology TI - Effects of the multikinase inhibitor regorafenib in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617435606&from=export VL - 35 ID - 1693 ER - TY - JOUR AD - J.C. Malpartida AU - Malpartida, J. C. AU - Vick, E. AU - Richardson, N. H. AU - Patel, K. AU - Stein, M. K. AU - Martin, M. G. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617538242 2017-08-01 PY - 2017 SN - 0732-183X ST - Distribution of ETV6-NTRK3 translocations across neoplasms identified from the Mitelman Database T2 - Journal of Clinical Oncology TI - Distribution of ETV6-NTRK3 translocations across neoplasms identified from the Mitelman Database UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617538242&from=export VL - 35 ID - 1694 ER - TY - JOUR AD - Y. Zheng, Cardiovascular Center, The First Hospital of Jilin University, Changchun, Jilin, China AU - Wang, S. AU - Gu, J. AU - Xu, Z. AU - Zhang, Z. AU - Bai, T. AU - Xu, J. AU - Cai, J. AU - Barnes, G. AU - Liu, Q. J. AU - Freedman, J. H. AU - Wang, Y. AU - Liu, Q. AU - Zheng, Y. AU - Cai, L. DB - Embase Medline DO - 10.1111/jcmm.13050 IS - 6 LA - English M3 - Article N1 - L614478198 2017-02-22 2017-05-31 PY - 2017 SN - 1582-1838 SP - 1182-1192 ST - Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway T2 - Journal of Cellular and Molecular Medicine TI - Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614478198&from=export http://dx.doi.org/10.1111/jcmm.13050 VL - 21 ID - 1695 ER - TY - JOUR AD - B.M. Seo, Department of Oral and Maxillofacial Surgery, Seoul National University, 101 DaeHak-ro Jongno-gu, Seoul, South Korea AU - Um, S. AU - Kim, H. Y. AU - Lee, J. H. AU - Song, I. S. AU - Seo, B. M. DB - Embase Medline DO - 10.1007/s00441-017-2581-4 IS - 3 LA - English M3 - Article N1 - L614614355 2017-03-06 2017-06-01 PY - 2017 SN - 1432-0878 0302-766X SP - 551-561 ST - TSG-6 secreted by mesenchymal stem cells suppresses immune reactions influenced by BMP-2 through p38 and MEK mitogen-activated protein kinase pathway T2 - Cell and Tissue Research TI - TSG-6 secreted by mesenchymal stem cells suppresses immune reactions influenced by BMP-2 through p38 and MEK mitogen-activated protein kinase pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614614355&from=export http://dx.doi.org/10.1007/s00441-017-2581-4 VL - 368 ID - 1696 ER - TY - JOUR AD - Z. Marinova, Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zürich, Wagistrasse 12, Schlieren, Zurich, Switzerland AU - Marinova, Z. AU - Walitza, S. AU - Grünblatt, E. DB - Embase Medline DO - 10.1007/s00702-017-1706-y IS - 6 LA - English M3 - Article N1 - L614918040 2017-03-24 2017-06-06 PY - 2017 SN - 1435-1463 0300-9564 SP - 749-759 ST - The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension T2 - Journal of Neural Transmission TI - The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614918040&from=export http://dx.doi.org/10.1007/s00702-017-1706-y VL - 124 ID - 1697 ER - TY - JOUR AD - K.K. Yadav AU - Yadav, S. S. AU - Li, J. AU - Stockert, J. A. AU - Herzog, B. AU - O'Connor, J. AU - Garzon-Manco, L. AU - Parsons, R. AU - Tewari, A. K. AU - Yadav, K. K. C1 - chir 258 tki 258 DB - Embase DO - 10.1016/j.tranon.2017.01.011 IS - 3 LA - English M3 - Article N1 - L616104061 2017-05-16 2017-05-18 PY - 2017 SN - 1936-5233 SP - 357-366 ST - Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications T2 - Translational Oncology TI - Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616104061&from=export http://dx.doi.org/10.1016/j.tranon.2017.01.011 VL - 10 ID - 1698 ER - TY - JOUR AD - A.-K. Yi, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, 858 Madison Avenue, Memphis, TN, United States AU - Upadhyay, K. AU - Park, J. E. AU - Yoon, T. W. AU - Halder, P. AU - Kim, Y. I. AU - Metcalfe, V. AU - Talati, A. J. AU - English, B. K. AU - Yi, A. K. DB - Embase Medline DO - 10.4049/jimmunol.1601089 IS - 11 LA - English M3 - Article N1 - L616353437 2017-05-29 2017-06-02 PY - 2017 SN - 1550-6606 0022-1767 SP - 4448-4457 ST - Group B streptococci induce proinflammatory responses via a protein kinase D1-dependent pathway T2 - Journal of Immunology TI - Group B streptococci induce proinflammatory responses via a protein kinase D1-dependent pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616353437&from=export http://dx.doi.org/10.4049/jimmunol.1601089 VL - 198 ID - 1700 ER - TY - JOUR AD - H. Koga, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Japan AU - Ikezono, Y. AU - Koga, H. AU - Akiba, J. AU - Abe, M. AU - Yoshida, T. AU - Wada, F. AU - Nakamura, T. AU - Iwamoto, H. AU - Masuda, A. AU - Sakaue, T. AU - Yano, H. AU - Tsuruta, O. AU - Torimura, T. DB - Embase Medline DO - 10.1158/1541-7786.MCR-16-0285 IS - 6 LA - English M3 - Article N1 - L616742605 2017-06-15 2017-06-20 PY - 2017 SN - 1557-3125 1541-7786 SP - 744-752 ST - Pancreatic neuroendocrine tumors and EMT behavior are driven by the CSC marker DCLK1 T2 - Molecular Cancer Research TI - Pancreatic neuroendocrine tumors and EMT behavior are driven by the CSC marker DCLK1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616742605&from=export http://dx.doi.org/10.1158/1541-7786.MCR-16-0285 VL - 15 ID - 1702 ER - TY - JOUR AU - Mukherjee, S. AU - Dash, S. AU - Lohitesh, K. AU - Chowdhury, R. DB - Embase Medline DO - 10.1371/journal.pone.0179203 IS - 6 LA - English M3 - Article N1 - L616748964 2017-06-20 2017-06-22 PY - 2017 SN - 1932-6203 ST - The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells T2 - PLoS ONE TI - The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616748964&from=export http://dx.doi.org/10.1371/journal.pone.0179203 VL - 12 ID - 1703 ER - TY - JOUR AD - X.-X. He, Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Fan, Y. P. AU - Liao, J. Z. AU - Lu, Y. Q. AU - Tian, D. A. AU - Ye, F. AU - Zhao, P. X. AU - Xiang, G. Y. AU - Tang, W. X. AU - He, X. X. DB - Embase DO - 10.1016/j.omtn.2017.03.010 LA - English M3 - Article N1 - L616751658 2017-06-20 2017-06-28 PY - 2017 SN - 2162-2531 SP - 181-189 ST - MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma T2 - Molecular Therapy - Nucleic Acids TI - MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616751658&from=export http://dx.doi.org/10.1016/j.omtn.2017.03.010 VL - 7 ID - 1704 ER - TY - JOUR AD - Y. Wang, Department of Neonatology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China AU - Liu, Y. AU - Qingjuan, S. AU - Gao, Z. AU - Deng, C. AU - Wang, Y. AU - Guo, C. DB - Embase Medline DO - 10.1097/MD.0000000000007400 IS - 26 LA - English M3 - Article N1 - L617228888 2017-07-12 2017-07-18 PY - 2017 SN - 1536-5964 0025-7974 ST - Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis T2 - Medicine (United States) TI - Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617228888&from=export http://dx.doi.org/10.1097/MD.0000000000007400 VL - 96 ID - 1705 ER - TY - JOUR AD - S. Yi, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, China AU - Cheng, Q. AU - Wang, Y. X. AU - Yu, J. AU - Yi, S. DB - Embase DO - 10.4103/1673-5374.208596 IS - 6 LA - English M3 - Article N1 - L617297943 2017-07-18 2017-07-20 PY - 2017 SN - 1876-7958 1673-5374 SP - 995-1002 ST - Critical signaling pathways during wallerian degeneration of peripheral nerve T2 - Neural Regeneration Research TI - Critical signaling pathways during wallerian degeneration of peripheral nerve UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617297943&from=export http://dx.doi.org/10.4103/1673-5374.208596 VL - 12 ID - 1706 ER - TY - JOUR AD - A. Alhammer, Newcastle University, Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom AU - Alhammer, A. AU - Case, M. AU - Matheson, E. AU - Blair, H. AU - Vormoor, J. AU - Irving, J. DB - Embase LA - English M3 - Conference Abstract N1 - L617378538 2017-07-24 PY - 2017 SN - 1592-8721 SP - 195 ST - Therapeutic targeting of pre-B cell receptor signalling in childhood acute lymphoblastic leukemia T2 - Haematologica TI - Therapeutic targeting of pre-B cell receptor signalling in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378538&from=export VL - 102 ID - 1707 ER - TY - JOUR AD - M. Krumbholz, Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany AU - Krumbholz, M. AU - Damm-Welk, C. AU - Woessmann, W. AU - Metzler, M. DB - Embase LA - English M3 - Conference Abstract N1 - L617378795 2017-07-24 PY - 2017 SN - 1592-8721 SP - 571 ST - Identification and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large cell lymphomas T2 - Haematologica TI - Identification and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378795&from=export VL - 102 ID - 1708 ER - TY - JOUR AD - F. Farina, School of Medicine, Milano Bicocca University, Italy AU - Farina, F. AU - Ceccon, M. AU - Mori, S. AU - Verga, L. AU - Borin, L. M. AU - Mologni, L. AU - Fontana, D. AU - Geeta, G. AU - Piazza, R. AU - Gambacorti-Passerini, C. DB - Embase LA - English M3 - Conference Abstract N1 - L617378980 2017-07-24 PY - 2017 SN - 1592-8721 SP - 221-222 ST - Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: Clinical and biological correlates T2 - Haematologica TI - Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: Clinical and biological correlates UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378980&from=export VL - 102 ID - 1709 ER - TY - JOUR AD - P. Angulo, University of Kansas Cancer Center, Children's Mercy Hospital, Kansas City, KS, United States AU - Angulo, P. AU - Subramaniam, D. AU - Chastain, K. AU - Guest, E. AU - Fulbright, J. AU - August, K. AU - Anant, S. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687759 2017-08-11 PY - 2017 SN - 1545-5017 SP - S51 ST - Antagonizing prolactin induced JAK/STAT signaling in osteosarcoma T2 - Pediatric Blood and Cancer TI - Antagonizing prolactin induced JAK/STAT signaling in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687759&from=export http://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 1710 ER - TY - JOUR AD - K. Harmoney, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States AU - Harmoney, K. AU - Modi, A. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687854 2017-08-11 PY - 2017 SN - 1545-5017 SP - S75 ST - Sustained remission in a patient with malignant histiocytosis using targeted therapy against BRAF-V600E mutation T2 - Pediatric Blood and Cancer TI - Sustained remission in a patient with malignant histiocytosis using targeted therapy against BRAF-V600E mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687854&from=export http://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 1711 ER - TY - JOUR AD - M. Manalang, Children's Mercy Hospital, Kansas City, MO, United States AU - Manalang, M. AU - Mitchell, G. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687886 2017-08-11 PY - 2017 SN - 1545-5017 SP - S87-S88 ST - Successful use of crizotinib in treatment of a pulmonary inflammatory myofibroblastic tumor without any ALK rearrangement or other known genetic target, case report T2 - Pediatric Blood and Cancer TI - Successful use of crizotinib in treatment of a pulmonary inflammatory myofibroblastic tumor without any ALK rearrangement or other known genetic target, case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687886&from=export http://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 1712 ER - TY - JOUR AD - K. Harmoney, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States AU - Harmoney, K. AU - Al-Huniti, A. AU - Clepp, J. AU - Modi, A. AU - Sato, M. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617688057 2017-08-11 PY - 2017 SN - 1545-5017 SP - S91-S92 ST - A tale of two cases - BRAF-V600E targeted therapy in Iowa T2 - Pediatric Blood and Cancer TI - A tale of two cases - BRAF-V600E targeted therapy in Iowa UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617688057&from=export http://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 1713 ER - TY - JOUR AD - S. Mallick, Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Mallick, S. AU - Lone, M. R. AU - Ramteke, P. AU - Purokait, S. AU - Gogia, A. AU - Batra, A. AU - Bakhshi, S. AU - Sharma, A. AU - Sharma, M. C. DB - Embase DO - 10.1002/hon.2439 LA - English M3 - Conference Abstract N1 - L617728884 2017-08-15 PY - 2017 SN - 0278-0232 SP - 395-396 ST - Clinico-pathological profile and CMYC immunoreactivity of ALK positive large B cell lymphoma: Report of nine cases T2 - Hematological Oncology TI - Clinico-pathological profile and CMYC immunoreactivity of ALK positive large B cell lymphoma: Report of nine cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617728884&from=export http://dx.doi.org/10.1002/hon.2439 VL - 35 ID - 1714 ER - TY - JOUR AD - W. Zhao, State Key Laboratory of Medical Genomics, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University, Shanghai, China AU - Zhao, W. AU - Xu, P. AU - Fu, D. AU - Li, J. AU - Wang, X. AU - Hu, J. AU - Zhou, J. AU - Yu, H. AU - Zhao, X. AU - Su, L. AU - Chen, Z. AU - Zeng, Q. AU - Chen, J. AU - Fang, M. AU - Ma, J. AU - Liu, T. AU - Song, Y. AU - Yu, K. AU - Li, Y. AU - Qiu, L. AU - Chen, X. AU - Gu, J. AU - Yan, J. AU - Hou, M. AU - Xiong, H. DB - Embase DO - 10.1002/hon.2438 LA - English M3 - Conference Abstract N1 - L617732372 2017-08-15 PY - 2017 SN - 0278-0232 SP - 187-188 ST - Anthracycline dose intensification in diffuse large B-cell lymphoma T2 - Hematological Oncology TI - Anthracycline dose intensification in diffuse large B-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617732372&from=export http://dx.doi.org/10.1002/hon.2438 VL - 35 ID - 1715 ER - TY - JOUR AD - J. Schmidt, Institute of Pathology, University Hospital Tübingen, Tübingen, Germany AU - Schmidt, J. AU - Ramis-Záldivar, J. AU - Nadeu, F. AU - Gonzalez-Farre, B. AU - Navarro, A. AU - Dojcinov, S. AU - Rosenwald, A. AU - Ott, G. AU - Campo, E. AU - Fend, F. AU - Egan, C. AU - Jaffe, E. AU - Salaverria, I. AU - Quintanilla-Martinez, L. DB - Embase DO - 10.1002/hon.2438 LA - English M3 - Conference Abstract N1 - L617732401 2017-08-15 PY - 2017 SN - 0278-0232 SP - 149-150 ST - Integrative mutational analysis of pediatric-type follicular lymphoma reveals TNFRSF14 and MAP2K1 as the most frequently mutated genes T2 - Hematological Oncology TI - Integrative mutational analysis of pediatric-type follicular lymphoma reveals TNFRSF14 and MAP2K1 as the most frequently mutated genes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617732401&from=export http://dx.doi.org/10.1002/hon.2438 VL - 35 ID - 1716 ER - TY - JOUR AD - G. Raverot, Groupement Hospitalier Est, Fédération d'Endocrinologie, Hospices Civils de Lyon, Bron, France AU - Lasolle, H. AU - Cortet, C. AU - Castinetti, F. AU - Cloix, L. AU - Caron, P. AU - Delemer, B. AU - Desailloud, R. AU - Jublanc, C. AU - Lebrun-Frenay, C. AU - Sadoul, J. L. AU - Taillandier, L. AU - Batisse-Lignier, M. AU - Bonnet, F. AU - Bourcigaux, N. AU - Bresson, D. AU - Chabre, O. AU - Chanson, P. AU - Garcia, C. AU - Haissaguerre, M. AU - Reznik, Y. AU - Borot, S. AU - Villa, C. AU - Vasiljevic, A. AU - Gaillard, S. AU - Jouanneau, E. AU - Assié, G. AU - Raverot, G. C1 - adriblastine DB - Embase Medline DO - 10.1530/EJE-16-0979 IS - 6 LA - English M3 - Article N1 - L618093973 2017-09-06 2017-09-13 PY - 2017 SN - 1479-683X 0804-4643 SP - 769-777 ST - Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas T2 - European Journal of Endocrinology TI - Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618093973&from=export http://dx.doi.org/10.1530/EJE-16-0979 VL - 176 ID - 1717 ER - TY - JOUR AD - S. Ašikovali, Ege University, Faculty of Medicine, Department of Medical Genetics, Izmir, Turkey AU - Ašikovali, S. AU - Aykut, A. AU - Durmaz, A. AU - Onay, H. AU - Hazan, F. AU - Özen, S. AU - Atik, T. AU - Kara, C. AU - Mihçi, E. AU - Gökšen, D. DB - Embase LA - English M3 - Conference Abstract N1 - L619523526 2017-12-08 PY - 2017 SN - 1308-5735 SP - 25 ST - PTPN11, SOS1, and BRAF gene mutation spectrum in RASopathies in molecular diagnosis T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - PTPN11, SOS1, and BRAF gene mutation spectrum in RASopathies in molecular diagnosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619523526&from=export VL - 9 ID - 1718 ER - TY - JOUR AD - M.H. Meel, VU University Medical Center, Amsterdam, Netherlands AU - Meel, M. H. AU - Guillén-Navarro, M. AU - De Gooijer, M. C. AU - Waranecki, P. AU - De Winter, M. P. AU - Van Vuurden, D. G. AU - Kaspers, G. J. L. AU - Hulleman, E. DB - Embase DO - 10.1093/neuonc/nox083 LA - English M3 - Conference Abstract N1 - L620678189 2018-02-19 PY - 2017 SN - 1523-5866 SP - iv2 ST - Preclinical efficacy of radiation-free treatment of atypical teratoid/rhabdoid tumors by combined mek and melk inhibition T2 - Neuro-Oncology TI - Preclinical efficacy of radiation-free treatment of atypical teratoid/rhabdoid tumors by combined mek and melk inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620678189&from=export http://dx.doi.org/10.1093/neuonc/nox083 VL - 19 ID - 1719 ER - TY - JOUR AD - S. Rangaraju, Ignyta, Inc, San Diego, CA, United States AU - Rangaraju, S. AU - Li, G. AU - Christiansen, J. AU - Hornby, Z. AU - Multani, P. AU - Esquibel, V. AU - Maneval, E. C. DB - Embase DO - 10.1093/neuonc/nox083 LA - English M3 - Conference Abstract N1 - L620678279 2018-02-19 PY - 2017 SN - 1523-5866 SP - iv53 ST - Pediatric phase 1/1B study of entrectinib in patients with primary brain tumors, neuroblastoma, and ntrk, ros1, or alk fusions T2 - Neuro-Oncology TI - Pediatric phase 1/1B study of entrectinib in patients with primary brain tumors, neuroblastoma, and ntrk, ros1, or alk fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620678279&from=export http://dx.doi.org/10.1093/neuonc/nox083 VL - 19 ID - 1720 ER - TY - JOUR AU - Cao, H. AU - Alrejaye, N. AU - Klein, O. D. AU - Goodwin, A. F. AU - Oberoi, S. DB - Medline DO - 10.1111/ocr.12144 LA - English M3 - Review N1 - L622854899 2018-07-06 PY - 2017 SN - 1601-6343 SP - 32-38 ST - A review of craniofacial and dental findings of the RASopathies T2 - Orthodontics & craniofacial research TI - A review of craniofacial and dental findings of the RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622854899&from=export http://dx.doi.org/10.1111/ocr.12144 VL - 20 ID - 1722 ER - TY - JOUR AD - J. Chen, Three Gorges Central Hospital of Chongqing, New City Road 165, Wanzhou District, Chongqing, China AU - Yang, C. AU - Xuan, D. AU - Chen, T. AU - Chen, J. AU - Tang, L. AU - Yang, Z. AU - Li, Z. AU - Deng, E. C2 - GenePharma(United States) DB - Embase IS - 5 LA - English M3 - Article N1 - L616389182 2017-06-05 2017-06-07 PY - 2017 SN - 1940-5901 SP - 7767-7773 ST - The effect of miR27b on osteosarcoma cell proliferation and invasion T2 - International Journal of Clinical and Experimental Medicine TI - The effect of miR27b on osteosarcoma cell proliferation and invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616389182&from=export VL - 10 ID - 1723 ER - TY - JOUR AD - S.T. Cooper, Institute for Neuroscience and Muscle Research, Children's Hospital at Westmead, Sydney, NSW, Australia AU - Piper, A. K. AU - Ross, S. E. AU - Redpath, G. M. AU - Lemckert, F. A. AU - Woolger, N. AU - Bournazos, A. AU - Greer, P. A. AU - Sutton, R. B. AU - Cooper, S. T. DB - Embase Medline DO - 10.1016/j.cellsig.2017.02.009 LA - English M3 - Article N1 - L614406403 2017-02-21 2017-03-15 PY - 2017 SN - 1873-3913 0898-6568 SP - 30-40 ST - Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling T2 - Cellular Signalling TI - Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614406403&from=export http://dx.doi.org/10.1016/j.cellsig.2017.02.009 VL - 33 ID - 1724 ER - TY - JOUR AD - D.J. Adams, Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom AU - Rabbie, R. AU - Rashid, M. AU - Arance, A. M. AU - Sánchez, M. AU - Tell-Marti, G. AU - Potrony, M. AU - Conill, C. AU - van Doorn, R. AU - Dentro, S. AU - Gruis, N. A. AU - Corrie, P. AU - Iyer, V. AU - Robles-Espinoza, C. D. AU - Puig-Butille, J. A. AU - Puig, S. AU - Adams, D. J. DB - Embase Medline DO - 10.1111/pcmr.12574 IS - 3 LA - English M3 - Article N1 - L615618077 2017-04-27 2017-05-11 PY - 2017 SN - 1755-148X 1755-1471 SP - 307-316 ST - Genomic analysis and clinical management of adolescent cutaneous melanoma T2 - Pigment Cell and Melanoma Research TI - Genomic analysis and clinical management of adolescent cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615618077&from=export http://dx.doi.org/10.1111/pcmr.12574 VL - 30 ID - 1725 ER - TY - JOUR AD - A. Scott, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia AU - Scott, A. AU - Harris, A. AU - Thornton, A. AU - Van Der Westhuizen, A. AU - Gillespie, R. DB - Embase DO - 10.1111/ajd.12652 LA - English M3 - Conference Abstract N1 - L615732001 2017-05-03 PY - 2017 SN - 1440-0960 SP - 79 ST - A tattoo pigment reaction in a patient with metastatic melanoma treated with dabrafenib and trametinib T2 - Australasian Journal of Dermatology TI - A tattoo pigment reaction in a patient with metastatic melanoma treated with dabrafenib and trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615732001&from=export http://dx.doi.org/10.1111/ajd.12652 VL - 58 ID - 1726 ER - TY - JOUR AD - P. Kadam, St Vincent's Centre for Applied Medical Research, Darlinghurst, NSW, Australia AU - Kadam, P. DB - Embase DO - 10.1111/ajd.12652 LA - English M3 - Conference Abstract N1 - L615732058 2017-05-03 PY - 2017 SN - 1440-0960 SP - 64-65 ST - Systemic cutaneous anaplastic large t-cell lymphoma T2 - Australasian Journal of Dermatology TI - Systemic cutaneous anaplastic large t-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615732058&from=export http://dx.doi.org/10.1111/ajd.12652 VL - 58 ID - 1727 ER - TY - JOUR AD - J. Xia, Department of Chemistry, Chinese University of Hong Kong, Shatin, Hong Kong AU - Yu, Y. AU - Nie, Y. AU - Feng, Q. AU - Qu, J. AU - Wang, R. AU - Bian, L. AU - Xia, J. DB - Embase Medline DO - 10.1021/acs.molpharmaceut.6b00952 IS - 5 LA - English M3 - Article N1 - L615770242 2017-05-08 2017-05-11 PY - 2017 SN - 1543-8392 1543-8384 SP - 1548-1557 ST - Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells T2 - Molecular Pharmaceutics TI - Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615770242&from=export http://dx.doi.org/10.1021/acs.molpharmaceut.6b00952 VL - 14 ID - 1728 ER - TY - JOUR AD - M.S. Cairo, Department of Pediatrics, New York Medical College, Valhalla, NY, United States AU - Lee, S. AU - Day, N. S. AU - Miles, R. R. AU - Perkins, S. L. AU - Lim, M. S. AU - Ayello, J. AU - van de Ven, C. AU - Harrison, L. AU - El-Mallawany, N. K. AU - Goldman, S. AU - Cairo, M. S. DB - Embase Medline DO - 10.1111/bjh.14604 IS - 4 LA - English M3 - Article N1 - L616034108 2017-05-12 2017-06-01 PY - 2017 SN - 1365-2141 0007-1048 SP - 601-611 ST - Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report T2 - British Journal of Haematology TI - Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616034108&from=export http://dx.doi.org/10.1111/bjh.14604 VL - 177 ID - 1729 ER - TY - JOUR AD - M.A. Hardyman, University of Reading, Reading, United Kingdom AU - Hardyman, M. A. AU - Fuller, S. J. AU - Leonard, S. J. AU - Sugden, P. H. AU - Angela Clerk, A. DB - Embase DO - 10.1002/ejhf.833 LA - English M3 - Conference Abstract N1 - L616172961 2017-05-18 PY - 2017 SN - 1878-1314 SP - 168 ST - BRaf inhibitors, dabrafenib and SB590885, enhance ERK1/2 signalling in cardiomyocytes and increase angiotensin II-induced cardiac hypertrophy T2 - European Journal of Heart Failure TI - BRaf inhibitors, dabrafenib and SB590885, enhance ERK1/2 signalling in cardiomyocytes and increase angiotensin II-induced cardiac hypertrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616172961&from=export http://dx.doi.org/10.1002/ejhf.833 VL - 19 ID - 1730 ER - TY - JOUR AU - Krengel, S. AU - Reyes-Múgica, M. DB - Embase Medline DO - 10.1111/bjd.15477 IS - 5 LA - English M3 - Note N1 - L616192162 2017-05-19 2017-06-01 PY - 2017 SN - 1365-2133 0007-0963 SP - 1114 ST - Melanoma risk in congenital melanocytic naevi T2 - British Journal of Dermatology TI - Melanoma risk in congenital melanocytic naevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616192162&from=export http://dx.doi.org/10.1111/bjd.15477 VL - 176 ID - 1731 ER - TY - JOUR AD - M. Hisadome, Department of Dermatology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan AU - Hisadome, M. AU - Ohnishi, T. AU - Kakimoto, K. AU - Kusuyama, J. AU - Bandow, K. AU - Kanekura, T. AU - Matsuguchi, T. DB - Embase DO - 10.1016/j.jdermsci.2017.02.171 IS - 2 LA - English M3 - Conference Abstract N1 - L616240546 2017-05-23 PY - 2017 SN - 0923-1811 SP - e58 ST - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes T2 - Journal of Dermatological Science TI - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616240546&from=export http://dx.doi.org/10.1016/j.jdermsci.2017.02.171 VL - 86 ID - 1732 ER - TY - JOUR AD - C. Ruggeri, Laboratory of Cardiovascular Biology, Department of Internal Medicine, University of Genova, Genova, Italy AU - Ruggeri, C. AU - Lazzarini, E. AU - Bertero, E. AU - Aquila, G. AU - Fortini, F. AU - Ferrari, R. AU - Brunelli, C. AU - Rizzo, P. AU - Ameri, P. DB - Embase LA - English M3 - Conference Abstract N1 - L616278024 2017-05-23 PY - 2017 SN - 1365-2362 SP - 101 ST - Evidence for a crosstalk between Erbb2 and Notch-1 in cardiomyocytes T2 - European Journal of Clinical Investigation TI - Evidence for a crosstalk between Erbb2 and Notch-1 in cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616278024&from=export VL - 47 ID - 1733 ER - TY - JOUR AU - Shen, T. N. Y. AU - Kanazawa, S. AU - Kado, M. AU - Okada, K. AU - Luo, L. AU - Hayashi, A. AU - Mizuno, H. AU - Tanaka, R. C1 - sb 203580 DB - Embase Medline DO - 10.1371/journal.pone.0178232 IS - 5 LA - English M3 - Article N1 - L616317373 2017-05-30 2019-05-14 PY - 2017 SN - 1932-6203 ST - Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice T2 - PLoS ONE TI - Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616317373&from=export http://dx.doi.org/10.1371/journal.pone.0178232 VL - 12 ID - 1734 ER - TY - JOUR AD - N. Finelt, Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, NY, United States AU - Finelt, N. AU - Lulla, R. R. AU - Melin-Aldana, H. AU - Ruth, J. S. AU - Lin, F. Y. AU - Su, J. M. AU - Pourciau, C. Y. AU - Hunt, R. D. AU - Kenner-Bell, B. M. DB - Embase Medline DO - 10.1111/pde.13148 IS - 3 LA - English M3 - Article N1 - L616403078 2017-05-30 2017-06-01 PY - 2017 SN - 1525-1470 0736-8046 SP - 337-341 ST - Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib T2 - Pediatric Dermatology TI - Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616403078&from=export http://dx.doi.org/10.1111/pde.13148 VL - 34 ID - 1735 ER - TY - JOUR AD - E.M. Speer, Department of Pediatrics, Stony Brook University, School of Medicine, Stony Brook, NY, United States AU - Speer, E. M. AU - Dowling, D. J. AU - Ozog, L. S. AU - Xu, J. AU - Yang, J. AU - Kennady, G. AU - Levy, O. DB - Embase Medline DO - 10.1038/pr.2017.6 IS - 5 LA - English M3 - Article N1 - L617159861 2017-07-10 2017-07-13 PY - 2017 SN - 1530-0447 0031-3998 SP - 806-816 ST - Pentoxifylline inhibits TLR- A nd inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns T2 - Pediatric Research TI - Pentoxifylline inhibits TLR- A nd inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617159861&from=export http://dx.doi.org/10.1038/pr.2017.6 VL - 81 ID - 1736 ER - TY - JOUR AD - B. Qi, Department of Intensive Care Unit, Xuzhou Children’s Hospital, 18 Sudi North Road, Xuzhou, Jiangsu, China AU - Zhu, L. AU - Li, W. AU - Qi, G. AU - Liu, N. AU - Sheng, L. AU - Shang, L. AU - Qi, B. DB - Embase DO - 10.3892/etm.2017.4245 IS - 5 LA - English M3 - Article N1 - L619106610 2017-11-10 2017-11-15 PY - 2017 SN - 1792-1015 1792-0981 SP - 2263-2266 ST - The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe handfoot-and-mouth disease and the MAPK pathway T2 - Experimental and Therapeutic Medicine TI - The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe handfoot-and-mouth disease and the MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619106610&from=export http://dx.doi.org/10.3892/etm.2017.4245 VL - 13 ID - 1737 ER - TY - JOUR AD - P. Malgulwar, All India Institute of Medical Sciences (AIIMS), New Delhi, India AU - Malgulwar, P. AU - Tomar, A. AU - Singh, M. AU - Suri, V. AU - Sarkar, C. AU - Sharma, M. DB - Embase DO - 10.1093/neuonc/nox036 LA - English M3 - Conference Abstract N1 - L620930857 2018-03-06 PY - 2017 SN - 1523-5866 SP - iii52 ST - A gene co-expression network analysis for snail and slug identifies IL1R1, an inflammatory interleukin to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas T2 - Neuro-Oncology TI - A gene co-expression network analysis for snail and slug identifies IL1R1, an inflammatory interleukin to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620930857&from=export http://dx.doi.org/10.1093/neuonc/nox036 VL - 19 ID - 1738 ER - TY - JOUR AD - L.M. Wagner, Division of Pediatric Hematology/ Oncology, Office C-453, 800 Rose Street, Lexington, KY, United States AU - Wagner, L. M. AU - Adams, V. R. DB - Embase DO - 10.2147/OTT.S124008 LA - English M3 - Review N1 - L615381317 2017-04-24 2017-05-02 PY - 2017 SN - 1178-6930 SP - 2097-2106 ST - Targeting the PD-1 pathway in pediatric solid tumors and brain tumors T2 - OncoTargets and Therapy TI - Targeting the PD-1 pathway in pediatric solid tumors and brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615381317&from=export http://dx.doi.org/10.2147/OTT.S124008 VL - 10 ID - 1740 ER - TY - JOUR AD - S.L. Cohn, Department of Pediatrics, University of Chicago, 900 E. 57th St., KCBD 5100, Chicago, IL, United States AU - Applebaum, M. A. AU - Desai, A. V. AU - Glade Bender, J. L. AU - Cohn, S. L. C1 - imgn 901 DB - Embase DO - 10.1080/21678707.2017.1304212 IS - 4 LA - English M3 - Review N1 - L615066787 2017-04-04 2017-04-21 PY - 2017 SN - 2167-8707 SP - 355-368 ST - Emerging and investigational therapies for neuroblastoma T2 - Expert Opinion on Orphan Drugs TI - Emerging and investigational therapies for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615066787&from=export http://dx.doi.org/10.1080/21678707.2017.1304212 VL - 5 ID - 1742 ER - TY - JOUR AD - M.R. Schneider, Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Feodor-Lynen-Str. 25, Munich, Germany AU - Dahlhoff, M. AU - Muzumdar, S. AU - Schäfer, M. AU - Schneider, M. R. DB - Embase DO - 10.1016/j.jid.2016.11.023 IS - 4 LA - English M3 - Article N1 - L614966740 2017-03-28 2017-04-25 PY - 2017 SN - 1523-1747 0022-202X SP - 921-930 ST - ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice T2 - Journal of Investigative Dermatology TI - ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614966740&from=export http://dx.doi.org/10.1016/j.jid.2016.11.023 VL - 137 ID - 1743 ER - TY - JOUR AD - A.E. Frankel, NB102.S, Simmons Cancer Center, 2201 Inwood Road, Dallas, TX, United States AU - Frankel, A. E. AU - Eskiocak, U. AU - Gill, J. G. AU - Yuan, S. AU - Ramesh, V. AU - Froehlich, T. W. AU - Ahn, C. AU - Morrison, S. J. C2 - Glaxo SmithKline jerome stevens Selleck Sigma DB - Embase Medline DO - 10.1016/j.neo.2017.01.010 IS - 4 LA - English M3 - Article N1 - L615174119 2017-04-10 2017-04-11 PY - 2017 SN - 1476-5586 1522-8002 SP - 255-260 ST - Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients T2 - Neoplasia (United States) TI - Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615174119&from=export http://dx.doi.org/10.1016/j.neo.2017.01.010 VL - 19 ID - 1744 ER - TY - JOUR AU - Tomić, T. T. AU - Olausson, J. AU - Wilzén, A. AU - Sabel, M. AU - Truvé, K. AU - Sjögren, H. AU - Dósa, S. AU - Tisell, M. AU - Lannering, B. AU - Enlund, F. AU - Martinsson, T. AU - Åman, P. AU - Abel, F. DB - Embase Medline DO - 10.1371/journal.pone.0175638 IS - 4 LA - English M3 - Article N1 - L615757421 2017-05-08 2017-05-12 PY - 2017 SN - 1932-6203 ST - A new fusion mediating MAPK pathway activation in pilocytic astrocytoma T2 - PLoS ONE TI - A new fusion mediating MAPK pathway activation in pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615757421&from=export http://dx.doi.org/10.1371/journal.pone.0175638 VL - 12 ID - 1745 ER - TY - JOUR AD - M. Quinn, The University of Melbourne, Royal Women's Hospital, 20 Flemington Rd, Melbourne, VIC, Australia AU - Leary, A. F. AU - Quinn, M. AU - Fujiwara, K. AU - Coleman, R. L. AU - Kohn, E. AU - Sugiyama, T. AU - Glasspoo, R. AU - Ray-Coquard, I. AU - Colombo, N. AU - Bacon, M. AU - Zeimet, A. AU - Westermann, A. AU - Gomez-Garcia, E. AU - Provencher, D. AU - Welch, S. AU - Small, W. AU - Millan, D. AU - Okamoto, A. AU - Stuart, G. AU - Ochiai, K. DB - Embase Medline DO - 10.1093/annonc/mdw662 IS - 4 LA - English M3 - Review N1 - L616106023 2017-05-16 2019-10-31 PY - 2017 SN - 1569-8041 0923-7534 SP - 718-726 ST - Fifth ovarian cancer consensus conference of the Gynecologic Cancer InterGroup (GCIG): Clinical trial design for rare ovarian tumours T2 - Annals of Oncology TI - Fifth ovarian cancer consensus conference of the Gynecologic Cancer InterGroup (GCIG): Clinical trial design for rare ovarian tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616106023&from=export http://dx.doi.org/10.1093/annonc/mdw662 VL - 28 ID - 1746 ER - TY - JOUR AD - H.R. Madala, Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, United States AU - Madala, H. R. AU - Punganuru, S. R. AU - Kalkunte, S. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L616904789 2017-06-28 PY - 2017 SN - 1530-6860 ST - Synthesis of a novel non-diuretic, brain-penetrating, ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models T2 - FASEB Journal TI - Synthesis of a novel non-diuretic, brain-penetrating, ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616904789&from=export VL - 31 ID - 1747 ER - TY - JOUR AD - G. Kapoor, Department of Pediatric Oncology and Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India AU - Verma, P. AU - Jain, S. AU - Kapoor, G. DB - Embase DO - 10.4103/2278-330X.208855 IS - 2 LA - English M3 - Letter N1 - L617148890 2017-07-10 2017-07-12 PY - 2017 SN - 2278-4306 2278-330X SP - 89-90 ST - Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma T2 - South Asian Journal of Cancer TI - Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617148890&from=export http://dx.doi.org/10.4103/2278-330X.208855 VL - 6 ID - 1748 ER - TY - JOUR AD - Y. Wang, Cardiovascular Center & Geriatric Medicine, The First Hospital of Jilin University, Changchun, Jilin, China AU - Wang, S. AU - Wang, B. AU - Wang, Y. AU - Tong, Q. AU - Liu, Q. AU - Sun, J. AU - Zheng, Y. AU - Cai, L. DB - Embase Medline DO - 10.3390/ijms18030580 IS - 3 LA - English M3 - Article N1 - L614688608 2017-03-15 2017-03-20 PY - 2017 SN - 1422-0067 1661-6596 ST - Zinc prevents the development of diabetic cardiomyopathy in db/db mice T2 - International Journal of Molecular Sciences TI - Zinc prevents the development of diabetic cardiomyopathy in db/db mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614688608&from=export http://dx.doi.org/10.3390/ijms18030580 VL - 18 ID - 1750 ER - TY - JOUR AD - C.-F. Lin, Department of Cosmetic Science, Chang Gung University of Science and Technology, No. 261, Wenhua 1st Rd., Guishan Dist., Taoyuan City, Taiwan AU - Liou, C. J. AU - Huang, Y. L. AU - Huang, W. C. AU - Yeh, K. W. AU - Huang, T. Y. AU - Lin, C. F. DB - Embase Medline DO - 10.1016/j.jep.2017.01.043 LA - English M3 - Article N1 - L614254497 2017-02-20 2017-02-24 PY - 2017 SN - 1872-7573 0378-8741 SP - 30-38 ST - Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways T2 - Journal of Ethnopharmacology TI - Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614254497&from=export http://dx.doi.org/10.1016/j.jep.2017.01.043 VL - 199 ID - 1751 ER - TY - JOUR AD - A.K. Greene, Department of Plastic & Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States AU - Couto, J. A. AU - Huang, A. Y. AU - Konczyk, D. J. AU - Goss, J. A. AU - Fishman, S. J. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. DB - Embase Medline DO - 10.1016/j.ajhg.2017.01.018 IS - 3 LA - English M3 - Article N1 - L614441974 2017-02-21 2017-03-14 PY - 2017 SN - 1537-6605 0002-9297 SP - 546-554 ST - Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation T2 - American Journal of Human Genetics TI - Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614441974&from=export http://dx.doi.org/10.1016/j.ajhg.2017.01.018 VL - 100 ID - 1752 ER - TY - JOUR AD - A. Banerjee, Vaccine and Infectious Disease Research Center (VIDRC), Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, PO box #04, Faridabad, India AU - Goswami, S. AU - Banerjee, A. AU - Kumari, B. AU - Bandopadhyay, B. AU - Bhattacharya, N. AU - Basu, N. AU - Vrati, S. AU - Banerjee, A. DB - Embase Medline DO - 10.1007/s12035-016-9764-y IS - 2 LA - English M3 - Article N1 - L608267810 2016-02-16 2017-03-07 PY - 2017 SN - 1559-1182 0893-7648 SP - 1541-1551 ST - Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus T2 - Molecular Neurobiology TI - Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608267810&from=export http://dx.doi.org/10.1007/s12035-016-9764-y VL - 54 ID - 1753 ER - TY - JOUR AD - W. Deng, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Li, A. AU - Shi, D. AU - Xu, B. AU - Wang, J. AU - Tang, Y. L. AU - Xiao, W. AU - Shen, G. AU - Deng, W. AU - Zhao, C. DB - Embase Medline DO - 10.1002/mc.22563 IS - 3 LA - English M3 - Article N1 - L612488325 2016-10-10 2017-03-14 PY - 2017 SN - 1098-2744 0899-1987 SP - 972-984 ST - S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway T2 - Molecular Carcinogenesis TI - S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612488325&from=export http://dx.doi.org/10.1002/mc.22563 VL - 56 ID - 1754 ER - TY - JOUR AD - Y. Xu, Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing City, Jiangsu, China AU - Weng, L. AU - Zhang, H. AU - Li, X. AU - Zhan, H. AU - Chen, F. AU - Han, L. AU - Xu, Y. AU - Cao, X. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1016/j.intimp.2016.12.018 LA - English M3 - Article N1 - L613702424 2016-12-22 2017-03-02 PY - 2017 SN - 1878-1705 1567-5769 SP - 1-8 ST - Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia T2 - International Immunopharmacology TI - Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613702424&from=export http://dx.doi.org/10.1016/j.intimp.2016.12.018 VL - 44 ID - 1755 ER - TY - JOUR AU - Palacios, G. AU - Shaw, T. I. AU - Li, Y. AU - Singh, R. K. AU - Valentine, M. AU - Sandlund, J. T. AU - Lim, M. S. AU - Mullighan, C. G. AU - Leventaki, V. DB - Embase DO - 10.1038/leu.2016.331 IS - 3 LA - English M3 - Letter N1 - L613994768 2017-01-11 2017-03-14 PY - 2017 SN - 1476-5551 0887-6924 SP - 743-747 ST - Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex T2 - Leukemia TI - Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613994768&from=export http://dx.doi.org/10.1038/leu.2016.331 VL - 31 ID - 1756 ER - TY - JOUR AD - C.-H. Hung, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan AU - Lin, Y. C. AU - Lin, Y. C. AU - Huang, M. Y. AU - Kuo, P. L. AU - Wu, C. C. AU - Lee, M. S. AU - Hsieh, C. C. AU - Kuo, H. F. AU - Kuo, C. H. AU - Tsai, W. C. AU - Hung, C. H. C1 - enbrel(Immunex,United States) humira(AbbVie,United States) C2 - AbbVie(United States) Immunex(United States) DB - Embase Medline DO - 10.1016/j.molimm.2017.01.009 LA - English M3 - Article N1 - L614115945 2017-01-25 2017-01-30 PY - 2017 SN - 1872-9142 0161-5890 SP - 82-91 ST - Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification T2 - Molecular Immunology TI - Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614115945&from=export http://dx.doi.org/10.1016/j.molimm.2017.01.009 VL - 83 ID - 1757 ER - TY - JOUR AD - S.-X. Lin, Department of Pathology, Sun Yat-Sen University, Cancer Center, Guangzhou, China AU - Huang, J. L. AU - Zeng, J. AU - Wang, F. AU - Huang, Q. T. AU - Lu, J. B. AU - Li, X. M. AU - Chen, W. Q. AU - Zhu, C. M. AU - Jin, J. T. AU - Lin, S. X. DB - Embase Medline DO - 10.2217/pme-2016-0080 IS - 2 LA - English M3 - Article N1 - L614330059 2017-02-10 2018-09-14 PY - 2017 SN - 1744-828X 1741-0541 SP - 99-107 ST - Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions T2 - Personalized Medicine TI - Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614330059&from=export http://dx.doi.org/10.2217/pme-2016-0080 VL - 14 ID - 1758 ER - TY - JOUR AD - L. Mou, Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, China AU - Gao, H. AU - Liu, L. AU - Zhao, Y. AU - Hara, H. AU - Chen, P. AU - Xu, J. AU - Tang, J. AU - Wei, L. AU - Li, Z. AU - Cooper, D. K. C. AU - Cai, Z. AU - Mou, L. DB - Embase Medline DO - 10.1111/xen.12291 IS - 2 LA - English M3 - Article N1 - L615149944 2017-04-07 2017-05-04 PY - 2017 SN - 1399-3089 0908-665X ST - Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells T2 - Xenotransplantation TI - Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615149944&from=export http://dx.doi.org/10.1111/xen.12291 VL - 24 ID - 1759 ER - TY - JOUR AD - E.M. Sierra, CHU Sainte-Justine Research Center, Montreal, QC, Canada AU - Sierra, E. M. AU - Quiniou, C. AU - Nadeau-Vallée, M. AU - Hou, X. AU - Hales, B. AU - Chemtob, S. DB - Embase DO - 10.1177/1933719117699773 IS - 1 LA - English M3 - Conference Abstract N1 - L615323338 2017-04-17 PY - 2017 SN - 1933-7205 SP - 109A-110A ST - An anti-IL-6R peptide as a potential therapeutic agent in inflammation-and infection-induced preterm birth T2 - Reproductive Sciences TI - An anti-IL-6R peptide as a potential therapeutic agent in inflammation-and infection-induced preterm birth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615323338&from=export http://dx.doi.org/10.1177/1933719117699773 VL - 24 ID - 1760 ER - TY - JOUR AD - C. Miller, Department of Neurosurgery, University of Minnesota, 420 Delaware St. SE, MMC 96, Rm. D429, Mayo Building, Minneapolis, MN, United States AU - Miller, C. AU - Guillaume, D. AU - Dusenbery, K. AU - Clark, H. B. AU - Moertel, C. C1 - mekinist(Glaxo SmithKline) C2 - Glaxo SmithKline DB - Embase Medline DO - 10.3171/2016.9.PEDS16328 IS - 3 LA - English M3 - Article N1 - L616482184 2017-06-01 2017-06-06 PY - 2017 SN - 1933-0715 1933-0707 SP - 319-324 ST - Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: Documentation of volumetric response T2 - Journal of Neurosurgery: Pediatrics TI - Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: Documentation of volumetric response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616482184&from=export http://dx.doi.org/10.3171/2016.9.PEDS16328 VL - 19 ID - 1761 ER - TY - JOUR AD - J.A. Suárez, Hospital Sant Joan de Déu-Barcelona, Department of Pharmacy, Barcelona, Spain AU - Escoda, A. C. AU - Genestar, J. L. V. AU - Salvador, H. H. AU - Busquets, F. B. AU - Suárez, J. A. AU - Celma, M. S. DB - Embase DO - 10.1136/ejhpharm-2017-000640.289 LA - English M3 - Conference Abstract N1 - L617772590 2017-08-18 PY - 2017 SN - 2047-9964 SP - A131-A132 ST - Trametinib safety and acceptability in paediatric oncology patients: Experience based on a case series T2 - European Journal of Hospital Pharmacy TI - Trametinib safety and acceptability in paediatric oncology patients: Experience based on a case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617772590&from=export http://dx.doi.org/10.1136/ejhpharm-2017-000640.289 VL - 24 ID - 1762 ER - TY - JOUR AD - T. John, Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, United States AU - John, T. AU - Sasa, G. AU - Gottschalk, S. AU - Ahmed, N. AU - Allen, C. AU - Omer, B. AU - Hegde, M. AU - Naik, S. AU - Leung, K. AU - Martinez, C. AU - Krance, R. A. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L619101729 2017-11-10 PY - 2017 SN - 1523-6536 SP - S281 ST - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619101729&from=export VL - 23 ID - 1763 ER - TY - JOUR AD - J. Ding, Shanghai Jiao Tong University School of Medicine, Department of Neurology and Institute of Neurology, Ruijin Hospital, 197 Ruijin Er Road, Shanghai, China AU - Yang, X. AU - Lou, Y. AU - Liu, G. AU - Wang, X. AU - Qian, Y. AU - Ding, J. AU - Chen, S. AU - Xiao, Q. DB - Embase Medline DO - 10.1186/s12974-017-0795-8 IS - 1 LA - English M3 - Article N1 - L614476641 2017-02-27 2017-03-22 PY - 2017 SN - 1742-2094 ST - Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process T2 - Journal of Neuroinflammation TI - Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614476641&from=export http://dx.doi.org/10.1186/s12974-017-0795-8 VL - 14 ID - 1764 ER - TY - JOUR AD - P.G. Gibson, John Hunter Hospital, Newcastle, NSW, Australia AU - Gibson, P. G. AU - Peters, M. J. AU - Wainwright, C. E. DB - Embase Medline DO - 10.5694/mja16.00731 IS - 3 LA - English M3 - Review N1 - L620162556 2018-01-22 2018-01-25 PY - 2017 SN - 1326-5377 0025-729X SP - 136-140 ST - Targeted therapy for chronic respiratory disease: A new paradigm T2 - Medical Journal of Australia TI - Targeted therapy for chronic respiratory disease: A new paradigm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620162556&from=export http://dx.doi.org/10.5694/mja16.00731 VL - 206 ID - 1765 ER - TY - JOUR AD - H. Liu, Department of Rheumatology, Shandong University Qilu Hospital, 107 Wenhua Xi Road, Jinan, Shandong Province, China AU - Chen, C. AU - Bai, X. AU - Bi, Y. AU - Liu, G. AU - Li, H. AU - Liu, Z. AU - Liu, H. C1 - ly 294002 pd 98059 DB - Embase Medline DO - 10.1179/1476830514Y.0000000147 IS - 2 LA - English M3 - Article N1 - L611287798 2016-07-25 2017-01-24 PY - 2017 SN - 1476-8305 1028-415X SP - 89-102 ST - Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro T2 - Nutritional Neuroscience TI - Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611287798&from=export http://dx.doi.org/10.1179/1476830514Y.0000000147 VL - 20 ID - 1766 ER - TY - JOUR AD - H.-K. Yi, Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Chonbuk National University, 634-18, Deokjin-dong, Deokjin-gu, Jeonju, Jeonbuk, South Korea AU - Kim, J. S. AU - Lee, Y. H. AU - Chang, Y. U. AU - Yi, H. K. DB - Embase Medline DO - 10.1007/s13105-016-0523-3 IS - 1 LA - English M3 - Article N1 - L612666915 2016-10-18 2017-03-22 PY - 2017 SN - 1877-8755 1138-7548 SP - 49-57 ST - PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells T2 - Journal of Physiology and Biochemistry TI - PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612666915&from=export http://dx.doi.org/10.1007/s13105-016-0523-3 VL - 73 ID - 1767 ER - TY - JOUR AU - Pomari, E. AU - Basso, G. AU - Bresolin, S. AU - Pillon, M. AU - Carraro, E. AU - D'Amore, E. S. AU - Viola, G. AU - Frasson, C. AU - Basso, K. AU - Bonvini, P. AU - Mussolin, L. DB - Embase Medline DO - 10.1038/leu.2016.292 IS - 2 LA - English M3 - Letter N1 - L613339624 2016-11-28 2017-02-15 PY - 2017 SN - 1476-5551 0887-6924 SP - 498-501 ST - NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma T2 - Leukemia TI - NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613339624&from=export http://dx.doi.org/10.1038/leu.2016.292 VL - 31 ID - 1769 ER - TY - JOUR AD - L. Zhu, Department of Orthopedic Surgery, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China AU - Jiang, C. AU - Li, M. AU - Jiang, W. AU - Tian, F. AU - Zhu, L. AU - Bian, Z. C1 - amd 3100(Sigma,United States) C2 - sinobest(China) Sigma(United States) DB - Embase Medline DO - 10.1016/j.biopha.2016.12.055 LA - English M3 - Article N1 - L613861610 2017-01-04 2017-01-09 PY - 2017 SN - 1950-6007 0753-3322 SP - 677-685 ST - AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells T2 - Biomedicine and Pharmacotherapy TI - AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613861610&from=export http://dx.doi.org/10.1016/j.biopha.2016.12.055 VL - 86 ID - 1770 ER - TY - JOUR AD - M. Abbaszadegan, Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran AU - Tafazoli, A. AU - Eshraghi, P. AU - Koleti, Z. K. AU - Abbaszadegan, M. DB - Embase DO - 10.5114/aoms.2017.64720 IS - 1 LA - English M3 - Review N1 - L613935415 2017-01-06 2017-02-02 PY - 2017 SN - 1896-9151 1734-1922 SP - 215-222 ST - Noonan syndrome-a new survey T2 - Archives of Medical Science TI - Noonan syndrome-a new survey UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613935415&from=export http://dx.doi.org/10.5114/aoms.2017.64720 VL - 13 ID - 1771 ER - TY - JOUR AD - T. Asano, Department of Pediatrics, Nippon Medical School, Tokyo, Japan AU - Asano, T. AU - Narazaki, H. AU - Fujita, A. DB - Embase DO - 10.1002/prp2.285 IS - 1 LA - English M3 - Article N1 - L614248858 2017-02-09 2017-02-14 PY - 2017 SN - 2052-1707 ST - Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance T2 - Pharmacology Research and Perspectives TI - Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614248858&from=export http://dx.doi.org/10.1002/prp2.285 VL - 5 ID - 1772 ER - TY - JOUR AD - A. Bongaarts, Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, Utrecht, Netherlands AU - Bongaarts, A. AU - Reinten, R. J. A. AU - Jansen, F. E. AU - Spliet, W. G. M. AU - Feucht, M. AU - Buccoliero, A. M. AU - Giordano, F. AU - Mühlebner, A. AU - Aronica, E. M. DB - Embase LA - English M3 - Conference Abstract N1 - L614692173 2017-03-10 PY - 2017 SN - 0305-1846 SP - 55-56 ST - Absence of BRAF V600E mutation in Subependymal giant cell astrocytomas associated with tuberous sclerosis T2 - Neuropathology and Applied Neurobiology TI - Absence of BRAF V600E mutation in Subependymal giant cell astrocytomas associated with tuberous sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614692173&from=export VL - 43 ID - 1773 ER - TY - JOUR AD - L. Debelenko, New York Medical College, Valhalla, NY, United States AU - Debelenko, L. AU - Weihua, H. AU - Zhuge, J. AU - Yin, C. AU - Zhong, M. AU - Ozkaynak, M. AU - Fallon, J. T. DB - Embase DO - 10.1038/labinvest.2016.180 LA - English M3 - Conference Abstract N1 - L615115562 2017-04-06 PY - 2017 SN - 1530-0307 SP - 465A ST - Identification of 2 novel transcript fusions coexisting with EML4-ALK in a New Case of ALK-positive pediatric renal cell carcinoma T2 - Laboratory Investigation TI - Identification of 2 novel transcript fusions coexisting with EML4-ALK in a New Case of ALK-positive pediatric renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615115562&from=export http://dx.doi.org/10.1038/labinvest.2016.180 VL - 97 ID - 1774 ER - TY - JOUR AD - D. Zhang AU - Zhang, D. AU - Kongkarnka, S. AU - Komissarova, E. V. AU - Del Portillo, A. AU - Neto, A. G. AU - Sepulveda, J. AU - Sepulveda, A. DB - Embase DO - 10.1038/labinvest.2016.168 LA - English M3 - Conference Abstract N1 - L615116464 2017-04-06 PY - 2017 SN - 1530-0307 SP - 209A ST - Morphological and molecular features of gastric glomus tumors T2 - Laboratory Investigation TI - Morphological and molecular features of gastric glomus tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615116464&from=export http://dx.doi.org/10.1038/labinvest.2016.168 VL - 97 ID - 1775 ER - TY - JOUR AD - Z. Song, Pain Research Center, Department of Anesthesiology, University of Cincinnati, Cincinnati, OH, United States AU - Ding, Z. AU - Xu, W. AU - Zhang, J. AU - Zou, W. AU - Guo, Q. AU - Huang, C. AU - Liu, C. AU - Zhong, T. AU - Zhang, J. M. AU - Song, Z. DB - Embase Medline DO - 10.1002/ijc.30438 IS - 2 LA - English M3 - Article N1 - L612734338 2016-10-19 2016-12-16 PY - 2017 SN - 1097-0215 0020-7136 SP - 411-422 ST - Normalizing GDNF expression in the spinal cord alleviates cutaneous hyperalgesia but not ongoing pain in a rat model of bone cancer pain T2 - International Journal of Cancer TI - Normalizing GDNF expression in the spinal cord alleviates cutaneous hyperalgesia but not ongoing pain in a rat model of bone cancer pain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612734338&from=export http://dx.doi.org/10.1002/ijc.30438 VL - 140 ID - 1776 ER - TY - JOUR AD - J. Gao, Department of Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, 1 Jianshe East Rd, Henan, China AU - Tan, H. AU - Wang, B. AU - Xiao, H. AU - Lian, Y. AU - Gao, J. C1 - magnevist(Schering,Germany) ultravist(Schering) C2 - Schering Schering(Germany) DB - Embase Medline DO - 10.1097/RCT.0000000000000444 IS - 1 LA - English M3 - Article N1 - L610529405 2016-06-03 2017-01-31 PY - 2017 SN - 1532-3145 0363-8715 SP - 90-97 ST - Radiologic and clinicopathologic findings of inflammatory myofibroblastic tumor T2 - Journal of Computer Assisted Tomography TI - Radiologic and clinicopathologic findings of inflammatory myofibroblastic tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610529405&from=export http://dx.doi.org/10.1097/RCT.0000000000000444 VL - 41 ID - 1777 ER - TY - JOUR AD - K.R. Schultz, 4480 Oak Street, B315, Vancouver, BC, Canada AU - Kariminia, A. AU - Ivison, S. M. AU - Leung, V. M. AU - Sung, S. AU - Couto, N. AU - Rozmus, J. AU - Rolf, N. AU - Narendran, A. AU - Dunn, S. E. AU - Reid, G. S. D. AU - Schultz, K. R. DB - Embase DO - 10.3892/ol.2016.5437 IS - 1 LA - English M3 - Article N1 - L613676017 2016-12-19 2017-01-03 PY - 2017 SN - 1792-1082 1792-1074 SP - 497-505 ST - Y-box-binding protein 1 contributes to IL-7-Mediated survival signaling in B-cell precursor acute lymphoblastic leukemia T2 - Oncology Letters TI - Y-box-binding protein 1 contributes to IL-7-Mediated survival signaling in B-cell precursor acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613676017&from=export http://dx.doi.org/10.3892/ol.2016.5437 VL - 13 ID - 1780 ER - TY - JOUR AD - D. O'Connell, Department of Neurology, University of California, Irvine Medical Center, Orange, CA, United States AU - O'Connell, D. AU - Shen, V. AU - Loudon, W. AU - Bota, D. A. DB - Embase Medline DO - 10.2217/cns-2016-0018 IS - 1 LA - English M3 - Article N1 - L614048923 2017-01-17 2017-01-24 PY - 2017 SN - 2045-0915 2045-0907 SP - 11-18 ST - First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: A case report T2 - CNS Oncology TI - First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614048923&from=export http://dx.doi.org/10.2217/cns-2016-0018 VL - 6 ID - 1783 ER - TY - JOUR AD - Y. Fan, Department of Traditional Chinese Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China AU - Yang, T. AU - Wang, S. AU - Yang, X. AU - Zheng, Q. AU - Wang, L. AU - Li, Q. AU - Wei, M. AU - Du, Z. AU - Fan, Y. DB - Embase DO - 10.3389/fnins.2017.00011 IS - JAN LA - English M3 - Article N1 - L614312738 2017-02-14 2017-02-28 PY - 2017 SN - 1662-453X 1662-4548 ST - Upregulation of Bcl-2 and its promoter signals in CD4+ T cells during neuromyelitis optica remission T2 - Frontiers in Neuroscience TI - Upregulation of Bcl-2 and its promoter signals in CD4+ T cells during neuromyelitis optica remission UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614312738&from=export http://dx.doi.org/10.3389/fnins.2017.00011 VL - 11 ID - 1784 ER - TY - JOUR AD - S. Hong, Department of Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Dongguk University, Dongguk-ro 27, Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea AU - Yang, J. AU - Min, S. AU - Hong, S. DB - Embase DO - 10.1155/2017/5469125 LA - English M3 - Article N1 - L614478692 2017-02-28 2017-03-28 PY - 2017 SN - 1741-4288 1741-427X ST - Therapeutic effects of fermented flax seed oil on NC/Nga mice with atopic dermatitis-like skin lesions T2 - Evidence-based Complementary and Alternative Medicine TI - Therapeutic effects of fermented flax seed oil on NC/Nga mice with atopic dermatitis-like skin lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614478692&from=export http://dx.doi.org/10.1155/2017/5469125 VL - 2017 ID - 1785 ER - TY - JOUR AD - D. Vincent, Department of Paediatric Neurology, Cork University Hospital, United Kingdom AU - Vincent, D. AU - O'Connor, G. AU - McSweeney, N. DB - Embase DO - 10.1111/dmcn.13347 LA - English M3 - Conference Abstract N1 - L614879055 2017-03-22 PY - 2017 SN - 1469-8749 SP - 104-105 ST - Primary congenital glaucoma as a neonatal presentation of neurofibromatosis 1: A case report T2 - Developmental Medicine and Child Neurology TI - Primary congenital glaucoma as a neonatal presentation of neurofibromatosis 1: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614879055&from=export http://dx.doi.org/10.1111/dmcn.13347 VL - 59 ID - 1786 ER - TY - JOUR AD - L. Zhang, Medical Oncoloyg Dept., Sun Yat-Sen University Cancer Center, Guangzhou, China AU - Zhang, L. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L615339319 2017-04-18 PY - 2017 SN - 1556-1380 SP - S113-S114 ST - Lung cancer in China: Challenges and perspectives T2 - Journal of Thoracic Oncology TI - Lung cancer in China: Challenges and perspectives UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615339319&from=export VL - 12 ID - 1787 ER - TY - JOUR AD - Y.-N. Yang, Department of Pediatrics, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan AU - Hsieh, M. T. AU - Wang, L. M. AU - Changou, C. A. AU - Chin, Y. T. AU - Yang, Y. S. H. AU - Lai, H. Y. AU - Lee, S. Y. AU - Yang, Y. N. AU - Whang-Peng, J. AU - Liu, L. F. AU - Lin, H. Y. AU - Mousa, S. A. AU - Davis, P. J. DB - Embase DO - 10.18632/oncotarget.10757 IS - 15 LA - English M3 - Article N1 - L615419967 2017-04-21 2017-05-03 PY - 2017 SN - 1949-2553 SP - 24237-24249 ST - Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells T2 - Oncotarget TI - Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615419967&from=export http://dx.doi.org/10.18632/oncotarget.10757 VL - 8 ID - 1788 ER - TY - JOUR AD - L. Yang, Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China AU - Tang, L. AU - Chai, W. AU - Ye, F. AU - Yu, Y. AU - Cao, L. AU - Yang, M. AU - Xie, M. AU - Yang, L. C2 - Cell Signaling Technology(United States) DB - Embase DO - 10.18632/oncotarget.15432 IS - 16 LA - English M3 - Article N1 - L615452440 2017-04-24 2017-05-12 PY - 2017 SN - 1949-2553 SP - 27314-27327 ST - HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells T2 - Oncotarget TI - HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615452440&from=export http://dx.doi.org/10.18632/oncotarget.15432 VL - 8 ID - 1789 ER - TY - JOUR AD - N.B. Ramachandra, Department of Studies in Zoology, Genetics & Genomics Laboratory, University of Mysore, Mysuru, Karnataka, India AU - Suresh, R. V. AU - Lingaiah, K. AU - Veerappa, A. M. AU - Ramachandra, N. B. DB - Embase Medline DO - 10.4103/ijmr.IJMR_965_14 IS - JANUARY LA - English M3 - Article N1 - L616584942 2017-06-07 2017-06-12 PY - 2017 SN - 0971-5916 SP - 39-50 ST - Identifying the risk of producing aneuploids using meiotic recombination genes as biomarkers: A copy number variation approach T2 - Indian Journal of Medical Research TI - Identifying the risk of producing aneuploids using meiotic recombination genes as biomarkers: A copy number variation approach UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616584942&from=export http://dx.doi.org/10.4103/ijmr.IJMR_965_14 VL - 145 ID - 1790 ER - TY - JOUR AD - F. Liu, Department of Pediatric Surgery, Xuzhou Children’s Hospital, 18 Sudibei Road, Xuzhou, Jiangsu, China AU - Li, Z. AU - Yin, Y. AU - Liu, F. DB - Embase DO - 10.3892/ol.2017.6243 IS - 1 LA - English M3 - Article N1 - L616650170 2017-06-12 2017-06-15 PY - 2017 SN - 1792-1082 1792-1074 SP - 497-500 ST - Recent developments in predictive biomarkers of pediatric glioma (Review) T2 - Oncology Letters TI - Recent developments in predictive biomarkers of pediatric glioma (Review) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616650170&from=export http://dx.doi.org/10.3892/ol.2017.6243 VL - 14 ID - 1791 ER - TY - JOUR AD - S. Haston, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom AU - Haston, S. AU - Pozzi, S. AU - Carreno, G. AU - Manshaei, S. AU - Panousopoulos, L. AU - Gonzalez-Meljem, J. M. AU - Apps, J. R. AU - Virasami, A. AU - Thavaraj, S. AU - Gutteridge, A. AU - Forshew, T. AU - Marais, R. AU - Brandner, S. AU - Jacques, T. S. AU - Andoniadou, C. L. AU - Martinez-Barbera, J. P. DB - Embase Medline DO - 10.1242/dev.150490 IS - 12 LA - English M3 - Article N1 - L616963837 2017-06-29 2017-07-04 PY - 2017 SN - 1477-9129 0950-1991 SP - 2141-2152 ST - MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma T2 - Development (Cambridge) TI - MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616963837&from=export http://dx.doi.org/10.1242/dev.150490 VL - 144 ID - 1792 ER - TY - JOUR AD - Y. Adachi, Department of Diagnostic Pathology, Toyooka Hospital, 1094 Tobera, Toyooka, Hyogo, Japan AU - Miyoshi, K. AU - Adachi, Y. AU - Nakaji, H. AU - Okamura, A. AU - Sakai, Y. AU - Hirano, R. AU - Yahata, S. AU - Li, M. AU - Ikehara, S. DB - Embase DO - 10.3892/mco.2017.1308 IS - 2 LA - English M3 - Article N1 - L617153298 2017-07-10 2017-07-12 PY - 2017 SN - 2049-9469 2049-9450 SP - 188-192 ST - Neuroendocrine carcinoma of the lung expressing anaplastic lymphoma kinase on high-sensitivity immunohistochemistry: A case report T2 - Molecular and Clinical Oncology TI - Neuroendocrine carcinoma of the lung expressing anaplastic lymphoma kinase on high-sensitivity immunohistochemistry: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617153298&from=export http://dx.doi.org/10.3892/mco.2017.1308 VL - 7 ID - 1793 ER - TY - JOUR AD - M. He, Department of Pharmacology and Molecular Therapeutics, Nanchang University School of Pharmaceutical Science, Bayi Avenue, Nanchang, Jiangxi, China AU - Zou, Y. AU - Liu, F. Y. AU - Wu, J. AU - Wan, L. AU - Fang, S. F. AU - Zhang, Z. Y. AU - Luo, Y. AU - Chen, M. H. AU - Huang, M. Z. AU - He, M. AU - Huang, O. P. DB - Embase DO - 10.3892/ol.2017.6435 IS - 2 LA - English M3 - Article N1 - L617154196 2017-07-10 2017-07-17 PY - 2017 SN - 1792-1082 1792-1074 SP - 2427-2431 ST - Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 han Chinese patients with cervical carcinoma T2 - Oncology Letters TI - Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 han Chinese patients with cervical carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617154196&from=export http://dx.doi.org/10.3892/ol.2017.6435 VL - 14 ID - 1794 ER - TY - JOUR AD - A. Decherney, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States AU - Zolton, J. R. AU - Decherney, A. DB - Embase Medline DO - 10.1097/GRF.0000000000000310 IS - 3 LA - English M3 - Article N1 - L617534864 2017-08-01 2017-08-03 PY - 2017 SN - 1532-5520 0009-9201 SP - 539-542 ST - Summary of Future Developments T2 - Clinical Obstetrics and Gynecology TI - Summary of Future Developments UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617534864&from=export http://dx.doi.org/10.1097/GRF.0000000000000310 VL - 60 ID - 1796 ER - TY - JOUR AD - C. Yu, Prenatal Diagnosis Center, Hubei Maternal and Child Hospital, 745 Wuluo Road, Wuhan, Hubei, China AU - Huang, Z. AU - Wang, R. AU - Wei, G. AU - Jiang, R. AU - Zheng, Y. AU - Tian, Y. AU - Chen, B. AU - Ye, C. AU - Xue, M. AU - Yu, C. DB - Embase DO - 10.3892/ol.2017.6648 IS - 3 LA - English M3 - Article N1 - L617554952 2017-08-02 2017-08-04 PY - 2017 SN - 1792-1082 1792-1074 SP - 3839-3845 ST - RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α T2 - Oncology Letters TI - RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617554952&from=export http://dx.doi.org/10.3892/ol.2017.6648 VL - 14 ID - 1797 ER - TY - JOUR AD - C. Zou, Department of Laboratory, Weihaiwei People’s Hospital, No. 70 Qingdao North Road, Weihai, Shandong, China AU - Sun, Y. AU - Fan, X. AU - Zhang, Q. AU - Shi, X. AU - Xu, G. AU - Zou, C. DB - Embase Medline DO - 10.1177/1010428317712592 IS - 7 LA - English M3 - Article N1 - L617650547 2017-08-15 2017-08-16 PY - 2017 SN - 1423-0380 1010-4283 SP - 1-10 ST - Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling T2 - Tumor Biology TI - Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617650547&from=export http://dx.doi.org/10.1177/1010428317712592 VL - 39 ID - 1798 ER - TY - JOUR AD - M.A. White, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX, United States AU - Eskiocak, B. AU - McMillan, E. A. AU - Mendiratta, S. AU - Kollipara, R. K. AU - Zhang, H. AU - Humphries, C. G. AU - Wang, C. AU - Garcia-Rodriguez, J. AU - Ding, M. AU - Zaman, A. AU - Rosales, T. I. AU - Eskiocak, U. AU - Smith, M. P. AU - Sudderth, J. AU - Komurov, K. AU - Deberardinis, R. J. AU - Wellbrock, C. AU - Davies, M. A. AU - Wargo, J. A. AU - Yu, Y. AU - De Brabander, J. K. AU - Williams, N. S. AU - Chin, L. AU - Rizos, H. AU - Long, G. V. AU - Kittler, R. AU - White, M. A. DB - Embase Medline DO - 10.1158/2159-8290.CD-16-0955 IS - 8 LA - English M3 - Article N1 - L617700053 2017-08-17 2017-08-21 PY - 2017 SN - 2159-8290 2159-8274 SP - 832-851 ST - Biomarker accessible and chemically addressable mechanistic subtypes of braf melanoma T2 - Cancer Discovery TI - Biomarker accessible and chemically addressable mechanistic subtypes of braf melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617700053&from=export http://dx.doi.org/10.1158/2159-8290.CD-16-0955 VL - 7 ID - 1799 ER - TY - JOUR AD - G. Koltsida, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Koltsida, G. AU - Piccione, J. AU - Tapia, I. AU - Phinizy, P. DB - Embase DO - 10.1164/ajrccm-conference.2017.B67. LA - English M3 - Conference Abstract N1 - L617707886 2017-08-15 PY - 2017 SN - 1535-4970 ST - Novel approach to inflammatory myofibroblastic bronchial tumor: a case report T2 - American Journal of Respiratory and Critical Care Medicine TI - Novel approach to inflammatory myofibroblastic bronchial tumor: a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617707886&from=export http://dx.doi.org/10.1164/ajrccm-conference.2017.B67. VL - 195 ID - 1800 ER - TY - JOUR AD - A. Jain, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research College of Nursing, Chandigarh, Punjab, India AU - Jain, A. AU - Gupta, N. DB - Embase Medline DO - 10.1136/bcr-2017-221250 LA - English M3 - Note N1 - L617723198 2017-08-18 2018-10-26 PY - 2017 SN - 1757-790X ST - 'Fatal journey of a cutaneous ulcer' T2 - BMJ Case Reports TI - 'Fatal journey of a cutaneous ulcer' UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617723198&from=export http://dx.doi.org/10.1136/bcr-2017-221250 VL - 2017 ID - 1801 ER - TY - JOUR AD - G. Tchernev, Department of Dermatology, Venereology and Dermatologic Surgery, Medical Institute of Ministry of Interior (MVR), General Skobelev 79, Sofia, Bulgaria AU - Tchernev, G. AU - Lozev, I. AU - Pidakev, I. AU - Lotti, T. AU - Wollina, U. AU - Gianfaldoni, S. AU - Lotti, J. AU - França, K. AU - Batashki, A. AU - Maximov, G. K. AU - Chokoeva, A. DB - Embase DO - 10.3889/oamjms.2017.121 IS - 4 Special Issue GlobalDermatology LA - English M3 - Article N1 - L617801813 2017-08-22 2017-08-25 PY - 2017 SN - 1857-9655 SP - 549-550 ST - Giant congenital melanocytic nevus (GCMN) - A new hope for targeted therapy? T2 - Open Access Macedonian Journal of Medical Sciences TI - Giant congenital melanocytic nevus (GCMN) - A new hope for targeted therapy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617801813&from=export http://dx.doi.org/10.3889/oamjms.2017.121 VL - 5 ID - 1802 ER - TY - JOUR AD - C.-y. Fan, Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yishan Road, Shanghai, China AU - Cheng, D. d AU - Zhu, B. AU - Li, S. j AU - Yuan, T. AU - Yang, Q. c AU - Fan, C. y DB - Embase DO - 10.7150/jca.19130 IS - 14 LA - English M3 - Article N1 - L618029868 2017-09-06 2017-09-13 PY - 2017 SN - 1837-9664 SP - 2720-2728 ST - Down-regulation of RPS9 inhibits osteosarcoma cell growth through inactivation of MAPK signaling pathway T2 - Journal of Cancer TI - Down-regulation of RPS9 inhibits osteosarcoma cell growth through inactivation of MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618029868&from=export http://dx.doi.org/10.7150/jca.19130 VL - 8 ID - 1803 ER - TY - GEN AD - J. Hochberg, Departments of Pediatrics, New York Medical College, Valhalla, NY, United States AU - Hochberg, J. AU - El-Mallawany, N. K. AU - Brugieres, L. AU - McMillan, A. AU - Cairo, M. S. DB - Embase DO - 10.1007/978-3-319-33679-4_4 J2 - Pediatr. Oncol. LA - English M1 - (Hochberg J., jessica_hochberg@nymc.edu; El-Mallawany N.K., nader_kim@nymc.edu; Cairo M.S., mitchell_cairo@nymc.edu) Departments of Pediatrics, New York Medical College, Valhalla, NY, United States M3 - Chapter N1 - L618183517 2017-09-19 2017-09-20 PY - 2017 SN - 2191-0812 1613-5318 SP - 69-117 ST - Non-Hodgkin Lymphoma TI - Non-Hodgkin Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618183517&from=export http://dx.doi.org/10.1007/978-3-319-33679-4_4 ID - 1804 ER - TY - GEN AD - A. Ferrari, Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian, 1, Milano, Italy AU - Ferrari, A. AU - Patel, S. R. AU - Wunder, J. AU - Albritton, K. H. DB - Embase DO - 10.1007/978-3-319-33679-4_15 J2 - Pediatr. Oncol. LA - English M1 - (Ferrari A., andrea.ferrari@istitutotumori.mi.it) Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian, 1, Milano, Italy M3 - Chapter N1 - L618183531 2017-09-19 PY - 2017 SN - 2191-0812 1613-5318 SP - 383-416 ST - Soft Tissue Sarcoma TI - Soft Tissue Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618183531&from=export http://dx.doi.org/10.1007/978-3-319-33679-4_15 ID - 1805 ER - TY - JOUR AD - R. He, Department of Clinical Genetics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning, China AU - Li, J. AU - Wang, J. AU - Zhou, W. AU - Zhang, S. AU - Le, Y. AU - He, R. DB - Embase DO - 10.3892/ol.2017.6770 IS - 4 LA - English M3 - Article N1 - L618214624 2017-09-13 2017-09-15 PY - 2017 SN - 1792-1082 1792-1074 SP - 4751-4757 ST - Downregulation of BRAF-Activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells T2 - Oncology Letters TI - Downregulation of BRAF-Activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618214624&from=export http://dx.doi.org/10.3892/ol.2017.6770 VL - 14 ID - 1806 ER - TY - JOUR AD - C.J. Burns, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia AU - McArthur, K. AU - D'Cruz, A. A. AU - Segal, D. AU - Lackovic, K. AU - Wilks, A. F. AU - O'Donnell, J. A. AU - Nowell, C. J. AU - Gerlic, M. AU - Huang, D. C. S. AU - Burns, C. J. AU - Croker, B. A. C1 - abt 737 abt 869 ac 220 ag 13958 akt i 1 akt i 1,2 amg tie2 1 ap 24534 as 252424 at 7519 at 9283 av 412 av 915 az 960 azd 6244 azd 7762 bez 235 bi 2536 bms 2 bms 3 bms 5 bx 795 bx 912 cc 401 ci 1033 ci 1040 cp 690550 cp 724714 cyc 116 e 7080 gd 0941 gsk 690693 gw 441756 ic 87114 jnj 38877605 jnj 7706621 ki 20227 ku 0063794 ku 55933 ku 57788 mp 470 pd 0325901 pf 04217903 pf 431396 pf 562271 pha 690509 pi 103 pik 294 pik 75 pik 90 pik 93 plx 4720 r 1487 rho 15 rwj 67657 sb 202190 sb 203580 sb 242235 sb 590885 sd 06 sd 169 smi 4a sns 032 sns 314 sr 3677 su 5402 su 6668 tak 715 tgx 221 vx 680 vx 702 ym 201636 C2 - SYN kinase(Australia) DB - Embase DO - 10.18632/oncotarget.19678 IS - 35 LA - English M3 - Article N1 - L618253787 2017-09-15 2017-09-21 PY - 2017 SN - 1949-2553 SP - 57948-57963 ST - Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia T2 - Oncotarget TI - Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618253787&from=export http://dx.doi.org/10.18632/oncotarget.19678 VL - 8 ID - 1807 ER - TY - JOUR AD - H. Wu, Department of Orthopedics, China–Japan Union Hospital of Jilin University, No. 126, Xiantai Street, Changchun, Jilin Province, China AU - Jiang, R. AU - Zhang, C. AU - Liu, G. AU - Gu, R. AU - Wu, H. DB - Embase Medline DO - 10.3727/096504017X14882829077237 IS - 8 LA - English M3 - Article N1 - L618512890 2017-10-05 2018-07-09 PY - 2017 SN - 1555-3906 0965-0407 SP - 1409-1419 ST - MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1 T2 - Oncology Research TI - MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618512890&from=export http://dx.doi.org/10.3727/096504017X14882829077237 VL - 25 ID - 1808 ER - TY - JOUR AD - M.G. Raga, Medical Oncology Department, Sagunto Hospital, Avenida Ramón y Cajal, s/n, Sagunto, Valencia, Spain AU - Raga, M. G. AU - González-Cruz, V. I. AU - Aguilera, M. J. S. C1 - bay43 9006(Bayer) nexavar(Onyx) C2 - Bayer Onyx DB - Embase IS - 1 LA - English M3 - Article N1 - L619466685 2017-12-05 2017-12-12 PY - 2017 SN - 1885-740X SP - 20-26 ST - Sorafenib in advanced hepatocellular carcinoma: Therapeutic approach and future research T2 - Cancer and Chemotherapy Reviews TI - Sorafenib in advanced hepatocellular carcinoma: Therapeutic approach and future research UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619466685&from=export VL - 12 ID - 1810 ER - TY - JOUR AD - D.C. Doval, Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India AU - Doval, D. C. AU - Sinha, R. AU - Batra, U. AU - Choudhury, K. D. AU - Azam, S. AU - Mehta, A. DB - Embase Medline DO - 10.4103/0019-509X.219591 IS - 1 LA - English M3 - Article N1 - L619849415 2017-12-25 2018-07-17 PY - 2017 SN - 1998-4774 0019-509X SP - 193-196 ST - Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center T2 - Indian Journal of Cancer TI - Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619849415&from=export http://dx.doi.org/10.4103/0019-509X.219591 VL - 54 ID - 1811 ER - TY - JOUR AD - Z. Li, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China AU - Wan, X. AU - Liu, R. AU - Li, Z. DB - Embase Medline DO - 10.1155/2017/5356737 LA - English M3 - Article N1 - L619904580 2017-12-29 2018-08-17 PY - 2017 SN - 2314-6141 2314-6133 ST - The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma T2 - BioMed Research International TI - The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619904580&from=export http://dx.doi.org/10.1155/2017/5356737 VL - 2017 ID - 1812 ER - TY - JOUR AD - N. Azarpira, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AU - Azarpira, N. AU - Safaie, A. AU - Monabati, A. AU - Hosseinzadeh, M. AU - Noori, S. AU - Moini, M. AU - Rahimi, A. AU - Heidari, T. AU - Rahsaz, M. DB - Embase DO - 10.22037/ghfbb.v0i0.1022 IS - 4 LA - English M3 - Article N1 - L619908851 2017-12-27 PY - 2017 SN - 2008-4234 2008-2258 SP - 332-336 ST - PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; A case report T2 - Gastroenterology and Hepatology from Bed to Bench TI - PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619908851&from=export http://dx.doi.org/10.22037/ghfbb.v0i0.1022 VL - 10 ID - 1813 ER - TY - JOUR AD - C. Lechler, II. Medizinische Klinik und Poliklinik, Klinikum Rechts der Isar, TU München, Munich, Germany AU - Lechler, C. AU - Roesner, T. AU - Kohnke-Ertel, B. AU - Saur, D. AU - Sage, J. AU - Schmid, R. M. AU - Ehmer, U. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L621223532 2018-03-19 PY - 2017 SN - 1600-0641 SP - S225-S226 ST - Role of RAS-dependent signaling pathways in hepatic carcinogenesis T2 - Journal of Hepatology TI - Role of RAS-dependent signaling pathways in hepatic carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621223532&from=export VL - 66 ID - 1815 ER - TY - JOUR AD - J.Z. Wilson, Saint Louis University, School of Medicine, St. Louis, MO, United States AU - Wilson, J. Z. AU - Moertel, C. L. AU - Miller, B. S. DB - Embase DO - 10.1159/000481424 LA - English M3 - Conference Abstract N1 - L627978030 2019-06-11 PY - 2017 SN - 1663-2826 SP - 515-516 ST - Increase in desmopressin duration of action during trametinib therapy in a child with optic pathway glioma complicated by central diabetes insipidus T2 - Hormone Research in Paediatrics TI - Increase in desmopressin duration of action during trametinib therapy in a child with optic pathway glioma complicated by central diabetes insipidus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627978030&from=export http://dx.doi.org/10.1159/000481424 VL - 88 ID - 1817 ER - TY - JOUR AD - A.L. Kung, Columbia University Medical Center, Department of Pediatrics, New York, NY, United States AU - Oberg, J. A. AU - Glade Bender, J. L. AU - Sulis, M. L. AU - Pendrick, D. AU - Sireci, A. N. AU - Hsiao, S. J. AU - Turk, A. T. AU - Dela Cruz, F. S. AU - Hibshoosh, H. AU - Remotti, H. AU - Zylber, R. J. AU - Pang, J. AU - Diolaiti, D. AU - Koval, C. AU - Andrews, S. J. AU - Garvin, J. H. AU - Yamashiro, D. J. AU - Chung, W. K. AU - Emerson, S. G. AU - Nagy, P. L. AU - Mansukhani, M. M. AU - Kung, A. L. DB - Embase Medline DO - 10.1186/s13073-016-0389-6 IS - 1 LA - English M3 - Article N1 - L613797608 2016-12-28 2017-01-23 PY - 2016 SN - 1756-994X ST - Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations T2 - Genome Medicine TI - Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613797608&from=export http://dx.doi.org/10.1186/s13073-016-0389-6 VL - 8 ID - 1819 ER - TY - JOUR AD - J.T. Dudley, 1 Gustave L Levy Place, New York, NY, United States AU - Smith, M. R. AU - Burman, P. AU - Sadahiro, M. AU - Kidd, B. A. AU - Dudley, J. T. AU - Morishita, H. DB - Embase Medline DO - 10.1523/ENEURO.0240-16.2016 IS - 6 LA - English M3 - Article N1 - L614172087 2017-02-02 2017-02-07 PY - 2016 SN - 2373-2822 ST - Integrative analysis of disease signatures shows inflammation disrupts juvenile experience-dependent cortical plasticity T2 - eNeuro TI - Integrative analysis of disease signatures shows inflammation disrupts juvenile experience-dependent cortical plasticity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614172087&from=export http://dx.doi.org/10.1523/ENEURO.0240-16.2016 VL - 3 ID - 1820 ER - TY - JOUR AD - D. Cao, Department of Radiology, The First hospital of Jilin University, XinMin Street 71, Chang Chun, China AU - Liu, L. AU - Kong, X. AU - Lu, X. AU - Cao, D. DB - Embase DO - 10.4081/cp.2016.853 IS - 4 LA - English M3 - Review N1 - L614248946 2017-02-07 2017-02-28 PY - 2016 SN - 2039-7283 2039-7275 SP - 113-116 ST - Pediatric endobronchial inflammatory myofibroblastic tumor: A case report and review of the literature T2 - Clinics and Practice TI - Pediatric endobronchial inflammatory myofibroblastic tumor: A case report and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614248946&from=export http://dx.doi.org/10.4081/cp.2016.853 VL - 6 ID - 1821 ER - TY - JOUR AD - K.G. Roberts AU - Roberts, K. G. AU - Bridges, O. AU - Janke, L. J. AU - Ebata, K. AU - Tuch, B. B. AU - Nanda, N. AU - Mullighan, C. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614224996 2017-02-01 PY - 2016 SN - 1528-0020 ST - Genetic modeling and therapeutic targeting of ETV6-NTRK3 with Loxo-101in acute lymphoblastic leukemia T2 - Blood TI - Genetic modeling and therapeutic targeting of ETV6-NTRK3 with Loxo-101in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614224996&from=export VL - 128 ID - 1822 ER - TY - JOUR AD - C. Tregnago AU - Tregnago, C. AU - Zampini, M. AU - Bisio, V. AU - Buldini, B. AU - Indraccolo, S. AU - Basso, G. AU - Locatelli, F. AU - Pigazzi, M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614225306 2017-02-01 PY - 2016 SN - 1528-0020 ST - New therapeutic opportunities for pediatric patients with T(6;11)-rearranged acute myeloid leukemia T2 - Blood TI - New therapeutic opportunities for pediatric patients with T(6;11)-rearranged acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614225306&from=export VL - 128 ID - 1823 ER - TY - JOUR AD - I.S. Jerchel AU - Jerchel, I. S. AU - Hoogkamer, A. Q. AU - Ariës, I. M. AU - Steeghs, E. M. P. AU - Boer, J. M. AU - Besselink, N. J. M. AU - Boeree, A. AU - Van De Ven, C. AU - De Groot-Kruseman, H. A. AU - De Haas, V. AU - Horstmann, M. A. AU - Escherich, G. AU - Stam, R. W. AU - Zwaan, C. M. AU - Cuppen, E. AU - Koudijs, M. J. AU - Pieters, R. AU - Den Boer, M. L. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614246633 2017-02-03 PY - 2016 SN - 1528-0020 ST - RAS pathway mutations as predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia T2 - Blood TI - RAS pathway mutations as predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614246633&from=export VL - 128 ID - 1824 ER - TY - JOUR AD - J. Gaynes AU - Gaynes, J. AU - Jonart, L. AU - Naumann, J. AU - Zamora, E. AU - Gossai, N. AU - Ebadi, M. AU - Gordon, P. M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247030 2017-02-03 PY - 2016 SN - 1528-0020 ST - The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance T2 - Blood TI - The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247030&from=export VL - 128 ID - 1825 ER - TY - JOUR AD - J.T. Leonard AU - Leonard, J. T. AU - Chang, B. H. AU - Tyner, J. W. AU - Hayes-Lattin, B. AU - Loriaux, M. M. AU - Druker, B. J. AU - Borate, U. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247113 2017-02-03 PY - 2016 SN - 1528-0020 ST - Novel targets identified by in vitro screening of patient samples with adult acute lymphoblastic leukemia T2 - Blood TI - Novel targets identified by in vitro screening of patient samples with adult acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247113&from=export VL - 128 ID - 1826 ER - TY - JOUR AD - A. Alhammer AU - Alhammer, A. AU - Case, M. AU - Blair, H. J. AU - Vormoor, J. AU - Irving, J. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247794 2017-02-03 PY - 2016 SN - 1528-0020 ST - Exploring pre-B cell receptor signalling as a therapeutic target in acute lymphoblastic leukaemia T2 - Blood TI - Exploring pre-B cell receptor signalling as a therapeutic target in acute lymphoblastic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247794&from=export VL - 128 ID - 1827 ER - TY - JOUR AD - M. Alzahrani AU - Alzahrani, M. AU - Savage, K. J. AU - Toze, C. L. AU - Sehn, L. H. AU - Broady, R. AU - Mourad, Y. A. AU - Barnett, M. J. AU - Forrest, D. L. AU - Gerrie, A. S. AU - Hogge, D. E. AU - Nantel, S. H. AU - Narayanan, S. AU - Nevill, T. J. AU - Power, M. M. AU - Sanford, D. AU - Scott, D. W. AU - Sutherland, H. J. AU - Villa, D. AU - O'Leary, H. AU - Connors, J. M. AU - Song, K. W. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614265721 2017-02-06 PY - 2016 SN - 1528-0020 ST - Outcome of patients with peripheral T-cell lymphoma undergoing allogeneic stem cell in British Columbia T2 - Blood TI - Outcome of patients with peripheral T-cell lymphoma undergoing allogeneic stem cell in British Columbia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614265721&from=export VL - 128 ID - 1828 ER - TY - JOUR AD - Y. Maeda AU - Maeda, Y. AU - Nishimori, H. AU - Hiramatsu, Y. AU - Yoshida, I. AU - Uno, M. AU - Masaki, Y. AU - Sunami, K. AU - Masunari, T. AU - Nawa, Y. AU - Gomyo, H. AU - Yamane, H. AU - Takahashi, T. AU - Yano, T. AU - Takimoto, H. AU - Matsuo, K. AU - Yoshino, T. AU - Tanimoto, M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614265735 2017-02-06 PY - 2016 SN - 1528-0020 ST - Dose-Adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: Multicenter phase II trial of west-jhog PTCL0707 T2 - Blood TI - Dose-Adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: Multicenter phase II trial of west-jhog PTCL0707 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614265735&from=export VL - 128 ID - 1829 ER - TY - JOUR AD - L. Bian, Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China AU - Wang, B. AU - Cui, Z. AU - Zhong, Z. AU - Sun, Y. AU - Yang, G. Y. AU - Sun, Q. AU - Bian, L. DB - Embase Medline DO - 10.1002/mc.22467 IS - 12 LA - English M3 - Article N1 - L608140507 2016-02-11 2016-12-06 PY - 2016 SN - 1098-2744 0899-1987 SP - 2268-2277 ST - The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges T2 - Molecular Carcinogenesis TI - The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608140507&from=export http://dx.doi.org/10.1002/mc.22467 VL - 55 ID - 1830 ER - TY - JOUR AD - S. He, Allergy and Clinical Immunology Research Centre, the First Affiliated Hospital of Liaoning Medical University, No. 2, Section 5, Renmin Street, Guta District, Jinzhou, Liaoning, China AU - Ge, S. AU - Li, T. AU - Yao, Q. AU - Yan, H. AU - Huiyun, Z. AU - Zheng, Y. AU - Zhang, B. AU - He, S. DB - Embase Medline DO - 10.1007/s10565-016-9353-x IS - 6 LA - English M3 - Article N1 - L611262173 2016-07-21 2017-03-10 PY - 2016 SN - 1573-6822 0742-2091 SP - 529-542 ST - Expression of proteinase-activated receptor (PAR)-2 in monocytes from allergic patients and potential molecular mechanism T2 - Cell Biology and Toxicology TI - Expression of proteinase-activated receptor (PAR)-2 in monocytes from allergic patients and potential molecular mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611262173&from=export http://dx.doi.org/10.1007/s10565-016-9353-x VL - 32 ID - 1831 ER - TY - JOUR AD - T.K. Olsen, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway AU - Olsen, T. K. AU - Panagopoulos, I. AU - Gorunova, L. AU - Micci, F. AU - Andersen, K. AU - Kilen Andersen, H. AU - Meling, T. R. AU - Due-Tønnessen, B. AU - Scheie, D. AU - Heim, S. AU - Brandal, P. DB - Embase Medline DO - 10.1002/gcc.22392 IS - 12 LA - English M3 - Article N1 - L611452772 2016-08-05 2016-11-30 PY - 2016 SN - 1098-2264 1045-2257 SP - 944-953 ST - Novel fusion genes and chimeric transcripts in ependymal tumors T2 - Genes Chromosomes and Cancer TI - Novel fusion genes and chimeric transcripts in ependymal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611452772&from=export http://dx.doi.org/10.1002/gcc.22392 VL - 55 ID - 1832 ER - TY - JOUR AD - H.-W. Yoo, Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, South Korea AU - Jhang, W. K. AU - Choi, J. H. AU - Lee, B. H. AU - Kim, G. H. AU - Yoo, H. W. DB - Embase Medline DO - 10.1007/s00246-016-1468-6 IS - 8 LA - English M3 - Article N1 - L611842075 2016-08-31 2016-12-14 PY - 2016 SN - 1432-1971 0172-0643 SP - 1539-1547 ST - Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies T2 - Pediatric Cardiology TI - Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611842075&from=export http://dx.doi.org/10.1007/s00246-016-1468-6 VL - 37 ID - 1833 ER - TY - JOUR AD - P. Zhang, Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China AU - Wang, Y. AU - Dai, X. AU - Liu, Y. AU - Li, J. AU - Liu, Z. AU - Yin, P. AU - Chen, J. AU - Wang, Y. AU - Wang, N. AU - Zhang, P. DB - Embase Medline DO - 10.1016/j.yjmcc.2016.10.012 LA - English M3 - Article N1 - L613221947 2016-11-28 2016-12-23 PY - 2016 SN - 1095-8584 0022-2828 SP - 1-10 ST - MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells T2 - Journal of Molecular and Cellular Cardiology TI - MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613221947&from=export http://dx.doi.org/10.1016/j.yjmcc.2016.10.012 VL - 101 ID - 1834 ER - TY - JOUR AD - Y. Jiang, Department of Genetic Diagnosis Center, Central Laboratory, First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin, China AU - Shi, X. AU - Lu, L. AU - Jin, X. AU - Liu, B. AU - Sun, X. AU - Lu, L. AU - Jiang, Y. DB - Embase Medline DO - 10.3892/mmr.2016.5923 IS - 6 LA - English M3 - Article N1 - L613505901 2016-12-07 2016-12-13 PY - 2016 SN - 1791-3004 1791-2997 SP - 5637-5643 ST - GRIN3A and MAPT stimulate nerve overgrowth in macrodactyly T2 - Molecular Medicine Reports TI - GRIN3A and MAPT stimulate nerve overgrowth in macrodactyly UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613505901&from=export http://dx.doi.org/10.3892/mmr.2016.5923 VL - 14 ID - 1837 ER - TY - JOUR AD - T. Tajiri, Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, 465 Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan AU - Tanaka, T. AU - Higashi, M. AU - Kimura, K. AU - Wakao, J. AU - Fumino, S. AU - Iehara, T. AU - Hosoi, H. AU - Sakai, T. AU - Tajiri, T. C1 - ch 5126766(Chugai) trametinib(LC) C2 - Chugai LC DB - Embase Medline DO - 10.1016/j.jpedsurg.2016.09.043 IS - 12 LA - English M3 - Article N1 - L613524343 2016-12-08 2016-12-14 PY - 2016 SN - 1531-5037 0022-3468 SP - 2074-2079 ST - MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy T2 - Journal of Pediatric Surgery TI - MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613524343&from=export http://dx.doi.org/10.1016/j.jpedsurg.2016.09.043 VL - 51 ID - 1838 ER - TY - JOUR AD - M. Fischer, University Children's Hospital of Cologne, Pediatric Oncology, Cologne, Germany AU - Fischer, M. AU - Wulff, B. AU - Baruchel, S. AU - Berlanga, P. AU - Trahair, T. AU - Mechinaud, F. AU - Schulte, J. AU - Modak, S. AU - Merks, J. H. AU - Zwaan, C. M. AU - Marshall, L. V. AU - Casanova, M. AU - Branle, F. AU - Malet, I. AU - Emeremni, A. C. AU - Geoerger, B. DB - Embase LA - English M3 - Conference Abstract N1 - L615060003 2017-04-04 PY - 2016 SN - 1879-0852 SP - S49-S50 ST - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population T2 - European Journal of Cancer TI - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615060003&from=export VL - 69 ID - 1840 ER - TY - JOUR AD - M. Berretta, Department of Medical Oncology, National Cancer Institute, Aviano, Italy AU - Berretta, M. AU - Rinaldi, L. AU - Di Benedetto, F. AU - Lleshi, A. AU - Re, V. D. AU - Facchini, G. AU - De Paoli, P. AU - Di Francia, R. C1 - abt 869 amg 386 azd 2171 bay 869766 ptk 787 DB - Embase DO - 10.3389/fphar.2016.00428 IS - NOV LA - English M3 - Review N1 - L613625705 2016-12-19 2017-01-17 PY - 2016 SN - 1663-9812 ST - Angiogenesis inhibitors for the treatment of hepatocellular carcinoma T2 - Frontiers in Pharmacology TI - Angiogenesis inhibitors for the treatment of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613625705&from=export http://dx.doi.org/10.3389/fphar.2016.00428 VL - 7 ID - 1842 ER - TY - JOUR AD - S.R.C. Toledo, Department of Pediatrics, Genetics Laboratory, Pediatric Oncology Institute (IOP/GRAACC), Federal University of São Paulo, São Paulo-SP, Brazil AU - Tesser-Gamba, F. AU - Lopes, L. J. D. S. AU - Petrilli, A. S. AU - Toledo, S. R. C. DB - Embase Medline DO - 10.1002/mc.22420 IS - 11 LA - English M3 - Article N1 - L607356012 2015-12-29 2016-10-14 PY - 2016 SN - 1098-2744 0899-1987 SP - 1700-1713 ST - MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma T2 - Molecular Carcinogenesis TI - MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607356012&from=export http://dx.doi.org/10.1002/mc.22420 VL - 55 ID - 1843 ER - TY - JOUR AD - S.H. Lee, Department of Otorhinolaryngology–Head & Neck Surgery, College of Medicine, Korea University, Seoul, South Korea AU - Kim, H. K. AU - Kook, J. H. AU - Kang, K. R. AU - Oh, D. J. AU - Kim, T. H. AU - Lee, S. H. DB - Embase Medline DO - 10.1002/lary.26109 IS - 11 LA - English M3 - Article N1 - L611063961 2016-07-08 2016-11-08 PY - 2016 SN - 1531-4995 0023-852X SP - E347-E355 ST - Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC T2 - Laryngoscope TI - Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611063961&from=export http://dx.doi.org/10.1002/lary.26109 VL - 126 ID - 1845 ER - TY - JOUR AD - T. Burke, Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States AU - Burke, T. AU - Chakraborty, R. AU - Hampton, O. AU - Zinn, D. AU - Scull, B. AU - Abhyankar, H. AU - Kumar, V. AU - Kakkar, N. AU - McClain, K. AU - Wheeler, D. AU - Roy, A. AU - Parsons, D. W. AU - Allen, C. DB - Embase DO - 10.1002/pbc.26239 LA - English M3 - Conference Abstract N1 - L612112364 2016-09-15 PY - 2016 SN - 1545-5009 SP - S13-S14 ST - Identification of novel braf alterations in LCH using an integrated genomic pipeline T2 - Pediatric Blood and Cancer TI - Identification of novel braf alterations in LCH using an integrated genomic pipeline UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612112364&from=export http://dx.doi.org/10.1002/pbc.26239 VL - 63 ID - 1847 ER - TY - JOUR AD - M. Ben Arush, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Joan and Sanford Weill Paediatric Haematology Oncology, Haifa, Israel AU - Ben Arush, M. AU - Mordechai, O. AU - Ben Barak, A. AU - Zaidman, I. AU - Postovsky, S. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612592670 2016-11-11 PY - 2016 SN - 1545-5017 SP - S274 ST - Biological therapy in refractory solid tumors as palliative care T2 - Pediatric Blood and Cancer TI - Biological therapy in refractory solid tumors as palliative care UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612592670&from=export http://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 1848 ER - TY - JOUR AD - T. Trippett, Memorial Sloan Kettering Cancer Center, Department of Paediatrics, New York, United States AU - Trippett, T. AU - Simko, S. AU - Ye, C. AU - Caron, H. AU - Geoerger, B. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593192 2016-11-11 PY - 2016 SN - 1545-5017 SP - S210 ST - iMATRIXcobi: A phase I/II, dose-escalation study of the safety, pharmacokinetics, and preliminary efficacy of cobimetinib in paediatric and young adult patients with refractory/relapsed tumours T2 - Pediatric Blood and Cancer TI - iMATRIXcobi: A phase I/II, dose-escalation study of the safety, pharmacokinetics, and preliminary efficacy of cobimetinib in paediatric and young adult patients with refractory/relapsed tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593192&from=export http://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 1849 ER - TY - JOUR AD - K. Katsibardi, Aghia Sophia Children's Hospital, Paediatric Haematology Oncology, Athens, Greece AU - Katsibardi, K. AU - Tourkantoni, N. AU - Roka, K. AU - Avgerinou, G. AU - Filippidou, M. AU - Tsipou, H. AU - Kattamis, A. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593203 2016-11-11 PY - 2016 SN - 1545-5017 SP - S180-S181 ST - Targeted therapy with brentuximab vedotin as a bridge to bone marrow transplantation in children with relapsed anaplastic lymphoma T2 - Pediatric Blood and Cancer TI - Targeted therapy with brentuximab vedotin as a bridge to bone marrow transplantation in children with relapsed anaplastic lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593203&from=export http://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 1850 ER - TY - JOUR AD - M. Csóka, Semmelweis University, 2nd Department of Paediatrics, Budapest, Hungary AU - Csóka, M. AU - Felkai, L. AU - Bánusz, R. AU - Váradi, Z. AU - Garami, M. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593287 2016-11-11 PY - 2016 SN - 1545-5017 SP - S259 ST - Alk status determination and crizotinib therapy in high risk neuroblastoma and soft tissue sarcoma T2 - Pediatric Blood and Cancer TI - Alk status determination and crizotinib therapy in high risk neuroblastoma and soft tissue sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593287&from=export http://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 1851 ER - TY - JOUR AD - G. Miculschi, Clinical Municipal Hospital, Paediatrics, Oradea, Romania AU - Miculschi, G. AU - Pop, O. AU - Baican, V. AU - Burca, C. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593408 2016-11-11 PY - 2016 SN - 1545-5017 SP - S182 ST - Anaplastic large cell lymphoma: Is it secondary or concurrent with castleman disease? T2 - Pediatric Blood and Cancer TI - Anaplastic large cell lymphoma: Is it secondary or concurrent with castleman disease? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593408&from=export http://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 1852 ER - TY - JOUR AD - L. Moreno, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Niño Jesús, Avenida Menéndez Pelayo 65, Madrid, Spain AU - Bautista, F. AU - Van der Lugt, J. AU - Kearns, P. R. AU - Mussai, F. J. AU - Zwaan, C. M. AU - Moreno, L. C1 - abt 199 epz 5676 DB - Embase Medline DO - 10.1080/17460441.2016.1237939 IS - 11 LA - English M3 - Review N1 - L612671267 2016-10-18 2016-11-02 PY - 2016 SN - 1746-045X 1746-0441 SP - 1111-1122 ST - The development of targeted new agents to improve the outcome for children with leukemia T2 - Expert Opinion on Drug Discovery TI - The development of targeted new agents to improve the outcome for children with leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612671267&from=export http://dx.doi.org/10.1080/17460441.2016.1237939 VL - 11 ID - 1853 ER - TY - JOUR AD - M. Han, Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Wang, H. AU - Wu, D. AU - Wang, X. AU - Chen, G. AU - Zhang, Y. AU - Yan, W. AU - Luo, X. AU - Han, M. AU - Ning, Q. DB - Embase Medline DO - 10.1515/hsz-2015-0290 IS - 11 LA - English M3 - Article N1 - L612802859 2016-11-09 2016-11-23 PY - 2016 SN - 1437-4315 1431-6730 SP - 1173-1185 ST - Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways T2 - Biological Chemistry TI - Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612802859&from=export http://dx.doi.org/10.1515/hsz-2015-0290 VL - 397 ID - 1854 ER - TY - JOUR AD - X. Shi, Department of Pediatrics, Women and Infants Hospital of Zhengzhou, 41 Jinshui Road, Zhengzhou, Henan, China AU - Ren, H. AU - Shi, X. AU - Li, Y. DB - Embase DO - 10.3892/etm.2016.3776 IS - 5 LA - English M3 - Article N1 - L612826432 2016-10-25 2016-10-28 PY - 2016 SN - 1792-1015 1792-0981 SP - 3425-3432 ST - Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas T2 - Experimental and Therapeutic Medicine TI - Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612826432&from=export http://dx.doi.org/10.3892/etm.2016.3776 VL - 12 ID - 1855 ER - TY - JOUR AD - S.M. Pfister, Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany AU - Bender, S. AU - Gronych, J. AU - Warnatz, H. J. AU - Hutter, B. AU - Gröbner, S. AU - Ryzhova, M. AU - Pfaff, E. AU - Hovestadt, V. AU - Weinberg, F. AU - Halbach, S. AU - Kool, M. AU - Northcott, P. A. AU - Sturm, D. AU - Bjerke, L. AU - Zichner, T. AU - Stütz, A. M. AU - Schramm, K. AU - Huang, B. AU - Buchhalter, I. AU - Heinold, M. AU - Risch, T. AU - Worst, B. C. AU - Van Tilburg, C. M. AU - Weber, U. D. AU - Zapatka, M. AU - Raeder, B. AU - Milford, D. AU - Heiland, S. AU - Von Kalle, C. AU - Previti, C. AU - Lawerenz, C. AU - Kulozik, A. E. AU - Unterberg, A. AU - Witt, O. AU - Von Deimling, A. AU - Capper, D. AU - Truffaux, N. AU - Grill, J. AU - Jabado, N. AU - Sehested, A. M. AU - Sumerauer, D. AU - Brahim, D. H. B. AU - Trabelsi, S. AU - Ng, H. K. AU - Zagzag, D. AU - Allen, J. C. AU - Karajannis, M. A. AU - Gottardo, N. G. AU - Jones, C. AU - Korbel, J. O. AU - Schmidt, S. AU - Wolf, S. AU - Reifenberger, G. AU - Felsberg, J. AU - Brors, B. AU - Herold-Mende, C. AU - Lehrach, H. AU - Brummer, T. AU - Korshunov, A. AU - Eils, R. AU - Yaspo, M. L. AU - Pfister, S. M. AU - Lichter, P. AU - Jones, D. T. W. DB - Embase Medline DO - 10.1038/nm.4204 IS - 11 LA - English M3 - Article N1 - L612827553 2016-10-25 2019-10-31 PY - 2016 SN - 1546-170X 1078-8956 SP - 1314-1320 ST - Recurrent MET fusion genes represent a drug target in pediatric glioblastoma T2 - Nature Medicine TI - Recurrent MET fusion genes represent a drug target in pediatric glioblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612827553&from=export http://dx.doi.org/10.1038/nm.4204 VL - 22 ID - 1856 ER - TY - JOUR AD - L.C. Lee, University of Cambridge, Cambridge, United Kingdom AU - Lee, L. C. AU - Han, M. AU - Luo, J. AU - Turner, S. DB - Embase IS - 6 LA - English M3 - Conference Abstract N1 - L613102105 2016-11-10 PY - 2016 SN - 1943-7811 SP - 1003 ST - CRISPR-based genome-wide knockout and overexpression screens identify novel and putative acquired resistance mechanisms to pharmacological inhibition of ALK in human neuroblastoma cell lines T2 - Journal of Molecular Diagnostics TI - CRISPR-based genome-wide knockout and overexpression screens identify novel and putative acquired resistance mechanisms to pharmacological inhibition of ALK in human neuroblastoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613102105&from=export VL - 18 ID - 1857 ER - TY - JOUR AD - D.L. Durden, Department of Pediatrics, Moores Cancer Center, University of California, 3855 Health Sciences Drive, San Diego, CA, United States AU - Singh, A. R. AU - Joshi, S. AU - Burgoyne, A. M. AU - Sicklick, J. K. AU - Ikeda, S. AU - Kono, Y. AU - Garlich, J. R. AU - Morales, G. A. AU - Durden, D. L. C1 - ly 294002 sf 1126 DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0976 IS - 11 LA - English M3 - Article N1 - L613162498 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2553-2562 ST - Single agent and synergistic activity of the "first-in-class" dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma T2 - Molecular Cancer Therapeutics TI - Single agent and synergistic activity of the "first-in-class" dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162498&from=export http://dx.doi.org/10.1158/1535-7163.MCT-15-0976 VL - 15 ID - 1858 ER - TY - JOUR AD - J. Lin, Department of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, 655 W Baltimore S, Baltimore, MD, United States AU - Wu, X. AU - Cao, Y. AU - Xiao, H. AU - Li, C. AU - Lin, J. DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0921 IS - 11 LA - English M3 - Article N1 - L613162523 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2609-2619 ST - Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy T2 - Molecular Cancer Therapeutics TI - Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162523&from=export http://dx.doi.org/10.1158/1535-7163.MCT-15-0921 VL - 15 ID - 1859 ER - TY - JOUR AD - R. Landgraf, Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Box 016129 (R-629), Miami, FL, United States AU - Liu, W. AU - Barnette, A. R. AU - Andreansky, S. AU - Landgraf, R. C2 - Chromadex LC DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0932 IS - 11 LA - English M3 - Article N1 - L613162561 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2750-2757 ST - ERBB2 overexpression establishes ERBB3-dependent hypersensitivity of breast cancer cells to withaferin A T2 - Molecular Cancer Therapeutics TI - ERBB2 overexpression establishes ERBB3-dependent hypersensitivity of breast cancer cells to withaferin A UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162561&from=export http://dx.doi.org/10.1158/1535-7163.MCT-15-0932 VL - 15 ID - 1860 ER - TY - JOUR AD - R. Baisya, Medical College and Hospital, Kolkata, India AU - Baisya, R. AU - Bhattacharjee, U. AU - Chattopadhyay, K. AU - Biswas, T. DB - Embase DO - 10.1007/s12288-016-0728-1 LA - English M3 - Conference Abstract N1 - L613199944 2016-11-30 PY - 2016 SN - 0974-0449 SP - S436 ST - ALK negative systemic anaplastic large cell lymphoma presenting with breast mass and paraparesis in an adult female-a case report T2 - Indian Journal of Hematology and Blood Transfusion TI - ALK negative systemic anaplastic large cell lymphoma presenting with breast mass and paraparesis in an adult female-a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613199944&from=export http://dx.doi.org/10.1007/s12288-016-0728-1 VL - 32 ID - 1861 ER - TY - JOUR AD - B. Machaliński, Department of General Pathology, Pomeranian Medical University, Powstancow Wlkp. 72, Szczecin, Poland AU - Pius-Sadowska, E. AU - Kawa, M. P. AU - Kłos, P. AU - Rogińska, D. AU - Rudnicki, M. AU - Boehlke, M. AU - Waloszczyk, P. AU - Machaliński, B. DB - Embase Medline DO - 10.1667/RR14457.1 IS - 5 LA - English M3 - Article N1 - L613318388 2016-11-25 2016-12-22 PY - 2016 SN - 1938-5404 0033-7587 SP - 489-507 ST - Alteration of Selected Neurotrophic Factors and their Receptor Expression in Mouse Brain Response to Whole-Brain Irradiation T2 - Radiation Research TI - Alteration of Selected Neurotrophic Factors and their Receptor Expression in Mouse Brain Response to Whole-Brain Irradiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613318388&from=export http://dx.doi.org/10.1667/RR14457.1 VL - 186 ID - 1862 ER - TY - JOUR AD - A.M. Martelli, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy AU - Lonetti, A. AU - Cappellini, A. AU - Bertaina, A. AU - Locatelli, F. AU - Pession, A. AU - Buontempo, F. AU - Evangelisti, C. AU - Evangelisti, C. AU - Orsini, E. AU - Zambonin, L. AU - Neri, L. M. AU - Martelli, A. M. AU - Chiarini, F. C1 - abt 199(Selleck,United States) zstk 474(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.1186/s13045-016-0344-4 IS - 1 LA - English M3 - Article N1 - L612885970 2016-10-31 2016-11-09 PY - 2016 SN - 1756-8722 SP - 1-16 ST - Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway T2 - Journal of Hematology and Oncology TI - Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612885970&from=export http://dx.doi.org/10.1186/s13045-016-0344-4 VL - 9 ID - 1863 ER - TY - JOUR AD - K.D. Burman, Division of Endocrinology, Department of 41 Medicine, MedStar Washington Hospital Center, 110 Irving Street Northwest, Washington, DC, United States AU - Bikas, A. AU - Vachhani, S. AU - Jensen, K. AU - Vasko, V. AU - Burman, K. D. DB - Embase DO - 10.1080/17512433.2016.1204230 IS - 10 LA - English M3 - Review N1 - L612316838 2016-09-28 2016-11-02 PY - 2016 SN - 1751-2441 1751-2433 SP - 1299-1313 ST - Targeted therapies in thyroid cancer: an extensive review of the literature T2 - Expert Review of Clinical Pharmacology TI - Targeted therapies in thyroid cancer: an extensive review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612316838&from=export http://dx.doi.org/10.1080/17512433.2016.1204230 VL - 9 ID - 1864 ER - TY - JOUR AD - R. Pezzani, Endocrinology Unit, Department of Medicine, University of Padova, Via Ospedale 105, Padova, Italy AU - Pezzani, R. AU - Rubin, B. AU - Bertazza, L. AU - Redaelli, M. AU - Barollo, S. AU - Monticelli, H. AU - Baldini, E. AU - Mian, C. AU - Mucignat, C. AU - Scaroni, C. AU - Mantero, F. AU - Ulisse, S. AU - Iacobone, M. AU - Boscaro, M. C1 - sns 314(Selleck) vx 680(Selleck) zm 447439(Selleck) C2 - Selleck Sigma Aldrich(Italy) DB - Embase Medline DO - 10.1007/s10637-016-0358-3 IS - 5 LA - English M3 - Article N1 - L610386009 2016-05-24 2016-09-12 PY - 2016 SN - 1573-0646 0167-6997 SP - 531-540 ST - The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line T2 - Investigational New Drugs TI - The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610386009&from=export http://dx.doi.org/10.1007/s10637-016-0358-3 VL - 34 ID - 1865 ER - TY - JOUR AD - P.S. Thorner, Division of Pathology, Hospital for Sick Children, Toronto, Canada AU - Thorner, P. S. AU - Shago, M. AU - Marrano, P. AU - Shaikh, F. AU - Somers, G. R. DB - Embase Medline DO - 10.1016/j.prp.2016.07.004 IS - 10 LA - English M3 - Article N1 - L611342082 2016-07-27 2016-12-02 PY - 2016 SN - 1618-0631 0344-0338 SP - 937-942 ST - TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation T2 - Pathology Research and Practice TI - TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611342082&from=export http://dx.doi.org/10.1016/j.prp.2016.07.004 VL - 212 ID - 1866 ER - TY - JOUR AD - R.K. Gutti, Stem Cells and Haematological Disorders Laboratory, Department of Biochemistry, School of Life Sciences, University of Hyderabad, (PO) Gachibowli, Hyderabad, Telangana, India AU - Undi, R. B. AU - Gutti, U. AU - Gutti, R. K. DB - Embase Medline DO - 10.1016/j.biocel.2016.08.009 LA - English M3 - Article N1 - L611639834 2016-08-19 2016-08-23 PY - 2016 SN - 1878-5875 1357-2725 SP - 61-68 ST - Role of let-7b/Fzd4 axis in mitochondrial biogenesis through wnt signaling: In neonatal and adult megakaryocytes T2 - International Journal of Biochemistry and Cell Biology TI - Role of let-7b/Fzd4 axis in mitochondrial biogenesis through wnt signaling: In neonatal and adult megakaryocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611639834&from=export http://dx.doi.org/10.1016/j.biocel.2016.08.009 VL - 79 ID - 1867 ER - TY - JOUR AD - M.B. Fernández, Department of Pediatric Hemato-Oncology, Hospital 12 de Octubre, Madrid, Spain AU - Fernández, M. B. AU - Alonso, V. P. DB - Embase DO - 10.1007/s00381-016-3132-0 IS - 10 LA - English M3 - Article N1 - L612281100 2016-09-28 2016-10-27 PY - 2016 SN - 1433-0350 0256-7040 SP - 1939-1945 ST - Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas T2 - Child's Nervous System TI - Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612281100&from=export http://dx.doi.org/10.1007/s00381-016-3132-0 VL - 32 ID - 1868 ER - TY - JOUR AD - L. Byer, School of Medicine, University of California, San Francisco (UCSF), 513 Parnassus Ave, San Francisco, CA, United States AU - Byer, L. AU - Kline, C. AU - Mueller, S. C1 - pd 0325901 DB - Embase Medline DO - 10.2217/cns-2016-0016 IS - 4 LA - English M3 - Review N1 - L612480011 2016-10-07 2016-10-12 PY - 2016 SN - 2045-0915 2045-0907 SP - 233-239 ST - Clinical trials in pediatric neuro-oncology: What is missing and how we can improve T2 - CNS Oncology TI - Clinical trials in pediatric neuro-oncology: What is missing and how we can improve UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612480011&from=export http://dx.doi.org/10.2217/cns-2016-0016 VL - 5 ID - 1869 ER - TY - JOUR AD - J.M. Llovet, Icahn School of Medicine at Mount Sinai, New York, NY, United States AU - Llovet, J. M. AU - Merle, P. AU - Weiss, K. H. AU - Yau, T. AU - Ross, P. AU - Mazzaferro, V. AU - Blanc, J. F. AU - Ma, Y. T. AU - Yen, C. J. AU - Kocsis, J. AU - Choo, S. P. AU - Sukeepaisarnjaroen, W. AU - Gérolami, R. AU - Dufour, J. F. AU - Gane, E. J. AU - Ryoo, B. Y. AU - Peck-Radosavljevic, M. AU - Dao, T. AU - Yeo, W. AU - Lamlertthon, W. AU - Thongsawat, S. AU - Teufel, M. AU - Krissel, H. AU - Lim, H. Y. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612594775 2016-11-11 PY - 2016 SN - 0270-9139 SP - 621A ST - Phase II studies with refametinib or refametinib plus sorafenib in patients with mutant RAS hepatocellular carcinoma (HCC) T2 - Hepatology TI - Phase II studies with refametinib or refametinib plus sorafenib in patients with mutant RAS hepatocellular carcinoma (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612594775&from=export VL - 64 ID - 1870 ER - TY - JOUR AD - O. Kuchuk, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute, New York, NY, United States AU - Kuchuk, O. AU - Akers, N. AU - Sia, D. AU - Simon-Coma, M. AU - Martinez-Quetglas, I. AU - Gambato, M. AU - Nonell, L. AU - Mallo, M. AU - Carrillo, J. AU - Cairo, S. AU - Guettier, C. AU - Branchereau, S. AU - Buendia, M. A. AU - Vázquez, M. AU - Royo, L. AU - Pedersen, K. AU - Sala, M. AU - Sarrias, M. R. AU - Mazzaferro, V. AU - Losic, B. AU - Armengol, C. AU - Llovet, J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612595102 2016-11-11 PY - 2016 SN - 0270-9139 SP - 243A ST - IGF signaling is a promising target for molecular therapies of hepatoblastoma T2 - Hepatology TI - IGF signaling is a promising target for molecular therapies of hepatoblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612595102&from=export VL - 64 ID - 1871 ER - TY - JOUR AD - H. Okada, Department of Gastroenterology, Kanazawa University, Ishikawa, Japan AU - Okada, H. AU - Honda, M. AU - S. Campbell, J. AU - Takabatake, R. AU - Takegoshi, K. AU - Yamashita, T. AU - Shirasaki, T. AU - Tanaka, T. AU - Kaneko, S. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612595199 2016-11-11 PY - 2016 SN - 0270-9139 SP - 244A ST - Promoted liver fibrosis and malignant phenotype in HCV/PDGF-C transgenic mice are accompanied by abnormal expression of the glycolysis-related gene pyruvate kinase M T2 - Hepatology TI - Promoted liver fibrosis and malignant phenotype in HCV/PDGF-C transgenic mice are accompanied by abnormal expression of the glycolysis-related gene pyruvate kinase M UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612595199&from=export VL - 64 ID - 1872 ER - TY - JOUR AD - E. Degui, Pharmacy, IUCT Oncopole Toulouse, Toulouse, France AU - Degui, E. AU - Vinson, C. AU - Pelagatti, V. C. AU - Canonge, J. M. AU - Puisset, F. DB - Embase DO - 10.1007/s11096-016-0347-9 IS - 5 LA - English M3 - Conference Abstract N1 - L612648476 2016-10-17 PY - 2016 SN - 2210-7711 SP - 1338 ST - Pharmacist counselling for outpatient treated by oral chemotherapy T2 - International Journal of Clinical Pharmacy TI - Pharmacist counselling for outpatient treated by oral chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612648476&from=export http://dx.doi.org/10.1007/s11096-016-0347-9 VL - 38 ID - 1873 ER - TY - JOUR AD - T. Matsuguchi, Department of Oral Biochemistry, Kagoshima University Graduate School of Medical and Dental Sciences, Japan AU - Hisadome, M. AU - Ohnishi, T. AU - Kakimoto, K. AU - Kusuyama, J. AU - Bandow, K. AU - Kanekura, T. AU - Matsuguchi, T. DB - Embase Medline DO - 10.1002/1873-3468.12452 IS - 20 LA - English M3 - Letter N1 - L612856043 2016-10-25 2016-11-15 PY - 2016 SN - 1873-3468 0014-5793 SP - 3595-3605 ST - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes T2 - FEBS Letters TI - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612856043&from=export http://dx.doi.org/10.1002/1873-3468.12452 VL - 590 ID - 1874 ER - TY - JOUR AD - J.S. Spat, New York, NY, United States AU - Spat, J. S. AU - Murphy, H. AU - Keatley, E. AU - Mandelbaum, S. AU - Stein, V. AU - Viqar, F. AU - Smity-Hyle, E. AU - Suzuki, J. AU - Bono, A. AU - Martinez, C. AU - Bender, H. A. DB - Embase DO - 10.1002/ana.24759 LA - English M3 - Conference Abstract N1 - L612892245 2016-11-10 PY - 2016 SN - 1531-8249 SP - S103-S104 ST - Cognitive, behavioral and social functioning of a child with cardiofaciocutaneous syndrome and co-occurring leukemia: A case study T2 - Annals of Neurology TI - Cognitive, behavioral and social functioning of a child with cardiofaciocutaneous syndrome and co-occurring leukemia: A case study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612892245&from=export http://dx.doi.org/10.1002/ana.24759 VL - 80 ID - 1875 ER - TY - JOUR AD - J.H. Aldrink, Division of Pediatric Surgery, Department of Surgery, Nationwide Childrens Hospital, The Ohio State University College of Medicine, Nationwide Childrens Dr, FB Suite 6B.1, Columbus, Ohio, United States AU - Tracy, E. T. AU - Aldrink, J. H. DB - Embase Medline DO - 10.1053/j.sempedsurg.2016.09.010 IS - 5 LA - English M3 - Article N1 - L613650817 2016-12-16 2017-01-12 PY - 2016 SN - 1532-9453 1055-8586 SP - 290-298 ST - Pediatric melanoma T2 - Seminars in Pediatric Surgery TI - Pediatric melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613650817&from=export http://dx.doi.org/10.1053/j.sempedsurg.2016.09.010 VL - 25 ID - 1876 ER - TY - JOUR AD - Q. Zhou, Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, United States AU - Zhou, Q. AU - Yu, X. AU - Demirkaya, E. AU - Deuitch, N. AU - Stone, D. L. AU - Tsai, W. L. AU - Wang, H. AU - Park, Y. H. AU - Ombrello, A. K. AU - Romeo, T. AU - Remmers, E. F. AU - Chae, J. J. AU - Gadina, M. G. AU - Welch, S. B. AU - Ozen, S. AU - Topaloglu, R. AU - Abinun, M. AU - Kastner, D. L. AU - Aksentijevich, I. DB - Embase DO - 10.1002/art.39977 LA - English M3 - Conference Abstract N1 - L613888182 2017-01-02 PY - 2016 SN - 2326-5205 SP - 1329-1330 ST - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease T2 - Arthritis and Rheumatology TI - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613888182&from=export http://dx.doi.org/10.1002/art.39977 VL - 68 ID - 1877 ER - TY - JOUR AD - Y.-J. Yang, College of Animal Medicine, Jilin University, No. 5333 Xi'an Road, Changchun, China AU - Lei, Q. Q. AU - Hu, G. Q. AU - Chen, W. AU - Yu, S. X. AU - Qi, S. AU - Du, C. T. AU - Gu, J. M. AU - Lin, T. J. AU - Yang, Y. J. DB - Embase Medline DO - 10.1016/j.molimm.2016.07.009 LA - English M3 - Article N1 - L611294203 2016-07-26 2016-08-05 PY - 2016 SN - 1872-9142 0161-5890 SP - 26-33 ST - RCAN1 deficiency protects against Salmonella intestinal infection by modulating JNK activation T2 - Molecular Immunology TI - RCAN1 deficiency protects against Salmonella intestinal infection by modulating JNK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611294203&from=export http://dx.doi.org/10.1016/j.molimm.2016.07.009 VL - 77 ID - 1878 ER - TY - JOUR AU - Wang, M. AU - Li, Y. AU - Zhou, K. AU - Zhang, G. AU - Wang, Y. AU - Liu, T. AU - Zhang, Y. AU - Guo, A. AU - An, Y. DB - Embase Medline DO - 10.1159/000447796 IS - 3 LA - English M3 - Article N1 - L611674653 2016-08-19 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 860-870 ST - Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism T2 - Cellular Physiology and Biochemistry TI - Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611674653&from=export http://dx.doi.org/10.1159/000447796 VL - 39 ID - 1879 ER - TY - JOUR AU - Graff, Z. AU - Mendoza, G. AU - Barche, A. AU - Turner, C. DB - Embase Medline DO - 10.1542/pir.2016-0034 IS - 9 LA - English M3 - Article N1 - L612036359 2016-09-13 2016-09-28 PY - 2016 SN - 1526-3347 0191-9601 SP - 399-401 ST - Two black eschars in a 6-year-old girl T2 - Pediatrics in Review TI - Two black eschars in a 6-year-old girl UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612036359&from=export http://dx.doi.org/10.1542/pir.2016-0034 VL - 37 ID - 1880 ER - TY - JOUR AD - J. Lin, Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children’s Hospital, Department of Pediatrics, The Ohio State University, 700 Children’s Drive, Columbus, OH, United States AU - Wu, X. AU - Xiao, H. AU - Wang, R. AU - Liu, L. AU - Li, C. AU - Lin, J. C1 - azd6244(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.2174/1568009615666150916093110 IS - 7 LA - English M3 - Article N1 - L612155724 2016-09-19 2016-09-22 PY - 2016 SN - 1873-5576 1568-0096 SP - 631-638 ST - Persistent GP130/STAT3 signaling contributes to the resistance of doxorubicin, cisplatin, and MEK inhibitor in human rhabdomyosarcoma cells T2 - Current Cancer Drug Targets TI - Persistent GP130/STAT3 signaling contributes to the resistance of doxorubicin, cisplatin, and MEK inhibitor in human rhabdomyosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612155724&from=export http://dx.doi.org/10.2174/1568009615666150916093110 VL - 16 ID - 1881 ER - TY - JOUR AD - E. Saleh, Department of Pediatrics, Division of Pediatric Infectious Diseases, Duke Clinical Vaccine Unit, Duke University School of Medicine, 2608 Erwin Road, Suite 210, Durham, NC, United States AU - Saleh, E. AU - Moody, M. A. AU - Walter, E. B. DB - Embase Medline DO - 10.1080/21645515.2016.1183077 IS - 9 LA - English M3 - Review N1 - L612233240 2016-09-22 2016-09-30 PY - 2016 SN - 2164-554X 2164-5515 SP - 2391-2402 ST - Effect of antipyretic analgesics on immune responses to vaccination T2 - Human Vaccines and Immunotherapeutics TI - Effect of antipyretic analgesics on immune responses to vaccination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612233240&from=export http://dx.doi.org/10.1080/21645515.2016.1183077 VL - 12 ID - 1882 ER - TY - JOUR AD - J.S. Hwang, Department of Genetic Engineering & Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, South Korea AU - Joo, Y. A. AU - Chung, H. AU - Yoon, S. AU - Park, J. I. AU - Lee, J. E. AU - Myung, C. H. AU - Hwang, J. S. C2 - Greenpharma(France) DB - Embase DO - 10.4062/biomolther.2016.011 IS - 5 LA - English M3 - Article N1 - L612291406 2016-09-27 2016-10-03 PY - 2016 SN - 2005-4483 1976-9148 SP - 529-535 ST - Skin barrier recovery by protease-activated receptor-2 antagonist lobaric acid T2 - Biomolecules and Therapeutics TI - Skin barrier recovery by protease-activated receptor-2 antagonist lobaric acid UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612291406&from=export http://dx.doi.org/10.4062/biomolther.2016.011 VL - 24 ID - 1883 ER - TY - JOUR AU - Yang, Q. AU - Liao, J. AU - Huang, J. AU - Li, Y. P. AU - Huang, S. AU - Zhou, H. AU - Xie, Y. AU - Pan, J. AU - Li, Y. AU - Huaiwang, J. AU - Wang, J. DB - Embase Medline DO - 10.1371/journal.pone.0162179 IS - 9 LA - English M3 - Article N1 - L612598445 2016-10-19 2016-10-27 PY - 2016 SN - 1932-6203 ST - Cardiopulmonary bypass down-regulates nod signaling and inflammatory response in children with congenital heart disease T2 - PLoS ONE TI - Cardiopulmonary bypass down-regulates nod signaling and inflammatory response in children with congenital heart disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612598445&from=export http://dx.doi.org/10.1371/journal.pone.0162179 VL - 11 ID - 1884 ER - TY - JOUR AD - N. Garnier, Institute of Pediatric Hematology and Oncology, IHOP, Centre Léon Bérard, 1 Place Joseph Renaut, Lyon Cedex 08, France AU - Garnier, N. AU - Bertrand, A. AU - Libbrecht, C. AU - Corradini, N. AU - Pacquement, H. AU - Gentet, J. C. AU - Lervat, C. AU - Girodet, M. AU - Bouclier, L. AU - Ray-Coquard, I. AU - Marec-Berard, P. C1 - vp 16 DB - Embase DO - 10.1055/s-0036-1597609 IS - 3 LA - English M3 - Article N1 - L613925055 2017-01-04 2017-02-07 PY - 2016 SN - 1879-5404 1879-5390 SP - 136-145 ST - Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes T2 - Journal of Pediatric Biochemistry TI - Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613925055&from=export http://dx.doi.org/10.1055/s-0036-1597609 VL - 6 ID - 1885 ER - TY - JOUR AD - L. Gregory, Developmental Endocrinology Research Group, UCL, Insititute of Child Health, London, United Kingdom AU - Gregory, L. AU - Kypranou, N. AU - Besser, R. AU - Vignola, L. AU - Temple, K. AU - Davis, J. AU - Gevers, E. AU - Dattani, M. AU - Gaston-Massuet, C. DB - Embase DO - 10.1159/000449142 LA - English M3 - Conference Abstract N1 - L615915447 2017-05-09 PY - 2016 SN - 1663-2826 SP - 33-34 ST - The MAPK effector BRAF is essential for the integrity of hypothalamic-pituitary development and deregulation of this pathway causes congenital hypopituitarism T2 - Hormone Research in Paediatrics TI - The MAPK effector BRAF is essential for the integrity of hypothalamic-pituitary development and deregulation of this pathway causes congenital hypopituitarism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615915447&from=export http://dx.doi.org/10.1159/000449142 VL - 86 ID - 1886 ER - TY - JOUR AD - S. Karnam, Shiley Eye Institute, University of California San Diego, San Diego, CA, United States AU - Karnam, S. AU - Chavali, V. R. M. AU - Reddy, G. B. AU - Ayyagari, R. DB - Embase IS - 12 LA - English M3 - Conference Abstract N1 - L616081777 2017-05-16 PY - 2016 SN - 0146-0404 SP - 3181 ST - Role of complement-1q tumor necrosis factor related protein 5 (CTRP5/C1QTNF5) in late-onset retinal degeneration (L-ORD) pathology T2 - Investigative Ophthalmology and Visual Science TI - Role of complement-1q tumor necrosis factor related protein 5 (CTRP5/C1QTNF5) in late-onset retinal degeneration (L-ORD) pathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616081777&from=export VL - 57 ID - 1887 ER - TY - JOUR AD - J.R. Walter, Prentice Women's Hospital, 250 E Superior, Suite 03-2303, Chicago, IL, United States AU - Walter, J. R. AU - Xu, S. AU - Paller, A. S. AU - Choi, J. N. AU - Woodruff, T. K. DB - Embase Medline DO - 10.1016/j.jaad.2016.04.031 IS - 3 LA - English M3 - Article N1 - L617755213 2017-08-17 2017-08-21 PY - 2016 SN - 1097-6787 0190-9622 SP - 528-534 ST - Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies T2 - Journal of the American Academy of Dermatology TI - Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617755213&from=export http://dx.doi.org/10.1016/j.jaad.2016.04.031 VL - 75 ID - 1888 ER - TY - JOUR AD - A. Louissaint, Massachusetts General Hospital, Department of Pathology, 55 Fruit St, Warren 2, Boston, MA, United States AU - Louissaint, A. AU - Schafernak, K. T. AU - Geyer, J. T. AU - Kovach, A. E. AU - Ghandi, M. AU - Gratzinger, D. AU - Roth, C. G. AU - Paxton, C. N. AU - Kim, S. AU - Namgyal, C. AU - Morin, R. AU - Morgan, E. A. AU - Neuberg, D. S. AU - South, S. T. AU - Harris, M. H. AU - Hasserjian, R. P. AU - Hochberg, E. P. AU - Garraway, L. A. AU - Harris, N. L. AU - Weinstock, D. M. DB - Embase Medline DO - 10.1182/blood-2015-12-682591 IS - 8 LA - English M3 - Article N1 - L611891113 2016-09-07 2016-09-16 PY - 2016 SN - 1528-0020 0006-4971 SP - 1093-1100 ST - Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations T2 - Blood TI - Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611891113&from=export http://dx.doi.org/10.1182/blood-2015-12-682591 VL - 128 ID - 1889 ER - TY - JOUR AD - F. Meng, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Zhu, Q. AU - Zhang, L. AU - Li, X. AU - Chen, F. AU - Jiang, L. AU - Yu, G. AU - Wang, Z. AU - Yin, C. AU - Jiang, X. AU - Zhong, Q. AU - Zhou, H. AU - Ding, B. AU - Wang, C. AU - Meng, F. DB - Embase Medline DO - 10.1007/s13277-016-4983-4 IS - 8 LA - English M3 - Article N1 - L609238443 2016-03-31 2016-09-06 PY - 2016 SN - 1423-0380 1010-4283 SP - 11409-11420 ST - Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia T2 - Tumor Biology TI - Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609238443&from=export http://dx.doi.org/10.1007/s13277-016-4983-4 VL - 37 ID - 1891 ER - TY - JOUR AD - M.D. Johnson, Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, Box 626, 601 Elmwood Avenue, Rochester, NY, United States AU - Johnson, M. D. AU - Reeder, J. E. AU - O'Connell, M. DB - Embase Medline DO - 10.1016/j.jocn.2015.12.031 LA - English M3 - Article N1 - L609403380 2016-04-06 2016-07-08 PY - 2016 SN - 1532-2653 0967-5868 SP - 110-114 ST - P38MAPK activation and DUSP10 expression in meningiomas T2 - Journal of Clinical Neuroscience TI - P38MAPK activation and DUSP10 expression in meningiomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609403380&from=export http://dx.doi.org/10.1016/j.jocn.2015.12.031 VL - 30 ID - 1892 ER - TY - JOUR AD - X.-K. Li, Division of Transplantation Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan AU - Fujino, M. AU - Nishio, Y. AU - Ito, H. AU - Tanaka, T. AU - Li, X. K. DB - Embase Medline DO - 10.1016/j.intimp.2015.11.034 LA - English M3 - Article N1 - L610446159 2016-05-27 2016-07-06 PY - 2016 SN - 1878-1705 1567-5769 SP - 71-78 ST - 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction T2 - International Immunopharmacology TI - 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610446159&from=export http://dx.doi.org/10.1016/j.intimp.2015.11.034 VL - 37 ID - 1894 ER - TY - JOUR AD - C. Kiss, University of Debrecen, Department of Pediatrics, Debrecen, Hungary AU - Kiss, C. AU - Horváth, J. AU - Lábiscsák, P. AU - Tar, I. AU - Szabó, A. AU - Csósz, É AU - Scholtz, B. AU - Márton, I. J. DB - Embase DO - 10.1002/eji.201670200 LA - English M3 - Conference Abstract N1 - L611906093 2016-09-05 PY - 2016 SN - 1521-4141 SP - 373 ST - Salivary expression of dysregulated immune/inflammatory genes provides a useful set of biomarkers in detection of oral cavity squamous cell carcinoma T2 - European Journal of Immunology TI - Salivary expression of dysregulated immune/inflammatory genes provides a useful set of biomarkers in detection of oral cavity squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611906093&from=export http://dx.doi.org/10.1002/eji.201670200 VL - 46 ID - 1895 ER - TY - JOUR AD - R. Ruggieri, Center of Oncology and Cell Biology, Feinstein Institute, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, United States AU - Markowitz, D. AU - Powell, C. AU - Tran, N. L. AU - Berens, M. E. AU - Ryken, T. C. AU - Vanan, M. AU - Rosen, L. AU - He, M. AU - Sun, S. AU - Symons, M. AU - Al-Abed, Y. AU - Ruggieri, R. C1 - m 443 DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0849 IS - 8 LA - English M3 - Article N1 - L611997026 2016-09-13 2016-10-04 PY - 2016 SN - 1538-8514 1535-7163 SP - 1799-1808 ST - Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma T2 - Molecular Cancer Therapeutics TI - Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611997026&from=export http://dx.doi.org/10.1158/1535-7163.MCT-15-0849 VL - 15 ID - 1896 ER - TY - JOUR AD - L. Kandolf Sekulovic, Medical Faculty, Military Medical Academy, Dermatology and Venerology, Belgrade, Serbia AU - Kandolf Sekulovic, L. AU - Babovic, N. AU - Nikolin, B. AU - Vrbic, S. AU - Vukanovic, T. AU - Ostojic, N. AU - Mijuskovic, Z. AU - Dinic, M. AU - Juskic, K. AU - Jevric, M. AU - Neric, D. AU - Todorovic, M. AU - Tiodorovic, D. AU - Nikolic, D. AU - Novakovic, M. DB - Embase DO - 10.1097/CMR.0000000000000285 LA - English M3 - Conference Abstract N1 - L612247927 2016-09-26 PY - 2016 SN - 1473-5636 SP - e16 ST - Clinicopathological characteristics, treatment patterns and outcome of cutaneous melanoma in South-East Europe: First results from the national registry of Serbian melanoma group T2 - Melanoma Research TI - Clinicopathological characteristics, treatment patterns and outcome of cutaneous melanoma in South-East Europe: First results from the national registry of Serbian melanoma group UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612247927&from=export http://dx.doi.org/10.1097/CMR.0000000000000285 VL - 26 ID - 1897 ER - TY - JOUR AD - C. Posch, Rudolfstiftung Hospital, Dermatology, Vienna, Austria AU - Posch, C. AU - Steffal, C. AU - Haider, A. AU - Flechl, B. AU - Kann, T. AU - Weihsengruber, F. AU - Schratter-Sehn, A. U. DB - Embase DO - 10.1097/CMR.0000000000000285 LA - English M3 - Conference Abstract N1 - L612247953 2016-09-26 PY - 2016 SN - 1473-5636 SP - e46 ST - Radiation therapy in melanoma patients with poor clinical characteristics-a collaborative experience with 107 patients T2 - Melanoma Research TI - Radiation therapy in melanoma patients with poor clinical characteristics-a collaborative experience with 107 patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612247953&from=export http://dx.doi.org/10.1097/CMR.0000000000000285 VL - 26 ID - 1898 ER - TY - JOUR AD - L. Jin, Zhenjiang Matemity and Child Health Care Hospital, Zhenjiang, China AU - Lu, L. AU - Chen, J. AU - Tang, H. AU - Bai, L. AU - Lu, C. AU - Wang, K. AU - Li, M. AU - Yan, Y. AU - Tang, L. AU - Wu, R. AU - Ye, Y. AU - Jin, L. AU - Liang, Z. DB - Embase Medline DO - 10.3390/nu8070380 IS - 7 LA - English M3 - Article N1 - L611285636 2016-08-02 PY - 2016 SN - 2072-6643 ST - EGCG suppresses ERK5 activation to reverse tobacco smoke-triggered gastric epithelial-mesenchymal transition in BALB/c mice T2 - Nutrients TI - EGCG suppresses ERK5 activation to reverse tobacco smoke-triggered gastric epithelial-mesenchymal transition in BALB/c mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611285636&from=export http://dx.doi.org/10.3390/nu8070380 VL - 8 ID - 1900 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Room 317, 950 west 28th Ave, Vancouver, BC, Canada AU - So, W. K. AU - Cheng, J. C. AU - Liu, Y. AU - Xu, C. AU - Zhao, J. AU - Chang, V. T. W. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1007/s13277-016-4790-y IS - 7 LA - English M3 - Article N1 - L607781462 2016-01-26 2016-09-07 PY - 2016 SN - 1423-0380 1010-4283 SP - 9197-9207 ST - Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells T2 - Tumor Biology TI - Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607781462&from=export http://dx.doi.org/10.1007/s13277-016-4790-y VL - 37 ID - 1901 ER - TY - JOUR AU - Segal, D. AU - Karajannis, M. A. DB - Embase Medline DO - 10.1016/j.cppeds.2016.04.004 IS - 7 LA - English M3 - Article N1 - L610620216 2016-06-10 2016-07-01 PY - 2016 SN - 1538-3199 1538-5442 SP - 242-250 ST - Pediatric Brain Tumors: An Update T2 - Current Problems in Pediatric and Adolescent Health Care TI - Pediatric Brain Tumors: An Update UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610620216&from=export http://dx.doi.org/10.1016/j.cppeds.2016.04.004 VL - 46 ID - 1902 ER - TY - JOUR AD - M. Chen, Department of Obstetrics and Gynecology, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, 123 Tianfei Xiang, MoChou Road, Nanjing, Jiangsu, China AU - Li, C. AU - Ding, H. AU - Tian, J. AU - Wu, L. AU - Wang, Y. AU - Xing, Y. AU - Chen, M. DB - Embase Medline DO - 10.1159/000445620 IS - 1 LA - English M3 - Article N1 - L611065315 2016-07-08 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 242-252 ST - Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin in Vitro and in Vivo T2 - Cellular Physiology and Biochemistry TI - Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin in Vitro and in Vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611065315&from=export http://dx.doi.org/10.1159/000445620 VL - 39 ID - 1904 ER - TY - JOUR AD - J.M. Cerutti, Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, SP, Brazil AU - Cordioli, M. I. C. V. AU - Moraes, L. AU - Carvalheira, G. AU - Sisdelli, L. AU - Alves, M. T. S. AU - Delcelo, R. AU - Monte, O. AU - Longui, C. A. AU - Cury, A. N. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1002/cam4.698 IS - 7 LA - English M3 - Article N1 - L611254669 2016-07-21 2016-07-28 PY - 2016 SN - 2045-7634 SP - 1535-1541 ST - AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma T2 - Cancer Medicine TI - AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611254669&from=export http://dx.doi.org/10.1002/cam4.698 VL - 5 ID - 1905 ER - TY - JOUR AD - B. McDonald, Department of Dermatology, Watford General Hospital, West Hertfordshire Hospitals NHS Trust, Watford, United Kingdom AU - McDonald, B. AU - Amieva, M. AU - Kelsell, D. P. AU - O'Toole, E. A. AU - Burkett-Wright, E. AU - Kerr, B. AU - Batta, K. DB - Embase DO - 10.1111/bjd.14580 LA - English M3 - Conference Abstract N1 - L613932448 2017-01-04 PY - 2016 SN - 1365-2133 SP - 163 ST - Noonan syndrome with multiple lentigines identified by next-generation sequencing T2 - British Journal of Dermatology TI - Noonan syndrome with multiple lentigines identified by next-generation sequencing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613932448&from=export http://dx.doi.org/10.1111/bjd.14580 VL - 175 ID - 1906 ER - TY - JOUR AD - C.V. Mahuad, Service of Hematology, Department of Internal Medicine, Hospital Alemán, Pueyrredón 1640, 1118 – CABA, Buenos Aires, Argentina AU - Mahuad, C. V. AU - Repáraz, M. Á V. AU - Zerga, M. E. AU - Aizpurua, M. F. AU - Casali, C. AU - Garate, G. DB - Embase DO - 10.4081/rt.2016.6266 IS - 2 LA - English M3 - Article N1 - L610956143 2016-07-05 2016-07-11 PY - 2016 SN - 2036-3613 2036-3605 SP - 88-89 ST - Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib T2 - Rare Tumors TI - Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610956143&from=export http://dx.doi.org/10.4081/rt.2016.6266 VL - 8 ID - 1908 ER - TY - JOUR AD - A.C. Xavier, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Children’s Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL, United States AU - Sorge, C. E. AU - McDaniel, J. K. AU - Xavier, A. C. C1 - pxd 101 DB - Embase DO - 10.3390/ph9020028 IS - 2 LA - English M3 - Review N1 - L610612294 2016-06-14 2016-06-20 PY - 2016 SN - 1424-8247 ST - Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: Present and future T2 - Pharmaceuticals TI - Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: Present and future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610612294&from=export http://dx.doi.org/10.3390/ph9020028 VL - 9 ID - 1911 ER - TY - JOUR AD - J.H. Suh, Foundation Medicine, Inc, 150 Second Street, Cambridge, MA, United States AU - Suh, J. H. AU - Johnson, A. AU - Albacker, L. AU - Wang, K. AU - Chmielecki, J. AU - Frampton, G. AU - Gay, L. AU - Elvin, J. A. AU - Vergilio, J. A. AU - Ali, S. AU - Miller, V. A. AU - Stephens, P. J. AU - Ross, J. S. DB - Embase Medline DO - 10.1634/theoncologist.2016-0030 IS - 6 LA - English M3 - Article N1 - L610847079 2016-06-28 2016-07-08 PY - 2016 SN - 1549-490X 1083-7159 SP - 684-691 ST - Comprehensive genomic profiling facilitates implementation of the national comprehensive cancer network guidelines for lung cancer biomarker testing and identifies Patientswho may benefit from enrollment in mechanism-driven clinical trials T2 - Oncologist TI - Comprehensive genomic profiling facilitates implementation of the national comprehensive cancer network guidelines for lung cancer biomarker testing and identifies Patientswho may benefit from enrollment in mechanism-driven clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610847079&from=export http://dx.doi.org/10.1634/theoncologist.2016-0030 VL - 21 ID - 1912 ER - TY - JOUR AD - C.A. Scrideli, Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, São Paulo, Brazil AU - Lira, R. C. P. AU - Fedatto, P. F. AU - Antonio, D. S. M. AU - Leal, L. F. AU - Martinelli, C. E. AU - De Castro, M. AU - Tucci, S. AU - Neder, L. AU - Ramalho, L. AU - Seidinger, A. L. AU - Cardinalli, I. AU - Mastellaro, M. J. AU - Yunes, J. A. AU - Brandalise, S. R. AU - Tone, L. G. AU - Antonini, S. R. R. AU - Scrideli, C. A. C1 - osi 906 DB - Embase Medline DO - 10.1530/ERC-15-0426 IS - 6 LA - English M3 - Article N1 - L611085521 2016-07-11 2016-07-19 PY - 2016 SN - 1479-6821 1351-0088 SP - 481-493 ST - IGF2 and IGF1R in pediatric adrenocortical tumors: Roles in metastasis and steroidogenesis T2 - Endocrine-Related Cancer TI - IGF2 and IGF1R in pediatric adrenocortical tumors: Roles in metastasis and steroidogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611085521&from=export http://dx.doi.org/10.1530/ERC-15-0426 VL - 23 ID - 1914 ER - TY - JOUR AD - F. Selt, CCU Pediatric Oncology (G340), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany AU - Selt, F. AU - Hohloch, J. AU - Gronych, J. AU - Marquardt, V. AU - Sahm, F. AU - Schuhmann, M. U. AU - Brummer, T. AU - Driever, P. H. AU - Thomale, U. W. AU - Bächli, H. AU - Kulozik, A. E. AU - Von Deimling, A. AU - Remke, M. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Milde, T. AU - Witt, O. DB - Embase DO - 10.1093/neuonc/now075.27 LA - English M3 - Conference Abstract N1 - L611934171 2016-09-07 PY - 2016 SN - 1523-5866 SP - iii84 ST - DKFZ-BT66-a novel pilocytic astrocytoma model for preclinical drug testing T2 - Neuro-Oncology TI - DKFZ-BT66-a novel pilocytic astrocytoma model for preclinical drug testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611934171&from=export http://dx.doi.org/10.1093/neuonc/now075.27 VL - 18 ID - 1915 ER - TY - JOUR AD - B.C. Worst, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany AU - Worst, B. C. AU - Van Tilburg, C. M. AU - Balasubramanian, G. P. AU - Fiesel, P. AU - Pfaff, E. AU - Witt, R. AU - Freitag, A. AU - Von Deimling, A. AU - Eggert, A. AU - Lichter, P. AU - Capper, D. AU - Witt, O. AU - Pfister, S. M. AU - Jones, D. T. W. DB - Embase DO - 10.1093/neuonc/now084.10 LA - English M3 - Conference Abstract N1 - L611934288 2016-09-07 PY - 2016 SN - 1523-5866 SP - iii171 ST - The inform personalized medicine study-new molecular insights into relapsed pediatric brain tumors T2 - Neuro-Oncology TI - The inform personalized medicine study-new molecular insights into relapsed pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611934288&from=export http://dx.doi.org/10.1093/neuonc/now084.10 VL - 18 ID - 1916 ER - TY - JOUR AD - C.-H. Kuo, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou First Road, Kaohsiung, Taiwan AU - Chang, K. T. AU - Lin, H. Y. H. AU - Kuo, C. H. AU - Hung, C. H. DB - Embase DO - 10.1016/j.jmii.2014.07.006 IS - 3 LA - English M3 - Article N1 - L612825168 2016-10-25 2016-11-21 PY - 2016 SN - 1995-9133 1684-1182 SP - 409-416 ST - Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes T2 - Journal of Microbiology, Immunology and Infection TI - Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612825168&from=export http://dx.doi.org/10.1016/j.jmii.2014.07.006 VL - 49 ID - 1917 ER - TY - JOUR AD - A. Lonetti, Department of Biomedical and Neuromotor Sciences, Bologna, Italy AU - Lonetti, A. AU - Masetti, R. AU - Bertuccio, S. N. AU - Serravalle, S. AU - Astolfi, A. AU - Bertaina, A. AU - Locatelli, F. AU - Martelli, A. M. AU - Pession, A. DB - Embase LA - English M3 - Conference Abstract N1 - L615548645 2017-04-26 PY - 2016 SN - 1592-8721 SP - 363 ST - Combining DOT1L inhibitor EPZ-5676 with sorafenib to treat MLL-rearranged (MLL-R) pediatric acute myeloid leukeamia (AML) T2 - Haematologica TI - Combining DOT1L inhibitor EPZ-5676 with sorafenib to treat MLL-rearranged (MLL-R) pediatric acute myeloid leukeamia (AML) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615548645&from=export VL - 101 ID - 1918 ER - TY - JOUR AD - I. Wlodarska, Center for Human Genetics, KU Leuven, Leuven, Belgium AU - Wlodarska, I. AU - Van Der Krogt, J. A. AU - Finalet Ferreiro, J. AU - Jacobs, K. AU - Geerdens, E. AU - Uyttebroeck, A. AU - Vandenberghe, P. AU - Tousseyn, T. AU - Cools, J. DB - Embase LA - English M3 - Conference Abstract N1 - L615549250 2017-04-26 PY - 2016 SN - 1592-8721 SP - 574 ST - ALK-positive anaplastic large cell lymphoma with the variant EEF1G-, RNF213-and ATIC-ALK fusions is featured by copy number gain of the rearranged ALK gene T2 - Haematologica TI - ALK-positive anaplastic large cell lymphoma with the variant EEF1G-, RNF213-and ATIC-ALK fusions is featured by copy number gain of the rearranged ALK gene UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615549250&from=export VL - 101 ID - 1919 ER - TY - JOUR AD - Y. Zhao, Department of Neurology, Jinshan Hospital Affiliated to Fudan University, No.1508 Longhang Road, Jinshan district, Shanghai, China AU - Zhang, J. AU - Wu, J. AU - Zeng, W. AU - Yao, K. AU - Zu, H. AU - Zhao, Y. DB - Embase Medline DO - 10.1159/000445578 IS - 6 LA - English M3 - Article N1 - L610480296 2016-05-31 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 2230-2238 ST - Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation T2 - Cellular Physiology and Biochemistry TI - Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610480296&from=export http://dx.doi.org/10.1159/000445578 VL - 38 ID - 1920 ER - TY - JOUR AD - Z. Wang, Department of Thoracic Medical Oncology, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China AU - Wang, Y. AU - Yan, P. AU - Liu, Z. AU - Yang, X. AU - Wang, Y. AU - Shen, Z. AU - Bai, H. AU - Wang, J. AU - Wang, Z. C1 - azd 6244(Selleck,United States) bez 235(Selleck,United States) C2 - Selleck(United States) DB - Embase DO - 10.1111/1759-7714.12325 IS - 3 LA - English M3 - Article N1 - L607391685 2015-12-30 2016-05-06 PY - 2016 SN - 1759-7714 1759-7706 SP - 279-287 ST - MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation T2 - Thoracic Cancer TI - MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607391685&from=export http://dx.doi.org/10.1111/1759-7714.12325 VL - 7 ID - 1921 ER - TY - JOUR AD - M.S. Lim, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Stellar-Chance Laboratories, 422 Curie Blvd, Philadelphia, PA, United States AU - Pillai, V. AU - Tallarico, M. AU - Bishop, M. R. AU - Lim, M. S. DB - Embase Medline DO - 10.1111/bjh.14044 IS - 4 LA - English M3 - Review N1 - L609152692 2016-03-30 2016-06-16 PY - 2016 SN - 1365-2141 0007-1048 SP - 573-581 ST - Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents T2 - British Journal of Haematology TI - Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609152692&from=export http://dx.doi.org/10.1111/bjh.14044 VL - 173 ID - 1924 ER - TY - JOUR AD - W. Liu, Institute of Radiation Medicine, Shandong Academy of Medical Science, 18877 Jingshi Road, Jinan, Shandong, China AU - Zhao, L. AU - Jiang, B. AU - Wang, D. AU - Liu, W. AU - Zhang, H. AU - Liu, W. AU - Qiu, Z. DB - Embase DO - 10.3892/etm.2016.3164 IS - 5 LA - English M3 - Article N1 - L609235546 2016-04-13 PY - 2016 SN - 1792-1015 1792-0981 SP - 2005-2010 ST - Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression T2 - Experimental and Therapeutic Medicine TI - Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609235546&from=export http://dx.doi.org/10.3892/etm.2016.3164 VL - 11 ID - 1925 ER - TY - JOUR AD - W. Klapper, Department of Pathology, Haematopathology Section, University-Hospital Schleswig-Holstein, University of Kiel, Michaelisstrasse 11, Kiel, Germany AU - Shiramizu, B. AU - Mussolin, L. AU - Woessmann, W. AU - Klapper, W. DB - Embase Medline DO - 10.1111/bjh.14009 IS - 4 LA - English M3 - Review N1 - L609267452 2016-04-01 2016-06-16 PY - 2016 SN - 1365-2141 0007-1048 SP - 617-624 ST - Paediatric non-Hodgkin lymphoma - perspectives in translational biology T2 - British Journal of Haematology TI - Paediatric non-Hodgkin lymphoma - perspectives in translational biology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609267452&from=export http://dx.doi.org/10.1111/bjh.14009 VL - 173 ID - 1926 ER - TY - JOUR AD - R. Groisberg AU - Groisberg, R. AU - Hong, D. S. AU - Janku, F. AU - Piha-Paul, S. A. AU - Ravi, V. AU - Benjamin, R. S. AU - Patel, S. AU - Somaiah, N. AU - Conley, A. P. AU - Herzog, C. E. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase LA - English M3 - Conference Abstract N1 - L611753837 2016-08-25 PY - 2016 SN - 1527-7755 ST - Clinical next-generation sequencing in sarcomas T2 - Journal of Clinical Oncology TI - Clinical next-generation sequencing in sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611753837&from=export VL - 34 ID - 1927 ER - TY - JOUR AD - S. Sen AU - Sen, S. AU - Rizwan-ul-Haq Khawaja, M. AU - Khatua, S. AU - Karp, D. D. AU - Janku, F. AU - Hong, D. S. AU - Munoz, J. AU - Tsimberidou, A. M. AU - Zaky, W. T. AU - Hwu, P. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase LA - English M3 - Conference Abstract N1 - L611754245 2016-08-25 PY - 2016 SN - 1527-7755 ST - Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study T2 - Journal of Clinical Oncology TI - Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611754245&from=export VL - 34 ID - 1928 ER - TY - JOUR AD - D. Bradford AU - Bradford, D. AU - Whitcomb, P. AU - Dombi, E. AU - Chen, A. P. AU - Baldwin, A. AU - Wolters, P. AU - Martin, S. AU - Glod, J. AU - Derdak, J. AU - Coyne, G. H. O. AU - Cowen, E. W. AU - Holmblad, M. AU - Trepel, J. AU - Wood, B. J. AU - Paul, S. M. AU - Clapp, W. AU - Johnson, G. L. AU - Rubinstein, L. AU - Doyle, L. A. AU - Widemann, B. C. DB - Embase LA - English M3 - Conference Abstract N1 - L611756106 2016-08-25 PY - 2016 SN - 1527-7755 ST - Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) T2 - Journal of Clinical Oncology TI - Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611756106&from=export VL - 34 ID - 1929 ER - TY - JOUR AD - O.V. Volpert, Northwestern University Feinberg School of Medicine, Tarry Bldg, Ste 16-761, 303 East Chicago Ave., Chicago, IL, United States AU - Nwani, N. G. AU - Deguiz, M. L. AU - Jimenez, B. AU - Vinokour, E. AU - Dubrovskyi, O. AU - Ugolkov, A. AU - Mazar, A. P. AU - Volpert, O. V. DB - Embase Medline DO - 10.1158/0008-5472.CAN-15-2468 IS - 8 LA - English M3 - Article N1 - L610185621 2016-06-07 PY - 2016 SN - 1538-7445 0008-5472 SP - 2265-2276 ST - Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts T2 - Cancer Research TI - Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610185621&from=export http://dx.doi.org/10.1158/0008-5472.CAN-15-2468 VL - 76 ID - 1931 ER - TY - JOUR AD - L.S. Sender, Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California-Irvine, 101 The City Drive South, Building 23, 4th Floor, Orange, CA, United States AU - McEachron, T. A. AU - Kirov, I. AU - Wungwattana, M. AU - Cortes, D. AU - Zabokrtsky, K. B. AU - Sassoon, A. AU - Craig, D. AU - Carpten, J. D. AU - Sender, L. S. DB - Embase Medline DO - 10.1002/pbc.25854 IS - 4 LA - English M3 - Article N1 - L607580000 2016-01-12 2016-03-22 PY - 2016 SN - 1545-5017 1545-5009 SP - 727-730 ST - Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation T2 - Pediatric Blood and Cancer TI - Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607580000&from=export http://dx.doi.org/10.1002/pbc.25854 VL - 63 ID - 1932 ER - TY - JOUR AD - Y. Qin, General Hospital of Jinan Iron and Steel Group Co., Ltd., Shandong, China AU - Wang, J. AU - Qin, Y. AU - Mi, X. DB - Embase Medline DO - 10.1016/j.biopha.2016.02.037 LA - English M3 - Article N1 - L608799483 2016-03-11 2016-03-22 PY - 2016 SN - 1950-6007 0753-3322 SP - 176-187 ST - The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-κB signaling pathways T2 - Biomedicine and Pharmacotherapy TI - The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-κB signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608799483&from=export http://dx.doi.org/10.1016/j.biopha.2016.02.037 VL - 79 ID - 1934 ER - TY - JOUR AU - Liu, W. AU - Xu, C. AU - You, X. AU - Olson, D. M. AU - Chemtob, S. AU - Gao, L. AU - Ni, X. DB - Embase Medline DO - 10.1371/journal.pone.0152838 IS - 4 LA - English M3 - Article N1 - L609632613 2016-04-14 2016-04-22 PY - 2016 SN - 1932-6203 ST - Hydrogen sulfide delays LPS-Induced preterm birth in mice via anti-inflammatory pathways T2 - PLoS ONE TI - Hydrogen sulfide delays LPS-Induced preterm birth in mice via anti-inflammatory pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609632613&from=export http://dx.doi.org/10.1371/journal.pone.0152838 VL - 11 ID - 1935 ER - TY - JOUR AD - S. Cabezas-Camarero, Department of Medical Oncology, Hospital Universitario Clinico San Carlos, Madrid, Spain AU - Cabezas-Camarero, S. AU - Luna-Barrera, A. M. AU - Pérez-Segura, P. DB - Embase IS - 2 LA - English M3 - Article N1 - L613012663 2016-11-08 2016-11-21 PY - 2016 SN - 1885-740X SP - 55-65 ST - Systemic treatment of low-grade gliomas T2 - Cancer and Chemotherapy Reviews TI - Systemic treatment of low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613012663&from=export VL - 11 ID - 1936 ER - TY - JOUR AD - E. Malle, Institute of Molecular Biology and Biochemistry, Medical University of Graz, Harrachgasse 21, Graz, Austria AU - Koyani, C. N. AU - Kitz, K. AU - Rossmann, C. AU - Bernhart, E. AU - Huber, E. AU - Trummer, C. AU - Windischhofer, W. AU - Sattler, W. AU - Malle, E. DB - Embase Medline DO - 10.1016/j.bcp.2016.01.011 LA - English M3 - Article N1 - L608135652 2016-02-11 2016-03-15 PY - 2016 SN - 1873-2968 0006-2952 SP - 29-41 ST - Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death T2 - Biochemical Pharmacology TI - Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608135652&from=export http://dx.doi.org/10.1016/j.bcp.2016.01.011 VL - 104 ID - 1937 ER - TY - JOUR AD - M. O'Driscoll, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom AU - Bennett, J. T. AU - Tan, T. Y. AU - Alcantara, D. AU - Tétrault, M. AU - Timms, A. E. AU - Jensen, D. AU - Collins, S. AU - Nowaczyk, M. J. M. AU - Lindhurst, M. J. AU - Christensen, K. M. AU - Braddock, S. R. AU - Brandling-Bennett, H. AU - Hennekam, R. C. M. AU - Chung, B. AU - Lehman, A. AU - Su, J. AU - Ng, S. AU - Amor, D. J. AU - Majewski, J. AU - Biesecker, L. G. AU - Boycott, K. M. AU - Dobyns, W. B. AU - O'Driscoll, M. AU - Moog, U. AU - McDonell, L. M. DB - Embase Medline DO - 10.1016/j.ajhg.2016.02.006 IS - 3 LA - English M3 - Article N1 - L608903995 2016-03-16 2016-03-24 PY - 2016 SN - 1537-6605 0002-9297 SP - 579-587 ST - Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis T2 - American Journal of Human Genetics TI - Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608903995&from=export http://dx.doi.org/10.1016/j.ajhg.2016.02.006 VL - 98 ID - 1938 ER - TY - JOUR AD - N. Saki, Health Research Institute, Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran AU - Heidari, N. AU - Saki, N. AU - De Filippis, L. AU - Shahjahani, M. AU - Teimouri, A. AU - Ahmadzadeh, A. DB - Embase Medline DO - 10.1007/s12094-015-1370-3 IS - 3 LA - English M3 - Article N1 - L605542175 2015-08-12 2016-02-29 PY - 2016 SN - 1699-3055 1699-048X SP - 240-250 ST - Central nervous system niche involvement in the leukemia T2 - Clinical and Translational Oncology TI - Central nervous system niche involvement in the leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605542175&from=export http://dx.doi.org/10.1007/s12094-015-1370-3 VL - 18 ID - 1939 ER - TY - JOUR AD - V. Keitel, Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf, Germany AU - Reich, M. AU - Deutschmann, K. AU - Sommerfeld, A. AU - Klindt, C. AU - Kluge, S. AU - Kubitz, R. AU - Ullmer, C. AU - Knoefel, W. T. AU - Herebian, D. AU - Mayatepek, E. AU - Häussinger, D. AU - Keitel, V. DB - Embase DO - 10.1136/gutjnl-2015-309458 IS - 3 LA - English M3 - Article N1 - L608884254 2016-03-21 2016-03-24 PY - 2016 SN - 1468-3288 0017-5749 SP - 487-501 ST - TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro T2 - Gut TI - TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608884254&from=export http://dx.doi.org/10.1136/gutjnl-2015-309458 VL - 65 ID - 1940 ER - TY - JOUR AD - K.M. Shannon AU - Shannon, K. M. DB - Embase DO - 10.1158/1538-7445.PEDCA15-IA20 IS - 5 LA - English M3 - Conference Abstract N1 - L613568437 2016-12-13 PY - 2016 SN - 1538-7445 ST - Targeting hyperactive Ras signaling in acute leukemia T2 - Cancer Research TI - Targeting hyperactive Ras signaling in acute leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613568437&from=export http://dx.doi.org/10.1158/1538-7445.PEDCA15-IA20 VL - 76 ID - 1941 ER - TY - JOUR AD - A. Budhipramono AU - Budhipramono, A. AU - Rakheja, D. AU - Chen, K. S. AU - Fustino, N. AU - Shukla, A. AU - Wickiser, J. AU - Laetsch, T. AU - Amatruda, J. F. DB - Embase DO - 10.1158/1538-7445.PEDCA15-B03 IS - 5 LA - English M3 - Conference Abstract N1 - L613568444 2016-12-13 PY - 2016 SN - 1538-7445 ST - EGFR and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors T2 - Cancer Research TI - EGFR and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613568444&from=export http://dx.doi.org/10.1158/1538-7445.PEDCA15-B03 VL - 76 ID - 1942 ER - TY - JOUR AD - H.K. Abtar, Department of Surgery, Makassed General Hospital, Beirut, Lebanon AU - Chehade, H. H. E. H. AU - Zbibo, R. H. AU - Hussein, B. M. A. AU - Abtar, H. K. DB - Embase Medline DO - 10.12659/AJCR.896036 LA - English M3 - Article N1 - L608634775 2016-04-27 2016-05-02 PY - 2016 SN - 1941-5923 SP - 79-83 ST - Highly vascularized primarily inflammatory pseudotumor of the omentum in an adult male: A case report T2 - American Journal of Case Reports TI - Highly vascularized primarily inflammatory pseudotumor of the omentum in an adult male: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608634775&from=export http://dx.doi.org/10.12659/AJCR.896036 VL - 17 ID - 1943 ER - TY - JOUR AD - S.L. Cohn, Department of Pediatrics, Comer Children's Hospital, University of Chicago, 57th Street, Chicago, IL, United States AU - Bagatell, R. AU - Cohn, S. L. C1 - mln 8237 DB - Embase Medline DO - 10.1097/MOP.0000000000000296 IS - 1 LA - English M3 - Review N1 - L606982464 2015-11-25 2016-01-21 PY - 2016 SN - 1531-698X 1040-8703 SP - 19-25 ST - Genetic discoveries and treatment advances in neuroblastoma T2 - Current Opinion in Pediatrics TI - Genetic discoveries and treatment advances in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606982464&from=export http://dx.doi.org/10.1097/MOP.0000000000000296 VL - 28 ID - 1944 ER - TY - JOUR AD - Z. Li, Department of Nephrology of Hunan Children’s Hospital, Hunan Institute for Pediatric Research, 86 Ziyuan Road, Changsha, Hunan, China AU - Li, Z. AU - Deng, X. AU - Kang, Z. AU - Wang, Y. AU - Xia, T. AU - Ding, N. AU - Yin, Y. DB - Embase Medline DO - 10.1007/s40620-015-0217-x IS - 1 LA - English M3 - Article N1 - L607989351 2016-02-04 2016-02-09 PY - 2016 SN - 1724-6059 1121-8428 SP - 27-36 ST - Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia–reperfusion induced kidney injury T2 - Journal of Nephrology TI - Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia–reperfusion induced kidney injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607989351&from=export http://dx.doi.org/10.1007/s40620-015-0217-x VL - 29 ID - 1945 ER - TY - JOUR AD - K. Zheng, Department of Neurosurgery, The First Affiliated Hospital of Wen Zhou Medical College, Wenzhou, Zhejiang, China AU - Chen, S. Y. AU - Zheng, K. AU - Wang, Z. Q. C2 - Sigma Aldrich(United States) DB - Embase DO - 10.4314/tjpr.v15i2.4 IS - 2 LA - English M3 - Article N1 - L608769110 2016-03-09 2016-03-14 PY - 2016 SN - 1596-9827 1596-5996 SP - 241-251 ST - Neuroprotective effects of ellagic acid on neonatal hypoxic brain injury via inhibition of inflammatory mediators and down-regulation of JNK/p38 MAPK activation T2 - Tropical Journal of Pharmaceutical Research TI - Neuroprotective effects of ellagic acid on neonatal hypoxic brain injury via inhibition of inflammatory mediators and down-regulation of JNK/p38 MAPK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608769110&from=export http://dx.doi.org/10.4314/tjpr.v15i2.4 VL - 15 ID - 1947 ER - TY - JOUR AD - S. Sathyanandan, Department of Immunohematology and Blood Transfusion, HLA-Immunogentics Lab, Tata Memorial Centre, Mumbai, India AU - Sathyanandan, S. AU - Jain, P. AU - Rajadhyaksha, S. B. AU - Meenakshi, S. AU - Roy, N. AU - Surjit, S. DB - Embase DO - 10.1159/000444288 IS - 6 LA - English M3 - Conference Abstract N1 - L615888612 2017-05-09 PY - 2016 SN - 1661-8777 SP - 325-326 ST - Chronic non-bacterial osteitis: Il-β dysregulation and EQ5D-5L validation of health outcome status T2 - Molecular Syndromology TI - Chronic non-bacterial osteitis: Il-β dysregulation and EQ5D-5L validation of health outcome status UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615888612&from=export http://dx.doi.org/10.1159/000444288 VL - 6 ID - 1949 ER - TY - JOUR AD - C. Pföhler, Universitätsklinikum Des Saarlandes, Klinik für Dermatologie, Venerologie und Allergologie, Homburg/Saar, Germany AU - Pföhler, C. AU - Krecké, N. AU - Schneider, G. AU - Solomayer, E. F. AU - Bohle, R. M. AU - Vogt, T. DB - Embase DO - 10.1159/000444354 LA - English M3 - Conference Abstract N1 - L72212747 2016-03-21 PY - 2016 SN - 2296-5270 SP - 149 ST - Metastatic melanoma in pregnancy-a diagnostic and therapeutic challenge T2 - Oncology Research and Treatment TI - Metastatic melanoma in pregnancy-a diagnostic and therapeutic challenge UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72212747&from=export http://dx.doi.org/10.1159/000444354 VL - 39 ID - 1950 ER - TY - JOUR AD - R.J. Brown, Diabetes, Endocrinology and Obesity Branch (DEOB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Building 10/CRC, MSC 1612, 10 Center Drive, Bethesda, MD, United States AU - Brown, R. J. AU - Chan, J. L. AU - Jaffe, E. S. AU - Cochran, E. AU - Depaoli, A. M. AU - Gautier, J. F. AU - Goujard, C. AU - Vigouroux, C. AU - Gorden, P. DB - Embase Medline DO - 10.3109/10428194.2015.1040015 IS - 1 LA - English M3 - Article N1 - L607757507 2016-01-26 2016-02-01 PY - 2016 SN - 1029-2403 1042-8194 SP - 45-50 ST - Lymphoma in acquired generalized lipodystrophy T2 - Leukemia and Lymphoma TI - Lymphoma in acquired generalized lipodystrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607757507&from=export http://dx.doi.org/10.3109/10428194.2015.1040015 VL - 57 ID - 1952 ER - TY - JOUR AD - S. Paruchuri, Department of Chemistry, University of Akron, KNCL 406, 185 E Mill street, Akron, OH, United States AU - Kondeti, V. AU - Al-Azzam, N. AU - Duah, E. AU - Thodeti, C. K. AU - Boyce, J. A. AU - Paruchuri, S. DB - Embase Medline DO - 10.1016/j.jaci.2015.06.030 IS - 1 LA - English M3 - Article N1 - L605510307 2015-08-11 2016-01-19 PY - 2016 SN - 1097-6825 0091-6749 SP - 289-298 ST - Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3 T2 - Journal of Allergy and Clinical Immunology TI - Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605510307&from=export http://dx.doi.org/10.1016/j.jaci.2015.06.030 VL - 137 ID - 1953 ER - TY - JOUR AD - S. Igawa, Department of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, Japan AU - Igawa, S. AU - Honma, M. AU - Minami-Hori, M. AU - Tsuchida, E. AU - Iizuka, H. AU - Ishida-Yamamoto, A. DB - Embase Medline DO - 10.1111/1346-8138.13153 IS - 1 LA - English M3 - Letter N1 - L607258737 2015-12-22 2016-04-19 PY - 2016 SN - 1346-8138 0385-2407 SP - 103-104 ST - Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi T2 - Journal of Dermatology TI - Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607258737&from=export http://dx.doi.org/10.1111/1346-8138.13153 VL - 43 ID - 1955 ER - TY - JOUR AD - N. Billestrup, Section of Cellular and Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, Copenhagen N, Denmark AU - Ibarra Urizar, A. AU - Friberg, J. AU - Christensen, D. P. AU - Lund Christensen, G. AU - Billestrup, N. DB - Embase Medline DO - 10.1089/jir.2014.0199 IS - 1 LA - English M3 - Article N1 - L607801541 2016-01-26 2016-01-29 PY - 2016 SN - 1557-7465 1079-9907 SP - 20-29 ST - Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells T2 - Journal of Interferon and Cytokine Research TI - Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607801541&from=export http://dx.doi.org/10.1089/jir.2014.0199 VL - 36 ID - 1957 ER - TY - JOUR AD - M. Firczuk, Department of Immunology, Medical University of Warsaw, Warsaw, Poland AU - Trzeciecka, A. AU - Klossowski, S. AU - Bajor, M. AU - Zagozdzon, R. AU - Gaj, P. AU - Muchowicz, A. AU - Malinowska, A. AU - Czerwoniec, A. AU - Barankiewicz, J. AU - Domagala, A. AU - Chlebowska, J. AU - Prochorec-Sobieszek, M. AU - Winiarska, M. AU - Ostaszewski, R. AU - Gwizdalska, I. AU - Golab, J. AU - Nowis, D. AU - Firczuk, M. DB - Embase Medline DO - 10.18632/oncotarget.6435 IS - 2 LA - English M3 - Article N1 - L608271560 2016-02-16 2016-02-23 PY - 2016 SN - 1949-2553 SP - 1717-1731 ST - Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma T2 - Oncotarget TI - Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608271560&from=export http://dx.doi.org/10.18632/oncotarget.6435 VL - 7 ID - 1958 ER - TY - JOUR AD - J. Jóźwiak, Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, 5 Chalubinskiego St., Warsaw, Poland AU - Borowska, A. AU - Jóźwiak, J. DB - Embase DO - 10.5114/aoms.2016.59939 IS - 3 LA - English M3 - Article N1 - L610734683 2016-06-15 2016-06-21 PY - 2016 SN - 1896-9151 1734-1922 SP - 659-666 ST - Medulloblastoma: Molecular pathways and histopathological classification T2 - Archives of Medical Science TI - Medulloblastoma: Molecular pathways and histopathological classification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610734683&from=export http://dx.doi.org/10.5114/aoms.2016.59939 VL - 12 ID - 1960 ER - TY - JOUR AD - Y.-Z. Chen, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, Fujian Province, China AU - Guo, J. R. AU - Li, W. AU - Wu, Y. AU - Wu, L. Q. AU - Li, X. AU - Guo, Y. F. AU - Zheng, X. H. AU - Lian, X. L. AU - Huang, H. F. AU - Chen, Y. Z. DB - Embase IS - 9 LA - English M3 - Article N1 - L612378986 2016-10-04 2016-10-18 PY - 2016 SN - 1943-8141 SP - 3630-3644 ST - Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway T2 - American Journal of Translational Research TI - Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612378986&from=export VL - 8 ID - 1961 ER - TY - JOUR AD - N. Ratner, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, M.L.C. 7013, Cincinnati, OH, United States AU - Patel, A. V. AU - Chaney, K. E. AU - Choi, K. AU - Largaespada, D. A. AU - Kumar, A. R. AU - Ratner, N. DB - Embase Medline DO - 10.1016/j.ebiom.2016.06.007 LA - English M3 - Article N1 - L612824826 2016-10-25 2016-10-28 PY - 2016 SN - 2352-3964 SP - 110-119 ST - An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors T2 - EBioMedicine TI - An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612824826&from=export http://dx.doi.org/10.1016/j.ebiom.2016.06.007 VL - 9 ID - 1962 ER - TY - JOUR AD - J. Wu, 23 Pingjiang Road, Hexi District, Tianjin, China AU - Wu, J. AU - Cui, H. AU - Zhu, Z. AU - Wang, L. DB - Embase Medline DO - 10.1016/j.bbrc.2016.08.085 IS - 3 LA - English M3 - Article N1 - L612905770 2016-11-07 2016-11-21 PY - 2016 SN - 1090-2104 0006-291X SP - 1158-1164 ST - MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5 T2 - Biochemical and Biophysical Research Communications TI - MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612905770&from=export http://dx.doi.org/10.1016/j.bbrc.2016.08.085 VL - 478 ID - 1963 ER - TY - JOUR AD - J. Wang, Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Henan, China AU - Wang, J. AU - Luo, H. AU - Yang, L. AU - Li, Y. C2 - Sigma(United States) DB - Embase Medline DO - 10.14715/cmb/2016.62.7.10 IS - 7 LA - English M3 - Article N1 - L613009803 2016-11-21 2016-12-08 PY - 2016 SN - 1165-158X 0145-5680 SP - 55-60 ST - Baicalein induces apoptosis and reduces inflammation in LPS-stimulated keratinocytes by blocking the activation of NF-κB: Implications for alleviating oral lichen planus T2 - Cellular and Molecular Biology TI - Baicalein induces apoptosis and reduces inflammation in LPS-stimulated keratinocytes by blocking the activation of NF-κB: Implications for alleviating oral lichen planus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613009803&from=export http://dx.doi.org/10.14715/cmb/2016.62.7.10 VL - 62 ID - 1964 ER - TY - JOUR AD - X. Zhang, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China AU - Ma, Z. AU - Liu, X. AU - Li, F. AU - Wang, Y. AU - Xu, Y. AU - Zhang, M. AU - Zhang, X. AU - Ying, X. AU - Zhang, X. DB - Embase Medline DO - 10.18632/oncotarget.11684 IS - 41 LA - English M3 - Article N1 - L613013865 2016-11-08 2016-11-30 PY - 2016 SN - 1949-2553 SP - 66558-66568 ST - Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/ mTOR signaling T2 - Oncotarget TI - Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/ mTOR signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613013865&from=export http://dx.doi.org/10.18632/oncotarget.11684 VL - 7 ID - 1965 ER - TY - JOUR AD - C. Wang, Dept. of Gastroenterology, West China Hospital, Sichuan Univ., Guo Xue St. 37, Chengdu, China AU - Li, X. AU - Cai, L. AU - Xu, H. AU - Geng, C. AU - Lu, J. AU - Tao, L. AU - Sun, D. AU - Ghishan, F. K. AU - Wang, C. C1 - l 817818 DB - Embase Medline DO - 10.1152/ajpgi.00239.2016 IS - 5 LA - English M3 - Article N1 - L613150549 2016-11-22 2016-12-08 PY - 2016 SN - 1522-1547 0193-1857 SP - G954-G963 ST - Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613150549&from=export http://dx.doi.org/10.1152/ajpgi.00239.2016 VL - 311 ID - 1966 ER - TY - JOUR AD - H. Zhang, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Shi, Y. AU - Yu, Y. AU - Wang, Z. AU - Wang, H. AU - Bieerkehazhi, S. AU - Zhao, Y. AU - Suzuk, L. AU - Zhang, H. C1 - ps 1145 C2 - LC(United States) Sigma Aldrich DB - Embase Medline DO - 10.18632/oncotarget.12048 IS - 45 LA - English M3 - Article N1 - L613339240 2016-11-28 2016-12-20 PY - 2016 SN - 1949-2553 SP - 73697-73710 ST - Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells T2 - Oncotarget TI - Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613339240&from=export http://dx.doi.org/10.18632/oncotarget.12048 VL - 7 ID - 1967 ER - TY - JOUR AD - Z.C. Hannoush, University of Miami, Jackson Memorial Hospital, Miami, FL, United States AU - Hannoush, Z. C. AU - Ayala, A. DB - Embase DO - 10.1210/endo-meetings.2016.TB.1.FRI-090 IS - 2 LA - English M3 - Conference Abstract N1 - L613520166 2016-12-08 PY - 2016 SN - 0163-769X ST - Estrogen exposure and testicular choriocarcinoma: Case report of a male to female transgender patient T2 - Endocrine Reviews TI - Estrogen exposure and testicular choriocarcinoma: Case report of a male to female transgender patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613520166&from=export http://dx.doi.org/10.1210/endo-meetings.2016.TB.1.FRI-090 VL - 37 ID - 1968 ER - TY - JOUR AD - P. Rana, Children's Mercy Hospital, Kansas City, MO, United States AU - Rana, P. AU - Mitre, N. DB - Embase DO - 10.1210/endo-meetings.2016.PE.13.SUN-028 IS - 2 LA - English M3 - Conference Abstract N1 - L613521469 2016-12-08 PY - 2016 SN - 0163-769X ST - Idiopathic hypoparathyroidism in neurofibromatosis type 1-noonan syndrome: A case report T2 - Endocrine Reviews TI - Idiopathic hypoparathyroidism in neurofibromatosis type 1-noonan syndrome: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613521469&from=export http://dx.doi.org/10.1210/endo-meetings.2016.PE.13.SUN-028 VL - 37 ID - 1969 ER - TY - JOUR AD - T.-Y. Chu, Department of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital, No. 707, Chung-Yang Rd., Sec. 3, Hualien, Taiwan AU - Ding, D. C. AU - Liu, H. W. AU - Chu, T. Y. DB - Embase DO - 10.7150/jca.16116 IS - 13 LA - English M3 - Article N1 - L613577040 2016-12-19 2016-12-21 PY - 2016 SN - 1837-9664 SP - 1815-1823 ST - Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3 T2 - Journal of Cancer TI - Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613577040&from=export http://dx.doi.org/10.7150/jca.16116 VL - 7 ID - 1970 ER - TY - JOUR AD - H. Tanaka AU - Tanaka, H. AU - Yamamoto, M. AU - Yamazaki, K. AU - Shimizu, K. AU - Ogawa, K. DB - Embase DO - 10.1158/1538-7445.AM2016-661 IS - 14 LA - English M3 - Conference Abstract N1 - L613608936 2016-12-19 PY - 2016 SN - 1538-7445 ST - Establishment of transgenic mice with liver-specific BRAF V600E mutation T2 - Cancer Research TI - Establishment of transgenic mice with liver-specific BRAF V600E mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613608936&from=export http://dx.doi.org/10.1158/1538-7445.AM2016-661 VL - 76 ID - 1971 ER - TY - JOUR AD - M.R. Khawaja AU - Khawaja, M. R. AU - Khatua, S. AU - Karp, D. AU - Janku, F. AU - Hong, D. AU - Munoz, J. AU - Tsimberidou, A. AU - Zaky, W. AU - Sherman, S. I. AU - Hwu, P. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase DO - 10.1158/1538-7445.AM2016-CT052 IS - 14 LA - English M3 - Conference Abstract N1 - L613610120 2016-12-19 PY - 2016 SN - 1538-7445 ST - A phase I dose escalation trial of vemurafenib in combination with the mTOR inhibitor everolimus for melanoma and non-melanoma cancers with a BRAF aberration T2 - Cancer Research TI - A phase I dose escalation trial of vemurafenib in combination with the mTOR inhibitor everolimus for melanoma and non-melanoma cancers with a BRAF aberration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613610120&from=export http://dx.doi.org/10.1158/1538-7445.AM2016-CT052 VL - 76 ID - 1972 ER - TY - JOUR AD - I. Kiss, Clinic of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic AU - Kiss, I. AU - Rodón, J. AU - Grande Pulido, E. AU - Rha, S. Y. AU - Sathornsumetee, S. AU - Hess, G. AU - Eigendorff, E. AU - Cesic, D. AU - Sutradhar, S. AU - Pramanik, B. AU - Kim, T. M. DB - Embase DO - 10.1093/annonc/mdw368.53 LA - English M3 - Conference Abstract N1 - L613911745 2017-01-03 PY - 2016 SN - 1569-8041 ST - Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 T2 - Annals of Oncology TI - Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613911745&from=export http://dx.doi.org/10.1093/annonc/mdw368.53 VL - 27 ID - 1973 ER - TY - JOUR AD - T. Guo, Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan,HuBei, China AU - Yu, W. AU - Cao, D. D. AU - Li, Q. B. AU - Mei, H. L. AU - Hu, Y. AU - Guo, T. DB - Embase IS - 52 LA - English M3 - Article N1 - L613929736 2017-01-09 PY - 2016 SN - 1949-2553 SP - 86075-86086 ST - Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy T2 - Oncotarget TI - Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613929736&from=export VL - 7 ID - 1974 ER - TY - JOUR DB - Embase IS - 4 LA - English M3 - Conference Review N1 - L614627021 2017-03-07 PY - 2016 SN - 1753-6561 ST - Abstracts from the 5th International Conference for Healthcare and Medical Students, ICHAMS 2016 T2 - BMC Proceedings TI - Abstracts from the 5th International Conference for Healthcare and Medical Students, ICHAMS 2016 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614627021&from=export VL - 10 ID - 1975 ER - TY - JOUR AD - E.A. Raetz, Department of Pediatrics, Huntsman Cancer Institute, University of Utah, 100 N. Mario Capecchi Dr, Salt Lake City, UT, United States AU - Raetz, E. A. AU - Teachey, D. T. DB - Embase Medline DO - 10.1182/asheducation-2016.1.580 IS - 1 LA - English M3 - Article N1 - L616751173 2017-09-06 2017-09-13 PY - 2016 SN - 1520-4383 1520-4391 SP - 580-588 ST - T-cell acute lymphoblastic leukemia TI - T-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616751173&from=export http://dx.doi.org/10.1182/asheducation-2016.1.580 VL - 2016 ID - 1976 ER - TY - JOUR AD - A.S. Levy, Montefiore Medical Center, Bronx, NY, United States AU - Levy, A. S. AU - Roth, M. AU - Patterson, N. AU - Scott, E. AU - Quispe-Tintaya, W. AU - Ewart, M. R. AU - Maslov, A. AU - Golden, A. AU - Montagna, C. DB - Embase DO - 10.1158/1557-3265.PMSCLINGEN15-15 IS - 1 LA - English M3 - Conference Abstract N1 - L624072536 2018-10-02 PY - 2016 SN - 1557-3265 ST - Target next sequencing profiling of pediatric solid tumors: Potential use for the identification of actionable mutations T2 - Clinical Cancer Research TI - Target next sequencing profiling of pediatric solid tumors: Potential use for the identification of actionable mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624072536&from=export http://dx.doi.org/10.1158/1557-3265.PMSCLINGEN15-15 VL - 22 ID - 1977 ER - TY - JOUR AD - G. Shokri, Islamic Azad University, Damghan, Iran AU - Shokri, G. AU - Fathi, M. AU - Kouhkan, F. DB - Embase LA - English M3 - Conference Abstract N1 - L626515957 2019-03-01 PY - 2016 SN - 2228-5814 SP - 62-63 ST - Evaluation of KDM5A knockdown by SHRNA in acute myeloid leukemia cell line T2 - Cell Journal TI - Evaluation of KDM5A knockdown by SHRNA in acute myeloid leukemia cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626515957&from=export VL - 18 ID - 1978 ER - TY - JOUR AD - B. Amulic, Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Chariteplatz 1, Berlin, Germany AU - Harbort, C. J. AU - Soeiro-Pereira, P. V. AU - Von Bernuth, H. AU - Kaindl, A. M. AU - Costa-Carvalho, B. T. AU - Condino-Neto, A. AU - Reichenbach, J. AU - Roesler, J. AU - Zychlinsky, A. AU - Amulic, B. DB - Embase Medline DO - 10.1182/blood-2015-05-645424 IS - 26 LA - English M3 - Article N1 - L607776617 2016-01-27 2016-02-02 PY - 2015 SN - 1528-0020 0006-4971 SP - 2842-2851 ST - Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis T2 - Blood TI - Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607776617&from=export http://dx.doi.org/10.1182/blood-2015-05-645424 VL - 126 ID - 1979 ER - TY - JOUR AD - M. Gardberg, Department of Pathology, Turku University Hospital, Kiinamyllynkatu 10, Turku, Finland AU - Gardberg, M. AU - Heuser, V. D. AU - Koskivuo, I. AU - Koivisto, M. AU - Carpen, O. DB - Embase DO - 10.1002/cjp2.34 IS - 1 LA - English M3 - Article N1 - L621738214 2018-04-27 2018-05-09 PY - 2016 SN - 2056-4538 SP - 41-52 ST - FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome T2 - Journal of Pathology: Clinical Research TI - FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621738214&from=export http://dx.doi.org/10.1002/cjp2.34 VL - 2 ID - 1980 ER - TY - JOUR AD - S. Weitzman, Division of Haematology/Oncology, Department of Pediatrics, Hospital for Sick Children, 555 University Ave, Toronto, ON, Canada AU - Abla, O. AU - Weitzman, S. DB - Embase Medline DO - 10.1182/asheducation-2015.1.565 IS - 1 LA - English M3 - Article N1 - L614261626 2017-02-06 2017-02-09 PY - 2015 SN - 1520-4383 1520-4391 SP - 565-570 ST - Treatment of Langerhans cell histiocytosis: Role of BRAF/MAPK inhibition TI - Treatment of Langerhans cell histiocytosis: Role of BRAF/MAPK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614261626&from=export http://dx.doi.org/10.1182/asheducation-2015.1.565 VL - 2015 ID - 1982 ER - TY - JOUR AD - F. Kuang, Institute of Neurosciences, Fourth Military Medical University, Xi'an, China AU - Liu, J. T. AU - Chen, B. Y. AU - Zhang, J. Q. AU - Kuang, F. AU - Chen, L. W. DB - Embase Medline DO - 10.1016/j.toxlet.2015.09.015 IS - 2 LA - English M3 - Article N1 - L606121862 2015-09-29 2015-10-02 PY - 2015 SN - 1879-3169 0378-4274 SP - 97-107 ST - Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades T2 - Toxicology Letters TI - Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606121862&from=export http://dx.doi.org/10.1016/j.toxlet.2015.09.015 VL - 239 ID - 1983 ER - TY - JOUR AD - M. Wang, Department of Haematology, Cambridge University Hospitals, Cambridge, United Kingdom AU - Wang, M. AU - Eskiocak, U. AU - Agathokleous, M. AU - Yuan, S. AU - Crawley, C. AU - Morrison, S. J. DB - Embase IS - 23 LA - English M3 - Conference Abstract N1 - L72171810 2016-02-08 PY - 2015 SN - 0006-4971 SP - 1264 ST - Therapeutic synergy from combined inhibition of the SERCA channel and MAPK signaling pathway in MAPK-dependent leukemia T2 - Blood TI - Therapeutic synergy from combined inhibition of the SERCA channel and MAPK signaling pathway in MAPK-dependent leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72171810&from=export http://www.bloodjournal.org/content/126/23/1264 VL - 126 ID - 1984 ER - TY - JOUR AD - A. Polak, Dept. of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland AU - Polak, A. AU - Kiliszek, P. AU - Sewastianik, T. AU - Szydlowski, M. AU - Jablonska, E. AU - Bialopiotrowicz, E. AU - Gorniak, P. AU - Markowicz, S. AU - Nowak, E. AU - Grygorowicz, M. A. AU - Nowis, D. AU - Golab, J. AU - Giebel, S. AU - Lech-Maranda, E. AU - Warzocha, K. AU - Juszczynski, P. DB - Embase IS - 23 LA - English M3 - Conference Abstract N1 - L72175607 2016-02-08 PY - 2015 SN - 0006-4971 SP - 4917 ST - MEK1 inhibitor selumetinib sensitizes precursor b-cell acute lymphoblastic leukemia cells (B-ALL) to dexamethasone through modulation of mTOR activity and stimulation of autophagy T2 - Blood TI - MEK1 inhibitor selumetinib sensitizes precursor b-cell acute lymphoblastic leukemia cells (B-ALL) to dexamethasone through modulation of mTOR activity and stimulation of autophagy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72175607&from=export http://www.bloodjournal.org/content/126/23/4917 VL - 126 ID - 1985 ER - TY - JOUR AD - A.E. Feldstein, Department of Pediatrics, University of California-San Diego, MC 0715, 9500 Gilman Drive, San Diego, CA, United States AU - Wree, A. AU - Johnson, C. D. AU - Font-Burgada, J. AU - Eguchi, A. AU - Povero, D. AU - Karin, M. AU - Feldstein, A. E. DB - Embase Medline DO - 10.1038/cdd.2015.46 IS - 12 LA - English M3 - Article N1 - L604025759 2015-05-01 2015-11-25 PY - 2015 SN - 1476-5403 1350-9047 SP - 1985-1994 ST - Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation T2 - Cell Death and Differentiation TI - Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604025759&from=export http://dx.doi.org/10.1038/cdd.2015.46 VL - 22 ID - 1986 ER - TY - JOUR AD - R. Rabadan, Department of Biomedical Informatics, Columbia University, New York, NY, United States AU - Da Silva Almeida, A. C. AU - Abate, F. AU - Khiabanian, H. AU - Martinez-Escala, E. AU - Guitart, J. AU - Tensen, C. P. AU - Vermeer, M. H. AU - Rabadan, R. AU - Ferrando, A. AU - Palomero, T. DB - Embase Medline DO - 10.1038/ng.3442 IS - 12 LA - English M3 - Article N1 - L606884099 2015-11-18 2015-12-14 PY - 2015 SN - 1546-1718 1061-4036 SP - 1465-1470 ST - The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome T2 - Nature Genetics TI - The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606884099&from=export http://dx.doi.org/10.1038/ng.3442 VL - 47 ID - 1987 ER - TY - JOUR AD - A. Comi, Department of Neurology, Kennedy Krieger Institute, 2901 E Biddle St, Baltimore, MD, United States AU - Comi, A. DB - Embase Medline DO - 10.1016/j.spen.2015.10.005 IS - 4 LA - English M3 - Review N1 - L607419215 2016-01-01 2016-01-07 PY - 2015 SN - 1558-0776 1071-9091 SP - 295-301 ST - Current Therapeutic Options in Sturge-Weber Syndrome T2 - Seminars in Pediatric Neurology TI - Current Therapeutic Options in Sturge-Weber Syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607419215&from=export http://dx.doi.org/10.1016/j.spen.2015.10.005 VL - 22 ID - 1988 ER - TY - JOUR AD - M. Ruggieri, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Via S. Sofia, 78, Catania, Italy AU - Ruggieri, M. AU - Praticò, A. D. AU - Muglia, M. AU - Maiolino, L. AU - Magro, G. AU - Evans, D. G. DB - Embase DO - 10.1055/s-0036-1572361 IS - 4 LA - English M3 - Review N1 - L608480999 2016-02-24 2016-04-13 PY - 2015 SN - 1879-5404 1879-5390 SP - 120-130 ST - Biochemical Insights into Merlin/NF2 Pathophysiology and Biologically Targeted Therapies in Childhood NF2 and Related Forms T2 - Journal of Pediatric Biochemistry TI - Biochemical Insights into Merlin/NF2 Pathophysiology and Biologically Targeted Therapies in Childhood NF2 and Related Forms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608480999&from=export http://dx.doi.org/10.1055/s-0036-1572361 VL - 5 ID - 1989 ER - TY - JOUR AD - K. Ohno, Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan AU - Mishima, K. AU - Kitoh, H. AU - Ohkawara, B. AU - Okuno, T. AU - Ito, M. AU - Masuda, A. AU - Ishiguro, N. AU - Ohno, K. DB - Embase Medline DO - 10.1016/j.ebiom.2015.11.024 IS - 12 LA - English M3 - Article N1 - L608512927 2016-03-02 2016-03-07 PY - 2015 SN - 2352-3964 SP - 2046-2061 ST - Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis T2 - EBioMedicine TI - Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608512927&from=export http://dx.doi.org/10.1016/j.ebiom.2015.11.024 VL - 2 ID - 1990 ER - TY - JOUR AD - P.-H. Lee, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan AU - Hsiao, C. C. AU - Chen, P. H. AU - Cheng, C. I. AU - Tsai, M. S. AU - Chang, C. Y. AU - Lu, S. C. AU - Hsieh, M. C. AU - Lin, Y. C. AU - Lee, P. H. AU - Kao, Y. H. DB - Embase Medline DO - 10.1016/j.canlet.2015.08.004 IS - 1 LA - English M3 - Article N1 - L605755127 2015-08-28 2015-09-03 PY - 2015 SN - 1872-7980 0304-3835 SP - 144-152 ST - Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells T2 - Cancer Letters TI - Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605755127&from=export http://dx.doi.org/10.1016/j.canlet.2015.08.004 VL - 368 ID - 1991 ER - TY - JOUR AD - R. Basha, Department of Pediatrics, Molecular and Medical Genetics and Institute for Cancer Research (ICR), University of North Texas Health Science Center, 3500Camp Bowie Blvd., CBH 328, Fort Worth, TX, United States AU - Shelake, S. AU - Eslin, D. AU - Sutphin, R. M. AU - Sankpal, U. T. AU - Wadwani, A. AU - Kenyon, L. E. AU - Tabor-Simecka, L. AU - Bowman, W. P. AU - Vishwanatha, J. K. AU - Basha, R. C2 - Sigma DB - Embase Medline DO - 10.1016/j.ijdevneu.2015.07.012 LA - English M3 - Article N1 - L605863236 2015-09-09 2020-10-08 PY - 2015 SN - 1873-474X 0736-5748 SP - 92-99 ST - Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation T2 - International Journal of Developmental Neuroscience TI - Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605863236&from=export http://dx.doi.org/10.1016/j.ijdevneu.2015.07.012 VL - 46 ID - 1992 ER - TY - JOUR AD - Y. Komatsu, Department of Pediatrics, University of Texas, Medical School at Houston, 6431 Fannin St, Houston, TX, United States AU - Kamiya, N. AU - Shen, J. AU - Noda, K. AU - Kitami, M. AU - Feng, G. S. AU - Chen, D. AU - Komatsu, Y. DB - Embase Medline DO - 10.1002/jbmr.2541 IS - 11 LA - English M3 - Article N1 - L606575279 2015-10-29 2015-10-30 PY - 2015 SN - 1523-4681 0884-0431 SP - 2028-2032 ST - SHP2-Deficiency in Chondrocytes Deforms Orofacial Cartilage and Ciliogenesis in Mice T2 - Journal of Bone and Mineral Research TI - SHP2-Deficiency in Chondrocytes Deforms Orofacial Cartilage and Ciliogenesis in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606575279&from=export http://dx.doi.org/10.1002/jbmr.2541 VL - 30 ID - 1993 ER - TY - JOUR AU - Huo, Z. AU - Wu, H. AU - Li, J. AU - Li, S. AU - Wu, S. AU - Liu, Y. AU - Luo, Y. AU - Cao, J. AU - Zeng, X. AU - Liang, Z. DB - Embase DO - 10.1371/journal.pone.0143169 IS - 11 LA - English M3 - Article N1 - L608007724 2016-02-09 2016-02-11 PY - 2015 SN - 1932-6203 ST - Primary pulmonary mucoepidermoid carcinoma: Histopathological and moleculargenetic studies of 26 cases T2 - PLoS ONE TI - Primary pulmonary mucoepidermoid carcinoma: Histopathological and moleculargenetic studies of 26 cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608007724&from=export http://dx.doi.org/10.1371/journal.pone.0143169 VL - 10 ID - 1994 ER - TY - JOUR AD - D. Sheer, Barts and The London School of Medicine and Dentistry, Blizard Institute, London, United Kingdom AU - Sheer, D. AU - Jeyapalan, J. AU - Doctor, G. T. AU - Jones, T. A. AU - Alberman, S. N. AU - Tep, A. AU - Haria, C. M. AU - Schwalbe, E. C. AU - Clifford, S. C. AU - Tatevossian, R. G. AU - Qaddoumi, I. AU - Ellison, D. W. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189431 2016-11-17 PY - 2015 SN - 1545-5017 SP - S283-S284 ST - Dna methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific signature at a set of enhancers T2 - Pediatric Blood and Cancer TI - Dna methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific signature at a set of enhancers UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189431&from=export http://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 1996 ER - TY - JOUR AD - P. Fedatto, Ribeirão Preto Medicine School, University of São Paulo, Pediatrics, Ribeirão Preto, Brazil AU - Fedatto, P. AU - Marco Antonio, D. AU - Baroni, M. AU - Panepucci, R. AU - Goes, A. AU - Martinelli, C. AU - Antonini, S. AU - De Castro, M. AU - Tucci, S. AU - Neder, L. AU - Seidinger, A. AU - Matellaro, M. AU - Yunes, J. AU - Brandalise, S. AU - Tone, L. AU - Scrideli, C. A. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189598 2016-11-17 PY - 2015 SN - 1545-5017 SP - S161 ST - Microrna signatures in pediatric adrenocortical tumors: Identification of micrornas and predicted pathways involved in tumorigenesis and prognosis T2 - Pediatric Blood and Cancer TI - Microrna signatures in pediatric adrenocortical tumors: Identification of micrornas and predicted pathways involved in tumorigenesis and prognosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189598&from=export http://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 1997 ER - TY - JOUR AD - M. Ramadwar, TATA Memorial Hospital, Mumbai, India AU - Ramadwar, M. AU - Qureshi, S. AU - Medhi, S. AU - Rekhi, B. AU - Vora, T. AU - Chinnaswamy, G. AU - Khanna, N. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189954 2016-11-17 PY - 2015 SN - 1545-5017 SP - S371 ST - Inflammatory myofibroblastic tumour (IMT) affecting paediatric patients: A study of 46 patients with emphasis on histopathologic diagnostic issues T2 - Pediatric Blood and Cancer TI - Inflammatory myofibroblastic tumour (IMT) affecting paediatric patients: A study of 46 patients with emphasis on histopathologic diagnostic issues UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189954&from=export http://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 1998 ER - TY - JOUR AD - E. Derenzini, Institute of Hematology and Medical Oncology L.A. Seragnoli, Department of Experimental, Diagnostic and Specialty Medicine- DIMES, University of Bologna, Bologna, Italy AU - Derenzini, E. AU - Zinzani, P. L. DB - Embase LA - English M3 - Conference Abstract N1 - L72081192 2015-11-27 PY - 2015 SN - 0390-6078 SP - 200-202 ST - Treatment of adult langerhans cell histiocytosis T2 - Haematologica TI - Treatment of adult langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72081192&from=export http://www.haematologica.org/content/100/supplement_3/1.full-text.pdf+html VL - 100 ID - 1999 ER - TY - JOUR AD - L. Zhong, Department of Gastroenterology, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, Shanghai, China AU - Zhao, M. AU - Chen, J. AU - Zhu, P. AU - Fujino, M. AU - Takahara, T. AU - Toyama, S. AU - Tomita, A. AU - Zhao, L. AU - Yang, Z. AU - Hei, M. AU - Zhong, L. AU - Zhuang, J. AU - Kimura, S. AU - Li, X. K. C2 - dhq(Japan) DB - Embase Medline DO - 10.1016/j.intimp.2015.04.032 IS - 2 LA - English M3 - Article N1 - L604393017 2015-05-20 2015-12-08 PY - 2015 SN - 1878-1705 1567-5769 SP - 938-944 ST - Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells T2 - International Immunopharmacology TI - Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604393017&from=export http://dx.doi.org/10.1016/j.intimp.2015.04.032 VL - 28 ID - 2000 ER - TY - JOUR AD - C. Lu, Nanjing Maternity and Child Health Care Hospital, Affiliated Nanjing Medical University, No. 123, Tianfei Street, Mochou Road, Nanjing, China AU - Xu, P. AU - Wang, L. AU - Huang, L. AU - Li, W. AU - Lv, S. AU - Lv, M. AU - Ma, J. AU - Zhou, Q. AU - Wu, X. AU - Fu, Z. AU - Lu, C. AU - Yin, H. DB - Embase Medline DO - 10.1016/j.biopha.2015.07.019 LA - English M3 - Article N1 - L605642396 2015-08-20 2015-10-22 PY - 2015 SN - 1950-6007 0753-3322 SP - 173-178 ST - Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology T2 - Biomedicine and Pharmacotherapy TI - Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605642396&from=export http://dx.doi.org/10.1016/j.biopha.2015.07.019 VL - 75 ID - 2001 ER - TY - JOUR AD - E.A. Fuller, Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia AU - Fuller, E. A. AU - Sominsky, L. AU - McLaughlin, E. A. AU - Hodgson, D. M. DB - Embase DO - 10.1016/j.bbi.2015.06.136 LA - English M3 - Conference Abstract N1 - L622992824 2018-07-17 PY - 2015 SN - 1090-2139 SP - e35 ST - Acute neonatal immune challenge: Lipopolysaccharide exposure alters neonatal ovarian inflammatory pathways and mediators T2 - Brain, Behavior, and Immunity TI - Acute neonatal immune challenge: Lipopolysaccharide exposure alters neonatal ovarian inflammatory pathways and mediators UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622992824&from=export http://dx.doi.org/10.1016/j.bbi.2015.06.136 VL - 49 ID - 2002 ER - TY - JOUR AD - H. Stumme, Stauferklinikum Schwaeb. Gmuend, Zentrum Innere Medizin, Schwerpunkt Haematologie/Onkologie, Mutlangen, Germany AU - Stumme, H. AU - Lang, P. AU - Woessmann, W. AU - Ott, G. AU - Vöhringer, M. AU - Handgretinger, R. AU - Hebart, H. DB - Embase DO - 10.1159/000439070 LA - English M3 - Conference Abstract N1 - L72071277 2015-11-20 PY - 2015 SN - 2296-5270 SP - 212 ST - Combination therapy with crizotinib/Brentuximab Vedotin in chemorefractory ALK-positive ALCL is feasible and highly effective-a case report T2 - Oncology Research and Treatment TI - Combination therapy with crizotinib/Brentuximab Vedotin in chemorefractory ALK-positive ALCL is feasible and highly effective-a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72071277&from=export http://dx.doi.org/10.1159/000439070 VL - 38 ID - 2003 ER - TY - JOUR AD - E. Lowe, Children's Hospital of The King's Daughters, Norfolk, VA, United States AU - Lowe, E. DB - Embase DO - 10.1111/bjh.13753 LA - English M3 - Conference Abstract N1 - L72231328 2016-04-13 PY - 2015 SN - 0007-1048 SP - 19-20 ST - Targeted therapeutic approaches in anaplastic large cell lymphoma T2 - British Journal of Haematology TI - Targeted therapeutic approaches in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72231328&from=export http://dx.doi.org/10.1111/bjh.13753 VL - 171 ID - 2004 ER - TY - JOUR AD - N. Lavoine, Gustave-Roussy, Villejuif, France AU - Lavoine, N. AU - Le Deley, M. C. AU - Woessmann, W. AU - Pillon, M. AU - Williams, D. AU - Horibe, K. AU - Wrobel, G. AU - Attarbaschi, A. AU - Bezhuisen, A. AU - Uyttebroeck, A. AU - Mellgren, K. AU - Brugières, L. DB - Embase DO - 10.1111/bjh.13753 LA - English M3 - Conference Abstract N1 - L72231395 2016-04-13 PY - 2015 SN - 0007-1048 SP - 55 ST - Second and subsequent relapses of ALCL: EICNHL experience T2 - British Journal of Haematology TI - Second and subsequent relapses of ALCL: EICNHL experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72231395&from=export http://dx.doi.org/10.1111/bjh.13753 VL - 171 ID - 2005 ER - TY - JOUR AD - X.-P. Wan, Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University, School of Medicine, 536 Changle Road, Jingan, Shanghai, China AU - Li, Y. AU - Che, Q. AU - Bian, Y. AU - Zhou, Q. AU - Jiang, F. AU - Tong, H. AU - Ke, J. AU - Wang, K. AU - Wan, X. P. DB - Embase Medline DO - 10.3892/ijo.2015.3091 IS - 3 LA - English M3 - Article N1 - L605406931 2015-08-04 2015-08-06 PY - 2015 SN - 1791-2423 1019-6439 SP - 1017-1024 ST - Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway T2 - International Journal of Oncology TI - Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605406931&from=export http://dx.doi.org/10.3892/ijo.2015.3091 VL - 47 ID - 2008 ER - TY - JOUR AD - S. Sukumar, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB 1, Baltimore, MD, United States AU - Jin, K. AU - Park, S. AU - Teo, W. W. AU - Korangath, P. AU - Cho, S. S. AU - Yoshida, T. AU - Győrffy, B. AU - Goswami, C. P. AU - Nakshatri, H. AU - Cruz, L. A. AU - Zhou, W. AU - Ji, H. AU - Su, Y. AU - Ekram, M. AU - Wu, Z. AU - Zhu, T. AU - Polyak, K. AU - Sukumar, S. DB - Embase Medline DO - 10.1158/2159-8290.CD-15-0090 IS - 9 LA - English M3 - Article N1 - L606030783 2015-09-24 2015-09-28 PY - 2015 SN - 2159-8290 2159-8274 SP - 944-959 ST - HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance T2 - Cancer Discovery TI - HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606030783&from=export http://dx.doi.org/10.1158/2159-8290.CD-15-0090 VL - 5 ID - 2009 ER - TY - JOUR AD - B.J. Bezak, Mayo Clinic, United States AU - Bezak, B. J. AU - Elvin, J. AU - Markovic, S. AU - Viozzi, C. F. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L620236285 2018-01-23 PY - 2015 SN - 1531-5053 SP - e42-e43 ST - Comprehensive genomic profiling of aggressive central giant cell lesion identifies targeted therapy treatment option with subsequent response T2 - Journal of Oral and Maxillofacial Surgery TI - Comprehensive genomic profiling of aggressive central giant cell lesion identifies targeted therapy treatment option with subsequent response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620236285&from=export VL - 73 ID - 2010 ER - TY - JOUR AD - G. Vassal, Gustave Roussy Istitute, Oncology, Villejuif, France AU - Vassal, G. AU - Moro-sibilot, D. AU - Le Deley, M. C. AU - Hoog-labouret, N. AU - Nowak, F. AU - Jimenez, M. AU - Tournigand, C. AU - Houot, R. AU - Malka, D. AU - Aparicio, T. AU - Escudier, B. AU - Ray-Coquard, I. AU - Godbert, Y. AU - Taillandier, L. AU - Bieche, I. AU - Lantuejoul, S. AU - Ferretti, G. AU - Menu, Y. AU - Blay, J. Y. AU - Buzyn, A. DB - Embase LA - English M3 - Conference Abstract N1 - L72068628 2015-11-20 PY - 2015 SN - 0959-8049 SP - S715 ST - Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé Program T2 - European Journal of Cancer TI - Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé Program UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72068628&from=export VL - 51 ID - 2011 ER - TY - JOUR AD - J. Xie, Departments of Pediatrics, Biochemistry and Molecular Biology, Pharmacology and Toxicology, The Wells Center for Pediatrics Research, 1044 W, Walnut Street, Indianapolis, IN, United States AU - Gu, D. AU - Xie, J. DB - Embase DO - 10.3390/cancers7030857 IS - 3 LA - English M3 - Review N1 - L605879006 2015-09-14 2015-09-17 PY - 2015 SN - 2072-6694 SP - 1684-1698 ST - Non-canonical Hh signaling in cancer—Current understanding and future directions T2 - Cancers TI - Non-canonical Hh signaling in cancer—Current understanding and future directions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605879006&from=export http://dx.doi.org/10.3390/cancers7030857 VL - 7 ID - 2012 ER - TY - JOUR AD - I. Lugowska, Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgen Street 5, Warsaw, Poland AU - Lugowska, I. AU - Koseła-Paterczyk, H. AU - Kozak, K. AU - Rutkowski, P. C1 - gsk 1120212 DB - Embase DO - 10.2147/OTT.S72951 LA - English M3 - Review N1 - L605766983 2015-09-02 2015-09-03 PY - 2015 SN - 1178-6930 SP - 2251-2259 ST - Trametinib: A MEK inhibitor for management of metastatic melanoma T2 - OncoTargets and Therapy TI - Trametinib: A MEK inhibitor for management of metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605766983&from=export http://dx.doi.org/10.2147/OTT.S72951 VL - 8 ID - 2013 ER - TY - JOUR AD - A. Karimi, Paediatric Infection Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran AU - Sayyahfar, S. AU - Karimi, A. AU - Gharib, A. AU - Fahimzad, A. DB - Embase DO - 10.17795/ijcp-3438 IS - 4 LA - English M3 - Article N1 - L606176692 2015-10-08 2015-10-13 PY - 2015 SN - 2538-497X 2538-4422 ST - Association of systemic anaplastic large cell lymphoma and active toxoplasmosis in a child T2 - International Journal of Cancer Management TI - Association of systemic anaplastic large cell lymphoma and active toxoplasmosis in a child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606176692&from=export http://dx.doi.org/10.17795/ijcp-3438 VL - 8 ID - 2014 ER - TY - JOUR AD - S.S.C. Cheung, Ike Barber Human Islet Transplantation Laboratory, R340, 828 W. 10th Avenue, VGH Research Pavilion, Vancouver, BC, Canada AU - Cheung, S. S. C. AU - Tai, J. AU - Hasman, D. AU - Ou, D. AU - Warnock, G. L. DB - Embase Medline DO - 10.1080/01635581.2015.1055367 IS - 6 LA - English M3 - Article N1 - L605475268 2015-08-11 2015-08-28 PY - 2015 SN - 1532-7914 0163-5581 SP - 954-964 ST - Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound T2 - Nutrition and Cancer TI - Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605475268&from=export http://dx.doi.org/10.1080/01635581.2015.1055367 VL - 67 ID - 2016 ER - TY - JOUR AD - R. Franca, Institute for Maternal and Child Health (I.R.C.C.S.) Burlo Garofolo, UO Pediatric Hemato-Oncology, Trieste, Italy AU - Franca, R. AU - Stocco, G. AU - Favretto, D. AU - Giurici, N. AU - Decorti, G. AU - Rabusin, M. DB - Embase Medline DO - 10.3390/ijms160818601 IS - 8 LA - English M3 - Review N1 - L605602344 2015-08-21 2015-08-25 PY - 2015 SN - 1422-0067 1661-6596 SP - 18601-18627 ST - Role of pharmacogenetics in hematopoietic stem cell transplantation outcome in children T2 - International Journal of Molecular Sciences TI - Role of pharmacogenetics in hematopoietic stem cell transplantation outcome in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605602344&from=export http://dx.doi.org/10.3390/ijms160818601 VL - 16 ID - 2017 ER - TY - JOUR AD - D.M. Duarte, INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P., National Authority of Medicines and Health Products, I.P., Parque Saúde de Lisboa, Av. do Brasil, 53, Lisboa, Portugal AU - Duarte, D. M. C1 - abt 263 afinitor apn 311 avastin busilvex caprelsa cometriq dacogen evoltra glivec iclusig mekinist mepact mozobil nexavar siklos stivarga tafinlar tasigna temodal tepadina votrient votubia xaluprine xgeva zaltrap DB - Embase Medline DO - 10.1016/j.reprotox.2015.05.005 LA - English M3 - Article N1 - L604484699 2015-05-28 2015-08-06 PY - 2015 SN - 1873-1708 0890-6238 SP - 97-104 ST - Use of juvenile animal studies to support oncology medicine development in children T2 - Reproductive Toxicology TI - Use of juvenile animal studies to support oncology medicine development in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604484699&from=export http://dx.doi.org/10.1016/j.reprotox.2015.05.005 VL - 56 ID - 2018 ER - TY - JOUR AD - S.Y. Shvartsman, Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United States AU - Jindal, G. A. AU - Goyal, Y. AU - Burdine, R. D. AU - Rauen, K. A. AU - Shvartsman, S. Y. DB - Embase Medline DO - 10.1242/dmm.020339 IS - 8 LA - English M3 - Review N1 - L605690182 2015-08-25 2015-08-27 PY - 2015 SN - 1754-8411 1754-8403 SP - 769-782 ST - RASopathies: Unraveling mechanisms with animal models T2 - DMM Disease Models and Mechanisms TI - RASopathies: Unraveling mechanisms with animal models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605690182&from=export http://dx.doi.org/10.1242/dmm.020339 VL - 8 ID - 2019 ER - TY - JOUR AD - J.P.-Y. Ting, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, United States AU - Callaway, J. B. AU - Smith, S. A. AU - McKinnon, K. P. AU - De Silva, A. M. AU - Crowe, J. E. AU - Ting, J. P. Y. DB - Embase Medline DO - 10.1074/jbc.M115.664136 IS - 28 LA - English M3 - Article N1 - L605761484 2015-09-03 2015-09-08 PY - 2015 SN - 1083-351X 0021-9258 SP - 17306-17320 ST - Spleen tyrosine kinase (Syk) mediates IL-1β induction by primary human monocytes during antibody-enhanced dengue virus infection T2 - Journal of Biological Chemistry TI - Spleen tyrosine kinase (Syk) mediates IL-1β induction by primary human monocytes during antibody-enhanced dengue virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605761484&from=export http://dx.doi.org/10.1074/jbc.M115.664136 VL - 290 ID - 2021 ER - TY - JOUR AD - J. Zhao, Department of Orthopedics, Southern Medical University, Jinling Hospital, 305 Zhongshan East Road, Nanjing, Jiangsu, China AU - Zhang, Z. AU - Fang, Y. AU - Wang, Q. AU - Sun, Y. AU - Xiong, C. AU - Cao, L. AU - Wang, B. AU - Bao, N. AU - Zhao, J. DB - Embase Medline DO - 10.3892/mmr.2015.3529 IS - 1 LA - English M3 - Article N1 - L603645562 2015-04-16 2015-04-23 PY - 2015 SN - 1791-3004 1791-2997 SP - 1499-1505 ST - Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway T2 - Molecular Medicine Reports TI - Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603645562&from=export http://dx.doi.org/10.3892/mmr.2015.3529 VL - 12 ID - 2022 ER - TY - JOUR AD - I. Szanto, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland AU - Carnesecchi, S. AU - Rougemont, A. L. AU - Doroshow, J. H. AU - Nagy, M. AU - Mouche, S. AU - Gumy-Pause, F. AU - Szanto, I. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2015.02.027 LA - English M3 - Article N1 - L603983267 2015-05-01 2015-05-22 PY - 2015 SN - 1873-4596 0891-5849 SP - 22-29 ST - The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines T2 - Free Radical Biology and Medicine TI - The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603983267&from=export http://dx.doi.org/10.1016/j.freeradbiomed.2015.02.027 VL - 84 ID - 2023 ER - TY - JOUR AD - F.M. Uckun, Children's Center for Cancer and Blood Diseases, CHLA, 4650 Sunset Boulevard, Smith Research Tower Suite 300-316, Los Angeles, CA, United States AU - Uckun, F. M. AU - Mitchell, L. G. AU - Qazi, S. AU - Liu, Y. AU - Zheng, N. AU - Myers, D. E. AU - Song, Z. AU - Ma, H. AU - Cheng, J. DB - Embase Medline DO - 10.1016/j.ebiom.2015.04.016 IS - 7 LA - English M3 - Article N1 - L604372218 2015-05-20 2015-12-24 PY - 2015 SN - 2352-3964 SP - 649-659 ST - Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL T2 - EBioMedicine TI - Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604372218&from=export http://dx.doi.org/10.1016/j.ebiom.2015.04.016 VL - 2 ID - 2024 ER - TY - JOUR AD - Y. Li, Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China AU - Jin, X. AU - Guo, B. AU - Yan, J. AU - Yang, R. AU - Chang, L. AU - Wang, Y. AU - Miao, C. AU - Liu, S. AU - Zhang, H. AU - Li, Y. DB - Embase Medline DO - 10.1007/s11010-015-2497-9 IS - 1-2 LA - English M3 - Article N1 - L605090890 2015-07-08 2015-10-01 PY - 2015 SN - 1573-4919 0300-8177 SP - 215-222 ST - Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes T2 - Molecular and Cellular Biochemistry TI - Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605090890&from=export http://dx.doi.org/10.1007/s11010-015-2497-9 VL - 408 ID - 2025 ER - TY - JOUR AD - D.H. Teitelbaum, Department of Surgery, Section of Pediatric Surgery, University of Michigan, Mott Children's Hospital, 1540 E Hospital Dr.,SPC 4211, Ann Arbor, United States AU - Freeman, J. J. AU - Feng, Y. AU - Demehri, F. R. AU - Dempsey, P. J. AU - Teitelbaum, D. H. DB - Embase Medline DO - 10.1096/fj.14-269480 IS - 7 LA - English M3 - Article N1 - L605761059 2015-09-03 2015-09-08 PY - 2015 SN - 1530-6860 0892-6638 SP - 2943-2958 ST - TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways T2 - FASEB Journal TI - TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605761059&from=export http://dx.doi.org/10.1096/fj.14-269480 VL - 29 ID - 2027 ER - TY - JOUR AD - M.-L. Jullie, St John's Institute of Dermatopathology and Dermatology, London, United Kingdom AU - Jullie, M. L. AU - Garcia-Herrera, A. AU - Calonje, E. AU - Child, F. AU - Ortonne, N. AU - Carp, L. AU - Coppen, M. DB - Embase DO - 10.1111/bjd.13796 LA - English M3 - Conference Abstract N1 - L71969638 2015-08-08 PY - 2015 SN - 0007-0963 SP - 126 ST - The relationship between CD30+ intravascular T-cell lymphoproliferations and reactive processes T2 - British Journal of Dermatology TI - The relationship between CD30+ intravascular T-cell lymphoproliferations and reactive processes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71969638&from=export http://dx.doi.org/10.1111/bjd.13796 VL - 173 ID - 2028 ER - TY - JOUR AD - L. Xiang, Laboratory of Early Developmental and Injuries, West China Institutes for Womanand Children’s Health, West China Second University Hospital Sichuan University, Chengdu, Sichuan, China AU - Yiwei, T. AU - Hua, H. AU - Hui, G. AU - Mao, M. AU - Xiang, L. DB - Embase Medline DO - 10.12659/MSM.893528 LA - English M3 - Article N1 - L605004157 2015-07-06 PY - 2015 SN - 1643-3750 1234-1010 SP - 1856-1863 ST - HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion T2 - Medical Science Monitor TI - HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605004157&from=export http://dx.doi.org/10.12659/MSM.893528 VL - 21 ID - 2029 ER - TY - JOUR AD - K. Katsibardi, Hematology-Oncology Unit, 1st Department of Pediatrics, Aghia Sofia Children's Hospital, Athens, Greece AU - Katsibardi, K. AU - Vlachou, A. AU - Tourkantoni, N. AU - Atmatzidou, E. AU - Kostaridou, S. AU - Kattamis, A. DB - Embase LA - English M3 - Conference Abstract N1 - L71963821 2015-08-08 PY - 2015 SN - 0390-6078 SP - 668 ST - Evaluation of minimal residual disease and usage of targeted therapy in pediatric patients with anaplastic large CEL lymphoma T2 - Haematologica TI - Evaluation of minimal residual disease and usage of targeted therapy in pediatric patients with anaplastic large CEL lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71963821&from=export http://www.haematologica.org/content/100/supplement_1/1.full-text.pdf+html VL - 100 ID - 2030 ER - TY - JOUR AD - W.L. Miller, University of California, San Francisco, United States AU - Miller, W. L. AU - Tee, M. K. C1 - sb 202190 sb 203580 DB - Embase Medline DO - 10.1016/j.mce.2014.09.010 LA - English M3 - Review N1 - L604021341 2015-05-08 2015-05-11 PY - 2015 SN - 1872-8057 0303-7207 SP - 99-106 ST - The post-translational regulation of 17,20 lyase activity T2 - Molecular and Cellular Endocrinology TI - The post-translational regulation of 17,20 lyase activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604021341&from=export http://dx.doi.org/10.1016/j.mce.2014.09.010 VL - 408 ID - 2031 ER - TY - JOUR AU - Chen, Y. AU - Yan, H. AU - Song, Z. AU - Chen, F. AU - Wang, H. AU - Niu, J. AU - Shi, X. AU - Zhang, D. AU - Zhang, N. AU - Zhai, Z. AU - Zhong, B. AU - Cheng, L. AU - Qian, T. AU - Hao, F. DB - Embase Medline DO - 10.1371/journal.pone.0127957 IS - 6 LA - English M3 - Article N1 - L604911661 2015-06-26 2015-06-30 PY - 2015 SN - 1932-6203 ST - Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis T2 - PLoS ONE TI - Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604911661&from=export http://dx.doi.org/10.1371/journal.pone.0127957 VL - 10 ID - 2032 ER - TY - JOUR AD - Y.S. Prakash, Mayo Clinic, 4-184W Jos SMH, 200 First St SW, Rochester, MN, United States AU - Britt, R. D. AU - Faksh, A. AU - Vogel, E. R. AU - Thompson, M. A. AU - Chu, V. AU - Pandya, H. C. AU - Amrani, Y. AU - Martin, R. J. AU - Pabelick, C. M. AU - Prakash, Y. S. DB - Embase Medline DO - 10.1002/jcp.24814 IS - 6 LA - English M3 - Article N1 - L602495402 2015-03-02 2015-03-05 PY - 2015 SN - 1097-4652 0021-9541 SP - 1189-1198 ST - Vitamin D Attenuates Cytokine-Induced Remodeling in Human Fetal Airway Smooth Muscle Cells T2 - Journal of Cellular Physiology TI - Vitamin D Attenuates Cytokine-Induced Remodeling in Human Fetal Airway Smooth Muscle Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602495402&from=export http://dx.doi.org/10.1002/jcp.24814 VL - 230 ID - 2034 ER - TY - JOUR AD - W. Woessmann, Dept. of Paediatric Haematology and Oncology, NHL-BFM Study Centre, Justus-Liebig-University, Feulgenstrasse 12, Giessen, Germany AU - Damm-Welk, C. AU - Pillon, M. AU - Woessmann, W. AU - Mussolin, L. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L604838437 2015-06-22 2015-06-26 PY - 2015 SN - 1945-0524 1945-0516 SP - 205-216 ST - Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK T2 - Frontiers in Bioscience - Scholar TI - Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604838437&from=export VL - 7S ID - 2035 ER - TY - JOUR AD - S. Whittle, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, United States AU - Whittle, S. AU - Du, M. AU - Woodfield, S. AU - Zhang, L. AU - Okcu, F. AU - Lupo, P. AU - Michael, S. AU - Peter, Z. DB - Embase DO - 10.1002/pbc.25540 LA - English M3 - Conference Abstract N1 - L613190792 2016-11-17 PY - 2015 SN - 1545-5017 SP - S100 ST - The impact of FGFR4 ARG388 on neuroblastoma incidence, outcome, and response to treatment T2 - Pediatric Blood and Cancer TI - The impact of FGFR4 ARG388 on neuroblastoma incidence, outcome, and response to treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613190792&from=export http://dx.doi.org/10.1002/pbc.25540 VL - 62 ID - 2036 ER - TY - JOUR AD - J. Hamm, University of Alabama at Birmingham, Birmingham, AL, United States AU - Hamm, J. AU - Cleveland, D. S. AU - Cramer, S. AU - Whelan, K. DB - Embase DO - 10.1002/pbc.25540 LA - English M3 - Conference Abstract N1 - L613190905 2016-11-17 PY - 2015 SN - 1545-5017 SP - S71-S72 ST - Difficult diagnosis and treatment of an adolescent renal tumor T2 - Pediatric Blood and Cancer TI - Difficult diagnosis and treatment of an adolescent renal tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613190905&from=export http://dx.doi.org/10.1002/pbc.25540 VL - 62 ID - 2037 ER - TY - JOUR AD - S. Hausmann, Department of General Surgery, Technische Universität München, Munich, Germany AU - Hausmann, S. AU - Regel, I. AU - Mazur, P. AU - Federlein, A. AU - Wagner, N. AU - Steiger, K. AU - Michalski, C. AU - Erkan, M. AU - Friess, H. AU - Kleeff, J. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L71952079 2015-07-27 PY - 2015 SN - 1424-3903 SP - S33 ST - Periostin promotes pancreatic carcinogenesis and metastatic spread T2 - Pancreatology TI - Periostin promotes pancreatic carcinogenesis and metastatic spread UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71952079&from=export VL - 15 ID - 2038 ER - TY - JOUR AD - A.K. Olow, University of California, San Francisco, CA, United States AU - Olow, A. K. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Meyerowitz, J. AU - Weiss, W. AU - Resnick, A. C. AU - Waanders, A. J. AU - Berger, M. S. AU - Gupta, N. AU - James, C. D. AU - Haas-Kogan, D. A. DB - Embase DO - 10.1093/neuonc/nov061.153 LA - English M3 - Conference Abstract N1 - L72189181 2016-02-19 PY - 2015 SN - 1522-8517 SP - iii38 ST - Targeted combinatorial approach for treatment of pediatric low grade gliomas in the context of BRAFV600E and KIAA1549:BRAF mutations T2 - Neuro-Oncology TI - Targeted combinatorial approach for treatment of pediatric low grade gliomas in the context of BRAFV600E and KIAA1549:BRAF mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72189181&from=export http://dx.doi.org/10.1093/neuonc/nov061.153 VL - 17 ID - 2039 ER - TY - JOUR AD - C. Lai AU - Lai, C. AU - Pittaluga, S. AU - Shovlin, M. AU - Steinberg, S. M. AU - Roschewski, M. J. AU - Jaffe, E. S. AU - Wilson, W. H. AU - Dunleavy, K. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72014953 2015-09-28 PY - 2015 SN - 0732-183X ST - The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH T2 - Journal of Clinical Oncology TI - The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72014953&from=export http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/8564?sid=15159491-756d-4d64-8132-ddcf7b94d26f VL - 33 ID - 2040 ER - TY - JOUR AD - B. Geoerger AU - Geoerger, B. AU - Schulte, J. AU - Zwaan, C. M. AU - Casanova, M. AU - Fischer, M. AU - Moreno, L. AU - Trahair, T. AU - Jimenez, I. AU - Kang, H. J. AU - Pappo, A. S. AU - Schafer, E. AU - Weiss, B. D. AU - Healy, M. E. AU - Li, K. AU - Lin, T. AU - Boral, A. AU - Pearson, A. D. J. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015800 2015-09-28 PY - 2015 SN - 0732-183X ST - Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results T2 - Journal of Clinical Oncology TI - Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015800&from=export http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10005?sid=1399ec67-05e7-4f7d-9c85-3f508502267a VL - 33 ID - 2041 ER - TY - JOUR AD - S.R. Rheingold AU - Rheingold, S. R. AU - Whitlock, J. AU - Tasian, S. K. AU - Teachey, D. T. AU - Borowitz, M. J. AU - Liu, X. AU - Ahern, C. H. AU - Minard, C. AU - Fox, E. AU - Weigel, B. AU - Blaney, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015824 2015-09-28 PY - 2015 SN - 0732-183X ST - Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A children's oncology group study T2 - Journal of Clinical Oncology TI - Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A children's oncology group study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015824&from=export http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10029?sid=a1f9e3a2-0a0d-494c-896f-69f5cc91b53c VL - 33 ID - 2042 ER - TY - JOUR AD - E.G. Greengard AU - Greengard, E. G. AU - Mosse, Y. P. AU - Liu, X. AU - Ahern, C. H. AU - Minard, C. AU - Blaney, S. AU - Fox, E. AU - Weigel, B. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015853 2015-09-28 PY - 2015 SN - 0732-183X ST - Safety and tolerability of crizotinib in combination with chemotherapy for relapsed or refractory solid tumors or anaplastic large cell lymphoma: A children's oncology group phase I consortium study T2 - Journal of Clinical Oncology TI - Safety and tolerability of crizotinib in combination with chemotherapy for relapsed or refractory solid tumors or anaplastic large cell lymphoma: A children's oncology group phase I consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015853&from=export http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10058?sid=a1f9e3a2-0a0d-494c-896f-69f5cc91b53c VL - 33 ID - 2043 ER - TY - JOUR AD - I.P. Giles, Centre for Rheumatology, Division of Medicine, University College London (UCL), Rayne Institute, Room 411, 5 University Street, London, United Kingdom AU - Poulton, K. AU - Ripoll, V. M. AU - Pericleous, C. AU - Meroni, P. L. AU - Gerosa, M. AU - Ioannou, Y. AU - Rahman, A. AU - Giles, I. P. DB - Embase Medline DO - 10.1111/aji.12341 IS - 5 LA - English M3 - Article N1 - L601029451 2014-12-30 2015-04-28 PY - 2015 SN - 1600-0897 1046-7408 SP - 390-401 ST - Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion T2 - American Journal of Reproductive Immunology TI - Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601029451&from=export http://dx.doi.org/10.1111/aji.12341 VL - 73 ID - 2044 ER - TY - JOUR AD - L. Moreno, Royal Marsden NHS Foundation Trust, Children and Young People's Unit, Sutton, Surrey, United Kingdom AU - Hirsch, S. AU - Marshall, L. V. AU - Carceller Lechon, F. AU - Pearson, A. D. J. AU - Moreno, L. DB - Embase Medline DO - 10.1517/17460441.2015.1025745 IS - 5 LA - English M3 - Review N1 - L604003033 2015-04-30 2015-05-18 PY - 2015 SN - 1746-045X 1746-0441 SP - 483-495 ST - Targeted approaches to childhood cancer: Progress in drug discovery and development T2 - Expert Opinion on Drug Discovery TI - Targeted approaches to childhood cancer: Progress in drug discovery and development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604003033&from=export http://dx.doi.org/10.1517/17460441.2015.1025745 VL - 10 ID - 2045 ER - TY - JOUR AD - M. Herbrink, Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, BK Amsterdam, Netherlands AU - Herbrink, M. AU - Nuijen, B. AU - Schellens, J. H. M. AU - Beijnen, J. H. C1 - bosulif caprelsa cometriq giotrif gleevec glivec iclusig inlyta iressa jakavi nexavar sprycel stivarga sutent tafinlar tarceva tasigna tyverb votrient xalkori zelboraf DB - Embase Medline DO - 10.1016/j.ctrv.2015.03.005 IS - 5 LA - English M3 - Review N1 - L606966338 2015-11-24 2015-11-30 PY - 2015 SN - 1532-1967 0305-7372 SP - 412-422 ST - Variability in bioavailability of small molecular tyrosine kinase inhibitors T2 - Cancer Treatment Reviews TI - Variability in bioavailability of small molecular tyrosine kinase inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606966338&from=export http://dx.doi.org/10.1016/j.ctrv.2015.03.005 VL - 41 ID - 2046 ER - TY - JOUR AD - Y. Zhang, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China AU - Gao, H. AU - Wang, F. AU - Lan, X. AU - Li, C. AU - Feng, J. AU - Bai, J. AU - Cao, L. AU - Gui, S. AU - Hong, L. AU - Zhang, Y. DB - Embase Medline DO - 10.1186/s12885-015-1267-0 IS - 1 LA - English M3 - Article N1 - L603887617 2015-04-30 2015-05-01 PY - 2015 SN - 1471-2407 ST - Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas T2 - BMC Cancer TI - Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603887617&from=export http://dx.doi.org/10.1186/s12885-015-1267-0 VL - 15 ID - 2047 ER - TY - JOUR AD - G. Sun, Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Luo, Y. AU - Dong, X. AU - Yu, Y. AU - Sun, G. AU - Sun, X. DB - Embase Medline DO - 10.1016/j.jep.2015.01.017 LA - English M3 - Article N1 - L602260866 2015-02-26 2015-03-03 PY - 2015 SN - 1872-7573 0378-8741 SP - 241-250 ST - Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice T2 - Journal of Ethnopharmacology TI - Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602260866&from=export http://dx.doi.org/10.1016/j.jep.2015.01.017 VL - 163 ID - 2049 ER - TY - JOUR AD - A. Forero-Torres, Kirklin Clinic, 2000 6th Avenue South, Birmingham, AL, United States AU - Forero-Torres, A. AU - Bartlett, N. L. AU - Berryman, R. B. AU - Chen, R. AU - Matous, J. V. AU - Fanale, M. A. AU - O'Connor, O. A. AU - Olshefski, R. AU - Smith, S. E. AU - Huebner, D. AU - Levine, P. L. AU - Grove, L. E. AU - Gopal, A. K. DB - Embase Medline DO - 10.3109/10428194.2014.951843 IS - 4 LA - English M3 - Article N1 - L604360863 2015-05-18 2015-06-18 PY - 2015 SN - 1029-2403 1042-8194 SP - 1151-1153 ST - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies T2 - Leukemia and Lymphoma TI - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604360863&from=export http://dx.doi.org/10.3109/10428194.2014.951843 VL - 56 ID - 2051 ER - TY - JOUR AD - J.W. Pollard, Center for the Study of Reproductive Biology and Women's Health, Albert Einstein College of Medicine, Bronx, United States AU - Wang, Y. AU - Zhu, L. AU - Kuokkanen, S. AU - Pollard, J. W. DB - Embase Medline DO - 10.1073/pnas.1418973112 IS - 11 LA - English M3 - Article N1 - L603022504 2015-03-27 2015-04-02 PY - 2015 SN - 1091-6490 0027-8424 SP - E1382-E1391 ST - Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK 1/2-mTOR signaling pathway T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK 1/2-mTOR signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603022504&from=export http://dx.doi.org/10.1073/pnas.1418973112 VL - 112 ID - 2052 ER - TY - JOUR AU - Kobus, K. AU - Hartl, D. AU - Ott, C. E. AU - Osswald, M. AU - Huebner, A. AU - Von Der Hagen, M. AU - Emmerich, D. AU - Kühnisch, J. AU - Morreau, H. AU - Hes, F. J. AU - Mautner, V. F. AU - Harder, A. AU - Tinschert, S. AU - Mundlos, S. AU - Kolanczyk, M. DB - Embase Medline DO - 10.1371/journal.pone.0119030 IS - 3 LA - English M3 - Article N1 - L603024271 2015-03-24 2015-03-30 PY - 2015 SN - 1932-6203 ST - Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient T2 - PLoS ONE TI - Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603024271&from=export http://dx.doi.org/10.1371/journal.pone.0119030 VL - 10 ID - 2053 ER - TY - JOUR AD - J.M. Kirkwood, Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, 5150 Centre Avenue, Pittsburgh, PA, United States AU - Davar, D. AU - Lin, Y. AU - Kirkwood, J. M. C1 - mekinist(Glaxo SmithKline) tafinlar(Glaxo SmithKline) zelboraf(Genentech) C2 - Genentech Glaxo SmithKline DB - Embase Medline DO - 10.1038/jid.2014.467 IS - 3 LA - English M3 - Review N1 - L602188562 2015-02-19 2015-02-24 PY - 2015 SN - 1523-1747 0022-202X SP - 659-662 ST - Unfolding the mutational landscape of human melanoma T2 - Journal of Investigative Dermatology TI - Unfolding the mutational landscape of human melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602188562&from=export http://dx.doi.org/10.1038/jid.2014.467 VL - 135 ID - 2054 ER - TY - JOUR AD - S. Loges, Department of Hematology and Oncology, Institute of Tumor Biology, University Comprehensive Cancer Center Hamburg, Martinistrasse 52, Hamburg, Germany AU - Waizenegger, J. S. AU - Ben-Batalla, I. AU - Weinhold, N. AU - Meissner, T. AU - Wroblewski, M. AU - Janning, M. AU - Riecken, K. AU - Binder, M. AU - Atanackovic, D. AU - Taipaleenmaeki, H. AU - Schewe, D. AU - Sawall, S. AU - Gensch, V. AU - Cubas-Cordova, M. AU - Seckinger, A. AU - Fiedler, W. AU - Hesse, E. AU - Kröger, N. AU - Fehse, B. AU - Hose, D. AU - Klein, B. AU - Raab, M. S. AU - Pantel, K. AU - Bokemeyer, C. AU - Loges, S. DB - Embase Medline DO - 10.1038/leu.2014.236 IS - 3 LA - English M3 - Article N1 - L602900796 2015-03-17 2020-09-01 PY - 2015 SN - 1476-5551 0887-6924 SP - 696-704 ST - Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma T2 - Leukemia TI - Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602900796&from=export http://dx.doi.org/10.1038/leu.2014.236 VL - 29 ID - 2055 ER - TY - JOUR AU - Oschlies, I. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Konovalov, D. AU - Abramov, D. AU - Myakova, N. AU - Lisfeld, J. AU - Attarbaschi, A. AU - Kontny, U. AU - Woessmann, W. AU - Klapper, W. DB - Embase Medline DO - 10.1111/bjd.13440 IS - 3 LA - English M3 - Letter N1 - L602100198 2015-02-13 2015-03-31 PY - 2015 SN - 1365-2133 0007-0963 SP - 793-797 ST - Subcutaneous panniculitis-like T-cell lymphoma in children: A detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome T2 - British Journal of Dermatology TI - Subcutaneous panniculitis-like T-cell lymphoma in children: A detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602100198&from=export http://dx.doi.org/10.1111/bjd.13440 VL - 172 ID - 2058 ER - TY - JOUR AD - W.-H. Li, Department of Skin Biology and Pharmacology, The Johnson & Johnson Skin Research Center, Johnson & Johnson Consumer and Personal Products Worldwide, Division of Johnson and Johnson Consumer Companies, Inc., 199 Grandview Road, Skillman, NJ, United States AU - Li, W. H. AU - Zhang, L. AU - Lyte, P. AU - Rodriguez, K. AU - Cavender, D. AU - Southall, M. D. C1 - sb 203580 scio 469(Scios,United States) DB - Embase DO - 10.1007/s13555-015-0072-7 IS - 1 LA - English M3 - Article N1 - L603280858 2015-04-02 2015-04-10 PY - 2015 SN - 2190-9172 2193-8210 SP - 53-66 ST - p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro T2 - Dermatology and Therapy TI - p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603280858&from=export http://dx.doi.org/10.1007/s13555-015-0072-7 VL - 5 ID - 2059 ER - TY - JOUR AD - J. Shen, Department of Pediatrics, the First Affiliated Hospital of Zhejiang University, No. 79 Qingchun Road, Hangzhou, China AU - Zhang, J. AU - Hong, Y. AU - Shen, J. C1 - mek 162(Selleck,China) C2 - Selleck(China) DB - Embase Medline DO - 10.1007/s13277-015-3244-2 IS - 7 LA - English M3 - Article N1 - L602481819 2015-02-27 2015-08-07 PY - 2015 SN - 1423-0380 1010-4283 SP - 5699-5706 ST - Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo T2 - Tumor Biology TI - Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602481819&from=export http://dx.doi.org/10.1007/s13277-015-3244-2 VL - 36 ID - 2061 ER - TY - JOUR AD - F. Locatelli, University of Pavia, Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Piazza Sant'Onofrio, 4., Rome, Italy AU - Locatelli, F. AU - Niemeyer, C. M. DB - Embase Medline DO - 10.1182/blood-2014-08-550483 IS - 7 LA - English M3 - Article N1 - L602248295 2015-03-02 2015-03-05 PY - 2015 SN - 1528-0020 0006-4971 SP - 1083-1090 ST - How I treat juvenile myelomonocytic leukemia T2 - Blood TI - How I treat juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602248295&from=export http://dx.doi.org/10.1182/blood-2014-08-550483 VL - 125 ID - 2062 ER - TY - JOUR AD - C.H. June, Abraham Cancer Center, Perelman School of Medicine, Philadelphia, PA, United States AU - June, C. H. DB - Embase DO - 10.1007/s00277-014-2297-4 IS - 1 LA - English M3 - Conference Abstract N1 - L71868763 2015-05-07 PY - 2015 SN - 0939-5555 SP - S14-S16 ST - Updates on cars for leukemia and beyond T2 - Annals of Hematology TI - Updates on cars for leukemia and beyond UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71868763&from=export http://dx.doi.org/10.1007/s00277-014-2297-4 VL - 94 ID - 2065 ER - TY - JOUR AD - Y. Zhang, The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue, Box 171, New York, NY, United States AU - Zhang, Y. AU - Brownstein, A. J. AU - Buonora, M. AU - Niikura, K. AU - Ho, A. AU - Correa da Rosa, J. AU - Kreek, M. J. AU - Ott, J. DB - Embase DO - 10.1016/j.neuroscience.2014.11.013 LA - English M3 - Article N1 - L601084542 2015-01-12 PY - 2015 SN - 1873-7544 0306-4522 SP - 34-46 ST - Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice T2 - Neuroscience TI - Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601084542&from=export http://dx.doi.org/10.1016/j.neuroscience.2014.11.013 VL - 285 ID - 2067 ER - TY - JOUR AD - Y. Wu, Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan St, Shapingba District, Chongqing, China AU - Shen, Z. AU - Tian, Z. AU - He, H. AU - Zhang, J. AU - Li, J. AU - Wu, Y. DB - Embase Medline DO - 10.1097/MPG.0000000000000493 IS - 1 LA - English M3 - Article N1 - L53256313 2014-08-01 2015-01-26 PY - 2015 SN - 1536-4801 0277-2116 SP - 11-17 ST - Antiviral effects of cyclosporin a in neonatal mice with rotavirus-induced diarrhea T2 - Journal of Pediatric Gastroenterology and Nutrition TI - Antiviral effects of cyclosporin a in neonatal mice with rotavirus-induced diarrhea UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53256313&from=export http://dx.doi.org/10.1097/MPG.0000000000000493 VL - 60 ID - 2068 ER - TY - JOUR AD - V. Chung, Department of Medical Oncology and Therapeutics Research, City of Hope, 1500 East Duarte Road, Duarte, CA, United States AU - Chung, V. C1 - g 202 nexavar xl 184 DB - Embase Medline DO - 10.1016/j.soc.2014.09.009 IS - 1 LA - English M3 - Review N1 - L600155486 2014-10-21 2015-02-24 PY - 2015 SN - 1558-5042 1055-3207 SP - 187-198 ST - Systemic therapy for hepatocellular Carcinoma and cholangiocarcinoma T2 - Surgical Oncology Clinics of North America TI - Systemic therapy for hepatocellular Carcinoma and cholangiocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600155486&from=export http://dx.doi.org/10.1016/j.soc.2014.09.009 VL - 24 ID - 2069 ER - TY - JOUR AD - A. Hoshino, Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Toyama, Japan AU - Hoshino, A. AU - Nomura, K. AU - Hamashima, T. AU - Isobe, T. AU - Seki, M. AU - Hiwatari, M. AU - Yoshida, K. AU - Shiraishi, Y. AU - Chiba, K. AU - Tanaka, H. AU - Miyano, S. AU - Ogawa, S. AU - Takita, J. AU - Kanegane, H. DB - Embase Medline DO - 10.1007/s12185-014-1701-0 IS - 2 LA - English M3 - Article N1 - L600545115 2014-11-28 2015-05-12 PY - 2015 SN - 1865-3774 0925-5710 SP - 198-202 ST - Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes T2 - International Journal of Hematology TI - Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600545115&from=export http://dx.doi.org/10.1007/s12185-014-1701-0 VL - 101 ID - 2070 ER - TY - JOUR AD - J. Yang, MC 3-3320, One Baylor Plaza-BCM320, 6621 Fannin St., Houston, TX, United States AU - Sun, W. AU - Quan, C. AU - Huang, Y. AU - Ji, W. AU - Yu, L. AU - Li, X. AU - Zhang, Y. AU - Zheng, Z. AU - Zou, H. AU - Li, Q. AU - Xu, P. AU - Feng, Y. AU - Li, L. AU - Zhang, Y. AU - Cui, Y. AU - Jia, X. AU - Meng, X. AU - Zhang, C. AU - Jin, Y. AU - Bai, J. AU - Yu, J. AU - Yu, Y. AU - Yang, J. AU - Fu, S. DB - Embase Medline DO - 10.1002/path.4439 IS - 1 LA - English M3 - Article N1 - L600739140 2014-12-19 PY - 2015 SN - 1096-9896 0022-3417 SP - 14-24 ST - Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells T2 - Journal of Pathology TI - Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600739140&from=export http://dx.doi.org/10.1002/path.4439 VL - 235 ID - 2073 ER - TY - GEN AD - P.B. Gahan, Department of Anatomy and Human Sciences, King’s College London, London Bridge, London, United Kingdom AU - Hui, L. AU - Maron, J. L. AU - Gahan, P. B. DB - Embase DO - 10.1007/978-94-017-9168-7_11 J2 - Adv. Predictive Prev. Personalised Med. LA - English M1 - (Hui L.) Department of Perinatal Medicine, Mercy Hospital for Women, Heidelberg, VIC, Australia M3 - Article N1 - L601380382 2015-02-02 2015-07-27 PY - 2015 SN - 2211-3509 2211-3495 SP - 295-323 ST - Other body fluids as non-invasive sources of cell-free DNA/RNA TI - Other body fluids as non-invasive sources of cell-free DNA/RNA UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601380382&from=export http://dx.doi.org/10.1007/978-94-017-9168-7_11 VL - 5 ID - 2074 ER - TY - JOUR AD - S. Nair, Department of Pediatric Hematology Oncology, University of Florida, 1600 SW Archer Road, Gainesville, FL, United States AU - Nair, S. AU - Fort, J. A. AU - Yachnis, A. T. AU - Williams, C. A. DB - Embase Medline DO - 10.1002/pbc.25382 IS - 6 LA - English M3 - Article N1 - L601630714 2015-01-30 2015-05-06 PY - 2015 SN - 1545-5017 1545-5009 SP - 1084-1086 ST - Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome T2 - Pediatric Blood and Cancer TI - Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601630714&from=export http://dx.doi.org/10.1002/pbc.25382 VL - 62 ID - 2075 ER - TY - JOUR AD - B. Vincent, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand AU - Shukla, M. AU - Htoo, H. H. AU - Wintachai, P. AU - Hernandez, J. F. AU - Dubois, C. AU - Postina, R. AU - Xu, H. AU - Checler, F. AU - Smith, D. R. AU - Govitrapong, P. AU - Vincent, B. DB - Embase Medline DO - 10.1111/jpi.12200 IS - 2 LA - English M3 - Article N1 - L602185400 2015-02-23 2015-02-25 PY - 2015 SN - 1600-079X 0742-3098 SP - 151-165 ST - Melatonin stimulates the nonamyloidogenic processing of βaPP through the positive transcriptional regulation of ADAM10 and ADAM17 T2 - Journal of Pineal Research TI - Melatonin stimulates the nonamyloidogenic processing of βaPP through the positive transcriptional regulation of ADAM10 and ADAM17 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602185400&from=export http://dx.doi.org/10.1111/jpi.12200 VL - 58 ID - 2078 ER - TY - JOUR AD - M. Chuma, Department of Gastroenterology and Hepatology, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Japan AU - Chuma, M. AU - Terashita, K. AU - Sakamoto, N. DB - Embase DO - 10.1111/hepr.12459 IS - 10 LA - English M3 - Review N1 - L602428028 2015-02-26 2015-11-09 PY - 2015 SN - 1872-034X 1386-6346 SP - E1-E11 ST - New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions T2 - Hepatology Research TI - New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602428028&from=export http://dx.doi.org/10.1111/hepr.12459 VL - 45 ID - 2080 ER - TY - JOUR AD - E. Benelli, University of Trieste, Trieste, Italy AU - Benelli, E. AU - Bruno, I. AU - Belcaro, C. AU - Ventura, A. AU - Berti, I. DB - Embase Medline DO - 10.1186/s13052-015-0115-9 IS - 1 LA - English M3 - Review N1 - L602649239 2015-03-12 2015-03-17 PY - 2015 SN - 1824-7288 1720-8424 ST - Legius syndrome: Case report and review of literature T2 - Italian Journal of Pediatrics TI - Legius syndrome: Case report and review of literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602649239&from=export http://dx.doi.org/10.1186/s13052-015-0115-9 VL - 41 ID - 2081 ER - TY - GEN AD - H. Hazin, New York Methodist Hospital, Brooklyn, NY, United States AU - Hazin, H. AU - Dosik, D. DB - Embase DO - 10.1007/978-3-319-12166-6_6 J2 - Adv. Predictive Prev. Personalised Med. LA - English M1 - (Hazin H., heshamhazin@yahoo.com; Dosik D., ddosik@aol.com) New York Methodist Hospital, Brooklyn, NY, United States M3 - Article N1 - L602792711 2015-03-18 2015-07-22 PY - 2015 SN - 2211-3509 2211-3495 SP - 53-60 ST - Personalized chemotherapy for hepatocellular carcinoma TI - Personalized chemotherapy for hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602792711&from=export http://dx.doi.org/10.1007/978-3-319-12166-6_6 VL - 8 ID - 2082 ER - TY - JOUR AD - P.C. Adamson, Children's Oncology Group, Children's Hospital of Philadelphia, CRTB 10060, 3501 Civic Center Boulevard, Philadelphia, PA, United States AU - Adamson, P. C. C1 - gleevec(Novartis,United States) C2 - Novartis(United States) DB - Embase Medline DO - 10.3322/caac.21273 IS - 3 LA - English M3 - Review N1 - L602833754 2015-03-13 2015-05-25 PY - 2015 SN - 1542-4863 0007-9235 SP - 212-220 ST - Improving the outcome for children with cancer: Development of targeted new agents T2 - CA Cancer Journal for Clinicians TI - Improving the outcome for children with cancer: Development of targeted new agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602833754&from=export http://dx.doi.org/10.3322/caac.21273 VL - 65 ID - 2083 ER - TY - JOUR AD - C.P. Kratz, Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Carl-Neuberg-Str. 1, Hannover, Germany AU - Kratz, C. P. AU - Franke, L. AU - Peters, H. AU - Kohlschmidt, N. AU - Kazmierczak, B. AU - Finckh, U. AU - Bier, A. AU - Eichhorn, B. AU - Blank, C. AU - Kraus, C. AU - Kohlhase, J. AU - Pauli, S. AU - Wildhardt, G. AU - Kutsche, K. AU - Auber, B. AU - Christmann, A. AU - Bachmann, N. AU - Mitter, D. AU - Cremer, F. W. AU - Mayer, K. AU - Daumer-Haas, C. AU - Nevinny-Stickel-Hinzpeter, C. AU - Oeffner, F. AU - Schlüter, G. AU - Gencik, M. AU - Überlacker, B. AU - Lissewski, C. AU - Schanze, I. AU - Greene, M. H. AU - Spix, C. AU - Zenker, M. DB - Embase Medline DO - 10.1038/bjc.2015.75 IS - 8 LA - English M3 - Article N1 - L602856158 2015-03-17 2015-05-12 PY - 2015 SN - 1532-1827 0007-0920 SP - 1392-1397 ST - Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes T2 - British Journal of Cancer TI - Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602856158&from=export http://dx.doi.org/10.1038/bjc.2015.75 VL - 112 ID - 2084 ER - TY - JOUR AD - H.-C. Kuo, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan AU - Hsieh, Y. Y. AU - Shen, C. H. AU - Huang, W. S. AU - Chin, C. C. AU - Kuo, Y. H. AU - Hsieh, M. C. AU - Yu, H. R. AU - Chang, T. S. AU - Lin, T. H. AU - Chiu, Y. W. AU - Chen, C. N. AU - Kuo, H. C. AU - Tung, S. Y. DB - Embase DO - 10.1186/1423-0127-21-59 IS - 1 LA - English M3 - Article N1 - L602967815 2015-03-24 2015-03-30 PY - 2015 SN - 1423-0127 1021-7770 ST - Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells T2 - Journal of Biomedical Science TI - Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602967815&from=export http://dx.doi.org/10.1186/1423-0127-21-59 VL - 21 ID - 2085 ER - TY - JOUR AD - K. Kadomatsu, Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan AU - Lu, F. AU - Kishida, S. AU - Mu, P. AU - Huang, P. AU - Cao, D. AU - Tsubota, S. AU - Kadomatsu, K. DB - Embase Medline DO - 10.1111/cas.12628 IS - 4 LA - English M3 - Article N1 - L602970192 2015-03-19 2015-05-11 PY - 2015 SN - 1349-7006 1347-9032 SP - 390-396 ST - NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK T2 - Cancer Science TI - NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602970192&from=export http://dx.doi.org/10.1111/cas.12628 VL - 106 ID - 2086 ER - TY - JOUR AD - X. Guo, Department of Gastroenterology, Shenyang General Hospital of PLA, 83 Wenhua Road, Shenyang, Liaoning, China AU - Ren, L. AU - Guo, X. AU - Shao, X. AU - Li, H. AU - Yao, H. DB - Embase Medline DO - 10.3892/mmr.2015.3340 IS - 6 LA - English M3 - Article N1 - L602972993 2015-03-19 2015-03-25 PY - 2015 SN - 1791-3004 1791-2997 SP - 4279-4284 ST - Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells T2 - Molecular Medicine Reports TI - Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602972993&from=export http://dx.doi.org/10.3892/mmr.2015.3340 VL - 11 ID - 2087 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Kumar, A. AU - Pathak, P. AU - Purkait, S. AU - Faruq, M. AU - Jha, P. AU - Mallick, S. AU - Suri, V. AU - Sharma, M. C. AU - Suri, A. AU - Sarkar, C. DB - Embase Medline DO - 10.1016/j.cancergen.2015.01.009 IS - 3 LA - English M3 - Article N1 - L603090008 2015-03-24 2015-04-28 PY - 2015 SN - 2210-7770 2210-7762 SP - 91-95 ST - Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas T2 - Cancer Genetics TI - Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603090008&from=export http://dx.doi.org/10.1016/j.cancergen.2015.01.009 VL - 208 ID - 2088 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child and Family Research Institute, University of British Columbia, Room 317, 950 West 28th Avenue, Vancouver, BC, Canada AU - Chang, H. M. AU - Cheng, J. C. AU - Fang, L. AU - Qiu, X. AU - Klausen, C. AU - Taylor, E. L. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1210/jc.2014-2496 IS - 3 LA - English M3 - Article N1 - L603095114 2015-03-24 2015-03-26 PY - 2015 SN - 1945-7197 0021-972X SP - E365-E374 ST - Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells T2 - Journal of Clinical Endocrinology and Metabolism TI - Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603095114&from=export http://dx.doi.org/10.1210/jc.2014-2496 VL - 100 ID - 2089 ER - TY - JOUR AD - J. Wang, Department of Thoracic and Cardiovascular Surgery, Jiangsu Province People's Hospital, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing, Jiangsu, China AU - Wang, J. AU - Li, Z. AU - Ge, Q. AU - Wu, W. AU - Zhu, Q. AU - Luo, J. AU - Chen, L. DB - Embase Medline DO - 10.1016/j.jtcvs.2015.02.012 IS - 5 LA - English M3 - Article N1 - L603245346 2015-03-27 2015-06-08 PY - 2015 SN - 1097-685X 0022-5223 SP - 1404-1414.e4 ST - Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma T2 - Journal of Thoracic and Cardiovascular Surgery TI - Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603245346&from=export http://dx.doi.org/10.1016/j.jtcvs.2015.02.012 VL - 149 ID - 2090 ER - TY - JOUR AD - N. Ratner, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, Cincinnati, OH, United States AU - Jousma, E. AU - Rizvi, T. A. AU - Wu, J. AU - Janhofer, D. AU - Dombi, E. AU - Dunn, R. S. AU - Kim, M. O. AU - Masters, A. R. AU - Jones, D. R. AU - Cripe, T. P. AU - Ratner, N. C1 - pd 0325901(Pfizer,United States) C2 - Pfizer(United States) DB - Embase Medline DO - 10.1002/pbc.25546 IS - 10 LA - English M3 - Article N1 - L603967621 2015-04-28 2015-08-28 PY - 2015 SN - 1545-5017 1545-5009 SP - 1709-1716 ST - Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1 T2 - Pediatric Blood and Cancer TI - Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603967621&from=export http://dx.doi.org/10.1002/pbc.25546 VL - 62 ID - 2092 ER - TY - JOUR AD - V.E. Palau, Division of Hematology-Oncology, Department of Internal Medicine, James H. Quillen College of Medicine, Johnson City, TN, United States AU - Rogers, M. AU - Kalra, S. AU - Moukharskaya, J. AU - Chakraborty, K. AU - Niyazi, M. AU - Krishnan, K. AU - Lightner, J. AU - Brannon, M. AU - Stone, W. L. AU - Palau, V. E. C2 - Sigma(United States) DB - Embase Medline IS - 4 LA - English M3 - Article N1 - L604019439 2015-05-01 2015-05-18 PY - 2015 SN - 0250-7005 SP - 1851-1860 ST - Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate T2 - Anticancer Research TI - Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604019439&from=export VL - 35 ID - 2093 ER - TY - JOUR AD - K. Sawada, Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan AU - Kinose, Y. AU - Sawada, K. AU - Nakamura, K. AU - Sawada, I. AU - Toda, A. AU - Nakatsuka, E. AU - Hashimoto, K. AU - Mabuchi, S. AU - Takahashi, K. AU - Kurachi, H. AU - Lengyel, E. AU - Kimura, T. DB - Embase Medline DO - 10.18632/oncotarget.3604 IS - 13 LA - English M3 - Article N1 - L604481763 2015-05-28 2015-06-03 PY - 2015 SN - 1949-2553 SP - 11342-11356 ST - The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma T2 - Oncotarget TI - The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604481763&from=export http://dx.doi.org/10.18632/oncotarget.3604 VL - 6 ID - 2094 ER - TY - JOUR AD - Y. Zhou, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China AU - Zhou, Y. AU - He, Y. AU - Sharma, R. AU - Xing, W. AU - Estwick, S. A. AU - Wu, X. AU - Rhodes, S. D. AU - Xu, M. AU - Yang, F. C. DB - Embase Medline DO - 10.3390/ijms160612345 IS - 6 LA - English M3 - Article N1 - L604778672 2015-06-18 PY - 2015 SN - 1422-0067 1661-6596 SP - 12345-12359 ST - Hyperactive RAS/PI3-K/MAPK signaling cascade in migration and adhesion of Nf1 haploinsufficient mesenchymal stem/progenitor cells T2 - International Journal of Molecular Sciences TI - Hyperactive RAS/PI3-K/MAPK signaling cascade in migration and adhesion of Nf1 haploinsufficient mesenchymal stem/progenitor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604778672&from=export http://dx.doi.org/10.3390/ijms160612345 VL - 16 ID - 2095 ER - TY - JOUR AD - Y. Mishina, Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, United States AU - Hayano, S. AU - Komatsu, Y. AU - Pan, H. AU - Mishina, Y. DB - Embase Medline DO - 10.1242/dev.118802 IS - 7 LA - English M3 - Article N1 - L604805172 2015-06-16 2015-06-23 PY - 2015 SN - 1477-9129 0950-1991 SP - 1357-1367 ST - Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis T2 - Development (Cambridge) TI - Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604805172&from=export http://dx.doi.org/10.1242/dev.118802 VL - 142 ID - 2096 ER - TY - JOUR AD - A. Cuenda, Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain AU - Zur, R. AU - Garcia-Ibanez, L. AU - Nunez-Buiza, A. AU - Aparicio, N. AU - Liappas, G. AU - Escós, A. AU - Risco, A. AU - Pagez, A. AU - Saiz-Ladera, C. AU - Alsina-Beauchamp, D. AU - Montans, J. AU - Paramio, J. M. AU - Cuenda, A. DB - Embase Medline DO - 10.18632/oncotarget.4320 IS - 15 LA - English M3 - Article N1 - L604883112 2015-06-23 2015-06-25 PY - 2015 SN - 1949-2553 SP - 12920-12935 ST - Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis T2 - Oncotarget TI - Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604883112&from=export http://dx.doi.org/10.18632/oncotarget.4320 VL - 6 ID - 2097 ER - TY - JOUR AD - T. Gupta, Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, India AU - Gupta, T. AU - Shirsat, N. AU - Jalali, R. DB - Embase Medline DO - 10.2174/1573396311666150702104030 IS - 2 LA - English M3 - Article N1 - L605196750 2015-07-22 2016-05-05 PY - 2015 SN - 1875-6336 1573-3963 SP - 106-119 ST - Molecular subgrouping of medulloblastoma: Impact upon research and clinical practice T2 - Current Pediatric Reviews TI - Molecular subgrouping of medulloblastoma: Impact upon research and clinical practice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605196750&from=export http://dx.doi.org/10.2174/1573396311666150702104030 VL - 11 ID - 2100 ER - TY - JOUR AD - B.K. Petroff, Diagnostic Companion Animal and Population Health Laboratory, Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, United States AU - Piasecka-Srader, J. AU - Blanco, F. F. AU - Delman, D. H. AU - Dixon, D. A. AU - Geiser, J. L. AU - Ciereszko, R. E. AU - Petroff, B. K. DB - Embase Medline DO - 10.1095/biolreprod.114.126136 IS - 5 LA - English M3 - Article N1 - L605213755 2015-07-21 2015-07-23 PY - 2015 SN - 1529-7268 0006-3363 ST - Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries T2 - Biology of Reproduction TI - Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605213755&from=export http://dx.doi.org/10.1095/biolreprod.114.126136 VL - 92 ID - 2101 ER - TY - JOUR AD - M.M. Talavera, Center for Perinatal Research, Research Institute at Nationwide Children's Hospital, Columbus, OH, United States AU - Talavera, M. M. AU - Kralik, N. AU - Jin, Y. AU - Chen, B. AU - Liu, Y. AU - Nelin, L. D. DB - Embase Medline DO - 10.1038/pr.2015.88 IS - 2 LA - English M3 - Article N1 - L605267937 2015-07-27 2015-07-28 PY - 2015 SN - 1530-0447 0031-3998 SP - 128-136 ST - Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells T2 - Pediatric Research TI - Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605267937&from=export http://dx.doi.org/10.1038/pr.2015.88 VL - 78 ID - 2102 ER - TY - JOUR AD - S. Berdnikovs, Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, 240 East Huron Avenue, Chicago, IL, United States AU - Abdala-Valencia, H. AU - Bryce, P. J. AU - Schleimer, R. P. AU - Wechsler, J. B. AU - Loffredo, L. F. AU - Cook-Mills, J. M. AU - Hsu, C. L. AU - Berdnikovs, S. DB - Embase Medline DO - 10.4049/jimmunol.1302874 IS - 4 LA - English M3 - Article N1 - L605595609 2015-08-18 2015-08-20 PY - 2015 SN - 1550-6606 0022-1767 SP - 1377-1387 ST - Tetraspanin CD151 is a negative regulator of FcεRI-mediated mast cell activation T2 - Journal of Immunology TI - Tetraspanin CD151 is a negative regulator of FcεRI-mediated mast cell activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605595609&from=export http://dx.doi.org/10.4049/jimmunol.1302874 VL - 195 ID - 2104 ER - TY - JOUR AD - R. Zhang, Department of Obstetrics and Gynecology, Fengxian Hospital, Southern Medical University, Shanghai, PR, China AU - Ren, Y. AU - Lu, H. AU - Zhao, D. AU - Ou, Y. AU - Yu, K. AU - Gu, J. AU - Wang, L. AU - Jiang, S. AU - Chen, M. AU - Wang, J. AU - Zhang, R. AU - Xu, C. DB - Embase IS - 6 LA - English M3 - Article N1 - L605711048 2015-08-26 2015-08-28 PY - 2015 SN - 1943-8141 SP - 1095-1105 ST - LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma T2 - American Journal of Translational Research TI - LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605711048&from=export VL - 7 ID - 2105 ER - TY - JOUR AD - R. Kobayashi, Department of Pediatrics, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishiku Sapporo, Hokkaido, Japan AU - Kobayashi, R. AU - Sunami, S. AU - Mitsui, T. AU - Nakazawa, A. AU - Koga, Y. AU - Mori, T. AU - Tanaka, F. AU - Ueyama, J. I. AU - Osumi, T. AU - Fukano, R. AU - Ohki, K. AU - Sekimizu, M. AU - Mori, T. DB - Embase Medline DO - 10.1111/ped.12725 IS - 4 LA - English M3 - Review N1 - L605838752 2015-09-04 2015-09-08 PY - 2015 SN - 1442-200X 1328-8067 SP - 523-534 ST - Treatment of pediatric lymphoma in Japan: Current status and plans for the future T2 - Pediatrics International TI - Treatment of pediatric lymphoma in Japan: Current status and plans for the future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605838752&from=export http://dx.doi.org/10.1111/ped.12725 VL - 57 ID - 2106 ER - TY - JOUR AD - F. Wang-Johanning, Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Zhou, F. AU - Krishnamurthy, J. AU - Wei, Y. AU - Li, M. AU - Hunt, K. AU - Johanning, G. L. AU - Cooper, L. J. N. AU - Wang-Johanning, F. DB - Embase DO - 10.1080/2162402X.2015.1047582 IS - 11 LA - English M3 - Article N1 - L606063912 2015-09-24 2015-09-28 PY - 2015 SN - 2162-402X 2162-4011 ST - Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras T2 - OncoImmunology TI - Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606063912&from=export http://dx.doi.org/10.1080/2162402X.2015.1047582 VL - 4 ID - 2107 ER - TY - JOUR AD - E. Hiyama, Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan AU - Kurihara, S. AU - Ueda, Y. AU - Onitake, Y. AU - Sueda, T. AU - Ohta, E. AU - Morihara, N. AU - Hirano, S. AU - Irisuna, F. AU - Hiyama, E. DB - Embase Medline DO - 10.1016/j.jpedsurg.2015.08.033 IS - 12 LA - English M3 - Conference Paper N1 - L606073599 2015-09-24 2016-04-14 PY - 2015 SN - 1531-5037 0022-3468 SP - 2094-2097 ST - Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors T2 - Journal of Pediatric Surgery TI - Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606073599&from=export http://dx.doi.org/10.1016/j.jpedsurg.2015.08.033 VL - 50 ID - 2108 ER - TY - JOUR AD - P. Brandal, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, P.O Box 4953, Oslo, Nydalen, Norway AU - Olsen, T. K. AU - Panagopoulos, I. AU - Meling, T. R. AU - Micci, F. AU - Gorunova, L. AU - Thorsen, J. AU - Due-Tønnessen, B. AU - Scheie, D. AU - Lund-Iversen, M. AU - Krossnes, B. AU - Saxhaug, C. AU - Heim, S. AU - Brandal, P. DB - Embase Medline DO - 10.1093/neuonc/nov039 IS - 10 LA - English M3 - Article N1 - L606337404 2015-10-14 2015-10-19 PY - 2015 SN - 1523-5866 1522-8517 SP - 1365-1373 ST - Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: A new brain tumor entity? T2 - Neuro-Oncology TI - Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: A new brain tumor entity? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606337404&from=export http://dx.doi.org/10.1093/neuonc/nov039 VL - 17 ID - 2109 ER - TY - JOUR AD - L. Li, Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, No. 71 Hedi Road, Nanning, Guangxi, China AU - Chen, J. AU - Wang, Q. AU - Yin, F. Q. AU - Zhang, W. AU - Yan, L. H. AU - Li, L. DB - Embase IS - 9 LA - English M3 - Article N1 - L606475192 2015-10-22 2015-10-27 PY - 2015 SN - 1943-8141 SP - 1510-1527 ST - MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy T2 - American Journal of Translational Research TI - MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606475192&from=export VL - 7 ID - 2110 ER - TY - JOUR AD - D.H. Teitelbaum, Section of Pediatric Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States AU - Feng, Y. AU - Tsai, Y. H. AU - Xiao, W. AU - Ralls, M. W. AU - Stoeck, A. AU - Wilson, C. L. AU - Raines, E. W. AU - Teitelbaum, D. H. AU - Dempsey, P. J. DB - Embase Medline DO - 10.1128/MCB.00143-15 IS - 21 LA - English M3 - Article N1 - L606538719 2015-10-28 2015-10-30 PY - 2015 SN - 1098-5549 0270-7306 SP - 3604-3621 ST - Loss of ADAM17-mediated tumor necrosis factor alpha signaling in intestinal cells attenuates mucosal atrophy in a mouse model of parenteral nutrition T2 - Molecular and Cellular Biology TI - Loss of ADAM17-mediated tumor necrosis factor alpha signaling in intestinal cells attenuates mucosal atrophy in a mouse model of parenteral nutrition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606538719&from=export http://dx.doi.org/10.1128/MCB.00143-15 VL - 35 ID - 2111 ER - TY - JOUR AD - J. Zheng, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong AU - Liu, M. AU - Zhou, C. AU - Zheng, J. DB - Embase IS - 10 LA - English M3 - Article N1 - L607026255 2015-11-30 2015-12-01 PY - 2015 SN - 1943-8141 SP - 2026-2035 ST - Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition T2 - American Journal of Translational Research TI - Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607026255&from=export VL - 7 ID - 2113 ER - TY - JOUR AD - H.M. Amin, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, United States AU - Vishwamitra, D. AU - Curry, C. V. AU - Shi, P. AU - Alkan, S. AU - Amin, H. M. DB - Embase Medline DO - 10.1016/j.neo.2015.09.005 IS - 9 LA - English M3 - Article N1 - L607172451 2015-12-15 PY - 2015 SN - 1476-5586 1522-8002 SP - 742-754 ST - SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein TI - SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607172451&from=export http://dx.doi.org/10.1016/j.neo.2015.09.005 VL - 17 ID - 2114 ER - TY - JOUR AD - S. Das, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA, United States AU - Melman, Y. F. AU - Shah, R. AU - Danielson, K. AU - Xiao, J. AU - Simonson, B. AU - Barth, A. AU - Chakir, K. AU - Lewis, G. D. AU - Lavender, Z. AU - Truong, Q. A. AU - Kleber, A. AU - Das, R. AU - Rosenzweig, A. AU - Wang, Y. AU - Kass, D. A. AU - Singh, J. P. AU - Das, S. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.114.013220 IS - 25 LA - English M3 - Review N1 - L607698694 2016-01-15 2016-01-21 PY - 2015 SN - 1524-4539 0009-7322 SP - 2202-2216 ST - Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: A translational pilot study T2 - Circulation TI - Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: A translational pilot study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607698694&from=export http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013220 VL - 131 ID - 2116 ER - TY - JOUR AD - N. Silverberg, Chief, Pediatric Dermatology, Department of Dermatology, Mt. Sinai, St. Luke's-Roosevelt Hospital Center, New York, NY, United States AU - Tuchman, M. AU - Silverberg, J. I. AU - Jacob, S. E. AU - Silverberg, N. DB - Embase Medline DO - 10.1016/j.clindermatol.2014.12.008 IS - 3 LA - English M3 - Article N1 - L607805602 2016-02-01 2016-02-02 PY - 2015 SN - 1879-1131 0738-081X SP - 320-326 ST - Nickel contact dermatitis in children T2 - Clinics in Dermatology TI - Nickel contact dermatitis in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607805602&from=export http://dx.doi.org/10.1016/j.clindermatol.2014.12.008 VL - 33 ID - 2117 ER - TY - JOUR AU - Qian, J. AU - Chen, Q. AU - Yao, D. M. AU - Yang, L. AU - Yang, J. AU - Wen, X. M. AU - Zhang, Y. Y. AU - Chai, H. Y. AU - Ma, J. C. AU - Deng, Z. Q. AU - Lin, J. DB - Medline IS - 1 LA - English M3 - Article N1 - L609476640 2016-04-13 PY - 2015 SN - 1936-2625 SP - 127-136 ST - MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia T2 - International journal of clinical and experimental pathology TI - MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609476640&from=export VL - 8 ID - 2118 ER - TY - JOUR AD - P.N. Cunningham, Section of Nephrology, Department of Medicine, University of Chicago, 5841 S. Maryland Ave, MC 5100, Chicago, IL, United States AU - Xu, C. AU - Wu, X. AU - Hack, B. K. AU - Bao, L. AU - Cunningham, P. N. DB - Embase DO - 10.14814/phy2.12636 IS - 12 LA - English M3 - Article N1 - L613726644 2016-12-23 2016-12-28 PY - 2015 SN - 2051-817X ST - TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism T2 - Physiological Reports TI - TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613726644&from=export http://dx.doi.org/10.14814/phy2.12636 VL - 3 ID - 2119 ER - TY - JOUR AD - I.L.M.H. Aye, Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado, Anschutz Medical Campus, Mail Code 7836, 12700 East 19th Avenue, Aurora, CO, United States AU - Aye, I. L. M. H. AU - Jansson, T. AU - Powell, T. L. DB - Embase DO - 10.14814/phy2.12594 IS - 10 LA - English M3 - Article N1 - L613727853 2016-12-23 2017-01-09 PY - 2015 SN - 2051-817X ST - TNF-α stimulates system a amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling T2 - Physiological Reports TI - TNF-α stimulates system a amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613727853&from=export http://dx.doi.org/10.14814/phy2.12594 VL - 3 ID - 2120 ER - TY - JOUR AD - A.K. Olow AU - Olow, A. K. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Weiss, W. AU - Resnick, A. C. AU - Sievert, A. J. AU - Berger, M. S. AU - Gupta, N. AU - James, D. C. AU - Haas-Kogan, D. A. DB - Embase DO - 10.1158/1538-8514.PI3K14-B42 IS - 7 LA - English M3 - Conference Abstract N1 - L616800969 2017-06-20 PY - 2015 SN - 1538-8514 ST - Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas T2 - Molecular Cancer Therapeutics TI - Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616800969&from=export http://dx.doi.org/10.1158/1538-8514.PI3K14-B42 VL - 14 ID - 2121 ER - TY - JOUR AD - F. Batteux, Immunology Department, Cochin Hospital, Paris Descartes University, Paris, France AU - Batteux, F. DB - Embase DO - 10.5301/je.5000214 LA - English M3 - Conference Abstract N1 - L618421485 2017-09-27 PY - 2015 SN - 2284-0273 SP - S10-S11 ST - Pro-inflammatory signals and endometriosis pathogenesis: Clinical applications T2 - Journal of Endometriosis and Pelvic Pain Disorders TI - Pro-inflammatory signals and endometriosis pathogenesis: Clinical applications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618421485&from=export http://dx.doi.org/10.5301/je.5000214 VL - 7 ID - 2122 ER - TY - JOUR AD - O.M.Z. Howard, Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, United States AU - Zhao, Z. AU - Fan, H. AU - Higgins, T. AU - Qi, J. AU - Haines, D. AU - Trivett, A. AU - Oppenheim, J. J. AU - Wei, H. AU - Li, J. AU - Lin, H. AU - Howard, O. M. Z. C2 - Shanxi Zhendong(China) DB - Embase Medline DO - 10.1016/j.canlet.2014.08.037 IS - 2 LA - English M3 - Article N1 - L600279848 2014-11-04 2014-11-10 PY - 2014 SN - 1872-7980 0304-3835 SP - 232-241 ST - Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways T2 - Cancer Letters TI - Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600279848&from=export http://dx.doi.org/10.1016/j.canlet.2014.08.037 VL - 355 ID - 2123 ER - TY - JOUR AD - K.V. Rosen, Atlantic Research Centre, 5849 University Avenue, Halifax, NS, Canada AU - Yoo, B. H. AU - Masson, O. AU - Li, Y. AU - Khan, I. A. AU - Gowda, P. S. AU - Rosen, K. V. DB - Embase Medline DO - 10.1038/onc.2014.415 IS - 38 LA - English M3 - Article N1 - L601087289 2015-01-08 2015-09-28 PY - 2015 SN - 1476-5594 0950-9232 SP - 4939-4951 ST - Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists T2 - Oncogene TI - Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601087289&from=export http://dx.doi.org/10.1038/onc.2014.415 VL - 34 ID - 2124 ER - TY - JOUR AD - K.M. Sakamoto, Department of Pediatrics, Stanford University School of Medicine, CCSR 1215C, 269 Campus Dr, Stanford, CA, United States AU - Bibikova, E. AU - Youn, M. Y. AU - Danilova, N. AU - Ono-Uruga, Y. AU - Konto-Ghiorghi, Y. AU - Ochoa, R. AU - Narla, A. AU - Glader, B. AU - Lin, S. AU - Sakamoto, K. M. DB - Embase Medline DO - 10.1182/blood-2014-06-584656 IS - 25 LA - English M3 - Article N1 - L600898379 2014-12-30 2015-01-12 PY - 2014 SN - 1528-0020 0006-4971 SP - 3791-3798 ST - TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors T2 - Blood TI - TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600898379&from=export http://dx.doi.org/10.1182/blood-2014-06-584656 VL - 124 ID - 2125 ER - TY - JOUR AD - K. Wang, Foundation Medicine,Inc., Cambridge, MA, United States AU - Wang, K. AU - Morosini, D. AU - Yelensky, R. AU - Palma, N. AU - Johnson, A. AU - Lipson, D. AU - Chmielecki, J. AU - Ali, S. AU - Ross, J. S. AU - Stephens, P. J. AU - Miller, V. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71759353 2015-02-03 PY - 2014 SN - 0006-4971 ST - Genomic alterations of histone modification genes are significantly less common in non-hodgkin lymphomas of adolescents and young adults compared to older patients T2 - Blood TI - Genomic alterations of histone modification genes are significantly less common in non-hodgkin lymphomas of adolescents and young adults compared to older patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71759353&from=export http://www.bloodjournal.org/content/124/21/1684 VL - 124 ID - 2126 ER - TY - JOUR AD - F. Ponthan, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom AU - Ponthan, F. AU - Bomken, S. AU - Pal, D. AU - Elder, A. AU - McNeill, H. AU - Vormoor, J. AU - Heidenreich, O. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71760051 2015-02-03 PY - 2014 SN - 0006-4971 ST - A genome-wide RNAi screen to identify novel genes involved in clonal maintenance of all T2 - Blood TI - A genome-wide RNAi screen to identify novel genes involved in clonal maintenance of all UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71760051&from=export http://www.bloodjournal.org/content/124/21/2390 VL - 124 ID - 2127 ER - TY - JOUR AD - N.E. Sharpless, The Lineberger Comprehensive Cancer Center, University of North Carolina School Medicine, Chapel Hill, NC, United States AU - Burd, C. E. AU - Liu, W. AU - Huynh, M. V. AU - Waqas, M. A. AU - Gillahan, J. E. AU - Clark, K. S. AU - Fu, K. AU - Martin, B. L. AU - Jeck, W. R. AU - Souroullas, G. P. AU - Darr, D. B. AU - Zedek, D. C. AU - Miley, M. J. AU - Baguley, B. C. AU - Campbell, S. L. AU - Sharpless, N. E. DB - Embase Medline DO - 10.1158/2159-8290.CD-14-0729 IS - 12 LA - English M3 - Article N1 - L600713749 2014-12-17 PY - 2014 SN - 2159-8290 2159-8274 SP - 1418-1429 ST - Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma T2 - Cancer Discovery TI - Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600713749&from=export http://dx.doi.org/10.1158/2159-8290.CD-14-0729 VL - 4 ID - 2128 ER - TY - JOUR AD - V. Subbiah, Phase 1 Program, UT MD AndersonCancer Center, Houston, United States AU - Subbiah, V. AU - Jiang, Y. AU - Janku, F. AU - Ludwig, J. A. AU - Naing, A. AU - Benjamin, R. S. AU - Brown, R. E. AU - Anderson, P. M. AU - Kurzrock, R. DB - Embase DO - 10.1002/pbc.25314 LA - English M3 - Conference Abstract N1 - L71655960 2014-10-31 PY - 2014 SN - 1545-5009 SP - S235 ST - Novel secondary somatic mutations in ewing's sarcoma and desmoplastic small round cell tumors in children, adolescents and young adults T2 - Pediatric Blood and Cancer TI - Novel secondary somatic mutations in ewing's sarcoma and desmoplastic small round cell tumors in children, adolescents and young adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71655960&from=export http://dx.doi.org/10.1002/pbc.25314 http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf VL - 61 ID - 2129 ER - TY - JOUR AD - A. Walker, Pediatric Oncology Branch, CCR, NCI, NIH, Bethesda, MD, United States AU - Walker, A. AU - Lopomo, P. AU - Babbitt, W. AU - Vigny, M. AU - Mackall, C. AU - Orentas, R. DB - Embase LA - English M3 - Conference Abstract N1 - L72035916 2015-10-17 PY - 2014 SN - 2051-1426 ST - Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246) T2 - Journal for ImmunoTherapy of Cancer TI - Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72035916&from=export VL - 2 ID - 2130 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, 950 west 28th Ave, Vancouver, BC, Canada AU - So, W. K. AU - Fan, Q. AU - Lau, M. T. AU - Qiu, X. AU - Cheng, J. C. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1016/j.febslet.2014.09.017 IS - 21 LA - English M3 - Article N1 - L600224384 2014-11-05 2014-11-10 PY - 2014 SN - 1873-3468 0014-5793 SP - 3998-4007 ST - Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression T2 - FEBS Letters TI - Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600224384&from=export http://dx.doi.org/10.1016/j.febslet.2014.09.017 VL - 588 ID - 2131 ER - TY - JOUR AD - H. Azevedo, Department of Pediatrics, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), São Paulo, SP, Brazil AU - Azevedo, H. AU - Fujita, A. AU - Bando, S. Y. AU - Iamashita, P. AU - Moreira-Filho, C. A. DB - Embase Medline DO - 10.1371/journal.pone.0110934 IS - 11 LA - English M3 - Article N1 - L600373044 2014-11-20 2014-11-24 PY - 2014 SN - 1932-6203 ST - Transcriptional network analysis reveals that AT1 and AT2 Angiotensin II receptors are both involved in the regulation of genes essential for glioma progression T2 - PLoS ONE TI - Transcriptional network analysis reveals that AT1 and AT2 Angiotensin II receptors are both involved in the regulation of genes essential for glioma progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600373044&from=export http://dx.doi.org/10.1371/journal.pone.0110934 VL - 9 ID - 2132 ER - TY - JOUR AD - C.M. Niemeyer, Department of Pediatric Hematology and Oncology, Universitätsklinikum Freiburg, Germany AU - Niemeyer, C. M. DB - Embase Medline DO - 10.3324/haematol.2014.114595 IS - 11 LA - English M3 - Review N1 - L600330070 2014-11-11 2014-11-19 PY - 2014 SN - 1592-8721 0390-6078 SP - 1653-1662 ST - RAS diseases in children T2 - Haematologica TI - RAS diseases in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600330070&from=export http://dx.doi.org/10.3324/haematol.2014.114595 VL - 99 ID - 2133 ER - TY - JOUR AD - M.Z. Ratajczak, Stem Cell Institute, James Graham Brown Cancer Center, University of Louisville, 500 S. Floyd Street, Louisville, KY, United States AU - Schneider, G. AU - Sellers, Z. P. AU - Abdel-Latif, A. AU - Morris, A. J. AU - Ratajczak, M. Z. DB - Embase Medline DO - 10.1158/1541-7786.MCR-14-0188 IS - 11 LA - English M3 - Article N1 - L600499409 2014-11-25 2014-12-01 PY - 2014 SN - 1557-3125 1541-7786 SP - 1560-1573 ST - Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy T2 - Molecular Cancer Research TI - Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600499409&from=export http://dx.doi.org/10.1158/1541-7786.MCR-14-0188 VL - 12 ID - 2134 ER - TY - JOUR AD - S. Penco, Department of Laboratory Medicine, Medical Genetics Unit - Niguarda Ca' Granda Hospital, Milan, Italy AU - Sole Cigoli, M. AU - Avemaria, F. AU - De Benedetti, S. AU - Gesu, G. P. AU - Giordano Accorsi, L. AU - Parmigiani, S. AU - Franca Corona, M. AU - Capra, V. AU - Mosca, A. AU - Giovannini, S. AU - Notturno, F. AU - Ciccocioppo, F. AU - Volpi, L. AU - Estienne, M. AU - De Michele, G. AU - Antenora, A. AU - Bilo, L. AU - Tavoni, A. AU - Zamponi, N. AU - Alfei, E. AU - Baranello, G. AU - Riva, D. AU - Penco, S. DB - Embase Medline DO - 10.1371/journal.pone.0110438 IS - 10 LA - English M3 - Article N1 - L600310275 2014-11-13 2014-11-19 PY - 2014 SN - 1932-6203 ST - PDCD10 gene mutations in multiple cerebral cavernous malformations T2 - PLoS ONE TI - PDCD10 gene mutations in multiple cerebral cavernous malformations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600310275&from=export http://dx.doi.org/10.1371/journal.pone.0110438 VL - 9 ID - 2135 ER - TY - JOUR AD - J. Wu, Cincinnati Children's Hospital, Medical Center, Cincinnati, OH, United States AU - Wu, J. AU - Jousma, E. AU - Rizvi, T. AU - Dunn, R. S. AU - Jones, D. R. AU - Cripe, T. P. AU - Kim, M. O. AU - Marcus, L. AU - Dombi, E. AU - Baldwin, A. AU - Long, L. M. AU - Andrea, G. AU - Whitcomb, P. AU - Peron, S. M. AU - Widemann, B. AU - Janhofer, D. AU - Ratner, N. DB - Embase DO - 10.1158/1538-7445.PEDCAN-A2 IS - 20 LA - English M3 - Conference Abstract N1 - L71713688 2014-12-15 PY - 2014 SN - 0008-5472 ST - Using plexiform neurofibroma preclinical therapeutics to help guide clinical trials T2 - Cancer Research TI - Using plexiform neurofibroma preclinical therapeutics to help guide clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713688&from=export http://dx.doi.org/10.1158/1538-7445.PEDCAN-A2 http://cancerres.aacrjournals.org/content/74/20_Supplement/A2.abstract?sid=0e6b4920-7f0c-4a79-bb1d-794f181c13b2 VL - 74 ID - 2136 ER - TY - JOUR AD - D. Vishwamitra, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Vishwamitra, D. AU - George, S. K. AU - Manshouri, R. AU - Shi, P. AU - Amin, H. M. DB - Embase DO - 10.1158/1538-7445.PEDCAN-A80 IS - 20 LA - English M3 - Conference Abstract N1 - L71713748 2014-12-15 PY - 2014 SN - 0008-5472 ST - In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK+ T-cell anaplastic large-cell lymphoma T2 - Cancer Research TI - In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK+ T-cell anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713748&from=export http://dx.doi.org/10.1158/1538-7445.PEDCAN-A80 http://cancerres.aacrjournals.org/content/74/20_Supplement/A80.abstract?sid=f9d3b7b2-62f6-43a3-b039-91967a1963e1 VL - 74 ID - 2137 ER - TY - JOUR AD - W.W. Zomerman, University Medical Center Groningen, Groningen, Netherlands AU - Zomerman, W. W. AU - Plasschaert, S. L. A. AU - Diks, S. H. AU - Lourens, H. J. AU - Hoving, E. W. AU - Den Dunnen, W. F. A. AU - De Bont, E. S. J. M. DB - Embase DO - 10.1158/1538-7445.PEDCAN-B10 IS - 20 LA - English M3 - Conference Abstract N1 - L71713760 2014-12-15 PY - 2014 SN - 0008-5472 ST - HGF enhances tumor cell survival in canertinib-treated medulloblastoma cell lines T2 - Cancer Research TI - HGF enhances tumor cell survival in canertinib-treated medulloblastoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713760&from=export http://dx.doi.org/10.1158/1538-7445.PEDCAN-B10 http://cancerres.aacrjournals.org/content/74/20_Supplement/B10.abstract?sid=f9b05294-a6e7-4cb0-9399-0ae34b2b4a9b VL - 74 ID - 2138 ER - TY - JOUR AD - J.R. Stehn, University of New South Wales, Sydney, Australia AU - Stehn, J. R. AU - Chen, D. AU - Currier, M. A. AU - Eaves, D. AU - Desouza, M. AU - Moosavian, M. AU - Cripe, T. P. AU - Gunning, P. W. DB - Embase DO - 10.1158/1538-7445.PEDCAN-B50 IS - 20 LA - English M3 - Conference Abstract N1 - L71713790 2014-12-15 PY - 2014 SN - 0008-5472 ST - Synergistic anti-neuroblastoma efficacy using combinatorial cytoskeletal inhibitors T2 - Cancer Research TI - Synergistic anti-neuroblastoma efficacy using combinatorial cytoskeletal inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713790&from=export http://dx.doi.org/10.1158/1538-7445.PEDCAN-B50 http://cancerres.aacrjournals.org/content/74/20_Supplement/B50.abstract?sid=897a1880-199a-4e71-ac50-5b103da1a6ee VL - 74 ID - 2139 ER - TY - JOUR AD - M. Snurdel, Massachusetts General Hospital, Boston, MA, United States AU - Snurdel, M. AU - Batista, A. AU - Kirkpatrick, N. AU - Almodovar, C. AU - Riedemann, L. AU - Peterson, T. AU - Ferrara, N. AU - Klagsbrun, M. AU - Duda, D. G. AU - Fukumura, D. AU - Xu, L. AU - Carmeliet, P. AU - Jain, R. DB - Embase DO - 10.1158/1538-7445.PEDCAN-IA17 IS - 20 LA - English M3 - Conference Abstract N1 - L71713818 2014-12-15 PY - 2014 SN - 0008-5472 ST - Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma T2 - Cancer Research TI - Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713818&from=export http://dx.doi.org/10.1158/1538-7445.PEDCAN-IA17 http://cancerres.aacrjournals.org/content/74/20_Supplement/IA17.abstract?sid=d535fed3-6e06-482c-974a-5f845d36f4b3 VL - 74 ID - 2140 ER - TY - JOUR AD - R. Chakravarty, ICMR Virus Unit, Kolkata, ID and BG Hospital Campus, 57, Dr. S C Banerjee Road, Beliaghata, Kolkata West Bengal, India AU - Bandopadhyay, M. AU - Banerjee, A. AU - Sarkar, N. AU - Panigrahi, R. AU - Datta, S. AU - Pal, A. AU - Singh, S. P. AU - Biswas, A. AU - Chakrabarti, S. AU - Chakravarty, R. DB - Embase Medline DO - 10.1186/1471-2407-14-721 IS - 1 LA - English M3 - Article N1 - L600442534 2014-11-20 2014-11-25 PY - 2014 SN - 1471-2407 ST - Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by Hepatitis B virus X protein in malignant hepatocytes T2 - BMC Cancer TI - Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by Hepatitis B virus X protein in malignant hepatocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600442534&from=export http://dx.doi.org/10.1186/1471-2407-14-721 VL - 14 ID - 2141 ER - TY - JOUR AD - Y.-H. Lee, Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan AU - Lee, Y. H. AU - Su, S. B. AU - Huang, C. C. AU - Sheu, H. M. AU - Tsai, J. C. AU - Lin, C. H. AU - Wang, Y. J. AU - Wang, B. J. C2 - Merck Chemical Company(Germany) DB - Embase Medline DO - 10.1371/journal.pone.0108317 IS - 9 LA - English M3 - Article N1 - L600067438 2014-10-09 2014-10-11 PY - 2014 SN - 1932-6203 ST - N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression T2 - PLoS ONE TI - N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600067438&from=export http://dx.doi.org/10.1371/journal.pone.0108317 VL - 9 ID - 2142 ER - TY - JOUR AD - U.J.F. Tietge, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands AU - De Boer, J. F. AU - Dikkers, A. AU - Jurdzinski, A. AU - Felden, J. V. AU - Gaestel, M. AU - Bavendiek, U. AU - Tietge, U. J. F. DB - Embase Medline DO - 10.1371/journal.pone.0106300 IS - 9 LA - English M3 - Article N1 - L600046302 2014-10-01 2019-12-30 PY - 2014 SN - 1932-6203 ST - Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice T2 - PLoS ONE TI - Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600046302&from=export http://dx.doi.org/10.1371/journal.pone.0106300 VL - 9 ID - 2143 ER - TY - JOUR AD - C.L.H. Yang, Molecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong AU - Luo, D. AU - Or, T. C. T. AU - Yang, C. L. H. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1021/cn5001205 IS - 9 LA - English M3 - Article N1 - L603046663 2015-03-24 2015-03-30 PY - 2014 SN - 1948-7193 SP - 855-866 ST - Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver T2 - ACS Chemical Neuroscience TI - Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603046663&from=export http://dx.doi.org/10.1021/cn5001205 VL - 5 ID - 2144 ER - TY - JOUR AD - K.S. Keene, University of Alabama at Birmingham, Birmingham, AL, United States AU - Keene, K. S. AU - Dubay, D. AU - McGuire, B. AU - Desmond, R. AU - Jacob, R. AU - Dobelbower, M. C. AU - Eckhoff, D. AU - Posey, J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L71624110 2014-09-30 PY - 2014 SN - 0360-3016 SP - S369 ST - Stereotactic body radiation therapy followed by sorafenib improves survival without increasing toxicity T2 - International Journal of Radiation Oncology Biology Physics TI - Stereotactic body radiation therapy followed by sorafenib improves survival without increasing toxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71624110&from=export VL - 90 ID - 2145 ER - TY - JOUR AD - T. Miyamoto, Department of Orthopedic Surgery, Keio University School of Medicine, 35 Shinano-machi, Tokyo 160-8582, Japan AU - Mori, T. AU - Sato, Y. AU - Miyamoto, K. AU - Kobayashi, T. AU - Shimizu, T. AU - Kanagawa, H. AU - Katsuyama, E. AU - Fujie, A. AU - Hao, W. AU - Tando, T. AU - Iwasaki, R. AU - Kawana, H. AU - Morioka, H. AU - Matsumoto, M. AU - Saya, H. AU - Toyama, Y. AU - Miyamoto, T. DB - Embase Medline DO - 10.1038/onc.2013.545 IS - 33 LA - English M3 - Article N1 - L52919830 2013-12-19 2014-09-04 PY - 2014 SN - 1476-5594 0950-9232 SP - 4236-4241 ST - TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state T2 - Oncogene TI - TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52919830&from=export http://dx.doi.org/10.1038/onc.2013.545 VL - 33 ID - 2147 ER - TY - JOUR AD - T. Rosenbaum, Klinikum Duisburg, Klinik für Kinder- U. Jugendmedizin, Zu den Rehwiesen 9, Duisburg, Germany AU - Rosenbaum, T. AU - Wimmer, K. DB - Embase Medline DO - 10.1055/s-0034-1382021 IS - 6-7 LA - English M3 - Review N1 - L53263891 2014-08-01 2015-10-09 PY - 2014 SN - 1439-3824 0300-8630 SP - 309-315 ST - Neurofibromatosis type 1 (NF1) and Associated Tumors T2 - Klinische Padiatrie TI - Neurofibromatosis type 1 (NF1) and Associated Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53263891&from=export http://dx.doi.org/10.1055/s-0034-1382021 VL - 226 ID - 2149 ER - TY - JOUR AD - E. Scoditti, Institute of Clinical Physiology-CNR, Lecce, Italy AU - Scoditti, E. AU - Massaro, M. AU - Carluccio, M. A. AU - Pellegrino, M. AU - Calabriso, N. AU - Wabitsch, M. AU - Storelli, C. AU - De Caterina, R. DB - Embase DO - 10.1093/cvr/cvu098.164 LA - English M3 - Conference Abstract N1 - L71588679 2014-08-23 PY - 2014 SN - 0008-6363 SP - S136 ST - Regulation of adiponectin expression by selective molecular components of mediterranean diets in human adipocytes T2 - Cardiovascular Research TI - Regulation of adiponectin expression by selective molecular components of mediterranean diets in human adipocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71588679&from=export http://dx.doi.org/10.1093/cvr/cvu098.164 VL - 103 ID - 2150 ER - TY - JOUR AU - Barysch, M. J. AU - Levesque, M. P. AU - Cheng, P. AU - Karpova, M. B. AU - Mihic-Probst, D. AU - Civenni, G. AU - Shakhova, O. AU - Sommer, L. AU - Biedermann, T. AU - Schiestl, C. AU - Dummer, R. DB - Embase DO - 10.1159/000362490 IS - 1 LA - English M3 - Article N1 - L611213174 2016-07-19 2016-07-26 PY - 2014 SN - 2296-3529 SP - 35-46 ST - Coexpression of SOX10/CD271 (p75NTR) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients T2 - Dermatopathology TI - Coexpression of SOX10/CD271 (p75NTR) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611213174&from=export http://dx.doi.org/10.1159/000362490 VL - 1 ID - 2151 ER - TY - JOUR AU - Tietz, S. M. AU - Hofmann, R. AU - Thomas, T. AU - Tackenberg, B. AU - Gaestel, M. AU - Berghoff, M. DB - Embase Medline DO - 10.1371/journal.pone.0100363 IS - 6 LA - English M3 - Article N1 - L373419024 2014-07-09 2014-07-14 PY - 2014 SN - 1932-6203 ST - MK2 and Fas receptor contribute to the severity of CNS demyelination T2 - PLoS ONE TI - MK2 and Fas receptor contribute to the severity of CNS demyelination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373419024&from=export http://dx.doi.org/10.1371/journal.pone.0100363 VL - 9 ID - 2152 ER - TY - JOUR AD - X. Feng, Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China AU - Tao, Y. F. AU - Xu, L. X. AU - Lu, J. AU - Cao, L. AU - Li, Z. H. AU - Hu, S. Y. AU - Wang, N. N. AU - Du, X. J. AU - Sun, L. C. AU - Zhao, W. L. AU - Xiao, P. F. AU - Fang, F. AU - Li, Y. H. AU - Li, G. AU - Zhao, H. AU - Li, Y. P. AU - Xu, Y. Y. AU - Ni, J. AU - Wang, J. AU - Feng, X. AU - Pan, J. DB - Embase Medline DO - 10.1186/1479-5876-12-182 IS - 1 LA - English M3 - Article N1 - L53214904 2014-07-01 2014-07-16 PY - 2014 SN - 1479-5876 ST - Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation T2 - Journal of Translational Medicine TI - Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53214904&from=export http://dx.doi.org/10.1186/1479-5876-12-182 VL - 12 ID - 2153 ER - TY - JOUR AD - N. Maulik, Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut Health Center, Farmington, CT 06032, United States AU - Selvaraju, V. AU - Parinandi, N. L. AU - Adluri, R. S. AU - Goldman, J. W. AU - Hussain, N. AU - Sanchez, J. A. AU - Maulik, N. C1 - fg 2216 gsk 360a(Glaxo SmithKline) tm 6008 tm 6089 C2 - FibroGen(United States) Glaxo SmithKline(United States) DB - Embase Medline DO - 10.1089/ars.2013.5186 IS - 16 LA - English M3 - Review N1 - L373064556 2014-05-22 2014-05-29 PY - 2014 SN - 1557-7716 1523-0864 SP - 2631-2665 ST - Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of hif-prolyl 4-hydroxylases for treatment of ischemic diseases T2 - Antioxidants and Redox Signaling TI - Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of hif-prolyl 4-hydroxylases for treatment of ischemic diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373064556&from=export http://dx.doi.org/10.1089/ars.2013.5186 VL - 20 ID - 2155 ER - TY - JOUR AD - T.-J. Lin, Department of Pediatrics, IWK Health Centre, Dalhousie University, 5850 University Avenue, Halifax, NS B3K 6R8, Canada AU - Wu, Z. AU - Chen, X. AU - Liu, F. AU - Chen, W. AU - Wu, P. AU - Wieschhaus, A. J. AU - Chishti, A. H. AU - Roche, P. A. AU - Chen, W. M. AU - Lin, T. J. DB - Embase Medline DO - 10.4049/jimmunol.1301677 IS - 11 LA - English M3 - Article N1 - L373143306 2014-06-02 2014-06-12 PY - 2014 SN - 1550-6606 0022-1767 SP - 5130-5139 ST - Calpain-1 contributes to IgE-mediated mast cell activation T2 - Journal of Immunology TI - Calpain-1 contributes to IgE-mediated mast cell activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373143306&from=export http://dx.doi.org/10.4049/jimmunol.1301677 VL - 192 ID - 2156 ER - TY - JOUR AD - R.P. Erickson, Department of Pediatrics, University of Arizona, Tucson, AZ, United States AU - Erickson, R. P. DB - Embase DO - 10.1016/j.gde.2014.06.001 LA - English M3 - Review N1 - L600110730 2014-10-21 2014-10-24 PY - 2014 SN - 1879-0380 0959-437X SP - 73-78 ST - Recent advances in the study of somatic mosaicism and diseases other than cancer T2 - Current Opinion in Genetics and Development TI - Recent advances in the study of somatic mosaicism and diseases other than cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600110730&from=export http://dx.doi.org/10.1016/j.gde.2014.06.001 VL - 26 ID - 2157 ER - TY - JOUR AD - M.J. Fisher, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Fisher, M. J. AU - Marcus, L. AU - Weiss, B. AU - Kim, A. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Martin, S. AU - Gillespie, A. AU - Doyle, A. AU - Widemann, B. C. DB - Embase DO - 10.1093/neuonc/nou081 LA - English M3 - Conference Abstract N1 - L71506038 2014-06-26 PY - 2014 SN - 1522-8517 SP - i129 ST - Selumetinib (AZD6244) hydrogen sulfate, a MEK1/2 inhibitor, in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNS): A phase i study T2 - Neuro-Oncology TI - Selumetinib (AZD6244) hydrogen sulfate, a MEK1/2 inhibitor, in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNS): A phase i study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71506038&from=export http://dx.doi.org/10.1093/neuonc/nou081 VL - 16 ID - 2158 ER - TY - JOUR AD - A. Banerjee AU - Banerjee, A. AU - Jakacki, R. AU - Onar-Thomas, A. AU - Wu, S. AU - Nicolaides, T. AU - Turner, D. AU - Richardson, S. AU - Young-Poussaint, T. AU - Phillips, J. J. AU - Prados, M. AU - Packer, R. AU - Qaddoumi, I. A. AU - Gururangan, S. AU - Goldman, S. AU - Pollack, I. AU - Doyle, L. A. AU - Stewart, C. F. AU - Boyett, J. M. AU - Fouladi, M. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523493 2014-07-16 PY - 2014 SN - 0732-183X ST - A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report T2 - Journal of Clinical Oncology TI - A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523493&from=export http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10065?sid=cd52d472-81c9-4f24-82f7-5862d43dd32e VL - 32 ID - 2159 ER - TY - JOUR AD - B.C. Widemann AU - Widemann, B. C. AU - Marcus, L. J. AU - Fisher, M. J. AU - Weiss, B. D. AU - Kim, A. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Martin, S. AU - Gillespie, A. AU - Doyle, A. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523507 2014-07-16 PY - 2014 SN - 0732-183X ST - Phase I study of the MEK1/2 inhibitor selumetinib (AZD6244) hydrogen sulfate in children and young adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) T2 - Journal of Clinical Oncology TI - Phase I study of the MEK1/2 inhibitor selumetinib (AZD6244) hydrogen sulfate in children and young adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523507&from=export http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10018?sid=cd52d472-81c9-4f24-82f7-5862d43dd32e VL - 32 ID - 2160 ER - TY - JOUR AD - Z. Eroglu AU - Eroglu, Z. AU - Tawbi, H. A. H. AU - Hu, J. AU - Guan, M. AU - Frankel, P. H. AU - Ruel, N. AU - Wilczynski, S. AU - Christensen, S. AU - Gandara, D. R. AU - Chow, W. A. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523586 2014-07-16 PY - 2014 SN - 0732-183X ST - NCI #8412: A randomized phase II trial of AZD6244 alone and AZD6244 plus temsirolimus for soft-tissue sarcomas T2 - Journal of Clinical Oncology TI - NCI #8412: A randomized phase II trial of AZD6244 alone and AZD6244 plus temsirolimus for soft-tissue sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523586&from=export http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10526?sid=bd57f2ae-089e-41c9-9100-7badef5fe01c VL - 32 ID - 2161 ER - TY - JOUR AD - R.J. Chan, Indiana University School of Medicine, Department of Pediatrics, Herman B Wells Center for Pediatric Research, United States AU - Goodwin, C. B. AU - Li, X. J. AU - Mali, R. S. AU - Chan, G. AU - Kang, M. AU - Liu, Z. AU - Vanhaesebroeck, B. AU - Neel, B. G. AU - Loh, M. L. AU - Lannutti, B. J. AU - Kapur, R. AU - Chan, R. J. C1 - gs 1101(Gilead) pd 0325901(Selleck) C2 - Gilead Selleck DB - Embase Medline DO - 10.1182/blood-2013-10-535104 IS - 18 LA - English M3 - Article N1 - L373379872 2014-07-04 2014-07-08 PY - 2014 SN - 1528-0020 0006-4971 SP - 2838-2842 ST - PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML T2 - Blood TI - PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373379872&from=export http://dx.doi.org/10.1182/blood-2013-10-535104 VL - 123 ID - 2162 ER - TY - JOUR AD - A. Areskeviciute, University of Copenhagen, Faculty of Science, Copenhagen, Denmark AU - Areskeviciute, A. AU - Sandager, C. N. AU - Skov, S. AU - Broholm, H. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L71992354 2015-09-08 PY - 2014 SN - 0722-5091 SP - 203 ST - RSK activity in pediatric tumors: Investigation of the MAP kinase pathway with special emphasis on RSK T2 - Clinical Neuropathology TI - RSK activity in pediatric tumors: Investigation of the MAP kinase pathway with special emphasis on RSK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71992354&from=export http://www.dustri.com/nc/journals-in-english/mag/clinical-neuropathology/vol/volume-33/issue/mayjune-7.html VL - 33 ID - 2163 ER - TY - JOUR AU - Basavarajappa, H. D. AU - Lee, B. AU - Fei, X. AU - Lim, D. AU - Callaghan, B. AU - Mund, J. A. AU - Case, J. AU - Rajashekhar, G. AU - Seo, S. Y. AU - Corson, T. W. C1 - sh 11052 DB - Embase Medline DO - 10.1371/journal.pone.0095694 IS - 4 LA - English M3 - Article N1 - L372991230 2014-05-12 2014-05-21 PY - 2014 SN - 1932-6203 ST - Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth T2 - PLoS ONE TI - Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372991230&from=export http://dx.doi.org/10.1371/journal.pone.0095694 VL - 9 ID - 2164 ER - TY - JOUR AD - D.B. Solit, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States AU - Nissan, M. H. AU - Pratilas, C. A. AU - Jones, A. M. AU - Ramirez, R. AU - Won, H. AU - Liu, C. AU - Tiwari, S. AU - Kong, L. AU - Hanrahan, A. J. AU - Yao, Z. AU - Merghoub, T. AU - Ribas, A. AU - Chapman, P. B. AU - Yaeger, R. AU - Taylor, B. S. AU - Schultz, N. AU - Berger, M. F. AU - Rosen, N. AU - Solit, D. B. C1 - azd 6244 mek 162 pd 0325901 DB - Embase Medline DO - 10.1158/0008-5472.CAN-13-2625 IS - 8 LA - English M3 - Article N1 - L372973668 2014-05-09 2014-05-14 PY - 2014 SN - 1538-7445 0008-5472 SP - 2340-2350 ST - Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence T2 - Cancer Research TI - Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372973668&from=export http://dx.doi.org/10.1158/0008-5472.CAN-13-2625 VL - 74 ID - 2166 ER - TY - JOUR AD - S. Kanazawa, Department of Plastic Surgery, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan AU - Tanigawa, T. AU - Kanazawa, S. AU - Ichibori, R. AU - Fujiwara, T. AU - Magome, T. AU - Shingaki, K. AU - Miyata, S. AU - Hata, Y. AU - Tomita, K. AU - Matsuda, K. AU - Kubo, T. AU - Tohyama, M. AU - Yano, K. AU - Hosokawa, K. DB - Embase Medline DO - 10.1186/1472-6882-14-133 LA - English M3 - Article N1 - L53096528 2014-05-09 2014-05-16 PY - 2014 SN - 1472-6882 ST - (+)-Catechin protects dermal fibroblasts against oxidative stress-induced apoptosis T2 - BMC Complementary and Alternative Medicine TI - (+)-Catechin protects dermal fibroblasts against oxidative stress-induced apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53096528&from=export http://dx.doi.org/10.1186/1472-6882-14-133 VL - 14 ID - 2167 ER - TY - JOUR AD - L. Alili, Institute of Biochemistry and Molecular Biology I, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany AU - Alili, L. AU - Sack, M. AU - Puschmann, K. AU - Brenneisen, P. DB - Embase DO - 10.1042/BSR20130091 IS - 1 LA - English M3 - Article N1 - L372460346 2014-03-04 2014-03-21 PY - 2014 SN - 0144-8463 1573-4935 SP - 7-17 ST - Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species T2 - Bioscience Reports TI - Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372460346&from=export http://dx.doi.org/10.1042/BSR20130091 http://www.bioscirep.org/bsr/034/e089/034e089.pdf VL - 34 ID - 2168 ER - TY - JOUR AD - Y. P. Han, Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China AU - Shi, H. AU - Han, Y. P. AU - He, M. X. AU - Huang, L. AU - Bai, C. AU - Li, Q. AU - Ma, D. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.20130695 IS - 4 LA - English M3 - Note N1 - L372411222 2014-02-27 2014-03-07 PY - 2014 SN - 0366-6999 SP - 794-795 ST - Primary tracheobronchial anaplastic large cell lymphoma in an 8-year-old child presenting with asthma-like symptoms T2 - Chinese Medical Journal TI - Primary tracheobronchial anaplastic large cell lymphoma in an 8-year-old child presenting with asthma-like symptoms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372411222&from=export http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20130695 http://www.cmj.org/ch/reader/create_pdf.aspx?file_no=20130695&year_id=2014&quarter_id=4&falg=1 VL - 127 ID - 2169 ER - TY - JOUR AD - H.-G. Liu, Department of Pathology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Dongcheng District, Beijing 100730, China AU - He, C. Y. AU - Dong, G. H. AU - Liu, H. G. DB - Embase Medline DO - 10.1186/1477-7819-12-54 IS - 1 LA - English M3 - Article N1 - L372938988 2014-05-05 2014-05-09 PY - 2014 SN - 1477-7819 ST - Recurrent laryngeal inflammatory myofibroblastic tumor with positive anaplastic lymphoma kinase mimicking recurrent respiratory papillomatosis: A case report T2 - World Journal of Surgical Oncology TI - Recurrent laryngeal inflammatory myofibroblastic tumor with positive anaplastic lymphoma kinase mimicking recurrent respiratory papillomatosis: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372938988&from=export http://dx.doi.org/10.1186/1477-7819-12-54 VL - 12 ID - 2170 ER - TY - JOUR AD - G.M. Brodeur, Children's Hospital of Philadelphias, Division of Oncology, 3501 Civic Center Blvd., Philadelphia, PA 19104-4302, United States AU - Brodeur, G. M. AU - Iyer, R. AU - Croucher, J. L. AU - Zhuang, T. AU - Higashi, M. AU - Kolla, V. DB - Embase Medline DO - 10.1517/14728222.2014.867946 IS - 3 LA - English M3 - Review N1 - L372394899 2014-02-26 2014-03-03 PY - 2014 SN - 1472-8222 1744-7631 SP - 277-292 ST - Therapeutic targets for neuroblastomas T2 - Expert Opinion on Therapeutic Targets TI - Therapeutic targets for neuroblastomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372394899&from=export http://dx.doi.org/10.1517/14728222.2014.867946 VL - 18 ID - 2171 ER - TY - JOUR AD - Y.-L. Wu, Division of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, No.106, Zhongshan Er Road, Guangzhou, 510080, China AU - Chen, H. J. AU - Yang, J. J. AU - Fang, L. Y. AU - Huang, M. M. AU - Yan, H. H. AU - Zhang, X. C. AU - Xu, C. R. AU - Wu, Y. L. DB - Embase DO - 10.1111/1759-7714.12076 IS - 2 LA - English M3 - Article N1 - L372513389 2014-03-11 2014-03-18 PY - 2014 SN - 1759-7706 1759-7714 SP - 155-161 ST - Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer T2 - Thoracic Cancer TI - Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372513389&from=export http://dx.doi.org/10.1111/1759-7714.12076 VL - 5 ID - 2173 ER - TY - JOUR AD - N. Çelik, Gazi University, Department of Pediatric Endocrinology, Ankara, Turkey AU - Çelik, N. AU - Cinaz, P. AU - Bideci, A. AU - Yüce, Ö AU - Emeksiz, H. C. AU - Döǧer, E. AU - Çamurdan, O. DB - Embase Medline DO - 10.4274/Jcrpe.1151 IS - 1 LA - English M3 - Article N1 - L372524653 2014-03-12 2014-03-26 PY - 2014 SN - 1308-5727 1308-5735 SP - 55-58 ST - Cardio-facio-cutaneous syndrome with precocious puberty, growth hormone deficiency and hyperprolactinemia T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - Cardio-facio-cutaneous syndrome with precocious puberty, growth hormone deficiency and hyperprolactinemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372524653&from=export http://dx.doi.org/10.4274/Jcrpe.1151 http://www.jcrpe.org/sayilar/49/buyuk/55-58.pdf VL - 6 ID - 2174 ER - TY - JOUR AD - J.K. Adamski, Department of Paediatric Oncology, Royal Manchester Children's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom AU - Adamski, J. K. AU - Kelsey, A. AU - Brennan, B. DB - Embase Medline DO - 10.1097/MPH.0b013e31827e5302 IS - 2 LA - English M3 - Article N1 - L52372862 2013-01-08 2014-03-13 PY - 2014 SN - 1077-4114 1536-3678 SP - 159-162 ST - Inflammatory myofibroblastic tumors following the treatment of malignancy in childhood: Case reports T2 - Journal of Pediatric Hematology/Oncology TI - Inflammatory myofibroblastic tumors following the treatment of malignancy in childhood: Case reports UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52372862&from=export http://dx.doi.org/10.1097/MPH.0b013e31827e5302 VL - 36 ID - 2175 ER - TY - JOUR AD - L. Sacchetti, Laboratori Misti, IRCCS Fondazione SDN-CEINGE, CEINGE-Biotecnologie Avanzate, Via E Gianturco 113, 80143 Naples, Italy AU - Nardelli, C. AU - Iaffaldano, L. AU - Ferrigno, M. AU - Labruna, G. AU - Maruotti, G. M. AU - Quaglia, F. AU - Capobianco, V. AU - Di Noto, R. AU - Del Vecchio, L. AU - Martinelli, P. AU - Pastore, L. AU - Sacchetti, L. DB - Embase Medline DO - 10.1038/ijo.2013.121 IS - 3 LA - English M3 - Article N1 - L52704577 2013-08-05 2014-03-27 PY - 2014 SN - 0307-0565 1476-5497 SP - 466-469 ST - Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women T2 - International Journal of Obesity TI - Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52704577&from=export http://dx.doi.org/10.1038/ijo.2013.121 VL - 38 ID - 2176 ER - TY - JOUR AD - K. Sakamoto, Department of Pediatrics, School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chou, Hirokouji, Kamigyo-ku, Kyoto, Japan AU - Sakamoto, K. AU - Imamura, T. AU - Asai, D. AU - Goto-Kawashima, S. AU - Yoshida, H. AU - Fujiki, A. AU - Furutani, A. AU - Ishida, H. AU - Aoki, Y. AU - Hosoi, H. DB - Embase Medline DO - 10.1097/MPH.0000000000000002 IS - 2 LA - English M3 - Article N1 - L52794026 2013-10-02 2014-03-13 PY - 2014 SN - 1077-4114 1536-3678 SP - e136-e139 ST - Acute lymphoblastic leukemia developing in a patient with noonan syndrome harboring a PTPN11 germline mutation T2 - Journal of Pediatric Hematology/Oncology TI - Acute lymphoblastic leukemia developing in a patient with noonan syndrome harboring a PTPN11 germline mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52794026&from=export http://dx.doi.org/10.1097/MPH.0000000000000002 VL - 36 ID - 2177 ER - TY - JOUR AD - M. Sie, University Medical Center Groningens, Department of Pediatricss, Beatrix Children's Hospital, Pediatric Oncology Division, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, Netherlands AU - Sie, M. AU - den Dunnen, W. F. A. AU - Hoving, E. W. AU - de Bont, E. S. J. M. C1 - avastin cc 5013 gleevec su 11248 su 5416 tarceva DB - Embase Medline DO - 10.1016/j.critrevonc.2013.09.005 IS - 3 LA - English M3 - Review N1 - L52832771 2013-10-31 2014-03-04 PY - 2014 SN - 1040-8428 1879-0461 SP - 418-132 ST - Anti-angiogenic therapy in pediatric brain tumors: An effective strategy? T2 - Critical Reviews in Oncology/Hematology TI - Anti-angiogenic therapy in pediatric brain tumors: An effective strategy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52832771&from=export http://dx.doi.org/10.1016/j.critrevonc.2013.09.005 VL - 89 ID - 2178 ER - TY - JOUR AD - K. Vakili, Department of Surgery, Pediatric Transplant Center, Boston Children's Hospital, Boston, MA, United States AU - Vakili, K. AU - Kim, H. B. DB - Embase Medline DO - 10.1111/ajt.12623 IS - 3 LA - English M3 - Article N1 - L52971816 2014-01-27 2014-03-11 PY - 2014 SN - 1600-6135 1600-6143 SP - 720-723 ST - Partial esophageal transplantation is possible as part of a multivisceral graft T2 - American Journal of Transplantation TI - Partial esophageal transplantation is possible as part of a multivisceral graft UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52971816&from=export http://dx.doi.org/10.1111/ajt.12623 VL - 14 ID - 2179 ER - TY - JOUR AU - Li, L. AU - Han, M. AU - Li, S. AU - Xu, Y. AU - Wang, L. DB - Medline DO - 10.1902/jop.2013.130048 IS - 3 LA - English M3 - Article N1 - L601990974 2015-02-09 PY - 2014 SN - 1943-3670 SP - 498-508 ST - Hypoxia regulates the proliferation and osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress via mitogen-activated protein kinase pathways T2 - Journal of periodontology TI - Hypoxia regulates the proliferation and osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress via mitogen-activated protein kinase pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601990974&from=export http://dx.doi.org/10.1902/jop.2013.130048 VL - 85 ID - 2180 ER - TY - JOUR AD - V.E. Velculescu, Ludwig Center for Cancer Genetics and Therapeutics, Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, United States AU - Bettegowda, C. AU - Sausen, M. AU - Leary, R. J. AU - Kinde, I. AU - Wang, Y. AU - Agrawal, N. AU - Bartlett, B. R. AU - Wang, H. AU - Luber, B. AU - Alani, R. M. AU - Antonarakis, E. S. AU - Azad, N. S. AU - Bardelli, A. AU - Brem, H. AU - Cameron, J. L. AU - Lee, C. C. AU - Fecher, L. A. AU - Gallia, G. L. AU - Gibbs, P. AU - Le, D. AU - Giuntoli, R. L. AU - Goggins, M. AU - Hogarty, M. D. AU - Holdhoff, M. AU - Hong, S. M. AU - Jiao, Y. AU - Juhl, H. H. AU - Kim, J. J. AU - Siravegna, G. AU - Laheru, D. A. AU - Lauricella, C. AU - Lim, M. AU - Lipson, E. J. AU - Marie, S. K. N. AU - Netto, G. J. AU - Oliner, K. S. AU - Olivi, A. AU - Olsson, L. AU - Riggins, G. J. AU - Sartore-Bianchi, A. AU - Schmidt, K. AU - Shih, I. M. AU - Oba-Shinjo, S. M. AU - Siena, S. AU - Theodorescu, D. AU - Tie, J. AU - Harkins, T. T. AU - Veronese, S. AU - Wang, T. L. AU - Weingart, J. D. AU - Wolfgang, C. L. AU - Wood, L. D. AU - Xing, D. AU - Hruban, R. H. AU - Wu, J. AU - Allen, P. J. AU - Schmidt, C. M. AU - Choti, M. A. AU - Velculescu, V. E. AU - Kinzler, K. W. AU - Vogelstein, B. AU - Papadopoulos, N. AU - Diaz Jr, L. A. DB - Embase Medline DO - 10.1126/scitranslmed.3007094 IS - 224 LA - English M3 - Article N1 - L372632674 2014-03-26 2014-04-01 PY - 2014 SN - 1946-6234 1946-6242 ST - Detection of circulating tumor DNA in early- and late-stage human malignancies T2 - Science Translational Medicine TI - Detection of circulating tumor DNA in early- and late-stage human malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372632674&from=export http://dx.doi.org/10.1126/scitranslmed.3007094 http://stm.sciencemag.org/content/6/224/224ra24.full.pdf VL - 6 ID - 2181 ER - TY - JOUR AD - E. Mayson, Haematology Department, Wollongong Hospital, Crown Street, Wollongong, NSW 2500, Australia AU - Mayson, E. AU - Saverimuttu, J. AU - Warburton, P. DB - Embase Medline DO - 10.1111/imj.12347 IS - 2 LA - English M3 - Article N1 - L372383321 2014-02-26 2014-02-28 PY - 2014 SN - 1444-0903 1445-5994 SP - 198-201 ST - Two-faced haemophagocytic lymphohistiocytosis: Comparative review of two cases of adult haemophagocytic lymphohistiocytosis T2 - Internal Medicine Journal TI - Two-faced haemophagocytic lymphohistiocytosis: Comparative review of two cases of adult haemophagocytic lymphohistiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372383321&from=export http://dx.doi.org/10.1111/imj.12347 VL - 44 ID - 2182 ER - TY - JOUR AD - K. Kosaki, Center for Medical Genetics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan AU - Takenouchi, T. AU - Shimizu, A. AU - Torii, C. AU - Kosaki, R. AU - Takahashi, T. AU - Saya, H. AU - Kosaki, K. DB - Embase Medline DO - 10.1002/ajmg.a.36288 IS - 2 LA - English M3 - Article N1 - L52907314 2013-12-11 2014-02-13 PY - 2014 SN - 1552-4825 1552-4833 SP - 392-396 ST - Multiple café au lait spots in familial patients with MAP2K2 mutation T2 - American Journal of Medical Genetics, Part A TI - Multiple café au lait spots in familial patients with MAP2K2 mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52907314&from=export http://dx.doi.org/10.1002/ajmg.a.36288 VL - 164 ID - 2183 ER - TY - JOUR AD - N. Andersson, Children's Hospital, University of Helsinki and Helsinki University Central Hospital, PO Box 20, 00014, Helsinki, Finland AU - Andersson, N. AU - Anttonen, M. AU - Färkkilä, A. AU - Pihlajoki, M. AU - Butzow, R. AU - Unkila-Kallio, L. AU - Heikinheimo, M. C2 - Selleck(United States) DB - Embase Medline DO - 10.1530/JME-13-0286 IS - 2 LA - English M3 - Article N1 - L372670254 2014-04-01 2014-04-02 PY - 2014 SN - 0952-5041 1479-6813 SP - 223-234 ST - Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition T2 - Journal of Molecular Endocrinology TI - Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372670254&from=export http://dx.doi.org/10.1530/JME-13-0286 http://jme.endocrinology-journals.org/content/52/2/223.full.pdf VL - 52 ID - 2184 ER - TY - JOUR AD - F.-L. Yen, Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan AU - Ko, H. H. AU - Chiang, Y. C. AU - Tsai, M. H. AU - Liang, C. J. AU - Hsu, L. F. AU - Li, S. Y. AU - Wang, M. C. AU - Yen, F. L. AU - Lee, C. W. DB - Embase Medline DO - 10.1016/j.jep.2013.10.054 IS - 1 LA - English M3 - Article N1 - L52913353 2013-12-18 2014-01-10 PY - 2014 SN - 0378-8741 1872-7573 SP - 386-393 ST - Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways T2 - Journal of Ethnopharmacology TI - Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52913353&from=export http://dx.doi.org/10.1016/j.jep.2013.10.054 VL - 151 ID - 2186 ER - TY - JOUR AD - Z. Chatterton, Murdoch Childrens Research Institute, The University of Melbourne, Department of Paediatrics at the Royal Children's Hospital, Victoria, VIC, Australia AU - Chatterton, Z. AU - Morenos, L. AU - Mechinaud, F. AU - Ashley, D. M. AU - Craig, J. M. AU - Sexton-Oates, A. AU - Halemba, M. S. AU - Parkinson-Bates, M. AU - Ng, J. AU - Morrison, D. AU - Carroll, W. L. AU - Saffery, R. AU - Wong, N. C. DB - Embase Medline DO - 10.4161/epi.27585 IS - 3 LA - English M3 - Article N1 - L372938716 2014-05-05 2014-05-12 PY - 2014 SN - 1559-2308 1559-2294 SP - 459-467 ST - Epigenetic deregulation in pediatric acute lymphoblastic leukemia T2 - Epigenetics TI - Epigenetic deregulation in pediatric acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372938716&from=export http://dx.doi.org/10.4161/epi.27585 VL - 9 ID - 2187 ER - TY - JOUR AD - D. Palmieri, Laboratory of Clinical and Experimental Vascular Biology, DISC, University of Genoa, IRCCS San Martino-IST, Largo Rosanna Benzi 8, 16132 Genoa, Italy AU - Palmieri, D. AU - Capponi, S. AU - Geroldi, A. AU - Mura, M. AU - Mandich, P. AU - Palombo, D. DB - Embase Medline DO - 10.1016/j.bbrc.2013.11.092 IS - 1 LA - English M3 - Article N1 - L52901511 2013-12-11 2014-01-02 PY - 2014 SN - 0006-291X 1090-2104 SP - 246-251 ST - TNFα induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149 T2 - Biochemical and Biophysical Research Communications TI - TNFα induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52901511&from=export http://dx.doi.org/10.1016/j.bbrc.2013.11.092 VL - 443 ID - 2189 ER - TY - JOUR AD - H. Wang AU - Yu, X. AU - Jia, B. AU - Wang, F. AU - Lv, X. AU - Peng, X. AU - Wang, Y. AU - Li, H. AU - Wang, Y. AU - Lu, D. AU - Wang, H. DB - Medline DO - 10.1111/jcmm.12184 IS - 2 LA - English M3 - Article N1 - L1052909406 2014-07-08 PY - 2014 SN - 1582-1838 SP - 263-273 ST - α1 adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway T2 - Journal of Cellular and Molecular Medicine TI - α1 adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L1052909406&from=export http://dx.doi.org/10.1111/jcmm.12184 VL - 18 ID - 2190 ER - TY - JOUR AD - C. Dessinioti, Department of Dermatology, Andreas Syggros Hospital, University of Athens, Athens, Greece AU - Dessinioti, C. AU - Antoniou, C. AU - Katsambas, A. DB - Embase Medline DO - 10.1016/j.clindermatol.2013.05.023 IS - 1 LA - English M3 - Note N1 - L370417430 2013-12-13 2014-01-14 PY - 2014 SN - 0738-081X 1879-1131 SP - 24-34 ST - Acneiform eruptions T2 - Clinics in Dermatology TI - Acneiform eruptions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370417430&from=export http://dx.doi.org/10.1016/j.clindermatol.2013.05.023 VL - 32 ID - 2193 ER - TY - JOUR AD - M.W. Kieran, Dana-Farber Cancer Institute and Boston Children's Hospital 450 Brookline Avenue, Boston, MA 02215, United States AU - Bergthold, G. AU - Bandopadhayay, P. AU - Bi, W. L. AU - Ramkissoon, L. AU - Stiles, C. AU - Segal, R. A. AU - Beroukhim, R. AU - Ligon, K. L. AU - Grill, J. AU - Kieran, M. W. C1 - vp 16 DB - Embase Medline DO - 10.1016/j.bbcan.2014.02.004 IS - 2 LA - English M3 - Article N1 - L372623831 2014-03-25 2020-10-08 PY - 2014 SN - 1879-2561 0304-419X SP - 294-307 ST - Pediatric low-grade gliomas: How modern biology reshapes the clinical field T2 - Biochimica et Biophysica Acta - Reviews on Cancer TI - Pediatric low-grade gliomas: How modern biology reshapes the clinical field UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372623831&from=export http://dx.doi.org/10.1016/j.bbcan.2014.02.004 VL - 1845 ID - 2194 ER - TY - JOUR AD - D.M. Shin, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA 30322, United States AU - Saba, N. F. AU - Hurwitz, S. J. AU - Kono, S. A. AU - Yang, C. S. AU - Zhao, Y. AU - Chen, Z. AU - Sica, G. AU - Mul̈ler, S. AU - Moreno-Williams, R. AU - Lewis, M. AU - Grist, W. AU - Chen, A. Y. AU - Moore, C. E. AU - Owonikoko, T. K. AU - Ramalingam, S. AU - Beitler, J. J. AU - Nannapaneni, S. AU - Shin, H. J. C. AU - Grandis, J. R. AU - Khuri, F. R. AU - Chen, Z. G. AU - Shin, D. M. DB - Embase Medline DO - 10.1158/1940-6207.CAPR-13-0215 IS - 3 LA - English M3 - Article N1 - L372723657 2014-04-09 2014-04-16 PY - 2014 SN - 1940-6215 1940-6207 SP - 283-291 ST - Chemoprevention of head and neck cancer with celecoxib and erlotinib: Results of a phase Ib and pharmacokinetic study T2 - Cancer Prevention Research TI - Chemoprevention of head and neck cancer with celecoxib and erlotinib: Results of a phase Ib and pharmacokinetic study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372723657&from=export http://dx.doi.org/10.1158/1940-6207.CAPR-13-0215 VL - 7 ID - 2195 ER - TY - JOUR AD - T. Tanaka, Department of Molecular Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan AU - Tanaka, T. AU - Arai, M. AU - Jiang, X. AU - Sugaya, S. AU - Kanda, T. AU - Fujii, K. AU - Kita, K. AU - Sugita, K. AU - Imazeki, F. AU - Miyashita, T. AU - Kaneda, A. AU - Yokosuka, O. C2 - PeproTech(United States) DB - Embase Medline DO - 10.3892/ijo.2014.2317 IS - 5 LA - English M3 - Article N1 - L372921254 2014-05-02 2014-05-15 PY - 2014 SN - 1791-2423 1019-6439 SP - 1685-1690 ST - Downregulation of microRNA-431 by human interferon-βinhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6 T2 - International Journal of Oncology TI - Downregulation of microRNA-431 by human interferon-βinhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372921254&from=export http://dx.doi.org/10.3892/ijo.2014.2317 VL - 44 ID - 2196 ER - TY - JOUR AD - P.I. Oteiza, Department of Nutrition, University of California at Davis, Davis, CA 95616, United States AU - Bettaieb, A. AU - Vazquez Prieto, M. A. AU - Rodriguez Lanzi, C. AU - Miatello, R. M. AU - Haj, F. G. AU - Fraga, C. G. AU - Oteiza, P. I. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2014.04.011 LA - English M3 - Article N1 - L373118256 2014-05-29 2014-06-02 PY - 2014 SN - 1873-4596 0891-5849 SP - 247-256 ST - (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress T2 - Free Radical Biology and Medicine TI - (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373118256&from=export http://dx.doi.org/10.1016/j.freeradbiomed.2014.04.011 VL - 72 ID - 2197 ER - TY - JOUR AD - S.P. Hunger, Center for Cancer and Blood Disorders, Children's Hospital Colorado, 13123 East 16th Avenue, Box B115, Aurora, CO 80045, United States AU - Bernt, K. M. AU - Hunger, S. P. C1 - bay 80 6946 pd 325901 px 866 sf 1126 DB - Embase DO - 10.3389/fonc.2014.00054 LA - English M3 - Review N1 - L373128654 2014-05-29 2014-06-05 PY - 2014 SN - 2234-943X ST - Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Frontiers in Oncology TI - Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373128654&from=export http://dx.doi.org/10.3389/fonc.2014.00054 VL - 4 MAR ID - 2198 ER - TY - JOUR AD - C. Konialis, Department of Molecular Genetics, InterGenetics - Diagnostic Genetic Center, Vas. Sofias 120, Athens 11526, Greece AU - Konialis, C. AU - Savola, S. AU - Karapanou, S. AU - Markaki, A. AU - Bela, M. K. AU - Polychronopoulou, S. AU - Ampatzidou, M. AU - Michael, V. V. AU - Vinious, N. A. AU - Variant, E. AU - Koumarianou, A. AU - Zoi, K. AU - Hagnefelt, B. AU - Schouten, J. P. AU - Pángalos, C. DB - Embase Medline DO - 10.1179/1607845413Y.0000000112 IS - 4 LA - English M3 - Article N1 - L373181493 2014-06-06 2014-06-11 PY - 2014 SN - 1607-8454 1024-5332 SP - 217-224 ST - Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics T2 - Hematology TI - Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373181493&from=export http://dx.doi.org/10.1179/1607845413Y.0000000112 VL - 19 ID - 2199 ER - TY - JOUR AD - S.-P. Lin, Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan AU - Liao, H. F. AU - Chen, W. S. C. AU - Chen, Y. H. AU - Kao, T. H. AU - Tseng, Y. T. AU - Lee, C. Y. AU - Chiu, Y. C. AU - Lee, P. L. AU - Lin, Q. J. AU - Ching, Y. H. AU - Hata, K. AU - Cheng, W. T. K. AU - Tsai, M. H. AU - Sasaki, H. AU - Ho, H. N. AU - Wu, S. C. AU - Huang, Y. H. AU - Yen, P. AU - Lin, S. P. DB - Embase Medline DO - 10.1242/dev.105130 IS - 12 LA - English M3 - Article N1 - L373276801 2014-06-19 2014-06-26 PY - 2014 SN - 1477-9129 0950-1991 SP - 2402-2413 ST - DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells T2 - Development (Cambridge) TI - DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373276801&from=export http://dx.doi.org/10.1242/dev.105130 VL - 141 ID - 2200 ER - TY - JOUR AD - T. Kawaguchi, Department of Neurosurgery, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8507, Japan AU - Kawaguchi, T. AU - Yoshikawa, K. AU - Kawamoto, K. AU - Yoshimura, K. AU - Oshige, H. AU - Asai, A. C2 - biogate(Japan) DB - Embase Medline IS - 6 LA - English M3 - Article N1 - L373341782 2014-07-01 2014-07-02 PY - 2014 SN - 1791-2423 1019-6439 SP - 1879-1885 ST - Molecular targeting of neuroblastoma with a novel p16INK4a transporter system T2 - International Journal of Oncology TI - Molecular targeting of neuroblastoma with a novel p16INK4a transporter system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373341782&from=export VL - 44 ID - 2201 ER - TY - JOUR AD - E.P. Rahrmann, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States AU - Rahrmann, E. P. AU - Moriarity, B. S. AU - Otto, G. M. AU - Watson, A. L. AU - Choi, K. AU - Collins, M. H. AU - Wallace, M. AU - Webber, B. R. AU - Forster, C. L. AU - Rizzardi, A. E. AU - Schmechel, S. C. AU - Ratner, N. AU - Largaespada, D. A. DB - Embase Medline DO - 10.1016/j.ajpath.2014.04.006 IS - 7 LA - English M3 - Article N1 - L373373122 2014-07-03 2014-07-14 PY - 2014 SN - 1525-2191 0002-9440 SP - 2082-2098 ST - Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis T2 - American Journal of Pathology TI - Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373373122&from=export http://dx.doi.org/10.1016/j.ajpath.2014.04.006 VL - 184 ID - 2202 ER - TY - JOUR AD - V. Vasko, Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4712, United States AU - Kushchayeva, Y. AU - Jensen, K. AU - Burman, K. D. AU - Vasko, V. C1 - viracept DB - Embase Medline DO - 10.1530/ERC-13-0473 IS - 3 LA - English M3 - Review N1 - L373428067 2014-07-10 2014-07-18 PY - 2014 SN - 1479-6821 1351-0088 SP - R183-R194 ST - Repositioning therapy for thyroid cancer: New insights on established medications T2 - Endocrine-Related Cancer TI - Repositioning therapy for thyroid cancer: New insights on established medications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373428067&from=export http://dx.doi.org/10.1530/ERC-13-0473 VL - 21 ID - 2204 ER - TY - JOUR AD - M.B. Hershenson, Medical Sciences Research Building II, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0688, United States AU - Ramirez, I. A. AU - Caverly, L. L. AU - Kalikin, L. M. AU - Goldsmith, A. M. AU - Lewis, T. C. AU - Burke, D. T. AU - LiPuma, J. J. AU - Sajjan, U. S. AU - Hershenson, M. B. DB - Embase Medline DO - 10.1513/AnnalsATS.201310-346OC IS - 4 LA - English M3 - Article N1 - L373432605 2014-07-10 2014-07-16 PY - 2014 SN - 2325-6621 SP - 554-561 ST - Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis T2 - Annals of the American Thoracic Society TI - Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373432605&from=export http://dx.doi.org/10.1513/AnnalsATS.201310-346OC VL - 11 ID - 2205 ER - TY - JOUR AD - H. Daniel Lacorazza, 1102 Bates Street, FC83.20, Houston, TX 77030, United States AU - Suppipat, K. AU - Daniel Lacorazza, H. DB - Embase Medline DO - 10.2174/1568009614666140521142950 IS - 5 LA - English M3 - Review N1 - L373609793 2014-08-01 2014-08-11 PY - 2014 SN - 1873-5576 1568-0096 SP - 434-445 ST - From the table to the bedside: Can food-derived sulforaphane be used as a novel agent to treat leukemia? T2 - Current Cancer Drug Targets TI - From the table to the bedside: Can food-derived sulforaphane be used as a novel agent to treat leukemia? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373609793&from=export http://dx.doi.org/10.2174/1568009614666140521142950 VL - 14 ID - 2206 ER - TY - JOUR AD - M. Komine, Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan AU - Karakawa, M. AU - Komine, M. AU - Hanakawa, Y. AU - Tsuda, H. AU - Sayama, K. AU - Tamaki, K. AU - Ohtsuki, M. DB - Embase Medline DO - 10.1002/jcp.24643 IS - 12 LA - English M3 - Article N1 - L373843905 2014-09-06 2014-09-10 PY - 2014 SN - 1097-4652 0021-9541 SP - 1935-1945 ST - CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes T2 - Journal of Cellular Physiology TI - CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373843905&from=export http://dx.doi.org/10.1002/jcp.24643 VL - 229 ID - 2208 ER - TY - JOUR AD - N. Bezniakow AU - Bezniakow, N. AU - Gos, M. AU - Obersztyn, E. DB - Medline IS - 3 LA - English M3 - Review N1 - L373970811 2014-10-17 PY - 2014 SN - 1428-345X SP - 285-296 ST - The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes T2 - Developmental period medicine TI - The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373970811&from=export VL - 18 ID - 2209 ER - TY - JOUR AD - C. McKay, Department of Dermatology, Sydney Children's Hospital, Sydney, NSW, Australia AU - McKay, C. AU - Nelson, A. AU - Sugo, E. AU - Cohn, R. AU - Wargon, O. DB - Embase DO - 10.1111/ajd.12064 IS - 4 LA - English M3 - Article N1 - L52608681 2013-06-04 2014-12-01 PY - 2014 SN - 1440-0960 0004-8380 SP - e60-e64 ST - Lymphomatoid papulosis with associated cerebellar lesion of similar histology and T-cell clonality T2 - Australasian Journal of Dermatology TI - Lymphomatoid papulosis with associated cerebellar lesion of similar histology and T-cell clonality UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52608681&from=export http://dx.doi.org/10.1111/ajd.12064 VL - 55 ID - 2210 ER - TY - JOUR AD - Q. Zeng, Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China AU - Liu, N. N. AU - Xi, Y. AU - Callaghan, M. U. AU - Fribley, A. AU - Moore-Smith, L. AU - Zimmerman, J. W. AU - Pasche, B. AU - Zeng, Q. AU - Li, Y. L. DB - Embase Medline DO - 10.1007/s13277-013-1088-1 IS - 1 LA - English M3 - Article N1 - L52745477 2013-08-29 2014-03-10 PY - 2014 SN - 1010-4283 1423-0380 SP - 641-650 ST - SMAD4 is a potential prognostic marker in human breast carcinomas T2 - Tumor Biology TI - SMAD4 is a potential prognostic marker in human breast carcinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52745477&from=export http://dx.doi.org/10.1007/s13277-013-1088-1 VL - 35 ID - 2211 ER - TY - JOUR AD - H. Chen, Department of Gastroenterology, Zhongda Hospital, Southeast University, Nanjing, 210009 Jiangsu, China AU - Chen, H. AU - Cheng, Z. Y. AU - Pan, Y. AU - Wang, Z. AU - Liu, Y. AU - Zhang, J. Q. DB - Embase Medline DO - 10.1007/s13577-014-0090-2 IS - 3 LA - English M3 - Article N1 - L53008625 2014-02-24 2014-07-25 PY - 2014 SN - 1749-0774 0914-7470 SP - 103-110 ST - RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway T2 - Human Cell TI - RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53008625&from=export http://dx.doi.org/10.1007/s13577-014-0090-2 VL - 27 ID - 2212 ER - TY - JOUR AD - E. Bouffet, Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada AU - Kilday, J. P. AU - Bartels, U. K. AU - Bouffet, E. C1 - azd 6244 mk 2206 DB - Embase Medline DO - 10.1007/s11910-014-0441-0 IS - 4 LA - English M3 - Review N1 - L53040742 2014-03-13 2019-12-20 PY - 2014 SN - 1534-6293 1528-4042 ST - Targeted therapy in pediatric low-grade glioma T2 - Current Neurology and Neuroscience Reports TI - Targeted therapy in pediatric low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53040742&from=export http://dx.doi.org/10.1007/s11910-014-0441-0 VL - 14 ID - 2215 ER - TY - JOUR AD - G. Kaspers, Paediatric Oncology/Haematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV, Amsterdam, Netherlands AU - Kaspers, G. C1 - ac 220 gsk 1120212 i bet 151 jq 1 mln 8237 DB - Embase Medline DO - 10.1111/bjh.12947 IS - 5 LA - English M3 - Article N1 - L53139956 2014-05-22 2014-08-29 PY - 2014 SN - 1365-2141 0007-1048 SP - 636-645 ST - How I treat paediatric relapsed acute myeloid leukaemia T2 - British Journal of Haematology TI - How I treat paediatric relapsed acute myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53139956&from=export http://dx.doi.org/10.1111/bjh.12947 VL - 166 ID - 2216 ER - TY - JOUR AD - C. Brehm, Clinic for Pediatric and Adolescent Medicine, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany AU - Brehm, C. AU - Huenecke, S. AU - Esser, R. AU - Kloess, S. AU - Quaiser, A. AU - Betz, S. AU - Zimmermann, O. AU - Soerensen, J. AU - Passweg, J. R. AU - Klingebiel, T. AU - Schwabe, D. AU - Bader, P. AU - Koehl, U. C1 - cellcept(Hoffmann La Roche) C2 - Hoffmann La Roche DB - Embase Medline DO - 10.1007/s00262-014-1556-5 IS - 8 LA - English M3 - Article N1 - L53156079 2014-06-09 2014-09-06 PY - 2014 SN - 1432-0851 0340-7004 SP - 821-833 ST - Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: Possible consequences for immunotherapy T2 - Cancer Immunology, Immunotherapy TI - Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: Possible consequences for immunotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53156079&from=export http://dx.doi.org/10.1007/s00262-014-1556-5 VL - 63 ID - 2217 ER - TY - JOUR AD - A.A. Nageswara Rao, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States AU - Nageswara Rao, A. A. AU - Packer, R. J. DB - Embase Medline DO - 10.1007/s11912-014-0398-9 IS - 8 LA - English M3 - Review N1 - L53192888 2014-06-17 2014-08-11 PY - 2014 SN - 1534-6269 1523-3790 ST - Advances in the management of low-grade gliomas T2 - Current Oncology Reports TI - Advances in the management of low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53192888&from=export http://dx.doi.org/10.1007/s11912-014-0398-9 VL - 16 ID - 2219 ER - TY - JOUR AD - L. Li, Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, 400010 Chongqing, China AU - Yang, M. AU - Dai, J. AU - Jia, Y. AU - Suo, L. AU - Li, S. AU - Guo, Y. AU - Liu, H. AU - Li, L. AU - Yang, G. DB - Embase Medline DO - 10.1111/febs.12853 IS - 14 LA - English M3 - Article N1 - L53199381 2014-06-26 2014-08-06 PY - 2014 SN - 1742-4658 1742-464X SP - 3193-3205 ST - Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB T2 - FEBS Journal TI - Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53199381&from=export http://dx.doi.org/10.1111/febs.12853 VL - 281 ID - 2220 ER - TY - JOUR AD - T. Shoda, Department of Allergy and Immunology, National Research Institute for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, Japan AU - Shoda, T. AU - Futamura, K. AU - Kobayashi, F. AU - Saito, H. AU - Matsumoto, K. AU - Matsuda, A. DB - Embase Medline DO - 10.1016/j.jdermsci.2014.08.009 IS - 2 LA - English M3 - Article N1 - L600220327 2014-10-29 2014-11-04 PY - 2014 SN - 1873-569X 0923-1811 SP - 90-95 ST - Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes T2 - Journal of Dermatological Science TI - Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600220327&from=export http://dx.doi.org/10.1016/j.jdermsci.2014.08.009 VL - 76 ID - 2223 ER - TY - JOUR AD - S.K. Banu, Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A and M University, College Station, TX, United States AU - Sivakumar, K. K. AU - Stanley, J. A. AU - Arosh, J. A. AU - Pepling, M. E. AU - Burghardt, R. C. AU - Banu, S. K. DB - Embase Medline DO - 10.1016/j.ydbio.2014.02.003 IS - 1 LA - English M3 - Article N1 - L600267460 2014-11-04 2014-11-06 PY - 2014 SN - 1095-564X 0012-1606 SP - 22-34 ST - Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring T2 - Developmental Biology TI - Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600267460&from=export http://dx.doi.org/10.1016/j.ydbio.2014.02.003 VL - 388 ID - 2224 ER - TY - JOUR AD - R.L. Barnhill, Department of Pathology and Laboratory Medicine, UCLA Medical Center, 924 Westwood Boulevard, 730, Los Angeles, CA, United States AU - Su, A. AU - Low, L. AU - Li, X. AU - Zhou, S. AU - Mascarenhas, L. AU - Barnhill, R. L. DB - Embase Medline DO - 10.1097/DAD.0000000000000128 IS - 11 LA - English M3 - Article N1 - L600682831 2014-12-15 PY - 2014 SN - 1533-0311 0193-1091 SP - 915-919 ST - De novo congenital melanoma: Analysis of 2 cases with array comparative genomic hybridization T2 - American Journal of Dermatopathology TI - De novo congenital melanoma: Analysis of 2 cases with array comparative genomic hybridization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600682831&from=export http://dx.doi.org/10.1097/DAD.0000000000000128 VL - 36 ID - 2225 ER - TY - JOUR AD - A.Y. Bedikian, Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, United States AU - Kolandijan, N. A. AU - Wei, C. AU - Burke, A. AU - Bedikian, A. Y. DB - Embase Medline DO - 10.1097/MPH.0000000000000231 IS - 7 LA - English M3 - Article N1 - L600873988 2014-12-24 2015-01-05 PY - 2014 SN - 1536-3678 1077-4114 SP - 552-558 ST - Malignant melanoma in teenagers and young adults T2 - Journal of Pediatric Hematology/Oncology TI - Malignant melanoma in teenagers and young adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600873988&from=export http://dx.doi.org/10.1097/MPH.0000000000000231 VL - 36 ID - 2226 ER - TY - JOUR AD - N. Kurucu, Department of Pediatric Oncology, Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Yenimahalle, Ankara, Turkey AU - Kurucu, N. AU - Sari, N. AU - Celasun, B. AU - Sarihan, H. AU - Ahmetoglu, A. AU - Ilhan, I. E. DB - Embase Medline DO - 10.1097/MPH.0b013e3182a8f73f IS - 8 LA - English M3 - Article N1 - L600873999 2014-12-24 2015-01-07 PY - 2014 SN - 1536-3678 1077-4114 SP - 649-652 ST - Gastrointestinal stromal tumor in a newborn diagnosed in prenatal period: A case report and review of literature T2 - Journal of Pediatric Hematology/Oncology TI - Gastrointestinal stromal tumor in a newborn diagnosed in prenatal period: A case report and review of literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600873999&from=export http://dx.doi.org/10.1097/MPH.0b013e3182a8f73f VL - 36 ID - 2227 ER - TY - JOUR AD - M.A. Karajannis, Department of Pediatrics, NYU Langone Medical Center, Hassenfeld Children's Center for Cancer and Blood Disorders, 160 East 32nd Street, New York, NY, United States AU - Legault, G. AU - Kieran, M. W. AU - Scott, R. M. AU - Chordas, C. AU - Milla, S. S. AU - Karajannis, M. A. DB - Embase Medline DO - 10.1097/MPH.0000000000000094 IS - 8 LA - English M3 - Article N1 - L600874059 2014-12-24 2015-01-07 PY - 2014 SN - 1536-3678 1077-4114 SP - e533-e535 ST - Recurrent ascites in a patient with low-grade astrocytoma and ventriculo-peritoneal shunt treated with the multikinase inhibitor sorafenib T2 - Journal of Pediatric Hematology/Oncology TI - Recurrent ascites in a patient with low-grade astrocytoma and ventriculo-peritoneal shunt treated with the multikinase inhibitor sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600874059&from=export http://dx.doi.org/10.1097/MPH.0000000000000094 VL - 36 ID - 2228 ER - TY - JOUR AD - P.A. Lio, Northwestern University Feinberg School of Medicine, 1455 N. Milwaukee Avenue, Chicago, IL, United States AU - Strom, M. A. AU - Lio, P. A. DB - Embase DO - 10.1007/s13671-014-0086-x IS - 4 LA - English M3 - Review N1 - L601038415 2015-01-08 PY - 2014 SN - 2162-4933 SP - 165-170 ST - Alternative Medicine in Pediatric Dermatology: What Is the Evidence? T2 - Current Dermatology Reports TI - Alternative Medicine in Pediatric Dermatology: What Is the Evidence? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601038415&from=export http://dx.doi.org/10.1007/s13671-014-0086-x VL - 3 ID - 2229 ER - TY - JOUR AD - M.R. Jeng, Department of Pediatrics, Hematology/Oncology/Stem Cell Transplantation, Stanford University School of Medicine, 1000Welch Road, Suite 300, Palo Alto, CA, United States AU - Jeng, M. R. AU - Fuh, B. AU - Blatt, J. AU - Gupta, A. AU - Merrow, A. C. AU - Hammill, A. AU - Adams, D. C1 - mekinist DB - Embase Medline DO - 10.1002/pbc.25067 IS - 11 LA - English M3 - Article N1 - L603768752 2015-04-20 2015-05-12 PY - 2014 SN - 1545-5017 1545-5009 SP - 2115-2117 ST - Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab T2 - Pediatric Blood and Cancer TI - Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603768752&from=export http://dx.doi.org/10.1002/pbc.25067 VL - 61 ID - 2230 ER - TY - JOUR AD - J. Bruix, Barcelona Clinic Liver Cancer (BCLC) Group, Hospital Clínic Barcelona, University of Barcelona, C/Villarroel 170, Barcelona, Spain AU - Reig, M. AU - Gazzola, A. AU - Di Donato, R. AU - Bruix, J. DB - Embase Medline DO - 10.1016/j.bpg.2014.08.003 IS - 5 LA - English M3 - Review N1 - L603882459 2015-04-24 2020-10-08 PY - 2014 SN - 1532-1916 1521-6918 SP - 921-935 ST - Systemic treatment T2 - Best Practice and Research: Clinical Gastroenterology TI - Systemic treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603882459&from=export http://dx.doi.org/10.1016/j.bpg.2014.08.003 VL - 28 ID - 2231 ER - TY - JOUR AD - S.L. Kleina, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States AU - Kleina, S. L. AU - Marriott, I. AU - Fish, E. N. DB - Embase Medline DO - 10.1093/trstmh/tru167 IS - 1 LA - English M3 - Article N1 - L604282631 2015-05-13 2015-05-26 PY - 2014 SN - 1878-3503 0035-9203 SP - 9-15 ST - Sex-based differences in immune function and responses to vaccination T2 - Transactions of the Royal Society of Tropical Medicine and Hygiene TI - Sex-based differences in immune function and responses to vaccination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604282631&from=export http://dx.doi.org/10.1093/trstmh/tru167 VL - 109 ID - 2232 ER - TY - JOUR AD - S.I. Bannykh, Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA, United States AU - Bannykh, S. I. AU - Mirocha, J. AU - Nuno, M. AU - Lopategui, J. AU - Kandala, G. DB - Embase Medline DO - 10.5414/NP300753 IS - 6 LA - English M3 - Article N1 - L604744029 2015-06-10 2015-06-18 PY - 2014 SN - 0722-5091 SP - 388-398 ST - V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior T2 - Clinical Neuropathology TI - V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604744029&from=export http://dx.doi.org/10.5414/NP300753 VL - 33 ID - 2233 ER - TY - JOUR AD - O.M. Tirado, Sarcoma research group, Molecular Oncology Lab, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain AU - Huertas-Martínez, J. AU - Rello-Varona, S. AU - Herrero-Martín, D. AU - Barrau, I. AU - García-Monclús, S. AU - Sáinz-Jaspeado, M. AU - Lagares-Tena, L. AU - Núñez-Álvarez, Y. AU - Mateo-Lozano, S. AU - Mora, J. AU - Roma, J. AU - Toran, N. AU - Moran, S. AU - López-Alemany, R. AU - Gallego, S. AU - Esteller, M. AU - Peinado, M. A. AU - del Muro, X. G. AU - Tirado, O. M. DB - Embase Medline DO - 10.18632/oncotarget.2403 IS - 20 LA - English M3 - Article N1 - L604753545 2015-06-11 2015-06-18 PY - 2014 SN - 1949-2553 SP - 9744-9755 ST - Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth T2 - Oncotarget TI - Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604753545&from=export http://dx.doi.org/10.18632/oncotarget.2403 VL - 5 ID - 2234 ER - TY - JOUR AD - S.-J. Li, Department of Pediatric Intensive Care Unit, First Affiliated Hospital, Xinxiang Medical College, Henan, China AU - Shang, Y. AU - Guo, X. X. AU - Li, W. W. AU - Rao, W. AU - Chen, M. L. AU - Mu, L. N. AU - Li, S. J. DB - Embase Medline IS - 21 LA - English M3 - Article N1 - L606144465 2015-09-30 2015-10-02 PY - 2014 SN - 1128-3602 SP - 3297-3303 ST - Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN T2 - European Review for Medical and Pharmacological Sciences TI - Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606144465&from=export VL - 18 ID - 2235 ER - TY - JOUR AU - Sun, Y. AU - Chen, C. AU - Zhang, P. AU - Xie, H. AU - Hou, L. AU - Hui, Z. AU - Xu, Y. AU - Du, Q. AU - Zhou, X. AU - Su, B. AU - Gao, W. DB - Medline DO - 10.1038/srep06527 LA - English M3 - Article N1 - L606788527 2015-11-12 PY - 2014 SN - 2045-2322 SP - 6527 ST - Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway T2 - Scientific reports TI - Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606788527&from=export http://dx.doi.org/10.1038/srep06527 VL - 4 ID - 2237 ER - TY - JOUR AD - J.A. McGrath, Dermatology Research Laboratories, Floor 9 Tower Wing, Guy's Hospital, Great Maze Pond, London, United Kingdom AU - Aslam, A. AU - Salam, A. AU - Griffiths, C. E. M. AU - McGrath, J. A. DB - Embase Medline DO - 10.1111/ced.12209 IS - 1 LA - English M3 - Article N1 - L607371914 2019-08-27 PY - 2014 SN - 1365-2230 0307-6938 SP - 1-6 ST - Naevus sebaceus: A mosaic RASopathy T2 - Clinical and Experimental Dermatology TI - Naevus sebaceus: A mosaic RASopathy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607371914&from=export http://dx.doi.org/10.1111/ced.12209 VL - 39 ID - 2238 ER - TY - JOUR AD - B. Gyorffy, MTA-TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary AU - Pénzváltó, Z. AU - Lánczky, A. AU - Lénárt, J. AU - Meggyesházi, N. AU - Krenács, T. AU - Szoboszlai, N. AU - Denkert, C. AU - Pete, I. AU - Gyorffy, B. C1 - pd 0325901 DB - Embase Medline DO - 10.1186/1471-2407-14-837 IS - 1 LA - English M3 - Article N1 - L612234534 2016-09-28 2016-10-04 PY - 2014 SN - 1471-2407 ST - MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer T2 - BMC Cancer TI - MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612234534&from=export http://dx.doi.org/10.1186/1471-2407-14-837 VL - 14 ID - 2239 ER - TY - JOUR AD - X.-J. Zhao AU - Zhao, X. J. AU - Zhuo, H. DB - Embase Medline DO - 10.1155/2014/850802 LA - English M3 - Article N1 - L612617938 2016-10-18 2016-11-02 PY - 2014 SN - 2314-6141 2314-6133 ST - ECR-MAPK regulation in liver early development T2 - BioMed Research International TI - ECR-MAPK regulation in liver early development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612617938&from=export http://dx.doi.org/10.1155/2014/850802 VL - 2014 ID - 2240 ER - TY - JOUR AD - M.M. Ali, University of California San Francisco, San Francisco, CA, United States AU - Ali, M. M. AU - Gilliam, A. E. AU - Gilliam, A. C. AU - Rauen, K. A. DB - Embase DO - 10.231/JIM.0000000000000033 IS - 1 LA - English M3 - Conference Abstract N1 - L71391554 2014-04-04 PY - 2014 SN - 1081-5589 SP - 231 ST - Juvenile xanthogranuloma in Noonan syndrome T2 - Journal of Investigative Medicine TI - Juvenile xanthogranuloma in Noonan syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71391554&from=export http://dx.doi.org/10.231/JIM.0000000000000033 VL - 62 ID - 2241 ER - TY - JOUR AD - J.A. Sosman, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN 37232, United States AU - Hutchinson, K. E. AU - Lipson, D. AU - Stephens, P. J. AU - Otto, G. AU - Lehmann, B. D. AU - Lyle, P. L. AU - Vnencak-Jones, C. L. AU - Ross, J. S. AU - Pietenpol, J. A. AU - Sosman, J. A. AU - Puzanov, I. AU - Miller, V. A. AU - Pao, W. DB - Embase Medline DO - 10.1158/1078-0432.CCR-13-1746 IS - 24 LA - English M3 - Article N1 - L370533080 2013-12-27 2014-01-21 PY - 2013 SN - 1078-0432 1557-3265 SP - 6696-6702 ST - BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition T2 - Clinical Cancer Research TI - BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370533080&from=export http://dx.doi.org/10.1158/1078-0432.CCR-13-1746 http://clincancerres.aacrjournals.org/content/19/24/6696.full.pdf+html VL - 19 ID - 2242 ER - TY - JOUR AD - J.K.C. Chan, Department of Pathology, Queen Elizabeth Hospital, Gascoigne Road, Kowloon, Hong Kong AU - Chan, J. K. C. DB - Embase Medline DO - 10.1177/1066896913507601 IS - 6 LA - English M3 - Review N1 - L370294276 2013-11-27 2013-11-29 PY - 2013 SN - 1066-8969 1940-2465 SP - 553-572 ST - Newly available antibodies with practical applications in surgical pathology T2 - International Journal of Surgical Pathology TI - Newly available antibodies with practical applications in surgical pathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370294276&from=export http://dx.doi.org/10.1177/1066896913507601 VL - 21 ID - 2243 ER - TY - JOUR AD - M.S. Staege, Department of Pediatrics, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06097 Halle, Germany AU - Kühnöl, C. AU - Herbarth, M. AU - Föll, J. AU - Staege, M. S. AU - Kramm, C. C1 - daclizumab(Hoffmann La Roche,Germany) sb 203580(Biaffin,Germany) C2 - Biaffin(Germany) Hoffmann La Roche(Germany) r mittler(United States) DB - Embase Medline DO - 10.1007/s00262-013-1484-9 IS - 12 LA - English M3 - Article N1 - L370484706 2013-12-23 2013-12-26 PY - 2013 SN - 0340-7004 1432-0851 SP - 1797-1809 ST - CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy T2 - Cancer Immunology, Immunotherapy TI - CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370484706&from=export http://dx.doi.org/10.1007/s00262-013-1484-9 VL - 62 ID - 2244 ER - TY - JOUR AD - H. Tsujimoto, Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan AU - Tomiyasu, H. AU - Watanabe, M. AU - Sugita, K. AU - Goto-Koshino, Y. AU - Fujino, Y. AU - Ohno, K. AU - Sugano, S. AU - Tsujimoto, H. DB - Embase Medline IS - 12 LA - English M3 - Article N1 - L372018523 2014-01-08 2014-01-10 PY - 2013 SN - 0250-7005 SP - 5317-5324 ST - Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines T2 - Anticancer Research TI - Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372018523&from=export http://ar.iiarjournals.org/content/33/12/5317.full.pdf+html VL - 33 ID - 2245 ER - TY - JOUR AD - F. Boulad, 1275 York Ave, NY 10065, United States AU - Giulino-Roth, L. AU - Ricafort, R. AU - Kernan, N. A. AU - Small, T. N. AU - Trippett, T. M. AU - Steinherz, P. G. AU - Prockop, S. E. AU - Scaradavou, A. AU - Chiu, M. AU - O'Reilly, R. J. AU - Boulad, F. C1 - vp 16 DB - Embase Medline DO - 10.1002/pbc.24722 IS - 12 LA - English M3 - Article N1 - L52759058 2013-09-06 2013-10-29 PY - 2013 SN - 1545-5009 1545-5017 SP - 2018-2024 ST - Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation T2 - Pediatric Blood and Cancer TI - Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52759058&from=export http://dx.doi.org/10.1002/pbc.24722 VL - 60 ID - 2248 ER - TY - JOUR AD - P.S. Dattatreya, Omega Hospitals, A Unit of Hyderabad, Institute of Oncology, India AU - Dattatreya, P. S. DB - Embase DO - 10.1007/s12288-013-0302-z IS - 4 LA - English M3 - Conference Abstract N1 - L71223165 2013-11-15 PY - 2013 SN - 0971-4502 SP - 320-321 ST - Crizotinib as a targeted therapy for paediatric alcl-a case report (exploring an unapproved option) T2 - Indian Journal of Hematology and Blood Transfusion TI - Crizotinib as a targeted therapy for paediatric alcl-a case report (exploring an unapproved option) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71223165&from=export http://dx.doi.org/10.1007/s12288-013-0302-z VL - 29 ID - 2249 ER - TY - JOUR AD - B.R. Agarwal, Department of Pediatric Hematology and Oncology, B.J. Wadia Hospital for Children, Parel, Mumbai, India AU - Agarwal, B. R. DB - Embase DO - 10.1007/s12288-013-0303-y IS - 4 LA - English M3 - Conference Abstract N1 - L71223414 2013-11-15 PY - 2013 SN - 0971-4502 SP - 200-201 ST - Juvenile myelomonocytic leukemia (JMML) T2 - Indian Journal of Hematology and Blood Transfusion TI - Juvenile myelomonocytic leukemia (JMML) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71223414&from=export http://dx.doi.org/10.1007/s12288-013-0303-y VL - 29 ID - 2250 ER - TY - JOUR AD - C. Cheng, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 303 E Superior Street, Chicago, IL 60611, United States AU - Zhao, P. AU - Damerow, M. S. AU - Stern, P. AU - Liu, A. H. AU - Sweet-Cordero, A. AU - Siziopikou, K. AU - Neilson, J. R. AU - Sharp, P. A. AU - Cheng, C. DB - Embase Medline DO - 10.1038/onc.2012.542 IS - 43 LA - English M3 - Article N1 - L52334161 2012-12-07 2013-11-13 PY - 2013 SN - 0950-9232 1476-5594 SP - 5186-5190 ST - CD44 promotes Kras-dependent lung adenocarcinoma T2 - Oncogene TI - CD44 promotes Kras-dependent lung adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52334161&from=export http://dx.doi.org/10.1038/onc.2012.542 VL - 32 ID - 2252 ER - TY - JOUR AD - G.S. Smelick, Clinical Pharmacology, Genentech Research and Early Development, 1 DNA Way, South San Francisco, CA 94080, United States AU - Smelick, G. S. AU - Heffron, T. P. AU - Chu, L. AU - Dean, B. AU - West, D. A. AU - Duvall, S. L. AU - Lum, B. L. AU - Budha, N. AU - Holden, S. N. AU - Benet, L. Z. AU - Frymoyer, A. AU - Dresser, M. J. AU - Ware, J. A. DB - Embase Medline DO - 10.1021/mp400403s IS - 11 LA - English M3 - Article N1 - L370224875 2013-11-20 PY - 2013 SN - 1543-8384 1543-8392 SP - 4055-4062 ST - Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development T2 - Molecular Pharmaceutics TI - Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370224875&from=export http://dx.doi.org/10.1021/mp400403s VL - 10 ID - 2253 ER - TY - JOUR AD - J.C.B. Li, Immunology Research Laboratory, Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, HKG, China AU - Ling, W. L. AU - Wang, L. J. AU - Pong, J. C. H. AU - Lau, A. S. Y. AU - Li, J. C. B. DB - Embase Medline DO - 10.1111/imm.12140 IS - 3 LA - English M3 - Article N1 - L369949507 2013-10-10 2013-10-15 PY - 2013 SN - 0019-2805 1365-2567 SP - 323-334 ST - A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages T2 - Immunology TI - A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369949507&from=export http://dx.doi.org/10.1111/imm.12140 VL - 140 ID - 2254 ER - TY - JOUR AD - M. Santoro, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, via S Pansini 5, 80131 Naples, Italy AU - Santoro, M. AU - Carlomagno, F. DB - Embase Medline DO - 10.1172/JCI72725 IS - 11 LA - English M3 - Article N1 - L370245421 2013-11-20 PY - 2013 SN - 0021-9738 1558-8238 SP - 4566-4568 ST - Oncogenic rearrangements driving ionizing radiation-associated human cancer T2 - Journal of Clinical Investigation TI - Oncogenic rearrangements driving ionizing radiation-associated human cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370245421&from=export http://dx.doi.org/10.1172/JCI72725 http://www.jci.org/articles/view/72725/pdf VL - 123 ID - 2255 ER - TY - JOUR AD - D.K. Graham, University of Colorado, Anschutz Medical Campus, Building RC1-N, 12800 E. 19th Ave, Aurora, CO 80045, United States AU - Christoph, S. AU - DeRyckere, D. AU - Schlegel, J. AU - Frazer, J. K. AU - Batchelor, L. A. AU - Trakhimets, A. Y. AU - Sather, S. AU - Hunter, D. M. AU - Cummings, C. T. AU - Liu, J. AU - Yang, C. AU - Kireev, D. AU - Simpson, C. AU - Norris-Drouin, J. AU - Hull-Ryde, E. A. AU - Janzen, W. P. AU - Johnson, G. L. AU - Wang, X. AU - Frye, S. V. AU - Earp Iii, H. S. AU - Graham, D. K. DB - Embase Medline DO - 10.1158/1535-7163 IS - 11 LA - English M3 - Article N1 - L370245471 2013-11-21 PY - 2013 SN - 1535-7163 1538-8514 SP - 2367-2377 ST - UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo T2 - Molecular Cancer Therapeutics TI - UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370245471&from=export http://dx.doi.org/10.1158/1535-7163 http://mct.aacrjournals.org/content/12/11/2367.full.pdf+html VL - 12 ID - 2256 ER - TY - JOUR AD - L. Xie, Department of Pharmacology, Institute of Natural Medicine, Anhui Medical University, Hefei, China AU - Xie, L. AU - Yang, Y. AU - Rui, W. J. AU - Jiang, J. M. AU - Hu, X. P. AU - Wu, C. DB - Embase DO - 10.1038/aps.2013.108 LA - English M3 - Conference Abstract N1 - L71285127 2014-01-15 PY - 2013 SN - 1671-4083 SP - 15 ST - Mitogen-activated protein kinases inhibitors exerts anti-fibrosis by mediating TGF-β/ Smad signaling in HepG2 cells and HSC cells T2 - Acta Pharmacologica Sinica TI - Mitogen-activated protein kinases inhibitors exerts anti-fibrosis by mediating TGF-β/ Smad signaling in HepG2 cells and HSC cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71285127&from=export http://dx.doi.org/10.1038/aps.2013.108 VL - 34 ID - 2257 ER - TY - JOUR AD - G.D. Romano, Oncology Unit, Vito Fazzi Hospital, Italy AU - Romano, G. D. AU - Cocciolo, A. AU - Vasta, I. AU - Gnoni, A. AU - Licchetta, A. AU - Nuzzo, C. AU - Cairo, G. AU - Saracino, V. AU - Tornesello, A. DB - Embase DO - 10.1097/01.JTO.0000438438.14562.c8 LA - English M3 - Conference Abstract N1 - L71397894 2014-04-08 PY - 2013 SN - 1556-0864 SP - S1298-S1299 ST - Lung adenocarcinoma with EML4-ALK traslocation and ovarian teratoma in a 20-year-old woman. A case report T2 - Journal of Thoracic Oncology TI - Lung adenocarcinoma with EML4-ALK traslocation and ovarian teratoma in a 20-year-old woman. A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71397894&from=export http://dx.doi.org/10.1097/01.JTO.0000438438.14562.c8 VL - 8 ID - 2259 ER - TY - JOUR AD - L. Hendriks, Pulmonary Diseases, Maastricht University Medical Center+, Netherlands AU - Hendriks, L. AU - Mellema, W. W. AU - Smit, E. F. AU - Troost, E. AU - Dingemans, A. M. DB - Embase DO - 10.1097/01.JTO.0000438438.14562.c8 LA - English M3 - Conference Abstract N1 - L71397919 2014-04-08 PY - 2013 SN - 1556-0864 SP - S1312-S1313 ST - Progression of radiation induced esophageal stenosis in a non-small cell lung cancer (NSCLC) patient treated with sorafenib T2 - Journal of Thoracic Oncology TI - Progression of radiation induced esophageal stenosis in a non-small cell lung cancer (NSCLC) patient treated with sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71397919&from=export http://dx.doi.org/10.1097/01.JTO.0000438438.14562.c8 VL - 8 ID - 2260 ER - TY - JOUR AD - R. Addeo, Medical Oncology Division, San Giovanni di Dio Frattamaggiore Hospital, ASLNA2 NORD, Naples, Italy AU - Vitagliano, O. AU - Addeo, R. AU - D'Angelo, V. AU - Indolfi, C. AU - Indolfi, P. AU - Casale, F. DB - Embase Medline DO - 10.1586/17474086.2013.827415 IS - 5 LA - English M3 - Review N1 - L370058326 2013-10-28 2013-10-31 PY - 2013 SN - 1747-4086 1747-4094 SP - 587-597 ST - The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: Implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches T2 - Expert Review of Hematology TI - The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: Implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370058326&from=export http://dx.doi.org/10.1586/17474086.2013.827415 VL - 6 ID - 2261 ER - TY - JOUR AD - W. Zhang, Department of Pharmacology, School of Medicine, Nantong University, 19 Qixiu Road, Nantong 226001, Jiangsu, China AU - Huang, C. AU - Wang, Y. AU - Wang, J. AU - Yao, W. AU - Chen, X. AU - Zhang, W. DB - Embase Medline DO - 10.1186/1742-2094-10-129 LA - English M3 - Article N1 - L52828633 2013-10-28 2020-07-28 PY - 2013 SN - 1742-2094 ST - TSG (2,3,4', 5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia T2 - Journal of Neuroinflammation TI - TSG (2,3,4', 5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52828633&from=export http://dx.doi.org/10.1186/1742-2094-10-129 VL - 10 ID - 2262 ER - TY - JOUR AD - M. Strullu, Hopital Mère-Enfant, Nantes Hospital, Nantes, France AU - Strullu, M. AU - Thomas, C. AU - Raus, N. AU - Paillard, C. AU - Bertrand, Y. AU - Jubert, C. AU - De La Tour, R. P. AU - Lutz, P. AU - Dalle, J. H. AU - Lamant, L. AU - Michel, G. AU - Brugieres, L. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71265702 2013-12-24 PY - 2013 SN - 0006-4971 ST - Hematopoietic stem cell transplantation in relapsed ALK + anaplastic large cell lymphoma of children and adolescent : A study on behalf of the sfce and SFGM-TC T2 - Blood TI - Hematopoietic stem cell transplantation in relapsed ALK + anaplastic large cell lymphoma of children and adolescent : A study on behalf of the sfce and SFGM-TC UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71265702&from=export http://bloodjournal.hematologylibrary.org/content/122/21/2120.abstract?sid=800eb0b7-24b5-49c3-baad-4bbdfe1e46cd VL - 122 ID - 2263 ER - TY - JOUR AD - K. Tokuda, Department of Pediatrics, Ehime University, Graduate School of Medicine, Toon, Ehime, Japan AU - Tokuda, K. AU - Eguchi-Ishimae, M. AU - Eguchi, M. AU - Ishii, E. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71266185 2013-12-24 PY - 2013 SN - 0006-4971 ST - In utero Cltc-ALK fusion in hematopoietic progenitor cells as a first step of leukemogenesis in blastic plasmacytoid dendritic cell neoplasm T2 - Blood TI - In utero Cltc-ALK fusion in hematopoietic progenitor cells as a first step of leukemogenesis in blastic plasmacytoid dendritic cell neoplasm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71266185&from=export http://bloodjournal.hematologylibrary.org/content/122/21/2587.abstract?sid=1dadfff3-c8f6-4ab4-a2eb-7ec494b6fd34 VL - 122 ID - 2264 ER - TY - JOUR AD - D. De Ryckere, Department of Pediatrics, University of Colorado- Denver, Children's Hospital Colorado, Aurora, CO, United States AU - De Ryckere, D. AU - Wang, X. AU - Hill, A. A. AU - Zhang, W. AU - Stashko, M. A. AU - Sather, S. AU - Cummings, C. E. AU - Janzen, W. P. AU - Frye, S. V. AU - Earp Iii, H. S. AU - Graham, D. K. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71266231 2013-12-24 PY - 2013 SN - 0006-4971 ST - Development of a novel small molecule inhibitor of the mer tyrosine kinase for treatment of acute lymphoblastic Leukemia T2 - Blood TI - Development of a novel small molecule inhibitor of the mer tyrosine kinase for treatment of acute lymphoblastic Leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71266231&from=export http://bloodjournal.hematologylibrary.org/content/122/21/2666.abstract?sid=00ae9aab-ed6f-4905-b17e-eed061c8f071 VL - 122 ID - 2265 ER - TY - JOUR AD - Q.-M. Yang, Department of Hematology and Oncology, First Affiliated Hospital, People's Liberation Army General Hospital, Beijing 100048, China AU - Cao, Z. G. AU - Zhou, H. W. AU - Peng, C. J. AU - Liu, M. AU - Du, Y. AU - Yang, Q. M. DB - Embase Medline DO - 10.5732/cjc.012.10221 IS - 9 LA - English M3 - Article N1 - L369825218 2013-09-25 2013-10-10 PY - 2013 SN - 1000-467X 1944-446X SP - 520-523 ST - A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin T2 - Chinese Journal of Cancer TI - A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369825218&from=export http://dx.doi.org/10.5732/cjc.012.10221 http://www.cjcsysu.cn/cn/ENtopdf.asp?ly=CJC&idno=20329 VL - 32 ID - 2266 ER - TY - JOUR AD - L. Dokmanovic, Department of Hematology and Oncology, University of Belgrade, University Children's Hospital, Dr Subotica 13, 11000 Belgrade, Serbia AU - Dokmanovic, L. DB - Embase Medline DO - 10.2217/bmm.13.84 IS - 5 LA - English M3 - Review N1 - L369878336 2013-10-02 2013-10-10 PY - 2013 SN - 1752-0363 1752-0371 SP - 791-801 ST - Biomarkers in childhood non-Hodgkin's lymphomas T2 - Biomarkers in Medicine TI - Biomarkers in childhood non-Hodgkin's lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369878336&from=export http://dx.doi.org/10.2217/bmm.13.84 VL - 7 ID - 2269 ER - TY - JOUR AD - S. Barbarot, Dermatology Department, CHU Hôtel Dieu, 1 place Alexis Ricordeau, 44093, Nantes Cedex, France AU - Miquel, J. AU - Vourc'H-Jourdain, M. AU - Thomas, C. AU - Cassagnau, E. AU - Stalder, J. F. AU - Barbarot, S. DB - Embase Medline DO - 10.1111/ced.12101 IS - 7 LA - English M3 - Article N1 - L369929738 2013-10-10 2013-10-11 PY - 2013 SN - 0307-6938 1365-2230 SP - 741-744 ST - Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant T2 - Clinical and Experimental Dermatology TI - Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369929738&from=export http://dx.doi.org/10.1111/ced.12101 VL - 38 ID - 2270 ER - TY - JOUR AD - P. Michaely, Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States AU - Hernandez, V. J. AU - Weng, J. AU - Ly, P. AU - Pompey, S. AU - Dong, H. AU - Mishra, L. AU - Schwarz, M. AU - Anderson, R. G. W. AU - Michaely, P. DB - Embase Medline DO - 10.7554/eLife.00905 IS - 2 LA - English M3 - Article N1 - L369903486 2013-10-04 2013-10-31 PY - 2013 SN - 2050-084X ST - Cavin-3 dictates the balance between ERK and Akt signaling T2 - eLife TI - Cavin-3 dictates the balance between ERK and Akt signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369903486&from=export http://dx.doi.org/10.7554/eLife.00905 http://elife.elifesciences.org/content/elife/2/e00905.full.pdf VL - 2013 ID - 2272 ER - TY - JOUR AD - K. Steinbrink, Department of Dermatology, University Medical Center, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany AU - Bacher, N. AU - Raker, V. AU - Hofmann, C. AU - Graulich, E. AU - Schwenk, M. AU - Baumgrass, R. AU - Bopp, T. AU - Zechner, U. AU - Merten, L. AU - Becker, C. AU - Steinbrink, K. DB - Embase Medline DO - 10.1158/0008-5472.CAN-12-3788 IS - 18 LA - English M3 - Article N1 - L369916041 2013-10-08 2013-10-28 PY - 2013 SN - 0008-5472 1538-7445 SP - 5647-5656 ST - Interferon-a suppresses cAMP to disarm human regulatory T cells T2 - Cancer Research TI - Interferon-a suppresses cAMP to disarm human regulatory T cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369916041&from=export http://dx.doi.org/10.1158/0008-5472.CAN-12-3788 http://cancerres.aacrjournals.org/content/73/18/5647.full.pdf+html VL - 73 ID - 2273 ER - TY - JOUR AD - K. Shannon, 1450 Third Street, San Francisco, CA 94158, United States AU - Xu, J. AU - Haigis, K. M. AU - Firestone, A. J. AU - McNerney, M. E. AU - Li, Q. AU - Davis, E. AU - Chen, S. C. AU - Nakitandwe, J. AU - Downing, J. AU - Jacks, T. AU - Le Beau, M. M. AU - Shannon, K. C1 - pd0325901 DB - Embase Medline DO - 10.1158/2159-8290.CD-13-0096 IS - 9 LA - English M3 - Article N1 - L369991176 2013-10-17 2013-10-24 PY - 2013 SN - 2159-8274 2159-8290 SP - 993-1001 ST - Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation T2 - Cancer Discovery TI - Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369991176&from=export http://dx.doi.org/10.1158/2159-8290.CD-13-0096 http://cancerdiscovery.aacrjournals.org/content/3/9/993.full.pdf+html VL - 3 ID - 2274 ER - TY - JOUR AD - I. Singh, Department of Pediatrics, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, United States AU - Paintlia, A. S. AU - Paintlia, M. K. AU - Singh, A. K. AU - Singh, I. DB - Embase Medline DO - 10.1002/glia.22537 IS - 9 LA - English M3 - Article N1 - L52681332 2013-07-17 2013-08-09 PY - 2013 SN - 0894-1491 1098-1136 SP - 1500-1517 ST - Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism T2 - GLIA TI - Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52681332&from=export http://dx.doi.org/10.1002/glia.22537 VL - 61 ID - 2276 ER - TY - JOUR AD - Z. Wang, State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Changle West Road #169, Xi'an 710032, China AU - Fan, L. AU - Li, P. AU - Yin, Z. AU - Fu, G. AU - Liao, D. J. AU - Liu, Y. AU - Zhu, J. AU - Zhang, Y. AU - Wang, L. AU - Yan, Q. AU - Guo, Y. AU - Shao, C. AU - Huang, G. AU - Wang, Z. DB - Embase Medline DO - 10.1038/bjc.2013.463 IS - 5 LA - English M3 - Article N1 - L52728569 2013-08-16 2013-09-18 PY - 2013 SN - 0007-0920 1532-1827 SP - 1137-1146 ST - Ribosomal s6 protein kinase 4: A prognostic factor for renal cell carcinoma T2 - British Journal of Cancer TI - Ribosomal s6 protein kinase 4: A prognostic factor for renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52728569&from=export http://dx.doi.org/10.1038/bjc.2013.463 VL - 109 ID - 2277 ER - TY - GEN AD - K.A. Rauen, Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, United States AU - Rauen, K. A. C5 - 23875798 DB - Embase Medline DO - 10.1146/annurev-genom-091212-153523 J2 - Annu. Rev. Genomics Hum. Genet. LA - English M1 - (Rauen K.A., rauenk@peds.ucsf.edu) Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, United States M3 - Review N1 - L369839424 2013-09-26 2013-09-30 PY - 2013 SN - 1527-8204 1545-293X SP - 355-369 ST - The RASopathies TI - The RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369839424&from=export http://dx.doi.org/10.1146/annurev-genom-091212-153523 VL - 14 ID - 2278 ER - TY - JOUR AD - A.J.M. Ferreri, Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy AU - Martelli, M. AU - Ferreri, A. J. M. AU - Agostinelli, C. AU - Di Rocco, A. AU - Pfreundschuh, M. AU - Pileri, S. A. DB - Embase Medline DO - 10.1016/j.critrevonc.2012.12.009 IS - 2 LA - English M3 - Review N1 - L52418664 2013-02-01 2013-08-23 PY - 2013 SN - 1040-8428 1879-0461 SP - 146-171 ST - Diffuse large B-cell lymphoma T2 - Critical Reviews in Oncology/Hematology TI - Diffuse large B-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52418664&from=export http://dx.doi.org/10.1016/j.critrevonc.2012.12.009 VL - 87 ID - 2279 ER - TY - JOUR AD - T. Imaizumi, Department of Vascular Biology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan AU - Imaizumi, T. AU - Murakami, K. AU - Ohta, K. AU - Seki, H. AU - Matsumiya, T. AU - Meng, P. AU - Hayakari, R. AU - Xing, F. AU - Aizawa-Yashiro, T. AU - Tatsuta, T. AU - Yoshida, H. AU - Kijima, H. DB - Embase Medline DO - 10.1016/j.neures.2013.05.002 IS - 4 LA - English M3 - Article N1 - L52615374 2013-06-06 2013-08-07 PY - 2013 SN - 0168-0102 1872-8111 SP - 195-206 ST - MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells T2 - Neuroscience Research TI - MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52615374&from=export http://dx.doi.org/10.1016/j.neures.2013.05.002 VL - 76 ID - 2280 ER - TY - JOUR AD - M.H. Sohn, Department of Pediatrics, Yonsei University College of Medicine, 134 Sinchon-Dong, Seoul 120-752, South Korea AU - Lee, K. E. AU - Kim, K. W. AU - Hong, J. Y. AU - Kim, K. E. AU - Sohn, M. H. DB - Embase Medline DO - 10.1007/s10875-013-9909-y IS - 6 LA - English M3 - Article N1 - L52639299 2013-06-20 2013-08-03 PY - 2013 SN - 0271-9142 1573-2592 SP - 1117-1125 ST - Modulation of IL-8 boosted by mycoplasma pneumoniae lysate in human airway epithelial cells T2 - Journal of Clinical Immunology TI - Modulation of IL-8 boosted by mycoplasma pneumoniae lysate in human airway epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52639299&from=export http://dx.doi.org/10.1007/s10875-013-9909-y VL - 33 ID - 2281 ER - TY - JOUR AD - N.J. Hewitt, SWS, Wingertstrasse 25, 64390 Erzhausen, Germany AU - Godoy, P. AU - Hewitt, N. J. AU - Albrecht, U. AU - Andersen, M. E. AU - Ansari, N. AU - Bhattacharya, S. AU - Bode, J. G. AU - Bolleyn, J. AU - Borner, C. AU - Böttger, J. AU - Braeuning, A. AU - Budinsky, R. A. AU - Burkhardt, B. AU - Cameron, N. R. AU - Camussi, G. AU - Cho, C. S. AU - Choi, Y. J. AU - Craig Rowlands, J. AU - Dahmen, U. AU - Damm, G. AU - Dirsch, O. AU - Donato, M. T. AU - Dong, J. AU - Dooley, S. AU - Drasdo, D. AU - Eakins, R. AU - Ferreira, K. S. AU - Fonsato, V. AU - Fraczek, J. AU - Gebhardt, R. AU - Gibson, A. AU - Glanemann, M. AU - Goldring, C. E. P. AU - Gómez-Lechón, M. J. AU - Groothuis, G. M. M. AU - Gustavsson, L. AU - Guyot, C. AU - Hallifax, D. AU - Hammad, S. AU - Hayward, A. AU - Häussinger, D. AU - Hellerbrand, C. AU - Hewitt, P. AU - Hoehme, S. AU - Holzhütter, H. G. AU - Houston, J. B. AU - Hrach, J. AU - Ito, K. AU - Jaeschke, H. AU - Keitel, V. AU - Kelm, J. M. AU - Kevin Park, B. AU - Kordes, C. AU - Kullak-Ublick, G. A. AU - Lecluyse, E. L. AU - Lu, P. AU - Luebke-Wheeler, J. AU - Lutz, A. AU - Maltman, D. J. AU - Matz-Soja, M. AU - McMullen, P. AU - Merfort, I. AU - Messner, S. AU - Meyer, C. AU - Mwinyi, J. AU - Naisbitt, D. J. AU - Nussler, A. K. AU - Olinga, P. AU - Pampaloni, F. AU - Pi, J. AU - Pluta, L. AU - Przyborski, S. A. AU - Ramachandran, A. AU - Rogiers, V. AU - Rowe, C. AU - Schelcher, C. AU - Schmich, K. AU - Schwarz, M. AU - Singh, B. AU - Stelzer, E. H. K. AU - Stieger, B. AU - Stöber, R. AU - Sugiyama, Y. AU - Tetta, C. AU - Thasler, W. E. AU - Vanhaecke, T. AU - Vinken, M. AU - Weiss, T. S. AU - Widera, A. AU - Woods, C. G. AU - Xu, J. J. AU - Yarborough, K. M. AU - Hengstler, J. G. DB - Embase Medline DO - 10.1007/s00204-013-1078-5 IS - 8 LA - English M3 - Review N1 - L52745520 2013-08-29 2013-09-27 PY - 2013 SN - 0340-5761 1432-0738 SP - 1315-1530 ST - Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME T2 - Archives of Toxicology TI - Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52745520&from=export http://dx.doi.org/10.1007/s00204-013-1078-5 VL - 87 ID - 2282 ER - TY - JOUR AD - C. Skurk, Department of Cardiology and Pneumology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany AU - Jenke, A. AU - Wilk, S. AU - Poller, W. AU - Eriksson, U. AU - Valaperti, A. AU - Rauch, B. H. AU - Stroux, A. AU - Liu, P. AU - Schultheiss, H. P. AU - Scheibenbogen, C. AU - Skurk, C. DB - Embase Medline DO - 10.1093/cvr/cvt118 IS - 3 LA - English M3 - Article N1 - L608851341 2016-03-14 2016-03-22 PY - 2013 SN - 1755-3245 0008-6363 SP - 422-431 ST - Adiponectin protects against toll-like receptor 4-mediated cardiac inflammation and injury T2 - Cardiovascular Research TI - Adiponectin protects against toll-like receptor 4-mediated cardiac inflammation and injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608851341&from=export http://dx.doi.org/10.1093/cvr/cvt118 VL - 99 ID - 2283 ER - TY - JOUR AD - L.A. Hansen, Department of Biomedical Sciences, School of Medicine, Creighton University, 2500 California Plaza, Omaha, NE 68178, United States AU - El-Abaseri, T. B. AU - Hammiller, B. AU - Repertinger, S. K. AU - Hansen, L. A. C1 - ag 1478 DB - Embase DO - 10.1155/2013/848705 LA - English M3 - Article N1 - L369322080 2013-07-23 2013-07-26 PY - 2013 SN - 2090-4592 2090-4606 ST - The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation T2 - ISRN Dermatology TI - The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369322080&from=export http://dx.doi.org/10.1155/2013/848705 VL - 2013 ID - 2284 ER - TY - JOUR AD - J.-M. Wong, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, Taipei 100, Taiwan AU - Wei, S. C. AU - Tsao, P. N. AU - Weng, M. T. AU - Cao, Z. AU - Wong, J. M. DB - Embase Medline DO - 10.1186/1423-0127-20-39 IS - 1 LA - English M3 - Article N1 - L52647637 2013-06-26 2013-07-24 PY - 2013 SN - 1021-7770 1423-0127 ST - Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway T2 - Journal of Biomedical Science TI - Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52647637&from=export http://dx.doi.org/10.1186/1423-0127-20-39 VL - 20 ID - 2285 ER - TY - JOUR AD - X. Chen, Department of Pharmacology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China AU - Wang, P. AU - Zhang, P. AU - Huang, J. AU - Li, M. AU - Chen, X. DB - Embase Medline DO - 10.1016/j.neuro.2013.03.007 LA - English M3 - Article N1 - L368884007 2013-05-16 2013-06-06 PY - 2013 SN - 0161-813X 1872-9711 SP - 51-62 ST - Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function T2 - NeuroToxicology TI - Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368884007&from=export http://dx.doi.org/10.1016/j.neuro.2013.03.007 VL - 37 ID - 2286 ER - TY - JOUR AD - J. Argente, Hospital Infantil Universitario Niño Jesús, Department of Endocrinology, Instituto de Investigación la Princesa, 28009 Madrid, Spain AU - Fuente-Martín, E. AU - García-Cáceres, C. AU - Díaz, F. AU - Argente-Arizón, P. AU - Granado, M. AU - Barrios, V. AU - Argente, J. AU - Chowen, J. A. DB - Embase Medline DO - 10.1210/en.2012-2196 IS - 7 LA - English M3 - Article N1 - L369165344 2013-07-02 2013-07-04 PY - 2013 SN - 0013-7227 1945-7170 SP - 2318-2330 ST - Hypothalamic inflammation without astrogliosis in response to high sucrose intake is modulated by neonatal nutrition in male rats T2 - Endocrinology TI - Hypothalamic inflammation without astrogliosis in response to high sucrose intake is modulated by neonatal nutrition in male rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369165344&from=export http://dx.doi.org/10.1210/en.2012-2196 http://endo.endojournals.org/content/154/7/2318.full.pdf+html VL - 154 ID - 2287 ER - TY - JOUR AD - X. Paoletti, Biostatistics Department, INSERM U900, Institut Curie, 26, rue d'Ulm, 75005 Paris, France AU - Paoletti, X. AU - Geoerger, B. AU - Doz, F. AU - Baruchel, A. AU - Lokiec, F. AU - Le Tourneau, C. DB - Embase Medline DO - 10.1016/j.ejca.2013.02.028 IS - 10 LA - English M3 - Article N1 - L52512154 2013-03-29 2013-06-11 PY - 2013 SN - 0959-8049 1879-0852 SP - 2392-2402 ST - A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials T2 - European Journal of Cancer TI - A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52512154&from=export http://dx.doi.org/10.1016/j.ejca.2013.02.028 VL - 49 ID - 2289 ER - TY - JOUR AD - X. Liang, Department of Pathology, Children's Hospital Colorado, 13123 East 16th Avenue, B120, Aurora, CO 80045, United States AU - Liang, X. AU - Branchford, B. AU - Greffe, B. AU - McGavran, L. AU - Carstens, B. AU - Meltesen, L. AU - Albano, E. A. AU - Quinones, R. AU - Cook, B. AU - Graham, D. K. DB - Embase Medline DO - 10.1097/MPH.0b013e3182815046 IS - 5 LA - English M3 - Article N1 - L52553482 2013-04-30 2013-08-07 PY - 2013 SN - 1077-4114 1536-3678 SP - e209-e213 ST - Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma T2 - Journal of Pediatric Hematology/Oncology TI - Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52553482&from=export http://dx.doi.org/10.1097/MPH.0b013e3182815046 VL - 35 ID - 2290 ER - TY - JOUR AD - S. Madhogaria, Birmingham Children's Hospital, Birmingham, United Kingdom AU - Madhogaria, S. AU - Sharif, S. AU - Moss, C. DB - Embase DO - 10.1111/bjd.12360 LA - English M3 - Conference Abstract N1 - L71125561 2013-08-07 PY - 2013 SN - 0007-0963 SP - 119 ST - LEOPARD syndrome or Noonan syndrome? A difficult distinction in early childhood T2 - British Journal of Dermatology TI - LEOPARD syndrome or Noonan syndrome? A difficult distinction in early childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71125561&from=export http://dx.doi.org/10.1111/bjd.12360 VL - 169 ID - 2291 ER - TY - JOUR AD - A. K. Rishi, John D. Dingell Veterans Affairs Medical Center, Detroit, MI, United States AU - Ashour, A. E. AU - Jamal, S. AU - Cheryan, V. T. AU - Muthu, M. AU - Zoheir, K. M. A. AU - Alafeefy, A. M. AU - Abd-Allah, A. R. AU - Levi, E. AU - Tarca, A. L. AU - Polin, L. A. AU - Rishi, A. K. DB - Embase Medline DO - 10.1371/journal.pone.0066733 IS - 6 L1 - internal-pdf://3516805449/journal.pone.0066733.PDF LA - English M3 - Article N1 - L369200019 2013-07-05 2013-07-17 PY - 2013 SN - 1932-6203 ST - CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth T2 - PLoS ONE TI - CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369200019&from=export http://dx.doi.org/10.1371/journal.pone.0066733 VL - 8 ID - 2292 ER - TY - JOUR AD - A. K. Bauer, Department of Environmental and Occupational Health, University of Colorado Anschutz Medical Center, Aurora, CO, United States AU - Osgood, R. S. AU - Upham, B. L. AU - Hill Iii, T. AU - Helms, K. L. AU - Velmurugan, K. AU - Babica, P. AU - Bauer, A. K. C1 - sb202190 sb203580 u0126 DB - Embase Medline DO - 10.1371/journal.pone.0065150 IS - 6 L1 - internal-pdf://1346811305/journal.pone.0065150.PDF LA - English M3 - Article N1 - L369060150 2013-06-13 2013-06-27 PY - 2013 SN - 1932-6203 ST - Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure T2 - PLoS ONE TI - Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369060150&from=export http://dx.doi.org/10.1371/journal.pone.0065150 VL - 8 ID - 2293 ER - TY - JOUR AD - J.R. Park, Division of Pediatric Hematology and Oncology, Seattle Children's Hospital, 4800 Sandpoint Way NE, Mailstop B6553, Seattle, WA 98106, United States AU - Park, J. R. AU - Bagatell, R. AU - London, W. B. AU - Maris, J. M. AU - Cohn, S. L. AU - Mattay, K. M. AU - Hogarty, M. C1 - abt 751 mln 8237 DB - Embase Medline DO - 10.1002/pbc.24433 IS - 6 LA - English M3 - Review N1 - L368767468 2013-04-29 2013-05-02 PY - 2013 SN - 1545-5009 1545-5017 SP - 985-993 ST - Children's Oncology Group's 2013 blueprint for research: Neuroblastoma T2 - Pediatric Blood and Cancer TI - Children's Oncology Group's 2013 blueprint for research: Neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368767468&from=export http://dx.doi.org/10.1002/pbc.24433 VL - 60 ID - 2294 ER - TY - JOUR AD - H.B. Pride, Department of Dermatology, Geisinger Medical Center, 115 Woodbine Ln, Danville, PA 17822-5206, United States AU - Pride, H. B. AU - Tollefson, M. AU - Silverman, R. DB - Embase Medline DO - 10.1016/j.jaad.2013.03.001 IS - 6 LA - English M3 - Review N1 - L368923702 2013-05-23 2013-05-29 PY - 2013 SN - 0190-9622 1097-6787 SP - 885.e1-885.e12 ST - What's new in pediatric dermatology?: Part I. Diagnosis and pathogenesis T2 - Journal of the American Academy of Dermatology TI - What's new in pediatric dermatology?: Part I. Diagnosis and pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368923702&from=export http://dx.doi.org/10.1016/j.jaad.2013.03.001 VL - 68 ID - 2295 ER - TY - JOUR AD - V. Castel, Unidad de Oncología Pediátrica, Hospital Universitario y Politécnico la Fe, Torre G, 2 Planta, Bulevar Sur s/n, 46026 Valencia, Spain AU - Castel, V. AU - Segura, V. AU - Berlanga, P. C1 - avastin(Hoffmann La Roche) celgene nexavar(Bayer) pf 02341066 torisel(Wyeth) velcade(Janssen) xalxori(Pfizer) zolinza(Merck) zometa(Novartis) C2 - Bayer Hoffmann La Roche Janssen Merck Novartis Pfizer Wyeth DB - Embase Medline DO - 10.1517/14728214.2013.796927 IS - 2 LA - English M3 - Review N1 - L369046464 2013-06-12 2013-06-19 PY - 2013 SN - 1472-8214 SP - 155-171 ST - Emerging drugs for neuroblastoma T2 - Expert Opinion on Emerging Drugs TI - Emerging drugs for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369046464&from=export http://dx.doi.org/10.1517/14728214.2013.796927 VL - 18 ID - 2296 ER - TY - JOUR AD - Y. Zhao, Central Laboratory, Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan 250021, China AU - Sun, W. AU - Jiao, Y. AU - Cui, B. AU - Gao, X. AU - Xia, Y. AU - Zhao, Y. DB - Embase Medline DO - 10.1038/labinvest.2013.61 IS - 6 LA - English M3 - Article N1 - L369050474 2013-06-12 2013-06-18 PY - 2013 SN - 0023-6837 1530-0307 SP - 626-638 ST - Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis T2 - Laboratory Investigation TI - Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369050474&from=export http://dx.doi.org/10.1038/labinvest.2013.61 VL - 93 ID - 2297 ER - TY - JOUR AD - M.S. Lim, Department of Pathology, University of Michigan, 1301 Catherine St, 5242 Medical Science I, SPC 0602, Ann Arbor, MI 48109, United States AU - Lowe, E. J. AU - Lim, M. S. C1 - af 802(Chugai) C2 - Amgen Ariad Astellas Bristol Myers Squibb Chugai Glaxo SmithKline nerviano medical science Novartis Pfizer Xcovery DB - Embase Medline DO - 10.1007/s40272-013-0027-3 IS - 3 LA - English M3 - Article N1 - L369074142 2013-06-17 2013-06-19 PY - 2013 SN - 1174-5878 1179-2019 SP - 163-169 ST - Potential therapies for anaplastic lymphoma kinase-driven tumors in children: Progress to date T2 - Pediatric Drugs TI - Potential therapies for anaplastic lymphoma kinase-driven tumors in children: Progress to date UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369074142&from=export http://dx.doi.org/10.1007/s40272-013-0027-3 VL - 15 ID - 2298 ER - TY - JOUR AD - M.-A. Wörns, Department of Internal Medicine i, University Medical Center, Johannes Gutenberg University, Langenbeckstrasse 1, DE-55131 Mainz, Germany AU - Wörns, M. A. C1 - abt 869 arq 197 azd 6244 bay 73 4506 calgb 80802 imc 1121b imc a 12 lbh 589 pxd 101 DB - Embase Medline DO - 10.1159/000347202 IS - 1 LA - English M3 - Article N1 - L369214430 2013-07-09 2013-07-11 PY - 2013 SN - 0257-2753 1421-9875 SP - 104-111 ST - Systemic therapy and synergies by combination T2 - Digestive Diseases TI - Systemic therapy and synergies by combination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369214430&from=export http://dx.doi.org/10.1159/000347202 VL - 31 ID - 2299 ER - TY - JOUR AD - W.S. Choi, Department of Immunology and Physiology, Functional Genomics Institute, Konkuk University, Chungju 380-701, South Korea AU - Kim, D. K. AU - Kim, H. S. AU - Kim, A. R. AU - Kim, J. H. AU - Kim, B. AU - Noh, G. AU - Kim, H. S. AU - Beaven, M. A. AU - Kim, Y. M. AU - Choi, W. S. DB - Embase Medline DO - 10.1016/j.jaci.2012.10.012 IS - 6 LA - English M3 - Article N1 - L52315151 2012-11-26 2013-06-26 PY - 2013 SN - 0091-6749 1097-6825 SP - 1653-1662.e1 ST - DJ-1 regulates mast cell activation and IgE-mediated allergic responses T2 - Journal of Allergy and Clinical Immunology TI - DJ-1 regulates mast cell activation and IgE-mediated allergic responses UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52315151&from=export http://dx.doi.org/10.1016/j.jaci.2012.10.012 VL - 131 ID - 2300 ER - TY - JOUR AD - T.G. Gross, Pediatrics, Ohio State University, School of Medicine, Columbus, United States AU - Gross, T. G. DB - Embase DO - 10.1002/hon.2057 LA - English M3 - Conference Abstract N1 - L71147390 2013-08-30 PY - 2013 SN - 0278-0232 SP - 122 ST - Alk tyrosine kinase inhibitors for alk+ anaplastic large cell lymphoma (ALCL): Preliminary clinical experiences and perspectives T2 - Hematological Oncology TI - Alk tyrosine kinase inhibitors for alk+ anaplastic large cell lymphoma (ALCL): Preliminary clinical experiences and perspectives UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71147390&from=export http://dx.doi.org/10.1002/hon.2057 VL - 31 ID - 2302 ER - TY - JOUR AD - C.-W. Lee, Division of Basic Medical Sciences, Department of Nursing, and Chronic Diseases and Health Promotion Research Center, Chang Gung Institute of Technology, Chia-Yi, Taiwan AU - Yen, F. L. AU - Tsai, M. H. AU - Yang, C. M. AU - Liang, C. J. AU - Lin, C. C. AU - Chiang, Y. C. AU - Lee, H. C. AU - Ko, H. H. AU - Lee, C. W. C2 - Biomol(United States) DB - Embase Medline DO - 10.1371/journal.pone.0063845 IS - 5 L1 - internal-pdf://0434248626/journal.pone.0063845.PDF LA - English M3 - Article N1 - L368882664 2013-05-16 2013-05-23 PY - 2013 SN - 1932-6203 ST - Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-α-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways T2 - PLoS ONE TI - Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-α-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368882664&from=export http://dx.doi.org/10.1371/journal.pone.0063845 VL - 8 ID - 2303 ER - TY - JOUR AD - C. Bueno, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Avda de la Ilustracón 114, Granada, Spain AU - Bueno, C. AU - Ayllón, V. AU - Montes, R. AU - Navarro-Montero, O. AU - Ramos-Mejia, V. AU - Real, P. J. AU - Romero-Moya, D. AU - Araúzo-Bravo, M. J. AU - Menendez, P. DB - Embase Medline DO - 10.1182/blood-2012-11-470146 IS - 19 LA - English M3 - Article N1 - L617279156 2017-08-15 2017-08-17 PY - 2013 SN - 1528-0020 0006-4971 SP - 3867-3878 ST - FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs T2 - Blood TI - FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617279156&from=export http://dx.doi.org/10.1182/blood-2012-11-470146 VL - 121 ID - 2304 ER - TY - JOUR AD - E. Lazzari, Department of Pathology, San Bortolo Hospital, UO Anatomia Patologica, Viale F. Rodolfi 37, Vicenza, Italy AU - D'Amore, E. S. G. AU - Visco, C. AU - Menin, A. AU - Famengo, B. AU - Bonvini, P. AU - Lazzari, E. DB - Medline DO - 10.1097/PAS.0b013e318287791f IS - 5 LA - English M3 - Article N1 - L368789094 2013-06-07 PY - 2013 SN - 0147-5185 1532-0979 SP - 780-786 ST - STAT3 pathway is activated in ALK-positive large b-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target T2 - American Journal of Surgical Pathology TI - STAT3 pathway is activated in ALK-positive large b-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368789094&from=export http://dx.doi.org/10.1097/PAS.0b013e318287791f VL - 37 ID - 2305 ER - TY - JOUR AD - D.K. Graham, Department of Pediatrics, School of Medicine, University of Colorado, 12800 East 19th Avenue, Aurora, CO, 80045, United States AU - Schlegel, J. AU - Sambade, M. J. AU - Sather, S. AU - Moschos, S. J. AU - Tan, A. C. AU - Winges, A. AU - DeRyckere, D. AU - Carson, C. C. AU - Trembath, D. G. AU - Tentler, J. J. AU - Eckhardt, S. G. AU - Kuan, P. F. AU - Hamilton, R. L. AU - Duncan, L. M. AU - Miller, C. R. AU - Nikolaishvili-Feinberg, N. AU - Midkiff, B. R. AU - Liu, J. AU - Zhang, W. AU - Yang, C. AU - Wang, X. AU - Frye, S. V. AU - Earp, H. S. AU - Shields, J. M. AU - Graham, D. K. DB - Embase Medline DO - 10.1172/JCI67816 IS - 5 LA - English M3 - Article N1 - L368856944 2013-05-14 2013-05-16 PY - 2013 SN - 0021-9738 1558-8238 SP - 2257-2267 ST - MERTK receptor tyrosine kinase is a therapeutic target in melanoma T2 - Journal of Clinical Investigation TI - MERTK receptor tyrosine kinase is a therapeutic target in melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368856944&from=export http://dx.doi.org/10.1172/JCI67816 http://www.jci.org/articles/view/67816/pdf VL - 123 ID - 2306 ER - TY - JOUR AD - S.-C. Baik, Department of Microbiology, Gyeongsang National University School of Medicine, 92 Chilam-Dong, Jinju 660-751, South Korea AU - Kim, J. M. AU - Kim, K. M. AU - Park, E. H. AU - Seo, J. H. AU - Song, J. Y. AU - Shin, S. C. AU - Kang, H. L. AU - Lee, W. K. AU - Cho, M. J. AU - Rhee, K. H. AU - Youn, H. S. AU - Baik, S. C. DB - Embase Medline DO - 10.1111/1348-0421.12049 IS - 5 LA - English M3 - Article N1 - L368943857 2013-05-27 2013-06-05 PY - 2013 SN - 0385-5600 1348-0421 SP - 366-373 ST - Anthocyanins from black soybean inhibit Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells T2 - Microbiology and Immunology TI - Anthocyanins from black soybean inhibit Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368943857&from=export http://dx.doi.org/10.1111/1348-0421.12049 VL - 57 ID - 2307 ER - TY - JOUR AD - W. Jeong AU - Jeong, W. AU - Doroshow, J. H. AU - Kummar, S. C1 - bosulif(Pfizer) caprelsa(Astra Zeneca) erivedge(Genentech) gleevec(Novartis) iclusig(Ariad) inlyta(Pfizer) iressa(Astra Zeneca) jakafi(Incyte) nexavar(Bayer) nexavar(Onyx) sprycel(Bristol Myers Squibb) stivarga(Bayer) sutent(Pfizer) tarceva(Osi) tasigna(Novartis) tykerb(Glaxo SmithKline) votrient(Glaxo SmithKline) xalkori(Pfizer) C2 - Ariad Astra Zeneca Bayer Bristol Myers Squibb Genentech Glaxo SmithKline Incyte Novartis Onyx Osi Pfizer DB - Embase Medline DO - 10.1016/j.currproblcancer.2013.06.001 IS - 3 LA - English M3 - Article N1 - L369851237 2013-09-27 2013-10-01 PY - 2013 SN - 0147-0272 1535-6345 SP - 110-144 ST - United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies T2 - Current Problems in Cancer TI - United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369851237&from=export http://dx.doi.org/10.1016/j.currproblcancer.2013.06.001 VL - 37 ID - 2308 ER - TY - JOUR AD - Y.-F. Zhao, Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, Hubei 430079, China AU - Zou, H. X. AU - Jia, J. AU - Zhang, W. F. AU - Sun, Z. J. AU - Zhao, Y. F. DB - Embase Medline DO - 10.1016/j.carpath.2012.10.001 IS - 3 LA - English M3 - Article N1 - L52299755 2012-11-15 2013-05-24 PY - 2013 SN - 1054-8807 1879-1336 SP - 203-210 ST - Propranolol inhibits endothelial progenitor cell homing: A possible treatment mechanism of infantile hemangioma T2 - Cardiovascular Pathology TI - Propranolol inhibits endothelial progenitor cell homing: A possible treatment mechanism of infantile hemangioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52299755&from=export http://dx.doi.org/10.1016/j.carpath.2012.10.001 VL - 22 ID - 2309 ER - TY - JOUR AD - Department of Hematology, Affiliated Hospital of Zunyi Medical College, Guizhou 563003, China AU - Du, X. L. AU - Chen, Q. C1 - abt 737 ha 14 1 ps 341 velcade DB - Embase Medline DO - 10.1159/000345260 IS - 4 LA - English M3 - Review N1 - L52382715 2013-01-10 2013-05-31 PY - 2013 SN - 0001-5792 1421-9662 SP - 207-214 ST - Recent advancements of bortezomib in acute lymphocytic leukemia treatment T2 - Acta Haematologica TI - Recent advancements of bortezomib in acute lymphocytic leukemia treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52382715&from=export http://dx.doi.org/10.1159/000345260 VL - 129 ID - 2310 ER - TY - JOUR AD - X. Wang, Shanghai Institute of Materia Medica, Shanghai, China AU - Wang, X. AU - Li, B. S. AU - Ding, L. X. AU - Liang, C. AU - Ding, J. AU - Meng, L. H. DB - Embase DO - 10.1158/1538-7445.AM2013-3262 IS - 8 LA - English M3 - Conference Abstract N1 - L71344046 2014-03-01 PY - 2013 SN - 0008-5472 ST - Targeting PI3K-coupled MEK/ERK pathway for therapy in pediatric B-cell acute lymphocytic leukemia T2 - Cancer Research TI - Targeting PI3K-coupled MEK/ERK pathway for therapy in pediatric B-cell acute lymphocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71344046&from=export http://dx.doi.org/10.1158/1538-7445.AM2013-3262 VL - 73 ID - 2312 ER - TY - JOUR AD - D.H. Gutmann, Washington University School of Medicine, Department of Neurology, Washington University Neurofibromatosis Center, 660 South Euclid Avenue, St. Louis, MO 63110, United States AU - Gutmann, D. H. AU - Blakeley, J. O. AU - Korf, B. R. AU - Packer, R. J. C1 - azd 6244 plx 3397 ptc 299 rad 001 sarc 016 DB - Embase Medline DO - 10.1517/13543784.2013.772979 IS - 4 LA - English M3 - Review N1 - L368551011 2013-03-27 2013-04-04 PY - 2013 SN - 1354-3784 1744-7658 SP - 443-462 ST - Optimizing biologically targeted clinical trials for neurofibromatosis T2 - Expert Opinion on Investigational Drugs TI - Optimizing biologically targeted clinical trials for neurofibromatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368551011&from=export http://dx.doi.org/10.1517/13543784.2013.772979 VL - 22 ID - 2313 ER - TY - JOUR AD - F.M. Uckun, Children's Hospital Los Angeles, Children's Center for Cancer and Blood Diseases, Los Angeles, CA 90027, United States AU - D'Cruz, O. J. AU - Uckun, F. M. C2 - Ariad Novartis DB - Embase Medline DO - 10.1517/14656566.2013.780031 IS - 6 LA - English M3 - Review N1 - L368551088 2013-03-27 2013-04-03 PY - 2013 SN - 1465-6566 1744-7666 SP - 707-721 ST - Protein kinase inhibitors against malignant lymphoma T2 - Expert Opinion on Pharmacotherapy TI - Protein kinase inhibitors against malignant lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368551088&from=export http://dx.doi.org/10.1517/14656566.2013.780031 VL - 14 ID - 2314 ER - TY - JOUR AD - J. Milstrokoszewska, Department of Cell Biology, Cancer Centre and Institute of Oncology, Roentgena str. 5, 02-781 Warsaw, Poland AU - Milstrokoszewska, J. AU - Przybyszewska, M. AU - Gos, M. AU - Swoboda, P. AU - Trembacz, H. DB - Embase Medline DO - 10.1111/cpr.12015 IS - 2 LA - English M3 - Article N1 - L368577250 2013-04-02 2013-04-05 PY - 2013 SN - 0960-7722 1365-2184 SP - 146-152 ST - TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions T2 - Cell Proliferation TI - TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368577250&from=export http://dx.doi.org/10.1111/cpr.12015 VL - 46 ID - 2315 ER - TY - JOUR AD - O. Sampetrean, Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan AU - Osuka, S. AU - Sampetrean, O. AU - Shimizu, T. AU - Saga, I. AU - Onishi, N. AU - Sugihara, E. AU - Okubo, J. AU - Fujita, S. AU - Takano, S. AU - Matsumura, A. AU - Saya, H. DB - Embase Medline DO - 10.1002/stem.1328 IS - 4 LA - English M3 - Article N1 - L368652622 2013-04-12 2013-04-17 PY - 2013 SN - 1066-5099 SP - 627-640 ST - IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells T2 - Stem Cells TI - IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368652622&from=export http://dx.doi.org/10.1002/stem.1328 http://onlinelibrary.wiley.com/doi/10.1002/stem.1328/pdf VL - 31 ID - 2316 ER - TY - JOUR AD - M.B. Lodish, Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 10 Center Drive, Bethesda, MD 20892, United States AU - Lodish, M. B. DB - Embase DO - 10.1210/jc.2012-4085 IS - 4 LA - English M3 - Review N1 - L368740088 2013-04-24 2013-05-09 PY - 2013 SN - 0021-972X 1945-7197 SP - 1333-1342 ST - Kinase inhibitors: Adverse effects related to the endocrine system T2 - Journal of Clinical Endocrinology and Metabolism TI - Kinase inhibitors: Adverse effects related to the endocrine system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368740088&from=export http://dx.doi.org/10.1210/jc.2012-4085 http://jcem.endojournals.org/content/98/4/1333.full.pdf+html VL - 98 ID - 2317 ER - TY - JOUR AD - D.L. Durden, Department of Pediatrics, University of California, Rady Children's Hospital, 3855 Health Sciences Drive #0819, San Diego, CA 92093-0819, United States AU - De, P. AU - Dey, N. AU - Terakedis, B. AU - Bergsagel, P. L. AU - Li, Z. H. AU - Mahadevan, D. AU - Garlich, J. R. AU - Trudel, S. AU - Makale, M. T. AU - Durden, D. L. C1 - sf 1126 velcade DB - Embase Medline DO - 10.1007/s00280-013-2078-0 IS - 4 LA - English M3 - Article N1 - L52412917 2013-01-30 2013-07-16 PY - 2013 SN - 0344-5704 1432-0843 SP - 867-881 ST - An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo T2 - Cancer Chemotherapy and Pharmacology TI - An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52412917&from=export http://dx.doi.org/10.1007/s00280-013-2078-0 VL - 71 ID - 2319 ER - TY - JOUR AD - D. Iliopoulos, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02215, United States AU - Palumbo, T. AU - Faucz, F. R. AU - Azevedo, M. AU - Xekouki, P. AU - Iliopoulos, D. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1038/onc.2012.190 IS - 13 LA - English M3 - Article N1 - L52021400 2012-05-25 2013-04-19 PY - 2013 SN - 0950-9232 1476-5594 SP - 1651-1659 ST - Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway T2 - Oncogene TI - Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52021400&from=export http://dx.doi.org/10.1038/onc.2012.190 VL - 32 ID - 2320 ER - TY - JOUR AD - H. Nakagami, Division of Vascular Medicine and Epigenetics, United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan AU - Nakagami, F. AU - Koriyama, H. AU - Nakagami, H. AU - Osako, M. K. AU - Shimamura, M. AU - Kyutoku, M. AU - Miyake, T. AU - Katsuya, T. AU - Rakugi, H. AU - Morishita, R. DB - Embase Medline DO - 10.1371/journal.pone.0060493 IS - 3 L1 - internal-pdf://0552473416/journal.pone.0060493.PDF LA - English M3 - Article N1 - L368602234 2013-04-04 2013-04-17 PY - 2013 SN - 1932-6203 ST - Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice T2 - PLoS ONE TI - Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368602234&from=export http://dx.doi.org/10.1371/journal.pone.0060493 VL - 8 ID - 2321 ER - TY - JOUR AD - B. Salehian, City of Hope, Department of Diabetes, Endocrine and Metabolism, CA, United States AU - Salehian, B. AU - Samoa, R. DB - Embase Medline DO - 10.4274/Jcrpe.870 IS - SUPPL.1 LA - English M3 - Review N1 - L368446540 2013-03-11 2013-03-26 PY - 2013 SN - 1308-5727 1308-5735 SP - 70-78 ST - RET gene abnormalities and thyroid disease: Who should be screened and when T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - RET gene abnormalities and thyroid disease: Who should be screened and when UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368446540&from=export http://dx.doi.org/10.4274/Jcrpe.870 http://www.jcrpe.org/sayilar/44/buyuk/70-78.pdf VL - 5 ID - 2322 ER - TY - JOUR AD - S. Shalapour, Department of Pediatric Oncology/Hematology, Division of General Pediatrics, Charité-Universitätsmedizin Berlin, Berlin 13353, Germany AU - Bastian, L. AU - Hof, J. AU - Pfau, M. AU - Fichtner, I. AU - Eckert, C. AU - Henze, G. AU - Prada, J. AU - Von Stackelberg, A. AU - Seeger, K. AU - Shalapour, S. C2 - Janssen Cilag Klinke Sigma Aldrich DB - Embase Medline DO - 10.1158/1078-0432.CCR-12-1511 IS - 6 LA - English M3 - Article N1 - L368552622 2013-03-27 2013-04-12 PY - 2013 SN - 1078-0432 1557-3265 SP - 1445-1457 ST - Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB T2 - Clinical Cancer Research TI - Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368552622&from=export http://dx.doi.org/10.1158/1078-0432.CCR-12-1511 http://clincancerres.aacrjournals.org/content/19/6/1445.full.pdf+html VL - 19 ID - 2324 ER - TY - GEN AD - D. Claxton, Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, PA 17033, United States AU - Vasekar, M. AU - Allen, J. E. AU - Joudeh, J. AU - Claxton, D. C1 - gsk 1120212 mk 0457 ro 5045337 sar 3419 C5 - 23288648 DB - Embase Medline DO - 10.1007/978-1-4614-6176-0-16 J2 - Adv. Exp. Med. Biol. LA - English M1 - (Vasekar M.; Allen J.E., joshjea@gmail.com; Claxton D., dclaxton@hmc.psu.edu) Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, PA 17033, United States M3 - Article N1 - L368308941 2013-02-20 2013-03-05 PY - 2013 SN - 0065-2598 9781461461753 SP - 341-358 ST - Emerging molecular therapies for the treatment of acute lymphoblastic leukemia TI - Emerging molecular therapies for the treatment of acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368308941&from=export http://dx.doi.org/10.1007/978-1-4614-6176-0-16 VL - 779 ID - 2325 ER - TY - JOUR AD - C. Horbinski, University of Kentucky, 800 Rose St, Lexington, KY 40536, United States AU - Clark, K. AU - Voronovich, Z. AU - Horbinski, C. DB - Embase Medline DO - 10.1309/AJCPFO8IIDNBIJ8Y IS - 3 LA - English M3 - Article N1 - L368963003 2013-05-30 2013-06-04 PY - 2013 SN - 0002-9173 1943-7722 SP - 275-288 ST - How molecular testing can help (and hurt) in the workup of gliomas T2 - American Journal of Clinical Pathology TI - How molecular testing can help (and hurt) in the workup of gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368963003&from=export http://dx.doi.org/10.1309/AJCPFO8IIDNBIJ8Y http://ajcp.ascpjournals.org/content/139/3/275.full.pdf+html VL - 139 ID - 2326 ER - TY - JOUR AD - G. Vassal, Division of Clinical Research, Institut Gustave Roussy, Paris-Sud University, 94805 Villejuif, France AU - Vassal, G. AU - Zwaan, C. M. AU - Ashley, D. AU - Le Deley, M. C. AU - Hargrave, D. AU - Blanc, P. AU - Adamson, P. C. C1 - r 1507 DB - Embase Medline DO - 10.1016/S1470-2045(13)70013-5 IS - 3 LA - English M3 - Review N1 - L52453670 2013-02-23 2013-04-15 PY - 2013 SN - 1470-2045 1474-5488 SP - e117-e124 ST - New drugs for children and adolescents with cancer: The need for novel development pathways T2 - The Lancet Oncology TI - New drugs for children and adolescents with cancer: The need for novel development pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52453670&from=export http://dx.doi.org/10.1016/S1470-2045(13)70013-5 VL - 14 ID - 2328 ER - TY - JOUR AD - K. Dunleavy, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States AU - Lai, C. AU - Dunleavy, K. DB - Embase Medline DO - 10.1016/j.beha.2013.04.004 IS - 1 LA - English M3 - Review N1 - L52596740 2013-05-27 2013-06-28 PY - 2013 SN - 1521-6926 1532-1924 SP - 33-41 ST - NK/T-cell lymphomas in children T2 - Best Practice and Research: Clinical Haematology TI - NK/T-cell lymphomas in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52596740&from=export http://dx.doi.org/10.1016/j.beha.2013.04.004 VL - 26 ID - 2329 ER - TY - JOUR AD - F. Altmüller, Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany AU - Altmüller, F. AU - Schanze, D. AU - Schanze, I. AU - Fejtova, A. AU - Zenker, M. DB - Embase DO - 10.1007/s11825-013-0376-x IS - 1 LA - English M3 - Conference Abstract N1 - L71009549 2013-03-14 PY - 2013 SN - 0936-5931 SP - 96 ST - Morphological characterization of murine neurons exhibiting hyperactivation of the Ras-MAPK signaling pathway T2 - Medizinische Genetik TI - Morphological characterization of murine neurons exhibiting hyperactivation of the Ras-MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71009549&from=export http://dx.doi.org/10.1007/s11825-013-0376-x VL - 25 ID - 2330 ER - TY - JOUR AD - V.S. Silveira, Department of Pediatrics, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Avenida Bandeirantes 3900, 14049-900 Ribeirao Preto-SP, Brazil AU - Silveira, V. S. AU - Scrideli, C. A. AU - Moreno, D. A. AU - Yunes, J. A. AU - Queiroz, R. G. P. AU - Toledo, S. C. AU - Lee, M. L. M. AU - Petrilli, A. S. AU - Brandalise, S. R. AU - Tone, L. G. DB - Embase Medline DO - 10.3109/10428194.2012.710330 IS - 2 LA - English M3 - Article N1 - L368063482 2013-01-15 2013-01-22 PY - 2013 SN - 1042-8194 1029-2403 SP - 310-314 ST - Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia T2 - Leukemia and Lymphoma TI - Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368063482&from=export http://dx.doi.org/10.3109/10428194.2012.710330 VL - 54 ID - 2331 ER - TY - JOUR AD - L. Gore, Children's Hospital Colorado, 13123 East 16th Av., Aurora, CO 80045, United States AU - Gore, L. AU - DeGregori, J. AU - Porter, C. C. DB - Embase Medline DO - 10.1016/S1470-2045(12)70530-2 IS - 2 LA - English M3 - Review N1 - L368229223 2013-02-07 2013-02-20 PY - 2013 SN - 1470-2045 1474-5488 SP - e70-e78 ST - Targeting developmental pathways in children with cancer: What price success? T2 - The Lancet Oncology TI - Targeting developmental pathways in children with cancer: What price success? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368229223&from=export http://dx.doi.org/10.1016/S1470-2045(12)70530-2 VL - 14 ID - 2332 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica and Fondazione Città della Speranza, Azienda Ospedaliera-Università di Padova, Associazione Italiana Emato-Oncologia Pediatrica, via Giustiniani 3, Padova 35128, Italy AU - Mussolin, L. AU - Damm-Welk, C. AU - Pillon, M. AU - Zimmermann, M. AU - Franceschetto, G. AU - Pulford, K. AU - Reiter, A. AU - Rosolen, A. AU - Woessmann, W. DB - Embase Medline DO - 10.1038/leu.2012.205 IS - 2 LA - English M3 - Article N1 - L52171483 2012-08-23 2013-02-27 PY - 2013 SN - 0887-6924 1476-5551 SP - 416-422 ST - Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis T2 - Leukemia TI - Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52171483&from=export http://dx.doi.org/10.1038/leu.2012.205 VL - 27 ID - 2333 ER - TY - JOUR AD - M. Athar, Department of Dermatology, University of Alabama at Birmingham, 1530 3rd Avenue South, VH 509, Birmingham, AL 35294-0019, United States AU - Kurundkar, D. AU - Srivastava, R. K. AU - Chaudhary, S. C. AU - Ballestas, M. E. AU - Kopelovich, L. AU - Elmets, C. A. AU - Athar, M. DB - Embase Medline DO - 10.1016/j.taap.2012.11.002 IS - 2 LA - English M3 - Article N1 - L368019476 2013-01-09 2013-01-11 PY - 2013 SN - 0041-008X 1096-0333 SP - 233-244 ST - Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model T2 - Toxicology and Applied Pharmacology TI - Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368019476&from=export http://dx.doi.org/10.1016/j.taap.2012.11.002 VL - 266 ID - 2334 ER - TY - JOUR AD - M. Mus̈chen, Deptartment of Laboratory Medicine, University of California, San Francisco, 521 Parnassus Ave, San Francisco, CA 94143, United States AU - Ramezani-Rad, P. AU - Geng, H. AU - Hurtz, C. AU - Chan, L. N. AU - Chen, Z. AU - Jumaa, H. AU - Melnick, A. AU - Paietta, E. AU - Carroll, W. L. AU - Willman, C. L. AU - Lefebvre, V. AU - Mus̈chen, M. DB - Embase Medline DO - 10.1182/blood-2012-05-428938 IS - 1 LA - English M3 - Article N1 - L368072153 2013-01-16 2013-01-22 PY - 2013 SN - 0006-4971 1528-0020 SP - 148-155 ST - SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia T2 - Blood TI - SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368072153&from=export http://dx.doi.org/10.1182/blood-2012-05-428938 http://bloodjournal.hematologylibrary.org/content/121/1/148.full.pdf+html VL - 121 ID - 2335 ER - TY - JOUR AD - M.S. Cairo, Division of Pediatric Oncology, Hematology and Stem Cell Transplantation, Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, Department of Pediatrics, New York Medical College, Munger Pavilion, Valhalla, NY 10595, United States AU - Cairo, M. S. AU - Woessmann, W. AU - Pagel, J. C1 - vp 16 DB - Embase Medline DO - 10.1016/j.bbmt.2012.10.003 IS - 1 SUPPL. LA - English M3 - Article N1 - L368045423 2013-01-10 2013-01-16 PY - 2013 SN - 1083-8791 1523-6536 SP - S38-S43 ST - Advances in Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Lymphomas T2 - Biology of Blood and Marrow Transplantation TI - Advances in Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368045423&from=export http://dx.doi.org/10.1016/j.bbmt.2012.10.003 VL - 19 ID - 2336 ER - TY - JOUR AD - A. Sukhanova, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, United States AU - Sukhanova, A. AU - Gorin, A. AU - Serebriiskii, I. G. AU - Gabitova, L. AU - Zheng, H. AU - Restifo, D. AU - Egleston, B. L. AU - Cunningham, D. AU - Bagnyukova, T. AU - Liu, H. AU - Nikonova, A. AU - Adams, G. P. AU - Zhou, Y. AU - Yang, D. H. AU - Mehra, R. AU - Burtness, B. AU - Cai, K. Q. AU - Klein-Szanto, A. AU - Kratz, L. E. AU - Kelley, R. I. AU - Weiner, L. M. AU - Herman, G. E. AU - Golemis, E. A. AU - Astsaturov, I. C1 - cpt 11 ly 294022 u 0126 C2 - Fox DB - Embase Medline DO - 10.1158/2159-8290.CD-12-0031 IS - 1 LA - English M3 - Article N1 - L368187371 2013-02-01 2013-02-07 PY - 2013 SN - 2159-8274 2159-8290 SP - 96-112 ST - Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation T2 - Cancer Discovery TI - Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368187371&from=export http://dx.doi.org/10.1158/2159-8290.CD-12-0031 http://cancerdiscovery.aacrjournals.org/content/3/1/96.full.pdf+html VL - 3 ID - 2338 ER - TY - JOUR AD - H.-Z. Lu, Deptartment of Pediatrics, Clinical Medical College, Yangtze University, Jingzhou 434000, China AU - Lu, H. Z. AU - Zhou, J. H. DB - Embase Medline DO - 10.1016/S2221-1691(13)60053-2 IS - 3 LA - English M3 - Article N1 - L368228696 2013-02-07 2013-02-14 PY - 2013 SN - 2221-1691 SP - 217-222 ST - Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways T2 - Asian Pacific Journal of Tropical Biomedicine TI - Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368228696&from=export http://dx.doi.org/10.1016/S2221-1691(13)60053-2 VL - 3 ID - 2339 ER - TY - GEN AU - Rodriguez, F. J. AU - Lim, K. S. AU - Bowers, D. AU - Eberhart, C. G. C1 - nexavar rapamune tarceva C5 - 23121055 DB - Embase Medline DO - 10.1146/annurev-pathol-020712-164009 J2 - Annu. Rev. Pathol. Mech. Dis. LA - English M1 - (Rodriguez F.J.; Lim K.S.; Eberhart C.G., ceberha@jhmi.edu) Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States M3 - Review N1 - L369002373 2013-06-05 2013-06-10 PY - 2013 SN - 1553-4014 1553-4006 SP - 361-379 ST - Pathological and molecular advances in pediatric low-grade astrocytoma TI - Pathological and molecular advances in pediatric low-grade astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369002373&from=export http://dx.doi.org/10.1146/annurev-pathol-020712-164009 VL - 8 ID - 2340 ER - TY - JOUR AD - D. Fernández-López, Neonatal Brain Disorders Center, Department of Neurology, University of California San Francisco, San Francisco, 94158 CA, United States AU - Fernández-López, D. AU - Lizasoain, I. AU - Moro, M. A. AU - Martínez-Orgado, J. C1 - cp 55 cp 940 sr 144528 win 55212 2 DB - Embase DO - 10.3390/brainsci3031043 IS - 3 LA - English M3 - Review N1 - L369304901 2013-07-19 2013-07-25 PY - 2013 SN - 2076-3425 SP - 1043-1059 ST - Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury T2 - Brain Sciences TI - Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369304901&from=export http://dx.doi.org/10.3390/brainsci3031043 VL - 3 ID - 2341 ER - TY - JOUR AD - E. Gitto, Neonatal Intensive Care Unit, Department of Pediatrics, University of Messina, Via Consolare Valeria, 98125 Messina, Italy AU - Gitto, E. AU - Marseglia, L. AU - Manti, S. AU - D'Angelo, G. AU - Barberi, I. AU - Salpietro, C. AU - Reiter, R. J. DB - Embase DO - 10.1155/2013/980374 LA - English M3 - Review N1 - L370449339 2013-12-18 2013-12-23 PY - 2013 SN - 1942-0994 1942-0900 ST - Protective role of melatonin in neonatal diseases T2 - Oxidative Medicine and Cellular Longevity TI - Protective role of melatonin in neonatal diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370449339&from=export http://dx.doi.org/10.1155/2013/980374 ID - 2342 ER - TY - JOUR AD - X. P. Wan, Department of Obstetrics and Gynaecology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, China AU - Lu, W. AU - Xia, Y. H. AU - Qu, J. J. AU - He, Y. Y. AU - Li, B. L. AU - Lu, C. AU - Luo, X. AU - Wan, X. P. DB - Embase Medline DO - 10.4149/neo_2013_064 IS - 5 LA - English M3 - Article N1 - L372233209 2014-02-06 2020-06-05 PY - 2013 SN - 1338-4317 0028-2685 SP - 493-503 ST - p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion T2 - Neoplasma TI - p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372233209&from=export http://dx.doi.org/10.4149/neo_2013_064 VL - 60 ID - 2343 ER - TY - JOUR AD - E.E.W. Cohen, Department of Medicine, Section of Hematology/Oncology, University of Chicago, 900 East 57th Street, Chicago, IL, 60637, United States AU - Young, N. R. AU - Liu, J. AU - Pierce, C. AU - Wei, T. F. AU - Grushko, T. AU - Olopade, O. I. AU - Liu, W. AU - Shen, C. AU - Seiwert, T. Y. AU - Cohen, E. E. W. C1 - zd 1839(Astra Zeneca,United Kingdom) C2 - Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1016/j.molonc.2012.11.001 IS - 3 LA - English M3 - Article N1 - L52327277 2012-11-30 2013-06-05 PY - 2013 SN - 1878-0261 1574-7891 SP - 359-368 ST - Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition T2 - Molecular Oncology TI - Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52327277&from=export http://dx.doi.org/10.1016/j.molonc.2012.11.001 VL - 7 ID - 2344 ER - TY - JOUR AD - C. Horbinski, Department of Pathology, University of Kentucky, MS-155, 800 Rose St, Lexington, KY 40536, United States AU - Horbinski, C. C1 - azd 6244 plx 4032 DB - Embase Medline DO - 10.1097/NEN.0b013e318279f3db IS - 1 LA - English M3 - Review N1 - L52353587 2012-12-18 2013-01-22 PY - 2013 SN - 0022-3069 1554-6578 SP - 2-7 ST - To BRAF or not to BRAF: Is that even a question anymore? T2 - Journal of Neuropathology and Experimental Neurology TI - To BRAF or not to BRAF: Is that even a question anymore? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52353587&from=export http://dx.doi.org/10.1097/NEN.0b013e318279f3db VL - 72 ID - 2345 ER - TY - JOUR AU - Liu, H. AU - Song, G. AU - Zhou, L. AU - Hu, X. AU - Liu, M. AU - Nie, J. AU - Lu, S. AU - Wu, X. AU - Cao, Y. AU - Tao, L. AU - Chen, L. AU - Qian, L. DB - Embase Medline DO - 10.1159/000356586 IS - 5 LA - English M3 - Article N1 - L603692455 2015-04-17 2015-04-30 PY - 2013 SN - 1421-9778 1015-8987 SP - 1497-1508 ST - Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points T2 - Cellular Physiology and Biochemistry TI - Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603692455&from=export http://dx.doi.org/10.1159/000356586 VL - 32 ID - 2347 ER - TY - JOUR AU - Zhang, Q. AU - Xiao, Z. AU - He, F. AU - Zou, J. AU - Wu, S. AU - Liu, Z. DB - Embase Medline DO - 10.1159/000343750 IS - 2 LA - English M3 - Article N1 - L603917486 2015-04-27 2015-05-11 PY - 2013 SN - 1423-0100 0300-5526 SP - 104-113 ST - MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis T2 - Intervirology TI - MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603917486&from=export http://dx.doi.org/10.1159/000343750 VL - 56 ID - 2348 ER - TY - JOUR AD - E.A. Croonen, Department of Pediatrics, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen, Netherlands AU - Croonen, E. A. AU - Nillesen, W. AU - Schrander, C. AU - Jongmans, M. AU - Scheffer, H. AU - Noordam, C. AU - Draaisma, J. M. T. AU - Van Der Burgt, I. AU - Yntema, H. G. DB - Embase DO - 10.1159/000350686 IS - 5 LA - English M3 - Article N1 - L603918074 2015-04-27 2015-05-11 PY - 2013 SN - 1661-8777 1661-8769 SP - 227-234 ST - Noonan syndrome: Comparing mutation-positive with mutation-negative dutch patients T2 - Molecular Syndromology TI - Noonan syndrome: Comparing mutation-positive with mutation-negative dutch patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603918074&from=export http://dx.doi.org/10.1159/000350686 VL - 4 ID - 2349 ER - TY - JOUR AD - D.K. Graham, Department of Pediatrics, P18-4401, Mail Stop 8302, Aurora, CO, United States AU - Linger, R. M. A. AU - Lee-Sherick, A. B. AU - DeRyckere, D. AU - Cohen, R. A. AU - Jacobsen, K. M. AU - McGranahan, A. AU - Brandão, L. N. AU - Winges, A. AU - Sawczyn, K. K. AU - Liang, X. AU - Keating, A. K. AU - Tan, A. C. AU - Earp, H. S. AU - Graham, D. K. DB - Embase Medline DO - 10.1182/blood-2013-01-478156 IS - 9 LA - English M3 - Article N1 - L617279397 2017-07-18 2017-07-24 PY - 2013 SN - 1528-0020 0006-4971 SP - 1599-1609 ST - Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia T2 - Blood TI - Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617279397&from=export http://dx.doi.org/10.1182/blood-2013-01-478156 VL - 122 ID - 2350 ER - TY - JOUR AD - A. Quincozes-Santos, Department of Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil AU - Bobermin, L. D. AU - Quincozes-Santos, A. AU - Guerra, M. C. AU - Leite, M. C. AU - Souza, D. O. AU - Gonçalves, C. A. AU - Gottfried, C. C2 - Sigma(United States) DB - Embase Medline DO - 10.1371/journal.pone.0052164 IS - 12 L1 - internal-pdf://1884167637/journal.pone.0052164.PDF LA - English M3 - Article N1 - L366301817 2012-12-27 2013-01-09 PY - 2012 SN - 1932-6203 ST - Resveratrol Prevents Ammonia Toxicity in Astroglial Cells T2 - PLoS ONE TI - Resveratrol Prevents Ammonia Toxicity in Astroglial Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L366301817&from=export http://dx.doi.org/10.1371/journal.pone.0052164 VL - 7 ID - 2352 ER - TY - JOUR AD - K. Wuertz, Spine Research Group, Competence Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland AU - Klawitter, M. AU - Quero, L. AU - Klasen, J. AU - Gloess, A. N. AU - Klopprogge, B. AU - Hausmann, O. AU - Boos, N. AU - Wuertz, K. DB - Embase DO - 10.1186/1476-9255-9-29 LA - English M3 - Article N1 - L52174427 2012-08-24 2012-12-17 PY - 2012 SN - 1476-9255 ST - Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity T2 - Journal of Inflammation (United Kingdom) TI - Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52174427&from=export http://dx.doi.org/10.1186/1476-9255-9-29 VL - 9 ID - 2353 ER - TY - JOUR AD - Y. Sonobe, Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan AU - Parajuli, B. AU - Sonobe, Y. AU - Kawanokuchi, J. AU - Doi, Y. AU - Noda, M. AU - Takeuchi, H. AU - Mizuno, T. AU - Suzumura, A. DB - Embase Medline DO - 10.1186/1742-2094-9-268 LA - English M3 - Article N1 - L52356790 2012-12-20 2013-02-25 PY - 2012 SN - 1742-2094 ST - GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia T2 - Journal of Neuroinflammation TI - GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52356790&from=export http://dx.doi.org/10.1186/1742-2094-9-268 http://www.jneuroinflammation.com/content/9/1/268 VL - 9 ID - 2354 ER - TY - JOUR AD - N. Cobanoglu, Near East University, Department of Paediatric Pulmonology, Nicosia, Cyprus AU - Cobanoglu, N. DB - Embase Medline DO - 10.2174/1871523011202030210 IS - 3 LA - English M3 - Review N1 - L368919626 2013-05-22 2013-05-30 PY - 2012 SN - 1871-5230 1875-614X SP - 210-216 ST - Success of inhaled corticosteroids in the treatment of non-asthmatic respiratory diseases T2 - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry TI - Success of inhaled corticosteroids in the treatment of non-asthmatic respiratory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368919626&from=export http://dx.doi.org/10.2174/1871523011202030210 VL - 11 ID - 2355 ER - TY - JOUR AD - F. Correa, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, PO BOX 420, 405 30 Göteborg, Sweden AU - Correa, F. AU - Mallard, C. AU - Nilsson, M. AU - Sandberg, M. DB - Embase Medline DO - 10.1007/s11064-012-0878-y IS - 12 LA - English M3 - Article N1 - L52189805 2012-09-07 2013-01-10 PY - 2012 SN - 0364-3190 1573-6903 SP - 2842-2855 ST - Dual TNFα-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: Role of protein kinase activation T2 - Neurochemical Research TI - Dual TNFα-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: Role of protein kinase activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52189805&from=export http://dx.doi.org/10.1007/s11064-012-0878-y VL - 37 ID - 2356 ER - TY - JOUR AD - M. Kurdi, Department of Chemistry and Biochemistry, Lebanese University, Rafic Hariri Educational Campus, Hadath, Lebanon AU - Kurdi, M. AU - Sivakumaran, V. AU - Duhé, R. J. AU - Aon, M. A. AU - Paolocci, N. AU - Booz, G. W. DB - Embase Medline DO - 10.1016/j.biocel.2012.08.016 IS - 12 LA - English M3 - Article N1 - L52227880 2012-09-27 2012-11-26 PY - 2012 SN - 1357-2725 1878-5875 SP - 2106-2115 ST - Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes T2 - International Journal of Biochemistry and Cell Biology TI - Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52227880&from=export http://dx.doi.org/10.1016/j.biocel.2012.08.016 VL - 44 ID - 2357 ER - TY - JOUR AD - J. Zhang, Pediatrics, San Francisco, CA, United States AU - Zhang, J. AU - Hashizume, R. AU - Hariono, S. AU - Tom, M. AU - Sidhu, A. AU - James, C. D. AU - Weiss, W. AU - Nicolaides, T. DB - Embase DO - 10.1002/pbc.24295 IS - 6 LA - English M3 - Conference Abstract N1 - L70986119 2013-02-11 PY - 2012 SN - 1545-5009 SP - 1075 ST - Concurrent MEK and BRAF inhibition in BRAF-mutant pediatric astrocytomas: Increased efficacy with decreased risk of secondary malignancies T2 - Pediatric Blood and Cancer TI - Concurrent MEK and BRAF inhibition in BRAF-mutant pediatric astrocytomas: Increased efficacy with decreased risk of secondary malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70986119&from=export http://dx.doi.org/10.1002/pbc.24295 VL - 59 ID - 2358 ER - TY - JOUR AD - N. Kopp, Dana-Farber Cancer Institute, Boston, MA, United States AU - Kopp, N. AU - Ott, C. J. AU - Bird, L. AU - Paranal, R. AU - Qi, J. AU - Bowman, T. AU - Rodig, S. J. AU - Kung, A. L. AU - Bradner, J. E. AU - Weinstock, D. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70960919 2013-01-17 PY - 2012 SN - 0006-4971 ST - Bet bromodomain inhibition targets both C-MYC and IL7R in acute lymphoblastic leukemia T2 - Blood TI - Bet bromodomain inhibition targets both C-MYC and IL7R in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70960919&from=export http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/672?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=880&displaysectionid=Oral+Session&fdate=1/1/2012&tdate=12/31/2012&resourcetype=HWCIT VL - 120 ID - 2359 ER - TY - JOUR AD - M. Masselli, Experimental Pathology and Oncology, University of Florence, Florence, Italy AU - Masselli, M. AU - Pillozzi, S. AU - D'Amico, M. AU - Gasparoli, L. AU - Crociani, O. AU - Stefanini, M. AU - Mugridge, K. AU - Tiedke, W. AU - Becchetti, A. AU - Arcangeli, A. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70961946 2013-01-17 PY - 2012 SN - 0006-4971 ST - Identification of non-cardiotoxic hERG1 blockers to overcome chemoresistance in acute lymphoblastic leukemias T2 - Blood TI - Identification of non-cardiotoxic hERG1 blockers to overcome chemoresistance in acute lymphoblastic leukemias UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70961946&from=export http://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/1506?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=0&displaysectionid=Poster+Session&fdate=1/1/2012&tdate=12/31/2012&resourcetype=HWCIT VL - 120 ID - 2360 ER - TY - JOUR AD - L. Cai, Department of Orthopedics, Wuhan General Hospital of Guangzhou Command, Wuhan University, No. 169 Donghu Road, Wuhan, Hubei 430071, China AU - Hu, H. AU - Zhang, Y. AU - Cai, X. H. AU - Huang, J. F. AU - Cai, L. DB - Embase DO - 10.3892/ol.2012.866 IS - 5 LA - English M3 - Article N1 - L365624185 2012-09-19 2012-09-24 PY - 2012 SN - 1792-1074 1792-1082 SP - 1037-1042 ST - Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts T2 - Oncology Letters TI - Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365624185&from=export http://dx.doi.org/10.3892/ol.2012.866 http://www.spandidos-publications.com/serveFile/ol_4_5_1037_PDF.pdf?type=article&article_id=ol_4_5_1037&item=PDF VL - 4 ID - 2361 ER - TY - JOUR AD - K. Gomes, Centre for Children's Cancer and Blood Disorders, Sydney Children's Hospital, Randwick, Sydney, NSW, Australia AU - Gomes, K. AU - Sugo, E. AU - Barbaric, D. AU - Trahair, T. DB - Embase DO - 10.1111/ajco.12030 LA - English M3 - Conference Abstract N1 - L70911116 2012-11-06 PY - 2012 SN - 1743-7555 SP - 300 ST - Rapid regression of life threatening alk positive epithelioid inflammatory myofibroblastic sarcoma following single agent crizotinib therapy T2 - Asia-Pacific Journal of Clinical Oncology TI - Rapid regression of life threatening alk positive epithelioid inflammatory myofibroblastic sarcoma following single agent crizotinib therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70911116&from=export http://dx.doi.org/10.1111/ajco.12030 VL - 8 ID - 2362 ER - TY - JOUR AD - M. Llano, Centro Médico de los Andes, Colombia AU - Llano, M. DB - Embase LA - English M3 - Conference Abstract N1 - L70931677 2012-12-07 PY - 2012 SN - 1663-2818 SP - 32 ST - Rasopathies: Molecular entities with pediatric endocrine outcome? T2 - Hormone Research in Paediatrics TI - Rasopathies: Molecular entities with pediatric endocrine outcome? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70931677&from=export VL - 78 ID - 2363 ER - TY - JOUR AD - S. Murase, Laboratory of Molecular Biology, National Institute of Neurological Disorder and Stroke, Bethesda, MD 20892, United States AU - Murase, S. AU - Kim, E. AU - Lin, L. AU - Hoffman, D. A. AU - McKay, R. D. DB - Embase Medline DO - 10.1523/JNEUROSCI.2940-12.2012 IS - 44 LA - English M3 - Article N1 - L365951217 2012-11-07 2012-11-13 PY - 2012 SN - 0270-6474 1529-2401 SP - 15511-15520 ST - Loss of signal transducer and activator of transcription 3 (STAT3) signaling during elevated activity causes vulnerability in hippocampal neurons T2 - Journal of Neuroscience TI - Loss of signal transducer and activator of transcription 3 (STAT3) signaling during elevated activity causes vulnerability in hippocampal neurons UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365951217&from=export http://dx.doi.org/10.1523/JNEUROSCI.2940-12.2012 http://www.jneurosci.org/content/32/44/15511.full.pdf+html VL - 32 ID - 2364 ER - TY - JOUR AD - J. A. Martinez-Agosto, Division of Medical Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States AU - Chiang, J. AU - Martinez-Agosto, J. A. DB - Embase DO - 10.3390/cells1040886 IS - 4 L1 - internal-pdf://0776532036/cells-01-00886.pdf LA - English M3 - Article N1 - L368409405 2013-03-05 2013-06-04 PY - 2012 SN - 2073-4409 SP - 886-904 ST - Effects of mTOR inhibitors on components of the salvador-warts-hippo pathway T2 - Cells TI - Effects of mTOR inhibitors on components of the salvador-warts-hippo pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368409405&from=export http://dx.doi.org/10.3390/cells1040886 VL - 1 ID - 2365 ER - TY - JOUR AD - S.E. Dunn, Department of Pediatrics, Child and Family Research Institute, University of British Columbia, 950 West 28th Ave, Vancouver, BC, V5Z 4H4, Canada AU - Astanehe, A. AU - Finkbeiner, M. R. AU - Krzywinski, M. AU - Fotovati, A. AU - Dhillon, J. AU - Berquin, I. M. AU - Mills, G. B. AU - Marra, M. A. AU - Dunn, S. E. C1 - herceptin DB - Embase Medline DO - 10.1038/onc.2011.617 IS - 41 LA - English M3 - Article N1 - L51815436 2012-01-18 2012-10-26 PY - 2012 SN - 0950-9232 1476-5594 SP - 4434-4446 ST - MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition T2 - Oncogene TI - MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51815436&from=export http://dx.doi.org/10.1038/onc.2011.617 VL - 31 ID - 2366 ER - TY - JOUR AD - S. Krishnakumar, Department of Ocular pathology, Vision Research Foundation, Sankara Nethralaya, 41, College Road, Chennai, 600006, India AU - Venkatesan, N. AU - Krishnakumar, S. AU - Deepa, P. R. AU - Deepa, M. AU - Khetan, V. AU - Ashwin Reddy, M. DB - Embase Medline LA - English M3 - Article N1 - L365863419 2012-10-24 2012-11-02 PY - 2012 SN - 1090-0535 SP - 2420-2437 ST - Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells T2 - Molecular Vision TI - Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365863419&from=export http://www.molvis.org/molvis/v18/a255 VL - 18 ID - 2367 ER - TY - JOUR AD - Y. Luo, National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing, China AU - Zhuo, W. AU - Jia, L. AU - Song, N. AU - Lu, X. A. AU - Ding, Y. AU - Wang, X. AU - Song, X. AU - Fu, Y. AU - Luo, Y. DB - Embase Medline DO - 10.1158/1078-0432.CCR-12-0708 IS - 19 LA - English M3 - Article N1 - L365754128 2012-10-09 2012-10-15 PY - 2012 SN - 1078-0432 1557-3265 SP - 5387-5398 ST - The CXCL12 -CXCR4 chemokine pathway: A novel axis regulates lymphangiogenesis T2 - Clinical Cancer Research TI - The CXCL12 -CXCR4 chemokine pathway: A novel axis regulates lymphangiogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365754128&from=export http://dx.doi.org/10.1158/1078-0432.CCR-12-0708 http://clincancerres.aacrjournals.org/content/18/19/5387.full.pdf+html VL - 18 ID - 2368 ER - TY - JOUR AD - P. A. Jänne, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, HIM 223, Boston,MA 02215, United States AU - Ercan, D. AU - Xu, C. AU - Yanagita, M. AU - Monast, C. S. AU - Pratilas, C. A. AU - Montero, J. AU - Butaney, M. AU - Shimamura, T. AU - Sholl, L. AU - Ivanova, E. V. AU - Tadi, M. AU - Rogers, A. AU - Repellin, C. AU - Capelletti, M. AU - Maertens, O. AU - Goetz, E. M. AU - Letai, A. AU - Garraway, L. A. AU - Lazzara, M. J. AU - Rosen, N. AU - Gray, N. S. AU - Wong, K. K. AU - Jänne, P. A. C1 - ci 1040(Selleck) gsk 1120212(Haoyuan Chemexpress) mk 2206(Selleck) C2 - Haoyuan Chemexpress Selleck DB - Embase Medline DO - 0.1158/2159-8290.CD-12-0103 IS - 10 LA - English M3 - Article N1 - L365940012 2012-11-06 2012-11-12 PY - 2012 SN - 2159-8274 2159-8290 SP - 934-947 ST - Reactivation of ERK signaling causes resistance to EGFR Kinase inhibitors T2 - Cancer Discovery TI - Reactivation of ERK signaling causes resistance to EGFR Kinase inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365940012&from=export http://dx.doi.org/0.1158/2159-8290.CD-12-0103 http://cancerdiscovery.aacrjournals.org/content/2/10/934.full.pdf+html VL - 2 ID - 2369 ER - TY - JOUR AD - M.A. Karajannis, NYU Langone Medical Center, New York, NY, United States AU - Karajannis, M. A. AU - Fisher, M. J. AU - Milla, S. S. AU - Cohen, K. J. AU - Legault, G. AU - Wisoff, J. H. AU - Harter, D. H. AU - Hartnett, E. AU - Merkelson, A. AU - Bloom, M. C. AU - Dhall, G. AU - Jones, D. AU - Korshunov, A. AU - Pfister, S. AU - Eberhart, C. G. AU - Zagzag, D. AU - Allen, J. C. DB - Embase DO - 10.1093/neuonc/nos232 LA - English M3 - Conference Abstract N1 - L70929624 2012-11-29 PY - 2012 SN - 1522-8517 SP - vi101 ST - Phase II study of sorafenib in children with recurrent/progressive low-grade astrocytomas T2 - Neuro-Oncology TI - Phase II study of sorafenib in children with recurrent/progressive low-grade astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70929624&from=export http://dx.doi.org/10.1093/neuonc/nos232 VL - 14 ID - 2370 ER - TY - JOUR AD - C. Caloisi, Pediatric Department, L'Aquila University, Italy AU - Caloisi, C. AU - Maiorani, D. AU - Gentile, T. DB - Embase LA - English M3 - Conference Abstract N1 - L71690795 2014-12-01 PY - 2012 SN - 1590-8658 SP - S270 ST - Celiac disease and noonan syndrome: Case report T2 - Digestive and Liver Disease TI - Celiac disease and noonan syndrome: Case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71690795&from=export VL - 44 ID - 2371 ER - TY - JOUR AD - D.A. Stevenson, University of Utah, Division of Medical Genetics, 2C412 SOM, Salt Lake City, UT 84132, United States AU - Stevenson, D. A. AU - Allen, S. AU - Tidyman, W. E. AU - Carey, J. C. AU - Viskochil, D. H. AU - Stevens, A. AU - Hanson, H. AU - Sheng, X. AU - Thompson, B. A. AU - J. Okumura, M. AU - Reinker, K. AU - Johnson, B. AU - Rauen, K. A. DB - Embase Medline DO - 10.1002/mus.23324 IS - 3 LA - English M3 - Article N1 - L365498347 2012-08-31 2012-09-05 PY - 2012 SN - 0148-639X 1097-4598 SP - 394-399 ST - Peripheral muscle weakness in RASopathies T2 - Muscle and Nerve TI - Peripheral muscle weakness in RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365498347&from=export http://dx.doi.org/10.1002/mus.23324 VL - 46 ID - 2372 ER - TY - JOUR AD - N.L. Bartlett, Division of Oncology, School of Medicine, Washington University, 660 South Euclid Ave, St Louis, MO 63110, United States AU - Foyil, K. V. AU - Bartlett, N. L. C1 - adcetris(Seattle Genetics,United States) pf 02341066(Pfizer,United States) sgn 35(Seattle Genetics,United States) xalkori(Pfizer,United States) C2 - Pfizer(United States) Seattle Genetics(United States) DB - Embase Medline DO - 10.1097/PPO.0b013e31826aef4a IS - 5 LA - English M3 - Review N1 - L365749842 2012-10-09 2012-10-15 PY - 2012 SN - 1528-9117 1540-336X SP - 450-456 ST - Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma T2 - Cancer Journal (United States) TI - Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365749842&from=export http://dx.doi.org/10.1097/PPO.0b013e31826aef4a VL - 18 ID - 2373 ER - TY - JOUR AD - K. Ichimura, Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan AU - Ichimura, K. AU - Nishikawa, R. AU - Matsutani, M. DB - Embase Medline DO - 10.1093/neuonc/nos204 IS - SUPPL.4 LA - English M3 - Article N1 - L365938486 2012-11-06 2012-11-08 PY - 2012 SN - 1522-8517 1523-5866 SP - iv90-iv99 ST - Molecular markers in pediatric neuro-oncology T2 - Neuro-Oncology TI - Molecular markers in pediatric neuro-oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365938486&from=export http://dx.doi.org/10.1093/neuonc/nos204 VL - 14 ID - 2374 ER - TY - JOUR AD - I. Oschlies, Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospitals Schleswig-Holstein, Germany AU - Oschlies, I. AU - Lisfeld, J. AU - Lamant, L. AU - Nakazawa, A. AU - D'Amore, E. S. G. AU - Hansson, U. AU - Hebeda, K. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Muellauer, L. AU - Tinguely, M. AU - Stuecker, M. AU - LeDeley, M. C. AU - Siebert, R. AU - Reiter, A. AU - Brugieres, L. AU - Klapper, W. AU - Wössmann, W. DB - Embase DO - 10.1007/s12308-012-0160-x IS - 3 LA - English M3 - Conference Abstract N1 - L622416349 2018-06-06 PY - 2012 SN - 1865-5785 SP - 219-220 ST - ALK-positive anaplastic large cell lymphoma limited to the skin: Clinical, histopathological and molecular analysis of 6 pediatric cases-a report from the ALCL99 study T2 - Journal of Hematopathology TI - ALK-positive anaplastic large cell lymphoma limited to the skin: Clinical, histopathological and molecular analysis of 6 pediatric cases-a report from the ALCL99 study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622416349&from=export http://dx.doi.org/10.1007/s12308-012-0160-x VL - 5 ID - 2375 ER - TY - JOUR AD - S. Gieseler, Medical Faculty of Otto-von-Guericke, University Magdeburg, Experimental Pediatrics, Magdeburg, Germany AU - Gieseler, S. AU - Mertens, P. R. AU - Brunner-Weinzierl, M. C. DB - Embase DO - 10.1111/imm.12002 LA - English M3 - Conference Abstract N1 - L70945914 2012-12-21 PY - 2012 SN - 0019-2805 SP - 486 ST - The cold-shock protein YB-1 controls T-cell proliferation and survival T2 - Immunology TI - The cold-shock protein YB-1 controls T-cell proliferation and survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70945914&from=export http://dx.doi.org/10.1111/imm.12002 VL - 137 ID - 2376 ER - TY - JOUR AD - J. Badaut, Departments of Physiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, United States AU - Berezowski, V. AU - Fukuda, A. M. AU - Cecchelli, R. AU - Badaut, J. DB - Embase DO - 10.1155/2012/176287 LA - English M3 - Review N1 - L365425132 2012-08-21 2012-08-24 PY - 2012 SN - 1687-8876 1687-8884 ST - Endothelial cells and astrocytes: A concerto en duo in ischemic pathophysiology T2 - International Journal of Cell Biology TI - Endothelial cells and astrocytes: A concerto en duo in ischemic pathophysiology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365425132&from=export http://dx.doi.org/10.1155/2012/176287 ID - 2377 ER - TY - JOUR AD - H. M. Hermanns, The Rudolf-Virchow-Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany AU - Drechsler, J. AU - Grötzinger, J. AU - Hermanns, H. M. DB - Embase Medline DO - 10.1371/journal.pone.0043155 IS - 8 L1 - internal-pdf://0620145550/journal.pone.0043155.PDF LA - English M3 - Article N1 - L365470682 2012-08-28 2012-09-04 PY - 2012 SN - 1932-6203 ST - Characterization of the rat oncostatin m receptor complex which resembles the human, but differs from the murine cytokine receptor T2 - PLoS ONE TI - Characterization of the rat oncostatin m receptor complex which resembles the human, but differs from the murine cytokine receptor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365470682&from=export http://dx.doi.org/10.1371/journal.pone.0043155 VL - 7 ID - 2378 ER - TY - JOUR AD - N. Gross, Pediatric Oncology Research Unit, Department of Pediatrics, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland AU - Liberman, J. AU - Sartelet, H. AU - Flahaut, M. AU - Mühlethaler-Mottet, A. AU - Coulon, A. AU - Nyalendo, C. AU - Vassal, G. AU - Joseph, J. M. AU - Gross, N. DB - Embase Medline DO - 10.1371/journal.pone.0043665 IS - 8 L1 - internal-pdf://2554970779/journal.pone.0043665.PDF LA - English M3 - Article N1 - L365470319 2012-08-28 2012-09-07 PY - 2012 SN - 1932-6203 ST - Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma T2 - PLoS ONE TI - Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365470319&from=export http://dx.doi.org/10.1371/journal.pone.0043665 VL - 7 ID - 2379 ER - TY - JOUR AD - Y. Zhu, Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, United States AU - Wang, Y. AU - Kim, E. AU - Wang, X. AU - Novitch, B. G. AU - Yoshikawa, K. AU - Chang, L. S. AU - Zhu, Y. DB - Embase Medline DO - 10.1016/j.cell.2012.06.034 IS - 4 LA - English M3 - Article N1 - L365479289 2012-08-29 2012-09-03 PY - 2012 SN - 0092-8674 1097-4172 SP - 816-830 ST - ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities T2 - Cell TI - ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365479289&from=export http://dx.doi.org/10.1016/j.cell.2012.06.034 VL - 150 ID - 2380 ER - TY - JOUR AD - N. Federman, Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States AU - Anderson, J. L. AU - Denny, C. T. AU - Tap, W. D. AU - Federman, N. C1 - amg 655 arq 197 cp 751871 g 3139 gleevec imc 3g3 imc a 12 imc c 225 mln 8237 pci 24781 pf 02341066 r 1507 rad 001 sb 939 DB - Embase Medline DO - 10.1038/pr.2012.54 IS - 2 LA - English M3 - Review N1 - L365329139 2012-08-03 2012-08-13 PY - 2012 SN - 0031-3998 1530-0447 SP - 112-121 ST - Pediatric sarcomas: Translating molecular pathogenesis of disease to novel therapeutic possibilities T2 - Pediatric Research TI - Pediatric sarcomas: Translating molecular pathogenesis of disease to novel therapeutic possibilities UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365329139&from=export http://dx.doi.org/10.1038/pr.2012.54 VL - 72 ID - 2381 ER - TY - JOUR AD - G. Fond, Service Universitaire de Psychiatrie Adulte (Pr JP. Boulenger), Hôpital la Colombiere, CHU Montpellier, 39, avenue Charles Flahault 34295, Montpellier cedex 05, France AU - Fond, G. AU - MacGregor, A. AU - Attal, J. AU - Larue, A. AU - Brittner, M. AU - Ducasse, D. AU - Capdevielle, D. DB - Embase Medline DO - 10.1111/j.1440-1819.2012.02359.x IS - 5 LA - English M3 - Review N1 - L365337124 2012-08-07 2012-08-09 PY - 2012 SN - 1323-1316 1440-1819 SP - 375-382 ST - Treating patients with schizophrenia deficit with erythropoietin? T2 - Psychiatry and Clinical Neurosciences TI - Treating patients with schizophrenia deficit with erythropoietin? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365337124&from=export http://dx.doi.org/10.1111/j.1440-1819.2012.02359.x VL - 66 ID - 2382 ER - TY - JOUR AD - M. Maggiolini, Department of Pharmaco-Biology, University of Calabria, 87036 Rende, Italy AU - Pupo, M. AU - Pisano, A. AU - Lappano, R. AU - Santolla, M. F. AU - de Francesco, E. M. AU - Abonante, S. AU - Rosano, C. AU - Maggiolini, M. DB - Embase Medline DO - 10.1289/ehp.1104526 IS - 8 L1 - internal-pdf://0711845894/fetchObjectAttachment.action.txt LA - English M3 - Article N1 - L365366901 2012-08-10 2012-08-15 PY - 2012 SN - 0091-6765 1552-9924 SP - 1177-1182 ST - Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts T2 - Environmental Health Perspectives TI - Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365366901&from=export http://dx.doi.org/10.1289/ehp.1104526 VL - 120 ID - 2383 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3V5, Canada AU - Cheng, J. C. AU - Chang, H. M. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1210/jc.2011-2751 IS - 8 LA - English M3 - Article N1 - L365401991 2012-08-16 2012-09-06 PY - 2012 SN - 0021-972X 1945-7197 SP - E1380-E1389 ST - Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression T2 - Journal of Clinical Endocrinology and Metabolism TI - Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365401991&from=export http://dx.doi.org/10.1210/jc.2011-2751 http://jcem.endojournals.org/content/97/8/E1380.full.pdf+html VL - 97 ID - 2384 ER - TY - JOUR AD - J.-G. Lü, Department of Cardiovascular Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China AU - Qu, W. S. AU - Tian, D. S. AU - Guo, Z. B. AU - Fang, J. AU - Zhang, Q. AU - Yu, Z. Y. AU - Xie, M. J. AU - Zhang, H. Q. AU - Lü, J. G. AU - Wang, W. C1 - ag 1478 c 225 sb 203580 sp 600125 u 0126 DB - Embase Medline DO - 10.1186/1742-2094-9-178 LA - English M3 - Article N1 - L365472167 2012-08-28 2020-07-28 PY - 2012 SN - 1742-2094 ST - Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury T2 - Journal of Neuroinflammation TI - Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365472167&from=export http://dx.doi.org/10.1186/1742-2094-9-178 VL - 9 ID - 2385 ER - TY - JOUR AD - Q.-Y. Wu, Heart Center, First Hospital of Tsinghua University, Beijing 100016, China AU - Zhang, H. S. AU - Wu, Q. Y. AU - Xu, M. AU - Zhou, Y. X. AU - Shui, C. X. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2012.13.001 IS - 13 LA - English M3 - Article N1 - L365240035 2012-07-20 2012-08-06 PY - 2012 SN - 0366-6999 SP - 2243-2249 ST - Mitogen-activated protein kinase signal pathways play an important role in right ventricular hypertrophy of tetralogy of Fallot T2 - Chinese Medical Journal TI - Mitogen-activated protein kinase signal pathways play an important role in right ventricular hypertrophy of tetralogy of Fallot UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365240035&from=export http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2012.13.001 http://www.cmj.org/Periodical/PdfList.asp?id=CMJLW201273383785202457 VL - 125 ID - 2386 ER - TY - JOUR AD - N. Kanazawa, Department of Dermatology, Wakayama Medical University, Wakayama 641-0012, Japan AU - Kanazawa, N. DB - Embase Medline DO - 10.2332/allergolint.11-RAI-0416 IS - 2 L1 - internal-pdf://4120871629/61_11-OA-0385.pdf LA - English M3 - Article N1 - L365065764 2012-06-29 2012-07-05 PY - 2012 SN - 1323-8930 1440-1592 SP - 197-206 ST - Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy T2 - Allergology International TI - Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365065764&from=export http://dx.doi.org/10.2332/allergolint.11-RAI-0416 VL - 61 ID - 2387 ER - TY - JOUR AD - E.E. Patton, Institute for Genetics and Molecular Medicine, Edinburgh University, Western General Hospital Campus, Crewe Road South, EH4 2XR, United Kingdom AU - Anastasaki, C. AU - Rauen, K. A. AU - Patton, E. E. C1 - pd 0325901 DB - Embase Medline DO - 10.1242/dmm.008672 IS - 4 LA - English M3 - Article N1 - L365162312 2012-07-11 2012-07-17 PY - 2012 SN - 1754-8403 1754-8411 SP - 546-552 ST - Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish T2 - DMM Disease Models and Mechanisms TI - Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365162312&from=export http://dx.doi.org/10.1242/dmm.008672 http://dmm.biologists.org/content/5/4/546.full.pdf+html VL - 5 ID - 2388 ER - TY - JOUR AD - F.S. Ong, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States AU - Ong, F. S. AU - Das, K. AU - Wang, J. AU - Vakil, H. AU - Kuo, J. Z. AU - Blackwell, W. L. B. AU - Lim, S. W. AU - Goodarzi, M. O. AU - Bernstein, K. E. AU - Rotter, J. I. AU - Grody, W. W. DB - Embase Medline DO - 10.1586/erm.12.59 IS - 6 LA - English M3 - Review N1 - L365379001 2012-08-14 2012-08-21 PY - 2012 SN - 1473-7159 1744-8352 SP - 593-602 ST - Personalized medicine and pharmacogenetic biomarkers: Progress in molecular oncology testing T2 - Expert Review of Molecular Diagnostics TI - Personalized medicine and pharmacogenetic biomarkers: Progress in molecular oncology testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365379001&from=export http://dx.doi.org/10.1586/erm.12.59 VL - 12 ID - 2390 ER - TY - JOUR AD - D.S. Morrell, UNC Dermatology and Skin Cancer Center, 401 Market Street, Chapel Hill, NC 27516, United States AU - Ju, E. AU - Adigun, C. AU - Dunphy, C. AU - Gold, S. AU - Morrell, D. S. DB - Embase Medline DO - 10.1111/j.1525-1470.2011.01465.x IS - 4 LA - English M3 - Article N1 - L51655382 2011-10-10 2012-07-18 PY - 2012 SN - 0736-8046 1525-1470 SP - 498-503 ST - Anaplastic large cell lymphoma: An unusual presentation in a 7-year-old girl T2 - Pediatric Dermatology TI - Anaplastic large cell lymphoma: An unusual presentation in a 7-year-old girl UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51655382&from=export http://dx.doi.org/10.1111/j.1525-1470.2011.01465.x VL - 29 ID - 2391 ER - TY - JOUR AD - J.H. Kim, Seoul National University and Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744, South Korea AU - Jo, D. H. AU - Kim, J. H. AU - Yu, Y. S. AU - Lee, T. G. AU - Kim, J. H. DB - Embase Medline DO - 10.1016/j.nano.2011.09.003 IS - 5 LA - English M3 - Article N1 - L51695363 2011-11-04 2012-07-05 PY - 2012 SN - 1549-9634 1549-9642 SP - 784-791 ST - Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor T2 - Nanomedicine: Nanotechnology, Biology, and Medicine TI - Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51695363&from=export http://dx.doi.org/10.1016/j.nano.2011.09.003 VL - 8 ID - 2392 ER - TY - JOUR AD - A.L. Feldman, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States AU - Sciallis, A. P. AU - Law, M. E. AU - Inwards, D. J. AU - McClure, R. F. AU - MacOn, W. R. AU - Kurtin, P. J. AU - Dogan, A. AU - Feldman, A. L. DB - Embase Medline DO - 10.1038/modpathol.2012.38 IS - 7 LA - English M3 - Article N1 - L51893168 2012-03-07 2012-07-15 PY - 2012 SN - 0893-3952 1530-0285 SP - 983-992 ST - Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders T2 - Modern Pathology TI - Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51893168&from=export http://dx.doi.org/10.1038/modpathol.2012.38 VL - 25 ID - 2394 ER - TY - JOUR AD - J. Romero, Laboratorio de Apoyo A la Investigación, Hospital Universitario Fundación Alcorcón, Alcorcón, 28922 Madrid, Spain AU - Benito, C. AU - Tolõn, R. M. AU - Castillo, A. I. AU - Ruiz-Valdepeñas, L. AU - Martínez-Orgado, J. A. AU - Fernández-Sánchez, F. J. AU - Vázquez, C. AU - Cravatt, B. F. AU - Romero, J. DB - Embase Medline DO - 10.1111/j.1476-5381.2012.01889.x IS - 4 LA - English M3 - Article N1 - L364856389 2012-05-30 2012-06-06 PY - 2012 SN - 0007-1188 1476-5381 SP - 1474-1489 ST - β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors T2 - British Journal of Pharmacology TI - β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364856389&from=export http://dx.doi.org/10.1111/j.1476-5381.2012.01889.x VL - 166 ID - 2395 ER - TY - JOUR AD - J.G. Rheinwald, BWH Dermatology, HIM 664, 77 Avenue Louis Pasteur, Boston, MA 02115, United States AU - Degen, M. AU - Natarajan, E. AU - Barron, P. AU - Widlund, H. R. AU - Rheinwald, J. G. DB - Embase Medline DO - 10.1016/j.ajpath.2012.02.028 IS - 6 LA - English M3 - Article N1 - L364909551 2012-06-07 2012-06-15 PY - 2012 SN - 0002-9440 1525-2191 SP - 2462-2478 ST - MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma T2 - American Journal of Pathology TI - MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364909551&from=export http://dx.doi.org/10.1016/j.ajpath.2012.02.028 VL - 180 ID - 2396 ER - TY - JOUR AD - P. Bonvini, Pediatric Onco-Hematology Clinic, University Hospital Padova, Via Giustiniani 3, 35100 Padova, Italy AU - Bonvini, P. AU - Zorzi, E. AU - Mussolin, L. AU - Pillon, M. AU - Romualdi, C. AU - Peron, M. AU - D'Amore, E. S. G. AU - Lamant, L. AU - Rosolen, A. C1 - whi p 154 DB - Embase Medline DO - 10.1038/leu.2011.367 IS - 6 LA - English M3 - Article N1 - L364976304 2012-06-19 2012-06-22 PY - 2012 SN - 0887-6924 1476-5551 SP - 1375-1382 ST - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30 NPM-ALK anaplastic large-cell lymphomas T2 - Leukemia TI - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30 NPM-ALK anaplastic large-cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364976304&from=export http://dx.doi.org/10.1038/leu.2011.367 VL - 26 ID - 2397 ER - TY - JOUR AD - S.-J. Kim, Seoul National University Hospital, Seoul, South Korea AU - Kim, S. J. AU - Kim, D. W. AU - Kim, T. M. AU - Lee, S. H. AU - Heo, D. S. AU - Bang, Y. J. DB - Embase Medline DO - 10.1200/JCO.2011.39.9766 IS - 16 LA - English M3 - Article N1 - L365265679 2012-07-25 2012-07-31 PY - 2012 SN - 0732-183X 1527-7755 SP - e147-e150 ST - Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer T2 - Journal of Clinical Oncology TI - Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365265679&from=export http://dx.doi.org/10.1200/JCO.2011.39.9766 http://jco.ascopubs.org/content/30/16/e147.full.pdf+html VL - 30 ID - 2398 ER - TY - JOUR AD - X.-J. Qu, Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, China AU - Xue, X. AU - Sun, D. F. AU - Sun, C. C. AU - Liu, H. P. AU - Yue, B. AU - Zhao, C. R. AU - Lou, H. X. AU - Qu, X. J. DB - Embase Medline DO - 10.1016/j.lungcan.2011.12.013 IS - 3 LA - English M3 - Article N1 - L51816947 2012-01-19 2012-05-16 PY - 2012 SN - 0169-5002 1872-8332 SP - 300-308 ST - Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies T2 - Lung Cancer TI - Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51816947&from=export http://dx.doi.org/10.1016/j.lungcan.2011.12.013 VL - 76 ID - 2399 ER - TY - JOUR AD - N. Ali, Department of Cardiology, Royal Children's Hospital, Flemington Road, Parkville, VIC 3052, Australia AU - Ali, N. AU - Konstantinov, I. AU - Heath, J. A. AU - Bhagwat, K. AU - Cheung, M. DB - Embase Medline DO - 10.1007/s00246-012-0230-y IS - 5 LA - English M3 - Article N1 - L51859468 2012-02-21 2012-07-31 PY - 2012 SN - 0172-0643 1432-1971 SP - 843-845 ST - Nonbacterial thrombotic endocarditis in a child with non-hodgkin's lymphoma T2 - Pediatric Cardiology TI - Nonbacterial thrombotic endocarditis in a child with non-hodgkin's lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51859468&from=export http://dx.doi.org/10.1007/s00246-012-0230-y VL - 33 ID - 2400 ER - TY - JOUR AD - X. Lu, Department of Geriatrics, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210011, China AU - Yuan, Q. AU - Yang, H. AU - Cheng, C. AU - Li, C. AU - Wu, X. AU - Huan, W. AU - Sun, H. AU - Zhou, Z. AU - Wang, Y. AU - Zhao, Y. AU - Lu, X. AU - Shen, A. DB - Embase Medline DO - 10.1007/s11010-012-1254-6 IS - 1-2 LA - English M3 - Article N1 - L51876293 2012-02-27 2012-05-08 PY - 2012 SN - 0300-8177 1573-4919 SP - 149-158 ST - β-1,4-Galactosyltransferase i involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways T2 - Molecular and Cellular Biochemistry TI - β-1,4-Galactosyltransferase i involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51876293&from=export http://dx.doi.org/10.1007/s11010-012-1254-6 VL - 365 ID - 2401 ER - TY - JOUR AD - T. Kamijo, Division of Biochemistry and Molecular Carcinogenesis, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Chiba 260-8717, Japan AU - Kamijo, T. AU - Nakagawara, A. DB - Embase Medline DO - 10.1007/s10147-012-0415-7 IS - 3 LA - English M3 - Review N1 - L52012382 2012-05-18 2012-07-12 PY - 2012 SN - 1341-9625 1437-7772 SP - 190-195 ST - Molecular and genetic bases of neuroblastoma T2 - International Journal of Clinical Oncology TI - Molecular and genetic bases of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52012382&from=export http://dx.doi.org/10.1007/s10147-012-0415-7 VL - 17 ID - 2402 ER - TY - JOUR AD - J.A. Fahrner, McKusick-Nathans Institute of Genetic Medicine, 600 N. Wolfe St., Blalock 1008, Baltimore, MD 21287, United States AU - Fahrner, J. A. AU - Frazier, A. AU - Bachir, S. AU - Walsh, M. F. AU - Applegate, C. D. AU - Thompson, R. AU - Halushka, M. K. AU - Murphy, A. M. AU - Gunay-Aygun, M. DB - Embase Medline DO - 10.1002/ajmg.a.35363 IS - 6 LA - English M3 - Article N1 - L52013244 2012-05-18 2012-05-31 PY - 2012 SN - 1552-4825 1552-4833 SP - 1414-1421 ST - A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1 T2 - American Journal of Medical Genetics, Part A TI - A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52013244&from=export http://dx.doi.org/10.1002/ajmg.a.35363 VL - 158 A ID - 2403 ER - TY - JOUR AD - H.Y. Lim AU - Lim, H. Y. AU - Yen, C. J. AU - Tak, W. Y. AU - Heo, J. AU - Choi, H. J. AU - Lin, C. Y. AU - Yoon, J. H. AU - Hsu, C. AU - Rau, K. M. AU - Ping Poon, R. T. AU - Yeo, W. AU - Park, J. W. AU - Tay, M. H. AU - Hsieh, W. S. AU - Kappeler, C. AU - Rajagopalan, P. AU - Krissel, H. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71003872 2013-03-08 PY - 2012 SN - 0732-183X ST - A phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC) T2 - Journal of Clinical Oncology TI - A phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71003872&from=export http://meeting.ascopubs.org/cgi/content/abstract/30/15_suppl/4103?sid=3beffa44-7c95-44cc-99bb-073fc0df7598 VL - 30 ID - 2404 ER - TY - JOUR AD - Y.P. Mosse AU - Mosse, Y. P. AU - Balis, F. M. AU - Lim, M. S. AU - Laliberte, J. AU - Voss, S. D. AU - Fox, E. AU - Bagatell, R. AU - Weigel, B. AU - Adamson, P. C. AU - Ingle, A. M. AU - Ahern, C. H. AU - Blaney, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71005095 2013-03-08 PY - 2012 SN - 0732-183X ST - Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study T2 - Journal of Clinical Oncology TI - Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71005095&from=export http://meeting.ascopubs.org/cgi/content/abstract/30/15_suppl/9500?sid=43ece5a8-cdf8-4d8c-9686-ddebd9604458 VL - 30 ID - 2405 ER - TY - JOUR AD - C.J. Thiele, National Cancer Institute, CRC, 1W-3940, MSC-1105, 10 Center Drive, Bethesda, MD 20892, United States AU - Thiele, C. J. AU - Cohn, S. L. C1 - gleevac(Novartis) C2 - Novartis DB - Embase Medline DO - 10.1158/1078-0432.CCR-11-1940 IS - 10 LA - English M3 - Review N1 - L364826423 2012-05-24 2012-05-30 PY - 2012 SN - 1078-0432 1557-3265 SP - 2735-2739 ST - Genetically informed therapies-a "gift" for children with cancer T2 - Clinical Cancer Research TI - Genetically informed therapies-a "gift" for children with cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364826423&from=export http://dx.doi.org/10.1158/1078-0432.CCR-11-1940 http://clincancerres.aacrjournals.org/content/18/10/2735.full.pdf+html VL - 18 ID - 2406 ER - TY - JOUR AD - X. Wan, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University, No. 910, Hengshan Road, Shanghai 200030, China AU - Wu, X. AU - Yan, Q. AU - Zhang, Z. AU - Du, G. AU - Wan, X. C1 - Acrp 30(PeproTech,United States) C2 - PeproTech(United States) DB - Embase Medline DO - 10.3892/oror.2012.1670 IS - 5 LA - English M3 - Article N1 - L364429022 2012-03-21 2012-03-27 PY - 2012 SN - 1021-335X 1791-2431 SP - 1488-1496 ST - Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells T2 - Oncology Reports TI - Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364429022&from=export http://dx.doi.org/10.3892/oror.2012.1670 http://www.spandidos-publications.com/serveFile/or_27_5_1488_PDF.pdf?type=article&article_id=or_27_5_1488&item=PDF VL - 27 ID - 2408 ER - TY - JOUR AD - J.B. Aragon-Ching, Division of Hematology and Oncology, Department of Medicine, George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, Washington, DC 20037, United States AU - Aragon-Ching, J. B. AU - Maki, R. G. C1 - et 743 yondelis DB - Embase Medline DO - 10.3109/07357907.2012.658936 IS - 4 LA - English M3 - Article N1 - L364675375 2012-05-07 PY - 2012 SN - 0735-7907 1532-4192 SP - 300-308 ST - Treatment of adult soft tissue sarcoma: Old concepts, new insights, and potential for drug discovery T2 - Cancer Investigation TI - Treatment of adult soft tissue sarcoma: Old concepts, new insights, and potential for drug discovery UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364675375&from=export http://dx.doi.org/10.3109/07357907.2012.658936 VL - 30 ID - 2409 ER - TY - JOUR AD - K. Svojgr, CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 150 06, Prague 5, Czech Republic AU - Svojgr, K. AU - Kalina, T. AU - Kanderova, V. AU - Skopcova, T. AU - Brdicka, T. AU - Zuna, J. DB - Embase Medline DO - 10.1016/j.exphem.2012.01.011 IS - 5 LA - English M3 - Article N1 - L51868268 2012-02-27 2012-04-25 PY - 2012 SN - 0301-472X 1873-2399 SP - 379-385 ST - The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL T2 - Experimental Hematology TI - The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51868268&from=export http://dx.doi.org/10.1016/j.exphem.2012.01.011 VL - 40 ID - 2410 ER - TY - JOUR AD - E.M. Kwon, Dermatology, Medical College of Wisconsin, Milwaukee, WI, United States AU - Kwon, E. M. AU - Rosen, A. H. AU - Paller, A. S. AU - Siegel, D. H. DB - Embase DO - 10.1038/jid.2012.84 LA - English M3 - Conference Abstract N1 - L70730959 2012-05-07 PY - 2012 SN - 0022-202X SP - S67 ST - Progressive ectodermal phenotype of costello syndrome T2 - Journal of Investigative Dermatology TI - Progressive ectodermal phenotype of costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70730959&from=export http://dx.doi.org/10.1038/jid.2012.84 VL - 132 ID - 2411 ER - TY - JOUR AD - W. Pao, Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, United States AU - Lovly, C. M. AU - Dahlman, K. B. AU - Fohn, L. E. AU - Su, Z. AU - Dias-Santagata, D. AU - Hicks, D. J. AU - Hucks, D. AU - Berry, E. AU - Terry, C. AU - Duke, M. AU - Su, Y. AU - Sobolik-Delmaire, T. AU - Richmond, A. AU - Kelley, M. C. AU - Vnencak-Jones, C. L. AU - Iafrate, A. J. AU - Sosman, J. AU - Pao, W. DB - Embase Medline DO - 10.1371/journal.pone.0035309 IS - 4 L1 - internal-pdf://3620197421/journal.pone.0035309.PDF LA - English M3 - Article N1 - L364661823 2012-05-07 PY - 2012 SN - 1932-6203 ST - Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials T2 - PLoS ONE TI - Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364661823&from=export http://dx.doi.org/10.1371/journal.pone.0035309 VL - 7 ID - 2412 ER - TY - JOUR AD - W.C. Chan, Center for Research in Lymphoma and Leukemia, Department of Pathology and Microbiology, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, United States AU - Deffenbacher, K. E. AU - Iqbal, J. AU - Sanger, W. AU - Shen, Y. AU - Lachel, C. AU - Liu, Z. AU - Liu, Y. AU - Lim, M. S. AU - Perkins, S. L. AU - Fu, K. AU - Smith, L. AU - Lynch, J. AU - Staudt, L. M. AU - Rimsza, L. M. AU - Jaffe, E. AU - Rosenwald, A. AU - Ott, G. K. AU - Delabie, J. AU - Campo, E. AU - Gascoyne, R. D. AU - Cairo, M. S. AU - Weisenburger, D. D. AU - Greiner, T. C. AU - Gross, T. G. AU - Chan, W. C. DB - Embase Medline DO - 10.1182/blood-2011-05-349662 IS - 16 LA - English M3 - Article N1 - L364702337 2012-05-07 2012-05-09 PY - 2012 SN - 0006-4971 1528-0020 SP - 3757-3766 ST - Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling T2 - Blood TI - Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364702337&from=export http://dx.doi.org/10.1182/blood-2011-05-349662 http://bloodjournal.hematologylibrary.org/content/119/16/3757.full.pdf+html VL - 119 ID - 2413 ER - TY - JOUR AD - L. Visser, Department of Pathology and Medical Biology, University Medical Center Groningen, PO Box 30.001, Hanzeplein 1, HPC EA10, 9700 RB Groningen, Netherlands AU - Xu, C. AU - Plattel, W. AU - van den Berg, A. AU - Rüther, N. AU - Huang, X. AU - Wang, M. AU - de Jong, D. AU - Vos, H. AU - van Imhoff, G. AU - Viardot, A. AU - Möller, P. AU - Poppema, S. AU - Diepstra, A. AU - Visser, L. DB - Embase Medline DO - 10.3324/haematol.2011.056101 IS - 4 LA - English M3 - Article N1 - L364585138 2012-04-13 2012-04-19 PY - 2012 SN - 0390-6078 1592-8721 SP - 572-578 ST - Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma T2 - Haematologica TI - Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364585138&from=export http://dx.doi.org/10.3324/haematol.2011.056101 http://www.haematologica.org/content/97/4/572.full.pdf+html VL - 97 ID - 2414 ER - TY - JOUR AD - R.J. Packer, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, United States AU - Nageswara Rao, A. A. AU - Scafidi, J. AU - Wells, E. M. AU - Packer, R. J. C1 - avastin(Genentech,United States) gleevac(Novartis,United States) iressa(Astra Zeneca,United States) nexavar(Bayer,United States) rapamycin(Wyeth,United States) revlimid(Celgene) sarasar(Schering Plough,United States) sutent(Pfizer,United States) tarceva(Cydex,United States) thalomid(Celgene,United States) tykerb(Glaxo SmithKline,United States) zarnestra(Selleck,United States) C2 - Astra Zeneca(United States) Bayer(United States) Celgene(United States) Cydex(United States) Genentech(United States) Glaxo SmithKline(United States) Novartis(United States) Onyx(United States) Pfizer(United States) Schering Plough(United States) Selleck(United States) Wyeth(United States) DB - Embase Medline DO - 10.1016/j.pediatrneurol.2012.02.005 IS - 4 LA - English M3 - Review N1 - L364594188 2012-04-17 2012-04-20 PY - 2012 SN - 0887-8994 1873-5150 SP - 203-211 ST - Biologically targeted therapeutics in pediatric brain tumors T2 - Pediatric Neurology TI - Biologically targeted therapeutics in pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594188&from=export http://dx.doi.org/10.1016/j.pediatrneurol.2012.02.005 VL - 46 ID - 2415 ER - TY - JOUR AD - R.J. Packer, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, United States AU - Wells, E. M. AU - Nageswara Rao, A. A. AU - Scafidi, J. AU - Packer, R. J. C1 - avastin(Genentech) azd2281(Astra Zeneca) cci 779(Pfizer) depakote(Abbott,United States) gleevac(Novartis,United States) iressa(Astra Zeneca,United States) krx 0401(Keryx,United States) rapamycin(Pfizer) revlimid(Celgene,United States) semagacestat(Lilly,United States) sutent(Pfizer,United States) tarceva(Genentech,United States) tykerb(Glaxo SmithKline,United States) vismodegib(Hoffmann La Roche,Switzerland) vorinostat(Patheon,United States) zarnestra(Johnson and Johnson,United States) C2 - Abbott(United States) Astra Zeneca(United States) Celgene(United States) Genentech(United States) Glaxo SmithKline(United States) Hoffmann La Roche(Switzerland) Johnson and Johnson(United States) Keryx(United States) Lilly(United States) Novartis(United States) Patheon(United States) Pfizer(United States) DB - Embase Medline DO - 10.1016/j.pediatrneurol.2012.02.006 IS - 4 LA - English M3 - Review N1 - L364594189 2012-04-17 2012-04-20 PY - 2012 SN - 0887-8994 1873-5150 SP - 212-221 ST - Neurotoxicity of biologically targeted agents in pediatric cancer trials T2 - Pediatric Neurology TI - Neurotoxicity of biologically targeted agents in pediatric cancer trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594189&from=export http://dx.doi.org/10.1016/j.pediatrneurol.2012.02.006 VL - 46 ID - 2416 ER - TY - JOUR AD - C.A. Stratakis, Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, United States AU - Almeida, M. Q. AU - Azevedo, M. F. AU - Xekouki, P. AU - Bimpaki, E. I. AU - Horvath, A. AU - Collins, M. T. AU - Karaviti, L. P. AU - Jeha, G. S. AU - Bhattacharyya, N. AU - Cheadle, C. AU - Watkins, T. AU - Bourdeau, I. AU - Nesterova, M. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1210/jc.2011-3000 IS - 4 LA - English M3 - Article N1 - L364594559 2012-04-17 2012-04-24 PY - 2012 SN - 0021-972X 1945-7197 SP - E687-E693 ST - Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations T2 - Journal of Clinical Endocrinology and Metabolism TI - Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594559&from=export http://dx.doi.org/10.1210/jc.2011-3000 http://jcem.endojournals.org/content/97/4/E687.full.pdf+html VL - 97 ID - 2417 ER - TY - JOUR AD - G. Terrin, Department of Women Health and Territorial Medicine, University of Rome La Sapienza, via di Grottarossa 1035/1039, Rome, Italy AU - Terrin, G. AU - Passariello, A. AU - Canani, R. B. DB - Embase Medline DO - 10.1097/MPG.0b013e3182472372 IS - 4 LA - English M3 - Note N1 - L51784436 2011-12-28 2012-04-11 PY - 2012 SN - 0277-2116 1536-4801 SP - 444-445 ST - Drugs and tight junctions: Adverse effects and opportunities for new therapeutic approaches T2 - Journal of Pediatric Gastroenterology and Nutrition TI - Drugs and tight junctions: Adverse effects and opportunities for new therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51784436&from=export http://dx.doi.org/10.1097/MPG.0b013e3182472372 VL - 54 ID - 2418 ER - TY - JOUR AD - A.F. Nascimento, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, United States AU - Morgan, E. A. AU - Nascimento, A. F. C2 - Pfizer DB - Embase DO - 10.1155/2012/529572 LA - English M3 - Review N1 - L364444365 2012-03-23 2012-03-27 PY - 2012 SN - 1687-9104 1687-9112 ST - Anaplastic lymphoma kinase-positive large b-cell lymphoma: An underrecognized aggressive lymphoma T2 - Advances in Hematology TI - Anaplastic lymphoma kinase-positive large b-cell lymphoma: An underrecognized aggressive lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364444365&from=export http://dx.doi.org/10.1155/2012/529572 VL - 2012 ID - 2419 ER - TY - JOUR AD - M.M. Van Noesel, Erasmus MC-Sophia Children's Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, Netherlands AU - Duijkers, F. A. M. AU - Gaal, J. AU - Meijerink, J. P. P. AU - Admiraal, P. AU - Pieters, R. AU - De Krijger, R. R. AU - Van Noesel, M. M. DB - Embase Medline DO - 10.1016/j.ajpath.2011.12.003 IS - 3 LA - English M3 - Article N1 - L364289854 2012-02-28 2012-03-01 PY - 2012 SN - 0002-9440 1525-2191 SP - 1223-1231 ST - High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome T2 - American Journal of Pathology TI - High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364289854&from=export http://dx.doi.org/10.1016/j.ajpath.2011.12.003 VL - 180 ID - 2420 ER - TY - JOUR AD - S. Bringhen, University of Torino, Division of Hematology, Myeloma Unit, AOU S Giovanni Battista, Torino, Italy AU - Guglielmelli, T. AU - Bringhen, S. AU - Palumbo, A. DB - Embase Medline DO - 10.1517/14712598.2012.657623 IS - 3 LA - English M3 - Article N1 - L364300414 2012-02-29 PY - 2012 SN - 1471-2598 SP - 353-361 ST - Update on the use of defibrotide T2 - Expert Opinion on Biological Therapy TI - Update on the use of defibrotide UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364300414&from=export http://dx.doi.org/10.1517/14712598.2012.657623 VL - 12 ID - 2421 ER - TY - JOUR AD - F. Yan, 2215 Garland Ave., MRB IV, Nashville, TN 37232-0696, United States AU - Yan, F. AU - Wang, L. AU - Shi, Y. AU - Cao, H. AU - Liu, L. AU - Kay Washington, M. AU - Chaturvedi, R. AU - Israel, D. A. AU - Cao, H. AU - Wang, B. AU - Peek Jr, R. M. AU - Wilson, K. T. AU - Brent Polk, D. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1152/ajpgi.00312.2011 IS - 5 L1 - internal-pdf://1967681095/ajpgi.00312.2011.pdf LA - English M3 - Article N1 - L364308253 2012-02-29 2012-03-02 PY - 2012 SN - 0193-1857 1522-1547 SP - G504-G514 ST - Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364308253&from=export http://dx.doi.org/10.1152/ajpgi.00312.2011 VL - 302 ID - 2422 ER - TY - JOUR AD - R.G. Maki, Department of Medicine and Pediatrics, Sarcoma Service Memorial Sloan Kettering Cancer Center, New York, United States AU - Roubaud, G. AU - Kind, M. AU - Coindre, J. M. AU - Maki, R. G. AU - Bui, B. AU - Italiano, A. DB - Embase Medline DO - 10.1093/annonc/mdr631 IS - 3 LA - English M3 - Letter N1 - L364351593 2012-03-07 2012-03-26 PY - 2012 SN - 0923-7534 1569-8041 SP - 804-805 ST - Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: A case series T2 - Annals of Oncology TI - Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: A case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364351593&from=export http://dx.doi.org/10.1093/annonc/mdr631 VL - 23 ID - 2424 ER - TY - JOUR AD - J. Irving, Northern Institute for Cancer Research, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne, Tyne and Wear, NE2 4HH, United Kingdom AU - Nicholson, L. AU - Knight, T. AU - Matheson, E. AU - Minto, L. AU - Case, M. AU - Sanichar, M. AU - Bomken, S. AU - Vormoor, J. AU - Hall, A. AU - Irving, J. DB - Embase Medline DO - 10.1002/gcc.20949 IS - 3 LA - English M3 - Article N1 - L51714587 2011-11-16 2012-01-17 PY - 2012 SN - 1045-2257 1098-2264 SP - 250-256 ST - Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia T2 - Genes Chromosomes and Cancer TI - Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51714587&from=export http://dx.doi.org/10.1002/gcc.20949 VL - 51 ID - 2425 ER - TY - JOUR AD - D.Y.M. Leung, National Jewish Health, 1400 Jackson St, K926i, Denver, CO 80206, United States AU - Goleva, E. AU - Jackson, L. P. AU - Gleason, M. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1016/j.jaci.2011.12.001 IS - 3 LA - English M3 - Article N1 - L51804475 2012-01-12 2012-03-14 PY - 2012 SN - 0091-6749 1097-6825 SP - 687-693.e1 ST - Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients T2 - Journal of Allergy and Clinical Immunology TI - Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51804475&from=export http://dx.doi.org/10.1016/j.jaci.2011.12.001 VL - 129 ID - 2426 ER - TY - JOUR AD - H.S. Bernstein, University of California, Box 1346, 513 Parnassus Avenue, San Francisco, CA 941431346, United States AU - Yeghiazarians, Y. AU - Gaur, M. AU - Zhang, Y. AU - Sievers, R. E. AU - Ritner, C. AU - Prasad, M. AU - Boyle, A. AU - Bernstein, H. S. DB - Embase Medline DO - 10.3109/14653249.2011.623690 IS - 2 LA - English M3 - Article N1 - L364100177 2012-01-25 2012-01-27 PY - 2012 SN - 1465-3249 1477-2566 SP - 223-231 ST - Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition T2 - Cytotherapy TI - Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364100177&from=export http://dx.doi.org/10.3109/14653249.2011.623690 VL - 14 ID - 2427 ER - TY - JOUR AD - S.D. Held, University of Texas, Health Science Center at San Antonio, San Antonio, TX, United States AU - Held, S. D. AU - Kinney, M. C. AU - Medina, E. A. AU - Higgins, R. A. DB - Embase DO - 10.1038/labinvest.2012.38 LA - English M3 - Conference Abstract N1 - L70662882 2012-02-13 PY - 2012 SN - 0023-6837 SP - 339A ST - Novel recurrent gains and deletions in adults with anaplastic large cell lymphoma T2 - Laboratory Investigation TI - Novel recurrent gains and deletions in adults with anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70662882&from=export http://dx.doi.org/10.1038/labinvest.2012.38 VL - 92 ID - 2428 ER - TY - JOUR AD - M.-E. Halatsch, Department of Neurosurgery, University of Ulm, School of Medicine, Steinhövelstrasse 9, D-89075 Ulm, Germany AU - Merkur, N. AU - Westhoff, M. A. AU - Karpel-Massler, G. AU - Halatsch, M. E. DB - Embase DO - 10.2174/157436212799278034 IS - 1 LA - English M3 - Article N1 - L364958642 2012-06-19 2012-06-20 PY - 2012 SN - 1574-3624 SP - 3-13 ST - Targeting the epidermal growth factor receptor in glioblastoma treatment T2 - Current Signal Transduction Therapy TI - Targeting the epidermal growth factor receptor in glioblastoma treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364958642&from=export http://dx.doi.org/10.2174/157436212799278034 VL - 7 ID - 2429 ER - TY - JOUR AD - C. Laurent, Université Paul-Sabatier, Toulouse, France AU - Laurent, C. AU - Lopez, C. AU - Desjobert, C. AU - Berrebi, A. AU - Damm-Welk, C. AU - Delsol, G. AU - Brousset, P. AU - Lamant, L. DB - Embase Medline DO - 10.1038/leu.2011.209 IS - 1 LA - English M3 - Letter N1 - L51570248 2011-08-17 2012-02-15 PY - 2012 SN - 0887-6924 1476-5551 SP - 188-190 ST - Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns T2 - Leukemia TI - Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51570248&from=export http://dx.doi.org/10.1038/leu.2011.209 VL - 26 ID - 2430 ER - TY - JOUR AD - M.-S. Lee, Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taiwan AU - Huang, H. P. AU - Chang, M. H. AU - Chen, Y. T. AU - Hsu, H. Y. AU - Chiang, C. L. AU - Cheng, T. S. AU - Wu, Y. M. AU - Wu, M. Z. AU - Hsu, Y. C. AU - Shen, C. C. AU - Lee, C. N. AU - Chuang, Y. H. AU - Hong, C. L. AU - Jeng, Y. M. AU - Chen, P. H. AU - Chen, H. L. AU - Lee, M. S. DB - Embase Medline DO - 10.1002/hep.24657 IS - 1 LA - English M3 - Article N1 - L51723667 2011-11-22 2012-01-03 PY - 2012 SN - 0270-9139 1527-3350 SP - 161-172 ST - Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation T2 - Hepatology TI - Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51723667&from=export http://dx.doi.org/10.1002/hep.24657 VL - 55 ID - 2431 ER - TY - JOUR AD - R. Kapur, Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 W Walnut Street, Indianapolis, IN 46202, United States AU - Ma, P. AU - Mali, R. S. AU - Martin, H. AU - Ramdas, B. AU - Sims, E. AU - Kapur, R. DB - Embase Medline DO - 10.1038/leu.2012.22 IS - 7 LA - English M3 - Article N1 - L51841038 2012-02-03 2012-07-25 PY - 2012 SN - 1476-5551 0887-6924 SP - 1499-1506 ST - Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease T2 - Leukemia TI - Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51841038&from=export http://dx.doi.org/10.1038/leu.2012.22 VL - 26 ID - 2433 ER - TY - JOUR AD - R. Salgia, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637, United States AU - La Madrid, A. M. AU - Campbell, N. AU - Smith, S. AU - Cohn, S. L. AU - Salgia, R. C1 - 17 AAG ap 26113 asp 3026(Astellas) cep 28122(Cephalon) ch 5424802(Chugai) crl 151104a ipi 204 ldk 378 pf 03446962 sta 9090 tae 684 C2 - Astellas Cephalon Chugai DB - Embase Medline DO - 10.1007/s11523-012-0227-8 IS - 3 LA - English M3 - Review N1 - L52205203 2012-09-15 2019-07-22 PY - 2012 SN - 1776-260X 1776-2596 SP - 199-210 ST - Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma T2 - Targeted Oncology TI - Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52205203&from=export http://dx.doi.org/10.1007/s11523-012-0227-8 VL - 7 ID - 2434 ER - TY - JOUR AD - L.-J. Gao, Clinical Laboratory, Nanjing Maternity and Child Health Care Hospital Tianfei Alley, Nanjing Mochou Road, 210004, Nanjing, China AU - Liu, Z. AU - Su, Y. J. AU - Gu, P. Q. AU - Ji, Z. Y. AU - Wang, X. G. AU - Gao, L. J. DB - Embase Medline DO - 10.1159/000343308 IS - 5 LA - English M3 - Article N1 - L52253610 2012-10-16 2019-05-14 PY - 2012 SN - 1421-9778 1015-8987 SP - 1181-1190 ST - The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma T2 - Cellular Physiology and Biochemistry TI - The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52253610&from=export http://dx.doi.org/10.1159/000343308 VL - 30 ID - 2435 ER - TY - JOUR AD - D. K. Graham, Department of Pediatrics, University of Colorado Denver School of Medicine, Pediatrics Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Brandão, L. AU - Migdall-Wilson, J. AU - Eisenman, K. AU - Graham, D. K. C1 - bms 777607(Bristol Myers Squibb) gsk 1363089(Glaxo SmithKline) mp 470(Supergen) pf 2341066(Pfizer) C2 - Bristol Myers Squibb Glaxo SmithKline Pfizer Supergen DB - Embase Medline DO - 10.1615/CritRevOncog.v16.i1-2.60 IS - 1-2 LA - English M3 - Review N1 - L363072194 2011-12-19 2011-12-21 PY - 2011 SN - 0893-9675 SP - 47-63 ST - TAM receptors in leukemia: Expression, signaling, and therapeutic implications T2 - Critical Reviews in Oncogenesis TI - TAM receptors in leukemia: Expression, signaling, and therapeutic implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L363072194&from=export http://dx.doi.org/10.1615/CritRevOncog.v16.i1-2.60 http://www.dl.begellhouse.com/download/article/305b0e1923e5c7e0/CRO-11-105%20revised%202.pdf VL - 16 ID - 2436 ER - TY - JOUR AD - L. Zou, Center for Clinical Molecular Medicine, Children's Hospital, Chongqing Medical University, Chongqing 400014, China AU - Zhang, P. AU - He, X. AU - Tan, J. AU - Zhou, X. AU - Zou, L. DB - Embase Medline DO - 10.3892/or.2011.1417 IS - 6 LA - English M3 - Article N1 - L362696756 2011-10-13 2011-10-21 PY - 2011 SN - 1021-335X 1791-2431 SP - 1471-1477 ST - β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression T2 - Oncology Reports TI - β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362696756&from=export http://dx.doi.org/10.3892/or.2011.1417 http://www.spandidos-publications.com/serveFile/or_26_6_1471_PDF.pdf?type=article&article_id=or_26_6_1471&item=PDF VL - 26 ID - 2437 ER - TY - JOUR AD - M.R. Litzow, Division of Hematology, Mayo Clinic, 200 First Street, South West, Rochester, MN 55905, United States AU - Litzow, M. R. C1 - cat 3888 cat 8015 cci 779 dt 2219 ly 231514 rad 001 DB - Embase Medline DO - 10.1016/j.hoc.2011.09.019 IS - 6 LA - English M3 - Review N1 - L362941069 2011-11-23 2011-11-25 PY - 2011 SN - 0889-8588 1558-1977 SP - 1303-1317 ST - Novel Therapeutic Approaches for Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Novel Therapeutic Approaches for Acute Lymphoblastic Leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362941069&from=export http://dx.doi.org/10.1016/j.hoc.2011.09.019 VL - 25 ID - 2438 ER - TY - JOUR AD - E. Vreugdenhil, Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University Medical Center, PO Box 9502, 2300 RA Leiden, Netherlands AU - Verissimo, C. S. AU - Molenaar, J. J. AU - Fitzsimons, C. P. AU - Vreugdenhil, E. C1 - cep 701 imc a12 mln8237 pf 02341066 DB - Embase Medline DO - 10.1530/ERC-11-0251 IS - 6 LA - English M3 - Review N1 - L364102828 2012-01-25 2012-01-27 PY - 2011 SN - 1351-0088 1479-6821 SP - R213-R231 ST - Neuroblastoma therapy: What is in the pipeline? T2 - Endocrine-Related Cancer TI - Neuroblastoma therapy: What is in the pipeline? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364102828&from=export http://dx.doi.org/10.1530/ERC-11-0251 http://erc.endocrinology-journals.org/content/18/6/R213.full.pdf+html VL - 18 ID - 2439 ER - TY - JOUR AD - J.S. Fitzgerald, Department of Obstetrics, University Hospital of Jena, Bachstrasse 18, 07743 Jena, Germany AU - Fitzgerald, J. S. AU - Abad, C. AU - Alvarez, A. M. AU - Mehta, R. B. AU - Chaiwangyen, W. AU - Dubinsky, V. AU - Silva, B. G. AU - Gutierrez, G. AU - Hofmann, S. AU - Hölters, S. AU - Joukadar, J. AU - Junovich, G. AU - Kuhn, C. AU - Morales-Prieto, D. M. AU - Nevers, T. AU - Ospina-Prieto, S. AU - Pastuschek, J. AU - Pereira De Sousa, F. L. AU - San Martin, S. AU - Suman, P. AU - Weber, M. AU - Markert, U. R. DB - Embase DO - 10.3233/NIB-2011-023 IS - 1-2 LA - English M3 - Review N1 - L364671899 2012-05-07 2012-05-09 PY - 2011 SN - 1878-948X 1878-9498 SP - 61-97 ST - Cytokines regulating trophoblast invasion T2 - Advances in Neuroimmune Biology TI - Cytokines regulating trophoblast invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364671899&from=export http://dx.doi.org/10.3233/NIB-2011-023 VL - 2 ID - 2440 ER - TY - JOUR AD - H.-K. Yi, Department of Oral Biochemistry, School of Dentistry, Chonbuk National University, 664-14, Dukjin-dong, Deokjin-ku, Jeonju, Jeonbuk, 561-712, South Korea AU - Bhattarai, G. AU - Lee, Y. H. AU - Lee, N. H. AU - Yun, J. S. AU - Hwang, P. H. AU - Yi, H. K. DB - Embase Medline DO - 10.1002/cbf.1808 IS - 8 LA - English M3 - Article N1 - L51654837 2011-10-10 2011-12-16 PY - 2011 SN - 0263-6484 1099-0844 SP - 686-693 ST - c-myb mediates inflammatory reaction against oxidative stress in human breast cancer cell line, MCF-7 T2 - Cell Biochemistry and Function TI - c-myb mediates inflammatory reaction against oxidative stress in human breast cancer cell line, MCF-7 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51654837&from=export http://dx.doi.org/10.1002/cbf.1808 VL - 29 ID - 2441 ER - TY - JOUR AD - S.R. Wilson, Department of Paediatric Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom AU - Wilson, S. R. AU - Weston, V. J. AU - Stankovic, T. AU - Kearns, P. R. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70769243 2012-06-19 PY - 2011 SN - 0006-4971 ST - Tyrosine kinase inhibitor screen identifies the multikinase inhibitor, foretinib, as a sensitisor of treatment-resistant B-precursor ALL to core chemotherapeutic agents T2 - Blood TI - Tyrosine kinase inhibitor screen identifies the multikinase inhibitor, foretinib, as a sensitisor of treatment-resistant B-precursor ALL to core chemotherapeutic agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70769243&from=export http://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/1509?maxtoshow=&hits=60&RESULTFORMAT=&searchid=1&FIRSTINDEX=2040&displaysectionid=Poster+Sessions&fdate=1/1/2011&tdate=12/31/2011&resourcetype=HWCIT VL - 118 ID - 2442 ER - TY - JOUR AD - A.R. Kahn, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States AU - Kahn, A. R. AU - Hartwell, K. A. AU - Miller, P. G. AU - Ebert, B. L. AU - Golub, T. R. AU - Moore, M. A. S. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70770278 2012-06-19 PY - 2011 SN - 0006-4971 ST - Selective targeting of leukemic over normal stem cells by the serotonin receptor antagonist SB-216641 T2 - Blood TI - Selective targeting of leukemic over normal stem cells by the serotonin receptor antagonist SB-216641 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70770278&from=export http://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/1884?maxtoshow=&hits=60&RESULTFORMAT=&searchid=1&FIRSTINDEX=3000&displaysectionid=Poster+Sessions&fdate=1/1/2011&tdate=12/31/2011&resourcetype=HWCIT VL - 118 ID - 2443 ER - TY - JOUR AD - Z. Zhao, Department of Orthodontics, West China College of Stomatology, Sichuan University, Renmin Nan Road 14#, Chengdu, Sichuan, China AU - Wu, J. AU - Li, Y. AU - Fan, X. AU - Zhang, C. AU - Wang, Y. AU - Zhao, Z. DB - Embase Medline DO - 10.1089/dna.2010.1139 IS - 11 LA - English M3 - Article N1 - L362886282 2011-11-15 2011-11-17 PY - 2011 SN - 1044-5498 1557-7430 SP - 865-873 ST - Analysis of gene expression profile of periodontal ligament cells subjected to cyclic compressive force T2 - DNA and Cell Biology TI - Analysis of gene expression profile of periodontal ligament cells subjected to cyclic compressive force UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362886282&from=export http://dx.doi.org/10.1089/dna.2010.1139 VL - 30 ID - 2444 ER - TY - JOUR AD - M. Proytcheva, Children's Memorial Hospital, Box 17, 2300 Children's Plaza, Chicago, IL 60614, United States AU - Proytcheva, M. DB - Embase Medline DO - 10.1053/j.semdp.2011.08.007 IS - 4 LA - English M3 - Article N1 - L363018157 2011-12-07 2011-12-22 PY - 2011 SN - 0740-2570 1930-1111 SP - 298-303 ST - Juvenile myelomonocytic leukemia T2 - Seminars in Diagnostic Pathology TI - Juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L363018157&from=export http://dx.doi.org/10.1053/j.semdp.2011.08.007 VL - 28 ID - 2445 ER - TY - JOUR AD - S. Bonnet, Centre de Recherche du CHUQ, Hôtel-Dieu de Québec, 10 Rue McMahon, Québec, QC G1R 2J6, Canada AU - Paulin, R. AU - Courboulin, A. AU - Barrier, M. AU - Bonnet, S. C1 - azd 0530 rta 402 ski 606 DB - Embase Medline DO - 10.1007/s00109-011-0788-5 IS - 11 LA - English M3 - Review N1 - L51525217 2011-07-20 2011-11-18 PY - 2011 SN - 0946-2716 1432-1440 SP - 1089-1101 ST - From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension T2 - Journal of Molecular Medicine TI - From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51525217&from=export http://dx.doi.org/10.1007/s00109-011-0788-5 VL - 89 ID - 2446 ER - TY - JOUR AD - J.H. Chung, Department of Dermatology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea AU - Park, C. H. AU - Chung, J. H. DB - Embase Medline DO - 10.1016/j.jdermsci.2011.07.002 IS - 2 LA - English M3 - Article N1 - L51590615 2011-08-30 2011-10-13 PY - 2011 SN - 0923-1811 1873-569X SP - 134-141 ST - Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts T2 - Journal of Dermatological Science TI - Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51590615&from=export http://dx.doi.org/10.1016/j.jdermsci.2011.07.002 VL - 64 ID - 2447 ER - TY - JOUR AD - C.P. Reynolds, Texas Tech University Health Sciences Center, Lubbock, TX, United States AU - Reynolds, C. P. AU - Kang, M. H. AU - Carol, H. AU - Lock, R. B. AU - Gorlick, R. AU - Kolb, E. A. AU - Alexander, D. AU - Kurmasheva, R. T. AU - Keir, S. T. AU - Maris, J. M. AU - Wu, J. AU - Houghton, P. J. AU - Smith, M. A. DB - Embase DO - 10.1158/1535-7163.TARG-11-C106 IS - 11 LA - English M3 - Conference Abstract N1 - L70609702 2011-12-20 PY - 2011 SN - 1535-7163 ST - Pediatric Preclinical Testing Program (PPTP) Stage 1 evaluation of the PI3K inhibitor XL147 (SAR245408) T2 - Molecular Cancer Therapeutics TI - Pediatric Preclinical Testing Program (PPTP) Stage 1 evaluation of the PI3K inhibitor XL147 (SAR245408) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70609702&from=export http://dx.doi.org/10.1158/1535-7163.TARG-11-C106 http://mct.aacrjournals.org/search?tocsectionid=Pharmacokinetics+and+Pharmacodynamics%3A+Poster+Presentations+-+Proffered+Abstracts&displaysectionid=Pharmacokinetics+and+Pharmacodynamics%3A+Poster+Presentations+-+Proffered+Abstracts&volume=10&issue=Supplement+1&hits=10&flag=MTG_ABSTRACT_ARTICLE&submit=Submit VL - 10 ID - 2448 ER - TY - JOUR AD - C. Rossig, Department of Pediatric Hematology and Oncology, University Children's Hospital M̈unster, Building A1, Albert-Schweitzer Campus 1, 48149 M̈unster, Germany AU - Rossig, C. AU - Juergens, H. AU - Berdel, W. E. C1 - herceptin iressa tarceva tykerb tyverb DB - Embase Medline DO - 10.3109/08880018.2011.613094 IS - 7 LA - English M3 - Review N1 - L362607494 2011-09-29 2011-10-05 PY - 2011 SN - 0888-0018 1521-0669 SP - 539-555 ST - New targets and targeted drugs for the treatment of cancer: An outlook to pediatric oncology T2 - Pediatric Hematology and Oncology TI - New targets and targeted drugs for the treatment of cancer: An outlook to pediatric oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362607494&from=export http://dx.doi.org/10.3109/08880018.2011.613094 VL - 28 ID - 2449 ER - TY - JOUR AD - T. Niihori, Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980-8574, Japan AU - Niihori, T. AU - Aoki, Y. AU - Okamoto, N. AU - Kurosawa, K. AU - Ohashi, H. AU - Mizuno, S. AU - Kawame, H. AU - Inazawa, J. AU - Ohura, T. AU - Arai, H. AU - Nabatame, S. AU - Kikuchi, K. AU - Kuroki, Y. AU - Miura, M. AU - Tanaka, T. AU - Ohtake, A. AU - Omori, I. AU - Ihara, K. AU - Mabe, H. AU - Watanabe, K. AU - Niijima, S. AU - Okano, E. AU - Numabe, H. AU - Matsubara, Y. DB - Embase Medline DO - 10.1038/jhg.2011.85 IS - 10 LA - English M3 - Article N1 - L362842938 2011-11-09 2011-11-11 PY - 2011 SN - 1434-5161 1435-232X SP - 707-715 ST - HRAS mutants identified in Costello syndrome patients can induce cellular senescence: Possible implications for the pathogenesis of Costello syndrome T2 - Journal of Human Genetics TI - HRAS mutants identified in Costello syndrome patients can induce cellular senescence: Possible implications for the pathogenesis of Costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362842938&from=export http://dx.doi.org/10.1038/jhg.2011.85 VL - 56 ID - 2450 ER - TY - JOUR AD - P.L. Myskowski, Dermatology Service, Department of Medicine, Rockefeller Outpatient Pavilion, Memorial Sloan-Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, United States AU - Balagula, Y. AU - Huston, K. B. AU - Busam, K. J. AU - Lacouture, M. E. AU - Chapman, P. B. AU - Myskowski, P. L. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1007/s10637-010-9567-3 IS - 5 LA - English M3 - Review N1 - L51126657 2010-10-29 2012-06-15 PY - 2011 SN - 0167-6997 1573-0646 SP - 1114-1121 ST - Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) T2 - Investigational New Drugs TI - Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51126657&from=export http://dx.doi.org/10.1007/s10637-010-9567-3 VL - 29 ID - 2451 ER - TY - JOUR AD - S.R. Lambert, University of Cambridge, United Kingdom AU - Lambert, S. R. AU - Jones, D. T. W. AU - Pearson, D. AU - Ichimura, I. AU - Collins, V. P. DB - Embase DO - 10.1093/neuonc/nor144 LA - English M3 - Conference Abstract N1 - L70964997 2013-01-17 PY - 2011 SN - 1522-8517 SP - ii6 ST - Gene expression profiling of pilocytic astrocytoma T2 - Neuro-Oncology TI - Gene expression profiling of pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70964997&from=export http://dx.doi.org/10.1093/neuonc/nor144 VL - 13 ID - 2452 ER - TY - JOUR AD - F.-C. Yang, Departments of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States AU - He, Y. AU - Staser, K. AU - Rhodes, S. D. AU - Liu, Y. AU - Wu, X. AU - Park, S. J. AU - Yuan, J. AU - Yang, X. AU - Li, X. AU - Jiang, L. AU - Chen, S. AU - Yang, F. C. DB - Embase Medline DO - 10.1371/journal.pone.0024780 IS - 9 L1 - internal-pdf://1176911340/journal.pone.0024780.PDF LA - English M3 - Article N1 - L362610375 2011-09-29 2011-10-12 PY - 2011 SN - 1932-6203 ST - Erk1 positively regulates osteoclast differentiation and bone resorptive activity T2 - PLoS ONE TI - Erk1 positively regulates osteoclast differentiation and bone resorptive activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362610375&from=export http://dx.doi.org/10.1371/journal.pone.0024780 VL - 6 ID - 2453 ER - TY - JOUR AD - M.S. Herridge, Toronto General Hospital, EN10-212, 200 Elizabeth Street, Toronto, ON M5G 2N2, Canada AU - Flaherty, K. R. AU - Herridge, M. S. C1 - pf 02341066(Pfizer) vx 770 C2 - Pfizer DB - Embase Medline DO - 10.1513/pats.201108-044TT IS - 5 LA - English M3 - Review N1 - L362593100 2011-09-28 2011-09-30 PY - 2011 SN - 1546-3222 1943-5665 SP - 398-403 ST - Lung cancer, sleep apnea, interventional pulmonary/pleural disease, cystic fibrosis T2 - Proceedings of the American Thoracic Society TI - Lung cancer, sleep apnea, interventional pulmonary/pleural disease, cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362593100&from=export http://dx.doi.org/10.1513/pats.201108-044TT http://pats.atsjournals.org/cgi/reprint/8/5/398 VL - 8 ID - 2454 ER - TY - JOUR AD - K. Krishnan, Department of Internal Medicine, JamesH. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States AU - Shin-Kang, S. AU - Ramsauer, V. P. AU - Lightner, J. AU - Chakraborty, K. AU - Stone, W. AU - Campbell, S. AU - Reddy, S. A. G. AU - Krishnan, K. C2 - Cayman(United States) Tama(Japan) DB - Embase Medline DO - 10.1016/j.freeradbiomed.2011.06.008 IS - 6 LA - English M3 - Article N1 - L51515938 2011-07-13 2011-08-26 PY - 2011 SN - 0891-5849 1873-4596 SP - 1164-1174 ST - Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway T2 - Free Radical Biology and Medicine TI - Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51515938&from=export http://dx.doi.org/10.1016/j.freeradbiomed.2011.06.008 VL - 51 ID - 2455 ER - TY - JOUR AD - R. González-Cámpora, Department of Pathology, University Hospital Virgen Macarena, Avda. Dr Fedriani s/n, 41009 Seville, Spain AU - Ríos-Moreno, M. J. AU - Jaramillo, S. AU - Díaz-Delgado, M. AU - Sánchez-León, M. AU - Trigo-Sánchez, I. AU - Polo Padillo, J. AU - Amérigo, J. AU - González-Cámpora, R. DB - Embase Medline IS - 9 LA - English M3 - Article N1 - L362333311 2011-08-22 PY - 2011 SN - 0250-7005 SP - 3019-3025 ST - Differential activation of MAPK and PI3K/AKT/mTOR pathways and IGF1R expression in gastrointestinal stromal tumors T2 - Anticancer Research TI - Differential activation of MAPK and PI3K/AKT/mTOR pathways and IGF1R expression in gastrointestinal stromal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362333311&from=export VL - 31 ID - 2456 ER - TY - JOUR AD - M.J. Kuehn, Department of Biochemistry, Duke University Medical Center, Box 3711, Durham, NC 27710, United States AU - Chutkan, H. AU - Kuehn, M. J. DB - Embase Medline DO - 10.1128/IAI.05336-11 IS - 9 L1 - internal-pdf://1876855542/Infection and Immunity-2011-Chutkan-3760.full.pdf LA - English M3 - Article N1 - L362474278 2011-09-09 2011-09-13 PY - 2011 SN - 0019-9567 1098-5522 SP - 3760-3769 ST - Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin T2 - Infection and Immunity TI - Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362474278&from=export http://dx.doi.org/10.1128/IAI.05336-11 VL - 79 ID - 2457 ER - TY - JOUR AD - J.A. Benjamins, Department of Neurology, Wayne State University School of Medicine, 1228 Elliman Building, 421 E. Canfield Ave., Detroit, MI 48201, United States AU - Benjamins, J. A. AU - Nedelkoska, L. AU - Lisak, R. P. AU - Hannigan, J. H. AU - Sokol, R. J. DB - Embase Medline DO - 10.1007/s11064-011-0401-x IS - 9 LA - English M3 - Article N1 - L51255031 2011-11-16 2011-11-22 PY - 2011 SN - 0364-3190 1573-6903 SP - 1677-1686 ST - Cytokines reduce toxic effects of ethanol on oligodendroglia T2 - Neurochemical Research TI - Cytokines reduce toxic effects of ethanol on oligodendroglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51255031&from=export http://dx.doi.org/10.1007/s11064-011-0401-x VL - 36 ID - 2458 ER - TY - JOUR AD - R. Dantzer, Integrative Immunology and Behavior Program, Department of Animal Sciences, College of ACES, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States AU - Fu, X. AU - Lawson, M. A. AU - Kelley, K. W. AU - Dantzer, R. DB - Embase Medline DO - 10.1186/1742-2094-8-88 LA - English M3 - Article N1 - L51557415 2011-08-05 2011-09-16 PY - 2011 SN - 1742-2094 ST - HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner T2 - Journal of Neuroinflammation TI - HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51557415&from=export http://dx.doi.org/10.1186/1742-2094-8-88 http://www.jneuroinflammation.com/content/8/1/88 VL - 8 ID - 2459 ER - TY - JOUR AD - M. Zenker, Institute of Human Genetics, University Hospital Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany AU - Zenker, M. DB - Embase Medline DO - 10.1097/MOP.0b013e32834881dd IS - 4 LA - English M3 - Review N1 - L362213699 2011-08-03 2011-08-05 PY - 2011 SN - 1040-8703 1531-698X SP - 443-451 ST - Clinical manifestations of mutations in RAS and related intracellular signal transduction factors T2 - Current Opinion in Pediatrics TI - Clinical manifestations of mutations in RAS and related intracellular signal transduction factors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362213699&from=export http://dx.doi.org/10.1097/MOP.0b013e32834881dd VL - 23 ID - 2460 ER - TY - JOUR AD - D. B. Polk, Departments of Pediatrics and Biochemistry and Molecular Biology, The Saban Research Institute of Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, 4650 Sunset Blvd., Mailstop 126, Los Angeles, CA 37232-0696, United States AU - Hobbs, S. S. AU - Goettel, J. A. AU - Liang, D. AU - Yan, F. AU - Edelblum, K. L. AU - Frey, M. R. AU - Mullane, M. T. AU - Polk, D. B. DB - Embase Medline DO - 10.1152/ajpgi.00383.2010 IS - 2 L1 - internal-pdf://2735703404/ajpgi.00383.2010.pdf LA - English M3 - Article N1 - L362255411 2011-08-09 2011-08-11 PY - 2011 SN - 0193-1857 1522-1547 SP - G220-G229 ST - TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362255411&from=export http://dx.doi.org/10.1152/ajpgi.00383.2010 VL - 301 ID - 2461 ER - TY - JOUR AD - W.S. Kim, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea AU - Yi, J. H. AU - Kim, J. H. AU - Baek, K. K. AU - Lim, T. AU - Lee, D. J. AU - Ahn, Y. C. AU - Kim, K. AU - Kim, S. J. AU - Ko, Y. H. AU - Kim, W. S. DB - Embase Medline DO - 10.1093/annonc/mdq645 IS - 7 LA - English M3 - Article N1 - L362042357 2011-07-06 2011-07-12 PY - 2011 SN - 0923-7534 1569-8041 SP - 1636-1643 ST - Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma T2 - Annals of Oncology TI - Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362042357&from=export http://dx.doi.org/10.1093/annonc/mdq645 VL - 22 ID - 2462 ER - TY - JOUR AD - N. F. Schor, Department of Pediatrics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Ganeshan, V. R. AU - Schor, N. F. C1 - abt 751 DB - Embase Medline DO - 10.2165/11591630-000000000-00000 IS - 4 LA - English M3 - Review N1 - L362016658 2011-07-04 PY - 2011 SN - 1174-5878 1179-2019 SP - 245-255 ST - Pharmacologic management of high-risk neuroblastoma in children T2 - Pediatric Drugs TI - Pharmacologic management of high-risk neuroblastoma in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362016658&from=export http://dx.doi.org/10.2165/11591630-000000000-00000 VL - 13 ID - 2463 ER - TY - JOUR AD - D. J. Hackam, Division of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, United States AU - Lin, J. AU - Hackam, D. J. DB - Embase Medline DO - 10.1242/dmm.007252 IS - 4 LA - English M3 - Note N1 - L362029265 2011-07-05 2011-07-07 PY - 2011 SN - 1754-8403 1754-8411 SP - 447-456 ST - Worms, flies and four-legged friends: The applicability of biological models to the understanding of intestinal inflammatory diseases T2 - DMM Disease Models and Mechanisms TI - Worms, flies and four-legged friends: The applicability of biological models to the understanding of intestinal inflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362029265&from=export http://dx.doi.org/10.1242/dmm.007252 http://dmm.biologists.org/content/4/4/447.full.pdf+html VL - 4 ID - 2464 ER - TY - JOUR AD - J. Hong, UMDNJ New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, United States AU - Hong, J. AU - Bielory, L. C1 - grazax(Alk Abello,Denmark) oralair(Stallergenes,France) C2 - Alk Abello(Denmark) Stallergenes(France) DB - Embase Medline DO - 10.1586/eci.11.36 IS - 4 LA - English M3 - Article N1 - L362235584 2011-08-05 2011-08-09 PY - 2011 SN - 1744-666X 1744-8409 SP - 437-444 ST - Oralair®: Sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis T2 - Expert Review of Clinical Immunology TI - Oralair®: Sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362235584&from=export http://dx.doi.org/10.1586/eci.11.36 VL - 7 ID - 2465 ER - TY - JOUR AD - V. Subbiah, Department of Pediatrics, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Subbiah, V. AU - Kurzrock, R. C1 - amg 479(Amgen,United States) azd 2171(Astra Zeneca,United States) cp 751871 imc a12 jnj 26854165 pf 02341066(Pfizer,United States) r 1507 rg 7112(Hoffmann La Roche,United States) sb 715992 su11248 C2 - Amgen(United States) Astra Zeneca(United States) Hoffmann La Roche(United States) Pfizer(United States) DB - Embase Medline DO - 10.1097/CCO.0b013e3283477a94 IS - 4 LA - English M3 - Review N1 - L51386460 2011-04-28 2011-06-23 PY - 2011 SN - 1040-8746 1531-703X SP - 352-360 ST - Phase 1 clinical trials for sarcomas: The cutting edge T2 - Current Opinion in Oncology TI - Phase 1 clinical trials for sarcomas: The cutting edge UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51386460&from=export http://dx.doi.org/10.1097/CCO.0b013e3283477a94 VL - 23 ID - 2466 ER - TY - JOUR AD - M. D. Johnson, Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Ave. Box 626, Rochester, NY 14642, United States AU - Johnson, M. D. AU - Shaw, A. K. AU - O'Connell, M. J. AU - Sim, F. J. AU - Moses, H. L. DB - Embase Medline DO - 10.1007/s11060-010-0399-y IS - 2 LA - English M3 - Article N1 - L51077587 2010-09-22 2011-08-09 PY - 2011 SN - 0167-594X 1573-7373 SP - 277-285 ST - Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas T2 - Journal of Neuro-Oncology TI - Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51077587&from=export http://dx.doi.org/10.1007/s11060-010-0399-y VL - 103 ID - 2468 ER - TY - JOUR AD - M. Pigazzi, University of Padova-Città della Speranza, Padova, Italy AU - Pigazzi, M. AU - Manara, E. AU - Baron, E. AU - Beghin, A. AU - Tregnago, C. AU - Basso, G. DB - Embase LA - English M3 - Conference Abstract N1 - L71698418 2014-12-09 PY - 2011 SN - 0390-6078 SP - 250 ST - T(6;11)(Q27;Q23)MLL/AF6 enhances RAS pathway weakening af6 function in myeloid cells T2 - Haematologica TI - T(6;11)(Q27;Q23)MLL/AF6 enhances RAS pathway weakening af6 function in myeloid cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71698418&from=export http://www.haematologica.org/content/96/supplement_2/1.full-text.pdf+html VL - 96 ID - 2469 ER - TY - JOUR AD - N.S. Day, Pediatrics, Columbia University, New York, United States AU - Day, N. S. AU - Ayello, J. AU - Miles, R. R. AU - Perkins, S. AU - Lim, M. S. AU - Waxman, I. AU - Van De Ven, C. AU - Sanger, W. G. AU - Harrison, L. AU - Goldman, S. AU - Cairo, M. S. DB - Embase LA - English M3 - Conference Abstract N1 - L71916723 2015-06-19 PY - 2011 SN - 0923-7534 SP - 146-147 ST - Comparative genomic identification of signaling pathways and targets in pediatric burkitt lymphoma (PBL) T2 - Annals of Oncology TI - Comparative genomic identification of signaling pathways and targets in pediatric burkitt lymphoma (PBL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71916723&from=export VL - 22 ID - 2470 ER - TY - JOUR AD - R. Ciarapica, Department of Oncohematology, IRCCS, Ospedale Pediatrico Bambino Gesù, Roma, Italy AU - Ciarapica, R. AU - Miele, L. AU - Giordano, A. AU - Locatelli, F. AU - Rota, R. C1 - amg 479 ap 23573 mk 0646 r 1507 DB - Embase Medline DO - 10.1186/1741-7015-9-63 LA - English M3 - Short Survey N1 - L51446721 2011-05-31 2011-07-12 PY - 2011 SN - 1741-7015 ST - Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: First implications T2 - BMC Medicine TI - Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: First implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51446721&from=export http://dx.doi.org/10.1186/1741-7015-9-63 http://www.biomedcentral.com/1741-7015/9/63 VL - 9 ID - 2471 ER - TY - JOUR AD - J.M. Hubbard, NCCTG Division of Medical Oncology, Mayo Clinic, Rochester, MN, United States AU - Hubbard, J. M. AU - Alberts, S. R. AU - Loui, W. S. AU - Mahoney, M. R. AU - Roberts, L. R. AU - Smyrk, T. C. AU - Gatalica, Z. AU - Kumar, S. AU - Dakhil, S. R. AU - Flynn, P. J. AU - Lafky, J. M. AU - Bury, M. J. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70710020 2012-04-10 PY - 2011 SN - 0732-183X ST - Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745 T2 - Journal of Clinical Oncology TI - Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70710020&from=export http://meeting.ascopubs.org/cgi/content/abstract/29/15-suppl/4116?sid=4d50f7b6-eb01-440e-95dc-2c30a26d3d85 VL - 29 ID - 2472 ER - TY - JOUR AD - J.C. Van Gaal, Radboud University, Nijmegen Medical Centre, Nijmegen, Netherlands AU - Van Gaal, J. C. AU - Flucke, U. E. AU - Roeffen, M. H. S. AU - De Bont, E. S. AU - Suurmeijer, A. J. AU - Van Der Graaf, W. T. AU - Versleijen-Jonkers, Y. M. H. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70712124 2012-04-10 PY - 2011 SN - 0732-183X ST - Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma T2 - Journal of Clinical Oncology TI - Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70712124&from=export http://meeting.ascopubs.org/cgi/content/abstract/29/15-suppl/9530?sid=8d9ad6cc-2a5b-4910-8d2e-f8e8e436e211 VL - 29 ID - 2473 ER - TY - JOUR AD - K.A. Rauen, UCSF Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, Box 0808, San Francisco, CA 94115, United States AU - Rauen, K. A. AU - Banerjee, A. AU - Bishop, W. R. AU - Lauchle, J. O. AU - McCormick, F. AU - McMahon, M. AU - Melese, T. AU - Munster, P. N. AU - Nadaf, S. AU - Packer, R. J. AU - Sebolt-Leopold, J. AU - Viskochil, D. H. C1 - arry 162(array) arry 162(Novartis) arry 300(array) arry 300(Novartis) arry 704(array) arry 886(array) as 703026(EMD Serono) azd 6244(Astra Zeneca) azd 8330(Astra Zeneca) bms 908662(Bristol Myers Squibb) ch 4987655(Chugai) ci 1040(Pfizer) e 6201(Eisai) gdc 0973(Genentech) gsk 1120212(Glaxo SmithKline) nexavar(Bayer) nexavar(Onyx) pd 0325901(Pfizer) plx 4032(Hoffmann La Roche) plx 4032(Plexxikon) plx 5568(Hoffmann La Roche) plx 5568(Plexxikon) raf 265(Novartis) rdea 119(Ardea) rdea 119(Bayer) rdea 436(Ardea) rdea 436(Bayer) rg 7168(Hoffmann La Roche) sarasar(Merck) sarasar(Schering Plough) tak 733(Millennium) tak 733(Takeda) wx 554(Wilex) xl 281(Exelixis) zarnestra(Johnson and Johnson) C2 - Ardea array Astra Zeneca Bayer Bristol Myers Squibb Chugai Concordia Eisai EMD Serono Exelixis Genentech Glaxo SmithKline Hoffmann La Roche Johnson and Johnson Merck Millennium Novartis Onyx Pfizer Plexxikon Schering Plough Takeda Wilex DB - Embase Medline DO - 10.1002/ajmg.c.30294 IS - 2 LA - English M3 - Article N1 - L51380324 2011-04-19 2011-05-05 PY - 2011 SN - 1552-4868 1552-4876 SP - 136-146 ST - Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies T2 - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics TI - Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51380324&from=export http://dx.doi.org/10.1002/ajmg.c.30294 VL - 157 ID - 2474 ER - TY - JOUR AD - W. P. Schiemann, Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, United States AU - Taylor, M. A. AU - Amin, J. D. AU - Kirschmann, D. A. AU - Schiemann, W. P. DB - Embase Medline DO - 10.1593/neo.101086 IS - 5 LA - English M3 - Article N1 - L361747176 2011-05-18 2011-05-30 PY - 2011 SN - 1522-8002 1476-5586 SP - 406-418 ST - Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells T2 - Neoplasia TI - Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361747176&from=export http://dx.doi.org/10.1593/neo.101086 http://www.neoplasia.com/pdf/manuscript/v13i05/neo101086.pdf VL - 13 ID - 2476 ER - TY - JOUR AD - M. Strazzabosco, Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street/1080 LMP, PO Box 208019, New Haven, CT 06520-8019, United States AU - Wrzesinski, S. H. AU - Taddei, T. H. AU - Strazzabosco, M. C1 - abt 869 azd 2171 gw 786034 ptk 787 zk 222584 DB - Embase Medline DO - 10.1016/j.cld.2011.03.002 IS - 2 LA - English M3 - Review N1 - L361974952 2011-06-27 2011-07-01 PY - 2011 SN - 1089-3261 1557-8224 SP - 423-441 ST - Systemic Therapy in Hepatocellular Carcinoma T2 - Clinics in Liver Disease TI - Systemic Therapy in Hepatocellular Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361974952&from=export http://dx.doi.org/10.1016/j.cld.2011.03.002 VL - 15 ID - 2477 ER - TY - JOUR AD - T. M. Horton, Texas Children's Cancer Center, Baylor College of Medicine, 1102 Bates, Houston, TX 77030, United States AU - Horton, T. M. AU - Berg, S. L. C1 - avastin clolar gleevec nexavar sprycel tasigna velcade yondelis zolinza DB - Embase Medline DO - 10.1007/s00431-010-1374-5 IS - 5 LA - English M3 - Review N1 - L51209450 2011-01-04 2011-05-17 PY - 2011 SN - 0340-6199 SP - 555-559 ST - Educational paper: The development of new therapies for pediatric oncology T2 - European Journal of Pediatrics TI - Educational paper: The development of new therapies for pediatric oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51209450&from=export http://dx.doi.org/10.1007/s00431-010-1374-5 VL - 170 ID - 2478 ER - TY - JOUR AD - A. S. Y. Lau, Molecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong AU - Or, T. C. T. AU - Yang, C. L. H. AU - Law, A. H. Y. AU - Li, J. C. B. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1016/j.neuropharm.2010.12.002 IS - 6 LA - English M3 - Article N1 - L51243361 2011-01-28 2011-03-24 PY - 2011 SN - 0028-3908 SP - 823-831 ST - Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia T2 - Neuropharmacology TI - Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51243361&from=export http://dx.doi.org/10.1016/j.neuropharm.2010.12.002 VL - 60 ID - 2479 ER - TY - JOUR AD - K. Scotlandi, CRS Development of Biomolecular Therapies, Laboratory of Experimental Oncology, Orthopaedic Institute Rizzoli, Bologna 40136, Italy AU - Scotlandi, K. AU - Manara, M. C. AU - Serra, M. AU - Marino, M. T. AU - Ventura, S. AU - Garofalo, C. AU - Alberghini, M. AU - Magagnoli, G. AU - Ferrari, S. AU - Lopez-Guerrero, J. A. AU - Llombard-Bosch, A. AU - Picci, P. DB - Embase Medline DO - 10.1016/j.ejca.2011.01.007 IS - 8 LA - English M3 - Article N1 - L51287721 2011-02-25 2011-05-13 PY - 2011 SN - 0959-8049 SP - 1258-1266 ST - Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival T2 - European Journal of Cancer TI - Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51287721&from=export http://dx.doi.org/10.1016/j.ejca.2011.01.007 VL - 47 ID - 2480 ER - TY - JOUR AD - H. Cin, Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany AU - Cin, H. AU - Meyer, C. AU - Herr, R. AU - Janzarik, W. G. AU - Lambert, S. AU - Jones, D. T. W. AU - Jacob, K. AU - Witt, H. AU - Remke, M. AU - Bender, S. AU - Scheurlen, W. AU - Witt, O. AU - Omran, H. AU - Jabado, N. AU - Peter Collins, V. AU - Brummer, T. AU - Marschalek, R. AU - Lichter, P. AU - Korshunov, A. AU - Pfister, S. M. DB - Embase DO - 10.1093/neuonc/nor018 LA - English M3 - Conference Abstract N1 - L70462918 2011-07-16 PY - 2011 SN - 1522-8517 SP - i2 ST - A novel BRAF fusion gene resulting from 7Q34 deletion constitutes an alternative mechanism of mitogen-activated protein kinase pathway activation in pilocytic astrocytoma T2 - Neuro-Oncology TI - A novel BRAF fusion gene resulting from 7Q34 deletion constitutes an alternative mechanism of mitogen-activated protein kinase pathway activation in pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70462918&from=export http://dx.doi.org/10.1093/neuonc/nor018 VL - 13 ID - 2481 ER - TY - JOUR AD - V. Subbiah, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Subbiah, V. AU - Naing, A. AU - Brown, R. E. AU - Chen, H. AU - Doyle, L. AU - LoRusso, P. AU - Benjamin, R. AU - Anderson, P. AU - Kurzrock, R. C1 - imc a12(Imclone,United States) r 1507(Hoffmann La Roche,United States) sch 717454(Schering,United States) C2 - Hoffmann La Roche(United States) Imclone(United States) Schering(United States) DB - Embase Medline DO - 10.1371/journal.pone.0018424 IS - 4 L1 - internal-pdf://1823089412/journal.pone.0018424.PDF LA - English M3 - Article N1 - L361565151 2011-04-14 2011-04-18 PY - 2011 SN - 1932-6203 ST - Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures T2 - PLoS ONE TI - Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361565151&from=export http://dx.doi.org/10.1371/journal.pone.0018424 VL - 6 ID - 2482 ER - TY - JOUR AD - G. I. Liou, Department of Ophthalmology, Medical College of Georgia, Augusta, GA, United States AU - Ibrahim, A. S. AU - El-Remessy, A. B. AU - Matragoon, S. AU - Zhang, W. AU - Patel, Y. AU - Khan, S. AU - Al-Gayyar, M. M. AU - El-Shishtawy, M. M. AU - Liou, G. I. DB - Embase Medline DO - 10.2337/db10-1160 IS - 4 LA - English M3 - Article N1 - L361526539 2011-04-06 2011-04-12 PY - 2011 SN - 0012-1797 1939-327X SP - 1122-1133 ST - Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes T2 - Diabetes TI - Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361526539&from=export http://dx.doi.org/10.2337/db10-1160 http://diabetes.diabetesjournals.org/content/60/4/1122.full.pdf+html VL - 60 ID - 2483 ER - TY - JOUR AD - N.B. Goren, CEFYBO-UBA-CONICET, Paraguay 2155, Piso 12, Buenos Aires 1121, Argentina AU - Hovsepian, E. AU - Mirkin, G. A. AU - Penas, F. AU - Manzano, A. AU - Bartrons, R. AU - Goren, N. B. DB - Embase Medline DO - 10.1016/j.ijpara.2010.12.002 IS - 5 LA - English M3 - Article N1 - L51262179 2011-03-23 2011-03-29 PY - 2011 SN - 0020-7519 SP - 553-562 ST - Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes T2 - International Journal for Parasitology TI - Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51262179&from=export http://dx.doi.org/10.1016/j.ijpara.2010.12.002 VL - 41 ID - 2484 ER - TY - JOUR AD - B. S. Braun, Department of Pediatrics, University of California, San Francisco, CA 94158, United States AU - Lyubynska, N. AU - Gorman, M. F. AU - Lauchle, J. O. AU - Hong, W. X. AU - Akutagawa, J. K. AU - Shannon, K. AU - Braun, B. S. C1 - pd 0325901(Pfizer) C2 - Pfizer DB - Embase Medline DO - 10.1126/scitranslmed.3001069 IS - 76 LA - English M3 - Article N1 - L361532839 2011-04-07 2011-04-28 PY - 2011 SN - 1946-6234 1946-6242 ST - A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice T2 - Science Translational Medicine TI - A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361532839&from=export http://dx.doi.org/10.1126/scitranslmed.3001069 http://stm.sciencemag.org/content/3/76/76ra27.full.pdf VL - 3 ID - 2485 ER - TY - JOUR AD - M. R. Litzow, Department of Hematology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States AU - Litzow, M. R. C1 - bcx 1777 campath 1h DB - Embase Medline DO - 10.2165/11588950-000000000-00000 IS - 4 LA - English M3 - Review N1 - L361425437 2011-03-21 2011-03-28 PY - 2011 SN - 0012-6667 1179-1950 SP - 415-442 ST - Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults T2 - Drugs TI - Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361425437&from=export http://dx.doi.org/10.2165/11588950-000000000-00000 VL - 71 ID - 2486 ER - TY - JOUR AD - M.L. Loh, Health Sciences East 302, 513 Parnassus Ave, San Francisco, CA 94143-0519, United States AU - Loh, M. L. C1 - azd 6244 bay 43 9006 ci 1040 incb 018424(Incyte) incb 018424(Novartis) r 115777 C2 - Incyte Novartis DB - Embase Medline DO - 10.1111/j.1365-2141.2010.08525.x IS - 6 LA - English M3 - Article N1 - L361328443 2011-03-07 PY - 2011 SN - 0007-1048 1365-2141 SP - 677-687 ST - Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia T2 - British Journal of Haematology TI - Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361328443&from=export http://dx.doi.org/10.1111/j.1365-2141.2010.08525.x VL - 152 ID - 2487 ER - TY - JOUR AD - A.-L. Cheng, National Taiwan University Hospital, Taipei, Taiwan AU - Cheng, A. L. DB - Embase DO - 10.1007/s12072-010-9241-z IS - 1 LA - English M3 - Conference Abstract N1 - L70368944 2011-03-30 PY - 2011 SN - 1936-0533 SP - 28 ST - Molecular targeted therapy for advanced hepatocellular carcinoma: Sorafenib and beyond T2 - Hepatology International TI - Molecular targeted therapy for advanced hepatocellular carcinoma: Sorafenib and beyond UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70368944&from=export http://dx.doi.org/10.1007/s12072-010-9241-z VL - 5 ID - 2489 ER - TY - JOUR AD - K.W. Gripp, Department of Medical Genetics, Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE, United States AU - Gripp, K. W. DB - Embase DO - 10.1007/s11825-011-0264-1 IS - 1 LA - English M3 - Conference Abstract N1 - L70406898 2011-05-10 PY - 2011 SN - 0936-5931 SP - 65 ST - The rasopathies: Distinct disorders related by dysregulation of the Ras/MAPK signalling pathway T2 - Medizinische Genetik TI - The rasopathies: Distinct disorders related by dysregulation of the Ras/MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70406898&from=export http://dx.doi.org/10.1007/s11825-011-0264-1 VL - 23 ID - 2490 ER - TY - JOUR AD - A.M. Planas, Department of Brain Ischemia and Neurodegeneration, IIBB-CSIC, IDIBAPS, Rossello 161, planta 6, 08036-Barcelona, Spain AU - Gorina, R. AU - Font-Nieves, M. AU - Márquez-Kisinousky, L. AU - Santalucia, T. AU - Planas, A. M. DB - Embase Medline DO - 10.1002/glia.21094 IS - 2 LA - English M3 - Article N1 - L360172206 2010-12-24 2010-12-30 PY - 2011 SN - 0894-1491 1098-1136 SP - 242-255 ST - Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways T2 - GLIA TI - Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360172206&from=export http://dx.doi.org/10.1002/glia.21094 VL - 59 ID - 2492 ER - TY - JOUR AD - K. Hunter-Schaedle, Children's Tumor Foundation, 95 Pine Street, New York, NY 10005, United States AU - Huson, S. M. AU - Acosta, M. T. AU - Belzberg, A. J. AU - Bernards, A. AU - Chernoff, J. AU - Cichowski, K. AU - Gareth Evans, D. AU - Ferner, R. E. AU - Giovannini, M. AU - Korf, B. R. AU - Listernick, R. AU - North, K. N. AU - Packer, R. J. AU - Parada, L. F. AU - Peltonen, J. AU - Ramesh, V. AU - Reilly, K. M. AU - Risner, J. W. AU - Schorry, E. K. AU - Upadhyaya, M. AU - Viskochil, D. H. AU - Zhu, Y. AU - Hunter-Schaedle, K. AU - Giancotti, F. G. C1 - azd 6244 hdac 42 osu 03012 rad 001 DB - Embase Medline DO - 10.1002/ajmg.a.33804 IS - 2 LA - English M3 - Conference Paper N1 - L361175661 2011-02-02 2011-02-04 PY - 2011 SN - 1552-4825 1552-4833 SP - 307-321 ST - Back to the future: Proceedings from the 2010 NF Conference T2 - American Journal of Medical Genetics, Part A TI - Back to the future: Proceedings from the 2010 NF Conference UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361175661&from=export http://dx.doi.org/10.1002/ajmg.a.33804 VL - 155 ID - 2493 ER - TY - JOUR AD - J. F. Cryan, School of Pharmacy, Cavanagh Pharmacy Bldg., University College Cork, Cork, Ireland AU - O'Malley, D. AU - Liston, M. AU - Hyland, N. P. AU - Dinan, T. G. AU - Cryan, J. F. DB - Embase Medline DO - 10.1152/ajpgi.00385.2010 IS - 2 L1 - internal-pdf://1469262009/ajpgi.00385.2010.pdf LA - English M3 - Article N1 - L361185014 2011-02-04 2011-02-09 PY - 2011 SN - 0193-1857 1522-1547 SP - G241-G252 ST - Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361185014&from=export http://dx.doi.org/10.1152/ajpgi.00385.2010 VL - 300 ID - 2494 ER - TY - JOUR AD - R. Kobayashi, St. Lukes International Hospital, Tokyo, Japan AU - Kobayashi, R. AU - Eto, H. AU - Kajiwara, T. AU - Nakano, T. AU - Momose, Y. DB - Embase DO - 10.1016/j.jaad.2010.09.492 IS - 2 LA - English M3 - Conference Abstract N1 - L70331764 2011-02-03 PY - 2011 SN - 0190-9622 SP - AB116 ST - Childhood primary cutaneous CD30-positive anaplastic large cell lymphoma: A child case with spontaneous regression T2 - Journal of the American Academy of Dermatology TI - Childhood primary cutaneous CD30-positive anaplastic large cell lymphoma: A child case with spontaneous regression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70331764&from=export http://dx.doi.org/10.1016/j.jaad.2010.09.492 VL - 64 ID - 2495 ER - TY - JOUR AD - V.S. Budhram-Mahadeo, Cardiovascular Division, King's College London, Department of Cardiology, The Rayne Institute, St Thomas's Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom AU - Ounzain, S. AU - Bowen, S. AU - Patel, C. AU - Fujita, R. AU - Heads, R. J. AU - Budhram-Mahadeo, V. S. DB - Embase Medline DO - 10.1186/bcr2809 IS - 1 LA - English M3 - Article N1 - L51237515 2011-01-21 2011-08-30 PY - 2011 SN - 1465-5411 1465-542X ST - Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway T2 - Breast Cancer Research TI - Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51237515&from=export http://dx.doi.org/10.1186/bcr2809 http://breast-cancer-research.com/content/13/1/R5 VL - 13 ID - 2497 ER - TY - JOUR AD - A. Leonardi, via Giustiniani 2, 35128 Padova, Italy AU - Leonardi, A. AU - Di Stefano, A. AU - Motterle, L. AU - Zavan, B. AU - Abatangelo, G. AU - Brun, P. DB - Embase Medline DO - 10.1111/j.1365-2222.2010.03626.x IS - 1 LA - English M3 - Article N1 - L360135433 2010-12-20 2010-12-23 PY - 2011 SN - 0954-7894 1365-2222 SP - 52-60 ST - Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis T2 - Clinical and Experimental Allergy TI - Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360135433&from=export http://dx.doi.org/10.1111/j.1365-2222.2010.03626.x VL - 41 ID - 2498 ER - TY - JOUR AD - M. Mempel, Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU München, Biedersteiner Str. 29, D-80802 München, Germany AU - Claßen, A. AU - Kalali, B. N. AU - Schnopp, C. AU - Andres, C. AU - Aguilar-Pimentel, J. A. AU - Ring, J. AU - Ollert, M. AU - Mempel, M. DB - Embase Medline DO - 10.1111/j.1600-0625.2010.01174.x IS - 1 LA - English M3 - Article N1 - L360167305 2010-12-23 2011-01-04 PY - 2011 SN - 0906-6705 1600-0625 SP - 48-52 ST - TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP 1, and downstream gene transcription T2 - Experimental Dermatology TI - TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP 1, and downstream gene transcription UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360167305&from=export http://dx.doi.org/10.1111/j.1600-0625.2010.01174.x VL - 20 ID - 2499 ER - TY - JOUR AD - A. Mathew, Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, S6-862, 55 Lake Avenue North, Worcester, MA 01655, United States AU - Friberg, H. AU - Burns, L. AU - Woda, M. AU - Kalayanarooj, S. AU - Endy, T. P. AU - Stephens, H. A. F. AU - Green, S. AU - Rothman, A. L. AU - Mathew, A. DB - Embase Medline DO - 10.1038/icb.2010.61 IS - 1 LA - English M3 - Article N1 - L50889876 2010-04-29 2011-02-01 PY - 2011 SN - 0818-9641 1440-1711 SP - 122-129 ST - Memory CD8 T cells from naturally acquired primary dengue virus infection are highly cross-reactive T2 - Immunology and Cell Biology TI - Memory CD8 T cells from naturally acquired primary dengue virus infection are highly cross-reactive UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50889876&from=export http://dx.doi.org/10.1038/icb.2010.61 VL - 89 ID - 2501 ER - TY - JOUR AD - D. Y. M. Leung, Department of Pediatrics, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, United States AU - Kim, B. E. AU - Howell, M. D. AU - Guttman, E. AU - Gilleaudeau, P. M. AU - Cardinale, I. R. AU - Boguniewicz, M. AU - Krueger, J. G. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1038/jid.2011.24 IS - 6 LA - English M3 - Article N1 - L51293568 2011-05-24 2019-07-16 PY - 2011 SN - 1523-1747 0022-202X SP - 1272-1279 ST - TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-α antagonists to improve skin barrier T2 - Journal of Investigative Dermatology TI - TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-α antagonists to improve skin barrier UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51293568&from=export http://dx.doi.org/10.1038/jid.2011.24 VL - 131 ID - 2502 ER - TY - JOUR AD - G.-D. Li, Department of Pathology, West China Hospital of Sichuan University, Chengdu, China AU - Wang, W. Y. AU - Gu, L. AU - Liu, W. P. AU - Li, G. D. AU - Liu, H. J. AU - Ma, Z. G. DB - Embase Medline DO - 10.1016/j.prp.2011.07.001 IS - 9 LA - English M3 - Article N1 - L51579172 2011-08-23 2011-10-25 PY - 2011 SN - 1618-0631 0344-0338 SP - 587-591 ST - ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript T2 - Pathology Research and Practice TI - ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51579172&from=export http://dx.doi.org/10.1016/j.prp.2011.07.001 VL - 207 ID - 2503 ER - TY - JOUR AD - K. Dunleavy, National Cancer Institute, Building 10, 10 Center Drive, Bethesda, MD 20892-1868, United States AU - Dunleavy, K. AU - Piekarz, R. L. AU - Zain, J. AU - Janik, J. E. AU - Wilson, W. H. AU - O'Connor, O. A. AU - Bates, S. E. C1 - campath fk 228 MDX 060 ontak pxd 101 sgn 30 sgn 35 DB - Embase Medline DO - 10.1158/1078-0432.CCR-09-1995 IS - 23 LA - English M3 - Review N1 - L360186126 2010-12-28 2011-01-06 PY - 2010 SN - 1078-0432 1557-3265 SP - 5608-5617 ST - New strategies in peripheral T-cell lymphoma: Understanding tumor biology and developing novel therapies T2 - Clinical Cancer Research TI - New strategies in peripheral T-cell lymphoma: Understanding tumor biology and developing novel therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360186126&from=export http://dx.doi.org/10.1158/1078-0432.CCR-09-1995 http://clincancerres.aacrjournals.org/content/16/23/5608.full.pdf+html VL - 16 ID - 2505 ER - TY - JOUR AD - R. Béliveau, Laboratoire d'Oncologie Moléculaire, Université du Québec à Montréal, C.P. 8888, Succ. Centre-ville, Montréal, QC, H3C 3P8, Canada AU - Annabi, B. AU - Vaillancourt-Jean, E. AU - Weil, A. G. AU - Béliveau, R. DB - Embase DO - 10.2147/OTT.S14503 LA - English M3 - Article N1 - L365235894 2012-07-20 2012-08-02 PY - 2010 SN - 1178-6930 SP - 219-226 ST - Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells T2 - OncoTargets and Therapy TI - Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365235894&from=export http://dx.doi.org/10.2147/OTT.S14503 http://www.dovepress.com/oncotargets-and-therapy-journal VL - 3 ID - 2507 ER - TY - JOUR AD - G. I. Liou, Department of Ophthalmology, Medical College of Georgia, 1120 15th Street, Augusta, GA, 30912, United States AU - Ibrahim, A. S. AU - El-Shishtawy, M. M. AU - Peña Jr, A. AU - Liou, G. I. DB - Embase Medline L1 - internal-pdf://1057467587/mv-v16-a219-ibrahim.pdf LA - English M3 - Article N1 - L359944870 2010-11-22 2010-11-24 PY - 2010 SN - 1090-0535 SP - 2033-2042 ST - Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation T2 - Molecular Vision TI - Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359944870&from=export VL - 16 ID - 2508 ER - TY - JOUR AD - R. P. Piekorz, Institut Fü R Biochemie und Molekularbiologie II, Universitä Tsklinikum der Heinrich-Heine-Universitä T, Düsseldorf D-40225, Germany AU - Schmidt, S. AU - Schneider, L. AU - Essmann, F. AU - Cirstea, I. C. AU - Kuck, F. AU - Kletke, A. AU - Jänicke, R. U. AU - Wiek, C. AU - Hanenberg, H. AU - Ahmadian, M. R. AU - Schulze-Osthoff, K. AU - Nürnberg, B. AU - Piekorz, R. P. DB - Embase Medline DO - 10.1038/onc.2010.354 IS - 46 LA - English M3 - Article N1 - L51043985 2010-12-02 2010-12-07 PY - 2010 SN - 0950-9232 1476-5594 SP - 6184-6192 ST - The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program T2 - Oncogene TI - The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51043985&from=export http://dx.doi.org/10.1038/onc.2010.354 VL - 29 ID - 2509 ER - TY - JOUR AD - R.C. Bunn, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, United States AU - Bunn, R. C. AU - Cockrell, G. E. AU - Ou, Y. AU - Thrailkill, K. M. AU - Lumpkin Jr, C. K. AU - Fowlkes, J. L. DB - Embase Medline DO - 10.1186/1475-2840-9-73 LA - English M3 - Article N1 - L51142967 2010-11-11 2010-12-02 PY - 2010 SN - 1475-2840 ST - Palmitate and insulin synergistically induce IL-6 expression in human monocytes T2 - Cardiovascular Diabetology TI - Palmitate and insulin synergistically induce IL-6 expression in human monocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51142967&from=export http://dx.doi.org/10.1186/1475-2840-9-73 http://www.cardiab.com/content/9/1/73 VL - 9 ID - 2510 ER - TY - JOUR AD - A. Nakagawara, Division of Biochemistry, Innovative Cancer Therapeutics, Japan AU - Ohira, M. AU - Nakagawara, A. DB - Embase Medline DO - 10.1111/j.1349-7006.2010.01681.x IS - 11 LA - English M3 - Review N1 - L359878951 2010-11-11 2010-11-19 PY - 2010 SN - 1347-9032 1349-7006 SP - 2295-2301 ST - Global genomic and RNA profiles for novel risk stratification of neuroblastoma T2 - Cancer Science TI - Global genomic and RNA profiles for novel risk stratification of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359878951&from=export http://dx.doi.org/10.1111/j.1349-7006.2010.01681.x VL - 101 ID - 2511 ER - TY - JOUR AD - I. Jeremias, Helmholtz Zentrum Muenchen, Gene Vectors, Munich, Germany AU - Jeremias, I. AU - Gündisch, S. AU - Baader, E. AU - Amtmann, E. AU - Ehrhardt, H. DB - Embase DO - 10.1016/S1359-6349(10)72157-1 IS - 7 LA - English M3 - Conference Abstract N1 - L70310353 2010-12-10 PY - 2010 SN - 1359-6349 SP - 142 ST - Glucocorticoids frequently induce survival and growth in tumor cells by activation of classical survival and proliferation pathways which should be avoided during anti-cancer therapy T2 - European Journal of Cancer, Supplement TI - Glucocorticoids frequently induce survival and growth in tumor cells by activation of classical survival and proliferation pathways which should be avoided during anti-cancer therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70310353&from=export http://dx.doi.org/10.1016/S1359-6349(10)72157-1 VL - 8 ID - 2512 ER - TY - GEN AD - D. L. Stirewalt, Clinical Research Division, From Fred Hutchinson Cancer Research Center, Seattle, WA, United States AU - Stirewalt, D. L. AU - Meshinchi, S. C1 - amn 107 bms 354825 cep 5214(Cephalon) cep 701(Cephalon) ct 53518(Millennium) gleevec mln 518 pkc 412(Novartis) su 11248(Sugen) su 5614(Sugen) C2 - Cephalon Millennium Novartis Sugen C5 - 20306247 DB - Embase Medline DO - 10.1007/978-0-387-69259-3_6 J2 - Cancer Treat. Res. LA - English M1 - (Stirewalt D.L., dstirewa@fhcrc.org) Clinical Research Division, From Fred Hutchinson Cancer Research Center, Seattle, WA, United States M3 - Review N1 - L359445729 2010-09-08 2010-10-04 PY - 2010 SN - 0927-3042 9780387692579 SP - 85-108 ST - Receptor tyrosine kinase alterations in AML - Biology and therapy TI - Receptor tyrosine kinase alterations in AML - Biology and therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359445729&from=export http://dx.doi.org/10.1007/978-0-387-69259-3_6 VL - 145 ID - 2513 ER - TY - JOUR AD - D. K. Graham, University of Colorado, Denver School of Medicine, Department of Pediatrics, 12800 E. 19th Avenue, Aurora, CO 80045, United States AU - Linger, R. M. A. AU - Keating, A. K. AU - Earp, H. S. AU - Graham, D. K. C1 - bms 777607(Bristol Myers Squibb) gsk 1363089(Glaxo SmithKline) mp 470(Supergen) pf 2341066(Pfizer) pf 5208763(Pfizer) r 428(Rigel) ski 606(Wyeth) C2 - Bristol Myers Squibb Glaxo SmithKline Pfizer Rigel Supergen Wyeth DB - Embase Medline DO - 10.1517/14728222.2010.515980 IS - 10 LA - English M3 - Review N1 - L359632597 2010-10-04 2010-10-08 PY - 2010 SN - 1472-8222 SP - 1073-1090 ST - Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors T2 - Expert Opinion on Therapeutic Targets TI - Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359632597&from=export http://dx.doi.org/10.1517/14728222.2010.515980 VL - 14 ID - 2514 ER - TY - JOUR AD - S. Küpeli, Department of Pediatric Oncology, Institute of Oncology, Hacettepe University, 06100 Ankara, Turkey AU - Daar, G. AU - Küpeli, S. AU - Yalçin, B. AU - Kesik, V. AU - Orhan, D. AU - Büyükpamukçu, M. DB - Embase Medline DO - 10.3109/08880018.2010.493575 IS - 7 LA - English M3 - Article N1 - L359672096 2010-10-07 2010-10-13 PY - 2010 SN - 0888-0018 1521-0669 SP - 558-563 ST - Primary cutaneous anaplastic large cell lymphoma T2 - Pediatric Hematology and Oncology TI - Primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359672096&from=export http://dx.doi.org/10.3109/08880018.2010.493575 VL - 27 ID - 2515 ER - TY - JOUR AD - H. S. Bernstein, University of California, Box 1346, 513 Parnassus Avenue, San Francisco, CA 941431346, United States AU - Gaur, M. AU - Ritner, C. AU - Sievers, R. AU - Pedersen, A. AU - Prasad, M. AU - Bernstein, H. S. AU - Yeghiazarians, Y. DB - Embase Medline DO - 10.3109/14653249.2010.491821 IS - 6 LA - English M3 - Article N1 - L359686167 2010-10-11 2010-10-28 PY - 2010 SN - 1465-3249 1477-2566 SP - 807-817 ST - Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes T2 - Cytotherapy TI - Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359686167&from=export http://dx.doi.org/10.3109/14653249.2010.491821 VL - 12 ID - 2516 ER - TY - JOUR AD - B. Kerr, University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom AU - Burkitt Wright, E. M. M. AU - Kerr, B. DB - Embase Medline DO - 10.1136/adc.2009.160069 IS - 9 LA - English M3 - Review N1 - L359374104 2010-08-26 2010-09-02 PY - 2010 SN - 0003-9888 1468-2044 SP - 724-730 ST - RAS-MAPK pathway disorders: Important causes of congenital heart disease, feeding difficulties, developmental delay and short stature T2 - Archives of Disease in Childhood TI - RAS-MAPK pathway disorders: Important causes of congenital heart disease, feeding difficulties, developmental delay and short stature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359374104&from=export http://dx.doi.org/10.1136/adc.2009.160069 http://adc.bmj.com/content/95/9/724.full.pdf VL - 95 ID - 2517 ER - TY - JOUR AD - X. Wang, Department of Anesthesiology, Renji Hospital, Shanghai Jiaotong University School of Medicine, 1630 Dong Fang Road, Shanghai 200127, China AU - Su, D. AU - Gu, Y. AU - Wang, Z. AU - Wang, X. DB - Embase Medline DO - 10.1213/ANE.0b013e3181e9e897 IS - 3 LA - English M3 - Article N1 - L51021976 2010-08-13 2010-11-25 PY - 2010 SN - 0003-2999 SP - 768-774 ST - Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia T2 - Anesthesia and Analgesia TI - Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51021976&from=export http://dx.doi.org/10.1213/ANE.0b013e3181e9e897 VL - 111 ID - 2518 ER - TY - JOUR AD - B.-L. Chiang, Department of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan AU - Chiang, B. L. AU - Lee, J. H. AU - Wang, L. C. AU - Yu, H. H. AU - Lin, Y. T. AU - Yang, Y. H. DB - Embase Medline DO - 10.1155/2010/567351 LA - English M3 - Review N1 - L359312695 2010-08-17 2010-08-20 PY - 2010 SN - 0962-9351 1466-1861 ST - Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma T2 - Mediators of Inflammation TI - Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359312695&from=export http://dx.doi.org/10.1155/2010/567351 VL - 2010 ID - 2519 ER - TY - JOUR AD - N. Rosen, Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, United States AU - Joseph, E. W. AU - Pratilas, C. A. AU - Poulikakos, P. I. AU - Tadi, M. AU - Wang, W. AU - Taylor, B. S. AU - Halilovic, E. AU - Persaud, Y. AU - Xing, F. AU - Viale, A. AU - Tsai, J. AU - Chapman, P. B. AU - Bollag, G. AU - Solit, D. B. AU - Rosen, N. C1 - pd 0325901 plx 4032 DB - Embase Medline DO - 10.1073/pnas.1008990107 IS - 33 L1 - internal-pdf://2624151020/14903.full.pdf LA - English M3 - Article N1 - L359663606 2010-10-05 2010-10-12 PY - 2010 SN - 0027-8424 1091-6490 SP - 14903-14908 ST - The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner T2 - Proceedings of the National Academy of Sciences of the United States of America TI - The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359663606&from=export http://dx.doi.org/10.1073/pnas.1008990107 VL - 107 ID - 2520 ER - TY - JOUR AD - D.Y.M. Leung, Division of Pediatric Allergy and Immunology, National Jewish Health, 1400 Jackson Street, K926i, Denver, CO 80206, United States AU - Searing, D. A. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1016/j.iac.2010.05.005 IS - 3 LA - English M3 - Review N1 - L359338254 2010-08-19 2010-09-13 PY - 2010 SN - 0889-8561 SP - 397-409 ST - Vitamin D in atopic dermatitis, asthma and allergic diseases T2 - Immunology and Allergy Clinics of North America TI - Vitamin D in atopic dermatitis, asthma and allergic diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359338254&from=export http://dx.doi.org/10.1016/j.iac.2010.05.005 VL - 30 ID - 2521 ER - TY - JOUR AD - T. Forshew, Queen Mary University of London, Centre for Neuroscience and Trauma, Barts and the London School of Medicine and Dentistry, London El 2AT, United Kingdom AU - Lawson, A. R. J. AU - Tatevossian, R. G. AU - Phipps, K. P. AU - Picker, S. R. AU - Michalski, A. AU - Sheer, D. AU - Jacques, T. S. AU - Forshew, T. DB - Embase Medline DO - 10.1007/s00401-010-0693-y IS - 2 LA - English M3 - Note N1 - L50904185 2010-05-19 2010-12-02 PY - 2010 SN - 0001-6322 SP - 271-273 ST - RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort T2 - Acta Neuropathologica TI - RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50904185&from=export http://dx.doi.org/10.1007/s00401-010-0693-y VL - 120 ID - 2522 ER - TY - JOUR AD - W. A. Horton, Research Center, Shriners Hospital for Children, 3101 SW Sam Jackson Park Road, Portland, OR 97239, United States AU - Laederich, M. B. AU - Horton, W. A. DB - Embase Medline DO - 10.1097/MOP.0b013e32833b7a69 IS - 4 LA - English M3 - Review N1 - L50980323 2010-07-07 2010-08-18 PY - 2010 SN - 1040-8703 SP - 516-523 ST - Achondroplasia: Pathogenesis and implications for future treatment T2 - Current Opinion in Pediatrics TI - Achondroplasia: Pathogenesis and implications for future treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50980323&from=export http://dx.doi.org/10.1097/MOP.0b013e32833b7a69 VL - 22 ID - 2523 ER - TY - JOUR AD - R. D. Gascoyne, Department of Pathology and Advanced Therapeutics, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada AU - Steidl, C. AU - Telenius, A. AU - Shah, S. P. AU - Farinha, P. AU - Barclay, L. AU - Boyle, M. AU - Connors, J. M. AU - Horsman, D. E. AU - Gascoyne, R. D. DB - Embase Medline DO - 10.1182/blood-2009-12-257345 IS - 3 LA - English M3 - Article N1 - L359514020 2010-09-21 2010-09-27 PY - 2010 SN - 0006-4971 1528-0020 SP - 418-427 ST - Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome T2 - Blood TI - Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359514020&from=export http://dx.doi.org/10.1182/blood-2009-12-257345 http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/418 VL - 116 ID - 2524 ER - TY - JOUR AD - D. W. Clapp, Cancer Research Institute, Bldg. R4, 1044 W Walnut St, Indianapolis, IN 46202, United States AU - Staser, K. AU - Yang, F. C. AU - Clapp, D. W. C1 - gleevec DB - Embase Medline DO - 10.1182/blood-2009-09-242875 IS - 2 LA - English M3 - Review N1 - L359513990 2010-09-21 2010-09-27 PY - 2010 SN - 0006-4971 1528-0020 SP - 157-164 ST - Mast cells and the neurofibroma microenvironment T2 - Blood TI - Mast cells and the neurofibroma microenvironment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359513990&from=export http://dx.doi.org/10.1182/blood-2009-09-242875 http://bloodjournal.hematologylibrary.org/cgi/reprint/116/2/157 VL - 116 ID - 2525 ER - TY - JOUR AD - J. Tao, National University of Singapore, Singapore, Singapore AU - Tao, J. AU - Ramnarayanan, K. AU - Huang, B. AU - Tan, I. B. AU - Ooi, C. H. AU - Lee, M. AU - Zhang, S. AU - Leong, S. H. AU - Ivanova, T. AU - Ganesan, K. AU - Gopalakrishnan, V. AU - Rha, S. Y. AU - Chung, H. C. AU - Yap, C. AU - Palanisamy, N. AU - Tan, P. DB - Embase DO - 10.1158/1078-0432.TCMUSA10-PR1 IS - 14 LA - English M3 - Conference Abstract N1 - L70788188 2012-06-25 PY - 2010 SN - 1078-0432 ST - Genomic discovery of CD44-SLC1A2 gene fusions in gastric cancer T2 - Clinical Cancer Research TI - Genomic discovery of CD44-SLC1A2 gene fusions in gastric cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70788188&from=export http://dx.doi.org/10.1158/1078-0432.TCMUSA10-PR1 http://clincancerres.aacrjournals.org/cgi/content/meeting_abstract/16/14_MeetingAbstracts/PR1?sid=4ec36e38-e4de-48bd-bd64-ac3c9087fcb1 VL - 16 ID - 2526 ER - TY - JOUR AD - D. B. Solit, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States AU - Pratilas, C. A. AU - Solit, D. B. C1 - azd 6244(Astra Zeneca) ci 1040(Pfizer) exelixis nexavar pd 0325901(Pfizer) raf 265(Novartis) C2 - Astra Zeneca Hoffmann La Roche Novartis Pfizer Plexxikon DB - Embase Medline DO - 10.1158/1078-0432.CCR-09-3064 IS - 13 LA - English M3 - Review N1 - L359110829 2010-07-12 2010-07-19 PY - 2010 SN - 1078-0432 1557-3265 SP - 3329-3334 ST - Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response T2 - Clinical Cancer Research TI - Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359110829&from=export http://dx.doi.org/10.1158/1078-0432.CCR-09-3064 http://clincancerres.aacrjournals.org/content/16/13/3329.full.pdf+html VL - 16 ID - 2527 ER - TY - JOUR AD - D. P. M. Hughes, Department of Pediatrics Research, Children's Cancer Hospital, University of Texas M. D. Anderson Cancer Center, Box 0853, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Richards, K. N. AU - Zweidler-McKay, P. A. AU - Van Roy, N. AU - Speleman, F. AU - Trevino, J. AU - Zage, P. E. AU - Hughes, D. P. M. C1 - ci 1033(Pfizer,United States) C2 - Osi(United States) Pfizer(United States) DB - Embase Medline DO - 10.1002/cncr.25073 IS - 13 LA - English M3 - Article N1 - L359118913 2010-07-13 2010-07-19 PY - 2010 SN - 0008-543X 1097-0142 SP - 3233-3243 ST - Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo T2 - Cancer TI - Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359118913&from=export http://dx.doi.org/10.1002/cncr.25073 http://www3.interscience.wiley.com/cgi-bin/fulltext/123359347/PDFSTART VL - 116 ID - 2528 ER - TY - JOUR AD - P. Kovacic, Department of Chemistry, San Diego State University, 5500 Campanile Dr., San Diego, CA 92182 1030, United States AU - Kovacic, P. DB - Embase Medline DO - 10.1016/j.mehy.2010.03.002 IS - 1 LA - English M3 - Editorial N1 - L50859058 2010-04-07 2010-08-05 PY - 2010 SN - 0306-9877 SP - 1-4 ST - How safe is bisphenol A? Fundamentals of toxicity: Metabolism, electron transfer and oxidative stress T2 - Medical Hypotheses TI - How safe is bisphenol A? Fundamentals of toxicity: Metabolism, electron transfer and oxidative stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50859058&from=export http://dx.doi.org/10.1016/j.mehy.2010.03.002 VL - 75 ID - 2529 ER - TY - JOUR AD - J. Shipley, Molecular Cytogenetics Team, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom AU - Missiaglia, E. AU - Shepherd, C. J. AU - Patel, S. AU - Thway, K. AU - Pierron, G. AU - Pritchard-Jones, K. AU - Renard, M. AU - Sciot, R. AU - Rao, P. AU - Oberlin, O. AU - Delattre, O. AU - Shipley, J. DB - Embase Medline DO - 10.1038/sj.bjc.6605684 IS - 12 LA - English M3 - Article N1 - L50926958 2010-05-27 2010-06-28 PY - 2010 SN - 0007-0920 1532-1827 SP - 1769-1777 ST - MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas T2 - British Journal of Cancer TI - MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50926958&from=export http://dx.doi.org/10.1038/sj.bjc.6605684 VL - 102 ID - 2530 ER - TY - JOUR AD - M. L. Bernstein, IWK Health Center, Hematology-Oncology, 5850/5980 University Avenue, Halifax, NS B3K 6R8, Canada AU - George, R. E. AU - Diller, L. AU - Bernstein, M. L. C1 - 17 AAG cep 701 g 3139 imc a 12 pf 2341066 ps 341 DB - Embase Medline DO - 10.1517/14656566.2010.482100 IS - 9 LA - English M3 - Review N1 - L358877723 2010-06-02 2010-06-10 PY - 2010 SN - 1465-6566 SP - 1467-1478 ST - Pharmacotherapy of neuroblastoma T2 - Expert Opinion on Pharmacotherapy TI - Pharmacotherapy of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358877723&from=export http://dx.doi.org/10.1517/14656566.2010.482100 VL - 11 ID - 2531 ER - TY - JOUR AD - L.-O. Brandenburg, Department of Anatomy and Cell Biology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany AU - Brandenburg, L. O. AU - Kipp, M. AU - Lucius, R. AU - Pufe, T. AU - Wruck, C. J. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1007/s00011-009-0116-5 IS - 6 LA - English M3 - Article N1 - L50708965 2009-11-20 2010-07-22 PY - 2010 SN - 1023-3830 1420-908X SP - 443-450 ST - Sulforaphane suppresses LPS-induced inflammation in primary rat microglia T2 - Inflammation Research TI - Sulforaphane suppresses LPS-induced inflammation in primary rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50708965&from=export http://dx.doi.org/10.1007/s00011-009-0116-5 VL - 59 ID - 2532 ER - TY - JOUR AD - C.-M. Lin, Department of Emergency Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan AU - Shyu, K. G. AU - Wang, B. W. AU - Lin, C. M. AU - Chang, H. C1 - pd 98059(Calbiochem,United States) sb 203580(Calbiochem,United States) sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1186/1423-0127-17-15 IS - 1 LA - English M3 - Article N1 - L358526462 2010-04-02 2010-05-20 PY - 2010 SN - 1021-7770 1423-0127 ST - Cyclic stretch enhances the expression of Toll-like Receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-κB pathway T2 - Journal of Biomedical Science TI - Cyclic stretch enhances the expression of Toll-like Receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358526462&from=export http://dx.doi.org/10.1186/1423-0127-17-15 VL - 17 ID - 2533 ER - TY - JOUR AD - L. C. Platanias, Robert H. Lurie Comprehensive Cancer Center and Division of Hematology/Oncology, Northwestern University Medical School, Jesse Brown VA Medical Center, Chicago, IL, United States AU - McNeer, J. L. AU - Goussetis, D. J. AU - Sassano, A. AU - Dolniak, B. AU - Kroczynska, B. AU - Glaser, H. AU - Altman, J. K. AU - Platanias, L. C. DB - Embase Medline DO - 10.1124/mol.109.061507 IS - 5 LA - English M3 - Article N1 - L358653462 2010-04-27 2010-05-17 PY - 2010 SN - 0026-895X 1521-0111 SP - 828-835 ST - Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-β-activated kinase T2 - Molecular Pharmacology TI - Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-β-activated kinase UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358653462&from=export http://dx.doi.org/10.1124/mol.109.061507 http://molpharm.aspetjournals.org/content/77/5/828.full.pdf VL - 77 ID - 2534 ER - TY - JOUR AD - L. Diaz-Cueto, IMSS, Apartado Postal 99-065, Unidad Independencia 10101 México D. F., Mexico AU - Cuevas-Antonio, R. AU - Cancino, C. AU - Arechavaleta-Velasco, F. AU - Andrade, A. AU - Barron, L. AU - Estrada, I. AU - Fernandez, R. L. AU - Olguin, V. AU - Ruiz, S. AU - Imani, F. AU - Zeferino-Toquero, M. AU - Ulloa-Aguirre, A. AU - Gerton, G. L. AU - Diaz-Cueto, L. DB - Embase Medline DO - 10.3109/07357900903346455 IS - 5 LA - English M3 - Article N1 - L358798748 2010-05-20 2010-05-31 PY - 2010 SN - 0735-7907 1532-4192 SP - 452-458 ST - Expression of progranulin (acrogranin/pcdgf/granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line T2 - Cancer Investigation TI - Expression of progranulin (acrogranin/pcdgf/granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358798748&from=export http://dx.doi.org/10.3109/07357900903346455 VL - 28 ID - 2535 ER - TY - JOUR AD - V. Vasko, Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States AU - Jensen, K. AU - Patel, A. AU - Hoperia, V. AU - Larin, A. AU - Bauer, A. AU - Vasko, V. C1 - ly 294002(Sigma,United States) u 0126(Sigma,United States) C2 - Sigma(United States) DB - Embase DO - 10.3892/etm_00000071 IS - 3 LA - English M3 - Article N1 - L359461072 2010-09-09 2010-09-16 PY - 2010 SN - 1792-0981 1792-1015 SP - 457-462 ST - Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer T2 - Experimental and Therapeutic Medicine TI - Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359461072&from=export http://dx.doi.org/10.3892/etm_00000071 http://www.spandidos-publications.com/serveFile/etm_1_3_457_PDF.pdf?type=article&article_id=etm_1_3_457&item=PDF VL - 1 ID - 2536 ER - TY - JOUR AD - Y.A. DeClerck, Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine, Los Angeles, CA 90027, United States AU - Ara, T. AU - DeClerck, Y. A. C1 - 531 201 actemra(Chugai) amg 162 bay 43 9006 cnto 328(Centocor) diaclone(Besancon,France) incb 20(Incyte,United States) nexavar nsc 74859 revlimid(Celgene,United States) s31 201 su 11248 C2 - Besancon(France) Celgene(United States) Centocor Chugai Genentech Hoffmann La Roche Incyte(United States) DB - Embase Medline DO - 10.1016/j.ejca.2010.02.026 IS - 7 LA - English M3 - Article N1 - L50844345 2010-04-20 2010-06-15 PY - 2010 SN - 0959-8049 SP - 1223-1231 ST - Interleukin-6 in bone metastasis and cancer progression T2 - European Journal of Cancer TI - Interleukin-6 in bone metastasis and cancer progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50844345&from=export http://dx.doi.org/10.1016/j.ejca.2010.02.026 VL - 46 ID - 2537 ER - TY - JOUR AD - M.E. Tyburczy, Nencki Institute of Experimental Biology, Warsaw, Poland AU - Tyburczy, M. E. AU - Kotulska, K. AU - Pokarowski, P. AU - Mieczkowski, J. AU - Grajkowska, W. AU - Jozwiak, S. AU - Kaminska, B. DB - Embase DO - 10.1158/1538-7445.AM10-4353 IS - 8 LA - English M3 - Conference Abstract N1 - L71450238 2014-05-15 PY - 2010 SN - 0008-5472 ST - Identification of proteins regulated by mTOR in brain tumors of patients with tuberous sclerosis complex T2 - Cancer Research TI - Identification of proteins regulated by mTOR in brain tumors of patients with tuberous sclerosis complex UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71450238&from=export http://dx.doi.org/10.1158/1538-7445.AM10-4353 http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/70/8_MeetingAbstracts/4353?sid=6094f6a0-f326-4179-9021-9c962373bce7 VL - 70 ID - 2538 ER - TY - JOUR AD - B. S. Bochner, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, United States AU - Park, Y. M. AU - Bochner, B. S. DB - Embase DO - 10.4168/aair.2010.2.2.87 IS - 2 L1 - internal-pdf://2921528247/aair-2-87.pdf LA - English M3 - Review N1 - L358888252 2010-06-03 2010-06-25 PY - 2010 SN - 2092-7355 2092-7363 SP - 87-101 ST - Eosinophil survival and apoptosis in health and disease T2 - Allergy, Asthma and Immunology Research TI - Eosinophil survival and apoptosis in health and disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358888252&from=export http://dx.doi.org/10.4168/aair.2010.2.2.87 VL - 2 ID - 2540 ER - TY - JOUR AD - J.A. Moscow, Department of Pediatrics, College of Medicine, University of Kentucky, 740 S. Limestone Room J457, Lexington, KY 40536, United States AU - Daily, A. AU - Monks, N. R. AU - Leggas, M. AU - Moscow, J. A. DB - Embase Medline DO - 10.1016/j.toxicon.2009.11.019 IS - 4 LA - English M3 - Article N1 - L50723101 2009-12-04 2012-05-24 PY - 2010 SN - 1879-3150 0041-0101 SP - 827-837 ST - Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition T2 - Toxicon TI - Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50723101&from=export http://dx.doi.org/10.1016/j.toxicon.2009.11.019 VL - 55 ID - 2541 ER - TY - JOUR AD - J. R. Dry, 33G83 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom AU - Dry, J. R. AU - Pavey, S. AU - Pratilas, C. A. AU - Harbron, C. AU - Runswick, S. AU - Hodgson, D. AU - Chresta, C. AU - McCormack, R. AU - Byrne, N. AU - Cockerill, M. AU - Graham, A. AU - Beran, G. AU - Cassidy, A. AU - Haggerty, C. AU - Brown, H. AU - Ellison, G. AU - Dering, J. AU - Taylor, B. S. AU - Stark, M. AU - Bonazzi, V. AU - Ravishankar, S. AU - Packer, L. AU - Xing, F. AU - Solit, D. B. AU - Finn, R. S. AU - Rosen, N. AU - Hayward, N. K. AU - French, T. AU - Smith, P. D. C1 - azd 6244 DB - Embase Medline DO - 10.1158/0008-5472.CAN-09-1577 IS - 6 L1 - internal-pdf://1335939811/2264.full.pdf LA - English M3 - Article N1 - L358549108 2010-04-08 2010-04-28 PY - 2010 SN - 0008-5472 1538-7445 SP - 2264-2273 ST - Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244) T2 - Cancer Research TI - Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358549108&from=export http://dx.doi.org/10.1158/0008-5472.CAN-09-1577 VL - 70 ID - 2542 ER - TY - JOUR AD - B. B. Hasinoff, Apotex Centre, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada AU - Hasinoff, B. B. AU - Patel, D. C1 - cardioxane icrf 187 zinecard C2 - Adria(United States) LC(United States) DB - Embase Medline DO - 10.1007/s12012-009-9056-0 IS - 1 LA - English M3 - Article N1 - L50704754 2009-11-19 2010-05-10 PY - 2010 SN - 1530-7905 SP - 1-8 ST - Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib T2 - Cardiovascular Toxicology TI - Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50704754&from=export http://dx.doi.org/10.1007/s12012-009-9056-0 VL - 10 ID - 2545 ER - TY - JOUR AD - E. S. Kleinerman, Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States AU - Yu, L. AU - Su, B. AU - Hollomon, M. AU - Deng, Y. AU - Facchinetti, V. AU - Kleinerman, E. S. DB - Embase Medline DO - 10.1158/0008-5472.CAN-09-2795 IS - 4 L1 - internal-pdf://2866829876/1334.full.pdf LA - English M3 - Article N1 - L358308285 2010-02-24 2010-03-02 PY - 2010 SN - 0008-5472 1538-7445 SP - 1334-1343 ST - Vasculogenesis driven by bone marrow-derived cells is essential for growth of ewing's sarcomas T2 - Cancer Research TI - Vasculogenesis driven by bone marrow-derived cells is essential for growth of ewing's sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358308285&from=export http://dx.doi.org/10.1158/0008-5472.CAN-09-2795 VL - 70 ID - 2547 ER - TY - JOUR AD - M. Hirabayashi, Section of Mammalian Transgenesis, Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, 5-1 Higashiyama, Myodaiji-cho, Okazaki, Aichi 444-8787, Japan AU - Hirabayashi, M. AU - Kato, M. AU - Kobayashi, T. AU - Sanbo, M. AU - Yagi, T. AU - Hochi, S. AU - Nakauchi, H. DB - Embase Medline DO - 10.1002/mrd.21123 IS - 2 LA - English M3 - Letter N1 - L358031983 2010-02-01 PY - 2010 SN - 1040-452X 1098-2795 SP - 94 ST - Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency T2 - Molecular Reproduction and Development TI - Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358031983&from=export http://dx.doi.org/10.1002/mrd.21123 http://www3.interscience.wiley.com/cgi-bin/fulltext/122679560/PDFSTART VL - 77 ID - 2548 ER - TY - JOUR AD - R. Becher, Department of Air Pollution and Noise, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, Nydalen, N-0403 Oslo, Norway AU - Rakkestad, K. E. AU - Holme, J. A. AU - Paulsen, R. E. AU - Schwarze, P. E. AU - Becher, R. DB - Embase Medline DO - 10.3109/08958370903019885 IS - 2 LA - English M3 - Article N1 - L358196991 2010-03-01 PY - 2010 SN - 0895-8378 1091-7691 SP - 140-150 ST - Mono(2-ethylhexyl) phthalate induces both pro- and anti-inflammatory responses in rat alveolar macrophages through crosstalk between p38, the lipoxygenase pathway and PPARα T2 - Inhalation Toxicology TI - Mono(2-ethylhexyl) phthalate induces both pro- and anti-inflammatory responses in rat alveolar macrophages through crosstalk between p38, the lipoxygenase pathway and PPARα UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358196991&from=export http://dx.doi.org/10.3109/08958370903019885 VL - 22 ID - 2549 ER - TY - JOUR AD - H. Li, Cardiovascular Research Institute, Wuhan University, JieFang Road 238, Wuhan 430060, China AU - Shen, D. F. AU - Tang, Q. Z. AU - Yan, L. AU - Zhang, Y. AU - Zhu, L. H. AU - Wang, L. AU - Liu, C. AU - Bian, Z. Y. AU - Li, H. DB - Embase Medline DO - 10.1111/j.1476-5381.2009.00605.x IS - 4 LA - English M3 - Article N1 - L358350124 2010-03-03 2010-03-11 PY - 2010 SN - 0007-1188 1476-5381 SP - 970-981 ST - Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling T2 - British Journal of Pharmacology TI - Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358350124&from=export http://dx.doi.org/10.1111/j.1476-5381.2009.00605.x VL - 159 ID - 2550 ER - TY - JOUR AD - B. Zoll, Institut für Humangenetik, Universitätsmedizin Göttingen, Germany AU - Zoll, B. AU - Pauli, S. AU - Kühnle, I. AU - Schubert, C. AU - Bartels, I. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L70451258 2011-07-05 PY - 2010 SN - 0936-5931 SP - 127 ST - Coincidence of two constitutional de novo mutations, KRAS mutation and trisomy 8 mosaicism, in a patient with Noonan syndrome and JMML T2 - Medizinische Genetik TI - Coincidence of two constitutional de novo mutations, KRAS mutation and trisomy 8 mosaicism, in a patient with Noonan syndrome and JMML UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70451258&from=export VL - 22 ID - 2551 ER - TY - JOUR AD - C. Y. Chen, Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline Ave., Boston, MA 02215, United States AU - Nishioka, T. AU - Guo, J. AU - Yamamoto, D. AU - Chen, L. AU - Huppi, P. AU - Chen, C. Y. DB - Embase Medline DO - 10.1002/jcb.22392 IS - 1 LA - English M3 - Article N1 - L358085624 2010-01-28 PY - 2010 SN - 0730-2312 1097-4644 SP - 152-161 ST - Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation T2 - Journal of Cellular Biochemistry TI - Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358085624&from=export http://dx.doi.org/10.1002/jcb.22392 http://www3.interscience.wiley.com/cgi-bin/fulltext/122682680/PDFSTART VL - 109 ID - 2554 ER - TY - JOUR AD - E. L. Langmack, Department of Medicine, National Jewish Health, 1400 Jackson Street J210, Denver, CO 80206, United States AU - Langmack, E. L. AU - Martin, R. J. DB - Embase Medline DO - 10.1097/MCP.0b013e328333af9c IS - 1 LA - English M3 - Review N1 - L358137026 2010-02-22 PY - 2010 SN - 1070-5287 1531-6971 SP - 13-18 ST - Heterogeneity of response to asthma controller therapy: Clinical implications T2 - Current Opinion in Pulmonary Medicine TI - Heterogeneity of response to asthma controller therapy: Clinical implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358137026&from=export http://dx.doi.org/10.1097/MCP.0b013e328333af9c VL - 16 ID - 2555 ER - TY - JOUR AD - R. Alaggio, Pathology Department, University Hospital of Padova, Via A. Gabelli, 61, 35128 Padova, Italy AU - Alaggio, R. AU - Cecchetto, G. AU - Bisogno, G. AU - Gambini, C. AU - Calabrò, M. L. AU - Inserra, A. AU - Boldrini, R. AU - De Salvo, G. L. AU - D'Amore, E. S. G. AU - Dall'Igna, P. DB - Embase Medline DO - 10.1002/cncr.24684 IS - 1 LA - English M3 - Article N1 - L358142833 2010-02-02 PY - 2010 SN - 0008-543X 1097-0142 SP - 216-226 ST - Inflammatory myofibroblastic tumors in childhood: A report from the italian cooperative group studies T2 - Cancer TI - Inflammatory myofibroblastic tumors in childhood: A report from the italian cooperative group studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358142833&from=export http://dx.doi.org/10.1002/cncr.24684 http://www3.interscience.wiley.com/cgi-bin/fulltext/122659817/PDFSTART VL - 116 ID - 2556 ER - TY - JOUR AD - Z. Gil, Department of Otolaryngology, Head and Neck Surgery, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel AU - Gil, Z. AU - Cavel, O. AU - Kelly, K. AU - Brader, P. AU - Rein, A. AU - Gao, S. P. AU - Carlson, D. L. AU - Shah, J. P. AU - Fong, Y. AU - Wong, R. J. DB - Embase Medline DO - 10.1093/jnci/djp456 IS - 2 LA - English M3 - Article N1 - L358181550 2010-02-04 2019-09-12 PY - 2010 SN - 1460-2105 0027-8874 SP - 107-118 ST - Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves T2 - Journal of the National Cancer Institute TI - Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358181550&from=export http://dx.doi.org/10.1093/jnci/djp456 VL - 102 ID - 2557 ER - TY - JOUR AD - P. Babica, Institute of Botany, Academy of Sciences, Lidická 25/27, CZ65720 Brno, Czech Republic AU - Bláha, L. AU - Babica, P. AU - Hilscherová, K. AU - Upham, B. L. DB - Embase Medline DO - 10.1016/j.toxicon.2009.07.009 IS - 1 LA - English M3 - Article N1 - L50600184 2010-01-08 PY - 2010 SN - 0041-0101 SP - 126-134 ST - Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts - Indications of novel tumor-promoting cyanotoxins? T2 - Toxicon TI - Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts - Indications of novel tumor-promoting cyanotoxins? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50600184&from=export http://dx.doi.org/10.1016/j.toxicon.2009.07.009 VL - 55 ID - 2560 ER - TY - JOUR AD - M.J. Fisher, Division of Oncology, Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, United States AU - Sievert, A. J. AU - Fisher, M. J. DB - Embase Medline DO - 10.1177/0883073809342005 IS - 11 LA - English M3 - Conference Paper N1 - L355575986 2009-12-11 PY - 2009 SN - 0883-0738 1708-8283 SP - 1397-1408 ST - Pediatric low-grade gliomas T2 - Journal of Child Neurology TI - Pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355575986&from=export http://dx.doi.org/10.1177/0883073809342005 VL - 24 ID - 2561 ER - TY - JOUR AD - B.K.W. Cheung, Cytokine Biology Group, Department of Paediatrics and, Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Ksong Special Administrative Region, Pokfulam, China AU - Cheung, B. K. W. AU - Yim, H. C. H. AU - Lee, N. C. M. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1186/1471-2172-10-64 LA - English M3 - Article N1 - L358128738 2010-02-23 PY - 2009 SN - 1471-2172 ST - A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1 T2 - BMC Immunology TI - A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358128738&from=export http://dx.doi.org/10.1186/1471-2172-10-64 VL - 10 ID - 2562 ER - TY - JOUR AD - D. K. Graham, University of Colorado Denver School of Medicine, Department of Pediatrics, Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Linger, R. M. A. AU - DeRyckere, D. AU - Brandão, L. AU - Sawczyn, K. K. AU - Jacobsen, K. M. AU - Liang, X. AU - Keating, A. K. AU - Graham, D. K. DB - Embase Medline DO - 10.1182/blood-2009-03-209247 IS - 13 LA - English M3 - Article N1 - L355629953 2009-12-03 PY - 2009 SN - 0006-4971 1528-0020 SP - 2678-2687 ST - Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia T2 - Blood TI - Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355629953&from=export http://dx.doi.org/10.1182/blood-2009-03-209247 http://bloodjournal.hematologylibrary.org/cgi/reprint/114/13/2678 VL - 114 ID - 2563 ER - TY - JOUR AD - J. C. Gray, University of Southampton, Tenovus Research Laboratory, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom AU - Gray, J. C. AU - Kohler, J. A. DB - Embase Medline DO - 10.1002/pbc.22153 IS - 6 LA - English M3 - Review N1 - L355737011 2010-01-15 PY - 2009 SN - 1545-5009 1545-5017 SP - 931-940 ST - Immunotherapy for neuroblastoma: Turning promise into reality T2 - Pediatric Blood and Cancer TI - Immunotherapy for neuroblastoma: Turning promise into reality UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355737011&from=export http://dx.doi.org/10.1002/pbc.22153 http://www3.interscience.wiley.com/cgi-bin/fulltext/122506809/PDFSTART VL - 53 ID - 2564 ER - TY - JOUR AD - T. Rohrer, Department of Pediatrics and Neonatology, Saarland University Hospital, Kirrberger Strasse 1, Geb. 9, DE-66421 Homburg/Saar, Germany AU - Rohrer, T. DB - Embase Medline DO - 10.1159/000243772 IS - SUPPL. 2 LA - English M3 - Conference Paper N1 - L358081721 2010-02-15 PY - 2009 SN - 0301-0163 SP - 3-7 ST - Noonan syndrome: Introduction and basic clinical features T2 - Hormone Research TI - Noonan syndrome: Introduction and basic clinical features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358081721&from=export http://dx.doi.org/10.1159/000243772 VL - 72 ID - 2565 ER - TY - JOUR AD - H. Hasle, Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark AU - Hasle, H. DB - Embase Medline DO - 10.1159/000243773 IS - SUPPL. 2 LA - English M3 - Conference Paper N1 - L358081722 2010-02-15 PY - 2009 SN - 0301-0163 SP - 8-14 ST - Malignant diseases in noonan syndrome and related disorders T2 - Hormone Research TI - Malignant diseases in noonan syndrome and related disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358081722&from=export http://dx.doi.org/10.1159/000243773 VL - 72 ID - 2566 ER - TY - JOUR AD - S. W. Sunnarborg, Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, United States AU - Myers, T. J. AU - Brennaman, L. H. AU - Stevenson, M. AU - Higashiyama, S. AU - Russell, W. E. AU - Lee, D. C. AU - Sunnarborg, S. W. DB - Embase Medline DO - 10.1091/mbc.E08-12-1256 IS - 24 LA - English M3 - Article N1 - L358082990 2010-02-02 PY - 2009 SN - 1059-1524 SP - 5236-5249 ST - Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-α shedding T2 - Molecular Biology of the Cell TI - Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-α shedding UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358082990&from=export http://dx.doi.org/10.1091/mbc.E08-12-1256 http://www.molbiolcell.org/cgi/reprint/20/24/5236 VL - 20 ID - 2567 ER - TY - JOUR AD - A. Williams, Oncology, Johns Hopkins University, Baltimore, MD, United States AU - Williams, A. AU - Koch, S. AU - Christian, T. AU - Brown, P. AU - Levis, M. AU - Small, D. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L70248475 2010-09-03 PY - 2009 SN - 0006-4971 ST - Glycosylation and surface localization are required for FLT3 activation but not for FLT3/ITD T2 - Blood TI - Glycosylation and surface localization are required for FLT3 activation but not for FLT3/ITD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70248475&from=export http://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/2747?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=1200&displaysectionid=Poster+Session&fdate=1/1/2009&tdate=12/31/2009&resourcetype=HWCIT VL - 114 ID - 2568 ER - TY - JOUR AD - L. F. Parada, Dept. of Developmental Biology, Kent Waldrep Foundation Ctr. for Basic Neuroscience Research on Nerve Growth and Regeneration, Univ. of Texas Southwestern Medical Ctr., Dallas, TX 75390-9133, United States AU - Lin, L. AU - Chen, J. AU - Richardson, J. A. AU - Parada, L. F. DB - Embase Medline DO - 10.1152/ajpgi.00007.2009 IS - 4 LA - English M3 - Article N1 - L355385680 2009-11-20 PY - 2009 SN - 0193-1857 1522-1547 SP - G751-G761 ST - Mice lacking neurofibromin develop gastric hyperplasia T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Mice lacking neurofibromin develop gastric hyperplasia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355385680&from=export http://dx.doi.org/10.1152/ajpgi.00007.2009 http://ajpgi.physiology.org/cgi/reprint/297/4/G751 VL - 297 ID - 2569 ER - TY - JOUR AD - S. D. Turner, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Lab Block, Box 231, Cambridge CB20QQ, United Kingdom AU - Youssif, C. AU - Goldenbogen, J. AU - Hamoudi, R. AU - Carreras, J. AU - Viskaduraki, M. AU - Cui, Y. X. AU - Bacon, C. M. AU - Burke, G. A. A. AU - Turner, S. D. DB - Embase Medline DO - 10.1002/gcc.20701 IS - 11 LA - English M3 - Article N1 - L355315883 2009-10-20 PY - 2009 SN - 1045-2257 1098-2264 SP - 1018-1026 ST - Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: A children's cancer and leukaemia group study T2 - Genes Chromosomes and Cancer TI - Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: A children's cancer and leukaemia group study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355315883&from=export http://dx.doi.org/10.1002/gcc.20701 http://www3.interscience.wiley.com/cgi-bin/fulltext/122558999/PDFSTART VL - 48 ID - 2570 ER - TY - JOUR AD - M.S. Cairo, Department of Pediatrics, Medicine and Pathology, Morgan Stanley Children's Hospital of New York, Presbyterian, NY, United States AU - Cairo, M. S. DB - Embase IS - 5 L1 - internal-pdf://0555996658/519-Article Text-1980-1-10-20090610.pdf LA - English M3 - Conference Abstract N1 - L70007658 2009-11-27 PY - 2009 SN - 1970-7339 SP - 79-80 ST - New therapeutic targets in childhood and adolescent NHL T2 - Haematologica Meeting Reports TI - New therapeutic targets in childhood and adolescent NHL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70007658&from=export VL - 3 ID - 2571 ER - TY - JOUR AD - J.-Z. Zhao, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China AU - Liu, W. AU - Gong, Y. H. AU - Chao, T. F. AU - Peng, X. Z. AU - Yuan, J. G. AU - Ma, Z. Y. AU - Jia, G. AU - Zhao, J. Z. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2009.20.002 IS - 20 LA - English M3 - Article N1 - L355564511 2009-12-09 PY - 2009 SN - 0366-6999 SP - 2405-2411 ST - Identification of differentially expressed microRNAs by microarray: A possible role for microRNAs gene in medulloblastomas T2 - Chinese Medical Journal TI - Identification of differentially expressed microRNAs by microarray: A possible role for microRNAs gene in medulloblastomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355564511&from=export http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2009.20.002 http://www.cmj.org/Periodical/PDF/2009101931992490.pdf VL - 122 ID - 2573 ER - TY - JOUR AD - P.B. McCray, Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States AU - Winder, A. A. AU - Wohlford-Lenane, C. AU - Scheetz, T. E. AU - Nardy, B. N. AU - Manzel, L. J. AU - Look, D. C. AU - McCray Jr, P. B. C2 - Sigma(United States) DB - Embase Medline DO - 10.1186/1465-9921-10-96 LA - English M3 - Article N1 - L361205848 2011-02-09 2011-02-22 PY - 2009 SN - 1465-9921 1465-993X ST - Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epithelia T2 - Respiratory Research TI - Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epithelia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361205848&from=export http://dx.doi.org/10.1186/1465-9921-10-96 http://respiratory-research.com/content/10/1/96 VL - 10 ID - 2574 ER - TY - JOUR AD - A. Santoro, Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Via Manzoni 56, 20089 Rozzano, Milan, Italy AU - Rimassa, L. AU - Santoro, A. C1 - nexavar(Bayer) C2 - Bayer Onyx DB - Embase Medline DO - 10.1586/ERA.09.41 IS - 6 LA - English M3 - Article N1 - L355146727 2009-10-07 PY - 2009 SN - 1473-7140 1744-8328 SP - 739-745 ST - Sorafenib therapy in advanced hepatocellular carcinoma: The SHARP trial T2 - Expert Review of Anticancer Therapy TI - Sorafenib therapy in advanced hepatocellular carcinoma: The SHARP trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355146727&from=export http://dx.doi.org/10.1586/ERA.09.41 http://www.expert-reviews.com/doi/pdf/10.1586/era.09.41 VL - 9 ID - 2575 ER - TY - JOUR AD - J. O. Lauchle, Department of Pediatrics, University of California, San Francisco, CA 94143, United States AU - Lauchle, J. O. AU - Kim, D. AU - Le, D. T. AU - Akagi, K. AU - Crone, M. AU - Krisman, K. AU - Warner, K. AU - Bonifas, J. M. AU - Li, Q. AU - Coakley, K. M. AU - Diaz-Flores, E. AU - Gorman, M. AU - Przybranowski, S. AU - Tran, M. AU - Kogan, S. C. AU - Roose, J. P. AU - Copeland, N. G. AU - Jenkins, N. A. AU - Parada, L. AU - Wolff, L. AU - Sebolt-Leopold, J. AU - Shannon, K. C1 - ci 1040(Pfizer) pd 0325901(Pfizer) sb 202190(Calbiochem) C2 - Calbiochem Pfizer DB - Embase Medline DO - 10.1038/nature08279 IS - 7262 LA - English M3 - Article N1 - L50629907 2009-10-02 PY - 2009 SN - 0028-0836 1476-4687 SP - 411-414 ST - Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras T2 - Nature TI - Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50629907&from=export http://dx.doi.org/10.1038/nature08279 VL - 461 ID - 2576 ER - TY - JOUR AD - R.-M. Jin, Pediatric Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China AU - Xu, J. W. AU - Jin, R. M. AU - Li, E. Q. AU - Wang, Y. R. AU - Bai, Y. DB - Embase Medline DO - 10.1007/s12519-009-0028-z IS - 2 LA - English M3 - Article N1 - L354947028 2009-08-18 PY - 2009 SN - 1708-8569 SP - 140-145 ST - Signal pathways in ouabain-induced proliferation of leukemia cells T2 - World Journal of Pediatrics TI - Signal pathways in ouabain-induced proliferation of leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354947028&from=export http://dx.doi.org/10.1007/s12519-009-0028-z VL - 5 ID - 2577 ER - TY - JOUR AD - M. Sun, Department of Pediatrics, China Medical University, Shenyang 110004 Liaoning Province, China AU - Yuan, Y. AU - Sun, M. AU - Li, K. S. DB - Embase Medline DO - 10.3748/wjg.15.3676 IS - 29 LA - English M3 - Article N1 - L355357089 2009-11-19 PY - 2009 SN - 1007-9327 SP - 3676-3680 ST - Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-α and interleukin-8 T2 - World Journal of Gastroenterology TI - Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-α and interleukin-8 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355357089&from=export http://dx.doi.org/10.3748/wjg.15.3676 http://www.wjgnet.com/1007-9327/15/3676.pdf VL - 15 ID - 2578 ER - TY - JOUR AD - D. Hargrave, Paediatric Oncology Unit, Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom AU - Hargrave, D. C1 - avastin azd 6244 iressa tarceva DB - Embase Medline DO - 10.1080/02688690903158809 IS - 4 LA - English M3 - Review N1 - L355108910 2009-10-12 PY - 2009 SN - 0268-8697 1360-046X SP - 351-363 ST - Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy T2 - British Journal of Neurosurgery TI - Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355108910&from=export http://dx.doi.org/10.1080/02688690903158809 VL - 23 ID - 2581 ER - TY - JOUR AD - E. Fox, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, 1-5750, 10 Center Dr, Bethesda, MD 20892, United States AU - Fox, E. AU - Citrin, D. AU - Balis, F. M. DB - Embase Medline DO - 10.1093/jnci/djp238 IS - 16 LA - English M3 - Editorial N1 - L355154126 2009-09-21 PY - 2009 SN - 0027-8874 1460-2105 SP - 1105-1107 ST - The legacy of cancer therapy in children T2 - Journal of the National Cancer Institute TI - The legacy of cancer therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355154126&from=export http://dx.doi.org/10.1093/jnci/djp238 VL - 101 ID - 2582 ER - TY - JOUR AD - A.K. Godwin, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States AU - Rink, L. AU - Godwin, A. K. C1 - nvp aew 541(Novartis) C2 - Novartis DB - Embase Medline DO - 10.1007/s11912-009-0044-0 IS - 4 LA - English M3 - Review N1 - L354803792 2009-07-27 PY - 2009 SN - 1523-3790 SP - 314-321 ST - Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population T2 - Current Oncology Reports TI - Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354803792&from=export http://dx.doi.org/10.1007/s11912-009-0044-0 VL - 11 ID - 2583 ER - TY - JOUR AD - M. F. Benner, Department of Dermatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands AU - Benner, M. F. AU - Jansen, P. M. AU - Meijer, C. J. L. M. AU - Willemze, R. DB - Embase Medline DO - 10.1111/j.1365-2133.2009.09147.x IS - 1 LA - English M3 - Article N1 - L354862617 2009-08-25 PY - 2009 SN - 0007-0963 1365-2133 SP - 121-127 ST - Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders T2 - British Journal of Dermatology TI - Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354862617&from=export http://dx.doi.org/10.1111/j.1365-2133.2009.09147.x VL - 161 ID - 2585 ER - TY - JOUR AD - E. Pasmant, UMR745 INSERM, Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, 4 avenue de l'Observatoire, 75006, Paris, France AU - Pasmant, E. AU - Sabbagh, A. AU - Hanna, N. AU - Masliah-Planchon, J. AU - Jolly, E. AU - Goussard, P. AU - Ballerini, P. AU - Cartault, F. AU - Barbarot, S. AU - Landman-Parker, J. AU - Soufir, N. AU - Parfait, B. AU - Vidaud, M. AU - Wolkenstein, P. AU - Vidaud, D. AU - France, R. N. F. DB - Embase Medline DO - 10.1136/jmg.2008.065243 IS - 7 L1 - internal-pdf://1389867269/425.full.pdf LA - English M3 - Article N1 - L354913312 2009-08-18 PY - 2009 SN - 0022-2593 1468-6244 SP - 425-430 ST - SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype T2 - Journal of Medical Genetics TI - SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354913312&from=export http://dx.doi.org/10.1136/jmg.2008.065243 VL - 46 ID - 2586 ER - TY - JOUR AD - C. E. Bacchi, Consultoria em Patologia, Rua Major Leônidas Cardoso 739, Botucatu, SP, 18602-010, Brazil AU - Gualco, G. AU - Chioato, L. AU - Weiss, L. M. AU - Harrington Jr, W. J. AU - Bacchi, C. E. DB - Embase Medline DO - 10.1309/AJCP6Q7QMUVGMVMF IS - 1 LA - English M3 - Article N1 - L354914494 2009-08-19 PY - 2009 SN - 0002-9173 SP - 28-33 ST - Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children T2 - American Journal of Clinical Pathology TI - Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354914494&from=export http://dx.doi.org/10.1309/AJCP6Q7QMUVGMVMF http://ajcp.ascpjournals.org/content/132/1/28.full.pdf VL - 132 ID - 2587 ER - TY - JOUR AD - A. S. Y. Lau, Department of Paediatrics and Adolescent Medicine, Cytokine Biology Group, University of Hong Kong, Pokfulam, Hong Kong AU - Yim, H. C. H. AU - Li, J. C. B. AU - Lau, J. S. H. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1097/QAD.0b013e32832d7abe IS - 12 LA - English M3 - Article N1 - L355094122 2009-09-15 PY - 2009 SN - 0269-9370 1473-5571 SP - 1473-1484 ST - HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: Microbial interactions in HIV infection T2 - AIDS TI - HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: Microbial interactions in HIV infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355094122&from=export http://dx.doi.org/10.1097/QAD.0b013e32832d7abe VL - 23 ID - 2588 ER - TY - JOUR AD - L. Altucci, Dipartimento di Patologia Generale, Seconda Università di Napoli, Via L. De Crecchio 7, Napoli, Italy AU - Bontempo, P. AU - Mita, L. AU - Doto, A. AU - Miceli, M. AU - Nebbioso, A. AU - Lepore, I. AU - Franci, G. L. AU - Menafra, R. AU - Carafa, V. AU - Conte, M. AU - De Bellis, F. AU - Manzo, F. AU - Di Cerbo, V. AU - Benedetti, R. AU - D'Amato, L. AU - Marino, M. AU - Bolli, A. AU - Del Pozzo, G. AU - Diano, N. AU - Portaccio, M. AU - Mita, G. D. AU - Vietri, M. T. AU - Cioffi, M. AU - Nola, E. AU - Dell'Aversana, C. AU - Sica, V. AU - Molinari, A. M. AU - Altucci, L. DB - Embase Medline DO - 10.1186/1479-5876-7-48 LA - English M3 - Article N1 - L355071327 2009-09-14 PY - 2009 SN - 1479-5876 ST - Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells T2 - Journal of Translational Medicine TI - Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355071327&from=export http://dx.doi.org/10.1186/1479-5876-7-48 VL - 7 ID - 2590 ER - TY - JOUR AD - T. Jiang, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China AU - Zhang, W. AU - Qiu, X. G. AU - Chen, B. S. AU - Li, S. W. AU - Cui, Y. AU - Ren, H. AU - Jiang, T. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2009.11.003 IS - 11 LA - English M3 - Article N1 - L355058376 2009-08-31 PY - 2009 SN - 0366-6999 SP - 1250-1254 ST - Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: Analysis of the response and core pathway aberrations T2 - Chinese Medical Journal TI - Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: Analysis of the response and core pathway aberrations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355058376&from=export http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2009.11.003 http://www.cmj.org/Periodical/PdfList.asp?id=LW200964457450503472 VL - 122 ID - 2591 ER - TY - JOUR AD - W.E. Tidyman, Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, CA 94115, United States AU - Tidyman, W. E. AU - Rauen, K. A. DB - Embase Medline DO - 10.1016/j.gde.2009.04.001 IS - 3 LA - English M3 - Review N1 - L355090784 2009-09-14 PY - 2009 SN - 0959-437X SP - 230-236 ST - The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation T2 - Current Opinion in Genetics and Development TI - The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355090784&from=export http://dx.doi.org/10.1016/j.gde.2009.04.001 VL - 19 ID - 2592 ER - TY - JOUR AD - B.S. Cetin, Department of Pediatrics, Dokuz Eylul University, Izmir, Turkey AU - Cetin, B. S. AU - Yesilirmak, D. AU - Tuzun, F. AU - Kumral, A. AU - Duman, N. AU - Ozkan, H. DB - Embase Medline DO - 10.1016/j.mehy.2009.01.011 IS - 6 LA - English M3 - Letter N1 - L50440712 2009-04-10 PY - 2009 SN - 0306-9877 SP - 757-758 ST - Can curry protect the brain from bilirubin toxicity? T2 - Medical Hypotheses TI - Can curry protect the brain from bilirubin toxicity? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50440712&from=export http://dx.doi.org/10.1016/j.mehy.2009.01.011 VL - 72 ID - 2593 ER - TY - JOUR AD - A.S.-Y. Lau, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, 1/F, New Clinical Science Building, Pokfulam Road, Hong Kong AU - Cheung, B. K. W. AU - Chan, M. M. P. AU - Yim, H. C. H. AU - Chan, L. L. AU - Li, J. C. B. AU - Lee, D. C. W. AU - Lau, A. S. Y. DB - Embase Medline IS - 3 LA - English M3 - Note N1 - L610283700 2016-05-13 2016-05-27 PY - 2009 SN - 1024-2708 SP - S32-S36 ST - Immunotherapy of mycobacterial infections: A cell and molecular model T2 - Hong Kong Medical Journal TI - Immunotherapy of mycobacterial infections: A cell and molecular model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610283700&from=export VL - 15 ID - 2594 ER - TY - JOUR AD - C.C. Yau AU - Yau, C. C. AU - Chen, P. J. AU - Curtis, C. M. AU - Murphy, P. S. AU - Suttle, A. B. AU - Arumugham, T. AU - Hodge, J. P. AU - Dar, M. M. AU - Poon, R. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70240943 2010-08-18 PY - 2009 SN - 0732-183X SP - 3561 ST - A phase I study of pazopanib in patients with advanced hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - A phase I study of pazopanib in patients with advanced hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70240943&from=export http://meeting.ascopubs.org/cgi/content/abstract/27/15S/3561 VL - 27 ID - 2595 ER - TY - JOUR AD - A.S.Y. Lau, Cytokine Biology Group, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong AU - Lee, D. C. W. AU - Yang, C. L. H. AU - Chik, S. C. C. AU - Li, J. C. B. AU - Rong, J. H. AU - Chan, G. C. F. AU - Lau, A. S. Y. C2 - Shanghai Institute of Materia Medica(China) DB - Embase Medline DO - 10.1186/1479-5876-7-34 LA - English M3 - Article N1 - L354714556 2009-07-01 PY - 2009 SN - 1479-5876 ST - Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells T2 - Journal of Translational Medicine TI - Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354714556&from=export http://dx.doi.org/10.1186/1479-5876-7-34 VL - 7 ID - 2596 ER - TY - JOUR AD - Y.-K. Park, Department of Pathology, Kyung-Hee University, College of Medicine, 1 Heoigi-dong, Dongdaemun-gu, Seoul 130-702, South Korea AU - Do, S. I. AU - Jung, W. W. AU - Kim, H. S. AU - Park, Y. K. DB - Embase Medline DO - 10.3892/ijo_00000205 IS - 3 LA - English M3 - Article N1 - L354461355 2009-04-23 PY - 2009 SN - 1019-6439 1791-2423 SP - 797-803 ST - The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma T2 - International Journal of Oncology TI - The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354461355&from=export http://dx.doi.org/10.3892/ijo_00000205 http://www.spandidos-publications.com/serveFile/ijo_34_3_797_PDF.pdf?type=article&article_id=ijo_34_3_797&item=PDF VL - 34 ID - 2598 ER - TY - JOUR AD - B.L. Upham, Michigan State University, National Food Safety and Toxicology Center, East Lansing, MI 48824, United States AU - Upham, B. L. AU - Park, J. S. AU - Babica, P. AU - Sovadinova, I. AU - Rummel, A. M. AU - Trosko, J. E. AU - Hirose, A. AU - Hasegawa, R. AU - Kanno, J. AU - Sai, K. DB - Embase Medline DO - 10.1289/ehp.11728 IS - 4 L1 - internal-pdf://0195740084/11728.pdf.txt LA - English M3 - Article N1 - L354438396 2009-04-20 PY - 2009 SN - 0091-6765 1552-9924 SP - 545-551 ST - Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems T2 - Environmental Health Perspectives TI - Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354438396&from=export http://dx.doi.org/10.1289/ehp.11728 VL - 117 ID - 2599 ER - TY - JOUR AD - R.T. Jensen, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1804, United States AU - Berna, M. J. AU - Tapia, J. A. AU - Sancho, V. AU - Thill, M. AU - Pace, A. AU - Hoffmann, K. M. AU - Gonzalez-Fernandez, L. AU - Jensen, R. T. DB - Embase Medline DO - 10.1016/j.cellsig.2009.01.003 IS - 4 LA - English M3 - Article N1 - L354158465 2009-03-02 PY - 2009 SN - 0898-6568 SP - 622-638 ST - Gastrointestinal growth factors and hormones have divergent effects on Akt activation T2 - Cellular Signalling TI - Gastrointestinal growth factors and hormones have divergent effects on Akt activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354158465&from=export http://dx.doi.org/10.1016/j.cellsig.2009.01.003 VL - 21 ID - 2600 ER - TY - JOUR AD - X. Zhou, Department of Pathology, Cancer Hospital, Department of Oncology, 270 Dongan Road, Shanghai 200032, China AU - Huang, W. AU - Li, X. AU - Yao, X. AU - Lu, Y. AU - Li, B. AU - Sheng, W. AU - Lu, H. AU - Jin, A. AU - Zhou, X. DB - Embase Medline DO - 10.1016/j.yexmp.2008.11.012 IS - 2 LA - English M3 - Article N1 - L354381317 2009-04-15 PY - 2009 SN - 0014-4800 1096-0945 SP - 121-126 ST - Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma T2 - Experimental and Molecular Pathology TI - Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354381317&from=export http://dx.doi.org/10.1016/j.yexmp.2008.11.012 VL - 86 ID - 2601 ER - TY - JOUR AD - Y. Yuhas, Laboratory of Infectious Diseases, Felsenstein Medical Research Center, Beilinson Campus, Petach Tikva 49100, Israel AU - Yuhas, Y. AU - Berent, E. AU - Cohen, R. AU - Ashkenazi, S. DB - Embase Medline DO - 10.1128/AAC.00961-08 IS - 4 L1 - internal-pdf://2717557498/Antimicrobial Agents and Chemotherapy-2009-Yuh.pdf LA - English M3 - Article N1 - L354592520 2009-06-22 PY - 2009 SN - 0066-4804 1098-6596 SP - 1539-1545 ST - Roles of NF-KB activation and peroxisome proliferator-activated teceptor famma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells T2 - Antimicrobial Agents and Chemotherapy TI - Roles of NF-KB activation and peroxisome proliferator-activated teceptor famma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354592520&from=export http://dx.doi.org/10.1128/AAC.00961-08 VL - 53 ID - 2602 ER - TY - JOUR AD - F. K. Ghishan, Dept. of Pediatrics, Steele Children's Research Ctr., Univ. of Arizona Health Sciences Ctr., 1501 N. Campbell Ave., Tucson, AZ 85724, United States AU - Chen, H. AU - Xu, H. AU - Dong, J. AU - Li, J. AU - Ghishan, F. K. DB - Embase Medline DO - 10.1152/ajpgi.90722.2008 IS - 4 LA - English M3 - Article N1 - L354862521 2009-08-03 PY - 2009 SN - 0193-1857 1522-1547 SP - G775-G781 ST - Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354862521&from=export http://dx.doi.org/10.1152/ajpgi.90722.2008 http://ajpgi.physiology.org/cgi/reprint/296/4/G775 VL - 296 ID - 2603 ER - TY - JOUR AD - M. Kawahara, Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan AU - Sogo, T. AU - Kawahara, M. AU - Ueda, H. AU - Otsu, M. AU - Onodera, M. AU - Nakauchi, H. AU - Nagamune, T. DB - Embase Medline DO - 10.1016/j.cyto.2008.12.020 IS - 1 LA - English M3 - Article N1 - L50425734 2009-04-10 PY - 2009 SN - 1043-4666 SP - 127-136 ST - T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera T2 - Cytokine TI - T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50425734&from=export http://dx.doi.org/10.1016/j.cyto.2008.12.020 VL - 46 ID - 2604 ER - TY - JOUR AD - M. Reig, Hospital Clinic, BCLC Group, Liver Unit, Barcelona, Spain AU - Reig, M. AU - Forner, A. AU - Rimola, J. AU - De Lope, C. R. AU - Ayuso, C. AU - Llovet, J. M. AU - Bruix, J. DB - Embase LA - English M3 - Conference Abstract N1 - L70134075 2010-05-19 PY - 2009 SN - 0168-8278 SP - S298 ST - Sorafenib for the treatment of advanced hepatocellular carcinoma. Feasibility and safety outside research trials T2 - Journal of Hepatology TI - Sorafenib for the treatment of advanced hepatocellular carcinoma. Feasibility and safety outside research trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70134075&from=export VL - 50 ID - 2606 ER - TY - JOUR AD - M. Pigazzi, Laboratory of Hematology-Oncology, Department of Pediatries, University of Padova, Via Giustiniani 3, 35128 Padova, Italy AU - Pigazzi, M. AU - Manara, E. AU - Baron, E. AU - Basso, G. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-3404 IS - 6 L1 - internal-pdf://0337739299/2471.full.pdf LA - English M3 - Article N1 - L354656706 2009-06-10 PY - 2009 SN - 0008-5472 1538-7445 SP - 2471-2478 ST - MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia T2 - Cancer Research TI - MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354656706&from=export http://dx.doi.org/10.1158/0008-5472.CAN-08-3404 VL - 69 ID - 2607 ER - TY - JOUR AD - Y. Zhu, Department of Neurosurgery, University of Duisburg-Essen, Hufelandstr.55, 45122 Essen, Germany AU - Zhu, Y. AU - Wloch, A. AU - Wu, Q. AU - Peters, C. AU - Pagenstecher, A. AU - Bertalanffy, H. AU - Sure, U. DB - Embase Medline DO - 10.1161/STROKEAHA.108.526376 IS - 3 LA - English M3 - Article N1 - L354355355 2009-04-10 PY - 2009 SN - 0039-2499 SP - 820-826 ST - Involvement of PTEN promoter methylation in cerebral cavernous malformations T2 - Stroke TI - Involvement of PTEN promoter methylation in cerebral cavernous malformations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354355355&from=export http://dx.doi.org/10.1161/STROKEAHA.108.526376 VL - 40 ID - 2608 ER - TY - JOUR AD - S. Krueger, Institute of Pathology, Otto-von-Guericke University, Leipziger Strasse 44, D-39120 Magdeburg, Germany AU - Krueger, S. AU - Kuester, D. AU - Bernhardt, A. AU - Wex, T. AU - Roessner, A. DB - Embase Medline DO - 10.1002/path.2485 IS - 4 LA - English M3 - Article N1 - L354450659 2009-05-05 PY - 2009 SN - 0022-3417 1096-9896 SP - 581-588 ST - Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages T2 - Journal of Pathology TI - Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354450659&from=export http://dx.doi.org/10.1002/path.2485 http://www3.interscience.wiley.com/cgi-bin/fulltext/121506167/PDFSTART VL - 217 ID - 2609 ER - TY - JOUR AD - E. J. Lowe, Division of Pediatric Hematology-Oncology, Children's Hospital of the King's Daughters, 601 Children's Lane, Norfolk, VA 23507 AU - Lowe, E. J. AU - Sposto, R. AU - Perkins, S. L. AU - Gross, T. G. AU - Finlay, J. AU - Zwick, D. AU - Abromowitch, M. DB - Embase Medline DO - 10.1002/pbc.21817 IS - 3 LA - English M3 - Article N1 - L354496785 2009-05-08 PY - 2009 SN - 1545-5009 1545-5017 SP - 335-339 ST - Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941 T2 - Pediatric Blood and Cancer TI - Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354496785&from=export http://dx.doi.org/10.1002/pbc.21817 http://www3.interscience.wiley.com/cgi-bin/fulltext/121501532/PDFSTART VL - 52 ID - 2610 ER - TY - JOUR AD - T. Yau, Queen Mary Hospital, Hong Kong, Hong Kong AU - Yau, T. AU - Chen, P. J. AU - Curtis, C. M. AU - Murphy, P. S. AU - Suttle, A. B. AU - Arumugham, T. AU - Hodge, J. P. AU - Dar, M. M. AU - Poon, R. T. DB - Embase DO - 10.1002/hep.23307 LA - English M3 - Conference Abstract N1 - L70075182 2010-03-12 PY - 2009 SN - 0270-9139 SP - 1124A-1125A ST - Phase i study of pazopanib (PAZ) in hepatocellular carcinoma (HCC): Determination of MTD and evaluation of clinical activity, pharmacokinetics (PK), and pharmacodynamic (PD) changes in dynamic contrast enhanced MRI (DCE-MRI) T2 - Hepatology TI - Phase i study of pazopanib (PAZ) in hepatocellular carcinoma (HCC): Determination of MTD and evaluation of clinical activity, pharmacokinetics (PK), and pharmacodynamic (PD) changes in dynamic contrast enhanced MRI (DCE-MRI) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70075182&from=export http://dx.doi.org/10.1002/hep.23307 VL - 50 ID - 2611 ER - TY - JOUR AD - B. L. Upham, 243 Food Safety and Toxicology Center, Michigan State University, East Lansing, MI 48824, United States AU - Upham, B. L. AU - Trosko, J. E. DB - Embase Medline DO - 10.1089/ars.2008.2146 IS - 2 LA - English M3 - Review N1 - L354018066 2009-01-30 PY - 2009 SN - 1523-0864 SP - 297-307 ST - Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression T2 - Antioxidants and Redox Signaling TI - Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354018066&from=export http://dx.doi.org/10.1089/ars.2008.2146 VL - 11 ID - 2612 ER - TY - JOUR AD - H.-S. Lee, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Cheng-Gong Road, Taipei 114, Taiwan AU - Cheng, M. F. AU - Lee, C. H. AU - Huang, G. S. AU - Wu, H. W. AU - Chiang, P. C. AU - Sheu, L. F. AU - Lee, H. S. C2 - Sigma(United States) DB - Embase IS - 1 LA - English M3 - Article N1 - L354272949 2009-03-18 PY - 2009 SN - 1011-4564 SP - 13-18 ST - Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells T2 - Journal of Medical Sciences TI - Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354272949&from=export VL - 29 ID - 2613 ER - TY - JOUR AD - R. A. Gottlieb, Bioscience Center, San Diego State Univ., 5500 Campanile Dr., San Diego, CA 92182-4650 AU - Yuan, H. AU - Perry, C. N. AU - Huang, C. AU - Iwai-Kanai, E. AU - Carreira, R. S. AU - Glembotski, C. C. AU - Gottlieb, R. A. DB - Embase Medline DO - 10.1152/ajpheart.01051.2008 IS - 2 LA - English M3 - Article N1 - L354657598 2009-06-16 PY - 2009 SN - 0363-6135 1522-1539 SP - H470-H479 ST - LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection T2 - American Journal of Physiology - Heart and Circulatory Physiology TI - LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354657598&from=export http://dx.doi.org/10.1152/ajpheart.01051.2008 http://ajpheart.physiology.org/cgi/reprint/296/2/H470 VL - 296 ID - 2614 ER - TY - JOUR AD - S. Surendran, Department of Pediatrics, University of Texas Health Science Center, Houston, TX 77030, United States AU - Surendran, S. DB - Embase Medline DO - 10.1007/s11033-007-9167-2 IS - 1 LA - English M3 - Article N1 - L352727305 2008-12-22 PY - 2009 SN - 0301-4851 1573-4978 SP - 201-206 ST - Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility T2 - Molecular Biology Reports TI - Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352727305&from=export http://dx.doi.org/10.1007/s11033-007-9167-2 VL - 36 ID - 2615 ER - TY - JOUR AD - S. H. Yuspa, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20892-4255, United States AU - Cataisson, C. AU - Ohman, R. AU - Patel, G. AU - Pearson, A. AU - Tsien, M. AU - Jay, S. AU - Wright, L. AU - Hennings, H. AU - Yuspa, S. H. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-2490 IS - 1 L1 - internal-pdf://0446340713/319.full.pdf LA - English M3 - Article N1 - L354074700 2009-02-12 PY - 2009 SN - 0008-5472 1538-7445 SP - 319-328 ST - Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis T2 - Cancer Research TI - Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354074700&from=export http://dx.doi.org/10.1158/0008-5472.CAN-08-2490 VL - 69 ID - 2616 ER - TY - JOUR AD - J. Shipley, Molecular Cytogenetics, MUCRC, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom AU - Gilbert, D. C. AU - Chandler, I. AU - McLntyre, A. AU - Goddard, N. C. AU - Gabe, R. AU - Huddart, R. A. AU - Shipley, J. DB - Embase Medline DO - 10.1002/path.2436 IS - 1 LA - English M3 - Article N1 - L354091901 2009-02-16 PY - 2009 SN - 0022-3417 1096-9896 SP - 94-102 ST - Clinical and biological significance of CXCLI2 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents T2 - Journal of Pathology TI - Clinical and biological significance of CXCLI2 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354091901&from=export http://dx.doi.org/10.1002/path.2436 http://www3.interscience.wiley.com/cgi-bin/fulltext/121387921/PDFSTART VL - 217 ID - 2617 ER - TY - JOUR AD - F.E. Ahmed, GEM Tox Consultants and Labs, Inc., 2607 Calvin Way, Greenville, NC 27834, United States AU - Ahmed, F. E. AU - Vos, P. W. AU - Jeffries, C. AU - Wiley, J. E. AU - Weidner, D. A. AU - Mota, H. AU - Bonnerup, C. AU - Sibata, C. AU - Allison, R. R. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L354607410 2009-06-02 PY - 2009 SN - 1790-6245 1109-6535 SP - 109-128 ST - Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensity-modulated radiation therapy (IMRT), or conventional radiation therapy (RT) T2 - Cancer Genomics and Proteomics TI - Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensity-modulated radiation therapy (IMRT), or conventional radiation therapy (RT) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354607410&from=export VL - 6 ID - 2618 ER - TY - JOUR AD - H. Arakawa, Department of Pediatrics and Developmental Medicine, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan AU - Tadaki, H. AU - Arakawa, H. AU - Mizuno, T. AU - Suzuki, T. AU - Takeyama, K. AU - Mochizuki, H. AU - Tokuyama, K. AU - Yokota, S. AU - Morikawa, A. DB - Embase Medline DO - 10.4049/jimmunol.182.1.293 IS - 1 LA - English M3 - Article N1 - L358189344 2010-02-05 2020-09-23 PY - 2009 SN - 1550-6606 0022-1767 SP - 293-300 ST - Double-stranded RNA and TGF-α promote MUC5AC induction in respiratory cells T2 - Journal of Immunology TI - Double-stranded RNA and TGF-α promote MUC5AC induction in respiratory cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358189344&from=export http://dx.doi.org/10.4049/jimmunol.182.1.293 VL - 182 ID - 2619 ER - TY - JOUR AD - L. Mussolin, Clinica di Oncoematologia Pediatrica, Dipartimento di Pediatria, Università di Padova, Padua, Italy AU - Mussolin, L. AU - Bonvini, P. AU - Ait-Tahar, K. AU - Pillon, M. AU - Tridello, G. AU - Buffardi, S. AU - Lombardi, A. AU - Pulford, K. AU - Rosolen, A. DB - Embase Medline DO - 10.1038/leu.2008.184 IS - 2 LA - English M3 - Letter N1 - L50204107 2009-02-26 PY - 2009 SN - 1476-5551 0887-6924 SP - 400-402 ST - Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL T2 - Leukemia TI - Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50204107&from=export http://dx.doi.org/10.1038/leu.2008.184 VL - 23 ID - 2620 ER - TY - JOUR AD - T. Ichiyama, Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan AU - Ichiyama, T. AU - Hasegawa, M. AU - Hashimoto, K. AU - Matsushige, T. AU - Hirano, R. AU - Furukawa, S. DB - Embase Medline DO - 10.1159/000155745 IS - 2 LA - English M3 - Article N1 - L50277992 2009-02-12 PY - 2009 SN - 1018-2438 SP - 147-153 ST - Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages T2 - International Archives of Allergy and Immunology TI - Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50277992&from=export http://dx.doi.org/10.1159/000155745 VL - 148 ID - 2621 ER - TY - JOUR AD - L. Gore, Pediatrics Mail Stop 8302, Aurora, CO 80045, United States AU - Macy, M. E. AU - Sawczyn, K. K. AU - Garrington, T. P. AU - Graham, D. K. AU - Gore, L. C1 - bms 354825 cep 701 ps 341 sti 571 DB - Embase Medline DO - 10.1007/s11912-008-0073-0 IS - 6 LA - English M3 - Review N1 - L354099820 2009-02-17 PY - 2008 SN - 1523-3790 SP - 477-490 ST - Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials T2 - Current Oncology Reports TI - Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354099820&from=export http://dx.doi.org/10.1007/s11912-008-0073-0 VL - 10 ID - 2622 ER - TY - JOUR AD - F. Blasi, IFOM, Fondazione Istituto FIRC di Oncologia Moleculare, via Adamello 16, 20139 Milano, Italy AU - d'Alessio, S. AU - Gerasi, L. AU - Blasi, F. DB - Embase Medline DO - 10.1242/jcs.037549 IS - 23 L1 - internal-pdf://2994426238/3922.full.pdf LA - English M3 - Article N1 - L354136850 2009-02-16 PY - 2008 SN - 0021-9533 SP - 3922-3932 ST - uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro T2 - Journal of Cell Science TI - uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354136850&from=export http://dx.doi.org/10.1242/jcs.037549 VL - 121 ID - 2623 ER - TY - JOUR AD - D. W. Clapp, Indiana University School of Medicine, Cancer Research Institute, 1044 W Walnut Street, R4 402, Indianapolis, IN 46202 AU - McDaniel, A. S. AU - Allen, J. D. AU - Park, S. J. AU - Jaffer, Z. M. AU - Michels, E. G. AU - Burgin, S. J. AU - Chen, S. AU - Bessler, W. K. AU - Hofmann, C. AU - Ingram, D. A. AU - Chernoff, J. AU - Clapp, D. W. DB - Embase Medline DO - 10.1182/blood-2008-04-155085 IS - 12 LA - English M3 - Article N1 - L354286425 2009-04-01 PY - 2008 SN - 0006-4971 1528-0020 SP - 4646-4654 ST - Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/ mast cells T2 - Blood TI - Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/ mast cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354286425&from=export http://dx.doi.org/10.1182/blood-2008-04-155085 http://bloodjournal.hematologylibrary.org/cgi/reprint/112/12/4646 VL - 112 ID - 2624 ER - TY - JOUR AD - G. Lozano, Department of Genetics, The Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Valentin-Vega, Y. A. AU - Okano, H. AU - Lozano, G. DB - Embase Medline DO - 10.1038/cdd.2008.109 IS - 11 LA - English M3 - Article N1 - L50213954 2008-11-12 PY - 2008 SN - 1350-9047 1476-5403 SP - 1772-1781 ST - The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival T2 - Cell Death and Differentiation TI - The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50213954&from=export http://dx.doi.org/10.1038/cdd.2008.109 VL - 15 ID - 2626 ER - TY - JOUR AD - T. Shinjyo, Department of Endocrinoiogy and Metabolism, Department of Internal Medicine, University of Ryukyus, Nakagami-Nishihara, Okinawa 903-0215, Japan AU - Shinjyo, T. AU - Kurosawa, H. AU - Miyagi, J. I. AU - Ohama, K. AU - Masuda, M. AU - Nagasaki, A. AU - Matsui, H. AU - Inaba, T. AU - Furukawa, Y. AU - Takasu, N. DB - Embase Medline DO - 10.1620/tjem.216.25 IS - 1 LA - English M3 - Article N1 - L352525891 2008-10-31 PY - 2008 SN - 0040-8727 1349-3329 SP - 25-34 ST - Ras-mediated up-regulation of survivin expression in cytokine-dependent murine pro-B lymphocytic cells T2 - Tohoku Journal of Experimental Medicine TI - Ras-mediated up-regulation of survivin expression in cytokine-dependent murine pro-B lymphocytic cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352525891&from=export http://dx.doi.org/10.1620/tjem.216.25 http://www.jstage.jst.go.jp/article/tjem/216/1/25/_pdf VL - 216 ID - 2627 ER - TY - GEN AD - P. Rodriguez-Viciana, UCSF Helen Diller Family, Comprehensive Cancer Center, Cancer Research Institute, San Francisco, CA, United States AU - Rodriguez-Viciana, P. AU - Rauen, K. A. C5 - 18413255 DB - Embase Medline DO - 10.1016/S0076-6879(07)38019-1 J2 - Methods Enzymol. LA - English M1 - (Rodriguez-Viciana P.; Rauen K.A.) UCSF Helen Diller Family, Comprehensive Cancer Center, Cancer Research Institute, San Francisco, CA, United States M3 - Review N1 - L352382922 2008-10-28 PY - 2008 SN - 0076-6879 9780123739681 SP - 277-289 ST - Biochemical Characterization of Novel Germline BRAF and MEK Mutations in Cardio-Facio-Cutaneous Syndrome TI - Biochemical Characterization of Novel Germline BRAF and MEK Mutations in Cardio-Facio-Cutaneous Syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352382922&from=export http://dx.doi.org/10.1016/S0076-6879(07)38019-1 VL - 438 ID - 2628 ER - TY - JOUR AD - J. Versalovic, Department of Pathology, Texas Children's Hospital, MC 1-2261, 6621 Fannin Street, Houston, TX 77030, United States AU - Versalovic, J. AU - Iyer, C. AU - Ping Lin, Y. AU - Huang, Y. AU - Dobrogosz, W. DB - Embase DO - 10.1080/08910600802106491 IS - 2 LA - English M3 - Review N1 - L352451692 2008-10-28 PY - 2008 SN - 0891-060X 1651-2235 SP - 86-93 ST - Commensal-derived probiotics as anti-inflammatory agents T2 - Microbial Ecology in Health and Disease TI - Commensal-derived probiotics as anti-inflammatory agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352451692&from=export http://dx.doi.org/10.1080/08910600802106491 VL - 20 ID - 2629 ER - TY - JOUR AD - J. P. P. Meijerink, Erasmus MC, Sophia Children's Hospital, Department of Paediatric Oncology/Haematology, Dr Molewaterplein 60, 3000 CB Rotterdam, Netherlands AU - Van Vlierberghe, P. AU - Pieters, R. AU - Beverloo, H. B. AU - Meijerink, J. P. P. DB - Embase Medline DO - 10.1111/j.1365-2141.2008.07314.x IS - 2 LA - English M3 - Review N1 - L352431827 2008-10-29 PY - 2008 SN - 0007-1048 1365-2141 SP - 153-168 ST - Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352431827&from=export http://dx.doi.org/10.1111/j.1365-2141.2008.07314.x VL - 143 ID - 2631 ER - TY - JOUR AD - E. R. Sutherland, National Jewish Health Center, 1400 Jackson Street, J-220, Denver, CO 80206, United States AU - Sutherland, E. R. AU - Goleva, E. AU - Strand, M. AU - Beuther, D. A. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1164/rccm.200801-076OC IS - 7 LA - English M3 - Article N1 - L352459250 2008-11-07 PY - 2008 SN - 1073-449X 1535-4970 SP - 682-687 ST - Body mass and glucocorticoid response in asthma T2 - American Journal of Respiratory and Critical Care Medicine TI - Body mass and glucocorticoid response in asthma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352459250&from=export http://dx.doi.org/10.1164/rccm.200801-076OC http://ajrccm.atsjournals.org/cgi/reprint/178/7/682 VL - 178 ID - 2632 ER - TY - JOUR AD - L.C. Krab, Department of Neuroscience, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands AU - Krab, L. C. AU - Goorden, S. M. I. AU - Elgersma, Y. DB - Embase Medline DO - 10.1016/j.tig.2008.07.005 IS - 10 LA - English M3 - Review N1 - L50260643 2008-11-05 PY - 2008 SN - 0168-9525 SP - 498-510 ST - Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases T2 - Trends in Genetics TI - Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50260643&from=export http://dx.doi.org/10.1016/j.tig.2008.07.005 VL - 24 ID - 2633 ER - TY - JOUR AD - M. E. Kadin, Roger Williams Medical Center, Elmhurst Bldg., 50 Maude street, Providence, RI AU - Kadin, M. E. AU - Pinkus, J. L. AU - Pinkus, G. S. AU - Duran, I. H. AU - Fuller, C. E. AU - Onciu, M. AU - Kawaguchi, H. AU - Morris, S. W. DB - Embase Medline DO - 10.1097/PAS.0b013e3181648d6d IS - 9 LA - English M3 - Article N1 - L354635349 2009-06-05 PY - 2008 SN - 0147-5185 1532-0979 SP - 1421-1426 ST - Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative T2 - American Journal of Surgical Pathology TI - Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354635349&from=export http://dx.doi.org/10.1097/PAS.0b013e3181648d6d VL - 32 ID - 2634 ER - TY - JOUR AD - Y. Nagatoshi, Section of Pediatrics, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan AU - Takahashi, D. AU - Nagatoshi, Y. AU - Nagayama, J. AU - Inagaki, J. AU - Itonoaga, N. AU - Takeshita, M. AU - Okamura, J. DB - Embase Medline DO - 10.1097/MPH.0b013e31817e4a98 IS - 9 LA - English M3 - Article N1 - L354655898 2009-06-30 PY - 2008 SN - 1077-4114 1536-3678 SP - 696-700 ST - Anaplastic Large Cell Lymphoma in Leukemic Presentation: A Case Report and a Review of the Literature T2 - Journal of Pediatric Hematology/Oncology TI - Anaplastic Large Cell Lymphoma in Leukemic Presentation: A Case Report and a Review of the Literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354655898&from=export http://dx.doi.org/10.1097/MPH.0b013e31817e4a98 VL - 30 ID - 2635 ER - TY - JOUR AD - M. Kool, Department of Human Genetics, Academic Medical Center, Amsterdam, Netherlands AU - Kool, M. AU - Koster, J. AU - Bunt, J. AU - Hasselt, N. E. AU - Lakeman, A. AU - van Sluis, P. AU - Troost, D. AU - Schouten-van Meeteren, N. AU - Caron, H. N. AU - Cloos, J. AU - Mršić, A. AU - Ylstra, B. AU - Grajkowska, W. AU - Hartmann, W. AU - Pietsch, T. AU - Ellison, D. AU - Clifford, S. C. AU - Versteeg, R. DB - Embase Medline DO - 10.1371/journal.pone.0003088 IS - 8 L1 - internal-pdf://1371499336/journal.pone.0003088.PDF LA - English M3 - Article N1 - L352410178 2008-10-09 PY - 2008 SN - 1932-6203 ST - Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features T2 - PLoS ONE TI - Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352410178&from=export http://dx.doi.org/10.1371/journal.pone.0003088 VL - 3 ID - 2637 ER - TY - JOUR AD - J. A. E. Irving, Northern Institute for Cancer Research, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne, Tyne and Wear, United Kingdom AU - Case, M. AU - Matheson, E. AU - Minto, L. AU - Hassan, R. AU - Harrison, C. J. AU - Bown, N. AU - Bailey, S. AU - Vormoor, J. AU - Hall, A. G. AU - Irving, J. A. E. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-0101 IS - 16 L1 - internal-pdf://2439701652/6803.full.pdf LA - English M3 - Article N1 - L352481122 2008-11-04 PY - 2008 SN - 0008-5472 SP - 6803-6809 ST - Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia T2 - Cancer Research TI - Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352481122&from=export http://dx.doi.org/10.1158/0008-5472.CAN-08-0101 VL - 68 ID - 2638 ER - TY - JOUR AD - J. Versalovic, Department of Pathology, Texas Children's Hospital, 6621 Fannin St., Houston, TX 77030, United States AU - Lin, Y. P. AU - Thibodeaux, C. H. AU - Peña, J. A. AU - Ferry, G. D. AU - Versalovic, J. DB - Embase Medline DO - 10.1002/ibd.20448 IS - 8 LA - English M3 - Article N1 - L352180720 2008-09-03 PY - 2008 SN - 1078-0998 1536-4844 SP - 1068-1083 ST - Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun T2 - Inflammatory Bowel Diseases TI - Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352180720&from=export http://dx.doi.org/10.1002/ibd.20448 VL - 14 ID - 2640 ER - TY - JOUR AD - C.-H. Hung, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan AU - Chiu, P. R. AU - Lee, W. T. AU - Chu, Y. T. AU - Lee, M. S. AU - Jong, Y. J. AU - Hung, C. H. DB - Embase Medline DO - 10.1016/S1875-9572(08)60028-5 IS - 4 LA - English M3 - Article N1 - L352749482 2008-12-31 PY - 2008 SN - 1875-9572 SP - 135-140 ST - Effect of the Chinese Herb Extract Osthol on IL-4-induced Eotaxin Expression in BEAS-2B Cells T2 - Pediatrics and Neonatology TI - Effect of the Chinese Herb Extract Osthol on IL-4-induced Eotaxin Expression in BEAS-2B Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352749482&from=export http://dx.doi.org/10.1016/S1875-9572(08)60028-5 VL - 49 ID - 2641 ER - TY - JOUR AD - L.E. Samelson, Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States AU - Sommers, C. L. AU - Gurson, J. M. AU - Surana, R. AU - Barda-Saad, M. AU - Lee, J. AU - Kishor, A. AU - Li, W. AU - Gasser, A. J. AU - Barr, V. A. AU - Miyaji, M. AU - Love, P. E. AU - Samelson, L. E. DB - Embase Medline DO - 10.1093/intimm/dxn039 IS - 7 LA - English M3 - Article N1 - L351865857 2008-07-07 PY - 2008 SN - 0953-8178 1460-2377 SP - 811-818 ST - Bam32: A novel mediator of Erk activation in T cells T2 - International Immunology TI - Bam32: A novel mediator of Erk activation in T cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351865857&from=export http://dx.doi.org/10.1093/intimm/dxn039 VL - 20 ID - 2642 ER - TY - JOUR AD - B. N. Kang, Dept. of Veterinary and Biomedical Sciences, College of Veterinary Medicine, Univ. of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, United States AU - Kang, B. N. AU - Jude, J. A. AU - Panettieri Jr, R. A. AU - Walseth, T. F. AU - Kannan, M. S. DB - Embase Medline DO - 10.1152/ajplung.00352.2007 IS - 1 LA - English M3 - Article N1 - L352763450 2008-12-24 PY - 2008 SN - 1040-0605 1522-1504 SP - L186-L193 ST - Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: Role of dual specificity phosphatase 1 T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: Role of dual specificity phosphatase 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352763450&from=export http://dx.doi.org/10.1152/ajplung.00352.2007 http://ajplung.physiology.org/cgi/reprint/295/1/L186 VL - 295 ID - 2643 ER - TY - JOUR AD - H.-S. Kim, Department of Neuroscience, School of Medicine, Ewha Womans University, Mok-6-dong 911-1, Yangchun-Ku, Seoul 158-710, South Korea AU - Woo, M. S. AU - Park, J. S. AU - Choi, I. Y. AU - Kimf, W. K. AU - Kim, H. S. DB - Embase Medline DO - 10.1111/j.1471-4159.2008.05430.x IS - 2 LA - English M3 - Article N1 - L354462658 2009-05-06 PY - 2008 SN - 0022-3042 1471-4159 SP - 770-780 ST - Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia T2 - Journal of Neurochemistry TI - Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354462658&from=export http://dx.doi.org/10.1111/j.1471-4159.2008.05430.x VL - 106 ID - 2644 ER - TY - JOUR AD - J. Shou, China Novartis Institutes for BioMedical Research, Shanghai 201203, China AU - Chen, Y. AU - Wei, T. AU - Yan, L. AU - Lawrence, F. AU - Qian, H. R. AU - Burkholder, T. P. AU - Starling, J. J. AU - Yingling, J. M. AU - Shou, J. C1 - ly 2401401 ptk 787 su 11248 sutent DB - Embase Medline DO - 10.1186/1471-2164-9-264 LA - English M3 - Article N1 - L351895450 2008-07-09 PY - 2008 SN - 1471-2164 ST - Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model T2 - BMC Genomics TI - Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351895450&from=export http://dx.doi.org/10.1186/1471-2164-9-264 VL - 9 ID - 2646 ER - TY - JOUR AD - L. M. Gjerdrum, Department of Pathology, 5441, Copenhagen University Hospital, Rigshospitalet, Frederik V's vej 11, 2100 Copenhagen, Denmark AU - Gjerdrum, L. M. AU - Woetmann, A. AU - Odum, N. AU - Hother, C. AU - Henrik-Nielsen, R. AU - Gniadecki, R. AU - Ralfkiaer, E. DB - Embase Medline DO - 10.1111/j.1600-0609.2008.01064.x IS - 6 LA - English M3 - Article N1 - L351677463 2008-06-06 PY - 2008 SN - 0902-4441 1600-0609 SP - 483-489 ST - FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations T2 - European Journal of Haematology TI - FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351677463&from=export http://dx.doi.org/10.1111/j.1600-0609.2008.01064.x VL - 80 ID - 2647 ER - TY - JOUR AD - C.-H. Tang, Department of Pharmacology, College of Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, Taiwan AU - Fong, Y. C. AU - Maa, M. C. AU - Tsai, F. J. AU - Chen, W. C. AU - Lin, J. G. AU - Jeng, L. B. AU - Yang, R. S. AU - Fu, W. M. AU - Tang, C. H. DB - Embase Medline DO - 10.1359/jbmr.080206 IS - 6 LA - English M3 - Article N1 - L351768814 2008-06-19 PY - 2008 SN - 0884-0431 SP - 961-970 ST - Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells T2 - Journal of Bone and Mineral Research TI - Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351768814&from=export http://dx.doi.org/10.1359/jbmr.080206 VL - 23 ID - 2648 ER - TY - JOUR AD - P. H. Rao, Texas Children's Cancer Center, Baylor College of Medicine, MC 3-3320, 6621 Fannin Street, Houston, TX 77030, United States AU - Lu, X. Y. AU - Lu, Y. AU - Zhao, Y. J. AU - Jaeweon, K. AU - Kang, J. AU - Li, X. N. AU - Ge, G. AU - Meyer, R. AU - Perlaky, L. AU - Hicks, J. AU - Chintagumpala, M. AU - Cai, W. W. AU - Ladanyi, M. AU - Gorlick, R. AU - Lau, C. C. AU - Pati, D. AU - Sheldon, M. AU - Rao, P. H. DB - Embase Medline DO - 10.1158/1541-7786.MCR-07-2115 IS - 6 L1 - internal-pdf://3695831790/937.full.pdf LA - English M3 - Article N1 - L352467514 2008-11-12 PY - 2008 SN - 1541-7786 SP - 937-946 ST - Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma T2 - Molecular Cancer Research TI - Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352467514&from=export http://dx.doi.org/10.1158/1541-7786.MCR-07-2115 VL - 6 ID - 2649 ER - TY - JOUR AD - M.S. Sidik, Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia AU - Shiran, M. S. AU - Tan, G. C. AU - Sabariah, A. R. AU - Chye, P. C. AU - Pathmanathan, R. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L352582367 2008-11-07 PY - 2008 SN - 0300-5283 SP - 150-151 ST - Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99 T2 - Medical Journal of Malaysia TI - Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352582367&from=export VL - 63 ID - 2650 ER - TY - JOUR AD - E. Noguchi, Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan AU - Fujimoto, M. AU - Imai, K. AU - Hirata, K. AU - Kashiwagi, R. AU - Morinishi, Y. AU - Kitazawa, K. AU - Sasaki, S. AU - Arinami, T. AU - Nonoyama, S. AU - Noguchi, E. DB - Embase Medline DO - 10.1186/1471-2350-9-42 LA - English M3 - Article N1 - L351803795 2008-06-20 PY - 2008 SN - 1471-2350 ST - Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes T2 - BMC Medical Genetics TI - Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351803795&from=export http://dx.doi.org/10.1186/1471-2350-9-42 VL - 9 ID - 2651 ER - TY - JOUR AD - Y. Zhu, Rashid Laboratory Developmental Neurobiology, Silver Child Development Center, University of South Florida College of Medicine, Tampa, FL, United States AU - Zhu, Y. AU - Hou, H. AU - Nikolic, W. V. AU - Ehrhart, J. AU - Rrapo, E. AU - Bickford, P. AU - Giunta, B. AU - Tan, J. DB - Embase Medline DO - 10.1371/journal.pone.0002135 IS - 5 L1 - internal-pdf://3667706853/journal.pone.0002135.PDF LA - English M3 - Article N1 - L352025171 2008-08-12 PY - 2008 SN - 1932-6203 ST - CD45RB is a novel molecular therapeutic target to inhibit Aβ peptide-induced microglial MAPK activation T2 - PLoS ONE TI - CD45RB is a novel molecular therapeutic target to inhibit Aβ peptide-induced microglial MAPK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352025171&from=export http://dx.doi.org/10.1371/journal.pone.0002135 VL - 3 ID - 2652 ER - TY - JOUR AD - R. Di Nicolantonio, Department of Physiology, University of Melbourne, Melbourne, VIC 3010, Australia AU - Dwyer, J. P. AU - Ritchie, M. W. AU - Smyth, G. K. AU - Harrap, S. B. AU - Delbridge, L. M. D. AU - Domenighetti, A. A. AU - Nicolantonio, R. DB - Embase Medline DO - 10.1291/hypres.31.941 IS - 5 LA - English M3 - Article N1 - L351895039 2008-07-09 PY - 2008 SN - 0916-9636 1348-4214 SP - 941-955 ST - Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension T2 - Hypertension Research TI - Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351895039&from=export http://dx.doi.org/10.1291/hypres.31.941 VL - 31 ID - 2653 ER - TY - JOUR AD - P.K. Wlodarski, Medical University of Warsaw, Center for Biostructure Research, Department of Histology and Embryology, Warsaw, Poland AU - Wlodarski, P. K. AU - Jozwiak, J. C1 - amd 3100 cur 61414 gant 58 gant 61 hhantag 691 DB - Embase Medline DO - 10.1517/14728222.12.4.449 IS - 4 LA - English M3 - Review N1 - L351546371 2008-05-01 PY - 2008 SN - 1472-8222 SP - 449-461 ST - Therapeutic targets for medulloblastoma T2 - Expert Opinion on Therapeutic Targets TI - Therapeutic targets for medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351546371&from=export http://dx.doi.org/10.1517/14728222.12.4.449 VL - 12 ID - 2654 ER - TY - JOUR AD - J.M. Olson, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, Seattle, WA 98109, United States AU - Spiller, S. E. AU - Ditzler, S. H. AU - Pullar, B. J. AU - Olson, J. M. C2 - Aton(United States) Sigma DB - Embase Medline DO - 10.1007/s11060-007-9505-1 IS - 2 LA - English M3 - Article N1 - L50007232 2008-04-15 PY - 2008 SN - 0167-594X 1573-7373 SP - 133-141 ST - Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA) T2 - Journal of Neuro-Oncology TI - Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50007232&from=export http://dx.doi.org/10.1007/s11060-007-9505-1 VL - 87 ID - 2655 ER - TY - JOUR AD - E. Campo, Laboratory of Pathology, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain AU - Salaverria, I. AU - Beà, S. AU - Lopez-Guillermo, A. AU - Lespinet, V. AU - Pinyol, M. AU - Burkhardt, B. AU - Lamant, L. AU - Zettl, A. AU - Horsman, D. AU - Gascoyne, R. AU - Ott, G. AU - Siebert, R. AU - Delsol, G. AU - Campo, E. DB - Embase Medline DO - 10.1111/j.1365-2141.2007.06924.x IS - 5 LA - English M3 - Article N1 - L351230071 2008-02-27 PY - 2008 SN - 0007-1048 1365-2141 SP - 516-526 ST - Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas T2 - British Journal of Haematology TI - Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351230071&from=export http://dx.doi.org/10.1111/j.1365-2141.2007.06924.x VL - 140 ID - 2657 ER - TY - JOUR AD - C. M. Klinge, Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, 580 South Preston Street, Louisville, KY 40202, United States AU - Mattingly, K. A. AU - Ivanova, M. M. AU - Riggs, K. A. AU - Wickramasinghe, N. S. AU - Barch, M. J. AU - Klinge, C. M. DB - Embase Medline DO - 10.1210/me.2007-0029 IS - 3 LA - English M3 - Article N1 - L351397789 2008-04-01 PY - 2008 SN - 0888-8809 SP - 609-622 ST - Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis T2 - Molecular Endocrinology TI - Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351397789&from=export http://dx.doi.org/10.1210/me.2007-0029 http://mend.endojournals.org/cgi/reprint/22/3/609 VL - 22 ID - 2658 ER - TY - JOUR AD - D. Jeoung, Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chunchon, 200-701, South Korea AU - Kim, K. AU - Kim, Y. AU - Kim, H. Y. AU - Ro, J. Y. AU - Jeoung, D. DB - Embase Medline DO - 10.1016/j.ejphar.2007.11.033 IS - 1-2 LA - English M3 - Article N1 - L50014138 2008-02-22 PY - 2008 SN - 0014-2999 SP - 191-203 ST - Inhibitory mechanism of anti-allergic peptides in RBL2H3 cells T2 - European Journal of Pharmacology TI - Inhibitory mechanism of anti-allergic peptides in RBL2H3 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50014138&from=export http://dx.doi.org/10.1016/j.ejphar.2007.11.033 VL - 581 ID - 2659 ER - TY - JOUR AD - O. Tetsu, UCSF, 2340 Sutter Street N111, San Francisco, CA 94143-0128, United States AU - Senawong, T. AU - Phuchareon, J. AU - Ohara, O. AU - McCormick, F. AU - Rauen, K. A. AU - Tetsu, O. C1 - sb 590885(Calbiochem,United States) u 0126(Promega,United States) C2 - Calbiochem(United States) Promega(United States) DB - Embase Medline DO - 10.1093/hmg/ddm319 IS - 3 LA - English M3 - Article N1 - L351135956 2008-02-05 PY - 2008 SN - 0964-6906 1460-2083 SP - 419-430 ST - Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: Implications for therapeutic options T2 - Human Molecular Genetics TI - Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: Implications for therapeutic options UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351135956&from=export http://dx.doi.org/10.1093/hmg/ddm319 VL - 17 ID - 2660 ER - TY - JOUR AD - M. U. Sani, Cardiology Unit, Department of Medicine, Aminu Kano Teaching Hospital, P.M.B 3452, Kano, Nigeria AU - Sani, M. U. DB - Embase Medline DO - 10.1007/s00508-008-0935-3 IS - 3-4 LA - English M3 - Review N1 - L351361645 2008-03-25 PY - 2008 SN - 0043-5325 SP - 77-87 ST - Myocardial disease in human immunodeficiency virus (HIV) infection: A review T2 - Wiener Klinische Wochenschrift TI - Myocardial disease in human immunodeficiency virus (HIV) infection: A review UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351361645&from=export http://dx.doi.org/10.1007/s00508-008-0935-3 VL - 120 ID - 2661 ER - TY - JOUR AD - M.-C. Liu, Department of Pediatrics, Chi-Mei Foundation Hospital, Liouying, No.201, Taikang Village, Liouying Township, Tainan 736, Taiwan AU - Hung, T. Y. AU - Lin, Y. C. AU - Sun, H. L. AU - Liu, M. C. DB - Embase Medline DO - 10.1007/s00431-006-0409-4 IS - 1 LA - English M3 - Article N1 - L350159812 2007-12-04 PY - 2008 SN - 0340-6199 SP - 111-113 ST - Primary cutaneous anaplastic large cell lymphoma in a young child T2 - European Journal of Pediatrics TI - Primary cutaneous anaplastic large cell lymphoma in a young child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350159812&from=export http://dx.doi.org/10.1007/s00431-006-0409-4 VL - 167 ID - 2662 ER - TY - JOUR AD - H.S. Ahn, Department of Pediatrics, Seoul National University College of Medicine, Seoul, 110-799, South Korea AU - Seo, Y. J. AU - Koh, S. H. AU - Kang, H. J. AU - Shin, H. Y. AU - Jeong, G. AU - Ahn, H. S. DB - Embase Medline DO - 10.1016/j.bbrc.2007.10.023 IS - 2 LA - English M3 - Article N1 - L47633426 2007-11-21 PY - 2007 SN - 0006-291X 1090-2104 SP - 388-394 ST - Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation T2 - Biochemical and Biophysical Research Communications TI - Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47633426&from=export http://dx.doi.org/10.1016/j.bbrc.2007.10.023 VL - 364 ID - 2663 ER - TY - JOUR AD - B. Homey, Department of Dermatology, Heinrich Heine University, Moorenstrasse 5, D-40225 Düsseldorf, Germany AU - Pivarcsi, A. AU - Müller, A. AU - Hippe, A. AU - Rieker, J. AU - Van Lierop, A. AU - Steinhoff, M. AU - Seeliger, S. AU - Kubitza, R. AU - Pippirs, U. AU - Meller, S. AU - Gerber, P. A. AU - Liersch, R. AU - Buenemann, E. AU - Sonkoly, E. AU - Wiesner, U. AU - Hoffmann, T. K. AU - Schneider, L. AU - Piekorz, R. AU - Enderlein, E. AU - Reifenberger, J. AU - Rohr, U. P. AU - Haas, R. AU - Boukamp, P. AU - Haase, I. AU - Nürnberg, B. AU - Ruzicka, T. AU - Zlotnik, A. AU - Homey, B. DB - Embase Medline DO - 10.1073/pnas.0705673104 IS - 48 L1 - internal-pdf://2349174261/19055.full.pdf LA - English M3 - Article N1 - L351024692 2008-01-23 PY - 2007 SN - 0027-8424 1091-6490 SP - 19055-19060 ST - Tumor immune escape by the loss of homeostatic chemokine expression T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Tumor immune escape by the loss of homeostatic chemokine expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351024692&from=export http://dx.doi.org/10.1073/pnas.0705673104 VL - 104 ID - 2665 ER - TY - JOUR AD - J.A. Epstein, 954 BRB II, 421 Curie Blvd, Philadelphia, PA 19104, United States AU - Xu, J. AU - Ismat, F. A. AU - Wang, T. AU - Yang, J. AU - Epstein, J. A. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.107.707752 IS - 19 LA - English M3 - Article N1 - L350060352 2007-11-28 PY - 2007 SN - 0009-7322 SP - 2148-2156 ST - NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response T2 - Circulation TI - NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350060352&from=export http://dx.doi.org/10.1161/CIRCULATIONAHA.107.707752 VL - 116 ID - 2666 ER - TY - JOUR AD - E. Legius, Department of Human Genetics, Catholic University of Leuven, Herestraat 49, 3000 Leuven, Belgium AU - Denayer, E. AU - Legius, E. DB - Embase Medline DO - 10.1007/s00431-007-0535-7 IS - 11 LA - English M3 - Review N1 - L47476634 2007-11-01 PY - 2007 SN - 0340-6199 SP - 1091-1098 ST - What's new in the neuro-cardio-facial-cutaneous syndromes? T2 - European Journal of Pediatrics TI - What's new in the neuro-cardio-facial-cutaneous syndromes? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47476634&from=export http://dx.doi.org/10.1007/s00431-007-0535-7 VL - 166 ID - 2667 ER - TY - JOUR AD - T. Kielian, University of Arkansas for Medical Sciences, Department of Neurobiology and Developmental Sciences, 4301 W. Markham Street, Slot 846, Little Rock, AR 72205, United States AU - Syed, M. Md AU - Phulwani, N. K. AU - Kielian, T. DB - Embase Medline DO - 10.1111/j.1471-4159.2007.04838.x IS - 4 LA - English M3 - Article N1 - L47631804 2007-11-01 PY - 2007 SN - 0022-3042 1471-4159 SP - 1461-1471 ST - Tumor necrosis factor-alpha (TNF-α) regulates Toll-like receptor 2 (TLR2) expression in microglia T2 - Journal of Neurochemistry TI - Tumor necrosis factor-alpha (TNF-α) regulates Toll-like receptor 2 (TLR2) expression in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47631804&from=export http://dx.doi.org/10.1111/j.1471-4159.2007.04838.x VL - 103 ID - 2668 ER - TY - JOUR AD - L.-P. Yang, Peking University Eye Center, Peking University Third Hospital, 49 North Garden Road, Beijing 100083, China AU - Yang, L. P. AU - Zhu, X. A. AU - Tso, M. O. M. DB - Embase Medline L1 - internal-pdf://1411154259/v13a232-yang.pdf LA - English M3 - Article N1 - L350031852 2007-12-21 PY - 2007 SN - 1090-0535 SP - 2048-2057 ST - A possible mechanism of microglia-photoreceptor crosstalk T2 - Molecular Vision TI - A possible mechanism of microglia-photoreceptor crosstalk UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350031852&from=export VL - 13 ID - 2669 ER - TY - JOUR AD - R.M. Beattie, Department of Nutrition, Paediatric Medical Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom AU - Bremner, A. R. AU - Beattie, R. M. C1 - cdp 571 DB - Embase Medline DO - 10.1517/14656566.8.15.2553 IS - 15 LA - English M3 - Review N1 - L350031293 2007-11-22 PY - 2007 SN - 1465-6566 SP - 2553-2568 ST - Recent advances in the medical therapy of Crohn's disease in childhood T2 - Expert Opinion on Pharmacotherapy TI - Recent advances in the medical therapy of Crohn's disease in childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350031293&from=export http://dx.doi.org/10.1517/14656566.8.15.2553 VL - 8 ID - 2670 ER - TY - JOUR AD - M.-J. Zhu, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Zhu, M. J. AU - Ou, W. B. AU - Fletcher, C. D. M. AU - Cohen, P. S. AU - Demetri, G. D. AU - Fletcher, J. A. DB - Embase Medline DO - 10.1038/sj.onc.1210464 IS - 44 LA - English M3 - Article N1 - L47494217 2007-09-27 PY - 2007 SN - 0950-9232 1476-5594 SP - 6386-6395 ST - KIT oncoprotein interactions in gastrointestinal stromal tumors: Therapeutic relevance T2 - Oncogene TI - KIT oncoprotein interactions in gastrointestinal stromal tumors: Therapeutic relevance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47494217&from=export http://dx.doi.org/10.1038/sj.onc.1210464 VL - 26 ID - 2672 ER - TY - JOUR AD - G. Rajashekhar, Indiana Univ. School of Medicine, Indiana Center of Vascular Biology and Medicine, IB464, 975 W. Walnut St., Indianapolis, IN 46202, United States AU - Rajashekhar, G. AU - Grow, M. AU - Willuweit, A. AU - Patterson, C. E. AU - Clauss, M. DB - Embase Medline DO - 10.1152/physiolgenomics.00157.2006 IS - 1 LA - English M3 - Article N1 - L47443852 2007-09-19 PY - 2007 SN - 1094-8341 1531-2267 SP - 104-113 ST - Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation T2 - Physiological Genomics TI - Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47443852&from=export http://dx.doi.org/10.1152/physiolgenomics.00157.2006 http://physiolgenomics.physiology.org/cgi/reprint/31/1/104 VL - 31 ID - 2673 ER - TY - JOUR AD - M. Steinhoff, Department of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany AU - Rattenholl, A. AU - Seeliger, S. AU - Buddenkotte, J. AU - Schön, M. AU - Schön, M. P. AU - Ständer, S. AU - Vergnolle, N. AU - Steinhoff, M. C1 - pd 153035 C2 - Sigma(Germany) DB - Embase Medline DO - 10.1038/sj.jid.5700847 IS - 9 LA - English M3 - Article N1 - L47258489 2007-09-01 PY - 2007 SN - 0022-202X 1523-1747 SP - 2245-2252 ST - Proteinase-activated receptor-2 (PAR2): A tumor suppressor in skin carcinogenesis T2 - Journal of Investigative Dermatology TI - Proteinase-activated receptor-2 (PAR2): A tumor suppressor in skin carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47258489&from=export http://dx.doi.org/10.1038/sj.jid.5700847 VL - 127 ID - 2674 ER - TY - JOUR AD - W.B. Isaacs, Department of Urology, Johns Hopkins Medical Institutions, Marburg 115, 600 North Wolfe Street, Baltimore, MD 21287, United States AU - Liu, W. AU - Chang, B. L. AU - Cramer, S. AU - Koty, P. P. AU - Li, T. AU - Sun, J. AU - Turner, A. R. AU - Kap-Herr, C. AU - Bobby, P. AU - Rao, J. AU - Zheng, S. L. AU - Isaacs, W. B. AU - Xu, J. DB - Embase Medline DO - 10.1158/1078-0432.CCR-07-0300 IS - 17 L1 - internal-pdf://0950390868/5028.full.pdf LA - English M3 - Article N1 - L47502067 2007-09-01 PY - 2007 SN - 1078-0432 SP - 5028-5033 ST - Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers T2 - Clinical Cancer Research TI - Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47502067&from=export http://dx.doi.org/10.1158/1078-0432.CCR-07-0300 VL - 13 ID - 2675 ER - TY - JOUR AD - J.S. Grewal, Department of Internal Medicine, Reichert Health Center, St. Joseph Mercy Hospital, 5333 McAuley Drive, Ann Arbor, MI 48106-0995, United States AU - Grewal, J. S. AU - Smith, L. B. AU - Winegarden Iii, J. D. AU - Krauss, J. C. AU - Tworek, J. A. AU - Schnitzer, B. C1 - vm 26 vp 16 DB - Embase Medline DO - 10.1007/s00277-007-0289-3 IS - 7 LA - English M3 - Article N1 - L46863887 2007-07-01 PY - 2007 SN - 0939-5555 SP - 499-508 ST - Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: A report of three cases and a review of the literature T2 - Annals of Hematology TI - Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: A report of three cases and a review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46863887&from=export http://dx.doi.org/10.1007/s00277-007-0289-3 VL - 86 ID - 2677 ER - TY - JOUR AD - B. Tang, 38 Ballylenaghan Road, Belfast BT8 6WU, United Kingdom AU - Tang, B. AU - Reardon, W. AU - Black, G. C. AU - Kerr, B. A. DB - Embase Medline DO - 10.1097/MCD.0b013e328011f974 IS - 3 LA - English M3 - Article N1 - L46884182 2007-07-01 PY - 2007 SN - 0962-8827 SP - 203-206 ST - Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome T2 - Clinical Dysmorphology TI - Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46884182&from=export http://dx.doi.org/10.1097/MCD.0b013e328011f974 VL - 16 ID - 2678 ER - TY - JOUR AD - N. Kanda, School of Medicine, Department of Dermatology, Teikyo University, 11-1, Kaga-2, Itabashi-Ku, Tokyo 173-8605, Japan AU - Kanda, N. AU - Watanabe, S. DB - Embase Medline DO - 10.1111/j.1365-2222.2007.02743.x IS - 7 LA - English M3 - Article N1 - L46955520 2007-07-01 PY - 2007 SN - 0954-7894 1365-2222 SP - 1074-1082 ST - Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes T2 - Clinical and Experimental Allergy TI - Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46955520&from=export http://dx.doi.org/10.1111/j.1365-2222.2007.02743.x VL - 37 ID - 2679 ER - TY - JOUR AD - M.M. Al-Rahawan, Department of Health and Human Services, National Institute of Health, EPS, 6120 Executive Blvd, Rockville, MD 20852, United States AU - Al-Rahawan, M. M. AU - Chute, D. J. AU - Sol-Church, K. AU - Gripp, K. W. AU - Stabley, D. L. AU - McDaniel, N. L. AU - Wilson, W. G. AU - Waldron, P. E. DB - Embase Medline DO - 10.1002/ajmg.a.31819 IS - 13 LA - English M3 - Article N1 - L47051027 2007-07-01 PY - 2007 SN - 1552-4825 1552-4833 SP - 1481-1488 ST - Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome T2 - American Journal of Medical Genetics, Part A TI - Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47051027&from=export http://dx.doi.org/10.1002/ajmg.a.31819 VL - 143 ID - 2681 ER - TY - JOUR AD - L.C. Hofbauer, Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, Technical University of Dresden, Fetscherstrasse 74, Dresden D-01307, Germany AU - Schrader, J. AU - Rennekamp, W. AU - Niebergall, U. AU - Schoppet, M. AU - Jahr, H. AU - Brendel, M. D. AU - Hörsch, D. AU - Hofbauer, L. C. DB - Embase Medline DO - 10.1007/s00125-007-0672-6 IS - 6 LA - English M3 - Article N1 - L46701570 2007-06-01 PY - 2007 SN - 0012-186X SP - 1243-1247 ST - Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death T2 - Diabetologia TI - Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46701570&from=export http://dx.doi.org/10.1007/s00125-007-0672-6 VL - 50 ID - 2682 ER - TY - JOUR AD - S.K. Dey, Division of Reproductive and Developmental Biology, Vanderbilt University, Nashville, TN 37232-2678, United States AU - Daikoku, T. AU - Tranguch, S. AU - Chakrabarty, A. AU - Wang, D. AU - Khabele, D. AU - Orsulic, S. AU - Morrow, J. D. AU - DuBois, R. N. AU - Dey, S. K. C1 - aspirin DB - Embase Medline DO - 10.1158/0008-5472.CAN-07-0828 IS - 11 L1 - internal-pdf://1137949908/5285.full.pdf LA - English M3 - Article N1 - L46997267 2007-06-01 PY - 2007 SN - 0008-5472 SP - 5285-5292 ST - Extracellular signal-regulated kinase is a target of cyclooxygenase-1- peroxisome proliferator-activated receptor-δ signaling in epithelial ovarian cancer T2 - Cancer Research TI - Extracellular signal-regulated kinase is a target of cyclooxygenase-1- peroxisome proliferator-activated receptor-δ signaling in epithelial ovarian cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46997267&from=export http://dx.doi.org/10.1158/0008-5472.CAN-07-0828 VL - 67 ID - 2685 ER - TY - JOUR AD - C. Lopez-Pedrera, Unidad de Investigación Hospital Reina Sofía, Córdoba, Spain AU - Barbarroja, N. AU - Arístides-Torres, L. AU - Hernandez, V. AU - Martín, C. AU - Dorado, G. AU - Torres, A. AU - Velasco, F. AU - Lopez-Pedrera, C. DB - Embase Medline DO - 10.1080/10428190701340616 IS - 6 LA - English M3 - Article N1 - L47009209 2007-06-01 PY - 2007 SN - 1042-8194 1029-2403 SP - 1187-1199 ST - Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia T2 - Leukemia and Lymphoma TI - Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47009209&from=export http://dx.doi.org/10.1080/10428190701340616 VL - 48 ID - 2686 ER - TY - JOUR AD - B. Gerstner, Department of Neonatology, Universitätsmedizin Berlin, Charité, Augustenburger Platz 1, 13353 Berlin, Germany AU - Gerstner, B. AU - Sifringer, M. AU - Dzietko, M. AU - Schüller, A. AU - Lee, J. AU - Simons, S. AU - Obladen, M. AU - Volpe, J. J. AU - Rosenberg, P. A. AU - Felderhoff-Mueser, U. DB - Embase Medline DO - 10.1002/ana.21118 IS - 6 LA - English M3 - Article N1 - L47068138 2007-06-01 PY - 2007 SN - 0364-5134 SP - 562-573 ST - Estradiol attenuates hyperoxia-induced cell death in the developing white matter T2 - Annals of Neurology TI - Estradiol attenuates hyperoxia-induced cell death in the developing white matter UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47068138&from=export http://dx.doi.org/10.1002/ana.21118 VL - 61 ID - 2687 ER - TY - JOUR AD - M.-H. Tai, 3164 Biomedical and Physical Sciences Building, Department of Physiology, Michigan State University, East Lansing, MI 48824, United States AU - Tai, M. H. AU - Upham, B. L. AU - Olson, L. K. AU - Tsao, M. S. AU - Reed Jr, D. N. AU - Trosko, J. E. DB - Embase Medline DO - 10.1002/ijc.22530 IS - 9 LA - English M3 - Article N1 - L46418360 2007-04-29 PY - 2007 SN - 0020-7136 1097-0215 SP - 1855-1862 ST - Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells T2 - International Journal of Cancer TI - Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46418360&from=export http://dx.doi.org/10.1002/ijc.22530 VL - 120 ID - 2689 ER - TY - JOUR AD - A.L. Wang, Peking University Eye Centre, Peking University Third Hospital, Peking University, Beijing, 100083, China AU - Wang, A. L. AU - Yu, A. C. H. AU - He, Q. H. AU - Zhu, X. AU - Tso, M. O. M. DB - Embase Medline DO - 10.1016/j.exer.2007.01.011 IS - 5 LA - English M3 - Article N1 - L46613882 2007-05-01 PY - 2007 SN - 0014-4835 SP - 905-913 ST - AGEs mediated expression and secretion of TNF alpha in rat retinal microglia T2 - Experimental Eye Research TI - AGEs mediated expression and secretion of TNF alpha in rat retinal microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46613882&from=export http://dx.doi.org/10.1016/j.exer.2007.01.011 VL - 84 ID - 2690 ER - TY - JOUR AD - D.B. Solit, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, United States AU - Pratilas, C. A. AU - Solit, D. B. C1 - arry 142886(Array Biopharma) azd 6244(Astra Zeneca) bay 439006(Bayer) bay 439006(Onyx) chir 265(Chiron) chir 265(Novartis) ci 1040(Pfizer) cnf 2024(Biogen) exel 2819(Exelixis) letx(Van Andel Research Institute) nexavar(Bayer) nexavar(Onyx) pd 0325901(Pfizer) pd 184352(Pfizer) plx 4032(Plexxikon) raf 265(Chiron) raf 265(Novartis) sb 590885(Glaxo SmithKline) snx 5542(Serenex) ver 49009(Vernalis) xl 281(Exelixis) C2 - Array Biopharma Astra Zeneca Bayer Biogen Chiron Exelixis Glaxo SmithKline Infinity Kosan Novartis Onyx Pfizer Plexxikon Serenex Van Andel Research Institute Vernalis DB - Embase Medline DO - 10.2174/157488707780599393 IS - 2 LA - English M3 - Review N1 - L46773880 2007-05-01 PY - 2007 SN - 1574-8871 SP - 121-134 ST - Therapeutic strategies for targeting BRAF in human cancer T2 - Reviews on Recent Clinical Trials TI - Therapeutic strategies for targeting BRAF in human cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46773880&from=export http://dx.doi.org/10.2174/157488707780599393 http://www.ingentaconnect.com/content/ben/rrct/2007/00000002/00000002/art00006 VL - 2 ID - 2692 ER - TY - JOUR AD - A.-G. Shen, Jiangsu Province Key Lab. of Neuroregeneration, Nantong University, Nantong, 226001, China AU - Sun, L. L. AU - Cheng, C. AU - Liu, H. O. AU - Shen, C. C. AU - Xiao, F. AU - Qin, J. AU - Yang, J. L. AU - Shen, A. G. C1 - go 6983(Sigma) C2 - Sigma DB - Embase Medline DO - 10.1007/s12031-007-0003-x IS - 1 LA - English M3 - Article N1 - L47450552 2007-05-01 PY - 2007 SN - 0895-8696 SP - 16-24 ST - Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-α biosynthesis in rat astrocytes T2 - Journal of Molecular Neuroscience TI - Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-α biosynthesis in rat astrocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47450552&from=export http://dx.doi.org/10.1007/s12031-007-0003-x VL - 32 ID - 2693 ER - TY - JOUR AD - Y. Liu, Center for Perinatal Research, Columbus Children's Research Institute, 700 Children's Drive, Columbus, OH 43205, United States AU - Wang, X. AU - Meng, X. AU - Kuhlman, J. R. AU - Nelin, L. D. AU - Nicol, K. K. AU - English, B. K. AU - Liu, Y. DB - Embase Medline DO - 10.4049/jimmunol.178.8.5312 IS - 8 LA - English M3 - Article N1 - L46595317 2007-04-15 PY - 2007 SN - 0022-1767 SP - 5312-5320 ST - Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria T2 - Journal of Immunology TI - Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46595317&from=export http://dx.doi.org/10.4049/jimmunol.178.8.5312 VL - 178 ID - 2694 ER - TY - JOUR AD - S. Hashioka, Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan AU - Hashioka, S. AU - Han, Y. H. AU - Fujii, S. AU - Kato, T. AU - Monji, A. AU - Utsumi, H. AU - Sawada, M. AU - Nakanishi, H. AU - Kanba, S. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2006.12.003 IS - 7 LA - English M3 - Article N1 - L46356888 2007-04-12 PY - 2007 SN - 0891-5849 SP - 945-954 ST - Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation T2 - Free Radical Biology and Medicine TI - Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46356888&from=export http://dx.doi.org/10.1016/j.freeradbiomed.2006.12.003 VL - 42 ID - 2695 ER - TY - JOUR AD - G.A. McArthur, Division of Clinical Haematology and Medical Oncology, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Vic. 3002, Australia AU - Liu, W. AU - Kelly, J. W. AU - Trivett, M. AU - Murray, W. K. AU - Dowling, J. P. AU - Wolfe, R. AU - Mason, G. AU - Magee, J. AU - Angel, C. AU - Dobrovic, A. AU - McArthur, G. A. DB - Embase Medline DO - 10.1038/sj.jid.5700632 IS - 4 LA - English M3 - Article N1 - L46434654 2007-04-11 PY - 2007 SN - 0022-202X 1523-1747 SP - 900-905 ST - Distinct clinical and pathological features are associated with the BRAFT1799A(V600E) mutation in primary melanoma T2 - Journal of Investigative Dermatology TI - Distinct clinical and pathological features are associated with the BRAFT1799A(V600E) mutation in primary melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46434654&from=export http://dx.doi.org/10.1038/sj.jid.5700632 VL - 127 ID - 2696 ER - TY - JOUR AD - D. Heyman, Université de Nantes, INSERM, ERI 7, 1 Rue Gaston Veil, 44035 Nantes Cedex 01, France AU - Mori, K. AU - Le Goff, B. AU - Berreur, M. AU - Riet, A. AU - Moreau, A. AU - Blanchard, F. AU - Chevalier, C. AU - Guisle-Marsollier, I. AU - Léger, J. AU - Guicheux, J. AU - Masson, M. AU - Gouin, F. AU - Rédini, F. AU - Heymann, D. DB - Embase Medline DO - 10.1002/path.2140 IS - 5 LA - English M3 - Article N1 - L46502432 2007-04-01 PY - 2007 SN - 0022-3417 1096-9896 SP - 555-562 ST - Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B T2 - Journal of Pathology TI - Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46502432&from=export http://dx.doi.org/10.1002/path.2140 VL - 211 ID - 2698 ER - TY - JOUR AD - M. Simkó, Division of Environmental Physiology, Department of Cell Biology and Biosystems Technology, University of Rostock, Albert-Einstein-Straße 3, D-18059 Rostock, Germany AU - Simkó, M. DB - Embase Medline DO - 10.2174/092986707780362835 IS - 10 LA - English M3 - Review N1 - L46672632 2007-04-01 PY - 2007 SN - 0929-8673 SP - 1141-1152 ST - Cell type specific redox status is responsible for diverse electromagnetic field effects T2 - Current Medicinal Chemistry TI - Cell type specific redox status is responsible for diverse electromagnetic field effects UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46672632&from=export http://dx.doi.org/10.2174/092986707780362835 http://www.ingentaconnect.com/content/ben/cmc/2007/00000014/00000010/art00008 VL - 14 ID - 2699 ER - TY - JOUR AD - M.O. Arcasoy, Department of Medicine, Duke University School of Medicine, DUMC Box 3912, Durham, NC 27710, United States AU - Fu, P. AU - Arcasoy, M. O. DB - Embase Medline DO - 10.1016/j.bbrc.2007.01.044 IS - 2 LA - English M3 - Article N1 - L46161367 2007-02-28 PY - 2007 SN - 0006-291X 1090-2104 SP - 372-378 ST - Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis T2 - Biochemical and Biophysical Research Communications TI - Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46161367&from=export http://dx.doi.org/10.1016/j.bbrc.2007.01.044 VL - 354 ID - 2700 ER - TY - JOUR AD - J.F. Val-Bernal, Departamento de Anatomía Patológica, Hospital Universitario Marqués de Valdecilla, Avda. Valdecilla 1, ES-39008 Santander, Spain AU - González-vela, M. C. AU - Val-bernal, J. F. AU - Arce, F. P. AU - Gómez-Roman, J. AU - González-López, M. A. AU - Fernández-Llaca, J. H. DB - Embase Medline DO - 10.1111/j.1468-3083.2006.01876.x IS - 3 LA - English M3 - Letter N1 - L46243339 2007-03-08 PY - 2007 SN - 0926-9959 1468-3083 SP - 399-401 ST - Presence of human herpesvirus-8 in inflammatory myofibroblastic tumor of the skin [6] T2 - Journal of the European Academy of Dermatology and Venereology TI - Presence of human herpesvirus-8 in inflammatory myofibroblastic tumor of the skin [6] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46243339&from=export http://dx.doi.org/10.1111/j.1468-3083.2006.01876.x VL - 21 ID - 2701 ER - TY - JOUR AD - C.P. Kratz, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Kratz, C. P. AU - Niemeyer, C. M. AU - Zenker, M. DB - Embase Medline DO - 10.1007/s00109-006-0135-4 IS - 3 LA - English M3 - Review N1 - L46295245 2007-03-15 PY - 2007 SN - 0946-2716 SP - 223-231 ST - An unexpected new role of mutant Ras: Perturbation of human embryonic development T2 - Journal of Molecular Medicine TI - An unexpected new role of mutant Ras: Perturbation of human embryonic development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46295245&from=export http://dx.doi.org/10.1007/s00109-006-0135-4 VL - 85 ID - 2702 ER - TY - JOUR AD - M.B. Madonna, Department of Surgery, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, United States AU - Chiu, B. AU - Mirkin, B. AU - Madonna, M. B. DB - Embase Medline DO - 10.1016/j.jpedsurg.2006.10.055 IS - 3 LA - English M3 - Article N1 - L46319163 2007-04-01 PY - 2007 SN - 0022-3468 SP - 482-488 ST - Epidermal growth factor can induce apoptosis in neuroblastoma T2 - Journal of Pediatric Surgery TI - Epidermal growth factor can induce apoptosis in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46319163&from=export http://dx.doi.org/10.1016/j.jpedsurg.2006.10.055 VL - 42 ID - 2703 ER - TY - JOUR AD - M.G. Fakih, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States AU - Fakih, M. G. AU - Trump, D. L. AU - Muindi, J. R. AU - Black, J. D. AU - Bernardi, R. J. AU - Creaven, P. J. AU - Schwartz, J. AU - Brattain, M. G. AU - Hutson, A. AU - French, R. AU - Johnson, C. S. C1 - calcijex(Abbott,United States) iressa(Astra Zeneca,United Kingdom) C2 - Abbott(United States) Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1158/1078-0432.CCR-06-1165 IS - 4 LA - English M3 - Article N1 - L46424063 2007-04-11 PY - 2007 SN - 1078-0432 SP - 1216-1223 ST - A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors T2 - Clinical Cancer Research TI - A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46424063&from=export http://dx.doi.org/10.1158/1078-0432.CCR-06-1165 VL - 13 ID - 2704 ER - TY - JOUR AD - C.J. Thiele, Cell and Molecular Biology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States AU - Li, Z. AU - Zhang, J. AU - Liu, Z. AU - Woo, C. W. AU - Thiele, C. J. C2 - Sigma(United States) DB - Embase Medline DO - 10.1038/sj.cdd.4401983 IS - 2 LA - English M3 - Article N1 - L46092234 2007-02-13 PY - 2007 SN - 1350-9047 1476-5403 SP - 318-326 ST - Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death T2 - Cell Death and Differentiation TI - Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46092234&from=export http://dx.doi.org/10.1038/sj.cdd.4401983 VL - 14 ID - 2705 ER - TY - JOUR AD - S. Schubbert, Department of Pediatrics, University of California, 513 Parnassus Avenue, Room HSE-302, San Francisco, CA 94143, United States AU - Schubbert, S. AU - Bollag, G. AU - Shannon, K. DB - Embase Medline DO - 10.1016/j.gde.2006.12.004 IS - 1 LA - English M3 - Review N1 - L46109294 2007-02-19 PY - 2007 SN - 0959-437X SP - 15-22 ST - Deregulated Ras signaling in developmental disorders: new tricks for an old dog T2 - Current Opinion in Genetics and Development TI - Deregulated Ras signaling in developmental disorders: new tricks for an old dog UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46109294&from=export http://dx.doi.org/10.1016/j.gde.2006.12.004 VL - 17 ID - 2706 ER - TY - JOUR AD - K.A. Rauen, UCSF, Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA 94115, United States AU - Rauen, K. A. DB - Embase Medline DO - 10.1111/j.1399-0004.2007.00743.x IS - 2 LA - English M3 - Review N1 - L46189213 2007-02-26 PY - 2007 SN - 0009-9163 1399-0004 SP - 101-108 ST - HRAS and the Costello syndrome T2 - Clinical Genetics TI - HRAS and the Costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46189213&from=export http://dx.doi.org/10.1111/j.1399-0004.2007.00743.x VL - 71 ID - 2707 ER - TY - JOUR AD - S.-D. Lee, Department of Physical Therapy, China Medical University, 91 Hsueh-Shih Road, Taichung 40202, Taiwan AU - Chen, L. M. AU - Kuo, W. W. AU - Yang, J. J. AU - Wang, S. G. P. AU - Yeh, Y. L. AU - Tsai, F. J. AU - Ho, Y. J. AU - Chang, M. H. AU - Huang, C. Y. AU - Lee, S. D. DB - Embase Medline DO - 10.1113/expphysiol.2006.036590 IS - 2 LA - English M3 - Article N1 - L46376327 2007-04-10 PY - 2007 SN - 1469-445X 0958-0670 SP - 409-416 ST - Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats T2 - Experimental Physiology TI - Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46376327&from=export http://dx.doi.org/10.1113/expphysiol.2006.036590 VL - 92 ID - 2708 ER - TY - JOUR AD - A.S. Paller, Department of Dermatology, Northwestern University's Feinberg School of Medicine, 676 N. St. Clair Street, Chicago, IL 60611, United States AU - Wang, X. Q. AU - Sun, P. AU - Go, L. AU - Koti, V. AU - Fliman, M. AU - Paller, A. S. DB - Embase Medline DO - 10.1038/sj.jid.5700469 IS - 12 LA - English M3 - Article N1 - L44764053 2006-11-30 PY - 2006 SN - 0022-202X 1523-1747 SP - 2687-2696 ST - Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling T2 - Journal of Investigative Dermatology TI - Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44764053&from=export http://dx.doi.org/10.1038/sj.jid.5700469 VL - 126 ID - 2709 ER - TY - JOUR AD - C.H. Dunphy, Department of Pathology and Laboratory Medicine, CB# 7525, UNC, Chapel Hill, NC 27599-7525, United States AU - Dunphy, C. H. AU - DeMello, D. E. AU - Gale, G. B. C1 - adriamycin DB - Embase Medline IS - 12 LA - English M3 - Review N1 - L44906967 2007-01-11 PY - 2006 SN - 0003-9985 SP - 1859-1864 ST - Pediatric CD56+ anaplastic large cell lymphoma: A review of the literature T2 - Archives of Pathology and Laboratory Medicine TI - Pediatric CD56+ anaplastic large cell lymphoma: A review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44906967&from=export VL - 130 ID - 2710 ER - TY - JOUR AD - S.M. de la Monte, Rhode Island Hospital, Brown Medical School, Brown University, Providence, RI, United States AU - Lahousse, S. A. AU - Carter, J. J. AU - Xu, X. J. AU - Wands, J. R. AU - de la Monte, S. M. DB - Embase Medline DO - 10.1186/1471-2121-7-41 LA - English M3 - Article N1 - L46158171 2007-02-27 PY - 2006 SN - 1471-2121 ST - Differential growth factor regulation of aspartyl-(asparaginyl)-β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells T2 - BMC Cell Biology TI - Differential growth factor regulation of aspartyl-(asparaginyl)-β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46158171&from=export http://dx.doi.org/10.1186/1471-2121-7-41 VL - 7 ID - 2711 ER - TY - JOUR AD - S. Albani, University of California, Department of Pediatrics, 9500 Gilman Drive, La Jolla, CA 92093, United States AU - Tremouler, A. H. AU - Albani, S. C1 - incb 3284 medi 522 mln 1202 tgn 1412 tmi 005 tmi 2 C2 - Amgen Vertex DB - Embase Medline DO - 10.1517/13543784.15.11.1427 IS - 11 LA - English M3 - Review N1 - L44615290 2006-11-15 PY - 2006 SN - 1354-3784 SP - 1427-1441 ST - Novel therapies for rheumatoid arthritis T2 - Expert Opinion on Investigational Drugs TI - Novel therapies for rheumatoid arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44615290&from=export http://dx.doi.org/10.1517/13543784.15.11.1427 VL - 15 ID - 2712 ER - TY - JOUR AD - J.T. Rutka, Division of Neurosurgery, The Hospital for Sick Children, 555 University Avenue, Toronto, ON 518, Canada AU - Tamber, M. S. AU - Bansal, K. AU - Liang, M. L. AU - Mainprize, T. G. AU - Salhia, B. AU - Northcott, P. AU - Taylor, M. AU - Rutka, J. T. C1 - osi 774 DB - Embase Medline DO - 10.1007/s00381-006-0187-3 IS - 11 LA - English M3 - Review N1 - L44650671 2006-11-27 PY - 2006 SN - 0256-7040 SP - 1379-1394 ST - Current concepts in the molecular genetics of pediatric brain tumors: Implications for emerging therapies T2 - Child's Nervous System TI - Current concepts in the molecular genetics of pediatric brain tumors: Implications for emerging therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44650671&from=export http://dx.doi.org/10.1007/s00381-006-0187-3 VL - 22 ID - 2713 ER - TY - JOUR AD - G. Neri, Istituto di Genetica Medica, Università Cattolica, Largo F Vito, 1, 00168 Roma, Italy AU - Roberts, A. AU - Allanson, J. AU - Jadico, S. K. AU - Kavamura, M. I. AU - Noonan, J. AU - Opitz, J. M. AU - Young, T. AU - Neri, G. DB - Embase Medline DO - 10.1136/jmg.2006.042796 IS - 11 LA - English M3 - Review N1 - L44787108 2006-11-29 PY - 2006 SN - 0022-2593 SP - 833-842 ST - The cardiofaciocutaneous syndrome T2 - Journal of Medical Genetics TI - The cardiofaciocutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44787108&from=export http://dx.doi.org/10.1136/jmg.2006.042796 VL - 43 ID - 2714 ER - TY - JOUR AD - B.D. Gelb, Department of Pediatrics, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States AU - Gelb, B. D. AU - Tartaglia, M. DB - Embase Medline DO - 10.1093/hmg/ddl197 IS - SUPPL. 2 LA - English M3 - Article N1 - L44446797 2006-10-11 PY - 2006 SN - 0964-6906 1460-2083 SP - R220-R226 ST - Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction T2 - Human Molecular Genetics TI - Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44446797&from=export http://dx.doi.org/10.1093/hmg/ddl197 VL - 15 ID - 2715 ER - TY - JOUR AD - S.K. Srivastava, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, United States AU - Ramana, K. V. AU - Willis, M. S. AU - White, M. D. AU - Horton, J. W. AU - Dimaio, J. M. AU - Srivastava, D. AU - Bhatnagar, A. AU - Srivastava, S. K. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.106.630830 IS - 17 LA - English M3 - Article N1 - L44673359 2006-11-15 PY - 2006 SN - 0009-7322 SP - 1838-1846 ST - Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition T2 - Circulation TI - Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44673359&from=export http://dx.doi.org/10.1161/CIRCULATIONAHA.106.630830 VL - 114 ID - 2717 ER - TY - JOUR AD - K.C. Kim, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, United States AU - Kuwahara, I. AU - Lillehoj, E. P. AU - Lu, W. AU - Singh, I. S. AU - Isohama, Y. AU - Miyata, T. AU - Kim, K. C. DB - Embase Medline DO - 10.1152/ajplung.00471.2005 IS - 3 LA - English M3 - Article N1 - L44343717 2006-09-18 PY - 2006 SN - 1040-0605 1522-1504 SP - L407-L416 ST - Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR transactivation in a lung epithelial cell line T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR transactivation in a lung epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44343717&from=export http://dx.doi.org/10.1152/ajplung.00471.2005 http://ajplung.physiology.org/cgi/reprint/291/3/L407 VL - 291 ID - 2718 ER - TY - JOUR AD - G.K. Abou-Alfa, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10022, United States AU - Abou-Alfa, G. K. AU - Schwartz, L. AU - Ricci, S. AU - Amadori, D. AU - Santoro, A. AU - Figer, A. AU - De Greve, J. AU - Douillard, J. Y. AU - Lathia, C. AU - Schwartz, B. AU - Taylor, I. AU - Moscovici, M. AU - Saltz, L. B. DB - Embase Medline DO - 10.1200/JCO.2005.01.3441 IS - 26 LA - English M3 - Article N1 - L46630787 2006-09-10 PY - 2006 SN - 0732-183X SP - 4293-4300 ST - Phase II study of sorafenib in patients with advanced hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - Phase II study of sorafenib in patients with advanced hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46630787&from=export http://dx.doi.org/10.1200/JCO.2005.01.3441 VL - 24 ID - 2719 ER - TY - JOUR AD - G.P. Yang, Department of Surgery, Stanford University Medical School, Stanford, CA, United States AU - Xia, W. AU - Phan, T. T. AU - Lim, I. J. AU - Longaker, M. T. AU - Yang, G. P. DB - Embase Medline DO - 10.1016/j.jss.2006.01.031 IS - 1 LA - English M3 - Article N1 - L44215903 2006-08-30 PY - 2006 SN - 0022-4804 1095-8673 SP - 156-163 ST - Differential Transcriptional Responses of Keloid and Normal Keratinocytes to Serum Stimulation T2 - Journal of Surgical Research TI - Differential Transcriptional Responses of Keloid and Normal Keratinocytes to Serum Stimulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44215903&from=export http://dx.doi.org/10.1016/j.jss.2006.01.031 VL - 135 ID - 2720 ER - TY - JOUR AD - J. Anderson, Unit of Molecular Haematology and Cancer Biology, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom AU - Rees, H. AU - Williamson, D. AU - Papanastasiou, A. AU - Jina, N. AU - Nabarro, S. AU - Shipley, J. AU - Anderson, J. DB - Embase Medline DO - 10.1080/08977190600759923 IS - 3 LA - English M3 - Article N1 - L44669350 2006-11-27 PY - 2006 SN - 0897-7194 1029-2292 SP - 197-208 ST - The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas T2 - Growth Factors TI - The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44669350&from=export http://dx.doi.org/10.1080/08977190600759923 VL - 24 ID - 2721 ER - TY - JOUR AD - I. Nindl, Department of Dermatology, Skin Cancer Center Charité, University Hospital of Berlin, Charitéplatz 1, D-10117 Berlin, Germany AU - Nindl, I. AU - Dang, C. AU - Forschner, T. AU - Kuban, R. J. AU - Meyer, T. AU - Sterry, W. AU - Stockfleth, E. DB - Embase Medline DO - 10.1186/1476-4598-5-30 LA - English M3 - Article N1 - L44420010 2006-10-10 PY - 2006 SN - 1476-4598 ST - Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling T2 - Molecular Cancer TI - Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44420010&from=export http://dx.doi.org/10.1186/1476-4598-5-30 http://www.molecular-cancer.com/content/5/1/30 VL - 5 ID - 2722 ER - TY - JOUR AD - K. Page, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, ML7006, 3333 Burnet Ave., Cincinnati, OH 45229, United States AU - Page, K. AU - Hughes, V. S. AU - Bennett, G. W. AU - Wong, H. R. DB - Embase Medline DO - 10.1111/j.1398-9995.2006.01103.x IS - 8 LA - English M3 - Article N1 - L44024898 2006-07-19 PY - 2006 SN - 0105-4538 1398-9995 SP - 988-995 ST - German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells T2 - Allergy: European Journal of Allergy and Clinical Immunology TI - German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44024898&from=export http://dx.doi.org/10.1111/j.1398-9995.2006.01103.x VL - 61 ID - 2723 ER - TY - JOUR AD - V. Kotoula, Department of Pathology, School of Medicine, Aristotle University, Thessaloniki, Greece AU - Kotoula, V. AU - Bobos, M. AU - Kostopoulos, I. AU - Kaloutsi, V. AU - Koletsa, T. AU - Karayannopoulou, G. AU - Papadimitriou, C. S. DB - Embase Medline DO - 10.1080/10428190600653317 IS - 8 LA - English M3 - Article N1 - L44364032 2006-10-01 PY - 2006 SN - 1042-8194 1029-2403 SP - 1639-1650 ST - In situ detection of hTERT variants in anaplastic large cell lymphoma T2 - Leukemia and Lymphoma TI - In situ detection of hTERT variants in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44364032&from=export http://dx.doi.org/10.1080/10428190600653317 VL - 47 ID - 2724 ER - TY - JOUR AD - C.J. Xian, Department of Orthopaedic Surgery, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia AU - Zhou, F. H. AU - Foster, B. K. AU - Zhou, X. F. AU - Cowin, A. J. AU - Xian, C. J. C1 - etanercept(Wyeth,Australia) sb 239063 C2 - Wyeth(Australia) DB - Embase Medline DO - 10.1359/jbmr.060410 IS - 7 LA - English M3 - Article N1 - L43962836 2006-07-18 PY - 2006 SN - 0884-0431 SP - 1075-1088 ST - TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats T2 - Journal of Bone and Mineral Research TI - TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43962836&from=export http://dx.doi.org/10.1359/jbmr.060410 VL - 21 ID - 2725 ER - TY - JOUR AD - L. Rifas, Department of Pediatrics, Washington University School of Medicine, Campus Box 8208, 660 South Euclid Avenue, St. Louis, MO 63110, United States AU - Rifas, L. DB - Embase Medline DO - 10.1002/jcb.20933 IS - 4 LA - English M3 - Article N1 - L43993389 2006-07-24 PY - 2006 SN - 0730-2312 1097-4644 SP - 706-714 ST - T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization T2 - Journal of Cellular Biochemistry TI - T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43993389&from=export http://dx.doi.org/10.1002/jcb.20933 VL - 98 ID - 2726 ER - TY - JOUR AD - Y. Kondo, Department of Neurosurgery, Unit BSRB1004, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Kanzawa, T. AU - Iwado, E. AU - Aoki, H. AU - Iwamaru, A. AU - Hollingsworth, E. F. AU - Sawaya, R. AU - Kondo, S. AU - Kondo, Y. C1 - sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1038/sj.onc.1209414 IS - 26 LA - English M3 - Article N1 - L43980485 2006-07-19 PY - 2006 SN - 0950-9232 1476-5594 SP - 3638-3648 ST - Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway T2 - Oncogene TI - Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43980485&from=export http://dx.doi.org/10.1038/sj.onc.1209414 VL - 25 ID - 2727 ER - TY - JOUR AD - K. Page, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Parilla, N. W. AU - Hughes, V. S. AU - Lierl, K. M. AU - Wong, H. R. AU - Page, K. DB - Embase Medline DO - 10.1186/1465-9921-7-84 LA - English M3 - Article N1 - L44004619 2006-07-25 PY - 2006 SN - 1465-993X ST - CpG DNA modulates interleukin Iβ-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells T2 - Respiratory Research TI - CpG DNA modulates interleukin Iβ-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44004619&from=export http://dx.doi.org/10.1186/1465-9921-7-84 http://respiratory-research.com/content/7/1/84 VL - 7 ID - 2728 ER - TY - JOUR AD - J. Varga, Division of Rheumatology, Northwestern University Feinberg School of Medicine, 2300 McGaw, 240 East Huron Street, Chicago, IL, United States AU - Ghosh, A. K. AU - Bhattacharyya, S. AU - Mori, Y. AU - Varga, J. DB - Embase Medline DO - 10.1002/jcp.20559 IS - 1 LA - English M3 - Article N1 - L43391089 2006-04-02 PY - 2006 SN - 0021-9541 SP - 251-260 ST - Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ) T2 - Journal of Cellular Physiology TI - Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43391089&from=export http://dx.doi.org/10.1002/jcp.20559 VL - 207 ID - 2729 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera-Università di Padova, Via Giustiniani 3, 35128 Padova, Italy AU - Isimbaldi, G. AU - Bandiera, L. AU - D'Amore, E. S. G. AU - Conter, V. AU - Milani, M. AU - Mussolin, L. AU - Rosolen, A. DB - Embase Medline DO - 10.1002/pbc.20540 IS - 3 LA - English M3 - Letter N1 - L43201862 2006-03-02 PY - 2006 SN - 1545-5009 1545-5017 SP - 390-391 ST - ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement [4] T2 - Pediatric Blood and Cancer TI - ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement [4] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43201862&from=export http://dx.doi.org/10.1002/pbc.20540 VL - 46 ID - 2731 ER - TY - JOUR AD - C.S. Mantzoros, Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, United States AU - Kelesidis, T. AU - Mantzoros, C. S. DB - Embase Medline IS - 3 LA - English M3 - Review N1 - L43486108 2006-04-10 PY - 2006 SN - 1565-4753 SP - 239-248 ST - The emerging role of leptin in humans T2 - Pediatric Endocrinology Reviews TI - The emerging role of leptin in humans UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43486108&from=export VL - 3 ID - 2732 ER - TY - JOUR AD - W.L. Kwok, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, Hong Kong AU - Lo, A. K. F. AU - Kwok, W. L. AU - Sai, W. T. AU - Hing, L. W. AU - Hui, J. W. Y. AU - Ka, F. T. AU - Hayward, S. D. AU - Yiu, L. C. AU - Yu, L. L. AU - Takada, K. AU - Huang, D. P. DB - Embase Medline DO - 10.1593/neo.05625 IS - 3 LA - English M3 - Article N1 - L43671232 2006-05-25 PY - 2006 SN - 1522-8002 1476-5586 SP - 173-180 ST - Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells T2 - Neoplasia TI - Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43671232&from=export http://dx.doi.org/10.1593/neo.05625 http://docserver.ingentaconnect.com/deliver/connect/neo/15228002/v8n3/s2.pdf?expires=1146913086&id=28914531&titleid=3829&accname=Guest+User&checksum=70555B79B01831F028D3AAAC66EE9618 VL - 8 ID - 2733 ER - TY - JOUR AD - S.F. Ahmed, Bone and Endocrine Research Group, Department of Child Health, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, United Kingdom AU - MacRae, V. E. AU - Farquharson, C. AU - Ahmed, S. F. DB - Embase Medline DO - 10.1093/rheumatology/kei091 IS - 1 LA - English M3 - Review N1 - L43033868 2006-01-16 PY - 2006 SN - 1462-0324 1462-0332 SP - 11-19 ST - The pathophysiology of the growth plate in juvenile idiopathic arthritis T2 - Rheumatology TI - The pathophysiology of the growth plate in juvenile idiopathic arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43033868&from=export http://dx.doi.org/10.1093/rheumatology/kei091 VL - 45 ID - 2735 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029, India AU - Sarkar, C. AU - Deb, P. AU - Sharma, M. C. DB - Embase Medline DO - 10.4103/0028-3886.24696 IS - 1 LA - English M3 - Review N1 - L43748718 2006-06-13 PY - 2006 SN - 0028-3886 SP - 16-23 ST - Medulloblastomas: New directions in risk stratification T2 - Neurology India TI - Medulloblastomas: New directions in risk stratification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43748718&from=export http://dx.doi.org/10.4103/0028-3886.24696 VL - 54 ID - 2736 ER - TY - JOUR AD - P. Krejci, Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States AU - Krejci, P. AU - Mekikian, P. B. AU - Wilcox, W. R. DB - Embase Medline DO - 10.1038/sj.leu.2404202 IS - 6 LA - English M3 - Letter N1 - L43797315 2006-06-13 PY - 2006 SN - 1476-5551 0887-6924 SP - 1165-1168 ST - The fibroblast growth factors in multiple myeloma [5] T2 - Leukemia TI - The fibroblast growth factors in multiple myeloma [5] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43797315&from=export http://dx.doi.org/10.1038/sj.leu.2404202 VL - 20 ID - 2737 ER - TY - JOUR AD - C. Reimann, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany AU - Reimann, C. AU - Arola, M. AU - Bierings, M. AU - Karow, A. AU - van den Heuvel-Eibrink, M. M. AU - Hasle, H. AU - Niemeyer, C. M. AU - Kratz, C. P. DB - Embase Medline DO - 10.1038/sj.leu.2404303 IS - 9 LA - English M3 - Letter N1 - L44264116 2006-09-07 PY - 2006 SN - 1476-5551 0887-6924 SP - 1637-1638 ST - A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia [11] T2 - Leukemia TI - A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia [11] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44264116&from=export http://dx.doi.org/10.1038/sj.leu.2404303 VL - 20 ID - 2738 ER - TY - JOUR AD - R.S. Geha, Division of Immunology, Children's Hospital, One Blackfan Circle, Boston, MA 02115, United States AU - Kumar, L. AU - Feske, S. AU - Rao, A. AU - Geha, R. S. DB - Embase Medline DO - 10.1073/pnas.0509176102 IS - 52 LA - English M3 - Article N1 - L43049566 2006-01-25 PY - 2005 SN - 0027-8424 SP - 19063-19068 ST - A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function T2 - Proceedings of the National Academy of Sciences of the United States of America TI - A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43049566&from=export http://dx.doi.org/10.1073/pnas.0509176102 VL - 102 ID - 2739 ER - TY - JOUR AD - K.E. Warren, National Cancer Institute, Neuro-Oncology Branch, 9030 Old Georgetown Road, Bethesda, MD 20892-8200, United States AU - Warren, K. E. C1 - gleevec(Novartis,United States) gw 572016 iressa osi 774(Osi,United States) r 115777 sch 66336 sti 571(Novartis,United States) su 101 tarceva(Osi,United States) zarnestra zd 1839 C2 - Novartis(United States) Osi(United States) DB - Embase Medline DO - 10.1007/s11060-005-6765-5 IS - 3 LA - English M3 - Review N1 - L43019489 2006-01-10 PY - 2005 SN - 0167-594X 1573-7373 SP - 335-343 ST - Molecularly targeted therapy for pediatric brain tumors T2 - Journal of Neuro-Oncology TI - Molecularly targeted therapy for pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43019489&from=export http://dx.doi.org/10.1007/s11060-005-6765-5 VL - 75 ID - 2740 ER - TY - JOUR AD - J.L. Finlay, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States AU - Finlay, J. L. AU - Zacharoulis, S. C1 - gw 572016 iressa osi 774 r 115777 sch 66336 tarceva zd 1839 DB - Embase Medline DO - 10.1007/s11060-005-6747-7 IS - 3 LA - English M3 - Review N1 - L43023756 2006-01-18 PY - 2005 SN - 0167-594X 1573-7373 SP - 253-266 ST - The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical - and futuristic - perspective T2 - Journal of Neuro-Oncology TI - The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical - and futuristic - perspective UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43023756&from=export http://dx.doi.org/10.1007/s11060-005-6747-7 VL - 75 ID - 2741 ER - TY - JOUR AD - M. Xue, Sutton Arthritis Research Laboratory, University of Sydney at Royal North Shore Hospital, St. Leonards, NSW 2065, Australia AU - Xue, M. AU - Campbell, D. AU - Sambrook, P. N. AU - Fukudome, K. AU - Jackson, C. J. DB - Embase Medline DO - 10.1111/j.0022-202X.2005.23952.x IS - 6 LA - English M3 - Article N1 - L43714312 2006-05-30 PY - 2005 SN - 0022-202X 1523-1747 SP - 1279-1285 ST - Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C T2 - Journal of Investigative Dermatology TI - Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43714312&from=export http://dx.doi.org/10.1111/j.0022-202X.2005.23952.x VL - 125 ID - 2742 ER - TY - JOUR AD - M.I. Lewis, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, United States AU - Lewis, M. I. AU - Da, X. AU - Li, H. AU - Fournier, M. DB - Embase Medline DO - 10.1152/japplphysiol.00238.2005 IS - 5 LA - English M3 - Article N1 - L41547159 2005-11-22 PY - 2005 SN - 8750-7587 SP - 1649-1657 ST - Tumor necrosis factor-α and malnutrition-induced inhibition of diaphragm fiber growth in young rats T2 - Journal of Applied Physiology TI - Tumor necrosis factor-α and malnutrition-induced inhibition of diaphragm fiber growth in young rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41547159&from=export http://dx.doi.org/10.1152/japplphysiol.00238.2005 VL - 99 ID - 2743 ER - TY - JOUR AD - N. Kanda, Department of Dermatology, Teikyo University, School of Medicine, 11-1, Kaga-2, Itabashi-Ku, Tokyo 173-8605, Japan AU - Kanda, N. AU - Koike, S. AU - Watanabe, S. C1 - bay 117082(Biomol,United States) ns 398(Sigma,United States) pd 98059(Calbiochem,United States) sb 203580(Calbiochem,United States) sc 560(Sigma,United States) sp 600125(Biomol,United States) C2 - Biomol(United States) Calbiochem(United States) R and D Systems(United States) Sigma(United States) DB - Embase Medline DO - 10.1016/j.jaci.2005.08.014 IS - 5 LA - English M3 - Article N1 - L41571801 2005-11-30 PY - 2005 SN - 0091-6749 SP - 1144-1150 ST - IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes T2 - Journal of Allergy and Clinical Immunology TI - IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41571801&from=export http://dx.doi.org/10.1016/j.jaci.2005.08.014 VL - 116 ID - 2744 ER - TY - JOUR AD - C.A. Stratakis, Section on Endocrinology and Genetics, NICHD, NIH, 10 Center Dr., Bethesda, MD 20892, United States AU - Bauer, A. J. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1136/jmg.2003.017806 IS - 11 LA - English M3 - Review N1 - L41598187 2005-11-24 PY - 2005 SN - 0022-2593 SP - 801-810 ST - The lentiginoses: Cutaneous markers of systemic disease and a window to new aspects of tumourigenesis T2 - Journal of Medical Genetics TI - The lentiginoses: Cutaneous markers of systemic disease and a window to new aspects of tumourigenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41598187&from=export http://dx.doi.org/10.1136/jmg.2003.017806 VL - 42 ID - 2745 ER - TY - JOUR AD - Y. Nakamura, Department of Food Sciences and Nutritional Health, Kyoto Prefectoral University, Sakyo, Kyoto 606-8522, Japan AU - Nakamura, Y. AU - Chang, C. C. AU - Mori, T. AU - Sato, K. AU - Ohtsuki, K. AU - Upham, B. L. AU - Trosko, J. E. DB - Embase Medline DO - 10.1093/carcin/bgi003 IS - 3 LA - English M3 - Article N1 - L41214158 2005-10-02 PY - 2005 SN - 0143-3334 SP - 665-671 ST - Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells T2 - Carcinogenesis TI - Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41214158&from=export http://dx.doi.org/10.1093/carcin/bgi003 VL - 26 ID - 2746 ER - TY - JOUR AD - M.D. Ringel, Ohio State University, 445D McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, United States AU - Stathatos, N. AU - Bourdeau, I. AU - Espinosa, A. V. AU - Saji, M. AU - Vasko, V. V. AU - Burman, K. D. AU - Stratakis, C. A. AU - Ringel, M. D. DB - Embase Medline DO - 10.1210/jc.2005-0963 IS - 9 LA - English M3 - Article N1 - L41262312 2005-09-29 PY - 2005 SN - 0021-972X SP - 5432-5440 ST - KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity T2 - Journal of Clinical Endocrinology and Metabolism TI - KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41262312&from=export http://dx.doi.org/10.1210/jc.2005-0963 http://jcem.endojournals.org/cgi/reprint/90/9/5432 VL - 90 ID - 2747 ER - TY - JOUR AD - S. Cesaro, Clinic of Pediatric Hematology Oncology, Department of Pediatrics, University of Padova, Via Giustiniani 3, 35128, Padova, Italy AU - Cesaro, S. AU - Pillon, M. AU - Visintin, G. AU - Putti, M. C. AU - Gazzola, M. V. AU - D'Amore, E. AU - Scarzello, G. AU - Zanesco, L. AU - Messina, C. AU - Rosolen, A. DB - Embase Medline DO - 10.1111/j.1600-0609.2005.00422.x IS - 1 LA - English M3 - Article N1 - L40873957 2005-07-06 PY - 2005 SN - 0902-4441 SP - 22-26 ST - Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: A single center case series T2 - European Journal of Haematology TI - Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: A single center case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40873957&from=export http://dx.doi.org/10.1111/j.1600-0609.2005.00422.x VL - 75 ID - 2748 ER - TY - JOUR AD - J.N. Finkelstein, Department of Pediatrics, Box 850, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Singal, M. AU - Finkelstein, J. N. DB - Embase Medline DO - 10.1080/019021490951504 IS - 6 LA - English M3 - Article N1 - L40967243 2005-08-09 PY - 2005 SN - 0190-2148 1521-0499 SP - 581-597 ST - Amorphous silica particles promote inflammatory gene expression through the redox sensitive transcription factor, AP-1, in alveolar epithelial cells T2 - Experimental Lung Research TI - Amorphous silica particles promote inflammatory gene expression through the redox sensitive transcription factor, AP-1, in alveolar epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40967243&from=export http://dx.doi.org/10.1080/019021490951504 VL - 31 ID - 2749 ER - TY - JOUR AD - S. Ubol, Department of Microbiology, Faculty of Science, Mahidol University, 272 Rama VI Rd., Ratchatewee, Bangkok 10400, Thailand AU - Ubol, S. AU - Kasisith, J. AU - Pitidhammabhorn, D. AU - Tepsumethanol, V. DB - Embase Medline DO - 10.1111/j.1348-0421.2005.tb03746.x IS - 5 LA - English M3 - Article N1 - L40806067 2005-06-26 PY - 2005 SN - 0385-5600 SP - 423-431 ST - Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain T2 - Microbiology and Immunology TI - Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40806067&from=export http://dx.doi.org/10.1111/j.1348-0421.2005.tb03746.x VL - 49 ID - 2750 ER - TY - JOUR AD - E.R. Maher, Section of Medical and Molecular Genetics, Institute of Biomedical Research, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom AU - Morris, M. R. AU - Gentle, D. AU - Abdulrahman, M. AU - Maina, E. N. AU - Gupta, K. AU - Banks, R. E. AU - Wiesener, M. S. AU - Kishida, T. AU - Yao, M. AU - Teh, B. AU - Lauf, F. AU - Maher, E. R. C1 - gf 109203x(Calbiochem) pd 98059(Calbiochem,United States) u 0126(Promega) u 73122(Calbiochem) C2 - Calbiochem(United States) Promega DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-3371 IS - 11 LA - English M3 - Article N1 - L40740795 2005-06-26 PY - 2005 SN - 0008-5472 SP - 4598-4606 ST - Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma T2 - Cancer Research TI - Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40740795&from=export http://dx.doi.org/10.1158/0008-5472.CAN-04-3371 VL - 65 ID - 2751 ER - TY - JOUR AD - T. Herdegen, Institute of Pharmacology, University Hospital Kiel, Hospitalstrasse 4, 24105 Kiel, Germany AU - Waetzig, V. AU - Czeloth, K. AU - Hidding, U. AU - Mielke, K. AU - Kanzow, M. AU - Brecht, S. AU - Goetz, M. AU - Lucius, R. AU - Herdegen, T. AU - Hanisch, U. R. DB - Embase Medline DO - 10.1002/glia.20173 IS - 3 LA - English M3 - Article N1 - L40769853 2005-06-15 PY - 2005 SN - 0894-1491 SP - 235-246 ST - c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia T2 - GLIA TI - c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40769853&from=export http://dx.doi.org/10.1002/glia.20173 VL - 50 ID - 2753 ER - TY - JOUR AD - L.E. Clarke, Department of Pathology, Penn State College of Medicine, Hershey Medical Center, 500 University Drive, Hershey, PA 17033, United States AU - Clarke, L. E. AU - Bayerl, M. G. AU - Bruggeman, R. D. AU - Mauger, D. AU - Ioffreda, M. D. AU - Abou-Elella, A. AU - Helm, K. F. DB - Embase Medline DO - 10.1097/01.pas.0000155154.46434.93 IS - 4 LA - English M3 - Article N1 - L40411175 2005-04-10 PY - 2005 SN - 0147-5185 SP - 452-459 ST - Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin T2 - American Journal of Surgical Pathology TI - Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40411175&from=export http://dx.doi.org/10.1097/01.pas.0000155154.46434.93 VL - 29 ID - 2754 ER - TY - JOUR AD - J.M. Low, Dept. of Molec. Microbiol./Immunol., Division of Rheumatology, Saint Louis Univ. School of Medicine, Saint Louis, MO, United States AU - Low, J. M. AU - Moore, T. L. DB - Embase Medline DO - 10.2174/1381612053381936 IS - 5 LA - English M3 - Review N1 - L40277873 2005-03-09 PY - 2005 SN - 1381-6128 SP - 655-670 ST - A role for the complement system in rheumatoid arthritis T2 - Current Pharmaceutical Design TI - A role for the complement system in rheumatoid arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40277873&from=export http://dx.doi.org/10.2174/1381612053381936 VL - 11 ID - 2755 ER - TY - JOUR AD - J. Golay, Lab. Cell. Gene Ther. G. L., Presidio Matteo Rota, Ospedali Riuniti Bergamo, via Garibaldi 11-13, 24128 Bergamo, Italy AU - Cittera, E. AU - Onofri, C. AU - D'Apolito, M. AU - Cartron, G. AU - Cazzaniga, G. AU - Zelante, L. AU - Paolucci, P. AU - Biondi, A. AU - Introna, M. AU - Golay, J. DB - Embase Medline DO - 10.1007/s00262-004-0599-4 IS - 3 LA - English M3 - Article N1 - L40174245 2005-02-11 PY - 2005 SN - 0340-7004 SP - 273-286 ST - Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines T2 - Cancer Immunology, Immunotherapy TI - Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40174245&from=export http://dx.doi.org/10.1007/s00262-004-0599-4 VL - 54 ID - 2756 ER - TY - JOUR AD - A. Komatsuda, 3rd Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita City, Akita 010-8543, Japan AU - Okuyama, S. AU - Komatsuda, A. AU - Wakui, H. AU - Aiba, N. AU - Fujishima, N. AU - Iwamoto, K. AU - Ohtani, H. AU - Sawada, K. I. DB - Embase Medline DO - 10.1093/ndt/gfh673 IS - 3 LA - English M3 - Article N1 - L40378422 2005-04-03 PY - 2005 SN - 0931-0509 SP - 539-544 ST - Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome T2 - Nephrology Dialysis Transplantation TI - Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40378422&from=export http://dx.doi.org/10.1093/ndt/gfh673 VL - 20 ID - 2757 ER - TY - JOUR AD - R.N. DuBois, Vanderbilt-Ingram Cancer Center, Preston Research Building, 2300 Pierce Avenue, Nashville, TN 37232-6838, United States AU - Wang, D. AU - Buchanan, F. G. AU - Wang, H. AU - Dey, S. K. AU - DuBois, R. N. DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-3671 IS - 5 LA - English M3 - Article N1 - L40478610 2005-05-01 PY - 2005 SN - 0008-5472 SP - 1822-1829 ST - Prostaglandin E2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade T2 - Cancer Research TI - Prostaglandin E2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40478610&from=export http://dx.doi.org/10.1158/0008-5472.CAN-04-3671 VL - 65 ID - 2758 ER - TY - JOUR AD - U. Renner, Max-Planck-Institute of Psychiatry, Neuroendocrinology Group, Kraepelinstrasse 10, D-80804 Munich, Germany AU - Tichomirowa, M. AU - Theodoropoulou, M. AU - Lohrer, P. AU - Schaaf, L. AU - Losa, M. AU - Uhl, E. AU - Lange, M. AU - Arzt, E. AU - Stalla, G. K. AU - Renner, U. C1 - sb 203580 DB - Embase Medline DO - 10.1111/j.1365-2826.2005.01286.x IS - 3 LA - English M3 - Article N1 - L40553014 2005-05-03 PY - 2005 SN - 0953-8194 SP - 152-160 ST - Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 T2 - Journal of Neuroendocrinology TI - Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40553014&from=export http://dx.doi.org/10.1111/j.1365-2826.2005.01286.x VL - 17 ID - 2759 ER - TY - JOUR AD - H.-Y. Park, Department of Dermatology, Boston University, School of Medicine, 609 Albany Street, Boston, MA 02118, United States AU - Ching, C. S. AU - Phillips, T. J. AU - Howard, C. E. AU - Panova, I. P. AU - Hayes, C. M. AU - Asandra, A. S. AU - Park, H. Y. DB - Embase Medline DO - 10.1111/j.0022-202X.2004.23557.x IS - 2 LA - English M3 - Article N1 - L40175897 2005-02-15 PY - 2005 SN - 0022-202X SP - 466-474 ST - Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway T2 - Journal of Investigative Dermatology TI - Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40175897&from=export http://dx.doi.org/10.1111/j.0022-202X.2004.23557.x VL - 124 ID - 2760 ER - TY - JOUR AD - N.J. Sebire, Department of Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH, United Kingdom AU - Sebire, N. J. AU - Webb, D. AU - Ramsay, A. D. DB - Embase Medline DO - 10.1080/15227950590961216 IS - 1 LA - English M3 - Article N1 - L41018237 2005-08-21 PY - 2005 SN - 1551-3815 1551-3823 SP - 63-70 ST - Anaplastic large cell lymphoma with alk expression and presence of the t(2;5) translocation in a 5-month-old infant T2 - Fetal and Pediatric Pathology TI - Anaplastic large cell lymphoma with alk expression and presence of the t(2;5) translocation in a 5-month-old infant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41018237&from=export http://dx.doi.org/10.1080/15227950590961216 VL - 24 ID - 2762 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera-Università di Padova, Via Giustiniani 3, Padova 35128, Italy AU - Mussolin, L. AU - Pillon, M. AU - d'Amore, E. S. AU - Santoro, N. AU - Lombardi, A. AU - Fagioli, F. AU - Zanesco, L. AU - Rosolen, A. DB - Embase Medline DO - 10.1038/sj.leu.2403888 IS - 9 LA - English M3 - Article N1 - L43090410 2006-02-20 PY - 2005 SN - 1476-5551 0887-6924 SP - 1643-1647 ST - Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma T2 - Leukemia TI - Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43090410&from=export http://dx.doi.org/10.1038/sj.leu.2403888 VL - 19 ID - 2763 ER - TY - JOUR AD - J.A. Boyce, Smith Building, One Jimmy Fund Way, Boston, MA 02115, United States AU - Feng, C. AU - Mery, A. G. AU - Beller, E. M. AU - Favot, C. AU - Boyce, J. A. DB - Embase Medline DO - 10.4049/jimmunol.173.12.7539 IS - 12 LA - English M3 - Article N1 - L39628195 2005-01-10 PY - 2004 SN - 0022-1767 SP - 7539-7547 ST - Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor T2 - Journal of Immunology TI - Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39628195&from=export http://dx.doi.org/10.4049/jimmunol.173.12.7539 VL - 173 ID - 2764 ER - TY - JOUR AD - G.H. Lyman, James P. Wilmot Cancer Center, Univ. of Rochester Medical Center, Strong Memorial Hospital, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Komrokji, R. S. AU - Lyman, G. H. C1 - leucomax(Novartis) leukine(Berlex) neulasta(Amgen) neupogen(Amgen) neutrogin(Chugai) C2 - Amgen Berlex Chugai Novartis DB - Embase Medline DO - 10.1517/14712598.4.12.1897 IS - 12 LA - English M3 - Review N1 - L39627141 2005-01-03 PY - 2004 SN - 1471-2598 SP - 1897-1910 ST - The colony-stimulating factors: Use to prevent and treat neutropenia and its complications T2 - Expert Opinion on Biological Therapy TI - The colony-stimulating factors: Use to prevent and treat neutropenia and its complications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39627141&from=export http://dx.doi.org/10.1517/14712598.4.12.1897 VL - 4 ID - 2766 ER - TY - JOUR AD - Department of Pediatrics, Apps Medical Research Centre, Kingston Gen. Hosp., Qu.'s Univ., D. AU - Wang, W. AU - Solc, M. AU - Ji, P. AU - Dow, K. E. C1 - pd 98059 sb 203580 DB - Embase Medline DO - 10.1016/j.neulet.2004.08.055 IS - 2-3 LA - English M3 - Article N1 - L39440759 2004-11-17 PY - 2004 SN - 0304-3940 SP - 133-137 ST - Corticotropin-releasing hormone potentiates neural injury induced by oxygen-glucose deprivation: A possible involvement of microglia T2 - Neuroscience Letters TI - Corticotropin-releasing hormone potentiates neural injury induced by oxygen-glucose deprivation: A possible involvement of microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39440759&from=export http://dx.doi.org/10.1016/j.neulet.2004.08.055 VL - 371 ID - 2767 ER - TY - JOUR AD - J.W. Horton, Dept. of Surgery, Univ. of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9160, United States AU - Horton, J. W. AU - Tan, J. AU - White, D. J. AU - Maass, D. L. AU - Thomas, J. A. DB - Embase Medline DO - 10.1152/ajpheart.00390.2004 IS - 5 56-5 LA - English M3 - Article N1 - L39430765 2004-11-16 PY - 2004 SN - 0363-6135 SP - H2241-H2251 ST - Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury T2 - American Journal of Physiology - Heart and Circulatory Physiology TI - Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39430765&from=export http://dx.doi.org/10.1152/ajpheart.00390.2004 VL - 287 ID - 2768 ER - TY - JOUR AD - G.V. Dahl, PO Box 60012, Arcadia, CA 91066-6012, United States AU - Lacayo, N. J. AU - Meshinchi, S. AU - Kinnunen, P. AU - Yu, R. AU - Wang, Y. AU - Stuber, C. M. AU - Douglas, L. AU - Wahab, R. AU - Becton, D. L. AU - Weinstein, H. AU - Chang, M. N. AU - Willman, C. L. AU - Radich, J. P. AU - Tibshirani, R. AU - Ravindranath, Y. AU - Sikic, B. I. AU - Dahl, G. V. DB - Embase Medline DO - 10.1182/blood-2003-12-4449 IS - 9 LA - English M3 - Article N1 - L39434943 2004-11-22 PY - 2004 SN - 0006-4971 SP - 2646-2654 ST - Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes T2 - Blood TI - Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39434943&from=export http://dx.doi.org/10.1182/blood-2003-12-4449 VL - 104 ID - 2769 ER - TY - JOUR AD - Medizinische Klinik I, Abteilung Kardiologie, Univ. Klin. Leipzig, J. AU - Salameh, A. AU - Schneider, P. AU - Mühlberg, K. AU - Hagendorff, A. AU - Dhein, S. AU - Pfeiffer, D. C1 - pd 98059(New England Nuclear) sb 203580(Alexis,United States) C2 - Alexis(United States) New England Nuclear DB - Embase Medline DO - 10.1016/j.ejphar.2004.09.024 IS - 1-3 LA - English M3 - Article N1 - L39445934 2004-11-16 PY - 2004 SN - 0014-2999 SP - 9-16 ST - Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes T2 - European Journal of Pharmacology TI - Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39445934&from=export http://dx.doi.org/10.1016/j.ejphar.2004.09.024 VL - 503 ID - 2770 ER - TY - JOUR AD - D.B. Polk, Department of Pediatrics, Vanderbilt University, Nashville, TN, United States AU - Polk, D. B. DB - Embase IS - 1-2 LA - English M3 - Conference Paper N1 - L39287200 2004-10-17 PY - 2004 SN - 0392-6699 SP - 29-34 ST - Probiotic initiation of intestinal epithelial cell survival response T2 - EOS Rivista di Immunologia ed Immunofarmacologia TI - Probiotic initiation of intestinal epithelial cell survival response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39287200&from=export VL - 24 ID - 2771 ER - TY - JOUR AD - M.A. Pulsipher, Division of Hematology, Univ. of Utah School of Medicine, Primary Children's Medical Center, 50 North Medical Drive, Salt Lake City, UT 84132, United States AU - Pulsipher, M. A. C1 - gleevec sti 571 DB - Embase Medline DO - 10.1002/pbc.20062 IS - 5 LA - English M3 - Review N1 - L39313948 2004-10-21 PY - 2004 SN - 1545-5009 SP - 523-533 ST - Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? T2 - Pediatric Blood and Cancer TI - Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39313948&from=export http://dx.doi.org/10.1002/pbc.20062 VL - 43 ID - 2772 ER - TY - JOUR AD - F.M. Watt, Kerationocyte Laboratory, Cancer Res. UK London Res. Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom AU - Hobbs, R. M. AU - Silva-Vargas, V. AU - Groves, R. AU - Watt, F. M. DB - Embase Medline DO - 10.1111/j.0022-202X.2004.23225.x IS - 3 LA - English M3 - Article N1 - L39095621 2004-08-31 PY - 2004 SN - 0022-202X SP - 503-515 ST - Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions T2 - Journal of Investigative Dermatology TI - Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39095621&from=export http://dx.doi.org/10.1111/j.0022-202X.2004.23225.x VL - 123 ID - 2773 ER - TY - JOUR AD - T.J. Triche, Dept. of Pathol. and Lab. Medicine, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard, Los Angeles, CA 90027, United States AU - Zhang, J. AU - Hu, S. AU - Schofield, D. E. AU - Sorensen, P. H. B. AU - Triche, T. J. DB - Embase Medline DO - 10.1158/0008-5472.CAN-03-2594 IS - 17 LA - English M3 - Article N1 - L39129400 2004-09-19 PY - 2004 SN - 0008-5472 SP - 6026-6034 ST - Selective usage of D-type cyclins by Ewing's tumors and rhabdomyosarcomas T2 - Cancer Research TI - Selective usage of D-type cyclins by Ewing's tumors and rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39129400&from=export http://dx.doi.org/10.1158/0008-5472.CAN-03-2594 VL - 64 ID - 2774 ER - TY - JOUR AD - N.R. Bhat, Department of Neurology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, United States AU - Pawate, S. AU - Shen, Q. AU - Fan, F. AU - Bhat, N. R. DB - Embase Medline DO - 10.1002/jnr.20180 IS - 4 LA - English M3 - Article N1 - L39007006 2004-08-29 PY - 2004 SN - 0360-4012 SP - 540-551 ST - Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ T2 - Journal of Neuroscience Research TI - Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39007006&from=export http://dx.doi.org/10.1002/jnr.20180 VL - 77 ID - 2775 ER - TY - JOUR AD - A. Fusco, Dipto. di Biol./Patol. Cell./Molec., Inst. Endocrinol. Oncol. Sperim. CNR, Univ. degli Studi Napoli Federico II, via Pansini 5, 80131 Napoles, Italy AU - Hoyos, J. M. AU - Fedele, M. AU - Battista, S. AU - Pentimalli, F. AU - Kruhoffer, M. AU - Arra, C. AU - Orntoft, T. F. AU - Croce, C. M. AU - Fusco, A. DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-1410 IS - 16 LA - English M3 - Article N1 - L39095571 2004-09-05 PY - 2004 SN - 0008-5472 SP - 5728-5735 ST - Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: Tissue specificity of the HMGA1-dependent gene regulation T2 - Cancer Research TI - Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: Tissue specificity of the HMGA1-dependent gene regulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39095571&from=export http://dx.doi.org/10.1158/0008-5472.CAN-04-1410 VL - 64 ID - 2776 ER - TY - JOUR AD - R.S. Geha, Div. of Immunology, 1 Blackfan Circle, Boston, MA 02115, United States AU - Vivarelli, M. S. AU - McDonald, D. AU - Miller, M. AU - Cusson, N. AU - Kelliher, M. AU - Geha, R. S. DB - Embase Medline DO - 10.1084/jem.20040446 IS - 3 LA - English M3 - Article N1 - L39031258 2004-08-23 PY - 2004 SN - 0022-1007 SP - 399-404 ST - RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation T2 - Journal of Experimental Medicine TI - RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39031258&from=export http://dx.doi.org/10.1084/jem.20040446 VL - 200 ID - 2777 ER - TY - JOUR AD - I. Singh, Div. of Developmental Neurogenetics, Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, United States AU - Pannu, R. AU - Won, J. S. AU - Khan, M. AU - Singh, A. K. AU - Singh, I. DB - Embase Medline DO - 10.1523/JNEUROSCI.1271-04.2004 IS - 26 LA - English M3 - Article N1 - L38859392 2004-07-29 PY - 2004 SN - 0270-6474 SP - 5942-5954 ST - A novel role of lactosylceramide in the regulation of lipopolysaccharide/ interferon-γ-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases T2 - Journal of Neuroscience TI - A novel role of lactosylceramide in the regulation of lipopolysaccharide/ interferon-γ-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38859392&from=export http://dx.doi.org/10.1523/JNEUROSCI.1271-04.2004 VL - 24 ID - 2778 ER - TY - JOUR AD - P. Ashwood, Div. Rheumatol., Allerg./Clin. I., Department of Internal Medicine, University of California, One Shield's Avenue, Davis, CA 95616, United States AU - Ashwood, P. AU - Van De Water, J. DB - Embase Medline DO - 10.1080/10446670410001722096 IS - 2 LA - English M3 - Review N1 - L38955074 2004-08-10 PY - 2004 SN - 1740-2522 SP - 165-174 ST - A review of autism and the immune response T2 - Clinical and Developmental Immunology TI - A review of autism and the immune response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38955074&from=export http://dx.doi.org/10.1080/10446670410001722096 VL - 11 ID - 2780 ER - TY - JOUR AD - A.J. De Bold, Cardiovasc. Endocrinology Laboratory, Dept. of Cell. and Molec. Medicine, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ont. K1Y 4W7, Canada AU - Ma, K. K. AU - Ogawa, T. AU - De Bold, A. J. DB - Embase Medline DO - 10.1016/j.yjmcc.2004.01.001 IS - 4 LA - English M3 - Article N1 - L38469941 2004-04-26 PY - 2004 SN - 0022-2828 SP - 505-513 ST - Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase T2 - Journal of Molecular and Cellular Cardiology TI - Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38469941&from=export http://dx.doi.org/10.1016/j.yjmcc.2004.01.001 VL - 36 ID - 2782 ER - TY - JOUR AD - J. Tan, Dept. of Psychiat. and Behav. Med., Institute for Research in Psychiatry, Univ. of S. Florida Coll. of Med., Tampa, FL, United States AU - Shytle, R. D. AU - Mori, T. AU - Townsend, K. AU - Vendrame, M. AU - Sun, N. AU - Zeng, J. AU - Ehrhart, J. AU - Silver, A. A. AU - Sanberg, P. R. AU - Tan, J. DB - Embase Medline DO - 10.1046/j.1471-4159.2004.02347.x IS - 2 LA - English M3 - Article N1 - L38495982 2004-05-03 PY - 2004 SN - 0022-3042 SP - 337-343 ST - Cholinergic modulation of microglial activation by α7 nicotinic receptors T2 - Journal of Neurochemistry TI - Cholinergic modulation of microglial activation by α7 nicotinic receptors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38495982&from=export http://dx.doi.org/10.1046/j.1471-4159.2004.02347.x VL - 89 ID - 2783 ER - TY - JOUR AD - S. Genc, Dept. of Med. Biology and Genetics, School of Medicine, Dokuz Eylul University, Inciralti, 35340, Izmir, Turkey AU - Genc, S. AU - Koroglu, T. F. AU - Genc, K. DB - Embase Medline DO - 10.1016/j.brainres.2003.12.037 IS - 1-2 LA - English M3 - Review N1 - L38446486 2004-04-20 PY - 2004 SN - 0006-8993 SP - 19-31 ST - Erythropoietin and the nervous system T2 - Brain Research TI - Erythropoietin and the nervous system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38446486&from=export http://dx.doi.org/10.1016/j.brainres.2003.12.037 VL - 1000 ID - 2784 ER - TY - JOUR AD - A. Liu, Ctrl. Ins. Electron Microscopic Res., Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan AU - Liu, A. AU - Sugisaki, Y. AU - Hosone, M. AU - Namimatsu, S. DB - Embase DO - 10.1267/ahc.37.21 IS - 1 LA - English M3 - Article N1 - L38248374 2004-03-07 PY - 2004 SN - 0044-5991 SP - 21-30 ST - CD30+ TIA-1+ ALK+ Anaplastic Large Cell Lymphoma: Studies of Three Cases by Flow Cytometry Analysis, Immunohistochemistry and Electron Microscopy T2 - Acta Histochemica et Cytochemica TI - CD30+ TIA-1+ ALK+ Anaplastic Large Cell Lymphoma: Studies of Three Cases by Flow Cytometry Analysis, Immunohistochemistry and Electron Microscopy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38248374&from=export http://dx.doi.org/10.1267/ahc.37.21 VL - 37 ID - 2785 ER - TY - JOUR AD - S.C. Land, Tayside Inst. of Child Health, Ninewells Hosp. and Medical School, Univ. of Dundee, Dundee, DD1 9SY, United Kingdom AU - Land, S. C. AU - Darakhshan, F. DB - Embase Medline IS - 3 30-3 LA - English M3 - Article N1 - L38233617 2004-03-05 PY - 2004 SN - 1040-0605 SP - L473-L487 ST - Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38233617&from=export VL - 286 ID - 2786 ER - TY - JOUR AD - E.M. Frohman, Department of Neurology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235, United States AU - Frohman, E. M. AU - Brannon, K. AU - Racke, M. K. AU - Hawker, K. DB - Embase Medline DO - 10.1097/00002826-200403000-00006 IS - 2 LA - English M3 - Review N1 - L38569179 2004-05-27 PY - 2004 SN - 0362-5664 SP - 80-83 ST - Mycophenolate Mofetil in Multiple Sclerosis T2 - Clinical Neuropharmacology TI - Mycophenolate Mofetil in Multiple Sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38569179&from=export http://dx.doi.org/10.1097/00002826-200403000-00006 VL - 27 ID - 2787 ER - TY - JOUR AD - J.D. Piganelli, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15213-3205, United States AU - Tse, H. M. AU - Milton, M. J. AU - Piganelli, J. D. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2003.10.029 IS - 2 LA - English M3 - Article N1 - L38117241 2004-02-17 PY - 2004 SN - 0891-5849 SP - 233-247 ST - Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation-reduction reactions in innate immunity T2 - Free Radical Biology and Medicine TI - Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation-reduction reactions in innate immunity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38117241&from=export http://dx.doi.org/10.1016/j.freeradbiomed.2003.10.029 VL - 36 ID - 2788 ER - TY - JOUR AD - I. Hide, Department of Pharmacology, Grad. School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan AU - Suzuki, T. AU - Hide, I. AU - Ido, K. AU - Kohsaka, S. AU - Inoue, K. AU - Nakata, Y. DB - Embase Medline DO - 10.1523/JNEUROSCI.3792-03.2004 IS - 1 LA - English M3 - Article N1 - L38181664 2004-02-26 PY - 2004 SN - 0270-6474 SP - 1-7 ST - Production and Release of Neuroprotective Tumor Necrosis Factor by P2X 7 Receptor-Activated Microglia T2 - Journal of Neuroscience TI - Production and Release of Neuroprotective Tumor Necrosis Factor by P2X 7 Receptor-Activated Microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38181664&from=export http://dx.doi.org/10.1523/JNEUROSCI.3792-03.2004 VL - 24 ID - 2789 ER - TY - JOUR AD - S. Adachi, Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin Sakyo-ku, Kyoto 606-8507, Japan AU - Adachi, S. AU - Leoni, L. M. AU - Carson, D. A. AU - Nakahata, T. C1 - aspirin cep 701 ct 53518 pkc 412 sdx 101 sti 571 su 11248 su 5416 DB - Embase Medline DO - 10.1159/000074490 IS - 1-2 LA - English M3 - Review N1 - L37499959 2003-12-29 PY - 2004 SN - 0001-5792 SP - 107-123 ST - Apoptosis induced by molecular targeting therapy in hematological malignancies T2 - Acta Haematologica TI - Apoptosis induced by molecular targeting therapy in hematological malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37499959&from=export http://dx.doi.org/10.1159/000074490 VL - 111 ID - 2790 ER - TY - JOUR AD - C.J. Kim, Department of Pathology, Seoul National Univ. Coll. of Med., 28 Yongon-dong, Chonggu-gu, Seoul 110-799, South Korea AU - Kim, M. S. AU - Kim, C. J. AU - Jung, H. S. AU - Seo, M. R. AU - Juhnn, Y. S. AU - Shin, H. Y. AU - Ahn, Y. S. AU - Thiele, C. J. AU - Chi, J. G. C1 - pd 98059 sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1002/path.1497 IS - 1 LA - English M3 - Article N1 - L38072851 2004-01-26 PY - 2004 SN - 0022-3417 SP - 103-112 ST - Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells T2 - Journal of Pathology TI - Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38072851&from=export http://dx.doi.org/10.1002/path.1497 VL - 202 ID - 2791 ER - TY - JOUR AD - S.E. Dunn, Department of Pediatrics, Laboratory for Oncogenomic Research, BC Inst. Children's/Women's Hlth., 950 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada AU - Nielsen, T. O. AU - Andrews, H. N. AU - Cheang, M. AU - Kucab, J. E. AU - Hsu, F. D. AU - Ragaz, J. AU - Gilks, C. B. AU - Makretsov, N. AU - Bajdik, C. D. AU - Brookes, C. AU - Neckers, L. M. AU - Evdokimova, V. AU - Huntsman, D. G. AU - Dunn, S. E. DB - Embase Medline DO - 10.1158/0008-5472.CAN-03-1242 IS - 1 LA - English M3 - Article N1 - L38114109 2004-02-16 PY - 2004 SN - 0008-5472 SP - 286-291 ST - Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival: Potential for Intervention with 17-Allylamino Geldanamycin T2 - Cancer Research TI - Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival: Potential for Intervention with 17-Allylamino Geldanamycin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38114109&from=export http://dx.doi.org/10.1158/0008-5472.CAN-03-1242 VL - 64 ID - 2792 ER - TY - JOUR AD - Y. Yamaoka, Vet. Affairs Medical Center (111D), 2002 Holcombe Boulevard, Houston, TX 77030, United States AU - Yamaoka, Y. AU - Kudo, T. AU - Lu, H. AU - Casola, A. AU - Brasier, A. R. AU - Graham, D. Y. DB - Embase Medline DO - 10.1053/j.gastro.2003.12.048 IS - 4 LA - English M3 - Article N1 - L38451175 2004-05-06 PY - 2004 SN - 0016-5085 SP - 1030-1043 ST - Role of Interferon-Stimulated Responsive Element-like Element in Interleukin-8 Promoter in Helicobacter pylori Infection T2 - Gastroenterology TI - Role of Interferon-Stimulated Responsive Element-like Element in Interleukin-8 Promoter in Helicobacter pylori Infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38451175&from=export http://dx.doi.org/10.1053/j.gastro.2003.12.048 VL - 126 ID - 2793 ER - TY - JOUR AD - M. Fiala, UCLA CHS 63-090, 10833 Le Conte Avenue, Los Angeles, CA 90095-1760, United States AU - Fiala, M. AU - Popik, W. AU - Qiao, J. H. AU - Lossinsky, A. S. AU - Alce, T. AU - Tran, K. AU - Yang, W. AU - Roos, K. P. AU - Arthos, J. DB - Embase Medline DO - 10.1385/ct:4:2:097 IS - 2 LA - English M3 - Article N1 - L39310744 2004-10-14 PY - 2004 SN - 1530-7905 SP - 97-107 ST - HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling T2 - Cardiovascular Toxicology TI - HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39310744&from=export http://dx.doi.org/10.1385/ct:4:2:097 VL - 4 ID - 2794 ER - TY - JOUR AD - M.E. Bromberg, Temple University School of Medicine, Sol Sherry Thrombosis Research Ctr., 3400 North Broad Street, Philadelphia, PA 19140, United States AU - Jiang, X. AU - Bailly, M. A. AU - Panetti, T. S. AU - Cappello, M. AU - Konigsberg, W. H. AU - Bromberg, M. E. DB - Embase Medline DO - 10.1111/j.1538-7836.2004.00545.x IS - 1 LA - English M3 - Article N1 - L40185625 2005-02-15 PY - 2004 SN - 1538-7933 SP - 93-101 ST - Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells T2 - Journal of Thrombosis and Haemostasis TI - Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40185625&from=export http://dx.doi.org/10.1111/j.1538-7836.2004.00545.x VL - 2 ID - 2795 ER - TY - JOUR AD - A. Borkhardt, Dept. of Pediat. Hematol. and Oncol., Justus-Liebig-University, 35385 Giessen, Germany AU - Ritter, U. AU - Damm-Welk, C. AU - Fuchs, U. AU - Bohle, R. M. AU - Borkhardt, A. AU - Woessmann, W. DB - Embase Medline DO - 10.1089/154545703322617041 IS - 5 LA - English M3 - Article N1 - L38404821 2004-04-14 PY - 2003 SN - 1545-4576 SP - 365-373 ST - Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL) T2 - Oligonucleotides TI - Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38404821&from=export http://dx.doi.org/10.1089/154545703322617041 VL - 13 ID - 2796 ER - TY - JOUR AD - M. Machala, Dept. of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 70, 62132 Brno, Czech Republic AU - Machala, M. AU - Bláha, L. AU - Vondráček, J. AU - Trosko, J. E. AU - Scott, J. AU - Upham, B. L. DB - Embase Medline DO - 10.1093/toxsci/kfg209 IS - 1 LA - English M3 - Article N1 - L37361889 2003-11-17 PY - 2003 SN - 1096-6080 SP - 102-111 ST - Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: Inhibitory potencies and screening for potential mode(s) of action T2 - Toxicological Sciences TI - Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: Inhibitory potencies and screening for potential mode(s) of action UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37361889&from=export http://dx.doi.org/10.1093/toxsci/kfg209 VL - 76 ID - 2797 ER - TY - JOUR AD - V.I. Avramis, #57, 4650 Sunset Blvd., Los Angeles, CA 90027, United States AU - Avramis, V. I. C1 - gleevec glivec nsc 680410 sti 571 DB - Embase IS - 11 LA - English M3 - Review N1 - L38133151 2004-02-12 PY - 2003 SN - 0377-8282 SP - 1087-1102 ST - Modulation of signaling pathways by adaphostin (NSC-680410), an antileukemic tyrosine kinase inhibitor: The past, the present and recommendations for the future T2 - Drugs of the Future TI - Modulation of signaling pathways by adaphostin (NSC-680410), an antileukemic tyrosine kinase inhibitor: The past, the present and recommendations for the future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38133151&from=export VL - 28 ID - 2798 ER - TY - JOUR AD - C.M. Niemeyer, Div. of Pediatric Hematol./Oncology, Dept. of Pediat./Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Niemeyer, C. M. AU - Kratz, C. C1 - e 21r intron A(Schering Plough,United States) l 744832 r 115777 C2 - Schering Plough(United States) DB - Embase Medline DO - 10.1007/s11912-003-0013-y IS - 6 LA - English M3 - Review N1 - L38898823 2004-07-25 PY - 2003 SN - 1523-3790 SP - 510-515 ST - Juvenile myelomonocytic leukemia T2 - Current Oncology Reports TI - Juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38898823&from=export http://dx.doi.org/10.1007/s11912-003-0013-y VL - 5 ID - 2799 ER - TY - JOUR AD - M. Torres, M.S.57, 4650 Sunset Blvd., Los Angeles, CA 90027, United States AU - Torres, M. AU - Forman, H. J. DB - Embase Medline DO - 10.1002/biof.5520170128 IS - 1-4 LA - English M3 - Conference Paper N1 - L37267162 2003-10-29 PY - 2003 SN - 0951-6433 SP - 287-296 ST - Redox signaling and the MAP kinase pathways T2 - BioFactors TI - Redox signaling and the MAP kinase pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37267162&from=export http://dx.doi.org/10.1002/biof.5520170128 VL - 17 ID - 2800 ER - TY - JOUR AD - S. Galli, Laboratory of Oxygen Metabolism, University Hospital, Cordoba 2351, 1120 Buenos Aires, Argentina AU - Galli, S. AU - Labato, M. I. AU - Bal de Kier Joffé, E. AU - Carreras, M. C. AU - Poderoso, J. J. DB - Embase Medline IS - 19 LA - English M3 - Article N1 - L37255186 2003-11-05 PY - 2003 SN - 0008-5472 SP - 6370-6377 ST - Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior T2 - Cancer Research TI - Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37255186&from=export VL - 63 ID - 2803 ER - TY - JOUR AD - A. Ferrante, Department of Immunopathology, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia AU - Moghaddami, N. AU - Costabile, M. AU - Grover, P. K. AU - Jersmann, H. P. A. AU - Huang, Z. H. AU - Hii, C. S. T. AU - Ferrante, A. DB - Embase Medline DO - 10.4049/jimmunol.171.5.2616 IS - 5 LA - English M3 - Article N1 - L37025574 2003-09-09 PY - 2003 SN - 0022-1767 SP - 2616-2624 ST - Unique effect of arachidonic acid on human neutrophil TNF receptor expression: Up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2 T2 - Journal of Immunology TI - Unique effect of arachidonic acid on human neutrophil TNF receptor expression: Up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37025574&from=export http://dx.doi.org/10.4049/jimmunol.171.5.2616 VL - 171 ID - 2804 ER - TY - JOUR AD - B. Stuhlmüller, Dept. of Int. Medicine, R./C. I., Charité University Hospital, Tucholskystrasse 2, D-10117-Berlin, Germany AU - Stuhlmüller, B. AU - Kunisch, E. AU - Franz, J. AU - Martinez-Gamboa, L. AU - Hernandez, M. M. AU - Pruss, A. AU - Ulbrich, N. AU - Erdmann, V. A. AU - Burmester, G. R. AU - Kinnet, R. W. DB - Embase Medline DO - 10.1016/S0002-9440(10)63450-5 IS - 3 LA - English M3 - Article N1 - L37040126 2003-09-09 PY - 2003 SN - 0002-9440 SP - 901-911 ST - Detection of oncofetal H19 RNA in rheumatoid arthritis synovial tissue T2 - American Journal of Pathology TI - Detection of oncofetal H19 RNA in rheumatoid arthritis synovial tissue UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37040126&from=export http://dx.doi.org/10.1016/S0002-9440(10)63450-5 VL - 163 ID - 2805 ER - TY - JOUR AD - H.B. Gaspar, Molecular Immunology Unit, Institute of Child Health, University College London, 30 Guildford Street, London WC1N 1EH, United Kingdom AU - Gilmour, K. C. AU - Gaspar, H. B. C1 - cymevene(Hoffmann La Roche,Switzerland) endoxana(Baxter,United States) foscavir(Astra Zeneca,United Kingdom) myleran(Glaxo SmithKline,United Kingdom) vepesid(Bristol Myers Squibb,United States) C2 - Astra Zeneca(United Kingdom) Baxter(United States) Bristol Myers Squibb(United States) Glaxo SmithKline(United Kingdom) Hoffmann La Roche(Switzerland) DB - Embase Medline DO - 10.1586/14737159.3.5.549 IS - 5 LA - English M3 - Review N1 - L37101871 2003-10-05 PY - 2003 SN - 1473-7159 SP - 549-561 ST - Pathogenesis and diagnosis of X-linked lymphoproliferative disease T2 - Expert Review of Molecular Diagnostics TI - Pathogenesis and diagnosis of X-linked lymphoproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37101871&from=export http://dx.doi.org/10.1586/14737159.3.5.549 VL - 3 ID - 2807 ER - TY - JOUR AD - A.E. Evans, Children's Hospital of Philadelphia, Division of Oncology, 902 Abramson Research Center, 3615 Civic Center Boulevard, Philadelphia, PA 19104-4318, United States AU - Evans, A. E. C1 - cep 701 genasense gleevac zarnestra DB - Embase Medline DO - 10.1002/mpo.10259 IS - 2 LA - English M3 - Conference Paper N1 - L36858335 2003-07-30 PY - 2003 SN - 0098-1532 SP - 141-144 ST - Commentary: Symposium on New Drugs in Cancer Therapy October 29 - November 2, 2001 T2 - Medical and Pediatric Oncology TI - Commentary: Symposium on New Drugs in Cancer Therapy October 29 - November 2, 2001 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36858335&from=export http://dx.doi.org/10.1002/mpo.10259 VL - 41 ID - 2808 ER - TY - JOUR AD - A.B.R. Thomson, University of Alberta, College Plaza, 205, 8215-112 Street, Edmonton, Alta. T6G 2C8, Canada AU - Thomson, A. B. R. AU - Drozdowski, L. AU - Iordache, C. AU - Thomson, B. K. A. AU - Vermeire, S. AU - Clandinin, M. T. AU - Wild, G. DB - Embase Medline DO - 10.1023/A:1024724109128 IS - 8 LA - English M3 - Review N1 - L36936694 2003-08-13 PY - 2003 SN - 0163-2116 SP - 1565-1581 ST - Small bowel review: Normal physiology, part 2 T2 - Digestive Diseases and Sciences TI - Small bowel review: Normal physiology, part 2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36936694&from=export http://dx.doi.org/10.1023/A:1024724109128 VL - 48 ID - 2809 ER - TY - JOUR AD - W. Chien, Dept. of Hematology/Oncology, Cedars-Sinai Medical Center, 110 George Burns Rd., Los Angeles, CA 90048, United States AU - Chien, W. AU - Tidow, N. AU - Williamson, E. A. AU - Shih, L. Y. AU - Krug, U. AU - Kettenbach, A. AU - Fermin, A. C. AU - Roifman, C. M. AU - Koeffler, H. P. DB - Embase Medline DO - 10.1074/jbc.M304575200 IS - 30 LA - English M3 - Article N1 - L36899923 2003-08-14 PY - 2003 SN - 0021-9258 SP - 27413-27420 ST - Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway T2 - Journal of Biological Chemistry TI - Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36899923&from=export http://dx.doi.org/10.1074/jbc.M304575200 VL - 278 ID - 2810 ER - TY - JOUR AD - K.S.J. Elenitoba-Johnson, Department of Pathology, University of Utah, Salt Lake City, UT 84132, United States AU - Elenitoba-Johnson, K. S. J. AU - Jenson, S. D. AU - Abbott, R. T. AU - Palais, R. A. AU - Bohling, S. D. AU - Lin, Z. AU - Tripp, S. AU - Shami, P. J. AU - Wang, L. Y. AU - Coupland, R. W. AU - Buckstein, R. AU - Perez-Ordonez, B. AU - Perkins, S. L. AU - Dube, I. D. AU - Lim, M. S. C1 - sb 203580 DB - Embase Medline DO - 10.1073/pnas.1137463100 IS - 12 LA - English M3 - Article N1 - L36706426 2003-07-01 PY - 2003 SN - 0027-8424 SP - 7259-7264 ST - Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36706426&from=export http://dx.doi.org/10.1073/pnas.1137463100 VL - 100 ID - 2811 ER - TY - JOUR AD - S. Nakamura, Dept. of Pathol./Molec. Diagnostics, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-Ku, Nagoya 464-8681, Japan AU - Ichimura, K. AU - Kagami, Y. AU - Suzuki, R. AU - Kojima, M. AU - Yoshino, T. AU - Ohshima, K. AU - Koike, K. AU - Kondo, E. AU - Taji, H. AU - Ogura, M. AU - Morishima, Y. AU - Akagi, T. AU - Takahashi, T. AU - Nakamura, S. DB - Embase Medline DO - 10.1046/j.1440-1827.2003.01479.x IS - 6 LA - English M3 - Article N1 - L36859624 2003-07-30 PY - 2003 SN - 1320-5463 SP - 333-344 ST - Phenotypic analysis of peripheral T/NK cell lymphoma: Study of 408 Japanese cases with special reference to their anatomical sites T2 - Pathology International TI - Phenotypic analysis of peripheral T/NK cell lymphoma: Study of 408 Japanese cases with special reference to their anatomical sites UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36859624&from=export http://dx.doi.org/10.1046/j.1440-1827.2003.01479.x VL - 53 ID - 2812 ER - TY - JOUR AD - G.B. Segel, Department of Pediatrics, Univ. Rochester Sch. of Med./Dent., 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Segel, G. B. AU - Woodlock, T. J. AU - Xu, J. AU - Li, L. AU - Felgar, R. E. AU - Ryan, D. H. AU - Lichtman, M. A. AU - Wang, N. DB - Embase Medline DO - 10.1016/S1079-9796(03)00035-4 IS - 3 LA - English M3 - Article N1 - L36539429 2003-05-19 PY - 2003 SN - 1079-9796 SP - 277-287 ST - Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype T2 - Blood Cells, Molecules, and Diseases TI - Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36539429&from=export http://dx.doi.org/10.1016/S1079-9796(03)00035-4 VL - 30 ID - 2815 ER - TY - JOUR AD - B.L. Upham, 243 Food Safety/Toxicology Center, Michigan State University, East Lansing, MI 48824-1302, United States AU - Upham, B. L. AU - Rummel, A. M. AU - Carbone, J. M. AU - Trosko, J. E. AU - Ouyang, Y. AU - Crawford, R. B. AU - Kaminski, N. E. DB - Embase Medline DO - 10.1002/ijc.10899 IS - 1 LA - English M3 - Article N1 - L36184142 2003-02-27 PY - 2003 SN - 0020-7136 SP - 12-18 ST - Cannabinoids inhibit gap junctional intercellular communication and activate erk in a rat liver epithelial cell line T2 - International Journal of Cancer TI - Cannabinoids inhibit gap junctional intercellular communication and activate erk in a rat liver epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36184142&from=export http://dx.doi.org/10.1002/ijc.10899 VL - 104 ID - 2818 ER - TY - JOUR AD - D.L. Stirewalt, Fred Hutchinson Cancer Res. Center, 1100 Fairview Avenue, North Seattle, WA 98109, United States AU - Stirewalt, D. L. AU - Meshinchi, S. AU - Radich, J. P. C1 - cep 5214(Cephalon,United States) gleevec pkc 412(Novartis,United States) sti 571 su 5416 su 6668 C2 - Cephalon(United States) Novartis(United States) DB - Embase Medline DO - 10.1016/S0268-960X(02)00057-7 IS - 1 LA - English M3 - Article N1 - L36176208 2003-02-20 PY - 2003 SN - 0268-960X SP - 15-23 ST - Molecular targets in acute myelogenous leukemia T2 - Blood Reviews TI - Molecular targets in acute myelogenous leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36176208&from=export http://dx.doi.org/10.1016/S0268-960X(02)00057-7 VL - 17 ID - 2819 ER - TY - JOUR AD - J. Jankovic, Parkinson's Disease Center, Department of Neurology, Baylor College of Medicine, 6550 Fannin St., Houston, TX 77030, United States AU - Thomas, M. AU - Le, W. D. AU - Jankovic, J. C1 - cep 1347 DB - Embase Medline DO - 10.1097/00002826-200301000-00005 IS - 1 LA - English M3 - Article N1 - L36184111 2003-02-26 PY - 2003 SN - 0362-5664 SP - 18-23 ST - Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease T2 - Clinical Neuropharmacology TI - Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36184111&from=export http://dx.doi.org/10.1097/00002826-200301000-00005 VL - 26 ID - 2820 ER - TY - JOUR AD - C.A. Scrideli, Centro Ricerca M. Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Via Donizetti, Monza, Italy AU - Scrideli, C. A. AU - Cazzaniga, G. AU - Fazio, G. AU - Pirola, L. AU - Callegaro, A. AU - Bassan, R. AU - Rambaldi, A. AU - Lo Nigro, L. AU - Basso, G. AU - Masera, G. AU - Biondi, A. DB - Embase Medline DO - 10.1038/sj.leu.2403110 IS - 11 LA - English M3 - Letter N1 - L37428393 2003-12-03 PY - 2003 SN - 0887-6924 SP - 2234-2237 ST - Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia [2] T2 - Leukemia TI - Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia [2] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37428393&from=export http://dx.doi.org/10.1038/sj.leu.2403110 VL - 17 ID - 2821 ER - TY - JOUR AD - M.W. Konstan, Department of Pediatrics, Case Western Reserve Univ. Sch. Med., Rainbow Babies and Children's Hosp., 11100 Euclid Avenue, Cleveland, OH 44106, United States AU - Konstan, M. W. AU - Davis, P. B. DB - Embase Medline DO - 10.1016/S0169-409X(02)00146-1 IS - 11 LA - English M3 - Review N1 - L35375768 2002-12-11 PY - 2002 SN - 0169-409X SP - 1409-1423 ST - Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis T2 - Advanced Drug Delivery Reviews TI - Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35375768&from=export http://dx.doi.org/10.1016/S0169-409X(02)00146-1 VL - 54 ID - 2822 ER - TY - JOUR AD - M.J. García, Department of Pathology, Fundacion Jimenez Diaz, Universidad Autónoma (UAM), Madrid, Spain AU - García, M. J. AU - Castrillo, J. M. AU - Granizo, J. J. AU - Cazorla, A. AU - Rivas, C. DB - Embase Medline DO - 10.1046/j.1365-2141.2002.03870_3.x IS - 3 LA - English M3 - Letter N1 - L35366240 2002-12-03 PY - 2002 SN - 0007-1048 SP - 877-878 ST - Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma [3] T2 - British Journal of Haematology TI - Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma [3] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35366240&from=export http://dx.doi.org/10.1046/j.1365-2141.2002.03870_3.x VL - 119 ID - 2823 ER - TY - JOUR AD - B.V. Madhukar, Departments of Pediatrics/Human Development, Michigan State University, East Lansing, Michigan 48824-1317, USA. AU - Madhukar, B. V. AU - Dimitrov, N. V. AU - Meyer-Leece, C. AU - Contreras, M. L. AU - Crowell, J. DB - Medline IS - 12 LA - English M3 - Article N1 - L135720313 2004-04-04 PY - 2002 SN - 1535-7163 SP - 1125-1128 ST - Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz T2 - Molecular cancer therapeutics TI - Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz UR - https://www.embase.com/search/results?subaction=viewrecord&id=L135720313&from=export VL - 1 ID - 2824 ER - TY - JOUR AD - D. Ellison, Northern Inst. for Cancer Research, Medical School, University of Newcastle, Framlington Place, Newcastle-upon-Tyne NE2 4HH, United Kingdom AU - Ellison, D. DB - Embase Medline DO - 10.1046/j.1365-2990.2002.00419.x IS - 4 LA - English M3 - Review N1 - L34989289 2002-09-17 PY - 2002 SN - 0305-1846 SP - 257-282 ST - Classifying the medulloblastoma: Insights from morphology and molecular genetics T2 - Neuropathology and Applied Neurobiology TI - Classifying the medulloblastoma: Insights from morphology and molecular genetics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34989289&from=export http://dx.doi.org/10.1046/j.1365-2990.2002.00419.x VL - 28 ID - 2825 ER - TY - JOUR AD - C.D.M. Fletcher, FRCPath, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Nascimento, A. F. AU - Ruiz, R. AU - Hornick, J. L. AU - Fletcher, C. D. M. DB - Embase Medline DO - 10.1177/106689690201000304 IS - 3 LA - English M3 - Article N1 - L34988513 2002-09-19 PY - 2002 SN - 1066-8969 SP - 189-196 ST - Calcifying fibrous 'pseudotumor': Clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor T2 - International Journal of Surgical Pathology TI - Calcifying fibrous 'pseudotumor': Clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34988513&from=export http://dx.doi.org/10.1177/106689690201000304 VL - 10 ID - 2827 ER - TY - JOUR AD - D.G. Gilliland, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, United States AU - Gilliland, D. G. AU - Griffin, J. D. C1 - ag 1295 ag 1296 cep 701(Cephalon,United States) ct 53518(Millennium,United States) pkc 412(Novartis,United States) sti 571 su 11248(Sugen) su 5416(Sugen) su 5614(Sugen) C2 - Cephalon(United States) Millennium(United States) Novartis(United States) Sugen DB - Embase Medline DO - 10.1097/00062752-200207000-00003 IS - 4 LA - English M3 - Review N1 - L34596870 2002-06-17 PY - 2002 SN - 1065-6251 SP - 274-281 ST - Role of FLT3 in leukemia T2 - Current Opinion in Hematology TI - Role of FLT3 in leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34596870&from=export http://dx.doi.org/10.1097/00062752-200207000-00003 VL - 9 ID - 2828 ER - TY - JOUR AD - W. Zumkeller, Department of Pediatrics, Martin-Luther-Univ. Halle-Wittenberg, Children's University Hospital, Ernst-Grube-Str. 40, 06097 Halle Saale, Germany AU - Zumkeller, W. DB - Embase Medline DO - 10.1080/10428190290011958 IS - 3 LA - English M3 - Review N1 - L34232914 2002-03-28 PY - 2002 SN - 1042-8194 SP - 487-491 ST - The insulin-like growth factor system in hematopoietic cells T2 - Leukemia and Lymphoma TI - The insulin-like growth factor system in hematopoietic cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34232914&from=export http://dx.doi.org/10.1080/10428190290011958 VL - 43 ID - 2829 ER - TY - JOUR AD - R.H. Scott, Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD Scotland, United Kingdom AU - Pollock, J. AU - McFarlane, S. M. AU - Connell, M. C. AU - Zehavi, U. AU - Vandenabeele, P. AU - MacEwan, D. J. AU - Scott, R. H. DB - Embase Medline DO - 10.1016/S0028-3908(01)00163-0 IS - 1 LA - English M3 - Article N1 - L34062825 2002-01-30 PY - 2002 SN - 0028-3908 SP - 93-106 ST - TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones T2 - Neuropharmacology TI - TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34062825&from=export http://dx.doi.org/10.1016/S0028-3908(01)00163-0 VL - 42 ID - 2830 ER - TY - JOUR AD - B.L. Upham, Department of Pediatrics, Hum. Devmt./N. F. S./Toxicol. Ctr., Michigan State University, East Lansing, MI 48824, United States AU - Horvath, A. AU - Upham, B. L. AU - Ganev, V. AU - Trosko, J. E. DB - Embase Medline DO - 10.1016/S0041-0101(01)00219-7 IS - 3 LA - English M3 - Article N1 - L33044571 2001-11-21 PY - 2001 SN - 0041-0101 SP - 273-282 ST - Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line T2 - Toxicon TI - Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L33044571&from=export http://dx.doi.org/10.1016/S0041-0101(01)00219-7 VL - 40 ID - 2831 ER - TY - JOUR AD - S.P. Hunger, UCHSC Campus Box C229, 4200 East Ninth Ave, Denver, CO 80262, United States AU - Meech, S. J. AU - McGavran, L. AU - Odom, L. F. AU - Liang, X. AU - Maltesen, L. AU - Gump, J. AU - Wei, Q. AU - Carlsen, S. AU - Hunger, S. P. DB - Embase Medline DO - 10.1182/blood.V98.4.1209 IS - 4 LA - English M3 - Article N1 - L35119686 2002-10-22 PY - 2001 SN - 0006-4971 SP - 1209-1216 ST - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4 - Anaplastic lymphoma kinase gene fusion T2 - Blood TI - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4 - Anaplastic lymphoma kinase gene fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35119686&from=export http://dx.doi.org/10.1182/blood.V98.4.1209 VL - 98 ID - 2834 ER - TY - JOUR AD - S. Sacchi, Dipartimento di Scienze Mediche, 5 piano Policlinico, 4100 Modena, Italy AU - Fiorani, C. AU - Vinci, G. AU - Sacchi, S. AU - Bonaccorsi, G. AU - Artusi, T. DB - Embase Medline DO - 10.3816/CLM.2001.n.009 IS - 1 LA - English M3 - Article N1 - L32677847 2001-08-06 PY - 2001 SN - 1526-9655 SP - 29-37 ST - Primary systemic anaplastic large-cell lymphoma (CD30+): Advances in biology and current therapeutic approaches T2 - Clinical Lymphoma TI - Primary systemic anaplastic large-cell lymphoma (CD30+): Advances in biology and current therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32677847&from=export http://dx.doi.org/10.3816/CLM.2001.n.009 VL - 2 ID - 2835 ER - TY - JOUR AD - D.W. Clapp, Cancer Research Institute, 1044 W. Walnut, Indianapolis, IN 46202, United States AU - Ingram, D. A. AU - Hiatt, K. AU - King, A. J. AU - Fisher, L. AU - Shivakumar, R. AU - Derstine, C. AU - Wenning, M. J. AU - Diaz, B. AU - Travers, J. B. AU - Hood, A. AU - Marshall, M. AU - Williams, D. A. AU - Clapp, D. W. DB - Embase Medline DO - 10.1084/jem.194.1.57 IS - 1 LA - English M3 - Article N1 - L32660437 2001-08-01 PY - 2001 SN - 0022-1007 SP - 57-69 ST - Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro T2 - Journal of Experimental Medicine TI - Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32660437&from=export http://dx.doi.org/10.1084/jem.194.1.57 VL - 194 ID - 2836 ER - TY - JOUR AD - P.J. Gebicke-Haerter, Central Institute for Mental Health, Dept. of Psychopharmacology, J5, D-68159 Mannheim, Germany AU - Kitamura, Y. AU - Spleiss, O. AU - Li, H. AU - Taniguchi, T. AU - Kimura, H. AU - Nomura, Y. AU - Gebicke-Haerter, P. J. DB - Embase Medline DO - 10.1002/jnr.1107 IS - 6 LA - English M3 - Article N1 - L32520676 2001-06-28 PY - 2001 SN - 0360-4012 SP - 553-563 ST - Lipopolysaccharide-induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)-16 messenger RNAs in cultured rat microglia T2 - Journal of Neuroscience Research TI - Lipopolysaccharide-induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)-16 messenger RNAs in cultured rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32520676&from=export http://dx.doi.org/10.1002/jnr.1107 VL - 64 ID - 2837 ER - TY - JOUR AD - Y.J. Kang, Department of Medicine, Univ. of Louisville Sch. of Medicine, 511 S. Floyd St., MDR 530, Louisville, KY 40202, United States AU - Kang, Y. J. DB - Embase Medline DO - 10.1289/ehp.01109s127 IS - SUPPL. 1 LA - English M3 - Article N1 - L32303228 2001-05-01 PY - 2001 SN - 0091-6765 SP - 27-34 ST - Molecular and cellular mechanisms of cardiotoxicity T2 - Environmental Health Perspectives TI - Molecular and cellular mechanisms of cardiotoxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32303228&from=export http://dx.doi.org/10.1289/ehp.01109s127 VL - 109 ID - 2839 ER - TY - JOUR AD - V. Ganapathy, Dept. of Biochemistry/Molec. Biol., Medical College of Georgia, Augusta, GA 30912-2100, United States AU - Kekuda, R. AU - Leibach, F. H. AU - Furesz, T. C. AU - Smith, C. H. AU - Ganapathy, V. DB - Embase Medline IS - 3 LA - English M3 - Article N1 - L30136598 2000-03-20 PY - 2000 SN - 0022-3565 SP - 1032-1041 ST - Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta T2 - Journal of Pharmacology and Experimental Therapeutics TI - Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta UR - https://www.embase.com/search/results?subaction=viewrecord&id=L30136598&from=export VL - 292 ID - 2840 ER - TY - JOUR AD - D.W. Clapp, Indiana University, School of Medicine, Cancer Research Institute, 1044 W. Walnut St., Indianapolis, IN 46202, United States AU - Ingram, D. A. AU - Yang, F. C. AU - Travers, J. B. AU - Wenning, M. J. AU - Hiatt, K. AU - New, S. AU - Hood, A. AU - Shannon, K. AU - Williams, D. A. AU - Clapp, D. W. DB - Embase Medline DO - 10.1084/jem.191.1.181 IS - 1 LA - English M3 - Article N1 - L30043659 2000-01-26 PY - 2000 SN - 0022-1007 SP - 181-187 ST - Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo T2 - Journal of Experimental Medicine TI - Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L30043659&from=export http://dx.doi.org/10.1084/jem.191.1.181 VL - 191 ID - 2841 ER - TY - JOUR AD - B.L. Upham, Dept. of Pediatrics/Human Devt., Michigan State University, B240 Life Sciences, East Lansing, MI 48824, United States AU - Rummel, A. M. AU - Trosko, J. E. AU - Wilson, M. R. AU - Upham, B. L. DB - Embase Medline DO - 10.1093/toxsci/49.2.232 IS - 2 LA - English M3 - Article N1 - L29300409 1999-07-12 PY - 1999 SN - 1096-6080 SP - 232-240 ST - Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity T2 - Toxicological Sciences TI - Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L29300409&from=export http://dx.doi.org/10.1093/toxsci/49.2.232 VL - 49 ID - 2842 ER - TY - JOUR AD - Department of Pathology, University of Manitoba, Winnipeg, MB, Canada Pediatric Hematology-Oncology, Bone Marrow Transplant Unit, University of Manitoba, Winnipeg, MB, Canada AU - Shuying, Ji AU - Shash, Hwazen AU - Stefanovici, Camelia AU - Phillips, Susan AU - Cuvelier, Geoff DB - ccm DP - EBSCOhost N1 - Accession Number: 138682130. Language: English. Entry Date: In Process. Revision Date: 20190919. Publication Type: Article. Supplement Title: 2016 Supplement. PY - 2016 SN - 1918-915X SP - 8-9 ST - Metastatic inflammatory myofibroblastic tumour following allogeneic stem cell transplant with fatal pulmonary toxicity from Crizotinib T2 - Canadian Journal of Pathology TI - Metastatic inflammatory myofibroblastic tumour following allogeneic stem cell transplant with fatal pulmonary toxicity from Crizotinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138682130&site=ehost-live&scope=site VL - 8 ID - 2852 ER - TY - JOUR AD - Inserm CIC 1402, University Hospital, Poitiers, France Medical Faculty, Pediatric Hemato-oncology, Technical University, Dresden, Germany Department of Pediatric Oncology/Hematology, Princess Maxima Center, Utrecht, Netherlands Department of Pediatric Hematology Oncology and Transplantation, Wroclaw Medical University, Wroclaw, Poland Department of Pediatric Hematology-oncology, University Hospital, Lille, France Department of Pediatric Hematology-oncology, University Hospital, Bordeaux, France Department of Pediatric Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France Department of Pediatric Hematology, Robert Debré Hospital, Paris, France AN - 144991000. Language: English. Entry Date: 20200902. Revision Date: 20200902. Publication Type: Article AU - Millot, Frédéric AU - Suttorp, Meinolf AU - Versluys, Anne B. AU - Kalwak, Krzysztof AU - Nelken, Brigitte AU - Ducassou, Stephane AU - Bertrand, Yves AU - Baruchel, André DB - ccm DO - 10.1016/j.ejca.2020.05.020 DP - EBSCOhost N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9005373. PY - 2020 SN - 0959-8049 SP - 107-112 ST - Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia study T2 - European Journal of Cancer TI - Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144991000&site=ehost-live&scope=site VL - 136 ID - 2857 ER - TY - JOUR AD - Speciality Medical Officer, Department of Pathology, Melaka Manipal Medical College, Manipal campus, Manipal Academy of Higher Education, Karnataka, India Assistant Professor, Department of Pathology, Melaka Manipal Medical College, Manipal campus, Manipal Academy of Higher Education, Karnataka, India Junior Resident, Dept. of Pathology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India Associate Professor, Dept. of Pathology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India AN - 144463835. Language: English. Entry Date: 20200720. Revision Date: 20200720. Publication Type: Article AU - Shanthakumari, B. R. AU - Singh, Varun Kumar AU - Ramakrishnan, Karthik AU - Belurkar, Sushma DB - ccm DP - EBSCOhost IS - 4 N1 - case study; pictorial. Journal Subset: Allied Health; Asia. PY - 2019 SN - 0972-5997 SP - 1-3 ST - Pediatric Chronic Myeloid Leukemia: Case Report of a Disease with a Unique Biology T2 - Online Journal of Health & Allied Sciences TI - Pediatric Chronic Myeloid Leukemia: Case Report of a Disease with a Unique Biology UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144463835&site=ehost-live&scope=site VL - 18 ID - 2864 ER - TY - JOUR AN - 144768968. Language: English. Entry Date: 20200730. Revision Date: 20200803. Publication Type: Article DB - ccm DO - 10.1093/ajhp/zxaa165 DP - EBSCOhost IS - 15 N1 - practice guidelines. Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA. NLM UID: 9503023. PY - 2020 SN - 1079-2082 SP - 1180-1182 ST - Selumetinib Sulfate T2 - American Journal of Health-System Pharmacy TI - Selumetinib Sulfate UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144768968&site=ehost-live&scope=site VL - 77 ID - 2866 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ 07601, USA Division of Pediatric Hematology/Oncology, NYU Winthrop Hospital, Mineola, NY 11501, USA AU - Jing, Chen AU - Glasser, Chana L. DB - ccm DO - 10.3390/children7020012 DP - EBSCOhost IS - 2 N1 - Accession Number: 142484061. Language: English. Entry Date: In Process. Revision Date: 20200403. Publication Type: Article. PY - 2020 SN - 2227-9067 SP - 1-15 ST - New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) T2 - Children TI - New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=142484061&site=ehost-live&scope=site VL - 7 ID - 2868 ER - TY - JOUR AD - Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia USA Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia USA AN - 104061069. Language: English. Entry Date: 20140402. Revision Date: 20200708. Publication Type: Journal Article AU - Ruebner, Rebecca AU - Copelovitch, Lawrence AU - Evageliou, Nicholas AU - Denburg, Michelle AU - Belasco, Jean AU - Kaplan, Bernard DB - ccm DO - 10.1007/s00467-013-2696-0 DP - EBSCOhost IS - 5 N1 - case study; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Special Interest: Pediatric Care. NLM UID: 8708728. PMID: NLM24310825. PY - 2014 SN - 0931-041X SP - 863-869 ST - Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature T2 - Pediatric Nephrology TI - Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104061069&site=ehost-live&scope=site VL - 29 ID - 2870 ER - TY - CASE A4 - Charfi, Lamia A2 - Houcine, Yoldez A2 - Yahyaoui, Yosra A2 - Sahraoui, Gada A2 - Chraiet, Nesrine A2 - Mrad, Karima A2 - Doghri, Raoudha AB - The article presents a case study of a 16-year-old girl presented with erythematous and infiltrative changes which appeared one month ago in the left breast. Topics include reports that physical examination showed an increase in the volume of the left breast with diffuse thickening, induration, and variable edema, but no mass was palpated. AD - Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia Medical Oncology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia DB - ccm DO - 10.1111/tbj.13949 DP - EBSCOhost J2 - Breast Journal KW - Breast Neoplasms -- Diagnosis -- In Adolescence Anaplastic Lymphoma Kinase -- In Adolescence Breast Examination Breast Neoplasms -- Surgery Lymph Node Excision Adolescence Female Breast -- Ultrasonography Biopsy Immunohistochemistry Paraffin Embedding Polymerase Chain Reaction N1 - Accession Number: 146733960. Language: English. Entry Date: 20201107. Revision Date: 20201107. Publication Type: Case Study; case study; pictorial. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Peer Reviewed; USA. NLM UID: 9505539. NV - Malden, Massachusetts PB - Wiley-Blackwell PY - 2020 SP - 2068-2069 ST - Primary breast Anaplasic Lymphoma Kinase‐positive anaplastic lymphoma in an adolescent TI - Primary breast Anaplasic Lymphoma Kinase‐positive anaplastic lymphoma in an adolescent UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146733960&site=ehost-live&scope=site VL - 26 ID - 2877 ER - TY - JOUR AD - Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM) and 3rd Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany Department of Neurosurgery, Klinikum Idar-Oberstein, Idar-Oberstein, Germany Department of Neurosurgery, Charité University Hospital, Humboldt University Berlin, Berlin, Germany Department of Neuroradiology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany Department of Neurosurgery, Ruhr-University Bochum, Bochum, Germany Department of Internal Medicine II, University Hospital Jena, Jena, Germany University Medical Center Freiburg, Freiburg, Germany AN - 141102990. Language: English. Entry Date: 20200111. Revision Date: 20201104. Publication Type: Article AU - Sautter, Lisa AU - Hofheinz, Ralf AU - Tuettenberg, Jochen AU - Grimm, Mario AU - Vajkoczy, Peter AU - Groden, Christoph AU - Schmieder, Kirsten AU - Hochhaus, Andreas AU - Wenz, Frederik AU - Giordano, Frank A DB - ccm DO - 10.1159/000502483 DP - EBSCOhost IS - 1 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Eastern Cooperative Oncology Group (ECOG) Performance Status Scale. NLM UID: 0135054. PY - 2020 SN - 0030-2414 SP - 16-22 ST - Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma T2 - Oncology TI - Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141102990&site=ehost-live&scope=site VL - 98 ID - 2878 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing People's Republic of China AN - 137587818. Language: English. Entry Date: 20190723. Revision Date: 20190723. Publication Type: Article AU - Xie, Lu AU - Xu, Jie AU - Sun, Xin AU - Tang, Xiaodong AU - Yan, Taiqiang AU - Yang, Rongli AU - Guo, Wei DB - ccm DO - 10.1634/theoncologist.2018-0542 DP - EBSCOhost IS - 7 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2019 SN - 1083-7159 SP - e542-e550 ST - Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial T2 - Oncologist TI - Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137587818&site=ehost-live&scope=site VL - 24 ID - 2879 ER - TY - JOUR AD - F Hoffmann-La Roche Ltd., Global Access, 4070 Basel, Switzerland Mtech Access Ltd., 30 Murdock Road, Bicester, OX26 4PP, UK Roche Products Ltd., Health Economics and Strategic Pricing, Welwyn Garden City, AL7 1TW, UK AN - 141291180. Language: English. Entry Date: 20201014. Revision Date: 20201014. Publication Type: journal article AU - Chu, Paula AU - Batson, Sarah AU - Hodgson, Matthew AU - Mitchell, Catherine R. AU - Steenrod, Anna DB - ccm DO - 10.2217/fon-2019-0534 DP - EBSCOhost IS - 4 N1 - meta analysis; research. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Evidence-Based Practice. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins); Longitudinal Interval Follow-Up Evaluation (LIFE); Ferrans and Powers Quality of Life Index. NLM UID: 101256629. PMID: NLM31942815. PY - 2020 SN - 1479-6694 SP - 61-74 ST - Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy T2 - Future Oncology TI - Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141291180&site=ehost-live&scope=site VL - 16 ID - 2880 ER - TY - JOUR AD - The University of Toledo College of Medicine & Life Sciences, Toledo, OH 43606, USA ProMedica Health System, Toledo, OH 43606, USA West German Cancer Center, Deparment of Medical Oncology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany Centre Léon Bérard, Unicancer, LYRICAN and Université Claude Bernard Lyon 1, Lyon, France Leiden University Medical Center, Leiden, The Netherlands Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA University Hospitals Leuven, Department of General Medical Oncology, Leuven Cancer Institute, Leuven, Belgium Fox Chase Cancer Center, Philadelphia, PA 19111, USA Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University & Department of Medical Oncology Alfred Health, Melbourne, Australia Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA AN - 140274518. Language: English. Entry Date: 20200625. Revision Date: 20200806. Publication Type: journal article AU - Nemunaitis, John AU - Bauer, Sebastian AU - Blay, Jean-Yves AU - Choucair, Khalil AU - Gelderblom, Hans AU - George, Suzanne AU - Schöffski, Patrick AU - Mehren, Margaret von AU - Zalcberg, John AU - Achour, Haroun AU - Ruiz-Soto, Rodrigo AU - Heinrich, Michael C. DB - ccm DO - 10.2217/fon-2019-0633 DP - EBSCOhost IS - 1 N1 - clinical trial; research; randomized controlled trial. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Evidence-Based Practice. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins); Global Assessment of Functioning Scale (GAF). Grant Information: I01 BX000338/BX/BLRD VA/United States. NLM UID: 101256629. PMID: NLM31755321. PY - 2020 SN - 1479-6694 SP - 4251-4264 ST - Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib T2 - Future Oncology TI - Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=140274518&site=ehost-live&scope=site VL - 16 ID - 2881 ER - TY - JOUR AD - Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta Georgia Department of Radiation Oncology, Emory School of Medicine, Atlanta Georgia Department of Hematology and Medical Oncology, Emory School of Medicine, Atlanta Georgia AN - 145624540. Language: English. Entry Date: 20200914. Revision Date: 20200914. Publication Type: Article AU - Yeager, Katherine A. AU - Waldrop‐Valverde, Drenna AU - Paul, Sudeshna AU - Bruner, Deborah Watkins AU - Klisovic, Rebecca AU - Burns, Emily AU - Mason, Tamara A. AU - Patel, Nisha AU - Jennings, Bonnie Mowinski DB - ccm DO - 10.1002/nur.22069 DP - EBSCOhost IS - 5 N1 - research; review; tables/charts. Journal Subset: Core Nursing; Nursing; Peer Reviewed; USA. Instrumentation: EORTC QLQ-C30. Grant Information: This work was supported by the National Cancer Institute; National Institutes of Health.. NLM UID: 7806136. PY - 2020 SN - 0160-6891 SP - 443-452 ST - Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol T2 - Research in Nursing & Health TI - Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145624540&site=ehost-live&scope=site VL - 43 ID - 2882 ER - TY - JOUR AN - 141262304. Language: English. Entry Date: 20200129. Revision Date: 20200131. Publication Type: Article DB - ccm DP - EBSCOhost IS - 6 N1 - abstract; research. Supplement Title: Dec2019/Jan2020. Journal Subset: Core Nursing; Editorial Board Reviewed; Expert Peer Reviewed; Nursing; Peer Reviewed; USA. NLM UID: 100972358. PY - 2019 SN - 1531-037X SP - 24-29 ST - LITSCAN FOR CASE MANAGERS T2 - Care Management TI - LITSCAN FOR CASE MANAGERS UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141262304&site=ehost-live&scope=site VL - 25 ID - 2883 ER - TY - JOUR AN - 143541412. Language: English. Entry Date: 20200608. Revision Date: 20200706. Publication Type: Article AU - Bender, E. V. E. DB - ccm DO - 10.1097/01.nt.0000666940.43909.b0 DP - EBSCOhost IS - 9 N1 - commentary; pictorial; tables/charts. Original Study: Gross AM. Selumetinib in children with inoperable plexiform neurofibromas. (N Engl J Med) 2020;. Journal Subset: Biomedical; USA. NLM UID: 101231920. PY - 2020 SN - 1533-7006 SP - 1-24 ST - FDA Approves Selumetinib for Children with Inoperable Plexiform Neurofibromas T2 - Neurology Today TI - FDA Approves Selumetinib for Children with Inoperable Plexiform Neurofibromas UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143541412&site=ehost-live&scope=site VL - 20 ID - 2884 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia National Cancer Institute, Cairo University, Giza, Egypt Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia AN - 126387341. Language: English. Entry Date: 20171128. Revision Date: 20171128. Publication Type: Article AU - Alkhayat, Nawaf AU - Eiborai, Yasser AU - Al Sharif, Omer AU - Al Shahrani, Mohammad AU - Alsuhaibani, Omar AU - Awad, Mohammed AU - Elghezal, Hatem AU - Bouhajar, Inesse ben-abdallah AU - Alfaraj, Mona AU - Al Mussaed, Eman AU - Alabbas, Fahad AU - Elyamany, Ghaleb DB - ccm DO - 10.1177/1179554917721710 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Australia & New Zealand; Biomedical. PY - 2017 SN - 1179-5549 SP - 1-6 ST - Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia T2 - Clinical Medicine Insights: Oncology TI - Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126387341&site=ehost-live&scope=site ID - 2885 ER - TY - JOUR AD - Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Department Medicine, University of Southern California-Keck School of Medicine AN - 135207523. Language: English. Entry Date: 20190320. Revision Date: 20191029. Publication Type: Article AU - Hermel, David J. AU - Chiu, Victor AU - Hermel, Melody H. AU - Tulpule, Anil AU - Akhtari, Mojtaba DB - ccm DO - 10.1177/1078155217745710 DP - EBSCOhost IS - 3 N1 - case study. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9511372. PY - 2019 SN - 1078-1552 SP - 699-702 ST - Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib T2 - Journal of Oncology Pharmacy Practice TI - Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135207523&site=ehost-live&scope=site VL - 25 ID - 2886 ER - TY - GEN AD - Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Department of Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Orthopedic Surgery, Orthopedic Oncologic Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway AU - Longhi, Alessandra AU - Paioli, Anna AU - Palmerini, Emanuela AU - Cesari, Marilena AU - Abate, Massimo E. AU - Setola, Elisabetta AU - Spinnato, Paolo AU - Donati, Davide AU - Hompland, Ivar AU - Boye, Kjetil CY - Philadelphia, Pennsylvania DB - ccm DO - 10.1080/0284186X.2018.1503714 DP - EBSCOhost J2 - Acta Oncologica N1 - Accession Number: 134747712. Language: English. Entry Date: 20190219. Revision Date: 20200624. Publication Type: Letter to the Editor; case study; diagnostic images; letter; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. NLM UID: 8709065. PB - Taylor & Francis Ltd PY - 2019 SN - 0284-186X SP - 124-128 ST - Pazopanib in relapsed osteosarcoma patients: report on 15 cases TI - Pazopanib in relapsed osteosarcoma patients: report on 15 cases UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134747712&site=ehost-live&scope=site VL - 58 ID - 2887 ER - TY - JOUR AD - Department of Oncology, St George's University Hospital NHS Foundation Trust, London, UK Department of Urology, University of Tromso, Tromso, Norway Department of Oncology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK Department of Statistics, Indira Gandhi Institute of Development Research, Mumbai, India Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK The Cancer Centre, Queen Elizabeth Hospital Birmingham, Birmingham, UK AN - 136806657. Language: English. Entry Date: In Process. Revision Date: 20200321. Publication Type: journal article. Journal Subset: Biomedical AU - Afshar, Mehran AU - Patel, Hiten R. H. AU - Jain, Ankit AU - Kumar, Abhishek AU - Patel, Prashant AU - James, Nicholas D. AU - Porfiri, Emilio DB - ccm DO - 10.1080/14737140.2019.1609355 DP - EBSCOhost IS - 6 N1 - Europe; UK & Ireland. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 101123358. PMID: NLM30995130. PY - 2019 SN - 1473-7140 SP - 529-532 ST - Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism? T2 - Expert Review of Anticancer Therapy TI - Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136806657&site=ehost-live&scope=site VL - 19 ID - 2889 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing People's Republic of China Collaborative Innovation Center of Hematology, Soochow University, Suzhou People's Republic of China AN - 139646169. Language: English. Entry Date: 20191119. Revision Date: 20191119. Publication Type: Article AU - Dou, Xuelin AU - Qin, Yazhen AU - Huang, Xiaojun AU - Jiang, Qian DB - ccm DO - 10.1634/theoncologist.2019-0109 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2019 SN - 1083-7159 SP - e1141-e1147 ST - Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy T2 - Oncologist TI - Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139646169&site=ehost-live&scope=site VL - 24 ID - 2890 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, 100044, Beijing, China Peking University People's Hospital, Department of Nephrology, Beijing, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China AN - 137146984. Language: English. Entry Date: 20190814. Revision Date: 20200630. Publication Type: journal article AU - Ren, Xin AU - Qin, Yazhen AU - Huang, Xiaojun AU - Zuo, Li AU - Jiang, Qian DB - ccm DO - 10.1007/s00277-019-03690-2 DP - EBSCOhost IS - 7 N1 - clinical trial; research. Journal Subset: Biomedical; Continental Europe; Europe. Special Interest: Evidence-Based Practice. Grant Information: 81770161//National Natural Science Foundation of China/. NLM UID: 9107334. PMID: NLM31089794. PY - 2019 SN - 0939-5555 SP - 1627-1640 ST - Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors T2 - Annals of Hematology TI - Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137146984&site=ehost-live&scope=site VL - 98 ID - 2893 ER - TY - JOUR AD - Neonatal Intensive Care Unit, Department of Health Promotion, Mother-Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University Hospital "P. Giaccone", Via Alfonso Giordano n. 3, 90127, Palermo, Italy Pediatric Surgery Unit, Department of Health Promotion, Mother-Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University Hospital "P. Giaccone", Via Alfonso Giordano n. 3, 90127, Palermo, Italy AN - 145947953. Language: English. Entry Date: 20201009. Revision Date: 20201009. Publication Type: Article AU - Schierz, Ingrid Anne Mandy AU - Cimador, Marcello AU - Giuffrè, Mario AU - Aiello, Claudia Maria AU - Antona, Vincenzo AU - Corsello, Giovanni AU - Piro, Ettore DB - ccm DO - 10.1186/s13052-020-00901-9 DP - EBSCOhost IS - 1 N1 - case study; diagnostic images; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed. NLM UID: 101510759. PY - 2020 SN - 1720-8424 SP - N.PAG-N.PAG ST - Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report T2 - Italian Journal of Pediatrics TI - Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145947953&site=ehost-live&scope=site VL - 46 ID - 2894 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Divison of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA AN - 128398722. Language: English. Entry Date: 20180314. Revision Date: 20190619. Publication Type: Article AU - Menegaz, Brian A. AU - Cuglievan, Branko AU - Benson, Jalen AU - Camacho, Pamela AU - Lamhamedi‐Cherradi, Salah‐Eddine AU - Leung, Cheuk Hong AU - Warneke, Carla L. AU - Huh, Winston AU - Subbiah, Vivek AU - Benjamin, Robert S. AU - Patel, Shreyaskumar AU - Daw, Najat AU - Hayes‐Jordan, Andrea AU - Ludwig, Joseph A. DB - ccm DO - 10.1634/theoncologist.2017-0408 DP - EBSCOhost IS - 3 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2018 SN - 1083-7159 SP - 360-366 ST - Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor T2 - Oncologist TI - Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128398722&site=ehost-live&scope=site VL - 23 ID - 2895 ER - TY - JOUR AD - Renato Bassan, Ospedale dell'Angelo, Mestre-Venezia AN - 133447938. Language: English. Entry Date: 20200528. Revision Date: 20181222. Publication Type: journal article. Journal Subset: Biomedical AU - Bassan, Renato AU - Bourquin, Jean-Pierre AU - DeAngelo, Daniel J. AU - Chiaretti, Sabina DB - ccm DO - 10.1200/JCO.2017.77.3648 DP - EBSCOhost IS - 35 N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 8309333. PMID: NLM30240326. PY - 2018 SN - 0732-183X SP - 3504-3519 ST - New Approaches to the Management of Adult Acute Lymphoblastic Leukemia T2 - Journal of Clinical Oncology TI - New Approaches to the Management of Adult Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133447938&site=ehost-live&scope=site VL - 36 ID - 2897 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston Texas Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange California Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas AN - 121147618. Language: English. Entry Date: 20170606. Revision Date: 20190912. Publication Type: journal article AU - Koller, Paul B. AU - Kantarjian, Hagop M. AU - Nogueras‐Gonzalez, Graciela M. AU - Jabbour, Elias AU - Verstovsek, Srdan AU - Borthakur, Gautam AU - Estrov, Zeev AU - Wierda, William G. AU - Garcia‐Manero, Guillermo AU - Ferrajoli, Alessandra AU - Ravandi, Farhad AU - O'Brien, Susan M. AU - Cortes, Jorge E. AU - Nogueras-Gonzalez, Graciela M. AU - Garcia-Manero, Guillermo DB - ccm DO - 10.1002/cncr.30362 DP - EBSCOhost IS - 4 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM27763690. PY - 2017 SN - 0008-543X SP - 609-616 ST - Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship T2 - Cancer (0008543X) TI - Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121147618&site=ehost-live&scope=site VL - 123 ID - 2898 ER - TY - JOUR AD - Department of Thoracic Oncology and Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan Department of Thoracic Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Oita, Japan AN - 129372048. Language: English. Entry Date: 20180508. Revision Date: 20190711. Publication Type: Article AU - Kometani, Takuro AU - Sugio, Kenji AU - Osoegawa, Atsushi AU - Seto, Takashi AU - Ichinose, Yukito DB - ccm DO - 10.1111/1759-7714.12616 DP - EBSCOhost IS - 5 N1 - pictorial; research; tables/charts. Journal Subset: Biomedical; USA. NLM UID: 101531441. PY - 2018 SN - 1759-7706 SP - 563-570 ST - Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene T2 - Thoracic Cancer TI - Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129372048&site=ehost-live&scope=site VL - 9 ID - 2899 ER - TY - JOUR AD - Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India AN - 143193223. Language: English. Entry Date: 20200927. Revision Date: 20200927. Publication Type: journal article AU - Bansal, Deepak DB - ccm DO - 10.1007/s12098-020-03234-x DP - EBSCOhost IS - 6 N1 - review. Journal Subset: Asia; Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed. NLM UID: 0417442. PMID: NLM32086760. PY - 2020 SN - 0019-5456 SP - 443-450 ST - Chronic Myeloid Leukemia in Children: Challenges and Opportunities : Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019 T2 - Indian Journal of Pediatrics TI - Chronic Myeloid Leukemia in Children: Challenges and Opportunities : Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019 UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143193223&site=ehost-live&scope=site VL - 87 ID - 2900 ER - TY - JOUR AD - Servicio de Hematología, Hospital General Universitario Gregorio Marañón, Madrid, Spain Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain Servicio de Hematología, Hospital Universitario Clínico Virgen de la Arrixaca, Murcia, Spain Servicio de Hematología, Hospital Universitario 12 de Octubre, Madrid, Spain Servicio de Hematología, Hospital Universitari Mútua Terrassa, Terrassa, Spain Servicio de Hematología, Hospital Universitario Ramón y Cajal, Madrid, Spain Servicio de Hematología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain Servicio de Hematología, Complejo Hospitalario Universitario Insular Materno Infantil de Canarias, Las Palmas de Gran Canaria, Spain Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain Servicio de Hematología, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain Servicio de Hematología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain Servicio de Hematología, Hospital General Universitario de Elche, Elche, Alicante, Spain Servicio de Hematología, Hospital Universitario Virgen Macarena, Sevilla, Spain Servicio de Hematología, Hospital Virgen de la Salud, Toledo, Spain Servicio de Hematología, Hospital Universitario de la Princesa, Madrid, Spain AN - 132112504. Language: English. Entry Date: 20181011. Revision Date: 20191101. Publication Type: Article AU - Osorio, Santiago AU - Escudero-Vilaplana, Vicente AU - Gómez-Centurión, Ignacio AU - Pérez-López, Raúl AU - Ayala, Rosa AU - Vall-Llovera, Ferrán AU - García-Gutierrez, Valentín AU - Gómez Casares, María Teresa AU - González San Miguel, José David AU - Hernández-Rivas, José-Ángel AU - Sánchez-Guijo, Fermín AU - Martínez-García, Ana Belén AU - Villalón, Lucia AU - Conesa-García, Venancio AU - Rodriguez, Alicia AU - Casado, Felipe AU - Garcia-Gonzalez, Xandra AU - Sáez Perdomo, María Nieves AU - Baños, Úrsula AU - Steegmann, Juan Luis DB - ccm DO - 10.1007/s00277-018-3413-7 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Special Interest: Evidence-Based Practice. NLM UID: 9107334. PMID: NLM29955943. PY - 2018 SN - 0939-5555 SP - 2089-2098 ST - Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem? T2 - Annals of Hematology TI - Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132112504&site=ehost-live&scope=site VL - 97 ID - 2901 ER - TY - JOUR AD - Assistant Clinical Professor of Medicine, University of California, San Francisco Associate Clinical Professor, School of Pharmacy, University of California, San Francisco AN - 144418659. Language: English. Entry Date: 20200715. Revision Date: 20201026. Publication Type: Article. Journal Subset: Biomedical AU - Elliott, William AU - Chan, James DB - ccm DP - EBSCOhost IS - 12 N1 - USA. NLM UID: 8003602. PY - 2020 SN - 0195-315X SP - 10-11 ST - Selpercatinib Capsules (Retevmo) T2 - Internal Medicine Alert TI - Selpercatinib Capsules (Retevmo) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144418659&site=ehost-live&scope=site VL - 42 ID - 2902 ER - TY - JOUR AD - Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, P.R. China Department of Hematology, the First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, P.R. China Key Laboratory of Hematopoietic Malignancies, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China AN - 118924712. Language: English. Entry Date: 20171102. Revision Date: 20190517. Publication Type: journal article AU - Yin, Xiu-Feng AU - Wang, Jing-Han AU - Li, Xia AU - Yu, Meng-Xia AU - Ma, Zhi-Xin AU - Jin, Jie DB - ccm DO - 10.1016/j.clml.2016.06.010 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM27397576. PY - 2016 SN - 2152-2650 SP - 577-581 ST - Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors T2 - Clinical Lymphoma, Myeloma & Leukemia TI - Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=118924712&site=ehost-live&scope=site VL - 16 ID - 2904 ER - TY - JOUR AD - Department of Radiology, Boston Children's Hospital Dana -Farber Cancer Institute, Boston, Massachusetts. AN - 103858268. Language: English. Entry Date: 20150306. Revision Date: 20200708. Publication Type: journal article AU - Voss, Stephan D. AU - Glade-Bender, Julia AU - Spunt, Sheri L. AU - DuBois, Steven G. AU - Widemann, Brigitte C. AU - Park, Julie R. AU - Leary, Sarah E. S. AU - Nelson, Marvin D. AU - Adamson, Peter C. AU - Blaney, Susan M. AU - Weigel, Brenda DB - ccm DO - 10.1002/pbc.25229 DP - EBSCOhost IS - 1 N1 - clinical trial; research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Oncologic Care; Pediatric Care. Grant Information: 5UM1 CA097452-12/CA/NCI NIH HHS/United States. NLM UID: 101186624. PMID: NLM25257751. PY - 2015 SN - 1545-5009 SP - 45-51 ST - Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium T2 - Pediatric Blood & Cancer TI - Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103858268&site=ehost-live&scope=site VL - 62 ID - 2907 ER - TY - JOUR AD - Bradley Jellerichs, MSN, ARNP, DCNP, Clinic Dermatology, Federal Way, WA. Mary Elizabeth Kim, BS, Clinic Dermatology, Federal Way, WA. AN - 144727786. Language: English. Entry Date: 20200811. Revision Date: 20200811. Publication Type: Article AU - Jellerichs, Bradley AU - Kim, Mary Elizabeth DB - ccm DO - 10.1097/JDN.0000000000000551 DP - EBSCOhost IS - 4 N1 - case study; pictorial. Journal Subset: Core Nursing; Nursing; USA. Special Interest: Pediatric Care. NLM UID: 101519494. PY - 2020 SN - 1945-760X SP - 168-169 ST - A Case Study of Cutaneous Mastocytoma in a 9-Month-Old Infant T2 - Journal of the Dermatology Nurses' Association TI - A Case Study of Cutaneous Mastocytoma in a 9-Month-Old Infant UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144727786&site=ehost-live&scope=site VL - 12 ID - 2908 ER - TY - JOUR AD - Mental Health and Behavioral Sciences, James A. Haley Veterans' Hospital, Tampa, FL, USA. AN - 104242885. Language: English. Entry Date: 20130927. Revision Date: 20200708. Publication Type: journal article AU - Phillips, Kristin M. AU - Pinilla-Ibarz, Javier AU - Sotomayor, Eduardo AU - Lee, Morgan R. AU - Jim, Heather S. L. AU - Small, Brent J. AU - Sokol, Lubomir AU - Lancet, Jeffrey AU - Tinsley, Sara AU - Sweet, Kendra AU - Komrokji, Rami AU - Jacobsen, Paul B. DB - ccm DO - 10.1007/s00520-012-1630-5 DP - EBSCOhost IS - 4 N1 - research. Journal Subset: Biomedical; Continental Europe; Double Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. Special Interest: Oncologic Care. NLM UID: 9302957. PMID: NLM23179489. PY - 2013 SN - 0941-4355 SP - 1097-1103 ST - Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison T2 - Supportive Care in Cancer TI - Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104242885&site=ehost-live&scope=site VL - 21 ID - 2909 ER - TY - JOUR AD - Division of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Sapienza University, Via Benevento 6, 00161, Rome, Italy Department of Statistical Sciences, Policlinico Umberto I, Sapienza University, Rome, Italy AN - 131216731. Language: English. Entry Date: 20180827. Revision Date: 20191001. Publication Type: journal article AU - Molica, Matteo AU - Scalzulli, Emilia AU - Colafigli, Gioia AU - Massaro, Fulvio AU - Latagliata, Roberto AU - Foà, Robin AU - Breccia, Massimo AU - Fegatelli, Danilo Alunni DB - ccm DO - 10.1007/s00277-018-3375-9 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe. NLM UID: 9107334. PMID: NLM29806063. PY - 2018 SN - 0939-5555 SP - 1803-1808 ST - Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events T2 - Annals of Hematology TI - Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=131216731&site=ehost-live&scope=site VL - 97 ID - 2910 ER - TY - JOUR AD - Pharmacy Department, University Hospital Hematological Malignancies Registry, Burgundy University Hematology Department, University Hospital AN - 109815057. Language: English. Entry Date: 20150728. Revision Date: 20200708. Publication Type: Journal Article AU - Lang, A. S. AU - Mounier, M. AU - Roques, M. AU - Chretien, M. L. AU - Boulin, M. DB - ccm DO - 10.1111/jcpt.12273 DP - EBSCOhost IS - 4 N1 - research; tables/charts. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. NLM UID: 8704308. PMID: NLM25865674. PY - 2015 SN - 0269-4727 SP - 391-397 ST - A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years T2 - Journal of Clinical Pharmacy & Therapeutics TI - A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109815057&site=ehost-live&scope=site VL - 40 ID - 2911 ER - TY - JOUR AD - Department of Hematology and Cellular Therapy Unit, Hôpital Emile Muller, Mulhouse, France Centre de Competences on Thrombotic Microangiopathies, Region Alsace, France Laboratory of Hematology, Hôpital Emile Muller, Mulhouse, France Central Pharmacy, Hôpital Emile Muller, Mulhouse, France Department of Internal Medicine, Hôpital Emile Muller, Mulhouse, France Department of Cardiology, Hôpital Emile Muller, Mulhouse, France Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Antoine Béclère, Université Paris, Clamart, France Department of Nephrology, Hôpital Emile Muller, Mulhouse, France AN - 115469173. Language: English. Entry Date: 20161207. Revision Date: 20190712. Publication Type: Article AU - Ojeda-Uribe, Mario AU - Merieau, Sylvain AU - Guillon, Marie AU - Aujoulat, Olivier AU - Hinschberger, Olivier AU - Eisenmann, Jean-Claude AU - Kenizou, David AU - Debliquis, Agathe AU - Veyradier, Agnès AU - Chantrel, François DB - ccm DO - 10.1177/1078155214568580 DP - EBSCOhost IS - 2 N1 - case study; research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9511372. PY - 2016 SN - 1078-1552 SP - 361-370 ST - Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate T2 - Journal of Oncology Pharmacy Practice TI - Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=115469173&site=ehost-live&scope=site VL - 22 ID - 2912 ER - TY - JOUR AN - 104974399. Language: English. Entry Date: 20110218. Revision Date: 20200708. Publication Type: Journal Article AU - MacDonald, Tamara DB - ccm DO - 10.3821/1913-701X-143.5.240 DP - EBSCOhost IS - 5 N1 - pictorial. Journal Subset: Biomedical; Canada; Peer Reviewed. NLM UID: 101257110. PY - 2010 SN - 1715-1635 SP - 240-247 ST - Pediatric cancer: a comprehensive review. Part II: chemotherapy, monoclonal antibodies and tyrosine kinase inhibitors T2 - Canadian Pharmacists Journal TI - Pediatric cancer: a comprehensive review. Part II: chemotherapy, monoclonal antibodies and tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104974399&site=ehost-live&scope=site VL - 143 ID - 2913 ER - TY - JOUR AD - Department of Hematology, Juntendo University School of Medicine, 3-1-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan AN - 132112503. Language: English. Entry Date: 20181011. Revision Date: 20191101. Publication Type: Article AU - Fujioka, Isao AU - Takaku, Tomoiku AU - Iriyama, Noriyoshi AU - Tokuhira, Michihide AU - Kimura, Yuta AU - Sato, Eriko AU - Ishikawa, Maho AU - Nakazato, Tomonori AU - Sugimoto, Kei-Ji AU - Fujita, Hiroyuki AU - Asou, Norio AU - Kizaki, Masahiro AU - Hatta, Yoshihiro AU - Komatsu, Norio AU - Kawaguchi, Tatsuya DB - ccm DO - 10.1007/s00277-018-3412-8 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Framingham Risk Score. NLM UID: 9107334. PMID: NLM29946911. PY - 2018 SN - 0939-5555 SP - 2081-2088 ST - Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database T2 - Annals of Hematology TI - Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132112503&site=ehost-live&scope=site VL - 97 ID - 2916 ER - TY - JOUR AD - Sun Yat‐sen University Cancer Center, Guangzhou, China Fudan University Shanghai Cancer Center, Shanghai, China China Development Unit, AstraZeneca, Zhangjiang Hi‐Tech Park, Shanghai, China AstraZeneca, Macclesfield, United Kingdom AN - 128708760. Language: English. Entry Date: 20180412. Revision Date: 20201026. Publication Type: Article AU - Zhao, Hongyun AU - Cao, Junning AU - Chang, Jianhua AU - Zhang, Zhenxian AU - Yang, Li AU - Wang, Jia AU - Cantarini, Mireille AU - Zhang, Li DB - ccm DO - 10.1002/jcph.1042 DP - EBSCOhost IS - 4 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 0366372. PY - 2018 SN - 0091-2700 SP - 504-513 ST - Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study T2 - Journal of Clinical Pharmacology TI - Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128708760&site=ehost-live&scope=site VL - 58 ID - 2917 ER - TY - JOUR AD - Department of Genetics, Portuguese Oncology Institute, Porto, Portugal Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal AN - 133518468. Language: English. Entry Date: In Process. Revision Date: 20190403. Publication Type: journal article. Journal Subset: Biomedical AU - Cerveira, Nuno AU - Loureiro, Bruno AU - Bizarro, Susana AU - Correia, Cecília AU - Torres, Lurdes AU - Lisboa, Susana AU - Vieira, Joana AU - Santos, Rui AU - Pereira, Dulcineia AU - Moreira, Cláudia AU - Chacim, Sérgio AU - Domingues, Nélson AU - Espírito-Santo, Ana AU - Oliveira, Isabel AU - Moreira, Ilídia AU - Viterbo, Luísa AU - Martins, Ângelo AU - Teixeira, Manuel R. AU - Mariz, José M. DB - ccm DO - 10.1186/s12885-018-5167-y DP - EBSCOhost IS - 1 N1 - Europe; UK & Ireland. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 100967800. PMID: NLM30541488. PY - 2018 SN - 1471-2407 SP - 1-10 ST - Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution T2 - BMC Cancer TI - Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133518468&site=ehost-live&scope=site VL - 18 ID - 2918 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California AN - 128331326. Language: English. Entry Date: 20190825. Revision Date: 20190830. Publication Type: journal article. Journal Subset: Biomedical AU - Sasaki, Koji AU - Kantarjian, Hagop AU - O'Brien, Susan AU - Ravandi, Farhad AU - Konopleva, Marina AU - Borthakur, Gautam AU - Garcia‐Manero, Guillermo AU - Wierda, William AU - Daver, Naval AU - Ferrajoli, Alessandra AU - Takahashi, Koichi AU - Jain, Preetesh AU - Rios, Mary Beth AU - Pierce, Sherry AU - Jabbour, Elias AU - Cortes, Jorge E. AU - O'Brien, Susan AU - Garcia-Manero, Guillermo DB - ccm DO - 10.1002/cncr.31187 DP - EBSCOhost IS - 6 N1 - Peer Reviewed; USA. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM29266206. PY - 2018 SN - 0008-543X SP - 1160-1168 ST - Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase T2 - Cancer (0008543X) TI - Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128331326&site=ehost-live&scope=site VL - 124 ID - 2920 ER - TY - JOUR AD - Eisai Co, Ltd, Tokyo, Japan Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Hepatology, Toranomon Hospital, Tokyo, Japan AN - 124659195. Language: English. Entry Date: 20170825. Revision Date: 20191111. Publication Type: Article AU - Tamai, Toshiyuki AU - Hayato, Seiichi AU - Hojo, Seiichiro AU - Suzuki, Takuya AU - Okusaka, Takuji AU - Ikeda, Kenji AU - Kumada, Hiromitsu DB - ccm DO - 10.1002/jcph.917 DP - EBSCOhost IS - 9 N1 - equations & formulas; research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: This study was funded by Eisai, Inc.. NLM UID: 0366372. PY - 2017 SN - 0091-2700 SP - 1138-1147 ST - Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses T2 - Journal of Clinical Pharmacology TI - Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124659195&site=ehost-live&scope=site VL - 57 ID - 2922 ER - TY - JOUR AD - Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK; Unit of Bone and Soft Tissue Oncology, Tel-Aviv Sourasky Medical Center and Tel-Aviv University Sackler School of Medicine, Tel-Aviv, Israel; Divisione Oncologia Medica, Candiolo Cancer Institute – FPO I.R.C.C.S., Candiolo, Italy; Hadassah-Hebrew University Medical Center, Jerusalem, Israel; United BioSource (Germany) GmbH, Loerrach, Germany; United BioSource Corporation, Quebec, Canada; bluebird bio, London, UK; Bristol-Myers Squibb, Uxbridge, UK; Novartis Oncology, East Hanover, NJ, USA; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy AN - 126327981. Language: English. Entry Date: 20171128. Revision Date: 20201026. Publication Type: Article AU - Gelderblom, Hans AU - Judson, Ian R. AU - Benson, Charlotte AU - Merimsky, Ofer AU - Grignani, Giovanni AU - Katz, Daniela AU - Freivogel, Klaus W. AU - Stein, Dara AU - Jobanputra, Minesh AU - Mungul, Arron AU - Manson, Stephanie C. AU - Sanfilippo, Roberta DB - ccm DO - 10.1080/0284186X.2017.1332779 DP - EBSCOhost IS - 12 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. NLM UID: 8709065. PY - 2017 SN - 0284-186X SP - 1769-1775 ST - Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study T2 - Acta Oncologica TI - Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126327981&site=ehost-live&scope=site VL - 56 ID - 2923 ER - TY - JOUR AD - Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX AN - 137747932. Language: English. Entry Date: 20200808. Revision Date: 20200810. Publication Type: journal article AU - Paul, Shilpa AU - Rausch, Caitlin R. AU - Welch, Mary Alma AU - Kantarjian, Hagop M. AU - Jabbour, Elias J. DB - ccm DO - 10.1016/j.clml.2019.06.011 DP - EBSCOhost IS - 8 N1 - review. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM31307896. PY - 2019 SN - 2152-2650 SP - 471-479 ST - SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia T2 - Clinical Lymphoma, Myeloma & Leukemia TI - SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137747932&site=ehost-live&scope=site VL - 19 ID - 2924 ER - TY - JOUR AD - Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada Duke-NUS Medical School, Singapore General Hospital, Singapore Brabois Hospital, Vandoeuvre-lès-Nancy, France Institute of Hematology, University of Bologna, Bologna, Italy North Shore Hospital, Westlake, Auckland, New Zealand Department of Oncology, Jewish General Hospital, McGill University, Montréal, QC, Canada Département d'Hématologie, Institut Bergonié, Bordeaux, France Haematology Department, Centre Hospitalier Lyon Sud, Pierre Bénite, France Department of Hematology, Oncology and Tumor Immunology, Charité–Universitätsmedizin Berlin, Berlin, Germany Department of Haematology, Royal Liverpool University Hospital, Liverpool, Merseyside, UK Department of Oncology–Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden Rocky Mountain Cancer Centers, Boulder, CO, USA Fred Hutchinson Cancer Research Center, Seattle, WA, USA ARIAD Pharmaceuticals, Inc, Cambridge, MA, USA Department of Hematology and Oncology, University of Bologna, Bologna, Italy The University of Texas MD Anderson Cancer Center, Houston, TX, USA INSERM Clinical Investigation Center 1402, Centre Hospitalier et Universitaire de Poitiers, Poitiers, France AN - 114878963. Corporate Author: EPIC investigators. Language: English. Entry Date: 20180304. Revision Date: 20190516. Publication Type: journal article AU - Lipton, Jeffrey H. AU - Chuah, Charles AU - Guerci-Bresler, Agnès AU - Rosti, Gianantonio AU - Simpson, David AU - Assouline, Sarit AU - Etienne, Gabriel AU - Nicolini, Franck E. AU - le Coutre, Philipp AU - Clark, Richard E. AU - Stenke, Leif AU - Andorsky, David AU - Oehler, Vivian AU - Lustgarten, Stephanie AU - Rivera, Victor M. AU - Clackson, Timothy AU - Haluska, Frank G. AU - Baccarani, Michele AU - Cortes, Jorge E. AU - Guilhot, François DB - ccm DO - 10.1016/S1470-2045(16)00080-2 DP - EBSCOhost IS - 5 N1 - research; randomized controlled trial. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Special Interest: Evidence-Based Practice. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 100957246. PMID: NLM27083332. PY - 2016 SN - 1470-2045 SP - 612-621 ST - Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial T2 - Lancet Oncology TI - Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114878963&site=ehost-live&scope=site VL - 17 ID - 2925 ER - TY - JOUR AD - Research Laboratory of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands AN - 124419921. Language: English. Entry Date: 20170809. Revision Date: 20170809. Publication Type: Article AU - Boer, Judith M. AU - den Boer, Monique L. DB - ccm DO - 10.1016/j.ejca.2017.06.012 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9005373. PY - 2017 SN - 0959-8049 SP - 203-218 ST - BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside T2 - European Journal of Cancer TI - BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124419921&site=ehost-live&scope=site VL - 82 ID - 2927 ER - TY - JOUR AD - Department of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi, Japan Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya Japan Department of Pediatrics, Iwate Prefectural Chubu Hospital, Iwate, Japan Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan Department of Pediatrics, Keio University School of Medicine, Tokyo Japan Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya Japan Department of Pediatrics, Soma General Hospital, Fukushima, Japan Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo Japan Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital, Hiroshima Japan Department of Pediatrics, Japan Community Healthcare Organization Tokuyama Central Hospital, Tokuyama Japan Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki Japan Department of Pediatrics, St. Luke's International Hospital, Tokyo Japan Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo Japan Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan AN - 132481169. Language: English. Entry Date: 20190519. Revision Date: 20201026. Publication Type: journal article AU - Kurosawa, Hidemitsu AU - Tanizawa, Akihiko AU - Muramatsu, Hideki AU - Tono, Chikako AU - Watanabe, Akihiro AU - Shima, Haruko AU - Ito, Masaki AU - Yuza, Yuki AU - Hamamoto, Kazuko AU - Hotta, Noriko AU - Okada, Masahiko AU - Saito, Akiko Moriya AU - Manabe, Atsushi AU - Mizutani, Shuki AU - Adachi, Souichi AU - Horibe, Keizo AU - Ishii, Eiichi AU - Shimada, Hiroyuki DB - ccm DO - 10.1002/pbc.27368 DP - EBSCOhost IS - 12 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 101186624. PMID: NLM30084127. PY - 2018 SN - 1545-5009 SP - N.PAG-N.PAG ST - Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group T2 - Pediatric Blood & Cancer TI - Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132481169&site=ehost-live&scope=site VL - 65 ID - 2928 ER - TY - JOUR AD - Division of Oral Medicine, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Department of Biostatistics and Computational Biology, 450 Brookline Avenue, Dana-Farber Cancer Institute, Boston, MA 02215, USA Department of Medical Oncology, Rhode Island Hospital Comprehensive Cancer Center, 1454 South County Trail, Suite 2100, East Greenwich, RI 02818, USA Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA AN - 110512235. Language: English. Entry Date: 20161120. Revision Date: 20180718. Publication Type: journal article AU - Yuan, Anna AU - Kurtz, Sharyn L. AU - Barysauskas, Constance M. AU - Pilotte, Amy P. AU - Wagner, Andrew J. AU - Treister, Nathaniel S. DB - ccm DO - 10.1016/j.oraloncology.2015.09.003 DP - EBSCOhost IS - 11 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9709118. PMID: NLM26403941. PY - 2015 SN - 1368-8375 SP - 1026-1033 ST - Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors T2 - Oral Oncology TI - Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110512235&site=ehost-live&scope=site VL - 51 ID - 2929 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston USA Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Houston 77030 USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston USA Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert USA Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston USA Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 455, Houston, TX, 77030, USA AN - 116396807. Language: English. Entry Date: 20170614. Revision Date: 20190513. Publication Type: journal article AU - Bilen, Mehmet AU - Patel, Amy AU - Hess, Kenneth AU - Munoz, Javier AU - Busaidy, Naifa AU - Wheler, Jennifer AU - Janku, Filip AU - Falchook, Gerald AU - Hong, David AU - Meric-Bernstam, Funda AU - Habra, Mouhammed AU - Naing, Aung AU - Bilen, Mehmet Asim AU - Hess, Kenneth R. AU - Busaidy, Naifa L. AU - Wheler, Jennifer J. AU - Falchook, Gerald S. AU - Hong, David S. AU - Habra, Mouhammed Amir DB - ccm DO - 10.1007/s00280-016-3073-z DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 7806519. PMID: NLM27286994. PY - 2016 SN - 0344-5704 SP - 167-171 ST - Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials T2 - Cancer Chemotherapy & Pharmacology TI - Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116396807&site=ehost-live&scope=site VL - 78 ID - 2930 ER - TY - JOUR AD - Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul Korea Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-gu, Seoul, 05505, Korea AN - 117066168. Language: English. Entry Date: 20180723. Revision Date: 20180725. Publication Type: journal article AU - Kim, Jwa AU - Park, Inkeun AU - Lee, Jae AU - Kim, Jwa Hoon AU - Lee, Jae Lyun DB - ccm DO - 10.1007/s00280-016-3093-8 DP - EBSCOhost IS - 2 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. NLM UID: 7806519. PMID: NLM27324136. PY - 2016 SN - 0344-5704 SP - 325-332 ST - Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features T2 - Cancer Chemotherapy & Pharmacology TI - Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=117066168&site=ehost-live&scope=site VL - 78 ID - 2931 ER - TY - JOUR AD - Department of Pediatric Oncology, Léon Bérard Cancer Center, 28, rue Laennec, 69008 Lyon, France Université Claude Bernard Lyon 1, Lyon, France Hôpital Mère-enfant, 7 quai Moncousu, Nantes, France CHU Hautepierre, 1 avenue Molière, Strasbourg, France Institut Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, France Centre Oscar Lambret, 3 rue Frédéric Combemale, Lille, France Institut Curie, 26 rue d'Ulm, Paris, France Centre Jean Perrin, 58 Rue Montalembert, Clermont-Ferrand, France CHU La Timone, 264 rue Saint-Pierre, Marseille, France Centre Antoine Lacassagne, 33 Avenue Valombrose, Nice, France CHU Jean Minjoz, 2 Bd Fleming, Besançon, France CHU Bretonneau, 2 Bd Tonnellé, Tours, France CHU Raymond Poincaré, 104 Bd Raymond Poincaré, Garches, France AN - 110830257. Language: English. Entry Date: 20180801. Revision Date: 20201026. Publication Type: journal article AU - Penel-Page, Mathilde AU - Ray-Coquard, Isabelle AU - Larcade, Julie AU - Girodet, Magali AU - Bouclier, Laure AU - Rogasik, Muriel AU - Corradini, Nadège AU - Entz-Werle, Natacha AU - Brugieres, Laurence AU - Domont, Julien AU - Lervat, Cyril AU - Piperno-Neumann, Sophie AU - Pacquement, Helène AU - Bay, Jacques-Olivier AU - Gentet, Jean-Claude AU - Thyss, Antoine AU - Chaigneau, Loic AU - Narciso, Bérangère AU - Cornille, Helène AU - Blay, Jean-Yves DB - ccm DO - 10.1186/s12885-015-1894-5 DP - EBSCOhost N1 - research; tables/charts. Journal Subset: Biomedical; Europe; UK & Ireland. NLM UID: 100967800. PMID: NLM26541413. PY - 2015 SN - 1471-2407 SP - 1-9 ST - Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes) T2 - BMC Cancer TI - Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110830257&site=ehost-live&scope=site VL - 15 ID - 2932 ER - TY - JOUR AD - Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, People's Republic of China Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510220, Guangzhou, People's Republic of China OrigiMed, Inc, NO.115 XinJunhuan Road, 201114, Shanghai, People's Republic of China AN - 137026094. Language: English. Entry Date: In Process. Revision Date: 20191220. Publication Type: journal article. Journal Subset: Biomedical AU - Fang, Wenfeng AU - Huang, Yihua AU - Hong, Shaodong AU - Zhang, Zhonghan AU - Wang, Minghui AU - Gan, Jiadi AU - Wang, Wenjing AU - Guo, Honglin AU - Wang, Kai AU - Zhang, Li DB - ccm DO - 10.1186/s12885-019-5820-0 DP - EBSCOhost IS - 1 N1 - Europe; UK & Ireland. Instrumentation: Piper Fatigue Scale (PFS); Defining Issues Test (DIT) (Rest). Grant Information: 81602005//National Natural Science Foundation of China/. NLM UID: 100967800. PMID: NLM31208370. PY - 2019 SN - 1471-2407 SP - N.PAG-N.PAG ST - EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer T2 - BMC Cancer TI - EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137026094&site=ehost-live&scope=site VL - 19 ID - 2933 ER - TY - JOUR AD - Kaposi Mór Teaching Hospital, Kaposvár, Hungary Tawam Hospital, AlAin-United Arab Emirates Pécs University, Faculty of General Medicine, Department of Pathology, Pécs-Hungary AN - 111644894. Language: English. Entry Date: 20160928. Revision Date: 20180925. Publication Type: journal article AU - Alizadeh, Hussain AU - Jaafar, Hassan AU - Kajtár, Béla DB - ccm DO - 10.5144/0256-4947.2015.468 DP - EBSCOhost IS - 6 N1 - case study. Journal Subset: Biomedical; Middle East; Peer Reviewed. NLM UID: 8507355. PMID: NLM26657232. PY - 2015 SN - 0256-4947 SP - 468-471 ST - Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports T2 - Annals of Saudi Medicine TI - Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111644894&site=ehost-live&scope=site VL - 35 ID - 2934 ER - TY - JOUR AD - Departments of Nuclear Medicine and Endocrine Oncology (L.L., S.I., A.B., M.T., D.D., M.S., E.B., S.L.), Radiology (M.D., F.B.), Biostatistics and Epidemiology (I.B.), Medical Biology and Pathology (A.A.G.), Surgery (D.H.), and Department of Radiotherapy (P.B.), Gustave Roussy and University Paris Saclay, 94805 Villejuif, France AN - 116654071. Language: English. Entry Date: 20170708. Revision Date: 20191111. Publication Type: journal article AU - Lamartina, Livia AU - Ippolito, S. AU - Danis, M. AU - Bidault, F. AU - Borget, I. AU - Berdelou, A. AU - Al Ghuzlan, A. AU - Hartl, D. AU - Blanchard, P. AU - Terroir, M. AU - Deandreis, D. AU - Schlumberger, M. AU - Baudin, E. AU - Leboulleux, S. DB - ccm DO - 10.1210/jc.2015-4391 DP - EBSCOhost IS - 7 N1 - research. Journal Subset: Biomedical; USA. NLM UID: 0375362. PMID: NLM27082933. PY - 2016 SN - 0021-972X SP - 2733-2741 ST - Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer T2 - Journal of Clinical Endocrinology & Metabolism TI - Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116654071&site=ehost-live&scope=site VL - 101 ID - 2935 ER - TY - JOUR AD - Kaiser Permanente Research, Department of Research and Evaluation, 100 S Los Robles, 2nd Floor, Pasadena, CA, 91101 AN - 125074375. Language: English. Entry Date: 20180302. Revision Date: 20190516. Publication Type: journal article AU - Haque, Reina AU - Jiaxiao, Shi AU - Joanie, Chung AU - Xiaoqing, Xu AU - Avila, Chantal AU - Campbell, Christopher AU - Ahmed, Syed A. AU - Lei, Chen AU - Schottinger, Joanne E. AU - Shi, Jiaxiao AU - Chung, Joanie AU - Xu, Xiaoqing AU - Chen, Lei DB - ccm DO - 10.1016/j.japh.2017.01.004 DP - EBSCOhost IS - 3 N1 - research. Supplement Title: May2017:Supplement. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 101176252. PMID: NLM28259737. PY - 2017 SN - 1544-3191 SP - 303-310.e2 ST - Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO T2 - Journal of the American Pharmacists Association: JAPhA TI - Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125074375&site=ehost-live&scope=site VL - 57 ID - 2936 ER - TY - JOUR AD - a Novosys Health , Green Brook , NJ , USA b Bristol-Myers Squibb , Princeton , NJ , USA AN - 121816418. Language: English. Entry Date: 20180730. Revision Date: 20191107. Publication Type: journal article AU - Lin, Jay AU - Makenbaeva, Dinara AU - Lingohr-Smith, Melissa AU - Bilmes, Robyn DB - ccm DO - 10.1080/13696998.2017.1302947 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Health Services Administration; USA. NLM UID: 9892255. PMID: NLM28287043. PY - 2017 SN - 1369-6998 SP - 1-5 ST - Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors T2 - Journal of Medical Economics TI - Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121816418&site=ehost-live&scope=site ID - 2937 ER - TY - JOUR AD - Murdoch Children's Research Institute, Royal Children's Hospital, Parkville Australia Department of Paediatrics, University of Melbourne, Parkville Australia School of BioSciences, University of Melbourne, Parkville Australia Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville Australia Children's Cancer Centre, Royal Children's Hospital, Parkville Australia Walter and Eliza Hall Institute, Parkville Australia Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville Australia Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia Department of Paediatrics, University of Melbourne, Parkville, Australia Children's Cancer Centre, Royal Children's Hospital, Parkville, Australia AN - 138225095. Language: English. Entry Date: 20200131. Revision Date: 20200930. Publication Type: journal article AU - Brown, Lauren M. AU - Bartolo, Ray C. AU - Davidson, Nadia M. AU - Schmidt, Breon AU - Brooks, Ian AU - Challis, Jackie AU - Petrovic, Vida AU - Khuong‐Quang, Dong‐Anh AU - Mechinaud, Francoise AU - Khaw, Seong L. AU - Majewski, Ian J. AU - Oshlack, Alicia AU - Ekert, Paul G. AU - Khuong-Quang, Dong-Anh DB - ccm DO - 10.1002/pbc.27897 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: //Felton Bequest/. NLM UID: 101186624. PMID: NLM31250523. PY - 2019 SN - 1545-5009 SP - N.PAG-N.PAG ST - Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia T2 - Pediatric Blood & Cancer TI - Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138225095&site=ehost-live&scope=site VL - 66 ID - 2938 ER - TY - JOUR AN - 134090981. Language: English. Entry Date: 20190116. Revision Date: 20190220. Publication Type: Article DB - ccm DO - 10.4103/ijd.IJD_514_16 DP - EBSCOhost IS - 1 N1 - case study; pictorial. Journal Subset: Asia; Biomedical; Double Blind Peer Reviewed; Peer Reviewed. NLM UID: 0370750. PY - 2019 SN - 0019-5154 SP - 83-84 ST - Cutaneous abscess: An isolated manifestation of disseminated anaplastic large-cell lymphoma in a child T2 - Indian Journal of Dermatology TI - Cutaneous abscess: An isolated manifestation of disseminated anaplastic large-cell lymphoma in a child UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134090981&site=ehost-live&scope=site VL - 64 ID - 2940 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto Japan AN - 124587041. Language: English. Entry Date: 20170822. Revision Date: 20190513. Publication Type: Article AU - Umeda, Katsutsugu AU - Kato, Itaru AU - Saida, Satoshi AU - Okamoto, Takeshi AU - Adachi, Souchi DB - ccm DO - 10.1111/ped.13307 DP - EBSCOhost IS - 8 N1 - case study; diagnostic images; tables/charts. Journal Subset: Asia; Biomedical; Peer Reviewed. NLM UID: 100886002. PY - 2017 SN - 1328-8067 SP - 937-938 ST - Pazopanib for second recurrence of osteosarcoma in pediatric patients T2 - Pediatrics International TI - Pazopanib for second recurrence of osteosarcoma in pediatric patients UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124587041&site=ehost-live&scope=site VL - 59 ID - 2942 ER - TY - JOUR AD - Department of Internal Medicine , Seoul National University Bundang Hospital , Gumi-ro 173 Beon-gil, Bundang-gu Seongnam-Si 13620 Korea Department of Internal Medicine , Inje University Haeundae Paik Hospital , Busan Korea Department of Internal Medicine, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-Si, Gyeonggi-di, 13620, Korea Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea AN - 124090090. Language: English. Entry Date: 20171007. Revision Date: 20180801. Publication Type: journal article. Journal Subset: Biomedical AU - Suh, Koung AU - Lee, Ji AU - Shin, Dong-Yeop AU - Koh, Youngil AU - Bang, Soo-Mee AU - Yoon, Sung-Soo AU - Park, Seonyang AU - Kim, Inho AU - Lee, Jeong-Ok AU - Suh, Koung Jin AU - Lee, Ji Yun DB - ccm DO - 10.1007/s12185-017-2225-1 DP - EBSCOhost IS - 2 N1 - Continental Europe; Europe. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 9111627. PMID: NLM28378056. PY - 2017 SN - 0925-5710 SP - 229-239 ST - Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials T2 - International Journal of Hematology TI - Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124090090&site=ehost-live&scope=site VL - 106 ID - 2944 ER - TY - JOUR AD - Oncology Research, The Children's Hospital of Philadelphia, CTRB Rm. 3018, 3501 Civic Center Blvd., Philadelphia, PA, 19104-4302, USA. AN - 103874181. Language: English. Entry Date: 20150320. Revision Date: 20200708. Publication Type: journal article AU - Croucher, Jamie L. AU - Iyer, Radhika AU - Li, Nanxin AU - Molteni, Valentina AU - Loren, Jon AU - Gordon, W. Perry AU - Tuntland, Tove AU - Liu, Bo AU - Brodeur, Garrett M. DB - ccm DO - 10.1007/s00280-014-2627-1 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Special Interest: Oncologic Care. Grant Information: CA-094194/CA/NCI NIH HHS/United States. NLM UID: 7806519. PMID: NLM25394774. PY - 2015 SN - 0344-5704 SP - 131-141 ST - TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts T2 - Cancer Chemotherapy & Pharmacology TI - TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103874181&site=ehost-live&scope=site VL - 75 ID - 2949 ER - TY - JOUR AD - Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina Servicio de Hematología, Hospital Ramos Mejía, Buenos Aires, Argentina Departamento de Hemato-oncología, Academia Nacional de Medicina, Buenos Aires, Argentina FUNDALEU, Buenos Aires, Argentina AN - 119380087. Language: English. Entry Date: 20170614. Revision Date: 20180521. Publication Type: journal article AU - Weich, Natalia AU - Ferri, Cristian AU - Moiraghi, Beatriz AU - Bengió, Raquel AU - Giere, Isabel AU - Pavlovsky, Carolina AU - Larripa, Irene B. AU - Fundia, Ariela F. DB - ccm DO - 10.1016/j.canep.2016.07.008 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Public Health; USA. NLM UID: 101508793. PMID: NLM27454607. PY - 2016 SN - 1877-7821 SP - 16-21 ST - GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response T2 - Cancer Epidemiology TI - GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=119380087&site=ehost-live&scope=site ID - 2950 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 103942432. Language: English. Entry Date: 20140627. Revision Date: 20200708. Publication Type: journal article AU - Jeha, Sima AU - Coustan-Smith, Elaine AU - Pei, Deqing AU - Sandlund, John T. AU - Rubnitz, Jeffrey E. AU - Howard, Scott C. AU - Inaba, Hiroto AU - Bhojwani, Deepa AU - Metzger, Monika L. AU - Cheng, Cheng AU - Choi, John K. AU - Jacobsen, Jeffrey AU - Shurtleff, Sheila A. AU - Raimondi, Susana AU - Ribeiro, Raul C. AU - Pui, Ching-Hon AU - Campana, Dario DB - ccm DO - 10.1002/cncr.28598 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P30 CA-21,765/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM24501014. PY - 2014 SN - 0008-543X SP - 1514-1519 ST - Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Cancer (0008543X) TI - Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103942432&site=ehost-live&scope=site VL - 120 ID - 2951 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria Kiel Pediatric Tumor Registry, Department of Pediatric Pathology, University of Schleswig-Holstein, Campus Kiel, Germany Department of Pathology, University of Bonn Medical School, Germany Department of Pediatric Hematology/Oncology, Dr. von Haunersches Kinderspital, Ludwig Maximilians University Munich, Germany Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Germany Department of Pediatrics, Children’s Hospital Linz, Austria St. Anna Children’s Hospital, Vienna, Austria Department of Pediatric Hematology and Oncology, Saarland University, Homburg/Saar, Germany Department of Pediatrics and Adolescent Medicine, Municipal Clinics Dortmund, Germany Department of Pediatric Hematology/Oncology/Endocrinology, Children’s Hospital, University of Essen, Germany Institute of Pathology, Medical University of Vienna, Austria Department of Internal Medicine III – Hematology/Oncology, University Hospital Munich-Campus, Grosshadern, Munich, Germany Institute for Medical Statistics, Medical University of Graz, Austria Division of Pediatric Hematology and Oncology, Department of Pediatrics, J.W. Goethe University Children’s Hospital of Frankfurt, Germany Olgahospital, Klinikum Stuttgart, Pediatrics 5 (Oncology), Stuttgart, Germany AN - 104655101. Language: English. Entry Date: 20110810. Revision Date: 20150711. Publication Type: Journal Article AU - Benesch, Martin AU - Leuschner, Ivo AU - Wardelmann, Eva AU - Thielen, Mareike AU - Schmid, Irene AU - Kontny, Udo AU - Ebetsberger, Georg AU - Frey, Eva AU - Graf, Norbert AU - Schneider, Dominik T. AU - Kremens, Bernhard AU - Amann, Gabriele AU - Urban, Christian AU - Schlemmer, Marcus AU - Quehenberger, Franz AU - Klingebiel, Thomas AU - Dantonello, Tobias AU - Koscielniak, Ewa DB - ccm DO - 10.1016/j.ejca.2011.03.014 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 9005373. PMID: NLM21486690. PY - 2011 SN - 0959-8049 SP - 1692-1698 ST - Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS) T2 - European Journal of Cancer TI - Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104655101&site=ehost-live&scope=site VL - 47 ID - 2952 ER - TY - JOUR AD - St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom Hôpital Robert Debré and University of Paris Diderot, Paris, France Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, University Hospital Rigshospitalet, Copenhagen, Denmark Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany Nagoya Medical Center, Clinical Research Center, Nagoya, Japan Universiteit Gent, Gent, Belgium Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, Singapore Viva-University Children's Cancer Centre, National University Hospital, Singapore Mackay Memorial Hospital, Taipei, Taiwan AN - 109393729. Language: English. Entry Date: 20151217. Revision Date: 20161223. Publication Type: journal article AU - Ching-Hon, Pui AU - Yang, Jun J. AU - Hunger, Stephen P. AU - Pieters, Rob AU - Schrappe, Martin AU - Biondi, Andrea AU - Vora, Ajay AU - Baruchel, André AU - Silverman, Lewis B. AU - Schmiegelow, Kjeld AU - Escherich, Gabriele AU - Keizo, Horibe AU - Benoit, Yves C. M. AU - Izraeli, Shai AU - Yeoh, Allen Eng Juh AU - Der-Cherng, Liang AU - Downing, James R. AU - Evans, William E. AU - Relling, Mary V. AU - Mullighan, Charles G. DB - ccm DO - 10.1200/JCO.2014.59.1636 DP - EBSCOhost IS - 27 N1 - review; tables/charts. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Grant Information: R01 CA036401/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM26304874. PY - 2015 SN - 0732-183X SP - 2938-2948 ST - Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration T2 - Journal of Clinical Oncology TI - Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109393729&site=ehost-live&scope=site VL - 33 ID - 2954 ER - TY - JOUR AD - Department of Hematology and Oncology, Baylor College of Medicine, Houston Texas Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston Texas AN - 110427909. Language: English. Entry Date: 20160214. Revision Date: 20180809. Publication Type: journal article AU - Yilmaz, Musa AU - Lahoti, Amit AU - O'Brien, Susan AU - Nogueras‐González, Graciela M. AU - Burger, Jan AU - Ferrajoli, Alessandra AU - Borthakur, Gautam AU - Ravandi, Farhad AU - Pierce, Sherry AU - Jabbour, Elias AU - Kantarjian, Hagop AU - Cortes, Jorge E. DB - ccm DO - 10.1002/cncr.29587 DP - EBSCOhost IS - 21 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM26217876. PY - 2015 SN - 0008-543X SP - 3894-3904 ST - Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors T2 - Cancer (0008543X) TI - Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110427909&site=ehost-live&scope=site VL - 121 ID - 2955 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan Takamatsu Red Cross Hospital, Takamatsu 760-0017, Japan Ehime Prefectural Central Hospital, Ehime 790-0024, Japan Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GE, UK AN - 137798480. Language: English. Entry Date: 20190802. Revision Date: 20190802. Publication Type: Article AU - Ueshima, Kazuomi AU - Nishida, Naoshi AU - Hagiwara, Satoru AU - Aoki, Tomoko AU - Minami, Tomohiro AU - Chishina, Hirokazu AU - Takita, Masahiro AU - Minami, Yasunori AU - Ida, Hiroshi AU - Takenaka, Mamoru AU - Sakurai, Toshiharu AU - Watanabe, Tomohiro AU - Morita, Masahiro AU - Ogawa, Chikara AU - Hiraoka, Atsushi AU - Johnson, Philip AU - Kudo, Masatoshi DB - ccm DO - 10.3390/cancers11070952 DP - EBSCOhost IS - 7 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Child-Pugh Score. NLM UID: 101526829. PY - 2019 SN - 2072-6694 SP - 952-952 ST - Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study T2 - Cancers TI - Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137798480&site=ehost-live&scope=site VL - 11 ID - 2956 ER - TY - JOUR AD - Department of Pharmacy, Foothills Medical Centre, Calgary, Canada Kristin.anderson2@albertahealthservices.ca Pharmacy Department, Tom Baker Cancer Centre, Calgary, Canada Division of Hematology and Hematologic Malignancies, Tom Baker Cancer Centre, Calgary, Canada AN - 103867187. Language: English. Entry Date: 20141230. Revision Date: 20200708. Publication Type: Journal Article AU - Anderson, Kristin R. AU - Chambers, Carole R. AU - Lam, Nadine AU - Yau, Patrick S. AU - Cusano, Frances AU - Savoie, M. Lynn AU - Sheikh, Naureen DB - ccm DO - 10.1177/1078155213520261 DP - EBSCOhost IS - 1 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. NLM UID: 9511372. PMID: NLM24503243. PY - 2015 SN - 1078-1552 SP - 19-25 ST - Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia T2 - Journal of Oncology Pharmacy Practice TI - Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103867187&site=ehost-live&scope=site VL - 21 ID - 2957 ER - TY - JOUR AD - Department of Pathology, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden AN - 104266352. Language: English. Entry Date: 20130418. Revision Date: 20200708. Publication Type: Journal Article AU - Arne, Gabriella AU - Nilsson, Bengt AU - Dalmo, Johanna AU - Kristiansson, Erik AU - Arvidsson, Yvonne AU - Forssell-Aronsson, Eva AU - Nilsson, Ola AU - Ahlman, Håkan DB - ccm DO - 10.3109/0284186X.2012.733075 DP - EBSCOhost IS - 4 N1 - pictorial; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. Special Interest: Oncologic Care. Grant Information: This study was supported by the Swedish Cancer Society, the Swedish Research Council, Sahlgrenska Academy (the government ALF agreement), the Johan Jansson Foundation for Cancer Research, the Assar Gabrielsson Research Foundation, the Sahlgrenska University Hospital Research Foundation, and the Royal Society of Arts and Sciences in Gothenburg.. NLM UID: 8709065. PMID: NLM23116418. PY - 2013 SN - 0284-186X SP - 783-792 ST - Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs T2 - Acta Oncologica TI - Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104266352&site=ehost-live&scope=site VL - 52 ID - 2958 ER - TY - JOUR AD - Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX Onkologikum, Frankfurt am Museumsufer, Frankfurt, Germany AN - 129330876. Language: English. Entry Date: 20190529. Revision Date: 20200528. Publication Type: journal article AU - Chiaretti, Sabina AU - Jabbour, Elias AU - Hoelzer, Dieter DB - ccm DO - 10.1016/j.clml.2018.03.014 DP - EBSCOhost IS - 5 N1 - review; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM29653823. PY - 2018 SN - 2152-2650 SP - 301-310 ST - "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL T2 - Clinical Lymphoma, Myeloma & Leukemia TI - "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129330876&site=ehost-live&scope=site VL - 18 ID - 2959 ER - TY - JOUR AD - Division of Clinical Haematology, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa Department of Haematology and Cell Biology, National Health Laboratory Service, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa AN - 108007239. Language: English. Entry Date: 20130502. Revision Date: 20200708. Publication Type: Journal Article AU - Webb, Michael J. AU - Jafta, Debbie DB - ccm DO - 10.5505/tjh.2012.82542 DP - EBSCOhost IS - 4 N1 - case study. Journal Subset: Biomedical; Blind Peer Reviewed; Double Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Middle East; Peer Reviewed. Special Interest: Obstetric Care; Women's Health. PY - 2012 SN - 1300-7777 SP - 405-408 ST - Imatinib Use in Pregnancy T2 - Turkish Journal of Hematology TI - Imatinib Use in Pregnancy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108007239&site=ehost-live&scope=site VL - 29 ID - 2960 ER - TY - JOUR AD - Center for Cancer and Blood Disorders, The Children's Hospital and the Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado. AN - 104841933. Language: English. Entry Date: 20110520. Revision Date: 20150711. Publication Type: Journal Article. Journal Subset: Biomedical AU - Hunger, S. P. AU - Raetz, E. A. AU - Loh, M. L. AU - Mullighan, C. G. DB - ccm DO - 10.1002/pbc.22996 DP - EBSCOhost IS - 6 N1 - Peer Reviewed; USA. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 101186624. PMID: NLM21370430. PY - 2011 SN - 1545-5009 SP - 984-993 ST - Improving outcomes for high-risk ALL: Translating new discoveries into clinical care T2 - Pediatric Blood & Cancer TI - Improving outcomes for high-risk ALL: Translating new discoveries into clinical care UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104841933&site=ehost-live&scope=site VL - 56 ID - 2961 ER - TY - JOUR AD - Institut Gustave Roussy, Université Paris-Sud, Villejuif, France AN - 104501546. Language: English. Entry Date: 20121116. Revision Date: 20200708. Publication Type: journal article AU - Leboulleux, S. AU - Bastholt, L. AU - Krause, T. AU - de la Fouchardiere, C. AU - Tennvall, J. AU - Awada, A. AU - Gómez, J. M. AU - Bonichon, F. AU - Leenhardt, L. AU - Soufflet, C. AU - Licour, M. AU - Schlumberger, M. J. AU - Leboulleux, Sophie AU - Bastholt, Lars AU - Krause, Thomas AU - de la Fouchardiere, Christelle AU - Tennvall, Jan AU - Awada, Ahmad AU - Gómez, José Manuel AU - Bonichon, Françoise DB - ccm DO - 10.1016/S1470-2045(12)70335-2 DP - EBSCOhost IS - 9 N1 - research; randomized controlled trial. Commentary: Bible KC, Bible Keith C. Treating advanced radioresistant differentiated thyroid cancer. (LANCET ONCOL) Sep2012; 13 (9): 854-855. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Special Interest: Oncologic Care. NLM UID: 100957246. PMID: NLM22898678. PY - 2012 SN - 1470-2045 SP - 897-905 ST - Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial T2 - Lancet Oncology TI - Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104501546&site=ehost-live&scope=site VL - 13 ID - 2962 ER - TY - JOUR AD - Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan AN - 108214646. Language: English. Entry Date: 20120518. Revision Date: 20170411. Publication Type: journal article AU - Minami-Shimmyo, Y. AU - Ohe, Y. AU - Yamamoto, S. AU - Sumi, M. AU - Nokihara, H. AU - Horinouchi, H. AU - Yamamoto, N. AU - Sekine, I. AU - Kubota, K. AU - Tamura, T. AU - Minami-Shimmyo, Yuko AU - Ohe, Yuichiro AU - Yamamoto, Seiichiro AU - Sumi, Minako AU - Nokihara, Hiroshi AU - Horinouchi, Hidehito AU - Yamamoto, Noboru AU - Sekine, Ikuo AU - Kubota, Kaoru AU - Tamura, Tomohide DB - ccm DO - 10.1097/JTO.0b013e31823c4c07 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. NLM UID: 101274235. PMID: NLM22134071. PY - 2012 SN - 1556-0864 SP - 177-182 ST - Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer T2 - Journal of Thoracic Oncology TI - Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108214646&site=ehost-live&scope=site VL - 7 ID - 2964 ER - TY - JOUR AD - Peking University People’s HospitalPekingChina Peking University Shougang HospitalPekingChina Peking University International HospitalPekingChina AN - 128936529. Language: English. Entry Date: In Process. Revision Date: 20190619. Publication Type: journal article AU - Xie, Lu AU - Guo, Wei AU - Wang, Ye AU - Yan, Taiqiang AU - Ji, Tao AU - Xu, Jie DB - ccm DO - 10.1186/s12885-018-4303-z DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Europe; UK & Ireland. Instrumentation: Piper Fatigue Scale (PFS). Grant Information: 81402382//National Natural Science Foundation of China/International. NLM UID: 100967800. PMID: NLM29625604. PY - 2018 SN - 1471-2407 SP - 1-1 ST - Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China T2 - BMC Cancer TI - Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128936529&site=ehost-live&scope=site VL - 18 ID - 2965 ER - TY - JOUR AD - Liver and Gastrointestinal Transplant Division, Department of GastroenterologyUniversity of São Paulo School of MedicineRua Dr. Enéas de Carvalho Aguiar, 255-9o andar-sala 9113/9114CEP05403-900São PauloSPBrazil Department of PathologyUniversity of São Paulo School of MedicineSão PauloBrazil Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, Rua Dr. Enéas de Carvalho Aguiar, 255-9o andar-sala 9113/9114, São Paulo, SP, CEP05403-900, Brazil AN - 128384046. Language: English. Entry Date: In Process. Revision Date: 20180929. Publication Type: journal article AU - Nacif, Lucas Souto AU - Waisberg, Daniel R. AU - Pinheiro, Rafael Soares AU - Lima, Fabiana Roberto AU - Rocha-Santos, Vinicius AU - Andraus, Wellington AU - D’Albuquerque, Luiz Carneiro AU - D'Albuquerque, Luiz Carneiro DB - ccm DO - 10.1186/s13256-018-1588-0 DP - EBSCOhost IS - 1 N1 - case study; research. Journal Subset: Biomedical; Europe; UK & Ireland. NLM UID: 101293382. PMID: NLM29523185. PY - 2018 SN - 1752-1947 SP - 1-1 ST - Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report T2 - Journal of Medical Case Reports TI - Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128384046&site=ehost-live&scope=site VL - 12 ID - 2966 ER - TY - JOUR AD - Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan Department of Clinical Sciences and Community Health; Università degli Studi di Milano, Milan, Italy AN - 132770711. Language: English. Entry Date: 20191130. Revision Date: 20200311. Publication Type: journal article. Journal Subset: Biomedical AU - Colombo, Carla AU - De Leo, Simone AU - Di Stefano, Marta AU - Vannucchi, Guia AU - Persani, Luca AU - Fugazzola, Laura DB - ccm DO - 10.1210/jc.2018-01836 DP - EBSCOhost N1 - USA. Instrumentation: Impact of Events Scale (IES); Personality Assessment Inventory (PAI). NLM UID: 0375362. PMID: NLM30383218. PY - 2018 SN - 0021-972X SP - N.PAG-N.PAG ST - Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy T2 - Journal of Clinical Endocrinology & Metabolism TI - Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132770711&site=ehost-live&scope=site ID - 2967 ER - TY - JOUR AD - The University of Texas MD Anderson Cancer Center, Houston, TX, USA AN - 111878926. Language: English. Entry Date: 20160507. Revision Date: 20191111. Publication Type: journal article AU - Cabanillas, Maria E. AU - Habra, Mouhammed Amir DB - ccm DO - 10.1016/j.ctrv.2015.11.003 DP - EBSCOhost N1 - review. Journal Subset: Biomedical; Double Blind Peer Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 7502030. PMID: NLM26678514. PY - 2016 SN - 0305-7372 SP - 47-55 ST - Lenvatinib: Role in thyroid cancer and other solid tumors T2 - Cancer Treatment Reviews TI - Lenvatinib: Role in thyroid cancer and other solid tumors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111878926&site=ehost-live&scope=site VL - 42 ID - 2968 ER - TY - JOUR AD - Children's Mercy Hospitals and Clinics, 2401 Gillham Road Kansas City USA Alberta Children's Hospital, Calgary Canada AN - 104279147. Language: English. Entry Date: 20130426. Revision Date: 20200708. Publication Type: Journal Article AU - August, Keith AU - Narendran, Aru AU - Neville, Kathleen DB - ccm DO - 10.1007/s40265-013-0026-2 DP - EBSCOhost IS - 5 N1 - review; tables/charts. Journal Subset: Australia & New Zealand; Biomedical; Peer Reviewed. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 7600076. PMID: NLM23568274. PY - 2013 SN - 0012-6667 SP - 439-461 ST - Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions T2 - Drugs TI - Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104279147&site=ehost-live&scope=site VL - 73 ID - 2971 ER - TY - JOUR AD - Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui Japan AN - 113528458. Language: English. Entry Date: 20170731. Revision Date: 20170731. Publication Type: Article AU - Tanizawa, Akihiko DB - ccm DO - 10.1111/ped.12876 DP - EBSCOhost IS - 3 N1 - review; tables/charts. Journal Subset: Asia; Biomedical; Peer Reviewed. NLM UID: 100886002. PY - 2016 SN - 1328-8067 SP - 171-179 ST - Optimal management for pediatric chronic myeloid leukemia T2 - Pediatrics International TI - Optimal management for pediatric chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113528458&site=ehost-live&scope=site VL - 58 ID - 2973 ER - TY - JOUR AD - Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, MA. AN - 103999062. Language: English. Entry Date: 20140314. Revision Date: 20200708. Publication Type: journal article AU - Ræder, Helge AU - McAllister, Fiona E. AU - Tjora, Erling AU - Bhatt, Shweta AU - Haldorsen, Ingfrid AU - Hu, Jiang AU - Willems, Stefan M. AU - Vesterhus, Mette AU - El Ouaamari, Abdelfattah AU - Liu, Manway AU - Ræder, Maria B. AU - Immervoll, Heike AU - Hoem, Dag AU - Dimcevski, Georg AU - Njølstad, Pål R. AU - Molven, Anders AU - Gygi, Steven P. AU - Kulkarni, Rohit N. DB - ccm DO - 10.2337/db13-1012 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: R01 DK-67536/DK/NIDDK NIH HHS/United States. NLM UID: 0372763. PMID: NLM24062244. PY - 2014 SN - 0012-1797 SP - 259-269 ST - Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid T2 - Diabetes TI - Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103999062&site=ehost-live&scope=site VL - 63 ID - 2974 ER - TY - JOUR AN - 108185958. Language: English. Entry Date: 20120727. Revision Date: 20200706. Publication Type: Journal Article AU - Montani, D. AU - Bergot, E. AU - Günther, S. AU - Savale, L. AU - Bergeron, A. AU - Bourdin, A. AU - Bouvaist, H. AU - Canuet, M. AU - Pison, C. AU - Macro, M. AU - Poubeau, P. AU - Girerd, B. AU - Natali, D. AU - Guignabert, C. AU - Perros, F. AU - O'Callaghan, D. S. AU - Jaïs, X. AU - Tubert-Bitter, P. AU - Zalcman, G. AU - Sitbon, O. DB - ccm DO - 10.1161/circulationaha.111.079921 DP - EBSCOhost IS - 17 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 0147763. PMID: NLM22451584. PY - 2012 SN - 0009-7322 SP - 2128-2137 ST - Pulmonary arterial hypertension in patients treated by dasatinib T2 - Circulation TI - Pulmonary arterial hypertension in patients treated by dasatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108185958&site=ehost-live&scope=site VL - 125 ID - 2975 ER - TY - JOUR AD - Imperial College, Hammersmith Campus, London, England W12 0NN. j.apperley@imperial.ac.uk. AN - 105251458. Language: English. Entry Date: 20100319. Revision Date: 20150711. Publication Type: Journal Article. Journal Subset: Biomedical AU - Apperley, J. DB - ccm DP - EBSCOhost IS - 10 N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101162515. PMID: NLM19930974. PY - 2009 SN - 1540-1405 SP - 1050-1058 ST - Issues of imatinib and pregnancy outcome T2 - Journal of the National Comprehensive Cancer Network TI - Issues of imatinib and pregnancy outcome UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105251458&site=ehost-live&scope=site VL - 7 ID - 2976 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030; ejabbour@mdanderson.org. AN - 104597006. Language: English. Entry Date: 20120323. Revision Date: 20200708. Publication Type: journal article AU - Jabbour, E. AU - Kantarjian, H. M. AU - O'Brien, S. AU - Shan, J. AU - Quintás-Cardama, A. AU - Garcia-Manero, G. AU - Rios, M. B. AU - Cortes, J. E. AU - Jabbour, Elias AU - Kantarjian, Hagop M. AU - O'Brien, Susan AU - Shan, Jianqin AU - Quintás-Cardama, Alfonso AU - Garcia-Manero, Guillermo AU - Rios, Mary Beth AU - Cortes, Jorge E. DB - ccm DO - 10.1200/JCO.2011.36.0693 DP - EBSCOhost IS - 32 N1 - clinical trial; research. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM21990394. PY - 2011 SN - 0732-183X SP - 4260-4265 ST - Front-line therapy with second-generation tyrosine kinase inhibitors in patients with early chronic phase chronic myeloid leukemia: what is the optimal response? T2 - Journal of Clinical Oncology TI - Front-line therapy with second-generation tyrosine kinase inhibitors in patients with early chronic phase chronic myeloid leukemia: what is the optimal response? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104597006&site=ehost-live&scope=site VL - 29 ID - 2977 ER - TY - JOUR AD - Department of Pathology, The University of Texas Medical Center Health Sciences Center, Houston, Texas, USA Department of Pathology, The University of Texas Medical Center Health Sciences Center, Houston, Texas. AN - 104672894. Language: English. Entry Date: 20111028. Revision Date: 20170817. Publication Type: journal article. Journal Subset: Biomedical AU - Jaso, J. AU - Thomas, D. A. AU - Cunningham, K. AU - Jorgensen, J. L. AU - Kantarjian, H. M. AU - Medeiros, L. J. AU - Wang, S. A. AU - Jaso, Jesse AU - Thomas, Deborah A. AU - Cunningham, Krista AU - Jorgensen, Jeffrey L. AU - Kantarjian, Hagop M. AU - Medeiros, L. Jeffrey AU - Wang, Sa A. DB - ccm DO - 10.1002/cncr.25978 DP - EBSCOhost IS - 17 N1 - Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM21365622. PY - 2011 SN - 0008-543X SP - 4009-4017 ST - Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors T2 - Cancer (0008543X) TI - Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104672894&site=ehost-live&scope=site VL - 117 ID - 2978 ER - TY - JOUR AN - 105803809. Language: English. Entry Date: 20080829. Revision Date: 20161115. Publication Type: journal article AU - Shah, N. P. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Réa, D. AU - Dorlhiac-Llacer, P. E. AU - Milone, J. H. AU - Vela-Ojeda, J. AU - Silver, R. T. AU - Khoury, H. J. AU - Charbonnier, A. AU - Khoroshko, N. AU - Paquette, R. L. AU - Deininger, M. AU - Collins, R. H. AU - Otero, I. AU - Hughes, T. AU - Bleickardt, E. AU - Strauss, L. AU - Francis, S. AU - Hochhaus, A. DB - ccm DO - 10.1200/JCO.2007.14.9260 DP - EBSCOhost IS - 19 N1 - clinical trial; research. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Grant Information: CA180-034/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM18541900. PY - 2008 SN - 0732-183X SP - 3204-3212 ST - Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia T2 - Journal of Clinical Oncology TI - Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105803809&site=ehost-live&scope=site VL - 26 ID - 2979 ER - TY - JOUR AD - Department of Surgery Unit 3, Christian Medical College and Hospital, Vellore 632004 India AN - 111984525. Language: English. Entry Date: 20180117. Revision Date: 20180118. Publication Type: Article AU - Yacob, Myla AU - Inian, Samarasam AU - Sudhakar, Chandran DB - ccm DO - 10.1007/s12262-013-0899-z DP - EBSCOhost N1 - review; tables/charts. Supplement Title: Dec2015 Supplement. Journal Subset: Asia; Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed. NLM UID: 0373026. PY - 2015 SN - 0972-2068 SP - 505-510 ST - Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre T2 - Indian Journal of Surgery TI - Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111984525&site=ehost-live&scope=site VL - 77 ID - 2980 ER - TY - JOUR AN - 104489052. Language: English. Entry Date: 20130726. Revision Date: 20200708. Publication Type: journal article AU - Rutkowski, Piotr AU - Bylina, Elbieta AU - Klimczak, Anna AU - Switaj, Tomasz AU - Falkowski, Slawomir AU - Kroc, Jacek AU - Lugowska, Iwona AU - Brzeskwiniewicz, Magdalena AU - Melerowicz, Wojciech AU - Osuch, Czeslaw AU - Mierzejewska, Ewa AU - Wasielewski, Kacper AU - Wozniak, Agnieszka AU - Grzesiakowska, Urszula AU - Nowecki, Zbigniew I. AU - Siedlecki, Janusz A. AU - Limon, Janusz AU - Bylina, Elżbieta AU - Falkowski, Sławomir AU - Osuch, Czesław DB - ccm DO - 10.1186/1471-2407-12-107 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Oncologic Care. NLM UID: 100967800. PMID: NLM22439647. PY - 2012 SN - 1471-2407 SP - 107-107 ST - The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study T2 - BMC Cancer TI - The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104489052&site=ehost-live&scope=site VL - 12 ID - 2984 ER - TY - JOUR AD - Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, NICHD, NIH, Building 10, CRC, Room 1-3330, 10 Center Dr., MSC1103, Bethesda, MD 20892, USA Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, NICHD, NIH, Building 10, CRC, Room 1-3330, 10 Center Dr., MSC1103, Bethesda, MD 20892, USA. stratakc@mail.nih.gov AN - 105368757. Language: English. Entry Date: 20090724. Revision Date: 20200313. Publication Type: journal article AU - Stratakis, C. A. AU - Carney, J. A. AU - Stratakis, C. A. AU - Carney, J. A. DB - ccm DO - 10.1111/j.1365-2796.2009.02110.x DP - EBSCOhost IS - 1 N1 - review. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Grant Information: Z01 HD000642/ImNIH/Intramural NIH HHS/United States. NLM UID: 8904841. PMID: NLM19522824. PY - 2009 SN - 0954-6820 SP - 43-52 ST - The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications T2 - Journal of Internal Medicine TI - The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105368757&site=ehost-live&scope=site VL - 266 ID - 2985 ER - TY - JOUR AD - UNC Chapel Hill, Chapel Hill, NC; Vanderbilt-Ingram Cancer Center Comprehensive Cancer Center, Nashville, TN; Emory University, Atlanta, GA; The Ohio State University, Columbus, OH; Moffitt Cancer Center, Tampa, FL; VCU Massey Cancer Center, Richmond, VA AN - 120350922. Language: English. Entry Date: In Process. Revision Date: 20161223. Publication Type: journal article. Supplement Title: 5/21/2009 Supplement Part 1 of 2. Journal Subset: Biomedical AU - O'Neil, B. H. AU - Williams-Goff, L. W. AU - Kauh, J. AU - Bekaii-Saab, T. AU - Strosberg, J. R. AU - Lee, R. AU - Deal, A. M. AU - Sullivan, D. AU - Sebti, S. M. DB - ccm DP - EBSCOhost N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 8309333. PMID: NLM27962385. PY - 2009 SN - 0732-183X SP - e15574-e15574 ST - A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120350922&site=ehost-live&scope=site VL - 27 ID - 2986 ER - TY - JOUR AD - Department of Stem Cell Transplantation and Cellular Therapies, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030; sgiralt@notes.mdcc.tmc.edu AN - 105827023. Language: English. Entry Date: 20080307. Revision Date: 20150711. Publication Type: Journal Article. Supplement Title: Mar2007 Supplement 3. Journal Subset: Biomedical AU - Ginalt, S. DB - ccm DP - EBSCOhost N1 - Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101256500. PMID: NLM17382018. PY - 2007 SN - 1557-9190 SP - S102-2 ST - Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date T2 - Clinical Lymphoma & Myeloma TI - Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105827023&site=ehost-live&scope=site VL - 7 ID - 2987 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. deepa.bhojwani@stjude.org AN - 105330944. Language: English. Entry Date: 20091211. Revision Date: 20200708. Publication Type: Journal Article AU - Bhojwani, D. AU - Howard, S. C. AU - Pui, C. DB - ccm DO - 10.3816/CLM.2009.s.016 DP - EBSCOhost N1 - review; tables/charts. Supplement Title: Sep2009 Supplement 3. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101256500. PMID: NLM19778845. PY - 2009 SN - 1557-9190 SP - S222-30 ST - High-risk childhood acute lymphoblastic leukemia T2 - Clinical Lymphoma & Myeloma TI - High-risk childhood acute lymphoblastic leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105330944&site=ehost-live&scope=site VL - 9 ID - 2989 ER - TY - JOUR AN - CN-02009912 AU - Nct PY - 2019 ST - A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma T2 - https://clinicaltrials.gov/show/NCT04166409 TI - A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02009912/full ID - 2999 ER - TY - JOUR AN - CN-01393704 AU - Hazarika, M. AU - Chuk, M. K. AU - Theoret, M. R. AU - Mushti, S. AU - He, K. AU - Weis, S. L. AU - Putman, A. H. AU - Helms, W. S. AU - Cao, X. AU - Li, H. AU - et al. DO - 10.1158/1078-0432.CCR-16-0712 IS - 14 M3 - Journal Article; Randomized Controlled Trial PY - 2017 SP - 3484‐3488 ST - U.S. FDA Approval Summary: nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab T2 - Clinical cancer research TI - U.S. FDA Approval Summary: nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01393704/full VL - 23 ID - 3003 ER - TY - JOUR AN - CN-02181751 AU - Nct PY - 2020 ST - A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma T2 - https://clinicaltrials.gov/show/NCT04576117 TI - A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02181751/full ID - 3009 ER - TY - JOUR AN - CN-01937246 AU - Camidge, D. R. AU - Dziadziuszko, R. AU - Peters, S. AU - Mok, T. AU - Noe, J. AU - Nowicka, M. AU - Gadgeel, S. M. AU - Cheema, P. AU - Pavlakis, N. AU - de Marinis, F. AU - et al. DO - 10.1016/j.jtho.2019.03.007 IS - 7 M3 - Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov't PY - 2019 SP - 1233‐1243 ST - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study T2 - Journal of thoracic oncology TI - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01937246/full VL - 14 ID - 3011 ER - TY - JOUR AN - CN-01875554 AU - Ntr PY - 2014 ST - Trial with melanoma patients who are treated with dabrafenib and trametinib to make the tumor smaller, so it can be surgically removed T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4654 TI - Trial with melanoma patients who are treated with dabrafenib and trametinib to make the tumor smaller, so it can be surgically removed UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01875554/full ID - 3020 ER - TY - JOUR AN - CN-02067629 AU - Euctr, G. B. PY - 2017 ST - A trial to compare giving chemotherapy intermittently to chemotherapy administered continuously to patients with inoperable or metastatic melanoma T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-005228-27-GB TI - A trial to compare giving chemotherapy intermittently to chemotherapy administered continuously to patients with inoperable or metastatic melanoma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02067629/full ID - 3021 ER - TY - JOUR AN - CN-01909643 AU - Euctr, F. R. PY - 2018 ST - Nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma in patients with progressive disease or in patients in complete remission after relapse T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-001447-31-FR TI - Nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma in patients with progressive disease or in patients in complete remission after relapse UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01909643/full ID - 3022 ER - TY - JOUR AN - CN-01895662 AU - Isrctn PY - 2018 ST - SeluDex: an international trial of selumetinib in combination with dexamethasone for the treatment of acute lymphoblastic leukaemia T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN92323261 TI - SeluDex: an international trial of selumetinib in combination with dexamethasone for the treatment of acute lymphoblastic leukaemia UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01895662/full ID - 3023 ER - TY - JOUR AN - CN-01894510 AU - Isrctn PY - 2017 ST - A research study to compare treatment with dabrafenib and trametinib, either taken continuously every day, or intermittently (with planned treatment breaks in each cycle), in patients with metastatic Melanoma T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18183156 TI - A research study to compare treatment with dabrafenib and trametinib, either taken continuously every day, or intermittently (with planned treatment breaks in each cycle), in patients with metastatic Melanoma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01894510/full ID - 3024 ER - TY - JOUR AN - CN-01988728 AU - Couch, D. G. AU - Cook, H. AU - Ortori, C. AU - Barrett, D. AU - Lund, J. N. AU - O'Sullivan, S. E. DO - 10.1093/ibd/izz017 IS - 6 M3 - Journal Article; Randomized Controlled Trial PY - 2019 SP - 1006‐1018 ST - Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial T2 - Inflammatory bowel diseases TI - Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01988728/full VL - 25 ID - 3028 ER - TY - JOUR AN - CN-01570826 AU - Patel, N. R. AU - Cunoosamy, D. M. AU - Fagerås, M. AU - Taib, Z. AU - Asimus, S. AU - Hegelund-Myrbäck, T. AU - Lundin, S. AU - Pardali, K. AU - Kurian, N. AU - Ersdal, E. AU - et al. DO - 10.2147/COPD.S150576 M3 - Journal Article; Multicenter Study; Randomized Controlled Trial PY - 2018 SP - 1009‐1019 ST - The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial T2 - International journal of chronic obstructive pulmonary disease TI - The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01570826/full VL - 13 ID - 3029 ER - TY - JOUR AN - CN-01501791 AU - Nct PY - 2010 ST - Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: a Randomized and Prospective Study T2 - https://clinicaltrials.gov/show/NCT01238471 TI - Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: a Randomized and Prospective Study UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01501791/full ID - 3033 ER - TY - JOUR AD - Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States Department of Pathology, Washington University School of Medicine, St. Louis, MO, United States AU - Guo, X. AU - Pan, Y. AU - Xiong, M. AU - Sanapala, S. AU - Anastasaki, C. AU - Cobb, O. AU - Dahiya, S. AU - Gutmann, D. H. C7 - 2177 DB - Scopus DO - 10.1038/s41467-020-15770-3 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 ST - Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth T2 - Nature Communications TI - Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084080912&doi=10.1038%2fs41467-020-15770-3&partnerID=40&md5=7ee0011b178457df7a07f3110dfdede9 VL - 11 ID - 3036 ER - TY - JOUR AD - Department of Radiology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-ku, Saitama, Saitama Prefecture, 330-8777, Japan Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan Department of Radiology, Keio University, School of Medicine, Tokyo, Japan AU - Hosokawa, T. AU - Hara, T. AU - Arakawa, Y. AU - Oguma, E. AU - Yamada, Y. DB - Scopus DO - 10.1097/MPH.0000000000001595 IS - 8 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - e822-e825 ST - Periosteal Reaction Possibly Induced by Pazopanib: A Case Report and Literature Review T2 - Journal of Pediatric Hematology/Oncology TI - Periosteal Reaction Possibly Induced by Pazopanib: A Case Report and Literature Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089906421&doi=10.1097%2fMPH.0000000000001595&partnerID=40&md5=882325a05ca5ba48868b8900855f875b VL - 42 ID - 3037 ER - TY - JOUR AD - Clinical pharmacy specialist in GI oncology and a clinical coordinator in oncology, Emory Winship Cancer Institute, Atlanta, United States AU - Draper, A. DB - Scopus DO - 10.37765/ajmc.2020.88512 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - S211-S219 ST - A concise review of the changing landscape of hepatocellular carcinoma T2 - The American journal of managed care TI - A concise review of the changing landscape of hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092885574&doi=10.37765%2fajmc.2020.88512&partnerID=40&md5=20b5c223b3f6e0ee24d3fbadf5c740ea VL - 26 ID - 3042 ER - TY - JOUR AD - Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Department of Internal Medicine, Division of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan AU - Komatsu, S. AU - Yano, Y. AU - Sofue, K. AU - Kido, M. AU - Tanaka, M. AU - Kuramitsu, K. AU - Awazu, M. AU - Gon, H. AU - Yamamoto, A. AU - Yanagimoto, H. AU - Toyama, H. AU - Kodama, Y. AU - Murakami, T. AU - Fukumoto, T. DB - Scopus DO - 10.1016/j.hpb.2020.03.002 IS - 10 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 1450-1456 ST - Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis T2 - HPB TI - Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082474177&doi=10.1016%2fj.hpb.2020.03.002&partnerID=40&md5=d474c7df6eafb783f6a7c2794b2aa01e VL - 22 ID - 3043 ER - TY - JOUR AD - Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province 450008, China Department of Medical Oncology, The Affiliated People’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450003, China Department of Orthopedics, the People’s Hospital of Jiyuan, Jiyuan, Henan Province 459000, China Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province 450008, China AU - Tian, Z. AU - Liu, H. AU - Zhang, F. AU - Li, L. AU - Du, X. AU - Li, C. AU - Yang, J. AU - Wang, J. DB - Scopus DO - 10.1007/s10637-020-00912-7 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 1559-1569 ST - Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma T2 - Investigational New Drugs TI - Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087841867&doi=10.1007%2fs10637-020-00912-7&partnerID=40&md5=f4dd324779ddb38e13314ac35d4db40d VL - 38 ID - 3044 ER - TY - JOUR AD - BCLC group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd, University of Barcelona, Barcelona, Spain Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd, University of Barcelona, Barcelona, Spain Medical Statistics Core Facility, IDIBAPS. Hospital Clínic de Barcelona. Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain BCLC group. Radiology department, Hospital Clínic de Barcelona. IDIBAPS, University of Barcelona, Barcelona, Spain AU - Díaz-González, Á AU - Sapena, V. AU - Boix, L. AU - Brunet, M. AU - Torres, F. AU - Llarch, N. AU - Samper, E. AU - Millán, O. AU - Corominas, J. AU - Iserte, G. AU - Sanduzzi-Zamparelli, M. AU - da Fonseca, L. G. AU - Darnell, A. AU - Belmonte, E. AU - Forner, A. AU - Ayuso, C. AU - Bruix, J. AU - Reig, M. DB - Scopus DO - 10.1111/liv.14587 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 2476-2488 ST - Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials T2 - Liver International TI - Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088370181&doi=10.1111%2fliv.14587&partnerID=40&md5=cd5c6a5b70b41b2dbafc71f996d43491 VL - 40 ID - 3046 ER - TY - JOUR AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom School of Medicine, Taylor's University, Subang Jaya, Malaysia University of Colorado School of Medicine, Denver, CO, United States Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, United States AU - Sawangjit, R. AU - Dilokthornsakul, P. AU - Lloyd-Lavery, A. AU - Lai, N. M. AU - Dellavalle, R. AU - Chaiyakunapruk, N. C7 - Cd013206 DB - Scopus DO - 10.1002/14651858.CD013206.pub2 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 ST - Systemic treatments for eczema: a network meta-analysis T2 - Cochrane Database of Systematic Reviews TI - Systemic treatments for eczema: a network meta-analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071450014&doi=10.1002%2f14651858.CD013206.pub2&partnerID=40&md5=ca714ad052325eff801f658953fafcf9 VL - 2020 ID - 3049 ER - TY - JOUR AD - Department of Dermatology, University Hospital of Pontevedra, Pontevedra (Galicia), Spain Department of Dermatology, University Hospital La Paz, Madrid, Spain Department of Pathology, University Hospital La Paz, Madrid, Spain AU - Oro-Ayude, M. AU - Feito, M. AU - Quintana-Castanedo, L. AU - Beato-Merino, M. J. AU - De Lucas, R. DB - Scopus DO - 10.1111/pde.14267 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 968-969 ST - Keratosis pilaris-like eruption secondary to nilotinib in a child T2 - Pediatric Dermatology TI - Keratosis pilaris-like eruption secondary to nilotinib in a child UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087299326&doi=10.1111%2fpde.14267&partnerID=40&md5=9192768269aa05d5b55009ce9884fb2b VL - 37 ID - 3050 ER - TY - JOUR AD - ACCELERATE/ITCC, European Union Princess Máxima Center, Utrecht, Erasmus MC, Rotterdam, Netherlands ITCC, European Union Nemours/Alfred I. duPont Hospital for Children, United States European Medicines Agency, Amsterdam, Netherlands Fred Hutchinson Cancer Research Center, Leukaemia Lymphoma Society, Target Paediatric AML, United States AbbVie, United States Royal Marsden Hospital, The Institute of Cancer Research, United Kingdom Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, United States National Institutes of Health, National Cancer Institute, United States Seattle Children's Hospital, United States Sanofi US, Emeritus Professor of Paediatrics & Pharmacology, Perelman School of Medicine, University of Pennsylvania, United States Pfizer, United States Celgene, United States Servier, United States Jazz Pharmaceuticals, Ireland Novartis Pharma, Switzerland Astellas Pharma Global Development, Inc., United States Takeda Pharmaceuticals, United States Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Sanofi Genzyme, United States Department of Paediatrics, Aarhus University Hospital, Denmark KickCancer, Belgium BMS, United States Martin Luther University Halle-Wittenberg, Germany Helsinn Healthcare, Switzerland FORMA Therapeutics, United States Queensland Children's Hospital, Brisbane, Australia Amgen, United States Janssen Research & Development, United States University Hospital Essen, Germany Zoé4life, Switzerland CCI, European Union Roche/Genentech, Switzerland Agios Pharmaceuticals, United States Universitair Ziekenhuis Antwerpen, FAMHP, Belgium Food and Drug Administration, United States Gustave Roussy Cancer Centre, France AU - Pearson, A. D. J. AU - Zwaan, C. M. AU - Kolb, E. A. AU - Karres, D. AU - Guillot, J. AU - Kim, S. Y. AU - Marshall, L. AU - Tasian, S. K. AU - Smith, M. AU - Cooper, T. AU - Adamson, P. C. AU - Barry, E. AU - Benettaib, B. AU - Binlich, F. AU - Borgman, A. AU - Brivio, E. AU - Capdeville, R. AU - Delgado, D. AU - Faller, D. V. AU - Fogelstrand, L. AU - Fraenkel, P. G. AU - Hasle, H. AU - Heenen, D. AU - Kaspers, G. AU - Kieran, M. AU - Klusmann, J. H. AU - Lesa, G. AU - Ligas, F. AU - Mappa, S. AU - Mohamed, H. AU - Moore, A. AU - Morris, J. AU - Nottage, K. AU - Reinhardt, D. AU - Scobie, N. AU - Simko, S. AU - Winkler, T. AU - Norga, K. AU - Reaman, G. AU - Vassal, G. DB - Scopus DO - 10.1016/j.ejca.2020.04.038 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 116-129 ST - Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration T2 - European Journal of Cancer TI - Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087974955&doi=10.1016%2fj.ejca.2020.04.038&partnerID=40&md5=400596b1d7351b95399744446034cb5d VL - 136 ID - 3053 ER - TY - JOUR AD - Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden Division of Laboratory Medicine, Department of Clinical Genetics and Pathology, Lund, Sweden Department of Hematology, Skåne University Hospital, Lund, Sweden Department of Pediatrics, Linköping University Hospital, Linköping, Sweden Department of Pediatrics, Skåne University Hospital, Lund, Sweden AU - Biloglav, A. AU - Olsson-Arvidsson, L. AU - Theander, J. AU - Behrendtz, M. AU - Castor, A. AU - Johansson, B. DB - Scopus DO - 10.1002/gcc.22852 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 540-543 ST - SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias T2 - Genes Chromosomes and Cancer TI - SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084229626&doi=10.1002%2fgcc.22852&partnerID=40&md5=4b48cfc1340e659e4155b928b66aeafd VL - 59 ID - 3056 ER - TY - JOUR AD - Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada Division of Haematology/Oncology, McMaster University, Hamilton, ON, Canada Division of Hematology/Oncology, University of Ottawa, Ottawa, ON, Canada Centre for Health Services Research, University of Queensland, Brisbane, QLD, Australia Division of Haematology/Oncology, Kingston General Hospital, Kingston, ON, Canada Division of Haematology/Oncology, Western University, London, ON, Canada AU - Egan, G. AU - Athale, U. AU - Johnston, D. AU - Pole, J. D. AU - Silva, M. AU - Zorzi, A. AU - Alexander, S. C7 - e28491 DB - Scopus DO - 10.1002/pbc.28491 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Outcomes of children with chronic myeloid leukemia: A population-based cohort study T2 - Pediatric Blood and Cancer TI - Outcomes of children with chronic myeloid leukemia: A population-based cohort study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087169364&doi=10.1002%2fpbc.28491&partnerID=40&md5=b97b0eb980d9652a307bc21b71e673fa VL - 67 ID - 3057 ER - TY - JOUR AD - Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States Department of Medicine, Weill Cornell Medical College, New York, United States Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, United States Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, United States Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, United States AU - Liu, D. AU - Flory, J. AU - Lin, A. AU - Offin, M. AU - Falcon, C. J. AU - Murciano-Goroff, Y. R. AU - Rosen, E. AU - Guo, R. AU - Basu, E. AU - Li, B. T. AU - Harding, J. J. AU - Iyer, G. AU - Jhaveri, K. AU - Gounder, M. M. AU - Shukla, N. N. AU - Roberts, S. S. AU - Glade-Bender, J. AU - Kaplanis, L. AU - Schram, A. AU - Hyman, D. M. AU - Drilon, A. DB - Scopus DO - 10.1016/j.annonc.2020.05.006 IS - 9 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1207-1215 ST - Characterization of on-target adverse events caused by TRK inhibitor therapy T2 - Annals of Oncology TI - Characterization of on-target adverse events caused by TRK inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087429837&doi=10.1016%2fj.annonc.2020.05.006&partnerID=40&md5=97f22591a3568234a1aac362d66137f8 VL - 31 ID - 3059 ER - TY - JOUR AD - University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, RES 435B, Fort Worth, TX 76107, United States Department of Pharmacy, Memorial Regional Hospital, 3501 Johnson Street, Hollywood, FL 33021, United States AU - Monestime, S. AU - Lazaridis, D. DB - Scopus DO - 10.1007/s40268-020-00314-3 IS - 3 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 189-195 ST - Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor T2 - Drugs in R and D TI - Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087503907&doi=10.1007%2fs40268-020-00314-3&partnerID=40&md5=e43e935212411feff88b8c6dd3345dc5 VL - 20 ID - 3060 ER - TY - JOUR AD - Division of Gastroenterology, Department of Medicine, Kurume University, School of Medicine, Kurume, Fukuoka, 830-0011, Japan Department of Gastroenterology and Hepatology, Yokokura Hospital, Miyama, Fukuoka, 839-0295, Japan Department of Gastroenterology and Hepatology, Yanagawa Hospital, Yanagawa, Fukuoka, 832-0077, Japan Department OfGastroenterology and Hepatology, Iwamoto Internal Medical Clinic, Kitakyushu, Fukuoka, 802-0832, Japan Department of Gastroenterology and Hepatology, Omuta City Hospital, Omuta, Fukuoka, 836-8567, Japan AU - Shimose, S. AU - Kawaguchi, T. AU - Tanaka, M. AU - Iwamoto, H. AU - Miyazaki, K. AU - Moriyama, E. AU - Suzuki, H. AU - Niizeki, T. AU - Shirono, T. AU - Nakano, M. AU - Suga, H. AU - Yamaguchi, T. AU - Yokokura, Y. AU - Noguchi, K. AU - Koga, H. AU - Torimura, T. DB - Scopus DO - 10.3892/ol.2020.11758 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 2257-2265 ST - Lenvatinib prolongs the progression.free survival time of patients with intermediate.stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis T2 - Oncology Letters TI - Lenvatinib prolongs the progression.free survival time of patients with intermediate.stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090512273&doi=10.3892%2fol.2020.11758&partnerID=40&md5=6b1733af1d92510c9c3ae68d6cc5143c VL - 20 ID - 3062 ER - TY - JOUR AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, SINH-Changzheng Hospital Joint Center for Translational Medicine, Institutes for Translational Medicine (CAS-SMMU), Changzheng Hospital, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai, 200031, China Department of General Surgery, PLA General Hospital, Beijing, China Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Nanjing, China AU - Zeng, C. AU - Zhu, L. AU - Jia, X. AU - Pang, Y. AU - Li, Z. AU - Lu, X. AU - Xie, F. AU - Duan, L. AU - Wang, Y. DB - Scopus DO - 10.1007/s10120-020-01069-1 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 837-847 ST - Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors T2 - Gastric Cancer TI - Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083459214&doi=10.1007%2fs10120-020-01069-1&partnerID=40&md5=e67565adae9dfc3f0392b982ca2ed3d0 VL - 23 ID - 3063 ER - TY - JOUR AD - Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States AU - Cook, J. AU - Litzow, M. DB - Scopus DO - 10.1007/s11899-020-00585-2 IS - 4 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 276-293 ST - Advances in Supportive Care for Acute Lymphoblastic Leukemia T2 - Current Hematologic Malignancy Reports TI - Advances in Supportive Care for Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087359310&doi=10.1007%2fs11899-020-00585-2&partnerID=40&md5=fa026ead7fe5a85fb40d752b8eb43448 VL - 15 ID - 3069 ER - TY - JOUR AD - Department of Hematology, Tongji Hospital of Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan, Hubei, 430030, China Department of Hematology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, 471000, China AU - Liu, J. AU - Yang, H. AU - Xu, X. AU - Yi, S. AU - Meng, L. DB - Scopus DO - 10.3892/ol.2020.11650 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1071-1076 ST - Mutations in the bcr-abl1 kinase domain in patients with chronic myeloid leukaemia treated with tkis or at diagnosis T2 - Oncology Letters TI - Mutations in the bcr-abl1 kinase domain in patients with chronic myeloid leukaemia treated with tkis or at diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087212700&doi=10.3892%2fol.2020.11650&partnerID=40&md5=1a0849e086bf7feab3530ceb76944dbb VL - 20 ID - 3072 ER - TY - JOUR AD - CML Advocates Network, Bern, Switzerland Israeli CML Patients Organization, Netanya, Israel Quality Health Ltd, Derbyshire, United Kingdom Leukaemia Care, Worcester, United Kingdom Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy LyLe Patientforeningenen for Lymfekræft Leukæmi og MDS, Sealand Region, Denmark Association des malades atteints de leucémies AMAL, Marrakech, Morocco LMC France, Marseille, France LeukaNET e.V, Riemerling, Germany AU - Sharf, G. AU - Marin, C. AU - Bradley, J. A. AU - Pemberton-Whiteley, Z. AU - Bombaci, F. AU - Christensen, R. I. O. AU - Gouimi, B. AU - Deekes, N. B. AU - Daban, M. AU - Geissler, J. DB - Scopus DO - 10.1038/s41375-020-0867-0 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 2102-2112 ST - Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs T2 - Leukemia TI - Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085365110&doi=10.1038%2fs41375-020-0867-0&partnerID=40&md5=5df7429b944b4048a108897db2bf330f VL - 34 ID - 3073 ER - TY - JOUR AD - Department of Woman’s and Child’s Health, University of Padua, Via Giustiniani 3, Padua, 35128, Italy AU - Zulian, F. AU - Tirelli, F. C7 - 45 DB - Scopus DO - 10.1007/s11926-020-00910-x IS - 8 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Treatment in Juvenile Scleroderma T2 - Current Rheumatology Reports TI - Treatment in Juvenile Scleroderma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086847271&doi=10.1007%2fs11926-020-00910-x&partnerID=40&md5=8a9b7c5c5ca6bd77a3193323096f7a9d VL - 22 ID - 3074 ER - TY - JOUR AD - Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil Hematologia, Centro de Pesquisas Oncológicas (CEPON), Florianópolis, Brazil Hematologia, Hospital de Clínicas da Universidade Federal do Paraná (UFPR), Curitiba, Brazil AU - Silva, W. F. D. AU - Massaut, I. H. B. AU - Bendlin, R. M. AU - Rosa, L. I. AU - Velloso, E. D. R. P. AU - Rego, E. M. AU - Rocha, V. DB - Scopus DO - 10.1016/j.clml.2020.04.001 IS - 8 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - e523-e528 ST - Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085100506&doi=10.1016%2fj.clml.2020.04.001&partnerID=40&md5=7315d98727550456c6ba9f35f2d15a37 VL - 20 ID - 3075 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea AU - Oh, C. R. AU - Hong, J. Y. AU - Kim, J. H. AU - Lee, J. S. AU - Kim, H. S. AU - Kim, T. W. AU - Ahn, J. H. AU - Kim, J. E. DB - Scopus DO - 10.1007/s11523-020-00731-z IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 485-493 ST - Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study T2 - Targeted Oncology TI - Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087312051&doi=10.1007%2fs11523-020-00731-z&partnerID=40&md5=74600f86f204f08d1c13c72f148b7603 VL - 15 ID - 3077 ER - TY - JOUR AD - Department of Laboratory Medicine and Clinical Immunology of Developmental Age, Medical University of Warsaw, Zwirki i Wigury 63a Street, Warsaw, 02-091, Poland Postgraduate School of Molecular Medicine, Medical University of Warsaw, Zwirki i Wigury 61 Street, Warsaw, 02-091, Poland The Finsen Laboratory, Faculty of Health Sciences, Rigshospitalet, University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Faculty of Health Sciences, Danish Stem Cell Centre (DanStem), University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Department of Biology, The Bioinformatics Centre, University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Department of Histology and Embryology, Medical University of Warsaw, Chalubinskiego 5 Street, Warsaw, 02-004, Poland Department of Immunology, The Children’s Memorial Health Institute, Aleja Dzieci Polskich 20, Warsaw, 04-730, Poland Department of Immunology, Medical University of Warsaw, Jana Nielubowicza 5 Street, Warsaw, 02-097, Poland Department of Laboratory Diagnostics, Medical University of Warsaw, Banacha 1a Street, Warsaw, 02-097, Poland AU - Manda-Handzlik, A. AU - Bystrzycka, W. AU - Cieloch, A. AU - Glodkowska-Mrowka, E. AU - Jankowska-Steifer, E. AU - Heropolitanska-Pliszka, E. AU - Skrobot, A. AU - Muchowicz, A. AU - Ciepiela, O. AU - Wachowska, M. AU - Demkow, U. DB - Scopus DO - 10.1007/s00018-019-03331-x IS - 15 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 3059-3075 ST - Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps T2 - Cellular and Molecular Life Sciences TI - Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074327911&doi=10.1007%2fs00018-019-03331-x&partnerID=40&md5=0efd315e4a517048a8c88fc70df6bf78 VL - 77 ID - 3081 ER - TY - JOUR AD - The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom The Institute of Cancer Research, Division of Clinical Studies and Cancer Therapeutics, Sutton, Surrey, United Kingdom AU - Pearson, H. AU - Marshall, L. V. AU - Carceller, F. DB - Scopus DO - 10.1080/08880018.2020.1740844 IS - 5 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 412-423 ST - Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective T2 - Pediatric Hematology and Oncology TI - Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082187940&doi=10.1080%2f08880018.2020.1740844&partnerID=40&md5=ba212e945af10a7ebef0c6073d2f5816 VL - 37 ID - 3083 ER - TY - JOUR AD - MD Anderson Cancer Center, University of Texas, Houston, TX, United States AU - Triche, L. AU - Yarbrough, A. AU - Roth, M. AU - Ying, A. AU - Wells, R. DB - Scopus DO - 10.1080/08880018.2020.1751755 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 375-379 ST - Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story T2 - Pediatric Hematology and Oncology TI - Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084253202&doi=10.1080%2f08880018.2020.1751755&partnerID=40&md5=90ef390e1404b6a514427b6e5af7a4be VL - 37 ID - 3084 ER - TY - JOUR AD - Pediatric Residency Program, Nationwide Children's Hospital, Columbus, OH, United States Department of Pharmacy, Nationwide Children's Hospital, Columbus, OH, United States Division of Hematology/Oncology/Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, United States Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States AU - Perisa, M. P. AU - Storey, M. AU - Streby, K. A. AU - Ranalli, M. A. AU - Skeens, M. AU - Shah, N. C7 - e28317 DB - Scopus DO - 10.1002/pbc.28317 IS - 7 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Cabozantinib for relapsed neuroblastoma: Single institution case series T2 - Pediatric Blood and Cancer TI - Cabozantinib for relapsed neuroblastoma: Single institution case series UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084235800&doi=10.1002%2fpbc.28317&partnerID=40&md5=48f5686268b00998824dbe99ef464484 VL - 67 ID - 3087 ER - TY - JOUR AD - Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/ S.Gerardo Hospital, Monza, Italy St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic Molecular Diagnostics, Children’s Cancer Institute, University of NSW, Sydney, NSW, Australia Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Israel Pediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany Department of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS), Childrens' Hospital Bambino Gesù, Sapienza, University of Rome, Rome, Italy IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy Department of Human Genetics, Medical School Hannover, Hannover, Germany Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia Women’s and Children’s Hospital, SA Pathology, University of Adelaide, Adelaide, Australia Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany University Children’s Hospital Zurich, Zurich, Switzerland Pediatric Hematology-Oncology Department, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel AU - Cario, G. AU - Leoni, V. AU - Conter, V. AU - Attarbaschi, A. AU - Zaliova, M. AU - Sramkova, L. AU - Cazzaniga, G. AU - Fazio, G. AU - Sutton, R. AU - Elitzur, S. AU - Izraeli, S. AU - Lauten, M. AU - Locatelli, F. AU - Basso, G. AU - Buldini, B. AU - Bergmann, A. K. AU - Lentes, J. AU - Steinemann, D. AU - Göhring, G. AU - Schlegelberger, B. AU - Haas, O. A. AU - Schewe, D. AU - Buchmann, S. AU - Moericke, A. AU - White, D. AU - Revesz, T. AU - Stanulla, M. AU - Mann, G. AU - Bodmer, N. AU - Arad-Cohen, N. AU - Zuna, J. AU - Valsecchi, M. G. AU - Zimmermann, M. AU - Schrappe, M. AU - Biondi, A. DB - Scopus DO - 10.3324/haematol.2019.231720 IS - 7 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 1887-1894 ST - Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols T2 - Haematologica TI - Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084210841&doi=10.3324%2fhaematol.2019.231720&partnerID=40&md5=ef079e8c7ed84160f1d645d20b3826f7 VL - 105 ID - 3088 ER - TY - JOUR AD - Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Akahoshi, Y. AU - Igarashi, A. AU - Fukuda, T. AU - Uchida, N. AU - Tanaka, M. AU - Ozawa, Y. AU - Kanda, Y. AU - Onizuka, M. AU - Ichinohe, T. AU - Tanaka, J. AU - Atsuta, Y. AU - Kako, S. DB - Scopus DO - 10.1111/bjh.16540 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 84-92 ST - Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - British Journal of Haematology TI - Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081029421&doi=10.1111%2fbjh.16540&partnerID=40&md5=d3dea099fdfac9019835b66abaf654ac VL - 190 ID - 3089 ER - TY - JOUR AD - Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany Gemeinschaftspraxis Hämatologie und Onkologie, Magdeburg, Germany Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany Germany Study Group MPN, GSG-MPN, Germany Praxis Hämatologie und Onkologie, Lüneburg, Germany OSHO Study Group—Working Party MPN, WP-CMPN, Germany Johannes Wesling Klinikum, Universitätsklinikum für Onkologie, Hämostaseologie und Palliativmedizin, UKRUB, Universität Bochum, Minden, Germany Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany Medizinische Klinik 3, Hämatologie, Onkologie, Klinikum rechts der Isar, Technische Universität München, München, Germany Klinik für Hämatologie und Onkologie, Universitätsklinikum Magdeburg, Magdeburg, Germany Praxis für Hämatologie und Onkologie, Erding, Germany Institute of Hematology and Clinical Oncology “L. and A. Seràgnoli” Sant’Orsola-Malpighi University Hospital, Bologna, Italy AU - Crodel, C. C. AU - Jentsch-Ullrich, K. AU - Koschmieder, S. AU - Kämpfe, D. AU - Griesshammer, M. AU - Döhner, K. AU - Jost, P. J. AU - Wolleschak, D. AU - Isfort, S. AU - Stegelmann, F. AU - Jilg, S. AU - Hofmann, V. AU - Auteri, G. AU - Rachow, T. AU - Ernst, P. AU - Brioli, A. AU - von Lilienfeld-Toal, M. AU - Hochhaus, A. AU - Palandri, F. AU - Heidel, F. H. DB - Scopus DO - 10.1038/s41375-020-0890-1 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1949-1953 ST - Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study T2 - Leukemia TI - Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085754076&doi=10.1038%2fs41375-020-0890-1&partnerID=40&md5=1002596f68e3d78123e827dc5fc5c76f VL - 34 ID - 3092 ER - TY - JOUR AD - Division of Cardiology, Tufts Medical Center, Boston, MA, United States AU - Upshaw, J. N. C7 - 72 DB - Scopus DO - 10.1007/s11912-020-00923-w IS - 7 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review T2 - Current Oncology Reports TI - Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086723435&doi=10.1007%2fs11912-020-00923-w&partnerID=40&md5=5b785a97dce147584221193ca7c1d1c5 VL - 22 ID - 3094 ER - TY - JOUR AD - Department of Medicine, Centre Léon Bérard, Lyon, France Headquarters, Unicancer, Paris, France LYRICAN, Lyon, France Faculte Lyon Est, Université Claude Bernard, Lyon, France Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain Department of Medicine, Portland VA Health Care System, Portland, OR, United States OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States Department of Epidemiology and Preventative Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia Department of Medical Oncology, West German Cancer Center, University of Duisburg-Essen, Essen, Germany German Consortium for Translational Cancer Research (DKTK), Partner Site Essen, Germany Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands Leuven Cancer Institute and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Weill Cornell Medicine, New York, NY, United States Department of Oncology, Helios Klinikum Berlin-Buch, Berlin, Germany Deciphera Pharmaceuticals, Waltham, MA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States AU - Blay, J. Y. AU - Serrano, C. AU - Heinrich, M. C. AU - Zalcberg, J. AU - Bauer, S. AU - Gelderblom, H. AU - Schöffski, P. AU - Jones, R. L. AU - Attia, S. AU - D'Amato, G. AU - Chi, P. AU - Reichardt, P. AU - Meade, J. AU - Shi, K. AU - Ruiz-Soto, R. AU - George, S. AU - von Mehren, M. DB - Scopus DO - 10.1016/S1470-2045(20)30168-6 IS - 7 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2020 SP - 923-934 ST - Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial T2 - The Lancet Oncology TI - Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086649923&doi=10.1016%2fS1470-2045%2820%2930168-6&partnerID=40&md5=5a5064c6246fc952dbd010121f7f9e7b VL - 21 ID - 3096 ER - TY - JOUR AD - VA Eastern Colorado Health Care System, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States AU - N Heck, J. AU - A Null, A. DB - Scopus DO - 10.1177/1078155219882077 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1097-1102 ST - Frequency of appropriate lab monitoring of oral chemotherapy in an outpatient setting T2 - Journal of Oncology Pharmacy Practice TI - Frequency of appropriate lab monitoring of oral chemotherapy in an outpatient setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074848525&doi=10.1177%2f1078155219882077&partnerID=40&md5=f9e042ac916ffa82ae38bd539040fa5d VL - 26 ID - 3099 ER - TY - JOUR AD - Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, 110002, India AU - Agrwal, S. AU - Sahi, P. K. DB - Scopus DO - 10.1007/s13312-020-1855-1 IS - 6 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 561-564 ST - National Comprehensive Cancer Network Guidelines for Pediatric Acute Lymphoblastic Leukemia T2 - Indian Pediatrics TI - National Comprehensive Cancer Network Guidelines for Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086752444&doi=10.1007%2fs13312-020-1855-1&partnerID=40&md5=a5e7b83dea6b90ac62c1445c1dcc7296 VL - 57 ID - 3100 ER - TY - JOUR AD - Key Laboratory of Organ Regeneration and Transplantation, Ministry of Education, Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, 1163 Xinmin Street, Changchun, 130021, China Department of Neurology, Neuroscience Center, First Hospital of Jilin University, Jilin University, Changchun, China Nursing Department, Second Hospital, Jilin University, Changchun, China AU - Pan, P. AU - Wang, L. AU - Wang, Y. AU - Shen, L. AU - Zheng, P. AU - Bi, C. AU - Zhang, A. AU - Lv, Y. AU - Xue, Z. AU - Sun, M. AU - Sun, C. AU - Li, J. AU - Jin, L. AU - Yao, Y. DB - Scopus DO - 10.1159/000501537 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 204-216 ST - Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia T2 - Acta Haematologica TI - Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072191395&doi=10.1159%2f000501537&partnerID=40&md5=539fcd44df95b7b22d6e57d069d02d2b VL - 143 ID - 3104 ER - TY - JOUR AD - Pediatric Hematology/Oncology, National Cancer Institute, Cairo University, Cairo, Egypt Pediatric Hematology/Oncology, Children Cancer Hospital Egypt, Cairo, Egypt Clinical Pathology, Children Cancer Hospital Egypt, Cairo, Egypt Research Department, Children Cancer Hospital Egypt, Cairo, Egypt AU - Hafez, H. A. AU - Abdallah, A. AU - Hammad, M. AU - Hamdy, N. AU - Yassin, D. AU - Salem, S. AU - Hassanain, O. AU - Elhalaby, L. AU - Elhaddad, A. C7 - e13664 DB - Scopus DO - 10.1111/petr.13664 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience T2 - Pediatric Transplantation TI - Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079431955&doi=10.1111%2fpetr.13664&partnerID=40&md5=3af3db2f68f31657e601ac033bf2d316 VL - 24 ID - 3105 ER - TY - JOUR AD - Merck Pharmaceuticals, North Wales, PA, United States Division of Pediatric Hematology/Oncology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States Division of Pediatric Hematology/Oncology, Department of Oncology, Essentia Health Duluth Clinic, Duluth, MN, United States Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States AU - Bidadi, B. AU - Watson, A. AU - Weigel, B. AU - Oliveira, A. AU - Kirkham, J. AU - Arndt, C. C7 - e28288 DB - Scopus DO - 10.1002/pbc.28288 IS - 6 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 ST - Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report T2 - Pediatric Blood and Cancer TI - Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083663846&doi=10.1002%2fpbc.28288&partnerID=40&md5=a837b790d9c673fa14834f59df7c942c VL - 67 ID - 3107 ER - TY - JOUR AD - Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, St. James' Hospital Campus, Dublin, Ireland Irish Centre for Vascular Biology, Trinity College Dublin, Dublin, Ireland Peking-Tsinghua Center for Life Sciences, Beijing, China AU - Wang, L. Y. AU - Sun, X. J. AU - Wang, C. AU - Chen, S. F. AU - Li, Z. Y. AU - Chen, M. AU - Little, M. A. AU - Zhao, M. H. DB - Scopus DO - 10.1042/CS20200497 IS - 12 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1475-1489 ST - Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner T2 - Clinical Science TI - Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087110575&doi=10.1042%2fCS20200497&partnerID=40&md5=3e48c86fbe1f844caba47f438a4cea4f VL - 134 ID - 3111 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, 600 036, India AU - Karunakaran, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_36_20 IS - 3 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 383-392 ST - Drug review: Ibrutinib T2 - Indian Journal of Medical and Paediatric Oncology TI - Drug review: Ibrutinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088495407&doi=10.4103%2fijmpo.ijmpo_36_20&partnerID=40&md5=aef16998f1f387b30e47d15a31dcecd5 VL - 41 ID - 3113 ER - TY - JOUR AD - Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Mishra, K. AU - Jandial, A. AU - Singh, V. AU - Radotra, B. AU - Malhotra, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_234_18 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 418-420 ST - Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions T2 - Indian Journal of Medical and Paediatric Oncology TI - Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088495194&doi=10.4103%2fijmpo.ijmpo_234_18&partnerID=40&md5=006381fba332ab7187ca50918f536f8f VL - 41 ID - 3117 ER - TY - JOUR AD - Department of Hematology and Oncology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Hämatologie und Onkologie, III. Medizinische Klinik, Wissenschaftliches Labor, Universitätsklinikum Mannheim GmbH, Pettenkoferstraße 22, Mannheim, 68169, Germany AU - Spiess, B. AU - Kleiner, H. AU - Flach, J. AU - Fabarius, A. AU - Saussele, S. AU - Hofmann, W. K. AU - Seifarth, W. DB - Scopus DO - 10.1007/s00277-020-04007-4 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 991-1006 ST - Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients T2 - Annals of Hematology TI - Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083058819&doi=10.1007%2fs00277-020-04007-4&partnerID=40&md5=ea7b49126d90354f5822075de0d80540 VL - 99 ID - 3120 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Center for Personalized Cancer Therapy, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San diego, CA, United States Sarah Cannon Research Institute at HealthONE, Denver, CO, United States Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Subbiah, V. AU - Dumbrava, E. I. AU - Jiang, Y. AU - Thein, K. Z. AU - Naing, A. AU - Hong, D. S. AU - Fu, S. AU - Piha-Paul, S. A. AU - Tsimberidou, A. M. AU - Janku, F. AU - Meric-Bernstam, F. AU - Kurzrock, R. AU - Falchook, G. C7 - 7 DB - Scopus DO - 10.1186/s40164-020-00159-1 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: A phase 1 dose escalation triplet combination trial T2 - Experimental Hematology and Oncology TI - Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: A phase 1 dose escalation triplet combination trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084392612&doi=10.1186%2fs40164-020-00159-1&partnerID=40&md5=408a9eec51646fc869e21201a90c7b01 VL - 9 ID - 3122 ER - TY - JOUR AD - Department of Hematology, First Affiliated Hospital of Anhui Medical University, Hefei, China Department of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China AU - Ni, J. AU - Hong, J. AU - Zhang, Z. AU - Li, Q. AU - Xia, R. AU - Zeng, Q. AU - Sun, G. DB - Scopus DO - 10.1080/10428194.2019.1702186 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1195-1200 ST - Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia T2 - Leukemia and Lymphoma TI - Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076927453&doi=10.1080%2f10428194.2019.1702186&partnerID=40&md5=7b302e9057dc6bfc5c067644e596e609 VL - 61 ID - 3123 ER - TY - JOUR AD - Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, United States AU - Shulman, D. S. AU - DuBois, S. G. DB - Scopus DO - 10.1007/s40272-020-00380-9 IS - 2 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 189-197 ST - The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers T2 - Pediatric Drugs TI - The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078202727&doi=10.1007%2fs40272-020-00380-9&partnerID=40&md5=44afe8664405fae8eaecc43f28faa3fc VL - 22 ID - 3126 ER - TY - JOUR AD - Klinik für Innere Medizin II, Universitätsklinikum, Jena, Germany Department of Hematology/Oncology, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy Weill Cornell Medical College, New York, NY, United States Karmanos Cancer Center, Detroit, MI, United States Hammersmith Hospital, Imperial College, London, United Kingdom Hospital Clinic IDIBAPS, Barcelona, Spain Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom Georgia Cancer Center, Augusta University, Augusta, GA, United States Huntsman Cancer Center Salt Lake City, Salt Lake City, UT, United States Centre Hospitalier Universitaire de Poitiers, Poitiers, France Norwegian University of Science and Technology, Trondheim, Norway South Australian Health and Medical Research Institute, Adelaide, SA, Australia Amsterdam University Medical Center, VUMC, Amsterdam, Netherlands MD Anderson Cancer Center, Houston, TX, United States St. Mary´s Hematology Hospital, The Catholic University, Seoul, South Korea University of Chicago, Chicago, IL, United States University of Toronto, Toronto, Canada Institut Bergonie, Université de Bordeaux, Bordeaux, France Department of Internal Medicine, Masaryk University Hospital, Brno, Czech Republic Centre Léon Bérard, Lyon, France Universitätsklinikum, Leipzig, Germany Department Clinical Medicine and Surgery, University Federico Secondo, Naples, Italy Fred Hutchinson Cancer Center, Seattle, WA, United States Hôpital St. Louis, Paris, France University of Lund, Lund, Sweden Centre Hospitalier de Versailles, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France University of Turin, Turin, Italy III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany Hospital de la Princesa, Madrid, Spain National Research Center for Hematology, Moscow, Russian Federation Almazov National Research Centre, St. Petersburg, Russian Federation ELN Foundation, Weinheim, Germany AU - Hochhaus, A. AU - Baccarani, M. AU - Silver, R. T. AU - Schiffer, C. AU - Apperley, J. F. AU - Cervantes, F. AU - Clark, R. E. AU - Cortes, J. E. AU - Deininger, M. W. AU - Guilhot, F. AU - Hjorth-Hansen, H. AU - Hughes, T. P. AU - Janssen, J. J. W. M. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Larson, R. A. AU - Lipton, J. H. AU - Mahon, F. X. AU - Mayer, J. AU - Nicolini, F. AU - Niederwieser, D. AU - Pane, F. AU - Radich, J. P. AU - Rea, D. AU - Richter, J. AU - Rosti, G. AU - Rousselot, P. AU - Saglio, G. AU - Saußele, S. AU - Soverini, S. AU - Steegmann, J. L. AU - Turkina, A. AU - Zaritskey, A. AU - Hehlmann, R. DB - Scopus DO - 10.1038/s41375-020-0776-2 IS - 4 M3 - Review N1 - Cited By :47 Export Date: 18 November 2020 PY - 2020 SP - 966-984 ST - European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia T2 - Leukemia TI - European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081568026&doi=10.1038%2fs41375-020-0776-2&partnerID=40&md5=917a18fb64e4bbf2aaf86b5588ba1f44 VL - 34 ID - 3130 ER - TY - JOUR AD - Divisions of Hospital Medicine Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, FL, Miami, United States AU - Florindez, J. AU - Trent, J. DB - Scopus DO - 10.1097/COC.0000000000000659 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 270-278 ST - Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients T2 - American journal of clinical oncology TI - Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082561193&doi=10.1097%2fCOC.0000000000000659&partnerID=40&md5=3c60f8cfaa50fb56dd556aa06ad6a686 VL - 43 ID - 3132 ER - TY - JOUR AD - National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Sano Suzhou Precision Medicine Co., Ltd, Suzhou, China Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States AU - Dai, H. P. AU - Yin, J. AU - Li, Z. AU - Yang, C. X. AU - Cao, T. AU - Chen, P. AU - Zong, Y. H. AU - Zhu, M. Q. AU - Zhu, X. M. AU - Xiao, S. AU - Wu, D. P. AU - Tang, X. W. C7 - 359 DB - Scopus DO - 10.3389/fonc.2020.00359 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion T2 - Frontiers in Oncology TI - Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083055764&doi=10.3389%2ffonc.2020.00359&partnerID=40&md5=078cbc4d4df57455cf8832cb185b1429 VL - 10 ID - 3136 ER - TY - JOUR AD - Department of Hematology Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Japan Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Interfactulty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan Department of Hematology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Division of Hematology and Oncology, Japanese Red Cross Society, Narita Red Cross Hospital, Narita, Japan Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan Hematology Division, Showa General Hospital, Tokyo, Japan Division of Hematology and Oncology, Gunma Prefectural Cancer Center, Ohta, Japan Department of Hematology, National Hospital Organization, Mito Medical Center, Higashiibarakigun, Ibaraki, Japan Department of Hematology, Tokyo Medical University, Tokyo, Japan Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan Tokai Central Hospital, Kakamigahara, Japan Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan AU - Yamaguchi, H. AU - Takezako, N. AU - Ohashi, K. AU - Oba, K. AU - Kumagai, T. AU - Kozai, Y. AU - Wakita, H. AU - Yamamoto, K. AU - Fujita, A. AU - Igarashi, T. AU - Yoshida, C. AU - Ohyashiki, K. AU - Okamoto, S. AU - Sakamoto, J. AU - Sakamaki, H. AU - Inokuchi, K. DB - Scopus DO - 10.1007/s12185-019-02801-z IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 401-408 ST - Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group T2 - International Journal of Hematology TI - Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077208389&doi=10.1007%2fs12185-019-02801-z&partnerID=40&md5=daab5920b2b89b6a2031e6ab4f1b6d10 VL - 111 ID - 3138 ER - TY - JOUR AD - Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China AU - Liu, Y. AU - Chen, X. AU - Gao, X. AU - Chen, J. X. AU - Chen, J. DB - Scopus DO - 10.1177/1078155219846253 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 465-470 ST - Apatinib-induced hyperammonemic encephalopathy T2 - Journal of Oncology Pharmacy Practice TI - Apatinib-induced hyperammonemic encephalopathy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065647457&doi=10.1177%2f1078155219846253&partnerID=40&md5=11f23bc210c5b79d50c2f560669dabe1 VL - 26 ID - 3140 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Kuzuya, T. AU - Ishigami, M. AU - Ito, T. AU - Ishizu, Y. AU - Honda, T. AU - Ishikawa, T. AU - Fujishiro, M. DB - Scopus DO - 10.1111/hepr.13452 IS - 3 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2020 SP - 374-381 ST - Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma T2 - Hepatology Research TI - Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076898400&doi=10.1111%2fhepr.13452&partnerID=40&md5=b709e528c615ab2cd43fb59888a9c537 VL - 50 ID - 3141 ER - TY - JOUR AD - Department of Oncology, Aarhus University Hospital, Aarhus, Denmark AU - Aggerholm-Pedersen, N. AU - Rossen, P. AU - Rose, H. AU - Safwat, A. DB - Scopus DO - 10.1016/j.tranon.2019.12.001 IS - 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 295-299 ST - Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience T2 - Translational Oncology TI - Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076851219&doi=10.1016%2fj.tranon.2019.12.001&partnerID=40&md5=6a233f179be9fd2de995d96ce8194f8f VL - 13 ID - 3153 ER - TY - JOUR AD - Departments of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Department of Anesthesiology, Tianjin Hospital, Tianjin, Tianjin, 300000, China Molecular Imaging, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pharmacological Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Key Laboratory of Molecular Cancer Epidemiology, Tianjin, 300060, China AU - Liu, X. AU - Xu, J. AU - Li, F. AU - Liao, Z. AU - Ren, Z. AU - Zhu, L. AU - Shi, Y. AU - Zhao, G. AU - Bai, X. AU - Zhao, J. AU - Xing, R. AU - Teng, S. AU - Yang, Y. AU - Yang, J. C7 - 109587 DB - Scopus DO - 10.1016/j.biopha.2019.109587 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846 T2 - Biomedicine and Pharmacotherapy TI - Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075526595&doi=10.1016%2fj.biopha.2019.109587&partnerID=40&md5=86f60c405fdf02ea3e7e0937064901fa VL - 122 ID - 3154 ER - TY - JOUR AD - Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan Department of Dermatology, Fukuoka University School of Medicine, Fukuoka, Japan AU - Ehara, Y. AU - Koga, M. AU - Imafuku, S. AU - Yamamoto, O. AU - Yoshida, Y. DB - Scopus DO - 10.1111/1346-8138.15194 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 190-192 ST - Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1 T2 - Journal of Dermatology TI - Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076765321&doi=10.1111%2f1346-8138.15194&partnerID=40&md5=838c685741f64208de90accd959d3e17 VL - 47 ID - 3157 ER - TY - JOUR AD - Department of Pathology, University of New Mexico, School of Medicine, Albuquerque, NM, United States University of New Mexico, Comprehensive Cancer Center, Albuquerque, NM, United States Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States AU - Harvey, R. C. AU - Tasian, S. K. DB - Scopus DO - 10.1182/bloodadvances.2019000163 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2020 SP - 218-228 ST - Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia T2 - Blood Advances TI - Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078112931&doi=10.1182%2fbloodadvances.2019000163&partnerID=40&md5=80886b123d1b3095edd76d05106be304 VL - 4 ID - 3161 ER - TY - JOUR AD - Dipartimento di Farmacia Scienze del Farmaco Università degli Studi di Bari “Aldo Moro”, via Orabona 4, Bari, 70125, Italy AU - Carofiglio, F. AU - Lopalco, A. AU - Lopedota, A. AU - Cutrignelli, A. AU - Nicolotti, O. AU - Denora, N. AU - Stefanachi, A. AU - Leonetti, F. C7 - 4469 DB - Scopus DO - 10.3390/ijms21124469 IS - 12 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1-21 ST - Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml T2 - International Journal of Molecular Sciences TI - Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086938282&doi=10.3390%2fijms21124469&partnerID=40&md5=bec416c6d5eaae98ff97d0e60e69dd89 VL - 21 ID - 3163 ER - TY - JOUR AD - Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, 1 and 2 Press Enclave Marg, Saket Institutional Area, Saket, New Delhi, 110017, India AU - Jeyaraman, P. AU - Naithani, R. DB - Scopus DO - 10.1097/MPH.0000000000001624 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - e64-e65 ST - Discontinuation of Imatinib in a Child with Chronic Myeloid Leukemia T2 - Journal of Pediatric Hematology/Oncology TI - Discontinuation of Imatinib in a Child with Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074465964&doi=10.1097%2fMPH.0000000000001624&partnerID=40&md5=7a612b6d740b1e8c923a76f152cbbd20 VL - 42 ID - 3167 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin and Children's Milwaukee, Milwaukee, WI, United States Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pharmacy, Wolfson Children's Hospital, United States Department of Pediatrics, Division of Pediatric Hematology/Oncology, Nemours Children's Specialty Care and Wolfson Children's Hospital JacksonvilleFL, United States AU - Pommert, L. AU - Liberio, N. AU - Ng, J. S. AU - Egelund, T. A. AU - Siver, M. J. AU - Katzenstein, H. M. AU - Burke, M. J. DB - Scopus DO - 10.1097/MPH.0000000000001816 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Concurrent Imatinib Dosing with High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients with Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia T2 - Journal of Pediatric Hematology/Oncology TI - Concurrent Imatinib Dosing with High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients with Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085508892&doi=10.1097%2fMPH.0000000000001816&partnerID=40&md5=664566a62720f526d4e5bf0cc7df9bb0 ID - 3168 ER - TY - JOUR AD - Clinical and Translational Oncology Group, Clínica del Country, Calle 116 No. 9-72, c. 318, Bogotá, Colombia Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCaN), México city, Mexico Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia Thoracic Oncology Program, Memorial Cancer Institute (MCI), Florida International University (FIU), Miami, FL, United States Thoracic Medical Oncology and Early Clinical Trials Unit, University of Maryland, Baltimore, MD, United States Global Clinical Development, Merck KGaA, Darmstadt, Germany Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Catalunya, Spain Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Catalunya, Spain AU - Cardona, A. F. AU - Arrieta, O. AU - Ruiz-Patiño, A. AU - Sotelo, C. AU - Zamudio-Molano, N. AU - Zatarain-Barrón, Z. L. AU - Ricaurte, L. AU - Raez, L. AU - Álvarez, M. P. P. AU - Barrón, F. AU - Rojas, L. AU - Rolfo, C. AU - Karachaliou, N. AU - Molina-Vila, M. A. AU - Rosell, R. DB - Scopus DO - 10.1177/1753466620938553 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries T2 - Therapeutic Advances in Respiratory Disease TI - Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087711760&doi=10.1177%2f1753466620938553&partnerID=40&md5=448bf48411c49086f9230b613ee1e135 VL - 14 ID - 3170 ER - TY - JOUR AD - Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey AU - Aksu, T. AU - Ünal, Ş AU - Gümrük, F. DB - Scopus DO - 10.24953/turkjped.2020.03.016 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 479-481 ST - The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia T2 - Turkish Journal of Pediatrics TI - The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086719637&doi=10.24953%2fturkjped.2020.03.016&partnerID=40&md5=25d84900d78bbcbd06b12ad2df83c678 VL - 62 ID - 3171 ER - TY - JOUR AD - Department of Surgical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, 380 004, India AU - Tadaiya, M. V. K. AU - Tankshali, R. DB - Scopus DO - 10.4103/ijmpo.ijmpo_73_18 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 89-92 ST - Multiple small bowel perforations in a patient of chronic myeloid leukemia on imatinib T2 - Indian Journal of Medical and Paediatric Oncology TI - Multiple small bowel perforations in a patient of chronic myeloid leukemia on imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085148436&doi=10.4103%2fijmpo.ijmpo_73_18&partnerID=40&md5=062869cf9ada0d50cccf426b874d0427 VL - 41 ID - 3172 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People’s Hospital, Beijing, China AU - Xie, L. AU - Xu, J. AU - Sun, X. AU - Tang, X. AU - Yan, T. AU - Yang, R. AU - Guo, W. DB - Scopus DO - 10.2147/CMAR.S232823 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 91-102 ST - Anorexia, hypertension, pneumothorax, and hypothyroidism: Potential signs of improved clinical outcome following apatinib in advanced osteosarcoma T2 - Cancer Management and Research TI - Anorexia, hypertension, pneumothorax, and hypothyroidism: Potential signs of improved clinical outcome following apatinib in advanced osteosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077842518&doi=10.2147%2fCMAR.S232823&partnerID=40&md5=dd98433bc7a1bb03f709c30a2bf270b6 VL - 12 ID - 3173 ER - TY - JOUR AD - Department of Pediatric Hematology, Medical Faculty, Uludag University, Nilüfer, Bursa, Turkey Pediatric Oncology Unit, University Hospital, Poitiers, France Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland Department of Pediatric and Adolescent Medicine, University of Copenhagen, Copenhagen, Denmark Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic Department of Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands Children's Cancer Research Institute and St. Anna Children's Hospital, Pediatric Clinic, Medical University of Vienna, Vienna, Austria Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium Medical Faculty, Pediatric Hematology-Oncology, Technical University of Dresden, Dresden, Germany AU - Meral Günes, A. AU - Millot, F. AU - Kalwak, K. AU - Lausen, B. AU - Sedlacek, P. AU - Versluys, A. B. AU - Dworzak, M. AU - De Moerloose, B. AU - Suttorp, M. DB - Scopus DO - 10.1002/pbc.28706 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry T2 - Pediatric Blood and Cancer TI - Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092357102&doi=10.1002%2fpbc.28706&partnerID=40&md5=959d5f6c26711d8e9e184a169f707bd6 ID - 3174 ER - TY - JOUR AD - Pediatric Oncology Research Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark AU - Rank, C. U. AU - Schmiegelow, K. DB - Scopus DO - 10.1053/j.seminhematol.2020.08.001 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020 T2 - Seminars in Hematology TI - Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091018632&doi=10.1053%2fj.seminhematol.2020.08.001&partnerID=40&md5=10b203fc58065f3a86c210ab129c663a ID - 3176 ER - TY - JOUR AD - Division of Hematology/Oncology, University of California, San Diego, CA, United States Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California, San Diego, CA, United States AU - Schwartz, M. AU - Wieduwilt, M. J. DB - Scopus DO - 10.1053/j.seminhematol.2020.09.001 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - New approaches to the treatment of older adults with acute lymphoblastic leukemia T2 - Seminars in Hematology TI - New approaches to the treatment of older adults with acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091711352&doi=10.1053%2fj.seminhematol.2020.09.001&partnerID=40&md5=f4254a9b1cb877531113eaaa445e4358 ID - 3177 ER - TY - JOUR AD - Early Drug Development and Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Weill Cornell Medical College, New York, NY, United States Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States AU - Drilon, A. AU - Jenkins, C. AU - Iyer, S. AU - Schoenfeld, A. AU - Keddy, C. AU - Davare, M. A. DB - Scopus DO - 10.1038/s41571-020-0408-9 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - ROS1-dependent cancers — biology, diagnostics and therapeutics T2 - Nature Reviews Clinical Oncology TI - ROS1-dependent cancers — biology, diagnostics and therapeutics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089025894&doi=10.1038%2fs41571-020-0408-9&partnerID=40&md5=48169b53fe4ea380670b0bb085f2e16c ID - 3178 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, Fukushima Medical University, Fukushima, 960-1295, Japan Fukushima Medical Center for Children and Women, Fukushima Medical University, Fukushima, 960-1295, Japan AU - Furukawa, Y. AU - Takahashi, T. AU - Suganuma, R. AU - Ohara, M. AU - Ota, K. AU - Kyozuka, H. AU - Yamaguchi, A. AU - Soeda, S. AU - Watanabe, T. AU - Komiya, H. AU - Mizunuma, H. AU - Fujimori, K. C7 - e2020005 DB - Scopus DO - 10.4084/MJHID.2020.005 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: Case report and literature review T2 - Mediterranean Journal of Hematology and Infectious Diseases TI - Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077906144&doi=10.4084%2fMJHID.2020.005&partnerID=40&md5=0759d611f34a85b206960aac2bcab0e0 VL - 11 ID - 3181 ER - TY - JOUR AD - Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China AU - Wang, H. Y. AU - Chu, J. F. AU - Zhang, P. AU - Wang, J. Q. AU - Yan, Z. AU - Yao, S. N. AU - Yao, Z. H. AU - Liu, Y. Y. DB - Scopus DO - 10.2147/OTT.S235349 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2020 SP - 1561-1568 ST - Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma T2 - OncoTargets and Therapy TI - Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079846649&doi=10.2147%2fOTT.S235349&partnerID=40&md5=3c2b50804c55aa89c863cad701c3572f VL - 13 ID - 3183 ER - TY - JOUR AD - Departments of Oncology and Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, United States AU - Pui, C. H. DB - Scopus DO - 10.1007/s11684-020-0759-8 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Precision medicine in acute lymphoblastic leukemia T2 - Frontiers of Medicine TI - Precision medicine in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092742355&doi=10.1007%2fs11684-020-0759-8&partnerID=40&md5=da76e8a77251846621bcf906fbc763e5 ID - 3184 ER - TY - JOUR AD - Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center Hospital, Yokohama, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan Department of Gastroenterology, Shonan Fujisawa General Hospital, Fujisawa, Japan Department of Gastroenterology, Kanagawa Prefectural Ashigarakami Hospital, Kanagawa, Japan Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan Department of Gastroenterology, Yokohama City University Hospital, Yokohama, Japan Department of Gastroenterology, Shonan Kamakura General Hospital, Kamakura, Japan Gastroenterology Division, Hadano Red Cross Hospital, Hadano, Japan AU - Ogushi, K. AU - Chuma, M. AU - Uojima, H. AU - Hidaka, H. AU - Numata, K. AU - Kobayashi, S. AU - Hirose, S. AU - Hattori, N. AU - Fujikawa, T. AU - Nakazawa, T. AU - Wada, N. AU - Iwasaki, S. AU - Fukushima, T. AU - Sano, Y. AU - Ueno, M. AU - Kawano, K. AU - Tsuruya, K. AU - Shomura, M. AU - Watanabe, T. AU - Matsunaga, K. AU - Kunishi, Y. AU - Saigusa, Y. AU - Irie, K. AU - Iwabuchi, S. AU - Kako, M. AU - Morimoto, M. AU - Kagawa, T. AU - Tanaka, K. AU - Maeda, S. DB - Scopus DO - 10.2147/CEG.S256691 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 385-396 ST - Safety and efficacy of lenvatinib treatment in child–pugh a and b patients with unresectable hepatocellular carcinoma in clinical practice: a multicenter analysis T2 - Clinical and Experimental Gastroenterology TI - Safety and efficacy of lenvatinib treatment in child–pugh a and b patients with unresectable hepatocellular carcinoma in clinical practice: a multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091910417&doi=10.2147%2fCEG.S256691&partnerID=40&md5=b852839033b04856b49e52f5b0183a7f VL - 13 ID - 3186 ER - TY - JOUR AD - Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China AU - Ma, X. AU - Li, L. AU - Zhang, L. AU - Fu, X. AU - Li, X. AU - Wang, X. AU - Wu, J. AU - Sun, Z. AU - Zhang, X. AU - Feng, X. AU - Chang, Y. AU - Zhou, Z. AU - Nan, F. AU - Zhang, J. AU - Li, Z. AU - Zhang, M. DB - Scopus DO - 10.2147/DDDT.S227477 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 275-284 ST - Apatinib in patients with relapsed or refractory diffuse large B cell lymphoma: A phase ii, open-label, single-arm, prospective study T2 - Drug Design, Development and Therapy TI - Apatinib in patients with relapsed or refractory diffuse large B cell lymphoma: A phase ii, open-label, single-arm, prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078676833&doi=10.2147%2fDDDT.S227477&partnerID=40&md5=8b713c9a11a7c532c93da4bcdede44af VL - 14 ID - 3187 ER - TY - JOUR AD - Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Universitat de Barcelona, 170 Villarroel street, Barcelona, 08036, Spain BCLC Group, Pathology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C/Villarroel 170, Escala 3 Planta 1, Barcelona, 08036, Spain BCLC Group, Radiology Department, Hospital Clinic of Barcelona, Biomedical Research Center Network for Liver and Digestive Diseases (CIBERehd), University of Barcelona, C/Villarroel 170, Escala 3 Planta 1, Barcelona, 08036, Spain AU - Diáz-González, Á AU - Belmonte, E. AU - Sapena, V. AU - Sanduzzi-Zamparelli, M. AU - Darnell, A. AU - Diáz, A. AU - Gomes Da Fonseca, L. AU - Llarch, N. AU - Iserte, G. AU - Ayuso, C. AU - Forner, A. AU - Bruix, J. AU - Rimola, J. AU - Reig, M. DB - Scopus DO - 10.1097/MCG.0000000000001366 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Pancreatic Insufficiency in Patients under Sorafenib Treatment for Hepatocellular Carcinoma T2 - Journal of Clinical Gastroenterology TI - Pancreatic Insufficiency in Patients under Sorafenib Treatment for Hepatocellular Carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086773844&doi=10.1097%2fMCG.0000000000001366&partnerID=40&md5=16748abb30b0e985fa2a4995f3857063 ID - 3188 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Matsuyama, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan AU - Tada, T. AU - Kumada, T. AU - Hiraoka, A. AU - Michitaka, K. AU - Atsukawa, M. AU - Hirooka, M. AU - Tsuji, K. AU - Ishikawa, T. AU - Takaguchi, K. AU - Kariyama, K. AU - Itobayashi, E. AU - Tajiri, K. AU - Shimada, N. AU - Shibata, H. AU - Ochi, H. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Nagano, T. AU - Itokawa, N. AU - Hayama, K. AU - Imai, M. AU - Joko, K. AU - Koizumi, Y. AU - Hiasa, Y. DB - Scopus DO - 10.1111/hepr.13427 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2020 SP - 75-83 ST - Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching T2 - Hepatology Research TI - Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076343239&doi=10.1111%2fhepr.13427&partnerID=40&md5=3c98d11fc35abca7a9879ca8549c501a VL - 50 ID - 3192 ER - TY - JOUR AD - Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China AU - Wang, Y. AU - Lu, M. AU - Zhou, Y. AU - Zhou, S. AU - Yu, X. AU - Tang, F. AU - Luo, Y. AU - Zhang, W. AU - Duan, H. AU - Min, L. AU - Tu, C. DB - Scopus DO - 10.2147/CMAR.S254296 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 5255-5264 ST - The efficacy and safety of apatinib in advanced synovial sarcoma: A case series of twenty-one patients in one single institution T2 - Cancer Management and Research TI - The efficacy and safety of apatinib in advanced synovial sarcoma: A case series of twenty-one patients in one single institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087385601&doi=10.2147%2fCMAR.S254296&partnerID=40&md5=55b0db6d26005413fb0658c2feb20628 VL - 12 ID - 3193 ER - TY - JOUR AD - Institution of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road 1277 Jianghan District, Wuhan, Hubei Province, China Institution of Hematology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Li, X. AU - Cai, S. AU - Zhong, Z. AU - Wang, H. AU - Wang, L. AU - You, Y. AU - Zhang, M. C7 - e19256 DB - Scopus DO - 10.1097/MD.0000000000019256 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report T2 - Medicine (United States) TI - Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080068200&doi=10.1097%2fMD.0000000000019256&partnerID=40&md5=d72652f97dd6dc0de852707fc86c7aa9 VL - 99 ID - 3194 ER - TY - JOUR AD - Department of Biochemistry, Faculty of Medicine, Level 17, Preclinical Building, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaakob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia AU - Jaafar, F. AU - Durani, L. W. AU - Makpol, S. DB - Scopus DO - 10.1007/s11033-019-05140-8 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 369-379 ST - Chlorella vulgaris modulates the expression of senescence-associated genes in replicative senescence of human diploid fibroblasts T2 - Molecular Biology Reports TI - Chlorella vulgaris modulates the expression of senescence-associated genes in replicative senescence of human diploid fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074044385&doi=10.1007%2fs11033-019-05140-8&partnerID=40&md5=8560857663ceb059173f5f104c56806c VL - 47 ID - 3203 ER - TY - JOUR AD - School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, South Korea Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea AU - Kim, S. AU - Kim, Y. E. AU - Hong, S. AU - Kim, K. T. AU - Sung, D. K. AU - Lee, Y. AU - Park, W. S. AU - Chang, Y. S. AU - Song, M. R. DB - Scopus DO - 10.1002/glia.23712 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 178-192 ST - Reactive microglia and astrocytes in neonatal intraventricular hemorrhage model are blocked by mesenchymal stem cells T2 - GLIA TI - Reactive microglia and astrocytes in neonatal intraventricular hemorrhage model are blocked by mesenchymal stem cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071277310&doi=10.1002%2fglia.23712&partnerID=40&md5=47e847acb68884838c1557be4ea7d3f6 VL - 68 ID - 3205 ER - TY - JOUR AD - Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza e Brianza per il Bambino e la sua Mamma Foundation, Azienda Socio Sanitaria Territoriale Monza, Monza, Italy Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan IRCCS Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy Division of Hematology/Oncology, Kanagawa Children’s Medical Center, Yokohama, Japan Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital, Seoul, South Korea Department of Pediatrics, Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Nationwide Children’s Hospital, Ohio State University, Columbus, OH, United States Department of Pediatrics, Hematology/Oncology Unit, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey Department of Pediatric Oncology, Hospital Niño Jesus, Madrid, Spain Centre Hospitalier Universitaire (CHU) Bordeaux, Oncologie Hématologie Pédiatrique, Université de Bordeaux, Unité INSERM U1218, Bordeaux, France Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, Netherlands Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands Innovative Therapies for Children with Cancer Consortium, Utrecht, Netherlands Unité d’Onco-Hématologie Pédiatrique, Clinical Investigation Center 1402 INSERM, CHU de Poitiers, Poitiers, France Novartis Pharma AG, Basel, Switzerland Clinical Development and Analytics Pharmacokinetics Sciences, and Trial Management, Novartis Pharma AG, Basel, Switzerland Trial Management, Novartis Pharma AG, Basel, Switzerland Department of Pediatrics, Hematology and Oncology Division, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Pediatrics, Columbia University Medical Center, 161 Fort Washington Ave, New York, NY 10032, United States AU - Hijiya, N. AU - Maschan, A. AU - Rizzari, C. AU - Shimada, H. AU - Dufour, C. AU - Goto, H. AU - Kang, H. J. AU - Guinipero, T. AU - Karakas, Z. AU - Bautista, F. AU - Ducassou, S. AU - Yoo, K. H. AU - Zwaan, C. M. AU - Millot, F. AU - Aimone, P. AU - Allepuz, A. AU - Quenet, S. AU - Hourcade-Potelleret, F. AU - Hertle, S. AU - Sosothikul, D. DB - Scopus DO - 10.1182/blood.2019000069 IS - 23 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 2036-2045 ST - Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia T2 - Blood TI - Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076196337&doi=10.1182%2fblood.2019000069&partnerID=40&md5=c1d0e0ed45d3dab8ba640249fd4e1710 VL - 134 ID - 3207 ER - TY - JOUR AD - Department of Pathology, Linyi People's Hospital, Linyi, China Department of Infectious Diseases, Linyi People's Hospital, Linyi, China AU - Liu, L. AU - Wang, L. AU - Li, X. AU - Tian, P. AU - Xu, H. AU - Li, Z. AU - Liu, E. DB - Scopus DO - 10.1080/21691401.2019.1664561 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3729-3736 ST - Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo T2 - Artificial Cells, Nanomedicine and Biotechnology TI - Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072389678&doi=10.1080%2f21691401.2019.1664561&partnerID=40&md5=6ba37820f103e46f14e0ebc9747c55e9 VL - 47 ID - 3209 ER - TY - JOUR AD - Massachusetts General Hospital, Boston, MA, United States Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy Memorial Sloan Kettering Cancer Center, New York, NY, United States Gustave Roussy Cancer Campus, Villejuif, France Department of Cancer Medicine, Paris-Sud University, Orsay, France National University Cancer Institute, Singapore, Singapore Chris O'Brien Lifehouse, Camperdown, NSW, Australia National Taiwan University Hospital, Taipei, Taiwan Sarah Cannon Cancer Research Institute and Tennessee Oncology, PLLC, Nashville, TN, United States Pfizer Global Product Development-Oncology, Cambridge, MA, United States Pfizer Global Product Development-Oncology, La Jolla, CA, United States Pfizer Oncology, Groton, CT, United States Pfizer Global Product Development-Oncology, Milan, Italy University of California Irvine, Irvine, CA, United States AU - Shaw, A. T. AU - Solomon, B. J. AU - Chiari, R. AU - Riely, G. J. AU - Besse, B. AU - Soo, R. A. AU - Kao, S. AU - Lin, C. C. AU - Bauer, T. M. AU - Clancy, J. S. AU - Thurm, H. AU - Martini, J. F. AU - Peltz, G. AU - Abbattista, A. AU - Li, S. AU - Ou, S. H. I. DB - Scopus DO - 10.1016/S1470-2045(19)30655-2 IS - 12 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2019 SP - 1691-1701 ST - Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial T2 - The Lancet Oncology TI - Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075141426&doi=10.1016%2fS1470-2045%2819%2930655-2&partnerID=40&md5=85de2eb31eb7479e8444b84816f3561f VL - 20 ID - 3211 ER - TY - JOUR AD - Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, United States ZS Associates, Evanston, IL, United States US Medical Affairs, AstraZeneca LP, Gaithersburg, MD, United States AU - Patel, K. AU - Sudhir, V. S. AU - Kabadi, S. AU - Huang, J. C. AU - Porwal, S. AU - Thakkar, K. AU - Pagel, J. M. DB - Scopus DO - 10.1177/1078155219827637 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 1897-1906 ST - Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees T2 - Journal of Oncology Pharmacy Practice TI - Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061489800&doi=10.1177%2f1078155219827637&partnerID=40&md5=434f1dce296b4e21a42781c39710da93 VL - 25 ID - 3212 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan Department of Hematology and Rheumatology, Kindai University, Osaka, Japan Clinical Research Support Center Kyushu, Fukuoka, Japan Department of Hematology and Infectious Diseases, Kumamoto University, Kumamoto, Japan Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan Department of Hematology, Osaka City University, Osaka, Japan Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan Department of Internal Medicine, Kagawa University, Kagawa, Japan Department of Hematology and Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan Division of Hematology, St. Mary’s Hospital, Kurume, Japan Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan Department of Hematology and Oncology, Osaka University, Osaka, Japan AU - Nagafuji, K. AU - Matsumura, I. AU - Shimose, T. AU - Kawaguchi, T. AU - Kuroda, J. AU - Nakamae, H. AU - Miyamoto, T. AU - Kadowaki, N. AU - Ishikawa, J. AU - Imamura, Y. AU - Yamazaki, H. AU - Akashi, K. AU - Kanakura, Y. DB - Scopus DO - 10.1007/s12185-019-02736-5 IS - 6 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 675-682 ST - Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) T2 - International Journal of Hematology TI - Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073942632&doi=10.1007%2fs12185-019-02736-5&partnerID=40&md5=952fdc3fd39b45604e0bca4880eea163 VL - 110 ID - 3213 ER - TY - JOUR AD - Department of Haematology, Toulouse University Cancer Institute, Toulouse, France Laboratory of Haematology, University Hospital Saint-Louis AP-HP and EA3518, University Paris Diderot, Paris, France Department of Oncology and Haematology, Saint Vincent de Paul Hospital, Lille, France Novartis Pharma S.A.S., Rueil-Malmaison, France Department of Haematology, University Hospital Centre, Reunion Island, Saint-Pierre, France Department of Clinical Haematology and Cell Therapy, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France Department of Medical Oncology, Institut Bergonié, Bordeaux, France AU - Huguet, F. AU - Cayuela, J. M. AU - Cambier, N. AU - Carpentier, N. AU - Tindel, M. AU - Violet, I. AU - Zunic, P. AU - Lascaux, A. AU - Etienne, G. AU - On behalf of Adhe, R. M. C. Investigators DB - Scopus DO - 10.1111/bjh.16145 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 615-626 ST - Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice T2 - British Journal of Haematology TI - Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070720553&doi=10.1111%2fbjh.16145&partnerID=40&md5=fa2c9909ba95ac18f8e9b1d0014f3ada VL - 187 ID - 3216 ER - TY - JOUR AD - Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, United States Department of Medicine, University of Minnesota, Minneapolis, MN, United States Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States Department of Medicine, City of Hope National Medical Center, Duarte, CA, United States Hematology-Oncology and Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, United States Department of Social Sciences and Pediatrics, City of Hope National Medical Center, Duarte, CA, United States Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States AU - Wu, J. AU - Chen, Y. AU - Hageman, L. AU - Francisco, L. AU - Ness, E. C. AU - Parman, M. AU - Kung, M. AU - Watson, J. A. AU - Weisdorf, D. J. AU - Snyder, D. S. AU - McGlave, P. B. AU - Forman, S. J. AU - Arora, M. AU - Armenian, S. H. AU - Bhatia, R. AU - Bhatia, S. DB - Scopus DO - 10.1002/cncr.32443 IS - 22 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 4033-4042 ST - Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report T2 - Cancer TI - Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070747925&doi=10.1002%2fcncr.32443&partnerID=40&md5=dd5e8824cf53a0b6fcf3c755560f809a VL - 125 ID - 3218 ER - TY - JOUR AD - School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, Jiangsu, China School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang, Jiangsu, China Institute of Environmental Health and Ecological Security, Jiangsu University, Zhenjiang, Jiangsu, China AU - Ding, Y. AU - Gao, K. AU - Liu, Y. AU - Mao, G. AU - Chen, K. AU - Qiu, X. AU - Zhao, T. AU - Yang, L. AU - Feng, W. AU - Wu, X. DB - Scopus DO - 10.1007/s00204-019-02590-8 IS - 11 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3183-3206 ST - Transcriptome analysis revealed the mechanism of the metabolic toxicity and susceptibility of di-(2-ethylhexyl)phthalate on adolescent male ICR mice with type 2 diabetes mellitus T2 - Archives of Toxicology TI - Transcriptome analysis revealed the mechanism of the metabolic toxicity and susceptibility of di-(2-ethylhexyl)phthalate on adolescent male ICR mice with type 2 diabetes mellitus UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074229900&doi=10.1007%2fs00204-019-02590-8&partnerID=40&md5=f18206e4a5f09ed7cf61090372123d2e VL - 93 ID - 3224 ER - TY - JOUR AD - Department of Plastic & Oral Surgery, Boston Children’s Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, United States Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Radiology, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Orthopedic Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Genetics, Harvard Medical School, Boston, United States AU - Goss, J. A. AU - Konczyk, D. J. AU - Smits, P. J. AU - Kozakewich, H. P. W. AU - Alomari, A. I. AU - Al-Ibraheemi, A. AU - Taghinia, A. H. AU - Dickie, B. H. AU - Adams, D. M. AU - Fishman, S. J. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. DB - Scopus DO - 10.1007/s10456-019-09678-w IS - 4 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 547-552 ST - Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations T2 - Angiogenesis TI - Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071748658&doi=10.1007%2fs10456-019-09678-w&partnerID=40&md5=1289d9c76fabfe4d387f764c0e9d2991 VL - 22 ID - 3225 ER - TY - JOUR AD - Department of Anatomy & Cell Biology, Gachon University College of Medicine, Incheon, 21936, South Korea Functional Cellular Networks Laboratory, College of Medicine, Department of Medicine, Graduate School and Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 21999, South Korea Shinwoo cooperation. Ltd., 991, Worasan-ro, Munsan-eup, Jinju, Gyeongsangnam-do 52839, South Korea Aqua Green Technology Co., Ltd., Smart Bldg., Jeju Science Park, Cheomdan-ro, Jeju, 63309, South Korea Department of Marine Life Science, Jeju National University, Jeju, 63243, South Korea Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University, Incheon, 21565, South Korea AU - Son, M. AU - Oh, S. AU - Lee, H. S. AU - Chung, D. M. AU - Jang, J. T. AU - Jeon, Y. J. AU - Choi, C. H. AU - Park, K. Y. AU - Son, K. H. AU - Byun, K. C7 - 2795 DB - Scopus DO - 10.3390/nu11112795 IS - 11 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Ecklonia cava extract attenuates endothelial cell dysfunction by modulation of inflammation and brown adipocyte function in perivascular fat tissue T2 - Nutrients TI - Ecklonia cava extract attenuates endothelial cell dysfunction by modulation of inflammation and brown adipocyte function in perivascular fat tissue UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075060755&doi=10.3390%2fnu11112795&partnerID=40&md5=be390521590ef8fceecce1fd5ccbe042 VL - 11 ID - 3227 ER - TY - JOUR AD - Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China AU - Xue, M. AU - Wang, Q. AU - Huo, L. AU - Wen, L. AU - Yang, X. AU - Wu, Q. AU - Pan, J. AU - Cen, J. AU - Ruan, C. AU - Wu, D. AU - Chen, S. DB - Scopus DO - 10.1080/10428194.2019.1607329 IS - 12 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 3051-3057 ST - Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts T2 - Leukemia and Lymphoma TI - Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068535211&doi=10.1080%2f10428194.2019.1607329&partnerID=40&md5=9fc6fba7e20822de1fe51e17d71b3f67 VL - 60 ID - 3229 ER - TY - JOUR AD - Department of Pediatrics and Orthopedics, David Geffen School of Medicine, University of California, Los Angeles, CA, United States Department of Medical Oncology, St. Vincent’s University Hospital & University College Dublin, Dublin, Ireland AU - Federman, N. AU - McDermott, R. DB - Scopus DO - 10.1080/17512433.2019.1661775 IS - 10 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 931-939 ST - Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer T2 - Expert Review of Clinical Pharmacology TI - Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073313039&doi=10.1080%2f17512433.2019.1661775&partnerID=40&md5=60050b74925aeffd3fb7afc064e90799 VL - 12 ID - 3230 ER - TY - JOUR AD - Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany EBMT Data Office Leiden, Leiden, Netherlands Chaim Sheba Medical Center, Tel-Hashomer, Israel University Hospital Eppendorf, Hamburg, Germany University of Freiburg, Freiburg, Germany Depariment of Internal Medicine III, University Hospital of Munich-Grosshadern, LMU, Munich, Germany Masaryk University Hospital Brno, Brno, Czech Republic Medical Park Hospitals, Antalya, Turkey Universita Cattolica S. Cuore, Rome, Italy University Hospital, Basel, Switzerland Nottingham University Hospital, Nottingham, United Kingdom Charles University Hospital, Pilsen, Czech Republic Leiden University Hospital, Leiden, Netherlands Hopital St. Louis, Paris, France University Hospital Gasthuisberg, Leuven, Belgium Radboud University Medical Centre, Nijmegen, Netherlands Hannover Medical School, Hannover, Germany HUCH Comprehensive Cancer Center, Helsinki, Finland Manchester Royal Infirmary, Manchester, United Kingdom Florence Nightingale Sisli Hospital, Istanbul, Turkey Hospital Sirio-Libanes, Sao Paulo, Brazil Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden CHU de Lille, LIRIC, INSERM U995, Universite de Lille, Lille, France Division of Hematology, Department of Oncology, University Hospital, Geneva, Switzerland Faculty of Medicine of Geneva, University of Geneva, Geneva, Switzerland AU - Radujkovic, A. AU - Dietrich, S. AU - Blok, H. J. AU - Nagler, A. AU - Ayuk, F. AU - Finke, J. AU - Tischer, J. AU - Mayer, J. AU - Koc, Y. AU - Sorà, F. AU - Passweg, J. AU - Byrne, J. L. AU - Jindra, P. AU - Veelken, J. H. AU - Socié, G. AU - Maertens, J. AU - Schaap, N. AU - Stadler, M. AU - Itälä-Remes, M. AU - Tholouli, E. AU - Arat, M. AU - Rocha, V. AU - Ljungman, P. AU - Yakoub-Agha, I. AU - Kröger, N. AU - Chalandon, Y. DB - Scopus DO - 10.1016/j.bbmt.2019.06.028 IS - 10 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2008-2016 ST - Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071381239&doi=10.1016%2fj.bbmt.2019.06.028&partnerID=40&md5=5eb22a803ee03c94e7fca23fc3225f01 VL - 25 ID - 3231 ER - TY - JOUR AD - Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea AU - Lee, T. Y. AU - Lee, S. AU - Bae, J. S. AU - Park, W. C. AU - Park, S. S. AU - Lee, S. E. AU - Lee, J. W. AU - Kim, S. K. AU - Cho, B. AU - Jung, C. K. DB - Scopus DO - 10.1245/s10434-019-07442-4 IS - 11 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 3586-3592 ST - Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation T2 - Annals of Surgical Oncology TI - Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066055089&doi=10.1245%2fs10434-019-07442-4&partnerID=40&md5=02564458e5c9c34bfe54797193391ee8 VL - 26 ID - 3232 ER - TY - JOUR AD - Institute of Pathology and Molecular Diagnostics, University Clinic Augsburg, Germany II. Medical Clinic, University Clinic Augsburg, Germany AU - Märkl, B. AU - Hirschbühl, K. AU - Dhillon, C. C7 - 152572 DB - Scopus DO - 10.1016/j.prp.2019.152572 IS - 10 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 ST - NTRK-Fusions – A new kid on the block T2 - Pathology Research and Practice TI - NTRK-Fusions – A new kid on the block UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072351002&doi=10.1016%2fj.prp.2019.152572&partnerID=40&md5=f0d4fef0ad2ec373d577de1a4df71fd4 VL - 215 ID - 3233 ER - TY - JOUR AD - Department of Medical Oncology, Clínica Universidad de Navarra, University of Navarra, Avda Pío XII, 36, Pamplona, 31008, Spain Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia Olivia Newton-John Cancer Research Institute at Austin Hospital, Heidelberg, VIC, Australia Gallipoli Medical Research Foundation, University of Queensland and Princess Alexandra Hospital, Brisbane, QLD, Australia School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia Auckland City Hospital, Auckland, New Zealand Melanoma Unit, European Institute of Oncology, Milano, Italy Department of Medical Oncology, Candiolo Cancer Institute, University of Torino, Torino, Italy Melanoma and Esophageal Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura A Carattere Scientifico, Padova, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy Department of Medical Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy UOC Oncologia Medica, IRCCS San Martino-IST, Genova, Italy Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom First Department of Oncology, Metropolitan Hospital, Athens, Greece UBC, Lörrach, Germany UBC, Montreal, QC, Canada Novartis Norge AS, Oslo, Norway Novartis Pharma AG, Basel, Switzerland AU - Martin-Algarra, S. AU - Hinshelwood, R. AU - Mesnage, S. AU - Cebon, J. AU - Ferrucci, P. F. AU - Aglietta, M. AU - Neyns, B. AU - Chiarion-Sileni, V. AU - Lindsay, C. R. AU - Del Vecchio, M. AU - Linardou, H. AU - Merelli, B. AU - Tonini, G. AU - Atkinson, V. AU - Freivogel, K. AU - Stein, D. AU - Dalland, L. AU - Lau, M. AU - Legenne, P. AU - Queirolo, P. AU - Millward, M. DB - Scopus DO - 10.1097/CMR.0000000000000608 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 527-532 ST - Effectiveness of dabrafenib in the treatment of patients with braf v600-mutated metastatic melanoma in a named patient program T2 - Melanoma Research TI - Effectiveness of dabrafenib in the treatment of patients with braf v600-mutated metastatic melanoma in a named patient program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071713811&doi=10.1097%2fCMR.0000000000000608&partnerID=40&md5=480058145b908e36fd4c14d0b60a790f VL - 29 ID - 3234 ER - TY - JOUR AD - Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan Blood Disorders Center, Aiiku Hospital, S4W25, Chuo-ku, Sapporo, 064-0804, Japan Department of Cell Physiology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan Department of Internal Medicine, Japan Labour Health and Welfare Organization, Kushiro Rosai Hospital, Kushiro, Japan Department of Hematology, Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo, Japan Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan Department of Hematology, Sapporo City General Hospital, Sapporo, Japan Department of Hematology, Tonan Hospital, Sapporo, Japan Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan AU - Kondo, T. AU - Fujioka, M. AU - Fujisawa, S. AU - Sato, K. AU - Tsuda, M. AU - Miyagishima, T. AU - Mori, A. AU - Iwasaki, H. AU - Kakinoki, Y. AU - Yamamoto, S. AU - Haseyama, Y. AU - Ando, S. AU - Shindo, M. AU - Ota, S. AU - Kurosawa, M. AU - Ohba, Y. AU - Teshima, T. AU - The North Japan Hematology Study, Group DB - Scopus DO - 10.1007/s12185-019-02696-w IS - 4 M3 - Article N1 - (NJHSG) Export Date: 18 November 2020 PY - 2019 SP - 482-489 ST - Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test T2 - International Journal of Hematology TI - Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068151164&doi=10.1007%2fs12185-019-02696-w&partnerID=40&md5=3710de66fa5fd1b1c202e8826839406b VL - 110 ID - 3235 ER - TY - JOUR AD - Department of Cytogenetics, National Institute of Immunohaematology (ICMR), 13th Floor, New Multistoried Building, KEM Hospital Campus, Parel, Mumbai, 400012, India Department of Hematology, KEM Hospital, 10th Floor, New Multistoried Building, Parel, Mumbai, 400012, India AU - Dhangar, S. AU - Shanbhag, V. AU - Shanmukhaiah, C. AU - Vundinti, B. R. DB - Scopus DO - 10.1007/s11033-019-04950-0 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 4997-5003 ST - Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients T2 - Molecular Biology Reports TI - Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068822582&doi=10.1007%2fs11033-019-04950-0&partnerID=40&md5=2671567626e4e986718dca7ae97f0804 VL - 46 ID - 3236 ER - TY - JOUR AD - Department of Clinical Pharmacology, Akros Pharma, Inc., Princeton, NJ, United States Chaikin Associates LLC, Sarasota, FL, United States DaVita Clinical Research, Minneapolis, MN, United States AU - Pai, S. M. AU - Chaikin, P. AU - Berg, J. K. DB - Scopus DO - 10.1002/jcph.1430 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 1379-1383 ST - Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance Hemodialysis T2 - Journal of Clinical Pharmacology TI - Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance Hemodialysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065748574&doi=10.1002%2fjcph.1430&partnerID=40&md5=67ecfdff3373012cc96c14c7ddb9139d VL - 59 ID - 3238 ER - TY - JOUR AD - Department of Medicine Division of Oncology, University of Washington, Seattle, WA, United States Clinical Research Division Fred Hutchinson Cancer Research Center, Seattle, WA, United States Seattle Cancer Care Alliance, Seattle, WA, United States AU - Bezerra, E. D. AU - Flowers, M. E. AU - Onstad, L. E. AU - Chielens, D. AU - Radich, J. AU - Higano, C. S. DB - Scopus DO - 10.1080/10428194.2019.1605508 IS - 11 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2754-2761 ST - A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation T2 - Leukemia and Lymphoma TI - A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064818998&doi=10.1080%2f10428194.2019.1605508&partnerID=40&md5=a5e4dbd8bf0803a8092acf19021a3bb3 VL - 60 ID - 3240 ER - TY - JOUR AD - Division of Hematology/Oncology, McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, ON, Canada Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Division of Pediatric Endocrinology and Metabolism, Emory University School of Medicine, Atlanta, GA, United States Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States Division of Hematology/Oncology, Golisano Children's Hospital, University of Rochester, Rochester, NY, United States Division of Hematology/Oncology, Ste Justine University Hospital Center, Montreal, QC, Canada Division of Hematology/Oncology/BMT, British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada Division of Hematology/Oncology, Children's Hospital of Wisconsin, Milwaukee, WI, United States Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States Nemours Center for Cancer and Blood Disorders, Nemours/Alfred I DuPont Hospital for Children, Wilmington, DE, United States Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada AU - Athale, U. AU - Hijiya, N. AU - Patterson, B. C. AU - Bergsagel, J. AU - Andolina, J. R. AU - Bittencourt, H. AU - Schultz, K. R. AU - Burke, M. J. AU - Redell, M. S. AU - Kolb, E. A. AU - Johnston, D. L. C7 - e27827 DB - Scopus DO - 10.1002/pbc.27827 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 ST - Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group T2 - Pediatric Blood and Cancer TI - Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067390025&doi=10.1002%2fpbc.27827&partnerID=40&md5=39f6d6856e105520c885fe6251a8c25b VL - 66 ID - 3241 ER - TY - JOUR AD - Institute for Digestive Heath and Liver Disease, Mercy Medical Center, Baltimore, MD, United States University of Maryland School of Medicine, 655 W Baltimore S, Baltimore, MD 21201, United States AU - Doycheva, I. AU - Thuluvath, P. J. DB - Scopus DO - 10.1016/j.jceh.2019.07.012 IS - 5 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 588-596 ST - Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field T2 - Journal of Clinical and Experimental Hepatology TI - Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071333373&doi=10.1016%2fj.jceh.2019.07.012&partnerID=40&md5=f94cd8d0a9a9038f75f88e3e00610dfb VL - 9 ID - 3243 ER - TY - JOUR AD - Department of Hepato-Gastroenterology, University Hospital F. Mitterrand, Dijon, France Department of Hepato-Gastroenterology, University Hospital Trousseau, Tours, France Department of Hepato-Gastroenterology, Robert Debré Hospital, Reims, France Fédération Française de Cancérologie Digestive (FFCD), Dijon, France Department of Hepato-Gastroenterology, Saint-Jean Hospital, Perpignan, France Department of Hepato-Gastroenterology, University Hospital Charles Nicolle, Rouen, France Department of Hepato-Gastroenterology, University Hospital Nord, Amiens, France Department of Hepato-Gastroenterology, University Hospital Côte de Nacre, Caen, France Department of Hepato-Gastroenterology, University Hospital Dupuytren, Limoges, France Department of Hepato-Gastroenterology, Les Oudairies Hospital, La Roche-sur-Yon, France Department of Medical Oncology, Auxerre Hospital, Auxerre, France Department of Hepato-Gastroenterology, University Hospital Haut-Lévêque, Pessac, France Department of Medical Oncology, Centre Catherine de Sienne, Nantes, France INSERM U954, University of Lorraine and University Hospital of Nancy, Vandoeuvre-les-Nancy, France Department of Oncology and Hepato-Gastroenterology, University Hospital La Timone, Marseille, France Department of Hepato-Gastroenterology, La Source Hospital, Orléans, France Department of Hepato-Gastroenterology, Louise Michel Hospital, Evry, France INSERM U1231, University of Bourgogne - Franche-Comté, Faculté de Médecine, Dijon, France Department of Hepato-Gastroenterology, University Hospital of Saint-Etienne – Hôpital Nord, Saint-Priest-en-Jarez, France AU - Jouve, J. L. AU - Lecomte, T. AU - Bouché, O. AU - Barbier, E. AU - Khemissa Akouz, F. AU - Riachi, G. AU - Nguyen Khac, E. AU - Ollivier-Hourmand, I. AU - Debette-Gratien, M. AU - Faroux, R. AU - Villing, A. L. AU - Vergniol, J. AU - Ramee, J. F. AU - Bronowicki, J. P. AU - Seitz, J. F. AU - Legoux, J. L. AU - Denis, J. AU - Manfredi, S. AU - Phelip, J. M. DB - Scopus DO - 10.1016/j.jhep.2019.04.021 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - 516-522 ST - Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma T2 - Journal of Hepatology TI - Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068447598&doi=10.1016%2fj.jhep.2019.04.021&partnerID=40&md5=15430b972d5b898451948edd3ad5be72 VL - 71 ID - 3244 ER - TY - JOUR AD - Texas Children's Cancer Center, Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States Division of Pediatric Surgery, Texas Children's Hospital Department of Surgery, Michael E. DeBakey Department of Surgery, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, United States Department of Cardiothoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China AU - Li, H. AU - Yu, Y. AU - Zhao, Y. AU - Wu, D. AU - Yu, X. AU - Lu, J. AU - Chen, Z. AU - Zhang, H. AU - Hu, Y. AU - Zhai, Y. AU - Su, J. AU - Aheman, A. AU - De las Casas, A. AU - Jin, J. AU - Xu, X. AU - Shi, Z. AU - Woodfield, S. E. AU - Vasudevan, S. A. AU - Agarwal, S. AU - Yan, Y. AU - Yang, J. AU - Foster, J. H. DB - Scopus DO - 10.1016/j.canlet.2019.05.011 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 129-141 ST - Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling T2 - Cancer Letters TI - Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065832592&doi=10.1016%2fj.canlet.2019.05.011&partnerID=40&md5=5ec9498a3dfddfcbf5e7276068a6d27b VL - 457 ID - 3249 ER - TY - JOUR AD - Department of Hepatology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan AU - Kotani, K. AU - Enomoto, M. AU - Okada, M. AU - Yoshida, K. AU - Motoyama, H. AU - Fujii, H. AU - Hagihara, A. AU - Uchida-Kobayashi, S. AU - Morikawa, H. AU - Murakami, Y. AU - Tamori, A. AU - Kawada, N. DB - Scopus DO - 10.1007/s12328-019-00983-x IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 355-360 ST - Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma T2 - Clinical Journal of Gastroenterology TI - Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064741462&doi=10.1007%2fs12328-019-00983-x&partnerID=40&md5=4790f9995df3abd4b8ff576047cf8320 VL - 12 ID - 3251 ER - TY - JOUR AD - Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China AU - Xue, Y. J. AU - Cheng, Y. F. AU - Lu, A. D. AU - Wang, Y. AU - Zuo, Y. X. AU - Yan, C. H. AU - Wu, J. AU - Sun, Y. Q. AU - Suo, P. AU - Chen, Y. H. AU - Chen, H. AU - Jia, Y. P. AU - Liu, K. Y. AU - Han, W. AU - Xu, L. P. AU - Zhang, L. P. AU - Huang, X. J. DB - Scopus DO - 10.1016/j.bbmt.2018.12.007 IS - 8 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - 1611-1620 ST - Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068741392&doi=10.1016%2fj.bbmt.2018.12.007&partnerID=40&md5=6aacfc93e6623a3e330bc507df395bdd VL - 25 ID - 3254 ER - TY - JOUR AD - Section of Adult and Pediatric Endocrinology, Diabetes, & Metabolism, The University of Chicago, United States AU - Yu, C. DB - Scopus DO - 10.3928/19382359-20190729-02 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - e326-e332 ST - Endocrine consequences of childhood cancer therapy and transition considerations T2 - Pediatric Annals TI - Endocrine consequences of childhood cancer therapy and transition considerations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071470048&doi=10.3928%2f19382359-20190729-02&partnerID=40&md5=a0012be913eb344d3b00cbd17652b30c VL - 48 ID - 3255 ER - TY - JOUR AD - Jiangsu Institute of Haematology, Key Laboratory of Thrombosis and Haemostasis, Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China Nanjing Medical University, Affiliated Wuxi Second Hospital, Department of Haematology, Zhongshan Road 68, Wuxi, 214002, China Jiangsu Institute of Haematology, First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou, 215006, China AU - Tan, J. AU - Xue, M. AU - Pan, J. AU - Cen, J. AU - Qi, X. AU - Liu, P. AU - Zhao, X. AU - Wu, P. AU - Wang, Q. AU - Liu, D. AU - Liu, Y. AU - Chen, S. AU - Wang, Z. DB - Scopus DO - 10.1159/000495335 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 79-86 ST - Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients T2 - Acta Haematologica TI - Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065909166&doi=10.1159%2f000495335&partnerID=40&md5=c27249b0d0a6918760c81eb9d22c4fcf VL - 142 ID - 3256 ER - TY - JOUR AD - Department of Dermatology, Medical Faculty, University Dresden, Dresden, D-01307, Germany Centre for Translational Bone, Joint and Soft Tissue Research, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany Department of Pediatrics, Shriners Hospital for Children, McGill University, Montreal, QC H4A 0A9, Canada Simon Alberti Group, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, D-01307, Germany Institute for Biochemistry, ETH Zurich, Zurich, CH-8093, Switzerland Department of Pediatrics, Division of Pediatric Hematology and Oncology, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany Department of Medicine III and Center for Healthy Aging, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany AU - Kroschwald, L. M. AU - Tauer, J. T. AU - Kroschwald, S. I. AU - Suttorp, M. AU - Wiedenfeld, A. AU - Beissert, S. AU - Bauer, A. AU - Rauner, M. DB - Scopus DO - 10.3892/ol.2019.10518 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2102-2108 ST - Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro T2 - Oncology Letters TI - Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069805676&doi=10.3892%2fol.2019.10518&partnerID=40&md5=463eafa6e85458ebc62bfa8f72e0ac90 VL - 18 ID - 3257 ER - TY - JOUR AD - Department of Interventional Oncology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China Interventional Department, Dongguan People's Hospital, Dongguan, China Liver and Gall Surgical Department, Gaozhou People's Hospital, Gaozhou, China Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Department of Medical Imaging, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China AU - Fan, W. AU - Yuan, G. AU - Fan, H. AU - Li, F. AU - Wu, Y. AU - Zhao, Y. AU - Yao, W. AU - Wang, Y. AU - Xue, M. AU - Yang, J. AU - Li, J. DB - Scopus DO - 10.1016/j.clinthera.2019.04.036 IS - 8 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 SP - 1463-1476 ST - Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study T2 - Clinical Therapeutics TI - Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068539821&doi=10.1016%2fj.clinthera.2019.04.036&partnerID=40&md5=6397147cf16120e2dbf6a87517ec7a1a VL - 41 ID - 3258 ER - TY - JOUR AD - Laboratory of Immunology and Virology, Shanghai University of Traditional Chinese Medicine, Shanghai, China Central Laboratory, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China Hutchison MediPharma Ltd, Shanghai, China Department of Emergency, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China AU - Qian, H. AU - Fan, S. AU - Li, K. AU - Sai, Y. AU - Su, W. AU - Chen, Q. AU - Liu, Y. AU - Li, T. AU - Wang, W. AU - Jia, J. AU - Yu, C. AU - Liu, Y. DB - Scopus DO - 10.1016/j.clinthera.2019.05.014 IS - 8 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 1537-1544 ST - Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects T2 - Clinical Therapeutics TI - Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068055019&doi=10.1016%2fj.clinthera.2019.05.014&partnerID=40&md5=4b37a1c50f12baa96d8709131d8416bc VL - 41 ID - 3260 ER - TY - JOUR AD - Department of Pathology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Chennai, Tamil Nadu, 600 116, India Department of Pediatric Hematology Oncology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Chennai, Tamil Nadu, India AU - Bernard, C. AU - Suman, F. R. AU - Rashmika, R. AU - Latha, M. S. AU - Scott, J. X. AU - Rajesh, V. DB - Scopus DO - 10.4103/ijmpo.ijmpo_234_17 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - S77-S81 ST - Profile of pediatric chronic myeloid leukemia in the era of imatinib: A study from South India T2 - Indian Journal of Medical and Paediatric Oncology TI - Profile of pediatric chronic myeloid leukemia in the era of imatinib: A study from South India UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070757605&doi=10.4103%2fijmpo.ijmpo_234_17&partnerID=40&md5=ed33d82c8ce16d974be3fdc18d480aa7 VL - 40 ID - 3265 ER - TY - JOUR AD - RCSI Centre for Systems Medicine, Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, D02 HX03, Ireland OncoMark Ltd., NovaUCD, Bellfield, University College Dublin, Dublin 4, D04 V2P1, Ireland Pathology Experts GmBH, Basel, CH-4108, Switzerland Beaumont Education Resource Centre, Beaumont Hospital, Dublin 9, D09 YD60, Ireland Department of Medical Oncology, VU University Medical CentreAmsterdam 1081HV, Netherlands UCD Cancer Biology and Therapeutics Laboratory, School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College DublinDublin D04 W6F6, Ireland Bayer AG, Wuppertal, 42117, Germany AU - O'Farrell, A. C. AU - Miller, I. S. AU - Evans, R. AU - Alamanou, M. AU - Cary, M. AU - Mallya Udupi, G. AU - Lafferty, A. AU - Monsefi, N. AU - Cremona, M. AU - Prehn, J. H. M. AU - Verheul, H. M. AU - Gallagher, W. M. AU - Gehrmann, M. AU - Byrne, A. T. C7 - 1800159 DB - Scopus DO - 10.1002/prca.201800159 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate T2 - Proteomics - Clinical Applications TI - Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063082592&doi=10.1002%2fprca.201800159&partnerID=40&md5=cbe6760cf55bf7f26668c1f2075fb3f5 VL - 13 ID - 3268 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan Faculty of Medicine, Department of Gastroenterology and Hepatology, Kindai University, Osaka, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Atsukawa, M. AU - Hirooka, M. AU - Tsuji, K. AU - Ishikawa, T. AU - Takaguchi, K. AU - Kariyama, K. AU - Itobayashi, E. AU - Tajiri, K. AU - Shimada, N. AU - Shibata, H. AU - Ochi, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Nagano, T. AU - Itokawa, N. AU - Hayama, K. AU - Imai, M. AU - Joko, K. AU - Koizumi, Y. AU - Hiasa, Y. AU - Michitaka, K. AU - Kudo, M. AU - the Real-life Practice Experts for Hcc Study Group, H. C. C. Group DB - Scopus DO - 10.1002/cam4.2241 IS - 8 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :41 Export Date: 18 November 2020 PY - 2019 SP - 3719-3728 ST - Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions—Multicenter analysis T2 - Cancer Medicine TI - Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions—Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069483972&doi=10.1002%2fcam4.2241&partnerID=40&md5=0ee6a371d70be5db38c9da3b2055d16e VL - 8 ID - 3270 ER - TY - JOUR AD - Department of Pediatrics, SSCIandH Lucknow, India Pediatric Hematology-Oncology Unit, Department of Pediatrics, King George's Medical University, Lucknow, 226006, India Department of Pediatric Oncology, Medanta-The Medicity, Gurgaon, India Department of Pediatrics, BVP, Pune, Maharashtra, India AU - Pant, G. AU - Kumar, A. AU - Verma, N. AU - Pooniya, V. AU - Sharma, A. AU - Gupta, B. DB - Scopus DO - 10.1097/MPH.0000000000001492 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 376-381 ST - Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: A Single-center Experience T2 - Journal of Pediatric Hematology/Oncology TI - Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: A Single-center Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064953909&doi=10.1097%2fMPH.0000000000001492&partnerID=40&md5=b0c44fd15b99c27b6cb9783c31ec9aec VL - 41 ID - 3273 ER - TY - JOUR AD - Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medical Affairs, Loxo Oncology, Inc., Stamford, CT, United States Department of Pathology, University of Colorado, Aurora, CO, United States AU - Hsiao, S. J. AU - Zehir, A. AU - Sireci, A. N. AU - Aisner, D. L. DB - Scopus DO - 10.1016/j.jmoldx.2019.03.008 IS - 4 M3 - Review N1 - Cited By :29 Export Date: 18 November 2020 PY - 2019 SP - 553-571 ST - Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy T2 - Journal of Molecular Diagnostics TI - Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067551421&doi=10.1016%2fj.jmoldx.2019.03.008&partnerID=40&md5=09a6065b2228293d0995457f0c6d0a32 VL - 21 ID - 3274 ER - TY - JOUR AD - Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, 63000, France UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France Department of Laboratories, Seattle Children's Hospital, University of Washington Medical Center, Seattle, WA, United States Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States AU - Penault-Llorca, F. AU - Rudzinski, E. R. AU - Sepulveda, A. R. DB - Scopus DO - 10.1136/jclinpath-2018-205679 IS - 7 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2019 SP - 460-467 ST - Testing algorithm for identification of patients with TRK fusion cancer T2 - Journal of Clinical Pathology TI - Testing algorithm for identification of patients with TRK fusion cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065572475&doi=10.1136%2fjclinpath-2018-205679&partnerID=40&md5=b6a140852ae144f378ffc20bcaedcd13 VL - 72 ID - 3275 ER - TY - JOUR AD - Department of Medical Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France Department of Surgical Oncology, Gustave Roussy Cancer Campus, Villejuif, France Department of Medical Oncology, Pitie-Salpêtrière Hospital, Paris, France Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France Department of Pathology, Institut Bergonié, Bordeaux, France Department of Adult Medical Oncology, Centre Leon Berard, Lyon, France Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM 1136, Paris, France AU - Malouf, G. G. AU - Beinse, G. AU - Adam, J. AU - Mir, O. AU - Chamseddine, A. N. AU - Terrier, P. AU - Honore, C. AU - Spano, J. P. AU - Italiano, A. AU - Kurtz, J. E. AU - Coindre, J. M. AU - Blay, J. Y. AU - Le Cesne, A. DB - Scopus DO - 10.1634/theoncologist.2018-0074 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 980-988 ST - Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group T2 - Oncologist TI - Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059681769&doi=10.1634%2ftheoncologist.2018-0074&partnerID=40&md5=59d8925a7be6003e8a1ccba1971d7ff0 VL - 24 ID - 3276 ER - TY - JOUR AD - Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Wu, X. AU - Liu, Q. DB - Scopus DO - 10.1053/j.seminhematol.2019.04.001 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 209-214 ST - Prophylaxis and treatment of relapse after haploidentical stem cell transplantation: What is known vs unknown? T2 - Seminars in Hematology TI - Prophylaxis and treatment of relapse after haploidentical stem cell transplantation: What is known vs unknown? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065531587&doi=10.1053%2fj.seminhematol.2019.04.001&partnerID=40&md5=b8019051350fa5a4f83dde2527943103 VL - 56 ID - 3277 ER - TY - JOUR AD - Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey Department of Medical Genetics, School of Medicine, Mehmet Ali Aydinlar Acibadem University, Istanbul, Turkey AU - Soysal, T. AU - Eskazan, A. E. AU - Serin, I. AU - Sadri, S. AU - Keskin, D. AU - Ozgur Yurttas, N. AU - Berk, S. AU - Erdogan Ozunal, I. AU - Salihoglu, A. AU - Ar, M. C. AU - Ongoren, S. AU - Baslar, Z. AU - Ozbek, U. AU - Aydin, Y. DB - Scopus DO - 10.1016/j.clml.2019.03.028 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - e377-e384 ST - The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations T2 - Clinical Lymphoma, Myeloma and Leukemia TI - The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065290051&doi=10.1016%2fj.clml.2019.03.028&partnerID=40&md5=44685e4a6a2d9c5b5527660590cb1086 VL - 19 ID - 3279 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, Department of Pediatrics-Patient Care, University of Texas MD Anderson Cancer Center, Unit 1461, PO Box 301402, Houston, TX 77230, United States AU - Waguespack, S. G. DB - Scopus DO - 10.1159/000495040 IS - 2 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 104-117 ST - Thyroid Sequelae of Pediatric Cancer Therapy T2 - Hormone Research in Paediatrics TI - Thyroid Sequelae of Pediatric Cancer Therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058817712&doi=10.1159%2f000495040&partnerID=40&md5=c217cd155cecddf02498ebe9d62dcac2 VL - 91 ID - 3284 ER - TY - JOUR AD - Director, Florida Craniofacial Institute, Tampa, FL, United States Previous Fellow, Florida Craniofacial Institute, Tampa, FL, United States Pediatric Hematology Oncology, St Joseph's Children's Hospital, Tampa, FL, United States AU - Ricalde, P. AU - Ahson, I. AU - Schaefer, S. T. DB - Scopus DO - 10.1016/j.joms.2019.02.021 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 1278.e1-1278.e7 ST - A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib T2 - Journal of Oral and Maxillofacial Surgery TI - A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065603239&doi=10.1016%2fj.joms.2019.02.021&partnerID=40&md5=c06e5c5e7915e8772443dc8a72facee3 VL - 77 ID - 3292 ER - TY - JOUR AD - Department of Otolaryngology Head and Neck Surgery, Guangxi Medical University, Nanning, Guangxi 530007, China Department of Otolaryngology Head and Neck Surgery, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi 530021, China AU - Ban, Z. AU - He, J. AU - Tang, Z. AU - Zhang, L. AU - Xu, Z. DB - Scopus DO - 10.3892/or.2019.7123 IS - 6 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 3270-3280 ST - LRG‑1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial‑mesenchymal transition by activating MAPK/p38 signaling T2 - Oncology Reports TI - LRG‑1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial‑mesenchymal transition by activating MAPK/p38 signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064427361&doi=10.3892%2for.2019.7123&partnerID=40&md5=53ce0c2e38e0c2341c77b514dbf79264 VL - 41 ID - 3293 ER - TY - JOUR AD - Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Firenze, Italy Dipartimento di Scienze Chimiche, Università degli Studi di Napoli “Federico II”, Napoli, Italy Dipartimento di Scienze degli Alimenti e del Farmaco, Università di Parma, Parma, Italy AU - Bianchini, F. AU - De Santis, A. AU - Portioli, E. AU - Russo Krauss, I. AU - Battistini, L. AU - Curti, C. AU - Peppicelli, S. AU - Calorini, L. AU - D'Errico, G. AU - Zanardi, F. AU - Sartori, A. DB - Scopus DO - 10.1016/j.nano.2019.02.015 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 135-145 ST - Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools T2 - Nanomedicine: Nanotechnology, Biology, and Medicine TI - Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063633857&doi=10.1016%2fj.nano.2019.02.015&partnerID=40&md5=d5766bee94abbe00e5315fcc4ed0d753 VL - 18 ID - 3294 ER - TY - JOUR AD - Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, PO Box 49534, Montebello, Nydalen, Oslo, 0424, Norway Section for Applied Informatics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Genomics Core Facility, Department of Core Facilities, Oslo University Hospital, Oslo, Norway Department of Pediatrics, Division of Child and Adolescent Health, University Hospital of North-Norway, Tromsø, 9038, Norway Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Science, Arctic University of Norway-UiT, Tromsø, 9037, Norway Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway AU - Panagopoulos, I. AU - Brunetti, M. AU - Stoltenberg, M. AU - Strandabø, Rø A. U. AU - Staurseth, J. AU - Andersen, K. AU - Kostolomov, I. AU - Hveem, T. S. AU - Lorenz, S. AU - Nystad, T. A. AU - Flægstad, T. AU - Micci, F. AU - Heim, S. C7 - 12 DB - Scopus DO - 10.1186/s40164-019-0136-y IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 ST - Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype T2 - Experimental Hematology and Oncology TI - Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066954234&doi=10.1186%2fs40164-019-0136-y&partnerID=40&md5=fb4508ef8ee2887e75d0136b4d0205d2 VL - 8 ID - 3299 ER - TY - JOUR AD - Department of Pediatric Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China AU - Pan, J. AU - Zhang, D. AU - Zhang, J. AU - Qin, P. AU - Wang, J. DB - Scopus DO - 10.1080/15384047.2018.1550568 IS - 5 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2019 SP - 653-665 ST - LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases T2 - Cancer Biology and Therapy TI - LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059081065&doi=10.1080%2f15384047.2018.1550568&partnerID=40&md5=54af07dedcb1a5d80bfce0d34ff96c3f VL - 20 ID - 3301 ER - TY - JOUR AD - Department of Medical Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110 029, India AU - Pushpam, D. AU - Bakhshi, S. DB - Scopus DO - 10.4103/ijmr.IJMR_331_19 IS - 5 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 600-609 ST - Paediatric chronic myeloid leukaemia: Is it really a different disease? T2 - Indian Journal of Medical Research TI - Paediatric chronic myeloid leukaemia: Is it really a different disease? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071039498&doi=10.4103%2fijmr.IJMR_331_19&partnerID=40&md5=a7a9a81858a62bba18f3425ddf71e0d9 VL - 149 ID - 3304 ER - TY - JOUR AD - Department of Haematology, Belfast City Hospital, Belfast, United Kingdom Department of Haematology, Altnagelvin Hospital, Derry, United Kingdom Centre for Medical Education, Queen’s University Belfast, Belfast, United Kingdom AU - McMullan, R. R. AU - McConville, C. AU - McMullin, M. F. DB - Scopus IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 105-110 ST - Response to therapy, treatment intolerance and tyrosine Kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid Leukaemia patients T2 - Ulster Medical Journal TI - Response to therapy, treatment intolerance and tyrosine Kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid Leukaemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065657881&partnerID=40&md5=dc0b9eaf5a5d26002fbfe85b4c96598d VL - 88 ID - 3305 ER - TY - JOUR AD - Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China Department of Respiratory Disease, Xinqiao Hospital, Third Military Medical University, Chongqing, China Department of Respiratory Medicine, Southwest Hospital, Third Military Medical University, Chongqing, China Department of Respiratory, Zhongda Hospital, Southeast University, Nanjing, China Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, China Department of Respiratory Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, China Divsion of Respiratory Diseases, Department of Internal Medicine, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institutes of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China Department of Respiratory Medicine, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China Department of Pulmonary Medicine, He'nan Provincial People's Hospital, Zhengzhou, China Department of Pulmonary Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou, China Department of Pulmonary Medicine, The Second Hospital of Dalian Medical University, Dalian, China GloriousMed Technology Co.,Ltd., Shanghai, China Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China AU - Song, P. AU - Cui, X. AU - Bai, L. AU - Zhou, X. AU - Zhu, X. AU - Zhang, J. AU - Jin, F. AU - Zhao, J. AU - Zhou, C. AU - Zhou, Y. AU - Zhang, X. AU - Wang, K. AU - Wang, Q. AU - Yu, Y. AU - Zhang, X. AU - Bai, C. AU - Zhang, L. DB - Scopus DO - 10.1111/1759-7714.13078 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 1303-1309 ST - Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients T2 - Thoracic Cancer TI - Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065131627&doi=10.1111%2f1759-7714.13078&partnerID=40&md5=49d21ad82a9e885efba3198c0df8e860 VL - 10 ID - 3307 ER - TY - JOUR AD - Bilad Al-Rafidain University College, Diyala, Baquba, Iraq College of Pharmacy, University of Al Qadisiyah, Diwaniyah, Iraq AU - Khaleq, M. A. A. AU - Saheb, H. A. AU - Sultan, A. M. AU - Alrodhan, M. A. N. DB - Scopus DO - 10.26452/ijrps.v10i2.274 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 909-913 ST - Detection of BCR-ABL gene in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors drugs by gene expert system T2 - International Journal of Research in Pharmaceutical Sciences TI - Detection of BCR-ABL gene in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors drugs by gene expert system UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070286327&doi=10.26452%2fijrps.v10i2.274&partnerID=40&md5=10166aff1310b0a77e5935a64e0e0c29 VL - 10 ID - 3310 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Bambino Gesù Children’s Hospital, Piazza Sant’Onofrio, 4, Rome, 00165, Italy Sapienza University of Rome, Rome, Italy AU - Merli, P. AU - Algeri, M. AU - Del Bufalo, F. AU - Locatelli, F. DB - Scopus DO - 10.1007/s11899-019-00502-2 IS - 2 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 94-105 ST - Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia T2 - Current Hematologic Malignancy Reports TI - Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062605860&doi=10.1007%2fs11899-019-00502-2&partnerID=40&md5=0a602b82e38c3c5b3966b13f8a0fbbed VL - 14 ID - 3311 ER - TY - JOUR AD - Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita 010-8543, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan Division of Hematology, Department of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan Department of Hematology, Nippon Medical School, Tokyo, Japan Department of Hematology, Chiba University Hospital, Chiba, Japan Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan Japanese Red Cross Aichi Blood Center, Seto, Japan Kindai University Faculty of Medicine, Osaka-Sayama, Japan National Hospital Organization Nagoya Medical Center, Nagoya, Japan AU - Kizaki, M. AU - Takahashi, N. AU - Iriyama, N. AU - Okamoto, S. AU - Ono, T. AU - Usui, N. AU - Inokuchi, K. AU - Nakaseko, C. AU - Kurokawa, M. AU - Sumi, M. AU - Nakamura, F. AU - Kawaguchi, T. AU - Suzuki, R. AU - Yamamoto, K. AU - Ohnishi, K. AU - Matsumura, I. AU - Naoe, T. AU - Kizaki, M. AU - Mori, S. AU - Nemoto, T. AU - Sagawa, M. AU - Tabayashi, T. AU - Tokuhira, M. AU - Tomikawa, T. AU - Watanabe, R. AU - Hatta, Y. AU - Inoue, Y. AU - Iriyama, N. AU - Kobayashi, S. AU - Kobayashi, Y. AU - Kurita, D. AU - Karigane, D. AU - Kasahara, H. AU - Koda, Y. AU - Miyakawa, Y. AU - Murakami, K. AU - Okamoto, S. AU - Watanuki, S. AU - Ono, T. AU - Nagata, Y. AU - Takeshita, A. AU - Takahashi, N. AU - Kameoka, Y. AU - Yoshioka, T. AU - Takahashi, S. AU - Usui, N. AU - Dan, K. AU - Inokuchi, K. AU - Nakamura, K. AU - Abe, D. AU - Nakaseko, C. AU - Ohwada, C. AU - Sakaida, E. AU - Shimizu, N. AU - Takeuchi, M. AU - Arai, S. AU - Kogure, Y. AU - Koya, A. AU - Masamoto, Y. AU - Masuda, A. AU - Nakazaki, K. AU - Toyama, K. AU - Hiroshima, Y. AU - Ichikawa, N. AU - Kirihara, T. AU - Kobayashi, H. AU - Shimizu, I. AU - Sumi, M. AU - Ueki, T. AU - Hagiwara, S. AU - Hirai, R. AU - Miwa, T. AU - Nakamura, F. AU - Nakamura, M. AU - Takeshita, M. AU - Tanimura, A. AU - Hayakawa, F. AU - Ishikawa, Y. AU - Kiyoi, H. AU - Murata, M. AU - Tomita, A. AU - Kurokawa, T. AU - Sugimori, C. AU - Arai, A. AU - Miura, O. AU - Yamamoto, M. AU - Imai, K. AU - Kobayashi, N. AU - Minauchi, K. AU - Obara, M. AU - Ota, S. AU - Ikezoe, T. AU - Mori, M. AU - Sakai, M. AU - Taniguchi, A. AU - Togitani, K. AU - Hayakawa, H. AU - Kajiguchi, T. AU - Kamoshita, S. AU - Otsuka, E. AU - Nishida, A. AU - Saburi, M. AU - Saburi, Y. AU - Iida, H. AU - Kato, C. AU - Kojima, Y. AU - Ohashi, H. AU - Miyata, Y. AU - Sugimoto, K. AU - Yamamoto, H. AU - Yokozawa, T. AU - Kamae, T. AU - Kuyama, J. AU - Mitsui, H. AU - Morikawa, Y. AU - Uchida, Y. AU - Ashida, T. AU - Hirase, C. AU - Kawanishi, K. AU - Matsumura, I. AU - Miyatake, J. AU - Morita, Y. AU - Sano, T. AU - Shimada, T. AU - Tanaka, H. AU - Taniguchi, Y. AU - Tatsumi, Y. AU - Yamaguchi, K. AU - Ishida, F. AU - Momose, K. AU - Nakazawa, H. AU - Nishina, S. AU - Sakai, H. AU - Sekiguchi, N. AU - Ito, Y. AU - Ohyashiki, K. AU - Tauchi, T. AU - Hata, T. AU - Imaizumi, Y. AU - Imanishi, D. AU - Itonaga, H. AU - Makiyama, J. AU - Sawayama, Y. AU - Taguchi, J. AU - Taguchi, M. AU - Taniguchi, H. AU - Eguchi, G. AU - Matsuda, M. AU - Yamairi, N. AU - Fukushima, N. AU - Ozeki, K. AU - Kohno, A. AU - Sakura, T. AU - Takada, S. AU - Kobayashi, T. AU - Sakamaki, H. AU - Asou, N. AU - Kawaguchi, T. AU - Kiguchi, T. AU - Masunari, T. AU - Sezaki, N. AU - Iino, M. AU - Morinaga, K. AU - Ikeda, K. AU - Ogawa, K. AU - Noji, H. AU - Iwasaki, H. AU - Takenaka, K. AU - Miyamoto, T. AU - Handa, H. AU - Murakami, H. AU - Tsukamoto, N. AU - Eto, T. AU - Henzan, H. AU - Kamitsuji, Y. AU - Uoshima, N. AU - Hagihara, M. AU - Takahashi, H. AU - Emi, N. AU - Okamoto, M. AU - Kawakami, K. AU - Waki, M. AU - Fukuhara, N. AU - Harigae, H. AU - Murayama, T. AU - Mizuno, I. AU - Okumura, H. AU - Tsutsumi, Y. AU - Usuki, K. AU - Fujisaki, T. AU - Maeda, Y. AU - Suehiro, Y. AU - Suzushima, H. AU - Yamamoto, K. AU - Kanakura, Y. AU - Nagasaki, K. AU - Muto, H. AU - Fujisawa, S. AU - Adachi, M. AU - Mugitani, A. AU - Yamasaki, S. AU - Adachi, Y. AU - Kamimura, T. AU - Takamatsu, Y. AU - Ryu, T. AU - Chiba, S. AU - Ohishi, K. AU - Suzuki, K. AU - Ogawa, D. AU - Mihara, H. AU - Fujita, H. AU - Kubo, K. AU - Yokota, A. AU - Miyamura, K. AU - Yoshida, C. AU - Nakachi, S. AU - Myojyo, T. AU - Kitabayashi, A. AU - Suzumiya, J. AU - Hino, M. AU - Wakita, A. AU - Shibata, T. AU - Takahashi, T. AU - Takamatsu, H. AU - Fujimaki, K. AU - Tajika, K. AU - Mita, M. AU - Terui, Y. AU - Ito, M. AU - Yamane, T. AU - Yamauchi, T. AU - Kohara, Y. AU - Takebayashi, C. AU - Inagaki, A. AU - Tsuji, M. AU - Shinzaki, H. AU - Moriuchi, Y. AU - Ishikawa, M. AU - Miyazaki, K. AU - Shima, E. AU - Kinugawa, N. AU - the New, Target investigators DB - Scopus DO - 10.1007/s12185-019-02613-1 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2019 SP - 426-439 ST - Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system T2 - International Journal of Hematology TI - Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061644674&doi=10.1007%2fs12185-019-02613-1&partnerID=40&md5=7090aff2d3adf84576d7351fbf52a9aa VL - 109 ID - 3312 ER - TY - JOUR AD - Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany Department of Internal Medicine II, Oncology, Hematology, Clinical Immunology, Rheumatology and Pneumology, University Hospital Tübingen, Tübingen, Germany Medical Clinic I, University Hospital, TU Dresden, Dresden, Germany Medical Clinic II, Hematology and Hemostaseology, Medical Oncology, Rheumatology, Infectious Disease, University Hospital Frankfurt, Frankfurt, Germany Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charite University Hospital, Berlin, Germany Department of Pediatrics I, Pediatric Hematology and Oncology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Medical Faculty, Halle, Germany Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany Department of Internal Medicine V, Hematology, Oncology und Rheumatology, University Hospital Heidelberg, Heidelberg, Germany Medical Clinic and Policlinic 1, University Hospital Leipzig, Leipzig, Germany Department of Internal Medicine 5, Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany Department of Pediatric Hematology and Oncology, University Hospital, Hannover Medical School, Hannover, Germany Department of Internal Medicine II, Klinikum Augsburg, Augsburg, Germany Department of Internal Medicine A/Hematology and Oncology, University of Münster, Münster, Germany Department of Internal Medicine IV, Hematology and Oncology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany AU - Zeiser, R. AU - Beelen, D. W. AU - Bethge, W. AU - Bornhäuser, M. AU - Bug, G. AU - Burchert, A. AU - Christopeit, M. AU - Duyster, J. AU - Finke, J. AU - Gerbitz, A. AU - Klusmann, J. H. AU - Kobbe, G. AU - Lübbert, M. AU - Müller-Tidow, C. AU - Platzbecker, U. AU - Rösler, W. AU - Sauer, M. AU - Schmid, C. AU - Schroeder, T. AU - Stelljes, M. AU - Kröger, N. AU - Müller, L. P. DB - Scopus DO - 10.1016/j.bbmt.2019.01.016 IS - 4 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - e128-e140 ST - Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation T2 - Biology of Blood and Marrow Transplantation TI - Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061457375&doi=10.1016%2fj.bbmt.2019.01.016&partnerID=40&md5=47d8483dadf35685806911b971b429e5 VL - 25 ID - 3318 ER - TY - JOUR AD - Joint Surgery Department, No.1 Hospital of Jilin University, Changchun, China Jilin Provincial Key Laboratory for Molecular Biology of Special Economic Animals, Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Beijing, China AU - Han, Y. AU - Zhao, X. AU - Sun, Y. AU - Sui, Y. AU - Liu, J. DB - Scopus DO - 10.1002/jcp.27048 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 SP - 3598-3612 ST - Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway T2 - Journal of Cellular Physiology TI - Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057008406&doi=10.1002%2fjcp.27048&partnerID=40&md5=49cb3be911db2afcbf74ddaddc2470a4 VL - 234 ID - 3320 ER - TY - JOUR AD - Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, South Korea AU - Yoon, J. H. AU - Min, G. J. AU - Park, S. S. AU - Jeon, Y. W. AU - Lee, S. E. AU - Cho, B. S. AU - Eom, K. S. AU - Kim, Y. J. AU - Kim, H. J. AU - Min, C. K. AU - Cho, S. G. AU - Kim, D. W. AU - Lee, J. W. AU - Lee, S. DB - Scopus DO - 10.1002/cncr.31874 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2019 SP - 873-883 ST - Minimal residual disease–based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia T2 - Cancer TI - Minimal residual disease–based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058036805&doi=10.1002%2fcncr.31874&partnerID=40&md5=9db3c44d2ede50810740e2c1cb2d94ca VL - 125 ID - 3322 ER - TY - JOUR AD - Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China AU - Wang, X. AU - Li, J. AU - Lu, C. AU - Wang, G. AU - Wang, Z. AU - Liu, X. AU - Liu, B. AU - Wang, G. AU - Zhang, Q. AU - Yang, Q. DB - Scopus DO - 10.1016/j.yexcr.2019.01.021 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 192-197 ST - IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation T2 - Experimental Cell Research TI - IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061650624&doi=10.1016%2fj.yexcr.2019.01.021&partnerID=40&md5=c7f31ae5440238964d91a97ef3dfc99e VL - 376 ID - 3323 ER - TY - JOUR AD - Departments of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Molecular Imaging, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pharmacological Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China AU - Liao, Z. AU - Li, F. AU - Zhang, C. AU - Zhu, L. AU - Shi, Y. AU - Zhao, G. AU - Bai, X. AU - Hassan, S. AU - Liu, X. AU - Li, T. AU - Xing, P. AU - Zhao, J. AU - Zhang, J. AU - Xing, R. AU - Teng, S. AU - Yang, Y. AU - Chen, K. AU - Yang, J. C7 - 24 DB - Scopus DO - 10.1038/s12276-019-0221-7 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2019 ST - Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety T2 - Experimental and Molecular Medicine TI - Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062397370&doi=10.1038%2fs12276-019-0221-7&partnerID=40&md5=080f4f49db230de13f15ca83c739c9d3 VL - 51 ID - 3324 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea AU - Kim, J. H. AU - Ryu, M. H. AU - Yoo, C. AU - Chae, H. AU - Na, H. AU - Beck, M. AU - Kim, B. S. AU - Yoo, M. W. AU - Yook, J. H. AU - Kim, B. S. AU - Kim, K. H. AU - Kim, C. W. AU - Kang, Y. K. DB - Scopus DO - 10.1002/cam4.1994 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 1034-1043 ST - Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience T2 - Cancer Medicine TI - Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063410948&doi=10.1002%2fcam4.1994&partnerID=40&md5=96ed7fdc2e32299c13c04a7e3184e8bd VL - 8 ID - 3325 ER - TY - JOUR AD - Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, Aachen, DE-52074, Germany Division of Gastroenterology Hepatology and Hepatobiliary Oncology, Aachen, Germany AU - Roderburg, C. AU - Berres, M. L. AU - Wree, A. AU - Loosen, S. H. AU - Luedde, T. AU - Trautwein, C. DB - Scopus DO - 10.1159/000497465 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 43-46 ST - Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib T2 - Visceral Medicine TI - Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061668950&doi=10.1159%2f000497465&partnerID=40&md5=7de64ed39604650c16a10d00337ef561 VL - 35 ID - 3326 ER - TY - JOUR AD - Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Department of Next Generation Hematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan AU - Kitamura, H. AU - Tabe, Y. AU - Ai, T. AU - Tsuchiya, K. AU - Yuri, M. AU - Misawa, S. AU - Horii, T. AU - Kawaguchi, A. AU - Ohsaka, A. AU - Kimura, S. C7 - e0207170 DB - Scopus DO - 10.1371/journal.pone.0207170 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib T2 - PLoS ONE TI - A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062606205&doi=10.1371%2fjournal.pone.0207170&partnerID=40&md5=f06f11bda04531ee392882cd565c2bd8 VL - 14 ID - 3328 ER - TY - JOUR AD - Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, 100029, China AU - Song, Z. M. AU - Liu, F. AU - Chen, Y. M. AU - Liu, Y. J. AU - Wang, X. D. AU - Du, S. Y. DB - Scopus DO - 10.1016/j.biopha.2018.12.063 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 1429-1437 ST - CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis T2 - Biomedicine and Pharmacotherapy TI - CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060090240&doi=10.1016%2fj.biopha.2018.12.063&partnerID=40&md5=82cb517272220f37a9d3137e42bc96be VL - 111 ID - 3330 ER - TY - JOUR AD - Massachusetts General Hospital Cancer Center, Boston, MA 02114, United States Dana Farber Cancer Institute, Boston, United States Department of Dermatology, Essen University Hospital, Essen, Germany Department of Dermatology, University Hospital Zurich, Zurich, Switzerland Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland Department of Biomedicine, Switzerland Department of Dermatology, University Hospital of Basel, Basel, Switzerland AU - Drago, J. Z. AU - Lawrence, D. AU - Livingstone, E. AU - Zimmer, L. AU - Chen, T. AU - Giobbie-Hurder, A. AU - Amann, V. C. AU - Mangana, J. AU - Siano, M. AU - Zippelius, A. AU - Dummer, R. AU - Goldinger, S. M. AU - Sullivan, R. J. DB - Scopus DO - 10.1097/CMR.0000000000000527 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2019 SP - 65-69 ST - Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: A real-life multicenter study T2 - Melanoma Research TI - Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: A real-life multicenter study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058765141&doi=10.1097%2fCMR.0000000000000527&partnerID=40&md5=69251bbb5a543500269818cdd04a06f3 VL - 29 ID - 3332 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Davidoff Cancer Center, Tel-Aviv University, Petah Tikva, Israel William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom Leiden University Medical Center, Leiden, Netherlands Thyroid Unit, University of Siena, Siena, Italy Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy M. Sklodowska-Curie Memorial Institute Cancer Center, Gliwice Branch, Gliwice, Poland Sanofi Genzyme, Cambridge, MA, United States AU - Hu, M. I. AU - Elisei, R. AU - Dedecjus, M. AU - Popovtzer, A. AU - Druce, M. AU - Kapiteijn, E. AU - Pacini, F. AU - Locati, L. AU - Krajewska, J. AU - Weiss, R. AU - Gagel, R. F. DB - Scopus DO - 10.1530/ERC-18-0258 IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 241-250 ST - Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer T2 - Endocrine-Related Cancer TI - Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058745190&doi=10.1530%2fERC-18-0258&partnerID=40&md5=0ec40273d805dabb3c0eab0113b7af25 VL - 26 ID - 3334 ER - TY - JOUR AD - Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China AU - Yao, Y. AU - Peng, M. AU - Shen, Q. AU - Hu, Q. AU - Gong, H. AU - Li, Q. AU - Zheng, Z. AU - Xu, B. AU - Li, Y. AU - Dong, Y. DB - Scopus DO - 10.1111/1759-7714.12932 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 193-202 ST - Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples T2 - Thoracic Cancer TI - Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058706015&doi=10.1111%2f1759-7714.12932&partnerID=40&md5=8baa30fc56ed2994197b887ade0e349c VL - 10 ID - 3335 ER - TY - JOUR AD - Molecular Inflammation Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens veg 18, Tromsø, 9019, Norway Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Tomtebodav 18A, Stockholm, 17177, Sweden IRCM, Inserm U1194, Université Montpellier, ICM, Institut régional du Cancer Montpellier, Campus Val d'Aurelle, 208 Rue des Apothicaires, Montpellier Cedex 5, 34298, France Department of Clinical Pathology, University Hospital of Northern Norway, Sykehusveien 38, Tromsø, 9019, Norway AU - Tümmler, C. AU - Dumitriu, G. AU - Wickström, M. AU - Coopman, P. AU - Valkov, A. AU - Kogner, P. AU - Johnsen, J. I. AU - Moens, U. AU - Sveinbjörnsson, B. C7 - 202 DB - Scopus DO - 10.3390/cancers11020202 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 ST - SYK inhibition potentiates the effect of chemotherapeutic drugs on neuroblastoma cells in vitro T2 - Cancers TI - SYK inhibition potentiates the effect of chemotherapeutic drugs on neuroblastoma cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062395353&doi=10.3390%2fcancers11020202&partnerID=40&md5=867b12f7f0beff30cfbe6ad783602d41 VL - 11 ID - 3338 ER - TY - JOUR AD - Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Chamoun, K. AU - Kantarjian, H. AU - Atallah, R. AU - Gonzalez, G. N. AU - Issa, G. C. AU - Rios, M. B. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Ravandi, F. AU - Jain, N. AU - Daver, N. AU - Konopleva, M. AU - Dinardo, C. D. AU - Kadia, T. AU - Pemmaraju, N. AU - Jabbour, E. AU - Cortes, J. C7 - 1 DB - Scopus DO - 10.1186/s13045-018-0686-1 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2019 ST - Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: A single-institution experience T2 - Journal of Hematology and Oncology TI - Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: A single-institution experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059493271&doi=10.1186%2fs13045-018-0686-1&partnerID=40&md5=b7c4efe7e810d6f0496f8cc244c4c87a VL - 12 ID - 3344 ER - TY - JOUR AD - Yildirim Beyazit University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Konya Training and Research Hospital, Department of Medical Oncology, Konya, Turkey Ankara Numune Training and Research Hospital, Department of Internal Medicine, Ankara, Turkey Diskapi Yildiriım Beyazit Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey Gazi University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey Ankara Numune Education and Research Hospital, Department of Medical Oncology, Talatpasa Boulevard no.44, Sihhiye/Altindag, Ankara, 06100, Turkey AU - Ergun, Y. AU - Ozdemir, N. Y. AU - Toptas, S. AU - Kurtipek, A. AU - Eren, T. AU - Yazic, O. AU - Sendur, M. A. N. AU - Akinci, B. AU - Ucar, G. AU - Oksuzoglu, B. AU - Uncu, D. DB - Scopus IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 1719-1726 ST - Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study T2 - Journal of B.U.ON. TI - Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071697979&partnerID=40&md5=32719534d8bff4f216df69aa3f0cbead VL - 24 ID - 3349 ER - TY - JOUR AD - Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Xin, N. AU - Fen, Z. AU - Li, C. AU - Yan, X. AU - Runming, J. C7 - 1072 DB - Scopus DO - 10.3389/fphar.2019.01072 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Intracranial hemorrhage following oral low-dose methotrexate after multiple toxicities caused by high-dose methotrexate in childhood acute lymphoblastic leukemia T2 - Frontiers in Pharmacology TI - Intracranial hemorrhage following oral low-dose methotrexate after multiple toxicities caused by high-dose methotrexate in childhood acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072924578&doi=10.3389%2ffphar.2019.01072&partnerID=40&md5=6fdba687e373d3df8016c29cdb3c9fc4 VL - 10 ID - 3350 ER - TY - JOUR AD - Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, 500 034, India Department of Laboratory Medicine, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India Department of Radiodiagnosis, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India AU - Jaiswal, R. AU - Pinninti, R. AU - Krishna, M. M. AU - Santa, A. AU - Boyella, P. K. AU - Nambaru, L. AU - Murthy, S. S. AU - Chowdary, K. V. AU - Rajappa, S. DB - Scopus DO - 10.4103/ijmpo.ijmpo_215_18 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 73-78 ST - T790M mutation and clinical outcomes with osimertinib in patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer T2 - Indian Journal of Medical and Paediatric Oncology TI - T790M mutation and clinical outcomes with osimertinib in patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064870891&doi=10.4103%2fijmpo.ijmpo_215_18&partnerID=40&md5=2999786270999641e22717c5f65e33bd VL - 40 ID - 3351 ER - TY - JOUR AD - Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy AU - Fallahi, P. AU - Ferrari, S. M. AU - Elia, G. AU - Ragusa, F. AU - Paparo, S. R. AU - Ruffilli, I. AU - Patrizio, A. AU - Materazzi, G. AU - Antonelli, A. DB - Scopus DO - 10.2147/CMAR.S127848 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 7893-7907 ST - Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes T2 - Cancer Management and Research TI - Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073352098&doi=10.2147%2fCMAR.S127848&partnerID=40&md5=a221a0289547e00f190726508028a9fe VL - 11 ID - 3352 ER - TY - JOUR AD - Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel Institut de Recerca Sant Joan de Deu, Barcelona, Spain Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, 08950, Spain AU - Zaritski, A. AU - Castillo-Ecija, H. AU - Kumarasamy, M. AU - Peled, E. AU - Sverdlov Arzi, R. AU - Carcaboso, Á M. AU - Sosnik, A. DB - Scopus DO - 10.1021/acsami.9b12682 IS - 42 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 38483-38496 ST - Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression T2 - ACS Applied Materials and Interfaces TI - Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073143274&doi=10.1021%2facsami.9b12682&partnerID=40&md5=d834618160a4d31d332c7f9b95903371 VL - 11 ID - 3353 ER - TY - JOUR AD - Dept. of Urology, Rechts der Isar Medical Center, Technical University of Munich, Ismaninger Str. 22, Munich, 81675, Germany Dept. of Urology, Eberhard Karls University Tübingen, Hoppe-Seyler-Str.3, Tübingen, 72076, Germany Dept. of Urology, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Münster, 48149, Germany Dept. of Urology, Universitätsklinikum Jena, Lessingstr. 1, Jena, 07743, Germany Dept. of Urology, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Str., Greifswald, 17475, Germany Medical Oncology, Onkologie Leer–Emden–Papenburg, Annenestr. 11, Leer, 26789, Germany Dept. of Urology, Universitätsklinikum Freiburg, Hugstetter Str. 55, Freiburg, 79106, Germany Dept. of Urology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany Dept. of Urology, Universitätsklinikum Dresden, Fetscherstr. 74, Dresden, 01307, Germany Dept. of Urology, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, Ulm, 89081, Germany Dept. of Oncology, Elisabeth Tweesteden Ziekenhuis, Dr. Deelenlaan 5, Tilburg, AD 5042, Netherlands Dept. of Oncology, Kaiser-Franz-Josef-Spital and Department of Urology, Medical University of Vienna, Kundratstr. 3, Vienna, 1100, Austria Dept. of Oncology, Spaarne Ziekenhuis, Spaarnepoort 1, Hoofddorp, TM 2134, Netherlands Dept. of Urology, Städtisches Krankenhaus Kiel, Chemnitzstr. 33, Kiel, 24116, Germany IOMEDICO AG, Hanferstr. 28, Freiburg, 79108, Germany Center for Oncology, II. Medical Clinic and Polyclinic, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany AUO Study Group, Germany AU - Retz, M. AU - Bedke, J. AU - Bögemann, M. AU - Grimm, M. O. AU - Zimmermann, U. AU - Müller, L. AU - Leiber, C. AU - Teber, D. AU - Wirth, M. AU - Bolenz, C. AU - van Alphen, R. AU - De Santis, M. AU - Beeker, A. AU - Lehmann, J. AU - Indorf, M. AU - Frank, M. AU - Bokemeyer, C. AU - Gschwend, J. E. DB - Scopus DO - 10.1016/j.ejca.2018.11.001 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 37-45 ST - SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) T2 - European Journal of Cancer TI - SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057599396&doi=10.1016%2fj.ejca.2018.11.001&partnerID=40&md5=ff84878f426fd48fa9a02a9c6913f619 VL - 107 ID - 3355 ER - TY - JOUR AD - Department of Biology, College of Education for pure Sciences, Kerbala University, Kerbala, Iraq AU - Al-Mafragy, H. S. AU - Al-Awade, H. A. R. DB - Scopus DO - 10.25258/ijpqa.10.1.16 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 100-107 ST - Validations of prognostic scoring systems in Iraqi patients with chronic myeloid leukemia in single center T2 - International Journal of Pharmaceutical Quality Assurance TI - Validations of prognostic scoring systems in Iraqi patients with chronic myeloid leukemia in single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069862739&doi=10.25258%2fijpqa.10.1.16&partnerID=40&md5=705d6ed5149a601723eade5d42157ec3 VL - 10 ID - 3357 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Division of Gastroenterology and Hepatology, Ootakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of MedicineEhime, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Kariyama, K. AU - Takaguchi, K. AU - Itobayashi, E. AU - Shimada, N. AU - Tajiri, K. AU - Tsuji, K. AU - Ishikawa, T. AU - Ochi, H. AU - Hirooka, M. AU - Tsutsui, A. AU - Shibata, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Joko, K. AU - Hiasa, Y. AU - Michitaka, K. AU - On behalf of the Real-life Practice Experts for, H. C. C. Study Group AU - the, H. C. C. Group DB - Scopus DO - 10.1111/hepr.13243 IS - 1 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :41 Export Date: 18 November 2020 PY - 2019 SP - 111-117 ST - Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis T2 - Hepatology Research TI - Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054634693&doi=10.1111%2fhepr.13243&partnerID=40&md5=111e2c750cae283fcc95921b3e94ba72 VL - 49 ID - 3360 ER - TY - JOUR AD - Department of Molecular Biology and Genetics, Gebze Technical University, Kocaeli, Turkey Department of Molecular Biology and Genetics, Istanbul Medeniyet University, Istanbul, Turkey AU - Sagir, F. AU - Demiroglu-Zergeroglu, A. DB - Scopus DO - 10.1515/tjb-2017-0276 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 62-69 ST - Targeting epidermal growth factor receptor pathway with irreversible tyrosine kinase inhibitor T2 - Turkish Journal of Biochemistry TI - Targeting epidermal growth factor receptor pathway with irreversible tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065657486&doi=10.1515%2ftjb-2017-0276&partnerID=40&md5=448599b1095ae993b24a0c65896a088a VL - 44 ID - 3361 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Kariyama, K. AU - Takaguchi, K. AU - Atsukawa, M. AU - Itobayashi, E. AU - Tsuji, K. AU - Tajiri, K. AU - Hirooka, M. AU - Shimada, N. AU - Shibata, H. AU - Ishikawa, T. AU - Ochi, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Itokawa, N. AU - Imai, M. AU - Joko, K. AU - Hiasa, Y. AU - Michitaka, K. AU - the Real-life Practice Experts for Hcc Study Group, H. C. C. Group DB - Scopus DO - 10.1002/cam4.1909 IS - 1 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :47 Export Date: 18 November 2020 PY - 2019 SP - 137-146 ST - Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis T2 - Cancer Medicine TI - Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058930583&doi=10.1002%2fcam4.1909&partnerID=40&md5=a009438339852057be5c702f7dc521e2 VL - 8 ID - 3363 ER - TY - JOUR AD - Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China AU - Wang, Y. AU - Min, L. AU - Zhou, Y. AU - Tang, F. AU - Luo, Y. AU - Zhang, W. AU - Duan, H. AU - Tu, C. DB - Scopus DO - 10.2147/CMAR.S198429 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3583-3591 ST - The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: A case series of six patients in one institution T2 - Cancer Management and Research TI - The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: A case series of six patients in one institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065513078&doi=10.2147%2fCMAR.S198429&partnerID=40&md5=56c4baa0068e1d3a351c43d8f316608c VL - 11 ID - 3364 ER - TY - JOUR AD - Department of Clinical and Experimental Medicine, University of Catania, Center of Experimental Oncology and Hematology, Building 8D/2 - Via Santa Sofia, 78, Catania, 95123, Italy Center of Experimental Oncology and Hematology, A.O.U. Policlinico-Vittorio Emanuele, Catania, Italy Division of Hematology, University of Messina, Messina, Italy Division of Hematology and Bone Marrow Transplant, A.O.U. Policlinico-Vittorio Emanuele, Catania, Italy Department of Surgery, Medical and Surgical Specialities, University of Catania, Catania, Italy AU - Stella, S. AU - Tirró, E. AU - Massimino, M. AU - Vitale, S. R. AU - Russo, S. AU - Pennisi, M. S. AU - Puma, A. AU - Romano, C. AU - Di Gregorio, S. AU - Innao, V. AU - Stagno, F. AU - Di Raimondo, F. AU - Musolino, C. AU - Manzella, L. DB - Scopus DO - 10.21873/invivo.11641 IS - 5 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 1593-1598 ST - Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib T2 - In Vivo TI - Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071739559&doi=10.21873%2finvivo.11641&partnerID=40&md5=57b9d8e1a172310b8dff2f655cf5ec6b VL - 33 ID - 3367 ER - TY - JOUR AD - Department of Orthopedics, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province 450008, China Department of Orthopedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China Department of Orthopedics, the Affiliated People’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450003, China Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province 450008, China AU - Tian, Z. AU - Wang, X. AU - Liu, Z. AU - Wang, J. AU - Yao, W. AU - Zhao, Y. AU - Gao, S. AU - Zhang, P. AU - Ge, H. DB - Scopus DO - 10.2147/CMAR.S207150 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 5293-5300 ST - Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: An observational study from multiple institutions T2 - Cancer Management and Research TI - Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: An observational study from multiple institutions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068013542&doi=10.2147%2fCMAR.S207150&partnerID=40&md5=637798f43d223cbb380569990c580fb5 VL - 11 ID - 3372 ER - TY - JOUR AD - PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, 210002, China Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China Division of Medical Oncology, National Cancer Center Singapore, Singapore Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Medical Oncology, Sir Run Shaw Hospital, Zhejiang University, Hangzhou, China Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong Nanfang Hospital, Guangzhou Southern Medical University, Guangzhou, China Sun Yat-Sen University Cancer Center, Guangzhou, China Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China Department of Gastrointestinal Oncology, 307 Hospital of People’s Liberation Army, Beijing, China Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City, Taiwan Department of Oncology, National Taiwan University Hospital, Taipei City, Taiwan Translational Clinical Oncology, Novartis Institutes for BioMedical Research, East Hanover, NJ, United States PK Sciences, China Novartis Institutes for BioMedical Research, Shanghai, China Translational Clinical Oncology, China Novartis Institutes for BioMedical Research, Shanghai, China Novartis Institutes for BioMedical Research, Basel, Basel-Stadt, Switzerland Division of Gastroenterology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand AU - Qin, S. AU - Chan, S. L. AU - Sukeepaisarnjaroen, W. AU - Han, G. AU - Choo, S. P. AU - Sriuranpong, V. AU - Pan, H. AU - Yau, T. AU - Guo, Y. AU - Chen, M. AU - Ren, Z. AU - Xu, J. AU - Yen, C. J. AU - Lin, Z. Z. AU - Manenti, L. AU - Gu, Y. AU - Sun, Y. AU - Tiedt, R. AU - Hao, L. AU - Song, W. AU - Tanwandee, T. DB - Scopus DO - 10.1177/1758835919889001 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 ST - A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma T2 - Therapeutic Advances in Medical Oncology TI - A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076565560&doi=10.1177%2f1758835919889001&partnerID=40&md5=0dc5aeb27bbe0cae43b92c9a0f0d4c28 VL - 11 ID - 3373 ER - TY - JOUR AD - Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Service d'Hématologie et d'Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France Association Pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France Centre Antoine Lacassagne, Nice, France Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, United States IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France Service d'Hématologie et d'Oncologie Pédiatrique, Hopital Armand-Trousseau, Paris, France Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, United States Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States Service d'Anatomopathologie, Hôpital Armand-Trousseau, Paris, France Department of Bioinformatics and Computational Biology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l'Hôpital, Strasbourg, 67000, France AU - Boilève, A. AU - Carlo, M. I. AU - Barthélémy, P. AU - Oudard, S. AU - Borchiellini, D. AU - Voss, M. H. AU - George, S. AU - Chevreau, C. AU - Landman-Parker, J. AU - Tabone, M. D. AU - Chism, D. D. AU - Amin, A. AU - Bilen, M. A. AU - Bosse, D. AU - Coulomb-L'Hermine, A. AU - Su, X. AU - Choueiri, T. K. AU - Tannir, N. M. AU - Malouf, G. G. C7 - 159 DB - Scopus DO - 10.1186/s40425-018-0482-z IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2018 ST - Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders T2 - Journal for ImmunoTherapy of Cancer TI - Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059239376&doi=10.1186%2fs40425-018-0482-z&partnerID=40&md5=795c08a998209a84a20ac87e929d80e1 VL - 6 ID - 3381 ER - TY - JOUR AD - Department of Hematology and Oncology, Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, INSERM U1173, Centre Hospitalier de Versailles, Le Chesnay, France AU - Rousselot, P. DB - Scopus DO - 10.1080/10428194.2018.1459611 IS - 12 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 2782-2791 ST - The story of tyrosine kinase inhibitors discontinuation in clinical practice T2 - Leukemia and Lymphoma TI - The story of tyrosine kinase inhibitors discontinuation in clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048831867&doi=10.1080%2f10428194.2018.1459611&partnerID=40&md5=2aeecc58f958fadc19b14728629cceee VL - 59 ID - 3387 ER - TY - JOUR AD - Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States Developmental Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA, United States Children’s Oncology Group, Monrovia, CA, United States Dan L, Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, United States Department of Oncology Research, Mayo Clinic, Rochester, MN, United States Department of Pediatrics, Masonic Children’s Hospital, University of Minnesota Medical Center, Minneapolis, MN, United States AU - Geller, J. I. AU - Fox, E. AU - Turpin, B. K. AU - Goldstein, S. L. AU - Liu, X. AU - Minard, C. G. AU - Kudgus, R. A. AU - Reid, J. M. AU - Berg, S. L. AU - Weigel, B. J. DB - Scopus DO - 10.1002/cncr.31725 IS - 23 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 4548-4555 ST - A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315) T2 - Cancer TI - A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056097679&doi=10.1002%2fcncr.31725&partnerID=40&md5=01b7f11453fcf3dbe1ee55bbac61ba78 VL - 124 ID - 3389 ER - TY - JOUR AD - Department of Pediatrics, Section of Pediatric Hematology-Oncology, Baylor College of Medicine, Houston, TX, United States Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States AU - Heikamp, E. B. AU - Pui, C. H. DB - Scopus DO - 10.1016/j.jpeds.2018.07.039 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 14-24.e2 ST - Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia T2 - Journal of Pediatrics TI - Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053036994&doi=10.1016%2fj.jpeds.2018.07.039&partnerID=40&md5=2b7502149e1aea8b1b6b3fd867d674dc VL - 203 ID - 3390 ER - TY - JOUR AD - Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary AU - Kassa, C. AU - Reményi, P. AU - Sinkó, J. AU - Kállay, K. AU - Kertész, G. AU - Kriván, G. C7 - e13302 DB - Scopus DO - 10.1111/petr.13302 IS - 8 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 ST - Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder T2 - Pediatric Transplantation TI - Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055277134&doi=10.1111%2fpetr.13302&partnerID=40&md5=9afb22c1d25b2294ac120826d35540a7 VL - 22 ID - 3395 ER - TY - JOUR AD - Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia VU University Medical Center, Amsterdam, Netherlands Genetic and Molecular Pathology, SA Pathology, Adelaide, Australia School of Biological Sciences, Faculty of Sciences, University of Adelaide, Australia School of Paediatrics, Faculty of Health Sciences, University of Adelaide, Australia Health Sciences UniSA, Adelaide, Australia Australasian Leukaemia and Lymphoma Group, Melbourne, Australia Department of Haematology, Royal Adelaide Hospital and SA Pathology, Australia Centre for Cancer Biology, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia Flinders University and Medical Centre, Adelaide, Australia AU - Pagani, I. S. AU - Dang, P. AU - Kommers, I. O. AU - Goyne, J. M. AU - Nicola, M. AU - Saunders, V. A. AU - Braley, J. AU - White, D. L. AU - Yeung, D. T. AU - Branford, S. AU - Hughes, T. P. AU - Ross, D. M. DB - Scopus DO - 10.3324/haematol.2018.189787 IS - 12 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 2026-2032 ST - BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia T2 - Haematologica TI - BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054736766&doi=10.3324%2fhaematol.2018.189787&partnerID=40&md5=3c6bae1d8eecf5f77266e4b4e33751b3 VL - 103 ID - 3398 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Zulbaran-Rojas, A. AU - Lin, H. K. AU - Shi, Q. AU - Williams, L. A. AU - George, B. AU - Garcia-Manero, G. AU - Jabbour, E. AU - O’Brien, S. AU - Ravandi, F. AU - Wierda, W. AU - Estrov, Z. AU - Borthakur, G. AU - Kadia, T. AU - Cleeland, C. AU - Cortes, J. E. AU - Kantarjian, H. DB - Scopus DO - 10.1002/cam4.1808 IS - 11 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - 5457-5469 ST - A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors T2 - Cancer Medicine TI - A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054924309&doi=10.1002%2fcam4.1808&partnerID=40&md5=fe4aed5a3e08b114b4f47b8fa890df18 VL - 7 ID - 3400 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Cancer Center, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, 6701 Fannin Street, Suite 1510.23, Houston, TX 77030, United States Department of Pediatrics, Division of Endocrinology, Alberta Children's Hospital, Calgary, AB, Canada Department of Pediatrics, Division of Hematology/Oncology, Loma Linda University, San Bernardino, CA, United States Department of Pathology and Immunology, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States Michael E. DeBakey Department of Surgery, Division of Pediatric Surgery, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States Department of Radiology, Texas Children's Hospital, Houston, TX, United States Department of Pediatrics, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States AU - Mahajan, P. AU - Dawrant, J. AU - Kheradpour, A. AU - Quintanilla, N. M. AU - Lopez, M. E. AU - Orth, R. C. AU - Athanassaki, I. AU - Venkatramani, R. DB - Scopus DO - 10.1089/thy.2018.0064 IS - 11 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 1450-1454 ST - Response to lenvatinib in children with papillary thyroid carcinoma T2 - Thyroid TI - Response to lenvatinib in children with papillary thyroid carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056307571&doi=10.1089%2fthy.2018.0064&partnerID=40&md5=5b4f72c8fb03b6cea0d322e41d0ab957 VL - 28 ID - 3402 ER - TY - JOUR AD - Hematology Department, Centre Léon Bérard, Lyon, France INSERM U1170, Normal and Pathologic Hematopoiesis, Institut Gustave Roussy, Créteil, France Hematology Department, Hôpital Saint Louis, Paris, France Hematology Department, Centre Hospitalier Universitaire du Bocage, Dijon, France Hematology Department, Institut Paoli Calmettes, Marseilles, France Hematology Department, Hôpital A. Mignot, Le Chesnay, University Paris Saclay EA4340, Fontenay aux Roses, France Hematology Department, Hôpital Claude Huriez, Lille, France Hematology Department, Hôpital Pontchaillou, Rennes, France Hematology Department, Hotel Dieu, Nantes, France Hematology Department, Institut Universitaire du Cancer, Toulouse, France Hematology Department, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Hematology Department, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France Hematology Department, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France Hematology Department, Hôpital Civil, Strasbourg, France Incyte Biosciences France, Boulogne-Billancourt, France Hematology Department, Hôpital Henri Mondor, Créteil, France Hematology Department, Institut Bergonié, Bordeaux, France INSERM U1052, CRCL, Lyon, France French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France AU - Heiblig, M. AU - Rea, D. AU - Chrétien, M. L. AU - Charbonnier, A. AU - Rousselot, P. AU - Coiteux, V. AU - Escoffre-Barbe, M. AU - Dubruille, V. AU - Huguet, F. AU - Cayssials, E. AU - Hermet, E. AU - Guerci-Bresler, A. AU - Amé, S. AU - Sackmann-Sala, L. AU - Roy, L. AU - Sobh, M. AU - Morisset, S. AU - Etienne, G. AU - Nicolini, F. E. DB - Scopus DO - 10.1016/j.exphem.2018.08.006 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 41-48 ST - Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study T2 - Experimental Hematology TI - Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053878617&doi=10.1016%2fj.exphem.2018.08.006&partnerID=40&md5=524426ab32c80885f3c537805aa38b37 VL - 67 ID - 3403 ER - TY - JOUR AD - Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan AU - Iriyama, N. AU - Sugimoto, K. J. AU - Sato, E. AU - Takaku, T. AU - Tokuhira, M. AU - Nakazato, T. AU - Ishikawa, M. AU - Fujita, H. AU - Fujioka, I. AU - Kimura, Y. AU - Asou, N. AU - Kizaki, M. AU - Komatsu, N. AU - Hatta, Y. AU - Kawaguchi, T. C7 - 142 DB - Scopus DO - 10.1007/s12032-018-1203-7 IS - 11 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 ST - Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis T2 - Medical Oncology TI - Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052993878&doi=10.1007%2fs12032-018-1203-7&partnerID=40&md5=6dcebe67cdf7310d89cd88e9e66dfe90 VL - 35 ID - 3404 ER - TY - JOUR AD - Instituto de Matemática e Computação, Universidade Federal de Itajubá, Brazil Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany National Center for Tumor Diseases (NCT), Partner Site, Dresden, Germany AU - Fassoni, A. C. AU - Baldow, C. AU - Roeder, I. AU - Glauche, I. DB - Scopus DO - 10.3324/haematol.2018.194522 IS - 11 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2018 SP - 1825-1834 ST - Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: A simulation study based on phase III trial data T2 - Haematologica TI - Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: A simulation study based on phase III trial data UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055844213&doi=10.3324%2fhaematol.2018.194522&partnerID=40&md5=4046c648e903a80c490f6eb98e7a659f VL - 103 ID - 3407 ER - TY - JOUR AD - University of Calgary, Alberta Health Services, Calgary, Alberta, Canada University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec City, Quebec, Canada Department of Oncology, McMaster University, Hamilton, Ontario, Canada Department of Medicine, McMaster University, Hamilton, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada AU - Savoie, M. L. AU - Bence-Bruckler, I. AU - Huebsch, L. B. AU - Lalancette, M. AU - Hillis, C. AU - Walker, I. AU - Lipton, J. H. AU - Forrest, D. L. AU - Kim, D. D. H. DB - Scopus DO - 10.1016/j.leukres.2018.08.021 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 67-75 ST - Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era T2 - Leukemia Research TI - Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053318650&doi=10.1016%2fj.leukres.2018.08.021&partnerID=40&md5=2ce1fc5d39f7cdb8ab0a4ea44112deb8 VL - 73 ID - 3409 ER - TY - JOUR AD - Laboratory of Intracellular Signaling in Health and Disease, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russian Federation Biological Faculty, Lomonosov Moscow State University, Moscow, 119234, Russian Federation AU - Gorbacheva, A. M. AU - Korneev, K. V. AU - Kuprash, D. V. AU - Mitkin, N. A. C7 - 2911 DB - Scopus DO - 10.3390/ijms19102911 IS - 10 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 ST - The risk G allele of the single-nucleotide polymorphism rs928413 creates a CREB1-binding site that activates IL33 promoter in lung epithelial cells T2 - International Journal of Molecular Sciences TI - The risk G allele of the single-nucleotide polymorphism rs928413 creates a CREB1-binding site that activates IL33 promoter in lung epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054130043&doi=10.3390%2fijms19102911&partnerID=40&md5=66cfa9e6112f6a502bb1d33c2c1aef77 VL - 19 ID - 3413 ER - TY - JOUR AD - Department of Diagnostic and Interventional Radiology and Neuroradiology, Klinikum Augsburg, Stenglinstraße 286156, Germany Department of Diagnostic and Interventional Radiology and Neuroradiology, University Ulm, Albert-Einstein-Allee 2389081, Germany Department of Radiology at The Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, United States AU - Herzberg, M. AU - Beer, M. AU - Anupindi, S. AU - Vollert, K. AU - Kröncke, T. DB - Scopus DO - 10.1016/j.jpedsurg.2018.03.022 IS - 9 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 1862-1870 ST - Imaging pediatric gastrointestinal stromal tumor (GIST) T2 - Journal of Pediatric Surgery TI - Imaging pediatric gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045708930&doi=10.1016%2fj.jpedsurg.2018.03.022&partnerID=40&md5=558e1bf5946261014fad1e8978638a6d VL - 53 ID - 3416 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, Warsaw, 02-781, Poland Early Phase Clinical Trial Unit, Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, Warsaw, 02-781, Poland Department of Oncology, Iagiellonian University, Cracow, Poland Department of General Surgery, Iagiellonian University, Cracow, Poland AU - Rutkowski, P. AU - Bylina, E. AU - Lugowska, I. AU - Teterycz, P. AU - Klimczak, A. AU - Streb, J. AU - Czarnecka, A. M. AU - Osuch, C. DB - Scopus DO - 10.1016/j.jgo.2018.03.009 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 520-525 ST - Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST) T2 - Journal of Geriatric Oncology TI - Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044366163&doi=10.1016%2fj.jgo.2018.03.009&partnerID=40&md5=c3ce8b3e2b04d37e6b75d1aabf3e3442 VL - 9 ID - 3419 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China Collaborative Innovation Centre of Haematology, Soochow University, Suzhou, China Peking-Tsinghua Centre for Life Sciences, Beijing, China AU - Qin, Y. Z. AU - Jiang, Q. AU - Jiang, H. AU - Lai, Y. Y. AU - Shi, H. X. AU - Chen, W. M. AU - Yu, L. AU - Huang, X. J. DB - Scopus DO - 10.1111/bjh.15453 IS - 5 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 693-700 ST - Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre T2 - British Journal of Haematology TI - Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050613726&doi=10.1111%2fbjh.15453&partnerID=40&md5=12579701ea7b516ca7161b847d379564 VL - 182 ID - 3420 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China AU - Wang, W. J. AU - Zheng, C. F. AU - Liu, Z. AU - Tan, Y. H. AU - Chen, X. H. AU - Zhao, B. L. AU - Li, G. X. AU - Xu, Z. F. AU - Ren, F. G. AU - Zhang, Y. F. AU - Chang, J. M. AU - Wang, H. W. DB - Scopus DO - 10.1111/ejh.13084 IS - 3 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2018 SP - 291-296 ST - Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression T2 - European Journal of Haematology TI - Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050397829&doi=10.1111%2fejh.13084&partnerID=40&md5=9c028fced2b07162c1b5a4d914b1a041 VL - 101 ID - 3422 ER - TY - JOUR AD - Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Cancer Prevention Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Lan, C. Y. AU - Wang, Y. AU - Xiong, Y. AU - Li, J. D. AU - Shen, J. X. AU - Li, Y. F. AU - Zheng, M. AU - Zhang, Y. N. AU - Feng, Y. L. AU - Liu, Q. AU - Huang, H. Q. AU - Huang, X. DB - Scopus DO - 10.1016/S1470-2045(18)30349-8 IS - 9 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2018 SP - 1239-1246 ST - Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study T2 - The Lancet Oncology TI - Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055017750&doi=10.1016%2fS1470-2045%2818%2930349-8&partnerID=40&md5=1c311001b9a642e7fe7921d3b2e32949 VL - 19 ID - 3423 ER - TY - JOUR AD - Department of Dermatology, Ehime University Graduate School of Medicine, Toon City, Japan Department of Dermatology, Ehime Prefectural Central Hospital, Matsuyama City, Japan AU - Utsunomiya, R. AU - Dai, X. AU - Murakami, M. AU - Masuda, K. AU - Okazaki, H. AU - Tsuda, T. AU - Mori, H. AU - Shiraishi, K. AU - Tohyama, M. AU - Sayama, K. DB - Scopus DO - 10.1111/exd.13685 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 981-988 ST - Heparinoid suppresses Der p-induced IL-1β production by inhibiting ERK and p38 MAPK pathways in keratinocytes T2 - Experimental Dermatology TI - Heparinoid suppresses Der p-induced IL-1β production by inhibiting ERK and p38 MAPK pathways in keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052535906&doi=10.1111%2fexd.13685&partnerID=40&md5=9b2185c42ae1b727590518625d014ca4 VL - 27 ID - 3426 ER - TY - JOUR AD - National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States AU - Lundberg, L. AU - Brahms, A. AU - Hooper, I. AU - Carey, B. AU - Lin, S. C. AU - Dahal, B. AU - Narayanan, A. AU - Kehn-Hall, K. DB - Scopus DO - 10.1016/j.antiviral.2018.07.005 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 57-67 ST - Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses T2 - Antiviral Research TI - Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049512324&doi=10.1016%2fj.antiviral.2018.07.005&partnerID=40&md5=b1e189fba014d86537b9208b22060541 VL - 157 ID - 3428 ER - TY - JOUR AD - Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, United States Department of Pathology, Ohio State University, Columbus, OH, United States Department of Pathology, University of New Mexico Cancer Center, Albuquerque, NM, United States Department of Biostatistics, University of Florida, Gainesville, FL, United States Department of Cytogenetics, United States Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, United States Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pediatrics, NYU Langone Health, New York, NY, United States Department of Pathology, Johns Hopkins University, Baltimore, MD, United States Department of Pathology, Seattle Children’s Hospital, Seattle, WA, United States HARP Pharma Consulting, Mystic, CT, United States Department of Pediatrics, University of Colorado School of Medicine, Children’s Hospital, Aurora, CO, United States Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States Department of Pediatrics, UCSF Benioff Children’s Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States St. Jude Children’s Research Hospital, Memphis, TN 38105, United States Children’s Hospital of Philadelphia, CTRB 3060, 3501 Civic Center Blvd, Philadelphia, PA 19104, United States AU - Roberts, K. G. AU - Reshmi, S. C. AU - Harvey, R. C. AU - Chen, I. M. AU - Patel, K. AU - Stonerock, E. AU - Jenkins, H. AU - Dai, Y. AU - Valentine, M. AU - Gu, Z. AU - Zhao, Y. AU - Zhang, J. AU - Payne-Turner, D. AU - Devidas, M. AU - Heerema, N. A. AU - Carroll, A. J. AU - Raetz, E. A. AU - Borowitz, M. J. AU - Wood, B. L. AU - Mattano, L. A. AU - Maloney, K. W. AU - Carroll, W. L. AU - Loh, M. L. AU - Willman, C. L. AU - Gastier-Foster, J. M. AU - Mullighan, C. G. AU - Hunger, S. P. DB - Scopus DO - 10.1182/blood-2018-04-841676 IS - 8 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2018 SP - 815-824 ST - Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group T2 - Blood TI - Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052111502&doi=10.1182%2fblood-2018-04-841676&partnerID=40&md5=32e290f1b2ebace043a1a71ec77e5621 VL - 132 ID - 3430 ER - TY - JOUR AD - Institute for Biomechanics, ETH Zurich, Zurich, Switzerland Fukushima Medical University, Fukushima, Japan Biostatistics, Research Office, Paracelsus Medical University, Salzburg, Austria Department of Ophthalmology and Optometry, Paracelsus Medical University, Salzburg, Austria Neuro and Spine Center, Hirslanden Klinik St. Anna, Lucerne, Switzerland Prodorso, Zurich, Switzerland Academic Teaching Hospital, Spine Research Institute, Paracelsus Medical University, Salzburg, Austria Spine Center, Schön Klinic Munich Harlaching, Munich, Germany Department of Health Sciences, University of Potsdam, Potsdam, Germany AU - Krupkova, O. AU - Sadowska, A. AU - Kameda, T. AU - Hitzl, W. AU - Hausmann, O. N. AU - Klasen, J. AU - Wuertz-Kozak, K. C7 - 1706 DB - Scopus DO - 10.3389/fimmu.2018.01706 IS - AUG M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 ST - p38 MAPK facilitates crosstalk between endoplasmic reticulum stress and IL-6 release in the intervertebral disc T2 - Frontiers in Immunology TI - p38 MAPK facilitates crosstalk between endoplasmic reticulum stress and IL-6 release in the intervertebral disc UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051627378&doi=10.3389%2ffimmu.2018.01706&partnerID=40&md5=8f704b619ccdb2d6ac74f27bf1ae236c VL - 9 ID - 3431 ER - TY - JOUR AD - Department of Radiology, Miller School of Medicine, University of Miami, Coral Gables, FL, United States Department of Surgery, Miller School of Medicine, University of Miami, Coral Gables, FL 33146, United States AU - Quiroz, H. J. AU - Willobee, B. A. AU - Sussman, M. S. AU - Fox, B. R. AU - Thorson, C. M. AU - Sola, J. E. AU - Perez, E. A. C7 - 54 DB - Scopus DO - 10.21037/tgh.2018.07.08 IS - August M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 ST - Pediatric gastrointestinal stromal tumors—a review of diagnostic modalities T2 - Translational Gastroenterology and Hepatology TI - Pediatric gastrointestinal stromal tumors—a review of diagnostic modalities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051752995&doi=10.21037%2ftgh.2018.07.08&partnerID=40&md5=28da4b66df6e272c7e84fab89c58c88b VL - 3 ID - 3436 ER - TY - JOUR AD - Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom Center for Primary Health Care Research, Lund University, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, United States Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Finland Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom AU - Chattopadhyay, S. AU - Zheng, G. AU - Sud, A. AU - Yu, H. AU - Sundquist, K. AU - Sundquist, J. AU - Försti, A. AU - Hemminki, A. AU - Houlston, R. AU - Hemminki, K. DB - Scopus DO - 10.1016/S2352-3026(18)30108-X IS - 8 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - e368-e377 ST - Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden T2 - The Lancet Haematology TI - Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050728636&doi=10.1016%2fS2352-3026%2818%2930108-X&partnerID=40&md5=194eecb2ac6e74169aca380460b2d52f VL - 5 ID - 3437 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China AU - Li, Z. AU - Yang, L. AU - Liu, X. AU - Nie, Z. AU - Luo, J. DB - Scopus DO - 10.1016/j.biopha.2018.05.047 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2018 SP - 181-192 ST - Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21 T2 - Biomedicine and Pharmacotherapy TI - Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047065941&doi=10.1016%2fj.biopha.2018.05.047&partnerID=40&md5=df3cca7842a963315df99002d334930c VL - 104 ID - 3439 ER - TY - JOUR AD - Endocrine and Sarcoma Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, P9:03, Stockholm, 171 76, Sweden Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden AU - Åhlén, J. AU - Karlsson, F. AU - Wejde, J. AU - Nilsson, I. L. AU - Larsson, C. AU - Bränström, R. DB - Scopus DO - 10.1007/s00268-018-4498-9 IS - 8 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 2512-2521 ST - Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs) T2 - World Journal of Surgery TI - Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041908122&doi=10.1007%2fs00268-018-4498-9&partnerID=40&md5=54a2d69da1212b29205a7157b218aa5e VL - 42 ID - 3440 ER - TY - JOUR AD - Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, Netherlands Department of Neurology, Radboud University Medical Center, Nijmegen, Netherlands Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, Netherlands Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands Newcastle University, Northern Institute for Cancer Research, Wolfson Childhood Cancer Research Centre, Newcastle upon Tyne, United Kingdom Departamento de Medicina Interna, Universidade Federal do Parana, Hospital de Clinicas de Curitiba, Curitiba, Brazil AU - Urbano, P. C. M. AU - Aguirre-Gamboa, R. AU - Ashikov, A. AU - van Heeswijk, B. AU - Krippner-Heidenreich, A. AU - Tijssen, H. AU - Li, Y. AU - Azevedo, V. F. AU - Smits, L. J. T. AU - Hoentjen, F. AU - Joosten, I. AU - Koenen, H. J. P. M. DB - Scopus DO - 10.1016/j.jaci.2017.11.024 IS - 2 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 517-529 ST - TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression T2 - Journal of Allergy and Clinical Immunology TI - TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041092351&doi=10.1016%2fj.jaci.2017.11.024&partnerID=40&md5=6d6c5561082425c81adf67b3a307a5ca VL - 142 ID - 3443 ER - TY - JOUR AD - University of Milano-Bicocca, Monza, Italy University of Texas MD Anderson Cancer Center, Houston, TX, United States Princess Margaret Cancer Centre, Toronto, ON, Canada Seoul St. Mary’s Hospital, South Korea Department of Internal Medicine II, Hubertus Wald Tumor Center, University Cancer Center Hamburg, Germany Pfizer Inc., Collegeville, PA, United States Pfizer Global Research and Development, Paris, France Pfizer Inc., Cambridge, MA, United States Pfizer Inc., Groton, CT, United States Universitätsklinikum RWTH Aachen, Germany Winship Cancer Institute of Emory University, Atlanta, GA, United States AU - Gambacorti-Passerini, C. AU - Cortes, J. E. AU - Lipton, J. H. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Schafhausen, P. AU - Crescenzo, R. AU - Bardy-Bouxin, N. AU - Shapiro, M. AU - Noonan, K. AU - Leip, E. AU - Deannuntis, L. AU - Brümmendorf, T. H. AU - Jean Khoury, H. DB - Scopus DO - 10.3324/haematol.2017.171249 IS - 8 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2018 SP - 1298-1307 ST - Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: Final results of a phase I/II study T2 - Haematologica TI - Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: Final results of a phase I/II study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051142821&doi=10.3324%2fhaematol.2017.171249&partnerID=40&md5=f7856d58ded073defb07d1ab92048328 VL - 103 ID - 3450 ER - TY - JOUR AD - Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan Department of Hematology, Sapporo City General Hospital, Sapporo, Japan Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan Department of Hematology, Asahikawa Medical University, Asahikawa, Japan Department of Hematology/Oncology, Asahikawa Kosei Hospital, Asahikawa, Japan Faculty of Medicine and Graduate School of Medicine, Department of Hematology, Hokkaido University, Sapporo, Japan Department of Hematology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan Department of Hematology, Aiiku Hospital, Sapporo, Japan Department of Hematology, Tenshi Hospital, Sapporo, Japan Department of Hematology, Sapporo Medical University, Sapporo, Japan Department of Hematology, Steel Memorial Muroran Hospital, Muroran, Japan Department of Hematology, Tonan Hospital, Sapporo, Japan Department of Pediatrics, Sapporo Medical University, Sapporo, Japan Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan Department of Pediatrics, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan Department of Hematology/Oncology for Children and Adolescent, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology and Oncology, NTT East Japan Sapporo Hospital, Sapporo, Japan Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan Department of Hematology, Higashisapporo Hospital, Sapporo, Japan Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan Department of Hematology, Obihiro Kosei HospitalObihiro, Japan Palliative Care Center, Sapporo Kosei Hospital, Sapporo, Japan Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan AU - Ota, S. AU - Matsukawa, T. AU - Yamamoto, S. AU - Ito, S. AU - Shindo, M. AU - Sato, K. AU - Kondo, T. AU - Kohda, K. AU - Sakai, H. AU - Mori, A. AU - Takahashi, T. AU - Ikeda, H. AU - Kuroda, H. AU - Haseyama, Y. AU - Yamamoto, M. AU - Sarashina, T. AU - Yoshida, M. AU - Kobayashi, R. AU - Nishio, M. AU - Ishihara, T. AU - Hirayama, Y. AU - Kakinoki, Y. AU - Kobayashi, H. AU - Fukuhara, T. AU - Imamura, M. AU - Kurosawa, M. DB - Scopus DO - 10.1111/ejh.13081 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 95-105 ST - Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemia T2 - European Journal of Haematology TI - Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047499349&doi=10.1111%2fejh.13081&partnerID=40&md5=46100baf99299974eae95de73f057e84 VL - 101 ID - 3454 ER - TY - JOUR AD - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Translational Genomics, Via Sommarive, 9, Trento, 38123, Italy UOC Bioterapie, Ospedale Policlinico San Martino, Lgo R. Benzi, 10, Genova, 16132, Italy Istituto di Ricerca Pediatrica (IRP), Citta della Speranza, Padova, Italy High Throughput Screening Core Facility, CIBIO, University of Trento, Trento, Italy University of Naples Federico II, Napoli, Italy CEINGE Biotecnologie Avanzate, Napoli, Italy Animal Facility, Ospedale Policlinico San Martino, Genova, Italy University of Genova, Genova, Italy Ospedale Policlinico San Martino, Genova, Italy IRCCS SDN, Istituto di Ricerca Diagnostica e Nucleare, Napoli, Italy Laboratory of Biosciences, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl - IRCCS, Meldola, Italy AU - Sidarovich, V. AU - De Mariano, M. AU - Aveic, S. AU - Pancher, M. AU - Adami, V. AU - Gatto, P. AU - Pizzini, S. AU - Pasini, L. AU - Croce, M. AU - Parodi, F. AU - Cimmino, F. AU - Avitabile, M. AU - Emionite, L. AU - Cilli, M. AU - Ferrini, S. AU - Pagano, A. AU - Capasso, M. AU - Quattrone, A. AU - Tonini, G. P. AU - Longo, L. DB - Scopus DO - 10.1158/1535-7163.MCT-17-0841 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 1405-1415 ST - A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy T2 - Molecular Cancer Therapeutics TI - A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045926808&doi=10.1158%2f1535-7163.MCT-17-0841&partnerID=40&md5=5a558c5d95f45acab7c69ca5bf990776 VL - 17 ID - 3455 ER - TY - JOUR AD - Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Interventional Radiology, Jieyang Affiliated Hospital, Sun Yat-sen University, Jieyang, China Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China Medical Imaging Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Lyu, N. AU - Kong, Y. AU - Mu, L. AU - Lin, Y. AU - Li, J. AU - Liu, Y. AU - Zhang, Z. AU - Zheng, L. AU - Deng, H. AU - Li, S. AU - Xie, Q. AU - Guo, R. AU - Shi, M. AU - Xu, L. AU - Cai, X. AU - Wu, P. AU - Zhao, M. DB - Scopus DO - 10.1016/j.jhep.2018.02.008 IS - 1 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2018 SP - 60-69 ST - Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma T2 - Journal of Hepatology TI - Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044338249&doi=10.1016%2fj.jhep.2018.02.008&partnerID=40&md5=289b6b66f07b9c47dee7ad45e4b3c618 VL - 69 ID - 3456 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu 600036, India Department of Molecular Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu 600036, India AU - Manuprasad, A. AU - Ganesan, P. AU - Ganesan, T. S. AU - Radhakrishnan, V. AU - Dhanushkodi, M. AU - Mani, S. AU - Sagar, T. G. DB - Scopus DO - 10.1007/s12288-017-0877-x IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 443-447 ST - Experience with the Use of Nilotinib in Indian Patients T2 - Indian Journal of Hematology and Blood Transfusion TI - Experience with the Use of Nilotinib in Indian Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030723866&doi=10.1007%2fs12288-017-0877-x&partnerID=40&md5=ad024b8642e288bbfd19aca6a38ac3c9 VL - 34 ID - 3458 ER - TY - JOUR AD - Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, South Korea Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, South Korea Institute of Evidence Based Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea AU - Lee, K. J. AU - Jang, Y. O. AU - Cha, S. K. AU - Kim, M. Y. AU - Park, K. S. AU - Eom, Y. W. AU - Baik, S. K. DB - Scopus DO - 10.5009/gnl17443 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 449-456 ST - Expression of fibroblast growth factor 21 and ß-Klotho regulates hepatic fibrosis through the nuclear factor-?B and c-Jun N-Terminal kinase pathways T2 - Gut and Liver TI - Expression of fibroblast growth factor 21 and ß-Klotho regulates hepatic fibrosis through the nuclear factor-?B and c-Jun N-Terminal kinase pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049949317&doi=10.5009%2fgnl17443&partnerID=40&md5=ee373ea45455e36e97c44ce6184a5be5 VL - 12 ID - 3459 ER - TY - JOUR AD - Department of Orthopedic, Children’s Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China AU - Zhou, P. AU - Liu, H. AU - Wu, Y. AU - Chen, D. DB - Scopus DO - 10.12659/MSM.908592 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 4379-4385 ST - Propofol promotes ankle fracture healing in children by inhibiting inflammatory response T2 - Medical Science Monitor TI - Propofol promotes ankle fracture healing in children by inhibiting inflammatory response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049695626&doi=10.12659%2fMSM.908592&partnerID=40&md5=9bca95bc24fb27eebc974d59a7e5dad9 VL - 24 ID - 3460 ER - TY - JOUR AD - Pharmacy Department, Hospital de Pediatría Dr. Prof. Juan P. Garrahan, Buenos Aires, Argentina Pharmacy Department, Hospital Interzonal Especializado Materno Infantil “Victorio Tetamanti”, Mar del Plata, Argentina Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Madrid, Spain AU - González, J. AU - Quiroga, M. AU - Escudero-Vilaplana, V. AU - Collado-Borrell, R. AU - Herranz-Alonso, A. AU - Sanjurjo Sáez, M. DB - Scopus DO - 10.1080/14740338.2018.1477937 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 553-572 ST - Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities T2 - Expert Opinion on Drug Safety TI - Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047481669&doi=10.1080%2f14740338.2018.1477937&partnerID=40&md5=490db6fafb63b5145a84b796acea124b VL - 17 ID - 3462 ER - TY - JOUR AD - Division of Hematology-Oncology, University of Massachusetts Medical School, Worcester, MA, United States Institut Gustave Roussy, Villejuif, France Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States University of Virginia School of Medicine, Charlottesville, VA, United States AU - Mittal, K. AU - Derosa, L. AU - Albiges, L. AU - Wood, L. AU - Elson, P. AU - Gilligan, T. AU - Garcia, J. AU - Dreicer, R. AU - Escudier, B. AU - Rini, B. DB - Scopus DO - 10.1016/j.clgc.2017.12.014 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - e663-e667 ST - Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors T2 - Clinical Genitourinary Cancer TI - Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044652791&doi=10.1016%2fj.clgc.2017.12.014&partnerID=40&md5=ad41c6c442bcdcdf97d6e81d750f314c VL - 16 ID - 3463 ER - TY - JOUR AD - Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland Department of Hematology, Pomeranian Medical University, Szczecin, Poland Department of Haematology Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland Department of Hematology, Medical University of Białystok, Białystok, Poland AU - Lewandowski, K. AU - Gniot, M. AU - Wojtaszewska, M. AU - Kanduła, Z. AU - Becht, R. AU - Paczkowska, E. AU - Mędraś, E. AU - Wasilewska, E. AU - Iwoła, M. DB - Scopus DO - 10.1111/ijlh.12798 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 SP - 366-371 ST - Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors T2 - International Journal of Laboratory Hematology TI - Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043351088&doi=10.1111%2fijlh.12798&partnerID=40&md5=8d6997b486bc5fe85820565ad45fc614 VL - 40 ID - 3466 ER - TY - JOUR AD - Haematology, Department of Cellular Biotechnologies and Haematology, “Sapienza” University, Rome, Italy GIMEMA Data Centre, GIMEMA Foundation, Rome, Italy Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, United States Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, United States Institute of Haematology, Centro Ricerche Onco-Ematologiche (CREO), University of Perugia, Perugia, Italy Department of Paediatric Haematology/Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Institute of Haematology and Blood Transfusion, Prague, Czech Republic Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Molecular Medicine, “Sapienza” University, Rome, Italy AU - Chiaretti, S. AU - Messina, M. AU - Grammatico, S. AU - Piciocchi, A. AU - Fedullo, A. L. AU - Di Giacomo, F. AU - Peragine, N. AU - Gianfelici, V. AU - Lauretti, A. AU - Bareja, R. AU - Martelli, M. P. AU - Vignetti, M. AU - Apicella, V. AU - Vitale, A. AU - Li, L. S. AU - Salek, C. AU - Elemento, O. AU - Inghirami, G. AU - Weinstock, D. M. AU - Guarini, A. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.15251 IS - 5 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2018 SP - 642-652 ST - Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications T2 - British Journal of Haematology TI - Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047562389&doi=10.1111%2fbjh.15251&partnerID=40&md5=2e07e4618ec43f14acfd1930ae19bbeb VL - 181 ID - 3467 ER - TY - JOUR AD - Dept. of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland Acute Leukemia Working Party of the EBMT, Paris, France Dept. of Hematology, Hôpital Saint-Antoine, Paris, France Leukemia Myeloma Units, The Royal Marsden Center, London, United Kingdom Dept. of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium Dept. of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Dept. of Hematology –, BMT, Hopital St. Louis, Paris, France Institut Universitaire Du Cancer, Oncopole IUCT, Toulouse, France R.M. Gorbacheva Memorial Institute of Children Oncology, Academician I.P. Pavlov First St. Petersburg State Medical University, Saint-Petersburg, Russian Federation Clinic of Hematology, University Hospital Zurich, Zurich, Switzerland Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Stockholm, Sweden Dept. of Internal Medicine I, Bone Marrow Transplamntation, Medical University of Vienna, Vienna, Austria Dept. of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany BMT Unit, Instituto Português de Oncologia, Porto, Portugal 3rd Dept. of Internal Medicine Semmelweis University, St. István & St. Laszlo Hospital, Budapest, Hungary Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv University, Israel AU - Giebel, S. AU - Labopin, M. AU - Potter, M. AU - Poiré, X. AU - Sengeloev, H. AU - Socié, G. AU - Huynh, A. AU - Afanasyev, B. V. AU - Schanz, U. AU - Ringden, O. AU - Kalhs, P. AU - Beelen, D. W. AU - Campos, A. M. AU - Masszi, T. AU - Canaani, J. AU - Mohty, M. AU - Nagler, A. DB - Scopus DO - 10.1016/j.ejca.2018.03.018 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 73-81 ST - Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT T2 - European Journal of Cancer TI - Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045673193&doi=10.1016%2fj.ejca.2018.03.018&partnerID=40&md5=1ad1eb2e5593090749d5b3fd827f6b02 VL - 96 ID - 3468 ER - TY - JOUR AD - Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium Department of Pathology, University Hospitals Leuven, Leuven, Belgium Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium Department of Hematology, University Hospitals Leuven, Leuven, Belgium Center for Human Genetics, KU Leuven, Leuven, Belgium Department of Oncology, KU Leuven, Leuven, Belgium AU - Claerhout, H. AU - Van Aelst, S. AU - Melis, C. AU - Tousseyn, T. AU - Gheysens, O. AU - Vandenberghe, P. AU - Dierickx, D. AU - Boeckx, N. DB - Scopus DO - 10.1111/ejh.13056 IS - 6 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 603-612 ST - Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study T2 - European Journal of Haematology TI - Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045850422&doi=10.1111%2fejh.13056&partnerID=40&md5=fe23277364c2429b24430e63cf2d2704 VL - 100 ID - 3469 ER - TY - JOUR AD - Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Advanced Centre for Human Genetics, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India AU - Azad, N. A. AU - Shah, Z. A. AU - Pandith, A. A. AU - Khan, M. S. AU - Rasool, R. AU - Rasool, J. AU - Aziz, S. A. DB - Scopus DO - 10.22034/APJCP.2018.19.6.1479 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 1479-1485 ST - Prognostic implication of BCR-ABL fusion transcript variants in Chronic myeloid leukemia (CML) treated with Imatinib. A first of its kind study on CML patients of Kashmir T2 - Asian Pacific Journal of Cancer Prevention TI - Prognostic implication of BCR-ABL fusion transcript variants in Chronic myeloid leukemia (CML) treated with Imatinib. A first of its kind study on CML patients of Kashmir UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048978199&doi=10.22034%2fAPJCP.2018.19.6.1479&partnerID=40&md5=45033950a6e48582b06910679858bdb3 VL - 19 ID - 3471 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China AU - Tan, Y. AU - Liu, Z. AU - Wang, W. AU - Zhu, G. AU - Guo, J. AU - Chen, X. AU - Zheng, C. AU - Xu, Z. AU - Chang, J. AU - Ren, F. AU - Wang, H. DB - Scopus DO - 10.1016/j.leukres.2018.04.013 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 89-93 ST - Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia T2 - Leukemia Research TI - Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046161901&doi=10.1016%2fj.leukres.2018.04.013&partnerID=40&md5=dbd67d55b70a4c2d04ee9f66831d1e8b VL - 69 ID - 3472 ER - TY - JOUR AD - Northwestern University, Department of Dermatology, Chicago, IL, United States AU - Tan, A. U. AU - Schlosser, B. J. AU - Paller, A. S. DB - Scopus DO - 10.1016/j.ijwd.2017.10.006 IS - 2 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2018 SP - 56-71 ST - A review of diagnosis and treatment of acne in adult female patients T2 - International Journal of Women's Dermatology TI - A review of diagnosis and treatment of acne in adult female patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038860277&doi=10.1016%2fj.ijwd.2017.10.006&partnerID=40&md5=240752adebd156d7f7cc656ae864b228 VL - 4 ID - 3473 ER - TY - JOUR AD - Hematology Unit, Mansoura University Oncology Center, Mansoura University, Mansoura, Egypt Hematology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt Physiology, Zoology Department, Faculty of Science, Damietta University, Damietta, Egypt AU - Aref, S. AU - Azmy, E. AU - El-Bakry, K. AU - Ibrahim, L. AU - Mabed, M. DB - Scopus DO - 10.1080/10245332.2017.1404276 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 263-270 ST - Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients T2 - Hematology TI - Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034669629&doi=10.1080%2f10245332.2017.1404276&partnerID=40&md5=359a36c9bd30703d931f26f1d73d6c5a VL - 23 ID - 3478 ER - TY - JOUR AD - Department of Medicine, Division of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan AU - Sato, E. AU - Iriyama, N. AU - Tokuhira, M. AU - Takaku, T. AU - Ishikawa, M. AU - Nakazato, T. AU - Sugimoto, K. J. AU - Fujita, H. AU - Fujioka, I. AU - Asou, N. AU - Komatsu, N. AU - Kizaki, M. AU - Hatta, Y. AU - Kawaguchi, T. DB - Scopus DO - 10.1080/10428194.2017.1365858 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 1105-1112 ST - Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score T2 - Leukemia and Lymphoma TI - Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028574636&doi=10.1080%2f10428194.2017.1365858&partnerID=40&md5=fa8ade391ca83fed2d58867b4d61edbd VL - 59 ID - 3481 ER - TY - JOUR AD - Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center – New OrleansLA 70112, United States Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States Arkansas Children’s Nutrition Center, Little Rock, AR 72202, United States AU - Ronis, M. J. J. AU - Gomez-Acevedo, H. AU - Shankar, K. AU - Sharma, N. AU - Blackburn, M. AU - Singhal, R. AU - Mercer, K. E. AU - Badger, T. M. DB - Scopus DO - 10.1177/1535370218771333 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 695-707 ST - EB 2017 Article: Soy protein isolate feeding does not result in reproductive toxicity in the pre-pubertal rat testis T2 - Experimental Biology and Medicine TI - EB 2017 Article: Soy protein isolate feeding does not result in reproductive toxicity in the pre-pubertal rat testis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046999578&doi=10.1177%2f1535370218771333&partnerID=40&md5=0e8c7270660e62443f019121bf970ea6 VL - 243 ID - 3492 ER - TY - JOUR AD - Department of Pediatrics, Division of Neonatology, Stony Brook University School of Medicine, Stony Brook, NY, United States Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, United States Precision Vaccine Program, Boston Children’s Hospital, Boston, MA, United States AU - Speer, E. M. AU - Dowling, D. J. AU - Xu, J. AU - Ozog, L. S. AU - Mathew, J. A. AU - Chander, A. AU - Yin, D. AU - Levy, O. C7 - e0196352 DB - Scopus DO - 10.1371/journal.pone.0196352 IS - 5 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 ST - Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro T2 - PLoS ONE TI - Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046364989&doi=10.1371%2fjournal.pone.0196352&partnerID=40&md5=318800f9b20a3e075462c4cb89cfd43a VL - 13 ID - 3493 ER - TY - JOUR AD - Department of Pediatric Hematology-Oncology, Lorestan University of Medical Sciences, Khoramabad, Iran Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Department of Pediatric Hematology-Oncology, Iran University of Medical Sciences, Tehran, Iran AU - Abdolkarimi, B. AU - Zareifar, S. AU - Karimi, M. AU - Salajegheh, P. DB - Scopus IS - 2 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 77-84 ST - Management of refractory/relapsed acute leukemia with heart limitation by anthracycline-free chemotherapy regimens in pediatric patients: New hypothesis and new approach T2 - Middle East Journal of Cancer TI - Management of refractory/relapsed acute leukemia with heart limitation by anthracycline-free chemotherapy regimens in pediatric patients: New hypothesis and new approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044354622&partnerID=40&md5=c9343e7919cd631d83005a55cb75f25c VL - 9 ID - 3496 ER - TY - JOUR AD - Peking University People’s Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Beijing, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom AU - Jiang, Q. AU - Yu, L. AU - Gale, R. P. DB - Scopus DO - 10.1007/s00432-018-2594-8 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 735-741 ST - Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia T2 - Journal of Cancer Research and Clinical Oncology TI - Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041100387&doi=10.1007%2fs00432-018-2594-8&partnerID=40&md5=d48b9375ca90f9967e35456867092d23 VL - 144 ID - 3497 ER - TY - JOUR AD - Department of Stem Cell Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center Research Institute, Tampa, Florida, United States Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin, United States CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, United States Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio, United States Division of Hematology and Oncology, Emory University Hospital, Atlanta, Georgia, United States Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States Section of Hematology/Oncology, University of Chicago School of Medicine, Chicago, Illinois, United States Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, Minnesota, United States Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States Ottawa Hospital Blood and Marrow Transplant Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California, United States University Medical Center Utrecht, Utrecht, Netherlands Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom AU - Kebriaei, P. AU - Anasetti, C. AU - Zhang, M. J. AU - Wang, H. L. AU - Aldoss, I. AU - de Lima, M. AU - Khoury, H. J. AU - Sandmaier, B. M. AU - Horowitz, M. M. AU - Artz, A. AU - Bejanyan, N. AU - Ciurea, S. AU - Lazarus, H. M. AU - Gale, R. P. AU - Litzow, M. AU - Bredeson, C. AU - Seftel, M. D. AU - Pulsipher, M. A. AU - Boelens, J. J. AU - Alvarnas, J. AU - Champlin, R. AU - Forman, S. AU - Pullarkat, V. AU - Weisdorf, D. AU - Marks, D. I. AU - Hogan, W. AU - Battiwalla, M. AU - Copelan, E. AU - Hildebrandt, G. AU - Ganguly, S. AU - Majhail, N. AU - Woolfrey, A. AU - Nivison-Smith, I. AU - Hertzberg, M. AU - Diaz, M. A. AU - Jakubowski, A. AU - Ustun, C. AU - Yong, A. AU - Freytes, C. AU - DeFilipp, Z. AU - Inamoto, Y. AU - Cahn, J. Y. AU - Savani, B. AU - Yared, J. AU - Bajel, A. AU - Bacher, U. AU - Uy, G. AU - Rizzieri, D. AU - Wieduwilt, M. AU - Schultz, K. AU - Grunwald, M. AU - Kamble, R. AU - Qayed, M. AU - Brammer, J. AU - Ballen, K. AU - Khera, N. AU - Schouten, H. AU - Bierings, M. AU - Kanakry, C. AU - Wood, W. A. AU - Saad, A. AU - Savoie, L. AU - Hamilton, B. K. AU - Aljurf, M. AU - Vij, R. AU - Pawarode, A. AU - Olsson, R. AU - Wirk, B. M. AU - Beitinjaneh, A. AU - Seo, S. AU - Cerny, J. AU - Akpek, G. AU - Norkin, M. AU - Nishihori, T. AU - Lazaryan, A. AU - Sabloff, M. AU - Acute Leukemia Committee of the, Cibmtr DB - Scopus DO - 10.1016/j.bbmt.2017.11.025 IS - 4 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2018 SP - 726-733 ST - Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia T2 - Biology of Blood and Marrow Transplantation TI - Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041917243&doi=10.1016%2fj.bbmt.2017.11.025&partnerID=40&md5=4825d4fa62a20056770732632fcc00e5 VL - 24 ID - 3498 ER - TY - JOUR AD - Department of Medical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh 530 053, India Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India AU - Kagita, S. AU - Mamidi, T. AU - Digumarti, L. AU - Gundeti, S. AU - Digumarti, R. DB - Scopus DO - 10.4103/ijmpo.ijmpo_80_17 IS - 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 165-171 ST - Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients T2 - Indian Journal of Medical and Paediatric Oncology TI - Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044465440&doi=10.4103%2fijmpo.ijmpo_80_17&partnerID=40&md5=3b906a18806a82f404b81a93964a73ab VL - 39 ID - 3500 ER - TY - JOUR AD - Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia University of Aberdeen, United Kingdom AU - Kuan, J. W. AU - Michael, M. S. DB - Scopus IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 78-85 ST - The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island T2 - Medical Journal of Malaysia TI - The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046142881&partnerID=40&md5=eefc0babce4732b61d888957053c0fd7 VL - 73 ID - 3502 ER - TY - JOUR AD - Hematology Department, Aziza Othmana University Hospital, Tunis, Tunisia Hematology Department, Military Hospital Tunis, Tunis, Tunisia Hematology Department, Hedi Chaker Hospital, Sfax, Tunisia Hematology Department, Farhat Hached Hospital, Sousse, Tunisia Biology, Institut Pasteur, Tunis, Tunisia Hematology Department, La Rabta Hospital, Tunis, Tunisia Hematology Department, Fattouma Bourguiba Hospital, Monastir, Tunisia Centre national de greffe de moelle osseuse, Tunis, Tunisia Department of Haematology, Aziza Othmana University Hospital, Tunis, Tunisia AU - Ben Lakhal, R. AU - Ghedira, H. AU - Bellaaj, H. AU - Ben Youssef, Y. AU - Menif, S. AU - Manai, Z. AU - Bedoui, M. AU - Lakhal, A. AU - M’Sadek, F. AU - Elloumi, M. AU - Khélif, A. AU - Ben Romdhane, N. AU - Laatiri, M. A. AU - Ben Othmen, T. AU - Meddeb, B. DB - Scopus DO - 10.1007/s00277-017-3224-2 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 597-604 ST - Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) T2 - Annals of Hematology TI - Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040088966&doi=10.1007%2fs00277-017-3224-2&partnerID=40&md5=909e76c1d21b5d4b0c3f8c76e951ea75 VL - 97 ID - 3503 ER - TY - JOUR AD - Unidad de Dermatología, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria La Fe, Valencia, Spain Grupo de Investigación en Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Valencia, Spain Grupo de Investigación Clínica y Traslacional del Cáncer, Hospital Universitario y Politécnico La Fe, Valencia, Spain Grupo de Investigación de Dermatología y Regeneración Tisular, Hospital Universitario y Politécnico La Fe, Valencia, Spain AU - Molés-Poveda, P. AU - Montesinos, P. AU - Sanz-Caballer, J. AU - de Unamuno, B. AU - Piñana, J. L. AU - Sahuquillo, A. AU - Botella-Estrada, R. DB - Scopus DO - 10.1016/j.ad.2017.11.003 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 241-247 ST - Tratamiento de la enfermedad de injerto contra huésped crónica esclerodermiforme con imatinib: una perspectiva dermatológica T2 - Actas Dermo-Sifiliograficas TI - Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044610449&doi=10.1016%2fj.ad.2017.11.003&partnerID=40&md5=31a286ae9129aec84a507d34e0a54f7f VL - 109 ID - 3506 ER - TY - JOUR AD - QCP, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States Seda Pharmaceutical Development Services, The BioHub at Alderley Park, Alderley Edge, Cheshire, United Kingdom Department of Medicine, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, Lyon, France Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, United Kingdom Quintiles IMS, Overland Park, KS, United States START Madrid—FJD, Hospital Fundación Jimenez Díaz, Avenida Reyes Católicos 2, Madrid, Spain Oncology TMU, Early Clinical Development, AstraZeneca, Charter Way, Macclesfield, United Kingdom Karen Thomas Statistics Limited, 54 Pullman Lane, Godalming, Surrey, United Kingdom Drug Development Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom The Institute of Cancer Research, London, United Kingdom AU - Vishwanathan, K. AU - Dickinson, P. A. AU - Bui, K. AU - Cassier, P. A. AU - Greystoke, A. AU - Lisbon, E. AU - Moreno, V. AU - So, K. AU - Thomas, K. AU - Weilert, D. AU - Yap, T. A. AU - Plummer, R. DB - Scopus DO - 10.1002/jcph.1035 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - 474-484 ST - The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers T2 - Journal of Clinical Pharmacology TI - The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044463184&doi=10.1002%2fjcph.1035&partnerID=40&md5=ac7f34be63e9867df95a3901ee539df6 VL - 58 ID - 3507 ER - TY - JOUR AD - Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China Department of Orthopaedic, First Affiliated Hospital, School of Medicine, Shihezi University, ShiHeZi, Xinjiang, China AU - Ruan, Z. AU - Ma, H. AU - Li, J. AU - Liu, H. AU - Jia, H. AU - Li, F. DB - Scopus DO - 10.1177/1535370218760774 IS - 7 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 595-600 ST - The long non-coding RNA NEAT1 contributes to extracellular matrix degradation in degenerative human nucleus pulposus cells T2 - Experimental Biology and Medicine TI - The long non-coding RNA NEAT1 contributes to extracellular matrix degradation in degenerative human nucleus pulposus cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045075322&doi=10.1177%2f1535370218760774&partnerID=40&md5=eb8d590c4465d746d890495c5e73b10d VL - 243 ID - 3509 ER - TY - JOUR AD - Pediatric Hematology and Oncology, University Hospital ‘Carl Gustav Carus’, Dresden, Germany I. Medical Clinic, University Hospital ‘Carl Gustav Carus’, Dresden, Germany Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany Pediatric Oncology Unit, CIC 802 INSERM, University Hospital, Poitiers, France AU - Suttorp, M. AU - Bornhäuser, M. AU - Metzler, M. AU - Millot, F. AU - Schleyer, E. DB - Scopus DO - 10.1080/17512433.2018.1398644 IS - 3 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 219-231 ST - Pharmacology and pharmacokinetics of imatinib in pediatric patients T2 - Expert Review of Clinical Pharmacology TI - Pharmacology and pharmacokinetics of imatinib in pediatric patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042332935&doi=10.1080%2f17512433.2018.1398644&partnerID=40&md5=17b497c372243d58f8e748dd93e05b1a VL - 11 ID - 3511 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands Dutch Childhood Oncology Group, The Hague, Netherlands Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands AU - Klein, K. AU - de Haas, V. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1080/14737140.2018.1428091 IS - 3 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 277-293 ST - Clinical challenges in de novo pediatric acute myeloid leukemia T2 - Expert Review of Anticancer Therapy TI - Clinical challenges in de novo pediatric acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042385581&doi=10.1080%2f14737140.2018.1428091&partnerID=40&md5=9fc80bd380a1f6f5a794320a978d2002 VL - 18 ID - 3512 ER - TY - JOUR AD - Department of Oncology Minimally Invasive, The 307th Hospital of PLA, Affiliated Hospital of Military Medical Sciences, Beijing, China AU - Zhu, B. AU - Li, J. AU - Xie, Q. AU - Diao, L. AU - Gai, L. AU - Yang, W. DB - Scopus DO - 10.1080/15384047.2017.1416275 IS - 3 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2018 SP - 198-204 ST - Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study T2 - Cancer Biology and Therapy TI - Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040991975&doi=10.1080%2f15384047.2017.1416275&partnerID=40&md5=460c33dde9e104e1bb6546dd66487319 VL - 19 ID - 3513 ER - TY - JOUR AD - Department of Internal Medicine/Oncology, College of Medicine, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Al-Khobar, Eastern Province, Saudi Arabia AU - Al-Amri, A. M. DB - Scopus DO - 10.1016/j.clml.2018.01.002 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 199-203 ST - Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041577947&doi=10.1016%2fj.clml.2018.01.002&partnerID=40&md5=339cc8d33af93d05f71936ef50f0f668 VL - 18 ID - 3514 ER - TY - JOUR AD - Department of Medicine and Surgery, University of Insubria, Varese, Italy Department of Science and High Technology, University of Insubria, Como, Italy IFN (National Institute of Nuclear Physics), Como, Italy Department of Biology and Life Sciences, University of Insubria, Varese, Italy Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Genetics and Cytogenetics, ASST Sette Laghi, Ospedale di Circolo Fondazione Macchi, Varese, Italy Department of Health Sciences, University of Milan, Milan, Italy Biomedical Technologies Institute, CNR, Milan, Italy AU - Rainero, A. AU - Angaroni, F. AU - Conti, A. AU - Pirrone, C. AU - Micheloni, G. AU - Tararà, L. AU - Millefanti, G. AU - Maserati, E. AU - Valli, R. AU - Spinelli, O. AU - Buklijas, K. AU - Michelato, A. AU - Casalone, R. AU - Barlassina, C. AU - Barcella, M. AU - Sirchia, S. AU - Piscitelli, E. AU - Caccia, M. AU - Porta, G. C7 - 349 DB - Scopus DO - 10.1038/s41419-018-0387-2 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 ST - GDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML T2 - Cell Death and Disease TI - GDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042789497&doi=10.1038%2fs41419-018-0387-2&partnerID=40&md5=349fd8f744504e9a9492442ac380b9d4 VL - 9 ID - 3517 ER - TY - JOUR AD - Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China AU - Zhou, J. D. AU - Lin, J. AU - Zhang, T. J. AU - Ma, J. C. AU - Li, X. X. AU - Wen, X. M. AU - Guo, H. AU - Xu, Z. J. AU - Deng, Z. Q. AU - Zhang, W. AU - Qian, J. DB - Scopus DO - 10.1002/jcp.26119 IS - 3 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2018 SP - 2444-2450 ST - Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia T2 - Journal of Cellular Physiology TI - Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034981319&doi=10.1002%2fjcp.26119&partnerID=40&md5=04ae22d5af26dd19526068a2bdc5974a VL - 233 ID - 3518 ER - TY - JOUR AD - Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of SydneyNSW 2006, Australia Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Imperial College London, Hammersmith Campus, United Kingdom School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia AU - Murray, M. AU - Gillani, T. B. AU - Ghassabian, S. AU - Edwards, R. J. AU - Rawling, T. DB - Scopus DO - 10.1016/j.ejps.2017.12.003 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 SP - 55-63 ST - Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver T2 - European Journal of Pharmaceutical Sciences TI - Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037634876&doi=10.1016%2fj.ejps.2017.12.003&partnerID=40&md5=f82c3f4d3d01fed1b7acc8cd60eed9be VL - 114 ID - 3520 ER - TY - JOUR AD - College of Veterinary Medicine, Cornell University, Ithaca, NY, United States Department of Animal Science, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY, United States Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States Oncology Services, Veterinary Medical Center of Long Island, West Islip, NY, United States AU - Moirano, S. J. AU - Lima, S. F. AU - Hume, K. R. AU - Brodsky, E. M. DB - Scopus DO - 10.1111/vco.12373 IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - E194-E201 ST - Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs T2 - Veterinary and Comparative Oncology TI - Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038019500&doi=10.1111%2fvco.12373&partnerID=40&md5=429fd29dbdcade7dbfb9eb9214f3d4ec VL - 16 ID - 3521 ER - TY - JOUR AD - Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea Department of Dermatology, Seoul Medical Center, Seoul, South Korea Department of Biochemistry, Ajou University School of Medicine, Suwon, South Korea Department of Biomedical Sciences, Graduate School, Ajou University, Suwon, South Korea Ellead Skin & Bio Research, Ellead Co., Ltd., Osong Research Center, Cheongju-si, South Korea AU - Kim, S. K. AU - Oh, S. J. AU - Park, S. Y. AU - Kim, W. J. AU - Kim, Y. S. AU - Kim, Y. C. DB - Scopus DO - 10.1111/pcmr.12658 IS - 2 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2018 SP - 277-286 ST - Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts T2 - Pigment Cell and Melanoma Research TI - Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041824693&doi=10.1111%2fpcmr.12658&partnerID=40&md5=42b8088fa79eb45d42495b3dd10ac799 VL - 31 ID - 3523 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, Justus-Liebig University of Giessen, Feulgenstraße 12, Giessen, 35392, Germany Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany Clinical Cooperation Unit Pediatric Oncology, German Cancer Research center (DKFZ), Heidelberg, Germany Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Halle, Germany AU - Mauz-Körholz, C. AU - Ströter, N. AU - Baumann, J. AU - Botzen, A. AU - Körholz, K. AU - Körholz, D. DB - Scopus DO - 10.1007/s40272-017-0265-x IS - 1 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 43-57 ST - Pharmacotherapeutic Management of Pediatric Lymphoma T2 - Pediatric Drugs TI - Pharmacotherapeutic Management of Pediatric Lymphoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033459854&doi=10.1007%2fs40272-017-0265-x&partnerID=40&md5=c6a265c8927e46b97ebedcc419719365 VL - 20 ID - 3527 ER - TY - JOUR AD - Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Wells, S. A., Jr. DB - Scopus DO - 10.1530/ERC-17-0325 IS - 2 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - T1-T13 ST - Advances in the management of MEN2: From improved surgical and medical treatment to novel kinase inhibitors T2 - Endocrine-Related Cancer TI - Advances in the management of MEN2: From improved surgical and medical treatment to novel kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042589993&doi=10.1530%2fERC-17-0325&partnerID=40&md5=dbe9343b41224915c813f9c3af8f4ecb VL - 25 ID - 3528 ER - TY - JOUR AD - Pusan National University, Department of Microbiology, Disivion of Natural Science, Busan, 609-735, South Korea KM Convergence Research DivisionKorea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Daejeon, Yuseong-gu, 34054, South Korea Chonnam National University, School of Biological Sciences and Technology, 77 Yongbong-ro, Gwangju, Buk-gu, 500-757, South Korea University of Science and Technology, 217 Gajeong-ro, Daejeon, Yuseong-gu, 305-333, South Korea AU - Lee, H. J. AU - Im, A. R. AU - Kim, S. M. AU - Kang, H. S. AU - Lee, J. D. AU - Chae, S. C7 - 39 DB - Scopus DO - 10.1186/s12906-017-2058-8 IS - 1 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2018 ST - The flavonoid hesperidin exerts anti-photoaging effect by downregulating matrix metalloproteinase (MMP)-9 expression via mitogen activated protein kinase (MAPK)-dependent signaling pathways T2 - BMC Complementary and Alternative Medicine TI - The flavonoid hesperidin exerts anti-photoaging effect by downregulating matrix metalloproteinase (MMP)-9 expression via mitogen activated protein kinase (MAPK)-dependent signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041362695&doi=10.1186%2fs12906-017-2058-8&partnerID=40&md5=69dcb3004eda65f3c1ca39da541a6c44 VL - 18 ID - 3531 ER - TY - JOUR AD - Department of Urology, Austin Health, Heidelberg, VIC, Australia Cancer Surgery, Peter MacCallum Cancer Center, Melbourne, VIC, Australia Department of Pathology, Tissue Path, Mount Waverley, VIC, Australia YURO, Young Urology Researchers Organisation, Melbourne, VIC, Australia AU - Pascoe, C. AU - Christidis, D. AU - Clouston, D. AU - Lawrentschuk, N. C7 - bcr-2017-223423 DB - Scopus DO - 10.1136/bcr-2017-223423 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 ST - Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: First reported case of yet another mask T2 - BMJ Case Reports TI - Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: First reported case of yet another mask UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045904872&doi=10.1136%2fbcr-2017-223423&partnerID=40&md5=4b7cdba0d43aeb5cbafc5e4ebb419859 VL - 2018 ID - 3532 ER - TY - JOUR AD - Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Poland Department of Pediatrics, Hematology and Oncology, Dr Edward Hanke Chorzów Center of Pediatrics and Oncology, Poland Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, Poland Silesian Children's Health Center, Department of Oncology, Hematology and Pediatric Chemotherapy, Medical University of Silesia in Katowice, Poland Department of Oncology and Hematology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Poland Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland Department of Pediatrics, Pediatric Hematology and Oncology, Pomeranian Medical University in Szczecin, Poland Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland Department of Oncology, Hematology and Pediatric Transplantatology, Poznan University of Medical Sciences, Poland Department of Pediatrics, Hematology and Oncology, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland Department of Hematooncology, Wladyslaw Buszkowski Provincial Specialist Children's Hospital in Kielce, Poland Department and Clinic of Pediatric Hematology and Oncology, Prof. Stanisław Popowski Provincial Specialist Childrens Hospital in Olsztyn, Poland AU - Janeczko-Czarnecka, M. AU - Krawczuk-Rybak, M. AU - Karpińska-Derda, I. AU - Maciej Niedzwiecki, I. AU - Musioł, K. AU - Cwiklińska, M. AU - Drabko, K. AU - Mycko, K. AU - Ociepa, T. AU - Pawelec, K. AU - Januszkiewicz-Lewandowska, D. AU - Ussowicz, M. AU - Rybka, B. AU - Ryczan-Krawczyk, R. AU - Kołtan, A. AU - Karolczyk, G. AU - Zaucha-Prazmo, A. AU - Badowska, W. AU - Kałwak, K. DB - Scopus DO - 10.17219/acem/66462 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 91-98 ST - Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas T2 - Advances in Clinical and Experimental Medicine TI - Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041488834&doi=10.17219%2facem%2f66462&partnerID=40&md5=5fd08d8e2f86fc571bda02b60e0cfdd0 VL - 27 ID - 3534 ER - TY - JOUR AD - Department of Pharmacy, International University of Health, Welfare Ichikawa Hospital, 6-1-14 Kounodai, Ichikawa-shi, Chiba, 272-0827, Japan Department of Pharmacy, Institute of Medical Science, University of Tokyo Department of Pharmacotherapy, Meiji Pharmaceutical University Department of Medicinal Therapy Research, Meiji Pharmaceutical University Department of Pharmacotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo Department of Respiratory Surgery, International University of Health, Welfare Ichikawa Hospital, Chiba, Japan AU - Iimura, Y. AU - Shimomura, H. AU - Yasu, T. AU - Imanaka, K. AU - Ogawa, R. AU - Ito, A. AU - Suzuki, K. AU - Yamaguchi, G. AU - Kawasaki, N. AU - Konaka, C. DB - Scopus DO - 10.5414/CP203323 IS - 11 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 551-554 ST - NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients T2 - International Journal of Clinical Pharmacology and Therapeutics TI - NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055613356&doi=10.5414%2fCP203323&partnerID=40&md5=fe50c231f647a4bb66b92763873201c3 VL - 56 ID - 3536 ER - TY - JOUR AD - Department of Dermatology and Allergology, University Hospital of RWTH Aachen, Aachen, Germany Department of Medical Engineering and Technomathematics, FH Aachen University of Applied Sciences, Campus Jülich, Germany AU - Balakirski, G. AU - Kotliar, K. AU - Pauly, K. J. AU - Krings, L. K. AU - Rübben, A. AU - Baron, J. M. AU - Schmitt, L. DB - Scopus DO - 10.1097/DSS.0000000000001615 IS - 12 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 1525-1536 ST - Surgical site infections after dermatologic surgery in immunocompromised patients: A single-center experience T2 - Dermatologic Surgery TI - Surgical site infections after dermatologic surgery in immunocompromised patients: A single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057204219&doi=10.1097%2fDSS.0000000000001615&partnerID=40&md5=b938c7430bf8eb3e29b1396a35f8fe1e VL - 44 ID - 3537 ER - TY - JOUR AD - University of Texas, MD Anderson Cancer Center, Houston, TX, United States National Institutes of Health, Bethesda, MD, United States University of California Los Angeles, Los Angeles, CA, United States Yonsei University, College of Medicine, Gangnam Severance Hospital, South Korea Seoul National University Hospital, Seoul, South Korea Netherlands Cancer Institute, Amsterdam, Netherlands Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands Institut Gustave Roussy, University of Paris-Sud, University of Paris-Saclay, Villejuif, France Dana-Farber Cancer Institute, Boston, MA, United States Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria Novartis Oncology, East Hanover, NJ, United States AU - Subbiah, V. AU - Cabanillas, M. E. AU - Kreitman, R. J. AU - Wainberg, Z. A. AU - Cho, J. Y. AU - Keam, B. AU - Schellens, J. H. M. AU - Soria, J. C. AU - Wen, P. Y. AU - Zielinski, C. AU - Urbanowitz, G. AU - Mookerjee, B. AU - Wang, D. AU - Rangwala, F. DB - Scopus DO - 10.1200/JCO.2017.73.6785 IS - 1 M3 - Article N1 - Cited By :180 Export Date: 18 November 2020 PY - 2018 SP - 7-13 ST - Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer T2 - Journal of Clinical Oncology TI - Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039975292&doi=10.1200%2fJCO.2017.73.6785&partnerID=40&md5=616d0dce81bb22c014607f3c01fb89a8 VL - 36 ID - 3538 ER - TY - JOUR AD - Department of Pathology & Immunology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX, United States AU - Huho, A. N. AU - Issaq, N. AU - Iacobas, I. AU - Elghetany, T. M. AU - López-Terrada, D. AU - Fisher, K. E. AU - Punia, J. N. DB - Scopus DO - 10.1177/1093526617698601 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 100-104 ST - A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis T2 - Pediatric and Developmental Pathology TI - A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041574454&doi=10.1177%2f1093526617698601&partnerID=40&md5=814ad2c31295631b26f28481b5ee4cf4 VL - 21 ID - 3539 ER - TY - JOUR AD - National Research Center for Hematology, Moscow, Russian Federation Center of Pharmaceutical Analytics Ltd, Moscow, Russian Federation FSBI National Research Center of Obstetrics, Gynecology and Perinatology of the Healthcare Ministry named after V.I. Kulakov, Moscow, Russian Federation FSBI N.D. Zelinsky Institute of Organic Chemistry of Russian Academy of Sciences, Moscow, Russian Federation AU - Chelysheva, E. AU - Aleshin, S. AU - Polushkina, E. AU - Shmakov, R. AU - Shokhin, I. AU - Chilov, G. AU - Turkina, A. C7 - e2018027 DB - Scopus DO - 10.4084/MJHID.2018.027 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 ST - Breastfeeding in patients with chronic myeloid leukaemia: Case series with measurements of drug concentrations in maternal milk and literature review T2 - Mediterranean Journal of Hematology and Infectious Diseases TI - Breastfeeding in patients with chronic myeloid leukaemia: Case series with measurements of drug concentrations in maternal milk and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049244121&doi=10.4084%2fMJHID.2018.027&partnerID=40&md5=42090cd56e6004f4e52a3810d55807ae VL - 10 ID - 3541 ER - TY - JOUR AD - Department of Hematology, Kuwait Cancer Control Center, Shuwaikh city, Kuwait Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Alhuraiji, A. AU - Kantarjian, H. AU - Boddu, P. AU - Ravandi, F. AU - Borthakur, G. AU - DiNardo, C. AU - Daver, N. AU - Kadia, T. AU - Pemmaraju, N. AU - Pierce, S. AU - Garcia-Manero, G. AU - Wierda, W. AU - Verstovsek, S. AU - Jabbour, E. AU - Cortes, J. DB - Scopus DO - 10.1002/ajh.24943 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2018 SP - 84-90 ST - Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033486402&doi=10.1002%2fajh.24943&partnerID=40&md5=0dc4f5659b62be5df0785b49fdf5d6d8 VL - 93 ID - 3542 ER - TY - JOUR AD - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, China AU - Xiao, B. AU - Peng, J. AU - Tang, J. AU - Zhang, R. AU - Li, C. AU - Lin, J. AU - Ding, P. AU - Wan, D. AU - Pan, Z. AU - Wu, X. DB - Scopus DO - 10.2147/CMAR.S187061 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 6121-6127 ST - Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: A retrospective study from a single center T2 - Cancer Management and Research TI - Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: A retrospective study from a single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057615960&doi=10.2147%2fCMAR.S187061&partnerID=40&md5=94d86ee067acf417744795a02daac784 VL - 10 ID - 3543 ER - TY - JOUR AD - Department of Hematology/Oncology, Osaka Medical Center, Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka, 594-1101, Japan AU - Mayumi, A. AU - Sawada, A. AU - Ioi, A. AU - Higuchi, K. AU - Shimizu, M. AU - Sato, M. AU - Yasui, M. AU - Inoue, M. DB - Scopus DO - 10.1097/MPH.0000000000000937 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - e129-e132 ST - Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse after Haploidentical Hematopoietic Stem Cell Transplantation T2 - Journal of Pediatric Hematology/Oncology TI - Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse after Haploidentical Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044369088&doi=10.1097%2fMPH.0000000000000937&partnerID=40&md5=3f353393564f0565b07c1444a780f28c VL - 40 ID - 3544 ER - TY - JOUR AD - Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China Fudan University Affiliated Zhongshan Hospital, Shanghai, China Zhejiang Cancer Hospital, Hangzhou, China Hunan Cancer Hospital, Changsha, China The Affiliated Hospital of Medical College Qingdao University, Qingdao, China Liaoning Cancer Hospital, Shenyang, China Fujian Medical University Union Hospital, Fuzhou, China Jilin Provincial Tumor Hospital, Changchun, China Jiangsu Cancer Hospital, Nanjing, China The People's Hospital of Peking University, Beijing, China Shanghai Pulmonary Hospital, Tongji University, Shanghai, China Tangdu Hospital, Xi'an, China Peking University First Hospital, Beijing, China Fujian Cancer Hospital, Fuzhou, China Beijing Chest Hospital, Beijing, China The First Hospital of China Medical University, Shenyang, China Beijing Cancer Hospital, Beijing, China Harbin Medical University Cancer Hospital, Harbin, China West China Hospital of Sichuan University, Chengdu, China Sichuan Cancer Hospital, Chengdu, China The Northern Jiangsu People's Hospital, Yangzhou, China The First Affiliated Hospital of Suzhou University, Suzhou, China AU - Zhong, W. Z. AU - Wang, Q. AU - Mao, W. M. AU - Xu, S. T. AU - Wu, L. AU - Shen, Y. AU - Liu, Y. Y. AU - Chen, C. AU - Cheng, Y. AU - Xu, L. AU - Wang, J. AU - Fei, K. AU - Li, X. F. AU - Li, J. AU - Huang, C. AU - Liu, Z. D. AU - Xu, S. AU - Chen, K. N. AU - Xu, S. D. AU - Liu, L. X. AU - Yu, P. AU - Wang, B. H. AU - Ma, H. T. AU - Yan, H. H. AU - Yang, X. N. AU - Zhou, Q. AU - Wu, Y. L. AU - Wu, Y. L. AU - Wang, Q. AU - Mao, W. M. AU - Wu, L. AU - Shen, Y. AU - Liu, Y. Y. AU - Chen, C. AU - Cheng, Y. AU - Xu, L. AU - Wang, J. AU - Fei, K. AU - Li, X. F. AU - Li, J. AU - Huang, C. AU - Liu, Z. D. AU - Xu, S. AU - Chen, K. N. AU - Xu, S. D. AU - Liu, L. X. AU - Yu, P. AU - Wang, B. H. AU - Ma, H. T. AU - Wang, S. Y. AU - Hu, J. AU - Liu, W. AU - Li, W. AU - Shi, J. H. AU - investigators, Adjuvant AU - investigators, Adjuvant DB - Scopus DO - 10.1016/S1470-2045(17)30729-5 IS - 1 M3 - Article N1 - Cited By :151 Export Date: 18 November 2020 PY - 2018 SP - 139-148 ST - Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study T2 - The Lancet Oncology TI - Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034633134&doi=10.1016%2fS1470-2045%2817%2930729-5&partnerID=40&md5=41935d1d33ff5ab7a9a5a3a4bea164e1 VL - 19 ID - 3546 ER - TY - JOUR AD - Departments of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India Departments of Surgical Gastroenterology, India Departments of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India AU - Kumari, N. AU - Priyaa, V. AU - Shukla, P. AU - Kumar, A. AU - Aggarwal, R. AU - Krishnani, N. DB - Scopus DO - 10.1097/PAI.0000000000000395 IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 153-160 ST - Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic Relevance T2 - Applied Immunohistochemistry and Molecular Morphology TI - Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic Relevance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973322873&doi=10.1097%2fPAI.0000000000000395&partnerID=40&md5=37226115dccecbd8ac2f00ac9aba354a VL - 26 ID - 3548 ER - TY - JOUR AD - Department of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, 1090, Belgium Department of Medical and Radiation Oncology, AZ Sint-Lucas Gent, Ghent, Belgium Department of Medical Oncology, CHU Liège, Liège, Belgium Department of Medical Oncology, GHDC, Charleroi, Belgium Department of Medical Oncology, ZNA Middelheim, Antwerp, Belgium Department of Neurosurgery, CHU Charleroi, Charleroi, Belgium Department of Pathology, Hopital Erasme Université Libre de Bruxelles, Brussels, Belgium Department of Psychiatry, CHU Brugmann, Brussels, Belgium Departments of Pathology and Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium AU - Duerinck, J. AU - Du Four, S. AU - Bouttens, F. AU - Andre, C. AU - Verschaeve, V. AU - Van Fraeyenhove, F. AU - Chaskis, C. AU - D’Haene, N. AU - Le Mercier, M. AU - Rogiers, A. AU - Michotte, A. AU - Salmon, I. AU - Neyns, B. DB - Scopus DO - 10.1007/s11060-017-2629-z IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 115-125 ST - Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma T2 - Journal of Neuro-Oncology TI - Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030699211&doi=10.1007%2fs11060-017-2629-z&partnerID=40&md5=8af11decc7b5546debb909873cb0f86d VL - 136 ID - 3550 ER - TY - JOUR AD - Department of Emergency Trauma Surgery, Jining No.1 People's Hospital, No.6 Jiankang Road, Jining,Shandong, 272011, China Second Department of Orthopedics, Hospital of Shandong University of Traditional Chinese Medicine, Jinan,Shandong, China Department of Cardiology, Weihai Hospital of Traditional Chinese Medicine, Weihai,Shandong, China AU - Xia, B. AU - Wang, L. AU - Feng, L. AU - Tian, B. AU - Tan, Y. AU - Du, B. DB - Scopus DO - 10.3727/096504018X15199511344806 IS - 1 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 89-98 ST - Knockdown of long noncoding RNA CAT104 inhibits the proliferation, migration, and invasion of human osteosarcoma cells by regulating microrna-381 T2 - Oncology Research TI - Knockdown of long noncoding RNA CAT104 inhibits the proliferation, migration, and invasion of human osteosarcoma cells by regulating microrna-381 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059374730&doi=10.3727%2f096504018X15199511344806&partnerID=40&md5=7eed68e3c9e1b4e3d8a17604a4437e9c VL - 27 ID - 3552 ER - TY - JOUR AD - Department of Dermatology, University of Michigan Health System, Ann Arbor, MI, United States Department of Pathology, University of Michigan Health System, Ann Arbor, MI, United States Department of Biostatistics, University of Michigan Health System, Ann Arbor, MI, United States University of Michigan Medical School, Ann Arbor, MI, United States Department of Otolaryngology - Head and Neck Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgery, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon, NH, United States AU - Durham, A. B. AU - Schwartz, J. L. AU - Lowe, L. AU - Zhao, L. AU - Johnson, A. G. AU - Harms, K. L. AU - Bichakjian, C. K. AU - Orsini, A. P. AU - McLean, S. A. AU - Bradford, C. R. AU - Cohen, M. S. AU - Johnson, T. M. AU - Sabel, M. S. AU - Wong, S. L. DB - Scopus DO - 10.1002/jso.24765 IS - 8 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 1185-1192 ST - The natural history of thin melanoma and the utility of sentinel lymph node biopsy T2 - Journal of Surgical Oncology TI - The natural history of thin melanoma and the utility of sentinel lymph node biopsy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024831137&doi=10.1002%2fjso.24765&partnerID=40&md5=574ac83a11f34c02b4812af0e1098cbc VL - 116 ID - 3557 ER - TY - JOUR AD - Division of Hematology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States University College, London, United Kingdom University of Pennsylvania, Philadelphia, PA, United States Montefiore Medical Center, Bronx, NY, United States Rambam Healthcare Campus, Haifa, Israel Shaare Zedek Medical Center, Jerusalem, Israel Memorial Sloan Kettering Cancer Center, New York, NY, United States University Hospitals Cleveland Medical Center, Cleveland, OH, United States AU - Litzow, M. R. AU - Fielding, A. K. AU - Luger, S. M. AU - Paietta, E. AU - Ofran, Y. AU - Rowe, J. M. AU - Goldstone, A. H. AU - Tallman, M. S. AU - Lazarus, H. M. DB - Scopus DO - 10.1038/bmt.2017.110 IS - 12 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2017 SP - 1592-1598 ST - The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults T2 - Bone Marrow Transplantation TI - The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031733851&doi=10.1038%2fbmt.2017.110&partnerID=40&md5=1fb68780f8a1eca0a4a3f7799515fb4a VL - 52 ID - 3559 ER - TY - JOUR AD - Oncology Centre, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia AU - El Fakih, R. AU - Ahmed, S. AU - Alfraih, F. AU - Hanbali, A. DB - Scopus DO - 10.1016/j.hemonc.2017.05.015 IS - 4 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 252-258 ST - Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients T2 - Hematology/ Oncology and Stem Cell Therapy TI - Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023599512&doi=10.1016%2fj.hemonc.2017.05.015&partnerID=40&md5=2401144f2ebd75266fe892dca32c39d2 VL - 10 ID - 3560 ER - TY - JOUR AD - Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China Cancer Center, First Hospital of Jilin University, Changchun, China Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, China Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Military Command, Nanjing, China Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Respiratory Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, China Department of Oncology, First Affiliated Hospital of Soochow University, Soochow, China Department of Respiratory Medicine, Changhai Hospital Affiliated to Shanghai Second Military Medical University, Shanghai, China Department of Radiotherapy, Hangzhou First People's Hospital, Hangzhou, China Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China Department of Medical Oncology, PLA 81 Hospital, Nanjing, China Department of Medical Oncology, Wuxi Fourth People's Hospital, Wuxi, China AU - Jian, H. AU - Li, W. AU - Ma, Z. AU - Huang, J. AU - Feng, J. AU - Song, Y. AU - Gao, B. AU - Zhu, H. AU - Tao, M. AU - Bai, C. AU - Ma, S. AU - Pan, H. AU - Qin, S. AU - Hua, D. AU - Yu, Y. AU - Lu, S. C7 - 8483 DB - Scopus DO - 10.1038/s41598-017-08399-8 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 ST - Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status T2 - Scientific Reports TI - Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027518666&doi=10.1038%2fs41598-017-08399-8&partnerID=40&md5=d897102accfa7f31fb5c5cdf82443eeb VL - 7 ID - 3562 ER - TY - JOUR AD - Department of Hematology and Oncology, Faculty of Medicine, University of Jordan, Al-Jubeiha, Amman, Jordan Department of Internal Medicine, Hematology and Oncology, King Hussein Cancer Center, Al-Jubeiha, Amman, Jordan Department of Public Health, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan AU - Awidi, A. AU - Abbasi, S. AU - Alrabi, K. AU - Kheirallah, K. A. DB - Scopus DO - 10.1016/j.clml.2017.08.001 IS - 12 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - e55-e61 ST - Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028339039&doi=10.1016%2fj.clml.2017.08.001&partnerID=40&md5=152f2a6285625dcb226651d021724dc0 VL - 17 ID - 3563 ER - TY - JOUR AD - Janssen Research & Development, LLC, San Diego, CA, United States Pharmacyclics LLC, an AbbVie Company, Sunnyvale, United States AU - de Jong, J. AU - Hellemans, P. AU - Jiao, J. J. AU - Huang, Y. AU - Mesens, S. AU - Sukbuntherng, J. AU - Ouellet, D. DB - Scopus DO - 10.1007/s00280-017-3471-x IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 1227-1237 ST - Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study T2 - Cancer Chemotherapy and Pharmacology TI - Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032378580&doi=10.1007%2fs00280-017-3471-x&partnerID=40&md5=03666ce71e3c4fd50eb595422d159a5d VL - 80 ID - 3564 ER - TY - JOUR AD - Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Health, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Department of Pediatrics, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China AU - Zhang, G. AU - Zhang, Y. AU - Wu, J. AU - Chen, Y. AU - Ma, Z. DB - Scopus DO - 10.12659/AJCR.906300 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 1204-1208 ST - Acute lymphoblastic leukemia patient with variant ATF7IP/PDGFRB fusion and favorable response to tyrosine kinase inhibitor treatment: A case report T2 - American Journal of Case Reports TI - Acute lymphoblastic leukemia patient with variant ATF7IP/PDGFRB fusion and favorable response to tyrosine kinase inhibitor treatment: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034239372&doi=10.12659%2fAJCR.906300&partnerID=40&md5=7ca36c3eeb17af8d198113fa87920be5 VL - 18 ID - 3565 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, United States Department of Pediatrics, Ohio State University College of Medicine, Columbus, OH, United States AU - Wedekind, M. F. AU - Ranalli, M. AU - Shah, N. C7 - e26586 DB - Scopus DO - 10.1002/pbc.26586 IS - 11 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 ST - Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma T2 - Pediatric Blood and Cancer TI - Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018554022&doi=10.1002%2fpbc.26586&partnerID=40&md5=db9d8111c49668edb41cdc19308d21c1 VL - 64 ID - 3567 ER - TY - JOUR AD - John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom AU - Bhatnagar, N. AU - Qureshi, A. AU - Hall, G. DB - Scopus DO - 10.1016/j.paed.2017.08.007 IS - 11 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 489-494 ST - Leukaemias: a review T2 - Paediatrics and Child Health (United Kingdom) TI - Leukaemias: a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029494578&doi=10.1016%2fj.paed.2017.08.007&partnerID=40&md5=64ee4be0d174dfad85660cf18a5e78c9 VL - 27 ID - 3570 ER - TY - JOUR AD - AMEOS Reha Klinikum Ratzeburg, Röpersberg 47, Ratzeburg, 23909, Germany Klinik Reinhardshöhe, Bad Wildungen, Germany Facharztpraxis für Innere Medizin, Bad Bocklet, Germany MediClin Klinik Reichshof, Reichshof-Eckenhagen, Germany Strandklinik Boltenhagen, Boltenhagen, Germany AU - Schmielau, J. AU - Rick, O. AU - Reuss-Borst, M. AU - Kalusche-Bontemps, E. M. AU - Steimann, M. DB - Scopus DO - 10.1159/000485187 IS - 12 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2017 SP - 764-771 ST - Rehabilitation of Cancer Survivors with Long-Term Toxicities T2 - Oncology Research and Treatment TI - Rehabilitation of Cancer Survivors with Long-Term Toxicities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85036606633&doi=10.1159%2f000485187&partnerID=40&md5=6ed26604bf4bf2ae74fb01ef3dc8d66c VL - 40 ID - 3571 ER - TY - JOUR AD - Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China AU - Ma, F. C. AU - Yu, Q. AU - Zeng, Z. M. AU - He, R. Q. AU - Mo, C. H. AU - Zhong, J. C. AU - Ma, J. AU - Feng, Z. B. AU - Chen, G. AU - Hu, X. H. DB - Scopus DO - 10.2147/OTT.S146051 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 5237-5242 ST - Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: A case report T2 - OncoTargets and Therapy TI - Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034067380&doi=10.2147%2fOTT.S146051&partnerID=40&md5=2879793651f3ca81d1a724df890a0765 VL - 10 ID - 3572 ER - TY - JOUR AD - UOC Oncologia Pediatrica, Fondazione Policlinico Universitario 'A Gemelli', Rome, Italy Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesu, Rome, Italy Department of Oncology and Molecular Medicine, Istituto Superiore di Sanita, Rome, Italy Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy Institute of Neurology, Catholic University, Rome, Italy UOC Neurologia, Fondazione Policlinico Universitario a Gemelli, Rome, Italy Institute of Pathology, Catholic University, Rome, Italy Institute of Neurosurgery, Catholic University, Rome, Italy Department of Pediatrics, Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States AU - Servidei, T. AU - Meco, D. AU - Muto, V. AU - Bruselles, A. AU - Ciolfi, A. AU - Trivieri, N. AU - Lucchini, M. AU - Morosetti, R. AU - Mirabella, M. AU - Martini, M. AU - Caldarelli, M. AU - Lasorella, A. AU - Tartaglia, M. AU - Riccardi, R. DB - Scopus DO - 10.1158/0008-5472.CAN-17-0790 IS - 21 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 5860-5872 ST - Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens T2 - Cancer Research TI - Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035031657&doi=10.1158%2f0008-5472.CAN-17-0790&partnerID=40&md5=24c1baf92cb86ad03b1942aa170e4501 VL - 77 ID - 3573 ER - TY - JOUR AD - South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, SA Pathology, Adelaide, SA, Australia Hospital Erasto Gaertner – Liga Paranaense Combate ao Câncer, Curitiba, Brazil Hospital São Rafael-Monte Tabor & Hospital Universitario Professor Edgard Santos-Universidade Federal da Bahia, Salvador, Brazil Hospital Ampang, Selangor, Malaysia National Cancer Institute, Cairo University, Cairo, Egypt School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia FUNDALEU, Hospitalization and Clinical Research Centre, Buenos Aires, Argentina University of the Free State, Bloemfontein, South Africa Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan City, Taiwan FGB Haematology Research Centre Health Ministry Research Facility, Moscow, Russian Federation Hospital de Especialidades, CMN Siglo XXI, Mexico City, Mexico Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Novartis Healthcare Pvt. Ltd., Hyderabad, India Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada AU - Hughes, T. P. AU - Munhoz, E. AU - Aurelio Salvino, M. AU - Ong, T. C. AU - Elhaddad, A. AU - Shortt, J. AU - Quach, H. AU - Pavlovsky, C. AU - Louw, V. J. AU - Shih, L. Y. AU - Turkina, A. G. AU - Meillon, L. AU - Jin, Y. AU - Acharya, S. AU - Dalal, D. AU - Lipton, J. H. DB - Scopus DO - 10.1111/bjh.14829 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 SP - 219-228 ST - Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd T2 - British Journal of Haematology TI - Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023209621&doi=10.1111%2fbjh.14829&partnerID=40&md5=2db3b51ac8db0ddb377ca6a184458c22 VL - 179 ID - 3577 ER - TY - JOUR AD - Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, 110039, China Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, 110122, China Department of Urology, Shengjing Hospital, China Medical University, Shenyang, 110004, China Laboratory of Molecular Neuro-Oncology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, United States AU - Wang, H. AU - Wang, X. AU - Xin, N. AU - Qi, L. AU - Liao, A. AU - Yang, W. AU - Liu, Z. AU - Zhao, C. DB - Scopus DO - 10.1007/s11010-017-3032-y IS - 1-2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 25-32 ST - Live kinase B1 maintains CD34+CD38− AML cell proliferation and self-renewal T2 - Molecular and Cellular Biochemistry TI - Live kinase B1 maintains CD34+CD38− AML cell proliferation and self-renewal UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017273532&doi=10.1007%2fs11010-017-3032-y&partnerID=40&md5=1b2c906fbf56c03e5c4d818e00fc9084 VL - 434 ID - 3578 ER - TY - JOUR AD - Department of Haematology, Bombay Hospital and Medical Research Centre, Mumbai Hematology Group, Hematology Centre, Ghamat Lodge, 804.A, Dr. B. Ambedkar Road, Dadar, Mumbai, Maharashtra 400 014, India Department of Hemato-Oncology and Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India Department of Medical Oncology and Haematology, Apollo Hospitals International, Ahmedabad, Gujarat, India Department of Medical Oncology and Haematology, Medanta-The Medicity, Gurgaon, Haryana, India Departmemt of Medical Oncology, Indraprastha Apollo Hospitals, New Delhi, India Departmemt of Oncology and Haematology, Jupiter Hospital, Thane, Maharashtra, India Department of Haematology, Haemato-oncology and Bone Marrow Transplant, MIOT Hospitals, Chennai, Tamil Nadu, India Medical Affairs, Janssen, Mumbai, India AU - Agarwal, M. B. AU - Bhurani, D. AU - Shah, C. AU - Sood, N. AU - Singhal, M. AU - Kamat, A. AU - Chezhian, S. AU - Mishra, S. AU - Nagrale, D. DB - Scopus DO - 10.4103/ijmpo.ijmpo_43_17 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 508-515 ST - Efficacy and safety of ibrutinib in indian patients with relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma: Cases from a named patient program T2 - Indian Journal of Medical and Paediatric Oncology TI - Efficacy and safety of ibrutinib in indian patients with relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma: Cases from a named patient program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041447328&doi=10.4103%2fijmpo.ijmpo_43_17&partnerID=40&md5=baaac71685ee1837c5a50d5ab5151d8a VL - 38 ID - 3579 ER - TY - JOUR AD - University of Texas M.D. Anderson Cancer Center, Houston, TX, United States University of Milano-Bicocca, Monza, Italy Seoul St Mary's Hospital, Seoul, South Korea Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, Canada University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States Pfizer Inc, New York, NY, United States Pfizer Inc, Cambridge, MA, United States Universitätsklinikum RWTH Aachen, Aachen, Germany Department of Internal Medicine II, Hubertus Wald Tumorzentrum University Cancer Center Hamburg, Hamburg, Germany Winship Cancer Institute of Emory University, Atlanta, GA, United States AU - Cortes, J. E. AU - Gambacorti-Passerini, C. AU - Kim, D. W. AU - Kantarjian, H. M. AU - Lipton, J. H. AU - Lahoti, A. AU - Talpaz, M. AU - Matczak, E. AU - Barry, E. AU - Leip, E. AU - Brümmendorf, T. H. AU - Khoury, H. J. DB - Scopus DO - 10.1016/j.clml.2017.06.001 IS - 10 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 684-695.e6 ST - Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028350315&doi=10.1016%2fj.clml.2017.06.001&partnerID=40&md5=2d7f1d7e699b9d2b2293355529172723 VL - 17 ID - 3580 ER - TY - JOUR AD - Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, United States Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, United States Germline High Risk Focus Group, CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States AU - Chen, H. J. AU - Romigh, T. AU - Sesock, K. AU - Eng, C. DB - Scopus DO - 10.1002/humu.23288 IS - 10 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 1372-1377 ST - Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome T2 - Human Mutation TI - Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024391574&doi=10.1002%2fhumu.23288&partnerID=40&md5=1e119aac67ce9b9473ae702a370aa74d VL - 38 ID - 3581 ER - TY - JOUR AD - Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100000, China AU - Jiang, Y. AU - Jiao, Y. AU - Wang, Z. AU - Li, T. AU - Liu, Y. AU - Li, Y. AU - Zhao, X. AU - Wang, D. C7 - A1945 DB - Scopus DO - 10.3390/ijms18091945 IS - 9 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2017 ST - Sinomenine hydrochloride inhibits human glioblastoma cell growth through reactive oxygen species generation and autophagy-lysosome pathway activation: An in vitro and in vivo study T2 - International Journal of Molecular Sciences TI - Sinomenine hydrochloride inhibits human glioblastoma cell growth through reactive oxygen species generation and autophagy-lysosome pathway activation: An in vitro and in vivo study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029371078&doi=10.3390%2fijms18091945&partnerID=40&md5=f897cd3969f6fbd294ba3707970951a7 VL - 18 ID - 3584 ER - TY - JOUR AD - Department of Clinical Hematology, King Georges Medical University, Lucknow, UP, India AU - Tripathi, A. K. AU - Verma, S. P. AU - Kumar, N. DB - Scopus DO - 10.1007/s12288-016-0755-y IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 316-320 ST - Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response T2 - Indian Journal of Hematology and Blood Transfusion TI - Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85000868520&doi=10.1007%2fs12288-016-0755-y&partnerID=40&md5=ca906047bcef1d068bd33ba9f06601c8 VL - 33 ID - 3588 ER - TY - JOUR AD - Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States Department of Pediatrics, Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States AU - Maese, L. AU - Tasian, S. K. AU - Raetz, E. A. DB - Scopus DO - 10.1016/j.beha.2017.06.001 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2017 SP - 222-228 ST - How is the Ph-like signature being incorporated into ALL therapy? T2 - Best Practice and Research: Clinical Haematology TI - How is the Ph-like signature being incorporated into ALL therapy? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021100450&doi=10.1016%2fj.beha.2017.06.001&partnerID=40&md5=392a5a33cb0cf6781c55e79e3ee9437a VL - 30 ID - 3589 ER - TY - JOUR AD - Department of Molecular and Translational Medicine (DMMT), University of Brescia, Viale Europa 11, Brescia, 25123, Italy AU - Fanzani, A. AU - Poli, M. C7 - 1718 DB - Scopus DO - 10.3390/ijms18081718 IS - 8 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2017 ST - Iron, oxidative damage and ferroptosis in rhabdomyosarcoma T2 - International Journal of Molecular Sciences TI - Iron, oxidative damage and ferroptosis in rhabdomyosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027053896&doi=10.3390%2fijms18081718&partnerID=40&md5=8de1afb652a4c8a32e493010b884845e VL - 18 ID - 3593 ER - TY - JOUR AD - Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan Department of Pediatrics, Kansai Medical University Hirakata Hospital, Osaka, Japan Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan Department of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Japan Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan Department of Pediatric Hematology and Oncology, Okayama University Hospital, Okayama, Japan Human Health Sciences, Kyoto University, Kyoto, Japan Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan AU - Kodama, Y. AU - Manabe, A. AU - Kawasaki, H. AU - Kato, I. AU - Kato, K. AU - Sato, A. AU - Matsumoto, K. AU - Kato, M. AU - Hiramatsu, H. AU - Sano, H. AU - Kaneko, T. AU - Oda, M. AU - Saito, A. M. AU - Adachi, S. AU - Horibe, K. AU - Mizutani, S. AU - Ishii, E. AU - Shimada, H. C7 - e26423 DB - Scopus DO - 10.1002/pbc.26423 IS - 8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 ST - Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Pediatric Blood and Cancer TI - Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020670584&doi=10.1002%2fpbc.26423&partnerID=40&md5=5ee766c0de9c490bf497d7185fe98aba VL - 64 ID - 3600 ER - TY - JOUR AD - Sanford Children's Health Research Center, Department of Pediatrics, University of South Dakota School of Medicine, Vermillion, United States Biomedical Engineering Department, University of South Dakota, Vermillion, United States BioSNTR, Brookings, United States AU - Messerli, S. M. AU - Hoffman, M. M. AU - Gnimpieba, E. Z. AU - Bhardwaj, R. D. DB - Scopus DO - 10.1158/1541-7786.MCR-16-0432 IS - 8 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 973-983 ST - Therapeutic targeting of PTK7 is cytotoxic in atypical teratoid rhabdoid tumors T2 - Molecular Cancer Research TI - Therapeutic targeting of PTK7 is cytotoxic in atypical teratoid rhabdoid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026643566&doi=10.1158%2f1541-7786.MCR-16-0432&partnerID=40&md5=df48110d76ff30d328f4610507717cc0 VL - 15 ID - 3601 ER - TY - JOUR AD - Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, China Collaborative Innovation Center of Hematology, Soochow University, 188 Shizi Street, Suzhou, 215006, China Suzhou Institute of Blood and Marrow Transplantation, 188 Shizi Street, Suzhou, 215006, China AU - Gu, B. AU - Wu, X. AU - Chen, G. AU - Ma, X. AU - Jin, Z. AU - Tang, X. AU - Han, Y. AU - Fu, C. AU - Qiu, H. AU - Sun, A. AU - Wu, D. DB - Scopus DO - 10.1016/j.leukres.2017.05.013 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 41-46 ST - Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Leukemia Research TI - Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019936536&doi=10.1016%2fj.leukres.2017.05.013&partnerID=40&md5=0322f084ae693da28a61c812881f3606 VL - 59 ID - 3602 ER - TY - JOUR AD - Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, “S.Orsola-Malpighi” University Hospital, University of Bologna, Bologna, Italy Hematology Unit, Department of Cellular Biotechnologies and Hematology, “La Sapienza” University, Roma, Italy Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy Hematology Unit, “Pugliese-Ciaccio” Hospital, Catanzaro, Italy Department of Hematology, University of Bari, Bari, Italy Unit of Medical Oncology, A.O.U. Policlinico “Vittorio Emanuele”, University of Catania, Catania, Italy Hematology Unit, “S. Eugenio” Hospital, Roma, Italy Hematology Unit, Azienda Ospedaliera “Spedali Civili”, Brescia, Italy Hematology Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy Chair of Hematology, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy Hematology Unit, Azienda Ospedaliera “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy Hematology Unit, “S. Matteo” University Hospital, Pavia, Italy Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy Hematology Unit, “A. Cardarelli” Hospital, Napoli, Italy Hematology Unit, “A. Businco” Hospital, Cagliari, Italy Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy Chair of Hematology, “A. Gemelli” University Hospital, Roma, Italy Hematology Section, Department of Medicine, University of Verona, Verona, Italy Hematology Unit, “Ordine Mauriziano” Hospital, University of Torino, Torino, Italy Hematology Unit, “Ca' Foncello” Hospital, ULSS2 Marca Trevigiana, Treviso, Italy Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy Chair of Hematology, Department of Biochemistry and Medical Biotechnologies, “Federico II” University, Naples, Italy Department of Hematology and Oncology “L. and A. Seràgnoli”, University of Bologna, Bologna, Italy AU - Castagnetti, F. AU - Gugliotta, G. AU - Breccia, M. AU - Iurlo, A. AU - Levato, L. AU - Albano, F. AU - Vigneri, P. AU - Abruzzese, E. AU - Rossi, G. AU - Rupoli, S. AU - Cavazzini, F. AU - Martino, B. AU - Orlandi, E. AU - Pregno, P. AU - Annunziata, M. AU - Usala, E. AU - Tiribelli, M. AU - Sica, S. AU - Bonifacio, M. AU - Fava, C. AU - Gherlinzoni, F. AU - Bocchia, M. AU - Soverini, S. AU - Bochicchio, M. T. AU - Cavo, M. AU - Giovanni, M. AU - Saglio, G. AU - Pane, F. AU - Baccarani, M. AU - Rosti, G. AU - on behalf of the, Gimema C. M. L. Working Party DB - Scopus DO - 10.1002/ajh.24774 IS - 8 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2017 SP - 797-805 ST - The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib T2 - American Journal of Hematology TI - The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019754981&doi=10.1002%2fajh.24774&partnerID=40&md5=5786cc2f8d274299623d24001cfa5dcc VL - 92 ID - 3603 ER - TY - JOUR AD - Divison of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Department of Neurosurgery, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Brain Research Institute, University of California-Los Angeles, Los Angeles, CA, United States Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, United States AU - Movassaghi, M. AU - Shabihkhani, M. AU - Hojat, S. A. AU - Williams, R. R. AU - Chung, L. K. AU - Im, K. AU - Lucey, G. M. AU - Wei, B. AU - Mareninov, S. AU - Wang, M. W. AU - Ng, D. W. AU - Tashjian, R. S. AU - Magaki, S. AU - Perez-Rosendahl, M. AU - Yang, I. AU - Khanlou, N. AU - Vinters, H. V. AU - Liau, L. M. AU - Nghiemphu, P. L. AU - Lai, A. AU - Cloughesy, T. F. AU - Yong, W. H. DB - Scopus DO - 10.1016/j.yexmp.2017.06.006 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 87-93 ST - Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats T2 - Experimental and Molecular Pathology TI - Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024845659&doi=10.1016%2fj.yexmp.2017.06.006&partnerID=40&md5=ae31be756e1f3d0961931e0be64774b8 VL - 103 ID - 3605 ER - TY - JOUR AD - Department of Internal Medicine, Florida Hospital Internal Medicine Residency, Orlando, FL, United States Department of Pathology, Florida Hospital, Orlando, FL, United States Department of Obstetrics and Gynecology, Florida Hospital, Orlando, FL, United States Florida Hospital Cancer Institute, Orlando, FL, United States AU - Yuan, C. AU - Ma, M. J. AU - Parker, J. V. AU - Mekhail, T. M. DB - Scopus DO - 10.12659/AJCR.903698 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 799-804 ST - Metastatic anaplastic lymphoma kinase-1 (ALK-1)-rearranged inflammatory myofibroblastic sarcoma to the brain with leptomeningeal involvement: Favorable response to serial ALK inhibitors: A case report T2 - American Journal of Case Reports TI - Metastatic anaplastic lymphoma kinase-1 (ALK-1)-rearranged inflammatory myofibroblastic sarcoma to the brain with leptomeningeal involvement: Favorable response to serial ALK inhibitors: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026432042&doi=10.12659%2fAJCR.903698&partnerID=40&md5=408e4c2067c373906b55255726fa2c41 VL - 18 ID - 3609 ER - TY - JOUR AD - Department of Medical Oncology, Radiology, Nuclear Medicine and Pathology, Tata Memorial Hospital, Dr. E Borges Road, Parel, Mumbai, Maharashtra, 400 012, India AU - Ramaswamy, A. AU - Joshi, A. AU - Noronha, V. AU - Patil, V. AU - Sahu, A. AU - Manickam, D. AU - Kothari, R. AU - Sable, N. AU - Agrawal, A. AU - Menon, S. AU - Prabhash, K. DB - Scopus DO - 10.4103/ijmpo.ijmpo_154_16 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 311-315 ST - Poor risk advanced renal cell carcinoma: Outcomes from a registry in a tertiary cancer center T2 - Indian Journal of Medical and Paediatric Oncology TI - Poor risk advanced renal cell carcinoma: Outcomes from a registry in a tertiary cancer center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048143670&doi=10.4103%2fijmpo.ijmpo_154_16&partnerID=40&md5=c0ceb83c1f2e9523d84b0a14eb4f7d3a VL - 38 ID - 3611 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, 500 082, India AU - Chaitanya, P. AU - Kumar, K. AU - Stalin, B. AU - Sadashivudu, G. AU - Srinivas, M. DB - Scopus DO - 10.4103/ijmpo.ijmpo_115_17 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 328-333 ST - The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years T2 - Indian Journal of Medical and Paediatric Oncology TI - The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048121611&doi=10.4103%2fijmpo.ijmpo_115_17&partnerID=40&md5=60e33ed5db395c66cc6a12cc4ec05132 VL - 38 ID - 3612 ER - TY - JOUR AD - Department of Pharmacy, Erasmus MC, Rotterdam, Netherlands Faculty of Pharmacy, Utrecht University, Utrecht, Netherlands Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands Department of Pediatric Hematology-Oncology, Erasmus MC-Sophia, Rotterdam, Netherlands AU - Balk, T. E. AU - van der Sijs, I. H. AU - van Gelder, T. AU - Janssen, J. J. B. AU - van der Sluis, I. M. AU - van Leeuwen, R. W. F. AU - Engels, F. K. C7 - e26410 DB - Scopus DO - 10.1002/pbc.26410 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 ST - Drug–drug interactions in pediatric oncology patients T2 - Pediatric Blood and Cancer TI - Drug–drug interactions in pediatric oncology patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013271878&doi=10.1002%2fpbc.26410&partnerID=40&md5=b6ccf8f25507d6c785f604d40e94b39f VL - 64 ID - 3613 ER - TY - JOUR AD - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico Department of Oncological Surgery, Centro Médico Nacional Siglo XXI, IMSS, Ciudad de México, Mexico AU - Sarre-Lazcano, C. AU - Ruiz-García, E. AU - Medrano-Guzmán, R. AU - Motola-Kuba, D. AU - Medina-Franco, H. DB - Scopus DO - 10.24875/j.gamo.M18000116 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 226-229 ST - Tumores del estroma gastrointestinal: Experiencia del grupo cooperativo de tumores del tracto digestivo y análisis de factores pronósticos T2 - Gaceta Mexicana de Oncologia TI - Gastrointestinal stromal tumors: Experience of the digestive tract tumors and prognostic risk analysis cooperative group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043998276&doi=10.24875%2fj.gamo.M18000116&partnerID=40&md5=08d1f7b441801da5ec7c2660e0eac5eb VL - 16 ID - 3615 ER - TY - JOUR AD - Leukemia Patient Advocates Foundation, Bern, Switzerland LeukaNET e.V., Riemerling, Germany Israeli CML Patients Organization, Netanya, Israel Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy LMC France, Marseille, France Stichting Hematon, Utrecht, Netherlands Leukaemia CARE, Worcester, United Kingdom Diagnoza CML, Prague, Czech Republic Polish Nationwide Association for CML Patients Aid, Warsaw, Poland Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany Münzgraben 6 P.O.B. 453, Bern, CH-3000, Switzerland AU - Geissler, J. AU - Sharf, G. AU - Bombaci, F. AU - Daban, M. AU - De Jong, J. AU - Gavin, T. AU - Pelouchova, J. AU - Dziwinski, E. AU - Hasford, J. AU - Hoffmann, V. S. DB - Scopus DO - 10.1007/s00432-017-2372-z IS - 7 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2017 SP - 1167-1176 ST - Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries T2 - Journal of Cancer Research and Clinical Oncology TI - Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014989094&doi=10.1007%2fs00432-017-2372-z&partnerID=40&md5=f098654c8ebf53f0f8fed62b3cccce91 VL - 143 ID - 3616 ER - TY - JOUR AD - Chemistry and Life Sciences College, Xingzhi College, Zhejiang Provincial Key Laboratory of Ecology, Key laboratory of wildlife biotechnology and conservation and utilization of Zhejiang Province, Zhejiang Normal University, China School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou, China AU - Fang, Z. AU - Zhu, Q. AU - Gu, T. AU - Shen, X. AU - Yang, Y. AU - Liang, Y. AU - Zhang, Z. AU - Xu, X. DB - Scopus DO - 10.1016/j.yhbeh.2017.05.014 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 151-158 ST - Anti-androgenic effects of bisphenol-A on spatial memory and synaptic plasticity of the hippocampus in mice T2 - Hormones and Behavior TI - Anti-androgenic effects of bisphenol-A on spatial memory and synaptic plasticity of the hippocampus in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020317473&doi=10.1016%2fj.yhbeh.2017.05.014&partnerID=40&md5=6ef53e0ff1d01dbb1ac1b8dc3c048530 VL - 93 ID - 3619 ER - TY - JOUR AD - Hematology, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy Hematology, Sant’Eugenio Hospital, Roma, Italy Gynecology and Obstetrics, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy AU - Sgherza, N. AU - Abruzzese, E. AU - Perla, G. AU - Minervini, M. M. AU - Chiello, V. AU - Sciannamè, N. AU - Cascavilla, N. DB - Scopus DO - 10.2147/TCRM.S137103 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 751-755 ST - Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: Case report and revision of literature T2 - Therapeutics and Clinical Risk Management TI - Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: Case report and revision of literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021664467&doi=10.2147%2fTCRM.S137103&partnerID=40&md5=aa9a2b3c156ae01136460d85d984922c VL - 13 ID - 3621 ER - TY - JOUR AD - Rambam Health Care Campus, Israel Institute of Technology, Israel AU - Ofran, Y. DB - Scopus IS - 25 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 3280-3282 ST - Activated kinases in ALL: Time to act T2 - Blood TI - Activated kinases in ALL: Time to act UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021344426&partnerID=40&md5=927e00c7630965e6fbdc0fd884fd2d7e VL - 129 ID - 3622 ER - TY - JOUR AD - Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Department of Surgery, Kochi Medical School, Kochi, Japan Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan AU - Kakoki, K. AU - Miyata, Y. AU - Mochizuki, Y. AU - Iwata, T. AU - Obatake, M. AU - Abe, K. AU - Nagayasu, T. AU - Sakai, H. DB - Scopus DO - 10.1016/j.clgc.2016.12.026 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - e503-e506 ST - Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature T2 - Clinical Genitourinary Cancer TI - Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012904204&doi=10.1016%2fj.clgc.2016.12.026&partnerID=40&md5=72b530566a1828de613f28d67c11c8bf VL - 15 ID - 3623 ER - TY - JOUR AD - Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan Department of Cell Therapy and Transplantation Medicine, Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan Hematology and Oncology Division, St. Luke's International Hospital, Tokyo, Japan AU - Miyamoto, T. AU - Fukuda, T. AU - Nakashima, M. AU - Henzan, T. AU - Kusakabe, S. AU - Kobayashi, N. AU - Sugita, J. AU - Mori, T. AU - Kurokawa, M. AU - Mori, S. I. AU - Medical Committee of Japan Marrow Donor Program, Japanese Data Center for Hematopoietic Cell Transplantation DB - Scopus DO - 10.1016/j.bbmt.2017.02.012 IS - 6 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2017 SP - 938-944 ST - Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program T2 - Biology of Blood and Marrow Transplantation TI - Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015759601&doi=10.1016%2fj.bbmt.2017.02.012&partnerID=40&md5=8eb3cadb4e8c49cb943a558dce951507 VL - 23 ID - 3624 ER - TY - JOUR AD - Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936-1080, United States AU - Lau, Y. Y. AU - Gu, W. AU - Lin, T. AU - Viraswami-Appanna, K. AU - Cai, C. AU - Scott, J. W. AU - Shi, M. DB - Scopus DO - 10.1007/s00280-017-3308-7 IS - 6 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 1119-1128 ST - Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer T2 - Cancer Chemotherapy and Pharmacology TI - Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018499294&doi=10.1007%2fs00280-017-3308-7&partnerID=40&md5=a09785f25152b70326d7e4218f494f90 VL - 79 ID - 3625 ER - TY - JOUR AD - National Institute of Child Health & Human Development, National Institutes of Health (NIH), Building 10-CRC, Room 1-3330 10 Center Drive, Bethesda, MD 20892, United States Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, United States Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, United States Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, United States Children's Healthcare of Atlanta, Atlanta, GA 30144, United States AU - Kasturi, K. AU - Fernandes, L. AU - Quezado, M. AU - Eid, M. AU - Marcus, L. AU - Chittiboina, P. AU - Rappaport, M. AU - Stratakis, C. A. AU - Widemann, B. AU - Lodish, M. DB - Scopus DO - 10.1016/j.jecr.2017.02.001 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 1-4 ST - Cushing disease in a patient with multiple endocrine neoplasia type 2B T2 - Journal of Clinical and Translational Endocrinology: Case Reports TI - Cushing disease in a patient with multiple endocrine neoplasia type 2B UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014078512&doi=10.1016%2fj.jecr.2017.02.001&partnerID=40&md5=326d2bc348f68b37a188dc8cb8ef103f VL - 4 ID - 3627 ER - TY - JOUR AD - Patan Academy of Health Science, Kathmandu, Nepal Patan Hospital, Kathmandu, Nepal National Health Service Blood and Transplant and Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom Oxford University Clinical Research Unit-Nepal, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States Department of Oncology, Mayo Clinic, Rochester, MN, United States AU - Kayastha, G. K. AU - Ranjitkar, N. AU - Gurung, R. AU - Raj K, K. C. AU - Karki, S. AU - Shrestha, R. AU - Thapa, R. K. AU - Rajbhandari, P. AU - Poudyal, B. AU - Acharya, P. AU - Roberts, D. J. AU - Hayes, B. AU - Zimmerman, M. AU - Basnyat, B. AU - Mansfield, A. DB - Scopus DO - 10.1111/bjh.14645 IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 991-999 ST - Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal T2 - British Journal of Haematology TI - Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016558897&doi=10.1111%2fbjh.14645&partnerID=40&md5=02c88988da7658edc4936c7db444823d VL - 177 ID - 3628 ER - TY - JOUR AD - Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China AU - Xu, X. H. AU - Zhang, L. AU - Cao, X. X. AU - Li, J. AU - Zhang, W. AU - Zhu, T. N. AU - Cai, H. C. AU - Chen, M. AU - Han, X. AU - Yang, C. AU - Han, B. AU - Zhang, Y. AU - Zhuang, J. L. AU - Zhou, D. B. AU - Duan, M. H. DB - Scopus DO - 10.1016/j.jiac.2017.02.011 IS - 6 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 360-367 ST - Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China T2 - Journal of Infection and Chemotherapy TI - Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015804863&doi=10.1016%2fj.jiac.2017.02.011&partnerID=40&md5=7aa33ab1648405d05db1dbe39e8ce06a VL - 23 ID - 3629 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Environmental Health, Biomedical Research Center, School of Medicine, University of Coahuila, Torreon, Coahuila, Mexico Department of Cellular and Molecular Medicine, University of Arizona, Tuscon, AZ 85721, United States AU - Smeester, L. AU - Bommarito, P. A. AU - Martin, E. M. AU - Recio-Vega, R. AU - Gonzalez-Cortes, T. AU - Olivas-Calderon, E. AU - Lantz, R. C. AU - Fry, R. C. DB - Scopus DO - 10.1016/j.etap.2017.04.007 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 183-187 ST - Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response T2 - Environmental Toxicology and Pharmacology TI - Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018472294&doi=10.1016%2fj.etap.2017.04.007&partnerID=40&md5=65e6868ed1ff6b56f3154f8b0c814dc3 VL - 52 ID - 3630 ER - TY - JOUR AD - Institute of Pathology, University Hospital Basel, Basel, Switzerland Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland AU - Menter, T. AU - Dickenmann, M. AU - Juskevicius, D. AU - Steiger, J. AU - Dirnhofer, S. AU - Tzankov, A. DB - Scopus DO - 10.1002/hon.2280 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 187-197 ST - Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling T2 - Hematological Oncology TI - Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955619474&doi=10.1002%2fhon.2280&partnerID=40&md5=d18ef9174ffb89744753cdb42d296252 VL - 35 ID - 3635 ER - TY - JOUR AD - Arkansas Children's Nutrition Center, 15 Children's Way, Little Rock, AK 72202, United States Department of Animal Science and Reproductive and Developmental Sciences Program, Michigan State University, East Lansing, MI 48824, United States Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AK 72205, United States Arkansas Fertility and Gynecology Clinic, Little Rock, AK 72205, United States AU - Ruebel, M. L. AU - Cotter, M. AU - Sims, C. R. AU - Moutos, D. M. AU - Badger, T. M. AU - Cleves, M. A. AU - Shankar, K. AU - Andres, A. DB - Scopus DO - 10.1210/jc.2016-3524 IS - 6 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2017 SP - 2029-2038 ST - Obesity modulates inflammation and lipidmetabolism oocyte gene expression: A single-cell transcriptome perspective T2 - Journal of Clinical Endocrinology and Metabolism TI - Obesity modulates inflammation and lipidmetabolism oocyte gene expression: A single-cell transcriptome perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020476087&doi=10.1210%2fjc.2016-3524&partnerID=40&md5=78dd1ccfd5f40f57d2e6a753a0bf0e09 VL - 102 ID - 3639 ER - TY - JOUR AD - Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, Paris, 75012, France Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy ALWP office, Hôpital Saint-Antoine, Paris, France Department of Hematology II, Ospedale San Martino, Genova, Italy Università cattolica del Sacro Cuore, Roma, Italy Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Hematology Department, Anadolu Medical Center Hospital, Kocaeli, Turkey Bone Marrow Transplantation Center, First Affiliated Hospital, School of Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Hematology and Transplantology, Ratsa Gorbacheva Memorial Children’s Institute, Saint Petersburg State Medical Pavlov University, St. Petersburg, Russian Federation Stem Cell Transplant Unit, Department of Hematology, Tor Vergata “University Hospital”, Rome, Italy Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Munich, Germany Department of Hematology and Trasfusional Medicine, Lund University, Ospedale Civile, Pescara, Sweden Department of Bone Marrow Transplantation and Onco-Hematology, Comprehensive Cancer Center M. Sklodowska-Curie Memorial Institute, Gliwice Branch, Gliwice, Poland Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel AU - Santoro, N. AU - Ruggeri, A. AU - Labopin, M. AU - Bacigalupo, A. AU - Ciceri, F. AU - Gülbaş, Z. AU - Huang, H. AU - Afanasyev, B. AU - Arcese, W. AU - Wu, D. AU - Koc, Y. AU - Tischer, J. AU - Santarone, S. AU - Giebel, S. AU - Mohty, M. AU - Nagler, A. C7 - 113 DB - Scopus DO - 10.1186/s13045-017-0480-5 IS - 1 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2017 ST - Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT T2 - Journal of Hematology and Oncology TI - Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019733626&doi=10.1186%2fs13045-017-0480-5&partnerID=40&md5=06ceb113ec2279264313ad750a081bf0 VL - 10 ID - 3640 ER - TY - JOUR AD - Children's Hospital of Philadelphia, United States AU - Hunger, S. P. DB - Scopus DO - 10.1182/blood-2017-04-776369 IS - 20 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 2713-2714 ST - CML in blast crisis: More common than we think? T2 - Blood TI - CML in blast crisis: More common than we think? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019674960&doi=10.1182%2fblood-2017-04-776369&partnerID=40&md5=c4419945c6bd66696ec26d6d7e2a380b VL - 129 ID - 3642 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Pediatrics, The Catholic University of Korea, College of Medicine, Seoul, South Korea AU - Lee, J. W. AU - Cho, B. DB - Scopus DO - 10.3345/kjp.2017.60.5.129 IS - 5 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 129-137 ST - Prognostic factors and treatment of pediatric acute lymphoblastic leukemia T2 - Korean Journal of Pediatrics TI - Prognostic factors and treatment of pediatric acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019563402&doi=10.3345%2fkjp.2017.60.5.129&partnerID=40&md5=81825768da0cb8fbbf59b65aaac21f8b VL - 60 ID - 3644 ER - TY - JOUR AD - Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre León Bérard, Cancer Research Center of Lyon, Equipe Labelliseé Ligue Contre le Cancer, Lyon, France LabEx DEVweCAN, Université de Lyon, Lyon, France Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe Labelliseé Ligue Contre le Cancer, Marseille, France Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France Centre León Bérard, Lyon, France Fondation Synergie Lyon Cancer, Centre León Bérard, Lyon, France ProfileXpert, Bron, France Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labelliseé Ligue Contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France Clinique Phenicia, Marseille, France Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Department of Pathology, Jean Perrin Cancer Center, ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France Department of Pathology, University of Melbourne, Parkville, VIC, Australia AU - Morel, A. P. AU - Ginestier, C. AU - Pommier, R. M. AU - Cabaud, O. AU - Ruiz, E. AU - Wicinski, J. AU - Devouassoux-Shisheboran, M. AU - Combaret, V. AU - Finetti, P. AU - Chassot, C. AU - Pinatel, C. AU - Fauvet, F. AU - Saintigny, P. AU - Thomas, E. AU - Moyret-Lalle, C. AU - Lachuer, J. AU - Despras, E. AU - Jauffret, J. L. AU - Bertucci, F. AU - Guitton, J. AU - Wierinckx, A. AU - Wang, Q. AU - Radosevic-Robin, N. AU - Penault-Llorca, F. AU - Cox, D. G. AU - Hollande, F. AU - Ansieau, S. AU - Caramel, J. AU - Birnbaum, D. AU - Vigneron, A. M. AU - Tissier, A. AU - Charafe-Jauffret, E. AU - Puisieux, A. DB - Scopus DO - 10.1038/nm.4323 IS - 5 M3 - Article N1 - Cited By :55 Export Date: 18 November 2020 PY - 2017 SP - 568-578 ST - A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability T2 - Nature Medicine TI - A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017248475&doi=10.1038%2fnm.4323&partnerID=40&md5=5c1d833f200484fdb9b1fe02beb70d8f VL - 23 ID - 3647 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, MG, Brazil International Center for Research - CIPE, A. C. Camargo Cancer Center, São Paulo, SP, Brazil Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia – UnB, Brasilia, DF, Brazil Clinical Genetics Department and Institute of Regional Health, University of Southern Denmark, Odense, Denmark Urology Department, Faculty of Medicine, UNESP, Botucatu, SP, Brazil Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Geras-UFMG, Belo Horizonte, MG, Brazil AU - Diniz, M. G. AU - Duarte, A. P. AU - Villacis, R. A. AU - Guimarães, B. V. A. AU - Duarte, L. C. P. AU - Rogatto, S. R. AU - Gomez, R. S. AU - Gomes, C. C. DB - Scopus DO - 10.1111/jop.12505 IS - 5 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 371-376 ST - Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis T2 - Journal of Oral Pathology and Medicine TI - Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991660125&doi=10.1111%2fjop.12505&partnerID=40&md5=cc67bdc0da656ed5115f2e07718c8ab2 VL - 46 ID - 3648 ER - TY - JOUR AD - Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos, 6627 Pampulha, Belo Horizonte, MG, 31270-901, Brazil Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil Laboratório de Imunoparasitologia, Núcleo de Pesquisas em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35400-000, Brazil Laboratório de Inflamação, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, 21040-360, Brazil Programa de Pos-Graduacao em Ciencias Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil Setor de Patologia Clínica, Colégio Técnico, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil AU - Oliveira, L. G. AU - Souza-Testasicca, M. C. AU - Vago, J. P. AU - Figueiredo, A. B. AU - Canavaci, A. M. C. AU - Perucci, L. O. AU - Ferreira, T. P. T. AU - Coelho, E. A. F. AU - Gonçalves, D. U. AU - Rocha, M. O. C. AU - E Silva, P. M. R. AU - Ferreira, C. N. AU - Queiroz-Junior, C. AU - Sousa, L. P. AU - Fernandes, A. P. DB - Scopus DO - 10.4049/jimmunol.1602028 IS - 8 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 3227-3236 ST - Annexin A1 is involved in the resolution of inflammatory responses during Leishmania braziliensis infection T2 - Journal of Immunology TI - Annexin A1 is involved in the resolution of inflammatory responses during Leishmania braziliensis infection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017333296&doi=10.4049%2fjimmunol.1602028&partnerID=40&md5=968425725a482d4fff536387bd475076 VL - 198 ID - 3653 ER - TY - JOUR AD - Department of Orthopedics, 37 Guoxuexiang Lane, Wuhou District, Chengdu, Sichuan, 610041, China Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China AU - Zhou, Y. AU - Zhang, W. AU - Tang, F. AU - Luo, Y. AU - Min, L. AU - Zhang, W. AU - Shi, R. AU - Duan, H. AU - Tu, C. C7 - e6578 DB - Scopus DO - 10.1097/MD.0000000000006578 IS - 15 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2017 ST - A case report of apatinib in treating osteosarcoma with pulmonary metastases T2 - Medicine (United States) TI - A case report of apatinib in treating osteosarcoma with pulmonary metastases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017629324&doi=10.1097%2fMD.0000000000006578&partnerID=40&md5=67e06dda27e98208188548a3057792a1 VL - 96 ID - 3658 ER - TY - JOUR AD - Department of Psycho-oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Chennai, Tamil Nadu, 600 036, India AU - Unnikrishnan, R. AU - Veeraiah, S. AU - Ganesan, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_160_16 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 165-168 ST - Symptom burden and quality of life issues among patients of chronic myeloid leukemia on long-term imatinib therapy T2 - Indian Journal of Medical and Paediatric Oncology TI - Symptom burden and quality of life issues among patients of chronic myeloid leukemia on long-term imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027878771&doi=10.4103%2fijmpo.ijmpo_160_16&partnerID=40&md5=04f8b45ac16954895117bea2f0dc0110 VL - 38 ID - 3659 ER - TY - JOUR AD - Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran Department of Pediatrics, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran AU - Eskandari-Nasab, E. AU - Hashemi, M. AU - Hasani, S. S. A. AU - Naderi, M. AU - Sadeghi-Bojd, S. AU - Taheri, M. DB - Scopus DO - 10.1080/15257770.2016.1243716 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 170-180 ST - Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran T2 - Nucleosides, Nucleotides and Nucleic Acids TI - Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008204227&doi=10.1080%2f15257770.2016.1243716&partnerID=40&md5=d99aa3d2707509909392e14b6afc8390 VL - 36 ID - 3663 ER - TY - JOUR AD - Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan AU - Sano, H. AU - Mochizuki, K. AU - Akaihata, M. AU - Kobayashi, S. AU - Ohto, H. AU - Kikuta, A. C7 - e26242 DB - Scopus DO - 10.1002/pbc.26242 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 ST - T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy T2 - Pediatric Blood and Cancer TI - T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84999806623&doi=10.1002%2fpbc.26242&partnerID=40&md5=c355b763abf8d4aa3ac59587fea1b7f2 VL - 64 ID - 3665 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Division of Pediatric Endocrinology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand AU - Choeyprasert, W. AU - Yansomdet, T. AU - Natesirinilkul, R. AU - Wejaphikul, K. AU - Charoenkwan, P. DB - Scopus DO - 10.1111/ped.13136 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 286-292 ST - Adverse effects of imatinib in children with chronic myelogenous leukemia T2 - Pediatrics International TI - Adverse effects of imatinib in children with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85005810433&doi=10.1111%2fped.13136&partnerID=40&md5=dcf726799d539de67b818005c27caa99 VL - 59 ID - 3666 ER - TY - JOUR AD - Institute for Medical Information Sciences, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Marchioninistrasse 15, München, 81377, Germany University of Bologna, Bologna, Italy Institute of Hematology 'L and A Seragnoli, Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy Division of Hematology, AOU Policlinico-OVE, University of Catania, Catania, Italy Servicio de Hematologiá, Hospital Virgen de la Salud, Toledo, Spain Federal State-Funded Institution, National Research Center for Hematology', Ministry of Healthcare of Russian Federation, Moscow, Russian Federation Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Haematology, VU University Medical Center, Amsterdam, Netherlands St Petersburg State Medical University, St Petersburg, Russian Federation University of Uppsala, Uppsala, Sweden Department Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic Department of Hematology, University Hospital, Bratislava, Slovakia Katedra i Klinika Hematologii UJCM, Kraków, Poland Royal Liverpool University, Liverpool, United Kingdom Clinic of Hematology CCS, Faculty of Medicine, University of Belgrade, Belgrade, Serbia Department of Hematology and Transplantation, Medical University of Gdansk, Gdansk, Poland Vilnius University, Hospital Santariskiu Klinikos, Vilnius, Lithuania Munich Cancer Registry, Ludwig-Maximilians-Universitaet, Munich, Germany Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia INSERM CIC, CHU Poitiers, Poitiers, France Riga East Clinical University, Riga, Latvia Department of Hematology, University Clinical Centre, Ljubljana, Slovenia Klinikum Wells-Grieskirchen Wells, Austria Helsinki University Central Hospital, Hematology Research Unit, Biomedicum Helsinki, Helsinki, Finland Tartu University Hospital, Tartu, Estonia Karaiskakio Foundation, Nicosia, Cyprus Department of Oncology and Hematology, St Orsola University Hospital, Bologna, Italy III. Medizinische Klinik, University of Heidelberg at Mannheim, Mannheim, Germany Abteilung Hämatologie Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany AU - Hoffmann, V. S. AU - Baccarani, M. AU - Hasford, J. AU - Castagnetti, F. AU - Di Raimondo, F. AU - Casado, L. F. AU - Turkina, A. AU - Zackova, D. AU - Ossenkoppele, G. AU - Zaritskey, A. AU - Höglund, M. AU - Simonsson, B. AU - Indrak, K. AU - Sninska, Z. AU - Sacha, T. AU - Clark, R. AU - Bogdanovic, A. AU - Hellmann, A. AU - Griskevicius, L. AU - Schubert-Fritschle, G. AU - Sertic, D. AU - Guilhot, J. AU - Lejniece, S. AU - Zupan, I. AU - Burgstaller, S. AU - Koskenvesa, P. AU - Everaus, H. AU - Costeas, P. AU - Lindoerfer, D. AU - Rosti, G. AU - Saussele, S. AU - Hochhaus, A. AU - Hehlmann, R. DB - Scopus DO - 10.1038/leu.2016.246 IS - 3 M3 - Article N1 - Cited By :41 Export Date: 18 November 2020 PY - 2017 SP - 593-601 ST - Treatment and outcome of 2904 CML patients from the EUTOS population-based registry T2 - Leukemia TI - Treatment and outcome of 2904 CML patients from the EUTOS population-based registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988566338&doi=10.1038%2fleu.2016.246&partnerID=40&md5=8548882baf9d0bd4b6b2e26388f02164 VL - 31 ID - 3668 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States Department of Pathology, United States Surgical Oncology, University of Texas, Maryland Anderson Cancer Center, Houston, TX 77030, United States AU - Bagheri-Yarmand, R. AU - Williams, M. D. AU - Grubbs, E. G. AU - Gagel, R. F. DB - Scopus DO - 10.1210/jc.2016-2878 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 SP - 933-941 ST - ATF4 targets ret for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer T2 - Journal of Clinical Endocrinology and Metabolism TI - ATF4 targets ret for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015233508&doi=10.1210%2fjc.2016-2878&partnerID=40&md5=18962fc9872722b2b157718fcbd0128d VL - 102 ID - 3669 ER - TY - JOUR AD - The Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, United Kingdom University Hospitals Birmingham NHS Foundation Trust, Department of Radiology, Edgbaston, Birmingham, B15 2TH, United Kingdom The Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, United Kingdom AU - Atkin, C. AU - Earwaker, P. AU - Pallan, A. AU - Shetty, S. AU - Punia, P. AU - Ma, Y. T. C7 - 30 DB - Scopus DO - 10.1186/s12876-017-0585-x IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 ST - Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: Case report and review of the literature T2 - BMC Gastroenterology TI - Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: Case report and review of the literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013343505&doi=10.1186%2fs12876-017-0585-x&partnerID=40&md5=49ca4c38ebc9a5a85efec8526624e600 VL - 17 ID - 3673 ER - TY - JOUR AD - Masaryk University, Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Central European Institute of Technology, Kamenice 753/5, Brno, 625 00, Czech Republic Masaryk University, Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Kotlarska 2, Brno, 611 37, Czech Republic Masaryk University, Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Department of Pathology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Department of Pediatric Radiology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic St. Anne's University Hospital Brno, International Clinical Research Center, Pekarska 53, Brno, 656 91, Czech Republic AU - Mudry, P. AU - Slaby, O. AU - Neradil, J. AU - Soukalova, J. AU - Melicharkova, K. AU - Rohleder, O. AU - Jezova, M. AU - Seehofnerova, A. AU - Michu, E. AU - Veselska, R. AU - Sterba, J. C7 - 119 DB - Scopus DO - 10.1186/s12885-017-3115-x IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2017 ST - Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene T2 - BMC Cancer TI - Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012055108&doi=10.1186%2fs12885-017-3115-x&partnerID=40&md5=59d4c330a6a04dc528569cbf820e6c12 VL - 17 ID - 3674 ER - TY - JOUR AD - Boston Children's Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Dana-Farber/Boston Children's Cancer, Blood Disorders Center, Boston, MA, United States Brigham and Women's Hospital, Boston, MA, United States Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States Fox Chase Cancer Center, Philadelphia, PA, United States St Jude Children's Research Hospital, Memphis, TN, United States Huntsman Cancer Institute, Salt Lake City, UT, United States Sylvester Comprehensive Cancer Center, Miami, FL, United States Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States National Cancer Institute, Bethesda, MD, United States Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States Department of Surgery, 300 Longwood Ave, Fegan 3, Boston, MA 02115, United States AU - Weldon, C. B. AU - Madenci, A. L. AU - Boikos, S. A. AU - Janeway, K. A. AU - George, S. AU - Von Mehren, M. AU - Pappo, A. S. AU - Schiffman, J. D. AU - Wright, J. AU - Trent, J. C. AU - Pacak, K. AU - Stratakis, C. A. AU - Helman, L. J. AU - Quaglia, M. P. L. DB - Scopus DO - 10.1200/JCO.2016.68.6733 IS - 5 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2017 SP - 523-528 ST - Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic T2 - Journal of Clinical Oncology TI - Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012866987&doi=10.1200%2fJCO.2016.68.6733&partnerID=40&md5=0caebae2c2a21c9bfac18fd53c200376 VL - 35 ID - 3675 ER - TY - JOUR AD - Department of Hematology, Marmara University Hospital, Istanbul, Turkey Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey AU - Kaygusuz Atagunduz, I. AU - Toptas, T. AU - Deniz, R. AU - Kara, O. AU - Eser, A. AU - Sezgin, A. AU - Ozgumus, T. AU - Gecgel, F. AU - Firatli Tuglular, T. DB - Scopus DO - 10.1016/j.clml.2016.09.006 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 120-125 ST - Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011636538&doi=10.1016%2fj.clml.2016.09.006&partnerID=40&md5=14c51b0729755e0df599d9e89452fb7e VL - 17 ID - 3678 ER - TY - JOUR AD - Department of Neurosurgery, Universitatsklinikum Essen, Germany Institute of Neuropathology, University Hospital Essen, Essen, Germany Department of Neurosurgery, KRH Hospital Nordstadt, Hannover, Germany AU - Pierscianek, D. AU - Wolf, S. AU - Keyvani, K. AU - El Hindy, N. AU - Stein, K. P. AU - Sandalcioglu, I. E. AU - Sure, U. AU - Mueller, O. AU - Zhu, Y. DB - Scopus DO - 10.1111/neup.12316 IS - 1 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 3-11 ST - Study of angiogenic signaling pathways in hemangioblastoma T2 - Neuropathology TI - Study of angiogenic signaling pathways in hemangioblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978224560&doi=10.1111%2fneup.12316&partnerID=40&md5=1f201e0a9c7f1a01baaafbe4e11e328e VL - 37 ID - 3680 ER - TY - JOUR AD - Sarcoma Unit, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, SW3 6JJ, United Kingdom Department of Oncology, Cambridge University Hospitals, NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom Institute of Cancer Research, Sutton, United Kingdom AU - Szucs, Z. AU - Messiou, C. AU - Wong, H. H. AU - Hatcher, H. AU - Miah, A. AU - Zaidi, S. AU - Van Der Graaf, W. T. A. AU - Judson, I. AU - Jones, R. L. AU - Benson, C. DB - Scopus DO - 10.1097/CAD.0000000000000474 IS - 4 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2017 SP - 421-426 ST - Pazopanib, a promising option for the treatment of aggressive fibromatosis T2 - Anti-Cancer Drugs TI - Pazopanib, a promising option for the treatment of aggressive fibromatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009774549&doi=10.1097%2fCAD.0000000000000474&partnerID=40&md5=9329b598aded3010878e6c48edb8fb64 VL - 28 ID - 3682 ER - TY - JOUR AD - Department of Pediatric Oncology, Adolescents and Young Adults, Institut Curie, 26 rue d'Ulm, Paris, 75005, France Department of Translational Research, Institut Curie, Paris, France Department of Radiology, Institut Curie, Paris, France Department of Pathology, Institut Curie, Paris, France Department of Pediatric Surgery, Necker Enfants-Malades Hospital, Assistance Publique, Paris, France Department of Somatic Genetics, Institut Curie, Paris, France Department of Pediatrics, University of Paris-Descartes, Sorbonne Paris Cité, Paris, France Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U830 Research Center, Institut Curie, Paris, France AU - Jiménez, I. AU - Brisse, H. J. AU - Fréneaux, P. AU - Sarnacki, S. AU - Michon, J. AU - Orbach, D. AU - Pierron, G. AU - Clément, N. AU - Doz, F. AU - Escudier, B. AU - Schleiermacher, G. DB - Scopus DO - 10.1097/MPH.0000000000000774 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - e279-e284 ST - Pediatric Patient with Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature T2 - Journal of Pediatric Hematology/Oncology TI - Pediatric Patient with Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016171171&doi=10.1097%2fMPH.0000000000000774&partnerID=40&md5=2abefef3495c813e8066b3eace9b0a8e VL - 39 ID - 3685 ER - TY - JOUR AD - Department of Pediatrics, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, China AU - Jin, M. AU - Xu, S. AU - An, Q. DB - Scopus DO - 10.3892/ol.2017.6106 IS - 1 M3 - Review N1 - Export Date: 18 November 2020 PY - 2017 SP - 10-14 ST - Pediatric haematopoiesis and related malignancies (Review) T2 - Oncology Letters TI - Pediatric haematopoiesis and related malignancies (Review) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020222334&doi=10.3892%2fol.2017.6106&partnerID=40&md5=26caef9c17b5815d8d91f2642801ec3c VL - 14 ID - 3686 ER - TY - JOUR AD - School of Women's and Infants' Health, King Edward Memorial Hospital, University of Western Australia, 374 Bagot Road, Perth, WA 6008, Australia Women and Infants Research Foundation of Western Australia, King Edward Memorial Hospital, Perth, WA, Australia Department of Pathology, Sidra Medical and Research Center, Doha, Qatar AU - Ireland, D. J. AU - Nathan, E. A. AU - Li, S. AU - Charles, A. K. AU - Stinson, L. F. AU - Kemp, M. W. AU - Newnham, J. P. AU - Keelan, J. A. DB - Scopus DO - 10.1177/1753425916672313 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 20-33 ST - Preclinical evaluation of drugs to block inflammation-driven preterm birth T2 - Innate Immunity TI - Preclinical evaluation of drugs to block inflammation-driven preterm birth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006743981&doi=10.1177%2f1753425916672313&partnerID=40&md5=bea6f2f40942de55b2a4f5af2b1506c6 VL - 23 ID - 3688 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, and Howard Hughes Medical Institute, Portland, Oregon AU - Burwick, R. M. AU - Kuo, K. AU - Brewer, D. AU - Druker, B. J. DB - Scopus DO - 10.1097/AOG.0000000000001972 IS - 5 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 831-834 ST - Maternal, fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy T2 - Obstetrics and Gynecology TI - Maternal, fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017091406&doi=10.1097%2fAOG.0000000000001972&partnerID=40&md5=cb1be24ea1ddec331645678abbbd4abe VL - 129 ID - 3693 ER - TY - JOUR AD - Catholic Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea Department of Hematology, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea AU - Lee, S. E. AU - Choi, S. Y. AU - Kim, S. H. AU - Song, H. Y. AU - Yoo, H. L. AU - Lee, M. Y. AU - Kang, K. H. AU - Hwang, H. J. AU - Jang, E. J. AU - Kim, D. W. C7 - Pmc5214723 DB - Scopus DO - 10.3904/kjim.2015.187 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 125-136 ST - BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia T2 - Korean Journal of Internal Medicine TI - BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009477201&doi=10.3904%2fkjim.2015.187&partnerID=40&md5=8305d83555ab51e80582eb23d6582c65 VL - 32 ID - 3694 ER - TY - JOUR AD - Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands Department of Pharmacy, Leiden University Medical Center, Leiden, Netherlands The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom AU - Lankheet, N. A. G. AU - Desar, I. M. E. AU - Mulder, S. F. AU - Burger, D. M. AU - Kweekel, D. M. AU - van Herpen, C. M. L. AU - van der Graaf, W. T. A. AU - van Erp, N. P. DB - Scopus DO - 10.1111/bcp.13327 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2017 SP - 2195-2204 ST - Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib T2 - British Journal of Clinical Pharmacology TI - Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021786134&doi=10.1111%2fbcp.13327&partnerID=40&md5=fc7bd4ed134812600602b377dab04287 VL - 83 ID - 3696 ER - TY - JOUR AU - Department of, Medical AU - Pediatric Oncology, The Gujarat Cancer AU - Research Institute, Ahmedabad Gujarat India DB - Scopus IS - 23 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 15-20 ST - A Retrospective Study of Clinical Profile and Long Term Outcome to Imatinib Mesylate Alone in Childhood Chronic Myeloid Leukemia in Chronic Phase T2 - The Gulf journal of oncology TI - A Retrospective Study of Clinical Profile and Long Term Outcome to Imatinib Mesylate Alone in Childhood Chronic Myeloid Leukemia in Chronic Phase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061116921&partnerID=40&md5=dd2ff5073763525c4e64d8bd6208111b VL - 1 ID - 3697 ER - TY - JOUR AD - Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea Tumor Microenvironment Research Center, Global Core Research Center, Seoul National University, Seoul, South Korea Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea Department of Biomolecular Science, University of Science and Technology, Daejeon, South Korea Department of Pathology, College of Medicine, Seoul National University, Seoul, South Korea Department of Chemistry, Dongguk University, Seoul, South Korea Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea AU - Jo, D. H. AU - Lee, K. AU - Kim, J. H. AU - Jun, H. O. AU - Kim, Y. AU - Cho, Y. L. AU - Yu, Y. S. AU - Min, J. K. AU - Kim, J. H. DB - Scopus DO - 10.18632/oncotarget.14487 IS - 9 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 15441-15452 ST - L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma T2 - Oncotarget TI - L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014066896&doi=10.18632%2foncotarget.14487&partnerID=40&md5=67258552108a4726e3294adf26381d56 VL - 8 ID - 3698 ER - TY - JOUR AD - IRO - Institute for Research in Ophthalmology, Sion, CH-1950, Switzerland AU - Allaman-Pillet, N. AU - Oberson, A. AU - Schorderet, D. F. DB - Scopus DO - 10.18632/oncotarget.14659 IS - 9 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 SP - 15490-15506 ST - Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model T2 - Oncotarget TI - Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014120188&doi=10.18632%2foncotarget.14659&partnerID=40&md5=deda2ff3ce8e9ce7dda065a3f48b9fee VL - 8 ID - 3699 ER - TY - JOUR AD - West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China AU - Wang, Y. AU - Deng, J. AU - Guo, G. AU - Tong, A. AU - Peng, X. AU - Chen, H. AU - Xu, J. AU - Liu, Y. AU - You, C. AU - Zhou, L. DB - Scopus DO - 10.1007/s11060-016-2273-z IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 21-29 ST - Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma T2 - Journal of Neuro-Oncology TI - Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988322199&doi=10.1007%2fs11060-016-2273-z&partnerID=40&md5=77785393c57acb9916379bbd8f90b8cd VL - 131 ID - 3701 ER - TY - JOUR AD - Department of Prosthodontics, Qingdao Stomatological Hospital, Qingdao, China Department of Periodontology, Qingdao Stomatological Hospital, Qingdao, China Department of Stomatology, Longkou Hospital of Traditional Chinese Medicine, Yantai, China Department of Oral and Maxillofacial Surgery, Yantai Affiliated Hospital of Binzhou Medical University, No 717, Jinbu Street, Muping District, Yantai, 264100, China AU - Cui, Y. M. AU - Han, X. H. AU - Lin, Y. Y. AU - Lv, W. W. AU - Wang, Y. L. DB - Scopus DO - 10.1691/ph.2017.7450 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 329-333 ST - TNF-α was involved in calcium hydroxide-promoted osteogenic differentiation of human DPSCs through NF-κB/p38MAPK/Wnt pathway T2 - Pharmazie TI - TNF-α was involved in calcium hydroxide-promoted osteogenic differentiation of human DPSCs through NF-κB/p38MAPK/Wnt pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020253751&doi=10.1691%2fph.2017.7450&partnerID=40&md5=93aa2f5f82d53a4ab4fdd4b26c807e0b VL - 72 ID - 3703 ER - TY - JOUR AD - Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Institute of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China AU - Zhang, Y. AU - Yu, S. AU - Li, X. AU - Yang, B. AU - Wu, C. DB - Scopus DO - 10.1042/CS20160547 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 SP - 297-308 ST - The ligands of translocator protein inhibit human th1 responses and the rejection of murine skin allografts T2 - Clinical Science TI - The ligands of translocator protein inhibit human th1 responses and the rejection of murine skin allografts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014119202&doi=10.1042%2fCS20160547&partnerID=40&md5=f3662253288aaa14bd01f4b29d379482 VL - 131 ID - 3707 ER - TY - JOUR AD - Department of Research, Australasian College of Cutaneous Oncology, Docklands, VIC, Australia DermOne Dermatology Centre, Department of Dermatology, Irving, TX, United States Maffra Medical Group, Maffra, Australia Department of Pathology, Australasian College of Cutaneous Oncology, Docklands, VIC, Australia Baker IDI Heart and Diabetes Institute, Department of Research, Melbourne, VIC, Australia AU - Dixon, A. AU - Steinman, H. AU - Anderson, S. AU - Nirenberg, A. AU - Dixon, J. DB - Scopus DO - 10.1111/bjd.14769 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 SP - 1340-1341 ST - Routine usage of sentinel node biopsy in melanoma management must cease T2 - British Journal of Dermatology TI - Routine usage of sentinel node biopsy in melanoma management must cease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006401771&doi=10.1111%2fbjd.14769&partnerID=40&md5=3a5fe19dc5a75281933ff2aa3f206583 VL - 175 ID - 3712 ER - TY - JOUR AD - St. Jude Children's Research Hospital, University of Tennessee, Health Science Center, United States Robert H. Lurie Comprehensive Cancer Center, Northwestern University, United States Memorial Sloan Kettering Cancer Center, United States Siteman Cancer Center, Barnes-Jewish Hospital, Washington University, School of Medicine, United States Ohio State University, Comprehensive Cancer Center, James Cancer Hospital, Solove Research Institute, United States UC San Diego Moores Cancer Center, United States Dana-Farber/Brigham and Women's Cancer Center, United States Stanford Cancer Institute, United States Fred and Pamela Buffett Cancer Center, United States Massachusetts General Hospital Cancer Center, United States Vanderbilt-Ingram Cancer Center, United States University of Texas, MD Anderson Cancer Center, United States Fox Chase Cancer Center, United States Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland Clinic Taussig Cancer Institute, United States Duke Cancer Institute, United States Roswell Park Cancer Institute, United States University of Colorado Cancer Center, United States University of Michigan, Comprehensive Cancer Center, United States University of Alabama at Birmingham, Comprehensive Cancer Center, United States Yale Cancer Center, Smilow Cancer Hospital, United States UCSF Helen Diller Family Comprehensive Cancer Center, United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, United States City of Hope Comprehensive Cancer Center, United States Moffitt Cancer Center, United States Mayo Clinic Cancer Center, United States University of Wisconsin Carbone Cancer Center, United States National Comprehensive Cancer Network, United States Huntsman Cancer Institute, University of Utah, United States Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, United States AU - Pallera, A. AU - Altman, J. K. AU - Berman, E. AU - Abboud, C. N. AU - Bhatnagar, B. AU - Curtin, P. AU - DeAngelo, D. J. AU - Gotlib, J. AU - Tanner Hagelstrom, R. AU - Hobbs, G. AU - Jagasia, M. AU - Kantarjian, H. M. AU - Kropf, P. AU - Metheny, L. AU - Moore, J. O. AU - Ontiveros, E. AU - Purev, E. AU - Quiery, A. AU - Reddy, V. V. B. AU - Rose, M. G. AU - Shah, N. P. AU - Douglas Smith, B. AU - Snyder, D. S. AU - Sweet, K. L. AU - Tibes, R. AU - Yang, D. T. AU - Gregory, K. AU - Sundar, H. AU - Deininger, M. AU - Radich, J. P. DB - Scopus DO - 10.6004/jnccn.2016.0162 IS - 12 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2016 SP - 1505-1512 ST - NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85005990816&doi=10.6004%2fjnccn.2016.0162&partnerID=40&md5=88441b7830bf32ed85fd0fa28106e385 VL - 14 ID - 3713 ER - TY - JOUR AD - Department of Medical Oncology, CERIA, Paris Descartes University, AP-HP, Cochin Hospital, Paris, France UMR8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France AU - Boudou-Rouquette, P. AU - Tlemsani, C. AU - Blanchet, B. AU - Huillard, O. AU - Jouinot, A. AU - Arrondeau, J. AU - Thomas-Schoemann, A. AU - Vidal, M. AU - Alexandre, J. AU - Goldwasser, F. DB - Scopus DO - 10.1080/17425255.2016.1225038 IS - 12 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 1433-1444 ST - Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review T2 - Expert Opinion on Drug Metabolism and Toxicology TI - Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84996503759&doi=10.1080%2f17425255.2016.1225038&partnerID=40&md5=1a2fbf4af76725ca1b31cfb29477c756 VL - 12 ID - 3715 ER - TY - JOUR AD - Hematology Oncology Infusion Clinic, Kaiser Permanente Health Plan, 4501 Sand Creek Road, Antioch, CA 94531, United States AU - Lam, M. S. H. AU - Cheung, N. DB - Scopus DO - 10.1177/1078155215608523 IS - 6 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2016 SP - 741-748 ST - Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia T2 - Journal of Oncology Pharmacy Practice TI - Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994060974&doi=10.1177%2f1078155215608523&partnerID=40&md5=00764c5debfe799386efb40938e7dc03 VL - 22 ID - 3716 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Princess Margaret Hospital, Toronto, ON, Canada Seoul St. Mary's Hospital, Seoul, South Korea Department of Internal Medicine II, Hubertus Wald Tumor Center, University Cancer Center Hamburg, Hamburg, Germany Pfizer Inc, New York, NY, United States Pfizer Inc, Cambridge, MA, United States Pfizer Inc, Groton, CT, United States Universitätsklinikum RWTH Aachen, Aachen, Germany University of Milano-Bicocca, Monza, Italy AU - Cortes, J. E. AU - Khoury, H. J. AU - Kantarjian, H. M. AU - Lipton, J. H. AU - Kim, D. W. AU - Schafhausen, P. AU - Matczak, E. AU - Leip, E. AU - Noonan, K. AU - Brümmendorf, T. H. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1002/ajh.24536 IS - 12 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2016 SP - 1206-1214 ST - Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib T2 - American Journal of Hematology TI - Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84993972082&doi=10.1002%2fajh.24536&partnerID=40&md5=5c8af8002dcfdf8a22cd170e6da263d3 VL - 91 ID - 3717 ER - TY - JOUR AD - Medical Oncology Clinic, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 121, Brussels, B-1000, Belgium Division of Medical Oncology, Hospital Universitario la Princesa, Madrid, Spain Division of Breast Oncology, Saitama Cancer Center, Ina, Japan Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine Tata Memorial Centre, Parel, India University of the Witwatersrand Department of Medical Oncology, Wits Donald Gordon Medical Centre, Johannesburg, South Africa National University Cancer Institute, Singapore, Singapore Central India Cancer Research Institute, Nagpur, India Asan Medical Center, University of Ulsan, Seoul, South Korea Centre Léon Bérard, Lyon, France B. P. Poddar Hospital and Medical Research Ltd, Kolkata, India Institute Rotary Cancer Hospital, AIIMS, New Delhi, India Washington University School of Medicine, St Louis, MO, United States Puma Biotechnology Inc, Los Angeles, CA, United States Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, United States AU - Awada, A. AU - Colomer, R. AU - Inoue, K. AU - Bondarenko, I. AU - Badwe, R. A. AU - Demetriou, G. AU - Lee, S. C. AU - Mehta, A. O. AU - Kim, S. B. AU - Bachelot, T. AU - Goswami, C. AU - Deo, S. AU - Bose, R. AU - Wong, A. AU - Xu, F. AU - Yao, B. AU - Bryce, R. AU - Carey, L. A. DB - Scopus DO - 10.1001/jamaoncol.2016.0237 IS - 12 M3 - Article N1 - Cited By :99 Export Date: 18 November 2020 PY - 2016 SP - 1557-1564 ST - Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer the NEfERT-T randomized clinical trial T2 - JAMA Oncology TI - Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer the NEfERT-T randomized clinical trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013219022&doi=10.1001%2fjamaoncol.2016.0237&partnerID=40&md5=86eea349025f30292d39cef1b92a37f4 VL - 2 ID - 3719 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Takahashi, K. AU - Kantarjian, H. M. AU - Yang, Y. AU - Sasaki, K. AU - Jain, P. AU - DellaSala, S. AU - Ravandi, F. AU - Kadia, T. AU - Pemmaraju, N. AU - Daver, N. AU - Borthakur, G. AU - Garcia-Manero, G. AU - Jabbour, E. AU - Cortes, J. E. DB - Scopus DO - 10.1002/cncr.30197 IS - 21 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 3336-3343 ST - A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase T2 - Cancer TI - A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991584284&doi=10.1002%2fcncr.30197&partnerID=40&md5=3af7e1e28c3cbe78abed7a45b625d09e VL - 122 ID - 3726 ER - TY - JOUR AD - Research, Department of Veterans Affairs Medical Center, St. Louis, MO, United States Department of Obstetrics and Gynecology, Washington University School of Medicine in St. LouisMO 63110, United States AU - Esakky, P. AU - Moley, K. H. DB - Scopus DO - 10.1016/j.mce.2016.07.015 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 85-93 ST - Paternal smoking and germ cell death: A mechanistic link to the effects of cigarette smoke on spermatogenesis and possible long-term sequelae in offspring T2 - Molecular and Cellular Endocrinology TI - Paternal smoking and germ cell death: A mechanistic link to the effects of cigarette smoke on spermatogenesis and possible long-term sequelae in offspring UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978811066&doi=10.1016%2fj.mce.2016.07.015&partnerID=40&md5=5eec1e0b36bcad9f05f75ecf0ca02e19 VL - 435 ID - 3728 ER - TY - JOUR AD - Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Department of Experimental Medicine, “Sapienza”, University of Rome, Roma, Italy Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy AU - Fallahi, P. AU - Ferrari, S. M. AU - Baldini, E. AU - Biricotti, M. AU - Ulisse, S. AU - Materazzi, G. AU - Miccoli, P. AU - Antonelli, A. DB - Scopus DO - 10.1080/14737140.2016.1238764 IS - 11 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 1109-1118 ST - The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer T2 - Expert Review of Anticancer Therapy TI - The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989220549&doi=10.1080%2f14737140.2016.1238764&partnerID=40&md5=405c073d9434488249fe43dd9ba045f2 VL - 16 ID - 3730 ER - TY - JOUR AD - Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, 75 Mikras Asias Str, Athens, 11527, Greece Department of Pediatric Hematology-Oncology, “Pan & Agl. Kyriakou” Children's Hospital, Thivon and Papadiamantopoulou Str, Athens, 11527, Greece National Cancer Registry of Ukraine, National Institute of Cancer, Lomonosova str, 33/43, Kyiv, 03022, Ukraine Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Childhood Cancer Subregistry of Belarus, Lesnoe-2, Minsk Region, 223040, Belarus Bulgarian National Cancer Registry, National Oncology Hospital, 6, Plovdivsko Pole Street, Sofia, 1756, Bulgaria Institute of Public Health of Serbia, Dr Subotica 5, Belgrade, 11000, Serbia Izmir Cancer Registry, Izmir Hub, Izmir & Hacettepe University Institute of Public Health, Zubeyde Hanim Caddesi No:100, Karsiyaka, Izmir, 35067, Turkey North Region Cancer Registry of Portugal (RORENO), Portuguese Oncology Institute of Porto, Rua António Bernardino da Almeida, Porto, 4200-072, Portugal Croatian National Cancer Registry, Croatian Institute of Public Health, Rockefellerova 7, Zagreb, 10000, Croatia Cancer Registry of Republic of Slovenia, Institute of Oncology, Zaloška cesta 2, Ljubljana, SI-1000, Slovenia Central Region Cancer Registry of Portugal (ROR-Centro), Portuguese Oncology Institute of Coimbra, Av. Bissaya Barreto 98, Coimbra, 3000-075, Portugal Cyprus Cancer Registry-Health Monitoring Unit, Ministry of Health, 1 Prodromou Str & 17 Chilonos Str, Nicosia, 1448, Cyprus Malta National Cancer Registry, Department of Health Information and Research, 95, Guardamangia Hill, GuardamangiaMSD08, Malta Regional Cancer Registry of Iasio, National Institute of Public Health, 14 Victor Babes Street 700465, Iasi, Romania Regional Cancer Registry of Cluj, Oncological Institute ‘‘Ion Chiricuta”, Republicii Str no. 34-36, Cluj Napoca, 400015, Romania Department of Pediatric Haematology-Oncology, “Aghia Sophia” Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece Department of Pediatric Hematology-Oncology, University of Crete, University Hospital of Heraklion, Arsinois 23, Heraklion Crete, 71303, Greece Haematology-Oncology Unit, First Department of Pediatrics, Athens University Medical School, “Aghia Sophia” Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece 2nd Department of Pediatrics, Aristotelion University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece Department of Pediatric Hematology and Oncology, Hippokration Hospital, Konstantinoupoleos Str 49, Thessaloniki, 54642, Greece Stem Cell Transplantion Unit, Aghia Sophia Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, 20230-130, Brazil Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, United States Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Kirkeveien 166, Frederik Holsts hus, Oslo, 0450, Norway AU - Karalexi, M. A. AU - Baka, M. AU - Ryzhov, A. AU - Zborovskaya, A. AU - Dimitrova, N. AU - Zivkovic, S. AU - Eser, S. AU - Antunes, L. AU - Sekerija, M. AU - Zagar, T. AU - Bastos, J. AU - Demetriou, A. AU - Agius, D. AU - Florea, M. AU - Coza, D. AU - Polychronopoulou, S. AU - Stiakaki, E. AU - Moschovi, M. AU - Hatzipantelis, E. AU - Kourti, M. AU - Graphakos, S. AU - Pombo-de-Oliveira, M. S. AU - Adami, H. O. AU - Petridou, E. T. DB - Scopus DO - 10.1016/j.ejca.2016.08.011 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 183-190 ST - Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America T2 - European Journal of Cancer TI - Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988664480&doi=10.1016%2fj.ejca.2016.08.011&partnerID=40&md5=4ddcdaa51ef3c9c2601b745bc6bf1b81 VL - 67 ID - 3731 ER - TY - JOUR AD - Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine University Dusseldorf, Düsseldorf, Germany AU - Bhatia, S. AU - Daschkey, S. AU - Lang, F. AU - Borkhardt, A. AU - Hauer, J. DB - Scopus DO - 10.1080/17460441.2016.1229297 IS - 11 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 1081-1091 ST - Mouse models for pre-clinical drug testing in leukemia T2 - Expert Opinion on Drug Discovery TI - Mouse models for pre-clinical drug testing in leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991000775&doi=10.1080%2f17460441.2016.1229297&partnerID=40&md5=094f289de247ed5f14e2b85feb8b4f86 VL - 11 ID - 3734 ER - TY - JOUR AD - Department of Paediatric Oncology and Haematology, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Cardiology, Aarhus University Hospital, Skejby, Denmark Department of Paediatrics, Aarhus University Hospital, Skejby, Denmark AU - Jarfelt, M. AU - Andersen, N. H. AU - Hasle, H. DB - Scopus DO - 10.1111/bjh.14374 IS - 4 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 577-587 ST - Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? T2 - British Journal of Haematology TI - Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991486824&doi=10.1111%2fbjh.14374&partnerID=40&md5=31ded55a46faf4c8a2fc821574129e38 VL - 175 ID - 3737 ER - TY - JOUR AD - Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada AU - Poch Martell, M. AU - Sibai, H. AU - Deotare, U. AU - Lipton, J. H. DB - Scopus DO - 10.1080/17474086.2016.1232163 IS - 10 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2016 SP - 923-932 ST - Ponatinib in the therapy of chronic myeloid leukemia T2 - Expert Review of Hematology TI - Ponatinib in the therapy of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989323320&doi=10.1080%2f17474086.2016.1232163&partnerID=40&md5=4aa3fba64494e84c26db8ca961028cda VL - 9 ID - 3741 ER - TY - JOUR AD - Department of Medicine, University of Chicago Medical Center, Chicago, IL, United States Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, United States Roswell Park Cancer Institute, Buffalo, NY, United States The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States City of Hope Comprehensive Cancer Center, Duarte, CA, United States Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Health Informatics Institute, University of South Florida, Tampa, FL, United States St. Jude Children’s Research Hospital, Memphis, TN, United States AU - DeBoer, R. AU - Koval, G. AU - Mulkey, F. AU - Wetzler, M. AU - Devine, S. AU - Marcucci, G. AU - Stone, R. M. AU - Larson, R. A. AU - Bloomfield, C. D. AU - Geyer, S. AU - Mullighan, C. G. AU - Stock, W. DB - Scopus DO - 10.3109/10428194.2016.1144881 IS - 10 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2016 SP - 2298-2306 ST - Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 T2 - Leukemia and Lymphoma TI - Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958751941&doi=10.3109%2f10428194.2016.1144881&partnerID=40&md5=010cac41cc16c5d01938c4ebd1566dac VL - 57 ID - 3742 ER - TY - JOUR AD - Qatar Medical Genetics Center, Hamad General Hospital (HGH), Hamad Medical Corporation, Doha, Qatar National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar Interim Translational Research Institute (iTRI), Hamad Medical Corporation, Doha, Qatar Faculty of Health and Social Care Sciences, Kingston University and St. George’s University of London, London, United Kingdom Academic Health System, Hamad Medical Corporation, Doha, Qatar Quality of Life Unit, Hamad Medical Corporation, Doha, Qatar Department of Psychology, Kingston University, London, United Kingdom Molecular Genetics Laboratory, Hamad Medical Corporation, Doha, Qatar Primary Health Care Center (PHCC), Hamad Medical Corporation, Doha, Qatar Medicines Management and Pharmacy Services, Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom Faculty of Medicines and Health, LICAMM, University of Leeds, Leeds, United Kingdom AU - Al-Dewik, N. I. AU - Morsi, H. M. AU - Samara, M. M. AU - Ghasoub, R. S. AU - Gnanam, C. C. AU - Bhaskaran, S. K. AU - Nashwan, A. J. AU - Al-Jurf, R. M. AU - Ismail, M. A. AU - Alsharshani, M. M. AU - Alsayab, A. A. AU - Ben-Omran, T. I. AU - Khatib, R. B. AU - Yassin, M. A. DB - Scopus DO - 10.4137/CMO.S32822 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 95-104 ST - Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar? T2 - Clinical Medicine Insights: Oncology TI - Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009433455&doi=10.4137%2fCMO.S32822&partnerID=40&md5=e6d17abc85ffc17700392b0d754aca1a VL - 10 ID - 3743 ER - TY - JOUR AD - Paediatric Surgery, Great Ormond Street Hospital, London, United Kingdom Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Fegan 3, Boston, Massachusetts 02445, United States AU - Mullassery, D. AU - Weldon, C. B. DB - Scopus DO - 10.1053/j.sempedsurg.2016.09.004 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 305-310 ST - Pediatric/“Wildtype” gastrointestinal stromal tumors T2 - Seminars in Pediatric Surgery TI - Pediatric/“Wildtype” gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002979737&doi=10.1053%2fj.sempedsurg.2016.09.004&partnerID=40&md5=2faadd309465983106b158bcfdff45dc VL - 25 ID - 3747 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad Telangana, 500 082, India AU - Kumar, K. AU - Sadashivudu, G. AU - Krishnamani, K. AU - Linga, V. AU - Maddali, L. AU - Digumarti, R. DB - Scopus DO - 10.4103/0971-5851.195738 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 260-264 ST - Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world T2 - Indian Journal of Medical and Paediatric Oncology TI - Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007443216&doi=10.4103%2f0971-5851.195738&partnerID=40&md5=748b724e4ba0c09b2deaffd81f4983a2 VL - 37 ID - 3749 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Telangana, 500 082, India AU - Bala, S. AU - Gundeti, S. AU - Linga, V. AU - Maddali, L. AU - Digumarti, R. AU - Uppin, S. DB - Scopus DO - 10.4103/0971-5851.195735 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 242-250 ST - Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy T2 - Indian Journal of Medical and Paediatric Oncology TI - Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007414183&doi=10.4103%2f0971-5851.195735&partnerID=40&md5=ddbc7f7eb57592d412f719c8f12939dc VL - 37 ID - 3750 ER - TY - JOUR AD - Leukemia Service, Department of Medicine, United States Cytogenetics Laboratory, United States Department of Pathology, New York University Langone Medical Center, United States Human Oncology and Pathogenesis Program, United States Adult Bone Marrow Transplant Service, all Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY, United States NeoGenomic Laboratories, Irvine, CA, United States AU - Berman, E. AU - Jhanwar, S. AU - Hedvat, C. AU - Arcila, M. E. AU - Wahab, O. A. AU - Levine, R. AU - Maloy, M. AU - Ma, W. AU - Albitar, M. DB - Scopus DO - 10.1016/j.leukres.2016.08.006 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2016 SP - 108-112 ST - Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL135INS T2 - Leukemia Research TI - Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL135INS UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988499747&doi=10.1016%2fj.leukres.2016.08.006&partnerID=40&md5=0d1263982d88e09ba4fbb516ffe30c25 VL - 49 ID - 3751 ER - TY - JOUR AD - Department of Laboratory Medicine, Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China AU - Zhang, X. AU - Liu, R. AU - Huang, B. AU - Zhang, X. AU - Yu, W. AU - Bao, C. AU - Li, J. AU - Sun, C. DB - Scopus DO - 10.3892/ol.2016.4942 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2016 SP - 2976-2981 ST - Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia T2 - Oncology Letters TI - Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983412049&doi=10.3892%2fol.2016.4942&partnerID=40&md5=cdcffb871c9770752fc1858f0f3ad8ef VL - 12 ID - 3752 ER - TY - JOUR AD - Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD 20892, United States Genetics and Pathogenesis of Allergy Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, United States Familial Mediterranean Fever Arthritis Vasculitis and Orphan Disease Research Center, Institute of Health Sciences, R and Center, Gulhane Military Medical Academy, Ankara, 06018, Turkey Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, United States Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD 20892, United States Laboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, United States National Institutes of Health Intramural Sequencing Center, National Human Genome Research Institute, Rockville, MD 20852, United States Heart of England National Health Service Foundation Trust, Birmingham, B9 5ST, United Kingdom Department of Pediatric Nephrology and Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, 06100, Turkey Institute of Cellular Medicine, Newcastle University, Newcastle, NE2 4HH, United Kingdom AU - Zhou, Q. AU - Yu, X. AU - Demirkaya, E. AU - Deuitch, N. AU - Stone, D. AU - Tsai, W. L. AU - Kuehn, H. S. AU - Wang, H. AU - Yang, D. AU - Park, Y. H. AU - Ombrello, A. K. AU - Blake, M. AU - Romeo, T. AU - Remmers, E. F. AU - Chae, J. J. AU - Mullikin, J. C. AU - Güzel, F. AU - Milner, J. D. AU - Boehm, M. AU - Rosenzweig, S. D. AU - Gadina, M. AU - Welch, S. B. AU - Özen, S. AU - Topaloglu, R. AU - Abinun, M. AU - Kastner, D. L. AU - Aksentijevich, I. DB - Scopus DO - 10.1073/pnas.1612594113 IS - 36 M3 - Article N1 - Cited By :97 Export Date: 18 November 2020 PY - 2016 SP - 10127-10132 ST - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84985992152&doi=10.1073%2fpnas.1612594113&partnerID=40&md5=1ac3b608d27c4c5e3f4984ff45540930 VL - 113 ID - 3758 ER - TY - JOUR AD - Department of Medical Oncology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan Department of Gynecology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan AU - Miyamoto, S. AU - Yamada, M. AU - Kasai, Y. AU - Miyauchi, A. AU - Andoh, K. DB - Scopus DO - 10.1093/jjco/hyw073 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 795-804 ST - Anticancer drugs during pregnancy T2 - Japanese Journal of Clinical Oncology TI - Anticancer drugs during pregnancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994074785&doi=10.1093%2fjjco%2fhyw073&partnerID=40&md5=b12a7be75b69539143102d4ca2582097 VL - 46 ID - 3759 ER - TY - JOUR AD - Division of Pediatric Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Division of Pediatric Hematology Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Child Health, The Ron Matricaria Institute of Molecular Medicine at Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ, United States Pediatric Hematology, Oncology & Stem Cell Transplantation, Department of Pediatrics, Children's Hospital, Technical University of Dresden, Dresden, Germany AU - Samis, J. AU - Lee, P. AU - Zimmerman, D. AU - Arceci, R. J. AU - Suttorp, M. AU - Hijiya, N. DB - Scopus DO - 10.1002/pbc.26028 IS - 8 M3 - Review N1 - Cited By :24 Export Date: 18 November 2020 PY - 2016 SP - 1332-1338 ST - Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia T2 - Pediatric Blood and Cancer TI - Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976474984&doi=10.1002%2fpbc.26028&partnerID=40&md5=1ad94d5ee6fb5ffdb6f288eb4948333d VL - 63 ID - 3766 ER - TY - JOUR AD - Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, United States Department of Pathology, Brigham and Women's Hospital BostonMA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States AU - O'Neill, A. C. AU - Shinagare, A. B. AU - Kurra, V. AU - Tirumani, S. H. AU - Jagannathan, J. P. AU - Baheti, A. D. AU - Hornick, J. L. AU - George, S. AU - Ramaiya, N. H. DB - Scopus DO - 10.1016/j.ejso.2016.03.032 IS - 8 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 1222-1228 ST - Assessment of metastatic risk of gastric GIST based on treatment-naïve CT features T2 - European Journal of Surgical Oncology TI - Assessment of metastatic risk of gastric GIST based on treatment-naïve CT features UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975159391&doi=10.1016%2fj.ejso.2016.03.032&partnerID=40&md5=caf10e0e875dfc6da8a580f3d515c9a9 VL - 42 ID - 3771 ER - TY - JOUR AD - Clinical Medicine, Guizhou Medical University, Guiyang, 550004, China Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Transplantation Center, Guiyang, 550004, China Department of Pharmacy, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, 550004, China Department of Hematology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China AU - Lin, X. AU - Zou, X. AU - Wang, Z. AU - Fang, Q. AU - Chen, S. AU - Huang, J. AU - Zhe, N. AU - Yu, M. AU - Zhang, Y. AU - Wang, J. DB - Scopus DO - 10.18632/oncotarget.10725 IS - 33 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 53679-53701 ST - Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL T2 - Oncotarget TI - Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84982267351&doi=10.18632%2foncotarget.10725&partnerID=40&md5=1e1a24de2a56038127301396cc717bce VL - 7 ID - 3772 ER - TY - JOUR AD - Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States University of Texas MD Anderson Cancer Center, Department of Leukemia, Unit 428, 1515 Holcombe Blvd, Houston, TX 77030, United States Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, United States Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, United States AU - Short, N. J. AU - Jabbour, E. AU - Sasaki, K. AU - Patel, K. AU - O'Brien, S. M. AU - Cortes, J. E. AU - Garris, R. AU - Issa, G. C. AU - Garcia-Manero, G. AU - Luthra, R. AU - Thomas, D. AU - Kantarjian, H. AU - Ravandi, F. DB - Scopus DO - 10.1182/blood-2016-03-707562 IS - 4 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2016 SP - 504-507 ST - Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Blood TI - Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979888012&doi=10.1182%2fblood-2016-03-707562&partnerID=40&md5=85bec6a818b41957a3a0111016e055cd VL - 128 ID - 3773 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Comenius University Medical School, University Children's Hospital, Limbova 1, Bratislava, 833 40, Slovakia Pediatric Hematology/Oncology/BMT, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO, United States Department of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States AU - Kolenova, A. AU - Maloney, K. W. AU - Hunger, S. P. DB - Scopus DO - 10.1097/MPH.0000000000000582 IS - 6 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - e193-e195 ST - Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast crisis T2 - Journal of Pediatric Hematology/Oncology TI - Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966430675&doi=10.1097%2fMPH.0000000000000582&partnerID=40&md5=36179a3e30c3c3dcb7c7f8c20918813f VL - 38 ID - 3774 ER - TY - JOUR AD - Medical Oncology Unit, San Giovanni di Dio Hospital, via D.Pirozzi 66, Frattamaggiore, Naples, 80027, Italy Oncology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, 80027, Italy AU - Montella, L. AU - Palmieri, G. AU - Addeo, R. AU - Del Prete, S. DB - Scopus DO - 10.3748/wjg.v22.i27.6114 IS - 27 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 6114-6126 ST - Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? T2 - World Journal of Gastroenterology TI - Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978499766&doi=10.3748%2fwjg.v22.i27.6114&partnerID=40&md5=daaa554df6c458da76b48b62f9ae1315 VL - 22 ID - 3775 ER - TY - JOUR AD - University of Tromsø, Molecular Inflammation Research Group, Department of Medical Biology, Faculty of Health Sciences, Tromsø, Norway Karolinska Institutet, Childhood Cancer Research Unit, Department of Women's and Children's Health, Stockholm, Sweden University of Tromsø, Endocrinology Research Group, Department of Clinical Medicine, Faculty of Health Sciences, Tromsø, Norway University of Tromsø, Department of Medical Biology, Faculty of Health Sciences, Tromsø, Norway University Hospital of North Norway, Department of Laboratory Medicine, Tromsø, Norway AU - Snapkov, I. AU - Öqvist, C. O. AU - Figenschau, Y. AU - Kogner, P. AU - Johnsen, J. I. AU - Sveinbjørnsson, B. C7 - 490 DB - Scopus DO - 10.1186/s12885-016-2545-1 IS - 1 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2016 ST - The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis T2 - BMC Cancer TI - The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978646011&doi=10.1186%2fs12885-016-2545-1&partnerID=40&md5=5ab8671594df2ff9bbbb1365dae91ec7 VL - 16 ID - 3776 ER - TY - JOUR AD - Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, 1760 Haygood Drive NE, Atlanta, GA 30322, United States Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, United States Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, United States Department of Hematology/Oncology, Seattle Children's Hospital, Seattle, WA 98145, United States Pediatric Oncology, Clinical Care Center, Baylor College of Medicine, Houston, TX 77030, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States AU - Wetmore, C. AU - Daryani, V. M. AU - Billups, C. A. AU - Boyett, J. M. AU - Leary, S. AU - Tanos, R. AU - Goldsmith, K. C. AU - Stewart, C. F. AU - Blaney, S. M. AU - Gajjar, A. DB - Scopus DO - 10.1002/cam4.713 IS - 7 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2016 SP - 1416-1424 ST - Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021 T2 - Cancer Medicine TI - Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006184468&doi=10.1002%2fcam4.713&partnerID=40&md5=7d4f626f2e7a36b64075c953ae6a5b4c VL - 5 ID - 3777 ER - TY - JOUR AD - Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, State University of New Jersey, Piscataway, NJ 08854, United States First Department of Medicine, Medical School, University of Athens, Athens, Greece Department of Surgery, Rutgers Robert Wood Johnson Medical School, State University of New JerseyNJ, United States Division of Hematology-Oncology, Department of Medicine, University of PittsburghPA, United States Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, United States AU - Lasfar, A. AU - Gogas, H. AU - Zloza, A. AU - Kaufman, H. L. AU - Kirkwood, J. M. DB - Scopus DO - 10.2217/imt-2015-0021 IS - 8 M3 - Review N1 - Cited By :11 Export Date: 18 November 2020 PY - 2016 SP - 877-888 ST - IFN-λ cancer immunotherapy: New kid on the block T2 - Immunotherapy TI - IFN-λ cancer immunotherapy: New kid on the block UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978954013&doi=10.2217%2fimt-2015-0021&partnerID=40&md5=f7194f24da67e5d84fb8b94cca7c9066 VL - 8 ID - 3779 ER - TY - JOUR AD - Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 11 Xizhimen South Street, Beijing, 100044, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China New Sunshine Charity Foundation, Beijing, China Division of Experimental Medicine, Department of Medicine, Haematology Research Centre, Imperial College London, London, United Kingdom AU - Jiang, Q. AU - Liu, Z. C. AU - Zhang, S. X. AU - Gale, R. P. DB - Scopus DO - 10.1007/s00432-016-2159-7 IS - 7 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2016 SP - 1539-1547 ST - Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia T2 - Journal of Cancer Research and Clinical Oncology TI - Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963747511&doi=10.1007%2fs00432-016-2159-7&partnerID=40&md5=361d97fb01ffe63e99cf262572aceaf1 VL - 142 ID - 3780 ER - TY - JOUR AD - Department of Public Health and Clinical Medicine, Umea University, Umea, 90187, Sweden Department of Medical Science, Division of Hematology, University Hospital, Uppsala, Sweden Department of Hematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Regional Cancer Centre, Uppsala, Örebro, Sweden Department of Hematology, University Hospital, Linköping, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Hematology, University Hospital, Umea, Sweden Department of Hematology, Sahlgrenska University Hospital, Göteborg, Sweden Department of Hematology and Vascular Disorders, Skane University Hospital, Lund, Sweden AU - Gunnarsson, N. AU - Höglund, M. AU - Stenke, L. AU - Wallberg-Jonsson, S. AU - Sandin, F. AU - Björkholm, M. AU - Dreimane, A. AU - Lambe, M. AU - Markevärn, B. AU - Olsson-Strömberg, U. AU - Wadenvik, H. AU - Richter, J. AU - Själander, A. DB - Scopus DO - 10.1038/leu.2016.59 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - 1562-1567 ST - Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia T2 - Leukemia TI - Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963540052&doi=10.1038%2fleu.2016.59&partnerID=40&md5=1946bdc48d490f9fc28bd308f02159d8 VL - 30 ID - 3781 ER - TY - JOUR AD - Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States Strategic Director, Surveillance Information, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States Director, Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, United States Branch Chief, Surveillance Research Program, National Cancer Institute, Bethesda, MD, United States Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States Director, Office of Cancer Survivorship, National Cancer Institute, Bethesda, MD, United States Vice President, Behavioral Research Center, American Cancer Society, Atlanta, GA, United States Medical Editor, American Cancer Society, Atlanta, GA, United States Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States AU - Miller, K. D. AU - Siegel, R. L. AU - Lin, C. C. AU - Mariotto, A. B. AU - Kramer, J. L. AU - Rowland, J. H. AU - Stein, K. D. AU - Alteri, R. AU - Jemal, A. DB - Scopus DO - 10.3322/caac.21349 IS - 4 M3 - Article N1 - Cited By :2674 Export Date: 18 November 2020 PY - 2016 SP - 271-289 ST - Cancer treatment and survivorship statistics, 2016 T2 - CA Cancer Journal for Clinicians TI - Cancer treatment and survivorship statistics, 2016 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973649618&doi=10.3322%2fcaac.21349&partnerID=40&md5=e98b7b1aa4f32d60b25a54e21847c835 VL - 66 ID - 3782 ER - TY - JOUR AD - Gustave Roussy Cancer Campus, Villejuif, France Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France CLCC Oscar-Lambret, Lille, France CHRU de Tours-Hospital Bretonneau, Tours, France Aix Marseille Univ.-Assistance Publique Hôpitaux de Marseille, Marseille, France Centre de Lutte Contre le Cancer François Baclesse, Caen, France University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France AU - Remon, J. AU - Girard, N. AU - Mazieres, J. AU - Dansin, E. AU - Pichon, E. AU - Grellier, L. AU - Dubos, C. AU - Lindsay, C. R. AU - Besse, B. DB - Scopus DO - 10.1016/j.lungcan.2016.04.024 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2016 SP - 99-104 ST - Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network T2 - Lung Cancer TI - Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966661202&doi=10.1016%2fj.lungcan.2016.04.024&partnerID=40&md5=dc4d91b9a1d56e125870e3f57404ea90 VL - 97 ID - 3783 ER - TY - JOUR AD - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States Weill Cornell Medical College, New York, NY, United States Columbia University College of Physicians and Surgeons, New York, NY, United States AU - Kuk, D. AU - Shoushtari, A. N. AU - Barker, C. A. AU - Panageas, K. S. AU - Munhoz, R. R. AU - Momtaz, P. AU - Ariyan, C. E. AU - Brady, M. S. AU - Coit, D. G. AU - Bogatch, K. AU - Callahan, M. K. AU - Wolchok, J. D. AU - Carvajal, R. D. AU - Postow, M. A. DB - Scopus DO - 10.1634/theoncologist.2015-0522 IS - 7 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2016 SP - 848-854 ST - Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis T2 - Oncologist TI - Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978473836&doi=10.1634%2ftheoncologist.2015-0522&partnerID=40&md5=d84f912d3931d5a2b301e8258d5b2674 VL - 21 ID - 3785 ER - TY - JOUR AD - Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500 (ICBS, Campus Centro/UFRGS), Porto Alegre, RS 90050-170, Brazil Laboratory of Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-360, Brazil Department of Pediatrics, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil Children’s Cancer Institute (ICI), Porto Alegre, RS 90420-140, Brazil AU - Thomaz, A. AU - Jaeger, M. AU - Buendia, M. AU - Bambini-Junior, V. AU - Gregianin, L. J. AU - Brunetto, A. L. AU - Brunetto, A. T. AU - de Farias, C. B. AU - Roesler, R. DB - Scopus DO - 10.1007/s12031-015-0689-0 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 326-333 ST - BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells T2 - Journal of Molecular Neuroscience TI - BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84948688742&doi=10.1007%2fs12031-015-0689-0&partnerID=40&md5=f91697855ea9386d9a7800c90d5e7ba7 VL - 59 ID - 3788 ER - TY - JOUR AD - Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina Servicio de Hematología, Hospital Ramos Mejía, Buenos Aires, Argentina Departamento de Hemato-oncología, Academia Nacional de Medicina, Buenos Aires, Argentina FUNDALEU, Buenos Aires, Argentina AU - Weich, N. AU - Ferri, C. AU - Moiraghi, B. AU - Bengió, R. AU - Giere, I. AU - Pavlovsky, C. AU - Larripa, I. AU - Fundia, A. DB - Scopus DO - 10.1016/j.bcmd.2016.05.007 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 129-133 ST - TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome T2 - Blood Cells, Molecules, and Diseases TI - TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969951872&doi=10.1016%2fj.bcmd.2016.05.007&partnerID=40&md5=4b61450aeb97afc884376f533175b10c VL - 59 ID - 3789 ER - TY - JOUR AD - Royal Marsden NHS Foundation Trust, Sarcoma Unit, Royal Marsden Hospital, Fulham Rd, London, SW3 6JJ, United Kingdom Centre Leon Berard, University Claude Bernard, Lyon, France Erasmus Medical Centre, Rotterdam, Netherlands EORTC Headquarters, Brussels, Belgium Institut Gustave Roussy, Villejuif, France Military Hospital-State Health Centre, Budapest, Hungary University Hospitals Leuven-KU Leuven, Leuven, Belgium Sarcoma Oncology Centre, Santa Monica, United States Institut Jules Bordet, Brussels, Belgium Institut Curie, Paris, France Novartis Pharma AG, Basel, Switzerland Institute of Cancer Research, London, United Kingdom AU - Benson, C. AU - Ray-Coquard, I. AU - Sleijfer, S. AU - Litière, S. AU - Blay, J. Y. AU - Le Cesne, A. AU - Papai, Z. AU - Judson, I. AU - Schöffski, P. AU - Chawla, S. AU - Gil, T. AU - Piperno-Neumann, S. AU - Marréaud, S. AU - Dewji, M. R. AU - Van Der Graaf, W. T. A. DB - Scopus DO - 10.1016/j.ygyno.2016.03.024 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2016 SP - 89-94 ST - Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European -rganisation for Research and Truatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072 T2 - Gynecologic Oncology TI - Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European -rganisation for Research and Truatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964647495&doi=10.1016%2fj.ygyno.2016.03.024&partnerID=40&md5=c08bf84d65966cd46cafbc494545d526 VL - 142 ID - 3790 ER - TY - JOUR AD - Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China Department of Ophthalmology, Second Hospital of Jilin University, Changchun, China AU - Zhang, Q. AU - Jin, Y. AU - Zhao, C. F. AU - Wang, W. J. AU - Liu, G. Y. C7 - gmr.15027817 DB - Scopus DO - 10.4238/gmr.15027817 IS - 2 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 ST - Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro T2 - Genetics and Molecular Research TI - Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975217561&doi=10.4238%2fgmr.15027817&partnerID=40&md5=3645adf8e8f76176afa945841317e5af VL - 15 ID - 3793 ER - TY - JOUR AD - Department of Cellular Biotechologies and Haematology, Sapienza University, Rome, Italy GIMEMA Foundation, Rome, Italy Department of Clinical and Biological Sciences, University of Turin at Orbassano, Turin, Italy AU - Giona, F. AU - Moleti, M. L. AU - De Benedittis, D. AU - Santopietro, M. AU - Nanni, M. AU - Testi, A. M. AU - Orlando, S. AU - Iori, A. P. AU - Piciocchi, A. AU - Gottardi, E. AU - Barberi, W. AU - Diverio, D. AU - Saglio, G. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.13991 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 SP - 749-753 ST - Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience T2 - British Journal of Haematology TI - Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959432482&doi=10.1111%2fbjh.13991&partnerID=40&md5=1dc345efaac5fcd6cf6d2a22dfeda7ca VL - 173 ID - 3796 ER - TY - JOUR AD - Tecnologico de Monterrey School of Medicine, Monterrey, Nuevo León, Mexico AU - Rodríguez-Romo, L. DB - Scopus DO - 10.1016/j.jpeds.2015.12.051 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 121 ST - Vitamin B12 studies in myelogenous leukemia of childhood T2 - Journal of Pediatrics TI - Vitamin B12 studies in myelogenous leukemia of childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969749845&doi=10.1016%2fj.jpeds.2015.12.051&partnerID=40&md5=da2fb693322045c71334a4a3248ac341 VL - 173 ID - 3797 ER - TY - JOUR AD - Department of Hematology, Ankara University School of Medicine, Ankara, Turkey AU - Atilla, E. AU - Topcuoglu, P. AU - Ataca, P. AU - Pekcan, G. AU - Bozdag, S. C. AU - Yuksel, M. K. AU - Ozcan, M. AU - Gurman, G. AU - Toprak, S. K. DB - Scopus DO - 10.1111/ctr.12741 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2016 SP - 669-672 ST - A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis T2 - Clinical Transplantation TI - A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010670346&doi=10.1111%2fctr.12741&partnerID=40&md5=7ac51b5f39fa71e74f9d962e6f0d659f VL - 30 ID - 3798 ER - TY - JOUR AD - Institute of Hematology L. and A. Seràgnoli, Department of Experimental Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Chair of Hematology Sapienza University, Rome, Italy Chair of Hematology, Careggi Hospital, University of Florence, Florence, Italy Hematology Unit, A. Businco Hospital, Cagliari, Italy IRCCS AOU San Martino-IST, Hematology and Bone Marrow Transplantation Unit, Genova, Italy Chair of Hematology, Department of Clinical and Biological Sciences, S. Luigi Gonzaga University Hospital, University of Torino, Orbassano, Italy Hematology Unit, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy Hematology Unit S. Eugenio Hospital, Rome, Italy Chair of Hematology, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy Chair of Hematology, Ferrarotto Hospital, University of Catania, Catania, Italy Chair of Hematology, Department of Biochemistry and Medical Biotechnologies, Federico II University, Naples, Italy Hematology Unit, Spedali Civili Hospital, Brescia, Italy Chair of Hematology, S.Maria alle Scotte Hospital, Siena, Italy Chair of Hematology, S. AnnaHospital, University of Ferrara, Ferrara, Italy Chair of Hematology, University of Udine, Udine, Italy Chair of Hematology, A. Avogadro University of Eastern Piedmont, Novara, Italy Hematology Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, S.Giovanni Rotondo, Italy Chair of Hematology, University of Messina, Messina, Italy Hematology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy Department of Hematology and Oncology L. and A. Seràgnoli, University of Bologna, Bologna, Italy AU - Gugliotta, G. AU - Castagnetti, F. AU - Breccia, M. AU - Gozzini, A. AU - Usala, E. AU - Carella, A. M. AU - Rege-Cambrin, G. AU - Martino, B. AU - Abruzzese, E. AU - Albano, F. AU - Stagno, F. AU - Luciano, L. AU - D'Adda, M. AU - Bocchia, M. AU - Cavazzini, F. AU - Tiribelli, M. AU - Lunghi, M. AU - Pia Falcone, A. AU - Musolino, C. AU - Levato, L. AU - Venturi, C. AU - Soverini, S. AU - Cavo, M. AU - Alimena, G. AU - Pane, F. AU - Martinelli, G. AU - Saglio, G. AU - Rosti, G. AU - Baccarani, M. DB - Scopus DO - 10.1002/ajh.24362 IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2016 SP - 617-622 ST - Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia T2 - American Journal of Hematology TI - Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84967225610&doi=10.1002%2fajh.24362&partnerID=40&md5=f35baa74d23e7e0f6d879db5427c70df VL - 91 ID - 3799 ER - TY - JOUR AD - Department of Physiology and Pharmacology, Karolinska Institutet, Sweden AU - Chagin, A. S. DB - Scopus DO - 10.1016/j.coph.2016.02.004 M3 - Review N1 - Cited By :40 Export Date: 18 November 2020 PY - 2016 SP - 1-7 ST - Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton T2 - Current Opinion in Pharmacology TI - Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959076797&doi=10.1016%2fj.coph.2016.02.004&partnerID=40&md5=d1e1f7141510bcbec7e67a9510ed950c VL - 28 ID - 3800 ER - TY - JOUR AD - Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada Department of Medical Oncology and Haematology, CancerCare Manitoba, 675 McDermott Avenue, Winnipeg, MB R3E 0V9, Canada AU - Speziali, C. AU - Paulson, K. AU - Seftel, M. DB - Scopus DO - 10.1007/s11899-016-0317-2 IS - 3 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 175-184 ST - Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults T2 - Current Hematologic Malignancy Reports TI - Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961226902&doi=10.1007%2fs11899-016-0317-2&partnerID=40&md5=c5230b75efe5d3b0be54c824960e0793 VL - 11 ID - 3802 ER - TY - JOUR AD - Department of Laboratory Medicine, Cleveland Clinic, L-11, Cleveland, OH 44195, United States AU - Shi, Y. AU - Zhao, X. AU - Durkin, L. AU - Rogers, H. J. AU - Hsi, E. D. DB - Scopus DO - 10.1016/j.humpath.2016.01.008 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 173-178 ST - Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia T2 - Human Pathology TI - Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962382653&doi=10.1016%2fj.humpath.2016.01.008&partnerID=40&md5=f76d79e1f3f6ef2ea7d1a250aa453d85 VL - 52 ID - 3803 ER - TY - JOUR AD - Department of Pediatrics-Hematology, Oncology and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States Division of Hematology Oncology and Blood and Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, United States Bone Marrow and Stem Cell Transplantation, Icahn School of Medicine at Mount Sinai, New York, NY, United States Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Froedtert Memorial Lutheran Hospital, Milwaukee, WI, United States Cumming School of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Centre Hamburg, Hamburg, Germany Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA, United States Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX, United States Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, United States Department of Hematology/Oncology, All Children's Hospital, St. Petersburg, FL, United States Cancer Research Foundation of New York, Bronx, NY, United States Department of Blood and Marrow Transplantation, Mayo Clinic, Rochester, MN, United States Pediatric Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom Division of Hematology Oncology and Transplantation, University of Minneapolis, Minneapolis, MN, United States Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, United States Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden AU - Chaudhury, S. AU - Sparapani, R. AU - Hu, Z. H. AU - Nishihori, T. AU - Abdel-Azim, H. AU - Malone, A. AU - Olsson, R. AU - Hamadani, M. AU - Daly, A. AU - Bacher, U. AU - Wirk, B. M. AU - Kamble, R. T. AU - Gale, R. P. AU - Wood, W. A. AU - Hale, G. AU - Wiernik, P. H. AU - Hashmi, S. K. AU - Marks, D. AU - Ustun, C. AU - Munker, R. AU - Savani, B. N. AU - Alyea, E. AU - Popat, U. AU - Sobecks, R. AU - Kalaycio, M. AU - Maziarz, R. AU - Hijiya, N. AU - Saber, W. DB - Scopus DO - 10.1016/j.bbmt.2016.02.015 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2016 SP - 1056-1064 ST - Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis T2 - Biology of Blood and Marrow Transplantation TI - Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963595294&doi=10.1016%2fj.bbmt.2016.02.015&partnerID=40&md5=d6c33585e9b4211365a2fbccdebb6f3e VL - 22 ID - 3806 ER - TY - JOUR AD - Stanbury Service PSP Group, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, United States Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, United States Harvard Medical School, Massachusetts General Hospital, Division of Hematology and Medical Oncology, Zero Emerson Place, Suite 118, Boston, MA 02114, United States AU - Fedorov, V. D. AU - Upadhyay, V. A. AU - Fathi, A. T. DB - Scopus DO - 10.1007/s11899-016-0316-3 IS - 3 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 SP - 165-174 ST - The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies T2 - Current Hematologic Malignancy Reports TI - The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960078050&doi=10.1007%2fs11899-016-0316-3&partnerID=40&md5=c3e45397edf6f64c4764c9d72ee2586f VL - 11 ID - 3807 ER - TY - JOUR AD - Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University, 100 Haining Road, Shanghai, 200080, China AU - Ma, X. AU - Sun, W. AU - Shen, J. AU - Hua, Y. AU - Yin, F. AU - Sun, M. AU - Cai, Z. DB - Scopus DO - 10.1007/s13277-015-4565-x IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2016 SP - 7165-7174 ST - Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma T2 - Tumor Biology TI - Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949664754&doi=10.1007%2fs13277-015-4565-x&partnerID=40&md5=732abfd00e64ba9dac13650fb2c68d5c VL - 37 ID - 3808 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Universitätsklinikum RWTH Aachen, Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Memorial Sloan Kettering Cancer Center, New York, NY, United States Pfizer Inc, New York, NY, United States Pfizer Inc, Groton, CT, United States Pfizer Inc, Cambridge, MA, United States Princess Margaret Cancer Center, Toronto, ON, Canada University of Milano-Bicocca, Monza, Italy AU - Cortes, J. E. AU - Jean Khoury, H. AU - Kantarjian, H. AU - Brümmendorf, T. H. AU - Mauro, M. J. AU - Matczak, E. AU - Pavlov, D. AU - Aguiar, J. M. AU - Fly, K. D. AU - Dimitrov, S. AU - Leip, E. AU - Shapiro, M. AU - Lipton, J. H. AU - Durand, J. B. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1002/ajh.24360 IS - 6 M3 - Article N1 - Cited By :33 Export Date: 18 November 2020 PY - 2016 SP - 606-616 ST - Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib T2 - American Journal of Hematology TI - Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963900816&doi=10.1002%2fajh.24360&partnerID=40&md5=0252f17a95e9ee5437cb3f64ac0b3e21 VL - 91 ID - 3810 ER - TY - JOUR AD - Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States Department of Pathology, University of Iowa, Iowa City, IA, United States Department of Internal Medicine, Division of Immunology, University of Iowa, Iowa City, IA, United States Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montreal, QC, Canada AU - Vacaflores, A. AU - Chapman, N. M. AU - Harty, J. T. AU - Richer, M. J. AU - Houtman, J. C. D. C7 - e0157175 DB - Scopus DO - 10.1371/journal.pone.0157175 IS - 6 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2016 ST - Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism T2 - PLoS ONE TI - Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975492419&doi=10.1371%2fjournal.pone.0157175&partnerID=40&md5=3a75bb651adf14f1080334408d5cd58c VL - 11 ID - 3811 ER - TY - JOUR AD - MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China Molecular Diagnostic Laboratory, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China AU - Qu, S. Q. AU - Qin, T. J. AU - Xu, Z. F. AU - Zhang, Y. AU - Ai, X. F. AU - Li, B. AU - Zhang, H. L. AU - Fang, L. W. AU - Pan, L. J. Li-Juan AU - Hu, N. B. AU - Xiao, Z. J. DB - Scopus DO - 10.18632/oncotarget.8906 IS - 22 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 33229-33236 ST - Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: Experience of a single center in China T2 - Oncotarget TI - Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: Experience of a single center in China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973569095&doi=10.18632%2foncotarget.8906&partnerID=40&md5=e4c9418b8795ce211c1c30f06f62ed99 VL - 7 ID - 3812 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom Bristol Genetics Laboratory, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, United Kingdom Department of Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India Department of Haematology, Great Ormond Street Hospital, London, United Kingdom Department of Haematology, Sheffield Children's Hospital, Sheffield, United Kingdom AU - Schwab, C. AU - Ryan, S. L. AU - Chilton, L. AU - Elliott, A. AU - Murray, J. AU - Richardson, S. AU - Wragg, C. AU - Moppett, J. AU - Cummins, M. AU - Tunstall, O. AU - Parker, C. A. AU - Saha, V. AU - Goulden, N. AU - Vora, A. AU - Moorman, A. V. AU - Harrison, C. J. DB - Scopus DO - 10.1182/blood-2015-09-670166 IS - 18 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2016 SP - 2214-2218 ST - EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): Genetic profile and clinical implications T2 - Blood TI - EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): Genetic profile and clinical implications UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016261576&doi=10.1182%2fblood-2015-09-670166&partnerID=40&md5=d69626c0983d99eceddeb131ebb7ae24 VL - 127 ID - 3813 ER - TY - JOUR AD - Department of Endocrinology and Diabetes, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC 3052, Australia Khoo Teck Puat-National University Children’s Medical Institute, National University Hospital, Singapore, 119074, Singapore Department of Endocrinology, Royal Children’s Hospital, Flemington Rd, Parkville, VIC 3052, Australia AU - Ho, W. L. C. AU - Zacharin, M. R. DB - Scopus DO - 10.1007/s00431-016-2692-z IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 677-683 ST - Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure T2 - European Journal of Pediatrics TI - Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955243651&doi=10.1007%2fs00431-016-2692-z&partnerID=40&md5=afd907f9e4068b0e8726a7faceeb9eff VL - 175 ID - 3815 ER - TY - JOUR AD - Department of Medical Oncology, Kantonsspital St Gallen, St Gallen, Switzerland Department of Hepatology, University Hospital Bern, Bern, Switzerland Department of Medical Oncology, St László Teaching Hospital, Budapest, Hungary SAKK Coordinating Center, Berne, Switzerland Quality of life Office, International Breast Cancer Study Group, Bern, Switzerland Department of Medical Oncology, University Hospital Zurich, Zürich, Switzerland Department of Medical Oncology, Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland Department of Medical Oncology, University Hospital of Geneva, Geneva, Switzerland Department of Medical Oncology, University Hospital Bern, Bern, Switzerland Department of Medical Oncology, University Hospital Lausanne, Lausanne, Switzerland Department of Medical Oncology, Hôpital du Valais (RSV)-CHCVs, Lausanne, Switzerland Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria Department of Medical Oncology, Spital STS AG, Bern, Switzerland Claraspital Basel, Switzerland Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland AU - Koeberle, D. AU - Dufour, J. F. AU - Demeter, G. AU - Li, Q. AU - Ribi, K. AU - Samaras, P. AU - Saletti, P. AU - Roth, A. D. AU - Horber, D. AU - Buehlmann, M. AU - Wagner, A. D. AU - Montemurro, M. AU - Lakatos, G. AU - Feilchenfeldt, J. AU - Peck-Radosavljevic, M. AU - Rauch, D. AU - Tschanz, B. AU - Bodoky, G. AU - for the Swiss Group for Clinical Cancer, Research C7 - 10.1093/annonc/mdw052 DB - Scopus DO - 10.1093/annonc/mdw054 IS - 5 M3 - Article N1 - (SAKK) Cited By :43 Export Date: 18 November 2020 PY - 2016 SP - 856-861 ST - Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) T2 - Annals of Oncology TI - Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964786369&doi=10.1093%2fannonc%2fmdw054&partnerID=40&md5=264ca8e291582ff8445bc39e86b7bb08 VL - 27 ID - 3817 ER - TY - JOUR AD - Department of Cardiology, Boston Children's Hospital, Boston, MA 02115, United States Department of Pediatrics, University of Pittsburgh, Richard King Mellon Institute for Pediatric Research, Division of Pediatric Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, United States Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, United States Department of Pediatrics, Harvard Medical School, Boston, MA 02115, United States Pre-clinical MRI Core, Beth Israel Deaconess Medical Center, Boston, MA 02115, United States Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15224, United States Rangos Research Center Animal Imaging Core, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, United States McGowan Institute for Regenerative Medicine, Pittsburgh, PA 15219, United States Interdisciplinary Biomedical Graduate Program, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, United States PAREXEL Informatics, Billerica, MA 01821, United States AU - Ganapathy, B. AU - Nandhagopal, N. AU - Polizzotti, B. D. AU - Bennett, D. AU - Asan, A. AU - Wu, Y. AU - Kühn, B. C7 - e0155456 DB - Scopus DO - 10.1371/journal.pone.0155456 IS - 5 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 ST - Neuregulin-1 administration protocols sufficient for stimulating cardiac regeneration in young mice do not induce somatic, organ, or neoplastic growth T2 - PLoS ONE TI - Neuregulin-1 administration protocols sufficient for stimulating cardiac regeneration in young mice do not induce somatic, organ, or neoplastic growth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84970028928&doi=10.1371%2fjournal.pone.0155456&partnerID=40&md5=965313b6b1f5fb03e95eda573ccc48d3 VL - 11 ID - 3823 ER - TY - JOUR AD - Department of Medicine, Center for Patient Care and Outcomes Research, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, United States Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226, United States AU - Flynn, K. E. AU - Atallah, E. DB - Scopus DO - 10.1007/s11899-016-0306-5 IS - 2 M3 - Review N1 - Cited By :19 Export Date: 18 November 2020 PY - 2016 SP - 80-85 ST - Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia T2 - Current Hematologic Malignancy Reports TI - Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958241812&doi=10.1007%2fs11899-016-0306-5&partnerID=40&md5=1be78e2e5ea07b341a2d78a50c1e2513 VL - 11 ID - 3825 ER - TY - JOUR AD - Zhejiang University Division of Neurobiology and Physiology, Department of Basic Medical Sciences, Institute of Neuroscience, School of Medicine, Key Lab. of Medical Neurobiology Ministry of Health, Zhejiang Province Key Laboratory of Neurobiology, Hangzhou, 310058, China Third Military Medical University, Department of Pathophysiology and High Altitude Physiology, College of High Altitude Military Medicine, Chongqing, 400038, China University of Birmingham, School of Clinical and Experimental Medicine, Birmingham, B15 2TT, United Kingdom AU - Song, T. T. AU - Bi, Y. H. AU - Gao, Y. Q. AU - Huang, R. AU - Hao, K. AU - Xu, G. AU - Tang, J. W. AU - Ma, Z. Q. AU - Kong, F. P. AU - Coote, J. H. AU - Chen, X. Q. AU - Du, J. Z. C7 - 63 DB - Scopus DO - 10.1186/s12974-016-0528-4 IS - 1 M3 - Article N1 - Cited By :51 Export Date: 18 November 2020 PY - 2016 ST - Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia T2 - Journal of Neuroinflammation TI - Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960414098&doi=10.1186%2fs12974-016-0528-4&partnerID=40&md5=13d97b920c1ec1aa0d259f15acbcf723 VL - 13 ID - 3828 ER - TY - JOUR AD - Department of Paediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany AU - Bleckmann, K. AU - Schrappe, M. DB - Scopus DO - 10.1111/bjh.13896 IS - 6 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2016 SP - 855-869 ST - Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence T2 - British Journal of Haematology TI - Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959887457&doi=10.1111%2fbjh.13896&partnerID=40&md5=8d82e5046af4ba3262af13fddae355f7 VL - 172 ID - 3831 ER - TY - JOUR AD - Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Internal Medicine Service, Hôpital Pitié–Salpêtrière, Paris, France Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, United States Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, United States Genome Technology Center, NYU Langone Medical Center, New York, NY, United States Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Foundation Medicine, Cambridge, MA, United States Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC, United States Hematopathology, Carolinas Pathology Group, Charlotte, NC, United States French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France EA4340, Versailles University, Boulogne-Billancourt, France Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Pathology Service, Hopital universitaire Ambroise Pare, APHP, Boulogne, France Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Diamond, E. L. AU - Durham, B. H. AU - Haroche, J. AU - Yao, Z. AU - Ma, J. AU - Parikh, S. A. AU - Wang, Z. AU - Choi, J. AU - Kim, E. AU - Cohen-Aubart, F. AU - Lee, S. C. W. AU - Gao, Y. AU - Micol, J. B. AU - Campbell, P. AU - Walsh, M. P. AU - Sylvester, B. AU - Dolgalev, I. AU - Aminova, O. AU - Heguy, A. AU - Zappile, P. AU - Nakitandwe, J. AU - Ganzel, C. AU - Dalton, J. D. AU - Ellison, D. W. AU - Estrada-Veras, J. AU - Lacouture, M. AU - Gahl, W. A. AU - Stephens, P. J. AU - Miller, V. A. AU - Ross, J. S. AU - Ali, S. M. AU - Briggs, S. R. AU - Fasan, O. AU - Block, J. AU - Heritier, S. AU - Donadieu, J. AU - Solit, D. B. AU - Hyman, D. M. AU - Baselga, J. AU - Janku, F. AU - Taylor, B. S. AU - Park, C. Y. AU - Amoura, Z. AU - Dogan, A. AU - Emile, J. F. AU - Rosen, N. AU - Gruber, T. A. AU - Abdel-Wahab, O. DB - Scopus DO - 10.1158/2159-8290.CD-15-0913 IS - 2 M3 - Article N1 - Cited By :180 Export Date: 18 November 2020 PY - 2016 SP - 154-165 ST - Diverse and targetable kinase alterations drive histiocytic neoplasms T2 - Cancer Discovery TI - Diverse and targetable kinase alterations drive histiocytic neoplasms UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957056573&doi=10.1158%2f2159-8290.CD-15-0913&partnerID=40&md5=a42cb4d24d65520872642d7e0d319595 VL - 6 ID - 3833 ER - TY - JOUR AD - Department of Pediatrics, Division of Pediatric Hematology/Oncology, NYU Langone Medical Center, 522 First Avenue, New York, NY 10016, United States Department of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, United States University of Philadelphia, Perelman School of Medicine, Philadelphia, PA, United States AU - Carroll, W. L. AU - Hunger, S. P. DB - Scopus DO - 10.1097/MOP.0000000000000293 IS - 1 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 12-18 ST - Therapies on the horizon for childhood acute lymphoblastic leukemia T2 - Current Opinion in Pediatrics TI - Therapies on the horizon for childhood acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954026407&doi=10.1097%2fMOP.0000000000000293&partnerID=40&md5=d932d29505e5bbb9b199fd43546af73a VL - 28 ID - 3834 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States School of Public Health, University of California, Berkeley, CA, United States National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Research Triangle Park, North Carolina, United States Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, United States School of Environmental Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand NIEHS, NIH, DHHS, Research Triangle ParkNC, United States AU - Bailey, K. A. AU - Smith, A. H. AU - Tokar, E. J. AU - Graziano, J. H. AU - Kim, K. W. AU - Navasumrit, P. AU - Ruchirawat, M. AU - Thiantanawat, A. AU - Suk, W. A. AU - Fry, R. C. DB - Scopus DO - 10.1289/ehp.1409360 IS - 2 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2016 SP - 170-175 ST - Mechanisms underlying latent disease risk associated with early-life arsenic exposure: Current research trends and scientific gaps T2 - Environmental Health Perspectives TI - Mechanisms underlying latent disease risk associated with early-life arsenic exposure: Current research trends and scientific gaps UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956617044&doi=10.1289%2fehp.1409360&partnerID=40&md5=3c1d0eb1e6ade4cd54149a373110840e VL - 124 ID - 3836 ER - TY - JOUR AD - Department of Pediatrics, University of California San Diego (UCSD), Rady Children's Hospital, San Diego, CA, United States Department of Internal Medicine III, University Hospital, RWTH-Aachen, Germany Yale University, West Haven Veterans Medical Center, New Haven, CT, United States AU - Wree, A. AU - Mehal, W. Z. AU - Feldstein, A. E. DB - Scopus DO - 10.1055/s-0035-1571272 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2016 SP - 27-36 ST - Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis T2 - Seminars in Liver Disease TI - Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958178106&doi=10.1055%2fs-0035-1571272&partnerID=40&md5=57287355ddd4e536f6180de1fefe2d68 VL - 36 ID - 3837 ER - TY - JOUR AD - Department of Respiratory Medicine, Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, 210008, China Department of Pediatrics, Jiangsu Huai'an Maternity and Children's Hospital, Huai'an, Jiangsu, 223002, China AU - Zhou, Y. AU - Yang, Q. AU - Xu, H. AU - Zhang, J. AU - Deng, H. AU - Gao, H. AU - Yang, J. AU - Zhao, D. AU - Liu, F. C7 - e0148821 DB - Scopus DO - 10.1371/journal.pone.0148821 IS - 2 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2016 ST - MiRNA-221-3p enhances the secretion of interleukin-4 in mast cells through the phosphatase and tensin homolog/p38/nuclear factor-kappaB pathway T2 - PLoS ONE TI - MiRNA-221-3p enhances the secretion of interleukin-4 in mast cells through the phosphatase and tensin homolog/p38/nuclear factor-kappaB pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960540793&doi=10.1371%2fjournal.pone.0148821&partnerID=40&md5=c74284dd019c95fe3612c4fa48312f1d VL - 11 ID - 3839 ER - TY - JOUR AD - Division of Hematology/Oncology/Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Pediatrics, Northwestern University Feinberg, School of Medicine, Chicago, IL, United States Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital, Child and Family Research Institute, Vancouver, BC, Canada Division of Pediatric Oncology and Hematology, Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany Centre d'Investigation Clinique 1402, INSERM, University Hospital Poitiers, Poitiers, France Division of Pediatric Hematology and Oncology, University Children's Hospital, Dresden, Germany AU - Hijiya, N. AU - Schultz, K. R. AU - Metzler, M. AU - Millot, F. AU - Suttorp, M. DB - Scopus DO - 10.1182/blood-2015-06-648667 IS - 4 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2016 SP - 392-399 ST - Pediatric chronic myeloid leukemia is a unique disease that requires a different approach T2 - Blood TI - Pediatric chronic myeloid leukemia is a unique disease that requires a different approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958225376&doi=10.1182%2fblood-2015-06-648667&partnerID=40&md5=e50316650e109c4c35d45303facd4535 VL - 127 ID - 3840 ER - TY - JOUR AD - Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu, 520-2192, Japan AU - Nishida, A. AU - Hidaka, K. AU - Kanda, T. AU - Imaeda, H. AU - Shioya, M. AU - Inatomi, O. AU - Bamba, S. AU - Kitoh, K. AU - Sugimoto, M. AU - Andoh, A. DB - Scopus DO - 10.1097/MIB.0000000000000654 IS - 2 M3 - Article N1 - Cited By :54 Export Date: 18 November 2020 PY - 2016 SP - 303-314 ST - Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease T2 - Inflammatory Bowel Diseases TI - Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955592969&doi=10.1097%2fMIB.0000000000000654&partnerID=40&md5=9cc1d58bd1f346484ec74014d2d1d064 VL - 22 ID - 3841 ER - TY - JOUR AD - CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom Centro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy Pediatric Hematology and Oncology, Hannover Medical School, Germany University of New Mexico Cancer Center, Albuquerque, NM, United States Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States South Australia Health and Medical Research Institute, Adelaide, Australia Department of Pediatrics, Hematology-Oncology, Benioff Children’s Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, United States Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Department of Haematology, Our Lady’s Children’s Hospital, Dublin, Ireland Department of Cancer Biology, Institut Paoli Calmettes, Marseille, France Department of Hematology, Institut Paoli Calmettes, Marseille, France Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hematology, Leiden University Medical Center, Netherlands Birmingham Children’s Hospital, NHS Foundation Trust, United Kingdom Department of Cytogenetics, Leicester Royal Infirmary NHS Trust, United Kingdom St. Anna Children’s Hospital, Childrens Cancer Research Institute, Vienna, Austria Department of Pediatrics, Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of MedicinePA, United States AU - Zaliova, M. AU - Moorman, A. V. AU - Cazzaniga, G. AU - Stanulla, M. AU - Harvey, R. C. AU - Roberts, K. G. AU - Heatley, S. L. AU - Loh, M. L. AU - Konopleva, M. AU - Chen, I. M. AU - Zimmermannova, O. AU - Schwab, C. AU - Smith, O. AU - Mozziconacci, M. J. AU - Chabannon, C. AU - Kim, M. AU - Frederik Falkenburg, J. H. AU - Norton, A. AU - Marshall, K. AU - Haas, O. A. AU - Starkova, J. AU - Stuchly, J. AU - Hunger, S. P. AU - White, D. AU - Mullighan, C. G. AU - Willman, C. L. AU - Stary, J. AU - Trka, J. AU - Zuna, J. DB - Scopus DO - 10.3324/haematol.2016.144345 IS - 9 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2016 SP - 1082-1093 ST - Characterization of leukemias with ETV6-ABL1 fusion T2 - Haematologica TI - Characterization of leukemias with ETV6-ABL1 fusion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84986237322&doi=10.3324%2fhaematol.2016.144345&partnerID=40&md5=3940ea4739fc2e38d624421795ba6037 VL - 101 ID - 3842 ER - TY - JOUR AD - Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China Department of Hematology, The Central Hospital of Wuhan, Wuhan, 430016, China Bioinformatics and Molecular Imaging Key Laboratory, Department of Biomedical Engineering, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China AU - Li, Q. AU - Zhong, Z. AU - Zeng, C. AU - Meng, L. AU - Li, C. AU - Luo, Y. AU - Wang, H. AU - Li, W. AU - Wang, J. AU - Cheng, F. AU - Guo, A. AU - Liu, S. AU - Jin, C. AU - Zhu, X. AU - You, Y. AU - Zou, P. DB - Scopus DO - 10.18632/oncotarget.11281 IS - 36 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - 58234-58243 ST - A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors T2 - Oncotarget TI - A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988349865&doi=10.18632%2foncotarget.11281&partnerID=40&md5=5d29e3ec5cca9d457434764cf7266665 VL - 7 ID - 3843 ER - TY - JOUR AD - Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China Guangzhou Air Force Headquarters Hospital, Huanshi East Road, Yuexiu District, Guangzhou, 510071, China Department of Hematology, Second People's Hospital of Guangdong Province, Guangzhou, 510317, China Department of Hematology, Hospital of Guizhou Province, Guizhou, 550002, China AU - Xu, N. AU - Li, Y. L. AU - Li, X. AU - Zhou, X. AU - Cao, R. AU - Li, H. AU - Li, L. AU - Lu, Z. Y. AU - Huang, J. X. AU - Fan, Z. P. AU - Huang, F. AU - Zhou, H. S. AU - Zhang, S. AU - Liu, Z. AU - Zhu, H. Q. AU - Liu, Q. F. AU - Liu, X. L. C7 - 40 DB - Scopus DO - 10.1186/s13045-016-0270-5 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 ST - Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Journal of Hematology and Oncology TI - Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007579919&doi=10.1186%2fs13045-016-0270-5&partnerID=40&md5=56372874f2e8e132748cf685e0606200 VL - 9 ID - 3844 ER - TY - JOUR AD - Department of Surgery, University of Helsinki, Helsinki University Hospital, PO Box 340, Huch, 00029, Finland Department of Pathology, Haartman Institute and HUSLab, University of Helsinki, Helsinki University Hospital, Helsinki, Finland Department of Oncology, Helsinki University Hospital, Helsinki, Finland Research Programs Unit, Translational Cancer Biology, University of Helsinki, Finland AU - Siironen, P. AU - Hagström, J. AU - Mäenpää, H. O. AU - Louhimo, J. AU - Arola, J. AU - Haglund, C. DB - Scopus DO - 10.3109/0284186X.2015.1070963 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 357-364 ST - Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma T2 - Acta Oncologica TI - Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940728332&doi=10.3109%2f0284186X.2015.1070963&partnerID=40&md5=decee2d95f97f22ec18b975825f91432 VL - 55 ID - 3846 ER - TY - JOUR AD - Universitätsklinikum RWTH Aachen, Aachen, Germany Department of Internal Medicine II, Hubertus Wald Tumorzentrum University Cancer Centre Hamburg, Hamburg, Germany University of Texas MD, Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Seoul St. Mary's Hospital, Seoul, South Korea Pfizer Inc, La Jolla, CA, United States Pfizer Inc, Cambridge, MA, United States University of Milano-Bicocca, Monza, Italy Princess Margaret Cancer Centre, Toronto, ON, Canada ARIAD Pharmaceuticals, Cambridge, MA, United States AU - Brümmendorf, T. H. AU - Cortes, J. E. AU - Khoury, H. J. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Schafhausen, P. AU - Conlan, M. G. AU - Shapiro, M. AU - Turnbull, K. AU - Leip, E. AU - Gambacorti-Passerini, C. AU - Lipton, J. H. DB - Scopus DO - 10.1111/bjh.13801 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2016 SP - 97-110 ST - Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib T2 - British Journal of Haematology TI - Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955673175&doi=10.1111%2fbjh.13801&partnerID=40&md5=9aeb59492e72181fd1006cedeeafdf9a VL - 172 ID - 3848 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China Department of Oncology, First Affiliated Hospital, Xinxiang Medical University, Xinxiang, China Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China Department of Medical Oncology, Chifeng Municipal Hospital, Chifeng, China Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China Betta Pharmaceuticals Co., Ltd, Hangzhou, China AU - Huang, J. AU - Fan, Q. AU - Lu, P. AU - Ying, J. AU - Ma, C. AU - Liu, W. AU - Liu, Y. AU - Tan, F. AU - Sun, Y. DB - Scopus DO - 10.1016/j.jtho.2016.02.020 IS - 6 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2016 SP - 910-917 ST - Icotinib in patients with pretreated advanced esophageal squamous cell Carcinoma with EGFR overexpression or EGFR gene amplification: A single-arm, multicenter phase 2 study T2 - Journal of Thoracic Oncology TI - Icotinib in patients with pretreated advanced esophageal squamous cell Carcinoma with EGFR overexpression or EGFR gene amplification: A single-arm, multicenter phase 2 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979779235&doi=10.1016%2fj.jtho.2016.02.020&partnerID=40&md5=fc8f25e247e51c8844750cfda3cf3e42 VL - 11 ID - 3849 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Rady Children's Hospital-San Diego, University of California, 3020 Children's Way, MC 5035, San Diego, CA 92123, United States Division of Pediatric Hematology-Oncology, St Joseph's Children's Hospital, Paterson, NJ, United States Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, NY, United States AU - Kuo, D. J. AU - Menell, J. S. AU - Bender, J. L. G. DB - Scopus DO - 10.1097/MPH.0000000000000571 IS - 5 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - e169-e172 ST - Treatment of metastatic, refractory alveolar soft part sarcoma: Case reports and literature review of treatment options in the era of targeted therapy T2 - Journal of Pediatric Hematology/Oncology TI - Treatment of metastatic, refractory alveolar soft part sarcoma: Case reports and literature review of treatment options in the era of targeted therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966293296&doi=10.1097%2fMPH.0000000000000571&partnerID=40&md5=b77996d72636de5b3e4d2a65bc43e947 VL - 38 ID - 3850 ER - TY - JOUR AD - Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Division of Hematology and Oncology, Toyohashi Municipal Hospital, 50 Aza Hachiken Nishi, Aotake-cho, Toyohashi, 441-8570, Japan Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sappro, Japan Department of Hematology, Fujita Health University Hospital, Toyoake, Japan Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan Division of Hematology, Tokyo Metropolitan Cancer, Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan Division of Molecular Therapy, Institute of Medical Science, Advanced Clinical Research Center, University of Tokyo, Tokyo, Japan Department of Hematology, Toranomon Hospital, Tokyo, Japan Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan Department of Hematology, Osaka City University Hospital, Osaka, Japan Third Department of Internal of Medicine, Yamaguchi University School of Medicine, Ube, Japan Department of Hematology and Oncology, St. Luke's International Hospital, Tokyo, Japan Department of Cell Processing and Transfusion, Institute of Medical Science, University of Tokyo, Tokyo, Japan Department of HSCT Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan AU - Nishiwaki, S. AU - Imai, K. AU - Mizuta, S. AU - Kanamori, H. AU - Ohashi, K. AU - Fukuda, T. AU - Onishi, Y. AU - Takahashi, S. AU - Uchida, N. AU - Eto, T. AU - Nakamae, H. AU - Yujiri, T. AU - Mori, S. AU - Nagamura-Inoue, T. AU - Suzuki, R. AU - Atsuta, Y. AU - Tanaka, J. AU - Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell, Transplantation DB - Scopus DO - 10.1038/bmt.2015.217 IS - 1 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2016 SP - 43-50 ST - Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: A study from the adult ALL WG of the JSHCT T2 - Bone Marrow Transplantation TI - Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: A study from the adult ALL WG of the JSHCT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953366591&doi=10.1038%2fbmt.2015.217&partnerID=40&md5=4f026387b5fb030b4282481b10f14941 VL - 51 ID - 3851 ER - TY - JOUR AD - Department of Medicine, Boston Children's Hospital, Boston, MA, United States Nemours Center for Cancer and Blood Disorders, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, United States Department of Pathology and Laboratory Medicine, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, United States Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Department of Medicine, Division of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Lewen, M. AU - Gresh, R. AU - Queenan, M. AU - Paessler, M. AU - Pillai, V. AU - Hexner, E. AU - Frank, D. AU - Bagg, A. AU - Aplenc, R. AU - Caywood, E. AU - Wertheim, G. C7 - 14 DB - Scopus DO - 10.1186/s40364-016-0069-0 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 ST - Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report T2 - Biomarker Research TI - Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056447718&doi=10.1186%2fs40364-016-0069-0&partnerID=40&md5=ab9f0aed5f0eb89521f7ac2c64e3b855 VL - 4 ID - 3852 ER - TY - JOUR AD - Department of Internal Medicine, Alb-Fils-Kliniken, Göppingen, Germany Department of General and Visceral Surgery, University Hospital Ulm, Ulm, Germany Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany Department of Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany AU - Schmieder, M. AU - Henne-Bruns, D. AU - Mayer, B. AU - Knippschild, U. AU - Rolke, C. AU - Schwab, M. AU - Kramer, K. C7 - 504 DB - Scopus DO - 10.3389/fphar.2016.00504 IS - DEC M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 ST - Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection T2 - Frontiers in Pharmacology TI - Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009223162&doi=10.3389%2ffphar.2016.00504&partnerID=40&md5=5bd51b23d2c71bdfd67ea3d2516e008f VL - 7 ID - 3853 ER - TY - JOUR AD - Department of Dermatology, University Hospital Würzburg, Würzburg, Germany Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Essen, Germany Department of Dermatology, University Duisburg-Essen, Essen, Germany Department of Dermatology, Medical University of Graz, Graz, Austria AU - Willmes, C. AU - Kumar, R. AU - Becker, J. C. AU - Fried, I. AU - Rachakonda, P. S. AU - Poppe, L. M. AU - Hesbacher, S. AU - Schadendorf, D. AU - Sucker, A. AU - Schrama, D. AU - Ugurel, S. DB - Scopus DO - 10.18632/oncotarget.6956 IS - 9 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 10117-10132 ST - SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma T2 - Oncotarget TI - SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961588345&doi=10.18632%2foncotarget.6956&partnerID=40&md5=e2de23f45f2761fa90e76cf121310aba VL - 7 ID - 3854 ER - TY - JOUR AD - Department of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Institute of Child Health, University College London, United Kingdom International Neuroscience Institute, Hannover, Germany Department of Neurosurgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany Department of Neurosurgery, University Hospital Erlangen-Nuremberg, Erlangen, Germany Department of Neurosurgery, Medical University of Vienna, Austria Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany AU - Stache, C. AU - Bils, C. AU - Fahlbusch, R. AU - Flitsch, J. AU - Buchfelder, M. AU - Stefanits, H. AU - Czech, T. AU - Gaipl, U. AU - Frey, B. AU - Buslei, R. AU - Hölsken, A. C7 - E14 DB - Scopus DO - 10.3171/2016.9.FOCUS16316 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 ST - Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin T2 - Neurosurgical Focus TI - Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002194582&doi=10.3171%2f2016.9.FOCUS16316&partnerID=40&md5=78a1d2598c58aeddf13800c494b12f44 VL - 41 ID - 3856 ER - TY - JOUR AD - Division of Drug Research/Clinical Pharmacology, Department of Medical and Health Sciences, Linkoping University, Linkoping, 58185, Sweden Department of Hematology and Coagulation, Skane University Hospital, Lund, Sweden Department of Medical Sciences, Uppsala University, Department of Hematology, University Hospital, Sweden Analytical Chemistry, Department of Chemistry, Biomedical Center and Science for Life Laboratory, Uppsala University, Sweden Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden Department of Internal Medicine, Motala Hospital, Sweden Department of Medicine, Ryhov County Hospital, Jonkoping, Sweden Department of Internal Medicine, Vastervik Hospital, Sweden Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linkoping, Sweden AU - Skoglund, K. AU - Richter, J. AU - Olsson-Strömberg, U. AU - Bergquist, J. AU - Aluthgedara, W. AU - Ubhayasekera, S. J. K. A. AU - Vikingsson, S. AU - Svedberg, A. AU - Soderlund, S. AU - Sandstedt, A. AU - Johnsson, A. AU - Aagesen, J. AU - Alsenhed, J. AU - Hagg, S. AU - Peterson, C. AU - Lotfi, K. AU - Green, H. DB - Scopus DO - 10.1097/FTD.0000000000000268 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 230-238 ST - In vivo cytochrome P450 3A isoenzyme activity and pharmacokinetics of imatinib in relation to therapeutic outcome in patients with chronic myeloid Leukemia T2 - Therapeutic Drug Monitoring TI - In vivo cytochrome P450 3A isoenzyme activity and pharmacokinetics of imatinib in relation to therapeutic outcome in patients with chronic myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951310669&doi=10.1097%2fFTD.0000000000000268&partnerID=40&md5=b063b6302c231ab99b06b690f9ae4629 VL - 38 ID - 3857 ER - TY - JOUR AD - Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Internal Medicine, Lampang Hospital, Lampang, Thailand Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Anatomy, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand AU - Tantiworawit, A. AU - Kongjarern, S. AU - Rattarittamrong, E. AU - Lekawanvijit, S. AU - Bumroongkit, K. AU - Boonma, N. AU - Rattanathammethee, T. AU - Hantrakool, S. AU - Chai-Adisaksopha, C. AU - Norasetthada, L. DB - Scopus DO - 10.7314/APJCP.2016.17.4.2159 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 2159-2164 ST - Diagnosis and monitoring of chronic myeloid leukemia: Chiang Mai university experience T2 - Asian Pacific Journal of Cancer Prevention TI - Diagnosis and monitoring of chronic myeloid leukemia: Chiang Mai university experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973098756&doi=10.7314%2fAPJCP.2016.17.4.2159&partnerID=40&md5=a1e5220f4f88ceff68283ef6e4672ad5 VL - 17 ID - 3858 ER - TY - JOUR AD - Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan Department of Nursing, Hung Kuang University, Taichung, Taiwan Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan School of Chinese Medicine, China Medical University, Taichung, Taiwan Department of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Orthopaedics, Taichung Veterans General Hospital, Taichung, Taiwan Department of Pathology, China Medical University Hospital, Taichung, Taiwan Department of Orthopedic Surgery, Tungs' Taichung Metroharbor Hospital, Taichung, Taiwan Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan AU - Liao, Y. Y. AU - Tsai, H. C. AU - Chou, P. Y. AU - Wang, S. W. AU - Chen, H. T. AU - Lin, Y. M. AU - Chiang, I. P. AU - Chang, T. M. AU - Hsu, S. K. AU - Chou, M. C. AU - Tang, C. H. AU - Fong, Y. C. DB - Scopus DO - 10.18632/oncotarget.6708 IS - 4 M3 - Article N1 - Cited By :48 Export Date: 18 November 2020 PY - 2016 SP - 4310-4325 ST - CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells T2 - Oncotarget TI - CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957999067&doi=10.18632%2foncotarget.6708&partnerID=40&md5=54a5aa76478c1634f2d92de550ebf55e VL - 7 ID - 3859 ER - TY - JOUR AD - Department of Prosthodontics, Shanghai Key Laboratory of Stomatology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Road, Shanghai, China Shanghai Key Laboratory of Orthopaedic Implant, Department of Orthopaedics Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Road, Shanghai, China AU - Mao, C. Y. AU - Wang, Y. G. AU - Zhang, X. AU - Zheng, X. Y. AU - Tang, T. T. AU - Lu, E. Y. C7 - e2296 DB - Scopus DO - 10.1038/cddis.2016.204 IS - 7 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2016 ST - Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways T2 - Cell Death and Disease TI - Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019700567&doi=10.1038%2fcddis.2016.204&partnerID=40&md5=66d52e059b51871cfc43ad1ea43a3571 VL - 7 ID - 3866 ER - TY - JOUR AD - Department of Otorhinolaryngology-Head and Neck Surgery, Chosun University College of Medicine, Gwangju, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Graduate school of Medicine, Seoul National University, Seoul, South Korea Sensory Organ Research Center, Seoul National University Biomedical Research Institute, Seoul, South Korea Institute of Allergy and Clinical Immunology, Seoul National University Biomedical Research Institute, Seoul, South Korea Graduate School of Immunology, Seoul National University, Seoul, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, South Korea AU - Lee, J. E. AU - Kim, Y. H. AU - Rhee, C. S. AU - Kim, D. Y. DB - Scopus DO - 10.4168/aair.2016.8.5.445 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 SP - 445-456 ST - AntibiSynergistic effect of Dermatophagoides farinae and lipopolysaccharides in human middle ear epithelial cells T2 - Allergy, Asthma and Immunology Research TI - AntibiSynergistic effect of Dermatophagoides farinae and lipopolysaccharides in human middle ear epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976340342&doi=10.4168%2faair.2016.8.5.445&partnerID=40&md5=b774b2f89b69750ea7faf9128e257946 VL - 8 ID - 3867 ER - TY - JOUR AD - Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan Department of Hematology, Harasanshin Hospital, 1-8 Taihaku-machi, Hakata-ku, Fukuoka, 812-0033, Japan Department of Hematology, Hamanomachi Hospital, 3-1-1 Nagahama Chuo-ku, Fukuoka, 810-8539, Japan Department of Internal Medicine, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Tsurumi, Beppu, 874-0838, Japan Department of Internal Medicine, Kitakyushu Municipal Medical Center, 2-1-1 Bashaku, Kokurakita-ku, Kitakyushu, 802-0077, Japan Department of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan Department of Hematology, Hokkaido University Graduate School of Medicine, N15 W7, Kita-Ku, Sapporo, 060-8638, Japan AU - Takashima, S. AU - Miyamoto, T. AU - Kamimura, T. AU - Yoshimoto, G. AU - Yoshida, S. AU - Henzan, H. AU - Takase, K. AU - Kato, K. AU - Ito, Y. AU - Ohno, Y. AU - Nagafuji, K. AU - Eto, T. AU - Teshima, T. AU - Akashi, K. DB - Scopus DO - 10.1007/s12185-015-1883-0 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 689-696 ST - Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - International Journal of Hematology TI - Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949102205&doi=10.1007%2fs12185-015-1883-0&partnerID=40&md5=fee923e5f20172d4f813d9400e0d66a2 VL - 102 ID - 3872 ER - TY - JOUR AD - Department of Hematology and Oncology, Iwate Medical University, Morioka, Japan Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan Department of Hematology, Iwate Prefectural Chubu Hospital, Kitakami, Japan Department of Hematology, Osaki Citizen Hospital, Osaki, Japan Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan Department of Hematology, Morioka Red Cross Hospital, Morioka, Japan Department of Internal Medicine, Omagari Kosei Medical Center, Omagari, Japan Department of Hematology, National Hospital Organization, Sendai Medical Center, Sendai, Japan Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology (DNHMED), Yamagata University Faculty of Medicine, Yamagata, Japan Department of Hematology, Yamagata City Hospital Saiseikan, Yamagata, Japan Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan Tokai Central Hospital, Kakamigahara, Japan AU - Murai, K. AU - Akagi, T. AU - Shimosegawa, K. AU - Sugawara, T. AU - Ishizawa, K. AU - Ito, S. AU - Murai, K. AU - Motegi, M. AU - Yokoyama, H. AU - Noji, H. AU - Tajima, K. AU - Kimura, J. AU - Chou, T. AU - Ogawa, K. AU - Harigae, H. AU - Kubo, K. AU - Oba, K. AU - Sakamoto, J. AU - Ishida, Y. DB - Scopus DO - 10.1111/ejh.12536 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 558-565 ST - A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria T2 - European Journal of Haematology TI - A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955261006&doi=10.1111%2fejh.12536&partnerID=40&md5=5489d95e786ab5dc6a09f5a9cccbf251 VL - 95 ID - 3873 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy Federal State-Funded Institution National Research, Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Bristol-Myers Squibb, Princeton, NJ, United States Centre for Haematology, Imperial College, London, United Kingdom AU - Cortes, J. E. AU - Abruzzese, E. AU - Chelysheva, E. AU - Guha, M. AU - Wallis, N. AU - Apperley, J. F. DB - Scopus DO - 10.1002/ajh.24186 IS - 12 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2015 SP - 1111-1115 ST - The impact of dasatinib on pregnancy outcomes T2 - American Journal of Hematology TI - The impact of dasatinib on pregnancy outcomes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954220288&doi=10.1002%2fajh.24186&partnerID=40&md5=2cd1e5dce64ab3901add6ab301dc54d4 VL - 90 ID - 3874 ER - TY - JOUR AD - Pediatric Rheumatology and Immunology, Children's Hospital, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States Vivantes Klinikum Friedrichshain, Children's Hospital, Berlin, Germany Pediatric Rheumatology and Immunology, Children's Hospital, University of Würzburg, Würzburg, Germany AU - Hofmann, S. R. AU - Kubasch, A. S. AU - Ioannidis, C. AU - Rösen-Wolff, A. AU - Girschick, H. J. AU - Morbach, H. AU - Hedrich, C. M. DB - Scopus DO - 10.1016/j.clim.2015.09.013 IS - 2 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2015 SP - 300-307 ST - Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release T2 - Clinical Immunology TI - Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943523723&doi=10.1016%2fj.clim.2015.09.013&partnerID=40&md5=e8a6c917b2e0063e34bfd93b96068a69 VL - 161 ID - 3876 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas-UNICAMP, Rua Carlos Chagas 480, Campinas, SP, 13083-878, Brazil AU - Ribeiro, B. F. AU - Vergílio, B. R. AU - Miranda, E. C. M. AU - Almeida, M. H. AU - Delamain, M. T. AU - Da Silveira, R. A. AU - De Souza, C. A. AU - Albuquerque, D. M. AU - Dos Santos, A. AU - Duarte, V. O. AU - Oliveira-Duarte, G. B. AU - Lorand-Metze, I. AU - Pagnano, K. B. B. DB - Scopus DO - 10.1159/000430835 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2015 SP - 248-254 ST - BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution T2 - Acta Haematologica TI - BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84936976940&doi=10.1159%2f000430835&partnerID=40&md5=72feb0c73b664df297a1090d1b834507 VL - 134 ID - 3877 ER - TY - JOUR AD - PUCRS School of Medicine, Porto Alegre, Brazil Mount Sinai Hospital, Toronto, ON, Canada Universite Claude Bernard, Lyon, France Istituto Nazionale Tumori, Milan, Italy Alexander Fleming Institute, Department of Medical Oncology, Buenos Aires, Argentina Peking University Cancer Hospital, Beijing, China University of Ulsan College of Medicine, Seoul, South Korea National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, Berlin, 13125, Germany AU - Barrios, C. H. AU - Blackstein, M. E. AU - Blay, J. Y. AU - Casali, P. G. AU - Chacon, M. AU - Gu, J. AU - Kang, Y. K. AU - Nishida, T. AU - Purkayastha, D. AU - Woodman, R. C. AU - Reichardt, P. DB - Scopus DO - 10.1016/j.ejca.2015.07.010 IS - 16 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 SP - 2423-2433 ST - The GOLD ReGISTry: A Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours T2 - European Journal of Cancer TI - The GOLD ReGISTry: A Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943660159&doi=10.1016%2fj.ejca.2015.07.010&partnerID=40&md5=e0a3d8a0662ec106e40064ebc9768d5b VL - 51 ID - 3882 ER - TY - JOUR AD - Bone Marrow Transplantation Unit, Hospital Israelita Albert Einstein (HIAE) and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Estadual de Campinas (Unicamp), Campinas and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Instituto de Tratamento do Câncer Infantil (ITACI), Instituto da Criança (ICR), Hospital de Clínicas da Universidade de São Paulo (HC-USP) and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Federal do Paraná (UFP), Paraná and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Centro de Tratamento Oncológico (Centron), São Paulo and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Federal do Rio de Janeiro (UFRJ), and Head of the Hematology Service, Hospital Universitário Clementino Fraga Filho (HUCCFF), Universidade Federal do Rio de Janeiro (UFRJ), Brasileira de Linfoma e Leucemia (ABRALE), Rio de Janeiro, São Paulo, Brazil Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil AU - Hamerschlak, N. AU - de Souza, C. AU - Cornacchioni, A. L. AU - Pasquini, R. AU - Tabak, D. AU - Spector, N. AU - Steagall, M. DB - Scopus DO - 10.1590/1516-3180.2014.0001306 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 471-479 ST - Percepções dos pacientes sobre diagnóstico e tratamento da leucemia mieloide crônica: Estudo transversal entre pacientes brasileiros T2 - Sao Paulo Medical Journal TI - Patients’ perceptions about diagnosis and treatment of chronic myeloid leukemia: A cross-sectional study among Brazilian patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954349301&doi=10.1590%2f1516-3180.2014.0001306&partnerID=40&md5=0b4c1d12069c6fec67486667760383c4 VL - 133 ID - 3883 ER - TY - JOUR AD - Division of Hematology/Oncology, San Francisco School of Medicine, University of California, San Francisco, CA, United States Department of Pulmonary Medicine, Critical Care and Allergy, Bristol-Myers Squibb, Princeton, NJ, United States Boston University School of Medicine, Boston, MA, United States Memorial Sloan Kettering Cancer Center, New York, NY, United States Santa Croce Hospital, Cuneo, Italy Hôpital Saint-Louis, Paris, France Scottish Pulmonary Vascular Unit, Glasgow, United Kingdom AU - Shah, N. P. AU - Wallis, N. AU - Farber, H. W. AU - Mauro, M. J. AU - Wolf, R. A. AU - Mattei, D. AU - Guha, M. AU - Rea, D. AU - Peacock, A. DB - Scopus DO - 10.1002/ajh.24174 IS - 11 M3 - Article N1 - Cited By :65 Export Date: 18 November 2020 PY - 2015 SP - 1060-1064 ST - Clinical features of pulmonary arterial hypertension in patients receiving dasatinib T2 - American Journal of Hematology TI - Clinical features of pulmonary arterial hypertension in patients receiving dasatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944522481&doi=10.1002%2fajh.24174&partnerID=40&md5=e04bccfc889da1a0acbac3677a4aa57d VL - 90 ID - 3884 ER - TY - JOUR AD - Exelixis, Inc., 210 East Grand Avenue, San Francisco, CA, United States Mamelok Consulting, Palo Alto, CA, United States Celerion, Montreal, QC, Canada Celerion, Tempe, AZ, United States AU - Nguyen, L. AU - Holland, J. AU - Mamelok, R. AU - Laberge, M. K. AU - Grenier, J. AU - Swearingen, D. AU - Armas, D. AU - Lacy, S. DB - Scopus DO - 10.1002/jcph.526 IS - 11 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2015 SP - 1293-1302 ST - Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects T2 - Journal of Clinical Pharmacology TI - Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942980894&doi=10.1002%2fjcph.526&partnerID=40&md5=aca56cfbcc82f38ba6a9493d7f378fd8 VL - 55 ID - 3887 ER - TY - JOUR AD - Medical Genetics/Hematology and Oncology, CLS, CAMS, King Saud Bin Abdulaziz University for Health Sciences/KAIMRC, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, Saudi Arabia Department of Zoology, University of the Punjab, Lahore, Pakistan Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan Division of Hematology/Oncology, Department of Medicine, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia Centre of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia Translational Genomic Instability Program, Harvard (Dana-Farber) Cancer Institute, Harvard Medical School, Harvard University, Boston, MA, United States Department of Oncology, Allied Hospital, Punjab Medical College, Faisalabad, Pakistan Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan Hayatabad Medical Complex, Peshawar, Pakistan Department of Oncology, Khyber Teaching Hospital, Peshawar, Pakistan Cox Health System, Springfield, MO, United States Department of Biotechnology, University of Peshawar, Peshawar, Pakistan Core DNA Facilities, Centre for Advanced Molecular Biology, University of the Punjab, Lahore, Pakistan Department of Biotechnology, University of Sargodha, Sargodha, Pakistan Institute of Molecular Biology and Biotechnology (IMBB), Centre for Research in Molecular Medicine (CRiMM), The University of Lahore, Lahore, Pakistan Stem Cell Research Group, Department of Anatomy, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia Asian Medical Institute and National Surgical Centre, Kant, Kyrgyzstan Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan Prince Abdullah Bin Khalid Celiac Disease Research Chair, King Saud University, Riyadh, Saudi Arabia Department of Chemistry, University of Sargodha, Sargodha, Pakistan AU - Iqbal, Z. AU - Akhtar, T. AU - Awan, T. AU - Aleem, A. AU - Sabir, N. AU - Rasool, M. AU - Absar, M. AU - Akram, A. M. AU - Shammas, M. A. AU - Shah, I. H. AU - Khalid, M. AU - Taj, A. S. AU - Jameel, A. AU - Alanazi, A. AU - Gill, A. T. AU - Hashmi, J. A. AU - Hussain, A. AU - Sabar, M. F. AU - Khalid, A. M. AU - Qazi, M. H. AU - Karim, S. AU - Siddiqi, M. H. AU - Mahmood, A. AU - Iqbal, M. AU - Saeed, A. AU - Irfan, M. I. DB - Scopus DO - 10.1007/s40291-015-0149-0 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 277-287 ST - High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan T2 - Molecular Diagnosis and Therapy TI - High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942504078&doi=10.1007%2fs40291-015-0149-0&partnerID=40&md5=2cb2b09ec40778d79bc38c3a40d60d9d VL - 19 ID - 3888 ER - TY - JOUR AD - APHP, Groupe Henri Mondor Albert Chenevier, Liver Unit, Henri Mondor Hospital, Créteil, France APHP, Groupe Henri Mondor Albert Chenevier, Department of Radiology, Henri Mondor Hospital, Créteil, France APHP, Groupe Hôpital Européen Georges Pompidou, Department of Clinical Research, Paris, France INSERM, UMRS 1138, Department of Research of Les Cordeliers, Team 22, Paris, France University Paris 5 René Descartes, Paris, France Department of Statistics, George Mason University, Fairfax, VA, United States APHP, Groupe Henri Mondor Albert Chenevier, Department of Hepatobiliary Surgery, Henri Mondor Hospital, Créteil, France University Paris Est Créteil, Créteil, France INSERM U955, Team 18, Créteil, France Université Paris 13, Sorbonne Paris Cité, UFR SMBH, Bobigny, F-93000, France APHP, Hôpitaux Universitaires Paris, France Seine Saint-Denis, Site Jean Verdier, Pôle d'Activité Cancérologique Spécialisée, Service d'Hépatologie, Bondy, F-93143, France INSERM, UMR-1162, Génomique fonctionnelle des Tumeurs solides, IUH, Paris, F-75010, France CHU de Grenoble, Pôle DIGI-DUNE, Service d'Hépatologie et de Gastroentérologie, Grenoble, F-38000, France INSERM U823, Institut Albert Bonniot, équipe 8, Grenoble, F-38000, France AU - Nault, J. C. AU - Pigneur, F. AU - Nelson, A. C. AU - Costentin, C. AU - Tselikas, L. AU - Katsahian, S. AU - Diao, G. AU - Laurent, A. AU - Mallat, A. AU - Duvoux, C. AU - Luciani, A. AU - Decaens, T. DB - Scopus DO - 10.1016/j.dld.2015.07.001 IS - 10 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2015 SP - 869-876 ST - Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors T2 - Digestive and Liver Disease TI - Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942199209&doi=10.1016%2fj.dld.2015.07.001&partnerID=40&md5=7268ba67bfab5109d4c5d77d3de8975d VL - 47 ID - 3889 ER - TY - JOUR AD - Rocky Mountain Cancer Centers, 1700 S Potomac Street, Aurora, CO 80012, United States McKesson Specialty Health/US Oncology Network, Woodlands, TX, United States Bristol-Myers Squibb, Princeton, NJ, United States MD Anderson Cancer Center, University of Texas, Houston, TX, United States AU - Di Bella, N. J. AU - Bhowmik, D. AU - Bhor, M. AU - Yap, M. AU - Middlebrook, B. AU - Rembert, D. AU - Cain, Z. AU - Okoro, T. AU - Bolinder, B. AU - Patt, D. AU - Jabbour, E. J. DB - Scopus DO - 10.1016/j.clml.2015.06.006 IS - 10 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 599-605 ST - The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Community Setting T2 - Clinical Lymphoma, Myeloma and Leukemia TI - The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Community Setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942827594&doi=10.1016%2fj.clml.2015.06.006&partnerID=40&md5=3e688cba79a9f56f9fd04124626c79bf VL - 15 ID - 3890 ER - TY - JOUR AD - Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic Clinical Laboratories Department, AL-Assad Hospital, Damascus University, Damascus, Syrian Arab Republic AU - Kelani, R. AU - Monem, F. DB - Scopus DO - 10.1111/ijlh.12394 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2015 SP - 723-728 ST - Reconsideration of BCR-ABL protein flow cytometric immunobead assay: How potent to diagnose and monitor chronic myeloid leukemia? T2 - International Journal of Laboratory Hematology TI - Reconsideration of BCR-ABL protein flow cytometric immunobead assay: How potent to diagnose and monitor chronic myeloid leukemia? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941745747&doi=10.1111%2fijlh.12394&partnerID=40&md5=2daacc81d6a14e7d0d4d886439971ace VL - 37 ID - 3891 ER - TY - JOUR AD - Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy Hematology, Cattolica University, Rome, Italy Hematology, S. Eugenio Hospital, Rome, Italy S. Giovanni Hospital, Rome, Italy Hospital Cervello, Palermo, Italy San Martino Hospital, Genoa, Italy Hematology Unit, IRCCS AOU San Martino-IST, Genoa, Italy Careggi Hospital, Florence, Italy Hematology and Bone Marrow Transplant Unit, Businco Hopsital, Cagliari, Italy Ferrara University, Ferrara, Italy Department of Oncology Hematology, ASL Salerno, Sapri, Italy Udine University, Udine, Italy Padua University, Padova, Italy S. Giovanni Battista Hospital, Turin, Italy Siena University, Siena, Italy Amedeo Avogadro University of Eastern Piedmont, Novara, Italy Parma University, Parma, Italy Verona University, Verona, Italy Modena University, Modena, Italy Belcolle Hospital, Viterbo, Italy Trento Hospital, Trento, Italy Bianchi Melacrino Morelli Hospital, Reggio Calabria, Italy Cardarelli Hospital, Naples, Italy Federico II University, Naples, Italy Ferrarotto Hospital, Catania University, Catania, Italy Haematology Unit and Bone Marrow Transplant Centre, Guglielmo da Saliceto Hospital, Piacenza, Italy Niguarda Hospital, Milan, Italy IRCSS Cà Granda Policlinico, Milan, Italy Hematology and Bone Marrow Transplant Units, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy Brescia University, Brescia, Italy S. Matteo Hospital, Pavia, Italy Department of Health Sciences, University of Milano-Bicocca, Monza, Italy AU - Breccia, M. AU - Efficace, F. AU - Sica, S. AU - Abruzzese, E. AU - Cedrone, M. AU - Turri, D. AU - Gobbi, M. AU - Carella, A. M. AU - Gozzini, A. AU - Usala, E. AU - Cavazzini, F. AU - Danise, P. AU - Tiribelli, M. AU - Binotto, G. AU - Pregno, P. AU - Bocchia, M. AU - Gaidano, G. AU - Crugnola, M. AU - Bonifacio, M. AU - Avanzini, P. AU - Celesti, F. AU - Guella, A. AU - Martino, B. AU - Annunziata, M. AU - Luciano, L. AU - Stagno, F. AU - Vallisa, D. AU - Pungolino, E. AU - Iurlo, A. AU - Rambaldi, A. AU - Nardiello, I. AU - Orlandi, E. AU - Gambacorti-Passerini, C. AU - Alimena, G. DB - Scopus DO - 10.1016/j.leukres.2015.07.004 IS - 10 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2015 SP - 1055-1059 ST - Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients T2 - Leukemia Research TI - Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941317056&doi=10.1016%2fj.leukres.2015.07.004&partnerID=40&md5=f0d802ce5576ebcb6d20693921b8ee7b VL - 39 ID - 3892 ER - TY - JOUR AD - Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, China Department of Biochemistry and Molecular Biology, School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou, China Department of clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China AU - Wang, W. Z. AU - Pu, Q. H. AU - Lin, X. H. AU - Liu, M. Y. AU - Wu, L. R. AU - Wu, Q. Q. AU - Chen, Y. H. AU - Liao, F. F. AU - Zhu, J. Y. AU - Jin, X. B. DB - Scopus DO - 10.1016/j.leukres.2015.07.008 IS - 10 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2015 SP - 1117-1124 ST - Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway T2 - Leukemia Research TI - Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941316648&doi=10.1016%2fj.leukres.2015.07.008&partnerID=40&md5=ecbf06834a0700219cf2c68a8a81d391 VL - 39 ID - 3893 ER - TY - JOUR AD - Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India Department of Radiodiagnosis, Tata Memorial Hospital, Mumbai, Maharashtra, India AU - Pandey, A. V. AU - Phillip, D. S. AU - Noronha, V. AU - Joshi, A. AU - Janu, A. AU - Jambekar, N. AU - Kaushal, R. AU - Mahajan, A. AU - Prabhash, K. DB - Scopus DO - 10.4103/0971-5851.171544 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 238-242 ST - Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center T2 - Indian Journal of Medical and Paediatric Oncology TI - Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953307055&doi=10.4103%2f0971-5851.171544&partnerID=40&md5=1c7364ae35c6772f8dc494f1bdc7a2b3 VL - 36 ID - 3894 ER - TY - JOUR AD - Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States Department of Pathology, Botucatu Medical School, UNESP-Univ. Estadual Paulista, Botucatu, Sao Paulo, Brazil Department of Epidemiology and Biostatistics, Texas A and M University System Health Science Center, College Station, Texas, United States Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, North Carolina, United States AU - Polettini, J. AU - Behnia, F. AU - Taylor, B. D. AU - Saade, G. R. AU - Taylor, R. N. AU - Menon, R. C7 - e0137188 DB - Scopus DO - 10.1371/journal.pone.0137188 IS - 9 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2015 ST - Telomere fragment induced amnion cell senescence: A contributor to parturition? T2 - PLoS ONE TI - Telomere fragment induced amnion cell senescence: A contributor to parturition? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946934889&doi=10.1371%2fjournal.pone.0137188&partnerID=40&md5=d277c2ba69c2bdb03e5c44c21ca9806a VL - 10 ID - 3895 ER - TY - JOUR AD - Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Division of Hematology, Jichi Medical University, Tochigi, Japan AU - Sakurai, M. AU - Mori, T. AU - Karigane, D. AU - Tozawa, K. AU - Matsuki, E. AU - Shimizu, T. AU - Yokoyama, K. AU - Nakajima, H. AU - Kanda, Y. AU - Okamoto, S. DB - Scopus DO - 10.1007/s12185-015-1840-y IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 342-348 ST - Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors T2 - International Journal of Hematology TI - Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941259031&doi=10.1007%2fs12185-015-1840-y&partnerID=40&md5=983c1af3f271286a9fe4effe7d551c5a VL - 102 ID - 3899 ER - TY - JOUR AD - Department of Internal Medicine, University of Milano-Bicocca, Monza, Italy Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Seoul St. Mary's Hospital, Seoul, South Korea Division of Hematology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Hematology Research Center, Moscow, Russian Federation Clinic for Oncology, Hematology, and Stem Cell Transplantation, Universitätsklinikum Aachen, RWTH Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Pfizer, New York, NY, United States Pfizer Global Research and Development, Paris, France Pfizer, Cambridge, MA, United States AU - Gambacorti-Passerini, C. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Khoury, H. J. AU - Turkina, A. G. AU - Brümmendorf, T. H. AU - Matczak, E. AU - Bardy-Bouxin, N. AU - Shapiro, M. AU - Turnbull, K. AU - Leip, E. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.24034 IS - 9 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2015 SP - 755-768 ST - Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939565243&doi=10.1002%2fajh.24034&partnerID=40&md5=c6f1bc57ee47941fc925566d2d76f5a2 VL - 90 ID - 3900 ER - TY - JOUR AD - Oncological Endocrinology Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Via Genova 3, Turin, 10126, Italy Unit of Clinical Epidemiology, AOU Città della Salute e della Scienza di Torino, CPO-Piemonte and University of Turin, Turin, Italy AU - Gallo, M. AU - Michelon, F. AU - Castiglione, A. AU - Felicetti, F. AU - Viansone, A. A. AU - Nervo, A. AU - Zichi, C. AU - Ciccone, G. AU - Piovesan, A. AU - Arvat, E. DB - Scopus DO - 10.1007/s12020-014-0481-x IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2015 SP - 726-734 ST - Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center T2 - Endocrine TI - Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937970280&doi=10.1007%2fs12020-014-0481-x&partnerID=40&md5=96d674aebffd5d99e26baca525259cbb VL - 49 ID - 3901 ER - TY - JOUR AD - Institute of Bioengineering and Nanotechnology, Singapore, Singapore Health Services Research, Singapore General Hospital, Singapore, Singapore Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore Department of Pathology, Singapore General Hospital, Singapore, Singapore Laboratory of Clinical Pharmacology, Division Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore Clinical Pharmacology Core, SingHealth, Singapore, Singapore Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore AU - Chu, Y. H. AU - Li, H. AU - Tan, H. S. AU - Koh, V. AU - Lai, J. AU - Phyo, W. M. AU - Choudhury, Y. AU - Kanesvaran, R. AU - Chau, N. M. AU - Toh, C. K. AU - Ng, Q. S. AU - Tan, P. H. AU - Chowbay, B. AU - Tan, M. H. C7 - e0134102 DB - Scopus DO - 10.1371/journal.pone.0134102 IS - 8 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2015 ST - Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinoma T2 - PLoS ONE TI - Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942110373&doi=10.1371%2fjournal.pone.0134102&partnerID=40&md5=c5731492547e0fb2e78eda78e253ca5a VL - 10 ID - 3905 ER - TY - JOUR AD - Department of Neurological Surgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States Department of Neurological Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, 525 E. 68th St, New York, NY 10065, United States Professor of Surgery (Neurosurgery), Cleveland Clinic/ND40, 9500 Euclid Avenue, Cleveland, OH 44195, United States AU - Juthani, R. G. AU - Bilsky, M. H. AU - Vogelbaum, M. A. C7 - 39 DB - Scopus DO - 10.1007/s11864-015-0358-0 IS - 8 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2015 ST - Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors T2 - Current Treatment Options in Oncology TI - Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938350083&doi=10.1007%2fs11864-015-0358-0&partnerID=40&md5=9d7e464794f1f4f56c944aad60961dc0 VL - 16 ID - 3906 ER - TY - JOUR AD - Department of Hematology, Xinqiao Hospital, Third Military Medical University, Xinqiao Street Shangpinba District, Chongqing, 400037, China Department of Hematology, General Hospital of Chengdu Military Region of PLA, Sichuan, China Department of Hematology, General Hospital of Kunming Military Region of PLA, Yunnan, China Department of Hematology, Yunnan Provincial Peoples Hospital, Yunnan, China Department of Hematology, Second Yunnan Provincial Peoples Hospital, Yunnan, China Department of Hematology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China AU - Gao, L. AU - Zhang, C. AU - Gao, L. AU - Liu, Y. AU - Su, Y. AU - Wang, S. AU - Li, B. AU - Yang, T. AU - Yuan, Z. AU - Zhang, X. C7 - 90 DB - Scopus DO - 10.1186/s13045-015-0186-5 IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 ST - Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: A multicenter study in Southwest China T2 - Journal of Hematology and Oncology TI - Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: A multicenter study in Southwest China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938417686&doi=10.1186%2fs13045-015-0186-5&partnerID=40&md5=9021b9f692b9fbab51336eb98cd890b0 VL - 8 ID - 3909 ER - TY - JOUR AD - Department of Morphology and Physiology, Semmelweis University, Budapest, Hungary First Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi Street 26, Budapest, 1085, Hungary Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, 3990 John R, Detroit, MI 48201, United States University of Chicago, Chicago, IL, United States Department of Dermatology, Dermatooncology and Venerology, Semmelweis University, Budapest, Hungary First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary Maternity Private Department, Kutvolgyi Clinical Block, Semmelweis University, Budapest, Hungary Center for Molecular Medicine and Genetics, School of Medicine, Wayne State University, Detroit, MI, United States Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, United States Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary AU - Szabo, S. AU - Mody, M. AU - Romero, R. AU - Xu, Y. AU - Karaszi, K. AU - Mihalik, N. AU - Xu, Z. AU - Bhatti, G. AU - Fule, T. AU - Hupuczi, P. AU - Krenacs, T. AU - Rigo, J., Jr. AU - Tarca, A. L. AU - Hassan, S. S. AU - Chaiworapongsa, T. AU - Kovalszky, I. AU - Papp, Z. AU - Than, N. G. DB - Scopus DO - 10.1007/s12253-014-9872-9 IS - 3 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2015 SP - 659-668 ST - Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome T2 - Pathology and Oncology Research TI - Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939416015&doi=10.1007%2fs12253-014-9872-9&partnerID=40&md5=07d29292a6a5f932b73195b5e300f549 VL - 21 ID - 3911 ER - TY - JOUR AD - Registro Español de Investigación y Tratamiento de Leucemia Mieloide Crnica (RELMC), Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Virgen de la Salud, Toledo, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Valle de Hebrón, Barcelona, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Miguel Servet, Zaragoza, Spain Servicio de Hematología y Hemoterapia, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario La Paz, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Puerta de Hierro, Majadahonda, Spain Servicio de Hematología y Hemoterapia, Hospital General Universitario Gregorio Marañón, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Severo Ochoa, Leganés, Spain Servicio de Hematología y Hemoterapia, Hospital Lozano Blesa, Zaragoza, Spain Servicio de Hematología y Hemoterapia, Hospital Clínico Universitario de Valladolid, Valladolid, Spain Servicio de Hematología y Hemoterapia, Hospital General de Ciudad Real, Ciudad Real, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Infanta Leonor, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario de la Princesa, Madrid, Spain AU - Casado, L. F. AU - García-Gutiérrez, J. V. AU - Massagué, I. AU - Giraldo, P. AU - Pérez-Encinas, M. AU - de Paz, R. AU - Martínez-López, J. AU - Bautista, G. AU - Osorio, S. AU - Requena, M. J. AU - Palomera, L. AU - Peñarrubia, M. J. AU - Calle, C. AU - Hernández-Rivas, J. A. AU - Burgaleta, C. AU - Maestro, B. AU - García-Ormeña, N. AU - Steegmann, J. L. DB - Scopus DO - 10.1002/cam4.440 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 995-1002 ST - Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months T2 - Cancer Medicine TI - Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006200849&doi=10.1002%2fcam4.440&partnerID=40&md5=1c4b2fbe6952860975e6fcde00d255c2 VL - 4 ID - 3912 ER - TY - JOUR AD - Department of Pediatrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany Experimental Center of Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany Medical Faculty Carl Gustav Carus, Institute for Medical Informatics and Biometry, TU Dresden, Dresden, Germany Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria AU - Tauer, J. T. AU - Hofbauer, L. C. AU - Jung, R. AU - Gerdes, S. AU - Glauche, I. AU - Erben, R. G. AU - Suttorp, M. C7 - e0131192 DB - Scopus DO - 10.1371/journal.pone.0131192 IS - 6 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 ST - Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats T2 - PLoS ONE TI - Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939193147&doi=10.1371%2fjournal.pone.0131192&partnerID=40&md5=5be351ffe9dba1239f7293f9bdbcaf9d VL - 10 ID - 3915 ER - TY - JOUR AD - Centro de Oncologia e Hematologia Do Hospital Israelita Albert Einstein, São Paulo, Brazil Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), University of Texas MD Anderson Cancer Center, Unit 455, 1400 Holcombe Boulevard, Houston, TX 77030, United States Sarah Cannon Research Institute at HealthONE, Denver, CO, United States Department of Medicine, University of California, San Diego, San Diego, CA, United States AU - Rodrigues, H. V. AU - Ke, D. AU - Lim, J. AU - Stephen, B. AU - Bellido, J. AU - Janku, F. AU - Zinner, R. AU - Tsimberidou, A. AU - Hong, D. AU - Piha-Paul, S. AU - Fu, S. AU - Naing, A. AU - Subbiah, V. AU - Karp, D. AU - Falchook, G. AU - Kurzrock, R. AU - Wheler, J. DB - Scopus DO - 10.1007/s10637-015-0238-2 IS - 3 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 700-709 ST - Phase i combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy T2 - Investigational New Drugs TI - Phase i combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937758561&doi=10.1007%2fs10637-015-0238-2&partnerID=40&md5=9f54315058a922351e430a4e43d20ca7 VL - 33 ID - 3917 ER - TY - JOUR AD - Division of Hematology, Department of Medical Specialties, University Hospital and University of Geneva, Geneva, Switzerland Swiss Group for Clinical Cancer Research, Bern, Switzerland Division of Hematology, Hospices Civils de Lyon, Switzerland Division of Hematology, Hôpital Saint-Louis, University Paris Diderot, Paris, France Division of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Division of Hematology, Institut Universitaire de Cancérologie, Toulouse, France Division of Hematology, Hôpital Haut-Levêque, Pessac, France Division of Hematology, Hôpital Mignot, Versailles, France Division of Hematology, Centre Henri Becquerel, Rouen, France Division of Hematology, Hôpital Pontchailloux, Rennes, France Division of Hematology, Hôpital Henri Mondor, University Paris Est Créteil, Créteil, France Division of Hematology, Hôpital Claude Huriez, Lille, France Division of Hematology, Institut de Cancérologie Lucien-Neuwirth, Saint-Priest-en-Jarez, France Division of Hematology, Hôpital de la Timone, Marseille, France Group for Research on Adult Acute Lymphoblastic Leukemia, Lyon, France Division of Biostatistics, Hôpital Saint-Louis, University Paris Diderot, Paris, France Division of Hematology, Centre Hospitalier Universitaire d'Angers And, INSERM U892, Angers, France AU - Chalandon, Y. AU - Thomas, X. AU - Hayette, S. AU - Cayuela, J. M. AU - Abbal, C. AU - Huguet, F. AU - Raffoux, E. AU - Leguay, T. AU - Rousselot, P. AU - Lepretre, S. AU - Escoffre-Barbe, M. AU - Maury, S. AU - Berthon, C. AU - Tavernier, E. AU - Lambert, J. F. AU - Lafage-Pochitaloff, M. AU - Lhéritier, V. AU - Chevret, S. AU - Ifrah, N. AU - Dombret, H. AU - Group for Research on Adult Acute Lymphoblastic, Leukemia DB - Scopus DO - 10.1182/blood-2015-02-627935 IS - 24 M3 - Article N1 - (GRAALL) Cited By :156 Export Date: 18 November 2020 PY - 2015 SP - 3711-3719 ST - Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia T2 - Blood TI - Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930352842&doi=10.1182%2fblood-2015-02-627935&partnerID=40&md5=103006e9194489b16225131e7c565436 VL - 125 ID - 3918 ER - TY - JOUR AD - Hematology Department of Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran Tehran University of Medical Sciences, Tehran, Iran AU - Ghotaslou, A. AU - Abbasian, S. AU - Ghasemi, A. AU - Nadali, F. DB - Scopus IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 184-190 ST - Analysis of expression of SIRT1 gene in patients with Chronic Myeloid Leukemia Resistant to Imatinib mesylate T2 - Iranian Journal of Blood and Cancer TI - Analysis of expression of SIRT1 gene in patients with Chronic Myeloid Leukemia Resistant to Imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944744507&partnerID=40&md5=62168262e8f3302b0b1c00f1d5044336 VL - 7 ID - 3920 ER - TY - JOUR AD - Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, Cachan, France Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France Division of Allergy and Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States Clinical Hematology Department, Faculty of Medicine and AP-HP Necker-Enfants Malades, Paris Descartes University, Paris, France Imagine Institute, INSERM U1168, CNRS ERL 8654, National Reference Center on Mastocytosis, Paris, France Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria AU - Arock, M. AU - Akin, C. AU - Hermine, O. AU - Valent, P. DB - Scopus DO - 10.1111/ejh.12544 IS - 6 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2015 SP - 474-490 ST - Current treatment options in patients with mastocytosis: Status in 2015 and future perspectives T2 - European Journal of Haematology TI - Current treatment options in patients with mastocytosis: Status in 2015 and future perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929129792&doi=10.1111%2fejh.12544&partnerID=40&md5=4d03861959e483d5cc074aeff06de863 VL - 94 ID - 3921 ER - TY - JOUR AD - J.C.D. Dental College, Sirsa, India Department of Neonatology, Fernandez Hospital, Hyderabad, AP, 500029, India Department of Pediatrics, S.P. Medical College, Bikaner, India AU - Jain, N. AU - Sharma, D. AU - Agrawal, R. AU - Jain, A. DB - Scopus DO - 10.1159/000381806 IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2015 SP - 291-293 ST - A newborn with teratogenic effect of imatinib mesylate: A very rare case report T2 - Medical Principles and Practice TI - A newborn with teratogenic effect of imatinib mesylate: A very rare case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929943564&doi=10.1159%2f000381806&partnerID=40&md5=214bb52ddf68f032b25845756f1d1b04 VL - 24 ID - 3923 ER - TY - JOUR AD - Hematology Branch, NHLBI, NIH, Building 10, Room 7C103, 9000 Rockville Pike, Bethesda, MD 20892, United States AU - Barrett, A. J. AU - Ito, S. DB - Scopus DO - 10.1182/blood-2014-10-567784 IS - 21 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2015 SP - 3230-3235 ST - The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century T2 - Blood TI - The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929999516&doi=10.1182%2fblood-2014-10-567784&partnerID=40&md5=862ab9e94724f0611f80d4842931a2e3 VL - 125 ID - 3924 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan AU - Sasaki, K. AU - Strom, S. S. AU - O'Brien, S. AU - Jabbour, E. AU - Ravandi, F. AU - Konopleva, M. AU - Borthakur, G. AU - Pemmaraju, N. AU - Daver, N. AU - Jain, P. AU - Pierce, S. AU - Kantarjian, H. AU - Cortes, J. E. DB - Scopus DO - 10.1016/S2352-3026(15)00048-4 IS - 5 M3 - Article N1 - Cited By :112 Export Date: 18 November 2020 PY - 2015 SP - e186-e193 ST - Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials T2 - The Lancet Haematology TI - Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029353793&doi=10.1016%2fS2352-3026%2815%2900048-4&partnerID=40&md5=9aba92d53a23f6f6f177f23884afd6b7 VL - 2 ID - 3927 ER - TY - JOUR AD - Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Diagnostic Radiology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Division of Pulmonology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Applied Mathematics, Institute of Statistics, National Chung-Hsing University, Taichung, Taiwan Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan Institute of Genomics and Bioinformatics, National Chung-Hsing University, Taichung, Taiwan Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Pathology, Tzu-Chi Medical Center, Tzu-Chi University, Taipei, Taiwan AU - Chang, J. W. C. AU - Hou, M. M. AU - Hsieh, J. J. AU - Cheung, Y. C. AU - Wang, H. M. AU - Chen, J. S. AU - Wang, C. H. AU - Chen, C. H. AU - Yeh, K. Y. AU - Ou, L. Y. AU - Hsieh, C. H. AU - Wu, H. D. I. AU - Chen, Y. T. AU - Chang, I. C. AU - Huang, S. F. DB - Scopus DO - 10.4103/2319-4170.138320 IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 221-228 ST - Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study T2 - Biomedical Journal TI - Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933513414&doi=10.4103%2f2319-4170.138320&partnerID=40&md5=bb6814a33bd05f78aac8d85e836c45c8 VL - 38 ID - 3928 ER - TY - JOUR AD - State Key Laboratory of Experimental Hematology, Department of Clinical Hematology, Institute of Hematology, Tianjin, China Shanghai Institute of Hematology, Shanghai Ruijin Hospital, Shanghai, China Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Orbassano, Italy Department of Hematology, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang Province, China Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Wuhan Hubei, China Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou Guangdong, China Department of Hematology, Jiangsu Province People's Hospital, Nan-Jing, China Department of Hematology, Nanfang Hospital, Guangzhou Southern Medical University, Guangzhou Guangdong, China Department of Hematology, West China Hospital of Sichuan University, Chengdu Sichuan, China Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China Department of Hematology, Changhai Hospital, Second Military Medical University, Shanghai, China Department of Hematology, Qilu Hospital, Shandong University, Jinan, China Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Beijing Novartis Pharma Company, Limited, Beijing, China Department of Hematology-Oncology, University of Bologna, Bologna, Italy Peking University People's Hospital, Institute of Hematology, Peking University Institute of Hematology, 11 Xizhimen South Street, Beijing, 100044, China AU - Wang, J. AU - Shen, Z. X. AU - Saglio, G. AU - Jin, J. AU - Huang, H. AU - Hu, Y. AU - Du, X. AU - Li, J. AU - Meng, F. AU - Zhu, H. AU - Hu, J. AU - Wang, J. AU - Hou, M. AU - Hertle, S. AU - Menssen, H. D. AU - Ortmann, C. E. AU - Tribouley, C. AU - Yuan, Y. AU - Baccarani, M. AU - Huang, X. DB - Scopus DO - 10.1182/blood-2014-09-601674 IS - 18 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2015 SP - 2771-2778 ST - Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina T2 - Blood TI - Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929494071&doi=10.1182%2fblood-2014-09-601674&partnerID=40&md5=e1f3a7ed847f93a6cd49294e16a29674 VL - 125 ID - 3929 ER - TY - JOUR AD - Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Oncology, No. 111 Dade Road, Guangzhou, Guangdong, 510120, China AU - Yang, X. B. AU - Wu, W. Y. AU - Long, S. Q. AU - Deng, H. AU - Pan, Z. Q. AU - He, W. F. AU - Zhou, Y. S. AU - Liao, G. Y. AU - Li, Q. P. AU - Xiao, S. J. AU - Cai, J. Z. C7 - 146 DB - Scopus DO - 10.1186/s13063-015-0685-2 IS - 1 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2015 ST - Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Study protocol for a randomized controlled trial T2 - Trials TI - Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Study protocol for a randomized controlled trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927523821&doi=10.1186%2fs13063-015-0685-2&partnerID=40&md5=cc6bd2a4d3f268e3d5145e377cc971de VL - 16 ID - 3932 ER - TY - JOUR AD - Department of Dermatology, Division of Pediatric Hematology and Oncology, University Hospital Carl Gustav Carus, Fetscherstraße 74, Dresden, D-01307, Germany Department of Pediatrics, Division of Pediatric Hematology and Oncology, University Hospital Carl Gustav Carus, Dresden, D-01307, Germany AU - Mehlig, L. M. AU - Garve, C. AU - Tauer, J. T. AU - Suttorp, M. AU - Bauer, A. DB - Scopus DO - 10.3892/mmr.2014.3074 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2015 SP - 3143-3147 ST - Inhibitory effects of imatinib on vitamin D3 synthesis in human keratinocytes T2 - Molecular Medicine Reports TI - Inhibitory effects of imatinib on vitamin D3 synthesis in human keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921395708&doi=10.3892%2fmmr.2014.3074&partnerID=40&md5=ceffa00c183f1d859ca845331da2bea7 VL - 11 ID - 3933 ER - TY - JOUR AD - Department of Developmental Neurobiology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, United States Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, United States Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, United States Department of Computational Biology and Bioinformatics, St Jude Children's Research Hospital, Memphis, TN, United States Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States Department of Biological Sciences, University of Memphis, Memphis, TN, United States AU - Eden, C. J. AU - Ju, B. AU - Murugesan, M. AU - Phoenix, T. N. AU - Nimmervoll, B. AU - Tong, Y. AU - Ellison, D. W. AU - Finkelstein, D. AU - Wright, K. AU - Boulos, N. AU - Dapper, J. AU - Thiruvenkatam, R. AU - Lessman, C. A. AU - Taylor, M. R. AU - Gilbertson, R. J. DB - Scopus DO - 10.1038/onc.2014.107 IS - 13 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2015 SP - 1736-1742 ST - Orthotopic models of pediatric brain tumors in zebrafish T2 - Oncogene TI - Orthotopic models of pediatric brain tumors in zebrafish UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898520210&doi=10.1038%2fonc.2014.107&partnerID=40&md5=48b94c64e792b20145ddbcf80ed25464 VL - 34 ID - 3936 ER - TY - JOUR AD - Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden Department of Haematology, Karolinska University Hospital, Stockholm, Sweden Department of Medicine, Karolinska Institutet, Stockholm, Sweden Department of Medical Science and Division of Haematology, University Hospital, Uppsala, Sweden Regional Cancer Centre, Uppsala-Örebro, Sweden Department of Haematology, University Hospital, Linköping, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Haematology, University Hospital, Umeå, Sweden Department of Haematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden AU - Gunnarsson, N. AU - Stenke, L. AU - Höglund, M. AU - Sandin, F. AU - Björkholm, M. AU - Dreimane, A. AU - Lambe, M. AU - Markevärn, B. AU - Olsson-Strömberg, U. AU - Richter, J. AU - Wadenvik, H. AU - Wallvik, J. AU - Själander, A. DB - Scopus DO - 10.1111/bjh.13346 IS - 5 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2015 SP - 683-688 ST - Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era T2 - British Journal of Haematology TI - Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929234796&doi=10.1111%2fbjh.13346&partnerID=40&md5=bb7706fad0b4bde892742c9339e83582 VL - 169 ID - 3944 ER - TY - JOUR AD - Paediatric Haematology Section, Hospital Universitario Virgen Del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, Spain Department of Haematology, Hospital Universitario Virgen Del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, Spain Department of Immunology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain Paediatric Haematology, Department of Haematology, Hospital Vírgen Del Rocío, Av/Manuel Siurot S/N, Sevilla, ES-41013, Spain AU - Molinos-Quintana, A. AU - Aquino, V. AU - Montero, I. AU - Pérez-De Soto, C. AU - García-Lozano, R. AU - Pérez-Simón, J. A. AU - Pérez-Hurtado, J. M. DB - Scopus DO - 10.1159/000371831 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 71-75 ST - Emerging BCR/ABL1 Mutations under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia T2 - Acta Haematologica TI - Emerging BCR/ABL1 Mutations under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928158370&doi=10.1159%2f000371831&partnerID=40&md5=9b0b66c32f3c465a2e0cf81bc820c667 VL - 134 ID - 3945 ER - TY - JOUR AD - Department of Hematology/Oncology, Cook Children's Medical Center, 1500 Cooper Street, Fort Worth, TX 76104, United States Medical Science Liaison-Hematology, Celgene Corporation, Dallas, TX, United States Office of the Chief Quality Officer, Baylor Scott and White Health, Dallas, TX, United States AU - Heym, K. M. AU - Gressett Ussery, S. M. AU - Trinkman, H. AU - Philpot, L. M. DB - Scopus DO - 10.1097/MPH.0000000000000277 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - e111-e113 ST - Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: A predominance of musculoskeletal pain T2 - Journal of Pediatric Hematology/Oncology TI - Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: A predominance of musculoskeletal pain UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924175013&doi=10.1097%2fMPH.0000000000000277&partnerID=40&md5=ae1efa635249000acf6a176585540047 VL - 37 ID - 3946 ER - TY - JOUR AD - Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box#30, Chicago, IL 60611, United States Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Centre d'Investigation Clinique 1402, Institut National de la Santé et de la Recherche Médicale (INSERM), University Hospital of Poitiers, 2 rue de la Milétrie, Poitiers, 86000, France Department of Pediatrics, University Hospital Carl Gustav Carus, Fetscherstrasse 74, Dresden, D-01307, Germany AU - Hijiya, N. AU - Millot, F. AU - Suttorp, M. DB - Scopus DO - 10.1016/j.pcl.2014.09.008 IS - 1 M3 - Review N1 - Cited By :30 Export Date: 18 November 2020 PY - 2015 SP - 107-119 ST - Chronic myeloid leukemia in children: Clinical findings, management, and unanswered questions T2 - Pediatric Clinics of North America TI - Chronic myeloid leukemia in children: Clinical findings, management, and unanswered questions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84915758765&doi=10.1016%2fj.pcl.2014.09.008&partnerID=40&md5=7180062ab7939d562a5f5ecba6bdf61d VL - 62 ID - 3951 ER - TY - JOUR AD - Paediatric Haematology-Oncology Department and ‘Tettamanti’ Research Centre, Milano-Bicocca University, ‘Fondazione MBBM’ San Gerardo Hospital, Monza, Italy AU - Leoni, V. AU - Biondi, A. DB - Scopus DO - 10.3324/haematol.2015.124016 IS - 3 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 SP - 295 ST - Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia T2 - Haematologica TI - Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924664857&doi=10.3324%2fhaematol.2015.124016&partnerID=40&md5=ba63bb0590b3b5e4aa2d76cf15bcfa64 VL - 100 ID - 3952 ER - TY - JOUR AD - Haematology Department, Amiri Hospital, Kuwait City, Kuwait Leukemia Center, Sabah Hospital, Shuwaikh, Kuwait Shuwaikh Residential Center, Kuwait City, Kuwait AU - Al-Jafar, H. A. AU - Al-Mulla, A. AU - Aldallal, S. AU - Buhamad, J. H. AU - Askar, H. DB - Scopus DO - 10.1159/000380905 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 122-127 ST - Successful nilotinib treatment in a child with chronic myeloid leukemia T2 - Case Reports in Oncology TI - Successful nilotinib treatment in a child with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929575858&doi=10.1159%2f000380905&partnerID=40&md5=0f6b2f30eba1ab2c2373f5cadd93bde8 VL - 8 ID - 3954 ER - TY - JOUR AD - Université Pierre et Marie Curie, Paris, France INSERM-UMRs 938, Paris, France Service d’Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France CHRU Hôtel-Dieu, Nantes, France University Hospital Leuven, Leuven, Belgium Hôpital Saint Louis, Paris, France Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy Helsinki University Central Hospital, Finland University of Freiburg Medical Center, Germany Lund University Hospital, Sweden University Hospital Hamburg-Eppendorf, Hamburg, Germany VU University Medical Center, Amsterdam, Netherlands Queen Elizabeth Hospital, Birmingham, United Kingdom CHRU Lille, France Ankara University, Ankara, Turkey Nottingham University Hospital, Nottingham, United Kingdom King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia The Royal Marsden NHS Foundation Trust, London, United Kingdom Chaim Sheba Medical Center, Tel Hasomer, Israel Goethe-University Frankfurt, Germany Erasmus Medical Center–Daniel den Hoed Cancer Center, Rotterdam, Netherlands Hospital Clinic Institut d’investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain AU - Brissot, E. AU - Labopin, M. AU - Beckers, M. M. AU - Socié, G. AU - Rambaldi, A. AU - Volin, L. AU - Finke, J. AU - Lenhoff, S. AU - Kröger, N. AU - Ossenkoppele, G. J. AU - Craddock, C. F. AU - Yakoub-Agha, I. AU - Gürman, G. AU - Russell, N. H. AU - Aljurf, M. AU - Potter, M. N. AU - Nagler, A. AU - Ottmann, O. AU - Cornelissen, J. J. AU - Esteve, J. AU - Mohty, M. DB - Scopus DO - 10.3324/haematol.2014.116954 IS - 3 M3 - Article N1 - Cited By :66 Export Date: 18 November 2020 PY - 2015 SP - 392-399 ST - Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with philadelphia chromosome positive acute lymphoblastic leukemia T2 - Haematologica TI - Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with philadelphia chromosome positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924737371&doi=10.3324%2fhaematol.2014.116954&partnerID=40&md5=3ddfdae987b135819469fbb400de9c27 VL - 100 ID - 3956 ER - TY - JOUR AD - Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, United States AU - Mei, L. AU - Ontiveros, E. P. AU - Griffiths, E. A. AU - Thompson, J. E. AU - Wang, E. S. AU - Wetzler, M. DB - Scopus DO - 10.1016/j.blre.2015.01.001 IS - 4 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2015 SP - 243-249 ST - Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy T2 - Blood Reviews TI - Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937163670&doi=10.1016%2fj.blre.2015.01.001&partnerID=40&md5=008864be70b08417389479b2638ad097 VL - 29 ID - 3957 ER - TY - JOUR AD - Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States AU - Kadia, T. M. AU - Kantarjian, H. M. AU - Thomas, D. A. AU - O'Brien, S. AU - Estrov, Z. AU - Ravandi, F. AU - Jabbour, E. AU - Pemmaraju, N. AU - Daver, N. AU - Wang, X. AU - Jain, P. AU - Pierce, S. AU - Brandt, M. AU - Garcia-Manero, G. AU - Cortes, J. AU - Borthakur, G. DB - Scopus DO - 10.1002/ajh.23886 IS - 2 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2015 SP - 120-124 ST - Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia T2 - American Journal of Hematology TI - Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921405793&doi=10.1002%2fajh.23886&partnerID=40&md5=ebd8355d4c13061c0409980afac9e7b5 VL - 90 ID - 3959 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, NYU Langone Medical Center, 550 First Avenue, New York, NY 10016, United States Departments of Gynecologic and Oncology, New York, United States Departments of Pathology, New York, United States Departments of Pediatric Hematology-Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, New York, United States AU - Conroy, E. M. AU - Frimer, M. AU - Karabakhtsian, R. G. AU - Gorlick, R. AU - Goldberg, G. L. DB - Scopus DO - 10.1097/MPH.0000000000000261 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2015 SP - 63-67 ST - Vulvar fibromatosis: A clinical enigma T2 - Journal of Pediatric Hematology/Oncology TI - Vulvar fibromatosis: A clinical enigma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920595635&doi=10.1097%2fMPH.0000000000000261&partnerID=40&md5=9e63726d8c1ede1d00623b95bf7c54aa VL - 37 ID - 3960 ER - TY - JOUR AD - Department of Oncology, University of Torino Medical School, Torino, Italy Investigative Clinical Oncology (INCO), Fondazione Del Piemonte per l'Oncologia, Candiolo Cancer Institute (IRCCs), Turin, Italy Laboratory of Cell Adhesion Dynamics, University of Torino School of Medicine, Fondazione Del Piemonte per l'Oncologia-Candiolo Cancer Institute (IRCCs), Candiolo, Italy AU - Aversa, C. AU - Leone, F. AU - Zucchini, G. AU - Serini, G. AU - Geuna, E. AU - Milani, A. AU - Valdembri, D. AU - Martinello, R. AU - Montemurro, F. DB - Scopus DO - 10.1586/14737140.2015.1042369 IS - 6 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 677-687 ST - Linifanib: Current status and future potential in cancer therapy T2 - Expert Review of Anticancer Therapy TI - Linifanib: Current status and future potential in cancer therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930451779&doi=10.1586%2f14737140.2015.1042369&partnerID=40&md5=fa9bcd7bb856544c1c230bf09090bc78 VL - 15 ID - 3961 ER - TY - JOUR DB - Scopus IS - 157 M3 - Article N1 - Export Date: 18 November 2020 PY - 2015 SP - 38 ST - Imatinib (GLIVEC°) and acute lymphoblastic leukaemia in children: Prolonged survival in Philadelphia chromosome-positive cases T2 - Prescrire International TI - Imatinib (GLIVEC°) and acute lymphoblastic leukaemia in children: Prolonged survival in Philadelphia chromosome-positive cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922326933&partnerID=40&md5=3254b295132411ece024ae000bff257f VL - 24 ID - 3962 ER - TY - JOUR AD - Division of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Hematology, Singapore General Hospital, Level 3, Academia, 20 College Road, Singapore, 169856, Singapore Department of Hematology-Oncology, National University Cancer Institute, Singapore AU - Ma, L. AU - Hao, S. AU - Diong, C. AU - Goh, Y. T. AU - Gopalakrishnan, S. AU - Ho, A. AU - Hwang, W. AU - Koh, L. P. AU - Koh, M. AU - Lim, Z. Y. AU - Loh, Y. AU - Poon, M. AU - Tan, L. K. AU - Tan, P. AU - Linn, Y. C. DB - Scopus DO - 10.3109/10428194.2014.956318 IS - 5 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2015 SP - 1362-1369 ST - Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: An analysis of Southeast Asian patients T2 - Leukemia and Lymphoma TI - Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: An analysis of Southeast Asian patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84932094704&doi=10.3109%2f10428194.2014.956318&partnerID=40&md5=b388631b12298b1f9196dd370a8e5325 VL - 56 ID - 3963 ER - TY - JOUR AD - Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States AU - Zeidner, J. F. AU - Zahurak, M. AU - Rosner, G. L. AU - Gocke, C. D. AU - Jones, R. J. AU - Smith, B. D. DB - Scopus DO - 10.3109/10428194.2014.910868 IS - 1 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 128-134 ST - The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions? T2 - Leukemia and Lymphoma TI - The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922346751&doi=10.3109%2f10428194.2014.910868&partnerID=40&md5=ae6c75cd393c8eca512b667bb68796ba VL - 56 ID - 3964 ER - TY - JOUR AD - Haematology, Department of Cellular Biotechnologies and Haematology, ‘Sapienza’ University, Rome, Italy Haemato-Oncology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy Clinical Experimental Haematology Unit, Gaslini Research Institute of Genoa, Genoa, Italy Paediatric Haematology Unit, Pausilipon Hospital, Naples, Italy Department of Paediatrics, Paediatric Unit ‘F. Vecchio’, University of Bari, Bari, Italy Division of Haematology, ‘Bianchi-Melacrino-Morelli’ Hospital, Reggio Calabria, Italy Department of Paediatrics, Haemato-Oncology Unit, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy Paediatric Haemato-Oncology Unit, Sant'Anna Hospital, Ferrara, Italy Haemato-Oncology Unit, Azienda Ospedaliera ‘Pugliese-Ciaccio’, Catanzaro, Italy Department of Paediatrics, University of Milano-Bicocca, Monza, Italy Haemato-Oncology Unit, Department of Paediatrics, University of Bologna, Bologna, Italy Department of Paediatrics, University of Pavia, Pavia, Italy Paediatric Haematology-Oncology, IRCCS Ospedale Paediatrico Bambino Gesù, Rome, Italy Biostatistics Unit, GIMEMA Foundation, Rome, Italy Department of Clinical and Biological Sciences, University of Turin at Orbassano, Turin, Italy AU - Giona, F. AU - Putti, M. C. AU - Micalizzi, C. AU - Menna, G. AU - Moleti, M. L. AU - Santoro, N. AU - Iaria, G. AU - Ladogana, S. AU - Burnelli, R. AU - Consarino, C. AU - Varotto, S. AU - Tucci, F. AU - Messina, C. AU - Nanni, M. AU - Diverio, D. AU - Biondi, A. AU - Pession, A. AU - Locatelli, F. AU - Piciocchi, A. AU - Gottardi, E. AU - Saglio, G. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.13453 IS - 3 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 SP - 398-407 ST - Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience T2 - British Journal of Haematology TI - Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942103657&doi=10.1111%2fbjh.13453&partnerID=40&md5=014838c23996a3175fda6ebcbc47dbda VL - 170 ID - 3967 ER - TY - JOUR AD - Universidade de Campinas (Unicamp), Centro de Hematologia e Hemoterapia, Campinas, SP, Brazil AU - Ribeiro, B. F. AU - Miranda, E. C. M. AU - de Albuquerque, D. M. AU - Delamain, M. T. AU - Oliveira-Duarte, G. AU - Almeida, M. H. AU - Vergilio, B. AU - da Silveira, R. A. AU - Oliveira-Duarte, V. AU - Lorand-Metze, I. AU - de Souza, C. A. AU - Pagnano, K. B. B. DB - Scopus DO - 10.6061/clinics/2015(08)04 IS - 8 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2015 SP - 550-555 ST - Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors -a single center experience T2 - Clinics TI - Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors -a single center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938792608&doi=10.6061%2fclinics%2f2015%2808%2904&partnerID=40&md5=93919942245f72d1ab3bafb4beb4d1e4 VL - 70 ID - 3968 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, South Korea AU - Byun, Y. J. AU - Suh, J. K. AU - Lee, S. W. AU - Lee, D. AU - Kim, H. AU - Choi, E. S. AU - Koh, K. N. AU - Im, H. J. AU - Seo, J. J. DB - Scopus DO - 10.5045/br.2015.50.3.147 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 147-153 ST - Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Blood Research TI - Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944029972&doi=10.5045%2fbr.2015.50.3.147&partnerID=40&md5=9ed89f7867e5cb999a712f11fca76026 VL - 50 ID - 3970 ER - TY - JOUR AD - Northwestern Medicine Developmental Therapeutics Institute (NMDTI), Chicago, IL, United States Division of Hematology and Oncology, Robert H. Lurie Medical Research Center, 303 East Superior, Chicago, IL 60611, United States Division of Hepatology and Gastroenterology, Northwestern University, 676 North St Clair, 19th Floor, Chicago, IL 60611, United States AU - Kalyan, A. AU - Nimeiri, H. AU - Kulik, L. DB - Scopus DO - 10.1016/j.cld.2015.01.009 IS - 2 M3 - Review N1 - Cited By :17 Export Date: 18 November 2020 PY - 2015 SP - 421-432 ST - Systemic Therapy of Hepatocellular Carcinoma: Current and Promising T2 - Clinics in Liver Disease TI - Systemic Therapy of Hepatocellular Carcinoma: Current and Promising UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928824816&doi=10.1016%2fj.cld.2015.01.009&partnerID=40&md5=7a5840dbb584f708a619e7b65dc2916c VL - 19 ID - 3971 ER - TY - JOUR AD - Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel AU - Shimoni, A. AU - Volchek, Y. AU - Koren-Michowitz, M. AU - Varda-Bloom, N. AU - Somech, R. AU - Shem-Tov, N. AU - Yerushalmi, R. AU - Nagler, A. DB - Scopus DO - 10.1002/cncr.29141 IS - 6 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2015 SP - 863-871 ST - Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Cancer TI - Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924108845&doi=10.1002%2fcncr.29141&partnerID=40&md5=44561bb1cdce26b8485ed88928a9a50e VL - 121 ID - 3974 ER - TY - JOUR AD - Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States AU - Daver, N. AU - Thomas, D. AU - Ravandi, F. AU - Cortes, J. AU - Garris, R. AU - Jabbour, E. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Kadia, T. AU - Rytting, M. AU - Konopleva, M. AU - Kantarjian, H. AU - O’Brien, S. DB - Scopus DO - 10.3324/haematol.2014.118588 IS - 5 M3 - Article N1 - Cited By :91 Export Date: 18 November 2020 PY - 2015 SP - 653-661 ST - Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic Leukemia T2 - Haematologica TI - Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929148590&doi=10.3324%2fhaematol.2014.118588&partnerID=40&md5=0018803f94aeaac06e13dcf6a50ed89d VL - 100 ID - 3976 ER - TY - JOUR AD - AVEO Oncology, Cambridge, MA, United States Covance, Madison, WI, United States Covance, Daytona, FL, United States Alnylam Pharmaceuticals, Cambridge, MA, United States AU - Cotreau, M. M. AU - Siebers, N. M. AU - Miller, J. AU - Strahs, A. L. AU - Slichenmyer, W. DB - Scopus DO - 10.1002/cpdd.145 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2015 SP - 137-142 ST - Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor T2 - Clinical Pharmacology in Drug Development TI - Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924935950&doi=10.1002%2fcpdd.145&partnerID=40&md5=656e0a617bac680b9c7ff0c9bc870623 VL - 4 ID - 3980 ER - TY - JOUR AD - Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, United States Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, United States Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States Division of Experimental Medicine, Department of Medicine, Hematology Research Centre, Imperial College of London, London, United Kingdom Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, United States Department of Hematology/Oncology, All Children's Hospital, St Petersburg, FL, United States University Hospitals Bristol NHS Trust, Bristol, United Kingdom Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States Division of Hematology Oncology, UMass Memorial Medical Center, Worcester, MA, United States Department of Hematology, University Hospital, Grenoble, France Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, United States Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States Divison of Hematology, Academische Ziekenhuis Maastricht, Maastricht, Netherlands Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, United States Department of Hematology, Mayo Clinic, Rochester, MN, United States Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia Department of Medical Oncology, Weill Cornell Medical College, New York, NY, United States Ottawa Hospital Research Institute, Ottawa, ON, Canada Department of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Parkville, VIC, Australia Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Division of Cancer Medicine, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR, United States AU - Copelan, E. A. AU - Avalos, B. R. AU - Ahn, K. W. AU - Zhu, X. AU - Gale, R. P. AU - Grunwald, M. R. AU - Hamadani, M. AU - Hamilton, B. K. AU - Hale, G. A. AU - Marks, D. I. AU - Waller, E. K. AU - Savani, B. N. AU - Costa, L. J. AU - Ramanathan, M. AU - Cahn, J. Y. AU - Khoury, H. J. AU - Weisdorf, D. J. AU - Inamoto, Y. AU - Kamble, R. T. AU - Schouten, H. C. AU - Wirk, B. AU - Litzow, M. R. AU - Aljurf, M. D. AU - van Besien, K. W. AU - Ustun, C. AU - Bolwell, B. J. AU - Bredeson, C. N. AU - Fasan, O. AU - Ghosh, N. AU - Horowitz, M. M. AU - Arora, M. AU - Szer, J. AU - Loren, A. W. AU - Alyea, E. P. AU - Cortes, J. AU - Maziarz, R. T. AU - Kalaycio, M. E. AU - Saber, W. DB - Scopus DO - 10.1016/j.bbmt.2014.12.010 IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 552-558 ST - Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation T2 - Biology of Blood and Marrow Transplantation TI - Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922826985&doi=10.1016%2fj.bbmt.2014.12.010&partnerID=40&md5=e0a631558a31a38b173202a1aaf21b98 VL - 21 ID - 3981 ER - TY - JOUR AD - Department of Gastroenterology, First Affiliated Hospital, Zhejiang University, No. 79 Qing Chun Road, Hangzhou, Zhejiang Province, 310003, China AU - Wang, Y. M. AU - Gu, M. L. AU - Ji, F. DB - Scopus DO - 10.3748/wjg.v21.i8.2303 IS - 8 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 SP - 2303-2314 ST - Succinate dehydrogenase-deficient gastrointestinal stromal tumors T2 - World Journal of Gastroenterology TI - Succinate dehydrogenase-deficient gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923827409&doi=10.3748%2fwjg.v21.i8.2303&partnerID=40&md5=fdbf1cf78eadc820cb01c8f08d2f7410 VL - 21 ID - 3983 ER - TY - JOUR DB - Scopus DO - 10.1016/j.bbmt.2014.09.012 IS - 1 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 184-189 ST - Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation T2 - Biology of Blood and Marrow Transplantation TI - Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927127674&doi=10.1016%2fj.bbmt.2014.09.012&partnerID=40&md5=41db58e65d6c8f4a22296197d13bf715 VL - 21 ID - 3987 ER - TY - JOUR AU - Pavkovic, M. AU - Angelkovic, R. AU - Popova-Simjanovska, M. AU - Genadieva-Stavric, S. AU - Cevreska, L. AU - Stojanovic, A. DB - Scopus DO - 10.1515/prilozi-2015-0065 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 179-186 ST - Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre Experience T2 - Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) TI - Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984848175&doi=10.1515%2fprilozi-2015-0065&partnerID=40&md5=55781e4a7325a9edd73ddbf36067319a VL - 36 ID - 3988 ER - TY - JOUR AD - Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, 226-3, Chile Laboratory for Diagnostic Genome Analysis, Department of Clinical Genetics, Leiden University Medical Center, ZA Leiden, 2333, Netherlands Department of Genetics, Erasmus MC, CE Rotterdam, 3015, Netherlands Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Pediatrics Division, Faculty of Medicine, Pontificia Universidad Catolica de Chile Santiago, Santiago, 340, Chile Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Institute of Human Development, University of Manchester and Manchester Academic Health Sciences Centre, Manchester, M13 9PL, United Kingdom Department of Pediatrics, Leiden University Medical Center, ZA Leiden, 2333, Netherlands AU - De Bruin, C. AU - Mericq, V. AU - Andrew, S. F. AU - Van Duyvenvoorde, H. A. AU - Verkaik, N. S. AU - Losekoot, M. AU - Porollo, A. AU - Garcia, H. AU - Kuang, Y. AU - Hanson, D. AU - Clayton, P. AU - Van Gent, D. C. AU - Wit, J. M. AU - Hwa, V. AU - Dauber, A. DB - Scopus DO - 10.1210/jc.2015-1098 IS - 5 M3 - Article N1 - Cited By :33 Export Date: 18 November 2020 PY - 2015 SP - E789-E798 ST - An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome T2 - Journal of Clinical Endocrinology and Metabolism TI - An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929359433&doi=10.1210%2fjc.2015-1098&partnerID=40&md5=e5884a550ed85cb0cd8384ab8a57385a VL - 100 ID - 3990 ER - TY - JOUR AD - Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden Department of Clinical Genetics, University and Regional Laboratories, Region Skåne, Lund, Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden Department of Pediatrics, Linköping University Hospital, Linköping, Sweden Department of Pediatrics, Skåne University Hospital, Lund University, Lund, Sweden Division of Hematology, Skåne University Hospital, Lund University, Lund, Sweden AU - Safavi, S. AU - Olsson, L. AU - Biloglav, A. AU - Veerla, S. AU - Blendberg, M. AU - Tayebwa, J. AU - Behrendtz, M. AU - Castor, A. AU - Hansson, M. AU - Johansson, B. AU - Paulsson, K. DB - Scopus DO - 10.18632/oncotarget.6000 IS - 40 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2015 SP - 42793-42802 ST - Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia T2 - Oncotarget TI - Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952319620&doi=10.18632%2foncotarget.6000&partnerID=40&md5=8d0b32584af9916c82b333dd4be5af20 VL - 6 ID - 3994 ER - TY - JOUR AD - ARIAD Pharmaceuticals, Inc., Cambridge, MA, United States Sonnichsen Pharmaceutical Associates, Collegeville, PA, United States AU - Narasimhan, N. I. AU - Dorer, D. J. AU - Davis, J. AU - Turner, C. D. AU - Sonnichsen, D. DB - Scopus DO - 10.1002/cpdd.182 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2015 SP - 354-360 ST - Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects T2 - Clinical Pharmacology in Drug Development TI - Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942193676&doi=10.1002%2fcpdd.182&partnerID=40&md5=542b81b6032899d4c65dc35cb2a44075 VL - 4 ID - 3995 ER - TY - JOUR AD - Samsung Genome Institute, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul, 135-710, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea Department of Internal Medicine, Eulji University School of Medicine, Eulji General Hospital, Seoul, South Korea Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea AU - Park, G. AU - Kim, T. H. AU - Lee, H. O. AU - Lim, J. A. AU - Won, J. K. AU - Min, H. S. AU - Lee, K. E. AU - Park, D. J. AU - Park, Y. J. AU - Park, W. Y. DB - Scopus DO - 10.1530/ERC-14-0467 IS - 1 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 55-63 ST - Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer T2 - Endocrine-Related Cancer TI - Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923637478&doi=10.1530%2fERC-14-0467&partnerID=40&md5=b1f353e9b0808ce197f54921914562ca VL - 22 ID - 3999 ER - TY - JOUR AD - Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, 231 Albert Sabin Way, PO Box 670575, Cincinnati, OH 45267-0575, United States AU - Cookman, C. J. AU - Belcher, S. M. DB - Scopus DO - 10.1210/en.2015-1141 IS - 7 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2015 SP - 2395-2408 ST - Estrogen receptor-β up-regulates IGF1R expression and activity to inhibit apoptosis and increase growth of medulloblastoma T2 - Endocrinology TI - Estrogen receptor-β up-regulates IGF1R expression and activity to inhibit apoptosis and increase growth of medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937605783&doi=10.1210%2fen.2015-1141&partnerID=40&md5=7bf6b68097c9d02f3ce3c6d87100845e VL - 156 ID - 4002 ER - TY - JOUR AD - Department of Conservative Dentistry, Dental Research Institute and School of Dentistry, Seoul National University, Jongno-gu, Yeongun-dong 275-1, Seoul, 110-749, South Korea Department of Family Medicine, Eulji University School of Medicine, Joong-gu, Yongdu-dong 143-5, Daejeon, South Korea School of Dentistry, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, United States AU - Ko, Y. J. AU - Kwon, K. Y. AU - Kum, K. Y. AU - Lee, W. C. AU - Baek, S. H. AU - Kang, M. K. AU - Shon, W. J. C7 - 385127 DB - Scopus DO - 10.1155/2015/385127 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 ST - The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells T2 - Mediators of Inflammation TI - The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947440683&doi=10.1155%2f2015%2f385127&partnerID=40&md5=b19dc2154cd0facd3fe42140b0116cb2 VL - 2015 ID - 4004 ER - TY - JOUR AD - Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Medical Oncology, University of Texas, Southwestern Dallas, TX, United States Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Jain, P. AU - Kantarjian, H. AU - Alattar, M. L. AU - Jabbour, E. AU - Sasaki, K. AU - Gonzalez, G. N. AU - Dellasala, S. AU - Pierce, S. AU - Verstovsek, S. AU - Wierda, W. AU - Borthakur, G. AU - Ravandi, F. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.1016/S2352-3026(15)00021-6 IS - 3 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2015 SP - e118-e128 ST - Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: Retrospective analysis of patient data from five clinical trials T2 - The Lancet Haematology TI - Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: Retrospective analysis of patient data from five clinical trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940550022&doi=10.1016%2fS2352-3026%2815%2900021-6&partnerID=40&md5=757a7d5d39ccb7219fdcddfae0ba8ed9 VL - 2 ID - 4007 ER - TY - JOUR AD - Laboratory of Bone and Metabolic Biochemistry, Faculty of Medicine, Université Libre de Bruxelles, Unité Mixte de Recherche en Santé Unité 1166, 808 Route de Lennik, Brussels, B-1070, Belgium Institute of Life Sciences, Université Catholique de Louvain, Louvain-la-Neuve, 1348, Belgium Department of Rheumatology and Physical Medicine, Erasme Hospital, Brussels, B-1070, Belgium AU - Gillet, C. AU - Spruyt, D. AU - Rigutto, S. AU - Dalla Valle, A. AU - Berlier, J. AU - Louis, C. AU - Debier, C. AU - Gaspard, N. AU - Malaisse, W. J. AU - Gangji, V. AU - Rasschaert, J. DB - Scopus DO - 10.1210/en.2015-1303 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2015 SP - 4081-4093 ST - Oleate abrogates palmitate-induced lipotoxicity and proinflammatory response in human bone marrow-derived mesenchymal stem cells and osteoblastic cells T2 - Endocrinology TI - Oleate abrogates palmitate-induced lipotoxicity and proinflammatory response in human bone marrow-derived mesenchymal stem cells and osteoblastic cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946029992&doi=10.1210%2fen.2015-1303&partnerID=40&md5=179a452d9da6482b385338bd0d5280ec VL - 156 ID - 4009 ER - TY - JOUR AD - Blood Diseases Institute, Xuzhou Medical College, No. 84 West Huaihai Road, Xuzhou, Jiangsu 221002, China Key Laboratory of Bone Marrow Stem Cell, No. 84 West Huaihai Road, Xuzhou, Jiangsu Province 221002, China Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, No. 99 West Huaihai Road, Xuzhou, Jiangsu Province 221002, China AU - Zhao, K. AU - Yin, L. L. AU - Zhao, D. M. AU - Pan, B. AU - Chen, W. AU - Cao, J. AU - Cheng, H. AU - Li, Z. Y. AU - Li, D. P. AU - Sang, W. AU - Zeng, L. Y. AU - Xu, K. L. DB - Scopus IS - 12 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2014 SP - 4787-4798 ST - IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients T2 - International Journal of Clinical and Experimental Medicine TI - IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921484619&partnerID=40&md5=3854df31f22ad04d92d79fa2a5c20adb VL - 7 ID - 4010 ER - TY - JOUR AD - Centre Léon Bérard, 28 rue Laennec 69 373, LYON CEDEX, 08, France Université Claude Bernard Lyon 1, Lyon, France Institut Gustave Roussy, Villejuif, France Centre Oscar Lambret, Lille, France Institut Claudius Regaud, Toulouse, France Centre Jean Perrin, Clermont-Ferrand, France CHU Estaing, Clermont-Ferrand, France Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France Institut régional du Cancer, Montpellier, France CHU La Timone, Marseille, France Institut Curie, Paris, France Centre René Gauducheau, Nantes, France Centre Antoine Lacassagne, Nice, France CHU Jean Minjoz, Besançon, France Institut Paoli-Calmettes, Marseille, France AU - Eberst, L. AU - Cropet, C. AU - Le Cesne, A. AU - Pautier, P. AU - Penel, N. AU - Adenis, A. AU - Chevreau, C. AU - Bay, J. O. AU - Collard, O. AU - Cupissol, D. AU - Duffaud, F. AU - Gentet, J. C. AU - Piperno-Neumann, S. AU - Marec-Berard, P. AU - Bompas, E. AU - Thyss, A. AU - Chaigneau, L. AU - Cassier, P. AU - Bertucci, F. AU - Blay, J. Y. AU - Ray-Coquard, I. C7 - 870 DB - Scopus DO - 10.1186/1471-2407-14-870 IS - 1 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 ST - The off-label use of targeted therapies in sarcomas: The OUTC'S program T2 - BMC Cancer TI - The off-label use of targeted therapies in sarcomas: The OUTC'S program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924345871&doi=10.1186%2f1471-2407-14-870&partnerID=40&md5=31c8ae026784a9ddee461d2fa8d13b17 VL - 14 ID - 4011 ER - TY - JOUR AD - Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni, 56, Rozzano, Milano, 20089, Italy Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy Istituto Superiore di Sanità, Roma, Italy San Raffaele Institute, Sulmona, Italy Human Tumors Immunobiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Hematology and BMT Unit, University of Brescia, Brescia, Italy Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Division of Hematology, S. Croce and Carle Hospital, Cuneo, Italy Hematology and BMT Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Biostatistic Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy Hematology, University of Milano, Milano, Italy AU - Guidetti, A. AU - Carlo-Stella, C. AU - Locatelli, S. L. AU - Malorni, W. AU - Mortarini, R. AU - Viviani, S. AU - Russo, D. AU - Marchianò, A. AU - Sorasio, R. AU - Dodero, A. AU - Farina, L. AU - Giordano, L. AU - Di Nicola, M. AU - Anichini, A. AU - Corradini, P. AU - Gianni, A. M. DB - Scopus DO - 10.1158/1078-0432.CCR-14-0770 IS - 22 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2014 SP - 5641-5651 ST - Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases T2 - Clinical Cancer Research TI - Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918509201&doi=10.1158%2f1078-0432.CCR-14-0770&partnerID=40&md5=1c3af8c9c1b2c9269d9438bf205df7e7 VL - 20 ID - 4013 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Traverwood 2, Suite C, 2910 Huron Parkway, Ann Arbor, MI 48105-3450, United States Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States AU - Brown, N. A. AU - Rolland, D. AU - McHugh, J. B. AU - Weigelin, H. C. AU - Zhao, L. AU - Lim, M. S. AU - Elenitoba-Johnson, K. S. J. AU - Betz, B. L. DB - Scopus DO - 10.1158/1078-0432.CCR-14-1069 IS - 21 M3 - Article N1 - Cited By :99 Export Date: 18 November 2020 PY - 2014 SP - 5517-5526 ST - Activating FGFR2-RAS-BRAF mutations in ameloblastoma T2 - Clinical Cancer Research TI - Activating FGFR2-RAS-BRAF mutations in ameloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84909591990&doi=10.1158%2f1078-0432.CCR-14-1069&partnerID=40&md5=a60f8bce0c094d5d0d693865a5e26b98 VL - 20 ID - 4018 ER - TY - JOUR AD - Paediatrics Department, Saint Mary Hospital, London, United Kingdom Department of Paediatric Haematology, Hopital Robert Debré, Paris, France M. Tettamanti Research Centre, Paediatrics Department, University of Milano-Bicocca, Monza, Italy Department of Paediatric Oncology, Beatrix Children's Hospital, Groningen, Netherlands Department of Paediatric Haematology-Oncology, CHR La Citadelle, Liège, Belgium Department of Paediatric Haematology and Oncology, University Hospital, Technical University Dresden, Dresden, Germany Department of Paediatric Oncology, CHU Poitiers, Poitiers, France AU - de la Fuente, J. AU - Baruchel, A. AU - Biondi, A. AU - de Bont, E. AU - Dresse, M. F. AU - Suttorp, M. AU - Millot, F. AU - International, B. F. M. Group Study Group Chronic Myeloid Leukaemia Committee DB - Scopus DO - 10.1111/bjh.12977 IS - 1 M3 - Article N1 - (iBFM) Cited By :54 Export Date: 18 November 2020 PY - 2014 SP - 33-47 ST - Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years T2 - British Journal of Haematology TI - Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84909980867&doi=10.1111%2fbjh.12977&partnerID=40&md5=3bc0b1f113e0b4bca043b87d79f7fa7d VL - 167 ID - 4020 ER - TY - JOUR AD - Department of Health Sciences, University of Milano-Bicocca, via Cadore 48, Monza, Italy San Gerardo Hospital, Clinical Research Unit, Monza, Italy AU - Viganò, I. AU - Di Giacomo, N. AU - Bozzani, S. AU - Antolini, L. AU - Piazza, R. AU - Gambacorti Passerini, C. DB - Scopus DO - 10.1002/ajh.23804 IS - 10 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2014 SP - E184-E187 ST - First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis T2 - American Journal of Hematology TI - First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908054155&doi=10.1002%2fajh.23804&partnerID=40&md5=c06ff242abf6f5795e7097800d49f93e VL - 89 ID - 4021 ER - TY - JOUR AD - Armed Forces Medical College, Pune, 411040, India Army Hospital (R and R), Delhi Cantt, 110010, India Maulana Azad Medical College, New Delhi, 110002, India PGIMER, Chandigarh, India AFMS, O/o DGAFMS, Ministry of Defence, New Delhi, India Dept of Community Medicine, Army College of Medical Sciences, New Delhi, 11001, India AU - Nair, V. AU - Sharma, A. AU - Kotwal, J. AU - Bhikshapathy, M. AU - Mishra, D. K. AU - Das, S. AU - Sharma, S. AU - Kapoor, R. AU - Singh, J. AU - Nair, V. AU - Uday, Y. AU - Kotwal, A. AU - Kotwal, A. DB - Scopus DO - 10.1016/j.mjafi.2014.07.005 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 315-320 ST - Monitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP) T2 - Medical Journal Armed Forces India TI - Monitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908505977&doi=10.1016%2fj.mjafi.2014.07.005&partnerID=40&md5=a9a5b6cb90d4058bc6b174174fc7b51d VL - 70 ID - 4022 ER - TY - JOUR AD - III. Medizinische Klinik - Hämatologie und Onkologie, Universitätsmedizin Mannheim, Germany Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie der Ludwig-Maximilians, Universität München, Germany MLL Münchner Leukämielabor, München, Germany Medizinische Klinik 5, Universitätsklinikum Erlangen, Germany Klinik für Hämatologie, Onkologie und Palliativmedizin, Evangelisches Krankenhaus Hamm, Germany Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Germany Klinik für Innere Medizin III, Klinikum Chemnitz, Germany Medizinische Universitätsklinik, Abteilung Innere Medizin V, Ruprecht-Karls-Universität Heidelberg, Germany Medizinische Klinik 5, Klinikum Nürnberg Nord, Germany Medizinische Klinik II, Universitätsklinikum Tübingen, Germany Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Marburg, Germany II. Medizinische Klinik und Poliklinik im Städtischen Krankenhaus, Universitätsklinikum Schleswig-Holstein, Kiel, Germany Klinik für Innere Medizin III, Universitätsklinikum Ulm, Germany Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany Klinik für Innere Medizin I, Universitätsklinikum Freiburg, Germany Medizinische Klinik und Poliklinik III, Ludwig-Maximilians-Universität München, Germany Universitätsklinik für Hämatologie, Inselspital Bern, Switzerland Abteilung für Hämatologie und Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Germany AU - Hanfstein, B. AU - Lauseker, M. AU - Hehlmann, R. AU - Saussele, S. AU - Erben, P. AU - Dietz, C. AU - Fabarius, A. AU - Proetel, U. AU - Schnittger, S. AU - Haferlach, C. AU - Krause, S. W. AU - Schubert, J. AU - Einsele, H. AU - Hänel, M. AU - Dengler, J. AU - Falge, C. AU - Kanz, L. AU - Neubauer, A. AU - Kneba, M. AU - Stegelmann, F. AU - Pfreundschuh, M. AU - Waller, C. F. AU - Spiekermann, K. AU - Baerlocher, G. M. AU - Pfirrmann, M. AU - Hasford, J. AU - Hofmann, W. K. AU - Hochhaus, A. AU - Müller, M. C. DB - Scopus DO - 10.3324/haematol.2013.096537 IS - 9 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2014 SP - 1441-1447 ST - Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib T2 - Haematologica TI - Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907371261&doi=10.3324%2fhaematol.2013.096537&partnerID=40&md5=91a6886316843ab1a4dd63df811c3859 VL - 99 ID - 4024 ER - TY - JOUR AD - John D. Dingell VA Medical Center, Wayne State University, Detroit, MI, United States Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States Oncology Department, Wayne State University, Detroit, MI, United States Pathology Department, Wayne State University, Detroit, MI, United States Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia College of Pharmacy and Pharmaceutical Sciences, Florida A and M University, Tallahassee, FL, United States AU - Muthu, M. AU - Cheriyan, V. T. AU - Munie, S. AU - Levi, E. AU - Frank, J. AU - Ashour, A. E. AU - Singh, M. AU - Rishi, A. K. C7 - e102567 DB - Scopus DO - 10.1371/journal.pone.0102567 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 ST - Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics T2 - PLoS ONE TI - Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904463200&doi=10.1371%2fjournal.pone.0102567&partnerID=40&md5=30a562969f8ce269c06d8eee4247af1f VL - 9 ID - 4029 ER - TY - JOUR AD - General and Esophageal Surgery Clinic, "Sf. Maria" Hospital, Bucharest Department of Anatomopathology, "Sf. Maria" Hospital, Bucharest Department of Oncology, "Sf. Maria" Hospital, Bucharest AU - Gheorghe, M. AU - Predescu, D. AU - Iosif, C. AU - Ardeleanu, C. AU - Băcanu, F. AU - Constantinoiu, S. DB - Scopus IS - 2 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 139-149 ST - Clinical and therapeutic considerations of GIST T2 - Journal of medicine and life TI - Clinical and therapeutic considerations of GIST UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930884349&partnerID=40&md5=1f34dfff5efd86f45451f943e62e8028 VL - 7 ID - 4031 ER - TY - JOUR AD - Department of Microbiology, National University of Singapore, Singapore, Singapore Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore Infectious Diseases, Genome Institute of Singapore, Singapore, Singapore Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden Gut Microbiology, Danone Nutricia Research, Singapore, Singapore AU - Wang, S. AU - Hibberd, M. L. AU - Pettersson, S. AU - Lee, Y. K. C7 - e97523 DB - Scopus DO - 10.1371/journal.pone.0097523 IS - 5 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2014 ST - Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways T2 - PLoS ONE TI - Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901375209&doi=10.1371%2fjournal.pone.0097523&partnerID=40&md5=d3fa2b734260b95584c06f3813284895 VL - 9 ID - 4033 ER - TY - JOUR AD - Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku. Kyoto, Japan AU - Marumo, S. AU - Hoshino, Y. AU - Kiyokawa, H. AU - Tanabe, N. AU - Sato, A. AU - Ogawa, E. AU - Muro, S. AU - Hirai, T. AU - Mishima, M. C7 - 79 DB - Scopus DO - 10.1186/1471-2466-14-79 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2014 ST - P38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice T2 - BMC Pulmonary Medicine TI - P38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900846903&doi=10.1186%2f1471-2466-14-79&partnerID=40&md5=38ccab33324f5c382b8adff786ed2581 VL - 14 ID - 4034 ER - TY - JOUR AD - Children's Healthcare of Atlanta, United States AU - Bunting, S. T. AU - Lew, G. DB - Scopus DO - 10.1182/blood-2014-01-547513 IS - 16 M3 - Article N1 - Export Date: 18 November 2020 PY - 2014 SP - 2448 ST - "Russell-like" bodies in Philadelphia chromosome-positive B-lymphoblastic leukemia T2 - Blood TI - "Russell-like" bodies in Philadelphia chromosome-positive B-lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899063302&doi=10.1182%2fblood-2014-01-547513&partnerID=40&md5=39b76d565a6aa29d95ca92812d45e285 VL - 123 ID - 4035 ER - TY - JOUR AD - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China Shanghai Allist Pharmaceuticals, Shanghai, China AU - Zhang, J. AU - Cao, J. AU - Li, J. AU - Zhang, Y. AU - Chen, Z. AU - Peng, W. AU - Sun, S. AU - Zhao, N. AU - Wang, J. AU - Zhong, D. AU - Zhang, X. AU - Zhang, J. C7 - 22 DB - Scopus DO - 10.1186/1756-8722-7-22 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2014 ST - A phase i study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors T2 - Journal of Hematology and Oncology TI - A phase i study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907444509&doi=10.1186%2f1756-8722-7-22&partnerID=40&md5=7eb29c29dabe80f666c0694c402d4946 VL - 7 ID - 4036 ER - TY - JOUR AD - Department of Hematology, Xiang Ya Hospital, Central South University, Changsha, Hunan, China Department of Hematology, West China Hospital, Si Chuan University, Chengdu, Sichuan, China AU - Huang, F. F. AU - Zhang, L. AU - Wu, D. S. AU - Yuan, X. Y. AU - Chen, F. P. AU - Zeng, H. AU - Yu, Y. H. AU - Zhao, X. L. C7 - e88298 DB - Scopus DO - 10.1371/journal.pone.0088298 IS - 3 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2014 ST - PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia T2 - PLoS ONE TI - PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897406427&doi=10.1371%2fjournal.pone.0088298&partnerID=40&md5=3fbc437f682668f36461155a87f4ed86 VL - 9 ID - 4037 ER - TY - JOUR AD - Texas Scottish Rite Hospital for Children, 2222 Welborn Street, Dallas, TX 75219, United States Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States Department of Pathology, Division of Biological Sciences, University of California San Diego, San Diego, CA, United States Department of Biochemistry, Rush University Medical Center, Chicago, IL, United States Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States AU - Kim, H. K. W. AU - Feng, G. S. AU - Chen, D. AU - King, P. D. AU - Kamiya, N. DB - Scopus DO - 10.1002/jbmr.2062 IS - 3 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2014 SP - 761-769 ST - Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions T2 - Journal of Bone and Mineral Research TI - Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888875580&doi=10.1002%2fjbmr.2062&partnerID=40&md5=44254d2bc5e53f9008e980a3c87107bc VL - 29 ID - 4041 ER - TY - JOUR AD - Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Seoul St. Mary's Hospital, Seoul, South Korea Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Hematology, Oncology, and Stem Cell Transplantation, Universitätsklinikum Aachen, Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen, Germany Hematology, Oncology, and Stem Cell Transplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy Bone Marrow Transplant Unit, Royal Brisbane Hospital, Herston, Australia Oncology Clinical Statistics, Pfizer Inc., Cambridge, MA, United States Oncology Clinical Research, Pfizer Inc., Cambridge, MA, United States Oncology Clinical Development, Pfizer Inc., Cambridge, MA, United States Pfizer Global Research and Development, Paris, France Clinical Research Unit, University of Milano-Bicocca, Monza, Italy AU - Kantarjian, H. M. AU - Cortes, J. E. AU - Kim, D. W. AU - Khoury, H. J. AU - Brümmendorf, T. H. AU - Porkka, K. AU - Martinelli, G. AU - Durrant, S. AU - Leip, E. AU - Kelly, V. AU - Turnbull, K. AU - Besson, N. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1182/blood-2013-07-513937 IS - 9 M3 - Article N1 - Cited By :83 Export Date: 18 November 2020 PY - 2014 SP - 1309-1318 ST - Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors T2 - Blood TI - Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896622957&doi=10.1182%2fblood-2013-07-513937&partnerID=40&md5=98214c9aa1686f424d0576d4e7f93136 VL - 123 ID - 4042 ER - TY - JOUR AD - Division of Hepatology, Department of Internal Medicine, Dankook University College of Medicine, 16-5 Anseo-dong, Cheonan 330-715, Chungnam, South Korea Department of Internal Medicine, Hallym University Sacred Heart Hospital, 896 Pyeongchon-dong, Anyang 431-070, Gyeonggi-do, South Korea AU - Kang, H. Y. AU - Moon, S. H. AU - Song, I. H. C7 - 72 DB - Scopus DO - 10.1186/1752-1947-8-72 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 ST - A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: A case report T2 - Journal of Medical Case Reports TI - A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895927542&doi=10.1186%2f1752-1947-8-72&partnerID=40&md5=8d1b9e79b49f2d09cfda76a56ea39b6d VL - 8 ID - 4043 ER - TY - JOUR AD - Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan Department of Thoracic Surgery, Itami City Hospital, Koyaike 1-100, Itami 664-8540, Japan Second Department of Surgery, University of Occupational and Environmental Health, Iseigaoka 1-1, Kitakyusyu 807-8555, Japan Department of Genetic Disease Research, Graduate School of Medicine, Osaka City University, Asahimachi 1-5-7, Osaka 545-8586, Japan Department of Pathology, National Institute of Cancer Research and Hospital (NICRH), Mohakhali, Dhaka 1212, Bangladesh Department of Thoracic Surgery, National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali Dhaka, Bangladesh AU - Rahman, S. AU - Kondo, N. AU - Yoneda, K. AU - Takuwa, T. AU - Hashimoto, M. AU - Orui, H. AU - Okumura, Y. AU - Tanaka, F. AU - Kumamoto, K. AU - Mostafa, M. G. AU - Chowdhury, G. M. A. AU - Haque, A. AU - Hasegawa, S. DB - Scopus DO - 10.1007/s10147-012-0515-4 IS - 1 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 45-49 ST - Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung T2 - International Journal of Clinical Oncology TI - Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894515014&doi=10.1007%2fs10147-012-0515-4&partnerID=40&md5=12551ee55d0bbcdfdc09d80f9b1041d5 VL - 19 ID - 4044 ER - TY - JOUR AD - Department of Radiation Oncology, Hacettepe University, Ankara, 06100, Turkey AU - Zorlu, F. AU - Gultekin, M. AU - Cengiz, M. AU - Yildiz, F. AU - Akyol, F. AU - Gurkaynak, M. AU - Ozyigit, G. DB - Scopus DO - 10.7785/tcrt.2012.500354 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 11-19 ST - Fractionated stereotactic radiosurgery treatment results for skull base chordomas T2 - Technology in Cancer Research and Treatment TI - Fractionated stereotactic radiosurgery treatment results for skull base chordomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892751802&doi=10.7785%2ftcrt.2012.500354&partnerID=40&md5=a88bfe2d6f39a5a8fb0935865d15ba09 VL - 13 ID - 4045 ER - TY - JOUR AD - Department of Pathology, Maastricht University Medical Center, Postbus 5800, NL-6202 AZ Maastricht, Netherlands Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands Department of Pathology, VieCuri Medical Center, Venlo, Netherlands AU - Koopmans, S. M. AU - Schouten, H. C. AU - Van Marion, A. M. W. DB - Scopus DO - 10.1159/000356187 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 60-68 ST - Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia T2 - Pathobiology TI - Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896716107&doi=10.1159%2f000356187&partnerID=40&md5=caf7198546c0e66c7c9166684271d8e4 VL - 81 ID - 4047 ER - TY - JOUR AD - University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Houston, TX 77030, United States University of Torino, Ospedale San Luigi Gonzaga, Orbassano-Torino, Italy Hospital de la Princesa, Madrid, Spain University of California, San Francisco School of Medicine, San Francisco, CA, United States Department of Clinical Hematology, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain Singapore General Hospital, Duke-National University of Singapore, Graduate Medical School, Singapore, Singapore Fundación Para Combatir la Leucemia, Angelica Ocampo Hospitalization and Clinical Research Center, Buenos Aires, Argentina University Hospital Brno, Central European Institute of Technology, Masaryk University, Brno, Czech Republic University of Bologna, Bologna, Italy Catholic University of Korea, Seoul, South Korea Bristol-Myers Squibb, Wallingford, CT, United States Bristol-Myers Squibb, Princeton, NJ, United States Universitätsklinikum Jena, Jena, Germany AU - Jabbour, E. AU - Kantarjian, H. M. AU - Saglio, G. AU - Steegmann, J. L. AU - Shah, N. P. AU - Boqué, C. AU - Chuah, C. AU - Pavlovsky, C. AU - Mayer, J. AU - Cortes, J. AU - Baccarani, M. AU - Kim, D. W. AU - Bradley-Garelik, M. B. AU - Mohamed, H. AU - Wildgust, M. AU - Hochhaus, A. DB - Scopus DO - 10.1182/blood-2013-06-511592 IS - 4 M3 - Article N1 - Cited By :289 Export Date: 18 November 2020 PY - 2014 SP - 494-500 ST - Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION) T2 - Blood TI - Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893136765&doi=10.1182%2fblood-2013-06-511592&partnerID=40&md5=7b407b891a5a36a2bc9f72dac5205c2d VL - 123 ID - 4048 ER - TY - JOUR AD - Molecular Biology Division, Defence Institute of Physiology and Allied Sciences (DIPAS), DRDO, Delhi, India AU - Sharma, M. AU - Singh, S. B. AU - Sarkar, S. C7 - e85902 DB - Scopus DO - 10.1371/journal.pone.0085902 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2014 ST - Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema T2 - PLoS ONE TI - Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899851626&doi=10.1371%2fjournal.pone.0085902&partnerID=40&md5=7ece09dcf93a9c99a42077e54bbe7cfe VL - 9 ID - 4049 ER - TY - JOUR AD - Département d' Anatomie et de Biologie Cellulaire, Université de Sherbrooke, Sherbrooke J1E 4K8, QC, Canada AU - Babeu, J. P. AU - Boudreau, F. DB - Scopus DO - 10.3748/wjg.v20.i1.22 IS - 1 M3 - Article N1 - Cited By :77 Export Date: 18 November 2020 PY - 2014 SP - 22-30 ST - Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks T2 - World Journal of Gastroenterology TI - Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891780760&doi=10.3748%2fwjg.v20.i1.22&partnerID=40&md5=1069d15cf55e625b0aaf1aa3b5d1176a VL - 20 ID - 4050 ER - TY - JOUR AD - Pediatric Drug Development Unit, Children and Young People's Unit, Royal Marsden NHS Foundation Trust, Sutton, SM2 5PT, United Kingdom Pediatric Drug Development Team, Divisions of Cancer Therapeutics and Clinical Studies, Institute of Cancer Research, Sutton, United Kingdom Pediatric Oncology Department, Great Ormond Street Hospital, London, United Kingdom Institute of Child Health, University College London, London, United Kingdom AU - Morgenstern, D. A. AU - Hargrave, D. AU - Marshall, L. V. AU - Gatz, S. A. AU - Barone, G. AU - Crowe, T. AU - Pritchard-Jones, K. AU - Zacharoulis, S. AU - Lancaster, D. L. AU - Vaidya, S. J. AU - Chisholm, J. C. AU - Pearson, A. D. J. AU - Moreno, L. DB - Scopus DO - 10.1097/MPH.0000000000000003 IS - 3 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 218-223 ST - Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: The Royal Marsden experience T2 - Journal of Pediatric Hematology/Oncology TI - Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: The Royal Marsden experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897476173&doi=10.1097%2fMPH.0000000000000003&partnerID=40&md5=bd6a043070e48d5d303da01cfba2524c VL - 36 ID - 4052 ER - TY - JOUR AD - Pediatric Oncology Unit, Anti Cancer Center Oscar Lambret, Lille Cedex, France Department of Pathology, University Hospital of Lille, Lille Nord, France Department of Breast Surgery, Anti Cancer Center Oscar Lambret, Lille Cedex, France Department of Pathology, Anti Cancer Center Oscar Lambret, Lille Cedex, France AU - Sudour-Bonnange, H. AU - Leroy, X. AU - Chauvet, M. P. AU - Classe, M. AU - Robin, P. M. AU - Leblond, P. DB - Scopus DO - 10.1002/pbc.25015 IS - 9 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2014 SP - 1698-1700 ST - Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager T2 - Pediatric Blood and Cancer TI - Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904440764&doi=10.1002%2fpbc.25015&partnerID=40&md5=ff7e2340fc48ab68aeac8ba19feaf0ee VL - 61 ID - 4055 ER - TY - JOUR AD - Departments of Paediatric Dermatology, Starship Children's Health, Auckland, New Zealand Departments of Paediatric Haematology and Oncology, Starship Children's Health, Auckland, New Zealand AU - Mahon, C. AU - Purvis, D. AU - Laughton, S. AU - Bradbeer, P. AU - Teague, L. DB - Scopus DO - 10.1111/pde.12380 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 603-607 ST - Imatinib mesylate-induced pseudoporphyria in two children T2 - Pediatric Dermatology TI - Imatinib mesylate-induced pseudoporphyria in two children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908381838&doi=10.1111%2fpde.12380&partnerID=40&md5=1d69c4e1fbe9cc7c0bc534aeecbd932c VL - 31 ID - 4057 ER - TY - SER AB - Sorafenib (BAY 43-9006, Nexavar®) is an oral multiple tyrosine kinase inhibitor. Main targets are receptor tyrosine kinase pathways frequently deregulated in cancer such as the Raf–Ras pathway, vascular endothelial growth factor (VEGF) pathway, and FMS-like tyrosine kinase 3 (FLT3). Sorafenib was approved by the FDA in fast track for advanced renal cell cancer and hepatocellular cancer and shows good clinical activity in thyroid cancer. Multiple clinical trials are undertaken to further investigate the role of sorafenib alone or in combination for the treatment of various tumor entities. © Springer-Verlag Berlin Heidelberg 2014. AD - Department Innere Medizin, Klinik für Innere Medizin I, Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation, Hugstetter Str. 55, Freiburg, 79102, Germany AU - Hasskarl, J. DB - Scopus DO - 10.1007/978-3-642-54490-3_8 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2014 SP - 145-164 ST - Sorafenib: Targeting multiple tyrosine kinases in cancer T2 - Recent Results in Cancer Research TI - Sorafenib: Targeting multiple tyrosine kinases in cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906923306&doi=10.1007%2f978-3-642-54490-3_8&partnerID=40&md5=186beb0a9fcdd0a830ce7472b1ab175f VL - 201 ID - 4058 ER - TY - JOUR AD - Department of Hematology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Cancer Research Institute, The Catholic University of Korea, Seoul, South Korea AU - Lee, S. E. AU - Choi, S. Y. AU - Kim, S. H. AU - Jang, E. J. AU - Bang, J. H. AU - Byeun, J. Y. AU - Park, J. E. AU - Jeon, H. R. AU - Oh, Y. J. AU - Yahng, S. A. AU - Cho, B. S. AU - Eom, K. S. AU - Kim, Y. J. AU - Lee, S. AU - Min, C. K. AU - Kim, H. J. AU - Lee, J. W. AU - Min, W. S. AU - Park, C. W. AU - Kim, D. W. DB - Scopus DO - 10.1179/1607845413Y.0000000100 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 63-72 ST - Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors T2 - Hematology TI - Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896039551&doi=10.1179%2f1607845413Y.0000000100&partnerID=40&md5=34e73cbb25ac517e930b244fb141a691 VL - 19 ID - 4059 ER - TY - JOUR AD - Division of Medical Support, Okayama University Hospital, Okayama, Japan Department of Pediatrics, Pediatric Hematology/Oncology, Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan Department of Pediatrics, Kochi Health Sciences Center, Kochi, Japan Department of Pediatrics, Osaka University, Osaka, Japan Department of Pediatrics, Toyonaka Municipal Hospital, Osaka, Japan Field of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan AU - Aoe, M. AU - Shimada, A. AU - Muraoka, M. AU - Washio, K. AU - Nakamura, Y. AU - Takahashi, T. AU - Imada, M. AU - Watanabe, T. AU - Okada, K. AU - Nishiuchi, R. AU - Miyamura, T. AU - Chayama, K. AU - Shibakura, M. AU - Oda, M. AU - Morishima, T. DB - Scopus DO - 10.1007/s12185-014-1565-3 IS - 5 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 609-615 ST - ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases T2 - International Journal of Hematology TI - ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901588114&doi=10.1007%2fs12185-014-1565-3&partnerID=40&md5=1da6b5d1a0985e48b78958d26636d7d4 VL - 99 ID - 4061 ER - TY - JOUR AD - Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States AU - Zeidner, J. F. AU - Gladstone, D. E. AU - Zahurak, M. AU - Matsui, W. H. AU - Gocke, C. AU - Jones, R. J. AU - Smith, B. D. DB - Scopus DO - 10.1016/j.leukres.2014.05.012 IS - 8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 886-890 ST - Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) T2 - Leukemia Research TI - Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907193462&doi=10.1016%2fj.leukres.2014.05.012&partnerID=40&md5=234c6a4badf5e2d97030515d2dd1a9a8 VL - 38 ID - 4062 ER - TY - JOUR AD - Al-Karama Teaching Hospital, Al-Kut, Baghdad, Iraq AU - Al-Husseinawi, E. K. DB - Scopus DO - 10.1097/MPH.0000000000000091 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2014 SP - e207-e211 ST - A pilot study for the detection of FLT3-ITD mutation frequency in 25 Iraqi patients with acute lymphoid leukemia in 2 Iraqi hospitals T2 - Journal of Pediatric Hematology/Oncology TI - A pilot study for the detection of FLT3-ITD mutation frequency in 25 Iraqi patients with acute lymphoid leukemia in 2 Iraqi hospitals UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899981378&doi=10.1097%2fMPH.0000000000000091&partnerID=40&md5=f628b4fd1a4e356bbcbf27bb95864550 VL - 36 ID - 4064 ER - TY - JOUR AD - Department of Pediatrics, University of Colorado School of Medicine/Anschutz Medical Campus, Aurora, CO, United States Children's Hospital Colorado, Aurora, CO, United States University of Colorado Cancer Center, Aurora, CO, United States Developmental Therapeutics Program, Aurora, CO, United States Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA, United States AU - Faulk, K. AU - Gore, L. AU - Cooper, T. DB - Scopus DO - 10.1007/s40272-014-0067-3 IS - 3 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2014 SP - 213-227 ST - Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia T2 - Pediatric Drugs TI - Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902378710&doi=10.1007%2fs40272-014-0067-3&partnerID=40&md5=8078013588557e901d3399de87876397 VL - 16 ID - 4065 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI, United States Gastrointestinal, University of Michigan, Ann Arbor, MI, United States AU - Speck, O. AU - Greenson, J. K. DB - Scopus DO - 10.1016/j.mpdhp.2014.03.012 IS - 6 M3 - Review N1 - Export Date: 18 November 2020 PY - 2014 SP - 222-227 ST - New issues in gastrointestinal stromal tumors of the stomach T2 - Diagnostic Histopathology TI - New issues in gastrointestinal stromal tumors of the stomach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901695266&doi=10.1016%2fj.mpdhp.2014.03.012&partnerID=40&md5=af553b1bdb9b19a4d55a5c77138887f0 VL - 20 ID - 4066 ER - TY - JOUR AD - UCL Cancer Institute, University College London, Gower Street, London, WC1E 6BT, United Kingdom Royal Free Hospital, London, United Kingdom AU - Goldstein, R. AU - Yu, D. AU - Gillmore, R. AU - Thirlwell, C. AU - O'Donoghue, P. AU - Mayer, A. AU - Meyer, T. DB - Scopus DO - 10.2217/FON.14.108 IS - 13 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 2007-2014 ST - Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: Case report and single-center retrospective review T2 - Future Oncology TI - Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: Case report and single-center retrospective review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911164273&doi=10.2217%2fFON.14.108&partnerID=40&md5=68f6a84f6ae643f61b06edc731c4b965 VL - 10 ID - 4068 ER - TY - JOUR AD - University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy Universitätsklinikum Aachen, RWTH Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Seoul St. Mary's Hospital, Seoul, South Korea Hematology Research Center, Moscow, Russian Federation St. István and St. László Hospital, Budapest, Hungary Jewish General Hospital, McGill University, Montreal, QC, Canada Royal Brisbane Hospital, Herston, QLD, Australia University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States University of Pavlov and Almazov Federal Heart, Blood, and Endocrinology Centre, St Petersburg, Russian Federation Ruijin Hospital, Shanghai, China First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China University of Groningen and University Medical Center Groningen, Groningen, Netherlands Hospital das Clínicas da Universidade Federal do Paraná, Paraná, Brazil Christian Medical College, Vellore, Tamil Nadu, India Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain Pfizer Global Research and Development, Paris, France Pfizer, Cambridge, MA, United States AU - Gambacorti-Passerini, C. AU - Brümmendorf, T. H. AU - Kim, D. W. AU - Turkina, A. G. AU - Masszi, T. AU - Assouline, S. AU - Durrant, S. AU - Kantarjian, H. M. AU - Khoury, H. J. AU - Zaritskey, A. AU - Shen, Z. X. AU - Jin, J. AU - Vellenga, E. AU - Pasquini, R. AU - Mathews, V. AU - Cervantes, F. AU - Besson, N. AU - Turnbull, K. AU - Leip, E. AU - Kelly, V. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.23728 IS - 7 M3 - Article N1 - Cited By :71 Export Date: 18 November 2020 PY - 2014 SP - 732-742 ST - Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up T2 - American Journal of Hematology TI - Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902843429&doi=10.1002%2fajh.23728&partnerID=40&md5=a286e951ab0e73620dc58680d0a8b7a3 VL - 89 ID - 4070 ER - TY - JOUR AD - Service de gynécologie-obstétrique, hÔpital Foch, 40 rue Worth, Suresnes, France Inserm, UMRS-1139, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France PremUp Foundation, Paris, France Service de pharmacologie et d'analyse du médicament, Gustave Roussy, Villejuif, France Université Paris-Sud, France Service de pneumologie, hÔpital Foch, 40 rue Worth, Suresnes, France Faculté de Medecine Paris-Ile de France-Ouest, Université Versailles Saint Quentin en Yvelines, France UPRES EA220, Foch Hospital, University of Versailles Saint-Quentin, Suresnes, France AU - Gil, S. AU - Goetgheluck, J. AU - Paci, A. AU - Broutin, S. AU - Friard, S. AU - Couderc, L. J. AU - Ayoubi, J. M. AU - Picone, O. AU - Tcherakian, C. DB - Scopus DO - 10.1016/j.lungcan.2014.06.003 IS - 3 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 481-484 ST - Efficacy and safety of gefitinib during pregnancy: Case report and literature review T2 - Lung Cancer TI - Efficacy and safety of gefitinib during pregnancy: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926420857&doi=10.1016%2fj.lungcan.2014.06.003&partnerID=40&md5=8c34935a79b26ffca5de8947875a9651 VL - 85 ID - 4071 ER - TY - JOUR AD - Institute for Pediatric Research, Soochow University Suzhou, China Department of Pediatric Cardiology, Affiliated Children's Hospital, Soochow University, Suzhou, China Department of Pediatric Surgery, Affiliated Children's Hospital, Soochow University, Suzhou, China Institute of Medical Biotechnology, Soochow University Suzhou, Suzhou, China Department of Academic Surgery, University College Cork, Cork University Hospital, Cork, Ireland AU - Li, Y. P. AU - Huang, J. AU - Huang, S. G. AU - Xu, Y. G. AU - Xu, Y. Y. AU - Liao, J. Y. AU - Feng, X. AU - Zhang, X. G. AU - Wang, J. H. AU - Wang, J. DB - Scopus DO - 10.1016/j.jcrc.2013.10.008 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 312.e7-312.e13 ST - The compromised inflammatory response to bacterial components after pediatric cardiac surgery is associated with cardiopulmonary bypass-suppressed Toll-like receptor signal transduction pathways T2 - Journal of Critical Care TI - The compromised inflammatory response to bacterial components after pediatric cardiac surgery is associated with cardiopulmonary bypass-suppressed Toll-like receptor signal transduction pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896728322&doi=10.1016%2fj.jcrc.2013.10.008&partnerID=40&md5=89baa3cbce809fc526c67fe8fefb161e VL - 29 ID - 4072 ER - TY - JOUR AD - Pituitary Center, Cedars-Sinai Medical Center, 8700 Beverly Blvd., B-131, Los Angeles, CA 90048, United States Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, United States Division of Hematology and Oncology, Department of Medicine, CSMC, Los Angeles, CA, United States Biostatistics and Bioinformatics Research Center, Samuel Oschin Comprehensive Cancer Institute, CSMC, Los Angeles, CA, United States AU - Cooper, O. AU - Mamelak, A. AU - Bannykh, S. AU - Carmichael, J. AU - Bonert, V. AU - Lim, S. AU - Cook-Wiens, G. AU - Ben-Shlomo, A. DB - Scopus DO - 10.1007/s12020-013-0093-x IS - 2 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2014 SP - 318-327 ST - Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors T2 - Endocrine TI - Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902304359&doi=10.1007%2fs12020-013-0093-x&partnerID=40&md5=1095f6d44edc957baad8c70b71ad0a40 VL - 46 ID - 4075 ER - TY - JOUR AD - Department of Pharmacy, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto, Japan Department of Clinical and Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan AU - Taguchi, K. AU - Kouroki, M. AU - Ohmura, T. AU - Jono, H. AU - Endo, F. AU - Saito, H. DB - Scopus DO - 10.1111/ped.12382 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - e33-e36 ST - Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia T2 - Pediatrics International TI - Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961297020&doi=10.1111%2fped.12382&partnerID=40&md5=b86d55c86641bf545afc1673ea545d41 VL - 56 ID - 4078 ER - TY - JOUR AD - Department of Hematology, Second Hospital of Hebei Medical University, Key Laboratory of Hematology, 215 West Heping Road, Shijiazhuang, Hebei 050000, China Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei 053000, China AU - Li, Y. AU - Yang, L. AU - Pan, Y. AU - Yang, J. AU - Shang, Y. AU - Luo, J. DB - Scopus DO - 10.3892/or.2014.3098 IS - 5 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2014 SP - 2438-2446 ST - Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia T2 - Oncology Reports TI - Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898623920&doi=10.3892%2for.2014.3098&partnerID=40&md5=a1b7a72f6badae0243368fc9f3d094ea VL - 31 ID - 4079 ER - TY - JOUR AD - Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione G. Pascale, Via Mariano Semmola, Naples 80131, Italy Regina Elena National Cancer Institute, Rome, Italy National Research Council, Sassari, Italy San Martino Hospital, National Institute for Cancer Research, Genoa, Italy Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy Sant'Andrea Hospital, University Sapienza, Rome, Italy Paolo Giaccone Polyclinic University Hospital, Palermo, Italy AU - Simeone, E. AU - Gentilcore, G. AU - Giannarelli, D. AU - Grimaldi, A. M. AU - Caracò, C. AU - Curvietto, M. AU - Esposito, A. AU - Paone, M. AU - Palla, M. AU - Cavalcanti, E. AU - Sandomenico, F. AU - Petrillo, A. AU - Botti, G. AU - Fulciniti, F. AU - Palmieri, G. AU - Queirolo, P. AU - Marchetti, P. AU - Ferraresi, V. AU - Rinaldi, G. AU - Pistillo, M. P. AU - Ciliberto, G. AU - Mozzillo, N. AU - Ascierto, P. A. DB - Scopus DO - 10.1007/s00262-014-1545-8 IS - 7 M3 - Article N1 - Cited By :164 Export Date: 18 November 2020 PY - 2014 SP - 675-683 ST - Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma T2 - Cancer Immunology, Immunotherapy TI - Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903818245&doi=10.1007%2fs00262-014-1545-8&partnerID=40&md5=1893b18b61e8e4b4e1dba9291096b9a5 VL - 63 ID - 4080 ER - TY - JOUR AD - Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai Medical School, No. 270, Dong'an Road, Shanghai 200032, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China AU - Cao, J. AU - Zhang, J. AU - Wang, Z. AU - Wang, B. AU - Lv, F. AU - Wang, L. AU - Hu, X. DB - Scopus DO - 10.1007/s00280-014-2505-x IS - 2 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2014 SP - 389-398 ST - Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer T2 - Cancer Chemotherapy and Pharmacology TI - Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907598458&doi=10.1007%2fs00280-014-2505-x&partnerID=40&md5=7aa5a62b2d72fd0cc26f5f36c8599828 VL - 74 ID - 4081 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston TX 77030, United States Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Apocell Molecular Profiling and Diagnostics, Houston, TX, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Division of Hematology and Oncology, Moores Cancer Center, University of California at San Diego, San Diego, CA, United States AU - Hong, D. S. AU - Garrido-Laguna, I. AU - Ekmekcioglu, S. AU - Falchook, G. S. AU - Naing, A. AU - Wheler, J. J. AU - Fu, S. AU - Moulder, S. L. AU - Piha-Paul, S. AU - Tsimberidou, A. M. AU - Wen, Y. AU - Culotta, K. S. AU - Anderes, K. AU - Davis, D. W. AU - Liu, W. AU - George, G. C. AU - Camacho, L. H. AU - Percy Ivy, S. AU - Kurzrock, R. DB - Scopus DO - 10.1002/cncr.28701 IS - 14 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2014 SP - 2164-2173 ST - Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors T2 - Cancer TI - Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903768222&doi=10.1002%2fcncr.28701&partnerID=40&md5=cba31bdcb9cb799423b393b913853cf4 VL - 120 ID - 4082 ER - TY - JOUR AD - Departments of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra pradesh, India Departments of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra pradesh, India AU - Thota, N. K. AU - Gundeti, S. AU - Linga, V. G. AU - Coca, P. AU - Tara, R. P. AU - Raghunadharao DB - Scopus DO - 10.4103/0019-509X.134598 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 5-9 ST - Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: A retrospective analysis T2 - Indian Journal of Cancer TI - Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: A retrospective analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903288981&doi=10.4103%2f0019-509X.134598&partnerID=40&md5=634fbf807bf4f4fdc453c9b9fd0769df VL - 51 ID - 4083 ER - TY - JOUR AD - Pediatric Hematology and Oncology, University Children's Hospital Carl Gustav Carus, Fetscherstrasse 74, 01307 Dresden, Germany Institute for Medical Informatics and Biometry, Medical Faculty Carl Gustav Carus, Dresden, Germany Experimental Center, Medical Faculty Carl Gustav Carus, Technical University, Dresden, Germany AU - Tauer, J. T. AU - Ulmer, A. AU - Glauche, I. AU - Jung, R. AU - Suttorp, M. DB - Scopus DO - 10.1055/s-0034-1372643 IS - 3 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 169-174 ST - Long-term imatinib treatment does not cause testicular toxicity in male adolescents with chronic myeloid leukemia and in a juvenile rat model T2 - Klinische Padiatrie TI - Long-term imatinib treatment does not cause testicular toxicity in male adolescents with chronic myeloid leukemia and in a juvenile rat model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900539712&doi=10.1055%2fs-0034-1372643&partnerID=40&md5=0364183c72fef4834788a40ca65098dc VL - 226 ID - 4085 ER - TY - JOUR AD - Department of Hematology and Oncology, The First Affiliated Hospital of the People's Liberation Army General Hospital, Beijing 100048, China AU - Zhou, M. H. AU - Yang, Q. M. DB - Scopus DO - 10.3892/ol.2014.2263 IS - 3 M3 - Review N1 - Cited By :19 Export Date: 18 November 2020 PY - 2014 SP - 959-962 ST - NUP214 fusion genes in acute leukemia (Review) T2 - Oncology Letters TI - NUP214 fusion genes in acute leukemia (Review) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904267839&doi=10.3892%2fol.2014.2263&partnerID=40&md5=454ef586e4110c9b45e691e1f3ab622a VL - 8 ID - 4087 ER - TY - JOUR AD - Free Radical and Radiation Biology Division, Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242-1181, United States Integrated DNA Technologies, Inc., 1710 Commercial Park, Coralville, IA 52241, United States AU - Sarsour, E. H. AU - Goswami, M. AU - Kalen, A. L. AU - Lafin, J. T. AU - Goswami, P. C. C7 - 9645 DB - Scopus DO - 10.1007/s11357-014-9645-0 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 1213-1224 ST - Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation T2 - Age TI - Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905381011&doi=10.1007%2fs11357-014-9645-0&partnerID=40&md5=ba8f947a88a942cc6cd67eba2e2e1f16 VL - 36 ID - 4089 ER - TY - JOUR AD - Department of Surgery, Royal Marsden, Fulham Road, London SW3 6JJ, United Kingdom Sarcoma Unit, Royal Marsden, Fulham Road, London SW3 6JJ, United Kingdom AU - Cananzi, F. C. M. AU - Lorenzi, B. AU - Belgaumkar, A. AU - Benson, C. AU - Judson, I. AU - Mudan, S. DB - Scopus DO - 10.1007/s00423-014-1160-3 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 323-332 ST - Prognostic factors for primary gastrointestinal stromal tumours: Are they the same in the multidisciplinary treatment era? T2 - Langenbeck's Archives of Surgery TI - Prognostic factors for primary gastrointestinal stromal tumours: Are they the same in the multidisciplinary treatment era? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898839615&doi=10.1007%2fs00423-014-1160-3&partnerID=40&md5=7bc7eb7f1b8f8526c6694df0f7c5927e VL - 399 ID - 4090 ER - TY - JOUR AD - Eurocord APHP, University Paris-Diderot, Hospital Saint Louis, Paris, France Centro de Oncologia, Hospital Sirio Libanes, Sao Paulo, Brazil Service d'Hématologie et Thérapie Cellulaire, AP-HP, UPMC Université Paris 6, UMR-S 938, CEREST-TC EBMT, Hôpital Saint Antoine, Paris, France Cord Blood Committee - Immunobiology Working Party, EBMT, Paris, France Servicio de Hematologia, Hospital University La Fe, Valencia, Spain Haematology, Institut Paoli Calmettes, Marseille, France Haematology, Erasmus MC/Daniel Den Hoed, Rotterdam, Netherlands Medical University Graz, Graz, Austria Hôpital de l'ARCHET, Nice, France ICO-Hospital Universitari Germans Trias i Pujol, Jose Carreras Research Institute, Badalona, Spain Department of Haematology, LUMC, Rotterdam, Netherlands CHU de Lille, Lille, France Haematology Department, Carlos Haya Hospital, Malaga, Spain Division of Clinical Haematology, Ziekenhuis University, Brussel, Belgium Haematology Division - Stem Cell Transplant Unit, University of Rome Tor Vergata, Rome, Italy Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom AU - Tucunduva, L. AU - Ruggeri, A. AU - Sanz, G. AU - Furst, S. AU - Cornelissen, J. AU - Linkesch, W. AU - Mannone, L. AU - Ribera, J. M. AU - Veelken, H. AU - Yakoub-Agha, I. AU - González Valentín, M. E. AU - Schots, R. AU - Arcese, W. AU - Montesinos, P. AU - Labopin, M. AU - Gluckman, E. AU - Mohty, M. AU - Rocha, V. DB - Scopus DO - 10.1111/bjh.12970 IS - 5 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 749-757 ST - Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: An analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation T2 - British Journal of Haematology TI - Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: An analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906048142&doi=10.1111%2fbjh.12970&partnerID=40&md5=728c5b0829535ee015c679fe86505951 VL - 166 ID - 4091 ER - TY - JOUR AD - Wayne State University School of Medicine, Detroit, MI, United States Cancer Biology Graduate Program, Wayne State University School of Medicine, Detroit, MI, United States Department of Oncology, Wayne State University School of Medicine, Detroit, MI, United States Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, United States Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, United States AU - Caldwell, J. T. AU - Edwards, H. AU - Buck, S. A. AU - Ge, Y. AU - Taub, J. W. DB - Scopus DO - 10.1002/pbc.25081 IS - 10 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 1767-1773 ST - Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia T2 - Pediatric Blood and Cancer TI - Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908500934&doi=10.1002%2fpbc.25081&partnerID=40&md5=0cf83b1a88243656073118cb84164f57 VL - 61 ID - 4093 ER - TY - JOUR AD - Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Univ. de São Paulo, Brazil Centro Regional de Hemoterapia de Ribeirão Preto, Brazil Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brazil Hospital Israelita Albert Einstein, São Paulo, Brazil Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Center for RNA Interference and Non-Coding RNAs, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Ferreira, A. F. AU - Moura, L. G. AU - Tojal, I. AU - Ambrósio, L. AU - Pinto-Simões, B. AU - Hamerschlak, N. AU - Calin, G. A. AU - Ivan, C. AU - Covas, D. T. AU - Kashima, S. AU - Castro, F. A. DB - Scopus DO - 10.1016/j.bcmd.2014.02.008 IS - 1-2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 47-55 ST - ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance T2 - Blood Cells, Molecules, and Diseases TI - ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900030676&doi=10.1016%2fj.bcmd.2014.02.008&partnerID=40&md5=2fc7324ae3f4517beb48e812c75d5860 VL - 53 ID - 4096 ER - TY - JOUR AD - Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy Washington Hospital Center, WA, D.C. 20010 AU - Biondi, B. AU - Wartofsky, L. DB - Scopus DO - 10.1210/er.2013-1083 IS - 3 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2014 SP - 433-512 ST - Treatment with thyroid hormone T2 - Endocrine Reviews TI - Treatment with thyroid hormone UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901484766&doi=10.1210%2fer.2013-1083&partnerID=40&md5=e46061b7aa0a1da567d790f07034dd8f VL - 35 ID - 4099 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas/Hemocentro - Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States Laboratory of Investigative and Molecular Pathology, CIPED, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, United States Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil AU - de Melo Campos, P. AU - Machado-Neto, J. A. AU - Scopim-Ribeiro, R. AU - Visconte, V. AU - Tabarroki, A. AU - Duarte, A. S. S. AU - Barra, F. F. C. AU - Vassalo, J. AU - Rogers, H. J. AU - Lorand-Metze, I. AU - Tiu, R. V. AU - Costa, F. F. AU - Olalla Saad, S. T. AU - Traina, F. DB - Scopus DO - 10.1016/j.leukres.2014.07.010 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2014 SP - 1245-1251 ST - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 T2 - Leukemia Research TI - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908024600&doi=10.1016%2fj.leukres.2014.07.010&partnerID=40&md5=cd67a87b5f022f4614674791e006e0d8 VL - 38 ID - 4100 ER - TY - JOUR AD - Memorial Sloan-Kettering Cancer Center, New York, NY, United States Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Matteo Univ. Hospital Foundation, Pavia, Italy Comprehensive Cancer Centers of Nevada, Las Vegas, NV, United States San Camillo and Forlanini Hospitals, Rome, Italy Military Institute of Health Services in Warsaw, Warsaw, Poland Maria Sklodowska-Curie Institute, Warsaw, Poland BC Cancer Agency Vancouver Cancer Centre, Vancouver, BC, Canada Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea Sunnybrook Odette Cancer Centre, Toronto, ON, Canada Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy Hanover Medical School, Hanover, Germany Monash University Eastern Health Clinical School, Melbourne, VIC, Australia Asan Medical Center, Seoul, South Korea Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Novartis Pharma, Basel, Switzerland Institut Gustave Roussy, Villejuif, France AU - Motzer, R. J. AU - Porta, C. AU - Vogelzang, N. J. AU - Sternberg, C. N. AU - Szczylik, C. AU - Zolnierek, J. AU - Kollmannsberger, C. AU - Rha, S. Y. AU - Bjarnason, G. A. AU - Melichar, B. AU - De Giorgi, U. AU - Grünwald, V. AU - Davis, I. D. AU - Lee, J. L. AU - Esteban, E. AU - Urbanowitz, G. AU - Cai, C. AU - Squires, M. AU - Marker, M. AU - Shi, M. M. AU - Escudier, B. DB - Scopus DO - 10.1016/S1470-2045(14)70030-0 IS - 3 M3 - Article N1 - Cited By :192 Export Date: 18 November 2020 PY - 2014 SP - 286-296 ST - Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial T2 - The Lancet Oncology TI - Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896713052&doi=10.1016%2fS1470-2045%2814%2970030-0&partnerID=40&md5=88e9eaacbfa0d3d40f65bc5b8b4c6208 VL - 15 ID - 4101 ER - TY - JOUR AD - Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland Department of Clinical Pharmacology and Toxicology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Novartis Oncology Region Europe, Milan, Italy Laboratory of Clinical Pharmacology, Innovation and Development Unit, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Bordeaux, France AU - Gotta, V. AU - Bouchet, S. AU - Widmer, N. AU - Schuld, P. AU - Decosterd, L. A. AU - Buclin, T. AU - Mahon, F. X. AU - Csajka, C. AU - Molimard, M. DB - Scopus DO - 10.1016/j.leukres.2014.03.023 IS - 7 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2014 SP - 764-772 ST - Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions T2 - Leukemia Research TI - Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902110431&doi=10.1016%2fj.leukres.2014.03.023&partnerID=40&md5=109c870c237280e5bd1abe4821f628fe VL - 38 ID - 4102 ER - TY - JOUR AD - Department of Medical Oncology, Sichuan Cancer Hospital, No.55 South Renmin Road, Chengdu, Sichuan 610041, China AU - Chen, J. AU - Zhou, C. AU - Long, Y. AU - Yin, X. DB - Scopus DO - 10.1007/s13277-014-2608-3 IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 183-191 ST - Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study T2 - Tumor Biology TI - Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922220283&doi=10.1007%2fs13277-014-2608-3&partnerID=40&md5=ee944876184c4e7698cc75284af0b225 VL - 36 ID - 4103 ER - TY - JOUR AD - Department of Human Genetics, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium Laboratory of Experimental Oncology, Department of General Medical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium Department of Soft Tissue/Bone Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland AU - Quattrone, A. AU - Wozniak, A. AU - Dewaele, B. AU - Floris, G. AU - Vanspauwen, V. AU - Van Looy, T. AU - Schöffski, P. AU - Rutkowski, P. AU - Sciot, R. AU - Debiec-Rychter, M. DB - Scopus DO - 10.1038/modpathol.2014.53 IS - 11 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2014 SP - 1510-1520 ST - Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors T2 - Modern Pathology TI - Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926180527&doi=10.1038%2fmodpathol.2014.53&partnerID=40&md5=cc3204bf8cb5b1d983f3fb9645a3b883 VL - 27 ID - 4109 ER - TY - JOUR AD - State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, China Collaborative Innovation Center for Biotherapy, Nankai University, China USC Norris Cancer Hospital, Department of Medicine, University of Southern California, 1441 Eastlake Avenue, NOR 6330, Los Angeles, CA 90033, United States Nankai University School of Medicine, Tianjin, China Sichuan University College of Life Sciences, Chengdu, China AU - Xu, L. X. AU - Grimaldo, S. AU - Qi, J. W. AU - Yang, G. L. AU - Qin, T. T. AU - Xiao, H. Y. AU - Xiang, R. AU - Xiao, Z. AU - Li, L. Y. AU - Zhang, Z. S. DB - Scopus DO - 10.1016/j.biocel.2014.08.015 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2014 SP - 109-118 ST - Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis T2 - International Journal of Biochemistry and Cell Biology TI - Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907320822&doi=10.1016%2fj.biocel.2014.08.015&partnerID=40&md5=5f0571fdadcc1ee3085c3374f40696e9 VL - 55 ID - 4110 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Facultad de Medicina, Universidad Juárez del Estado de Durango, Gómez Palacio, Durango 34000, Mexico AU - Bailey, K. A. AU - Laine, J. AU - Rager, J. E. AU - Sebastian, E. AU - Olshan, A. AU - Smeester, L. AU - Drobná, Z. AU - Stýblo, M. AU - Rubio-Andrade, M. AU - García-Vargas, G. AU - Fry, R. C. C7 - kfu053 DB - Scopus DO - 10.1093/toxsci/kfu053 IS - 2 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2014 SP - 328-337 ST - Prenatal arsenic exposure and shifts in the newborn proteome: Interindividual differences in tumor necrosis factor (TNF)-responsive signaling T2 - Toxicological Sciences TI - Prenatal arsenic exposure and shifts in the newborn proteome: Interindividual differences in tumor necrosis factor (TNF)-responsive signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899981472&doi=10.1093%2ftoxsci%2fkfu053&partnerID=40&md5=822aed0bfbac3c77fb48162914d1491c VL - 139 ID - 4113 ER - TY - JOUR AD - Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom AU - Balfour-Lynn, I. M. DB - Scopus DO - 10.1016/j.prrv.2014.04.003 IS - S1 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2014 SP - 2-5 ST - Personalised medicine in cystic fibrosis is unaffordable T2 - Paediatric Respiratory Reviews TI - Personalised medicine in cystic fibrosis is unaffordable UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901639121&doi=10.1016%2fj.prrv.2014.04.003&partnerID=40&md5=68810dad80d8535ae1e3a028eb850e83 VL - 15 ID - 4118 ER - TY - JOUR AD - Cellular and Molecular Neuroscience, National Brain Research Centre (NBRC), NH-8, Nainwal Road, Manesar, Gurgaon, Haryana 122051, India Sagol Department of Neurobiology and Ethology, University of Haifa, Haifa, Israel AU - Malik, S. AU - Saha, R. AU - Seth, P. DB - Scopus DO - 10.1007/s11481-014-9523-7 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2014 SP - 340-353 ST - Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure T2 - Journal of Neuroimmune Pharmacology TI - Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901259174&doi=10.1007%2fs11481-014-9523-7&partnerID=40&md5=e458b439b735988c707e728cdd28f47c VL - 9 ID - 4119 ER - TY - JOUR AD - Howard Hughes Medical Institute Molecular Medicine Program, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, United States Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue NE-50, Cleveland, OH 44195, United States Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, United States Center for Autism, Pediatric Institute, Cleveland Clinic, Cleveland, OH 44195, United States Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, United States Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic, Cleveland, OH 44195, United States Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States AU - Tilot, A. K. AU - Gaugler, M. K. AU - Yu, Q. AU - Romigh, T. AU - Yu, W. AU - Miller, R. H. AU - Frazier Ii, T. W. AU - Eng, C. DB - Scopus DO - 10.1093/hmg/ddu031 IS - 12 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2014 SP - 3212-3227 ST - Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production T2 - Human Molecular Genetics TI - Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901362837&doi=10.1093%2fhmg%2fddu031&partnerID=40&md5=747cc436aebc9abf9e4393bfa93153d7 VL - 23 ID - 4120 ER - TY - JOUR AD - Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Verona, Italy Neurosciences Medicines Development Centre, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Neurosciences Medicines Development Centre, GlaxoSmithKline R and D Ltd, Durham, NC, United States Discovery Biometrics, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline R and D Ltd, Verona, Italy Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Durham, NC, United States Takeda Development Centre Europe Ltd., 61 Aldwych, London, WC2B 4AE, United Kingdom Neuroscience DTA, F. Hoffman-la Roche, Basel, Switzerland AU - Inamdar, A. AU - Merlo-Pich, E. AU - Gee, M. AU - Makumi, C. AU - Mistry, P. AU - Robertson, J. AU - Steinberg, E. AU - Zamuner, S. AU - Learned, S. AU - Alexander, R. AU - Ratti, E. DB - Scopus DO - 10.1177/0269881114529377 IS - 6 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 570-581 ST - Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach T2 - Journal of Psychopharmacology TI - Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901596872&doi=10.1177%2f0269881114529377&partnerID=40&md5=8dcaa2168078281a3aa7b3dfe99d77af VL - 28 ID - 4122 ER - TY - JOUR AD - Department of Microbiology, Harbin Medical University, Harbin 150081, China Department of Cell Biology, Harbin Medical University, Harbin 150081, China Department of Microbiology, Peking University Health Science Center, Beijing 100191, China AU - Guo, Z. AU - Zhong, X. AU - Lin, L. AU - Wu, S. AU - Wang, T. AU - Chen, Y. AU - Zhai, X. AU - Wang, Y. AU - Wu, H. AU - Tong, L. AU - Han, Y. AU - Pan, B. AU - Peng, Y. AU - Si, X. AU - Zhang, F. AU - Zhao, W. AU - Zhong, Z. DB - Scopus DO - 10.1016/j.antiviral.2013.11.002 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 82-92 ST - A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents T2 - Antiviral Research TI - A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888816786&doi=10.1016%2fj.antiviral.2013.11.002&partnerID=40&md5=b718cfcdf89d1508ba52b58fc865bb09 VL - 101 ID - 4123 ER - TY - JOUR AD - Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing 100050 ccmu.edu.cn, China Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing 100050, China Department of Biochemistry and Molecular Biology, Capital Medical University School of Basic Medical Sciences, Beijing 100069, China Department of Stomatology, Yidu Central Hospital, Weifang Medical University, No. 4138 Linglong Mountain South Road, Qinzhou 262500, China AU - Dong, R. AU - Du, J. AU - Wang, L. AU - Wang, J. AU - Ding, G. AU - Wang, S. AU - Fan, Z. C7 - 317853 DB - Scopus DO - 10.1155/2014/317853 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2014 ST - Comparison of long noncoding RNA and mRNA expression profiles in mesenchymal stem cells derived from human periodontal ligament and bone marrow T2 - BioMed Research International TI - Comparison of long noncoding RNA and mRNA expression profiles in mesenchymal stem cells derived from human periodontal ligament and bone marrow UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899540989&doi=10.1155%2f2014%2f317853&partnerID=40&md5=3773db65224d854eaab0ffb0c9c327ea VL - 2014 ID - 4125 ER - TY - JOUR AD - Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong AU - Fong, O. N. AU - Chan, K. Y. Y. AU - Leung, K. T. AU - Lam, H. S. AU - Cheung, H. M. AU - Leung, T. Y. AU - Li, K. AU - Ng, P. C. DB - Scopus DO - 10.1189/jlb.0413219 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 169-178 ST - Expression profile of cord blood neutrophils and dysregulation of HSPA1A and OLR1 upon challenge by bacterial peptidoglycan T2 - Journal of Leukocyte Biology TI - Expression profile of cord blood neutrophils and dysregulation of HSPA1A and OLR1 upon challenge by bacterial peptidoglycan UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897019347&doi=10.1189%2fjlb.0413219&partnerID=40&md5=9e188833faf35cb6e0e2dd7625d1a9c4 VL - 95 ID - 4127 ER - TY - JOUR AD - 1 Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, China 2 Department of Huiqiao Building, Southern Medical University, Guangzhou, China AU - Xie, F. AU - Sun, S. AU - Xu, A. AU - Zheng, S. AU - Xue, M. AU - Wu, P. AU - Zeng, J. H. AU - Bai, L. DB - Scopus DO - 10.1038/cddis.2013.542 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2014 ST - Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway T2 - Cell death & disease TI - Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906920653&doi=10.1038%2fcddis.2013.542&partnerID=40&md5=cb2bd277056c46f6fd9c47ce03a60eb1 VL - 5 ID - 4128 ER - TY - JOUR AD - Liver Research Unit, 'Bambino Gesù' Children's Hospital, IRCCS, Rome 00165, Italy Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong Department of Oncohematology, 'Bambino Gesù' Children's Hospital, IRCCS, Rome 00165, Italy AU - Alisi, A. AU - Cho, W. C. AU - Locatelli, F. AU - Fruci, D. DB - Scopus DO - 10.3390/ijms141224706 IS - 12 M3 - Review N1 - Cited By :55 Export Date: 18 November 2020 PY - 2013 SP - 24706-24725 ST - Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma T2 - International Journal of Molecular Sciences TI - Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890953102&doi=10.3390%2fijms141224706&partnerID=40&md5=8830a1d7644a82b3bc760f4c863c2d89 VL - 14 ID - 4129 ER - TY - JOUR AD - Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China AU - Zhang, Q. AU - Ding, Y. AU - Yao, Y. AU - Yu, Y. AU - Yang, L. AU - Cui, H. C7 - e83589 DB - Scopus DO - 10.1371/journal.pone.0083589 IS - 12 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2013 ST - Creating rat model for hypoxic brain damage in neonates by oxygen deprivation T2 - PLoS ONE TI - Creating rat model for hypoxic brain damage in neonates by oxygen deprivation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892935508&doi=10.1371%2fjournal.pone.0083589&partnerID=40&md5=6a838338b7147e1160789bef877195be VL - 8 ID - 4130 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Falchi, L. AU - Kantarjian, H. M. AU - Wang, X. AU - Verma, D. AU - Quintás-Cardama, A. AU - O'Brien, S. AU - Jabbour, E. J. AU - Ravandi-Kashani, F. AU - Borthakur, G. AU - Garcia-Manero, G. AU - Verstovsek, S. AU - Burger, J. A. AU - Luthra, R. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.23560 IS - 12 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2013 SP - 1024-1029 ST - Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888066021&doi=10.1002%2fajh.23560&partnerID=40&md5=ae38bca514920b81ea6523fd426de7f6 VL - 88 ID - 4132 ER - TY - JOUR AD - Laboratório de Microbiologia Experimental, Instituto Nacional de Ciência e Tecnologia Translacional em Medicina, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, SC, Brazil Núcleo de Excelência em Neurociências Aplicadas de Santa Catarina (NENASC), Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, SC, Brazil Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil AU - Barichello, T. AU - Fagundes, G. D. AU - Generoso, J. S. AU - Elias, S. G. AU - Simões, L. R. AU - Teixeira, A. L. DB - Scopus DO - 10.1099/jmm.0.059840-0 IS - PART 12 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2013 SP - 1781-1789 ST - Pathophysiology of neonatal acute bacterial meningitis T2 - Journal of Medical Microbiology TI - Pathophysiology of neonatal acute bacterial meningitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887902364&doi=10.1099%2fjmm.0.059840-0&partnerID=40&md5=8742b24abdbc891be82159e96072b7c3 VL - 62 ID - 4134 ER - TY - JOUR AD - Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryocho, Aoba-ku, Sendai 980-8574, Japan AU - Shimizu, T. AU - Fukumoto, Y. AU - Tanaka, S. I. AU - Satoh, K. AU - Ikeda, S. AU - Shimokawa, H. DB - Scopus DO - 10.1161/ATVBAHA.113.301357 IS - 12 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2013 SP - 2780-2791 ST - Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice T2 - Arteriosclerosis, Thrombosis, and Vascular Biology TI - Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888202856&doi=10.1161%2fATVBAHA.113.301357&partnerID=40&md5=3dc9f47ad97a7803f738430f327412bd VL - 33 ID - 4135 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of General Surgery, Jagiellonian University, Kopernika 40, 31-501 Cracow, Poland Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Radiology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Biochemistry and Molecular Biology, Institute of Rheumatology, Spartanska 1, 02-637 Warsaw, Poland Laboratory of Experimental Oncology, Catholic University of Leuven, Herestraat 49, Post 815, 3000 Louvain, Belgium Department of Biology and Genetics, Medical University of Gdansk, Debinki 1, 80-211 Gdańsk, Poland Center for Human Genetics, Catholic University of Leuven, Herestraat 49, Post 815, 3000 Louvain, Belgium Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland AU - Rutkowski, P. AU - Andrzejuk, J. AU - Bylina, E. AU - Osuch, C. AU - Świtaj, T. AU - Jerzak Vel Dobosz, A. AU - Grzesiakowska, U. AU - Jurkowska, M. AU - Wozniak, A. AU - Limon, J. AU - Dȩbiec-Rychter, M. AU - Siedlecki, J. A. C7 - 765 DB - Scopus DO - 10.1007/s12032-013-0765-7 IS - 4 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 ST - What are the current outcomes of advanced gastrointestinal stromal tumors: Who are the long-term survivors treated initially with imatinib? T2 - Medical Oncology TI - What are the current outcomes of advanced gastrointestinal stromal tumors: Who are the long-term survivors treated initially with imatinib? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887030495&doi=10.1007%2fs12032-013-0765-7&partnerID=40&md5=767adddacfaee66c5fc4eae3467c4bd0 VL - 30 ID - 4136 ER - TY - JOUR AD - Global Medical Affairs Dermatology, Bayer Pharma AG, Müllerstrasse 170-178, DE-13342 Berlin, Germany AU - Sieber, M. A. AU - Hegel, J. K. E. DB - Scopus DO - 10.1159/000354888 IS - SUPPL.1 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2013 SP - 9-17 ST - Azelaic acid: Properties and mode of action T2 - Skin Pharmacology and Physiology TI - Azelaic acid: Properties and mode of action UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890110527&doi=10.1159%2f000354888&partnerID=40&md5=fa3c52fb15d3b699acbeb07c13ead3a4 VL - 27 ID - 4140 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Oncology, University of Alberta, Edmonton, Canada Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Veasey Rodrigues, H. AU - Baracos, V. E. AU - Wheler, J. J. AU - Parsons, H. A. AU - Hong, D. S. AU - Naing, A. AU - Fu, S. AU - Falchoock, G. AU - Tsimberidou, A. M. AU - Piha-Paul, S. AU - Chisholm, G. AU - Kurzrock, R. DB - Scopus DO - 10.1016/j.ejca.2013.06.026 IS - 15 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2013 SP - 3068-3075 ST - Body composition and survival in the early clinical trials setting T2 - European Journal of Cancer TI - Body composition and survival in the early clinical trials setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884905418&doi=10.1016%2fj.ejca.2013.06.026&partnerID=40&md5=aa1e1fb31e768d4b414a3f65ca8fc264 VL - 49 ID - 4143 ER - TY - JOUR AD - Hematology Division, Università degli Studi di Torino, Turin, Italy Hematology Division, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy AU - Cerrano, M. AU - Crisà, E. AU - Pregno, P. AU - Aguzzi, C. AU - Riccomagno, P. AU - Boccadoro, M. AU - Ferrero, D. DB - Scopus DO - 10.1002/ajh.23501 IS - 10 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2013 SP - 838-842 ST - Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients T2 - American Journal of Hematology TI - Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884729410&doi=10.1002%2fajh.23501&partnerID=40&md5=79f9a69b7df2c0287a99829f61c9ed8d VL - 88 ID - 4145 ER - TY - JOUR AD - Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United States AU - Nagle, S. J. AU - Woo, K. AU - Schuster, S. J. AU - Nasta, S. D. AU - Stadtmauer, E. AU - Mick, R. AU - Svoboda, J. DB - Scopus DO - 10.1002/ajh.23524 IS - 10 M3 - Article N1 - Cited By :72 Export Date: 18 November 2020 PY - 2013 SP - 890-894 ST - Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era T2 - American Journal of Hematology TI - Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884708515&doi=10.1002%2fajh.23524&partnerID=40&md5=fcfa49a41dff079884f90d71cb298916 VL - 88 ID - 4146 ER - TY - JOUR AD - Division of Haematology and Internal Medicine, Department of Clinical and Biological Science, University of Turin, Turin, Italy Bome Marrow Unit, Molinette Hospital, Turin, Italy AU - Fava, C. AU - Rege-Cambrin, G. AU - Busca, A. AU - Gottardi, E. AU - Daraio, F. AU - Saglio, G. DB - Scopus DO - 10.1016/j.clml.2013.05.017 IS - SUPPL. 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - S272-S275 ST - Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84889058902&doi=10.1016%2fj.clml.2013.05.017&partnerID=40&md5=f4c3b823412842e0bf0fd97a275f60c7 VL - 13 ID - 4149 ER - TY - JOUR AD - Pediatric Hematology and Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Pediatric Hematology/Oncology/BMT, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, United States AU - Teachey, D. T. AU - Hunger, S. P. DB - Scopus DO - 10.1111/bjh.12442 IS - 5 M3 - Review N1 - Cited By :53 Export Date: 18 November 2020 PY - 2013 SP - 606-620 ST - Predicting relapse risk in childhood acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Predicting relapse risk in childhood acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881669095&doi=10.1111%2fbjh.12442&partnerID=40&md5=720cd31f17afa5610178ac199b7a5e00 VL - 162 ID - 4150 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China Peking-Tsinghua Center for Life Sciences, Beijing 100871, China AU - Qin, Y. Z. AU - Jiang, Q. AU - Jiang, H. AU - Li, J. L. AU - Li, L. D. AU - Zhu, H. H. AU - Lai, Y. Y. AU - Lu, X. J. AU - Liu, Y. R. AU - Jiang, B. AU - Huang, X. J. DB - Scopus DO - 10.1016/j.leukres.2013.06.003 IS - 9 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2013 SP - 1035-1040 ST - Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABLIS or log reduction from the baseline level? T2 - Leukemia Research TI - Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABLIS or log reduction from the baseline level? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880963686&doi=10.1016%2fj.leukres.2013.06.003&partnerID=40&md5=986c5ec831fb646feef26a7dc43e69ac VL - 37 ID - 4153 ER - TY - JOUR AD - Institute of Stomatology, Nanjing Medical University, Nanjing, China Department of Orthodontics, School of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing 210029, China Department of Periodontics, School of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing 210029, China AU - Li, L. AU - Han, M. AU - Li, S. AU - Wang, L. AU - Xu, Y. DB - Scopus DO - 10.1089/dna.2013.2070 IS - 9 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2013 SP - 488-497 ST - Cyclic tensile stress during physiological occlusal force enhances osteogenic differentiation of human periodontal ligament cells via ERK1/2-Elk1 MAPK pathway T2 - DNA and Cell Biology TI - Cyclic tensile stress during physiological occlusal force enhances osteogenic differentiation of human periodontal ligament cells via ERK1/2-Elk1 MAPK pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882994341&doi=10.1089%2fdna.2013.2070&partnerID=40&md5=a68f04200b060597227fc0d202794844 VL - 32 ID - 4154 ER - TY - JOUR AD - Development of Biomolecular therapies, Experimental Oncology Lab, Rizzoli Institute, Via Di Barbiano 1/10, 40136 Bologna, Italy Clinical Oncology, Rizzoli Institute, Bologna, Italy Department of Health, University of Catanzaro, Catanzaro, Italy AU - Manara, M. C. AU - Garofalo, C. AU - Ferrari, S. AU - Belfiore, A. AU - Scotlandi, K. DB - Scopus DO - 10.2174/1381612811319300004 IS - 30 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2013 SP - 5344-5361 ST - Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis T2 - Current Pharmaceutical Design TI - Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881357185&doi=10.2174%2f1381612811319300004&partnerID=40&md5=0984aaa7c92ce14882906eb170e9dcf5 VL - 19 ID - 4155 ER - TY - JOUR AD - Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada National Cancer Institute, Bethesda, MD 20852-7426, United States Juravinski Cancer Centre, 699 Concession Street, Hamilton, ON L8V 5C2, Canada AU - Sahebjam, S. AU - Bedard, P. L. AU - Castonguay, V. AU - Chen, Z. AU - Reedijk, M. AU - Liu, G. AU - Cohen, B. AU - Zhang, W. J. AU - Clarke, B. AU - Zhang, T. AU - Kamel-Reid, S. AU - Chen, H. AU - Ivy, S. P. AU - Razak, A. R. A. AU - Oza, A. M. AU - Chen, E. X. AU - Hirte, H. W. AU - McGarrity, A. AU - Wang, L. AU - Siu, L. L. AU - Hotte, S. J. DB - Scopus DO - 10.1038/bjc.2013.380 IS - 4 M3 - Article N1 - Cited By :50 Export Date: 18 November 2020 PY - 2013 SP - 943-949 ST - A phase i study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) T2 - British Journal of Cancer TI - A phase i study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883185608&doi=10.1038%2fbjc.2013.380&partnerID=40&md5=44b113a8488fcc554f76602dd68b1767 VL - 109 ID - 4156 ER - TY - JOUR AD - Department of Dermatology, Columbia University, 1150 Street, St. Nicholas Avenue, New York, NY 10032, United States Department of Pathology, Mount Sinai Medical School, New York, NY, United States Department of Bioinformatics, Columbia University, New York, NY, United States Melanoma Research Center, Wistar Institute, Philadelphia, PA, United States Department of Pathology, Columbia University, New York, NY, United States Department of Cancer Research, Fachklinik Hornheide, Munster, Germany Department of Biostatistics, Columbia University, New York, NY, United States AU - Yang, Y. AU - Wu, J. AU - Demir, A. AU - Castillo-Martin, M. AU - Melamed, R. D. AU - Zhang, G. AU - Fukunaga-Kanabis, M. AU - Perez-Lorenzo, R. AU - Zheng, B. AU - Silvers, D. N. AU - Brunner, G. AU - Wang, S. AU - Rabadan, R. AU - Cordon-Cardo, C. AU - Celebi, J. T. DB - Scopus DO - 10.1038/onc.2012.367 IS - 31 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2013 SP - 3627-3637 ST - GAB2 induces tumor angiogenesis in NRAS-driven melanoma T2 - Oncogene TI - GAB2 induces tumor angiogenesis in NRAS-driven melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881219979&doi=10.1038%2fonc.2012.367&partnerID=40&md5=f166c18e8282512b64d0b51abe8c8b87 VL - 32 ID - 4157 ER - TY - JOUR AD - Department of Clinical Pharmacology Pfizer, 500 Arcola Road, Collegeville, PA 19426, United States AU - Abbas, R. AU - Leister, C. AU - Sonnichsen, D. DB - Scopus DO - 10.1007/s40261-013-0103-z IS - 8 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2013 SP - 589-595 ST - A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects T2 - Clinical Drug Investigation TI - A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880875942&doi=10.1007%2fs40261-013-0103-z&partnerID=40&md5=e8dc4b1f5905fd72d459dc7cc5270aa5 VL - 33 ID - 4159 ER - TY - JOUR AU - Greene, M. AU - Kobierska, M. AU - Kent, P. M. AU - Piasecki, P. DB - Scopus DO - 10.1016/j.currproblcancer.2013.07.011 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 236-243 ST - Survivorship in young patients with bone cancer T2 - Current Problems in Cancer TI - Survivorship in young patients with bone cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887545130&doi=10.1016%2fj.currproblcancer.2013.07.011&partnerID=40&md5=15f54c734c5eeae6293e96624b54d2a5 VL - 37 ID - 4161 ER - TY - JOUR AD - Haematology Department, Royal Liverpool University Hospital, Liverpool, United Kingdom Haematology Department, Warrington Hospital, Lovely Lane, Warrington, United Kingdom Haematology Department, Countess of Chester Hospital, Liverpool Road, Chester, United Kingdom Haematology Department, Southport District General Hospital, Town Lane, Kew, Southport, United Kingdom Department of Haematology, Arrowe Park Hospital, Upton, Wirral, United Kingdom Haematology Department, University Hospital Aintree, Liverpool, United Kingdom Haematology Department, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, United Kingdom Alaw Unit, Ysbyty Gwynedd Hospital, Bangor, United Kingdom AU - Francis, S. AU - Lucas, C. AU - Lane, S. AU - Wang, L. AU - Watmough, S. AU - Knight, K. AU - Bell, J. AU - Kaleel-Rahman, M. AU - Lee, E. AU - O'Brien, D. AU - Butt, N. M. AU - Sadik, W. AU - De Soysa, L. AU - Seale, J. R. C. AU - Salim, R. AU - Clark, R. E. DB - Scopus DO - 10.1016/j.leukres.2013.04.003 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2013 SP - 752-758 ST - A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia T2 - Leukemia Research TI - A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878490313&doi=10.1016%2fj.leukres.2013.04.003&partnerID=40&md5=6a03c92388100c57ff53dea129c2fe29 VL - 37 ID - 4162 ER - TY - JOUR AD - Paul o'Gorman Leukaemia Research Centre, University of Glasgow, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, United Kingdom AU - Campbell, V. AU - Copland, M. DB - Scopus DO - 10.2217/cpr.13.43 IS - 4 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 415-425 ST - Dasatinib for the treatment of chronic phase chronic myeloid leukemia T2 - Clinical Practice TI - Dasatinib for the treatment of chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880237702&doi=10.2217%2fcpr.13.43&partnerID=40&md5=cf19bf5e2539ec7f8022b4c0e81524ef VL - 10 ID - 4164 ER - TY - JOUR AD - Ashirwad Haematology Centre, Ghamat Lodge, 804/A, Dr. B. Ambedkar Road, Mumbai - 400 014, Maharashtra, India AU - Agarwal, M. B. AU - Agarwal, U. AU - Rathi, S. AU - Masurkar, S. AU - Zaveri, B. DB - Scopus DO - 10.4103/0971-5851.123741 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 199-203 ST - Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009 T2 - Indian Journal of Medical and Paediatric Oncology TI - Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891845037&doi=10.4103%2f0971-5851.123741&partnerID=40&md5=b548787d576b9747d924624266f3fcfa VL - 34 ID - 4165 ER - TY - JOUR AD - USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Los Angeles, CA 90033, United States University of Alabama at Birmingham, Birmingham, AL, United States Clinical Assay Unit Phase I-II, Virgen del Rocío University Hospital, Seville University, Seville, Spain Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH, United States Bristol-Myers Squibb, Princeton, NJ, United States AU - El-Khoueiry, A. AU - Posey, J. A. AU - Castillo Ferrando, J. R. AU - Krishnamurthi, S. S. AU - Syed, S. AU - Kollia, G. AU - Walters, I. AU - Fischer, B. S. AU - Masson, E. DB - Scopus DO - 10.1007/s00280-013-2168-z IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - 53-64 ST - The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases T2 - Cancer Chemotherapy and Pharmacology TI - The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879799535&doi=10.1007%2fs00280-013-2168-z&partnerID=40&md5=b9c47f6f4cc438b355c7fda8cdb8efc5 VL - 72 ID - 4167 ER - TY - JOUR AD - Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatric Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India AU - Narayanan, K. R. AU - Bansal, D. AU - Walia, R. AU - Sachdeva, N. AU - Bhansali, A. AU - Varma, N. AU - Marwaha, R. K. DB - Scopus DO - 10.1002/pbc.24397 IS - 7 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2013 SP - 1148-1153 ST - Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis T2 - Pediatric Blood and Cancer TI - Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878255303&doi=10.1002%2fpbc.24397&partnerID=40&md5=17873bba91dbbd268291b55b4957e8ed VL - 60 ID - 4168 ER - TY - JOUR AD - Servicio de Hematología, Hospital Universitario 'Dr. José Eleuterio González', UANL, Mexico Departamento de Bioquímica y Medicina Molecular, UANL, Mexico AU - Gutierrez-Aguirre, C. H. AU - Garcia-Rodriguez, F. AU - Ortiz-Galvez, V. M. AU - Cantu-Rodriguez, O. G. AU - Salazar-Riojas, R. AU - Martinez-Gonzalez, O. L. AU - Gonzalez-Llano, O. AU - Jaime-Pérez, J. C. AU - Ortiz-Lopez, R. AU - Flores-Jimenez, J. A. AU - Alatorre-Ricardo, J. AU - Mancias-Guerra, C. AU - Gomez-Almaguer, D. DB - Scopus DO - 10.1179/1607845412Y.0000000069 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - 224-229 ST - Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia T2 - Hematology TI - Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880008373&doi=10.1179%2f1607845412Y.0000000069&partnerID=40&md5=6a0c61cb7035f7f8d024aad7d7b5e1e9 VL - 18 ID - 4169 ER - TY - JOUR AD - Mersin University, Medical School, Department of Pathology, Turkey Mersin University, Medical School, Department of Biostatistics, Turkey Mersin University, Medical School, Department of Medical Oncology, Turkey Mersin University, Medical School, Department of General Surgery, Turkey AU - Kara, T. AU - Serinsoz, E. AU - Arpaci, R. B. AU - Gubur, O. AU - Orekici, G. AU - Ata, A. AU - Colak, T. AU - Arican, A. DB - Scopus DO - 10.1016/j.prp.2013.04.005 IS - 7 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2013 SP - 413-417 ST - Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors T2 - Pathology Research and Practice TI - Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880041202&doi=10.1016%2fj.prp.2013.04.005&partnerID=40&md5=ab0c42cc183b6fb500bca3a89f346f3e VL - 209 ID - 4170 ER - TY - JOUR AD - Department of Surgery, St James s Hospital, James s St, Dublin 8, Ireland AU - Mongan, A. M. AU - Malik, V. AU - Rowley, S. AU - Claxton, Z. AU - Muldoon, C. AU - O'Toole, D. AU - Ravi, N. AU - Reynolds, J. V. DB - Scopus IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 ST - Presentation and management of gastrointestinal stromal tumours T2 - Irish Medical Journal TI - Presentation and management of gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878977227&partnerID=40&md5=c0b8dc6fb3e8b10a319f68704c874147 VL - 106 ID - 4172 ER - TY - JOUR AD - Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Jain, P. AU - Kantarjian, H. AU - Nazha, A. AU - O’Brien, S. AU - Jabbour, E. AU - Romo, C. G. AU - Pierce, S. AU - Cardenas-Turanzas, M. AU - Verstovsek, S. AU - Borthakur, G. AU - Ravandi, F. AU - Quintás-Cardama, A. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2013-03-490128 IS - 24 M3 - Article N1 - Cited By :100 Export Date: 18 November 2020 PY - 2013 SP - 4867-4874 ST - Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: Results with four tyrosine kinase inhibitor modalities T2 - Blood TI - Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: Results with four tyrosine kinase inhibitor modalities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881289808&doi=10.1182%2fblood-2013-03-490128&partnerID=40&md5=55de7f1ba986f4dde540bce78982e5c7 VL - 121 ID - 4173 ER - TY - JOUR AD - Department of Pediatrics, Klinik und Poliklinik für Kinder- und Jugendmedizin, University Hospital Carl Gustav Caruso, Fetscherstraße 74, 1307 Dresden, Germany Medical Faculty Carl Gustav Caruso, Institute for Medical Informatics and Biometry, Dresden, Germany Medical Faculty Carl Gustav Caruso Experimental Center, Dresden, Germany AU - Ulmer, A. AU - Tabea Tauer, J. AU - Glauche, I. AU - Jung, R. AU - Suttorp, M. DB - Scopus DO - 10.1055/s-0033-1343483 IS - 3 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2013 SP - 120-126 ST - TK inhibitor treatment disrupts growth hormone axis: Clinical observations in children with CML and experimental data from a Juvenile Animal Model T2 - Klinische Padiatrie TI - TK inhibitor treatment disrupts growth hormone axis: Clinical observations in children with CML and experimental data from a Juvenile Animal Model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878387514&doi=10.1055%2fs-0033-1343483&partnerID=40&md5=4f0358dd9197b3af61bf005f8573b69e VL - 225 ID - 4174 ER - TY - JOUR AD - Department of Pediatrics, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Chuo-ku, Niigata City, Niigata 951-8566, Japan Department of Pediatrics, Niigata University Graduate School of Medicine, Niigata, Japan AU - Watanabe, A. AU - Chansu, S. AU - Ogawa, A. AU - Asami, K. AU - Imamura, M. DB - Scopus DO - 10.1111/ped.12019 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2013 SP - e56-e58 ST - Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Pediatrics International TI - Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879361000&doi=10.1111%2fped.12019&partnerID=40&md5=7bed62b52cd34b782fd196586355c450 VL - 55 ID - 4177 ER - TY - JOUR AD - Department of Hematology, Oncology of the University Hospitals, Frankfurt, Germany Department of Hematology, Oncology of the University Hospitals, Tübingen, Germany Department of Hematology, Oncology of the University Hospitals, Heidelberg, Germany Department of Hematology, Oncology of the University Hospitals, Dresden, Germany Department of Hematology, Hemostasis, Oncology, Stem Cell Transplantation, Hannover Medical School, Hannover, Germany Department of Bone Marrow Transplantation, Westdeutsches Tumorzentrum, Universitätsklinikum Essen, Essen, Germany Department of Hematology, Oncology of the University Hospitals, Leipzig, Germany Department of Hematology, Oncology of the University Hospitals, Berlin, Germany Department of Hematology, Oncology of the University Hospitals, Münster, Germany Department of Bone Marrow Transplantation, Medizinische Klinik 5 des Klinikum Nürnberg Nord, Nürnberg, Germany Deutsche Klinik für Diagnostik, Wiesbaden, Germany Evangelisches Krankenhaus Hamm, Germany Department of Hematology and Oncology, Universitätsklinikum des Saarlandes, Homburg Saar, Germany Medizinische Klinik und Poliklinik, Uni-Klinikum Campus Kiel II, Kiel, Germany Sektion Stammzell und Immuntherapie im Dr Mildred-Scheel-Haus, Klinik für Innere Medizin i, Uni-Klinikum Campus Kiel, Kiel, Germany AU - Pfeifer, H. AU - Wassmann, B. AU - Bethge, W. AU - Dengler, J. AU - Bornhäuser, M. AU - Stadler, M. AU - Beelen, D. AU - Vucinic, V. AU - Burmeister, T. AU - Stelljes, M. AU - Faul, C. AU - Dreger, P. AU - Kiani, A. AU - Schäfer-Eckart, K. AU - Schwerdtfeger, R. AU - Lange, E. AU - Kubuschok, B. AU - Horst, H. A. AU - Gramatzki, M. AU - Brück, P. AU - Serve, H. AU - Hoelzer, D. AU - Gökbuget, N. AU - Ottmann, O. G. DB - Scopus DO - 10.1038/leu.2012.352 IS - 6 M3 - Article N1 - Cited By :127 Export Date: 18 November 2020 PY - 2013 SP - 1254-1262 ST - Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia T2 - Leukemia TI - Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878915659&doi=10.1038%2fleu.2012.352&partnerID=40&md5=7468369177a154a45532d4fb66547038 VL - 27 ID - 4179 ER - TY - JOUR AD - University of Rochester Medical Center, Rochester, NY, United States Westchester Medical Center, New York Medical College, Valhalla, NY, United States AU - Schwartz, R. G. AU - Jain, D. AU - Storozynsky, E. DB - Scopus DO - 10.1007/s12350-013-9707-1 IS - 3 M3 - Review N1 - Cited By :63 Export Date: 18 November 2020 PY - 2013 SP - 443-464 ST - Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively T2 - Journal of Nuclear Cardiology TI - Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878013653&doi=10.1007%2fs12350-013-9707-1&partnerID=40&md5=fc2e5d2500270797a5d4869c321ae000 VL - 20 ID - 4180 ER - TY - JOUR AD - Division of Molecular Life Sciences, Tokai University School of Medicine, 143 Shimokasuya, Isehara Kanagawa 259-1193, Japan Institute of Cellular Medicine, University of Newcastle, Medical School Framlington Place, Newcastle upon Tyne NE2 4HH, United Kingdom Department of Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara Kanagawa 259-1193, Japan Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics Yata, 111, Mishima, Shizuoka 411-8540, Japan Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden Chikusaku, Nagoya 646-8681, Japan AU - Harkensee, C. AU - Oka, A. AU - Onizuka, M. AU - Middleton, P. G. AU - Inoko, H. AU - Nakaoka, H. AU - Gennery, A. R. AU - Ando, K. AU - Morishima, Y. DB - Scopus DO - 10.1007/s00251-013-0691-z IS - 6 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2013 SP - 417-427 ST - Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation T2 - Immunogenetics TI - Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878017009&doi=10.1007%2fs00251-013-0691-z&partnerID=40&md5=2eca51a123f26a787e6160202f7fb5e3 VL - 65 ID - 4183 ER - TY - JOUR AD - Pediatric Hospital, University of Tübingen, Germany University Hospital for Children and Adolescents, Goethe University, Frankfurt, Germany AU - Niethammer, D. AU - Bader, P. AU - Handgretinger, R. AU - Klingebiel, T. DB - Scopus DO - 10.1055/s-0033-1337970 IS - SUPPL1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2013 SP - S94-S98 ST - Stem cell transplantation T2 - Klinische Padiatrie TI - Stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878099045&doi=10.1055%2fs-0033-1337970&partnerID=40&md5=aa7d4e4213264d71a42f31d2bde9fba7 VL - 225 ID - 4186 ER - TY - JOUR AD - Histopathology Department, School of Medicine, Trinity College Dublin, Dublin, Ireland National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland Computational Biology, Systems Biology/Immunology, Animal and Grassland Research and Innovation Centre, Teagasc, Dunsany, County Meath, Ireland Centre for Cancer Research, National Cancer Institute, Bethesda, MD, United States Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA, United States Institute of Pathology, University of Cologne Medical Centre, Cologne, Germany Department of Pathology, Stanford University Medical Centre, Stanford, CA, United States Department of Human Genetics, Catholic University Leuven and University Hospitals, Leuven, Belgium AU - Kelly, L. AU - Bryan, K. AU - Kim, S. Y. AU - Janeway, K. A. AU - Killian, J. K. AU - Schildhaus, H. U. AU - Miettinen, M. AU - Helman, L. AU - Meltzer, P. S. AU - van de Rijn, M. AU - Debiec-Rychter, M. AU - O'Sullivan, M. C7 - e64102 DB - Scopus DO - 10.1371/journal.pone.0064102 IS - 5 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2013 ST - Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST] T2 - PLoS ONE TI - Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST] UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878144906&doi=10.1371%2fjournal.pone.0064102&partnerID=40&md5=a0c0ce70018df59784398c7e6bb180c5 VL - 8 ID - 4187 ER - TY - JOUR AD - Department of Surgical Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan Department of Surgery, Osaka University Graduate School of Medicine, Suita, Japan Department of Surgery, Osaka Police Hospital, Osaka, Japan AU - Liu, N. N. AU - Ohkouchi, M. AU - Hashikura, Y. AU - Kajimoto, N. AU - Matsuda, I. AU - Isozaki, K. AU - Toh, Y. AU - Takahashi, T. AU - Nishida, T. AU - Hirota, S. DB - Scopus DO - 10.1038/labinvest.2013.43 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 502-507 ST - Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib-and nilotinib-sensitive than that with duplication of Ala502Tyr503 T2 - Laboratory Investigation TI - Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib-and nilotinib-sensitive than that with duplication of Ala502Tyr503 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877251422&doi=10.1038%2flabinvest.2013.43&partnerID=40&md5=d45e4c6d9454967abb4dc6f1727a6b12 VL - 93 ID - 4193 ER - TY - JOUR AD - Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, United States Department of Ophthalmology, Kyung Hee University Hospital, Gangdong, Seoul, South Korea AU - Kang, M. H. AU - Oh, D. J. AU - Kang, J. AU - Rhee, D. J. DB - Scopus DO - 10.1167/iovs.12-11474 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2013 SP - 2523-2532 ST - Regulation of SPARC by transforming growth factor β2 in human trabecular meshwork T2 - Investigative Ophthalmology and Visual Science TI - Regulation of SPARC by transforming growth factor β2 in human trabecular meshwork UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876119431&doi=10.1167%2fiovs.12-11474&partnerID=40&md5=38947a4e84efb2d68bb8a756a75635cb VL - 54 ID - 4194 ER - TY - JOUR AD - Department of Genetics, University of Alabama at Birmingham, 1720 Second Ave S, Kaul 230, Birmingham, AL 35294, United States Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine, Cambridge, MA, United States AU - Korf, B. R. AU - Rehm, H. L. DB - Scopus DO - 10.1001/jama.2013.3239 IS - 14 M3 - Review N1 - Cited By :86 Export Date: 18 November 2020 PY - 2013 SP - 1511-1521 ST - New approaches to molecular diagnosis T2 - JAMA - Journal of the American Medical Association TI - New approaches to molecular diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875932002&doi=10.1001%2fjama.2013.3239&partnerID=40&md5=ee49e239b79bfd3abebc751702a46b4a VL - 309 ID - 4195 ER - TY - JOUR AD - Department for Stem Cell Transplantation, University Cancer Center Hamburg (UCCH), Martinistr. 52, 20246 Hamburg, Germany Department of Hematology and Immunology, Obafemi Awolowo University (OAU), Ile-Ife, Nigeria Department of Oncology and Hematology, University Cancer Center Hamburg (UCCH), Hamburg, Germany Department for Oncology and Haematology, University Hospital, Medical Faculty Halle, Halle, Germany Department of Pediatric Hematology and Oncology, University of Hamburg, Hamburg, Germany MLL Munich Leukemia Laboratory, Munich, Germany AU - Oyekunle, A. AU - Zander, A. R. AU - Binder, M. AU - Ayuk, F. AU - Zabelina, T. AU - Christopeit, M. AU - Stübig, T. AU - Alchalby, H. AU - Schafhausen, P. AU - Lellek, H. AU - Wolschke, C. AU - Müller, I. AU - Bacher, U. AU - Kröger, N. DB - Scopus DO - 10.1007/s00277-012-1650-8 IS - 4 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2013 SP - 487-496 ST - Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy T2 - Annals of Hematology TI - Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877028031&doi=10.1007%2fs00277-012-1650-8&partnerID=40&md5=9a94687de5c051cb88b7e541a856e63e VL - 92 ID - 4200 ER - TY - JOUR AD - Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea Departments of Urology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea Asan Cancer Centre, University of Ulsan College of Medicine, Seoul, South Korea AU - Park, S. J. AU - Lee, J. L. AU - Park, I. AU - Park, K. AU - Ahn, Y. AU - Ahn, J. H. AU - Lee, D. H. AU - Ahn, S. AU - Song, C. AU - Hong, J. H. AU - Kim, C. S. AU - Ahn, H. DB - Scopus DO - 10.1159/000346484 IS - 6 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2013 SP - 468-474 ST - Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma T2 - Chemotherapy TI - Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875645855&doi=10.1159%2f000346484&partnerID=40&md5=daf3a48980a742dcf7917bdf18f370ba VL - 58 ID - 4201 ER - TY - JOUR AD - Division of Integrated Oncology, Institute of Biomedical Research and Innovation, Japan AU - Hata, A. AU - Fujita, S. AU - Kaji, R. AU - Nanjo, S. AU - Katakami, N. DB - Scopus DO - 10.2169/internalmedicine.52.8543 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2013 SP - 599-603 ST - Dose reduction or intermittent administration of erlotinib: Which is better for patients suffering from intolerable toxicities? T2 - Internal Medicine TI - Dose reduction or intermittent administration of erlotinib: Which is better for patients suffering from intolerable toxicities? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874742163&doi=10.2169%2finternalmedicine.52.8543&partnerID=40&md5=f8afe38796b708f735410734f9f2840f VL - 52 ID - 4205 ER - TY - JOUR AD - Strelitz Diabetes Center and Neuroendocrine Unit, Department of Internal Medicine, Eastern Virginia Medical School, PA-C, 855 W Brambleton Ave, Norfolk, VA 23510, United States AU - Bourcier, M. E. AU - Vinik, A. I. DB - Scopus DO - 10.1097/MPA.0b013e31825c53fa IS - 2 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2013 SP - 348-352 ST - Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma) T2 - Pancreas TI - Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874058676&doi=10.1097%2fMPA.0b013e31825c53fa&partnerID=40&md5=166daa5f7e8e564fe07bde07782d258a VL - 42 ID - 4208 ER - TY - JOUR AD - Mayo Clinic, 13400 E. Shea Blvd., Scottsdale, AZ 85259, United States Astex Pharmaceuticals Inc., 4140 Dublin Blvd., Ste. 200, Dublin, CA 94568, United States South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio TX 78229, United States AU - Tibes, R. AU - Fine, G. AU - Choy, G. AU - Redkar, S. AU - Taverna, P. AU - Oganesian, A. AU - Sahai, A. AU - Azab, M. AU - Tolcher, A. W. DB - Scopus DO - 10.1007/s00280-012-2019-3 IS - 2 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2013 SP - 463-471 ST - A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors T2 - Cancer Chemotherapy and Pharmacology TI - A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874118848&doi=10.1007%2fs00280-012-2019-3&partnerID=40&md5=28257ccb718a34b12524dc95f3447b74 VL - 71 ID - 4213 ER - TY - JOUR AD - Department of Pharmacology, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy Institute of Hematology and Medical Oncology 'Landa Seràgnoli', Sant'Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy Department of Public Health, Epidemiological Service, Local Health Authority of Bologna, Via del Seminario, 1, 40068 San Lazzaro di Savena (BO), Italy Faculty of Statistics, University of Bologna, Via Belle Arti 41, Bologna I-40126, Italy Faculty of Education, Free University of Bolzano, Italy Adult Mesenchymal Tumour Medical Oncology Unit, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy AU - Angelini, S. AU - Pantaleo, M. A. AU - Ravegnini, G. AU - Zenesini, C. AU - Cavrini, G. AU - Nannini, M. AU - Fumagalli, E. AU - Palassini, E. AU - Saponara, M. AU - Di Battista, M. AU - Casali, P. G. AU - Hrelia, P. AU - Cantelli-Forti, G. AU - Biasco, G. DB - Scopus DO - 10.1016/j.phrs.2012.10.015 IS - 1 M3 - Article N1 - Cited By :52 Export Date: 18 November 2020 PY - 2013 SP - 1-6 ST - Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy T2 - Pharmacological Research TI - Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872339745&doi=10.1016%2fj.phrs.2012.10.015&partnerID=40&md5=129ac8d60b79f4983fbcdfc36d4d8680 VL - 68 ID - 4215 ER - TY - JOUR AD - INSERM UMR1037, Cancer Research Center of Toulouse, Pavillon Lefebvre, BP3028, Toulouse, France Laboratoire d'Hématologie, CHU Toulouse, Hô Pital Purpan, Toulouse, France Service d'Hématologie, CHU de Toulouse, Hô Pital Purpan, place du Dr Baylac, Toulouse Cedex 31059, France Université Toulouse III Paul Sabatier, Toulouse, France CNRS UMR5237, Université de Montpellier, CRBM, Montpellier, France AU - Fialin, C. AU - Larrue, C. AU - Vergez, F. AU - Sarry, J. E. AU - Bertoli, S. AU - Mansat-De Mas, V. AU - Demur, C. AU - Delabesse, E. AU - Payrastre, B. AU - Manenti, S. AU - Roche, S. AU - Récher, C. DB - Scopus DO - 10.1038/leu.2012.240 IS - 2 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 SP - 325-335 ST - The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors T2 - Leukemia TI - The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873568032&doi=10.1038%2fleu.2012.240&partnerID=40&md5=43fb2823b747988d9a9fab5b5aaa2af9 VL - 27 ID - 4217 ER - TY - JOUR AD - Hospital Pharmacy Department, Health Department of Gandia, Valencia, Spain Health Department, Hospital General, Valencia, Spain AU - Pérez Feliu, A. AU - Marco Garbayo, J. L. AU - Blasco Segura, P. AU - Pérez Castelĺo, I. AU - Peiró Barber, E. DB - Scopus IS - 6 M3 - Article N1 - Export Date: 18 November 2020 PY - 2013 SP - 390-396 ST - Adherence to treatment with tyrosine kinase inhibitors T2 - Atencion Farmaceutica TI - Adherence to treatment with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895782848&partnerID=40&md5=6e75cd7c8862658cc49cca209eb3ff08 VL - 15 ID - 4220 ER - TY - JOUR AD - Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan Bone Marrow and Stem Cell Transplantation Program, King Hussein Cancer Center, Amman, Jordan AU - Salami, K. AU - Alkayed, K. AU - Halalsheh, H. AU - Hussein, A. A. AU - Riziq, M. AU - Madanat, F. DB - Scopus DO - 10.1016/j.hemonc.2013.03.001 IS - 1 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2013 SP - 34-41 ST - Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) T2 - Hematology/ Oncology and Stem Cell Therapy TI - Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884676390&doi=10.1016%2fj.hemonc.2013.03.001&partnerID=40&md5=c7b18cd2469b0bccf4837458ffebc843 VL - 6 ID - 4223 ER - TY - JOUR AD - Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, United States Texas Children's Cancer Center, Section on Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States AU - Hsu, D. AU - Shohet, J. M. AU - Kim, E. S. DB - Scopus DO - 10.2174/22115528112019990004 IS - 1 M3 - Review N1 - Export Date: 18 November 2020 PY - 2013 SP - 30-39 ST - Targeting vascular endothelial growth factor in neuroblastoma T2 - Current Angiogenesis TI - Targeting vascular endothelial growth factor in neuroblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952995753&doi=10.2174%2f22115528112019990004&partnerID=40&md5=ec5ed1974c115e6f1931c0d625b49e86 VL - 2 ID - 4224 ER - TY - JOUR AD - Department of Mathematics and Statistics, California State University, 1250 Bellflower Boulevard, Long Beach, CA 90840-1001, United States Department of Computer Science, University of California, Santa Cruz, CA 95064, United States Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, FDA, Jefferson, AR 72079, United States Graduate Institute of Biostatistics, Biostatistics Center, China Medical University, Taichung, Taiwan AU - Moon, H. AU - Lopez, K. L. AU - Lin, G. I. AU - Chen, J. J. DB - Scopus DO - 10.1155/2013/393020 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2013 SP - 661-667 ST - Sex-specific genomic biomarkers for individualized treatment of life-threatening diseases T2 - Disease Markers TI - Sex-specific genomic biomarkers for individualized treatment of life-threatening diseases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888862868&doi=10.1155%2f2013%2f393020&partnerID=40&md5=d796cc1b1bcffb65485dfb93d15bf556 VL - 35 ID - 4227 ER - TY - JOUR AD - HRB Clinical Research Facilities, National University of Ireland Galway, Trinity College Dublin, Galway, Ireland Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States Chaim Sheba Medical Center, Tel-Hashomer, Israel Universitätsklinikum Jena, Jena, Germany Johann Wolfgang Goethe Universität, Frankfurt, Germany Division of Cellular Therapy, Duke University Hospital, Durham, NC, United States University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States Merck and Co., Inc., North Wales, PA, United States Hematology and Oncology Department, Charité, Berlin, Germany University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Giles, F. J. AU - Swords, R. T. AU - Nagler, A. AU - Hochhaus, A. AU - Ottmann, O. G. AU - Rizzieri, D. A. AU - Talpaz, M. AU - Clark, J. AU - Watson, P. AU - Xiao, A. AU - Zhao, B. AU - Bergstrom, D. AU - Le Coutre, P. D. AU - Freedman, S. J. AU - Cortes, J. E. DB - Scopus DO - 10.1038/leu.2012.186 IS - 1 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2013 SP - 113-117 ST - MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia T2 - Leukemia TI - MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873570889&doi=10.1038%2fleu.2012.186&partnerID=40&md5=d93afb3ea93951515cc5715a7cde9226 VL - 27 ID - 4229 ER - TY - JOUR AD - HRB Clinical Research Facilities, National University of Ireland Galway, Trinity College, Dublin, Ireland Department of Hematology and Oncology, Charité-Humboldt-Universität, Campus Virchow Klinikum, Berlin, Germany H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, United States University of Chicago, Chicago, IL, United States Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-Universität, Düsseldorf, Germany Department of Medicine, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany Department of Hematology and Oncology, Universitätsklinikum Jena, Jena, Germany Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States Department of Cellular Biotechnologies and Hematology, University at Orbassano, Turin, Italy Institute of Medical and Veterinary Science, Adelaide, SA, Australia Department of Hematology/Oncology L and A Seragnoli, University of Bologna, Bologna, Italy Seoul St Mary's Hospital, Seoul, South Korea Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Giles, F. J. AU - Le Coutre, P. D. AU - Pinilla-Ibarz, J. AU - Larson, R. A. AU - Gattermann, N. AU - Ottmann, O. G. AU - Hochhaus, A. AU - Radich, J. P. AU - Saglio, G. AU - Hughes, T. P. AU - Martinelli, G. AU - Kim, D. W. AU - Novick, S. AU - Gillis, K. AU - Fan, X. AU - Cortes, J. AU - Baccarani, M. AU - Kantarjian, H. M. DB - Scopus DO - 10.1038/leu.2012.181 IS - 1 M3 - Article N1 - Cited By :147 Export Date: 18 November 2020 PY - 2013 SP - 107-112 ST - Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study T2 - Leukemia TI - Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873568081&doi=10.1038%2fleu.2012.181&partnerID=40&md5=5c564bc24c02a05821c766d910910c8f VL - 27 ID - 4230 ER - TY - JOUR AD - Policy Analysis Inc., Brookline, MA, United States GlaxoSmithKline, Philadelphia, PA, United States AU - Hagiwara, M. AU - Borker, R. AU - Oster, G. DB - Scopus DO - 10.1016/j.clinthera.2013.10.010 IS - 12 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 SP - 1955-1963.e2 ST - Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma T2 - Clinical Therapeutics TI - Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890314255&doi=10.1016%2fj.clinthera.2013.10.010&partnerID=40&md5=db7fe5b71c848f7ff4ca6d9ecae2ea6e VL - 35 ID - 4233 ER - TY - JOUR AD - Marine Science Institute, University of Texas at Austin, Port Aransas, TX 78373, United States AU - Pang, Y. AU - Dong, J. AU - Thomas, P. DB - Scopus DO - 10.1210/en.2012-1772 IS - 1 M3 - Article N1 - Cited By :110 Export Date: 18 November 2020 PY - 2013 SP - 283-295 ST - Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis T2 - Endocrinology TI - Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871689323&doi=10.1210%2fen.2012-1772&partnerID=40&md5=69b005aec6caf087eb54edec8055972a VL - 154 ID - 4236 ER - TY - JOUR AD - Department of Neurosurgery, Third Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530031, China Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States AU - Ma, H. AU - Sinha, B. AU - Pandya, R. S. AU - Lin, N. AU - Popp, A. J. AU - Li, J. AU - Yao, J. AU - Wang, X. DB - Scopus DO - 10.2174/156652412803833517 IS - 10 M3 - Review N1 - Cited By :29 Export Date: 18 November 2020 PY - 2012 SP - 1282-1296 ST - Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury T2 - Current Molecular Medicine TI - Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870202240&doi=10.2174%2f156652412803833517&partnerID=40&md5=fb3c6ef1cc35d4a08eb63327fc36a717 VL - 12 ID - 4238 ER - TY - JOUR AD - Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States AU - Spratt, D. E. AU - Lee, N. DB - Scopus DO - 10.2147/OTT.S28032 M3 - Review N1 - Cited By :31 Export Date: 18 November 2020 PY - 2012 SP - 297-308 ST - Current and emerging treatment options for nasopharyngeal carcinoma T2 - OncoTargets and Therapy TI - Current and emerging treatment options for nasopharyngeal carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873904977&doi=10.2147%2fOTT.S28032&partnerID=40&md5=2c3a66efa9b3c88e17e1413351808c43 VL - 5 ID - 4239 ER - TY - JOUR AD - Department of Molecular Medicine and Haematology, Faculty of Health Sciences, Wits Medical School, National Health Laboratory Services and University of the Witwatersrand, Parktown, Johannesburg 2195, South Africa National Cancer Registry and Research, NHLS/MRC Cancer Epidemiology Research Group, National Health Laboratory Services, Johannesburg, South Africa Department of Histopathology, Partner Drs Gritzman and Thatcher, The Wits University Donald Gordon Medical Centre, Johannesburg, South Africa Department of Anatomical Pathology, National Health Laboratory Service and University of Pretoria, Tshwane, South Africa Department of Anatomical Pathology, Faculty of Health Sciences, National Health Laboratory Service and University of the Free State, Bloemfontein, South Korea Department of Pathology, Edouard Herriot Hospital and University of Lyon, University Claude Bernard, Lyon, France Department of Medical Oncology, Center Leon Berard, University Claude Bernard, Lyon, France AU - Baker, G. AU - Babb, C. AU - Schnugh, D. AU - Nayler, S. AU - Louw, M. AU - Goedhals, J. AU - Bringuier, P. P. AU - Blay, J. Y. AU - Willem, P. DB - Scopus DO - 10.3892/ol.2012.1013 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2012 SP - 155-160 ST - Molecular characterisation of gastrointestinal stromal tumours in a South African population T2 - Oncology Letters TI - Molecular characterisation of gastrointestinal stromal tumours in a South African population UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869030780&doi=10.3892%2fol.2012.1013&partnerID=40&md5=c0171d660180bfe5be04f5eea5e4a9cc VL - 5 ID - 4240 ER - TY - JOUR AD - Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China AU - Alshorafa, A. K. H. AU - Guo, Q. AU - Zeng, F. AU - Chen, M. AU - Yin, R. AU - Tan, G. AU - Tang, Z. DB - Scopus DO - 10.1620/tiem.228.325 IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2012 SP - 325-332 ST - Psoriasis is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory molecule T2 - Tohoku Journal of Experimental Medicine TI - Psoriasis is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory molecule UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869021999&doi=10.1620%2ftiem.228.325&partnerID=40&md5=8ee66269e36c7c0bcdd944f5aad104ea VL - 228 ID - 4241 ER - TY - JOUR AD - Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany Division of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Carl Gustav Carus, Dresden, Germany Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany AU - Krumbholz, M. AU - Karl, M. AU - Tauer, J. T. AU - Thiede, C. AU - Rascher, W. AU - Suttorp, M. AU - Metzler, M. DB - Scopus DO - 10.1002/gcc.21989 IS - 11 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 1045-1053 ST - Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia T2 - Genes Chromosomes and Cancer TI - Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865980394&doi=10.1002%2fgcc.21989&partnerID=40&md5=c6fdea54407bd84aff0abfa59a235064 VL - 51 ID - 4242 ER - TY - JOUR AD - Rainbow Babies and Children's Hospital, Pediatric Hematology/Oncology, 11100 Euclid Avenue, Cleveland, OH 44106, United States AU - Norris, R. E. AU - Adamson, P. C. DB - Scopus DO - 10.1038/nrc3370 IS - 11 M3 - Review N1 - Cited By :36 Export Date: 18 November 2020 PY - 2012 SP - 776-782 ST - Challenges and opportunities in childhood cancer drug development T2 - Nature Reviews Cancer TI - Challenges and opportunities in childhood cancer drug development UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867839214&doi=10.1038%2fnrc3370&partnerID=40&md5=ef264d3b0e05a6c7cdcc8421021d3149 VL - 12 ID - 4243 ER - TY - JOUR AD - Division of Pediatric Endocrinology, Department of Pediatrics, Oregon Health and Science University, Portland, OR, United States Division of Pediatric Hematology/Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Department of Internal Medicine, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Department of Education, Oregon Health and Science University, Portland, OR, United States AU - Rastogi, M. V. AU - Stork, L. AU - Druker, B. AU - Blasdel, C. AU - Nguyen, T. AU - Boston, B. A. DB - Scopus DO - 10.1002/pbc.24121 IS - 5 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2012 SP - 840-845 ST - Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia T2 - Pediatric Blood and Cancer TI - Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866167173&doi=10.1002%2fpbc.24121&partnerID=40&md5=f60d368013669391d2fb681a1291d6b6 VL - 59 ID - 4244 ER - TY - JOUR AD - Medical Oncology Department, Centre François Baclesse, Caen, France Clinical Research Department, Centre François-Baclesse, 3 avenue Général Harris, 14076 Caen Cedex 5, France Unit of Biology and Innovative Therapies of Locally Aggressive Cancers, Groupe Régional d'Etudes sur le Cancer (GRECAN), Université de Caen, France Clinical Biology and Oncology Laboratory, Centre François Baclesse, Caen, France Medical Oncology Department, Centre Alexis Vautrin, Nancy, France Medical Oncology Department, Institut Gustave Roussy, Villejuif, France Medical Oncology Department, Centre Val d'Aurelle Paul Lamarque, Montpellier, France Medical Oncology Department, Centre Hospitalo-Universitaire Tenon, Paris, France Medical Oncology Department, Clinique Victor Hugo, Le Mans, France Medical Oncology Department, Centre Paul Strauss, Strasbourg, France Medical Oncology Department, Clinique Catherine de Sienne, Nantes, France Medical Oncology Department, Hôpital des Diaconesses, Paris, France Medical Oncology Department, Centre Hospitalier Universitaire, Caen, France AU - Lheureux, S. AU - Krieger, S. AU - Weber, B. AU - Pautier, P. AU - Fabbro, M. AU - Selle, F. AU - Bourgeois, H. AU - Petit, T. AU - Lortholary, A. AU - Plantade, A. AU - Briand, M. AU - Leconte, A. AU - Richard, N. AU - Vilquin, P. AU - Clarisse, B. AU - Blanc-Fournier, C. AU - Joly, F. DB - Scopus DO - 10.1097/IGC.0b013e31826d1438 IS - 9 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2012 SP - 1483-1488 ST - Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile : A phase 2 trial T2 - International Journal of Gynecological Cancer TI - Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile : A phase 2 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872300929&doi=10.1097%2fIGC.0b013e31826d1438&partnerID=40&md5=8d0c092b8a6220e62267b3ab9c81639c VL - 22 ID - 4245 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, United States AU - Naing, A. AU - Veasey-Rodrigues, H. AU - Hong, D. S. AU - Fu, S. AU - Falchook, G. S. AU - Wheler, J. J. AU - Tsimberidou, A. M. AU - Wen, S. AU - Fessahaye, S. N. AU - Golden, E. C. AU - Aaron, J. AU - Ewer, M. S. AU - Kurzrock, R. C7 - mds130 DB - Scopus DO - 10.1093/annonc/mds130 IS - 11 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 2960-2963 ST - Electrocardiograms (ECGs) in phase I anticancer drug development: The MD anderson cancer center experience with 8518 ECGs T2 - Annals of Oncology TI - Electrocardiograms (ECGs) in phase I anticancer drug development: The MD anderson cancer center experience with 8518 ECGs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868113707&doi=10.1093%2fannonc%2fmds130&partnerID=40&md5=7d92535961d3d5646af8b3fe4c9ee093 VL - 23 ID - 4246 ER - TY - JOUR AD - Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, China AU - Jin, Z. AU - Zhao, C. AU - Han, X. AU - Han, Y. C7 - 480 DB - Scopus DO - 10.1186/1471-2407-12-480 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2012 ST - Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression T2 - BMC Cancer TI - Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870656223&doi=10.1186%2f1471-2407-12-480&partnerID=40&md5=4eb7d4d0719e924e8ba83460b95d7783 VL - 12 ID - 4248 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, United States Pfizer, Cambridge, MA, United States Pfizer, San Diego, CA, United States Seoul St Mary's Hospital, Seoul, South Korea Universitäts-Klinikum Aachen, Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen, Germany Universitäts-Klinikum Hamburg-Eppendorf, Hamburg, Germany Research Center for Radiation Medicine, Academy of Medical Sciences, Kiev, Ukraine Vilnius University Hospital Santarškiu Klinikos, Vilnius University, Vilnius, Lithuania Birla Cancer Centre, SMS Medical College, Jaipur, India Pfizer Global Research and Development, Paris, France University Milano Bicocca, Monza, Italy AU - Cortes, J. E. AU - Kim, D. W. AU - Kantarjian, H. M. AU - Brümmendorf, T. H. AU - Dyagil, I. AU - Griskevicius, L. AU - Malhotra, H. AU - Powell, C. AU - Gogat, K. AU - Countouriotis, A. M. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1200/JCO.2011.38.7522 IS - 28 M3 - Article N1 - Cited By :308 Export Date: 18 November 2020 PY - 2012 SP - 3486-3492 ST - Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial T2 - Journal of Clinical Oncology TI - Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866175467&doi=10.1200%2fJCO.2011.38.7522&partnerID=40&md5=6aa9cb4bbf91abf5a26c3c230f45b0e8 VL - 30 ID - 4250 ER - TY - JOUR AD - Advanced Pediatric Center, Pediatric Hematology-Oncology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Bansal, D. AU - Shava, U. AU - Varma, N. AU - Trehan, A. AU - Marwaha, R. K. DB - Scopus DO - 10.1002/pbc.23389 IS - 3 M3 - Article N1 - Cited By :58 Export Date: 18 November 2020 PY - 2012 SP - 481-484 ST - Imatinib has adverse effect on growth in children with chronic myeloid leukemia T2 - Pediatric Blood and Cancer TI - Imatinib has adverse effect on growth in children with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863865642&doi=10.1002%2fpbc.23389&partnerID=40&md5=4af208142f2671d4b81f5b4beb1efc82 VL - 59 ID - 4253 ER - TY - JOUR AD - Department of Hematology Oncology, Dell Children's Medical Center of Central Texas, Austin, TX, United States Division of Pediatric Stem Cell Transplantation, Texas Transplant Institute, San Antonio, TX, United States Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, United States AU - Lockhart, S. AU - McDonald, L. AU - Rytting, M. AU - Chan, K. W. DB - Scopus DO - 10.1002/pbc.23318 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2012 SP - 573-575 ST - Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ all resolution after decitabine therapy T2 - Pediatric Blood and Cancer TI - Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ all resolution after decitabine therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863880422&doi=10.1002%2fpbc.23318&partnerID=40&md5=ecaec35e5d7dfe677333433a9598ba7d VL - 59 ID - 4255 ER - TY - JOUR AD - Department of Hematology and Oncology, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa 920-8641, Japan Department of Internal Medicine, Toyama City Hospital, Toyama, Japan Department of Hematology and Immunology, Kanazawa Medical University, Kahoku, Japan Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan Department of Hematology, Tonami General Hospital, Tonami, Japan Department of Hematology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan AU - Takami, A. AU - Ohtake, S. AU - Morishita, E. AU - Terasaki, Y. AU - Fukushima, T. AU - Kurokawa, T. AU - Sugimori, N. AU - Matano, S. AU - Ohata, K. AU - Saito, C. AU - Yamaguchi, M. AU - Hosokawa, K. AU - Yamazaki, H. AU - Kondo, Y. AU - Nakao, S. DB - Scopus DO - 10.1007/s12185-012-1155-1 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2012 SP - 357-363 ST - Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia T2 - International Journal of Hematology TI - Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866994353&doi=10.1007%2fs12185-012-1155-1&partnerID=40&md5=ba4218fb8971c762577f1b0f01f99de3 VL - 96 ID - 4257 ER - TY - JOUR AD - Faculté de médecine, L'université de Lomé, Togo Unité d'hématologie, CHU Campus de Lomé, Lomé, Togo Hématologie biologique, APHP hôpital Henri-Mondor, Créteil, France AU - Segbena, A. Y. AU - Kueviakoe, I. M. D. AU - Agbetiafa, K. AU - Padaro, E. AU - Layibo, Y. AU - Dorkenoo, A. AU - Agbo, Y. M. AU - Bories, D. DB - Scopus DO - 10.1684/mst.2012.0083 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2012 SP - 307-311 ST - Leucémie myéloïde chronique et imatinib, expérience du CHU campus de lome ́ au Togo T2 - Medecine et Sante Tropicales TI - Chronic myeloid leukemia and imatinib: Experience at the lome campus teaching hospital (Togo) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871628983&doi=10.1684%2fmst.2012.0083&partnerID=40&md5=ef42b36893f9b6bba2f4679d91980987 VL - 22 ID - 4259 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, Netherlands Neuro-Oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, Amsterdam, Netherlands Department of Leukemia, Division of Cancer Medicine, University of Texas, 1515 Holcombe Boulevard, Houston, TX, United States Department of Neurosurgery, University Medical Center Groningen, Hanzeplein 1, Groningen, Netherlands Department of Gastroenterology and Hepatology, Erasmus MC, L-459, 's-Gravendijkwal 230, Rotterdam, Netherlands AU - Sikkema, A. H. AU - Den Dunnen, W. F. A. AU - Hulleman, E. AU - Van Vuurden, D. G. AU - Garcia-Manero, G. AU - Yang, H. AU - Scherpen, F. J. G. AU - Kampen, K. R. AU - Hoving, E. W. AU - Kamps, W. A. AU - Diks, S. H. AU - Peppelenbosch, M. P. AU - De Bont, E. S. J. M. DB - Scopus DO - 10.1093/neuonc/nos130 IS - 9 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 1125-1135 ST - EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion T2 - Neuro-Oncology TI - EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867519695&doi=10.1093%2fneuonc%2fnos130&partnerID=40&md5=b87f8ebac9830679f11e69746ebae3fa VL - 14 ID - 4260 ER - TY - JOUR AD - Department of Pediatric Oncology, Catholic University of Rome, Largo A. Gemelli, 8, 00168 Rome, Italy Unit of Cancer Stem Cell Biology, Stemgen SPA, Milan, Italy Department of Pathology, Policlinico Gemelli, Rome, Italy Mendel Laboratory, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy Institute of Neurosurgery, Catholic University, Rome, Italy AU - Servidei, T. AU - Meco, D. AU - Trivieri, N. AU - Patriarca, V. AU - Vellone, V. G. AU - Zannoni, G. F. AU - Lamorte, G. AU - Pallini, R. AU - Riccardi, R. DB - Scopus DO - 10.1002/ijc.27377 IS - 5 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - E791-E803 ST - Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models T2 - International Journal of Cancer TI - Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863206336&doi=10.1002%2fijc.27377&partnerID=40&md5=543aef842163570fbd7f1cb61a8c50ad VL - 131 ID - 4261 ER - TY - JOUR AD - Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada AU - Thyagu, S. AU - Minden, M. D. AU - Gupta, V. AU - Yee, K. W. AU - Schimmer, A. D. AU - Schuh, A. C. AU - Lipton, J. H. AU - Messner, H. A. AU - Xu, W. AU - Brandwein, J. M. DB - Scopus DO - 10.1111/j.1365-2141.2012.09182.x IS - 4 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2012 SP - 506-514 ST - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol T2 - British Journal of Haematology TI - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864297804&doi=10.1111%2fj.1365-2141.2012.09182.x&partnerID=40&md5=0d6e7f6c026df0a0bb37d6ee534fd9ba VL - 158 ID - 4266 ER - TY - JOUR AD - Endocrinology Unit, Department of Medicine, University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Gattamelata 64, 35128 Padua, Italy Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128 Padua, Italy Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padua, Italy Department of Environmental Medicine and Public Health, University of Padua, Via Loredan 18, Padua, Italy Surgical Pathology and Cytopathology Unit, Department of Diagnostic Medical Sciences and Special Therapies, University of Padua, Via Gabelli 61, 35100 Padua, Italy AU - Mariniello, B. AU - Rosato, A. AU - Zuccolotto, G. AU - Rubin, B. AU - Cicala, M. V. AU - Finco, I. AU - Iacobone, M. AU - Frigo, A. C. AU - Fassina, A. AU - Pezzani, R. AU - Mantero, F. DB - Scopus DO - 10.1530/ERC-11-0337 IS - 4 M3 - Article N1 - Cited By :41 Export Date: 18 November 2020 PY - 2012 SP - 527-539 ST - Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models T2 - Endocrine-Related Cancer TI - Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864408099&doi=10.1530%2fERC-11-0337&partnerID=40&md5=5a59b388d1876e8f102463fb03cfc47d VL - 19 ID - 4268 ER - TY - JOUR AD - Laboratory of Pharmacology, Division of Pediatric Oncology, Catholic University of Rome, L.go A. Gemelli, 8, 00168 Rome, Italy Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy Research and Development, Sigma-Tau, Via Pontina Km 30,400, 00040 Pomezia, Rome, Italy AU - Di Francesco, A. M. AU - Ubezio, P. AU - Torella, A. R. AU - Meco, D. AU - Pierri, F. AU - Barone, G. AU - Cusano, G. AU - Pisano, C. AU - D'Incalci, M. AU - Riccardi, R. DB - Scopus DO - 10.1007/s10637-011-9689-2 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2012 SP - 1319-1330 ST - Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models T2 - Investigational New Drugs TI - Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866730037&doi=10.1007%2fs10637-011-9689-2&partnerID=40&md5=a1cb4056b0259f74147e8d71459cdedb VL - 30 ID - 4271 ER - TY - JOUR AD - Department of Hematology and Oncology L. e A. Seràgnoli, University of Bologna, Bologna, Italy Department of Hematology, University of Bari, Bari, Italy Cytogenetics Unit, Treviso, Italy Department of Clinical and Biological Sciences, University of Torino, Orbassano, Italy Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy Department of Hematology, S. Eugenio, TorVergata University Hospital, Rome, Italy Department of Oncology and Hematology, Santa Maria Delle Croci Hospital, Ravenna, Italy Department of Medicine, Pathology Unit, University of Milano, Milan, Italy Department of Medicine and Immunological Sciences, Division of Hematology and Transplants, University of Siena, Siena, Italy Hematology Unit, Spedali Civili, Brescia, Italy Department of Biomedical Sciences, Section of Medical Genetics, University of Chieti, Chieti, Italy Institute of Hematology, Fondazione Policlinico San Matteo Istituto di Ricovero e Cura A Carattere Scientifico, University of Pavia, Pavia, Italy Department of Biochemistry and Medical Biotechnology, Federico II University, Napoli, Italy AU - Luatti, S. AU - Castagnetti, F. AU - Marzocchi, G. AU - Baldazzi, C. AU - Gugliotta, G. AU - Iacobucci, I. AU - Specchia, G. AU - Zanatta, L. AU - Rege-Cambrin, G. AU - Mancini, M. AU - Abruzzese, E. AU - Zaccaria, A. AU - Grimoldi, M. G. AU - Gozzetti, A. AU - Ameli, G. AU - Capucci, M. A. AU - Palka, G. AU - Bernasconi, P. AU - Palandri, F. AU - Pane, F. AU - Saglio, G. AU - Martinelli, G. AU - Rosti, G. AU - Baccarani, M. AU - Testoni, N. DB - Scopus DO - 10.1182/blood-2011-10-384651 IS - 4 M3 - Article N1 - Cited By :78 Export Date: 18 November 2020 PY - 2012 SP - 761-767 ST - Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis T2 - Blood TI - Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864478365&doi=10.1182%2fblood-2011-10-384651&partnerID=40&md5=260edbe106222c4499f63ac2dc14c195 VL - 120 ID - 4272 ER - TY - JOUR AD - The University of Texas, MD Anderson Cancer Center, Department of Leukemia, PO Box 301402, Unit 428, Houston, TX 77230, United States AU - Pemmaraju, N. AU - Kantarjian, H. AU - Shan, J. AU - Jabbour, E. AU - Quintas-Cardama, A. AU - Verstovsek, S. AU - Ravandi, F. AU - Wierda, W. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.3324/haematol.2011.056721 IS - 7 M3 - Review N1 - Cited By :49 Export Date: 18 November 2020 PY - 2012 SP - 1029-1035 ST - Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy T2 - Haematologica TI - Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863955295&doi=10.3324%2fhaematol.2011.056721&partnerID=40&md5=a40e7b941d66a89a38e3f02ccfe31b07 VL - 97 ID - 4274 ER - TY - JOUR AD - HELIOS Klinikum Bad Saarow, Sarkomzentrum Berlin-Brandenburg, Bad Saarow, Germany Léon Bérar Comprehensive Cancer Centre, Université Claude Bernard Lyon I, Lyon, France Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands Department of Internal Medicine III, University Hospitals Grosshadern, Ludwig Maximilians University Munich, Munich, Germany Center for Sarcoma and Bone Oncology, Ludwig Center at Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, Boston, United States Institut Bergonié, Bordeaux, France Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia Novartis Pharmaceuticals Corporation, Florham Park, United States Novartis Pharma AG, Basel, Switzerland Department of Soft Tissue/Bone Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland AU - Reichardt, P. AU - Blay, J. Y. AU - Gelderblom, H. AU - Schlemmer, M. AU - Demetri, G. D. AU - Bui-nguyen, B. AU - McArthur, G. A. AU - Yazji, S. AU - Hsu, Y. AU - Galetic, I. AU - Rutkowski, P. C7 - mdr598 DB - Scopus DO - 10.1093/annonc/mdr598 IS - 7 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2012 SP - 1680-1687 ST - Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib T2 - Annals of Oncology TI - Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864293774&doi=10.1093%2fannonc%2fmdr598&partnerID=40&md5=51bdef44d34c960c43b81d4543ad71b4 VL - 23 ID - 4276 ER - TY - JOUR AD - Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Medical Oncology, University of Milano, Milano, Italy Istituto Superiore di Sanità, Roma, Italy Istituto San Raffaele Sulmona, Sulmona, Italy Centre of Integrated Metabolomics, Roma, Italy Human Tumours Immunobiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Haematology and BMT Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Haematology and Molecular Biotechnology Centre, University of Torino, Torino, Italy Haematology, University of Milano, Milano, Italy AU - Guidetti, A. AU - Carlo-Stella, C. AU - Locatelli, S. L. AU - Malorni, W. AU - Pierdominici, M. AU - Barbati, C. AU - Mortarini, R. AU - Devizzi, L. AU - Matteucci, P. AU - Marchianò, A. AU - Lanocita, R. AU - Farina, L. AU - Dodero, A. AU - Tarella, C. AU - Di Nicola, M. AU - Corradini, P. AU - Anichini, A. AU - Gianni, A. M. DB - Scopus DO - 10.1111/j.1365-2141.2012.09139.x IS - 1 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2012 SP - 108-119 ST - Phase II study of sorafenib in patients with relapsed or refractory lymphoma T2 - British Journal of Haematology TI - Phase II study of sorafenib in patients with relapsed or refractory lymphoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862256588&doi=10.1111%2fj.1365-2141.2012.09139.x&partnerID=40&md5=1ee8104e2fee77aca97d55a7fdfd6199 VL - 158 ID - 4277 ER - TY - JOUR AD - City of Hope Comprehensive Cancer Center, United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, United States UNMC Eppley Cancer Center, Nebraska Medical Center, United States Massachusetts General Hospital Cancer Center, United States University of Alabama, Birmingham Comprehensive Cancer Center, United States Ohio State University Comprehensive Cancer Center, James Cancer Hospital, Solove Research Institute, United States Huntsman Cancer Institute, University of Utah, United States Stanford Cancer Institute, United States H. Lee Moffitt Cancer Center, Research Institute, United States UCSF Helen Diller Family Comprehensive Cancer Center, United States Dana-Farber/Brigham and Women's Cancer Center, United States Memorial Sloan-Kettering Cancer Center, United States Vanderbilt-Ingram Cancer Center, United States Robert H. Lurie Comprehensive Cancer Center, Northwestern University, United States St. Jude Children's Research Hospital, University of Tennessee Cancer Institute, United States Fox Chase Cancer Center, United States University of Texas MD Anderson Cancer Center, United States University of Washington, Seattle Cancer Care Alliance, United States Duke Cancer Institute, United States Siteman Cancer Center, Barnes-Jewish Hospital, Washington University, United States Roswell Park Cancer Institute, United States AU - Alvarnas, J. C. AU - Brown, P. A. AU - Aoun, P. AU - Ballen, K. K. AU - Bellam, N. AU - Blum, W. AU - Boyer, M. W. AU - Carraway, H. E. AU - Coccia, P. F. AU - Coutre, S. E. AU - Cultrera, J. AU - Damon, L. E. AU - DeAngelo, D. J. AU - Douer, D. AU - Frangoul, H. AU - Frankfurt, O. AU - Goorha, S. AU - Millenson, M. M. AU - O'Brien, S. AU - Petersdorf, S. H. AU - Rao, A. V. AU - Terezakis, S. AU - Uy, G. AU - Wetzler, M. AU - Zelenetz, A. D. AU - Naganuma, M. AU - Gregory, K. M. DB - Scopus DO - 10.6004/jnccn.2012.0089 IS - 7 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2012 SP - 858-914 ST - Acute lymphoblastic leukemia: Clinical practice guidelines in oncology T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - Acute lymphoblastic leukemia: Clinical practice guidelines in oncology UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865327021&doi=10.6004%2fjnccn.2012.0089&partnerID=40&md5=e0c56234a29cab22dbc03f04b0a91eae VL - 10 ID - 4278 ER - TY - JOUR AD - Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany Center for Internal Medicine, Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany St. Johannes Hospital, Department of Medicine, Duisburg, Germany Department of Hematology and Oncology, University of Münster, Münster, Germany Department of Hematology and Oncology, Eberhardt-Karls University, Tübingen, Germany Center for Internal Medicine, Department of Hematology and Oncology, University of Essen, Essen, Germany AU - Pfeifer, H. AU - Lange, T. AU - Wystub, S. AU - Wassmann, B. AU - Maier, J. AU - Binckebanck, A. AU - Giagounidis, A. AU - Stelljes, M. AU - Schmalzing, M. AU - Dührsen, U. AU - Wunderle, L. AU - Serve, H. AU - Brück, P. AU - Schmidt, A. AU - Hoelzer, D. AU - Ottmann, O. G. DB - Scopus DO - 10.1038/leu.2012.5 IS - 7 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2012 SP - 1475-1481 ST - Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia T2 - Leukemia TI - Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863782824&doi=10.1038%2fleu.2012.5&partnerID=40&md5=e0edb643f543132734316c4df02895fe VL - 26 ID - 4279 ER - TY - JOUR AD - Department of Medicine, University of Western Ontario, London, ON N6A 5A5, Canada Division of General Internal Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, AB T6G 2R1, Canada Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T 2B5, Canada AU - Thomson, A. B. R. AU - Chopra, A. AU - Clandinin, M. T. AU - Freeman, H. DB - Scopus DO - 10.3748/wjg.v18.i26.3336 IS - 26 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2012 SP - 3336-3352 ST - Recent advances in small bowel diseases: Part I T2 - World Journal of Gastroenterology TI - Recent advances in small bowel diseases: Part I UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863902263&doi=10.3748%2fwjg.v18.i26.3336&partnerID=40&md5=f7dff67e62457df8af37ac885fa4e8f4 VL - 18 ID - 4282 ER - TY - JOUR AD - Division of HematologyOncology, Childrens Hospital Los Angeles, Los Angeles, CA, United States Department of HematologyOncology, St Jude Childrens Research Hospital, Memphis, TN, United States Department of Pediatric Surgery and Pediatric Urology, University of Tbingen, Tbingen, Germany Division of HematologyOncologyBone Marrow Transplant, Childrens Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, United States AU - Venkatramani, R. AU - Furman, W. L. AU - Fuchs, J. AU - Warmann, S. W. AU - Malogolowkin, M. H. DB - Scopus DO - 10.2165/11597740-000000000-00000 IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2012 SP - 221-232 ST - Current and future management strategies for relapsed or progressive hepatoblastoma T2 - Pediatric Drugs TI - Current and future management strategies for relapsed or progressive hepatoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862534798&doi=10.2165%2f11597740-000000000-00000&partnerID=40&md5=1efda21800a4dee6a3c928148380107c VL - 14 ID - 4284 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, University Children's Hospital, Fetscherstr. 74, 01307 Dresden, Germany Department of Oncology, Hematology, And Cellular Therapy University Hospital, Poitiers, France AU - Suttorp, M. AU - Eckardt, L. AU - Tauer, J. T. AU - Millot, F. DB - Scopus DO - 10.1007/s11899-012-0113-6 IS - 2 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 116-124 ST - Management of chronic myeloid leukemia in childhood T2 - Current Hematologic Malignancy Reports TI - Management of chronic myeloid leukemia in childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860835140&doi=10.1007%2fs11899-012-0113-6&partnerID=40&md5=9f4aaef4e8397ca90d3e6ec0892beff8 VL - 7 ID - 4285 ER - TY - JOUR AD - Department of Hematology and Oncology, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina Department of Genetics, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina Department of Immunology, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina AU - Alonso, C. N. AU - Gallego, M. S. AU - Rossi, J. G. AU - Medina, A. AU - Rubio, P. L. AU - Bernasconi, A. R. AU - Zubizarreta, P. A. AU - Felice, M. S. DB - Scopus DO - 10.1016/j.leukres.2011.12.003 IS - 6 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 704-708 ST - RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina T2 - Leukemia Research TI - RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859835234&doi=10.1016%2fj.leukres.2011.12.003&partnerID=40&md5=13f3a33c8a609b646ce5f15cbc84e18f VL - 36 ID - 4287 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Children's Medical Center, Osaka City General Hospital, 2-13-22 Miyakojimahondouri, Miyakojimaku, Osaka 534-0021, Japan AU - Hara, J. DB - Scopus DO - 10.1007/s10147-012-0417-5 IS - 3 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2012 SP - 196-203 ST - Development of treatment strategies for advanced neuroblastoma T2 - International Journal of Clinical Oncology TI - Development of treatment strategies for advanced neuroblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862873055&doi=10.1007%2fs10147-012-0417-5&partnerID=40&md5=a8a7fd80e8ff9a10d017f00ad6631249 VL - 17 ID - 4289 ER - TY - JOUR AD - Department of Pathology, First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Road 2nd, Guangzhou, Guangdong, 510080, China Department of Urinary Surgery, Affiliated Xixiang People's Hospital, Guangdong Medical College, Shenzhen, Guangdong, China Department of Pathology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China AU - Zhu, J. AU - Feng, Y. AU - Ke, Z. AU - Yang, Z. AU - Zhou, J. AU - Huang, X. AU - Wang, L. DB - Scopus DO - 10.1016/j.ajpath.2012.02.023 IS - 6 M3 - Article N1 - Cited By :120 Export Date: 18 November 2020 PY - 2012 SP - 2440-2451 ST - Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin T2 - American Journal of Pathology TI - Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861626895&doi=10.1016%2fj.ajpath.2012.02.023&partnerID=40&md5=d998da5f59de9feb3d44d2c831de2a8b VL - 180 ID - 4291 ER - TY - JOUR AD - Department of Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, University of Hull, Hull, United Kingdom Department of Oncology, Castle Hill Hospital, Hull and East Yorkshire Hospitals Trust, Hull, United Kingdom AU - Sathyapalan, T. AU - Dixit, S. DB - Scopus DO - 10.1586/era.12.27 IS - 5 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 669-683 ST - Radiotherapy-induced hypopituitarism: A review T2 - Expert Review of Anticancer Therapy TI - Radiotherapy-induced hypopituitarism: A review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861308420&doi=10.1586%2fera.12.27&partnerID=40&md5=17ad2d787b94b1899a14d579ee10a2c6 VL - 12 ID - 4296 ER - TY - JOUR AD - CIC 802 INSERM, CHU de Poitiers, Poitiers, France Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia Leukemia Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Istituto di Ematologia L. e A. Seràgnoli, University of Bologna, Bologna, Italy Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States Clinical Pharmacology Oncology, Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States AU - Guilhot, F. AU - Hughes, T. P. AU - Cortes, J. AU - Druker, B. J. AU - Baccarani, M. AU - Gathmann, I. AU - Hayes, M. AU - Granvil, C. AU - Wang, Y. DB - Scopus DO - 10.3324/haematol.2011.045666 IS - 5 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2012 SP - 731-738 ST - Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor OPtimization and Selectivity trial T2 - Haematologica TI - Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor OPtimization and Selectivity trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860549849&doi=10.3324%2fhaematol.2011.045666&partnerID=40&md5=11a8656677b758a8025e497188c3b55e VL - 97 ID - 4297 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, United Kingdom AU - Moorman, A. V. DB - Scopus DO - 10.1016/j.blre.2012.01.001 IS - 3 M3 - Article N1 - Cited By :104 Export Date: 18 November 2020 PY - 2012 SP - 123-135 ST - The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia T2 - Blood Reviews TI - The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859209595&doi=10.1016%2fj.blre.2012.01.001&partnerID=40&md5=e3e7f33303cf128d2a4cf09217b7cc1c VL - 26 ID - 4298 ER - TY - JOUR AD - Novartis Oncology, East Hanover, NJ, United States Novartis Pharmaceuticals Corporation, 180 Park Avenue, Florham Park, NJ 07932, United States Novartis Oncology, Basel, Switzerland ERT, East Bridgewater, NJ, United States Osborne Research Center, LLC, Little Rock, AR, United States AU - Del Corral, A. AU - Dutreix, C. AU - Huntsman-Labed, A. AU - Lorenzo, S. AU - Morganroth, J. AU - Harrell, R. AU - Wang, Y. DB - Scopus DO - 10.1007/s00280-012-1825-y IS - 5 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2012 SP - 1255-1263 ST - Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers T2 - Cancer Chemotherapy and Pharmacology TI - Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862270599&doi=10.1007%2fs00280-012-1825-y&partnerID=40&md5=63f19375e513216d5fdd84de03fedd89 VL - 69 ID - 4300 ER - TY - JOUR AD - CEINGE, Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naple, Italy Department of Biochemistry, Medical Biotechnologies (DBBM), Federico II University of Naples, Naples, Italy Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy Haemato-Oncology Laboratory, Department of Paediatrics, University of Padova, Padua, Italy AU - Andolfo, I. AU - Liguori, L. AU - De Antonellis, P. AU - Cusanelli, E. AU - Marinaro, F. AU - Pistollato, F. AU - Garzia, L. AU - De Vita, G. AU - Petrosino, G. AU - Accordi, B. AU - Migliorati, R. AU - Basso, G. AU - Iolascon, A. AU - Cinalli, G. AU - Zollo, M. DB - Scopus DO - 10.1093/neuonc/nos002 IS - 5 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2012 SP - 596-612 ST - The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma T2 - Neuro-Oncology TI - The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860378895&doi=10.1093%2fneuonc%2fnos002&partnerID=40&md5=3d37d353e09907780cf66a7dd7c0ff37 VL - 14 ID - 4302 ER - TY - JOUR AD - Department of Oncohematology, Ospedale Pediatrico Bambino Gesù, IRCCS, Piazza S. Onofrio 4, 00165 Roma, Italy Paris VI-Université Pierre et Marie Curie, UR4, Vieillissement, Stress et Inflammation, Paris, France SAFU, Istituto Regina Elena, Roma, Italy Department of Scientific Directorate, Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy Department of Medicine, Hematology-Oncology Division, University of Virginia, Charlottesville, VA, United States Department of Pediatrics, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States Cancer Institute, University of Mississippi Medical Center, Jackson, MS, United States Centre for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, QC, Canada Dipartimento di Scienze Pediatriche, Università di Pavia, Italy AU - Raimondi, L. AU - Ciarapica, R. AU - De Salvo, M. AU - Verginelli, F. AU - Gueguen, M. AU - Martini, C. AU - De Sio, L. AU - Cortese, G. AU - Locatelli, M. AU - Dang, T. P. AU - Carlesso, N. AU - Miele, L. AU - Stifani, S. AU - Limon, I. AU - Locatelli, F. AU - Rota, R. DB - Scopus DO - 10.1038/cdd.2011.171 IS - 5 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2012 SP - 871-881 ST - Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21 Cip1 expression and hampers tumour cell growth in vitro and in vivo T2 - Cell Death and Differentiation TI - Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21 Cip1 expression and hampers tumour cell growth in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859569795&doi=10.1038%2fcdd.2011.171&partnerID=40&md5=3f94e912c2af77cdd602244995d6cdef VL - 19 ID - 4303 ER - TY - JOUR AD - Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China Institute of Biomedical Sciences, Fudan Universit, Shanghai, China AU - Liang, Y. AU - Li, W. W. AU - Yang, B. W. AU - Tao, Z. H. AU - Sun, H. C. AU - Wang, L. AU - Xia, J. L. AU - Qin, L. X. AU - Tang, Z. Y. AU - Fan, J. AU - Wu, W. Z. DB - Scopus DO - 10.1002/ijc.26166 IS - 8 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 1745-1754 ST - Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma T2 - International Journal of Cancer TI - Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857501900&doi=10.1002%2fijc.26166&partnerID=40&md5=d60a61b2df22f14bc42f1b813c94a3b6 VL - 130 ID - 4306 ER - TY - JOUR AD - Department of Pediatrics, UCSF School of Medicine, 505 Parnassus Avenue, M646, San Francisco, CA 94143-0106, United States Department of Pediatrics, Children's Hospital Boston, Harvard Medical School, Boston, MA, United States Department of Pharmacology, Mayo College of Medicine, Rochester, MN, United States Children's Oncology Group Operations Center, Arcadia, CA, United States Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada Department of Pediatrics, Morgan Stanley Children's Hospital, Columbia University School of Medicine, New York, NY, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Department of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States AU - DuBois, S. G. AU - Shusterman, S. AU - Reid, J. M. AU - Ingle, A. M. AU - Ahern, C. H. AU - Baruchel, S. AU - Glade-Bender, J. AU - Ivy, P. AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1007/s00280-011-1798-2 IS - 4 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 1021-1027 ST - Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: A Children's Oncology Group study T2 - Cancer Chemotherapy and Pharmacology TI - Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: A Children's Oncology Group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859801305&doi=10.1007%2fs00280-011-1798-2&partnerID=40&md5=611c66adb10f4ccd8bf02fc8fa311ed8 VL - 69 ID - 4309 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea Cancer Emergency Room, Asan Cancer Center, University of Ulsan College of Medicine, Seoul, South Korea Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea AU - Lee, J. L. AU - Park, I. AU - Park, K. AU - Park, S. AU - Ahn, Y. AU - Ahn, J. H. AU - Kim, T. W. AU - Ahn, S. AU - Song, C. AU - Hong, J. H. AU - Kim, C. S. AU - Ahn, H. DB - Scopus DO - 10.1007/s00432-012-1148-8 IS - 4 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2012 SP - 687-693 ST - Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features T2 - Journal of Cancer Research and Clinical Oncology TI - Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863086907&doi=10.1007%2fs00432-012-1148-8&partnerID=40&md5=6e123fef1f8af3c7d178a87800c0e09a VL - 138 ID - 4310 ER - TY - JOUR AD - Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, United States Department of Cellular Therapy and Stem Cell Transplant, MD Anderson Cancer Center, Houston, TX, United States Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, United States Department of Hematology Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, United States Department of Immunochemistry, PPD, Richmond, VA, United States AU - Kantarjian, H. AU - Thomas, D. AU - Jorgensen, J. AU - Jabbour, E. AU - Kebriaei, P. AU - Rytting, M. AU - York, S. AU - Ravandi, F. AU - Kwari, M. AU - Faderl, S. AU - Rios, M. B. AU - Cortes, J. AU - Fayad, L. AU - Tarnai, R. AU - Wang, S. A. AU - Champlin, R. AU - Advani, A. AU - O'Brien, S. DB - Scopus DO - 10.1016/S1470-2045(11)70386-2 IS - 4 M3 - Article N1 - Cited By :284 Export Date: 18 November 2020 PY - 2012 SP - 403-411 ST - Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: A phase 2 study T2 - The Lancet Oncology TI - Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: A phase 2 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862786326&doi=10.1016%2fS1470-2045%2811%2970386-2&partnerID=40&md5=ce6d8f3899db28f3aa1b72a9581c6607 VL - 13 ID - 4311 ER - TY - JOUR AD - Life Raft Group, 155 Route 46 West, Suite 202, Wayne, NJ 07470, United States LPC, 2004 MacGregor Park Circle, Ft Myers, FL 33908-5419, United States Department of Biostatistics and Medical Informatics, University of Wisconsin, School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792-4675, United States AU - Call, J. AU - Walentas, C. D. AU - Eickhoff, J. C. AU - Scherzer, N. C7 - 90 DB - Scopus DO - 10.1186/1471-2407-12-90 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2012 ST - Survival of gastrointestinal stromal tumor patients in the imatinib era: Life raft group observational registry T2 - BMC Cancer TI - Survival of gastrointestinal stromal tumor patients in the imatinib era: Life raft group observational registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858304485&doi=10.1186%2f1471-2407-12-90&partnerID=40&md5=c97bcbf996d4e18b933ca2bab3e968a7 VL - 12 ID - 4316 ER - TY - JOUR AD - Department of Forensic Medicine, Harbin Medical University, 157th Bao-jian Road, Nan-gang District, Harbin 150081, China Research Institute of Criminal Technology, Hulunbeier Municipal Public Security Bureau, Hulunbeier, China AU - Gao, T. L. AU - Yuan, X. T. AU - Yang, D. AU - Dai, H. L. AU - Wang, W. J. AU - Peng, X. AU - Shao, H. J. AU - Jin, Z. F. AU - Fu, Z. J. DB - Scopus DO - 10.1097/TA.0b013e31823c54a6 IS - 3 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2012 SP - 643-649 ST - Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury T2 - Journal of Trauma and Acute Care Surgery TI - Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862653321&doi=10.1097%2fTA.0b013e31823c54a6&partnerID=40&md5=109b3a2e23e334e6c5a97342d02621b3 VL - 72 ID - 4320 ER - TY - JOUR AD - Department of Dental Medicine, Division of Pediatric Dentistry, Karolinska Institutet, 141 04 Huddinge, Sweden Science for Life Laboratory, Division of Gene Technology, School of Biotechnology, Royal Institute of Technology, Solna, Sweden Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden Department of Dental Medicine, Division of Cariology, Karolinska Institutet, 141 04 Huddinge, Sweden AU - Davanian, H. AU - Båge, T. AU - Lindberg, J. AU - Lundeberg, J. AU - Q. Concha, H. AU - Sällberg Chen, M. AU - Yucel-Lindberg, T. DB - Scopus DO - 10.1016/j.cyto.2011.12.008 IS - 3 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 406-416 ST - Signaling pathways involved in the regulation of TNFα-induced toll-like receptor 2 expression in human gingival fibroblasts T2 - Cytokine TI - Signaling pathways involved in the regulation of TNFα-induced toll-like receptor 2 expression in human gingival fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856370445&doi=10.1016%2fj.cyto.2011.12.008&partnerID=40&md5=06bc312e068f6e7200c1d26e6cf23306 VL - 57 ID - 4321 ER - TY - JOUR AD - Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, NY, United States Department of Pediatrics, Children's Hospital of Orange County, Orange, CA, United States Department of Pediatrics and Cell and Molecular Biology, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, United States AU - Andolina, J. R. AU - Neudorf, S. M. AU - Corey, S. J. DB - Scopus DO - 10.1182/blood-2011-10-380774 IS - 8 M3 - Review N1 - Cited By :56 Export Date: 18 November 2020 PY - 2012 SP - 1821-1830 ST - How I treat childhood CML T2 - Blood TI - How I treat childhood CML UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857606947&doi=10.1182%2fblood-2011-10-380774&partnerID=40&md5=89b04434f48154de7d9f0d2f5d52174b VL - 119 ID - 4322 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Subbiah, V. AU - Slopis, J. AU - Hong, D. S. AU - Ketonen, L. M. AU - Hamilton, J. AU - McCutcheon, I. E. AU - Kurzrock, R. DB - Scopus DO - 10.1200/JCO.2011.38.2614 IS - 5 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2012 SP - e64-e68 ST - Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: From bench to bedside T2 - Journal of Clinical Oncology TI - Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: From bench to bedside UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856873458&doi=10.1200%2fJCO.2011.38.2614&partnerID=40&md5=de18c10a62e2ae1c86e5f34376d99a79 VL - 30 ID - 4323 ER - TY - JOUR AD - Medical Oncology Unit, Institute for Cancer Research and Treatment, Candiolo, Italy Chemotherapy Unit, Department of Musculoskeletal Oncology, Istituti Ortopedici Rizzoli, Bologna, Italy Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Department of Pediatric Oncology, Ospedale Infantile Regina Margherita, Torino, Italy 5th Department of Orthopedics, Istituti Ortopedici Rizzoli and University of Bologna, Bologna, Italy Laboratory of Experimental Oncology, Istituti Ortopedici Rizzoli, Bologna, Italy AU - Grignani, G. AU - Palmerini, E. AU - Dileo, P. AU - Asaftei, S. D. AU - D'Ambrosio, L. AU - Pignochino, Y. AU - Mercuri, M. AU - Picci, P. AU - Fagioli, F. AU - Casali, P. G. AU - Ferrari, S. AU - Aglietta, M. DB - Scopus DO - 10.1093/annonc/mdr151 IS - 2 M3 - Article N1 - Cited By :182 Export Date: 18 November 2020 PY - 2012 SP - 508-516 ST - A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study T2 - Annals of Oncology TI - A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856343533&doi=10.1093%2fannonc%2fmdr151&partnerID=40&md5=ab920d0cf6d3f4210afaf2b6cdf07db6 VL - 23 ID - 4325 ER - TY - JOUR AD - Department of Hematology and Medical Oncology, Hospital Clínico Universitario, Avd. Blasco Ibáñez 17, 46010 Valencia, Spain Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain Department of Hematology, Hospital del Mar, Barcelona, Spain Department of Pathology, Hospital del Mar, Barcelona, Spain Department of Hematology, Hospital La Fe, Valencia, Spain Department of Statistics, University of Valencia, Valencia, Spain AU - Guillem, V. AU - Amat, P. AU - Cervantes, F. AU - Alvarez-Larrán, A. AU - Cervera, J. AU - Maffioli, M. AU - Bellosillo, B. AU - Collado, M. AU - Marugán, I. AU - Martínez-Ruiz, F. AU - Hernández-Boluda, J. C. DB - Scopus DO - 10.1016/j.leukres.2011.06.011 IS - 2 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 174-181 ST - Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia T2 - Leukemia Research TI - Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855202791&doi=10.1016%2fj.leukres.2011.06.011&partnerID=40&md5=9d4d9a0e1401bcd9581366f79529bbd7 VL - 36 ID - 4326 ER - TY - JOUR AD - Fred Hutchinson Cancer Research Center, The University of Washington, Seattle, WA, United States Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Carpenter, P. A. AU - Meshinchi, S. AU - Davies, S. M. DB - Scopus DO - 10.1016/j.bbmt.2011.10.035 IS - 1 SUPPL. M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2012 SP - S33-S39 ST - Transplantation for AML in Children T2 - Biology of Blood and Marrow Transplantation TI - Transplantation for AML in Children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855379199&doi=10.1016%2fj.bbmt.2011.10.035&partnerID=40&md5=71a07c1d78bf10aa42d3328b0af01ef8 VL - 18 ID - 4327 ER - TY - JOUR AD - Department of Hematology, Institute of Hematology and Transfusion Medicine, Indiry Gandhi 14 str, 02-776 Warsaw, Poland Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland AU - Lech-Maranda, E. AU - Mlynarski, W. DB - Scopus DO - 10.2174/156800912800673275 IS - 5 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2012 SP - 505-521 ST - Novel and emerging drugs for acute lymphoblastic leukemia T2 - Current Cancer Drug Targets TI - Novel and emerging drugs for acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861730938&doi=10.2174%2f156800912800673275&partnerID=40&md5=fd9ea0c7420140f6ddfa9a82e35af8c7 VL - 12 ID - 4328 ER - TY - JOUR AD - Laboratory Research Pathology, Graduate Program in Pathology, Universidade Federal de Ciências da Sáude de Porto Alegre, Porto Alegre, Brazil Graduate Program in Medical Sciences, Universidade Federal Do Rio Grande Do sul, Rio Grande do Sul, Brazil Laboratory Research Pathology, Universidade Federal de Ciências da Sáude de Porto Alegre, Porto Alegre, Brazil Department of Clinical Medicine, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil Department of Pediatrics, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil AU - Zavalhia, L. S. AU - Romitti, M. AU - Netto, G. C. AU - Dos Santos, G. T. AU - Meurer, R. T. AU - Hilbig, A. AU - Michalowski, M. B. AU - De Castro Ribeiro, M. DB - Scopus DO - 10.3233/DMA-2012-0905 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2012 SP - 61-68 ST - Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas T2 - Disease Markers TI - Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864445325&doi=10.3233%2fDMA-2012-0905&partnerID=40&md5=0bbc9a7dfb82e0d294691483b62647cf VL - 33 ID - 4331 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426, United States Department of Clinical Pharmacology, Pfizer Global Research and Development, Paris, France AU - Abbas, R. AU - Hug, B. A. AU - Leister, C. AU - Gaaloul, M. E. AU - Chalon, S. AU - Sonnichsen, D. DB - Scopus DO - 10.1007/s00280-011-1688-7 IS - 1 M3 - Article N1 - Cited By :63 Export Date: 18 November 2020 PY - 2012 SP - 221-227 ST - A phase i ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects T2 - Cancer Chemotherapy and Pharmacology TI - A phase i ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856689752&doi=10.1007%2fs00280-011-1688-7&partnerID=40&md5=073fe157eca40b17a58cd594f35330ae VL - 69 ID - 4332 ER - TY - JOUR AD - Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, United States Department of Clinical Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, United States Field Analytics, BASF Plant Science, Ames, IA, United States AU - Castellino, S. AU - O'Mara, M. AU - Koch, K. AU - Borts, D. J. AU - Bowers, G. D. AU - MacLauchlin, C. DB - Scopus DO - 10.1124/dmd.111.040949 IS - 1 M3 - Article N1 - Cited By :68 Export Date: 18 November 2020 PY - 2012 SP - 139-150 ST - Human metabolism of lapatinib, a dual kinase inhibitor: Implications for hepatotoxicity T2 - Drug Metabolism and Disposition TI - Human metabolism of lapatinib, a dual kinase inhibitor: Implications for hepatotoxicity UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84455171485&doi=10.1124%2fdmd.111.040949&partnerID=40&md5=08bca86252f1d56b0cf159cf23ab98d5 VL - 40 ID - 4333 ER - TY - JOUR AD - Dept. of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Japan Division of Haematology, Respiratory Medicine, and Oncology, Faculty of Medicine, Saga University, Saga 849-8501, Japan Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Japan Department of Haematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan Division of Haematology and Oncology, Narita Red Cross Hospital, Japan Division of Oncology and Haematology, National Cancer Centre Hospital East, Japan Department of Oncology and Haematology, The Jikei University Kashiwa Hospital, Japan Department of Haematology, Japanese Red Cross Medical Centre, Japan Department of Haematology, Johann Wolfgang Goethe-Universitat, Frankfurt, Germany Department of Haematology, Centre for Cancer Biology SA Pathology, Adelaide, Australia AU - Tanaka, R. AU - Kimura, S. AU - Ashihara, E. AU - Yoshimura, M. AU - Takahashi, N. AU - Wakita, H. AU - Itoh, K. AU - Nishiwaki, K. AU - Suzuki, K. AU - Nagao, R. AU - Yao, H. AU - Hayashi, Y. AU - Satake, S. AU - Hirai, H. AU - Sawada, K. I. AU - Ottmann, O. G. AU - Melo, J. V. AU - Maekawa, T. DB - Scopus DO - 10.1016/j.canlet.2011.08.009 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 228-234 ST - Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients T2 - Cancer Letters TI - Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053987395&doi=10.1016%2fj.canlet.2011.08.009&partnerID=40&md5=250b53a533a4e44d987fae9b435e5b8d VL - 312 ID - 4336 ER - TY - JOUR AD - National Cancer Institute, Laboratory of Pathology, Building 10, 9000 Rockville Pike, Bethesda 20892, MA, United States Armed Forces Institute of Pathology, Washington, DC, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus DO - 10.1002/jso.21945 IS - 8 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2011 SP - 865-873 ST - Histopathology of gastrointestinal stromal tumor T2 - Journal of Surgical Oncology TI - Histopathology of gastrointestinal stromal tumor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80855130376&doi=10.1002%2fjso.21945&partnerID=40&md5=e470eb0f280d190c77049ef767fc78bb VL - 104 ID - 4338 ER - TY - JOUR AD - Department of Surgical Oncology, Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, United States Division of Medical Oncology, University of British Columbia, Vancouver, Canada Department of Medical Oncology, Sarcoma Program, Fox Chase Cancer Center, Philadelphia, PA, United States Division of Oncology, Medical Oncology Section, Washington University, St Louis, WA, United States Novartis Pharmaceuticals Corp., East Hanover, United States Department of Medical Oncology, Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Pisters, P. W. T. AU - Blanke, C. D. AU - von Mehren, M. AU - Picus, J. AU - Sirulnik, A. AU - Stealey, E. AU - Trent, J. C. DB - Scopus DO - 10.1093/annonc/mdq773 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2011 SP - 2523-2529 ST - A USA registry of gastrointestinal stromal tumor patients: Changes in practice over time and differences between community and academic practices T2 - Annals of Oncology TI - A USA registry of gastrointestinal stromal tumor patients: Changes in practice over time and differences between community and academic practices UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80355143677&doi=10.1093%2fannonc%2fmdq773&partnerID=40&md5=4c7a116d953aeecd90393b6d20d34f88 VL - 22 ID - 4342 ER - TY - JOUR AD - Department of Histopathology, Bristol Royal Infirmary, Bristol, United Kingdom AU - Wong, N. A. C. S. DB - Scopus DO - 10.1111/j.1365-2559.2011.03812.x IS - 5 M3 - Review N1 - Cited By :32 Export Date: 18 November 2020 PY - 2011 SP - 807-821 ST - Gastrointestinal stromal tumours-an update for histopathologists T2 - Histopathology TI - Gastrointestinal stromal tumours-an update for histopathologists UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-81555216746&doi=10.1111%2fj.1365-2559.2011.03812.x&partnerID=40&md5=1265200617e9af9592caec0e87660969 VL - 59 ID - 4343 ER - TY - JOUR AD - Department of Medical Genetics, Faculty of Medicine, Baskent University, Ankara, Turkey Department of Hematology, Faculty of Medicine, Baskent University, Ankara, Turkey AU - Balci, T. B. AU - Sahin, F. I. AU - Karakus, S. AU - Ozdogu, H. DB - Scopus DO - 10.1179/102453311X13127324303272 IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2011 SP - 357-360 ST - AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients T2 - Hematology TI - AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-82955213546&doi=10.1179%2f102453311X13127324303272&partnerID=40&md5=10babd0e1fb5006e6c6b625033013c39 VL - 16 ID - 4345 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Experimental Oncology, Catholic University Leuven, Leuven, Belgium Center for Human Genetics, Catholic University Leuven, Leuven, Belgium Department of Surgical Oncology, Medical University of Gdansk, Poland Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Department Biology and Genetics, Medical University of Gdansk, Poland AU - Rutkowski, P. AU - Wozniak, A. AU - Dȩbiec-Rychter, M. AU - Kåkol, M. AU - Dziewirski, W. AU - Zdzienicki, M. AU - Ptaszynski, K. AU - Jurkowska, M. AU - Limon, J. AU - Siedlecki, J. A. DB - Scopus DO - 10.1002/cncr.26079 IS - 21 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2011 SP - 4916-4924 ST - Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resection T2 - Cancer TI - Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054828280&doi=10.1002%2fcncr.26079&partnerID=40&md5=3e5e133e7bdbd87cba95d27f57a7e28c VL - 117 ID - 4346 ER - TY - JOUR AD - First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece Univ. Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children's Hospital, Thivon and Levadias, 11527 Goudi-Athens, Greece Science Department, Agricultural University of Athens, Athens, Greece AU - Hatziagapiou, K. AU - Braoudaki, M. AU - Karpusas, M. AU - Tzortzatou-Stathopoulou, F. DB - Scopus IS - 9-10 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2011 SP - 781-784 ST - Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells T2 - Clinical Laboratory TI - Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054793072&partnerID=40&md5=31abcb4b0eacd92fffb37847497635ef VL - 57 ID - 4350 ER - TY - JOUR AD - Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada AU - Brandwein, J. M. DB - Scopus DO - 10.1007/s11912-011-0185-9 IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 371-378 ST - Treatment of acute lymphoblastic leukemia in adolescents and young adults T2 - Current Oncology Reports TI - Treatment of acute lymphoblastic leukemia in adolescents and young adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80755139631&doi=10.1007%2fs11912-011-0185-9&partnerID=40&md5=bc874370b101d5ebf40e87a2f4e6a526 VL - 13 ID - 4353 ER - TY - JOUR AD - Medical Oncology Service, Hospital Universitario Central de Asturias, C/Celestino Villamil s/n, 33006 Oviedo, Spain Department of Medical Oncology, Hospital Juan Canalejo, A Coruña, Spain Department of Medical Oncology, Hospital de Cabueñes, Gijón, Spain Department of Medical Oncology, Hospital de León, León, Spain Department of Medical Oncology, University Clinic of Navarra, Pamplona, Spain Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain Department of Medical Oncology, Hospital General Yagüe, Burgos, Spain AstraZeneca, Madrid, Spain AU - Viéitez, J. M. AU - Valladares, M. AU - Peláez, I. AU - De Sande González, L. AU - García-Foncillas, J. AU - García-López, J. L. AU - García-Girón, C. AU - Reboredo, M. AU - Bovio, H. AU - Lacave, A. J. DB - Scopus DO - 10.1007/s10637-010-9400-z IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 1038-1044 ST - A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143) T2 - Investigational New Drugs TI - A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856077157&doi=10.1007%2fs10637-010-9400-z&partnerID=40&md5=2de8936789b3b6df9a80ab902f6866b3 VL - 29 ID - 4354 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO 64108, United States AU - Fulbright, J. M. C7 - 942090 DB - Scopus DO - 10.4061/2011/942090 IS - 1 M3 - Review N1 - Cited By :41 Export Date: 18 November 2020 PY - 2011 ST - Review of cardiotoxicity in pediatric cancer patients: During and after therapy T2 - Cardiology Research and Practice TI - Review of cardiotoxicity in pediatric cancer patients: During and after therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052679204&doi=10.4061%2f2011%2f942090&partnerID=40&md5=2aa3cd40a55d2961c60504004600bf54 VL - 1 ID - 4356 ER - TY - JOUR AD - Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Balagula, Y. AU - Pulitzer, M. P. AU - Maki, R. G. AU - Myskowski, P. L. DB - Scopus IS - 9 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2011 SP - 1062-1066 ST - Pigmentary changes in a patient treated with imatinib T2 - Journal of Drugs in Dermatology TI - Pigmentary changes in a patient treated with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053330202&partnerID=40&md5=ad3e302b9005ebe434f06e9c14e8b77a VL - 10 ID - 4358 ER - TY - JOUR AD - Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing 100034, China Department of Urology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China AU - Li, X. S. AU - Wu, X. AU - Zhao, P. J. AU - Huang, L. H. AU - Song, Y. AU - Gong, K. AU - Shen, C. AU - Yu, W. AU - Song, G. AU - Zhao, Z. AU - Zhang, Z. AU - Zhang, Q. AU - Wang, G. AU - He, Z. S. AU - Zhou, L. Q. AU - Jin, J. DB - Scopus DO - 10.3760/cma.j.issn.0366-6999.2011.18.023 IS - 18 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2011 SP - 2920-2924 ST - Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma T2 - Chinese Medical Journal TI - Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052975506&doi=10.3760%2fcma.j.issn.0366-6999.2011.18.023&partnerID=40&md5=6ec66ecdde0b6e9cced1445aa06b44d9 VL - 124 ID - 4359 ER - TY - JOUR AD - Dipartimento di Medicina Interna e Specialità Mediche, Università di Roma 'Sapienza', V.le del Policlinico, 155, 00161 Roma, Italy Dipartimento di Ematologia e Scienze Oncologiche 'L. e A. Seragnoli', Università di Bologna, 40139 Bologna, Italy Dipartimento di Medicina Interna, Università di Perugia, 06126 Perugia, Italy Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, 06126 Perugia, Italy U.O. Genetica Medica, Dipartimento di Scienze Ginecologiche Ostetriche e Pediatriche, Università di Bologna, 40139 Bologna, Italy Dipartimento di Scienze Chirurgiche, Università di Roma 'Sapienza', 00161 Roma, Italy Dipartimento di Scienze Farmacobiologiche, Università di Catanzaro 'Magna Graecia', 88100 Catanzaro, Italy AU - Durante, C. AU - Tallini, G. AU - Puxeddu, E. AU - Sponziello, M. AU - Moretti, S. AU - Ligorio, C. AU - Cavaliere, A. AU - Rhoden, K. J. AU - Verrienti, A. AU - Maranghi, M. AU - Giacomelli, L. AU - Russo, D. AU - Filetti, S. DB - Scopus DO - 10.1530/EJE-11-0283 IS - 3 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2011 SP - 455-463 ST - BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas T2 - European Journal of Endocrinology TI - BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051706001&doi=10.1530%2fEJE-11-0283&partnerID=40&md5=73306346f84df9bd4f7d8065fe93a5b7 VL - 165 ID - 4361 ER - TY - JOUR AD - Department of Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53792, United States AU - Durrani, S. R. AU - Viswanathan, R. K. AU - Busse, W. W. DB - Scopus DO - 10.1016/j.jaci.2011.06.002 IS - 3 M3 - Review N1 - Cited By :126 Export Date: 18 November 2020 PY - 2011 SP - 439-448 ST - What effect does asthma treatment have on airway remodeling? Current perspectives T2 - Journal of Allergy and Clinical Immunology TI - What effect does asthma treatment have on airway remodeling? Current perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052267387&doi=10.1016%2fj.jaci.2011.06.002&partnerID=40&md5=88b0edd2425fd0f97e9797ec05fd9b9d VL - 128 ID - 4363 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Kantarjian, H. AU - O'Brien, S. AU - Jabbour, E. AU - Shan, J. AU - Ravandi, F. AU - Kadia, T. AU - Faderl, S. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Cortes, J. DB - Scopus DO - 10.1200/JCO.2010.33.4169 IS - 23 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2011 SP - 3173-3178 ST - Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia T2 - Journal of Clinical Oncology TI - Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051821734&doi=10.1200%2fJCO.2010.33.4169&partnerID=40&md5=657a272bdab9bf33351691c252007721 VL - 29 ID - 4366 ER - TY - JOUR AD - Department of Pediatrics, UCSF, School of Medicine, 505, Parnassus Avenue, M646, San Francisco, CA 94143-0106, United States Department of Pediatrics, Children's Hospital Boston, Harvard Medical School, Boston, MA, United States Children's Oncology Group Operations Center, Arcadia, CA, United States Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Pharmacology, Mayo College of Medicine, Rochester, MN, United States Department of Hematology/ Oncology, Hospital for Sick Children, Toronto, ON, Canada Department of Pediatrics, Morgan Stanley Children's Hospital, Columbia University School of Medicine, New York, NY, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Department of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States AU - DuBois, S. G. AU - Shusterman, S. AU - Ingle, A. M. AU - Ahern, C. H. AU - Reid, J. M. AU - Wu, B. AU - Baruchel, S. AU - Glade-Bender, J. AU - Ivy, P. AU - Grier, H. E. AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1158/1078-0432.CCR-11-0237 IS - 15 M3 - Article N1 - Cited By :82 Export Date: 18 November 2020 PY - 2011 SP - 5113-5122 ST - Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: A children's oncology group study T2 - Clinical Cancer Research TI - Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: A children's oncology group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960983264&doi=10.1158%2f1078-0432.CCR-11-0237&partnerID=40&md5=ed265068a4313b85a531fde27ae055e4 VL - 17 ID - 4367 ER - TY - JOUR AD - Department of Hemato-Oncology, University Hospital, Olomouc, Czech Republic Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic Department of Hemato-Oncology, University Hospital, Plzeň, Czech Republic Department of Hematology and Blood Transfusion, University Hospital, Bratislava, Slovakia 2nd Department of Internal Medicine, Division of Hematology, University Hospital, Hradec Králové, Czech Republic Department of Internal Medicine, National Oncology Institute, Bratislava, Slovakia Department of Hematology and Blood Transfusion, University Hospital, Martin, Slovakia Department of Hematology, FD Roosevelt University Hospital, Banská Bystrica, Slovakia Department of Internal Medicine, Division of Hematology, General University Hospital, Prague, Czech Republic Department of Hematology, University Hospital, Královské Vinohrady, Prague, Czech Republic Department of Hematology and Hemato-Oncology, L Pasteur University Hospital, Košice, Slovakia AU - Faber, E. AU - Mužík, J. AU - Koza, V. AU - Demečková, E. AU - Voglová, J. AU - Demitrovičová, L. AU - Chudej, J. AU - Markuljak, I. AU - Cmunt, E. AU - Kozák, T. AU - Tóthová, E. AU - Jarošová, M. AU - Dušek, L. AU - Indrák, K. DB - Scopus DO - 10.1111/j.1600-0609.2011.01637.x IS - 2 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2011 SP - 157-168 ST - Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry T2 - European Journal of Haematology TI - Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960408943&doi=10.1111%2fj.1600-0609.2011.01637.x&partnerID=40&md5=e987b2405fa172f1d3cb414305c6c8ba VL - 87 ID - 4369 ER - TY - JOUR AD - INSERM U999, Centre Chirurgical Marie Lannelongue, 133 avenue de la Résistance, F-92350 Le Plessis-Robinson, France University of Paris-Sud 11, Orsay, France Free University of Brussels, Brussels, Belgium AP-HP, Hôpital Antoine-Béclère, Clamart, France AU - Tu, L. AU - Dewachter, L. AU - Gore, B. AU - Fadel, E. AU - Dartevelle, P. AU - Simonneau, G. AU - Humbert, M. AU - Eddahibi, S. AU - Guignabert, C. DB - Scopus DO - 10.1165/rcmb.2010-0317OC IS - 2 M3 - Article N1 - Cited By :84 Export Date: 18 November 2020 PY - 2011 SP - 311-322 ST - Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension T2 - American Journal of Respiratory Cell and Molecular Biology TI - Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051615782&doi=10.1165%2frcmb.2010-0317OC&partnerID=40&md5=fb6409aa7fc26de6d32453276216cecd VL - 45 ID - 4370 ER - TY - JOUR AD - Medical University of Gdańsk, Department of Oncology Propaedeutics, Powstania Styczniowego 9b, 81-519 Gdynia, Poland Opole Oncology Center, Poland Department of Oncology, Poznan University of Medical Sciences, Poland AU - Leśniewski-Kmak, K. AU - Radecka, B. AU - Litwiniuk, M. DB - Scopus DO - 10.5114/wo.2011.23004 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2011 SP - 147-154 ST - Bone tissue as the site of action of oncological drugs T2 - Wspolczesna Onkologia TI - Bone tissue as the site of action of oncological drugs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960240781&doi=10.5114%2fwo.2011.23004&partnerID=40&md5=3cb837712d609e6ecfcec6db1c35ae2f VL - 15 ID - 4371 ER - TY - JOUR AD - Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan Hematology Division, Miyagi Cancer Center, Miyagi, Japan AU - Onishi, Y. AU - Sasaki, O. AU - Ichikawa, S. AU - Inokura, K. AU - Katsuoka, Y. AU - Ohtsuka Ohba, R. AU - Okitsu, Y. AU - Kohata, K. AU - Ohguchi, H. AU - Fukuhara, N. AU - Yokoyama, H. AU - Yamada, M. F. AU - Yamamoto, J. AU - Ishizawa, K. AU - Kameoka, J. AU - Harigae, H. DB - Scopus DO - 10.1016/j.bbmt.2011.01.010 IS - 7 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 1093-1097 ST - Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Biology of Blood and Marrow Transplantation TI - Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958722346&doi=10.1016%2fj.bbmt.2011.01.010&partnerID=40&md5=714bc526ef71baaca78b9389b882b98f VL - 17 ID - 4373 ER - TY - JOUR AD - FUNDALEU, Centro de Internación e Investigación Clínica Angélica Ocampo, Buenos Aires, Argentina Hospital General de Agudos J.M. Ramos Mejia, Buenos Aires, Argentina Instituto Privado de Hematología, Entre Ríos, Argentina Hospital Privado de Córdoba, Córdoba, Argentina II HEMA Academia Nacional de Medicina, Buenos Aires, Argentina Hospital Italiano de la Plata, Argentina Hospital Central de Mendoza, Mendoza, Argentina Asociación Espaola Primera de Socorros Mutuos, Montevideo, Uruguay Hospital Maciel, ASSE, Montevideo, Uruguay Novartis, Buenos Aires, Argentina Grupo Argentino de Tratamiento de la Leucemia Aguda, Statistical Office, Buenos Aires, Argentina AU - Pavlovsky, C. AU - Giere, I. AU - Moiraghi, B. AU - Pavlovsky, M. A. AU - Aranguren, P. N. AU - García, J. AU - Fernandez, I. AU - Bengió, R. AU - Milone, J. AU - Labanca, V. AU - Uriarte, R. AU - Lombardi, V. AU - Reinoso, F. G. AU - Magarios, A. E. AU - Martinez, L. AU - Murro, H. AU - Lastiri, F. AU - Pavlovsky, S. DB - Scopus DO - 10.1016/j.clml.2011.03.016 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2011 SP - 280-285 ST - Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053355373&doi=10.1016%2fj.clml.2011.03.016&partnerID=40&md5=16df6faa326f78ba0716ff422e22c6db VL - 11 ID - 4377 ER - TY - JOUR AD - Department of Dermatology, University of Regensburg, Regensburg, Germany Department of Dermatology, University of Saarland, Homburg/Saar, Germany Center of Excellence for Fluorescent Bioanalysis, University of Regensburg, Regensburg, Germany Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland AU - Mauerer, A. AU - Roesch, A. AU - Hafner, C. AU - Stempfl, T. AU - Wild, P. AU - Meyer, S. AU - Landthaler, M. AU - Vogt, T. DB - Scopus DO - 10.1111/j.1600-0625.2011.01254.x IS - 6 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2011 SP - 502-507 ST - Identification of new genes associated with melanoma T2 - Experimental Dermatology TI - Identification of new genes associated with melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956072498&doi=10.1111%2fj.1600-0625.2011.01254.x&partnerID=40&md5=a013322c2862f74a98695e9feee9659a VL - 20 ID - 4378 ER - TY - JOUR AD - Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970, United States Department of Pathology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC, United States Department of Pediatrics, George Washington University School of Medicine, Washington, DC, United States Department of Neuropathology, Armed Forces Institute of Pathology, Washington, DC, United States Cancer Genetics Branch, National Human Genome Research Institute NIH, Bethesda, MD, United States AU - Smith, C. AU - Santi, M. AU - Rushing, E. J. AU - Cornelison, R. AU - MacDonald, T. J. AU - Vukmanovic, S. DB - Scopus DO - 10.1007/s11060-010-0378-3 IS - 2 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2011 SP - 197-206 ST - Characterization of signaling function and expression of HLA class I molecules in medulloblastoma T2 - Journal of Neuro-Oncology TI - Characterization of signaling function and expression of HLA class I molecules in medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959833129&doi=10.1007%2fs11060-010-0378-3&partnerID=40&md5=7e032f45875a70031f3d7ccb52a7610e VL - 103 ID - 4380 ER - TY - JOUR AD - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Pediatrics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Andersson, B. S. AU - Valdez, B. C. AU - de Lima, M. AU - Wang, X. AU - Thall, P. F. AU - Worth, L. L. AU - Popat, U. AU - Madden, T. AU - Hosing, C. AU - Alousi, A. AU - Rondon, G. AU - Kebriaei, P. AU - Shpall, E. J. AU - Jones, R. B. AU - Champlin, R. E. DB - Scopus DO - 10.1016/j.bbmt.2010.09.022 IS - 6 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 2011 SP - 893-900 ST - Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS T2 - Biology of Blood and Marrow Transplantation TI - Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956017109&doi=10.1016%2fj.bbmt.2010.09.022&partnerID=40&md5=448d1d77c03d1bab82657075bfad0ff0 VL - 17 ID - 4381 ER - TY - JOUR AD - Department of Neurosurgery, Wenzhou Medical College, 109 Xueyuan Street, Wenzhou 325000, China Department of Neurosurgery, Union Hospital, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China AU - Zhou, H. AU - Rao, J. AU - Lin, J. AU - Yin, B. AU - Sheng, H. AU - Lin, F. AU - Zhang, N. AU - Yang, L. DB - Scopus DO - 10.3892/or.2011.1233 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2011 SP - 1565-1571 ST - The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy T2 - Oncology Reports TI - The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954545017&doi=10.3892%2for.2011.1233&partnerID=40&md5=977f012f0a6d1506d6c32c38928c663c VL - 25 ID - 4382 ER - TY - JOUR AD - Royal Marsden Hospital, Institute of Cancer Research, Sutton, United Kingdom Institut Gustave Roussy, Université Paris XI, Villejuif, France Institut Curie, INSERM U900, Paris, France AU - Postel-Vinay, S. AU - Gomez-Roca, C. AU - Molife, L. R. AU - Anghan, B. AU - Levy, A. AU - Judson, I. AU - De Bono, J. AU - Soria, J. C. AU - Kaye, S. AU - Paoletti, X. DB - Scopus DO - 10.1200/JCO.2010.31.9236 IS - 13 M3 - Article N1 - Cited By :93 Export Date: 18 November 2020 PY - 2011 SP - 1728-1735 ST - Phase I trials of molecularly targeted agents: Should we pay more attention to late toxicities? T2 - Journal of Clinical Oncology TI - Phase I trials of molecularly targeted agents: Should we pay more attention to late toxicities? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955617684&doi=10.1200%2fJCO.2010.31.9236&partnerID=40&md5=7dbfc309c0161887d4f210aa911b71ce VL - 29 ID - 4385 ER - TY - JOUR AD - Institute of Molecular Radiation Biology, Helmholtz Center Munich, German Research Center for Environmental Health GmbH, Neuherberg, Germany Department of Histopathology, Imperial College London Hammersmith Hospital, London, United Kingdom AU - Zitzelsberger, H. AU - Unger, K. DB - Scopus DO - 10.1016/j.clon.2011.01.154 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 289-296 ST - DNA Copy Number Alterations in Radiation-induced Thyroid Cancer T2 - Clinical Oncology TI - DNA Copy Number Alterations in Radiation-induced Thyroid Cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955039547&doi=10.1016%2fj.clon.2011.01.154&partnerID=40&md5=96a812c2e7a7c8a2dca99f3309b72158 VL - 23 ID - 4386 ER - TY - JOUR AD - Department of Immunology and Experimental Therapeutics, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Cancer Biology PhD Program, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States Department of Pathology, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Hematology Research Unit, Biomedicum Helsinki, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland AU - Powers, J. J. AU - Dubovsky, J. A. AU - Epling-Burnette, P. K. AU - Moscinski, L. AU - Zhang, L. AU - Mustjoki, S. AU - Sotomayor, E. M. AU - Pinilla-Ibarz, J. A. DB - Scopus DO - 10.3109/10428194.2010.550074 IS - 4 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2011 SP - 668-679 ST - A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors T2 - Leukemia and Lymphoma TI - A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953206281&doi=10.3109%2f10428194.2010.550074&partnerID=40&md5=3cc30a6ff1b56e99218dc8c79a5a1e62 VL - 52 ID - 4389 ER - TY - JOUR AD - UCL Cancer Institute, Department of Haematology, Paul o'Gorman Building, 72 Huntley Street, London, WC1E 6BT, United Kingdom AU - Roddie, C. AU - Peggs, K. S. DB - Scopus DO - 10.1517/14712598.2011.554811 IS - 4 M3 - Review N1 - Cited By :73 Export Date: 18 November 2020 PY - 2011 SP - 473-487 ST - Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation T2 - Expert Opinion on Biological Therapy TI - Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952590640&doi=10.1517%2f14712598.2011.554811&partnerID=40&md5=9f9cdb80a2419fe9d6a52162b98dc1a7 VL - 11 ID - 4390 ER - TY - JOUR AD - Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom Wessex Regional Genetics Laboratory, Salisbury, United Kingdom Oregon Health and Science University, Hematology Portland, OR, United States Division of Infection Inflammation and Immunity, University of Southampton School of Medicine, Southampton, United Kingdom Harbor Hospital, Hematology/Immunology Unit, Baltimore, MD, United States Department of Haematology, Hammersmith Hospital, Imperial College, Du Cane Road, London, United Kingdom AU - Ernst, T. AU - Score, J. AU - Deininger, M. AU - Hidalgo-Curtis, C. AU - Lackie, P. AU - Ershler, W. B. AU - Goldman, J. M. AU - Cross, N. C. AU - Grand, F. DB - Scopus DO - 10.1111/j.1365-2141.2010.08457.x IS - 1 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2011 SP - 43-46 ST - Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952592616&doi=10.1111%2fj.1365-2141.2010.08457.x&partnerID=40&md5=78bf7ccbfa01664c4503a93568a1bcb3 VL - 153 ID - 4391 ER - TY - JOUR AD - Department of Medicine, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, 91200 Jerusalem, Israel Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel AU - Szalat, A. AU - Fraenkel, M. AU - Doviner, V. AU - Salmon, A. AU - Gross, D. J. DB - Scopus DO - 10.1007/s12020-010-9422-5 IS - 2 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2011 SP - 160-166 ST - Malignant pheochromocytoma: Predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center T2 - Endocrine TI - Malignant pheochromocytoma: Predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953655714&doi=10.1007%2fs12020-010-9422-5&partnerID=40&md5=79802c835c14d53d75df50ec6fe30cad VL - 39 ID - 4392 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States Harvard Medical School, United States Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston, MA, United States Department of Pathology, United States Division of Hematology and Oncology, Portland VA Medical Center, United States Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States AU - Rege, T. A. AU - Wagner, A. J. AU - Corless, C. L. AU - Heinrich, M. C. AU - Hornick, J. L. DB - Scopus DO - 10.1097/PAS.0b013e31820e5f7d IS - 4 M3 - Article N1 - Cited By :82 Export Date: 18 November 2020 PY - 2011 SP - 495-504 ST - "Pediatric-type" gastrointestinal stromal tumors in adults: Distinctive histology predicts genotype and clinical behavior T2 - American Journal of Surgical Pathology TI - "Pediatric-type" gastrointestinal stromal tumors in adults: Distinctive histology predicts genotype and clinical behavior UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953183996&doi=10.1097%2fPAS.0b013e31820e5f7d&partnerID=40&md5=9d314af3efcb6f58746ac523aee09799 VL - 35 ID - 4393 ER - TY - JOUR AD - Greehey Children's Cancer Research Institute, University of Texas Health Science Center, San Antonio, TX, United States Pape' Family Pediatric Research Institute, Department of Pediatrics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239-3098, United States Department of Medicine, University of Texas Health Science Center, San Antonio, TX, United States Department of Genetics and Development, Columbia University, New York, NY, United States Department of Pathology, University of Virginia, Charlottesville, VA, United States Department of Mechanical Engineering, University of Texas, San Antonio, TX, United States Department of Anatomic Pathology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, United States AU - Abraham, J. AU - Prajapati, S. I. AU - Nishijo, K. AU - Schaffer, B. S. AU - Taniguchi, E. AU - Kilcoyne, A. AU - McCleish, A. T. AU - Nelon, L. D. AU - Giles, F. G. AU - Efstratiadis, A. AU - LeGallo, R. D. AU - Nowak, B. M. AU - Rubin, B. P. AU - Malempati, S. AU - Keller, C. DB - Scopus DO - 10.1158/1535-7163.MCT-10-0695 IS - 4 M3 - Article N1 - Cited By :44 Export Date: 18 November 2020 PY - 2011 SP - 697-707 ST - Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma T2 - Molecular Cancer Therapeutics TI - Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955779350&doi=10.1158%2f1535-7163.MCT-10-0695&partnerID=40&md5=cb56b82fa66b430771173ede4c15032c VL - 10 ID - 4394 ER - TY - JOUR AD - Department of Hematology, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China Key Lab. of Hematology, Diagnose and Treatment, Hangzhou, Zhejiang, China Key Lab. of Combined Muti-organ Transplantation, Ministry of Public Health, #79 Qingchun Road, Hangzhou 310003, Zhejiang, China AU - Huang, J. AU - Ding, T. AU - Yang, M. AU - Liu, H. AU - Sun, X. AU - Jin, J. DB - Scopus DO - 10.1007/s12185-011-0821-z IS - 4 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2011 SP - 482-493 ST - Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells T2 - International Journal of Hematology TI - Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955942563&doi=10.1007%2fs12185-011-0821-z&partnerID=40&md5=6674c936d59f20fe52b93446ec4d4df5 VL - 93 ID - 4395 ER - TY - JOUR AD - Department of Hematology and Medial Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road NE, Atlanta, GA 30322, United States Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States Department of Biostatistics and Bioinformatics, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States AU - Lima, L. AU - Bernal-Mizrachi, L. AU - Saxe, D. AU - Mann, K. P. AU - Tighiouart, M. AU - Arellano, M. AU - Heffner, L. AU - McLemore, M. AU - Langston, A. AU - Winton, E. AU - Khoury, H. J. DB - Scopus DO - 10.1002/cncr.25678 IS - 6 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2011 SP - 1245-1252 ST - Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond T2 - Cancer TI - Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952375521&doi=10.1002%2fcncr.25678&partnerID=40&md5=4d82c6a4f751d32dfdf013bc4603942b VL - 117 ID - 4397 ER - TY - JOUR AU - Aplenc, R. AU - Blaney, S. M. AU - Strauss, L. C. AU - Balis, F. M. AU - Shusterman, S. AU - Ingle, A. M. AU - Agrawal, S. AU - Sun, J. AU - Wright, J. J. AU - Adamson, P. C. DB - Scopus DO - 10.1200/JCO.2010.30.7231 IS - 7 M3 - Article N1 - Cited By :75 Export Date: 18 November 2020 PY - 2011 SP - 839-844 ST - Pediatric phase I trial and pharmacokinetic study of dasatinib: A report from the children's oncology group phase I consortium T2 - Journal of Clinical Oncology TI - Pediatric phase I trial and pharmacokinetic study of dasatinib: A report from the children's oncology group phase I consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952319155&doi=10.1200%2fJCO.2010.30.7231&partnerID=40&md5=a165c96eaa0b981bbca31ff8a1381cb3 VL - 29 ID - 4399 ER - TY - JOUR AD - Department of Leukemia, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Santos, F. P. S. AU - Alvarado, Y. AU - Kantarjian, H. AU - Verma, D. AU - O'Brien, S. AU - Mattiuzzi, G. AU - Ravandi, F. AU - Borthakur, G. AU - Cortes, J. DB - Scopus DO - 10.1002/cncr.25533 IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 982-991 ST - Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib T2 - Cancer TI - Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952009886&doi=10.1002%2fcncr.25533&partnerID=40&md5=9339bd778514e14a2d272ae9e0ee099d VL - 117 ID - 4401 ER - TY - JOUR AD - Pediatric Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, Italy University of Bonn, Childreǹs Medical Hospital, Department of Paediatric Haematology/Oncology, Bonn, Germany AU - Massimino, M. AU - Bode, U. AU - Biassoni, V. AU - Fleischhack, G. DB - Scopus DO - 10.1517/14712598.2011.546341 IS - 2 M3 - Article N1 - Cited By :54 Export Date: 18 November 2020 PY - 2011 SP - 247-256 ST - Nimotuzumab for pediatric diffuse intrinsic pontine gliomas T2 - Expert Opinion on Biological Therapy TI - Nimotuzumab for pediatric diffuse intrinsic pontine gliomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651369365&doi=10.1517%2f14712598.2011.546341&partnerID=40&md5=a2f17ad9ca6ca844be7f1933cbac44bb VL - 11 ID - 4404 ER - TY - JOUR AD - St Jude Children's Research Hospital, Department of Pathology, Mail Stop 342, 262 Danny Thomas Place, Memphis, TN 38105, United States AU - Mullighan, C. G. DB - Scopus DO - 10.1158/1078-0432.CCR-10-1203 IS - 3 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2011 SP - 396-400 ST - New strategies in acute lymphoblastic leukemia: Translating advances in genomics into clinical practice T2 - Clinical Cancer Research TI - New strategies in acute lymphoblastic leukemia: Translating advances in genomics into clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79551699535&doi=10.1158%2f1078-0432.CCR-10-1203&partnerID=40&md5=0d10d2556c34a2cd333e4d1e33c1a170 VL - 17 ID - 4405 ER - TY - JOUR AD - Department of Pediatrics, Nagoya University, Graduate School of Medicine, 65 Tsuruma-Cho, Showa-ku, Nagoya, Aichi 466-8650, Japan Department of Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan AU - Muramatsu, H. AU - Takahashi, Y. AU - Sakaguchi, H. AU - Shimada, A. AU - Nishio, N. AU - Hama, A. AU - Doisaki, S. AU - Yagasaki, H. AU - Matsumoto, K. AU - Kato, K. AU - Kojima, S. DB - Scopus DO - 10.1007/s12185-010-0764-9 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 186-191 ST - Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era T2 - International Journal of Hematology TI - Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952251630&doi=10.1007%2fs12185-010-0764-9&partnerID=40&md5=36acaa78b6de07e261990b4cc3becd91 VL - 93 ID - 4406 ER - TY - JOUR AD - Department of Gastroenterology, University of Tokyo, Tokyo, Japan Department of Clinical Drug Evaluation, Graduate School of Medicine, University of Tokyo, Tokyo, Japan Department of Hepatology, Kyoundo Hospital, Tokyo, Japan Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan Division of Medical Oncology, Yokohama Rosai Hospital, Yokohama, Japan Department of Gastroenterology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan AU - Kanai, F. AU - Yoshida, H. AU - Tateishi, R. AU - Sato, S. AU - Kawabe, T. AU - Obi, S. AU - Kondo, Y. AU - Taniguchi, M. AU - Tagawa, K. AU - Ikeda, M. AU - Morizane, C. AU - Okusaka, T. AU - Arioka, H. AU - Shiina, S. AU - Omata, M. DB - Scopus DO - 10.1007/s00280-010-1320-2 IS - 2 M3 - Article N1 - Cited By :61 Export Date: 18 November 2020 PY - 2011 SP - 315-324 ST - A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma T2 - Cancer Chemotherapy and Pharmacology TI - A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953803472&doi=10.1007%2fs00280-010-1320-2&partnerID=40&md5=20f37afada5bc645c4a3abc1021e9732 VL - 67 ID - 4407 ER - TY - JOUR AD - Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Internal Medicine, Ohio State University, Columbus, OH 43210, United States Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, United States Institute of Behavioral Medicine Research, Ohio State University, Columbus, OH 43210, United States Booz Allen Hamilton, 4001 Fairfax Drive, Arlington, VA 22203, United States Lake Erie College of Osteopathic Medicine, 5000 Lakewood Ranch Boulevard, Bradenton, FL 34211, United States AU - Hinzey, A. AU - Alexander, J. AU - Corry, J. AU - Adams, K. M. AU - Claggett, A. M. AU - Traylor, Z. P. AU - Davis, I. C. AU - Marketon, J. I. W. DB - Scopus DO - 10.1210/en.2010-0774 IS - 2 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2011 SP - 483-494 ST - Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation T2 - Endocrinology TI - Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951635405&doi=10.1210%2fen.2010-0774&partnerID=40&md5=60c6b155e67c43d00bbe2c38de830e6e VL - 152 ID - 4408 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Al-Kali, A. AU - Kantarjian, H. AU - Shan, J. AU - Bassett, R. AU - Quintás-Cardama, A. AU - Borthakur, G. AU - Jabbour, E. AU - Verstovsek, S. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.1002/cncr.25604 IS - 2 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2011 SP - 327-335 ST - Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia T2 - Cancer TI - Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650989779&doi=10.1002%2fcncr.25604&partnerID=40&md5=0f08ec348de05df65416b6a5c5730511 VL - 117 ID - 4410 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology-Blood and Marrow Transplantation, University Hospital Carl Gustav Carus, Fetscherstr. 74, Dresden, Germany Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Division of Pediatric Hematology-Oncology-Blood and Marrow Transplantation, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada AU - Suttorp, M. AU - Yaniv, I. AU - Schultz, K. R. DB - Scopus DO - 10.1016/j.bbmt.2010.09.003 IS - 1 SUPPL M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2011 SP - S115-S122 ST - Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT? T2 - Biology of Blood and Marrow Transplantation TI - Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650659462&doi=10.1016%2fj.bbmt.2010.09.003&partnerID=40&md5=9e1d3e37a018a9e221fbff5a72299e10 VL - 17 ID - 4411 ER - TY - JOUR AD - Children's Hospital Colorado and Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, United States AU - Hunger, S. P. DB - Scopus DO - 10.1182/asheducation-2011.1.361 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2011 SP - 361-365 ST - Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859377971&doi=10.1182%2fasheducation-2011.1.361&partnerID=40&md5=5af35e7a8b615d4c22db1f46b95020ff VL - 2011 ID - 4412 ER - TY - JOUR AD - Texas Childrens Cancer Center, Baylor College of Medicine, Houston, TX, United States AU - Rabin, K. R. AU - Poplack, D. G. DB - Scopus IS - 4 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 ST - Management strategies in acute lymphoblastic leukemia T2 - Oncology TI - Management strategies in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956226779&partnerID=40&md5=579ebbf4bf92a2603d221e51b586b04d VL - 25 ID - 4414 ER - TY - JOUR AD - Department of Pediatrics, Catholic University of Korea Colledge of Medicine, Seoul, South Korea AU - Lee, J. W. AU - Chung, N. G. DB - Scopus DO - 10.3345/kjp.2011.54.3.110 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2011 SP - 110-115 ST - The treatment of pediatric chronic myelogenous leukemia in the imatinib era T2 - Korean Journal of Pediatrics TI - The treatment of pediatric chronic myelogenous leukemia in the imatinib era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958069450&doi=10.3345%2fkjp.2011.54.3.110&partnerID=40&md5=290f69840b3a5cdb0d4f4898d62fa5db VL - 54 ID - 4415 ER - TY - JOUR AD - Jena University Hospital, Jena, Germany AU - Hochhaus, A. DB - Scopus DO - 10.1182/asheducation-2011.1.128 M3 - Review N1 - Cited By :43 Export Date: 18 November 2020 PY - 2011 SP - 128-135 ST - Educational session: managing chronic myeloid leukemia as a chronic disease T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Educational session: managing chronic myeloid leukemia as a chronic disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856508611&doi=10.1182%2fasheducation-2011.1.128&partnerID=40&md5=5c684c52ea64e4c4b48ceaf790d87c0c VL - 2011 ID - 4416 ER - TY - JOUR AD - Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China AU - Huang, Q. AU - Yang, Y. AU - Li, X. AU - Huang, S. DB - Scopus DO - 10.1007/s13277-011-0222-1 IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2011 SP - 1191-1197 ST - Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells T2 - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine TI - Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879789506&doi=10.1007%2fs13277-011-0222-1&partnerID=40&md5=098e25d14163ca7a7c05d681b5c8c586 VL - 32 ID - 4417 ER - TY - JOUR AD - Department of Internal Medicine, Patan Hospital, Lalitpur, Nepal Department of Emergency Medicine, Patan Hospital, Lalitpur, Nepal Nick Simon Institute, Lalitpur, Nepal Division of Hematology of the Department of Internal Medicine, Department of Oncology, Mayo Clinic, Rochester, MN, United States AU - Kayastha, G. K. AU - Gurung, P. AU - Acharya, P. K. AU - Paudyal, B. P. AU - Hayes, B. AU - Zimmerman, M. AU - Karki, A. AU - Mansfield, A. S. C7 - 8 DB - Scopus DO - 10.1186/1471-2326-10-8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2010 ST - Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor T2 - BMC Blood Disorders TI - Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649750354&doi=10.1186%2f1471-2326-10-8&partnerID=40&md5=044f3bb735e3f0989f494b3cca1dcd6f VL - 10 ID - 4421 ER - TY - JOUR AD - Division of Pedatric Hematology, Oncology, Blood and Marrow Transplantation, British Columbia Childrens Hospital, University of British Columbia, Vancouver, BC, V6H 3V4, Canada Division of Hematology/Oncology/Transplantation, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, WI, United States AU - Schultz, K. R. AU - Prestidge, T. AU - Camitta, B. DB - Scopus DO - 10.1586/ehm.10.60 IS - 6 M3 - Review N1 - Cited By :11 Export Date: 18 November 2020 PY - 2010 SP - 731-742 ST - Philadelphia chromosome-positive acute lymphoblastic leukemia in children: New and emerging treatment options T2 - Expert Review of Hematology TI - Philadelphia chromosome-positive acute lymphoblastic leukemia in children: New and emerging treatment options UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649505429&doi=10.1586%2fehm.10.60&partnerID=40&md5=afdfde40e8855872d31914f9dfde803a VL - 3 ID - 4422 ER - TY - JOUR AD - Department of Medicine III, University of Aachen, Pauwelstraße 30, Aachen 52074, Germany AU - Roderburg, C. AU - Bubenzer, J. AU - Spannbauer, M. AU - do Nicole, O. AU - Mahnken, A. AU - Luedde, T. AU - Trautwein, C. AU - Tischendorf, J. J. W. DB - Scopus DO - 10.4254/wjh.v2.i6.239 IS - 6 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2010 SP - 239-242 ST - Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib T2 - World Journal of Hepatology TI - Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871747719&doi=10.4254%2fwjh.v2.i6.239&partnerID=40&md5=39db91604657caf7bb5d20b999f5fc43 VL - 2 ID - 4423 ER - TY - JOUR AD - Department of Clinical Pharmacology, Hoffman-La Roche, Inc, 340 Kingsland Street, Nutley, NJ 07110, United States Department of Oncology Discovery, Nutley, NJ, United States Department of Drug Metabolism and Pharmacokinetics, Nutley, NJ, United States Department of Biomarkers and Experimental Medicine, Nutley, NJ, United States Department of Clinical Drug Safety, Nutley, NJ, United States Department of Biostatistics, Nutley, NJ, United States Department of Clinical Development, Hoffmann-La Roche, Nutley, NJ, United States Molecular Laboratories, HistoGeneX, Lindendreef, Belgium Institute of Translational and Experimental Medicine, Strasbourg, France AU - Lee, L. AU - Niu, H. AU - Goelzer, P. AU - Rueger, R. AU - Deutsch, J. AU - Busse-Reid, R. AU - Deschepper, S. AU - Blotner, S. AU - Barrett, J. AU - Weissgerber, G. AU - Peck, R. DB - Scopus DO - 10.1177/0091270010361254 IS - 12 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2010 SP - 1397-1405 ST - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: Assessment of target suppression T2 - Journal of Clinical Pharmacology TI - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: Assessment of target suppression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649790745&doi=10.1177%2f0091270010361254&partnerID=40&md5=64e65070d8bf56834915e9e641aac519 VL - 50 ID - 4424 ER - TY - JOUR AD - Division of Hematology, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India Division of Hematology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand Department of Hematology, Singapore General Hospital, Singapore Department of Hematology, Christchurch Hospital, Christchurch, New Zealand Bone Marrow Transplant Center, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China Haematology and Bone Marrow Transplant, Townsville Hospital, Townsville, QLD, Australia Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand Molecular Genetic Research Institute, Catholic University of Korea, Seoul, South Korea Department of Hematology-Oncology, National University Cancer Institute, Singapore Department of Medicine, Cancer Center, First Hospital of Jilin University, Changchun, China Department of Hematology and Oncology, Nagoya University Hospital, Nagoya, Japan Department of Hematology, Sime Darby Medical Center Subang Jaya, Selangor, Malaysia Department of Hematology, Ampang Hospital, Ampang, Selangor, Malaysia Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taoyuan, Taiwan Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan Department of Hematology, Shanghai Changhai Hospital, Shanghai, China Division of Haematology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, N.T., Hong Kong, China AU - Kim, D. W. AU - Banavali, S. D. AU - Bunworasate, U. AU - Goh, Y. T. AU - Ganly, P. AU - Huang, H. AU - Irving, I. AU - Jootar, S. AU - Goh, H. G. AU - Koh, L. P. AU - Li, W. AU - Naoe, T. AU - Ng, S. C. AU - Purushotaman, V. AU - Reksodiputro, H. AU - Shih, L. Y. AU - Tang, J. L. AU - Tojo, A. AU - Wang, J. AU - Wong, R. DB - Scopus DO - 10.1016/j.leukres.2010.03.033 IS - 11 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2010 SP - 1459-1471 ST - Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era T2 - Leukemia Research TI - Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957018636&doi=10.1016%2fj.leukres.2010.03.033&partnerID=40&md5=e901982f16399bad2e8322bd129b5bc1 VL - 34 ID - 4426 ER - TY - JOUR AD - Department of Paediatrics, Section of Haematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver School of Medicine, Aurora, CO, United States AU - Lee-Sherick, A. B. AU - Linger, R. M. A. AU - Gore, L. AU - Keating, A. K. AU - Graham, D. K. DB - Scopus DO - 10.1111/j.1365-2141.2010.08282.x IS - 4 M3 - Review N1 - Cited By :34 Export Date: 18 November 2020 PY - 2010 SP - 295-311 ST - Targeting paediatric acute lymphoblastic leukaemia: Novel therapies currently in development T2 - British Journal of Haematology TI - Targeting paediatric acute lymphoblastic leukaemia: Novel therapies currently in development UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958542555&doi=10.1111%2fj.1365-2141.2010.08282.x&partnerID=40&md5=737c5e583e732e48b0464183965b6765 VL - 151 ID - 4427 ER - TY - JOUR AD - Department of Hematology, University Hospital, Uppsala, Sweden Department of Genetics and Pathology, University Hospital, Uppsala, Sweden Hematology Research Unit, Biomedicum Helsinki, Helsinki, Finland Division of Hematology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Medicine, HUCH, Helsinki, Finland Clinical Genetics Unit, Department of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden AU - Olsson-Strömberg, U. AU - Hermansson, M. AU - Lundán, T. AU - Ohm, A. C. AU - Engdahl, I. AU - Höglund, M. AU - Simonsson, B. AU - Porkka, K. AU - Barbany, G. DB - Scopus DO - 10.1111/j.1600-0609.2010.01506.x IS - 5 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2010 SP - 399-404 ST - Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib T2 - European Journal of Haematology TI - Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958574010&doi=10.1111%2fj.1600-0609.2010.01506.x&partnerID=40&md5=e09b8eb3454c8bf9ebb2831c0bcb0f50 VL - 85 ID - 4428 ER - TY - JOUR AD - Department of Cell Biology, Lerner Research Institute Cleveland Clinic College of Medicine of CWRU, 9500 Euclid Avenue, Cleveland, OH 44195, United States Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, OH, United States Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, United States AU - Feldstein, A. E. DB - Scopus DO - 10.1055/s-0030-1267539 IS - 4 M3 - Review N1 - Cited By :89 Export Date: 18 November 2020 PY - 2010 SP - 391-401 ST - Novel insights into the pathophysiology of nonalcoholic fatty liver disease T2 - Seminars in Liver Disease TI - Novel insights into the pathophysiology of nonalcoholic fatty liver disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958183243&doi=10.1055%2fs-0030-1267539&partnerID=40&md5=4b39787a2ad19f1c55c749ba5a6b5a43 VL - 30 ID - 4430 ER - TY - JOUR AD - Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, Netherlands Pediatric Oncology and Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands AML-BFM Study Group, Hannover Medical School, Hannover, Germany DCOG, The Hague, Netherlands UK Childhood Leukaemia Working Party, United Kingdom AU - Goemans, B. F. AU - Zwaan, C. M. AU - Cloos, J. AU - de Lange, D. AU - Loonen, A. H. AU - Reinhardt, D. AU - Hählen, K. AU - Gibson, B. E. S. AU - Creutzig, U. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1016/j.leukres.2010.04.004 IS - 10 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2010 SP - 1302-1307 ST - FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657 T2 - Leukemia Research TI - FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955980691&doi=10.1016%2fj.leukres.2010.04.004&partnerID=40&md5=f5eef909abda75b90ac7ab3149839e69 VL - 34 ID - 4432 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, H.C. Andersen Children's Hospital, Odense University Hospital, Odense, Denmark Department of Pathology, Odense University Hospital, Odense, Denmark AU - Rathe, M. AU - Kristensen, T. K. AU - Møller, M. B. AU - Carlsen, N. L. T. DB - Scopus DO - 10.1002/pbc.22655 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - 730-732 ST - Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate T2 - Pediatric Blood and Cancer TI - Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957056628&doi=10.1002%2fpbc.22655&partnerID=40&md5=f63b5054f4ec62183514739dd99049de VL - 55 ID - 4433 ER - TY - JOUR AD - Department of Internal Medicine V, Haematology and Oncology, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria Klinikum Wels - Grieskirchen, Wels, Austria Division of Hematology, Medical University of Graz, Graz, Austria Krankenhaus der Barmherzigen Schwestern, Linz, Austria Allgemeines Krankenhaus der Stadt Linz, Linz, Austria Landeskrankenhaus Feldkirch, Feldkirch, Austria Klinik für Innere Medizin i, Abteilung für Hämatologie und Hämostaseologie, Medizinische Universität Wien, Wien, Austria Aö. Krankenhaus der Elisabethinen, Linz, Austria Aö. Bezirkskrankenhaus Lienz, Lienz, Austria Krankenhaus der Barmherzigen Brüder, Eisenstadt, Austria Hanusch-Krankenhaus, Wien, Austria Krankenhaus Wien-Hietzing, Wien, Austria St. Vinzenz-Krankenhaus, Zams, Austria Krankenhaus Meran, Merano, Italy Department of Internal Medicine i, Innsbruck Medical University, Innsbruck, Austria Landeskrankenhaus St. Pölten, St. Pölten, Austria AU - Schmidt, S. AU - Wolf, D. AU - Thaler, J. AU - Burgstaller, S. AU - Linkesch, W. AU - Petzer, A. AU - Fridrik, M. AU - Lang, A. AU - Agis, H. AU - Valent, P. AU - Krieger, O. AU - Walder, A. AU - Korger, M. AU - Schlögl, E. AU - Sliwa, T. AU - Wöll, E. AU - Mitterer, M. AU - Eisterer, W. AU - Pober, M. AU - Gastl, G. DB - Scopus DO - 10.1007/s00508-010-1450-x IS - 19-20 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 558-566 ST - First annual report of the Austrian CML registry T2 - Wiener Klinische Wochenschrift TI - First annual report of the Austrian CML registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78249280604&doi=10.1007%2fs00508-010-1450-x&partnerID=40&md5=80e53cf827344ee6997723e2590f3d39 VL - 122 ID - 4434 ER - TY - JOUR AD - Division of Hematology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya-ku, Saitama, Saitama 330-8503, Japan AU - Ishida, Y. AU - Terasako, K. AU - Oshima, K. AU - Sakamoto, K. AU - Ashizawa, M. AU - Sato, M. AU - Kikuchi, M. AU - Kimura, S. I. AU - Nakasone, H. AU - Okuda, S. AU - Kako, S. AU - Yamazaki, R. AU - Nishida, J. AU - Kanda, Y. DB - Scopus DO - 10.1007/s12185-010-0678-6 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2010 SP - 542-546 ST - Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation T2 - International Journal of Hematology TI - Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78549294155&doi=10.1007%2fs12185-010-0678-6&partnerID=40&md5=f460f092bb44613d4ba1019d6cd8a141 VL - 92 ID - 4435 ER - TY - JOUR AD - Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5843, United States Department of Pathology, University of Michigan, Ann Arbor, MI, United States Department of Radiology, University of Michigan, Ann Arbor, MI, United States Division of Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Memorial Sloan-Kettering Cancer Center, New York, NY, United States Washington Cancer Institute, Washington, DC, United States Kootenai Cancer Center, Coeur d'Alene, ID, United States AU - Chugh, R. AU - Wathen, J. K. AU - Patel, S. R. AU - Maki, R. G. AU - Meyers, P. A. AU - Schuetze, S. M. AU - Priebat, D. A. AU - Thomas, D. G. AU - Jacobson, J. A. AU - Samuels, B. L. AU - Benjamin, R. S. AU - Baker, L. H. DB - Scopus DO - 10.1158/1078-0432.CCR-10-1177 IS - 19 M3 - Article N1 - Cited By :130 Export Date: 18 November 2020 PY - 2010 SP - 4884-4891 ST - Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial T2 - Clinical Cancer Research TI - Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957570698&doi=10.1158%2f1078-0432.CCR-10-1177&partnerID=40&md5=6150a99dd6487a401e7816f0b1b0fbdc VL - 16 ID - 4436 ER - TY - JOUR AD - Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT, United States Children's Hospital of Philadelphia, Philadelphia, PA, United States Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, United States Rady Children's Hospital, San Diego, CA, United States Johns Hopkins University School of Medicine, Baltimore, MD, United States Monroe Carell Jr Children's Hospital at Vanderbilt Children's Hospital, Nashville, TN, United States Children's Cancer Hospital, M.D. Anderson Cancer Center, Houston, TX, United States Children's Memorial Medical Center at Chicago, Chicago, IL, United States Children's Hospital of Pittsburgh, Pittsburgh, PA, United States Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada All Children's Hospital, St. Petersburg, FL, United States C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, United States University of California San Francisco School of Medicine, San Francisco, CA, United States Nationwide Children'sHospital, Columbus, OH, United States NYU Medical Center, Hassenfeld Children's Center, New York University, New York, United States Washington University Medical Center, Washington University, St Louis, MO, United States University of California Medical Center, University of California Davis, Sacramento, CA, United States Columbia Presbyterian College of Physicians and Surgeons, New York, United States British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada AU - Pulsipher, M. A. AU - Horwitz, E. M. AU - Haight, A. E. AU - Kadota, R. AU - Chen, A. R. AU - Frangoul, H. AU - Cooper, L. J. N. AU - Jacobsohn, D. A. AU - Goyal, R. K. AU - Mitchell, D. AU - Nieder, M. L. AU - Yanik, G. AU - Cowan, M. J. AU - Soni, S. AU - Gardner, S. AU - Shenoy, S. AU - Taylor, D. AU - Cairo, M. AU - Schultz, K. R. DB - Scopus DO - 10.1016/j.bbmt.2009.12.536 IS - 9 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - 1212-1221 ST - Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium T2 - Biology of Blood and Marrow Transplantation TI - Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955509680&doi=10.1016%2fj.bbmt.2009.12.536&partnerID=40&md5=752ad9d78ec31b4aa7d93b9b3c34dae8 VL - 16 ID - 4438 ER - TY - JOUR AD - Department of Colorectal Surgery, First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang, China AU - Cheng, X. AU - Chen, D. AU - Wang, Y. AU - Wang, J. AU - Lin, J. AU - Chen, W. DB - Scopus IS - 102-103 M3 - Article N1 - Export Date: 18 November 2020 PY - 2010 SP - 1128-1135 ST - Colorectal gastrointestinal stromal tumors (GISTs): A retrospective study of reported cases T2 - Hepato-Gastroenterology TI - Colorectal gastrointestinal stromal tumors (GISTs): A retrospective study of reported cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79251541760&partnerID=40&md5=1e2a6ba4184034117f3fdfc4f14106d0 VL - 57 ID - 4439 ER - TY - JOUR AD - Institute of Pathology, Friedrich-Alexander-University, Erlangen, Germany AU - Agaimy, A. DB - Scopus IS - 5 M3 - Review N1 - Cited By :88 Export Date: 18 November 2020 PY - 2010 SP - 461-471 ST - Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting T2 - International Journal of Clinical and Experimental Pathology TI - Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956022283&partnerID=40&md5=f456c287429dc2fee640dfe8b87a2a51 VL - 3 ID - 4441 ER - TY - JOUR AD - Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain Hospital Ruiz de Alda, Granada, Spain Hospital Virgen del Rocío, Seville, Spain Hospital Central de Asturias, Oviedo, Spain Hospital Universitario La Fe, Valencia, Spain Hospital Clínico, Valencia, Spain Hospital Ramón y Cajal, Madrid, Spain Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Hospital Gregorio Marañón, Madrid, Spain Hospital Morales Masaguer, Murcia, Spain Hospital Clínico de San Carlos, Madrid, Spain Hospital Reina Sofía, Córdoba, Spain Hospital Clínico Universitario, Salamanca, Spain AU - Cervantes, F. AU - López-Garrido, P. AU - Montero, M. I. AU - Jonte, F. AU - Martínez, J. AU - Hernández-Boluda, J. C. AU - Calbacho, M. AU - Sureda, A. AU - Pérez-Rus, G. AU - Nieto, J. B. AU - Pérez-López, C. AU - Román-Gómez, J. AU - González, M. AU - Pereira, A. AU - Colomer, D. DB - Scopus DO - 10.3324/haematol.2009.021154 IS - 8 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2010 SP - 1317-1324 ST - Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: A study of the Spanish PETHEMA group T2 - Haematologica TI - Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: A study of the Spanish PETHEMA group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956034332&doi=10.3324%2fhaematol.2009.021154&partnerID=40&md5=6d1c97f582788497b39f12bef525c443 VL - 95 ID - 4443 ER - TY - JOUR AD - APEX GmbH, Munich, Germany AstraZeneca, Alderley Park, Macclesfield SK10 4TG, Cheshire, Germany AU - Weil, A. AU - Martin, P. AU - Smith, R. AU - Oliver, S. AU - Langmuir, P. AU - Read, J. AU - Molz, K. H. DB - Scopus DO - 10.2165/11534330-000000000-00000 IS - 9 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2010 SP - 607-618 ST - Pharmacokinetics of vandetanib in subjects with renal or hepatic impairment T2 - Clinical Pharmacokinetics TI - Pharmacokinetics of vandetanib in subjects with renal or hepatic impairment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955454200&doi=10.2165%2f11534330-000000000-00000&partnerID=40&md5=84e15ad2cc8fdd762fc48d733c347bbf VL - 49 ID - 4444 ER - TY - JOUR AD - Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Santos, F. P. S. AU - Kantarjian, H. AU - Fava, C. AU - O'Brien, S. AU - Garcia-Manero, G. AU - Ravandi, F. AU - Wierda, W. AU - Thomas, D. AU - Shan, J. AU - Cortes, J. DB - Scopus DO - 10.1111/j.1365-2141.2010.08245.x IS - 3 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2010 SP - 303-312 ST - Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia T2 - British Journal of Haematology TI - Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954612906&doi=10.1111%2fj.1365-2141.2010.08245.x&partnerID=40&md5=46639f46c2c859d7a2039166151f5e40 VL - 150 ID - 4446 ER - TY - JOUR AD - Laboratoire de Biologie et Pharmacologie Appliquée, CNRS UMR 8113, Ecole Normale Supérieure de Cachan, 61, Ave du Président Wilson, 94235 Cachan Cedex, France Department of Internal Medicine i, Division of Hematology and Hemostaseology, Medical University of Vienna and Ludwig Boltzmann Cluster Oncology Vienna Austria, Waehringer Guertel 18-20, A-1090 Vienna, Austria AU - Arock, M. AU - Valent, P. DB - Scopus DO - 10.1586/ehm.10.42 IS - 4 M3 - Review N1 - Cited By :94 Export Date: 18 November 2020 PY - 2010 SP - 497-516 ST - Pathogenesis, classification and treatment of mastocytosis: State of the art in 2010 and future perspectives T2 - Expert Review of Hematology TI - Pathogenesis, classification and treatment of mastocytosis: State of the art in 2010 and future perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955642537&doi=10.1586%2fehm.10.42&partnerID=40&md5=7e8a636ac2f5a3e946fb2e0c3ae7bea0 VL - 3 ID - 4447 ER - TY - JOUR AD - Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Laboratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Yamaki, M. AU - Sugiura, K. AU - Muro, Y. AU - Shimoyama, Y. AU - Tomita, Y. DB - Scopus DO - 10.1111/j.1600-0625.2010.01108.x IS - 8 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2010 SP - 730-735 ST - Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes T2 - Experimental Dermatology TI - Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954841807&doi=10.1111%2fj.1600-0625.2010.01108.x&partnerID=40&md5=27ab49690bd5a92dc3b8dcf10fea68c2 VL - 19 ID - 4448 ER - TY - JOUR AD - Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami- Kogushi, Ube City, Yamaguchi 755-8505, Japan AU - Adachi, T. AU - Fukuda, K. AU - Kondo, Y. AU - Nishida, T. DB - Scopus DO - 10.1167/iovs.09-4161 IS - 8 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2010 SP - 3954-3960 ST - Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCRM-1 in human corneal fibroblasts T2 - Investigative Ophthalmology and Visual Science TI - Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCRM-1 in human corneal fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955885245&doi=10.1167%2fiovs.09-4161&partnerID=40&md5=4d09af770e5724ca043c820c7e012787 VL - 51 ID - 4449 ER - TY - JOUR AD - Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany InfectoPharm Arzneimittel und Consilium GmbH, Von-Humboldt-Straße 1, D-64646 Heppenheim, Germany Department of Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Liliencronstraße 130, D-22149 Hamburg, Germany AU - Storch, C. H. AU - Hoeger, P. H. DB - Scopus DO - 10.1111/j.1365-2133.2010.09848.x IS - 2 M3 - Review N1 - Cited By :359 Export Date: 18 November 2020 PY - 2010 SP - 269-274 ST - Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action T2 - British Journal of Dermatology TI - Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954867089&doi=10.1111%2fj.1365-2133.2010.09848.x&partnerID=40&md5=88fac99ffc0dc96a9768029431ee8ed6 VL - 163 ID - 4450 ER - TY - JOUR AD - Department of Anatomy, Melaka Manipal Medical College, Manipal University, Manipal 576104, India Melaka Manipal Medical College, Manipal University, Manipal 576104, India Kasturba Medical College, Manipal University, Manipal 576104, India AU - Prasad, A. M. AU - Ramnarayan, K. AU - Bairy, K. L. DB - Scopus M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2010 SP - 469-478 ST - Effect of imatinib on the reproductive function in male swiss albino mice T2 - Pharmacologyonline TI - Effect of imatinib on the reproductive function in male swiss albino mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953201109&partnerID=40&md5=649ecc42f0ae9a63f0ca046bba7c67e5 VL - 1 ID - 4454 ER - TY - JOUR AD - Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, Auenbruggerplatz 30, 8036 Graz, Austria Department of Surgery, Reconstructive Surgery, Medical University of Graz, Austria Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Austria AU - Hanzer, M. AU - Nebl, A. AU - Spendel, S. AU - Pilhatsch, A. AU - Urban, C. AU - Benesch, M. DB - Scopus DO - 10.1055/s-0030-1249093 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2010 SP - 184-186 ST - Necrosisof a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh T2 - Klinische Padiatrie TI - Necrosisof a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953143593&doi=10.1055%2fs-0030-1249093&partnerID=40&md5=62dadf703e44489704e1beae0697cba8 VL - 222 ID - 4455 ER - TY - JOUR AD - Leukemia Department, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States Charite Universitatsmedizin, Campus Virchow Klinkum, Berlin, Germany Malignant Hematology Deparment, H. Lee Moffitt Cancer Center, Tampa, FL, United States Bone Marrow Transplantation and Cord Blood Bank Div., Chaim Sheba Medical Center, Tel Hashomer, Israel Medical Clinic III, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Division of Hematology, Respiratory Medication and Oncology, Saga University, Saga, Japan Medical Clinic II, Johann Wolfgang Goethe University, Frankfurt, Germany AU - Kantarjian, H. AU - Le Coutre, P. AU - Cortes, J. AU - Pinilla-Ibarz, J. AU - Nagler, A. AU - Hochhaus, A. AU - Kimura, S. AU - Ottmann, O. DB - Scopus DO - 10.1002/cncr.25079 IS - 11 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2010 SP - 2665-2672 ST - Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in philadelphia chromosome-positive leukemias after imatinib resistance or intolerance T2 - Cancer TI - Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in philadelphia chromosome-positive leukemias after imatinib resistance or intolerance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952840150&doi=10.1002%2fcncr.25079&partnerID=40&md5=c29984f77a3df3fae7179112a63db617 VL - 116 ID - 4458 ER - TY - JOUR AD - First Aid Center, Shanghai Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China Department of General Surgery, Shanghai, Chang Zheng Hospital, Second Military Medical University, Shanghai, China Institute of Pathophysiology, Second Military Medical University, Shanghai, China AU - Wang, Y. X. AU - Xu, X. Y. AU - Su, W. L. AU - Wang, Q. AU - Zhu, W. X. AU - Chen, F. AU - Jin, G. AU - Liu, Y. J. AU - Li, Y. D. AU - Sun, Y. P. AU - Gao, W. C. AU - Ruan, C. P. DB - Scopus DO - 10.1016/j.jss.2008.10.030 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2010 SP - 119-125 ST - Activation and Clinical Significance of p38 MAPK Signaling Pathway in Patients With Severe Trauma T2 - Journal of Surgical Research TI - Activation and Clinical Significance of p38 MAPK Signaling Pathway in Patients With Severe Trauma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951621847&doi=10.1016%2fj.jss.2008.10.030&partnerID=40&md5=f2fdbab41c45e351e56d3ca04fddb6d8 VL - 161 ID - 4459 ER - TY - JOUR AD - Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030, United States Division of Pediatrics, Children's Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Nilsson, M. B. AU - Zage, P. E. AU - Zeng, L. AU - Xu, L. AU - Cascone, T. AU - Wu, H. K. AU - Saigal, B. AU - Zweidler-Mckay, P. A. AU - Heymach, J. V. DB - Scopus DO - 10.1038/onc.2010.60 IS - 20 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2010 SP - 2938-2949 ST - Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: Implications for antiangiogenic mechanisms of multikinase inhibitors T2 - Oncogene TI - Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: Implications for antiangiogenic mechanisms of multikinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952671059&doi=10.1038%2fonc.2010.60&partnerID=40&md5=5ceaa123b7165990ac64dd8a6cdcfcd0 VL - 29 ID - 4460 ER - TY - JOUR AD - Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Solid Tumor Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Radiation Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Neurosurgery, Geisinger Health System, Danville, PA, United States Quantitative Health Services, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, United States AU - Peereboom, D. M. AU - Shepard, D. R. AU - Ahluwalia, M. S. AU - Brewer, C. J. AU - Agarwal, N. AU - Stevens, G. H. J. AU - Suh, J. H. AU - Toms, S. A. AU - Vogelbaum, M. A. AU - Weil, R. J. AU - Elson, P. AU - Barnett, G. H. DB - Scopus DO - 10.1007/s11060-009-0067-2 IS - 1 M3 - Article N1 - Cited By :134 Export Date: 18 November 2020 PY - 2010 SP - 93-99 ST - Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme T2 - Journal of Neuro-Oncology TI - Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953617053&doi=10.1007%2fs11060-009-0067-2&partnerID=40&md5=1914513201a76241fd3c5b902b8ebab1 VL - 98 ID - 4461 ER - TY - JOUR AD - Kantonsspital, St. Gallen, Switzerland University Hospital CHUV, Lausanne, Switzerland University Hospital, Zurich, Switzerland University Hospital, Geneva, Switzerland SASL, Zurich, Switzerland SAKK Coordinating Center, Bern, Switzerland St. László Teaching Hospital, Budapest, Hungary University Hospital, Basel, Switzerland Oncology Institute of Southern Switzerland, Bellinzona, Switzerland University Hospital, Bern, Switzerland AU - Koeberle, D. AU - Montemurro, M. AU - Samaras, P. AU - Majno, P. AU - Simcock, M. AU - Limacher, A. AU - Lerch, S. AU - Katalin, K. AU - Inauen, R. AU - Hess, V. AU - Saletti, P. AU - Borner, M. AU - Roth, A. AU - Bodoky, G. DB - Scopus DO - 10.1634/theoncologist.2009-0316 IS - 3 M3 - Article N1 - Cited By :89 Export Date: 18 November 2020 PY - 2010 SP - 285-292 ST - Continuous sunitinib treatment in patients with advanced hepatocellular carcinoma: A swiss group for clinical cancer research (SAKK) and swiss association for the study of the liver (SASL) multicenter phase II trial (SAKK 77/06) T2 - Oncologist TI - Continuous sunitinib treatment in patients with advanced hepatocellular carcinoma: A swiss group for clinical cancer research (SAKK) and swiss association for the study of the liver (SASL) multicenter phase II trial (SAKK 77/06) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950546450&doi=10.1634%2ftheoncologist.2009-0316&partnerID=40&md5=7498def6d64916beae125a92450bebf0 VL - 15 ID - 4463 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, San Francisco, CA, United States Department of Genetics, LSU Health Sciences Center, New Orleans, LA, United States McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MD, United States Center for Pediatric and Adolescent Medicine, Thibodaux, LA, United States GeneDx, Gaithersburg, MD, United States Pediatrics, LSUHSC and Children's Hospital, 200 Henry Clay, New Orleans, LA 70118, United States AU - Rauen, K. A. AU - Tidyman, W. E. AU - Estep, A. L. AU - Sampath, S. AU - Peltier, H. M. AU - Bale, S. J. AU - Lacassie, Y. DB - Scopus DO - 10.1002/ajmg.a.33342 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2010 SP - 807-814 ST - Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations T2 - American Journal of Medical Genetics, Part A TI - Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950409870&doi=10.1002%2fajmg.a.33342&partnerID=40&md5=f5bd091c1dcce4d96ddf65076dcfa429 VL - 152 ID - 4464 ER - TY - JOUR AD - Department of Dermatology, Seoul National University Hospital, Seoul, South Korea Center for Skin Cancer and Adverse Skin Reaction to Chemotherapeutics, Seoul National University Cancer Hospital, Seoul, South Korea Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea AU - Cho, S. I. AU - Lee, J. AU - Lim, J. AU - Park, J. S. AU - Kim, M. AU - Kim, T. Y. AU - Kim, T. M. AU - Lee, K. H. AU - Keam, B. AU - Han, S. W. AU - Jo, S. J. DB - Scopus DO - 10.2340/00015555-3129 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 435-441 ST - Pruritus in patients under targeted anticancer therapy: A multidimensional analysis using the 5-D itch scale T2 - Acta Dermato-Venereologica TI - Pruritus in patients under targeted anticancer therapy: A multidimensional analysis using the 5-D itch scale UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064109738&doi=10.2340%2f00015555-3129&partnerID=40&md5=9f241b6376438ae0f74a561523abad38 VL - 99 ID - 4465 ER - TY - JOUR AD - Robinson Institute, Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Frome Road, Adelaide, SA 5005, Australia AU - Clifton, V. L. DB - Scopus DO - 10.1016/j.placenta.2009.11.010 IS - SUPPL. M3 - Article N1 - Cited By :420 Export Date: 18 November 2020 PY - 2010 SP - S33-S39 ST - Review: Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival T2 - Placenta TI - Review: Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77049105365&doi=10.1016%2fj.placenta.2009.11.010&partnerID=40&md5=aedbe66df2fc9a303c431f596ad627e6 VL - 31 ID - 4468 ER - TY - JOUR AD - Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, MSC 1104, Bethesda, MD 20892-1104, United States Department of Pediatric Immunology, Hematology, Oncology, Bone Marrow Transplantation and Auto-immune Diseases, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, Netherlands AU - Wayne, A. S. AU - Baird, K. AU - Egeler, R. M. DB - Scopus DO - 10.1016/j.pcl.2009.11.005 IS - 1 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2010 SP - 1-25 ST - Hematopoietic stem cell transplantation for leukemia T2 - Pediatric Clinics of North America TI - Hematopoietic stem cell transplantation for leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951082463&doi=10.1016%2fj.pcl.2009.11.005&partnerID=40&md5=f856bb71aca41e811d06550294a77fde VL - 57 ID - 4470 ER - TY - JOUR AD - Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy Institute of Hematology and Medical Oncology Lorenzo and Ariosto Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy AU - Breccia, M. AU - Palandri, F. AU - Iori, A. P. AU - Colaci, E. AU - Latagliata, R. AU - Castagnetti, F. AU - Torelli, G. F. AU - Usai, S. AU - Valle, V. AU - Martinelli, G. AU - Rosti, G. AU - Foà, R. AU - Baccarani, M. AU - Alimena, G. DB - Scopus DO - 10.1016/j.leukres.2009.04.036 IS - 2 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2010 SP - 143-147 ST - Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib T2 - Leukemia Research TI - Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74849117346&doi=10.1016%2fj.leukres.2009.04.036&partnerID=40&md5=69702b194d33bc2eb4565e85b3a5777e VL - 34 ID - 4471 ER - TY - JOUR AU - Cortes, J. E. AU - Baccarani, M. AU - Guilhot, F. AU - Druker, B. J. AU - Branford, S. AU - Kim, D. W. AU - Pane, F. AU - Pasquini, R. AU - Goldberg, S. L. AU - Kalaycio, M. AU - Moiraghi, B. AU - Rowe, J. M. AU - Tothova, E. AU - De Souza, C. AU - Rudoltz, M. AU - Yu, R. AU - Krahnke, T. AU - Kantarjian, H. M. AU - Radich, J. P. AU - Hughes, T. P. DB - Scopus DO - 10.1200/JCO.2009.25.3724 IS - 3 M3 - Article N1 - Cited By :213 Export Date: 18 November 2020 PY - 2010 SP - 424-430 ST - Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine kinase inhibitor optimization and selectivity study T2 - Journal of Clinical Oncology TI - Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine kinase inhibitor optimization and selectivity study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-75749105885&doi=10.1200%2fJCO.2009.25.3724&partnerID=40&md5=bdf7bc53c27e59304e9ee9fad042a323 VL - 28 ID - 4473 ER - TY - JOUR AD - Department of Transplantation, Medical College, Jagiellonian University, ul. Wielicka 265, 30-663 Krakow, Poland University Childrens Hospital, Department of Oncology and Hematology, Wielicka 265, 30-663 Krakow, Poland AU - Skoczen, S. AU - Surmiak, M. AU - Strojny, W. DB - Scopus DO - 10.1517/14740330903410213 IS - 1 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 65-77 ST - Survivors of acute lymphoblastic leukemia and body mass changes T2 - Expert Opinion on Drug Safety TI - Survivors of acute lymphoblastic leukemia and body mass changes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74349086889&doi=10.1517%2f14740330903410213&partnerID=40&md5=8b801fbb32bebf2be82809dc9b30c7d0 VL - 9 ID - 4475 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Carl Gustav Carus, Dresden, Germany. AU - Suttorp, M. AU - Millot, F. DB - Scopus DO - 10.1182/asheducation-2010.1.368 M3 - Review N1 - Cited By :71 Export Date: 18 November 2020 PY - 2010 SP - 368-376 ST - Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955040838&doi=10.1182%2fasheducation-2010.1.368&partnerID=40&md5=8a617123d89a737b9bb704a573faf749 VL - 2010 ID - 4476 ER - TY - JOUR AU - Demetri, G. D. AU - Von Mehren, M. AU - Antonescu, C. R. AU - DeMatteo, R. P. AU - Ganjoo, K. N. AU - Maki, R. G. AU - Pisters, P. W. T. AU - Raut, C. P. AU - Riedel, R. F. AU - Schuetze, S. AU - Sundar, H. M. AU - Trent, J. C. AU - Wayne, J. D. DB - Scopus DO - 10.6004/jnccn.2010.0116 IS - SUPPL. 2 M3 - Review N1 - Cited By :616 Export Date: 18 November 2020 PY - 2010 SP - S1-S40 ST - NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951875556&doi=10.6004%2fjnccn.2010.0116&partnerID=40&md5=e48c7455fe79e9f49f6489adf5580e98 VL - 8 ID - 4477 ER - TY - JOUR AD - Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States AU - Iyer, R. AU - Fetterly, G. AU - Lugade, A. AU - Thanavala, Y. DB - Scopus DO - 10.1517/14656566.2010.496453 IS - 11 M3 - Review N1 - Cited By :100 Export Date: 18 November 2020 PY - 2010 SP - 1943-1955 ST - Sorafenib: A clinical and pharmacologic review T2 - Expert Opinion on Pharmacotherapy TI - Sorafenib: A clinical and pharmacologic review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954781214&doi=10.1517%2f14656566.2010.496453&partnerID=40&md5=23b07dcfc29eabd74e7c3b7e45b053ea VL - 11 ID - 4478 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Vienna, Austria Children's Cancer Research Institute (CCRI), St. Anna Kinderkrebsforschung, Vienna, Austria Department of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany Department of Paediatric Haematology and Oncology, Children's University Hospital, University Hospital Schleswig-Holstein, Kiel, Germany AU - Attarbaschi, A. AU - Pisecker, M. AU - Inthal, A. AU - Mann, G. AU - Janousek, D. AU - Dworzak, M. AU - Pötschger, U. AU - Ullmann, R. AU - Schrappe, M. AU - Gadner, H. AU - Haas, O. A. AU - Panzer-Grümayer, R. AU - Strehl, S. DB - Scopus DO - 10.1111/j.1365-2141.2009.07944.x IS - 2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2010 SP - 293-300 ST - Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements T2 - British Journal of Haematology TI - Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-72649097977&doi=10.1111%2fj.1365-2141.2009.07944.x&partnerID=40&md5=4cbba85b4d5c73b934186b810628fd4c VL - 148 ID - 4479 ER - TY - JOUR AD - Department of Surgery, St Jude Children's Research Hospital, Mail Stop 133, 262 Danny Thomas Place, Memphis, TN 38105, United States Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, United States Department of Hematology, University College London, London, United Kingdom AU - Tracey, L. AU - Streck, C. J. AU - Du, Z. AU - Williams, R. F. AU - Pfeffer, L. M. AU - Nathwani, A. C. AU - Davidoff, A. M. DB - Scopus DO - 10.1038/leu.2010.2 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2010 SP - 806-812 ST - NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia T2 - Leukemia TI - NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950930700&doi=10.1038%2fleu.2010.2&partnerID=40&md5=50582c8716e244d537d8141d7ef5b4bc VL - 24 ID - 4481 ER - TY - JOUR AD - Laboratoire d'Onco-Virologie, Institut Pasteur du Maroc, Casablanca, Morocco Laboratoire de Biochimie et de Biologie Moléculaire, Université Hassan II, Casablanca, Morocco Unité de Biologie et recherche Médicale, Centre National de l'Energie, Des Sciences et Techniques Nucléaires (CNESTEN), Rabat, Morocco Centre d'Oncologie, Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Morocco Institut National d'Oncologie, Rabat, Morocco Laboratoire Virologie Hygiène and Mcrobiologie, Faculté des Sciences et Techniques Mohammédia, Morocco AU - Naji, F. AU - Attaleb, M. AU - Laantri, N. AU - Benchakroun, N. AU - El Gueddari, B. AU - Benider, A. AU - Azeddoug, H. AU - Ennaji, M. M. AU - El Mzibri, M. AU - Khyatti, M. DB - Scopus DO - 10.1170/163 IS - SUPPL.1 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - OL1442-OL1446 ST - Identification of G2607A mutation in EGFR gene with a significative rate in moroccan patients with nasopharyngeal carcinoma T2 - Cellular and Molecular Biology TI - Identification of G2607A mutation in EGFR gene with a significative rate in moroccan patients with nasopharyngeal carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954442133&doi=10.1170%2f163&partnerID=40&md5=7403330a25de2e66accacf7a5ba86fe3 VL - 56 ID - 4482 ER - TY - JOUR AD - Department of Institute of Hematology and Medical Oncology, L and A Seràgnoli S Orsola Malpighi Hospital, University of Bologna, Via Massarenti, Bologna 9-40138, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Turin, Italy Gruppo Italiano Malattie Ematologiche Maligne DellAdulto (GIMEMA) Data Center, GIMEMA Foundation, Rome, Italy Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy Department of Pathology, Section of General Pathology, University of Verona, Verona, Italy AU - Iacobucci, I. AU - Lonetti, A. AU - Messa, F. AU - Ferrari, A. AU - Cilloni, D. AU - Soverini, S. AU - Paoloni, F. AU - Arruga, F. AU - Ottaviani, E. AU - Chiaretti, S. AU - Messina, M. AU - Vignetti, M. AU - Papayannidis, C. AU - Vitale, A. AU - Pane, F. AU - Piccaluga, P. P. AU - Paolini, S. AU - Berton, G. AU - Baruzzi, A. AU - Saglio, G. AU - Baccarani, M. AU - Fo, R. AU - Martinelli, G. DB - Scopus DO - 10.1038/leu.2009.197 IS - 1 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2010 SP - 66-73 ST - Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients T2 - Leukemia TI - Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74249101770&doi=10.1038%2fleu.2009.197&partnerID=40&md5=0c2f5c6624baf0e16c939585e06f68fc VL - 24 ID - 4483 ER - TY - JOUR AD - Section of Adult hematology and hematopoietic Stem Cell Transplant, Oncology Centre and Department of research Administration, King Fahad Specialist hospital, Dammam 31444, Saudi Arabia Section of Adult hematology and hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist hospital and research Centre, Riyadh 11211, Saudi Arabia AU - Al-Anazi, K. A. AU - Chaudhri, N. AU - Al-Mohareb, F. I. AU - Al-Zahrani, H. A. AU - Al-Omar, H. M. AU - Al-Shanqeeti, A. AU - Sahovic, E. AU - Al Sharif, F. Z. AU - Mohamed, S. Y. AU - Rasheed, W. AU - Beihani, A. AU - Hejazi, A. AU - Zaidi, Z. AU - Morshid, M. AU - Seth, P. AU - El-Tayeb, K. I. AU - Nassar, A. AU - Bakr, M. AU - Jafar, S. A. AU - Othman, I. A. AU - Abdulwahab, A. AU - Al-Sultan, O. AU - Aljurf, M. D. DB - Scopus DO - 10.4137/CMT.S5784 M3 - Article N1 - Export Date: 18 November 2020 PY - 2010 SP - 877-888 ST - The negative impact of imatinib mesylate therapy prior to allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia T2 - Clinical Medicine Insights: Therapeutics TI - The negative impact of imatinib mesylate therapy prior to allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650751012&doi=10.4137%2fCMT.S5784&partnerID=40&md5=a91ec98d2a642bd2391eca0c7c92b304 VL - 2 ID - 4486 ER - TY - JOUR AD - Bone Marrow Transplantation Unit, Hospital Italiano de la Plata, La Plata, Argentina AU - Milone, J. H. AU - Enrico, A. DB - Scopus DO - 10.3109/10428190903370395 IS - SUPPL. 2 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 2009 SP - 9-15 ST - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Leukemia and Lymphoma TI - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73849107115&doi=10.3109%2f10428190903370395&partnerID=40&md5=c2e03e6bf15c44af445027f3b1afa2e9 VL - 50 ID - 4490 ER - TY - JOUR AD - Department of Hematology/Oncology, 'L and A Seràgnoli S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy Molecular Biology Unit, Institute of Hematology and Medical Oncology 'Sergnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Turin, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy AU - Martinelli, G. AU - Iacobucci, I. AU - Soverini, S. AU - Piccaluga, P. P. AU - Cilloni, D. AU - Pane, F. DB - Scopus DO - 10.1586/ehm.09.16 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2009 SP - 297-303 ST - New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia T2 - Expert Review of Hematology TI - New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953418690&doi=10.1586%2fehm.09.16&partnerID=40&md5=fdf55d263cf6b2153501c91fc5ba9b74 VL - 2 ID - 4491 ER - TY - JOUR AD - Hospital for Sick Children, Division for Haematology/Oncology, 555 University Ave, Toronto, ON M5G 1X8, Canada AU - Lam, C. AU - Bouffet, E. AU - Bartels, U. DB - Scopus DO - 10.2217/fon.09.119 IS - 9 M3 - Review N1 - Cited By :17 Export Date: 18 November 2020 PY - 2009 SP - 1349-1361 ST - Nimotuzumab in pediatric glioma T2 - Future Oncology TI - Nimotuzumab in pediatric glioma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74949130000&doi=10.2217%2ffon.09.119&partnerID=40&md5=486ad82828a6a0c49fd996c4c963dcab VL - 5 ID - 4492 ER - TY - JOUR AD - Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D3100, Seattle, WA 98109, United States San Raffaele Scientific Institute, Milan, Italy AU - Travi, G. AU - Pergam, S. A. AU - Xie, H. AU - Carpenter, P. AU - Kiem, H. P. AU - Corey, L. AU - Boeckh, M. J. DB - Scopus DO - 10.1086/648120 IS - 11 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2009 SP - s120-s123 ST - The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation T2 - Clinical Infectious Diseases TI - The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-72849109573&doi=10.1086%2f648120&partnerID=40&md5=e764359eaaf98095a90ea6f00db40453 VL - 49 ID - 4493 ER - TY - JOUR AD - Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy BD Biosciences, San Jose, CA, United States AU - Raponi, S. AU - De Propris, M. S. AU - Wai, H. AU - Intoppa, S. AU - Elia, L. AU - Diverio, D. AU - Vitale, A. AU - Foà, R. AU - Guarini, A. DB - Scopus DO - 10.3324/haematol.2009.010900 IS - 12 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2009 SP - 1767-1770 ST - An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia T2 - Haematologica TI - An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73149096711&doi=10.3324%2fhaematol.2009.010900&partnerID=40&md5=0139fd40f2e8075bd1670aa114a3a02b VL - 94 ID - 4494 ER - TY - JOUR AD - Departments of Oncology and Pediatrics, School of Medicine, Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231, United States Division of Pediatric Hematology/Oncology, University of Colorado, Childrens Hospital, Aurora, CO, United States Division of Hematology/Oncology, University of Cincinnati, Cincinnati Childrens Hospital, Cincinnati, OH, United States Department of Pediatrics, Cancer Institute, New York University, New York, NY, United States Division of Pediatric Oncology, Group Cheirs Office, Childrens Oncology Group, Washington, DC, United States AU - Brown, P. AU - Hunger, S. P. AU - Smith, F. O. AU - Carroll, W. L. AU - Reaman, G. H. DB - Scopus DO - 10.1586/ehm.09.1 IS - 2 M3 - Review N1 - Cited By :27 Export Date: 18 November 2020 PY - 2009 SP - 145-158 ST - Novel targeted drug therapies for the treatment of childhood acute leukemia T2 - Expert Review of Hematology TI - Novel targeted drug therapies for the treatment of childhood acute leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953384502&doi=10.1586%2fehm.09.1&partnerID=40&md5=68b3396b2a938e6059e9d916c20e532b VL - 2 ID - 4495 ER - TY - JOUR AD - Departments of Clinical Pharmacy and Toxicology, University Medical Center, Leiden, Netherlands Departments of Clinical Oncology, University Medical Center, Leiden, Netherlands AU - van Erp, N. P. AU - Gelderblom, H. AU - Guchelaar, H. J. DB - Scopus DO - 10.1016/j.ctrv.2009.08.004 IS - 8 M3 - Review N1 - Cited By :300 Export Date: 18 November 2020 PY - 2009 SP - 692-706 ST - Clinical pharmacokinetics of tyrosine kinase inhibitors T2 - Cancer Treatment Reviews TI - Clinical pharmacokinetics of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449704111&doi=10.1016%2fj.ctrv.2009.08.004&partnerID=40&md5=26772b683ef7d9e6a2b59d3179f67ed8 VL - 35 ID - 4497 ER - TY - JOUR AD - Medical Oncology Division, Versilia Hospital, via Aurelia 335, 55041 Lido di Camaiore (LU), Italy Cardiology Division, Ospedale San Sebastiano, via Circondaria 1, 42015 Correggio (RE), Italy AU - Valsuani, C. AU - Siclari, O. AU - Camerini, A. AU - Canale, M. L. AU - Rondini, M. AU - Donati, S. AU - Puccinelli, P. AU - Tartarelli, G. AU - Puccetti, C. AU - Amoroso, D. C7 - 9133 DB - Scopus DO - 10.1186/1757-1626-2-9133 IS - 12 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2009 ST - Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: A case report T2 - Cases Journal TI - Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953409338&doi=10.1186%2f1757-1626-2-9133&partnerID=40&md5=523826b77597d299afc6ecbde589ef00 VL - 2 ID - 4499 ER - TY - JOUR AD - Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States Novartis Pharma AG, Basel, Switzerland Novartis Institutes for BioMedical Research, East Hanover, NJ, United States Hunter Holmes McGuire VA Medical Center, Richmond, VA, United States AU - Yin, O. Q. P. AU - Gallagher, N. AU - Tanaka, C. AU - Fisher, D. AU - Sethuraman, V. AU - Zhou, W. AU - Lin, T. H. AU - Heuman, D. AU - Schran, H. DB - Scopus DO - 10.1016/j.clinthera.2009.11.015 IS - PART. 2 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2009 SP - 2459-2469 ST - Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study T2 - Clinical Therapeutics TI - Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74549214984&doi=10.1016%2fj.clinthera.2009.11.015&partnerID=40&md5=b863e682b43abb2573cada7451c7a336 VL - 31 ID - 4500 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States AU - Jabbour, E. AU - Jones, D. AU - Kantarjian, H. M. AU - O'Brien, S. AU - Tam, C. AU - Koller, C. AU - Burger, J. A. AU - Borthakur, G. AU - Wierda, W. G. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2009-01-197715 IS - 10 M3 - Article N1 - Cited By :96 Export Date: 18 November 2020 PY - 2009 SP - 2037-2043 ST - Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations T2 - Blood TI - Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349245253&doi=10.1182%2fblood-2009-01-197715&partnerID=40&md5=b61a92006467e262a2c95d3a15421aac VL - 114 ID - 4501 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Box 428, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Garg, R. J. AU - Kantarjian, H. AU - O'Brien, S. AU - Quintás-Cardama, A. AU - Faderl, S. AU - Estrov, Z. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2009-05-221531 IS - 20 M3 - Article N1 - Cited By :95 Export Date: 18 November 2020 PY - 2009 SP - 4361-4368 ST - The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: Long-term follow-up T2 - Blood TI - The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: Long-term follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73349100015&doi=10.1182%2fblood-2009-05-221531&partnerID=40&md5=46bd8eb4b1727bbc9a3128fac9327ae8 VL - 114 ID - 4503 ER - TY - JOUR AD - Department of Hematology and Oncology 'L. and A. Seràgnoli,' University of Bologna, Bologna; Department of Genetics and Microbiology, University of Bari, Bari; Department of Biotechnological Sciences and Hematology, 'La Sapienza' University; Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Data Center, GIMEMA Foundation; Department of Hematology, Tor Vergata University Hospital, Rome; Department of Clinical and Biological Science, University of Turin at Orbassano, Orbassano; and University of Naples Federico II, Naples, Italy AU - Martinelli, G. AU - Iacobucci, I. AU - Storlazzi, C. T. AU - Vignetti, M. AU - Paoloni, F. AU - Cilloni, D. AU - Soverini, S. AU - Vitale, A. AU - Chiaretti, S. AU - Cimino, G. AU - Papayannidis, C. AU - Paolini, S. AU - Elia, L. AU - Fazi, P. AU - Meloni, G. AU - Amadori, S. AU - Saglio, G. AU - Pane, F. AU - Baccarani, M. AU - Foà, R. DB - Scopus DO - 10.1200/JCO.2008.21.6408 IS - 31 M3 - Article N1 - Cited By :207 Export Date: 18 November 2020 PY - 2009 SP - 5202-5207 ST - IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report T2 - Journal of Clinical Oncology TI - IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449719091&doi=10.1200%2fJCO.2008.21.6408&partnerID=40&md5=5094f2cc14b8cf16217be95686683b00 VL - 27 ID - 4504 ER - TY - JOUR AD - Fox Chase Cancer Center, Philadelphia, PA; Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH; Dana-Farber Cancer Center, Boston, MA; and Pfizer Oncology, New London, CT AU - Lewis, N. L. AU - Lewis, L. D. AU - Eder, J. P. AU - Reddy, N. J. AU - Guo, F. AU - Pierce, K. J. AU - Olszanski, A. J. AU - Cohen, R. B. DB - Scopus DO - 10.1200/JCO.2009.21.8487 IS - 31 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2009 SP - 5262-5269 ST - Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers T2 - Journal of Clinical Oncology TI - Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449707509&doi=10.1200%2fJCO.2009.21.8487&partnerID=40&md5=5f9d3861b649196e31b683b5baba3602 VL - 27 ID - 4505 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States Leukemia/Lymphoma Developmental Therapeutics, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Hematological Malignancies Program, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Jeha, S. AU - Pui, C. H. DB - Scopus DO - 10.1016/j.hoc.2009.07.009 IS - 5 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2009 SP - 973-990 ST - Risk-adapted Treatment of Pediatric Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Risk-adapted Treatment of Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349756898&doi=10.1016%2fj.hoc.2009.07.009&partnerID=40&md5=9fc4038049542cc65c186170187a0b99 VL - 23 ID - 4510 ER - TY - JOUR AD - Department of Leukemia, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, United States Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, United States AU - Ravandi, F. AU - Kebriaei, P. DB - Scopus DO - 10.1016/j.hoc.2009.07.007 IS - 5 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2009 SP - 1043-1063 ST - Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349754444&doi=10.1016%2fj.hoc.2009.07.007&partnerID=40&md5=6554eb9c8494cbb177a32903c52fc146 VL - 23 ID - 4511 ER - TY - JOUR AD - Department of Pediatrics and Molecular Pharmacology, Children's Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, 3415 Bainbridge Avenue, Rosenthal, Bronx, NY 10467, United States A.I. duPont Hospital for Children, Wilmington, DE, United States St. Jude Children's Research Hospital, Memphis, TN, United States Duke University Medical Center, Durham, NC, United States Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia Texas Tech. University Health Science Center, Lubbock, TX, United States Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Abramson Family Cancer Research Institute, Philadelphia, PA, United States Cancer Therapy Evaluation Program, NCI, Bethesda, MD, United States Hematology-Oncology, United States AU - Gorlick, R. AU - Kolb, E. A. AU - Houghton, P. J. AU - Morton, C. L. AU - Phelps, D. AU - Schaiquevich, P. AU - Stewart, C. AU - Keir, S. T. AU - Lock, R. AU - Carol, H. AU - Reynolds, C. P. AU - Maris, J. M. AU - Wu, J. AU - Smith, M. A. DB - Scopus DO - 10.1002/pbc.21989 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2009 SP - 594-598 ST - Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program T2 - Pediatric Blood and Cancer TI - Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-69849094782&doi=10.1002%2fpbc.21989&partnerID=40&md5=28cdc6338c6688fde3d5439cb83272c5 VL - 53 ID - 4512 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, Guro Hospital, Korea University College of Medicine, 80 Guro-dong, Guro-gu, Seoul, 152-703, South Korea AU - Cho, J. G. AU - Woo, J. S. AU - Lee, H. M. AU - Jung, H. H. AU - Hwang, S. J. AU - Chae, S. DB - Scopus DO - 10.1016/j.ijporl.2009.07.016 IS - 10 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2009 SP - 1447-1451 ST - Effects of cigarette smoking on mucin production in human middle ear epithelial cells T2 - International Journal of Pediatric Otorhinolaryngology TI - Effects of cigarette smoking on mucin production in human middle ear epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249209696&doi=10.1016%2fj.ijporl.2009.07.016&partnerID=40&md5=e39360a2a5be8bef2af6e27915c15a22 VL - 73 ID - 4513 ER - TY - JOUR AD - Center for Clinical Pharmacology, Bdbeq S.A., Hospital Italiano Umberto Primo, Montevideo, Uruguay Center for Biomedical Sciences, University of Montevideo, Montevideo, Uruguay AU - Parrillo-Campiglia, S. AU - Ercoli, M. C. AU - Umpierrez, O. AU - Rodríguez, P. AU - Márquez, S. AU - Guarneri, C. AU - Estevez-Parrillo, F. T. AU - Laurenz, M. AU - Estevez-Carrizo, F. E. DB - Scopus DO - 10.1016/j.clinthera.2009.10.009 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2009 SP - 2224-2232 ST - Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers T2 - Clinical Therapeutics TI - Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-71549153468&doi=10.1016%2fj.clinthera.2009.10.009&partnerID=40&md5=4f04e777e52c63bb02f29ff821331b1d VL - 31 ID - 4514 ER - TY - JOUR AU - Furman, W. L. AU - Navid, F. AU - Daw, N. C. AU - Beth McCarville, M. AU - McGregor, L. M. AU - Spunt, S. L. AU - Rodriguez-Galindo, C. AU - Panetta, J. C. AU - Crews, K. R. AU - Wu, J. AU - Gajjar, A. J. AU - Houghton, P. J. AU - Santana, V. M. AU - Stewart, C. F. DB - Scopus DO - 10.1200/JCO.2008.19.6642 IS - 27 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2009 SP - 4599-4604 ST - Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors T2 - Journal of Clinical Oncology TI - Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-76749168084&doi=10.1200%2fJCO.2008.19.6642&partnerID=40&md5=c1e885886b0fd768ddd3841b03cc88f4 VL - 27 ID - 4515 ER - TY - JOUR AD - Department of Hematology, BMT, Cairo University, Egypt Department of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Egypt Department of Hematology, Nasser Institute, Ministry of Health, Egypt Clinical Oncology Center, School of Medicine, Cairo University, Egypt AU - Mahmoud, H. K. AU - El Nahas, Y. AU - Moaty, M. A. AU - Fattah, R. A. AU - El Emary, M. AU - El Metnawy, W. DB - Scopus IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2009 SP - 223-228 ST - Kinetics of BCR-ABL transcripts in imatinib mesylate treated chronic phase CML (CPCML), a predictor of response and progression free survival T2 - International Journal of Biomedical Science TI - Kinetics of BCR-ABL transcripts in imatinib mesylate treated chronic phase CML (CPCML), a predictor of response and progression free survival UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953391705&partnerID=40&md5=9ece2093a613dfc46aab002cb89387df VL - 5 ID - 4516 ER - TY - JOUR AD - Department of Paediatrics, Institut Gustave Roussy, University Paris-XI, 39 Rue Camille Desmoulins, 94805 Villejuif, France Children's Hospital, Steelhouse Lane, B4 6NH Birmingham, United Kingdom Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif; University Paris-XI, 39 Rue Camille Desmoulins, France Paediatrics, Institut Curie, 26 Rue d'Ulm, 75248 Paris cedex 05, France CHU Cochin Port Royal, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France CHU Fondation Lenval, 57 Avenue de la Californie, 06000 Nice, France Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 307, 59020 Lille, France Centre Léon Bérard, 28 Rue Laennec, 69373 Lyon, France EA3035 Institut Claudius-Regaud, 31052 Toulouse, France UMR8121, Vectorology and Gene Transfer, Institut Gustave Roussy, 39 Rue Camille Desmoulins, Villejuif, France University College Hospital, 235 Euston Road, NW1 2BU London, United Kingdom CHU Nantes, 50 Route St Sebastien sur Loire, 44093 Nantes, France Pathology Departments, Institut Gustave Roussy, 39 Rue Camille Desmoulins, Villejuif, France Department of Pathology, Centre Ambroise Pare, 9 Avenue Charles de Gaulle, 92104 Boulogne, France Novartis Pharma AG, Lichtstrasse 35, Basel, CH-4002, Switzerland AU - Geoerger, B. AU - Morland, B. AU - Ndiaye, A. AU - Doz, F. AU - Kalifa, G. AU - Geoffray, A. AU - Pichon, F. AU - Frappaz, D. AU - Chatelut, E. AU - Opolon, P. AU - Hain, S. AU - Boderet, F. AU - Bosq, J. AU - Emile, J. F. AU - Deley, M. C. L. AU - Capdeville, R. AU - Vassal, G. DB - Scopus DO - 10.1016/j.ejca.2009.03.007 IS - 13 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2009 SP - 2342-2351 ST - Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium T2 - European Journal of Cancer TI - Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949170337&doi=10.1016%2fj.ejca.2009.03.007&partnerID=40&md5=8e0e2a2035f989783d5462ec9c332bab VL - 45 ID - 4517 ER - TY - JOUR AD - Department of Haematology, Imperial College, Hammersmith Hospital, Ducane Road, London, W120NN, United Kingdom AU - Apperley, J. DB - Scopus DO - 10.1016/j.beha.2009.09.008 IS - 3 M3 - Review N1 - Cited By :49 Export Date: 18 November 2020 PY - 2009 SP - 455-474 ST - CML in pregnancy and childhood T2 - Best Practice and Research: Clinical Haematology TI - CML in pregnancy and childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-71849109234&doi=10.1016%2fj.beha.2009.09.008&partnerID=40&md5=6904e0a84e30e648a6fa7ed3d6a3e447 VL - 22 ID - 4518 ER - TY - JOUR AU - Eskens, F. A. L. M. AU - Steeghs, N. AU - Verweij, J. AU - Bloem, J. L. AU - Christensen, O. AU - Van Doorn, L. AU - Ouwerkerk, J. AU - De Jonge, M. J. A. AU - Nortier, J. W. R. AU - Kraetzschmar, J. AU - Rajagopalan, P. AU - Gelderblom, H. DB - Scopus DO - 10.1200/JCO.2008.18.8193 IS - 25 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2009 SP - 4169-4176 ST - Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor β, and c-Kit, in patients with advanced or metastatic solid tumors T2 - Journal of Clinical Oncology TI - Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor β, and c-Kit, in patients with advanced or metastatic solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70249129087&doi=10.1200%2fJCO.2008.18.8193&partnerID=40&md5=5c59e240efef6b5483e464325ef70267 VL - 27 ID - 4519 ER - TY - JOUR AD - Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-2 dong, Songpa-gu, 138736 Seoul, South Korea AU - Kim, J. E. AU - Lee, D. H. AU - Choi, Y. AU - Yoon, D. H. AU - Kim, S. W. AU - Suh, C. AU - Lee, J. S. DB - Scopus DO - 10.1016/j.lungcan.2008.12.011 IS - 3 M3 - Article N1 - Cited By :182 Export Date: 18 November 2020 PY - 2009 SP - 351-354 ST - Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis T2 - Lung Cancer TI - Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67849103953&doi=10.1016%2fj.lungcan.2008.12.011&partnerID=40&md5=3f101406bca95f1c213626128c81da4d VL - 65 ID - 4520 ER - TY - JOUR AD - Centro de Patogénese Molecular/iMed.UL, Faculdade de Farmácia, University of Lisbon, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal AU - Fernandes, A. AU - Brites, D. DB - Scopus DO - 10.2174/138161209789058165 IS - 25 M3 - Review N1 - Cited By :22 Export Date: 18 November 2020 PY - 2009 SP - 2915-2926 ST - Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents T2 - Current Pharmaceutical Design TI - Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449389923&doi=10.2174%2f138161209789058165&partnerID=40&md5=3f0d6a6ba40e7ff3554cabd0f2a2af28 VL - 15 ID - 4521 ER - TY - JOUR AD - University Hospital Munich-Grosshadern, Department of Medicine II, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany AU - Dambacher, J. AU - Beigel, F. AU - Zitzmann, K. AU - De Toni, E. N. AU - Göke, B. AU - Diepolder, H. M. AU - Auernhammer, C. J. AU - Brand, S. DB - Scopus DO - 10.1136/gut.2007.130112 IS - 9 M3 - Article N1 - Cited By :148 Export Date: 18 November 2020 PY - 2009 SP - 1207-1217 ST - The role of the novel Th17 cytokine IL-26 in intestinal inflammation T2 - Gut TI - The role of the novel Th17 cytokine IL-26 in intestinal inflammation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68849124464&doi=10.1136%2fgut.2007.130112&partnerID=40&md5=1f790e44a90685bf4aa2d3b7b3492c2d VL - 58 ID - 4522 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil AU - Mascarenhas, C. C. AU - Cunha, A. F. AU - Miranda, E. C. AU - Zulli, R. AU - Silveira, R. A. AU - Costa, F. F. AU - Pagnano, K. B. AU - De Souza, C. A. DB - Scopus DO - 10.1080/10428190902930496 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2009 SP - 1148-1154 ST - New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors T2 - Leukemia and Lymphoma TI - New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68449086340&doi=10.1080%2f10428190902930496&partnerID=40&md5=4564ab8c3359382f8ea1d84544ef2e2b VL - 50 ID - 4525 ER - TY - JOUR AD - Department of Pathology, St Jude Childrens Research Hospital, Memphis, TN, United States St Jude Children's Research Hospital, Pathology, Mail Stop 342, 262 Danny Thomas Place, Memphis, TN 38105, United States AU - Mullighan, C. G. DB - Scopus DO - 10.1111/j.1751-553X.2009.01167.x IS - 4 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2009 SP - 384-397 ST - Genomic analysis of acute leukemia T2 - International Journal of Laboratory Hematology TI - Genomic analysis of acute leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651108658&doi=10.1111%2fj.1751-553X.2009.01167.x&partnerID=40&md5=cc696b74607a21224d29b3b86bb0f080 VL - 31 ID - 4527 ER - TY - JOUR AD - Department of Leukemia, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Fullmer, A. AU - O'Brien, S. AU - Kantarjian, H. AU - Jabbour, E. DB - Scopus DO - 10.1007/s11899-009-0021-6 IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2009 SP - 148-156 ST - Novel therapies for relapsed acute lymphoblastic leukemia T2 - Current Hematologic Malignancy Reports TI - Novel therapies for relapsed acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650227612&doi=10.1007%2fs11899-009-0021-6&partnerID=40&md5=b7c55fa1ca82bfe775edcdef71c61fcc VL - 4 ID - 4529 ER - TY - JOUR AD - Molecular Oncology Laboratory, Institute of Comparative Medicine, University of Glasgow, Bearsden Road, Bearsden, Glasgow G61 1QH, United Kingdom Lincoln's Inn Fields Laboratories, London Research Institute, London, United Kingdom Heinrich-Pette-Institute for Experimental Virology and Immunology, Hamburg, Germany AU - Wolyniec, K. AU - Wotton, S. AU - Kilbey, A. AU - Jenkins, A. AU - Terry, A. AU - Peters, G. AU - Stocking, C. AU - Cameron, E. AU - Neil, J. C. DB - Scopus DO - 10.1038/onc.2009.101 IS - 27 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2009 SP - 2502-2512 ST - RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress T2 - Oncogene TI - RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650432153&doi=10.1038%2fonc.2009.101&partnerID=40&md5=b1b896c46dd827f653fa29200c31300a VL - 28 ID - 4531 ER - TY - JOUR AD - Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pharmaceutical Services, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States Department of Pharmaceutical Sciences, University of Tennessee, Memphis, TN, United States AU - Christiansen, S. R. AU - Broniscer, A. AU - Panetta, J. C. AU - Stewart, C. F. DB - Scopus DO - 10.1592/phco.29.7.858 IS - 7 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2009 SP - 858-866 ST - Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: Case report and review of the literature T2 - Pharmacotherapy TI - Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: Case report and review of the literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650786282&doi=10.1592%2fphco.29.7.858&partnerID=40&md5=fd2a4b3f69a989fc3b4989a8c3c5fc28 VL - 29 ID - 4533 ER - TY - JOUR AD - Departments of Dermatology and Genetics, University of Alabama at Birmingham, Birmingham, AL, United States AU - Boyd, K. P. AU - Korf, B. R. AU - Theos, A. DB - Scopus DO - 10.1016/j.jaad.2008.12.051 IS - 1 M3 - Review N1 - Cited By :246 Export Date: 18 November 2020 PY - 2009 SP - 1-14 ST - Neurofibromatosis type 1 T2 - Journal of the American Academy of Dermatology TI - Neurofibromatosis type 1 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66949142979&doi=10.1016%2fj.jaad.2008.12.051&partnerID=40&md5=97f8dc4c7adf7f02ccc9f323150ffc56 VL - 61 ID - 4534 ER - TY - JOUR AU - Maki, R. G. AU - D'Adamo, D. R. AU - Keohan, M. L. AU - Saulle, M. AU - Schuetze, S. M. AU - Undevia, S. D. AU - Livingston, M. B. AU - Cooney, M. M. AU - Hensley, M. L. AU - Mita, M. M. AU - Takimoto, C. H. AU - Kraft, A. S. AU - Elias, A. D. AU - Brockstein, B. AU - Blachère, N. E. AU - Edgar, M. A. AU - Schwartz, L. H. AU - Qin, L. X. AU - Antonescu, C. R. AU - Schwartz, G. K. DB - Scopus DO - 10.1200/JCO.2008.20.4495 IS - 19 M3 - Article N1 - Cited By :393 Export Date: 18 November 2020 PY - 2009 SP - 3133-3140 ST - Phase II study of sorafenib in patients with metastatic or recurrent sarcomas T2 - Journal of Clinical Oncology TI - Phase II study of sorafenib in patients with metastatic or recurrent sarcomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650293850&doi=10.1200%2fJCO.2008.20.4495&partnerID=40&md5=2b3dd93930d251c46b8f735e8f26c85f VL - 27 ID - 4535 ER - TY - JOUR AD - Service d'Oncologie Hématologique et de Thérapie Cellulaire, Centre Hospitalier Universitaire de Poitiers, 2 rue de la Milétrie, 86 021 Poitiers, France Centre d'Investigation Clinique INSERM 802, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Service d'Hématologie et Oncologie Biologique, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Service d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France AU - Millot, F. AU - Cividin, M. AU - Brizard, F. AU - Chomel, J. C. AU - Méchinaud, F. AU - Guilhot, F. DB - Scopus DO - 10.1002/pbc.21938 IS - 7 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2009 SP - 891-892 ST - Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia T2 - Pediatric Blood and Cancer TI - Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650478307&doi=10.1002%2fpbc.21938&partnerID=40&md5=23a7cc09a1286e87dad644a85fe0a284 VL - 52 ID - 4538 ER - TY - JOUR AD - Department of Medicine, University of Chicago Medical Center, Chicago, IL, United States AU - Stock, W. DB - Scopus IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2009 SP - 244-246 ST - Pediatric regimens for adult acute lymphoblastic leukemia T2 - Clinical Advances in Hematology and Oncology TI - Pediatric regimens for adult acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66449131835&partnerID=40&md5=fbaec450eeb7a4d58a453cff857c20c0 VL - 7 ID - 4540 ER - TY - JOUR AD - Department of Pharmacology, University of Tromso, Tromso, Norway Haematology Research Unit, Biomedicum Helsinki, Finland Departments of Medicine (Division of Haematology) and Clinical Chemistry, Helsinki University, Central Hospital, Helsinki, Finland Helsinki University Central Hospital, Biomedicum Helsinki, Haematology Research Unit, PO Box 700, FIN-00029 HUCH, Helsinki, Finland AU - Gruber, F. AU - Mustjoki, S. AU - Porkka, K. DB - Scopus DO - 10.1111/j.1365-2141.2009.07666.x IS - 5 M3 - Review N1 - Cited By :44 Export Date: 18 November 2020 PY - 2009 SP - 581-597 ST - Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66149170248&doi=10.1111%2fj.1365-2141.2009.07666.x&partnerID=40&md5=8bcde1f88eff46cdfc3dca8e3a29ab0f VL - 145 ID - 4542 ER - TY - JOUR AD - Belgrade University School of Medicine, Belgrade, Serbia Vertex Pharmaceuticals, Inc., Cambridge, MA, United States Vertex Pharmaceuticals, Inc., 130 Waverly Street, Cambridge, MA 02139-4242, United States AU - Damjanov, N. AU - Kauffman, R. S. AU - Spencer-Green, G. T. DB - Scopus DO - 10.1002/art.24485 IS - 5 M3 - Article N1 - Cited By :163 Export Date: 18 November 2020 PY - 2009 SP - 1232-1241 ST - Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies T2 - Arthritis and Rheumatism TI - Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66049086274&doi=10.1002%2fart.24485&partnerID=40&md5=f899223e6752ac6d3123d02c10923873 VL - 60 ID - 4545 ER - TY - JOUR AD - Department of Internal Medicine III, Friedrich-Schiller-University, Erlanger Allee 101, D-07740 Jena, Germany Department of Internal Medicine II, Division of Gastroenterology, Friedrich-Schiller-University, Jena, Germany AU - Drinda, S. AU - Franke, S. AU - Eidner, T. AU - Schmidt, C. AU - Rüster, C. AU - Bondeva, T. AU - Hein, G. AU - Wolf, G. DB - Scopus IS - 3 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2009 SP - 483-490 ST - Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis T2 - Clinical and Experimental Rheumatology TI - Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651149868&partnerID=40&md5=1dfd35dfd4b84286b218d71c1bbf6574 VL - 27 ID - 4546 ER - TY - JOUR AD - Section of Pathologic Anatomy, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Section of Oncology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Respiratory Diseases Clinic, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Operative Unit of Pathology, Santa Maria Nuova Hospital, Reggio Emilia, Italy Centro di Ricerche Oncologiche GiovanniXXIII, Institute of General Pathology, Catholic University, Rome, Italy Division of Pneumology, Civic Hospital, Mirandola, Italy Division of Oncology, Civic Hospital Ramazzini, Carpi, Italy Operative Unit of Pathologic Anatomy, Hospital Umberto I, Mestre, Italy Operative Unit of Oncology, Civic Hospital degli Infermi, Faenza, Italy Section of Pathologic Anatomy, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 71, 41100- Modena, Italy AU - Sartori, G. AU - Cavazza, A. AU - Sgambato, A. AU - Marchioni, A. AU - Barbieri, F. AU - Longo, L. AU - Bavieri, M. AU - Murer, B. AU - Meschiari, E. AU - Tamberi, S. AU - Cadioli, A. AU - Luppi, F. AU - Migaldi, M. AU - Rossi, G. DB - Scopus DO - 10.1309/AJCPH0TRMPXVZW2F IS - 4 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2009 SP - 478-489 ST - EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to egfr inhibitors T2 - American Journal of Clinical Pathology TI - EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to egfr inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-65349167234&doi=10.1309%2fAJCPH0TRMPXVZW2F&partnerID=40&md5=876eaca148fb658d35f74d2bc62fb305 VL - 131 ID - 4548 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Inc., San Diego, CA, United States Department of Clinical Pharmacology, Pfizer Inc., 10578 Science Center Drive, CB10, San Diego, CA 92121, United States AU - Houk, B. E. AU - Bello, C. L. AU - Kang, D. AU - Amantea, M. DB - Scopus DO - 10.1158/1078-0432.CCR-08-1893 IS - 7 M3 - Article N1 - Cited By :177 Export Date: 18 November 2020 PY - 2009 SP - 2497-2506 ST - A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients T2 - Clinical Cancer Research TI - A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-65249087328&doi=10.1158%2f1078-0432.CCR-08-1893&partnerID=40&md5=54e56e6941be9f33f003a47ec0779802 VL - 15 ID - 4549 ER - TY - JOUR AD - Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy Department of Pathology, Bellaria Hospital, Bologna, Italy 5th Orthopaedic Division, Rizzoli Orthopaedic Institute, Bologna, Italy AU - Pazzaglia, L. AU - Chiechi, A. AU - Conti, A. AU - Gamberi, G. AU - Magagnoli, G. AU - Novello, C. AU - Morandi, L. AU - Picci, P. AU - Mercuri, M. AU - Benassi, M. S. DB - Scopus IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2009 SP - 61-67 ST - Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes T2 - Histology and Histopathology TI - Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-60549112596&partnerID=40&md5=8cc39a16d0282478a61bb8977a004d7d VL - 24 ID - 4550 ER - TY - JOUR AD - Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, United States Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, CRC 1w-3750, Bethesda, MD 20892, United States AU - Kim, S. Y. AU - Toretsky, J. A. AU - Scher, D. AU - Helman, L. J. DB - Scopus DO - 10.1634/theoncologist.2008-0189 IS - 1 M3 - Article N1 - Cited By :74 Export Date: 18 November 2020 PY - 2009 SP - 83-91 ST - The role of IGF-1R in pediatric malignancies T2 - Oncologist TI - The role of IGF-1R in pediatric malignancies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-61449097712&doi=10.1634%2ftheoncologist.2008-0189&partnerID=40&md5=f5a9968c15964206ba865e61394911af VL - 14 ID - 4552 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, United States AU - Jabbour, E. AU - Kantarjian, H. M. AU - Jones, D. AU - Shan, J. AU - O'Brien, S. AU - Reddy, N. AU - Wierda, W. G. AU - Faderl, S. AU - Garcia-Manero, G. AU - Verstovsek, S. AU - Rios, M. B. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2008-04-154344 IS - 10 M3 - Article N1 - Cited By :114 Export Date: 18 November 2020 PY - 2009 SP - 2154-2160 ST - Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy T2 - Blood TI - Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-64049099666&doi=10.1182%2fblood-2008-04-154344&partnerID=40&md5=a48dc997e87ffb2ad1ee0891a9d279f9 VL - 113 ID - 4553 ER - TY - JOUR AD - Department of Pathology, Brigham and Women(tm)s Hospital, Harvard Medical School, Boston, MA, United States Department of Pathology, Medical University of Graz, Graz, Austria Department of Pathology, Oregon Health and Science University, Portland, OR, United States Department of Pathology, Brigham and Womenh(tm)s Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Liegl, B. AU - Hornick, J. L. AU - Corless, C. L. AU - Fletcher, C. D. M. DB - Scopus DO - 10.1097/PAS.0b013e318186b158 IS - 3 M3 - Article N1 - Cited By :196 Export Date: 18 November 2020 PY - 2009 SP - 437-446 ST - Monoclonal antibody DOG1.1 Shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes T2 - American Journal of Surgical Pathology TI - Monoclonal antibody DOG1.1 Shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-62849083680&doi=10.1097%2fPAS.0b013e318186b158&partnerID=40&md5=1a155a9e3f58df9b63d802edd286b127 VL - 33 ID - 4554 ER - TY - JOUR AD - Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Tyrol, 6020, Austria AU - Crazzolara, R. AU - Bendall, L. DB - Scopus DO - 10.2174/156800909787314057 IS - 1 M3 - Review N1 - Cited By :21 Export Date: 18 November 2020 PY - 2009 SP - 19-31 ST - Emerging treatments in acute lymphoblastic leukemia T2 - Current Cancer Drug Targets TI - Emerging treatments in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-62549143973&doi=10.2174%2f156800909787314057&partnerID=40&md5=863b4fe718693c810f4599f12cc792ab VL - 9 ID - 4557 ER - TY - JOUR AD - Pediatric Neuro-Oncology Program, Dana-Farber Cancer Institute, Boston, MA, United States Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, United States Operations and Biostatistics Center, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Radiology, Children's Hospital Boston, Boston, MA, United States Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, PA, United States Department of Neurology, Children's National Medical Center, Washington, DC, United States Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States Department of Pediatrics, Children's Hospital, Regional Medical Center, Seattle, WA, United States Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, United States Hematology/Oncology Division, Children's Memorial Hospital, Memphis, TN, United States Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States Division of Hematology/Oncology, Children's National Medical Center, Washington, DC, United States Pediatric Neuro-Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, United States AU - Kieran, M. W. AU - Supko, J. G. AU - Wallace, D. AU - Fruscio, R. AU - Poussaint, T. Y. AU - Phillips, P. AU - Pollack, I. AU - Packer, R. AU - Boyett, J. M. AU - Blaney, S. AU - Banerjee, A. AU - Geyer, R. AU - Friedman, H. AU - Goldman, S. AU - Kun, L. E. AU - MacDonald, T. DB - Scopus DO - 10.1002/pbc.21873 IS - 2 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2009 SP - 169-176 ST - Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors T2 - Pediatric Blood and Cancer TI - Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59449108256&doi=10.1002%2fpbc.21873&partnerID=40&md5=0ae459236a31016f60ff6cd4968e972c VL - 52 ID - 4558 ER - TY - JOUR AD - Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku,Chiba, 260-8670, Japan Department of Public Health, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku,Chiba, 260-8670, Japan DNA Chip Research Inc., 1-1-43, Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan Department of Otorhinolaryngology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Cancer Molecular Immunotherapeutics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan AU - Sugimoto, T. AU - Seki, N. AU - Shimizu, S. AU - Kikkawa, N. AU - Tsukada, J. AU - Shimada, H. AU - Sasaki, K. AU - Hanazawa, T. AU - Okamoto, Y. AU - Hata, A. DB - Scopus DO - 10.1002/gcc.20626 IS - 2 M3 - Article N1 - Cited By :51 Export Date: 18 November 2020 PY - 2009 SP - 132-142 ST - The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma T2 - Genes Chromosomes and Cancer TI - The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59949102128&doi=10.1002%2fgcc.20626&partnerID=40&md5=6dc07336246bc6248b47909e87d383de VL - 48 ID - 4559 ER - TY - JOUR AD - Centre for Biotechnology, Anna University, Chennai, 600025, India Department of Genetics, University of Leicester, Leicester, LE1 7RH, United Kingdom AU - Shankar, B. AU - Krishnan, S. AU - Malladi, V. AU - Balakrishnan, A. AU - Williams, P. H. DB - Scopus DO - 10.1016/j.ijmm.2008.07.005 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2009 SP - 121-132 ST - Outer membrane proteins of wild-type and intimin-deficient enteropathogenic Escherichia coli induce Hep-2 cell death through intrinsic and extrinsic pathways of apoptosis T2 - International Journal of Medical Microbiology TI - Outer membrane proteins of wild-type and intimin-deficient enteropathogenic Escherichia coli induce Hep-2 cell death through intrinsic and extrinsic pathways of apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-58649085440&doi=10.1016%2fj.ijmm.2008.07.005&partnerID=40&md5=58adfc02ea3e63ac9a5aa3a6100668c7 VL - 299 ID - 4560 ER - TY - JOUR AD - Ontologie, Hämatologie und Palliativmedizin, Marienhospital, Stuttgart, Germany Department of Internal Medicine III, Marienhospital, Boeheimstr. 37, 70199 Stuttgart, Germany AU - Hass, H. G. AU - Denzlinger, C. DB - Scopus DO - 10.1055/s-2008-1027482 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2009 SP - 27-29 ST - Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva®) - A case report T2 - Zeitschrift fur Gastroenterologie TI - Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva®) - A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59849096953&doi=10.1055%2fs-2008-1027482&partnerID=40&md5=6de75643b37251b57f076ec579a2f38b VL - 47 ID - 4561 ER - TY - JOUR AD - Division of Surgical Oncology, Oregon Health and Science University, OHSU-Knight Cancer Institute, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239, United States AU - Vetto, J. T. DB - Scopus DO - 10.2147/ott.s4740 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2009 SP - 151-159 ST - Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs) T2 - OncoTargets and Therapy TI - Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953446464&doi=10.2147%2fott.s4740&partnerID=40&md5=8bf5f8ce932d6b6af19579f75cfff0e6 VL - 2 ID - 4562 ER - TY - JOUR AD - Departments of Pathology, Brown University, Providence, RI 02905, United States Department of Pharmacy, Women and Infants Hospital, Brown University, Providence, RI 02905, United States Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02905, United States AU - Abellar, R. G. AU - Pepperell, J. R. AU - Greco, D. AU - Gundogan, F. AU - Kostadinov, S. AU - Schwartz, J. AU - Tantravahi, U. AU - De Paepe, M. E. DB - Scopus DO - 10.2350/08-03-0435.1 IS - 1 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2009 SP - 35-41 ST - Effects of chemotherapy during pregnancy on the placenta T2 - Pediatric and Developmental Pathology TI - Effects of chemotherapy during pregnancy on the placenta UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-61449181312&doi=10.2350%2f08-03-0435.1&partnerID=40&md5=fca86d69be9f45b6dcfd60ad8d90239b VL - 12 ID - 4563 ER - TY - JOUR AD - Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, United States Texas Children's Cancer Center/Baylor College of Medicine, Houston, TX, United States IWK Health Centre, Halifax, NS, United States British Columbia Children's Hospital, Vancouver, BC, United States Hôpital Sainte-Justine, Montreal, QC, United States Adjunct Faculty, University of Pennsylvania, Philadelphia, PA, United States AU - Menon-Andersen, D. AU - Mondick, J. T. AU - Jayaraman, B. AU - Thompson, P. A. AU - Blaney, S. M. AU - Bernstein, M. AU - Bond, M. AU - Champagne, M. AU - Fossler, M. J. AU - Barrett, J. S. DB - Scopus DO - 10.1007/s00280-008-0730-x IS - 2 M3 - Article N1 - Cited By :48 Export Date: 18 November 2020 PY - 2009 SP - 229-238 ST - Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults T2 - Cancer Chemotherapy and Pharmacology TI - Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57249088703&doi=10.1007%2fs00280-008-0730-x&partnerID=40&md5=7af0963b03559a1038acffea96599ff0 VL - 63 ID - 4564 ER - TY - JOUR AD - Department of Genetics, Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Hacettepe University Medical School, TR-06100 Sihhiye-Ankara, Turkey Department of Internal Medicine, Haematology Division, Marmara University Medical Faculty, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Marmara School of Medicine Hospital, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Osmangazi University Medical Faculty, Eskisehir, Turkey Department of Internal Medicine, Haematology Division, Erciyes University Medical Faculty, Kayseri, Turkey Department of Internal Medicine, Haematology Division, Karadeniz Technical University Medical Faculty, Trabzon, Turkey Department of Internal Medicine, Haematology Division, Istanbul University Medical Faculty, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Ankara Numune Hospital, Ankara, Turkey Department of Internal Medicine, Haematology Division, Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey Medical Department, Novartis Oncology Turkey, Istanbul, Turkey Department of Internal Medicine, Genetics Division, Ankara University Medical Faculty, Ankara, Turkey Department of Internal Medicine, Haematology Division, Ankara University Medical Faculty, Ankara, Turkey AU - Sayitoglu, M. AU - Haznedaroǧlu, I. C. AU - Hatirnaz, O. AU - Erbilgin, Y. AU - Aksu, S. AU - Koca, E. AU - Adiguzel, C. AU - Bayik, M. AU - Akalin, I. AU - Gülbas, Z. AU - Akay, M. AU - Unal, A. AU - Kaynar, L. AU - Ovali, E. AU - Yilmaz, M. AU - Yenerel, M. AU - Dagdas, S. AU - Ozet, G. AU - Ar, C. AU - Aydin, Y. AU - Soysal, T. AU - Durgun, B. AU - Ozcebe, O. AU - Tukun, A. AU - Ilhan, O. AU - Ozbek, U. DB - Scopus DO - 10.1177/147323000903700406 IS - 4 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2009 SP - 1018-1028 ST - Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia T2 - Journal of International Medical Research TI - Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350494257&doi=10.1177%2f147323000903700406&partnerID=40&md5=7d4504152ee660de7165a08b45b6d677 VL - 37 ID - 4567 ER - TY - JOUR AD - Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan Department of Allergy and Immunology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan Department of Anatomy, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan Department of Laboratory Medicine, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan Center for Cooperative Research in Advanced Science and Technology, Nagoya University, Japan AU - Sugiura, K. AU - Muro, Y. AU - Futamura, K. AU - Matsumoto, K. AU - Hashimoto, N. AU - Nishizawa, Y. AU - Nagasaka, T. AU - Saito, H. AU - Tomita, Y. AU - Usukura, J. DB - Scopus DO - 10.1038/jid.2009.51 IS - 9 M3 - Article N1 - Cited By :53 Export Date: 18 November 2020 PY - 2009 SP - 2126-2135 ST - The unfolded protein response is activated in differentiating epidermal keratinocytes T2 - Journal of Investigative Dermatology TI - The unfolded protein response is activated in differentiating epidermal keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940363675&doi=10.1038%2fjid.2009.51&partnerID=40&md5=431e43e6323ad63b5920aab591c64b9e VL - 129 ID - 4569 ER - TY - JOUR DB - Scopus IS - 98 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2008 SP - 226-228 ST - Imatinib: Longer follow-up in chronic myeloid leukaemia: Clear advantages T2 - Prescrire International TI - Imatinib: Longer follow-up in chronic myeloid leukaemia: Clear advantages UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349190712&partnerID=40&md5=c929a6828488b34d77e9537d12b220ce VL - 17 ID - 4571 ER - TY - JOUR AD - Department of Hematology, Oncology L. and A. Seràgnoli S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Division of Hematology, AIEOP, Milano, Italy Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy Division of Hematology, Ospedale Niguarda, Milano, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Torino, Italy Division of Hematology, San Martino Hospital, Genova, Italy Division of Hematology, Bari, Italy Division of Hematology, Ravenna, Italy Division of Hematology, Napoli, Italy Hematology Section, University of Perugia, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Napoli, Italy Novartis Pharmaceutical, East Hanover, NJ, United States Institute of Hematology and Medical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi University Hospital, via Massarenti, 9, 40138 Bologna, Italy AU - Palandri, F. AU - Castagnetti, F. AU - Testoni, N. AU - Luatti, S. AU - Marzocchi, G. AU - Bassi, S. AU - Breccia, M. AU - Alimena, G. AU - Pungolino, E. AU - Rege-Cambrin, G. AU - Varaldo, R. AU - Miglino, M. AU - Specchia, G. AU - Zuffa, E. AU - Ferrara, F. AU - Bocchia, M. AU - Saglio, G. AU - Pane, F. AU - Alberti, D. AU - Martinelli, G. AU - Baccarani, M. AU - Rosti, G. DB - Scopus DO - 10.3324/haematol.13068 IS - 12 M3 - Article N1 - Cited By :69 Export Date: 18 November 2020 PY - 2008 SP - 1792-1796 ST - Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up T2 - Haematologica TI - Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349124075&doi=10.3324%2fhaematol.13068&partnerID=40&md5=285d14ecf3262e24f347a1907ae83d5e VL - 93 ID - 4572 ER - TY - JOUR AD - Department of Hematology/Oncology, L. and A. Seragnoli, S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy Department of Clinical and Biologic Science, University of Turin at Orbassano, Turin, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy Department of Pathology, Section of General Pathology, University of Verona, Verona, Italy La Sapienza University, Department of Cellular Biotechnologies and Hematology, Rome, Italy Department of Biology, University of Bologna, Bologna, Italy Molecular Biology Unit, Institute of Hematology and Medical Oncology Seràgnoli, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy AU - Lacobucci, I. AU - Lonetti, A. AU - Messa, F. AU - Cilloni, D. AU - Arruga, F. AU - Ottaviani, E. AU - Paolini, S. AU - Papayannidis, C. AU - Piccaluga, P. P. AU - Giannoulia, P. AU - Soverini, S. AU - Amabile, M. AU - Poerio, A. AU - Saglio, G. AU - Pane, F. AU - Berton, G. AU - Baruzzi, A. AU - Vitale, A. AU - Chiaretti, S. AU - Perini, G. AU - Foà, R. AU - Baccarani, M. AU - Martinelli, G. DB - Scopus DO - 10.1182/blood-2007-09-112631 IS - 9 M3 - Article N1 - Cited By :89 Export Date: 18 November 2020 PY - 2008 SP - 3847-3855 ST - Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance T2 - Blood TI - Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-55749102434&doi=10.1182%2fblood-2007-09-112631&partnerID=40&md5=1431e9264a69bd3676c8d6faa30c2bc3 VL - 112 ID - 4574 ER - TY - JOUR AD - Institute of Medical Science, Tzu Chi University, Taiwan Department of Laboratory Medicine, Tzu Chi Hospital, Taichung Branch, Taiwan Department of Internal Medicine, Medical Center, National Taiwan University, Taiwan Department of Pediatrics, Tzu Chi Medical Center, Taiwan Department of Hemato-Oncology, Tzu Chi Medical Center, Taiwan Department of Biochemistry, Tzu Chi University, 970 No. 701, Section 3, Zhongyang Rd., Hualien, Taiwan AU - Chien, J. H. AU - Tang, J. L. AU - Chen, R. L. AU - Li, C. C. AU - Lee, C. P. DB - Scopus DO - 10.1016/j.leukres.2008.04.023 IS - 11 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2008 SP - 1724-1734 ST - Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy T2 - Leukemia Research TI - Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-47249117433&doi=10.1016%2fj.leukres.2008.04.023&partnerID=40&md5=047fde9b3d1b6be018f937951129bc1a VL - 32 ID - 4575 ER - TY - JOUR AD - Department of Orthopaedics Surgery, University of Melbourne, St. Vincent's Health, Melbourne, VIC, Australia Bone and Soft Tissue Sarcoma Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan Department of Orthopaedics Surgery, University of Melbourne, St. Vincent's Health, P.O. Box 2900, Melbourne, VIC 3065, Australia AU - Akiyama, T. AU - Dass, C. R. AU - Choong, P. F. M. DB - Scopus DO - 10.1158/1535-7163.MCT-08-0530 IS - 11 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2008 SP - 3461-3469 ST - Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway T2 - Molecular Cancer Therapeutics TI - Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-56249123993&doi=10.1158%2f1535-7163.MCT-08-0530&partnerID=40&md5=c57cea1a7682a54cafe82512895e3ffb VL - 7 ID - 4576 ER - TY - JOUR AD - Department of Parasitology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, Netherlands Noguchi Memorial Institute for Medical Research, University of Ghana, P.O. Box LG581, Legon, Accra, Ghana AU - Hartgers, F. C. AU - Obeng, B. B. AU - Voskamp, A. AU - Larbi, I. A. AU - Amoah, A. S. AU - Luty, A. J. F. AU - Boakye, D. AU - Yazdanbakhsh, M. DB - Scopus DO - 10.1128/IAI.01579-07 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2008 SP - 5149-5157 ST - Enhanced toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children T2 - Infection and Immunity TI - Enhanced toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849137954&doi=10.1128%2fIAI.01579-07&partnerID=40&md5=9fc829f89774339a7615c5b2e45f2ae0 VL - 76 ID - 4577 ER - TY - JOUR AD - Centre for Virus Research, Westmead Millennium Institute, Westmead, NSW, Australia University of Sydney, NSW, Australia La Jolla Institute for Allergy and Immunology, San Diego, CA 92037, United States Taylor Square Private Clinic, Darlinghurst, NSW, Australia Parramatta Sexual Health Clinic, Parramatta, NSW, Australia Australian Red Cross Blood Service, Sydney, NSW, Australia Westmead Hospital, Westmead, NSW, Australia GlaxoSmithKline Biologicals, Rixensart, Belgium Queensland Institute of Medical Research, Herston, QLD, Australia AU - Kim, M. AU - Taylor, J. AU - Sidney, J. AU - Mikloska, Z. AU - Bodsworth, N. AU - Lagios, K. AU - Dunckley, H. AU - Byth-Wilson, K. AU - Denis, M. AU - Finlayson, R. AU - Khanna, R. AU - Sette, A. AU - Cunningham, A. L. DB - Scopus DO - 10.4049/jimmunol.181.9.6604 IS - 9 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2008 SP - 6604-6615 ST - Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects T2 - Journal of Immunology TI - Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-58749094126&doi=10.4049%2fjimmunol.181.9.6604&partnerID=40&md5=a1f69c37104863ef2fc7e61dd7add982 VL - 181 ID - 4578 ER - TY - JOUR AD - Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, United States Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, United States AU - Belinsky, M. G. AU - Rink, L. AU - Cai, K. Q. AU - Ochs, M. F. AU - Eisenberg, B. AU - Huang, M. AU - Von Mehren, M. AU - Godwin, A. K. DB - Scopus DO - 10.4161/cc.7.19.6760 IS - 19 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2008 SP - 2949-2955 ST - The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors T2 - Cell Cycle TI - The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-53649108514&doi=10.4161%2fcc.7.19.6760&partnerID=40&md5=6cda63addeb4fdd68479ed361f34c0f2 VL - 7 ID - 4582 ER - TY - JOUR AD - Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States Department of Orthopedics, Imam Khomeini University Hospital, Tehran University of Medical Sciences, Tehran, Iran Howard Hughes Medical Institute, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States Dept. of Medical and Molecular Genetics, 975 West Walnut St., IB130, Indianapolis, IN 46202, United States AU - Garringer, H. J. AU - Malekpour, M. AU - Esteghamat, F. AU - Mortazavi, S. M. J. AU - Davis, S. I. AU - Farrow, E. G. AU - Yu, X. AU - Arking, D. E. AU - Dietz, H. C. AU - White, K. E. DB - Scopus DO - 10.1152/ajpendo.90456.2008 IS - 4 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2008 SP - E929-E937 ST - Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis T2 - American Journal of Physiology - Endocrinology and Metabolism TI - Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-56049106116&doi=10.1152%2fajpendo.90456.2008&partnerID=40&md5=80f4a69f98acd959771e93b7821803ad VL - 295 ID - 4583 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Bldg. 54, 6825 16th Street, N.W., Washington, DC 20306-6000, United States Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, United States AU - Lasota, J. AU - Miettinen, M. DB - Scopus DO - 10.1111/j.1365-2559.2008.02977.x IS - 3 M3 - Review N1 - Cited By :319 Export Date: 18 November 2020 PY - 2008 SP - 245-266 ST - Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours T2 - Histopathology TI - Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-49749122255&doi=10.1111%2fj.1365-2559.2008.02977.x&partnerID=40&md5=4f3c77723e3896cb46ab78501c89c628 VL - 53 ID - 4586 ER - TY - JOUR AD - Department of Biochemistry and Molecular Biology, The Aging and Apoptosis Research Center, Seoul National University College of Medicine, Seoul 110-799, South Korea Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science, Incheon 406-840, South Korea AU - Ryu, S. J. AU - An, H. J. AU - Oh, Y. S. AU - Choi, H. R. AU - Ha, M. K. AU - Park, S. C. DB - Scopus DO - 10.1038/cdd.2008.96 IS - 11 M3 - Article N1 - Cited By :43 Export Date: 18 November 2020 PY - 2008 SP - 1673-1680 ST - On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis T2 - Cell Death and Differentiation TI - On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54049117149&doi=10.1038%2fcdd.2008.96&partnerID=40&md5=2110b24e4749d0381e274882bcc6dfc8 VL - 15 ID - 4591 ER - TY - JOUR AD - Centro de Hematología y Medicina Interna, Clinica Ruiz, Puebla, Mexico Laboratorios Clínicos de Puebla, Clinica Ruiz, Puebla, Mexico Departamento de Hematología, Hospital Universitario, Monterrey, Mexico Department of Hematology, MD Anderson Cancer Center, Houston, TX, United States AU - Ruiz-Argüelles, G. J. AU - Tarin-Arzaga, L. C. AU - Gonzalez-Carrillo, M. L. AU - Gutierrez-Riveroll, K. I. AU - Rangel-Malo, R. AU - Gutiérrez-Aguirre, C. H. AU - Cantú-Rodríguez, O. G. AU - Gómez-Almaguer, D. AU - Giralt, S. DB - Scopus DO - 10.1038/bmt.2008.90 IS - 1 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2008 SP - 23-28 ST - Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? T2 - Bone Marrow Transplantation TI - Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-47549110816&doi=10.1038%2fbmt.2008.90&partnerID=40&md5=154e12a2af810efd8d660bf60cf018c4 VL - 42 ID - 4592 ER - TY - JOUR AD - Department of Life Science, Faculty of Medicine, Shimane University, Izumo, Shimane, 693-8501, Japan Department of Pediatrics, Faculty of Medicine, Shimane University, Izumo, Shimane, 693-8501, Japan Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo, 173-8610, Japan AU - Horie, A. AU - Akimoto, M. AU - Tsumura, H. AU - Makishima, M. AU - Taketani, T. AU - Yamaguchi, S. AU - Honma, Y. DB - Scopus DO - 10.1016/j.leukres.2007.12.004 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 1112-1123 ST - Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A T2 - Leukemia Research TI - Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-41949090235&doi=10.1016%2fj.leukres.2007.12.004&partnerID=40&md5=32a8a67216d78423207ebc83c417c328 VL - 32 ID - 4594 ER - TY - JOUR AD - Stony Brook University Cancer Center, 9447 SUNY, Stony Brook, NY 11794-9447, United States Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL, United States Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611, United States Department of Dermatology, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611, United States AU - Rosenbaum, S. E. AU - Wu, S. AU - Newman, M. A. AU - West, D. P. AU - Kuzel, T. AU - Lacouture, M. E. DB - Scopus DO - 10.1007/s00520-008-0409-1 IS - 6 M3 - Review N1 - Cited By :91 Export Date: 18 November 2020 PY - 2008 SP - 557-566 ST - Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib T2 - Supportive Care in Cancer TI - Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-44449171930&doi=10.1007%2fs00520-008-0409-1&partnerID=40&md5=09f4af46538250478ab110efef153d07 VL - 16 ID - 4596 ER - TY - JOUR AD - State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China Zhejiang Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China AU - Wang, L. N. AU - Pan, Q. AU - Fu, J. F. AU - Shi, J. Y. AU - Jin, J. AU - Li, J. M. AU - Hu, J. AU - Zhao, W. L. AU - Chen, Z. AU - Chen, S. J. DB - Scopus DO - 10.1097/00029330-200805020-00001 IS - 10 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 867-873 ST - FIP1L1-PDGFRα alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib T2 - Chinese Medical Journal TI - FIP1L1-PDGFRα alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-51149106522&doi=10.1097%2f00029330-200805020-00001&partnerID=40&md5=fe99451ea8aed032661480fe3ed8fbd1 VL - 121 ID - 4597 ER - TY - JOUR AD - III. Medizinische Klinik, Klinikum Mannheim, Universitaet Heidelberg, Wiesbadenerstraße 7-11, D-68305 Mannheim, Germany III. Medizinische Klinik, Klinikum Mannheim, University of Heidelberg, Mannheim, Germany AU - Hummel, M. AU - Reiter, S. AU - Adam, K. AU - Hehlmann, R. AU - Buchheidt, D. DB - Scopus DO - 10.1111/j.1600-0609.2007.01013.x IS - 4 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2008 SP - 331-336 ST - Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase T2 - European Journal of Haematology TI - Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449091758&doi=10.1111%2fj.1600-0609.2007.01013.x&partnerID=40&md5=cc5f8c245360955caeb19250e7141013 VL - 80 ID - 4599 ER - TY - JOUR AD - London Bone and Soft Tissue Tumor Service, University College Hospital, London, United Kingdom Department of Oncology, London Bone and Soft Tissue Tumor Service, University College Hospital NHS Trust, Central, 250 Euston Road, London, NW1 2PG, United Kingdom AU - Seddon, B. M. AU - Whelan, J. S. DB - Scopus DO - 10.2165/00148581-200810020-00004 IS - 2 M3 - Review N1 - Cited By :15 Export Date: 18 November 2020 PY - 2008 SP - 93-105 ST - Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma T2 - Pediatric Drugs TI - Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40949125279&doi=10.2165%2f00148581-200810020-00004&partnerID=40&md5=e0d4720ac40416c50eca3ef2ef0c66e7 VL - 10 ID - 4603 ER - TY - JOUR AD - Hereditary Endocrine Cancer Research Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Research Institute, Santa Creu and Sant Pau Hospital, Barcelona, Spain Biochemistry and Molecular Biology Department, Autonomous University of Barcelona (UAB), Barcelona, Spain Pathology Service, Santa Creu and Sant Pau Hospital, Barcelona, Spain Endocrinology Unit, Hospital of Sabadell, Spain Department of Pathology and Molecular Genetics, Arnau de Vilanova Hospital (IRBLLEIDA), Lleida, Spain Pathology Service, Hospital of Sabadell, Spain Bioinformatics Department, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Spain Functional Genomics Node INB, Spain Department of Endocrinology and Nutrition, Santa Creu and Sant Pau Hospital, Barcelona, Spain ISCIII CIBER-BBN, Spain Department of Endocrinology, Arnau de Vilanova Hospital (IRBLLEIDA), Lleida, Spain Spanish NationalCancer Centre, Melchor Fernández Almagro 3, E-28029 Madrid, Spain Department of Endocrinology, Arnau de Vilanova Hospital, Av. Alcalde Rovira Roure 80, E-25198 Lleida, Spain AU - Montero-Conde, C. AU - Martín-Campos, J. M. AU - Lerma, E. AU - Gimenez, G. AU - Martínez-Guitarte, J. L. AU - Combalía, N. AU - Montaner, D. AU - Matías-Guiu, X. AU - Dopazo, J. AU - De Leiva, A. AU - Robledo, M. AU - Mauricio, D. DB - Scopus DO - 10.1038/sj.onc.1210792 IS - 11 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 2008 SP - 1554-1561 ST - Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information T2 - Oncogene TI - Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449117749&doi=10.1038%2fsj.onc.1210792&partnerID=40&md5=7a2447f2e11af6425e53a9e1ad36b464 VL - 27 ID - 4604 ER - TY - JOUR AD - Department of Pediatrics, University School of Medicine, Las Vegas, NV, United States Red Rock Medical Group, Las Vegas, NV, United States University Medical Center of Southern Nevada, Las Vegas, NV, United States Quest Diagnostics, Las Vegas, NV, United States 10232 Splendor Ridge Avenue, Las Vegas, NV 89135, United States AU - Khatua, S. AU - Bilodeau, L. L. DB - Scopus DO - 10.1080/08880010701884709 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 147-153 ST - Chronic diarrhea and facial dysmorphism in children - A clue to MEN 2B syndrome: A case report T2 - Pediatric Hematology and Oncology TI - Chronic diarrhea and facial dysmorphism in children - A clue to MEN 2B syndrome: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-41149178114&doi=10.1080%2f08880010701884709&partnerID=40&md5=f24f63a21eed09ae7136b5541002e9be VL - 25 ID - 4605 ER - TY - JOUR AD - Department of Hematology, Soochow University, Jiangsu Institute of Hematology, 188 Shizi Sreet, 215006 Suzhou, China AU - Wang, Y. AU - Wu, D. AU - Sun, A. AU - Jin, Z. AU - Qiu, H. AU - Miao, M. AU - Tang, X. AU - Fu, Z. DB - Scopus DO - 10.1007/s12185-008-0032-4 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2008 SP - 167-171 ST - Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis T2 - International Journal of Hematology TI - Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-42049088722&doi=10.1007%2fs12185-008-0032-4&partnerID=40&md5=63533989cef0c3f7238119b92f5782bc VL - 87 ID - 4606 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstr. 1, 79106 Freiburg, Germany University of Paris-Sud, UPRES EA3535 Pharmacology and New Treatments in Cancer, Institut Gustave Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif Cedex, France Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, 79106 Freiburg, Germany UPRES EA 3535 Pharmacology and New Treatments in Cancer, Faculty of Medicine, University Paris-Sud AU - Rössler, J. AU - Geoerger, B. AU - Taylor, M. AU - Vassal, G. DB - Scopus DO - 10.2174/156800908783497113 IS - 1 M3 - Review N1 - Cited By :15 Export Date: 18 November 2020 PY - 2008 SP - 76-85 ST - Small molecule tyrosine kinase inhibitors: Potential role in pediatric malignant solid tumors T2 - Current Cancer Drug Targets TI - Small molecule tyrosine kinase inhibitors: Potential role in pediatric malignant solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-39049098974&doi=10.2174%2f156800908783497113&partnerID=40&md5=4ae433bc462a8c5d7eb0fc561ff90370 VL - 8 ID - 4608 ER - TY - JOUR AD - Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Developmental Biology, Sloan-Kettering Institute, New York, NY, United States Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, United States AU - DeMatteo, R. P. AU - Gold, J. S. AU - Saran, L. AU - Gönen, M. AU - Kui, H. L. AU - Maki, R. G. AU - Singer, S. AU - Besmer, P. AU - Brennan, M. F. AU - Antonescu, C. R. DB - Scopus DO - 10.1002/cncr.23199 IS - 3 M3 - Article N1 - Cited By :354 Export Date: 18 November 2020 PY - 2008 SP - 608-615 ST - Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) T2 - Cancer TI - Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38749149936&doi=10.1002%2fcncr.23199&partnerID=40&md5=4cba9f63165c2e6d62ab89aa86bdce55 VL - 112 ID - 4609 ER - TY - JOUR AD - University of Rochester Medical Center, Rochester, NY, United States University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14620, United States AU - Lichtman, M. A. DB - Scopus DO - 10.1634/theoncologist.2007-0228 IS - 2 M3 - Review N1 - Cited By :62 Export Date: 18 November 2020 PY - 2008 SP - 126-138 ST - Battling the hematological malignancies: The 200 years' war T2 - Oncologist TI - Battling the hematological malignancies: The 200 years' war UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40349113288&doi=10.1634%2ftheoncologist.2007-0228&partnerID=40&md5=f7d0e2b3ea4f4b261373f31388c35d07 VL - 13 ID - 4610 ER - TY - JOUR AD - Oncology Department, Addenbrooke's Hospital, Cambridge, United Kingdom Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom Sarcoma Unit, Royal Marsden Hospital, Sutton, London, United Kingdom Pediatric Oncology Department, Box 181, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom AU - Murray, M. AU - Hatcher, H. AU - Jessop, F. AU - Williams, D. AU - Carroll, N. AU - Bulusu, R. AU - Judson, I. DB - Scopus DO - 10.1002/pbc.21312 IS - 2 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 386-388 ST - Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib T2 - Pediatric Blood and Cancer TI - Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37549052917&doi=10.1002%2fpbc.21312&partnerID=40&md5=7ed5fbef7cf12daed3e10f89ad5a997d VL - 50 ID - 4611 ER - TY - JOUR AD - Department of Pathology, Stanford University Medical Center, Stanford, CA, United States Applied Genomics Inc., Burlingame, CA, United States Department of Pathology, OHSU Cancer Institute, Oregon Health and Science University, Portland, OR, United States Departments of Anatomic Pathology and Molecular Genetics, Lerner Research Institute, Taussig Cancer Center, Cleveland, OH, United States Department of Pathology, University of British Columbia, Vancouver, BC, Canada Department of Pathology, L-235, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States AU - Espinosa, I. AU - Lee, C. H. AU - Kim, M. K. AU - Rouse, B. T. AU - Subramanian, S. AU - Montgomery, K. AU - Varma, S. AU - Corless, C. L. AU - Heinrich, M. C. AU - Smith, K. S. AU - Wang, Z. AU - Rubin, B. AU - Nielsen, T. O. AU - Seitz, R. S. AU - Ross, D. T. AU - West, R. B. AU - Cleary, M. L. AU - Van De Rijn, M. DB - Scopus DO - 10.1097/PAS.0b013e3181238cec IS - 2 M3 - Article N1 - Cited By :315 Export Date: 18 November 2020 PY - 2008 SP - 210-218 ST - A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors T2 - American Journal of Surgical Pathology TI - A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649098794&doi=10.1097%2fPAS.0b013e3181238cec&partnerID=40&md5=c49c9f51218265a62a35398c9587a638 VL - 32 ID - 4612 ER - TY - JOUR AD - Department of Pediatric Hematology, Oncology and Endocrinology, University Hospital of Essen, Essen, Germany Department of Ophthalmology, University Hospital of Essen, Essen, Germany Department of Human Genetics, University Hospital of Essen, Essen, Germany University Hospital of Essen, Department of Pediatric Hematology, Oncology and Endocrinology, Hufelandstrasse 55, 45122 Essen, Germany AU - Stephan, H. AU - Zakrzewski, J. L. AU - Bölöni, R. AU - Grasemann, C. AU - Lohmann, D. R. AU - Eggert, A. DB - Scopus DO - 10.1002/pbc.21369 IS - 2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2008 SP - 218-222 ST - Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines T2 - Pediatric Blood and Cancer TI - Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37549026852&doi=10.1002%2fpbc.21369&partnerID=40&md5=ca2a42891b253404dff442a9c924c940 VL - 50 ID - 4613 ER - TY - JOUR AD - Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, Netherlands Department of Medical Oncology, University Hospital, Groningen, Netherlands Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United States Boehringer Ingelheim BV, Alkmaar, Netherlands Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany Department of Medical Oncology, Erasmus University Medical Center, PO Box 2040, Rotterdam, 3000 CA, Netherlands AU - Eskens, F. A. L. M. AU - Mom, C. H. AU - Planting, A. S. T. AU - Gietema, J. A. AU - Amelsberg, A. AU - Huisman, H. AU - Van Doorn, L. AU - Burger, H. AU - Stopfer, P. AU - Verweij, J. AU - De Vries, E. G. E. DB - Scopus DO - 10.1038/sj.bjc.6604108 IS - 1 M3 - Article N1 - Cited By :199 Export Date: 18 November 2020 PY - 2008 SP - 80-85 ST - A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours T2 - British Journal of Cancer TI - A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049038935&doi=10.1038%2fsj.bjc.6604108&partnerID=40&md5=8279dde1914d53375f689b726335cd60 VL - 98 ID - 4614 ER - TY - JOUR AD - Department of Pediatrics, Washington University School of Medicine, St Louis Children's Hospital, St Louis, MO, United States Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Shenoy, S. AU - Smith, F. O. DB - Scopus DO - 10.1038/sj.bmt.1705961 IS - 2 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2008 SP - 141-148 ST - Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin T2 - Bone Marrow Transplantation TI - Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38849113856&doi=10.1038%2fsj.bmt.1705961&partnerID=40&md5=c9d572f830b359ec6d043044fe916a7f VL - 41 ID - 4615 ER - TY - JOUR AD - Duke University, Division of Hematology/Oncology, Durham, NC, United States St. Jude Children's Research Hospital, Division of Bone Marrow Transplantation and Cellular Therapy, Memphis, TN, United States MS 260, 262 Danny Thomas Place, Memphis, TN 38105, United States AU - Barfield, R. C. AU - Kasow, K. A. AU - Hale, G. A. DB - Scopus DO - 10.4161/cbt.7.10.7046 IS - 10 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2008 SP - 1533-1539 ST - Advances in pediatric hematopoietic stem cell transplantation T2 - Cancer Biology and Therapy TI - Advances in pediatric hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54349108616&doi=10.4161%2fcbt.7.10.7046&partnerID=40&md5=05cf48d0d64bf219782d236d92fa5f7b VL - 7 ID - 4616 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Teaching Hospital Motol, Charles University, Prague, Czech Republic Institute of Clinical Biochemistry and Laboratory Diagnostics, General Faculty Hospital, Charles University, Prague, Czech Republic Institute of Hematology and Blood Transfusion, Prague, Czech Republic Czech Stem Cell Donor Registry, Prague, Czech Republic Czech National Marrow Donors Registry, Prague, Czech Republic AU - Krol, L. AU - Formankova, R. AU - Keslova, P. AU - Vavra, V. AU - Zemanova, Z. AU - Michalova, K. AU - Dobrovolna, M. AU - Moravcova, J. AU - Kobylka, P. AU - Ivaskova, E. AU - Navratilova, J. AU - Stary, J. AU - Sedlacek, P. DB - Scopus IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 101-106 ST - Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic T2 - Neoplasma TI - Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-48549106575&partnerID=40&md5=5b0d07b65460822183409c0fe5cfb29e VL - 55 ID - 4617 ER - TY - JOUR AD - Department of Pediatrics, Onze-Lieve-Vrouw Hospital, Aalst, Belgium Department of Dermatology and Venereology, University Medical Center, Sophia Children's Hospital, Rotterdam, Netherlands AU - Van Gysel, D. AU - Oranje, A. P. DB - Scopus IS - 2 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 101-104 ST - Mastocytosis T2 - European Journal of Pediatric Dermatology TI - Mastocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-51749122863&partnerID=40&md5=5130641e14d1236f2bfc3c7197224a59 VL - 18 ID - 4618 ER - TY - JOUR AD - Department of Haematology, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom Glasgow Area Medicines Evaluation Unit, Royal Infirmary, Glasgow, United Kingdom Scotland Leukaemia Registry, Public Health Sciences, University of Edinburgh, Edinburgh, United Kingdom University of Glasgow, Academic Transfusion Medicine Unit, Royal Infirmary, Glasgow, United Kingdom AU - Shepherd, P. AU - Dhanapala, C. AU - Maguire, C. AU - White, J. AU - Drummond, M. AU - Holyoake, T. AU - Johnson, P. R. E. DB - Scopus DO - 10.1258/RSMSMJ.53.3.8 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2008 SP - 8-12 ST - Successful use of national cancer registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia T2 - Scottish Medical Journal TI - Successful use of national cancer registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54049145126&doi=10.1258%2fRSMSMJ.53.3.8&partnerID=40&md5=13742dc2f35178d21bfec1f54c714856 VL - 53 ID - 4619 ER - TY - JOUR AD - Prince Henry's Institute of Medical Research, Clayton, Vic., Australia AU - Chu, S. AU - Alexiadis, M. AU - Fuller, P. J. DB - Scopus DO - 10.1016/j.ygyno.2007.09.017 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2008 SP - 182-190 ST - Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors T2 - Gynecologic Oncology TI - Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37449013816&doi=10.1016%2fj.ygyno.2007.09.017&partnerID=40&md5=fc110bf40c68bad19914c2384690530c VL - 108 ID - 4620 ER - TY - JOUR AD - Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States Section on Endocrinology and Genetics, Pediatric Endocrinology Training Program, National Institutes of Health, Bethesda, MD, United States Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States INSERM U567, Institut Cochin, Département d'Endocrinologie, Paris, France Cancerologie Endocrinienne, Institut Gustave Roussy, Villejuif, France Oncogenetique, Institut Gustave Roussy, Villejuif, France Department of Medical Genetics, Mayo Clinic, Rochester, MN, United States INSERM, U676, Paris, France Faculté de Médecine Denis Diderot, Université Paris 7, IFR02, Paris, France Department of Genetics, Assistance Publique-Hopitaux de Paris, Hopital Européen Georges Pompidou, Paris, France Faculté de Médecine, Université Paris-Descartes, Paris, France INSERM, U772, College de France, Paris, France Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, United States Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States AU - Pasini, B. AU - McWhinney, S. R. AU - Bei, T. AU - Matyakhina, L. AU - Stergiopoulos, S. AU - Muchow, M. AU - Boikos, S. A. AU - Ferrando, B. AU - Pacak, K. AU - Assie, G. AU - Baudin, E. AU - Chompret, A. AU - Ellison, J. W. AU - Briere, J. J. AU - Rustin, P. AU - Gimenez-Roqueplo, A. P. AU - Eng, C. AU - Carney, J. A. AU - Stratakis, C. A. DB - Scopus DO - 10.1038/sj.ejhg.5201904 IS - 1 M3 - Article N1 - Cited By :324 Export Date: 18 November 2020 PY - 2008 SP - 79-88 ST - Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD T2 - European Journal of Human Genetics TI - Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37349074531&doi=10.1038%2fsj.ejhg.5201904&partnerID=40&md5=50c9892099a502f60039d8f08bf797cf VL - 16 ID - 4621 ER - TY - JOUR AD - University of Chicago Medical Center, Department of Pathology, 5841 S. Maryland Avenue, Chicago, IL 60637, United States AU - Pytel, P. DB - Scopus DO - 10.1586/14737140.7.12.S51 IS - 12 SUPPL. M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2007 SP - S51-S60 ST - Spectrum of pediatric gliomas: Implications for the development of future therapies T2 - Expert Review of Anticancer Therapy TI - Spectrum of pediatric gliomas: Implications for the development of future therapies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049110869&doi=10.1586%2f14737140.7.12.S51&partnerID=40&md5=bec62c1ed4bf432ff8bc67330d3b3c35 VL - 7 ID - 4624 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Cortes, J. AU - Jabbour, E. AU - Kantarjian, H. AU - Yin, C. C. AU - Shan, J. AU - O'Brien, S. AU - Garcia-Manero, G. AU - Giles, F. AU - Breeden, M. AU - Reeves, N. AU - Wierda, W. G. AU - Jones, D. DB - Scopus DO - 10.1182/blood-2007-03-080838 IS - 12 M3 - Article N1 - Cited By :216 Export Date: 18 November 2020 PY - 2007 SP - 4005-4011 ST - Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors T2 - Blood TI - Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37049003546&doi=10.1182%2fblood-2007-03-080838&partnerID=40&md5=7ddea454022888996a5e328fba6a48d4 VL - 110 ID - 4625 ER - TY - JOUR AD - Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands Pediatric Oncology/Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam (CNZ), Netherlands Pediatric Oncology/Hematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands AU - Kaspers, G. J. L. AU - Zwaan, C. N. DB - Scopus DO - 10.3324/haematol.11203 IS - 11 M3 - Review N1 - Cited By :125 Export Date: 18 November 2020 PY - 2007 SP - 1519-1532 ST - Pediatric acute myeloid leukemia: Towards high-quality cure of all patients T2 - Haematologica TI - Pediatric acute myeloid leukemia: Towards high-quality cure of all patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-36349018880&doi=10.3324%2fhaematol.11203&partnerID=40&md5=9d7e117ec457b397adea27498d0ac6d8 VL - 92 ID - 4630 ER - TY - JOUR AD - University of Michigan, Ann Arbor, MI, United States H. Lee Moffitt Cancer Center, Tampa, FL, United States University of Pennsylvania, Philadelphia, PA, United States Dana-Farber Cancer Institute, Boston, MA, United States University of Florida Shands Cancer Center, Gainesville, FL, United States Fred Hutchinson Cancer Research Center, Seattle, WA, United States BC Children's Hospital, UBC, Vancouver, Canada Stanford University, Stanford, CA, United States University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Medical College of Wisconsin, Milwaukee, WI, United States Baylor College of Medicine, Houston, TX, United States CIBMTR, Milwaukee, WI, United States AU - Ferrara, J. L. M. AU - Anasetti, C. AU - Stadtmauer, E. AU - Antin, J. AU - Wingard, J. AU - Lee, S. AU - Levine, J. AU - Schultz, K. AU - Appelbaum, F. AU - Negrin, R. AU - Giralt, S. AU - Bredeson, C. AU - Heslop, H. AU - Horowitz, M. DB - Scopus DO - 10.1016/j.bbmt.2007.08.005 IS - 11 M3 - Review N1 - Cited By :22 Export Date: 18 November 2020 PY - 2007 SP - 1268-1285 ST - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 T2 - Biology of Blood and Marrow Transplantation TI - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35348912524&doi=10.1016%2fj.bbmt.2007.08.005&partnerID=40&md5=c1d74c7283797a3af6cd060c2a32bd87 VL - 13 ID - 4631 ER - TY - JOUR AD - Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Surgery, University of Minnesota, Minneapolis, MN, United States AU - Tzeng, C. W. D. AU - Frolov, A. AU - Frolova, N. AU - Jhala, N. C. AU - Howard, J. H. AU - Vickers, S. M. AU - Buchsbaum, D. J. AU - Heslin, M. J. AU - Arnoletti, J. P. DB - Scopus DO - 10.1016/j.jss.2007.01.051 IS - 1 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2007 SP - 20-26 ST - EGFR Genomic Gain and Aberrant Pathway Signaling in Pancreatic Cancer Patients T2 - Journal of Surgical Research TI - EGFR Genomic Gain and Aberrant Pathway Signaling in Pancreatic Cancer Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35248866321&doi=10.1016%2fj.jss.2007.01.051&partnerID=40&md5=572ab59bf8e40e65f387670bbedbdbcb VL - 143 ID - 4633 ER - TY - JOUR AD - Division of Clinical Pharmacology and Therapeutics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States Division of Clinical Pharmacology and Therapeutics, Children's Hospital of Philadelphia, Abramson Research Center 916, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, United States AU - Skolnik, J. M. AU - Adamson, P. C. DB - Scopus DO - 10.1080/07357900701513074 IS - 7 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2007 SP - 606-612 ST - Tyrosine kinase inhibitors in pediatric malignancies T2 - Cancer Investigation TI - Tyrosine kinase inhibitors in pediatric malignancies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-36248955657&doi=10.1080%2f07357900701513074&partnerID=40&md5=503d4ebce886bf92ae125543526fa554 VL - 25 ID - 4634 ER - TY - JOUR AD - Haematology Department, Hammersmith Hospital, Imperial College London, London, United Kingdom AU - Olavarria, E. DB - Scopus DO - 10.1053/j.seminhematol.2007.08.003 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2007 SP - 252-258 ST - Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia T2 - Seminars in Hematology TI - Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35348942833&doi=10.1053%2fj.seminhematol.2007.08.003&partnerID=40&md5=70a41a7805a681e2d970b029917919c1 VL - 44 ID - 4637 ER - TY - JOUR AD - Institute of Hematology and Medical Oncology, L. and A. Seràgnoli S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Institute of Hematology and Medical Oncology, L. and A. Seràgnoli S. Orsola Malpighi Hospital, University of Bologna, Via Massarenti, 9-40, 138 Bologna, Italy AU - Piccaluga, P. P. AU - Paolini, S. AU - Martinelli, G. DB - Scopus DO - 10.1002/cncr.22881 IS - 6 M3 - Review N1 - Cited By :63 Export Date: 18 November 2020 PY - 2007 SP - 1178-1186 ST - Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia T2 - Cancer TI - Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548744667&doi=10.1002%2fcncr.22881&partnerID=40&md5=0761c917c8b07ec31955b43c94632ceb VL - 110 ID - 4638 ER - TY - JOUR AD - Department of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XW, United Kingdom AU - Knapper, S. DB - Scopus DO - 10.1111/j.1365-2141.2007.06700.x IS - 6 M3 - Review N1 - Cited By :55 Export Date: 18 November 2020 PY - 2007 SP - 687-699 ST - FLT3 inhibition in acute myeloid leukaemia T2 - British Journal of Haematology TI - FLT3 inhibition in acute myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548181032&doi=10.1111%2fj.1365-2141.2007.06700.x&partnerID=40&md5=c20eaf20d64ceb4cded04e240fd7649e VL - 138 ID - 4640 ER - TY - JOUR AD - University Department of Surgery, St James Hospital and Trinity College, Dublin 8, Ireland AU - Butt, J. AU - Rowley, S. AU - Byrne, P. J. AU - Reynolds, J. V. DB - Scopus DO - 10.1007/s11845-007-0054-6 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2007 SP - 157-160 ST - Management of gastrointestinal stromal tumours: A single-centre experience T2 - Irish Journal of Medical Science TI - Management of gastrointestinal stromal tumours: A single-centre experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548488952&doi=10.1007%2fs11845-007-0054-6&partnerID=40&md5=7f1a95924734df58f30093fa91069371 VL - 176 ID - 4641 ER - TY - JOUR AD - Experimental Molecular Pathology, Department of Pathology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Department of Experimental Oncology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Preventive-Predictive Medicine Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Department of Medical Oncology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy IFOM, FIRC Institute of Molecular Oncology, Milan, Italy Laboratory of Diagnostic and Experimental Molecular Pathology, Clinical Pathology, Istituto Cantonale di Patologia, Locarno, Switzerland Unit of Experimental Molecular Pathology, Department of Pathology, Fondazione IRCSS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy AU - Signoroni, S. AU - Frattini, M. AU - Negri, T. AU - Pastore, E. AU - Tamborini, E. AU - Casieri, P. AU - Orsenigo, M. AU - Da Riva, L. AU - Radice, P. AU - Sala, P. AU - Gronchi, A. AU - Bertario, L. AU - Pierotti, M. A. AU - Pilotti, S. DB - Scopus DO - 10.1158/1078-0432.CCR-07-0336 IS - 17 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2007 SP - 5034-5040 ST - Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis T2 - Clinical Cancer Research TI - Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548844748&doi=10.1158%2f1078-0432.CCR-07-0336&partnerID=40&md5=e7eb6eac8b42d725a41c5448dd36c0b9 VL - 13 ID - 4642 ER - TY - JOUR AD - Pediatric Oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom AU - Hargrave, D. R. AU - Zacharoulis, S. DB - Scopus DO - 10.1586/14737175.7.8.1029 IS - 8 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2007 SP - 1029-1042 ST - Pediatric CNS tumors: Current treatment and future directions T2 - Expert Review of Neurotherapeutics TI - Pediatric CNS tumors: Current treatment and future directions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548014961&doi=10.1586%2f14737175.7.8.1029&partnerID=40&md5=c73ed1b2eee2c191eb71e0676dd2153d VL - 7 ID - 4643 ER - TY - JOUR AD - Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Jabbour, E. AU - Cortes, J. AU - Kantarjian, H. AU - Giralt, S. AU - Andersson, B. S. AU - Giles, F. AU - Shpall, E. AU - Kebriaei, P. AU - Champlin, R. AU - De Lima, M. DB - Scopus DO - 10.1002/cncr.22778 IS - 2 M3 - Article N1 - Cited By :50 Export Date: 18 November 2020 PY - 2007 SP - 340-344 ST - Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity T2 - Cancer TI - Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547178987&doi=10.1002%2fcncr.22778&partnerID=40&md5=39d1b4b47d07da817b3c9f4a2cb98fa1 VL - 110 ID - 4645 ER - TY - JOUR AD - Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan Forsyth Institute, Boston, MA, United States Department of Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, United States 21st Century Center of Excellence Program, Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Tokyo, Japan Core to Core Program, JSPS, Tokyo Medical and Dental University, Tokyo, Japan Hard Tissue Genome Research Center, Tokyo Medical and Dental University, Tokyo, Japan Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 3-10 Kanda-Surugadai, 2-chome, Chiyoda-ku, Tokyo 101-0062, Japan AU - Hayashi, C. AU - Rittling, S. AU - Hayata, T. AU - Amagasa, T. AU - Denhardt, D. AU - Ezura, Y. AU - Nakashima, K. AU - Noda, M. DB - Scopus DO - 10.1002/jcb.21298 IS - 4 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2007 SP - 979-986 ST - Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration T2 - Journal of Cellular Biochemistry TI - Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34447265320&doi=10.1002%2fjcb.21298&partnerID=40&md5=9fe4047e7860391bfb0780a902d1f8c2 VL - 101 ID - 4646 ER - TY - JOUR AD - Department of Immunology, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, Netherlands AU - Staal, F. J. T. AU - Van Dongen, J. J. M. AU - Langerak, A. W. DB - Scopus DO - 10.1007/s11899-007-0024-0 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2007 SP - 176-182 ST - Novel insights into the development of T-cell acute lymphoblastic leukemia T2 - Current Hematologic Malignancy Reports TI - Novel insights into the development of T-cell acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547766674&doi=10.1007%2fs11899-007-0024-0&partnerID=40&md5=5fc17b55e4d02758f25da1bee45a1f6c VL - 2 ID - 4648 ER - TY - JOUR AD - Erasmus MC/Sophia Children's Hospital, Erasmus University Medical Center, Dept. of Pediatric Oncology and Hematology, Dr. Molewaterplein 60, 3015 GJ Rotterdam, Netherlands AU - den Boer, M. L. AU - Pieters, R. DB - Scopus DO - 10.2174/138945007780830755 IS - 6 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2007 SP - 761-764 ST - Microarray-based identification of new targets for specific therapies in pediatric leukemia T2 - Current Drug Targets TI - Microarray-based identification of new targets for specific therapies in pediatric leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34447513733&doi=10.2174%2f138945007780830755&partnerID=40&md5=5b1aec8ac56c7a5819b82d5c0e6a1774 VL - 8 ID - 4651 ER - TY - JOUR AD - Department of Pediatrics, Hematology/Oncology, Wake Forest University, School of Medicine, Winston-Salem, NC, United States Department of Pediatrics, Hematology/Oncology, Wake Forest University, Health Sciences Building, Medical Center Blvd, Winston-Salem, NC 27157, United States AU - Castellino, S. M. AU - McLean, T. W. DB - Scopus DO - 10.1097/CCO.0b013e3280ad43ce IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2007 SP - 248-253 ST - Pediatric genitourinary tumors T2 - Current Opinion in Oncology TI - Pediatric genitourinary tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247161829&doi=10.1097%2fCCO.0b013e3280ad43ce&partnerID=40&md5=374fd0c835c75eb3590767f4ad6fd21c VL - 19 ID - 4655 ER - TY - JOUR AD - Department of Biological Science, Sookmyung Women's University, Seoul, 140-742, South Korea Department of Biochemistry, Yonsei University, Seoul, 120-749, South Korea AU - Yoo, K. H. AU - Sung, Y. H. AU - Yang, M. H. AU - Jeon, J. O. AU - Yook, Y. J. AU - Woo, Y. M. AU - Lee, H. W. AU - Park, J. H. DB - Scopus DO - 10.1016/j.bbrc.2007.02.103 IS - 1 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2007 SP - 85-90 ST - Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney T2 - Biochemical and Biophysical Research Communications TI - Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947190405&doi=10.1016%2fj.bbrc.2007.02.103&partnerID=40&md5=561c755fba3fd80b95785c37b3bcb3fa VL - 356 ID - 4657 ER - TY - JOUR AD - Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Department of Medical Oncology, Division of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Via G. Venezian 1, 20133 Milan, Italy AU - Bozzi, F. AU - Tamborini, E. AU - Negri, T. AU - Pastore, E. AU - Ferrari, A. AU - Luksch, R. AU - Casanova, M. AU - Pierotti, M. A. AU - Bellani, F. F. AU - Pilotti, S. DB - Scopus DO - 10.1002/cncr.22587 IS - 8 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2007 SP - 1638-1645 ST - Evidence for activation of KIT, PDGFRα, and PDGFRβ receptors in the Ewing sarcoma family of tumors T2 - Cancer TI - Evidence for activation of KIT, PDGFRα, and PDGFRβ receptors in the Ewing sarcoma family of tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247098863&doi=10.1002%2fcncr.22587&partnerID=40&md5=79ea8d94ef537b337e5a0b53e676ba3a VL - 109 ID - 4658 ER - TY - JOUR AD - Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria Institute of Immunology, Medical University of Vienna, Austria Department of Clinical Pharmacology, Medical University of Vienna, Austria Department of Radiation Therapy, Medical University of Vienna, Austria Department of Clinical Pathology, Medical University of Vienna, Austria Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer Guertel 18-20, A-1097 Vienna, Austria AU - Aichberger, K. J. AU - Mayerhofer, M. AU - Gleixner, K. V. AU - Krauth, M. T. AU - Gruze, A. AU - Pickl, W. F. AU - Wacheck, V. AU - Selzer, E. AU - Müllauer, L. AU - Agis, H. AU - Sillaber, C. AU - Valent, P. DB - Scopus DO - 10.1182/blood-2006-07-032714 IS - 7 M3 - Article N1 - Cited By :52 Export Date: 18 November 2020 PY - 2007 SP - 3031-3041 ST - Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: Inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 T2 - Blood TI - Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: Inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947579975&doi=10.1182%2fblood-2006-07-032714&partnerID=40&md5=6629b43be1973324066b0a3e004a37b0 VL - 109 ID - 4661 ER - TY - JOUR AD - Cancer Therapy and Research Center, The Institute for Drug Development, San Antonio, TX, United States University of Texas Health Science Center at San Antonio, San Antonio, TX, United States Princess Margaret Hospital, University Health Network, Toronto, ON, Canada OSI Pharmaceuticals Inc., 41 Pinelawn Road, Melville, NY 11747, United States ImClone Systems, 33 ImClone Drive, Branchburg, NJ 08876, United States AU - Calvo, E. AU - Malik, S. N. AU - Siu, L. L. AU - Baillargeon, G. M. AU - Irish, J. AU - Chin, S. F. AU - Santabarbara, P. AU - Kreisberg, J. I. AU - Rowinsky, E. K. AU - Hidalgo, M. DB - Scopus DO - 10.1093/annonc/mdl495 IS - 4 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2007 SP - 761-767 ST - Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer T2 - Annals of Oncology TI - Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34047190928&doi=10.1093%2fannonc%2fmdl495&partnerID=40&md5=74c121bb9b517cc1919b4a737b66d61f VL - 18 ID - 4662 ER - TY - JOUR AD - Department of Human and Hereditary Pathology, Institute of Dermatology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Institute of Hematology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Department of Pediatrics, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy AU - Brazzelli, V. AU - Prestinari, F. AU - Barbagallo, T. AU - Rona, C. AU - Orlandi, E. AU - Passamonti, F. AU - Locatelli, F. AU - Zecca, M. AU - Villani, S. AU - Borroni, G. DB - Scopus DO - 10.1111/j.1468-3083.2006.01981.x IS - 3 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2007 SP - 384-387 ST - A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: A study of five patients T2 - Journal of the European Academy of Dermatology and Venereology TI - A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: A study of five patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847005917&doi=10.1111%2fj.1468-3083.2006.01981.x&partnerID=40&md5=03271a1ef24270714d5cb00ce101f133 VL - 21 ID - 4664 ER - TY - JOUR AD - Wolters Kluwer Health / Adis, Auckland, New Zealand Wolters Kluwer Health, Conshohocken, PA, United States Wolters Kluwer Health / Adis, 41 Centorian Drive, Mairangi Bay, Auckland 1311, New Zealand AU - Moen, M. D. AU - McKeage, K. AU - Plosker, G. L. AU - Siddiqui, M. A. A. DB - Scopus DO - 10.2165/00003495-200767020-00010 IS - 2 M3 - Review N1 - Cited By :96 Export Date: 18 November 2020 PY - 2007 SP - 299-320 ST - Imatinib: A review of its use in chronic myeloid leukaemia T2 - Drugs TI - Imatinib: A review of its use in chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847057304&doi=10.2165%2f00003495-200767020-00010&partnerID=40&md5=382d7940c86c329ec5cfaa703499bfe2 VL - 67 ID - 4665 ER - TY - JOUR AD - Department of Oncology, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, United States University of Tennessee Health Science Center, Memphis, TN 38163, United States AU - Pui, C. H. AU - Jeha, S. DB - Scopus DO - 10.1038/nrd2240 IS - 2 M3 - Review N1 - Cited By :170 Export Date: 18 November 2020 PY - 2007 SP - 149-165 ST - New therapeutic strategies for the treatment of acute lymphoblastic leukaemia T2 - Nature Reviews Drug Discovery TI - New therapeutic strategies for the treatment of acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947588149&doi=10.1038%2fnrd2240&partnerID=40&md5=e055f42a3c6bffff97f24cb910bc7470 VL - 6 ID - 4666 ER - TY - JOUR AD - Department of Pathology, Laboratory Medicine, King Khalid National Guard Hospital, PO Box 9515, Jeddah, Saudi Arabia Department Of Medical Oncology, King Khalid National Guard Hospital, PO Box 9515, Jeddah, Saudi Arabia AU - Al Sobhi, E. AU - Zahrani, Z. AU - Zevallos, E. AU - Zuraiki, A. DB - Scopus DO - 10.1080/10245330600937929 IS - 1 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2007 SP - 49-53 ST - Imatinib-induced immune hepatitis: Case report and literature review T2 - Hematology TI - Imatinib-induced immune hepatitis: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947164748&doi=10.1080%2f10245330600937929&partnerID=40&md5=c69863be8ff22756c34717a3f66b0963 VL - 12 ID - 4667 ER - TY - JOUR AD - Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, United States Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, United States AU - Mughal, T. AU - Goldman, J. M. DB - Scopus DO - 10.3816/CLM.2007.s.008 IS - SUPPL. 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2007 SP - S95-S101 ST - Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007 T2 - Clinical Lymphoma and Myeloma TI - Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249694651&doi=10.3816%2fCLM.2007.s.008&partnerID=40&md5=01230e96c7d441476770aac0d638b00b VL - 7 ID - 4668 ER - TY - JOUR AD - Department of Dermatology, St. Luke's-Roosevelt Hospital Center., United States AU - Scheinfeld, N. DB - Scopus IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2007 SP - 352-355 ST - A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine T2 - Journal of drugs in dermatology : JDD TI - A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247197662&partnerID=40&md5=d74d3fca6f20554f5bbec8f740a04cbc VL - 6 ID - 4670 ER - TY - JOUR AD - Roswell Park Cancer Institute, Buffalo, NY, United States Medical College of Wisconsin, Milwaukee, WI, United States NIH, NCI, CCR, Genetics Branch, Bethesda, MD, United States Kimmel Comprehensive Cancer Center, Baltimore, MD, United States Children's Oncology Group, Arcadia, CA, United States Childrens's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, United States Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States Cincinnati Children's Hospital, Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, United States Blue Shield of California, San Francisco, CA, United States AU - Oliansky, D. M. AU - Rizzo, J. D. AU - Aplan, P. D. AU - Arceci, R. J. AU - Leone, L. AU - Ravindranath, Y. AU - Sanders, J. E. AU - Smith Iii, F. O. AU - Wilmot, F. AU - McCarthy Jr, P. L. AU - Hahn, T. DB - Scopus DO - 10.1016/j.bbmt.2006.10.024 IS - 1 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2007 SP - 1-25 ST - The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review T2 - Biology of Blood and Marrow Transplantation TI - The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846057947&doi=10.1016%2fj.bbmt.2006.10.024&partnerID=40&md5=8bdc68d7d222414ecc38abdf11b3cf96 VL - 13 ID - 4671 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Department of Haematology, University College Hospital Galway (UCHG), Galway, Ireland Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio, CTRC Institute for Drug Development, San Antonio, TX, United States Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio, CTRC Institute for Drug Development, 7979 Wurzbach Road, San Antonio, TX 78229, United States AU - Apostolidou, E. AU - Swords, R. AU - Alvarado, Y. AU - Giles, F. J. DB - Scopus DO - 10.2165/00003495-200767150-00004 IS - 15 M3 - Review N1 - Cited By :44 Export Date: 18 November 2020 PY - 2007 SP - 2153-2171 ST - Treatment of acute lymphoblastic leukaemia: A new era T2 - Drugs TI - Treatment of acute lymphoblastic leukaemia: A new era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35048824745&doi=10.2165%2f00003495-200767150-00004&partnerID=40&md5=7bc90eaf48eafb6e483f3557bb15c22f VL - 67 ID - 4672 ER - TY - JOUR AD - Emory University Winship Cancer Institute, Atlanta, GA, United States AU - Arellano, M. L. AU - Langston, A. AU - Winton, E. AU - Flowers, C. R. AU - Waller, E. K. DB - Scopus DO - 10.1016/j.bbmt.2006.09.005 IS - 1 M3 - Article N1 - Cited By :73 Export Date: 18 November 2020 PY - 2007 SP - 116-123 ST - Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience T2 - Biology of Blood and Marrow Transplantation TI - Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846007694&doi=10.1016%2fj.bbmt.2006.09.005&partnerID=40&md5=baba69a87815ecc6e8d67f7b5fdbc643 VL - 13 ID - 4673 ER - TY - JOUR AD - Department of Oncology, Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Pui, C. H. DB - Scopus IS - 12 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2006 SP - 884-886 ST - Update on pediatric ALL T2 - Clinical Advances in Hematology and Oncology TI - Update on pediatric ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846426451&partnerID=40&md5=f479ff2e11e9c26d36bc8136506df48f VL - 4 ID - 4675 ER - TY - JOUR AD - Department of Pediatric Dentistry, Institute of Odontology, Karolinska Institutet, Box 4064, SE-141 04 Huddinge, Sweden AU - Yucel-Lindberg, T. AU - Olsson, T. AU - Kawakami, T. DB - Scopus DO - 10.1016/j.cellsig.2006.04.003 IS - 12 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2006 SP - 2131-2142 ST - Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts T2 - Cellular Signalling TI - Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750344327&doi=10.1016%2fj.cellsig.2006.04.003&partnerID=40&md5=b1d3f863f2d7aa0f1ec3304e892593a2 VL - 18 ID - 4677 ER - TY - JOUR AD - Department of Pediatrics, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States Midwest Research Institute, Kansas City, MO, United States Neonatology Research Laboratory, Children's Mercy Hospital, Pediatric Research Center, 2401 Gillham Rd., Kansas City, MO 64108, United States AU - Xu, D. AU - Guthrie, J. R. AU - Mabry, S. AU - Sack, T. M. AU - Truog, W. E. DB - Scopus DO - 10.1152/ajplung.00045.2006 IS - 5 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2006 SP - L966-L975 ST - Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751082661&doi=10.1152%2fajplung.00045.2006&partnerID=40&md5=95c94e621a0d85e07580f825e97d0b7a VL - 291 ID - 4678 ER - TY - JOUR AD - Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik III, Hindenburgdamm 30, 12200 Berlin, Germany AU - Burmeister, T. AU - Gökbuget, N. AU - Reinhardt, R. AU - Rieder, H. AU - Hoelzer, D. AU - Schwartz, S. DB - Scopus DO - 10.1182/blood-2006-04-014514 IS - 10 M3 - Article N1 - Cited By :36 Export Date: 18 November 2020 PY - 2006 SP - 3556-3559 ST - NUP214-ABL1 in adult T-ALL: The GMALL study group experience T2 - Blood TI - NUP214-ABL1 in adult T-ALL: The GMALL study group experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751173419&doi=10.1182%2fblood-2006-04-014514&partnerID=40&md5=e34fcaaad368beecd90d80d85dc5fce8 VL - 108 ID - 4679 ER - TY - JOUR AD - Department of Medicine, Kurume University School of Medicine, Research Center for Innovative Cancer Therapy, Kurume, Japan Department of Pathology, Kurume University School of Medicine, Research Center for Innovative Cancer Therapy, Kurume, Japan Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan AU - Yoshida, T. AU - Hisamoto, T. AU - Akiba, J. AU - Koga, H. AU - Nakamura, K. AU - Tokunaga, Y. AU - Hanada, S. AU - Kumemura, H. AU - Maeyama, M. AU - Harada, M. AU - Ogata, H. AU - Yano, H. AU - Kojiro, M. AU - Ueno, T. AU - Yoshimura, A. AU - Sata, M. DB - Scopus DO - 10.1038/sj.onc.1209635 IS - 45 M3 - Article N1 - Cited By :121 Export Date: 18 November 2020 PY - 2006 SP - 6056-6066 ST - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors T2 - Oncogene TI - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749836283&doi=10.1038%2fsj.onc.1209635&partnerID=40&md5=e25f2ccae397d427ce9f51470f49afcd VL - 25 ID - 4681 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, United States Armed Forces Institute of Pathology, Department of Soft Tissue Pathology, Bldg. 54, 6825 16th St, NW, Washington, DC 20306-6000, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus IS - 10 M3 - Review N1 - Cited By :954 Export Date: 18 November 2020 PY - 2006 SP - 1466-1478 ST - Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis T2 - Archives of Pathology and Laboratory Medicine TI - Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749459756&partnerID=40&md5=e92c2cb59a6e4e0de7a923e2735f9ca0 VL - 130 ID - 4682 ER - TY - JOUR AD - University of Colorado at Denver and Health Sciences Center (UCDHSC), Children's Hospital, Denver, CO, United States University of New Mexico Health Sciences Center, Albuquerque, NM, United States University of Colorado at Denver and Health Sciences Center, Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Foreman, N. K. AU - Gore, L. AU - Wells, D. AU - Straessle, J. AU - Heideman, R. AU - Donson, A. M. DB - Scopus DO - 10.1002/pbc.20619 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2006 SP - 293-298 ST - Gefitinib is effective against juvenile pilocytic astrocytoma in vitro T2 - Pediatric Blood and Cancer TI - Gefitinib is effective against juvenile pilocytic astrocytoma in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746640912&doi=10.1002%2fpbc.20619&partnerID=40&md5=10cf3f317b53d03c1b69ab54ec7ef6ee VL - 47 ID - 4684 ER - TY - JOUR AD - Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Ayuttaya Hospital, Ayuttaya, Thailand Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkoknoi Bangkok 10700, Thailand AU - Auewarakul, C. U. AU - Huang, S. AU - Yimyam, M. AU - Boonmoh, S. DB - Scopus DO - 10.1159/000093641 IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2006 SP - 114-119 ST - Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants T2 - Acta Haematologica TI - Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747439438&doi=10.1159%2f000093641&partnerID=40&md5=b8f892e968224ec651a7567b2fef7a2e VL - 116 ID - 4688 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States J.W. Goethe Universität, Frankfurt, Germany Moffitt Cancer Center, Tampa, FL, United States Novartis Pharmaceuticals, East Hanover, NJ, United States Quest Diagnostics, San Juan Capistrano, CA, United States Fakultät fur Klinische Medizin Mannheim, Universität Heidelberg, Mannheim, Germany Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Leukemia, University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, United States AU - Kantarjian, H. AU - Giles, F. AU - Wunderle, L. AU - Bhalla, K. AU - O'Brien, S. AU - Wassmann, B. AU - Tanaka, C. AU - Manley, P. AU - Rae, P. AU - Mietlowski, W. AU - Bochinski, K. AU - Hochhaus, A. AU - Griffin, J. D. AU - Hoelzer, D. AU - Albitar, M. AU - Dugan, M. AU - Cortes, J. AU - Alland, L. AU - Ottmann, O. G. DB - Scopus DO - 10.1056/NEJMoa055104 IS - 24 M3 - Article N1 - Cited By :1068 Export Date: 18 November 2020 PY - 2006 SP - 2542-2551 ST - Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL T2 - New England Journal of Medicine TI - Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745086350&doi=10.1056%2fNEJMoa055104&partnerID=40&md5=af92db40c295ac2500677aa18b6f969d VL - 354 ID - 4690 ER - TY - JOUR AD - Department of Pediatrics and Medicine, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, United States AU - Simone, J. V. DB - Scopus DO - 10.1016/j.beha.2005.11.003 IS - 2 M3 - Review N1 - Cited By :35 Export Date: 18 November 2020 PY - 2006 SP - 353-359 ST - History of the treatment of childhood ALL: A paradigm for cancer cure T2 - Best Practice and Research: Clinical Haematology TI - History of the treatment of childhood ALL: A paradigm for cancer cure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644560026&doi=10.1016%2fj.beha.2005.11.003&partnerID=40&md5=0f40d790090438eb1a5ff41e8214404c VL - 19 ID - 4691 ER - TY - JOUR AD - Institute of Pathology, University of Basel, Schönbeinstrasse 40, CH-4003 Basel, Switzerland Institute of Pathology, University of Basel, Basel, Switzerland AU - Tornillo, L. AU - Terracciano, L. M. DB - Scopus DO - 10.1136/jcp.2005.031112 IS - 6 M3 - Review N1 - Cited By :89 Export Date: 18 November 2020 PY - 2006 SP - 557-563 ST - An update on molecular genetics of gastrointestinal stromal tumours T2 - Journal of Clinical Pathology TI - An update on molecular genetics of gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745099617&doi=10.1136%2fjcp.2005.031112&partnerID=40&md5=cec025cae020bd3a05086c080a72d2fb VL - 59 ID - 4692 ER - TY - JOUR AD - Biomedical Research Institute, Department of Biological Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, United Kingdom Division of Clinical Science, Warwick Medical School, University of Warwick, Coventry, United Kingdom Medical School, University of Leeds, Leeds, United Kingdom AU - Chen, J. AU - Tan, B. AU - Karteris, E. AU - Zervou, S. AU - Digby, J. AU - Hillhouse, E. W. AU - Vatish, M. AU - Randeva, H. S. DB - Scopus DO - 10.1007/s00125-006-0194-7 IS - 6 M3 - Article N1 - Cited By :175 Export Date: 18 November 2020 PY - 2006 SP - 1292-1302 ST - Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines T2 - Diabetologia TI - Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646494846&doi=10.1007%2fs00125-006-0194-7&partnerID=40&md5=4fb40d0faaf5c97e33ab937b94ec607f VL - 49 ID - 4693 ER - TY - JOUR AD - Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pediatrics, Children's Hospital and Regional Medical Center, Seattle, WA, United States Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, MS313, 332 N. Lauderdale St., Memphis, TN 38105, United States AU - Freeman Iii, B. B. AU - Daw, N. C. AU - Geyer, J. R. AU - Furman, W. L. AU - Stewart, C. F. DB - Scopus DO - 10.1080/07357900600632058 IS - 3 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2006 SP - 310-317 ST - Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients T2 - Cancer Investigation TI - Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646494170&doi=10.1080%2f07357900600632058&partnerID=40&md5=4cc07022e6150253e5f41c557e655c5e VL - 24 ID - 4694 ER - TY - JOUR AD - Department of Pediatric Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD, United States Division of Comparative Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, United States ImClone Systems, Inc., New York, NY, United States Johns Hopkins University, School of Medicine, CRB 276, 1650 Orleans Street, Baltimore, MD 21231, United States AU - Piloto, O. AU - Nguyen, B. AU - Huso, D. AU - Kim, K. T. AU - Li, Y. AU - Witte, L. AU - Hicklin, D. J. AU - Brown, P. AU - Small, D. DB - Scopus DO - 10.1158/0008-5472.CAN-06-0018 IS - 9 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2006 SP - 4843-4851 ST - IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples T2 - Cancer Research TI - IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646432479&doi=10.1158%2f0008-5472.CAN-06-0018&partnerID=40&md5=f183dc76bcc00ee87d1a0a82c4ef4baa VL - 66 ID - 4695 ER - TY - JOUR AD - Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland AU - Bode, B. AU - Frigerio, S. AU - Behnke, S. AU - Senn, B. AU - Odermatt, B. AU - Zimmermann, D. R. AU - Moch, H. DB - Scopus DO - 10.1038/modpathol.3800560 IS - 4 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2006 SP - 541-547 ST - Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma T2 - Modern Pathology TI - Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645301012&doi=10.1038%2fmodpathol.3800560&partnerID=40&md5=3d4e129b75a3764a32cb67fa6527f3c6 VL - 19 ID - 4696 ER - TY - JOUR AD - First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece Sofokleous 24, 17671, Athens, Greece AU - Lilakos, K. AU - Viniou, N. A. AU - Mavrogianni, D. AU - Vassilakopoulos, T. P. AU - Dimopoulou, M. N. AU - Plata, E. AU - Angelopoulou, M. K. AU - Variami, E. AU - Stavrogianni, N. AU - Liapi, D. AU - Xilouri, I. AU - Galanopoulos, A. AU - Ageloudi, M. AU - Panayiotidis, P. AU - Voulgarelis, M. AU - Rombos, J. AU - Meletis, J. AU - Yataganas, X. AU - Pangalis, G. A. DB - Scopus IS - 2 A M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2006 SP - 1201-1207 ST - FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: A pilot study T2 - Anticancer Research TI - FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: A pilot study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645833694&partnerID=40&md5=d7d0f4c385f99b1586fdedf7b394844e VL - 26 ID - 4698 ER - TY - JOUR AD - Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, UT, United States Department of Pathology, Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE, United States Department of Orthopedics, Huntsman Cancer Institute Sarcoma Service, University of Utah, Salt Lake City, UT, United States Department of Laboratory Medicine, Columbus Children's Hospital, Columbus, OH, United States Children's Cancer Research Institute, University of Texas Health Science Center, 8403 Floyd Curl Drive, San Antonio, TX 78229-3900, United States AU - Blandford, M. C. AU - Barr, F. G. AU - Lynch, J. C. AU - Randall, R. L. AU - Qualman, S. J. AU - Keller, C. DB - Scopus DO - 10.1002/pbc.20466 IS - 3 M3 - Article N1 - Cited By :43 Export Date: 18 November 2020 PY - 2006 SP - 329-338 ST - Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group T2 - Pediatric Blood and Cancer TI - Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-32044469857&doi=10.1002%2fpbc.20466&partnerID=40&md5=498c5ff39f6487ced4606bf053808d0d VL - 46 ID - 4699 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Global Research and Development, San Diego, CA, United States Department of Biostatistics, Allergan Inc., Irvine, CA, United States Department of Clinical Pharmacology, Pfizer Global Research and Development, 10578 Science Center Drive, San Diego, CA 92121, United States AU - Bello, C. L. AU - Sherman, L. AU - Zhou, J. AU - Verkh, L. AU - Smeraglia, J. AU - Mount, J. AU - Klamerus, K. J. DB - Scopus DO - 10.1097/00001813-200603000-00015 IS - 3 M3 - Article N1 - Cited By :121 Export Date: 18 November 2020 PY - 2006 SP - 353-358 ST - Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: Results from a phase I study in healthy subjects T2 - Anti-Cancer Drugs TI - Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: Results from a phase I study in healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646108821&doi=10.1097%2f00001813-200603000-00015&partnerID=40&md5=d2ad652f3910c9a48a436da2fa3e1664 VL - 17 ID - 4700 ER - TY - JOUR AD - Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan 21st Century COE Program, University of Toyama, Toyama 930-0194, Japan Department of Microbiology, SORST, Kinki University School of Medicine, Osaka 589-8511, Japan AU - Nakamura, E. S. AU - Koizumi, K. AU - Kobayashi, M. AU - Saitoh, Y. AU - Arita, Y. AU - Nakayama, T. AU - Sakurai, H. AU - Yoshie, O. AU - Saiki, I. DB - Scopus DO - 10.1007/s10585-006-9006-1 IS - 1 M3 - Article N1 - Cited By :78 Export Date: 18 November 2020 PY - 2006 SP - 9-18 ST - RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 T2 - Clinical and Experimental Metastasis TI - RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750073849&doi=10.1007%2fs10585-006-9006-1&partnerID=40&md5=1f4b1d0409d6b19c0e8c60220eb0a6ed VL - 23 ID - 4701 ER - TY - JOUR AD - Deparetment of Digestive Surgery, Clinical Centre, Medical Faculty, Ss. Cyril and Methodius University, Skopje, North Macedonia AU - Jankulovski, N. AU - Popov, Z. AU - Bojadzieva, S. AU - Validire, P. AU - Gogusev, J. DB - Scopus IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2006 SP - 59-70 ST - Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment T2 - Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za biološki i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences TI - Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947704238&partnerID=40&md5=12d0ac1c8e166e90ffe21bf36aaa1082 VL - 27 ID - 4703 ER - TY - JOUR AD - Laboratoire d'Hématologie, AP-HP Necker, 149-161 rue de Sèvres, 75743 Paris Cedex 15, France INSERM EMI02.10, AP-HP Necker, Paris, France Service d'Hématologie Adultes, AP-HP Necker, Paris, France Service de Néphrologie, Laboratoire de Biostatistiques, Centre Hospitalier Lyon-Sud, Lyon, France Laboratoire d'Hématologie, AP-HP La Pitié-Salpétrière, Paris, France Service d'Oncologie et Hématologie, Hôpital d'Amiens, Paris, France Service d'Hématologie, AP-HP La Pitié-Salpétrière, Paris, France AU - Asnafi, V. AU - Rubio, M. T. AU - Delabesse, E. AU - Villar, E. AU - Davi, F. AU - Damaj, G. AU - Hirsch, I. AU - Dhédin, N. AU - Vernant, J. P. AU - Varet, B. AU - Buzyn, A. AU - Macintyre, E. DB - Scopus DO - 10.1038/sj.leu.2404170 IS - 5 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2006 SP - 793-799 ST - Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia T2 - Leukemia TI - Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646127175&doi=10.1038%2fsj.leu.2404170&partnerID=40&md5=35cf7090ddd4e2f2f646670c24166c1b VL - 20 ID - 4704 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY, United States AU - Antonescu, C. R. DB - Scopus DO - 10.1111/j.1365-2559.2005.02285.x IS - 1 M3 - Review N1 - Cited By :107 Export Date: 18 November 2020 PY - 2006 SP - 13-21 ST - The role of genetic testing in soft tissue sarcoma T2 - Histopathology TI - The role of genetic testing in soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645083214&doi=10.1111%2fj.1365-2559.2005.02285.x&partnerID=40&md5=beeb2f6569c19426e1eb35fe257d73d8 VL - 48 ID - 4706 ER - TY - JOUR AD - Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Memorial Sloan-Kettering Cancer Center, Howard Bldg., Box 437, 1275 York Ave, New York, NY 10021, United States AU - Miller, V. A. DB - Scopus DO - 10.1016/j.jpeds.2006.04.047 IS - SUPPL. 1 M3 - Article N1 - Cited By :64 Export Date: 18 November 2020 PY - 2006 SP - S25-S31 ST - Optimizing therapy in previously treated non-small cell lung cancer T2 - Seminars in Oncology TI - Optimizing therapy in previously treated non-small cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745633826&doi=10.1016%2fj.jpeds.2006.04.047&partnerID=40&md5=2cca856e81b1f0edf5f8b162711f39a0 VL - 33 ID - 4707 ER - TY - JOUR AD - Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States Department of Anatomy, University of California San Francisco, San Francisco, CA, United States Department of Pathology, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, United States Department of Pathology, Children's Hospital and Research Center at Oakland, Oakland, CA, United States Department of Pediatrics, Division of Medical Genetics, University of California San Francisco, San Francisco, CA, United States UCSF Comprehensive Cancer Center, Cancer Research Institute, Box 0128, 2340 Sutter Street, San Francisco, CA 94115, United States AU - Estep, A. L. AU - Tidyman, W. E. AU - Teitell, M. A. AU - Cotter, P. D. AU - Rauen, K. A. DB - Scopus DO - 10.1002/ajmg.a.31078 IS - 1 M3 - Article N1 - Cited By :128 Export Date: 18 November 2020 PY - 2006 SP - 8-16 ST - HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy T2 - American Journal of Medical Genetics TI - HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-30144434094&doi=10.1002%2fajmg.a.31078&partnerID=40&md5=5d9f767c624725dc1cb193373bc9ed83 VL - 140 A ID - 4710 ER - TY - JOUR AD - Department of Hematology-Oncology, Mail Stop 260, St. Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105-2794, United States AU - Daw, N. C. AU - Furman, W. L. AU - Stewart, C. F. AU - Iacono, L. C. AU - Krailo, M. AU - Bernstein, M. L. AU - Dancey, J. E. AU - Speights, R. A. AU - Blaney, S. M. AU - Croop, J. M. AU - Reaman, G. H. AU - Adamson, P. C. DB - Scopus DO - 10.1200/JCO.2005.11.429 IS - 25 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2005 SP - 6172-6180 ST - Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study T2 - Journal of Clinical Oncology TI - Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-24944519394&doi=10.1200%2fJCO.2005.11.429&partnerID=40&md5=9da75bb6cb022e4446a64540636b4d84 VL - 23 ID - 4711 ER - TY - JOUR AD - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children's Hospital, Harvard Medical School, 1 Blackfan Circle, Boston, MA 02115, United States AU - Armstrong, S. A. AU - Look, A. T. DB - Scopus DO - 10.1200/JCO.2005.05.047 IS - 26 M3 - Review N1 - Cited By :259 Export Date: 18 November 2020 PY - 2005 SP - 6306-6315 ST - Molecular genetics of acute lymphoblastic leukemia T2 - Journal of Clinical Oncology TI - Molecular genetics of acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-27244440324&doi=10.1200%2fJCO.2005.05.047&partnerID=40&md5=438ebc99b37ca6d69be193a6e8730863 VL - 23 ID - 4712 ER - TY - JOUR AD - Department of Internal Medicine and Medical Oncology, West German Cancer Center, University Medical School of Essen, Essen; Department of Hematology and Medical Oncology, University of Bochum, Herne; Bayer Healthcare, Pharma Research Center, Wuppertal, Germany; Bayer Pharmaceuticals Corporation, West Haven, CT; and Jules Bordet Institute, Brussels, Belgium AU - Strumberg, D. AU - Richly, H. AU - Hilger, R. A. AU - Schleucher, N. AU - Korfee, S. AU - Tewes, M. AU - Faghih, M. AU - Brendel, E. AU - Voliotis, D. AU - Haase, C. G. AU - Schwartz, B. AU - Awada, A. AU - Voigtmann, R. AU - Scheulen, M. E. AU - Seeber, S. DB - Scopus DO - 10.1200/JCO.2005.06.124 IS - 5 M3 - Article N1 - Cited By :751 Export Date: 18 November 2020 PY - 2005 SP - 965-972 ST - Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors T2 - Journal of Clinical Oncology TI - Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-20044382799&doi=10.1200%2fJCO.2005.06.124&partnerID=40&md5=b4a31f14eb97ed8f5473f87da33caf26 VL - 23 ID - 4715 ER - TY - JOUR AD - AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom Queen Elizabeth University Hospital, Birmingham, United Kingdom Christie Hospital, Manchester, United Kingdom University of Berne, Berne, Switzerland Clinical Pharmacology Unit, Aster, Paris, France AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom AU - Swaisland, H. C. AU - Smith, R. P. AU - Laight, A. AU - Kerr, D. J. AU - Ranson, M. AU - Wilder-Smith, C. H. AU - Duvauchelle, T. DB - Scopus DO - 10.2165/00003088-200544110-00004 IS - 11 M3 - Article N1 - Cited By :111 Export Date: 18 November 2020 PY - 2005 SP - 1165-1177 ST - Single-dose clinical pharmacokinetic studies of gefitinib T2 - Clinical Pharmacokinetics TI - Single-dose clinical pharmacokinetic studies of gefitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-26944478585&doi=10.2165%2f00003088-200544110-00004&partnerID=40&md5=4a745dd5f3da4d970467f0428555bd00 VL - 44 ID - 4719 ER - TY - JOUR AD - AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom Department of Medical Oncology, Cancer Research Campaign, Christie Hospital NHS Trust, Manchester, United Kingdom AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom AU - Swaisland, H. C. AU - Ranson, M. AU - Smith, R. P. AU - Leadbetter, J. AU - Laight, A. AU - McKillop, D. AU - Wild, M. J. DB - Scopus DO - 10.2165/00003088-200544100-00005 IS - 10 M3 - Article N1 - Cited By :115 Export Date: 18 November 2020 PY - 2005 SP - 1067-1081 ST - Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol T2 - Clinical Pharmacokinetics TI - Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-25144436285&doi=10.2165%2f00003088-200544100-00005&partnerID=40&md5=56535905a413c8e55767e421d842718d VL - 44 ID - 4720 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, VU University Medical Center, De Boelelaan 1117, NL-1080 HV Amsterdam, Netherlands Department of Pediatrics, Division of Oncology-Hematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands AU - ter Bals, E. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1586/14737140.5.5.917 IS - 5 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2005 SP - 917-929 ST - Treatment of childhood acute myeloid leukemia T2 - Expert Review of Anticancer Therapy TI - Treatment of childhood acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744598066&doi=10.1586%2f14737140.5.5.917&partnerID=40&md5=c7bae89f438dd895cebdc15ba9b0ef08 VL - 5 ID - 4721 ER - TY - JOUR AD - Department of Pathology, National Defence Medical Centre, Taipei, Taiwan Graduate Institution of Pathology, National Defence Medical Centre, Taipei, Taiwan Department of Haematology/Oncology, Tri-Service General Hospital, National Defence Medical Centre, No. 325 Sec 2, Cheng-Kung Road, Taipei 114, Taiwan Institution of Preventive Medicine, National Defence Medical Centre, Taipei, Taiwan Department and Graduate Institute of Pathology, Tri-Service General Hospital, No. 325 Sec 2, Cheng-Kung Road, Taipei 114, Taiwan AU - Sheu, L. F. AU - Lee, W. C. AU - Lee, H. S. AU - Kao, W. Y. AU - Chen, A. DB - Scopus DO - 10.1002/path.1822 IS - 2 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2005 SP - 216-223 ST - Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium T2 - Journal of Pathology TI - Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-26044434885&doi=10.1002%2fpath.1822&partnerID=40&md5=187f35e23b712fad461e61fc643d531b VL - 207 ID - 4722 ER - TY - JOUR AD - Department of Medical Oncology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey Department of Panthology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey AU - Kara, I. O. AU - Gonlusen, G. AU - Sahin, B. AU - Ergin, M. AU - Erdogan, S. DB - Scopus IS - 8 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2005 SP - 1190-1196 ST - A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma T2 - Saudi Medical Journal TI - A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-24744460561&partnerID=40&md5=2b191cfcf3c07c4bd99a3d0775ffcb1d VL - 26 ID - 4723 ER - TY - JOUR AD - Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States Clinical Pharmacology and Therapeutics, ARC 916, 3615 Civic Center Blvd., Philadelphia, PA 19104, United States AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1097/00130404-200507000-00008 IS - 4 M3 - Review N1 - Cited By :18 Export Date: 18 November 2020 PY - 2005 SP - 324-330 ST - New approaches to drug development in pediatric oncology T2 - Cancer Journal TI - New approaches to drug development in pediatric oncology UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-32944471321&doi=10.1097%2f00130404-200507000-00008&partnerID=40&md5=42f31a5f2f82107ca741b915f20437f3 VL - 11 ID - 4724 ER - TY - JOUR AD - Department of Medicine, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Division of Endocrinology, MRB 8.138, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1060, United States AU - Choudhary, S. AU - Boldogh, S. AU - Garofalo, R. AU - Jamaluddin, M. AU - Brasier, A. R. DB - Scopus DO - 10.1128/JVI.79.14.8948-8959.2005 IS - 14 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2005 SP - 8948-8959 ST - Respiratory syncytial virus influences NF-κB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-κB2 T2 - Journal of Virology TI - Respiratory syncytial virus influences NF-κB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-κB2 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21644463312&doi=10.1128%2fJVI.79.14.8948-8959.2005&partnerID=40&md5=6d43d9c125911e58f442033be5809425 VL - 79 ID - 4725 ER - TY - JOUR AD - Dana-Farber Cancer Institute; Brigham and Women's Hospital; Beth Israel Deaconess Medical Center, Boston, MA; Oregon Health Sciences University Cancer Institute & Portland VA Medical Center, Portland, OR; and Stanford University Medical Center, Stanford, CA AU - Li, F. P. AU - Fletcher, J. A. AU - Heinrich, M. C. AU - Garber, J. E. AU - Sallan, S. E. AU - Curiel-Lewandrowski, C. AU - Duensing, A. AU - Van De Rijn, M. AU - Schnipper, L. E. AU - Demetri, G. D. DB - Scopus DO - 10.1200/JCO.2005.06.009 IS - 12 M3 - Article N1 - Cited By :123 Export Date: 18 November 2020 PY - 2005 SP - 2735-2743 ST - Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred T2 - Journal of Clinical Oncology TI - Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21044439344&doi=10.1200%2fJCO.2005.06.009&partnerID=40&md5=0236d7fb3e64afaa156a92a53014936a VL - 23 ID - 4728 ER - TY - JOUR AD - BCLC Group, Liver Unit, University of Barcelona, Catalonia, Spain Division of Liver Diseases, RM Transplantation Institute, Mount Sinai School of Medicine, Madison Ave. 1425, New York, NY 10029, United States AU - Llovet, J. M. DB - Scopus DO - 10.1007/s00535-005-1566-3 IS - 3 M3 - Review N1 - Cited By :425 Export Date: 18 November 2020 PY - 2005 SP - 225-235 ST - Updated treatment approach to hepatocellular carcinoma T2 - Journal of Gastroenterology TI - Updated treatment approach to hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-18144411666&doi=10.1007%2fs00535-005-1566-3&partnerID=40&md5=86210985c670d04478a3947ed934e1b2 VL - 40 ID - 4729 ER - TY - JOUR AD - Department of Pathology, University of Michigan Health System, Ann Arbor, MI, United States Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, United States Department of Orthopedic Surgery, University of Michigan Health Syste, Ann Arbor, MI, United States Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgical Oncology, Univ. TX M. D. Anderson Cancer Ctr., Houston, TX, United States Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, United States Department of Pathology, M2242 Medical Science Building I, University of Michigan Cancer Center, 1301 Catherine Street, Ann Arbor, MI 48109-0602, United States AU - Thomas, D. G. AU - Giordano, T. J. AU - Sanders, D. AU - Biermann, S. AU - Sondak, V. K. AU - Trent, J. C. AU - Yu, D. AU - Pollock, R. E. AU - Baker, L. DB - Scopus DO - 10.1002/cncr.20847 IS - 4 M3 - Article N1 - Cited By :73 Export Date: 18 November 2020 PY - 2005 SP - 830-838 ST - Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/ neu in synovial sarcoma T2 - Cancer TI - Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/ neu in synovial sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-13444291031&doi=10.1002%2fcncr.20847&partnerID=40&md5=700ce782e15ba387e7b6a9d53fcd3a49 VL - 103 ID - 4732 ER - TY - JOUR AD - Department of Pathology, Haartman Inst. Helsinki Univ. C., P.O. Box 21, FIN-00014 Univ. H., Finland Department of Medical Genetics, Haartman Inst. Helsinki Univ. C., Univ. of Helsinki, Helsinki, Finland, Finland Dept. Oral and Maxillofacial Surg., Institute of Dentistry, University of Turku, Turku, Finland, Finland Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland, Finland Department of Biosciences, Division of Biochemistry, Univ. of Helsinki, Helsinki, Finland, Finland AU - Leivo, I. AU - Jee, K. J. AU - Heikinheimo, K. AU - Laine, M. AU - Ollila, J. AU - Nagy, B. AU - Knuutila, S. DB - Scopus DO - 10.1016/j.cancergencyto.2004.04.016 IS - 2 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2005 SP - 104-113 ST - Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation T2 - Cancer Genetics and Cytogenetics TI - Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-11844282189&doi=10.1016%2fj.cancergencyto.2004.04.016&partnerID=40&md5=7a719510a814fc0bde61a76921bba248 VL - 156 ID - 4734 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Niemeyer, C. M. AU - Kratz, C. P. AU - Hasle, H. DB - Scopus DO - 10.1007/s11864-005-0004-3 IS - 3 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2005 SP - 209-214 ST - Pediatric myelodysplastic syndromes T2 - Current Treatment Options in Oncology TI - Pediatric myelodysplastic syndromes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21744441996&doi=10.1007%2fs11864-005-0004-3&partnerID=40&md5=15224ad7e6f628114f9fbdd8f539b30b VL - 6 ID - 4735 ER - TY - JOUR AD - Haematological Oncology and Marrow Transplantation Clinic, Medical University of Lublin, Lublin, Poland Haematological Oncology and Marrow Transplantation Clinic, Staszica 11 str., 20-081 Lublin, Poland AU - Cioch, M. B. AU - Dmoszyńska, A. DB - Scopus DO - 10.1016/s1507-1367(05)71117-2 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2005 SP - 103-106 ST - Imatinib therapy of Ph positive acute lymphoblastic leukaemia - 2 Case reports T2 - Reports of Practical Oncology and Radiotherapy TI - Imatinib therapy of Ph positive acute lymphoblastic leukaemia - 2 Case reports UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21344471720&doi=10.1016%2fs1507-1367%2805%2971117-2&partnerID=40&md5=cc4872e3fe33bc2e5457eb171ca53a79 VL - 10 ID - 4736 ER - TY - JOUR AU - D'Antonio, J. DB - Scopus DO - 10.1188/05.CJON.535-538 IS - 5 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2005 SP - 535-538 ST - Chronic myelogenous leukemia T2 - Clinical journal of oncology nursing TI - Chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644651466&doi=10.1188%2f05.CJON.535-538&partnerID=40&md5=8428d07b446c9eee8e6050056269a7ef VL - 9 ID - 4737 ER - TY - JOUR AD - Department of Dermatology, St. Mary's Hospital, Catholic University of Korea, 62 Youido-dong, Seoul 150-713, South Korea Department of Clinical Pathology, St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea Korean Res. Inst. Biosci. Biotech., Taejon, South Korea Department of Life Science, Sookmyung Women's University, Chungpa-Dong 2-Ka, Yongsan-Ku, Seoul 140-742, South Korea AU - Park, H. J. AU - Kim, H. S. AU - Kim, H. J. AU - Lee, J. Y. AU - Cho, B. K. AU - Lee, A. W. AU - Yoon, D. Y. AU - Cho, D. H. DB - Scopus DO - 10.1016/j.jdermsci.2004.12.002 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2005 SP - 9-15 ST - Immunohistochemical characterization of cutaneous drug eruptions by STI571 T2 - Journal of Dermatological Science TI - Immunohistochemical characterization of cutaneous drug eruptions by STI571 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-15744390352&doi=10.1016%2fj.jdermsci.2004.12.002&partnerID=40&md5=9df274e217d26a2cdce54200cb2c6177 VL - 38 ID - 4738 ER - TY - JOUR AD - Div. of Pediat. Hematology Oncology, Minneapolis, MN, United States Division of Pathology, Minneapolis, MN, United States Children's Hospitals and Clinics, Pediatric ENT Associates, Minneapolis, MN, United States Div. of Pediatric Infectious Disease, Park-Nicollet Clinic, Minneapolis, MN, United States 2525 Chicago Ave S, Minneapolis, MN 55455, United States AU - Bostrom, B. AU - Sidman, J. AU - Marker, S. AU - Lander, T. AU - Drehner, D. DB - Scopus DO - 10.1001/archotol.131.1.64 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2005 SP - 64-67 ST - Gefitinib therapy for life-threatening laryngeal papillomatosis T2 - Archives of Otolaryngology - Head and Neck Surgery TI - Gefitinib therapy for life-threatening laryngeal papillomatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-12144269582&doi=10.1001%2farchotol.131.1.64&partnerID=40&md5=8d2da1e540be311705a3191db76d03ac VL - 131 ID - 4739 ER - TY - SER AB - Gastrointestinal stromal tumor (GIST) is defined as a specific, KIT-positive and KIT-signaling driven mesenchymal tumor of the gastrointestinal (GI) tract. This rumor reflects the phenotypic features of the interstitial cells of Cajal, KIT-positive mesenchymal cells dispersed in the gut wall. The specific identification of GIST now allows for application of KIT-selective tyrosine kinase inhibitors such as Imatinib mesylate (formerly STI571, Gleevec/Glivec® (Novartis Pharma) in the treatment of unresectable and metastatic examples. GIST is most the common mesenchymal neoplasm of the GI tract comprising most tumors earlier classified as gastrointestinal smooth muscle tumors and GI autonomic nerve tumors. GISTs typically present in adults over 40 years (median age around 60 years) and very rarely in children. They can occur anywhere in the GI-tract from the lower esophagus to the anus, most commonly in the stomach (60-70%) and small intestine (25-35%). Colon, rectum, appendix (together 5%) and esophagus (2-3%) are rare sites. GISTs can be primary in the omentum, mesentery or retroperitoneum, but most GISTs in these sites are metastases from a gastric or intestinal primary. Histologically GISTs vary from cellular spindle cell tumors to epithelioid and pleomorphic ones, and morphology varies somewhat by site. By definition, GISTs are KIT (CD117)-positive. Positivity for nestin (90-100%) and CD34 (70-80%) are also characteristic but less specific features. Smooth muscle actins (20-30%) and heavy caldesmon (80%) are often expressed, whereas desmin is usually absent. A minority of small intestinal GISTs (10-20%) are S 100-protein positive. Predictive of malignancy are mitotic rate over 5 per 50 HPF or size over 5 cm. However, mitotically inactive intestinal tumors can metastasize, although gastric tumors are in average less often malignant than the intestinal ones with low mitotic rates. Smooth muscle tumors, schwannoma, undifferentiated sarcomas, mesenteric desmoid, solitary fibrous tumor and metastatic melanoma can be separated from GISTs by histologic and immunohistochemical analysis. Recent identification of PDGFRA expression and mutations in some histologically GIST-like tumors necessitate expansion of the GIST definition to these tumors as well. AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 14th Street and Alaska Avenue, N.W., Washington, DC 20306-6000, United States AU - Miettinen, M. DB - Scopus M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2004 SP - 3-28 ST - Gastrointestinal stromal tumors (GISTS): Definition, pathology, occurrence, and differential diagnosis T2 - Gann Monographs on Cancer Research TI - Gastrointestinal stromal tumors (GISTS): Definition, pathology, occurrence, and differential diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-23844458217&partnerID=40&md5=8eaafc1a56d85b6f4f155b95da573595 VL - 53 ID - 4741 ER - TY - JOUR AD - Second Department of Medicine, Bogenhausen Acad. Teaching Hospital, Munich, Germany Department of Pathology, Bogenhausen Acad. Teaching Hospital, Munich, Germany Department of Pathology, Heinrich-Heine-University, Düsseldorf, Germany Department of Pathology, Technical University of Munich, Munich, Germany Third Department of Medicine, Technical University of Munich, Munich, Germany Department of Surgery, Technical University of Munich, Munich, Germany Second Department of Medicine, Bogenhausen Acad. Teaching Hospital, Englschalkinger Strasse 77, 81925 Munich, Germany AU - Czekalla, R. AU - Fuchs, M. AU - Stölzle, A. AU - Nerlich, A. AU - Poremba, C. AU - Schaefer, K. L. AU - Weirich, G. AU - Höfler, H. AU - Schneller, F. AU - Peschel, C. AU - Siewert, J. R. AU - Schepp, W. DB - Scopus DO - 10.1097/00042737-200412000-00026 IS - 12 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2004 SP - 1391-1400 ST - Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: A case report T2 - European Journal of Gastroenterology and Hepatology TI - Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-10344225694&doi=10.1097%2f00042737-200412000-00026&partnerID=40&md5=10512ec9bf324aaa52d0d44f640aa60c VL - 16 ID - 4742 ER - TY - JOUR AD - Roche Pharmaceuticals, 3431 Hillview Avenue, Palo Alto, CA 94304, USA, United States AU - Srinivasan, D. AU - Kosaka, A. H. AU - Daniels, D. V. AU - Ford, A. P. D. W. AU - Bhattacharya, A. DB - Scopus DO - 10.1016/j.ejphar.2004.10.004 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2004 SP - 155-167 ST - Pharmacological and functional characterization of bradykinin B 2 receptor in human prostate T2 - European Journal of Pharmacology TI - Pharmacological and functional characterization of bradykinin B 2 receptor in human prostate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8444231324&doi=10.1016%2fj.ejphar.2004.10.004&partnerID=40&md5=0567206e9f1427d3adb1655bc89afe6d VL - 504 ID - 4744 ER - TY - JOUR AD - Dept. of Paediatr. Haematol./Oncol., VU University Medical Center, Amsterdam, Netherlands Dept. of Paediatr. Haematol./Oncol., VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, Netherlands AU - Zwaan, Ch M. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1111/j.1365-2141.2004.05167.x IS - 3 M3 - Review N1 - Cited By :23 Export Date: 18 November 2020 PY - 2004 SP - 264-279 ST - Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia T2 - British Journal of Haematology TI - Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8344272920&doi=10.1111%2fj.1365-2141.2004.05167.x&partnerID=40&md5=6c9fee7904121031393a378dc6babe96 VL - 127 ID - 4745 ER - TY - JOUR AD - U488 Inserm, 80 rue du Gi Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France Neurology Unit, Dept. of Clin. Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, United Kingdom AU - Zrouri, H. AU - Le Goascogne, C. AU - Li, W. W. AU - Pierre, M. AU - Courtin, F. DB - Scopus DO - 10.1111/j.1460-9568.2004.03641.x IS - 7 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2004 SP - 1811-1818 ST - The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve T2 - European Journal of Neuroscience TI - The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8144231119&doi=10.1111%2fj.1460-9568.2004.03641.x&partnerID=40&md5=8a62a64f5fc8eb7ac6e6540ee4f736fd VL - 20 ID - 4748 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto, Japan Department of Microbiology, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto, Japan Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan Department of Pediatrics, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kamigyo-ku, Kyoto 602-8566, Japan AU - Kuwahara, Y. AU - Hosoi, H. AU - Osone, S. AU - Kita, M. AU - Iehara, T. AU - Kuroda, H. AU - Sugimoto, T. DB - Scopus DO - 10.1158/1078-0432.CCR-04-0192 IS - 17 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2004 SP - 5940-5948 ST - Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo T2 - Clinical Cancer Research TI - Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444322871&doi=10.1158%2f1078-0432.CCR-04-0192&partnerID=40&md5=e22bf5583de997e5e7e305eb6f852ade VL - 10 ID - 4749 ER - TY - JOUR AD - Department of Neurosurgery, Osaka University Medical School, Suita, Japan Department of Neurosurgery, Spine and Spinal Cord Center, Yukioka Hospital, Osaka, Japan Department of Neurosurgery, Kobe Univ. Grad. School of Medicine, Kobe, Japan Department of Neurosurgery, Spine and Spinal Cord Center, Yukioka Hospital, 2-2-3 Ukita, Kita-ku Osaka City, Osaka 530-0021, Japan AU - Akiyama, C. AU - Yuguchi, T. AU - Nishio, M. AU - Tomishima, T. AU - Fujinaka, T. AU - Taniguchi, M. AU - Nakajima, Y. AU - Kohmura, E. AU - Yoshimine, T. DB - Scopus DO - 10.1089/0897715041526230 IS - 7 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2004 SP - 923-931 ST - Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats T2 - Journal of Neurotrauma TI - Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-3242892545&doi=10.1089%2f0897715041526230&partnerID=40&md5=f1de46279999ea7c3ecef624c7ad0a3b VL - 21 ID - 4751 ER - TY - JOUR AD - Department of Immunology, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States Department of Biochemistry, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States Department of Hematology, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States AU - Cetkovic-Cvrlje, M. AU - Tibbles, H. E. DB - Scopus DO - 10.2174/1381612043384529 IS - 15 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2004 SP - 1767-1784 ST - Therapeutic potential of Janus kinase 3 (JAK3) inhibitors T2 - Current Pharmaceutical Design TI - Therapeutic potential of Janus kinase 3 (JAK3) inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442464602&doi=10.2174%2f1381612043384529&partnerID=40&md5=d93b5bc5e9727a6db42ebb4b0fe0df5a VL - 10 ID - 4752 ER - TY - JOUR AD - Department of Oncology, S.K. Compreh. Cancer Ctr. J. Hopkins, CRB, 1650 Orleans St, Baltimore, MD 21231, United States AU - Smith, B. D. AU - Levis, M. AU - Beran, M. AU - Giles, F. AU - Kantarjian, H. AU - Berg, K. AU - Murphy, K. M. AU - Dauses, T. AU - Allebach, J. AU - Small, D. DB - Scopus DO - 10.1182/blood-2003-11-3775 IS - 10 M3 - Article N1 - Cited By :500 Export Date: 18 November 2020 PY - 2004 SP - 3669-3676 ST - Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia T2 - Blood TI - Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842420032&doi=10.1182%2fblood-2003-11-3775&partnerID=40&md5=4c124567a2eda30bbc00d8d11224ffa8 VL - 103 ID - 4754 ER - TY - JOUR AD - Department of Obstetrics, Division of Gynecology Oncology, Toronto, Ont., Canada Department of Medical Oncology, Toronto, Ont., Canada Department of Pathology, University of Toronto, Princess Margaret Hospital, Toronto, Ont., Canada Division of Gynecology Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, Ont. M5G 2M9, Canada AU - Steed, H. AU - Oza, A. AU - Chapman, W. B. AU - Yaron, M. AU - De Petrillo, D. DB - Scopus DO - 10.1111/j.1048-891x.2004.014319.x IS - 3 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2004 SP - 546-550 ST - Female adnexal tumor of probable wolffian origin: A clinicopathological case report and a possible new treatment T2 - International Journal of Gynecological Cancer TI - Female adnexal tumor of probable wolffian origin: A clinicopathological case report and a possible new treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942566195&doi=10.1111%2fj.1048-891x.2004.014319.x&partnerID=40&md5=e7a0fed64daec4083914f437207909a2 VL - 14 ID - 4755 ER - TY - JOUR AD - Department of Medical Sciences, Indiana Univ. School of Medicine, Jordan Hall 105, Bloomington, IN 47405-4401, United States Department of Dermatology, Indiana Univ. School of Medicine, Indianapolis, IN 46202, United States The Ohio State University, Department of Veterinary Biosciences, Columbus, OH 43210, United States Dept. of Biochemistry/Molec. Biology, Indianapolis School of Medicine, Indianapolis, IN 46202, United States Dept. of Pathology/Laboratory Med., Indianapolis School of Medicine, Indianapolis, IN 46202, United States AU - Cho, Y. M. AU - Lewis, D. A. AU - Koltz, P. F. AU - Richard, V. AU - Gocken, T. A. AU - Rosol, T. J. AU - Konger, R. L. AU - Spandau, D. F. AU - Foley, J. DB - Scopus DO - 10.1677/joe.0.1810179 IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2004 SP - 179-190 ST - Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes T2 - Journal of Endocrinology TI - Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342647462&doi=10.1677%2fjoe.0.1810179&partnerID=40&md5=b0e587b55cac9afd2d93044e4b29b2bf VL - 181 ID - 4756 ER - TY - JOUR AD - Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, United States AU - Barata, J. T. AU - Boussiotis, V. A. AU - Yunes, J. A. AU - Ferrando, A. A. AU - Moreau, L. A. AU - Veiga, J. P. AU - Sallan, S. E. AU - Look, A. T. AU - Nadler, L. M. AU - Cardoso, A. A. DB - Scopus DO - 10.1182/blood-2002-12-3861 IS - 5 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2004 SP - 1891-1900 ST - IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL T2 - Blood TI - IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744230130&doi=10.1182%2fblood-2002-12-3861&partnerID=40&md5=c4f9de6bd0c9a643d85776de3aee4c0e VL - 103 ID - 4757 ER - TY - JOUR AD - Dept. of Hematology and Oncology, University Medical Center II, Otfried-Müller-Str 10, 72076 Tübingen, Germany AU - Bartolovic, K. AU - Balabanov, S. AU - Hartmann, U. AU - Komor, M. AU - Boehmler, A. M. AU - Bühring, H. J. AU - Möhle, R. AU - Hoelzer, D. AU - Kanz, L. AU - Hofmann, W. K. AU - Brümmendorf, T. H. DB - Scopus DO - 10.1182/blood-2003-05-1535 IS - 2 M3 - Article N1 - Cited By :91 Export Date: 18 November 2020 PY - 2004 SP - 523-529 ST - Inhibitory effect of imatinib on normal progenitor cells in vitro T2 - Blood TI - Inhibitory effect of imatinib on normal progenitor cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-9144233483&doi=10.1182%2fblood-2003-05-1535&partnerID=40&md5=663e0b6103250cf71e46bc6b94b71810 VL - 103 ID - 4758 ER - TY - JOUR AD - Diabetes Center, Tokyo Women's Medical University, School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Dept. Biochem. Molec. Vasc. Biol., Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan Department of Biochemistry, Faculty of Pharmaceutical Science, Hokuriku University, Kanazawa, Japan Department of Stem Cell Biology, Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan Div. of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka-ken, Japan Diabetes Center, Eastern Japan Medical Institute, Kanagawa, Japan AU - Miura, J. AU - Uchigata, Y. AU - Yamamoto, Y. AU - Takeuchi, M. AU - Sakurai, S. AU - Watanabe, T. AU - Yonekura, H. AU - Yamagishi, S. I. AU - Makita, Z. AU - Omori, A. AU - Omori, Y. AU - Yamamoto, H. AU - Iwamoto, Y. DB - Scopus DO - 10.1016/S1056-8727(02)00281-7 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2004 SP - 53-59 ST - AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes T2 - Journal of Diabetes and its Complications TI - AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-12144291515&doi=10.1016%2fS1056-8727%2802%2900281-7&partnerID=40&md5=a22226b0a49359bea5e4925e91b47f0f VL - 18 ID - 4759 ER - TY - JOUR AD - Consultancy and Regulatory Services, Covance Laboratories Ltd., Harrogate, United Kingdom AU - Baldrick, P. DB - Scopus DO - 10.1016/j.yrtph.2004.03.004 IS - 3 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2004 SP - 381-389 ST - Developing drugs for pediatric use: A role for juvenile animal studies? T2 - Regulatory Toxicology and Pharmacology TI - Developing drugs for pediatric use: A role for juvenile animal studies? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342523349&doi=10.1016%2fj.yrtph.2004.03.004&partnerID=40&md5=c798344d77eec3e285360ea43e28218b VL - 39 ID - 4760 ER - TY - JOUR AD - Dept. of Pediat. Hematology/Oncology, Golisano Children's Hosp. at Strong, Univ. of Rochester Medial Center, 601 Elmwood Avenue, Rochester, NY 14642, United States Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury SP2 8BJ, United Kingdom Dana Farber Cancer Institute, Boston, MA 02115, United States AU - Wittman, B. AU - Horan, J. AU - Baxter, J. AU - Goldberg, J. AU - Felgar, R. AU - Baylor, E. AU - Cromwell, B. AU - Cross, N. AU - Bennett, J. M. DB - Scopus DO - 10.1016/j.leukres.2003.10.011 IS - SUPPL. 1 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2004 SP - 65-69 ST - A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate T2 - Leukemia Research TI - A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1342279448&doi=10.1016%2fj.leukres.2003.10.011&partnerID=40&md5=b6ec359f906857f4647393db537f331a VL - 28 ID - 4761 ER - TY - JOUR AD - Washington Univ. School of Medicine, St. Louis Children's Hospital, St. Louis, MO, United States St. Louis Children's Hospital, Hale Irwin Ctr. for Hematol./Oncol., Washington Univ. School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, United States AU - Grossman, W. J. AU - Wilson, D. B. DB - Scopus DO - 10.1097/00043426-200403000-00016 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2004 SP - 214 ST - Hypopigmentation from Imatinib Mesylate (Gleevec) T2 - Journal of Pediatric Hematology/Oncology TI - Hypopigmentation from Imatinib Mesylate (Gleevec) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542316943&doi=10.1097%2f00043426-200403000-00016&partnerID=40&md5=03f27d837eed44fef40b2772e0980d64 VL - 26 ID - 4763 ER - TY - JOUR DB - Scopus IS - 68 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2003 SP - 216-218 ST - Imatinib. Chronic myeloid leukaemia, first-line option: Favourable findings to be confirmed T2 - Prescrire International TI - Imatinib. Chronic myeloid leukaemia, first-line option: Favourable findings to be confirmed UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344877302&partnerID=40&md5=27620f47b4f53afb4e72232686076fbb VL - 12 ID - 4764 ER - TY - JOUR AD - Bambino Gesu Children's Hospital, Laboratory of Oncology, Rome, Italy ENEA Research Center Casaccia, Sect. of Toxicol./Biomed. Sciences, Rome, Italy Biotechnology Institute, CNR, Rome, Italy RLC NHS Trust Alder Hey, Liverpool, United Kingdom Bambino Gesu Children's Hospital, Division of Oncology, Rome, Italy La Sapienza University, Department of Pediatrics, Rome, Italy Regina Elena Natl. Cancer Institute, Laboratory of Immunology, Rome, Italy Department of Pediatrics, Viale Regina Elena 324, I-00161 Rome, Italy AU - Vitali, R. AU - Cesi, V. AU - Nicotra, M. R. AU - McDowell, H. P. AU - Donfrancesco, A. AU - Mannarino, O. AU - Natali, P. G. AU - Raschellà, G. AU - Dominici, C. DB - Scopus DO - 10.1002/ijc.11187 IS - 2 M3 - Article N1 - Cited By :71 Export Date: 18 November 2020 PY - 2003 SP - 147-152 ST - c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 T2 - International Journal of Cancer TI - c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037479907&doi=10.1002%2fijc.11187&partnerID=40&md5=7f9d9e07f2f706fa013ef11fbf0d10e4 VL - 106 ID - 4767 ER - TY - JOUR AD - Division of Oncology Drug Products, Ctr. for Drug Eval. and Research, U.S. Food and Drug Administration, Rockville, MD, United States U.S. Food and Drug Administration, HFD-150, 5600 Fishers Lane, Rockville, MD 20857, United States AU - Cohen, M. H. AU - Williams, G. A. AU - Sridhara, R. AU - Chen, G. AU - Pazdur, R. DB - Scopus DO - 10.1634/theoncologist.8-4-303 IS - 4 M3 - Review N1 - Cited By :427 Export Date: 18 November 2020 PY - 2003 SP - 303-306 ST - FDA drug approval summary: Gefitinib (ZD1839) (Iressa®) tablets T2 - Oncologist TI - FDA drug approval summary: Gefitinib (ZD1839) (Iressa®) tablets UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0043210670&doi=10.1634%2ftheoncologist.8-4-303&partnerID=40&md5=900e9a18ee677d68c62bf45cb443492b VL - 8 ID - 4768 ER - TY - JOUR AD - Department of Surgery, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Pathology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Radiology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Oncology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-417 45 Göteborg, Sweden AU - Bümming, P. AU - Andersson, J. AU - Meis-Kindblom, J. M. AU - Klingenstierna, H. AU - Engström, K. AU - Stierner, U. AU - Wängberg, B. AU - Jansson, S. AU - Ahlman, H. AU - Kindblom, L. G. AU - Nilsson, B. DB - Scopus DO - 10.1038/sj.bjc.6600965 IS - 3 M3 - Article N1 - Cited By :132 Export Date: 18 November 2020 PY - 2003 SP - 460-464 ST - Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients T2 - British Journal of Cancer TI - Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042978501&doi=10.1038%2fsj.bjc.6600965&partnerID=40&md5=4b9a9b8da913aea595776fa8192cc391 VL - 89 ID - 4769 ER - TY - JOUR AD - Howard Hughes Medical Institute, Dept. of Biol./Ctr. for Cancer Res., Massachusetts Inst. of Technology, Cambridge, MA, United States Department of Pathology, Children's Hospital, Boston, MA, United States Department of Radiology, Children's Hosp./Harvard Med. Sch., Boston, MA, United States Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Department of Neurology, Children's Hospital, Harvard Medical School, Boston, MA, United States Department of Pediatrics, Division of Hematology-Oncology, Univ. of TX Southwestern Med. Ctr., Dallas, TX 75019-9063, United States AU - McLaughlin, M. E. AU - Robson, C. D. AU - Kieran, M. W. AU - Jacks, T. AU - Pomeroy, S. L. AU - Cameron, S. DB - Scopus DO - 10.1097/00043426-200308000-00012 IS - 8 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2003 SP - 644-648 ST - Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation T2 - Journal of Pediatric Hematology/Oncology TI - Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042570478&doi=10.1097%2f00043426-200308000-00012&partnerID=40&md5=32769c068441cd8967ebead8369351a4 VL - 25 ID - 4770 ER - TY - JOUR AD - University Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong Department of Pathology, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong AU - Au, W. Y. AU - Chan, E. C. AU - Lie, A. K. W. AU - Liang, R. AU - Leung, A. Y. H. AU - Ma, S. K. AU - Kwong, Y. L. DB - Scopus DO - 10.1007/s00277-003-0676-3 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2003 SP - 410-415 ST - Poor engraftment after allogeneic bone marrow transplantation: Role of chimerism analysis in treatment and outcome T2 - Annals of Hematology TI - Poor engraftment after allogeneic bone marrow transplantation: Role of chimerism analysis in treatment and outcome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042634274&doi=10.1007%2fs00277-003-0676-3&partnerID=40&md5=961d5df5334bbf7a7ddcf565bc250728 VL - 82 ID - 4772 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 14th Street and Alaska Avenue, N.W., Washington, DC 20306-6000, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus IS - 1 M3 - Review N1 - Cited By :251 Export Date: 18 November 2020 PY - 2003 SP - 3-24 ST - Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics T2 - Polish Journal of Pathology TI - Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037572285&partnerID=40&md5=ab89074a844f23e51ce757e1ef51873f VL - 54 ID - 4774 ER - TY - JOUR AD - Service de Pédiatrie, Ctr. Hosp. Universitaire de Nice, Nice, France Laboratoire de Genetique, Ctr. Hosp. Universitaire de Nice, Nice, France Laboratoire de Genetique, Hôpital de l'Archet, BP 3079, 06202 Nice Cedex 3, France AU - Sirvent, N. AU - Maire, G. AU - Pedeutour, F. DB - Scopus DO - 10.1002/gcc.10202 IS - 1 M3 - Review N1 - Cited By :191 Export Date: 18 November 2020 PY - 2003 SP - 1-19 ST - Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment T2 - Genes Chromosomes and Cancer TI - Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037402488&doi=10.1002%2fgcc.10202&partnerID=40&md5=e77550a132c5a9f75a10d7451fe36b36 VL - 37 ID - 4775 ER - TY - JOUR AD - Division of Medical Oncology, Department of Internal Medicine, University of Michigan Medical Center, Comprehensive Cancer Center, Ann Arbor, MI, United States Department of Orthopedic Surgery, University of Michigan Medical Center, Comprehensive Cancer Center, Ann Arbor, MI, United States Division of Hematology, University of Michigan, 7216 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0948, United States AU - Mace, J. AU - Sybil Biermann, J. AU - Sondak, V. AU - McGinn, C. AU - Hayes, C. AU - Thomas, D. AU - Baker, L. DB - Scopus DO - 10.1002/cncr.11029 IS - 11 M3 - Article N1 - Cited By :155 Export Date: 18 November 2020 PY - 2002 SP - 2373-2379 ST - Response of extraabdominal desmoid tumors to therapy with imatinib mesylate T2 - Cancer TI - Response of extraabdominal desmoid tumors to therapy with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036890418&doi=10.1002%2fcncr.11029&partnerID=40&md5=8695cf0eaa4ab0d14a5c6caf8b76f0a7 VL - 95 ID - 4778 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States MediCity Research Laboratories, Department of Medical Biochemistry and Molecular Biology, University of Turku, FIN-20520 Turku, Finland Turku Graduate School of Biomedical Sciences, University of Turku, FIN-20520 Turku, Finland Department of Pathology, Tampere University Hospital, FIN-33521 Tampere, Finland Northern Institute for Cancer Research, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, United Kingdom Department of Neuropathology, Newcastle General Hospital, Newcastle Upon Tyne NE4 6BE, United Kingdom AU - Gilbertson, R. J. AU - Bentley, L. AU - Hernan, R. AU - Junttila, T. T. AU - Frank, A. J. AU - Haapasalo, H. AU - Connelly, M. AU - Wetmore, C. AU - Curran, T. AU - Elenius, K. AU - Ellison, D. W. DB - Scopus IS - 10 M3 - Article N1 - Cited By :145 Export Date: 18 November 2020 PY - 2002 SP - 3054-3064 ST - ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease T2 - Clinical Cancer Research TI - ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036793917&partnerID=40&md5=ec651277cedf66f156aa1ea8ac45a67d VL - 8 ID - 4780 ER - TY - JOUR AD - Department of Ophthalmology, Seoul National University Hospital, 28 Yeongun-dong Chongro-ku, Seoul 110-744, South Korea AU - Lee, J. J. AU - Park, J. K. AU - Kim, Y. T. AU - Kwon, B. M. AU - Kang, S. G. AU - Yoo, Y. D. AU - Yu, Y. S. AU - Chung, H. DB - Scopus IS - 9 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2002 SP - 3117-3124 ST - Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model T2 - Investigative Ophthalmology and Visual Science TI - Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036707518&partnerID=40&md5=8bceda66e3feac243bd2d1eeb642761c VL - 43 ID - 4782 ER - TY - JOUR AD - Dana-Farber Cancer Institute, Harvard Cancer Center, Boston Fox Chase Cancer Center, Philadelphia Oregon Health and Science University, Portland Veterans Affairs Medical Center, Portland University of Turku, Turku, Finland Novartis Oncology, Basel, Switzerland University of Helsinki, Helsinki, Finland Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, SW 530, 44 Binney St., Boston, MA 02115, United States AU - Demetri, G. D. AU - Von Mehren, M. AU - Blanke, C. D. AU - Van Den Abbeele, A. D. AU - Eisenberg, B. AU - Roberts, P. J. AU - Heinrich, M. C. AU - Tuveson, D. A. AU - Singer, S. AU - Janicek, M. AU - Fletcher, J. A. AU - Silverman, S. G. AU - Silberman, S. L. AU - Capdeville, R. AU - Kiese, B. AU - Peng, B. AU - Dimitrijevic, S. AU - Druker, B. J. AU - Corless, C. AU - Fletcher, C. D. M. AU - Joensuu, H. DB - Scopus DO - 10.1056/NEJMoa020461 IS - 7 M3 - Article N1 - Cited By :3439 Export Date: 18 November 2020 PY - 2002 SP - 472-480 ST - Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors T2 - New England Journal of Medicine TI - Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037103424&doi=10.1056%2fNEJMoa020461&partnerID=40&md5=8ff0a99fd6795afafebc3fb378d9a9d0 VL - 347 ID - 4783 ER - TY - JOUR AD - Cytokine Receptor Laboratory, Department of Human Immunology, Hanson Centre for Cancer Research, IMVS, Adelaide, SA, Australia Department of Haematology, IMVS, Transplant Services Australian Redcross Blood Service, SA, Australia Department of Haematology, IMVS, P.O. Box 14 Rundle Mall, Adelaide, SA 5001, Australia AU - Ramshaw, H. AU - Lopez, A. AU - Bardy, P. DB - Scopus DO - 10.2174/1381612023396005 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2002 SP - 357-368 ST - The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders T2 - Current Pharmaceutical Design TI - The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036242410&doi=10.2174%2f1381612023396005&partnerID=40&md5=9d198b929c9814949b35b6c47bf90a6e VL - 8 ID - 4785 ER - TY - JOUR AD - South-American Office for Anticancer Drug Development (SOAD), Comprehensive Cancer Center, Lutheran University of Brazil, Canoas, RS, Brazil South-American Office for Anticancer Drug Development (SOAD), Comprehensive Cancer Center, Lutheran University of Brazil, Rua Miguel Tostes 101, 92420-280 Canoas, RS, Brazil AU - Da Rocha, A. B. AU - Mans, D. R. A. AU - Regner, A. AU - Schwartsmann, G. DB - Scopus DO - 10.1634/theoncologist.7-1-17 IS - 1 M3 - Review N1 - Cited By :129 Export Date: 18 November 2020 PY - 2002 SP - 17-33 ST - Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? T2 - Oncologist TI - Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036177115&doi=10.1634%2ftheoncologist.7-1-17&partnerID=40&md5=10b96fd23c0256e2dc85f2e0bb8cd5dd VL - 7 ID - 4786 ER - TY - JOUR AD - The Hebrew University of Jerusalem, Facul. Agri. Food/Envtl. Qlty. Sci., P.O. Box 12, Rehovot 76100, Israel AU - Stark, A. AU - Madar, Z. DB - Scopus DO - 10.1515/JPEM.2002.15.5.561 IS - 5 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2002 SP - 561-572 ST - Phytoestrogens: A review of recent findings T2 - Journal of Pediatric Endocrinology and Metabolism TI - Phytoestrogens: A review of recent findings UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036013248&doi=10.1515%2fJPEM.2002.15.5.561&partnerID=40&md5=daf0450e84ec08e7622898437893ddeb VL - 15 ID - 4787 ER - TY - JOUR AD - Peninsula Technol. Assessment Group, Exeter, United Kingdom Southampton Hlth. Technol. Assessm., Wessex Inst. for Hlth. Res./Devmt., Southampton, United Kingdom AU - Garside, R. AU - Round, A. AU - Dalziel, K. AU - Stein, K. AU - Royle, P. DB - Scopus DO - 10.3310/hta6330 IS - 33 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2002 ST - The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: A systematic review T2 - Health Technology Assessment TI - The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: A systematic review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045797522&doi=10.3310%2fhta6330&partnerID=40&md5=fb6ef6c6a28b53908b0b8453ee952226 VL - 6 ID - 4788 ER - TY - JOUR AD - Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong AU - Au, W. Y. AU - Lie, A. K. W. AU - Ma, S. K. AU - Wan, T. S. AU - Liang, R. AU - Chan, E. C. AU - Kwong, Y. L. DB - Scopus DO - 10.1038/sj.bmt.1703678 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2002 SP - 453-457 ST - Tyrosine kinase inhibitor sti571 in the treatment of philadelphia chromosome-positive leukemia failing myeloablative stem cell transplantation T2 - Bone Marrow Transplantation TI - Tyrosine kinase inhibitor sti571 in the treatment of philadelphia chromosome-positive leukemia failing myeloablative stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036775905&doi=10.1038%2fsj.bmt.1703678&partnerID=40&md5=4d5b4d659f677f99500eb278d08227e6 VL - 30 ID - 4789 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, USA. AU - Miettinen, M. AU - Majidi, M. AU - Lasota, J. DB - Scopus DO - 10.1016/s0959-8049(02)80602-5 M3 - Review N1 - Cited By :402 Export Date: 18 November 2020 PY - 2002 SP - S39-51 ST - Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review T2 - European journal of cancer (Oxford, England : 1990) TI - Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036769966&doi=10.1016%2fs0959-8049%2802%2980602-5&partnerID=40&md5=fa23d2cdd779168654a6a51adbfa25fe VL - 38 Suppl 5 ID - 4790 ER - TY - JOUR AD - Box 428, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Kantarjian, H. M. AU - O'Brien, S. AU - Cortes, J. E. AU - Smith, T. L. AU - Rios, M. B. AU - Shan, J. AU - Yang, Y. AU - Giles, F. J. AU - Thomas, D. A. AU - Faderl, S. AU - Garcia-Manero, G. AU - Jeha, S. AU - Wierda, W. AU - Issa, J. P. J. AU - Kornblau, S. M. AU - Keating, M. AU - Resta, D. AU - Capdeville, R. AU - Talpaz, M. DB - Scopus IS - 7 M3 - Article N1 - Cited By :98 Export Date: 18 November 2020 PY - 2002 SP - 2167-2176 ST - Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate T2 - Clinical Cancer Research TI - Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035992318&partnerID=40&md5=68571b6b8a7ff866151d1e7e3261a26a VL - 8 ID - 4791 ER - TY - JOUR AD - Dept. Haematology/Bone Marrow Trans., University College London Hospital, London, United Kingdom Dept. Haematology/Bone Marrow Trans., Medical Centre, Rambam, Haifa, Israel AU - Avivi, I. AU - Rowe, J. M. AU - Goldstone, A. H. DB - Scopus DO - 10.1053/beha.2003.0232 IS - 4 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2002 SP - 653-674 ST - Stem cell transplantation in adult ALL patients T2 - Best Practice and Research: Clinical Haematology TI - Stem cell transplantation in adult ALL patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036950005&doi=10.1053%2fbeha.2003.0232&partnerID=40&md5=59ff2ce0edf6cae8496ab0387ccf81a8 VL - 15 ID - 4792 ER - TY - JOUR AD - Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, University of Melbourne, Western Hospital, Footscray, VIC, Australia Department of Pathology, Peter MacCallum Institute, East Melbourne, VIC, Australia Laboratoire de Signalisation Cellulaire Normale et Tumorale, Faculté de Pharmacie, Montpellier, France AU - Tebbutt, N. C. AU - Giraud, A. S. AU - Inglese, M. AU - Jenkins, B. AU - Waring, P. AU - Clay, F. J. AU - Malki, S. AU - Alderman, B. M. AU - Grail, D. AU - Hollande, F. AU - Heath, J. K. AU - Ernst, M. DB - Scopus DO - 10.1038/nm763 IS - 10 M3 - Article N1 - Cited By :368 Export Date: 18 November 2020 PY - 2002 SP - 1089-1097 ST - Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice T2 - Nature Medicine TI - Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036796060&doi=10.1038%2fnm763&partnerID=40&md5=56560725b1b86619c872d226524f0909 VL - 8 ID - 4793 ER - TY - JOUR AD - Division of Hematology and Oncology, 1956 The Vanderbilt Clinic, 22nd Avenue, Nashville, TN 37232-5536, United States AU - Johnson, D. H. AU - Sandler, A. DB - Scopus IS - 1 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2001 SP - 133-164 ST - Treatment of metastatic non-small-cell lung cancer T2 - Chest Surgery Clinics of North America TI - Treatment of metastatic non-small-cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035099625&partnerID=40&md5=f626fe7c069ce2cd8327224d0d8975e5 VL - 11 ID - 4796 ER - TY - JOUR AD - St. Jude Children's Research Hospital, University of Tennessee, TN, United States College of Medicine, Memphis, TN, United States Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Children's Hospital, Harvard Medical School, Boston, MA, United States College of Pharmacy, Memphis, TN, United States Department of Pediatrics, University of Milan-Bicocca, Ospedale San Gerardo, Monza, Italy AU - Pui, C. H. AU - Sallan, S. AU - Relling, M. V. AU - Masera, G. AU - Evans, W. E. DB - Scopus DO - 10.1038/sj.leu.2402111 IS - 5 M3 - Review N1 - Cited By :36 Export Date: 18 November 2020 PY - 2001 SP - 707-715 ST - International childhood Acute Lymphoblastic Leukemia wokshop: Sausalito, CA, 30 November-1 December 2000 T2 - Leukemia TI - International childhood Acute Lymphoblastic Leukemia wokshop: Sausalito, CA, 30 November-1 December 2000 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035001835&doi=10.1038%2fsj.leu.2402111&partnerID=40&md5=1b645958abbb605c9838711dbed94ce2 VL - 15 ID - 4797 ER - TY - JOUR AD - Clinical Trial Service Unit, Epidemiological Studies Unit, Radcliffe Infirmary, Oxford, United Kingdom Royal Free and University College, School of Medicine, Royal Free Campus, London, United Kingdom University College Hospital, National Health Service Trust, London, United Kingdom AU - Durrant, I. J. AU - Richards, S. M. AU - Prentice, H. G. AU - Goldstone, A. H. DB - Scopus DO - 10.1016/S0889-8588(05)70189-1 IS - 6 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2000 SP - 1327-1352 ST - The medical research council trials in adult acute lymphocytic leukemia T2 - Hematology/Oncology Clinics of North America TI - The medical research council trials in adult acute lymphocytic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033637014&doi=10.1016%2fS0889-8588%2805%2970189-1&partnerID=40&md5=8fff60ef9197f7fa6d7cd3b6a3a832b9 VL - 14 ID - 4800 ER - TY - JOUR AD - Department of Pulmonary Diseases, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, Netherlands AU - Bracke, M. AU - Van de Graaf, E. AU - Lammers, J. W. J. AU - Coffer, P. J. AU - Koenderman, L. DB - Scopus IS - 5 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2000 SP - 655-661 ST - In vivo priming of FcαR functioning on eosinophils of allergic asthmatics T2 - Journal of Leukocyte Biology TI - In vivo priming of FcαR functioning on eosinophils of allergic asthmatics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033623481&partnerID=40&md5=dcd0e0ca67b1c1fdbe985710bf9648dc VL - 68 ID - 4801 ER - TY - JOUR AD - Parker Hughes Cancer Center, Hughes Institute, St. Paul, MN 55113, United States Biotherapy Program, Univ. of MN Academic Health Center, Minneapolis, MN 55455, United States Kenneth Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, United States Univ. of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States Cedar Sinai Medical Center, Los Angeles, CA 90048, United States University of Wisconsin, Milwaukee, WI 53226, United States Hughes Institute, 2665 Long Lake Road, St. Paul, MN 55113, United States AU - Uckun, F. M. AU - Messinger, Y. AU - Chen, C. L. AU - O'Neill, K. AU - Myers, D. E. AU - Goldman, F. AU - Hurvitz, C. AU - Casper, J. T. AU - Levine, A. DB - Scopus IS - 12 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 1999 SP - 3906-3913 ST - Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor T2 - Clinical Cancer Research TI - Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033387144&partnerID=40&md5=d57c0ce876c60a31fcdbe09b88ed25c7 VL - 5 ID - 4802 ER - TY - JOUR AD - Parker Hughes Cancer Center, Hughes Institute, 2665 Long Lake Road, St Paul Minnesota 55113, United States AU - Sudbeck, E. A. AU - Uckun, F. M. DB - Scopus IS - 10 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 1999 SP - 1026-1030 ST - Recent advances in JAK3 kinase inhibitors T2 - IDrugs TI - Recent advances in JAK3 kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032853338&partnerID=40&md5=37c5a19ef3021a21f85bfc7f0d476f9f VL - 2 ID - 4803 ER - TY - JOUR AD - Ottawa Regional Cancer Centre, Department of Biochemistry, University of Ottawa, Ottawa, Ont., Canada W. Alton Jones Cell Science Center, 10 Old Barn Road, Lake Placid, NY 12946, United States Ottawa Regional Cancer Centre, 501 Smyth Rd., Ottawa, Ont. K1H 8L6, Canada AU - Bennett, S. A. L. AU - Birnboim, H. C. DB - Scopus DO - 10.1002/(SICI)1098-2744(199712)20:4<366::AID-MC6>3.0.CO;2-H IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 1997 SP - 366-375 ST - Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor T2 - Molecular Carcinogenesis TI - Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031416120&doi=10.1002%2f%28SICI%291098-2744%28199712%2920%3a4%3c366%3a%3aAID-MC6%3e3.0.CO%3b2-H&partnerID=40&md5=a968e083fe83bd439cecd80152389e08 VL - 20 ID - 4804 ER - TY - JOUR AD - Division of Ophthalmology, 455 Hospital, PLA, Shanghai, PR China. AN - 21769948 AU - Min, H. AU - Ghatnekar, G. S. AU - Ghatnekar, A. V. AU - You, X. AU - Bu, M. AU - Guo, X. AU - Bu, S. AU - Shen, B. AU - Huang, Q. DA - Jul DO - 10.1002/mc.20825 10.1002/mc.20825. Epub 2011 Jul 18. DP - Nlm ET - 2011/07/20 IS - 7 LA - eng PY - 2012 SN - 0899-1987 SP - 576-85 ST - 2-Methoxyestradiol induced Bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation T2 - Mol Carcinog TI - 2-Methoxyestradiol induced Bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation VL - 51 ID - 4805 ER - TY - JOUR AD - Dept. of Pediat. Hematology/Oncology, Golisano Children's Hosp. at Strong, Univ. of Rochester Medial Center, 601 Elmwood Avenue, Rochester, NY 14642, United States Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury SP2 8BJ, United Kingdom Dana Farber Cancer Institute, Boston, MA 02115, United States AU - Wittman, B. AU - Horan, J. AU - Baxter, J. AU - Goldberg, J. AU - Felgar, R. AU - Baylor, E. AU - Cromwell, B. AU - Cross, N. AU - Bennett, J. M. DB - Scopus DO - 10.1016/j.leukres.2003.10.011 IS - SUPPL. 1 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2004 SP - 65-69 ST - A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate T2 - Leukemia Research TI - A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1342279448&doi=10.1016%2fj.leukres.2003.10.011&partnerID=40&md5=b6ec359f906857f4647393db537f331a VL - 28 ID - 4806 ER - TY - JOUR AD - Department of Microbiology, Harbin Medical University, Harbin 150081, China Department of Cell Biology, Harbin Medical University, Harbin 150081, China Department of Microbiology, Peking University Health Science Center, Beijing 100191, China AU - Guo, Z. AU - Zhong, X. AU - Lin, L. AU - Wu, S. AU - Wang, T. AU - Chen, Y. AU - Zhai, X. AU - Wang, Y. AU - Wu, H. AU - Tong, L. AU - Han, Y. AU - Pan, B. AU - Peng, Y. AU - Si, X. AU - Zhang, F. AU - Zhao, W. AU - Zhong, Z. DB - Scopus DO - 10.1016/j.antiviral.2013.11.002 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 82-92 ST - A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents T2 - Antiviral Research TI - A 3Cpro-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888816786&doi=10.1016%2fj.antiviral.2013.11.002&partnerID=40&md5=b718cfcdf89d1508ba52b58fc865bb09 VL - 101 ID - 4807 ER - TY - JOUR AD - M. Fujino, Division of Transplantation Immunology, Research Institute, National Center for Child Health and Development, Tokyo, Japan AU - Liu, C. AU - Zhu, P. AU - Fujino, M. AU - Zhu, S. AU - Ito, H. AU - Takahashi, K. AU - Nakajima, M. AU - Tanaka, T. AU - Zhuang, J. AU - Li, X. K. DB - Embase Medline DO - 10.1111/acer.14117 IS - 8 LA - English M3 - Article N1 - L628157974 2019-06-24 2019-08-19 PY - 2019 SN - 1530-0277 0145-6008 SP - 1651-1661 ST - 5-ALA/SFC Attenuated Binge Alcohol–Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats T2 - Alcoholism: Clinical and Experimental Research TI - 5-ALA/SFC Attenuated Binge Alcohol–Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628157974&from=exporthttp://dx.doi.org/10.1111/acer.14117 VL - 43 ID - 4808 ER - TY - JOUR AD - X.-K. Li, Division of Transplantation Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan AU - Fujino, M. AU - Nishio, Y. AU - Ito, H. AU - Tanaka, T. AU - Li, X. K. DB - Embase Medline DO - 10.1016/j.intimp.2015.11.034 LA - English M3 - Article N1 - L610446159 2016-05-27 2016-07-06 PY - 2016 SN - 1878-1705 1567-5769 SP - 71-78 ST - 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction T2 - International Immunopharmacology TI - 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610446159&from=exporthttp://dx.doi.org/10.1016/j.intimp.2015.11.034 VL - 37 ID - 4809 ER - TY - JOUR AD - M.S. Lan, Louisiana State University Health Sciences Center, CSRB Box, 533 Bolivar St., New Orleans, LA, United States AU - Chen, C. AU - Breslin, M. B. AU - Guidry, J. J. AU - Lan, M. S. DB - Embase Medline DO - 10.1074/jbc.RA118.006761 IS - 14 LA - English M3 - Article N1 - L2001816090 2019-05-14 2020-04-07 PY - 2019 SN - 1083-351X 0021-9258 SP - 5456-5465 ST - 5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth T2 - Journal of Biological Chemistry TI - 5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001816090&from=exporthttp://dx.doi.org/10.1074/jbc.RA118.006761 VL - 294 ID - 4810 ER - TY - JOUR AD - M. Srinivas, Hackensack University Medical Center, Hackensack, NJ, United States AU - Srinivas, M. AU - Burton, A. AU - Bhattacharyya, P. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305601 2019-05-14 PY - 2019 SN - 1545-5017 SP - S78 ST - An 8-year old boy with localized anaplastic large cell lymphoma T2 - Pediatric Blood and Cancer TI - An 8-year old boy with localized anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305601&from=exporthttp://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 4811 ER - TY - JOUR AD - R.S. Geha, Division of Immunology, Children's Hospital, One Blackfan Circle, Boston, MA 02115, United States AU - Kumar, L. AU - Feske, S. AU - Rao, A. AU - Geha, R. S. DB - Embase Medline DO - 10.1073/pnas.0509176102 IS - 52 LA - English M3 - Article N1 - L43049566 2006-01-25 PY - 2005 SN - 0027-8424 SP - 19063-19068 ST - A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function T2 - Proceedings of the National Academy of Sciences of the United States of America TI - A 10-aa-long sequence in SLP-76 upstream of the Gads binding site is essential for T cell development and function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43049566&from=exporthttp://dx.doi.org/10.1073/pnas.0509176102 VL - 102 ID - 4812 ER - TY - JOUR AD - K.M. Boycott, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada AU - Boycott, K. M. AU - Innes, A. M. DB - Embase Medline DO - 10.1002/ajmg.a.61063 IS - 4 LA - English M3 - Conference Paper N1 - L626328495 2019-02-16 2019-03-20 PY - 2019 SN - 1552-4833 1552-4825 SP - 674-746 ST - 39th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2018 Annual Meeting T2 - American Journal of Medical Genetics, Part A TI - 39th Annual David W. Smith Workshop on Malformations and Morphogenesis: Abstracts of the 2018 Annual Meeting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626328495&from=exporthttp://dx.doi.org/10.1002/ajmg.a.61063 VL - 179 ID - 4813 ER - TY - JOUR AU - Chen, W. AU - Twaroski, K. AU - Pickett-Leonard, M. AU - Tolar, J. DB - Embase DO - 10.1016/j.jid.2019.03.215 IS - 5 LA - English M3 - Conference Abstract N1 - L2001808820 2019-04-16 PY - 2019 SN - 1523-1747 0022-202X SP - S24 ST - 139 Transforming growth factor-β1 secreted by dermal fibroblasts induces an epithelial-to-mesenchymal transition in recessive dystrophic epidermolysis bullosa squamous cell carcinoma T2 - Journal of Investigative Dermatology TI - 139 Transforming growth factor-β1 secreted by dermal fibroblasts induces an epithelial-to-mesenchymal transition in recessive dystrophic epidermolysis bullosa squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001808820&from=exporthttp://dx.doi.org/10.1016/j.jid.2019.03.215 VL - 139 ID - 4814 ER - TY - JOUR AU - Wataya-Kaneda, M. AU - Nakamura, A. AU - Watanabe, Y. AU - Katayama, I. DB - Embase DO - 10.1016/j.jid.2019.03.630 IS - 5 LA - English M3 - Conference Abstract N1 - L2001808588 2019-04-16 PY - 2019 SN - 1523-1747 0022-202X SP - S95 ST - 554 Sirolimus gel effectively reduced neurofibromas in neurofibromatosis type 1 in a double-blind, placebo-controlled, randomized clinical trial T2 - Journal of Investigative Dermatology TI - 554 Sirolimus gel effectively reduced neurofibromas in neurofibromatosis type 1 in a double-blind, placebo-controlled, randomized clinical trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001808588&from=exporthttp://dx.doi.org/10.1016/j.jid.2019.03.630 VL - 139 ID - 4815 ER - TY - JOUR AD - M.A. Tanino, Dept. Cancer. Pathol., Fac. of Med., Hokkaido Univ., Japan AU - Tanino, M. A. AU - Nanjo, H. AU - Tsuda, M. AU - Sugino, H. AU - Wang, R. AU - Ishida, Y. AU - Tanaka, S. DB - Embase LA - English M3 - Conference Abstract N1 - L621977428 2018-05-08 PY - 2018 SN - 1349-7006 SP - 1128 ST - Aanalysis of relationship between BRAF V600E mutation and expression for p16 in pleomorphic xanthoastrocytoma T2 - Cancer Science TI - Aanalysis of relationship between BRAF V600E mutation and expression for p16 in pleomorphic xanthoastrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621977428&from=export VL - 109 ID - 4816 ER - TY - JOUR AD - Department of Laboratory Medicine, Cleveland Clinic, L-11, Cleveland, OH 44195, United States AU - Shi, Y. AU - Zhao, X. AU - Durkin, L. AU - Rogers, H. J. AU - Hsi, E. D. DB - Scopus DO - 10.1016/j.humpath.2016.01.008 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 173-178 ST - Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia T2 - Human Pathology TI - Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962382653&doi=10.1016%2fj.humpath.2016.01.008&partnerID=40&md5=f76d79e1f3f6ef2ea7d1a250aa453d85 VL - 52 ID - 4817 ER - TY - JOUR AD - J. Zhang, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin, China AU - Zhang, J. AU - Guo, Y. AU - Yang, W. AU - Chen, X. AU - Chao, L. AU - Chen, Y. AU - Zou, Y. AU - Zhu, X. AU - Zhang, Y. DB - Embase LA - English M3 - Conference Abstract N1 - L620310650 2018-01-26 PY - 2017 SN - 1528-0020 ST - Aberrant FLT3 transcription arised from polycomb repressive complex 2 inactivation indiactes a potential therapy target for pediatric T cell acute lymphoblastic leukemia T2 - Blood TI - Aberrant FLT3 transcription arised from polycomb repressive complex 2 inactivation indiactes a potential therapy target for pediatric T cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620310650&from=export VL - 130 ID - 4818 ER - TY - JOUR AD - Division of Medical Support, Okayama University Hospital, Okayama, Japan Department of Pediatrics, Pediatric Hematology/Oncology, Okayama University Hospital, 2-5-1 Shikatacho, Kitaku, Okayama 700-8558, Japan Department of Pediatrics, Kochi Health Sciences Center, Kochi, Japan Department of Pediatrics, Osaka University, Osaka, Japan Department of Pediatrics, Toyonaka Municipal Hospital, Osaka, Japan Field of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan AU - Aoe, M. AU - Shimada, A. AU - Muraoka, M. AU - Washio, K. AU - Nakamura, Y. AU - Takahashi, T. AU - Imada, M. AU - Watanabe, T. AU - Okada, K. AU - Nishiuchi, R. AU - Miyamura, T. AU - Chayama, K. AU - Shibakura, M. AU - Oda, M. AU - Morishima, T. DB - Scopus DO - 10.1007/s12185-014-1565-3 IS - 5 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 609-615 ST - ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases T2 - International Journal of Hematology TI - ABL kinase mutation and relapse in 4 pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901588114&doi=10.1007%2fs12185-014-1565-3&partnerID=40&md5=1da6b5d1a0985e48b78958d26636d7d4 VL - 99 ID - 4819 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK. AN - 23077088 AU - Al-Shehhi, H. AU - Konn, Z. J. AU - Schwab, C. J. AU - Erhorn, A. AU - Barber, K. E. AU - Wright, S. L. AU - Gabriel, A. S. AU - Harrison, C. J. AU - Moorman, A. V. DA - Feb DO - 10.1002/gcc.22021 10.1002/gcc.22021. Epub 2012 Oct 18. DP - Nlm ET - 2012/10/19 IS - 2 LA - eng PY - 2013 SN - 1045-2257 SP - 202-13 ST - Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia T2 - Genes Chromosomes Cancer TI - Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia VL - 52 ID - 4820 ER - TY - JOUR AD - J.A. Moscow, Department of Pediatrics, College of Medicine, University of Kentucky, 740 S. Limestone Room J457, Lexington, KY 40536, United States AU - Daily, A. AU - Monks, N. R. AU - Leggas, M. AU - Moscow, J. A. DB - Embase Medline DO - 10.1016/j.toxicon.2009.11.019 IS - 4 LA - English M3 - Article N1 - L50723101 2009-12-04 2012-05-24 PY - 2010 SN - 1879-3150 0041-0101 SP - 827-837 ST - Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition T2 - Toxicon TI - Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50723101&from=exporthttp://dx.doi.org/10.1016/j.toxicon.2009.11.019 VL - 55 ID - 4821 ER - TY - JOUR AD - University of Milan-Bicocca, Monza, Italy carlo.gambacorti@unimib.it. AN - 26736010 AU - Gambacorti-Passerini, C. AU - Mussolin, L. AU - Brugieres, L. DA - Jan 7 DO - 10.1056/NEJMc1511045 10.1056/NEJMc1511045. DP - Nlm ET - 2016/01/07 IS - 1 LA - eng PY - 2016 SN - 0028-4793 SP - 95-6 ST - Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib T2 - N Engl J Med TI - Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib VL - 374 ID - 4822 ER - TY - JOUR AD - A. Bongaarts, Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, Utrecht, Netherlands AU - Bongaarts, A. AU - Reinten, R. J. A. AU - Jansen, F. E. AU - Spliet, W. G. M. AU - Feucht, M. AU - Buccoliero, A. M. AU - Giordano, F. AU - Mühlebner, A. AU - Aronica, E. M. DB - Embase LA - English M3 - Conference Abstract N1 - L614692173 2017-03-10 PY - 2017 SN - 0305-1846 SP - 55-56 ST - Absence of BRAF V600E mutation in Subependymal giant cell astrocytomas associated with tuberous sclerosis T2 - Neuropathology and Applied Neurobiology TI - Absence of BRAF V600E mutation in Subependymal giant cell astrocytomas associated with tuberous sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614692173&from=export VL - 43 ID - 4823 ER - TY - JOUR AD - Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. hidetaka@surgpath.med.kyushu-u.ac.jp AN - 16984614 AU - Yamamoto, H. AU - Kohashi, K. AU - Oda, Y. AU - Tamiya, S. AU - Takahashi, Y. AU - Kinoshita, Y. AU - Ishizawa, S. AU - Kubota, M. AU - Tsuneyoshi, M. DA - Oct DO - 10.1111/j.1440-1827.2006.02012.x 10.1111/j.1440-1827.2006.02012.x. DP - Nlm ET - 2006/09/21 IS - 10 LA - eng PY - 2006 SN - 1320-5463 (Print) 1320-5463 SP - 584-90 ST - Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene T2 - Pathol Int TI - Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene VL - 56 ID - 4824 ER - TY - JOUR AD - Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA. AN - 17643094 AU - Tavora, F. AU - Shilo, K. AU - Ozbudak, I. H. AU - Przybocki, J. M. AU - Wang, G. AU - Travis, W. D. AU - Franks, T. J. DA - Sep DO - 10.1038/modpathol.3800938 10.1038/modpathol.3800938. Epub 2007 Jul 20. DP - Nlm ET - 2007/07/24 IS - 9 LA - eng PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 995-9 ST - Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases T2 - Mod Pathol TI - Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases VL - 20 ID - 4825 ER - TY - JOUR DB - Embase IS - 4 LA - English M3 - Conference Review N1 - L614627021 2017-03-07 PY - 2016 SN - 1753-6561 ST - Abstracts from the 5th International Conference for Healthcare and Medical Students, ICHAMS 2016 T2 - BMC Proceedings TI - Abstracts from the 5th International Conference for Healthcare and Medical Students, ICHAMS 2016 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614627021&from=export VL - 10 ID - 4826 ER - TY - JOUR AD - G.C. Sun, Pediatrics, University of Miami Leonard M Miller School of Med, Miami, FL, United States AU - Sun, G. C. AU - Shvab, A. C. AU - Li, B. C. AU - Beckedorff, F. C. AU - Leclerc, G. J. AU - Shiekhattar, R. AU - Barredo, J. C. DB - Embase DO - 10.1182/blood-2018-99-112678 LA - English M3 - Conference Abstract N1 - L626478939 2019-02-27 PY - 2018 SN - 0006-4971 ST - Acadesine elicits a rapid epigenetic reprograming of immediate early genes through the protein kinase D1 pathway in acute lymphoblastic leukemia cells undergoing energy/metabolic stress T2 - Blood TI - Acadesine elicits a rapid epigenetic reprograming of immediate early genes through the protein kinase D1 pathway in acute lymphoblastic leukemia cells undergoing energy/metabolic stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626478939&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-112678 VL - 132 ID - 4827 ER - TY - JOUR AD - L. Moreno, Paediatric Phase I-II Clinical Trials Unit, Paediatric Haematology & Oncology, Hospital Niño Jesus, Madrid, Spain AU - Moreno, L. AU - Caron, H. AU - Geoerger, B. AU - Eggert, A. AU - Schleiermacher, G. AU - Brock, P. AU - Valteau-Couanet, D. AU - Chesler, L. AU - Schulte, J. H. AU - De Preter, K. AU - Molenaar, J. AU - Schramm, A. AU - Eilers, M. AU - Van Maerken, T. AU - Johnsen, J. I. AU - Garrett, M. AU - George, S. L. AU - Tweddle, D. A. AU - Kogner, P. AU - Berthold, F. AU - Koster, J. AU - Barone, G. AU - Tucker, E. R. AU - Marshall, L. AU - Herold, R. AU - Sterba, J. AU - Norga, K. AU - Vassal, G. AU - Pearson, A. D. C1 - azd 7762 azd 8055 cct 137690 cct 244747 cct 245737 gsk 1324726a jq 1 ldk 378 lee 011 ly 2835219 mk 8776 mln 8237 sch 900776 ym 155 DB - Embase Medline DO - 10.1080/17460441.2017.1340269 IS - 8 LA - English M3 - Review N1 - L617310291 2017-07-18 2017-07-19 PY - 2017 SN - 1746-045X 1746-0441 SP - 801-811 ST - Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project T2 - Expert Opinion on Drug Discovery TI - Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617310291&from=exporthttp://dx.doi.org/10.1080/17460441.2017.1340269 VL - 12 ID - 4828 ER - TY - JOUR AD - Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy AU - Raponi, S. AU - De Propris, M. S. AU - Wai, H. AU - Intoppa, S. AU - Elia, L. AU - Diverio, D. AU - Vitale, A. AU - Foà, R. AU - Guarini, A. DB - Scopus DO - 10.3324/haematol.2009.010900 IS - 12 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2009 SP - 1767-1770 ST - An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia T2 - Haematologica TI - An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73149096711&doi=10.3324%2fhaematol.2009.010900&partnerID=40&md5=0139fd40f2e8075bd1670aa114a3a02b VL - 94 ID - 4829 ER - TY - JOUR AD - A.C. Simões-E-silva, Pediatric Branch, Interdisciplinary Laboratory of Medical Investigation, Faculty of Medicine, UFMG, Brazil AU - Gonzaga, A. L. A. C. P. AU - Palmeira, V. A. AU - Ri-Beiro, T. F. S. AU - Costa, L. B. AU - de Sá Rodrigues, K. E. AU - Simões-E-silva, A. C. C1 - a 779 pd 123319 txa 127(Tarix Pharmaceutical) C2 - Tarix Pharmaceutical DB - Embase Medline DO - 10.2174/1389450121666200210124217 IS - 9 LA - English M3 - Review N1 - L2004548832 2020-07-24 2020-09-08 PY - 2020 SN - 1873-5592 1389-4501 SP - 892-901 ST - ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: Potential role for pediatric tumors T2 - Current Drug Targets TI - ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: Potential role for pediatric tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004548832&from=exporthttp://dx.doi.org/10.2174/1389450121666200210124217 VL - 21 ID - 4830 ER - TY - JOUR AD - W. A. Horton, Research Center, Shriners Hospital for Children, 3101 SW Sam Jackson Park Road, Portland, OR 97239, United States AU - Laederich, M. B. AU - Horton, W. A. DB - Embase Medline DO - 10.1097/MOP.0b013e32833b7a69 IS - 4 LA - English M3 - Review N1 - L50980323 2010-07-07 2010-08-18 PY - 2010 SN - 1040-8703 SP - 516-523 ST - Achondroplasia: Pathogenesis and implications for future treatment T2 - Current Opinion in Pediatrics TI - Achondroplasia: Pathogenesis and implications for future treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50980323&from=exporthttp://dx.doi.org/10.1097/MOP.0b013e32833b7a69 VL - 22 ID - 4831 ER - TY - JOUR AD - C. Dessinioti, Department of Dermatology, Andreas Syggros Hospital, University of Athens, Athens, Greece AU - Dessinioti, C. AU - Antoniou, C. AU - Katsambas, A. DB - Embase Medline DO - 10.1016/j.clindermatol.2013.05.023 IS - 1 LA - English M3 - Note N1 - L370417430 2013-12-13 2014-01-14 PY - 2014 SN - 0738-081X 1879-1131 SP - 24-34 ST - Acneiform eruptions T2 - Clinics in Dermatology TI - Acneiform eruptions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370417430&from=exporthttp://dx.doi.org/10.1016/j.clindermatol.2013.05.023 VL - 32 ID - 4832 ER - TY - JOUR AD - J.I. Geller, Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Bartlett, A. L. AU - Leslie, N. D. AU - Gupta, A. AU - Geller, J. I. DB - Embase Medline DO - 10.1002/pbc.27392 IS - 12 LA - English M3 - Article N1 - L623776406 2018-09-11 2019-05-29 PY - 2018 SN - 1545-5017 1545-5009 ST - Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma T2 - Pediatric Blood and Cancer TI - Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623776406&from=exporthttp://dx.doi.org/10.1002/pbc.27392 VL - 65 ID - 4833 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA. Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. Department of Neurology, University of California San Francisco, San Francisco, CA, USA. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. AN - 27611946 AU - Yao, T. W. AU - Zhang, J. AU - Prados, M. AU - Weiss, W. A. AU - James, C. D. AU - Nicolaides, T. C2 - PMC5352180 DA - Jan 3 DO - 10.18632/oncotarget.11882 10.18632/oncotarget.11882. DP - Nlm ET - 2016/09/10 IS - 1 LA - eng PY - 2017 SN - 1949-2553 SP - 583-595 ST - Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas T2 - Oncotarget TI - Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas VL - 8 ID - 4834 ER - TY - JOUR AD - R. Gong, Blood Purification Center, Institute of Nephrology, First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, Zhengzhou, China AU - Wang, P. AU - Zhang, Y. AU - Wang, Y. AU - Brem, A. S. AU - Liu, Z. AU - Gong, R. C2 - Shanghai The First Biochemical and Pharmaceutical(China) DB - Embase Medline DO - 10.1542/peds.2016-2169 IS - 1 LA - English M3 - Article N1 - L617228570 2017-07-12 2017-07-18 PY - 2017 SN - 1098-4275 0031-4005 ST - Acquired resistance to corticotropin therapy in nephrotic syndrome: Role of de novo neutralizing antibody T2 - Pediatrics TI - Acquired resistance to corticotropin therapy in nephrotic syndrome: Role of de novo neutralizing antibody UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617228570&from=exporthttp://dx.doi.org/10.1542/peds.2016-2169 VL - 140 ID - 4835 ER - TY - JOUR AD - X. Wan, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University, No. 910, Hengshan Road, Shanghai 200030, China AU - Wu, X. AU - Yan, Q. AU - Zhang, Z. AU - Du, G. AU - Wan, X. C1 - Acrp 30(PeproTech,United States) C2 - PeproTech(United States) DB - Embase Medline DO - 10.3892/oror.2012.1670 IS - 5 LA - English M3 - Article N1 - L364429022 2012-03-21 2012-03-27 PY - 2012 SN - 1021-335X 1791-2431 SP - 1488-1496 ST - Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells T2 - Oncology Reports TI - Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364429022&from=exporthttp://dx.doi.org/10.3892/oror.2012.1670http://www.spandidos-publications.com/serveFile/or_27_5_1488_PDF.pdf?type=article&article_id=or_27_5_1488&item=PDF VL - 27 ID - 4836 ER - TY - JOUR AD - Rambam Health Care Campus, Israel Institute of Technology, Israel AU - Ofran, Y. DB - Scopus IS - 25 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 3280-3282 ST - Activated kinases in ALL: Time to act T2 - Blood TI - Activated kinases in ALL: Time to act UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021344426&partnerID=40&md5=927e00c7630965e6fbdc0fd884fd2d7e VL - 129 ID - 4837 ER - TY - JOUR AD - *Department of Pathology †Department of Pediatric Hematology-Oncology, Institute of Pediatrics, University of Debrecen Clinical Centre, Debrecen, Hungary. AN - 25118810 AU - Méhes, G. AU - Irsai, G. AU - Bedekovics, J. AU - Beke, L. AU - Fazakas, F. AU - Rózsa, T. AU - Kiss, C. DA - Dec DO - 10.1097/pas.0000000000000304 10.1097/PAS.0000000000000304. DP - Nlm ET - 2014/08/15 IS - 12 LA - eng PY - 2014 SN - 0147-5185 SP - 1644-8 ST - Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry T2 - Am J Surg Pathol TI - Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry VL - 38 ID - 4838 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Traverwood 2, Suite C, 2910 Huron Parkway, Ann Arbor, MI 48105-3450, United States Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States AU - Brown, N. A. AU - Rolland, D. AU - McHugh, J. B. AU - Weigelin, H. C. AU - Zhao, L. AU - Lim, M. S. AU - Elenitoba-Johnson, K. S. J. AU - Betz, B. L. DB - Scopus DO - 10.1158/1078-0432.CCR-14-1069 IS - 21 M3 - Article N1 - Cited By :99 Export Date: 18 November 2020 PY - 2014 SP - 5517-5526 ST - Activating FGFR2-RAS-BRAF mutations in ameloblastoma T2 - Clinical Cancer Research TI - Activating FGFR2-RAS-BRAF mutations in ameloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84909591990&doi=10.1158%2f1078-0432.CCR-14-1069&partnerID=40&md5=a60f8bce0c094d5d0d693865a5e26b98 VL - 20 ID - 4839 ER - TY - JOUR AD - L. Ge, Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing, China AU - Zhai, Y. AU - Wang, Y. AU - Rao, N. AU - Li, J. AU - Li, X. AU - Fang, T. AU - Zhao, Y. AU - Ge, L. DB - Embase DO - 10.3389/fphys.2019.01304 LA - English M3 - Article N1 - L629756827 2019-11-13 2019-11-15 PY - 2019 SN - 1664-042X ST - Activation and Biological Properties of Human β Defensin 4 in Stem Cells Derived From Human Exfoliated Deciduous Teeth T2 - Frontiers in Physiology TI - Activation and Biological Properties of Human β Defensin 4 in Stem Cells Derived From Human Exfoliated Deciduous Teeth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629756827&from=exporthttp://dx.doi.org/10.3389/fphys.2019.01304 VL - 10 ID - 4840 ER - TY - JOUR AD - First Aid Center, Shanghai Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China Department of General Surgery, Shanghai, Chang Zheng Hospital, Second Military Medical University, Shanghai, China Institute of Pathophysiology, Second Military Medical University, Shanghai, China AU - Wang, Y. X. AU - Xu, X. Y. AU - Su, W. L. AU - Wang, Q. AU - Zhu, W. X. AU - Chen, F. AU - Jin, G. AU - Liu, Y. J. AU - Li, Y. D. AU - Sun, Y. P. AU - Gao, W. C. AU - Ruan, C. P. DB - Scopus DO - 10.1016/j.jss.2008.10.030 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2010 SP - 119-125 ST - Activation and Clinical Significance of p38 MAPK Signaling Pathway in Patients With Severe Trauma T2 - Journal of Surgical Research TI - Activation and Clinical Significance of p38 MAPK Signaling Pathway in Patients With Severe Trauma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951621847&doi=10.1016%2fj.jss.2008.10.030&partnerID=40&md5=f2fdbab41c45e351e56d3ca04fddb6d8 VL - 161 ID - 4841 ER - TY - JOUR AD - C.A. Stratakis, Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, United States AU - Almeida, M. Q. AU - Azevedo, M. F. AU - Xekouki, P. AU - Bimpaki, E. I. AU - Horvath, A. AU - Collins, M. T. AU - Karaviti, L. P. AU - Jeha, G. S. AU - Bhattacharyya, N. AU - Cheadle, C. AU - Watkins, T. AU - Bourdeau, I. AU - Nesterova, M. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1210/jc.2011-3000 IS - 4 LA - English M3 - Article N1 - L364594559 2012-04-17 2012-04-24 PY - 2012 SN - 0021-972X 1945-7197 SP - E687-E693 ST - Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations T2 - Journal of Clinical Endocrinology and Metabolism TI - Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594559&from=exporthttp://dx.doi.org/10.1210/jc.2011-3000http://jcem.endojournals.org/content/97/4/E687.full.pdf+html VL - 97 ID - 4842 ER - TY - JOUR AD - T. Ohta, Department of Obstetrics and Gynecology, Yamagata University, School of Medicine, 2-2-2 Iidanishi, Yamagata, Japan AU - Matsumura, S. AU - Ohta, T. AU - Yamanouchi, K. AU - Liu, Z. AU - Sudo, T. AU - Kojimahara, T. AU - Seino, M. AU - Narumi, M. AU - Tsutsumi, S. AU - Takahashi, T. AU - Takahashi, K. AU - Kurachi, H. AU - Nagase, S. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1080/15384047.2016.1235656 IS - 9 LA - English M3 - Article N1 - L618516647 2017-10-06 2018-08-06 PY - 2017 SN - 1555-8576 1538-4047 SP - 730-739 ST - Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells T2 - Cancer Biology and Therapy TI - Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618516647&from=exporthttp://dx.doi.org/10.1080/15384047.2016.1235656 VL - 18 ID - 4843 ER - TY - JOUR AD - Department of Pediatrics, Pediatric Nephrology Unit, Karolinska University Hospital-Huddinge, Stockholm, Sweden. ming.chen@klinvet.ki.se AN - 15195252 AU - Chen, M. AU - Bao, W. AU - Aizman, R. AU - Huang, P. AU - Aspevall, O. AU - Gustafsson, L. E. AU - Ceccatelli, S. AU - Celsi, G. DA - Jul 1 DO - 10.1086/421243 10.1086/421243. Epub 2004 Jun 2. DP - Nlm ET - 2004/06/15 IS - 1 LA - eng PY - 2004 SN - 0022-1899 (Print) 0022-1899 SP - 127-35 ST - Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1 T2 - J Infect Dis TI - Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1 VL - 190 ID - 4844 ER - TY - JOUR AD - J.W. Pollard, Center for the Study of Reproductive Biology and Women's Health, Albert Einstein College of Medicine, Bronx, United States AU - Wang, Y. AU - Zhu, L. AU - Kuokkanen, S. AU - Pollard, J. W. DB - Embase Medline DO - 10.1073/pnas.1418973112 IS - 11 LA - English M3 - Article N1 - L603022504 2015-03-27 2015-04-02 PY - 2015 SN - 1091-6490 0027-8424 SP - E1382-E1391 ST - Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK 1/2-mTOR signaling pathway T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC-ERK 1/2-mTOR signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603022504&from=exporthttp://dx.doi.org/10.1073/pnas.1418973112 VL - 112 ID - 4845 ER - TY - JOUR AD - Unità Citoistopatologia, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, Rome. AN - 15539382 AU - Branca, M. AU - Ciotti, M. AU - Santini, D. AU - Bonito, L. D. AU - Benedetto, A. AU - Giorgi, C. AU - Paba, P. AU - Favalli, C. AU - Costa, S. AU - Agarossi, A. AU - Alderisio, M. AU - Syrjänen, K. DA - Dec DO - 10.1309/vqxf-t880-jxc7-qd2w 10.1309/VQXF-T880-JXC7-QD2W. DP - Nlm ET - 2004/11/13 IS - 6 LA - eng PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 902-11 ST - Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer T2 - Am J Clin Pathol TI - Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer VL - 122 ID - 4846 ER - TY - JOUR AD - E. Malle, Institute of Molecular Biology and Biochemistry, Medical University of Graz, Harrachgasse 21, Graz, Austria AU - Koyani, C. N. AU - Kitz, K. AU - Rossmann, C. AU - Bernhart, E. AU - Huber, E. AU - Trummer, C. AU - Windischhofer, W. AU - Sattler, W. AU - Malle, E. DB - Embase Medline DO - 10.1016/j.bcp.2016.01.011 LA - English M3 - Article N1 - L608135652 2016-02-11 2016-03-15 PY - 2016 SN - 1873-2968 0006-2952 SP - 29-41 ST - Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death T2 - Biochemical Pharmacology TI - Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608135652&from=exporthttp://dx.doi.org/10.1016/j.bcp.2016.01.011 VL - 104 ID - 4847 ER - TY - JOUR AD - Department of Morphology and Physiology, Semmelweis University, Budapest, Hungary First Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi Street 26, Budapest, 1085, Hungary Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, 3990 John R, Detroit, MI 48201, United States University of Chicago, Chicago, IL, United States Department of Dermatology, Dermatooncology and Venerology, Semmelweis University, Budapest, Hungary First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary Maternity Private Department, Kutvolgyi Clinical Block, Semmelweis University, Budapest, Hungary Center for Molecular Medicine and Genetics, School of Medicine, Wayne State University, Detroit, MI, United States Department of Obstetrics and Gynecology, School of Medicine, Wayne State University, Detroit, MI, United States Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary AU - Szabo, S. AU - Mody, M. AU - Romero, R. AU - Xu, Y. AU - Karaszi, K. AU - Mihalik, N. AU - Xu, Z. AU - Bhatti, G. AU - Fule, T. AU - Hupuczi, P. AU - Krenacs, T. AU - Rigo, J., Jr. AU - Tarca, A. L. AU - Hassan, S. S. AU - Chaiworapongsa, T. AU - Kovalszky, I. AU - Papp, Z. AU - Than, N. G. DB - Scopus DO - 10.1007/s12253-014-9872-9 IS - 3 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2015 SP - 659-668 ST - Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome T2 - Pathology and Oncology Research TI - Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939416015&doi=10.1007%2fs12253-014-9872-9&partnerID=40&md5=07d29292a6a5f932b73195b5e300f549 VL - 21 ID - 4848 ER - TY - JOUR AU - Moreno, L. DB - Embase Medline DO - 10.1016/S1470-2045(18)30191-8 IS - 5 LA - English M3 - Note N1 - L2000612769 2018-04-04 2018-05-16 PY - 2018 SN - 1474-5488 1470-2045 SP - 594-595 ST - An active drug for TRK-positive paediatric solid tumours T2 - The Lancet Oncology TI - An active drug for TRK-positive paediatric solid tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000612769&from=exporthttp://dx.doi.org/10.1016/S1470-2045(18)30191-8 VL - 19 ID - 4849 ER - TY - JOUR AD - Unit of Medical Oncology 2, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliera-Universitaria Pisana, University of Pisa, Pisa, Italy. Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy. Department of Oncology, University and General Hospital, Udine, Italy. Department of Oncology, San Bortolo General Hospital, ULSS8 Berica, East District, Vicenza, Italy. Department of Medical Oncology, Hospital of Frosinone, Frosinone, Italy. Dipartimento di Oncologia Università Campus Bio-Medico di Roma, Rome, Italy. Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padua, Padova, Italy. Unit of Medical Oncology, Hospital Felice Lotti, Azienda Toscana Nord Ovest, Pontedera, Italy. Unit of Medical Oncology, Policlinico G. B. Rossi, Azienda Ospedaliera Integrata di Verona, Verona, Italy. Unit of Medical Oncology, Hospital San Giovanni Calibita Fatebenefratelli, Rome, Italy. Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy. Department of Oncology, Hospital San Raffaele IRCSS, Milan, Italy. Unit of Medical Oncology, Policlinico Sant'Orsola-Malpighi, Bologna, Italy. Department of Medical Oncology, Policlinico Umberto I Sapienza, University of Rome, Rome, Italy. Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Florence, Italy. AN - 29450468 AU - Cremolini, C. AU - Antoniotti, C. AU - Lonardi, S. AU - Aprile, G. AU - Bergamo, F. AU - Masi, G. AU - Grande, R. AU - Tonini, G. AU - Mescoli, C. AU - Cardellino, G. G. AU - Coltelli, L. AU - Salvatore, L. AU - Corsi, D. C. AU - Lupi, C. AU - Gemma, D. AU - Ronzoni, M. AU - Dell'Aquila, E. AU - Marmorino, F. AU - Di Fabio, F. AU - Mancini, M. L. AU - Marcucci, L. AU - Fontanini, G. AU - Zagonel, V. AU - Boni, L. AU - Falcone, A. C2 - PMC5885260 F. Hoffman–La Roche, Bayer, Sirtex, and Amgen. Dr Masi reported receiving personal fees from Amgen, F. Hoffman–La Roche, Bayer, Merk Serono, and Sirtex. Dr Tonini reported receiving personal fees from Novartis, F. Hoffman–La Roche, and Molteni. Dr Salvatore reported receiving personal fees from Servier, Bayer, and Sanofi. Dr Falcone reported receiving grants and personal fees from F. Hoffman–La Roche, Amgen, and Merck Serono as well as personal fees from Celgene, Bayer, and Sanofi Aventis. No other disclosures were reported. DA - Apr 1 DO - 10.1001/jamaoncol.2017.5314 10.1001/jamaoncol.2017.5314. DP - Nlm ET - 2018/02/17 IS - 4 LA - eng PY - 2018 SN - 2374-2437 (Print) 2374-2437 SP - 529-536 ST - Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial T2 - JAMA Oncol TI - Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial VL - 4 ID - 4850 ER - TY - JOUR AD - Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven. Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute, Warsaw. Oncology Center, Warsaw, Poland. Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France. Medical Clinic III, University Hospital of Munich, Munich, Germany. Department of Oncology, University College London Hospital NHS Trust, London. Institute of Oncology, Leeds Teaching Hospitals National Health Service Trust, St. James's University Hospital, Leeds, UK. Department of Medical Oncology, CHU la Timone Boulevard J Moulin Marseille, Marseille. Aix Marseille University (AMU), Marseille, France. University Cancer Center, Dresden. Medical Department I, University Hospital Carl Gustav Carus, Dresden. Department of Haematology, Haemostasis and Oncology, Hannover Medical School, Hannover, Germany. The Christie NHS Foundation Trust, Manchester, UK. HELIOS Klinikum Berlin-Buch, Sarcoma Center Berlin-Brandenburg, Berlin, Germany. National Cancer Institute, Bratislava, Slovakia. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. The Institute of Cancer Research, London, UK. Department of Pathology, University Hospitals Leuven, Leuven. Department of Human Genetics, KU Leuven, Leuven. European Organization for Research and Treatment of Cancer, Brussels, Belgium. Department of Internal Medicine, West German Cancer Center, University Hospital, University of Duisburg-Essen, Duisburg, Germany. AN - 28950372 AU - Schöffski, P. AU - Wozniak, A. AU - Stacchiotti, S. AU - Rutkowski, P. AU - Blay, J. Y. AU - Lindner, L. H. AU - Strauss, S. J. AU - Anthoney, A. AU - Duffaud, F. AU - Richter, S. AU - Grünwald, V. AU - Leahy, M. G. AU - Reichardt, P. AU - Sufliarsky, J. AU - van der Graaf, W. T. AU - Sciot, R. AU - Debiec-Rychter, M. AU - van Cann, T. AU - Marréaud, S. AU - Lia, M. AU - Raveloarivahy, T. AU - Collette, L. AU - Bauer, S. C2 - PMC5834120 DA - Dec 1 DO - 10.1093/annonc/mdx527 10.1093/annonc/mdx527. DP - Nlm ET - 2017/09/28 IS - 12 LA - eng PY - 2017 SN - 0923-7534 (Print) 0923-7534 SP - 3000-3008 ST - Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' T2 - Ann Oncol TI - Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' VL - 28 ID - 4851 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, and Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, Leuven, Belgium AU - Schöffski, P. AU - Wozniak, A. AU - Kasper, B. AU - Aamdal, S. AU - Leahy, M. G. AU - Rutkowski, P. AU - Bauer, S. AU - Gelderblom, H. AU - Italiano, A. AU - Lindner, L. H. AU - Hennig, I. AU - Strauss, S. AU - Zakotnik, B. AU - Anthoney, A. AU - Albiges, L. AU - Blay, J. Y. AU - Reichardt, P. AU - Sufliarsky, J. AU - van der Graaf, W. T. A. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Van Cann, T. AU - Marréaud, S. AU - Raveloarivahy, T. AU - Collette, S. AU - Stacchiotti, S. DB - Embase Medline DO - 10.1093/annonc/mdx774 IS - 3 LA - English M3 - Article N1 - L621930961 2018-05-04 2019-05-28 PY - 2018 SN - 1569-8041 0923-7534 SP - 758-765 ST - Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE' T2 - Annals of Oncology TI - Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE' UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621930961&from=exporthttp://dx.doi.org/10.1093/annonc/mdx774 VL - 29 ID - 4852 ER - TY - JOUR AD - The University of Texas MD Anderson Cancer Center, Houston, Tex., USA. AN - 27764830 AU - Subbiah, V. AU - Holmes, O. AU - Gowen, K. AU - Spritz, D. AU - Amini, B. AU - Wang, W. L. AU - Schrock, A. B. AU - Meric-Bernstam, F. AU - Zinner, R. AU - Piha-Paul, S. AU - Zarzour, M. AU - Elvin, J. A. AU - Erlich, R. L. AU - Stockman, D. L. AU - Vergilio, J. A. AU - Suh, J. H. AU - Stephens, P. J. AU - Miller, V. AU - Ross, J. S. AU - Ali, S. M. C2 - PMC5130597 C6 - NIHMS818564 DO - 10.1159/000449204 10.1159/000449204. Epub 2016 Oct 21. DP - Nlm ET - 2016/10/21 IS - 6 LA - eng PY - 2016 SN - 0030-2414 (Print) 0030-2414 SP - 348-353 ST - Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion T2 - Oncology TI - Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion VL - 91 ID - 4853 ER - TY - JOUR AD - From the Center for Cancer Research, Pediatric Oncology Branch, Bethesda (E.D., A. Baldwin, L.J.M., P. Whitcomb, S.M., R.E., P. Wolters, J.T., J.G., A.J.S., A.G., B.C.W.) and the Cancer Therapy Evaluation Program, Shady Grove (A.L.D.), National Cancer Institute, and the National Heart, Lung, and Blood Institute (A. Brofferio), Bethesda, National Institutes of Health, and the Food and Drug Administration, Silver Spring (L.J.M., R.E.) - all in Maryland; the Division of Oncology, Children's Hospital of Philadelphia, and the Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (M.J.F., J.B.B.); Children's National Health System, Washington, DC (A.K.); and Cincinnati Children's Hospital, Cincinnati (B.W., L.E.A.-S., T.A.R., J.W., E.S., N.R.). AN - 28029918 AU - Dombi, E. AU - Baldwin, A. AU - Marcus, L. J. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Whitcomb, P. AU - Martin, S. AU - Aschbacher-Smith, L. E. AU - Rizvi, T. A. AU - Wu, J. AU - Ershler, R. AU - Wolters, P. AU - Therrien, J. AU - Glod, J. AU - Belasco, J. B. AU - Schorry, E. AU - Brofferio, A. AU - Starosta, A. J. AU - Gillespie, A. AU - Doyle, A. L. AU - Ratner, N. AU - Widemann, B. C. C2 - PMC5508592 C6 - NIHMS848283 DA - Dec 29 DO - 10.1056/NEJMoa1605943 10.1056/NEJMoa1605943. DP - Nlm ET - 2016/12/29 IS - 26 LA - eng PY - 2016 SN - 0028-4793 (Print) 0028-4793 SP - 2550-2560 ST - Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas T2 - N Engl J Med TI - Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas VL - 375 ID - 4854 ER - TY - JOUR AD - Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy. AN - 22713244 AU - Buontempo, F. AU - Chiarini, F. AU - Bressanin, D. AU - Tabellini, G. AU - Melchionda, F. AU - Pession, A. AU - Fini, M. AU - Neri, L. M. AU - McCubrey, J. A. AU - Martelli, A. M. DA - Jul 1 DO - 10.4161/cc.20859 10.4161/cc.20859. Epub 2012 Jul 1. DP - Nlm ET - 2012/06/21 IS - 13 LA - eng PY - 2012 SN - 1551-4005 SP - 2467-75 ST - Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a T2 - Cell Cycle TI - Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a VL - 11 ID - 4855 ER - TY - JOUR AD - Division of Hematology-Oncology, Department of Pediatrics, University of Southern California, USA. AN - 17909043 AU - Peng, H. AU - Sohara, Y. AU - Moats, R. A. AU - Nelson, M. D., Jr. AU - Groshen, S. G. AU - Ye, W. AU - Reynolds, C. P. AU - DeClerck, Y. A. DA - Oct 1 DO - 10.1158/0008-5472.Can-06-4508 10.1158/0008-5472.CAN-06-4508. DP - Nlm ET - 2007/10/03 IS - 19 LA - eng PY - 2007 SN - 0008-5472 (Print) 0008-5472 SP - 9346-55 ST - The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation T2 - Cancer Res TI - The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation VL - 67 ID - 4856 ER - TY - JOUR AD - Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK; Current address: Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK. Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK. Beatson Institute for Cancer Research, Glasgow, UK. GOSgene, UCL Institute of Child Health, London, UK. Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK. Department of Veterans Affairs, Vanderbilt University Medical Center, Tennessee Valley Healthcare System, Nashville, Tennessee, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK; Pediatric Dermatology, Great Ormond St Hospital, London, UK. Electronic address: v.kinsler@ucl.ac.uk. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson Institute for Cancer Research, Glasgow, UK. Electronic address: p.adams@beatson.gla.ac.uk. AN - 25815427 AU - Pawlikowski, J. S. AU - Brock, C. AU - Chen, S. C. AU - Al-Olabi, L. AU - Nixon, C. AU - McGregor, F. AU - Paine, S. AU - Chanudet, E. AU - Lambie, W. AU - Holmes, W. M. AU - Mullin, J. M. AU - Richmond, A. AU - Wu, H. AU - Blyth, K. AU - King, A. AU - Kinsler, V. A. AU - Adams, P. D. C2 - PMC4539947 C6 - NIHMS674239 DA - Aug DO - 10.1038/jid.2015.114 10.1038/jid.2015.114. Epub 2015 Mar 27. DP - Nlm ET - 2015/03/31 IS - 8 LA - eng PY - 2015 SN - 0022-202X (Print) 0022-202x SP - 2093-2101 ST - Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling T2 - J Invest Dermatol TI - Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling VL - 135 ID - 4857 ER - TY - JOUR AD - K. Sakamoto, Department of Pediatrics, School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-chou, Hirokouji, Kamigyo-ku, Kyoto, Japan AU - Sakamoto, K. AU - Imamura, T. AU - Asai, D. AU - Goto-Kawashima, S. AU - Yoshida, H. AU - Fujiki, A. AU - Furutani, A. AU - Ishida, H. AU - Aoki, Y. AU - Hosoi, H. DB - Embase Medline DO - 10.1097/MPH.0000000000000002 IS - 2 LA - English M3 - Article N1 - L52794026 2013-10-02 2014-03-13 PY - 2014 SN - 1077-4114 1536-3678 SP - e136-e139 ST - Acute lymphoblastic leukemia developing in a patient with noonan syndrome harboring a PTPN11 germline mutation T2 - Journal of Pediatric Hematology/Oncology TI - Acute lymphoblastic leukemia developing in a patient with noonan syndrome harboring a PTPN11 germline mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52794026&from=exporthttp://dx.doi.org/10.1097/MPH.0000000000000002 VL - 36 ID - 4858 ER - TY - JOUR AD - Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Health, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Department of Pediatrics, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China AU - Zhang, G. AU - Zhang, Y. AU - Wu, J. AU - Chen, Y. AU - Ma, Z. DB - Scopus DO - 10.12659/AJCR.906300 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 1204-1208 ST - Acute lymphoblastic leukemia patient with variant ATF7IP/PDGFRB fusion and favorable response to tyrosine kinase inhibitor treatment: A case report T2 - American Journal of Case Reports TI - Acute lymphoblastic leukemia patient with variant ATF7IP/PDGFRB fusion and favorable response to tyrosine kinase inhibitor treatment: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034239372&doi=10.12659%2fAJCR.906300&partnerID=40&md5=7ca36c3eeb17af8d198113fa87920be5 VL - 18 ID - 4859 ER - TY - JOUR AD - Department of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo, Japan. tago-mg@pha.keio.ac.jp AN - 19289461 AU - Funakoshi-Tago, M. AU - Tago, K. AU - Sumi, K. AU - Abe, M. AU - Aizu-Yokota, E. AU - Oshio, T. AU - Sonoda, Y. AU - Kasahara, T. C2 - PMC2675997 DA - May 8 DO - 10.1074/jbc.M808879200 10.1074/jbc.M808879200. Epub 2009 Mar 16. DP - Nlm ET - 2009/03/18 IS - 19 LA - eng PY - 2009 SN - 0021-9258 (Print) 0021-9258 SP - 12680-90 ST - The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice T2 - J Biol Chem TI - The acute lymphoblastic leukemia-associated JAK2 L611S mutant induces tumorigenesis in nude mice VL - 284 ID - 4860 ER - TY - JOUR AD - City of Hope Comprehensive Cancer Center, United States Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, United States UNMC Eppley Cancer Center, Nebraska Medical Center, United States Massachusetts General Hospital Cancer Center, United States University of Alabama, Birmingham Comprehensive Cancer Center, United States Ohio State University Comprehensive Cancer Center, James Cancer Hospital, Solove Research Institute, United States Huntsman Cancer Institute, University of Utah, United States Stanford Cancer Institute, United States H. Lee Moffitt Cancer Center, Research Institute, United States UCSF Helen Diller Family Comprehensive Cancer Center, United States Dana-Farber/Brigham and Women's Cancer Center, United States Memorial Sloan-Kettering Cancer Center, United States Vanderbilt-Ingram Cancer Center, United States Robert H. Lurie Comprehensive Cancer Center, Northwestern University, United States St. Jude Children's Research Hospital, University of Tennessee Cancer Institute, United States Fox Chase Cancer Center, United States University of Texas MD Anderson Cancer Center, United States University of Washington, Seattle Cancer Care Alliance, United States Duke Cancer Institute, United States Siteman Cancer Center, Barnes-Jewish Hospital, Washington University, United States Roswell Park Cancer Institute, United States AU - Alvarnas, J. C. AU - Brown, P. A. AU - Aoun, P. AU - Ballen, K. K. AU - Bellam, N. AU - Blum, W. AU - Boyer, M. W. AU - Carraway, H. E. AU - Coccia, P. F. AU - Coutre, S. E. AU - Cultrera, J. AU - Damon, L. E. AU - DeAngelo, D. J. AU - Douer, D. AU - Frangoul, H. AU - Frankfurt, O. AU - Goorha, S. AU - Millenson, M. M. AU - O'Brien, S. AU - Petersdorf, S. H. AU - Rao, A. V. AU - Terezakis, S. AU - Uy, G. AU - Wetzler, M. AU - Zelenetz, A. D. AU - Naganuma, M. AU - Gregory, K. M. DB - Scopus DO - 10.6004/jnccn.2012.0089 IS - 7 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2012 SP - 858-914 ST - Acute lymphoblastic leukemia: Clinical practice guidelines in oncology T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - Acute lymphoblastic leukemia: Clinical practice guidelines in oncology UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865327021&doi=10.6004%2fjnccn.2012.0089&partnerID=40&md5=e0c56234a29cab22dbc03f04b0a91eae VL - 10 ID - 4861 ER - TY - JOUR AD - E.A. Fuller, Laboratory of Neuroimmunology, School of Psychology, University of Newcastle, Newcastle, NSW, Australia AU - Fuller, E. A. AU - Sominsky, L. AU - McLaughlin, E. A. AU - Hodgson, D. M. DB - Embase DO - 10.1016/j.bbi.2015.06.136 LA - English M3 - Conference Abstract N1 - L622992824 2018-07-17 PY - 2015 SN - 1090-2139 SP - e35 ST - Acute neonatal immune challenge: Lipopolysaccharide exposure alters neonatal ovarian inflammatory pathways and mediators T2 - Brain, Behavior, and Immunity TI - Acute neonatal immune challenge: Lipopolysaccharide exposure alters neonatal ovarian inflammatory pathways and mediators UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622992824&from=exporthttp://dx.doi.org/10.1016/j.bbi.2015.06.136 VL - 49 ID - 4862 ER - TY - JOUR AD - K. Svojgr, CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, V Uvalu 84, 150 06, Prague 5, Czech Republic AU - Svojgr, K. AU - Kalina, T. AU - Kanderova, V. AU - Skopcova, T. AU - Brdicka, T. AU - Zuna, J. DB - Embase Medline DO - 10.1016/j.exphem.2012.01.011 IS - 5 LA - English M3 - Article N1 - L51868268 2012-02-27 2012-04-25 PY - 2012 SN - 0301-472X 1873-2399 SP - 379-385 ST - The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL T2 - Experimental Hematology TI - The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51868268&from=exporthttp://dx.doi.org/10.1016/j.exphem.2012.01.011 VL - 40 ID - 4863 ER - TY - JOUR AD - Department of Hematology and Oncology L. e A. Seràgnoli, University of Bologna, Bologna, Italy Department of Hematology, University of Bari, Bari, Italy Cytogenetics Unit, Treviso, Italy Department of Clinical and Biological Sciences, University of Torino, Orbassano, Italy Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy Department of Hematology, S. Eugenio, TorVergata University Hospital, Rome, Italy Department of Oncology and Hematology, Santa Maria Delle Croci Hospital, Ravenna, Italy Department of Medicine, Pathology Unit, University of Milano, Milan, Italy Department of Medicine and Immunological Sciences, Division of Hematology and Transplants, University of Siena, Siena, Italy Hematology Unit, Spedali Civili, Brescia, Italy Department of Biomedical Sciences, Section of Medical Genetics, University of Chieti, Chieti, Italy Institute of Hematology, Fondazione Policlinico San Matteo Istituto di Ricovero e Cura A Carattere Scientifico, University of Pavia, Pavia, Italy Department of Biochemistry and Medical Biotechnology, Federico II University, Napoli, Italy AU - Luatti, S. AU - Castagnetti, F. AU - Marzocchi, G. AU - Baldazzi, C. AU - Gugliotta, G. AU - Iacobucci, I. AU - Specchia, G. AU - Zanatta, L. AU - Rege-Cambrin, G. AU - Mancini, M. AU - Abruzzese, E. AU - Zaccaria, A. AU - Grimoldi, M. G. AU - Gozzetti, A. AU - Ameli, G. AU - Capucci, M. A. AU - Palka, G. AU - Bernasconi, P. AU - Palandri, F. AU - Pane, F. AU - Saglio, G. AU - Martinelli, G. AU - Rosti, G. AU - Baccarani, M. AU - Testoni, N. DB - Scopus DO - 10.1182/blood-2011-10-384651 IS - 4 M3 - Article N1 - Cited By :78 Export Date: 18 November 2020 PY - 2012 SP - 761-767 ST - Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis T2 - Blood TI - Additional chromosomal abnormalities in Philadelphia-positive clone: Adverse prognostic influence on frontline imatinib therapy: A GIMEMA Working Party on CML analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864478365&doi=10.1182%2fblood-2011-10-384651&partnerID=40&md5=260edbe106222c4499f63ac2dc14c195 VL - 120 ID - 4864 ER - TY - JOUR AD - J.A. Boyce, Smith Building, One Jimmy Fund Way, Boston, MA 02115, United States AU - Feng, C. AU - Mery, A. G. AU - Beller, E. M. AU - Favot, C. AU - Boyce, J. A. DB - Embase Medline DO - 10.4049/jimmunol.173.12.7539 IS - 12 LA - English M3 - Article N1 - L39628195 2005-01-10 PY - 2004 SN - 0022-1767 SP - 7539-7547 ST - Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor T2 - Journal of Immunology TI - Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39628195&from=exporthttp://dx.doi.org/10.4049/jimmunol.173.12.7539 VL - 173 ID - 4865 ER - TY - JOUR AD - Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy Hematology, Cattolica University, Rome, Italy Hematology, S. Eugenio Hospital, Rome, Italy S. Giovanni Hospital, Rome, Italy Hospital Cervello, Palermo, Italy San Martino Hospital, Genoa, Italy Hematology Unit, IRCCS AOU San Martino-IST, Genoa, Italy Careggi Hospital, Florence, Italy Hematology and Bone Marrow Transplant Unit, Businco Hopsital, Cagliari, Italy Ferrara University, Ferrara, Italy Department of Oncology Hematology, ASL Salerno, Sapri, Italy Udine University, Udine, Italy Padua University, Padova, Italy S. Giovanni Battista Hospital, Turin, Italy Siena University, Siena, Italy Amedeo Avogadro University of Eastern Piedmont, Novara, Italy Parma University, Parma, Italy Verona University, Verona, Italy Modena University, Modena, Italy Belcolle Hospital, Viterbo, Italy Trento Hospital, Trento, Italy Bianchi Melacrino Morelli Hospital, Reggio Calabria, Italy Cardarelli Hospital, Naples, Italy Federico II University, Naples, Italy Ferrarotto Hospital, Catania University, Catania, Italy Haematology Unit and Bone Marrow Transplant Centre, Guglielmo da Saliceto Hospital, Piacenza, Italy Niguarda Hospital, Milan, Italy IRCSS Cà Granda Policlinico, Milan, Italy Hematology and Bone Marrow Transplant Units, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy Brescia University, Brescia, Italy S. Matteo Hospital, Pavia, Italy Department of Health Sciences, University of Milano-Bicocca, Monza, Italy AU - Breccia, M. AU - Efficace, F. AU - Sica, S. AU - Abruzzese, E. AU - Cedrone, M. AU - Turri, D. AU - Gobbi, M. AU - Carella, A. M. AU - Gozzini, A. AU - Usala, E. AU - Cavazzini, F. AU - Danise, P. AU - Tiribelli, M. AU - Binotto, G. AU - Pregno, P. AU - Bocchia, M. AU - Gaidano, G. AU - Crugnola, M. AU - Bonifacio, M. AU - Avanzini, P. AU - Celesti, F. AU - Guella, A. AU - Martino, B. AU - Annunziata, M. AU - Luciano, L. AU - Stagno, F. AU - Vallisa, D. AU - Pungolino, E. AU - Iurlo, A. AU - Rambaldi, A. AU - Nardiello, I. AU - Orlandi, E. AU - Gambacorti-Passerini, C. AU - Alimena, G. DB - Scopus DO - 10.1016/j.leukres.2015.07.004 IS - 10 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2015 SP - 1055-1059 ST - Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients T2 - Leukemia Research TI - Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941317056&doi=10.1016%2fj.leukres.2015.07.004&partnerID=40&md5=f0d802ce5576ebcb6d20693921b8ee7b VL - 39 ID - 4866 ER - TY - JOUR AD - Hospital Pharmacy Department, Health Department of Gandia, Valencia, Spain Health Department, Hospital General, Valencia, Spain AU - Pérez Feliu, A. AU - Marco Garbayo, J. L. AU - Blasco Segura, P. AU - Pérez Castelĺo, I. AU - Peiró Barber, E. DB - Scopus IS - 6 M3 - Article N1 - Export Date: 18 November 2020 PY - 2013 SP - 390-396 ST - Adherence to treatment with tyrosine kinase inhibitors T2 - Atencion Farmaceutica TI - Adherence to treatment with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895782848&partnerID=40&md5=6e75cd7c8862658cc49cca209eb3ff08 VL - 15 ID - 4867 ER - TY - JOUR AD - Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta Georgia Department of Radiation Oncology, Emory School of Medicine, Atlanta Georgia Department of Hematology and Medical Oncology, Emory School of Medicine, Atlanta Georgia AN - 145624540. Language: English. Entry Date: 20200914. Revision Date: 20200914. Publication Type: Article AU - Yeager, Katherine A. AU - Waldrop‐Valverde, Drenna AU - Paul, Sudeshna AU - Bruner, Deborah Watkins AU - Klisovic, Rebecca AU - Burns, Emily AU - Mason, Tamara A. AU - Patel, Nisha AU - Jennings, Bonnie Mowinski DB - ccm DO - 10.1002/nur.22069 DP - EBSCOhost IS - 5 N1 - research; review; tables/charts. Journal Subset: Core Nursing; Nursing; Peer Reviewed; USA. Instrumentation: EORTC QLQ-C30. Grant Information: This work was supported by the National Cancer Institute; National Institutes of Health.. NLM UID: 7806136. PY - 2020 SN - 0160-6891 SP - 443-452 ST - Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol T2 - Research in Nursing & Health TI - Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145624540&site=ehost-live&scope=site VL - 43 ID - 4868 ER - TY - JOUR AD - T. Guo, Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan,HuBei, China AU - Yu, W. AU - Cao, D. D. AU - Li, Q. B. AU - Mei, H. L. AU - Hu, Y. AU - Guo, T. DB - Embase IS - 52 LA - English M3 - Article N1 - L613929736 2017-01-09 PY - 2016 SN - 1949-2553 SP - 86075-86086 ST - Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy T2 - Oncotarget TI - Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613929736&from=export VL - 7 ID - 4869 ER - TY - JOUR AD - C. Skurk, Department of Cardiology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany AU - Jenke, A. AU - Schur, R. AU - Röger, C. AU - Karadeniz, Z. AU - Grüger, M. AU - Holzhauser, L. AU - Savvatis, K. AU - Poller, W. AU - Schultheiss, H. P. AU - Landmesser, U. AU - Skurk, C. C1 - pd 098059 r 848 sp 600125 DB - Embase Medline DO - 10.14814/phy2.13523 IS - 24 LA - English M3 - Article N1 - L619927826 2017-12-28 2017-12-29 PY - 2017 SN - 2051-817X ST - Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice T2 - Physiological Reports TI - Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619927826&from=exporthttp://dx.doi.org/10.14814/phy2.13523 VL - 5 ID - 4870 ER - TY - JOUR AD - C. Skurk, Department of Cardiology and Pneumology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany AU - Jenke, A. AU - Wilk, S. AU - Poller, W. AU - Eriksson, U. AU - Valaperti, A. AU - Rauch, B. H. AU - Stroux, A. AU - Liu, P. AU - Schultheiss, H. P. AU - Scheibenbogen, C. AU - Skurk, C. DB - Embase Medline DO - 10.1093/cvr/cvt118 IS - 3 LA - English M3 - Article N1 - L608851341 2016-03-14 2016-03-22 PY - 2013 SN - 1755-3245 0008-6363 SP - 422-431 ST - Adiponectin protects against toll-like receptor 4-mediated cardiac inflammation and injury T2 - Cardiovascular Research TI - Adiponectin protects against toll-like receptor 4-mediated cardiac inflammation and injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608851341&from=exporthttp://dx.doi.org/10.1093/cvr/cvt118 VL - 99 ID - 4871 ER - TY - JOUR AD - S. Naviglio, Dipartimento di Medicina di Precisione, Università Degli Studi della Campania Luigi Vanvitelli, Via L. De Crecchio 7, Naples, Italy AU - Sapio, L. AU - Nigro, E. AU - Ragone, A. AU - Salzillo, A. AU - Illiano, M. AU - Spina, A. AU - Polito, R. AU - Daniele, A. AU - Naviglio, S. DB - Embase DO - 10.1155/2020/7262479 LA - English M3 - Article N1 - L2004859118 2020-02-17 2020-02-24 PY - 2020 SN - 1687-8469 1687-8450 ST - AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells T2 - Journal of Oncology TI - AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004859118&from=exporthttp://dx.doi.org/10.1155/2020/7262479 VL - 2020 ID - 4872 ER - TY - JOUR AD - Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address: pippa.corrie@addenbrookes.nhs.uk. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. Medical Oncology, Mount Vernon Hospital, Northwood, UK. Department of Medical Oncology, Christie Hospital, Manchester, UK. Royal Marsden Hospital NHS Trust, London, UK. Oncology Research, Broomfield Hospital, Chelmsford, UK. Oncology Department, Leicester Royal Infirmary, Leicester, UK. Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle upon Tyne, UK. Leeds Cancer Centre, St James's University Hospital, Leeds, UK. Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, UK. Cancer & Palliative Care, St. Helen's Hospital, St. Helens, UK. Oncology Department, Royal Surrey County Hospital, Guildford, UK. Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. Clinical Trials Unit, Beatson WOS Cancer Centre, Glasgow, UK. Department of Clinical Oncology, Norfolk & Norwich University Hospital, Norwich, UK. Guy's & St. Thomas' Hospital, Guy's Cancer Centre, London, UK. Velindre Cancer Centre, Cardiff, UK. Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK. St George's Hospital, Cancer Centre, London, UK. Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK. Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK. Cancer Centre, Ninewells Hospital, Dundee, UK. Royal Free Hospital, London, UK. Castle Hill Hospital, Cottingham, UK. Academic Unit of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK. CRUK and NIHR Southampton Experimental Cancer Medicine Centre, Southampton University Hospitals NHS Foundation Trust, Southampton, UK. Oncology Centre, Cheltenham General Hospital, Cheltenham, UK. Oncology Department, James Cook University Hospital, Middlesbrough, UK. Oncology Department, Poole Hospital, Dorset, UK. Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Department of Oncology, University of Oxford, Oxford, UK; Experimental Cancer Medicine Centre, Oxford, UK. Melanoma Focus, Cambridge, UK. Oxford NIHR Biomedical Research Centre, Oxford, UK. AN - 30010756 AU - Corrie, P. G. AU - Marshall, A. AU - Nathan, P. D. AU - Lorigan, P. AU - Gore, M. AU - Tahir, S. AU - Faust, G. AU - Kelly, C. G. AU - Marples, M. AU - Danson, S. J. AU - Marshall, E. AU - Houston, S. J. AU - Board, R. E. AU - Waterston, A. M. AU - Nobes, J. P. AU - Harries, M. AU - Kumar, S. AU - Goodman, A. AU - Dalgleish, A. AU - Martin-Clavijo, A. AU - Westwell, S. AU - Casasola, R. AU - Chao, D. AU - Maraveyas, A. AU - Patel, P. M. AU - Ottensmeier, C. H. AU - Farrugia, D. AU - Humphreys, A. AU - Eccles, B. AU - Young, G. AU - Barker, E. O. AU - Harman, C. AU - Weiss, M. AU - Myers, K. A. AU - Chhabra, A. AU - Rodwell, S. H. AU - Dunn, J. A. AU - Middleton, M. R. AU - Nathan, P. AU - Lorigan, P. AU - Dziewulski, P. AU - Holikova, S. AU - Panwar, U. AU - Tahir, S. AU - Faust, G. AU - Thomas, A. AU - Corrie, P. AU - Sirohi, B. AU - Kelly, C. AU - Middleton, M. AU - Marples, M. AU - Danson, S. AU - Lester, J. AU - Marshall, E. AU - Ajaz, M. AU - Houston, S. AU - Board, R. AU - Eaton, D. AU - Waterston, A. AU - Nobes, J. AU - Loo, S. AU - Gray, G. AU - Stubbings, H. AU - Gore, M. AU - Harries, M. AU - Kumar, S. AU - Goodman, A. AU - Dalgleish, A. AU - Martin-Clavijo, A. AU - Marsden, J. AU - Westwell, S. AU - Casasola, R. AU - Chao, D. AU - Maraveyas, A. AU - Marshall, E. AU - Patel, P. AU - Ottensmeier, C. AU - Farrugia, D. AU - Humphreys, A. AU - Eccles, B. AU - Dega, R. AU - Herbert, C. AU - Price, C. AU - Brunt, M. AU - Scott-Brown, M. AU - Hamilton, J. AU - Hayward, R. L. AU - Smyth, J. AU - Woodings, P. AU - Nayak, N. AU - Burrows, L. AU - Wolstenholme, V. AU - Wagstaff, J. AU - Nicolson, M. AU - Wilson, A. AU - Barlow, C. AU - Scrase, C. AU - Podd, T. AU - Gonzalez, M. AU - Stewart, J. AU - Highley, M. AU - Wolstenholme, V. AU - Grumett, S. AU - Goodman, A. AU - Talbot, T. AU - Nathan, K. AU - Coltart, R. AU - Gee, B. AU - Gore, M. AU - Farrugia, D. AU - Martin-Clavijo, A. AU - Marsden, J. AU - Price, C. AU - Farrugia, D. AU - Nathan, K. AU - Coltart, R. AU - Nathan, K. AU - Coltart, R. C2 - PMC6096737 DA - Aug 1 DO - 10.1093/annonc/mdy229 10.1093/annonc/mdy229. DP - Nlm ET - 2018/07/17 IS - 8 LA - eng PY - 2018 SN - 0923-7534 (Print) 0923-7534 SP - 1843-1852 ST - Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial T2 - Ann Oncol TI - Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial VL - 29 ID - 4873 ER - TY - JOUR AD - From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). AN - 28891408 AU - Long, G. V. AU - Hauschild, A. AU - Santinami, M. AU - Atkinson, V. AU - Mandalà, M. AU - Chiarion-Sileni, V. AU - Larkin, J. AU - Nyakas, M. AU - Dutriaux, C. AU - Haydon, A. AU - Robert, C. AU - Mortier, L. AU - Schachter, J. AU - Schadendorf, D. AU - Lesimple, T. AU - Plummer, R. AU - Ji, R. AU - Zhang, P. AU - Mookerjee, B. AU - Legos, J. AU - Kefford, R. AU - Dummer, R. AU - Kirkwood, J. M. DA - Nov 9 DO - 10.1056/NEJMoa1708539 10.1056/NEJMoa1708539. Epub 2017 Sep 10. DP - Nlm ET - 2017/09/12 IS - 19 LA - eng PY - 2017 SN - 0028-4793 SP - 1813-1823 ST - Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma T2 - N Engl J Med TI - Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma VL - 377 ID - 4874 ER - TY - JOUR AD - University Hospital Zürich Skin Cancer Center, Zürich, Switzerland. Electronic address: reinhard.dummer@usz.ch. Novartis Pharma, Basel, Switzerland. Novartis Institutes for BioMedical Research, Cambridge, MA, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane, QLD, Australia. Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy. Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA. Royal Marsden NHS Foundation Trust, London, UK. Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif, France. Macquarie University and Westmead Hospital, Sydney, NSW, Australia; Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia. Melanoma Program, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. University Hospital Schleswig-Holstein, Kiel, Germany. University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. Melanoma Institute Australia and The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. AN - 32007138 AU - Dummer, R. AU - Brase, J. C. AU - Garrett, J. AU - Campbell, C. D. AU - Gasal, E. AU - Squires, M. AU - Gusenleitner, D. AU - Santinami, M. AU - Atkinson, V. AU - Mandalà, M. AU - Chiarion-Sileni, V. AU - Flaherty, K. AU - Larkin, J. AU - Robert, C. AU - Kefford, R. AU - Kirkwood, J. M. AU - Hauschild, A. AU - Schadendorf, D. AU - Long, G. V. DA - Mar DO - 10.1016/s1470-2045(20)30062-0 10.1016/S1470-2045(20)30062-0. Epub 2020 Jan 30. DP - Nlm ET - 2020/02/03 IS - 3 LA - eng PY - 2020 SN - 1470-2045 SP - 358-372 ST - Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial T2 - Lancet Oncol TI - Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial VL - 21 ID - 4875 ER - TY - JOUR AD - B. Dréno, Dermato-cancerology Department, CHU Nantes, Place Alexis Ricordeau, Nantes, France AU - Saint-Jean, M. AU - Knol, A. C. AU - Volteau, C. AU - Quéreux, G. AU - Peuvrel, L. AU - Brocard, A. AU - Pandolfino, M. C. AU - Saiagh, S. AU - Nguyen, J. M. AU - Bedane, C. AU - Basset-Seguin, N. AU - Khammari, A. AU - Dréno, B. C1 - azd 6244(Astra Zeneca) proleukin(Chiron,United States) C2 - Astra Zeneca Chiron(United States) DB - Embase Medline DO - 10.1155/2018/3530148 LA - English M3 - Article N1 - L624692383 2018-11-16 2019-01-24 PY - 2018 SN - 2314-7156 2314-8861 ST - Adoptive cell therapy with tumor-infiltrating lymphocytes in advanced melanoma patients T2 - Journal of Immunology Research TI - Adoptive cell therapy with tumor-infiltrating lymphocytes in advanced melanoma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624692383&from=exporthttp://dx.doi.org/10.1155/2018/3530148 VL - 2018 ID - 4876 ER - TY - JOUR AD - 1 Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, China 2 Department of Huiqiao Building, Southern Medical University, Guangzhou, China AU - Xie, F. AU - Sun, S. AU - Xu, A. AU - Zheng, S. AU - Xue, M. AU - Wu, P. AU - Zeng, J. H. AU - Bai, L. DB - Scopus DO - 10.1038/cddis.2013.542 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2014 ST - Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway T2 - Cell death & disease TI - Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906920653&doi=10.1038%2fcddis.2013.542&partnerID=40&md5=cb2bd277056c46f6fd9c47ce03a60eb1 VL - 5 ID - 4877 ER - TY - JOUR AD - M.A. Piris, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain AU - Pérez, C. AU - Mondéjar, R. AU - García-Díaz, N. AU - Cereceda, L. AU - León, A. AU - Montes, S. AU - Durán Vian, C. AU - Pérez Paredes, M. G. AU - González-Morán, A. AU - Alegre de Miguel, V. AU - Sanz Anquela, J. M. AU - Frias, J. AU - Limeres, M. A. AU - González, L. M. AU - Martín Dávila, F. AU - Beltrán, M. AU - Mollejo, M. AU - Méndez, J. R. AU - González, M. A. AU - González García, J. AU - López, R. AU - Gómez, A. AU - Izquierdo, F. AU - Ramos, R. AU - Camacho, C. AU - Rodriguez-Pinilla, S. M. AU - Martínez, N. AU - Vaqué, J. P. AU - Ortiz-Romero, P. L. AU - Piris, M. A. DB - Embase Medline DO - 10.1111/bjd.18098 IS - 1 LA - English M3 - Article N1 - L628873092 2019-08-16 2020-01-16 PY - 2020 SN - 1365-2133 0007-0963 SP - 147-155 ST - Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways T2 - British Journal of Dermatology TI - Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628873092&from=exporthttp://dx.doi.org/10.1111/bjd.18098 VL - 182 ID - 4878 ER - TY - JOUR AD - Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, UT, United States Children's Hospital of Philadelphia, Philadelphia, PA, United States Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, United States Rady Children's Hospital, San Diego, CA, United States Johns Hopkins University School of Medicine, Baltimore, MD, United States Monroe Carell Jr Children's Hospital at Vanderbilt Children's Hospital, Nashville, TN, United States Children's Cancer Hospital, M.D. Anderson Cancer Center, Houston, TX, United States Children's Memorial Medical Center at Chicago, Chicago, IL, United States Children's Hospital of Pittsburgh, Pittsburgh, PA, United States Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada All Children's Hospital, St. Petersburg, FL, United States C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, United States University of California San Francisco School of Medicine, San Francisco, CA, United States Nationwide Children'sHospital, Columbus, OH, United States NYU Medical Center, Hassenfeld Children's Center, New York University, New York, United States Washington University Medical Center, Washington University, St Louis, MO, United States University of California Medical Center, University of California Davis, Sacramento, CA, United States Columbia Presbyterian College of Physicians and Surgeons, New York, United States British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada AU - Pulsipher, M. A. AU - Horwitz, E. M. AU - Haight, A. E. AU - Kadota, R. AU - Chen, A. R. AU - Frangoul, H. AU - Cooper, L. J. N. AU - Jacobsohn, D. A. AU - Goyal, R. K. AU - Mitchell, D. AU - Nieder, M. L. AU - Yanik, G. AU - Cowan, M. J. AU - Soni, S. AU - Gardner, S. AU - Shenoy, S. AU - Taylor, D. AU - Cairo, M. AU - Schultz, K. R. DB - Scopus DO - 10.1016/j.bbmt.2009.12.536 IS - 9 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - 1212-1221 ST - Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium T2 - Biology of Blood and Marrow Transplantation TI - Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955509680&doi=10.1016%2fj.bbmt.2009.12.536&partnerID=40&md5=752ad9d78ec31b4aa7d93b9b3c34dae8 VL - 16 ID - 4879 ER - TY - JOUR AD - J.M. Brandwein, Division of Hematology, Department of Medicine, University of Alberta, 11350-83 Ave., Suite 4-112 CSB, Edmonton, AB, Canada AU - Mohseni, M. AU - Uludag, H. AU - Brandwein, J. M. DB - Embase IS - 4 LA - English M3 - Review N1 - L2001995030 2019-06-11 PY - 2018 SN - 2160-1992 SP - 29-56 ST - Advances in biology of acute lymphoblastic leukemia (All) and therapeutic implications T2 - American Journal of Blood Research TI - Advances in biology of acute lymphoblastic leukemia (All) and therapeutic implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001995030&from=export VL - 8 ID - 4880 ER - TY - JOUR AD - M.S. Cairo, Division of Pediatric Oncology, Hematology and Stem Cell Transplantation, Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, Department of Pediatrics, New York Medical College, Munger Pavilion, Valhalla, NY 10595, United States AU - Cairo, M. S. AU - Woessmann, W. AU - Pagel, J. C1 - vp 16 DB - Embase Medline DO - 10.1016/j.bbmt.2012.10.003 IS - 1 SUPPL. LA - English M3 - Article N1 - L368045423 2013-01-10 2013-01-16 PY - 2013 SN - 1083-8791 1523-6536 SP - S38-S43 ST - Advances in Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Lymphomas T2 - Biology of Blood and Marrow Transplantation TI - Advances in Hematopoietic Stem Cell Transplantation in Childhood and Adolescent Lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368045423&from=exporthttp://dx.doi.org/10.1016/j.bbmt.2012.10.003 VL - 19 ID - 4881 ER - TY - JOUR AD - Duke University, Division of Hematology/Oncology, Durham, NC, United States St. Jude Children's Research Hospital, Division of Bone Marrow Transplantation and Cellular Therapy, Memphis, TN, United States AU - Barfield, R. C. AU - Kasow, K. A. AU - Hale, G. A. DB - Scopus DO - 10.4161/cbt.7.10.7046 IS - 10 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2008 SP - 1533-1539 ST - Advances in pediatric hematopoietic stem cell transplantation T2 - Cancer Biology and Therapy TI - Advances in pediatric hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54349108616&doi=10.4161%2fcbt.7.10.7046&partnerID=40&md5=05cf48d0d64bf219782d236d92fa5f7b VL - 7 ID - 4882 ER - TY - JOUR AD - Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States AU - Cook, J. AU - Litzow, M. DB - Scopus DO - 10.1007/s11899-020-00585-2 IS - 4 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 276-293 ST - Advances in Supportive Care for Acute Lymphoblastic Leukemia T2 - Current Hematologic Malignancy Reports TI - Advances in Supportive Care for Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087359310&doi=10.1007%2fs11899-020-00585-2&partnerID=40&md5=fa026ead7fe5a85fb40d752b8eb43448 VL - 15 ID - 4883 ER - TY - JOUR AD - S. Mueller, Department of Oncology and Children’s Research Center, University Children’s Hospital Zurich, Steinwiesstrasse 75, Zurich, Switzerland AU - Mueller, T. AU - Stucklin, A. S. G. AU - Postlmayr, A. AU - Metzger, S. AU - Gerber, N. AU - Kline, C. AU - Grotzer, M. AU - Nazarian, J. AU - Mueller, S. DB - Embase DO - 10.1007/s11940-020-00651-3 IS - 12 LA - English M3 - Review N1 - L2007249949 2020-11-16 PY - 2020 SN - 1534-3138 1092-8480 ST - Advances in Targeted Therapies for Pediatric Brain Tumors T2 - Current Treatment Options in Neurology TI - Advances in Targeted Therapies for Pediatric Brain Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007249949&from=exporthttp://dx.doi.org/10.1007/s11940-020-00651-3 VL - 22 ID - 4884 ER - TY - JOUR AD - A.A. Nageswara Rao, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, United States AU - Nageswara Rao, A. A. AU - Packer, R. J. DB - Embase Medline DO - 10.1007/s11912-014-0398-9 IS - 8 LA - English M3 - Review N1 - L53192888 2014-06-17 2014-08-11 PY - 2014 SN - 1534-6269 1523-3790 ST - Advances in the management of low-grade gliomas T2 - Current Oncology Reports TI - Advances in the management of low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53192888&from=exporthttp://dx.doi.org/10.1007/s11912-014-0398-9 VL - 16 ID - 4885 ER - TY - JOUR AD - Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Wells, S. A., Jr. DB - Scopus DO - 10.1530/ERC-17-0325 IS - 2 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - T1-T13 ST - Advances in the management of MEN2: From improved surgical and medical treatment to novel kinase inhibitors T2 - Endocrine-Related Cancer TI - Advances in the management of MEN2: From improved surgical and medical treatment to novel kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042589993&doi=10.1530%2fERC-17-0325&partnerID=40&md5=dbe9343b41224915c813f9c3af8f4ecb VL - 25 ID - 4886 ER - TY - JOUR AD - V. Ramaswamy, Department of Medical Biophysics and Pediatrics, University of Toronto, Toronto, ON, Canada AU - Cacciotti, C. AU - Fleming, A. AU - Ramaswamy, V. DB - Embase Medline DO - 10.1002/path.5457 IS - 3 LA - English M3 - Review N1 - L2005188464 2020-06-30 2020-07-09 PY - 2020 SN - 1096-9896 0022-3417 SP - 249-261 ST - Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy T2 - Journal of Pathology TI - Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005188464&from=exporthttp://dx.doi.org/10.1002/path.5457 VL - 251 ID - 4887 ER - TY - JOUR AD - Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY. AN - 26637768 AU - Kobos, R. AU - Terry, W. DO - 10.1182/asheducation-2015.1.522 10.1182/asheducation-2015.1.522. DP - Nlm ET - 2015/12/08 LA - eng PY - 2015 SN - 1520-4383 SP - 522-8 ST - Advances in therapies for non-Hodgkin lymphoma in children T2 - Hematology Am Soc Hematol Educ Program TI - Advances in therapies for non-Hodgkin lymphoma in children VL - 2015 ID - 4888 ER - TY - JOUR AD - Department of Paediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany AU - Bleckmann, K. AU - Schrappe, M. DB - Scopus DO - 10.1111/bjh.13896 IS - 6 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2016 SP - 855-869 ST - Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence T2 - British Journal of Haematology TI - Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959887457&doi=10.1111%2fbjh.13896&partnerID=40&md5=8d82e5046af4ba3262af13fddae355f7 VL - 172 ID - 4889 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Division of Pediatric Endocrinology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand AU - Choeyprasert, W. AU - Yansomdet, T. AU - Natesirinilkul, R. AU - Wejaphikul, K. AU - Charoenkwan, P. DB - Scopus DO - 10.1111/ped.13136 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 286-292 ST - Adverse effects of imatinib in children with chronic myelogenous leukemia T2 - Pediatrics International TI - Adverse effects of imatinib in children with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85005810433&doi=10.1111%2fped.13136&partnerID=40&md5=dcf726799d539de67b818005c27caa99 VL - 59 ID - 4890 ER - TY - JOUR AD - K. Amaro Hosey, Clinical Pharmacology Service, Vall d'Hebron University Hospital, Barcelona, Spain AU - Amaro Hosey, K. AU - Danés Carreras, I. AU - Vendrell Bosch, L. AU - Cereza García, G. AU - RenedoMiró, B. AU - Alonso García, L. AU - Dapena Díaz, J. L. AU - Gros Subías, L. AU - Diogène Fadini, E. DB - Embase DO - 10.1007/s00228-019-02685-2 LA - English M3 - Conference Abstract N1 - L628798457 2019-08-08 PY - 2019 SN - 1432-1041 SP - S23 ST - Adverse reactions to drugs of special interest in a pediatric oncohematology service T2 - European Journal of Clinical Pharmacology TI - Adverse reactions to drugs of special interest in a pediatric oncohematology service UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628798457&from=exporthttp://dx.doi.org/10.1007/s00228-019-02685-2 VL - 75 ID - 4891 ER - TY - JOUR AD - Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, PO box 9600, 2300 RC Leiden, The Netherlands. Department of Medical Oncology, Maastricht University Medical Center, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands. Department of Medical Oncology, Zuyderland Medical Center, 6130 MB Sittard-Geleen, The Netherlands. Department of Medical Oncology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands. Department of Pediatric Oncology, Princess Máxima Center, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands. Isala Oncology Center, Isala, 8000 GK Zwolle, The Netherlands. Department of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Department of Medical Oncology, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands. Department of Medical Oncology, Medical Center Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands. Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Department of Medical Oncology, Amphia Ziekenhuis, Langendijk 175, 4819 EV Breda, The Netherlands. Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3000 CA Rotterdam, The Netherlands. Department of Medical Oncology, Maxima Medical Center, de Run 4600, 5500 MB Veldhoven, The Netherlands. Department of Surgical Oncology, Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands. Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, PO box 9600, 2300 RC Leiden, The Netherlands. AN - 32726988 AU - van der Kooij, M. K. AU - Wetzels, Mjal AU - Aarts, M. J. B. AU - van den Berkmortel, Fwpj AU - Blank, C. U. AU - Boers-Sonderen, M. J. AU - Dierselhuis, M. P. AU - de Groot, J. W. B. AU - Hospers, G. A. P. AU - Piersma, D. AU - van Rijn, R. S. AU - Suijkerbuijk, K. P. M. AU - Ten Tije, A. J. AU - van der Veldt, A. A. M. AU - Vreugdenhil, G. AU - Wouters, Mwjm AU - Haanen, Jbag AU - van den Eertwegh, A. J. M. AU - Bastiaannet, E. AU - Kapiteijn, E. C2 - PMC7464956 DA - Jul 27 DO - 10.3390/cancers12082072 10.3390/cancers12082072. DP - Nlm ET - 2020/07/31 IS - 8 LA - eng PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response T2 - Cancers (Basel) TI - Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response VL - 12 ID - 4892 ER - TY - JOUR AD - Diabetes Center, Tokyo Women's Medical University, School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Dept. Biochem. Molec. Vasc. Biol., Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan Department of Biochemistry, Faculty of Pharmaceutical Science, Hokuriku University, Kanazawa, Japan Department of Stem Cell Biology, Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan Div. of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka-ken, Japan Diabetes Center, Eastern Japan Medical Institute, Kanagawa, Japan AU - Miura, J. AU - Uchigata, Y. AU - Yamamoto, Y. AU - Takeuchi, M. AU - Sakurai, S. AU - Watanabe, T. AU - Yonekura, H. AU - Yamagishi, S. I. AU - Makita, Z. AU - Omori, A. AU - Omori, Y. AU - Yamamoto, H. AU - Iwamoto, Y. DB - Scopus DO - 10.1016/S1056-8727(02)00281-7 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2004 SP - 53-59 ST - AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes T2 - Journal of Diabetes and its Complications TI - AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-12144291515&doi=10.1016%2fS1056-8727%2802%2900281-7&partnerID=40&md5=a22226b0a49359bea5e4925e91b47f0f VL - 18 ID - 4893 ER - TY - JOUR AD - A.L. Wang, Peking University Eye Centre, Peking University Third Hospital, Peking University, Beijing, 100083, China AU - Wang, A. L. AU - Yu, A. C. H. AU - He, Q. H. AU - Zhu, X. AU - Tso, M. O. M. DB - Embase Medline DO - 10.1016/j.exer.2007.01.011 IS - 5 LA - English M3 - Article N1 - L46613882 2007-05-01 PY - 2007 SN - 0014-4835 SP - 905-913 ST - AGEs mediated expression and secretion of TNF alpha in rat retinal microglia T2 - Experimental Eye Research TI - AGEs mediated expression and secretion of TNF alpha in rat retinal microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46613882&from=exporthttp://dx.doi.org/10.1016/j.exer.2007.01.011 VL - 84 ID - 4894 ER - TY - JOUR AD - R. Kebudi, Pediatric Hematology-Oncology, Istanbul University, Cerrahpasa Medical Faculty and Oncology Institute, Istanbul, Turkey AU - Kebudi, R. AU - Gorgun, O. AU - Dogan, O. DB - Embase LA - English M3 - Conference Abstract N1 - L620333990 2018-01-30 PY - 2017 SN - 1528-0020 ST - Aggresive lymphoma-leukemia presenting as a solitary bone tumor and mimicking ewing's sarcoma T2 - Blood TI - Aggresive lymphoma-leukemia presenting as a solitary bone tumor and mimicking ewing's sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620333990&from=export VL - 130 ID - 4895 ER - TY - JOUR AD - *Pediatric Hematology-Oncology-BMT, CancerCare Manitoba ‡Department of Pathology, University of Manitoba, Winnipeg, MB, Canada †Department of Pediatrics, King Fahd Hospital of the University and Medical College, University of Dammam, Dammam, Saudi Arabia. AN - 27271810 AU - Shash, H. AU - Stefanovici, C. AU - Phillips, S. AU - Cuvelier, G. D. DA - Nov DO - 10.1097/mph.0000000000000594 10.1097/MPH.0000000000000594. DP - Nlm ET - 2016/10/22 IS - 8 LA - eng PY - 2016 SN - 1077-4114 SP - 642-645 ST - Aggressive Metastatic Inflammatory Myofibroblastic Tumor After Allogeneic Stem Cell Transplant With Fatal Pulmonary Toxicity From Crizotinib T2 - J Pediatr Hematol Oncol TI - Aggressive Metastatic Inflammatory Myofibroblastic Tumor After Allogeneic Stem Cell Transplant With Fatal Pulmonary Toxicity From Crizotinib VL - 38 ID - 4896 ER - TY - JOUR AD - A. Hoshino, Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Toyama, Japan AU - Hoshino, A. AU - Nomura, K. AU - Hamashima, T. AU - Isobe, T. AU - Seki, M. AU - Hiwatari, M. AU - Yoshida, K. AU - Shiraishi, Y. AU - Chiba, K. AU - Tanaka, H. AU - Miyano, S. AU - Ogawa, S. AU - Takita, J. AU - Kanegane, H. DB - Embase Medline DO - 10.1007/s12185-014-1701-0 IS - 2 LA - English M3 - Article N1 - L600545115 2014-11-28 2015-05-12 PY - 2015 SN - 1865-3774 0925-5710 SP - 198-202 ST - Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes T2 - International Journal of Hematology TI - Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600545115&from=exporthttp://dx.doi.org/10.1007/s12185-014-1701-0 VL - 101 ID - 4897 ER - TY - JOUR AD - J.M. Cerutti, Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, SP, Brazil AU - Cordioli, M. I. C. V. AU - Moraes, L. AU - Carvalheira, G. AU - Sisdelli, L. AU - Alves, M. T. S. AU - Delcelo, R. AU - Monte, O. AU - Longui, C. A. AU - Cury, A. N. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1002/cam4.698 IS - 7 LA - English M3 - Article N1 - L611254669 2016-07-21 2016-07-28 PY - 2016 SN - 2045-7634 SP - 1535-1541 ST - AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma T2 - Cancer Medicine TI - AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611254669&from=exporthttp://dx.doi.org/10.1002/cam4.698 VL - 5 ID - 4898 ER - TY - JOUR AD - J.M. Cerutti, Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil AU - Sisdelli, L. AU - Cordioli, M. I. C. V. AU - Vaisman, F. AU - Moraes, L. AU - Colozza-Gama, G. A. AU - Alves, P. A. G. AU - Araújo, M. L. AU - Alves, M. T. S. AU - Monte, O. AU - Longui, C. A. AU - Cury, A. N. AU - Carvalheira, G. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1002/pbc.27707 IS - 7 LA - English M3 - Article N1 - L626985467 2019-04-04 2019-06-03 PY - 2019 SN - 1545-5017 1545-5009 ST - AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma T2 - Pediatric Blood and Cancer TI - AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626985467&from=exporthttp://dx.doi.org/10.1002/pbc.27707 VL - 66 ID - 4899 ER - TY - JOUR AD - Department of Medical Genetics, Faculty of Medicine, Baskent University, Ankara, Turkey Department of Hematology, Faculty of Medicine, Baskent University, Ankara, Turkey AU - Balci, T. B. AU - Sahin, F. I. AU - Karakus, S. AU - Ozdogu, H. DB - Scopus DO - 10.1179/102453311X13127324303272 IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2011 SP - 357-360 ST - AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients T2 - Hematology TI - AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-82955213546&doi=10.1179%2f102453311X13127324303272&partnerID=40&md5=10babd0e1fb5006e6c6b625033013c39 VL - 16 ID - 4900 ER - TY - JOUR AD - J. Roth, Institute of Immunology, University of Muenster, Münster, Germany AU - Holzinger, D. AU - Tenbrock, K. AU - Roth, J. DB - Embase Medline DO - 10.3389/fimmu.2019.00182 IS - FEB LA - English M3 - Review N1 - L627779955 2019-05-29 PY - 2019 SN - 1664-3224 ST - Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases T2 - Frontiers in Immunology TI - Alarmins of the S100-family in juvenile autoimmune and auto-inflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627779955&from=exporthttp://dx.doi.org/10.3389/fimmu.2019.00182 VL - 10 ID - 4901 ER - TY - JOUR AD - H. Bian, Newborn Department, Yancheng Maternity and Child Health Care Hospital, Yancheng, Jiangsu Province, China AU - Cai, Z. AU - Liu, J. AU - Bian, H. AU - Cai, J. C2 - National Institute for Food and Drug Control(China) DB - Embase IS - 12 LA - English M3 - Article N1 - L2004518887 2020-01-23 2020-01-31 PY - 2019 SN - 1943-8141 SP - 7300-7309 ST - Albiflorin alleviates ovalbumin (OVA)-induced pulmonary inflammation in asthmatic mice T2 - American Journal of Translational Research TI - Albiflorin alleviates ovalbumin (OVA)-induced pulmonary inflammation in asthmatic mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004518887&from=export VL - 11 ID - 4902 ER - TY - JOUR AD - J. Luo, Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, United States AU - Luo, J. DB - Embase DO - 10.1111/acer.13748 LA - English M3 - Conference Abstract N1 - L622676155 2018-06-28 PY - 2018 SN - 1530-0277 SP - 305A ST - Alcohol and breast cancer stem cells T2 - Alcoholism: Clinical and Experimental Research TI - Alcohol and breast cancer stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622676155&from=exporthttp://dx.doi.org/10.1111/acer.13748 VL - 42 ID - 4903 ER - TY - JOUR AD - Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands. AN - 10911802 AU - ten Berge, R. L. AU - Oudejans, J. J. AU - Ossenkoppele, G. J. AU - Pulford, K. AU - Willemze, R. AU - Falini, B. AU - Chott, A. AU - Meijer, C. J. C2 - PMC1731216 DA - Jun DO - 10.1136/jcp.53.6.445 10.1136/jcp.53.6.445. DP - Nlm ET - 2000/07/27 IS - 6 LA - eng PY - 2000 SN - 0021-9746 (Print) 0021-9746 SP - 445-50 ST - ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination T2 - J Clin Pathol TI - ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination VL - 53 ID - 4904 ER - TY - JOUR AD - Department of Pathology, A. I. DuPont Hospital for Children, Wilmington, DE, USA. dcorao@nemours.org AN - 18788887 AU - Corao, D. A. AU - Biegel, J. A. AU - Coffin, C. M. AU - Barr, F. G. AU - Wainwright, L. M. AU - Ernst, L. M. AU - Choi, J. K. AU - Zhang, P. J. AU - Pawel, B. R. DA - Jul-Aug DO - 10.2350/08-03-0434.1 10.2350/08-03-0434.1. DP - Nlm ET - 2008/09/16 IS - 4 LA - eng PY - 2009 SN - 1093-5266 (Print) 1093-5266 SP - 275-83 ST - ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status T2 - Pediatr Dev Pathol TI - ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status VL - 12 ID - 4905 ER - TY - JOUR AD - Prinses Maxima Centrum, Center for Pediatric Oncology, Utrecht, the Netherlands. Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. AN - 30697903 AU - Brivio, E. AU - Zwaan, C. M. DA - May DO - 10.1002/pbc.27645 10.1002/pbc.27645. Epub 2019 Jan 29. DP - Nlm ET - 2019/01/31 IS - 5 LA - eng PY - 2019 SN - 1545-5009 SP - e27645 ST - ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects T2 - Pediatr Blood Cancer TI - ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects VL - 66 ID - 4906 ER - TY - JOUR AD - R. Baisya, Medical College and Hospital, Kolkata, India AU - Baisya, R. AU - Bhattacharjee, U. AU - Chattopadhyay, K. AU - Biswas, T. DB - Embase DO - 10.1007/s12288-016-0728-1 LA - English M3 - Conference Abstract N1 - L613199944 2016-11-30 PY - 2016 SN - 0974-0449 SP - S436 ST - ALK negative systemic anaplastic large cell lymphoma presenting with breast mass and paraparesis in an adult female-a case report T2 - Indian Journal of Hematology and Blood Transfusion TI - ALK negative systemic anaplastic large cell lymphoma presenting with breast mass and paraparesis in an adult female-a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613199944&from=exporthttp://dx.doi.org/10.1007/s12288-016-0728-1 VL - 32 ID - 4907 ER - TY - JOUR AD - M. Kalinova, Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine Motol University Hospital, Prague, Czech Republic AU - Kalinova, M. AU - Krskova, L. AU - Mrhalova, M. AU - Kabickova, E. AU - Riha, P. AU - Kodet, R. DB - Embase DO - 10.1093/annonc/mdy286.006 LA - English M3 - Conference Abstract N1 - L628560315 2019-07-23 PY - 2018 SN - 1569-8041 SP - viii361 ST - ALK positive anaplastic large cell lymphoma: Molecular diagnosis and minimal residual disease monitoring T2 - Annals of Oncology TI - ALK positive anaplastic large cell lymphoma: Molecular diagnosis and minimal residual disease monitoring UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628560315&from=exporthttp://dx.doi.org/10.1093/annonc/mdy286.006 VL - 29 ID - 4908 ER - TY - JOUR AD - Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. AN - 28546523 AU - Lee, J. W. AU - Park, S. H. AU - Kang, H. J. AU - Park, K. D. AU - Shin, H. Y. AU - Ahn, H. S. C2 - PMC5912141 DA - Apr DO - 10.4143/crt.2016.577 10.4143/crt.2016.577. Epub 2017 May 22. DP - Nlm ET - 2017/05/27 IS - 2 LA - eng PY - 2018 SN - 1598-2998 (Print) 1598-2998 SP - 495-505 ST - ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor T2 - Cancer Res Treat TI - ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor VL - 50 ID - 4909 ER - TY - JOUR AD - M. Csóka, Semmelweis University, 2nd Department of Paediatrics, Budapest, Hungary AU - Csóka, M. AU - Felkai, L. AU - Bánusz, R. AU - Váradi, Z. AU - Garami, M. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593287 2016-11-11 PY - 2016 SN - 1545-5017 SP - S259 ST - Alk status determination and crizotinib therapy in high risk neuroblastoma and soft tissue sarcoma T2 - Pediatric Blood and Cancer TI - Alk status determination and crizotinib therapy in high risk neuroblastoma and soft tissue sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593287&from=exporthttp://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 4910 ER - TY - JOUR AD - T.G. Gross, Pediatrics, Ohio State University, School of Medicine, Columbus, United States AU - Gross, T. G. DB - Embase DO - 10.1002/hon.2057 LA - English M3 - Conference Abstract N1 - L71147390 2013-08-30 PY - 2013 SN - 0278-0232 SP - 122 ST - Alk tyrosine kinase inhibitors for alk+ anaplastic large cell lymphoma (ALCL): Preliminary clinical experiences and perspectives T2 - Hematological Oncology TI - Alk tyrosine kinase inhibitors for alk+ anaplastic large cell lymphoma (ALCL): Preliminary clinical experiences and perspectives UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71147390&from=exporthttp://dx.doi.org/10.1002/hon.2057 VL - 31 ID - 4911 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. AN - 25404214 AU - Pulitzer, M. AU - Ogunrinade, O. AU - Lin, O. AU - Steinherz, P. C2 - PMC5108361 C6 - NIHMS819955 DA - Mar DO - 10.1111/cup.12446 10.1111/cup.12446. Epub 2015 Feb 5. DP - Nlm ET - 2014/11/19 IS - 3 LA - eng PY - 2015 SN - 0303-6987 (Print) 0303-6987 SP - 182-7 ST - ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient T2 - J Cutan Pathol TI - ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient VL - 42 ID - 4912 ER - TY - JOUR AD - I. Oschlies, Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospitals Schleswig-Holstein, Germany AU - Oschlies, I. AU - Lisfeld, J. AU - Lamant, L. AU - Nakazawa, A. AU - D'Amore, E. S. G. AU - Hansson, U. AU - Hebeda, K. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Muellauer, L. AU - Tinguely, M. AU - Stuecker, M. AU - LeDeley, M. C. AU - Siebert, R. AU - Reiter, A. AU - Brugieres, L. AU - Klapper, W. AU - Wössmann, W. DB - Embase DO - 10.1007/s12308-012-0160-x IS - 3 LA - English M3 - Conference Abstract N1 - L622416349 2018-06-06 PY - 2012 SN - 1865-5785 SP - 219-220 ST - ALK-positive anaplastic large cell lymphoma limited to the skin: Clinical, histopathological and molecular analysis of 6 pediatric cases-a report from the ALCL99 study T2 - Journal of Hematopathology TI - ALK-positive anaplastic large cell lymphoma limited to the skin: Clinical, histopathological and molecular analysis of 6 pediatric cases-a report from the ALCL99 study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622416349&from=exporthttp://dx.doi.org/10.1007/s12308-012-0160-x VL - 5 ID - 4913 ER - TY - JOUR AD - Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. ioschlies@path.uni-kiel.de AN - 22773605 AU - Oschlies, I. AU - Lisfeld, J. AU - Lamant, L. AU - Nakazawa, A. AU - d'Amore, E. S. AU - Hansson, U. AU - Hebeda, K. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Müllauer, L. AU - Tinguely, M. AU - Stücker, M. AU - Ledeley, M. C. AU - Siebert, R. AU - Reiter, A. AU - Brugières, L. AU - Klapper, W. AU - Woessmann, W. C2 - PMC3533659 DA - Jan DO - 10.3324/haematol.2012.065664 10.3324/haematol.2012.065664. Epub 2012 Jul 6. DP - Nlm ET - 2012/07/10 IS - 1 LA - eng PY - 2013 SN - 0390-6078 (Print) 0390-6078 SP - 50-6 ST - ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study T2 - Haematologica TI - ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study VL - 98 ID - 4914 ER - TY - JOUR AD - Dept of Pathology, St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA. AN - 14560573 AU - Onciu, M. AU - Behm, F. G. AU - Raimondi, S. C. AU - Moore, S. AU - Harwood, E. L. AU - Pui, C. H. AU - Sandlund, J. T. DA - Oct DO - 10.1309/wh8p-nu9p-k4rr-v852 DP - Nlm ET - 2003/10/17 IS - 4 LA - eng N1 - Onciu, Mihaela Behm, Frederick G Raimondi, Susana C Moore, Sheila Harwood, Emma L Pui, Ching-Hon Sandlund, John T PY - 2003 SN - 0002-9173 (Print) 0002-9173 SP - 617-25 ST - ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature T2 - Am J Clin Pathol TI - ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature VL - 120 ID - 4915 ER - TY - JOUR AD - I. Wlodarska, Center for Human Genetics, KU Leuven, Leuven, Belgium AU - Wlodarska, I. AU - Van Der Krogt, J. A. AU - Finalet Ferreiro, J. AU - Jacobs, K. AU - Geerdens, E. AU - Uyttebroeck, A. AU - Vandenberghe, P. AU - Tousseyn, T. AU - Cools, J. DB - Embase LA - English M3 - Conference Abstract N1 - L615549250 2017-04-26 PY - 2016 SN - 1592-8721 SP - 574 ST - ALK-positive anaplastic large cell lymphoma with the variant EEF1G-, RNF213-and ATIC-ALK fusions is featured by copy number gain of the rearranged ALK gene T2 - Haematologica TI - ALK-positive anaplastic large cell lymphoma with the variant EEF1G-, RNF213-and ATIC-ALK fusions is featured by copy number gain of the rearranged ALK gene UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615549250&from=export VL - 101 ID - 4916 ER - TY - JOUR AN - 27563714 AU - Li, W. AU - Repnikova, E. DA - Apr 21 DO - 10.1182/blood-2016-01-695288 10.1182/blood-2016-01-695288. DP - Nlm ET - 2016/08/27 IS - 16 LA - eng PY - 2016 SN - 0006-4971 SP - 2041 ST - ALK-positive anaplastic large-cell lymphoma with marked leukemoid reaction and hemophagocytic lymphohistiocytosis T2 - Blood TI - ALK-positive anaplastic large-cell lymphoma with marked leukemoid reaction and hemophagocytic lymphohistiocytosis VL - 127 ID - 4917 ER - TY - JOUR AD - G.-D. Li, Department of Pathology, West China Hospital of Sichuan University, Chengdu, China AU - Wang, W. Y. AU - Gu, L. AU - Liu, W. P. AU - Li, G. D. AU - Liu, H. J. AU - Ma, Z. G. DB - Embase Medline DO - 10.1016/j.prp.2011.07.001 IS - 9 LA - English M3 - Article N1 - L51579172 2011-08-23 2011-10-25 PY - 2011 SN - 1618-0631 0344-0338 SP - 587-591 ST - ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript T2 - Pathology Research and Practice TI - ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51579172&from=exporthttp://dx.doi.org/10.1016/j.prp.2011.07.001 VL - 207 ID - 4918 ER - TY - JOUR AD - Departments of Diagnostic Pathology. Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Breast Surgery. Hematology. Rare Cancer Center, National Cancer Center Hospital. Breast and Medical Oncology. AN - 32826530 AU - Kashima, J. AU - Yoshida, M. AU - Jimbo, K. AU - Izutsu, K. AU - Ushiku, T. AU - Yonemori, K. AU - Yoshida, A. DA - Aug 20 DO - 10.1097/pas.0000000000001567 10.1097/PAS.0000000000001567. DP - Nlm ET - 2020/08/23 LA - eng PY - 2020 SN - 0147-5185 ST - ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology T2 - Am J Surg Pathol TI - ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology ID - 4919 ER - TY - JOUR AD - K.T.E. Chang, Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital, Singapore, Singapore AU - Chang, K. T. E. AU - Tay, A. Z. E. AU - Kuick, C. H. AU - Chen, H. AU - Algar, E. AU - Taubenheim, N. AU - Campbell, J. AU - Mechinaud, F. AU - Campbell, M. AU - Super, L. AU - Chantranuwat, C. AU - Yuen, S. T. AU - Chan, J. K. C. AU - Chow, C. W. DB - Embase Medline DO - 10.1038/s41379-018-0168-6 IS - 5 LA - English M3 - Article N1 - L625590795 2018-12-27 2019-05-14 PY - 2019 SN - 1530-0285 0893-3952 SP - 598-608 ST - ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion T2 - Modern Pathology TI - ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625590795&from=exporthttp://dx.doi.org/10.1038/s41379-018-0168-6 VL - 32 ID - 4920 ER - TY - JOUR AD - Sarcoma Unit, Royal Marsden Hospital, London, UK. Clinical Cytogenetics, Royal Marsden Hospital, Sutton, Surrey, UK. Sarcoma Unit, Royal Marsden Hospital, London, UK. Electronic address: khin.thway@rmh.nhs.uk. AN - 27155927 AU - Vroobel, K. AU - Judson, I. AU - Dainton, M. AU - McCormick, A. AU - Fisher, C. AU - Thway, K. DA - Aug DO - 10.1016/j.prp.2016.04.007 10.1016/j.prp.2016.04.007. Epub 2016 Apr 26. DP - Nlm ET - 2016/05/09 IS - 8 LA - eng PY - 2016 SN - 0344-0338 SP - 743-6 ST - ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male T2 - Pathol Res Pract TI - ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male VL - 212 ID - 4921 ER - TY - JOUR AD - *Department of Pathology, University of Colorado Denver, Aurora, CO †Department of Hematopathology, MD Anderson Cancer Center, Houston, TX §Department of Laboratory Medicine, University of Washington, Seattle, WA ∥Department of Pathology, City of Hope National Medical Center, Duarte ††Department of Pathology, University of California Davis, Sacramento ‡‡Department of Pathology, University of California San Diego, La Jolla, CA ¶Department of Pathology, University of Alabama at Birmingham, Birmingham, AL #Human Genetics Laboratory **Department of Biostatistics §§Department of Pathology and Microbiology, University of Nebraska Medical Center, NE ‡Department of Pathology, Peking University Health Science Center, Beijing, China. AN - 27740969 AU - Pan, Z. AU - Hu, S. AU - Li, M. AU - Zhou, Y. AU - Kim, Y. S. AU - Reddy, V. AU - Sanmann, J. N. AU - Smith, L. M. AU - Chen, M. AU - Gao, Z. AU - Wang, H. Y. AU - Yuan, J. DA - Jan DO - 10.1097/pas.0000000000000753 10.1097/PAS.0000000000000753. DP - Nlm ET - 2016/10/16 IS - 1 LA - eng PY - 2017 SN - 0147-5185 SP - 25-38 ST - ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature T2 - Am J Surg Pathol TI - ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature VL - 41 ID - 4922 ER - TY - JOUR AD - Department of Cytology, General Hospital of Chania, Crete, Greece. AN - 15933425 AU - Tamiolakis, D. AU - Papadopoulos, N. AU - Venizelos, J. AU - Kakagia, D. AU - Nikolaidou, S. AU - Bolioti, S. AU - Kouskoukis, C. DA - Jun DO - 10.1159/000085475 10.1159/000085475. Epub 2005 Jun 2. DP - Nlm ET - 2005/06/04 IS - 6-7 LA - eng PY - 2005 SN - 0378-584X (Print) 0378-584x SP - 356-8 ST - ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma T2 - Onkologie TI - ALK-positive neutrophil-rich variant of anaplastic large cell lymphoma diagnosed after head trauma VL - 28 ID - 4923 ER - TY - JOUR AD - Department of Pathology, St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA. mihaela.onciu@stjude.org AN - 12816858 AU - Onciu, M. AU - Behm, F. G. AU - Downing, J. R. AU - Shurtleff, S. A. AU - Raimondi, S. C. AU - Ma, Z. AU - Morris, S. W. AU - Kennedy, W. AU - Jones, S. C. AU - Sandlund, J. T. DA - Oct 1 DO - 10.1182/blood-2003-04-1095 10.1182/blood-2003-04-1095. Epub 2003 Jun 19. DP - Nlm ET - 2003/06/21 IS - 7 LA - eng PY - 2003 SN - 0006-4971 (Print) 0006-4971 SP - 2642-4 ST - ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases T2 - Blood TI - ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases VL - 102 ID - 4924 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera-Università di Padova, Via Giustiniani 3, 35128 Padova, Italy AU - Isimbaldi, G. AU - Bandiera, L. AU - D'Amore, E. S. G. AU - Conter, V. AU - Milani, M. AU - Mussolin, L. AU - Rosolen, A. DB - Embase Medline DO - 10.1002/pbc.20540 IS - 3 LA - English M3 - Letter N1 - L43201862 2006-03-02 PY - 2006 SN - 1545-5009 1545-5017 SP - 390-391 ST - ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement [4] T2 - Pediatric Blood and Cancer TI - ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement [4] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43201862&from=exporthttp://dx.doi.org/10.1002/pbc.20540 VL - 46 ID - 4925 ER - TY - JOUR AD - S. Geller, Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medicine, New York, NY, United States AU - Geller, S. AU - Canavan, T. N. AU - Pulitzer, M. AU - Moskowitz, A. J. AU - Myskowski, P. L. DB - Embase Medline DO - 10.1111/ijd.13804 IS - 5 LA - English M3 - Review N1 - L621613876 2018-04-16 2018-10-16 PY - 2018 SN - 1365-4632 0011-9059 SP - 515-520 ST - ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature T2 - International Journal of Dermatology TI - ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621613876&from=exporthttp://dx.doi.org/10.1111/ijd.13804 VL - 57 ID - 4926 ER - TY - JOUR AN - 20169312 AU - Ando, K. AU - Tamada, Y. AU - Shimizu, K. AU - Akita, Y. AU - Watanabe, D. AU - Nakamura, S. AU - Hara, K. AU - Matsumoto, Y. DA - Mar DO - 10.2340/00015555-0775 10.2340/00015555-0775. DP - Nlm ET - 2010/02/20 IS - 2 LA - eng PY - 2010 SN - 0001-5555 SP - 198-200 ST - ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation T2 - Acta Derm Venereol TI - ALK-positive primary systemic anaplastic large cell lymphoma with extensive cutaneous manifestation VL - 90 ID - 4927 ER - TY - JOUR AD - Department of Anatomical Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan. Department of Pathology, National Kyushu Cancer Center, Fukuoka, Japan. Department of Pathology, Faculty of Medicine, University of Miyazaki, Kiyotake, Japan. Department of Pathology, Saga Medical Centre Koseikan, Saga, Japan. AN - 26647767 AU - Yamamoto, H. AU - Yoshida, A. AU - Taguchi, K. AU - Kohashi, K. AU - Hatanaka, Y. AU - Yamashita, A. AU - Mori, D. AU - Oda, Y. DA - Jul DO - 10.1111/his.12910 10.1111/his.12910. Epub 2016 Jan 19. DP - Nlm ET - 2015/12/10 IS - 1 LA - eng PY - 2016 SN - 0309-0167 SP - 72-83 ST - ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours T2 - Histopathology TI - ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours VL - 69 ID - 4928 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Oncology Research Unit, Pfizer Worldwide Research and Development, San Diego, California. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. mosse@chop.edu. AN - 26554404 AU - Infarinato, N. R. AU - Park, J. H. AU - Krytska, K. AU - Ryles, H. T. AU - Sano, R. AU - Szigety, K. M. AU - Li, Y. AU - Zou, H. Y. AU - Lee, N. V. AU - Smeal, T. AU - Lemmon, M. A. AU - Mossé, Y. P. C2 - PMC4707106 C6 - NIHMS737610 NRF, JHP, KK, HTR, RS, KS, MAL and YPM. HYZ, NVL and TS are employees at Pfizer, Inc. Disclosure of Potential Conflicts of Interest Helen Y. Zou, Nathan V. Lee, and Tod Smeal are employees and shareholders of Pfizer, Inc. Yaël Mossé is an inventor on a patent filed by the Children’s Hospital of Philadelphia (WO/2009/103061 or PCT/US2009/034288: Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma). DA - Jan DO - 10.1158/2159-8290.Cd-15-1056 10.1158/2159-8290.CD-15-1056. Epub 2015 Nov 10. DP - Nlm ET - 2015/11/12 IS - 1 LA - eng PY - 2016 SN - 2159-8274 (Print) 2159-8274 SP - 96-107 ST - The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma T2 - Cancer Discov TI - The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma VL - 6 ID - 4929 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. AN - 11380391 AU - Morris, S. W. AU - Xue, L. AU - Ma, Z. AU - Kinney, M. C. DA - May DO - 10.1046/j.1365-2141.2001.02574.x 10.1046/j.1365-2141.2001.02574.x. DP - Nlm ET - 2001/06/14 IS - 2 LA - eng PY - 2001 SN - 0007-1048 (Print) 0007-1048 SP - 275-95 ST - Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma T2 - Br J Haematol TI - Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma VL - 113 ID - 4930 ER - TY - JOUR AD - A. Branco, Departamento de Saúde, Universidade Estadual de Feira de Santana, Av. Transnordestina s/n, Feira de Santana, BA, Brazil AU - Reis, I. M. A. AU - Conceição, R. S. AU - Ferreira, R. S. AU - dos Santos, C. C. AU - da Silva, G. R. AU - de Mattos Oliveira, L. AU - Cassiano, D. S. A. AU - dos Santos Junior, M. C. AU - Botura, M. B. AU - da Silva, V. D. A. AU - Costa, S. L. AU - da Silva, T. M. S. AU - Vieira, I. J. C. AU - Braz-Filho, R. AU - Branco, A. DB - Embase Medline DO - 10.1016/j.bioorg.2019.02.023 LA - English M3 - Article N1 - L2001637033 2019-03-05 2019-03-08 PY - 2019 SN - 1090-2120 0045-2068 SP - 665-673 ST - Alkene lactones from Persea fulva (Lauraceae): Evaluation of their effects on tumor cell growth in vitro and molecular docking studies T2 - Bioorganic Chemistry TI - Alkene lactones from Persea fulva (Lauraceae): Evaluation of their effects on tumor cell growth in vitro and molecular docking studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001637033&from=exporthttp://dx.doi.org/10.1016/j.bioorg.2019.02.023 VL - 86 ID - 4931 ER - TY - JOUR AD - ARUP Institute for Clinical and Experimental Pathology®, ARUP Laboratories, Inc., and Department of Pathology, University of Utah, Salt Lake City, Utah, USA. AN - 22156469 AU - Smith, G. D. AU - Zhou, L. AU - Rowe, L. R. AU - Jarboe, E. A. AU - Collins, B. T. AU - Bentz, J. S. AU - Wittwer, C. T. AU - Chadwick, B. E. DO - 10.1159/000333453 10.1159/000333453. Epub 2011 Dec 9. DP - Nlm ET - 2011/12/14 IS - 6 LA - eng PY - 2011 SN - 0001-5547 (Print) 0001-5547 SP - 576-83 ST - Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens T2 - Acta Cytol TI - Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens VL - 55 ID - 4932 ER - TY - JOUR AD - T. John, Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, TX, United States AU - John, T. AU - Sasa, G. AU - Gottschalk, S. AU - Ahmed, N. AU - Allen, C. AU - Omer, B. AU - Hegde, M. AU - Naik, S. AU - Leung, K. AU - Martinez, C. AU - Krance, R. A. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L619101729 2017-11-10 PY - 2017 SN - 1523-6536 SP - S281 ST - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619101729&from=export VL - 23 ID - 4933 ER - TY - JOUR AD - Department of Pediatrics, Center for Cell and Gene Therapy, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA. Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA. AN - 29719098 AU - John, T. D. AU - Naik, S. AU - Leung, K. AU - Sasa, G. AU - Martinez, C. AU - Krance, R. A. DA - Aug DO - 10.1111/petr.13210 10.1111/petr.13210. Epub 2018 May 2. DP - Nlm ET - 2018/05/03 IS - 5 LA - eng PY - 2018 SN - 1397-3142 SP - e13210 ST - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma T2 - Pediatr Transplant TI - Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma VL - 22 ID - 4934 ER - TY - JOUR AD - Department of Stem Cell Transplantation and Cellular Therapies, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030; sgiralt@notes.mdcc.tmc.edu AN - 105827023. Language: English. Entry Date: 20080307. Revision Date: 20150711. Publication Type: Journal Article. Supplement Title: Mar2007 Supplement 3. Journal Subset: Biomedical AU - Ginalt, S. DB - ccm DP - EBSCOhost N1 - Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101256500. PMID: NLM17382018. PY - 2007 SN - 1557-9190 SP - S102-2 ST - Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date T2 - Clinical Lymphoma & Myeloma TI - Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105827023&site=ehost-live&scope=site VL - 7 ID - 4935 ER - TY - JOUR AD - Department of Hematology, Soochow University, Jiangsu Institute of Hematology, 188 Shizi Sreet, 215006 Suzhou, China AU - Wang, Y. AU - Wu, D. AU - Sun, A. AU - Jin, Z. AU - Qiu, H. AU - Miao, M. AU - Tang, X. AU - Fu, Z. DB - Scopus DO - 10.1007/s12185-008-0032-4 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2008 SP - 167-171 ST - Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis T2 - International Journal of Hematology TI - Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-42049088722&doi=10.1007%2fs12185-008-0032-4&partnerID=40&md5=63533989cef0c3f7238119b92f5782bc VL - 87 ID - 4936 ER - TY - JOUR AD - Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China AU - Xue, Y. J. AU - Cheng, Y. F. AU - Lu, A. D. AU - Wang, Y. AU - Zuo, Y. X. AU - Yan, C. H. AU - Wu, J. AU - Sun, Y. Q. AU - Suo, P. AU - Chen, Y. H. AU - Chen, H. AU - Jia, Y. P. AU - Liu, K. Y. AU - Han, W. AU - Xu, L. P. AU - Zhang, L. P. AU - Huang, X. J. DB - Scopus DO - 10.1016/j.bbmt.2018.12.007 IS - 8 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - 1611-1620 ST - Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068741392&doi=10.1016%2fj.bbmt.2018.12.007&partnerID=40&md5=6aacfc93e6623a3e330bc507df395bdd VL - 25 ID - 4937 ER - TY - JOUR AD - Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany EBMT Data Office Leiden, Leiden, Netherlands Chaim Sheba Medical Center, Tel-Hashomer, Israel University Hospital Eppendorf, Hamburg, Germany University of Freiburg, Freiburg, Germany Depariment of Internal Medicine III, University Hospital of Munich-Grosshadern, LMU, Munich, Germany Masaryk University Hospital Brno, Brno, Czech Republic Medical Park Hospitals, Antalya, Turkey Universita Cattolica S. Cuore, Rome, Italy University Hospital, Basel, Switzerland Nottingham University Hospital, Nottingham, United Kingdom Charles University Hospital, Pilsen, Czech Republic Leiden University Hospital, Leiden, Netherlands Hopital St. Louis, Paris, France University Hospital Gasthuisberg, Leuven, Belgium Radboud University Medical Centre, Nijmegen, Netherlands Hannover Medical School, Hannover, Germany HUCH Comprehensive Cancer Center, Helsinki, Finland Manchester Royal Infirmary, Manchester, United Kingdom Florence Nightingale Sisli Hospital, Istanbul, Turkey Hospital Sirio-Libanes, Sao Paulo, Brazil Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden CHU de Lille, LIRIC, INSERM U995, Universite de Lille, Lille, France Division of Hematology, Department of Oncology, University Hospital, Geneva, Switzerland Faculty of Medicine of Geneva, University of Geneva, Geneva, Switzerland AU - Radujkovic, A. AU - Dietrich, S. AU - Blok, H. J. AU - Nagler, A. AU - Ayuk, F. AU - Finke, J. AU - Tischer, J. AU - Mayer, J. AU - Koc, Y. AU - Sorà, F. AU - Passweg, J. AU - Byrne, J. L. AU - Jindra, P. AU - Veelken, J. H. AU - Socié, G. AU - Maertens, J. AU - Schaap, N. AU - Stadler, M. AU - Itälä-Remes, M. AU - Tholouli, E. AU - Arat, M. AU - Rocha, V. AU - Ljungman, P. AU - Yakoub-Agha, I. AU - Kröger, N. AU - Chalandon, Y. DB - Scopus DO - 10.1016/j.bbmt.2019.06.028 IS - 10 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2008-2016 ST - Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party T2 - Biology of Blood and Marrow Transplantation TI - Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071381239&doi=10.1016%2fj.bbmt.2019.06.028&partnerID=40&md5=5eb22a803ee03c94e7fca23fc3225f01 VL - 25 ID - 4938 ER - TY - JOUR AD - L.Y. Li, Department of Gynecological Oncology, Jiangxi Medical College of Nanchang University, 318 Bayi Street, Nanchang, Jiangxi, China AU - Jiang, T. AU - Zhou, B. AU - Li, Y. M. AU - Yang, Q. Y. AU - Tu, K. J. AU - Li, L. Y. DB - Embase DO - 10.3892/ol.2020.11641 IS - 2 LA - English M3 - Article N1 - L2006816293 2020-07-28 2020-09-28 PY - 2020 SN - 1792-1082 1792-1074 SP - 1360-1368 ST - ALOX12B promotes carcinogenesis in cervical cancer by regulating the PI3K/ERK1 signaling pathway T2 - Oncology Letters TI - ALOX12B promotes carcinogenesis in cervical cancer by regulating the PI3K/ERK1 signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006816293&from=exporthttp://dx.doi.org/10.3892/ol.2020.11641 VL - 20 ID - 4939 ER - TY - JOUR AD - B. Machaliński, Department of General Pathology, Pomeranian Medical University, Powstancow Wlkp. 72, Szczecin, Poland AU - Pius-Sadowska, E. AU - Kawa, M. P. AU - Kłos, P. AU - Rogińska, D. AU - Rudnicki, M. AU - Boehlke, M. AU - Waloszczyk, P. AU - Machaliński, B. DB - Embase Medline DO - 10.1667/RR14457.1 IS - 5 LA - English M3 - Article N1 - L613318388 2016-11-25 2016-12-22 PY - 2016 SN - 1938-5404 0033-7587 SP - 489-507 ST - Alteration of Selected Neurotrophic Factors and their Receptor Expression in Mouse Brain Response to Whole-Brain Irradiation T2 - Radiation Research TI - Alteration of Selected Neurotrophic Factors and their Receptor Expression in Mouse Brain Response to Whole-Brain Irradiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613318388&from=exporthttp://dx.doi.org/10.1667/RR14457.1 VL - 186 ID - 4940 ER - TY - JOUR AD - Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: sarkar.chitra@gmail.com. AN - 27599148 AU - Kakkar, A. AU - Majumdar, A. AU - Kumar, A. AU - Tripathi, M. AU - Pathak, P. AU - Sharma, M. C. AU - Suri, V. AU - Tandon, V. AU - Chandra, S. P. AU - Sarkar, C. DA - Nov DO - 10.1016/j.eplepsyres.2016.08.028 10.1016/j.eplepsyres.2016.08.028. Epub 2016 Aug 28. DP - Nlm ET - 2016/10/30 LA - eng PY - 2016 SN - 0920-1211 SP - 141-151 ST - Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) T2 - Epilepsy Res TI - Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) VL - 127 ID - 4941 ER - TY - JOUR AD - Pediatric Rheumatology and Immunology, Children's Hospital, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States Vivantes Klinikum Friedrichshain, Children's Hospital, Berlin, Germany Pediatric Rheumatology and Immunology, Children's Hospital, University of Würzburg, Würzburg, Germany AU - Hofmann, S. R. AU - Kubasch, A. S. AU - Ioannidis, C. AU - Rösen-Wolff, A. AU - Girschick, H. J. AU - Morbach, H. AU - Hedrich, C. M. DB - Scopus DO - 10.1016/j.clim.2015.09.013 IS - 2 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2015 SP - 300-307 ST - Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release T2 - Clinical Immunology TI - Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and release UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943523723&doi=10.1016%2fj.clim.2015.09.013&partnerID=40&md5=e8a6c917b2e0063e34bfd93b96068a69 VL - 161 ID - 4942 ER - TY - JOUR AD - Departments of Surgery, Sections of Cardiac and Vascular Surgery, Washington University School of Medicine, 9901 Wohl Hospital, 4960 Children's Place, St. Louis, MO 63110, USA. AN - 12928630 AU - Absi, T. S. AU - Sundt, T. M., 3rd AU - Tung, W. S. AU - Moon, M. AU - Lee, J. K. AU - Damiano, R. R., Jr. AU - Thompson, R. W. DA - Aug DO - 10.1016/s0022-5223(02)73576-9 DP - Nlm ET - 2003/08/21 IS - 2 LA - eng N1 - Absi, Tarek S Sundt, Thoralf M 3rd Tung, William S Moon, Marc Lee, Jason K Damiano, Ralph R Jr Thompson, Robert W PY - 2003 SN - 0022-5223 (Print) 0022-5223 SP - 344-57; discission 357 ST - Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease T2 - J Thorac Cardiovasc Surg TI - Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease VL - 126 ID - 4943 ER - TY - JOUR AD - P.A. Lio, Northwestern University Feinberg School of Medicine, 1455 N. Milwaukee Avenue, Chicago, IL, United States AU - Strom, M. A. AU - Lio, P. A. DB - Embase DO - 10.1007/s13671-014-0086-x IS - 4 LA - English M3 - Review N1 - L601038415 2015-01-08 PY - 2014 SN - 2162-4933 SP - 165-170 ST - Alternative Medicine in Pediatric Dermatology: What Is the Evidence? T2 - Current Dermatology Reports TI - Alternative Medicine in Pediatric Dermatology: What Is the Evidence? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601038415&from=exporthttp://dx.doi.org/10.1007/s13671-014-0086-x VL - 3 ID - 4944 ER - TY - JOUR AD - L. Zhu, Department of Orthopedic Surgery, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China AU - Jiang, C. AU - Li, M. AU - Jiang, W. AU - Tian, F. AU - Zhu, L. AU - Bian, Z. C1 - amd 3100(Sigma,United States) C2 - sinobest(China) Sigma(United States) DB - Embase Medline DO - 10.1016/j.biopha.2016.12.055 LA - English M3 - Article N1 - L613861610 2017-01-04 2017-01-09 PY - 2017 SN - 1950-6007 0753-3322 SP - 677-685 ST - AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells T2 - Biomedicine and Pharmacotherapy TI - AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613861610&from=exporthttp://dx.doi.org/10.1016/j.biopha.2016.12.055 VL - 86 ID - 4945 ER - TY - JOUR AD - Pediatric Department of Longhua Hospital, Shanghai University of TCM, Shanghai, 200126, China. Institute for TCM Pediatric, Shanghai TCM Academy, Shanghai, 200071, China. Pediatric Department of Longhua Hospital, Shanghai University of TCM, Shanghai, 200126, China. Xiaozhen@126.com. AN - 26590157 AU - Jiang, Y. H. AU - Yu, J. E. AU - Guo, A. H. AU - Li, X. AU - Lin, Y. AU - Jiang, Z. Y. AU - Xiao, Z. DA - Apr DO - 10.1007/s11418-015-0944-2 10.1007/s11418-015-0944-2. Epub 2015 Nov 20. DP - Nlm ET - 2015/11/22 IS - 2 LA - eng PY - 2016 SN - 1340-3443 SP - 145-51 ST - Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice T2 - J Nat Med TI - Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice VL - 70 ID - 4946 ER - TY - JOUR AD - J.N. Finkelstein, Department of Pediatrics, Box 850, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Singal, M. AU - Finkelstein, J. N. DB - Embase Medline DO - 10.1080/019021490951504 IS - 6 LA - English M3 - Article N1 - L40967243 2005-08-09 PY - 2005 SN - 0190-2148 1521-0499 SP - 581-597 ST - Amorphous silica particles promote inflammatory gene expression through the redox sensitive transcription factor, AP-1, in alveolar epithelial cells T2 - Experimental Lung Research TI - Amorphous silica particles promote inflammatory gene expression through the redox sensitive transcription factor, AP-1, in alveolar epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40967243&from=exporthttp://dx.doi.org/10.1080/019021490951504 VL - 31 ID - 4947 ER - TY - JOUR AD - Y. Xu, Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing City, Jiangsu, China AU - Weng, L. AU - Zhang, H. AU - Li, X. AU - Zhan, H. AU - Chen, F. AU - Han, L. AU - Xu, Y. AU - Cao, X. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1016/j.intimp.2016.12.018 LA - English M3 - Article N1 - L613702424 2016-12-22 2017-03-02 PY - 2017 SN - 1878-1705 1567-5769 SP - 1-8 ST - Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia T2 - International Immunopharmacology TI - Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613702424&from=exporthttp://dx.doi.org/10.1016/j.intimp.2016.12.018 VL - 44 ID - 4948 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, 950 west 28th Ave, Vancouver, BC, Canada AU - So, W. K. AU - Fan, Q. AU - Lau, M. T. AU - Qiu, X. AU - Cheng, J. C. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1016/j.febslet.2014.09.017 IS - 21 LA - English M3 - Article N1 - L600224384 2014-11-05 2014-11-10 PY - 2014 SN - 1873-3468 0014-5793 SP - 3998-4007 ST - Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression T2 - FEBS Letters TI - Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600224384&from=exporthttp://dx.doi.org/10.1016/j.febslet.2014.09.017 VL - 588 ID - 4949 ER - TY - JOUR AD - Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. AN - 8781434 AU - Sarris, A. H. AU - Luthra, R. AU - Papadimitracopoulou, V. AU - Waasdorp, M. AU - Dimopoulos, M. A. AU - McBride, J. A. AU - Cabanillas, F. AU - Duvic, M. AU - Deisseroth, A. AU - Morris, S. W. AU - Pugh, W. C. DA - Sep 1 DP - Nlm ET - 1996/09/01 IS - 5 LA - eng N1 - Sarris, A H Luthra, R Papadimitracopoulou, V Waasdorp, M Dimopoulos, M A McBride, J A Cabanillas, F Duvic, M Deisseroth, A Morris, S W Pugh, W C PY - 1996 SN - 0006-4971 (Print) 0006-4971 SP - 1771-9 ST - Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis T2 - Blood TI - Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis VL - 88 ID - 4950 ER - TY - JOUR AD - Department of Internal Medicine , Seoul National University Bundang Hospital , Gumi-ro 173 Beon-gil, Bundang-gu Seongnam-Si 13620 Korea Department of Internal Medicine , Inje University Haeundae Paik Hospital , Busan Korea Department of Internal Medicine, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-Si, Gyeonggi-di, 13620, Korea Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea AN - 124090090. Language: English. Entry Date: 20171007. Revision Date: 20180801. Publication Type: journal article. Journal Subset: Biomedical AU - Suh, Koung AU - Lee, Ji AU - Shin, Dong-Yeop AU - Koh, Youngil AU - Bang, Soo-Mee AU - Yoon, Sung-Soo AU - Park, Seonyang AU - Kim, Inho AU - Lee, Jeong-Ok AU - Suh, Koung Jin AU - Lee, Ji Yun DB - ccm DO - 10.1007/s12185-017-2225-1 DP - EBSCOhost IS - 2 N1 - Continental Europe; Europe. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 9111627. PMID: NLM28378056. PY - 2017 SN - 0925-5710 SP - 229-239 ST - Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials T2 - International Journal of Hematology TI - Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124090090&site=ehost-live&scope=site VL - 106 ID - 4951 ER - TY - JOUR AD - A.P. Singh, Vanderbilt Univ Med. Cntr, Nashville, TN, United States AU - Singh, A. P. AU - Glennon, M. S. AU - Umbarkar, P. P. AU - Gupte, M. AU - Galindo, C. L. AU - Zhang, Q. AU - Force, T. AU - Becker, J. R. AU - Lal, H. DB - Embase DO - 10.1161/res.123.suppl_1.361 LA - English M3 - Conference Abstract N1 - L628264730 2019-07-01 PY - 2018 SN - 1524-4571 ST - Analysis of cardiotoxic mechanisms associated with tyrosine kinase inhibitor ponatinib T2 - Circulation Research TI - Analysis of cardiotoxic mechanisms associated with tyrosine kinase inhibitor ponatinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628264730&from=exporthttp://dx.doi.org/10.1161/res.123.suppl_1.361 VL - 123 ID - 4952 ER - TY - JOUR AD - Hematology Department of Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran Tehran University of Medical Sciences, Tehran, Iran AU - Ghotaslou, A. AU - Abbasian, S. AU - Ghasemi, A. AU - Nadali, F. DB - Scopus IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 184-190 ST - Analysis of expression of SIRT1 gene in patients with Chronic Myeloid Leukemia Resistant to Imatinib mesylate T2 - Iranian Journal of Blood and Cancer TI - Analysis of expression of SIRT1 gene in patients with Chronic Myeloid Leukemia Resistant to Imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944744507&partnerID=40&md5=62168262e8f3302b0b1c00f1d5044336 VL - 7 ID - 4953 ER - TY - JOUR AD - Z. Zhao, Department of Orthodontics, West China College of Stomatology, Sichuan University, Renmin Nan Road 14#, Chengdu, Sichuan, China AU - Wu, J. AU - Li, Y. AU - Fan, X. AU - Zhang, C. AU - Wang, Y. AU - Zhao, Z. DB - Embase Medline DO - 10.1089/dna.2010.1139 IS - 11 LA - English M3 - Article N1 - L362886282 2011-11-15 2011-11-17 PY - 2011 SN - 1044-5498 1557-7430 SP - 865-873 ST - Analysis of gene expression profile of periodontal ligament cells subjected to cyclic compressive force T2 - DNA and Cell Biology TI - Analysis of gene expression profile of periodontal ligament cells subjected to cyclic compressive force UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362886282&from=exporthttp://dx.doi.org/10.1089/dna.2010.1139 VL - 30 ID - 4954 ER - TY - JOUR AD - C. E. Bacchi, Consultoria em Patologia, Rua Major Leônidas Cardoso 739, Botucatu, SP, 18602-010, Brazil AU - Gualco, G. AU - Chioato, L. AU - Weiss, L. M. AU - Harrington Jr, W. J. AU - Bacchi, C. E. DB - Embase Medline DO - 10.1309/AJCP6Q7QMUVGMVMF IS - 1 LA - English M3 - Article N1 - L354914494 2009-08-19 PY - 2009 SN - 0002-9173 SP - 28-33 ST - Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children T2 - American Journal of Clinical Pathology TI - Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354914494&from=exporthttp://dx.doi.org/10.1309/AJCP6Q7QMUVGMVMFhttp://ajcp.ascpjournals.org/content/132/1/28.full.pdf VL - 132 ID - 4955 ER - TY - JOUR AD - Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tübingen, Calwerstr. 3, 72076, Tübingen, Germany. Department of Pathology, University of Tübingen, Tübingen, Germany. Pediatric Oncology, University Childrens Hospital, University of Tübingen, Tübingen, Germany. Department of Neurosurgery, University of Tuebingen, Tübingen, Germany. Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tübingen, Calwerstr. 3, 72076, Tübingen, Germany. jens.schittenhelm@med.uni-tuebingen.de. AN - 26115961 AU - Gierke, M. AU - Sperveslage, J. AU - Schwab, D. AU - Beschorner, R. AU - Ebinger, M. AU - Schuhmann, M. U. AU - Schittenhelm, J. DA - Jan DO - 10.1007/s00432-015-2006-2 10.1007/s00432-015-2006-2. Epub 2015 Jun 27. DP - Nlm ET - 2015/06/28 IS - 1 LA - eng PY - 2016 SN - 0171-5216 SP - 89-100 ST - Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification T2 - J Cancer Res Clin Oncol TI - Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification VL - 142 ID - 4956 ER - TY - JOUR AD - Department of Pediatrics, Pediatrics Oncology Institute-GRAACC (Grupo de Apoio ao Adolescente e à Criança com Câncer), UNIFESP (Federal University of São Paulo), Rua Botucatu, no 743, Floor 8 - Genetics Laboratory, Vila Clementino, São Paulo, SP, 04023-062, Brazil, gabi.rampazzo@gmail.com. AN - 24532263 AU - Cruz, G. R. AU - Dias Oliveira, I. AU - Moraes, L. AU - Del Giudice Paniago, M. AU - de Seixas Alves, M. T. AU - Capellano, A. M. AU - Saba-Silva, N. AU - Cavalheiro, S. AU - Cerutti, J. M. AU - Toledo, S. R. DA - Apr DO - 10.1007/s11060-014-1398-1 10.1007/s11060-014-1398-1. Epub 2014 Feb 17. DP - Nlm ET - 2014/02/18 IS - 2 LA - eng PY - 2014 SN - 0167-594x SP - 235-42 ST - Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas T2 - J Neurooncol TI - Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas VL - 117 ID - 4957 ER - TY - JOUR AD - Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. m.vandijk@pathol.umcn.nl AN - 16096402 AU - van Dijk, M. C. AU - Bernsen, M. R. AU - Ruiter, D. J. DA - Sep DO - 10.1097/01.pas.0000157749.18591.9e 10.1097/01.pas.0000157749.18591.9e. DP - Nlm ET - 2005/08/13 IS - 9 LA - eng PY - 2005 SN - 0147-5185 (Print) 0147-5185 SP - 1145-51 ST - Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma T2 - Am J Surg Pathol TI - Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma VL - 29 ID - 4958 ER - TY - JOUR AD - The University of Texas, MD Anderson Cancer Center, Department of Leukemia, PO Box 301402, Unit 428, Houston, TX 77230, United States AU - Pemmaraju, N. AU - Kantarjian, H. AU - Shan, J. AU - Jabbour, E. AU - Quintas-Cardama, A. AU - Verstovsek, S. AU - Ravandi, F. AU - Wierda, W. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.3324/haematol.2011.056721 IS - 7 M3 - Review N1 - Cited By :49 Export Date: 18 November 2020 PY - 2012 SP - 1029-1035 ST - Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy T2 - Haematologica TI - Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863955295&doi=10.3324%2fhaematol.2011.056721&partnerID=40&md5=a40e7b941d66a89a38e3f02ccfe31b07 VL - 97 ID - 4959 ER - TY - JOUR AD - P. Macigova, Department of Experimental Biology, Masaryk University, University Hospital Brno, Brno, Czech Republic AU - Macigova, P. AU - Neradil, J. AU - Melicharkova, K. AU - Kyr, M. AU - Mudry, P. AU - Veselska, R. AU - Sterba, J. DB - Embase DO - 10.1093/annonc/mdx511 LA - English M3 - Conference Abstract N1 - L619416979 2017-11-30 PY - 2017 SN - 1569-8041 SP - vii19 ST - Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors T2 - Annals of Oncology TI - Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619416979&from=exporthttp://dx.doi.org/10.1093/annonc/mdx511 VL - 28 ID - 4960 ER - TY - JOUR AD - Department of Pathology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA. AN - 12894500 AU - Paner, G. P. AU - Silberman, S. AU - Hartman, G. AU - Micetich, K. C. AU - Aranha, G. V. AU - Alkan, S. DA - May-Jun DP - Nlm ET - 2003/08/05 IS - 3b LA - eng N1 - Paner, Gladell P Silberman, Simone Hartman, Grace Micetich, Kenneth C Aranha, Gerard V Alkan, Serhan Journal Article Greece Anticancer Res. 2003 May-Jun;23(3B):2253-60. PY - 2003 SN - 0250-7005 (Print) 0250-7005 SP - 2253-60 ST - Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors T2 - Anticancer Res TI - Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors VL - 23 ID - 4961 ER - TY - JOUR AD - Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. AN - 7662979 AU - Wellmann, A. AU - Otsuki, T. AU - Vogelbruch, M. AU - Clark, H. M. AU - Jaffe, E. S. AU - Raffeld, M. DA - Sep 15 DP - Nlm ET - 1995/09/15 IS - 6 LA - eng N1 - Wellmann, A Otsuki, T Vogelbruch, M Clark, H M Jaffe, E S Raffeld, M Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1995 Sep 15;86(6):2321-8. PY - 1995 SN - 0006-4971 (Print) 0006-4971 SP - 2321-8 ST - Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease T2 - Blood TI - Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease VL - 86 ID - 4962 ER - TY - JOUR AD - M. D. Johnson, Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Ave. Box 626, Rochester, NY 14642, United States AU - Johnson, M. D. AU - Shaw, A. K. AU - O'Connell, M. J. AU - Sim, F. J. AU - Moses, H. L. DB - Embase Medline DO - 10.1007/s11060-010-0399-y IS - 2 LA - English M3 - Article N1 - L51077587 2010-09-22 2011-08-09 PY - 2011 SN - 0167-594X 1573-7373 SP - 277-285 ST - Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas T2 - Journal of Neuro-Oncology TI - Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51077587&from=exporthttp://dx.doi.org/10.1007/s11060-010-0399-y VL - 103 ID - 4963 ER - TY - JOUR AD - Y. Nagatoshi, Section of Pediatrics, National Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan AU - Takahashi, D. AU - Nagatoshi, Y. AU - Nagayama, J. AU - Inagaki, J. AU - Itonoaga, N. AU - Takeshita, M. AU - Okamura, J. DB - Embase Medline DO - 10.1097/MPH.0b013e31817e4a98 IS - 9 LA - English M3 - Article N1 - L354655898 2009-06-30 PY - 2008 SN - 1077-4114 1536-3678 SP - 696-700 ST - Anaplastic Large Cell Lymphoma in Leukemic Presentation: A Case Report and a Review of the Literature T2 - Journal of Pediatric Hematology/Oncology TI - Anaplastic Large Cell Lymphoma in Leukemic Presentation: A Case Report and a Review of the Literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354655898&from=exporthttp://dx.doi.org/10.1097/MPH.0b013e31817e4a98 VL - 30 ID - 4964 ER - TY - JOUR AD - Department of Pathology, Division of Molecular Histopathology, University of Cambridge, Cambridge, UK. European Research Initiative for ALK related Malignancies, Toulouse, France. Institut Universitaire de Cancérologie Oncopole, Toulouse, France. Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. Department of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. Département de Cancérologie de l'Enfant et l'Adolescent, Gustave Roussy, Villejuif, France. AN - 26913827 AU - Turner, S. D. AU - Lamant, L. AU - Kenner, L. AU - Brugières, L. DA - May DO - 10.1111/bjh.13958 10.1111/bjh.13958. Epub 2016 Feb 23. DP - Nlm ET - 2016/02/26 IS - 4 LA - eng PY - 2016 SN - 0007-1048 SP - 560-72 ST - Anaplastic large cell lymphoma in paediatric and young adult patients T2 - Br J Haematol TI - Anaplastic large cell lymphoma in paediatric and young adult patients VL - 173 ID - 4965 ER - TY - JOUR AD - N.J. Sebire, Department of Histopathology, Camelia Botnar Laboratories, Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH, United Kingdom AU - Sebire, N. J. AU - Webb, D. AU - Ramsay, A. D. DB - Embase Medline DO - 10.1080/15227950590961216 IS - 1 LA - English M3 - Article N1 - L41018237 2005-08-21 PY - 2005 SN - 1551-3815 1551-3823 SP - 63-70 ST - Anaplastic large cell lymphoma with alk expression and presence of the t(2;5) translocation in a 5-month-old infant T2 - Fetal and Pediatric Pathology TI - Anaplastic large cell lymphoma with alk expression and presence of the t(2;5) translocation in a 5-month-old infant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41018237&from=exporthttp://dx.doi.org/10.1080/15227950590961216 VL - 24 ID - 4966 ER - TY - JOUR AD - Department of Pathology and Groupe d'Etude des Lymphomes Malins CNRS/UPR2163 CHU Purpan, 31300 Toulouse, France. AN - 11215285 AU - Greenland, C. AU - Dastugue, N. AU - Touriol, C. AU - Lamant, L. AU - Delsol, G. AU - Brousset, P. C2 - PMC1731343 DA - Feb DO - 10.1136/jcp.54.2.152 10.1136/jcp.54.2.152. DP - Nlm ET - 2001/02/24 IS - 2 LA - eng PY - 2001 SN - 0021-9746 (Print) 0021-9746 SP - 152-4 ST - Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene T2 - J Clin Pathol TI - Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene VL - 54 ID - 4967 ER - TY - JOUR AD - D.S. Morrell, UNC Dermatology and Skin Cancer Center, 401 Market Street, Chapel Hill, NC 27516, United States AU - Ju, E. AU - Adigun, C. AU - Dunphy, C. AU - Gold, S. AU - Morrell, D. S. DB - Embase Medline DO - 10.1111/j.1525-1470.2011.01465.x IS - 4 LA - English M3 - Article N1 - L51655382 2011-10-10 2012-07-18 PY - 2012 SN - 0736-8046 1525-1470 SP - 498-503 ST - Anaplastic large cell lymphoma: An unusual presentation in a 7-year-old girl T2 - Pediatric Dermatology TI - Anaplastic large cell lymphoma: An unusual presentation in a 7-year-old girl UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51655382&from=exporthttp://dx.doi.org/10.1111/j.1525-1470.2011.01465.x VL - 29 ID - 4968 ER - TY - JOUR AD - Division of Hematology, Department of Medicine, University of Washington School of Medicine, 617 Eastlake Ave. East, P.O. Box CE3-300, Seattle, WA, 98109, USA. ashustov@uw.edu. Department of Laboratory Medicine, University of Washington School of Medicine, 825 Eastlake Ave. East, P.O. Box G7-800, Seattle, WA, 98109, USA. AN - 30596216 AU - Shustov, A. AU - Soma, L. DO - 10.1007/978-3-319-99716-2_6 10.1007/978-3-319-99716-2_6. DP - Nlm ET - 2019/01/01 LA - eng PY - 2019 SN - 0927-3042 (Print) 0927-3042 SP - 127-144 ST - Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management T2 - Cancer Treat Res TI - Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management VL - 176 ID - 4969 ER - TY - JOUR AD - G. Miculschi, Clinical Municipal Hospital, Paediatrics, Oradea, Romania AU - Miculschi, G. AU - Pop, O. AU - Baican, V. AU - Burca, C. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593408 2016-11-11 PY - 2016 SN - 1545-5017 SP - S182 ST - Anaplastic large cell lymphoma: Is it secondary or concurrent with castleman disease? T2 - Pediatric Blood and Cancer TI - Anaplastic large cell lymphoma: Is it secondary or concurrent with castleman disease? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593408&from=exporthttp://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 4970 ER - TY - JOUR AD - Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK. AN - 10886208 AU - Haralambieva, E. AU - Pulford, K. A. AU - Lamant, L. AU - Pileri, S. AU - Roncador, G. AU - Gatter, K. C. AU - Delsol, G. AU - Mason, D. Y. DA - Jun DO - 10.1046/j.1365-2141.2000.02045.x 10.1046/j.1365-2141.2000.02045.x. DP - Nlm ET - 2000/07/11 IS - 3 LA - eng PY - 2000 SN - 0007-1048 (Print) 0007-1048 SP - 584-91 ST - Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas T2 - Br J Haematol TI - Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas VL - 109 ID - 4971 ER - TY - JOUR AD - Lauren V. Ackerman Division of Surgical Pathology, Washington University School of Medicine, St. Louis, Missouri, USA. AN - 11684952 AU - Cook, J. R. AU - Dehner, L. P. AU - Collins, M. H. AU - Ma, Z. AU - Morris, S. W. AU - Coffin, C. M. AU - Hill, D. A. DA - Nov DO - 10.1097/00000478-200111000-00003 10.1097/00000478-200111000-00003. DP - Nlm ET - 2001/10/31 IS - 11 LA - eng PY - 2001 SN - 0147-5185 (Print) 0147-5185 SP - 1364-71 ST - Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study T2 - Am J Surg Pathol TI - Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study VL - 25 ID - 4972 ER - TY - JOUR AD - J.C. Van Gaal, Radboud University, Nijmegen Medical Centre, Nijmegen, Netherlands AU - Van Gaal, J. C. AU - Flucke, U. E. AU - Roeffen, M. H. S. AU - De Bont, E. S. AU - Suurmeijer, A. J. AU - Van Der Graaf, W. T. AU - Versleijen-Jonkers, Y. M. H. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70712124 2012-04-10 PY - 2011 SN - 0732-183X ST - Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma T2 - Journal of Clinical Oncology TI - Anaplastic lymphoma kinase (ALK) in rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70712124&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/29/15-suppl/9530?sid=8d9ad6cc-2a5b-4910-8d2e-f8e8e436e211 VL - 29 ID - 4973 ER - TY - JOUR AD - Department of Pediatric Oncology-Hematology, Erasmus MC- Sophia Children's Hospital, Dr. Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands. f.duijkers@erasmusmc.nl AN - 21625996 AU - Duijkers, F. A. AU - Gaal, J. AU - Meijerink, J. P. AU - Admiraal, P. AU - Pieters, R. AU - de Krijger, R. R. AU - van Noesel, M. M. C2 - PMC3219872 DA - Oct DO - 10.1007/s13402-011-0048-2 10.1007/s13402-011-0048-2. Epub 2011 May 31. DP - Nlm ET - 2011/06/01 IS - 5 LA - eng PY - 2011 SN - 2211-3428 (Print) 2211-3428 SP - 409-17 ST - Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels T2 - Cell Oncol (Dordr) TI - Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels VL - 34 ID - 4974 ER - TY - JOUR AD - Department of Lymphoma-Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. AN - 11697652 AU - Herling, M. AU - Rassidakis, G. Z. AU - Viviani, S. AU - Bonfante, V. AU - Giardini, R. AU - Gianni, M. AU - Morris, S. W. AU - Cabanillas, F. AU - Medeiros, L. J. AU - Sarris, A. H. DA - Sep-Oct DO - 10.3109/10428190109097716 10.3109/10428190109097716. DP - Nlm ET - 2001/11/08 IS - 5 LA - eng PY - 2001 SN - 1042-8194 (Print) 1026-8022 SP - 969-79 ST - Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients T2 - Leuk Lymphoma TI - Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients VL - 42 ID - 4975 ER - TY - JOUR AD - Department of Anatomical Pathology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. Department of Medical Services, Electron Microscopy Laboratory, Institute of Pathology, Ministry of Public Health, Bangkok, Thailand. Department of Medical Oncology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. AN - 26179668 AU - Loharamtaweethong, K. AU - Puripat, N. AU - Aoonjai, N. AU - Sutepvarnon, A. AU - Bandidwattanawong, C. DA - Mar DO - 10.1111/his.12779 10.1111/his.12779. Epub 2015 Sep 2. DP - Nlm ET - 2015/07/17 IS - 4 LA - eng PY - 2016 SN - 0309-0167 SP - 603-7 ST - Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum T2 - Histopathology TI - Anaplastic lymphoma kinase (ALK) translocation in paediatric malignant peritoneal mesothelioma: a case report of novel ALK-related tumour spectrum VL - 68 ID - 4976 ER - TY - JOUR AD - Service of Pathologic Anatomy and Haematopathology, Institute of Hematology and Clinical Oncology "L. & A. Seràgnoli", Bologna University, Policlinico S. Orsola, Bologna, Italy. AN - 10980638 AU - Piccaluga, P. P. AU - Ascani, S. AU - Fraternali Orcioni, G. AU - Piccioli, M. AU - Pileri, A., Jr. AU - Falini, B. AU - Pileri, S. DA - Sep DP - Nlm ET - 2000/09/12 IS - 9 LA - eng N1 - Piccaluga, P P Ascani, S Fraternali Orcioni, G Piccioli, M Pileri, A Jr Falini, B Pileri, S Case Reports Journal Article Research Support, Non-U.S. Gov't Italy Haematologica. 2000 Sep;85(9):978-81. PY - 2000 SN - 0390-6078 (Print) 0390-6078 SP - 978-81 ST - Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction T2 - Haematologica TI - Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction VL - 85 ID - 4977 ER - TY - JOUR AD - Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan. akyoshid@ncc.go.jp AN - 23307059 AU - Yoshida, A. AU - Shibata, T. AU - Wakai, S. AU - Ushiku, T. AU - Tsuta, K. AU - Fukayama, M. AU - Makimoto, A. AU - Furuta, K. AU - Tsuda, H. DA - Jun DO - 10.1038/modpathol.2012.222 10.1038/modpathol.2012.222. Epub 2013 Jan 11. DP - Nlm ET - 2013/01/12 IS - 6 LA - eng PY - 2013 SN - 0893-3952 SP - 772-81 ST - Anaplastic lymphoma kinase status in rhabdomyosarcomas T2 - Mod Pathol TI - Anaplastic lymphoma kinase status in rhabdomyosarcomas VL - 26 ID - 4978 ER - TY - JOUR AD - A.F. Nascimento, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, United States AU - Morgan, E. A. AU - Nascimento, A. F. C2 - Pfizer DB - Embase DO - 10.1155/2012/529572 LA - English M3 - Review N1 - L364444365 2012-03-23 2012-03-27 PY - 2012 SN - 1687-9104 1687-9112 ST - Anaplastic lymphoma kinase-positive large b-cell lymphoma: An underrecognized aggressive lymphoma T2 - Advances in Hematology TI - Anaplastic lymphoma kinase-positive large b-cell lymphoma: An underrecognized aggressive lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364444365&from=exporthttp://dx.doi.org/10.1155/2012/529572 VL - 2012 ID - 4979 ER - TY - JOUR AD - Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. AN - 28665943 AU - Jiang, X. N. AU - Yu, B. H. AU - Wang, W. G. AU - Zhou, X. Y. AU - Li, X. Q. C2 - PMC5493294 DO - 10.1371/journal.pone.0178416 10.1371/journal.pone.0178416. eCollection 2017. DP - Nlm ET - 2017/07/01 IS - 6 LA - eng PY - 2017 SN - 1932-6203 SP - e0178416 ST - Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature T2 - PLoS One TI - Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature VL - 12 ID - 4980 ER - TY - JOUR AD - A. Thomas, University of Vermont Medical Center, Burlington, VT, United States AU - Thomas, A. AU - Tucker, S. AU - Nelson, C. AU - Nickerson, J. AU - Durham, S. AU - Homans, A. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619947536 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi216 ST - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab T2 - Neuro-Oncology TI - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619947536&from=exporthttp://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 4981 ER - TY - JOUR AD - A.A. Thomas, Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, United States AU - Thomas, A. A. AU - Tucker, S. M. AU - Nelson, C. J. AU - Nickerson, J. P. AU - Durham, S. R. AU - Homans, A. C. DB - Embase Medline DO - 10.1002/pbc.27465 IS - 1 LA - English M3 - Letter N1 - L624036022 2018-10-01 2019-10-31 PY - 2019 SN - 1545-5017 1545-5009 ST - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab T2 - Pediatric Blood and Cancer TI - Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination responsive to BRAF inhibition and bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624036022&from=exporthttp://dx.doi.org/10.1002/pbc.27465 VL - 66 ID - 4982 ER - TY - JOUR AD - G. Agabekyan, National Medical Research Centre for Neurosurgery n.a. N.N. Burdenko, Moscow, Russian Federation AU - Agabekyan, G. AU - Kobyakov, G. AU - Lodygina, K. AU - Kobyakov, N. AU - Absalyamova, O. AU - Ryzhova, M. AU - Inozemceva, M. AU - Poddubsky, A. DB - Embase DO - 10.1093/neuonc/noz126.300 LA - English M3 - Conference Abstract N1 - L631167679 2020-03-17 PY - 2019 SN - 1523-5866 SP - iii82 ST - Anaplastic pleomorphic xanthoastrocytoma: Literature review& case report T2 - Neuro-Oncology TI - Anaplastic pleomorphic xanthoastrocytoma: Literature review& case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631167679&from=exporthttp://dx.doi.org/10.1093/neuonc/noz126.300 VL - 21 ID - 4983 ER - TY - JOUR AD - Department of Pathology, The University of Colorado Health Sciences Center, 12605 E. 16th Avenue, Room 3026, MS F768, Aurora, CO 80045, USA. AN - 23096133 AU - Schmidt, Y. AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Lillehei, K. O. AU - Damek, D. C2 - PMC4617340 C6 - NIHMS730193 DA - Jan DO - 10.1007/s11060-012-0991-4 10.1007/s11060-012-0991-4. Epub 2012 Oct 25. DP - Nlm ET - 2012/10/26 IS - 1 LA - eng PY - 2013 SN - 0167-594X (Print) 0167-594x SP - 59-69 ST - Anaplastic PXA in adults: case series with clinicopathologic and molecular features T2 - J Neurooncol TI - Anaplastic PXA in adults: case series with clinicopathologic and molecular features VL - 111 ID - 4984 ER - TY - JOUR AD - Y.-Y. Le, Key Laboratory of Food Safety Research, Chinese Academy of Sciences, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Shanghai, China AU - Yao, P. L. AU - Zhuo, S. AU - Mei, H. AU - Chen, X. F. AU - Li, N. AU - Zhu, T. F. AU - Chen, S. T. AU - Wang, J. M. AU - Hou, R. X. AU - Le, Y. Y. DB - Embase Medline DO - 10.1111/cns.12757 IS - 11 LA - English M3 - Article N1 - L618516238 2017-10-06 2018-07-23 PY - 2017 SN - 1755-5949 1755-5930 SP - 855-865 ST - Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ T2 - CNS Neuroscience and Therapeutics TI - Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618516238&from=exporthttp://dx.doi.org/10.1111/cns.12757 VL - 23 ID - 4985 ER - TY - JOUR AD - Anna Meyer Children's Hospital, Florence, Italy. ambuccoliero@unifi.it AN - 23073165 AU - Buccoliero, A. M. AU - Castiglione, F. AU - Degl'innocenti, D. R. AU - Moncini, D. AU - Spacca, B. AU - Giordano, F. AU - Genitori, L. AU - Taddei, G. L. DA - Mar-Apr DO - 10.5414/np300500 10.5414/NP300500. DP - Nlm ET - 2012/10/18 IS - 2 LA - eng PY - 2013 SN - 0722-5091 (Print) 0722-5091 SP - 107-13 ST - Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases T2 - Clin Neuropathol TI - Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases VL - 32 ID - 4986 ER - TY - JOUR AD - M. Berretta, Department of Medical Oncology, National Cancer Institute, Aviano, Italy AU - Berretta, M. AU - Rinaldi, L. AU - Di Benedetto, F. AU - Lleshi, A. AU - Re, V. D. AU - Facchini, G. AU - De Paoli, P. AU - Di Francia, R. C1 - abt 869 amg 386 azd 2171 bay 869766 ptk 787 DB - Embase DO - 10.3389/fphar.2016.00428 IS - NOV LA - English M3 - Review N1 - L613625705 2016-12-19 2017-01-17 PY - 2016 SN - 1663-9812 ST - Angiogenesis inhibitors for the treatment of hepatocellular carcinoma T2 - Frontiers in Pharmacology TI - Angiogenesis inhibitors for the treatment of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613625705&from=exporthttp://dx.doi.org/10.3389/fphar.2016.00428 VL - 7 ID - 4987 ER - TY - JOUR AD - Y. Li, Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China AU - Jin, X. AU - Guo, B. AU - Yan, J. AU - Yang, R. AU - Chang, L. AU - Wang, Y. AU - Miao, C. AU - Liu, S. AU - Zhang, H. AU - Li, Y. DB - Embase Medline DO - 10.1007/s11010-015-2497-9 IS - 1-2 LA - English M3 - Article N1 - L605090890 2015-07-08 2015-10-01 PY - 2015 SN - 1573-4919 0300-8177 SP - 215-222 ST - Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes T2 - Molecular and Cellular Biochemistry TI - Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605090890&from=exporthttp://dx.doi.org/10.1007/s11010-015-2497-9 VL - 408 ID - 4988 ER - TY - JOUR AD - E.A. Tallant AU - Tallant, E. A. AU - Rahimi, O. AU - Varagic, J. AU - Westwood, B. M. AU - Gallagher, P. E. DB - Embase DO - 10.1161/hyp.74.suppl_1.P3006 LA - English M3 - Conference Abstract N1 - L629597945 2019-10-21 PY - 2019 SN - 1524-4563 ST - Angiotensin-(1-7) prevents doxorubicin-induced aortic dysfunction through anti-fibrotic mechanisms in juvenile male and female Sprague Dawley rats T2 - Hypertension TI - Angiotensin-(1-7) prevents doxorubicin-induced aortic dysfunction through anti-fibrotic mechanisms in juvenile male and female Sprague Dawley rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629597945&from=exporthttp://dx.doi.org/10.1161/hyp.74.suppl_1.P3006 VL - 74 ID - 4989 ER - TY - JOUR AD - Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos, 6627 Pampulha, Belo Horizonte, MG, 31270-901, Brazil Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil Laboratório de Imunoparasitologia, Núcleo de Pesquisas em Ciências Biológicas, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, 35400-000, Brazil Laboratório de Inflamação, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, 21040-360, Brazil Programa de Pos-Graduacao em Ciencias Saude: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil Setor de Patologia Clínica, Colégio Técnico, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil AU - Oliveira, L. G. AU - Souza-Testasicca, M. C. AU - Vago, J. P. AU - Figueiredo, A. B. AU - Canavaci, A. M. C. AU - Perucci, L. O. AU - Ferreira, T. P. T. AU - Coelho, E. A. F. AU - Gonçalves, D. U. AU - Rocha, M. O. C. AU - E Silva, P. M. R. AU - Ferreira, C. N. AU - Queiroz-Junior, C. AU - Sousa, L. P. AU - Fernandes, A. P. DB - Scopus DO - 10.4049/jimmunol.1602028 IS - 8 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 3227-3236 ST - Annexin A1 is involved in the resolution of inflammatory responses during Leishmania braziliensis infection T2 - Journal of Immunology TI - Annexin A1 is involved in the resolution of inflammatory responses during Leishmania braziliensis infection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017333296&doi=10.4049%2fjimmunol.1602028&partnerID=40&md5=968425725a482d4fff536387bd475076 VL - 198 ID - 4990 ER - TY - JOUR AD - K.V. Rosen, Atlantic Research Centre, 5849 University Avenue, Halifax, NS, Canada AU - Yoo, B. H. AU - Masson, O. AU - Li, Y. AU - Khan, I. A. AU - Gowda, P. S. AU - Rosen, K. V. DB - Embase Medline DO - 10.1038/onc.2014.415 IS - 38 LA - English M3 - Article N1 - L601087289 2015-01-08 2015-09-28 PY - 2015 SN - 1476-5594 0950-9232 SP - 4939-4951 ST - Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists T2 - Oncogene TI - Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601087289&from=exporthttp://dx.doi.org/10.1038/onc.2014.415 VL - 34 ID - 4991 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People’s Hospital, Beijing, China AU - Xie, L. AU - Xu, J. AU - Sun, X. AU - Tang, X. AU - Yan, T. AU - Yang, R. AU - Guo, W. DB - Scopus DO - 10.2147/CMAR.S232823 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 91-102 ST - Anorexia, hypertension, pneumothorax, and hypothyroidism: Potential signs of improved clinical outcome following apatinib in advanced osteosarcoma T2 - Cancer Management and Research TI - Anorexia, hypertension, pneumothorax, and hypothyroidism: Potential signs of improved clinical outcome following apatinib in advanced osteosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077842518&doi=10.2147%2fCMAR.S232823&partnerID=40&md5=dd98433bc7a1bb03f709c30a2bf270b6 VL - 12 ID - 4992 ER - TY - JOUR AD - P. Angulo, University of Kansas Cancer Center, Children's Mercy Hospital, Kansas City, KS, United States AU - Angulo, P. AU - Subramaniam, D. AU - Chastain, K. AU - Guest, E. AU - Fulbright, J. AU - August, K. AU - Anant, S. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687759 2017-08-11 PY - 2017 SN - 1545-5017 SP - S51 ST - Antagonizing prolactin induced JAK/STAT signaling in osteosarcoma T2 - Pediatric Blood and Cancer TI - Antagonizing prolactin induced JAK/STAT signaling in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687759&from=exporthttp://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 4993 ER - TY - JOUR AD - S.-C. Baik, Department of Microbiology, Gyeongsang National University School of Medicine, 92 Chilam-Dong, Jinju 660-751, South Korea AU - Kim, J. M. AU - Kim, K. M. AU - Park, E. H. AU - Seo, J. H. AU - Song, J. Y. AU - Shin, S. C. AU - Kang, H. L. AU - Lee, W. K. AU - Cho, M. J. AU - Rhee, K. H. AU - Youn, H. S. AU - Baik, S. C. DB - Embase Medline DO - 10.1111/1348-0421.12049 IS - 5 LA - English M3 - Article N1 - L368943857 2013-05-27 2013-06-05 PY - 2013 SN - 0385-5600 1348-0421 SP - 366-373 ST - Anthocyanins from black soybean inhibit Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells T2 - Microbiology and Immunology TI - Anthocyanins from black soybean inhibit Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368943857&from=exporthttp://dx.doi.org/10.1111/1348-0421.12049 VL - 57 ID - 4994 ER - TY - JOUR AD - W. Zhao, State Key Laboratory of Medical Genomics, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University, Shanghai, China AU - Zhao, W. AU - Xu, P. AU - Fu, D. AU - Li, J. AU - Wang, X. AU - Hu, J. AU - Zhou, J. AU - Yu, H. AU - Zhao, X. AU - Su, L. AU - Chen, Z. AU - Zeng, Q. AU - Chen, J. AU - Fang, M. AU - Ma, J. AU - Liu, T. AU - Song, Y. AU - Yu, K. AU - Li, Y. AU - Qiu, L. AU - Chen, X. AU - Gu, J. AU - Yan, J. AU - Hou, M. AU - Xiong, H. DB - Embase DO - 10.1002/hon.2438 LA - English M3 - Conference Abstract N1 - L617732372 2017-08-15 PY - 2017 SN - 0278-0232 SP - 187-188 ST - Anthracycline dose intensification in diffuse large B-cell lymphoma T2 - Hematological Oncology TI - Anthracycline dose intensification in diffuse large B-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617732372&from=exporthttp://dx.doi.org/10.1002/hon.2438 VL - 35 ID - 4995 ER - TY - JOUR AD - Chemistry and Life Sciences College, Xingzhi College, Zhejiang Provincial Key Laboratory of Ecology, Key laboratory of wildlife biotechnology and conservation and utilization of Zhejiang Province, Zhejiang Normal University, China School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou, China AU - Fang, Z. AU - Zhu, Q. AU - Gu, T. AU - Shen, X. AU - Yang, Y. AU - Liang, Y. AU - Zhang, Z. AU - Xu, X. DB - Scopus DO - 10.1016/j.yhbeh.2017.05.014 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 151-158 ST - Anti-androgenic effects of bisphenol-A on spatial memory and synaptic plasticity of the hippocampus in mice T2 - Hormones and Behavior TI - Anti-androgenic effects of bisphenol-A on spatial memory and synaptic plasticity of the hippocampus in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020317473&doi=10.1016%2fj.yhbeh.2017.05.014&partnerID=40&md5=6ef53e0ff1d01dbb1ac1b8dc3c048530 VL - 93 ID - 4996 ER - TY - JOUR AD - M. Sie, University Medical Center Groningens, Department of Pediatricss, Beatrix Children's Hospital, Pediatric Oncology Division, Hanzeplein 1, PO Box 30001, 9700 RB Groningen, Netherlands AU - Sie, M. AU - den Dunnen, W. F. A. AU - Hoving, E. W. AU - de Bont, E. S. J. M. C1 - avastin cc 5013 gleevec su 11248 su 5416 tarceva DB - Embase Medline DO - 10.1016/j.critrevonc.2013.09.005 IS - 3 LA - English M3 - Review N1 - L52832771 2013-10-31 2014-03-04 PY - 2014 SN - 1040-8428 1879-0461 SP - 418-132 ST - Anti-angiogenic therapy in pediatric brain tumors: An effective strategy? T2 - Critical Reviews in Oncology/Hematology TI - Anti-angiogenic therapy in pediatric brain tumors: An effective strategy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52832771&from=exporthttp://dx.doi.org/10.1016/j.critrevonc.2013.09.005 VL - 89 ID - 4997 ER - TY - JOUR AD - Y. Lee, Department of Dermatology, College of Medicine, Chung-Ang University, 102 Heukseok-ro, Seoul, South Korea AU - Na, J. AU - Bak, D. H. AU - Im, S. I. AU - Choi, H. AU - Hwang, J. H. AU - Kong, S. Y. AU - No, Y. A. AU - Lee, Y. AU - Kim, B. J. DB - Embase Medline DO - 10.3892/ijmm.2018.3483 IS - 5 LA - English M3 - Article N1 - L621003658 2018-03-09 2018-03-19 PY - 2018 SN - 1791-244X 1107-3756 SP - 3090-3098 ST - Anti-apoptotic effects of glycosaminoglycans via inhibition of ERK/AP-1 signaling in TNF-ααstimulated human dermal fibroblasts T2 - International Journal of Molecular Medicine TI - Anti-apoptotic effects of glycosaminoglycans via inhibition of ERK/AP-1 signaling in TNF-ααstimulated human dermal fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621003658&from=exporthttp://dx.doi.org/10.3892/ijmm.2018.3483 VL - 41 ID - 4998 ER - TY - JOUR AD - Department of Pathology, Maastricht University Medical Center, Postbus 5800, NL-6202 AZ Maastricht, Netherlands Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands Department of Pathology, VieCuri Medical Center, Venlo, Netherlands AU - Koopmans, S. M. AU - Schouten, H. C. AU - Van Marion, A. M. W. DB - Scopus DO - 10.1159/000356187 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 60-68 ST - Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia T2 - Pathobiology TI - Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896716107&doi=10.1159%2f000356187&partnerID=40&md5=caf7198546c0e66c7c9166684271d8e4 VL - 81 ID - 4999 ER - TY - JOUR AD - E.M. Sierra, CHU Sainte-Justine Research Center, Montreal, QC, Canada AU - Sierra, E. M. AU - Quiniou, C. AU - Nadeau-Vallée, M. AU - Hou, X. AU - Hales, B. AU - Chemtob, S. DB - Embase DO - 10.1177/1933719117699773 IS - 1 LA - English M3 - Conference Abstract N1 - L615323338 2017-04-17 PY - 2017 SN - 1933-7205 SP - 109A-110A ST - An anti-IL-6R peptide as a potential therapeutic agent in inflammation-and infection-induced preterm birth T2 - Reproductive Sciences TI - An anti-IL-6R peptide as a potential therapeutic agent in inflammation-and infection-induced preterm birth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615323338&from=exporthttp://dx.doi.org/10.1177/1933719117699773 VL - 24 ID - 5000 ER - TY - JOUR AD - C.L.H. Yang, Molecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong AU - Luo, D. AU - Or, T. C. T. AU - Yang, C. L. H. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1021/cn5001205 IS - 9 LA - English M3 - Article N1 - L603046663 2015-03-24 2015-03-30 PY - 2014 SN - 1948-7193 SP - 855-866 ST - Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver T2 - ACS Chemical Neuroscience TI - Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603046663&from=exporthttp://dx.doi.org/10.1021/cn5001205 VL - 5 ID - 5001 ER - TY - JOUR AD - B. Liu, School of Traditional Chinese Medicine, Southern Medical University, 1063 Shatai Road, Guangzhou, Guangdong, China AU - Fan, H. J. AU - Xie, Z. P. AU - Lu, Z. W. AU - Tan, Z. B. AU - Bi, Y. M. AU - Xie, L. P. AU - Wu, Y. T. AU - Zhang, W. T. AU - Liu-Kot, K. AU - Liu, B. AU - Zhou, Y. C. C2 - sanjiu medical and pharmaceutical(China) shanghai chemical reagent company(China) DB - Embase Medline DO - 10.1016/j.jep.2018.04.032 LA - English M3 - Article N1 - L2000730406 2018-05-17 2018-10-24 PY - 2018 SN - 1872-7573 0378-8741 SP - 1-10 ST - Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction T2 - Journal of Ethnopharmacology TI - Anti-inflammatory and immune response regulation of Si-Ni-San in 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin dysfunction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000730406&from=exporthttp://dx.doi.org/10.1016/j.jep.2018.04.032 VL - 222 ID - 5002 ER - TY - JOUR AD - C.-J. Chen, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan AU - Chen, W. Y. AU - Chang, C. Y. AU - Li, J. R. AU - Wang, J. D. AU - Wu, C. C. AU - Kuan, Y. H. AU - Liao, S. L. AU - Wang, W. Y. AU - Chen, C. J. DB - Embase Medline DO - 10.3390/ijms19113678 IS - 11 LA - English M3 - Article N1 - L625185235 2018-12-12 2019-02-28 PY - 2018 SN - 1422-0067 1661-6596 ST - Anti-inflammatory and neuroprotective effects of fungal immunomodulatory protein involving microglial inhibition T2 - International Journal of Molecular Sciences TI - Anti-inflammatory and neuroprotective effects of fungal immunomodulatory protein involving microglial inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625185235&from=exporthttp://dx.doi.org/10.3390/ijms19113678 VL - 19 ID - 5003 ER - TY - JOUR AD - H.-T. Wang, Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan AU - Ho, W. C. AU - Hsu, C. C. AU - Huang, H. J. AU - Wang, H. T. AU - Lin, A. M. Y. C1 - azd 6244(Astra Zeneca,United Kingdom) C2 - Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1007/s12035-019-01758-8 IS - 1 LA - English M3 - Article N1 - L2003768719 2019-12-04 PY - 2020 SN - 1559-1182 0893-7648 SP - 88-95 ST - Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation T2 - Molecular Neurobiology TI - Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003768719&from=exporthttp://dx.doi.org/10.1007/s12035-019-01758-8 VL - 57 ID - 5004 ER - TY - JOUR AD - X. Fu, School of Pharmacy, Ningxia Medical University, Yinchuan, China AU - Dong, L. AU - Yin, L. AU - Chen, R. AU - Zhang, Y. AU - Hua, S. AU - Quan, H. AU - Fu, X. C2 - Quality Control Chemicals(United States) DB - Embase Medline DO - 10.1016/j.gene.2018.06.057 LA - English M3 - Article N1 - L2000915604 2018-07-09 2018-10-05 PY - 2018 SN - 1879-0038 0378-1119 SP - 94-101 ST - Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells T2 - Gene TI - Anti-inflammatory effect of Calycosin glycoside on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000915604&from=exporthttp://dx.doi.org/10.1016/j.gene.2018.06.057 VL - 675 ID - 5005 ER - TY - JOUR AD - Department of Conservative Dentistry, Dental Research Institute and School of Dentistry, Seoul National University, Jongno-gu, Yeongun-dong 275-1, Seoul, 110-749, South Korea Department of Family Medicine, Eulji University School of Medicine, Joong-gu, Yongdu-dong 143-5, Daejeon, South Korea School of Dentistry, David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, United States AU - Ko, Y. J. AU - Kwon, K. Y. AU - Kum, K. Y. AU - Lee, W. C. AU - Baek, S. H. AU - Kang, M. K. AU - Shon, W. J. C7 - 385127 DB - Scopus DO - 10.1155/2015/385127 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 ST - The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells T2 - Mediators of Inflammation TI - The Anti-Inflammatory Effect of Human Telomerase-Derived Peptide on P. gingivalis Lipopolysaccharide-Induced Inflammatory Cytokine Production and Its Mechanism in Human Dental Pulp Cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947440683&doi=10.1155%2f2015%2f385127&partnerID=40&md5=b19dc2154cd0facd3fe42140b0116cb2 VL - 2015 ID - 5006 ER - TY - JOUR AD - Y. Tang, Department of Orthopedics, Children's Hospital Affiliated to Nanjing Medical University, 8 Jiangdong South Road, Nanjing, Jiangsu, China AU - Cao, D. AU - Pi, J. AU - Shan, Y. AU - Tang, Y. AU - Zhou, P. DB - Embase DO - 10.3892/etm.2018.6721 IS - 5 LA - English M3 - Article N1 - L624052373 2018-10-02 2018-10-05 PY - 2018 SN - 1792-1015 1792-0981 SP - 4283-4288 ST - Anti-inflammatory effect of resolvin D1 on LPS-treated MG-63 cells T2 - Experimental and Therapeutic Medicine TI - Anti-inflammatory effect of resolvin D1 on LPS-treated MG-63 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624052373&from=exporthttp://dx.doi.org/10.3892/etm.2018.6721 VL - 16 ID - 5007 ER - TY - JOUR AD - Department of Food Science, Dairy Technology, University of Copenhagen, Faculty of Science, Frederiksberg C, Denmark. dcha@life.ku.dk AN - 23660296 AU - Chatterton, D. E. AU - Nguyen, D. N. AU - Bering, S. B. AU - Sangild, P. T. DA - Aug DO - 10.1016/j.biocel.2013.04.028 10.1016/j.biocel.2013.04.028. Epub 2013 May 6. DP - Nlm ET - 2013/05/11 IS - 8 LA - eng PY - 2013 SN - 1357-2725 SP - 1730-47 ST - Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns T2 - Int J Biochem Cell Biol TI - Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns VL - 45 ID - 5008 ER - TY - JOUR AD - Discovery Biology, Inflammation Research, Pfizer Global Research and Development, Chesterfield, Missouri 63017, USA. heidi.r.hope@pfizer.com AN - 19720877 AU - Hope, H. R. AU - Anderson, G. D. AU - Burnette, B. L. AU - Compton, R. P. AU - Devraj, R. V. AU - Hirsch, J. L. AU - Keith, R. H. AU - Li, X. AU - Mbalaviele, G. AU - Messing, D. M. AU - Saabye, M. J. AU - Schindler, J. F. AU - Selness, S. R. AU - Stillwell, L. I. AU - Webb, E. G. AU - Zhang, J. AU - Monahan, J. B. DA - Dec DO - 10.1124/jpet.109.158329 10.1124/jpet.109.158329. Epub 2009 Aug 31. DP - Nlm ET - 2009/09/02 IS - 3 LA - eng PY - 2009 SN - 0022-3565 SP - 882-95 ST - Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation T2 - J Pharmacol Exp Ther TI - Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation VL - 331 ID - 5009 ER - TY - JOUR AD - C.-Y. Cheng, Graduate Institute of Health Industry Technology, Research Center for Chinese Herbal Medicine and Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, 261 Wen-Hwa 1st Road, Guishan Dist., Taoyuan City, Taiwan AU - Cheng, S. C. AU - Wu, Y. H. AU - Huang, W. C. AU - Pang, J. H. S. AU - Huang, T. H. AU - Cheng, C. Y. C1 - bay 11 7082(Enzo Life Sciences,United States) sp 600125(Enzo Life Sciences,United States) u 0126(Enzo Life Sciences,United States) C2 - Biotic Chemical(Taiwan) Enzo Life Sciences(United States) DB - Embase Medline DO - 10.1016/j.cyto.2019.01.001 LA - English M3 - Article N1 - L2001490388 2019-01-29 2019-02-06 PY - 2019 SN - 1096-0023 1043-4666 SP - 48-60 ST - Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells T2 - Cytokine TI - Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-α-activated retinal pigment epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001490388&from=exporthttp://dx.doi.org/10.1016/j.cyto.2019.01.001 VL - 116 ID - 5010 ER - TY - JOUR AD - Z. Xia, Department of Pharmacy, School & Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China AU - Tang, Z. AU - Lu, L. AU - Xia, Z. DB - Embase Medline DO - 10.2147/DDDT.S258811 LA - English M3 - Article N1 - L2005142445 2020-11-02 PY - 2020 SN - 1177-8881 SP - 3965-3976 ST - Anti-tumor xanthones from garcinia nujiangensis suppress proliferation, and induce apoptosis via parp, pi3k/akt/mtor, and mapk/erk signaling pathways in human ovarian cancers cells T2 - Drug Design, Development and Therapy TI - Anti-tumor xanthones from garcinia nujiangensis suppress proliferation, and induce apoptosis via parp, pi3k/akt/mtor, and mapk/erk signaling pathways in human ovarian cancers cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005142445&from=exporthttp://dx.doi.org/10.2147/DDDT.S258811 VL - 14 ID - 5011 ER - TY - JOUR AD - J.H. Kim, Seoul National University and Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744, South Korea AU - Jo, D. H. AU - Kim, J. H. AU - Yu, Y. S. AU - Lee, T. G. AU - Kim, J. H. DB - Embase Medline DO - 10.1016/j.nano.2011.09.003 IS - 5 LA - English M3 - Article N1 - L51695363 2011-11-04 2012-07-05 PY - 2012 SN - 1549-9634 1549-9642 SP - 784-791 ST - Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor T2 - Nanomedicine: Nanotechnology, Biology, and Medicine TI - Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51695363&from=exporthttp://dx.doi.org/10.1016/j.nano.2011.09.003 VL - 8 ID - 5012 ER - TY - JOUR AD - T. Jiang, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China AU - Zhang, W. AU - Qiu, X. G. AU - Chen, B. S. AU - Li, S. W. AU - Cui, Y. AU - Ren, H. AU - Jiang, T. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2009.11.003 IS - 11 LA - English M3 - Article N1 - L355058376 2009-08-31 PY - 2009 SN - 0366-6999 SP - 1250-1254 ST - Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: Analysis of the response and core pathway aberrations T2 - Chinese Medical Journal TI - Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: Analysis of the response and core pathway aberrations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355058376&from=exporthttp://dx.doi.org/10.3760/cma.j.issn.0366-6999.2009.11.003http://www.cmj.org/Periodical/PdfList.asp?id=LW200964457450503472 VL - 122 ID - 5013 ER - TY - JOUR AD - Departments of Nuclear Medicine and Endocrine Oncology (L.L., S.I., A.B., M.T., D.D., M.S., E.B., S.L.), Radiology (M.D., F.B.), Biostatistics and Epidemiology (I.B.), Medical Biology and Pathology (A.A.G.), Surgery (D.H.), and Department of Radiotherapy (P.B.), Gustave Roussy and University Paris Saclay, 94805 Villejuif, France AN - 116654071. Language: English. Entry Date: 20170708. Revision Date: 20191111. Publication Type: journal article AU - Lamartina, Livia AU - Ippolito, S. AU - Danis, M. AU - Bidault, F. AU - Borget, I. AU - Berdelou, A. AU - Al Ghuzlan, A. AU - Hartl, D. AU - Blanchard, P. AU - Terroir, M. AU - Deandreis, D. AU - Schlumberger, M. AU - Baudin, E. AU - Leboulleux, S. DB - ccm DO - 10.1210/jc.2015-4391 DP - EBSCOhost IS - 7 N1 - research. Journal Subset: Biomedical; USA. NLM UID: 0375362. PMID: NLM27082933. PY - 2016 SN - 0021-972X SP - 2733-2741 ST - Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer T2 - Journal of Clinical Endocrinology & Metabolism TI - Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116654071&site=ehost-live&scope=site VL - 101 ID - 5014 ER - TY - JOUR AD - Department of Otorhinolaryngology-Head and Neck Surgery, Chosun University College of Medicine, Gwangju, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Graduate school of Medicine, Seoul National University, Seoul, South Korea Sensory Organ Research Center, Seoul National University Biomedical Research Institute, Seoul, South Korea Institute of Allergy and Clinical Immunology, Seoul National University Biomedical Research Institute, Seoul, South Korea Graduate School of Immunology, Seoul National University, Seoul, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, South Korea AU - Lee, J. E. AU - Kim, Y. H. AU - Rhee, C. S. AU - Kim, D. Y. DB - Scopus DO - 10.4168/aair.2016.8.5.445 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 SP - 445-456 ST - AntibiSynergistic effect of Dermatophagoides farinae and lipopolysaccharides in human middle ear epithelial cells T2 - Allergy, Asthma and Immunology Research TI - AntibiSynergistic effect of Dermatophagoides farinae and lipopolysaccharides in human middle ear epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976340342&doi=10.4168%2faair.2016.8.5.445&partnerID=40&md5=b774b2f89b69750ea7faf9128e257946 VL - 8 ID - 5015 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. AN - 22266870 AU - Carpenter, E. L. AU - Haglund, E. A. AU - Mace, E. M. AU - Deng, D. AU - Martinez, D. AU - Wood, A. C. AU - Chow, A. K. AU - Weiser, D. A. AU - Belcastro, L. T. AU - Winter, C. AU - Bresler, S. C. AU - Vigny, M. AU - Mazot, P. AU - Asgharzadeh, S. AU - Seeger, R. C. AU - Zhao, H. AU - Guo, R. AU - Christensen, J. G. AU - Orange, J. S. AU - Pawel, B. R. AU - Lemmon, M. A. AU - Mossé, Y. P. C2 - PMC3730824 C6 - NIHMS470414 DA - Nov 15 DO - 10.1038/onc.2011.647 10.1038/onc.2011.647. Epub 2012 Jan 23. DP - Nlm ET - 2012/01/24 IS - 46 LA - eng PY - 2012 SN - 0950-9232 (Print) 0950-9232 SP - 4859-67 ST - Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma T2 - Oncogene TI - Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma VL - 31 ID - 5016 ER - TY - JOUR AD - W.-H. Qi, Department of Obstetrics and Gynaecology, Beijing Hospital, 1 Dongdan Dahua Road, Beijing, China AU - Wang, Y. AU - Shi, L. Y. AU - Qi, W. H. AU - Yang, J. AU - Qi, Y. C2 - Sigma(United States) DB - Embase DO - 10.5114/aoms.2017.71420 IS - 2 LA - English M3 - Article N1 - L2005265090 2020-03-24 2020-04-07 PY - 2020 SN - 1896-9151 1734-1922 SP - 428-435 ST - Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway T2 - Archives of Medical Science TI - Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005265090&from=exporthttp://dx.doi.org/10.5114/aoms.2017.71420 VL - 16 ID - 5017 ER - TY - JOUR AD - Department of Medical Oncology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan Department of Gynecology, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan AU - Miyamoto, S. AU - Yamada, M. AU - Kasai, Y. AU - Miyauchi, A. AU - Andoh, K. DB - Scopus DO - 10.1093/jjco/hyw073 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 795-804 ST - Anticancer drugs during pregnancy T2 - Japanese Journal of Clinical Oncology TI - Anticancer drugs during pregnancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994074785&doi=10.1093%2fjjco%2fhyw073&partnerID=40&md5=b12a7be75b69539143102d4ca2582097 VL - 46 ID - 5018 ER - TY - JOUR AD - Departments of Orthopedics. Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. AN - 29420337 AU - Qing, X. AU - Shao, Z. AU - Lv, X. AU - Pu, F. AU - Gao, F. AU - Liu, L. AU - Shi, D. C2 - PMC5882294 DA - Apr DO - 10.1097/cad.0000000000000602 10.1097/CAD.0000000000000602. DP - Nlm ET - 2018/02/09 IS - 4 LA - eng PY - 2018 SN - 0959-4973 (Print) 0959-4973 SP - 341-352 ST - Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species T2 - Anticancer Drugs TI - Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species VL - 29 ID - 5019 ER - TY - JOUR AD - Y.M. Hosakote, University of Texas, Medical Branch at Galveston, United States AU - Hosakote, Y. M. AU - Rayavara, K. AU - Hallberg, L. M. AU - Ameredes, B. T. AU - Kurosky, A. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L623264266 2018-08-02 PY - 2018 SN - 1550-6606 ST - Antioxidant treatment ameliorates cigarette smoke and respiratory syncytial virus-induced inflammatory response by blocking HMGB1 release T2 - Journal of Immunology TI - Antioxidant treatment ameliorates cigarette smoke and respiratory syncytial virus-induced inflammatory response by blocking HMGB1 release UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623264266&from=export VL - 200 ID - 5020 ER - TY - JOUR AD - Department of Hematology, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China Key Lab. of Hematology, Diagnose and Treatment, Hangzhou, Zhejiang, China Key Lab. of Combined Muti-organ Transplantation, Ministry of Public Health, #79 Qingchun Road, Hangzhou 310003, Zhejiang, China AU - Huang, J. AU - Ding, T. AU - Yang, M. AU - Liu, H. AU - Sun, X. AU - Jin, J. DB - Scopus DO - 10.1007/s12185-011-0821-z IS - 4 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2011 SP - 482-493 ST - Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells T2 - International Journal of Hematology TI - Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955942563&doi=10.1007%2fs12185-011-0821-z&partnerID=40&md5=6674c936d59f20fe52b93446ec4d4df5 VL - 93 ID - 5021 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto, Japan Department of Microbiology, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kyoto, Japan Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan Department of Pediatrics, Kyoto Pref. University of Medicine, Graduate School of Medical Science, Kamigyo-ku, Kyoto 602-8566, Japan AU - Kuwahara, Y. AU - Hosoi, H. AU - Osone, S. AU - Kita, M. AU - Iehara, T. AU - Kuroda, H. AU - Sugimoto, T. DB - Scopus DO - 10.1158/1078-0432.CCR-04-0192 IS - 17 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2004 SP - 5940-5948 ST - Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo T2 - Clinical Cancer Research TI - Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444322871&doi=10.1158%2f1078-0432.CCR-04-0192&partnerID=40&md5=e22bf5583de997e5e7e305eb6f852ade VL - 10 ID - 5022 ER - TY - JOUR AD - D.J. Daniels, Department of Neurosurgery, Mayo Clinic, Rochester, MN, United States AU - Zhang, L. AU - Peterson, T. E. AU - Lu, V. M. AU - Parney, I. F. AU - Daniels, D. J. DB - Embase Medline DO - 10.1371/journal.pone.0220569 IS - 7 LA - English M3 - Article N1 - L2002481033 2019-08-09 2020-08-26 PY - 2019 SN - 1932-6203 ST - Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells T2 - PLoS ONE TI - Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002481033&from=exporthttp://dx.doi.org/10.1371/journal.pone.0220569 VL - 14 ID - 5023 ER - TY - JOUR AD - Y. Wu, Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan St, Shapingba District, Chongqing, China AU - Shen, Z. AU - Tian, Z. AU - He, H. AU - Zhang, J. AU - Li, J. AU - Wu, Y. DB - Embase Medline DO - 10.1097/MPG.0000000000000493 IS - 1 LA - English M3 - Article N1 - L53256313 2014-08-01 2015-01-26 PY - 2015 SN - 1536-4801 0277-2116 SP - 11-17 ST - Antiviral effects of cyclosporin a in neonatal mice with rotavirus-induced diarrhea T2 - Journal of Pediatric Gastroenterology and Nutrition TI - Antiviral effects of cyclosporin a in neonatal mice with rotavirus-induced diarrhea UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53256313&from=exporthttp://dx.doi.org/10.1097/MPG.0000000000000493 VL - 60 ID - 5024 ER - TY - JOUR AD - Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. German Rheumatism Research Centre, German Rheumatism Research Centre (DRFZ), A Leibniz Institute, 10117, Berlin, Germany. Medical Department I, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117, Berlin, Germany. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. The Scripps Research Institute, Jupiter, FL, 33458, USA. Department of Molecular Biotechnology and Health Sciences, Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy. NHL-BFM Study Centre and Department of Paediatric Haematology and Oncology, Justus-Liebig-University, Giessen, Germany. Department of Nephrology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University Vienna, Vienna, Austria. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. Department of Pathology, University of Cambridge, Cambridge, CB21QP, UK. Department of Medicine A, Albert-Schweitzer-Campus 1, University Hospital Münster, 48149, Münster, Germany. Cluster of Excellence EXC 1003, Cells in Motion, 48149, Münster, Germany. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. lukas.kenner@meduniwien.ac.at. Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria. lukas.kenner@meduniwien.ac.at. University of Veterinary Medicine, Vienna, Austria. lukas.kenner@meduniwien.ac.at. CBmed, Center for Biomarker Research in Medicine, 8010, Graz, Austria. lukas.kenner@meduniwien.ac.at. Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück-Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, 13125, Berlin, Germany. Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. stephan.mathas@charite.de. Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 12200, Berlin, Germany. stephan.mathas@charite.de. European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. stephan.mathas@charite.de. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. stephan.mathas@charite.de. Experimental and Clinical Research Center, a joint cooperation of Max-Delbrück-Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, 13125, Berlin, Germany. stephan.mathas@charite.de. AN - 29588546 AU - Schleussner, N. AU - Merkel, O. AU - Costanza, M. AU - Liang, H. C. AU - Hummel, F. AU - Romagnani, C. AU - Durek, P. AU - Anagnostopoulos, I. AU - Hummel, M. AU - Jöhrens, K. AU - Niedobitek, A. AU - Griffin, P. R. AU - Piva, R. AU - Sczakiel, H. L. AU - Woessmann, W. AU - Damm-Welk, C. AU - Hinze, C. AU - Stoiber, D. AU - Gillissen, B. AU - Turner, S. D. AU - Kaergel, E. AU - von Hoff, L. AU - Grau, M. AU - Lenz, G. AU - Dörken, B. AU - Scheidereit, C. AU - Kenner, L. AU - Janz, M. AU - Mathas, S. C2 - PMC6127090 DA - Sep DO - 10.1038/s41375-018-0045-9 10.1038/s41375-018-0045-9. Epub 2018 Mar 28. DP - Nlm ET - 2018/03/29 IS - 9 LA - eng PY - 2018 SN - 0887-6924 (Print) 0887-6924 SP - 1994-2007 ST - The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma T2 - Leukemia TI - The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma VL - 32 ID - 5025 ER - TY - JOUR AD - The Airway Mucus Institute, Yonsei University College of Medicine, Seoul, South Korea. AN - 20564234 AU - Moon, U. Y. AU - Kim, C. H. AU - Choi, J. Y. AU - Kim, Y. J. AU - Choi, Y. H. AU - Yoon, H. G. AU - Kim, H. AU - Yoon, J. H. DA - Aug 15 DO - 10.1002/jcb.22655 10.1002/jcb.22655. DP - Nlm ET - 2010/06/22 IS - 6 LA - eng PY - 2010 SN - 0730-2312 SP - 1386-98 ST - AP2alpha is essential for MUC8 gene expression in human airway epithelial cells T2 - J Cell Biochem TI - AP2alpha is essential for MUC8 gene expression in human airway epithelial cells VL - 110 ID - 5026 ER - TY - JOUR AD - K.-K. Park, Department of Pathology, College of Medicine, Catholic University of Daegu, Daegu, South Korea AU - Park, J. AU - Jang, K. M. AU - Park, K. K. DB - Embase Medline DO - 10.3390/ijms21124319 IS - 12 LA - English M3 - Article N1 - L2004569019 2020-07-24 2020-08-31 PY - 2020 SN - 1422-0067 1661-6596 SP - 1-14 ST - Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK channels and TLR4-mediated signaling pathways T2 - International Journal of Molecular Sciences TI - Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK channels and TLR4-mediated signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004569019&from=exporthttp://dx.doi.org/10.3390/ijms21124319 VL - 21 ID - 5027 ER - TY - JOUR AD - Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Cancer Prevention Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Lan, C. Y. AU - Wang, Y. AU - Xiong, Y. AU - Li, J. D. AU - Shen, J. X. AU - Li, Y. F. AU - Zheng, M. AU - Zhang, Y. N. AU - Feng, Y. L. AU - Liu, Q. AU - Huang, H. Q. AU - Huang, X. DB - Scopus DO - 10.1016/S1470-2045(18)30349-8 IS - 9 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2018 SP - 1239-1246 ST - Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study T2 - The Lancet Oncology TI - Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055017750&doi=10.1016%2fS1470-2045%2818%2930349-8&partnerID=40&md5=1c311001b9a642e7fe7921d3b2e32949 VL - 19 ID - 5028 ER - TY - JOUR AD - Department of Interventional Oncology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China Interventional Department, Dongguan People's Hospital, Dongguan, China Liver and Gall Surgical Department, Gaozhou People's Hospital, Gaozhou, China Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Department of Medical Imaging, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China AU - Fan, W. AU - Yuan, G. AU - Fan, H. AU - Li, F. AU - Wu, Y. AU - Zhao, Y. AU - Yao, W. AU - Wang, Y. AU - Xue, M. AU - Yang, J. AU - Li, J. DB - Scopus DO - 10.1016/j.clinthera.2019.04.036 IS - 8 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 SP - 1463-1476 ST - Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study T2 - Clinical Therapeutics TI - Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068539821&doi=10.1016%2fj.clinthera.2019.04.036&partnerID=40&md5=6397147cf16120e2dbf6a87517ec7a1a VL - 41 ID - 5029 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing People's Republic of China AN - 137587818. Language: English. Entry Date: 20190723. Revision Date: 20190723. Publication Type: Article AU - Xie, Lu AU - Xu, Jie AU - Sun, Xin AU - Tang, Xiaodong AU - Yan, Taiqiang AU - Yang, Rongli AU - Guo, Wei DB - ccm DO - 10.1634/theoncologist.2018-0542 DP - EBSCOhost IS - 7 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2019 SN - 1083-7159 SP - e542-e550 ST - Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial T2 - Oncologist TI - Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137587818&site=ehost-live&scope=site VL - 24 ID - 5030 ER - TY - JOUR AD - Peking University People’s HospitalPekingChina Peking University Shougang HospitalPekingChina Peking University International HospitalPekingChina AN - 128936529. Language: English. Entry Date: In Process. Revision Date: 20190619. Publication Type: journal article AU - Xie, Lu AU - Guo, Wei AU - Wang, Ye AU - Yan, Taiqiang AU - Ji, Tao AU - Xu, Jie DB - ccm DO - 10.1186/s12885-018-4303-z DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Europe; UK & Ireland. Instrumentation: Piper Fatigue Scale (PFS). Grant Information: 81402382//National Natural Science Foundation of China/International. NLM UID: 100967800. PMID: NLM29625604. PY - 2018 SN - 1471-2407 SP - 1-1 ST - Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China T2 - BMC Cancer TI - Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128936529&site=ehost-live&scope=site VL - 18 ID - 5031 ER - TY - JOUR AD - Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China AU - Ma, X. AU - Li, L. AU - Zhang, L. AU - Fu, X. AU - Li, X. AU - Wang, X. AU - Wu, J. AU - Sun, Z. AU - Zhang, X. AU - Feng, X. AU - Chang, Y. AU - Zhou, Z. AU - Nan, F. AU - Zhang, J. AU - Li, Z. AU - Zhang, M. DB - Scopus DO - 10.2147/DDDT.S227477 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 275-284 ST - Apatinib in patients with relapsed or refractory diffuse large B cell lymphoma: A phase ii, open-label, single-arm, prospective study T2 - Drug Design, Development and Therapy TI - Apatinib in patients with relapsed or refractory diffuse large B cell lymphoma: A phase ii, open-label, single-arm, prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078676833&doi=10.2147%2fDDDT.S227477&partnerID=40&md5=8b713c9a11a7c532c93da4bcdede44af VL - 14 ID - 5032 ER - TY - JOUR AD - Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China AU - Liu, Y. AU - Chen, X. AU - Gao, X. AU - Chen, J. X. AU - Chen, J. DB - Scopus DO - 10.1177/1078155219846253 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 465-470 ST - Apatinib-induced hyperammonemic encephalopathy T2 - Journal of Oncology Pharmacy Practice TI - Apatinib-induced hyperammonemic encephalopathy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065647457&doi=10.1177%2f1078155219846253&partnerID=40&md5=11f23bc210c5b79d50c2f560669dabe1 VL - 26 ID - 5033 ER - TY - JOUR AD - Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Univ. de São Paulo, Brazil Centro Regional de Hemoterapia de Ribeirão Preto, Brazil Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Brazil Hospital Israelita Albert Einstein, São Paulo, Brazil Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Center for RNA Interference and Non-Coding RNAs, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Ferreira, A. F. AU - Moura, L. G. AU - Tojal, I. AU - Ambrósio, L. AU - Pinto-Simões, B. AU - Hamerschlak, N. AU - Calin, G. A. AU - Ivan, C. AU - Covas, D. T. AU - Kashima, S. AU - Castro, F. A. DB - Scopus DO - 10.1016/j.bcmd.2014.02.008 IS - 1-2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 47-55 ST - ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance T2 - Blood Cells, Molecules, and Diseases TI - ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900030676&doi=10.1016%2fj.bcmd.2014.02.008&partnerID=40&md5=2fc7324ae3f4517beb48e812c75d5860 VL - 53 ID - 5034 ER - TY - JOUR AD - S. Adachi, Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin Sakyo-ku, Kyoto 606-8507, Japan AU - Adachi, S. AU - Leoni, L. M. AU - Carson, D. A. AU - Nakahata, T. C1 - aspirin cep 701 ct 53518 pkc 412 sdx 101 sti 571 su 11248 su 5416 DB - Embase Medline DO - 10.1159/000074490 IS - 1-2 LA - English M3 - Review N1 - L37499959 2003-12-29 PY - 2004 SN - 0001-5792 SP - 107-123 ST - Apoptosis induced by molecular targeting therapy in hematological malignancies T2 - Acta Haematologica TI - Apoptosis induced by molecular targeting therapy in hematological malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37499959&from=exporthttp://dx.doi.org/10.1159/000074490 VL - 111 ID - 5035 ER - TY - JOUR AD - K. Li, Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China AU - Wang, J. AU - Yao, W. AU - Li, K. DB - Embase DO - 10.1136/wjps-2020-000164 IS - 2 LA - English M3 - Review N1 - L632230666 2020-07-22 2020-07-24 PY - 2020 SN - 2516-5410 ST - Applications and prospects of targeted therapy for neuroblastoma T2 - World Journal of Pediatric Surgery TI - Applications and prospects of targeted therapy for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632230666&from=exporthttp://dx.doi.org/10.1136/wjps-2020-000164 VL - 3 ID - 5036 ER - TY - JOUR AD - Stanbury Service PSP Group, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, United States Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, United States Harvard Medical School, Massachusetts General Hospital, Division of Hematology and Medical Oncology, Zero Emerson Place, Suite 118, Boston, MA 02114, United States AU - Fedorov, V. D. AU - Upadhyay, V. A. AU - Fathi, A. T. DB - Scopus DO - 10.1007/s11899-016-0316-3 IS - 3 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 SP - 165-174 ST - The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies T2 - Current Hematologic Malignancy Reports TI - The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960078050&doi=10.1007%2fs11899-016-0316-3&partnerID=40&md5=c3e45397edf6f64c4764c9d72ee2586f VL - 11 ID - 5037 ER - TY - JOUR AD - Y. Zu, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Cancer Pathology Research Laboratory, Houston Methodist Research Institute, Houston, TX, United States AU - Zeng, Z. AU - Tung, C. H. AU - Zu, Y. C2 - Sigma Aldrich(United States) DB - Embase DO - 10.3390/cancers12040780 IS - 4 LA - English M3 - Article N1 - L2004111171 2020-04-13 2020-04-20 PY - 2020 SN - 2072-6694 ST - Aptamer-equipped protamine nanomedicine for precision lymphoma therapy T2 - Cancers TI - Aptamer-equipped protamine nanomedicine for precision lymphoma therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004111171&from=exporthttp://dx.doi.org/10.3390/cancers12040780 VL - 12 ID - 5038 ER - TY - JOUR AD - H. Hakonarson, Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA, United States AU - Li, D. AU - March, M. E. AU - Gutierrez-Uzquiza, A. AU - Kao, C. AU - Seiler, C. AU - Pinto, E. AU - Matsuoka, L. S. AU - Battig, M. R. AU - Bhoj, E. J. AU - Wenger, T. L. AU - Tian, L. AU - Robinson, N. AU - Wang, T. AU - Liu, Y. AU - Weinstein, B. M. AU - Swift, M. AU - Jung, H. M. AU - Kaminski, C. N. AU - Chiavacci, R. AU - Perkins, J. A. AU - Levine, M. A. AU - Sleiman, P. M. A. AU - Hicks, P. J. AU - Strausbaugh, J. T. AU - Belasco, J. B. AU - Dori, Y. AU - Hakonarson, H. C1 - mekinist DB - Embase Medline DO - 10.1038/s41591-019-0479-2 IS - 7 LA - English M3 - Article N1 - L628408257 2019-07-11 2020-04-27 PY - 2019 SN - 1546-170X 1078-8956 SP - 1116-1122 ST - ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor T2 - Nature Medicine TI - ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628408257&from=exporthttp://dx.doi.org/10.1038/s41591-019-0479-2 VL - 25 ID - 5039 ER - TY - JOUR AD - Department of Dermatology, Columbia University Medical Center, New York, NY 10032, USA. AN - 16421887 AU - Lee, D. A. AU - Cohen, J. A. AU - Twaddell, W. S. AU - Palacios, G. AU - Gill, M. AU - Levit, E. AU - Halperin, A. J. AU - Mones, J. AU - Busam, K. J. AU - Silvers, D. N. AU - Celebi, J. T. DA - Feb 15 DO - 10.1002/cncr.21686 10.1002/cncr.21686. DP - Nlm ET - 2006/01/20 IS - 4 LA - eng PY - 2006 SN - 0008-543X (Print) 0008-543x SP - 907-13 ST - Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma T2 - Cancer TI - Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma VL - 106 ID - 5040 ER - TY - JOUR AD - Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan; Brain Research Unit, Innovation Center for Medical Redox Navigation, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: takahiro@npsych.med.kyushu-u.ac.jp. Department of Psychiatry, Saga University Faculty of Medicine, Saga 849-8501, Japan. Faculty of Medicine, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. AN - 27614570 AU - Sato-Kasai, M. AU - Kato, T. A. AU - Ohgidani, M. AU - Mizoguchi, Y. AU - Sagata, N. AU - Inamine, S. AU - Horikawa, H. AU - Hayakawa, K. AU - Shimokawa, N. AU - Kyuragi, S. AU - Seki, Y. AU - Monji, A. AU - Kanba, S. DA - Dec DO - 10.1016/j.schres.2016.08.022 10.1016/j.schres.2016.08.022. Epub 2016 Sep 7. DP - Nlm ET - 2016/09/12 IS - 1-3 LA - eng PY - 2016 SN - 0920-9964 SP - 35-43 ST - Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7 T2 - Schizophr Res TI - Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7 VL - 178 ID - 5041 ER - TY - JOUR AD - Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan. AN - 18089783 AU - Liao, Y. H. AU - Hsu, S. M. AU - Huang, P. H. DA - Dec 15 DO - 10.1158/0008-5472.Can-07-1930 10.1158/0008-5472.CAN-07-1930. DP - Nlm ET - 2007/12/20 IS - 24 LA - eng PY - 2007 SN - 0008-5472 SP - 11547-56 ST - ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma T2 - Cancer Res TI - ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma VL - 67 ID - 5042 ER - TY - JOUR AD - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing, China. AN - 21946058 AU - Zhang, S. AU - Guo, W. AU - Ren, T. T. AU - Lu, X. C. AU - Tang, G. Q. AU - Zhao, F. L. DA - Jan DO - 10.1097/CAD.0b013e32834bfd68 10.1097/CAD.0b013e32834bfd68. DP - Nlm ET - 2011/09/29 IS - 1 LA - eng PY - 2012 SN - 0959-4973 SP - 108-18 ST - Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase T2 - Anticancer Drugs TI - Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase VL - 23 ID - 5043 ER - TY - JOUR AD - L. C. Platanias, Robert H. Lurie Comprehensive Cancer Center and Division of Hematology/Oncology, Northwestern University Medical School, Jesse Brown VA Medical Center, Chicago, IL, United States AU - McNeer, J. L. AU - Goussetis, D. J. AU - Sassano, A. AU - Dolniak, B. AU - Kroczynska, B. AU - Glaser, H. AU - Altman, J. K. AU - Platanias, L. C. DB - Embase Medline DO - 10.1124/mol.109.061507 IS - 5 LA - English M3 - Article N1 - L358653462 2010-04-27 2010-05-17 PY - 2010 SN - 0026-895X 1521-0111 SP - 828-835 ST - Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-β-activated kinase T2 - Molecular Pharmacology TI - Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-β-activated kinase UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358653462&from=exporthttp://dx.doi.org/10.1124/mol.109.061507http://molpharm.aspetjournals.org/content/77/5/828.full.pdf VL - 77 ID - 5044 ER - TY - JOUR AD - Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China Institute of Biomedical Sciences, Fudan Universit, Shanghai, China AU - Liang, Y. AU - Li, W. W. AU - Yang, B. W. AU - Tao, Z. H. AU - Sun, H. C. AU - Wang, L. AU - Xia, J. L. AU - Qin, L. X. AU - Tang, Z. Y. AU - Fan, J. AU - Wu, W. Z. DB - Scopus DO - 10.1002/ijc.26166 IS - 8 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 1745-1754 ST - Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma T2 - International Journal of Cancer TI - Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857501900&doi=10.1002%2fijc.26166&partnerID=40&md5=d60a61b2df22f14bc42f1b813c94a3b6 VL - 130 ID - 5045 ER - TY - JOUR AD - Department of Medical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh 530 053, India Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India AU - Kagita, S. AU - Mamidi, T. AU - Digumarti, L. AU - Gundeti, S. AU - Digumarti, R. DB - Scopus DO - 10.4103/ijmpo.ijmpo_80_17 IS - 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 165-171 ST - Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients T2 - Indian Journal of Medical and Paediatric Oncology TI - Assessment of BCR-ABL1 fusion transcripts and their association with response to imatinib treatment in chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044465440&doi=10.4103%2fijmpo.ijmpo_80_17&partnerID=40&md5=3b906a18806a82f404b81a93964a73ab VL - 39 ID - 5046 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, 100044, Beijing, China Peking University People's Hospital, Department of Nephrology, Beijing, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China AN - 137146984. Language: English. Entry Date: 20190814. Revision Date: 20200630. Publication Type: journal article AU - Ren, Xin AU - Qin, Yazhen AU - Huang, Xiaojun AU - Zuo, Li AU - Jiang, Qian DB - ccm DO - 10.1007/s00277-019-03690-2 DP - EBSCOhost IS - 7 N1 - clinical trial; research. Journal Subset: Biomedical; Continental Europe; Europe. Special Interest: Evidence-Based Practice. Grant Information: 81770161//National Natural Science Foundation of China/. NLM UID: 9107334. PMID: NLM31089794. PY - 2019 SN - 0939-5555 SP - 1627-1640 ST - Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors T2 - Annals of Hematology TI - Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137146984&site=ehost-live&scope=site VL - 98 ID - 5047 ER - TY - JOUR AD - Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936-1080, United States AU - Lau, Y. Y. AU - Gu, W. AU - Lin, T. AU - Viraswami-Appanna, K. AU - Cai, C. AU - Scott, J. W. AU - Shi, M. DB - Scopus DO - 10.1007/s00280-017-3308-7 IS - 6 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 1119-1128 ST - Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer T2 - Cancer Chemotherapy and Pharmacology TI - Assessment of drug–drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018499294&doi=10.1007%2fs00280-017-3308-7&partnerID=40&md5=a09785f25152b70326d7e4218f494f90 VL - 79 ID - 5048 ER - TY - JOUR AD - Cancer Therapy and Research Center, The Institute for Drug Development, San Antonio, TX, United States University of Texas Health Science Center at San Antonio, San Antonio, TX, United States Princess Margaret Hospital, University Health Network, Toronto, ON, Canada OSI Pharmaceuticals Inc., 41 Pinelawn Road, Melville, NY 11747, United States ImClone Systems, 33 ImClone Drive, Branchburg, NJ 08876, United States AU - Calvo, E. AU - Malik, S. N. AU - Siu, L. L. AU - Baillargeon, G. M. AU - Irish, J. AU - Chin, S. F. AU - Santabarbara, P. AU - Kreisberg, J. I. AU - Rowinsky, E. K. AU - Hidalgo, M. DB - Scopus DO - 10.1093/annonc/mdl495 IS - 4 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2007 SP - 761-767 ST - Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer T2 - Annals of Oncology TI - Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34047190928&doi=10.1093%2fannonc%2fmdl495&partnerID=40&md5=74c121bb9b517cc1919b4a737b66d61f VL - 18 ID - 5049 ER - TY - JOUR AD - Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Department of Internal Medicine, Division of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan AU - Komatsu, S. AU - Yano, Y. AU - Sofue, K. AU - Kido, M. AU - Tanaka, M. AU - Kuramitsu, K. AU - Awazu, M. AU - Gon, H. AU - Yamamoto, A. AU - Yanagimoto, H. AU - Toyama, H. AU - Kodama, Y. AU - Murakami, T. AU - Fukumoto, T. DB - Scopus DO - 10.1016/j.hpb.2020.03.002 IS - 10 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 1450-1456 ST - Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis T2 - HPB TI - Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082474177&doi=10.1016%2fj.hpb.2020.03.002&partnerID=40&md5=d474c7df6eafb783f6a7c2794b2aa01e VL - 22 ID - 5050 ER - TY - JOUR AD - Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, United States Department of Pathology, Brigham and Women's Hospital BostonMA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States AU - O'Neill, A. C. AU - Shinagare, A. B. AU - Kurra, V. AU - Tirumani, S. H. AU - Jagannathan, J. P. AU - Baheti, A. D. AU - Hornick, J. L. AU - George, S. AU - Ramaiya, N. H. DB - Scopus DO - 10.1016/j.ejso.2016.03.032 IS - 8 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 1222-1228 ST - Assessment of metastatic risk of gastric GIST based on treatment-naïve CT features T2 - European Journal of Surgical Oncology TI - Assessment of metastatic risk of gastric GIST based on treatment-naïve CT features UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975159391&doi=10.1016%2fj.ejso.2016.03.032&partnerID=40&md5=caf10e0e875dfc6da8a580f3d515c9a9 VL - 42 ID - 5051 ER - TY - JOUR AD - A. Stone, Department of Pediatrics, Division of Pulmonology, Oregon Health and Science University, Portland, OR, United States AU - Stone, A. AU - Friedman, D. N. AU - Kushner, B. H. AU - Wolden, S. AU - Modak, S. AU - LaQuaglia, M. P. AU - Costello, J. AU - Wu, X. AU - Cheung, N. K. AU - Sklar, C. A. DB - Embase Medline DO - 10.1002/pbc.27960 IS - 11 LA - English M3 - Article N1 - L2002476160 2019-08-21 2019-10-25 PY - 2019 SN - 1545-5017 1545-5009 ST - Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma T2 - Pediatric Blood and Cancer TI - Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002476160&from=exporthttp://dx.doi.org/10.1002/pbc.27960 VL - 66 ID - 5052 ER - TY - JOUR AD - Department of Pathology, University of Colorado School of Medicine, Denver, USA. AN - 15080301 AU - Liang, X. AU - Meech, S. J. AU - Odom, L. F. AU - Bitter, M. A. AU - Ryder, J. W. AU - Hunger, S. P. AU - Lovell, M. A. AU - Meltesen, L. AU - Wei, Q. AU - Williams, S. A. AU - Hutchinson, R. N. AU - McGavran, L. DA - Apr DO - 10.1309/tle8-fn6e-yf0n-jgp7 10.1309/TLE8-FN6E-YF0N-JGP7. DP - Nlm ET - 2004/04/15 IS - 4 LA - eng PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 496-506 ST - Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma T2 - Am J Clin Pathol TI - Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma VL - 121 ID - 5053 ER - TY - JOUR AD - S. Frankford, Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States AU - Frankford, S. AU - Reynolds, S. AU - Patel, A. AU - Mendonca-Torres, M. AU - Costello, J. AU - Bikas, A. AU - Burman, K. D. AU - Jensen, K. E. AU - Vasko, V. DB - Embase DO - 10.1089/thy.2019.29085.abstracts LA - English M3 - Conference Abstract N1 - L629777078 2019-11-12 PY - 2019 SN - 1557-9077 SP - A129 ST - Assessment of therapy-inducible molecular changes in patient-derived xenograft of thyroid cancer T2 - Thyroid TI - Assessment of therapy-inducible molecular changes in patient-derived xenograft of thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629777078&from=exporthttp://dx.doi.org/10.1089/thy.2019.29085.abstracts VL - 29 ID - 5054 ER - TY - JOUR AD - 1Department of Pathology and Cytology, Division of Clinical Cytology, Karolinska University Hospital, Solna 17176, Sweden. vitalijs.svjatoha@karolinska.se AN - 20944096 AU - Sviatoha, V. AU - Tani, E. AU - Ghaderi, M. AU - Kleina, R. AU - Skoog, L. DA - Sep DP - Nlm ET - 2010/10/15 IS - 9 LA - eng N1 - 1791-7530 Sviatoha, Vitali Tani, Edneia Ghaderi, Mehran Kleina, Regina Skoog, Lambert Journal Article Research Support, Non-U.S. Gov't Greece Anticancer Res. 2010 Sep;30(9):3267-72. PY - 2010 SN - 0250-7005 SP - 3267-72 ST - Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas T2 - Anticancer Res TI - Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas VL - 30 ID - 5055 ER - TY - JOUR AD - Departamento de Biorregulação, Laboratório de Estudo da Tireoide, Instituto de Saúde e Ciência, Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil. Departamento de Anatomia Patológica e Citopatologia, Hospital São Rafael, Salvador, BA, Brasil. Departamento de Anatomia Patológica e Medicina Legal, Faculdade de Medicina da Bahia, Universidade Federal da Bahia (UFBA), Salvador, BA, Brasil. Departamento de Medicina Nuclear, Hospital São Rafael, Salvador, BA, Brasil. Departamento de Cirurgia de Cabeça e Pescoço, Hospital São Rafael, Salvador, BA, Brasil. AN - 30916170 AU - Pessôa-Pereira, D. AU - Medeiros, Mfds AU - Lima, V. M. S. AU - Silva, J. C. D., Jr. AU - Cerqueira, T. L. O. AU - Silva, I. C. D. AU - Fonseca, L. E., Jr. AU - Sampaio, L. J. L. AU - Lima, C. R. A. AU - Ramos, H. E. DA - Mar-Apr DO - 10.20945/2359-3997000000120 10.20945/2359-3997000000120. Epub 2019 Mar 21. DP - Nlm ET - 2019/03/28 IS - 2 LA - eng PY - 2019 SN - 2359-3997 SP - 97-106 ST - Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series T2 - Arch Endocrinol Metab TI - Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series VL - 63 ID - 5056 ER - TY - JOUR AD - Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College People's Republic of China. Department of Pathology, Xuanwu Hospital, Capital Medical University People's Republic of China. AN - 25755776 AU - Lu, J. AU - Gao, J. AU - Zhang, J. AU - Sun, J. AU - Wu, H. AU - Shi, X. AU - Teng, L. AU - Liang, Z. C2 - PMC4348874 DP - Nlm ET - 2015/03/11 IS - 1 LA - eng N1 - 1936-2625 Lu, Junliang Gao, Jie Zhang, Jing Sun, Jian Wu, Huanwen Shi, Xiaohua Teng, Lianghong Liang, Zhiyong Journal Article Int J Clin Exp Pathol. 2015 Jan 1;8(1):793-9. eCollection 2015. PY - 2015 SN - 1936-2625 SP - 793-9 ST - Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma T2 - Int J Clin Exp Pathol TI - Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma VL - 8 ID - 5057 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston USA Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Houston 77030 USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston USA Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert USA Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston USA Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 455, Houston, TX, 77030, USA AN - 116396807. Language: English. Entry Date: 20170614. Revision Date: 20190513. Publication Type: journal article AU - Bilen, Mehmet AU - Patel, Amy AU - Hess, Kenneth AU - Munoz, Javier AU - Busaidy, Naifa AU - Wheler, Jennifer AU - Janku, Filip AU - Falchook, Gerald AU - Hong, David AU - Meric-Bernstam, Funda AU - Habra, Mouhammed AU - Naing, Aung AU - Bilen, Mehmet Asim AU - Hess, Kenneth R. AU - Busaidy, Naifa L. AU - Wheler, Jennifer J. AU - Falchook, Gerald S. AU - Hong, David S. AU - Habra, Mouhammed Amir DB - ccm DO - 10.1007/s00280-016-3073-z DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 7806519. PMID: NLM27286994. PY - 2016 SN - 0344-5704 SP - 167-171 ST - Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials T2 - Cancer Chemotherapy & Pharmacology TI - Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116396807&site=ehost-live&scope=site VL - 78 ID - 5058 ER - TY - JOUR AD - Institute of Bioengineering and Nanotechnology, Singapore, Singapore Health Services Research, Singapore General Hospital, Singapore, Singapore Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore Department of Pathology, Singapore General Hospital, Singapore, Singapore Laboratory of Clinical Pharmacology, Division Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore Clinical Pharmacology Core, SingHealth, Singapore, Singapore Clinical Sciences, Duke-NUS Graduate Medical School, Singapore, Singapore AU - Chu, Y. H. AU - Li, H. AU - Tan, H. S. AU - Koh, V. AU - Lai, J. AU - Phyo, W. M. AU - Choudhury, Y. AU - Kanesvaran, R. AU - Chau, N. M. AU - Toh, C. K. AU - Ng, Q. S. AU - Tan, P. H. AU - Chowbay, B. AU - Tan, M. H. C7 - e0134102 DB - Scopus DO - 10.1371/journal.pone.0134102 IS - 8 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2015 ST - Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinoma T2 - PLoS ONE TI - Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942110373&doi=10.1371%2fjournal.pone.0134102&partnerID=40&md5=c5731492547e0fb2e78eda78e253ca5a VL - 10 ID - 5059 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jmcquade@mdanderson.org. University of Texas MD Anderson Cancer Center, Houston, TX, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Vanderbilt University Medical Center, Nashville, TN, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. Genentech, San Francisco, CA, USA. University of California Los Angeles Medical Center, Los Angeles, CA, USA. Bristol-Myers Squibb, New York, NY, USA. Dana-Farber Cancer Institute, Boston, MA, USA. Memorial Sloan Kettering Cancer Center, New York, NY, USA. Northwestern University, Chicago, IL, USA. University Hospital Essen and German Cancer Consortium, Essen, Germany. Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. Massachusetts General Hospital Cancer Center, Boston, MA, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. AN - 29449192 AU - McQuade, J. L. AU - Daniel, C. R. AU - Hess, K. R. AU - Mak, C. AU - Wang, D. Y. AU - Rai, R. R. AU - Park, J. J. AU - Haydu, L. E. AU - Spencer, C. AU - Wongchenko, M. AU - Lane, S. AU - Lee, D. Y. AU - Kaper, M. AU - McKean, M. AU - Beckermann, K. E. AU - Rubinstein, S. M. AU - Rooney, I. AU - Musib, L. AU - Budha, N. AU - Hsu, J. AU - Nowicki, T. S. AU - Avila, A. AU - Haas, T. AU - Puligandla, M. AU - Lee, S. AU - Fang, S. AU - Wargo, J. A. AU - Gershenwald, J. E. AU - Lee, J. E. AU - Hwu, P. AU - Chapman, P. B. AU - Sosman, J. A. AU - Schadendorf, D. AU - Grob, J. J. AU - Flaherty, K. T. AU - Walker, D. AU - Yan, Y. AU - McKenna, E. AU - Legos, J. J. AU - Carlino, M. S. AU - Ribas, A. AU - Kirkwood, J. M. AU - Long, G. V. AU - Johnson, D. B. AU - Menzies, A. M. AU - Davies, M. A. C2 - PMC5840029 C6 - NIHMS944499 DA - Mar DO - 10.1016/s1470-2045(18)30078-0 10.1016/S1470-2045(18)30078-0. Epub 2018 Feb 12. DP - Nlm ET - 2018/02/17 IS - 3 LA - eng PY - 2018 SN - 1470-2045 (Print) 1470-2045 SP - 310-322 ST - Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis T2 - Lancet Oncol TI - Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis VL - 19 ID - 5060 ER - TY - JOUR AD - Department of Pathology, University of Colorado School of Medicine, Denver, USA. AN - 11863224 AU - Liang, X. AU - Golitz, L. E. AU - Smoller, B. R. AU - Meech, S. J. AU - Odom, L. F. AU - Williams, S. A. AU - Ryder, J. W. DA - Feb DO - 10.1309/trw0-kxwv-qwg0-9xdf 10.1309/trw0-kxwv-qwg0-9xdf. DP - Nlm ET - 2002/02/28 IS - 2 LA - eng PY - 2002 SN - 0002-9173 (Print) 0002-9173 SP - 276-82 ST - Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma T2 - Am J Clin Pathol TI - Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: comparison with primary cutaneous anaplastic large cell lymphoma VL - 117 ID - 5061 ER - TY - JOUR AN - 30923800 AU - Burbidge, T. E. AU - Bastian, B. C. AU - Guo, D. AU - Li, H. AU - Morris, D. G. AU - Monzon, J. G. AU - Leung, G. AU - Yang, H. AU - Cheng, T. C2 - PMC6855935 DA - Nov 1 DO - 10.1093/jnci/djz048 10.1093/jnci/djz048. DP - Nlm ET - 2019/03/30 IS - 11 LA - eng PY - 2019 SN - 0027-8874 (Print) 0027-8874 SP - 1228-1231 ST - Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations T2 - J Natl Cancer Inst TI - Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations VL - 111 ID - 5062 ER - TY - JOUR AD - College of Veterinary Medicine, Cornell University, Ithaca, NY, United States Department of Animal Science, College of Agriculture and Life Sciences, Cornell University, Ithaca, NY, United States Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States Oncology Services, Veterinary Medical Center of Long Island, West Islip, NY, United States AU - Moirano, S. J. AU - Lima, S. F. AU - Hume, K. R. AU - Brodsky, E. M. DB - Scopus DO - 10.1111/vco.12373 IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - E194-E201 ST - Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs T2 - Veterinary and Comparative Oncology TI - Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038019500&doi=10.1111%2fvco.12373&partnerID=40&md5=429fd29dbdcade7dbfb9eb9214f3d4ec VL - 16 ID - 5063 ER - TY - JOUR AD - A. Karimi, Paediatric Infection Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran AU - Sayyahfar, S. AU - Karimi, A. AU - Gharib, A. AU - Fahimzad, A. DB - Embase DO - 10.17795/ijcp-3438 IS - 4 LA - English M3 - Article N1 - L606176692 2015-10-08 2015-10-13 PY - 2015 SN - 2538-497X 2538-4422 ST - Association of systemic anaplastic large cell lymphoma and active toxoplasmosis in a child T2 - International Journal of Cancer Management TI - Association of systemic anaplastic large cell lymphoma and active toxoplasmosis in a child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606176692&from=exporthttp://dx.doi.org/10.17795/ijcp-3438 VL - 8 ID - 5064 ER - TY - JOUR AD - 1Department of Neurosurgery, Hokkaido University School of Medicine, Kita-ku, Sapporo. 2Department of Surgical Pathology, Hokkaido University Hospital, Kita-ku, Sapporo; and. 3Department of Neurosurgery, Kashiwaba Neurosurgical Hospital, Toyohira-ku, Sapporo, Hokkaido, Japan. AN - 32059187 AU - Ishi, Y. AU - Yamaguchi, S. AU - Hatanaka, K. C. AU - Okamoto, M. AU - Motegi, H. AU - Kobayashi, H. AU - Terasaka, S. AU - Houkin, K. DA - Feb 14 DO - 10.3171/2019.12.Jns192155 10.3171/2019.12.JNS192155. DP - Nlm ET - 2020/02/15 LA - eng PY - 2020 SN - 0022-3085 SP - 1-9 ST - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients T2 - J Neurosurg TI - Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients ID - 5065 ER - TY - JOUR AD - M. Sun, Department of Pediatrics, China Medical University, Shenyang 110004 Liaoning Province, China AU - Yuan, Y. AU - Sun, M. AU - Li, K. S. DB - Embase Medline DO - 10.3748/wjg.15.3676 IS - 29 LA - English M3 - Article N1 - L355357089 2009-11-19 PY - 2009 SN - 1007-9327 SP - 3676-3680 ST - Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-α and interleukin-8 T2 - World Journal of Gastroenterology TI - Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-α and interleukin-8 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355357089&from=exporthttp://dx.doi.org/10.3748/wjg.15.3676http://www.wjgnet.com/1007-9327/15/3676.pdf VL - 15 ID - 5066 ER - TY - JOUR AD - Laboratory of Molecular Nutrition and Immunity, Northeast Agricultural University, Harbin, P.R. China. AN - 32037545 AU - Dong, N. AU - Li, X. AU - Xue, C. AU - Zhang, L. AU - Wang, C. AU - Xu, X. AU - Shan, A. DA - Jul DO - 10.1002/jcp.29452 10.1002/jcp.29452. Epub 2020 Feb 9. DP - Nlm ET - 2020/02/11 IS - 7-8 LA - eng PY - 2020 SN - 0021-9541 SP - 5525-5540 ST - Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway T2 - J Cell Physiol TI - Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway VL - 235 ID - 5067 ER - TY - JOUR AD - A.M. Planas, Department of Brain Ischemia and Neurodegeneration, IIBB-CSIC, IDIBAPS, Rossello 161, planta 6, 08036-Barcelona, Spain AU - Gorina, R. AU - Font-Nieves, M. AU - Márquez-Kisinousky, L. AU - Santalucia, T. AU - Planas, A. M. DB - Embase Medline DO - 10.1002/glia.21094 IS - 2 LA - English M3 - Article N1 - L360172206 2010-12-24 2010-12-30 PY - 2011 SN - 0894-1491 1098-1136 SP - 242-255 ST - Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways T2 - GLIA TI - Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360172206&from=exporthttp://dx.doi.org/10.1002/glia.21094 VL - 59 ID - 5068 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States Department of Pathology, United States Surgical Oncology, University of Texas, Maryland Anderson Cancer Center, Houston, TX 77030, United States AU - Bagheri-Yarmand, R. AU - Williams, M. D. AU - Grubbs, E. G. AU - Gagel, R. F. DB - Scopus DO - 10.1210/jc.2016-2878 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 SP - 933-941 ST - ATF4 targets ret for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer T2 - Journal of Clinical Endocrinology and Metabolism TI - ATF4 targets ret for degradation and is a candidate tumor suppressor gene in medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015233508&doi=10.1210%2fjc.2016-2878&partnerID=40&md5=18962fc9872722b2b157718fcbd0128d VL - 102 ID - 5069 ER - TY - JOUR AD - S. Ilangumaran, Department of Pediatrics, Immunology division, Faculty of Medicine and Health Sciences, University of Sherbrooke, 3001 North 12th avenue, Sherbrooke, QC, Canada AU - Gui, Y. AU - Khan, M. G. M. AU - Bobbala, D. AU - Dubois, C. AU - Ramanathan, S. AU - Saucier, C. AU - Ilangumaran, S. DB - Embase Medline DO - 10.3748/wjg.v23.i36.6639 IS - 36 LA - English M3 - Article N1 - L618521083 2017-10-06 2018-07-02 PY - 2017 SN - 2219-2840 1007-9327 SP - 6639-6649 ST - Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1 T2 - World Journal of Gastroenterology TI - Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618521083&from=exporthttp://dx.doi.org/10.3748/wjg.v23.i36.6639 VL - 23 ID - 5070 ER - TY - JOUR AD - Division of Pathological Anatomy, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy. Daniela.massi@UNIFI.IT AN - 21496703 AU - Massi, D. AU - Cesinaro, A. M. AU - Tomasini, C. AU - Paglierani, M. AU - Bettelli, S. AU - Dal Maso, L. AU - Simi, L. AU - Salvianti, F. AU - Pinzani, P. AU - Orlando, C. AU - De Giorgi, V. AU - Lukic, S. AU - Maiorana, A. AU - Santucci, M. AU - Canzonieri, V. DA - May DO - 10.1016/j.jaad.2010.05.043 10.1016/j.jaad.2010.05.043. DP - Nlm ET - 2011/04/19 IS - 5 LA - eng PY - 2011 SN - 0190-9622 SP - 919-35 ST - Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis T2 - J Am Acad Dermatol TI - Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis VL - 64 ID - 5071 ER - TY - JOUR AD - Department of Pathology, Anschutz Medical Campus, University of Colorado, Denver, CO 80045, USA. bk.demasters@ucdenver.edu AN - 22082607 AU - Kleinschmidt-DeMasters, B. K. AU - Birks, D. K. AU - Aisner, D. L. AU - Hankinson, T. C. AU - Rosenblum, M. K. DA - Dec DO - 10.1097/PAS.0b013e3182382a3f 10.1097/PAS.0b013e3182382a3f. DP - Nlm ET - 2011/11/16 IS - 12 LA - eng PY - 2011 SN - 0147-5185 SP - 1894-901 ST - Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization T2 - Am J Surg Pathol TI - Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization VL - 35 ID - 5072 ER - TY - JOUR AD - Y. Nakamura, Department of Food Sciences and Nutritional Health, Kyoto Prefectoral University, Sakyo, Kyoto 606-8522, Japan AU - Nakamura, Y. AU - Chang, C. C. AU - Mori, T. AU - Sato, K. AU - Ohtsuki, K. AU - Upham, B. L. AU - Trosko, J. E. DB - Embase Medline DO - 10.1093/carcin/bgi003 IS - 3 LA - English M3 - Article N1 - L41214158 2005-10-02 PY - 2005 SN - 0143-3334 SP - 665-671 ST - Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells T2 - Carcinogenesis TI - Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41214158&from=exporthttp://dx.doi.org/10.1093/carcin/bgi003 VL - 26 ID - 5073 ER - TY - JOUR AD - Y. Mishina, Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI, United States AU - Hayano, S. AU - Komatsu, Y. AU - Pan, H. AU - Mishina, Y. DB - Embase Medline DO - 10.1242/dev.118802 IS - 7 LA - English M3 - Article N1 - L604805172 2015-06-16 2015-06-23 PY - 2015 SN - 1477-9129 0950-1991 SP - 1357-1367 ST - Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis T2 - Development (Cambridge) TI - Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604805172&from=exporthttp://dx.doi.org/10.1242/dev.118802 VL - 142 ID - 5074 ER - TY - JOUR AD - R. Pezzani, Endocrinology Unit, Department of Medicine, University of Padova, Via Ospedale 105, Padova, Italy AU - Pezzani, R. AU - Rubin, B. AU - Bertazza, L. AU - Redaelli, M. AU - Barollo, S. AU - Monticelli, H. AU - Baldini, E. AU - Mian, C. AU - Mucignat, C. AU - Scaroni, C. AU - Mantero, F. AU - Ulisse, S. AU - Iacobone, M. AU - Boscaro, M. C1 - sns 314(Selleck) vx 680(Selleck) zm 447439(Selleck) C2 - Selleck Sigma Aldrich(Italy) DB - Embase Medline DO - 10.1007/s10637-016-0358-3 IS - 5 LA - English M3 - Article N1 - L610386009 2016-05-24 2016-09-12 PY - 2016 SN - 1573-0646 0167-6997 SP - 531-540 ST - The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line T2 - Investigational New Drugs TI - The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610386009&from=exporthttp://dx.doi.org/10.1007/s10637-016-0358-3 VL - 34 ID - 5075 ER - TY - JOUR AD - Department of Psychiatry, University of California San Francisco, San Francisco, California, USA. AN - 24101678 AU - Adviento, B. AU - Corbin, I. L. AU - Widjaja, F. AU - Desachy, G. AU - Enrique, N. AU - Rosser, T. AU - Risi, S. AU - Marco, E. J. AU - Hendren, R. L. AU - Bearden, C. E. AU - Rauen, K. A. AU - Weiss, L. A. C2 - PMC4230531 C6 - NIHMS597979 DA - Jan DO - 10.1136/jmedgenet-2013-101951 10.1136/jmedgenet-2013-101951. Epub 2013 Oct 7. DP - Nlm ET - 2013/10/09 IS - 1 LA - eng PY - 2014 SN - 0022-2593 (Print) 0022-2593 SP - 10-20 ST - Autism traits in the RASopathies T2 - J Med Genet TI - Autism traits in the RASopathies VL - 51 ID - 5076 ER - TY - JOUR AD - INSERM U999, Centre Chirurgical Marie Lannelongue, 133 avenue de la Résistance, F-92350 Le Plessis-Robinson, France University of Paris-Sud 11, Orsay, France Free University of Brussels, Brussels, Belgium AU - Tu, L. AU - Dewachter, L. AU - Gore, B. AU - Fadel, E. AU - Dartevelle, P. AU - Simonneau, G. AU - Humbert, M. AU - Eddahibi, S. AU - Guignabert, C. DB - Scopus DO - 10.1165/rcmb.2010-0317OC IS - 2 M3 - Article N1 - Cited By :84 Export Date: 18 November 2020 PY - 2011 SP - 311-322 ST - Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension T2 - American Journal of Respiratory Cell and Molecular Biology TI - Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051615782&doi=10.1165%2frcmb.2010-0317OC&partnerID=40&md5=fb6409aa7fc26de6d32453276216cecd VL - 45 ID - 5077 ER - TY - JOUR AD - X.-P. Wan, Department of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University, School of Medicine, 536 Changle Road, Jingan, Shanghai, China AU - Li, Y. AU - Che, Q. AU - Bian, Y. AU - Zhou, Q. AU - Jiang, F. AU - Tong, H. AU - Ke, J. AU - Wang, K. AU - Wan, X. P. DB - Embase Medline DO - 10.3892/ijo.2015.3091 IS - 3 LA - English M3 - Article N1 - L605406931 2015-08-04 2015-08-06 PY - 2015 SN - 1791-2423 1019-6439 SP - 1017-1024 ST - Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway T2 - International Journal of Oncology TI - Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605406931&from=exporthttp://dx.doi.org/10.3892/ijo.2015.3091 VL - 47 ID - 5078 ER - TY - JOUR AD - Haematology Department, Hammersmith Hospital, Imperial College London, London, United Kingdom AU - Olavarria, E. DB - Scopus DO - 10.1053/j.seminhematol.2007.08.003 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2007 SP - 252-258 ST - Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia T2 - Seminars in Hematology TI - Autologous Stem Cell Transplantation in Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35348942833&doi=10.1053%2fj.seminhematol.2007.08.003&partnerID=40&md5=70a41a7805a681e2d970b029917919c1 VL - 44 ID - 5079 ER - TY - JOUR AD - Authors' Affiliations: Departments of Pediatrics, Jean.Mulcahy-Levy@childrenscolorado.org. Authors' Affiliations: Departments of Pediatrics. Neurosurgery. Pharmacology, and. Radiology, University of Colorado Denver, Aurora, Colorado. AN - 24823863 AU - Levy, J. M. AU - Thompson, J. C. AU - Griesinger, A. M. AU - Amani, V. AU - Donson, A. M. AU - Birks, D. K. AU - Morgan, M. J. AU - Mirsky, D. M. AU - Handler, M. H. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC4090283 C6 - NIHMS596029 DA - Jul DO - 10.1158/2159-8290.Cd-14-0049 10.1158/2159-8290.CD-14-0049. Epub 2014 May 13. DP - Nlm ET - 2014/05/16 IS - 7 LA - eng PY - 2014 SN - 2159-8274 (Print) 2159-8274 SP - 773-80 ST - Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors T2 - Cancer Discov TI - Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors VL - 4 ID - 5080 ER - TY - JOUR AD - Department of Pediatrics, University of Colorado Denver, Aurora, United States. Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, United States. Department of Pathology, University of Colorado Denver, Aurora, United States. Department of Neurosurgery, University of Colorado Denver, Aurora, United States. Department of Pharmacology, University of Colorado Denver, Aurora, United States. Department of Radiology, University of Colorado Denver, Aurora, United States. AN - 28094001 AU - Mulcahy Levy, J. M. AU - Zahedi, S. AU - Griesinger, A. M. AU - Morin, A. AU - Davies, K. D. AU - Aisner, D. L. AU - Kleinschmidt-DeMasters, B. K. AU - Fitzwalter, B. E. AU - Goodall, M. L. AU - Thorburn, J. AU - Amani, V. AU - Donson, A. M. AU - Birks, D. K. AU - Mirsky, D. M. AU - Hankinson, T. C. AU - Handler, M. H. AU - Green, A. L. AU - Vibhakar, R. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC5241115 DA - Jan 17 DO - 10.7554/eLife.19671 10.7554/eLife.19671. DP - Nlm ET - 2017/01/18 LA - eng PY - 2017 SN - 2050-084x ST - Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors T2 - Elife TI - Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors VL - 6 ID - 5081 ER - TY - JOUR AD - a Department of Oncology, Tongji Hospital, Tongji Medical College , Huazhong University of Science and Technology , Wuhan , China. b Biological Sciences, Faculty of Environmental and Life Sciences , University of Southampton , Southampton , UK. c Institute for Life Sciences , University of Southampton , Southampton , UK. d Ludwig Institute for Cancer Research Ltd., Nuffield Department of Clinical Medicine , University of Oxford , Oxford , UK. e Rutgers Cancer Institute of New Jersey , New Brunswick , NJ , USA. f Oncogene Biology Laboratory , The Francis Crick Institute , London , UK. g Centre for Pathology , St Mary's Hospital, Imperial College London , London , UK. AN - 30782064 AU - Wang, Y. AU - Xiong, H. AU - Liu, D. AU - Hill, C. AU - Ertay, A. AU - Li, J. AU - Zou, Y. AU - Miller, P. AU - White, E. AU - Downward, J. AU - Goldin, R. D. AU - Yuan, X. AU - Lu, X. C2 - PMC6517269 C6 - EMS80343 DA - May DO - 10.1080/15548627.2019.1569912 10.1080/15548627.2019.1569912. Epub 2019 Feb 20. DP - Nlm ET - 2019/02/21 IS - 5 LA - eng PY - 2019 SN - 1554-8627 (Print) 1554-8627 SP - 886-899 ST - Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells T2 - Autophagy TI - Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells VL - 15 ID - 5082 ER - TY - JOUR AD - Departamento de Biología de Sistemas, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universidad de Alcalá, 28871 Alcalá de Henares, Spain. AN - 23958494 AU - Hernández-Breijo, B. AU - Monserrat, J. AU - Román, I. D. AU - González-Rodríguez, Á AU - Fernández-Moreno, M. D. AU - Lobo, M. V. AU - Valverde Á, M. AU - Gisbert, J. P. AU - Guijarro, L. G. DA - Nov 1 DO - 10.1016/j.taap.2013.07.024 10.1016/j.taap.2013.07.024. Epub 2013 Aug 16. DP - Nlm ET - 2013/08/21 IS - 3 LA - eng PY - 2013 SN - 0041-008x SP - 568-78 ST - Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1 T2 - Toxicol Appl Pharmacol TI - Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1 VL - 272 ID - 5083 ER - TY - JOUR AD - Global Medical Affairs Dermatology, Bayer Pharma AG, Müllerstrasse 170-178, DE-13342 Berlin, Germany AU - Sieber, M. A. AU - Hegel, J. K. E. DB - Scopus DO - 10.1159/000354888 IS - SUPPL.1 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2013 SP - 9-17 ST - Azelaic acid: Properties and mode of action T2 - Skin Pharmacology and Physiology TI - Azelaic acid: Properties and mode of action UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890110527&doi=10.1159%2f000354888&partnerID=40&md5=fa3c52fb15d3b699acbeb07c13ead3a4 VL - 27 ID - 5084 ER - TY - JOUR AD - Ta-Kuo Clinic, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: lms870088@gmail.com. Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Laboratory Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: pedhung@gmail.com. AN - 31759853 AU - Kuo, C. H. AU - Lee, M. S. AU - Kuo, H. F. AU - Lin, Y. C. AU - Hung, C. H. DA - Dec DO - 10.1016/j.jmii.2019.10.001 10.1016/j.jmii.2019.10.001. Epub 2019 Nov 5. DP - Nlm ET - 2019/11/25 IS - 6 LA - eng PY - 2019 SN - 1684-1182 SP - 872-879 ST - Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line T2 - J Microbiol Immunol Infect TI - Azithromycin suppresses Th1- and Th2-related chemokines IP-10/MDC in human monocytic cell line VL - 52 ID - 5085 ER - TY - JOUR AD - K. Hunter-Schaedle, Children's Tumor Foundation, 95 Pine Street, New York, NY 10005, United States AU - Huson, S. M. AU - Acosta, M. T. AU - Belzberg, A. J. AU - Bernards, A. AU - Chernoff, J. AU - Cichowski, K. AU - Gareth Evans, D. AU - Ferner, R. E. AU - Giovannini, M. AU - Korf, B. R. AU - Listernick, R. AU - North, K. N. AU - Packer, R. J. AU - Parada, L. F. AU - Peltonen, J. AU - Ramesh, V. AU - Reilly, K. M. AU - Risner, J. W. AU - Schorry, E. K. AU - Upadhyaya, M. AU - Viskochil, D. H. AU - Zhu, Y. AU - Hunter-Schaedle, K. AU - Giancotti, F. G. C1 - azd 6244 hdac 42 osu 03012 rad 001 DB - Embase Medline DO - 10.1002/ajmg.a.33804 IS - 2 LA - English M3 - Conference Paper N1 - L361175661 2011-02-02 2011-02-04 PY - 2011 SN - 1552-4825 1552-4833 SP - 307-321 ST - Back to the future: Proceedings from the 2010 NF Conference T2 - American Journal of Medical Genetics, Part A TI - Back to the future: Proceedings from the 2010 NF Conference UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361175661&from=exporthttp://dx.doi.org/10.1002/ajmg.a.33804 VL - 155 ID - 5086 ER - TY - JOUR AD - U. Renner, Max-Planck-Institute of Psychiatry, Neuroendocrinology Group, Kraepelinstrasse 10, D-80804 Munich, Germany AU - Tichomirowa, M. AU - Theodoropoulou, M. AU - Lohrer, P. AU - Schaaf, L. AU - Losa, M. AU - Uhl, E. AU - Lange, M. AU - Arzt, E. AU - Stalla, G. K. AU - Renner, U. C1 - sb 203580 DB - Embase Medline DO - 10.1111/j.1365-2826.2005.01286.x IS - 3 LA - English M3 - Article N1 - L40553014 2005-05-03 PY - 2005 SN - 0953-8194 SP - 152-160 ST - Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 T2 - Journal of Neuroendocrinology TI - Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40553014&from=exporthttp://dx.doi.org/10.1111/j.1365-2826.2005.01286.x VL - 17 ID - 5087 ER - TY - JOUR AD - Department of Nephrology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Department of Transplantation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. AN - 30088539 AU - Chen, Y. AU - Zheng, Y. AU - Zhou, Z. AU - Wang, J. C2 - PMC6086549 DA - Aug 6 DO - 10.1590/1414-431x20187476 10.1590/1414-431X20187476. DP - Nlm ET - 2018/08/09 IS - 10 LA - eng PY - 2018 SN - 0100-879X (Print) 0100-879x SP - e7476 ST - Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways T2 - Braz J Med Biol Res TI - Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways VL - 51 ID - 5088 ER - TY - JOUR AD - J. Wang, Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Henan, China AU - Wang, J. AU - Luo, H. AU - Yang, L. AU - Li, Y. C2 - Sigma(United States) DB - Embase Medline DO - 10.14715/cmb/2016.62.7.10 IS - 7 LA - English M3 - Article N1 - L613009803 2016-11-21 2016-12-08 PY - 2016 SN - 1165-158X 0145-5680 SP - 55-60 ST - Baicalein induces apoptosis and reduces inflammation in LPS-stimulated keratinocytes by blocking the activation of NF-κB: Implications for alleviating oral lichen planus T2 - Cellular and Molecular Biology TI - Baicalein induces apoptosis and reduces inflammation in LPS-stimulated keratinocytes by blocking the activation of NF-κB: Implications for alleviating oral lichen planus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613009803&from=exporthttp://dx.doi.org/10.14715/cmb/2016.62.7.10 VL - 62 ID - 5089 ER - TY - JOUR AD - L.E. Samelson, Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States AU - Sommers, C. L. AU - Gurson, J. M. AU - Surana, R. AU - Barda-Saad, M. AU - Lee, J. AU - Kishor, A. AU - Li, W. AU - Gasser, A. J. AU - Barr, V. A. AU - Miyaji, M. AU - Love, P. E. AU - Samelson, L. E. DB - Embase Medline DO - 10.1093/intimm/dxn039 IS - 7 LA - English M3 - Article N1 - L351865857 2008-07-07 PY - 2008 SN - 0953-8178 1460-2377 SP - 811-818 ST - Bam32: A novel mediator of Erk activation in T cells T2 - International Immunology TI - Bam32: A novel mediator of Erk activation in T cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351865857&from=exporthttp://dx.doi.org/10.1093/intimm/dxn039 VL - 20 ID - 5090 ER - TY - JOUR AD - University of Rochester Medical Center, Rochester, NY, United States University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14620, United States AU - Lichtman, M. A. DB - Scopus DO - 10.1634/theoncologist.2007-0228 IS - 2 M3 - Review N1 - Cited By :62 Export Date: 18 November 2020 PY - 2008 SP - 126-138 ST - Battling the hematological malignancies: The 200 years' war T2 - Oncologist TI - Battling the hematological malignancies: The 200 years' war UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40349113288&doi=10.1634%2ftheoncologist.2007-0228&partnerID=40&md5=f7d0e2b3ea4f4b261373f31388c35d07 VL - 13 ID - 5091 ER - TY - JOUR AD - J. Lin, Department of Biochemistry and Molecular Biology, University of Maryland, School of Medicine, 655 W Baltimore S, Baltimore, MD, United States AU - Wu, X. AU - Cao, Y. AU - Xiao, H. AU - Li, C. AU - Lin, J. DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0921 IS - 11 LA - English M3 - Article N1 - L613162523 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2609-2619 ST - Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy T2 - Molecular Cancer Therapeutics TI - Bazedoxifene as a novel GP130 inhibitor for pancreatic cancer therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162523&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-15-0921 VL - 15 ID - 5092 ER - TY - JOUR AD - R. Addeo, Medical Oncology Division, San Giovanni di Dio Frattamaggiore Hospital, ASLNA2 NORD, Naples, Italy AU - Vitagliano, O. AU - Addeo, R. AU - D'Angelo, V. AU - Indolfi, C. AU - Indolfi, P. AU - Casale, F. DB - Embase Medline DO - 10.1586/17474086.2013.827415 IS - 5 LA - English M3 - Review N1 - L370058326 2013-10-28 2013-10-31 PY - 2013 SN - 1747-4086 1747-4094 SP - 587-597 ST - The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: Implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches T2 - Expert Review of Hematology TI - The Bcl-2/Bax and Ras/Raf/MEK/ERK signaling pathways: Implications in pediatric leukemia pathogenesis and new prospects for therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370058326&from=exporthttp://dx.doi.org/10.1586/17474086.2013.827415 VL - 6 ID - 5093 ER - TY - JOUR AD - Dipartimento di Farmacia Scienze del Farmaco Università degli Studi di Bari “Aldo Moro”, via Orabona 4, Bari, 70125, Italy AU - Carofiglio, F. AU - Lopalco, A. AU - Lopedota, A. AU - Cutrignelli, A. AU - Nicolotti, O. AU - Denora, N. AU - Stefanachi, A. AU - Leonetti, F. C7 - 4469 DB - Scopus DO - 10.3390/ijms21124469 IS - 12 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1-21 ST - Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml T2 - International Journal of Molecular Sciences TI - Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086938282&doi=10.3390%2fijms21124469&partnerID=40&md5=bec416c6d5eaae98ff97d0e60e69dd89 VL - 21 ID - 5094 ER - TY - JOUR AD - Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia School of Medicine, Faculty of Health Sciences, University of Adelaide, Australia AU - Pagani, I. S. AU - Dang, P. AU - Kommers, I. O. AU - Goyne, J. M. AU - Nicola, M. AU - Saunders, V. A. AU - Braley, J. AU - White, D. L. AU - Yeung, D. T. AU - Branford, S. AU - Hughes, T. P. AU - Ross, D. M. DB - Scopus DO - 10.3324/haematol.2018.189787 IS - 12 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 2026-2032 ST - BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia T2 - Haematologica TI - BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054736766&doi=10.3324%2fhaematol.2018.189787&partnerID=40&md5=3c6bae1d8eecf5f77266e4b4e33751b3 VL - 103 ID - 5095 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas-UNICAMP, Rua Carlos Chagas 480, Campinas, SP, 13083-878, Brazil AU - Ribeiro, B. F. AU - Vergílio, B. R. AU - Miranda, E. C. M. AU - Almeida, M. H. AU - Delamain, M. T. AU - Da Silveira, R. A. AU - De Souza, C. A. AU - Albuquerque, D. M. AU - Dos Santos, A. AU - Duarte, V. O. AU - Oliveira-Duarte, G. B. AU - Lorand-Metze, I. AU - Pagnano, K. B. B. DB - Scopus DO - 10.1159/000430835 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2015 SP - 248-254 ST - BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution T2 - Acta Haematologica TI - BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84936976940&doi=10.1159%2f000430835&partnerID=40&md5=72feb0c73b664df297a1090d1b834507 VL - 134 ID - 5096 ER - TY - JOUR AD - Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, “S.Orsola-Malpighi” University Hospital, University of Bologna, Bologna, Italy Hematology Unit, Department of Cellular Biotechnologies and Hematology, “La Sapienza” University, Roma, Italy Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy Hematology Unit, “Pugliese-Ciaccio” Hospital, Catanzaro, Italy Department of Hematology, University of Bari, Bari, Italy Unit of Medical Oncology, A.O.U. Policlinico “Vittorio Emanuele”, University of Catania, Catania, Italy Hematology Unit, “S. Eugenio” Hospital, Roma, Italy Hematology Unit, Azienda Ospedaliera “Spedali Civili”, Brescia, Italy Hematology Unit, Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Italy Chair of Hematology, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Ferrara, Italy Hematology Unit, Azienda Ospedaliera “Bianchi-Melacrino-Morelli”, Reggio Calabria, Italy Hematology Unit, “S. Matteo” University Hospital, Pavia, Italy Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy Hematology Unit, “A. Cardarelli” Hospital, Napoli, Italy Hematology Unit, “A. Businco” Hospital, Cagliari, Italy Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy Chair of Hematology, “A. Gemelli” University Hospital, Roma, Italy Hematology Section, Department of Medicine, University of Verona, Verona, Italy Hematology Unit, “Ordine Mauriziano” Hospital, University of Torino, Torino, Italy Hematology Unit, “Ca' Foncello” Hospital, ULSS2 Marca Trevigiana, Treviso, Italy Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy Chair of Hematology, Department of Biochemistry and Medical Biotechnologies, “Federico II” University, Naples, Italy Department of Hematology and Oncology “L. and A. Seràgnoli”, University of Bologna, Bologna, Italy AU - Castagnetti, F. AU - Gugliotta, G. AU - Breccia, M. AU - Iurlo, A. AU - Levato, L. AU - Albano, F. AU - Vigneri, P. AU - Abruzzese, E. AU - Rossi, G. AU - Rupoli, S. AU - Cavazzini, F. AU - Martino, B. AU - Orlandi, E. AU - Pregno, P. AU - Annunziata, M. AU - Usala, E. AU - Tiribelli, M. AU - Sica, S. AU - Bonifacio, M. AU - Fava, C. AU - Gherlinzoni, F. AU - Bocchia, M. AU - Soverini, S. AU - Bochicchio, M. T. AU - Cavo, M. AU - Giovanni, M. AU - Saglio, G. AU - Pane, F. AU - Baccarani, M. AU - Rosti, G. AU - on behalf of the, Gimema C. M. L. Working Party DB - Scopus DO - 10.1002/ajh.24774 IS - 8 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2017 SP - 797-805 ST - The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib T2 - American Journal of Hematology TI - The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019754981&doi=10.1002%2fajh.24774&partnerID=40&md5=5786cc2f8d274299623d24001cfa5dcc VL - 92 ID - 5097 ER - TY - JOUR AD - Catholic Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea Department of Hematology, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea AU - Lee, S. E. AU - Choi, S. Y. AU - Kim, S. H. AU - Song, H. Y. AU - Yoo, H. L. AU - Lee, M. Y. AU - Kang, K. H. AU - Hwang, H. J. AU - Jang, E. J. AU - Kim, D. W. C7 - Pmc5214723 DB - Scopus DO - 10.3904/kjim.2015.187 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 125-136 ST - BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia T2 - Korean Journal of Internal Medicine TI - BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009477201&doi=10.3904%2fkjim.2015.187&partnerID=40&md5=8305d83555ab51e80582eb23d6582c65 VL - 32 ID - 5098 ER - TY - JOUR AD - Research Laboratory of Pediatric Oncology, Erasmus MC – Sophia Children's Hospital, Rotterdam, The Netherlands AN - 124419921. Language: English. Entry Date: 20170809. Revision Date: 20170809. Publication Type: Article AU - Boer, Judith M. AU - den Boer, Monique L. DB - ccm DO - 10.1016/j.ejca.2017.06.012 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9005373. PY - 2017 SN - 0959-8049 SP - 203-218 ST - BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside T2 - European Journal of Cancer TI - BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124419921&site=ehost-live&scope=site VL - 82 ID - 5099 ER - TY - JOUR AD - Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500 (ICBS, Campus Centro/UFRGS), Porto Alegre, RS 90050-170, Brazil Laboratory of Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, RJ 21040-360, Brazil Department of Pediatrics, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil Children’s Cancer Institute (ICI), Porto Alegre, RS 90420-140, Brazil AU - Thomaz, A. AU - Jaeger, M. AU - Buendia, M. AU - Bambini-Junior, V. AU - Gregianin, L. J. AU - Brunetto, A. L. AU - Brunetto, A. T. AU - de Farias, C. B. AU - Roesler, R. DB - Scopus DO - 10.1007/s12031-015-0689-0 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 326-333 ST - BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells T2 - Journal of Molecular Neuroscience TI - BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84948688742&doi=10.1007%2fs12031-015-0689-0&partnerID=40&md5=f91697855ea9386d9a7800c90d5e7ba7 VL - 59 ID - 5100 ER - TY - JOUR AD - R.-F. Wang, NRT5503, 1450 Biggy St., Los Angeles, CA, United States G. Nie, Beiyitiao 11, Zhongguancun, Beijing, China AU - Zhu, M. AU - Deng, G. AU - Tan, P. AU - Xing, C. AU - Guan, C. AU - Jiang, C. AU - Zhang, Y. AU - Ning, B. AU - Li, C. AU - Yin, B. AU - Chen, K. AU - Zhao, Y. AU - Wang, H. Y. AU - Levine, B. AU - Nie, G. AU - Wang, R. F. DB - Embase Medline DO - 10.1172/JCI133283 IS - 10 LA - English M3 - Article N1 - L2008018743 2020-10-14 2020-11-16 PY - 2020 SN - 1558-8238 0021-9738 SP - 5349-5369 ST - Beclin 2 negatively regulates innate immune signaling and tumor development T2 - Journal of Clinical Investigation TI - Beclin 2 negatively regulates innate immune signaling and tumor development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008018743&from=exporthttp://dx.doi.org/10.1172/JCI133283 VL - 130 ID - 5101 ER - TY - JOUR AD - M.-L. Kuo, Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan AU - Ma, J. AU - Chan, C. C. AU - Huang, W. C. AU - Kuo, M. L. C2 - Sigma Aldrich DB - Embase Medline DO - 10.7150/ijms.45400 IS - 10 LA - English M3 - Article N1 - L2004579276 2020-08-07 2020-09-07 PY - 2020 SN - 1449-1907 SP - 1464-1473 ST - Berberine inhibits pro-inflammatory cytokine-induced IL-6 and ccl11 production via modulation of stat6 pathway in human bronchial epithelial cells T2 - International Journal of Medical Sciences TI - Berberine inhibits pro-inflammatory cytokine-induced IL-6 and ccl11 production via modulation of stat6 pathway in human bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004579276&from=exporthttp://dx.doi.org/10.7150/ijms.45400 VL - 17 ID - 5102 ER - TY - JOUR AD - F. Yan, 2215 Garland Ave., MRB IV, Nashville, TN 37232-0696, United States AU - Yan, F. AU - Wang, L. AU - Shi, Y. AU - Cao, H. AU - Liu, L. AU - Kay Washington, M. AU - Chaturvedi, R. AU - Israel, D. A. AU - Cao, H. AU - Wang, B. AU - Peek Jr, R. M. AU - Wilson, K. T. AU - Brent Polk, D. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1152/ajpgi.00312.2011 IS - 5 L1 - internal-pdf://1967681095/ajpgi.00312.2011.pdf LA - English M3 - Article N1 - L364308253 2012-02-29 2012-03-02 PY - 2012 SN - 0193-1857 1522-1547 SP - G504-G514 ST - Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364308253&from=exporthttp://dx.doi.org/10.1152/ajpgi.00312.2011 VL - 302 ID - 5103 ER - TY - JOUR AD - N. Kopp, Dana-Farber Cancer Institute, Boston, MA, United States AU - Kopp, N. AU - Ott, C. J. AU - Bird, L. AU - Paranal, R. AU - Qi, J. AU - Bowman, T. AU - Rodig, S. J. AU - Kung, A. L. AU - Bradner, J. E. AU - Weinstock, D. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70960919 2013-01-17 PY - 2012 SN - 0006-4971 ST - Bet bromodomain inhibition targets both C-MYC and IL7R in acute lymphoblastic leukemia T2 - Blood TI - Bet bromodomain inhibition targets both C-MYC and IL7R in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70960919&from=exporthttp://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/672?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=880&displaysectionid=Oral+Session&fdate=1/1/2012&tdate=12/31/2012&resourcetype=HWCIT VL - 120 ID - 5104 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Room 317, 950 West 28th Ave, Vancouver, British Columbia, Canada AU - Zhao, J. AU - Klausen, C. AU - Yi, Y. AU - Cheng, J. C. AU - Chang, H. M. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1016/j.cellsig.2019.109439 LA - English M3 - Article N1 - L2003556180 2019-11-01 2019-11-07 PY - 2020 SN - 1873-3913 0898-6568 ST - Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling T2 - Cellular Signalling TI - Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003556180&from=exporthttp://dx.doi.org/10.1016/j.cellsig.2019.109439 VL - 65 ID - 5105 ER - TY - JOUR AD - Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD 20892, United States Genetics and Pathogenesis of Allergy Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, United States Familial Mediterranean Fever Arthritis Vasculitis and Orphan Disease Research Center, Institute of Health Sciences, R and Center, Gulhane Military Medical Academy, Ankara, 06018, Turkey Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, United States Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD 20892, United States Laboratory of Cardiovascular Regenerative Medicine, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, United States National Institutes of Health Intramural Sequencing Center, National Human Genome Research Institute, Rockville, MD 20852, United States Heart of England National Health Service Foundation Trust, Birmingham, B9 5ST, United Kingdom Department of Pediatric Nephrology and Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, 06100, Turkey Institute of Cellular Medicine, Newcastle University, Newcastle, NE2 4HH, United Kingdom AU - Zhou, Q. AU - Yu, X. AU - Demirkaya, E. AU - Deuitch, N. AU - Stone, D. AU - Tsai, W. L. AU - Kuehn, H. S. AU - Wang, H. AU - Yang, D. AU - Park, Y. H. AU - Ombrello, A. K. AU - Blake, M. AU - Romeo, T. AU - Remmers, E. F. AU - Chae, J. J. AU - Mullikin, J. C. AU - Güzel, F. AU - Milner, J. D. AU - Boehm, M. AU - Rosenzweig, S. D. AU - Gadina, M. AU - Welch, S. B. AU - Özen, S. AU - Topaloglu, R. AU - Abinun, M. AU - Kastner, D. L. AU - Aksentijevich, I. DB - Scopus DO - 10.1073/pnas.1612594113 IS - 36 M3 - Article N1 - Cited By :97 Export Date: 18 November 2020 PY - 2016 SP - 10127-10132 ST - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84985992152&doi=10.1073%2fpnas.1612594113&partnerID=40&md5=1ac3b608d27c4c5e3f4984ff45540930 VL - 113 ID - 5106 ER - TY - JOUR AD - Q. Zhou, Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, United States AU - Zhou, Q. AU - Yu, X. AU - Demirkaya, E. AU - Deuitch, N. AU - Stone, D. L. AU - Tsai, W. L. AU - Wang, H. AU - Park, Y. H. AU - Ombrello, A. K. AU - Romeo, T. AU - Remmers, E. F. AU - Chae, J. J. AU - Gadina, M. G. AU - Welch, S. B. AU - Ozen, S. AU - Topaloglu, R. AU - Abinun, M. AU - Kastner, D. L. AU - Aksentijevich, I. DB - Embase DO - 10.1002/art.39977 LA - English M3 - Conference Abstract N1 - L613888182 2017-01-02 PY - 2016 SN - 2326-5205 SP - 1329-1330 ST - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease T2 - Arthritis and Rheumatology TI - Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset systemic autoinflammatory disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613888182&from=exporthttp://dx.doi.org/10.1002/art.39977 VL - 68 ID - 5107 ER - TY - JOUR AD - Z. Li, Heart Center, Qingdao Women and Children’s Hospital, No. 6 Tongfu Road, Shibei District, Qingdao, China AU - Nie, N. AU - Bai, C. AU - Song, S. AU - Zhang, Y. AU - Wang, B. AU - Li, Z. C1 - sb 203580 sn 50 DB - Embase Medline DO - 10.1007/s11010-019-03651-3 IS - 1-2 LA - English M3 - Article N1 - L2003629974 2019-11-25 PY - 2020 SN - 1573-4919 0300-8177 SP - 83-91 ST - Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways T2 - Molecular and Cellular Biochemistry TI - Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003629974&from=exporthttp://dx.doi.org/10.1007/s11010-019-03651-3 VL - 464 ID - 5108 ER - TY - JOUR AD - IRO - Institute for Research in Ophthalmology, Sion, CH-1950, Switzerland AU - Allaman-Pillet, N. AU - Oberson, A. AU - Schorderet, D. F. DB - Scopus DO - 10.18632/oncotarget.14659 IS - 9 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 SP - 15490-15506 ST - Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model T2 - Oncotarget TI - Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014120188&doi=10.18632%2foncotarget.14659&partnerID=40&md5=deda2ff3ce8e9ce7dda065a3f48b9fee VL - 8 ID - 5109 ER - TY - JOUR AD - N. Rasool, Department of Ophthalmology, University of California San Francisco, 10 Koret Way, San Francisco, CA, United States AU - Mekonnen, B. AU - Richardson, Q. AU - Bhisitkul, J. M. AU - Diab, M. AU - Rasool, N. DB - Embase DO - 10.1016/j.ajoc.2020.100749 LA - English M3 - Article N1 - L2006071711 2020-06-05 2020-06-11 PY - 2020 SN - 2451-9936 ST - Bilateral optic disc pits in a pediatric patient with Cobb syndrome T2 - American Journal of Ophthalmology Case Reports TI - Bilateral optic disc pits in a pediatric patient with Cobb syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006071711&from=exporthttp://dx.doi.org/10.1016/j.ajoc.2020.100749 VL - 19 ID - 5110 ER - TY - JOUR AD - Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. woodfiel@bcm.edu. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. lxzhang@txch.org. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. kascorso@txch.org. Department of Neurobiology and Anatomy, The University of Texas Medical School, Houston, TX, USA. yin.liu@uth.tmc.edu. Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA. yin.liu@uth.tmc.edu. Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. zage@bcm.edu. Texas Children's Cancer Center, Houston, TX, USA. zage@bcm.edu. AN - 26925841 AU - Woodfield, S. E. AU - Zhang, L. AU - Scorsone, K. A. AU - Liu, Y. AU - Zage, P. E. C2 - PMC4772351 DA - Mar 1 DO - 10.1186/s12885-016-2199-z 10.1186/s12885-016-2199-z. DP - Nlm ET - 2016/03/02 LA - eng PY - 2016 SN - 1471-2407 SP - 172 ST - Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression T2 - BMC Cancer TI - Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression VL - 16 ID - 5111 ER - TY - JOUR C1 - braftovi(Fabre) mektovi(Fabre) C2 - Fabre DB - Embase DO - 10.18773/austprescr.2019.057 IS - 5 LA - English M3 - Note N1 - L2002733501 2019-10-22 2019-10-24 PY - 2019 SN - 1839-3942 0312-8008 SP - 168-169 ST - Binimetinib plus encorafenib for metastatic melanoma T2 - Australian Prescriber TI - Binimetinib plus encorafenib for metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002733501&from=exporthttp://dx.doi.org/10.18773/austprescr.2019.057 VL - 42 ID - 5112 ER - TY - JOUR AD - M.Z. Ratajczak, Stem Cell Institute, James Graham Brown Cancer Center, University of Louisville, 500 S. Floyd Street, Louisville, KY, United States AU - Schneider, G. AU - Sellers, Z. P. AU - Abdel-Latif, A. AU - Morris, A. J. AU - Ratajczak, M. Z. DB - Embase Medline DO - 10.1158/1541-7786.MCR-14-0188 IS - 11 LA - English M3 - Article N1 - L600499409 2014-11-25 2014-12-01 PY - 2014 SN - 1557-3125 1541-7786 SP - 1560-1573 ST - Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy T2 - Molecular Cancer Research TI - Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600499409&from=exporthttp://dx.doi.org/10.1158/1541-7786.MCR-14-0188 VL - 12 ID - 5113 ER - TY - JOUR AD - A.S.Y. Lau, Cytokine Biology Group, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong AU - Lee, D. C. W. AU - Yang, C. L. H. AU - Chik, S. C. C. AU - Li, J. C. B. AU - Rong, J. H. AU - Chan, G. C. F. AU - Lau, A. S. Y. C2 - Shanghai Institute of Materia Medica(China) DB - Embase Medline DO - 10.1186/1479-5876-7-34 LA - English M3 - Article N1 - L354714556 2009-07-01 PY - 2009 SN - 1479-5876 ST - Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells T2 - Journal of Translational Medicine TI - Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354714556&from=exporthttp://dx.doi.org/10.1186/1479-5876-7-34 VL - 7 ID - 5114 ER - TY - GEN AD - P. Rodriguez-Viciana, UCSF Helen Diller Family, Comprehensive Cancer Center, Cancer Research Institute, San Francisco, CA, United States AU - Rodriguez-Viciana, P. AU - Rauen, K. A. C5 - 18413255 DB - Embase Medline DO - 10.1016/S0076-6879(07)38019-1 J2 - Methods Enzymol. LA - English M1 - (Rodriguez-Viciana P.; Rauen K.A.) UCSF Helen Diller Family, Comprehensive Cancer Center, Cancer Research Institute, San Francisco, CA, United States M3 - Review N1 - L352382922 2008-10-28 PY - 2008 SN - 0076-6879 9780123739681 SP - 277-289 ST - Biochemical Characterization of Novel Germline BRAF and MEK Mutations in Cardio-Facio-Cutaneous Syndrome TI - Biochemical Characterization of Novel Germline BRAF and MEK Mutations in Cardio-Facio-Cutaneous Syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352382922&from=exporthttp://dx.doi.org/10.1016/S0076-6879(07)38019-1 VL - 438 ID - 5115 ER - TY - JOUR AD - M. Ruggieri, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Via S. Sofia, 78, Catania, Italy AU - Ruggieri, M. AU - Praticò, A. D. AU - Muglia, M. AU - Maiolino, L. AU - Magro, G. AU - Evans, D. G. DB - Embase DO - 10.1055/s-0036-1572361 IS - 4 LA - English M3 - Review N1 - L608480999 2016-02-24 2016-04-13 PY - 2015 SN - 1879-5404 1879-5390 SP - 120-130 ST - Biochemical Insights into Merlin/NF2 Pathophysiology and Biologically Targeted Therapies in Childhood NF2 and Related Forms T2 - Journal of Pediatric Biochemistry TI - Biochemical Insights into Merlin/NF2 Pathophysiology and Biologically Targeted Therapies in Childhood NF2 and Related Forms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608480999&from=exporthttp://dx.doi.org/10.1055/s-0036-1572361 VL - 5 ID - 5116 ER - TY - JOUR AD - Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, United States of America. Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain. Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline R&D, Heidelberg, Germany. Department of Chemistry, University of Washington, Seattle, Washington, United States of America. Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. Drug Discovery, Medicines for Malaria Venture, Geneva, Switzerland. AN - 26934697 AU - Crowther, G. J. AU - Hillesland, H. K. AU - Keyloun, K. R. AU - Reid, M. C. AU - Lafuente-Monasterio, M. J. AU - Ghidelli-Disse, S. AU - Leonard, S. E. AU - He, P. AU - Jones, J. C. AU - Krahn, M. M. AU - Mo, J. S. AU - Dasari, K. S. AU - Fox, A. M. AU - Boesche, M. AU - El Bakkouri, M. AU - Rivas, K. L. AU - Leroy, D. AU - Hui, R. AU - Drewes, G. AU - Maly, D. J. AU - Van Voorhis, W. C. AU - Ojo, K. K. C2 - PMC4774911 GlaxoSmithKline (GSK), which partially funded this work (in the form of employee salaries) and hold patent WO 2006/134056 on the kinobeads technology used in this study. Cellzome/GSK does not offer any commercial services related to this technology. DL is an employee of the Medicines for Malaria Venture (MMV), which partially funded this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. DO - 10.1371/journal.pone.0149996 10.1371/journal.pone.0149996. eCollection 2016. DP - Nlm ET - 2016/03/05 IS - 3 LA - eng PY - 2016 SN - 1932-6203 SP - e0149996 ST - Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds T2 - PLoS One TI - Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds VL - 11 ID - 5117 ER - TY - JOUR AD - Center for Clinical Pharmacology, Bdbeq S.A., Hospital Italiano Umberto Primo, Montevideo, Uruguay Center for Biomedical Sciences, University of Montevideo, Montevideo, Uruguay AU - Parrillo-Campiglia, S. AU - Ercoli, M. C. AU - Umpierrez, O. AU - Rodríguez, P. AU - Márquez, S. AU - Guarneri, C. AU - Estevez-Parrillo, F. T. AU - Laurenz, M. AU - Estevez-Carrizo, F. E. DB - Scopus DO - 10.1016/j.clinthera.2009.10.009 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2009 SP - 2224-2232 ST - Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers T2 - Clinical Therapeutics TI - Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-71549153468&doi=10.1016%2fj.clinthera.2009.10.009&partnerID=40&md5=4f04e777e52c63bb02f29ff821331b1d VL - 31 ID - 5118 ER - TY - JOUR AD - S. Reif, Hadassah Medical Center, Jerusalem, Israel AU - Reif, S. AU - Golan-Gerstl, R. AU - Shiff, Y. E. DB - Embase LA - English M3 - Conference Abstract N1 - L622343934 2018-06-01 PY - 2018 SN - 1536-4801 SP - 961 ST - The biological function of milk-derived miRNAs T2 - Journal of Pediatric Gastroenterology and Nutrition TI - The biological function of milk-derived miRNAs UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622343934&from=export VL - 66 ID - 5119 ER - TY - JOUR AD - Growth Factor Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Tokyo 104-0045, Japan. AN - 15972965 AU - Osajima-Hakomori, Y. AU - Miyake, I. AU - Ohira, M. AU - Nakagawara, A. AU - Nakagawa, A. AU - Sakai, R. C2 - PMC1603453 DA - Jul DO - 10.1016/s0002-9440(10)62966-5 10.1016/S0002-9440(10)62966-5. DP - Nlm ET - 2005/06/24 IS - 1 LA - eng PY - 2005 SN - 0002-9440 (Print) 0002-9440 SP - 213-22 ST - Biological role of anaplastic lymphoma kinase in neuroblastoma T2 - Am J Pathol TI - Biological role of anaplastic lymphoma kinase in neuroblastoma VL - 167 ID - 5120 ER - TY - JOUR AD - M. Ben Arush, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Joan and Sanford Weill Paediatric Haematology Oncology, Haifa, Israel AU - Ben Arush, M. AU - Mordechai, O. AU - Ben Barak, A. AU - Zaidman, I. AU - Postovsky, S. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612592670 2016-11-11 PY - 2016 SN - 1545-5017 SP - S274 ST - Biological therapy in refractory solid tumors as palliative care T2 - Pediatric Blood and Cancer TI - Biological therapy in refractory solid tumors as palliative care UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612592670&from=exporthttp://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 5121 ER - TY - JOUR AD - R.J. Packer, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, United States AU - Nageswara Rao, A. A. AU - Scafidi, J. AU - Wells, E. M. AU - Packer, R. J. C1 - avastin(Genentech,United States) gleevac(Novartis,United States) iressa(Astra Zeneca,United States) nexavar(Bayer,United States) rapamycin(Wyeth,United States) revlimid(Celgene) sarasar(Schering Plough,United States) sutent(Pfizer,United States) tarceva(Cydex,United States) thalomid(Celgene,United States) tykerb(Glaxo SmithKline,United States) zarnestra(Selleck,United States) C2 - Astra Zeneca(United States) Bayer(United States) Celgene(United States) Cydex(United States) Genentech(United States) Glaxo SmithKline(United States) Novartis(United States) Onyx(United States) Pfizer(United States) Schering Plough(United States) Selleck(United States) Wyeth(United States) DB - Embase Medline DO - 10.1016/j.pediatrneurol.2012.02.005 IS - 4 LA - English M3 - Review N1 - L364594188 2012-04-17 2012-04-20 PY - 2012 SN - 0887-8994 1873-5150 SP - 203-211 ST - Biologically targeted therapeutics in pediatric brain tumors T2 - Pediatric Neurology TI - Biologically targeted therapeutics in pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594188&from=exporthttp://dx.doi.org/10.1016/j.pediatrneurol.2012.02.005 VL - 46 ID - 5122 ER - TY - JOUR AD - Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany Department of Internal Medicine II, Oncology, Hematology, Clinical Immunology, Rheumatology and Pneumology, University Hospital Tübingen, Tübingen, Germany Medical Clinic I, University Hospital, TU Dresden, Dresden, Germany Medical Clinic II, Hematology and Hemostaseology, Medical Oncology, Rheumatology, Infectious Disease, University Hospital Frankfurt, Frankfurt, Germany Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Medical Department, Division of Hematology, Oncology and Tumor Immunology, Charite University Hospital, Berlin, Germany Department of Pediatrics I, Pediatric Hematology and Oncology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Medical Faculty, Halle, Germany Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany Department of Internal Medicine V, Hematology, Oncology und Rheumatology, University Hospital Heidelberg, Heidelberg, Germany Medical Clinic and Policlinic 1, University Hospital Leipzig, Leipzig, Germany Department of Internal Medicine 5, Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany Department of Pediatric Hematology and Oncology, University Hospital, Hannover Medical School, Hannover, Germany Department of Internal Medicine II, Klinikum Augsburg, Augsburg, Germany Department of Internal Medicine A/Hematology and Oncology, University of Münster, Münster, Germany Department of Internal Medicine IV, Hematology and Oncology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany AU - Zeiser, R. AU - Beelen, D. W. AU - Bethge, W. AU - Bornhäuser, M. AU - Bug, G. AU - Burchert, A. AU - Christopeit, M. AU - Duyster, J. AU - Finke, J. AU - Gerbitz, A. AU - Klusmann, J. H. AU - Kobbe, G. AU - Lübbert, M. AU - Müller-Tidow, C. AU - Platzbecker, U. AU - Rösler, W. AU - Sauer, M. AU - Schmid, C. AU - Schroeder, T. AU - Stelljes, M. AU - Kröger, N. AU - Müller, L. P. DB - Scopus DO - 10.1016/j.bbmt.2019.01.016 IS - 4 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - e128-e140 ST - Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation T2 - Biology of Blood and Marrow Transplantation TI - Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061457375&doi=10.1016%2fj.bbmt.2019.01.016&partnerID=40&md5=47d8483dadf35685806911b971b429e5 VL - 25 ID - 5123 ER - TY - JOUR AD - M.A. White, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX, United States AU - Eskiocak, B. AU - McMillan, E. A. AU - Mendiratta, S. AU - Kollipara, R. K. AU - Zhang, H. AU - Humphries, C. G. AU - Wang, C. AU - Garcia-Rodriguez, J. AU - Ding, M. AU - Zaman, A. AU - Rosales, T. I. AU - Eskiocak, U. AU - Smith, M. P. AU - Sudderth, J. AU - Komurov, K. AU - Deberardinis, R. J. AU - Wellbrock, C. AU - Davies, M. A. AU - Wargo, J. A. AU - Yu, Y. AU - De Brabander, J. K. AU - Williams, N. S. AU - Chin, L. AU - Rizos, H. AU - Long, G. V. AU - Kittler, R. AU - White, M. A. DB - Embase Medline DO - 10.1158/2159-8290.CD-16-0955 IS - 8 LA - English M3 - Article N1 - L617700053 2017-08-17 2017-08-21 PY - 2017 SN - 2159-8290 2159-8274 SP - 832-851 ST - Biomarker accessible and chemically addressable mechanistic subtypes of braf melanoma T2 - Cancer Discovery TI - Biomarker accessible and chemically addressable mechanistic subtypes of braf melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617700053&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-16-0955 VL - 7 ID - 5124 ER - TY - JOUR AD - G. Vassal, Gustave Roussy Istitute, Oncology, Villejuif, France AU - Vassal, G. AU - Moro-sibilot, D. AU - Le Deley, M. C. AU - Hoog-labouret, N. AU - Nowak, F. AU - Jimenez, M. AU - Tournigand, C. AU - Houot, R. AU - Malka, D. AU - Aparicio, T. AU - Escudier, B. AU - Ray-Coquard, I. AU - Godbert, Y. AU - Taillandier, L. AU - Bieche, I. AU - Lantuejoul, S. AU - Ferretti, G. AU - Menu, Y. AU - Blay, J. Y. AU - Buzyn, A. DB - Embase LA - English M3 - Conference Abstract N1 - L72068628 2015-11-20 PY - 2015 SN - 0959-8049 SP - S715 ST - Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé Program T2 - European Journal of Cancer TI - Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé Program UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72068628&from=export VL - 51 ID - 5125 ER - TY - JOUR AD - Division of Cancer Treatment and Diagnosis, National Cancer Institute, 31 Center Drive, Bldg 31, Rm 3A44, Bethesda, MD, 20892, USA. AN - 25637165 AU - Do, K. AU - Speranza, G. AU - Bishop, R. AU - Khin, S. AU - Rubinstein, L. AU - Kinders, R. J. AU - Datiles, M. AU - Eugeni, M. AU - Lam, M. H. AU - Doyle, L. A. AU - Doroshow, J. H. AU - Kummar, S. DA - Jun DO - 10.1007/s10637-015-0212-z 10.1007/s10637-015-0212-z. Epub 2015 Feb 1. DP - Nlm ET - 2015/02/01 IS - 3 LA - eng PY - 2015 SN - 0167-6997 SP - 720-8 ST - Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer T2 - Invest New Drugs TI - Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer VL - 33 ID - 5126 ER - TY - JOUR AD - L. Dokmanovic, Department of Hematology and Oncology, University of Belgrade, University Children's Hospital, Dr Subotica 13, 11000 Belgrade, Serbia AU - Dokmanovic, L. DB - Embase Medline DO - 10.2217/bmm.13.84 IS - 5 LA - English M3 - Review N1 - L369878336 2013-10-02 2013-10-10 PY - 2013 SN - 1752-0363 1752-0371 SP - 791-801 ST - Biomarkers in childhood non-Hodgkin's lymphomas T2 - Biomarkers in Medicine TI - Biomarkers in childhood non-Hodgkin's lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369878336&from=exporthttp://dx.doi.org/10.2217/bmm.13.84 VL - 7 ID - 5127 ER - TY - JOUR AD - M. Maggiolini, Department of Pharmaco-Biology, University of Calabria, 87036 Rende, Italy AU - Pupo, M. AU - Pisano, A. AU - Lappano, R. AU - Santolla, M. F. AU - de Francesco, E. M. AU - Abonante, S. AU - Rosano, C. AU - Maggiolini, M. DB - Embase Medline DO - 10.1289/ehp.1104526 IS - 8 L1 - internal-pdf://0711845894/fetchObjectAttachment.action.txt LA - English M3 - Article N1 - L365366901 2012-08-10 2012-08-15 PY - 2012 SN - 0091-6765 1552-9924 SP - 1177-1182 ST - Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts T2 - Environmental Health Perspectives TI - Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365366901&from=exporthttp://dx.doi.org/10.1289/ehp.1104526 VL - 120 ID - 5128 ER - TY - JOUR AD - M.-F. Heymann, Institut de Cancérologie de l'Ouest, Blvd Jacques Monod, Saint-Herblain, France AU - Heymann, M. F. AU - Lezot, F. AU - Heymann, D. DB - Embase Medline DO - 10.1016/j.bone.2020.115523 LA - English M3 - Article N1 - L2007034765 2020-07-22 2020-07-28 PY - 2020 SN - 8756-3282 ST - Bisphosphonates in common pediatric and adult bone sarcomas T2 - Bone TI - Bisphosphonates in common pediatric and adult bone sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007034765&from=exporthttp://dx.doi.org/10.1016/j.bone.2020.115523 VL - 139 ID - 5129 ER - TY - JOUR AD - University of Michigan, Ann Arbor, MI, United States H. Lee Moffitt Cancer Center, Tampa, FL, United States University of Pennsylvania, Philadelphia, PA, United States Dana-Farber Cancer Institute, Boston, MA, United States University of Florida Shands Cancer Center, Gainesville, FL, United States Fred Hutchinson Cancer Research Center, Seattle, WA, United States AU - Ferrara, J. L. M. AU - Anasetti, C. AU - Stadtmauer, E. AU - Antin, J. AU - Wingard, J. AU - Lee, S. AU - Levine, J. AU - Schultz, K. AU - Appelbaum, F. AU - Negrin, R. AU - Giralt, S. AU - Bredeson, C. AU - Heslop, H. AU - Horowitz, M. DB - Scopus DO - 10.1016/j.bbmt.2007.08.005 IS - 11 M3 - Review N1 - Cited By :22 Export Date: 18 November 2020 PY - 2007 SP - 1268-1285 ST - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 T2 - Biology of Blood and Marrow Transplantation TI - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35348912524&doi=10.1016%2fj.bbmt.2007.08.005&partnerID=40&md5=c1d74c7283797a3af6cd060c2a32bd87 VL - 13 ID - 5130 ER - TY - JOUR AD - C. Damm-Welk, NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany AU - Knörr, F. AU - Damm-Welk, C. AU - Ruf, S. AU - Singh, V. K. AU - Zimmermann, M. AU - Reiter, A. AU - Woessmann, W. DB - Embase Medline DO - 10.3324/haematol.2017.177972 IS - 3 LA - English M3 - Article N1 - L621006469 2018-03-09 2018-03-16 PY - 2018 SN - 1592-8721 0390-6078 SP - 477-485 ST - Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma T2 - Haematologica TI - Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621006469&from=exporthttp://dx.doi.org/10.3324/haematol.2017.177972 VL - 103 ID - 5131 ER - TY - JOUR AD - W.L. Shaib, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States AU - Zakka, K. AU - Nagy, R. AU - Drusbosky, L. AU - Akce, M. AU - Wu, C. AU - Alese, O. B. AU - El-Rayes, B. F. AU - Kasi, P. M. AU - Mody, K. AU - Starr, J. AU - Shaib, W. L. DB - Embase DO - 10.18632/oncotarget.27588 IS - 19 LA - English M3 - Article N1 - L632012639 2020-06-30 2020-07-14 PY - 2020 SN - 1949-2553 SP - 1749-1757 ST - Blood-based next-generation sequencing analysis of neuroendocrine neoplasms T2 - Oncotarget TI - Blood-based next-generation sequencing analysis of neuroendocrine neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632012639&from=exporthttp://dx.doi.org/10.18632/oncotarget.27588 VL - 11 ID - 5132 ER - TY - JOUR AD - C. Koschmann, Department of Pediatrics, Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital at the University of Michigan, 1500 E Medical Center Dr., Ann Arbor, MI, United States AU - Marini, B. L. AU - Benitez, L. L. AU - Zureick, A. H. AU - Salloum, R. AU - Gauthier, A. C. AU - Brown, J. AU - Wu, Y. M. AU - Robinson, D. R. AU - Kumar, C. AU - Lonigro, R. AU - Vats, P. AU - Cao, X. AU - Kasaian, K. AU - Anderson, B. AU - Mullan, B. AU - Chandler, B. AU - Linzey, J. R. AU - Camelo-Piragua, S. I. AU - Venneti, S. AU - McKeever, P. E. AU - McFadden, K. A. AU - Lieberman, A. P. AU - Brown, N. AU - Shao, L. AU - Leonard, M. A. S. AU - Junck, L. AU - McKean, E. AU - Maher, C. O. AU - Garton, H. J. L. AU - Muraszko, K. M. AU - Hervey-Jumper, S. AU - Mulcahy-Levy, J. M. AU - Green, A. AU - Hoffman, L. M. AU - Dorris, K. AU - Vitanza, N. A. AU - Wang, J. AU - Schwartz, J. AU - Lulla, R. AU - Smiley, N. P. AU - Bornhorst, M. AU - Haas-Kogan, D. A. AU - Robertson, P. L. AU - Chinnaiyan, A. M. AU - Mody, R. AU - Koschmann, C. DB - Embase Medline DO - 10.1016/j.trsl.2017.08.001 LA - English M3 - Article N1 - L618256912 2017-09-20 2020-10-08 PY - 2017 SN - 1878-1810 1931-5244 SP - 27.e1-27.e14 ST - Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors T2 - Translational Research TI - Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618256912&from=exporthttp://dx.doi.org/10.1016/j.trsl.2017.08.001 VL - 188 ID - 5133 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Oncology, University of Alberta, Edmonton, Canada Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Veasey Rodrigues, H. AU - Baracos, V. E. AU - Wheler, J. J. AU - Parsons, H. A. AU - Hong, D. S. AU - Naing, A. AU - Fu, S. AU - Falchoock, G. AU - Tsimberidou, A. M. AU - Piha-Paul, S. AU - Chisholm, G. AU - Kurzrock, R. DB - Scopus DO - 10.1016/j.ejca.2013.06.026 IS - 15 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2013 SP - 3068-3075 ST - Body composition and survival in the early clinical trials setting T2 - European Journal of Cancer TI - Body composition and survival in the early clinical trials setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884905418&doi=10.1016%2fj.ejca.2013.06.026&partnerID=40&md5=aa1e1fb31e768d4b414a3f65ca8fc264 VL - 49 ID - 5134 ER - TY - JOUR AD - E. R. Sutherland, National Jewish Health Center, 1400 Jackson Street, J-220, Denver, CO 80206, United States AU - Sutherland, E. R. AU - Goleva, E. AU - Strand, M. AU - Beuther, D. A. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1164/rccm.200801-076OC IS - 7 LA - English M3 - Article N1 - L352459250 2008-11-07 PY - 2008 SN - 1073-449X 1535-4970 SP - 682-687 ST - Body mass and glucocorticoid response in asthma T2 - American Journal of Respiratory and Critical Care Medicine TI - Body mass and glucocorticoid response in asthma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352459250&from=exporthttp://dx.doi.org/10.1164/rccm.200801-076OChttp://ajrccm.atsjournals.org/cgi/reprint/178/7/682 VL - 178 ID - 5135 ER - TY - JOUR AD - Q. Liu, Department of Oral Pathology, Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China H. Sun, Department of Oral Pathology, Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China AU - Meng, L. AU - Zhao, Y. AU - Bu, W. AU - Li, X. AU - Liu, X. AU - Zhou, D. AU - Chen, Y. AU - Zheng, S. AU - Lin, Q. AU - Liu, Q. AU - Sun, H. DB - Embase Medline DO - 10.1111/cpr.12859 IS - 8 LA - English M3 - Article N1 - L2005436711 2020-07-14 2020-10-23 PY - 2020 SN - 1365-2184 0960-7722 ST - Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma T2 - Cell Proliferation TI - Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005436711&from=exporthttp://dx.doi.org/10.1111/cpr.12859 VL - 53 ID - 5136 ER - TY - JOUR AD - Division of Endocrinology, Diabetes and Metabolism, Departments of Medicine, Biological Chemistry and Pharmacology, University of California, Irvine, California, USA. AN - 10220513 AU - Kleeff, J. AU - Maruyama, H. AU - Ishiwata, T. AU - Sawhney, H. AU - Friess, H. AU - Büchler, M. W. AU - Korc, M. DA - May DO - 10.1016/s0016-5085(99)70024-7 DP - Nlm ET - 1999/04/30 IS - 5 LA - eng N1 - Kleeff, J Maruyama, H Ishiwata, T Sawhney, H Friess, H Büchler, M W Korc, M PY - 1999 SN - 0016-5085 (Print) 0016-5085 SP - 1202-16 ST - Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo T2 - Gastroenterology TI - Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo VL - 116 ID - 5137 ER - TY - JOUR AD - Laboratory of Osteoblast Biology and Pathology, INSERM U 349, Affiliated CNRS, Lariboisière Hospital, 75475 Cedex 10 Paris, France. AN - 11395480 AU - Haÿ, E. AU - Lemonnier, J. AU - Fromigué, O. AU - Marie, P. J. DA - Aug 3 DO - 10.1074/jbc.M011265200 10.1074/jbc.M011265200. Epub 2001 Jun 6. DP - Nlm ET - 2001/06/08 IS - 31 LA - eng PY - 2001 SN - 0021-9258 (Print) 0021-9258 SP - 29028-36 ST - Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway T2 - J Biol Chem TI - Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway VL - 276 ID - 5138 ER - TY - JOUR AD - Medical University of Gdańsk, Department of Oncology Propaedeutics, Powstania Styczniowego 9b, 81-519 Gdynia, Poland Opole Oncology Center, Poland Department of Oncology, Poznan University of Medical Sciences, Poland AU - Leśniewski-Kmak, K. AU - Radecka, B. AU - Litwiniuk, M. DB - Scopus DO - 10.5114/wo.2011.23004 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2011 SP - 147-154 ST - Bone tissue as the site of action of oncological drugs T2 - Wspolczesna Onkologia TI - Bone tissue as the site of action of oncological drugs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960240781&doi=10.5114%2fwo.2011.23004&partnerID=40&md5=3cb837712d609e6ecfcec6db1c35ae2f VL - 15 ID - 5139 ER - TY - JOUR AD - University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy Universitätsklinikum Aachen, RWTH Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Seoul St. Mary's Hospital, Seoul, South Korea Hematology Research Center, Moscow, Russian Federation St. István and St. László Hospital, Budapest, Hungary Jewish General Hospital, McGill University, Montreal, QC, Canada Royal Brisbane Hospital, Herston, QLD, Australia University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States University of Pavlov and Almazov Federal Heart, Blood, and Endocrinology Centre, St Petersburg, Russian Federation Ruijin Hospital, Shanghai, China First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China University of Groningen and University Medical Center Groningen, Groningen, Netherlands Hospital das Clínicas da Universidade Federal do Paraná, Paraná, Brazil Christian Medical College, Vellore, Tamil Nadu, India Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain Pfizer Global Research and Development, Paris, France Pfizer, Cambridge, MA, United States AU - Gambacorti-Passerini, C. AU - Brümmendorf, T. H. AU - Kim, D. W. AU - Turkina, A. G. AU - Masszi, T. AU - Assouline, S. AU - Durrant, S. AU - Kantarjian, H. M. AU - Khoury, H. J. AU - Zaritskey, A. AU - Shen, Z. X. AU - Jin, J. AU - Vellenga, E. AU - Pasquini, R. AU - Mathews, V. AU - Cervantes, F. AU - Besson, N. AU - Turnbull, K. AU - Leip, E. AU - Kelly, V. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.23728 IS - 7 M3 - Article N1 - Cited By :71 Export Date: 18 November 2020 PY - 2014 SP - 732-742 ST - Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up T2 - American Journal of Hematology TI - Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902843429&doi=10.1002%2fajh.23728&partnerID=40&md5=a286e951ab0e73620dc58680d0a8b7a3 VL - 89 ID - 5140 ER - TY - JOUR AD - Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Seoul St. Mary's Hospital, Seoul, South Korea Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Hematology, Oncology, and Stem Cell Transplantation, Universitätsklinikum Aachen, Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen, Germany Hematology, Oncology, and Stem Cell Transplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy Bone Marrow Transplant Unit, Royal Brisbane Hospital, Herston, Australia Oncology Clinical Statistics, Pfizer Inc., Cambridge, MA, United States Oncology Clinical Research, Pfizer Inc., Cambridge, MA, United States Oncology Clinical Development, Pfizer Inc., Cambridge, MA, United States Pfizer Global Research and Development, Paris, France Clinical Research Unit, University of Milano-Bicocca, Monza, Italy AU - Kantarjian, H. M. AU - Cortes, J. E. AU - Kim, D. W. AU - Khoury, H. J. AU - Brümmendorf, T. H. AU - Porkka, K. AU - Martinelli, G. AU - Durrant, S. AU - Leip, E. AU - Kelly, V. AU - Turnbull, K. AU - Besson, N. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1182/blood-2013-07-513937 IS - 9 M3 - Article N1 - Cited By :83 Export Date: 18 November 2020 PY - 2014 SP - 1309-1318 ST - Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors T2 - Blood TI - Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896622957&doi=10.1182%2fblood-2013-07-513937&partnerID=40&md5=98214c9aa1686f424d0576d4e7f93136 VL - 123 ID - 5141 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, United States Pfizer, Cambridge, MA, United States Pfizer, San Diego, CA, United States Seoul St Mary's Hospital, Seoul, South Korea Universitäts-Klinikum Aachen, Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen, Germany Universitäts-Klinikum Hamburg-Eppendorf, Hamburg, Germany Research Center for Radiation Medicine, Academy of Medical Sciences, Kiev, Ukraine Vilnius University Hospital Santarškiu Klinikos, Vilnius University, Vilnius, Lithuania Birla Cancer Centre, SMS Medical College, Jaipur, India Pfizer Global Research and Development, Paris, France University Milano Bicocca, Monza, Italy AU - Cortes, J. E. AU - Kim, D. W. AU - Kantarjian, H. M. AU - Brümmendorf, T. H. AU - Dyagil, I. AU - Griskevicius, L. AU - Malhotra, H. AU - Powell, C. AU - Gogat, K. AU - Countouriotis, A. M. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1200/JCO.2011.38.7522 IS - 28 M3 - Article N1 - Cited By :308 Export Date: 18 November 2020 PY - 2012 SP - 3486-3492 ST - Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial T2 - Journal of Clinical Oncology TI - Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866175467&doi=10.1200%2fJCO.2011.38.7522&partnerID=40&md5=6aa9cb4bbf91abf5a26c3c230f45b0e8 VL - 30 ID - 5142 ER - TY - JOUR AD - Department of Pediatric Dentistry, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden. AN - 15664665 AU - Brunius, G. AU - Domeij, H. AU - Gustavsson, A. AU - Yucel-Lindberg, T. DA - Mar 30 DO - 10.1016/j.regpep.2004.09.005 10.1016/j.regpep.2004.09.005. DP - Nlm ET - 2005/01/25 IS - 3 LA - eng PY - 2005 SN - 0167-0115 (Print) 0167-0115 SP - 183-8 ST - Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha T2 - Regul Pept TI - Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha VL - 126 ID - 5143 ER - TY - JOUR AD - Department of Genetics, Saint Savvas Hospital, Athens, Greece. AN - 23612919 AU - Dimitriadis, E. AU - Alexiou, G. A. AU - Tsotsou, P. AU - Simeonidi, E. AU - Stefanaki, K. AU - Patereli, A. AU - Prodromou, N. AU - Pandis, N. DA - Jul DO - 10.1007/s11060-013-1131-5 10.1007/s11060-013-1131-5. Epub 2013 Apr 24. DP - Nlm ET - 2013/04/25 IS - 3 LA - eng PY - 2013 SN - 0167-594x SP - 353-8 ST - BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors T2 - J Neurooncol TI - BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors VL - 113 ID - 5144 ER - TY - JOUR AD - Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. AN - 30265855 AU - Maraka, S. AU - Janku, F. DA - Aug DP - Nlm ET - 2018/09/29 IS - 141 LA - eng N1 - 1944-7930 Maraka, Stefania Janku, Filip Journal Article Research Support, Non-U.S. Gov't Review United States Discov Med. 2018 Aug;26(141):51-60. PY - 2018 SN - 1539-6509 SP - 51-60 ST - BRAF alterations in primary brain tumors T2 - Discov Med TI - BRAF alterations in primary brain tumors VL - 26 ID - 5145 ER - TY - JOUR AD - Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. AN - 22157620 AU - Lin, A. AU - Rodriguez, F. J. AU - Karajannis, M. A. AU - Williams, S. C. AU - Legault, G. AU - Zagzag, D. AU - Burger, P. C. AU - Allen, J. C. AU - Eberhart, C. G. AU - Bar, E. E. C2 - PMC4629834 C6 - NIHMS729483 DA - Jan DO - 10.1097/NEN.0b013e31823f2cb0 10.1097/NEN.0b013e31823f2cb0. DP - Nlm ET - 2011/12/14 IS - 1 LA - eng PY - 2012 SN - 0022-3069 (Print) 0022-3069 SP - 66-72 ST - BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants T2 - J Neuropathol Exp Neurol TI - BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants VL - 71 ID - 5146 ER - TY - JOUR AD - *Department of Pathology, American University of Beirut Medical Center, Beirut, Lebanon; †Department of Internal Medicine, Outcomes Research Unit, American University of Beirut Medical Center, Beirut, Lebanon; ‡Department of Pathology, Saad Specialist Hospital, Al Khobar, Kingdom of Saudi Arabia; §Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; ¶Department of Pathology, Tishreen University, Lattakia, Syrian Arab Republic; ‖Department of Pathology, Dhahran Health Center, Dhahran, Kingdom of Saudi Arabia; **Department of Pathology, King Fahd Specialist Hospital, Dammam, Kingdom of Saudi Arabia; ††Department of Pathology, King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia; and ‡‡ViennaLab Diagnostics GmbH, Vienna, Austria. AN - 23782679 AU - Saroufim, M. AU - Habib, R. AU - Karram, S. AU - Youssef Massad, C. AU - Taraif, S. AU - Loya, A. AU - Houreih, M. A. AU - Sheikh, S. S. AU - Amr, S. S. AU - Satti, M. AU - Oberkanins, C. AU - Khalifeh, I. DA - Jan DO - 10.1097/DAD.0b013e318293f355 10.1097/DAD.0b013e318293f355. DP - Nlm ET - 2013/06/21 IS - 1 LA - eng PY - 2014 SN - 0193-1091 SP - 68-73 ST - BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions T2 - Am J Dermatopathol TI - BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions VL - 36 ID - 5147 ER - TY - JOUR AD - Department of Pathology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA. laueran@ohsu.edu AN - 22317887 AU - Chakrapani, A. AU - Warrick, A. AU - Nelson, D. AU - Beadling, C. AU - Corless, C. L. DA - Jul DO - 10.1097/DAD.0b013e31823931b4 10.1097/DAD.0b013e31823931b4. DP - Nlm ET - 2012/02/10 IS - 5 LA - eng PY - 2012 SN - 0193-1091 SP - 533-5 ST - BRAF and KRAS mutations in sporadic glomus tumors T2 - Am J Dermatopathol TI - BRAF and KRAS mutations in sporadic glomus tumors VL - 34 ID - 5148 ER - TY - JOUR AD - a Division of Pediatric Oncology , Catholic University of Rome , Rome , Italy. AN - 27494648 AU - Rizzo, D. AU - Ruggiero, A. AU - Amato, M. AU - Maurizi, P. AU - Riccardi, R. DA - Dec DO - 10.1080/17425255.2016.1214710 10.1080/17425255.2016.1214710. Epub 2016 Aug 5. DP - Nlm ET - 2016/08/06 IS - 12 LA - eng PY - 2016 SN - 1742-5255 SP - 1397-1405 ST - BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities T2 - Expert Opin Drug Metab Toxicol TI - BRAF and MEK inhibitors in pediatric glioma: new therapeutic strategies, new toxicities VL - 12 ID - 5149 ER - TY - JOUR AD - Department of Pathology, University of Hong Kong, Queen Mary Hospital, Hong Kong. AN - 15917418 AU - Wong, C. W. AU - Fan, Y. S. AU - Chan, T. L. AU - Chan, A. S. AU - Ho, L. C. AU - Ma, T. K. AU - Yuen, S. T. AU - Leung, S. Y. C2 - PMC1770697 DA - Jun DO - 10.1136/jcp.2004.022509 10.1136/jcp.2004.022509. DP - Nlm ET - 2005/05/27 IS - 6 LA - eng PY - 2005 SN - 0021-9746 (Print) 0021-9746 SP - 640-4 ST - BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs T2 - J Clin Pathol TI - BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs VL - 58 ID - 5150 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI 48109-0602, USA. dfullen@med.umich.edu AN - 16799476 AU - Fullen, D. R. AU - Poynter, J. N. AU - Lowe, L. AU - Su, L. D. AU - Elder, J. T. AU - Nair, R. P. AU - Johnson, T. M. AU - Gruber, S. B. DA - Oct DO - 10.1038/modpathol.3800653 10.1038/modpathol.3800653. Epub 2006 Jun 23. DP - Nlm ET - 2006/06/27 IS - 10 LA - eng PY - 2006 SN - 0893-3952 (Print) 0893-3952 SP - 1324-32 ST - BRAF and NRAS mutations in spitzoid melanocytic lesions T2 - Mod Pathol TI - BRAF and NRAS mutations in spitzoid melanocytic lesions VL - 19 ID - 5151 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Electronic address: mcajaiba@luriechildrens.org. AN - 27769870 AU - Marsden, L. AU - Jennings, L. J. AU - Gadd, S. AU - Yu, M. AU - Perlman, E. J. AU - Cajaiba, M. M. DA - Feb DO - 10.1016/j.humpath.2016.09.025 10.1016/j.humpath.2016.09.025. Epub 2016 Oct 18. DP - Nlm ET - 2016/10/23 LA - eng PY - 2017 SN - 0046-8177 SP - 32-36 ST - BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors T2 - Hum Pathol TI - BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors VL - 60 ID - 5152 ER - TY - JOUR AD - Department of Dermatology, No 1 Hospital of China Medical University, Shenyang, Liaoning, China. AN - 21326296 AU - Qi, R. Q. AU - He, L. AU - Zheng, S. AU - Hong, Y. AU - Ma, L. AU - Zhang, S. AU - Zhao, L. AU - Guo, X. AU - Wang, Y. AU - Yu, J. Y. AU - Fu, L. AU - Zhang, W. AU - Long, T. AU - Zhang, C. AU - Chen, G. AU - Lin, J. AU - Wang, C. AU - Zhou, L. AU - Mi, Q. AU - Weiland, M. AU - Chen, J. Z. AU - McHenga, S. S. AU - Wang, Y. K. AU - McHepange, U. AU - Wang, Z. AU - Chen, H. D. AU - Gao, X. H. DA - May DO - 10.1038/jid.2010.405 10.1038/jid.2010.405. Epub 2011 Feb 17. DP - Nlm ET - 2011/02/18 IS - 5 LA - eng PY - 2011 SN - 0022-202x SP - 1129-38 ST - BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han T2 - J Invest Dermatol TI - BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han VL - 131 ID - 5153 ER - TY - JOUR AD - From the Bristol Genetics Laboratory, Pathology Sciences, Southmead Hospital, Bristol (CF, AP, CW, MG, MW); Brain Tumour Research Group, Institute of Clinical Neurosciences, Southmead Hospital (HPE, AS, CP, HRH, HW, KMK); Department of Paediatric Oncology, Bristol Royal Hospital for Children (SL); and Applied Statistics Group, University of the West of England (PW), Bristol, UK; and Department of Neuropathology, Institute of Pathology, University of Heidelberg and CCU Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. AN - 26222501 AU - Faulkner, C. AU - Ellis, H. P. AU - Shaw, A. AU - Penman, C. AU - Palmer, A. AU - Wragg, C. AU - Greenslade, M. AU - Haynes, H. R. AU - Williams, H. AU - Lowis, S. AU - White, P. AU - Williams, M. AU - Capper, D. AU - Kurian, K. M. C2 - PMC4554227 DA - Sep DO - 10.1097/nen.0000000000000226 10.1097/NEN.0000000000000226. DP - Nlm ET - 2015/07/30 IS - 9 LA - eng PY - 2015 SN - 0022-3069 (Print) 0022-3069 SP - 867-72 ST - BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum T2 - J Neuropathol Exp Neurol TI - BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum VL - 74 ID - 5154 ER - TY - JOUR AD - J.A. Sosman, Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2220 Pierce Avenue, Nashville, TN 37232, United States AU - Hutchinson, K. E. AU - Lipson, D. AU - Stephens, P. J. AU - Otto, G. AU - Lehmann, B. D. AU - Lyle, P. L. AU - Vnencak-Jones, C. L. AU - Ross, J. S. AU - Pietenpol, J. A. AU - Sosman, J. A. AU - Puzanov, I. AU - Miller, V. A. AU - Pao, W. DB - Embase Medline DO - 10.1158/1078-0432.CCR-13-1746 IS - 24 LA - English M3 - Article N1 - L370533080 2013-12-27 2014-01-21 PY - 2013 SN - 1078-0432 1557-3265 SP - 6696-6702 ST - BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition T2 - Clinical Cancer Research TI - BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370533080&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-13-1746http://clincancerres.aacrjournals.org/content/19/24/6696.full.pdf+html VL - 19 ID - 5155 ER - TY - JOUR AD - Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India. Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India. AN - 28879901 AU - Kakkar, A. AU - Majumdar, A. AU - Pathak, P. AU - Kumar, A. AU - Kumari, K. AU - Tripathi, M. AU - Sharma, M. C. AU - Suri, V. AU - Tandon, V. AU - Chandra, S. P. AU - Sarkar, C. DA - Sep-Oct DO - 10.4103/neuroindia.NI_207_17 10.4103/neuroindia.NI_207_17. DP - Nlm ET - 2017/09/08 IS - 5 LA - eng PY - 2017 SN - 0028-3886 (Print) 0028-3886 SP - 1076-1082 ST - BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas T2 - Neurol India TI - BRAF gene alterations and enhanced mammalian target of rapamycin signaling in gangliogliomas VL - 65 ID - 5156 ER - TY - JOUR AD - P. Juszczyński, Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland AU - Górniak, P. AU - Wasylecka-Juszczyńska, M. AU - Ługowska, I. AU - Rutkowski, P. AU - Polak, A. AU - Szydłowski, M. AU - Juszczyński, P. DB - Embase Medline DO - 10.1002/1878-0261.12695 IS - 8 LA - English M3 - Article N1 - L2004987594 2020-05-26 2020-09-30 PY - 2020 SN - 1878-0261 1574-7891 SP - 1817-1832 ST - BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells T2 - Molecular Oncology TI - BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004987594&from=exporthttp://dx.doi.org/10.1002/1878-0261.12695 VL - 14 ID - 5157 ER - TY - JOUR AD - Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. AN - 24463458 AU - Rizos, H. AU - Menzies, A. M. AU - Pupo, G. M. AU - Carlino, M. S. AU - Fung, C. AU - Hyman, J. AU - Haydu, L. E. AU - Mijatov, B. AU - Becker, T. M. AU - Boyd, S. C. AU - Howle, J. AU - Saw, R. AU - Thompson, J. F. AU - Kefford, R. F. AU - Scolyer, R. A. AU - Long, G. V. DA - Apr 1 DO - 10.1158/1078-0432.Ccr-13-3122 10.1158/1078-0432.CCR-13-3122. Epub 2014 Jan 24. DP - Nlm ET - 2014/01/28 IS - 7 LA - eng PY - 2014 SN - 1078-0432 (Print) 1078-0432 SP - 1965-77 ST - BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact T2 - Clin Cancer Res TI - BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact VL - 20 ID - 5158 ER - TY - JOUR AD - M.A. Hardyman, University of Reading, Reading, United Kingdom AU - Hardyman, M. A. AU - Fuller, S. J. AU - Leonard, S. J. AU - Sugden, P. H. AU - Angela Clerk, A. DB - Embase DO - 10.1002/ejhf.833 LA - English M3 - Conference Abstract N1 - L616172961 2017-05-18 PY - 2017 SN - 1878-1314 SP - 168 ST - BRaf inhibitors, dabrafenib and SB590885, enhance ERK1/2 signalling in cardiomyocytes and increase angiotensin II-induced cardiac hypertrophy T2 - European Journal of Heart Failure TI - BRaf inhibitors, dabrafenib and SB590885, enhance ERK1/2 signalling in cardiomyocytes and increase angiotensin II-induced cardiac hypertrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616172961&from=exporthttp://dx.doi.org/10.1002/ejhf.833 VL - 19 ID - 5159 ER - TY - JOUR AD - 1Department of Pathology, Institut Bergonié, Bordeaux, France. AN - 20023270 AU - Hostein, I. AU - Faur, N. AU - Primois, C. AU - Boury, F. AU - Denard, J. AU - Emile, J. F. AU - Bringuier, P. P. AU - Scoazec, J. Y. AU - Coindre, J. M. DA - Jan DO - 10.1309/ajcppckga2qgbj1r 10.1309/AJCPPCKGA2QGBJ1R. DP - Nlm ET - 2009/12/22 IS - 1 LA - eng PY - 2010 SN - 0002-9173 SP - 141-8 ST - BRAF mutation status in gastrointestinal stromal tumors T2 - Am J Clin Pathol TI - BRAF mutation status in gastrointestinal stromal tumors VL - 133 ID - 5160 ER - TY - JOUR AD - Department of Clinical Pathology, Cleveland Clinic, Cleveland, Ohio, USA. AN - 19738460 AU - Jakubowski, M. AU - Hunt, J. L. DA - Nov DO - 10.1097/PAS.0b013e3181b7c7ae 10.1097/PAS.0b013e3181b7c7ae. DP - Nlm ET - 2009/09/10 IS - 11 LA - eng PY - 2009 SN - 0147-5185 SP - 1590-3 ST - BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns T2 - Am J Surg Pathol TI - BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns VL - 33 ID - 5161 ER - TY - JOUR AD - 1 Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. AN - 25490715 AU - Salgado, C. M. AU - Basu, D. AU - Nikiforova, M. AU - Bauer, B. S. AU - Johnson, D. AU - Rundell, V. AU - Grunwaldt, L. J. AU - Reyes-Múgica, M. DA - Jan-Feb DO - 10.2350/14-10-1566-oa.1 10.2350/14-10-1566-OA.1. Epub 2014 Dec 9. DP - Nlm ET - 2014/12/10 IS - 1 LA - eng PY - 2015 SN - 1093-5266 (Print) 1093-5266 SP - 1-9 ST - BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi T2 - Pediatr Dev Pathol TI - BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi VL - 18 ID - 5162 ER - TY - JOUR AD - Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. kaladym@ccf.org AN - 22228154 AU - Kalady, M. F. AU - Dejulius, K. L. AU - Sanchez, J. A. AU - Jarrar, A. AU - Liu, X. AU - Manilich, E. AU - Skacel, M. AU - Church, J. M. DA - Feb DO - 10.1097/DCR.0b013e31823c08b3 10.1097/DCR.0b013e31823c08b3. DP - Nlm ET - 2012/01/10 IS - 2 LA - eng PY - 2012 SN - 0012-3706 SP - 128-33 ST - BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis T2 - Dis Colon Rectum TI - BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis VL - 55 ID - 5163 ER - TY - JOUR AD - Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada M5S1A1. Department of Pathology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China. Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8. Chula GenePRO Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Chula GenePRO Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Division of Pathology, The Hospital for Sick Children, Toronto, Canada M5G 1X8; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada M5S1A1; Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. Electronic address: paul.thorner@sickkids.ca. AN - 26014474 AU - Chami, R. AU - Yin, M. AU - Marrano, P. AU - Teerapakpinyo, C. AU - Shuangshoti, S. AU - Thorner, P. S. DA - Aug DO - 10.1016/j.humpath.2015.03.019 10.1016/j.humpath.2015.03.019. Epub 2015 Apr 21. DP - Nlm ET - 2015/05/28 IS - 8 LA - eng PY - 2015 SN - 0046-8177 SP - 1153-61 ST - BRAF mutations in pediatric metanephric tumors T2 - Hum Pathol TI - BRAF mutations in pediatric metanephric tumors VL - 46 ID - 5164 ER - TY - JOUR AD - Programa de Mestrado em Genética e Programa de Mestrado em Ciências Ambientais e Saúde, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil rcsilvaf@gmail.com. Programa de Mestrado em Genética e Programa de Mestrado em Ciências Ambientais e Saúde, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil. Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brasil. Hospital Araújo Jorge, Associação de Combate ao Câncer em Goiás, Goiânia, GO, Brasil. Departamento de Biologia, Universidade Estadual de Goiás, Morrinhos, GO, Brasil. AN - 26125698 AU - da Silva, R. C. AU - de Paula, H. S. AU - Leal, C. B. AU - Cunha, B. C. AU - de Paula, E. C. AU - Alencar, R. C. AU - Meneghini, A. J. AU - Silva, A. M. AU - Gontijo, A. P. AU - Wastowski, I. J. AU - Saddi, V. A. DA - May 12 DO - 10.4238/2015.May.12.9 10.4238/2015.May.12.9. DP - Nlm ET - 2015/07/01 IS - 2 LA - eng PY - 2015 SN - 1676-5680 SP - 5065-75 ST - BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas T2 - Genet Mol Res TI - BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas VL - 14 ID - 5165 ER - TY - JOUR AD - Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California. Brain Tumor Research Center, University of California, San Francisco, Helen-Diller Cancer Diller Cancer Research Center, San Francisco, California. Department of Neurology, University of California, San Francisco, San Francisco, California. Department of Pediatrics, University of California, San Francisco, San Francisco, California. Department of Neurological Surgery, University of California, San Francisco, San Francisco, California. Department of Neurological Surgery, Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Radiotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Brain Tumor Research Center, University of California, San Francisco, Helen-Diller Cancer Diller Cancer Research Center, San Francisco, California. dhaas-kogan@lroc.harvard.edu. Department of Radiation Oncology, Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. AN - 27217440 AU - Olow, A. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Meyerowitz, J. AU - Weiss, W. AU - Resnick, A. C. AU - Waanders, A. J. AU - Stalpers, L. J. AU - Berger, M. S. AU - Gupta, N. AU - James, C. D. AU - Petritsch, C. K. AU - Haas-Kogan, D. A. C2 - PMC5093033 C6 - NIHMS791672 to report. DA - Nov 1 DO - 10.1158/1078-0432.Ccr-15-1101 10.1158/1078-0432.CCR-15-1101. Epub 2016 May 23. DP - Nlm ET - 2016/11/03 IS - 21 LA - eng PY - 2016 SN - 1078-0432 (Print) 1078-0432 SP - 5312-5321 ST - BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas T2 - Clin Cancer Res TI - BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas VL - 22 ID - 5166 ER - TY - JOUR AD - Department of Pathology, Cork University Hospital, Cork, Ireland. Department of Medical Oncology, Cork University Hospital, Cork, Ireland. AN - 28424234 AU - O'Brien, O. AU - Lyons, T. AU - Murphy, S. AU - Feeley, L. AU - Power, D. AU - Heffron, Ccbb DA - Nov DO - 10.1136/jclinpath-2017-204367 10.1136/jclinpath-2017-204367. Epub 2017 Apr 19. DP - Nlm ET - 2017/04/21 IS - 11 LA - eng PY - 2017 SN - 0021-9746 SP - 935-940 ST - BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods T2 - J Clin Pathol TI - BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods VL - 70 ID - 5167 ER - TY - JOUR AD - Department of Pathology, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. tatsuno-m@ncchd.go.jp. Department of Children's Cancer Center, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Pathology, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Clinical Laboratory Medicine, National Center for Child Health and Development, PO Box 157-8535, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan. Department of Pathology, Tokai University School of Medicine, PO Box 259-1193, 143 Shimokasuya, Isehara-shi, Kanagawa, Japan. AN - 27094161 AU - Tatsuno, M. AU - Shioda, Y. AU - Iwafuchi, H. AU - Yamazaki, S. AU - Iijima, K. AU - Takahashi, C. AU - Ono, H. AU - Uchida, K. AU - Okamura, O. AU - Matubayashi, M. AU - Okuyama, T. AU - Matsumoto, K. AU - Yoshioka, T. AU - Nakazawa, A. C2 - PMC4837618 DA - Apr 19 DO - 10.1186/s13000-016-0489-z 10.1186/s13000-016-0489-z. DP - Nlm ET - 2016/04/21 LA - eng PY - 2016 SN - 1746-1596 SP - 39 ST - BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay T2 - Diagn Pathol TI - BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay VL - 11 ID - 5168 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. AN - 26075701 AU - Rodrigues, L. N. AU - Correa, G. B. AU - Diniz, M. G. AU - Galvão, C. F. AU - Gomes, C. C. AU - Gomez, R. S. DA - Sep DO - 10.1111/jop.12337 10.1111/jop.12337. Epub 2015 Jun 15. DP - Nlm ET - 2015/06/16 IS - 8 LA - eng PY - 2015 SN - 0904-2512 SP - 634-7 ST - BRAF V600E and loss of heterozygosity assessment in benign oralneural tumours T2 - J Oral Pathol Med TI - BRAF V600E and loss of heterozygosity assessment in benign oralneural tumours VL - 44 ID - 5169 ER - TY - JOUR AD - Boston University School of Medicine, Boston, MA, USA. AN - 19919630 AU - Nguyen, L. P. AU - Emley, A. AU - Wajapeyee, N. AU - Green, M. R. AU - Mahalingam, M. C2 - PMC2921125 C6 - HHMIMS221883 DA - Mar DO - 10.1111/j.1365-2133.2009.09558.x 10.1111/j.1365-2133.2009.09558.x. Epub 2009 Nov 16. DP - Nlm ET - 2009/11/19 IS - 3 LA - eng PY - 2010 SN - 0007-0963 (Print) 0007-0963 SP - 677-80 ST - BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi T2 - Br J Dermatol TI - BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi VL - 162 ID - 5170 ER - TY - JOUR AD - Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland. hanna.pelttari@kolumbus.fi AN - 22515292 AU - Pelttari, H. AU - Schalin-Jäntti, C. AU - Arola, J. AU - Löyttyniemi, E. AU - Knuutila, S. AU - Välimäki, M. J. DA - May DO - 10.1111/j.1600-0463.2011.02844.x 10.1111/j.1600-0463.2011.02844.x. Epub 2011 Nov 25. DP - Nlm ET - 2012/04/21 IS - 5 LA - eng PY - 2012 SN - 0903-4641 SP - 380-6 ST - BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients T2 - Apmis TI - BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients VL - 120 ID - 5171 ER - TY - JOUR AD - Department of Surgery, Haeundae Paik Hospital, Inje University College of Medicine, 1435 Jwa-dong, Haeundae-gu, Busan, 612-030, Korea. su.jin.kim.md@gmail.com AN - 22190222 AU - Kim, S. J. AU - Lee, K. E. AU - Myong, J. P. AU - Park, J. H. AU - Jeon, Y. K. AU - Min, H. S. AU - Park, S. Y. AU - Jung, K. C. AU - Koo do, H. AU - Youn, Y. K. DA - Feb DO - 10.1007/s00268-011-1383-1 10.1007/s00268-011-1383-1. DP - Nlm ET - 2011/12/23 IS - 2 LA - eng PY - 2012 SN - 0364-2313 SP - 310-7 ST - BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer T2 - World J Surg TI - BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer VL - 36 ID - 5172 ER - TY - JOUR AD - Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea. AN - 25346165 AU - Lee, D. AU - Cho, Y. H. AU - Kang, S. Y. AU - Yoon, N. AU - Sung, C. O. AU - Suh, Y. L. DA - Mar DO - 10.1002/jso.23822 10.1002/jso.23822. Epub 2014 Oct 24. DP - Nlm ET - 2014/10/28 IS - 3 LA - eng PY - 2015 SN - 0022-4790 SP - 359-64 ST - BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas T2 - J Surg Oncol TI - BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas VL - 111 ID - 5173 ER - TY - JOUR AD - Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21287, USA. Division of Pediatric Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. The Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. Center for Cancer and Blood Disorders, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, D.C. 20010, USA. AN - 32238401 AU - Obasaju, P. AU - Shahab, S. AU - Dunn, E. AU - Rhee, D. S. AU - Jiang, L. AU - Dome, J. S. AU - Friedman, A. D. AU - Argani, P. AU - Pratilas, C. A. C2 - PMC7133746 DA - Apr DO - 10.1101/mcs.a004820 10.1101/mcs.a004820. Print 2020 Apr. DP - Nlm ET - 2020/04/03 IS - 2 LA - eng PY - 2020 SN - 2373-2873 ST - BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition T2 - Cold Spring Harb Mol Case Stud TI - BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition VL - 6 ID - 5174 ER - TY - JOUR AD - Department of Pathology, Faculty of Medicine, Ege University, Izmir, Turkey. AN - 26630683 AU - Yaman, B. AU - Kandiloğlu, G. AU - Akalin, T. DA - Feb DO - 10.1097/dad.0000000000000404 10.1097/DAD.0000000000000404. DP - Nlm ET - 2015/12/03 IS - 2 LA - eng PY - 2016 SN - 0193-1091 SP - 113-20 ST - BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry T2 - Am J Dermatopathol TI - BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry VL - 38 ID - 5175 ER - TY - JOUR AD - Pathology Department Angers University Hospital Angers France. Genetics and Biochemistry Department Angers University Hospital Angers France. Pathology Department Angers University Hospital Angers France; INSERM UMR-1066, Micro- and Nanomedicine Biomimetics (MINT) Angers University Hospital Angers France. INSERM UMR-1066, Micro- and Nanomedicine Biomimetics (MINT) Angers University Hospital Angers France; Neurosurgery Department Angers University Hospital Angers France. AN - 28293477 AU - Breton, Q. AU - Plouhinec, H. AU - Prunier-Mirebeau, D. AU - Boisselier, B. AU - Michalak, S. AU - Menei, P. AU - Rousseau, A. C2 - PMC5346524 DA - Mar DO - 10.1002/brb3.641 10.1002/brb3.641. eCollection 2017 Mar. DP - Nlm ET - 2017/03/16 IS - 3 LA - eng PY - 2017 SP - e00641 ST - BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors T2 - Brain Behav TI - BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors VL - 7 ID - 5176 ER - TY - JOUR AD - D. Zinn, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States AU - Zinn, D. AU - Picarsic, J. AU - Chakraborty, R. AU - Lin, H. AU - Abhyankar, H. AU - Scull, B. AU - Shih, A. AU - Lim, K. P. H. AU - Eckstein, O. S. AU - Peters, T. L. AU - Olea, W. AU - Burke, T. AU - Ahmed, N. AU - Hicks, J. AU - Tran, B. AU - Jones, J. AU - Dauser, R. AU - Jeng, M. R. AU - Baiocchi, R. A. AU - Schiff, D. E. AU - Goldman, S. AU - Heym, K. M. AU - Wilson, H. AU - Carcamo, B. AU - Kumar, A. AU - Rodriguez-Galindo, C. AU - Whipple, N. AU - Campbell, P. AU - Murdoch, G. AU - Heales, S. AU - Malone, M. AU - Woltjer, R. AU - Quinn, J. AU - Orchard, P. AU - Kruer, M. AU - Jaffe, R. AU - Manz, M. G. AU - Lira, S. AU - Parsons, D. W. AU - Merad, M. AU - Man, T. K. AU - McClain, K. L. AU - Allen, C. E. DB - Embase LA - English M3 - Conference Abstract N1 - L620334442 2018-01-30 PY - 2017 SN - 1528-0020 ST - BRAF-V600E in peripheral mononuclear cells and microglia-like brain cells suggest hematopoietic origin of langerhans cell histiocytosis-associated neurodegeneration T2 - Blood TI - BRAF-V600E in peripheral mononuclear cells and microglia-like brain cells suggest hematopoietic origin of langerhans cell histiocytosis-associated neurodegeneration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334442&from=export VL - 130 ID - 5177 ER - TY - JOUR AD - Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Department of Ophthalmology, Weill-Cornell Medical Center, New York, New York, United States. Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, United States. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. Department of Pathology, Weill-Cornell Medical Center, New York, New York, United States. AN - 29332123 AU - Francis, J. H. AU - Grossniklaus, H. E. AU - Habib, L. A. AU - Marr, B. AU - Abramson, D. H. AU - Busam, K. J. C2 - PMC6110167 DA - Jan 1 DO - 10.1167/iovs.17-22517 10.1167/iovs.17-22517. DP - Nlm ET - 2018/01/15 IS - 1 LA - eng PY - 2018 SN - 0146-0404 (Print) 0146-0404 SP - 117-121 ST - BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi T2 - Invest Ophthalmol Vis Sci TI - BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi VL - 59 ID - 5178 ER - TY - JOUR AD - Department of Endocrinology, Acibadem Maslak Hospital, Buyukdere Cad. No: 40, Maslak, Istanbul, Turkey. neslihandr@hotmail.com AN - 22426956 AU - Kurtulmus, N. AU - Duren, M. AU - Ince, U. AU - Cengiz Yakicier, M. AU - Peker, O. AU - Aydın, O. AU - Altiok, E. AU - Giray, S. AU - Azizlerli, H. DA - Oct DO - 10.1007/s12020-012-9651-x 10.1007/s12020-012-9651-x. Epub 2012 Mar 17. DP - Nlm ET - 2012/03/20 IS - 2 LA - eng PY - 2012 SN - 1355-008x SP - 404-10 ST - BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness T2 - Endocrine TI - BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness VL - 42 ID - 5179 ER - TY - JOUR AD - From the Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands (IV, KvdH, CMHAS, GMJMR, AzH, E-JMS, VJLW); GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands (KvdH, AzH, E-JMS, VJLW); Department of Clinical Pathology, Atrium Medical Centre Parkstad, Heerlen, The Netherlands (RC); Department of Pathology, St. Laurentius ziekenhuis, Roermond, The Netherlands (APW); and Laboratory of Translational Cell & Tissue Research and Department of Pathology, University Hospital, KULeuven, Leuven, Belgium (JJvdO). AN - 25526463 AU - Verlinden, I. AU - van den Hurk, K. AU - Clarijs, R. AU - Willig, A. P. AU - Stallinga, C. M. AU - Roemen, G. M. AU - van den Oord, J. J. AU - zur Hausen, A. AU - Speel, E. J. AU - Winnepenninckx, V. J. C2 - PMC4603111 DA - Dec DO - 10.1097/md.0000000000000285 10.1097/MD.0000000000000285. DP - Nlm ET - 2014/12/20 IS - 28 LA - eng PY - 2014 SN - 0025-7974 (Print) 0025-7974 SP - e285 ST - BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article T2 - Medicine (Baltimore) TI - BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article VL - 93 ID - 5180 ER - TY - JOUR AD - Dipartimento di Medicina Interna e Specialità Mediche, Università di Roma 'Sapienza', V.le del Policlinico, 155, 00161 Roma, Italy Dipartimento di Ematologia e Scienze Oncologiche 'L. e A. Seragnoli', Università di Bologna, 40139 Bologna, Italy Dipartimento di Medicina Interna, Università di Perugia, 06126 Perugia, Italy Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università di Perugia, 06126 Perugia, Italy U.O. Genetica Medica, Dipartimento di Scienze Ginecologiche Ostetriche e Pediatriche, Università di Bologna, 40139 Bologna, Italy Dipartimento di Scienze Chirurgiche, Università di Roma 'Sapienza', 00161 Roma, Italy Dipartimento di Scienze Farmacobiologiche, Università di Catanzaro 'Magna Graecia', 88100 Catanzaro, Italy AU - Durante, C. AU - Tallini, G. AU - Puxeddu, E. AU - Sponziello, M. AU - Moretti, S. AU - Ligorio, C. AU - Cavaliere, A. AU - Rhoden, K. J. AU - Verrienti, A. AU - Maranghi, M. AU - Giacomelli, L. AU - Russo, D. AU - Filetti, S. DB - Scopus DO - 10.1530/EJE-11-0283 IS - 3 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2011 SP - 455-463 ST - BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas T2 - European Journal of Endocrinology TI - BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051706001&doi=10.1530%2fEJE-11-0283&partnerID=40&md5=73306346f84df9bd4f7d8065fe93a5b7 VL - 165 ID - 5181 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. School of Dentistry, Universidade Federal do Ceará-UFC, Ceará, Brazil. Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, Brazil. rsgomez@ufmg.br. AN - 27084044 AU - Pereira, N. B. AU - Pereira, K. M. AU - Coura, B. P. AU - Diniz, M. G. AU - de Castro, W. H. AU - Gomes, C. C. AU - Gomez, R. S. DA - Nov DO - 10.1111/jop.12443 10.1111/jop.12443. Epub 2016 Apr 15. DP - Nlm ET - 2016/10/27 IS - 10 LA - eng PY - 2016 SN - 0904-2512 SP - 780-785 ST - BRAFV600E mutation in the diagnosis of unicystic ameloblastoma T2 - J Oral Pathol Med TI - BRAFV600E mutation in the diagnosis of unicystic ameloblastoma VL - 45 ID - 5182 ER - TY - JOUR AD - Department of Radiology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. AN - 22964613 AU - Kwak, J. Y. AU - Han, K. H. AU - Yoon, J. H. AU - Kim, E. K. AU - Moon, H. J. AU - Kim, Y. L. AU - Park, S. J. AU - Choi, J. R. DA - Summer DP - Nlm ET - 2012/09/12 IS - 3 LA - eng N1 - 1550-8080 Kwak, Jin Young Han, Kyung Hwa Yoon, Jung Hyun Kim, Eun-Kyung Moon, Hee Jung Kim, Yoo-Li Park, Seo-Jin Choi, Jong Rak Journal Article Research Support, Non-U.S. Gov't United States Ann Clin Lab Sci. 2012 Summer;42(3):258-65. PY - 2012 SN - 0091-7370 SP - 258-65 ST - BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR T2 - Ann Clin Lab Sci TI - BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR VL - 42 ID - 5183 ER - TY - JOUR AD - K. Kudo AU - Kudo, K. AU - Kanezaki, R. AU - Kobayashi, A. AU - Sato, T. AU - Kamio, T. AU - Sasaki, S. AU - Masaru, I. AU - Imai, C. AU - Irie, M. AU - Sasahara, Y. AU - Ando, K. AU - Kakuda, H. AU - Doi, T. AU - Kawaguchi, H. AU - Kudo, K. AU - Kanegane, H. AU - Terui, K. AU - Toki, T. AU - Ito, E. DB - Embase DO - 10.1182/blood-2019-127536 LA - English M3 - Conference Abstract N1 - L630318538 2019-12-31 PY - 2019 SN - 1528-0020 ST - Brafv600e-positive precursors as molecular markers of bone marrow involvement in pediatric langerhans cell histiocytosis T2 - Blood TI - Brafv600e-positive precursors as molecular markers of bone marrow involvement in pediatric langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630318538&from=exporthttp://dx.doi.org/10.1182/blood-2019-127536 VL - 134 ID - 5184 ER - TY - JOUR AD - Department of Medical Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France Department of Surgical Oncology, Gustave Roussy Cancer Campus, Villejuif, France Department of Medical Oncology, Pitie-Salpêtrière Hospital, Paris, France Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France Department of Pathology, Institut Bergonié, Bordeaux, France Department of Adult Medical Oncology, Centre Leon Berard, Lyon, France Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM 1136, Paris, France AU - Malouf, G. G. AU - Beinse, G. AU - Adam, J. AU - Mir, O. AU - Chamseddine, A. N. AU - Terrier, P. AU - Honore, C. AU - Spano, J. P. AU - Italiano, A. AU - Kurtz, J. E. AU - Coindre, J. M. AU - Blay, J. Y. AU - Le Cesne, A. DB - Scopus DO - 10.1634/theoncologist.2018-0074 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 980-988 ST - Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group T2 - Oncologist TI - Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059681769&doi=10.1634%2ftheoncologist.2018-0074&partnerID=40&md5=59d8925a7be6003e8a1ccba1971d7ff0 VL - 24 ID - 5185 ER - TY - JOUR AD - Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Center for Molecular Oncologic Pathology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Program in Molecular Pharmacology, Department of Medicine, and Center for Mechanism Based Therapeutics Memorial Sloan Kettering Cancer Center, New York, USA. Division of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, USA. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. Departments of Neurosurgery and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. AN - 28082416 AU - Sun, Y. AU - Alberta, J. A. AU - Pilarz, C. AU - Calligaris, D. AU - Chadwick, E. J. AU - Ramkissoon, S. H. AU - Ramkissoon, L. A. AU - Garcia, V. M. AU - Mazzola, E. AU - Goumnerova, L. AU - Kane, M. AU - Yao, Z. AU - Kieran, M. W. AU - Ligon, K. L. AU - Hahn, W. C. AU - Garraway, L. A. AU - Rosen, N. AU - Gray, N. S. AU - Agar, N. Y. AU - Buhrlage, S. J. AU - Segal, R. A. AU - Stiles, C. D. C2 - PMC5464455 DA - Jun 1 DO - 10.1093/neuonc/now261 10.1093/neuonc/now261. DP - Nlm ET - 2017/01/14 IS - 6 LA - eng PY - 2017 SN - 1522-8517 (Print) 1522-8517 SP - 774-785 ST - A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas T2 - Neuro Oncol TI - A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas VL - 19 ID - 5186 ER - TY - JOUR AD - University of Colorado Denver, Denver, CO, USA. srush@chmca.org AN - 23358987 AU - Rush, S. AU - Foreman, N. AU - Liu, A. DA - Apr 1 DO - 10.1200/jco.2012.44.1568 10.1200/JCO.2012.44.1568. Epub 2013 Jan 28. DP - Nlm ET - 2013/01/30 IS - 10 LA - eng PY - 2013 SN - 0732-183x SP - e159-60 ST - Brainstem ganglioglioma successfully treated with vemurafenib T2 - J Clin Oncol TI - Brainstem ganglioglioma successfully treated with vemurafenib VL - 31 ID - 5187 ER - TY - JOUR AD - Inserm, U900, Paris, France ; Institut Curie, Centre de Recherche, Paris, France ; Mines ParisTech, Fontainebleau, France. AN - 23991058 AU - Boeva, V. AU - Jouannet, S. AU - Daveau, R. AU - Combaret, V. AU - Pierre-Eugène, C. AU - Cazes, A. AU - Louis-Brennetot, C. AU - Schleiermacher, G. AU - Ferrand, S. AU - Pierron, G. AU - Lermine, A. AU - Rio Frio, T. AU - Raynal, V. AU - Vassal, G. AU - Barillot, E. AU - Delattre, O. AU - Janoueix-Lerosey, I. C2 - PMC3753337 DO - 10.1371/journal.pone.0072182 10.1371/journal.pone.0072182. eCollection 2013. DP - Nlm ET - 2013/08/31 IS - 8 LA - eng PY - 2013 SN - 1932-6203 SP - e72182 ST - Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis T2 - PLoS One TI - Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis VL - 8 ID - 5188 ER - TY - JOUR AD - National Research Center for Hematology, Moscow, Russian Federation Center of Pharmaceutical Analytics Ltd, Moscow, Russian Federation FSBI National Research Center of Obstetrics, Gynecology and Perinatology of the Healthcare Ministry named after V.I. Kulakov, Moscow, Russian Federation FSBI N.D. Zelinsky Institute of Organic Chemistry of Russian Academy of Sciences, Moscow, Russian Federation AU - Chelysheva, E. AU - Aleshin, S. AU - Polushkina, E. AU - Shmakov, R. AU - Shokhin, I. AU - Chilov, G. AU - Turkina, A. C7 - e2018027 DB - Scopus DO - 10.4084/MJHID.2018.027 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 ST - Breastfeeding in patients with chronic myeloid leukaemia: Case series with measurements of drug concentrations in maternal milk and literature review T2 - Mediterranean Journal of Hematology and Infectious Diseases TI - Breastfeeding in patients with chronic myeloid leukaemia: Case series with measurements of drug concentrations in maternal milk and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049244121&doi=10.4084%2fMJHID.2018.027&partnerID=40&md5=42090cd56e6004f4e52a3810d55807ae VL - 10 ID - 5189 ER - TY - JOUR AD - N.L. Bartlett, Division of Oncology, School of Medicine, Washington University, 660 South Euclid Ave, St Louis, MO 63110, United States AU - Foyil, K. V. AU - Bartlett, N. L. C1 - adcetris(Seattle Genetics,United States) pf 02341066(Pfizer,United States) sgn 35(Seattle Genetics,United States) xalkori(Pfizer,United States) C2 - Pfizer(United States) Seattle Genetics(United States) DB - Embase Medline DO - 10.1097/PPO.0b013e31826aef4a IS - 5 LA - English M3 - Review N1 - L365749842 2012-10-09 2012-10-15 PY - 2012 SN - 1528-9117 1540-336X SP - 450-456 ST - Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma T2 - Cancer Journal (United States) TI - Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365749842&from=exporthttp://dx.doi.org/10.1097/PPO.0b013e31826aef4a VL - 18 ID - 5190 ER - TY - JOUR AD - F. Locatelli, Department of Pediatric Haematology and Oncology IRCCS, Ospedale Pediatrico Bambino Gesú, Rome, Italy AU - Locatelli, F. AU - Mauz-Koerholz, C. AU - Neville, K. AU - Llort, A. AU - Beishuizen, A. AU - Daw, S. AU - Pillon, M. AU - Aladjidi, N. AU - Klingebiel, T. AU - Landman-Parker, J. AU - Medina-Sanson, A. AU - August, K. AU - Sachs, J. AU - Hoffman, K. AU - Kinley, J. AU - Song, S. AU - Song, G. AU - Zhang, S. AU - Suri, A. AU - Gore, L. DB - Embase Medline DO - 10.1016/S2352-3026(18)30153-4 IS - 10 LA - English M3 - Article N1 - L2001149306 2018-10-08 2018-10-11 PY - 2018 SN - 2352-3026 SP - e450-e461 ST - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study T2 - The Lancet Haematology TI - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001149306&from=exporthttp://dx.doi.org/10.1016/S2352-3026(18)30153-4 VL - 5 ID - 5191 ER - TY - JOUR AD - Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO. AN - 28475456 AU - Kim, D. W. AU - Tiseo, M. AU - Ahn, M. J. AU - Reckamp, K. L. AU - Hansen, K. H. AU - Kim, S. W. AU - Huber, R. M. AU - West, H. L. AU - Groen, H. J. M. AU - Hochmair, M. J. AU - Leighl, N. B. AU - Gettinger, S. N. AU - Langer, C. J. AU - Paz-Ares Rodríguez, L. G. AU - Smit, E. F. AU - Kim, E. S. AU - Reichmann, W. AU - Haluska, F. G. AU - Kerstein, D. AU - Camidge, D. R. DA - Aug 1 DO - 10.1200/jco.2016.71.5904 10.1200/JCO.2016.71.5904. Epub 2017 May 5. DP - Nlm ET - 2017/05/06 IS - 22 LA - eng PY - 2017 SN - 0732-183x SP - 2490-2498 ST - Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial T2 - J Clin Oncol TI - Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial VL - 35 ID - 5192 ER - TY - JOUR AD - Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. Department of Pediatric Hematology and Oncology, Children's Teaching Hospital and St. Elizabeth University, Bratislava, Slovakia. Memorial Sloan Kettering Cancer Center, New York, New York. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Roche Innovation Center, New York, New York. Roche Products Limited, Welwyn Garden City, UK. Genentech, South San Francisco, California. AN - 29350463 AU - Chisholm, J. C. AU - Suvada, J. AU - Dunkel, I. J. AU - Casanova, M. AU - Zhang, W. AU - Ritchie, N. AU - Choi, Y. AU - Park, J. AU - Das Thakur, M. AU - Simko, S. AU - Wan Rachel Tam, N. AU - Ferrari, A. C2 - PMC5867229 C6 - NIHMS928012 DA - May DO - 10.1002/pbc.26947 10.1002/pbc.26947. Epub 2018 Jan 19. DP - Nlm ET - 2018/01/20 IS - 5 LA - eng PY - 2018 SN - 1545-5009 (Print) 1545-5009 SP - e26947 ST - BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma T2 - Pediatr Blood Cancer TI - BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma VL - 65 ID - 5193 ER - TY - JOUR AD - N. Finelt, Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, NY, United States AU - Finelt, N. AU - Lulla, R. R. AU - Melin-Aldana, H. AU - Ruth, J. S. AU - Lin, F. Y. AU - Su, J. M. AU - Pourciau, C. Y. AU - Hunt, R. D. AU - Kenner-Bell, B. M. DB - Embase Medline DO - 10.1111/pde.13148 IS - 3 LA - English M3 - Article N1 - L616403078 2017-05-30 2017-06-01 PY - 2017 SN - 1525-1470 0736-8046 SP - 337-341 ST - Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib T2 - Pediatric Dermatology TI - Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616403078&from=exporthttp://dx.doi.org/10.1111/pde.13148 VL - 34 ID - 5194 ER - TY - JOUR AD - Department of Internal Medicine, Hematology Division, University Medical School of Patras, Patras, Greece. lagadin@med.upatras.gr AN - 18650843 AU - Lagadinou, E. D. AU - Ziros, P. G. AU - Tsopra, O. A. AU - Dimas, K. AU - Kokkinou, D. AU - Thanopoulou, E. AU - Karakantza, M. AU - Pantazis, P. AU - Spyridonidis, A. AU - Zoumbos, N. C. DA - Oct DO - 10.1038/leu.2008.192 10.1038/leu.2008.192. Epub 2008 Jul 24. DP - Nlm ET - 2008/07/25 IS - 10 LA - eng PY - 2008 SN - 0887-6924 SP - 1899-908 ST - c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia T2 - Leukemia TI - c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia VL - 22 ID - 5195 ER - TY - JOUR AD - T. Herdegen, Institute of Pharmacology, University Hospital Kiel, Hospitalstrasse 4, 24105 Kiel, Germany AU - Waetzig, V. AU - Czeloth, K. AU - Hidding, U. AU - Mielke, K. AU - Kanzow, M. AU - Brecht, S. AU - Goetz, M. AU - Lucius, R. AU - Herdegen, T. AU - Hanisch, U. R. DB - Embase Medline DO - 10.1002/glia.20173 IS - 3 LA - English M3 - Article N1 - L40769853 2005-06-15 PY - 2005 SN - 0894-1491 SP - 235-246 ST - c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia T2 - GLIA TI - c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40769853&from=exporthttp://dx.doi.org/10.1002/glia.20173 VL - 50 ID - 5196 ER - TY - JOUR AD - Bambino Gesu Children's Hospital, Laboratory of Oncology, Rome, Italy ENEA Research Center Casaccia, Sect. of Toxicol./Biomed. Sciences, Rome, Italy Biotechnology Institute, CNR, Rome, Italy RLC NHS Trust Alder Hey, Liverpool, United Kingdom Bambino Gesu Children's Hospital, Division of Oncology, Rome, Italy La Sapienza University, Department of Pediatrics, Rome, Italy Regina Elena Natl. Cancer Institute, Laboratory of Immunology, Rome, Italy Department of Pediatrics, Viale Regina Elena 324, I-00161 Rome, Italy AU - Vitali, R. AU - Cesi, V. AU - Nicotra, M. R. AU - McDowell, H. P. AU - Donfrancesco, A. AU - Mannarino, O. AU - Natali, P. G. AU - Raschellà, G. AU - Dominici, C. DB - Scopus DO - 10.1002/ijc.11187 IS - 2 M3 - Article N1 - Cited By :71 Export Date: 18 November 2020 PY - 2003 SP - 147-152 ST - c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 T2 - International Journal of Cancer TI - c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037479907&doi=10.1002%2fijc.11187&partnerID=40&md5=7f9d9e07f2f706fa013ef11fbf0d10e4 VL - 106 ID - 5197 ER - TY - JOUR AD - H.-K. Yi, Department of Oral Biochemistry, School of Dentistry, Chonbuk National University, 664-14, Dukjin-dong, Deokjin-ku, Jeonju, Jeonbuk, 561-712, South Korea AU - Bhattarai, G. AU - Lee, Y. H. AU - Lee, N. H. AU - Yun, J. S. AU - Hwang, P. H. AU - Yi, H. K. DB - Embase Medline DO - 10.1002/cbf.1808 IS - 8 LA - English M3 - Article N1 - L51654837 2011-10-10 2011-12-16 PY - 2011 SN - 0263-6484 1099-0844 SP - 686-693 ST - c-myb mediates inflammatory reaction against oxidative stress in human breast cancer cell line, MCF-7 T2 - Cell Biochemistry and Function TI - c-myb mediates inflammatory reaction against oxidative stress in human breast cancer cell line, MCF-7 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51654837&from=exporthttp://dx.doi.org/10.1002/cbf.1808 VL - 29 ID - 5198 ER - TY - JOUR AD - P. Hu, Department of Pediatrics, First Affiliated Hospital, Anhui Medical University, No. 218 Ji-Xi Road, Hefei, China AU - Wu, Y. F. AU - Zhang, D. D. AU - Liu, S. Y. AU - Luo, H. H. AU - Jiang, G. M. AU - Xu, Y. AU - Wu, Y. AU - Wang, J. J. AU - Liu, F. F. AU - Samadli, S. AU - Wei, W. AU - Hu, B. AU - Hu, P. DB - Embase Medline DO - 10.1089/jir.2018.0051 IS - 11 LA - English M3 - Article N1 - L625122398 2018-11-28 2018-12-04 PY - 2018 SN - 1557-7465 1079-9907 SP - 500-509 ST - C-type natriuretic peptide dampens fibroblast growth factor-23 expression through MAPK signaling pathway in human mesangial cells T2 - Journal of Interferon and Cytokine Research TI - C-type natriuretic peptide dampens fibroblast growth factor-23 expression through MAPK signaling pathway in human mesangial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625122398&from=exporthttp://dx.doi.org/10.1089/jir.2018.0051 VL - 38 ID - 5199 ER - TY - JOUR AD - Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan. Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan. Departments of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan. AN - 26816265 AU - Zenitani, M. AU - Nojiri, T. AU - Uehara, S. AU - Miura, K. AU - Hosoda, H. AU - Kimura, T. AU - Nakahata, K. AU - Miyazato, M. AU - Okuyama, H. AU - Kangawa, K. C2 - PMC4864809 DA - May DO - 10.1002/cam4.642 10.1002/cam4.642. Epub 2016 Jan 26. DP - Nlm ET - 2016/01/28 IS - 5 LA - eng PY - 2016 SN - 2045-7634 SP - 795-805 ST - C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells T2 - Cancer Med TI - C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells VL - 5 ID - 5200 ER - TY - JOUR AD - Y. Liu, Department of Pediatrics, Tongji Hospital Affiliated, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Liu, Y. AU - Xu, S. Q. AU - Long, W. J. AU - Zhang, X. Y. AU - Lu, H. L. DB - Embase Medline DO - 10.26355/eurrev-201811-16428 IS - 22 LA - English M3 - Article N1 - L625358192 2018-12-11 2018-12-18 PY - 2018 SN - 2284-0729 1128-3602 SP - 7994-8003 ST - C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway T2 - European Review for Medical and Pharmacological Sciences TI - C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625358192&from=exporthttp://dx.doi.org/10.26355/eurrev-201811-16428 VL - 22 ID - 5201 ER - TY - JOUR AD - Pediatric Residency Program, Nationwide Children's Hospital, Columbus, OH, United States Department of Pharmacy, Nationwide Children's Hospital, Columbus, OH, United States Division of Hematology/Oncology/Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, United States Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States AU - Perisa, M. P. AU - Storey, M. AU - Streby, K. A. AU - Ranalli, M. A. AU - Skeens, M. AU - Shah, N. C7 - e28317 DB - Scopus DO - 10.1002/pbc.28317 IS - 7 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Cabozantinib for relapsed neuroblastoma: Single institution case series T2 - Pediatric Blood and Cancer TI - Cabozantinib for relapsed neuroblastoma: Single institution case series UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084235800&doi=10.1002%2fpbc.28317&partnerID=40&md5=48f5686268b00998824dbe99ef464484 VL - 67 ID - 5202 ER - TY - JOUR AD - U. Demirsoy, Kocaeli Üniversitesi Tip Fakültesi Çocuk Onkoloji Bölümü, Turkey AU - Demirsoy, U. AU - Demirsoy, E. O. DB - Embase IS - 2 LA - English M3 - Conference Abstract N1 - L631449885 2020-04-20 PY - 2020 SN - 2147-2092 SP - P50 ST - Cafe-au-lait spots and hypopigmented macules: constitutional mismatch repair deficiency syndrome T2 - Gazi Medical Journal TI - Cafe-au-lait spots and hypopigmented macules: constitutional mismatch repair deficiency syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631449885&from=export VL - 31 ID - 5203 ER - TY - JOUR AD - C.D.M. Fletcher, FRCPath, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Nascimento, A. F. AU - Ruiz, R. AU - Hornick, J. L. AU - Fletcher, C. D. M. DB - Embase Medline DO - 10.1177/106689690201000304 IS - 3 LA - English M3 - Article N1 - L34988513 2002-09-19 PY - 2002 SN - 1066-8969 SP - 189-196 ST - Calcifying fibrous 'pseudotumor': Clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor T2 - International Journal of Surgical Pathology TI - Calcifying fibrous 'pseudotumor': Clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34988513&from=exporthttp://dx.doi.org/10.1177/106689690201000304 VL - 10 ID - 5204 ER - TY - JOUR AD - Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu and Fundació Sant Joan de Déu, Barcelona, Spain. AN - 23108190 AU - Casalà, C. AU - Gil-Guiñón, E. AU - Ordóñez, J. L. AU - Miguel-Queralt, S. AU - Rodríguez, E. AU - Galván, P. AU - Lavarino, C. AU - Munell, F. AU - de Alava, E. AU - Mora, J. AU - de Torres, C. DA - Feb DO - 10.1093/carcin/bgs338 10.1093/carcin/bgs338. Epub 2012 Oct 29. DP - Nlm ET - 2012/10/31 IS - 2 LA - eng PY - 2013 SN - 0143-3334 SP - 268-76 ST - The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis T2 - Carcinogenesis TI - The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis VL - 34 ID - 5205 ER - TY - JOUR AD - T.-J. Lin, Department of Pediatrics, IWK Health Centre, Dalhousie University, 5850 University Avenue, Halifax, NS B3K 6R8, Canada AU - Wu, Z. AU - Chen, X. AU - Liu, F. AU - Chen, W. AU - Wu, P. AU - Wieschhaus, A. J. AU - Chishti, A. H. AU - Roche, P. A. AU - Chen, W. M. AU - Lin, T. J. DB - Embase Medline DO - 10.4049/jimmunol.1301677 IS - 11 LA - English M3 - Article N1 - L373143306 2014-06-02 2014-06-12 PY - 2014 SN - 1550-6606 0022-1767 SP - 5130-5139 ST - Calpain-1 contributes to IgE-mediated mast cell activation T2 - Journal of Immunology TI - Calpain-1 contributes to IgE-mediated mast cell activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373143306&from=exporthttp://dx.doi.org/10.4049/jimmunol.1301677 VL - 192 ID - 5206 ER - TY - JOUR AD - Department of Cellular Biotechologies and Haematology, Sapienza University, Rome, Italy GIMEMA Foundation, Rome, Italy Department of Clinical and Biological Sciences, University of Turin at Orbassano, Turin, Italy AU - Giona, F. AU - Moleti, M. L. AU - De Benedittis, D. AU - Santopietro, M. AU - Nanni, M. AU - Testi, A. M. AU - Orlando, S. AU - Iori, A. P. AU - Piciocchi, A. AU - Gottardi, E. AU - Barberi, W. AU - Diverio, D. AU - Saglio, G. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.13991 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 SP - 749-753 ST - Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience T2 - British Journal of Haematology TI - Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959432482&doi=10.1111%2fbjh.13991&partnerID=40&md5=1dc345efaac5fcd6cf6d2a22dfeda7ca VL - 173 ID - 5207 ER - TY - JOUR AD - B.S. Cetin, Department of Pediatrics, Dokuz Eylul University, Izmir, Turkey AU - Cetin, B. S. AU - Yesilirmak, D. AU - Tuzun, F. AU - Kumral, A. AU - Duman, N. AU - Ozkan, H. DB - Embase Medline DO - 10.1016/j.mehy.2009.01.011 IS - 6 LA - English M3 - Letter N1 - L50440712 2009-04-10 PY - 2009 SN - 0306-9877 SP - 757-758 ST - Can curry protect the brain from bilirubin toxicity? T2 - Medical Hypotheses TI - Can curry protect the brain from bilirubin toxicity? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50440712&from=exporthttp://dx.doi.org/10.1016/j.mehy.2009.01.011 VL - 72 ID - 5208 ER - TY - JOUR AD - INSERM ERI-21/EA4319, University of Nice Sophia Antipolis, 06107 Nice, France. AN - 21778212 AU - Lassalle, S. AU - Hofman, V. AU - Ilie, M. AU - Bonnetaud, C. AU - Puisségur, M. P. AU - Brest, P. AU - Loubatier, C. AU - Guevara, N. AU - Bordone, O. AU - Cardinaud, B. AU - Lebrigand, K. AU - Rios, G. AU - Santini, J. AU - Franc, B. AU - Mari, B. AU - Al Ghuzlan, A. AU - Vielh, P. AU - Barbry, P. AU - Hofman, P. DA - Oct DO - 10.1530/erc-10-0283 10.1530/ERC-10-0283. Print 2011 Oct. DP - Nlm ET - 2011/07/23 IS - 5 LA - eng PY - 2011 SN - 1351-0088 SP - 579-94 ST - Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? T2 - Endocr Relat Cancer TI - Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? VL - 18 ID - 5209 ER - TY - JOUR AD - University of Calgary, Alberta Health Services, Calgary, Alberta, Canada University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada CHU de Québec Research Center, Faculty of Medicine, Laval University, Québec City, Quebec, Canada Department of Oncology, McMaster University, Hamilton, Ontario, Canada Department of Medicine, McMaster University, Hamilton, Ontario, Canada Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada Leukemia/BMT Program of British Columbia, Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada AU - Savoie, M. L. AU - Bence-Bruckler, I. AU - Huebsch, L. B. AU - Lalancette, M. AU - Hillis, C. AU - Walker, I. AU - Lipton, J. H. AU - Forrest, D. L. AU - Kim, D. D. H. DB - Scopus DO - 10.1016/j.leukres.2018.08.021 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 67-75 ST - Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era T2 - Leukemia Research TI - Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053318650&doi=10.1016%2fj.leukres.2018.08.021&partnerID=40&md5=2ce1fc5d39f7cdb8ab0a4ea44112deb8 VL - 73 ID - 5210 ER - TY - JOUR AD - C.P. Kratz, Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Carl-Neuberg-Str. 1, Hannover, Germany AU - Kratz, C. P. AU - Franke, L. AU - Peters, H. AU - Kohlschmidt, N. AU - Kazmierczak, B. AU - Finckh, U. AU - Bier, A. AU - Eichhorn, B. AU - Blank, C. AU - Kraus, C. AU - Kohlhase, J. AU - Pauli, S. AU - Wildhardt, G. AU - Kutsche, K. AU - Auber, B. AU - Christmann, A. AU - Bachmann, N. AU - Mitter, D. AU - Cremer, F. W. AU - Mayer, K. AU - Daumer-Haas, C. AU - Nevinny-Stickel-Hinzpeter, C. AU - Oeffner, F. AU - Schlüter, G. AU - Gencik, M. AU - Überlacker, B. AU - Lissewski, C. AU - Schanze, I. AU - Greene, M. H. AU - Spix, C. AU - Zenker, M. DB - Embase Medline DO - 10.1038/bjc.2015.75 IS - 8 LA - English M3 - Article N1 - L602856158 2015-03-17 2015-05-12 PY - 2015 SN - 1532-1827 0007-0920 SP - 1392-1397 ST - Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes T2 - British Journal of Cancer TI - Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602856158&from=exporthttp://dx.doi.org/10.1038/bjc.2015.75 VL - 112 ID - 5211 ER - TY - JOUR AD - Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States Strategic Director, Surveillance Information, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States Director, Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, United States Branch Chief, Surveillance Research Program, National Cancer Institute, Bethesda, MD, United States Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States Director, Office of Cancer Survivorship, National Cancer Institute, Bethesda, MD, United States Vice President, Behavioral Research Center, American Cancer Society, Atlanta, GA, United States Medical Editor, American Cancer Society, Atlanta, GA, United States Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, United States AU - Miller, K. D. AU - Siegel, R. L. AU - Lin, C. C. AU - Mariotto, A. B. AU - Kramer, J. L. AU - Rowland, J. H. AU - Stein, K. D. AU - Alteri, R. AU - Jemal, A. DB - Scopus DO - 10.3322/caac.21349 IS - 4 M3 - Article N1 - Cited By :2674 Export Date: 18 November 2020 PY - 2016 SP - 271-289 ST - Cancer treatment and survivorship statistics, 2016 T2 - CA Cancer Journal for Clinicians TI - Cancer treatment and survivorship statistics, 2016 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973649618&doi=10.3322%2fcaac.21349&partnerID=40&md5=e98b7b1aa4f32d60b25a54e21847c835 VL - 66 ID - 5212 ER - TY - JOUR AD - C. Zou, Department of Laboratory, Weihaiwei People’s Hospital, No. 70 Qingdao North Road, Weihai, Shandong, China AU - Sun, Y. AU - Fan, X. AU - Zhang, Q. AU - Shi, X. AU - Xu, G. AU - Zou, C. DB - Embase Medline DO - 10.1177/1010428317712592 IS - 7 LA - English M3 - Article N1 - L617650547 2017-08-15 2017-08-16 PY - 2017 SN - 1423-0380 1010-4283 SP - 1-10 ST - Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling T2 - Tumor Biology TI - Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617650547&from=exporthttp://dx.doi.org/10.1177/1010428317712592 VL - 39 ID - 5213 ER - TY - JOUR AD - A. Gácser, Department of Microbiology, University of Szeged Interdisciplinary Excellence Centre, Szeged, Hungary AU - Tóth, R. AU - Nosek, J. AU - Mora-Montes, H. M. AU - Gabaldon, T. AU - Bliss, J. M. AU - Nosanchuk, J. D. AU - Turner, S. A. AU - Butler, G. AU - Vágvölgyi, C. AU - Gácser, A. DB - Embase Medline DO - 10.1128/CMR.00111-18 IS - 2 LA - English M3 - Review N1 - L2001743919 2019-04-17 PY - 2019 SN - 1098-6618 0893-8512 ST - Candida parapsilosis: From genes to the bedside T2 - Clinical Microbiology Reviews TI - Candida parapsilosis: From genes to the bedside UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001743919&from=exporthttp://dx.doi.org/10.1128/CMR.00111-18 VL - 32 ID - 5214 ER - TY - JOUR AD - B.L. Upham, 243 Food Safety/Toxicology Center, Michigan State University, East Lansing, MI 48824-1302, United States AU - Upham, B. L. AU - Rummel, A. M. AU - Carbone, J. M. AU - Trosko, J. E. AU - Ouyang, Y. AU - Crawford, R. B. AU - Kaminski, N. E. DB - Embase Medline DO - 10.1002/ijc.10899 IS - 1 LA - English M3 - Article N1 - L36184142 2003-02-27 PY - 2003 SN - 0020-7136 SP - 12-18 ST - Cannabinoids inhibit gap junctional intercellular communication and activate erk in a rat liver epithelial cell line T2 - International Journal of Cancer TI - Cannabinoids inhibit gap junctional intercellular communication and activate erk in a rat liver epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36184142&from=exporthttp://dx.doi.org/10.1002/ijc.10899 VL - 104 ID - 5215 ER - TY - JOUR AD - D. Fernández-López, Neonatal Brain Disorders Center, Department of Neurology, University of California San Francisco, San Francisco, 94158 CA, United States AU - Fernández-López, D. AU - Lizasoain, I. AU - Moro, M. A. AU - Martínez-Orgado, J. C1 - cp 55 cp 940 sr 144528 win 55212 2 DB - Embase DO - 10.3390/brainsci3031043 IS - 3 LA - English M3 - Review N1 - L369304901 2013-07-19 2013-07-25 PY - 2013 SN - 2076-3425 SP - 1043-1059 ST - Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury T2 - Brain Sciences TI - Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369304901&from=exporthttp://dx.doi.org/10.3390/brainsci3031043 VL - 3 ID - 5216 ER - TY - JOUR AD - Department of Pharmacy, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto, Japan Department of Clinical and Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan AU - Taguchi, K. AU - Kouroki, M. AU - Ohmura, T. AU - Jono, H. AU - Endo, F. AU - Saito, H. DB - Scopus DO - 10.1111/ped.12382 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - e33-e36 ST - Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia T2 - Pediatrics International TI - Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961297020&doi=10.1111%2fped.12382&partnerID=40&md5=b86d55c86641bf545afc1673ea545d41 VL - 56 ID - 5217 ER - TY - JOUR AD - Section of Islet Cell Biology and Regenerative Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, MA. AN - 103999062. Language: English. Entry Date: 20140314. Revision Date: 20200708. Publication Type: journal article AU - Ræder, Helge AU - McAllister, Fiona E. AU - Tjora, Erling AU - Bhatt, Shweta AU - Haldorsen, Ingfrid AU - Hu, Jiang AU - Willems, Stefan M. AU - Vesterhus, Mette AU - El Ouaamari, Abdelfattah AU - Liu, Manway AU - Ræder, Maria B. AU - Immervoll, Heike AU - Hoem, Dag AU - Dimcevski, Georg AU - Njølstad, Pål R. AU - Molven, Anders AU - Gygi, Steven P. AU - Kulkarni, Rohit N. DB - ccm DO - 10.2337/db13-1012 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: R01 DK-67536/DK/NIDDK NIH HHS/United States. NLM UID: 0372763. PMID: NLM24062244. PY - 2014 SN - 0012-1797 SP - 259-269 ST - Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid T2 - Diabetes TI - Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103999062&site=ehost-live&scope=site VL - 63 ID - 5218 ER - TY - JOUR AD - H. Pan, Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong An Road, Shanghai, China AU - Pan, H. AU - Pan, J. AU - Ji, L. AU - Song, S. AU - Lv, H. AU - Yang, Z. AU - Guo, Y. DB - Embase Medline DO - 10.1016/j.ijbiomac.2019.07.028 LA - English M3 - Article N1 - L2002311255 2019-07-22 2019-07-26 PY - 2019 SN - 1879-0003 0141-8130 SP - 125-134 ST - Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer T2 - International Journal of Biological Macromolecules TI - Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002311255&from=exporthttp://dx.doi.org/10.1016/j.ijbiomac.2019.07.028 VL - 138 ID - 5219 ER - TY - JOUR AD - Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, Department Medicine, University of Southern California-Keck School of Medicine AN - 135207523. Language: English. Entry Date: 20190320. Revision Date: 20191029. Publication Type: Article AU - Hermel, David J. AU - Chiu, Victor AU - Hermel, Melody H. AU - Tulpule, Anil AU - Akhtari, Mojtaba DB - ccm DO - 10.1177/1078155217745710 DP - EBSCOhost IS - 3 N1 - case study. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9511372. PY - 2019 SN - 1078-1552 SP - 699-702 ST - Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib T2 - Journal of Oncology Pharmacy Practice TI - Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135207523&site=ehost-live&scope=site VL - 25 ID - 5220 ER - TY - JOUR AD - H.-W. Yoo, Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, South Korea AU - Jhang, W. K. AU - Choi, J. H. AU - Lee, B. H. AU - Kim, G. H. AU - Yoo, H. W. DB - Embase Medline DO - 10.1007/s00246-016-1468-6 IS - 8 LA - English M3 - Article N1 - L611842075 2016-08-31 2016-12-14 PY - 2016 SN - 1432-1971 0172-0643 SP - 1539-1547 ST - Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies T2 - Pediatric Cardiology TI - Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611842075&from=exporthttp://dx.doi.org/10.1007/s00246-016-1468-6 VL - 37 ID - 5221 ER - TY - JOUR AD - H.-Y. Lin, Department of Pediatrics and Rare Disease Center, Mackay Memorial Hospital, Taipei, Taiwan AU - Lee, C. L. AU - Tan, L. T. H. C. AU - Lin, H. Y. AU - Hwu, W. L. AU - Lee, N. C. AU - Chien, Y. H. AU - Chuang, C. K. AU - Wu, M. H. AU - Wang, J. K. AU - Chu, S. Y. AU - Lin, J. L. AU - Lo, F. S. AU - Su, P. H. AU - Hsu, C. C. AU - Ko, Y. Y. AU - Chen, M. R. AU - Chiu, H. C. AU - Lin, S. P. DB - Embase Medline DO - 10.1002/ajmg.a.61429 IS - 2 LA - English M3 - Article N1 - L2003911388 2019-12-27 2020-01-23 PY - 2020 SN - 1552-4833 1552-4825 SP - 357-364 ST - Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan T2 - American Journal of Medical Genetics, Part A TI - Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003911388&from=exporthttp://dx.doi.org/10.1002/ajmg.a.61429 VL - 182 ID - 5222 ER - TY - JOUR AD - C. Balbi, CardioCentro Ticino, Lugano, Italy AU - Balbi, C. AU - Bolis, S. AU - Barile, L. AU - Vassalli, G. DB - Embase DO - 10.1093/eurheartj/ehz748.0912 LA - English M3 - Conference Abstract N1 - L630047966 2019-12-13 PY - 2019 SN - 0195-668X SP - 1546 ST - Cardiac progenitor cell exosome-associated periostin triggers reentry of cardiomyocytes into cell cycle T2 - European Heart Journal TI - Cardiac progenitor cell exosome-associated periostin triggers reentry of cardiomyocytes into cell cycle UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630047966&from=exporthttp://dx.doi.org/10.1093/eurheartj/ehz748.0912 VL - 40 ID - 5223 ER - TY - JOUR AD - Department of Genetics, AP-HP, Hôpital Robert Debré, Paris, France. AN - 17704260 AU - Nava, C. AU - Hanna, N. AU - Michot, C. AU - Pereira, S. AU - Pouvreau, N. AU - Niihori, T. AU - Aoki, Y. AU - Matsubara, Y. AU - Arveiler, B. AU - Lacombe, D. AU - Pasmant, E. AU - Parfait, B. AU - Baumann, C. AU - Héron, D. AU - Sigaudy, S. AU - Toutain, A. AU - Rio, M. AU - Goldenberg, A. AU - Leheup, B. AU - Verloes, A. AU - Cavé, H. C2 - PMC2652823 DA - Dec DO - 10.1136/jmg.2007.050450 10.1136/jmg.2007.050450. Epub 2007 Aug 17. DP - Nlm ET - 2007/08/21 IS - 12 LA - eng PY - 2007 SN - 0022-2593 (Print) 0022-2593 SP - 763-71 ST - Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome T2 - J Med Genet TI - Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome VL - 44 ID - 5224 ER - TY - JOUR AD - N. Çelik, Gazi University, Department of Pediatric Endocrinology, Ankara, Turkey AU - Çelik, N. AU - Cinaz, P. AU - Bideci, A. AU - Yüce, Ö AU - Emeksiz, H. C. AU - Döǧer, E. AU - Çamurdan, O. DB - Embase Medline DO - 10.4274/Jcrpe.1151 IS - 1 LA - English M3 - Article N1 - L372524653 2014-03-12 2014-03-26 PY - 2014 SN - 1308-5727 1308-5735 SP - 55-58 ST - Cardio-facio-cutaneous syndrome with precocious puberty, growth hormone deficiency and hyperprolactinemia T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - Cardio-facio-cutaneous syndrome with precocious puberty, growth hormone deficiency and hyperprolactinemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372524653&from=exporthttp://dx.doi.org/10.4274/Jcrpe.1151http://www.jcrpe.org/sayilar/49/buyuk/55-58.pdf VL - 6 ID - 5225 ER - TY - JOUR AD - Department of Child Health, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China; School of Public Health, Xiamen University, Xiamen, Fujian, China. School of Public Health, Xiamen University, Xiamen, Fujian, China. Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China; Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, China; Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China. Fulgent Technologies Inc, Minhang District, Shanghai, China. Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Electronic address: chenjing8469899@126.com. Genetic and Metabolic Central Laboratory, Birth Defect Prevention Research Institute, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; Division of Genetics and Genomics, Boston Children's Hospital, Department of Neurology, Harvard Medical School, Boston, MA, USA. Electronic address: yiping.shen@childrens.harvard.edu. AN - 31972311 AU - Chen, J. AU - Che, L. AU - Xu, C. AU - Zhao, S. AU - Yang, J. AU - Li, M. AU - Li, G. AU - Shen, Y. DA - Apr 5 DO - 10.1016/j.gene.2020.144369 10.1016/j.gene.2020.144369. Epub 2020 Jan 20. DP - Nlm ET - 2020/01/24 LA - eng PY - 2020 SN - 0378-1119 SP - 144369 ST - Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy T2 - Gene TI - Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy VL - 733 ID - 5226 ER - TY - JOUR AD - R. Atkar, Addenbrookes Hospital, Cambridge, United Kingdom AU - Atkar, R. AU - Holden, S. AU - Firth, H. AU - Burrows, N. AU - Gass, J. DB - Embase DO - 10.1111/pde.13555 LA - English M3 - Conference Abstract N1 - L622129876 2018-05-18 PY - 2018 SN - 1525-1470 SP - S12 ST - Cardiofaciocutaneous syndrome T2 - Pediatric Dermatology TI - Cardiofaciocutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622129876&from=exporthttp://dx.doi.org/10.1111/pde.13555 VL - 35 ID - 5227 ER - TY - JOUR AD - G. Neri, Istituto di Genetica Medica, Università Cattolica, Largo F Vito, 1, 00168 Roma, Italy AU - Roberts, A. AU - Allanson, J. AU - Jadico, S. K. AU - Kavamura, M. I. AU - Noonan, J. AU - Opitz, J. M. AU - Young, T. AU - Neri, G. DB - Embase Medline DO - 10.1136/jmg.2006.042796 IS - 11 LA - English M3 - Review N1 - L44787108 2006-11-29 PY - 2006 SN - 0022-2593 SP - 833-842 ST - The cardiofaciocutaneous syndrome T2 - Journal of Medical Genetics TI - The cardiofaciocutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44787108&from=exporthttp://dx.doi.org/10.1136/jmg.2006.042796 VL - 43 ID - 5228 ER - TY - JOUR AD - D.N. Meijles AU - Meijles, D. N. AU - Rostron, K. A. AU - Fuller, S. J. AU - Sugden, P. H. AU - Clerk, A. DB - Embase DO - 10.1161/res.123.suppl_1.491 LA - English M3 - Conference Abstract N1 - L628264720 2019-07-01 PY - 2018 SN - 1524-4571 ST - Cardiomyocyte braf promotes hypertrophy and is required for hypertrophic adaptation to hypertension in mice in vivo, but raf inhibitors have differential effects T2 - Circulation Research TI - Cardiomyocyte braf promotes hypertrophy and is required for hypertrophic adaptation to hypertension in mice in vivo, but raf inhibitors have differential effects UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628264720&from=exporthttp://dx.doi.org/10.1161/res.123.suppl_1.491 VL - 123 ID - 5229 ER - TY - JOUR AD - G. Kessler-Icekson, Felsenstein Medical Research Center, Beilinson Campus, Rabin Medical Center, Petach-Tikva, Israel AU - Nudelman, V. AU - Zahalka, M. A. AU - Nudelman, A. AU - Rephaeli, A. AU - Kessler-Icekson, G. DB - Embase Medline DO - 10.1016/j.ejphar.2020.173255 LA - English M3 - Article N1 - L2006928542 2020-07-17 2020-07-22 PY - 2020 SN - 1879-0712 0014-2999 ST - Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts T2 - European Journal of Pharmacology TI - Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006928542&from=exporthttp://dx.doi.org/10.1016/j.ejphar.2020.173255 VL - 882 ID - 5230 ER - TY - JOUR AD - Division of Cardiology, Tufts Medical Center, Boston, MA, United States AU - Upshaw, J. N. C7 - 72 DB - Scopus DO - 10.1007/s11912-020-00923-w IS - 7 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review T2 - Current Oncology Reports TI - Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086723435&doi=10.1007%2fs11912-020-00923-w&partnerID=40&md5=5b785a97dce147584221193ca7c1d1c5 VL - 22 ID - 5231 ER - TY - JOUR AU - Yang, Q. AU - Liao, J. AU - Huang, J. AU - Li, Y. P. AU - Huang, S. AU - Zhou, H. AU - Xie, Y. AU - Pan, J. AU - Li, Y. AU - Huaiwang, J. AU - Wang, J. DB - Embase Medline DO - 10.1371/journal.pone.0162179 IS - 9 LA - English M3 - Article N1 - L612598445 2016-10-19 2016-10-27 PY - 2016 SN - 1932-6203 ST - Cardiopulmonary bypass down-regulates nod signaling and inflammatory response in children with congenital heart disease T2 - PLoS ONE TI - Cardiopulmonary bypass down-regulates nod signaling and inflammatory response in children with congenital heart disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612598445&from=exporthttp://dx.doi.org/10.1371/journal.pone.0162179 VL - 11 ID - 5232 ER - TY - JOUR AD - A. K. Rishi, John D. Dingell Veterans Affairs Medical Center, Detroit, MI, United States AU - Ashour, A. E. AU - Jamal, S. AU - Cheryan, V. T. AU - Muthu, M. AU - Zoheir, K. M. A. AU - Alafeefy, A. M. AU - Abd-Allah, A. R. AU - Levi, E. AU - Tarca, A. L. AU - Polin, L. A. AU - Rishi, A. K. DB - Embase Medline DO - 10.1371/journal.pone.0066733 IS - 6 L1 - internal-pdf://3516805449/journal.pone.0066733.PDF LA - English M3 - Article N1 - L369200019 2013-07-05 2013-07-17 PY - 2013 SN - 1932-6203 ST - CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth T2 - PLoS ONE TI - CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369200019&from=exporthttp://dx.doi.org/10.1371/journal.pone.0066733 VL - 8 ID - 5233 ER - TY - JOUR AD - Y. Zhu, Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, East Jianshe Road, Zhengzhou, China AU - Zhou, T. AU - Zhu, Y. DB - Embase Medline DO - 10.1007/s12031-019-01289-w LA - English M3 - Article in Press N1 - L626735133 2019-03-18 PY - 2019 SN - 1559-1166 0895-8696 ST - Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation T2 - Journal of Molecular Neuroscience TI - Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626735133&from=exporthttp://dx.doi.org/10.1007/s12031-019-01289-w ID - 5234 ER - TY - JOUR AD - Department of Pathology & Dermatology, University of Virginia, Charlottesville, VA. Department of Pathology, University of Virginia, Charlottesville, VA. AN - 29905579 AU - Gru, A. A. AU - Voorhess, P. J. DA - Jul DO - 10.1097/dad.0000000000001061 10.1097/DAD.0000000000001061. DP - Nlm ET - 2018/06/16 IS - 7 LA - eng PY - 2018 SN - 0193-1091 SP - 519-522 ST - A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation T2 - Am J Dermatopathol TI - A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation VL - 40 ID - 5235 ER - TY - JOUR AD - S. Joychan, St. Petersburg, FL, United States AU - Joychan, S. AU - Patel, B. AU - Mayer, J. AU - Sriaroon, P. DB - Embase IS - 5 LA - English M3 - Conference Abstract N1 - L619349028 2017-11-27 PY - 2017 SN - 1534-4436 SP - S29 ST - A case of anaphylaxis to methotrexate and successful desensitization T2 - Annals of Allergy, Asthma and Immunology TI - A case of anaphylaxis to methotrexate and successful desensitization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619349028&from=export VL - 119 ID - 5236 ER - TY - JOUR AD - K.L. Gleghorn, Department of Dermatology, University of Texas Medical Branch, Galveston, TX, United States AU - Gleghorn, K. L. AU - Wagner, K. AU - Quian, Y. W. AU - Totman, K. AU - Goodwin, B. DB - Embase DO - 10.1016/j.jaad.2019.06.571 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643224 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB153 ST - A case of pediatric CD30+ primary cutaneous anaplastic large cell lymphoma T2 - Journal of the American Academy of Dermatology TI - A case of pediatric CD30+ primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643224&from=exporthttp://dx.doi.org/10.1016/j.jaad.2019.06.571 VL - 81 ID - 5237 ER - TY - JOUR AD - Departments of Dermatology and Faculty of Medicine, University of Tokyo, Bunkyo-Ku, Tokyo 113-8655, Japan. simazuk-tky@umin.ac.jp AN - 15214912 AU - Sasaki, K. AU - Sugaya, M. AU - Fujita, H. AU - Takeuchi, K. AU - Torii, H. AU - Asahina, A. AU - Tamaki, K. DA - Jun DO - 10.1111/j.1365-2133.2004.05987.x 10.1111/j.1365-2133.2004.05987.x. DP - Nlm ET - 2004/06/25 IS - 6 LA - eng PY - 2004 SN - 0007-0963 (Print) 0007-0963 SP - 1202-7 ST - A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation T2 - Br J Dermatol TI - A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation VL - 150 ID - 5238 ER - TY - JOUR AD - Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ki, Tokyo, 104-0045, Japan. tkumamot@ncc.go.jp. Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ki, Tokyo, 104-0045, Japan. Department of Pediatrics, Nippon Medical School, Tokyo, Japan. Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. Department of Pathology, National Cancer Hospital, Tokyo, Japan. AN - 30361829 AU - Kumamoto, T. AU - Aoki, Y. AU - Sonoda, T. AU - Yamanishi, M. AU - Arakawa, A. AU - Sugiyama, M. AU - Shirakawa, N. AU - Ishimaru, S. AU - Saito, Y. AU - Maeshima, A. AU - Maeda, M. AU - Ogawa, C. DA - Feb DO - 10.1007/s12185-018-2553-9 10.1007/s12185-018-2553-9. Epub 2018 Oct 25. DP - Nlm ET - 2018/10/27 IS - 2 LA - eng PY - 2019 SN - 0925-5710 SP - 228-232 ST - A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib T2 - Int J Hematol TI - A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib VL - 109 ID - 5239 ER - TY - JOUR AD - Department of Orthopedics, 37 Guoxuexiang Lane, Wuhou District, Chengdu, Sichuan, 610041, China Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China AU - Zhou, Y. AU - Zhang, W. AU - Tang, F. AU - Luo, Y. AU - Min, L. AU - Zhang, W. AU - Shi, R. AU - Duan, H. AU - Tu, C. C7 - e6578 DB - Scopus DO - 10.1097/MD.0000000000006578 IS - 15 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2017 ST - A case report of apatinib in treating osteosarcoma with pulmonary metastases T2 - Medicine (United States) TI - A case report of apatinib in treating osteosarcoma with pulmonary metastases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017629324&doi=10.1097%2fMD.0000000000006578&partnerID=40&md5=67e06dda27e98208188548a3057792a1 VL - 96 ID - 5240 ER - TY - JOUR AD - D.B. Johnson, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States AU - Johnson, D. B. AU - McDonnell, W. J. AU - Gonzalez-Ericsson, P. I. AU - Al-Rohil, R. N. AU - Mobley, B. C. AU - Salem, J. E. AU - Wang, D. Y. AU - Sanchez, V. AU - Wang, Y. AU - Chastain, C. A. AU - Barker, K. AU - Liang, Y. AU - Warren, S. AU - Beechem, J. M. AU - Menzies, A. M. AU - Tio, M. AU - Long, G. V. AU - Cohen, J. V. AU - Guidon, A. C. AU - O’Hare, M. AU - Chandra, S. AU - Chowdhary, A. AU - Lebrun-Vignes, B. AU - Goldinger, S. M. AU - Rushing, E. J. AU - Buchbinder, E. I. AU - Mallal, S. A. AU - Shi, C. AU - Xu, Y. AU - Moslehi, J. J. AU - Sanders, M. E. AU - Sosman, J. A. AU - Balko, J. M. DB - Embase Medline DO - 10.1038/s41591-019-0523-2 IS - 8 LA - English M3 - Article N1 - L2002413009 2019-08-14 2020-04-27 PY - 2019 SN - 1546-170X 1078-8956 SP - 1243-1250 ST - A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis T2 - Nature Medicine TI - A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002413009&from=exporthttp://dx.doi.org/10.1038/s41591-019-0523-2 VL - 25 ID - 5241 ER - TY - JOUR AD - Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. OrigiMed, Shanghai, China. Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address: cairuijun20@163.com. AN - 30642440 AU - Mai, S. AU - Xiong, G. AU - Diao, D. AU - Wang, W. AU - Zhou, Y. AU - Cai, R. DA - Feb DO - 10.1016/j.lungcan.2018.12.016 10.1016/j.lungcan.2018.12.016. Epub 2018 Dec 17. DP - Nlm ET - 2019/01/16 LA - eng PY - 2019 SN - 0169-5002 SP - 101-104 ST - Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor T2 - Lung Cancer TI - Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor VL - 128 ID - 5242 ER - TY - JOUR AD - Masaryk University, Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Central European Institute of Technology, Kamenice 753/5, Brno, 625 00, Czech Republic Masaryk University, Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Kotlarska 2, Brno, 611 37, Czech Republic Masaryk University, Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Department of Pathology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic Masaryk University, Department of Pediatric Radiology, University Hospital Brno and School of Medicine, Cernopolni 9, Brno, 613 00, Czech Republic St. Anne's University Hospital Brno, International Clinical Research Center, Pekarska 53, Brno, 656 91, Czech Republic AU - Mudry, P. AU - Slaby, O. AU - Neradil, J. AU - Soukalova, J. AU - Melicharkova, K. AU - Rohleder, O. AU - Jezova, M. AU - Seehofnerova, A. AU - Michu, E. AU - Veselska, R. AU - Sterba, J. C7 - 119 DB - Scopus DO - 10.1186/s12885-017-3115-x IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2017 ST - Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene T2 - BMC Cancer TI - Case report: Rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012055108&doi=10.1186%2fs12885-017-3115-x&partnerID=40&md5=59d4c330a6a04dc528569cbf820e6c12 VL - 17 ID - 5243 ER - TY - JOUR AD - *Center for Cancer and Blood Disorders †Institute for Molecular Medicine Departments of ‡Neuro-Radiology §Pathology ∥Barrow's Neurologic Institute, Phoenix Children's Hospital, Phoenix, AZ. AN - 26886222 AU - Rosenfeld, A. AU - Etzl, M. AU - Lee, D. AU - Miller, J. AU - Carpenteri, D. AU - Shafron, D. AU - Kaplan, A. DA - Mar DO - 10.1097/mph.0000000000000457 10.1097/MPH.0000000000000457. DP - Nlm ET - 2016/02/18 IS - 2 LA - eng PY - 2016 SN - 1077-4114 SP - e63-6 ST - A Case Series Characterizing Pilomyxoid Astrocytomas in Childhood T2 - J Pediatr Hematol Oncol TI - A Case Series Characterizing Pilomyxoid Astrocytomas in Childhood VL - 38 ID - 5244 ER - TY - JOUR AD - Bradley Jellerichs, MSN, ARNP, DCNP, Clinic Dermatology, Federal Way, WA. Mary Elizabeth Kim, BS, Clinic Dermatology, Federal Way, WA. AN - 144727786. Language: English. Entry Date: 20200811. Revision Date: 20200811. Publication Type: Article AU - Jellerichs, Bradley AU - Kim, Mary Elizabeth DB - ccm DO - 10.1097/JDN.0000000000000551 DP - EBSCOhost IS - 4 N1 - case study; pictorial. Journal Subset: Core Nursing; Nursing; USA. Special Interest: Pediatric Care. NLM UID: 101519494. PY - 2020 SN - 1945-760X SP - 168-169 ST - A Case Study of Cutaneous Mastocytoma in a 9-Month-Old Infant T2 - Journal of the Dermatology Nurses' Association TI - A Case Study of Cutaneous Mastocytoma in a 9-Month-Old Infant UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144727786&site=ehost-live&scope=site VL - 12 ID - 5245 ER - TY - JOUR AD - J. Irving, Northern Institute for Cancer Research, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne, Tyne and Wear, NE2 4HH, United Kingdom AU - Nicholson, L. AU - Knight, T. AU - Matheson, E. AU - Minto, L. AU - Case, M. AU - Sanichar, M. AU - Bomken, S. AU - Vormoor, J. AU - Hall, A. AU - Irving, J. DB - Embase Medline DO - 10.1002/gcc.20949 IS - 3 LA - English M3 - Article N1 - L51714587 2011-11-16 2012-01-17 PY - 2012 SN - 1045-2257 1098-2264 SP - 250-256 ST - Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia T2 - Genes Chromosomes and Cancer TI - Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51714587&from=exporthttp://dx.doi.org/10.1002/gcc.20949 VL - 51 ID - 5246 ER - TY - JOUR AD - S. Kanazawa, Department of Plastic Surgery, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan AU - Tanigawa, T. AU - Kanazawa, S. AU - Ichibori, R. AU - Fujiwara, T. AU - Magome, T. AU - Shingaki, K. AU - Miyata, S. AU - Hata, Y. AU - Tomita, K. AU - Matsuda, K. AU - Kubo, T. AU - Tohyama, M. AU - Yano, K. AU - Hosokawa, K. DB - Embase Medline DO - 10.1186/1472-6882-14-133 LA - English M3 - Article N1 - L53096528 2014-05-09 2014-05-16 PY - 2014 SN - 1472-6882 ST - (+)-Catechin protects dermal fibroblasts against oxidative stress-induced apoptosis T2 - BMC Complementary and Alternative Medicine TI - (+)-Catechin protects dermal fibroblasts against oxidative stress-induced apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53096528&from=exporthttp://dx.doi.org/10.1186/1472-6882-14-133 VL - 14 ID - 5247 ER - TY - JOUR AD - O.M. Tirado, Sarcoma research group, Molecular Oncology Lab, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain AU - Huertas-Martínez, J. AU - Rello-Varona, S. AU - Herrero-Martín, D. AU - Barrau, I. AU - García-Monclús, S. AU - Sáinz-Jaspeado, M. AU - Lagares-Tena, L. AU - Núñez-Álvarez, Y. AU - Mateo-Lozano, S. AU - Mora, J. AU - Roma, J. AU - Toran, N. AU - Moran, S. AU - López-Alemany, R. AU - Gallego, S. AU - Esteller, M. AU - Peinado, M. A. AU - del Muro, X. G. AU - Tirado, O. M. DB - Embase Medline DO - 10.18632/oncotarget.2403 IS - 20 LA - English M3 - Article N1 - L604753545 2015-06-11 2015-06-18 PY - 2014 SN - 1949-2553 SP - 9744-9755 ST - Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth T2 - Oncotarget TI - Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604753545&from=exporthttp://dx.doi.org/10.18632/oncotarget.2403 VL - 5 ID - 5248 ER - TY - JOUR AD - P. Michaely, Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, United States AU - Hernandez, V. J. AU - Weng, J. AU - Ly, P. AU - Pompey, S. AU - Dong, H. AU - Mishra, L. AU - Schwarz, M. AU - Anderson, R. G. W. AU - Michaely, P. DB - Embase Medline DO - 10.7554/eLife.00905 IS - 2 LA - English M3 - Article N1 - L369903486 2013-10-04 2013-10-31 PY - 2013 SN - 2050-084X ST - Cavin-3 dictates the balance between ERK and Akt signaling T2 - eLife TI - Cavin-3 dictates the balance between ERK and Akt signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369903486&from=exporthttp://dx.doi.org/10.7554/eLife.00905http://elife.elifesciences.org/content/elife/2/e00905.full.pdf VL - 2013 ID - 5249 ER - TY - JOUR AD - Department of Orthopaedic Surgery, Surgical Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Kanagawa, Japan. Research Center for Regenerative Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Kanagawa, Japan. AN - 26505752 AU - Hiyama, A. AU - Hiraishi, S. AU - Sakai, D. AU - Mochida, J. DA - May DO - 10.1002/jor.23085 10.1002/jor.23085. Epub 2016 Jan 21. DP - Nlm ET - 2015/10/28 IS - 5 LA - eng PY - 2016 SN - 0736-0266 SP - 865-75 ST - CCAAT/enhancer binding protein β regulates the expression of tumor necrosis factor-α in the nucleus pulposus cells T2 - J Orthop Res TI - CCAAT/enhancer binding protein β regulates the expression of tumor necrosis factor-α in the nucleus pulposus cells VL - 34 ID - 5250 ER - TY - JOUR AD - Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan Department of Nursing, Hung Kuang University, Taichung, Taiwan Department of Medicine, Mackay Medical College, New Taipei City, Taiwan Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan School of Chinese Medicine, China Medical University, Taichung, Taiwan Department of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Orthopaedics, Taichung Veterans General Hospital, Taichung, Taiwan Department of Pathology, China Medical University Hospital, Taichung, Taiwan Department of Orthopedic Surgery, Tungs' Taichung Metroharbor Hospital, Taichung, Taiwan Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan AU - Liao, Y. Y. AU - Tsai, H. C. AU - Chou, P. Y. AU - Wang, S. W. AU - Chen, H. T. AU - Lin, Y. M. AU - Chiang, I. P. AU - Chang, T. M. AU - Hsu, S. K. AU - Chou, M. C. AU - Tang, C. H. AU - Fong, Y. C. DB - Scopus DO - 10.18632/oncotarget.6708 IS - 4 M3 - Article N1 - Cited By :48 Export Date: 18 November 2020 PY - 2016 SP - 4310-4325 ST - CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells T2 - Oncotarget TI - CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957999067&doi=10.18632%2foncotarget.6708&partnerID=40&md5=54a5aa76478c1634f2d92de550ebf55e VL - 7 ID - 5251 ER - TY - JOUR AD - M. Komine, Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan AU - Karakawa, M. AU - Komine, M. AU - Hanakawa, Y. AU - Tsuda, H. AU - Sayama, K. AU - Tamaki, K. AU - Ohtsuki, M. DB - Embase Medline DO - 10.1002/jcp.24643 IS - 12 LA - English M3 - Article N1 - L373843905 2014-09-06 2014-09-10 PY - 2014 SN - 1097-4652 0021-9541 SP - 1935-1945 ST - CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes T2 - Journal of Cellular Physiology TI - CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373843905&from=exporthttp://dx.doi.org/10.1002/jcp.24643 VL - 229 ID - 5252 ER - TY - JOUR AD - J. Lee, Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA, United States AU - Lee, J. AU - Geng, H. AU - Chen, Z. AU - Xiao, G. AU - Cosgun, K. N. N. AU - Zammarchi, F. AU - Van Berkel, P. AU - Melnick, A. AU - Paietta, E. AU - Muschen, M. DB - Embase LA - English M3 - Conference Abstract N1 - L620385938 2018-02-01 PY - 2017 SN - 1528-0020 ST - CD25 enables oncogenic BCR-signaling and represents a therapeutic target in B cell malignancies T2 - Blood TI - CD25 enables oncogenic BCR-signaling and represents a therapeutic target in B cell malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385938&from=export VL - 130 ID - 5253 ER - TY - JOUR AD - A. Liu, Ctrl. Ins. Electron Microscopic Res., Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan AU - Liu, A. AU - Sugisaki, Y. AU - Hosone, M. AU - Namimatsu, S. DB - Embase DO - 10.1267/ahc.37.21 IS - 1 LA - English M3 - Article N1 - L38248374 2004-03-07 PY - 2004 SN - 0044-5991 SP - 21-30 ST - CD30+ TIA-1+ ALK+ Anaplastic Large Cell Lymphoma: Studies of Three Cases by Flow Cytometry Analysis, Immunohistochemistry and Electron Microscopy T2 - Acta Histochemica et Cytochemica TI - CD30+ TIA-1+ ALK+ Anaplastic Large Cell Lymphoma: Studies of Three Cases by Flow Cytometry Analysis, Immunohistochemistry and Electron Microscopy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38248374&from=exporthttp://dx.doi.org/10.1267/ahc.37.21 VL - 37 ID - 5254 ER - TY - JOUR AD - C. Cheng, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, 303 E Superior Street, Chicago, IL 60611, United States AU - Zhao, P. AU - Damerow, M. S. AU - Stern, P. AU - Liu, A. H. AU - Sweet-Cordero, A. AU - Siziopikou, K. AU - Neilson, J. R. AU - Sharp, P. A. AU - Cheng, C. DB - Embase Medline DO - 10.1038/onc.2012.542 IS - 43 LA - English M3 - Article N1 - L52334161 2012-12-07 2013-11-13 PY - 2013 SN - 0950-9232 1476-5594 SP - 5186-5190 ST - CD44 promotes Kras-dependent lung adenocarcinoma T2 - Oncogene TI - CD44 promotes Kras-dependent lung adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52334161&from=exporthttp://dx.doi.org/10.1038/onc.2012.542 VL - 32 ID - 5255 ER - TY - JOUR AD - Y. Zhu, Rashid Laboratory Developmental Neurobiology, Silver Child Development Center, University of South Florida College of Medicine, Tampa, FL, United States AU - Zhu, Y. AU - Hou, H. AU - Nikolic, W. V. AU - Ehrhart, J. AU - Rrapo, E. AU - Bickford, P. AU - Giunta, B. AU - Tan, J. DB - Embase Medline DO - 10.1371/journal.pone.0002135 IS - 5 L1 - internal-pdf://3667706853/journal.pone.0002135.PDF LA - English M3 - Article N1 - L352025171 2008-08-12 PY - 2008 SN - 1932-6203 ST - CD45RB is a novel molecular therapeutic target to inhibit Aβ peptide-induced microglial MAPK activation T2 - PLoS ONE TI - CD45RB is a novel molecular therapeutic target to inhibit Aβ peptide-induced microglial MAPK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352025171&from=exporthttp://dx.doi.org/10.1371/journal.pone.0002135 VL - 3 ID - 5256 ER - TY - JOUR AD - M.S. Staege, Department of Pediatrics, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Str. 40, 06097 Halle, Germany AU - Kühnöl, C. AU - Herbarth, M. AU - Föll, J. AU - Staege, M. S. AU - Kramm, C. C1 - daclizumab(Hoffmann La Roche,Germany) sb 203580(Biaffin,Germany) C2 - Biaffin(Germany) Hoffmann La Roche(Germany) r mittler(United States) DB - Embase Medline DO - 10.1007/s00262-013-1484-9 IS - 12 LA - English M3 - Article N1 - L370484706 2013-12-23 2013-12-26 PY - 2013 SN - 0340-7004 1432-0851 SP - 1797-1809 ST - CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy T2 - Cancer Immunology, Immunotherapy TI - CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370484706&from=exporthttp://dx.doi.org/10.1007/s00262-013-1484-9 VL - 62 ID - 5257 ER - TY - JOUR AD - Regenerative Medicine Program, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. Central Animal Care Services, University of Manitoba, Winnipeg, Manitoba, Canada. Ottawa Bioinformatics Core Facility, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Department of Pathology, University of Manitoba and the Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada. Program in Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada. Department of Neurosurgery, University of Kansas, Kansas City, Kansas. The Arthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children, Toronto, Ontario, Canada. Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada. Division of Neurosurgery, The Hospital for Sick Children, Toronto, Ontario, Canada. The Arthur and Sonia Labatt Brain Tumour Research Center, The Hospital for Sick Children, Toronto, Ontario, Canada. Tamra.Ogilvie@umanitoba.ca vijay.ramaswamy@sickkids.ca. Division of Haematology/Oncology, University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada. Program in Neuroscience and Mental Health and Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada. Regenerative Medicine Program, Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada. Tamra.Ogilvie@umanitoba.ca vijay.ramaswamy@sickkids.ca. AN - 29930101 AU - Liang, L. AU - Coudière-Morrison, L. AU - Tatari, N. AU - Stromecki, M. AU - Fresnoza, A. AU - Porter, C. J. AU - Del Bigio, M. R. AU - Hawkins, C. AU - Chan, J. A. AU - Ryken, T. C. AU - Taylor, M. D. AU - Ramaswamy, V. AU - Werbowetski-Ogilvie, T. E. DA - Aug 15 DO - 10.1158/0008-5472.Can-18-0027 10.1158/0008-5472.CAN-18-0027. Epub 2018 Jun 21. DP - Nlm ET - 2018/06/23 IS - 16 LA - eng PY - 2018 SN - 0008-5472 SP - 4745-4759 ST - CD271(+) Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma T2 - Cancer Res TI - CD271(+) Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma VL - 78 ID - 5258 ER - TY - JOUR AD - P. Ravanan, Apoptosis and Cell Survival Research Lab, Department of Biosciences, School of Biosciences and Technology, VIT University, Vellore, India AU - Chaudhari, N. AU - Talwar, P. AU - Lefebvre D’hellencourt, C. AU - Ravanan, P. C1 - t 0070907(Cayman) C2 - Cayman Sigma Aldrich DB - Embase DO - 10.3389/fnmol.2017.00310 LA - English M3 - Article N1 - L618882869 2017-11-01 2017-11-02 PY - 2017 SN - 1662-5099 ST - CDDO and ATRA instigate differentiation of IMR32 human neuroblastoma cells T2 - Frontiers in Molecular Neuroscience TI - CDDO and ATRA instigate differentiation of IMR32 human neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618882869&from=exporthttp://dx.doi.org/10.3389/fnmol.2017.00310 VL - 10 ID - 5259 ER - TY - JOUR AD - C. Caloisi, Pediatric Department, L'Aquila University, Italy AU - Caloisi, C. AU - Maiorani, D. AU - Gentile, T. DB - Embase LA - English M3 - Conference Abstract N1 - L71690795 2014-12-01 PY - 2012 SN - 1590-8658 SP - S270 ST - Celiac disease and noonan syndrome: Case report T2 - Digestive and Liver Disease TI - Celiac disease and noonan syndrome: Case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71690795&from=export VL - 44 ID - 5260 ER - TY - JOUR AD - E.-M. Domsa, Fourth Medical Clinic, 5th Department of Internal Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy, 18 Republicii Street, Cluj-Napoca, Romania AU - Domsa, E. M. AU - Berindan-Neagoe, I. AU - Para, I. AU - Munteanu, L. AU - Matei, D. AU - Andreica, V. DB - Embase Medline DO - 10.26402/jpp.2020.1.01 IS - 1 LA - English M3 - Review N1 - L2004325145 2020-05-15 2020-05-20 PY - 2020 SN - 1899-1505 0867-5910 SP - 1-12 ST - Celiac disease: A multi-faceted medical condition T2 - Journal of Physiology and Pharmacology TI - Celiac disease: A multi-faceted medical condition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004325145&from=exporthttp://dx.doi.org/10.26402/jpp.2020.1.01 VL - 71 ID - 5261 ER - TY - JOUR AD - L. Palova-Jelinkova, SOTIO A.s., Prague, Czech Republic AU - Grohová, A. AU - Daóòvá, K. AU - Špíšek, R. AU - Palova-Jelinkova, L. DB - Embase Medline DO - 10.3389/fimmu.2019.00079 IS - FEB LA - English M3 - Article N1 - L627728458 2019-05-29 2019-06-03 PY - 2019 SN - 1664-3224 ST - Cell based therapy for type 1 diabetes: Should we take hyperglycemia into accout? T2 - Frontiers in Immunology TI - Cell based therapy for type 1 diabetes: Should we take hyperglycemia into accout? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627728458&from=exporthttp://dx.doi.org/10.3389/fimmu.2019.00079 VL - 10 ID - 5262 ER - TY - JOUR AD - P. H. Rao, Texas Children's Cancer Center, Baylor College of Medicine, MC 3-3320, 6621 Fannin Street, Houston, TX 77030, United States AU - Lu, X. Y. AU - Lu, Y. AU - Zhao, Y. J. AU - Jaeweon, K. AU - Kang, J. AU - Li, X. N. AU - Ge, G. AU - Meyer, R. AU - Perlaky, L. AU - Hicks, J. AU - Chintagumpala, M. AU - Cai, W. W. AU - Ladanyi, M. AU - Gorlick, R. AU - Lau, C. C. AU - Pati, D. AU - Sheldon, M. AU - Rao, P. H. DB - Embase Medline DO - 10.1158/1541-7786.MCR-07-2115 IS - 6 L1 - internal-pdf://3695831790/937.full.pdf LA - English M3 - Article N1 - L352467514 2008-11-12 PY - 2008 SN - 1541-7786 SP - 937-946 ST - Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma T2 - Molecular Cancer Research TI - Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352467514&from=exporthttp://dx.doi.org/10.1158/1541-7786.MCR-07-2115 VL - 6 ID - 5263 ER - TY - JOUR AD - University of Alabama, Birmingham, Birmingham, AL 35233, USA. AN - 22934706 AU - Megison, M. L. AU - Gillory, L. A. AU - Beierle, E. A. C2 - PMC3710698 C6 - NIHMS487768 DA - May DO - 10.2174/1871520611313040005 10.2174/1871520611313040005. DP - Nlm ET - 2012/09/01 IS - 4 LA - eng PY - 2013 SN - 1871-5206 (Print) 1871-5206 SP - 563-75 ST - Cell survival signaling in neuroblastoma T2 - Anticancer Agents Med Chem TI - Cell survival signaling in neuroblastoma VL - 13 ID - 5264 ER - TY - JOUR AD - M. Simkó, Division of Environmental Physiology, Department of Cell Biology and Biosystems Technology, University of Rostock, Albert-Einstein-Straße 3, D-18059 Rostock, Germany AU - Simkó, M. DB - Embase Medline DO - 10.2174/092986707780362835 IS - 10 LA - English M3 - Review N1 - L46672632 2007-04-01 PY - 2007 SN - 0929-8673 SP - 1141-1152 ST - Cell type specific redox status is responsible for diverse electromagnetic field effects T2 - Current Medicinal Chemistry TI - Cell type specific redox status is responsible for diverse electromagnetic field effects UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46672632&from=exporthttp://dx.doi.org/10.2174/092986707780362835http://www.ingentaconnect.com/content/ben/cmc/2007/00000014/00000010/art00008 VL - 14 ID - 5265 ER - TY - JOUR AD - Department of Pathology, National University Health System, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore. char_loo_tan@nuhs.edu.sg. Department of Pathology, National University Health System, Singapore, Singapore. Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore. Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. AN - 31820133 AU - Tan, C. L. AU - Lian, D. W. Q. AU - Kuick, C. H. AU - Chan, Y. H. AU - Chang, K. T. E. DA - Jan DO - 10.1007/s10014-019-00356-9 10.1007/s10014-019-00356-9. Epub 2019 Dec 9. DP - Nlm ET - 2019/12/11 IS - 1 LA - eng PY - 2020 SN - 1433-7398 SP - 14-21 ST - Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall T2 - Brain Tumor Pathol TI - Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall VL - 37 ID - 5266 ER - TY - JOUR AD - J. Gaynes AU - Gaynes, J. AU - Jonart, L. AU - Naumann, J. AU - Zamora, E. AU - Gossai, N. AU - Ebadi, M. AU - Gordon, P. M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247030 2017-02-03 PY - 2016 SN - 1528-0020 ST - The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance T2 - Blood TI - The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247030&from=export VL - 128 ID - 5267 ER - TY - JOUR AD - N. Saki, Health Research Institute, Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran AU - Heidari, N. AU - Saki, N. AU - De Filippis, L. AU - Shahjahani, M. AU - Teimouri, A. AU - Ahmadzadeh, A. DB - Embase Medline DO - 10.1007/s12094-015-1370-3 IS - 3 LA - English M3 - Article N1 - L605542175 2015-08-12 2016-02-29 PY - 2016 SN - 1699-3055 1699-048X SP - 240-250 ST - Central nervous system niche involvement in the leukemia T2 - Clinical and Translational Oncology TI - Central nervous system niche involvement in the leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605542175&from=exporthttp://dx.doi.org/10.1007/s12094-015-1370-3 VL - 18 ID - 5268 ER - TY - JOUR AD - Y.-H. Zhang, Beijing Key Laboratory of Pediatric Hematology Oncology, National Discipline of Pediatrics, Ministry of Education, MOE Key Laboratory of Major Diseases in Children, Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, Nanlishi Road, Beijing, China AU - Yang, J. AU - Li, J. AU - Gu, W. Y. AU - Jin, L. AU - Duan, Y. L. AU - Huang, S. AU - Zhang, M. AU - Wang, X. S. AU - Liu, Y. AU - Zhou, C. J. AU - Gao, C. AU - Zheng, H. Y. AU - Zhang, Y. H. DB - Embase DO - 10.12998/WJCC.V8.I9.1685 IS - 9 LA - English M3 - Article N1 - L632109016 2020-07-08 2020-07-09 PY - 2020 SN - 2307-8960 SP - 1685-1692 ST - Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report T2 - World Journal of Clinical Cases TI - Central nervous system relapse in a pediatric anaplastic large cell lymphoma patient with CLTC/ALK translocation treated with alectinib: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632109016&from=exporthttp://dx.doi.org/10.12998/WJCC.V8.I9.1685 VL - 8 ID - 5269 ER - TY - JOUR AD - R. P. Piekorz, Institut Fü R Biochemie und Molekularbiologie II, Universitä Tsklinikum der Heinrich-Heine-Universitä T, Düsseldorf D-40225, Germany AU - Schmidt, S. AU - Schneider, L. AU - Essmann, F. AU - Cirstea, I. C. AU - Kuck, F. AU - Kletke, A. AU - Jänicke, R. U. AU - Wiek, C. AU - Hanenberg, H. AU - Ahmadian, M. R. AU - Schulze-Osthoff, K. AU - Nürnberg, B. AU - Piekorz, R. P. DB - Embase Medline DO - 10.1038/onc.2010.354 IS - 46 LA - English M3 - Article N1 - L51043985 2010-12-02 2010-12-07 PY - 2010 SN - 0950-9232 1476-5594 SP - 6184-6192 ST - The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program T2 - Oncogene TI - The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51043985&from=exporthttp://dx.doi.org/10.1038/onc.2010.354 VL - 29 ID - 5270 ER - TY - JOUR AD - Pediatric Hematology/Oncology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. University Cancer Center of the University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany. Pediatric Hematology/Oncology, Children's Hospital, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. claudia.paret@unimedizin-mainz.de. University Cancer Center of the University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany. claudia.paret@unimedizin-mainz.de. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. claudia.paret@unimedizin-mainz.de. Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK)-German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Section of Pediatric Neurosurgery, Department of Neurosurgery, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Neurological Institute (Edinger-Institute), Goethe-University Medical School, 60528 Frankfurt am Main, Germany. Frankfurt Cancer Institute (FCI), 60596 Frankfurt am Main, Germany. Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. Institute of Neuropathology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. Department of Neuroradiology, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany. Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, 53127 Bonn, Germany. AN - 31480400 AU - Russo, A. AU - Paret, C. AU - Alt, F. AU - Burhenne, J. AU - Fresnais, M. AU - Wagner, W. AU - Glaser, M. AU - Bender, H. AU - Huprich, S. AU - Harter, P. N. AU - Filipski, K. AU - Lehmann, N. AU - Backes, N. AU - Roth, L. AU - Seidmann, L. AU - Sommer, C. AU - Brockmann, M. A. AU - Pietsch, T. AU - Neu, M. A. AU - Wingerter, A. AU - Faber, J. C2 - PMC6747232 DA - Aug 30 DO - 10.3390/ijms20174267 10.3390/ijms20174267. DP - Nlm ET - 2019/09/05 IS - 17 LA - eng PY - 2019 SN - 1422-0067 ST - Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor T2 - Int J Mol Sci TI - Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor VL - 20 ID - 5271 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan Department of Hematology and Rheumatology, Kindai University, Osaka, Japan Clinical Research Support Center Kyushu, Fukuoka, Japan Department of Hematology and Infectious Diseases, Kumamoto University, Kumamoto, Japan Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan Department of Hematology, Osaka City University, Osaka, Japan Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan Department of Internal Medicine, Kagawa University, Kagawa, Japan Department of Hematology and Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan Division of Hematology, St. Mary’s Hospital, Kurume, Japan Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan Department of Hematology and Oncology, Osaka University, Osaka, Japan AU - Nagafuji, K. AU - Matsumura, I. AU - Shimose, T. AU - Kawaguchi, T. AU - Kuroda, J. AU - Nakamae, H. AU - Miyamoto, T. AU - Kadowaki, N. AU - Ishikawa, J. AU - Imamura, Y. AU - Yamazaki, H. AU - Akashi, K. AU - Kanakura, Y. DB - Scopus DO - 10.1007/s12185-019-02736-5 IS - 6 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 675-682 ST - Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) T2 - International Journal of Hematology TI - Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073942632&doi=10.1007%2fs12185-019-02736-5&partnerID=40&md5=952fdc3fd39b45604e0bca4880eea163 VL - 110 ID - 5272 ER - TY - JOUR AD - Rainbow Babies and Children's Hospital, Pediatric Hematology/Oncology, 11100 Euclid Avenue, Cleveland, OH 44106, United States AU - Norris, R. E. AU - Adamson, P. C. DB - Scopus DO - 10.1038/nrc3370 IS - 11 M3 - Review N1 - Cited By :36 Export Date: 18 November 2020 PY - 2012 SP - 776-782 ST - Challenges and opportunities in childhood cancer drug development T2 - Nature Reviews Cancer TI - Challenges and opportunities in childhood cancer drug development UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867839214&doi=10.1038%2fnrc3370&partnerID=40&md5=ef264d3b0e05a6c7cdcc8421021d3149 VL - 12 ID - 5273 ER - TY - JOUR AD - Division of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Sapienza University, Via Benevento 6, 00161, Rome, Italy Department of Statistical Sciences, Policlinico Umberto I, Sapienza University, Rome, Italy AN - 131216731. Language: English. Entry Date: 20180827. Revision Date: 20191001. Publication Type: journal article AU - Molica, Matteo AU - Scalzulli, Emilia AU - Colafigli, Gioia AU - Massaro, Fulvio AU - Latagliata, Roberto AU - Foà, Robin AU - Breccia, Massimo AU - Fegatelli, Danilo Alunni DB - ccm DO - 10.1007/s00277-018-3375-9 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe. NLM UID: 9107334. PMID: NLM29806063. PY - 2018 SN - 0939-5555 SP - 1803-1808 ST - Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events T2 - Annals of Hematology TI - Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=131216731&site=ehost-live&scope=site VL - 97 ID - 5274 ER - TY - JOUR AD - L. Cai, Department of Orthopedics, Wuhan General Hospital of Guangzhou Command, Wuhan University, No. 169 Donghu Road, Wuhan, Hubei 430071, China AU - Hu, H. AU - Zhang, Y. AU - Cai, X. H. AU - Huang, J. F. AU - Cai, L. DB - Embase DO - 10.3892/ol.2012.866 IS - 5 LA - English M3 - Article N1 - L365624185 2012-09-19 2012-09-24 PY - 2012 SN - 1792-1074 1792-1082 SP - 1037-1042 ST - Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts T2 - Oncology Letters TI - Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365624185&from=exporthttp://dx.doi.org/10.3892/ol.2012.866http://www.spandidos-publications.com/serveFile/ol_4_5_1037_PDF.pdf?type=article&article_id=ol_4_5_1037&item=PDF VL - 4 ID - 5275 ER - TY - JOUR AD - Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada. Division of Oncology, University Children's Hospital of Zurich, Zurich, Switzerland. AN - 26764564 AU - Guerreiro Stucklin, A. S. AU - Tabori, U. AU - Grotzer, M. A. DA - Apr DO - 10.1055/s-0035-1570491 10.1055/s-0035-1570491. Epub 2016 Jan 14. DP - Nlm ET - 2016/01/15 IS - 2 LA - eng PY - 2016 SN - 0174-304x SP - 70-83 ST - The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies T2 - Neuropediatrics TI - The Changing Landscape of Pediatric Low-Grade Gliomas: Clinical Challenges and Emerging Therapies VL - 47 ID - 5276 ER - TY - JOUR AD - M. Krumbholz, University Hospital Erlangen, Department of Pediatrics, Erlangen, Germany AU - Krumbholz, M. AU - Woessmann, W. AU - Zierk, J. AU - Seniuk, D. AU - Ceppi, P. AU - Zimmermann, M. AU - Singh, V. K. AU - Metzler, M. AU - Damm-Welk, C. DB - Embase DO - 10.18632/oncotarget.25489 IS - 41 LA - English M3 - Article N1 - L622363913 2018-06-04 2018-06-07 PY - 2018 SN - 1949-2553 SP - 26543-26555 ST - Characterization and diagnostic application of genomic NPMALK fusion sequences in anaplastic large-cell lymphoma T2 - Oncotarget TI - Characterization and diagnostic application of genomic NPMALK fusion sequences in anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622363913&from=exporthttp://dx.doi.org/10.18632/oncotarget.25489 VL - 9 ID - 5277 ER - TY - JOUR AD - L. Sacchetti, Laboratori Misti, IRCCS Fondazione SDN-CEINGE, CEINGE-Biotecnologie Avanzate, Via E Gianturco 113, 80143 Naples, Italy AU - Nardelli, C. AU - Iaffaldano, L. AU - Ferrigno, M. AU - Labruna, G. AU - Maruotti, G. M. AU - Quaglia, F. AU - Capobianco, V. AU - Di Noto, R. AU - Del Vecchio, L. AU - Martinelli, P. AU - Pastore, L. AU - Sacchetti, L. DB - Embase Medline DO - 10.1038/ijo.2013.121 IS - 3 LA - English M3 - Article N1 - L52704577 2013-08-05 2014-03-27 PY - 2014 SN - 0307-0565 1476-5497 SP - 466-469 ST - Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women T2 - International Journal of Obesity TI - Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52704577&from=exporthttp://dx.doi.org/10.1038/ijo.2013.121 VL - 38 ID - 5278 ER - TY - JOUR AD - W. Chien, Dept. of Hematology/Oncology, Cedars-Sinai Medical Center, 110 George Burns Rd., Los Angeles, CA 90048, United States AU - Chien, W. AU - Tidow, N. AU - Williamson, E. A. AU - Shih, L. Y. AU - Krug, U. AU - Kettenbach, A. AU - Fermin, A. C. AU - Roifman, C. M. AU - Koeffler, H. P. DB - Embase Medline DO - 10.1074/jbc.M304575200 IS - 30 LA - English M3 - Article N1 - L36899923 2003-08-14 PY - 2003 SN - 0021-9258 SP - 27413-27420 ST - Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway T2 - Journal of Biological Chemistry TI - Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36899923&from=exporthttp://dx.doi.org/10.1074/jbc.M304575200 VL - 278 ID - 5279 ER - TY - JOUR AD - Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, United States Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, United States Germline High Risk Focus Group, CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States AU - Chen, H. J. AU - Romigh, T. AU - Sesock, K. AU - Eng, C. DB - Scopus DO - 10.1002/humu.23288 IS - 10 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 1372-1377 ST - Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome T2 - Human Mutation TI - Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024391574&doi=10.1002%2fhumu.23288&partnerID=40&md5=1e119aac67ce9b9473ae702a370aa74d VL - 38 ID - 5280 ER - TY - JOUR AD - Department of Pathology, Haartman Inst. Helsinki Univ. C., P.O. Box 21, FIN-00014 Univ. H., Finland Department of Medical Genetics, Haartman Inst. Helsinki Univ. C., Univ. of Helsinki, Helsinki, Finland, Finland Dept. Oral and Maxillofacial Surg., Institute of Dentistry, University of Turku, Turku, Finland, Finland Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland, Finland Department of Biosciences, Division of Biochemistry, Univ. of Helsinki, Helsinki, Finland, Finland AU - Leivo, I. AU - Jee, K. J. AU - Heikinheimo, K. AU - Laine, M. AU - Ollila, J. AU - Nagy, B. AU - Knuutila, S. DB - Scopus DO - 10.1016/j.cancergencyto.2004.04.016 IS - 2 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2005 SP - 104-113 ST - Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation T2 - Cancer Genetics and Cytogenetics TI - Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-11844282189&doi=10.1016%2fj.cancergencyto.2004.04.016&partnerID=40&md5=7a719510a814fc0bde61a76921bba248 VL - 156 ID - 5281 ER - TY - JOUR AD - S.M. Krams, Surgery/Division of Abdominal Transplant, Stanford University, Stanford, CA, United States AU - Krams, S. M. AU - Arvedson, M. AU - Maloney, E. AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. D. AU - Esquivel, C. O. AU - Martinez, O. M. DB - Embase DO - 10.1111/petr.13441 LA - English M3 - Conference Abstract N1 - L627772922 2019-05-28 PY - 2019 SN - 1399-3046 ST - Characterization of genomic alterations in EBV+ PTLD T2 - Pediatric Transplantation TI - Characterization of genomic alterations in EBV+ PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627772922&from=exporthttp://dx.doi.org/10.1111/petr.13441 VL - 23 ID - 5282 ER - TY - JOUR AD - CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom Centro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy Pediatric Hematology and Oncology, Hannover Medical School, Germany University of New Mexico Cancer Center, Albuquerque, NM, United States Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States South Australia Health and Medical Research Institute, Adelaide, Australia Department of Pediatrics, Hematology-Oncology, Benioff Children’s Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, United States Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Department of Haematology, Our Lady’s Children’s Hospital, Dublin, Ireland Department of Cancer Biology, Institut Paoli Calmettes, Marseille, France Department of Hematology, Institut Paoli Calmettes, Marseille, France Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hematology, Leiden University Medical Center, Netherlands Birmingham Children’s Hospital, NHS Foundation Trust, United Kingdom Department of Cytogenetics, Leicester Royal Infirmary NHS Trust, United Kingdom St. Anna Children’s Hospital, Childrens Cancer Research Institute, Vienna, Austria Department of Pediatrics, Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and the University of Pennsylvania Perelman School of MedicinePA, United States AU - Zaliova, M. AU - Moorman, A. V. AU - Cazzaniga, G. AU - Stanulla, M. AU - Harvey, R. C. AU - Roberts, K. G. AU - Heatley, S. L. AU - Loh, M. L. AU - Konopleva, M. AU - Chen, I. M. AU - Zimmermannova, O. AU - Schwab, C. AU - Smith, O. AU - Mozziconacci, M. J. AU - Chabannon, C. AU - Kim, M. AU - Frederik Falkenburg, J. H. AU - Norton, A. AU - Marshall, K. AU - Haas, O. A. AU - Starkova, J. AU - Stuchly, J. AU - Hunger, S. P. AU - White, D. AU - Mullighan, C. G. AU - Willman, C. L. AU - Stary, J. AU - Trka, J. AU - Zuna, J. DB - Scopus DO - 10.3324/haematol.2016.144345 IS - 9 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2016 SP - 1082-1093 ST - Characterization of leukemias with ETV6-ABL1 fusion T2 - Haematologica TI - Characterization of leukemias with ETV6-ABL1 fusion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84986237322&doi=10.3324%2fhaematol.2016.144345&partnerID=40&md5=3940ea4739fc2e38d624421795ba6037 VL - 101 ID - 5283 ER - TY - JOUR AD - J. Wang, Department of Thoracic and Cardiovascular Surgery, Jiangsu Province People's Hospital, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd, Nanjing, Jiangsu, China AU - Wang, J. AU - Li, Z. AU - Ge, Q. AU - Wu, W. AU - Zhu, Q. AU - Luo, J. AU - Chen, L. DB - Embase Medline DO - 10.1016/j.jtcvs.2015.02.012 IS - 5 LA - English M3 - Article N1 - L603245346 2015-03-27 2015-06-08 PY - 2015 SN - 1097-685X 0022-5223 SP - 1404-1414.e4 ST - Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma T2 - Journal of Thoracic and Cardiovascular Surgery TI - Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603245346&from=exporthttp://dx.doi.org/10.1016/j.jtcvs.2015.02.012 VL - 149 ID - 5284 ER - TY - JOUR AD - Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States Department of Medicine, Weill Cornell Medical College, New York, United States Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, United States Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, United States Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, United States AU - Liu, D. AU - Flory, J. AU - Lin, A. AU - Offin, M. AU - Falcon, C. J. AU - Murciano-Goroff, Y. R. AU - Rosen, E. AU - Guo, R. AU - Basu, E. AU - Li, B. T. AU - Harding, J. J. AU - Iyer, G. AU - Jhaveri, K. AU - Gounder, M. M. AU - Shukla, N. N. AU - Roberts, S. S. AU - Glade-Bender, J. AU - Kaplanis, L. AU - Schram, A. AU - Hyman, D. M. AU - Drilon, A. DB - Scopus DO - 10.1016/j.annonc.2020.05.006 IS - 9 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1207-1215 ST - Characterization of on-target adverse events caused by TRK inhibitor therapy T2 - Annals of Oncology TI - Characterization of on-target adverse events caused by TRK inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087429837&doi=10.1016%2fj.annonc.2020.05.006&partnerID=40&md5=97f22591a3568234a1aac362d66137f8 VL - 31 ID - 5285 ER - TY - JOUR AD - Center for Cancer and Immunology Research, Children's Research Institute, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010-2970, United States Department of Pathology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC, United States Department of Pediatrics, George Washington University School of Medicine, Washington, DC, United States Department of Neuropathology, Armed Forces Institute of Pathology, Washington, DC, United States Cancer Genetics Branch, National Human Genome Research Institute NIH, Bethesda, MD, United States AU - Smith, C. AU - Santi, M. AU - Rushing, E. J. AU - Cornelison, R. AU - MacDonald, T. J. AU - Vukmanovic, S. DB - Scopus DO - 10.1007/s11060-010-0378-3 IS - 2 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2011 SP - 197-206 ST - Characterization of signaling function and expression of HLA class I molecules in medulloblastoma T2 - Journal of Neuro-Oncology TI - Characterization of signaling function and expression of HLA class I molecules in medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79959833129&doi=10.1007%2fs11060-010-0378-3&partnerID=40&md5=7e032f45875a70031f3d7ccb52a7610e VL - 103 ID - 5286 ER - TY - JOUR AD - H. M. Hermanns, The Rudolf-Virchow-Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany AU - Drechsler, J. AU - Grötzinger, J. AU - Hermanns, H. M. DB - Embase Medline DO - 10.1371/journal.pone.0043155 IS - 8 L1 - internal-pdf://0620145550/journal.pone.0043155.PDF LA - English M3 - Article N1 - L365470682 2012-08-28 2012-09-04 PY - 2012 SN - 1932-6203 ST - Characterization of the rat oncostatin m receptor complex which resembles the human, but differs from the murine cytokine receptor T2 - PLoS ONE TI - Characterization of the rat oncostatin m receptor complex which resembles the human, but differs from the murine cytokine receptor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365470682&from=exporthttp://dx.doi.org/10.1371/journal.pone.0043155 VL - 7 ID - 5287 ER - TY - JOUR AD - Y. Balachandran, Abdominal Transplant, Stanford University, Stanford, United States AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. AU - Esquivel, C. AU - Krams, S. AU - Martinez, O. DB - Embase DO - 10.1111/ajt.14917 LA - English M3 - Conference Abstract N1 - L622280150 2018-05-29 PY - 2018 SN - 1600-6143 SP - 353-354 ST - Characterization of viral and host cell genomic alterations in EBV+ PTLD T2 - American Journal of Transplantation TI - Characterization of viral and host cell genomic alterations in EBV+ PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622280150&from=exporthttp://dx.doi.org/10.1111/ajt.14917 VL - 18 ID - 5288 ER - TY - JOUR AD - Marine Science Institute, University of Texas at Austin, Port Aransas, TX 78373, United States AU - Pang, Y. AU - Dong, J. AU - Thomas, P. DB - Scopus DO - 10.1210/en.2012-1772 IS - 1 M3 - Article N1 - Cited By :110 Export Date: 18 November 2020 PY - 2013 SP - 283-295 ST - Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis T2 - Endocrinology TI - Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and ε (mPRδ and mPRε) and mPRδ involvement in neurosteroid inhibition of apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871689323&doi=10.1210%2fen.2012-1772&partnerID=40&md5=69b005aec6caf087eb54edec8055972a VL - 154 ID - 5289 ER - TY - JOUR AD - D.M. Shin, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA 30322, United States AU - Saba, N. F. AU - Hurwitz, S. J. AU - Kono, S. A. AU - Yang, C. S. AU - Zhao, Y. AU - Chen, Z. AU - Sica, G. AU - Mul̈ler, S. AU - Moreno-Williams, R. AU - Lewis, M. AU - Grist, W. AU - Chen, A. Y. AU - Moore, C. E. AU - Owonikoko, T. K. AU - Ramalingam, S. AU - Beitler, J. J. AU - Nannapaneni, S. AU - Shin, H. J. C. AU - Grandis, J. R. AU - Khuri, F. R. AU - Chen, Z. G. AU - Shin, D. M. DB - Embase Medline DO - 10.1158/1940-6207.CAPR-13-0215 IS - 3 LA - English M3 - Article N1 - L372723657 2014-04-09 2014-04-16 PY - 2014 SN - 1940-6215 1940-6207 SP - 283-291 ST - Chemoprevention of head and neck cancer with celecoxib and erlotinib: Results of a phase Ib and pharmacokinetic study T2 - Cancer Prevention Research TI - Chemoprevention of head and neck cancer with celecoxib and erlotinib: Results of a phase Ib and pharmacokinetic study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372723657&from=exporthttp://dx.doi.org/10.1158/1940-6207.CAPR-13-0215 VL - 7 ID - 5290 ER - TY - JOUR AD - H. Zhang, Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, Guangdong, China F. Wei, Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China AU - Zhang, H. AU - Xu, H. AU - Zhang, R. AU - Zhao, X. AU - Liang, M. AU - Wei, F. C2 - Sigma Aldrich DB - Embase Medline DO - 10.1007/s00280-020-04115-y IS - 2 LA - English M3 - Article N1 - L2005633159 2020-07-29 PY - 2020 SN - 1432-0843 0344-5704 SP - 257-266 ST - Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells T2 - Cancer Chemotherapy and Pharmacology TI - Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005633159&from=exporthttp://dx.doi.org/10.1007/s00280-020-04115-y VL - 86 ID - 5291 ER - TY - JOUR AD - E. Guo, Medstar Washington Hospital Center, Georgetown University Hospital, United States AU - Guo, E. AU - Dollani, L. AU - Marathe, K. AU - Norton, S. DB - Embase DO - 10.1016/j.jaad.2019.06.581 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643828 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB155 ST - A child with an unknown Noonan-like syndrome with CNS tumors, café-au-lait patches, pigmented axillary papules, punctate leukoderma, and cutaneous and gastric granular cell tumors T2 - Journal of the American Academy of Dermatology TI - A child with an unknown Noonan-like syndrome with CNS tumors, café-au-lait patches, pigmented axillary papules, punctate leukoderma, and cutaneous and gastric granular cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643828&from=exporthttp://dx.doi.org/10.1016/j.jaad.2019.06.581 VL - 81 ID - 5292 ER - TY - JOUR AD - St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom Hôpital Robert Debré and University of Paris Diderot, Paris, France Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, University Hospital Rigshospitalet, Copenhagen, Denmark Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany Nagoya Medical Center, Clinical Research Center, Nagoya, Japan Universiteit Gent, Gent, Belgium Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, Singapore Viva-University Children's Cancer Centre, National University Hospital, Singapore Mackay Memorial Hospital, Taipei, Taiwan AN - 109393729. Language: English. Entry Date: 20151217. Revision Date: 20161223. Publication Type: journal article AU - Ching-Hon, Pui AU - Yang, Jun J. AU - Hunger, Stephen P. AU - Pieters, Rob AU - Schrappe, Martin AU - Biondi, Andrea AU - Vora, Ajay AU - Baruchel, André AU - Silverman, Lewis B. AU - Schmiegelow, Kjeld AU - Escherich, Gabriele AU - Keizo, Horibe AU - Benoit, Yves C. M. AU - Izraeli, Shai AU - Yeoh, Allen Eng Juh AU - Der-Cherng, Liang AU - Downing, James R. AU - Evans, William E. AU - Relling, Mary V. AU - Mullighan, Charles G. DB - ccm DO - 10.1200/JCO.2014.59.1636 DP - EBSCOhost IS - 27 N1 - review; tables/charts. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Grant Information: R01 CA036401/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM26304874. PY - 2015 SN - 0732-183X SP - 2938-2948 ST - Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration T2 - Journal of Clinical Oncology TI - Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109393729&site=ehost-live&scope=site VL - 33 ID - 5293 ER - TY - JOUR AD - Department of Pediatrics and the Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. lohm@itsa.ucsf.edu AN - 21239819 AU - Loh, M. L. DO - 10.1182/asheducation-2010.1.357 10.1182/asheducation-2010.1.357. DP - Nlm ET - 2011/01/18 LA - eng PY - 2010 SN - 1520-4383 SP - 357-62 ST - Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia T2 - Hematology Am Soc Hematol Educ Program TI - Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia VL - 2010 ID - 5294 ER - TY - JOUR AD - R. Kobayashi, St. Lukes International Hospital, Tokyo, Japan AU - Kobayashi, R. AU - Eto, H. AU - Kajiwara, T. AU - Nakano, T. AU - Momose, Y. DB - Embase DO - 10.1016/j.jaad.2010.09.492 IS - 2 LA - English M3 - Conference Abstract N1 - L70331764 2011-02-03 PY - 2011 SN - 0190-9622 SP - AB116 ST - Childhood primary cutaneous CD30-positive anaplastic large cell lymphoma: A child case with spontaneous regression T2 - Journal of the American Academy of Dermatology TI - Childhood primary cutaneous CD30-positive anaplastic large cell lymphoma: A child case with spontaneous regression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70331764&from=exporthttp://dx.doi.org/10.1016/j.jaad.2010.09.492 VL - 64 ID - 5295 ER - TY - JOUR AD - N.A. Vitanza, Division of Hematology/Oncology, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, 4800 Sand Point Way NE, M/S MB.8.501, PO Box 5371, Seattle, WA, United States AU - Crotty, E. E. AU - Leary, S. E. S. AU - Geyer, J. R. AU - Olson, J. M. AU - Millard, N. E. AU - Sato, A. A. AU - Ermoian, R. P. AU - Cole, B. L. AU - Lockwood, C. M. AU - Paulson, V. A. AU - Browd, S. R. AU - Ellenbogen, R. G. AU - Hauptman, J. S. AU - Lee, A. AU - Ojemann, J. G. AU - Vitanza, N. A. DB - Embase Medline DO - 10.1007/s11060-020-03558-w IS - 3 LA - English M3 - Article N1 - L2005272014 2020-07-06 PY - 2020 SN - 1573-7373 0167-594X SP - 607-617 ST - Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience T2 - Journal of Neuro-Oncology TI - Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005272014&from=exporthttp://dx.doi.org/10.1007/s11060-020-03558-w VL - 148 ID - 5296 ER - TY - JOUR AD - J.R. Park, Division of Pediatric Hematology and Oncology, Seattle Children's Hospital, 4800 Sandpoint Way NE, Mailstop B6553, Seattle, WA 98106, United States AU - Park, J. R. AU - Bagatell, R. AU - London, W. B. AU - Maris, J. M. AU - Cohn, S. L. AU - Mattay, K. M. AU - Hogarty, M. C1 - abt 751 mln 8237 DB - Embase Medline DO - 10.1002/pbc.24433 IS - 6 LA - English M3 - Review N1 - L368767468 2013-04-29 2013-05-02 PY - 2013 SN - 1545-5009 1545-5017 SP - 985-993 ST - Children's Oncology Group's 2013 blueprint for research: Neuroblastoma T2 - Pediatric Blood and Cancer TI - Children's Oncology Group's 2013 blueprint for research: Neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368767468&from=exporthttp://dx.doi.org/10.1002/pbc.24433 VL - 60 ID - 5297 ER - TY - JOUR AD - F. Wang-Johanning, Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Zhou, F. AU - Krishnamurthy, J. AU - Wei, Y. AU - Li, M. AU - Hunt, K. AU - Johanning, G. L. AU - Cooper, L. J. N. AU - Wang-Johanning, F. DB - Embase DO - 10.1080/2162402X.2015.1047582 IS - 11 LA - English M3 - Article N1 - L606063912 2015-09-24 2015-09-28 PY - 2015 SN - 2162-402X 2162-4011 ST - Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras T2 - OncoImmunology TI - Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606063912&from=exporthttp://dx.doi.org/10.1080/2162402X.2015.1047582 VL - 4 ID - 5298 ER - TY - JOUR AD - Department of Pathology, BC Research Institute for Children's and Women's Health, Vancouver, British Columbia, V6H 3V4. AN - 11751416 AU - Tognon, C. AU - Garnett, M. AU - Kenward, E. AU - Kay, R. AU - Morrison, K. AU - Sorensen, P. H. DA - Dec 15 DP - Nlm ET - 2001/12/26 IS - 24 LA - eng N1 - Tognon, C Garnett, M Kenward, E Kay, R Morrison, K Sorensen, P H U01-CA88199/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Cancer Res. 2001 Dec 15;61(24):8909-16. PY - 2001 SN - 0008-5472 (Print) 0008-5472 SP - 8909-16 ST - The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation T2 - Cancer Res TI - The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation VL - 61 ID - 5299 ER - TY - JOUR AD - Q.-M. Yang, Department of Hematology and Oncology, First Affiliated Hospital, People's Liberation Army General Hospital, Beijing 100048, China AU - Cao, Z. G. AU - Zhou, H. W. AU - Peng, C. J. AU - Liu, M. AU - Du, Y. AU - Yang, Q. M. DB - Embase Medline DO - 10.5732/cjc.012.10221 IS - 9 LA - English M3 - Article N1 - L369825218 2013-09-25 2013-10-10 PY - 2013 SN - 1000-467X 1944-446X SP - 520-523 ST - A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin T2 - Chinese Journal of Cancer TI - A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369825218&from=exporthttp://dx.doi.org/10.5732/cjc.012.10221http://www.cjcsysu.cn/cn/ENtopdf.asp?ly=CJC&idno=20329 VL - 32 ID - 5300 ER - TY - JOUR AD - Department of Biochemistry, Faculty of Medicine, Level 17, Preclinical Building, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaakob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia AU - Jaafar, F. AU - Durani, L. W. AU - Makpol, S. DB - Scopus DO - 10.1007/s11033-019-05140-8 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 369-379 ST - Chlorella vulgaris modulates the expression of senescence-associated genes in replicative senescence of human diploid fibroblasts T2 - Molecular Biology Reports TI - Chlorella vulgaris modulates the expression of senescence-associated genes in replicative senescence of human diploid fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074044385&doi=10.1007%2fs11033-019-05140-8&partnerID=40&md5=8560857663ceb059173f5f104c56806c VL - 47 ID - 5301 ER - TY - JOUR AD - J. Tan, Dept. of Psychiat. and Behav. Med., Institute for Research in Psychiatry, Univ. of S. Florida Coll. of Med., Tampa, FL, United States AU - Shytle, R. D. AU - Mori, T. AU - Townsend, K. AU - Vendrame, M. AU - Sun, N. AU - Zeng, J. AU - Ehrhart, J. AU - Silver, A. A. AU - Sanberg, P. R. AU - Tan, J. DB - Embase Medline DO - 10.1046/j.1471-4159.2004.02347.x IS - 2 LA - English M3 - Article N1 - L38495982 2004-05-03 PY - 2004 SN - 0022-3042 SP - 337-343 ST - Cholinergic modulation of microglial activation by α7 nicotinic receptors T2 - Journal of Neurochemistry TI - Cholinergic modulation of microglial activation by α7 nicotinic receptors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38495982&from=exporthttp://dx.doi.org/10.1046/j.1471-4159.2004.02347.x VL - 89 ID - 5302 ER - TY - JOUR AD - Department of Pediatrics, University School of Medicine, Las Vegas, NV, United States Red Rock Medical Group, Las Vegas, NV, United States University Medical Center of Southern Nevada, Las Vegas, NV, United States Quest Diagnostics, Las Vegas, NV, United States 10232 Splendor Ridge Avenue, Las Vegas, NV 89135, United States AU - Khatua, S. AU - Bilodeau, L. L. DB - Scopus DO - 10.1080/08880010701884709 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 147-153 ST - Chronic diarrhea and facial dysmorphism in children - A clue to MEN 2B syndrome: A case report T2 - Pediatric Hematology and Oncology TI - Chronic diarrhea and facial dysmorphism in children - A clue to MEN 2B syndrome: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-41149178114&doi=10.1080%2f08880010701884709&partnerID=40&md5=f24f63a21eed09ae7136b5541002e9be VL - 25 ID - 5303 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Environmental Health, Biomedical Research Center, School of Medicine, University of Coahuila, Torreon, Coahuila, Mexico Department of Cellular and Molecular Medicine, University of Arizona, Tuscon, AZ 85721, United States AU - Smeester, L. AU - Bommarito, P. A. AU - Martin, E. M. AU - Recio-Vega, R. AU - Gonzalez-Cortes, T. AU - Olivas-Calderon, E. AU - Lantz, R. C. AU - Fry, R. C. DB - Scopus DO - 10.1016/j.etap.2017.04.007 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 183-187 ST - Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response T2 - Environmental Toxicology and Pharmacology TI - Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018472294&doi=10.1016%2fj.etap.2017.04.007&partnerID=40&md5=65e6868ed1ff6b56f3154f8b0c814dc3 VL - 52 ID - 5304 ER - TY - JOUR AD - V. Kon, Departments of Pediatrics, Vanderbilt University Medical Center, C-4204 Medical Center North, 1161 21st Avenue South, Nashville, TN, United States AU - Kaseda, R. AU - Tsuchida, Y. AU - Yang, H. C. AU - Yancey, P. G. AU - Zhong, J. AU - Tao, H. AU - Bian, A. AU - Fogo, A. B. AU - Linton, M. R. F. AU - Fazio, S. AU - Ikizler, T. A. AU - Kon, V. DB - Embase Medline DO - 10.1186/s12882-018-0814-8 IS - 1 LA - English M3 - Article N1 - L620339057 2018-02-07 2018-09-03 PY - 2018 SN - 1471-2369 ST - Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: Effects of liver X receptor agonism T2 - BMC Nephrology TI - Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: Effects of liver X receptor agonism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620339057&from=exporthttp://dx.doi.org/10.1186/s12882-018-0814-8 VL - 19 ID - 5305 ER - TY - JOUR AU - D'Antonio, J. DB - Scopus DO - 10.1188/05.CJON.535-538 IS - 5 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2005 SP - 535-538 ST - Chronic myelogenous leukemia T2 - Clinical journal of oncology nursing TI - Chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644651466&doi=10.1188%2f05.CJON.535-538&partnerID=40&md5=8428d07b446c9eee8e6050056269a7ef VL - 9 ID - 5306 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston Texas Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange California Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas AN - 121147618. Language: English. Entry Date: 20170606. Revision Date: 20190912. Publication Type: journal article AU - Koller, Paul B. AU - Kantarjian, Hagop M. AU - Nogueras‐Gonzalez, Graciela M. AU - Jabbour, Elias AU - Verstovsek, Srdan AU - Borthakur, Gautam AU - Estrov, Zeev AU - Wierda, William G. AU - Garcia‐Manero, Guillermo AU - Ferrajoli, Alessandra AU - Ravandi, Farhad AU - O'Brien, Susan M. AU - Cortes, Jorge E. AU - Nogueras-Gonzalez, Graciela M. AU - Garcia-Manero, Guillermo DB - ccm DO - 10.1002/cncr.30362 DP - EBSCOhost IS - 4 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM27763690. PY - 2017 SN - 0008-543X SP - 609-616 ST - Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship T2 - Cancer (0008543X) TI - Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121147618&site=ehost-live&scope=site VL - 123 ID - 5307 ER - TY - JOUR AD - Faculté de médecine, L'université de Lomé, Togo Unité d'hématologie, CHU Campus de Lomé, Lomé, Togo Hématologie biologique, APHP hôpital Henri-Mondor, Créteil, France AU - Segbena, A. Y. AU - Kueviakoe, I. M. D. AU - Agbetiafa, K. AU - Padaro, E. AU - Layibo, Y. AU - Dorkenoo, A. AU - Agbo, Y. M. AU - Bories, D. DB - Scopus DO - 10.1684/mst.2012.0083 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2012 SP - 307-311 ST - Leucémie myéloïde chronique et imatinib, expérience du CHU campus de lome ́ au Togo T2 - Medecine et Sante Tropicales TI - Chronic myeloid leukemia and imatinib: Experience at the lome campus teaching hospital (Togo) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871628983&doi=10.1684%2fmst.2012.0083&partnerID=40&md5=ef42b36893f9b6bba2f4679d91980987 VL - 22 ID - 5308 ER - TY - JOUR AD - Department of Pathology, Penn State University, Hershey, PA 16802, USA. AN - 17889677 AU - Alsop, S. AU - Sanger, W. G. AU - Elenitoba-Johnson, K. S. AU - Lim, M. S. DA - Oct DO - 10.1016/j.humpath.2007.05.018 10.1016/j.humpath.2007.05.018. DP - Nlm ET - 2007/09/25 IS - 10 LA - eng PY - 2007 SN - 0046-8177 (Print) 0046-8177 SP - 1576-80 ST - Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma T2 - Hum Pathol TI - Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma VL - 38 ID - 5309 ER - TY - JOUR AD - Department of Hematology, Oncology L. and A. Seràgnoli S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Division of Hematology, AIEOP, Milano, Italy Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy Division of Hematology, Ospedale Niguarda, Milano, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Torino, Italy Division of Hematology, San Martino Hospital, Genova, Italy Division of Hematology, Bari, Italy Division of Hematology, Ravenna, Italy Division of Hematology, Napoli, Italy Hematology Section, University of Perugia, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Napoli, Italy Novartis Pharmaceutical, East Hanover, NJ, United States Institute of Hematology and Medical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi University Hospital, via Massarenti, 9, 40138 Bologna, Italy AU - Palandri, F. AU - Castagnetti, F. AU - Testoni, N. AU - Luatti, S. AU - Marzocchi, G. AU - Bassi, S. AU - Breccia, M. AU - Alimena, G. AU - Pungolino, E. AU - Rege-Cambrin, G. AU - Varaldo, R. AU - Miglino, M. AU - Specchia, G. AU - Zuffa, E. AU - Ferrara, F. AU - Bocchia, M. AU - Saglio, G. AU - Pane, F. AU - Alberti, D. AU - Martinelli, G. AU - Baccarani, M. AU - Rosti, G. DB - Scopus DO - 10.3324/haematol.13068 IS - 12 M3 - Article N1 - Cited By :69 Export Date: 18 November 2020 PY - 2008 SP - 1792-1796 ST - Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up T2 - Haematologica TI - Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: Outcome of the patients alive after a 6-year follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349124075&doi=10.3324%2fhaematol.13068&partnerID=40&md5=285d14ecf3262e24f347a1907ae83d5e VL - 93 ID - 5310 ER - TY - JOUR AD - Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India AN - 143193223. Language: English. Entry Date: 20200927. Revision Date: 20200927. Publication Type: journal article AU - Bansal, Deepak DB - ccm DO - 10.1007/s12098-020-03234-x DP - EBSCOhost IS - 6 N1 - review. Journal Subset: Asia; Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed. NLM UID: 0417442. PMID: NLM32086760. PY - 2020 SN - 0019-5456 SP - 443-450 ST - Chronic Myeloid Leukemia in Children: Challenges and Opportunities : Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019 T2 - Indian Journal of Pediatrics TI - Chronic Myeloid Leukemia in Children: Challenges and Opportunities : Based on 7th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 29th Sept. 2019 UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143193223&site=ehost-live&scope=site VL - 87 ID - 5311 ER - TY - JOUR AD - Division of Hematology, Oncology, and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box#30, Chicago, IL 60611, United States Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Centre d'Investigation Clinique 1402, Institut National de la Santé et de la Recherche Médicale (INSERM), University Hospital of Poitiers, 2 rue de la Milétrie, Poitiers, 86000, France Department of Pediatrics, University Hospital Carl Gustav Carus, Fetscherstrasse 74, Dresden, D-01307, Germany AU - Hijiya, N. AU - Millot, F. AU - Suttorp, M. DB - Scopus DO - 10.1016/j.pcl.2014.09.008 IS - 1 M3 - Review N1 - Cited By :30 Export Date: 18 November 2020 PY - 2015 SP - 107-119 ST - Chronic myeloid leukemia in children: Clinical findings, management, and unanswered questions T2 - Pediatric Clinics of North America TI - Chronic myeloid leukemia in children: Clinical findings, management, and unanswered questions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84915758765&doi=10.1016%2fj.pcl.2014.09.008&partnerID=40&md5=7180062ab7939d562a5f5ecba6bdf61d VL - 62 ID - 5312 ER - TY - JOUR AD - Division of Hematology, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India Division of Hematology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand Department of Hematology, Singapore General Hospital, Singapore Department of Hematology, Christchurch Hospital, Christchurch, New Zealand Bone Marrow Transplant Center, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China Haematology and Bone Marrow Transplant, Townsville Hospital, Townsville, QLD, Australia Department of Medicine, Ramathibodi Hospital, Bangkok, Thailand Molecular Genetic Research Institute, Catholic University of Korea, Seoul, South Korea Department of Hematology-Oncology, National University Cancer Institute, Singapore Department of Medicine, Cancer Center, First Hospital of Jilin University, Changchun, China Department of Hematology and Oncology, Nagoya University Hospital, Nagoya, Japan Department of Hematology, Sime Darby Medical Center Subang Jaya, Selangor, Malaysia Department of Hematology, Ampang Hospital, Ampang, Selangor, Malaysia Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taoyuan, Taiwan Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan Department of Hematology and Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan Department of Hematology, Shanghai Changhai Hospital, Shanghai, China Division of Haematology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, N.T., Hong Kong, China AU - Kim, D. W. AU - Banavali, S. D. AU - Bunworasate, U. AU - Goh, Y. T. AU - Ganly, P. AU - Huang, H. AU - Irving, I. AU - Jootar, S. AU - Goh, H. G. AU - Koh, L. P. AU - Li, W. AU - Naoe, T. AU - Ng, S. C. AU - Purushotaman, V. AU - Reksodiputro, H. AU - Shih, L. Y. AU - Tang, J. L. AU - Tojo, A. AU - Wang, J. AU - Wong, R. DB - Scopus DO - 10.1016/j.leukres.2010.03.033 IS - 11 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2010 SP - 1459-1471 ST - Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era T2 - Leukemia Research TI - Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957018636&doi=10.1016%2fj.leukres.2010.03.033&partnerID=40&md5=e901982f16399bad2e8322bd129b5bc1 VL - 34 ID - 5313 ER - TY - JOUR AD - Hematology Department, Aziza Othmana University Hospital, Tunis, Tunisia Hematology Department, Military Hospital Tunis, Tunis, Tunisia Hematology Department, Hedi Chaker Hospital, Sfax, Tunisia Hematology Department, Farhat Hached Hospital, Sousse, Tunisia Biology, Institut Pasteur, Tunis, Tunisia Hematology Department, La Rabta Hospital, Tunis, Tunisia Hematology Department, Fattouma Bourguiba Hospital, Monastir, Tunisia Centre national de greffe de moelle osseuse, Tunis, Tunisia Department of Haematology, Aziza Othmana University Hospital, Tunis, Tunisia AU - Ben Lakhal, R. AU - Ghedira, H. AU - Bellaaj, H. AU - Ben Youssef, Y. AU - Menif, S. AU - Manai, Z. AU - Bedoui, M. AU - Lakhal, A. AU - M’Sadek, F. AU - Elloumi, M. AU - Khélif, A. AU - Ben Romdhane, N. AU - Laatiri, M. A. AU - Ben Othmen, T. AU - Meddeb, B. DB - Scopus DO - 10.1007/s00277-017-3224-2 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 597-604 ST - Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) T2 - Annals of Hematology TI - Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040088966&doi=10.1007%2fs00277-017-3224-2&partnerID=40&md5=909e76c1d21b5d4b0c3f8c76e951ea75 VL - 97 ID - 5314 ER - TY - JOUR AD - S. Sathyanandan, Department of Immunohematology and Blood Transfusion, HLA-Immunogentics Lab, Tata Memorial Centre, Mumbai, India AU - Sathyanandan, S. AU - Jain, P. AU - Rajadhyaksha, S. B. AU - Meenakshi, S. AU - Roy, N. AU - Surjit, S. DB - Embase DO - 10.1159/000444288 IS - 6 LA - English M3 - Conference Abstract N1 - L615888612 2017-05-09 PY - 2016 SN - 1661-8777 SP - 325-326 ST - Chronic non-bacterial osteitis: Il-β dysregulation and EQ5D-5L validation of health outcome status T2 - Molecular Syndromology TI - Chronic non-bacterial osteitis: Il-β dysregulation and EQ5D-5L validation of health outcome status UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615888612&from=exporthttp://dx.doi.org/10.1159/000444288 VL - 6 ID - 5315 ER - TY - JOUR AD - Medizinische Klinik I, Abteilung Kardiologie, Univ. Klin. Leipzig, J. AU - Salameh, A. AU - Schneider, P. AU - Mühlberg, K. AU - Hagendorff, A. AU - Dhein, S. AU - Pfeiffer, D. C1 - pd 98059(New England Nuclear) sb 203580(Alexis,United States) C2 - Alexis(United States) New England Nuclear DB - Embase Medline DO - 10.1016/j.ejphar.2004.09.024 IS - 1-3 LA - English M3 - Article N1 - L39445934 2004-11-16 PY - 2004 SN - 0014-2999 SP - 9-16 ST - Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes T2 - European Journal of Pharmacology TI - Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39445934&from=exporthttp://dx.doi.org/10.1016/j.ejphar.2004.09.024 VL - 503 ID - 5316 ER - TY - JOUR AD - Department of Oncology, St George's University Hospital NHS Foundation Trust, London, UK Department of Urology, University of Tromso, Tromso, Norway Department of Oncology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK Department of Statistics, Indira Gandhi Institute of Development Research, Mumbai, India Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK The Cancer Centre, Queen Elizabeth Hospital Birmingham, Birmingham, UK AN - 136806657. Language: English. Entry Date: In Process. Revision Date: 20200321. Publication Type: journal article. Journal Subset: Biomedical AU - Afshar, Mehran AU - Patel, Hiten R. H. AU - Jain, Ankit AU - Kumar, Abhishek AU - Patel, Prashant AU - James, Nicholas D. AU - Porfiri, Emilio DB - ccm DO - 10.1080/14737140.2019.1609355 DP - EBSCOhost IS - 6 N1 - Europe; UK & Ireland. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 101123358. PMID: NLM30995130. PY - 2019 SN - 1473-7140 SP - 529-532 ST - Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism? T2 - Expert Review of Anticancer Therapy TI - Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136806657&site=ehost-live&scope=site VL - 19 ID - 5317 ER - TY - JOUR AD - H.-Y. Park, Department of Dermatology, Boston University, School of Medicine, 609 Albany Street, Boston, MA 02118, United States AU - Ching, C. S. AU - Phillips, T. J. AU - Howard, C. E. AU - Panova, I. P. AU - Hayes, C. M. AU - Asandra, A. S. AU - Park, H. Y. DB - Embase Medline DO - 10.1111/j.0022-202X.2004.23557.x IS - 2 LA - English M3 - Article N1 - L40175897 2005-02-15 PY - 2005 SN - 0022-202X SP - 466-474 ST - Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway T2 - Journal of Investigative Dermatology TI - Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40175897&from=exporthttp://dx.doi.org/10.1111/j.0022-202X.2004.23557.x VL - 124 ID - 5318 ER - TY - JOUR AD - M.-H. Tai, 3164 Biomedical and Physical Sciences Building, Department of Physiology, Michigan State University, East Lansing, MI 48824, United States AU - Tai, M. H. AU - Upham, B. L. AU - Olson, L. K. AU - Tsao, M. S. AU - Reed Jr, D. N. AU - Trosko, J. E. DB - Embase Medline DO - 10.1002/ijc.22530 IS - 9 LA - English M3 - Article N1 - L46418360 2007-04-29 PY - 2007 SN - 0020-7136 1097-0215 SP - 1855-1862 ST - Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells T2 - International Journal of Cancer TI - Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46418360&from=exporthttp://dx.doi.org/10.1002/ijc.22530 VL - 120 ID - 5319 ER - TY - JOUR AD - J. Zheng, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong AU - Liu, M. AU - Zhou, C. AU - Zheng, J. DB - Embase IS - 10 LA - English M3 - Article N1 - L607026255 2015-11-30 2015-12-01 PY - 2015 SN - 1943-8141 SP - 2026-2035 ST - Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition T2 - American Journal of Translational Research TI - Cigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607026255&from=export VL - 7 ID - 5320 ER - TY - JOUR AD - Y.-L. He, Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China AU - Huang, X. B. AU - Song, K. J. AU - Chen, G. B. AU - Liu, R. AU - Jiang, Z. F. AU - He, Y. L. DB - Embase Medline DO - 10.1080/15384047.2020.1824513 LA - English M3 - Article in Press N1 - L2006950162 2020-10-19 PY - 2020 SN - 1555-8576 1538-4047 ST - Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway T2 - Cancer Biology and Therapy TI - Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006950162&from=exporthttp://dx.doi.org/10.1080/15384047.2020.1824513 ID - 5321 ER - TY - JOUR AD - Y. Wang, Department of Neonatology, Yongchuan Hospital, Chongqing Medical University, Chongqing, China AU - Liu, Y. AU - Qingjuan, S. AU - Gao, Z. AU - Deng, C. AU - Wang, Y. AU - Guo, C. DB - Embase Medline DO - 10.1097/MD.0000000000007400 IS - 26 LA - English M3 - Article N1 - L617228888 2017-07-12 2017-07-18 PY - 2017 SN - 1536-5964 0025-7974 ST - Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis T2 - Medicine (United States) TI - Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617228888&from=exporthttp://dx.doi.org/10.1097/MD.0000000000007400 VL - 96 ID - 5322 ER - TY - JOUR AD - E. Hiyama, Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan AU - Kurihara, S. AU - Ueda, Y. AU - Onitake, Y. AU - Sueda, T. AU - Ohta, E. AU - Morihara, N. AU - Hirano, S. AU - Irisuna, F. AU - Hiyama, E. DB - Embase Medline DO - 10.1016/j.jpedsurg.2015.08.033 IS - 12 LA - English M3 - Conference Paper N1 - L606073599 2015-09-24 2016-04-14 PY - 2015 SN - 1531-5037 0022-3468 SP - 2094-2097 ST - Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors T2 - Journal of Pediatric Surgery TI - Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606073599&from=exporthttp://dx.doi.org/10.1016/j.jpedsurg.2015.08.033 VL - 50 ID - 5323 ER - TY - JOUR AD - S. Das, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA, United States AU - Melman, Y. F. AU - Shah, R. AU - Danielson, K. AU - Xiao, J. AU - Simonson, B. AU - Barth, A. AU - Chakir, K. AU - Lewis, G. D. AU - Lavender, Z. AU - Truong, Q. A. AU - Kleber, A. AU - Das, R. AU - Rosenzweig, A. AU - Wang, Y. AU - Kass, D. A. AU - Singh, J. P. AU - Das, S. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.114.013220 IS - 25 LA - English M3 - Review N1 - L607698694 2016-01-15 2016-01-21 PY - 2015 SN - 1524-4539 0009-7322 SP - 2202-2216 ST - Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: A translational pilot study T2 - Circulation TI - Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: A translational pilot study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607698694&from=exporthttp://dx.doi.org/10.1161/CIRCULATIONAHA.114.013220 VL - 131 ID - 5324 ER - TY - JOUR AD - C. Laurent, Université Paul-Sabatier, Toulouse, France AU - Laurent, C. AU - Lopez, C. AU - Desjobert, C. AU - Berrebi, A. AU - Damm-Welk, C. AU - Delsol, G. AU - Brousset, P. AU - Lamant, L. DB - Embase Medline DO - 10.1038/leu.2011.209 IS - 1 LA - English M3 - Letter N1 - L51570248 2011-08-17 2012-02-15 PY - 2012 SN - 0887-6924 1476-5551 SP - 188-190 ST - Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns T2 - Leukemia TI - Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51570248&from=exporthttp://dx.doi.org/10.1038/leu.2011.209 VL - 26 ID - 5325 ER - TY - JOUR AD - Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. semen_yesil@yahoo.com.tr. Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Pathology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul, Turkey. Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Nuclear Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Department of Pathology, University Health Network, Toronto, ON, Canada. ozgur.mete2@uhn.ca. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. ozgur.mete2@uhn.ca. Endocrine Oncology Site Group, Princess Margaret Cancer Center, Toronto, ON, Canada. ozgur.mete2@uhn.ca. AN - 26951110 AU - Onder, S. AU - Ozturk Sari, S. AU - Yegen, G. AU - Sormaz, I. C. AU - Yilmaz, I. AU - Poyrazoglu, S. AU - Sanlı, Y. AU - Giles Senyurek, Y. AU - Kapran, Y. AU - Mete, O. DA - Jun DO - 10.1007/s12022-016-9420-0 10.1007/s12022-016-9420-0. DP - Nlm ET - 2016/03/10 IS - 2 LA - eng PY - 2016 SN - 1046-3976 SP - 153-61 ST - Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas T2 - Endocr Pathol TI - Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas VL - 27 ID - 5326 ER - TY - JOUR AD - Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Research Center (MBC 03), PO Box 3354, Riyadh, 11211, Saudi Arabia. Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Research Center (MBC 03), PO Box 3354, Riyadh, 11211, Saudi Arabia. aliz@kfshrc.edu.sa. Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. aliz@kfshrc.edu.sa. AN - 27387551 AU - Murugan, A. K. AU - Qasem, E. AU - Al-Hindi, H. AU - Shi, Y. AU - Alzahrani, A. S. C2 - PMC4936197 DA - Jul 7 DO - 10.1186/s12967-016-0958-x 10.1186/s12967-016-0958-x. DP - Nlm ET - 2016/07/09 IS - 1 LA - eng PY - 2016 SN - 1479-5876 SP - 204 ST - Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer T2 - J Transl Med TI - Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer VL - 14 ID - 5327 ER - TY - JOUR AD - D. Ellison, Northern Inst. for Cancer Research, Medical School, University of Newcastle, Framlington Place, Newcastle-upon-Tyne NE2 4HH, United Kingdom AU - Ellison, D. DB - Embase Medline DO - 10.1046/j.1365-2990.2002.00419.x IS - 4 LA - English M3 - Review N1 - L34989289 2002-09-17 PY - 2002 SN - 0305-1846 SP - 257-282 ST - Classifying the medulloblastoma: Insights from morphology and molecular genetics T2 - Neuropathology and Applied Neurobiology TI - Classifying the medulloblastoma: Insights from morphology and molecular genetics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34989289&from=exporthttp://dx.doi.org/10.1046/j.1365-2990.2002.00419.x VL - 28 ID - 5328 ER - TY - JOUR AD - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Divison of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA AN - 128398722. Language: English. Entry Date: 20180314. Revision Date: 20190619. Publication Type: Article AU - Menegaz, Brian A. AU - Cuglievan, Branko AU - Benson, Jalen AU - Camacho, Pamela AU - Lamhamedi‐Cherradi, Salah‐Eddine AU - Leung, Cheuk Hong AU - Warneke, Carla L. AU - Huh, Winston AU - Subbiah, Vivek AU - Benjamin, Robert S. AU - Patel, Shreyaskumar AU - Daw, Najat AU - Hayes‐Jordan, Andrea AU - Ludwig, Joseph A. DB - ccm DO - 10.1634/theoncologist.2017-0408 DP - EBSCOhost IS - 3 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2018 SN - 1083-7159 SP - 360-366 ST - Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor T2 - Oncologist TI - Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128398722&site=ehost-live&scope=site VL - 23 ID - 5329 ER - TY - JOUR AD - R.G. Maki, Department of Medicine and Pediatrics, Sarcoma Service Memorial Sloan Kettering Cancer Center, New York, United States AU - Roubaud, G. AU - Kind, M. AU - Coindre, J. M. AU - Maki, R. G. AU - Bui, B. AU - Italiano, A. DB - Embase Medline DO - 10.1093/annonc/mdr631 IS - 3 LA - English M3 - Letter N1 - L364351593 2012-03-07 2012-03-26 PY - 2012 SN - 0923-7534 1569-8041 SP - 804-805 ST - Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: A case series T2 - Annals of Oncology TI - Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: A case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364351593&from=exporthttp://dx.doi.org/10.1093/annonc/mdr631 VL - 23 ID - 5330 ER - TY - JOUR AD - Molecular Cytogenetics, Section of Molecular Carcinogenesis, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. AN - 18839394 AU - Gilbert, D. C. AU - Chandler, I. AU - McIntyre, A. AU - Goddard, N. C. AU - Gabe, R. AU - Huddart, R. A. AU - Shipley, J. DA - Jan DO - 10.1002/path.2436 10.1002/path.2436. DP - Nlm ET - 2008/10/08 IS - 1 LA - eng PY - 2009 SN - 0022-3417 SP - 94-102 ST - Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents T2 - J Pathol TI - Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents VL - 217 ID - 5331 ER - TY - JOUR AD - J. Shipley, Molecular Cytogenetics, MUCRC, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom AU - Gilbert, D. C. AU - Chandler, I. AU - McLntyre, A. AU - Goddard, N. C. AU - Gabe, R. AU - Huddart, R. A. AU - Shipley, J. DB - Embase Medline DO - 10.1002/path.2436 IS - 1 LA - English M3 - Article N1 - L354091901 2009-02-16 PY - 2009 SN - 0022-3417 1096-9896 SP - 94-102 ST - Clinical and biological significance of CXCLI2 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents T2 - Journal of Pathology TI - Clinical and biological significance of CXCLI2 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354091901&from=exporthttp://dx.doi.org/10.1002/path.2436http://www3.interscience.wiley.com/cgi-bin/fulltext/121387921/PDFSTART VL - 217 ID - 5332 ER - TY - JOUR AD - A.K. Godwin, Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, United States AU - Rink, L. AU - Godwin, A. K. C1 - nvp aew 541(Novartis) C2 - Novartis DB - Embase Medline DO - 10.1007/s11912-009-0044-0 IS - 4 LA - English M3 - Review N1 - L354803792 2009-07-27 PY - 2009 SN - 1523-3790 SP - 314-321 ST - Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population T2 - Current Oncology Reports TI - Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354803792&from=exporthttp://dx.doi.org/10.1007/s11912-009-0044-0 VL - 11 ID - 5333 ER - TY - JOUR AD - S. Chen, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, China AU - Wen, L. AU - Xu, Y. AU - Yao, L. AU - Wang, N. AU - Wang, Q. AU - Liu, T. AU - Pan, J. AU - Cen, J. AU - Zhou, H. AU - Miao, M. AU - Shao, Y. W. AU - Wang, X. AU - Wang, X. AU - Ruan, C. AU - Wu, D. AU - Chen, S. DB - Embase Medline DO - 10.3324/haematol.2018.205369 IS - 5 LA - English M3 - Letter N1 - L2002006551 2019-07-10 2019-07-15 PY - 2019 SN - 1592-8721 0390-6078 SP - e195-e199 ST - Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions T2 - Haematologica TI - Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002006551&from=exporthttp://dx.doi.org/10.3324/haematol.2018.205369 VL - 104 ID - 5334 ER - TY - JOUR AD - Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy Department of Molecular Genetics, The Ohio State University, Columbus, OH, United States Section on Endocrinology and Genetics, Pediatric Endocrinology Training Program, National Institutes of Health, Bethesda, MD, United States Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States INSERM U567, Institut Cochin, Département d'Endocrinologie, Paris, France Cancerologie Endocrinienne, Institut Gustave Roussy, Villejuif, France Oncogenetique, Institut Gustave Roussy, Villejuif, France Department of Medical Genetics, Mayo Clinic, Rochester, MN, United States INSERM, U676, Paris, France Faculté de Médecine Denis Diderot, Université Paris 7, IFR02, Paris, France Department of Genetics, Assistance Publique-Hopitaux de Paris, Hopital Européen Georges Pompidou, Paris, France Faculté de Médecine, Université Paris-Descartes, Paris, France INSERM, U772, College de France, Paris, France Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH, United States Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States AU - Pasini, B. AU - McWhinney, S. R. AU - Bei, T. AU - Matyakhina, L. AU - Stergiopoulos, S. AU - Muchow, M. AU - Boikos, S. A. AU - Ferrando, B. AU - Pacak, K. AU - Assie, G. AU - Baudin, E. AU - Chompret, A. AU - Ellison, J. W. AU - Briere, J. J. AU - Rustin, P. AU - Gimenez-Roqueplo, A. P. AU - Eng, C. AU - Carney, J. A. AU - Stratakis, C. A. DB - Scopus DO - 10.1038/sj.ejhg.5201904 IS - 1 M3 - Article N1 - Cited By :324 Export Date: 18 November 2020 PY - 2008 SP - 79-88 ST - Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD T2 - European Journal of Human Genetics TI - Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37349074531&doi=10.1038%2fsj.ejhg.5201904&partnerID=40&md5=50c9892099a502f60039d8f08bf797cf VL - 16 ID - 5335 ER - TY - JOUR AD - *Department of Pathology §Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY †Dermatopathologie Friedrichshafen, Friedrichshafen, Germany ‡Department of Dermatology, Medical University Graz, Graz, Austria. AN - 24698967 AU - Busam, K. J. AU - Kutzner, H. AU - Cerroni, L. AU - Wiesner, T. C2 - PMC5042334 C6 - NIHMS708433 DA - Jul DO - 10.1097/pas.0000000000000187 10.1097/PAS.0000000000000187. DP - Nlm ET - 2014/04/05 IS - 7 LA - eng PY - 2014 SN - 0147-5185 (Print) 0147-5185 SP - 925-33 ST - Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions T2 - Am J Surg Pathol TI - Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions VL - 38 ID - 5336 ER - TY - JOUR AD - West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China AU - Wang, Y. AU - Deng, J. AU - Guo, G. AU - Tong, A. AU - Peng, X. AU - Chen, H. AU - Xu, J. AU - Liu, Y. AU - You, C. AU - Zhou, L. DB - Scopus DO - 10.1007/s11060-016-2273-z IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 21-29 ST - Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma T2 - Journal of Neuro-Oncology TI - Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988322199&doi=10.1007%2fs11060-016-2273-z&partnerID=40&md5=77785393c57acb9916379bbd8f90b8cd VL - 131 ID - 5337 ER - TY - JOUR AD - Department of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey. AN - 31058533 AU - Tas, F. AU - Erturk, K. DA - Jul 23 DO - 10.4149/neo_2018_181006N740 10.4149/neo_2018_181006N740. Epub 2019 Apr 24. DP - Nlm ET - 2019/05/07 IS - 4 LA - eng PY - 2019 SN - 0028-2685 (Print) 0028-2685 SP - 631-636 ST - Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients T2 - Neoplasma TI - Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients VL - 66 ID - 5338 ER - TY - JOUR AD - General and Esophageal Surgery Clinic, "Sf. Maria" Hospital, Bucharest Department of Anatomopathology, "Sf. Maria" Hospital, Bucharest Department of Oncology, "Sf. Maria" Hospital, Bucharest AU - Gheorghe, M. AU - Predescu, D. AU - Iosif, C. AU - Ardeleanu, C. AU - Băcanu, F. AU - Constantinoiu, S. DB - Scopus IS - 2 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 139-149 ST - Clinical and therapeutic considerations of GIST T2 - Journal of medicine and life TI - Clinical and therapeutic considerations of GIST UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930884349&partnerID=40&md5=1f34dfff5efd86f45451f943e62e8028 VL - 7 ID - 5339 ER - TY - JOUR AD - Department of Plastic and Reconstructive Surgery, University Sapienza, Rome, Italy. AN - 18201759 AU - Scuderi, N. AU - Onesti, M. G. AU - Bistoni, G. AU - Ceccarelli, S. AU - Rotolo, S. AU - Angeloni, A. AU - Marchese, C. DA - Apr DO - 10.1016/j.biomaterials.2007.12.024 10.1016/j.biomaterials.2007.12.024. Epub 2008 Jan 16. DP - Nlm ET - 2008/01/19 IS - 11 LA - eng PY - 2008 SN - 0142-9612 (Print) 0142-9612 SP - 1620-9 ST - The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold T2 - Biomaterials TI - The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold VL - 29 ID - 5340 ER - TY - JOUR AD - Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. soojincha36@gmail.com. Interdisciplinary Program for Bioengineering of Graduate School, Seoul National University, Seoul, Republic of Korea. jeleedict@gmail.com. Genomic Medicine Institute, Seoul National University, Seoul, Republic of Korea. jongyeon.anna@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. medijiyeon@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. cantusprote@gmail.com. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. bhumsuk@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. bhumsuk@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. gabriel9@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. gabriel9@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. kimdw@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. kimdw@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. heo1013@snu.ac.kr. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. heo1013@snu.ac.kr. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. sehoon.lee119@gmail.com. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. sehoon.lee119@gmail.com. Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. sehoon.lee119@gmail.com. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. sehoon.lee119@gmail.com. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. jongil@snu.ac.kr. Genomic Medicine Institute, Seoul National University, Seoul, Republic of Korea. jongil@snu.ac.kr. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Republic of Korea. jongil@snu.ac.kr. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Republic of Korea. jongil@snu.ac.kr. AN - 26925973 AU - Cha, S. AU - Lee, J. AU - Shin, J. Y. AU - Kim, J. Y. AU - Sim, S. H. AU - Keam, B. AU - Kim, T. M. AU - Kim, D. W. AU - Heo, D. S. AU - Lee, S. H. AU - Kim, J. I. C2 - PMC4772349 DA - Feb 29 DO - 10.1186/s12885-016-2209-1 10.1186/s12885-016-2209-1. DP - Nlm ET - 2016/03/02 LA - eng PY - 2016 SN - 1471-2407 SP - 170 ST - Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis T2 - BMC Cancer TI - Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis VL - 16 ID - 5341 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands Dutch Childhood Oncology Group, The Hague, Netherlands Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands AU - Klein, K. AU - de Haas, V. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1080/14737140.2018.1428091 IS - 3 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 277-293 ST - Clinical challenges in de novo pediatric acute myeloid leukemia T2 - Expert Review of Anticancer Therapy TI - Clinical challenges in de novo pediatric acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042385581&doi=10.1080%2f14737140.2018.1428091&partnerID=40&md5=9fc80bd380a1f6f5a794320a978d2002 VL - 18 ID - 5342 ER - TY - JOUR AD - Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China AU - Xue, M. AU - Wang, Q. AU - Huo, L. AU - Wen, L. AU - Yang, X. AU - Wu, Q. AU - Pan, J. AU - Cen, J. AU - Ruan, C. AU - Wu, D. AU - Chen, S. DB - Scopus DO - 10.1080/10428194.2019.1607329 IS - 12 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 3051-3057 ST - Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts T2 - Leukemia and Lymphoma TI - Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068535211&doi=10.1080%2f10428194.2019.1607329&partnerID=40&md5=9fc6fba7e20822de1fe51e17d71b3f67 VL - 60 ID - 5343 ER - TY - JOUR AD - Department of Pathology, University of New Mexico, School of Medicine, Albuquerque, NM, United States University of New Mexico, Comprehensive Cancer Center, Albuquerque, NM, United States Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States AU - Harvey, R. C. AU - Tasian, S. K. DB - Scopus DO - 10.1182/bloodadvances.2019000163 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2020 SP - 218-228 ST - Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia T2 - Blood Advances TI - Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078112931&doi=10.1182%2fbloodadvances.2019000163&partnerID=40&md5=80886b123d1b3095edd76d05106be304 VL - 4 ID - 5344 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics, START Center, San Antonio, Texas 78229, USA. AN - 22261800 AU - Shimizu, T. AU - Tolcher, A. W. AU - Papadopoulos, K. P. AU - Beeram, M. AU - Rasco, D. W. AU - Smith, L. S. AU - Gunn, S. AU - Smetzer, L. AU - Mays, T. A. AU - Kaiser, B. AU - Wick, M. J. AU - Alvarez, C. AU - Cavazos, A. AU - Mangold, G. L. AU - Patnaik, A. DA - Apr 15 DO - 10.1158/1078-0432.Ccr-11-2381 10.1158/1078-0432.CCR-11-2381. Epub 2012 Jan 19. DP - Nlm ET - 2012/01/21 IS - 8 LA - eng PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 2316-25 ST - The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer T2 - Clin Cancer Res TI - The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer VL - 18 ID - 5345 ER - TY - JOUR AD - Department of Hematology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan Blood Disorders Center, Aiiku Hospital, S4W25, Chuo-ku, Sapporo, 064-0804, Japan Department of Cell Physiology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan Department of Internal Medicine, Japan Labour Health and Welfare Organization, Kushiro Rosai Hospital, Kushiro, Japan Department of Hematology, Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital, Sapporo, Japan Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan Department of Hematology, Sapporo City General Hospital, Sapporo, Japan Department of Hematology, Tonan Hospital, Sapporo, Japan Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan AU - Kondo, T. AU - Fujioka, M. AU - Fujisawa, S. AU - Sato, K. AU - Tsuda, M. AU - Miyagishima, T. AU - Mori, A. AU - Iwasaki, H. AU - Kakinoki, Y. AU - Yamamoto, S. AU - Haseyama, Y. AU - Ando, S. AU - Shindo, M. AU - Ota, S. AU - Kurosawa, M. AU - Ohba, Y. AU - Teshima, T. AU - The North Japan Hematology Study, Group DB - Scopus DO - 10.1007/s12185-019-02696-w IS - 4 M3 - Article N1 - (NJHSG) Export Date: 18 November 2020 PY - 2019 SP - 482-489 ST - Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test T2 - International Journal of Hematology TI - Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068151164&doi=10.1007%2fs12185-019-02696-w&partnerID=40&md5=3710de66fa5fd1b1c202e8826839406b VL - 110 ID - 5346 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, United States Department of Pediatrics, Ohio State University College of Medicine, Columbus, OH, United States AU - Wedekind, M. F. AU - Ranalli, M. AU - Shah, N. C7 - e26586 DB - Scopus DO - 10.1002/pbc.26586 IS - 11 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 ST - Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma T2 - Pediatric Blood and Cancer TI - Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018554022&doi=10.1002%2fpbc.26586&partnerID=40&md5=db9d8111c49668edb41cdc19308d21c1 VL - 64 ID - 5347 ER - TY - JOUR AD - P. O'Hare, Department of Paediatric Oncology, Great Ormond Street Hospital NHS Trust, London, United Kingdom AU - O'Hare, P. AU - Loka, T. AU - D'Arco, F. AU - Depani, S. AU - Michalski, A. AU - Slater, O. AU - Jorgensen, M. AU - Jacques, T. AU - Hargrave, D. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098647 2018-07-25 PY - 2018 SN - 1523-5866 SP - i113 ST - Clinical experience of BRAF and MEK inhibitor therapy in paediatric glioma T2 - Neuro-Oncology TI - Clinical experience of BRAF and MEK inhibitor therapy in paediatric glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098647&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 5348 ER - TY - JOUR AD - Massachusetts General Hospital Cancer Center, Boston, MA 02114, United States Dana Farber Cancer Institute, Boston, United States Department of Dermatology, Essen University Hospital, Essen, Germany Department of Dermatology, University Hospital Zurich, Zurich, Switzerland Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland Department of Biomedicine, Switzerland Department of Dermatology, University Hospital of Basel, Basel, Switzerland AU - Drago, J. Z. AU - Lawrence, D. AU - Livingstone, E. AU - Zimmer, L. AU - Chen, T. AU - Giobbie-Hurder, A. AU - Amann, V. C. AU - Mangana, J. AU - Siano, M. AU - Zippelius, A. AU - Dummer, R. AU - Goldinger, S. M. AU - Sullivan, R. J. DB - Scopus DO - 10.1097/CMR.0000000000000527 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2019 SP - 65-69 ST - Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: A real-life multicenter study T2 - Melanoma Research TI - Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: A real-life multicenter study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058765141&doi=10.1097%2fCMR.0000000000000527&partnerID=40&md5=69251bbb5a543500269818cdd04a06f3 VL - 29 ID - 5349 ER - TY - JOUR AD - Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Department of Pathology, Seoul National University Hospital, Seoul, Korea. AN - 29950554 AU - Ock, C. Y. AU - Yoo, S. H. AU - Keam, B. AU - Kim, M. AU - Kim, T. M. AU - Jeon, Y. K. AU - Kim, D. W. AU - Chung, D. H. AU - Heo, D. S. C2 - PMC6718771 DA - Sep DO - 10.3904/kjim.2018.011 10.3904/kjim.2018.011. Epub 2018 Jun 29. DP - Nlm ET - 2018/06/29 IS - 5 LA - eng PY - 2019 SN - 1226-3303 (Print) 1226-3303 SP - 1116-1124 ST - Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer T2 - Korean J Intern Med TI - Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer VL - 34 ID - 5350 ER - TY - JOUR AD - Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. Division of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp. Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp. AN - 32514929 AU - Kobayashi, M. AU - Ando, S. AU - Kawamata, T. AU - Makiyama, J. AU - Yokoyama, K. AU - Imai, Y. AU - Tojo, A. DA - Aug DO - 10.1007/s12185-020-02892-z 10.1007/s12185-020-02892-z. Epub 2020 Jun 8. DP - Nlm ET - 2020/06/10 IS - 2 LA - eng PY - 2020 SN - 0925-5710 SP - 185-192 ST - Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience T2 - Int J Hematol TI - Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience VL - 112 ID - 5351 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Kariyama, K. AU - Takaguchi, K. AU - Atsukawa, M. AU - Itobayashi, E. AU - Tsuji, K. AU - Tajiri, K. AU - Hirooka, M. AU - Shimada, N. AU - Shibata, H. AU - Ishikawa, T. AU - Ochi, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Itokawa, N. AU - Imai, M. AU - Joko, K. AU - Hiasa, Y. AU - Michitaka, K. AU - the Real-life Practice Experts for Hcc Study Group, H. C. C. Group DB - Scopus DO - 10.1002/cam4.1909 IS - 1 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :47 Export Date: 18 November 2020 PY - 2019 SP - 137-146 ST - Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis T2 - Cancer Medicine TI - Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058930583&doi=10.1002%2fcam4.1909&partnerID=40&md5=a009438339852057be5c702f7dc521e2 VL - 8 ID - 5352 ER - TY - JOUR AD - Division of Hematology/Oncology, San Francisco School of Medicine, University of California, San Francisco, CA, United States Department of Pulmonary Medicine, Critical Care and Allergy, Bristol-Myers Squibb, Princeton, NJ, United States Boston University School of Medicine, Boston, MA, United States Memorial Sloan Kettering Cancer Center, New York, NY, United States Santa Croce Hospital, Cuneo, Italy Hôpital Saint-Louis, Paris, France Scottish Pulmonary Vascular Unit, Glasgow, United Kingdom AU - Shah, N. P. AU - Wallis, N. AU - Farber, H. W. AU - Mauro, M. J. AU - Wolf, R. A. AU - Mattei, D. AU - Guha, M. AU - Rea, D. AU - Peacock, A. DB - Scopus DO - 10.1002/ajh.24174 IS - 11 M3 - Article N1 - Cited By :65 Export Date: 18 November 2020 PY - 2015 SP - 1060-1064 ST - Clinical features of pulmonary arterial hypertension in patients receiving dasatinib T2 - American Journal of Hematology TI - Clinical features of pulmonary arterial hypertension in patients receiving dasatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944522481&doi=10.1002%2fajh.24174&partnerID=40&md5=e04bccfc889da1a0acbac3677a4aa57d VL - 90 ID - 5353 ER - TY - JOUR AD - Department of Medicine, University of Chicago Medical Center, Chicago, IL, United States Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, United States Roswell Park Cancer Institute, Buffalo, NY, United States The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States City of Hope Comprehensive Cancer Center, Duarte, CA, United States Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Health Informatics Institute, University of South Florida, Tampa, FL, United States St. Jude Children’s Research Hospital, Memphis, TN, United States AU - DeBoer, R. AU - Koval, G. AU - Mulkey, F. AU - Wetzler, M. AU - Devine, S. AU - Marcucci, G. AU - Stone, R. M. AU - Larson, R. A. AU - Bloomfield, C. D. AU - Geyer, S. AU - Mullighan, C. G. AU - Stock, W. DB - Scopus DO - 10.3109/10428194.2016.1144881 IS - 10 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2016 SP - 2298-2306 ST - Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 T2 - Leukemia and Lymphoma TI - Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958751941&doi=10.3109%2f10428194.2016.1144881&partnerID=40&md5=010cac41cc16c5d01938c4ebd1566dac VL - 57 ID - 5354 ER - TY - JOUR AD - Department of Leukemia, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Santos, F. P. S. AU - Kantarjian, H. AU - Fava, C. AU - O'Brien, S. AU - Garcia-Manero, G. AU - Ravandi, F. AU - Wierda, W. AU - Thomas, D. AU - Shan, J. AU - Cortes, J. DB - Scopus DO - 10.1111/j.1365-2141.2010.08245.x IS - 3 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2010 SP - 303-312 ST - Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia T2 - British Journal of Haematology TI - Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954612906&doi=10.1111%2fj.1365-2141.2010.08245.x&partnerID=40&md5=46639f46c2c859d7a2039166151f5e40 VL - 150 ID - 5355 ER - TY - JOUR AD - Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Department of Radiology, Konyang University Hospital, Konyang University College of Medicine, Seoul, Korea. Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Biostatistics Collaboration Unit, Medical Research Center, Yonsei University College of Medicine, Seoul, Korea. Department of Pathology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea docjin@yuhs.ac. AN - 25404749 AU - Seo, J. Y. AU - Choi, J. R. AU - Moon, H. J. AU - Kim, E. K. AU - Han, K. H. AU - Kim, H. AU - Kwak, J. Y. DA - May DO - 10.1177/0003489414560433 10.1177/0003489414560433. Epub 2014 Nov 17. DP - Nlm ET - 2014/11/19 IS - 5 LA - eng PY - 2015 SN - 0003-4894 (Print) 0003-4894 SP - 392-9 ST - Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma T2 - Ann Otol Rhinol Laryngol TI - Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma VL - 124 ID - 5356 ER - TY - JOUR AD - M. Zenker, Institute of Human Genetics, University Hospital Magdeburg, Leipziger Straße 44, 39120 Magdeburg, Germany AU - Zenker, M. DB - Embase Medline DO - 10.1097/MOP.0b013e32834881dd IS - 4 LA - English M3 - Review N1 - L362213699 2011-08-03 2011-08-05 PY - 2011 SN - 1040-8703 1531-698X SP - 443-451 ST - Clinical manifestations of mutations in RAS and related intracellular signal transduction factors T2 - Current Opinion in Pediatrics TI - Clinical manifestations of mutations in RAS and related intracellular signal transduction factors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362213699&from=exporthttp://dx.doi.org/10.1097/MOP.0b013e32834881dd VL - 23 ID - 5357 ER - TY - JOUR AD - R. Groisberg AU - Groisberg, R. AU - Hong, D. S. AU - Janku, F. AU - Piha-Paul, S. A. AU - Ravi, V. AU - Benjamin, R. S. AU - Patel, S. AU - Somaiah, N. AU - Conley, A. P. AU - Herzog, C. E. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase LA - English M3 - Conference Abstract N1 - L611753837 2016-08-25 PY - 2016 SN - 1527-7755 ST - Clinical next-generation sequencing in sarcomas T2 - Journal of Clinical Oncology TI - Clinical next-generation sequencing in sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611753837&from=export VL - 34 ID - 5358 ER - TY - JOUR AD - Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China Department of Hematology, The Central Hospital of Wuhan, Wuhan, 430016, China Bioinformatics and Molecular Imaging Key Laboratory, Department of Biomedical Engineering, Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China AU - Li, Q. AU - Zhong, Z. AU - Zeng, C. AU - Meng, L. AU - Li, C. AU - Luo, Y. AU - Wang, H. AU - Li, W. AU - Wang, J. AU - Cheng, F. AU - Guo, A. AU - Liu, S. AU - Jin, C. AU - Zhu, X. AU - You, Y. AU - Zou, P. DB - Scopus DO - 10.18632/oncotarget.11281 IS - 36 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - 58234-58243 ST - A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors T2 - Oncotarget TI - A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988349865&doi=10.18632%2foncotarget.11281&partnerID=40&md5=5d29e3ec5cca9d457434764cf7266665 VL - 7 ID - 5359 ER - TY - JOUR AD - O.S. Eckstein, Texas Children's Cancer Center, Department of Pediatrics, Texas Children's Hospital, Houston, TX, United States AU - Eckstein, O. S. AU - Zinn, D. AU - Levy, C. F. AU - Henry, M. M. AU - Campbell, P. AU - Jordan, M. B. AU - Kumar, A. R. AU - Rodriguez-Galindo, C. AU - Hijiya, N. AU - Abla, O. AU - McClain, K. L. AU - Allen, C. E. DB - Embase DO - 10.1182/blood-2018-99-120393 LA - English M3 - Conference Abstract N1 - L626415138 2019-02-22 PY - 2018 SN - 0006-4971 ST - Clinical outcomes and molecular responses in children with langerhans cell histiocytosis treated with mapk pathway inhibitors T2 - Blood TI - Clinical outcomes and molecular responses in children with langerhans cell histiocytosis treated with mapk pathway inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626415138&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-120393 VL - 132 ID - 5360 ER - TY - JOUR AD - O. Eckstein, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States AU - Eckstein, O. AU - Zinn, D. AU - Visser, J. AU - Fein Levy, C. AU - Karras, N. AU - Henry, M. AU - Campbell, P. AU - Jordan, M. AU - Kumar, A. AU - Rodriguez-Galindo, C. AU - McClain, K. AU - Allen, C. DB - Embase DO - 10.1002/pbc.27057 LA - English M3 - Conference Abstract N1 - L621728488 2018-04-24 PY - 2018 SN - 1545-5017 SP - S238-S239 ST - Clinical outcomes with mapk inhibition in pediatric langerhans cell histiocytosis T2 - Pediatric Blood and Cancer TI - Clinical outcomes with mapk inhibition in pediatric langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621728488&from=exporthttp://dx.doi.org/10.1002/pbc.27057 VL - 65 ID - 5361 ER - TY - JOUR AD - Departments of Clinical Pharmacy and Toxicology, University Medical Center, Leiden, Netherlands Departments of Clinical Oncology, University Medical Center, Leiden, Netherlands AU - van Erp, N. P. AU - Gelderblom, H. AU - Guchelaar, H. J. DB - Scopus DO - 10.1016/j.ctrv.2009.08.004 IS - 8 M3 - Review N1 - Cited By :300 Export Date: 18 November 2020 PY - 2009 SP - 692-706 ST - Clinical pharmacokinetics of tyrosine kinase inhibitors T2 - Cancer Treatment Reviews TI - Clinical pharmacokinetics of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449704111&doi=10.1016%2fj.ctrv.2009.08.004&partnerID=40&md5=26772b683ef7d9e6a2b59d3179f67ed8 VL - 35 ID - 5362 ER - TY - JOUR AD - Department of Medical Oncology, CERIA, Paris Descartes University, AP-HP, Cochin Hospital, Paris, France UMR8638 CNRS, UFR de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France AU - Boudou-Rouquette, P. AU - Tlemsani, C. AU - Blanchet, B. AU - Huillard, O. AU - Jouinot, A. AU - Arrondeau, J. AU - Thomas-Schoemann, A. AU - Vidal, M. AU - Alexandre, J. AU - Goldwasser, F. DB - Scopus DO - 10.1080/17425255.2016.1225038 IS - 12 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 1433-1444 ST - Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review T2 - Expert Opinion on Drug Metabolism and Toxicology TI - Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84996503759&doi=10.1080%2f17425255.2016.1225038&partnerID=40&md5=1a2fbf4af76725ca1b31cfb29477c756 VL - 12 ID - 5363 ER - TY - JOUR AD - D.C. Doval, Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India AU - Doval, D. C. AU - Sinha, R. AU - Batra, U. AU - Choudhury, K. D. AU - Azam, S. AU - Mehta, A. DB - Embase Medline DO - 10.4103/0019-509X.219591 IS - 1 LA - English M3 - Article N1 - L619849415 2017-12-25 2018-07-17 PY - 2017 SN - 1998-4774 0019-509X SP - 193-196 ST - Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center T2 - Indian Journal of Cancer TI - Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619849415&from=exporthttp://dx.doi.org/10.4103/0019-509X.219591 VL - 54 ID - 5364 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, United Kingdom AU - Moorman, A. V. DB - Scopus DO - 10.1016/j.blre.2012.01.001 IS - 3 M3 - Article N1 - Cited By :104 Export Date: 18 November 2020 PY - 2012 SP - 123-135 ST - The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia T2 - Blood Reviews TI - The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859209595&doi=10.1016%2fj.blre.2012.01.001&partnerID=40&md5=e3e7f33303cf128d2a4cf09217b7cc1c VL - 26 ID - 5365 ER - TY - JOUR AD - H. Ahlert, Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, University Hospital Dusseldorf, Dusseldorf, Germany AU - Ahlert, H. AU - Bhatia, S. AU - Sonnichsen, M. AU - Dienstbier, N. AU - Remke, M. AU - Fischer, U. AU - Hauer, J. AU - Borkhardt, A. DB - Embase LA - English M3 - Conference Abstract N1 - L629911706 2019-11-26 PY - 2019 SN - 2572-9241 SP - 762-763 ST - The clinical relevance of indirect myc inhibitors for personalized T-all treatment T2 - HemaSphere TI - The clinical relevance of indirect myc inhibitors for personalized T-all treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629911706&from=export VL - 3 ID - 5366 ER - TY - JOUR AD - Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. Children's Hospital Affiliated to Zhengzhou University, 450018 Zhengzhou, China. Department of Pathology and Genetics, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. Childhood Cancer Research Unit, Department of Women's and Children's Health, and Pediatric Oncology Program Karolinska University Hospital, Stockholm 17176, Sweden. Institute of Molecular Biology, Umeå University, Umeå 90187, Sweden. Department of Oncology-Pathology, Karolinska Institutet, Stockholm 17176, Sweden. Department of Clinical Pathology, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Radiology, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatric Radiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatric Surgery, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm 17176, Sweden. Department of Pediatrics and Pathology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden. AN - 29907598 AU - Guan, J. AU - Fransson, S. AU - Siaw, J. T. AU - Treis, D. AU - Van den Eynden, J. AU - Chand, D. AU - Umapathy, G. AU - Ruuth, K. AU - Svenberg, P. AU - Wessman, S. AU - Shamikh, A. AU - Jacobsson, H. AU - Gordon, L. AU - Stenman, J. AU - Svensson, P. J. AU - Hansson, M. AU - Larsson, E. AU - Martinsson, T. AU - Palmer, R. H. AU - Kogner, P. AU - Hallberg, B. C2 - PMC6071567 DA - Aug DO - 10.1101/mcs.a002550 10.1101/mcs.a002550. Print 2018 Aug. DP - Nlm ET - 2018/06/17 IS - 4 LA - eng PY - 2018 SN - 2373-2873 ST - Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib T2 - Cold Spring Harb Mol Case Stud TI - Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib VL - 4 ID - 5367 ER - TY - JOUR AD - ENT Department, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. ignafernandez@yahoo.it AN - 23482475 AU - Fernandez, I. J. AU - Piccin, O. AU - Sciascia, S. AU - Cavicchi, O. AU - Repaci, A. AU - Vicennati, V. AU - Fiorentino, M. DA - Jun DO - 10.1177/0194599813481942 10.1177/0194599813481942. Epub 2013 Mar 12. DP - Nlm ET - 2013/03/14 IS - 6 LA - eng PY - 2013 SN - 0194-5998 SP - 919-25 ST - Clinical significance of BRAF mutation in thyroid papillary cancer T2 - Otolaryngol Head Neck Surg TI - Clinical significance of BRAF mutation in thyroid papillary cancer VL - 148 ID - 5368 ER - TY - JOUR AD - Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030; Department of Dermatology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Biostatistics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Department of Pathology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030; Department of Dermatology, The University of Texas-MD Anderson Cancer Center, Houston, TX 77030. Electronic address: vprieto@mdanderson.org. AN - 27666765 AU - Siroy, A. E. AU - Aung, P. P. AU - Torres-Cabala, C. A. AU - Tetzlaff, M. T. AU - Nagarajan, P. AU - Milton, D. R. AU - Curry, J. L. AU - Ivan, D. AU - Prieto, V. G. DA - Jan DO - 10.1016/j.humpath.2016.09.010 10.1016/j.humpath.2016.09.010. Epub 2016 Sep 22. DP - Nlm ET - 2016/09/27 LA - eng PY - 2017 SN - 0046-8177 SP - 48-54 ST - Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma T2 - Hum Pathol TI - Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma VL - 59 ID - 5369 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Bldg. 54, 6825 16th Street, N.W., Washington, DC 20306-6000, United States Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, United States AU - Lasota, J. AU - Miettinen, M. DB - Scopus DO - 10.1111/j.1365-2559.2008.02977.x IS - 3 M3 - Review N1 - Cited By :319 Export Date: 18 November 2020 PY - 2008 SP - 245-266 ST - Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours T2 - Histopathology TI - Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-49749122255&doi=10.1111%2fj.1365-2559.2008.02977.x&partnerID=40&md5=4f3c77723e3896cb46ab78501c89c628 VL - 53 ID - 5370 ER - TY - JOUR AD - Department of Clinical Pharmacology Pfizer, 500 Arcola Road, Collegeville, PA 19426, United States AU - Abbas, R. AU - Leister, C. AU - Sonnichsen, D. DB - Scopus DO - 10.1007/s40261-013-0103-z IS - 8 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2013 SP - 589-595 ST - A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects T2 - Clinical Drug Investigation TI - A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880875942&doi=10.1007%2fs40261-013-0103-z&partnerID=40&md5=e8dc4b1f5905fd72d459dc7cc5270aa5 VL - 33 ID - 5371 ER - TY - JOUR AD - L. Byer, School of Medicine, University of California, San Francisco (UCSF), 513 Parnassus Ave, San Francisco, CA, United States AU - Byer, L. AU - Kline, C. AU - Mueller, S. C1 - pd 0325901 DB - Embase Medline DO - 10.2217/cns-2016-0016 IS - 4 LA - English M3 - Review N1 - L612480011 2016-10-07 2016-10-12 PY - 2016 SN - 2045-0915 2045-0907 SP - 233-239 ST - Clinical trials in pediatric neuro-oncology: What is missing and how we can improve T2 - CNS Oncology TI - Clinical trials in pediatric neuro-oncology: What is missing and how we can improve UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612480011&from=exporthttp://dx.doi.org/10.2217/cns-2016-0016 VL - 5 ID - 5372 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Experimental Oncology, Catholic University Leuven, Leuven, Belgium Center for Human Genetics, Catholic University Leuven, Leuven, Belgium Department of Surgical Oncology, Medical University of Gdansk, Poland Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Department Biology and Genetics, Medical University of Gdansk, Poland AU - Rutkowski, P. AU - Wozniak, A. AU - Dȩbiec-Rychter, M. AU - Kåkol, M. AU - Dziewirski, W. AU - Zdzienicki, M. AU - Ptaszynski, K. AU - Jurkowska, M. AU - Limon, J. AU - Siedlecki, J. A. DB - Scopus DO - 10.1002/cncr.26079 IS - 21 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2011 SP - 4916-4924 ST - Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resection T2 - Cancer TI - Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: Current overall survival after primary tumor resection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054828280&doi=10.1002%2fcncr.26079&partnerID=40&md5=3e5e133e7bdbd87cba95d27f57a7e28c VL - 117 ID - 5373 ER - TY - JOUR AD - Departments of Dermatology. Pathology, Leiden University Medical Center, Leiden. Department of Dermatology, Academic Medical Center and Vrije University Medical Center, Amsterdam. Department of Dermatology, University Medical Center of Groningen, Groningen, The Netherlands. AN - 32412717 AU - Melchers, R. C. AU - Willemze, R. AU - van de Loo, M. AU - van Doorn, R. AU - Jansen, P. M. AU - Cleven, A. H. G. AU - Solleveld, N. AU - Bekkenk, M. W. AU - van Kester, M. S. AU - Diercks, G. F. H. AU - Vermeer, M. H. AU - Quint, K. D. DA - Jun DO - 10.1097/pas.0000000000001449 10.1097/PAS.0000000000001449. DP - Nlm ET - 2020/05/16 IS - 6 LA - eng PY - 2020 SN - 0147-5185 SP - 776-781 ST - Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma T2 - Am J Surg Pathol TI - Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma VL - 44 ID - 5374 ER - TY - JOUR AD - Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Service des Maladies du Sang, Centre François Magendie, Hôpital du Haut-Lévèque, Pessac, France. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Adult Hematology, Hôpital Saint Louis, Paris, France. Department of Hematology, Hôpital Hotel Dieu, Nantes, France. Department of Hematology, Hôpital Edouard Herriot, Lyon, France. Clinical Biomarkers, Merck KGaA, Darmstadt, Germany. Clinical Oncology, Early Development, EMD Serono, Billerica, MA, USA. Global Biostatistics, Hematologic Cancer and BMT, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, MD, USA. AN - 26657199 AU - Ravandi, F. AU - Pigneux, A. AU - DeAngelo, D. J. AU - Raffoux, E. AU - Delaunay, J. AU - Thomas, X. AU - Kadia, T. AU - Kantarjian, H. AU - Scheuenpflug, J. AU - Zhao, C. AU - Guo, W. AU - Smith, B. D. C2 - PMC4735070 of this study. JS is employed by Merck KGaA, Darmstadt, Germany. CZ and WG are employed by EMD Serono, Billerica, USA. AP has received honorarium for coordination of this study. The remaining authors have no conflict of interest. DA - Dec 11 DO - 10.1038/bcj.2015.103 10.1038/bcj.2015.103. DP - Nlm ET - 2015/12/15 IS - 12 LA - eng PY - 2015 SN - 2044-5385 SP - e375 ST - Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies T2 - Blood Cancer J TI - Clinical, pharmacokinetic and pharmacodynamic data for the MEK1/2 inhibitor pimasertib in patients with advanced hematologic malignancies VL - 5 ID - 5375 ER - TY - JOUR AD - Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany; Cluster of Excellence "Cells in Motion", Westfälische Wilhelms-Universität, Münster, Germany. Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany. University of Tübingen, Interfaculty Institute for Cell Biology, Department of Immunology, Tübingen, Germany. Institute of Virology (IVM), Westfälische Wilhelms-Universität, Münster, Germany; Cluster of Excellence "Cells in Motion", Westfälische Wilhelms-Universität, Münster, Germany. Electronic address: ludwigs@uni-muenster.de. AN - 29990517 AU - Schräder, T. AU - Dudek, S. E. AU - Schreiber, A. AU - Ehrhardt, C. AU - Planz, O. AU - Ludwig, S. DA - Sep DO - 10.1016/j.antiviral.2018.07.006 10.1016/j.antiviral.2018.07.006. Epub 2018 Jul 7. DP - Nlm ET - 2018/07/11 LA - eng PY - 2018 SN - 0166-3542 SP - 80-92 ST - The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression T2 - Antiviral Res TI - The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression VL - 157 ID - 5376 ER - TY - JOUR AD - S. Mallick, Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Mallick, S. AU - Lone, M. R. AU - Ramteke, P. AU - Purokait, S. AU - Gogia, A. AU - Batra, A. AU - Bakhshi, S. AU - Sharma, A. AU - Sharma, M. C. DB - Embase DO - 10.1002/hon.2439 LA - English M3 - Conference Abstract N1 - L617728884 2017-08-15 PY - 2017 SN - 0278-0232 SP - 395-396 ST - Clinico-pathological profile and CMYC immunoreactivity of ALK positive large B cell lymphoma: Report of nine cases T2 - Hematological Oncology TI - Clinico-pathological profile and CMYC immunoreactivity of ALK positive large B cell lymphoma: Report of nine cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617728884&from=exporthttp://dx.doi.org/10.1002/hon.2439 VL - 35 ID - 5377 ER - TY - JOUR AD - Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Department of Pathology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Internal Medicine, Division of Endocrinology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Department of Pathology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea; Thyroid Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea. Electronic address: hkim1967@gmail.com. AN - 25468810 AU - Jung, Y. Y. AU - Yoo, J. H. AU - Park, E. S. AU - Kim, M. K. AU - Lee, T. J. AU - Cho, B. Y. AU - Chung, Y. J. AU - Kang, K. H. AU - Ahn, H. Y. AU - Kim, H. S. DA - Feb DO - 10.1016/j.prp.2014.10.005 10.1016/j.prp.2014.10.005. Epub 2014 Oct 27. DP - Nlm ET - 2014/12/04 IS - 2 LA - eng PY - 2015 SN - 0344-0338 SP - 162-70 ST - Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma T2 - Pathol Res Pract TI - Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma VL - 211 ID - 5378 ER - TY - JOUR AD - Department of Surgical Pathology, Tata Memorial Hospital, Mumbai, India. Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey. Department of Pathology, Istanbul University, Capa School of Medicine, Istanbul, Turkey. AN - 28452074 AU - Rekhi, B. AU - Kosemehmetoglu, K. AU - Tezel, G. G. AU - Dervisoglu, S. DA - Aug DO - 10.1111/apm.12702 10.1111/apm.12702. Epub 2017 Apr 27. DP - Nlm ET - 2017/04/30 IS - 8 LA - eng PY - 2017 SN - 0903-4641 SP - 679-689 ST - Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis T2 - Apmis TI - Clinicopathologic features and immunohistochemical spectrum of 11 cases of epithelioid malignant peripheral nerve sheath tumors, including INI1/SMARCB1 results and BRAF V600E analysis VL - 125 ID - 5379 ER - TY - JOUR AN - 24471189 AU - Estrozi, B. AU - Machado, J. AU - Rodriguez, R. AU - Bacchi, C. E. DA - Jan DO - 10.1097/pdm.0b013e318298c1d9 10.1097/pdm.0b013e318298c1d9. DP - Nlm ET - 2014/01/29 IS - 1 LA - eng PY - 2014 SN - 1533-4058 SP - 57-64 ST - Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults T2 - Appl Immunohistochem Mol Morphol TI - Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults VL - 22 ID - 5380 ER - TY - JOUR AD - Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium Department of Pathology, University Hospitals Leuven, Leuven, Belgium Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium Department of Hematology, University Hospitals Leuven, Leuven, Belgium Center for Human Genetics, KU Leuven, Leuven, Belgium Department of Oncology, KU Leuven, Leuven, Belgium AU - Claerhout, H. AU - Van Aelst, S. AU - Melis, C. AU - Tousseyn, T. AU - Gheysens, O. AU - Vandenberghe, P. AU - Dierickx, D. AU - Boeckx, N. DB - Scopus DO - 10.1111/ejh.13056 IS - 6 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 603-612 ST - Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study T2 - European Journal of Haematology TI - Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045850422&doi=10.1111%2fejh.13056&partnerID=40&md5=fe23277364c2429b24430e63cf2d2704 VL - 100 ID - 5381 ER - TY - JOUR AD - L. Kandolf Sekulovic, Medical Faculty, Military Medical Academy, Dermatology and Venerology, Belgrade, Serbia AU - Kandolf Sekulovic, L. AU - Babovic, N. AU - Nikolin, B. AU - Vrbic, S. AU - Vukanovic, T. AU - Ostojic, N. AU - Mijuskovic, Z. AU - Dinic, M. AU - Juskic, K. AU - Jevric, M. AU - Neric, D. AU - Todorovic, M. AU - Tiodorovic, D. AU - Nikolic, D. AU - Novakovic, M. DB - Embase DO - 10.1097/CMR.0000000000000285 LA - English M3 - Conference Abstract N1 - L612247927 2016-09-26 PY - 2016 SN - 1473-5636 SP - e16 ST - Clinicopathological characteristics, treatment patterns and outcome of cutaneous melanoma in South-East Europe: First results from the national registry of Serbian melanoma group T2 - Melanoma Research TI - Clinicopathological characteristics, treatment patterns and outcome of cutaneous melanoma in South-East Europe: First results from the national registry of Serbian melanoma group UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612247927&from=exporthttp://dx.doi.org/10.1097/CMR.0000000000000285 VL - 26 ID - 5382 ER - TY - JOUR AD - M.J. García, Department of Pathology, Fundacion Jimenez Diaz, Universidad Autónoma (UAM), Madrid, Spain AU - García, M. J. AU - Castrillo, J. M. AU - Granizo, J. J. AU - Cazorla, A. AU - Rivas, C. DB - Embase Medline DO - 10.1046/j.1365-2141.2002.03870_3.x IS - 3 LA - English M3 - Letter N1 - L35366240 2002-12-03 PY - 2002 SN - 0007-1048 SP - 877-878 ST - Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma [3] T2 - British Journal of Haematology TI - Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma [3] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35366240&from=exporthttp://dx.doi.org/10.1046/j.1365-2141.2002.03870_3.x VL - 119 ID - 5383 ER - TY - JOUR AD - Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. AN - 27911979 AU - Kim, D. W. AU - Haydu, L. E. AU - Joon, A. Y. AU - Bassett, R. L., Jr. AU - Siroy, A. E. AU - Tetzlaff, M. T. AU - Routbort, M. J. AU - Amaria, R. N. AU - Wargo, J. A. AU - McQuade, J. L. AU - Kemnade, J. AU - Hwu, P. AU - Woodman, S. E. AU - Roszik, J. AU - Kim, K. B. AU - Gershenwald, J. E. AU - Lazar, A. J. AU - Davies, M. A. C2 - PMC5384865 C6 - NIHMS828172 DA - Apr 15 DO - 10.1002/cncr.30463 10.1002/cncr.30463. Epub 2016 Dec 2. DP - Nlm ET - 2016/12/03 IS - 8 LA - eng PY - 2017 SN - 0008-543X (Print) 0008-543x SP - 1372-1381 ST - Clinicopathological features and clinical outcomes associated with TP53 and BRAF(N)(on-)(V)(600) mutations in cutaneous melanoma patients T2 - Cancer TI - Clinicopathological features and clinical outcomes associated with TP53 and BRAF(N)(on-)(V)(600) mutations in cutaneous melanoma patients VL - 123 ID - 5384 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Telangana, 500 082, India AU - Bala, S. AU - Gundeti, S. AU - Linga, V. AU - Maddali, L. AU - Digumarti, R. AU - Uppin, S. DB - Scopus DO - 10.4103/0971-5851.195735 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 242-250 ST - Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy T2 - Indian Journal of Medical and Paediatric Oncology TI - Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007414183&doi=10.4103%2f0971-5851.195735&partnerID=40&md5=ddbc7f7eb57592d412f719c8f12939dc VL - 37 ID - 5385 ER - TY - JOUR AD - Department of Thoracic Oncology and Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan Department of Thoracic Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan Department of Thoracic and Breast Surgery, Oita University Faculty of Medicine, Oita, Japan AN - 129372048. Language: English. Entry Date: 20180508. Revision Date: 20190711. Publication Type: Article AU - Kometani, Takuro AU - Sugio, Kenji AU - Osoegawa, Atsushi AU - Seto, Takashi AU - Ichinose, Yukito DB - ccm DO - 10.1111/1759-7714.12616 DP - EBSCOhost IS - 5 N1 - pictorial; research; tables/charts. Journal Subset: Biomedical; USA. NLM UID: 101531441. PY - 2018 SN - 1759-7706 SP - 563-570 ST - Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene T2 - Thoracic Cancer TI - Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129372048&site=ehost-live&scope=site VL - 9 ID - 5386 ER - TY - JOUR AD - Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Research Unit Analytical Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Institute of Endocrinology and Metabolism, National Academy of Medical Sciences of the Ukraine, Kiev, Ukraine. Institute of Radiation Protection, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany. Bundeswehr Institute of Radiobiology, Munich, Germany. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, MD, USA. AN - 25284583 AU - Selmansberger, M. AU - Feuchtinger, A. AU - Zurnadzhy, L. AU - Michna, A. AU - Kaiser, J. C. AU - Abend, M. AU - Brenner, A. AU - Bogdanova, T. AU - Walch, A. AU - Unger, K. AU - Zitzelsberger, H. AU - Hess, J. DA - Jul 23 DO - 10.1038/onc.2014.311 10.1038/onc.2014.311. Epub 2014 Oct 6. DP - Nlm ET - 2014/10/07 IS - 30 LA - eng PY - 2015 SN - 0950-9232 SP - 3917-25 ST - CLIP2 as radiation biomarker in papillary thyroid carcinoma T2 - Oncogene TI - CLIP2 as radiation biomarker in papillary thyroid carcinoma VL - 34 ID - 5387 ER - TY - JOUR AD - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Pediatrics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Andersson, B. S. AU - Valdez, B. C. AU - de Lima, M. AU - Wang, X. AU - Thall, P. F. AU - Worth, L. L. AU - Popat, U. AU - Madden, T. AU - Hosing, C. AU - Alousi, A. AU - Rondon, G. AU - Kebriaei, P. AU - Shpall, E. J. AU - Jones, R. B. AU - Champlin, R. E. DB - Scopus DO - 10.1016/j.bbmt.2010.09.022 IS - 6 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 2011 SP - 893-900 ST - Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS T2 - Biology of Blood and Marrow Transplantation TI - Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956017109&doi=10.1016%2fj.bbmt.2010.09.022&partnerID=40&md5=448d1d77c03d1bab82657075bfad0ff0 VL - 17 ID - 5388 ER - TY - JOUR AD - Department of Hematology Oncology, Dell Children's Medical Center of Central Texas, Austin, TX, United States Division of Pediatric Stem Cell Transplantation, Texas Transplant Institute, San Antonio, TX, United States Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, United States AU - Lockhart, S. AU - McDonald, L. AU - Rytting, M. AU - Chan, K. W. DB - Scopus DO - 10.1002/pbc.23318 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2012 SP - 573-575 ST - Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ all resolution after decitabine therapy T2 - Pediatric Blood and Cancer TI - Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ all resolution after decitabine therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863880422&doi=10.1002%2fpbc.23318&partnerID=40&md5=ecaec35e5d7dfe677333433a9598ba7d VL - 59 ID - 5389 ER - TY - JOUR AD - Ludwig Institute for Cancer Research, Melbourne, Australia. AN - 15000491 AU - Hirokawa, Y. AU - Tikoo, A. AU - Huynh, J. AU - Utermark, T. AU - Hanemann, C. O. AU - Giovannini, M. AU - Xiao, G. H. AU - Testa, J. R. AU - Wood, J. AU - Maruta, H. DA - Jan-Feb DO - 10.1097/00130404-200401000-00006 10.1097/00130404-200401000-00006. DP - Nlm ET - 2004/03/06 IS - 1 LA - eng PY - 2004 SN - 1528-9117 (Print) 1528-9117 SP - 20-6 ST - A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor T2 - Cancer J TI - A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor VL - 10 ID - 5390 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA. AN - 15151211 AU - Nascimento, A. F. AU - Pinkus, J. L. AU - Pinkus, G. S. DA - May DO - 10.1309/gq2r-lndw-lb9w-y6uu 10.1309/GQ2R-LNDW-LB9W-Y6UU. DP - Nlm ET - 2004/05/21 IS - 5 LA - eng PY - 2004 SN - 0002-9173 (Print) 0002-9173 SP - 709-17 ST - Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms T2 - Am J Clin Pathol TI - Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms VL - 121 ID - 5391 ER - TY - JOUR AD - Children's Hospital of Philadelphia, United States AU - Hunger, S. P. DB - Scopus DO - 10.1182/blood-2017-04-776369 IS - 20 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 2713-2714 ST - CML in blast crisis: More common than we think? T2 - Blood TI - CML in blast crisis: More common than we think? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019674960&doi=10.1182%2fblood-2017-04-776369&partnerID=40&md5=c4419945c6bd66696ec26d6d7e2a380b VL - 129 ID - 5392 ER - TY - JOUR AD - Department of Haematology, Imperial College, Hammersmith Hospital, Ducane Road, London, W120NN, United Kingdom AU - Apperley, J. DB - Scopus DO - 10.1016/j.beha.2009.09.008 IS - 3 M3 - Review N1 - Cited By :49 Export Date: 18 November 2020 PY - 2009 SP - 455-474 ST - CML in pregnancy and childhood T2 - Best Practice and Research: Clinical Haematology TI - CML in pregnancy and childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-71849109234&doi=10.1016%2fj.beha.2009.09.008&partnerID=40&md5=6904e0a84e30e648a6fa7ed3d6a3e447 VL - 22 ID - 5393 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Justus Liebig University Giessen, Giessen, Germany. Department of Internal Medicine, Stauferklinikum Schwaebisch Gmuend, Mutlangen, Germany. The Child and Youth Clinic, Department of Pediatric Hematology and Oncology, University Hospital Copenhagen, Copenhagen, Denmark. Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic. Department of Pediatric Hematology and Oncology, Eberhard Karls University Tuebingen, Tuebingen, Germany. Department of Pediatric Hematology and Oncology, University Hospital Ulm, Ulm, Germany. Children's Hospital Cottbus, Cottbus, Germany. AN - 29512859 AU - Ruf, S. AU - Hebart, H. AU - Hjalgrim, L. L. AU - Kabickova, E. AU - Lang, P. AU - Steinbach, D. AU - Schwabe, G. C. AU - Woessmann, W. DA - Jun DO - 10.1002/pbc.27003 10.1002/pbc.27003. Epub 2018 Mar 7. DP - Nlm ET - 2018/03/08 IS - 6 LA - eng PY - 2018 SN - 1545-5009 SP - e27003 ST - CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series T2 - Pediatr Blood Cancer TI - CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series VL - 65 ID - 5394 ER - TY - JOUR AD - Department of Pediatrics, Faculty of Medicine and Dentistry, Cardiovascular Research Centre, University of Alberta, 87th Avenue and 112 Street, Edmonton, Alberta T6G 2S2, Canada. Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 308 Harvard Street S.E., Minneapolis, MN 55455, USA. Department of Medicine, Cardiovascular Research Centre, Faculty of Medicine and Dentistry, University of Alberta, 87th Avenue and 112 Street, Edmonton, Alberta T6G 2S2, Canada. Department of Integrative Biology and Physiology, Medical School, University of Minnesota, 2231 6th Street S.E. Minneapolis, MN 55455, USA. AN - 29566148 AU - Matsumura, N. AU - Zordoky, B. N. AU - Robertson, I. M. AU - Hamza, S. M. AU - Parajuli, N. AU - Soltys, C. M. AU - Beker, D. L. AU - Grant, M. K. AU - Razzoli, M. AU - Bartolomucci, A. AU - Dyck, J. R. B. C2 - PMC6054166 DA - Aug 1 DO - 10.1093/cvr/cvy064 10.1093/cvr/cvy064. DP - Nlm ET - 2018/03/23 IS - 10 LA - eng PY - 2018 SN - 0008-6363 (Print) 0008-6363 SP - 1350-1359 ST - Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes T2 - Cardiovasc Res TI - Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes VL - 114 ID - 5395 ER - TY - JOUR AD - P. Hardy, Department of Pediatrics, Physiology and Pharmacology Research Center of CHU Sainte-Justine, 3175 Côte-Sainte-Catherine, Room 2714, Montréal, QC, Canada AU - Tabatabaei, S. N. AU - Derbali, R. M. AU - Yang, C. AU - Superstein, R. AU - Hamel, P. AU - Chain, J. L. AU - Hardy, P. C1 - mirvana(Life Technologies) C2 - alkeran(Canada) Life Technologies DB - Embase Medline DO - 10.1016/j.jconrel.2019.02.014 LA - English M3 - Article N1 - L2001603128 2019-02-26 2019-03-05 PY - 2019 SN - 1873-4995 0168-3659 SP - 177-185 ST - Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma T2 - Journal of Controlled Release TI - Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001603128&from=exporthttp://dx.doi.org/10.1016/j.jconrel.2019.02.014 VL - 298 ID - 5396 ER - TY - JOUR AD - Department of Pathology, National Defence Medical Centre, Taipei, Taiwan Graduate Institution of Pathology, National Defence Medical Centre, Taipei, Taiwan Department of Haematology/Oncology, Tri-Service General Hospital, National Defence Medical Centre, No. 325 Sec 2, Cheng-Kung Road, Taipei 114, Taiwan Institution of Preventive Medicine, National Defence Medical Centre, Taipei, Taiwan Department and Graduate Institute of Pathology, Tri-Service General Hospital, No. 325 Sec 2, Cheng-Kung Road, Taipei 114, Taiwan AU - Sheu, L. F. AU - Lee, W. C. AU - Lee, H. S. AU - Kao, W. Y. AU - Chen, A. DB - Scopus DO - 10.1002/path.1822 IS - 2 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2005 SP - 216-223 ST - Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium T2 - Journal of Pathology TI - Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-26044434885&doi=10.1002%2fpath.1822&partnerID=40&md5=187f35e23b712fad461e61fc643d531b VL - 207 ID - 5397 ER - TY - JOUR AD - S. Sen AU - Sen, S. AU - Rizwan-ul-Haq Khawaja, M. AU - Khatua, S. AU - Karp, D. D. AU - Janku, F. AU - Hong, D. S. AU - Munoz, J. AU - Tsimberidou, A. M. AU - Zaky, W. T. AU - Hwu, P. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase LA - English M3 - Conference Abstract N1 - L611754245 2016-08-25 PY - 2016 SN - 1527-7755 ST - Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study T2 - Journal of Clinical Oncology TI - Co-targeting BRAF with mTOR inhibition in solid tumors harboring BRAF mutations: A phase I study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611754245&from=export VL - 34 ID - 5398 ER - TY - JOUR AD - Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Department of Pediatric Neurology, University Medical Center Utrecht, Utrecht, The Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Department of Pediatrics, Medical University of Vienna, Vienna, Austria. Institute of Neurology, Medical University of Vienna, Vienna, Austria. Department of Neurology and Epileptology, Children's Memorial Health Institute, Warsaw, Poland. Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland. Department of Pathology, Children's Memorial Health Institute, Warsaw, Poland. Pathology Unit, Anna Meyer Children's Hospital, Florence, Italy. Department of Neurosurgery, Anna Meyer Children's Hospital, Florence, Italy. Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany. Department of Paediatric Neurology, Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic. Department of Pathology and Molecular Medicine, Charles University, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Center for Experimental and Molecular Medicine and Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Stichting Epilepsie Instellingen Nederland (SEIN), The Netherlands. AN - 31834371 AU - Bongaarts, A. AU - van Scheppingen, J. AU - Korotkov, A. AU - Mijnsbergen, C. AU - Anink, J. J. AU - Jansen, F. E. AU - Spliet, W. G. M. AU - den Dunnen, W. F. A. AU - Gruber, V. E. AU - Scholl, T. AU - Samueli, S. AU - Hainfellner, J. A. AU - Feucht, M. AU - Kotulska, K. AU - Jozwiak, S. AU - Grajkowska, W. AU - Buccoliero, A. M. AU - Caporalini, C. AU - Giordano, F. AU - Genitori, L. AU - Coras, R. AU - Blümcke, I. AU - Krsek, P. AU - Zamecnik, J. AU - Meijer, L. AU - Scicluna, B. P. AU - Schouten-van Meeteren, A. Y. N. AU - Mühlebner, A. AU - Mills, J. D. AU - Aronica, E. C2 - PMC6935755 DA - Jan 1 DO - 10.1093/brain/awz370 10.1093/brain/awz370. DP - Nlm ET - 2019/12/14 IS - 1 LA - eng PY - 2020 SN - 0006-8950 (Print) 0006-8950 SP - 131-149 ST - The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas T2 - Brain TI - The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas VL - 143 ID - 5399 ER - TY - JOUR AD - Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland Department of Hematology, Pomeranian Medical University, Szczecin, Poland Department of Haematology Blood Neoplasms, and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland Department of Hematology, Medical University of Białystok, Białystok, Poland AU - Lewandowski, K. AU - Gniot, M. AU - Wojtaszewska, M. AU - Kanduła, Z. AU - Becht, R. AU - Paczkowska, E. AU - Mędraś, E. AU - Wasilewska, E. AU - Iwoła, M. DB - Scopus DO - 10.1111/ijlh.12798 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 SP - 366-371 ST - Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors T2 - International Journal of Laboratory Hematology TI - Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043351088&doi=10.1111%2fijlh.12798&partnerID=40&md5=8d6997b486bc5fe85820565ad45fc614 VL - 40 ID - 5400 ER - TY - JOUR AU - Barysch, M. J. AU - Levesque, M. P. AU - Cheng, P. AU - Karpova, M. B. AU - Mihic-Probst, D. AU - Civenni, G. AU - Shakhova, O. AU - Sommer, L. AU - Biedermann, T. AU - Schiestl, C. AU - Dummer, R. DB - Embase DO - 10.1159/000362490 IS - 1 LA - English M3 - Article N1 - L611213174 2016-07-19 2016-07-26 PY - 2014 SN - 2296-3529 SP - 35-46 ST - Coexpression of SOX10/CD271 (p75NTR) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients T2 - Dermatopathology TI - Coexpression of SOX10/CD271 (p75NTR) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611213174&from=exporthttp://dx.doi.org/10.1159/000362490 VL - 1 ID - 5401 ER - TY - JOUR AD - J.S. Spat, New York, NY, United States AU - Spat, J. S. AU - Murphy, H. AU - Keatley, E. AU - Mandelbaum, S. AU - Stein, V. AU - Viqar, F. AU - Smity-Hyle, E. AU - Suzuki, J. AU - Bono, A. AU - Martinez, C. AU - Bender, H. A. DB - Embase DO - 10.1002/ana.24759 LA - English M3 - Conference Abstract N1 - L612892245 2016-11-10 PY - 2016 SN - 1531-8249 SP - S103-S104 ST - Cognitive, behavioral and social functioning of a child with cardiofaciocutaneous syndrome and co-occurring leukemia: A case study T2 - Annals of Neurology TI - Cognitive, behavioral and social functioning of a child with cardiofaciocutaneous syndrome and co-occurring leukemia: A case study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612892245&from=exporthttp://dx.doi.org/10.1002/ana.24759 VL - 80 ID - 5402 ER - TY - JOUR AD - B. Zoll, Institut für Humangenetik, Universitätsmedizin Göttingen, Germany AU - Zoll, B. AU - Pauli, S. AU - Kühnle, I. AU - Schubert, C. AU - Bartels, I. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L70451258 2011-07-05 PY - 2010 SN - 0936-5931 SP - 127 ST - Coincidence of two constitutional de novo mutations, KRAS mutation and trisomy 8 mosaicism, in a patient with Noonan syndrome and JMML T2 - Medizinische Genetik TI - Coincidence of two constitutional de novo mutations, KRAS mutation and trisomy 8 mosaicism, in a patient with Noonan syndrome and JMML UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70451258&from=export VL - 22 ID - 5403 ER - TY - JOUR AD - S. Gieseler, Medical Faculty of Otto-von-Guericke, University Magdeburg, Experimental Pediatrics, Magdeburg, Germany AU - Gieseler, S. AU - Mertens, P. R. AU - Brunner-Weinzierl, M. C. DB - Embase DO - 10.1111/imm.12002 LA - English M3 - Conference Abstract N1 - L70945914 2012-12-21 PY - 2012 SN - 0019-2805 SP - 486 ST - The cold-shock protein YB-1 controls T-cell proliferation and survival T2 - Immunology TI - The cold-shock protein YB-1 controls T-cell proliferation and survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70945914&from=exporthttp://dx.doi.org/10.1111/imm.12002 VL - 137 ID - 5404 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, 1000 Welch Rd, Suite 300, Palo Alto, CA 94304-1812, USA. mlink@stanford.edu AN - 23341511 AU - Link, M. P. DA - Mar 1 DO - 10.1200/jco.2012.48.0293 10.1200/JCO.2012.48.0293. Epub 2013 Jan 22. DP - Nlm ET - 2013/01/24 IS - 7 LA - eng PY - 2013 SN - 0732-183x SP - 825-32 ST - Collaborating to conquer cancer: lessons from our children T2 - J Clin Oncol TI - Collaborating to conquer cancer: lessons from our children VL - 31 ID - 5405 ER - TY - JOUR AD - J. F. Cryan, School of Pharmacy, Cavanagh Pharmacy Bldg., University College Cork, Cork, Ireland AU - O'Malley, D. AU - Liston, M. AU - Hyland, N. P. AU - Dinan, T. G. AU - Cryan, J. F. DB - Embase Medline DO - 10.1152/ajpgi.00385.2010 IS - 2 L1 - internal-pdf://1469262009/ajpgi.00385.2010.pdf LA - English M3 - Article N1 - L361185014 2011-02-04 2011-02-09 PY - 2011 SN - 0193-1857 1522-1547 SP - G241-G252 ST - Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361185014&from=exporthttp://dx.doi.org/10.1152/ajpgi.00385.2010 VL - 300 ID - 5406 ER - TY - JOUR AD - G.H. Lyman, James P. Wilmot Cancer Center, Univ. of Rochester Medical Center, Strong Memorial Hospital, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Komrokji, R. S. AU - Lyman, G. H. C1 - leucomax(Novartis) leukine(Berlex) neulasta(Amgen) neupogen(Amgen) neutrogin(Chugai) C2 - Amgen Berlex Chugai Novartis DB - Embase Medline DO - 10.1517/14712598.4.12.1897 IS - 12 LA - English M3 - Review N1 - L39627141 2005-01-03 PY - 2004 SN - 1471-2598 SP - 1897-1910 ST - The colony-stimulating factors: Use to prevent and treat neutropenia and its complications T2 - Expert Opinion on Biological Therapy TI - The colony-stimulating factors: Use to prevent and treat neutropenia and its complications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39627141&from=exporthttp://dx.doi.org/10.1517/14712598.4.12.1897 VL - 4 ID - 5407 ER - TY - JOUR AD - Department of Colorectal Surgery, First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang, China AU - Cheng, X. AU - Chen, D. AU - Wang, Y. AU - Wang, J. AU - Lin, J. AU - Chen, W. DB - Scopus IS - 102-103 M3 - Article N1 - Export Date: 18 November 2020 PY - 2010 SP - 1128-1135 ST - Colorectal gastrointestinal stromal tumors (GISTs): A retrospective study of reported cases T2 - Hepato-Gastroenterology TI - Colorectal gastrointestinal stromal tumors (GISTs): A retrospective study of reported cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79251541760&partnerID=40&md5=1e2a6ba4184034117f3fdfc4f14106d0 VL - 57 ID - 5408 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Department of Internal Medicine, Division of Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Electronic address: pair@upmc.edu. AN - 26826419 AU - Olevian, D. C. AU - Nikiforova, M. N. AU - Chiosea, S. AU - Sun, W. AU - Bahary, N. AU - Kuan, S. F. AU - Pai, R. K. DA - Mar DO - 10.1016/j.humpath.2015.11.004 10.1016/j.humpath.2015.11.004. Epub 2015 Nov 17. DP - Nlm ET - 2016/01/31 LA - eng PY - 2016 SN - 0046-8177 SP - 124-34 ST - Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival T2 - Hum Pathol TI - Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival VL - 49 ID - 5409 ER - TY - JOUR AD - R. Basha, Department of Pediatrics, Molecular and Medical Genetics and Institute for Cancer Research (ICR), University of North Texas Health Science Center, 3500Camp Bowie Blvd., CBH 328, Fort Worth, TX, United States AU - Shelake, S. AU - Eslin, D. AU - Sutphin, R. M. AU - Sankpal, U. T. AU - Wadwani, A. AU - Kenyon, L. E. AU - Tabor-Simecka, L. AU - Bowman, W. P. AU - Vishwanatha, J. K. AU - Basha, R. C2 - Sigma DB - Embase Medline DO - 10.1016/j.ijdevneu.2015.07.012 LA - English M3 - Article N1 - L605863236 2015-09-09 2020-10-08 PY - 2015 SN - 1873-474X 0736-5748 SP - 92-99 ST - Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation T2 - International Journal of Developmental Neuroscience TI - Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605863236&from=exporthttp://dx.doi.org/10.1016/j.ijdevneu.2015.07.012 VL - 46 ID - 5410 ER - TY - JOUR AD - Department of Hematology, West China Hospital of Sichuan University, China. Department of Human Sciences, Texas A&M University-Kingsville, Kingsville, TX 78363, USA. School of Medicine, University of Electronic Science and Technology of China, China. Department of Hematology, West China Hospital of Sichuan University, China. Electronic address: gongyuping@hotmail.com. AN - 30389549 AU - Guo, Y. AU - Li, Y. AU - Wang, F. F. AU - Xiang, B. AU - Huang, X. O. AU - Ma, H. B. AU - Gong, Y. P. DA - Jan DO - 10.1016/j.biocel.2018.10.008 10.1016/j.biocel.2018.10.008. Epub 2018 Oct 30. DP - Nlm ET - 2018/11/06 LA - eng PY - 2019 SN - 1357-2725 SP - 8-20 ST - The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway T2 - Int J Biochem Cell Biol TI - The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway VL - 106 ID - 5411 ER - TY - JOUR AD - A. Gomez-Brouchet, Department of Pathology and Cytology, Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Paul Sabatier University Toulouse III, Toulouse, France AU - Brunac, A. C. AU - Laprie, A. AU - Castex, M. P. AU - Laurent, C. AU - Le Loarer, F. AU - Karanian, M. AU - Le Guellec, S. AU - Guillemot, D. AU - Pierron, G. AU - Gomez-Brouchet, A. DB - Embase Medline DO - 10.1002/pbc.28185 IS - 5 LA - English M3 - Letter N1 - L2004155918 2020-02-04 2020-04-10 PY - 2020 SN - 1545-5017 1545-5009 ST - The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript T2 - Pediatric Blood and Cancer TI - The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004155918&from=exporthttp://dx.doi.org/10.1002/pbc.28185 VL - 67 ID - 5412 ER - TY - JOUR AD - Orthopaedic Research & Biotechnology Unit, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. E-mail address for J. El-Hoss: jel-hoss@ccia.unsw.edu.au. E-mail address for T. Cheng: tegan.cheng@sydney.edu.au. E-mail address for E.C. Carpenter: carpie@doctors.org.uk. E-mail address for K. Sullivan: kates3@live.com. E-mail address for N. Deo: nikita.deo@sydney.edu.au. E-mail address for K. Mikulec: kathy.mikulec@health.nsw.gov.au. E-mail address for D.G. Little: david.little@health.nsw.gov.au. E-mail address for A. Schindeler: aaron.schindeler@sydney.edu.au. AN - 25031379 AU - El-Hoss, J. AU - Cheng, T. AU - Carpenter, E. C. AU - Sullivan, K. AU - Deo, N. AU - Mikulec, K. AU - Little, D. G. AU - Schindeler, A. DA - Jul 16 DO - 10.2106/jbjs.M.00862 10.2106/JBJS.M.00862. DP - Nlm ET - 2014/07/18 IS - 14 LA - eng PY - 2014 SN - 0021-9355 SP - e117 ST - A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis T2 - J Bone Joint Surg Am TI - A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis VL - 96 ID - 5413 ER - TY - JOUR AD - Endocrinology Unit, Department of Medicine, University of Padua, Via Ospedale Civile 105, 35128 Padua, Italy Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Gattamelata 64, 35128 Padua, Italy Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128 Padua, Italy Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padua, Italy Department of Environmental Medicine and Public Health, University of Padua, Via Loredan 18, Padua, Italy Surgical Pathology and Cytopathology Unit, Department of Diagnostic Medical Sciences and Special Therapies, University of Padua, Via Gabelli 61, 35100 Padua, Italy AU - Mariniello, B. AU - Rosato, A. AU - Zuccolotto, G. AU - Rubin, B. AU - Cicala, M. V. AU - Finco, I. AU - Iacobone, M. AU - Frigo, A. C. AU - Fassina, A. AU - Pezzani, R. AU - Mantero, F. DB - Scopus DO - 10.1530/ERC-11-0337 IS - 4 M3 - Article N1 - Cited By :41 Export Date: 18 November 2020 PY - 2012 SP - 527-539 ST - Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models T2 - Endocrine-Related Cancer TI - Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864408099&doi=10.1530%2fERC-11-0337&partnerID=40&md5=5a59b388d1876e8f102463fb03cfc47d VL - 19 ID - 5414 ER - TY - JOUR AD - H. Stumme, Stauferklinikum Schwaeb. Gmuend, Zentrum Innere Medizin, Schwerpunkt Haematologie/Onkologie, Mutlangen, Germany AU - Stumme, H. AU - Lang, P. AU - Woessmann, W. AU - Ott, G. AU - Vöhringer, M. AU - Handgretinger, R. AU - Hebart, H. DB - Embase DO - 10.1159/000439070 LA - English M3 - Conference Abstract N1 - L72071277 2015-11-20 PY - 2015 SN - 2296-5270 SP - 212 ST - Combination therapy with crizotinib/Brentuximab Vedotin in chemorefractory ALK-positive ALCL is feasible and highly effective-a case report T2 - Oncology Research and Treatment TI - Combination therapy with crizotinib/Brentuximab Vedotin in chemorefractory ALK-positive ALCL is feasible and highly effective-a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72071277&from=exporthttp://dx.doi.org/10.1159/000439070 VL - 38 ID - 5415 ER - TY - JOUR AD - J. Shen, Department of Pediatrics, the First Affiliated Hospital of Zhejiang University, No. 79 Qingchun Road, Hangzhou, China AU - Zhang, J. AU - Hong, Y. AU - Shen, J. C1 - mek 162(Selleck,China) C2 - Selleck(China) DB - Embase Medline DO - 10.1007/s13277-015-3244-2 IS - 7 LA - English M3 - Article N1 - L602481819 2015-02-27 2015-08-07 PY - 2015 SN - 1423-0380 1010-4283 SP - 5699-5706 ST - Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo T2 - Tumor Biology TI - Combination treatment with perifosine and MEK-162 demonstrates synergism against lung cancer cells in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602481819&from=exporthttp://dx.doi.org/10.1007/s13277-015-3244-2 VL - 36 ID - 5416 ER - TY - JOUR AD - T. Yang, Postal Address: No.56 Xinjian South Road, Taiyuan, Shanxi, China AU - Chen, J. AU - Dai, J. AU - Kang, Z. AU - Yang, T. AU - Zhao, Q. AU - Zheng, J. AU - Zhang, X. AU - Zhang, J. AU - Xu, J. AU - Sun, G. AU - Yang, L. AU - Yang, T. C1 - bms 754807 gsk 2126458 DB - Embase Medline DO - 10.1016/j.yexcr.2020.112060 IS - 1 LA - English M3 - Article N1 - L2005878448 2020-05-19 2020-05-26 PY - 2020 SN - 1090-2422 0014-4827 ST - A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer T2 - Experimental Cell Research TI - A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005878448&from=exporthttp://dx.doi.org/10.1016/j.yexcr.2020.112060 VL - 393 ID - 5417 ER - TY - JOUR AD - Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. douglas.b.johnson@vanderbilt.edu. Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. AN - 25287827 AU - Johnson, D. B. AU - Flaherty, K. T. AU - Weber, J. S. AU - Infante, J. R. AU - Kim, K. B. AU - Kefford, R. F. AU - Hamid, O. AU - Schuchter, L. AU - Cebon, J. AU - Sharfman, W. H. AU - McWilliams, R. R. AU - Sznol, M. AU - Lawrence, D. P. AU - Gibney, G. T. AU - Burris, H. A., 3rd AU - Falchook, G. S. AU - Algazi, A. AU - Lewis, K. AU - Long, G. V. AU - Patel, K. AU - Ibrahim, N. AU - Sun, P. AU - Little, S. AU - Cunningham, E. AU - Sosman, J. A. AU - Daud, A. AU - Gonzalez, R. C2 - PMC4226803 online at www.jco.org. Author contributions are found at the end of this article. DA - Nov 20 DO - 10.1200/jco.2014.57.3535 10.1200/JCO.2014.57.3535. Epub 2014 Oct 6. DP - Nlm ET - 2014/10/08 IS - 33 LA - eng PY - 2014 SN - 0732-183X (Print) 0732-183x SP - 3697-704 ST - Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor T2 - J Clin Oncol TI - Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor VL - 32 ID - 5418 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Tarry Building, 300 E Superior, Chicago, IL, 60611, USA. Department of Neurology, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, HD400, San Francisco, CA, 94158, USA. Department of Pediatrics, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA. Theodore.Nicolaides@ucsf.edu. Department of Neurological Surgery, University of California San Francisco, 1450 3rd Street, HD400, San Francisco, CA, 94158, USA. Theodore.Nicolaides@ucsf.edu. AN - 27848137 AU - Zhang, J. AU - Yao, T. W. AU - Hashizume, R. AU - Hariono, S. AU - Barkovich, K. J. AU - Fan, Q. W. AU - Prados, M. AU - James, C. D. AU - Weiss, W. A. AU - Nicolaides, T. C2 - PMC5560871 C6 - NIHMS830203 DA - Feb DO - 10.1007/s11060-016-2333-4 10.1007/s11060-016-2333-4. Epub 2016 Nov 15. DP - Nlm ET - 2016/11/17 IS - 3 LA - eng PY - 2017 SN - 0167-594X (Print) 0167-594x SP - 495-505 ST - Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas T2 - J Neurooncol TI - Combined BRAF(V600E) and MEK blockade for BRAF(V600E)-mutant gliomas VL - 131 ID - 5419 ER - TY - JOUR AD - I. Kazantsev, R.M.Gorbacheva Memorial Institute for Pediatric Oncology, Hematology and Transplantation, Pediatric Oncology, Saint-Petersburg, Russian Federation AU - Kazantsev, I. AU - Gevorgyan, A. AU - Jukhta, T. AU - Tolkunova, P. AU - Kozlov, A. AU - Andreeva, T. AU - Morozova, E. AU - Safonova, S. AU - Punanov, Y. AU - Zubarovskaya, L. AU - Afanasyev, B. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624178671 2018-10-11 PY - 2018 SN - 1545-5017 SP - S257-S258 ST - Combined chemo-and targeted therapy in primary resistant/relapsed neuroblastoma patients: A single-center experience T2 - Pediatric Blood and Cancer TI - Combined chemo-and targeted therapy in primary resistant/relapsed neuroblastoma patients: A single-center experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624178671&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 5420 ER - TY - JOUR AD - A. Cuenda, Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain AU - Zur, R. AU - Garcia-Ibanez, L. AU - Nunez-Buiza, A. AU - Aparicio, N. AU - Liappas, G. AU - Escós, A. AU - Risco, A. AU - Pagez, A. AU - Saiz-Ladera, C. AU - Alsina-Beauchamp, D. AU - Montans, J. AU - Paramio, J. M. AU - Cuenda, A. DB - Embase Medline DO - 10.18632/oncotarget.4320 IS - 15 LA - English M3 - Article N1 - L604883112 2015-06-23 2015-06-25 PY - 2015 SN - 1949-2553 SP - 12920-12935 ST - Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis T2 - Oncotarget TI - Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604883112&from=exporthttp://dx.doi.org/10.18632/oncotarget.4320 VL - 6 ID - 5421 ER - TY - JOUR AD - Appareil Digestif Environnement Nutrition EA4311, Institute for Biomedical Research, IFRMP23, Rouen University and Rouen University Hospital, Rouen, France. AN - 19022976 AU - Lecleire, S. AU - Hassan, A. AU - Marion-Letellier, R. AU - Antonietti, M. AU - Savoye, G. AU - Bôle-Feysot, C. AU - Lerebours, E. AU - Ducrotté, P. AU - Déchelotte, P. AU - Coëffier, M. DA - Dec DO - 10.3945/jn.108.099127 10.3945/jn.108.099127. DP - Nlm ET - 2008/11/22 IS - 12 LA - eng PY - 2008 SN - 0022-3166 SP - 2481-6 ST - Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways T2 - J Nutr TI - Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways VL - 138 ID - 5422 ER - TY - JOUR AD - Terry Fox Lab, British Columbia Cancer Agency, Vancouver, BC, Canada. yxing@bccrc.ca AN - 23522913 AU - Xing, Y. AU - Hogge, D. E. DA - Jun DO - 10.1016/j.leukres.2013.03.003 10.1016/j.leukres.2013.03.003. Epub 2013 Mar 21. DP - Nlm ET - 2013/03/26 IS - 6 LA - eng PY - 2013 SN - 0145-2126 SP - 697-704 ST - Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors T2 - Leuk Res TI - Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors VL - 37 ID - 5423 ER - TY - JOUR AD - Vanderbilt Center for Bone Biology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. AN - 25043591 AU - de la Croix Ndong, J. AU - Stevens, D. M. AU - Vignaux, G. AU - Uppuganti, S. AU - Perrien, D. S. AU - Yang, X. AU - Nyman, J. S. AU - Harth, E. AU - Elefteriou, F. C2 - PMC4280331 C6 - NIHMS638051 DA - Jan DO - 10.1002/jbmr.2316 10.1002/jbmr.2316. DP - Nlm ET - 2014/07/22 IS - 1 LA - eng PY - 2015 SN - 0884-0431 (Print) 0884-0431 SP - 55-63 ST - Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice T2 - J Bone Miner Res TI - Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice VL - 30 ID - 5424 ER - TY - JOUR AD - 1Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India. 2Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. 3Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. AN - 30994389 AU - Biswas, A. AU - Devnani, B. AU - Agarwal, S. AU - Sharma, M. C. AU - Sharma, A. DA - Aug DO - 10.1089/jayao.2018.0158 10.1089/jayao.2018.0158. Epub 2019 Apr 17. DP - Nlm ET - 2019/04/18 IS - 4 LA - eng PY - 2019 SN - 2156-5333 SP - 469-476 ST - Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case T2 - J Adolesc Young Adult Oncol TI - Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case VL - 8 ID - 5425 ER - TY - JOUR AD - Department of Neurosurgery; Department of Neuropathology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Spain. Department of Neurosurgery, Neurotraumatology, and Neurosurgery Research Unit; and. AN - 27015517 AU - Cicuendez, M. AU - Martinez-Saez, E. AU - Martinez-Ricarte, F. AU - Asanza, E. C. AU - Sahuquillo, J. DA - Jul DO - 10.3171/2016.1.Peds15558 10.3171/2016.1.PEDS15558. Epub 2016 Mar 25. DP - Nlm ET - 2016/03/26 IS - 1 LA - eng PY - 2016 SN - 1933-0707 SP - 53-7 ST - Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report T2 - J Neurosurg Pediatr TI - Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report VL - 18 ID - 5426 ER - TY - JOUR AD - C. Li, Department of Interventional MRI, Shandong Medical Imaging Research Institute Affiliated to Shandong University, Jinan, Shandong, China AU - Liu, C. AU - Wang, L. AU - Qiu, H. AU - Dong, Q. AU - Feng, Y. AU - Li, D. AU - Li, C. AU - Fan, C. DB - Embase Medline DO - 10.1007/s11064-018-2547-2 IS - 7 LA - English M3 - Article N1 - L622315566 2018-05-30 2018-11-23 PY - 2018 SN - 1573-6903 0364-3190 SP - 1317-1327 ST - Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk T2 - Neurochemical Research TI - Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622315566&from=exporthttp://dx.doi.org/10.1007/s11064-018-2547-2 VL - 43 ID - 5427 ER - TY - JOUR AD - G. Nayyar, Pediatrics, New York Medical College, Valhalla, NY, United States AU - Nayyar, G. AU - Chu, Y. AU - Su, N. K. AU - Rosenblum, J. AU - Wong, H. C. AU - Lee, D. AU - Cairo, M. S. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L621900063 2018-05-02 PY - 2018 SN - 1523-6536 SP - S472-S473 ST - Combining dinutuximab with ALT-803 (IL-15 Superagonist) significantly improves the activity of ex vivo expanded natural killer cells against GD2+ pediatric solid tumors (ST) T2 - Biology of Blood and Marrow Transplantation TI - Combining dinutuximab with ALT-803 (IL-15 Superagonist) significantly improves the activity of ex vivo expanded natural killer cells against GD2+ pediatric solid tumors (ST) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621900063&from=export VL - 24 ID - 5428 ER - TY - JOUR AD - A. Lonetti, Department of Biomedical and Neuromotor Sciences, Bologna, Italy AU - Lonetti, A. AU - Masetti, R. AU - Bertuccio, S. N. AU - Serravalle, S. AU - Astolfi, A. AU - Bertaina, A. AU - Locatelli, F. AU - Martelli, A. M. AU - Pession, A. DB - Embase LA - English M3 - Conference Abstract N1 - L615548645 2017-04-26 PY - 2016 SN - 1592-8721 SP - 363 ST - Combining DOT1L inhibitor EPZ-5676 with sorafenib to treat MLL-rearranged (MLL-R) pediatric acute myeloid leukeamia (AML) T2 - Haematologica TI - Combining DOT1L inhibitor EPZ-5676 with sorafenib to treat MLL-rearranged (MLL-R) pediatric acute myeloid leukeamia (AML) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615548645&from=export VL - 101 ID - 5429 ER - TY - JOUR AD - J. Versalovic, Department of Pathology, Texas Children's Hospital, MC 1-2261, 6621 Fannin Street, Houston, TX 77030, United States AU - Versalovic, J. AU - Iyer, C. AU - Ping Lin, Y. AU - Huang, Y. AU - Dobrogosz, W. DB - Embase DO - 10.1080/08910600802106491 IS - 2 LA - English M3 - Review N1 - L352451692 2008-10-28 PY - 2008 SN - 0891-060X 1651-2235 SP - 86-93 ST - Commensal-derived probiotics as anti-inflammatory agents T2 - Microbial Ecology in Health and Disease TI - Commensal-derived probiotics as anti-inflammatory agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352451692&from=exporthttp://dx.doi.org/10.1080/08910600802106491 VL - 20 ID - 5430 ER - TY - JOUR AU - Bhat, T. AU - Rosman, I. S. AU - Coughlin, C. C. DB - Embase Medline DO - 10.1111/pde.13381 IS - 2 LA - English M3 - Letter N1 - L621392031 2018-03-29 2018-08-06 PY - 2018 SN - 1525-1470 0736-8046 SP - 287-288 ST - Comment on “Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib” T2 - Pediatric Dermatology TI - Comment on “Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib” UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621392031&from=exporthttp://dx.doi.org/10.1111/pde.13381 VL - 35 ID - 5431 ER - TY - JOUR AD - A.E. Evans, Children's Hospital of Philadelphia, Division of Oncology, 902 Abramson Research Center, 3615 Civic Center Boulevard, Philadelphia, PA 19104-4318, United States AU - Evans, A. E. C1 - cep 701 genasense gleevac zarnestra DB - Embase Medline DO - 10.1002/mpo.10259 IS - 2 LA - English M3 - Conference Paper N1 - L36858335 2003-07-30 PY - 2003 SN - 0098-1532 SP - 141-144 ST - Commentary: Symposium on New Drugs in Cancer Therapy October 29 - November 2, 2001 T2 - Medical and Pediatric Oncology TI - Commentary: Symposium on New Drugs in Cancer Therapy October 29 - November 2, 2001 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36858335&from=exporthttp://dx.doi.org/10.1002/mpo.10259 VL - 41 ID - 5432 ER - TY - JOUR AD - Dept. of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland Acute Leukemia Working Party of the EBMT, Paris, France Dept. of Hematology, Hôpital Saint-Antoine, Paris, France Leukemia Myeloma Units, The Royal Marsden Center, London, United Kingdom Dept. of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium Dept. of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Dept. of Hematology –, BMT, Hopital St. Louis, Paris, France Institut Universitaire Du Cancer, Oncopole IUCT, Toulouse, France R.M. Gorbacheva Memorial Institute of Children Oncology, Academician I.P. Pavlov First St. Petersburg State Medical University, Saint-Petersburg, Russian Federation Clinic of Hematology, University Hospital Zurich, Zurich, Switzerland Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Stockholm, Sweden Dept. of Internal Medicine I, Bone Marrow Transplamntation, Medical University of Vienna, Vienna, Austria Dept. of Bone Marrow Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany BMT Unit, Instituto Português de Oncologia, Porto, Portugal 3rd Dept. of Internal Medicine Semmelweis University, St. István & St. Laszlo Hospital, Budapest, Hungary Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv University, Israel AU - Giebel, S. AU - Labopin, M. AU - Potter, M. AU - Poiré, X. AU - Sengeloev, H. AU - Socié, G. AU - Huynh, A. AU - Afanasyev, B. V. AU - Schanz, U. AU - Ringden, O. AU - Kalhs, P. AU - Beelen, D. W. AU - Campos, A. M. AU - Masszi, T. AU - Canaani, J. AU - Mohty, M. AU - Nagler, A. DB - Scopus DO - 10.1016/j.ejca.2018.03.018 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 73-81 ST - Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT T2 - European Journal of Cancer TI - Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045673193&doi=10.1016%2fj.ejca.2018.03.018&partnerID=40&md5=1ad1eb2e5593090749d5b3fd827f6b02 VL - 96 ID - 5433 ER - TY - JOUR AD - Departments of *Dermatology ‡Preventive Medicine §Robert H. Lurie Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL †Department of Dermatopathology, Memorial Sloan-Kettering Cancer Center, New York, NY. AN - 24451276 AU - Yazdan, P. AU - Cooper, C. AU - Sholl, L. M. AU - Busam, K. AU - Rademaker, A. AU - Weitner, B. B. AU - Obregon, R. AU - Guitart, J. AU - Gerami, P. DA - May DO - 10.1097/pas.0000000000000160 10.1097/PAS.0000000000000160. DP - Nlm ET - 2014/01/24 IS - 5 LA - eng PY - 2014 SN - 0147-5185 SP - 638-45 ST - Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression T2 - Am J Surg Pathol TI - Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression VL - 38 ID - 5434 ER - TY - JOUR AD - Department of Neurosurgery, University Hospital Münster, Münster, Germany; Institute of Neuropathology, University Hospital Münster, Münster, Germany. AN - 24750136 AU - Brokinkel, B. AU - Peetz-Dienhart, S. AU - Ligges, S. AU - Brentrup, A. AU - Stummer, W. AU - Paulus, W. AU - Hasselblatt, M. DA - Feb DO - 10.1111/nan.12145 10.1111/nan.12145. DP - Nlm ET - 2014/04/23 IS - 2 LA - eng PY - 2015 SN - 0305-1846 SP - 258-61 ST - A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive. [corrected] T2 - Neuropathol Appl Neurobiol TI - A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age-related and mutually exclusive. [corrected] VL - 41 ID - 5435 ER - TY - JOUR AD - X. Paoletti, Biostatistics Department, INSERM U900, Institut Curie, 26, rue d'Ulm, 75005 Paris, France AU - Paoletti, X. AU - Geoerger, B. AU - Doz, F. AU - Baruchel, A. AU - Lokiec, F. AU - Le Tourneau, C. DB - Embase Medline DO - 10.1016/j.ejca.2013.02.028 IS - 10 LA - English M3 - Article N1 - L52512154 2013-03-29 2013-06-11 PY - 2013 SN - 0959-8049 1879-0852 SP - 2392-2402 ST - A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials T2 - European Journal of Cancer TI - A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52512154&from=exporthttp://dx.doi.org/10.1016/j.ejca.2013.02.028 VL - 49 ID - 5436 ER - TY - JOUR AD - Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea Departments of Urology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea Asan Cancer Centre, University of Ulsan College of Medicine, Seoul, South Korea AU - Park, S. J. AU - Lee, J. L. AU - Park, I. AU - Park, K. AU - Ahn, Y. AU - Ahn, J. H. AU - Lee, D. H. AU - Ahn, S. AU - Song, C. AU - Hong, J. H. AU - Kim, C. S. AU - Ahn, H. DB - Scopus DO - 10.1159/000346484 IS - 6 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2013 SP - 468-474 ST - Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma T2 - Chemotherapy TI - Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875645855&doi=10.1159%2f000346484&partnerID=40&md5=daf3a48980a742dcf7917bdf18f370ba VL - 58 ID - 5437 ER - TY - JOUR AD - M.S. Cairo, Department of Pediatrics, New York Medical College, Valhalla, NY, United States AU - Lee, S. AU - Day, N. S. AU - Miles, R. R. AU - Perkins, S. L. AU - Lim, M. S. AU - Ayello, J. AU - van de Ven, C. AU - Harrison, L. AU - El-Mallawany, N. K. AU - Goldman, S. AU - Cairo, M. S. DB - Embase Medline DO - 10.1111/bjh.14604 IS - 4 LA - English M3 - Article N1 - L616034108 2017-05-12 2017-06-01 PY - 2017 SN - 1365-2141 0007-1048 SP - 601-611 ST - Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report T2 - British Journal of Haematology TI - Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616034108&from=exporthttp://dx.doi.org/10.1111/bjh.14604 VL - 177 ID - 5438 ER - TY - JOUR AD - N.S. Day, Pediatrics, Columbia University, New York, United States AU - Day, N. S. AU - Ayello, J. AU - Miles, R. R. AU - Perkins, S. AU - Lim, M. S. AU - Waxman, I. AU - Van De Ven, C. AU - Sanger, W. G. AU - Harrison, L. AU - Goldman, S. AU - Cairo, M. S. DB - Embase LA - English M3 - Conference Abstract N1 - L71916723 2015-06-19 PY - 2011 SN - 0923-7534 SP - 146-147 ST - Comparative genomic identification of signaling pathways and targets in pediatric burkitt lymphoma (PBL) T2 - Annals of Oncology TI - Comparative genomic identification of signaling pathways and targets in pediatric burkitt lymphoma (PBL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71916723&from=export VL - 22 ID - 5439 ER - TY - JOUR AD - University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Electronic address: martina.sanlorenzo@hotmail.it. University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California. University of California-San Francisco, Mt Zion Cancer Research Center, San Francisco, California; Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria. Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Department of Dermatology, Rudolfstiftung Hospital, Academic Teaching Hospital, Medical University Vienna, Vienna, Austria. AN - 25440439 AU - Sanlorenzo, M. AU - Choudhry, A. AU - Vujic, I. AU - Posch, C. AU - Chong, K. AU - Johnston, K. AU - Meier, M. AU - Osella-Abate, S. AU - Quaglino, P. AU - Daud, A. AU - Algazi, A. AU - Rappersberger, K. AU - Ortiz-Urda, S. C2 - PMC4254519 C6 - NIHMS627049 DA - Dec DO - 10.1016/j.jaad.2014.09.002 10.1016/j.jaad.2014.09.002. Epub 2014 Oct 16. DP - Nlm ET - 2014/12/03 IS - 6 LA - eng PY - 2014 SN - 0190-9622 (Print) 0190-9622 SP - 1102-1109.e1 ST - Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma T2 - J Am Acad Dermatol TI - Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma VL - 71 ID - 5440 ER - TY - JOUR AU - Shen, C. H. AU - Tung, S. Y. AU - Huang, W. S. AU - Lee, K. F. AU - Hsieh, Y. Y. AU - Hsieh, M. C. AU - Chen, C. N. AU - Kuo, H. C. DB - Embase Medline DO - 10.1159/000487968 IS - 5 LA - English M3 - Article N1 - L621207972 2018-03-19 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1915-1926 ST - Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes T2 - Cellular Physiology and Biochemistry TI - Comparative Proteomic Identification of Protein Disulphide Isomerase A6 Associated with Tert-Butylhydroperoxide-Induced Liver Injury in Rat Hepatocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621207972&from=exporthttp://dx.doi.org/10.1159/000487968 VL - 45 ID - 5441 ER - TY - JOUR AU - Liu, H. AU - Song, G. AU - Zhou, L. AU - Hu, X. AU - Liu, M. AU - Nie, J. AU - Lu, S. AU - Wu, X. AU - Cao, Y. AU - Tao, L. AU - Chen, L. AU - Qian, L. DB - Embase Medline DO - 10.1159/000356586 IS - 5 LA - English M3 - Article N1 - L603692455 2015-04-17 2015-04-30 PY - 2013 SN - 1421-9778 1015-8987 SP - 1497-1508 ST - Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points T2 - Cellular Physiology and Biochemistry TI - Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603692455&from=exporthttp://dx.doi.org/10.1159/000356586 VL - 32 ID - 5442 ER - TY - JOUR AD - Department of Internal Medicine, Alb-Fils-Kliniken, Göppingen, Germany Department of General and Visceral Surgery, University Hospital Ulm, Ulm, Germany Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany Department of Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany Department of Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany AU - Schmieder, M. AU - Henne-Bruns, D. AU - Mayer, B. AU - Knippschild, U. AU - Rolke, C. AU - Schwab, M. AU - Kramer, K. C7 - 504 DB - Scopus DO - 10.3389/fphar.2016.00504 IS - DEC M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 ST - Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection T2 - Frontiers in Pharmacology TI - Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after R0-resection UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009223162&doi=10.3389%2ffphar.2016.00504&partnerID=40&md5=5bd51b23d2c71bdfd67ea3d2516e008f VL - 7 ID - 5443 ER - TY - JOUR AD - Clinical Cancer Research Center, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. Genesmile Company, Nanjing, China. AN - 31021028 AU - Wang, Z. AU - Sun, K. AU - Jing, C. AU - Cao, H. AU - Ma, R. AU - Wu, J. C2 - PMC6642310 DA - Jul DO - 10.1002/jcla.22902 10.1002/jcla.22902. Epub 2019 Apr 25. DP - Nlm ET - 2019/04/26 IS - 6 LA - eng PY - 2019 SN - 0887-8013 (Print) 0887-8013 SP - e22902 ST - Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma T2 - J Clin Lab Anal TI - Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma VL - 33 ID - 5444 ER - TY - JOUR AD - Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing 100050 ccmu.edu.cn, China Molecular Laboratory for Gene Therapy and Tooth Regeneration, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of Stomatology, Beijing 100050, China Department of Biochemistry and Molecular Biology, Capital Medical University School of Basic Medical Sciences, Beijing 100069, China Department of Stomatology, Yidu Central Hospital, Weifang Medical University, No. 4138 Linglong Mountain South Road, Qinzhou 262500, China AU - Dong, R. AU - Du, J. AU - Wang, L. AU - Wang, J. AU - Ding, G. AU - Wang, S. AU - Fan, Z. C7 - 317853 DB - Scopus DO - 10.1155/2014/317853 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2014 ST - Comparison of long noncoding RNA and mRNA expression profiles in mesenchymal stem cells derived from human periodontal ligament and bone marrow T2 - BioMed Research International TI - Comparison of long noncoding RNA and mRNA expression profiles in mesenchymal stem cells derived from human periodontal ligament and bone marrow UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899540989&doi=10.1155%2f2014%2f317853&partnerID=40&md5=3773db65224d854eaab0ffb0c9c327ea VL - 2014 ID - 5445 ER - TY - JOUR AD - *Department of Dermatology, Feinberg School of Medicine †The Robert H. Lurie Cancer Center, Northwestern University, Chicago, IL. AN - 27776007 AU - Amin, S. M. AU - Haugh, A. M. AU - Lee, C. Y. AU - Zhang, B. AU - Bubley, J. A. AU - Merkel, E. A. AU - Verzì, A. E. AU - Gerami, P. DA - Apr DO - 10.1097/pas.0000000000000761 10.1097/PAS.0000000000000761. DP - Nlm ET - 2016/10/25 IS - 4 LA - eng PY - 2017 SN - 0147-5185 SP - 491-498 ST - A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms T2 - Am J Surg Pathol TI - A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms VL - 41 ID - 5446 ER - TY - JOUR AD - Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, United States Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, United States Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States Division of Experimental Medicine, Department of Medicine, Hematology Research Centre, Imperial College of London, London, United Kingdom Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, United States Department of Hematology/Oncology, All Children's Hospital, St Petersburg, FL, United States University Hospitals Bristol NHS Trust, Bristol, United Kingdom Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC, United States Division of Hematology Oncology, UMass Memorial Medical Center, Worcester, MA, United States Department of Hematology, University Hospital, Grenoble, France Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, United States Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States Divison of Hematology, Academische Ziekenhuis Maastricht, Maastricht, Netherlands Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, United States Department of Hematology, Mayo Clinic, Rochester, MN, United States Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia Department of Medical Oncology, Weill Cornell Medical College, New York, NY, United States Ottawa Hospital Research Institute, Ottawa, ON, Canada Department of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Parkville, VIC, Australia Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Division of Cancer Medicine, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR, United States AU - Copelan, E. A. AU - Avalos, B. R. AU - Ahn, K. W. AU - Zhu, X. AU - Gale, R. P. AU - Grunwald, M. R. AU - Hamadani, M. AU - Hamilton, B. K. AU - Hale, G. A. AU - Marks, D. I. AU - Waller, E. K. AU - Savani, B. N. AU - Costa, L. J. AU - Ramanathan, M. AU - Cahn, J. Y. AU - Khoury, H. J. AU - Weisdorf, D. J. AU - Inamoto, Y. AU - Kamble, R. T. AU - Schouten, H. C. AU - Wirk, B. AU - Litzow, M. R. AU - Aljurf, M. D. AU - van Besien, K. W. AU - Ustun, C. AU - Bolwell, B. J. AU - Bredeson, C. N. AU - Fasan, O. AU - Ghosh, N. AU - Horowitz, M. M. AU - Arora, M. AU - Szer, J. AU - Loren, A. W. AU - Alyea, E. P. AU - Cortes, J. AU - Maziarz, R. T. AU - Kalaycio, M. E. AU - Saber, W. DB - Scopus DO - 10.1016/j.bbmt.2014.12.010 IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 552-558 ST - Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation T2 - Biology of Blood and Marrow Transplantation TI - Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922826985&doi=10.1016%2fj.bbmt.2014.12.010&partnerID=40&md5=e0a631558a31a38b173202a1aaf21b98 VL - 21 ID - 5447 ER - TY - JOUR AD - Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan AU - Iriyama, N. AU - Sugimoto, K. J. AU - Sato, E. AU - Takaku, T. AU - Tokuhira, M. AU - Nakazato, T. AU - Ishikawa, M. AU - Fujita, H. AU - Fujioka, I. AU - Kimura, Y. AU - Asou, N. AU - Kizaki, M. AU - Komatsu, N. AU - Hatta, Y. AU - Kawaguchi, T. C7 - 142 DB - Scopus DO - 10.1007/s12032-018-1203-7 IS - 11 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 ST - Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis T2 - Medical Oncology TI - Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052993878&doi=10.1007%2fs12032-018-1203-7&partnerID=40&md5=6dcebe67cdf7310d89cd88e9e66dfe90 VL - 35 ID - 5448 ER - TY - JOUR AD - H.-D. Chae, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States AU - Chae, H. D. AU - Murphy, L. C. AU - Donato, M. AU - Lee, A. G. AU - Alejandro Sweet-Cordero, E. AU - Abidi, P. AU - Bittencourt, H. AU - Lacayo, N. J. AU - Van Houten Dahl, G. AU - Aftandilian, C. AU - Davis, K. L. AU - Huang, M. AU - Sumarsono, N. AU - Redell, M. AU - Fu, C. H. AU - Chen, I. M. L. AU - Alonzo, T. A. AU - Eklund, E. A. AU - Gotlib, J. R. AU - Khatri, P. AU - Hijiya, N. AU - Sakamoto, K. M. DB - Embase DO - 10.1182/blood-2018-99-119974 LA - English M3 - Conference Abstract N1 - L626671631 2019-03-12 PY - 2018 SN - 0006-4971 ST - Comparison of the transcriptomic signature of pediatric vs. adult CML and normal bone marrow stem cells T2 - Blood TI - Comparison of the transcriptomic signature of pediatric vs. adult CML and normal bone marrow stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626671631&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-119974 VL - 132 ID - 5449 ER - TY - JOUR AD - G. Kapoor, Department of Pediatric Oncology and Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India AU - Verma, P. AU - Jain, S. AU - Kapoor, G. DB - Embase DO - 10.4103/2278-330X.208855 IS - 2 LA - English M3 - Letter N1 - L617148890 2017-07-10 2017-07-12 PY - 2017 SN - 2278-4306 2278-330X SP - 89-90 ST - Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma T2 - South Asian Journal of Cancer TI - Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617148890&from=exporthttp://dx.doi.org/10.4103/2278-330X.208855 VL - 6 ID - 5450 ER - TY - JOUR AD - Center for Human Genetics, Catholic University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. Maria.Debiec-Rychter@med.kuleuven.ac.be AN - 12937132 AU - Debiec-Rychter, M. AU - Croes, R. AU - De Vos, R. AU - Marynen, P. AU - Roskams, T. AU - Hagemeijer, A. AU - Lombaerts, R. AU - Sciot, R. C2 - PMC1868245 DA - Sep DO - 10.1016/s0002-9440(10)63451-7 10.1016/S0002-9440(10)63451-7. DP - Nlm ET - 2003/08/26 IS - 3 LA - eng PY - 2003 SN - 0002-9440 (Print) 0002-9440 SP - 913-22 ST - Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor T2 - Am J Pathol TI - Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor VL - 163 ID - 5451 ER - TY - JOUR AN - 24321241 AU - Aisner, D. L. AU - Newell, K. L. AU - Pollack, A. G. AU - Kleinschmidt-Demasters, B. K. AU - Steinberg, G. K. AU - Smyth, L. T. AU - Vogel, H. C2 - PMC4594433 DA - Mar-Apr DO - 10.5414/np300679 10.5414/NP300679. DP - Nlm ET - 2013/12/11 IS - 2 LA - eng PY - 2014 SN - 0722-5091 (Print) 0722-5091 SP - 112-21 ST - Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases T2 - Clin Neuropathol TI - Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases VL - 33 ID - 5452 ER - TY - JOUR AD - J.P. Roose, Department of Anatomy, University of California San Francisco, San Francisco, CA, United States AU - Ksionda, O. AU - Mues, M. AU - Wandler, A. M. AU - Donker, L. AU - Tenhagen, M. AU - Jun, J. AU - Ducker, G. S. AU - Matlawska-Wasowska, K. AU - Shannon, K. AU - Shokat, K. M. AU - Roose, J. P. C1 - as 605240(Selleck) gdc 0941(Selleck) pd 0325901 C2 - Selleck DB - Embase Medline DO - 10.1371/journal.pone.0193849 IS - 5 LA - English M3 - Article N1 - L622278654 2018-06-01 2018-08-03 PY - 2018 SN - 1932-6203 ST - Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy T2 - PLoS ONE TI - Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622278654&from=exporthttp://dx.doi.org/10.1371/journal.pone.0193849 VL - 13 ID - 5453 ER - TY - JOUR AD - J.H. Suh, Foundation Medicine, Inc, 150 Second Street, Cambridge, MA, United States AU - Suh, J. H. AU - Johnson, A. AU - Albacker, L. AU - Wang, K. AU - Chmielecki, J. AU - Frampton, G. AU - Gay, L. AU - Elvin, J. A. AU - Vergilio, J. A. AU - Ali, S. AU - Miller, V. A. AU - Stephens, P. J. AU - Ross, J. S. DB - Embase Medline DO - 10.1634/theoncologist.2016-0030 IS - 6 LA - English M3 - Article N1 - L610847079 2016-06-28 2016-07-08 PY - 2016 SN - 1549-490X 1083-7159 SP - 684-691 ST - Comprehensive genomic profiling facilitates implementation of the national comprehensive cancer network guidelines for lung cancer biomarker testing and identifies Patientswho may benefit from enrollment in mechanism-driven clinical trials T2 - Oncologist TI - Comprehensive genomic profiling facilitates implementation of the national comprehensive cancer network guidelines for lung cancer biomarker testing and identifies Patientswho may benefit from enrollment in mechanism-driven clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610847079&from=exporthttp://dx.doi.org/10.1634/theoncologist.2016-0030 VL - 21 ID - 5454 ER - TY - JOUR AD - B.J. Bezak, Mayo Clinic, United States AU - Bezak, B. J. AU - Elvin, J. AU - Markovic, S. AU - Viozzi, C. F. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L620236285 2018-01-23 PY - 2015 SN - 1531-5053 SP - e42-e43 ST - Comprehensive genomic profiling of aggressive central giant cell lesion identifies targeted therapy treatment option with subsequent response T2 - Journal of Oral and Maxillofacial Surgery TI - Comprehensive genomic profiling of aggressive central giant cell lesion identifies targeted therapy treatment option with subsequent response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620236285&from=export VL - 73 ID - 5455 ER - TY - JOUR AD - N. Li, Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Wang, S. AU - Chen, R. AU - Tang, Y. AU - Yu, Y. AU - Fang, Y. AU - Huang, H. AU - Wu, D. AU - Fang, H. AU - Bai, Y. AU - Sun, C. AU - Yu, A. AU - Fan, Q. AU - Gu, D. AU - Yi, X. AU - Li, N. DB - Embase DO - 10.3389/fonc.2020.00536 LA - English M3 - Article N1 - L631649634 2020-05-13 2020-05-15 PY - 2020 SN - 2234-943X ST - Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies T2 - Frontiers in Oncology TI - Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631649634&from=exporthttp://dx.doi.org/10.3389/fonc.2020.00536 VL - 10 ID - 5456 ER - TY - JOUR AD - Institute of Pathology, University Hospital Basel, Basel, Switzerland Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland AU - Menter, T. AU - Dickenmann, M. AU - Juskevicius, D. AU - Steiger, J. AU - Dirnhofer, S. AU - Tzankov, A. DB - Scopus DO - 10.1002/hon.2280 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 187-197 ST - Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling T2 - Hematological Oncology TI - Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955619474&doi=10.1002%2fhon.2280&partnerID=40&md5=d18ef9174ffb89744753cdb42d296252 VL - 35 ID - 5457 ER - TY - JOUR AD - Institute for Pediatric Research, Soochow University Suzhou, China Department of Pediatric Cardiology, Affiliated Children's Hospital, Soochow University, Suzhou, China Department of Pediatric Surgery, Affiliated Children's Hospital, Soochow University, Suzhou, China Institute of Medical Biotechnology, Soochow University Suzhou, Suzhou, China Department of Academic Surgery, University College Cork, Cork University Hospital, Cork, Ireland AU - Li, Y. P. AU - Huang, J. AU - Huang, S. G. AU - Xu, Y. G. AU - Xu, Y. Y. AU - Liao, J. Y. AU - Feng, X. AU - Zhang, X. G. AU - Wang, J. H. AU - Wang, J. DB - Scopus DO - 10.1016/j.jcrc.2013.10.008 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 312.e7-312.e13 ST - The compromised inflammatory response to bacterial components after pediatric cardiac surgery is associated with cardiopulmonary bypass-suppressed Toll-like receptor signal transduction pathways T2 - Journal of Critical Care TI - The compromised inflammatory response to bacterial components after pediatric cardiac surgery is associated with cardiopulmonary bypass-suppressed Toll-like receptor signal transduction pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896728322&doi=10.1016%2fj.jcrc.2013.10.008&partnerID=40&md5=89baa3cbce809fc526c67fe8fefb161e VL - 29 ID - 5458 ER - TY - JOUR AD - Clinical pharmacy specialist in GI oncology and a clinical coordinator in oncology, Emory Winship Cancer Institute, Atlanta, United States AU - Draper, A. DB - Scopus DO - 10.37765/ajmc.2020.88512 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - S211-S219 ST - A concise review of the changing landscape of hepatocellular carcinoma T2 - The American journal of managed care TI - A concise review of the changing landscape of hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092885574&doi=10.37765%2fajmc.2020.88512&partnerID=40&md5=20b5c223b3f6e0ee24d3fbadf5c740ea VL - 26 ID - 5459 ER - TY - JOUR AD - Department of Pathology. Department of Internal Medicine. Department of Pathology junarplus@chol.com. Department of Nuclear Medicine. Department of Pathology Biomedical Sciences, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea. AN - 25403583 AU - Won, J. K. AU - Keam, B. AU - Koh, J. AU - Cho, H. J. AU - Jeon, Y. K. AU - Kim, T. M. AU - Lee, S. H. AU - Lee, D. S. AU - Kim, D. W. AU - Chung, D. H. DA - Feb DO - 10.1093/annonc/mdu530 10.1093/annonc/mdu530. Epub 2014 Nov 17. DP - Nlm ET - 2014/11/19 IS - 2 LA - eng PY - 2015 SN - 0923-7534 SP - 348-54 ST - Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor T2 - Ann Oncol TI - Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor VL - 26 ID - 5460 ER - TY - JOUR AD - 1 Department of Genetics, King Faisal Specialist Hospital and Research Centre , Riyadh, Saudi Arabia . AN - 24798740 AU - Zou, M. AU - Baitei, E. Y. AU - Alzahrani, A. S. AU - BinHumaid, F. S. AU - Alkhafaji, D. AU - Al-Rijjal, R. A. AU - Meyer, B. F. AU - Shi, Y. C2 - PMC4106383 DA - Aug DO - 10.1089/thy.2013.0610 10.1089/thy.2013.0610. Epub 2014 Jun 10. DP - Nlm ET - 2014/05/07 IS - 8 LA - eng PY - 2014 SN - 1050-7256 (Print) 1050-7256 SP - 1256-66 ST - Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma T2 - Thyroid TI - Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma VL - 24 ID - 5461 ER - TY - JOUR AD - Department of Neurology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Department of Pathology, Johns Hopkins University; Department of Radiology and Radiological Science, Johns Hopkins Hospital; and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. AN - 29632053 AU - Schreck, K. C. AU - Guajardo, A. AU - Lin, D. D. M. AU - Eberhart, C. G. AU - Grossman, S. A. DA - Apr DO - 10.6004/jnccn.2017.7052 10.6004/jnccn.2017.7052. DP - Nlm ET - 2018/04/11 IS - 4 LA - eng PY - 2018 SN - 1540-1405 SP - 343-347 ST - Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors T2 - J Natl Compr Canc Netw TI - Concurrent BRAF/MEK Inhibitors in BRAF V600-Mutant High-Grade Primary Brain Tumors VL - 16 ID - 5462 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin and Children's Milwaukee, Milwaukee, WI, United States Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pharmacy, Wolfson Children's Hospital, United States Department of Pediatrics, Division of Pediatric Hematology/Oncology, Nemours Children's Specialty Care and Wolfson Children's Hospital JacksonvilleFL, United States AU - Pommert, L. AU - Liberio, N. AU - Ng, J. S. AU - Egelund, T. A. AU - Siver, M. J. AU - Katzenstein, H. M. AU - Burke, M. J. DB - Scopus DO - 10.1097/MPH.0000000000001816 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Concurrent Imatinib Dosing with High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients with Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia T2 - Journal of Pediatric Hematology/Oncology TI - Concurrent Imatinib Dosing with High-dose Methotrexate Leads to Acute Kidney Injury and Delayed Methotrexate Clearance in Pediatric Patients with Philadelphia Chromosome-positive B-Cell Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085508892&doi=10.1097%2fMPH.0000000000001816&partnerID=40&md5=664566a62720f526d4e5bf0cc7df9bb0 ID - 5463 ER - TY - JOUR AD - J. Zhang, Pediatrics, San Francisco, CA, United States AU - Zhang, J. AU - Hashizume, R. AU - Hariono, S. AU - Tom, M. AU - Sidhu, A. AU - James, C. D. AU - Weiss, W. AU - Nicolaides, T. DB - Embase DO - 10.1002/pbc.24295 IS - 6 LA - English M3 - Conference Abstract N1 - L70986119 2013-02-11 PY - 2012 SN - 1545-5009 SP - 1075 ST - Concurrent MEK and BRAF inhibition in BRAF-mutant pediatric astrocytomas: Increased efficacy with decreased risk of secondary malignancies T2 - Pediatric Blood and Cancer TI - Concurrent MEK and BRAF inhibition in BRAF-mutant pediatric astrocytomas: Increased efficacy with decreased risk of secondary malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70986119&from=exporthttp://dx.doi.org/10.1002/pbc.24295 VL - 59 ID - 5464 ER - TY - JOUR AD - Department of Ophthalmology, Summa Health System, Akron, Ohio, USA. dedwar39@jhmi.edu AN - 22480745 AU - Edward, D. P. AU - Morales, J. AU - Bouhenni, R. A. AU - Patil, J. AU - Edward, P. R. AU - Cummings, T. J. AU - Chaudhry, I. A. AU - Alkatan, H. DA - Jul DO - 10.1016/j.ophtha.2012.01.027 10.1016/j.ophtha.2012.01.027. Epub 2012 Apr 4. DP - Nlm ET - 2012/04/07 IS - 7 LA - eng PY - 2012 SN - 0161-6420 SP - 1485-94 ST - Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights T2 - Ophthalmology TI - Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights VL - 119 ID - 5465 ER - TY - JOUR AU - Moustafa, D. AU - Blundell, A. R. AU - Hawryluk, E. B. DB - Medline DO - 10.1097/MOP.0000000000000924 IS - 4 LA - English M3 - Article N1 - L632415902 2020-07-30 PY - 2020 SN - 1531-698X SP - 491-497 ST - Congenital melanocytic nevi T2 - Current opinion in pediatrics TI - Congenital melanocytic nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632415902&from=exporthttp://dx.doi.org/10.1097/MOP.0000000000000924 VL - 32 ID - 5466 ER - TY - JOUR AD - Departments of *Pathology, †Dermatology, and ‡Plastic and Reconstructive Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea; and §Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. AN - 25365497 AU - Seo, A. N. AU - Lee, S. J. AU - Choi, Y. H. AU - Chung, H. Y. AU - Huh, J. AU - Yoon, G. S. DA - May DO - 10.1097/dad.0000000000000219 10.1097/DAD.0000000000000219. DP - Nlm ET - 2014/11/05 IS - 5 LA - eng PY - 2015 SN - 0193-1091 SP - 398-400 ST - Congenital primary cutaneous anaplastic large-cell lymphoma: a case report T2 - Am J Dermatopathol TI - Congenital primary cutaneous anaplastic large-cell lymphoma: a case report VL - 37 ID - 5467 ER - TY - JOUR AD - B. Tang, 38 Ballylenaghan Road, Belfast BT8 6WU, United Kingdom AU - Tang, B. AU - Reardon, W. AU - Black, G. C. AU - Kerr, B. A. DB - Embase Medline DO - 10.1097/MCD.0b013e328011f974 IS - 3 LA - English M3 - Article N1 - L46884182 2007-07-01 PY - 2007 SN - 0962-8827 SP - 203-206 ST - Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome T2 - Clinical Dysmorphology TI - Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46884182&from=exporthttp://dx.doi.org/10.1097/MCD.0b013e328011f974 VL - 16 ID - 5468 ER - TY - JOUR AD - P. Bonvini, Pediatric Onco-Hematology Clinic, University Hospital Padova, Via Giustiniani 3, 35100 Padova, Italy AU - Bonvini, P. AU - Zorzi, E. AU - Mussolin, L. AU - Pillon, M. AU - Romualdi, C. AU - Peron, M. AU - D'Amore, E. S. G. AU - Lamant, L. AU - Rosolen, A. C1 - whi p 154 DB - Embase Medline DO - 10.1038/leu.2011.367 IS - 6 LA - English M3 - Article N1 - L364976304 2012-06-19 2012-06-22 PY - 2012 SN - 0887-6924 1476-5551 SP - 1375-1382 ST - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30 NPM-ALK anaplastic large-cell lymphomas T2 - Leukemia TI - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30 NPM-ALK anaplastic large-cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364976304&from=exporthttp://dx.doi.org/10.1038/leu.2011.367 VL - 26 ID - 5469 ER - TY - JOUR AD - Pediatric Onco-Hematology Clinic, University Hospital Padova, Padova, Italy. paolo.bonvini@unipd.it AN - 22289917 AU - Bonvini, P. AU - Zorzi, E. AU - Mussolin, L. AU - Pillon, M. AU - Romualdi, C. AU - Peron, M. AU - d'Amore, E. S. AU - Lamant, L. AU - Rosolen, A. DA - Jun DO - 10.1038/leu.2011.367 10.1038/leu.2011.367. Epub 2012 Jan 6. DP - Nlm ET - 2012/02/01 IS - 6 LA - eng PY - 2012 SN - 0887-6924 SP - 1375-82 ST - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas T2 - Leukemia TI - Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas VL - 26 ID - 5470 ER - TY - JOUR AD - Department of Biology, University of Padova, Padova, Italy. Endocrinology Division, Department of Medicine, Hospital/University of Padova, Padova, Italy. Surgical Pathology & Cytopathology Unit, Department of Medicine, Hospital/University of Padova, Padova, Italy. Department of Clinical and Biotechnological Sciences, University of L'Aquila, L'Aquila, Italy. Neuromed Institute, Department of Neurological Sciences, University of L'Aquila, L'Aquila, Italy. Department of Radiotherapy, Istituto Oncologico del Veneto, IOV-IRCCS, Padova, Italy. Department of Molecular Medicine, University of Padova, Padova, Italy. AN - 26392334 AU - Occhi, G. AU - Barollo, S. AU - Regazzo, D. AU - Bertazza, L. AU - Galuppini, F. AU - Guzzardo, V. AU - Jaffrain-Rea, M. L. AU - Vianello, F. AU - Ciato, D. AU - Ceccato, F. AU - Watutantrige-Fernando, S. AU - Bisognin, A. AU - Bortoluzzi, S. AU - Pennelli, G. AU - Boscaro, M. AU - Scaroni, C. AU - Mian, C. C2 - PMC4741662 DA - Oct 13 DO - 10.18632/oncotarget.5194 10.18632/oncotarget.5194. DP - Nlm ET - 2015/09/24 IS - 31 LA - eng PY - 2015 SN - 1949-2553 SP - 32104-14 ST - A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC T2 - Oncotarget TI - A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC VL - 6 ID - 5471 ER - TY - JOUR AD - J. Yang, MC 3-3320, One Baylor Plaza-BCM320, 6621 Fannin St., Houston, TX, United States AU - Sun, W. AU - Quan, C. AU - Huang, Y. AU - Ji, W. AU - Yu, L. AU - Li, X. AU - Zhang, Y. AU - Zheng, Z. AU - Zou, H. AU - Li, Q. AU - Xu, P. AU - Feng, Y. AU - Li, L. AU - Zhang, Y. AU - Cui, Y. AU - Jia, X. AU - Meng, X. AU - Zhang, C. AU - Jin, Y. AU - Bai, J. AU - Yu, J. AU - Yu, Y. AU - Yang, J. AU - Fu, S. DB - Embase Medline DO - 10.1002/path.4439 IS - 1 LA - English M3 - Article N1 - L600739140 2014-12-19 PY - 2015 SN - 1096-9896 0022-3417 SP - 14-24 ST - Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells T2 - Journal of Pathology TI - Constitutive ERK1/2 activation contributes to production of double minute chromosomes in tumour cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600739140&from=exporthttp://dx.doi.org/10.1002/path.4439 VL - 235 ID - 5472 ER - TY - JOUR AD - M.J. Kuehn, Department of Biochemistry, Duke University Medical Center, Box 3711, Durham, NC 27710, United States AU - Chutkan, H. AU - Kuehn, M. J. DB - Embase Medline DO - 10.1128/IAI.05336-11 IS - 9 L1 - internal-pdf://1876855542/Infection and Immunity-2011-Chutkan-3760.full.pdf LA - English M3 - Article N1 - L362474278 2011-09-09 2011-09-13 PY - 2011 SN - 0019-9567 1098-5522 SP - 3760-3769 ST - Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin T2 - Infection and Immunity TI - Context-dependent activation kinetics elicited by soluble versus outer membrane vesicle-associated heat-labile enterotoxin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362474278&from=exporthttp://dx.doi.org/10.1128/IAI.05336-11 VL - 79 ID - 5473 ER - TY - JOUR AD - E.E. Patton, Institute for Genetics and Molecular Medicine, Edinburgh University, Western General Hospital Campus, Crewe Road South, EH4 2XR, United Kingdom AU - Anastasaki, C. AU - Rauen, K. A. AU - Patton, E. E. C1 - pd 0325901 DB - Embase Medline DO - 10.1242/dmm.008672 IS - 4 LA - English M3 - Article N1 - L365162312 2012-07-11 2012-07-17 PY - 2012 SN - 1754-8403 1754-8411 SP - 546-552 ST - Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish T2 - DMM Disease Models and Mechanisms TI - Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365162312&from=exporthttp://dx.doi.org/10.1242/dmm.008672http://dmm.biologists.org/content/5/4/546.full.pdf+html VL - 5 ID - 5474 ER - TY - JOUR AD - Kantonsspital, St. Gallen, Switzerland University Hospital CHUV, Lausanne, Switzerland University Hospital, Zurich, Switzerland University Hospital, Geneva, Switzerland SASL, Zurich, Switzerland SAKK Coordinating Center, Bern, Switzerland St. László Teaching Hospital, Budapest, Hungary University Hospital, Basel, Switzerland Oncology Institute of Southern Switzerland, Bellinzona, Switzerland University Hospital, Bern, Switzerland AU - Koeberle, D. AU - Montemurro, M. AU - Samaras, P. AU - Majno, P. AU - Simcock, M. AU - Limacher, A. AU - Lerch, S. AU - Katalin, K. AU - Inauen, R. AU - Hess, V. AU - Saletti, P. AU - Borner, M. AU - Roth, A. AU - Bodoky, G. DB - Scopus DO - 10.1634/theoncologist.2009-0316 IS - 3 M3 - Article N1 - Cited By :89 Export Date: 18 November 2020 PY - 2010 SP - 285-292 ST - Continuous sunitinib treatment in patients with advanced hepatocellular carcinoma: A swiss group for clinical cancer research (SAKK) and swiss association for the study of the liver (SASL) multicenter phase II trial (SAKK 77/06) T2 - Oncologist TI - Continuous sunitinib treatment in patients with advanced hepatocellular carcinoma: A swiss group for clinical cancer research (SAKK) and swiss association for the study of the liver (SASL) multicenter phase II trial (SAKK 77/06) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950546450&doi=10.1634%2ftheoncologist.2009-0316&partnerID=40&md5=7498def6d64916beae125a92450bebf0 VL - 15 ID - 5475 ER - TY - JOUR AD - Mersin University, Medical School, Department of Pathology, Turkey Mersin University, Medical School, Department of Biostatistics, Turkey Mersin University, Medical School, Department of Medical Oncology, Turkey Mersin University, Medical School, Department of General Surgery, Turkey AU - Kara, T. AU - Serinsoz, E. AU - Arpaci, R. B. AU - Gubur, O. AU - Orekici, G. AU - Ata, A. AU - Colak, T. AU - Arican, A. DB - Scopus DO - 10.1016/j.prp.2013.04.005 IS - 7 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2013 SP - 413-417 ST - Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors T2 - Pathology Research and Practice TI - Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880041202&doi=10.1016%2fj.prp.2013.04.005&partnerID=40&md5=ab0c42cc183b6fb500bca3a89f346f3e VL - 209 ID - 5476 ER - TY - JOUR AD - Centro de Patogénese Molecular/iMed.UL, Faculdade de Farmácia, University of Lisbon, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal AU - Fernandes, A. AU - Brites, D. DB - Scopus DO - 10.2174/138161209789058165 IS - 25 M3 - Review N1 - Cited By :22 Export Date: 18 November 2020 PY - 2009 SP - 2915-2926 ST - Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents T2 - Current Pharmaceutical Design TI - Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449389923&doi=10.2174%2f138161209789058165&partnerID=40&md5=3f0d6a6ba40e7ff3554cabd0f2a2af28 VL - 15 ID - 5477 ER - TY - JOUR AD - Y.A. DeClerck, Children’s Hospital Los Angeles, 4650 Sunset Boulevard, MS#54, Los Angeles, CA, United States AU - Nakata, R. AU - Shimada, H. AU - Fernandez, G. E. AU - Fanter, R. AU - Fabbri, M. AU - Malvar, J. AU - Zimmermann, P. AU - DeClerck, Y. A. DB - Embase DO - 10.1080/20013078.2017.1332941 IS - 1 LA - English M3 - Article N1 - L620605866 2018-02-19 2018-02-26 PY - 2017 SN - 2001-3078 ST - Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells T2 - Journal of Extracellular Vesicles TI - Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620605866&from=exporthttp://dx.doi.org/10.1080/20013078.2017.1332941 VL - 6 ID - 5478 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology-Blood and Marrow Transplantation, University Hospital Carl Gustav Carus, Fetscherstr. 74, Dresden, Germany Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Division of Pediatric Hematology-Oncology-Blood and Marrow Transplantation, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada AU - Suttorp, M. AU - Yaniv, I. AU - Schultz, K. R. DB - Scopus DO - 10.1016/j.bbmt.2010.09.003 IS - 1 SUPPL M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2011 SP - S115-S122 ST - Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT? T2 - Biology of Blood and Marrow Transplantation TI - Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650659462&doi=10.1016%2fj.bbmt.2010.09.003&partnerID=40&md5=9e1d3e37a018a9e221fbff5a72299e10 VL - 17 ID - 5479 ER - TY - JOUR AD - M.B. Fernández, Department of Pediatric Hemato-Oncology, Hospital 12 de Octubre, Madrid, Spain AU - Fernández, M. B. AU - Alonso, V. P. DB - Embase DO - 10.1007/s00381-016-3132-0 IS - 10 LA - English M3 - Article N1 - L612281100 2016-09-28 2016-10-27 PY - 2016 SN - 1433-0350 0256-7040 SP - 1939-1945 ST - Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas T2 - Child's Nervous System TI - Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612281100&from=exporthttp://dx.doi.org/10.1007/s00381-016-3132-0 VL - 32 ID - 5480 ER - TY - JOUR AD - a Evidera, Inc , Bethesda , MD , USA. b Millennium Pharmaceuticals, Inc , Cambridge , MA , USA , a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. AN - 31125274 AU - Kawata, A. K. AU - Lenderking, W. R. AU - Eseyin, O. R. AU - Kerstein, D. AU - Huang, J. AU - Huang, H. AU - Zhang, P. AU - Lin, H. M. DA - Sep DO - 10.1080/13696998.2019.1624080 10.1080/13696998.2019.1624080. Epub 2019 Jun 25. DP - Nlm ET - 2019/05/28 IS - 9 LA - eng PY - 2019 SN - 1369-6998 SP - 924-935 ST - Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study T2 - J Med Econ TI - Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study VL - 22 ID - 5481 ER - TY - JOUR AD - Department of Pediatrics, University of California, San Francisco, CA 94143, USA. AN - 22586120 AU - Huillard, E. AU - Hashizume, R. AU - Phillips, J. J. AU - Griveau, A. AU - Ihrie, R. A. AU - Aoki, Y. AU - Nicolaides, T. AU - Perry, A. AU - Waldman, T. AU - McMahon, M. AU - Weiss, W. A. AU - Petritsch, C. AU - James, C. D. AU - Rowitch, D. H. C2 - PMC3365162 DA - May 29 DO - 10.1073/pnas.1117255109 10.1073/pnas.1117255109. Epub 2012 May 14. DP - Nlm ET - 2012/05/16 IS - 22 LA - eng PY - 2012 SN - 0027-8424 (Print) 0027-8424 SP - 8710-5 ST - Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy T2 - Proc Natl Acad Sci U S A TI - Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy VL - 109 ID - 5482 ER - TY - JOUR AD - C. Lopez-Pedrera, Unidad de Investigación Hospital Reina Sofía, Córdoba, Spain AU - Barbarroja, N. AU - Arístides-Torres, L. AU - Hernandez, V. AU - Martín, C. AU - Dorado, G. AU - Torres, A. AU - Velasco, F. AU - Lopez-Pedrera, C. DB - Embase Medline DO - 10.1080/10428190701340616 IS - 6 LA - English M3 - Article N1 - L47009209 2007-06-01 PY - 2007 SN - 1042-8194 1029-2403 SP - 1187-1199 ST - Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia T2 - Leukemia and Lymphoma TI - Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47009209&from=exporthttp://dx.doi.org/10.1080/10428190701340616 VL - 48 ID - 5483 ER - TY - JOUR AD - C. Chen, Teaching and Research Section of Clinical Examination and Diagnosis, School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, China AU - Li, H. AU - Song, Y. H. AU - Du, Z. P. AU - Zhang, X. AU - An, C. X. AU - Hu, Y. AU - Tian, Y. AU - Wu, Z. AU - Wu, H. AU - Chen, C. DB - Embase DO - 10.21037/tcr.2018.12.18 IS - 6 LA - English M3 - Article N1 - L625778419 2019-01-11 PY - 2018 SN - 2219-6803 2218-676X SP - 1714-1727 ST - COPB2-shRNA suppresses cell growth and induces apoptosis of STAD SGC-7901 cells via inactivation of p38 MAPK/Smad2/Chk1/2 as an oncogene T2 - Translational Cancer Research TI - COPB2-shRNA suppresses cell growth and induces apoptosis of STAD SGC-7901 cells via inactivation of p38 MAPK/Smad2/Chk1/2 as an oncogene UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625778419&from=exporthttp://dx.doi.org/10.21037/tcr.2018.12.18 VL - 7 ID - 5484 ER - TY - JOUR AD - Service de Génétique, C.H.U. de Poitiers, Centre de Référence Anomalies du Développement Ouest, Poitiers, France. AN - 27450488 AU - Gilbert-Dussardier, B. AU - Briand-Suleau, A. AU - Laurendeau, I. AU - Bilan, F. AU - Cavé, H. AU - Verloes, A. AU - Vidaud, M. AU - Vidaud, D. AU - Pasmant, E. C2 - PMC4957908 DA - Jul 22 DO - 10.1186/s13023-016-0479-y 10.1186/s13023-016-0479-y. DP - Nlm ET - 2016/07/28 IS - 1 LA - eng PY - 2016 SN - 1750-1172 SP - 101 ST - Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities T2 - Orphanet J Rare Dis TI - Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities VL - 11 ID - 5485 ER - TY - JOUR AD - Department of Pathology, Griffith Medical School, Gold Coast, Queensland, Gold Coast QLD 4222, Australia. AN - 21167555 AU - Smith, R. A. AU - Salajegheh, A. AU - Weinstein, S. AU - Nassiri, M. AU - Lam, A. K. DA - Apr DO - 10.1016/j.humpath.2009.09.023 10.1016/j.humpath.2009.09.023. Epub 2010 Dec 16. DP - Nlm ET - 2010/12/21 IS - 4 LA - eng PY - 2011 SN - 0046-8177 SP - 500-6 ST - Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant T2 - Hum Pathol TI - Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant VL - 42 ID - 5486 ER - TY - JOUR AD - Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China Guangzhou Air Force Headquarters Hospital, Huanshi East Road, Yuexiu District, Guangzhou, 510071, China Department of Hematology, Second People's Hospital of Guangdong Province, Guangzhou, 510317, China Department of Hematology, Hospital of Guizhou Province, Guizhou, 550002, China AU - Xu, N. AU - Li, Y. L. AU - Li, X. AU - Zhou, X. AU - Cao, R. AU - Li, H. AU - Li, L. AU - Lu, Z. Y. AU - Huang, J. X. AU - Fan, Z. P. AU - Huang, F. AU - Zhou, H. S. AU - Zhang, S. AU - Liu, Z. AU - Zhu, H. Q. AU - Liu, Q. F. AU - Liu, X. L. C7 - 40 DB - Scopus DO - 10.1186/s13045-016-0270-5 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 ST - Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Journal of Hematology and Oncology TI - Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007579919&doi=10.1186%2fs13045-016-0270-5&partnerID=40&md5=56372874f2e8e132748cf685e0606200 VL - 9 ID - 5487 ER - TY - JOUR AD - Aix Marseille Univ, CRO2, 13284 Marseille, France. sebastien.salas@ap-hm.fr. AN - 25146150 AU - Salas, S. AU - Jiguet-Jiglaire, C. AU - Campion, L. AU - Bartoli, C. AU - Frassineti, F. AU - Deville, J. L. AU - Maues De Paula, A. AU - Forest, F. AU - Jézéquel, P. AU - Gentet, J. C. AU - Bouvier, C. C2 - PMC4150966 DA - Aug 20 DO - 10.1186/1471-2407-14-606 10.1186/1471-2407-14-606. DP - Nlm ET - 2014/08/26 LA - eng PY - 2014 SN - 1471-2407 SP - 606 ST - Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma T2 - BMC Cancer TI - Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma VL - 14 ID - 5488 ER - TY - JOUR AD - Medical Oncology Department, Institut Català d'Oncologia de Girona, Girona, Spain. jrubio@iconcologia.net. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. jrubio@iconcologia.net. Faculty of Medicine, University of Girona (UdG), Girona, Catalonia, Spain. jrubio@iconcologia.net. Medical Oncology Department, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Spain. jborras@grupsagessa.com. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. jborras@grupsagessa.com. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. jborras@grupsagessa.com. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. jborras@grupsagessa.com. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. mccarmonagarcia22@gmail.com. Epidemiology Unit and Girona Cancer Registry (UERC), Oncology Coordination Plan Department of Health Government of Catalonia, Girona, Spain. mccarmonagarcia22@gmail.com. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. aameijide@grupsagessa.com. Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. AGonzalezV@santpau.cat. Faculty of Medicine, University of Girona (UdG), Girona, Catalonia, Spain. rortizduran.girona.ics@gencat.cat. Department of Pathology, University Hospital Josep Trueta, Girona, Spain. rortizduran.girona.ics@gencat.cat. Department of Pathology, University Hospital Verge de la Cinta, Institut d'Investigació Sanitària Pere Virgili (IISPV), Fundació Dr. Ferran (FF), Tortosa, Spain. rbosch.ebre.ics@gencat.cat. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. friu@grupsagessa.com. Department of Pathology, University Hospital Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. friu@grupsagessa.com. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. dparada@grupsagessa.com. Department of Pathology, University Hospital Sant Joan, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. dparada@grupsagessa.com. Department of Pathology, Hospital Santa Tecla, Tarragona, Spain. emc@xarxatecla.cat. Department of Pathology, Clinica Girona, Girona, Spain. pmiroap@clinicagirona.cat. Faculty of Medicine, Universitat Rovira i Virgili, Tarragona, Spain. jsirvent.hj23.ics@gencat.cat. Department of Pathology, University Hospital Joan XXIII, Tarragona, Spain. jsirvent.hj23.ics@gencat.cat. Tarragona Cancer Registry, Fundació per a la Investigació i Prevenció del Càncer (FUNCA), IISPV, Universitat Rovira i Virgili, Tarragona, Spain. jgalceran@grupsagessa.com. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. jgalceran@grupsagessa.com. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain. rmarcos@iconcologia.net. Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain. rmarcos@iconcologia.net. Epidemiology Unit and Girona Cancer Registry (UERC), Oncology Coordination Plan Department of Health Government of Catalonia, Girona, Spain. rmarcos@iconcologia.net. AN - 25885906 AU - Rubió-Casadevall, J. AU - Borràs, J. L. AU - Carmona-García, M. C. AU - Ameijide, A. AU - Gonzalez-Vidal, A. AU - Ortiz, M. R. AU - Bosch, R. AU - Riu, F. AU - Parada, D. AU - Martí, E. AU - Miró, J. AU - Sirvent, J. J. AU - Galceran, J. AU - Marcos-Gragera, R. C2 - PMC4336765 DA - Feb 13 DO - 10.1186/s12957-015-0474-0 10.1186/s12957-015-0474-0. DP - Nlm ET - 2015/04/18 LA - eng PY - 2015 SN - 1477-7819 SP - 47 ST - Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study T2 - World J Surg Oncol TI - Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study VL - 13 ID - 5489 ER - TY - JOUR AD - Department of Pathology, Nanfang Hospital affiliated to Southern Medical University, Guangzhou 510515 Guangdong, China. AN - 22365399 AU - Li, H. L. AU - Huang, X. P. AU - Zhou, X. H. AU - Ji, T. H. AU - Wu, Z. Q. AU - Wang, Z. Q. AU - Jiang, H. Y. AU - Liu, F. R. AU - Zhao, T. DA - Dec DO - 10.3967/0895-3988.2011.06.007 10.3967/0895-3988.2011.06.007. DP - Nlm ET - 2012/03/01 IS - 6 LA - eng PY - 2011 SN - 0895-3988 (Print) 0895-3988 SP - 630-41 ST - Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma T2 - Biomed Environ Sci TI - Correlation of seven biological factors (Hsp90a, p53, MDM2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma VL - 24 ID - 5490 ER - TY - JOUR AD - Department of Pediatrics, Apps Medical Research Centre, Kingston Gen. Hosp., Qu.'s Univ., D. AU - Wang, W. AU - Solc, M. AU - Ji, P. AU - Dow, K. E. C1 - pd 98059 sb 203580 DB - Embase Medline DO - 10.1016/j.neulet.2004.08.055 IS - 2-3 LA - English M3 - Article N1 - L39440759 2004-11-17 PY - 2004 SN - 0304-3940 SP - 133-137 ST - Corticotropin-releasing hormone potentiates neural injury induced by oxygen-glucose deprivation: A possible involvement of microglia T2 - Neuroscience Letters TI - Corticotropin-releasing hormone potentiates neural injury induced by oxygen-glucose deprivation: A possible involvement of microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39440759&from=exporthttp://dx.doi.org/10.1016/j.neulet.2004.08.055 VL - 371 ID - 5491 ER - TY - JOUR AD - K.A. Rauen, UCSF Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, Box 0808, San Francisco, CA 94115, United States AU - Rauen, K. A. AU - Banerjee, A. AU - Bishop, W. R. AU - Lauchle, J. O. AU - McCormick, F. AU - McMahon, M. AU - Melese, T. AU - Munster, P. N. AU - Nadaf, S. AU - Packer, R. J. AU - Sebolt-Leopold, J. AU - Viskochil, D. H. C1 - arry 162(array) arry 162(Novartis) arry 300(array) arry 300(Novartis) arry 704(array) arry 886(array) as 703026(EMD Serono) azd 6244(Astra Zeneca) azd 8330(Astra Zeneca) bms 908662(Bristol Myers Squibb) ch 4987655(Chugai) ci 1040(Pfizer) e 6201(Eisai) gdc 0973(Genentech) gsk 1120212(Glaxo SmithKline) nexavar(Bayer) nexavar(Onyx) pd 0325901(Pfizer) plx 4032(Hoffmann La Roche) plx 4032(Plexxikon) plx 5568(Hoffmann La Roche) plx 5568(Plexxikon) raf 265(Novartis) rdea 119(Ardea) rdea 119(Bayer) rdea 436(Ardea) rdea 436(Bayer) rg 7168(Hoffmann La Roche) sarasar(Merck) sarasar(Schering Plough) tak 733(Millennium) tak 733(Takeda) wx 554(Wilex) xl 281(Exelixis) zarnestra(Johnson and Johnson) C2 - Ardea array Astra Zeneca Bayer Bristol Myers Squibb Chugai Concordia Eisai EMD Serono Exelixis Genentech Glaxo SmithKline Hoffmann La Roche Johnson and Johnson Merck Millennium Novartis Onyx Pfizer Plexxikon Schering Plough Takeda Wilex DB - Embase Medline DO - 10.1002/ajmg.c.30294 IS - 2 LA - English M3 - Article N1 - L51380324 2011-04-19 2011-05-05 PY - 2011 SN - 1552-4868 1552-4876 SP - 136-146 ST - Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies T2 - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics TI - Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51380324&from=exporthttp://dx.doi.org/10.1002/ajmg.c.30294 VL - 157 ID - 5492 ER - TY - JOUR AD - Division of Medical Genetics, A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. AN - 18025929 AU - Quezada, E. AU - Gripp, K. W. DA - Dec DO - 10.1097/MOP.0b013e3282f161dc 10.1097/MOP.0b013e3282f161dc. DP - Nlm ET - 2007/11/21 IS - 6 LA - eng PY - 2007 SN - 1040-8703 (Print) 1040-8703 SP - 636-44 ST - Costello syndrome and related disorders T2 - Curr Opin Pediatr TI - Costello syndrome and related disorders VL - 19 ID - 5493 ER - TY - JOUR AD - Y. Aoki, Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan AU - Katata, Y. AU - Inoue, S. I. AU - Asao, A. AU - Kobayashi, S. AU - Terui, H. AU - Inoue-Shibui, A. AU - Abe, T. AU - Niihori, T. AU - Aiba, S. AU - Ishii, N. AU - Kure, S. AU - Aoki, Y. C1 - pd 0325901 DB - Embase Medline DO - 10.1038/s41419-020-02845-8 IS - 8 LA - English M3 - Article N1 - L2005852584 2020-08-19 2020-08-25 PY - 2020 SN - 2041-4889 ST - Costello syndrome model mice with a Hras G12S/+ mutation are susceptible to develop house dust mite-induced atopic dermatitis T2 - Cell Death and Disease TI - Costello syndrome model mice with a Hras G12S/+ mutation are susceptible to develop house dust mite-induced atopic dermatitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005852584&from=exporthttp://dx.doi.org/10.1038/s41419-020-02845-8 VL - 11 ID - 5494 ER - TY - JOUR AD - Division of Medical Genetics, Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA. kgripp@nemours.org AN - 22261753 AU - Gripp, K. W. AU - Lin, A. E. DA - Mar DO - 10.1038/gim.0b013e31822dd91f 10.1038/gim.0b013e31822dd91f. DP - Nlm ET - 2012/01/21 IS - 3 LA - eng PY - 2012 SN - 1098-3600 SP - 285-92 ST - Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations T2 - Genet Med TI - Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations VL - 14 ID - 5495 ER - TY - JOUR AU - Dong, J. AU - Jan, Y. J. AU - Cheng, J. AU - Zhang, R. Y. AU - Meng, M. AU - Smalley, M. AU - Chen, P. J. AU - Tang, X. AU - Tseng, P. AU - Bao, L. AU - Huang, T. Y. AU - Zhou, D. AU - Liu, Y. AU - Chai, X. AU - Zhang, H. AU - Zhou, A. AU - Agopian, V. G. AU - Posadas, E. M. AU - Shyue, J. J. AU - Jonas, S. J. AU - Weiss, P. S. AU - Li, M. AU - Zheng, G. AU - Yu, H. H. AU - Zhao, M. AU - Tseng, H. R. AU - Zhu, Y. DB - Medline DO - 10.1126/sciadv.aav9186 IS - 7 LA - English M3 - Article N1 - L629044121 2019-09-20 2020-05-11 PY - 2019 SN - 2375-2548 SP - eaav9186 ST - Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells T2 - Science advances TI - Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629044121&from=exporthttp://dx.doi.org/10.1126/sciadv.aav9186 VL - 5 ID - 5496 ER - TY - JOUR AD - J.-B. Kim, Department of Pediatrics, Hangang Sacred Heart Hospital, Hallym University, 94-200 Yeong-deungpo-Dong, Yeongdeungpo-Ku, Seoul, South Korea AU - Cui, H. S. AU - Joo, S. Y. AU - Cho, Y. S. AU - Kim, J. B. AU - Seo, C. H. DB - Embase Medline DO - 10.1016/j.abb.2020.108322 LA - English M3 - Article N1 - L2005097748 2020-03-04 2020-03-10 PY - 2020 SN - 1096-0384 0003-9861 ST - CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts T2 - Archives of Biochemistry and Biophysics TI - CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005097748&from=exporthttp://dx.doi.org/10.1016/j.abb.2020.108322 VL - 683 ID - 5497 ER - TY - JOUR AD - K. Page, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Parilla, N. W. AU - Hughes, V. S. AU - Lierl, K. M. AU - Wong, H. R. AU - Page, K. DB - Embase Medline DO - 10.1186/1465-9921-7-84 LA - English M3 - Article N1 - L44004619 2006-07-25 PY - 2006 SN - 1465-993X ST - CpG DNA modulates interleukin Iβ-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells T2 - Respiratory Research TI - CpG DNA modulates interleukin Iβ-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44004619&from=exporthttp://dx.doi.org/10.1186/1465-9921-7-84http://respiratory-research.com/content/7/1/84 VL - 7 ID - 5498 ER - TY - JOUR AD - S. Sharif, Department of Pathobiology, University of Guelph, Guelph, ON, Canada AU - Kulkarni, R. R. AU - Villanueva, A. I. AU - Read, L. R. AU - Brisbin, J. T. AU - Bhaumik, S. K. AU - LaMarre, J. AU - Murali-Krishna, K. AU - Sharif, S. DB - Embase Medline DO - 10.1007/s00441-017-2631-y IS - 3 LA - English M3 - Article N1 - L616479770 2017-06-01 2017-09-13 PY - 2017 SN - 1432-0878 0302-766X SP - 541-554 ST - CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status T2 - Cell and Tissue Research TI - CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616479770&from=exporthttp://dx.doi.org/10.1007/s00441-017-2631-y VL - 369 ID - 5499 ER - TY - JOUR AD - Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Osaka, Japan. Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan. AN - 28650561 AU - Ueda, K. AU - Yaoita, M. AU - Niihori, T. AU - Aoki, Y. AU - Okamoto, N. DA - Sep DO - 10.1002/ajmg.a.38337 10.1002/ajmg.a.38337. Epub 2017 Jun 26. DP - Nlm ET - 2017/06/27 IS - 9 LA - eng PY - 2017 SN - 1552-4825 SP - 2346-2352 ST - Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype T2 - Am J Med Genet A TI - Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype VL - 173 ID - 5500 ER - TY - JOUR AD - Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China AU - Zhang, Q. AU - Ding, Y. AU - Yao, Y. AU - Yu, Y. AU - Yang, L. AU - Cui, H. C7 - e83589 DB - Scopus DO - 10.1371/journal.pone.0083589 IS - 12 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2013 ST - Creating rat model for hypoxic brain damage in neonates by oxygen deprivation T2 - PLoS ONE TI - Creating rat model for hypoxic brain damage in neonates by oxygen deprivation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892935508&doi=10.1371%2fjournal.pone.0083589&partnerID=40&md5=6a838338b7147e1160789bef877195be VL - 8 ID - 5501 ER - TY - JOUR AD - Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210, USA. AN - 18004977 AU - Knostman, K. A. AU - Venkateswaran, A. AU - Zimmerman, B. AU - Capen, C. C. AU - Jhiang, S. M. DA - Dec DO - 10.1089/thy.2007.0224 10.1089/thy.2007.0224. DP - Nlm ET - 2007/11/17 IS - 12 LA - eng PY - 2007 SN - 1050-7256 (Print) 1050-7256 SP - 1181-8 ST - Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression T2 - Thyroid TI - Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression VL - 17 ID - 5502 ER - TY - JOUR AD - L.C. Lee, University of Cambridge, Cambridge, United Kingdom AU - Lee, L. C. AU - Han, M. AU - Luo, J. AU - Turner, S. DB - Embase IS - 6 LA - English M3 - Conference Abstract N1 - L613102105 2016-11-10 PY - 2016 SN - 1943-7811 SP - 1003 ST - CRISPR-based genome-wide knockout and overexpression screens identify novel and putative acquired resistance mechanisms to pharmacological inhibition of ALK in human neuroblastoma cell lines T2 - Journal of Molecular Diagnostics TI - CRISPR-based genome-wide knockout and overexpression screens identify novel and putative acquired resistance mechanisms to pharmacological inhibition of ALK in human neuroblastoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613102105&from=export VL - 18 ID - 5503 ER - TY - JOUR AD - S. Yi, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu Province, China AU - Cheng, Q. AU - Wang, Y. X. AU - Yu, J. AU - Yi, S. DB - Embase DO - 10.4103/1673-5374.208596 IS - 6 LA - English M3 - Article N1 - L617297943 2017-07-18 2017-07-20 PY - 2017 SN - 1876-7958 1673-5374 SP - 995-1002 ST - Critical signaling pathways during wallerian degeneration of peripheral nerve T2 - Neural Regeneration Research TI - Critical signaling pathways during wallerian degeneration of peripheral nerve UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617297943&from=exporthttp://dx.doi.org/10.4103/1673-5374.208596 VL - 12 ID - 5504 ER - TY - JOUR AD - Sydney Children's Hospital, Randwick, New South Wales, Australia. Children's Cancer Institute, Sydney, New South Wales, Australia. University of New South Wales, Sydney, New South Wales, Australia. Prince of Wales Hospital, Randwick, New South Wales, Australia. Canberra Hospital, Garran, Australian Capital Territory, Australia. Australian National University Medical School, Acton, Australian Capital Territory, Australia. St Vincent's Hospital, Darlinghurst, New South Wales, Australia. University of Auckland, Auckland, New Zealand. Perth Children's Hospital, Perth, Western Australia, Australia. Queensland Children's Hospital, South Brisbane, Queensland, Australia. Garvan Institute of Medical Research, Sydney, New South Wales, Australia. Altius Institute for Biomedical Sciences, Seattle, WA. Children's Medical Research Institute, Westmead New South Wales, Australia. AN - 32914017 AU - Trahair, T. AU - Gifford, A. J. AU - Fordham, A. AU - Mayoh, C. AU - Fadia, M. AU - Lukeis, R. AU - Wood, A. C. AU - Valvi, S. AU - Walker, R. D. AU - Blackburn, J. AU - Heyer, E. E. AU - Mercer, T. R. AU - Barbaric, D. AU - Marshall, G. M. AU - MacKenzie, K. L. C2 - PMC7446396 manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center. Toby TrahairStock and Other Ownership Interests: CSLAndrew C. WoodPatents, Royalties, Other Intellectual Property: PAT055863-US-PCT, inventor assigned to Genomics Institute of the Novartis Research Foundation involving combination inhibition of ALKTim R. MercerSpeakers’ Bureau: Oxford Nanopore Patents, Royalties, Other Intellectual Property: Inventor of two patents related to synthetic RNA and DNA controls for next-generation sequencingKaren L. MacKenzieResearch Funding: Komipharm (Inst) No other potential conflicts of interest were reported. DO - 10.1200/po.18.00297 10.1200/PO.18.00297. eCollection 2019. DP - Nlm ET - 2019/05/16 LA - eng PY - 2019 SN - 2473-4284 ST - Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors T2 - JCO Precis Oncol TI - Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors VL - 3 ID - 5505 ER - TY - JOUR AD - P.S. Dattatreya, Omega Hospitals, A Unit of Hyderabad, Institute of Oncology, India AU - Dattatreya, P. S. DB - Embase DO - 10.1007/s12288-013-0302-z IS - 4 LA - English M3 - Conference Abstract N1 - L71223165 2013-11-15 PY - 2013 SN - 0971-4502 SP - 320-321 ST - Crizotinib as a targeted therapy for paediatric alcl-a case report (exploring an unapproved option) T2 - Indian Journal of Hematology and Blood Transfusion TI - Crizotinib as a targeted therapy for paediatric alcl-a case report (exploring an unapproved option) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71223165&from=exporthttp://dx.doi.org/10.1007/s12288-013-0302-z VL - 29 ID - 5506 ER - TY - JOUR AD - L. Brugières, Gustave Roussy, Villejuif, France AU - Brugières, L. AU - Houot, R. AU - Cozic, N. AU - De La Fouchardière, C. AU - Morschhauser, F. AU - Brice, P. AU - Laboure, N. A. AU - Auvrignon, A. AU - Aladjidi, N. AU - Kolb, B. AU - Blanc, L. AU - Pagnier, A. AU - Arfi-Rouche, J. AU - Cottereau, A. S. AU - Oukhatar, C. A. AU - Labouret, N. H. AU - Vassal, G. DB - Embase LA - English M3 - Conference Abstract N1 - L620334263 2018-01-30 PY - 2017 SN - 1528-0020 ST - Crizotinib in advanced ALK+ anaplastic large cell lymphoma in children and adults: Results of the ACS© phase II trial T2 - Blood TI - Crizotinib in advanced ALK+ anaplastic large cell lymphoma in children and adults: Results of the ACS© phase II trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334263&from=export VL - 130 ID - 5507 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium AU - Schöffski, P. AU - Sufliarsky, J. AU - Gelderblom, H. AU - Blay, J. Y. AU - Strauss, S. J. AU - Stacchiotti, S. AU - Rutkowski, P. AU - Lindner, L. H. AU - Leahy, M. G. AU - Italiano, A. AU - Isambert, N. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Van Cann, T. AU - Marréaud, S. AU - Nzokirantevye, A. AU - Collette, S. AU - Wozniak, A. C1 - xalkori(Pfizer,United States) C2 - Pfizer(United States) DB - Embase Medline DO - 10.1016/S2213-2600(18)30116-4 IS - 6 LA - English M3 - Article N1 - L2000644913 2018-04-17 2018-06-01 PY - 2018 SN - 2213-2619 2213-2600 SP - 431-441 ST - Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial T2 - The Lancet Respiratory Medicine TI - Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000644913&from=exporthttp://dx.doi.org/10.1016/S2213-2600(18)30116-4 VL - 6 ID - 5508 ER - TY - JOUR AD - Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, New York. Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, New York. Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York. Department of Pathology, SUNY Upstate Medical University, Syracuse, New York. AN - 29697184 AU - Hudson, S. AU - Wang, D. AU - Middleton, F. AU - Nevaldine, B. H. AU - Naous, R. AU - Hutchison, R. E. DA - Aug DO - 10.1002/pbc.27094 10.1002/pbc.27094. Epub 2018 Apr 26. DP - Nlm ET - 2018/04/27 IS - 8 LA - eng PY - 2018 SN - 1545-5009 SP - e27094 ST - Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes T2 - Pediatr Blood Cancer TI - Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes VL - 65 ID - 5509 ER - TY - JOUR AD - Department of Pediatrics, Yokohama City University, Yokohama, Japan. Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan. AN - 27494825 AU - Hayashi, A. AU - Tanoshima, R. AU - Tsujimoto, S. I. AU - Yanagimachi, M. AU - Takeuchi, M. AU - Sasaki, K. AU - Ikeda, J. AU - Kajiwara, R. AU - Ito, S. AU - Takahashi, H. C2 - PMC5022176 DA - Aug 5 DO - 10.1038/bcj.2016.52 10.1038/bcj.2016.52. DP - Nlm ET - 2016/08/06 IS - 8 LA - eng PY - 2016 SN - 2044-5385 SP - e456 ST - Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene T2 - Blood Cancer J TI - Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene VL - 6 ID - 5510 ER - TY - JOUR AD - H.A. Stephany, Department of Urology, University of California, Irvine, CA, United States AU - Kopelevich, A. AU - Holzman, S. A. AU - La, J. AU - Lai, H. A. AU - Torno, L. AU - Stephany, H. A. DB - Embase Medline DO - 10.1016/j.urology.2020.08.032 LA - English M3 - Article in Press N1 - L2007934681 2020-10-07 PY - 2020 SN - 1527-9995 0090-4295 ST - Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma T2 - Urology TI - Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007934681&from=exporthttp://dx.doi.org/10.1016/j.urology.2020.08.032 ID - 5511 ER - TY - JOUR AD - Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. francesca.megiorni@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. hdominici@tin.it. Department of Oncology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. hdominici@tin.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. simona.camero@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. o.mannarino@libero.it. Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. simona.ceccarelli@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. milena.paiano@uniroma1.it. Department of Paediatric Surgery, Alder Hey Children's NHS Foundation Trust; Academic Paediatric Surgery Unit, University of Liverpool, Eaton Road, L12 2AP, Liverpool, UK. paul.losty@liverpool.ac.uk. Department of Oncology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. barry.pizer@alderhey.nhs.uk. Department of Perinatal and Paediatric Pathology, Alder Hey Children's NHS Foundation Trust, Eaton Road, L12 2AP, Liverpool, UK. rajeev.shukla@alderhey.nhs.uk. Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. antonio.pizzuti@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. anna.clerico@uniroma1.it. Department of Paediatrics and Infantile Neuropsychiatry, Sapienza University, Viale Regina Elena 324, 00161, Rome, Italy. carlo.dominici@uniroma1.it. AN - 26445453 AU - Megiorni, F. AU - McDowell, H. P. AU - Camero, S. AU - Mannarino, O. AU - Ceccarelli, S. AU - Paiano, M. AU - Losty, P. D. AU - Pizer, B. AU - Shukla, R. AU - Pizzuti, A. AU - Clerico, A. AU - Dominici, C. C2 - PMC4596370 DA - Oct 6 DO - 10.1186/s13046-015-0228-4 10.1186/s13046-015-0228-4. DP - Nlm ET - 2015/10/09 LA - eng PY - 2015 SN - 0392-9078 (Print) 0392-9078 SP - 112 ST - Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition T2 - J Exp Clin Cancer Res TI - Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition VL - 34 ID - 5512 ER - TY - JOUR AD - 1 University of Wisconsin Hospitals and Clinics, American Family Children's Hospital, Madison, WI, USA. 2 School of Pharmacy, University of Wisconsin, Madison, WI, USA. AN - 29357780 AU - Lubcke, N. AU - Van Camp, K. DA - Apr DO - 10.1177/1078155217752537 10.1177/1078155217752537. Epub 2018 Jan 22. DP - Nlm ET - 2018/01/24 IS - 3 LA - eng PY - 2019 SN - 1078-1552 SP - 724-726 ST - Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma T2 - J Oncol Pharm Pract TI - Crizotinib-induced erosive esophagitis in a pediatric patient with neuroblastoma VL - 25 ID - 5513 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, 510120, China. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China. State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China. zengmsh@sysucc.org.cn. Department of Otolaryngology-Head and Neck Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, 510120, China. hxming@mail.sysu.edu.cn. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. hxming@mail.sysu.edu.cn. AN - 29515111 AU - Yu, S. T. AU - Zhong, Q. AU - Chen, R. H. AU - Han, P. AU - Li, S. B. AU - Zhang, H. AU - Yuan, L. AU - Xia, T. L. AU - Zeng, M. S. AU - Huang, X. M. C2 - PMC5841418 DA - Mar 7 DO - 10.1038/s41419-018-0352-0 10.1038/s41419-018-0352-0. DP - Nlm ET - 2018/03/09 IS - 3 LA - eng PY - 2018 SP - 371 ST - CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways T2 - Cell Death Dis TI - CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways VL - 9 ID - 5514 ER - TY - JOUR AD - Y.-N. Yang, Department of Pediatrics, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan AU - Hsieh, M. T. AU - Wang, L. M. AU - Changou, C. A. AU - Chin, Y. T. AU - Yang, Y. S. H. AU - Lai, H. Y. AU - Lee, S. Y. AU - Yang, Y. N. AU - Whang-Peng, J. AU - Liu, L. F. AU - Lin, H. Y. AU - Mousa, S. A. AU - Davis, P. J. DB - Embase DO - 10.18632/oncotarget.10757 IS - 15 LA - English M3 - Article N1 - L615419967 2017-04-21 2017-05-03 PY - 2017 SN - 1949-2553 SP - 24237-24249 ST - Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells T2 - Oncotarget TI - Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615419967&from=exporthttp://dx.doi.org/10.18632/oncotarget.10757 VL - 8 ID - 5515 ER - TY - JOUR AD - Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryocho, Aoba-ku, Sendai 980-8574, Japan AU - Shimizu, T. AU - Fukumoto, Y. AU - Tanaka, S. I. AU - Satoh, K. AU - Ikeda, S. AU - Shimokawa, H. DB - Scopus DO - 10.1161/ATVBAHA.113.301357 IS - 12 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2013 SP - 2780-2791 ST - Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice T2 - Arteriosclerosis, Thrombosis, and Vascular Biology TI - Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888202856&doi=10.1161%2fATVBAHA.113.301357&partnerID=40&md5=3dc9f47ad97a7803f738430f327412bd VL - 33 ID - 5516 ER - TY - JOUR AD - P. Lu, International Medical Center, Hebei Yanda Lu Daopei Hospital, Langfang, China AU - Zhang, Y. AU - Wang, F. AU - Chen, X. AU - Zhang, Y. AU - Wang, M. AU - Liu, H. AU - Cao, P. AU - Ma, X. AU - Wang, T. AU - Zhang, J. AU - Zhang, X. AU - Lu, P. AU - Liu, H. DB - Embase Medline DO - 10.1002/cncr.31586 IS - 16 LA - English M3 - Article N1 - L623638082 2018-08-31 2018-09-04 PY - 2018 SN - 1097-0142 0008-543X SP - 3329-3338 ST - CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia T2 - Cancer TI - CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623638082&from=exporthttp://dx.doi.org/10.1002/cncr.31586 VL - 124 ID - 5517 ER - TY - JOUR AD - Department of Gastroenterology, China-Japan Friendship Hospital, Beijing, 100029, China AU - Song, Z. M. AU - Liu, F. AU - Chen, Y. M. AU - Liu, Y. J. AU - Wang, X. D. AU - Du, S. Y. DB - Scopus DO - 10.1016/j.biopha.2018.12.063 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 1429-1437 ST - CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis T2 - Biomedicine and Pharmacotherapy TI - CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060090240&doi=10.1016%2fj.biopha.2018.12.063&partnerID=40&md5=82cb517272220f37a9d3137e42bc96be VL - 111 ID - 5518 ER - TY - JOUR AD - K. Yang, Department of Joint Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, 195 Tongbai Road, Zhengzhou, Henan, China AU - Zhang, Z. R. AU - Gao, M. X. AU - Yang, K. DB - Embase DO - 10.3892/etm.2017.4547 IS - 1 LA - English M3 - Article N1 - L616852712 2017-06-22 2017-06-28 PY - 2017 SN - 1792-1015 1792-0981 SP - 805-812 ST - Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways T2 - Experimental and Therapeutic Medicine TI - Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616852712&from=exporthttp://dx.doi.org/10.3892/etm.2017.4547 VL - 14 ID - 5519 ER - TY - JOUR AD - S.-J. Li, Department of Pediatric Intensive Care Unit, First Affiliated Hospital, Xinxiang Medical College, Henan, China AU - Shang, Y. AU - Guo, X. X. AU - Li, W. W. AU - Rao, W. AU - Chen, M. L. AU - Mu, L. N. AU - Li, S. J. DB - Embase Medline IS - 21 LA - English M3 - Article N1 - L606144465 2015-09-30 2015-10-02 PY - 2014 SN - 1128-3602 SP - 3297-3303 ST - Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN T2 - European Review for Medical and Pharmacological Sciences TI - Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606144465&from=export VL - 18 ID - 5520 ER - TY - JOUR AD - K. Wuertz, Spine Research Group, Competence Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland AU - Klawitter, M. AU - Quero, L. AU - Klasen, J. AU - Gloess, A. N. AU - Klopprogge, B. AU - Hausmann, O. AU - Boos, N. AU - Wuertz, K. DB - Embase DO - 10.1186/1476-9255-9-29 LA - English M3 - Article N1 - L52174427 2012-08-24 2012-12-17 PY - 2012 SN - 1476-9255 ST - Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity T2 - Journal of Inflammation (United Kingdom) TI - Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52174427&from=exporthttp://dx.doi.org/10.1186/1476-9255-9-29 VL - 9 ID - 5521 ER - TY - JOUR AD - N. Yepuri, SUNY Upstate Medical University, Syracuse, NY, United States AU - Yepuri, N. AU - Meng, Q. AU - Cooney, R. N. DB - Embase DO - 10.1097/SHK.0000000000001158 IS - 6 LA - English M3 - Conference Abstract N1 - L622687470 2018-06-28 PY - 2018 SN - 1540-0514 SP - 61-62 ST - Curcumin induced activation of aryl hydrocarbon receptor attenuates fermented formula induced injury in neonatal enterocytes T2 - Shock TI - Curcumin induced activation of aryl hydrocarbon receptor attenuates fermented formula induced injury in neonatal enterocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622687470&from=exporthttp://dx.doi.org/10.1097/SHK.0000000000001158 VL - 49 ID - 5522 ER - TY - JOUR AD - C.-W. Lee, Division of Basic Medical Sciences, Department of Nursing, and Chronic Diseases and Health Promotion Research Center, Chang Gung Institute of Technology, Chia-Yi, Taiwan AU - Yen, F. L. AU - Tsai, M. H. AU - Yang, C. M. AU - Liang, C. J. AU - Lin, C. C. AU - Chiang, Y. C. AU - Lee, H. C. AU - Ko, H. H. AU - Lee, C. W. C2 - Biomol(United States) DB - Embase Medline DO - 10.1371/journal.pone.0063845 IS - 5 L1 - internal-pdf://0434248626/journal.pone.0063845.PDF LA - English M3 - Article N1 - L368882664 2013-05-16 2013-05-23 PY - 2013 SN - 1932-6203 ST - Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-α-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways T2 - PLoS ONE TI - Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-α-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368882664&from=exporthttp://dx.doi.org/10.1371/journal.pone.0063845 VL - 8 ID - 5523 ER - TY - JOUR AD - Centre for Digestive Diseases, Institute of Cell and Molecular Science, Barts and the London School of Medicine, Queen Mary, University of London, London E1 2AT, UK. j.epstein@qmul.ac.uk AN - 19878610 AU - Epstein, J. AU - Docena, G. AU - MacDonald, T. T. AU - Sanderson, I. R. DA - Mar DO - 10.1017/s0007114509992510 10.1017/S0007114509992510. Epub 2009 Nov 2. DP - Nlm ET - 2009/11/03 IS - 6 LA - eng PY - 2010 SN - 0007-1145 SP - 824-32 ST - Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease T2 - Br J Nutr TI - Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease VL - 103 ID - 5524 ER - TY - JOUR AD - Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States AU - Spratt, D. E. AU - Lee, N. DB - Scopus DO - 10.2147/OTT.S28032 M3 - Review N1 - Cited By :31 Export Date: 18 November 2020 PY - 2012 SP - 297-308 ST - Current and emerging treatment options for nasopharyngeal carcinoma T2 - OncoTargets and Therapy TI - Current and emerging treatment options for nasopharyngeal carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873904977&doi=10.2147%2fOTT.S28032&partnerID=40&md5=2c3a66efa9b3c88e17e1413351808c43 VL - 5 ID - 5525 ER - TY - JOUR AD - Division of HematologyOncology, Childrens Hospital Los Angeles, Los Angeles, CA, United States Department of HematologyOncology, St Jude Childrens Research Hospital, Memphis, TN, United States Department of Pediatric Surgery and Pediatric Urology, University of Tbingen, Tbingen, Germany Division of HematologyOncologyBone Marrow Transplant, Childrens Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, United States AU - Venkatramani, R. AU - Furman, W. L. AU - Fuchs, J. AU - Warmann, S. W. AU - Malogolowkin, M. H. DB - Scopus DO - 10.2165/11597740-000000000-00000 IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2012 SP - 221-232 ST - Current and future management strategies for relapsed or progressive hepatoblastoma T2 - Pediatric Drugs TI - Current and future management strategies for relapsed or progressive hepatoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862534798&doi=10.2165%2f11597740-000000000-00000&partnerID=40&md5=1efda21800a4dee6a3c928148380107c VL - 14 ID - 5526 ER - TY - JOUR AD - S.P. Hunger, Center for Cancer and Blood Disorders, Children's Hospital Colorado, 13123 East 16th Avenue, Box B115, Aurora, CO 80045, United States AU - Bernt, K. M. AU - Hunger, S. P. C1 - bay 80 6946 pd 325901 px 866 sf 1126 DB - Embase DO - 10.3389/fonc.2014.00054 LA - English M3 - Review N1 - L373128654 2014-05-29 2014-06-05 PY - 2014 SN - 2234-943X ST - Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Frontiers in Oncology TI - Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373128654&from=exporthttp://dx.doi.org/10.3389/fonc.2014.00054 VL - 4 MAR ID - 5527 ER - TY - JOUR AD - J.T. Rutka, Division of Neurosurgery, The Hospital for Sick Children, 555 University Avenue, Toronto, ON 518, Canada AU - Tamber, M. S. AU - Bansal, K. AU - Liang, M. L. AU - Mainprize, T. G. AU - Salhia, B. AU - Northcott, P. AU - Taylor, M. AU - Rutka, J. T. C1 - osi 774 DB - Embase Medline DO - 10.1007/s00381-006-0187-3 IS - 11 LA - English M3 - Review N1 - L44650671 2006-11-27 PY - 2006 SN - 0256-7040 SP - 1379-1394 ST - Current concepts in the molecular genetics of pediatric brain tumors: Implications for emerging therapies T2 - Child's Nervous System TI - Current concepts in the molecular genetics of pediatric brain tumors: Implications for emerging therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44650671&from=exporthttp://dx.doi.org/10.1007/s00381-006-0187-3 VL - 22 ID - 5528 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Al-Kali, A. AU - Kantarjian, H. AU - Shan, J. AU - Bassett, R. AU - Quintás-Cardama, A. AU - Borthakur, G. AU - Jabbour, E. AU - Verstovsek, S. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.1002/cncr.25604 IS - 2 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2011 SP - 327-335 ST - Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia T2 - Cancer TI - Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650989779&doi=10.1002%2fcncr.25604&partnerID=40&md5=0f08ec348de05df65416b6a5c5730511 VL - 117 ID - 5529 ER - TY - JOUR AD - Department of Neurological Surgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States Department of Neurological Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, 525 E. 68th St, New York, NY 10065, United States Professor of Surgery (Neurosurgery), Cleveland Clinic/ND40, 9500 Euclid Avenue, Cleveland, OH 44195, United States AU - Juthani, R. G. AU - Bilsky, M. H. AU - Vogelbaum, M. A. C7 - 39 DB - Scopus DO - 10.1007/s11864-015-0358-0 IS - 8 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2015 ST - Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors T2 - Current Treatment Options in Oncology TI - Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938350083&doi=10.1007%2fs11864-015-0358-0&partnerID=40&md5=9d7e464794f1f4f56c944aad60961dc0 VL - 16 ID - 5530 ER - TY - JOUR AD - S.A. Mousa, The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, United States AU - Pastor, E. R. AU - Mousa, S. A. C1 - 131I MIBG ap 26113(Ariad) asp 3026(Astellas) azd 3463(Astra Zeneca) ch 5424802(Chugai) hu 1418k 322a i bet 151 jq 1 ldk 378(Novartis) mg 132 mln 8237 otx 015 pf 02341066(Pfizer) pf 06463922(Pfizer) unituxin x 396(Betta) C2 - Ariad Astellas Astra Zeneca Betta Chugai Novartis Pfizer DB - Embase Medline DO - 10.1016/j.critrevonc.2019.03.013 LA - English M3 - Review N1 - L2001782543 2019-04-09 2019-04-11 PY - 2019 SN - 1879-0461 1040-8428 SP - 38-43 ST - Current management of neuroblastoma and future direction T2 - Critical Reviews in Oncology/Hematology TI - Current management of neuroblastoma and future direction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001782543&from=exporthttp://dx.doi.org/10.1016/j.critrevonc.2019.03.013 VL - 138 ID - 5531 ER - TY - JOUR AD - A. Comi, Department of Neurology, Kennedy Krieger Institute, 2901 E Biddle St, Baltimore, MD, United States AU - Comi, A. DB - Embase Medline DO - 10.1016/j.spen.2015.10.005 IS - 4 LA - English M3 - Review N1 - L607419215 2016-01-01 2016-01-07 PY - 2015 SN - 1558-0776 1071-9091 SP - 295-301 ST - Current Therapeutic Options in Sturge-Weber Syndrome T2 - Seminars in Pediatric Neurology TI - Current Therapeutic Options in Sturge-Weber Syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607419215&from=exporthttp://dx.doi.org/10.1016/j.spen.2015.10.005 VL - 22 ID - 5532 ER - TY - JOUR AD - Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, Cachan, France Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France Division of Allergy and Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States Clinical Hematology Department, Faculty of Medicine and AP-HP Necker-Enfants Malades, Paris Descartes University, Paris, France Imagine Institute, INSERM U1168, CNRS ERL 8654, National Reference Center on Mastocytosis, Paris, France Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria AU - Arock, M. AU - Akin, C. AU - Hermine, O. AU - Valent, P. DB - Scopus DO - 10.1111/ejh.12544 IS - 6 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2015 SP - 474-490 ST - Current treatment options in patients with mastocytosis: Status in 2015 and future perspectives T2 - European Journal of Haematology TI - Current treatment options in patients with mastocytosis: Status in 2015 and future perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929129792&doi=10.1111%2fejh.12544&partnerID=40&md5=4d03861959e483d5cc074aeff06de863 VL - 94 ID - 5533 ER - TY - JOUR AD - National Institute of Child Health & Human Development, National Institutes of Health (NIH), Building 10-CRC, Room 1-3330 10 Center Drive, Bethesda, MD 20892, United States Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, United States Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, United States Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, United States Children's Healthcare of Atlanta, Atlanta, GA 30144, United States AU - Kasturi, K. AU - Fernandes, L. AU - Quezado, M. AU - Eid, M. AU - Marcus, L. AU - Chittiboina, P. AU - Rappaport, M. AU - Stratakis, C. A. AU - Widemann, B. AU - Lodish, M. DB - Scopus DO - 10.1016/j.jecr.2017.02.001 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 1-4 ST - Cushing disease in a patient with multiple endocrine neoplasia type 2B T2 - Journal of Clinical and Translational Endocrinology: Case Reports TI - Cushing disease in a patient with multiple endocrine neoplasia type 2B UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014078512&doi=10.1016%2fj.jecr.2017.02.001&partnerID=40&md5=326d2bc348f68b37a188dc8cb8ef103f VL - 4 ID - 5534 ER - TY - JOUR AN - 134090981. Language: English. Entry Date: 20190116. Revision Date: 20190220. Publication Type: Article DB - ccm DO - 10.4103/ijd.IJD_514_16 DP - EBSCOhost IS - 1 N1 - case study; pictorial. Journal Subset: Asia; Biomedical; Double Blind Peer Reviewed; Peer Reviewed. NLM UID: 0370750. PY - 2019 SN - 0019-5154 SP - 83-84 ST - Cutaneous abscess: An isolated manifestation of disseminated anaplastic large-cell lymphoma in a child T2 - Indian Journal of Dermatology TI - Cutaneous abscess: An isolated manifestation of disseminated anaplastic large-cell lymphoma in a child UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134090981&site=ehost-live&scope=site VL - 64 ID - 5535 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Oncology Institute, Istanbul University. Division of Pediatric Hematology-Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. AN - 30376464 AU - Büyükkapu Bay, S. AU - Kebudi, R. AU - Zülfikar, B. DA - Feb DO - 10.1097/cmr.0000000000000537 10.1097/CMR.0000000000000537. DP - Nlm ET - 2018/10/31 IS - 1 LA - eng PY - 2019 SN - 0960-8931 SP - 99-101 ST - Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency T2 - Melanoma Res TI - Cutaneous adverse event associated with vemurafenib in a 3-year-old pediatric patient with BRAF mutation-positive metastatic melanoma and factor X deficiency VL - 29 ID - 5536 ER - TY - JOUR AD - Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address: jijulee@hanmail.net. AN - 26897385 AU - Lee, W. J. AU - Moon, I. J. AU - Lee, S. H. AU - Won, C. H. AU - Chang, S. E. AU - Choi, J. H. AU - Moon, K. C. AU - Park, C. S. AU - Huh, J. AU - Lee, M. W. DA - Jun DO - 10.1016/j.jaad.2015.12.053 10.1016/j.jaad.2015.12.053. Epub 2016 Feb 17. DP - Nlm ET - 2016/02/22 IS - 6 LA - eng PY - 2016 SN - 0190-9622 SP - 1135-43 ST - Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site T2 - J Am Acad Dermatol TI - Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site VL - 74 ID - 5537 ER - TY - JOUR AD - Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. Université Paul-Sabatier, Toulouse, France. Department of Dermatology, Larrey Hospital, CHU de Toulouse, Toulouse, France. Department of Biopathology, Institut Bergonié, Bordeaux, France. AN - 26100036 AU - Leguellec, S. AU - Tournier, E. AU - Karanian, M. AU - Brousset, P. AU - Mazereeuw, J. AU - Coindre, J. M. AU - Lamant, L. DA - Jan DO - 10.1111/his.12759 10.1111/his.12759. Epub 2015 Aug 7. DP - Nlm ET - 2015/06/24 IS - 2 LA - eng PY - 2016 SN - 0309-0167 SP - 297-302 ST - Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases T2 - Histopathology TI - Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases VL - 68 ID - 5538 ER - TY - JOUR AD - Melanoma Genetics, Department of Experimental Oncology, Immunotherapy of Human Tumors Unit, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. AN - 19158841 AU - Daniotti, M. AU - Ferrari, A. AU - Frigerio, S. AU - Casieri, P. AU - Miselli, F. AU - Zucca, E. AU - Collini, P. AU - Della Torre, G. AU - Manoukian, S. AU - Peissel, B. AU - Bono, A. AU - Santinami, M. AU - Parmiani, G. AU - Rivoltini, L. AU - Pilotti, S. AU - Rodolfo, M. DA - Jul DO - 10.1038/jid.2008.422 10.1038/jid.2008.422. Epub 2009 Jan 22. DP - Nlm ET - 2009/01/23 IS - 7 LA - eng PY - 2009 SN - 0022-202x SP - 1759-68 ST - Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT T2 - J Invest Dermatol TI - Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT VL - 129 ID - 5539 ER - TY - JOUR AD - Pediatric Oncology Unit, Anti Cancer Center Oscar Lambret, Lille Cedex, France Department of Pathology, University Hospital of Lille, Lille Nord, France Department of Breast Surgery, Anti Cancer Center Oscar Lambret, Lille Cedex, France Department of Pathology, Anti Cancer Center Oscar Lambret, Lille Cedex, France AU - Sudour-Bonnange, H. AU - Leroy, X. AU - Chauvet, M. P. AU - Classe, M. AU - Robin, P. M. AU - Leblond, P. DB - Scopus DO - 10.1002/pbc.25015 IS - 9 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2014 SP - 1698-1700 ST - Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager T2 - Pediatric Blood and Cancer TI - Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904440764&doi=10.1002%2fpbc.25015&partnerID=40&md5=ff7e2340fc48ab68aeac8ba19feaf0ee VL - 61 ID - 5540 ER - TY - JOUR AD - Departments of Pathology. Dermatopathology. Clinical Cancer Genomics Laboratory. Helen Diller Cancer Center, University of California, San Francisco. Orofacial Sciences, Pathology & Radiation Oncology. Department of Pathology, Zuckerberg San Francisco General Hospital, San Francisco, CA. AN - 30001233 AU - Cohen, J. N. AU - Yeh, I. AU - Jordan, R. C. AU - Wolsky, R. J. AU - Horvai, A. E. AU - McCalmont, T. H. AU - LeBoit, P. E. DA - Sep DO - 10.1097/pas.0000000000001122 10.1097/PAS.0000000000001122. DP - Nlm ET - 2018/07/13 IS - 9 LA - eng PY - 2018 SN - 0147-5185 SP - 1133-1142 ST - Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions T2 - Am J Surg Pathol TI - Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions VL - 42 ID - 5541 ER - TY - JOUR AD - INSERM, U.563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. AN - 19951975 AU - Lamant, L. AU - Pileri, S. AU - Sabattini, E. AU - Brugières, L. AU - Jaffe, E. S. AU - Delsol, G. C2 - PMC2833075 DA - Mar DO - 10.3324/haematol.2009.015024 10.3324/haematol.2009.015024. Epub 2009 Nov 30. DP - Nlm ET - 2009/12/03 IS - 3 LA - eng PY - 2010 SN - 0390-6078 (Print) 0390-6078 SP - 449-55 ST - Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases T2 - Haematologica TI - Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases VL - 95 ID - 5542 ER - TY - JOUR AD - University of Minnesota, Division of Pediatric Dermatology. University of Minnesota Medical School. Electronic address: gardeen@d.umn.edu. University of Toronto. Harvard Medical School. Washington School of Medicine in St Louis. Biostatistics Core, Masonic Cancer Center, University of Minnesota. Children's Hospital of Wisconsin - Milwaukee. Seattle Children's Hospital. Texas Children's Hospital. Children's Hospital Los Angeles. University of Minnesota Masonic Children's Hospital, Division of Pediatric Hematology and Oncology. Ann & Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Dermatology. Dermatology Program, Boston Children's Hospital, Harvard Medical School. University of Toronto, Division of Pediatric Medicine Section of Dermatology. AN - 32682884 AU - Boull, C. L. AU - Gardeen, S. AU - Abdali, T. AU - Li, E. AU - Potts, J. AU - Rubin, N. AU - Carlberg, V. M. AU - Gupta, D. AU - Hunt, R. AU - Luu, M. AU - Maguiness, S. M. AU - Moertel, C. L. AU - Song, H. AU - Vivar, K. L. AU - Coughlin, C. AU - Huang, J. T. AU - Lara-Corrales, I. DA - Jul 16 DO - 10.1016/j.jaad.2020.07.044 10.1016/j.jaad.2020.07.044. DP - Nlm ET - 2020/07/20 LA - eng PY - 2020 SN - 0190-9622 ST - Cutaneous Reactions in Children Treated with MEK Inhibitors, BRAF Inhibitors, or Combination Therapy: A Multi-Center Study T2 - J Am Acad Dermatol TI - Cutaneous Reactions in Children Treated with MEK Inhibitors, BRAF Inhibitors, or Combination Therapy: A Multi-Center Study ID - 5543 ER - TY - JOUR AD - Division of Pediatric Dermatology, Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Department of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, Minnesota. AN - 27981612 AU - Boull, C. AU - Hook, K. AU - Moertel, C. AU - Maguiness, S. DA - Jan DO - 10.1111/pde.13038 10.1111/pde.13038. Epub 2016 Dec 16. DP - Nlm ET - 2016/12/17 IS - 1 LA - eng PY - 2017 SN - 0736-8046 SP - 90-94 ST - Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors T2 - Pediatr Dermatol TI - Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors VL - 34 ID - 5544 ER - TY - JOUR AD - Department of Pediatrics, Massachusetts General Hospital, Massachusetts, Boston. Dermatology Program, Boston Children's Hospital, Boston, Massachusetts. Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer Center and Blood Disorder Center, Boston, Massachusetts. AN - 30821092 AU - Song, H. AU - Zhong, C. S. AU - Kieran, M. W. AU - Chi, S. N. AU - Wright, K. D. AU - Huang, J. T. DA - Jun DO - 10.1002/pbc.27682 10.1002/pbc.27682. Epub 2019 Feb 28. DP - Nlm ET - 2019/03/02 IS - 6 LA - eng PY - 2019 SN - 1545-5009 SP - e27682 ST - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study T2 - Pediatr Blood Cancer TI - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study VL - 66 ID - 5545 ER - TY - JOUR AD - C. Zhong, Harvard Medical School, Boston, MA, United States AU - Zhong, C. AU - Song, H. AU - Kieran, M. AU - Chi, S. AU - Wright, K. AU - Huang, J. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098233 2018-07-25 PY - 2018 SN - 1523-5866 SP - i163 ST - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study T2 - Neuro-Oncology TI - Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098233&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 5546 ER - TY - JOUR AD - T. Loka, Oncology Trials Unit, United Kingdom AU - Loka, T. AU - Mahon, C. AU - O'Hare, P. O. AU - Hargrave, D. DB - Embase DO - 10.1111/bjd.16141 IS - 2 LA - English M3 - Conference Abstract N1 - L621486274 2018-04-04 PY - 2018 SN - 1365-2133 SP - e150-e151 ST - The cutaneous toxicities of BRAF and MEK inhibitor therapy in children T2 - British Journal of Dermatology TI - The cutaneous toxicities of BRAF and MEK inhibitor therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621486274&from=exporthttp://dx.doi.org/10.1111/bjd.16141 VL - 178 ID - 5547 ER - TY - JOUR AD - T. Loka, Great Ormond Street Hospital NHS Trust, Department of Paediatric Oncology, London, United Kingdom AU - Loka, T. AU - Hare, P. O. AU - Mahon, C. AU - Hargrave, D. DB - Embase DO - 10.1007/s00520-018-4193-2 IS - 2 LA - English M3 - Conference Abstract N1 - L622327645 2018-05-31 PY - 2018 SN - 1433-7339 SP - S67 ST - Cutaneous toxicity of BRAF and MEK inhibitor therapy in children T2 - Supportive Care in Cancer TI - Cutaneous toxicity of BRAF and MEK inhibitor therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622327645&from=exporthttp://dx.doi.org/10.1007/s00520-018-4193-2 VL - 26 ID - 5548 ER - TY - JOUR AD - Y. Luo, National Engineering Laboratory for Anti-tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing, China AU - Zhuo, W. AU - Jia, L. AU - Song, N. AU - Lu, X. A. AU - Ding, Y. AU - Wang, X. AU - Song, X. AU - Fu, Y. AU - Luo, Y. DB - Embase Medline DO - 10.1158/1078-0432.CCR-12-0708 IS - 19 LA - English M3 - Article N1 - L365754128 2012-10-09 2012-10-15 PY - 2012 SN - 1078-0432 1557-3265 SP - 5387-5398 ST - The CXCL12 -CXCR4 chemokine pathway: A novel axis regulates lymphangiogenesis T2 - Clinical Cancer Research TI - The CXCL12 -CXCR4 chemokine pathway: A novel axis regulates lymphangiogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365754128&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-12-0708http://clincancerres.aacrjournals.org/content/18/19/5387.full.pdf+html VL - 18 ID - 5549 ER - TY - JOUR AD - Laboratory of Oncology, Department of Experimental and Laboratory Medicine, G. Gaslini Institute, Genoa, Italy. irmaairoldi@ospedale-gaslini.ge.it AN - 16397027 AU - Airoldi, I. AU - Raffaghello, L. AU - Piovan, E. AU - Cocco, C. AU - Carlini, B. AU - Amadori, A. AU - Corrias, M. V. AU - Pistoia, V. DA - Jan 1 DO - 10.1158/1078-0432.Ccr-05-1376 10.1158/1078-0432.CCR-05-1376. DP - Nlm ET - 2006/01/07 IS - 1 LA - eng PY - 2006 SN - 1078-0432 (Print) 1078-0432 SP - 77-82 ST - CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications T2 - Clin Cancer Res TI - CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications VL - 12 ID - 5550 ER - TY - JOUR AD - Dipartimento di Chirurgia, Università di Pisa, Pisa, Italy. AN - 21909080 AU - Torregrossa, L. AU - Giannini, R. AU - Borrelli, N. AU - Sensi, E. AU - Melillo, R. M. AU - Leocata, P. AU - Materazzi, G. AU - Miccoli, P. AU - Santoro, M. AU - Basolo, F. DA - Jan DO - 10.1038/modpathol.2011.140 10.1038/modpathol.2011.140. Epub 2011 Sep 9. DP - Nlm ET - 2011/09/13 IS - 1 LA - eng PY - 2012 SN - 0893-3952 SP - 46-55 ST - CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas T2 - Mod Pathol TI - CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas VL - 25 ID - 5551 ER - TY - JOUR AD - C.-M. Lin, Department of Emergency Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan AU - Shyu, K. G. AU - Wang, B. W. AU - Lin, C. M. AU - Chang, H. C1 - pd 98059(Calbiochem,United States) sb 203580(Calbiochem,United States) sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1186/1423-0127-17-15 IS - 1 LA - English M3 - Article N1 - L358526462 2010-04-02 2010-05-20 PY - 2010 SN - 1021-7770 1423-0127 ST - Cyclic stretch enhances the expression of Toll-like Receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-κB pathway T2 - Journal of Biomedical Science TI - Cyclic stretch enhances the expression of Toll-like Receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358526462&from=exporthttp://dx.doi.org/10.1186/1423-0127-17-15 VL - 17 ID - 5552 ER - TY - JOUR AD - Institute of Stomatology, Nanjing Medical University, Nanjing, China Department of Orthodontics, School of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing 210029, China Department of Periodontics, School of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing 210029, China AU - Li, L. AU - Han, M. AU - Li, S. AU - Wang, L. AU - Xu, Y. DB - Scopus DO - 10.1089/dna.2013.2070 IS - 9 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2013 SP - 488-497 ST - Cyclic tensile stress during physiological occlusal force enhances osteogenic differentiation of human periodontal ligament cells via ERK1/2-Elk1 MAPK pathway T2 - DNA and Cell Biology TI - Cyclic tensile stress during physiological occlusal force enhances osteogenic differentiation of human periodontal ligament cells via ERK1/2-Elk1 MAPK pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882994341&doi=10.1089%2fdna.2013.2070&partnerID=40&md5=a68f04200b060597227fc0d202794844 VL - 32 ID - 5553 ER - TY - JOUR AD - Experimental Molecular Pathology, Department of Pathology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Department of Experimental Oncology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Preventive-Predictive Medicine Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy Department of Medical Oncology, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy IFOM, FIRC Institute of Molecular Oncology, Milan, Italy Laboratory of Diagnostic and Experimental Molecular Pathology, Clinical Pathology, Istituto Cantonale di Patologia, Locarno, Switzerland Unit of Experimental Molecular Pathology, Department of Pathology, Fondazione IRCSS Istituto Nazionale dei Tumori, Via G. Venezian 1, 20133 Milan, Italy AU - Signoroni, S. AU - Frattini, M. AU - Negri, T. AU - Pastore, E. AU - Tamborini, E. AU - Casieri, P. AU - Orsenigo, M. AU - Da Riva, L. AU - Radice, P. AU - Sala, P. AU - Gronchi, A. AU - Bertario, L. AU - Pierotti, M. A. AU - Pilotti, S. DB - Scopus DO - 10.1158/1078-0432.CCR-07-0336 IS - 17 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2007 SP - 5034-5040 ST - Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis T2 - Clinical Cancer Research TI - Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548844748&doi=10.1158%2f1078-0432.CCR-07-0336&partnerID=40&md5=e7eb6eac8b42d725a41c5448dd36c0b9 VL - 13 ID - 5554 ER - TY - JOUR AD - X. Yin, Department of Cardiology, First Affiliated Hospital of Harbin Medical University, No. 199 Dazhi Street, Harbin, China AU - Chi, J. AU - Wang, L. AU - Zhang, X. AU - Fu, Y. AU - Liu, Y. AU - Chen, W. AU - Liu, W. AU - Shi, Z. AU - Yin, X. DB - Embase Medline DO - 10.1016/j.biochi.2018.02.017 LA - English M3 - Article N1 - L621032039 2018-03-13 2018-09-25 PY - 2018 SN - 6183-1638 0300-9084 SP - 55-62 ST - Cyclosporin A induces autophagy in cardiac fibroblasts through the NRP-2/WDFY-1 axis T2 - Biochimie TI - Cyclosporin A induces autophagy in cardiac fibroblasts through the NRP-2/WDFY-1 axis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621032039&from=exporthttp://dx.doi.org/10.1016/j.biochi.2018.02.017 VL - 148 ID - 5555 ER - TY - JOUR AD - Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Laboratory of Cancer Biology, Institute of Clinical Science, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Radiotherapy, The Second People's Hospital of Anhui Province, Hefei, Anhui, China. Department of Medical Oncology, Xiasha Branch of Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Respiratory Medicine, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Electronic address: panhongming@zju.edu.cn. Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China; Laboratory of Cancer Biology, Institute of Clinical Science, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Electronic address: hanwd@zju.edu.cn. AN - 30879923 AU - Liu, Z. AU - Jiang, L. AU - Li, Y. AU - Xie, B. AU - Xie, J. AU - Wang, Z. AU - Zhou, X. AU - Jiang, H. AU - Fang, Y. AU - Pan, H. AU - Han, W. C2 - PMC6491942 DA - Apr DO - 10.1016/j.ebiom.2019.03.019 10.1016/j.ebiom.2019.03.019. Epub 2019 Mar 15. DP - Nlm ET - 2019/03/19 LA - eng PY - 2019 SN - 2352-3964 SP - 326-339 ST - Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway T2 - EBioMedicine TI - Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2(+)/calcineurin/Erk pathway VL - 42 ID - 5556 ER - TY - JOUR AU - Falero-Perez, J. AU - Song, Y. S. AU - Zhao, Y. AU - Teixeira, L. AU - Sorenson, C. M. AU - Sheibani, N. DB - Embase Medline DO - 10.1371/journal.pone.0206756 IS - 10 LA - English M3 - Article N1 - L624584113 2018-11-16 2019-04-19 PY - 2018 SN - 1932-6203 ST - Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells T2 - PLoS ONE TI - Cyp1b1 expression impacts the angiogenic and inflammatory properties of liver sinusoidal endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624584113&from=exporthttp://dx.doi.org/10.1371/journal.pone.0206756 VL - 13 ID - 5557 ER - TY - JOUR AD - T. Ichiyama, Department of Pediatrics, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan AU - Ichiyama, T. AU - Hasegawa, M. AU - Hashimoto, K. AU - Matsushige, T. AU - Hirano, R. AU - Furukawa, S. DB - Embase Medline DO - 10.1159/000155745 IS - 2 LA - English M3 - Article N1 - L50277992 2009-02-12 PY - 2009 SN - 1018-2438 SP - 147-153 ST - Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages T2 - International Archives of Allergy and Immunology TI - Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50277992&from=exporthttp://dx.doi.org/10.1159/000155745 VL - 148 ID - 5558 ER - TY - JOUR AD - Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera, Università di Padova, Padova, Italy. AN - 20658615 AU - Mussolin, L. AU - Pillon, M. AU - Bonato, P. AU - Leszl, A. AU - Franceschetto, G. AU - Di Meglio, A. AU - d'Amore, E. S. AU - Sainati, L. AU - Rosolen, A. DA - Sep DO - 10.1002/pbc.22550 10.1002/pbc.22550. DP - Nlm ET - 2010/07/27 IS - 3 LA - eng PY - 2010 SN - 1545-5009 SP - 446-51 ST - Cytogenetic analysis of pediatric anaplastic large cell lymphoma T2 - Pediatr Blood Cancer TI - Cytogenetic analysis of pediatric anaplastic large cell lymphoma VL - 55 ID - 5559 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia National Cancer Institute, Cairo University, Giza, Egypt Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia AN - 126387341. Language: English. Entry Date: 20171128. Revision Date: 20171128. Publication Type: Article AU - Alkhayat, Nawaf AU - Eiborai, Yasser AU - Al Sharif, Omer AU - Al Shahrani, Mohammad AU - Alsuhaibani, Omar AU - Awad, Mohammed AU - Elghezal, Hatem AU - Bouhajar, Inesse ben-abdallah AU - Alfaraj, Mona AU - Al Mussaed, Eman AU - Alabbas, Fahad AU - Elyamany, Ghaleb DB - ccm DO - 10.1177/1179554917721710 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Australia & New Zealand; Biomedical. PY - 2017 SN - 1179-5549 SP - 1-6 ST - Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia T2 - Clinical Medicine Insights: Oncology TI - Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126387341&site=ehost-live&scope=site ID - 5560 ER - TY - JOUR AD - L.C. Hofbauer, Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine III, Technical University of Dresden, Fetscherstrasse 74, Dresden D-01307, Germany AU - Schrader, J. AU - Rennekamp, W. AU - Niebergall, U. AU - Schoppet, M. AU - Jahr, H. AU - Brendel, M. D. AU - Hörsch, D. AU - Hofbauer, L. C. DB - Embase Medline DO - 10.1007/s00125-007-0672-6 IS - 6 LA - English M3 - Article N1 - L46701570 2007-06-01 PY - 2007 SN - 0012-186X SP - 1243-1247 ST - Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death T2 - Diabetologia TI - Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46701570&from=exporthttp://dx.doi.org/10.1007/s00125-007-0672-6 VL - 50 ID - 5561 ER - TY - JOUR AD - J.A. Benjamins, Department of Neurology, Wayne State University School of Medicine, 1228 Elliman Building, 421 E. Canfield Ave., Detroit, MI 48201, United States AU - Benjamins, J. A. AU - Nedelkoska, L. AU - Lisak, R. P. AU - Hannigan, J. H. AU - Sokol, R. J. DB - Embase Medline DO - 10.1007/s11064-011-0401-x IS - 9 LA - English M3 - Article N1 - L51255031 2011-11-16 2011-11-22 PY - 2011 SN - 0364-3190 1573-6903 SP - 1677-1686 ST - Cytokines reduce toxic effects of ethanol on oligodendroglia T2 - Neurochemical Research TI - Cytokines reduce toxic effects of ethanol on oligodendroglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51255031&from=exporthttp://dx.doi.org/10.1007/s11064-011-0401-x VL - 36 ID - 5562 ER - TY - JOUR AD - J.S. Fitzgerald, Department of Obstetrics, University Hospital of Jena, Bachstrasse 18, 07743 Jena, Germany AU - Fitzgerald, J. S. AU - Abad, C. AU - Alvarez, A. M. AU - Mehta, R. B. AU - Chaiwangyen, W. AU - Dubinsky, V. AU - Silva, B. G. AU - Gutierrez, G. AU - Hofmann, S. AU - Hölters, S. AU - Joukadar, J. AU - Junovich, G. AU - Kuhn, C. AU - Morales-Prieto, D. M. AU - Nevers, T. AU - Ospina-Prieto, S. AU - Pastuschek, J. AU - Pereira De Sousa, F. L. AU - San Martin, S. AU - Suman, P. AU - Weber, M. AU - Markert, U. R. DB - Embase DO - 10.3233/NIB-2011-023 IS - 1-2 LA - English M3 - Review N1 - L364671899 2012-05-07 2012-05-09 PY - 2011 SN - 1878-948X 1878-9498 SP - 61-97 ST - Cytokines regulating trophoblast invasion T2 - Advances in Neuroimmune Biology TI - Cytokines regulating trophoblast invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364671899&from=exporthttp://dx.doi.org/10.3233/NIB-2011-023 VL - 2 ID - 5563 ER - TY - JOUR AD - Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. AN - 28192645 AU - Zhao, L. AU - Dias-Santagata, D. AU - Sadow, P. M. AU - Faquin, W. C. DA - May DO - 10.1002/cncy.21839 10.1002/cncy.21839. Epub 2017 Feb 13. DP - Nlm ET - 2017/02/14 IS - 5 LA - eng PY - 2017 SN - 1934-662x SP - 323-331 ST - Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma T2 - Cancer Cytopathol TI - Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma VL - 125 ID - 5564 ER - TY - JOUR AD - Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Department of Pathology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Department of Pathology, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. AN - 26139079 AU - Lee, J. C. AU - Wu, J. M. AU - Liau, J. Y. AU - Huang, H. Y. AU - Lo, C. Y. AU - Jan, I. S. AU - Hornick, J. L. AU - Qian, X. DA - Aug DO - 10.1002/cncy.21558 10.1002/cncy.21558. Epub 2015 Jul 2. DP - Nlm ET - 2015/07/04 IS - 8 LA - eng PY - 2015 SN - 1934-662x SP - 495-504 ST - Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis T2 - Cancer Cytopathol TI - Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis VL - 123 ID - 5565 ER - TY - JOUR AD - Abteilung Klinische Pharmakologie, Ruhr-Universitaet Bochum, Bochum, Germany. david.diaz-carballo@rub.de AN - 18194446 AU - Díaz-Carballo, D. AU - Malak, S. AU - Bardenheuer, W. AU - Freistuehler, M. AU - Reusch, H. P. C2 - PMC3828876 DA - Dec DO - 10.1111/j.1582-4934.2008.00232.x 10.1111/j.1582-4934.2008.00232.x. DP - Nlm ET - 2008/01/16 IS - 6b LA - eng PY - 2008 SN - 1582-1838 (Print) 1582-1838 SP - 2598-608 ST - Cytotoxic activity of nemorosone in neuroblastoma cells T2 - J Cell Mol Med TI - Cytotoxic activity of nemorosone in neuroblastoma cells VL - 12 ID - 5566 ER - TY - JOUR AD - Vivek Subbiah and Maria E. Cabanillas, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert J. Kreitman, National Institutes of Health, Bethesda, MD; Zev A. Wainberg, University of California Los Angeles, Los Angeles, CA; Jae Yong Cho, Yonsei University College of Medicine Gangnam Severance Hospital; Bhumsuk Keam, Seoul National University Hospital, Seoul, Republic of Korea; Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam; Jan H.M. Schellens, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands; Jean Charles Soria, Institut Gustave Roussy, University of Paris-Sud, and University of Paris-Saclay, Villejuif, France; Patrick Y. Wen, Dana-Farber Cancer Institute, Boston, MA; Christoph Zielinski, Comprehensive Cancer Center, Medical University Vienna; Vienna, Austria; and Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, and Fatima Rangwala, Novartis Oncology, East Hanover, NJ. AN - 29072975 AU - Subbiah, V. AU - Kreitman, R. J. AU - Wainberg, Z. A. AU - Cho, J. Y. AU - Schellens, J. H. M. AU - Soria, J. C. AU - Wen, P. Y. AU - Zielinski, C. AU - Cabanillas, M. E. AU - Urbanowitz, G. AU - Mookerjee, B. AU - Wang, D. AU - Rangwala, F. AU - Keam, B. C2 - PMC5791845 DA - Jan 1 DO - 10.1200/jco.2017.73.6785 10.1200/JCO.2017.73.6785. Epub 2017 Oct 26. DP - Nlm ET - 2017/10/27 IS - 1 LA - eng PY - 2018 SN - 0732-183X (Print) 0732-183x SP - 7-13 ST - Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer T2 - J Clin Oncol TI - Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer VL - 36 ID - 5567 ER - TY - JOUR AD - University of Texas, MD Anderson Cancer Center, Houston, TX, United States National Institutes of Health, Bethesda, MD, United States University of California Los Angeles, Los Angeles, CA, United States Yonsei University, College of Medicine, Gangnam Severance Hospital, South Korea Seoul National University Hospital, Seoul, South Korea Netherlands Cancer Institute, Amsterdam, Netherlands Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands Institut Gustave Roussy, University of Paris-Sud, University of Paris-Saclay, Villejuif, France Dana-Farber Cancer Institute, Boston, MA, United States Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria Novartis Oncology, East Hanover, NJ, United States AU - Subbiah, V. AU - Cabanillas, M. E. AU - Kreitman, R. J. AU - Wainberg, Z. A. AU - Cho, J. Y. AU - Keam, B. AU - Schellens, J. H. M. AU - Soria, J. C. AU - Wen, P. Y. AU - Zielinski, C. AU - Urbanowitz, G. AU - Mookerjee, B. AU - Wang, D. AU - Rangwala, F. DB - Scopus DO - 10.1200/JCO.2017.73.6785 IS - 1 M3 - Article N1 - Cited By :180 Export Date: 18 November 2020 PY - 2018 SP - 7-13 ST - Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer T2 - Journal of Clinical Oncology TI - Dabrafenib and trametinib treatment in patients with locally advanced or metastatic BRAF V600–mutant anaplastic thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039975292&doi=10.1200%2fJCO.2017.73.6785&partnerID=40&md5=616d0dce81bb22c014607f3c01fb89a8 VL - 36 ID - 5568 ER - TY - JOUR AN - 28062673 DA - Jan DO - 10.1158/2159-8290.Cd-nb2016-140 10.1158/2159-8290.CD-NB2016-140. Epub 2016 Nov 9. DP - Nlm ET - 2017/01/08 IS - 1 LA - eng PY - 2017 SN - 2159-8274 SP - Of5 ST - Dabrafenib Effective in Pediatric Glioma T2 - Cancer Discov TI - Dabrafenib Effective in Pediatric Glioma VL - 7 ID - 5569 ER - TY - JOUR AD - Department of Medical Oncology, Gustave Roussy, Villejuif, France. Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Thoracic Oncology Unit, Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. Pneumology Department, University Hospital of Strasbourg, Strasbourg, France. Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Joan and Sanfor I Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Livon, Marseille, France. Acute Respiratory Medicine and Thoracic Oncology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. Department of Pulmonary Diseases, University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, Netherlands. Upper Aerodigestive Malignancies Division, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. College of Medicine, Yonsei University, Seoul, South Korea. Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. Adaptimmune LLC, Philadelphia, PA, USA. GlaxoSmithKline, Collegeville, Pennsylvania, PA, USA. Biothera, Eagan, MN, USA. Novartis Pharmaceuticals, King of Prussia, PA, USA. Novartis Pharmaceuticals, East Hanover, NJ, USA. Novartis Pharmaceuticals, Morrisville, NC, USA. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Bruce_Johnson@dfci.harvard.edu. AN - 27080216 AU - Planchard, D. AU - Kim, T. M. AU - Mazieres, J. AU - Quoix, E. AU - Riely, G. AU - Barlesi, F. AU - Souquet, P. J. AU - Smit, E. F. AU - Groen, H. J. AU - Kelly, R. J. AU - Cho, B. C. AU - Socinski, M. A. AU - Pandite, L. AU - Nase, C. AU - Ma, B. AU - D'Amelio, A., Jr. AU - Mookerjee, B. AU - Curtis, C. M., Jr. AU - Johnson, B. E. C2 - PMC5006181 C6 - NIHMS812215 Boehinger, Lilly, Bristol-Myers Squibb, AstraZeneca, MSD and Pierre Fabre. GR reports grants from GlaxoSmithKline and Novartis; consulting with Novartis; and employer receives research funding from Pfizer, Chugai/Roche and Millennium for support of research led by him. FB reports personal fees from GlaxoSmithKline and Novartis. P-J Souquet reports clinical trial for GlaxoSmithKline. HJMG reports payments to his institution from Roche, MSD, Pfizer and GlaxoSmithKline. LP at the time of the study, was an employee of GlaxoSmithKline. CN reports employment at GlaxoSmithKline at the time the study was conducted, former employment at Novartis and current employment at GlaxoSmithKline. B. Ma reports employment at GlaxoSmithKline at the time the study was conducted. AD, at the time of the study, was an employee of GlaxoSmithKline, is now an employee of Novartis. B Mookerjee, at the time of the study, was an employee of GlaxoSmithKline, is now an employee of Novartis; and owns stock in GlaxoSmithKline and Novartis. CMC was an employee of Novartis and GlaxoSmithKline. BEJ reports personal fees from AstraZeneca, Clovis Oncology, Novartis, Merck, Genentech; honoraria from Chugai Pharmaceuticals; received shares of post-market revenue for EGFR Genotyping patent. TMK, JM, EQ, EFS, RJK, BCC, and MAS report nothing to disclose. DA - May DO - 10.1016/s1470-2045(16)00077-2 10.1016/S1470-2045(16)00077-2. Epub 2016 Apr 11. DP - Nlm ET - 2016/04/16 IS - 5 LA - eng PY - 2016 SN - 1470-2045 (Print) 1470-2045 SP - 642-50 ST - Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial T2 - Lancet Oncol TI - Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial VL - 17 ID - 5570 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: vsubbiah@mdanderson.org. Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Medical Oncology Department, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France. Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, and University of Milano, Milan, Italy. Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Dipartimento di Oncologia, Istituto Nazionale dei Tumori, Milan, Italy. Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria. Third Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, CCS Salzburg, Salzburg, Austria. Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Department of Clinical Pharmacology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands. Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Berry Consultants, Austin, TX, USA; Department of Biostatistics, University of Kentucky, Lexington, KY, USA. Precision Medicine, Novartis Pharmaceuticals, East Hanover, NJ, USA. Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA. Global Drug Development, Novartis Pharma, Basel, Switzerland. Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA. AN - 32818466 AU - Subbiah, V. AU - Lassen, U. AU - Élez, E. AU - Italiano, A. AU - Curigliano, G. AU - Javle, M. AU - de Braud, F. AU - Prager, G. W. AU - Greil, R. AU - Stein, A. AU - Fasolo, A. AU - Schellens, J. H. M. AU - Wen, P. Y. AU - Viele, K. AU - Boran, A. D. AU - Gasal, E. AU - Burgess, P. AU - Ilankumaran, P. AU - Wainberg, Z. A. DA - Sep DO - 10.1016/s1470-2045(20)30321-1 10.1016/S1470-2045(20)30321-1. Epub 2020 Aug 17. DP - Nlm ET - 2020/08/21 IS - 9 LA - eng PY - 2020 SN - 1470-2045 SP - 1234-1243 ST - Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial T2 - Lancet Oncol TI - Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial VL - 21 ID - 5571 ER - TY - JOUR AD - The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA. AN - 32869334 AU - Young, T. K. AU - Gutierrez, D. AU - Criscito, M. C. AU - Kim, R. H. AU - Lakdawala, N. AU - Oza, V. S. DA - Sep 1 DO - 10.1111/pde.14306 10.1111/pde.14306. DP - Nlm ET - 2020/09/02 LA - eng PY - 2020 SN - 0736-8046 ST - Dabrafenib-induced neutrophilic panniculitis in a child undergoing dual BRAF-MEK inhibitor therapy for glioblastoma multiforme T2 - Pediatr Dermatol TI - Dabrafenib-induced neutrophilic panniculitis in a child undergoing dual BRAF-MEK inhibitor therapy for glioblastoma multiforme ID - 5572 ER - TY - JOUR AD - Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. paolo.ascierto@gmail.com. European Institute of Oncology IRCCS, Milan, Italy. pier.ferrucci@ieo.it. Auckland City Hospital, Auckland, New Zealand. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. Aarhus University Hospital, Aarhus, Denmark. Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. IRCCS San Martino-IST, Genova, Italy. Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. Herlev Hospital, University of Copenhagen, Herlev, Denmark. Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. Rambam Health Care Campus, Haifa, Israel. Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. Novartis, East Hanover, NJ, USA. Merck & Co., Inc., Kenilworth, NJ, USA. University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. aribas@mednet.ucla.edu. AN - 31171878 AU - Ascierto, P. A. AU - Ferrucci, P. F. AU - Fisher, R. AU - Del Vecchio, M. AU - Atkinson, V. AU - Schmidt, H. AU - Schachter, J. AU - Queirolo, P. AU - Long, G. V. AU - Di Giacomo, A. M. AU - Svane, I. M. AU - Lotem, M. AU - Bar-Sela, G. AU - Couture, F. AU - Mookerjee, B. AU - Ghori, R. AU - Ibrahim, N. AU - Moreno, B. H. AU - Ribas, A. DA - Jun DO - 10.1038/s41591-019-0448-9 10.1038/s41591-019-0448-9. Epub 2019 Jun 6. DP - Nlm ET - 2019/06/07 IS - 6 LA - eng PY - 2019 SN - 1078-8956 SP - 941-946 ST - Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma T2 - Nat Med TI - Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma VL - 25 ID - 5573 ER - TY - JOUR AD - Division of Hematology, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya-ku, Saitama, Saitama 330-8503, Japan AU - Ishida, Y. AU - Terasako, K. AU - Oshima, K. AU - Sakamoto, K. AU - Ashizawa, M. AU - Sato, M. AU - Kikuchi, M. AU - Kimura, S. I. AU - Nakasone, H. AU - Okuda, S. AU - Kako, S. AU - Yamazaki, R. AU - Nishida, J. AU - Kanda, Y. DB - Scopus DO - 10.1007/s12185-010-0678-6 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2010 SP - 542-546 ST - Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation T2 - International Journal of Hematology TI - Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78549294155&doi=10.1007%2fs12185-010-0678-6&partnerID=40&md5=f460f092bb44613d4ba1019d6cd8a141 VL - 92 ID - 5574 ER - TY - JOUR AD - Paul o'Gorman Leukaemia Research Centre, University of Glasgow, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, United Kingdom AU - Campbell, V. AU - Copland, M. DB - Scopus DO - 10.2217/cpr.13.43 IS - 4 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 415-425 ST - Dasatinib for the treatment of chronic phase chronic myeloid leukemia T2 - Clinical Practice TI - Dasatinib for the treatment of chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880237702&doi=10.2217%2fcpr.13.43&partnerID=40&md5=cf19bf5e2539ec7f8022b4c0e81524ef VL - 10 ID - 5575 ER - TY - JOUR AD - Y. Xiao, Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Xiao, Y. AU - Deng, T. AU - Wang, D. DB - Embase Medline IS - 3 LA - English M3 - Article N1 - L2007417767 2020-09-08 2020-10-27 PY - 2020 SN - 1107-0625 SP - 1607-1613 ST - Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway T2 - Journal of B.U.ON. TI - Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007417767&from=export VL - 25 ID - 5576 ER - TY - JOUR AD - K. Yang, Institute of Cardiovascular Disease, Ruijin Hospital, Shanghai, China AU - Feng, D. AU - Wang, Y. AU - Liu, Y. AU - Wu, L. AU - Li, X. AU - Chen, Y. AU - Chen, Y. AU - Chen, Y. AU - Xu, C. AU - Yang, K. AU - Zhou, T. DB - Embase Medline DO - 10.1111/cei.13048 IS - 1 LA - English M3 - Article N1 - L619676722 2017-12-18 2017-12-20 PY - 2018 SN - 1365-2249 0009-9104 SP - 107-115 ST - DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury T2 - Clinical and Experimental Immunology TI - DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619676722&from=exporthttp://dx.doi.org/10.1111/cei.13048 VL - 191 ID - 5577 ER - TY - JOUR AD - School of Pharmacy, China Medical University, Taichung, Taiwan. AN - 18822283 AU - Chen, J. T. AU - Fong, Y. C. AU - Li, T. M. AU - Liu, J. F. AU - Hsu, C. W. AU - Chang, C. S. AU - Tang, C. H. DA - Nov 12 DO - 10.1016/j.ejphar.2008.08.036 10.1016/j.ejphar.2008.08.036. Epub 2008 Sep 16. DP - Nlm ET - 2008/09/30 IS - 1-3 LA - eng PY - 2008 SN - 0014-2999 (Print) 0014-2999 SP - 19-26 ST - DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells T2 - Eur J Pharmacol TI - DDTD, an isoflavone derivative, induces cell apoptosis through the reactive oxygen species/apoptosis signal-regulating kinase 1 pathway in human osteosarcoma cells VL - 597 ID - 5578 ER - TY - JOUR AD - R.L. Barnhill, Department of Pathology and Laboratory Medicine, UCLA Medical Center, 924 Westwood Boulevard, 730, Los Angeles, CA, United States AU - Su, A. AU - Low, L. AU - Li, X. AU - Zhou, S. AU - Mascarenhas, L. AU - Barnhill, R. L. DB - Embase Medline DO - 10.1097/DAD.0000000000000128 IS - 11 LA - English M3 - Article N1 - L600682831 2014-12-15 PY - 2014 SN - 1533-0311 0193-1091 SP - 915-919 ST - De novo congenital melanoma: Analysis of 2 cases with array comparative genomic hybridization T2 - American Journal of Dermatopathology TI - De novo congenital melanoma: Analysis of 2 cases with array comparative genomic hybridization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600682831&from=exporthttp://dx.doi.org/10.1097/DAD.0000000000000128 VL - 36 ID - 5579 ER - TY - JOUR AD - Gastrointestinal Cancer Research Laboratory, Baylor University Medical Center, Dallas, TX, USA. AN - 20473912 AU - Goel, A. AU - Nguyen, T. P. AU - Leung, H. C. AU - Nagasaka, T. AU - Rhees, J. AU - Hotchkiss, E. AU - Arnold, M. AU - Banerji, P. AU - Koi, M. AU - Kwok, C. T. AU - Packham, D. AU - Lipton, L. AU - Boland, C. R. AU - Ward, R. L. AU - Hitchins, M. P. C2 - PMC3794437 C6 - NIHMS517877 DA - Feb 15 DO - 10.1002/ijc.25422 10.1002/ijc.25422. DP - Nlm ET - 2010/05/18 IS - 4 LA - eng PY - 2011 SN - 0020-7136 (Print) 0020-7136 SP - 869-78 ST - De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one T2 - Int J Cancer TI - De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one VL - 128 ID - 5580 ER - TY - JOUR AD - W. Xu, Department of Orthopaedics, TongRen Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China AU - Li, Z. AU - Zhu, X. AU - Xu, R. AU - Wang, Y. AU - Hu, R. AU - Xu, W. C2 - MOLBASE(China) DB - Embase DO - 10.3389/fphar.2019.00599 IS - JUN LA - English M3 - Article N1 - L628533764 2019-07-24 2019-08-02 PY - 2019 SN - 1663-9812 ST - Deacylcynaropicrin inhibits RANKL-induced osteoclastogenesis by inhibiting NF-κB and MAPK and promoting M2 polarization of macrophages T2 - Frontiers in Pharmacology TI - Deacylcynaropicrin inhibits RANKL-induced osteoclastogenesis by inhibiting NF-κB and MAPK and promoting M2 polarization of macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628533764&from=exporthttp://dx.doi.org/10.3389/fphar.2019.00599 VL - 10 ID - 5581 ER - TY - JOUR AD - State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, China Collaborative Innovation Center for Biotherapy, Nankai University, China USC Norris Cancer Hospital, Department of Medicine, University of Southern California, 1441 Eastlake Avenue, NOR 6330, Los Angeles, CA 90033, United States Nankai University School of Medicine, Tianjin, China Sichuan University College of Life Sciences, Chengdu, China AU - Xu, L. X. AU - Grimaldo, S. AU - Qi, J. W. AU - Yang, G. L. AU - Qin, T. T. AU - Xiao, H. Y. AU - Xiang, R. AU - Xiao, Z. AU - Li, L. Y. AU - Zhang, Z. S. DB - Scopus DO - 10.1016/j.biocel.2014.08.015 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2014 SP - 109-118 ST - Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis T2 - International Journal of Biochemistry and Cell Biology TI - Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907320822&doi=10.1016%2fj.biocel.2014.08.015&partnerID=40&md5=5f0571fdadcc1ee3085c3374f40696e9 VL - 55 ID - 5582 ER - TY - JOUR AD - L.E. Clarke, Department of Pathology, Penn State College of Medicine, Hershey Medical Center, 500 University Drive, Hershey, PA 17033, United States AU - Clarke, L. E. AU - Bayerl, M. G. AU - Bruggeman, R. D. AU - Mauger, D. AU - Ioffreda, M. D. AU - Abou-Elella, A. AU - Helm, K. F. DB - Embase Medline DO - 10.1097/01.pas.0000155154.46434.93 IS - 4 LA - English M3 - Article N1 - L40411175 2005-04-10 PY - 2005 SN - 0147-5185 SP - 452-459 ST - Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin T2 - American Journal of Surgical Pathology TI - Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40411175&from=exporthttp://dx.doi.org/10.1097/01.pas.0000155154.46434.93 VL - 29 ID - 5583 ER - TY - JOUR AD - H. Nakagami, Division of Vascular Medicine and Epigenetics, United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan AU - Nakagami, F. AU - Koriyama, H. AU - Nakagami, H. AU - Osako, M. K. AU - Shimamura, M. AU - Kyutoku, M. AU - Miyake, T. AU - Katsuya, T. AU - Rakugi, H. AU - Morishita, R. DB - Embase Medline DO - 10.1371/journal.pone.0060493 IS - 3 L1 - internal-pdf://0552473416/journal.pone.0060493.PDF LA - English M3 - Article N1 - L368602234 2013-04-04 2013-04-17 PY - 2013 SN - 1932-6203 ST - Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice T2 - PLoS ONE TI - Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368602234&from=exporthttp://dx.doi.org/10.1371/journal.pone.0060493 VL - 8 ID - 5584 ER - TY - JOUR AD - 1 The First Affiliated Hospital of Chongqing Medical University , Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute, Chongqing, People's Republic of China . AN - 25343528 AU - Ye, Z. AU - Wang, C. AU - Tang, J. AU - Zhou, Y. AU - Bai, L. AU - Liu, Y. AU - Kijlstra, A. AU - Yang, P. DA - Apr DO - 10.1089/jir.2014.0042 10.1089/jir.2014.0042. Epub 2014 Oct 24. DP - Nlm ET - 2014/10/25 IS - 4 LA - eng PY - 2015 SN - 1079-9907 SP - 265-72 ST - Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment T2 - J Interferon Cytokine Res TI - Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment VL - 35 ID - 5585 ER - TY - JOUR AD - Department of Transplantation, Polish-American Institute of Pediatrics, Jagiellonian University School of Medicine, Cracow, Poland. AN - 23328666 AU - Miekus, K. AU - Lukasiewicz, E. AU - Jarocha, D. AU - Sekula, M. AU - Drabik, G. AU - Majka, M. C2 - PMC3563987 DA - Jan 17 DO - 10.1038/cddis.2012.199 10.1038/cddis.2012.199. DP - Nlm ET - 2013/01/19 IS - 1 LA - eng PY - 2013 SP - e459 ST - The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation T2 - Cell Death Dis TI - The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation VL - 4 ID - 5586 ER - TY - JOUR AD - S. Galli, Laboratory of Oxygen Metabolism, University Hospital, Cordoba 2351, 1120 Buenos Aires, Argentina AU - Galli, S. AU - Labato, M. I. AU - Bal de Kier Joffé, E. AU - Carreras, M. C. AU - Poderoso, J. J. DB - Embase Medline IS - 19 LA - English M3 - Article N1 - L37255186 2003-11-05 PY - 2003 SN - 0008-5472 SP - 6370-6377 ST - Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior T2 - Cancer Research TI - Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37255186&from=export VL - 63 ID - 5587 ER - TY - JOUR AD - Department of Internal Medicine III, Friedrich-Schiller-University, Erlanger Allee 101, D-07740 Jena, Germany Department of Internal Medicine II, Division of Gastroenterology, Friedrich-Schiller-University, Jena, Germany AU - Drinda, S. AU - Franke, S. AU - Eidner, T. AU - Schmidt, C. AU - Rüster, C. AU - Bondeva, T. AU - Hein, G. AU - Wolf, G. DB - Scopus IS - 3 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2009 SP - 483-490 ST - Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis T2 - Clinical and Experimental Rheumatology TI - Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651149868&partnerID=40&md5=1dfd35dfd4b84286b218d71c1bbf6574 VL - 27 ID - 5588 ER - TY - JOUR AD - X. Luo, Department of Hematology, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China AU - Luo, X. AU - Xu, L. AU - Wu, X. AU - Tan, H. AU - Liu, L. DB - Embase DO - 10.1186/s12935-019-0850-x IS - 1 LA - English M3 - Article N1 - L627732111 2019-05-29 2019-06-03 PY - 2019 SN - 1475-2867 ST - Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation T2 - Cancer Cell International TI - Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627732111&from=exporthttp://dx.doi.org/10.1186/s12935-019-0850-x VL - 19 ID - 5589 ER - TY - JOUR AD - N.E. Berlow, Children's Cancer Therapy Development Institute, Beaverton, OR, United States AU - Berlow, N. E. AU - Grasso, C. S. AU - Quist, M. J. AU - Cheng, M. AU - Gandour-Edwards, R. AU - Hernandez, B. S. AU - Michalek, J. E. AU - Ryan, C. AU - Spellman, P. AU - Pal, R. AU - Million, L. S. AU - Renneker, M. AU - Keller, C. C1 - abt 737 DB - Embase DO - 10.1155/2020/6312480 LA - English M3 - Article N1 - L2006779560 2020-07-08 2020-07-13 PY - 2020 SN - 1369-1643 1357-714X ST - Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma T2 - Sarcoma TI - Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006779560&from=exporthttp://dx.doi.org/10.1155/2020/6312480 VL - 2020 ID - 5590 ER - TY - JOUR AD - J. Fanburg-Smith, Penn State Health Milton S. Hershey Medical Center, McLean, VA, United States AU - Fanburg-Smith, J. AU - Reinhard, H. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631813260 2020-05-26 PY - 2019 SN - 1530-0285 ST - Deep juvenile xanthogranuloma harbors BRAF V600E mutation similar to other histiocytic lesions T2 - Modern Pathology TI - Deep juvenile xanthogranuloma harbors BRAF V600E mutation similar to other histiocytic lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631813260&from=export VL - 32 ID - 5591 ER - TY - JOUR AD - Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Westmead, New South Wales 2145, Australia. linda_bendall@wmi.usyd.edu.au AN - 15833862 AU - Bendall, L. J. AU - Baraz, R. AU - Juarez, J. AU - Shen, W. AU - Bradstock, K. F. DA - Apr 15 DO - 10.1158/0008-5472.Can-04-3402 10.1158/0008-5472.CAN-04-3402. DP - Nlm ET - 2005/04/19 IS - 8 LA - eng PY - 2005 SN - 0008-5472 (Print) 0008-5472 SP - 3290-8 ST - Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia T2 - Cancer Res TI - Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia VL - 65 ID - 5592 ER - TY - JOUR AD - C.J. Burns, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia AU - McArthur, K. AU - D'Cruz, A. A. AU - Segal, D. AU - Lackovic, K. AU - Wilks, A. F. AU - O'Donnell, J. A. AU - Nowell, C. J. AU - Gerlic, M. AU - Huang, D. C. S. AU - Burns, C. J. AU - Croker, B. A. C1 - abt 737 abt 869 ac 220 ag 13958 akt i 1 akt i 1,2 amg tie2 1 ap 24534 as 252424 at 7519 at 9283 av 412 av 915 az 960 azd 6244 azd 7762 bez 235 bi 2536 bms 2 bms 3 bms 5 bx 795 bx 912 cc 401 ci 1033 ci 1040 cp 690550 cp 724714 cyc 116 e 7080 gd 0941 gsk 690693 gw 441756 ic 87114 jnj 38877605 jnj 7706621 ki 20227 ku 0063794 ku 55933 ku 57788 mp 470 pd 0325901 pf 04217903 pf 431396 pf 562271 pha 690509 pi 103 pik 294 pik 75 pik 90 pik 93 plx 4720 r 1487 rho 15 rwj 67657 sb 202190 sb 203580 sb 242235 sb 590885 sd 06 sd 169 smi 4a sns 032 sns 314 sr 3677 su 5402 su 6668 tak 715 tgx 221 vx 680 vx 702 ym 201636 C2 - SYN kinase(Australia) DB - Embase DO - 10.18632/oncotarget.19678 IS - 35 LA - English M3 - Article N1 - L618253787 2017-09-15 2017-09-21 PY - 2017 SN - 1949-2553 SP - 57948-57963 ST - Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia T2 - Oncotarget TI - Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618253787&from=exporthttp://dx.doi.org/10.18632/oncotarget.19678 VL - 8 ID - 5593 ER - TY - JOUR AD - C. Lu, Department of Pediatrics, First Affiliated Hospital, Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, Zhejiang Province, China AU - Wang, K. AU - Zhou, A. AU - Ruan, M. AU - Jin, Z. AU - Lu, J. AU - Wang, Q. AU - Lu, C. DB - Embase IS - 9 LA - English M3 - Article N1 - L2004409880 2020-01-07 2020-01-09 PY - 2019 SN - 1943-8141 SP - 6159-6169 ST - Dehydrocostus lactone suppresses ox-LDL-induced attachment of monocytes to endothelial cells T2 - American Journal of Translational Research TI - Dehydrocostus lactone suppresses ox-LDL-induced attachment of monocytes to endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004409880&from=export VL - 11 ID - 5594 ER - TY - JOUR AD - W.B. Isaacs, Department of Urology, Johns Hopkins Medical Institutions, Marburg 115, 600 North Wolfe Street, Baltimore, MD 21287, United States AU - Liu, W. AU - Chang, B. L. AU - Cramer, S. AU - Koty, P. P. AU - Li, T. AU - Sun, J. AU - Turner, A. R. AU - Kap-Herr, C. AU - Bobby, P. AU - Rao, J. AU - Zheng, S. L. AU - Isaacs, W. B. AU - Xu, J. DB - Embase Medline DO - 10.1158/1078-0432.CCR-07-0300 IS - 17 L1 - internal-pdf://0950390868/5028.full.pdf LA - English M3 - Article N1 - L47502067 2007-09-01 PY - 2007 SN - 1078-0432 SP - 5028-5033 ST - Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers T2 - Clinical Cancer Research TI - Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47502067&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-07-0300 VL - 13 ID - 5595 ER - TY - JOUR AD - Y. Balachandran, Transplant Immunology Laboratory, Division of Abdominal Transplant, Stanford University, Stanford, CA, United States AU - Balachandran, Y. AU - McPherson, M. AU - Boyd, S. D. AU - Esquivel, C. O. AU - Krams, S. AU - Martinez, O. M. DB - Embase IS - 7 LA - English M3 - Conference Abstract N1 - L623701485 2018-09-05 PY - 2018 SN - 0041-1337 SP - S319 ST - Delineation of the viral and host cell genomic alterations in EBV-positive PTLD T2 - Transplantation TI - Delineation of the viral and host cell genomic alterations in EBV-positive PTLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623701485&from=export VL - 102 ID - 5596 ER - TY - JOUR AD - Department of Pediatrics, SSCIandH Lucknow, India Pediatric Hematology-Oncology Unit, Department of Pediatrics, King George's Medical University, Lucknow, 226006, India Department of Pediatric Oncology, Medanta-The Medicity, Gurgaon, India Department of Pediatrics, BVP, Pune, Maharashtra, India AU - Pant, G. AU - Kumar, A. AU - Verma, N. AU - Pooniya, V. AU - Sharma, A. AU - Gupta, B. DB - Scopus DO - 10.1097/MPH.0000000000001492 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 376-381 ST - Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: A Single-center Experience T2 - Journal of Pediatric Hematology/Oncology TI - Demographics and Outcome of Philadelphia-positive ALL in a Pediatric Population in North India: A Single-center Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064953909&doi=10.1097%2fMPH.0000000000001492&partnerID=40&md5=b0c44fd15b99c27b6cb9783c31ec9aec VL - 41 ID - 5597 ER - TY - JOUR AD - M. Kurdi, Department of Chemistry and Biochemistry, Lebanese University, Rafic Hariri Educational Campus, Hadath, Lebanon AU - Kurdi, M. AU - Sivakumaran, V. AU - Duhé, R. J. AU - Aon, M. A. AU - Paolocci, N. AU - Booz, G. W. DB - Embase Medline DO - 10.1016/j.biocel.2012.08.016 IS - 12 LA - English M3 - Article N1 - L52227880 2012-09-27 2012-11-26 PY - 2012 SN - 1357-2725 1878-5875 SP - 2106-2115 ST - Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes T2 - International Journal of Biochemistry and Cell Biology TI - Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52227880&from=exporthttp://dx.doi.org/10.1016/j.biocel.2012.08.016 VL - 44 ID - 5598 ER - TY - JOUR AD - Cancer Science Institute of Singapore, National University of Singapore, Singapore City, Singapore. AN - 23888996 AU - Yan, J. AU - Jiang, N. AU - Huang, G. AU - Tay, J. L. AU - Lin, B. AU - Bi, C. AU - Koh, G. S. AU - Li, Z. AU - Tan, J. AU - Chung, T. H. AU - Lu, Y. AU - Ariffin, H. AU - Kham, S. K. AU - Yeoh, A. E. AU - Chng, W. J. DA - Oct DO - 10.1111/bjh.12489 10.1111/bjh.12489. Epub 2013 Jul 25. DP - Nlm ET - 2013/07/31 IS - 1 LA - eng PY - 2013 SN - 0007-1048 SP - 93-103 ST - Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia T2 - Br J Haematol TI - Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia VL - 163 ID - 5599 ER - TY - JOUR AD - S. Schubbert, Department of Pediatrics, University of California, 513 Parnassus Avenue, Room HSE-302, San Francisco, CA 94143, United States AU - Schubbert, S. AU - Bollag, G. AU - Shannon, K. DB - Embase Medline DO - 10.1016/j.gde.2006.12.004 IS - 1 LA - English M3 - Review N1 - L46109294 2007-02-19 PY - 2007 SN - 0959-437X SP - 15-22 ST - Deregulated Ras signaling in developmental disorders: new tricks for an old dog T2 - Current Opinion in Genetics and Development TI - Deregulated Ras signaling in developmental disorders: new tricks for an old dog UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46109294&from=exporthttp://dx.doi.org/10.1016/j.gde.2006.12.004 VL - 17 ID - 5600 ER - TY - JOUR AD - P.L. Myskowski, Dermatology Service, Department of Medicine, Rockefeller Outpatient Pavilion, Memorial Sloan-Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, United States AU - Balagula, Y. AU - Huston, K. B. AU - Busam, K. J. AU - Lacouture, M. E. AU - Chapman, P. B. AU - Myskowski, P. L. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1007/s10637-010-9567-3 IS - 5 LA - English M3 - Review N1 - L51126657 2010-10-29 2012-06-15 PY - 2011 SN - 0167-6997 1573-0646 SP - 1114-1121 ST - Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) T2 - Investigational New Drugs TI - Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51126657&from=exporthttp://dx.doi.org/10.1007/s10637-010-9567-3 VL - 29 ID - 5601 ER - TY - JOUR AD - Department of Dermatology and Pediatrics, Oregon Health and Science University, Portland, USA. dsiegel@mcw.edu AN - 21062266 AU - Siegel, D. H. AU - McKenzie, J. AU - Frieden, I. J. AU - Rauen, K. A. C2 - PMC4063552 C6 - NIHMS252247 DA - Mar DO - 10.1111/j.1365-2133.2010.10122.x 10.1111/j.1365-2133.2010.10122.x. Epub 2011 Jan 28. DP - Nlm ET - 2010/11/11 IS - 3 LA - eng PY - 2011 SN - 0007-0963 (Print) 0007-0963 SP - 521-9 ST - Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome T2 - Br J Dermatol TI - Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome VL - 164 ID - 5602 ER - TY - JOUR AD - Department of Dermatology and Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Road TBRC, 2nd Floor, Suite C2010, Milwaukee, WI 53226, USA. dsiegel@mcw.edu AN - 22098123 AU - Siegel, D. H. AU - Mann, J. A. AU - Krol, A. L. AU - Rauen, K. A. C2 - PMC4063554 C6 - NIHMS339752 DA - Mar DO - 10.1111/j.1365-2133.2011.10744.x 10.1111/j.1365-2133.2011.10744.x. DP - Nlm ET - 2011/11/22 IS - 3 LA - eng PY - 2012 SN - 0007-0963 (Print) 0007-0963 SP - 601-7 ST - Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development T2 - Br J Dermatol TI - Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development VL - 166 ID - 5603 ER - TY - JOUR AD - Stony Brook University Cancer Center, 9447 SUNY, Stony Brook, NY 11794-9447, United States Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL, United States Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611, United States Department of Dermatology, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair St., Chicago, IL 60611, United States AU - Rosenbaum, S. E. AU - Wu, S. AU - Newman, M. A. AU - West, D. P. AU - Kuzel, T. AU - Lacouture, M. E. DB - Scopus DO - 10.1007/s00520-008-0409-1 IS - 6 M3 - Review N1 - Cited By :91 Export Date: 18 November 2020 PY - 2008 SP - 557-566 ST - Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib T2 - Supportive Care in Cancer TI - Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-44449171930&doi=10.1007%2fs00520-008-0409-1&partnerID=40&md5=09f4af46538250478ab110efef153d07 VL - 16 ID - 5604 ER - TY - JOUR AD - A. Borkhardt, Dept. of Pediat. Hematol. and Oncol., Justus-Liebig-University, 35385 Giessen, Germany AU - Ritter, U. AU - Damm-Welk, C. AU - Fuchs, U. AU - Bohle, R. M. AU - Borkhardt, A. AU - Woessmann, W. DB - Embase Medline DO - 10.1089/154545703322617041 IS - 5 LA - English M3 - Article N1 - L38404821 2004-04-14 PY - 2003 SN - 1545-4576 SP - 365-373 ST - Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL) T2 - Oligonucleotides TI - Design and Evaluation of Chemically Synthesized siRNA Targeting the NPM-ALK Fusion Site in Anaplastic Large Cell Lymphoma (ALCL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38404821&from=exporthttp://dx.doi.org/10.1089/154545703322617041 VL - 13 ID - 5605 ER - TY - JOUR AD - Development of Biomolecular therapies, Experimental Oncology Lab, Rizzoli Institute, Via Di Barbiano 1/10, 40136 Bologna, Italy Clinical Oncology, Rizzoli Institute, Bologna, Italy Department of Health, University of Catanzaro, Catanzaro, Italy AU - Manara, M. C. AU - Garofalo, C. AU - Ferrari, S. AU - Belfiore, A. AU - Scotlandi, K. DB - Scopus DO - 10.2174/1381612811319300004 IS - 30 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2013 SP - 5344-5361 ST - Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis T2 - Current Pharmaceutical Design TI - Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881357185&doi=10.2174%2f1381612811319300004&partnerID=40&md5=0984aaa7c92ce14882906eb170e9dcf5 VL - 19 ID - 5606 ER - TY - JOUR AD - Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China AU - Yao, Y. AU - Peng, M. AU - Shen, Q. AU - Hu, Q. AU - Gong, H. AU - Li, Q. AU - Zheng, Z. AU - Xu, B. AU - Li, Y. AU - Dong, Y. DB - Scopus DO - 10.1111/1759-7714.12932 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 193-202 ST - Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples T2 - Thoracic Cancer TI - Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058706015&doi=10.1111%2f1759-7714.12932&partnerID=40&md5=8baa30fc56ed2994197b887ade0e349c VL - 10 ID - 5607 ER - TY - JOUR AD - University Department of Cellular Science, John Radcliffe Hospital, Oxford, UK. AN - 9028963 AU - Pulford, K. AU - Lamant, L. AU - Morris, S. W. AU - Butler, L. H. AU - Wood, K. M. AU - Stroud, D. AU - Delsol, G. AU - Mason, D. Y. DA - Feb 15 DP - Nlm ET - 1997/02/15 IS - 4 LA - eng N1 - Pulford, K Lamant, L Morris, S W Butler, L H Wood, K M Stroud, D Delsol, G Mason, D Y Wellcome Trust/United Kingdom Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1997 Feb 15;89(4):1394-404. PY - 1997 SN - 0006-4971 (Print) 0006-4971 SP - 1394-404 ST - Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 T2 - Blood TI - Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1 VL - 89 ID - 5608 ER - TY - JOUR AD - Bilad Al-Rafidain University College, Diyala, Baquba, Iraq College of Pharmacy, University of Al Qadisiyah, Diwaniyah, Iraq AU - Khaleq, M. A. A. AU - Saheb, H. A. AU - Sultan, A. M. AU - Alrodhan, M. A. N. DB - Scopus DO - 10.26452/ijrps.v10i2.274 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 909-913 ST - Detection of BCR-ABL gene in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors drugs by gene expert system T2 - International Journal of Research in Pharmaceutical Sciences TI - Detection of BCR-ABL gene in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors drugs by gene expert system UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070286327&doi=10.26452%2fijrps.v10i2.274&partnerID=40&md5=10166aff1310b0a77e5935a64e0e0c29 VL - 10 ID - 5609 ER - TY - JOUR AD - Institute of Medical Science, Tzu Chi University, Taiwan Department of Laboratory Medicine, Tzu Chi Hospital, Taichung Branch, Taiwan Department of Internal Medicine, Medical Center, National Taiwan University, Taiwan Department of Pediatrics, Tzu Chi Medical Center, Taiwan Department of Hemato-Oncology, Tzu Chi Medical Center, Taiwan Department of Biochemistry, Tzu Chi University, 970 No. 701, Section 3, Zhongyang Rd., Hualien, Taiwan AU - Chien, J. H. AU - Tang, J. L. AU - Chen, R. L. AU - Li, C. C. AU - Lee, C. P. DB - Scopus DO - 10.1016/j.leukres.2008.04.023 IS - 11 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2008 SP - 1724-1734 ST - Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy T2 - Leukemia Research TI - Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-47249117433&doi=10.1016%2fj.leukres.2008.04.023&partnerID=40&md5=047fde9b3d1b6be018f937951129bc1a VL - 32 ID - 5610 ER - TY - JOUR AD - Department of Laboratory Medicine, Chosun University Medical School, Gwangju, Korea. AN - 23690118 AU - Kang, S. H. AU - Pyo, J. Y. AU - Yang, S. W. AU - Hong, S. W. DA - Jun DO - 10.1309/ajcpn3ulh6ywbhph 10.1309/AJCPN3ULH6YWBHPH. DP - Nlm ET - 2013/05/22 IS - 6 LA - eng PY - 2013 SN - 0002-9173 SP - 759-64 ST - Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR T2 - Am J Clin Pathol TI - Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR VL - 139 ID - 5611 ER - TY - JOUR AD - V.E. Velculescu, Ludwig Center for Cancer Genetics and Therapeutics, Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, United States AU - Bettegowda, C. AU - Sausen, M. AU - Leary, R. J. AU - Kinde, I. AU - Wang, Y. AU - Agrawal, N. AU - Bartlett, B. R. AU - Wang, H. AU - Luber, B. AU - Alani, R. M. AU - Antonarakis, E. S. AU - Azad, N. S. AU - Bardelli, A. AU - Brem, H. AU - Cameron, J. L. AU - Lee, C. C. AU - Fecher, L. A. AU - Gallia, G. L. AU - Gibbs, P. AU - Le, D. AU - Giuntoli, R. L. AU - Goggins, M. AU - Hogarty, M. D. AU - Holdhoff, M. AU - Hong, S. M. AU - Jiao, Y. AU - Juhl, H. H. AU - Kim, J. J. AU - Siravegna, G. AU - Laheru, D. A. AU - Lauricella, C. AU - Lim, M. AU - Lipson, E. J. AU - Marie, S. K. N. AU - Netto, G. J. AU - Oliner, K. S. AU - Olivi, A. AU - Olsson, L. AU - Riggins, G. J. AU - Sartore-Bianchi, A. AU - Schmidt, K. AU - Shih, I. M. AU - Oba-Shinjo, S. M. AU - Siena, S. AU - Theodorescu, D. AU - Tie, J. AU - Harkins, T. T. AU - Veronese, S. AU - Wang, T. L. AU - Weingart, J. D. AU - Wolfgang, C. L. AU - Wood, L. D. AU - Xing, D. AU - Hruban, R. H. AU - Wu, J. AU - Allen, P. J. AU - Schmidt, C. M. AU - Choti, M. A. AU - Velculescu, V. E. AU - Kinzler, K. W. AU - Vogelstein, B. AU - Papadopoulos, N. AU - Diaz Jr, L. A. DB - Embase Medline DO - 10.1126/scitranslmed.3007094 IS - 224 LA - English M3 - Article N1 - L372632674 2014-03-26 2014-04-01 PY - 2014 SN - 1946-6234 1946-6242 ST - Detection of circulating tumor DNA in early- and late-stage human malignancies T2 - Science Translational Medicine TI - Detection of circulating tumor DNA in early- and late-stage human malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372632674&from=exporthttp://dx.doi.org/10.1126/scitranslmed.3007094http://stm.sciencemag.org/content/6/224/224ra24.full.pdf VL - 6 ID - 5612 ER - TY - JOUR AD - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. AN - 21884820 AU - Tian, Y. AU - Rich, B. E. AU - Vena, N. AU - Craig, J. M. AU - Macconaill, L. E. AU - Rajaram, V. AU - Goldman, S. AU - Taha, H. AU - Mahmoud, M. AU - Ozek, M. AU - Sav, A. AU - Longtine, J. A. AU - Lindeman, N. I. AU - Garraway, L. A. AU - Ligon, A. H. AU - Stiles, C. D. AU - Santagata, S. AU - Chan, J. A. AU - Kieran, M. W. AU - Ligon, K. L. C2 - PMC3194058 DA - Nov DO - 10.1016/j.jmoldx.2011.07.002 10.1016/j.jmoldx.2011.07.002. Epub 2011 Aug 30. DP - Nlm ET - 2011/09/03 IS - 6 LA - eng PY - 2011 SN - 1525-1578 (Print) 1525-1578 SP - 669-77 ST - Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas T2 - J Mol Diagn TI - Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas VL - 13 ID - 5613 ER - TY - JOUR AD - B. Stuhlmüller, Dept. of Int. Medicine, R./C. I., Charité University Hospital, Tucholskystrasse 2, D-10117-Berlin, Germany AU - Stuhlmüller, B. AU - Kunisch, E. AU - Franz, J. AU - Martinez-Gamboa, L. AU - Hernandez, M. M. AU - Pruss, A. AU - Ulbrich, N. AU - Erdmann, V. A. AU - Burmester, G. R. AU - Kinnet, R. W. DB - Embase Medline DO - 10.1016/S0002-9440(10)63450-5 IS - 3 LA - English M3 - Article N1 - L37040126 2003-09-09 PY - 2003 SN - 0002-9440 SP - 901-911 ST - Detection of oncofetal H19 RNA in rheumatoid arthritis synovial tissue T2 - American Journal of Pathology TI - Detection of oncofetal H19 RNA in rheumatoid arthritis synovial tissue UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37040126&from=exporthttp://dx.doi.org/10.1016/S0002-9440(10)63450-5 VL - 163 ID - 5614 ER - TY - JOUR AD - K. Kudo, Department of Pediatrics, Hirosaki University, Graduate School of Medicine, Hirosaki, Japan AU - Kudo, K. AU - Kanezaki, R. AU - Kobayashi, A. AU - Sato, T. AU - Kamio, T. AU - Sasaki, S. AU - Terui, K. AU - Sato, A. AU - Irie, M. AU - Sasahara, Y. AU - Imamura, M. AU - Imai, C. AU - Toki, T. AU - Ito, E. DB - Embase DO - 10.1002/pbc.26770 LA - English M3 - Conference Abstract N1 - L618304361 2017-09-21 PY - 2017 SN - 1545-5017 SP - S19 ST - Detection of somatic mutations by PCR-based next-generation sequencing from fixed clinical specimens in childhood LCH T2 - Pediatric Blood and Cancer TI - Detection of somatic mutations by PCR-based next-generation sequencing from fixed clinical specimens in childhood LCH UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618304361&from=exporthttp://dx.doi.org/10.1002/pbc.26770 VL - 64 ID - 5615 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA. AN - 10555007 AU - Cataldo, K. A. AU - Jalal, S. M. AU - Law, M. E. AU - Ansell, S. M. AU - Inwards, D. J. AU - Fine, M. AU - Arber, D. A. AU - Pulford, K. A. AU - Strickler, J. G. DA - Nov DO - 10.1097/00000478-199911000-00009 10.1097/00000478-199911000-00009. DP - Nlm ET - 1999/11/11 IS - 11 LA - eng PY - 1999 SN - 0147-5185 (Print) 0147-5185 SP - 1386-92 ST - Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue T2 - Am J Surg Pathol TI - Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue VL - 23 ID - 5616 ER - TY - JOUR AD - Section of Cytopathology, University of Pisa and Pisa University Hospital, Pisa, Italy. i.marchetti@ao-pisa.toscana.it AN - 22181337 AU - Marchetti, I. AU - Iervasi, G. AU - Mazzanti, C. M. AU - Lessi, F. AU - Tomei, S. AU - Naccarato, A. G. AU - Aretini, P. AU - Alberti, B. AU - Di Coscio, G. AU - Bevilacqua, G. DA - Mar DO - 10.1089/thy.2011.0107 10.1089/thy.2011.0107. Epub 2011 Dec 19. DP - Nlm ET - 2011/12/21 IS - 3 LA - eng PY - 2012 SN - 1050-7256 SP - 292-8 ST - Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis T2 - Thyroid TI - Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis VL - 22 ID - 5617 ER - TY - JOUR AD - Centre Léon-Bérard, Laboratoire de Recherche Translationnelle, 28 rue Laennec, 69373, Lyon Cedex 08, France. AN - 25653133 AU - Combaret, V. AU - Iacono, I. AU - Bellini, A. AU - Bréjon, S. AU - Bernard, V. AU - Marabelle, A. AU - Coze, C. AU - Pierron, G. AU - Lapouble, E. AU - Schleiermacher, G. AU - Blay, J. Y. C2 - PMC4402069 DA - Apr DO - 10.1002/cam4.414 10.1002/cam4.414. Epub 2015 Feb 4. DP - Nlm ET - 2015/02/06 IS - 4 LA - eng PY - 2015 SN - 2045-7634 (Print) 2045-7634 SP - 540-50 ST - Detection of tumor ALK status in neuroblastoma patients using peripheral blood T2 - Cancer Med TI - Detection of tumor ALK status in neuroblastoma patients using peripheral blood VL - 4 ID - 5618 ER - TY - JOUR AD - Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medical Affairs, Loxo Oncology, Inc., Stamford, CT, United States Department of Pathology, University of Colorado, Aurora, CO, United States AU - Hsiao, S. J. AU - Zehir, A. AU - Sireci, A. N. AU - Aisner, D. L. DB - Scopus DO - 10.1016/j.jmoldx.2019.03.008 IS - 4 M3 - Review N1 - Cited By :29 Export Date: 18 November 2020 PY - 2019 SP - 553-571 ST - Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy T2 - Journal of Molecular Diagnostics TI - Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067551421&doi=10.1016%2fj.jmoldx.2019.03.008&partnerID=40&md5=09a6065b2228293d0995457f0c6d0a32 VL - 21 ID - 5619 ER - TY - JOUR AD - B.L. Upham, Department of Pediatrics, Hum. Devmt./N. F. S./Toxicol. Ctr., Michigan State University, East Lansing, MI 48824, United States AU - Horvath, A. AU - Upham, B. L. AU - Ganev, V. AU - Trosko, J. E. DB - Embase Medline DO - 10.1016/S0041-0101(01)00219-7 IS - 3 LA - English M3 - Article N1 - L33044571 2001-11-21 PY - 2001 SN - 0041-0101 SP - 273-282 ST - Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line T2 - Toxicon TI - Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L33044571&from=exporthttp://dx.doi.org/10.1016/S0041-0101(01)00219-7 VL - 40 ID - 5620 ER - TY - JOUR AD - J. Shou, China Novartis Institutes for BioMedical Research, Shanghai 201203, China AU - Chen, Y. AU - Wei, T. AU - Yan, L. AU - Lawrence, F. AU - Qian, H. R. AU - Burkholder, T. P. AU - Starling, J. J. AU - Yingling, J. M. AU - Shou, J. C1 - ly 2401401 ptk 787 su 11248 sutent DB - Embase Medline DO - 10.1186/1471-2164-9-264 LA - English M3 - Article N1 - L351895450 2008-07-09 PY - 2008 SN - 1471-2164 ST - Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model T2 - BMC Genomics TI - Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351895450&from=exporthttp://dx.doi.org/10.1186/1471-2164-9-264 VL - 9 ID - 5621 ER - TY - JOUR AD - Consultancy and Regulatory Services, Covance Laboratories Ltd., Harrogate, United Kingdom AU - Baldrick, P. DB - Scopus DO - 10.1016/j.yrtph.2004.03.004 IS - 3 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2004 SP - 381-389 ST - Developing drugs for pediatric use: A role for juvenile animal studies? T2 - Regulatory Toxicology and Pharmacology TI - Developing drugs for pediatric use: A role for juvenile animal studies? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342523349&doi=10.1016%2fj.yrtph.2004.03.004&partnerID=40&md5=c798344d77eec3e285360ea43e28218b VL - 39 ID - 5622 ER - TY - JOUR AD - W. Chen, Department of Toxicology, School of Public Health, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou, China AU - Chen, S. AU - Li, D. AU - Zhang, H. AU - Yu, D. AU - Chen, R. AU - Zhang, B. AU - Tan, Y. AU - Niu, Y. AU - Duan, H. AU - Mai, B. AU - Chen, S. AU - Yu, J. AU - Luan, T. AU - Chen, L. AU - Xing, X. AU - Li, Q. AU - Xiao, Y. AU - Dong, G. AU - Niu, Y. AU - Aschner, M. AU - Zhang, R. AU - Zheng, Y. AU - Chen, W. DB - Embase Medline DO - 10.1016/j.envint.2019.104943 LA - English M3 - Article N1 - L2002239205 2019-07-12 2019-07-19 PY - 2019 SN - 1873-6750 0160-4120 ST - The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure T2 - Environment International TI - The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002239205&from=exporthttp://dx.doi.org/10.1016/j.envint.2019.104943 VL - 131 ID - 5623 ER - TY - JOUR AD - J.M. Fischer, Uniformed Services University of the Health Sciences, Gaithersburg, MD, United States AU - Fischer, J. M. AU - Smith, B. AU - Waters, A. AU - Krishnamurthy, J. AU - Parekh, D. AU - Thiele, C. AU - Lieuw, K. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.609 IS - 1 LA - English M3 - Conference Abstract N1 - L630752770 2020-02-04 PY - 2018 SN - 1098-4275 ST - Development of a minimal residual disease assay for anaplastic lymphoma kinase mutations using digital droplet polymerase chain reaction T2 - Pediatrics TI - Development of a minimal residual disease assay for anaplastic lymphoma kinase mutations using digital droplet polymerase chain reaction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752770&from=exporthttp://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.609 VL - 142 ID - 5624 ER - TY - JOUR AD - D. Usta, Clinical Cooperation Unit Pediatric Oncology, Pre-Clinical Program, Hopp Children's Cancer Center at the NCT (KiTZ), Heidelberg, Germany AU - Usta, D. AU - Selt, F. AU - Hohloch, J. AU - Pusch, S. AU - Pfister, S. M. AU - Jones, D. T. W. AU - Brummer, T. AU - Witt, O. AU - Milde, T. DB - Embase DO - 10.1055/s-0037-1607404 IS - 6 LA - English M3 - Conference Abstract N1 - L627805151 2019-05-29 PY - 2017 SN - 1439-3824 ST - Development of a novel assay suitable for preclinical testing of MAPK inhibitors in low-grade glioma T2 - Klinische Padiatrie TI - Development of a novel assay suitable for preclinical testing of MAPK inhibitors in low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627805151&from=exporthttp://dx.doi.org/10.1055/s-0037-1607404 VL - 229 ID - 5625 ER - TY - JOUR AD - S.R. Punganuru, Texas Tech Univ. Health Sciences Ctr., Amarillo, TX, United States AU - Punganuru, S. R. AU - Madala, H. R. AU - Srivenugopal, K. S. DB - Embase DO - 10.1158/1538-7445.AM2017-185 IS - 13 LA - English M3 - Conference Abstract N1 - L618564890 2017-10-10 PY - 2017 SN - 1538-7445 ST - Development of a novel non-diuretic brain-penetrating ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models T2 - Cancer Research TI - Development of a novel non-diuretic brain-penetrating ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618564890&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2017-185 VL - 77 ID - 5626 ER - TY - JOUR AD - D. De Ryckere, Department of Pediatrics, University of Colorado- Denver, Children's Hospital Colorado, Aurora, CO, United States AU - De Ryckere, D. AU - Wang, X. AU - Hill, A. A. AU - Zhang, W. AU - Stashko, M. A. AU - Sather, S. AU - Cummings, C. E. AU - Janzen, W. P. AU - Frye, S. V. AU - Earp Iii, H. S. AU - Graham, D. K. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71266231 2013-12-24 PY - 2013 SN - 0006-4971 ST - Development of a novel small molecule inhibitor of the mer tyrosine kinase for treatment of acute lymphoblastic Leukemia T2 - Blood TI - Development of a novel small molecule inhibitor of the mer tyrosine kinase for treatment of acute lymphoblastic Leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71266231&from=exporthttp://bloodjournal.hematologylibrary.org/content/122/21/2666.abstract?sid=00ae9aab-ed6f-4905-b17e-eed061c8f071 VL - 122 ID - 5627 ER - TY - JOUR AN - CN-01570826 AU - Patel, N. R. AU - Cunoosamy, D. M. AU - Fagerås, M. AU - Taib, Z. AU - Asimus, S. AU - Hegelund-Myrbäck, T. AU - Lundin, S. AU - Pardali, K. AU - Kurian, N. AU - Ersdal, E. AU - et al. DO - 10.2147/COPD.S150576 M3 - Journal Article; Multicenter Study; Randomized Controlled Trial PY - 2018 SP - 1009‐1019 ST - The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial T2 - International journal of chronic obstructive pulmonary disease TI - The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01570826/full VL - 13 ID - 5628 ER - TY - JOUR AD - Cytokine Receptor Laboratory, Department of Human Immunology, Hanson Centre for Cancer Research, IMVS, Adelaide, SA, Australia Department of Haematology, IMVS, Transplant Services Australian Redcross Blood Service, SA, Australia Department of Haematology, IMVS, P.O. Box 14 Rundle Mall, Adelaide, SA 5001, Australia AU - Ramshaw, H. AU - Lopez, A. AU - Bardy, P. DB - Scopus DO - 10.2174/1381612023396005 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2002 SP - 357-368 ST - The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders T2 - Current Pharmaceutical Design TI - The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036242410&doi=10.2174%2f1381612023396005&partnerID=40&md5=9d198b929c9814949b35b6c47bf90a6e VL - 8 ID - 5629 ER - TY - JOUR AD - F.M. Uckun, Children's Center for Cancer and Blood Diseases, CHLA, 4650 Sunset Boulevard, Smith Research Tower Suite 300-316, Los Angeles, CA, United States AU - Uckun, F. M. AU - Mitchell, L. G. AU - Qazi, S. AU - Liu, Y. AU - Zheng, N. AU - Myers, D. E. AU - Song, Z. AU - Ma, H. AU - Cheng, J. DB - Embase Medline DO - 10.1016/j.ebiom.2015.04.016 IS - 7 LA - English M3 - Article N1 - L604372218 2015-05-20 2015-12-24 PY - 2015 SN - 2352-3964 SP - 649-659 ST - Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL T2 - EBioMedicine TI - Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604372218&from=exporthttp://dx.doi.org/10.1016/j.ebiom.2015.04.016 VL - 2 ID - 5630 ER - TY - JOUR AD - L. Moreno, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Niño Jesús, Avenida Menéndez Pelayo 65, Madrid, Spain AU - Bautista, F. AU - Van der Lugt, J. AU - Kearns, P. R. AU - Mussai, F. J. AU - Zwaan, C. M. AU - Moreno, L. C1 - abt 199 epz 5676 DB - Embase Medline DO - 10.1080/17460441.2016.1237939 IS - 11 LA - English M3 - Review N1 - L612671267 2016-10-18 2016-11-02 PY - 2016 SN - 1746-045X 1746-0441 SP - 1111-1122 ST - The development of targeted new agents to improve the outcome for children with leukemia T2 - Expert Opinion on Drug Discovery TI - The development of targeted new agents to improve the outcome for children with leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612671267&from=exporthttp://dx.doi.org/10.1080/17460441.2016.1237939 VL - 11 ID - 5631 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Children's Medical Center, Osaka City General Hospital, 2-13-22 Miyakojimahondouri, Miyakojimaku, Osaka 534-0021, Japan AU - Hara, J. DB - Scopus DO - 10.1007/s10147-012-0417-5 IS - 3 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2012 SP - 196-203 ST - Development of treatment strategies for advanced neuroblastoma T2 - International Journal of Clinical Oncology TI - Development of treatment strategies for advanced neuroblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862873055&doi=10.1007%2fs10147-012-0417-5&partnerID=40&md5=a8a7fd80e8ff9a10d017f00ad6631249 VL - 17 ID - 5632 ER - TY - JOUR AD - Authors' Affiliations: Center for Childhood Cancer & Blood Diseases, Nationwide Children's Hospital; Center for Biostatistics, The Ohio State University, Columbus, Ohio; Institut of Pathology, Department Neuropathology, Ruprecht-Karls University and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; and Astrazeneca Ltd., Oncology iMed, Macclesfield, United Kingdom. AN - 24132923 AU - Bid, H. K. AU - Kibler, A. AU - Phelps, D. A. AU - Manap, S. AU - Xiao, L. AU - Lin, J. AU - Capper, D. AU - Oswald, D. AU - Geier, B. AU - DeWire, M. AU - Smith, P. D. AU - Kurmasheva, R. T. AU - Mo, X. AU - Fernandez, S. AU - Houghton, P. J. C2 - PMC4086218 C6 - NIHMS532794 DA - Dec 15 DO - 10.1158/1078-0432.Ccr-13-0842 10.1158/1078-0432.CCR-13-0842. Epub 2013 Oct 16. DP - Nlm ET - 2013/10/18 IS - 24 LA - eng PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 6716-29 ST - Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma T2 - Clin Cancer Res TI - Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma VL - 19 ID - 5633 ER - TY - JOUR AD - Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622, USA. AN - 7588209 AU - King, A. P. AU - Carter-Su, C. DA - Nov DO - 10.1210/endo.136.11.7588209 DP - Nlm ET - 1995/11/01 IS - 11 LA - eng N1 - King, A P Carter-Su, C PY - 1995 SN - 0013-7227 (Print) 0013-7227 SP - 4796-803 ST - Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts T2 - Endocrinology TI - Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts VL - 136 ID - 5634 ER - TY - JOUR AD - Z. Shen, Department of Oncology, Affiliated Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China AU - Yu, W. AU - Tang, L. AU - Lin, F. AU - Yao, Y. AU - Shen, Z. DB - Embase DO - 10.3389/fonc.2019.00172 IS - JAN LA - English M3 - Article N1 - L626837748 2019-03-29 2019-04-01 PY - 2019 SN - 2234-943X ST - DGKZ acts as a potential oncogene in osteosarcoma proliferation through its possible interaction with ERK1/2 and MYC pathway T2 - Frontiers in Oncology TI - DGKZ acts as a potential oncogene in osteosarcoma proliferation through its possible interaction with ERK1/2 and MYC pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626837748&from=exporthttp://dx.doi.org/10.3389/fonc.2019.00172 VL - 9 ID - 5635 ER - TY - JOUR AD - G. Pugliese, Department of Clinical and Molecular Medicine, La Sapienza University, Via di Grottarossa, 1035-1039, Rome, Italy AU - Menini, S. AU - Iacobini, C. AU - De Latouliere, L. AU - Manni, I. AU - Vitale, M. AU - Pilozzi, E. AU - Pesce, C. AU - Cappello, P. AU - Novelli, F. AU - Piaggio, G. AU - Pugliese, G. DB - Embase Medline DO - 10.1186/s13046-020-01665-0 IS - 1 LA - English M3 - Article N1 - L632557241 2020-08-25 2020-09-29 PY - 2020 SN - 1756-9966 ST - Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice T2 - Journal of Experimental and Clinical Cancer Research TI - Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632557241&from=exporthttp://dx.doi.org/10.1186/s13046-020-01665-0 VL - 39 ID - 5636 ER - TY - JOUR AD - Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Internal Medicine, Lampang Hospital, Lampang, Thailand Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Department of Anatomy, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand AU - Tantiworawit, A. AU - Kongjarern, S. AU - Rattarittamrong, E. AU - Lekawanvijit, S. AU - Bumroongkit, K. AU - Boonma, N. AU - Rattanathammethee, T. AU - Hantrakool, S. AU - Chai-Adisaksopha, C. AU - Norasetthada, L. DB - Scopus DO - 10.7314/APJCP.2016.17.4.2159 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 2159-2164 ST - Diagnosis and monitoring of chronic myeloid leukemia: Chiang Mai university experience T2 - Asian Pacific Journal of Cancer Prevention TI - Diagnosis and monitoring of chronic myeloid leukemia: Chiang Mai university experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973098756&doi=10.7314%2fAPJCP.2016.17.4.2159&partnerID=40&md5=a1e5220f4f88ceff68283ef6e4672ad5 VL - 17 ID - 5637 ER - TY - JOUR AD - M. F. Benner, Department of Dermatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands AU - Benner, M. F. AU - Jansen, P. M. AU - Meijer, C. J. L. M. AU - Willemze, R. DB - Embase Medline DO - 10.1111/j.1365-2133.2009.09147.x IS - 1 LA - English M3 - Article N1 - L354862617 2009-08-25 PY - 2009 SN - 0007-0963 1365-2133 SP - 121-127 ST - Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders T2 - British Journal of Dermatology TI - Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354862617&from=exporthttp://dx.doi.org/10.1111/j.1365-2133.2009.09147.x VL - 161 ID - 5638 ER - TY - JOUR AD - F. Casamenti, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy AU - Nardiello, P. AU - Pantano, D. AU - Lapucci, A. AU - Stefani, M. AU - Casamenti, F. DB - Embase Medline DO - 10.3233/JAD-171124 IS - 3 LA - English M3 - Article N1 - L622275486 2018-05-29 2018-05-31 PY - 2018 SN - 1875-8908 1387-2877 SP - 1161-1172 ST - Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition T2 - Journal of Alzheimer's Disease TI - Diet Supplementation with Hydroxytyrosol Ameliorates Brain Pathology and Restores Cognitive Functions in a Mouse Model of Amyloid-β Deposition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622275486&from=exporthttp://dx.doi.org/10.3233/JAD-171124 VL - 63 ID - 5639 ER - TY - JOUR AD - F.E. Ahmed, GEM Tox Consultants and Labs, Inc., 2607 Calvin Way, Greenville, NC 27834, United States AU - Ahmed, F. E. AU - Vos, P. W. AU - Jeffries, C. AU - Wiley, J. E. AU - Weidner, D. A. AU - Mota, H. AU - Bonnerup, C. AU - Sibata, C. AU - Allison, R. R. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L354607410 2009-06-02 PY - 2009 SN - 1790-6245 1109-6535 SP - 109-128 ST - Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensity-modulated radiation therapy (IMRT), or conventional radiation therapy (RT) T2 - Cancer Genomics and Proteomics TI - Differences in mRNA and microRNA microarray expression profiles in human colon adenocarcinoma HT-29 cells treated with either intensity-modulated radiation therapy (IMRT), or conventional radiation therapy (RT) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354607410&from=export VL - 6 ID - 5640 ER - TY - JOUR AD - Department of Institute of Hematology and Medical Oncology, L and A Seràgnoli S Orsola Malpighi Hospital, University of Bologna, Via Massarenti, Bologna 9-40138, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Turin, Italy Gruppo Italiano Malattie Ematologiche Maligne DellAdulto (GIMEMA) Data Center, GIMEMA Foundation, Rome, Italy Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy Department of Pathology, Section of General Pathology, University of Verona, Verona, Italy AU - Iacobucci, I. AU - Lonetti, A. AU - Messa, F. AU - Ferrari, A. AU - Cilloni, D. AU - Soverini, S. AU - Paoloni, F. AU - Arruga, F. AU - Ottaviani, E. AU - Chiaretti, S. AU - Messina, M. AU - Vignetti, M. AU - Papayannidis, C. AU - Vitale, A. AU - Pane, F. AU - Piccaluga, P. P. AU - Paolini, S. AU - Berton, G. AU - Baruzzi, A. AU - Saglio, G. AU - Baccarani, M. AU - Fo, R. AU - Martinelli, G. DB - Scopus DO - 10.1038/leu.2009.197 IS - 1 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2010 SP - 66-73 ST - Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients T2 - Leukemia TI - Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74249101770&doi=10.1038%2fleu.2009.197&partnerID=40&md5=0c2f5c6624baf0e16c939585e06f68fc VL - 24 ID - 5641 ER - TY - JOUR AD - R. González-Cámpora, Department of Pathology, University Hospital Virgen Macarena, Avda. Dr Fedriani s/n, 41009 Seville, Spain AU - Ríos-Moreno, M. J. AU - Jaramillo, S. AU - Díaz-Delgado, M. AU - Sánchez-León, M. AU - Trigo-Sánchez, I. AU - Polo Padillo, J. AU - Amérigo, J. AU - González-Cámpora, R. DB - Embase Medline IS - 9 LA - English M3 - Article N1 - L362333311 2011-08-22 PY - 2011 SN - 0250-7005 SP - 3019-3025 ST - Differential activation of MAPK and PI3K/AKT/mTOR pathways and IGF1R expression in gastrointestinal stromal tumors T2 - Anticancer Research TI - Differential activation of MAPK and PI3K/AKT/mTOR pathways and IGF1R expression in gastrointestinal stromal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362333311&from=export VL - 31 ID - 5642 ER - TY - JOUR AD - Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. AN - 24057326 AU - Cykowski, M. D. AU - Allen, R. A. AU - Kanaly, A. C. AU - Fung, K. M. AU - Marshall, R. AU - Perry, A. AU - Stolzenberg, E. D. AU - Dunn, S. T. DA - Dec DO - 10.1007/s11060-013-1249-5 10.1007/s11060-013-1249-5. Epub 2013 Sep 21. DP - Nlm ET - 2013/09/24 IS - 3 LA - eng PY - 2013 SN - 0167-594x SP - 477-86 ST - The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features T2 - J Neurooncol TI - The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features VL - 115 ID - 5643 ER - TY - JOUR AD - P.B. McCray, Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA, United States AU - Winder, A. A. AU - Wohlford-Lenane, C. AU - Scheetz, T. E. AU - Nardy, B. N. AU - Manzel, L. J. AU - Look, D. C. AU - McCray Jr, P. B. C2 - Sigma(United States) DB - Embase Medline DO - 10.1186/1465-9921-10-96 LA - English M3 - Article N1 - L361205848 2011-02-09 2011-02-22 PY - 2009 SN - 1465-9921 1465-993X ST - Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epithelia T2 - Respiratory Research TI - Differential effects of cytokines and corticosteroids on Toll-like receptor 2 expression and activity in human airway epithelia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361205848&from=exporthttp://dx.doi.org/10.1186/1465-9921-10-96http://respiratory-research.com/content/10/1/96 VL - 10 ID - 5644 ER - TY - JOUR AD - Pharmacogenomics and Drug Development Group, Discipline of Pharmacology, School of Medical Sciences, Sydney Medical School, University of SydneyNSW 2006, Australia Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Imperial College London, Hammersmith Campus, United Kingdom School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia AU - Murray, M. AU - Gillani, T. B. AU - Ghassabian, S. AU - Edwards, R. J. AU - Rawling, T. DB - Scopus DO - 10.1016/j.ejps.2017.12.003 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 SP - 55-63 ST - Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver T2 - European Journal of Pharmaceutical Sciences TI - Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037634876&doi=10.1016%2fj.ejps.2017.12.003&partnerID=40&md5=f82c3f4d3d01fed1b7acc8cd60eed9be VL - 114 ID - 5645 ER - TY - JOUR AD - A. Banerjee, Vaccine and Infectious Disease Research Center (VIDRC), Translational Health Science and Technology Institute (THSTI), NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, PO box #04, Faridabad, India AU - Goswami, S. AU - Banerjee, A. AU - Kumari, B. AU - Bandopadhyay, B. AU - Bhattacharya, N. AU - Basu, N. AU - Vrati, S. AU - Banerjee, A. DB - Embase Medline DO - 10.1007/s12035-016-9764-y IS - 2 LA - English M3 - Article N1 - L608267810 2016-02-16 2017-03-07 PY - 2017 SN - 1559-1182 0893-7648 SP - 1541-1551 ST - Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus T2 - Molecular Neurobiology TI - Differential Expression and Significance of Circulating microRNAs in Cerebrospinal Fluid of Acute Encephalitis Patients Infected with Japanese Encephalitis Virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608267810&from=exporthttp://dx.doi.org/10.1007/s12035-016-9764-y VL - 54 ID - 5646 ER - TY - JOUR AD - Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA. jarbise@emory.edu AN - 11174372 AU - Arbiser, J. L. AU - Weiss, S. W. AU - Arbiser, Z. K. AU - Bravo, F. AU - Govindajaran, B. AU - Caceres-Rios, H. AU - Cotsonis, G. AU - Recavarren, S. AU - Swerlick, R. A. AU - Cohen, C. DA - Feb DO - 10.1067/mjd.2000.111632 10.1067/mjd.2000.111632. DP - Nlm ET - 2001/02/15 IS - 2 LA - eng PY - 2001 SN - 0190-9622 (Print) 0190-9622 SP - 193-7 ST - Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy T2 - J Am Acad Dermatol TI - Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy VL - 44 ID - 5647 ER - TY - JOUR AD - Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China. Electronic address: liangweiguo@tom.com. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. Guangzhou Institute of Traumatic Surgery, The Fourth Affiliated Hospital of Medical College, Jinan University, Guangzhou 510220, China; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Australia. Electronic address: jiake.xu@uwa.edu.au. AN - 24857985 AU - Liang, W. AU - Fang, D. AU - Ye, D. AU - Zou, L. AU - Shen, Y. AU - Dai, L. AU - Xu, J. DA - Jul 11 DO - 10.1016/j.bbrc.2014.05.042 10.1016/j.bbrc.2014.05.042. Epub 2014 May 21. DP - Nlm ET - 2014/05/27 IS - 4 LA - eng PY - 2014 SN - 0006-291x SP - 466-70 ST - Differential expression of extracellular-signal-regulated kinase 5 (ERK5) in normal and degenerated human nucleus pulposus tissues and cells T2 - Biochem Biophys Res Commun TI - Differential expression of extracellular-signal-regulated kinase 5 (ERK5) in normal and degenerated human nucleus pulposus tissues and cells VL - 449 ID - 5648 ER - TY - JOUR AD - C.S. Venegas López, Hospital General de México, Dept. of Pathology, Ciudad De México, Mexico AU - Venegas López, C. S. AU - Pilar Eguía-Aguilar, M. D. AU - Pérezpeña-Díazconti, J. M. AU - García-Quintana, J. AU - Aguirre Hernández, J. AU - Valencia Mayoral, P. AU - Luna Hernández, A. DB - Embase DO - 10.1007/s00428-018-2422-1 LA - English M3 - Conference Abstract N1 - L623968534 2018-09-25 PY - 2018 SN - 1432-2307 SP - 310 ST - Differential expression of microRNAs in mesenchymal hamartoma and undifferentiated embryonal sarcoma T2 - Virchows Archiv TI - Differential expression of microRNAs in mesenchymal hamartoma and undifferentiated embryonal sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623968534&from=exporthttp://dx.doi.org/10.1007/s00428-018-2422-1 VL - 473 ID - 5649 ER - TY - JOUR AD - X. Wu, Department of Dermatology and Venereology, People's Hospital of Xinjiang, No. 91, Tianchi Road, Uygur Autonomous Region, Urumqi, Xinjiang, China AU - Wu, X. AU - Zhao, Z. AU - Ding, Y. AU - Xiang, F. AU - Kang, X. AU - Pu, X. DB - Embase Medline DO - 10.1097/MD.0000000000009928 IS - 7 LA - English M3 - Article N1 - L620853705 2018-03-01 2018-03-07 PY - 2018 SN - 1536-5964 0025-7974 ST - Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province T2 - Medicine (United States) TI - Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620853705&from=exporthttp://dx.doi.org/10.1097/MD.0000000000009928 VL - 97 ID - 5650 ER - TY - JOUR AD - Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37332, USA. mary.ann.thompson@vanderbilt.edu AN - 15948116 AU - Thompson, M. A. AU - Stumph, J. AU - Henrickson, S. E. AU - Rosenwald, A. AU - Wang, Q. AU - Olson, S. AU - Brandt, S. J. AU - Roberts, J. AU - Zhang, X. AU - Shyr, Y. AU - Kinney, M. C. DA - May DO - 10.1016/j.humpath.2005.03.004 10.1016/j.humpath.2005.03.004. DP - Nlm ET - 2005/06/11 IS - 5 LA - eng PY - 2005 SN - 0046-8177 (Print) 0046-8177 SP - 494-504 ST - Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas T2 - Hum Pathol TI - Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas VL - 36 ID - 5651 ER - TY - JOUR AD - S.M. de la Monte, Rhode Island Hospital, Brown Medical School, Brown University, Providence, RI, United States AU - Lahousse, S. A. AU - Carter, J. J. AU - Xu, X. J. AU - Wands, J. R. AU - de la Monte, S. M. DB - Embase Medline DO - 10.1186/1471-2121-7-41 LA - English M3 - Article N1 - L46158171 2007-02-27 PY - 2006 SN - 1471-2121 ST - Differential growth factor regulation of aspartyl-(asparaginyl)-β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells T2 - BMC Cell Biology TI - Differential growth factor regulation of aspartyl-(asparaginyl)-β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46158171&from=exporthttp://dx.doi.org/10.1186/1471-2121-7-41 VL - 7 ID - 5652 ER - TY - JOUR AD - M.B. Hershenson, Medical Sciences Research Building II, 1150 W. Medical Center Drive, Ann Arbor, MI 48109-0688, United States AU - Ramirez, I. A. AU - Caverly, L. L. AU - Kalikin, L. M. AU - Goldsmith, A. M. AU - Lewis, T. C. AU - Burke, D. T. AU - LiPuma, J. J. AU - Sajjan, U. S. AU - Hershenson, M. B. DB - Embase Medline DO - 10.1513/AnnalsATS.201310-346OC IS - 4 LA - English M3 - Article N1 - L373432605 2014-07-10 2014-07-16 PY - 2014 SN - 2325-6621 SP - 554-561 ST - Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis T2 - Annals of the American Thoracic Society TI - Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373432605&from=exporthttp://dx.doi.org/10.1513/AnnalsATS.201310-346OC VL - 11 ID - 5653 ER - TY - JOUR AD - G.P. Yang, Department of Surgery, Stanford University Medical School, Stanford, CA, United States AU - Xia, W. AU - Phan, T. T. AU - Lim, I. J. AU - Longaker, M. T. AU - Yang, G. P. DB - Embase Medline DO - 10.1016/j.jss.2006.01.031 IS - 1 LA - English M3 - Article N1 - L44215903 2006-08-30 PY - 2006 SN - 0022-4804 1095-8673 SP - 156-163 ST - Differential Transcriptional Responses of Keloid and Normal Keratinocytes to Serum Stimulation T2 - Journal of Surgical Research TI - Differential Transcriptional Responses of Keloid and Normal Keratinocytes to Serum Stimulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44215903&from=exporthttp://dx.doi.org/10.1016/j.jss.2006.01.031 VL - 135 ID - 5654 ER - TY - JOUR AD - Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People's Republic of China; Department of Neurosurgery, Beijing Fengtai You'anmen Hospital, Beijing, People's Republic of China. Department of Neurosurgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China. Electronic address: mengguolu@sina.com. Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, People's Republic of China. Department of Neurosurgery, Beijing Fengtai You'anmen Hospital, Beijing, People's Republic of China. Department of Neurosurgery, Jiangyin Hospital, Medical School of Southeast University, Jiangsu Province, People's Republic of China. Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China. AN - 29454117 AU - Lin, X. AU - Meng, G. AU - Liu, X. AU - Yu, T. AU - Bai, C. AU - Fei, X. AU - Deng, S. AU - Zhao, J. AU - Ren, S. AU - Zhang, J. AU - Wu, Z. AU - Wang, S. AU - Zhang, J. AU - Zhang, L. DA - May DO - 10.1016/j.wneu.2018.02.002 10.1016/j.wneu.2018.02.002. Epub 2018 Feb 14. DP - Nlm ET - 2018/02/18 LA - eng PY - 2018 SN - 1878-8750 SP - e247-e270 ST - The Differentially Expressed Genes of Human Sporadic Cerebral Cavernous Malformations T2 - World Neurosurg TI - The Differentially Expressed Genes of Human Sporadic Cerebral Cavernous Malformations VL - 113 ID - 5655 ER - TY - JOUR AD - J. Hamm, University of Alabama at Birmingham, Birmingham, AL, United States AU - Hamm, J. AU - Cleveland, D. S. AU - Cramer, S. AU - Whelan, K. DB - Embase DO - 10.1002/pbc.25540 LA - English M3 - Conference Abstract N1 - L613190905 2016-11-17 PY - 2015 SN - 1545-5017 SP - S71-S72 ST - Difficult diagnosis and treatment of an adolescent renal tumor T2 - Pediatric Blood and Cancer TI - Difficult diagnosis and treatment of an adolescent renal tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613190905&from=exporthttp://dx.doi.org/10.1002/pbc.25540 VL - 62 ID - 5656 ER - TY - JOUR AD - A.J.M. Ferreri, Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy AU - Martelli, M. AU - Ferreri, A. J. M. AU - Agostinelli, C. AU - Di Rocco, A. AU - Pfreundschuh, M. AU - Pileri, S. A. DB - Embase Medline DO - 10.1016/j.critrevonc.2012.12.009 IS - 2 LA - English M3 - Review N1 - L52418664 2013-02-01 2013-08-23 PY - 2013 SN - 1040-8428 1879-0461 SP - 146-171 ST - Diffuse large B-cell lymphoma T2 - Critical Reviews in Oncology/Hematology TI - Diffuse large B-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52418664&from=exporthttp://dx.doi.org/10.1016/j.critrevonc.2012.12.009 VL - 87 ID - 5657 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, University Hospital of Essen, Essen, Germany. AN - 17464312 AU - Sheu, S. Y. AU - Schwertheim, S. AU - Worm, K. AU - Grabellus, F. AU - Schmid, K. W. DA - Jul DO - 10.1038/modpathol.3800797 10.1038/modpathol.3800797. Epub 2007 Apr 27. DP - Nlm ET - 2007/04/28 IS - 7 LA - eng PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 779-87 ST - Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements T2 - Mod Pathol TI - Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements VL - 20 ID - 5658 ER - TY - JOUR AD - V. Winnepenninckx, Department of Pathology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center (MUMC+), Maastricht, Netherlands AU - Hillen, L. M. AU - Geybels, M. S. AU - Spassova, I. AU - Becker, J. C. AU - Gambichler, T. AU - Garmyn, M. AU - zur Hausen, A. AU - van den Oord, J. AU - Winnepenninckx, V. DB - Embase Medline DO - 10.1002/2211-5463.12897 IS - 7 LA - English M3 - Article N1 - L2005154154 2020-06-10 2020-07-15 PY - 2020 SN - 2211-5463 SP - 1326-1341 ST - A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms T2 - FEBS Open Bio TI - A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005154154&from=exporthttp://dx.doi.org/10.1002/2211-5463.12897 VL - 10 ID - 5659 ER - TY - JOUR AD - A.E. Frankel, NB102.S, Simmons Cancer Center, 2201 Inwood Road, Dallas, TX, United States AU - Frankel, A. E. AU - Eskiocak, U. AU - Gill, J. G. AU - Yuan, S. AU - Ramesh, V. AU - Froehlich, T. W. AU - Ahn, C. AU - Morrison, S. J. C2 - Glaxo SmithKline jerome stevens Selleck Sigma DB - Embase Medline DO - 10.1016/j.neo.2017.01.010 IS - 4 LA - English M3 - Article N1 - L615174119 2017-04-10 2017-04-11 PY - 2017 SN - 1476-5586 1522-8002 SP - 255-260 ST - Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients T2 - Neoplasia (United States) TI - Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615174119&from=exporthttp://dx.doi.org/10.1016/j.neo.2017.01.010 VL - 19 ID - 5660 ER - TY - JOUR AD - L. Zhong, Department of Gastroenterology, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, Shanghai, China AU - Zhao, M. AU - Chen, J. AU - Zhu, P. AU - Fujino, M. AU - Takahara, T. AU - Toyama, S. AU - Tomita, A. AU - Zhao, L. AU - Yang, Z. AU - Hei, M. AU - Zhong, L. AU - Zhuang, J. AU - Kimura, S. AU - Li, X. K. C2 - dhq(Japan) DB - Embase Medline DO - 10.1016/j.intimp.2015.04.032 IS - 2 LA - English M3 - Article N1 - L604393017 2015-05-20 2015-12-08 PY - 2015 SN - 1878-1705 1567-5769 SP - 938-944 ST - Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells T2 - International Immunopharmacology TI - Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604393017&from=exporthttp://dx.doi.org/10.1016/j.intimp.2015.04.032 VL - 28 ID - 5661 ER - TY - JOUR AD - M. Firczuk, Department of Immunology, Medical University of Warsaw, Warsaw, Poland AU - Trzeciecka, A. AU - Klossowski, S. AU - Bajor, M. AU - Zagozdzon, R. AU - Gaj, P. AU - Muchowicz, A. AU - Malinowska, A. AU - Czerwoniec, A. AU - Barankiewicz, J. AU - Domagala, A. AU - Chlebowska, J. AU - Prochorec-Sobieszek, M. AU - Winiarska, M. AU - Ostaszewski, R. AU - Gwizdalska, I. AU - Golab, J. AU - Nowis, D. AU - Firczuk, M. DB - Embase Medline DO - 10.18632/oncotarget.6435 IS - 2 LA - English M3 - Article N1 - L608271560 2016-02-16 2016-02-23 PY - 2016 SN - 1949-2553 SP - 1717-1731 ST - Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma T2 - Oncotarget TI - Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608271560&from=exporthttp://dx.doi.org/10.18632/oncotarget.6435 VL - 7 ID - 5662 ER - TY - JOUR AD - J.H. Foster, Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, 6701 Fannin St., Houston, TX, United States AU - Greenwood, K. AU - Foster, J. H. DB - Embase Medline DO - 10.1358/DOT.2017.53.9.2693023 IS - 9 LA - English M3 - Article N1 - L620051629 2018-01-08 2018-01-11 PY - 2017 SN - 1699-4019 1699-3993 SP - 469-476 ST - Dinutuximab for the treatment of pediatric patients with neuroblastoma T2 - Drugs of Today TI - Dinutuximab for the treatment of pediatric patients with neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620051629&from=exporthttp://dx.doi.org/10.1358/DOT.2017.53.9.2693023 VL - 53 ID - 5663 ER - TY - JOUR AD - Division of Hematology and Bone Marrow Transplant, Max Super-specialty Hospital, 1 and 2 Press Enclave Marg, Saket Institutional Area, Saket, New Delhi, 110017, India AU - Jeyaraman, P. AU - Naithani, R. DB - Scopus DO - 10.1097/MPH.0000000000001624 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - e64-e65 ST - Discontinuation of Imatinib in a Child with Chronic Myeloid Leukemia T2 - Journal of Pediatric Hematology/Oncology TI - Discontinuation of Imatinib in a Child with Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074465964&doi=10.1097%2fMPH.0000000000001624&partnerID=40&md5=7a612b6d740b1e8c923a76f152cbbd20 VL - 42 ID - 5664 ER - TY - JOUR AD - Department of Genetics, Portuguese Oncology Institute, Porto, Portugal Department of Onco-Haematology, Portuguese Oncology Institute, Porto, Portugal Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal AN - 133518468. Language: English. Entry Date: In Process. Revision Date: 20190403. Publication Type: journal article. Journal Subset: Biomedical AU - Cerveira, Nuno AU - Loureiro, Bruno AU - Bizarro, Susana AU - Correia, Cecília AU - Torres, Lurdes AU - Lisboa, Susana AU - Vieira, Joana AU - Santos, Rui AU - Pereira, Dulcineia AU - Moreira, Cláudia AU - Chacim, Sérgio AU - Domingues, Nélson AU - Espírito-Santo, Ana AU - Oliveira, Isabel AU - Moreira, Ilídia AU - Viterbo, Luísa AU - Martins, Ângelo AU - Teixeira, Manuel R. AU - Mariz, José M. DB - ccm DO - 10.1186/s12885-018-5167-y DP - EBSCOhost IS - 1 N1 - Europe; UK & Ireland. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). NLM UID: 100967800. PMID: NLM30541488. PY - 2018 SN - 1471-2407 SP - 1-10 ST - Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution T2 - BMC Cancer TI - Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133518468&site=ehost-live&scope=site VL - 18 ID - 5665 ER - TY - JOUR AD - Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Division of Hematology, Oncology, and Blood & Bone Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, CA, USA. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. The Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Division of Pediatric Oncology, Johns Hopkins University, Baltimore, MD, USA. AN - 25638158 AU - Weingart, M. F. AU - Roth, J. J. AU - Hutt-Cabezas, M. AU - Busse, T. M. AU - Kaur, H. AU - Price, A. AU - Maynard, R. AU - Rubens, J. AU - Taylor, I. AU - Mao, X. G. AU - Xu, J. AU - Kuwahara, Y. AU - Allen, S. J. AU - Erdreich-Epstein, A. AU - Weissman, B. E. AU - Orr, B. A. AU - Eberhart, C. G. AU - Biegel, J. A. AU - Raabe, E. H. C2 - PMC4413645 DA - Feb 20 DO - 10.18632/oncotarget.3078 10.18632/oncotarget.3078. DP - Nlm ET - 2015/02/02 IS - 5 LA - eng PY - 2015 SN - 1949-2553 SP - 3165-77 ST - Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target T2 - Oncotarget TI - Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target VL - 6 ID - 5666 ER - TY - JOUR AD - M. Higashi, Kyoto Prefectural University of Medicine, Kyoto, Japan AU - Higashi, M. AU - Kin, K. AU - Tajiri, T. DB - Embase DO - 10.1158/1535-7163.TARG-17-B091 IS - 1 LA - English M3 - Conference Abstract N1 - L620384280 2018-02-01 PY - 2018 SN - 1538-8514 ST - Disruption of cancer stemness by targeting the JNK-STAT3 pathway in neuroblastoma T2 - Molecular Cancer Therapeutics TI - Disruption of cancer stemness by targeting the JNK-STAT3 pathway in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620384280&from=exporthttp://dx.doi.org/10.1158/1535-7163.TARG-17-B091 VL - 17 ID - 5667 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas. Pediatrics Neuro-oncology Program, MD Anderson Cancer Center, Houston, Texas. AN - 31502413 AU - Phadnis, S. S. AU - Chen, L. AU - Wang, W. L. AU - Migden, M. R. AU - Zaky, W. DA - Dec DO - 10.1002/pbc.27974 10.1002/pbc.27974. Epub 2019 Sep 10. DP - Nlm ET - 2019/09/11 IS - 12 LA - eng PY - 2019 SN - 1545-5009 SP - e27974 ST - Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy T2 - Pediatr Blood Cancer TI - Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy VL - 66 ID - 5668 ER - TY - JOUR AD - Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. ajdodgshun@gmail.com. Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia. ajdodgshun@gmail.com. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Longwood Ave, Boston, 02115, USA. Harvard Medical School, Boston, MA, USA. Department of Medical Oncology, Dana-Faber Cancer Institute, Boston, 02115, USA. Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. Department of Pathology, Boston Children's Hospital, Boston, MA, USA. Department of Pathology, Royal Children's Hospital, Melbourne, VIC, 3052, Australia. Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Department of Neurosurgery, Harvard Medical School, Boston, MA, USA. Children's Cancer Centre, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. Murdoch Children's Research Institute, Melbourne, VIC, 3052, Australia. Broad Institute of MIT and Harvard, Cambridge, USA. Department of Pathology, Harvard Medical School, Boston, MA, USA. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, USA. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Longwood Ave, Boston, 02115, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Harvard Medical School, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Broad Institute of MIT and Harvard, Cambridge, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu. AN - 26994902 AU - Dodgshun, A. J. AU - SantaCruz, N. AU - Hwang, J. AU - Ramkissoon, S. H. AU - Malkin, H. AU - Bergthold, G. AU - Manley, P. AU - Chi, S. AU - MacGregor, D. AU - Goumnerova, L. AU - Sullivan, M. AU - Ligon, K. AU - Beroukhim, R. AU - Herrington, B. AU - Kieran, M. W. AU - Hansford, J. R. AU - Bandopadhayay, P. DA - Jun DO - 10.1007/s11060-016-2109-x 10.1007/s11060-016-2109-x. Epub 2016 Mar 19. DP - Nlm ET - 2016/03/21 IS - 2 LA - eng PY - 2016 SN - 0167-594x SP - 293-302 ST - Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation T2 - J Neurooncol TI - Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation VL - 128 ID - 5669 ER - TY - JOUR AD - J. Wyss, Paediatric Haematology and Oncology, London, United Kingdom AU - Wyss, J. AU - Slater, O. AU - Jacques, T. AU - Jorgensen, M. DB - Embase LA - English M3 - Conference Abstract N1 - L626848529 2019-03-26 PY - 2018 SN - 1424-3997 SP - 46S-47S ST - Disseminated isolated intracranial juvenile xanthogranuloma T2 - Swiss Medical Weekly TI - Disseminated isolated intracranial juvenile xanthogranuloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626848529&from=export VL - 147 ID - 5670 ER - TY - JOUR AD - III. Medizinische Klinik - Hämatologie und Onkologie, Universitätsmedizin Mannheim, Germany Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie der Ludwig-Maximilians, Universität München, Germany MLL Münchner Leukämielabor, München, Germany Medizinische Klinik 5, Universitätsklinikum Erlangen, Germany Klinik für Hämatologie, Onkologie und Palliativmedizin, Evangelisches Krankenhaus Hamm, Germany Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Germany Klinik für Innere Medizin III, Klinikum Chemnitz, Germany Medizinische Universitätsklinik, Abteilung Innere Medizin V, Ruprecht-Karls-Universität Heidelberg, Germany Medizinische Klinik 5, Klinikum Nürnberg Nord, Germany Medizinische Klinik II, Universitätsklinikum Tübingen, Germany Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Marburg, Germany II. Medizinische Klinik und Poliklinik im Städtischen Krankenhaus, Universitätsklinikum Schleswig-Holstein, Kiel, Germany Klinik für Innere Medizin III, Universitätsklinikum Ulm, Germany Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany Klinik für Innere Medizin I, Universitätsklinikum Freiburg, Germany Medizinische Klinik und Poliklinik III, Ludwig-Maximilians-Universität München, Germany Universitätsklinik für Hämatologie, Inselspital Bern, Switzerland Abteilung für Hämatologie und Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Germany AU - Hanfstein, B. AU - Lauseker, M. AU - Hehlmann, R. AU - Saussele, S. AU - Erben, P. AU - Dietz, C. AU - Fabarius, A. AU - Proetel, U. AU - Schnittger, S. AU - Haferlach, C. AU - Krause, S. W. AU - Schubert, J. AU - Einsele, H. AU - Hänel, M. AU - Dengler, J. AU - Falge, C. AU - Kanz, L. AU - Neubauer, A. AU - Kneba, M. AU - Stegelmann, F. AU - Pfreundschuh, M. AU - Waller, C. F. AU - Spiekermann, K. AU - Baerlocher, G. M. AU - Pfirrmann, M. AU - Hasford, J. AU - Hofmann, W. K. AU - Hochhaus, A. AU - Müller, M. C. DB - Scopus DO - 10.3324/haematol.2013.096537 IS - 9 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2014 SP - 1441-1447 ST - Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib T2 - Haematologica TI - Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907371261&doi=10.3324%2fhaematol.2013.096537&partnerID=40&md5=91a6886316843ab1a4dd63df811c3859 VL - 99 ID - 5671 ER - TY - JOUR AD - G.A. McArthur, Division of Clinical Haematology and Medical Oncology, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Vic. 3002, Australia AU - Liu, W. AU - Kelly, J. W. AU - Trivett, M. AU - Murray, W. K. AU - Dowling, J. P. AU - Wolfe, R. AU - Mason, G. AU - Magee, J. AU - Angel, C. AU - Dobrovic, A. AU - McArthur, G. A. DB - Embase Medline DO - 10.1038/sj.jid.5700632 IS - 4 LA - English M3 - Article N1 - L46434654 2007-04-11 PY - 2007 SN - 0022-202X 1523-1747 SP - 900-905 ST - Distinct clinical and pathological features are associated with the BRAFT1799A(V600E) mutation in primary melanoma T2 - Journal of Investigative Dermatology TI - Distinct clinical and pathological features are associated with the BRAFT1799A(V600E) mutation in primary melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46434654&from=exporthttp://dx.doi.org/10.1038/sj.jid.5700632 VL - 127 ID - 5672 ER - TY - JOUR AD - Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea AU - Lee, T. Y. AU - Lee, S. AU - Bae, J. S. AU - Park, W. C. AU - Park, S. S. AU - Lee, S. E. AU - Lee, J. W. AU - Kim, S. K. AU - Cho, B. AU - Jung, C. K. DB - Scopus DO - 10.1245/s10434-019-07442-4 IS - 11 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 3586-3592 ST - Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation T2 - Annals of Surgical Oncology TI - Distinct Clinical Manifestations of Thyroid Cancer After Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066055089&doi=10.1245%2fs10434-019-07442-4&partnerID=40&md5=02564458e5c9c34bfe54797193391ee8 VL - 26 ID - 5673 ER - TY - JOUR AD - Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand. AN - 20854070 AU - Jovanovic, L. AU - Delahunt, B. AU - McIver, B. AU - Eberhardt, N. L. AU - Bhattacharya, A. AU - Lea, R. AU - Grebe, S. K. DO - 10.3109/00313025.2010.508780 10.3109/00313025.2010.508780. DP - Nlm ET - 2010/09/22 IS - 6 LA - eng PY - 2010 SN - 0031-3025 SP - 524-33 ST - Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma T2 - Pathology TI - Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma VL - 42 ID - 5674 ER - TY - JOUR AD - C.-P. Chiang, Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan AU - Gao, H. W. AU - Tsai, W. C. AU - Perng, C. L. AU - Wang, W. M. AU - Chiang, C. P. DB - Embase Medline DO - 10.1684/ejd.2018.3359 IS - 4 LA - English M3 - Article N1 - L624877894 2019-01-11 2019-04-19 PY - 2018 SN - 1952-4013 1167-1122 SP - 509-518 ST - Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals T2 - European Journal of Dermatology TI - Distinct MAPK and PI3K pathway mutations in different melanoma types in Taiwanese individuals UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624877894&from=exporthttp://dx.doi.org/10.1684/ejd.2018.3359 VL - 28 ID - 5675 ER - TY - JOUR AD - Academisch Ziekenhuis, Vrije Universiteit Brussel, Department of Dermatology, Belgium. AN - 16445780 AU - De Raeve, L. E. AU - Claes, A. AU - Ruiter, D. J. AU - van Muijen, G. N. AU - Roseeuw, D. AU - van Kempen, L. C. DA - Mar DO - 10.1111/j.1365-2133.2005.07055.x 10.1111/j.1365-2133.2005.07055.x. DP - Nlm ET - 2006/02/01 IS - 3 LA - eng PY - 2006 SN - 0007-0963 (Print) 0007-0963 SP - 485-92 ST - Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage T2 - Br J Dermatol TI - Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage VL - 154 ID - 5676 ER - TY - JOUR AD - Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA. AN - 18032947 AU - Wu, J. AU - Rosenbaum, E. AU - Begum, S. AU - Westra, W. H. DA - Dec DO - 10.1097/DAD.0b013e3181584950 10.1097/DAD.0b013e3181584950. DP - Nlm ET - 2007/11/23 IS - 6 LA - eng PY - 2007 SN - 0193-1091 SP - 534-7 ST - Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis T2 - Am J Dermatopathol TI - Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis VL - 29 ID - 5677 ER - TY - JOUR AD - Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan Department of Dermatology, Fukuoka University School of Medicine, Fukuoka, Japan AU - Ehara, Y. AU - Koga, M. AU - Imafuku, S. AU - Yamamoto, O. AU - Yoshida, Y. DB - Scopus DO - 10.1111/1346-8138.15194 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 190-192 ST - Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1 T2 - Journal of Dermatology TI - Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076765321&doi=10.1111%2f1346-8138.15194&partnerID=40&md5=838c685741f64208de90accd959d3e17 VL - 47 ID - 5678 ER - TY - JOUR AD - J.C. Malpartida AU - Malpartida, J. C. AU - Vick, E. AU - Richardson, N. H. AU - Patel, K. AU - Stein, M. K. AU - Martin, M. G. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617538242 2017-08-01 PY - 2017 SN - 0732-183X ST - Distribution of ETV6-NTRK3 translocations across neoplasms identified from the Mitelman Database T2 - Journal of Clinical Oncology TI - Distribution of ETV6-NTRK3 translocations across neoplasms identified from the Mitelman Database UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617538242&from=export VL - 35 ID - 5679 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, Justus-Liebig University, Giessen, Germany. AN - 19545284 AU - Damm-Welk, C. AU - Klapper, W. AU - Oschlies, I. AU - Gesk, S. AU - Röttgers, S. AU - Bradtke, J. AU - Siebert, R. AU - Reiter, A. AU - Woessmann, W. DA - Aug DO - 10.1111/j.1365-2141.2009.07754.x 10.1111/j.1365-2141.2009.07754.x. Epub 2009 May 26. DP - Nlm ET - 2009/06/24 IS - 3 LA - eng PY - 2009 SN - 0007-1048 SP - 306-9 ST - Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation T2 - Br J Haematol TI - Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation VL - 146 ID - 5680 ER - TY - JOUR AD - G. Rajashekhar, Indiana Univ. School of Medicine, Indiana Center of Vascular Biology and Medicine, IB464, 975 W. Walnut St., Indianapolis, IN 46202, United States AU - Rajashekhar, G. AU - Grow, M. AU - Willuweit, A. AU - Patterson, C. E. AU - Clauss, M. DB - Embase Medline DO - 10.1152/physiolgenomics.00157.2006 IS - 1 LA - English M3 - Article N1 - L47443852 2007-09-19 PY - 2007 SN - 1094-8341 1531-2267 SP - 104-113 ST - Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation T2 - Physiological Genomics TI - Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47443852&from=exporthttp://dx.doi.org/10.1152/physiolgenomics.00157.2006http://physiolgenomics.physiology.org/cgi/reprint/31/1/104 VL - 31 ID - 5681 ER - TY - JOUR AD - Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Internal Medicine Service, Hôpital Pitié–Salpêtrière, Paris, France Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, United States Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, United States Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN, United States Genome Technology Center, NYU Langone Medical Center, New York, NY, United States Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Foundation Medicine, Cambridge, MA, United States Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC, United States Hematopathology, Carolinas Pathology Group, Charlotte, NC, United States French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France EA4340, Versailles University, Boulogne-Billancourt, France Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Pathology Service, Hopital universitaire Ambroise Pare, APHP, Boulogne, France Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Diamond, E. L. AU - Durham, B. H. AU - Haroche, J. AU - Yao, Z. AU - Ma, J. AU - Parikh, S. A. AU - Wang, Z. AU - Choi, J. AU - Kim, E. AU - Cohen-Aubart, F. AU - Lee, S. C. W. AU - Gao, Y. AU - Micol, J. B. AU - Campbell, P. AU - Walsh, M. P. AU - Sylvester, B. AU - Dolgalev, I. AU - Aminova, O. AU - Heguy, A. AU - Zappile, P. AU - Nakitandwe, J. AU - Ganzel, C. AU - Dalton, J. D. AU - Ellison, D. W. AU - Estrada-Veras, J. AU - Lacouture, M. AU - Gahl, W. A. AU - Stephens, P. J. AU - Miller, V. A. AU - Ross, J. S. AU - Ali, S. M. AU - Briggs, S. R. AU - Fasan, O. AU - Block, J. AU - Heritier, S. AU - Donadieu, J. AU - Solit, D. B. AU - Hyman, D. M. AU - Baselga, J. AU - Janku, F. AU - Taylor, B. S. AU - Park, C. Y. AU - Amoura, Z. AU - Dogan, A. AU - Emile, J. F. AU - Rosen, N. AU - Gruber, T. A. AU - Abdel-Wahab, O. DB - Scopus DO - 10.1158/2159-8290.CD-15-0913 IS - 2 M3 - Article N1 - Cited By :180 Export Date: 18 November 2020 PY - 2016 SP - 154-165 ST - Diverse and targetable kinase alterations drive histiocytic neoplasms T2 - Cancer Discovery TI - Diverse and targetable kinase alterations drive histiocytic neoplasms UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957056573&doi=10.1158%2f2159-8290.CD-15-0913&partnerID=40&md5=a42cb4d24d65520872642d7e0d319595 VL - 6 ID - 5682 ER - TY - JOUR AU - Sahoo, D. AU - Abdul Wazid, M. AU - Gupta, A. K. AU - Meena, J. P. AU - Seth, R. DB - Embase DO - 10.1016/j.phoj.2019.08.071 IS - 2 LA - English M3 - Conference Abstract N1 - L2002713668 2019-09-05 PY - 2019 SN - 2468-1245 SP - S26 ST - Diverse clinical profile of children with anaplastic large cell lymphoma: a tertiary centre experience T2 - Pediatric Hematology Oncology Journal TI - Diverse clinical profile of children with anaplastic large cell lymphoma: a tertiary centre experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002713668&from=exporthttp://dx.doi.org/10.1016/j.phoj.2019.08.071 VL - 4 ID - 5683 ER - TY - JOUR AD - W.S. Choi, Department of Immunology and Physiology, Functional Genomics Institute, Konkuk University, Chungju 380-701, South Korea AU - Kim, D. K. AU - Kim, H. S. AU - Kim, A. R. AU - Kim, J. H. AU - Kim, B. AU - Noh, G. AU - Kim, H. S. AU - Beaven, M. A. AU - Kim, Y. M. AU - Choi, W. S. DB - Embase Medline DO - 10.1016/j.jaci.2012.10.012 IS - 6 LA - English M3 - Article N1 - L52315151 2012-11-26 2013-06-26 PY - 2013 SN - 0091-6749 1097-6825 SP - 1653-1662.e1 ST - DJ-1 regulates mast cell activation and IgE-mediated allergic responses T2 - Journal of Allergy and Clinical Immunology TI - DJ-1 regulates mast cell activation and IgE-mediated allergic responses UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52315151&from=exporthttp://dx.doi.org/10.1016/j.jaci.2012.10.012 VL - 131 ID - 5684 ER - TY - JOUR AD - F. Selt, CCU Pediatric Oncology (G340), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany AU - Selt, F. AU - Hohloch, J. AU - Gronych, J. AU - Marquardt, V. AU - Sahm, F. AU - Schuhmann, M. U. AU - Brummer, T. AU - Driever, P. H. AU - Thomale, U. W. AU - Bächli, H. AU - Kulozik, A. E. AU - Von Deimling, A. AU - Remke, M. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Milde, T. AU - Witt, O. DB - Embase DO - 10.1093/neuonc/now075.27 LA - English M3 - Conference Abstract N1 - L611934171 2016-09-07 PY - 2016 SN - 1523-5866 SP - iii84 ST - DKFZ-BT66-a novel pilocytic astrocytoma model for preclinical drug testing T2 - Neuro-Oncology TI - DKFZ-BT66-a novel pilocytic astrocytoma model for preclinical drug testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611934171&from=exporthttp://dx.doi.org/10.1093/neuonc/now075.27 VL - 18 ID - 5685 ER - TY - JOUR AD - Institute of Molecular Radiation Biology, Helmholtz Center Munich, German Research Center for Environmental Health GmbH, Neuherberg, Germany Department of Histopathology, Imperial College London Hammersmith Hospital, London, United Kingdom AU - Zitzelsberger, H. AU - Unger, K. DB - Scopus DO - 10.1016/j.clon.2011.01.154 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 289-296 ST - DNA Copy Number Alterations in Radiation-induced Thyroid Cancer T2 - Clinical Oncology TI - DNA Copy Number Alterations in Radiation-induced Thyroid Cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955039547&doi=10.1016%2fj.clon.2011.01.154&partnerID=40&md5=96a812c2e7a7c8a2dca99f3309b72158 VL - 23 ID - 5686 ER - TY - JOUR AD - D. Sheer, Barts and The London School of Medicine and Dentistry, Blizard Institute, London, United Kingdom AU - Sheer, D. AU - Jeyapalan, J. AU - Doctor, G. T. AU - Jones, T. A. AU - Alberman, S. N. AU - Tep, A. AU - Haria, C. M. AU - Schwalbe, E. C. AU - Clifford, S. C. AU - Tatevossian, R. G. AU - Qaddoumi, I. AU - Ellison, D. W. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189431 2016-11-17 PY - 2015 SN - 1545-5017 SP - S283-S284 ST - Dna methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific signature at a set of enhancers T2 - Pediatric Blood and Cancer TI - Dna methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific signature at a set of enhancers UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189431&from=exporthttp://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 5687 ER - TY - JOUR AD - S.-P. Lin, Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan AU - Liao, H. F. AU - Chen, W. S. C. AU - Chen, Y. H. AU - Kao, T. H. AU - Tseng, Y. T. AU - Lee, C. Y. AU - Chiu, Y. C. AU - Lee, P. L. AU - Lin, Q. J. AU - Ching, Y. H. AU - Hata, K. AU - Cheng, W. T. K. AU - Tsai, M. H. AU - Sasaki, H. AU - Ho, H. N. AU - Wu, S. C. AU - Huang, Y. H. AU - Yen, P. AU - Lin, S. P. DB - Embase Medline DO - 10.1242/dev.105130 IS - 12 LA - English M3 - Article N1 - L373276801 2014-06-19 2014-06-26 PY - 2014 SN - 1477-9129 0950-1991 SP - 2402-2413 ST - DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells T2 - Development (Cambridge) TI - DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373276801&from=exporthttp://dx.doi.org/10.1242/dev.105130 VL - 141 ID - 5688 ER - TY - JOUR AD - K. Shannon, 1450 Third Street, San Francisco, CA 94158, United States AU - Xu, J. AU - Haigis, K. M. AU - Firestone, A. J. AU - McNerney, M. E. AU - Li, Q. AU - Davis, E. AU - Chen, S. C. AU - Nakitandwe, J. AU - Downing, J. AU - Jacks, T. AU - Le Beau, M. M. AU - Shannon, K. C1 - pd0325901 DB - Embase Medline DO - 10.1158/2159-8290.CD-13-0096 IS - 9 LA - English M3 - Article N1 - L369991176 2013-10-17 2013-10-24 PY - 2013 SN - 2159-8274 2159-8290 SP - 993-1001 ST - Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation T2 - Cancer Discovery TI - Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369991176&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-13-0096http://cancerdiscovery.aacrjournals.org/content/3/9/993.full.pdf+html VL - 3 ID - 5689 ER - TY - JOUR AD - UCL Cancer Institute, Department of Haematology, Paul o'Gorman Building, 72 Huntley Street, London, WC1E 6BT, United Kingdom AU - Roddie, C. AU - Peggs, K. S. DB - Scopus DO - 10.1517/14712598.2011.554811 IS - 4 M3 - Review N1 - Cited By :73 Export Date: 18 November 2020 PY - 2011 SP - 473-487 ST - Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation T2 - Expert Opinion on Biological Therapy TI - Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952590640&doi=10.1517%2f14712598.2011.554811&partnerID=40&md5=9f9cdb80a2419fe9d6a52162b98dc1a7 VL - 11 ID - 5690 ER - TY - JOUR AD - Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan Department of Cell Therapy and Transplantation Medicine, Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan Hematology and Oncology Division, St. Luke's International Hospital, Tokyo, Japan AU - Miyamoto, T. AU - Fukuda, T. AU - Nakashima, M. AU - Henzan, T. AU - Kusakabe, S. AU - Kobayashi, N. AU - Sugita, J. AU - Mori, T. AU - Kurokawa, M. AU - Mori, S. I. AU - Medical Committee of Japan Marrow Donor Program, Japanese Data Center for Hematopoietic Cell Transplantation DB - Scopus DO - 10.1016/j.bbmt.2017.02.012 IS - 6 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2017 SP - 938-944 ST - Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program T2 - Biology of Blood and Marrow Transplantation TI - Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015759601&doi=10.1016%2fj.bbmt.2017.02.012&partnerID=40&md5=8eb3cadb4e8c49cb943a558dce951507 VL - 23 ID - 5691 ER - TY - JOUR AD - Eisai Co, Ltd, Tokyo, Japan Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Hepatology, Toranomon Hospital, Tokyo, Japan AN - 124659195. Language: English. Entry Date: 20170825. Revision Date: 20191111. Publication Type: Article AU - Tamai, Toshiyuki AU - Hayato, Seiichi AU - Hojo, Seiichiro AU - Suzuki, Takuya AU - Okusaka, Takuji AU - Ikeda, Kenji AU - Kumada, Hiromitsu DB - ccm DO - 10.1002/jcph.917 DP - EBSCOhost IS - 9 N1 - equations & formulas; research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: This study was funded by Eisai, Inc.. NLM UID: 0366372. PY - 2017 SN - 0091-2700 SP - 1138-1147 ST - Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses T2 - Journal of Clinical Pharmacology TI - Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124659195&site=ehost-live&scope=site VL - 57 ID - 5692 ER - TY - JOUR AD - B. Archambault, Duke University Medical Center, Durham, NC, United States AU - Archambault, B. AU - Landi, D. AU - Schroeder, K. DB - Embase DO - 10.1093/neuonc/noz175.854 LA - English M3 - Conference Abstract N1 - L631168740 2020-03-17 PY - 2019 SN - 1523-5866 SP - vi205 ST - Dose frequency modification of trametinib to mitigate severe rash and improve quality of life in pediatric low-grade glioma patients T2 - Neuro-Oncology TI - Dose frequency modification of trametinib to mitigate severe rash and improve quality of life in pediatric low-grade glioma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631168740&from=exporthttp://dx.doi.org/10.1093/neuonc/noz175.854 VL - 21 ID - 5693 ER - TY - JOUR AD - Division of Integrated Oncology, Institute of Biomedical Research and Innovation, Japan AU - Hata, A. AU - Fujita, S. AU - Kaji, R. AU - Nanjo, S. AU - Katakami, N. DB - Scopus DO - 10.2169/internalmedicine.52.8543 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2013 SP - 599-603 ST - Dose reduction or intermittent administration of erlotinib: Which is better for patients suffering from intolerable toxicities? T2 - Internal Medicine TI - Dose reduction or intermittent administration of erlotinib: Which is better for patients suffering from intolerable toxicities? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874742163&doi=10.2169%2finternalmedicine.52.8543&partnerID=40&md5=f8afe38796b708f735410734f9f2840f VL - 52 ID - 5694 ER - TY - JOUR AD - Y. Maeda AU - Maeda, Y. AU - Nishimori, H. AU - Hiramatsu, Y. AU - Yoshida, I. AU - Uno, M. AU - Masaki, Y. AU - Sunami, K. AU - Masunari, T. AU - Nawa, Y. AU - Gomyo, H. AU - Yamane, H. AU - Takahashi, T. AU - Yano, T. AU - Takimoto, H. AU - Matsuo, K. AU - Yoshino, T. AU - Tanimoto, M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614265735 2017-02-06 PY - 2016 SN - 1528-0020 ST - Dose-Adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: Multicenter phase II trial of west-jhog PTCL0707 T2 - Blood TI - Dose-Adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: Multicenter phase II trial of west-jhog PTCL0707 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614265735&from=export VL - 128 ID - 5695 ER - TY - JOUR AU - Kobus, K. AU - Hartl, D. AU - Ott, C. E. AU - Osswald, M. AU - Huebner, A. AU - Von Der Hagen, M. AU - Emmerich, D. AU - Kühnisch, J. AU - Morreau, H. AU - Hes, F. J. AU - Mautner, V. F. AU - Harder, A. AU - Tinschert, S. AU - Mundlos, S. AU - Kolanczyk, M. DB - Embase Medline DO - 10.1371/journal.pone.0119030 IS - 3 LA - English M3 - Article N1 - L603024271 2015-03-24 2015-03-30 PY - 2015 SN - 1932-6203 ST - Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient T2 - PLoS ONE TI - Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603024271&from=exporthttp://dx.doi.org/10.1371/journal.pone.0119030 VL - 10 ID - 5696 ER - TY - JOUR AD - Department of Prosthodontics, Shanghai Key Laboratory of Stomatology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Road, Shanghai, China Shanghai Key Laboratory of Orthopaedic Implant, Department of Orthopaedics Surgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, 639 Zhizaoju Road, Shanghai, China AU - Mao, C. Y. AU - Wang, Y. G. AU - Zhang, X. AU - Zheng, X. Y. AU - Tang, T. T. AU - Lu, E. Y. C7 - e2296 DB - Scopus DO - 10.1038/cddis.2016.204 IS - 7 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2016 ST - Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways T2 - Cell Death and Disease TI - Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019700567&doi=10.1038%2fcddis.2016.204&partnerID=40&md5=66d52e059b51871cfc43ad1ea43a3571 VL - 7 ID - 5697 ER - TY - JOUR AD - H. Arakawa, Department of Pediatrics and Developmental Medicine, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan AU - Tadaki, H. AU - Arakawa, H. AU - Mizuno, T. AU - Suzuki, T. AU - Takeyama, K. AU - Mochizuki, H. AU - Tokuyama, K. AU - Yokota, S. AU - Morikawa, A. DB - Embase Medline DO - 10.4049/jimmunol.182.1.293 IS - 1 LA - English M3 - Article N1 - L358189344 2010-02-05 2020-09-23 PY - 2009 SN - 1550-6606 0022-1767 SP - 293-300 ST - Double-stranded RNA and TGF-α promote MUC5AC induction in respiratory cells T2 - Journal of Immunology TI - Double-stranded RNA and TGF-α promote MUC5AC induction in respiratory cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358189344&from=exporthttp://dx.doi.org/10.4049/jimmunol.182.1.293 VL - 182 ID - 5698 ER - TY - JOUR AD - Memorial Sloan-Kettering Cancer Center, New York, NY, United States Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Matteo Univ. Hospital Foundation, Pavia, Italy Comprehensive Cancer Centers of Nevada, Las Vegas, NV, United States San Camillo and Forlanini Hospitals, Rome, Italy Military Institute of Health Services in Warsaw, Warsaw, Poland Maria Sklodowska-Curie Institute, Warsaw, Poland AU - Motzer, R. J. AU - Porta, C. AU - Vogelzang, N. J. AU - Sternberg, C. N. AU - Szczylik, C. AU - Zolnierek, J. AU - Kollmannsberger, C. AU - Rha, S. Y. AU - Bjarnason, G. A. AU - Melichar, B. AU - De Giorgi, U. AU - Grünwald, V. AU - Davis, I. D. AU - Lee, J. L. AU - Esteban, E. AU - Urbanowitz, G. AU - Cai, C. AU - Squires, M. AU - Marker, M. AU - Shi, M. M. AU - Escudier, B. DB - Scopus DO - 10.1016/S1470-2045(14)70030-0 IS - 3 M3 - Article N1 - Cited By :192 Export Date: 18 November 2020 PY - 2014 SP - 286-296 ST - Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial T2 - The Lancet Oncology TI - Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896713052&doi=10.1016%2fS1470-2045%2814%2970030-0&partnerID=40&md5=88e9eaacbfa0d3d40f65bc5b8b4c6208 VL - 15 ID - 5699 ER - TY - JOUR AD - Department of Pathology, First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Road 2nd, Guangzhou, Guangdong, 510080, China Department of Urinary Surgery, Affiliated Xixiang People's Hospital, Guangdong Medical College, Shenzhen, Guangdong, China Department of Pathology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China AU - Zhu, J. AU - Feng, Y. AU - Ke, Z. AU - Yang, Z. AU - Zhou, J. AU - Huang, X. AU - Wang, L. DB - Scopus DO - 10.1016/j.ajpath.2012.02.023 IS - 6 M3 - Article N1 - Cited By :120 Export Date: 18 November 2020 PY - 2012 SP - 2440-2451 ST - Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin T2 - American Journal of Pathology TI - Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861626895&doi=10.1016%2fj.ajpath.2012.02.023&partnerID=40&md5=d998da5f59de9feb3d44d2c831de2a8b VL - 180 ID - 5700 ER - TY - JOUR AD - Centre for Infectious Disease and Centre for Academic Surgery, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK. AN - 20731675 AU - Docena, G. AU - Rovedatti, L. AU - Kruidenier, L. AU - Fanning, A. AU - Leakey, N. A. AU - Knowles, C. H. AU - Lee, K. AU - Shanahan, F. AU - Nally, K. AU - McLean, P. G. AU - Di Sabatino, A. AU - MacDonald, T. T. C2 - PMC2990936 DA - Oct DO - 10.1111/j.1365-2249.2010.04203.x 10.1111/j.1365-2249.2010.04203.x. Epub 2010 Aug 20. DP - Nlm ET - 2010/08/25 IS - 1 LA - eng PY - 2010 SN - 0009-9104 (Print) 0009-9104 SP - 108-15 ST - Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease T2 - Clin Exp Immunol TI - Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease VL - 162 ID - 5701 ER - TY - JOUR AD - C.-y. Fan, Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yishan Road, Shanghai, China AU - Cheng, D. d AU - Zhu, B. AU - Li, S. j AU - Yuan, T. AU - Yang, Q. c AU - Fan, C. y DB - Embase DO - 10.7150/jca.19130 IS - 14 LA - English M3 - Article N1 - L618029868 2017-09-06 2017-09-13 PY - 2017 SN - 1837-9664 SP - 2720-2728 ST - Down-regulation of RPS9 inhibits osteosarcoma cell growth through inactivation of MAPK signaling pathway T2 - Journal of Cancer TI - Down-regulation of RPS9 inhibits osteosarcoma cell growth through inactivation of MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618029868&from=exporthttp://dx.doi.org/10.7150/jca.19130 VL - 8 ID - 5702 ER - TY - JOUR AD - C.J. Thiele, Cell and Molecular Biology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States AU - Li, Z. AU - Zhang, J. AU - Liu, Z. AU - Woo, C. W. AU - Thiele, C. J. C2 - Sigma(United States) DB - Embase Medline DO - 10.1038/sj.cdd.4401983 IS - 2 LA - English M3 - Article N1 - L46092234 2007-02-13 PY - 2007 SN - 1350-9047 1476-5403 SP - 318-326 ST - Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death T2 - Cell Death and Differentiation TI - Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46092234&from=exporthttp://dx.doi.org/10.1038/sj.cdd.4401983 VL - 14 ID - 5703 ER - TY - JOUR AD - R. He, Department of Clinical Genetics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning, China AU - Li, J. AU - Wang, J. AU - Zhou, W. AU - Zhang, S. AU - Le, Y. AU - He, R. DB - Embase DO - 10.3892/ol.2017.6770 IS - 4 LA - English M3 - Article N1 - L618214624 2017-09-13 2017-09-15 PY - 2017 SN - 1792-1082 1792-1074 SP - 4751-4757 ST - Downregulation of BRAF-Activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells T2 - Oncology Letters TI - Downregulation of BRAF-Activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618214624&from=exporthttp://dx.doi.org/10.3892/ol.2017.6770 VL - 14 ID - 5704 ER - TY - JOUR AD - Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China. Department of Ophthalmology, The First People's Hospital of Changde City, Changde, Hunan 415000, P.R. China. AN - 31115482 AU - Zeng, Z. AU - Gao, Z. L. AU - Zhang, Z. P. AU - Jiang, H. B. AU - Yang, C. Q. AU - Yang, J. AU - Xia, X. B. C2 - PMC6559318 DA - Jul DO - 10.3892/ijmm.2019.4183 10.3892/ijmm.2019.4183. Epub 2019 May 8. DP - Nlm ET - 2019/05/23 IS - 1 LA - eng PY - 2019 SN - 1107-3756 (Print) 1107-3756 SP - 103-114 ST - Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway T2 - Int J Mol Med TI - Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway VL - 44 ID - 5705 ER - TY - JOUR AD - T. Tanaka, Department of Molecular Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan AU - Tanaka, T. AU - Arai, M. AU - Jiang, X. AU - Sugaya, S. AU - Kanda, T. AU - Fujii, K. AU - Kita, K. AU - Sugita, K. AU - Imazeki, F. AU - Miyashita, T. AU - Kaneda, A. AU - Yokosuka, O. C2 - PeproTech(United States) DB - Embase Medline DO - 10.3892/ijo.2014.2317 IS - 5 LA - English M3 - Article N1 - L372921254 2014-05-02 2014-05-15 PY - 2014 SN - 1791-2423 1019-6439 SP - 1685-1690 ST - Downregulation of microRNA-431 by human interferon-βinhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6 T2 - International Journal of Oncology TI - Downregulation of microRNA-431 by human interferon-βinhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372921254&from=exporthttp://dx.doi.org/10.3892/ijo.2014.2317 VL - 44 ID - 5706 ER - TY - JOUR AU - Chen, Y. AU - Yan, H. AU - Song, Z. AU - Chen, F. AU - Wang, H. AU - Niu, J. AU - Shi, X. AU - Zhang, D. AU - Zhang, N. AU - Zhai, Z. AU - Zhong, B. AU - Cheng, L. AU - Qian, T. AU - Hao, F. DB - Embase Medline DO - 10.1371/journal.pone.0127957 IS - 6 LA - English M3 - Article N1 - L604911661 2015-06-26 2015-06-30 PY - 2015 SN - 1932-6203 ST - Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis T2 - PLoS ONE TI - Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604911661&from=exporthttp://dx.doi.org/10.1371/journal.pone.0127957 VL - 10 ID - 5707 ER - TY - JOUR AD - A.O.S. El-Kadi, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada AU - Maayah, Z. H. AU - Zhang, T. AU - Forrest, M. L. AU - Alrushaid, S. AU - Doschak, M. R. AU - Davies, N. M. AU - El-Kadi, A. O. S. DB - Embase DO - 10.3390/pharmaceutics10030144 IS - 3 LA - English M3 - Article N1 - L623783787 2018-09-18 2018-09-24 PY - 2018 SN - 1999-4923 ST - DOX-vit D, a novel doxorubicin delivery approach, inhibits human osteosarcoma cell proliferation by inducing apoptosis while inhibiting akt and mTOR signaling pathways T2 - Pharmaceutics TI - DOX-vit D, a novel doxorubicin delivery approach, inhibits human osteosarcoma cell proliferation by inducing apoptosis while inhibiting akt and mTOR signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623783787&from=exporthttp://dx.doi.org/10.3390/pharmaceutics10030144 VL - 10 ID - 5708 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan. Wayne State University School of Medicine, Detroit, Michigan. John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii. Department of Radiology, Children's Hospital of Michigan, Detroit, Michigan. Department of Pathology, Children's Hospital of Michigan, Detroit, Michigan. AN - 30251337 AU - Knight, T. AU - Shatara, M. AU - Carvalho, L. AU - Altinok, D. AU - Poulik, J. AU - Wang, Z. J. DA - Jan DO - 10.1002/pbc.27474 10.1002/pbc.27474. Epub 2018 Sep 24. DP - Nlm ET - 2018/09/27 IS - 1 LA - eng PY - 2019 SN - 1545-5009 SP - e27474 ST - Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma T2 - Pediatr Blood Cancer TI - Dramatic response to trametinib in a male child with neurofibromatosis type 1 and refractory astrocytoma VL - 66 ID - 5709 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China AU - Wang, W. J. AU - Zheng, C. F. AU - Liu, Z. AU - Tan, Y. H. AU - Chen, X. H. AU - Zhao, B. L. AU - Li, G. X. AU - Xu, Z. F. AU - Ren, F. G. AU - Zhang, Y. F. AU - Chang, J. M. AU - Wang, H. W. DB - Scopus DO - 10.1111/ejh.13084 IS - 3 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2018 SP - 291-296 ST - Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression T2 - European Journal of Haematology TI - Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050397829&doi=10.1111%2fejh.13084&partnerID=40&md5=9c028fced2b07162c1b5a4d914b1a041 VL - 101 ID - 5710 ER - TY - JOUR AD - Division of Hematology-Oncology, University of Massachusetts Medical School, Worcester, MA, United States Institut Gustave Roussy, Villejuif, France Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States University of Virginia School of Medicine, Charlottesville, VA, United States AU - Mittal, K. AU - Derosa, L. AU - Albiges, L. AU - Wood, L. AU - Elson, P. AU - Gilligan, T. AU - Garcia, J. AU - Dreicer, R. AU - Escudier, B. AU - Rini, B. DB - Scopus DO - 10.1016/j.clgc.2017.12.014 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - e663-e667 ST - Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors T2 - Clinical Genitourinary Cancer TI - Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044652791&doi=10.1016%2fj.clgc.2017.12.014&partnerID=40&md5=ad41c6c442bcdcdf97d6e81d750f314c VL - 16 ID - 5711 ER - TY - JOUR AD - Department of Neuropathology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Institute of Child Health, University College London, United Kingdom International Neuroscience Institute, Hannover, Germany Department of Neurosurgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany Department of Neurosurgery, University Hospital Erlangen-Nuremberg, Erlangen, Germany Department of Neurosurgery, Medical University of Vienna, Austria Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany AU - Stache, C. AU - Bils, C. AU - Fahlbusch, R. AU - Flitsch, J. AU - Buchfelder, M. AU - Stefanits, H. AU - Czech, T. AU - Gaipl, U. AU - Frey, B. AU - Buslei, R. AU - Hölsken, A. C7 - E14 DB - Scopus DO - 10.3171/2016.9.FOCUS16316 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 ST - Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin T2 - Neurosurgical Focus TI - Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002194582&doi=10.3171%2f2016.9.FOCUS16316&partnerID=40&md5=78a1d2598c58aeddf13800c494b12f44 VL - 41 ID - 5712 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, 600 036, India AU - Karunakaran, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_36_20 IS - 3 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 383-392 ST - Drug review: Ibrutinib T2 - Indian Journal of Medical and Paediatric Oncology TI - Drug review: Ibrutinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088495407&doi=10.4103%2fijmpo.ijmpo_36_20&partnerID=40&md5=aef16998f1f387b30e47d15a31dcecd5 VL - 41 ID - 5713 ER - TY - JOUR AD - Yildirim Beyazit University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Konya Training and Research Hospital, Department of Medical Oncology, Konya, Turkey Ankara Numune Training and Research Hospital, Department of Internal Medicine, Ankara, Turkey Diskapi Yildiriım Beyazit Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey Gazi University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey Ankara Numune Education and Research Hospital, Department of Medical Oncology, Talatpasa Boulevard no.44, Sihhiye/Altindag, Ankara, 06100, Turkey AU - Ergun, Y. AU - Ozdemir, N. Y. AU - Toptas, S. AU - Kurtipek, A. AU - Eren, T. AU - Yazic, O. AU - Sendur, M. A. N. AU - Akinci, B. AU - Ucar, G. AU - Oksuzoglu, B. AU - Uncu, D. DB - Scopus IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 1719-1726 ST - Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study T2 - Journal of B.U.ON. TI - Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071697979&partnerID=40&md5=32719534d8bff4f216df69aa3f0cbead VL - 24 ID - 5714 ER - TY - JOUR AD - Servicio de Hematología, Hospital General Universitario Gregorio Marañón, Madrid, Spain Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain Servicio de Farmacia, Hospital General Universitario Gregorio Marañón, Madrid, Spain Servicio de Hematología, Hospital Universitario Clínico Virgen de la Arrixaca, Murcia, Spain Servicio de Hematología, Hospital Universitario 12 de Octubre, Madrid, Spain Servicio de Hematología, Hospital Universitari Mútua Terrassa, Terrassa, Spain Servicio de Hematología, Hospital Universitario Ramón y Cajal, Madrid, Spain Servicio de Hematología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain Servicio de Hematología, Complejo Hospitalario Universitario Insular Materno Infantil de Canarias, Las Palmas de Gran Canaria, Spain Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain Servicio de Hematología, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain Servicio de Hematología, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain Servicio de Hematología, Hospital General Universitario de Elche, Elche, Alicante, Spain Servicio de Hematología, Hospital Universitario Virgen Macarena, Sevilla, Spain Servicio de Hematología, Hospital Virgen de la Salud, Toledo, Spain Servicio de Hematología, Hospital Universitario de la Princesa, Madrid, Spain AN - 132112504. Language: English. Entry Date: 20181011. Revision Date: 20191101. Publication Type: Article AU - Osorio, Santiago AU - Escudero-Vilaplana, Vicente AU - Gómez-Centurión, Ignacio AU - Pérez-López, Raúl AU - Ayala, Rosa AU - Vall-Llovera, Ferrán AU - García-Gutierrez, Valentín AU - Gómez Casares, María Teresa AU - González San Miguel, José David AU - Hernández-Rivas, José-Ángel AU - Sánchez-Guijo, Fermín AU - Martínez-García, Ana Belén AU - Villalón, Lucia AU - Conesa-García, Venancio AU - Rodriguez, Alicia AU - Casado, Felipe AU - Garcia-Gonzalez, Xandra AU - Sáez Perdomo, María Nieves AU - Baños, Úrsula AU - Steegmann, Juan Luis DB - ccm DO - 10.1007/s00277-018-3413-7 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Special Interest: Evidence-Based Practice. NLM UID: 9107334. PMID: NLM29955943. PY - 2018 SN - 0939-5555 SP - 2089-2098 ST - Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem? T2 - Annals of Hematology TI - Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132112504&site=ehost-live&scope=site VL - 97 ID - 5715 ER - TY - JOUR AD - Department of Pharmacy, Erasmus MC, Rotterdam, Netherlands Faculty of Pharmacy, Utrecht University, Utrecht, Netherlands Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands Department of Pediatric Hematology-Oncology, Erasmus MC-Sophia, Rotterdam, Netherlands AU - Balk, T. E. AU - van der Sijs, I. H. AU - van Gelder, T. AU - Janssen, J. J. B. AU - van der Sluis, I. M. AU - van Leeuwen, R. W. F. AU - Engels, F. K. C7 - e26410 DB - Scopus DO - 10.1002/pbc.26410 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 ST - Drug–drug interactions in pediatric oncology patients T2 - Pediatric Blood and Cancer TI - Drug–drug interactions in pediatric oncology patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013271878&doi=10.1002%2fpbc.26410&partnerID=40&md5=b6ccf8f25507d6c785f604d40e94b39f VL - 64 ID - 5716 ER - TY - JOUR AD - Division of Pediatric Oncology, Alberta Children's Hospital and POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada (Y.R., A.J., X.L., R.A., A.N.); Department of Biological Sciences, University of Lethbridge, Lethbridge, Canada (A.K., O.K.); Department of Pathology, Yokohama City University School of Medicine and Division of Diagnostic Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan (Y.N.); Department of Pathology and Laboratory Medicine, Alberta Children's Hospital and Calgary Laboratory Services, Calgary, Canada (J.R.W., A.P.); Department of Neurology, Alberta Children's Hospital, Calgary, Canada (A.K.). AN - 25395461 AU - Ruan, Y. AU - Kovalchuk, A. AU - Jayanthan, A. AU - Lun, X. AU - Nagashima, Y. AU - Kovalchuk, O. AU - Wright, J. R., Jr. AU - Pinto, A. AU - Kirton, A. AU - Anderson, R. AU - Narendran, A. C2 - PMC4483116 DA - Jun DO - 10.1093/neuonc/nou310 10.1093/neuonc/nou310. Epub 2014 Nov 12. DP - Nlm ET - 2014/11/15 IS - 6 LA - eng PY - 2015 SN - 1522-8517 (Print) 1522-8517 SP - 822-31 ST - Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy T2 - Neuro Oncol TI - Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy VL - 17 ID - 5717 ER - TY - JOUR AD - G. Terrin, Department of Women Health and Territorial Medicine, University of Rome La Sapienza, via di Grottarossa 1035/1039, Rome, Italy AU - Terrin, G. AU - Passariello, A. AU - Canani, R. B. DB - Embase Medline DO - 10.1097/MPG.0b013e3182472372 IS - 4 LA - English M3 - Note N1 - L51784436 2011-12-28 2012-04-11 PY - 2012 SN - 0277-2116 1536-4801 SP - 444-445 ST - Drugs and tight junctions: Adverse effects and opportunities for new therapeutic approaches T2 - Journal of Pediatric Gastroenterology and Nutrition TI - Drugs and tight junctions: Adverse effects and opportunities for new therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51784436&from=exporthttp://dx.doi.org/10.1097/MPG.0b013e3182472372 VL - 54 ID - 5718 ER - TY - JOUR AD - Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Genomics Institute of the Novartis Research Foundation, San Diego, California. Novartis Institutes of Biomedical Research, Cambridge, Massachusetts. Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. mosse@email.chop.edu. AN - 27986745 AU - Wood, A. C. AU - Krytska, K. AU - Ryles, H. T. AU - Infarinato, N. R. AU - Sano, R. AU - Hansel, T. D. AU - Hart, L. S. AU - King, F. J. AU - Smith, T. R. AU - Ainscow, E. AU - Grandinetti, K. B. AU - Tuntland, T. AU - Kim, S. AU - Caponigro, G. AU - He, Y. Q. AU - Krupa, S. AU - Li, N. AU - Harris, J. L. AU - Mossé, Y. P. C2 - PMC5457336 C6 - NIHMS837654 ALK mutations filed by the Children’s Hospital of Philadelphia (WO/2009/103061 or PCT/US2009/034288: Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma). A patent application has been filed on the combination of Ceritinib/Ribociclib for the treatment of neuroblastoma. FJK, TRS, EA, KBG, TT, SK, GC, YQH, SK, NL, JLH are Novartis employees. All other authors declare that they have no competing interests. DA - Jun 1 DO - 10.1158/1078-0432.Ccr-16-1114 10.1158/1078-0432.CCR-16-1114. Epub 2016 Dec 16. DP - Nlm ET - 2016/12/18 IS - 11 LA - eng PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 2856-2868 ST - Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma T2 - Clin Cancer Res TI - Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma VL - 23 ID - 5719 ER - TY - JOUR AD - X. Liang, Department of Pathology, Children's Hospital Colorado, 13123 East 16th Avenue, B120, Aurora, CO 80045, United States AU - Liang, X. AU - Branchford, B. AU - Greffe, B. AU - McGavran, L. AU - Carstens, B. AU - Meltesen, L. AU - Albano, E. A. AU - Quinones, R. AU - Cook, B. AU - Graham, D. K. DB - Embase Medline DO - 10.1097/MPH.0b013e3182815046 IS - 5 LA - English M3 - Article N1 - L52553482 2013-04-30 2013-08-07 PY - 2013 SN - 1077-4114 1536-3678 SP - e209-e213 ST - Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma T2 - Journal of Pediatric Hematology/Oncology TI - Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52553482&from=exporthttp://dx.doi.org/10.1097/MPH.0b013e3182815046 VL - 35 ID - 5720 ER - TY - JOUR AD - Authors' Affiliations: Divisions of Clinical Studies, Cancer Therapeutics, and Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey; Histopathology Department, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and Department of Neuropathology, University of Bonn, Bonn, Germany. AN - 23918606 AU - Renshaw, J. AU - Taylor, K. R. AU - Bishop, R. AU - Valenti, M. AU - De Haven Brandon, A. AU - Gowan, S. AU - Eccles, S. A. AU - Ruddle, R. R. AU - Johnson, L. D. AU - Raynaud, F. I. AU - Selfe, J. L. AU - Thway, K. AU - Pietsch, T. AU - Pearson, A. D. AU - Shipley, J. C2 - PMC3818134 C6 - EMS54323 DA - Nov 1 DO - 10.1158/1078-0432.Ccr-13-0850 10.1158/1078-0432.CCR-13-0850. Epub 2013 Aug 5. DP - Nlm ET - 2013/08/07 IS - 21 LA - eng PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 5940-51 ST - Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo T2 - Clin Cancer Res TI - Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo VL - 19 ID - 5721 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Center for Personalized Cancer Therapy, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San diego, CA, United States Sarah Cannon Research Institute at HealthONE, Denver, CO, United States Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Subbiah, V. AU - Dumbrava, E. I. AU - Jiang, Y. AU - Thein, K. Z. AU - Naing, A. AU - Hong, D. S. AU - Fu, S. AU - Piha-Paul, S. A. AU - Tsimberidou, A. M. AU - Janku, F. AU - Meric-Bernstam, F. AU - Kurzrock, R. AU - Falchook, G. C7 - 7 DB - Scopus DO - 10.1186/s40164-020-00159-1 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: A phase 1 dose escalation triplet combination trial T2 - Experimental Hematology and Oncology TI - Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: A phase 1 dose escalation triplet combination trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084392612&doi=10.1186%2fs40164-020-00159-1&partnerID=40&md5=408a9eec51646fc869e21201a90c7b01 VL - 9 ID - 5722 ER - TY - JOUR AD - *Programa de Pesquisa em Hemato-Oncologia Molecular, Laboratório de Hemato-oncologia Celular e Molecular, and Programa de Biologia Celular, Laboratório de Biologia Estrutural-Instituto Nacional de Câncer, Rio de Janeiro, Brazil; and Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom. *Programa de Pesquisa em Hemato-Oncologia Molecular, Laboratório de Hemato-oncologia Celular e Molecular, and Programa de Biologia Celular, Laboratório de Biologia Estrutural-Instituto Nacional de Câncer, Rio de Janeiro, Brazil; and Randall Division of Cell and Molecular Biophysics, King's College London, United Kingdom cklumb@inca.gov.br. AN - 26561567 AU - Ferreira, A. C. AU - de-Freitas-Junior, J. C. AU - Morgado-Díaz, J. A. AU - Ridley, A. J. AU - Klumb, C. E. DA - Apr DO - 10.1189/jlb.2A0415-162R 10.1189/jlb.2A0415-162R. Epub 2015 Nov 11. DP - Nlm ET - 2015/11/13 IS - 4 LA - eng PY - 2016 SN - 0741-5400 SP - 569-78 ST - Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration T2 - J Leukoc Biol TI - Dual inhibition of histone deacetylases and phosphoinositide 3-kinases: effects on Burkitt lymphoma cell growth and migration VL - 99 ID - 5723 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program), University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Blvd, Houston TX 77030, United States Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, United States Apocell Molecular Profiling and Diagnostics, Houston, TX, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Division of Hematology and Oncology, Moores Cancer Center, University of California at San Diego, San Diego, CA, United States AU - Hong, D. S. AU - Garrido-Laguna, I. AU - Ekmekcioglu, S. AU - Falchook, G. S. AU - Naing, A. AU - Wheler, J. J. AU - Fu, S. AU - Moulder, S. L. AU - Piha-Paul, S. AU - Tsimberidou, A. M. AU - Wen, Y. AU - Culotta, K. S. AU - Anderes, K. AU - Davis, D. W. AU - Liu, W. AU - George, G. C. AU - Camacho, L. H. AU - Percy Ivy, S. AU - Kurzrock, R. DB - Scopus DO - 10.1002/cncr.28701 IS - 14 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2014 SP - 2164-2173 ST - Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors T2 - Cancer TI - Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903768222&doi=10.1002%2fcncr.28701&partnerID=40&md5=cba31bdcb9cb799423b393b913853cf4 VL - 120 ID - 5724 ER - TY - JOUR AD - Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A basud@upmc.edu. Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, PA, U.S.A. Division of Plastic and Reconstructive Surgery, North Shore University Health System, Northbrook, IL, U.S.A. Department of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A. Department of Pediatrics, Weill Cornell Medical College, New York, NY, U.S.A. Dietrich School of Arts and Sciences, University of Pittsburgh, Pittsburgh, PA, U.S.A. AN - 29976629 AU - Basu, D. AU - Salgado, C. M. AU - Bauer, B. AU - Khakoo, Y. AU - Patel, J. R. AU - Hoehl, R. M. AU - Bertolini, D. M. AU - Zabec, J. AU - Brzozowski, M. R. AU - Reyes-Múgica, M. C2 - PMC6070711 DA - Jul-Aug DO - 10.21873/cgp.20082 10.21873/cgp.20082. DP - Nlm ET - 2018/07/07 IS - 4 LA - eng PY - 2018 SN - 1109-6535 (Print) 1109-6535 SP - 239-248 ST - The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis T2 - Cancer Genomics Proteomics TI - The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis VL - 15 ID - 5725 ER - TY - JOUR AD - R. Chang, Department of Neurosurgery, Weill Cornell Medicine, New York, NY, United States AU - Chang, R. AU - Tosi, U. AU - Maachani, U. B. AU - Voronina, I. AU - Schweitzer, M. AU - Wu, L. AU - Souweidane, M. DB - Embase DO - 10.1093/neuonc/noy148 LA - English M3 - Conference Abstract N1 - L628633890 2019-07-26 PY - 2018 SN - 1523-5866 SP - vi209 ST - Dual therapy with PI3K inhibitor ZSTK-474 and mek inhibitor trametinib via convection-enhanced delivery in a genetically-engineered mouse model of diffuse intrinsic pontine glioma T2 - Neuro-Oncology TI - Dual therapy with PI3K inhibitor ZSTK-474 and mek inhibitor trametinib via convection-enhanced delivery in a genetically-engineered mouse model of diffuse intrinsic pontine glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628633890&from=exporthttp://dx.doi.org/10.1093/neuonc/noy148 VL - 20 ID - 5726 ER - TY - JOUR AD - F. Correa, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, PO BOX 420, 405 30 Göteborg, Sweden AU - Correa, F. AU - Mallard, C. AU - Nilsson, M. AU - Sandberg, M. DB - Embase Medline DO - 10.1007/s11064-012-0878-y IS - 12 LA - English M3 - Article N1 - L52189805 2012-09-07 2013-01-10 PY - 2012 SN - 0364-3190 1573-6903 SP - 2842-2855 ST - Dual TNFα-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: Role of protein kinase activation T2 - Neurochemical Research TI - Dual TNFα-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: Role of protein kinase activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52189805&from=exporthttp://dx.doi.org/10.1007/s11064-012-0878-y VL - 37 ID - 5727 ER - TY - JOUR AD - Texas Children's Cancer Center, Department of Pediatrics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA. AN - 20562916 AU - Shang, X. AU - Vasudevan, S. A. AU - Yu, Y. AU - Ge, N. AU - Ludwig, A. D. AU - Wesson, C. L. AU - Wang, K. AU - Burlingame, S. M. AU - Zhao, Y. J. AU - Rao, P. H. AU - Lu, X. AU - Russell, H. V. AU - Okcu, M. F. AU - Hicks, M. J. AU - Shohet, J. M. AU - Donehower, L. A. AU - Nuchtern, J. G. AU - Yang, J. C2 - PMC7580258 C6 - NIHMS1638028 DA - Sep 2 DO - 10.1038/onc.2010.244 10.1038/onc.2010.244. Epub 2010 Jun 21. DP - Nlm ET - 2010/06/22 IS - 35 LA - eng PY - 2010 SN - 0950-9232 (Print) 0950-9232 SP - 4938-46 ST - Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma T2 - Oncogene TI - Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma VL - 29 ID - 5728 ER - TY - JOUR AD - Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. AN - 19016743 AU - Sievert, A. J. AU - Jackson, E. M. AU - Gai, X. AU - Hakonarson, H. AU - Judkins, A. R. AU - Resnick, A. C. AU - Sutton, L. N. AU - Storm, P. B. AU - Shaikh, T. H. AU - Biegel, J. A. C2 - PMC2850204 C6 - NIHMS184143 DA - Jul DO - 10.1111/j.1750-3639.2008.00225.x 10.1111/j.1750-3639.2008.00225.x. Epub 2008 Oct 21. DP - Nlm ET - 2008/11/20 IS - 3 LA - eng PY - 2009 SN - 1015-6305 (Print) 1015-6305 SP - 449-58 ST - Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene T2 - Brain Pathol TI - Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene VL - 19 ID - 5729 ER - TY - JOUR AD - Department of Pediatrics and Human Genetics, Montreal Children's Hospital, McGill University Health Center, Montreal H3Z 2Z3, Canada. nada.jabado@mcgill.ca AN - 19603027 AU - Jacob, K. AU - Albrecht, S. AU - Sollier, C. AU - Faury, D. AU - Sader, E. AU - Montpetit, A. AU - Serre, D. AU - Hauser, P. AU - Garami, M. AU - Bognar, L. AU - Hanzely, Z. AU - Montes, J. L. AU - Atkinson, J. AU - Farmer, J. P. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. AU - Jabado, N. C2 - PMC2736806 DA - Aug 18 DO - 10.1038/sj.bjc.6605179 10.1038/sj.bjc.6605179. Epub 2009 Jul 14. DP - Nlm ET - 2009/07/16 IS - 4 LA - eng PY - 2009 SN - 0007-0920 (Print) 0007-0920 SP - 722-33 ST - Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours T2 - Br J Cancer TI - Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours VL - 101 ID - 5730 ER - TY - JOUR AD - V. Vasko, Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States AU - Jensen, K. AU - Patel, A. AU - Hoperia, V. AU - Larin, A. AU - Bauer, A. AU - Vasko, V. C1 - ly 294002(Sigma,United States) u 0126(Sigma,United States) C2 - Sigma(United States) DB - Embase DO - 10.3892/etm_00000071 IS - 3 LA - English M3 - Article N1 - L359461072 2010-09-09 2010-09-16 PY - 2010 SN - 1792-0981 1792-1015 SP - 457-462 ST - Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer T2 - Experimental and Therapeutic Medicine TI - Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359461072&from=exporthttp://dx.doi.org/10.3892/etm_00000071http://www.spandidos-publications.com/serveFile/etm_1_3_457_PDF.pdf?type=article&article_id=etm_1_3_457&item=PDF VL - 1 ID - 5731 ER - TY - JOUR AU - Mukherjee, S. AU - Dash, S. AU - Lohitesh, K. AU - Chowdhury, R. DB - Embase Medline DO - 10.1371/journal.pone.0179203 IS - 6 LA - English M3 - Article N1 - L616748964 2017-06-20 2017-06-22 PY - 2017 SN - 1932-6203 ST - The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells T2 - PLoS ONE TI - The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616748964&from=exporthttp://dx.doi.org/10.1371/journal.pone.0179203 VL - 12 ID - 5732 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Cortes, J. AU - Jabbour, E. AU - Kantarjian, H. AU - Yin, C. C. AU - Shan, J. AU - O'Brien, S. AU - Garcia-Manero, G. AU - Giles, F. AU - Breeden, M. AU - Reeves, N. AU - Wierda, W. G. AU - Jones, D. DB - Scopus DO - 10.1182/blood-2007-03-080838 IS - 12 M3 - Article N1 - Cited By :216 Export Date: 18 November 2020 PY - 2007 SP - 4005-4011 ST - Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors T2 - Blood TI - Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37049003546&doi=10.1182%2fblood-2007-03-080838&partnerID=40&md5=7ddea454022888996a5e328fba6a48d4 VL - 110 ID - 5733 ER - TY - JOUR AD - School of Medicine, University of Dublin, Trinity College, Dublin, Ireland. Conway Institute, University College Dublin, Belfield, Dublin, Ireland. School of Genetics and Microbiology, University of Dublin, Trinity College, Dublin, Ireland. Our Lady's Children's Hospital, Crumlin, Dublin, Ireland. AN - 29243812 AU - Kenny, C. AU - McDonagh, N. AU - Lazaro, A. AU - O'Meara, E. AU - Klinger, R. AU - O'Connor, D. AU - Roche, F. AU - Hokamp, K. AU - O'Sullivan, M. J. DA - Mar DO - 10.1002/path.5020 10.1002/path.5020. Epub 2018 Jan 23. DP - Nlm ET - 2017/12/16 IS - 3 LA - eng PY - 2018 SN - 0022-3417 SP - 334-345 ST - Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney T2 - J Pathol TI - Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney VL - 244 ID - 5734 ER - TY - JOUR AD - Non-Hodgkin Lymphoma-Berlin-Frankfurt-Münster Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen, Germany; AN - 24297868 AU - Damm-Welk, C. AU - Mussolin, L. AU - Zimmermann, M. AU - Pillon, M. AU - Klapper, W. AU - Oschlies, I. AU - d'Amore, E. S. AU - Reiter, A. AU - Woessmann, W. AU - Rosolen, A. DA - Jan 16 DO - 10.1182/blood-2013-09-526202 10.1182/blood-2013-09-526202. Epub 2013 Dec 2. DP - Nlm ET - 2013/12/04 IS - 3 LA - eng PY - 2014 SN - 0006-4971 SP - 334-7 ST - Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma T2 - Blood TI - Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma VL - 123 ID - 5735 ER - TY - JOUR AD - Divison of Neuropathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Department of Neurosurgery, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, United States Brain Research Institute, University of California-Los Angeles, Los Angeles, CA, United States Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, United States AU - Movassaghi, M. AU - Shabihkhani, M. AU - Hojat, S. A. AU - Williams, R. R. AU - Chung, L. K. AU - Im, K. AU - Lucey, G. M. AU - Wei, B. AU - Mareninov, S. AU - Wang, M. W. AU - Ng, D. W. AU - Tashjian, R. S. AU - Magaki, S. AU - Perez-Rosendahl, M. AU - Yang, I. AU - Khanlou, N. AU - Vinters, H. V. AU - Liau, L. M. AU - Nghiemphu, P. L. AU - Lai, A. AU - Cloughesy, T. F. AU - Yong, W. H. DB - Scopus DO - 10.1016/j.yexmp.2017.06.006 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 87-93 ST - Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats T2 - Experimental and Molecular Pathology TI - Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024845659&doi=10.1016%2fj.yexmp.2017.06.006&partnerID=40&md5=ae31be756e1f3d0961931e0be64774b8 VL - 103 ID - 5736 ER - TY - JOUR AD - G.B. Segel, Department of Pediatrics, Univ. Rochester Sch. of Med./Dent., 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Segel, G. B. AU - Woodlock, T. J. AU - Xu, J. AU - Li, L. AU - Felgar, R. E. AU - Ryan, D. H. AU - Lichtman, M. A. AU - Wang, N. DB - Embase Medline DO - 10.1016/S1079-9796(03)00035-4 IS - 3 LA - English M3 - Article N1 - L36539429 2003-05-19 PY - 2003 SN - 1079-9796 SP - 277-287 ST - Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype T2 - Blood Cells, Molecules, and Diseases TI - Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36539429&from=exporthttp://dx.doi.org/10.1016/S1079-9796(03)00035-4 VL - 30 ID - 5737 ER - TY - JOUR AD - Arkansas Children's Nutrition Center, Little Rock, AR 72202, USA. AN - 23632636 AU - Saben, J. AU - Zhong, Y. AU - Gomez-Acevedo, H. AU - Thakali, K. M. AU - Borengasser, S. J. AU - Andres, A. AU - Shankar, K. C2 - PMC4116409 DA - Jul 1 DO - 10.1152/ajpendo.00076.2013 10.1152/ajpendo.00076.2013. Epub 2013 Apr 30. DP - Nlm ET - 2013/05/02 IS - 1 LA - eng PY - 2013 SN - 0193-1849 (Print) 0193-1849 SP - E1-14 ST - Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity T2 - Am J Physiol Endocrinol Metab TI - Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity VL - 305 ID - 5738 ER - TY - JOUR AD - Hematology Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain Hospital Ruiz de Alda, Granada, Spain Hospital Virgen del Rocío, Seville, Spain Hospital Central de Asturias, Oviedo, Spain Hospital Universitario La Fe, Valencia, Spain Hospital Clínico, Valencia, Spain Hospital Ramón y Cajal, Madrid, Spain Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Hospital Gregorio Marañón, Madrid, Spain Hospital Morales Masaguer, Murcia, Spain Hospital Clínico de San Carlos, Madrid, Spain Hospital Reina Sofía, Córdoba, Spain Hospital Clínico Universitario, Salamanca, Spain AU - Cervantes, F. AU - López-Garrido, P. AU - Montero, M. I. AU - Jonte, F. AU - Martínez, J. AU - Hernández-Boluda, J. C. AU - Calbacho, M. AU - Sureda, A. AU - Pérez-Rus, G. AU - Nieto, J. B. AU - Pérez-López, C. AU - Román-Gómez, J. AU - González, M. AU - Pereira, A. AU - Colomer, D. DB - Scopus DO - 10.3324/haematol.2009.021154 IS - 8 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2010 SP - 1317-1324 ST - Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: A study of the Spanish PETHEMA group T2 - Haematologica TI - Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: A study of the Spanish PETHEMA group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956034332&doi=10.3324%2fhaematol.2009.021154&partnerID=40&md5=6d1c97f582788497b39f12bef525c443 VL - 95 ID - 5739 ER - TY - JOUR AD - I. Maillard, Division of Hematology-Oncology, Department of Internal Medicine, University of Pennsylvania Perelman, School of Medicine, 421 Curie Boulevard, BRB-2/3, Philadelphia, PA, United States AU - Chung, J. AU - Radojcic, V. AU - Perkey, E. AU - Parnell, T. J. AU - Niknafs, Y. AU - Jin, X. AU - Friedman, A. AU - Labrecque, N. AU - Blazar, B. R. AU - Brennan, T. V. AU - Siebel, C. W. AU - Maillard, I. DB - Embase Medline DO - 10.4049/jimmunol.1900192 IS - 2 LA - English M3 - Article N1 - L2002312823 2019-07-23 2019-07-29 PY - 2019 SN - 1550-6606 0022-1767 SP - 557-568 ST - Early notch signals induce a pathogenic molecular signature during priming of alloantigen-specific conventional CD4+ T cells in graft-versus-host disease T2 - Journal of Immunology TI - Early notch signals induce a pathogenic molecular signature during priming of alloantigen-specific conventional CD4+ T cells in graft-versus-host disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002312823&from=exporthttp://dx.doi.org/10.4049/jimmunol.1900192 VL - 203 ID - 5740 ER - TY - JOUR AD - A.D.J. Pearson, Paediatric Drug Development, Children and Young Peoplefs Unit, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom AU - Moreno, L. AU - Pearson, A. D. J. AU - Paoletti, X. AU - Jimenez, I. AU - Geoerger, B. AU - Kearns, P. R. AU - Zwaan, C. M. AU - Doz, F. AU - Baruchel, A. AU - Vormoor, J. AU - Casanova, M. AU - Pfister, S. M. AU - Morland, B. AU - Vassal, G. DB - Embase Medline DO - 10.1038/nrclinonc.2017.59 IS - 8 LA - English M3 - Review N1 - L617482634 2017-07-28 2017-08-01 PY - 2017 SN - 1759-4782 1759-4774 SP - 497-507 ST - Early phase clinical trials of anticancer agents in children and adolescents-an ITCC perspective T2 - Nature Reviews Clinical Oncology TI - Early phase clinical trials of anticancer agents in children and adolescents-an ITCC perspective UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617482634&from=exporthttp://dx.doi.org/10.1038/nrclinonc.2017.59 VL - 14 ID - 5741 ER - TY - JOUR AD - Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Diagnostic Radiology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Division of Pulmonology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Applied Mathematics, Institute of Statistics, National Chung-Hsing University, Taichung, Taiwan Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Taiwan Institute of Genomics and Bioinformatics, National Chung-Hsing University, Taichung, Taiwan Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan Department of Pathology, Tzu-Chi Medical Center, Tzu-Chi University, Taipei, Taiwan AU - Chang, J. W. C. AU - Hou, M. M. AU - Hsieh, J. J. AU - Cheung, Y. C. AU - Wang, H. M. AU - Chen, J. S. AU - Wang, C. H. AU - Chen, C. H. AU - Yeh, K. Y. AU - Ou, L. Y. AU - Hsieh, C. H. AU - Wu, H. D. I. AU - Chen, Y. T. AU - Chang, I. C. AU - Huang, S. F. DB - Scopus DO - 10.4103/2319-4170.138320 IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 221-228 ST - Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study T2 - Biomedical Journal TI - Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933513414&doi=10.4103%2f2319-4170.138320&partnerID=40&md5=bb6814a33bd05f78aac8d85e836c45c8 VL - 38 ID - 5742 ER - TY - JOUR AD - W. Zhang, Department of Pediatric Lymphoma, Beijing Boren Hospital, Beijing, China AU - Zhang, W. AU - Yang, J. AU - Hu, B. AU - Liu, Y. AU - Jin, L. AU - Zhu, Q. AU - Liu, Y. AU - Wang, S. AU - Zheng, Q. AU - Zhou, C. AU - Gao, Z. AU - Zhang, Y. DB - Embase DO - 10.1097/HS9.0000000000000404 LA - English M3 - Conference Abstract N1 - L632447018 2020-07-31 PY - 2020 SN - 2572-9241 SP - 562-563 ST - Early response observation in alk kinase inhibitors combined with/without vinblastine in pediatric refractory/relapsed ALK+ anaplastic large cell lymphoma T2 - HemaSphere TI - Early response observation in alk kinase inhibitors combined with/without vinblastine in pediatric refractory/relapsed ALK+ anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632447018&from=exporthttp://dx.doi.org/10.1097/HS9.0000000000000404 VL - 4 ID - 5743 ER - TY - JOUR AD - University of Texas M.D. Anderson Cancer Center, Department of Leukemia, 1515 Holcombe Blvd, Houston, TX 77030, United States University of Torino, Ospedale San Luigi Gonzaga, Orbassano-Torino, Italy Hospital de la Princesa, Madrid, Spain University of California, San Francisco School of Medicine, San Francisco, CA, United States Department of Clinical Hematology, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain Singapore General Hospital, Duke-National University of Singapore, Graduate Medical School, Singapore, Singapore Fundación Para Combatir la Leucemia, Angelica Ocampo Hospitalization and Clinical Research Center, Buenos Aires, Argentina University Hospital Brno, Central European Institute of Technology, Masaryk University, Brno, Czech Republic University of Bologna, Bologna, Italy Catholic University of Korea, Seoul, South Korea Bristol-Myers Squibb, Wallingford, CT, United States Bristol-Myers Squibb, Princeton, NJ, United States Universitätsklinikum Jena, Jena, Germany AU - Jabbour, E. AU - Kantarjian, H. M. AU - Saglio, G. AU - Steegmann, J. L. AU - Shah, N. P. AU - Boqué, C. AU - Chuah, C. AU - Pavlovsky, C. AU - Mayer, J. AU - Cortes, J. AU - Baccarani, M. AU - Kim, D. W. AU - Bradley-Garelik, M. B. AU - Mohamed, H. AU - Wildgust, M. AU - Hochhaus, A. DB - Scopus DO - 10.1182/blood-2013-06-511592 IS - 4 M3 - Article N1 - Cited By :289 Export Date: 18 November 2020 PY - 2014 SP - 494-500 ST - Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION) T2 - Blood TI - Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893136765&doi=10.1182%2fblood-2013-06-511592&partnerID=40&md5=7b407b891a5a36a2bc9f72dac5205c2d VL - 123 ID - 5744 ER - TY - JOUR AD - Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Jain, P. AU - Kantarjian, H. AU - Nazha, A. AU - O’Brien, S. AU - Jabbour, E. AU - Romo, C. G. AU - Pierce, S. AU - Cardenas-Turanzas, M. AU - Verstovsek, S. AU - Borthakur, G. AU - Ravandi, F. AU - Quintás-Cardama, A. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2013-03-490128 IS - 24 M3 - Article N1 - Cited By :100 Export Date: 18 November 2020 PY - 2013 SP - 4867-4874 ST - Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: Results with four tyrosine kinase inhibitor modalities T2 - Blood TI - Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: Results with four tyrosine kinase inhibitor modalities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881289808&doi=10.1182%2fblood-2013-03-490128&partnerID=40&md5=55de7f1ba986f4dde540bce78982e5c7 VL - 121 ID - 5745 ER - TY - JOUR AD - A. Schriefer, Serviço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil AU - Sousa, R. AU - Andrade, V. M. AU - Bair, T. AU - Ettinger, N. A. AU - Guimarães, L. AU - Andrade, L. AU - Guimarães, L. H. AU - Machado, P. R. L. AU - Carvalho, E. M. AU - Wilson, M. E. AU - Schriefer, A. DB - Embase DO - 10.3389/fmicb.2018.02464 IS - OCT LA - English M3 - Article N1 - L624296268 2018-10-29 2018-10-31 PY - 2018 SN - 1664-302X ST - Early suppression of macrophage gene expression by Leishmania braziliensis T2 - Frontiers in Microbiology TI - Early suppression of macrophage gene expression by Leishmania braziliensis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624296268&from=exporthttp://dx.doi.org/10.3389/fmicb.2018.02464 VL - 9 ID - 5746 ER - TY - JOUR AD - Safety Assessment, GlaxoSmithKline, King of Prussia, Pennsylvania. Vet Path Services, Inc, Mason, Ohio. AN - 26626128 AU - Posobiec, L. M. AU - Vidal, J. D. AU - Hughes-Earle, A. AU - Laffan, S. B. AU - Hart, T. DA - Dec DO - 10.1002/bdrb.21165 10.1002/bdrb.21165. Epub 2015 Dec 1. DP - Nlm ET - 2015/12/03 IS - 6 LA - eng PY - 2015 SN - 1542-9733 SP - 244-52 ST - Early Vaginal Opening in Juvenile Female Rats Given BRAF-Inhibitor Dabrafenib Is Not Associated with Early Physiologic Sexual Maturation T2 - Birth Defects Res B Dev Reprod Toxicol TI - Early Vaginal Opening in Juvenile Female Rats Given BRAF-Inhibitor Dabrafenib Is Not Associated with Early Physiologic Sexual Maturation VL - 104 ID - 5747 ER - TY - JOUR AD - Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center – New OrleansLA 70112, United States Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States Arkansas Children’s Nutrition Center, Little Rock, AR 72202, United States AU - Ronis, M. J. J. AU - Gomez-Acevedo, H. AU - Shankar, K. AU - Sharma, N. AU - Blackburn, M. AU - Singhal, R. AU - Mercer, K. E. AU - Badger, T. M. DB - Scopus DO - 10.1177/1535370218771333 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 695-707 ST - EB 2017 Article: Soy protein isolate feeding does not result in reproductive toxicity in the pre-pubertal rat testis T2 - Experimental Biology and Medicine TI - EB 2017 Article: Soy protein isolate feeding does not result in reproductive toxicity in the pre-pubertal rat testis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046999578&doi=10.1177%2f1535370218771333&partnerID=40&md5=0e8c7270660e62443f019121bf970ea6 VL - 243 ID - 5748 ER - TY - JOUR AD - Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, United Kingdom Bristol Genetics Laboratory, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom Department of Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol, United Kingdom Children's Cancer Group, Manchester Academic Health Sciences Centre, Institute of Cancer, University of Manchester, Manchester, United Kingdom Department of Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India Department of Haematology, Great Ormond Street Hospital, London, United Kingdom Department of Haematology, Sheffield Children's Hospital, Sheffield, United Kingdom AU - Schwab, C. AU - Ryan, S. L. AU - Chilton, L. AU - Elliott, A. AU - Murray, J. AU - Richardson, S. AU - Wragg, C. AU - Moppett, J. AU - Cummins, M. AU - Tunstall, O. AU - Parker, C. A. AU - Saha, V. AU - Goulden, N. AU - Vora, A. AU - Moorman, A. V. AU - Harrison, C. J. DB - Scopus DO - 10.1182/blood-2015-09-670166 IS - 18 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2016 SP - 2214-2218 ST - EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): Genetic profile and clinical implications T2 - Blood TI - EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): Genetic profile and clinical implications UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016261576&doi=10.1182%2fblood-2015-09-670166&partnerID=40&md5=d69626c0983d99eceddeb131ebb7ae24 VL - 127 ID - 5749 ER - TY - JOUR AD - S.-D. Lee, Department of Physical Therapy, China Medical University, 91 Hsueh-Shih Road, Taichung 40202, Taiwan AU - Chen, L. M. AU - Kuo, W. W. AU - Yang, J. J. AU - Wang, S. G. P. AU - Yeh, Y. L. AU - Tsai, F. J. AU - Ho, Y. J. AU - Chang, M. H. AU - Huang, C. Y. AU - Lee, S. D. DB - Embase Medline DO - 10.1113/expphysiol.2006.036590 IS - 2 LA - English M3 - Article N1 - L46376327 2007-04-10 PY - 2007 SN - 1469-445X 0958-0670 SP - 409-416 ST - Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats T2 - Experimental Physiology TI - Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46376327&from=exporthttp://dx.doi.org/10.1113/expphysiol.2006.036590 VL - 92 ID - 5750 ER - TY - JOUR AD - Department of Anatomy & Cell Biology, Gachon University College of Medicine, Incheon, 21936, South Korea Functional Cellular Networks Laboratory, College of Medicine, Department of Medicine, Graduate School and Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, 21999, South Korea Shinwoo cooperation. Ltd., 991, Worasan-ro, Munsan-eup, Jinju, Gyeongsangnam-do 52839, South Korea Aqua Green Technology Co., Ltd., Smart Bldg., Jeju Science Park, Cheomdan-ro, Jeju, 63309, South Korea Department of Marine Life Science, Jeju National University, Jeju, 63243, South Korea Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University, Incheon, 21565, South Korea AU - Son, M. AU - Oh, S. AU - Lee, H. S. AU - Chung, D. M. AU - Jang, J. T. AU - Jeon, Y. J. AU - Choi, C. H. AU - Park, K. Y. AU - Son, K. H. AU - Byun, K. C7 - 2795 DB - Scopus DO - 10.3390/nu11112795 IS - 11 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Ecklonia cava extract attenuates endothelial cell dysfunction by modulation of inflammation and brown adipocyte function in perivascular fat tissue T2 - Nutrients TI - Ecklonia cava extract attenuates endothelial cell dysfunction by modulation of inflammation and brown adipocyte function in perivascular fat tissue UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075060755&doi=10.3390%2fnu11112795&partnerID=40&md5=be390521590ef8fceecce1fd5ccbe042 VL - 11 ID - 5751 ER - TY - JOUR AD - Policy Analysis Inc., Brookline, MA, United States GlaxoSmithKline, Philadelphia, PA, United States AU - Hagiwara, M. AU - Borker, R. AU - Oster, G. DB - Scopus DO - 10.1016/j.clinthera.2013.10.010 IS - 12 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 SP - 1955-1963.e2 ST - Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma T2 - Clinical Therapeutics TI - Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890314255&doi=10.1016%2fj.clinthera.2013.10.010&partnerID=40&md5=db7fe5b71c848f7ff4ca6d9ecae2ea6e VL - 35 ID - 5752 ER - TY - JOUR AD - X.-J. Zhao AU - Zhao, X. J. AU - Zhuo, H. DB - Embase Medline DO - 10.1155/2014/850802 LA - English M3 - Article N1 - L612617938 2016-10-18 2016-11-02 PY - 2014 SN - 2314-6141 2314-6133 ST - ECR-MAPK regulation in liver early development T2 - BioMed Research International TI - ECR-MAPK regulation in liver early development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612617938&from=exporthttp://dx.doi.org/10.1155/2014/850802 VL - 2014 ID - 5753 ER - TY - JOUR AD - T. M. Horton, Texas Children's Cancer Center, Baylor College of Medicine, 1102 Bates, Houston, TX 77030, United States AU - Horton, T. M. AU - Berg, S. L. C1 - avastin clolar gleevec nexavar sprycel tasigna velcade yondelis zolinza DB - Embase Medline DO - 10.1007/s00431-010-1374-5 IS - 5 LA - English M3 - Review N1 - L51209450 2011-01-04 2011-05-17 PY - 2011 SN - 0340-6199 SP - 555-559 ST - Educational paper: The development of new therapies for pediatric oncology T2 - European Journal of Pediatrics TI - Educational paper: The development of new therapies for pediatric oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51209450&from=exporthttp://dx.doi.org/10.1007/s00431-010-1374-5 VL - 170 ID - 5754 ER - TY - JOUR AD - Jena University Hospital, Jena, Germany AU - Hochhaus, A. DB - Scopus DO - 10.1182/asheducation-2011.1.128 M3 - Review N1 - Cited By :43 Export Date: 18 November 2020 PY - 2011 SP - 128-135 ST - Educational session: managing chronic myeloid leukemia as a chronic disease T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Educational session: managing chronic myeloid leukemia as a chronic disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856508611&doi=10.1182%2fasheducation-2011.1.128&partnerID=40&md5=5c684c52ea64e4c4b48ceaf790d87c0c VL - 2011 ID - 5755 ER - TY - JOUR AD - Department of Ophthalmology, Seoul National University Hospital, 28 Yeongun-dong Chongro-ku, Seoul 110-744, South Korea AU - Lee, J. J. AU - Park, J. K. AU - Kim, Y. T. AU - Kwon, B. M. AU - Kang, S. G. AU - Yoo, Y. D. AU - Yu, Y. S. AU - Chung, H. DB - Scopus IS - 9 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2002 SP - 3117-3124 ST - Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model T2 - Investigative Ophthalmology and Visual Science TI - Effect of 2′-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036707518&partnerID=40&md5=8bceda66e3feac243bd2d1eeb642761c VL - 43 ID - 5756 ER - TY - JOUR AD - E. Saleh, Department of Pediatrics, Division of Pediatric Infectious Diseases, Duke Clinical Vaccine Unit, Duke University School of Medicine, 2608 Erwin Road, Suite 210, Durham, NC, United States AU - Saleh, E. AU - Moody, M. A. AU - Walter, E. B. DB - Embase Medline DO - 10.1080/21645515.2016.1183077 IS - 9 LA - English M3 - Review N1 - L612233240 2016-09-22 2016-09-30 PY - 2016 SN - 2164-554X 2164-5515 SP - 2391-2402 ST - Effect of antipyretic analgesics on immune responses to vaccination T2 - Human Vaccines and Immunotherapeutics TI - Effect of antipyretic analgesics on immune responses to vaccination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612233240&from=exporthttp://dx.doi.org/10.1080/21645515.2016.1183077 VL - 12 ID - 5757 ER - TY - JOUR AD - Q. He, Department of Pediatrics, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China AU - Zhang, X. AU - Cheng, Y. AU - Zhou, Q. AU - Huang, H. AU - Dong, Y. AU - Yang, Y. AU - Zhao, M. AU - He, Q. DB - Embase Medline DO - 10.1155/2020/2153912 LA - English M3 - Review N1 - L2006929289 2020-07-17 2020-07-22 PY - 2020 SN - 1942-0994 1942-0900 ST - The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy T2 - Oxidative Medicine and Cellular Longevity TI - The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006929289&from=exporthttp://dx.doi.org/10.1155/2020/2153912 VL - 2020 ID - 5758 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Global Research and Development, San Diego, CA, United States Department of Biostatistics, Allergan Inc., Irvine, CA, United States Department of Clinical Pharmacology, Pfizer Global Research and Development, 10578 Science Center Drive, San Diego, CA 92121, United States AU - Bello, C. L. AU - Sherman, L. AU - Zhou, J. AU - Verkh, L. AU - Smeraglia, J. AU - Mount, J. AU - Klamerus, K. J. DB - Scopus DO - 10.1097/00001813-200603000-00015 IS - 3 M3 - Article N1 - Cited By :121 Export Date: 18 November 2020 PY - 2006 SP - 353-358 ST - Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: Results from a phase I study in healthy subjects T2 - Anti-Cancer Drugs TI - Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: Results from a phase I study in healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646108821&doi=10.1097%2f00001813-200603000-00015&partnerID=40&md5=d2ad652f3910c9a48a436da2fa3e1664 VL - 17 ID - 5759 ER - TY - JOUR AD - QCP, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States Seda Pharmaceutical Development Services, The BioHub at Alderley Park, Alderley Edge, Cheshire, United Kingdom Department of Medicine, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, Lyon, France Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, United Kingdom Quintiles IMS, Overland Park, KS, United States START Madrid—FJD, Hospital Fundación Jimenez Díaz, Avenida Reyes Católicos 2, Madrid, Spain Oncology TMU, Early Clinical Development, AstraZeneca, Charter Way, Macclesfield, United Kingdom Karen Thomas Statistics Limited, 54 Pullman Lane, Godalming, Surrey, United Kingdom Drug Development Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom The Institute of Cancer Research, London, United Kingdom AU - Vishwanathan, K. AU - Dickinson, P. A. AU - Bui, K. AU - Cassier, P. A. AU - Greystoke, A. AU - Lisbon, E. AU - Moreno, V. AU - So, K. AU - Thomas, K. AU - Weilert, D. AU - Yap, T. A. AU - Plummer, R. DB - Scopus DO - 10.1002/jcph.1035 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - 474-484 ST - The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers T2 - Journal of Clinical Pharmacology TI - The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044463184&doi=10.1002%2fjcph.1035&partnerID=40&md5=ac7f34be63e9867df95a3901ee539df6 VL - 58 ID - 5760 ER - TY - JOUR AD - Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D3100, Seattle, WA 98109, United States San Raffaele Scientific Institute, Milan, Italy AU - Travi, G. AU - Pergam, S. A. AU - Xie, H. AU - Carpenter, P. AU - Kiem, H. P. AU - Corey, L. AU - Boeckh, M. J. DB - Scopus DO - 10.1086/648120 IS - 11 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2009 SP - s120-s123 ST - The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation T2 - Clinical Infectious Diseases TI - The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-72849109573&doi=10.1086%2f648120&partnerID=40&md5=e764359eaaf98095a90ea6f00db40453 VL - 49 ID - 5761 ER - TY - JOUR AD - Department of Anatomy, Melaka Manipal Medical College, Manipal University, Manipal 576104, India Melaka Manipal Medical College, Manipal University, Manipal 576104, India Kasturba Medical College, Manipal University, Manipal 576104, India AU - Prasad, A. M. AU - Ramnarayan, K. AU - Bairy, K. L. DB - Scopus M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2010 SP - 469-478 ST - Effect of imatinib on the reproductive function in male swiss albino mice T2 - Pharmacologyonline TI - Effect of imatinib on the reproductive function in male swiss albino mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953201109&partnerID=40&md5=649ecc42f0ae9a63f0ca046bba7c67e5 VL - 1 ID - 5762 ER - TY - JOUR AD - Department of Pathology, Linyi People's Hospital, Linyi, China Department of Infectious Diseases, Linyi People's Hospital, Linyi, China AU - Liu, L. AU - Wang, L. AU - Li, X. AU - Tian, P. AU - Xu, H. AU - Li, Z. AU - Liu, E. DB - Scopus DO - 10.1080/21691401.2019.1664561 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3729-3736 ST - Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo T2 - Artificial Cells, Nanomedicine and Biotechnology TI - Effect of miR-21 on apoptosis in hepatoblastoma cell through activating ASPP2/p38 signaling pathway in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072389678&doi=10.1080%2f21691401.2019.1664561&partnerID=40&md5=6ba37820f103e46f14e0ebc9747c55e9 VL - 47 ID - 5763 ER - TY - JOUR AD - F.-M. Xie, Department of Neurosurgery, Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Shandong Academy of Medical Sciences, Taian, China AU - Yang, F. AU - Xing, W. W. AU - Shen, D. W. AU - Tong, M. F. AU - Xie, F. M. DB - Embase Medline DO - 10.26355/eurrev_202003_20691 IS - 6 LA - English M3 - Article N1 - L2005488263 2020-04-14 2020-04-20 PY - 2020 SN - 2284-0729 1128-3602 SP - 3245-3253 ST - Effect of miR-126 on intracranial aneurysms and its predictive value for rupture of aneurysms T2 - European Review for Medical and Pharmacological Sciences TI - Effect of miR-126 on intracranial aneurysms and its predictive value for rupture of aneurysms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005488263&from=exporthttp://dx.doi.org/10.26355/eurrev_202003_20691 VL - 24 ID - 5764 ER - TY - JOUR AD - J. Chen, Three Gorges Central Hospital of Chongqing, New City Road 165, Wanzhou District, Chongqing, China AU - Yang, C. AU - Xuan, D. AU - Chen, T. AU - Chen, J. AU - Tang, L. AU - Yang, Z. AU - Li, Z. AU - Deng, E. C2 - GenePharma(United States) DB - Embase IS - 5 LA - English M3 - Article N1 - L616389182 2017-06-05 2017-06-07 PY - 2017 SN - 1940-5901 SP - 7767-7773 ST - The effect of miR27b on osteosarcoma cell proliferation and invasion T2 - International Journal of Clinical and Experimental Medicine TI - The effect of miR27b on osteosarcoma cell proliferation and invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616389182&from=export VL - 10 ID - 5765 ER - TY - JOUR AD - K. Manokaran, Department of Medical Laboratory Technology, School of Allied Health Sciences, Manipal Academy of Higher Education, Madhav Nagar, Near Tiger Circle, Manipal, Karnataka, India AU - Ma, H. AU - Li, D. AU - Rengarajan, T. AU - Manokaran, K. DB - Embase DO - 10.4103/pm.pm_418_17 IS - 55 LA - English M3 - Article N1 - L623742790 2018-09-07 2018-09-11 PY - 2018 SN - 0976-4062 0973-1296 SP - S237-S244 ST - Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways T2 - Pharmacognosy Magazine TI - Effect of simvastatin on neuroinflammation in microglial cells via mitogen-activated protein kinase and nuclear factor κb pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623742790&from=exporthttp://dx.doi.org/10.4103/pm.pm_418_17 VL - 14 ID - 5766 ER - TY - JOUR AD - C.-H. Hung, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan AU - Chiu, P. R. AU - Lee, W. T. AU - Chu, Y. T. AU - Lee, M. S. AU - Jong, Y. J. AU - Hung, C. H. DB - Embase Medline DO - 10.1016/S1875-9572(08)60028-5 IS - 4 LA - English M3 - Article N1 - L352749482 2008-12-31 PY - 2008 SN - 1875-9572 SP - 135-140 ST - Effect of the Chinese Herb Extract Osthol on IL-4-induced Eotaxin Expression in BEAS-2B Cells T2 - Pediatrics and Neonatology TI - Effect of the Chinese Herb Extract Osthol on IL-4-induced Eotaxin Expression in BEAS-2B Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352749482&from=exporthttp://dx.doi.org/10.1016/S1875-9572(08)60028-5 VL - 49 ID - 5767 ER - TY - JOUR AD - III. Medizinische Klinik, Klinikum Mannheim, Universitaet Heidelberg, Wiesbadenerstraße 7-11, D-68305 Mannheim, Germany III. Medizinische Klinik, Klinikum Mannheim, University of Heidelberg, Mannheim, Germany AU - Hummel, M. AU - Reiter, S. AU - Adam, K. AU - Hehlmann, R. AU - Buchheidt, D. DB - Scopus DO - 10.1111/j.1600-0609.2007.01013.x IS - 4 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2008 SP - 331-336 ST - Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase T2 - European Journal of Haematology TI - Effective treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449091758&doi=10.1111%2fj.1600-0609.2007.01013.x&partnerID=40&md5=cc5f8c245360955caeb19250e7141013 VL - 80 ID - 5768 ER - TY - JOUR AD - Peninsula Technol. Assessment Group, Exeter, United Kingdom Southampton Hlth. Technol. Assessm., Wessex Inst. for Hlth. Res./Devmt., Southampton, United Kingdom AU - Garside, R. AU - Round, A. AU - Dalziel, K. AU - Stein, K. AU - Royle, P. DB - Scopus DO - 10.3310/hta6330 IS - 33 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2002 ST - The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: A systematic review T2 - Health Technology Assessment TI - The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: A systematic review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045797522&doi=10.3310%2fhta6330&partnerID=40&md5=fb6ef6c6a28b53908b0b8453ee952226 VL - 6 ID - 5769 ER - TY - JOUR AD - Department of Medical Oncology, Clínica Universidad de Navarra, University of Navarra, Avda Pío XII, 36, Pamplona, 31008, Spain Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia Olivia Newton-John Cancer Research Institute at Austin Hospital, Heidelberg, VIC, Australia Gallipoli Medical Research Foundation, University of Queensland and Princess Alexandra Hospital, Brisbane, QLD, Australia School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia Auckland City Hospital, Auckland, New Zealand Melanoma Unit, European Institute of Oncology, Milano, Italy Department of Medical Oncology, Candiolo Cancer Institute, University of Torino, Torino, Italy Melanoma and Esophageal Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura A Carattere Scientifico, Padova, Italy Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy Department of Medical Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy UOC Oncologia Medica, IRCCS San Martino-IST, Genova, Italy Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom First Department of Oncology, Metropolitan Hospital, Athens, Greece UBC, Lörrach, Germany UBC, Montreal, QC, Canada Novartis Norge AS, Oslo, Norway Novartis Pharma AG, Basel, Switzerland AU - Martin-Algarra, S. AU - Hinshelwood, R. AU - Mesnage, S. AU - Cebon, J. AU - Ferrucci, P. F. AU - Aglietta, M. AU - Neyns, B. AU - Chiarion-Sileni, V. AU - Lindsay, C. R. AU - Del Vecchio, M. AU - Linardou, H. AU - Merelli, B. AU - Tonini, G. AU - Atkinson, V. AU - Freivogel, K. AU - Stein, D. AU - Dalland, L. AU - Lau, M. AU - Legenne, P. AU - Queirolo, P. AU - Millward, M. DB - Scopus DO - 10.1097/CMR.0000000000000608 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 527-532 ST - Effectiveness of dabrafenib in the treatment of patients with braf v600-mutated metastatic melanoma in a named patient program T2 - Melanoma Research TI - Effectiveness of dabrafenib in the treatment of patients with braf v600-mutated metastatic melanoma in a named patient program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071713811&doi=10.1097%2fCMR.0000000000000608&partnerID=40&md5=480058145b908e36fd4c14d0b60a790f VL - 29 ID - 5770 ER - TY - JOUR AD - Rocky Mountain Cancer Centers, 1700 S Potomac Street, Aurora, CO 80012, United States McKesson Specialty Health/US Oncology Network, Woodlands, TX, United States Bristol-Myers Squibb, Princeton, NJ, United States AU - Di Bella, N. J. AU - Bhowmik, D. AU - Bhor, M. AU - Yap, M. AU - Middlebrook, B. AU - Rembert, D. AU - Cain, Z. AU - Okoro, T. AU - Bolinder, B. AU - Patt, D. AU - Jabbour, E. J. DB - Scopus DO - 10.1016/j.clml.2015.06.006 IS - 10 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 599-605 ST - The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Community Setting T2 - Clinical Lymphoma, Myeloma and Leukemia TI - The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Community Setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942827594&doi=10.1016%2fj.clml.2015.06.006&partnerID=40&md5=3e688cba79a9f56f9fd04124626c79bf VL - 15 ID - 5771 ER - TY - JOUR AD - Department of Physiology and Pharmacology, Karolinska Institutet, Sweden AU - Chagin, A. S. DB - Scopus DO - 10.1016/j.coph.2016.02.004 M3 - Review N1 - Cited By :40 Export Date: 18 November 2020 PY - 2016 SP - 1-7 ST - Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton T2 - Current Opinion in Pharmacology TI - Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959076797&doi=10.1016%2fj.coph.2016.02.004&partnerID=40&md5=d1e1f7141510bcbec7e67a9510ed950c VL - 28 ID - 5772 ER - TY - JOUR AD - Laboratory of Immunology and Virology, Shanghai University of Traditional Chinese Medicine, Shanghai, China Central Laboratory, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China Hutchison MediPharma Ltd, Shanghai, China Department of Emergency, Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China AU - Qian, H. AU - Fan, S. AU - Li, K. AU - Sai, Y. AU - Su, W. AU - Chen, Q. AU - Liu, Y. AU - Li, T. AU - Wang, W. AU - Jia, J. AU - Yu, C. AU - Liu, Y. DB - Scopus DO - 10.1016/j.clinthera.2019.05.014 IS - 8 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 1537-1544 ST - Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects T2 - Clinical Therapeutics TI - Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068055019&doi=10.1016%2fj.clinthera.2019.05.014&partnerID=40&md5=4b37a1c50f12baa96d8709131d8416bc VL - 41 ID - 5773 ER - TY - JOUR AD - University of Texas M.D. Anderson Cancer Center, Houston, TX, United States University of Milano-Bicocca, Monza, Italy Seoul St Mary's Hospital, Seoul, South Korea Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, Canada University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States Pfizer Inc, New York, NY, United States Pfizer Inc, Cambridge, MA, United States Universitätsklinikum RWTH Aachen, Aachen, Germany Department of Internal Medicine II, Hubertus Wald Tumorzentrum University Cancer Center Hamburg, Hamburg, Germany Winship Cancer Institute of Emory University, Atlanta, GA, United States AU - Cortes, J. E. AU - Gambacorti-Passerini, C. AU - Kim, D. W. AU - Kantarjian, H. M. AU - Lipton, J. H. AU - Lahoti, A. AU - Talpaz, M. AU - Matczak, E. AU - Barry, E. AU - Leip, E. AU - Brümmendorf, T. H. AU - Khoury, H. J. DB - Scopus DO - 10.1016/j.clml.2017.06.001 IS - 10 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 684-695.e6 ST - Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028350315&doi=10.1016%2fj.clml.2017.06.001&partnerID=40&md5=2d7f1d7e699b9d2b2293355529172723 VL - 17 ID - 5774 ER - TY - JOUR AU - Kong, X. AU - Yang, M. AU - Guo, J. AU - Feng, Z. DB - Medline DO - 10.1097/MPG.0000000000002636 IS - 5 LA - English M3 - Article N1 - L630707984 2020-01-31 PY - 2020 SN - 1536-4801 SP - 645-651 ST - Effects of Bovine Lactoferrin on Rat Intestinal Epithelial Cells T2 - Journal of pediatric gastroenterology and nutrition TI - Effects of Bovine Lactoferrin on Rat Intestinal Epithelial Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630707984&from=exporthttp://dx.doi.org/10.1097/MPG.0000000000002636 VL - 70 ID - 5775 ER - TY - JOUR AD - F. Rossi, Department of Women, Child and General and Specialist Surgery, University of Campania 'Luigi Vanvitelli', Naples, Italy AU - Punzo, F. AU - Manzo, I. AU - Tortora, C. AU - Pota, E. AU - D'Angelo, V. AU - Bellini, G. AU - Di Paola, A. AU - Verace, F. AU - Casale, F. AU - Rossi, F. C1 - jwh 133(Tocris,United States) C2 - Tocris(United States) DB - Embase DO - 10.18632/oncotarget.25052 IS - 30 LA - English M3 - Article N1 - L621802627 2018-04-30 2018-05-09 PY - 2018 SN - 1949-2553 SP - 21244-21258 ST - Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia T2 - Oncotarget TI - Effects of CB2 and TRPV1 receptors' stimulation in pediatric acute T-lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621802627&from=exporthttp://dx.doi.org/10.18632/oncotarget.25052 VL - 9 ID - 5776 ER - TY - JOUR AD - Departments of Pathology, Brown University, Providence, RI 02905, United States Department of Pharmacy, Women and Infants Hospital, Brown University, Providence, RI 02905, United States Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02905, United States AU - Abellar, R. G. AU - Pepperell, J. R. AU - Greco, D. AU - Gundogan, F. AU - Kostadinov, S. AU - Schwartz, J. AU - Tantravahi, U. AU - De Paepe, M. E. DB - Scopus DO - 10.2350/08-03-0435.1 IS - 1 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2009 SP - 35-41 ST - Effects of chemotherapy during pregnancy on the placenta T2 - Pediatric and Developmental Pathology TI - Effects of chemotherapy during pregnancy on the placenta UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-61449181312&doi=10.2350%2f08-03-0435.1&partnerID=40&md5=fca86d69be9f45b6dcfd60ad8d90239b VL - 12 ID - 5777 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, Guro Hospital, Korea University College of Medicine, 80 Guro-dong, Guro-gu, Seoul, 152-703, South Korea AU - Cho, J. G. AU - Woo, J. S. AU - Lee, H. M. AU - Jung, H. H. AU - Hwang, S. J. AU - Chae, S. DB - Scopus DO - 10.1016/j.ijporl.2009.07.016 IS - 10 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2009 SP - 1447-1451 ST - Effects of cigarette smoking on mucin production in human middle ear epithelial cells T2 - International Journal of Pediatric Otorhinolaryngology TI - Effects of cigarette smoking on mucin production in human middle ear epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249209696&doi=10.1016%2fj.ijporl.2009.07.016&partnerID=40&md5=e39360a2a5be8bef2af6e27915c15a22 VL - 73 ID - 5778 ER - TY - JOUR AD - Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan Department of Hematology, Harasanshin Hospital, 1-8 Taihaku-machi, Hakata-ku, Fukuoka, 812-0033, Japan Department of Hematology, Hamanomachi Hospital, 3-1-1 Nagahama Chuo-ku, Fukuoka, 810-8539, Japan Department of Internal Medicine, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Tsurumi, Beppu, 874-0838, Japan Department of Internal Medicine, Kitakyushu Municipal Medical Center, 2-1-1 Bashaku, Kokurakita-ku, Kitakyushu, 802-0077, Japan Department of Medicine, Division of Hematology and Oncology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan Department of Hematology, Hokkaido University Graduate School of Medicine, N15 W7, Kita-Ku, Sapporo, 060-8638, Japan AU - Takashima, S. AU - Miyamoto, T. AU - Kamimura, T. AU - Yoshimoto, G. AU - Yoshida, S. AU - Henzan, H. AU - Takase, K. AU - Kato, K. AU - Ito, Y. AU - Ohno, Y. AU - Nagafuji, K. AU - Eto, T. AU - Teshima, T. AU - Akashi, K. DB - Scopus DO - 10.1007/s12185-015-1883-0 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 689-696 ST - Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - International Journal of Hematology TI - Effects of conditioning intensity in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949102205&doi=10.1007%2fs12185-015-1883-0&partnerID=40&md5=fee923e5f20172d4f813d9400e0d66a2 VL - 102 ID - 5779 ER - TY - JOUR AD - Department of Hematology, Marmara University Hospital, Istanbul, Turkey Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey AU - Kaygusuz Atagunduz, I. AU - Toptas, T. AU - Deniz, R. AU - Kara, O. AU - Eser, A. AU - Sezgin, A. AU - Ozgumus, T. AU - Gecgel, F. AU - Firatli Tuglular, T. DB - Scopus DO - 10.1016/j.clml.2016.09.006 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 120-125 ST - Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011636538&doi=10.1016%2fj.clml.2016.09.006&partnerID=40&md5=14c51b0729755e0df599d9e89452fb7e VL - 17 ID - 5780 ER - TY - JOUR AD - Department of Pediatric Oncology, Catholic University of Rome, Largo A. Gemelli, 8, 00168 Rome, Italy Unit of Cancer Stem Cell Biology, Stemgen SPA, Milan, Italy Department of Pathology, Policlinico Gemelli, Rome, Italy Mendel Laboratory, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy Institute of Neurosurgery, Catholic University, Rome, Italy AU - Servidei, T. AU - Meco, D. AU - Trivieri, N. AU - Patriarca, V. AU - Vellone, V. G. AU - Zannoni, G. F. AU - Lamorte, G. AU - Pallini, R. AU - Riccardi, R. DB - Scopus DO - 10.1002/ijc.27377 IS - 5 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - E791-E803 ST - Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models T2 - International Journal of Cancer TI - Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863206336&doi=10.1002%2fijc.27377&partnerID=40&md5=543aef842163570fbd7f1cb61a8c50ad VL - 131 ID - 5781 ER - TY - JOUR AD - Joint Surgery Department, No.1 Hospital of Jilin University, Changchun, China Jilin Provincial Key Laboratory for Molecular Biology of Special Economic Animals, Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Beijing, China AU - Han, Y. AU - Zhao, X. AU - Sun, Y. AU - Sui, Y. AU - Liu, J. DB - Scopus DO - 10.1002/jcp.27048 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 SP - 3598-3612 ST - Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway T2 - Journal of Cellular Physiology TI - Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057008406&doi=10.1002%2fjcp.27048&partnerID=40&md5=49cb3be911db2afcbf74ddaddc2470a4 VL - 234 ID - 5782 ER - TY - JOUR AD - Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States Novartis Pharma AG, Basel, Switzerland Novartis Institutes for BioMedical Research, East Hanover, NJ, United States Hunter Holmes McGuire VA Medical Center, Richmond, VA, United States AU - Yin, O. Q. P. AU - Gallagher, N. AU - Tanaka, C. AU - Fisher, D. AU - Sethuraman, V. AU - Zhou, W. AU - Lin, T. H. AU - Heuman, D. AU - Schran, H. DB - Scopus DO - 10.1016/j.clinthera.2009.11.015 IS - PART. 2 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2009 SP - 2459-2469 ST - Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study T2 - Clinical Therapeutics TI - Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74549214984&doi=10.1016%2fj.clinthera.2009.11.015&partnerID=40&md5=b863e682b43abb2573cada7451c7a336 VL - 31 ID - 5783 ER - TY - JOUR AU - Wang, H. L. AU - Liang, N. AU - Huang, D. X. AU - Zhao, X. Y. AU - Dang, Q. Y. AU - Jiang, X. Y. AU - Xiao, R. AU - Yu, H. L. DB - Medline DO - 10.1016/j.placenta.2020.10.024 LA - English M3 - Article in Press N1 - L633369802 2020-11-16 PY - 2020 SN - 1532-3102 SP - 199-205 ST - The effects of high-density lipoprotein and oxidized high-density lipoprotein on forskolin-induced syncytialization of BeWo cells T2 - Placenta TI - The effects of high-density lipoprotein and oxidized high-density lipoprotein on forskolin-induced syncytialization of BeWo cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633369802&from=exporthttp://dx.doi.org/10.1016/j.placenta.2020.10.024 VL - 103 ID - 5784 ER - TY - JOUR AD - Department of Genetics, Institute for Experimental Medicine, Istanbul University, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Hacettepe University Medical School, TR-06100 Sihhiye-Ankara, Turkey Department of Internal Medicine, Haematology Division, Marmara University Medical Faculty, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Marmara School of Medicine Hospital, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Osmangazi University Medical Faculty, Eskisehir, Turkey Department of Internal Medicine, Haematology Division, Erciyes University Medical Faculty, Kayseri, Turkey Department of Internal Medicine, Haematology Division, Karadeniz Technical University Medical Faculty, Trabzon, Turkey Department of Internal Medicine, Haematology Division, Istanbul University Medical Faculty, Istanbul, Turkey Department of Internal Medicine, Haematology Division, Ankara Numune Hospital, Ankara, Turkey Department of Internal Medicine, Haematology Division, Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey Medical Department, Novartis Oncology Turkey, Istanbul, Turkey Department of Internal Medicine, Genetics Division, Ankara University Medical Faculty, Ankara, Turkey Department of Internal Medicine, Haematology Division, Ankara University Medical Faculty, Ankara, Turkey AU - Sayitoglu, M. AU - Haznedaroǧlu, I. C. AU - Hatirnaz, O. AU - Erbilgin, Y. AU - Aksu, S. AU - Koca, E. AU - Adiguzel, C. AU - Bayik, M. AU - Akalin, I. AU - Gülbas, Z. AU - Akay, M. AU - Unal, A. AU - Kaynar, L. AU - Ovali, E. AU - Yilmaz, M. AU - Yenerel, M. AU - Dagdas, S. AU - Ozet, G. AU - Ar, C. AU - Aydin, Y. AU - Soysal, T. AU - Durgun, B. AU - Ozcebe, O. AU - Tukun, A. AU - Ilhan, O. AU - Ozbek, U. DB - Scopus DO - 10.1177/147323000903700406 IS - 4 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2009 SP - 1018-1028 ST - Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia T2 - Journal of International Medical Research TI - Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350494257&doi=10.1177%2f147323000903700406&partnerID=40&md5=7d4504152ee660de7165a08b45b6d677 VL - 37 ID - 5785 ER - TY - JOUR AD - AVEO Oncology, Cambridge, MA, United States Covance, Madison, WI, United States Covance, Daytona, FL, United States Alnylam Pharmaceuticals, Cambridge, MA, United States AU - Cotreau, M. M. AU - Siebers, N. M. AU - Miller, J. AU - Strahs, A. L. AU - Slichenmyer, W. DB - Scopus DO - 10.1002/cpdd.145 IS - 2 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2015 SP - 137-142 ST - Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor T2 - Clinical Pharmacology in Drug Development TI - Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924935950&doi=10.1002%2fcpdd.145&partnerID=40&md5=656e0a617bac680b9c7ff0c9bc870623 VL - 4 ID - 5786 ER - TY - JOUR AD - USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Los Angeles, CA 90033, United States University of Alabama at Birmingham, Birmingham, AL, United States Clinical Assay Unit Phase I-II, Virgen del Rocío University Hospital, Seville University, Seville, Spain Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH, United States Bristol-Myers Squibb, Princeton, NJ, United States AU - El-Khoueiry, A. AU - Posey, J. A. AU - Castillo Ferrando, J. R. AU - Krishnamurthi, S. S. AU - Syed, S. AU - Kollia, G. AU - Walters, I. AU - Fischer, B. S. AU - Masson, E. DB - Scopus DO - 10.1007/s00280-013-2168-z IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - 53-64 ST - The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases T2 - Cancer Chemotherapy and Pharmacology TI - The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879799535&doi=10.1007%2fs00280-013-2168-z&partnerID=40&md5=b9c47f6f4cc438b355c7fda8cdb8efc5 VL - 72 ID - 5787 ER - TY - JOUR AD - W. Pan, Department of Pediatrics, The Second Hospital of Jilin University, Changchun, China AU - Xu, X. H. AU - Zhang, S. J. AU - Hu, Q. B. AU - Song, X. Y. AU - Pan, W. DB - Embase DO - 10.1002/jcb.27559 IS - 2 LA - English M3 - Article N1 - L624319485 2018-10-17 2018-12-28 PY - 2019 SN - 1097-4644 0730-2312 SP - 2594-2606 ST - Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway T2 - Journal of Cellular Biochemistry TI - Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624319485&from=exporthttp://dx.doi.org/10.1002/jcb.27559 VL - 120 ID - 5788 ER - TY - JOUR AD - J. A. Martinez-Agosto, Division of Medical Genetics, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States AU - Chiang, J. AU - Martinez-Agosto, J. A. DB - Embase DO - 10.3390/cells1040886 IS - 4 L1 - internal-pdf://0776532036/cells-01-00886.pdf LA - English M3 - Article N1 - L368409405 2013-03-05 2013-06-04 PY - 2012 SN - 2073-4409 SP - 886-904 ST - Effects of mTOR inhibitors on components of the salvador-warts-hippo pathway T2 - Cells TI - Effects of mTOR inhibitors on components of the salvador-warts-hippo pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368409405&from=exporthttp://dx.doi.org/10.3390/cells1040886 VL - 1 ID - 5789 ER - TY - JOUR AD - A.K.L. Goey, Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands AU - Goey, A. K. L. AU - With, M. D. AU - Agema, B. C. AU - Hoop, E. O. D. AU - Singh, R. K. AU - Van Der Veldt, A. A. M. AU - Mathijssen, R. H. J. AU - Van Schaik, R. H. N. AU - Bins, S. DB - Embase Medline DO - 10.2217/pgs-2019-0101 IS - 18 LA - English M3 - Article N1 - L630253861 2019-12-27 2019-12-31 PY - 2019 SN - 1744-8042 1462-2416 SP - 1283-1290 ST - Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma T2 - Pharmacogenomics TI - Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630253861&from=exporthttp://dx.doi.org/10.2217/pgs-2019-0101 VL - 20 ID - 5790 ER - TY - JOUR AD - People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China. Key Laboratory of Integrative Kidney Disease in Fujian Province, Fuzhou, Fujian, China. Fuzhou General Hospital of Nanjing Military District, Fuzhou, Fujian, China. Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China zjiandr@163.com. Key Laboratory of Integrative Kidney Disease in Fujian Province, Fuzhou, Fujian, China zjiandr@163.com. AN - 27706571 AU - Ai, S. AU - Lin, Y. Y. AU - Zheng, J. AU - Qiu, C. X. AU - Liu, Y. J. AU - Lin, X. DA - Aug 19 DO - 10.4238/gmr.15038131 10.4238/gmr.15038131. DP - Nlm ET - 2016/10/06 IS - 3 LA - eng PY - 2016 SN - 1676-5680 ST - Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy T2 - Genet Mol Res TI - Effects of Shenkangling intervention on the MAPK pathway in rats with doxorubicin-induced nephropathy VL - 15 ID - 5791 ER - TY - JOUR AD - Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. martin.sramek@mail.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. martin.sramek@mail.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. martin.sramek@mail.muni.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. jneradil@sci.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. jneradil@sci.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. jneradil@sci.muni.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. macigova@med.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. macigova@med.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. mudry.peter@fnbrno.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. polaskova.kristyna@fnbrno.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. polaskova.kristyna@fnbrno.cz. Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic. ondrej.slaby@ceitec.muni.cz. Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic. hana.noskova@ceitec.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. sterba.jaroslav@fnbrno.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. sterba.jaroslav@fnbrno.cz. Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, 61137 Brno, Czech Republic. veselska@sci.muni.cz. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 66263 Brno, Czech Republic. veselska@sci.muni.cz. International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic. veselska@sci.muni.cz. AN - 30200486 AU - Sramek, M. AU - Neradil, J. AU - Macigova, P. AU - Mudry, P. AU - Polaskova, K. AU - Slaby, O. AU - Noskova, H. AU - Sterba, J. AU - Veselska, R. C2 - PMC6163232 DA - Sep 1 DO - 10.3390/ijms19092599 10.3390/ijms19092599. DP - Nlm ET - 2018/09/12 IS - 9 LA - eng PY - 2018 SN - 1422-0067 ST - Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis T2 - Int J Mol Sci TI - Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis VL - 19 ID - 5792 ER - TY - JOUR AD - P.E. Zage AU - Zage, P. E. AU - Subramonian, D. AU - Mo, Q. AU - Huang, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617435606 2017-07-26 PY - 2017 SN - 0732-183X ST - Effects of the multikinase inhibitor regorafenib in neuroblastoma T2 - Journal of Clinical Oncology TI - Effects of the multikinase inhibitor regorafenib in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617435606&from=export VL - 35 ID - 5793 ER - TY - JOUR AD - Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China AU - Wang, Y. AU - Lu, M. AU - Zhou, Y. AU - Zhou, S. AU - Yu, X. AU - Tang, F. AU - Luo, Y. AU - Zhang, W. AU - Duan, H. AU - Min, L. AU - Tu, C. DB - Scopus DO - 10.2147/CMAR.S254296 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 5255-5264 ST - The efficacy and safety of apatinib in advanced synovial sarcoma: A case series of twenty-one patients in one single institution T2 - Cancer Management and Research TI - The efficacy and safety of apatinib in advanced synovial sarcoma: A case series of twenty-one patients in one single institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087385601&doi=10.2147%2fCMAR.S254296&partnerID=40&md5=55b0db6d26005413fb0658c2feb20628 VL - 12 ID - 5794 ER - TY - JOUR AD - Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China AU - Wang, Y. AU - Min, L. AU - Zhou, Y. AU - Tang, F. AU - Luo, Y. AU - Zhang, W. AU - Duan, H. AU - Tu, C. DB - Scopus DO - 10.2147/CMAR.S198429 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3583-3591 ST - The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: A case series of six patients in one institution T2 - Cancer Management and Research TI - The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: A case series of six patients in one institution UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065513078&doi=10.2147%2fCMAR.S198429&partnerID=40&md5=56c4baa0068e1d3a351c43d8f316608c VL - 11 ID - 5795 ER - TY - JOUR AD - Department of Oncology Minimally Invasive, The 307th Hospital of PLA, Affiliated Hospital of Military Medical Sciences, Beijing, China AU - Zhu, B. AU - Li, J. AU - Xie, Q. AU - Diao, L. AU - Gai, L. AU - Yang, W. DB - Scopus DO - 10.1080/15384047.2017.1416275 IS - 3 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2018 SP - 198-204 ST - Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study T2 - Cancer Biology and Therapy TI - Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040991975&doi=10.1080%2f15384047.2017.1416275&partnerID=40&md5=460c33dde9e104e1bb6546dd66487319 VL - 19 ID - 5796 ER - TY - JOUR AD - Pediatric Oncology Unit, UCL Great Ormond Street Institute of Child Health, London, United Kingdom. darren.hargrave@nhs.net. Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Arthur and Sonia Labatt Brain Tumor Research Center, Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Division of Pediatric Oncology, Baltimore, Maryland. Department of Pediatrics, The Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Victoria, Australia. Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. Novartis Healthcare Pvt. Ltd., Hyderabad, India. Harvard Medical School, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. AN - 31811016 AU - Hargrave, D. R. AU - Bouffet, E. AU - Tabori, U. AU - Broniscer, A. AU - Cohen, K. J. AU - Hansford, J. R. AU - Geoerger, B. AU - Hingorani, P. AU - Dunkel, I. J. AU - Russo, M. W. AU - Tseng, L. AU - Dasgupta, K. AU - Gasal, E. AU - Whitlock, J. A. AU - Kieran, M. W. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-19-2177 10.1158/1078-0432.CCR-19-2177. DP - Nlm ET - 2019/12/08 IS - 24 LA - eng PY - 2019 SN - 1078-0432 (Print) 1078-0432 SP - 7303-7311 ST - Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study T2 - Clin Cancer Res TI - Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study VL - 25 ID - 5797 ER - TY - JOUR AD - Service de gynécologie-obstétrique, hÔpital Foch, 40 rue Worth, Suresnes, France Inserm, UMRS-1139, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France PremUp Foundation, Paris, France Service de pharmacologie et d'analyse du médicament, Gustave Roussy, Villejuif, France Université Paris-Sud, France Service de pneumologie, hÔpital Foch, 40 rue Worth, Suresnes, France Faculté de Medecine Paris-Ile de France-Ouest, Université Versailles Saint Quentin en Yvelines, France UPRES EA220, Foch Hospital, University of Versailles Saint-Quentin, Suresnes, France AU - Gil, S. AU - Goetgheluck, J. AU - Paci, A. AU - Broutin, S. AU - Friard, S. AU - Couderc, L. J. AU - Ayoubi, J. M. AU - Picone, O. AU - Tcherakian, C. DB - Scopus DO - 10.1016/j.lungcan.2014.06.003 IS - 3 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 481-484 ST - Efficacy and safety of gefitinib during pregnancy: Case report and literature review T2 - Lung Cancer TI - Efficacy and safety of gefitinib during pregnancy: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926420857&doi=10.1016%2fj.lungcan.2014.06.003&partnerID=40&md5=8c34935a79b26ffca5de8947875a9651 VL - 85 ID - 5798 ER - TY - JOUR AD - Department of Haematology, Bombay Hospital and Medical Research Centre, Mumbai Hematology Group, Hematology Centre, Ghamat Lodge, 804.A, Dr. B. Ambedkar Road, Dadar, Mumbai, Maharashtra 400 014, India Department of Hemato-Oncology and Bone Marrow Transplant, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India Department of Medical Oncology and Haematology, Apollo Hospitals International, Ahmedabad, Gujarat, India Department of Medical Oncology and Haematology, Medanta-The Medicity, Gurgaon, Haryana, India Departmemt of Medical Oncology, Indraprastha Apollo Hospitals, New Delhi, India Departmemt of Oncology and Haematology, Jupiter Hospital, Thane, Maharashtra, India Department of Haematology, Haemato-oncology and Bone Marrow Transplant, MIOT Hospitals, Chennai, Tamil Nadu, India Medical Affairs, Janssen, Mumbai, India AU - Agarwal, M. B. AU - Bhurani, D. AU - Shah, C. AU - Sood, N. AU - Singhal, M. AU - Kamat, A. AU - Chezhian, S. AU - Mishra, S. AU - Nagrale, D. DB - Scopus DO - 10.4103/ijmpo.ijmpo_43_17 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 508-515 ST - Efficacy and safety of ibrutinib in indian patients with relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma: Cases from a named patient program T2 - Indian Journal of Medical and Paediatric Oncology TI - Efficacy and safety of ibrutinib in indian patients with relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma: Cases from a named patient program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041447328&doi=10.4103%2fijmpo.ijmpo_43_17&partnerID=40&md5=baaac71685ee1837c5a50d5ab5151d8a VL - 38 ID - 5799 ER - TY - JOUR AD - Dana-Farber Cancer Institute, Harvard Cancer Center, Boston Fox Chase Cancer Center, Philadelphia Oregon Health and Science University, Portland Veterans Affairs Medical Center, Portland University of Turku, Turku, Finland Novartis Oncology, Basel, Switzerland University of Helsinki, Helsinki, Finland Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, SW 530, 44 Binney St., Boston, MA 02115, United States AU - Demetri, G. D. AU - Von Mehren, M. AU - Blanke, C. D. AU - Van Den Abbeele, A. D. AU - Eisenberg, B. AU - Roberts, P. J. AU - Heinrich, M. C. AU - Tuveson, D. A. AU - Singer, S. AU - Janicek, M. AU - Fletcher, J. A. AU - Silverman, S. G. AU - Silberman, S. L. AU - Capdeville, R. AU - Kiese, B. AU - Peng, B. AU - Dimitrijevic, S. AU - Druker, B. J. AU - Corless, C. AU - Fletcher, C. D. M. AU - Joensuu, H. DB - Scopus DO - 10.1056/NEJMoa020461 IS - 7 M3 - Article N1 - Cited By :3439 Export Date: 18 November 2020 PY - 2002 SP - 472-480 ST - Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors T2 - New England Journal of Medicine TI - Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037103424&doi=10.1056%2fNEJMoa020461&partnerID=40&md5=8ff0a99fd6795afafebc3fb378d9a9d0 VL - 347 ID - 5800 ER - TY - JOUR AD - Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing 100034, China Department of Urology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China AU - Li, X. S. AU - Wu, X. AU - Zhao, P. J. AU - Huang, L. H. AU - Song, Y. AU - Gong, K. AU - Shen, C. AU - Yu, W. AU - Song, G. AU - Zhao, Z. AU - Zhang, Z. AU - Zhang, Q. AU - Wang, G. AU - He, Z. S. AU - Zhou, L. Q. AU - Jin, J. DB - Scopus DO - 10.3760/cma.j.issn.0366-6999.2011.18.023 IS - 18 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2011 SP - 2920-2924 ST - Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma T2 - Chinese Medical Journal TI - Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052975506&doi=10.3760%2fcma.j.issn.0366-6999.2011.18.023&partnerID=40&md5=6ec66ecdde0b6e9cced1445aa06b44d9 VL - 124 ID - 5801 ER - TY - JOUR AD - Departments of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Department of Anesthesiology, Tianjin Hospital, Tianjin, Tianjin, 300000, China Molecular Imaging, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pharmacological Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Key Laboratory of Molecular Cancer Epidemiology, Tianjin, 300060, China AU - Liu, X. AU - Xu, J. AU - Li, F. AU - Liao, Z. AU - Ren, Z. AU - Zhu, L. AU - Shi, Y. AU - Zhao, G. AU - Bai, X. AU - Zhao, J. AU - Xing, R. AU - Teng, S. AU - Yang, Y. AU - Yang, J. C7 - 109587 DB - Scopus DO - 10.1016/j.biopha.2019.109587 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846 T2 - Biomedicine and Pharmacotherapy TI - Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075526595&doi=10.1016%2fj.biopha.2019.109587&partnerID=40&md5=86f60c405fdf02ea3e7e0937064901fa VL - 122 ID - 5802 ER - TY - JOUR AD - Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita 010-8543, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan Division of Hematology, Department of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan Department of Hematology, Nippon Medical School, Tokyo, Japan Department of Hematology, Chiba University Hospital, Chiba, Japan Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan Japanese Red Cross Aichi Blood Center, Seto, Japan Kindai University Faculty of Medicine, Osaka-Sayama, Japan National Hospital Organization Nagoya Medical Center, Nagoya, Japan AU - Kizaki, M. AU - Takahashi, N. AU - Iriyama, N. AU - Okamoto, S. AU - Ono, T. AU - Usui, N. AU - Inokuchi, K. AU - Nakaseko, C. AU - Kurokawa, M. AU - Sumi, M. AU - Nakamura, F. AU - Kawaguchi, T. AU - Suzuki, R. AU - Yamamoto, K. AU - Ohnishi, K. AU - Matsumura, I. AU - Naoe, T. AU - Kizaki, M. AU - Mori, S. AU - Nemoto, T. AU - Sagawa, M. AU - Tabayashi, T. AU - Tokuhira, M. AU - Tomikawa, T. AU - Watanabe, R. AU - Hatta, Y. AU - Inoue, Y. AU - Iriyama, N. AU - Kobayashi, S. AU - Kobayashi, Y. AU - Kurita, D. AU - Karigane, D. AU - Kasahara, H. AU - Koda, Y. AU - Miyakawa, Y. AU - Murakami, K. AU - Okamoto, S. AU - Watanuki, S. AU - Ono, T. AU - Nagata, Y. AU - Takeshita, A. AU - Takahashi, N. AU - Kameoka, Y. AU - Yoshioka, T. AU - Takahashi, S. AU - Usui, N. AU - Dan, K. AU - Inokuchi, K. AU - Nakamura, K. AU - Abe, D. AU - Nakaseko, C. AU - Ohwada, C. AU - Sakaida, E. AU - Shimizu, N. AU - Takeuchi, M. AU - Arai, S. AU - Kogure, Y. AU - Koya, A. AU - Masamoto, Y. AU - Masuda, A. AU - Nakazaki, K. AU - Toyama, K. AU - Hiroshima, Y. AU - Ichikawa, N. AU - Kirihara, T. AU - Kobayashi, H. AU - Shimizu, I. AU - Sumi, M. AU - Ueki, T. AU - Hagiwara, S. AU - Hirai, R. AU - Miwa, T. AU - Nakamura, F. AU - Nakamura, M. AU - Takeshita, M. AU - Tanimura, A. AU - Hayakawa, F. AU - Ishikawa, Y. AU - Kiyoi, H. AU - Murata, M. AU - Tomita, A. AU - Kurokawa, T. AU - Sugimori, C. AU - Arai, A. AU - Miura, O. AU - Yamamoto, M. AU - Imai, K. AU - Kobayashi, N. AU - Minauchi, K. AU - Obara, M. AU - Ota, S. AU - Ikezoe, T. AU - Mori, M. AU - Sakai, M. AU - Taniguchi, A. AU - Togitani, K. AU - Hayakawa, H. AU - Kajiguchi, T. AU - Kamoshita, S. AU - Otsuka, E. AU - Nishida, A. AU - Saburi, M. AU - Saburi, Y. AU - Iida, H. AU - Kato, C. AU - Kojima, Y. AU - Ohashi, H. AU - Miyata, Y. AU - Sugimoto, K. AU - Yamamoto, H. AU - Yokozawa, T. AU - Kamae, T. AU - Kuyama, J. AU - Mitsui, H. AU - Morikawa, Y. AU - Uchida, Y. AU - Ashida, T. AU - Hirase, C. AU - Kawanishi, K. AU - Matsumura, I. AU - Miyatake, J. AU - Morita, Y. AU - Sano, T. AU - Shimada, T. AU - Tanaka, H. AU - Taniguchi, Y. AU - Tatsumi, Y. AU - Yamaguchi, K. AU - Ishida, F. AU - Momose, K. AU - Nakazawa, H. AU - Nishina, S. AU - Sakai, H. AU - Sekiguchi, N. AU - Ito, Y. AU - Ohyashiki, K. AU - Tauchi, T. AU - Hata, T. AU - Imaizumi, Y. AU - Imanishi, D. AU - Itonaga, H. AU - Makiyama, J. AU - Sawayama, Y. AU - Taguchi, J. AU - Taguchi, M. AU - Taniguchi, H. AU - Eguchi, G. AU - Matsuda, M. AU - Yamairi, N. AU - Fukushima, N. AU - Ozeki, K. AU - Kohno, A. AU - Sakura, T. AU - Takada, S. AU - Kobayashi, T. AU - Sakamaki, H. AU - Asou, N. AU - Kawaguchi, T. AU - Kiguchi, T. AU - Masunari, T. AU - Sezaki, N. AU - Iino, M. AU - Morinaga, K. AU - Ikeda, K. AU - Ogawa, K. AU - Noji, H. AU - Iwasaki, H. AU - Takenaka, K. AU - Miyamoto, T. AU - Handa, H. AU - Murakami, H. AU - Tsukamoto, N. AU - Eto, T. AU - Henzan, H. AU - Kamitsuji, Y. AU - Uoshima, N. AU - Hagihara, M. AU - Takahashi, H. AU - Emi, N. AU - Okamoto, M. AU - Kawakami, K. AU - Waki, M. AU - Fukuhara, N. AU - Harigae, H. AU - Murayama, T. AU - Mizuno, I. AU - Okumura, H. AU - Tsutsumi, Y. AU - Usuki, K. AU - Fujisaki, T. AU - Maeda, Y. AU - Suehiro, Y. AU - Suzushima, H. AU - Yamamoto, K. AU - Kanakura, Y. AU - Nagasaki, K. AU - Muto, H. AU - Fujisawa, S. AU - Adachi, M. AU - Mugitani, A. AU - Yamasaki, S. AU - Adachi, Y. AU - Kamimura, T. AU - Takamatsu, Y. AU - Ryu, T. AU - Chiba, S. AU - Ohishi, K. AU - Suzuki, K. AU - Ogawa, D. AU - Mihara, H. AU - Fujita, H. AU - Kubo, K. AU - Yokota, A. AU - Miyamura, K. AU - Yoshida, C. AU - Nakachi, S. AU - Myojyo, T. AU - Kitabayashi, A. AU - Suzumiya, J. AU - Hino, M. AU - Wakita, A. AU - Shibata, T. AU - Takahashi, T. AU - Takamatsu, H. AU - Fujimaki, K. AU - Tajika, K. AU - Mita, M. AU - Terui, Y. AU - Ito, M. AU - Yamane, T. AU - Yamauchi, T. AU - Kohara, Y. AU - Takebayashi, C. AU - Inagaki, A. AU - Tsuji, M. AU - Shinzaki, H. AU - Moriuchi, Y. AU - Ishikawa, M. AU - Miyazaki, K. AU - Shima, E. AU - Kinugawa, N. AU - the New, Target investigators DB - Scopus DO - 10.1007/s12185-019-02613-1 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2019 SP - 426-439 ST - Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system T2 - International Journal of Hematology TI - Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061644674&doi=10.1007%2fs12185-019-02613-1&partnerID=40&md5=7090aff2d3adf84576d7351fbf52a9aa VL - 109 ID - 5803 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea Cancer Emergency Room, Asan Cancer Center, University of Ulsan College of Medicine, Seoul, South Korea Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea AU - Lee, J. L. AU - Park, I. AU - Park, K. AU - Park, S. AU - Ahn, Y. AU - Ahn, J. H. AU - Kim, T. W. AU - Ahn, S. AU - Song, C. AU - Hong, J. H. AU - Kim, C. S. AU - Ahn, H. DB - Scopus DO - 10.1007/s00432-012-1148-8 IS - 4 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2012 SP - 687-693 ST - Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features T2 - Journal of Cancer Research and Clinical Oncology TI - Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863086907&doi=10.1007%2fs00432-012-1148-8&partnerID=40&md5=6e123fef1f8af3c7d178a87800c0e09a VL - 138 ID - 5804 ER - TY - JOUR AD - Y.P. Mosse AU - Mosse, Y. P. AU - Balis, F. M. AU - Lim, M. S. AU - Laliberte, J. AU - Voss, S. D. AU - Fox, E. AU - Bagatell, R. AU - Weigel, B. AU - Adamson, P. C. AU - Ingle, A. M. AU - Ahern, C. H. AU - Blaney, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71005095 2013-03-08 PY - 2012 SN - 0732-183X ST - Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study T2 - Journal of Clinical Oncology TI - Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71005095&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/30/15_suppl/9500?sid=43ece5a8-cdf8-4d8c-9686-ddebd9604458 VL - 30 ID - 5805 ER - TY - JOUR AD - Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5843, United States Department of Pathology, University of Michigan, Ann Arbor, MI, United States Department of Radiology, University of Michigan, Ann Arbor, MI, United States Division of Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Memorial Sloan-Kettering Cancer Center, New York, NY, United States Washington Cancer Institute, Washington, DC, United States Kootenai Cancer Center, Coeur d'Alene, ID, United States AU - Chugh, R. AU - Wathen, J. K. AU - Patel, S. R. AU - Maki, R. G. AU - Meyers, P. A. AU - Schuetze, S. M. AU - Priebat, D. A. AU - Thomas, D. G. AU - Jacobson, J. A. AU - Samuels, B. L. AU - Benjamin, R. S. AU - Baker, L. H. DB - Scopus DO - 10.1158/1078-0432.CCR-10-1177 IS - 19 M3 - Article N1 - Cited By :130 Export Date: 18 November 2020 PY - 2010 SP - 4884-4891 ST - Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial T2 - Clinical Cancer Research TI - Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957570698&doi=10.1158%2f1078-0432.CCR-10-1177&partnerID=40&md5=6150a99dd6487a401e7816f0b1b0fbdc VL - 16 ID - 5806 ER - TY - JOUR AD - E. Rossi, Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, L.go A. Gemelli 8, Rome, Italy AU - Rossi, E. AU - Schinzari, G. AU - Maiorano, B. A. AU - Indellicati, G. AU - Di Stefani, A. AU - Pagliara, M. M. AU - Fragomeni, S. M. AU - De Luca, E. V. AU - Sammarco, M. G. AU - Garganese, G. AU - Galli, J. AU - Blasi, M. A. AU - Paludetti, G. AU - Scambia, G. AU - Peris, K. AU - Tortora, G. DB - Embase Medline DO - 10.1080/21645515.2020.1771986 LA - English M3 - Article N1 - L2005603058 2020-07-24 2020-07-29 PY - 2020 SN - 2164-554X 2164-5515 SP - 1-10 ST - Efficacy of immune checkpoint inhibitors in different types of melanoma T2 - Human Vaccines and Immunotherapeutics TI - Efficacy of immune checkpoint inhibitors in different types of melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005603058&from=exporthttp://dx.doi.org/10.1080/21645515.2020.1771986 ID - 5807 ER - TY - JOUR AD - L. Brugieres, Department of Oncology for Children and Adolescents, Gustave Roussy Caner Campus, Villejuif, France AU - Rigaud, C. AU - Abbou, S. AU - Minard-Colin, V. AU - Geoerger, B. AU - Scoazec, J. Y. AU - Vassal, G. AU - Jaff, N. AU - Heuberger, L. AU - Valteau-Couanet, D. AU - Brugieres, L. DB - Embase Medline DO - 10.1002/pbc.26902 IS - 4 LA - English M3 - Letter N1 - L619506835 2017-12-07 2018-03-01 PY - 2018 SN - 1545-5017 1545-5009 ST - Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma T2 - Pediatric Blood and Cancer TI - Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619506835&from=exporthttp://dx.doi.org/10.1002/pbc.26902 VL - 65 ID - 5808 ER - TY - JOUR AD - Belgrade University School of Medicine, Belgrade, Serbia Vertex Pharmaceuticals, Inc., Cambridge, MA, United States Vertex Pharmaceuticals, Inc., 130 Waverly Street, Cambridge, MA 02139-4242, United States AU - Damjanov, N. AU - Kauffman, R. S. AU - Spencer-Green, G. T. DB - Scopus DO - 10.1002/art.24485 IS - 5 M3 - Article N1 - Cited By :163 Export Date: 18 November 2020 PY - 2009 SP - 1232-1241 ST - Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies T2 - Arthritis and Rheumatism TI - Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66049086274&doi=10.1002%2fart.24485&partnerID=40&md5=f899223e6752ac6d3123d02c10923873 VL - 60 ID - 5809 ER - TY - JOUR AD - Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. nakano_masahito@kurume-u.ac.jp AN - 23147476 AU - Nakano, M. AU - Tanaka, M. AU - Kuromatsu, R. AU - Nagamatsu, H. AU - Sakata, K. AU - Matsugaki, S. AU - Kajiwara, M. AU - Fukuizumi, K. AU - Tajiri, N. AU - Matsukuma, N. AU - Sakai, T. AU - Ono, N. AU - Yano, Y. AU - Koga, H. AU - Kurogi, J. AU - Takata, A. AU - Sumie, S. AU - Satani, M. AU - Yamada, S. AU - Niizeki, T. AU - Aino, H. AU - Iwamoto, H. AU - Torimura, T. AU - Sata, M. DO - 10.1159/000342650 10.1159/000342650. Epub 2012 Nov 9. DP - Nlm ET - 2012/11/14 IS - 2 LA - eng PY - 2013 SN - 0030-2414 SP - 108-14 ST - Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma T2 - Oncology TI - Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma VL - 84 ID - 5810 ER - TY - JOUR AD - Department of Medical Oncology, Erciyes University Faculty of Medicine, Turkey E-mail : veliberk@gmail.com. AN - 24460304 AU - Berk, V. AU - Kaplan, M. A. AU - Tonyali, O. AU - Buyukberber, S. AU - Balakan, O. AU - Ozkan, M. AU - Demirci, U. AU - Ozturk, T. AU - Bilici, A. AU - Tastekin, D. AU - Ozdemir, N. AU - Unal, O. U. AU - Oflazoglu, U. AU - Turkmen, E. AU - Erdogan, B. AU - Uyeturk, U. AU - Oksuzoglu, B. AU - Cinkir, H. Y. AU - Yasar, N. AU - Gumus, M. DO - 10.7314/apjcp.2013.14.12.7367 10.7314/apjcp.2013.14.12.7367. DP - Nlm ET - 2014/01/28 IS - 12 LA - eng PY - 2013 SN - 1513-7368 SP - 7367-9 ST - Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology T2 - Asian Pac J Cancer Prev TI - Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology VL - 14 ID - 5811 ER - TY - JOUR AD - Department of Thyroid and Breast Surgery, West China Hospital, Sichuan University, Chengdu, China. AN - 24301760 AU - Gong, R. X. AU - Gong, Y. P. AU - Yang, J. AU - Wei, T. AU - Li-Ling, J. AU - Zhu, J. Q. DA - Oct 24 DO - 10.4238/2013.October.24.11 10.4238/2013.October.24.11. DP - Nlm ET - 2013/12/05 IS - 4 LA - eng PY - 2013 SN - 1676-5680 SP - 4990-7 ST - Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography T2 - Genet Mol Res TI - Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography VL - 12 ID - 5812 ER - TY - JOUR AD - Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, PR China. Department of Respiratory Disease, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, PR China. Electronic address: qianyechang@163.com. Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, PR China. Electronic address: wsl@tongji.edu.cn. AN - 28923539 AU - Zhu, R. AU - Wang, Z. AU - Liang, P. AU - He, X. AU - Zhuang, X. AU - Huang, R. AU - Wang, M. AU - Wang, Q. AU - Qian, Y. AU - Wang, S. DA - Nov DO - 10.1016/j.actbio.2017.09.009 10.1016/j.actbio.2017.09.009. Epub 2017 Sep 18. DP - Nlm ET - 2017/09/20 LA - eng PY - 2017 SN - 1742-7061 SP - 163-180 ST - Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO(2)@LDH for anti-neuroblastoma therapy T2 - Acta Biomater TI - Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO(2)@LDH for anti-neuroblastoma therapy VL - 63 ID - 5813 ER - TY - JOUR AD - L. Jin, Zhenjiang Matemity and Child Health Care Hospital, Zhenjiang, China AU - Lu, L. AU - Chen, J. AU - Tang, H. AU - Bai, L. AU - Lu, C. AU - Wang, K. AU - Li, M. AU - Yan, Y. AU - Tang, L. AU - Wu, R. AU - Ye, Y. AU - Jin, L. AU - Liang, Z. DB - Embase Medline DO - 10.3390/nu8070380 IS - 7 LA - English M3 - Article N1 - L611285636 2016-08-02 PY - 2016 SN - 2072-6643 ST - EGCG suppresses ERK5 activation to reverse tobacco smoke-triggered gastric epithelial-mesenchymal transition in BALB/c mice T2 - Nutrients TI - EGCG suppresses ERK5 activation to reverse tobacco smoke-triggered gastric epithelial-mesenchymal transition in BALB/c mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611285636&from=exporthttp://dx.doi.org/10.3390/nu8070380 VL - 8 ID - 5814 ER - TY - JOUR AD - D. Rakheja, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, United States AU - Chen, K. S. AU - Fustino, N. J. AU - Shukla, A. A. AU - Stroup, E. K. AU - Budhipramono, A. AU - Ateek, C. AU - Stuart, S. H. AU - Yamaguchi, K. AU - Kapur, P. AU - Frazier, A. L. AU - Lum, L. AU - Looijenga, L. H. J. AU - Laetsch, T. W. AU - Rakheja, D. AU - Amatruda, J. F. C2 - LC DB - Embase Medline DO - 10.1158/1535-7163.MCT-17-0137 IS - 5 LA - English M3 - Article N1 - L622326967 2018-06-06 2018-06-08 PY - 2018 SN - 1538-8514 1535-7163 SP - 1079-1089 ST - EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors T2 - Molecular Cancer Therapeutics TI - EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622326967&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-17-0137 VL - 17 ID - 5815 ER - TY - JOUR AD - Q. Jiang, Department of Oncology, Second Clinical College, Harbin Medical University, Harbin, China AU - Li, L. AU - Huang, Y. AU - Gao, Y. AU - Shi, T. AU - Xu, Y. AU - Li, H. AU - Hyytiäinen, M. AU - Keski-Oja, J. AU - Jiang, Q. AU - Hu, Y. AU - Du, Z. DB - Embase Medline DO - 10.1186/s12885-018-5056-4 IS - 1 LA - English M3 - Article N1 - L625304121 2018-12-11 2018-12-13 PY - 2018 SN - 1471-2407 ST - EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence T2 - BMC Cancer TI - EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625304121&from=exporthttp://dx.doi.org/10.1186/s12885-018-5056-4 VL - 18 ID - 5816 ER - TY - JOUR AD - Section of Pathologic Anatomy, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Section of Oncology, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Respiratory Diseases Clinic, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy Operative Unit of Pathology, Santa Maria Nuova Hospital, Reggio Emilia, Italy Centro di Ricerche Oncologiche GiovanniXXIII, Institute of General Pathology, Catholic University, Rome, Italy Division of Pneumology, Civic Hospital, Mirandola, Italy Division of Oncology, Civic Hospital Ramazzini, Carpi, Italy Operative Unit of Pathologic Anatomy, Hospital Umberto I, Mestre, Italy Operative Unit of Oncology, Civic Hospital degli Infermi, Faenza, Italy Section of Pathologic Anatomy, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 71, 41100- Modena, Italy AU - Sartori, G. AU - Cavazza, A. AU - Sgambato, A. AU - Marchioni, A. AU - Barbieri, F. AU - Longo, L. AU - Bavieri, M. AU - Murer, B. AU - Meschiari, E. AU - Tamberi, S. AU - Cadioli, A. AU - Luppi, F. AU - Migaldi, M. AU - Rossi, G. DB - Scopus DO - 10.1309/AJCPH0TRMPXVZW2F IS - 4 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2009 SP - 478-489 ST - EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to egfr inhibitors T2 - American Journal of Clinical Pathology TI - EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to egfr inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-65349167234&doi=10.1309%2fAJCPH0TRMPXVZW2F&partnerID=40&md5=876eaca148fb658d35f74d2bc62fb305 VL - 131 ID - 5817 ER - TY - JOUR AD - A. Budhipramono AU - Budhipramono, A. AU - Rakheja, D. AU - Chen, K. S. AU - Fustino, N. AU - Shukla, A. AU - Wickiser, J. AU - Laetsch, T. AU - Amatruda, J. F. DB - Embase DO - 10.1158/1538-7445.PEDCA15-B03 IS - 5 LA - English M3 - Conference Abstract N1 - L613568444 2016-12-13 PY - 2016 SN - 1538-7445 ST - EGFR and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors T2 - Cancer Research TI - EGFR and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613568444&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCA15-B03 VL - 76 ID - 5818 ER - TY - JOUR AD - Departments of Pediatrics, University of California San Francisco, San Francisco, CA, USA. Departments of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. Departments of Neurology, University of California San Francisco, San Francisco, CA, USA. Departments of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. AN - 26023796 AU - Yao, T. W. AU - Zhang, J. AU - Prados, M. AU - Weiss, W. A. AU - James, C. D. AU - Nicolaides, T. C2 - PMC4673141 DA - Sep 8 DO - 10.18632/oncotarget.4014 10.18632/oncotarget.4014. DP - Nlm ET - 2015/05/30 IS - 26 LA - eng PY - 2015 SN - 1949-2553 SP - 21993-2005 ST - EGFR blockade prevents glioma escape from BRAFV600E targeted therapy T2 - Oncotarget TI - EGFR blockade prevents glioma escape from BRAFV600E targeted therapy VL - 6 ID - 5819 ER - TY - JOUR AD - Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 510060, Guangzhou, People's Republic of China Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510220, Guangzhou, People's Republic of China OrigiMed, Inc, NO.115 XinJunhuan Road, 201114, Shanghai, People's Republic of China AN - 137026094. Language: English. Entry Date: In Process. Revision Date: 20191220. Publication Type: journal article. Journal Subset: Biomedical AU - Fang, Wenfeng AU - Huang, Yihua AU - Hong, Shaodong AU - Zhang, Zhonghan AU - Wang, Minghui AU - Gan, Jiadi AU - Wang, Wenjing AU - Guo, Honglin AU - Wang, Kai AU - Zhang, Li DB - ccm DO - 10.1186/s12885-019-5820-0 DP - EBSCOhost IS - 1 N1 - Europe; UK & Ireland. Instrumentation: Piper Fatigue Scale (PFS); Defining Issues Test (DIT) (Rest). Grant Information: 81602005//National Natural Science Foundation of China/. NLM UID: 100967800. PMID: NLM31208370. PY - 2019 SN - 1471-2407 SP - N.PAG-N.PAG ST - EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer T2 - BMC Cancer TI - EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137026094&site=ehost-live&scope=site VL - 19 ID - 5820 ER - TY - JOUR AD - Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Surgery, University of Minnesota, Minneapolis, MN, United States AU - Tzeng, C. W. D. AU - Frolov, A. AU - Frolova, N. AU - Jhala, N. C. AU - Howard, J. H. AU - Vickers, S. M. AU - Buchsbaum, D. J. AU - Heslin, M. J. AU - Arnoletti, J. P. DB - Scopus DO - 10.1016/j.jss.2007.01.051 IS - 1 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2007 SP - 20-26 ST - EGFR Genomic Gain and Aberrant Pathway Signaling in Pancreatic Cancer Patients T2 - Journal of Surgical Research TI - EGFR Genomic Gain and Aberrant Pathway Signaling in Pancreatic Cancer Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35248866321&doi=10.1016%2fj.jss.2007.01.051&partnerID=40&md5=572ab59bf8e40e65f387670bbedbdbcb VL - 143 ID - 5821 ER - TY - JOUR AD - Université Paris XI-IFR54, UPRES EA 3535 Pharmacology and New Treatment in Cancers, Institut Gustave Roussy, Villejuif, France. geoerger@igr.fr AN - 18386816 AU - Geoerger, B. AU - Gaspar, N. AU - Opolon, P. AU - Morizet, J. AU - Devanz, P. AU - Lecluse, Y. AU - Valent, A. AU - Lacroix, L. AU - Grill, J. AU - Vassal, G. DA - Jul 1 DO - 10.1002/ijc.23488 10.1002/ijc.23488. DP - Nlm ET - 2008/04/05 IS - 1 LA - eng PY - 2008 SN - 0020-7136 SP - 209-16 ST - EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts T2 - Int J Cancer TI - EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts VL - 123 ID - 5822 ER - TY - JOUR AD - A.R. Kirane, Division of Surgical Oncology, Department of Surgery, University of California, Davis Medical Center, 4501 X Street, Sacramento, CA, United States AU - Bateni, S. B. AU - Johns, A. J. AU - Gingrich, A. A. AU - Gholami, S. AU - Bold, R. J. AU - Canter, R. J. AU - Kirane, A. R. DB - Embase Medline DO - 10.21873/anticanres.14266 IS - 5 LA - English M3 - Article N1 - L2005797121 2020-05-15 2020-05-19 PY - 2020 SN - 1791-7530 0250-7005 SP - 2895-2903 ST - Elderly age is associated with more conservative treatment of invasive melanoma T2 - Anticancer Research TI - Elderly age is associated with more conservative treatment of invasive melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005797121&from=exporthttp://dx.doi.org/10.21873/anticanres.14266 VL - 40 ID - 5823 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, United States Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, United States AU - Naing, A. AU - Veasey-Rodrigues, H. AU - Hong, D. S. AU - Fu, S. AU - Falchook, G. S. AU - Wheler, J. J. AU - Tsimberidou, A. M. AU - Wen, S. AU - Fessahaye, S. N. AU - Golden, E. C. AU - Aaron, J. AU - Ewer, M. S. AU - Kurzrock, R. C7 - mds130 DB - Scopus DO - 10.1093/annonc/mds130 IS - 11 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 2960-2963 ST - Electrocardiograms (ECGs) in phase I anticancer drug development: The MD anderson cancer center experience with 8518 ECGs T2 - Annals of Oncology TI - Electrocardiograms (ECGs) in phase I anticancer drug development: The MD anderson cancer center experience with 8518 ECGs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868113707&doi=10.1093%2fannonc%2fmds130&partnerID=40&md5=7d92535961d3d5646af8b3fe4c9ee093 VL - 23 ID - 5824 ER - TY - JOUR AD - W.S. Kim, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea AU - Yi, J. H. AU - Kim, J. H. AU - Baek, K. K. AU - Lim, T. AU - Lee, D. J. AU - Ahn, Y. C. AU - Kim, K. AU - Kim, S. J. AU - Ko, Y. H. AU - Kim, W. S. DB - Embase Medline DO - 10.1093/annonc/mdq645 IS - 7 LA - English M3 - Article N1 - L362042357 2011-07-06 2011-07-12 PY - 2011 SN - 0923-7534 1569-8041 SP - 1636-1643 ST - Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma T2 - Annals of Oncology TI - Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362042357&from=exporthttp://dx.doi.org/10.1093/annonc/mdq645 VL - 22 ID - 5825 ER - TY - JOUR AD - J. Bylund, The Phagocyte Research Group, Netherlands Institute for Neuroscience, An Institute of the Royal Netherlands Academy of Arts and Sciences, University of Gothenburg, Gothenburg, Sweden AU - Sundqvist, M. AU - Christenson, K. AU - Björnsdottir, H. AU - Osla, V. AU - Karlsson, A. AU - Dahlgren, C. AU - Speert, D. P. AU - Fasth, A. AU - Brown, K. L. AU - Bylund, J. DB - Embase DO - 10.3389/fimmu.2017.01828 IS - DEC LA - English M3 - Article N1 - L619910119 2017-12-29 2018-01-03 PY - 2017 SN - 1664-3224 ST - Elevated mitochondrial reactive oxygen species and cellular redox imbalance in human NADPH-oxidase-deficient phagocytes T2 - Frontiers in Immunology TI - Elevated mitochondrial reactive oxygen species and cellular redox imbalance in human NADPH-oxidase-deficient phagocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619910119&from=exporthttp://dx.doi.org/10.3389/fimmu.2017.01828 VL - 8 ID - 5826 ER - TY - JOUR AD - Z. Li, Department of Nephrology of Hunan Children’s Hospital, Hunan Institute for Pediatric Research, 86 Ziyuan Road, Changsha, Hunan, China AU - Li, Z. AU - Deng, X. AU - Kang, Z. AU - Wang, Y. AU - Xia, T. AU - Ding, N. AU - Yin, Y. DB - Embase Medline DO - 10.1007/s40620-015-0217-x IS - 1 LA - English M3 - Article N1 - L607989351 2016-02-04 2016-02-09 PY - 2016 SN - 1724-6059 1121-8428 SP - 27-36 ST - Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia–reperfusion induced kidney injury T2 - Journal of Nephrology TI - Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia–reperfusion induced kidney injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607989351&from=exporthttp://dx.doi.org/10.1007/s40620-015-0217-x VL - 29 ID - 5827 ER - TY - JOUR AD - J. Barredo, Univiersity of Miami Miller School of Medicine, Dept. of Pediatrics, Medicine and Biochmeistry and Molecular Biology, Miami, United States AU - Barredo, J. AU - Sun, G. AU - Shavab, A. AU - Li, B. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624178703 2018-10-11 PY - 2018 SN - 1545-5017 SP - S102 ST - Elucidating and targeting epigenetic metabolic stress response signatures in acute lymphoblastic leukemia (ALL) T2 - Pediatric Blood and Cancer TI - Elucidating and targeting epigenetic metabolic stress response signatures in acute lymphoblastic leukemia (ALL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624178703&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 5828 ER - TY - JOUR AD - S.L. Cohn, Department of Pediatrics, University of Chicago, 900 E. 57th St., KCBD 5100, Chicago, IL, United States AU - Applebaum, M. A. AU - Desai, A. V. AU - Glade Bender, J. L. AU - Cohn, S. L. C1 - imgn 901 DB - Embase DO - 10.1080/21678707.2017.1304212 IS - 4 LA - English M3 - Review N1 - L615066787 2017-04-04 2017-04-21 PY - 2017 SN - 2167-8707 SP - 355-368 ST - Emerging and investigational therapies for neuroblastoma T2 - Expert Opinion on Orphan Drugs TI - Emerging and investigational therapies for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615066787&from=exporthttp://dx.doi.org/10.1080/21678707.2017.1304212 VL - 5 ID - 5829 ER - TY - JOUR AD - Paediatric Haematology Section, Hospital Universitario Virgen Del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, Spain Department of Haematology, Hospital Universitario Virgen Del Rocío, Instituto de Biomedicina de Sevilla (IBIS), CSIC, Universidad de Sevilla, Sevilla, Spain Department of Immunology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain Paediatric Haematology, Department of Haematology, Hospital Vírgen Del Rocío, Av/Manuel Siurot S/N, Sevilla, ES-41013, Spain AU - Molinos-Quintana, A. AU - Aquino, V. AU - Montero, I. AU - Pérez-De Soto, C. AU - García-Lozano, R. AU - Pérez-Simón, J. A. AU - Pérez-Hurtado, J. M. DB - Scopus DO - 10.1159/000371831 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 71-75 ST - Emerging BCR/ABL1 Mutations under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia T2 - Acta Haematologica TI - Emerging BCR/ABL1 Mutations under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928158370&doi=10.1159%2f000371831&partnerID=40&md5=9b0b66c32f3c465a2e0cf81bc820c667 VL - 134 ID - 5830 ER - TY - JOUR AD - London Bone and Soft Tissue Tumor Service, University College Hospital, London, United Kingdom Department of Oncology, London Bone and Soft Tissue Tumor Service, University College Hospital NHS Trust, Central, 250 Euston Road, London, NW1 2PG, United Kingdom AU - Seddon, B. M. AU - Whelan, J. S. DB - Scopus DO - 10.2165/00148581-200810020-00004 IS - 2 M3 - Review N1 - Cited By :15 Export Date: 18 November 2020 PY - 2008 SP - 93-105 ST - Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma T2 - Pediatric Drugs TI - Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40949125279&doi=10.2165%2f00148581-200810020-00004&partnerID=40&md5=e0d4720ac40416c50eca3ef2ef0c66e7 VL - 10 ID - 5831 ER - TY - JOUR AD - V. Castel, Unidad de Oncología Pediátrica, Hospital Universitario y Politécnico la Fe, Torre G, 2 Planta, Bulevar Sur s/n, 46026 Valencia, Spain AU - Castel, V. AU - Segura, V. AU - Berlanga, P. C1 - avastin(Hoffmann La Roche) celgene nexavar(Bayer) pf 02341066 torisel(Wyeth) velcade(Janssen) xalxori(Pfizer) zolinza(Merck) zometa(Novartis) C2 - Bayer Hoffmann La Roche Janssen Merck Novartis Pfizer Wyeth DB - Embase Medline DO - 10.1517/14728214.2013.796927 IS - 2 LA - English M3 - Review N1 - L369046464 2013-06-12 2013-06-19 PY - 2013 SN - 1472-8214 SP - 155-171 ST - Emerging drugs for neuroblastoma T2 - Expert Opinion on Emerging Drugs TI - Emerging drugs for neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369046464&from=exporthttp://dx.doi.org/10.1517/14728214.2013.796927 VL - 18 ID - 5832 ER - TY - GEN AD - D. Claxton, Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, PA 17033, United States AU - Vasekar, M. AU - Allen, J. E. AU - Joudeh, J. AU - Claxton, D. C1 - gsk 1120212 mk 0457 ro 5045337 sar 3419 C5 - 23288648 DB - Embase Medline DO - 10.1007/978-1-4614-6176-0-16 J2 - Adv. Exp. Med. Biol. LA - English M1 - (Vasekar M.; Allen J.E., joshjea@gmail.com; Claxton D., dclaxton@hmc.psu.edu) Department of Medicine (Hematology/Oncology), Penn State Hershey Cancer Institute, Penn State Hershey Medical Center, Hershey, PA 17033, United States M3 - Article N1 - L368308941 2013-02-20 2013-03-05 PY - 2013 SN - 0065-2598 9781461461753 SP - 341-358 ST - Emerging molecular therapies for the treatment of acute lymphoblastic leukemia TI - Emerging molecular therapies for the treatment of acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368308941&from=exporthttp://dx.doi.org/10.1007/978-1-4614-6176-0-16 VL - 779 ID - 5833 ER - TY - JOUR AD - From the Department of Hematology/Oncology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN; Division of Hematology Oncology, Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. AN - 23714564 AU - Ferguson, M. AU - Hingorani, P. AU - Gupta, A. A. DO - 10.14694/EdBook_AM.2013.33.420 10.14694/EdBook_AM.2013.33.420. DP - Nlm ET - 2013/05/30 LA - eng PY - 2013 SN - 1548-8748 SP - 420-4 ST - Emerging molecular-targeted therapies in early-phase clinical trials and preclinical models T2 - Am Soc Clin Oncol Educ Book TI - Emerging molecular-targeted therapies in early-phase clinical trials and preclinical models ID - 5834 ER - TY - JOUR AD - C.S. Mantzoros, Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, United States AU - Kelesidis, T. AU - Mantzoros, C. S. DB - Embase Medline IS - 3 LA - English M3 - Review N1 - L43486108 2006-04-10 PY - 2006 SN - 1565-4753 SP - 239-248 ST - The emerging role of leptin in humans T2 - Pediatric Endocrinology Reviews TI - The emerging role of leptin in humans UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43486108&from=export VL - 3 ID - 5835 ER - TY - JOUR AD - Department of Pediatrics, Medical University of Innsbruck, Innsbruck, Austria Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Tyrol, 6020, Austria AU - Crazzolara, R. AU - Bendall, L. DB - Scopus DO - 10.2174/156800909787314057 IS - 1 M3 - Review N1 - Cited By :21 Export Date: 18 November 2020 PY - 2009 SP - 19-31 ST - Emerging treatments in acute lymphoblastic leukemia T2 - Current Cancer Drug Targets TI - Emerging treatments in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-62549143973&doi=10.2174%2f156800909787314057&partnerID=40&md5=863b4fe718693c810f4599f12cc792ab VL - 9 ID - 5836 ER - TY - JOUR AD - Biospectrum Life Science Institute, Gunpo City, Gyunggi Do, Republic of Korea. AN - 16959273 AU - Lee, J. AU - Jung, E. AU - Lee, J. AU - Huh, S. AU - Hwang, C. H. AU - Lee, H. Y. AU - Kim, E. J. AU - Cheon, J. M. AU - Hyun, C. G. AU - Kim, Y. S. AU - Park, D. DA - Nov 25 DO - 10.1016/j.lfs.2006.08.008 10.1016/j.lfs.2006.08.008. Epub 2006 Aug 17. DP - Nlm ET - 2006/09/09 IS - 26 LA - eng PY - 2006 SN - 0024-3205 (Print) 0024-3205 SP - 2480-5 ST - Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1) T2 - Life Sci TI - Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1) VL - 79 ID - 5837 ER - TY - JOUR AD - Department of Pathology, University of Virginia Health System, Charlottesville, VA 22908, USA. es7yj@virginia.edu AN - 20924280 AU - Woodford, R. L. AU - Nikiforov, Y. E. AU - Hunt, J. L. AU - Bellizzi, A. M. AU - Zhang, X. AU - Mills, S. E. AU - Stelow, E. B. DA - Nov DO - 10.1097/PAS.0b013e3181f2d820 10.1097/PAS.0b013e3181f2d820. DP - Nlm ET - 2010/10/07 IS - 11 LA - eng PY - 2010 SN - 0147-5185 SP - 1582-90 ST - Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases T2 - Am J Surg Pathol TI - Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases VL - 34 ID - 5838 ER - TY - JOUR AD - R. Dummer, Department of Dermatology, Skin Cancer Center, University Hospital ZÜrich, ZÜrich, Switzerland AU - Dummer, R. AU - Ascierto, P. A. AU - Gogas, H. J. AU - Arance, A. AU - Mandala, M. AU - Liszkay, G. AU - Garbe, C. AU - Schadendorf, D. AU - Krajsova, I. AU - Gutzmer, R. AU - Chiarion-Sileni, V. AU - Dutriaux, C. AU - de Groot, J. W. B. AU - Yamazaki, N. AU - Loquai, C. AU - Moutouh-de Parseval, L. A. AU - Pickard, M. D. AU - Sandor, V. AU - Robert, C. AU - Flaherty, K. T. DB - Embase Medline DO - 10.1016/S1470-2045(18)30142-6 IS - 5 LA - English M3 - Article N1 - L2000563995 2018-03-28 2018-05-16 PY - 2018 SN - 1474-5488 1470-2045 SP - 603-615 ST - Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial T2 - The Lancet Oncology TI - Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000563995&from=exporthttp://dx.doi.org/10.1016/S1470-2045(18)30142-6 VL - 19 ID - 5839 ER - TY - JOUR AD - Section of Adult and Pediatric Endocrinology, Diabetes, & Metabolism, The University of Chicago, United States AU - Yu, C. DB - Scopus DO - 10.3928/19382359-20190729-02 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - e326-e332 ST - Endocrine consequences of childhood cancer therapy and transition considerations T2 - Pediatric Annals TI - Endocrine consequences of childhood cancer therapy and transition considerations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071470048&doi=10.3928%2f19382359-20190729-02&partnerID=40&md5=a0012be913eb344d3b00cbd17652b30c VL - 48 ID - 5840 ER - TY - JOUR AD - X. Guo, Department of Gastroenterology, Shenyang General Hospital of PLA, 83 Wenhua Road, Shenyang, Liaoning, China AU - Ren, L. AU - Guo, X. AU - Shao, X. AU - Li, H. AU - Yao, H. DB - Embase Medline DO - 10.3892/mmr.2015.3340 IS - 6 LA - English M3 - Article N1 - L602972993 2015-03-19 2015-03-25 PY - 2015 SN - 1791-3004 1791-2997 SP - 4279-4284 ST - Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells T2 - Molecular Medicine Reports TI - Endocrine gland-derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602972993&from=exporthttp://dx.doi.org/10.3892/mmr.2015.3340 VL - 11 ID - 5841 ER - TY - JOUR AD - J.-H. Klusmann, University of Halle, Department of Pediatrics I, Pediatric Hematology and Oncology, Ernst-Grube-Str 40, Halle, Germany AU - Bhayadia, R. AU - Krowiorz, K. AU - Haetscher, N. AU - Jammal, R. AU - Emmrich, S. AU - Obulkasim, A. AU - Fiedler, J. AU - Schwarzer, A. AU - Rouhi, A. AU - Heuser, M. AU - Wingert, S. AU - Bothur, S. AU - Döhner, K. AU - Mätzig, T. AU - Ng, M. AU - Reinhardt, D. AU - Döhner, H. AU - Zwaan, C. M. AU - Van Den Heuvel Eibrink, M. AU - Heckl, D. AU - Fornerod, M. AU - Thum, T. AU - Humphries, R. K. AU - Rieger, M. A. AU - Kuchenbauer, F. AU - Klusmann, J. H. DB - Embase Medline DO - 10.1200/JCO.2017.75.2204 IS - 10 LA - English M3 - Article N1 - L621516143 2018-04-12 2018-05-09 PY - 2018 SN - 1527-7755 0732-183X SP - 1007-1016 ST - Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia T2 - Journal of Clinical Oncology TI - Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621516143&from=exporthttp://dx.doi.org/10.1200/JCO.2017.75.2204 VL - 36 ID - 5842 ER - TY - JOUR AD - F. Barra, Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy AU - Barra, F. AU - Ferro Desideri, L. AU - Leone Roberti Maggiore, U. AU - Gaetano Vellone, V. AU - Maramai, M. AU - Scala, C. AU - Ferrero, S. DB - Embase DO - 10.22074/ijfs.2020.5876 IS - 1 LA - English M3 - Letter N1 - L2003928403 2020-03-11 2020-03-17 PY - 2020 SN - 2008-0778 2008-076X SP - 76-77 ST - Endometriosis classification and the role of tumor necrosis factor-alpha polymorphisms as a therapeutic target T2 - International Journal of Fertility and Sterility TI - Endometriosis classification and the role of tumor necrosis factor-alpha polymorphisms as a therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003928403&from=exporthttp://dx.doi.org/10.22074/ijfs.2020.5876 VL - 14 ID - 5843 ER - TY - JOUR AD - J. Badaut, Departments of Physiology, Loma Linda University School of Medicine, Loma Linda, CA 92354, United States AU - Berezowski, V. AU - Fukuda, A. M. AU - Cecchelli, R. AU - Badaut, J. DB - Embase DO - 10.1155/2012/176287 LA - English M3 - Review N1 - L365425132 2012-08-21 2012-08-24 PY - 2012 SN - 1687-8876 1687-8884 ST - Endothelial cells and astrocytes: A concerto en duo in ischemic pathophysiology T2 - International Journal of Cell Biology TI - Endothelial cells and astrocytes: A concerto en duo in ischemic pathophysiology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365425132&from=exporthttp://dx.doi.org/10.1155/2012/176287 ID - 5844 ER - TY - JOUR AD - M. Xue, Sutton Arthritis Research Laboratory, University of Sydney at Royal North Shore Hospital, St. Leonards, NSW 2065, Australia AU - Xue, M. AU - Campbell, D. AU - Sambrook, P. N. AU - Fukudome, K. AU - Jackson, C. J. DB - Embase Medline DO - 10.1111/j.0022-202X.2005.23952.x IS - 6 LA - English M3 - Article N1 - L43714312 2006-05-30 PY - 2005 SN - 0022-202X 1523-1747 SP - 1279-1285 ST - Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C T2 - Journal of Investigative Dermatology TI - Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43714312&from=exporthttp://dx.doi.org/10.1111/j.0022-202X.2005.23952.x VL - 125 ID - 5845 ER - TY - JOUR AD - S.K. Srivastava, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, United States AU - Ramana, K. V. AU - Willis, M. S. AU - White, M. D. AU - Horton, J. W. AU - Dimaio, J. M. AU - Srivastava, D. AU - Bhatnagar, A. AU - Srivastava, S. K. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.106.630830 IS - 17 LA - English M3 - Article N1 - L44673359 2006-11-15 PY - 2006 SN - 0009-7322 SP - 1838-1846 ST - Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition T2 - Circulation TI - Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44673359&from=exporthttp://dx.doi.org/10.1161/CIRCULATIONAHA.106.630830 VL - 114 ID - 5846 ER - TY - JOUR AD - Department of Pathology, University of Yamanashi, Chuo, Yamanashi 409-3898, Japan. ktetsuo@yamanashi.ac.jp AN - 17714762 AU - Kondo, T. AU - Nakazawa, T. AU - Murata, S. AU - Kurebayashi, J. AU - Ezzat, S. AU - Asa, S. L. AU - Katoh, R. DA - Dec DO - 10.1016/j.humpath.2007.04.014 10.1016/j.humpath.2007.04.014. Epub 2007 Aug 21. DP - Nlm ET - 2007/08/24 IS - 12 LA - eng PY - 2007 SN - 0046-8177 (Print) 0046-8177 SP - 1810-8 ST - Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas T2 - Hum Pathol TI - Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas VL - 38 ID - 5847 ER - TY - JOUR AD - Laboratory of Pharmacology, Division of Pediatric Oncology, Catholic University of Rome, L.go A. Gemelli, 8, 00168 Rome, Italy Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy Research and Development, Sigma-Tau, Via Pontina Km 30,400, 00040 Pomezia, Rome, Italy AU - Di Francesco, A. M. AU - Ubezio, P. AU - Torella, A. R. AU - Meco, D. AU - Pierri, F. AU - Barone, G. AU - Cusano, G. AU - Pisano, C. AU - D'Incalci, M. AU - Riccardi, R. DB - Scopus DO - 10.1007/s10637-011-9689-2 IS - 4 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2012 SP - 1319-1330 ST - Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models T2 - Investigational New Drugs TI - Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866730037&doi=10.1007%2fs10637-011-9689-2&partnerID=40&md5=a1cb4056b0259f74147e8d71459cdedb VL - 30 ID - 5848 ER - TY - JOUR AD - Paediatric Oncology, Institute of Cancer Research, Sutton, United Kingdom. AN - 21659463 AU - Bielen, A. AU - Perryman, L. AU - Box, G. M. AU - Valenti, M. AU - de Haven Brandon, A. AU - Martins, V. AU - Jury, A. AU - Popov, S. AU - Gowan, S. AU - Jeay, S. AU - Raynaud, F. I. AU - Hofmann, F. AU - Hargrave, D. AU - Eccles, S. A. AU - Jones, C. C2 - PMC3160488 C6 - UKMS35725 DA - Aug DO - 10.1158/1535-7163.Mct-11-0205 10.1158/1535-7163.MCT-11-0205. Epub 2011 Jun 9. DP - Nlm ET - 2011/06/11 IS - 8 LA - eng PY - 2011 SN - 1535-7163 (Print) 1535-7163 SP - 1407-18 ST - Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β T2 - Mol Cancer Ther TI - Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β VL - 10 ID - 5849 ER - TY - JOUR AD - H.-T. Lin, Institute of Medical Science, University of Tokyo, Tokyo, Japan AU - Lin, H. T. AU - Kubara, K. AU - Yamazaki, K. AU - Takagi, M. AU - Naruto, T. AU - Morio, T. AU - Okumura, T. AU - Otsu, M. DB - Embase DO - 10.1182/blood-2018-99-117889 LA - English M3 - Conference Abstract N1 - L626479309 2019-02-27 PY - 2018 SN - 0006-4971 ST - Enhanced selective inhibition of KRAS mutant hematopoietic progenitor cell expansion by MEK and Bcl-2 inhibition T2 - Blood TI - Enhanced selective inhibition of KRAS mutant hematopoietic progenitor cell expansion by MEK and Bcl-2 inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626479309&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-117889 VL - 132 ID - 5850 ER - TY - JOUR AD - Department of Parasitology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands Department of Medical Microbiology, Radboud University, Nijmegen Medical Centre, Nijmegen, Netherlands Noguchi Memorial Institute for Medical Research, University of Ghana, P.O. Box LG581, Legon, Accra, Ghana AU - Hartgers, F. C. AU - Obeng, B. B. AU - Voskamp, A. AU - Larbi, I. A. AU - Amoah, A. S. AU - Luty, A. J. F. AU - Boakye, D. AU - Yazdanbakhsh, M. DB - Scopus DO - 10.1128/IAI.01579-07 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2008 SP - 5149-5157 ST - Enhanced toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children T2 - Infection and Immunity TI - Enhanced toll-like receptor responsiveness associated with mitogen-activated protein kinase activation in Plasmodium falciparum-infected children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849137954&doi=10.1128%2fIAI.01579-07&partnerID=40&md5=9fc829f89774339a7615c5b2e45f2ae0 VL - 76 ID - 5851 ER - TY - JOUR AD - R. Ciarapica, Department of Oncohematology, IRCCS, Ospedale Pediatrico Bambino Gesù, Roma, Italy AU - Ciarapica, R. AU - Miele, L. AU - Giordano, A. AU - Locatelli, F. AU - Rota, R. C1 - amg 479 ap 23573 mk 0646 r 1507 DB - Embase Medline DO - 10.1186/1741-7015-9-63 LA - English M3 - Short Survey N1 - L51446721 2011-05-31 2011-07-12 PY - 2011 SN - 1741-7015 ST - Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: First implications T2 - BMC Medicine TI - Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: First implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51446721&from=exporthttp://dx.doi.org/10.1186/1741-7015-9-63http://www.biomedcentral.com/1741-7015/9/63 VL - 9 ID - 5852 ER - TY - JOUR AD - M.H. Alhagamhmad, Faculty of Medicine, University of Benghazi (Al-Arab Medical University), Benghazi, Libyan Arab Jamahiriya AU - Alhagamhmad, M. H. DB - Embase Medline DO - 10.1002/ncp.10004 IS - 4 LA - English M3 - Review N1 - L620248614 2018-01-23 2018-11-21 PY - 2018 SN - 1941-2452 0884-5336 SP - 483-492 ST - Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy T2 - Nutrition in Clinical Practice TI - Enteral Nutrition in the Management of Crohn's Disease: Reviewing Mechanisms of Actions and Highlighting Potential Venues for Enhancing the Efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620248614&from=exporthttp://dx.doi.org/10.1002/ncp.10004 VL - 33 ID - 5853 ER - TY - JOUR AD - Department of Microbiology, National University of Singapore, Singapore, Singapore Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore Infectious Diseases, Genome Institute of Singapore, Singapore, Singapore Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden Gut Microbiology, Danone Nutricia Research, Singapore, Singapore AU - Wang, S. AU - Hibberd, M. L. AU - Pettersson, S. AU - Lee, Y. K. C7 - e97523 DB - Scopus DO - 10.1371/journal.pone.0097523 IS - 5 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2014 ST - Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways T2 - PLoS ONE TI - Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901375209&doi=10.1371%2fjournal.pone.0097523&partnerID=40&md5=d3fa2b734260b95584c06f3813284895 VL - 9 ID - 5854 ER - TY - JOUR AD - G. Robinson, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Robinson, G. AU - Desai, A. AU - Gauvain, K. AU - Basu, E. AU - Dorris, K. AU - Maese, L. AU - Sabnis, A. AU - Foster, J. AU - Shusterman, S. AU - Yoon, J. AU - Weiss, B. AU - Abdelbaki, M. AU - Farid-Kapadia, M. AU - Meneses-Lorente, G. AU - Cardenas, A. AU - Hutchinson, K. AU - Bergthold, G. AU - Maneval, E. C. AU - Fox, E. AU - Gajjar, A. DB - Embase DO - 10.1093/neuonc/noz175.774 LA - English M3 - Conference Abstract N1 - L631168490 2020-03-17 PY - 2019 SN - 1523-5866 SP - vi186 ST - Entrectinib in children and adolescents with recurrent or refractory solid tumors including primary CNS tumors T2 - Neuro-Oncology TI - Entrectinib in children and adolescents with recurrent or refractory solid tumors including primary CNS tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631168490&from=exporthttp://dx.doi.org/10.1093/neuonc/noz175.774 VL - 21 ID - 5855 ER - TY - JOUR AD - Z.T. Al-Salama, Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, New Zealand AU - Al-Salama, Z. T. AU - Keam, S. J. DB - Embase Medline DO - 10.1007/s40265-019-01177-y IS - 13 LA - English M3 - Review N1 - L2002394094 2019-08-13 2019-09-20 PY - 2019 SN - 1179-1950 0012-6667 SP - 1477-1483 ST - Entrectinib: First Global Approval T2 - Drugs TI - Entrectinib: First Global Approval UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002394094&from=exporthttp://dx.doi.org/10.1007/s40265-019-01177-y VL - 79 ID - 5856 ER - TY - JOUR AD - S.T. Cooper, Institute for Neuroscience and Muscle Research, Children's Hospital at Westmead, Sydney, NSW, Australia AU - Piper, A. K. AU - Ross, S. E. AU - Redpath, G. M. AU - Lemckert, F. A. AU - Woolger, N. AU - Bournazos, A. AU - Greer, P. A. AU - Sutton, R. B. AU - Cooper, S. T. DB - Embase Medline DO - 10.1016/j.cellsig.2017.02.009 LA - English M3 - Article N1 - L614406403 2017-02-21 2017-03-15 PY - 2017 SN - 1873-3913 0898-6568 SP - 30-40 ST - Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling T2 - Cellular Signalling TI - Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614406403&from=exporthttp://dx.doi.org/10.1016/j.cellsig.2017.02.009 VL - 33 ID - 5857 ER - TY - JOUR AD - B. S. Bochner, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, United States AU - Park, Y. M. AU - Bochner, B. S. DB - Embase DO - 10.4168/aair.2010.2.2.87 IS - 2 L1 - internal-pdf://2921528247/aair-2-87.pdf LA - English M3 - Review N1 - L358888252 2010-06-03 2010-06-25 PY - 2010 SN - 2092-7355 2092-7363 SP - 87-101 ST - Eosinophil survival and apoptosis in health and disease T2 - Allergy, Asthma and Immunology Research TI - Eosinophil survival and apoptosis in health and disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358888252&from=exporthttp://dx.doi.org/10.4168/aair.2010.2.2.87 VL - 2 ID - 5858 ER - TY - JOUR AU - Ramirez, L. AU - Villota, A. G. AU - Parga, J. H. AU - Velasco, M. AU - Lòpez, J. DB - Embase DO - 10.1016/j.jtho.2019.08.1985 IS - 10 LA - English M3 - Conference Abstract N1 - L2003406901 2019-10-24 PY - 2019 SN - 1556-1380 1556-0864 SP - S915 ST - EP1.01-26 Non-Small Cellular Pulmon Cancer ALK Positive in Pediatrics T2 - Journal of Thoracic Oncology TI - EP1.01-26 Non-Small Cellular Pulmon Cancer ALK Positive in Pediatrics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003406901&from=exporthttp://dx.doi.org/10.1016/j.jtho.2019.08.1985 VL - 14 ID - 5859 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, Netherlands Neuro-Oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, Amsterdam, Netherlands Department of Leukemia, Division of Cancer Medicine, University of Texas, 1515 Holcombe Boulevard, Houston, TX, United States Department of Neurosurgery, University Medical Center Groningen, Hanzeplein 1, Groningen, Netherlands Department of Gastroenterology and Hepatology, Erasmus MC, L-459, 's-Gravendijkwal 230, Rotterdam, Netherlands AU - Sikkema, A. H. AU - Den Dunnen, W. F. A. AU - Hulleman, E. AU - Van Vuurden, D. G. AU - Garcia-Manero, G. AU - Yang, H. AU - Scherpen, F. J. G. AU - Kampen, K. R. AU - Hoving, E. W. AU - Kamps, W. A. AU - Diks, S. H. AU - Peppelenbosch, M. P. AU - De Bont, E. S. J. M. DB - Scopus DO - 10.1093/neuonc/nos130 IS - 9 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 1125-1135 ST - EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion T2 - Neuro-Oncology TI - EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867519695&doi=10.1093%2fneuonc%2fnos130&partnerID=40&md5=b87f8ebac9830679f11e69746ebae3fa VL - 14 ID - 5860 ER - TY - JOUR AD - S. Hou, Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China AU - Hou, S. AU - Xu, X. AU - Wang, Y. AU - Yang, Y. DB - Embase Medline DO - 10.1007/s12038-020-0016-y IS - 1 LA - English M3 - Article N1 - L2004390428 2020-03-16 2020-03-24 PY - 2020 SN - 0973-7138 0250-5991 ST - Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus T2 - Journal of Biosciences TI - Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004390428&from=exporthttp://dx.doi.org/10.1007/s12038-020-0016-y VL - 45 ID - 5861 ER - TY - JOUR AD - P.I. Oteiza, Department of Nutrition, University of California at Davis, Davis, CA 95616, United States AU - Bettaieb, A. AU - Vazquez Prieto, M. A. AU - Rodriguez Lanzi, C. AU - Miatello, R. M. AU - Haj, F. G. AU - Fraga, C. G. AU - Oteiza, P. I. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2014.04.011 LA - English M3 - Article N1 - L373118256 2014-05-29 2014-06-02 PY - 2014 SN - 1873-4596 0891-5849 SP - 247-256 ST - (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress T2 - Free Radical Biology and Medicine TI - (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373118256&from=exporthttp://dx.doi.org/10.1016/j.freeradbiomed.2014.04.011 VL - 72 ID - 5862 ER - TY - JOUR AD - Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Sarawak, Malaysia University of Aberdeen, United Kingdom AU - Kuan, J. W. AU - Michael, M. S. DB - Scopus IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 78-85 ST - The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island T2 - Medical Journal of Malaysia TI - The epidemiology of chronic myeloid leukaemia in southern Sarawak, Borneo Island UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046142881&partnerID=40&md5=eefc0babce4732b61d888957053c0fd7 VL - 73 ID - 5863 ER - TY - JOUR AD - M.L. Metzger, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States AU - Metzger, M. L. AU - Mauz-Körholz, C. C1 - sb 1518 DB - Embase Medline DO - 10.1111/bjh.15789 IS - 6 LA - English M3 - Review N1 - L626328024 2019-02-16 2019-06-18 PY - 2019 SN - 1365-2141 0007-1048 SP - 1142-1157 ST - Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma T2 - British Journal of Haematology TI - Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626328024&from=exporthttp://dx.doi.org/10.1111/bjh.15789 VL - 185 ID - 5864 ER - TY - JOUR AD - M.B. Madonna, Department of Surgery, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, United States AU - Chiu, B. AU - Mirkin, B. AU - Madonna, M. B. DB - Embase Medline DO - 10.1016/j.jpedsurg.2006.10.055 IS - 3 LA - English M3 - Article N1 - L46319163 2007-04-01 PY - 2007 SN - 0022-3468 SP - 482-488 ST - Epidermal growth factor can induce apoptosis in neuroblastoma T2 - Journal of Pediatric Surgery TI - Epidermal growth factor can induce apoptosis in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46319163&from=exporthttp://dx.doi.org/10.1016/j.jpedsurg.2006.10.055 VL - 42 ID - 5865 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynecology, Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3V5, Canada AU - Cheng, J. C. AU - Chang, H. M. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1210/jc.2011-2751 IS - 8 LA - English M3 - Article N1 - L365401991 2012-08-16 2012-09-06 PY - 2012 SN - 0021-972X 1945-7197 SP - E1380-E1389 ST - Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression T2 - Journal of Clinical Endocrinology and Metabolism TI - Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365401991&from=exporthttp://dx.doi.org/10.1210/jc.2011-2751http://jcem.endojournals.org/content/97/8/E1380.full.pdf+html VL - 97 ID - 5866 ER - TY - JOUR AD - L.A. Hansen, Department of Biomedical Sciences, School of Medicine, Creighton University, 2500 California Plaza, Omaha, NE 68178, United States AU - El-Abaseri, T. B. AU - Hammiller, B. AU - Repertinger, S. K. AU - Hansen, L. A. C1 - ag 1478 DB - Embase DO - 10.1155/2013/848705 LA - English M3 - Article N1 - L369322080 2013-07-23 2013-07-26 PY - 2013 SN - 2090-4592 2090-4606 ST - The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation T2 - ISRN Dermatology TI - The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369322080&from=exporthttp://dx.doi.org/10.1155/2013/848705 VL - 2013 ID - 5867 ER - TY - JOUR AD - Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-2 dong, Songpa-gu, 138736 Seoul, South Korea AU - Kim, J. E. AU - Lee, D. H. AU - Choi, Y. AU - Yoon, D. H. AU - Kim, S. W. AU - Suh, C. AU - Lee, J. S. DB - Scopus DO - 10.1016/j.lungcan.2008.12.011 IS - 3 M3 - Article N1 - Cited By :182 Export Date: 18 November 2020 PY - 2009 SP - 351-354 ST - Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis T2 - Lung Cancer TI - Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67849103953&doi=10.1016%2fj.lungcan.2008.12.011&partnerID=40&md5=3f101406bca95f1c213626128c81da4d VL - 65 ID - 5868 ER - TY - JOUR AD - Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Laboratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Yamaki, M. AU - Sugiura, K. AU - Muro, Y. AU - Shimoyama, Y. AU - Tomita, Y. DB - Scopus DO - 10.1111/j.1600-0625.2010.01108.x IS - 8 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2010 SP - 730-735 ST - Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes T2 - Experimental Dermatology TI - Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954841807&doi=10.1111%2fj.1600-0625.2010.01108.x&partnerID=40&md5=27ab49690bd5a92dc3b8dcf10fea68c2 VL - 19 ID - 5869 ER - TY - JOUR AD - J.H. Chung, Department of Dermatology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea AU - Park, C. H. AU - Chung, J. H. DB - Embase Medline DO - 10.1016/j.jdermsci.2011.07.002 IS - 2 LA - English M3 - Article N1 - L51590615 2011-08-30 2011-10-13 PY - 2011 SN - 0923-1811 1873-569X SP - 134-141 ST - Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts T2 - Journal of Dermatological Science TI - Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51590615&from=exporthttp://dx.doi.org/10.1016/j.jdermsci.2011.07.002 VL - 64 ID - 5870 ER - TY - JOUR AD - G. Liang, Pharmaceutical College, Guangxi Medical University, Nanning, China AU - Liao, Z. H. AU - Zhu, H. Q. AU - Chen, Y. Y. AU - Chen, R. L. AU - Fu, L. X. AU - Li, L. AU - Zhou, H. AU - Zhou, J. L. AU - Liang, G. C2 - hangzhou hetian(China) DB - Embase Medline DO - 10.1016/j.jep.2020.112852 LA - English M3 - Article N1 - L2005874196 2020-05-19 2020-05-27 PY - 2020 SN - 1872-7573 0378-8741 ST - The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways T2 - Journal of Ethnopharmacology TI - The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005874196&from=exporthttp://dx.doi.org/10.1016/j.jep.2020.112852 VL - 259 ID - 5871 ER - TY - JOUR AD - Y.-F. Wang, Department of Medical Laboratory Science and Biotechnology, Fooyin-University, Kaohsiung, Taiwan AU - Tsai, C. Y. AU - Chen, C. Y. AU - Chiou, Y. H. AU - Shyu, H. W. AU - Lin, K. H. AU - Chou, M. C. AU - Huang, M. H. AU - Wang, Y. F. DB - Embase DO - 10.3390/ijms19010016 IS - 1 LA - English M3 - Article N1 - L619950609 2018-01-04 2018-01-08 PY - 2018 SN - 1422-0067 1661-6596 ST - Epigallocatechin-3-gallate suppresses human herpesvirus 8 replication and induces ROS leading to apoptosis and autophagy in primary effusion lymphoma cells T2 - International Journal of Molecular Sciences TI - Epigallocatechin-3-gallate suppresses human herpesvirus 8 replication and induces ROS leading to apoptosis and autophagy in primary effusion lymphoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619950609&from=exporthttp://dx.doi.org/10.3390/ijms19010016 VL - 19 ID - 5872 ER - TY - JOUR AD - Z. Chatterton, Murdoch Childrens Research Institute, The University of Melbourne, Department of Paediatrics at the Royal Children's Hospital, Victoria, VIC, Australia AU - Chatterton, Z. AU - Morenos, L. AU - Mechinaud, F. AU - Ashley, D. M. AU - Craig, J. M. AU - Sexton-Oates, A. AU - Halemba, M. S. AU - Parkinson-Bates, M. AU - Ng, J. AU - Morrison, D. AU - Carroll, W. L. AU - Saffery, R. AU - Wong, N. C. DB - Embase Medline DO - 10.4161/epi.27585 IS - 3 LA - English M3 - Article N1 - L372938716 2014-05-05 2014-05-12 PY - 2014 SN - 1559-2308 1559-2294 SP - 459-467 ST - Epigenetic deregulation in pediatric acute lymphoblastic leukemia T2 - Epigenetics TI - Epigenetic deregulation in pediatric acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372938716&from=exporthttp://dx.doi.org/10.4161/epi.27585 VL - 9 ID - 5873 ER - TY - JOUR AD - C.S. Chim, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong AU - Li, Z. AU - Wong, K. Y. AU - Calin, G. A. AU - Chng, W. J. AU - Chan, G. C. F. AU - Chim, C. S. DB - Embase Medline DO - 10.1186/s13148-019-0669-2 IS - 1 LA - English M3 - Article N1 - L627530849 2019-05-16 2019-05-17 PY - 2019 SN - 1868-7083 1868-7075 ST - Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impact T2 - Clinical Epigenetics TI - Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impact UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627530849&from=exporthttp://dx.doi.org/10.1186/s13148-019-0669-2 VL - 11 ID - 5874 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada. Department of Pathobiology and Laboratory Medicine, University of Toronto, Toronto, ON, Canada. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. Harvard Medical School, Boston, MA, USA. AN - 29327718 AU - Dickson, B. C. AU - Swanson, D. AU - Charames, G. S. AU - Fletcher, C. D. AU - Hornick, J. L. DA - May DO - 10.1038/modpathol.2017.191 10.1038/modpathol.2017.191. Epub 2018 Jan 12. DP - Nlm ET - 2018/01/13 IS - 5 LA - eng PY - 2018 SN - 0893-3952 SP - 753-762 ST - Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases T2 - Mod Pathol TI - Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases VL - 31 ID - 5875 ER - TY - JOUR AD - Department of Pathology, The University of Colorado Health Sciences Center, Aurora, CO 80045, USA. bk.demasters@ucdenver.edu). AN - 23552385 AU - Kleinschmidt-DeMasters, B. K. AU - Aisner, D. L. AU - Birks, D. K. AU - Foreman, N. K. C2 - PMC4610349 C6 - NIHMS726045 DA - May DO - 10.1097/PAS.0b013e31827f9c5e 10.1097/PAS.0b013e31827f9c5e. DP - Nlm ET - 2013/04/05 IS - 5 LA - eng PY - 2013 SN - 0147-5185 (Print) 0147-5185 SP - 685-98 ST - Epithelioid GBMs show a high percentage of BRAF V600E mutation T2 - Am J Surg Pathol TI - Epithelioid GBMs show a high percentage of BRAF V600E mutation VL - 37 ID - 5876 ER - TY - JOUR AD - Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, 270 Dong An Road, Shanghai, 200032, China. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University and Shanghai Respiratory Research Institute, Shanghai, 200032, China. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China. Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, 270 Dong An Road, Shanghai, 200032, China. softtissuetumor@163.com. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. softtissuetumor@163.com. AN - 27460384 AU - Yu, L. AU - Liu, J. AU - Lao, I. W. AU - Luo, Z. AU - Wang, J. C2 - PMC4962498 DA - Jul 27 DO - 10.1186/s13000-016-0517-z 10.1186/s13000-016-0517-z. DP - Nlm ET - 2016/07/28 IS - 1 LA - eng PY - 2016 SN - 1746-1596 SP - 67 ST - Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature T2 - Diagn Pathol TI - Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature VL - 11 ID - 5877 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. AN - 21164297 AU - Mariño-Enríquez, A. AU - Wang, W. L. AU - Roy, A. AU - Lopez-Terrada, D. AU - Lazar, A. J. AU - Fletcher, C. D. AU - Coffin, C. M. AU - Hornick, J. L. DA - Jan DO - 10.1097/PAS.0b013e318200cfd5 10.1097/PAS.0b013e318200cfd5. DP - Nlm ET - 2010/12/18 IS - 1 LA - eng PY - 2011 SN - 0147-5185 SP - 135-44 ST - Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK T2 - Am J Surg Pathol TI - Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK VL - 35 ID - 5878 ER - TY - JOUR AD - W.L. Kwok, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, Hong Kong AU - Lo, A. K. F. AU - Kwok, W. L. AU - Sai, W. T. AU - Hing, L. W. AU - Hui, J. W. Y. AU - Ka, F. T. AU - Hayward, S. D. AU - Yiu, L. C. AU - Yu, L. L. AU - Takada, K. AU - Huang, D. P. DB - Embase Medline DO - 10.1593/neo.05625 IS - 3 LA - English M3 - Article N1 - L43671232 2006-05-25 PY - 2006 SN - 1522-8002 1476-5586 SP - 173-180 ST - Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells T2 - Neoplasia TI - Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43671232&from=exporthttp://dx.doi.org/10.1593/neo.05625http://docserver.ingentaconnect.com/deliver/connect/neo/15228002/v8n3/s2.pdf?expires=1146913086&id=28914531&titleid=3829&accname=Guest+User&checksum=70555B79B01831F028D3AAAC66EE9618 VL - 8 ID - 5879 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States MediCity Research Laboratories, Department of Medical Biochemistry and Molecular Biology, University of Turku, FIN-20520 Turku, Finland Turku Graduate School of Biomedical Sciences, University of Turku, FIN-20520 Turku, Finland Department of Pathology, Tampere University Hospital, FIN-33521 Tampere, Finland Northern Institute for Cancer Research, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, United Kingdom Department of Neuropathology, Newcastle General Hospital, Newcastle Upon Tyne NE4 6BE, United Kingdom AU - Gilbertson, R. J. AU - Bentley, L. AU - Hernan, R. AU - Junttila, T. T. AU - Frank, A. J. AU - Haapasalo, H. AU - Connelly, M. AU - Wetmore, C. AU - Curran, T. AU - Elenius, K. AU - Ellison, D. W. DB - Scopus IS - 10 M3 - Article N1 - Cited By :145 Export Date: 18 November 2020 PY - 2002 SP - 3054-3064 ST - ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease T2 - Clinical Cancer Research TI - ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036793917&partnerID=40&md5=ec651277cedf66f156aa1ea8ac45a67d VL - 8 ID - 5880 ER - TY - JOUR AD - M.R. Schneider, Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Feodor-Lynen-Str. 25, Munich, Germany AU - Dahlhoff, M. AU - Muzumdar, S. AU - Schäfer, M. AU - Schneider, M. R. DB - Embase DO - 10.1016/j.jid.2016.11.023 IS - 4 LA - English M3 - Article N1 - L614966740 2017-03-28 2017-04-25 PY - 2017 SN - 1523-1747 0022-202X SP - 921-930 ST - ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice T2 - Journal of Investigative Dermatology TI - ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614966740&from=exporthttp://dx.doi.org/10.1016/j.jid.2016.11.023 VL - 137 ID - 5881 ER - TY - JOUR AD - R. Landgraf, Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Box 016129 (R-629), Miami, FL, United States AU - Liu, W. AU - Barnette, A. R. AU - Andreansky, S. AU - Landgraf, R. C2 - Chromadex LC DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0932 IS - 11 LA - English M3 - Article N1 - L613162561 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2750-2757 ST - ERBB2 overexpression establishes ERBB3-dependent hypersensitivity of breast cancer cells to withaferin A T2 - Molecular Cancer Therapeutics TI - ERBB2 overexpression establishes ERBB3-dependent hypersensitivity of breast cancer cells to withaferin A UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162561&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-15-0932 VL - 15 ID - 5882 ER - TY - JOUR AD - Y. Zhu, Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, United States AU - Wang, Y. AU - Kim, E. AU - Wang, X. AU - Novitch, B. G. AU - Yoshikawa, K. AU - Chang, L. S. AU - Zhu, Y. DB - Embase Medline DO - 10.1016/j.cell.2012.06.034 IS - 4 LA - English M3 - Article N1 - L365479289 2012-08-29 2012-09-03 PY - 2012 SN - 0092-8674 1097-4172 SP - 816-830 ST - ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities T2 - Cell TI - ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365479289&from=exporthttp://dx.doi.org/10.1016/j.cell.2012.06.034 VL - 150 ID - 5883 ER - TY - JOUR AD - F.-C. Yang, Departments of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States AU - He, Y. AU - Staser, K. AU - Rhodes, S. D. AU - Liu, Y. AU - Wu, X. AU - Park, S. J. AU - Yuan, J. AU - Yang, X. AU - Li, X. AU - Jiang, L. AU - Chen, S. AU - Yang, F. C. DB - Embase Medline DO - 10.1371/journal.pone.0024780 IS - 9 L1 - internal-pdf://1176911340/journal.pone.0024780.PDF LA - English M3 - Article N1 - L362610375 2011-09-29 2011-10-12 PY - 2011 SN - 1932-6203 ST - Erk1 positively regulates osteoclast differentiation and bone resorptive activity T2 - PLoS ONE TI - Erk1 positively regulates osteoclast differentiation and bone resorptive activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362610375&from=exporthttp://dx.doi.org/10.1371/journal.pone.0024780 VL - 6 ID - 5884 ER - TY - JOUR AD - Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba 6-3, Aramaki, Aoba-ku, Sendai 980-8578, Japan; Department of Pharmacology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. Electronic address: obaray@med.id.yamagata-u.ac.jp. Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba 6-3, Aramaki, Aoba-ku, Sendai 980-8578, Japan. Department of Physiology and Pharmacology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. The Vollum Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA. Department of Urology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. Department of Pharmacology, Yamagata University School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585, Japan. AN - 26739108 AU - Obara, Y. AU - Nagasawa, R. AU - Nemoto, W. AU - Pellegrino, M. J. AU - Takahashi, M. AU - Habecker, B. A. AU - Stork, P. J. S. AU - Ichiyanagi, O. AU - Ito, H. AU - Tomita, Y. AU - Ishii, K. AU - Nakahata, N. C2 - PMC6521842 C6 - NIHMS1026847 DA - Mar DO - 10.1016/j.cellsig.2015.12.016 10.1016/j.cellsig.2015.12.016. Epub 2015 Dec 29. DP - Nlm ET - 2016/01/08 IS - 3 LA - eng PY - 2016 SN - 0898-6568 (Print) 0898-6568 SP - 177-189 ST - ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells T2 - Cell Signal TI - ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells VL - 28 ID - 5885 ER - TY - JOUR AD - L. Zubritsky, University of Cincinnati, United States AU - Zubritsky, L. AU - Schimdt, F. B. DB - Embase DO - 10.1111/pde.13196 LA - English M3 - Conference Abstract N1 - L617274519 2017-07-17 PY - 2017 SN - 1525-1470 SP - S161 ST - Eruptive nevi in a 9-year-old female patient with low grade glioma after initiation of dabrafenib, a selective BRAF inhibitor T2 - Pediatric Dermatology TI - Eruptive nevi in a 9-year-old female patient with low grade glioma after initiation of dabrafenib, a selective BRAF inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617274519&from=exporthttp://dx.doi.org/10.1111/pde.13196 VL - 34 ID - 5886 ER - TY - JOUR AD - S. Genc, Dept. of Med. Biology and Genetics, School of Medicine, Dokuz Eylul University, Inciralti, 35340, Izmir, Turkey AU - Genc, S. AU - Koroglu, T. F. AU - Genc, K. DB - Embase Medline DO - 10.1016/j.brainres.2003.12.037 IS - 1-2 LA - English M3 - Review N1 - L38446486 2004-04-20 PY - 2004 SN - 0006-8993 SP - 19-31 ST - Erythropoietin and the nervous system T2 - Brain Research TI - Erythropoietin and the nervous system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38446486&from=exporthttp://dx.doi.org/10.1016/j.brainres.2003.12.037 VL - 1000 ID - 5887 ER - TY - JOUR AD - M.O. Arcasoy, Department of Medicine, Duke University School of Medicine, DUMC Box 3912, Durham, NC 27710, United States AU - Fu, P. AU - Arcasoy, M. O. DB - Embase Medline DO - 10.1016/j.bbrc.2007.01.044 IS - 2 LA - English M3 - Article N1 - L46161367 2007-02-28 PY - 2007 SN - 0006-291X 1090-2104 SP - 372-378 ST - Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis T2 - Biochemical and Biophysical Research Communications TI - Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46161367&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2007.01.044 VL - 354 ID - 5888 ER - TY - JOUR AD - Clinical Cooperation Unit Pediatric Oncology (G340), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Center for Individualized Pediatric Oncology (ZIPO) and Section of Pediatric Brain Tumors, Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany. Division of Biostatistics (C060), German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology (G380), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ), Heidelberg, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany. Division of Molecular Genetics (B060), German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Heidelberg, Germany. Current affiliation: AbbVie Deutschland GmbH & Co. KG, Medical Immunology, Wiesbaden, Germany. Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Germany. Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany. Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University and University Medical Centre, Freiburg, Germany. Division of Pediatric Neurooncology (B062), German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), Heidelberg, Germany. AN - 28002790 AU - Selt, F. AU - Hohloch, J. AU - Hielscher, T. AU - Sahm, F. AU - Capper, D. AU - Korshunov, A. AU - Usta, D. AU - Brabetz, S. AU - Ridinger, J. AU - Ecker, J. AU - Oehme, I. AU - Gronych, J. AU - Marquardt, V. AU - Pauck, D. AU - Bächli, H. AU - Stiles, C. D. AU - von Deimling, A. AU - Remke, M. AU - Schuhmann, M. U. AU - Pfister, S. M. AU - Brummer, T. AU - Jones, D. T. AU - Witt, O. AU - Milde, T. C2 - PMC5355278 DA - Feb 14 DO - 10.18632/oncotarget.14004 10.18632/oncotarget.14004. DP - Nlm ET - 2016/12/22 IS - 7 LA - eng PY - 2017 SN - 1949-2553 SP - 11460-11479 ST - Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing T2 - Oncotarget TI - Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing VL - 8 ID - 5889 ER - TY - JOUR AD - Guangxi Medical University. Spine and Osteopathy Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. AN - 33181717 AU - Zhang, Z. AU - Liu, C. AU - Liang, T. AU - Yu, C. AU - Qin, Z. AU - Zhou, X. AU - Xue, J. AU - Zeng, H. AU - Lu, Z. AU - Xu, G. AU - Wang, Z. AU - Chen, J. AU - Jiang, J. AU - Zhan, X. C2 - PMC7668544 DA - Nov 13 DO - 10.1097/md.0000000000023251 10.1097/MD.0000000000023251. DP - Nlm ET - 2020/11/13 IS - 46 LA - eng PY - 2020 SN - 0025-7974 (Print) 0025-7974 SP - e23251 ST - Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients T2 - Medicine (Baltimore) TI - Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients VL - 99 ID - 5890 ER - TY - JOUR AD - M. Hirabayashi, Section of Mammalian Transgenesis, Center for Genetic Analysis of Behavior, National Institute for Physiological Sciences, 5-1 Higashiyama, Myodaiji-cho, Okazaki, Aichi 444-8787, Japan AU - Hirabayashi, M. AU - Kato, M. AU - Kobayashi, T. AU - Sanbo, M. AU - Yagi, T. AU - Hochi, S. AU - Nakauchi, H. DB - Embase Medline DO - 10.1002/mrd.21123 IS - 2 LA - English M3 - Letter N1 - L358031983 2010-02-01 PY - 2010 SN - 1040-452X 1098-2795 SP - 94 ST - Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency T2 - Molecular Reproduction and Development TI - Establishment of rat embryonic stem cell lines that can participate in germline chimerae at high efficiency UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358031983&from=exporthttp://dx.doi.org/10.1002/mrd.21123http://www3.interscience.wiley.com/cgi-bin/fulltext/122679560/PDFSTART VL - 77 ID - 5891 ER - TY - JOUR AD - H. Tanaka AU - Tanaka, H. AU - Yamamoto, M. AU - Yamazaki, K. AU - Shimizu, K. AU - Ogawa, K. DB - Embase DO - 10.1158/1538-7445.AM2016-661 IS - 14 LA - English M3 - Conference Abstract N1 - L613608936 2016-12-19 PY - 2016 SN - 1538-7445 ST - Establishment of transgenic mice with liver-specific BRAF V600E mutation T2 - Cancer Research TI - Establishment of transgenic mice with liver-specific BRAF V600E mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613608936&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2016-661 VL - 76 ID - 5892 ER - TY - JOUR AD - Department of Hematology and Oncology, Baylor College of Medicine, Houston Texas Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Texas Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston Texas AN - 110427909. Language: English. Entry Date: 20160214. Revision Date: 20180809. Publication Type: journal article AU - Yilmaz, Musa AU - Lahoti, Amit AU - O'Brien, Susan AU - Nogueras‐González, Graciela M. AU - Burger, Jan AU - Ferrajoli, Alessandra AU - Borthakur, Gautam AU - Ravandi, Farhad AU - Pierce, Sherry AU - Jabbour, Elias AU - Kantarjian, Hagop AU - Cortes, Jorge E. DB - ccm DO - 10.1002/cncr.29587 DP - EBSCOhost IS - 21 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM26217876. PY - 2015 SN - 0008-543X SP - 3894-3904 ST - Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors T2 - Cancer (0008543X) TI - Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110427909&site=ehost-live&scope=site VL - 121 ID - 5893 ER - TY - JOUR AD - B. Gerstner, Department of Neonatology, Universitätsmedizin Berlin, Charité, Augustenburger Platz 1, 13353 Berlin, Germany AU - Gerstner, B. AU - Sifringer, M. AU - Dzietko, M. AU - Schüller, A. AU - Lee, J. AU - Simons, S. AU - Obladen, M. AU - Volpe, J. J. AU - Rosenberg, P. A. AU - Felderhoff-Mueser, U. DB - Embase Medline DO - 10.1002/ana.21118 IS - 6 LA - English M3 - Article N1 - L47068138 2007-06-01 PY - 2007 SN - 0364-5134 SP - 562-573 ST - Estradiol attenuates hyperoxia-induced cell death in the developing white matter T2 - Annals of Neurology TI - Estradiol attenuates hyperoxia-induced cell death in the developing white matter UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47068138&from=exporthttp://dx.doi.org/10.1002/ana.21118 VL - 61 ID - 5894 ER - TY - JOUR AD - C. M. Klinge, Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, 580 South Preston Street, Louisville, KY 40202, United States AU - Mattingly, K. A. AU - Ivanova, M. M. AU - Riggs, K. A. AU - Wickramasinghe, N. S. AU - Barch, M. J. AU - Klinge, C. M. DB - Embase Medline DO - 10.1210/me.2007-0029 IS - 3 LA - English M3 - Article N1 - L351397789 2008-04-01 PY - 2008 SN - 0888-8809 SP - 609-622 ST - Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis T2 - Molecular Endocrinology TI - Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351397789&from=exporthttp://dx.doi.org/10.1210/me.2007-0029http://mend.endojournals.org/cgi/reprint/22/3/609 VL - 22 ID - 5895 ER - TY - JOUR AD - Z.C. Hannoush, University of Miami, Jackson Memorial Hospital, Miami, FL, United States AU - Hannoush, Z. C. AU - Ayala, A. DB - Embase DO - 10.1210/endo-meetings.2016.TB.1.FRI-090 IS - 2 LA - English M3 - Conference Abstract N1 - L613520166 2016-12-08 PY - 2016 SN - 0163-769X ST - Estrogen exposure and testicular choriocarcinoma: Case report of a male to female transgender patient T2 - Endocrine Reviews TI - Estrogen exposure and testicular choriocarcinoma: Case report of a male to female transgender patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613520166&from=exporthttp://dx.doi.org/10.1210/endo-meetings.2016.TB.1.FRI-090 VL - 37 ID - 5896 ER - TY - JOUR AD - M. Umetani, Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, United States AU - Hiramitsu, S. AU - Ishikawa, T. AU - Lee, W. R. AU - Khan, T. AU - Crumbley, C. AU - Khwaja, N. AU - Zamanian, F. AU - Asghari, A. AU - Sen, M. AU - Zhang, Y. AU - Hawse, J. R. AU - Minna, J. D. AU - Umetani, M. DB - Embase DO - 10.3389/fendo.2018.00470 IS - AUG LA - English M3 - Article N1 - L623589424 2018-08-31 2018-09-05 PY - 2018 SN - 1664-2392 ST - Estrogen receptor beta-mediated modulation of lung cancer cell proliferation by 27-hydroxycholesterol T2 - Frontiers in Endocrinology TI - Estrogen receptor beta-mediated modulation of lung cancer cell proliferation by 27-hydroxycholesterol UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623589424&from=exporthttp://dx.doi.org/10.3389/fendo.2018.00470 VL - 9 ID - 5897 ER - TY - JOUR AD - Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, 231 Albert Sabin Way, PO Box 670575, Cincinnati, OH 45267-0575, United States AU - Cookman, C. J. AU - Belcher, S. M. DB - Scopus DO - 10.1210/en.2015-1141 IS - 7 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2015 SP - 2395-2408 ST - Estrogen receptor-β up-regulates IGF1R expression and activity to inhibit apoptosis and increase growth of medulloblastoma T2 - Endocrinology TI - Estrogen receptor-β up-regulates IGF1R expression and activity to inhibit apoptosis and increase growth of medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937605783&doi=10.1210%2fen.2015-1141&partnerID=40&md5=7bf6b68097c9d02f3ce3c6d87100845e VL - 156 ID - 5898 ER - TY - JOUR AD - J.M. Cerutti, Departamento de Morfologia e Genética, Genetic Bases of Thyroid Tumors Laboratory, Disciplina de Genética, Universidade Federal de São Paulo, São Paulo, Brazil AU - Bastos, A. U. AU - De Jesus, A. C. AU - Cerutti, J. M. DB - Embase Medline DO - 10.1530/EJE-17-0499 IS - 1 LA - English M3 - Article N1 - L620213047 2018-01-19 2018-01-22 PY - 2018 SN - 1479-683X 0804-4643 SP - 83-91 ST - ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population T2 - European Journal of Endocrinology TI - ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620213047&from=exporthttp://dx.doi.org/10.1530/EJE-17-0499 VL - 178 ID - 5899 ER - TY - JOUR AD - *Department of Pathology, Vancouver General Hospital §Genome Sciences Center ∥British Columbia Cancer Agency ¶British Columbia Children's Hospital #Department of Pathology, University of British Columbia, Vancouver, BC **Department of Pathology, Royal Alexandra Hospital, Edmonton, AB, Canada †Department of Pathology, King Abdulaziz Medical City, Riyadh, Saudi Arabia ‡Department of Pathology, Kuwait University, Kuwait. AN - 27259007 AU - Alassiri, A. H. AU - Ali, R. H. AU - Shen, Y. AU - Lum, A. AU - Strahlendorf, C. AU - Deyell, R. AU - Rassekh, R. AU - Sorensen, P. H. AU - Laskin, J. AU - Marra, M. AU - Yip, S. AU - Lee, C. H. AU - Ng, T. L. DA - Aug DO - 10.1097/pas.0000000000000677 10.1097/PAS.0000000000000677. DP - Nlm ET - 2016/06/04 IS - 8 LA - eng PY - 2016 SN - 0147-5185 SP - 1051-61 ST - ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors T2 - Am J Surg Pathol TI - ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors VL - 40 ID - 5900 ER - TY - JOUR AD - F.-L. Yen, Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, 100, Shih-Chuan 1st Road, Kaohsiung 807, Taiwan AU - Ko, H. H. AU - Chiang, Y. C. AU - Tsai, M. H. AU - Liang, C. J. AU - Hsu, L. F. AU - Li, S. Y. AU - Wang, M. C. AU - Yen, F. L. AU - Lee, C. W. DB - Embase Medline DO - 10.1016/j.jep.2013.10.054 IS - 1 LA - English M3 - Article N1 - L52913353 2013-12-18 2014-01-10 PY - 2014 SN - 0378-8741 1872-7573 SP - 386-393 ST - Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways T2 - Journal of Ethnopharmacology TI - Eupafolin, a skin whitening flavonoid isolated from Phyla nodiflora, downregulated melanogenesis: Role of MAPK and Akt pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52913353&from=exporthttp://dx.doi.org/10.1016/j.jep.2013.10.054 VL - 151 ID - 5901 ER - TY - JOUR AD - Klinik für Innere Medizin II, Universitätsklinikum, Jena, Germany Department of Hematology/Oncology, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy Weill Cornell Medical College, New York, NY, United States Karmanos Cancer Center, Detroit, MI, United States Hammersmith Hospital, Imperial College, London, United Kingdom Hospital Clinic IDIBAPS, Barcelona, Spain Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom Georgia Cancer Center, Augusta University, Augusta, GA, United States Huntsman Cancer Center Salt Lake City, Salt Lake City, UT, United States Centre Hospitalier Universitaire de Poitiers, Poitiers, France Norwegian University of Science and Technology, Trondheim, Norway South Australian Health and Medical Research Institute, Adelaide, SA, Australia Amsterdam University Medical Center, VUMC, Amsterdam, Netherlands AU - Hochhaus, A. AU - Baccarani, M. AU - Silver, R. T. AU - Schiffer, C. AU - Apperley, J. F. AU - Cervantes, F. AU - Clark, R. E. AU - Cortes, J. E. AU - Deininger, M. W. AU - Guilhot, F. AU - Hjorth-Hansen, H. AU - Hughes, T. P. AU - Janssen, J. J. W. M. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Larson, R. A. AU - Lipton, J. H. AU - Mahon, F. X. AU - Mayer, J. AU - Nicolini, F. AU - Niederwieser, D. AU - Pane, F. AU - Radich, J. P. AU - Rea, D. AU - Richter, J. AU - Rosti, G. AU - Rousselot, P. AU - Saglio, G. AU - Saußele, S. AU - Soverini, S. AU - Steegmann, J. L. AU - Turkina, A. AU - Zaritskey, A. AU - Hehlmann, R. DB - Scopus DO - 10.1038/s41375-020-0776-2 IS - 4 M3 - Review N1 - Cited By :47 Export Date: 18 November 2020 PY - 2020 SP - 966-984 ST - European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia T2 - Leukemia TI - European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081568026&doi=10.1038%2fs41375-020-0776-2&partnerID=40&md5=917a18fb64e4bbf2aaf86b5588ba1f44 VL - 34 ID - 5902 ER - TY - JOUR AD - Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy AU - Fallahi, P. AU - Ferrari, S. M. AU - Elia, G. AU - Ragusa, F. AU - Paparo, S. R. AU - Ruffilli, I. AU - Patrizio, A. AU - Materazzi, G. AU - Antonelli, A. DB - Scopus DO - 10.2147/CMAR.S127848 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 7893-7907 ST - Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes T2 - Cancer Management and Research TI - Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073352098&doi=10.2147%2fCMAR.S127848&partnerID=40&md5=a221a0289547e00f190726508028a9fe VL - 11 ID - 5903 ER - TY - JOUR AD - Rady Childrens Hospital, San Diego, CA (VW, JC, DM, HA); Foundation Medicine, Inc., Cambridge, MA (DP, TB, RY, JSR, VAM, PJS, SMA); Albany Medical College, Albany, NY (JSR). siraj@foundationmedicine.com. AN - 26563356 AU - Wong, V. AU - Pavlick, D. AU - Brennan, T. AU - Yelensky, R. AU - Crawford, J. AU - Ross, J. S. AU - Miller, V. A. AU - Malicki, D. AU - Stephens, P. J. AU - Ali, S. M. AU - Ahn, H. DA - Jan DO - 10.1093/jnci/djv307 10.1093/jnci/djv307. Print 2016 Jan. DP - Nlm ET - 2015/11/14 IS - 1 LA - eng PY - 2016 SN - 0027-8874 ST - Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib T2 - J Natl Cancer Inst TI - Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib VL - 108 ID - 5904 ER - TY - JOUR AD - 1 Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary , Calgary, Canada . 2 Divisions of Endocrinology and Nephrology, University of Leipzig , Leipzig, Germany . 3 Department of Pathology, University Hospital Halle , Halle, Germany . 4 Amedes MVZ wagnerstibbe für Laboratoriumsmedizin, Hämostaseologie, Humangenetik und Mikrobiologie , Hannover, Germany . 5 Zentrum für Nuklearmedizin und PET/CT , Bremen, Germany . 6 Radiologie Hoheluft , Hamburg, Germany . 7 Klinik Dr. Hancken , Stade, Germany . 8 Praxis für Nuklearmedizin , PET-CT Zentrum, Wiesbaden, Germany . 9 Praxis für Nuklearmedizin , Oldenburg, Germany . 10 Institut für Radiologie & Nuklearmedizin , Bremerhaven, Germany . 11 Endokrinologie & Diabetologie im Zentrum , Stuttgart, Germany . 12 Praxisgemeinschaft auf dem Meere , Lüneburg, Germany . 13 Radiologie und Nuklearmedizin in der Gottorpstraße , Oldenburg, Germany . 14 Radiologie Oldenburg, Praxis Stehen und Partner GbR , Oldenburg, Germany . 15 Amedes MVZ , Hamburg, Germany . 16 Nuklearmedizinische Praxis Dr.med.Klaushenke , Cloppenburg, Germany . 17 Endokrinologische Gemeinschaftspraxis , Zentrum für Hormon- und Stoffwechselstörungen, Frankfurt/Main, Germany . 18 Röntgenpraxis Georgstraße , Hannover, Germany . 19 Radiologisch-Nuklearmedizinische Gemeinschaftspraxis , Celle, Germany . 20 MVZ Westerwald GmbH , Dernbach, Germany . 21 Schilddrüsen- und Hormon-Praxis , Gera, Germany . 22 Diagnostisches Zentrum Göttingen, Gemeinschaftspraxis für Radiologie und Nuklearmedizin , Göttingen, Germany . 23 Schilddrüse Stuttgart, Fachärzte für Innere Medizin und Nuklearmedizinische Schilddrüsendiagnostik , Stuttgart, Germany . 24 MVZ wagnerstibbe für Gynäkologie, Reproduktionsmedizin, Zytologie, Pathologie und Innere Medizin GmbH , Einbeck, Germany . 25 Division of Endocrinology, Department of Medicine, and Departments of Oncology, and Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary , Calgary, Canada . AN - 28071986 AU - Eszlinger, M. AU - Böhme, K. AU - Ullmann, M. AU - Görke, F. AU - Siebolts, U. AU - Neumann, A. AU - Franzius, C. AU - Adam, S. AU - Molwitz, T. AU - Landvogt, C. AU - Amro, B. AU - Hach, A. AU - Feldmann, B. AU - Graf, D. AU - Wefer, A. AU - Niemann, R. AU - Bullmann, C. AU - Klaushenke, G. AU - Santen, R. AU - Tönshoff, G. AU - Ivancevic, V. AU - Kögler, A. AU - Bell, E. AU - Lorenz, B. AU - Kluge, G. AU - Hartenstein, C. AU - Ruschenburg, I. AU - Paschke, R. DA - Mar DO - 10.1089/thy.2016.0445 10.1089/thy.2016.0445. Epub 2017 Feb 7. DP - Nlm ET - 2017/01/11 IS - 3 LA - eng PY - 2017 SN - 1050-7256 SP - 402-411 ST - Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany T2 - Thyroid TI - Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany VL - 27 ID - 5905 ER - TY - JOUR AD - Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Verona, Italy Neurosciences Medicines Development Centre, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Neurosciences Medicines Development Centre, GlaxoSmithKline R and D Ltd, Durham, NC, United States Discovery Biometrics, GlaxoSmithKline R and D Ltd, Harlow, Essex, United Kingdom Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline R and D Ltd, Verona, Italy Neurosciences Centre for Excellence in Drug Discovery, GlaxoSmithKline R and D Ltd, Durham, NC, United States Takeda Development Centre Europe Ltd., 61 Aldwych, London, WC2B 4AE, United Kingdom Neuroscience DTA, F. Hoffman-la Roche, Basel, Switzerland AU - Inamdar, A. AU - Merlo-Pich, E. AU - Gee, M. AU - Makumi, C. AU - Mistry, P. AU - Robertson, J. AU - Steinberg, E. AU - Zamuner, S. AU - Learned, S. AU - Alexander, R. AU - Ratti, E. DB - Scopus DO - 10.1177/0269881114529377 IS - 6 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 570-581 ST - Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach T2 - Journal of Psychopharmacology TI - Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901596872&doi=10.1177%2f0269881114529377&partnerID=40&md5=8dcaa2168078281a3aa7b3dfe99d77af VL - 28 ID - 5906 ER - TY - JOUR AD - First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece Univ. Research Institute for the Study and Treatment of Childhood Genetic and Malignant Diseases, University of Athens, Aghia Sophia Children's Hospital, Thivon and Levadias, 11527 Goudi-Athens, Greece Science Department, Agricultural University of Athens, Athens, Greece AU - Hatziagapiou, K. AU - Braoudaki, M. AU - Karpusas, M. AU - Tzortzatou-Stathopoulou, F. DB - Scopus IS - 9-10 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2011 SP - 781-784 ST - Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells T2 - Clinical Laboratory TI - Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054793072&partnerID=40&md5=31abcb4b0eacd92fffb37847497635ef VL - 57 ID - 5907 ER - TY - JOUR AD - Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran Department of Pediatrics, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran AU - Eskandari-Nasab, E. AU - Hashemi, M. AU - Hasani, S. S. A. AU - Naderi, M. AU - Sadeghi-Bojd, S. AU - Taheri, M. DB - Scopus DO - 10.1080/15257770.2016.1243716 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 170-180 ST - Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran T2 - Nucleosides, Nucleotides and Nucleic Acids TI - Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008204227&doi=10.1080%2f15257770.2016.1243716&partnerID=40&md5=d99aa3d2707509909392e14b6afc8390 VL - 36 ID - 5908 ER - TY - JOUR AD - Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pediatrics, Children's Hospital and Regional Medical Center, Seattle, WA, United States Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, MS313, 332 N. Lauderdale St., Memphis, TN 38105, United States AU - Freeman Iii, B. B. AU - Daw, N. C. AU - Geyer, J. R. AU - Furman, W. L. AU - Stewart, C. F. DB - Scopus DO - 10.1080/07357900600632058 IS - 3 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2006 SP - 310-317 ST - Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients T2 - Cancer Investigation TI - Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646494170&doi=10.1080%2f07357900600632058&partnerID=40&md5=4cc07022e6150253e5f41c557e655c5e VL - 24 ID - 5909 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America. Department of Medicine, Division of Solid Tumors, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, United States of America; California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California, United States of America. Department of Pediatrics, Division of Hematology/Oncology, Gwynne Hazen Cherry Memorial Laboratories, University of California, Los Angeles, Los Angeles, California, United States of America; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California, United States of America; California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California, United States of America. AN - 26402468 AU - Anderson, J. L. AU - Park, A. AU - Akiyama, R. AU - Tap, W. D. AU - Denny, C. T. AU - Federman, N. C2 - PMC4581723 DO - 10.1371/journal.pone.0133610 10.1371/journal.pone.0133610. eCollection 2015. DP - Nlm ET - 2015/09/25 IS - 9 LA - eng PY - 2015 SN - 1932-6203 SP - e0133610 ST - Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas T2 - PLoS One TI - Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas VL - 10 ID - 5910 ER - TY - JOUR AD - G. Shokri, Islamic Azad University, Damghan, Iran AU - Shokri, G. AU - Fathi, M. AU - Kouhkan, F. DB - Embase LA - English M3 - Conference Abstract N1 - L626515957 2019-03-01 PY - 2016 SN - 2228-5814 SP - 62-63 ST - Evaluation of KDM5A knockdown by SHRNA in acute myeloid leukemia cell line T2 - Cell Journal TI - Evaluation of KDM5A knockdown by SHRNA in acute myeloid leukemia cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626515957&from=export VL - 18 ID - 5911 ER - TY - JOUR AD - Department of Pediatric Surgery, Fujita Medical University, Toyoake, Japan - watanabe@fujita-hu.ac.jp. Department of Pediatric Surgery, Fujita Medical University, Toyoake, Japan. AN - 30605998 AU - Watanabe, S. AU - Suzuki, T. AU - Kondo, Y. AU - Naoe, A. AU - Uga, N. AU - Yasui, T. AU - Hara, F. AU - Tsuchiya, T. DA - Jan 2 DO - 10.23736/s0026-4946.18.05444-0 10.23736/S0026-4946.18.05444-0. DP - Nlm ET - 2019/01/05 LA - eng PY - 2019 SN - 0026-4946 ST - Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with vascular endothelial growth factor and platelet-derived growth factor receptor T2 - Minerva Pediatr TI - Evaluation of Ki-67 as prognostic factor for pediatric neuroblastoma and the possibility of molecular-targeted drugs with vascular endothelial growth factor and platelet-derived growth factor receptor ID - 5912 ER - TY - JOUR AD - K. Katsibardi, Hematology-Oncology Unit, 1st Department of Pediatrics, Aghia Sofia Children's Hospital, Athens, Greece AU - Katsibardi, K. AU - Vlachou, A. AU - Tourkantoni, N. AU - Atmatzidou, E. AU - Kostaridou, S. AU - Kattamis, A. DB - Embase LA - English M3 - Conference Abstract N1 - L71963821 2015-08-08 PY - 2015 SN - 0390-6078 SP - 668 ST - Evaluation of minimal residual disease and usage of targeted therapy in pediatric patients with anaplastic large CEL lymphoma T2 - Haematologica TI - Evaluation of minimal residual disease and usage of targeted therapy in pediatric patients with anaplastic large CEL lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71963821&from=exporthttp://www.haematologica.org/content/100/supplement_1/1.full-text.pdf+html VL - 100 ID - 5913 ER - TY - JOUR AD - S. Pilotto, Section of Oncology, Department of Medicine, University of Verona, Azienda Ospedaliera Universitaria Integrata (AOUI) di Verona, Verona, Italy AU - Trestini, I. AU - Sperduti, I. AU - Sposito, M. AU - Kadrija, D. AU - Drudi, A. AU - Avancini, A. AU - Tregnago, D. AU - Carbognin, L. AU - Bovo, C. AU - Santo, A. AU - Lanza, M. AU - D'Onofrio, M. AU - Tortora, G. AU - Bria, E. AU - Milella, M. AU - Pilotto, S. DB - Embase Medline DO - 10.1136/esmoopen-2020-000689 IS - 3 LA - English M3 - Article N1 - L631797800 2020-06-02 2020-06-05 PY - 2020 SN - 2059-7029 ST - Evaluation of nutritional status in non-small-cell lung cancer: Screening, assessment and correlation with treatment outcome T2 - ESMO Open TI - Evaluation of nutritional status in non-small-cell lung cancer: Screening, assessment and correlation with treatment outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631797800&from=exporthttp://dx.doi.org/10.1136/esmoopen-2020-000689 VL - 5 ID - 5914 ER - TY - JOUR AD - P.J. Houghton, Greehey Children's Cancer Research Institute, University of Texas Health Science Center, San Antonio, TX, United States AU - Bandyopadhyay, A. AU - Favours, E. AU - Phelps, D. A. AU - Pozo, V. D. AU - Ghilu, S. AU - Kurmashev, D. AU - Michalek, J. AU - Trevino, A. AU - Guttridge, D. AU - London, C. AU - Hirotani, K. AU - Zhang, L. AU - Kurmasheva, R. T. AU - Houghton, P. J. C1 - erlotinib(Daiichi Sankyo) patritumab(Daiichi Sankyo) C2 - Daiichi Sankyo DB - Embase Medline DO - 10.1002/pbc.26870 IS - 2 LA - English M3 - Article N1 - L618975757 2017-11-01 2018-01-02 PY - 2018 SN - 1545-5017 1545-5009 ST - Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models T2 - Pediatric Blood and Cancer TI - Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618975757&from=exporthttp://dx.doi.org/10.1002/pbc.26870 VL - 65 ID - 5915 ER - TY - JOUR AD - Exelixis, Inc., 210 East Grand Avenue, San Francisco, CA, United States Mamelok Consulting, Palo Alto, CA, United States Celerion, Montreal, QC, Canada Celerion, Tempe, AZ, United States AU - Nguyen, L. AU - Holland, J. AU - Mamelok, R. AU - Laberge, M. K. AU - Grenier, J. AU - Swearingen, D. AU - Armas, D. AU - Lacy, S. DB - Scopus DO - 10.1002/jcph.526 IS - 11 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2015 SP - 1293-1302 ST - Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects T2 - Journal of Clinical Pharmacology TI - Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942980894&doi=10.1002%2fjcph.526&partnerID=40&md5=aca56cfbcc82f38ba6a9493d7f378fd8 VL - 55 ID - 5916 ER - TY - JOUR AD - ARIAD Pharmaceuticals, Inc., Cambridge, MA, United States Sonnichsen Pharmaceutical Associates, Collegeville, PA, United States AU - Narasimhan, N. I. AU - Dorer, D. J. AU - Davis, J. AU - Turner, C. D. AU - Sonnichsen, D. DB - Scopus DO - 10.1002/cpdd.182 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2015 SP - 354-360 ST - Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects T2 - Clinical Pharmacology in Drug Development TI - Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942193676&doi=10.1002%2fcpdd.182&partnerID=40&md5=542b81b6032899d4c65dc35cb2a44075 VL - 4 ID - 5917 ER - TY - JOUR AD - Laboratory Research Pathology, Graduate Program in Pathology, Universidade Federal de Ciências da Sáude de Porto Alegre, Porto Alegre, Brazil Graduate Program in Medical Sciences, Universidade Federal Do Rio Grande Do sul, Rio Grande do Sul, Brazil Laboratory Research Pathology, Universidade Federal de Ciências da Sáude de Porto Alegre, Porto Alegre, Brazil Department of Clinical Medicine, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil Department of Pediatrics, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil AU - Zavalhia, L. S. AU - Romitti, M. AU - Netto, G. C. AU - Dos Santos, G. T. AU - Meurer, R. T. AU - Hilbig, A. AU - Michalowski, M. B. AU - De Castro Ribeiro, M. DB - Scopus DO - 10.3233/DMA-2012-0905 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2012 SP - 61-68 ST - Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas T2 - Disease Markers TI - Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864445325&doi=10.3233%2fDMA-2012-0905&partnerID=40&md5=0bbc9a7dfb82e0d294691483b62647cf VL - 33 ID - 5918 ER - TY - JOUR AD - Department of Haematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China AU - Xu, X. H. AU - Zhang, L. AU - Cao, X. X. AU - Li, J. AU - Zhang, W. AU - Zhu, T. N. AU - Cai, H. C. AU - Chen, M. AU - Han, X. AU - Yang, C. AU - Han, B. AU - Zhang, Y. AU - Zhuang, J. L. AU - Zhou, D. B. AU - Duan, M. H. DB - Scopus DO - 10.1016/j.jiac.2017.02.011 IS - 6 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 360-367 ST - Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China T2 - Journal of Infection and Chemotherapy TI - Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015804863&doi=10.1016%2fj.jiac.2017.02.011&partnerID=40&md5=7aa33ab1648405d05db1dbe39e8ce06a VL - 23 ID - 5919 ER - TY - JOUR AD - Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia. Cancer Center, University of New Mexico, Albuquerque, New Mexico. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. Center for Childhood Cancer, Nationwide Children's Hospital, Columbus, Ohio. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatrics, University of California at San Francisco, San Francisco, California. University of Colorado Denver School of Medicine and Children's Hospital Colorado, Aurora, Colorado. CTEP/NCI, Bethesda, Maryland. Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia. rlock@ccia.unsw.edu.au. AN - 25504635 AU - Suryani, S. AU - Bracken, L. S. AU - Harvey, R. C. AU - Sia, K. C. AU - Carol, H. AU - Chen, I. M. AU - Evans, K. AU - Dietrich, P. A. AU - Roberts, K. G. AU - Kurmasheva, R. T. AU - Billups, C. A. AU - Mullighan, C. G. AU - Willman, C. L. AU - Loh, M. L. AU - Hunger, S. P. AU - Houghton, P. J. AU - Smith, M. A. AU - Lock, R. B. C2 - PMC4326541 C6 - NIHMS646510 Novartis to discuss the possible role of JAK inhibition in childhood leukemia. The remaining authors disclose no potential conflicts of interest. DA - Feb DO - 10.1158/1535-7163.Mct-14-0647 10.1158/1535-7163.MCT-14-0647. Epub 2014 Dec 10. DP - Nlm ET - 2014/12/17 IS - 2 LA - eng PY - 2015 SN - 1535-7163 (Print) 1535-7163 SP - 364-74 ST - Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia T2 - Mol Cancer Ther TI - Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia VL - 14 ID - 5920 ER - TY - JOUR AD - S. Hong, Sun Yat-Sen University Cancer Center, Guangzhou, China AU - Hong, S. AU - Zhang, L. DB - Embase IS - 11 LA - English M3 - Conference Abstract N1 - L620147483 2018-01-12 PY - 2017 SN - 1556-1380 SP - S2392 ST - Evaluation of toxicity profile of ALK inhibitors in non-small cell lung cancer (NSCLC) T2 - Journal of Thoracic Oncology TI - Evaluation of toxicity profile of ALK inhibitors in non-small cell lung cancer (NSCLC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620147483&from=export VL - 12 ID - 5921 ER - TY - JOUR AD - Greehey Children's Cancer Research Institute, University of Texas Health Science Center, San Antonio, TX, United States Pape' Family Pediatric Research Institute, Department of Pediatrics, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239-3098, United States Department of Medicine, University of Texas Health Science Center, San Antonio, TX, United States Department of Genetics and Development, Columbia University, New York, NY, United States Department of Pathology, University of Virginia, Charlottesville, VA, United States Department of Mechanical Engineering, University of Texas, San Antonio, TX, United States Department of Anatomic Pathology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, United States AU - Abraham, J. AU - Prajapati, S. I. AU - Nishijo, K. AU - Schaffer, B. S. AU - Taniguchi, E. AU - Kilcoyne, A. AU - McCleish, A. T. AU - Nelon, L. D. AU - Giles, F. G. AU - Efstratiadis, A. AU - LeGallo, R. D. AU - Nowak, B. M. AU - Rubin, B. P. AU - Malempati, S. AU - Keller, C. DB - Scopus DO - 10.1158/1535-7163.MCT-10-0695 IS - 4 M3 - Article N1 - Cited By :44 Export Date: 18 November 2020 PY - 2011 SP - 697-707 ST - Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma T2 - Molecular Cancer Therapeutics TI - Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955779350&doi=10.1158%2f1535-7163.MCT-10-0695&partnerID=40&md5=cb56b82fa66b430771173ede4c15032c VL - 10 ID - 5922 ER - TY - JOUR AD - C. Koschmann, Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Medical School, 3520D MSRB 1, 1150 West Medical Center Drive, Ann Arbor, MI, United States AU - Miklja, Z. AU - Yadav, V. N. AU - Cartaxo, R. T. AU - Siada, R. AU - Thomas, C. C. AU - Cummings, J. R. AU - Mullan, B. AU - Stallard, S. AU - Paul, A. AU - Bruzek, A. K. AU - Wierzbicki, K. AU - Yang, T. AU - Garcia, T. AU - Wolfe, I. AU - Leonard, M. AU - Robertson, P. L. AU - Garton, H. J. L. AU - Wahl, D. R. AU - Parmar, H. AU - Sarkaria, J. N. AU - Kline, C. AU - Mueller, S. AU - Nicolaides, T. AU - Glasser, C. AU - Leary, S. E. S. AU - Venneti, S. AU - Kumar-Sinha, C. AU - Chinnaiyan, A. M. AU - Mody, R. AU - Pai, M. P. AU - Phoenix, T. N. AU - Marini, B. L. AU - Koschmann, C. C2 - Selleck DB - Embase Medline DO - 10.1172/JCI133310 IS - 10 LA - English M3 - Article N1 - L2008018740 2020-10-14 2020-11-16 PY - 2020 SN - 1558-8238 0021-9738 SP - 5313-5325 ST - Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma T2 - Journal of Clinical Investigation TI - Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008018740&from=exporthttp://dx.doi.org/10.1172/JCI133310 VL - 130 ID - 5923 ER - TY - JOUR AD - C. Ruggeri, Laboratory of Cardiovascular Biology, Department of Internal Medicine, University of Genova, Genova, Italy AU - Ruggeri, C. AU - Lazzarini, E. AU - Bertero, E. AU - Aquila, G. AU - Fortini, F. AU - Ferrari, R. AU - Brunelli, C. AU - Rizzo, P. AU - Ameri, P. DB - Embase LA - English M3 - Conference Abstract N1 - L616278024 2017-05-23 PY - 2017 SN - 1365-2362 SP - 101 ST - Evidence for a crosstalk between Erbb2 and Notch-1 in cardiomyocytes T2 - European Journal of Clinical Investigation TI - Evidence for a crosstalk between Erbb2 and Notch-1 in cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616278024&from=export VL - 47 ID - 5924 ER - TY - JOUR AD - Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Department of Medical Oncology, Division of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy Experimental Molecular Pathology Unit, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Via G. Venezian 1, 20133 Milan, Italy AU - Bozzi, F. AU - Tamborini, E. AU - Negri, T. AU - Pastore, E. AU - Ferrari, A. AU - Luksch, R. AU - Casanova, M. AU - Pierotti, M. A. AU - Bellani, F. F. AU - Pilotti, S. DB - Scopus DO - 10.1002/cncr.22587 IS - 8 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2007 SP - 1638-1645 ST - Evidence for activation of KIT, PDGFRα, and PDGFRβ receptors in the Ewing sarcoma family of tumors T2 - Cancer TI - Evidence for activation of KIT, PDGFRα, and PDGFRβ receptors in the Ewing sarcoma family of tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247098863&doi=10.1002%2fcncr.22587&partnerID=40&md5=79ea8d94ef537b337e5a0b53e676ba3a VL - 109 ID - 5925 ER - TY - JOUR AD - Department of Orthopedic, College of Clinical Medicine, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China (mainland). Department of Orthopedics, Taizhou Fourth People's Hospital, Taizhou, Jiangsu, China (mainland). AN - 30135419 AU - Zhou, Y. AU - Hu, J. C2 - PMC6118161 DA - Aug 23 DO - 10.12659/msm.909682 10.12659/MSM.909682. DP - Nlm ET - 2018/08/24 LA - eng PY - 2018 SN - 1234-1010 (Print) 1234-1010 SP - 5874-5880 ST - Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway T2 - Med Sci Monit TI - Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway VL - 24 ID - 5926 ER - TY - JOUR AD - Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States AU - Zeidner, J. F. AU - Zahurak, M. AU - Rosner, G. L. AU - Gocke, C. D. AU - Jones, R. J. AU - Smith, B. D. DB - Scopus DO - 10.3109/10428194.2014.910868 IS - 1 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 128-134 ST - The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions? T2 - Leukemia and Lymphoma TI - The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: Can tyrosine kinase inhibitors replace donor lymphocyte infusions? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922346751&doi=10.3109%2f10428194.2014.910868&partnerID=40&md5=ae6c75cd393c8eca512b667bb68796ba VL - 56 ID - 5927 ER - TY - JOUR AD - Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, United States AU - Shulman, D. S. AU - DuBois, S. G. DB - Scopus DO - 10.1007/s40272-020-00380-9 IS - 2 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 189-197 ST - The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers T2 - Pediatric Drugs TI - The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078202727&doi=10.1007%2fs40272-020-00380-9&partnerID=40&md5=44afe8664405fae8eaecc43f28faa3fc VL - 22 ID - 5928 ER - TY - JOUR AD - Division of Hematology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States University College, London, United Kingdom University of Pennsylvania, Philadelphia, PA, United States Montefiore Medical Center, Bronx, NY, United States Rambam Healthcare Campus, Haifa, Israel Shaare Zedek Medical Center, Jerusalem, Israel Memorial Sloan Kettering Cancer Center, New York, NY, United States University Hospitals Cleveland Medical Center, Cleveland, OH, United States AU - Litzow, M. R. AU - Fielding, A. K. AU - Luger, S. M. AU - Paietta, E. AU - Ofran, Y. AU - Rowe, J. M. AU - Goldstone, A. H. AU - Tallman, M. S. AU - Lazarus, H. M. DB - Scopus DO - 10.1038/bmt.2017.110 IS - 12 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2017 SP - 1592-1598 ST - The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults T2 - Bone Marrow Transplantation TI - The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031733851&doi=10.1038%2fbmt.2017.110&partnerID=40&md5=1fb68780f8a1eca0a4a3f7799515fb4a VL - 52 ID - 5929 ER - TY - JOUR AD - Department of Pediatrics, Nagoya University, Graduate School of Medicine, 65 Tsuruma-Cho, Showa-ku, Nagoya, Aichi 466-8650, Japan Department of Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan AU - Muramatsu, H. AU - Takahashi, Y. AU - Sakaguchi, H. AU - Shimada, A. AU - Nishio, N. AU - Hama, A. AU - Doisaki, S. AU - Yagasaki, H. AU - Matsumoto, K. AU - Kato, K. AU - Kojima, S. DB - Scopus DO - 10.1007/s12185-010-0764-9 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 186-191 ST - Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era T2 - International Journal of Hematology TI - Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952251630&doi=10.1007%2fs12185-010-0764-9&partnerID=40&md5=36acaa78b6de07e261990b4cc3becd91 VL - 93 ID - 5930 ER - TY - JOUR AD - Department of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, Aachen, DE-52074, Germany Division of Gastroenterology Hepatology and Hepatobiliary Oncology, Aachen, Germany AU - Roderburg, C. AU - Berres, M. L. AU - Wree, A. AU - Loosen, S. H. AU - Luedde, T. AU - Trautwein, C. DB - Scopus DO - 10.1159/000497465 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 43-46 ST - Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib T2 - Visceral Medicine TI - Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061668950&doi=10.1159%2f000497465&partnerID=40&md5=7de64ed39604650c16a10d00337ef561 VL - 35 ID - 5931 ER - TY - JOUR AD - Hematology Division, Università degli Studi di Torino, Turin, Italy Hematology Division, Azienda Ospedaliera Città della Salute e della Scienza, Turin, Italy AU - Cerrano, M. AU - Crisà, E. AU - Pregno, P. AU - Aguzzi, C. AU - Riccomagno, P. AU - Boccadoro, M. AU - Ferrero, D. DB - Scopus DO - 10.1002/ajh.23501 IS - 10 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2013 SP - 838-842 ST - Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients T2 - American Journal of Hematology TI - Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884729410&doi=10.1002%2fajh.23501&partnerID=40&md5=79f9a69b7df2c0287a99829f61c9ed8d VL - 88 ID - 5932 ER - TY - JOUR AD - P. Green, Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Green, P. AU - Schwartz, R. H. AU - Shell, J. AU - Allgauer, M. AU - Chong, D. AU - Kebebew, E. C2 - Genentech(United States) DB - Embase DO - 10.2217/ije-2017-0016 IS - 4 LA - English M3 - Article N1 - L619850504 2017-12-25 2018-01-08 PY - 2017 SN - 2045-0877 2045-0869 SP - 159-165 ST - Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer T2 - International Journal of Endocrine Oncology TI - Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619850504&from=exporthttp://dx.doi.org/10.2217/ije-2017-0016 VL - 4 ID - 5933 ER - TY - JOUR AD - The Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, United Kingdom University Hospitals Birmingham NHS Foundation Trust, Department of Radiology, Edgbaston, Birmingham, B15 2TH, United Kingdom The Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham, B15 2TH, United Kingdom AU - Atkin, C. AU - Earwaker, P. AU - Pallan, A. AU - Shetty, S. AU - Punia, P. AU - Ma, Y. T. C7 - 30 DB - Scopus DO - 10.1186/s12876-017-0585-x IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 ST - Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: Case report and review of the literature T2 - BMC Gastroenterology TI - Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: Case report and review of the literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013343505&doi=10.1186%2fs12876-017-0585-x&partnerID=40&md5=49ca4c38ebc9a5a85efec8526624e600 VL - 17 ID - 5934 ER - TY - JOUR AD - Metabolic and Endocrine Disorders, Radboud University Medical Centre, Nijmegen, The Netherlands. c.noordam@cukz.umcn.nl AN - 18174700 AU - Noordam, K. DO - 10.1159/000110468 10.1159/000110468. Epub 2007 Dec 10. DP - Nlm ET - 2008/02/07 LA - eng PY - 2007 SN - 0301-0163 SP - 24-7 ST - Expanding the genetic spectrum of Noonan syndrome T2 - Horm Res TI - Expanding the genetic spectrum of Noonan syndrome VL - 68 Suppl 5 ID - 5935 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois. AN - 27225638 AU - Cajaiba, M. M. AU - Jennings, L. J. AU - George, D. AU - Perlman, E. J. C2 - PMC4980203 C6 - NIHMS790500 DA - Oct DO - 10.1002/gcc.22382 10.1002/gcc.22382. Epub 2016 Jul 7. DP - Nlm ET - 2016/05/27 IS - 10 LA - eng PY - 2016 SN - 1045-2257 (Print) 1045-2257 SP - 814-7 ST - Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript T2 - Genes Chromosomes Cancer TI - Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript VL - 55 ID - 5936 ER - TY - JOUR AD - Medical Oncology Department, Centre François Baclesse, Caen, France Clinical Research Department, Centre François-Baclesse, 3 avenue Général Harris, 14076 Caen Cedex 5, France Unit of Biology and Innovative Therapies of Locally Aggressive Cancers, Groupe Régional d'Etudes sur le Cancer (GRECAN), Université de Caen, France Clinical Biology and Oncology Laboratory, Centre François Baclesse, Caen, France Medical Oncology Department, Centre Alexis Vautrin, Nancy, France Medical Oncology Department, Institut Gustave Roussy, Villejuif, France Medical Oncology Department, Centre Val d'Aurelle Paul Lamarque, Montpellier, France Medical Oncology Department, Centre Hospitalo-Universitaire Tenon, Paris, France Medical Oncology Department, Clinique Victor Hugo, Le Mans, France Medical Oncology Department, Centre Paul Strauss, Strasbourg, France Medical Oncology Department, Clinique Catherine de Sienne, Nantes, France Medical Oncology Department, Hôpital des Diaconesses, Paris, France Medical Oncology Department, Centre Hospitalier Universitaire, Caen, France AU - Lheureux, S. AU - Krieger, S. AU - Weber, B. AU - Pautier, P. AU - Fabbro, M. AU - Selle, F. AU - Bourgeois, H. AU - Petit, T. AU - Lortholary, A. AU - Plantade, A. AU - Briand, M. AU - Leconte, A. AU - Richard, N. AU - Vilquin, P. AU - Clarisse, B. AU - Blanc-Fournier, C. AU - Joly, F. DB - Scopus DO - 10.1097/IGC.0b013e31826d1438 IS - 9 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2012 SP - 1483-1488 ST - Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile : A phase 2 trial T2 - International Journal of Gynecological Cancer TI - Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile : A phase 2 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872300929&doi=10.1097%2fIGC.0b013e31826d1438&partnerID=40&md5=8d0c092b8a6220e62267b3ab9c81639c VL - 22 ID - 5937 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu 600036, India Department of Molecular Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Guindy, Chennai, Tamilnadu 600036, India AU - Manuprasad, A. AU - Ganesan, P. AU - Ganesan, T. S. AU - Radhakrishnan, V. AU - Dhanushkodi, M. AU - Mani, S. AU - Sagar, T. G. DB - Scopus DO - 10.1007/s12288-017-0877-x IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 443-447 ST - Experience with the Use of Nilotinib in Indian Patients T2 - Indian Journal of Hematology and Blood Transfusion TI - Experience with the Use of Nilotinib in Indian Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030723866&doi=10.1007%2fs12288-017-0877-x&partnerID=40&md5=ad024b8642e288bbfd19aca6a38ac3c9 VL - 34 ID - 5938 ER - TY - JOUR AD - A. Alhammer AU - Alhammer, A. AU - Case, M. AU - Blair, H. J. AU - Vormoor, J. AU - Irving, J. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247794 2017-02-03 PY - 2016 SN - 1528-0020 ST - Exploring pre-B cell receptor signalling as a therapeutic target in acute lymphoblastic leukaemia T2 - Blood TI - Exploring pre-B cell receptor signalling as a therapeutic target in acute lymphoblastic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247794&from=export VL - 128 ID - 5939 ER - TY - JOUR AD - Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, SC, 88040-900, Brazil. AN - 17333127 AU - Posser, T. AU - de Aguiar, C. B. AU - Garcez, R. C. AU - Rossi, F. M. AU - Oliveira, C. S. AU - Trentin, A. G. AU - Neto, V. M. AU - Leal, R. B. DA - Jun DO - 10.1007/s00204-007-0177-6 10.1007/s00204-007-0177-6. Epub 2007 Feb 28. DP - Nlm ET - 2007/03/03 IS - 6 LA - eng PY - 2007 SN - 0340-5761 (Print) 0340-5761 SP - 407-14 ST - Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2 T2 - Arch Toxicol TI - Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2 VL - 81 ID - 5940 ER - TY - JOUR AD - Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States Department of Pathology, University of Iowa, Iowa City, IA, United States Department of Internal Medicine, Division of Immunology, University of Iowa, Iowa City, IA, United States Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montreal, QC, Canada AU - Vacaflores, A. AU - Chapman, N. M. AU - Harty, J. T. AU - Richer, M. J. AU - Houtman, J. C. D. C7 - e0157175 DB - Scopus DO - 10.1371/journal.pone.0157175 IS - 6 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2016 ST - Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism T2 - PLoS ONE TI - Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975492419&doi=10.1371%2fjournal.pone.0157175&partnerID=40&md5=3a75bb651adf14f1080334408d5cd58c VL - 11 ID - 5941 ER - TY - JOUR AD - Department of Anatomy and Cell Biology, RWTH Aachen University, Germany. lbrandenburg@ukaachen.de AN - 19879657 AU - Brandenburg, L. O. AU - Varoga, D. AU - Nicolaeva, N. AU - Leib, S. L. AU - Podschun, R. AU - Wruck, C. J. AU - Wilms, H. AU - Lucius, R. AU - Pufe, T. DA - Dec 10 DO - 10.1016/j.jneuroim.2009.10.004 10.1016/j.jneuroim.2009.10.004. Epub 2009 Oct 30. DP - Nlm ET - 2009/11/03 IS - 1-2 LA - eng PY - 2009 SN - 0165-5728 SP - 55-64 ST - Expression and regulation of antimicrobial peptide rCRAMP after bacterial infection in primary rat meningeal cells T2 - J Neuroimmunol TI - Expression and regulation of antimicrobial peptide rCRAMP after bacterial infection in primary rat meningeal cells VL - 217 ID - 5942 ER - TY - JOUR AD - Department of Translational Research & UMR1052, CRCL, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. INSERM U1218, Genetics and Biology of Sarcomas, Institut Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. University of Bordeaux, 146 Rue Léo Saignat, Bordeaux 33076, France. Department of Histopathology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Pathology, Institute Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. Department of Medical Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Surgery, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Radiation Oncology, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France. Department of Cancer Medicine, Gustave Roussy, 114 Rue Édouard-Vaillant, Villejuif Cedex 94805, France. Department of Surgery, Institute Curie, PSL Research University, 26 Rue d'Ulm, Paris Cedex 05 75248, France. Department of Medical Oncology, Institute Bergonié, 229 Cours de l'Argone, Bordeaux 33076, France. EMS Team, Centre Léon Bérard, 28 rue Laennec, Lyon 69008, France. AN - 29024938 AU - Dantas-Barbosa, C. AU - Lesluyes, T. AU - Loarer, F. L. AU - Chibon, F. AU - Treilleux, I. AU - Coindre, J. M. AU - Meeus, P. AU - Brahmi, M. AU - Bally, O. AU - Ray-Coquard, I. AU - Sunyach, M. P. AU - Cesne, A. L. AU - Mir, O. AU - Bonvalot, S. AU - Toulmonde, M. AU - Italiano, A. AU - Saintigny, P. AU - Jean-Denis, M. AU - Ducimetiere, F. AU - Ranchere, D. AU - El Sayadi, H. AU - Alberti, L. AU - Blay, J. Y. C2 - PMC5729471 DA - Dec 5 DO - 10.1038/bjc.2017.354 10.1038/bjc.2017.354. Epub 2017 Oct 12. DP - Nlm ET - 2017/10/13 IS - 12 LA - eng PY - 2017 SN - 0007-0920 (Print) 0007-0920 SP - 1787-1797 ST - Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma T2 - Br J Cancer TI - Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma VL - 117 ID - 5943 ER - TY - JOUR AD - R. de Cássia Viu Carrara, UNAERP, Avenida Costábile Romano, 2201, Ribeirania, Ribeirao Preto, Sao Paulo, Brazil AU - de Cássia Viu Carrara, R. AU - Fontes, A. M. AU - Abraham, K. J. AU - Orellana, M. D. AU - Haddad, S. K. AU - Palma, P. V. B. AU - Panepucci, R. A. AU - Zago, M. A. AU - Covas, D. T. DB - Embase Medline DO - 10.1007/s12094-017-1751-x IS - 4 LA - English M3 - Article N1 - L618299024 2017-09-21 2018-09-05 PY - 2018 SN - 1699-3055 1699-048X SP - 542-549 ST - Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls T2 - Clinical and Translational Oncology TI - Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618299024&from=exporthttp://dx.doi.org/10.1007/s12094-017-1751-x VL - 20 ID - 5944 ER - TY - JOUR AD - F.M. Watt, Kerationocyte Laboratory, Cancer Res. UK London Res. Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom AU - Hobbs, R. M. AU - Silva-Vargas, V. AU - Groves, R. AU - Watt, F. M. DB - Embase Medline DO - 10.1111/j.0022-202X.2004.23225.x IS - 3 LA - English M3 - Article N1 - L39095621 2004-08-31 PY - 2004 SN - 0022-202X SP - 503-515 ST - Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions T2 - Journal of Investigative Dermatology TI - Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39095621&from=exporthttp://dx.doi.org/10.1111/j.0022-202X.2004.23225.x VL - 123 ID - 5945 ER - TY - JOUR AD - X. Zhou, Department of Pathology, Cancer Hospital, Department of Oncology, 270 Dongan Road, Shanghai 200032, China AU - Huang, W. AU - Li, X. AU - Yao, X. AU - Lu, Y. AU - Li, B. AU - Sheng, W. AU - Lu, H. AU - Jin, A. AU - Zhou, X. DB - Embase Medline DO - 10.1016/j.yexmp.2008.11.012 IS - 2 LA - English M3 - Article N1 - L354381317 2009-04-15 PY - 2009 SN - 0014-4800 1096-0945 SP - 121-126 ST - Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma T2 - Experimental and Molecular Pathology TI - Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354381317&from=exporthttp://dx.doi.org/10.1016/j.yexmp.2008.11.012 VL - 86 ID - 5946 ER - TY - JOUR AD - Deparetment of Digestive Surgery, Clinical Centre, Medical Faculty, Ss. Cyril and Methodius University, Skopje, North Macedonia AU - Jankulovski, N. AU - Popov, Z. AU - Bojadzieva, S. AU - Validire, P. AU - Gogusev, J. DB - Scopus IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2006 SP - 59-70 ST - Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment T2 - Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za biološki i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences TI - Expression of c-KIT oncoprotein in gastrointestinal stromal tumors in adults and children: guideline for diagnosis and treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947704238&partnerID=40&md5=12d0ac1c8e166e90ffe21bf36aaa1082 VL - 27 ID - 5947 ER - TY - JOUR AD - Y.-K. Park, Department of Pathology, Kyung-Hee University, College of Medicine, 1 Heoigi-dong, Dongdaemun-gu, Seoul 130-702, South Korea AU - Do, S. I. AU - Jung, W. W. AU - Kim, H. S. AU - Park, Y. K. DB - Embase Medline DO - 10.3892/ijo_00000205 IS - 3 LA - English M3 - Article N1 - L354461355 2009-04-23 PY - 2009 SN - 1019-6439 1791-2423 SP - 797-803 ST - The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma T2 - International Journal of Oncology TI - The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354461355&from=exporthttp://dx.doi.org/10.3892/ijo_00000205http://www.spandidos-publications.com/serveFile/ijo_34_3_797_PDF.pdf?type=article&article_id=ijo_34_3_797&item=PDF VL - 34 ID - 5948 ER - TY - JOUR AD - Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, South Korea Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, South Korea Institute of Evidence Based Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea AU - Lee, K. J. AU - Jang, Y. O. AU - Cha, S. K. AU - Kim, M. Y. AU - Park, K. S. AU - Eom, Y. W. AU - Baik, S. K. DB - Scopus DO - 10.5009/gnl17443 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 449-456 ST - Expression of fibroblast growth factor 21 and ß-Klotho regulates hepatic fibrosis through the nuclear factor-?B and c-Jun N-Terminal kinase pathways T2 - Gut and Liver TI - Expression of fibroblast growth factor 21 and ß-Klotho regulates hepatic fibrosis through the nuclear factor-?B and c-Jun N-Terminal kinase pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049949317&doi=10.5009%2fgnl17443&partnerID=40&md5=ee373ea45455e36e97c44ce6184a5be5 VL - 12 ID - 5949 ER - TY - JOUR AD - Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA. AN - 9660487 AU - Fleming, T. P. AU - Song, Z. AU - Andley, U. P. DA - Jul DP - Nlm ET - 1998/07/11 IS - 8 LA - eng N1 - Fleming, T P Song, Z Andley, U P EY02687/EY/NEI NIH HHS/United States R01-EY05681/EY/NEI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1387-98. PY - 1998 SN - 0146-0404 (Print) 0146-0404 SP - 1387-98 ST - Expression of growth control and differentiation genes in human lens epithelial cells with extended life span T2 - Invest Ophthalmol Vis Sci TI - Expression of growth control and differentiation genes in human lens epithelial cells with extended life span VL - 39 ID - 5950 ER - TY - JOUR AD - Department of Forensic Medicine, Harbin Medical University, 157th Bao-jian Road, Nan-gang District, Harbin 150081, China Research Institute of Criminal Technology, Hulunbeier Municipal Public Security Bureau, Hulunbeier, China AU - Gao, T. L. AU - Yuan, X. T. AU - Yang, D. AU - Dai, H. L. AU - Wang, W. J. AU - Peng, X. AU - Shao, H. J. AU - Jin, Z. F. AU - Fu, Z. J. DB - Scopus DO - 10.1097/TA.0b013e31823c54a6 IS - 3 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2012 SP - 643-649 ST - Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury T2 - Journal of Trauma and Acute Care Surgery TI - Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862653321&doi=10.1097%2fTA.0b013e31823c54a6&partnerID=40&md5=109b3a2e23e334e6c5a97342d02621b3 VL - 72 ID - 5951 ER - TY - JOUR AD - K. Scotlandi, CRS Development of Biomolecular Therapies, Laboratory of Experimental Oncology, Orthopaedic Institute Rizzoli, Bologna 40136, Italy AU - Scotlandi, K. AU - Manara, M. C. AU - Serra, M. AU - Marino, M. T. AU - Ventura, S. AU - Garofalo, C. AU - Alberghini, M. AU - Magagnoli, G. AU - Ferrari, S. AU - Lopez-Guerrero, J. A. AU - Llombard-Bosch, A. AU - Picci, P. DB - Embase Medline DO - 10.1016/j.ejca.2011.01.007 IS - 8 LA - English M3 - Article N1 - L51287721 2011-02-25 2011-05-13 PY - 2011 SN - 0959-8049 SP - 1258-1266 ST - Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival T2 - European Journal of Cancer TI - Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51287721&from=exporthttp://dx.doi.org/10.1016/j.ejca.2011.01.007 VL - 47 ID - 5952 ER - TY - JOUR AD - Centro de Investigação de Patobiologia Molecular, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal. AN - 18710471 AU - Espadinha, C. AU - Santos, J. R. AU - Sobrinho, L. G. AU - Bugalho, M. J. DA - Apr DO - 10.1111/j.1365-2265.2008.03376.x 10.1111/j.1365-2265.2008.03376.x. Epub 2008 Aug 15. DP - Nlm ET - 2008/08/20 IS - 4 LA - eng PY - 2009 SN - 0300-0664 SP - 629-35 ST - Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency T2 - Clin Endocrinol (Oxf) TI - Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency VL - 70 ID - 5953 ER - TY - JOUR AD - Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran. Hematology, Oncology and BMT Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran. Hematology, Oncology and BMT Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran; Department of Molecular Medicine, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran; Department of Molecular Medicine, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mhghahremani@tums.ac.ir. AN - 20164150 AU - Mandegary, A. AU - Hosseini, R. AU - Ghaffari, S. H. AU - Alimoghaddam, K. AU - Rostami, S. AU - Ghavamzadeh, A. AU - Ghahremani, M. H. DA - Sep DO - 10.1093/annonc/mdq034 10.1093/annonc/mdq034. Epub 2010 Feb 17. DP - Nlm ET - 2010/02/19 IS - 9 LA - eng PY - 2010 SN - 0923-7534 SP - 1884-1890 ST - The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide T2 - Ann Oncol TI - The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide VL - 21 ID - 5954 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905; Department of Pathology, The China-Japan Union Hospital of Jilin University, Changchun, Jilin Province 130033, China. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905. Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905. Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton, NY 13790. Department of Dermatology, Roger Williams Medical Center, Providence, RI 02908. Division of Hematology, Mayo Clinic, Rochester, MN 55905. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905. Electronic address: feldman.andrew@mayo.edu. AN - 28153507 AU - Wang, X. AU - Boddicker, R. L. AU - Dasari, S. AU - Sidhu, J. S. AU - Kadin, M. E. AU - Macon, W. R. AU - Ansell, S. M. AU - Ketterling, R. P. AU - Rech, K. L. AU - Feldman, A. L. C2 - PMC5518937 C6 - NIHMS876504 DA - Jun DO - 10.1016/j.humpath.2017.01.003 10.1016/j.humpath.2017.01.003. Epub 2017 Jan 30. DP - Nlm ET - 2017/02/06 LA - eng PY - 2017 SN - 0046-8177 (Print) 0046-8177 SP - 19-27 ST - Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping T2 - Hum Pathol TI - Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping VL - 64 ID - 5955 ER - TY - JOUR AD - L. Diaz-Cueto, IMSS, Apartado Postal 99-065, Unidad Independencia 10101 México D. F., Mexico AU - Cuevas-Antonio, R. AU - Cancino, C. AU - Arechavaleta-Velasco, F. AU - Andrade, A. AU - Barron, L. AU - Estrada, I. AU - Fernandez, R. L. AU - Olguin, V. AU - Ruiz, S. AU - Imani, F. AU - Zeferino-Toquero, M. AU - Ulloa-Aguirre, A. AU - Gerton, G. L. AU - Diaz-Cueto, L. DB - Embase Medline DO - 10.3109/07357900903346455 IS - 5 LA - English M3 - Article N1 - L358798748 2010-05-20 2010-05-31 PY - 2010 SN - 0735-7907 1532-4192 SP - 452-458 ST - Expression of progranulin (acrogranin/pcdgf/granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line T2 - Cancer Investigation TI - Expression of progranulin (acrogranin/pcdgf/granulin-epithelin precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358798748&from=exporthttp://dx.doi.org/10.3109/07357900903346455 VL - 28 ID - 5956 ER - TY - JOUR AD - S. He, Allergy and Clinical Immunology Research Centre, the First Affiliated Hospital of Liaoning Medical University, No. 2, Section 5, Renmin Street, Guta District, Jinzhou, Liaoning, China AU - Ge, S. AU - Li, T. AU - Yao, Q. AU - Yan, H. AU - Huiyun, Z. AU - Zheng, Y. AU - Zhang, B. AU - He, S. DB - Embase Medline DO - 10.1007/s10565-016-9353-x IS - 6 LA - English M3 - Article N1 - L611262173 2016-07-21 2017-03-10 PY - 2016 SN - 1573-6822 0742-2091 SP - 529-542 ST - Expression of proteinase-activated receptor (PAR)-2 in monocytes from allergic patients and potential molecular mechanism T2 - Cell Biology and Toxicology TI - Expression of proteinase-activated receptor (PAR)-2 in monocytes from allergic patients and potential molecular mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611262173&from=exporthttp://dx.doi.org/10.1007/s10565-016-9353-x VL - 32 ID - 5957 ER - TY - JOUR AD - Department of Pathology, University of Michigan Health System, Ann Arbor, MI, United States Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, United States Department of Orthopedic Surgery, University of Michigan Health Syste, Ann Arbor, MI, United States Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgical Oncology, Univ. TX M. D. Anderson Cancer Ctr., Houston, TX, United States Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, United States Department of Pathology, M2242 Medical Science Building I, University of Michigan Cancer Center, 1301 Catherine Street, Ann Arbor, MI 48109-0602, United States AU - Thomas, D. G. AU - Giordano, T. J. AU - Sanders, D. AU - Biermann, S. AU - Sondak, V. K. AU - Trent, J. C. AU - Yu, D. AU - Pollock, R. E. AU - Baker, L. DB - Scopus DO - 10.1002/cncr.20847 IS - 4 M3 - Article N1 - Cited By :73 Export Date: 18 November 2020 PY - 2005 SP - 830-838 ST - Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/ neu in synovial sarcoma T2 - Cancer TI - Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/ neu in synovial sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-13444291031&doi=10.1002%2fcncr.20847&partnerID=40&md5=700ce782e15ba387e7b6a9d53fcd3a49 VL - 103 ID - 5958 ER - TY - JOUR AD - Department of Hematology/Oncology, L. and A. Seragnoli, S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy Department of Clinical and Biologic Science, University of Turin at Orbassano, Turin, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy Department of Pathology, Section of General Pathology, University of Verona, Verona, Italy La Sapienza University, Department of Cellular Biotechnologies and Hematology, Rome, Italy Department of Biology, University of Bologna, Bologna, Italy Molecular Biology Unit, Institute of Hematology and Medical Oncology Seràgnoli, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy AU - Lacobucci, I. AU - Lonetti, A. AU - Messa, F. AU - Cilloni, D. AU - Arruga, F. AU - Ottaviani, E. AU - Paolini, S. AU - Papayannidis, C. AU - Piccaluga, P. P. AU - Giannoulia, P. AU - Soverini, S. AU - Amabile, M. AU - Poerio, A. AU - Saglio, G. AU - Pane, F. AU - Berton, G. AU - Baruzzi, A. AU - Vitale, A. AU - Chiaretti, S. AU - Perini, G. AU - Foà, R. AU - Baccarani, M. AU - Martinelli, G. DB - Scopus DO - 10.1182/blood-2007-09-112631 IS - 9 M3 - Article N1 - Cited By :89 Export Date: 18 November 2020 PY - 2008 SP - 3847-3855 ST - Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance T2 - Blood TI - Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-55749102434&doi=10.1182%2fblood-2007-09-112631&partnerID=40&md5=1431e9264a69bd3676c8d6faa30c2bc3 VL - 112 ID - 5959 ER - TY - JOUR AD - Department of Pathology, Centre Hospitalo-Universitaire Purpan, Toulouse, France. AN - 10793082 AU - Lamant, L. AU - Pulford, K. AU - Bischof, D. AU - Morris, S. W. AU - Mason, D. Y. AU - Delsol, G. AU - Mariamé, B. C2 - PMC1876934 DA - May DO - 10.1016/s0002-9440(10)65042-0 DP - Nlm ET - 2000/05/04 IS - 5 LA - eng N1 - 1525-2191 Lamant, L Pulford, K Bischof, D Morris, S W Mason, D Y Delsol, G Mariamé, B P30 CA021765/CA/NCI NIH HHS/United States R01 CA069129/CA/NCI NIH HHS/United States PY - 2000 SN - 0002-9440 (Print) 0002-9440 SP - 1711-21 ST - Expression of the ALK tyrosine kinase gene in neuroblastoma T2 - Am J Pathol TI - Expression of the ALK tyrosine kinase gene in neuroblastoma VL - 156 ID - 5960 ER - TY - JOUR AD - L. Visser, Department of Pathology and Medical Biology, University Medical Center Groningen, PO Box 30.001, Hanzeplein 1, HPC EA10, 9700 RB Groningen, Netherlands AU - Xu, C. AU - Plattel, W. AU - van den Berg, A. AU - Rüther, N. AU - Huang, X. AU - Wang, M. AU - de Jong, D. AU - Vos, H. AU - van Imhoff, G. AU - Viardot, A. AU - Möller, P. AU - Poppema, S. AU - Diepstra, A. AU - Visser, L. DB - Embase Medline DO - 10.3324/haematol.2011.056101 IS - 4 LA - English M3 - Article N1 - L364585138 2012-04-13 2012-04-19 PY - 2012 SN - 0390-6078 1592-8721 SP - 572-578 ST - Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma T2 - Haematologica TI - Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364585138&from=exporthttp://dx.doi.org/10.3324/haematol.2011.056101http://www.haematologica.org/content/97/4/572.full.pdf+html VL - 97 ID - 5961 ER - TY - JOUR AD - *Department of Laboratory Medicine and Pathology ∥Division of Hematology, Mayo Clinic, Rochester, MN †Department of Pathology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China ‡Department of Hematology-Oncology, National University Cancer Institute of Singapore §Cancer Science Institute of Singapore, National University Cancer Institute of Singapore, Singapore, Singapore ¶Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City/Binghamton, NY. AN - 25390351 AU - Xing, X. AU - Flotte, T. J. AU - Law, M. E. AU - Blahnik, A. J. AU - Chng, W. J. AU - Huang, G. AU - Knudson, R. A. AU - Ketterling, R. P. AU - Porcher, J. C. AU - Ansell, S. M. AU - Sidhu, J. AU - Dogan, A. AU - Feldman, A. L. C2 - PMC4427553 C6 - NIHMS598418 DA - Sep DO - 10.1097/pai.0000000000000118 10.1097/PAI.0000000000000118. DP - Nlm ET - 2014/11/13 IS - 8 LA - eng PY - 2015 SN - 1541-2016 (Print) 1533-4058 SP - 580-9 ST - Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma T2 - Appl Immunohistochem Mol Morphol TI - Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma VL - 23 ID - 5962 ER - TY - JOUR AD - S.E. Dunn, Department of Pediatrics, Laboratory for Oncogenomic Research, BC Inst. Children's/Women's Hlth., 950 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada AU - Nielsen, T. O. AU - Andrews, H. N. AU - Cheang, M. AU - Kucab, J. E. AU - Hsu, F. D. AU - Ragaz, J. AU - Gilks, C. B. AU - Makretsov, N. AU - Bajdik, C. D. AU - Brookes, C. AU - Neckers, L. M. AU - Evdokimova, V. AU - Huntsman, D. G. AU - Dunn, S. E. DB - Embase Medline DO - 10.1158/0008-5472.CAN-03-1242 IS - 1 LA - English M3 - Article N1 - L38114109 2004-02-16 PY - 2004 SN - 0008-5472 SP - 286-291 ST - Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival: Potential for Intervention with 17-Allylamino Geldanamycin T2 - Cancer Research TI - Expression of the Insulin-Like Growth Factor I Receptor and Urokinase Plasminogen Activator in Breast Cancer Is Associated with Poor Survival: Potential for Intervention with 17-Allylamino Geldanamycin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38114109&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-03-1242 VL - 64 ID - 5963 ER - TY - JOUR AD - Department of Clinical Chemistry-Biochemistry, School of Medicine, University of Crete and University Hospital of Heraklion, 71110 Heraklion, Crete, Greece. christoforidou@hotmail.com AN - 15575964 AU - Christoforidou, A. V. AU - Papadaki, H. A. AU - Margioris, A. N. AU - Eliopoulos, G. D. AU - Tsatsanis, C. C2 - PMC539294 DA - Dec 3 DO - 10.1186/1476-4598-3-34 10.1186/1476-4598-3-34. DP - Nlm ET - 2004/12/04 IS - 1 LA - eng PY - 2004 SN - 1476-4598 SP - 34 ST - Expression of the Tpl2/Cot oncogene in human T-cell neoplasias T2 - Mol Cancer TI - Expression of the Tpl2/Cot oncogene in human T-cell neoplasias VL - 3 ID - 5964 ER - TY - JOUR AD - T. Shoda, Department of Allergy and Immunology, National Research Institute for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, Japan AU - Shoda, T. AU - Futamura, K. AU - Kobayashi, F. AU - Saito, H. AU - Matsumoto, K. AU - Matsuda, A. DB - Embase Medline DO - 10.1016/j.jdermsci.2014.08.009 IS - 2 LA - English M3 - Article N1 - L600220327 2014-10-29 2014-11-04 PY - 2014 SN - 1873-569X 0923-1811 SP - 90-95 ST - Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes T2 - Journal of Dermatological Science TI - Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600220327&from=exporthttp://dx.doi.org/10.1016/j.jdermsci.2014.08.009 VL - 76 ID - 5965 ER - TY - JOUR AD - Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong AU - Fong, O. N. AU - Chan, K. Y. Y. AU - Leung, K. T. AU - Lam, H. S. AU - Cheung, H. M. AU - Leung, T. Y. AU - Li, K. AU - Ng, P. C. DB - Scopus DO - 10.1189/jlb.0413219 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 169-178 ST - Expression profile of cord blood neutrophils and dysregulation of HSPA1A and OLR1 upon challenge by bacterial peptidoglycan T2 - Journal of Leukocyte Biology TI - Expression profile of cord blood neutrophils and dysregulation of HSPA1A and OLR1 upon challenge by bacterial peptidoglycan UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897019347&doi=10.1189%2fjlb.0413219&partnerID=40&md5=9e188833faf35cb6e0e2dd7625d1a9c4 VL - 95 ID - 5966 ER - TY - JOUR AD - Prince Henry's Institute of Medical Research, Clayton, Vic., Australia AU - Chu, S. AU - Alexiadis, M. AU - Fuller, P. J. DB - Scopus DO - 10.1016/j.ygyno.2007.09.017 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2008 SP - 182-190 ST - Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors T2 - Gynecologic Oncology TI - Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37449013816&doi=10.1016%2fj.ygyno.2007.09.017&partnerID=40&md5=fc110bf40c68bad19914c2384690530c VL - 108 ID - 5967 ER - TY - JOUR AD - Y. Lu, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China AU - Liu, N. W. AU - Huang, X. AU - Liu, S. AU - Lu, Y. DB - Embase Medline DO - 10.12659/MSM.918295 LA - English M3 - Article N1 - L2004761178 2020-02-04 2020-02-28 PY - 2019 SN - 1643-3750 1234-1010 SP - 6491-6503 ST - EXT1, regulated by miR-665, promotes cell apoptosis via ERK1/2 signaling pathway in acute lymphoblastic leukemia T2 - Medical Science Monitor TI - EXT1, regulated by miR-665, promotes cell apoptosis via ERK1/2 signaling pathway in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004761178&from=exporthttp://dx.doi.org/10.12659/MSM.918295 VL - 25 ID - 5968 ER - TY - JOUR AD - A. Forero-Torres, Kirklin Clinic, 2000 6th Avenue South, Birmingham, AL, United States AU - Forero-Torres, A. AU - Bartlett, N. L. AU - Berryman, R. B. AU - Chen, R. AU - Matous, J. V. AU - Fanale, M. A. AU - O'Connor, O. A. AU - Olshefski, R. AU - Smith, S. E. AU - Huebner, D. AU - Levine, P. L. AU - Grove, L. E. AU - Gopal, A. K. DB - Embase Medline DO - 10.3109/10428194.2014.951843 IS - 4 LA - English M3 - Article N1 - L604360863 2015-05-18 2015-06-18 PY - 2015 SN - 1029-2403 1042-8194 SP - 1151-1153 ST - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies T2 - Leukemia and Lymphoma TI - Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604360863&from=exporthttp://dx.doi.org/10.3109/10428194.2014.951843 VL - 56 ID - 5969 ER - TY - JOUR AD - M. Sadhukhan, Department of Pediatrics, Tunbridge Wells Hospital, Tonbridge Road, Royal Tunbridge Wells, United Kingdom AU - Sadhukhan, M. AU - Conry, B. AU - Bhaduri, B. C1 - gsk 116540(Glaxo SmithKline) C2 - Glaxo SmithKline DB - Embase Medline DO - 10.1007/s12098-017-2349-6 IS - 8 LA - English M3 - Letter N1 - L615667556 2017-05-01 2018-09-03 PY - 2017 SN - 0973-7693 0019-5456 SP - 645-646 ST - Extensive Retropharyngeal and Spinal Plexiform Neurofibromas in a Neonate with Type 1-Neurofibromatosis T2 - Indian Journal of Pediatrics TI - Extensive Retropharyngeal and Spinal Plexiform Neurofibromas in a Neonate with Type 1-Neurofibromatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615667556&from=exporthttp://dx.doi.org/10.1007/s12098-017-2349-6 VL - 84 ID - 5970 ER - TY - JOUR AD - Department of Pathology, Buffalo General Hospital, The State University of New York, Buffalo, NY, USA. AN - 15475930 AU - Kansal, R. AU - Sait, S. N. AU - Block, A. W. AU - Ward, P. M. AU - Kelly, F. L. AU - Cheney, R. T. AU - Czuczman, M. AU - Brecher, M. L. AU - Barcos, M. DA - Feb DO - 10.1038/modpathol.3800299 10.1038/modpathol.3800299. DP - Nlm ET - 2004/10/12 IS - 2 LA - eng PY - 2005 SN - 0893-3952 (Print) 0893-3952 SP - 235-43 ST - Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology T2 - Mod Pathol TI - Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology VL - 18 ID - 5971 ER - TY - JOUR AD - Department of Surgical Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka, Japan Department of Surgery, Osaka University Graduate School of Medicine, Suita, Japan Department of Surgery, Osaka Police Hospital, Osaka, Japan AU - Liu, N. N. AU - Ohkouchi, M. AU - Hashikura, Y. AU - Kajimoto, N. AU - Matsuda, I. AU - Isozaki, K. AU - Toh, Y. AU - Takahashi, T. AU - Nishida, T. AU - Hirota, S. DB - Scopus DO - 10.1038/labinvest.2013.43 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 502-507 ST - Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib-and nilotinib-sensitive than that with duplication of Ala502Tyr503 T2 - Laboratory Investigation TI - Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib-and nilotinib-sensitive than that with duplication of Ala502Tyr503 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877251422&doi=10.1038%2flabinvest.2013.43&partnerID=40&md5=d45e4c6d9454967abb4dc6f1727a6b12 VL - 93 ID - 5972 ER - TY - JOUR AD - S. Yamaguchi, Department of Dermatology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan AU - Kaneshima, A. AU - Yamaguchi, S. AU - Miyagi, T. AU - Kariya, Y. AU - Awazawa, T. AU - Ohshiro, T. AU - Hyakuna, N. AU - Nakanishi, K. AU - Takahashi, K. DB - Embase Medline DO - 10.1111/1346-8138.14996 IS - 9 LA - English M3 - Article N1 - L628430775 2019-07-12 2019-09-11 PY - 2019 SN - 1346-8138 0385-2407 SP - 812-815 ST - Extracellular signal-regulated kinase activation of self-healing Langerhans cell histiocytosis: A case report T2 - Journal of Dermatology TI - Extracellular signal-regulated kinase activation of self-healing Langerhans cell histiocytosis: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628430775&from=exporthttp://dx.doi.org/10.1111/1346-8138.14996 VL - 46 ID - 5973 ER - TY - JOUR AD - S.K. Dey, Division of Reproductive and Developmental Biology, Vanderbilt University, Nashville, TN 37232-2678, United States AU - Daikoku, T. AU - Tranguch, S. AU - Chakrabarty, A. AU - Wang, D. AU - Khabele, D. AU - Orsulic, S. AU - Morrow, J. D. AU - DuBois, R. N. AU - Dey, S. K. C1 - aspirin DB - Embase Medline DO - 10.1158/0008-5472.CAN-07-0828 IS - 11 L1 - internal-pdf://1137949908/5285.full.pdf LA - English M3 - Article N1 - L46997267 2007-06-01 PY - 2007 SN - 0008-5472 SP - 5285-5292 ST - Extracellular signal-regulated kinase is a target of cyclooxygenase-1- peroxisome proliferator-activated receptor-δ signaling in epithelial ovarian cancer T2 - Cancer Research TI - Extracellular signal-regulated kinase is a target of cyclooxygenase-1- peroxisome proliferator-activated receptor-δ signaling in epithelial ovarian cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46997267&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-07-0828 VL - 67 ID - 5974 ER - TY - JOUR AD - Department of Medical Oncology, Royal Marsden NHS Trust, London, UK. Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK. Department of Oncologic Pathology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan. AN - 26414886 AU - Seifert, H. AU - Hirata, E. AU - Gore, M. AU - Khabra, K. AU - Messiou, C. AU - Larkin, J. AU - Sahai, E. C2 - PMC4737278 DA - Jan DO - 10.1111/pcmr.12424 10.1111/pcmr.12424. Epub 2015 Nov 3. DP - Nlm ET - 2015/09/29 IS - 1 LA - eng PY - 2016 SN - 1755-1471 (Print) 1755-1471 SP - 92-100 ST - Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases T2 - Pigment Cell Melanoma Res TI - Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases VL - 29 ID - 5975 ER - TY - JOUR AD - Leukemia Patient Advocates Foundation, Bern, Switzerland LeukaNET e.V., Riemerling, Germany Israeli CML Patients Organization, Netanya, Israel Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy LMC France, Marseille, France Stichting Hematon, Utrecht, Netherlands Leukaemia CARE, Worcester, United Kingdom Diagnoza CML, Prague, Czech Republic Polish Nationwide Association for CML Patients Aid, Warsaw, Poland Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet, Munich, Germany Münzgraben 6 P.O.B. 453, Bern, CH-3000, Switzerland AU - Geissler, J. AU - Sharf, G. AU - Bombaci, F. AU - Daban, M. AU - De Jong, J. AU - Gavin, T. AU - Pelouchova, J. AU - Dziwinski, E. AU - Hasford, J. AU - Hoffmann, V. S. DB - Scopus DO - 10.1007/s00432-017-2372-z IS - 7 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2017 SP - 1167-1176 ST - Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries T2 - Journal of Cancer Research and Clinical Oncology TI - Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014989094&doi=10.1007%2fs00432-017-2372-z&partnerID=40&md5=f098654c8ebf53f0f8fed62b3cccce91 VL - 143 ID - 5976 ER - TY - JOUR AD - Universitätsklinikum RWTH Aachen, Aachen, Germany Department of Internal Medicine II, Hubertus Wald Tumorzentrum University Cancer Centre Hamburg, Hamburg, Germany University of Texas MD, Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Seoul St. Mary's Hospital, Seoul, South Korea Pfizer Inc, La Jolla, CA, United States Pfizer Inc, Cambridge, MA, United States University of Milano-Bicocca, Monza, Italy Princess Margaret Cancer Centre, Toronto, ON, Canada ARIAD Pharmaceuticals, Cambridge, MA, United States AU - Brümmendorf, T. H. AU - Cortes, J. E. AU - Khoury, H. J. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Schafhausen, P. AU - Conlan, M. G. AU - Shapiro, M. AU - Turnbull, K. AU - Leip, E. AU - Gambacorti-Passerini, C. AU - Lipton, J. H. DB - Scopus DO - 10.1111/bjh.13801 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2016 SP - 97-110 ST - Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib T2 - British Journal of Haematology TI - Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955673175&doi=10.1111%2fbjh.13801&partnerID=40&md5=9aeb59492e72181fd1006cedeeafdf9a VL - 172 ID - 5977 ER - TY - JOUR AD - Department of Dermatology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. Research and Education Network, Westmead Hospital, Westmead, Australia. Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Westmead, Australia. Department of Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Faculty of Medicine, University of Western Sydney, Sydney, Australia. Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. Department of Dermatology, Westmead Hospital, Westmead, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: pablo.fernandezpenas@sydney.edu.au. AN - 25748298 AU - Anforth, R. AU - Menzies, A. AU - Byth, K. AU - Carlos, G. AU - Chou, S. AU - Sharma, R. AU - Scolyer, R. A. AU - Kefford, R. AU - Long, G. V. AU - Fernandez-Peñas, P. DA - May DO - 10.1016/j.jaad.2015.01.018 10.1016/j.jaad.2015.01.018. Epub 2015 Mar 3. DP - Nlm ET - 2015/03/10 IS - 5 LA - eng PY - 2015 SN - 0190-9622 SP - 809-15.e1 ST - Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy T2 - J Am Acad Dermatol TI - Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy VL - 72 ID - 5978 ER - TY - JOUR AD - Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Herston, Queensland, Australia. Centre de recherche en Epidémiologie et Santé des Populations, Faculté de médecine-Université Paris-Sud, Faculté de médecine-Université de Versailles Saint-Quentin-en-Yvelines, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Villejuif, France; Gustave Roussy, Villejuif, France. Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK. Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. MEDLAB Pathology, Brisbane, Queensland, Australia. Princess Alexandra Hospital, Metro South Health, Brisbane, Queensland, Australia. AN - 29524457 AU - Pandeya, N. AU - Kvaskoff, M. AU - Olsen, C. M. AU - Green, A. C. AU - Perry, S. AU - Baxter, C. AU - Davis, M. B. AU - Mortimore, R. AU - Westacott, L. AU - Wood, D. AU - Triscott, J. AU - Williamson, R. AU - Whiteman, D. C. DA - Aug DO - 10.1016/j.jid.2017.12.036 10.1016/j.jid.2017.12.036. Epub 2018 Mar 7. DP - Nlm ET - 2018/03/11 IS - 8 LA - eng PY - 2018 SN - 0022-202x SP - 1816-1824 ST - Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study T2 - J Invest Dermatol TI - Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study VL - 138 ID - 5979 ER - TY - JOUR AD - Dana-Farber Cancer Institute; Brigham and Women's Hospital; Beth Israel Deaconess Medical Center, Boston, MA; Oregon Health Sciences University Cancer Institute & Portland VA Medical Center, Portland, OR; and Stanford University Medical Center, Stanford, CA AU - Li, F. P. AU - Fletcher, J. A. AU - Heinrich, M. C. AU - Garber, J. E. AU - Sallan, S. E. AU - Curiel-Lewandrowski, C. AU - Duensing, A. AU - Van De Rijn, M. AU - Schnipper, L. E. AU - Demetri, G. D. DB - Scopus DO - 10.1200/JCO.2005.06.009 IS - 12 M3 - Article N1 - Cited By :123 Export Date: 18 November 2020 PY - 2005 SP - 2735-2743 ST - Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred T2 - Journal of Clinical Oncology TI - Familial gastrointestinal stromal tumor syndrome: Phenotypic and molecular features in a kindred UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21044439344&doi=10.1200%2fJCO.2005.06.009&partnerID=40&md5=0236d7fb3e64afaa156a92a53014936a VL - 23 ID - 5980 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas/Hemocentro - Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States Laboratory of Investigative and Molecular Pathology, CIPED, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, United States Department of Internal Medicine, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil AU - de Melo Campos, P. AU - Machado-Neto, J. A. AU - Scopim-Ribeiro, R. AU - Visconte, V. AU - Tabarroki, A. AU - Duarte, A. S. S. AU - Barra, F. F. C. AU - Vassalo, J. AU - Rogers, H. J. AU - Lorand-Metze, I. AU - Tiu, R. V. AU - Costa, F. F. AU - Olalla Saad, S. T. AU - Traina, F. DB - Scopus DO - 10.1016/j.leukres.2014.07.010 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2014 SP - 1245-1251 ST - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 T2 - Leukemia Research TI - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908024600&doi=10.1016%2fj.leukres.2014.07.010&partnerID=40&md5=cd67a87b5f022f4614674791e006e0d8 VL - 38 ID - 5981 ER - TY - JOUR AD - A. Jain, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research College of Nursing, Chandigarh, Punjab, India AU - Jain, A. AU - Gupta, N. DB - Embase Medline DO - 10.1136/bcr-2017-221250 LA - English M3 - Note N1 - L617723198 2017-08-18 2018-10-26 PY - 2017 SN - 1757-790X ST - 'Fatal journey of a cutaneous ulcer' T2 - BMJ Case Reports TI - 'Fatal journey of a cutaneous ulcer' UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617723198&from=exporthttp://dx.doi.org/10.1136/bcr-2017-221250 VL - 2017 ID - 5982 ER - TY - JOUR AD - a Melanoma Unit , Istituto Europeo di Oncologia , Milano , Italy. b Division of Biostatistics , Istituto Europeo di Oncologia , Milano , Italy. c Fertility Unit , Istituto Europeo di Oncologia , Milano , Italy. AN - 29526130 AU - Cocorocchio, E. AU - Pala, L. AU - Battaglia, A. AU - Gandini, S. AU - Peccatori, F. A. AU - Ferrucci, P. F. DA - Aug DO - 10.1080/0284186x.2018.1449251 10.1080/0284186X.2018.1449251. Epub 2018 Mar 11. DP - Nlm ET - 2018/03/13 IS - 8 LA - eng PY - 2018 SN - 0284-186x SP - 1131-1133 ST - Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma T2 - Acta Oncol TI - Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma VL - 57 ID - 5983 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, South Korea AU - Byun, Y. J. AU - Suh, J. K. AU - Lee, S. W. AU - Lee, D. AU - Kim, H. AU - Choi, E. S. AU - Koh, K. N. AU - Im, H. J. AU - Seo, J. J. DB - Scopus DO - 10.5045/br.2015.50.3.147 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 147-153 ST - Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Blood Research TI - Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944029972&doi=10.5045%2fbr.2015.50.3.147&partnerID=40&md5=9ed89f7867e5cb999a712f11fca76026 VL - 50 ID - 5984 ER - TY - JOUR AD - Department of Hematology, Xinqiao Hospital, Third Military Medical University, Xinqiao Street Shangpinba District, Chongqing, 400037, China Department of Hematology, General Hospital of Chengdu Military Region of PLA, Sichuan, China Department of Hematology, General Hospital of Kunming Military Region of PLA, Yunnan, China Department of Hematology, Yunnan Provincial Peoples Hospital, Yunnan, China Department of Hematology, Second Yunnan Provincial Peoples Hospital, Yunnan, China Department of Hematology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, China AU - Gao, L. AU - Zhang, C. AU - Gao, L. AU - Liu, Y. AU - Su, Y. AU - Wang, S. AU - Li, B. AU - Yang, T. AU - Yuan, Z. AU - Zhang, X. C7 - 90 DB - Scopus DO - 10.1186/s13045-015-0186-5 IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 ST - Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: A multicenter study in Southwest China T2 - Journal of Hematology and Oncology TI - Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: A multicenter study in Southwest China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938417686&doi=10.1186%2fs13045-015-0186-5&partnerID=40&md5=9021b9f692b9fbab51336eb98cd890b0 VL - 8 ID - 5985 ER - TY - JOUR AD - Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan Hematology Division, Miyagi Cancer Center, Miyagi, Japan AU - Onishi, Y. AU - Sasaki, O. AU - Ichikawa, S. AU - Inokura, K. AU - Katsuoka, Y. AU - Ohtsuka Ohba, R. AU - Okitsu, Y. AU - Kohata, K. AU - Ohguchi, H. AU - Fukuhara, N. AU - Yokoyama, H. AU - Yamada, M. F. AU - Yamamoto, J. AU - Ishizawa, K. AU - Kameoka, J. AU - Harigae, H. DB - Scopus DO - 10.1016/j.bbmt.2011.01.010 IS - 7 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 1093-1097 ST - Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Biology of Blood and Marrow Transplantation TI - Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958722346&doi=10.1016%2fj.bbmt.2011.01.010&partnerID=40&md5=714bc526ef71baaca78b9389b882b98f VL - 17 ID - 5986 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Kuzuya, T. AU - Ishigami, M. AU - Ito, T. AU - Ishizu, Y. AU - Honda, T. AU - Ishikawa, T. AU - Fujishiro, M. DB - Scopus DO - 10.1111/hepr.13452 IS - 3 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2020 SP - 374-381 ST - Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma T2 - Hepatology Research TI - Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076898400&doi=10.1111%2fhepr.13452&partnerID=40&md5=b709e528c615ab2cd43fb59888a9c537 VL - 50 ID - 5987 ER - TY - JOUR AD - Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. meredith.chuk@fda.hhs.gov. Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. AN - 28235882 AU - Chuk, M. K. AU - Chang, J. T. AU - Theoret, M. R. AU - Sampene, E. AU - He, K. AU - Weis, S. L. AU - Helms, W. S. AU - Jin, R. AU - Li, H. AU - Yu, J. AU - Zhao, H. AU - Zhao, L. AU - Paciga, M. AU - Schmiel, D. AU - Rawat, R. AU - Keegan, P. AU - Pazdur, R. DA - Oct 1 DO - 10.1158/1078-0432.Ccr-16-0663 10.1158/1078-0432.CCR-16-0663. Epub 2017 Feb 24. DP - Nlm ET - 2017/02/27 IS - 19 LA - eng PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 5666-5670 ST - FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma T2 - Clin Cancer Res TI - FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma VL - 23 ID - 5988 ER - TY - JOUR AN - 143541412. Language: English. Entry Date: 20200608. Revision Date: 20200706. Publication Type: Article AU - Bender, E. V. E. DB - ccm DO - 10.1097/01.nt.0000666940.43909.b0 DP - EBSCOhost IS - 9 N1 - commentary; pictorial; tables/charts. Original Study: Gross AM. Selumetinib in children with inoperable plexiform neurofibromas. (N Engl J Med) 2020;. Journal Subset: Biomedical; USA. NLM UID: 101231920. PY - 2020 SN - 1533-7006 SP - 1-24 ST - FDA Approves Selumetinib for Children with Inoperable Plexiform Neurofibromas T2 - Neurology Today TI - FDA Approves Selumetinib for Children with Inoperable Plexiform Neurofibromas UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143541412&site=ehost-live&scope=site VL - 20 ID - 5989 ER - TY - JOUR AD - Division of Oncology Drug Products, Ctr. for Drug Eval. and Research, U.S. Food and Drug Administration, Rockville, MD, United States U.S. Food and Drug Administration, HFD-150, 5600 Fishers Lane, Rockville, MD 20857, United States AU - Cohen, M. H. AU - Williams, G. A. AU - Sridhara, R. AU - Chen, G. AU - Pazdur, R. DB - Scopus DO - 10.1634/theoncologist.8-4-303 IS - 4 M3 - Review N1 - Cited By :427 Export Date: 18 November 2020 PY - 2003 SP - 303-306 ST - FDA drug approval summary: Gefitinib (ZD1839) (Iressa®) tablets T2 - Oncologist TI - FDA drug approval summary: Gefitinib (ZD1839) (Iressa®) tablets UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0043210670&doi=10.1634%2ftheoncologist.8-4-303&partnerID=40&md5=900e9a18ee677d68c62bf45cb443492b VL - 8 ID - 5990 ER - TY - JOUR AD - J. Terada, Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Japan AU - Shikano, K. AU - Ishiwata, T. AU - Saegusa, F. AU - Terada, J. AU - Sakayori, M. AU - Abe, M. AU - Kawasaki, T. AU - Ikari, J. AU - Kawata, N. AU - Tada, Y. AU - Tatsumi, K. DB - Embase DO - 10.21037/jtd-20-671 IS - 6 LA - English M3 - Article N1 - L632741494 2020-09-08 2020-10-02 PY - 2020 SN - 2077-6624 2072-1439 SP - 3057-3064 ST - Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy T2 - Journal of Thoracic Disease TI - Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632741494&from=exporthttp://dx.doi.org/10.21037/jtd-20-671 VL - 12 ID - 5991 ER - TY - JOUR AD - Y.-L. Wu, Division of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, No.106, Zhongshan Er Road, Guangzhou, 510080, China AU - Chen, H. J. AU - Yang, J. J. AU - Fang, L. Y. AU - Huang, M. M. AU - Yan, H. H. AU - Zhang, X. C. AU - Xu, C. R. AU - Wu, Y. L. DB - Embase DO - 10.1111/1759-7714.12076 IS - 2 LA - English M3 - Article N1 - L372513389 2014-03-11 2014-03-18 PY - 2014 SN - 1759-7706 1759-7714 SP - 155-161 ST - Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer T2 - Thoracic Cancer TI - Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372513389&from=exporthttp://dx.doi.org/10.1111/1759-7714.12076 VL - 5 ID - 5992 ER - TY - JOUR AD - Department of Pediatric Hematology, Medical Faculty, Uludag University, Nilüfer, Bursa, Turkey Pediatric Oncology Unit, University Hospital, Poitiers, France Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland Department of Pediatric and Adolescent Medicine, University of Copenhagen, Copenhagen, Denmark Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic Department of Blood and Marrow Transplantation, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands Children's Cancer Research Institute and St. Anna Children's Hospital, Pediatric Clinic, Medical University of Vienna, Vienna, Austria Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium Medical Faculty, Pediatric Hematology-Oncology, Technical University of Dresden, Dresden, Germany AU - Meral Günes, A. AU - Millot, F. AU - Kalwak, K. AU - Lausen, B. AU - Sedlacek, P. AU - Versluys, A. B. AU - Dworzak, M. AU - De Moerloose, B. AU - Suttorp, M. DB - Scopus DO - 10.1002/pbc.28706 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry T2 - Pediatric Blood and Cancer TI - Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092357102&doi=10.1002%2fpbc.28706&partnerID=40&md5=959d5f6c26711d8e9e184a169f707bd6 ID - 5993 ER - TY - JOUR AD - Department of Hematology, Juntendo University School of Medicine, 3-1-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan AN - 132112503. Language: English. Entry Date: 20181011. Revision Date: 20191101. Publication Type: Article AU - Fujioka, Isao AU - Takaku, Tomoiku AU - Iriyama, Noriyoshi AU - Tokuhira, Michihide AU - Kimura, Yuta AU - Sato, Eriko AU - Ishikawa, Maho AU - Nakazato, Tomonori AU - Sugimoto, Kei-Ji AU - Fujita, Hiroyuki AU - Asou, Norio AU - Kizaki, Masahiro AU - Hatta, Yoshihiro AU - Komatsu, Norio AU - Kawaguchi, Tatsuya DB - ccm DO - 10.1007/s00277-018-3412-8 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Framingham Risk Score. NLM UID: 9107334. PMID: NLM29946911. PY - 2018 SN - 0939-5555 SP - 2081-2088 ST - Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database T2 - Annals of Hematology TI - Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132112503&site=ehost-live&scope=site VL - 97 ID - 5994 ER - TY - JOUR AD - Department of Obstetrics, Division of Gynecology Oncology, Toronto, Ont., Canada Department of Medical Oncology, Toronto, Ont., Canada Department of Pathology, University of Toronto, Princess Margaret Hospital, Toronto, Ont., Canada Division of Gynecology Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, Ont. M5G 2M9, Canada AU - Steed, H. AU - Oza, A. AU - Chapman, W. B. AU - Yaron, M. AU - De Petrillo, D. DB - Scopus DO - 10.1111/j.1048-891x.2004.014319.x IS - 3 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2004 SP - 546-550 ST - Female adnexal tumor of probable wolffian origin: A clinicopathological case report and a possible new treatment T2 - International Journal of Gynecological Cancer TI - Female adnexal tumor of probable wolffian origin: A clinicopathological case report and a possible new treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942566195&doi=10.1111%2fj.1048-891x.2004.014319.x&partnerID=40&md5=e7a0fed64daec4083914f437207909a2 VL - 14 ID - 5995 ER - TY - JOUR AD - D. Loetsch, Institute of Cancer Research, Vienna, Vienna, Austria AU - Loetsch, D. AU - Gojo, J. AU - Kirchhofer, D. AU - Van Schoonhoven, S. AU - Pajtler, K. AU - Kool, M. AU - Haberler, C. AU - Czech, T. AU - Slavc, I. AU - Berger, W. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239757 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii224 ST - FGFR a novel target in malignant pediatric ependymoma T2 - Neuro-Oncology TI - FGFR a novel target in malignant pediatric ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239757&from=exporthttp://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 5996 ER - TY - JOUR AD - J. Hu, Department and Institute of Infectious Diseases, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China AU - Hu, J. AU - Wang, H. AU - Li, X. AU - Liu, Y. AU - Mi, Y. AU - Kong, H. AU - Xi, D. AU - Yan, W. AU - Luo, X. AU - Ning, Q. AU - Wang, X. DB - Embase DO - 10.1007/s12072-020-10030-4 LA - English M3 - Conference Abstract N1 - L631553401 2020-04-28 PY - 2020 SN - 1936-0541 SP - S319 ST - Fibrinogen-like protein 2 exacerbates non-alcoholic steatohepatitis via interaction with TLR4 eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder T2 - Hepatology International TI - Fibrinogen-like protein 2 exacerbates non-alcoholic steatohepatitis via interaction with TLR4 eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631553401&from=exporthttp://dx.doi.org/10.1007/s12072-020-10030-4 VL - 14 ID - 5997 ER - TY - JOUR AD - C.J. Kim, Department of Pathology, Seoul National Univ. Coll. of Med., 28 Yongon-dong, Chonggu-gu, Seoul 110-799, South Korea AU - Kim, M. S. AU - Kim, C. J. AU - Jung, H. S. AU - Seo, M. R. AU - Juhnn, Y. S. AU - Shin, H. Y. AU - Ahn, Y. S. AU - Thiele, C. J. AU - Chi, J. G. C1 - pd 98059 sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1002/path.1497 IS - 1 LA - English M3 - Article N1 - L38072851 2004-01-26 PY - 2004 SN - 0022-3417 SP - 103-112 ST - Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells T2 - Journal of Pathology TI - Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38072851&from=exporthttp://dx.doi.org/10.1002/path.1497 VL - 202 ID - 5998 ER - TY - JOUR AD - Department of Medicine, Biological Chemistry and Pharmacology, University of California, Irvine 92697, USA. AN - 9333017 AU - Kornmann, M. AU - Ishiwata, T. AU - Beger, H. G. AU - Korc, M. DA - Sep 18 DO - 10.1038/sj.onc.1201307 DP - Nlm ET - 1997/10/23 IS - 12 LA - eng N1 - Kornmann, M Ishiwata, T Beger, H G Korc, M PY - 1997 SN - 0950-9232 (Print) 0950-9232 SP - 1417-24 ST - Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions T2 - Oncogene TI - Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions VL - 15 ID - 5999 ER - TY - JOUR AD - P. Krejci, Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States AU - Krejci, P. AU - Mekikian, P. B. AU - Wilcox, W. R. DB - Embase Medline DO - 10.1038/sj.leu.2404202 IS - 6 LA - English M3 - Letter N1 - L43797315 2006-06-13 PY - 2006 SN - 1476-5551 0887-6924 SP - 1165-1168 ST - The fibroblast growth factors in multiple myeloma [5] T2 - Leukemia TI - The fibroblast growth factors in multiple myeloma [5] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43797315&from=exporthttp://dx.doi.org/10.1038/sj.leu.2404202 VL - 20 ID - 6000 ER - TY - JOUR AD - L. Alili, Institute of Biochemistry and Molecular Biology I, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany AU - Alili, L. AU - Sack, M. AU - Puschmann, K. AU - Brenneisen, P. DB - Embase DO - 10.1042/BSR20130091 IS - 1 LA - English M3 - Article N1 - L372460346 2014-03-04 2014-03-21 PY - 2014 SN - 0144-8463 1573-4935 SP - 7-17 ST - Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species T2 - Bioscience Reports TI - Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372460346&from=exporthttp://dx.doi.org/10.1042/BSR20130091http://www.bioscirep.org/bsr/034/e089/034e089.pdf VL - 34 ID - 6001 ER - TY - JOUR AD - M. Quinn, The University of Melbourne, Royal Women's Hospital, 20 Flemington Rd, Melbourne, VIC, Australia AU - Leary, A. F. AU - Quinn, M. AU - Fujiwara, K. AU - Coleman, R. L. AU - Kohn, E. AU - Sugiyama, T. AU - Glasspoo, R. AU - Ray-Coquard, I. AU - Colombo, N. AU - Bacon, M. AU - Zeimet, A. AU - Westermann, A. AU - Gomez-Garcia, E. AU - Provencher, D. AU - Welch, S. AU - Small, W. AU - Millan, D. AU - Okamoto, A. AU - Stuart, G. AU - Ochiai, K. DB - Embase Medline DO - 10.1093/annonc/mdw662 IS - 4 LA - English M3 - Review N1 - L616106023 2017-05-16 2019-10-31 PY - 2017 SN - 1569-8041 0923-7534 SP - 718-726 ST - Fifth ovarian cancer consensus conference of the Gynecologic Cancer InterGroup (GCIG): Clinical trial design for rare ovarian tumours T2 - Annals of Oncology TI - Fifth ovarian cancer consensus conference of the Gynecologic Cancer InterGroup (GCIG): Clinical trial design for rare ovarian tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616106023&from=exporthttp://dx.doi.org/10.1093/annonc/mdw662 VL - 28 ID - 6002 ER - TY - JOUR AD - The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: ohamid@theangelesclinic.org. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. University of Zürich, Zürich, Switzerland. Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. University of California, San Francisco, San Francisco, CA, USA. University Hospital Essen, Essen, Germany. Netherlands Cancer Institute, Amsterdam, The Netherlands. University of Arizona Cancer Center, Tucson, AZ, USA. Gustave Roussy and Paris-Sud University, Villejuif, France. New York University Cancer Institute, New York, NY, USA. University of Colorado Denver, Aurora, CO, USA. Dana-Farber Cancer Institute, Boston, MA, USA. Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Duke Cancer Institute, Durham, NC, USA. City of Hope, Duarte, CA, USA. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. Merck & Co., Inc., Kenilworth, NJ, USA. University of California Los Angeles, Los Angeles, CA, USA. AN - 28961465 AU - Hamid, O. AU - Puzanov, I. AU - Dummer, R. AU - Schachter, J. AU - Daud, A. AU - Schadendorf, D. AU - Blank, C. AU - Cranmer, L. D. AU - Robert, C. AU - Pavlick, A. C. AU - Gonzalez, R. AU - Hodi, F. S. AU - Ascierto, P. A. AU - Salama, A. K. S. AU - Margolin, K. A. AU - Gangadhar, T. C. AU - Wei, Z. AU - Ebbinghaus, S. AU - Ibrahim, N. AU - Ribas, A. DA - Nov DO - 10.1016/j.ejca.2017.07.022 10.1016/j.ejca.2017.07.022. DP - Nlm ET - 2017/09/30 LA - eng PY - 2017 SN - 0959-8049 SP - 37-45 ST - Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma T2 - Eur J Cancer TI - Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma VL - 86 ID - 6003 ER - TY - JOUR AD - Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States AU - Daver, N. AU - Thomas, D. AU - Ravandi, F. AU - Cortes, J. AU - Garris, R. AU - Jabbour, E. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Kadia, T. AU - Rytting, M. AU - Konopleva, M. AU - Kantarjian, H. AU - O’Brien, S. DB - Scopus DO - 10.3324/haematol.2014.118588 IS - 5 M3 - Article N1 - Cited By :91 Export Date: 18 November 2020 PY - 2015 SP - 653-661 ST - Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic Leukemia T2 - Haematologica TI - Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929148590&doi=10.3324%2fhaematol.2014.118588&partnerID=40&md5=0018803f94aeaac06e13dcf6a50ed89d VL - 100 ID - 6004 ER - TY - JOUR AD - Department of Cytology and Cytogenetic, University Hospital Merkur, Zagreb, Croatia. School of Medicine, University of Zagreb, Croatia. Department of Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia. Department of Clinical Chemistry and Laboratory Medicine, Merkur, University Hospital, Zagreb, Croatia. Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia. AN - 27468968 AU - Bogdanic, M. AU - Ostojic Kolonic, S. AU - Kaic, G. AU - Kardum Paro, M. M. AU - Lasan Trcic, R. AU - Kardum-Skelin, I. DA - Jan DO - 10.1002/dc.23542 10.1002/dc.23542. Epub 2016 Jul 29. DP - Nlm ET - 2016/07/30 IS - 1 LA - eng PY - 2017 SN - 1097-0339 SP - 51-54 ST - Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation T2 - Diagn Cytopathol TI - Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation VL - 45 ID - 6005 ER - TY - JOUR AD - State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China Zhejiang Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China AU - Wang, L. N. AU - Pan, Q. AU - Fu, J. F. AU - Shi, J. Y. AU - Jin, J. AU - Li, J. M. AU - Hu, J. AU - Zhao, W. L. AU - Chen, Z. AU - Chen, S. J. DB - Scopus DO - 10.1097/00029330-200805020-00001 IS - 10 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 867-873 ST - FIP1L1-PDGFRα alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib T2 - Chinese Medical Journal TI - FIP1L1-PDGFRα alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-51149106522&doi=10.1097%2f00029330-200805020-00001&partnerID=40&md5=fe99451ea8aed032661480fe3ed8fbd1 VL - 121 ID - 6006 ER - TY - JOUR AD - Department of Internal Medicine V, Haematology and Oncology, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria Klinikum Wels - Grieskirchen, Wels, Austria Division of Hematology, Medical University of Graz, Graz, Austria Krankenhaus der Barmherzigen Schwestern, Linz, Austria Allgemeines Krankenhaus der Stadt Linz, Linz, Austria Landeskrankenhaus Feldkirch, Feldkirch, Austria Klinik für Innere Medizin i, Abteilung für Hämatologie und Hämostaseologie, Medizinische Universität Wien, Wien, Austria Aö. Krankenhaus der Elisabethinen, Linz, Austria Aö. Bezirkskrankenhaus Lienz, Lienz, Austria Krankenhaus der Barmherzigen Brüder, Eisenstadt, Austria Hanusch-Krankenhaus, Wien, Austria Krankenhaus Wien-Hietzing, Wien, Austria St. Vinzenz-Krankenhaus, Zams, Austria Krankenhaus Meran, Merano, Italy Department of Internal Medicine i, Innsbruck Medical University, Innsbruck, Austria Landeskrankenhaus St. Pölten, St. Pölten, Austria AU - Schmidt, S. AU - Wolf, D. AU - Thaler, J. AU - Burgstaller, S. AU - Linkesch, W. AU - Petzer, A. AU - Fridrik, M. AU - Lang, A. AU - Agis, H. AU - Valent, P. AU - Krieger, O. AU - Walder, A. AU - Korger, M. AU - Schlögl, E. AU - Sliwa, T. AU - Wöll, E. AU - Mitterer, M. AU - Eisterer, W. AU - Pober, M. AU - Gastl, G. DB - Scopus DO - 10.1007/s00508-010-1450-x IS - 19-20 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 558-566 ST - First annual report of the Austrian CML registry T2 - Wiener Klinische Wochenschrift TI - First annual report of the Austrian CML registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78249280604&doi=10.1007%2fs00508-010-1450-x&partnerID=40&md5=80e53cf827344ee6997723e2590f3d39 VL - 122 ID - 6007 ER - TY - JOUR AD - K.A. Rauen, Department of Pediatics, Division of Genomic Medicine, University of California Davis, Sacramento, CA, United States AU - Rauen, K. A. AU - Alsaegh, A. AU - Ben-Shachar, S. AU - Berman, Y. AU - Blakeley, J. AU - Cordeiro, I. AU - Elgersma, Y. AU - Evans, D. G. AU - Fisher, M. J. AU - Frayling, I. M. AU - George, J. AU - Huson, S. M. AU - Kerr, B. AU - Khire, U. AU - Korf, B. AU - Legius, E. AU - Messiaen, L. AU - van Minkelen, R. AU - Nampoothiri, S. AU - Ngeow, J. AU - Parada, L. F. AU - Phadke, S. AU - Pillai, A. AU - Plotkin, S. R. AU - Puri, R. AU - Raji, A. AU - Ramesh, V. AU - Ratner, N. AU - Shankar, S. P. AU - Sharda, S. AU - Tambe, A. AU - Vikkula, M. AU - Widemann, B. C. AU - Wolkenstein, P. AU - Upadhyaya, M. DB - Embase Medline DO - 10.1002/ajmg.a.61125 IS - 6 LA - English M3 - Conference Paper N1 - L626924414 2019-04-01 2019-05-15 PY - 2019 SN - 1552-4833 1552-4825 SP - 1091-1097 ST - First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics T2 - American Journal of Medical Genetics, Part A TI - First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626924414&from=exporthttp://dx.doi.org/10.1002/ajmg.a.61125 VL - 179 ID - 6008 ER - TY - JOUR AD - D. O'Connell, Department of Neurology, University of California, Irvine Medical Center, Orange, CA, United States AU - O'Connell, D. AU - Shen, V. AU - Loudon, W. AU - Bota, D. A. DB - Embase Medline DO - 10.2217/cns-2016-0018 IS - 1 LA - English M3 - Article N1 - L614048923 2017-01-17 2017-01-24 PY - 2017 SN - 2045-0915 2045-0907 SP - 11-18 ST - First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: A case report T2 - CNS Oncology TI - First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614048923&from=exporthttp://dx.doi.org/10.2217/cns-2016-0018 VL - 6 ID - 6009 ER - TY - JOUR AD - B.D. Ross, Radiology, University of Michigan, Ann Arbor, MI, United States AU - Ross, B. D. AU - Galban, S. AU - Hoff, B. A. AU - Van Dort, M. AU - Espinoza, C. AU - Xu, X. AU - Hardie, W. D. DB - Embase IS - MeetingAbstracts LA - English M3 - Conference Abstract N1 - L622967362 2018-07-16 PY - 2018 SN - 1535-4970 ST - First-in-class MAPK/PI3K small molecule exhibits reversal of fibroproliferative disease T2 - American Journal of Respiratory and Critical Care Medicine TI - First-in-class MAPK/PI3K small molecule exhibits reversal of fibroproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622967362&from=export VL - 197 ID - 6010 ER - TY - JOUR AD - Department of Health Sciences, University of Milano-Bicocca, via Cadore 48, Monza, Italy San Gerardo Hospital, Clinical Research Unit, Monza, Italy AU - Viganò, I. AU - Di Giacomo, N. AU - Bozzani, S. AU - Antolini, L. AU - Piazza, R. AU - Gambacorti Passerini, C. DB - Scopus DO - 10.1002/ajh.23804 IS - 10 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2014 SP - E184-E187 ST - First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis T2 - American Journal of Hematology TI - First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908054155&doi=10.1002%2fajh.23804&partnerID=40&md5=c06ff242abf6f5795e7097800d49f93e VL - 89 ID - 6011 ER - TY - JOUR AD - From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France; Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia; Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland; the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany; the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy; the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.); Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.); the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.); Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.); the University of California, Los Angeles, Los Angeles (A.R.); the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.); Novartis Pharma, Basel, Switzerland (P.B.); Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.); and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.). AN - 31166680 AU - Robert, C. AU - Grob, J. J. AU - Stroyakovskiy, D. AU - Karaszewska, B. AU - Hauschild, A. AU - Levchenko, E. AU - Chiarion Sileni, V. AU - Schachter, J. AU - Garbe, C. AU - Bondarenko, I. AU - Gogas, H. AU - Mandalá, M. AU - Haanen, Jbag AU - Lebbé, C. AU - Mackiewicz, A. AU - Rutkowski, P. AU - Nathan, P. D. AU - Ribas, A. AU - Davies, M. A. AU - Flaherty, K. T. AU - Burgess, P. AU - Tan, M. AU - Gasal, E. AU - Voi, M. AU - Schadendorf, D. AU - Long, G. V. DA - Aug 15 DO - 10.1056/NEJMoa1904059 10.1056/NEJMoa1904059. Epub 2019 Jun 4. DP - Nlm ET - 2019/06/06 IS - 7 LA - eng PY - 2019 SN - 0028-4793 SP - 626-636 ST - Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma T2 - N Engl J Med TI - Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma VL - 381 ID - 6012 ER - TY - JOUR AD - Pusan National University, Department of Microbiology, Disivion of Natural Science, Busan, 609-735, South Korea AU - Lee, H. J. AU - Im, A. R. AU - Kim, S. M. AU - Kang, H. S. AU - Lee, J. D. AU - Chae, S. C7 - 39 DB - Scopus DO - 10.1186/s12906-017-2058-8 IS - 1 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2018 ST - The flavonoid hesperidin exerts anti-photoaging effect by downregulating matrix metalloproteinase (MMP)-9 expression via mitogen activated protein kinase (MAPK)-dependent signaling pathways T2 - BMC Complementary and Alternative Medicine TI - The flavonoid hesperidin exerts anti-photoaging effect by downregulating matrix metalloproteinase (MMP)-9 expression via mitogen activated protein kinase (MAPK)-dependent signaling pathways UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041362695&doi=10.1186%2fs12906-017-2058-8&partnerID=40&md5=69dcb3004eda65f3c1ca39da541a6c44 VL - 18 ID - 6013 ER - TY - JOUR AD - J.-M. Wong, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, Taipei 100, Taiwan AU - Wei, S. C. AU - Tsao, P. N. AU - Weng, M. T. AU - Cao, Z. AU - Wong, J. M. DB - Embase Medline DO - 10.1186/1423-0127-20-39 IS - 1 LA - English M3 - Article N1 - L52647637 2013-06-26 2013-07-24 PY - 2013 SN - 1021-7770 1423-0127 ST - Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway T2 - Journal of Biomedical Science TI - Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52647637&from=exporthttp://dx.doi.org/10.1186/1423-0127-20-39 VL - 20 ID - 6014 ER - TY - JOUR AD - C. Bueno, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Avda de la Ilustracón 114, Granada, Spain AU - Bueno, C. AU - Ayllón, V. AU - Montes, R. AU - Navarro-Montero, O. AU - Ramos-Mejia, V. AU - Real, P. J. AU - Romero-Moya, D. AU - Araúzo-Bravo, M. J. AU - Menendez, P. DB - Embase Medline DO - 10.1182/blood-2012-11-470146 IS - 19 LA - English M3 - Article N1 - L617279156 2017-08-15 2017-08-17 PY - 2013 SN - 1528-0020 0006-4971 SP - 3867-3878 ST - FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs T2 - Blood TI - FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617279156&from=exporthttp://dx.doi.org/10.1182/blood-2012-11-470146 VL - 121 ID - 6015 ER - TY - JOUR AD - Pediatric Oncology and Hematology, VU University Medical Center, Amsterdam, Netherlands Pediatric Oncology and Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands AML-BFM Study Group, Hannover Medical School, Hannover, Germany DCOG, The Hague, Netherlands AU - Goemans, B. F. AU - Zwaan, C. M. AU - Cloos, J. AU - de Lange, D. AU - Loonen, A. H. AU - Reinhardt, D. AU - Hählen, K. AU - Gibson, B. E. S. AU - Creutzig, U. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1016/j.leukres.2010.04.004 IS - 10 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2010 SP - 1302-1307 ST - FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657 T2 - Leukemia Research TI - FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955980691&doi=10.1016%2fj.leukres.2010.04.004&partnerID=40&md5=f5eef909abda75b90ac7ab3149839e69 VL - 34 ID - 6016 ER - TY - JOUR AD - Department of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XW, United Kingdom AU - Knapper, S. DB - Scopus DO - 10.1111/j.1365-2141.2007.06700.x IS - 6 M3 - Review N1 - Cited By :55 Export Date: 18 November 2020 PY - 2007 SP - 687-699 ST - FLT3 inhibition in acute myeloid leukaemia T2 - British Journal of Haematology TI - FLT3 inhibition in acute myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548181032&doi=10.1111%2fj.1365-2141.2007.06700.x&partnerID=40&md5=c20eaf20d64ceb4cded04e240fd7649e VL - 138 ID - 6017 ER - TY - JOUR AD - First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece Sofokleous 24, 17671, Athens, Greece AU - Lilakos, K. AU - Viniou, N. A. AU - Mavrogianni, D. AU - Vassilakopoulos, T. P. AU - Dimopoulou, M. N. AU - Plata, E. AU - Angelopoulou, M. K. AU - Variami, E. AU - Stavrogianni, N. AU - Liapi, D. AU - Xilouri, I. AU - Galanopoulos, A. AU - Ageloudi, M. AU - Panayiotidis, P. AU - Voulgarelis, M. AU - Rombos, J. AU - Meletis, J. AU - Yataganas, X. AU - Pangalis, G. A. DB - Scopus IS - 2 A M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2006 SP - 1201-1207 ST - FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: A pilot study T2 - Anticancer Research TI - FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: A pilot study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645833694&partnerID=40&md5=d7d0f4c385f99b1586fdedf7b394844e VL - 26 ID - 6018 ER - TY - JOUR AD - M. Gardberg, Department of Pathology, Turku University Hospital, Kiinamyllynkatu 10, Turku, Finland AU - Gardberg, M. AU - Heuser, V. D. AU - Koskivuo, I. AU - Koivisto, M. AU - Carpen, O. DB - Embase DO - 10.1002/cjp2.34 IS - 1 LA - English M3 - Article N1 - L621738214 2018-04-27 2018-05-09 PY - 2016 SN - 2056-4538 SP - 41-52 ST - FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome T2 - Journal of Pathology: Clinical Research TI - FMNL2/FMNL3 formins are linked with oncogenic pathways and predict melanoma outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621738214&from=exporthttp://dx.doi.org/10.1002/cjp2.34 VL - 2 ID - 6019 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 25682942 AU - Ouchi, K. AU - Miyachi, M. AU - Tsuma, Y. AU - Tsuchiya, K. AU - Iehara, T. AU - Konishi, E. AU - Yanagisawa, A. AU - Hosoi, H. DA - May DO - 10.1002/pbc.25424 10.1002/pbc.25424. Epub 2015 Feb 14. DP - Nlm ET - 2015/02/17 IS - 5 LA - eng PY - 2015 SN - 1545-5009 SP - 909-11 ST - FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor T2 - Pediatr Blood Cancer TI - FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor VL - 62 ID - 6020 ER - TY - JOUR AD - G. Mugundu, Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States AU - Farha, M. AU - Masson, E. AU - Tomkinson, H. AU - Mugundu, G. DB - Embase Medline DO - 10.1002/jcph.1351 IS - 4 LA - English M3 - Review N1 - L625410613 2018-12-17 2019-03-25 PY - 2019 SN - 1552-4604 0091-2700 SP - 463-471 ST - Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology T2 - Journal of Clinical Pharmacology TI - Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625410613&from=exporthttp://dx.doi.org/10.1002/jcph.1351 VL - 59 ID - 6021 ER - TY - JOUR AD - M. Chen, Department of Obstetrics and Gynecology, Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, 123 Tianfei Xiang, MoChou Road, Nanjing, Jiangsu, China AU - Li, C. AU - Ding, H. AU - Tian, J. AU - Wu, L. AU - Wang, Y. AU - Xing, Y. AU - Chen, M. DB - Embase Medline DO - 10.1159/000445620 IS - 1 LA - English M3 - Article N1 - L611065315 2016-07-08 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 242-252 ST - Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin in Vitro and in Vivo T2 - Cellular Physiology and Biochemistry TI - Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin in Vitro and in Vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611065315&from=exporthttp://dx.doi.org/10.1159/000445620 VL - 39 ID - 6022 ER - TY - JOUR AD - M.E. Bromberg, Temple University School of Medicine, Sol Sherry Thrombosis Research Ctr., 3400 North Broad Street, Philadelphia, PA 19140, United States AU - Jiang, X. AU - Bailly, M. A. AU - Panetti, T. S. AU - Cappello, M. AU - Konigsberg, W. H. AU - Bromberg, M. E. DB - Embase Medline DO - 10.1111/j.1538-7836.2004.00545.x IS - 1 LA - English M3 - Article N1 - L40185625 2005-02-15 PY - 2004 SN - 1538-7933 SP - 93-101 ST - Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells T2 - Journal of Thrombosis and Haemostasis TI - Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40185625&from=exporthttp://dx.doi.org/10.1111/j.1538-7836.2004.00545.x VL - 2 ID - 6023 ER - TY - JOUR AD - L. M. Gjerdrum, Department of Pathology, 5441, Copenhagen University Hospital, Rigshospitalet, Frederik V's vej 11, 2100 Copenhagen, Denmark AU - Gjerdrum, L. M. AU - Woetmann, A. AU - Odum, N. AU - Hother, C. AU - Henrik-Nielsen, R. AU - Gniadecki, R. AU - Ralfkiaer, E. DB - Embase Medline DO - 10.1111/j.1600-0609.2008.01064.x IS - 6 LA - English M3 - Article N1 - L351677463 2008-06-06 PY - 2008 SN - 0902-4441 1600-0609 SP - 483-489 ST - FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations T2 - European Journal of Haematology TI - FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351677463&from=exporthttp://dx.doi.org/10.1111/j.1600-0609.2008.01064.x VL - 80 ID - 6024 ER - TY - JOUR AD - Department of Radiation Oncology, Hacettepe University, Ankara, 06100, Turkey AU - Zorlu, F. AU - Gultekin, M. AU - Cengiz, M. AU - Yildiz, F. AU - Akyol, F. AU - Gurkaynak, M. AU - Ozyigit, G. DB - Scopus DO - 10.7785/tcrt.2012.500354 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 11-19 ST - Fractionated stereotactic radiosurgery treatment results for skull base chordomas T2 - Technology in Cancer Research and Treatment TI - Fractionated stereotactic radiosurgery treatment results for skull base chordomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892751802&doi=10.7785%2ftcrt.2012.500354&partnerID=40&md5=a88bfe2d6f39a5a8fb0935865d15ba09 VL - 13 ID - 6025 ER - TY - JOUR AD - Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A. Michallon, and Université Joseph Fourier, INSERM U823, Institut Albert Bonniot, Grenoble, France SLantuejoul@chu-grenoble.fr. Service d'Anatomie Pathologique, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. Département de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Université Paris Descartes, INSERM S1147, Paris, France. Service d'Anatomie et de Cytologie Pathologiques, Registre MESONAT, CHU Côte de Nacre, U1086 INSERM-UCBN "Cancers et Préventions", Caen, France. Laboratoire de Pathologie Clinique et Expérimentale et Biobanque, Hôpital Pasteur, Centre Hospitalo-Universitaire de Nice, Université de Nice Sophia Antipolis, Nice, France. Service d'Anatomie Pathologique, Service de Biologie des Tumeurs, CHU Haut-Levêque, Pessac, France. Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU de Lille, Lille, France. Laboratoire d'Anatomie Pathologique, Hôpital Nord, Marseille, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Central, Nancy, France. Service d'Anatomie et Cytologie Pathologiques, Hôpital de la Croix Rousse, Lyon, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpitaux universitaire Paris centre, Paris, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Louis Pradel, Bron, France. Service d'Anatomie et de Cytologie Pathologiques, Hôpital Tenon, Paris, France. Service d'Anatomie Pathologique, Centre Jean Perrin, Clermont-Ferrand, France. Département d'Anatomie et de Cytologie Pathologiques, Pôle de Biologie et de Pathologie, CHU A. Michallon, and Université Joseph Fourier, INSERM U823, Institut Albert Bonniot, Grenoble, France. AN - 25929957 AU - Lantuejoul, S. AU - Rouquette, I. AU - Blons, H. AU - Le Stang, N. AU - Ilie, M. AU - Begueret, H. AU - Grégoire, V. AU - Hofman, P. AU - Gros, A. AU - Garcia, S. AU - Monhoven, N. AU - Devouassoux-Shisheboran, M. AU - Mansuet-Lupo, A. AU - Thivolet, F. AU - Antoine, M. AU - Vignaud, J. M. AU - Penault-Llorca, F. AU - Galateau-Sallé, F. AU - McLeer-Florin, A. DA - Jul DO - 10.1183/09031936.00119914 10.1183/09031936.00119914. Epub 2015 Apr 30. DP - Nlm ET - 2015/05/02 IS - 1 LA - eng PY - 2015 SN - 0903-1936 SP - 207-18 ST - French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas T2 - Eur Respir J TI - French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas VL - 46 ID - 6026 ER - TY - JOUR AD - VA Eastern Colorado Health Care System, Rocky Mountain Regional VA Medical Center, Aurora, CO, United States AU - N Heck, J. AU - A Null, A. DB - Scopus DO - 10.1177/1078155219882077 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1097-1102 ST - Frequency of appropriate lab monitoring of oral chemotherapy in an outpatient setting T2 - Journal of Oncology Pharmacy Practice TI - Frequency of appropriate lab monitoring of oral chemotherapy in an outpatient setting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074848525&doi=10.1177%2f1078155219882077&partnerID=40&md5=f9e042ac916ffa82ae38bd539040fa5d VL - 26 ID - 6027 ER - TY - JOUR AD - Department of Neurosurgery, Eberhard-Karls University, Hoppe-Seyler Street 3, 72076, Tübingen, Germany. felix.behling@med.uni-tuebingen.de. Department of Neuropathology, Georg-August University, Robert-Koch-Street 40, 37075, Göttingen, Germany. Department of Neurosurgery, Eberhard-Karls University, Hoppe-Seyler Street 3, 72076, Tübingen, Germany. Department of Pathology, Eberhard-Karls University, Liebermeisterstr. 8, 72076, Tübingen, Germany. Department of Neuropathology, Hannover Medical School, Carl-Neuberg Street 1, 30625, Hannover, Germany. Department of Neurosurgery, Städtisches Klinikum Dresden-Friedrichstadt, Friedrichstr. 41, 01067, Dresden, Germany. Department of Neurosurgery, Georg-August University, Robert-Koch-Street 40, 37075, Göttingen, Germany. Department of Neuropathology, Eberhard-Karls University, Calwer Str. 3, 72076, Tübingen, Germany. AN - 27350555 AU - Behling, F. AU - Barrantes-Freer, A. AU - Skardelly, M. AU - Nieser, M. AU - Christians, A. AU - Stockhammer, F. AU - Rohde, V. AU - Tatagiba, M. AU - Hartmann, C. AU - Stadelmann, C. AU - Schittenhelm, J. C2 - PMC4924254 DA - Jun 27 DO - 10.1186/s13000-016-0506-2 10.1186/s13000-016-0506-2. DP - Nlm ET - 2016/06/29 IS - 1 LA - eng PY - 2016 SN - 1746-1596 SP - 55 ST - Frequency of BRAF V600E mutations in 969 central nervous system neoplasms T2 - Diagn Pathol TI - Frequency of BRAF V600E mutations in 969 central nervous system neoplasms VL - 11 ID - 6028 ER - TY - JOUR AD - Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo 663-8501, Japan Department of Thoracic Surgery, Itami City Hospital, Koyaike 1-100, Itami 664-8540, Japan Second Department of Surgery, University of Occupational and Environmental Health, Iseigaoka 1-1, Kitakyusyu 807-8555, Japan Department of Genetic Disease Research, Graduate School of Medicine, Osaka City University, Asahimachi 1-5-7, Osaka 545-8586, Japan Department of Pathology, National Institute of Cancer Research and Hospital (NICRH), Mohakhali, Dhaka 1212, Bangladesh Department of Thoracic Surgery, National Institute of Diseases of the Chest and Hospital (NIDCH), Mohakhali Dhaka, Bangladesh AU - Rahman, S. AU - Kondo, N. AU - Yoneda, K. AU - Takuwa, T. AU - Hashimoto, M. AU - Orui, H. AU - Okumura, Y. AU - Tanaka, F. AU - Kumamoto, K. AU - Mostafa, M. G. AU - Chowdhury, G. M. A. AU - Haque, A. AU - Hasegawa, S. DB - Scopus DO - 10.1007/s10147-012-0515-4 IS - 1 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 45-49 ST - Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung T2 - International Journal of Clinical Oncology TI - Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894515014&doi=10.1007%2fs10147-012-0515-4&partnerID=40&md5=12551ee55d0bbcdfdc09d80f9b1041d5 VL - 19 ID - 6029 ER - TY - JOUR AD - Innere Medizin 2, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany Gemeinschaftspraxis Hämatologie und Onkologie, Magdeburg, Germany Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany Germany Study Group MPN, GSG-MPN, Germany Praxis Hämatologie und Onkologie, Lüneburg, Germany OSHO Study Group—Working Party MPN, WP-CMPN, Germany Johannes Wesling Klinikum, Universitätsklinikum für Onkologie, Hämostaseologie und Palliativmedizin, UKRUB, Universität Bochum, Minden, Germany Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany Medizinische Klinik 3, Hämatologie, Onkologie, Klinikum rechts der Isar, Technische Universität München, München, Germany Klinik für Hämatologie und Onkologie, Universitätsklinikum Magdeburg, Magdeburg, Germany Praxis für Hämatologie und Onkologie, Erding, Germany Institute of Hematology and Clinical Oncology “L. and A. Seràgnoli” Sant’Orsola-Malpighi University Hospital, Bologna, Italy AU - Crodel, C. C. AU - Jentsch-Ullrich, K. AU - Koschmieder, S. AU - Kämpfe, D. AU - Griesshammer, M. AU - Döhner, K. AU - Jost, P. J. AU - Wolleschak, D. AU - Isfort, S. AU - Stegelmann, F. AU - Jilg, S. AU - Hofmann, V. AU - Auteri, G. AU - Rachow, T. AU - Ernst, P. AU - Brioli, A. AU - von Lilienfeld-Toal, M. AU - Hochhaus, A. AU - Palandri, F. AU - Heidel, F. H. DB - Scopus DO - 10.1038/s41375-020-0890-1 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 1949-1953 ST - Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study T2 - Leukemia TI - Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085754076&doi=10.1038%2fs41375-020-0890-1&partnerID=40&md5=1002596f68e3d78123e827dc5fc5c76f VL - 34 ID - 6030 ER - TY - JOUR AD - Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. AN - 24720374 AU - Go, H. AU - Jeon, Y. K. AU - Huh, J. AU - Choi, S. J. AU - Choi, Y. D. AU - Cha, H. J. AU - Kim, H. J. AU - Park, G. AU - Min, S. AU - Kim, J. E. DA - Aug DO - 10.1111/his.12416 10.1111/his.12416. Epub 2014 May 12. DP - Nlm ET - 2014/04/12 IS - 2 LA - eng PY - 2014 SN - 0309-0167 SP - 261-72 ST - Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms T2 - Histopathology TI - Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms VL - 65 ID - 6031 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA. AN - 19289593 AU - Buxton, D. AU - Bacchi, C. E. AU - Gualco, G. AU - Weiss, L. M. AU - Zuppan, C. W. AU - Rowsell, E. H. AU - Huang, Q. AU - Wang, J. DA - Apr DO - 10.1309/ajcpe68hzxcgwtkk 10.1309/AJCPE68HZXCGWTKK. DP - Nlm ET - 2009/03/18 IS - 4 LA - eng PY - 2009 SN - 0002-9173 SP - 574-9 ST - Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases T2 - Am J Clin Pathol TI - Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases VL - 131 ID - 6032 ER - TY - JOUR AD - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. ebar1@jhmi.edu AN - 18716556 AU - Bar, E. E. AU - Lin, A. AU - Tihan, T. AU - Burger, P. C. AU - Eberhart, C. G. DA - Sep DO - 10.1097/NEN.0b013e3181845622 10.1097/NEN.0b013e3181845622. DP - Nlm ET - 2008/08/22 IS - 9 LA - eng PY - 2008 SN - 0022-3069 (Print) 0022-3069 SP - 878-87 ST - Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma T2 - J Neuropathol Exp Neurol TI - Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma VL - 67 ID - 6033 ER - TY - JOUR AD - Department of Human Genetics, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, B-3000, Belgium Laboratory of Experimental Oncology, Department of General Medical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium Department of Soft Tissue/Bone Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland AU - Quattrone, A. AU - Wozniak, A. AU - Dewaele, B. AU - Floris, G. AU - Vanspauwen, V. AU - Van Looy, T. AU - Schöffski, P. AU - Rutkowski, P. AU - Sciot, R. AU - Debiec-Rychter, M. DB - Scopus DO - 10.1038/modpathol.2014.53 IS - 11 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2014 SP - 1510-1520 ST - Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors T2 - Modern Pathology TI - Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926180527&doi=10.1038%2fmodpathol.2014.53&partnerID=40&md5=cc3204bf8cb5b1d983f3fb9645a3b883 VL - 27 ID - 6034 ER - TY - JOUR AD - Department of Pathology, Division of Cellular and Molecular Pathology, University of Cambridge, Cambridge, UK. European Research Initiative for ALK-related malignancies (www.erialcl.net), Cambridge, UK. Department of paediatric oncology, Addenbrooke's Hospital, Cambridge, UK. Division of Pediatric Hematology-Oncology, Children's Hospital of the Kings Daughter, Norfolk, Virginia, USA. AN - 30681723 AU - Larose, H. AU - Burke, G. A. A. AU - Lowe, E. J. AU - Turner, S. D. DA - Jun DO - 10.1111/bjh.15763 10.1111/bjh.15763. Epub 2019 Jan 25. DP - Nlm ET - 2019/01/27 IS - 6 LA - eng PY - 2019 SN - 0007-1048 SP - 1043-1054 ST - From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK T2 - Br J Haematol TI - From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK VL - 185 ID - 6035 ER - TY - JOUR AD - S. Bonnet, Centre de Recherche du CHUQ, Hôtel-Dieu de Québec, 10 Rue McMahon, Québec, QC G1R 2J6, Canada AU - Paulin, R. AU - Courboulin, A. AU - Barrier, M. AU - Bonnet, S. C1 - azd 0530 rta 402 ski 606 DB - Embase Medline DO - 10.1007/s00109-011-0788-5 IS - 11 LA - English M3 - Review N1 - L51525217 2011-07-20 2011-11-18 PY - 2011 SN - 0946-2716 1432-1440 SP - 1089-1101 ST - From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension T2 - Journal of Molecular Medicine TI - From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51525217&from=exporthttp://dx.doi.org/10.1007/s00109-011-0788-5 VL - 89 ID - 6036 ER - TY - JOUR AD - L.S. Sherman, Division of Neuroscience, Oregon National Primate Research Center, and Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, United States AU - Ferner, R. E. AU - Bakker, A. AU - Elgersma, Y. AU - Evans, D. G. R. AU - Giovannini, M. AU - Legius, E. AU - Lloyd, A. AU - Messiaen, L. M. AU - Plotkin, S. AU - Reilly, K. M. AU - Schindeler, A. AU - Smith, M. J. AU - Ullrich, N. J. AU - Widemann, B. AU - Sherman, L. S. C1 - azd 2014 mln 4924 pd 0325901 DB - Embase Medline DO - 10.1002/ajmg.a.61112 IS - 6 LA - English M3 - Conference Paper N1 - L626923732 2019-04-01 2019-05-15 PY - 2019 SN - 1552-4833 1552-4825 SP - 1098-1106 ST - From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis T2 - American Journal of Medical Genetics, Part A TI - From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626923732&from=exporthttp://dx.doi.org/10.1002/ajmg.a.61112 VL - 179 ID - 6037 ER - TY - JOUR AD - H. Daniel Lacorazza, 1102 Bates Street, FC83.20, Houston, TX 77030, United States AU - Suppipat, K. AU - Daniel Lacorazza, H. DB - Embase Medline DO - 10.2174/1568009614666140521142950 IS - 5 LA - English M3 - Review N1 - L373609793 2014-08-01 2014-08-11 PY - 2014 SN - 1873-5576 1568-0096 SP - 434-445 ST - From the table to the bedside: Can food-derived sulforaphane be used as a novel agent to treat leukemia? T2 - Current Cancer Drug Targets TI - From the table to the bedside: Can food-derived sulforaphane be used as a novel agent to treat leukemia? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373609793&from=exporthttp://dx.doi.org/10.2174/1568009614666140521142950 VL - 14 ID - 6038 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, USA University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030; ejabbour@mdanderson.org. AN - 104597006. Language: English. Entry Date: 20120323. Revision Date: 20200708. Publication Type: journal article AU - Jabbour, E. AU - Kantarjian, H. M. AU - O'Brien, S. AU - Shan, J. AU - Quintás-Cardama, A. AU - Garcia-Manero, G. AU - Rios, M. B. AU - Cortes, J. E. AU - Jabbour, Elias AU - Kantarjian, Hagop M. AU - O'Brien, Susan AU - Shan, Jianqin AU - Quintás-Cardama, Alfonso AU - Garcia-Manero, Guillermo AU - Rios, Mary Beth AU - Cortes, Jorge E. DB - ccm DO - 10.1200/JCO.2011.36.0693 DP - EBSCOhost IS - 32 N1 - clinical trial; research. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM21990394. PY - 2011 SN - 0732-183X SP - 4260-4265 ST - Front-line therapy with second-generation tyrosine kinase inhibitors in patients with early chronic phase chronic myeloid leukemia: what is the optimal response? T2 - Journal of Clinical Oncology TI - Front-line therapy with second-generation tyrosine kinase inhibitors in patients with early chronic phase chronic myeloid leukemia: what is the optimal response? UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104597006&site=ehost-live&scope=site VL - 29 ID - 6039 ER - TY - JOUR AD - O.M.Z. Howard, Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, United States AU - Zhao, Z. AU - Fan, H. AU - Higgins, T. AU - Qi, J. AU - Haines, D. AU - Trivett, A. AU - Oppenheim, J. J. AU - Wei, H. AU - Li, J. AU - Lin, H. AU - Howard, O. M. Z. C2 - Shanxi Zhendong(China) DB - Embase Medline DO - 10.1016/j.canlet.2014.08.037 IS - 2 LA - English M3 - Article N1 - L600279848 2014-11-04 2014-11-10 PY - 2014 SN - 1872-7980 0304-3835 SP - 232-241 ST - Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways T2 - Cancer Letters TI - Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600279848&from=exporthttp://dx.doi.org/10.1016/j.canlet.2014.08.037 VL - 355 ID - 6040 ER - TY - JOUR AD - Y. Zhao, Department of Neurology, Jinshan Hospital Affiliated to Fudan University, No.1508 Longhang Road, Jinshan district, Shanghai, China AU - Zhang, J. AU - Wu, J. AU - Zeng, W. AU - Yao, K. AU - Zu, H. AU - Zhao, Y. DB - Embase Medline DO - 10.1159/000445578 IS - 6 LA - English M3 - Article N1 - L610480296 2016-05-31 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 2230-2238 ST - Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation T2 - Cellular Physiology and Biochemistry TI - Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610480296&from=exporthttp://dx.doi.org/10.1159/000445578 VL - 38 ID - 6041 ER - TY - JOUR AD - Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. AN - 9220028 AU - Sharif, T. R. AU - Luo, W. AU - Sharif, M. DA - Jun 20 DO - 10.1016/s0303-7207(97)00080-4 10.1016/s0303-7207(97)00080-4. DP - Nlm ET - 1997/06/20 IS - 1-2 LA - eng PY - 1997 SN - 0303-7207 (Print) 0303-7207 SP - 119-30 ST - Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway T2 - Mol Cell Endocrinol TI - Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway VL - 130 ID - 6042 ER - TY - JOUR AD - Department of Hematology and Medical Oncology, Hospital Clínico Universitario, Avd. Blasco Ibáñez 17, 46010 Valencia, Spain Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain Department of Hematology, Hospital del Mar, Barcelona, Spain Department of Pathology, Hospital del Mar, Barcelona, Spain Department of Hematology, Hospital La Fe, Valencia, Spain Department of Statistics, University of Valencia, Valencia, Spain AU - Guillem, V. AU - Amat, P. AU - Cervantes, F. AU - Alvarez-Larrán, A. AU - Cervera, J. AU - Maffioli, M. AU - Bellosillo, B. AU - Collado, M. AU - Marugán, I. AU - Martínez-Ruiz, F. AU - Hernández-Boluda, J. C. DB - Scopus DO - 10.1016/j.leukres.2011.06.011 IS - 2 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 174-181 ST - Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia T2 - Leukemia Research TI - Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855202791&doi=10.1016%2fj.leukres.2011.06.011&partnerID=40&md5=9d4d9a0e1401bcd9581366f79529bbd7 VL - 36 ID - 6043 ER - TY - JOUR AD - D. Iliopoulos, Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02215, United States AU - Palumbo, T. AU - Faucz, F. R. AU - Azevedo, M. AU - Xekouki, P. AU - Iliopoulos, D. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1038/onc.2012.190 IS - 13 LA - English M3 - Article N1 - L52021400 2012-05-25 2013-04-19 PY - 2013 SN - 0950-9232 1476-5594 SP - 1651-1659 ST - Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway T2 - Oncogene TI - Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52021400&from=exporthttp://dx.doi.org/10.1038/onc.2012.190 VL - 32 ID - 6044 ER - TY - JOUR AD - Division of Medical Genetics, A.I. duPont Hospital for Children/Nemours Childrens' Clinic, Wilmington, DE 19899, USA. kgripp@nemours.org AN - 17551924 AU - Gripp, K. W. AU - Lin, A. E. AU - Nicholson, L. AU - Allen, W. AU - Cramer, A. AU - Jones, K. L. AU - Kutz, W. AU - Peck, D. AU - Rebolledo, M. A. AU - Wheeler, P. G. AU - Wilson, W. AU - Al-Rahawan, M. M. AU - Stabley, D. L. AU - Sol-Church, K. DA - Jul 1 DO - 10.1002/ajmg.a.31815 10.1002/ajmg.a.31815. DP - Nlm ET - 2007/06/07 IS - 13 LA - eng PY - 2007 SN - 1552-4825 (Print) 1552-4825 SP - 1472-80 ST - Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome T2 - Am J Med Genet A TI - Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome VL - 143a ID - 6045 ER - TY - JOUR AD - P. Brandal, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, P.O Box 4953, Oslo, Nydalen, Norway AU - Olsen, T. K. AU - Panagopoulos, I. AU - Meling, T. R. AU - Micci, F. AU - Gorunova, L. AU - Thorsen, J. AU - Due-Tønnessen, B. AU - Scheie, D. AU - Lund-Iversen, M. AU - Krossnes, B. AU - Saxhaug, C. AU - Heim, S. AU - Brandal, P. DB - Embase Medline DO - 10.1093/neuonc/nov039 IS - 10 LA - English M3 - Article N1 - L606337404 2015-10-14 2015-10-19 PY - 2015 SN - 1523-5866 1522-8517 SP - 1365-1373 ST - Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: A new brain tumor entity? T2 - Neuro-Oncology TI - Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: A new brain tumor entity? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606337404&from=exporthttp://dx.doi.org/10.1093/neuonc/nov039 VL - 17 ID - 6046 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA. AN - 12661011 AU - Ma, Z. AU - Hill, D. A. AU - Collins, M. H. AU - Morris, S. W. AU - Sumegi, J. AU - Zhou, M. AU - Zuppan, C. AU - Bridge, J. A. DA - May DO - 10.1002/gcc.10177 10.1002/gcc.10177. DP - Nlm ET - 2003/03/28 IS - 1 LA - eng PY - 2003 SN - 1045-2257 (Print) 1045-2257 SP - 98-105 ST - Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor T2 - Genes Chromosomes Cancer TI - Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor VL - 37 ID - 6047 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. AN - 22658521 AU - Wang, X. AU - Krishnan, C. AU - Nguyen, E. P. AU - Meyer, K. J. AU - Oliveira, J. L. AU - Yang, P. AU - Yi, E. S. AU - Erickson-Johnson, M. R. AU - Yaszemski, M. J. AU - Maran, A. AU - Oliveira, A. M. DA - Nov DO - 10.1016/j.humpath.2012.02.014 10.1016/j.humpath.2012.02.014. Epub 2012 Jun 1. DP - Nlm ET - 2012/06/05 IS - 11 LA - eng PY - 2012 SN - 0046-8177 SP - 2047-52 ST - Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor T2 - Hum Pathol TI - Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor VL - 43 ID - 6048 ER - TY - JOUR AD - Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium. AN - 15713800 AU - De Keersmaecker, K. AU - Graux, C. AU - Odero, M. D. AU - Mentens, N. AU - Somers, R. AU - Maertens, J. AU - Wlodarska, I. AU - Vandenberghe, P. AU - Hagemeijer, A. AU - Marynen, P. AU - Cools, J. DA - Jun 15 DO - 10.1182/blood-2004-12-4897 10.1182/blood-2004-12-4897. Epub 2005 Feb 15. DP - Nlm ET - 2005/02/17 IS - 12 LA - eng PY - 2005 SN - 0006-4971 (Print) 0006-4971 SP - 4849-52 ST - Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32) T2 - Blood TI - Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32) VL - 105 ID - 6049 ER - TY - JOUR AD - Department of Pathology, Center for Human Molecular Genetics, 983135 University of Nebraska Medical Center, Omaha, NE 68198, USA. jbridge@unmc.edu AN - 11485898 AU - Bridge, J. A. AU - Kanamori, M. AU - Ma, Z. AU - Pickering, D. AU - Hill, D. A. AU - Lydiatt, W. AU - Lui, M. Y. AU - Colleoni, G. W. AU - Antonescu, C. R. AU - Ladanyi, M. AU - Morris, S. W. C2 - PMC1850566 DA - Aug DO - 10.1016/s0002-9440(10)61711-7 10.1016/S0002-9440(10)61711-7. DP - Nlm ET - 2001/08/04 IS - 2 LA - eng PY - 2001 SN - 0002-9440 (Print) 0002-9440 SP - 411-5 ST - Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor T2 - Am J Pathol TI - Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor VL - 159 ID - 6050 ER - TY - JOUR AD - Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Oncology, No. 111 Dade Road, Guangzhou, Guangdong, 510120, China AU - Yang, X. B. AU - Wu, W. Y. AU - Long, S. Q. AU - Deng, H. AU - Pan, Z. Q. AU - He, W. F. AU - Zhou, Y. S. AU - Liao, G. Y. AU - Li, Q. P. AU - Xiao, S. J. AU - Cai, J. Z. C7 - 146 DB - Scopus DO - 10.1186/s13063-015-0685-2 IS - 1 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2015 ST - Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Study protocol for a randomized controlled trial T2 - Trials TI - Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: Study protocol for a randomized controlled trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927523821&doi=10.1186%2fs13063-015-0685-2&partnerID=40&md5=cc6bd2a4d3f268e3d5145e377cc971de VL - 16 ID - 6051 ER - TY - JOUR AD - B. Yan, Gynecological Oncology, Hubei Maternal and Child Health Hospital, Wuhan, China AU - Yan, B. AU - Wu, X. DB - Embase DO - 10.1093/annonc/mdx663.019 LA - English M3 - Conference Abstract N1 - L620035907 2018-01-05 PY - 2017 SN - 1569-8041 SP - x91 ST - G-CSF induces production of Bv8 in murine bone marrow neutrophils and promotes tumor growth and angiogenesis of U14 murine cervical cancer cell line T2 - Annals of Oncology TI - G-CSF induces production of Bv8 in murine bone marrow neutrophils and promotes tumor growth and angiogenesis of U14 murine cervical cancer cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620035907&from=exporthttp://dx.doi.org/10.1093/annonc/mdx663.019 VL - 28 ID - 6052 ER - TY - JOUR AD - Department of Dermatology, Columbia University, 1150 Street, St. Nicholas Avenue, New York, NY 10032, United States Department of Pathology, Mount Sinai Medical School, New York, NY, United States Department of Bioinformatics, Columbia University, New York, NY, United States Melanoma Research Center, Wistar Institute, Philadelphia, PA, United States Department of Pathology, Columbia University, New York, NY, United States Department of Cancer Research, Fachklinik Hornheide, Munster, Germany Department of Biostatistics, Columbia University, New York, NY, United States AU - Yang, Y. AU - Wu, J. AU - Demir, A. AU - Castillo-Martin, M. AU - Melamed, R. D. AU - Zhang, G. AU - Fukunaga-Kanabis, M. AU - Perez-Lorenzo, R. AU - Zheng, B. AU - Silvers, D. N. AU - Brunner, G. AU - Wang, S. AU - Rabadan, R. AU - Cordon-Cardo, C. AU - Celebi, J. T. DB - Scopus DO - 10.1038/onc.2012.367 IS - 31 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2013 SP - 3627-3637 ST - GAB2 induces tumor angiogenesis in NRAS-driven melanoma T2 - Oncogene TI - GAB2 induces tumor angiogenesis in NRAS-driven melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881219979&doi=10.1038%2fonc.2012.367&partnerID=40&md5=f166c18e8282512b64d0b51abe8c8b87 VL - 32 ID - 6053 ER - TY - JOUR AD - L. Li, Department of Pathology, Capital Medical University, Beijing, China AU - Sun, J. AU - Xu, S. AU - Li, H. AU - Li, L. AU - Xu, Z. Q. D. DB - Embase Medline DO - 10.1155/2019/2716028 LA - English M3 - Article N1 - L628630661 2019-08-02 PY - 2019 SN - 1466-1861 0962-9351 ST - Galanin protects rat cortical astrocyte from oxidative stress: Involvement of GALR2 and PERK1/2 signal pathway T2 - Mediators of Inflammation TI - Galanin protects rat cortical astrocyte from oxidative stress: Involvement of GALR2 and PERK1/2 signal pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628630661&from=exporthttp://dx.doi.org/10.1155/2019/2716028 VL - 2019 ID - 6054 ER - TY - JOUR AD - Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku,Chiba, 260-8670, Japan Department of Public Health, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku,Chiba, 260-8670, Japan DNA Chip Research Inc., 1-1-43, Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan Department of Otorhinolaryngology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Cancer Molecular Immunotherapeutics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan Department of Functional Genomics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan AU - Sugimoto, T. AU - Seki, N. AU - Shimizu, S. AU - Kikkawa, N. AU - Tsukada, J. AU - Shimada, H. AU - Sasaki, K. AU - Hanazawa, T. AU - Okamoto, Y. AU - Hata, A. DB - Scopus DO - 10.1002/gcc.20626 IS - 2 M3 - Article N1 - Cited By :51 Export Date: 18 November 2020 PY - 2009 SP - 132-142 ST - The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma T2 - Genes Chromosomes and Cancer TI - The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59949102128&doi=10.1002%2fgcc.20626&partnerID=40&md5=6dc07336246bc6248b47909e87d383de VL - 48 ID - 6055 ER - TY - JOUR AD - P. Fan, Department of Plastic and Esthetic surgery, Xiangya Hospital of Central South University, Changsha, China AU - Fan, P. AU - Chen, S. AU - Li, Z. AU - Yang, X. AU - Lei, S. AU - Tan, W. DB - Embase IS - 11 LA - English M3 - Article N1 - L625290452 2018-12-11 2018-12-13 PY - 2018 SN - 1940-5901 SP - 12124-12132 ST - Gallic acid inhibits lps induced hypertrophic scar inflammation via toll-like receptor 4/nuclear factor-κb/peroxisome proliferator-activated receptor γ signaling T2 - International Journal of Clinical and Experimental Medicine TI - Gallic acid inhibits lps induced hypertrophic scar inflammation via toll-like receptor 4/nuclear factor-κb/peroxisome proliferator-activated receptor γ signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625290452&from=export VL - 11 ID - 6056 ER - TY - JOUR AD - A.S. Paller, Department of Dermatology, Northwestern University's Feinberg School of Medicine, 676 N. St. Clair Street, Chicago, IL 60611, United States AU - Wang, X. Q. AU - Sun, P. AU - Go, L. AU - Koti, V. AU - Fliman, M. AU - Paller, A. S. DB - Embase Medline DO - 10.1038/sj.jid.5700469 IS - 12 LA - English M3 - Article N1 - L44764053 2006-11-30 PY - 2006 SN - 0022-202X 1523-1747 SP - 2687-2696 ST - Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling T2 - Journal of Investigative Dermatology TI - Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44764053&from=exporthttp://dx.doi.org/10.1038/sj.jid.5700469 VL - 126 ID - 6057 ER - TY - JOUR AD - Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI 48109-1078, USA. AN - 19922767 AU - Shiozawa, Y. AU - Pedersen, E. A. AU - Taichman, R. S. C2 - PMC2815170 C6 - NIHMS159568 DA - Feb DO - 10.1016/j.exphem.2009.11.002 10.1016/j.exphem.2009.11.002. Epub 2009 Nov 14. DP - Nlm ET - 2009/11/20 IS - 2 LA - eng PY - 2010 SN - 0301-472X (Print) 0301-472x SP - 132-40 ST - GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche T2 - Exp Hematol TI - GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche VL - 38 ID - 6058 ER - TY - JOUR AD - A. Bhargava, Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, United States AU - Hagiwara, S. I. AU - Kaushal, E. AU - Paruthiyil, S. AU - Pasricha, P. J. AU - Hasdemir, B. AU - Bhargava, A. DB - Embase Medline DO - 10.1371/journal.pone.0203704 IS - 9 LA - English M3 - Article N1 - L623831956 2018-09-18 2018-09-20 PY - 2018 SN - 1932-6203 ST - Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia T2 - PLoS ONE TI - Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623831956&from=exporthttp://dx.doi.org/10.1371/journal.pone.0203704 VL - 13 ID - 6059 ER - TY - JOUR AD - R.T. Jensen, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1804, United States AU - Berna, M. J. AU - Tapia, J. A. AU - Sancho, V. AU - Thill, M. AU - Pace, A. AU - Hoffmann, K. M. AU - Gonzalez-Fernandez, L. AU - Jensen, R. T. DB - Embase Medline DO - 10.1016/j.cellsig.2009.01.003 IS - 4 LA - English M3 - Article N1 - L354158465 2009-03-02 PY - 2009 SN - 0898-6568 SP - 622-638 ST - Gastrointestinal growth factors and hormones have divergent effects on Akt activation T2 - Cellular Signalling TI - Gastrointestinal growth factors and hormones have divergent effects on Akt activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354158465&from=exporthttp://dx.doi.org/10.1016/j.cellsig.2009.01.003 VL - 21 ID - 6060 ER - TY - JOUR AD - N. Kurucu, Department of Pediatric Oncology, Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Yenimahalle, Ankara, Turkey AU - Kurucu, N. AU - Sari, N. AU - Celasun, B. AU - Sarihan, H. AU - Ahmetoglu, A. AU - Ilhan, I. E. DB - Embase Medline DO - 10.1097/MPH.0b013e3182a8f73f IS - 8 LA - English M3 - Article N1 - L600873999 2014-12-24 2015-01-07 PY - 2014 SN - 1536-3678 1077-4114 SP - 649-652 ST - Gastrointestinal stromal tumor in a newborn diagnosed in prenatal period: A case report and review of literature T2 - Journal of Pediatric Hematology/Oncology TI - Gastrointestinal stromal tumor in a newborn diagnosed in prenatal period: A case report and review of literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600873999&from=exporthttp://dx.doi.org/10.1097/MPH.0b013e3182a8f73f VL - 36 ID - 6061 ER - TY - JOUR AD - Departments of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India Departments of Surgical Gastroenterology, India Departments of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India AU - Kumari, N. AU - Priyaa, V. AU - Shukla, P. AU - Kumar, A. AU - Aggarwal, R. AU - Krishnani, N. DB - Scopus DO - 10.1097/PAI.0000000000000395 IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 153-160 ST - Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic Relevance T2 - Applied Immunohistochemistry and Molecular Morphology TI - Gastrointestinal Stromal Tumor: Genotype Frequency and Prognostic Relevance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973322873&doi=10.1097%2fPAI.0000000000000395&partnerID=40&md5=37226115dccecbd8ac2f00ac9aba354a VL - 26 ID - 6062 ER - TY - JOUR AD - Department of Pathology and Molecular Medicine, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Electronic address: alena.kalfusova@fnmotol.cz. Department of Oncology, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Department of Pathology and Molecular Medicine, Charles University - 2nd Faculty of Medicine and Faculty Hospital Motol, Czech Republic. Department of Paediatric Haematology and Oncology, Charles University - 2nd Faculty of Medicine and University Hospital Motol, Czech Republic. AN - 31708372 AU - Kalfusova, A. AU - Linke, Z. AU - Kalinova, M. AU - Krskova, L. AU - Hilska, I. AU - Szabova, J. AU - Vicha, A. AU - Kodet, R. DA - Dec DO - 10.1016/j.prp.2019.152708 10.1016/j.prp.2019.152708. Epub 2019 Oct 29. DP - Nlm ET - 2019/11/12 IS - 12 LA - eng PY - 2019 SN - 0344-0338 SP - 152708 ST - Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects T2 - Pathol Res Pract TI - Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects VL - 215 ID - 6063 ER - TY - JOUR AD - Institute of Pathology, Friedrich-Alexander-University, Erlangen, Germany AU - Agaimy, A. DB - Scopus IS - 5 M3 - Review N1 - Cited By :88 Export Date: 18 November 2020 PY - 2010 SP - 461-471 ST - Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting T2 - International Journal of Clinical and Experimental Pathology TI - Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956022283&partnerID=40&md5=f456c287429dc2fee640dfe8b87a2a51 VL - 3 ID - 6064 ER - TY - JOUR AD - Department of Pathology, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Department of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden AN - 104266352. Language: English. Entry Date: 20130418. Revision Date: 20200708. Publication Type: Journal Article AU - Arne, Gabriella AU - Nilsson, Bengt AU - Dalmo, Johanna AU - Kristiansson, Erik AU - Arvidsson, Yvonne AU - Forssell-Aronsson, Eva AU - Nilsson, Ola AU - Ahlman, Håkan DB - ccm DO - 10.3109/0284186X.2012.733075 DP - EBSCOhost IS - 4 N1 - pictorial; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. Special Interest: Oncologic Care. Grant Information: This study was supported by the Swedish Cancer Society, the Swedish Research Council, Sahlgrenska Academy (the government ALF agreement), the Johan Jansson Foundation for Cancer Research, the Assar Gabrielsson Research Foundation, the Sahlgrenska University Hospital Research Foundation, and the Royal Society of Arts and Sciences in Gothenburg.. NLM UID: 8709065. PMID: NLM23116418. PY - 2013 SN - 0284-186X SP - 783-792 ST - Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs T2 - Acta Oncologica TI - Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104266352&site=ehost-live&scope=site VL - 52 ID - 6065 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 14th Street and Alaska Avenue, N.W., Washington, DC 20306-6000, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus IS - 1 M3 - Review N1 - Cited By :251 Export Date: 18 November 2020 PY - 2003 SP - 3-24 ST - Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics T2 - Polish Journal of Pathology TI - Gastrointestinal stromal tumors (GISTs): Definition, occurrence, pathology, differential diagnosis and molecular genetics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037572285&partnerID=40&md5=ab89074a844f23e51ce757e1ef51873f VL - 54 ID - 6066 ER - TY - SER AB - Gastrointestinal stromal tumor (GIST) is defined as a specific, KIT-positive and KIT-signaling driven mesenchymal tumor of the gastrointestinal (GI) tract. This rumor reflects the phenotypic features of the interstitial cells of Cajal, KIT-positive mesenchymal cells dispersed in the gut wall. The specific identification of GIST now allows for application of KIT-selective tyrosine kinase inhibitors such as Imatinib mesylate (formerly STI571, Gleevec/Glivec® (Novartis Pharma) in the treatment of unresectable and metastatic examples. GIST is most the common mesenchymal neoplasm of the GI tract comprising most tumors earlier classified as gastrointestinal smooth muscle tumors and GI autonomic nerve tumors. GISTs typically present in adults over 40 years (median age around 60 years) and very rarely in children. They can occur anywhere in the GI-tract from the lower esophagus to the anus, most commonly in the stomach (60-70%) and small intestine (25-35%). Colon, rectum, appendix (together 5%) and esophagus (2-3%) are rare sites. GISTs can be primary in the omentum, mesentery or retroperitoneum, but most GISTs in these sites are metastases from a gastric or intestinal primary. Histologically GISTs vary from cellular spindle cell tumors to epithelioid and pleomorphic ones, and morphology varies somewhat by site. By definition, GISTs are KIT (CD117)-positive. Positivity for nestin (90-100%) and CD34 (70-80%) are also characteristic but less specific features. Smooth muscle actins (20-30%) and heavy caldesmon (80%) are often expressed, whereas desmin is usually absent. A minority of small intestinal GISTs (10-20%) are S 100-protein positive. Predictive of malignancy are mitotic rate over 5 per 50 HPF or size over 5 cm. However, mitotically inactive intestinal tumors can metastasize, although gastric tumors are in average less often malignant than the intestinal ones with low mitotic rates. Smooth muscle tumors, schwannoma, undifferentiated sarcomas, mesenteric desmoid, solitary fibrous tumor and metastatic melanoma can be separated from GISTs by histologic and immunohistochemical analysis. Recent identification of PDGFRA expression and mutations in some histologically GIST-like tumors necessitate expansion of the GIST definition to these tumors as well. AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, 14th Street and Alaska Avenue, N.W., Washington, DC 20306-6000, United States AU - Miettinen, M. DB - Scopus M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2004 SP - 3-28 ST - Gastrointestinal stromal tumors (GISTS): Definition, pathology, occurrence, and differential diagnosis T2 - Gann Monographs on Cancer Research TI - Gastrointestinal stromal tumors (GISTS): Definition, pathology, occurrence, and differential diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-23844458217&partnerID=40&md5=8eaafc1a56d85b6f4f155b95da573595 VL - 53 ID - 6067 ER - TY - JOUR AD - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico Department of Oncological Surgery, Centro Médico Nacional Siglo XXI, IMSS, Ciudad de México, Mexico AU - Sarre-Lazcano, C. AU - Ruiz-García, E. AU - Medrano-Guzmán, R. AU - Motola-Kuba, D. AU - Medina-Franco, H. DB - Scopus DO - 10.24875/j.gamo.M18000116 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 226-229 ST - Tumores del estroma gastrointestinal: Experiencia del grupo cooperativo de tumores del tracto digestivo y análisis de factores pronósticos T2 - Gaceta Mexicana de Oncologia TI - Gastrointestinal stromal tumors: Experience of the digestive tract tumors and prognostic risk analysis cooperative group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043998276&doi=10.24875%2fj.gamo.M18000116&partnerID=40&md5=08d1f7b441801da5ec7c2660e0eac5eb VL - 16 ID - 6068 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, United States Armed Forces Institute of Pathology, Department of Soft Tissue Pathology, Bldg. 54, 6825 16th St, NW, Washington, DC 20306-6000, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus IS - 10 M3 - Review N1 - Cited By :954 Export Date: 18 November 2020 PY - 2006 SP - 1466-1478 ST - Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis T2 - Archives of Pathology and Laboratory Medicine TI - Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749459756&partnerID=40&md5=e92c2cb59a6e4e0de7a923e2735f9ca0 VL - 130 ID - 6069 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria Kiel Pediatric Tumor Registry, Department of Pediatric Pathology, University of Schleswig-Holstein, Campus Kiel, Germany Department of Pathology, University of Bonn Medical School, Germany Department of Pediatric Hematology/Oncology, Dr. von Haunersches Kinderspital, Ludwig Maximilians University Munich, Germany Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Germany Department of Pediatrics, Children’s Hospital Linz, Austria St. Anna Children’s Hospital, Vienna, Austria Department of Pediatric Hematology and Oncology, Saarland University, Homburg/Saar, Germany Department of Pediatrics and Adolescent Medicine, Municipal Clinics Dortmund, Germany Department of Pediatric Hematology/Oncology/Endocrinology, Children’s Hospital, University of Essen, Germany Institute of Pathology, Medical University of Vienna, Austria Department of Internal Medicine III – Hematology/Oncology, University Hospital Munich-Campus, Grosshadern, Munich, Germany Institute for Medical Statistics, Medical University of Graz, Austria Division of Pediatric Hematology and Oncology, Department of Pediatrics, J.W. Goethe University Children’s Hospital of Frankfurt, Germany Olgahospital, Klinikum Stuttgart, Pediatrics 5 (Oncology), Stuttgart, Germany AN - 104655101. Language: English. Entry Date: 20110810. Revision Date: 20150711. Publication Type: Journal Article AU - Benesch, Martin AU - Leuschner, Ivo AU - Wardelmann, Eva AU - Thielen, Mareike AU - Schmid, Irene AU - Kontny, Udo AU - Ebetsberger, Georg AU - Frey, Eva AU - Graf, Norbert AU - Schneider, Dominik T. AU - Kremens, Bernhard AU - Amann, Gabriele AU - Urban, Christian AU - Schlemmer, Marcus AU - Quehenberger, Franz AU - Klingebiel, Thomas AU - Dantonello, Tobias AU - Koscielniak, Ewa DB - ccm DO - 10.1016/j.ejca.2011.03.014 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 9005373. PMID: NLM21486690. PY - 2011 SN - 0959-8049 SP - 1692-1698 ST - Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS) T2 - European Journal of Cancer TI - Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104655101&site=ehost-live&scope=site VL - 47 ID - 6070 ER - TY - JOUR AD - Department of Histopathology, Bristol Royal Infirmary, Bristol, United Kingdom AU - Wong, N. A. C. S. DB - Scopus DO - 10.1111/j.1365-2559.2011.03812.x IS - 5 M3 - Review N1 - Cited By :32 Export Date: 18 November 2020 PY - 2011 SP - 807-821 ST - Gastrointestinal stromal tumours-an update for histopathologists T2 - Histopathology TI - Gastrointestinal stromal tumours-an update for histopathologists UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-81555216746&doi=10.1111%2fj.1365-2559.2011.03812.x&partnerID=40&md5=1265200617e9af9592caec0e87660969 VL - 59 ID - 6071 ER - TY - JOUR AD - Department of Surgery Unit 3, Christian Medical College and Hospital, Vellore 632004 India AN - 111984525. Language: English. Entry Date: 20180117. Revision Date: 20180118. Publication Type: Article AU - Yacob, Myla AU - Inian, Samarasam AU - Sudhakar, Chandran DB - ccm DO - 10.1007/s12262-013-0899-z DP - EBSCOhost N1 - review; tables/charts. Supplement Title: Dec2015 Supplement. Journal Subset: Asia; Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed. NLM UID: 0373026. PY - 2015 SN - 0972-2068 SP - 505-510 ST - Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre T2 - Indian Journal of Surgery TI - Gastrointestinal Stromal Tumours: Review of 150 Cases from a Single Centre UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111984525&site=ehost-live&scope=site VL - 77 ID - 6072 ER - TY - JOUR AD - Department of Medicine and Surgery, University of Insubria, Varese, Italy Department of Science and High Technology, University of Insubria, Como, Italy IFN (National Institute of Nuclear Physics), Como, Italy Department of Biology and Life Sciences, University of Insubria, Varese, Italy Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy Department of Genetics and Cytogenetics, ASST Sette Laghi, Ospedale di Circolo Fondazione Macchi, Varese, Italy Department of Health Sciences, University of Milan, Milan, Italy Biomedical Technologies Institute, CNR, Milan, Italy AU - Rainero, A. AU - Angaroni, F. AU - Conti, A. AU - Pirrone, C. AU - Micheloni, G. AU - Tararà, L. AU - Millefanti, G. AU - Maserati, E. AU - Valli, R. AU - Spinelli, O. AU - Buklijas, K. AU - Michelato, A. AU - Casalone, R. AU - Barlassina, C. AU - Barcella, M. AU - Sirchia, S. AU - Piscitelli, E. AU - Caccia, M. AU - Porta, G. C7 - 349 DB - Scopus DO - 10.1038/s41419-018-0387-2 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 ST - GDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML T2 - Cell Death and Disease TI - GDNA qPCR is statistically more reliable than mRNA analysis in detecting leukemic cells to monitor CML UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042789497&doi=10.1038%2fs41419-018-0387-2&partnerID=40&md5=349fd8f744504e9a9492442ac380b9d4 VL - 9 ID - 6073 ER - TY - JOUR AD - University of Colorado at Denver and Health Sciences Center (UCDHSC), Children's Hospital, Denver, CO, United States University of New Mexico Health Sciences Center, Albuquerque, NM, United States University of Colorado at Denver and Health Sciences Center, Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Foreman, N. K. AU - Gore, L. AU - Wells, D. AU - Straessle, J. AU - Heideman, R. AU - Donson, A. M. DB - Scopus DO - 10.1002/pbc.20619 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2006 SP - 293-298 ST - Gefitinib is effective against juvenile pilocytic astrocytoma in vitro T2 - Pediatric Blood and Cancer TI - Gefitinib is effective against juvenile pilocytic astrocytoma in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746640912&doi=10.1002%2fpbc.20619&partnerID=40&md5=10cf3f317b53d03c1b69ab54ec7ef6ee VL - 47 ID - 6074 ER - TY - JOUR AD - Div. of Pediat. Hematology Oncology, Minneapolis, MN, United States Division of Pathology, Minneapolis, MN, United States Children's Hospitals and Clinics, Pediatric ENT Associates, Minneapolis, MN, United States Div. of Pediatric Infectious Disease, Park-Nicollet Clinic, Minneapolis, MN, United States 2525 Chicago Ave S, Minneapolis, MN 55455, United States AU - Bostrom, B. AU - Sidman, J. AU - Marker, S. AU - Lander, T. AU - Drehner, D. DB - Scopus DO - 10.1001/archotol.131.1.64 IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2005 SP - 64-67 ST - Gefitinib therapy for life-threatening laryngeal papillomatosis T2 - Archives of Otolaryngology - Head and Neck Surgery TI - Gefitinib therapy for life-threatening laryngeal papillomatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-12144269582&doi=10.1001%2farchotol.131.1.64&partnerID=40&md5=8d2da1e540be311705a3191db76d03ac VL - 131 ID - 6075 ER - TY - JOUR AD - Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China Fudan University Affiliated Zhongshan Hospital, Shanghai, China Zhejiang Cancer Hospital, Hangzhou, China Hunan Cancer Hospital, Changsha, China The Affiliated Hospital of Medical College Qingdao University, Qingdao, China Liaoning Cancer Hospital, Shenyang, China Fujian Medical University Union Hospital, Fuzhou, China Jilin Provincial Tumor Hospital, Changchun, China Jiangsu Cancer Hospital, Nanjing, China The People's Hospital of Peking University, Beijing, China Shanghai Pulmonary Hospital, Tongji University, Shanghai, China Tangdu Hospital, Xi'an, China Peking University First Hospital, Beijing, China Fujian Cancer Hospital, Fuzhou, China Beijing Chest Hospital, Beijing, China The First Hospital of China Medical University, Shenyang, China Beijing Cancer Hospital, Beijing, China Harbin Medical University Cancer Hospital, Harbin, China West China Hospital of Sichuan University, Chengdu, China Sichuan Cancer Hospital, Chengdu, China The Northern Jiangsu People's Hospital, Yangzhou, China The First Affiliated Hospital of Suzhou University, Suzhou, China AU - Zhong, W. Z. AU - Wang, Q. AU - Mao, W. M. AU - Xu, S. T. AU - Wu, L. AU - Shen, Y. AU - Liu, Y. Y. AU - Chen, C. AU - Cheng, Y. AU - Xu, L. AU - Wang, J. AU - Fei, K. AU - Li, X. F. AU - Li, J. AU - Huang, C. AU - Liu, Z. D. AU - Xu, S. AU - Chen, K. N. AU - Xu, S. D. AU - Liu, L. X. AU - Yu, P. AU - Wang, B. H. AU - Ma, H. T. AU - Yan, H. H. AU - Yang, X. N. AU - Zhou, Q. AU - Wu, Y. L. AU - Wu, Y. L. AU - Wang, Q. AU - Mao, W. M. AU - Wu, L. AU - Shen, Y. AU - Liu, Y. Y. AU - Chen, C. AU - Cheng, Y. AU - Xu, L. AU - Wang, J. AU - Fei, K. AU - Li, X. F. AU - Li, J. AU - Huang, C. AU - Liu, Z. D. AU - Xu, S. AU - Chen, K. N. AU - Xu, S. D. AU - Liu, L. X. AU - Yu, P. AU - Wang, B. H. AU - Ma, H. T. AU - Wang, S. Y. AU - Hu, J. AU - Liu, W. AU - Li, W. AU - Shi, J. H. AU - investigators, Adjuvant AU - investigators, Adjuvant DB - Scopus DO - 10.1016/S1470-2045(17)30729-5 IS - 1 M3 - Article N1 - Cited By :151 Export Date: 18 November 2020 PY - 2018 SP - 139-148 ST - Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study T2 - The Lancet Oncology TI - Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034633134&doi=10.1016%2fS1470-2045%2817%2930729-5&partnerID=40&md5=41935d1d33ff5ab7a9a5a3a4bea164e1 VL - 19 ID - 6076 ER - TY - JOUR AD - Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University, 100 Haining Road, Shanghai, 200080, China AU - Ma, X. AU - Sun, W. AU - Shen, J. AU - Hua, Y. AU - Yin, F. AU - Sun, M. AU - Cai, Z. DB - Scopus DO - 10.1007/s13277-015-4565-x IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2016 SP - 7165-7174 ST - Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma T2 - Tumor Biology TI - Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949664754&doi=10.1007%2fs13277-015-4565-x&partnerID=40&md5=732abfd00e64ba9dac13650fb2c68d5c VL - 37 ID - 6077 ER - TY - JOUR AD - P. Malgulwar, All India Institute of Medical Sciences (AIIMS), New Delhi, India AU - Malgulwar, P. AU - Tomar, A. AU - Singh, M. AU - Suri, V. AU - Sarkar, C. AU - Sharma, M. DB - Embase DO - 10.1093/neuonc/nox036 LA - English M3 - Conference Abstract N1 - L620930857 2018-03-06 PY - 2017 SN - 1523-5866 SP - iii52 ST - A gene co-expression network analysis for snail and slug identifies IL1R1, an inflammatory interleukin to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas T2 - Neuro-Oncology TI - A gene co-expression network analysis for snail and slug identifies IL1R1, an inflammatory interleukin to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620930857&from=exporthttp://dx.doi.org/10.1093/neuonc/nox036 VL - 19 ID - 6078 ER - TY - JOUR AD - V.S. Silveira, Department of Pediatrics, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Avenida Bandeirantes 3900, 14049-900 Ribeirao Preto-SP, Brazil AU - Silveira, V. S. AU - Scrideli, C. A. AU - Moreno, D. A. AU - Yunes, J. A. AU - Queiroz, R. G. P. AU - Toledo, S. C. AU - Lee, M. L. M. AU - Petrilli, A. S. AU - Brandalise, S. R. AU - Tone, L. G. DB - Embase Medline DO - 10.3109/10428194.2012.710330 IS - 2 LA - English M3 - Article N1 - L368063482 2013-01-15 2013-01-22 PY - 2013 SN - 1042-8194 1029-2403 SP - 310-314 ST - Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia T2 - Leukemia and Lymphoma TI - Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368063482&from=exporthttp://dx.doi.org/10.3109/10428194.2012.710330 VL - 54 ID - 6079 ER - TY - JOUR AD - Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada. mmayne@cc.umanitoba.ca AN - 11689646 AU - Mayne, M. AU - Cheadle, C. AU - Soldan, S. S. AU - Cermelli, C. AU - Yamano, Y. AU - Akhyani, N. AU - Nagel, J. E. AU - Taub, D. D. AU - Becker, K. G. AU - Jacobson, S. C2 - PMC114751 DA - Dec DO - 10.1128/jvi.75.23.11641-11650.2001 10.1128/JVI.75.23.11641-11650.2001. DP - Nlm ET - 2001/11/02 IS - 23 LA - eng PY - 2001 SN - 0022-538X (Print) 0022-538x SP - 11641-50 ST - Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms T2 - J Virol TI - Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms VL - 75 ID - 6080 ER - TY - JOUR AD - C.A. Scrideli, Centro Ricerca M. Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Via Donizetti, Monza, Italy AU - Scrideli, C. A. AU - Cazzaniga, G. AU - Fazio, G. AU - Pirola, L. AU - Callegaro, A. AU - Bassan, R. AU - Rambaldi, A. AU - Lo Nigro, L. AU - Basso, G. AU - Masera, G. AU - Biondi, A. DB - Embase Medline DO - 10.1038/sj.leu.2403110 IS - 11 LA - English M3 - Letter N1 - L37428393 2003-12-03 PY - 2003 SN - 0887-6924 SP - 2234-2237 ST - Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia [2] T2 - Leukemia TI - Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia [2] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37428393&from=exporthttp://dx.doi.org/10.1038/sj.leu.2403110 VL - 17 ID - 6081 ER - TY - JOUR AD - G.V. Dahl, PO Box 60012, Arcadia, CA 91066-6012, United States AU - Lacayo, N. J. AU - Meshinchi, S. AU - Kinnunen, P. AU - Yu, R. AU - Wang, Y. AU - Stuber, C. M. AU - Douglas, L. AU - Wahab, R. AU - Becton, D. L. AU - Weinstein, H. AU - Chang, M. N. AU - Willman, C. L. AU - Radich, J. P. AU - Tibshirani, R. AU - Ravindranath, Y. AU - Sikic, B. I. AU - Dahl, G. V. DB - Embase Medline DO - 10.1182/blood-2003-12-4449 IS - 9 LA - English M3 - Article N1 - L39434943 2004-11-22 PY - 2004 SN - 0006-4971 SP - 2646-2654 ST - Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes T2 - Blood TI - Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39434943&from=exporthttp://dx.doi.org/10.1182/blood-2003-12-4449 VL - 104 ID - 6082 ER - TY - JOUR AD - IRIBHM, Université Libre de Bruxelles, Brussels, Belgium. vdetours@ulb.ac.be AN - 18769217 AU - Detours, V. AU - Versteyhe, S. AU - Dumont, J. E. AU - Maenhaut, C. DA - Oct DO - 10.1097/MED.0b013e32830eb874 10.1097/MED.0b013e32830eb874. DP - Nlm ET - 2008/09/05 IS - 5 LA - eng PY - 2008 SN - 1752-296x SP - 440-5 ST - Gene expression profiles of post-Chernobyl thyroid cancers T2 - Curr Opin Endocrinol Diabetes Obes TI - Gene expression profiles of post-Chernobyl thyroid cancers VL - 15 ID - 6083 ER - TY - JOUR AD - P. Rossner, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic AU - Honkova, K. AU - Rossnerova, A. AU - Pavlikova, J. AU - Svecova, V. AU - Klema, J. AU - Topinka, J. AU - Milcova, A. AU - Libalova, H. AU - Choi, H. AU - Veleminsky, M. AU - Sram, R. J. AU - Rossner, P. DB - Embase Medline DO - 10.1002/em.22184 IS - 5 LA - English M3 - Article N1 - L621494697 2018-04-04 PY - 2018 SN - 1098-2280 0893-6692 SP - 401-415 ST - Gene expression profiling in healthy newborns from diverse localities of the Czech Republic T2 - Environmental and Molecular Mutagenesis TI - Gene expression profiling in healthy newborns from diverse localities of the Czech Republic UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621494697&from=exporthttp://dx.doi.org/10.1002/em.22184 VL - 59 ID - 6084 ER - TY - JOUR AD - Senckenberg Institute for Pathology, University of Frankfurt, Medical School, Frankfurt/Main, Germany. AN - 19657361 AU - Eckerle, S. AU - Brune, V. AU - Döring, C. AU - Tiacci, E. AU - Bohle, V. AU - Sundström, C. AU - Kodet, R. AU - Paulli, M. AU - Falini, B. AU - Klapper, W. AU - Chaubert, A. B. AU - Willenbrock, K. AU - Metzler, D. AU - Bräuninger, A. AU - Küppers, R. AU - Hansmann, M. L. DA - Nov DO - 10.1038/leu.2009.161 10.1038/leu.2009.161. Epub 2009 Aug 6. DP - Nlm ET - 2009/08/07 IS - 11 LA - eng PY - 2009 SN - 0887-6924 SP - 2129-38 ST - Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma T2 - Leukemia TI - Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma VL - 23 ID - 6085 ER - TY - JOUR AD - S.R. Lambert, University of Cambridge, United Kingdom AU - Lambert, S. R. AU - Jones, D. T. W. AU - Pearson, D. AU - Ichimura, I. AU - Collins, V. P. DB - Embase DO - 10.1093/neuonc/nor144 LA - English M3 - Conference Abstract N1 - L70964997 2013-01-17 PY - 2011 SN - 1522-8517 SP - ii6 ST - Gene expression profiling of pilocytic astrocytoma T2 - Neuro-Oncology TI - Gene expression profiling of pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70964997&from=exporthttp://dx.doi.org/10.1093/neuonc/nor144 VL - 13 ID - 6086 ER - TY - JOUR AD - Service de Génétique & CNRS FRE 2939, Institut Gustave Roussy, Villejuif, France. AN - 19383316 AU - Kannengiesser, C. AU - Spatz, A. AU - Michiels, S. AU - Eychène, A. AU - Dessen, P. AU - Lazar, V. AU - Winnepenninckx, V. AU - Lesueur, F. AU - Druillennec, S. AU - Robert, C. AU - van den Oord, J. J. AU - Sarasin, A. AU - Bressac-de Paillerets, B. C2 - PMC5543835 DA - Apr DO - 10.1016/j.molonc.2008.01.002 10.1016/j.molonc.2008.01.002. Epub 2008 Jan 12. DP - Nlm ET - 2009/04/23 IS - 4 LA - eng PY - 2008 SN - 1574-7891 (Print) 1574-7891 SP - 425-30 ST - Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas T2 - Mol Oncol TI - Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas VL - 1 ID - 6087 ER - TY - JOUR AD - F. Mertens, Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden AU - Piarulli, G. AU - Puls, F. AU - Wängberg, B. AU - Fagman, H. AU - Hansson, M. AU - Nilsson, J. AU - Arbajian, E. AU - Mertens, F. DB - Embase Medline DO - 10.1111/his.13839 IS - 7 LA - English M3 - Article N1 - L627470005 2019-05-14 2019-05-21 PY - 2019 SN - 1365-2559 0309-0167 SP - 1098-1102 ST - Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour T2 - Histopathology TI - Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627470005&from=exporthttp://dx.doi.org/10.1111/his.13839 VL - 74 ID - 6088 ER - TY - JOUR AD - E.V. Preobrazhenskaya, N.N. Petrov Institute of Oncology, St. Petersburg, Russian Federation AU - Preobrazhenskaya, E. V. AU - Iyevleva, A. G. AU - Suleymanova, A. M. AU - Tiurin, V. I. AU - Mitiushkina, N. V. AU - Bizin, I. V. AU - Ivanstov, A. O. AU - Gorustovich, O. A. AU - Shelekhova, K. V. AU - Kachanov, D. Y. AU - Varfolomeeva, S. R. AU - Roschin, V. Y. AU - Kazakova, A. N. AU - Litvinov, D. V. AU - Shamanskaya, T. V. AU - Savelov, N. A. AU - Suspitsin, E. N. AU - Imyanitov, E. N. DB - Embase Medline DO - 10.1002/pbc.28220 IS - 5 LA - English M3 - Article N1 - L2004277507 2020-02-25 2020-04-10 PY - 2020 SN - 1545-5017 1545-5009 ST - Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors T2 - Pediatric Blood and Cancer TI - Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004277507&from=exporthttp://dx.doi.org/10.1002/pbc.28220 VL - 67 ID - 6089 ER - TY - JOUR AD - Y. Ebisuno, Immunology Unit, Takeda Pharmaceutical Company Limited, Pharmaceutical Research Division, 2-26-1, Muraoka-Higashi, Fujisawa, Japan AU - Gamo, K. AU - Okuzono, Y. AU - Yabuki, M. AU - Ochi, T. AU - Sugimura, K. AU - Sato, Y. AU - Sagara, M. AU - Hayashi, H. AU - Ishimura, Y. AU - Nishimoto, Y. AU - Murakawa, Y. AU - Shiokawa, Z. AU - Gotoh, M. AU - Miyazaki, T. AU - Ebisuno, Y. DB - Embase Medline DO - 10.1093/ibd/izy079 IS - 6 LA - English M3 - Article N1 - L622340107 2018-06-01 2018-06-07 PY - 2018 SN - 1536-4844 1078-0998 SP - 1251-1265 ST - Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated with Relapse after Anti-TNFα Treatment for Crohn's Disease T2 - Inflammatory Bowel Diseases TI - Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated with Relapse after Anti-TNFα Treatment for Crohn's Disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622340107&from=exporthttp://dx.doi.org/10.1093/ibd/izy079 VL - 24 ID - 6090 ER - TY - JOUR AD - Z. Yang, Department of Anesthesiology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Embryo Original Disease, Shanghai Municipal Key Clinical Specialty, Huashan Rd. 1961, Shanghai, China AU - Ji, C. AU - Ni, Q. AU - Chen, W. AU - Yang, Z. AU - Ma, D. DB - Embase Medline DO - 10.1016/j.neubiorev.2019.10.003 LA - English M3 - Review N1 - L2003666868 2019-11-07 2019-11-13 PY - 2019 SN - 1873-7528 0149-7634 SP - 883-896 ST - General anesthetic neurotoxicity in the young: Mechanism and prevention T2 - Neuroscience and Biobehavioral Reviews TI - General anesthetic neurotoxicity in the young: Mechanism and prevention UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003666868&from=exporthttp://dx.doi.org/10.1016/j.neubiorev.2019.10.003 VL - 107 ID - 6091 ER - TY - JOUR AD - Department of Medical Oncology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey Department of Panthology, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey AU - Kara, I. O. AU - Gonlusen, G. AU - Sahin, B. AU - Ergin, M. AU - Erdogan, S. DB - Scopus IS - 8 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2005 SP - 1190-1196 ST - A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma T2 - Saudi Medical Journal TI - A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-24744460561&partnerID=40&md5=2b191cfcf3c07c4bd99a3d0775ffcb1d VL - 26 ID - 6092 ER - TY - JOUR AD - Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, China. AN - 28892804 AU - Wang, P. AU - Lun, Y. AU - Fu, Y. AU - Wang, F. AU - Zhao, S. AU - Wang, Y. AU - Hou, X. DO - 10.1159/000477909 10.1159/000477909. Epub 2017 Sep 12. DP - Nlm ET - 2017/09/12 IS - 10 LA - eng PY - 2017 SN - 2296-5270 SP - 586-592 ST - Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation T2 - Oncol Res Treat TI - Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation VL - 40 ID - 6093 ER - TY - JOUR AD - M. Wilhelm, Dept. of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, Biomedicum B7, Stockholm, Sweden AU - Marin Navarro, A. AU - Day, K. AU - Kogner, P. AU - Wilhelm, M. AU - Falk, A. DB - Embase Medline DO - 10.1016/j.scr.2018.11.017 LA - English M3 - Article N1 - L2001420602 2019-01-03 2019-01-11 PY - 2019 SN - 1876-7753 1873-5061 ST - Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation T2 - Stem Cell Research TI - Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001420602&from=exporthttp://dx.doi.org/10.1016/j.scr.2018.11.017 VL - 34 ID - 6094 ER - TY - JOUR AD - Department of Hematology and Oncology, Faculty of Medicine, University of Jordan, Al-Jubeiha, Amman, Jordan Department of Internal Medicine, Hematology and Oncology, King Hussein Cancer Center, Al-Jubeiha, Amman, Jordan Department of Public Health, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan AU - Awidi, A. AU - Abbasi, S. AU - Alrabi, K. AU - Kheirallah, K. A. DB - Scopus DO - 10.1016/j.clml.2017.08.001 IS - 12 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - e55-e61 ST - Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028339039&doi=10.1016%2fj.clml.2017.08.001&partnerID=40&md5=152f2a6285625dcb226651d021724dc0 VL - 17 ID - 6095 ER - TY - JOUR AD - Department of Pathology, Istituto Giannina Gaslini, Genova, Italy. Department of Hematology-Oncology, Istituto Giannina Gaslini, Genova, Italy. U.O.C. Bioterapie IRCSS A.O.U. San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. Neuroblastoma Laboratory, Onco/Hematology Laboratory, SDB Department, University of Padova, Pediatric Research Institute, Fondazione Città della Speranza, Padova, Italy. Department of Pediatrics, University of Padova, Padova, Italy. Department of Pediatric Oncology, National Cancer Institute, Milano, Italy. Department of Pediatric Hematology and Oncology, ARNAS Civico Di Cristina Benfratelli Hospital, Palermo, Italy. Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", University of Bologna Sant'Orsola-Malpighi Hospital, Bologna, Italy. Department of Pediatric Hematology-Oncology, IRCCS, Ospedale Bambino Gesù, Rome, Italy. Department of Epidemiology and Biostatistics, Istituto Giannina Gaslini, Genova, Italy. AN - 25925003 AU - Mazzocco, K. AU - Defferrari, R. AU - Sementa, A. R. AU - Garaventa, A. AU - Longo, L. AU - De Mariano, M. AU - Esposito, M. R. AU - Negri, F. AU - Ircolò, D. AU - Viscardi, E. AU - Luksch, R. AU - D'Angelo, P. AU - Prete, A. AU - Castellano, A. AU - Massirio, P. AU - Erminio, G. AU - Gigliotti, A. R. AU - Tonini, G. P. AU - Conte, M. DA - Oct DO - 10.1002/pbc.25552 10.1002/pbc.25552. Epub 2015 Apr 29. DP - Nlm ET - 2015/05/01 IS - 10 LA - eng PY - 2015 SN - 1545-5009 SP - 1725-32 ST - Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group T2 - Pediatr Blood Cancer TI - Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group VL - 62 ID - 6096 ER - TY - JOUR AD - IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Dr Roberto Frias s/n, 4200-465 Porto, Portugal. AN - 23966419 AU - Boaventura, P. AU - Pereira, D. AU - Celestino, R. AU - Mendes, A. AU - Nakasawa, T. AU - Teixeira-Gomes, J. AU - Sobrinho-Simões, M. AU - Soares, P. DA - Nov DO - 10.1530/eje-13-0543 10.1530/EJE-13-0543. Print 2013 Nov. DP - Nlm ET - 2013/08/24 IS - 5 LA - eng PY - 2013 SN - 0804-4643 SP - 673-9 ST - Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment T2 - Eur J Endocrinol TI - Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment VL - 169 ID - 6097 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Pathak, P. AU - Kumar, A. AU - Jha, P. AU - Purkait, S. AU - Faruq, M. AU - Suri, A. AU - Suri, V. AU - Sharma, M. C. AU - Sarkar, C. DB - Embase Medline DO - 10.1111/bpa.12444 IS - 5 LA - English M3 - Article N1 - L613998421 2017-01-11 2018-08-24 PY - 2017 SN - 1750-3639 1015-6305 SP - 580-589 ST - Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma T2 - Brain Pathology TI - Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613998421&from=exporthttp://dx.doi.org/10.1111/bpa.12444 VL - 27 ID - 6098 ER - TY - JOUR AD - D.W. Clapp, Indiana University, School of Medicine, Cancer Research Institute, 1044 W. Walnut St., Indianapolis, IN 46202, United States AU - Ingram, D. A. AU - Yang, F. C. AU - Travers, J. B. AU - Wenning, M. J. AU - Hiatt, K. AU - New, S. AU - Hood, A. AU - Shannon, K. AU - Williams, D. A. AU - Clapp, D. W. DB - Embase Medline DO - 10.1084/jem.191.1.181 IS - 1 LA - English M3 - Article N1 - L30043659 2000-01-26 PY - 2000 SN - 0022-1007 SP - 181-187 ST - Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo T2 - Journal of Experimental Medicine TI - Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L30043659&from=exporthttp://dx.doi.org/10.1084/jem.191.1.181 VL - 191 ID - 6099 ER - TY - JOUR AD - Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden Department of Clinical Genetics, University and Regional Laboratories, Region Skåne, Lund, Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden Department of Pediatrics, Linköping University Hospital, Linköping, Sweden Department of Pediatrics, Skåne University Hospital, Lund University, Lund, Sweden Division of Hematology, Skåne University Hospital, Lund University, Lund, Sweden AU - Safavi, S. AU - Olsson, L. AU - Biloglav, A. AU - Veerla, S. AU - Blendberg, M. AU - Tayebwa, J. AU - Behrendtz, M. AU - Castor, A. AU - Hansson, M. AU - Johansson, B. AU - Paulsson, K. DB - Scopus DO - 10.18632/oncotarget.6000 IS - 40 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2015 SP - 42793-42802 ST - Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia T2 - Oncotarget TI - Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952319620&doi=10.18632%2foncotarget.6000&partnerID=40&md5=8d0b32584af9916c82b333dd4be5af20 VL - 6 ID - 6100 ER - TY - JOUR AD - Laboratory of Oncologic Research, Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy Department of Pathology, Bellaria Hospital, Bologna, Italy 5th Orthopaedic Division, Rizzoli Orthopaedic Institute, Bologna, Italy AU - Pazzaglia, L. AU - Chiechi, A. AU - Conti, A. AU - Gamberi, G. AU - Magagnoli, G. AU - Novello, C. AU - Morandi, L. AU - Picci, P. AU - Mercuri, M. AU - Benassi, M. S. DB - Scopus IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2009 SP - 61-67 ST - Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes T2 - Histology and Histopathology TI - Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-60549112596&partnerID=40&md5=8cc39a16d0282478a61bb8977a004d7d VL - 24 ID - 6101 ER - TY - JOUR AD - Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Department of Bioresource Research Center, Tokyo Medical and Dental University, Tokyo, Japan. Department of Oral Health Science Center, Tokyo Dental College, Tokyo, Japan. AN - 28658279 AU - Yukimori, A. AU - Oikawa, Y. AU - Morita, K. I. AU - Nguyen, C. T. K. AU - Harada, H. AU - Yamaguchi, S. AU - Kayamori, K. AU - Yamaguchi, A. AU - Ikeda, T. AU - Sakamoto, K. C2 - PMC5489209 DO - 10.1371/journal.pone.0180224 10.1371/journal.pone.0180224. eCollection 2017. DP - Nlm ET - 2017/06/29 IS - 6 LA - eng PY - 2017 SN - 1932-6203 SP - e0180224 ST - Genetic basis of calcifying cystic odontogenic tumors T2 - PLoS One TI - Genetic basis of calcifying cystic odontogenic tumors VL - 12 ID - 6102 ER - TY - JOUR AD - S.L. Cohn, Department of Pediatrics, Comer Children's Hospital, University of Chicago, 57th Street, Chicago, IL, United States AU - Bagatell, R. AU - Cohn, S. L. C1 - mln 8237 DB - Embase Medline DO - 10.1097/MOP.0000000000000296 IS - 1 LA - English M3 - Review N1 - L606982464 2015-11-25 2016-01-21 PY - 2016 SN - 1531-698X 1040-8703 SP - 19-25 ST - Genetic discoveries and treatment advances in neuroblastoma T2 - Current Opinion in Pediatrics TI - Genetic discoveries and treatment advances in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606982464&from=exporthttp://dx.doi.org/10.1097/MOP.0000000000000296 VL - 28 ID - 6103 ER - TY - JOUR AD - St Paul's Eye Unit, Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK. Pathology Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Department of Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, California, USA. AN - 27098748 AU - Krishna, Y. AU - Kalirai, H. AU - Thornton, S. AU - Damato, B. E. AU - Heimann, H. AU - Coupland, S. E. DA - Jul DO - 10.1136/bjophthalmol-2015-308301 10.1136/bjophthalmol-2015-308301. Epub 2016 Apr 20. DP - Nlm ET - 2016/04/22 IS - 7 LA - eng PY - 2016 SN - 0007-1161 SP - 1012-1016 ST - Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas T2 - Br J Ophthalmol TI - Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas VL - 100 ID - 6104 ER - TY - JOUR AD - P. Jain, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Jain, P. AU - Surrey, L. F. AU - Zhang, B. AU - Straka, J. AU - Zhao, X. AU - Storm, P. B. AU - Resnick, A. C. AU - Harding, B. N. AU - Li, M. M. AU - Buccoliero, A. M. AU - Santi, M. AU - Waanders, A. J. DB - Embase DO - 10.1093/neuonc/noz036.157 LA - English M3 - Conference Abstract N1 - L628911026 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA102 ST - The genetic landscape of dysembryoplastic neuroepithelial tumors T2 - Neuro-Oncology TI - The genetic landscape of dysembryoplastic neuroepithelial tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628911026&from=exporthttp://dx.doi.org/10.1093/neuonc/noz036.157 VL - 21 ID - 6105 ER - TY - JOUR AD - D.A. Solomon, Department of Pathology, University of California, San Francisco, CA, United States AU - López, G. Y. AU - Van Ziffle, J. AU - Onodera, C. AU - Grenert, J. P. AU - Yeh, I. AU - Bastian, B. C. AU - Clarke, J. AU - Oberheim Bush, N. A. AU - Taylor, J. AU - Chang, S. AU - Butowski, N. AU - Banerjee, A. AU - Mueller, S. AU - Kline, C. AU - Torkildson, J. AU - Samuel, D. AU - Siongco, A. AU - Raffel, C. AU - Gupta, N. AU - Kunwar, S. AU - Mummaneni, P. AU - Aghi, M. AU - Theodosopoulos, P. AU - Berger, M. AU - Phillips, J. J. AU - Pekmezci, M. AU - Tihan, T. AU - Bollen, A. W. AU - Perry, A. AU - Solomon, D. A. DB - Embase Medline DO - 10.1007/s00401-018-1906-z IS - 1 LA - English M3 - Article N1 - L623846105 2018-09-17 2019-01-31 PY - 2019 SN - 1432-0533 0001-6322 SP - 139-150 ST - The genetic landscape of gliomas arising after therapeutic radiation T2 - Acta Neuropathologica TI - The genetic landscape of gliomas arising after therapeutic radiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623846105&from=exporthttp://dx.doi.org/10.1007/s00401-018-1906-z VL - 137 ID - 6106 ER - TY - JOUR AD - K.G. Roberts AU - Roberts, K. G. AU - Bridges, O. AU - Janke, L. J. AU - Ebata, K. AU - Tuch, B. B. AU - Nanda, N. AU - Mullighan, C. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614224996 2017-02-01 PY - 2016 SN - 1528-0020 ST - Genetic modeling and therapeutic targeting of ETV6-NTRK3 with Loxo-101in acute lymphoblastic leukemia T2 - Blood TI - Genetic modeling and therapeutic targeting of ETV6-NTRK3 with Loxo-101in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614224996&from=export VL - 128 ID - 6107 ER - TY - JOUR AD - T.M. Martin, Ophthalmology, Oregon Health and Science University, Portland, OR, United States AU - Martin, T. M. AU - Ogle, K. AU - Stiefel, H. AU - Neff, T. AU - Albert, D. M. AU - Lee, M. J. AU - Planck, S. R. AU - Corless, C. AU - Rosenbaum, J. T. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L629938985 2019-11-29 PY - 2019 SN - 1552-5783 ST - Genetic mutations in archival ocular biopsies from histiocytic orbital disease lesions T2 - Investigative Ophthalmology and Visual Science TI - Genetic mutations in archival ocular biopsies from histiocytic orbital disease lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629938985&from=export VL - 60 ID - 6108 ER - TY - JOUR AD - C.J. Thiele, National Cancer Institute, CRC, 1W-3940, MSC-1105, 10 Center Drive, Bethesda, MD 20892, United States AU - Thiele, C. J. AU - Cohn, S. L. C1 - gleevac(Novartis) C2 - Novartis DB - Embase Medline DO - 10.1158/1078-0432.CCR-11-1940 IS - 10 LA - English M3 - Review N1 - L364826423 2012-05-24 2012-05-30 PY - 2012 SN - 1078-0432 1557-3265 SP - 2735-2739 ST - Genetically informed therapies-a "gift" for children with cancer T2 - Clinical Cancer Research TI - Genetically informed therapies-a "gift" for children with cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364826423&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-11-1940http://clincancerres.aacrjournals.org/content/18/10/2735.full.pdf+html VL - 18 ID - 6109 ER - TY - JOUR AD - T. Atik, Department of Pediatric Genetics, Ege University, School of Medicine, Izmir, Turkey AU - Atik, T. AU - Işik, E. DB - Embase IS - 2 LA - English M3 - Conference Abstract N1 - L631449685 2020-04-20 PY - 2020 SN - 2147-2092 SP - P21-P22 ST - Genetics of cutaneous vascular malformations and genetic counseling T2 - Gazi Medical Journal TI - Genetics of cutaneous vascular malformations and genetic counseling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631449685&from=export VL - 31 ID - 6110 ER - TY - JOUR AD - Service de Pédiatrie, Ctr. Hosp. Universitaire de Nice, Nice, France Laboratoire de Genetique, Ctr. Hosp. Universitaire de Nice, Nice, France Laboratoire de Genetique, Hôpital de l'Archet, BP 3079, 06202 Nice Cedex 3, France AU - Sirvent, N. AU - Maire, G. AU - Pedeutour, F. DB - Scopus DO - 10.1002/gcc.10202 IS - 1 M3 - Review N1 - Cited By :191 Export Date: 18 November 2020 PY - 2003 SP - 1-19 ST - Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment T2 - Genes Chromosomes and Cancer TI - Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037402488&doi=10.1002%2fgcc.10202&partnerID=40&md5=e77550a132c5a9f75a10d7451fe36b36 VL - 37 ID - 6111 ER - TY - JOUR AD - Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA. Electronic address: patild@ccf.org. Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA; Department of Molecular Genetics, Cleveland Clinic and Lerner Research Institute, 9500 Euclid Avenue, L-25, Cleveland, OH 44195, USA. AN - 26297068 AU - Patil, D. T. AU - Rubin, B. P. DA - Sep DO - 10.1016/j.path.2015.05.006 10.1016/j.path.2015.05.006. Epub 2015 Jul 7. DP - Nlm ET - 2015/08/25 IS - 3 LA - eng PY - 2015 SN - 1875-9157 SP - 515-24 ST - Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? T2 - Surg Pathol Clin TI - Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? VL - 8 ID - 6112 ER - TY - JOUR AD - G. I. Liou, Department of Ophthalmology, Medical College of Georgia, 1120 15th Street, Augusta, GA, 30912, United States AU - Ibrahim, A. S. AU - El-Shishtawy, M. M. AU - Peña Jr, A. AU - Liou, G. I. DB - Embase Medline L1 - internal-pdf://1057467587/mv-v16-a219-ibrahim.pdf LA - English M3 - Article N1 - L359944870 2010-11-22 2010-11-24 PY - 2010 SN - 1090-0535 SP - 2033-2042 ST - Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation T2 - Molecular Vision TI - Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359944870&from=export VL - 16 ID - 6113 ER - TY - JOUR AD - J.A. Dyer, Department of Dermatology, University of Missouri School of Medicine, Columbia, MO, United States AU - Ladd, R. AU - Davis, M. AU - Dyer, J. A. DB - Embase Medline DO - 10.1016/j.clindermatol.2020.03.007 IS - 4 LA - English M3 - Article N1 - L2006141072 2020-06-15 2020-09-30 PY - 2020 SN - 1879-1131 0738-081X SP - 432-454 ST - Genodermatoses with malignant potential T2 - Clinics in Dermatology TI - Genodermatoses with malignant potential UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006141072&from=exporthttp://dx.doi.org/10.1016/j.clindermatol.2020.03.007 VL - 38 ID - 6114 ER - TY - JOUR AD - Molecular Biology Division, Defence Institute of Physiology and Allied Sciences (DIPAS), DRDO, Delhi, India AU - Sharma, M. AU - Singh, S. B. AU - Sarkar, S. C7 - e85902 DB - Scopus DO - 10.1371/journal.pone.0085902 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2014 ST - Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema T2 - PLoS ONE TI - Genome wide expression analysis suggests perturbation of vascular homeostasis during high altitude pulmonary edema UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899851626&doi=10.1371%2fjournal.pone.0085902&partnerID=40&md5=7ece09dcf93a9c99a42077e54bbe7cfe VL - 9 ID - 6115 ER - TY - JOUR AD - I. Müller, Institute of Pathology, University Hospital Tübingen, Eberhard-Karls- University of Tübingen, Tübingen, Germany AU - Müller, I. AU - Ramis-Zaldívar, J. AU - Schmidt, J. AU - Egan, C. AU - Gonzalez-Farre, B. AU - Salmeron-Villalobos, J. AU - Mattern, S. AU - Szablewski, V. AU - Dojcinov, S. AU - Chott, A. AU - Copie-Bergman, C. AU - Bonzheim, I. AU - Campo, E. AU - Fend, F. AU - Jaffe, E. S. AU - Salaverria, I. AU - Quintanilla De Fend, L. DB - Embase DO - 10.1002/hon.102_2629 LA - English M3 - Conference Abstract N1 - L628867684 2019-08-14 PY - 2019 SN - 1099-1069 SP - 144-145 ST - Genome wide-analysis of t(14;18)-negative follicular lymphoma T2 - Hematological Oncology TI - Genome wide-analysis of t(14;18)-negative follicular lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628867684&from=exporthttp://dx.doi.org/10.1002/hon.102_2629 VL - 37 ID - 6116 ER - TY - JOUR AD - R. D. Gascoyne, Department of Pathology and Advanced Therapeutics, British Columbia Cancer Agency, BC Cancer Research Centre, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada AU - Steidl, C. AU - Telenius, A. AU - Shah, S. P. AU - Farinha, P. AU - Barclay, L. AU - Boyle, M. AU - Connors, J. M. AU - Horsman, D. E. AU - Gascoyne, R. D. DB - Embase Medline DO - 10.1182/blood-2009-12-257345 IS - 3 LA - English M3 - Article N1 - L359514020 2010-09-21 2010-09-27 PY - 2010 SN - 0006-4971 1528-0020 SP - 418-427 ST - Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome T2 - Blood TI - Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359514020&from=exporthttp://dx.doi.org/10.1182/blood-2009-12-257345http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/418 VL - 116 ID - 6117 ER - TY - JOUR AD - J. Tan, Center for Medical Genetics and School of Life Science, Central South University, Changsha, China AU - Cai, M. AU - Li, S. AU - Shuai, Y. AU - Li, J. AU - Tan, J. AU - Zeng, Q. DB - Embase Medline DO - 10.1002/jcp.27595 IS - 6 LA - English M3 - Article N1 - L624408565 2018-10-23 2019-05-14 PY - 2019 SN - 1097-4652 0021-9541 SP - 9184-9193 ST - Genome-wide CRISPR-Cas9 viability screen reveals genes involved in TNF-α-induced apoptosis of human umbilical vein endothelial cells T2 - Journal of Cellular Physiology TI - Genome-wide CRISPR-Cas9 viability screen reveals genes involved in TNF-α-induced apoptosis of human umbilical vein endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624408565&from=exporthttp://dx.doi.org/10.1002/jcp.27595 VL - 234 ID - 6118 ER - TY - JOUR AD - Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. marco.gessi@ukb.uni-bonn.de AN - 23965740 AU - Gessi, M. AU - Zur Mühlen, A. AU - Hammes, J. AU - Waha, A. AU - Denkhaus, D. AU - Pietsch, T. DA - Sep DO - 10.1097/NEN.0b013e3182a033a0 10.1097/NEN.0b013e3182a033a0. DP - Nlm ET - 2013/08/24 IS - 9 LA - eng PY - 2013 SN - 0022-3069 SP - 807-15 ST - Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas T2 - J Neuropathol Exp Neurol TI - Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas VL - 72 ID - 6119 ER - TY - JOUR AD - T. Asano, Department of Pediatrics, Nippon Medical School, Tokyo, Japan AU - Asano, T. AU - Narazaki, H. AU - Fujita, A. DB - Embase DO - 10.1002/prp2.285 IS - 1 LA - English M3 - Article N1 - L614248858 2017-02-09 2017-02-14 PY - 2017 SN - 2052-1707 ST - Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance T2 - Pharmacology Research and Perspectives TI - Genome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614248858&from=exporthttp://dx.doi.org/10.1002/prp2.285 VL - 5 ID - 6120 ER - TY - JOUR AD - F. Ponthan, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom AU - Ponthan, F. AU - Bomken, S. AU - Pal, D. AU - Elder, A. AU - McNeill, H. AU - Vormoor, J. AU - Heidenreich, O. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71760051 2015-02-03 PY - 2014 SN - 0006-4971 ST - A genome-wide RNAi screen to identify novel genes involved in clonal maintenance of all T2 - Blood TI - A genome-wide RNAi screen to identify novel genes involved in clonal maintenance of all UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71760051&from=exporthttp://www.bloodjournal.org/content/124/21/2390 VL - 124 ID - 6121 ER - TY - JOUR AD - K. Wang, Foundation Medicine,Inc., Cambridge, MA, United States AU - Wang, K. AU - Morosini, D. AU - Yelensky, R. AU - Palma, N. AU - Johnson, A. AU - Lipson, D. AU - Chmielecki, J. AU - Ali, S. AU - Ross, J. S. AU - Stephens, P. J. AU - Miller, V. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71759353 2015-02-03 PY - 2014 SN - 0006-4971 ST - Genomic alterations of histone modification genes are significantly less common in non-hodgkin lymphomas of adolescents and young adults compared to older patients T2 - Blood TI - Genomic alterations of histone modification genes are significantly less common in non-hodgkin lymphomas of adolescents and young adults compared to older patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71759353&from=exporthttp://www.bloodjournal.org/content/124/21/1684 VL - 124 ID - 6122 ER - TY - JOUR AD - D.J. Adams, Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom AU - Rabbie, R. AU - Rashid, M. AU - Arance, A. M. AU - Sánchez, M. AU - Tell-Marti, G. AU - Potrony, M. AU - Conill, C. AU - van Doorn, R. AU - Dentro, S. AU - Gruis, N. A. AU - Corrie, P. AU - Iyer, V. AU - Robles-Espinoza, C. D. AU - Puig-Butille, J. A. AU - Puig, S. AU - Adams, D. J. DB - Embase Medline DO - 10.1111/pcmr.12574 IS - 3 LA - English M3 - Article N1 - L615618077 2017-04-27 2017-05-11 PY - 2017 SN - 1755-148X 1755-1471 SP - 307-316 ST - Genomic analysis and clinical management of adolescent cutaneous melanoma T2 - Pigment Cell and Melanoma Research TI - Genomic analysis and clinical management of adolescent cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615618077&from=exporthttp://dx.doi.org/10.1111/pcmr.12574 VL - 30 ID - 6123 ER - TY - JOUR AD - Department of Pathology, St Jude Childrens Research Hospital, Memphis, TN, United States St Jude Children's Research Hospital, Pathology, Mail Stop 342, 262 Danny Thomas Place, Memphis, TN 38105, United States AU - Mullighan, C. G. DB - Scopus DO - 10.1111/j.1751-553X.2009.01167.x IS - 4 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2009 SP - 384-397 ST - Genomic analysis of acute leukemia T2 - International Journal of Laboratory Hematology TI - Genomic analysis of acute leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651108658&doi=10.1111%2fj.1751-553X.2009.01167.x&partnerID=40&md5=cc696b74607a21224d29b3b86bb0f080 VL - 31 ID - 6124 ER - TY - JOUR AD - J. Picarsic, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States AU - Picarsic, J. AU - Alaggio, R. AU - Jaffe, R. AU - Diamond, E. L. AU - Durham, B. H. AU - Abdel-Wahab, O. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283420 2018-12-05 PY - 2019 SN - 1545-5017 ST - Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns T2 - Pediatric Blood and Cancer TI - Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283420&from=exporthttp://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 6125 ER - TY - JOUR AD - Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, United States Department of Pathology, Ohio State University, Columbus, OH, United States Department of Pathology, University of New Mexico Cancer Center, Albuquerque, NM, United States Department of Biostatistics, University of Florida, Gainesville, FL, United States Department of Cytogenetics, United States Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, United States Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pediatrics, NYU Langone Health, New York, NY, United States Department of Pathology, Johns Hopkins University, Baltimore, MD, United States Department of Pathology, Seattle Children’s Hospital, Seattle, WA, United States HARP Pharma Consulting, Mystic, CT, United States Department of Pediatrics, University of Colorado School of Medicine, Children’s Hospital, Aurora, CO, United States Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States Department of Pediatrics, UCSF Benioff Children’s Hospital, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States St. Jude Children’s Research Hospital, Memphis, TN 38105, United States Children’s Hospital of Philadelphia, CTRB 3060, 3501 Civic Center Blvd, Philadelphia, PA 19104, United States AU - Roberts, K. G. AU - Reshmi, S. C. AU - Harvey, R. C. AU - Chen, I. M. AU - Patel, K. AU - Stonerock, E. AU - Jenkins, H. AU - Dai, Y. AU - Valentine, M. AU - Gu, Z. AU - Zhao, Y. AU - Zhang, J. AU - Payne-Turner, D. AU - Devidas, M. AU - Heerema, N. A. AU - Carroll, A. J. AU - Raetz, E. A. AU - Borowitz, M. J. AU - Wood, B. L. AU - Mattano, L. A. AU - Maloney, K. W. AU - Carroll, W. L. AU - Loh, M. L. AU - Willman, C. L. AU - Gastier-Foster, J. M. AU - Mullighan, C. G. AU - Hunger, S. P. DB - Scopus DO - 10.1182/blood-2018-04-841676 IS - 8 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2018 SP - 815-824 ST - Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group T2 - Blood TI - Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052111502&doi=10.1182%2fblood-2018-04-841676&partnerID=40&md5=32e290f1b2ebace043a1a71ec77e5621 VL - 132 ID - 6126 ER - TY - JOUR AD - Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany Division of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Carl Gustav Carus, Dresden, Germany Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany AU - Krumbholz, M. AU - Karl, M. AU - Tauer, J. T. AU - Thiede, C. AU - Rascher, W. AU - Suttorp, M. AU - Metzler, M. DB - Scopus DO - 10.1002/gcc.21989 IS - 11 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 1045-1053 ST - Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia T2 - Genes Chromosomes and Cancer TI - Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865980394&doi=10.1002%2fgcc.21989&partnerID=40&md5=c6fdea54407bd84aff0abfa59a235064 VL - 51 ID - 6127 ER - TY - JOUR AD - Department of Molecular Neuroscience, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, London, UK. n.potter@ion.ucl.ac.uk AN - 18670637 AU - Potter, N. AU - Karakoula, A. AU - Phipps, K. P. AU - Harkness, W. AU - Hayward, R. AU - Thompson, D. N. AU - Jacques, T. S. AU - Harding, B. AU - Thomas, D. G. AU - Palmer, R. W. AU - Rees, J. AU - Darling, J. AU - Warr, T. J. C2 - PMC2481566 DA - Aug DO - 10.1593/neo.07914 10.1593/neo.07914. DP - Nlm ET - 2008/08/02 IS - 8 LA - eng PY - 2008 SN - 1522-8002 (Print) 1476-5586 SP - 757-72 ST - Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma T2 - Neoplasia TI - Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma VL - 10 ID - 6128 ER - TY - JOUR AD - J. Tao, National University of Singapore, Singapore, Singapore AU - Tao, J. AU - Ramnarayanan, K. AU - Huang, B. AU - Tan, I. B. AU - Ooi, C. H. AU - Lee, M. AU - Zhang, S. AU - Leong, S. H. AU - Ivanova, T. AU - Ganesan, K. AU - Gopalakrishnan, V. AU - Rha, S. Y. AU - Chung, H. C. AU - Yap, C. AU - Palanisamy, N. AU - Tan, P. DB - Embase DO - 10.1158/1078-0432.TCMUSA10-PR1 IS - 14 LA - English M3 - Conference Abstract N1 - L70788188 2012-06-25 PY - 2010 SN - 1078-0432 ST - Genomic discovery of CD44-SLC1A2 gene fusions in gastric cancer T2 - Clinical Cancer Research TI - Genomic discovery of CD44-SLC1A2 gene fusions in gastric cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70788188&from=exporthttp://dx.doi.org/10.1158/1078-0432.TCMUSA10-PR1http://clincancerres.aacrjournals.org/cgi/content/meeting_abstract/16/14_MeetingAbstracts/PR1?sid=4ec36e38-e4de-48bd-bd64-ac3c9087fcb1 VL - 16 ID - 6129 ER - TY - JOUR AD - The Genome Institute, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, USA. The Genome Institute, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Genetics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Siteman Cancer Center, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Cytogenetics, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Genetics, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Department of Medicine, Washington University School of Medicine in St Louis, St Louis, Missouri, USA; Siteman Cancer Center, Washington University School of Medicine in St Louis, St Louis, Missouri, USA. Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: alberto.pappo@stjude.org. Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: armita.bahrami@stjude.org. AN - 25268584 AU - Lu, C. AU - Zhang, J. AU - Nagahawatte, P. AU - Easton, J. AU - Lee, S. AU - Liu, Z. AU - Ding, L. AU - Wyczalkowski, M. A. AU - Valentine, M. AU - Navid, F. AU - Mulder, H. AU - Tatevossian, R. G. AU - Dalton, J. AU - Davenport, J. AU - Yin, Z. AU - Edmonson, M. AU - Rusch, M. AU - Wu, G. AU - Li, Y. AU - Parker, M. AU - Hedlund, E. AU - Shurtleff, S. AU - Raimondi, S. AU - Bhavin, V. AU - Donald, Y. AU - Mardis, E. R. AU - Wilson, R. K. AU - Evans, W. E. AU - Ellison, D. W. AU - Pounds, S. AU - Dyer, M. AU - Downing, J. R. AU - Pappo, A. AU - Bahrami, A. C2 - PMC4340976 DA - Mar DO - 10.1038/jid.2014.425 10.1038/jid.2014.425. Epub 2014 Sep 30. DP - Nlm ET - 2014/10/01 IS - 3 LA - eng PY - 2015 SN - 0022-202X (Print) 0022-202x SP - 816-823 ST - The genomic landscape of childhood and adolescent melanoma T2 - J Invest Dermatol TI - The genomic landscape of childhood and adolescent melanoma VL - 135 ID - 6130 ER - TY - JOUR AD - J. Trka, CLIP - Childhood Leukaemia Investigation Prague, Czech Republic AU - Zaliova, M. AU - Stuchly, J. AU - Winkowska, L. AU - Musilova, A. AU - Fiser, K. AU - Slamova, M. AU - Starkova, J. AU - Vaskova, M. AU - Hrusak, O. AU - Sramkova, L. AU - Stary, J. AU - Zuna, J. AU - Trka, J. DB - Embase Medline DO - 10.3324/haematol.2018.204974 IS - 7 LA - English M3 - Article N1 - L2002200155 2019-08-22 2019-08-29 PY - 2019 SN - 1592-8721 0390-6078 SP - 1396-1406 ST - Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort T2 - Haematologica TI - Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002200155&from=exporthttp://dx.doi.org/10.3324/haematol.2018.204974 VL - 104 ID - 6131 ER - TY - JOUR AD - S. D. Turner, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Lab Block, Box 231, Cambridge CB20QQ, United Kingdom AU - Youssif, C. AU - Goldenbogen, J. AU - Hamoudi, R. AU - Carreras, J. AU - Viskaduraki, M. AU - Cui, Y. X. AU - Bacon, C. M. AU - Burke, G. A. A. AU - Turner, S. D. DB - Embase Medline DO - 10.1002/gcc.20701 IS - 11 LA - English M3 - Article N1 - L355315883 2009-10-20 PY - 2009 SN - 1045-2257 1098-2264 SP - 1018-1026 ST - Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: A children's cancer and leukaemia group study T2 - Genes Chromosomes and Cancer TI - Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: A children's cancer and leukaemia group study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355315883&from=exporthttp://dx.doi.org/10.1002/gcc.20701http://www3.interscience.wiley.com/cgi-bin/fulltext/122558999/PDFSTART VL - 48 ID - 6132 ER - TY - JOUR AD - M.J. Overman, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States AU - Schrock, A. B. AU - Devoe, C. E. AU - McWilliams, R. AU - Sun, J. AU - Aparicio, T. AU - Stephens, P. J. AU - Ross, J. S. AU - Wilson, R. AU - Miller, V. A. AU - Ali, S. M. AU - Overman, M. J. DB - Embase Medline DO - 10.1001/jamaoncol.2017.1051 IS - 11 LA - English M3 - Conference Paper N1 - L621081780 2018-03-13 2019-09-24 PY - 2017 SN - 2374-2445 2374-2437 SP - 1546-1553 ST - Genomic profiling of small-bowel adenocarcinoma T2 - JAMA Oncology TI - Genomic profiling of small-bowel adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621081780&from=exporthttp://dx.doi.org/10.1001/jamaoncol.2017.1051 VL - 3 ID - 6133 ER - TY - JOUR AD - E. Campo, Laboratory of Pathology, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain AU - Salaverria, I. AU - Beà, S. AU - Lopez-Guillermo, A. AU - Lespinet, V. AU - Pinyol, M. AU - Burkhardt, B. AU - Lamant, L. AU - Zettl, A. AU - Horsman, D. AU - Gascoyne, R. AU - Ott, G. AU - Siebert, R. AU - Delsol, G. AU - Campo, E. DB - Embase Medline DO - 10.1111/j.1365-2141.2007.06924.x IS - 5 LA - English M3 - Article N1 - L351230071 2008-02-27 PY - 2008 SN - 0007-1048 1365-2141 SP - 516-526 ST - Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas T2 - British Journal of Haematology TI - Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351230071&from=exporthttp://dx.doi.org/10.1111/j.1365-2141.2007.06924.x VL - 140 ID - 6134 ER - TY - JOUR AD - Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan. College of Health Professions, Ferris State University, Big Rapids, Michigan. Spectrum Health System, Helen DeVos Children's Hospital, Grand Rapids, Michigan. Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan. Genomics Core, Van Andel Research Institute, Grand Rapids, Michigan. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. Department of Pathology, Duke University Medical Center, Durham, North Carolina. Department Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina. Aix-Marseille Univ, CNRS, IBDM, Marseille, France. Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan. Matt.Steensma@vai.org. Michigan State University College of Human Medicine, Grand Rapids, Michigan. AN - 29720369 AU - Peacock, J. D. AU - Pridgeon, M. G. AU - Tovar, E. A. AU - Essenburg, C. J. AU - Bowman, M. AU - Madaj, Z. AU - Koeman, J. AU - Boguslawski, E. A. AU - Grit, J. AU - Dodd, R. D. AU - Khachaturov, V. AU - Cardona, D. M. AU - Chen, M. AU - Kirsch, D. G. AU - Maina, F. AU - Dono, R. AU - Winn, M. E. AU - Graveel, C. R. AU - Steensma, M. R. C2 - PMC6235171 C6 - NIHMS995301 DA - Jul 1 DO - 10.1158/0008-5472.Can-17-3167 10.1158/0008-5472.CAN-17-3167. Epub 2018 May 2. DP - Nlm ET - 2018/05/04 IS - 13 LA - eng PY - 2018 SN - 0008-5472 (Print) 0008-5472 SP - 3672-3687 ST - Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors T2 - Cancer Res TI - Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors VL - 78 ID - 6135 ER - TY - JOUR AD - H. Kadara, Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon AU - Rahal, Z. AU - Abdulhai, F. AU - Kadara, H. AU - Saab, R. C1 - herceptin DB - Embase IS - 8 LA - English M3 - Review N1 - L623730829 2018-09-06 2018-09-10 PY - 2018 SN - 2156-6976 SP - 1356-1386 ST - Genomics of adult and pediatric solid tumors T2 - American Journal of Cancer Research TI - Genomics of adult and pediatric solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623730829&from=export VL - 8 ID - 6136 ER - TY - JOUR AD - Division of Pediatric Dermatology, Department of Dermatology, Stanford University School of Medicine, Stanford, California. Section of Dermatology, Division of Ambulatory and Adolescent Medicine, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Department of Genetics, Yale School of Medicine, New Haven, Connecticut. AN - 30566190 AU - Lekwuttikarn, R. AU - Lim, Y. H. AU - Admani, S. AU - Choate, K. A. AU - Teng, J. M. C. C2 - PMC7186908 C6 - NIHMS1558774 DA - Feb 1 DO - 10.1001/jamadermatol.2018.4653 10.1001/jamadermatol.2018.4653. DP - Nlm ET - 2018/12/20 IS - 2 LA - eng PY - 2019 SN - 2168-6068 (Print) 2168-6068 SP - 256-257 ST - Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child T2 - JAMA Dermatol TI - Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child VL - 155 ID - 6137 ER - TY - JOUR AD - K. Page, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, ML7006, 3333 Burnet Ave., Cincinnati, OH 45229, United States AU - Page, K. AU - Hughes, V. S. AU - Bennett, G. W. AU - Wong, H. R. DB - Embase Medline DO - 10.1111/j.1398-9995.2006.01103.x IS - 8 LA - English M3 - Article N1 - L44024898 2006-07-19 PY - 2006 SN - 0105-4538 1398-9995 SP - 988-995 ST - German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells T2 - Allergy: European Journal of Allergy and Clinical Immunology TI - German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44024898&from=exporthttp://dx.doi.org/10.1111/j.1398-9995.2006.01103.x VL - 61 ID - 6138 ER - TY - JOUR AD - IRCCS-CSS, San Giovanni Rotondo and CSS-Mendel Institute, 00198 Rome, Italy. AN - 19142971 AU - Bottillo, I. AU - Ahlquist, T. AU - Brekke, H. AU - Danielsen, S. A. AU - van den Berg, E. AU - Mertens, F. AU - Lothe, R. A. AU - Dallapiccola, B. DA - Apr DO - 10.1002/path.2494 10.1002/path.2494. DP - Nlm ET - 2009/01/15 IS - 5 LA - eng PY - 2009 SN - 0022-3417 SP - 693-701 ST - Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours T2 - J Pathol TI - Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours VL - 217 ID - 6139 ER - TY - JOUR AD - Howard Hughes Medical Institute Molecular Medicine Program, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, United States Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue NE-50, Cleveland, OH 44195, United States Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, United States Center for Autism, Pediatric Institute, Cleveland Clinic, Cleveland, OH 44195, United States Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, United States Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic, Cleveland, OH 44195, United States Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, United States AU - Tilot, A. K. AU - Gaugler, M. K. AU - Yu, Q. AU - Romigh, T. AU - Yu, W. AU - Miller, R. H. AU - Frazier Ii, T. W. AU - Eng, C. DB - Scopus DO - 10.1093/hmg/ddu031 IS - 12 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2014 SP - 3212-3227 ST - Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production T2 - Human Molecular Genetics TI - Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901362837&doi=10.1093%2fhmg%2fddu031&partnerID=40&md5=747cc436aebc9abf9e4393bfa93153d7 VL - 23 ID - 6140 ER - TY - JOUR AD - Greenwood Genetic Center, Greenwood, SC 29646, USA. AN - 20735442 AU - Champion, K. J. AU - Bunag, C. AU - Estep, A. L. AU - Jones, J. R. AU - Bolt, C. H. AU - Rogers, R. C. AU - Rauen, K. A. AU - Everman, D. B. DA - May DO - 10.1111/j.1399-0004.2010.01495.x 10.1111/j.1399-0004.2010.01495.x. DP - Nlm ET - 2010/08/26 IS - 5 LA - eng PY - 2011 SN - 0009-9163 SP - 468-74 ST - Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome T2 - Clin Genet TI - Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome VL - 79 ID - 6141 ER - TY - JOUR AD - Comprehensive Cancer Center and Cancer Research Institute, University of California, San Francisco, CA 94115, USA. AN - 16439621 AU - Rodriguez-Viciana, P. AU - Tetsu, O. AU - Tidyman, W. E. AU - Estep, A. L. AU - Conger, B. A. AU - Cruz, M. S. AU - McCormick, F. AU - Rauen, K. A. DA - Mar 3 DO - 10.1126/science.1124642 10.1126/science.1124642. Epub 2006 Jan 26. DP - Nlm ET - 2006/01/28 IS - 5765 LA - eng PY - 2006 SN - 0036-8075 SP - 1287-90 ST - Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome T2 - Science TI - Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome VL - 311 ID - 6142 ER - TY - JOUR AD - O. Tetsu, UCSF, 2340 Sutter Street N111, San Francisco, CA 94143-0128, United States AU - Senawong, T. AU - Phuchareon, J. AU - Ohara, O. AU - McCormick, F. AU - Rauen, K. A. AU - Tetsu, O. C1 - sb 590885(Calbiochem,United States) u 0126(Promega,United States) C2 - Calbiochem(United States) Promega(United States) DB - Embase Medline DO - 10.1093/hmg/ddm319 IS - 3 LA - English M3 - Article N1 - L351135956 2008-02-05 PY - 2008 SN - 0964-6906 1460-2083 SP - 419-430 ST - Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: Implications for therapeutic options T2 - Human Molecular Genetics TI - Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: Implications for therapeutic options UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351135956&from=exporthttp://dx.doi.org/10.1093/hmg/ddm319 VL - 17 ID - 6143 ER - TY - JOUR AD - Department of Dermatology, Eberhard Karls University, Tübingen, Germany. AN - 19493000 AU - Bauer, J. AU - Weng, J. AU - Kebebew, E. AU - Soares, P. AU - Trovisco, V. AU - Bastian, B. C. C2 - PMC2862686 C6 - NIHMS178610 DA - Jun DO - 10.1111/j.1600-0625.2008.00827.x 10.1111/j.1600-0625.2008.00827.x. DP - Nlm ET - 2009/06/06 IS - 6 LA - eng PY - 2009 SN - 0906-6705 (Print) 0906-6705 SP - 548-52 ST - Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer T2 - Exp Dermatol TI - Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer VL - 18 ID - 6144 ER - TY - JOUR AD - G. Tchernev, Department of Dermatology, Venereology and Dermatologic Surgery, Medical Institute of Ministry of Interior (MVR), General Skobelev 79, Sofia, Bulgaria AU - Tchernev, G. AU - Lozev, I. AU - Pidakev, I. AU - Lotti, T. AU - Wollina, U. AU - Gianfaldoni, S. AU - Lotti, J. AU - França, K. AU - Batashki, A. AU - Maximov, G. K. AU - Chokoeva, A. DB - Embase DO - 10.3889/oamjms.2017.121 IS - 4 Special Issue GlobalDermatology LA - English M3 - Article N1 - L617801813 2017-08-22 2017-08-25 PY - 2017 SN - 1857-9655 SP - 549-550 ST - Giant congenital melanocytic nevus (GCMN) - A new hope for targeted therapy? T2 - Open Access Macedonian Journal of Medical Sciences TI - Giant congenital melanocytic nevus (GCMN) - A new hope for targeted therapy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617801813&from=exporthttp://dx.doi.org/10.3889/oamjms.2017.121 VL - 5 ID - 6145 ER - TY - JOUR AD - X. Fang, Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China AU - Jie, Z. AU - Xie, Z. AU - Zhao, X. AU - Sun, X. AU - Yu, H. AU - Pan, X. AU - Shen, S. AU - Qin, A. AU - Fang, X. AU - Fan, S. DB - Embase Medline DO - 10.1002/jcp.27171 IS - 4 LA - English M3 - Article N1 - L623674344 2018-09-04 2019-01-11 PY - 2019 SN - 1097-4652 0021-9541 SP - 4167-4178 ST - Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB–AP1 complexes formation T2 - Journal of Cellular Physiology TI - Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB–AP1 complexes formation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623674344&from=exporthttp://dx.doi.org/10.1002/jcp.27171 VL - 234 ID - 6146 ER - TY - JOUR AD - Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan. AN - 20615395 AU - Lu, D. Y. AU - Leung, Y. M. AU - Cheung, C. W. AU - Chen, Y. R. AU - Wong, K. L. DA - Oct 15 DO - 10.1016/j.bcp.2010.06.046 10.1016/j.bcp.2010.06.046. Epub 2010 Jul 6. DP - Nlm ET - 2010/07/10 IS - 8 LA - eng PY - 2010 SN - 0006-2952 SP - 1201-9 ST - Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells T2 - Biochem Pharmacol TI - Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells VL - 80 ID - 6147 ER - TY - JOUR AD - Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon, Republic of Korea. Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon, Republic of Korea. Electronic address: iohan@inha.ac.kr. AN - 27609291 AU - Hwang, J. S. AU - Jung, E. H. AU - Kwon, M. Y. AU - Han, I. O. DA - Sep 15 DO - 10.1016/j.jneuroim.2016.08.001 10.1016/j.jneuroim.2016.08.001. Epub 2016 Aug 2. DP - Nlm ET - 2016/09/10 LA - eng PY - 2016 SN - 0165-5728 SP - 165-71 ST - Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α T2 - J Neuroimmunol TI - Glioma-secreted soluble factors stimulate microglial activation: The role of interleukin-1β and tumor necrosis factor-α VL - 298 ID - 6148 ER - TY - JOUR AD - A. Nakagawara, Division of Biochemistry, Innovative Cancer Therapeutics, Japan AU - Ohira, M. AU - Nakagawara, A. DB - Embase Medline DO - 10.1111/j.1349-7006.2010.01681.x IS - 11 LA - English M3 - Review N1 - L359878951 2010-11-11 2010-11-19 PY - 2010 SN - 1347-9032 1349-7006 SP - 2295-2301 ST - Global genomic and RNA profiles for novel risk stratification of neuroblastoma T2 - Cancer Science TI - Global genomic and RNA profiles for novel risk stratification of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359878951&from=exporthttp://dx.doi.org/10.1111/j.1349-7006.2010.01681.x VL - 101 ID - 6149 ER - TY - JOUR AD - Department of Human Genetics, Catholic University Leuven, Leuven, Belgium. AN - 19738042 AU - Brems, H. AU - Park, C. AU - Maertens, O. AU - Pemov, A. AU - Messiaen, L. AU - Upadhyaya, M. AU - Claes, K. AU - Beert, E. AU - Peeters, K. AU - Mautner, V. AU - Sloan, J. L. AU - Yao, L. AU - Lee, C. C. AU - Sciot, R. AU - De Smet, L. AU - Legius, E. AU - Stewart, D. R. C2 - PMC2747722 C6 - NIHMS135382 DA - Sep 15 DO - 10.1158/0008-5472.Can-09-1752 10.1158/0008-5472.CAN-09-1752. Epub 2009 Sep 8. DP - Nlm ET - 2009/09/10 IS - 18 LA - eng PY - 2009 SN - 0008-5472 (Print) 0008-5472 SP - 7393-401 ST - Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association T2 - Cancer Res TI - Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association VL - 69 ID - 6150 ER - TY - JOUR AD - B. N. Kang, Dept. of Veterinary and Biomedical Sciences, College of Veterinary Medicine, Univ. of Minnesota, 1971 Commonwealth Ave., St. Paul, MN 55108, United States AU - Kang, B. N. AU - Jude, J. A. AU - Panettieri Jr, R. A. AU - Walseth, T. F. AU - Kannan, M. S. DB - Embase Medline DO - 10.1152/ajplung.00352.2007 IS - 1 LA - English M3 - Article N1 - L352763450 2008-12-24 PY - 2008 SN - 1040-0605 1522-1504 SP - L186-L193 ST - Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: Role of dual specificity phosphatase 1 T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: Role of dual specificity phosphatase 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352763450&from=exporthttp://dx.doi.org/10.1152/ajplung.00352.2007http://ajplung.physiology.org/cgi/reprint/295/1/L186 VL - 295 ID - 6151 ER - TY - JOUR AD - I. Jeremias, Helmholtz Zentrum Muenchen, Gene Vectors, Munich, Germany AU - Jeremias, I. AU - Gündisch, S. AU - Baader, E. AU - Amtmann, E. AU - Ehrhardt, H. DB - Embase DO - 10.1016/S1359-6349(10)72157-1 IS - 7 LA - English M3 - Conference Abstract N1 - L70310353 2010-12-10 PY - 2010 SN - 1359-6349 SP - 142 ST - Glucocorticoids frequently induce survival and growth in tumor cells by activation of classical survival and proliferation pathways which should be avoided during anti-cancer therapy T2 - European Journal of Cancer, Supplement TI - Glucocorticoids frequently induce survival and growth in tumor cells by activation of classical survival and proliferation pathways which should be avoided during anti-cancer therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70310353&from=exporthttp://dx.doi.org/10.1016/S1359-6349(10)72157-1 VL - 8 ID - 6152 ER - TY - JOUR AD - A. Williams, Oncology, Johns Hopkins University, Baltimore, MD, United States AU - Williams, A. AU - Koch, S. AU - Christian, T. AU - Brown, P. AU - Levis, M. AU - Small, D. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L70248475 2010-09-03 PY - 2009 SN - 0006-4971 ST - Glycosylation and surface localization are required for FLT3 activation but not for FLT3/ITD T2 - Blood TI - Glycosylation and surface localization are required for FLT3 activation but not for FLT3/ITD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70248475&from=exporthttp://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/2747?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=1200&displaysectionid=Poster+Session&fdate=1/1/2009&tdate=12/31/2009&resourcetype=HWCIT VL - 114 ID - 6153 ER - TY - JOUR AD - Y. Sonobe, Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan AU - Parajuli, B. AU - Sonobe, Y. AU - Kawanokuchi, J. AU - Doi, Y. AU - Noda, M. AU - Takeuchi, H. AU - Mizuno, T. AU - Suzumura, A. DB - Embase Medline DO - 10.1186/1742-2094-9-268 LA - English M3 - Article N1 - L52356790 2012-12-20 2013-02-25 PY - 2012 SN - 1742-2094 ST - GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia T2 - Journal of Neuroinflammation TI - GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52356790&from=exporthttp://dx.doi.org/10.1186/1742-2094-9-268http://www.jneuroinflammation.com/content/9/1/268 VL - 9 ID - 6154 ER - TY - JOUR AD - H.T. Michael, National Cancer Institutes, Bethesda, MD, United States AU - Michael, H. T. AU - Day, C. P. AU - Sassano, A. AU - Michalowski, A. AU - Yang, H. AU - Lee, M. AU - Merlino, G. DB - Embase DO - 10.1111/pcmr.12622 IS - 5 LA - English M3 - Conference Abstract N1 - L618288214 2017-09-20 PY - 2017 SN - 1755-1471 SP - e42-e43 ST - GNAQ/GNA11 pathway mutations are involved in malignant transformation in a mouse model of UV-induced melanocytic lesion progression T2 - Pigment Cell and Melanoma Research TI - GNAQ/GNA11 pathway mutations are involved in malignant transformation in a mouse model of UV-induced melanocytic lesion progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618288214&from=exporthttp://dx.doi.org/10.1111/pcmr.12622 VL - 30 ID - 6155 ER - TY - JOUR AD - PUCRS School of Medicine, Porto Alegre, Brazil Mount Sinai Hospital, Toronto, ON, Canada Universite Claude Bernard, Lyon, France Istituto Nazionale Tumori, Milan, Italy Alexander Fleming Institute, Department of Medical Oncology, Buenos Aires, Argentina Peking University Cancer Hospital, Beijing, China University of Ulsan College of Medicine, Seoul, South Korea National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, Berlin, 13125, Germany AU - Barrios, C. H. AU - Blackstein, M. E. AU - Blay, J. Y. AU - Casali, P. G. AU - Chacon, M. AU - Gu, J. AU - Kang, Y. K. AU - Nishida, T. AU - Purkayastha, D. AU - Woodman, R. C. AU - Reichardt, P. DB - Scopus DO - 10.1016/j.ejca.2015.07.010 IS - 16 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 SP - 2423-2433 ST - The GOLD ReGISTry: A Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours T2 - European Journal of Cancer TI - The GOLD ReGISTry: A Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943660159&doi=10.1016%2fj.ejca.2015.07.010&partnerID=40&md5=e0a3d8a0662ec106e40064ebc9768d5b VL - 51 ID - 6156 ER - TY - JOUR AD - Department of Pediatrics, Royal Hobart Hospital, Hobart, Australia. Department of Oncology, Royal Children's Hospital, Melbourne, Australia. Department of Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Australia. AN - 29603581 AU - Heath, J. A. AU - Campbell, M. A. AU - Thomas, A. AU - Solomon, B. DA - Jul DO - 10.1002/pbc.27055 10.1002/pbc.27055. Epub 2018 Mar 30. DP - Nlm ET - 2018/04/01 IS - 7 LA - eng PY - 2018 SN - 1545-5009 SP - e27055 ST - Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma T2 - Pediatr Blood Cancer TI - Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastoma VL - 65 ID - 6157 ER - TY - JOUR AD - Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Cosenza, Italy. Department of Medicine-DIMED, University of Padova, Padova, Italy. Department of Cell Biology and Neurosciences, National Institute of Health, Rome, Italy. Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Rome, Italy. Research Center, San Pietro Hospital-Fatebenefratelli, Rome, Italy. AN - 26131713 AU - Chimento, A. AU - Sirianni, R. AU - Casaburi, I. AU - Zolea, F. AU - Rizza, P. AU - Avena, P. AU - Malivindi, R. AU - De Luca, A. AU - Campana, C. AU - Martire, E. AU - Domanico, F. AU - Fallo, F. AU - Carpinelli, G. AU - Cerquetti, L. AU - Amendola, D. AU - Stigliano, A. AU - Pezzi, V. C2 - PMC4662484 DA - Aug 7 DO - 10.18632/oncotarget.4241 10.18632/oncotarget.4241. DP - Nlm ET - 2015/07/02 IS - 22 LA - eng PY - 2015 SN - 1949-2553 SP - 19190-203 ST - GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo T2 - Oncotarget TI - GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo VL - 6 ID - 6158 ER - TY - JOUR AD - R. Zeiser, Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Hugstetterstrasse 55, Freiburg, Germany AU - Mathew, N. R. AU - Vinnakota, J. M. AU - Apostolova, P. AU - Erny, D. AU - Hamarsheh, S. AU - Andrieux, G. AU - Kim, J. S. AU - Hanke, K. AU - Goldmann, T. AU - Chappell-Maor, L. AU - El-Khawanky, N. AU - Ihorst, G. AU - Schmidt, D. AU - Duyster, J. AU - Finke, J. AU - Blank, T. AU - Boerries, M. AU - Blazar, B. R. AU - Jung, S. AU - Prinz, M. AU - Zeiser, R. DB - Embase Medline DO - 10.1172/JCI130272 IS - 3 LA - English M3 - Article N1 - L2005136348 2020-03-16 2020-03-20 PY - 2020 SN - 1558-8238 0021-9738 SP - 1315-1329 ST - Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia T2 - Journal of Clinical Investigation TI - Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005136348&from=exporthttp://dx.doi.org/10.1172/JCI130272 VL - 130 ID - 6159 ER - TY - JOUR AD - Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Division of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, United States AU - Zeidner, J. F. AU - Gladstone, D. E. AU - Zahurak, M. AU - Matsui, W. H. AU - Gocke, C. AU - Jones, R. J. AU - Smith, B. D. DB - Scopus DO - 10.1016/j.leukres.2014.05.012 IS - 8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 886-890 ST - Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) T2 - Leukemia Research TI - Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907193462&doi=10.1016%2fj.leukres.2014.05.012&partnerID=40&md5=234c6a4badf5e2d97030515d2dd1a9a8 VL - 38 ID - 6160 ER - TY - JOUR AD - Y. Jiang, Department of Genetic Diagnosis Center, Central Laboratory, First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin, China AU - Shi, X. AU - Lu, L. AU - Jin, X. AU - Liu, B. AU - Sun, X. AU - Lu, L. AU - Jiang, Y. DB - Embase Medline DO - 10.3892/mmr.2016.5923 IS - 6 LA - English M3 - Article N1 - L613505901 2016-12-07 2016-12-13 PY - 2016 SN - 1791-3004 1791-2997 SP - 5637-5643 ST - GRIN3A and MAPT stimulate nerve overgrowth in macrodactyly T2 - Molecular Medicine Reports TI - GRIN3A and MAPT stimulate nerve overgrowth in macrodactyly UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613505901&from=exporthttp://dx.doi.org/10.3892/mmr.2016.5923 VL - 14 ID - 6161 ER - TY - JOUR AD - A.-K. Yi, Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, 858 Madison Avenue, Memphis, TN, United States AU - Upadhyay, K. AU - Park, J. E. AU - Yoon, T. W. AU - Halder, P. AU - Kim, Y. I. AU - Metcalfe, V. AU - Talati, A. J. AU - English, B. K. AU - Yi, A. K. DB - Embase Medline DO - 10.4049/jimmunol.1601089 IS - 11 LA - English M3 - Article N1 - L616353437 2017-05-29 2017-06-02 PY - 2017 SN - 1550-6606 0022-1767 SP - 4448-4457 ST - Group B streptococci induce proinflammatory responses via a protein kinase D1-dependent pathway T2 - Journal of Immunology TI - Group B streptococci induce proinflammatory responses via a protein kinase D1-dependent pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616353437&from=exporthttp://dx.doi.org/10.4049/jimmunol.1601089 VL - 198 ID - 6162 ER - TY - JOUR AD - Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatric Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India AU - Narayanan, K. R. AU - Bansal, D. AU - Walia, R. AU - Sachdeva, N. AU - Bhansali, A. AU - Varma, N. AU - Marwaha, R. K. DB - Scopus DO - 10.1002/pbc.24397 IS - 7 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2013 SP - 1148-1153 ST - Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis T2 - Pediatric Blood and Cancer TI - Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878255303&doi=10.1002%2fpbc.24397&partnerID=40&md5=17873bba91dbbd268291b55b4957e8ed VL - 60 ID - 6163 ER - TY - JOUR AD - Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China. AN - 24293393 AU - Yi, B. AU - Yang, J. AU - Wang, L. DA - Apr DO - 10.1007/s13277-013-1422-7 10.1007/s13277-013-1422-7. Epub 2013 Nov 30. DP - Nlm ET - 2013/12/03 IS - 4 LA - eng PY - 2014 SN - 1010-4283 SP - 3229-35 ST - The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line T2 - Tumour Biol TI - The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line VL - 35 ID - 6164 ER - TY - JOUR AD - Department of Radiology, Boston Children's Hospital Dana -Farber Cancer Institute, Boston, Massachusetts. AN - 103858268. Language: English. Entry Date: 20150306. Revision Date: 20200708. Publication Type: journal article AU - Voss, Stephan D. AU - Glade-Bender, Julia AU - Spunt, Sheri L. AU - DuBois, Steven G. AU - Widemann, Brigitte C. AU - Park, Julie R. AU - Leary, Sarah E. S. AU - Nelson, Marvin D. AU - Adamson, Peter C. AU - Blaney, Susan M. AU - Weigel, Brenda DB - ccm DO - 10.1002/pbc.25229 DP - EBSCOhost IS - 1 N1 - clinical trial; research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Oncologic Care; Pediatric Care. Grant Information: 5UM1 CA097452-12/CA/NCI NIH HHS/United States. NLM UID: 101186624. PMID: NLM25257751. PY - 2015 SN - 1545-5009 SP - 45-51 ST - Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium T2 - Pediatric Blood & Cancer TI - Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103858268&site=ehost-live&scope=site VL - 62 ID - 6165 ER - TY - JOUR AD - Department of Pediatrics, Beatrix Children's Hospital, Pediatric Oncology/Hematology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Department of Pathology and Medical Biology, Pathology division, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Department of Neurosurgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. AN - 25799134 AU - Sie, M. AU - den Dunnen, W. F. AU - Lourens, H. J. AU - Meeuwsen-de Boer, T. G. AU - Scherpen, F. J. AU - Zomerman, W. W. AU - Kampen, K. R. AU - Hoving, E. W. AU - de Bont, E. S. C2 - PMC4370756 DO - 10.1371/journal.pone.0122555 10.1371/journal.pone.0122555. eCollection 2015. DP - Nlm ET - 2015/03/24 IS - 3 LA - eng PY - 2015 SN - 1932-6203 SP - e0122555 ST - Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma T2 - PLoS One TI - Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma VL - 10 ID - 6166 ER - TY - JOUR AD - Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina Servicio de Hematología, Hospital Ramos Mejía, Buenos Aires, Argentina Departamento de Hemato-oncología, Academia Nacional de Medicina, Buenos Aires, Argentina FUNDALEU, Buenos Aires, Argentina AN - 119380087. Language: English. Entry Date: 20170614. Revision Date: 20180521. Publication Type: journal article AU - Weich, Natalia AU - Ferri, Cristian AU - Moiraghi, Beatriz AU - Bengió, Raquel AU - Giere, Isabel AU - Pavlovsky, Carolina AU - Larripa, Irene B. AU - Fundia, Ariela F. DB - ccm DO - 10.1016/j.canep.2016.07.008 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Public Health; USA. NLM UID: 101508793. PMID: NLM27454607. PY - 2016 SN - 1877-7821 SP - 16-21 ST - GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response T2 - Cancer Epidemiology TI - GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=119380087&site=ehost-live&scope=site ID - 6167 ER - TY - JOUR AD - Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States; Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, United States. Electronic address: rajivpat@med.umich.edu. AN - 28844540 AU - Udager, A. M. AU - Frisch, N. K. AU - Hong, L. J. AU - Stasenko, M. AU - Johnston, C. M. AU - Liu, J. R. AU - Chan, M. P. AU - Harms, P. W. AU - Fullen, D. R. AU - Orsini, A. AU - Thomas, D. G. AU - Lowe, L. AU - Patel, R. M. DA - Nov DO - 10.1016/j.ygyno.2017.08.023 10.1016/j.ygyno.2017.08.023. Epub 2017 Aug 24. DP - Nlm ET - 2017/08/29 IS - 2 LA - eng PY - 2017 SN - 0090-8258 SP - 351-357 ST - Gynecologic melanomas: A clinicopathologic and molecular analysis T2 - Gynecol Oncol TI - Gynecologic melanomas: A clinicopathologic and molecular analysis VL - 147 ID - 6168 ER - TY - JOUR AD - Z. Marinova, Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zürich, Wagistrasse 12, Schlieren, Zurich, Switzerland AU - Marinova, Z. AU - Walitza, S. AU - Grünblatt, E. DB - Embase Medline DO - 10.1007/s00702-017-1706-y IS - 6 LA - English M3 - Article N1 - L614918040 2017-03-24 2017-06-06 PY - 2017 SN - 1435-1463 0300-9564 SP - 749-759 ST - The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension T2 - Journal of Neural Transmission TI - The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614918040&from=exporthttp://dx.doi.org/10.1007/s00702-017-1706-y VL - 124 ID - 6169 ER - TY - JOUR AD - Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, China Collaborative Innovation Center of Hematology, Soochow University, 188 Shizi Street, Suzhou, 215006, China Suzhou Institute of Blood and Marrow Transplantation, 188 Shizi Street, Suzhou, 215006, China AU - Gu, B. AU - Wu, X. AU - Chen, G. AU - Ma, X. AU - Jin, Z. AU - Tang, X. AU - Han, Y. AU - Fu, C. AU - Qiu, H. AU - Sun, A. AU - Wu, D. DB - Scopus DO - 10.1016/j.leukres.2017.05.013 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 41-46 ST - Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Leukemia Research TI - Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019936536&doi=10.1016%2fj.leukres.2017.05.013&partnerID=40&md5=0322f084ae693da28a61c812881f3606 VL - 59 ID - 6170 ER - TY - JOUR AD - S. Ispasanie, Charité Universitätsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumour Pathology and Systems Biology, Berlin, Germany AU - Ispasanie, S. AU - Kistler, S. AU - Heberle, A. AU - Uhlitz, F. AU - Kasack, K. AU - Dittmar, G. AU - Blüthgen, N. AU - Thedieck, K. AU - Campbell, S. AU - Sers, C. DB - Embase DO - 10.1136/esmoopen-2018-EACR25.518 LA - English M3 - Conference Abstract N1 - L627974500 2019-06-11 PY - 2018 SN - 2059-7029 SP - A218-A219 ST - HDAC inhibitor resistance in colorectal cancer: RAS and amp; MYC-the partners in crime T2 - ESMO Open TI - HDAC inhibitor resistance in colorectal cancer: RAS and amp; MYC-the partners in crime UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627974500&from=exporthttp://dx.doi.org/10.1136/esmoopen-2018-EACR25.518 VL - 3 ID - 6171 ER - TY - JOUR AD - Department of Dermatology, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany; The German Cancer Consortium, Heidelberg, Germany. Electronic address: dirk.schadendorf@uk-essen.de. Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Banchi di Sotto, 55, 53100, Siena, SI, Italy. N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Russian Academy of Medical Sciences, Kashirskoye Shosse 24, 115478, Moscow, Russian Federation. Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Centro Ospedaliero, 24129, Bergamo, BG, Italy. Dnipropetrovsk State Medical Academy, Volodymyra Vernadskoho St, 9, Dnipropetrovsk, 49044, Ukraine. Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori, IRCCS Fondazione Pascale, Via Mariano Semmola, 53, 80131, Napoli, NA, Italy. Bristol Haematology and Oncology Centre, Horfield Rd, Avon, Bristol, BS2 8ED, United Kingdom. Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Collegium Maius, Fredry 10, 61-701, Poznań, Poland. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Wawelska 15 B, 00-001, Warsaw, Poland. Melanoma Translational Research Group, Melanoma Institute Australia, 40 Rocklands Rd, Wollstonecraft NSW, 2065, New South Wales, Australia. Genentech, Inc., 410 Allerton Ave, South San Francisco, CA, 94080, USA. University of Colorado Comprehensive Cancer Center, 1665 Aurora Court Anschutz Cancer Pavilion, Aurora, CO 80045, USA. AN - 31704549 AU - Schadendorf, D. AU - Di Giacomo, A. M. AU - Demidov, L. AU - Merelli, B. AU - Bondarenko, I. AU - Ascierto, P. A. AU - Herbert, C. AU - Mackiewicz, A. AU - Rutkowski, P. AU - Guminski, A. AU - Goodman, G. R. AU - Simmons, B. AU - Ye, C. AU - Hong, A. AU - Lewis, K. DA - Dec DO - 10.1016/j.ejca.2019.09.019 10.1016/j.ejca.2019.09.019. Epub 2019 Nov 5. DP - Nlm ET - 2019/11/11 LA - eng PY - 2019 SN - 0959-8049 SP - 155-161 ST - Health-related quality of life in patients with fully resected BRAF(V600) mutation-positive melanoma receiving adjuvant vemurafenib T2 - Eur J Cancer TI - Health-related quality of life in patients with fully resected BRAF(V600) mutation-positive melanoma receiving adjuvant vemurafenib VL - 123 ID - 6172 ER - TY - JOUR AD - a Novosys Health , Green Brook , NJ , USA b Bristol-Myers Squibb , Princeton , NJ , USA AN - 121816418. Language: English. Entry Date: 20180730. Revision Date: 20191107. Publication Type: journal article AU - Lin, Jay AU - Makenbaeva, Dinara AU - Lingohr-Smith, Melissa AU - Bilmes, Robyn DB - ccm DO - 10.1080/13696998.2017.1302947 DP - EBSCOhost N1 - research. Journal Subset: Biomedical; Health Services Administration; USA. NLM UID: 9892255. PMID: NLM28287043. PY - 2017 SN - 1369-6998 SP - 1-5 ST - Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors T2 - Journal of Medical Economics TI - Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121816418&site=ehost-live&scope=site ID - 6173 ER - TY - JOUR AD - Department of Academic Haematology, Cardiff University, Heath Park, Cardiff, UK. AN - 18373709 AU - Al Shaer, L. AU - Walsby, E. AU - Gilkes, A. AU - Tonks, A. AU - Walsh, V. AU - Mills, K. AU - Burnett, A. AU - Rowntree, C. DA - May DO - 10.1111/j.1365-2141.2008.07053.x 10.1111/j.1365-2141.2008.07053.x. Epub 2008 Mar 27. DP - Nlm ET - 2008/04/01 IS - 4 LA - eng PY - 2008 SN - 0007-1048 SP - 483-93 ST - Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling T2 - Br J Haematol TI - Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling VL - 141 ID - 6174 ER - TY - JOUR AD - J.A. Orellana, Departamento de Neurología, Escuela de Medicina and Centro Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile AU - Gómez, G. I. AU - Falcon, R. V. AU - Maturana, C. J. AU - Labra, V. C. AU - Salgado, N. AU - Rojas, C. A. AU - Oyarzun, J. E. AU - Cerpa, W. AU - Quintanilla, R. A. AU - Orellana, J. A. DB - Embase DO - 10.3389/fncel.2018.00472 LA - English M3 - Article N1 - L625557492 2018-12-28 2018-12-31 PY - 2018 SN - 1662-5102 ST - Heavy alcohol exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: Effects on neuroinflammation and astrocyte arborization T2 - Frontiers in Cellular Neuroscience TI - Heavy alcohol exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: Effects on neuroinflammation and astrocyte arborization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625557492&from=exporthttp://dx.doi.org/10.3389/fncel.2018.00472 VL - 12 ID - 6175 ER - TY - JOUR AD - Oncology Centre, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia AU - El Fakih, R. AU - Ahmed, S. AU - Alfraih, F. AU - Hanbali, A. DB - Scopus DO - 10.1016/j.hemonc.2017.05.015 IS - 4 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - 252-258 ST - Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients T2 - Hematology/ Oncology and Stem Cell Therapy TI - Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023599512&doi=10.1016%2fj.hemonc.2017.05.015&partnerID=40&md5=2401144f2ebd75266fe892dca32c39d2 VL - 10 ID - 6176 ER - TY - JOUR AD - Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada Department of Medical Oncology and Haematology, CancerCare Manitoba, 675 McDermott Avenue, Winnipeg, MB R3E 0V9, Canada AU - Speziali, C. AU - Paulson, K. AU - Seftel, M. DB - Scopus DO - 10.1007/s11899-016-0317-2 IS - 3 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 175-184 ST - Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults T2 - Current Hematologic Malignancy Reports TI - Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961226902&doi=10.1007%2fs11899-016-0317-2&partnerID=40&md5=c5230b75efe5d3b0be54c824960e0793 VL - 11 ID - 6177 ER - TY - JOUR AD - Institute of Cellular Medicine and. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. Department of Cellular Pathology, Newcastle upon Tyne Hospitals National Health Service Foundation Trust, Newcastle upon Tyne, United Kingdom. Internal Medicine Department, Hôtel-Dieu University Hopital, Nantes, France. Memorial Sloan Kettering Cancer Center, New York, NY. East Midlands Children's and Young Persons' Integrated Cancer Service, Leicester Children's Hospital, Leicester, United Kingdom. Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom. Rheumatology Department, North Bristol National Health Service Trust, Bristol, United Kingdom. Blackpool Teaching Hospitals National Health Service Foundation Trust, Blackpool, United Kingdom; and. Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX. AN - 28512190 AU - Milne, P. AU - Bigley, V. AU - Bacon, C. M. AU - Néel, A. AU - McGovern, N. AU - Bomken, S. AU - Haniffa, M. AU - Diamond, E. L. AU - Durham, B. H. AU - Visser, J. AU - Hunt, D. AU - Gunawardena, H. AU - Macheta, M. AU - McClain, K. L. AU - Allen, C. AU - Abdel-Wahab, O. AU - Collin, M. C2 - PMC5524529 DA - Jul 13 DO - 10.1182/blood-2016-12-757823 10.1182/blood-2016-12-757823. Epub 2017 May 16. DP - Nlm ET - 2017/05/18 IS - 2 LA - eng PY - 2017 SN - 0006-4971 (Print) 0006-4971 SP - 167-175 ST - Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults T2 - Blood TI - Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults VL - 130 ID - 6178 ER - TY - JOUR AD - Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan Bone Marrow and Stem Cell Transplantation Program, King Hussein Cancer Center, Amman, Jordan AU - Salami, K. AU - Alkayed, K. AU - Halalsheh, H. AU - Hussein, A. A. AU - Riziq, M. AU - Madanat, F. DB - Scopus DO - 10.1016/j.hemonc.2013.03.001 IS - 1 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2013 SP - 34-41 ST - Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) T2 - Hematology/ Oncology and Stem Cell Therapy TI - Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884676390&doi=10.1016%2fj.hemonc.2013.03.001&partnerID=40&md5=c7b18cd2469b0bccf4837458ffebc843 VL - 6 ID - 6179 ER - TY - JOUR AD - Department of Pediatrics, Washington University School of Medicine, St Louis Children's Hospital, St Louis, MO, United States Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Shenoy, S. AU - Smith, F. O. DB - Scopus DO - 10.1038/sj.bmt.1705961 IS - 2 M3 - Review N1 - Cited By :16 Export Date: 18 November 2020 PY - 2008 SP - 141-148 ST - Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin T2 - Bone Marrow Transplantation TI - Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38849113856&doi=10.1038%2fsj.bmt.1705961&partnerID=40&md5=c9d572f830b359ec6d043044fe916a7f VL - 41 ID - 6180 ER - TY - JOUR AD - Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, MSC 1104, Bethesda, MD 20892-1104, United States Department of Pediatric Immunology, Hematology, Oncology, Bone Marrow Transplantation and Auto-immune Diseases, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, Netherlands AU - Wayne, A. S. AU - Baird, K. AU - Egeler, R. M. DB - Scopus DO - 10.1016/j.pcl.2009.11.005 IS - 1 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2010 SP - 1-25 ST - Hematopoietic stem cell transplantation for leukemia T2 - Pediatric Clinics of North America TI - Hematopoietic stem cell transplantation for leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951082463&doi=10.1016%2fj.pcl.2009.11.005&partnerID=40&md5=f856bb71aca41e811d06550294a77fde VL - 57 ID - 6181 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Bambino Gesù Children’s Hospital, Piazza Sant’Onofrio, 4, Rome, 00165, Italy Sapienza University of Rome, Rome, Italy AU - Merli, P. AU - Algeri, M. AU - Del Bufalo, F. AU - Locatelli, F. DB - Scopus DO - 10.1007/s11899-019-00502-2 IS - 2 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 94-105 ST - Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia T2 - Current Hematologic Malignancy Reports TI - Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062605860&doi=10.1007%2fs11899-019-00502-2&partnerID=40&md5=0a602b82e38c3c5b3966b13f8a0fbbed VL - 14 ID - 6182 ER - TY - JOUR AD - M. Strullu, Hopital Mère-Enfant, Nantes Hospital, Nantes, France AU - Strullu, M. AU - Thomas, C. AU - Raus, N. AU - Paillard, C. AU - Bertrand, Y. AU - Jubert, C. AU - De La Tour, R. P. AU - Lutz, P. AU - Dalle, J. H. AU - Lamant, L. AU - Michel, G. AU - Brugieres, L. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71265702 2013-12-24 PY - 2013 SN - 0006-4971 ST - Hematopoietic stem cell transplantation in relapsed ALK + anaplastic large cell lymphoma of children and adolescent : A study on behalf of the sfce and SFGM-TC T2 - Blood TI - Hematopoietic stem cell transplantation in relapsed ALK + anaplastic large cell lymphoma of children and adolescent : A study on behalf of the sfce and SFGM-TC UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71265702&from=exporthttp://bloodjournal.hematologylibrary.org/content/122/21/2120.abstract?sid=800eb0b7-24b5-49c3-baad-4bbdfe1e46cd VL - 122 ID - 6183 ER - TY - JOUR AD - Department of Pediatric Oncology and Hematology, Hôpital Mère-Enfant, Nantes, France. 1] Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France [2] Paris Sud University, Le Kremlin-Bicêtre, France. Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France. Department of Pediatric Oncology and Hematology, Hôpital Estaing, Clermont-Ferrand, France. Department of Pediatric Hematology, IHOP, Lyon, France. Department of Pediatric Oncology and Hematology, Hôpital Pellegrin, Bordeaux, France. Department of Pediatric Hematology, Hôpital Robert Debré, Paris, France. Department of Pediatric Oncology and Hematology, Hôpital Hautepierre, Strasbourg, France. Department of Pathology, Hôpital Purpan, Toulouse, France. Department of Pediatric Hematology, Hôpital La Timone, Marseille, France. Department of Children and Adolescent Oncology, Gustave Roussy, Villejuif, France. AN - 25822227 AU - Strullu, M. AU - Thomas, C. AU - Le Deley, M. C. AU - Chevance, A. AU - Kanold, J. AU - Bertrand, Y. AU - Jubert, C. AU - Dalle, J. H. AU - Paillard, C. AU - Baruchel, A. AU - Lamant, L. AU - Michel, G. AU - Brugières, L. DA - Jun DO - 10.1038/bmt.2015.57 10.1038/bmt.2015.57. Epub 2015 Mar 30. DP - Nlm ET - 2015/03/31 IS - 6 LA - eng PY - 2015 SN - 0268-3369 SP - 795-801 ST - Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC T2 - Bone Marrow Transplant TI - Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC VL - 50 ID - 6184 ER - TY - JOUR AD - Department of Dermatology, Ehime University Graduate School of Medicine, Toon City, Japan Department of Dermatology, Ehime Prefectural Central Hospital, Matsuyama City, Japan AU - Utsunomiya, R. AU - Dai, X. AU - Murakami, M. AU - Masuda, K. AU - Okazaki, H. AU - Tsuda, T. AU - Mori, H. AU - Shiraishi, K. AU - Tohyama, M. AU - Sayama, K. DB - Scopus DO - 10.1111/exd.13685 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 981-988 ST - Heparinoid suppresses Der p-induced IL-1β production by inhibiting ERK and p38 MAPK pathways in keratinocytes T2 - Experimental Dermatology TI - Heparinoid suppresses Der p-induced IL-1β production by inhibiting ERK and p38 MAPK pathways in keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052535906&doi=10.1111%2fexd.13685&partnerID=40&md5=9b2185c42ae1b727590518625d014ca4 VL - 27 ID - 6185 ER - TY - JOUR AD - Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Interventional Radiology, Jieyang Affiliated Hospital, Sun Yat-sen University, Jieyang, China Department of Clinical Research, Sun Yat-sen University Cancer Center, Guangzhou, China Medical Imaging Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Lyu, N. AU - Kong, Y. AU - Mu, L. AU - Lin, Y. AU - Li, J. AU - Liu, Y. AU - Zhang, Z. AU - Zheng, L. AU - Deng, H. AU - Li, S. AU - Xie, Q. AU - Guo, R. AU - Shi, M. AU - Xu, L. AU - Cai, X. AU - Wu, P. AU - Zhao, M. DB - Scopus DO - 10.1016/j.jhep.2018.02.008 IS - 1 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2018 SP - 60-69 ST - Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma T2 - Journal of Hepatology TI - Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044338249&doi=10.1016%2fj.jhep.2018.02.008&partnerID=40&md5=289b6b66f07b9c47dee7ad45e4b3c618 VL - 69 ID - 6186 ER - TY - JOUR AD - M. Han, Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Wang, H. AU - Wu, D. AU - Wang, X. AU - Chen, G. AU - Zhang, Y. AU - Yan, W. AU - Luo, X. AU - Han, M. AU - Ning, Q. DB - Embase Medline DO - 10.1515/hsz-2015-0290 IS - 11 LA - English M3 - Article N1 - L612802859 2016-11-09 2016-11-23 PY - 2016 SN - 1437-4315 1431-6730 SP - 1173-1185 ST - Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways T2 - Biological Chemistry TI - Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612802859&from=exporthttp://dx.doi.org/10.1515/hsz-2015-0290 VL - 397 ID - 6187 ER - TY - JOUR AD - H.-Z. Lu, Deptartment of Pediatrics, Clinical Medical College, Yangtze University, Jingzhou 434000, China AU - Lu, H. Z. AU - Zhou, J. H. DB - Embase Medline DO - 10.1016/S2221-1691(13)60053-2 IS - 3 LA - English M3 - Article N1 - L368228696 2013-02-07 2013-02-14 PY - 2013 SN - 2221-1691 SP - 217-222 ST - Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways T2 - Asian Pacific Journal of Tropical Biomedicine TI - Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368228696&from=exporthttp://dx.doi.org/10.1016/S2221-1691(13)60053-2 VL - 3 ID - 6188 ER - TY - JOUR AD - M.M. Al-Rahawan, Department of Health and Human Services, National Institute of Health, EPS, 6120 Executive Blvd, Rockville, MD 20852, United States AU - Al-Rahawan, M. M. AU - Chute, D. J. AU - Sol-Church, K. AU - Gripp, K. W. AU - Stabley, D. L. AU - McDaniel, N. L. AU - Wilson, W. G. AU - Waldron, P. E. DB - Embase Medline DO - 10.1002/ajmg.a.31819 IS - 13 LA - English M3 - Article N1 - L47051027 2007-07-01 PY - 2007 SN - 1552-4825 1552-4833 SP - 1481-1488 ST - Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome T2 - American Journal of Medical Genetics, Part A TI - Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47051027&from=exporthttp://dx.doi.org/10.1002/ajmg.a.31819 VL - 143 ID - 6189 ER - TY - JOUR AD - Medical Oncology Unit, San Giovanni di Dio Hospital, via D.Pirozzi 66, Frattamaggiore, Naples, 80027, Italy Oncology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, 80027, Italy AU - Montella, L. AU - Palmieri, G. AU - Addeo, R. AU - Del Prete, S. DB - Scopus DO - 10.3748/wjg.v22.i27.6114 IS - 27 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 6114-6126 ST - Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? T2 - World Journal of Gastroenterology TI - Hepatocellular carcinoma: Will novel targeted drugs really impact the next future? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978499766&doi=10.3748%2fwjg.v22.i27.6114&partnerID=40&md5=daaa554df6c458da76b48b62f9ae1315 VL - 22 ID - 6190 ER - TY - JOUR AD - Y.-Z. Chen, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou, Fujian Province, China AU - Guo, J. R. AU - Li, W. AU - Wu, Y. AU - Wu, L. Q. AU - Li, X. AU - Guo, Y. F. AU - Zheng, X. H. AU - Lian, X. L. AU - Huang, H. F. AU - Chen, Y. Z. DB - Embase IS - 9 LA - English M3 - Article N1 - L612378986 2016-10-04 2016-10-18 PY - 2016 SN - 1943-8141 SP - 3630-3644 ST - Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway T2 - American Journal of Translational Research TI - Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612378986&from=export VL - 8 ID - 6191 ER - TY - JOUR AD - T. Matsuguchi, Department of Oral Biochemistry, Kagoshima University Graduate School of Medical and Dental Sciences, Japan AU - Hisadome, M. AU - Ohnishi, T. AU - Kakimoto, K. AU - Kusuyama, J. AU - Bandow, K. AU - Kanekura, T. AU - Matsuguchi, T. DB - Embase Medline DO - 10.1002/1873-3468.12452 IS - 20 LA - English M3 - Letter N1 - L612856043 2016-10-25 2016-11-15 PY - 2016 SN - 1873-3468 0014-5793 SP - 3595-3605 ST - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes T2 - FEBS Letters TI - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612856043&from=exporthttp://dx.doi.org/10.1002/1873-3468.12452 VL - 590 ID - 6192 ER - TY - JOUR AD - M. Hisadome, Department of Dermatology, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, Japan AU - Hisadome, M. AU - Ohnishi, T. AU - Kakimoto, K. AU - Kusuyama, J. AU - Bandow, K. AU - Kanekura, T. AU - Matsuguchi, T. DB - Embase DO - 10.1016/j.jdermsci.2017.02.171 IS - 2 LA - English M3 - Conference Abstract N1 - L616240546 2017-05-23 PY - 2017 SN - 0923-1811 SP - e58 ST - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes T2 - Journal of Dermatological Science TI - Hepatocyte growth factor reduces CXCL10 expression in keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616240546&from=exporthttp://dx.doi.org/10.1016/j.jdermsci.2017.02.171 VL - 86 ID - 6193 ER - TY - JOUR AD - Département d' Anatomie et de Biologie Cellulaire, Université de Sherbrooke, Sherbrooke J1E 4K8, QC, Canada AU - Babeu, J. P. AU - Boudreau, F. DB - Scopus DO - 10.3748/wjg.v20.i1.22 IS - 1 M3 - Article N1 - Cited By :77 Export Date: 18 November 2020 PY - 2014 SP - 22-30 ST - Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks T2 - World Journal of Gastroenterology TI - Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891780760&doi=10.3748%2fwjg.v20.i1.22&partnerID=40&md5=1069d15cf55e625b0aaf1aa3b5d1176a VL - 20 ID - 6194 ER - TY - JOUR AD - A.E. Feldstein, Department of Pediatrics, University of California-San Diego, MC 0715, 9500 Gilman Drive, San Diego, CA, United States AU - Wree, A. AU - Johnson, C. D. AU - Font-Burgada, J. AU - Eguchi, A. AU - Povero, D. AU - Karin, M. AU - Feldstein, A. E. DB - Embase Medline DO - 10.1038/cdd.2015.46 IS - 12 LA - English M3 - Article N1 - L604025759 2015-05-01 2015-11-25 PY - 2015 SN - 1476-5403 1350-9047 SP - 1985-1994 ST - Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation T2 - Cell Death and Differentiation TI - Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604025759&from=exporthttp://dx.doi.org/10.1038/cdd.2015.46 VL - 22 ID - 6195 ER - TY - JOUR AD - E. L. Langmack, Department of Medicine, National Jewish Health, 1400 Jackson Street J210, Denver, CO 80206, United States AU - Langmack, E. L. AU - Martin, R. J. DB - Embase Medline DO - 10.1097/MCP.0b013e328333af9c IS - 1 LA - English M3 - Review N1 - L358137026 2010-02-22 PY - 2010 SN - 1070-5287 1531-6971 SP - 13-18 ST - Heterogeneity of response to asthma controller therapy: Clinical implications T2 - Current Opinion in Pulmonary Medicine TI - Heterogeneity of response to asthma controller therapy: Clinical implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358137026&from=exporthttp://dx.doi.org/10.1097/MCP.0b013e328333af9c VL - 16 ID - 6196 ER - TY - JOUR AD - W.W. Zomerman, University Medical Center Groningen, Groningen, Netherlands AU - Zomerman, W. W. AU - Plasschaert, S. L. A. AU - Diks, S. H. AU - Lourens, H. J. AU - Hoving, E. W. AU - Den Dunnen, W. F. A. AU - De Bont, E. S. J. M. DB - Embase DO - 10.1158/1538-7445.PEDCAN-B10 IS - 20 LA - English M3 - Conference Abstract N1 - L71713760 2014-12-15 PY - 2014 SN - 0008-5472 ST - HGF enhances tumor cell survival in canertinib-treated medulloblastoma cell lines T2 - Cancer Research TI - HGF enhances tumor cell survival in canertinib-treated medulloblastoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713760&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCAN-B10http://cancerres.aacrjournals.org/content/74/20_Supplement/B10.abstract?sid=f9b05294-a6e7-4cb0-9399-0ae34b2b4a9b VL - 74 ID - 6197 ER - TY - JOUR AD - M.M. Van Noesel, Erasmus MC-Sophia Children's Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, Netherlands AU - Duijkers, F. A. M. AU - Gaal, J. AU - Meijerink, J. P. P. AU - Admiraal, P. AU - Pieters, R. AU - De Krijger, R. R. AU - Van Noesel, M. M. DB - Embase Medline DO - 10.1016/j.ajpath.2011.12.003 IS - 3 LA - English M3 - Article N1 - L364289854 2012-02-28 2012-03-01 PY - 2012 SN - 0002-9440 1525-2191 SP - 1223-1231 ST - High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome T2 - American Journal of Pathology TI - High anaplastic lymphoma kinase immunohistochemical staining in neuroblastoma and ganglioneuroblastoma is an independent predictor of poor outcome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364289854&from=exporthttp://dx.doi.org/10.1016/j.ajpath.2011.12.003 VL - 180 ID - 6198 ER - TY - JOUR AD - Medical Genetics/Hematology and Oncology, CLS, CAMS, King Saud Bin Abdulaziz University for Health Sciences/KAIMRC, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, Saudi Arabia Department of Zoology, University of the Punjab, Lahore, Pakistan Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan Hematology Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group, Health Sciences/Parasitology Laboratories (HSL), Department of Zoology, University of the Punjab (ZPU), Lahore, Pakistan Division of Hematology/Oncology, Department of Medicine, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia Centre of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia Translational Genomic Instability Program, Harvard (Dana-Farber) Cancer Institute, Harvard Medical School, Harvard University, Boston, MA, United States Department of Oncology, Allied Hospital, Punjab Medical College, Faisalabad, Pakistan Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan Hayatabad Medical Complex, Peshawar, Pakistan Department of Oncology, Khyber Teaching Hospital, Peshawar, Pakistan Cox Health System, Springfield, MO, United States Department of Biotechnology, University of Peshawar, Peshawar, Pakistan Core DNA Facilities, Centre for Advanced Molecular Biology, University of the Punjab, Lahore, Pakistan Department of Biotechnology, University of Sargodha, Sargodha, Pakistan Institute of Molecular Biology and Biotechnology (IMBB), Centre for Research in Molecular Medicine (CRiMM), The University of Lahore, Lahore, Pakistan Stem Cell Research Group, Department of Anatomy, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia Asian Medical Institute and National Surgical Centre, Kant, Kyrgyzstan Pakistan Society for Molecular and Clinical Hematology (PSMH) & Hematology Oncology and Pharmacogenetic Engineering Sciences Group (HOPES), Lahore, Pakistan Prince Abdullah Bin Khalid Celiac Disease Research Chair, King Saud University, Riyadh, Saudi Arabia Department of Chemistry, University of Sargodha, Sargodha, Pakistan AU - Iqbal, Z. AU - Akhtar, T. AU - Awan, T. AU - Aleem, A. AU - Sabir, N. AU - Rasool, M. AU - Absar, M. AU - Akram, A. M. AU - Shammas, M. A. AU - Shah, I. H. AU - Khalid, M. AU - Taj, A. S. AU - Jameel, A. AU - Alanazi, A. AU - Gill, A. T. AU - Hashmi, J. A. AU - Hussain, A. AU - Sabar, M. F. AU - Khalid, A. M. AU - Qazi, M. H. AU - Karim, S. AU - Siddiqi, M. H. AU - Mahmood, A. AU - Iqbal, M. AU - Saeed, A. AU - Irfan, M. I. DB - Scopus DO - 10.1007/s40291-015-0149-0 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 277-287 ST - High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan T2 - Molecular Diagnosis and Therapy TI - High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942504078&doi=10.1007%2fs40291-015-0149-0&partnerID=40&md5=2cb2b09ec40778d79bc38c3a40d60d9d VL - 19 ID - 6199 ER - TY - JOUR AD - Department of Medical Biochemistry and Genetics and MediCity Research Laboratories, University of Turku, Finland; Turku Doctoral Programme of Molecular Medicine, Turku, Finland. AN - 24374844 AU - Kurppa, K. J. AU - Catón, J. AU - Morgan, P. R. AU - Ristimäki, A. AU - Ruhin, B. AU - Kellokoski, J. AU - Elenius, K. AU - Heikinheimo, K. C2 - PMC4255689 DA - Apr DO - 10.1002/path.4317 10.1002/path.4317. Epub 2014 Jan 31. DP - Nlm ET - 2014/01/01 IS - 5 LA - eng PY - 2014 SN - 0022-3417 (Print) 0022-3417 SP - 492-8 ST - High frequency of BRAF V600E mutations in ameloblastoma T2 - J Pathol TI - High frequency of BRAF V600E mutations in ameloblastoma VL - 232 ID - 6200 ER - TY - JOUR AD - Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan. AN - 16691193 AU - Ichii-Nakato, N. AU - Takata, M. AU - Takayanagi, S. AU - Takashima, S. AU - Lin, J. AU - Murata, H. AU - Fujimoto, A. AU - Hatta, N. AU - Saida, T. DA - Sep DO - 10.1038/sj.jid.5700366 10.1038/sj.jid.5700366. Epub 2006 May 11. DP - Nlm ET - 2006/05/13 IS - 9 LA - eng PY - 2006 SN - 0022-202X (Print) 0022-202x SP - 2111-8 ST - High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi T2 - J Invest Dermatol TI - High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi VL - 126 ID - 6201 ER - TY - JOUR AD - Department of Pathology and CIGH/CNRS, CHU Purpan, Toulouse, France. AN - 8547653 AU - Lamant, L. AU - Meggetto, F. AU - al Saati, T. AU - Brugières, L. AU - de Paillerets, B. B. AU - Dastugue, N. AU - Bernheim, A. AU - Rubie, H. AU - Terrier-Lacombe, M. J. AU - Robert, A. AU - Rigal, F. AU - Schlaifer, D. AU - Shiuta, M. AU - Mori, S. AU - Delsol, G. DA - Jan 1 DP - Nlm ET - 1996/01/01 IS - 1 LA - eng N1 - Lamant, L Meggetto, F al Saati, T Brugières, L de Paillerets, B B Dastugue, N Bernheim, A Rubie, H Terrier-Lacombe, M J Robert, A Rigal, F Schlaifer, D Shiuta, M Mori, S Delsol, G Comparative Study Journal Article Research Support, Non-U.S. Gov't United States Blood. 1996 Jan 1;87(1):284-91. PY - 1996 SN - 0006-4971 (Print) 0006-4971 SP - 284-91 ST - High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining T2 - Blood TI - High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining VL - 87 ID - 6202 ER - TY - JOUR AD - Department of Clinical Laboratory Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, Japan. a-hishi@dokkyomed.ac.jp AN - 16187918 AU - Hishinuma, A. AU - Fukata, S. AU - Kakudo, K. AU - Murata, Y. AU - Ieiri, T. DA - Sep DO - 10.1089/thy.2005.15.1079 10.1089/thy.2005.15.1079. DP - Nlm ET - 2005/09/29 IS - 9 LA - eng PY - 2005 SN - 1050-7256 (Print) 1050-7256 SP - 1079-84 ST - High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations T2 - Thyroid TI - High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations VL - 15 ID - 6203 ER - TY - JOUR AD - Cancer Research Center of Toulouse, INSERM U1037-Université Toulouse III-Paul Sabatier-CNRS ERL5294, F-31037 Toulouse, France. Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. Ligue Nationale Contre le Cancer, équipe labellisée 2016, F-31037 Toulouse, France. European Research Initiative on ALK-related malignancies (ERIA), Cambridge CB2 0QQ, UK. Merck Serono S.A., Department of Biotechnology Process Sciences, Route de Fenil 25, Z.I. B, 1804 Corsier-sur-Vevey, Switzerland. Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy. Pôle Technologique du CRCT-Plateau de Cytométrie et Tri cellulaire-INSERM U1037, F-31037 Toulouse, France. TRANSAUTOPHAGY: European Network for Multidisciplinary Research and Translation of Autophagy Knowledge, COST Action CA15138, 08193 Barcelona, Spain. AN - 33066037 AU - Sorrentino, D. AU - Frentzel, J. AU - Mitou, G. AU - Blasco, R. B. AU - Torossian, A. AU - Hoareau-Aveilla, C. AU - Pighi, C. AU - Farcé, M. AU - Meggetto, F. AU - Manenti, S. AU - Espinos, E. AU - Chiarle, R. AU - Giuriato, S. C2 - PMC7650725 DA - Oct 13 DO - 10.3390/cancers12102951 10.3390/cancers12102951. DP - Nlm ET - 2020/10/18 IS - 10 LA - eng PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells T2 - Cancers (Basel) TI - High Levels of miR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells VL - 12 ID - 6204 ER - TY - JOUR AD - Division of Cancer Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, U.K. AN - 24641191 AU - Pourreyron, C. AU - Chen, M. AU - McGrath, J. A. AU - Salas-Alanis, J. C. AU - South, A. P. AU - Leigh, I. M. DA - Jun DO - 10.1111/bjd.12715 10.1111/bjd.12715. DP - Nlm ET - 2014/03/20 IS - 6 LA - eng PY - 2014 SN - 0007-0963 SP - 1256-65 ST - High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion T2 - Br J Dermatol TI - High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion VL - 170 ID - 6205 ER - TY - JOUR AD - Amgen Inc., Thousand Oaks, CA 91320-1799, USA. sross@amgen.com AN - 16945013 AU - Ross, S. AU - Chen, T. AU - Yu, V. AU - Tudor, Y. AU - Zhang, D. AU - Liu, L. AU - Tamayo, N. AU - Dominguez, C. AU - Powers, D. DA - Aug DO - 10.1089/adt.2006.4.397 10.1089/adt.2006.4.397. DP - Nlm ET - 2006/09/02 IS - 4 LA - eng PY - 2006 SN - 1540-658X (Print) 1540-658x SP - 397-409 ST - High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays T2 - Assay Drug Dev Technol TI - High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays VL - 4 ID - 6206 ER - TY - JOUR AD - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of Translational Genomics, Via Sommarive, 9, Trento, 38123, Italy UOC Bioterapie, Ospedale Policlinico San Martino, Lgo R. Benzi, 10, Genova, 16132, Italy Istituto di Ricerca Pediatrica (IRP), Citta della Speranza, Padova, Italy High Throughput Screening Core Facility, CIBIO, University of Trento, Trento, Italy University of Naples Federico II, Napoli, Italy CEINGE Biotecnologie Avanzate, Napoli, Italy Animal Facility, Ospedale Policlinico San Martino, Genova, Italy University of Genova, Genova, Italy Ospedale Policlinico San Martino, Genova, Italy IRCCS SDN, Istituto di Ricerca Diagnostica e Nucleare, Napoli, Italy Laboratory of Biosciences, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl - IRCCS, Meldola, Italy AU - Sidarovich, V. AU - De Mariano, M. AU - Aveic, S. AU - Pancher, M. AU - Adami, V. AU - Gatto, P. AU - Pizzini, S. AU - Pasini, L. AU - Croce, M. AU - Parodi, F. AU - Cimmino, F. AU - Avitabile, M. AU - Emionite, L. AU - Cilli, M. AU - Ferrini, S. AU - Pagano, A. AU - Capasso, M. AU - Quattrone, A. AU - Tonini, G. P. AU - Longo, L. DB - Scopus DO - 10.1158/1535-7163.MCT-17-0841 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 1405-1415 ST - A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy T2 - Molecular Cancer Therapeutics TI - A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045926808&doi=10.1158%2f1535-7163.MCT-17-0841&partnerID=40&md5=5a558c5d95f45acab7c69ca5bf990776 VL - 17 ID - 6207 ER - TY - JOUR AD - Department of Clinical Oncology, Odense University Hospital, Odense, Denmark. Electronic address: lars.bastholt@rsyd.dk. Center for Cancer Immune Therapy, Department of Oncology and Haematology, Copenhagen University Hospital, Herlev, Denmark. Department of Clinical Oncology, Odense University Hospital, Odense, Denmark. Center for Evidence-Based Medicine, University of Southern Denmark, Odense, Denmark. Department of Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. AN - 31108244 AU - Bastholt, L. AU - Svane, I. M. AU - Bjerregaard, J. K. AU - Herrstedt, J. AU - Hróbjartsson, A. AU - Schmidt, H. DA - Jul DO - 10.1016/j.ejca.2019.03.023 10.1016/j.ejca.2019.03.023. Epub 2019 May 17. DP - Nlm ET - 2019/05/21 LA - eng PY - 2019 SN - 0959-8049 SP - 61-67 ST - High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort T2 - Eur J Cancer TI - High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort VL - 115 ID - 6208 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. deepa.bhojwani@stjude.org AN - 105330944. Language: English. Entry Date: 20091211. Revision Date: 20200708. Publication Type: Journal Article AU - Bhojwani, D. AU - Howard, S. C. AU - Pui, C. DB - ccm DO - 10.3816/CLM.2009.s.016 DP - EBSCOhost N1 - review; tables/charts. Supplement Title: Sep2009 Supplement 3. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101256500. PMID: NLM19778845. PY - 2009 SN - 1557-9190 SP - S222-30 ST - High-risk childhood acute lymphoblastic leukemia T2 - Clinical Lymphoma & Myeloma TI - High-risk childhood acute lymphoblastic leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105330944&site=ehost-live&scope=site VL - 9 ID - 6209 ER - TY - JOUR AD - L. Lee, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Lee, L. AU - Krupski, M. C. AU - Clark, J. AU - Lorsbach, R. B. AU - Grimley, M. AU - Burwinkel, M. AU - Nelson, A. S. AU - Kumar, A. R. DB - Embase DO - 10.1182/blood-2018-99-119383 LA - English M3 - Conference Abstract N1 - L626531107 2019-03-04 PY - 2018 SN - 0006-4971 ST - High-risk langerhans cell histiocytosis in infants exhibits malignant features in a xenograft model but responds durably to targeted therapy T2 - Blood TI - High-risk langerhans cell histiocytosis in infants exhibits malignant features in a xenograft model but responds durably to targeted therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626531107&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-119383 VL - 132 ID - 6210 ER - TY - JOUR AD - Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; and. Division of Bone Marrow Transplant and Immune Deficiency. Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute, and. Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. AN - 32092141 AU - Lee, L. H. AU - Krupski, C. AU - Clark, J. AU - Wunderlich, M. AU - Lorsbach, R. B. AU - Grimley, M. S. AU - Burwinkel, M. AU - Nelson, A. AU - Kumar, A. R. C2 - PMC7042980 and Sobi for primary HLH therapy. The remaining authors declare no competing financial interests. DA - Feb 25 DO - 10.1182/bloodadvances.2019032367 10.1182/bloodadvances.2019032367. DP - Nlm ET - 2020/02/25 IS - 4 LA - eng PY - 2020 SN - 2473-9529 (Print) 2473-9529 SP - 717-727 ST - High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy T2 - Blood Adv TI - High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy VL - 4 ID - 6211 ER - TY - JOUR AD - W. Yang, NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China AU - Xu, H. AU - Cheng, M. AU - Chi, X. AU - Liu, X. AU - Zhou, J. AU - Lin, T. AU - Yang, W. DB - Embase DO - 10.1128/JVI.00758-19 IS - 19 LA - English M3 - Article N1 - L629624943 2019-10-23 2019-10-31 PY - 2019 SN - 1098-5514 0022-538X ST - High-throughput screening identifies mixed-lineage kinase 3 as a key host regulatory factor in Zika virus infection T2 - Journal of Virology TI - High-throughput screening identifies mixed-lineage kinase 3 as a key host regulatory factor in Zika virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629624943&from=exporthttp://dx.doi.org/10.1128/JVI.00758-19 VL - 93 ID - 6212 ER - TY - JOUR AD - F. Meng, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Zhu, Q. AU - Zhang, L. AU - Li, X. AU - Chen, F. AU - Jiang, L. AU - Yu, G. AU - Wang, Z. AU - Yin, C. AU - Jiang, X. AU - Zhong, Q. AU - Zhou, H. AU - Ding, B. AU - Wang, C. AU - Meng, F. DB - Embase Medline DO - 10.1007/s13277-016-4983-4 IS - 8 LA - English M3 - Article N1 - L609238443 2016-03-31 2016-09-06 PY - 2016 SN - 1423-0380 1010-4283 SP - 11409-11420 ST - Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia T2 - Tumor Biology TI - Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609238443&from=exporthttp://dx.doi.org/10.1007/s13277-016-4983-4 VL - 37 ID - 6213 ER - TY - JOUR AD - Drug Development Unit, Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom. Drug Development Unit, Division of Cancer Therapeutics and Division of Clinical Studies, The Institute of Cancer Research and The Royal Marsden, London, United Kingdom. udai.banerji@icr.ac.uk. AN - 25649020 AU - Rafii, S. AU - Roda, D. AU - Geuna, E. AU - Jimenez, B. AU - Rihawi, K. AU - Capelan, M. AU - Yap, T. A. AU - Molife, L. R. AU - Kaye, S. B. AU - de Bono, J. S. AU - Banerji, U. C2 - PMC4401558 C6 - EMS62092 DA - Apr 15 DO - 10.1158/1078-0432.Ccr-14-2424 10.1158/1078-0432.CCR-14-2424. Epub 2015 Feb 3. DP - Nlm ET - 2015/02/05 IS - 8 LA - eng PY - 2015 SN - 1078-0432 (Print) 1078-0432 SP - 1869-76 ST - Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials T2 - Clin Cancer Res TI - Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials VL - 21 ID - 6214 ER - TY - JOUR AD - J.S. Grewal, Department of Internal Medicine, Reichert Health Center, St. Joseph Mercy Hospital, 5333 McAuley Drive, Ann Arbor, MI 48106-0995, United States AU - Grewal, J. S. AU - Smith, L. B. AU - Winegarden Iii, J. D. AU - Krauss, J. C. AU - Tworek, J. A. AU - Schnitzer, B. C1 - vm 26 vp 16 DB - Embase Medline DO - 10.1007/s00277-007-0289-3 IS - 7 LA - English M3 - Article N1 - L46863887 2007-07-01 PY - 2007 SN - 0939-5555 SP - 499-508 ST - Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: A report of three cases and a review of the literature T2 - Annals of Hematology TI - Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: A report of three cases and a review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46863887&from=exporthttp://dx.doi.org/10.1007/s00277-007-0289-3 VL - 86 ID - 6215 ER - TY - JOUR AD - H.K. Abtar, Department of Surgery, Makassed General Hospital, Beirut, Lebanon AU - Chehade, H. H. E. H. AU - Zbibo, R. H. AU - Hussein, B. M. A. AU - Abtar, H. K. DB - Embase Medline DO - 10.12659/AJCR.896036 LA - English M3 - Article N1 - L608634775 2016-04-27 2016-05-02 PY - 2016 SN - 1941-5923 SP - 79-83 ST - Highly vascularized primarily inflammatory pseudotumor of the omentum in an adult male: A case report T2 - American Journal of Case Reports TI - Highly vascularized primarily inflammatory pseudotumor of the omentum in an adult male: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608634775&from=exporthttp://dx.doi.org/10.12659/AJCR.896036 VL - 17 ID - 6216 ER - TY - JOUR AD - C. Vanden Eycken, KU Leuven, Dermatology, Leuven, Belgium AU - Vanden Eycken, C. AU - Morren, M. A. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779133 2017-10-23 PY - 2017 SN - 1525-1470 SP - S51 ST - Histiocytic disorders: An atypical clinical presentation and histopathology T2 - Pediatric Dermatology TI - Histiocytic disorders: An atypical clinical presentation and histopathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779133&from=exporthttp://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 6217 ER - TY - JOUR AD - Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Queensland University of Technology, Institute of Health and Biomedical Innovation, Brisbane, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Cancer Research UK Manchester Institute & University of Manchester, Manchester, UK. Anatomical Pathology, Sullivan Nicolaides Pathology, Taringa, Queensland, Australia. Anatomical Pathology, IQ Pathology, West End, Queensland, Australia. Anatomical Pathology, Queensland Medical Laboratory, Murarrie, Queensland, Australia. Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: David.Whiteman@qimrberghofer.edu.au. AN - 26807515 AU - Hacker, E. AU - Olsen, C. M. AU - Kvaskoff, M. AU - Pandeya, N. AU - Yeo, A. AU - Green, A. C. AU - Williamson, R. M. AU - Triscott, J. AU - Wood, D. AU - Mortimore, R. AU - Hayward, N. K. AU - Whiteman, D. C. DA - Apr DO - 10.1016/j.jid.2015.12.035 10.1016/j.jid.2015.12.035. Epub 2016 Jan 22. DP - Nlm ET - 2016/01/26 IS - 4 LA - eng PY - 2016 SN - 0022-202x SP - 829-837 ST - Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas T2 - J Invest Dermatol TI - Histologic and Phenotypic Factors and MC1R Status Associated with BRAF(V600E), BRAF(V600K), and NRAS Mutations in a Community-Based Sample of 414 Cutaneous Melanomas VL - 136 ID - 6218 ER - TY - JOUR AD - Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu 210093, P.R. China. Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China. Department of Respiratory Medicine, Nanjing Children's Hospital Affiliated with Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China. AN - 27460781 AU - Feng, Q. AU - Su, Z. AU - Song, S. AU - Χu, H. AU - Zhang, B. AU - Yi, L. AU - Tian, M. AU - Wang, H. C2 - PMC4990302 DA - Sep DO - 10.3892/ijmm.2016.2691 10.3892/ijmm.2016.2691. Epub 2016 Jul 26. DP - Nlm ET - 2016/07/28 IS - 3 LA - eng PY - 2016 SN - 1107-3756 (Print) 1107-3756 SP - 812-22 ST - Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation T2 - Int J Mol Med TI - Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation VL - 38 ID - 6219 ER - TY - JOUR AD - Department of Dermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA. AN - 20732960 AU - Nardone, B. AU - Nicholson, K. AU - Newman, M. AU - Guitart, J. AU - Gerami, P. AU - Talarico, N. AU - Yang, X. J. AU - Rademaker, A. AU - West, D. P. AU - Lacouture, M. E. DA - Sep 1 DO - 10.1158/1078-0432.Ccr-10-0421 10.1158/1078-0432.CCR-10-0421. Epub 2010 Aug 23. DP - Nlm ET - 2010/08/25 IS - 17 LA - eng PY - 2010 SN - 1078-0432 (Print) 1078-0432 SP - 4452-60 ST - Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients T2 - Clin Cancer Res TI - Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients VL - 16 ID - 6220 ER - TY - JOUR AD - Laboratory of Morphology of Endocrine System, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. Department of Pathology, University of Pittsburgh School of Medicine, 3477 Euler Way, Pittsburgh, PA 15213, USA. Department of Fundamental and Applied Problems of Endocrinology, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 9609 Medical Center Drive, MSC 9778, Bethesda, MD 20892-9778, USA. Department of Dosimetry and Radiation Protection, State Institution 'National Research Center for Radiation Medicine of Academy of Medical Sciences of Ukraine', Melnikova Street 53, Kyiv 04050, Ukraine. Laboratory of Radiation Protection, State Institution 'National Research Centre for Radiation Medicine of Academy of Medical Sciences of Ukraine', Melnikova Street 53, Kyiv 04050, Ukraine. Department of Epidemiology and Biostatistics, University of California San Francisco, 3333 California Street, San Francisco, CA 94118-1944, USA. Department of Medical Consequences of the Chernobyl accident and International Cooperation, State Institution 'V.P. Komisarenko Institute of Endocrinology and Metabolism of Academy of Medical Sciences of Ukraine', Vishegorodskaya Street 69, Kyiv 254114, Ukraine. The Thyroid Center, Columbia University, 161 Fort Washington Avenue, New York, NY, 10032, USA. Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA. AN - 26625214 AU - Bogdanova, T. I. AU - Zurnadzhy, L. Y. AU - Nikiforov, Y. E. AU - Leeman-Neill, R. J. AU - Tronko, M. D. AU - Chanock, S. AU - Mabuchi, K. AU - Likhtarov, I. A. AU - Kovgan, L. M. AU - Drozdovitch, V. AU - Little, M. P. AU - Hatch, M. AU - Zablotska, L. B. AU - Shpak, V. M. AU - McConnell, R. J. AU - Brenner, A. V. C2 - PMC4705885 DA - Dec 1 DO - 10.1038/bjc.2015.372 10.1038/bjc.2015.372. Epub 2015 Dec 3. DP - Nlm ET - 2015/12/02 IS - 11 LA - eng PY - 2015 SN - 0007-0920 (Print) 0007-0920 SP - 1556-64 ST - Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort T2 - Br J Cancer TI - Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort VL - 113 ID - 6221 ER - TY - JOUR AD - National Cancer Institute, Laboratory of Pathology, Building 10, 9000 Rockville Pike, Bethesda 20892, MA, United States Armed Forces Institute of Pathology, Washington, DC, United States AU - Miettinen, M. AU - Lasota, J. DB - Scopus DO - 10.1002/jso.21945 IS - 8 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2011 SP - 865-873 ST - Histopathology of gastrointestinal stromal tumor T2 - Journal of Surgical Oncology TI - Histopathology of gastrointestinal stromal tumor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80855130376&doi=10.1002%2fjso.21945&partnerID=40&md5=e470eb0f280d190c77049ef767fc78bb VL - 104 ID - 6222 ER - TY - JOUR AD - Department of Pediatrics and Medicine, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, United States AU - Simone, J. V. DB - Scopus DO - 10.1016/j.beha.2005.11.003 IS - 2 M3 - Review N1 - Cited By :35 Export Date: 18 November 2020 PY - 2006 SP - 353-359 ST - History of the treatment of childhood ALL: A paradigm for cancer cure T2 - Best Practice and Research: Clinical Haematology TI - History of the treatment of childhood ALL: A paradigm for cancer cure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644560026&doi=10.1016%2fj.beha.2005.11.003&partnerID=40&md5=0f40d790090438eb1a5ff41e8214404c VL - 19 ID - 6223 ER - TY - JOUR AD - M. Fiala, UCLA CHS 63-090, 10833 Le Conte Avenue, Los Angeles, CA 90095-1760, United States AU - Fiala, M. AU - Popik, W. AU - Qiao, J. H. AU - Lossinsky, A. S. AU - Alce, T. AU - Tran, K. AU - Yang, W. AU - Roos, K. P. AU - Arthos, J. DB - Embase Medline DO - 10.1385/ct:4:2:097 IS - 2 LA - English M3 - Article N1 - L39310744 2004-10-14 PY - 2004 SN - 1530-7905 SP - 97-107 ST - HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling T2 - Cardiovascular Toxicology TI - HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39310744&from=exporthttp://dx.doi.org/10.1385/ct:4:2:097 VL - 4 ID - 6224 ER - TY - JOUR AD - R. Dantzer, Integrative Immunology and Behavior Program, Department of Animal Sciences, College of ACES, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States AU - Fu, X. AU - Lawson, M. A. AU - Kelley, K. W. AU - Dantzer, R. DB - Embase Medline DO - 10.1186/1742-2094-8-88 LA - English M3 - Article N1 - L51557415 2011-08-05 2011-09-16 PY - 2011 SN - 1742-2094 ST - HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner T2 - Journal of Neuroinflammation TI - HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51557415&from=exporthttp://dx.doi.org/10.1186/1742-2094-8-88http://www.jneuroinflammation.com/content/8/1/88 VL - 8 ID - 6225 ER - TY - JOUR AD - A. S. Y. Lau, Department of Paediatrics and Adolescent Medicine, Cytokine Biology Group, University of Hong Kong, Pokfulam, Hong Kong AU - Yim, H. C. H. AU - Li, J. C. B. AU - Lau, J. S. H. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1097/QAD.0b013e32832d7abe IS - 12 LA - English M3 - Article N1 - L355094122 2009-09-15 PY - 2009 SN - 0269-9370 1473-5571 SP - 1473-1484 ST - HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: Microbial interactions in HIV infection T2 - AIDS TI - HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: Microbial interactions in HIV infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355094122&from=exporthttp://dx.doi.org/10.1097/QAD.0b013e32832d7abe VL - 23 ID - 6226 ER - TY - JOUR AD - L. Yang, Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China AU - Tang, L. AU - Chai, W. AU - Ye, F. AU - Yu, Y. AU - Cao, L. AU - Yang, M. AU - Xie, M. AU - Yang, L. C2 - Cell Signaling Technology(United States) DB - Embase DO - 10.18632/oncotarget.15432 IS - 16 LA - English M3 - Article N1 - L615452440 2017-04-24 2017-05-12 PY - 2017 SN - 1949-2553 SP - 27314-27327 ST - HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells T2 - Oncotarget TI - HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615452440&from=exporthttp://dx.doi.org/10.18632/oncotarget.15432 VL - 8 ID - 6227 ER - TY - JOUR AD - Department of Stomatology, The Second Affiliated Hospital Of Xinjiang Medical University, Urumqi, China. 418617006@qq.com. AN - 30024628 AU - Xu, J. AU - Yang, Z. Y. AU - Chen, X. AU - Liu, X. DA - Jul DO - 10.26355/eurrev_201807_15435 10.26355/eurrev_201807_15435. DP - Nlm ET - 2018/07/20 IS - 13 LA - eng PY - 2018 SN - 1128-3602 SP - 4363-4370 ST - HMTH1 induces the metastasis and recurrence of the parotid adenoma by repairing DNA damage T2 - Eur Rev Med Pharmacol Sci TI - HMTH1 induces the metastasis and recurrence of the parotid adenoma by repairing DNA damage VL - 22 ID - 6228 ER - TY - JOUR AD - H.Y. Lu, BC Children's Hospital, University of British Columbia AU - Lu, H. Y. AU - Suresh, S. AU - McGonigle, L. AU - Luider, J. AU - Turvey, S. E. DB - Embase DO - 10.1007/s10875-019-00597-5 LA - English M3 - Conference Abstract N1 - L632157232 2020-07-24 PY - 2020 SN - 1573-2592 SP - S22 ST - Homozygosity for a novel CARD11 mutation causes severe combined immunodeficiency (SCID), inflammatory gastrointestinal disease, and complete abrogation of MALT1 activity T2 - Journal of Clinical Immunology TI - Homozygosity for a novel CARD11 mutation causes severe combined immunodeficiency (SCID), inflammatory gastrointestinal disease, and complete abrogation of MALT1 activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632157232&from=exporthttp://dx.doi.org/10.1007/s10875-019-00597-5 VL - 39 ID - 6229 ER - TY - JOUR AD - L. Xiang, Laboratory of Early Developmental and Injuries, West China Institutes for Womanand Children’s Health, West China Second University Hospital Sichuan University, Chengdu, Sichuan, China AU - Yiwei, T. AU - Hua, H. AU - Hui, G. AU - Mao, M. AU - Xiang, L. DB - Embase Medline DO - 10.12659/MSM.893528 LA - English M3 - Article N1 - L605004157 2015-07-06 PY - 2015 SN - 1643-3750 1234-1010 SP - 1856-1863 ST - HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion T2 - Medical Science Monitor TI - HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605004157&from=exporthttp://dx.doi.org/10.12659/MSM.893528 VL - 21 ID - 6230 ER - TY - JOUR AD - The Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. AN - 15547749 AU - Miao, J. AU - Kusafuka, T. AU - Fukuzawa, M. DA - Dec DP - Nlm ET - 2004/11/18 IS - 6 LA - eng N1 - Miao, Jiangyong Kusafuka, Takeshi Fukuzawa, Masahiro Journal Article Greece Oncol Rep. 2004 Dec;12(6):1269-72. PY - 2004 SN - 1021-335X (Print) 1021-335x SP - 1269-72 ST - Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms T2 - Oncol Rep TI - Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms VL - 12 ID - 6231 ER - TY - JOUR AD - Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, NY, United States Department of Pediatrics, Children's Hospital of Orange County, Orange, CA, United States Department of Pediatrics and Cell and Molecular Biology, Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, United States AU - Andolina, J. R. AU - Neudorf, S. M. AU - Corey, S. J. DB - Scopus DO - 10.1182/blood-2011-10-380774 IS - 8 M3 - Review N1 - Cited By :56 Export Date: 18 November 2020 PY - 2012 SP - 1821-1830 ST - How I treat childhood CML T2 - Blood TI - How I treat childhood CML UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857606947&doi=10.1182%2fblood-2011-10-380774&partnerID=40&md5=89b04434f48154de7d9f0d2f5d52174b VL - 119 ID - 6232 ER - TY - JOUR AD - F. Locatelli, University of Pavia, Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Piazza Sant'Onofrio, 4., Rome, Italy AU - Locatelli, F. AU - Niemeyer, C. M. DB - Embase Medline DO - 10.1182/blood-2014-08-550483 IS - 7 LA - English M3 - Article N1 - L602248295 2015-03-02 2015-03-05 PY - 2015 SN - 1528-0020 0006-4971 SP - 1083-1090 ST - How I treat juvenile myelomonocytic leukemia T2 - Blood TI - How I treat juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602248295&from=exporthttp://dx.doi.org/10.1182/blood-2014-08-550483 VL - 125 ID - 6233 ER - TY - JOUR AD - G. Kaspers, Paediatric Oncology/Haematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV, Amsterdam, Netherlands AU - Kaspers, G. C1 - ac 220 gsk 1120212 i bet 151 jq 1 mln 8237 DB - Embase Medline DO - 10.1111/bjh.12947 IS - 5 LA - English M3 - Article N1 - L53139956 2014-05-22 2014-08-29 PY - 2014 SN - 1365-2141 0007-1048 SP - 636-645 ST - How I treat paediatric relapsed acute myeloid leukaemia T2 - British Journal of Haematology TI - How I treat paediatric relapsed acute myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53139956&from=exporthttp://dx.doi.org/10.1111/bjh.12947 VL - 166 ID - 6234 ER - TY - JOUR AD - Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States Department of Pediatrics, Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States AU - Maese, L. AU - Tasian, S. K. AU - Raetz, E. A. DB - Scopus DO - 10.1016/j.beha.2017.06.001 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2017 SP - 222-228 ST - How is the Ph-like signature being incorporated into ALL therapy? T2 - Best Practice and Research: Clinical Haematology TI - How is the Ph-like signature being incorporated into ALL therapy? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021100450&doi=10.1016%2fj.beha.2017.06.001&partnerID=40&md5=392a5a33cb0cf6781c55e79e3ee9437a VL - 30 ID - 6235 ER - TY - JOUR AD - Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey. Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Yeditep University, Istanbul, Turkey. Division of Medical Oncology, Umraniye Research and Training Hospital, Istanbul, Turkey. Department of Pathology, Faculty of Medicine, Marmara University, Istanbul, Turkey. Department of Radiology, Faculty of Medicine, Marmara University, Istanbul, Turkey. Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey. AN - 31615346 AU - Alan, O. AU - Kuzhan, O. AU - Koca, S. AU - Telli, T. A. AU - Basoglu, T. AU - Ercelep, O. AU - Filinte, D. AU - Sengul, Y. AU - Arikan, H. AU - Kaya, S. AU - Babacan, N. A. AU - Dane, F. AU - Yumuk, P. F. DA - Jun DO - 10.1177/1078155219879757 10.1177/1078155219879757. Epub 2019 Oct 15. DP - Nlm ET - 2019/10/17 IS - 4 LA - eng PY - 2020 SN - 1078-1552 SP - 1011-1018 ST - How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature T2 - J Oncol Pharm Pract TI - How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature VL - 26 ID - 6236 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. Department of Experimental, Diagnostic and Specialty Medicine-Anatomic Pathology, University of Bologna School of Medicine, Bologna, Italy. AN - 31452453 AU - Xu, B. AU - Serrette, R. AU - Tuttle, R. M. AU - Alzumaili, B. AU - Ganly, I. AU - Katabi, N. AU - Tallini, G. AU - Ghossein, R. C2 - PMC6918873 DA - Dec DO - 10.1089/thy.2019.0328 10.1089/thy.2019.0328. Epub 2019 Oct 10. DP - Nlm ET - 2019/08/28 IS - 12 LA - eng PY - 2019 SN - 1050-7256 (Print) 1050-7256 SP - 1792-1803 ST - How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features T2 - Thyroid TI - How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features VL - 29 ID - 6237 ER - TY - JOUR AD - C. Horbinski, University of Kentucky, 800 Rose St, Lexington, KY 40536, United States AU - Clark, K. AU - Voronovich, Z. AU - Horbinski, C. DB - Embase Medline DO - 10.1309/AJCPFO8IIDNBIJ8Y IS - 3 LA - English M3 - Article N1 - L368963003 2013-05-30 2013-06-04 PY - 2013 SN - 0002-9173 1943-7722 SP - 275-288 ST - How molecular testing can help (and hurt) in the workup of gliomas T2 - American Journal of Clinical Pathology TI - How molecular testing can help (and hurt) in the workup of gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368963003&from=exporthttp://dx.doi.org/10.1309/AJCPFO8IIDNBIJ8Yhttp://ajcp.ascpjournals.org/content/139/3/275.full.pdf+html VL - 139 ID - 6238 ER - TY - JOUR AD - P. Kovacic, Department of Chemistry, San Diego State University, 5500 Campanile Dr., San Diego, CA 92182 1030, United States AU - Kovacic, P. DB - Embase Medline DO - 10.1016/j.mehy.2010.03.002 IS - 1 LA - English M3 - Editorial N1 - L50859058 2010-04-07 2010-08-05 PY - 2010 SN - 0306-9877 SP - 1-4 ST - How safe is bisphenol A? Fundamentals of toxicity: Metabolism, electron transfer and oxidative stress T2 - Medical Hypotheses TI - How safe is bisphenol A? Fundamentals of toxicity: Metabolism, electron transfer and oxidative stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50859058&from=exporthttp://dx.doi.org/10.1016/j.mehy.2010.03.002 VL - 75 ID - 6239 ER - TY - JOUR AD - S. Sukumar, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB 1, Baltimore, MD, United States AU - Jin, K. AU - Park, S. AU - Teo, W. W. AU - Korangath, P. AU - Cho, S. S. AU - Yoshida, T. AU - Győrffy, B. AU - Goswami, C. P. AU - Nakshatri, H. AU - Cruz, L. A. AU - Zhou, W. AU - Ji, H. AU - Su, Y. AU - Ekram, M. AU - Wu, Z. AU - Zhu, T. AU - Polyak, K. AU - Sukumar, S. DB - Embase Medline DO - 10.1158/2159-8290.CD-15-0090 IS - 9 LA - English M3 - Article N1 - L606030783 2015-09-24 2015-09-28 PY - 2015 SN - 2159-8290 2159-8274 SP - 944-959 ST - HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance T2 - Cancer Discovery TI - HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606030783&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-15-0090 VL - 5 ID - 6240 ER - TY - JOUR AD - K.A. Rauen, UCSF, Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA 94115, United States AU - Rauen, K. A. DB - Embase Medline DO - 10.1111/j.1399-0004.2007.00743.x IS - 2 LA - English M3 - Review N1 - L46189213 2007-02-26 PY - 2007 SN - 0009-9163 1399-0004 SP - 101-108 ST - HRAS and the Costello syndrome T2 - Clinical Genetics TI - HRAS and the Costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46189213&from=exporthttp://dx.doi.org/10.1111/j.1399-0004.2007.00743.x VL - 71 ID - 6241 ER - TY - JOUR AD - T. Niihori, Department of Medical Genetics, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980-8574, Japan AU - Niihori, T. AU - Aoki, Y. AU - Okamoto, N. AU - Kurosawa, K. AU - Ohashi, H. AU - Mizuno, S. AU - Kawame, H. AU - Inazawa, J. AU - Ohura, T. AU - Arai, H. AU - Nabatame, S. AU - Kikuchi, K. AU - Kuroki, Y. AU - Miura, M. AU - Tanaka, T. AU - Ohtake, A. AU - Omori, I. AU - Ihara, K. AU - Mabe, H. AU - Watanabe, K. AU - Niijima, S. AU - Okano, E. AU - Numabe, H. AU - Matsubara, Y. DB - Embase Medline DO - 10.1038/jhg.2011.85 IS - 10 LA - English M3 - Article N1 - L362842938 2011-11-09 2011-11-11 PY - 2011 SN - 1434-5161 1435-232X SP - 707-715 ST - HRAS mutants identified in Costello syndrome patients can induce cellular senescence: Possible implications for the pathogenesis of Costello syndrome T2 - Journal of Human Genetics TI - HRAS mutants identified in Costello syndrome patients can induce cellular senescence: Possible implications for the pathogenesis of Costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362842938&from=exporthttp://dx.doi.org/10.1038/jhg.2011.85 VL - 56 ID - 6242 ER - TY - JOUR AD - Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States Department of Anatomy, University of California San Francisco, San Francisco, CA, United States Department of Pathology, Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, United States Department of Pathology, Children's Hospital and Research Center at Oakland, Oakland, CA, United States Department of Pediatrics, Division of Medical Genetics, University of California San Francisco, San Francisco, CA, United States UCSF Comprehensive Cancer Center, Cancer Research Institute, Box 0128, 2340 Sutter Street, San Francisco, CA 94115, United States AU - Estep, A. L. AU - Tidyman, W. E. AU - Teitell, M. A. AU - Cotter, P. D. AU - Rauen, K. A. DB - Scopus DO - 10.1002/ajmg.a.31078 IS - 1 M3 - Article N1 - Cited By :128 Export Date: 18 November 2020 PY - 2006 SP - 8-16 ST - HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy T2 - American Journal of Medical Genetics TI - HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-30144434094&doi=10.1002%2fajmg.a.31078&partnerID=40&md5=5d9f767c624725dc1cb193373bc9ed83 VL - 140 A ID - 6243 ER - TY - JOUR AD - Y. Wei, Department of Gastrointestinal Surgery, Huzhou Central Hospital (Zhejiang University Huzhou Hospital), No. 198 Hongqi Road, Huzhou, China AU - Wei, Y. AU - Shao, J. AU - Wang, Y. AU - Shen, H. AU - Yu, S. AU - Zhang, J. AU - Yin, L. DB - Embase Medline DO - 10.1007/s11010-018-3382-0 IS - 1-2 LA - English M3 - Article N1 - L622664477 2018-06-26 2019-01-24 PY - 2019 SN - 1573-4919 0300-8177 SP - 159-166 ST - Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells T2 - Molecular and Cellular Biochemistry TI - Hsa-miR-370 inhibited P-selectin-induced cell adhesion in human colon adenocarcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622664477&from=exporthttp://dx.doi.org/10.1007/s11010-018-3382-0 VL - 450 ID - 6244 ER - TY - JOUR AD - Department of Ophthalmology, Ningbo Eye Hospital, Ningbo, Zhejiang 315040, P.R. China. Ningbo Central Blood Center, Ningbo, Zhejiang 315040, P.R. China. Department of Ophthalmology, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China. AN - 29845211 AU - Yi, Q. Y. AU - Bai, Z. S. AU - Cai, B. AU - Chen, N. AU - Chen, L. S. AU - Yuan, T. AU - Mao, J. H. C2 - PMC6072295 DA - Aug DO - 10.3892/or.2018.6454 10.3892/or.2018.6454. Epub 2018 May 21. DP - Nlm ET - 2018/05/31 IS - 2 LA - eng PY - 2018 SN - 1021-335X (Print) 1021-335x SP - 682-692 ST - HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK T2 - Oncol Rep TI - HSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK VL - 40 ID - 6245 ER - TY - JOUR AD - Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (mainland). AN - 32065117 AU - Xu, W. AU - Wang, Z. AU - Li, K. AU - Jin, R. C2 - PMC7043341 DA - Feb 17 DO - 10.12659/msm.921649 10.12659/MSM.921649. DP - Nlm ET - 2020/02/18 LA - eng PY - 2020 SN - 1234-1010 (Print) 1234-1010 SP - e921649 ST - Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α T2 - Med Sci Monit TI - Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α VL - 26 ID - 6246 ER - TY - JOUR AU - Xu, W. F. AU - Wang, Z. J. AU - Li, K. AU - Shen, Y. Q. AU - Lu, K. AU - Lv, X. Y. AU - Wen, Y. X. AU - Jin, R. M. DB - Medline DO - 10.1007/s11596-020-2181-5 IS - 2 LA - English M3 - Article N1 - L631651985 2020-05-08 PY - 2020 SN - 2523-899X SP - 354-362 ST - Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells T2 - Current medical science TI - Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631651985&from=exporthttp://dx.doi.org/10.1007/s11596-020-2181-5 VL - 40 ID - 6247 ER - TY - JOUR AD - Institute for Cell, Animal and Population Biology, Ashworth Laboratories, The University of Edinburgh, Edinburgh, Scotland. AN - 11110670 AU - Falcone, F. H. AU - Haas, H. AU - Gibbs, B. F. DA - Dec 15 DP - Nlm ET - 2000/12/09 IS - 13 LA - eng N1 - Falcone, F H Haas, H Gibbs, B F Journal Article Research Support, Non-U.S. Gov't Review United States Blood. 2000 Dec 15;96(13):4028-38. PY - 2000 SN - 0006-4971 (Print) 0006-4971 SP - 4028-38 ST - The human basophil: a new appreciation of its role in immune responses T2 - Blood TI - The human basophil: a new appreciation of its role in immune responses VL - 96 ID - 6248 ER - TY - JOUR AD - S. Otsuki, Pediatrics, Stanford University, Stanford, CA, United States AU - Otsuki, S. AU - Saito, T. AU - Taylor, S. AU - Li, D. AU - Moonen, J. R. AU - Marciano, D. AU - Harper, R. AU - Cao, A. AU - Wang, L. AU - Roof, M. B. AU - Ariza, M. E. AU - Rabinovitch, M. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L632376362 2020-07-27 PY - 2020 SN - 1535-4970 ST - Human endogenous retrovirus k induces a pro-inflammatory and endothelial to mesenchymal phenotype in pulmonary artery endothelial cells T2 - American Journal of Respiratory and Critical Care Medicine TI - Human endogenous retrovirus k induces a pro-inflammatory and endothelial to mesenchymal phenotype in pulmonary artery endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632376362&from=export VL - 201 ID - 6249 ER - TY - JOUR AD - L. Mou, Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, China AU - Gao, H. AU - Liu, L. AU - Zhao, Y. AU - Hara, H. AU - Chen, P. AU - Xu, J. AU - Tang, J. AU - Wei, L. AU - Li, Z. AU - Cooper, D. K. C. AU - Cai, Z. AU - Mou, L. DB - Embase Medline DO - 10.1111/xen.12291 IS - 2 LA - English M3 - Article N1 - L615149944 2017-04-07 2017-05-04 PY - 2017 SN - 1399-3089 0908-665X ST - Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells T2 - Xenotransplantation TI - Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615149944&from=exporthttp://dx.doi.org/10.1111/xen.12291 VL - 24 ID - 6250 ER - TY - JOUR AD - D.S. Kaufman, Department of Medicine, Division of Regenerative Medicine, Moores Cancer Center and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA, United States AU - Li, Y. AU - Hermanson, D. L. AU - Moriarity, B. S. AU - Kaufman, D. S. DB - Embase Medline DO - 10.1016/j.stem.2018.06.002 IS - 2 LA - English M3 - Article N1 - L2000887071 2018-06-29 2018-11-27 PY - 2018 SN - 1875-9777 1934-5909 SP - 181-192.e5 ST - Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity T2 - Cell Stem Cell TI - Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000887071&from=exporthttp://dx.doi.org/10.1016/j.stem.2018.06.002 VL - 23 ID - 6251 ER - TY - JOUR AD - Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, United States Department of Clinical Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC, United States Field Analytics, BASF Plant Science, Ames, IA, United States AU - Castellino, S. AU - O'Mara, M. AU - Koch, K. AU - Borts, D. J. AU - Bowers, G. D. AU - MacLauchlin, C. DB - Scopus DO - 10.1124/dmd.111.040949 IS - 1 M3 - Article N1 - Cited By :68 Export Date: 18 November 2020 PY - 2012 SP - 139-150 ST - Human metabolism of lapatinib, a dual kinase inhibitor: Implications for hepatotoxicity T2 - Drug Metabolism and Disposition TI - Human metabolism of lapatinib, a dual kinase inhibitor: Implications for hepatotoxicity UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84455171485&doi=10.1124%2fdmd.111.040949&partnerID=40&md5=08bca86252f1d56b0cf159cf23ab98d5 VL - 40 ID - 6252 ER - TY - JOUR AD - J. Zhu, Department of Epidemiology and Microbiology, Huadong Medical Institute of Biotechniques, 293 East Zhongshan Road, Nanjing, Jiangsu, China AU - Wang, Y. AU - Gong, D. AU - Yao, C. AU - Zheng, F. AU - Zhou, T. AU - Cao, Q. AU - Zhu, X. AU - Wang, M. AU - Zhu, J. DB - Embase Medline DO - 10.3892/mmr.2020.11500 IS - 5 LA - English M3 - Article N1 - L2007966264 2020-10-07 2020-10-30 PY - 2020 SN - 1791-3004 1791-2997 SP - 4125-4134 ST - Human monoclonal anti-TLR4 antibody negatively regulates lipopolysaccharide-induced inflammatory responses in mouse macrophages T2 - Molecular Medicine Reports TI - Human monoclonal anti-TLR4 antibody negatively regulates lipopolysaccharide-induced inflammatory responses in mouse macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007966264&from=exporthttp://dx.doi.org/10.3892/mmr.2020.11500 VL - 22 ID - 6253 ER - TY - JOUR AD - D. Heyman, Université de Nantes, INSERM, ERI 7, 1 Rue Gaston Veil, 44035 Nantes Cedex 01, France AU - Mori, K. AU - Le Goff, B. AU - Berreur, M. AU - Riet, A. AU - Moreau, A. AU - Blanchard, F. AU - Chevalier, C. AU - Guisle-Marsollier, I. AU - Léger, J. AU - Guicheux, J. AU - Masson, M. AU - Gouin, F. AU - Rédini, F. AU - Heymann, D. DB - Embase Medline DO - 10.1002/path.2140 IS - 5 LA - English M3 - Article N1 - L46502432 2007-04-01 PY - 2007 SN - 0022-3417 1096-9896 SP - 555-562 ST - Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B T2 - Journal of Pathology TI - Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46502432&from=exporthttp://dx.doi.org/10.1002/path.2140 VL - 211 ID - 6254 ER - TY - JOUR AD - Department of Cell Biology, Neurobiology and Anatomy, Loyola University Chicago Medical Center, Maywood, IL 60153, USA. AN - 8562514 AU - Schluns, K. S. AU - Grutkoski, P. S. AU - Cook, J. E. AU - Engelmann, G. L. AU - Le, P. T. DA - Oct DO - 10.1093/intimm/7.10.1681 10.1093/intimm/7.10.1681. DP - Nlm ET - 1995/10/01 IS - 10 LA - eng PY - 1995 SN - 0953-8178 (Print) 0953-8178 SP - 1681-90 ST - Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors T2 - Int Immunol TI - Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors VL - 7 ID - 6255 ER - TY - JOUR AD - C. Wang, Clinical and Translational Science Center, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Box 16, 1000 West Carson Street, Torrance, CA, United States AU - Jia, Y. AU - Lue, Y. AU - Swerdloff, R. S. AU - Lasky, J. L. AU - Panosyan, E. H. AU - Dai-Ju, J. AU - Wang, C. C2 - CPC Scientific(United States) Sigma(United States) DB - Embase Medline DO - 10.1016/j.yexmp.2019.104261 LA - English M3 - Article N1 - L2002083106 2019-06-13 2019-06-19 PY - 2019 SN - 1096-0945 0014-4800 SP - 42-50 ST - The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma T2 - Experimental and Molecular Pathology TI - The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002083106&from=exporthttp://dx.doi.org/10.1016/j.yexmp.2019.104261 VL - 109 ID - 6256 ER - TY - JOUR AD - A.B. Schrock, Foundation Medicine, Inc., Cambridge, MA, United States AU - Boussemart, L. AU - Nelson, A. AU - Wong, M. AU - Ross, J. S. AU - Sosman, J. AU - Mehnert, J. AU - Daniels, G. AU - Kendra, K. AU - Ali, S. M. AU - Miller, V. A. AU - Schrock, A. B. DB - Embase Medline DO - 10.1634/theoncologist.2018-0271 IS - 5 LA - English M3 - Review N1 - L626128153 2019-02-01 2019-05-28 PY - 2019 SN - 1549-490X 1083-7159 SP - 657-663 ST - Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing T2 - Oncologist TI - Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626128153&from=exporthttp://dx.doi.org/10.1634/theoncologist.2018-0271 VL - 24 ID - 6257 ER - TY - JOUR AU - Liu, W. AU - Xu, C. AU - You, X. AU - Olson, D. M. AU - Chemtob, S. AU - Gao, L. AU - Ni, X. DB - Embase Medline DO - 10.1371/journal.pone.0152838 IS - 4 LA - English M3 - Article N1 - L609632613 2016-04-14 2016-04-22 PY - 2016 SN - 1932-6203 ST - Hydrogen sulfide delays LPS-Induced preterm birth in mice via anti-inflammatory pathways T2 - PLoS ONE TI - Hydrogen sulfide delays LPS-Induced preterm birth in mice via anti-inflammatory pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609632613&from=exporthttp://dx.doi.org/10.1371/journal.pone.0152838 VL - 11 ID - 6258 ER - TY - JOUR AD - Free Radical and Radiation Biology Division, Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242-1181, United States Integrated DNA Technologies, Inc., 1710 Commercial Park, Coralville, IA 52241, United States AU - Sarsour, E. H. AU - Goswami, M. AU - Kalen, A. L. AU - Lafin, J. T. AU - Goswami, P. C. C7 - 9645 DB - Scopus DO - 10.1007/s11357-014-9645-0 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 SP - 1213-1224 ST - Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation T2 - Age TI - Hydroxytyrosol inhibits chemokine C-C motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905381011&doi=10.1007%2fs11357-014-9645-0&partnerID=40&md5=ba8f947a88a942cc6cd67eba2e2e1f16 VL - 36 ID - 6259 ER - TY - JOUR AD - D.W. Clapp, Cancer Research Institute, 1044 W. Walnut, Indianapolis, IN 46202, United States AU - Ingram, D. A. AU - Hiatt, K. AU - King, A. J. AU - Fisher, L. AU - Shivakumar, R. AU - Derstine, C. AU - Wenning, M. J. AU - Diaz, B. AU - Travers, J. B. AU - Hood, A. AU - Marshall, M. AU - Williams, D. A. AU - Clapp, D. W. DB - Embase Medline DO - 10.1084/jem.194.1.57 IS - 1 LA - English M3 - Article N1 - L32660437 2001-08-01 PY - 2001 SN - 0022-1007 SP - 57-69 ST - Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro T2 - Journal of Experimental Medicine TI - Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32660437&from=exporthttp://dx.doi.org/10.1084/jem.194.1.57 VL - 194 ID - 6260 ER - TY - JOUR AD - Department of Pediatrics, University of California, 513 Parnassus Avenue, Room HSE-302, San Francisco, California 94143, USA. AN - 17384584 AU - Schubbert, S. AU - Shannon, K. AU - Bollag, G. DA - Apr DO - 10.1038/nrc2109 10.1038/nrc2109. DP - Nlm ET - 2007/03/27 IS - 4 LA - eng PY - 2007 SN - 1474-175X (Print) 1474-175x SP - 295-308 ST - Hyperactive Ras in developmental disorders and cancer T2 - Nat Rev Cancer TI - Hyperactive Ras in developmental disorders and cancer VL - 7 ID - 6261 ER - TY - JOUR AD - Y. Zhou, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China AU - Zhou, Y. AU - He, Y. AU - Sharma, R. AU - Xing, W. AU - Estwick, S. A. AU - Wu, X. AU - Rhodes, S. D. AU - Xu, M. AU - Yang, F. C. DB - Embase Medline DO - 10.3390/ijms160612345 IS - 6 LA - English M3 - Article N1 - L604778672 2015-06-18 PY - 2015 SN - 1422-0067 1661-6596 SP - 12345-12359 ST - Hyperactive RAS/PI3-K/MAPK signaling cascade in migration and adhesion of Nf1 haploinsufficient mesenchymal stem/progenitor cells T2 - International Journal of Molecular Sciences TI - Hyperactive RAS/PI3-K/MAPK signaling cascade in migration and adhesion of Nf1 haploinsufficient mesenchymal stem/progenitor cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604778672&from=exporthttp://dx.doi.org/10.3390/ijms160612345 VL - 16 ID - 6262 ER - TY - JOUR AD - Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. leelsn@cuhk.edu.hk AN - 17712756 AU - Lee, N. AU - Wong, C. K. AU - Chan, P. K. AU - Lun, S. W. AU - Lui, G. AU - Wong, B. AU - Hui, D. S. AU - Lam, C. W. AU - Cockram, C. S. AU - Choi, K. W. AU - Yeung, A. C. AU - Tang, J. W. AU - Sung, J. J. DA - Sep 15 DO - 10.1086/520981 10.1086/520981. Epub 2007 Aug 8. DP - Nlm ET - 2007/08/23 IS - 6 LA - eng PY - 2007 SN - 1058-4838 SP - 723-31 ST - Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection T2 - Clin Infect Dis TI - Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection VL - 45 ID - 6263 ER - TY - JOUR AD - B. Campbell, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada, Department of Haematology/Oncology, Toronto, Canada AU - Campbell, B. AU - Morgenstern, D. AU - Lipman, T. AU - Fabrizio, D. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179824 2018-10-11 PY - 2018 SN - 1545-5017 SP - S68 ST - Hypermutant pediatric high grade gliomas are driven by RAS/MAPK mutations and respond to mek inhibition T2 - Pediatric Blood and Cancer TI - Hypermutant pediatric high grade gliomas are driven by RAS/MAPK mutations and respond to mek inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179824&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 6264 ER - TY - JOUR AD - Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City, Zhenjiang, Jiangsu, China Laboratory Center, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China AU - Zhou, J. D. AU - Lin, J. AU - Zhang, T. J. AU - Ma, J. C. AU - Li, X. X. AU - Wen, X. M. AU - Guo, H. AU - Xu, Z. J. AU - Deng, Z. Q. AU - Zhang, W. AU - Qian, J. DB - Scopus DO - 10.1002/jcp.26119 IS - 3 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2018 SP - 2444-2450 ST - Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia T2 - Journal of Cellular Physiology TI - Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034981319&doi=10.1002%2fjcp.26119&partnerID=40&md5=04ae22d5af26dd19526068a2bdc5974a VL - 233 ID - 6265 ER - TY - JOUR AD - Washington Univ. School of Medicine, St. Louis Children's Hospital, St. Louis, MO, United States St. Louis Children's Hospital, Hale Irwin Ctr. for Hematol./Oncol., Washington Univ. School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110, United States AU - Grossman, W. J. AU - Wilson, D. B. DB - Scopus DO - 10.1097/00043426-200403000-00016 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2004 SP - 214 ST - Hypopigmentation from Imatinib Mesylate (Gleevec) T2 - Journal of Pediatric Hematology/Oncology TI - Hypopigmentation from Imatinib Mesylate (Gleevec) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542316943&doi=10.1097%2f00043426-200403000-00016&partnerID=40&md5=03f27d837eed44fef40b2772e0980d64 VL - 26 ID - 6266 ER - TY - JOUR AD - J. Argente, Hospital Infantil Universitario Niño Jesús, Department of Endocrinology, Instituto de Investigación la Princesa, 28009 Madrid, Spain AU - Fuente-Martín, E. AU - García-Cáceres, C. AU - Díaz, F. AU - Argente-Arizón, P. AU - Granado, M. AU - Barrios, V. AU - Argente, J. AU - Chowen, J. A. DB - Embase Medline DO - 10.1210/en.2012-2196 IS - 7 LA - English M3 - Article N1 - L369165344 2013-07-02 2013-07-04 PY - 2013 SN - 0013-7227 1945-7170 SP - 2318-2330 ST - Hypothalamic inflammation without astrogliosis in response to high sucrose intake is modulated by neonatal nutrition in male rats T2 - Endocrinology TI - Hypothalamic inflammation without astrogliosis in response to high sucrose intake is modulated by neonatal nutrition in male rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369165344&from=exporthttp://dx.doi.org/10.1210/en.2012-2196http://endo.endojournals.org/content/154/7/2318.full.pdf+html VL - 154 ID - 6267 ER - TY - JOUR AD - Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai Medical School, No. 270, Dong'an Road, Shanghai 200032, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China AU - Cao, J. AU - Zhang, J. AU - Wang, Z. AU - Wang, B. AU - Lv, F. AU - Wang, L. AU - Hu, X. DB - Scopus DO - 10.1007/s00280-014-2505-x IS - 2 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2014 SP - 389-398 ST - Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer T2 - Cancer Chemotherapy and Pharmacology TI - Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907598458&doi=10.1007%2fs00280-014-2505-x&partnerID=40&md5=7aa5a62b2d72fd0cc26f5f36c8599828 VL - 74 ID - 6268 ER - TY - JOUR AD - H.S. Ahn, Department of Pediatrics, Seoul National University College of Medicine, Seoul, 110-799, South Korea AU - Seo, Y. J. AU - Koh, S. H. AU - Kang, H. J. AU - Shin, H. Y. AU - Jeong, G. AU - Ahn, H. S. DB - Embase Medline DO - 10.1016/j.bbrc.2007.10.023 IS - 2 LA - English M3 - Article N1 - L47633426 2007-11-21 PY - 2007 SN - 0006-291X 1090-2104 SP - 388-394 ST - Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation T2 - Biochemical and Biophysical Research Communications TI - Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47633426&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2007.10.023 VL - 364 ID - 6269 ER - TY - JOUR AU - Li, L. AU - Han, M. AU - Li, S. AU - Xu, Y. AU - Wang, L. DB - Medline DO - 10.1902/jop.2013.130048 IS - 3 LA - English M3 - Article N1 - L601990974 2015-02-09 PY - 2014 SN - 1943-3670 SP - 498-508 ST - Hypoxia regulates the proliferation and osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress via mitogen-activated protein kinase pathways T2 - Journal of periodontology TI - Hypoxia regulates the proliferation and osteogenic differentiation of human periodontal ligament cells under cyclic tensile stress via mitogen-activated protein kinase pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601990974&from=exporthttp://dx.doi.org/10.1902/jop.2013.130048 VL - 85 ID - 6270 ER - TY - JOUR AD - K. Sawada, Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan AU - Kinose, Y. AU - Sawada, K. AU - Nakamura, K. AU - Sawada, I. AU - Toda, A. AU - Nakatsuka, E. AU - Hashimoto, K. AU - Mabuchi, S. AU - Takahashi, K. AU - Kurachi, H. AU - Lengyel, E. AU - Kimura, T. DB - Embase Medline DO - 10.18632/oncotarget.3604 IS - 13 LA - English M3 - Article N1 - L604481763 2015-05-28 2015-06-03 PY - 2015 SN - 1949-2553 SP - 11342-11356 ST - The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma T2 - Oncotarget TI - The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604481763&from=exporthttp://dx.doi.org/10.18632/oncotarget.3604 VL - 6 ID - 6271 ER - TY - JOUR AD - Janssen Research & Development, LLC, San Diego, CA, United States Pharmacyclics LLC, an AbbVie Company, Sunnyvale, United States AU - de Jong, J. AU - Hellemans, P. AU - Jiao, J. J. AU - Huang, Y. AU - Mesens, S. AU - Sukbuntherng, J. AU - Ouellet, D. DB - Scopus DO - 10.1007/s00280-017-3471-x IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 1227-1237 ST - Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study T2 - Cancer Chemotherapy and Pharmacology TI - Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032378580&doi=10.1007%2fs00280-017-3471-x&partnerID=40&md5=03666ce71e3c4fd50eb595422d159a5d VL - 80 ID - 6272 ER - TY - JOUR AD - Department of Pediatrics, Laboratory of Hematology-Oncology, University of Padova, Padova, Italy. martina.pigazzi@unipd.it AN - 21325296 AU - Pigazzi, M. AU - Manara, E. AU - Beghin, A. AU - Baron, E. AU - Tregnago, C. AU - Basso, G. DA - Feb 15 DO - 10.1158/1078-0432.Ccr-10-0886 10.1158/1078-0432.CCR-10-0886. DP - Nlm ET - 2011/02/18 IS - 4 LA - eng PY - 2011 SN - 1078-0432 (Print) 1078-0432 SP - 742-52 ST - ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia T2 - Clin Cancer Res TI - ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia VL - 17 ID - 6273 ER - TY - JOUR AD - Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China Department of Oncology, First Affiliated Hospital, Xinxiang Medical University, Xinxiang, China Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China Department of Medical Oncology, Chifeng Municipal Hospital, Chifeng, China Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China Betta Pharmaceuticals Co., Ltd, Hangzhou, China AU - Huang, J. AU - Fan, Q. AU - Lu, P. AU - Ying, J. AU - Ma, C. AU - Liu, W. AU - Liu, Y. AU - Tan, F. AU - Sun, Y. DB - Scopus DO - 10.1016/j.jtho.2016.02.020 IS - 6 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2016 SP - 910-917 ST - Icotinib in patients with pretreated advanced esophageal squamous cell Carcinoma with EGFR overexpression or EGFR gene amplification: A single-arm, multicenter phase 2 study T2 - Journal of Thoracic Oncology TI - Icotinib in patients with pretreated advanced esophageal squamous cell Carcinoma with EGFR overexpression or EGFR gene amplification: A single-arm, multicenter phase 2 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979779235&doi=10.1016%2fj.jtho.2016.02.020&partnerID=40&md5=fc8f25e247e51c8844750cfda3cf3e42 VL - 11 ID - 6274 ER - TY - JOUR AD - C. Lu, Nanjing Maternity and Child Health Care Hospital, Affiliated Nanjing Medical University, No. 123, Tianfei Street, Mochou Road, Nanjing, China AU - Xu, P. AU - Wang, L. AU - Huang, L. AU - Li, W. AU - Lv, S. AU - Lv, M. AU - Ma, J. AU - Zhou, Q. AU - Wu, X. AU - Fu, Z. AU - Lu, C. AU - Yin, H. DB - Embase Medline DO - 10.1016/j.biopha.2015.07.019 LA - English M3 - Article N1 - L605642396 2015-08-20 2015-10-22 PY - 2015 SN - 1950-6007 0753-3322 SP - 173-178 ST - Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology T2 - Biomedicine and Pharmacotherapy TI - Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605642396&from=exporthttp://dx.doi.org/10.1016/j.biopha.2015.07.019 VL - 75 ID - 6275 ER - TY - JOUR AD - M. Krumbholz, Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany AU - Krumbholz, M. AU - Damm-Welk, C. AU - Woessmann, W. AU - Metzler, M. DB - Embase LA - English M3 - Conference Abstract N1 - L617378795 2017-07-24 PY - 2017 SN - 1592-8721 SP - 571 ST - Identification and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large cell lymphomas T2 - Haematologica TI - Identification and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large cell lymphomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378795&from=export VL - 102 ID - 6276 ER - TY - JOUR AD - L. Debelenko, New York Medical College, Valhalla, NY, United States AU - Debelenko, L. AU - Weihua, H. AU - Zhuge, J. AU - Yin, C. AU - Zhong, M. AU - Ozkaynak, M. AU - Fallon, J. T. DB - Embase DO - 10.1038/labinvest.2016.180 LA - English M3 - Conference Abstract N1 - L615115562 2017-04-06 PY - 2017 SN - 1530-0307 SP - 465A ST - Identification of 2 novel transcript fusions coexisting with EML4-ALK in a New Case of ALK-positive pediatric renal cell carcinoma T2 - Laboratory Investigation TI - Identification of 2 novel transcript fusions coexisting with EML4-ALK in a New Case of ALK-positive pediatric renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615115562&from=exporthttp://dx.doi.org/10.1038/labinvest.2016.180 VL - 97 ID - 6277 ER - TY - JOUR AD - Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. yonakano@ncc.go.jp. Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan. yonakano@ncc.go.jp. Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Department of Neurosurgery, National Defense Medical College, Saitama, Japan. Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan. Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan. Department of Pathology, Osaka City General Hospital, Osaka, Japan. Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan. AN - 30350109 AU - Nakano, Y. AU - Tomiyama, A. AU - Kohno, T. AU - Yoshida, A. AU - Yamasaki, K. AU - Ozawa, T. AU - Fukuoka, K. AU - Fukushima, H. AU - Inoue, T. AU - Hara, J. AU - Sakamoto, H. AU - Ichimura, K. DA - Jan DO - 10.1007/s10014-018-0330-3 10.1007/s10014-018-0330-3. Epub 2018 Oct 22. DP - Nlm ET - 2018/10/24 IS - 1 LA - eng PY - 2019 SN - 1433-7398 SP - 14-19 ST - Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma T2 - Brain Tumor Pathol TI - Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma VL - 36 ID - 6278 ER - TY - JOUR AD - 1 Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 2 Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 3 Department of Physics, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 4 Department of Chemistry and Biochemistry, Division of Hematology, Center for RNA Biology, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. 5 Department of Pathology, The Ohio State University Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio. AN - 29768105 AU - He, H. AU - Li, W. AU - Yan, P. AU - Bundschuh, R. AU - Killian, J. A. AU - Labanowska, J. AU - Brock, P. AU - Shen, R. AU - Heerema, N. A. AU - de la Chapelle, A. C2 - PMC5994666 DA - Jun DO - 10.1089/thy.2017.0258 10.1089/thy.2017.0258. Epub 2018 May 16. DP - Nlm ET - 2018/05/17 IS - 6 LA - eng PY - 2018 SN - 1050-7256 (Print) 1050-7256 SP - 748-754 ST - Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma T2 - Thyroid TI - Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma VL - 28 ID - 6279 ER - TY - JOUR AD - Cell Signaling Technology, Inc., Danvers, Massachusetts 01923, USA. AN - 22570254 AU - Ren, H. AU - Tan, Z. P. AU - Zhu, X. AU - Crosby, K. AU - Haack, H. AU - Ren, J. M. AU - Beausoleil, S. AU - Moritz, A. AU - Innocenti, G. AU - Rush, J. AU - Zhang, Y. AU - Zhou, X. M. AU - Gu, T. L. AU - Yang, Y. F. AU - Comb, M. J. DA - Jul 1 DO - 10.1158/0008-5472.Can-11-3931 10.1158/0008-5472.CAN-11-3931. Epub 2012 May 8. DP - Nlm ET - 2012/05/10 IS - 13 LA - eng PY - 2012 SN - 0008-5472 SP - 3312-23 ST - Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer T2 - Cancer Res TI - Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer VL - 72 ID - 6280 ER - TY - JOUR AD - Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom. Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Genetic Medicine, Central Parkway, Newcastle upon Tyne, NE1 3BZ, United Kingdom. Institut Curie, 75248 Paris cedex 05, France. Department of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA. AN - 27888620 AU - Chen, L. AU - Humphreys, A. AU - Turnbull, L. AU - Bellini, A. AU - Schleiermacher, G. AU - Salwen, H. AU - Cohn, S. L. AU - Bown, N. AU - Tweddle, D. A. C2 - PMC5349989 DA - Dec 27 DO - 10.18632/oncotarget.13541 10.18632/oncotarget.13541. DP - Nlm ET - 2016/11/27 IS - 52 LA - eng PY - 2016 SN - 1949-2553 SP - 87301-87311 ST - Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse T2 - Oncotarget TI - Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse VL - 7 ID - 6281 ER - TY - JOUR AD - I. Nindl, Department of Dermatology, Skin Cancer Center Charité, University Hospital of Berlin, Charitéplatz 1, D-10117 Berlin, Germany AU - Nindl, I. AU - Dang, C. AU - Forschner, T. AU - Kuban, R. J. AU - Meyer, T. AU - Sterry, W. AU - Stockfleth, E. DB - Embase Medline DO - 10.1186/1476-4598-5-30 LA - English M3 - Article N1 - L44420010 2006-10-10 PY - 2006 SN - 1476-4598 ST - Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling T2 - Molecular Cancer TI - Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44420010&from=exporthttp://dx.doi.org/10.1186/1476-4598-5-30http://www.molecular-cancer.com/content/5/1/30 VL - 5 ID - 6282 ER - TY - JOUR AD - J.-Z. Zhao, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China AU - Liu, W. AU - Gong, Y. H. AU - Chao, T. F. AU - Peng, X. Z. AU - Yuan, J. G. AU - Ma, Z. Y. AU - Jia, G. AU - Zhao, J. Z. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2009.20.002 IS - 20 LA - English M3 - Article N1 - L355564511 2009-12-09 PY - 2009 SN - 0366-6999 SP - 2405-2411 ST - Identification of differentially expressed microRNAs by microarray: A possible role for microRNAs gene in medulloblastomas T2 - Chinese Medical Journal TI - Identification of differentially expressed microRNAs by microarray: A possible role for microRNAs gene in medulloblastomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355564511&from=exporthttp://dx.doi.org/10.3760/cma.j.issn.0366-6999.2009.20.002http://www.cmj.org/Periodical/PDF/2009101931992490.pdf VL - 122 ID - 6283 ER - TY - JOUR AD - Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom Wessex Regional Genetics Laboratory, Salisbury, United Kingdom Oregon Health and Science University, Hematology Portland, OR, United States Division of Infection Inflammation and Immunity, University of Southampton School of Medicine, Southampton, United Kingdom Harbor Hospital, Hematology/Immunology Unit, Baltimore, MD, United States Department of Haematology, Hammersmith Hospital, Imperial College, Du Cane Road, London, United Kingdom AU - Ernst, T. AU - Score, J. AU - Deininger, M. AU - Hidalgo-Curtis, C. AU - Lackie, P. AU - Ershler, W. B. AU - Goldman, J. M. AU - Cross, N. C. AU - Grand, F. DB - Scopus DO - 10.1111/j.1365-2141.2010.08457.x IS - 1 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2011 SP - 43-46 ST - Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952592616&doi=10.1111%2fj.1365-2141.2010.08457.x&partnerID=40&md5=78bf7ccbfa01664c4503a93568a1bcb3 VL - 153 ID - 6284 ER - TY - JOUR AD - Laboratoire d'Onco-Virologie, Institut Pasteur du Maroc, Casablanca, Morocco Laboratoire de Biochimie et de Biologie Moléculaire, Université Hassan II, Casablanca, Morocco Unité de Biologie et recherche Médicale, Centre National de l'Energie, Des Sciences et Techniques Nucléaires (CNESTEN), Rabat, Morocco Centre d'Oncologie, Centre Hospitalier Universitaire Ibn Rochd, Casablanca, Morocco Institut National d'Oncologie, Rabat, Morocco Laboratoire Virologie Hygiène and Mcrobiologie, Faculté des Sciences et Techniques Mohammédia, Morocco AU - Naji, F. AU - Attaleb, M. AU - Laantri, N. AU - Benchakroun, N. AU - El Gueddari, B. AU - Benider, A. AU - Azeddoug, H. AU - Ennaji, M. M. AU - El Mzibri, M. AU - Khyatti, M. DB - Scopus DO - 10.1170/163 IS - SUPPL.1 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - OL1442-OL1446 ST - Identification of G2607A mutation in EGFR gene with a significative rate in moroccan patients with nasopharyngeal carcinoma T2 - Cellular and Molecular Biology TI - Identification of G2607A mutation in EGFR gene with a significative rate in moroccan patients with nasopharyngeal carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954442133&doi=10.1170%2f163&partnerID=40&md5=7403330a25de2e66accacf7a5ba86fe3 VL - 56 ID - 6285 ER - TY - JOUR AD - J. Jin, Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, China AU - Jin, J. AU - Xu, H. AU - Wu, R. AU - Gao, N. AU - Wu, N. AU - Li, S. AU - Niu, J. DB - Embase Medline DO - 10.1111/jcmm.14616 IS - 11 LA - English M3 - Article N1 - L2003430800 2019-11-01 2019-11-08 PY - 2019 SN - 1582-1838 SP - 7474-7489 ST - Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection T2 - Journal of Cellular and Molecular Medicine TI - Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003430800&from=exporthttp://dx.doi.org/10.1111/jcmm.14616 VL - 23 ID - 6286 ER - TY - JOUR AD - Departments of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. AN - 23052255 AU - Suehara, Y. AU - Arcila, M. AU - Wang, L. AU - Hasanovic, A. AU - Ang, D. AU - Ito, T. AU - Kimura, Y. AU - Drilon, A. AU - Guha, U. AU - Rusch, V. AU - Kris, M. G. AU - Zakowski, M. F. AU - Rizvi, N. AU - Khanin, R. AU - Ladanyi, M. C2 - PMC4234119 C6 - NIHMS641462 DA - Dec 15 DO - 10.1158/1078-0432.Ccr-12-0838 10.1158/1078-0432.CCR-12-0838. Epub 2012 Oct 10. DP - Nlm ET - 2012/10/12 IS - 24 LA - eng PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 6599-608 ST - Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions T2 - Clin Cancer Res TI - Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions VL - 18 ID - 6287 ER - TY - JOUR AD - Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria Institute of Immunology, Medical University of Vienna, Austria Department of Clinical Pharmacology, Medical University of Vienna, Austria Department of Radiation Therapy, Medical University of Vienna, Austria Department of Clinical Pathology, Medical University of Vienna, Austria Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer Guertel 18-20, A-1097 Vienna, Austria AU - Aichberger, K. J. AU - Mayerhofer, M. AU - Gleixner, K. V. AU - Krauth, M. T. AU - Gruze, A. AU - Pickl, W. F. AU - Wacheck, V. AU - Selzer, E. AU - Müllauer, L. AU - Agis, H. AU - Sillaber, C. AU - Valent, P. DB - Scopus DO - 10.1182/blood-2006-07-032714 IS - 7 M3 - Article N1 - Cited By :52 Export Date: 18 November 2020 PY - 2007 SP - 3031-3041 ST - Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: Inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 T2 - Blood TI - Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: Inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947579975&doi=10.1182%2fblood-2006-07-032714&partnerID=40&md5=6629b43be1973324066b0a3e004a37b0 VL - 109 ID - 6288 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore. AN - 23801497 AU - Yan, B. AU - Lim, M. AU - Zhou, L. AU - Kuick, C. H. AU - Leong, M. Y. AU - Yong, K. J. AU - Aung, L. AU - Salto-Tellez, M. AU - Chang, K. T. DA - Nov DO - 10.1136/jclinpath-2012-201375 10.1136/jclinpath-2012-201375. Epub 2013 Jun 25. DP - Nlm ET - 2013/06/27 IS - 11 LA - eng PY - 2013 SN - 0021-9746 SP - 985-91 ST - Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas T2 - J Clin Pathol TI - Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas VL - 66 ID - 6289 ER - TY - JOUR AD - Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Electronic address: bio-zcw@163.com. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China. First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China; First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Electronic address: yangqiuli@hotmail.com. AN - 27613090 AU - Zhang, Y. AU - Zeng, C. AU - Lu, S. AU - Qin, T. AU - Yang, L. AU - Chen, S. AU - Chen, J. AU - Li, Y. DA - Sep 30 DO - 10.1016/j.bbrc.2016.09.020 10.1016/j.bbrc.2016.09.020. Epub 2016 Sep 6. DP - Nlm ET - 2016/09/11 IS - 4 LA - eng PY - 2016 SN - 0006-291x SP - 1758-63 ST - Identification of miR-125b targets involved in acute promyelocytic leukemia cell proliferation T2 - Biochem Biophys Res Commun TI - Identification of miR-125b targets involved in acute promyelocytic leukemia cell proliferation VL - 478 ID - 6290 ER - TY - JOUR AD - Department of Dermatology, University of Regensburg, Regensburg, Germany Department of Dermatology, University of Saarland, Homburg/Saar, Germany Center of Excellence for Fluorescent Bioanalysis, University of Regensburg, Regensburg, Germany Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland AU - Mauerer, A. AU - Roesch, A. AU - Hafner, C. AU - Stempfl, T. AU - Wild, P. AU - Meyer, S. AU - Landthaler, M. AU - Vogt, T. DB - Scopus DO - 10.1111/j.1600-0625.2011.01254.x IS - 6 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2011 SP - 502-507 ST - Identification of new genes associated with melanoma T2 - Experimental Dermatology TI - Identification of new genes associated with melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956072498&doi=10.1111%2fj.1600-0625.2011.01254.x&partnerID=40&md5=a013322c2862f74a98695e9feee9659a VL - 20 ID - 6291 ER - TY - JOUR AD - M. Masselli, Experimental Pathology and Oncology, University of Florence, Florence, Italy AU - Masselli, M. AU - Pillozzi, S. AU - D'Amico, M. AU - Gasparoli, L. AU - Crociani, O. AU - Stefanini, M. AU - Mugridge, K. AU - Tiedke, W. AU - Becchetti, A. AU - Arcangeli, A. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70961946 2013-01-17 PY - 2012 SN - 0006-4971 ST - Identification of non-cardiotoxic hERG1 blockers to overcome chemoresistance in acute lymphoblastic leukemias T2 - Blood TI - Identification of non-cardiotoxic hERG1 blockers to overcome chemoresistance in acute lymphoblastic leukemias UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70961946&from=exporthttp://abstracts.hematologylibrary.org/cgi/content/abstract/120/21/1506?maxtoshow=&hits=80&RESULTFORMAT=&searchid=1&FIRSTINDEX=0&displaysectionid=Poster+Session&fdate=1/1/2012&tdate=12/31/2012&resourcetype=HWCIT VL - 120 ID - 6292 ER - TY - JOUR AD - Department of Pediatrics, Yamagata University Faculty of Medicine, Yamagata, Japan; Department of Immunology, Yamagata University Faculty of Medicine, Yamagata, Japan. AN - 24965693 AU - Onoda, T. AU - Kanno, M. AU - Sato, H. AU - Takahashi, N. AU - Izumino, H. AU - Ohta, H. AU - Emura, T. AU - Katoh, H. AU - Ohizumi, H. AU - Ohtake, H. AU - Asao, H. AU - Dehner, L. P. AU - Hill, A. D. AU - Hayasaka, K. AU - Mitsui, T. DA - Oct DO - 10.1002/gcc.22199 10.1002/gcc.22199. Epub 2014 Jun 26. DP - Nlm ET - 2014/06/27 IS - 10 LA - eng PY - 2014 SN - 1045-2257 SP - 865-74 ST - Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor T2 - Genes Chromosomes Cancer TI - Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor VL - 53 ID - 6293 ER - TY - JOUR AD - T. Burke, Department of Pediatrics, Texas Children's Cancer Center, Houston, TX, United States AU - Burke, T. AU - Chakraborty, R. AU - Hampton, O. AU - Zinn, D. AU - Scull, B. AU - Abhyankar, H. AU - Kumar, V. AU - Kakkar, N. AU - McClain, K. AU - Wheeler, D. AU - Roy, A. AU - Parsons, D. W. AU - Allen, C. DB - Embase DO - 10.1002/pbc.26239 LA - English M3 - Conference Abstract N1 - L612112364 2016-09-15 PY - 2016 SN - 1545-5009 SP - S13-S14 ST - Identification of novel braf alterations in LCH using an integrated genomic pipeline T2 - Pediatric Blood and Cancer TI - Identification of novel braf alterations in LCH using an integrated genomic pipeline UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612112364&from=exporthttp://dx.doi.org/10.1002/pbc.26239 VL - 63 ID - 6294 ER - TY - JOUR AD - M. Hiwatari, Department of Cell Therapy and Transplantation Medicine, Tokyo University Hospital, Tokyo, Japan AU - Hiwatari, M. AU - Watanabe, K. AU - Kubota, Y. AU - Kimura, S. AU - Takita, J. DB - Embase DO - 10.1182/blood-2018-99-111090 LA - English M3 - Conference Abstract N1 - L626530411 2019-03-04 PY - 2018 SN - 0006-4971 ST - Identification of novel pathways and small molecules able to down regulate oncogenes expression by compounds screening approaches in acute leukemia and neuroblastoma cells T2 - Blood TI - Identification of novel pathways and small molecules able to down regulate oncogenes expression by compounds screening approaches in acute leukemia and neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530411&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-111090 VL - 132 ID - 6295 ER - TY - JOUR AD - M.E. Tyburczy, Nencki Institute of Experimental Biology, Warsaw, Poland AU - Tyburczy, M. E. AU - Kotulska, K. AU - Pokarowski, P. AU - Mieczkowski, J. AU - Grajkowska, W. AU - Jozwiak, S. AU - Kaminska, B. DB - Embase DO - 10.1158/1538-7445.AM10-4353 IS - 8 LA - English M3 - Conference Abstract N1 - L71450238 2014-05-15 PY - 2010 SN - 0008-5472 ST - Identification of proteins regulated by mTOR in brain tumors of patients with tuberous sclerosis complex T2 - Cancer Research TI - Identification of proteins regulated by mTOR in brain tumors of patients with tuberous sclerosis complex UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71450238&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM10-4353http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/70/8_MeetingAbstracts/4353?sid=6094f6a0-f326-4179-9021-9c962373bce7 VL - 70 ID - 6296 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. Electronic address: kppatel@mdanderson.org. AN - 25128227 AU - Mehrotra, M. AU - Medeiros, L. J. AU - Luthra, R. AU - Sargent, R. L. AU - Yao, H. AU - Barkoh, B. A. AU - Singh, R. AU - Patel, K. P. DA - Oct DO - 10.1016/j.humpath.2014.06.012 10.1016/j.humpath.2014.06.012. Epub 2014 Jun 30. DP - Nlm ET - 2014/08/17 IS - 10 LA - eng PY - 2014 SN - 0046-8177 SP - 1995-2005 ST - Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma T2 - Hum Pathol TI - Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma VL - 45 ID - 6297 ER - TY - JOUR AD - A. Fusco, Dipto. di Biol./Patol. Cell./Molec., Inst. Endocrinol. Oncol. Sperim. CNR, Univ. degli Studi Napoli Federico II, via Pansini 5, 80131 Napoles, Italy AU - Hoyos, J. M. AU - Fedele, M. AU - Battista, S. AU - Pentimalli, F. AU - Kruhoffer, M. AU - Arra, C. AU - Orntoft, T. F. AU - Croce, C. M. AU - Fusco, A. DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-1410 IS - 16 LA - English M3 - Article N1 - L39095571 2004-09-05 PY - 2004 SN - 0008-5472 SP - 5728-5735 ST - Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: Tissue specificity of the HMGA1-dependent gene regulation T2 - Cancer Research TI - Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: Tissue specificity of the HMGA1-dependent gene regulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39095571&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-04-1410 VL - 64 ID - 6298 ER - TY - JOUR AD - R. Guiho, Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Institute of Child Health, London, United Kingdom AU - Guiho, R. AU - Apps, J. R. AU - Hong, Y. AU - Hargrave, D. AU - Brogan, P. AU - Jacques, T. S. AU - Martinez-Barbera, J. P. DB - Embase DO - 10.1159/000492307 LA - English M3 - Conference Abstract N1 - L630602135 2020-01-20 PY - 2018 SN - 1663-2826 SP - 58-59 ST - Identification of the MAPK/ERK pathway as a novel therapeutic target in adamantinomatous craniopharyngioma T2 - Hormone Research in Paediatrics TI - Identification of the MAPK/ERK pathway as a novel therapeutic target in adamantinomatous craniopharyngioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630602135&from=exporthttp://dx.doi.org/10.1159/000492307 VL - 90 ID - 6299 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Departments of Molecular and Cellular Biology and Pediatrics, BIO5 Institute, University of Arizona, Tucson, AZ 85721, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Integrated Biomedical Sciences, University of Tennessee Health Science Center, Memphis, TN 38105, USA. Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Proteomics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Preclinical Pharmacokinetics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. The McDonnell Genome Institute, Washington University, St. Louis, MO 63108, USA; Department of Genetics, Washington University, St. Louis, MO 63108, USA; Department of Medicine, Washington University, St. Louis, MO 63108, USA. The McDonnell Genome Institute, Washington University, St. Louis, MO 63108, USA; Department of Genetics, Washington University, St. Louis, MO 63108, USA; Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, MO 63108, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 323, Memphis, TN 38105-3678, USA; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38105, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: michael.dyer@stjude.org. AN - 30146332 AU - Stewart, E. AU - McEvoy, J. AU - Wang, H. AU - Chen, X. AU - Honnell, V. AU - Ocarz, M. AU - Gordon, B. AU - Dapper, J. AU - Blankenship, K. AU - Yang, Y. AU - Li, Y. AU - Shaw, T. I. AU - Cho, J. H. AU - Wang, X. AU - Xu, B. AU - Gupta, P. AU - Fan, Y. AU - Liu, Y. AU - Rusch, M. AU - Griffiths, L. AU - Jeon, J. AU - Freeman, B. B., 3rd AU - Clay, M. R. AU - Pappo, A. AU - Easton, J. AU - Shurtleff, S. AU - Shelat, A. AU - Zhou, X. AU - Boggs, K. AU - Mulder, H. AU - Yergeau, D. AU - Bahrami, A. AU - Mardis, E. R. AU - Wilson, R. K. AU - Zhang, J. AU - Peng, J. AU - Downing, J. R. AU - Dyer, M. A. C2 - PMC6158019 C6 - NIHMS1504174 DA - Sep 10 DO - 10.1016/j.ccell.2018.07.012 10.1016/j.ccell.2018.07.012. Epub 2018 Aug 23. DP - Nlm ET - 2018/08/28 IS - 3 LA - eng PY - 2018 SN - 1535-6108 (Print) 1535-6108 SP - 411-426.e19 ST - Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses T2 - Cancer Cell TI - Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses VL - 34 ID - 6300 ER - TY - JOUR AD - 1 Department of Radiation Medical Sciences, Atomic Bomb Disease Institute , Nagasaki University, Nagasaki, Japan . 2 Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan . 3 Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute , Nagasaki University, Nagasaki, Japan . 4 Department of Thyroid and Endocrinology, Fukushima Medical University , Fukushima, Japan . AN - 28351223 AU - Iyama, K. AU - Matsuse, M. AU - Mitsutake, N. AU - Rogounovitch, T. AU - Saenko, V. AU - Suzuki, K. AU - Ashizawa, M. AU - Ookouchi, C. AU - Suzuki, S. AU - Mizunuma, H. AU - Fukushima, T. AU - Suzuki, S. AU - Yamashita, S. DA - Jun DO - 10.1089/thy.2016.0673 10.1089/thy.2016.0673. Epub 2017 Apr 25. DP - Nlm ET - 2017/03/30 IS - 6 LA - eng PY - 2017 SN - 1050-7256 SP - 811-818 ST - Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima T2 - Thyroid TI - Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima VL - 27 ID - 6301 ER - TY - JOUR AD - N.B. Ramachandra, Department of Studies in Zoology, Genetics & Genomics Laboratory, University of Mysore, Mysuru, Karnataka, India AU - Suresh, R. V. AU - Lingaiah, K. AU - Veerappa, A. M. AU - Ramachandra, N. B. DB - Embase Medline DO - 10.4103/ijmr.IJMR_965_14 IS - JANUARY LA - English M3 - Article N1 - L616584942 2017-06-07 2017-06-12 PY - 2017 SN - 0971-5916 SP - 39-50 ST - Identifying the risk of producing aneuploids using meiotic recombination genes as biomarkers: A copy number variation approach T2 - Indian Journal of Medical Research TI - Identifying the risk of producing aneuploids using meiotic recombination genes as biomarkers: A copy number variation approach UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616584942&from=exporthttp://dx.doi.org/10.4103/ijmr.IJMR_965_14 VL - 145 ID - 6302 ER - TY - JOUR AD - Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Tumor Virus Molecular Biology Section, Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA. Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: jianyou@mail.med.upenn.edu. AN - 27212661 AU - Liu, W. AU - Yang, R. AU - Payne, A. S. AU - Schowalter, R. M. AU - Spurgeon, M. E. AU - Lambert, P. F. AU - Xu, X. AU - Buck, C. B. AU - You, J. C2 - PMC4900903 C6 - NIHMS783901 DA - Jun 8 DO - 10.1016/j.chom.2016.04.024 10.1016/j.chom.2016.04.024. Epub 2016 May 19. DP - Nlm ET - 2016/05/24 IS - 6 LA - eng PY - 2016 SN - 1931-3128 (Print) 1931-3128 SP - 775-87 ST - Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection T2 - Cell Host Microbe TI - Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection VL - 19 ID - 6303 ER - TY - JOUR AD - P. Rana, Children's Mercy Hospital, Kansas City, MO, United States AU - Rana, P. AU - Mitre, N. DB - Embase DO - 10.1210/endo-meetings.2016.PE.13.SUN-028 IS - 2 LA - English M3 - Conference Abstract N1 - L613521469 2016-12-08 PY - 2016 SN - 0163-769X ST - Idiopathic hypoparathyroidism in neurofibromatosis type 1-noonan syndrome: A case report T2 - Endocrine Reviews TI - Idiopathic hypoparathyroidism in neurofibromatosis type 1-noonan syndrome: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613521469&from=exporthttp://dx.doi.org/10.1210/endo-meetings.2016.PE.13.SUN-028 VL - 37 ID - 6304 ER - TY - JOUR AD - Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, State University of New Jersey, Piscataway, NJ 08854, United States First Department of Medicine, Medical School, University of Athens, Athens, Greece Department of Surgery, Rutgers Robert Wood Johnson Medical School, State University of New JerseyNJ, United States Division of Hematology-Oncology, Department of Medicine, University of PittsburghPA, United States Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, United States AU - Lasfar, A. AU - Gogas, H. AU - Zloza, A. AU - Kaufman, H. L. AU - Kirkwood, J. M. DB - Scopus DO - 10.2217/imt-2015-0021 IS - 8 M3 - Review N1 - Cited By :11 Export Date: 18 November 2020 PY - 2016 SP - 877-888 ST - IFN-λ cancer immunotherapy: New kid on the block T2 - Immunotherapy TI - IFN-λ cancer immunotherapy: New kid on the block UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978954013&doi=10.2217%2fimt-2015-0021&partnerID=40&md5=f7194f24da67e5d84fb8b94cca7c9066 VL - 8 ID - 6305 ER - TY - JOUR AD - O. Kuchuk, Department of Medicine, Department of Pathology, Recanati Miller Transplantation Institute, New York, NY, United States AU - Kuchuk, O. AU - Akers, N. AU - Sia, D. AU - Simon-Coma, M. AU - Martinez-Quetglas, I. AU - Gambato, M. AU - Nonell, L. AU - Mallo, M. AU - Carrillo, J. AU - Cairo, S. AU - Guettier, C. AU - Branchereau, S. AU - Buendia, M. A. AU - Vázquez, M. AU - Royo, L. AU - Pedersen, K. AU - Sala, M. AU - Sarrias, M. R. AU - Mazzaferro, V. AU - Losic, B. AU - Armengol, C. AU - Llovet, J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612595102 2016-11-11 PY - 2016 SN - 0270-9139 SP - 243A ST - IGF signaling is a promising target for molecular therapies of hepatoblastoma T2 - Hepatology TI - IGF signaling is a promising target for molecular therapies of hepatoblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612595102&from=export VL - 64 ID - 6306 ER - TY - JOUR AD - O. Sampetrean, Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan AU - Osuka, S. AU - Sampetrean, O. AU - Shimizu, T. AU - Saga, I. AU - Onishi, N. AU - Sugihara, E. AU - Okubo, J. AU - Fujita, S. AU - Takano, S. AU - Matsumura, A. AU - Saya, H. DB - Embase Medline DO - 10.1002/stem.1328 IS - 4 LA - English M3 - Article N1 - L368652622 2013-04-12 2013-04-17 PY - 2013 SN - 1066-5099 SP - 627-640 ST - IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells T2 - Stem Cells TI - IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368652622&from=exporthttp://dx.doi.org/10.1002/stem.1328http://onlinelibrary.wiley.com/doi/10.1002/stem.1328/pdf VL - 31 ID - 6307 ER - TY - JOUR AD - C. Paret, Section of Pediatric Oncology, Children’s Hospital, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany AU - Vewinger, N. AU - Huprich, S. AU - Seidmann, L. AU - Russo, A. AU - Alt, F. AU - Bender, H. AU - Sommer, C. AU - Samuel, D. AU - Lehmann, N. AU - Backes, N. AU - Roth, L. AU - Harter, P. N. AU - Filipski, K. AU - Faber, J. AU - Paret, C. DB - Embase Medline DO - 10.3390/ijms20123027 IS - 12 LA - English M3 - Article N1 - L2002248285 2019-08-14 2019-08-21 PY - 2019 SN - 1422-0067 1661-6596 ST - Igf1r is a potential new therapeutic target for hgnet-bcor brain tumor patients T2 - International Journal of Molecular Sciences TI - Igf1r is a potential new therapeutic target for hgnet-bcor brain tumor patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002248285&from=exporthttp://dx.doi.org/10.3390/ijms20123027 VL - 20 ID - 6308 ER - TY - JOUR AD - C.A. Scrideli, Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, São Paulo, Brazil AU - Lira, R. C. P. AU - Fedatto, P. F. AU - Antonio, D. S. M. AU - Leal, L. F. AU - Martinelli, C. E. AU - De Castro, M. AU - Tucci, S. AU - Neder, L. AU - Ramalho, L. AU - Seidinger, A. L. AU - Cardinalli, I. AU - Mastellaro, M. J. AU - Yunes, J. A. AU - Brandalise, S. R. AU - Tone, L. G. AU - Antonini, S. R. R. AU - Scrideli, C. A. C1 - osi 906 DB - Embase Medline DO - 10.1530/ERC-15-0426 IS - 6 LA - English M3 - Article N1 - L611085521 2016-07-11 2016-07-19 PY - 2016 SN - 1479-6821 1351-0088 SP - 481-493 ST - IGF2 and IGF1R in pediatric adrenocortical tumors: Roles in metastasis and steroidogenesis T2 - Endocrine-Related Cancer TI - IGF2 and IGF1R in pediatric adrenocortical tumors: Roles in metastasis and steroidogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611085521&from=exporthttp://dx.doi.org/10.1530/ERC-15-0426 VL - 23 ID - 6309 ER - TY - JOUR AD - Department of Hematology and Oncology 'L. and A. Seràgnoli,' University of Bologna, Bologna; Department of Genetics and Microbiology, University of Bari, Bari; Department of Biotechnological Sciences and Hematology, 'La Sapienza' University; Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Data Center, GIMEMA Foundation; Department of Hematology, Tor Vergata University Hospital, Rome; Department of Clinical and Biological Science, University of Turin at Orbassano, Orbassano; and University of Naples Federico II, Naples, Italy AU - Martinelli, G. AU - Iacobucci, I. AU - Storlazzi, C. T. AU - Vignetti, M. AU - Paoloni, F. AU - Cilloni, D. AU - Soverini, S. AU - Vitale, A. AU - Chiaretti, S. AU - Cimino, G. AU - Papayannidis, C. AU - Paolini, S. AU - Elia, L. AU - Fazi, P. AU - Meloni, G. AU - Amadori, S. AU - Saglio, G. AU - Pane, F. AU - Baccarani, M. AU - Foà, R. DB - Scopus DO - 10.1200/JCO.2008.21.6408 IS - 31 M3 - Article N1 - Cited By :207 Export Date: 18 November 2020 PY - 2009 SP - 5202-5207 ST - IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report T2 - Journal of Clinical Oncology TI - IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449719091&doi=10.1200%2fJCO.2008.21.6408&partnerID=40&md5=5094f2cc14b8cf16217be95686683b00 VL - 27 ID - 6310 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Department of Bioinformatics, Erasmus Medical Center, Rotterdam, The Netherlands. Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. Research Institute Children's Cancer Center Hamburg, Hamburg, Germany. Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Co-operative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Netherlands Translational Research Center, Oss, The Netherlands. AN - 27997540 AU - Li, Y. AU - Buijs-Gladdines, J. G. AU - Canté-Barrett, K. AU - Stubbs, A. P. AU - Vroegindeweij, E. M. AU - Smits, W. K. AU - van Marion, R. AU - Dinjens, W. N. AU - Horstmann, M. AU - Kuiper, R. P. AU - Buijsman, R. C. AU - Zaman, G. J. AU - van der Spek, P. J. AU - Pieters, R. AU - Meijerink, J. P. C2 - PMC5172551 Center B.V. The other authors have declared that no competing interests exist. DA - Dec DO - 10.1371/journal.pmed.1002200 10.1371/journal.pmed.1002200. eCollection 2016 Dec. DP - Nlm ET - 2016/12/21 IS - 12 LA - eng PY - 2016 SN - 1549-1277 (Print) 1549-1277 SP - e1002200 ST - IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study T2 - PLoS Med TI - IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study VL - 13 ID - 6311 ER - TY - JOUR AD - Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, United States AU - Barata, J. T. AU - Boussiotis, V. A. AU - Yunes, J. A. AU - Ferrando, A. A. AU - Moreau, L. A. AU - Veiga, J. P. AU - Sallan, S. E. AU - Look, A. T. AU - Nadler, L. M. AU - Cardoso, A. A. DB - Scopus DO - 10.1182/blood-2002-12-3861 IS - 5 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2004 SP - 1891-1900 ST - IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL T2 - Blood TI - IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744230130&doi=10.1182%2fblood-2002-12-3861&partnerID=40&md5=c4f9de6bd0c9a643d85776de3aee4c0e VL - 103 ID - 6312 ER - TY - JOUR AD - W. Wang, Department of Physiology, Basic Medical College, Jiamusi University, 148 Xuefu Street, Jiamusi, Heilongjiang, China AU - Jia, L. AU - Li, F. AU - Shao, M. AU - Zhang, W. AU - Zhang, C. AU - Zhao, X. AU - Luan, H. AU - Qi, Y. AU - Zhang, P. AU - Liang, L. AU - Jia, X. AU - Zhang, K. AU - Lu, Y. AU - Yang, Z. AU - Zhu, X. AU - Zhang, Q. AU - Du, J. AU - Wang, W. DB - Embase DO - 10.3892/ol.2017.7391 IS - 1 LA - English M3 - Article N1 - L619453170 2017-12-05 2017-12-08 PY - 2018 SN - 1792-1082 1792-1074 SP - 1350-1356 ST - IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells T2 - Oncology Letters TI - IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619453170&from=exporthttp://dx.doi.org/10.3892/ol.2017.7391 VL - 15 ID - 6313 ER - TY - JOUR AD - Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China AU - Wang, X. AU - Li, J. AU - Lu, C. AU - Wang, G. AU - Wang, Z. AU - Liu, X. AU - Liu, B. AU - Wang, G. AU - Zhang, Q. AU - Yang, Q. DB - Scopus DO - 10.1016/j.yexcr.2019.01.021 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 192-197 ST - IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation T2 - Experimental Cell Research TI - IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061650624&doi=10.1016%2fj.yexcr.2019.01.021&partnerID=40&md5=c7f31ae5440238964d91a97ef3dfc99e VL - 376 ID - 6314 ER - TY - JOUR AD - N. Kanda, Department of Dermatology, Teikyo University, School of Medicine, 11-1, Kaga-2, Itabashi-Ku, Tokyo 173-8605, Japan AU - Kanda, N. AU - Koike, S. AU - Watanabe, S. C1 - bay 117082(Biomol,United States) ns 398(Sigma,United States) pd 98059(Calbiochem,United States) sb 203580(Calbiochem,United States) sc 560(Sigma,United States) sp 600125(Biomol,United States) C2 - Biomol(United States) Calbiochem(United States) R and D Systems(United States) Sigma(United States) DB - Embase Medline DO - 10.1016/j.jaci.2005.08.014 IS - 5 LA - English M3 - Article N1 - L41571801 2005-11-30 PY - 2005 SN - 0091-6749 SP - 1144-1150 ST - IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes T2 - Journal of Allergy and Clinical Immunology TI - IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41571801&from=exporthttp://dx.doi.org/10.1016/j.jaci.2005.08.014 VL - 116 ID - 6315 ER - TY - JOUR AD - Cytokines and Growth Factors Section, Biotherapeutics Group, National Institute for Biological Standards and Control , Potters Bar, United Kingdom . AN - 27119567 AU - Jia, H. AU - Dilger, P. AU - Bird, C. AU - Wadhwa, M. C2 - PMC4854210 DA - May DO - 10.1089/jir.2015.0091 10.1089/jir.2015.0091. Epub 2016 Jan 27. DP - Nlm ET - 2016/04/28 IS - 5 LA - eng PY - 2016 SN - 1079-9907 (Print) 1079-9907 SP - 302-16 ST - IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs T2 - J Interferon Cytokine Res TI - IL-27 Promotes Proliferation of Human Leukemic Cell Lines Through the MAPK/ERK Signaling Pathway and Suppresses Sensitivity to Chemotherapeutic Drugs VL - 36 ID - 6316 ER - TY - JOUR AD - Department of Bioscience and Biotechnology, Bio/Molecular Informatics Center, Konkuk University, Seoul, Republic of Korea. Current address: Seegene Inc., Seoul, Korea. Department of Laboratory Medicine, Dankook University College of Medicine, Cheonan, Korea. Dankook University College of Health Sciences, Department of Biomedical Laboratory Science, Cheonan, Korea. College of Pharmacy, Medical Research Center, Chungbuk National University, Chungbuk, Korea. AN - 26516703 AU - Kim, M. S. AU - Kang, J. W. AU - Jeon, J. S. AU - Kim, J. K. AU - Kim, J. W. AU - Hong, J. AU - Yoon, D. Y. C2 - PMC4747366 DA - Dec 1 DO - 10.18632/oncotarget.5688 10.18632/oncotarget.5688. DP - Nlm ET - 2015/10/31 IS - 38 LA - eng PY - 2015 SN - 1949-2553 SP - 40747-61 ST - IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production T2 - Oncotarget TI - IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production VL - 6 ID - 6317 ER - TY - JOUR AD - Blood Diseases Institute, Xuzhou Medical College, No. 84 West Huaihai Road, Xuzhou, Jiangsu 221002, China Key Laboratory of Bone Marrow Stem Cell, No. 84 West Huaihai Road, Xuzhou, Jiangsu Province 221002, China Department of Hematology, The Affiliated Hospital of Xuzhou Medical College, No. 99 West Huaihai Road, Xuzhou, Jiangsu Province 221002, China AU - Zhao, K. AU - Yin, L. L. AU - Zhao, D. M. AU - Pan, B. AU - Chen, W. AU - Cao, J. AU - Cheng, H. AU - Li, Z. Y. AU - Li, D. P. AU - Sang, W. AU - Zeng, L. Y. AU - Xu, K. L. DB - Scopus IS - 12 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2014 SP - 4787-4798 ST - IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients T2 - International Journal of Clinical and Experimental Medicine TI - IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921484619&partnerID=40&md5=3854df31f22ad04d92d79fa2a5c20adb VL - 7 ID - 6318 ER - TY - JOUR AD - Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom. European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, United Kingdom. Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, Vienna, Austria. Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, University Hospital Tübingen, Eberhard-Karls-University, Tübingen, Germany. Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA. Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY. Central European Institute of Technology, Masaryk University, Brno, Czech Republic. Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. Department of Pediatric Hematology, Oncology and Palliative Care, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom. Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan. Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria. Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. Department of Pediatric, Adolescent, and Young Adult Oncology, Institute Curie Medical Centre, Paris, France. Department of Pediatric Oncology and Hematology, Sorbonne Université/Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Department of Pathology, (AP-HP), CHU Necker-Enfants Malades, Paris, France. Oncology Center SIREDO (Care, Innovation, Research for Cancer in Children, Adolescents and Young Adults with Cancer), Institut Curie, Paris, France. INSERM U830 Transfer Department, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. Equipe Integrated Cancer Research Site (SiRIC) Recherche Translationelle en Oncologie Pédiatrique (RTOP), Institut Curie, Paris, France. Department of Pathology, Hematopathology Section, Universitätsklinikum Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany. School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China. Department of Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Department of Clinical Research, Gustave Roussy Cancer Center, Villejuif, France. Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria. Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria. Center for Biomarker Research in Medicine (CBmed) Vienna, Core-Lab2, Medical University of Vienna, Vienna, Austria. Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France; and. INSERM U1015, Université Paris-Saclay, Villejuif, France. AN - 32573700 AU - Prokoph, N. AU - Probst, N. A. AU - Lee, L. C. AU - Monahan, J. M. AU - Matthews, J. D. AU - Liang, H. C. AU - Bahnsen, K. AU - Montes-Mojarro, I. A. AU - Karaca-Atabay, E. AU - Sharma, G. G. AU - Malik, V. AU - Larose, H. AU - Forde, S. D. AU - Ducray, S. P. AU - Lobello, C. AU - Wang, Q. AU - Luan, S. L. AU - Pospíšilová, Š AU - Gambacorti-Passerini, C. AU - Burke, G. A. A. AU - Pervez, S. AU - Attarbaschi, A. AU - Janíková, A. AU - Pacquement, H. AU - Landman-Parker, J. AU - Lambilliotte, A. AU - Schleiermacher, G. AU - Klapper, W. AU - Jauch, R. AU - Woessmann, W. AU - Vassal, G. AU - Kenner, L. AU - Merkel, O. AU - Mologni, L. AU - Chiarle, R. AU - Brugières, L. AU - Geoerger, B. AU - Barbieri, I. AU - Turner, S. D. C2 - PMC7530646 interests. DA - Oct 1 DO - 10.1182/blood.2019003793 10.1182/blood.2019003793. DP - Nlm ET - 2020/06/24 IS - 14 LA - eng PY - 2020 SN - 0006-4971 (Print) 0006-4971 SP - 1657-1669 ST - IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma T2 - Blood TI - IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma VL - 136 ID - 6319 ER - TY - JOUR AD - Department of Diagnostic and Interventional Radiology and Neuroradiology, Klinikum Augsburg, Stenglinstraße 286156, Germany Department of Diagnostic and Interventional Radiology and Neuroradiology, University Ulm, Albert-Einstein-Allee 2389081, Germany Department of Radiology at The Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104, United States AU - Herzberg, M. AU - Beer, M. AU - Anupindi, S. AU - Vollert, K. AU - Kröncke, T. DB - Scopus DO - 10.1016/j.jpedsurg.2018.03.022 IS - 9 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 1862-1870 ST - Imaging pediatric gastrointestinal stromal tumor (GIST) T2 - Journal of Pediatric Surgery TI - Imaging pediatric gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045708930&doi=10.1016%2fj.jpedsurg.2018.03.022&partnerID=40&md5=558e1bf5946261014fad1e8978638a6d VL - 53 ID - 6320 ER - TY - JOUR DB - Scopus IS - 157 M3 - Article N1 - Export Date: 18 November 2020 PY - 2015 SP - 38 ST - Imatinib (GLIVEC°) and acute lymphoblastic leukaemia in children: Prolonged survival in Philadelphia chromosome-positive cases T2 - Prescrire International TI - Imatinib (GLIVEC°) and acute lymphoblastic leukaemia in children: Prolonged survival in Philadelphia chromosome-positive cases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922326933&partnerID=40&md5=3254b295132411ece024ae000bff257f VL - 24 ID - 6321 ER - TY - JOUR AD - Advanced Pediatric Center, Pediatric Hematology-Oncology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Bansal, D. AU - Shava, U. AU - Varma, N. AU - Trehan, A. AU - Marwaha, R. K. DB - Scopus DO - 10.1002/pbc.23389 IS - 3 M3 - Article N1 - Cited By :58 Export Date: 18 November 2020 PY - 2012 SP - 481-484 ST - Imatinib has adverse effect on growth in children with chronic myeloid leukemia T2 - Pediatric Blood and Cancer TI - Imatinib has adverse effect on growth in children with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863865642&doi=10.1002%2fpbc.23389&partnerID=40&md5=4af208142f2671d4b81f5b4beb1efc82 VL - 59 ID - 6322 ER - TY - JOUR AD - Department and Clinic of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Poland Department of Pediatrics, Hematology and Oncology, Dr Edward Hanke Chorzów Center of Pediatrics and Oncology, Poland Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, Poland Silesian Children's Health Center, Department of Oncology, Hematology and Pediatric Chemotherapy, Medical University of Silesia in Katowice, Poland Department of Oncology and Hematology, Polish-American Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Poland Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland Department of Pediatrics, Pediatric Hematology and Oncology, Pomeranian Medical University in Szczecin, Poland Department and Clinic of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland Department of Oncology, Hematology and Pediatric Transplantatology, Poznan University of Medical Sciences, Poland Department of Pediatrics, Hematology and Oncology, Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Poland Department of Hematooncology, Wladyslaw Buszkowski Provincial Specialist Children's Hospital in Kielce, Poland Department and Clinic of Pediatric Hematology and Oncology, Prof. Stanisław Popowski Provincial Specialist Childrens Hospital in Olsztyn, Poland AU - Janeczko-Czarnecka, M. AU - Krawczuk-Rybak, M. AU - Karpińska-Derda, I. AU - Maciej Niedzwiecki, I. AU - Musioł, K. AU - Cwiklińska, M. AU - Drabko, K. AU - Mycko, K. AU - Ociepa, T. AU - Pawelec, K. AU - Januszkiewicz-Lewandowska, D. AU - Ussowicz, M. AU - Rybka, B. AU - Ryczan-Krawczyk, R. AU - Kołtan, A. AU - Karolczyk, G. AU - Zaucha-Prazmo, A. AU - Badowska, W. AU - Kałwak, K. DB - Scopus DO - 10.17219/acem/66462 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 91-98 ST - Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas T2 - Advances in Clinical and Experimental Medicine TI - Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041488834&doi=10.17219%2facem%2f66462&partnerID=40&md5=5fd08d8e2f86fc571bda02b60e0cfdd0 VL - 27 ID - 6323 ER - TY - JOUR AD - Department of Dermatology, Medical Faculty, University Dresden, Dresden, D-01307, Germany Centre for Translational Bone, Joint and Soft Tissue Research, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany Department of Pediatrics, Shriners Hospital for Children, McGill University, Montreal, QC H4A 0A9, Canada Simon Alberti Group, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, D-01307, Germany Institute for Biochemistry, ETH Zurich, Zurich, CH-8093, Switzerland Department of Pediatrics, Division of Pediatric Hematology and Oncology, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany Department of Medicine III and Center for Healthy Aging, Medical Faculty, Technical University Dresden, Dresden, D-01307, Germany AU - Kroschwald, L. M. AU - Tauer, J. T. AU - Kroschwald, S. I. AU - Suttorp, M. AU - Wiedenfeld, A. AU - Beissert, S. AU - Bauer, A. AU - Rauner, M. DB - Scopus DO - 10.3892/ol.2019.10518 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2102-2108 ST - Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro T2 - Oncology Letters TI - Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069805676&doi=10.3892%2fol.2019.10518&partnerID=40&md5=463eafa6e85458ebc62bfa8f72e0ac90 VL - 18 ID - 6324 ER - TY - JOUR AD - Departments of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra pradesh, India Departments of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra pradesh, India AU - Thota, N. K. AU - Gundeti, S. AU - Linga, V. G. AU - Coca, P. AU - Tara, R. P. AU - Raghunadharao DB - Scopus DO - 10.4103/0019-509X.134598 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 5-9 ST - Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: A retrospective analysis T2 - Indian Journal of Cancer TI - Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: A retrospective analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903288981&doi=10.4103%2f0019-509X.134598&partnerID=40&md5=634fbf807bf4f4fdc453c9b9fd0769df VL - 51 ID - 6325 ER - TY - JOUR AD - Division of Pediatric Endocrinology, Department of Pediatrics, Oregon Health and Science University, Portland, OR, United States Division of Pediatric Hematology/Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Department of Internal Medicine, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Department of Education, Oregon Health and Science University, Portland, OR, United States AU - Rastogi, M. V. AU - Stork, L. AU - Druker, B. AU - Blasdel, C. AU - Nguyen, T. AU - Boston, B. A. DB - Scopus DO - 10.1002/pbc.24121 IS - 5 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2012 SP - 840-845 ST - Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia T2 - Pediatric Blood and Cancer TI - Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866167173&doi=10.1002%2fpbc.24121&partnerID=40&md5=f60d368013669391d2fb681a1291d6b6 VL - 59 ID - 6326 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, United States AU - Jabbour, E. AU - Kantarjian, H. M. AU - Jones, D. AU - Shan, J. AU - O'Brien, S. AU - Reddy, N. AU - Wierda, W. G. AU - Faderl, S. AU - Garcia-Manero, G. AU - Verstovsek, S. AU - Rios, M. B. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2008-04-154344 IS - 10 M3 - Article N1 - Cited By :114 Export Date: 18 November 2020 PY - 2009 SP - 2154-2160 ST - Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy T2 - Blood TI - Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-64049099666&doi=10.1182%2fblood-2008-04-154344&partnerID=40&md5=a48dc997e87ffb2ad1ee0891a9d279f9 VL - 113 ID - 6327 ER - TY - JOUR AD - Departments of Paediatric Dermatology, Starship Children's Health, Auckland, New Zealand Departments of Paediatric Haematology and Oncology, Starship Children's Health, Auckland, New Zealand AU - Mahon, C. AU - Purvis, D. AU - Laughton, S. AU - Bradbeer, P. AU - Teague, L. DB - Scopus DO - 10.1111/pde.12380 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 603-607 ST - Imatinib mesylate-induced pseudoporphyria in two children T2 - Pediatric Dermatology TI - Imatinib mesylate-induced pseudoporphyria in two children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908381838&doi=10.1111%2fpde.12380&partnerID=40&md5=1d69c4e1fbe9cc7c0bc534aeecbd932c VL - 31 ID - 6328 ER - TY - JOUR AD - Haematological Oncology and Marrow Transplantation Clinic, Medical University of Lublin, Lublin, Poland Haematological Oncology and Marrow Transplantation Clinic, Staszica 11 str., 20-081 Lublin, Poland AU - Cioch, M. B. AU - Dmoszyńska, A. DB - Scopus DO - 10.1016/s1507-1367(05)71117-2 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2005 SP - 103-106 ST - Imatinib therapy of Ph positive acute lymphoblastic leukaemia - 2 Case reports T2 - Reports of Practical Oncology and Radiotherapy TI - Imatinib therapy of Ph positive acute lymphoblastic leukaemia - 2 Case reports UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21344471720&doi=10.1016%2fs1507-1367%2805%2971117-2&partnerID=40&md5=cc4872e3fe33bc2e5457eb171ca53a79 VL - 10 ID - 6329 ER - TY - JOUR AD - Division of Clinical Haematology, Department of Internal Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa Department of Haematology and Cell Biology, National Health Laboratory Service, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa AN - 108007239. Language: English. Entry Date: 20130502. Revision Date: 20200708. Publication Type: Journal Article AU - Webb, Michael J. AU - Jafta, Debbie DB - ccm DO - 10.5505/tjh.2012.82542 DP - EBSCOhost IS - 4 N1 - case study. Journal Subset: Biomedical; Blind Peer Reviewed; Double Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Middle East; Peer Reviewed. Special Interest: Obstetric Care; Women's Health. PY - 2012 SN - 1300-7777 SP - 405-408 ST - Imatinib Use in Pregnancy T2 - Turkish Journal of Hematology TI - Imatinib Use in Pregnancy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108007239&site=ehost-live&scope=site VL - 29 ID - 6330 ER - TY - JOUR AD - Liver and Gastrointestinal Transplant Division, Department of GastroenterologyUniversity of São Paulo School of MedicineRua Dr. Enéas de Carvalho Aguiar, 255-9o andar-sala 9113/9114CEP05403-900São PauloSPBrazil Department of PathologyUniversity of São Paulo School of MedicineSão PauloBrazil Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, Rua Dr. Enéas de Carvalho Aguiar, 255-9o andar-sala 9113/9114, São Paulo, SP, CEP05403-900, Brazil AN - 128384046. Language: English. Entry Date: In Process. Revision Date: 20180929. Publication Type: journal article AU - Nacif, Lucas Souto AU - Waisberg, Daniel R. AU - Pinheiro, Rafael Soares AU - Lima, Fabiana Roberto AU - Rocha-Santos, Vinicius AU - Andraus, Wellington AU - D’Albuquerque, Luiz Carneiro AU - D'Albuquerque, Luiz Carneiro DB - ccm DO - 10.1186/s13256-018-1588-0 DP - EBSCOhost IS - 1 N1 - case study; research. Journal Subset: Biomedical; Europe; UK & Ireland. NLM UID: 101293382. PMID: NLM29523185. PY - 2018 SN - 1752-1947 SP - 1-1 ST - Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report T2 - Journal of Medical Case Reports TI - Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128384046&site=ehost-live&scope=site VL - 12 ID - 6331 ER - TY - JOUR AD - Department of Pathology, Laboratory Medicine, King Khalid National Guard Hospital, PO Box 9515, Jeddah, Saudi Arabia Department Of Medical Oncology, King Khalid National Guard Hospital, PO Box 9515, Jeddah, Saudi Arabia AU - Al Sobhi, E. AU - Zahrani, Z. AU - Zevallos, E. AU - Zuraiki, A. DB - Scopus DO - 10.1080/10245330600937929 IS - 1 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2007 SP - 49-53 ST - Imatinib-induced immune hepatitis: Case report and literature review T2 - Hematology TI - Imatinib-induced immune hepatitis: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947164748&doi=10.1080%2f10245330600937929&partnerID=40&md5=c69863be8ff22756c34717a3f66b0963 VL - 12 ID - 6332 ER - TY - JOUR AD - Wolters Kluwer Health / Adis, Auckland, New Zealand Wolters Kluwer Health, Conshohocken, PA, United States Wolters Kluwer Health / Adis, 41 Centorian Drive, Mairangi Bay, Auckland 1311, New Zealand AU - Moen, M. D. AU - McKeage, K. AU - Plosker, G. L. AU - Siddiqui, M. A. A. DB - Scopus DO - 10.2165/00003495-200767020-00010 IS - 2 M3 - Review N1 - Cited By :96 Export Date: 18 November 2020 PY - 2007 SP - 299-320 ST - Imatinib: A review of its use in chronic myeloid leukaemia T2 - Drugs TI - Imatinib: A review of its use in chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847057304&doi=10.2165%2f00003495-200767020-00010&partnerID=40&md5=382d7940c86c329ec5cfaa703499bfe2 VL - 67 ID - 6333 ER - TY - JOUR DB - Scopus IS - 98 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2008 SP - 226-228 ST - Imatinib: Longer follow-up in chronic myeloid leukaemia: Clear advantages T2 - Prescrire International TI - Imatinib: Longer follow-up in chronic myeloid leukaemia: Clear advantages UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57349190712&partnerID=40&md5=c929a6828488b34d77e9537d12b220ce VL - 17 ID - 6334 ER - TY - JOUR DB - Scopus IS - 68 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2003 SP - 216-218 ST - Imatinib. Chronic myeloid leukaemia, first-line option: Favourable findings to be confirmed T2 - Prescrire International TI - Imatinib. Chronic myeloid leukaemia, first-line option: Favourable findings to be confirmed UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344877302&partnerID=40&md5=27620f47b4f53afb4e72232686076fbb VL - 12 ID - 6335 ER - TY - JOUR AD - T. Trippett, Memorial Sloan Kettering Cancer Center, Department of Paediatrics, New York, United States AU - Trippett, T. AU - Simko, S. AU - Ye, C. AU - Caron, H. AU - Geoerger, B. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593192 2016-11-11 PY - 2016 SN - 1545-5017 SP - S210 ST - iMATRIXcobi: A phase I/II, dose-escalation study of the safety, pharmacokinetics, and preliminary efficacy of cobimetinib in paediatric and young adult patients with refractory/relapsed tumours T2 - Pediatric Blood and Cancer TI - iMATRIXcobi: A phase I/II, dose-escalation study of the safety, pharmacokinetics, and preliminary efficacy of cobimetinib in paediatric and young adult patients with refractory/relapsed tumours UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593192&from=exporthttp://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 6336 ER - TY - JOUR AD - Department of Pediatric Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD, United States Division of Comparative Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD, United States ImClone Systems, Inc., New York, NY, United States Johns Hopkins University, School of Medicine, CRB 276, 1650 Orleans Street, Baltimore, MD 21231, United States AU - Piloto, O. AU - Nguyen, B. AU - Huso, D. AU - Kim, K. T. AU - Li, Y. AU - Witte, L. AU - Hicklin, D. J. AU - Brown, P. AU - Small, D. DB - Scopus DO - 10.1158/0008-5472.CAN-06-0018 IS - 9 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2006 SP - 4843-4851 ST - IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples T2 - Cancer Research TI - IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646432479&doi=10.1158%2f0008-5472.CAN-06-0018&partnerID=40&md5=f183dc76bcc00ee87d1a0a82c4ef4baa VL - 66 ID - 6337 ER - TY - JOUR AD - Department of Medical Oncology, Hôpital Universitaire Pitié-Salpétrière, Paris, France Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Service d'Hématologie et d'Oncologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France Association Pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France Centre Antoine Lacassagne, Nice, France Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, United States IUCT-Oncopole, Institut Claudius-Regaud, Toulouse, France Service d'Hématologie et d'Oncologie Pédiatrique, Hopital Armand-Trousseau, Paris, France Division of Hematology and Oncology, Department of Medicine, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States Carolinas Healthcare System, Levine Cancer Institute, Charlotte, NC, United States Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States Service d'Anatomopathologie, Hôpital Armand-Trousseau, Paris, France Department of Bioinformatics and Computational Biology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France Department of Hematology and Oncology, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l'Hôpital, Strasbourg, 67000, France AU - Boilève, A. AU - Carlo, M. I. AU - Barthélémy, P. AU - Oudard, S. AU - Borchiellini, D. AU - Voss, M. H. AU - George, S. AU - Chevreau, C. AU - Landman-Parker, J. AU - Tabone, M. D. AU - Chism, D. D. AU - Amin, A. AU - Bilen, M. A. AU - Bosse, D. AU - Coulomb-L'Hermine, A. AU - Su, X. AU - Choueiri, T. K. AU - Tannir, N. M. AU - Malouf, G. G. C7 - 159 DB - Scopus DO - 10.1186/s40425-018-0482-z IS - 1 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2018 ST - Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders T2 - Journal for ImmunoTherapy of Cancer TI - Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059239376&doi=10.1186%2fs40425-018-0482-z&partnerID=40&md5=795c08a998209a84a20ac87e929d80e1 VL - 6 ID - 6338 ER - TY - JOUR AD - Y. Zhao, Central Laboratory, Provincial Hospital Affiliated to Shandong University, 324 Jingwu Road, Jinan 250021, China AU - Sun, W. AU - Jiao, Y. AU - Cui, B. AU - Gao, X. AU - Xia, Y. AU - Zhao, Y. DB - Embase Medline DO - 10.1038/labinvest.2013.61 IS - 6 LA - English M3 - Article N1 - L369050474 2013-06-12 2013-06-18 PY - 2013 SN - 0023-6837 1530-0307 SP - 626-638 ST - Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis T2 - Laboratory Investigation TI - Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369050474&from=exporthttp://dx.doi.org/10.1038/labinvest.2013.61 VL - 93 ID - 6339 ER - TY - JOUR AD - B. Qi, Department of Intensive Care Unit, Xuzhou Children’s Hospital, 18 Sudi North Road, Xuzhou, Jiangsu, China AU - Zhu, L. AU - Li, W. AU - Qi, G. AU - Liu, N. AU - Sheng, L. AU - Shang, L. AU - Qi, B. DB - Embase DO - 10.3892/etm.2017.4245 IS - 5 LA - English M3 - Article N1 - L619106610 2017-11-10 2017-11-15 PY - 2017 SN - 1792-1015 1792-0981 SP - 2263-2266 ST - The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe handfoot-and-mouth disease and the MAPK pathway T2 - Experimental and Therapeutic Medicine TI - The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe handfoot-and-mouth disease and the MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619106610&from=exporthttp://dx.doi.org/10.3892/etm.2017.4245 VL - 13 ID - 6340 ER - TY - JOUR AD - H. Jin, Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Jiang, Y. AU - Wang, W. AU - Zheng, X. AU - Jin, H. C1 - aldara(3M) xt 311(BioXCell) C2 - 3M BioXCell DB - Embase Medline DO - 10.1155/2020/5980190 LA - English M3 - Article N1 - L2005487138 2020-04-13 2020-07-08 PY - 2020 SN - 2314-7156 2314-8861 ST - Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation T2 - Journal of Immunology Research TI - Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005487138&from=exporthttp://dx.doi.org/10.1155/2020/5980190 VL - 2020 ID - 6341 ER - TY - JOUR AD - Paediatric Solid Tumour Biology and Therapeutics Team, Division of Clinical Studies and Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Clinical Pharmacodynamic Biomarker Team, Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Tumour Biology and Metastasis, Cancer Therapeutics Division, The Institute of Cancer Research, Sutton, Surrey, UK. Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, Surrey, UK. AN - 28432815 AU - Tucker, E. R. AU - Tall, J. R. AU - Danielson, L. S. AU - Gowan, S. AU - Jamin, Y. AU - Robinson, S. P. AU - Banerji, U. AU - Chesler, L. C2 - PMC5537911 DA - Aug DO - 10.1002/1878-0261.12069 10.1002/1878-0261.12069. Epub 2017 May 31. DP - Nlm ET - 2017/04/23 IS - 8 LA - eng PY - 2017 SN - 1574-7891 (Print) 1574-7891 SP - 996-1006 ST - Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma T2 - Mol Oncol TI - Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma VL - 11 ID - 6342 ER - TY - JOUR AD - Centre for Virus Research, Westmead Millennium Institute, Westmead, NSW, Australia University of Sydney, NSW, Australia La Jolla Institute for Allergy and Immunology, San Diego, CA 92037, United States Taylor Square Private Clinic, Darlinghurst, NSW, Australia Parramatta Sexual Health Clinic, Parramatta, NSW, Australia Australian Red Cross Blood Service, Sydney, NSW, Australia Westmead Hospital, Westmead, NSW, Australia GlaxoSmithKline Biologicals, Rixensart, Belgium Queensland Institute of Medical Research, Herston, QLD, Australia AU - Kim, M. AU - Taylor, J. AU - Sidney, J. AU - Mikloska, Z. AU - Bodsworth, N. AU - Lagios, K. AU - Dunckley, H. AU - Byth-Wilson, K. AU - Denis, M. AU - Finlayson, R. AU - Khanna, R. AU - Sette, A. AU - Cunningham, A. L. DB - Scopus DO - 10.4049/jimmunol.181.9.6604 IS - 9 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2008 SP - 6604-6615 ST - Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects T2 - Journal of Immunology TI - Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-58749094126&doi=10.4049%2fjimmunol.181.9.6604&partnerID=40&md5=a1f69c37104863ef2fc7e61dd7add982 VL - 181 ID - 6343 ER - TY - JOUR AD - National Specialist Ophthalmic Pathology Service, Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK. hardeep.mudhar@sth.nhs.uk AN - 23685997 AU - Mudhar, H. S. AU - Doherty, R. AU - Salawu, A. AU - Sisley, K. AU - Rennie, I. G. DA - Jul DO - 10.1136/bjophthalmol-2013-303291 10.1136/bjophthalmol-2013-303291. Epub 2013 May 17. DP - Nlm ET - 2013/05/21 IS - 7 LA - eng PY - 2013 SN - 0007-1161 SP - 924-8 ST - Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations T2 - Br J Ophthalmol TI - Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations VL - 97 ID - 6344 ER - TY - JOUR AD - Department of Dermatology, St. Mary's Hospital, Catholic University of Korea, 62 Youido-dong, Seoul 150-713, South Korea Department of Clinical Pathology, St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea Korean Res. Inst. Biosci. Biotech., Taejon, South Korea Department of Life Science, Sookmyung Women's University, Chungpa-Dong 2-Ka, Yongsan-Ku, Seoul 140-742, South Korea AU - Park, H. J. AU - Kim, H. S. AU - Kim, H. J. AU - Lee, J. Y. AU - Cho, B. K. AU - Lee, A. W. AU - Yoon, D. Y. AU - Cho, D. H. DB - Scopus DO - 10.1016/j.jdermsci.2004.12.002 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2005 SP - 9-15 ST - Immunohistochemical characterization of cutaneous drug eruptions by STI571 T2 - Journal of Dermatological Science TI - Immunohistochemical characterization of cutaneous drug eruptions by STI571 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-15744390352&doi=10.1016%2fj.jdermsci.2004.12.002&partnerID=40&md5=9df274e217d26a2cdce54200cb2c6177 VL - 38 ID - 6345 ER - TY - JOUR AD - Department of Pathology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. m.lastowska@ipczd.pl. Department of Experimental and Clinical Pathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, A. Pawińskiego 5 Street, 02-106, Warsaw, Poland. m.lastowska@ipczd.pl. Department of Pathology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. Clinic of Oncology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730, Warsaw, Poland. Department of Experimental and Clinical Pathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, A. Pawińskiego 5 Street, 02-106, Warsaw, Poland. AN - 30523493 AU - Łastowska, M. AU - Trubicka, J. AU - Karkucińska-Więckowska, A. AU - Kaleta, M. AU - Tarasińska, M. AU - Perek-Polnik, M. AU - Sobocińska, A. A. AU - Dembowska-Bagińska, B. AU - Grajkowska, W. AU - Matyja, E. C2 - PMC6514113 DA - Jan DO - 10.1007/s10014-018-0331-2 10.1007/s10014-018-0331-2. Epub 2018 Dec 6. DP - Nlm ET - 2018/12/14 IS - 1 LA - eng PY - 2019 SN - 1433-7398 (Print) 1433-7398 SP - 1-6 ST - Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors T2 - Brain Tumor Pathol TI - Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors VL - 36 ID - 6346 ER - TY - JOUR AD - Servicio de Endocrinología, Hospital Universitario de Basurto, Bilbao, España; Universidad del País Vasco (UPV-EHU), Bilbao, España. Electronic address: miguel.pajafano@osakidetza.net. Servicio de Anatomía Patológica, Hospital Universitario de Basurto, Bilbao, España. Servicio de Endocrinología, Hospital Universitario de Basurto, Bilbao, España. AN - 28440781 AU - Paja Fano, M. AU - Ugalde Olano, A. AU - Fuertes Thomas, E. AU - Oleaga Alday, A. DA - Feb DO - 10.1016/j.endinu.2016.12.004 10.1016/j.endinu.2016.12.004. Epub 2017 Feb 10. DP - Nlm ET - 2017/04/26 IS - 2 LA - eng spa OP - Detección inmunohistoquímica de la mutación BRAF V600E en el carcinoma papilar de tiroides. Evaluación frente a la reacción en cadena de la polimerasa en tiempo real. PY - 2017 SN - 2530-0164 SP - 75-81 ST - Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction T2 - Endocrinol Diabetes Nutr TI - Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction VL - 64 ID - 6347 ER - TY - JOUR AD - Department of Histopathology, Bristol Royal Infirmary, Bristol, UK. AN - 25659413 AU - Wong, N. A. AU - Wingate, J. AU - Gradhand, E. DA - Sep DO - 10.1111/his.12667 10.1111/his.12667. Epub 2015 Mar 17. DP - Nlm ET - 2015/02/11 IS - 3 LA - eng PY - 2015 SN - 0309-0167 SP - 378-85 ST - An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours T2 - Histopathology TI - An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours VL - 67 ID - 6348 ER - TY - JOUR AD - Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100730, People's Republic of China. AN - 26823846 AU - Sun, J. AU - Zhang, J. AU - Lu, J. AU - Gao, J. AU - Lu, T. AU - Ren, X. AU - Duan, H. AU - Liang, Z. C2 - PMC4713632 DP - Nlm ET - 2016/01/30 IS - 11 LA - eng N1 - 1936-2625 Sun, Jian Zhang, Jing Lu, Junliang Gao, Jie Lu, Tao Ren, Xinyu Duan, Huanli Liang, Zhiyong Journal Article Int J Clin Exp Pathol. 2015 Nov 1;8(11):15072-8. eCollection 2015. PY - 2015 SN - 1936-2625 SP - 15072-8 ST - Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma T2 - Int J Clin Exp Pathol TI - Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma VL - 8 ID - 6349 ER - TY - JOUR AD - Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. Clinical Biochemistry Unit, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. Laboratory of Molecular Pathology, UO Pathological Anatomy III, Pisa, Italy. Unit of Mechanisms of Cancer, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. Clinical and Descriptive Epidemiology Unit, Institute for Study and Cancer Prevention (ISPO), Florence, Italy. Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. Dermatopathology Section, SM Annunziata Hospital, Florence, Italy. Unit of Medical Oncology, Division of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. AN - 25341653 AU - Massi, D. AU - Simi, L. AU - Sensi, E. AU - Baroni, G. AU - Xue, G. AU - Scatena, C. AU - Caldarella, A. AU - Pinzani, P. AU - Fontanini, G. AU - Carobbio, A. AU - Urso, C. AU - Mandalà, M. DA - Apr DO - 10.1038/modpathol.2014.137 10.1038/modpathol.2014.137. Epub 2014 Oct 24. DP - Nlm ET - 2014/10/25 IS - 4 LA - eng PY - 2015 SN - 0893-3952 SP - 487-97 ST - Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma T2 - Mod Pathol TI - Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma VL - 28 ID - 6350 ER - TY - JOUR AD - D. Bhojwani AU - Bhojwani, D. AU - Peterson, B. AU - Taraseviciute, A. AU - Pulsipher, M. A. AU - Wayne, A. S. AU - Sheard, M. AU - Allem, C. AU - Trampush, J. AU - Bansal, R. DB - Embase DO - 10.1182/blood-2019-127533 LA - English M3 - Conference Abstract N1 - L630319856 2019-12-31 PY - 2019 SN - 1528-0020 ST - Immunologic and brain bases of neurotoxicity associated with car t-cell therapy T2 - Blood TI - Immunologic and brain bases of neurotoxicity associated with car t-cell therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630319856&from=exporthttp://dx.doi.org/10.1182/blood-2019-127533 VL - 134 ID - 6351 ER - TY - JOUR AD - Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, IRCCS, Istituto Nazionale Tumori Fondazione G. Pascale, Via Mariano Semmola, Naples 80131, Italy Regina Elena National Cancer Institute, Rome, Italy National Research Council, Sassari, Italy San Martino Hospital, National Institute for Cancer Research, Genoa, Italy Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy Sant'Andrea Hospital, University Sapienza, Rome, Italy Paolo Giaccone Polyclinic University Hospital, Palermo, Italy AU - Simeone, E. AU - Gentilcore, G. AU - Giannarelli, D. AU - Grimaldi, A. M. AU - Caracò, C. AU - Curvietto, M. AU - Esposito, A. AU - Paone, M. AU - Palla, M. AU - Cavalcanti, E. AU - Sandomenico, F. AU - Petrillo, A. AU - Botti, G. AU - Fulciniti, F. AU - Palmieri, G. AU - Queirolo, P. AU - Marchetti, P. AU - Ferraresi, V. AU - Rinaldi, G. AU - Pistillo, M. P. AU - Ciliberto, G. AU - Mozzillo, N. AU - Ascierto, P. A. DB - Scopus DO - 10.1007/s00262-014-1545-8 IS - 7 M3 - Article N1 - Cited By :164 Export Date: 18 November 2020 PY - 2014 SP - 675-683 ST - Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma T2 - Cancer Immunology, Immunotherapy TI - Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903818245&doi=10.1007%2fs00262-014-1545-8&partnerID=40&md5=1893b18b61e8e4b4e1dba9291096b9a5 VL - 63 ID - 6352 ER - TY - JOUR AD - E. Noguchi, Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan AU - Fujimoto, M. AU - Imai, K. AU - Hirata, K. AU - Kashiwagi, R. AU - Morinishi, Y. AU - Kitazawa, K. AU - Sasaki, S. AU - Arinami, T. AU - Nonoyama, S. AU - Noguchi, E. DB - Embase Medline DO - 10.1186/1471-2350-9-42 LA - English M3 - Article N1 - L351803795 2008-06-20 PY - 2008 SN - 1471-2350 ST - Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes T2 - BMC Medical Genetics TI - Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351803795&from=exporthttp://dx.doi.org/10.1186/1471-2350-9-42 VL - 9 ID - 6353 ER - TY - JOUR AD - J.D. Spencer, Center for Clinical and Translational Research, The Research Institute at Nationwide Children's, Columbus, OH, United States AU - Schwartz, L. AU - Cohen, A. AU - Thomas, J. AU - Spencer, J. D. DB - Embase DO - 10.3390/vaccines6040076 IS - 4 LA - English M3 - Review N1 - L625466887 2018-12-25 2018-12-27 PY - 2018 SN - 2076-393X ST - The immunomodulatory and antimicrobial properties of the vertebrate ribonuclease a superfamily T2 - Vaccines TI - The immunomodulatory and antimicrobial properties of the vertebrate ribonuclease a superfamily UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625466887&from=exporthttp://dx.doi.org/10.3390/vaccines6040076 VL - 6 ID - 6354 ER - TY - JOUR AD - Childrens Hospital, University of Lübeck Medical School, Ratzeburger Allee 160, 23538 Lübeck, Germany. AN - 19215806 AU - Härtel, C. AU - Rupp, J. AU - Iblher, P. AU - Puzik, A. AU - Osthues, I. AU - Schultz, C. AU - Müller-Steinhardt, M. DO - 10.1016/j.imbio.2008.08.003 10.1016/j.imbio.2008.08.003. Epub 2008 Oct 11. DP - Nlm ET - 2009/02/14 IS - 3 LA - eng PY - 2009 SN - 0171-2985 SP - 235-43 ST - Immunomodulatory effects of Sanglifehrin A in the innate and acquired immune response of neonatal whole blood cells T2 - Immunobiology TI - Immunomodulatory effects of Sanglifehrin A in the innate and acquired immune response of neonatal whole blood cells VL - 214 ID - 6355 ER - TY - JOUR AD - J. C. Gray, University of Southampton, Tenovus Research Laboratory, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom AU - Gray, J. C. AU - Kohler, J. A. DB - Embase Medline DO - 10.1002/pbc.22153 IS - 6 LA - English M3 - Review N1 - L355737011 2010-01-15 PY - 2009 SN - 1545-5009 1545-5017 SP - 931-940 ST - Immunotherapy for neuroblastoma: Turning promise into reality T2 - Pediatric Blood and Cancer TI - Immunotherapy for neuroblastoma: Turning promise into reality UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355737011&from=exporthttp://dx.doi.org/10.1002/pbc.22153http://www3.interscience.wiley.com/cgi-bin/fulltext/122506809/PDFSTART VL - 53 ID - 6356 ER - TY - JOUR AD - A.S.-Y. Lau, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, 1/F, New Clinical Science Building, Pokfulam Road, Hong Kong AU - Cheung, B. K. W. AU - Chan, M. M. P. AU - Yim, H. C. H. AU - Chan, L. L. AU - Li, J. C. B. AU - Lee, D. C. W. AU - Lau, A. S. Y. DB - Embase Medline IS - 3 LA - English M3 - Note N1 - L610283700 2016-05-13 2016-05-27 PY - 2009 SN - 1024-2708 SP - S32-S36 ST - Immunotherapy of mycobacterial infections: A cell and molecular model T2 - Hong Kong Medical Journal TI - Immunotherapy of mycobacterial infections: A cell and molecular model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610283700&from=export VL - 15 ID - 6357 ER - TY - JOUR AD - Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. Department of Integrative Neuroscience, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. Division of Biostatistics and Clinical Epidemiology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan. AN - 29271010 AU - Hayashi, T. AU - Hayakawa, Y. AU - Koh, M. AU - Tomita, T. AU - Nagai, S. AU - Kashiwazaki, D. AU - Sugimori, M. AU - Origasa, H. AU - Kuroda, S. DA - Apr DO - 10.1111/neup.12446 10.1111/neup.12446. Epub 2017 Dec 21. DP - Nlm ET - 2017/12/23 IS - 2 LA - eng PY - 2018 SN - 0919-6544 SP - 144-153 ST - Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma T2 - Neuropathology TI - Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma VL - 38 ID - 6358 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan Takamatsu Red Cross Hospital, Takamatsu 760-0017, Japan Ehime Prefectural Central Hospital, Ehime 790-0024, Japan Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GE, UK AN - 137798480. Language: English. Entry Date: 20190802. Revision Date: 20190802. Publication Type: Article AU - Ueshima, Kazuomi AU - Nishida, Naoshi AU - Hagiwara, Satoru AU - Aoki, Tomoko AU - Minami, Tomohiro AU - Chishina, Hirokazu AU - Takita, Masahiro AU - Minami, Yasunori AU - Ida, Hiroshi AU - Takenaka, Mamoru AU - Sakurai, Toshiharu AU - Watanabe, Tomohiro AU - Morita, Masahiro AU - Ogawa, Chikara AU - Hiraoka, Atsushi AU - Johnson, Philip AU - Kudo, Masatoshi DB - ccm DO - 10.3390/cancers11070952 DP - EBSCOhost IS - 7 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Child-Pugh Score. NLM UID: 101526829. PY - 2019 SN - 2072-6694 SP - 952-952 ST - Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study T2 - Cancers TI - Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137798480&site=ehost-live&scope=site VL - 11 ID - 6359 ER - TY - JOUR AD - Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Institute of Pathology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland. Department of Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Department of Nuclear Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland. Clinical Trials Unit, Kantonsspital St. Gallen, St. Gallen, Switzerland. Cancer Registry Eastern Switzerland, St. Gallen, Switzerland. Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland. Electronic address: martina.broglie@kssg.ch. AN - 25482468 AU - Niederer-Wüst, S. M. AU - Jochum, W. AU - Förbs, D. AU - Brändle, M. AU - Bilz, S. AU - Clerici, T. AU - Oettli, R. AU - Müller, J. AU - Haile, S. R. AU - Ess, S. AU - Stoeckli, S. J. AU - Broglie, M. A. DA - Jan DO - 10.1016/j.surg.2014.07.015 10.1016/j.surg.2014.07.015. DP - Nlm ET - 2014/12/09 IS - 1 LA - eng PY - 2015 SN - 0039-6060 SP - 119-25 ST - Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer T2 - Surgery TI - Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer VL - 157 ID - 6360 ER - TY - JOUR AD - Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States University of Texas MD Anderson Cancer Center, Department of Leukemia, Unit 428, 1515 Holcombe Blvd, Houston, TX 77030, United States Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, United States Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA, United States AU - Short, N. J. AU - Jabbour, E. AU - Sasaki, K. AU - Patel, K. AU - O'Brien, S. M. AU - Cortes, J. E. AU - Garris, R. AU - Issa, G. C. AU - Garcia-Manero, G. AU - Luthra, R. AU - Thomas, D. AU - Kantarjian, H. AU - Ravandi, F. DB - Scopus DO - 10.1182/blood-2016-03-707562 IS - 4 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2016 SP - 504-507 ST - Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Blood TI - Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84979888012&doi=10.1182%2fblood-2016-03-707562&partnerID=40&md5=85bec6a818b41957a3a0111016e055cd VL - 128 ID - 6361 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy Federal State-Funded Institution National Research, Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Bristol-Myers Squibb, Princeton, NJ, United States Centre for Haematology, Imperial College, London, United Kingdom AU - Cortes, J. E. AU - Abruzzese, E. AU - Chelysheva, E. AU - Guha, M. AU - Wallis, N. AU - Apperley, J. F. DB - Scopus DO - 10.1002/ajh.24186 IS - 12 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2015 SP - 1111-1115 ST - The impact of dasatinib on pregnancy outcomes T2 - American Journal of Hematology TI - The impact of dasatinib on pregnancy outcomes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954220288&doi=10.1002%2fajh.24186&partnerID=40&md5=2cd1e5dce64ab3901add6ab301dc54d4 VL - 90 ID - 6362 ER - TY - JOUR AD - Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA, United States AU - Patel, K. AU - Sudhir, V. S. AU - Kabadi, S. AU - Huang, J. C. AU - Porwal, S. AU - Thakkar, K. AU - Pagel, J. M. DB - Scopus DO - 10.1177/1078155219827637 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 1897-1906 ST - Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees T2 - Journal of Oncology Pharmacy Practice TI - Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061489800&doi=10.1177%2f1078155219827637&partnerID=40&md5=434f1dce296b4e21a42781c39710da93 VL - 25 ID - 6363 ER - TY - JOUR AD - S. Whittle, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, United States AU - Whittle, S. AU - Du, M. AU - Woodfield, S. AU - Zhang, L. AU - Okcu, F. AU - Lupo, P. AU - Michael, S. AU - Peter, Z. DB - Embase DO - 10.1002/pbc.25540 LA - English M3 - Conference Abstract N1 - L613190792 2016-11-17 PY - 2015 SN - 1545-5017 SP - S100 ST - The impact of FGFR4 ARG388 on neuroblastoma incidence, outcome, and response to treatment T2 - Pediatric Blood and Cancer TI - The impact of FGFR4 ARG388 on neuroblastoma incidence, outcome, and response to treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613190792&from=exporthttp://dx.doi.org/10.1002/pbc.25540 VL - 62 ID - 6364 ER - TY - JOUR AD - Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan AU - Akahoshi, Y. AU - Igarashi, A. AU - Fukuda, T. AU - Uchida, N. AU - Tanaka, M. AU - Ozawa, Y. AU - Kanda, Y. AU - Onizuka, M. AU - Ichinohe, T. AU - Tanaka, J. AU - Atsuta, Y. AU - Kako, S. DB - Scopus DO - 10.1111/bjh.16540 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 84-92 ST - Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - British Journal of Haematology TI - Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081029421&doi=10.1111%2fbjh.16540&partnerID=40&md5=d3dea099fdfac9019835b66abaf654ac VL - 190 ID - 6365 ER - TY - JOUR AD - Department of Pediatrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany Department of Internal Medicine III, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany Experimental Center of Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany Medical Faculty Carl Gustav Carus, Institute for Medical Informatics and Biometry, TU Dresden, Dresden, Germany Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria AU - Tauer, J. T. AU - Hofbauer, L. C. AU - Jung, R. AU - Gerdes, S. AU - Glauche, I. AU - Erben, R. G. AU - Suttorp, M. C7 - e0131192 DB - Scopus DO - 10.1371/journal.pone.0131192 IS - 6 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 ST - Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats T2 - PLoS ONE TI - Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939193147&doi=10.1371%2fjournal.pone.0131192&partnerID=40&md5=5be351ffe9dba1239f7293f9bdbcaf9d VL - 10 ID - 6366 ER - TY - JOUR AD - Corresponding Author: Ulrike Stein, PhD, Experimental and Clinical Research Center, Charité University Medicine Berlin and the Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany. ustein@mdc-berlin.de. AN - 24220141 AU - Hagemann, C. AU - Fuchs, S. AU - Monoranu, C. M. AU - Herrmann, P. AU - Smith, J. AU - Hohmann, T. AU - Grabiec, U. AU - Kessler, A. F. AU - Dehghani, F. AU - Löhr, M. AU - Ernestus, R. I. AU - Vince, G. H. AU - Stein, U. C2 - PMC3829600 DA - Dec DO - 10.1093/neuonc/not136 10.1093/neuonc/not136. Epub 2013 Nov 11. DP - Nlm ET - 2013/11/14 IS - 12 LA - eng PY - 2013 SN - 1522-8517 (Print) 1522-8517 SP - 1696-709 ST - Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis T2 - Neuro Oncol TI - Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis VL - 15 ID - 6367 ER - TY - JOUR AD - Eurocord APHP, University Paris-Diderot, Hospital Saint Louis, Paris, France Centro de Oncologia, Hospital Sirio Libanes, Sao Paulo, Brazil Service d'Hématologie et Thérapie Cellulaire, AP-HP, UPMC Université Paris 6, UMR-S 938, CEREST-TC EBMT, Hôpital Saint Antoine, Paris, France Cord Blood Committee - Immunobiology Working Party, EBMT, Paris, France Servicio de Hematologia, Hospital University La Fe, Valencia, Spain Haematology, Institut Paoli Calmettes, Marseille, France Haematology, Erasmus MC/Daniel Den Hoed, Rotterdam, Netherlands Medical University Graz, Graz, Austria Hôpital de l'ARCHET, Nice, France ICO-Hospital Universitari Germans Trias i Pujol, Jose Carreras Research Institute, Badalona, Spain Department of Haematology, LUMC, Rotterdam, Netherlands CHU de Lille, Lille, France Haematology Department, Carlos Haya Hospital, Malaga, Spain Division of Clinical Haematology, Ziekenhuis University, Brussel, Belgium Haematology Division - Stem Cell Transplant Unit, University of Rome Tor Vergata, Rome, Italy Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom AU - Tucunduva, L. AU - Ruggeri, A. AU - Sanz, G. AU - Furst, S. AU - Cornelissen, J. AU - Linkesch, W. AU - Mannone, L. AU - Ribera, J. M. AU - Veelken, H. AU - Yakoub-Agha, I. AU - González Valentín, M. E. AU - Schots, R. AU - Arcese, W. AU - Montesinos, P. AU - Labopin, M. AU - Gluckman, E. AU - Mohty, M. AU - Rocha, V. DB - Scopus DO - 10.1111/bjh.12970 IS - 5 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 749-757 ST - Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: An analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation T2 - British Journal of Haematology TI - Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: An analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906048142&doi=10.1111%2fbjh.12970&partnerID=40&md5=728c5b0829535ee015c679fe86505951 VL - 166 ID - 6368 ER - TY - JOUR AD - Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Division of Hematology and Oncology, Toyohashi Municipal Hospital, 50 Aza Hachiken Nishi, Aotake-cho, Toyohashi, 441-8570, Japan Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan Department of Hematology, Sapporo Hokuyu Hospital, Sappro, Japan Department of Hematology, Fujita Health University Hospital, Toyoake, Japan Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan Division of Hematology, Tokyo Metropolitan Cancer, Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan Division of Molecular Therapy, Institute of Medical Science, Advanced Clinical Research Center, University of Tokyo, Tokyo, Japan Department of Hematology, Toranomon Hospital, Tokyo, Japan Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan Department of Hematology, Osaka City University Hospital, Osaka, Japan Third Department of Internal of Medicine, Yamaguchi University School of Medicine, Ube, Japan Department of Hematology and Oncology, St. Luke's International Hospital, Tokyo, Japan Department of Cell Processing and Transfusion, Institute of Medical Science, University of Tokyo, Tokyo, Japan Department of HSCT Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan AU - Nishiwaki, S. AU - Imai, K. AU - Mizuta, S. AU - Kanamori, H. AU - Ohashi, K. AU - Fukuda, T. AU - Onishi, Y. AU - Takahashi, S. AU - Uchida, N. AU - Eto, T. AU - Nakamae, H. AU - Yujiri, T. AU - Mori, S. AU - Nagamura-Inoue, T. AU - Suzuki, R. AU - Atsuta, Y. AU - Tanaka, J. AU - Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell, Transplantation DB - Scopus DO - 10.1038/bmt.2015.217 IS - 1 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2016 SP - 43-50 ST - Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: A study from the adult ALL WG of the JSHCT T2 - Bone Marrow Transplantation TI - Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: A study from the adult ALL WG of the JSHCT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953366591&doi=10.1038%2fbmt.2015.217&partnerID=40&md5=4f026387b5fb030b4282481b10f14941 VL - 51 ID - 6369 ER - TY - JOUR AD - Hematology Oncology Infusion Clinic, Kaiser Permanente Health Plan, 4501 Sand Creek Road, Antioch, CA 94531, United States AU - Lam, M. S. H. AU - Cheung, N. DB - Scopus DO - 10.1177/1078155215608523 IS - 6 M3 - Article N1 - Cited By :39 Export Date: 18 November 2020 PY - 2016 SP - 741-748 ST - Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia T2 - Journal of Oncology Pharmacy Practice TI - Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994060974&doi=10.1177%2f1078155215608523&partnerID=40&md5=00764c5debfe799386efb40938e7dc03 VL - 22 ID - 6370 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Kantarjian, H. AU - O'Brien, S. AU - Jabbour, E. AU - Shan, J. AU - Ravandi, F. AU - Kadia, T. AU - Faderl, S. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Cortes, J. DB - Scopus DO - 10.1200/JCO.2010.33.4169 IS - 23 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2011 SP - 3173-3178 ST - Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia T2 - Journal of Clinical Oncology TI - Impact of treatment end point definitions on perceived differences in long-term outcome with tyrosine kinase inhibitor therapy in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051821734&doi=10.1200%2fJCO.2010.33.4169&partnerID=40&md5=657a272bdab9bf33351691c252007721 VL - 29 ID - 6371 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 103942432. Language: English. Entry Date: 20140627. Revision Date: 20200708. Publication Type: journal article AU - Jeha, Sima AU - Coustan-Smith, Elaine AU - Pei, Deqing AU - Sandlund, John T. AU - Rubnitz, Jeffrey E. AU - Howard, Scott C. AU - Inaba, Hiroto AU - Bhojwani, Deepa AU - Metzger, Monika L. AU - Cheng, Cheng AU - Choi, John K. AU - Jacobsen, Jeffrey AU - Shurtleff, Sheila A. AU - Raimondi, Susana AU - Ribeiro, Raul C. AU - Pui, Ching-Hon AU - Campana, Dario DB - ccm DO - 10.1002/cncr.28598 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P30 CA-21,765/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM24501014. PY - 2014 SN - 0008-543X SP - 1514-1519 ST - Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Cancer (0008543X) TI - Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103942432&site=ehost-live&scope=site VL - 120 ID - 6372 ER - TY - JOUR AD - Department of Pharmacology, University of Tromso, Tromso, Norway Haematology Research Unit, Biomedicum Helsinki, Finland Departments of Medicine (Division of Haematology) and Clinical Chemistry, Helsinki University, Central Hospital, Helsinki, Finland Helsinki University Central Hospital, Biomedicum Helsinki, Haematology Research Unit, PO Box 700, FIN-00029 HUCH, Helsinki, Finland AU - Gruber, F. AU - Mustjoki, S. AU - Porkka, K. DB - Scopus DO - 10.1111/j.1365-2141.2009.07666.x IS - 5 M3 - Review N1 - Cited By :44 Export Date: 18 November 2020 PY - 2009 SP - 581-597 ST - Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66149170248&doi=10.1111%2fj.1365-2141.2009.07666.x&partnerID=40&md5=8bcde1f88eff46cdfc3dca8e3a29ab0f VL - 145 ID - 6373 ER - TY - JOUR AD - Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QR, United Kingdom. AN - 9486982 AU - Dib, K. AU - Whitehead, J. P. AU - Humphreys, P. J. AU - Soos, M. A. AU - Baynes, K. C. AU - Kumar, S. AU - Harvey, T. AU - O'Rahilly, S. C2 - PMC508663 DA - Mar 1 DO - 10.1172/jci119884 10.1172/JCI119884. DP - Nlm ET - 1998/04/16 IS - 5 LA - eng PY - 1998 SN - 0021-9738 (Print) 0021-9738 SP - 1111-20 ST - Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance T2 - J Clin Invest TI - Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance VL - 101 ID - 6374 ER - TY - JOUR AD - Soochow University Affiliated Children's Hospital, Suzhou, China. AN - 22443189 AU - Zhu, G. AU - Ge, X. AU - Zhu, J. AU - Wei, Y. AU - Wang, J. DA - Dec DO - 10.3109/15513815.2012.659401 10.3109/15513815.2012.659401. Epub 2012 Mar 23. DP - Nlm ET - 2012/03/27 IS - 6 LA - eng PY - 2012 SN - 1551-3815 SP - 365-73 ST - Impaired cytokine production and decreased TLR2-mediated signaling in mouse infant macrophages T2 - Fetal Pediatr Pathol TI - Impaired cytokine production and decreased TLR2-mediated signaling in mouse infant macrophages VL - 31 ID - 6375 ER - TY - JOUR AD - Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA. AN - 12060576 AU - Kerby, G. S. AU - Cottin, V. AU - Accurso, F. J. AU - Hoffmann, F. AU - Chan, E. D. AU - Fadok, V. A. AU - Riches, D. W. DA - Jul DO - 10.1152/ajplung.00263.2001 DP - Nlm ET - 2002/06/13 IS - 1 LA - eng N1 - Kerby, Gwendolyn S Cottin, Vincent Accurso, Frank J Hoffmann, Fukun Chan, Edward D Fadok, Valerie A Riches, David W H PY - 2002 SN - 1040-0605 (Print) 1040-0605 SP - L188-97 ST - Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis T2 - Am J Physiol Lung Cell Mol Physiol TI - Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis VL - 283 ID - 6376 ER - TY - JOUR AD - A.L. Kung, Columbia University Medical Center, Department of Pediatrics, New York, NY, United States AU - Oberg, J. A. AU - Glade Bender, J. L. AU - Sulis, M. L. AU - Pendrick, D. AU - Sireci, A. N. AU - Hsiao, S. J. AU - Turk, A. T. AU - Dela Cruz, F. S. AU - Hibshoosh, H. AU - Remotti, H. AU - Zylber, R. J. AU - Pang, J. AU - Diolaiti, D. AU - Koval, C. AU - Andrews, S. J. AU - Garvin, J. H. AU - Yamashiro, D. J. AU - Chung, W. K. AU - Emerson, S. G. AU - Nagy, P. L. AU - Mansukhani, M. M. AU - Kung, A. L. DB - Embase Medline DO - 10.1186/s13073-016-0389-6 IS - 1 LA - English M3 - Article N1 - L613797608 2016-12-28 2017-01-23 PY - 2016 SN - 1756-994X ST - Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations T2 - Genome Medicine TI - Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613797608&from=exporthttp://dx.doi.org/10.1186/s13073-016-0389-6 VL - 8 ID - 6377 ER - TY - JOUR AD - RCSI Centre for Systems Medicine, Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin 2, D02 HX03, Ireland OncoMark Ltd., NovaUCD, Bellfield, University College Dublin, Dublin 4, D04 V2P1, Ireland Pathology Experts GmBH, Basel, CH-4108, Switzerland Beaumont Education Resource Centre, Beaumont Hospital, Dublin 9, D09 YD60, Ireland Department of Medical Oncology, VU University Medical CentreAmsterdam 1081HV, Netherlands UCD Cancer Biology and Therapeutics Laboratory, School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College DublinDublin D04 W6F6, Ireland Bayer AG, Wuppertal, 42117, Germany AU - O'Farrell, A. C. AU - Miller, I. S. AU - Evans, R. AU - Alamanou, M. AU - Cary, M. AU - Mallya Udupi, G. AU - Lafferty, A. AU - Monsefi, N. AU - Cremona, M. AU - Prehn, J. H. M. AU - Verheul, H. M. AU - Gallagher, W. M. AU - Gehrmann, M. AU - Byrne, A. T. C7 - 1800159 DB - Scopus DO - 10.1002/prca.201800159 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate T2 - Proteomics - Clinical Applications TI - Implementing Reverse Phase Protein Array Profiling as a Sensitive Method for the Early Pre-Clinical Detection of Off-Target Toxicities Associated with Sunitinib Malate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063082592&doi=10.1002%2fprca.201800159&partnerID=40&md5=cbe6760cf55bf7f26668c1f2075fb3f5 VL - 13 ID - 6378 ER - TY - JOUR AD - Department of Dermatology, Bispebjerg Hospital, University of Copenhagen , Denmark. AN - 23697875 AU - Kamstrup, M. R. AU - Biskup, E. AU - Gjerdrum, L. M. AU - Ralfkiaer, E. AU - Niazi, O. AU - Gniadecki, R. DA - Mar DO - 10.3109/10428194.2013.807510 10.3109/10428194.2013.807510. Epub 2013 Aug 5. DP - Nlm ET - 2013/05/24 IS - 3 LA - eng PY - 2014 SN - 1026-8022 SP - 639-44 ST - The importance of Notch signaling in peripheral T-cell lymphomas T2 - Leuk Lymphoma TI - The importance of Notch signaling in peripheral T-cell lymphomas VL - 55 ID - 6379 ER - TY - JOUR AD - The authors' affiliations are listed in the Appendix. AN - 25399551 AU - Robert, C. AU - Karaszewska, B. AU - Schachter, J. AU - Rutkowski, P. AU - Mackiewicz, A. AU - Stroiakovski, D. AU - Lichinitser, M. AU - Dummer, R. AU - Grange, F. AU - Mortier, L. AU - Chiarion-Sileni, V. AU - Drucis, K. AU - Krajsova, I. AU - Hauschild, A. AU - Lorigan, P. AU - Wolter, P. AU - Long, G. V. AU - Flaherty, K. AU - Nathan, P. AU - Ribas, A. AU - Martin, A. M. AU - Sun, P. AU - Crist, W. AU - Legos, J. AU - Rubin, S. D. AU - Little, S. M. AU - Schadendorf, D. DA - Jan 1 DO - 10.1056/NEJMoa1412690 10.1056/NEJMoa1412690. Epub 2014 Nov 16. DP - Nlm ET - 2014/11/18 IS - 1 LA - eng PY - 2015 SN - 0028-4793 SP - 30-9 ST - Improved overall survival in melanoma with combined dabrafenib and trametinib T2 - N Engl J Med TI - Improved overall survival in melanoma with combined dabrafenib and trametinib VL - 372 ID - 6380 ER - TY - JOUR AD - Micro-Environnement et Renouvellement Cellulaire Intégré, MERCI UPRES EA 3829, Faculté de Médecine et Pharmacie, Université de Rouen, 76183 Rouen Cedex, France. Current address: Unité Inserm U1234/Université de Rouen/IRIB, Rouen, France. Service Immuno-Hémato-Oncologie Pédiatrique, CHU Charles Nicolle, 76031 ROUEN Cedex, France. AN - 28423696 AU - Abdoul-Azize, S. AU - Dubus, I. AU - Vannier, J. P. C2 - PMC5432339 DA - Apr 18 DO - 10.18632/oncotarget.16039 10.18632/oncotarget.16039. DP - Nlm ET - 2017/04/21 IS - 16 LA - eng PY - 2017 SN - 1949-2553 SP - 27339-27352 ST - Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation T2 - Oncotarget TI - Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation VL - 8 ID - 6381 ER - TY - JOUR AD - A.M. Martelli, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy AU - Lonetti, A. AU - Cappellini, A. AU - Bertaina, A. AU - Locatelli, F. AU - Pession, A. AU - Buontempo, F. AU - Evangelisti, C. AU - Evangelisti, C. AU - Orsini, E. AU - Zambonin, L. AU - Neri, L. M. AU - Martelli, A. M. AU - Chiarini, F. C1 - abt 199(Selleck,United States) zstk 474(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.1186/s13045-016-0344-4 IS - 1 LA - English M3 - Article N1 - L612885970 2016-10-31 2016-11-09 PY - 2016 SN - 1756-8722 SP - 1-16 ST - Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway T2 - Journal of Hematology and Oncology TI - Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612885970&from=exporthttp://dx.doi.org/10.1186/s13045-016-0344-4 VL - 9 ID - 6382 ER - TY - JOUR AD - Center for Cancer and Blood Disorders, The Children's Hospital and the Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado. AN - 104841933. Language: English. Entry Date: 20110520. Revision Date: 20150711. Publication Type: Journal Article. Journal Subset: Biomedical AU - Hunger, S. P. AU - Raetz, E. A. AU - Loh, M. L. AU - Mullighan, C. G. DB - ccm DO - 10.1002/pbc.22996 DP - EBSCOhost IS - 6 N1 - Peer Reviewed; USA. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 101186624. PMID: NLM21370430. PY - 2011 SN - 1545-5009 SP - 984-993 ST - Improving outcomes for high-risk ALL: Translating new discoveries into clinical care T2 - Pediatric Blood & Cancer TI - Improving outcomes for high-risk ALL: Translating new discoveries into clinical care UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104841933&site=ehost-live&scope=site VL - 56 ID - 6383 ER - TY - JOUR AD - P.C. Adamson, Children's Oncology Group, Children's Hospital of Philadelphia, CRTB 10060, 3501 Civic Center Boulevard, Philadelphia, PA, United States AU - Adamson, P. C. C1 - gleevec(Novartis,United States) C2 - Novartis(United States) DB - Embase Medline DO - 10.3322/caac.21273 IS - 3 LA - English M3 - Review N1 - L602833754 2015-03-13 2015-05-25 PY - 2015 SN - 1542-4863 0007-9235 SP - 212-220 ST - Improving the outcome for children with cancer: Development of targeted new agents T2 - CA Cancer Journal for Clinicians TI - Improving the outcome for children with cancer: Development of targeted new agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602833754&from=exporthttp://dx.doi.org/10.3322/caac.21273 VL - 65 ID - 6384 ER - TY - JOUR AD - Department of Experimental Medicine, University of Rome, Rome, Italy. AN - 22702340 AU - Ulisse, S. AU - Baldini, E. AU - Sorrenti, S. AU - Barollo, S. AU - Prinzi, N. AU - Catania, A. AU - Nesca, A. AU - Gnessi, L. AU - Pelizzo, M. R. AU - Mian, C. AU - De Vito, C. AU - Calvanese, A. AU - Palermo, S. AU - Persechino, S. AU - De Antoni, E. AU - D'Armiento, M. DA - Nov DO - 10.1111/j.1365-2265.2012.04465.x 10.1111/j.1365-2265.2012.04465.x. DP - Nlm ET - 2012/06/19 IS - 5 LA - eng PY - 2012 SN - 0300-0664 SP - 780-6 ST - In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval T2 - Clin Endocrinol (Oxf) TI - In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval VL - 77 ID - 6385 ER - TY - JOUR AD - V. Kotoula, Department of Pathology, School of Medicine, Aristotle University, Thessaloniki, Greece AU - Kotoula, V. AU - Bobos, M. AU - Kostopoulos, I. AU - Kaloutsi, V. AU - Koletsa, T. AU - Karayannopoulou, G. AU - Papadimitriou, C. S. DB - Embase Medline DO - 10.1080/10428190600653317 IS - 8 LA - English M3 - Article N1 - L44364032 2006-10-01 PY - 2006 SN - 1042-8194 1029-2403 SP - 1639-1650 ST - In situ detection of hTERT variants in anaplastic large cell lymphoma T2 - Leukemia and Lymphoma TI - In situ detection of hTERT variants in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44364032&from=exporthttp://dx.doi.org/10.1080/10428190600653317 VL - 47 ID - 6386 ER - TY - JOUR AD - K. Tokuda, Department of Pediatrics, Ehime University, Graduate School of Medicine, Toon, Ehime, Japan AU - Tokuda, K. AU - Eguchi-Ishimae, M. AU - Eguchi, M. AU - Ishii, E. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L71266185 2013-12-24 PY - 2013 SN - 0006-4971 ST - In utero Cltc-ALK fusion in hematopoietic progenitor cells as a first step of leukemogenesis in blastic plasmacytoid dendritic cell neoplasm T2 - Blood TI - In utero Cltc-ALK fusion in hematopoietic progenitor cells as a first step of leukemogenesis in blastic plasmacytoid dendritic cell neoplasm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71266185&from=exporthttp://bloodjournal.hematologylibrary.org/content/122/21/2587.abstract?sid=1dadfff3-c8f6-4ab4-a2eb-7ec494b6fd34 VL - 122 ID - 6387 ER - TY - JOUR AD - D. Vishwamitra, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Vishwamitra, D. AU - George, S. K. AU - Manshouri, R. AU - Shi, P. AU - Amin, H. M. DB - Embase DO - 10.1158/1538-7445.PEDCAN-A80 IS - 20 LA - English M3 - Conference Abstract N1 - L71713748 2014-12-15 PY - 2014 SN - 0008-5472 ST - In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK+ T-cell anaplastic large-cell lymphoma T2 - Cancer Research TI - In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK+ T-cell anaplastic large-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713748&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCAN-A80http://cancerres.aacrjournals.org/content/74/20_Supplement/A80.abstract?sid=f9d3b7b2-62f6-43a3-b039-91967a1963e1 VL - 74 ID - 6388 ER - TY - JOUR AD - Division of Drug Research/Clinical Pharmacology, Department of Medical and Health Sciences, Linkoping University, Linkoping, 58185, Sweden Department of Hematology and Coagulation, Skane University Hospital, Lund, Sweden Department of Medical Sciences, Uppsala University, Department of Hematology, University Hospital, Sweden Analytical Chemistry, Department of Chemistry, Biomedical Center and Science for Life Laboratory, Uppsala University, Sweden Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden Department of Internal Medicine, Motala Hospital, Sweden Department of Medicine, Ryhov County Hospital, Jonkoping, Sweden Department of Internal Medicine, Vastervik Hospital, Sweden Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linkoping, Sweden AU - Skoglund, K. AU - Richter, J. AU - Olsson-Strömberg, U. AU - Bergquist, J. AU - Aluthgedara, W. AU - Ubhayasekera, S. J. K. A. AU - Vikingsson, S. AU - Svedberg, A. AU - Soderlund, S. AU - Sandstedt, A. AU - Johnsson, A. AU - Aagesen, J. AU - Alsenhed, J. AU - Hagg, S. AU - Peterson, C. AU - Lotfi, K. AU - Green, H. DB - Scopus DO - 10.1097/FTD.0000000000000268 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 230-238 ST - In vivo cytochrome P450 3A isoenzyme activity and pharmacokinetics of imatinib in relation to therapeutic outcome in patients with chronic myeloid Leukemia T2 - Therapeutic Drug Monitoring TI - In vivo cytochrome P450 3A isoenzyme activity and pharmacokinetics of imatinib in relation to therapeutic outcome in patients with chronic myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951310669&doi=10.1097%2fFTD.0000000000000268&partnerID=40&md5=b063b6302c231ab99b06b690f9ae4629 VL - 38 ID - 6389 ER - TY - JOUR AD - Department of Pulmonary Diseases, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, Netherlands AU - Bracke, M. AU - Van de Graaf, E. AU - Lammers, J. W. J. AU - Coffer, P. J. AU - Koenderman, L. DB - Scopus IS - 5 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2000 SP - 655-661 ST - In vivo priming of FcαR functioning on eosinophils of allergic asthmatics T2 - Journal of Leukocyte Biology TI - In vivo priming of FcαR functioning on eosinophils of allergic asthmatics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033623481&partnerID=40&md5=dcd0e0ca67b1c1fdbe985710bf9648dc VL - 68 ID - 6390 ER - TY - JOUR AD - Department of Biological Science, Sookmyung Women's University, Seoul, 140-742, South Korea Department of Biochemistry, Yonsei University, Seoul, 120-749, South Korea AU - Yoo, K. H. AU - Sung, Y. H. AU - Yang, M. H. AU - Jeon, J. O. AU - Yook, Y. J. AU - Woo, Y. M. AU - Lee, H. W. AU - Park, J. H. DB - Scopus DO - 10.1016/j.bbrc.2007.02.103 IS - 1 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2007 SP - 85-90 ST - Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney T2 - Biochemical and Biophysical Research Communications TI - Inactivation of Mxi1 induces Il-8 secretion activation in polycystic kidney UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947190405&doi=10.1016%2fj.bbrc.2007.02.103&partnerID=40&md5=561c755fba3fd80b95785c37b3bcb3fa VL - 356 ID - 6391 ER - TY - JOUR AD - P. Kemps, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands AU - Kemps, P. AU - Zondag, T. AU - Steenwijk, E. AU - Verdijk, R. AU - Van Noesel, C. AU - Cleven, A. AU - Lang, V. AU - Egeler, M. AU - Solleveld-Westerink, N. AU - Van Eijk, R. AU - Van Wezel, T. AU - Beishuizen, A. AU - Van Laar, J. AU - Abla, O. AU - Van Den Bos, C. AU - Van Halteren, A. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283960 2018-12-05 PY - 2019 SN - 1545-5017 ST - Incidence and clinical correlations of somatic mapk pathway mutations in pediatric and adult langerhans cell histiocytosis T2 - Pediatric Blood and Cancer TI - Incidence and clinical correlations of somatic mapk pathway mutations in pediatric and adult langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283960&from=exporthttp://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 6392 ER - TY - JOUR AD - Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan. Department of Pathology, Nippon Medical School Hospital, Tokyo, Japan. Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan. AN - 31533501 AU - Kure, S. AU - Ishino, K. AU - Kudo, M. AU - Wada, R. AU - Saito, M. AU - Nagaoka, R. AU - Sugitani, I. AU - Naito, Z. C2 - PMC6862924 DA - Nov DO - 10.1177/0300060519873481 10.1177/0300060519873481. Epub 2019 Sep 18. DP - Nlm ET - 2019/09/20 IS - 11 LA - eng PY - 2019 SN - 0300-0605 (Print) 0300-0605 SP - 5560-5572 ST - Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience T2 - J Int Med Res TI - Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience VL - 47 ID - 6393 ER - TY - JOUR DB - Embase DO - 10.1016/j.jaapos.2019.08.114 IS - 4 LA - English M3 - Conference Abstract N1 - L2003104613 2019-10-04 PY - 2019 SN - 1528-3933 1091-8531 SP - e32-e33 ST - Incidence of mitogen-activated protein kinase inhibitor-associated retinopathy in pediatric pateints T2 - Journal of AAPOS TI - Incidence of mitogen-activated protein kinase inhibitor-associated retinopathy in pediatric pateints UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003104613&from=exporthttp://dx.doi.org/10.1016/j.jaapos.2019.08.114 VL - 23 ID - 6394 ER - TY - JOUR AD - Institute of Hematology, Zhejiang University School of Medicine, Hangzhou, P.R. China Department of Hematology, the First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, P.R. China Key Laboratory of Hematopoietic Malignancies, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, P.R. China AN - 118924712. Language: English. Entry Date: 20171102. Revision Date: 20190517. Publication Type: journal article AU - Yin, Xiu-Feng AU - Wang, Jing-Han AU - Li, Xia AU - Yu, Meng-Xia AU - Ma, Zhi-Xin AU - Jin, Jie DB - ccm DO - 10.1016/j.clml.2016.06.010 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM27397576. PY - 2016 SN - 2152-2650 SP - 577-581 ST - Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors T2 - Clinical Lymphoma, Myeloma & Leukemia TI - Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=118924712&site=ehost-live&scope=site VL - 16 ID - 6395 ER - TY - JOUR AD - J.Z. Wilson, Saint Louis University, School of Medicine, St. Louis, MO, United States AU - Wilson, J. Z. AU - Moertel, C. L. AU - Miller, B. S. DB - Embase DO - 10.1159/000481424 LA - English M3 - Conference Abstract N1 - L627978030 2019-06-11 PY - 2017 SN - 1663-2826 SP - 515-516 ST - Increase in desmopressin duration of action during trametinib therapy in a child with optic pathway glioma complicated by central diabetes insipidus T2 - Hormone Research in Paediatrics TI - Increase in desmopressin duration of action during trametinib therapy in a child with optic pathway glioma complicated by central diabetes insipidus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627978030&from=exporthttp://dx.doi.org/10.1159/000481424 VL - 88 ID - 6396 ER - TY - JOUR AD - 1 Department of Endocrinology, Holycross Cancer Centre , Kielce, Poland . 2 Department of Molecular Diagnostics, Holycross Cancer Centre , Kielce, Poland . 3 Department of Surgical Pathology, Holycross Cancer Centre , Kielce, Poland . 4 Department of Surgical Pathology, Medical University of Silesia , Katowice, Poland . 5 Department of Probability Theory and Statistics Institute of Mathematics, Faculty of Mathematics and Natural Science, Jan Kochanowski University , Kielce, Poland . 6 Department of Clinical Oncology, Holycross Cancer Centre , Kielce, Poland . 7 Faculty of Health Sciences, Jan Kochanowski University , Kielce, Poland . 8 Department of Endocrinology and Nuclear Medicine, Military Institute of Medicine , Warsaw, Poland . AN - 26889698 AU - Kowalska, A. AU - Walczyk, A. AU - Kowalik, A. AU - Pałyga, I. AU - Trybek, T. AU - Kopczyński, J. AU - Kajor, M. AU - Chrapek, M. AU - Pięciak, L. AU - Chłopek, M. AU - Góźdź, S. AU - Kamiński, G. DA - Apr DO - 10.1089/thy.2015.0352 10.1089/thy.2015.0352. Epub 2016 Feb 18. DP - Nlm ET - 2016/02/19 IS - 4 LA - eng PY - 2016 SN - 1050-7256 SP - 543-51 ST - Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study T2 - Thyroid TI - Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution Study VL - 26 ID - 6397 ER - TY - JOUR AD - S.H. Lee, Department of Otorhinolaryngology–Head & Neck Surgery, College of Medicine, Korea University, Seoul, South Korea AU - Kim, H. K. AU - Kook, J. H. AU - Kang, K. R. AU - Oh, D. J. AU - Kim, T. H. AU - Lee, S. H. DB - Embase Medline DO - 10.1002/lary.26109 IS - 11 LA - English M3 - Article N1 - L611063961 2016-07-08 2016-11-08 PY - 2016 SN - 1531-4995 0023-852X SP - E347-E355 ST - Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC T2 - Laryngoscope TI - Increased expression of hCLCA1 in chronic rhinosinusitis and its contribution to produce MUC5AC UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611063961&from=exporthttp://dx.doi.org/10.1002/lary.26109 VL - 126 ID - 6398 ER - TY - JOUR AD - Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu, 520-2192, Japan AU - Nishida, A. AU - Hidaka, K. AU - Kanda, T. AU - Imaeda, H. AU - Shioya, M. AU - Inatomi, O. AU - Bamba, S. AU - Kitoh, K. AU - Sugimoto, M. AU - Andoh, A. DB - Scopus DO - 10.1097/MIB.0000000000000654 IS - 2 M3 - Article N1 - Cited By :54 Export Date: 18 November 2020 PY - 2016 SP - 303-314 ST - Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease T2 - Inflammatory Bowel Diseases TI - Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955592969&doi=10.1097%2fMIB.0000000000000654&partnerID=40&md5=9cc1d58bd1f346484ec74014d2d1d064 VL - 22 ID - 6399 ER - TY - JOUR AD - Department of Public Health and Clinical Medicine, Umea University, Umea, 90187, Sweden Department of Medical Science, Division of Hematology, University Hospital, Uppsala, Sweden Department of Hematology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Regional Cancer Centre, Uppsala, Örebro, Sweden Department of Hematology, University Hospital, Linköping, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Hematology, University Hospital, Umea, Sweden Department of Hematology, Sahlgrenska University Hospital, Göteborg, Sweden Department of Hematology and Vascular Disorders, Skane University Hospital, Lund, Sweden AU - Gunnarsson, N. AU - Höglund, M. AU - Stenke, L. AU - Wallberg-Jonsson, S. AU - Sandin, F. AU - Björkholm, M. AU - Dreimane, A. AU - Lambe, M. AU - Markevärn, B. AU - Olsson-Strömberg, U. AU - Wadenvik, H. AU - Richter, J. AU - Själander, A. DB - Scopus DO - 10.1038/leu.2016.59 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - 1562-1567 ST - Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia T2 - Leukemia TI - Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963540052&doi=10.1038%2fleu.2016.59&partnerID=40&md5=1946bdc48d490f9fc28bd308f02159d8 VL - 30 ID - 6400 ER - TY - JOUR AD - Thyroid Section, Endocrine Division, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Porto Alegre, RS, Brazil. AN - 22823995 AU - Romitti, M. AU - Wajner, S. M. AU - Zennig, N. AU - Goemann, I. M. AU - Bueno, A. L. AU - Meyer, E. L. AU - Maia, A. L. DA - Sep DO - 10.1089/thy.2012.0031 10.1089/thy.2012.0031. Epub 2012 Jul 23. DP - Nlm ET - 2012/07/25 IS - 9 LA - eng PY - 2012 SN - 1050-7256 SP - 897-904 ST - Increased type 3 deiodinase expression in papillary thyroid carcinoma T2 - Thyroid TI - Increased type 3 deiodinase expression in papillary thyroid carcinoma VL - 22 ID - 6401 ER - TY - JOUR AD - K. Marshall, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom AU - Marshall, K. AU - O'Hare, P. AU - Hargrave, D. AU - Marshall, L. AU - Morland, B. AU - Hayden, J. AU - Murray, M. AU - Nicholson, J. AU - Pears, J. AU - Slater, O. AU - Bomken, S. AU - Collin, M. AU - Milne, P. AU - Nanduri, V. AU - Donadieu, J. AU - Visser, J. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283140 2018-12-05 PY - 2019 SN - 1545-5017 ST - Increasing number of children on long-term mapk inhibitors for refractory langerhans cell histiocytosis: Where do we go from here? T2 - Pediatric Blood and Cancer TI - Increasing number of children on long-term mapk inhibitors for refractory langerhans cell histiocytosis: Where do we go from here? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283140&from=exporthttp://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 6402 ER - TY - JOUR AD - M. Wang, Department of Radiation Therapy, Cangzhou Central Hospital, 16 Xinhua West Road, Cangzhou, Hebei, China AU - Wang, M. AU - Wang, L. AU - He, X. AU - Zhang, J. AU - Zhu, Z. AU - Zhang, M. AU - Li, X. DB - Embase Medline DO - 10.3892/ijo.2019.4929 IS - 1 LA - English M3 - Article N1 - L2004354222 2019-12-31 2020-01-06 PY - 2020 SN - 1791-2423 1019-6439 SP - 327-336 ST - IncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145/p70S6K1 and p53 pathway T2 - International Journal of Oncology TI - IncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR-145/p70S6K1 and p53 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004354222&from=exporthttp://dx.doi.org/10.3892/ijo.2019.4929 VL - 56 ID - 6403 ER - TY - JOUR AD - Medicine and Dermatology, University of California, 1600 Divisadero Street Rm A 743, San Francisco, CA, 94143, USA. Adil.Daud@ucsf.edu. PAREXEL International, Chandigarh, India. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. AN - 28052762 AU - Daud, A. AU - Gill, J. AU - Kamra, S. AU - Chen, L. AU - Ahuja, A. C2 - PMC5209913 DA - Jan 4 DO - 10.1186/s13045-016-0369-8 10.1186/s13045-016-0369-8. DP - Nlm ET - 2017/01/06 IS - 1 LA - eng PY - 2017 SN - 1756-8722 SP - 3 ST - Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients T2 - J Hematol Oncol TI - Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients VL - 10 ID - 6404 ER - TY - JOUR AD - L. Heimfarth, Department of Physiology, Laboratory of Neuroscience and Pharmacological Assays (LANEF), Federal University of Sergipe, Av. Marechal Rondom, s/n, São Cristóvão, Brazil AU - Heimfarth, L. AU - Carvalho, A. M. S. AU - Quintans, J. D. S. S. AU - Pereira, E. W. M. AU - Lima, N. T. AU - Bezerra Carvalho, M. T. AU - Barreto, R. D. S. S. AU - Moreira, J. C. F. AU - da Silva-Júnior, E. F. AU - Schmitt, M. AU - Bourguignon, J. J. AU - de Aquino, T. M. AU - Araújo-Júnior, J. X. D. AU - Quintans-Júnior, L. J. DB - Embase Medline DO - 10.1016/j.neuint.2019.104647 LA - English M3 - Article N1 - L2004466204 2020-01-03 2020-02-18 PY - 2020 SN - 1872-9754 0197-0186 ST - Indole-3-guanylhydrazone hydrochloride mitigates long-term cognitive impairment in a neonatal sepsis model with involvement of MAPK and NFκB pathways T2 - Neurochemistry International TI - Indole-3-guanylhydrazone hydrochloride mitigates long-term cognitive impairment in a neonatal sepsis model with involvement of MAPK and NFκB pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004466204&from=exporthttp://dx.doi.org/10.1016/j.neuint.2019.104647 VL - 134 ID - 6405 ER - TY - JOUR AD - S. H. Yuspa, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD 20892-4255, United States AU - Cataisson, C. AU - Ohman, R. AU - Patel, G. AU - Pearson, A. AU - Tsien, M. AU - Jay, S. AU - Wright, L. AU - Hennings, H. AU - Yuspa, S. H. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-2490 IS - 1 L1 - internal-pdf://0446340713/319.full.pdf LA - English M3 - Article N1 - L354074700 2009-02-12 PY - 2009 SN - 0008-5472 1538-7445 SP - 319-328 ST - Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis T2 - Cancer Research TI - Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354074700&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-08-2490 VL - 69 ID - 6406 ER - TY - JOUR AD - Department of Medical Biology, Faculty of Medicine, Pécs University, Hungary. AN - 11299726 AU - Fábián, Z. AU - Töröcsik, B. AU - Kiss, K. AU - Csatary, L. K. AU - Bodey, B. AU - Tigyi, J. AU - Csatary, C. AU - Szeberényi, J. DA - Jan-Feb DP - Nlm ET - 2001/04/13 IS - 1a LA - eng N1 - Fábián, Z Töröcsik, B Kiss, K Csatary, L K Bodey, B Tigyi, J Csatary, C Szeberényi, J Journal Article Greece Anticancer Res. 2001 Jan-Feb;21(1A):125-35. PY - 2001 SN - 0250-7005 (Print) 0250-7005 SP - 125-35 ST - Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells T2 - Anticancer Res TI - Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells VL - 21 ID - 6407 ER - TY - JOUR AD - Department of Life Science, Faculty of Medicine, Shimane University, Izumo, Shimane, 693-8501, Japan Department of Pediatrics, Faculty of Medicine, Shimane University, Izumo, Shimane, 693-8501, Japan Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo, 173-8610, Japan AU - Horie, A. AU - Akimoto, M. AU - Tsumura, H. AU - Makishima, M. AU - Taketani, T. AU - Yamaguchi, S. AU - Honma, Y. DB - Scopus DO - 10.1016/j.leukres.2007.12.004 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 1112-1123 ST - Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A T2 - Leukemia Research TI - Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-41949090235&doi=10.1016%2fj.leukres.2007.12.004&partnerID=40&md5=32a8a67216d78423207ebc83c417c328 VL - 32 ID - 6408 ER - TY - JOUR AD - K.K. Yadav AU - Yadav, S. S. AU - Li, J. AU - Stockert, J. A. AU - Herzog, B. AU - O'Connor, J. AU - Garzon-Manco, L. AU - Parsons, R. AU - Tewari, A. K. AU - Yadav, K. K. C1 - chir 258 tki 258 DB - Embase DO - 10.1016/j.tranon.2017.01.011 IS - 3 LA - English M3 - Article N1 - L616104061 2017-05-16 2017-05-18 PY - 2017 SN - 1936-5233 SP - 357-366 ST - Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications T2 - Translational Oncology TI - Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616104061&from=exporthttp://dx.doi.org/10.1016/j.tranon.2017.01.011 VL - 10 ID - 6409 ER - TY - JOUR AD - O. Lopez-Nunez, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, United States AU - Lopez-Nunez, O. AU - John, I. AU - Panasiti, R. N. AU - Ranganathan, S. AU - Santoro, L. AU - Grélaud, D. AU - Wu, T. AU - Buccoliero, A. M. AU - Casanova, M. AU - Alaggio, R. AU - Surrey, L. F. DB - Embase Medline DO - 10.1038/s41379-019-0406-6 IS - 4 LA - English M3 - Article N1 - L2003543687 2019-11-15 PY - 2020 SN - 1530-0285 0893-3952 SP - 576-590 ST - Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases T2 - Modern Pathology TI - Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003543687&from=exporthttp://dx.doi.org/10.1038/s41379-019-0406-6 VL - 33 ID - 6410 ER - TY - JOUR AD - Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt, 34116 Istanbul, Turkey. Electronic address: ezgi.oztas@istanbul.edu.tr. Karadeniz Technical University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 61000 Trabzo, Turkey. Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Beyazıt, 34116 Istanbul, Turkey. AN - 30550854 AU - Oztas, E. AU - Abudayyak, M. AU - Celiksoz, M. AU - Özhan, G. DA - Mar DO - 10.1016/j.tiv.2018.12.005 10.1016/j.tiv.2018.12.005. Epub 2018 Dec 12. DP - Nlm ET - 2018/12/15 LA - eng PY - 2019 SN - 0887-2333 SP - 101-107 ST - Inflammation and oxidative stress are key mediators in AKB48-induced neurotoxicity in vitro T2 - Toxicol In Vitro TI - Inflammation and oxidative stress are key mediators in AKB48-induced neurotoxicity in vitro VL - 55 ID - 6411 ER - TY - JOUR AD - A. Bolhassani, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran AU - Naderi, N. AU - Yousefi, H. AU - Mollazadeh, S. AU - Seyed Mikaeili, A. AU - Keshavarz Norouzpour, M. AU - Jazebi, M. AU - Moazezi Nekooi Asl, S. S. AU - Namvar, A. AU - Azizi Saraji, A. AU - Agi, E. AU - Bolhassani, A. DB - Embase Medline DO - 10.1080/08880018.2019.1585503 IS - 1 LA - English M3 - Article N1 - L626831829 2019-03-26 2019-05-20 PY - 2019 SN - 1521-0669 0888-0018 SP - 28-39 ST - Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients T2 - Pediatric Hematology and Oncology TI - Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626831829&from=exporthttp://dx.doi.org/10.1080/08880018.2019.1585503 VL - 36 ID - 6412 ER - TY - JOUR AD - N. Billestrup, Section of Cellular and Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, Copenhagen N, Denmark AU - Ibarra Urizar, A. AU - Friberg, J. AU - Christensen, D. P. AU - Lund Christensen, G. AU - Billestrup, N. DB - Embase Medline DO - 10.1089/jir.2014.0199 IS - 1 LA - English M3 - Article N1 - L607801541 2016-01-26 2016-01-29 PY - 2016 SN - 1557-7465 1079-9907 SP - 20-29 ST - Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells T2 - Journal of Interferon and Cytokine Research TI - Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607801541&from=exporthttp://dx.doi.org/10.1089/jir.2014.0199 VL - 36 ID - 6413 ER - TY - JOUR AD - L. Winnicka, NYU Winthrop University Hospital, Mineola, NY, United States AU - Winnicka, L. AU - Gour, A. C. AU - Spier, L. AU - Thomas, S. V. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L630355929 2020-01-01 PY - 2019 SN - 1535-4970 ST - An inflammatory myofibroblastic tumor masquerading as a bronchopulmonary sequestration T2 - American Journal of Respiratory and Critical Care Medicine TI - An inflammatory myofibroblastic tumor masquerading as a bronchopulmonary sequestration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630355929&from=export VL - 199 ID - 6414 ER - TY - JOUR AD - M. Sugawa, Department of Hematology and Oncology, Saitama Children's Medical Center, Saitama, Japan AU - Sugawa, M. AU - Watanabe, K. AU - Arakawa, Y. AU - Noguchi, J. AU - Kawakami, R. AU - Yanagi, M. AU - Itabashi, T. AU - Sasaki, K. AU - Isobe, K. AU - Mori, M. AU - Kawashima, H. AU - Oguma, E. AU - Kishimoto, H. AU - Takita, J. AU - Koh, K. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619368583 2017-11-28 PY - 2017 SN - 1545-5017 SP - S40-S41 ST - Inflammatory myofibroblastic tumor of the liver with a remarkable response to crizotinib in a young child T2 - Pediatric Blood and Cancer TI - Inflammatory myofibroblastic tumor of the liver with a remarkable response to crizotinib in a young child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619368583&from=exporthttp://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 6415 ER - TY - JOUR AD - Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, , Japan. AN - 12787312 AU - Hisaoka, M. AU - Shimajiri, S. AU - Matsuki, Y. AU - Meis-Kindblom, J. M. AU - Kindblom, L. G. AU - Li, X. Q. AU - Wang, J. AU - Hashimoto, H. DA - Jun DO - 10.1046/j.1440-1827.2003.01484.x 10.1046/j.1440-1827.2003.01484.x. DP - Nlm ET - 2003/06/06 IS - 6 LA - eng PY - 2003 SN - 1320-5463 (Print) 1320-5463 SP - 376-81 ST - Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype T2 - Pathol Int TI - Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype VL - 53 ID - 6416 ER - TY - JOUR AD - Department of Paediatric Oncology, Combined Military Hospital, Rawalpindi, Pakistan. Armed Forces Bone Marrow Transplant Centre, CMH Medical Complex, Rawalpindi, Pakistan. Medical Student at Army Medical College, Rawalpindi, Pakistan. AN - 32695536 AU - Khalil, S. AU - Ghafoor, T. AU - Raja, A. K. F. C2 - PMC7368202 DO - 10.1155/2020/6923103 10.1155/2020/6923103. eCollection 2020. DP - Nlm ET - 2020/07/23 LA - eng PY - 2020 SN - 2090-6706 (Print) SP - 6923103 ST - Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib T2 - Case Rep Oncol Med TI - Inflammatory Myofibroblastic Tumor: A Rare Presentation and an Effective Treatment with Crizotinib VL - 2020 ID - 6417 ER - TY - JOUR AD - Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, United Kingdom. Pathology Department, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy. Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester, United Kingdom. SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL University, Paris, France. Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Department of Pediatric Oncology, Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France. Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Hematology and Oncology Division, Department of Women's and Children's Health, University of Padova, Padova, Italy. Paediatric Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center Amsterdam, Netherlands. Clinical Trials and Biostatistics Unit, IRCCS Istituto Oncologico Veneto, Padova, Italy. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Electronic address: andrea.ferrari@istitutotumori.mi.it. AN - 32007712 AU - Casanova, M. AU - Brennan, B. AU - Alaggio, R. AU - Kelsey, A. AU - Orbach, D. AU - van Noesel, M. M. AU - Corradini, N. AU - Minard-Colin, V. AU - Zanetti, I. AU - Bisogno, G. AU - Gallego, S. AU - Merks, J. H. M. AU - De Salvo, G. L. AU - Ferrari, A. DA - Mar DO - 10.1016/j.ejca.2019.12.021 10.1016/j.ejca.2019.12.021. Epub 2020 Jan 30. DP - Nlm ET - 2020/02/03 LA - eng PY - 2020 SN - 0959-8049 SP - 123-129 ST - Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) T2 - Eur J Cancer TI - Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG) VL - 127 ID - 6418 ER - TY - JOUR AD - J.K. Adamski, Department of Paediatric Oncology, Royal Manchester Children's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom AU - Adamski, J. K. AU - Kelsey, A. AU - Brennan, B. DB - Embase Medline DO - 10.1097/MPH.0b013e31827e5302 IS - 2 LA - English M3 - Article N1 - L52372862 2013-01-08 2014-03-13 PY - 2014 SN - 1077-4114 1536-3678 SP - 159-162 ST - Inflammatory myofibroblastic tumors following the treatment of malignancy in childhood: Case reports T2 - Journal of Pediatric Hematology/Oncology TI - Inflammatory myofibroblastic tumors following the treatment of malignancy in childhood: Case reports UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52372862&from=exporthttp://dx.doi.org/10.1097/MPH.0b013e31827e5302 VL - 36 ID - 6419 ER - TY - JOUR AD - R. Alaggio, Pathology Department, University Hospital of Padova, Via A. Gabelli, 61, 35128 Padova, Italy AU - Alaggio, R. AU - Cecchetto, G. AU - Bisogno, G. AU - Gambini, C. AU - Calabrò, M. L. AU - Inserra, A. AU - Boldrini, R. AU - De Salvo, G. L. AU - D'Amore, E. S. G. AU - Dall'Igna, P. DB - Embase Medline DO - 10.1002/cncr.24684 IS - 1 LA - English M3 - Article N1 - L358142833 2010-02-02 PY - 2010 SN - 0008-543X 1097-0142 SP - 216-226 ST - Inflammatory myofibroblastic tumors in childhood: A report from the italian cooperative group studies T2 - Cancer TI - Inflammatory myofibroblastic tumors in childhood: A report from the italian cooperative group studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358142833&from=exporthttp://dx.doi.org/10.1002/cncr.24684http://www3.interscience.wiley.com/cgi-bin/fulltext/122659817/PDFSTART VL - 116 ID - 6420 ER - TY - JOUR AD - M. Tanaka, Department of Pathology, Kanagawa Children's Medical Center, Mutsukawa 2-138-4, Minami-ku, Yokohama, Japan AU - Tanaka, M. AU - Kohashi, K. AU - Kushitani, K. AU - Yoshida, M. AU - Kurihara, S. AU - Kawashima, M. AU - Ueda, Y. AU - Souzaki, R. AU - Kinoshita, Y. AU - Oda, Y. AU - Takeshima, Y. AU - Hiyama, E. AU - Taguchi, T. AU - Tanaka, Y. DB - Embase Medline DO - 10.1016/j.humpath.2017.06.013 LA - English M3 - Article N1 - L618198379 2017-09-14 2017-09-19 PY - 2017 SN - 1532-8392 0046-8177 SP - 177-182 ST - Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions T2 - Human Pathology TI - Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618198379&from=exporthttp://dx.doi.org/10.1016/j.humpath.2017.06.013 VL - 66 ID - 6421 ER - TY - JOUR AD - M. Ramadwar, TATA Memorial Hospital, Mumbai, India AU - Ramadwar, M. AU - Qureshi, S. AU - Medhi, S. AU - Rekhi, B. AU - Vora, T. AU - Chinnaswamy, G. AU - Khanna, N. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189954 2016-11-17 PY - 2015 SN - 1545-5017 SP - S371 ST - Inflammatory myofibroblastic tumour (IMT) affecting paediatric patients: A study of 46 patients with emphasis on histopathologic diagnostic issues T2 - Pediatric Blood and Cancer TI - Inflammatory myofibroblastic tumour (IMT) affecting paediatric patients: A study of 46 patients with emphasis on histopathologic diagnostic issues UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189954&from=exporthttp://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 6422 ER - TY - JOUR AU - Karunanithi, J. AU - Hong, K. C. AU - Yi, C. H. AU - Sittampalam, K. DB - Embase DO - 10.1016/j.pathol.2018.12.223 LA - English M3 - Conference Abstract N1 - L2001470507 2019-02-06 PY - 2019 SN - 1465-3931 0031-3025 SP - S86 ST - Inflammatory myofibroblastic tumour; a case report with a unique ROS1 fusion variant T2 - Pathology TI - Inflammatory myofibroblastic tumour; a case report with a unique ROS1 fusion variant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001470507&from=exporthttp://dx.doi.org/10.1016/j.pathol.2018.12.223 VL - 51 ID - 6423 ER - TY - JOUR AD - 1 Clinic of Pediatric Surgery, Martin-Luther-University Halle-Wittenberg - Halle, Halle - Germany. AN - 25983099 AU - Höhne, S. AU - Milzsch, M. AU - Adams, J. AU - Kunze, C. AU - Finke, R. DA - May-Jun DO - 10.5301/tj.5000353 10.5301/tj.5000353. Epub 2015 May 12. DP - Nlm ET - 2015/05/20 IS - 3 LA - eng PY - 2015 SN - 0300-8916 SP - 249-56 ST - Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-year-old child T2 - Tumori TI - Inflammatory pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a representative literature review occasioned by a rare IMT of the transverse colon in a 9-year-old child VL - 101 ID - 6424 ER - TY - JOUR AD - X.-Q. Zhang, Department of Obstetrics and Gynecology, Xiamen Maternal and Child Health Hospital, Xiamen, China AU - Lin, L. P. AU - Niu, G. H. AU - Zhang, X. Q. DB - Embase Medline DO - 10.26355/eurrev_201902_17025 IS - 3 LA - English M3 - Article N1 - L2001635271 2019-03-06 2019-03-07 PY - 2019 SN - 2284-0729 1128-3602 SP - 1296-1304 ST - Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway T2 - European Review for Medical and Pharmacological Sciences TI - Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001635271&from=exporthttp://dx.doi.org/10.26355/eurrev_201902_17025 VL - 23 ID - 6425 ER - TY - JOUR AD - B.C. Worst, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany AU - Worst, B. C. AU - Van Tilburg, C. M. AU - Balasubramanian, G. P. AU - Fiesel, P. AU - Pfaff, E. AU - Witt, R. AU - Freitag, A. AU - Von Deimling, A. AU - Eggert, A. AU - Lichter, P. AU - Capper, D. AU - Witt, O. AU - Pfister, S. M. AU - Jones, D. T. W. DB - Embase DO - 10.1093/neuonc/now084.10 LA - English M3 - Conference Abstract N1 - L611934288 2016-09-07 PY - 2016 SN - 1523-5866 SP - iii171 ST - The inform personalized medicine study-new molecular insights into relapsed pediatric brain tumors T2 - Neuro-Oncology TI - The inform personalized medicine study-new molecular insights into relapsed pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611934288&from=exporthttp://dx.doi.org/10.1093/neuonc/now084.10 VL - 18 ID - 6426 ER - TY - JOUR AD - W. Wang, Department of Obstetrics, Weifang Maternal and Child Health Hospital, Weifang, Shandong, China AU - Song, T. T. AU - Xu, F. AU - Wang, W. DB - Embase Medline DO - 10.1002/kjm2.12204 IS - 7 LA - English M3 - Article N1 - L2004463898 2020-03-27 PY - 2020 SN - 2410-8650 1607-551X SP - 501-507 ST - Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma T2 - Kaohsiung Journal of Medical Sciences TI - Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004463898&from=exporthttp://dx.doi.org/10.1002/kjm2.12204 VL - 36 ID - 6427 ER - TY - JOUR AD - Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami- Kogushi, Ube City, Yamaguchi 755-8505, Japan AU - Adachi, T. AU - Fukuda, K. AU - Kondo, Y. AU - Nishida, T. DB - Scopus DO - 10.1167/iovs.09-4161 IS - 8 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2010 SP - 3954-3960 ST - Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCRM-1 in human corneal fibroblasts T2 - Investigative Ophthalmology and Visual Science TI - Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCRM-1 in human corneal fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955885245&doi=10.1167%2fiovs.09-4161&partnerID=40&md5=4d09af770e5724ca043c820c7e012787 VL - 51 ID - 6428 ER - TY - JOUR AD - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555-0647, USA. AN - 17122129 AU - Pladzyk, A. AU - Reddy, A. B. AU - Yadav, U. C. AU - Tammali, R. AU - Ramana, K. V. AU - Srivastava, S. K. DA - Dec DO - 10.1167/iovs.06-0469 10.1167/iovs.06-0469. DP - Nlm ET - 2006/11/24 IS - 12 LA - eng PY - 2006 SN - 0146-0404 (Print) 0146-0404 SP - 5395-403 ST - Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells T2 - Invest Ophthalmol Vis Sci TI - Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells VL - 47 ID - 6429 ER - TY - JOUR AD - M. Yousef, Health Sciences, Brock Univsersity, St Catharines, ON, Canada AU - Yousef, M. AU - Hicks, N. J. AU - Boyd, T. AU - Tsiani, E. AU - MacNeil, A. J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622544928 2018-06-18 PY - 2018 SN - 1530-6860 ST - Inhibition of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.) T2 - FASEB Journal TI - Inhibition of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622544928&from=export VL - 32 ID - 6430 ER - TY - JOUR AD - X. Long AU - Long, X. AU - Man, C. AU - Narayanan, P. AU - Seashore, E. AU - Redell, M. DB - Embase DO - 10.1182/blood-2019-129074 LA - English M3 - Conference Abstract N1 - L630316813 2019-12-31 PY - 2019 SN - 1528-0020 ST - Inhibition of BMP-SMAD pathway reduces leukemic stemness in pediatric aml T2 - Blood TI - Inhibition of BMP-SMAD pathway reduces leukemic stemness in pediatric aml UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630316813&from=exporthttp://dx.doi.org/10.1182/blood-2019-129074 VL - 134 ID - 6431 ER - TY - JOUR AD - J. Varga, Division of Rheumatology, Northwestern University Feinberg School of Medicine, 2300 McGaw, 240 East Huron Street, Chicago, IL, United States AU - Ghosh, A. K. AU - Bhattacharyya, S. AU - Mori, Y. AU - Varga, J. DB - Embase Medline DO - 10.1002/jcp.20559 IS - 1 LA - English M3 - Article N1 - L43391089 2006-04-02 PY - 2006 SN - 0021-9541 SP - 251-260 ST - Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ) T2 - Journal of Cellular Physiology TI - Inhibition of collagen gene expression by interferon-γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43391089&from=exporthttp://dx.doi.org/10.1002/jcp.20559 VL - 207 ID - 6432 ER - TY - JOUR AD - J.-G. Lü, Department of Cardiovascular Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China AU - Qu, W. S. AU - Tian, D. S. AU - Guo, Z. B. AU - Fang, J. AU - Zhang, Q. AU - Yu, Z. Y. AU - Xie, M. J. AU - Zhang, H. Q. AU - Lü, J. G. AU - Wang, W. C1 - ag 1478 c 225 sb 203580 sp 600125 u 0126 DB - Embase Medline DO - 10.1186/1742-2094-9-178 LA - English M3 - Article N1 - L365472167 2012-08-28 2020-07-28 PY - 2012 SN - 1742-2094 ST - Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury T2 - Journal of Neuroinflammation TI - Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365472167&from=exporthttp://dx.doi.org/10.1186/1742-2094-9-178 VL - 9 ID - 6433 ER - TY - JOUR AU - Huang, H. I. AU - Chio, C. C. AU - Lin, J. Y. DB - Embase Medline DO - 10.1371/journal.pone.0191617 IS - 1 LA - English M3 - Article N1 - L620325723 2018-02-01 2018-02-06 PY - 2018 SN - 1932-6203 ST - Inhibition of EV71 by curcumin in intestinal epithelial cells T2 - PLoS ONE TI - Inhibition of EV71 by curcumin in intestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620325723&from=exporthttp://dx.doi.org/10.1371/journal.pone.0191617 VL - 13 ID - 6434 ER - TY - JOUR AD - Department of Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS. Department of Pathology and Laboratory Medicine, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS. AN - 28707818 AU - Le, T. AU - New, J. AU - Jones, J. W. AU - Usman, S. AU - Yalamanchali, S. AU - Tawfik, O. AU - Hoover, L. AU - Bruegger, D. E. AU - Thomas, S. M. C2 - PMC5827962 C6 - NIHMS944552 DA - Oct DO - 10.1002/alr.21987 10.1002/alr.21987. Epub 2017 Jul 14. DP - Nlm ET - 2017/07/15 IS - 10 LA - eng PY - 2017 SN - 2042-6976 (Print) 2042-6976 SP - 973-979 ST - Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma T2 - Int Forum Allergy Rhinol TI - Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma VL - 7 ID - 6435 ER - TY - JOUR AD - M. Machala, Dept. of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 70, 62132 Brno, Czech Republic AU - Machala, M. AU - Bláha, L. AU - Vondráček, J. AU - Trosko, J. E. AU - Scott, J. AU - Upham, B. L. DB - Embase Medline DO - 10.1093/toxsci/kfg209 IS - 1 LA - English M3 - Article N1 - L37361889 2003-11-17 PY - 2003 SN - 1096-6080 SP - 102-111 ST - Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: Inhibitory potencies and screening for potential mode(s) of action T2 - Toxicological Sciences TI - Inhibition of gap junctional intercellular communication by noncoplanar polychlorinated biphenyls: Inhibitory potencies and screening for potential mode(s) of action UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37361889&from=exporthttp://dx.doi.org/10.1093/toxsci/kfg209 VL - 76 ID - 6436 ER - TY - JOUR AD - P. Babica, Institute of Botany, Academy of Sciences, Lidická 25/27, CZ65720 Brno, Czech Republic AU - Bláha, L. AU - Babica, P. AU - Hilscherová, K. AU - Upham, B. L. DB - Embase Medline DO - 10.1016/j.toxicon.2009.07.009 IS - 1 LA - English M3 - Article N1 - L50600184 2010-01-08 PY - 2010 SN - 0041-0101 SP - 126-134 ST - Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts - Indications of novel tumor-promoting cyanotoxins? T2 - Toxicon TI - Inhibition of gap-junctional intercellular communication and activation of mitogen-activated protein kinases by cyanobacterial extracts - Indications of novel tumor-promoting cyanotoxins? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50600184&from=exporthttp://dx.doi.org/10.1016/j.toxicon.2009.07.009 VL - 55 ID - 6437 ER - TY - JOUR AD - B. Izar, Columbia University Medical Center, Division of Hematology and Oncology, 1790 Broadway, New York, NY, United States AU - Melms, J. C. AU - Vallabhaneni, S. AU - Mills, C. E. AU - Yapp, C. AU - Chen, J. Y. AU - Morelli, E. AU - Waszyk, P. AU - Kumar, S. AU - Deming, D. AU - Moret, N. AU - Rodriguez, S. AU - Subramanian, K. AU - Rogava, M. AU - Cartwright, A. N. R. AU - Luoma, A. AU - Mei, S. AU - Brinker, T. J. AU - Miller, D. M. AU - Spektor, A. AU - Schadendorf, D. AU - Riggi, N. AU - Wucherpfennig, K. W. AU - Sorger, P. K. AU - Izar, B. C1 - cx 6258 DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-2330 IS - 4 LA - English M3 - Article N1 - L2004972326 2020-02-25 2020-03-04 PY - 2020 SN - 1538-7445 0008-5472 SP - 798-810 ST - Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity T2 - Cancer Research TI - Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004972326&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-19-2330 VL - 80 ID - 6438 ER - TY - JOUR AD - Department of Immunochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-naka, Okayama 700-8530, Japan. AN - 15684480 AU - Motoki, T. AU - Takami, Y. AU - Yagi, Y. AU - Tai, A. AU - Yamamoto, I. AU - Gohda, E. DA - Feb DO - 10.1248/bpb.28.260 10.1248/bpb.28.260. DP - Nlm ET - 2005/02/03 IS - 2 LA - eng PY - 2005 SN - 0918-6158 (Print) 0918-6158 SP - 260-6 ST - Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin T2 - Biol Pharm Bull TI - Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by tryptanthrin VL - 28 ID - 6439 ER - TY - JOUR AD - Y. Zhong, Department of hematology, Zhumadian Central Hospital, No. 747 Zhonghua Road, Zhumadian, Henan, China AU - Zhong, Y. AU - Zhang, Y. AU - Ma, D. AU - Ren, X. AU - Xu, C. AU - Wan, D. DB - Embase Medline DO - 10.1016/j.lfs.2018.12.011 LA - English M3 - Article N1 - L2001386093 2018-12-21 2019-04-08 PY - 2019 SN - 1879-0631 0024-3205 SP - 1-7 ST - Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2 T2 - Life Sciences TI - Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001386093&from=exporthttp://dx.doi.org/10.1016/j.lfs.2018.12.011 VL - 218 ID - 6440 ER - TY - JOUR AD - S.S.C. Cheung, Ike Barber Human Islet Transplantation Laboratory, R340, 828 W. 10th Avenue, VGH Research Pavilion, Vancouver, BC, Canada AU - Cheung, S. S. C. AU - Tai, J. AU - Hasman, D. AU - Ou, D. AU - Warnock, G. L. DB - Embase Medline DO - 10.1080/01635581.2015.1055367 IS - 6 LA - English M3 - Article N1 - L605475268 2015-08-11 2015-08-28 PY - 2015 SN - 1532-7914 0163-5581 SP - 954-964 ST - Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound T2 - Nutrition and Cancer TI - Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605475268&from=exporthttp://dx.doi.org/10.1080/01635581.2015.1055367 VL - 67 ID - 6441 ER - TY - JOUR AD - Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany. Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany. AN - 24941214 AU - Choukair, D. AU - Hügel, U. AU - Sander, A. AU - Uhlmann, L. AU - Tönshoff, B. DA - Sep DO - 10.1038/pr.2014.84 10.1038/pr.2014.84. Epub 2014 Jun 18. DP - Nlm ET - 2014/06/19 IS - 3 LA - eng PY - 2014 SN - 0031-3998 SP - 245-51 ST - Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes T2 - Pediatr Res TI - Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes VL - 76 ID - 6442 ER - TY - JOUR AD - S. Bhattacharyya, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, OH, United States AU - Kong, F. AU - Liu, Z. AU - Jain, V. G. AU - Shima, K. AU - Suzuki, T. AU - Muglia, L. J. AU - Starczynowski, D. T. AU - Pasare, C. AU - Bhattacharyya, S. DB - Embase Medline DO - 10.4049/jimmunol.1700443 IS - 10 LA - English M3 - Article N1 - L619180893 2017-11-15 2017-11-23 PY - 2017 SN - 1550-6606 0022-1767 SP - 3654-3667 ST - Inhibition of IRAK1 ubiquitination determines glucocorticoid sensitivity for tlr9-induced inflammation in macrophages T2 - Journal of Immunology TI - Inhibition of IRAK1 ubiquitination determines glucocorticoid sensitivity for tlr9-induced inflammation in macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619180893&from=exporthttp://dx.doi.org/10.4049/jimmunol.1700443 VL - 199 ID - 6443 ER - TY - JOUR AD - W.-P. Lin, Department of Orthopedic Surgery, Second Affiliated Hospital, Fujian Medical University, Quanzhou, China AU - Chen, W. K. AU - Feng, L. J. AU - Liu, Q. D. AU - Ke, Q. F. AU - Cai, P. Y. AU - Zhang, P. R. AU - Cai, L. Q. AU - Huang, N. L. AU - Lin, W. P. DB - Embase Medline DO - 10.1186/s12974-020-01884-4 IS - 1 LA - English M3 - Article N1 - L632298509 2020-07-24 PY - 2020 SN - 1742-2094 ST - Inhibition of leucine-rich repeats and calponin homology domain containing 1 accelerates microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model T2 - Journal of Neuroinflammation TI - Inhibition of leucine-rich repeats and calponin homology domain containing 1 accelerates microglia-mediated neuroinflammation in a rat traumatic spinal cord injury model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632298509&from=exporthttp://dx.doi.org/10.1186/s12974-020-01884-4 VL - 17 ID - 6444 ER - TY - JOUR AD - A. Lonetti, “Giorgio Prodi” Cancer Research Center, University of Bologna, S. Orsola-Malpighi Hospital, Via Massarenti 11, Bologna, Italy AU - Lonetti, A. AU - Indio, V. AU - Laginestra, M. A. AU - Tarantino, G. AU - Chiarini, F. AU - Astolfi, A. AU - Bertuccio, S. N. AU - Martelli, A. M. AU - Locatelli, F. AU - Pession, A. AU - Masetti, R. C1 - az 628(Selleck,United States) gw 5074(Tocris,United Kingdom) C2 - Selleck Tocris(United Kingdom) Selleck(United States) DB - Embase DO - 10.3390/cancers12071972 IS - 7 LA - English M3 - Article N1 - L2004735145 2020-07-24 2020-07-30 PY - 2020 SN - 2072-6694 SP - 1-18 ST - Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml T2 - Cancers TI - Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004735145&from=exporthttp://dx.doi.org/10.3390/cancers12071972 VL - 12 ID - 6445 ER - TY - JOUR AD - B.V. Madhukar, Departments of Pediatrics/Human Development, Michigan State University, East Lansing, Michigan 48824-1317, USA. AU - Madhukar, B. V. AU - Dimitrov, N. V. AU - Meyer-Leece, C. AU - Contreras, M. L. AU - Crowell, J. DB - Medline IS - 12 LA - English M3 - Article N1 - L135720313 2004-04-04 PY - 2002 SN - 1535-7163 SP - 1125-1128 ST - Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz T2 - Molecular cancer therapeutics TI - Inhibition of mitogen-activated protein kinase activity of human lymphocytes after oral administration of Oltipraz UR - https://www.embase.com/search/results?subaction=viewrecord&id=L135720313&from=export VL - 1 ID - 6446 ER - TY - JOUR AD - H.-S. Kim, Department of Neuroscience, School of Medicine, Ewha Womans University, Mok-6-dong 911-1, Yangchun-Ku, Seoul 158-710, South Korea AU - Woo, M. S. AU - Park, J. S. AU - Choi, I. Y. AU - Kimf, W. K. AU - Kim, H. S. DB - Embase Medline DO - 10.1111/j.1471-4159.2008.05430.x IS - 2 LA - English M3 - Article N1 - L354462658 2009-05-06 PY - 2008 SN - 0022-3042 1471-4159 SP - 770-780 ST - Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia T2 - Journal of Neurochemistry TI - Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354462658&from=exporthttp://dx.doi.org/10.1111/j.1471-4159.2008.05430.x VL - 106 ID - 6447 ER - TY - JOUR AD - Translational Oncopathology, IRCSS A.O.U. San Martino-IST, National Cancer Research Institute, L.go R. Benzi 10, 16132 Genoa, Italy. AN - 22192458 AU - Del Grosso, F. AU - De Mariano, M. AU - Passoni, L. AU - Luksch, R. AU - Tonini, G. P. AU - Longo, L. C2 - PMC3267831 DA - Dec 22 DO - 10.1186/1471-2407-11-525 10.1186/1471-2407-11-525. DP - Nlm ET - 2011/12/24 LA - eng PY - 2011 SN - 1471-2407 SP - 525 ST - Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines T2 - BMC Cancer TI - Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines VL - 11 ID - 6448 ER - TY - JOUR AD - Department of Oncohematology, Ospedale Pediatrico Bambino Gesù, IRCCS, Piazza S. Onofrio 4, 00165 Roma, Italy Paris VI-Université Pierre et Marie Curie, UR4, Vieillissement, Stress et Inflammation, Paris, France SAFU, Istituto Regina Elena, Roma, Italy Department of Scientific Directorate, Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy Department of Medicine, Hematology-Oncology Division, University of Virginia, Charlottesville, VA, United States Department of Pediatrics, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States Cancer Institute, University of Mississippi Medical Center, Jackson, MS, United States Centre for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, QC, Canada Dipartimento di Scienze Pediatriche, Università di Pavia, Italy AU - Raimondi, L. AU - Ciarapica, R. AU - De Salvo, M. AU - Verginelli, F. AU - Gueguen, M. AU - Martini, C. AU - De Sio, L. AU - Cortese, G. AU - Locatelli, M. AU - Dang, T. P. AU - Carlesso, N. AU - Miele, L. AU - Stifani, S. AU - Limon, I. AU - Locatelli, F. AU - Rota, R. DB - Scopus DO - 10.1038/cdd.2011.171 IS - 5 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2012 SP - 871-881 ST - Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21 Cip1 expression and hampers tumour cell growth in vitro and in vivo T2 - Cell Death and Differentiation TI - Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21 Cip1 expression and hampers tumour cell growth in vitro and in vivo UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859569795&doi=10.1038%2fcdd.2011.171&partnerID=40&md5=3f94e912c2af77cdd602244995d6cdef VL - 19 ID - 6449 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. d.w.hommes@amc.uva.nl AN - 11781274 AU - Hommes, D. AU - van den Blink, B. AU - Plasse, T. AU - Bartelsman, J. AU - Xu, C. AU - Macpherson, B. AU - Tytgat, G. AU - Peppelenbosch, M. AU - Van Deventer, S. DA - Jan DO - 10.1053/gast.2002.30770 10.1053/gast.2002.30770. DP - Nlm ET - 2002/01/10 IS - 1 LA - eng PY - 2002 SN - 0016-5085 (Print) 0016-5085 SP - 7-14 ST - Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease T2 - Gastroenterology TI - Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease VL - 122 ID - 6450 ER - TY - JOUR AD - Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumor Research Centre, Toronto, Ontario, Canada. AN - 21151472 AU - Kongkham, P. N. AU - Onvani, S. AU - Smith, C. A. AU - Rutka, J. T. C2 - PMC3000458 DA - Dec 1 DO - 10.1593/tlo.10121 10.1593/tlo.10121. DP - Nlm ET - 2010/12/15 IS - 6 LA - eng PY - 2010 SN - 1936-5233 SP - 336-43 ST - Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma T2 - Transl Oncol TI - Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma VL - 3 ID - 6451 ER - TY - JOUR AD - Department of Anatomy and Developmental Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 22076433 AU - Sugiyama, N. AU - Kohno, M. AU - Yokoyama, T. DA - Apr DO - 10.1093/ndt/gfr550 10.1093/ndt/gfr550. Epub 2011 Nov 9. DP - Nlm ET - 2011/11/15 IS - 4 LA - eng PY - 2012 SN - 0931-0509 SP - 1351-8 ST - Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model T2 - Nephrol Dial Transplant TI - Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model VL - 27 ID - 6452 ER - TY - JOUR AD - Dept. of Hematology and Oncology, University Medical Center II, Otfried-Müller-Str 10, 72076 Tübingen, Germany AU - Bartolovic, K. AU - Balabanov, S. AU - Hartmann, U. AU - Komor, M. AU - Boehmler, A. M. AU - Bühring, H. J. AU - Möhle, R. AU - Hoelzer, D. AU - Kanz, L. AU - Hofmann, W. K. AU - Brümmendorf, T. H. DB - Scopus DO - 10.1182/blood-2003-05-1535 IS - 2 M3 - Article N1 - Cited By :91 Export Date: 18 November 2020 PY - 2004 SP - 523-529 ST - Inhibitory effect of imatinib on normal progenitor cells in vitro T2 - Blood TI - Inhibitory effect of imatinib on normal progenitor cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-9144233483&doi=10.1182%2fblood-2003-05-1535&partnerID=40&md5=663e0b6103250cf71e46bc6b94b71810 VL - 103 ID - 6453 ER - TY - JOUR AD - X.-J. Qu, Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, China AU - Xue, X. AU - Sun, D. F. AU - Sun, C. C. AU - Liu, H. P. AU - Yue, B. AU - Zhao, C. R. AU - Lou, H. X. AU - Qu, X. J. DB - Embase Medline DO - 10.1016/j.lungcan.2011.12.013 IS - 3 LA - English M3 - Article N1 - L51816947 2012-01-19 2012-05-16 PY - 2012 SN - 0169-5002 1872-8332 SP - 300-308 ST - Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies T2 - Lung Cancer TI - Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: In vitro and in vivo studies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51816947&from=exporthttp://dx.doi.org/10.1016/j.lungcan.2011.12.013 VL - 76 ID - 6454 ER - TY - JOUR AD - Y. Zhang, Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital Affiliated Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, China AU - Tang, M. AU - Wang, W. AU - Cheng, L. AU - Jin, R. AU - Zhang, L. AU - Bian, W. AU - Zhang, Y. C2 - fusheng pharmaceutical(China) DB - Embase DO - 10.22038/ijbms.2018.19451.5153 IS - 3 LA - English M3 - Article N1 - L620400500 2018-02-02 2018-02-21 PY - 2018 SN - 2008-3874 2008-3866 SP - 309-317 ST - The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro T2 - Iranian Journal of Basic Medical Sciences TI - The inhibitory effects of 20(R)-ginsenoside Rg3 on the proliferation, angiogenesis, and collagen synthesis of hypertrophic scar derived fibroblasts in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620400500&from=exporthttp://dx.doi.org/10.22038/ijbms.2018.19451.5153 VL - 21 ID - 6455 ER - TY - JOUR AD - Department of Dermatology, Division of Pediatric Hematology and Oncology, University Hospital Carl Gustav Carus, Fetscherstraße 74, Dresden, D-01307, Germany Department of Pediatrics, Division of Pediatric Hematology and Oncology, University Hospital Carl Gustav Carus, Dresden, D-01307, Germany AU - Mehlig, L. M. AU - Garve, C. AU - Tauer, J. T. AU - Suttorp, M. AU - Bauer, A. DB - Scopus DO - 10.3892/mmr.2014.3074 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2015 SP - 3143-3147 ST - Inhibitory effects of imatinib on vitamin D3 synthesis in human keratinocytes T2 - Molecular Medicine Reports TI - Inhibitory effects of imatinib on vitamin D3 synthesis in human keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921395708&doi=10.3892%2fmmr.2014.3074&partnerID=40&md5=ceffa00c183f1d859ca845331da2bea7 VL - 11 ID - 6456 ER - TY - JOUR AD - D. Jeoung, Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chunchon, 200-701, South Korea AU - Kim, K. AU - Kim, Y. AU - Kim, H. Y. AU - Ro, J. Y. AU - Jeoung, D. DB - Embase Medline DO - 10.1016/j.ejphar.2007.11.033 IS - 1-2 LA - English M3 - Article N1 - L50014138 2008-02-22 PY - 2008 SN - 0014-2999 SP - 191-203 ST - Inhibitory mechanism of anti-allergic peptides in RBL2H3 cells T2 - European Journal of Pharmacology TI - Inhibitory mechanism of anti-allergic peptides in RBL2H3 cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50014138&from=exporthttp://dx.doi.org/10.1016/j.ejphar.2007.11.033 VL - 581 ID - 6457 ER - TY - JOUR AD - Department of Pediatrics and Molecular Pharmacology, Children's Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, 3415 Bainbridge Avenue, Rosenthal, Bronx, NY 10467, United States A.I. duPont Hospital for Children, Wilmington, DE, United States St. Jude Children's Research Hospital, Memphis, TN, United States Duke University Medical Center, Durham, NC, United States Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia Texas Tech. University Health Science Center, Lubbock, TX, United States Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Abramson Family Cancer Research Institute, Philadelphia, PA, United States Cancer Therapy Evaluation Program, NCI, Bethesda, MD, United States Hematology-Oncology, United States AU - Gorlick, R. AU - Kolb, E. A. AU - Houghton, P. J. AU - Morton, C. L. AU - Phelps, D. AU - Schaiquevich, P. AU - Stewart, C. AU - Keir, S. T. AU - Lock, R. AU - Carol, H. AU - Reynolds, C. P. AU - Maris, J. M. AU - Wu, J. AU - Smith, M. A. DB - Scopus DO - 10.1002/pbc.21989 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2009 SP - 594-598 ST - Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program T2 - Pediatric Blood and Cancer TI - Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-69849094782&doi=10.1002%2fpbc.21989&partnerID=40&md5=28cdc6338c6688fde3d5439cb83272c5 VL - 53 ID - 6458 ER - TY - JOUR AD - H.T. Michael, Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States AU - Michael, H. T. AU - Day, C. P. AU - Sassano, A. AU - Liu, H. AU - Yang, H. AU - Lee, M. AU - Merlino, G. DB - Embase DO - 10.1111/pcmr.12747 IS - 1 LA - English M3 - Conference Abstract N1 - L628191062 2019-06-25 PY - 2019 SN - 1755-148X SP - 184 ST - Initiation and progression of BRAF/NRAS wildtype melanoma in a UV-induced mouse model of cutaneous melanoma T2 - Pigment Cell and Melanoma Research TI - Initiation and progression of BRAF/NRAS wildtype melanoma in a UV-induced mouse model of cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628191062&from=exporthttp://dx.doi.org/10.1111/pcmr.12747 VL - 32 ID - 6459 ER - TY - JOUR AD - Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, United States Department of Cellular Therapy and Stem Cell Transplant, MD Anderson Cancer Center, Houston, TX, United States Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, United States Department of Hematology Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH, United States Department of Immunochemistry, PPD, Richmond, VA, United States AU - Kantarjian, H. AU - Thomas, D. AU - Jorgensen, J. AU - Jabbour, E. AU - Kebriaei, P. AU - Rytting, M. AU - York, S. AU - Ravandi, F. AU - Kwari, M. AU - Faderl, S. AU - Rios, M. B. AU - Cortes, J. AU - Fayad, L. AU - Tarnai, R. AU - Wang, S. A. AU - Champlin, R. AU - Advani, A. AU - O'Brien, S. DB - Scopus DO - 10.1016/S1470-2045(11)70386-2 IS - 4 M3 - Article N1 - Cited By :284 Export Date: 18 November 2020 PY - 2012 SP - 403-411 ST - Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: A phase 2 study T2 - The Lancet Oncology TI - Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: A phase 2 study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862786326&doi=10.1016%2fS1470-2045%2811%2970386-2&partnerID=40&md5=ce6d8f3899db28f3aa1b72a9581c6607 VL - 13 ID - 6460 ER - TY - JOUR AD - Departments of Medical Oncology and Pathology and Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. AN - 18550829 AU - Tarn, C. AU - Rink, L. AU - Merkel, E. AU - Flieder, D. AU - Pathak, H. AU - Koumbi, D. AU - Testa, J. R. AU - Eisenberg, B. AU - von Mehren, M. AU - Godwin, A. K. C2 - PMC2448846 DA - Jun 17 DO - 10.1073/pnas.0803383105 10.1073/pnas.0803383105. Epub 2008 Jun 11. DP - Nlm ET - 2008/06/14 IS - 24 LA - eng PY - 2008 SN - 0027-8424 (Print) 0027-8424 SP - 8387-92 ST - Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors T2 - Proc Natl Acad Sci U S A TI - Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors VL - 105 ID - 6461 ER - TY - JOUR AD - Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China. AN - 12930919 AU - Liu, E. AU - Law, H. K. AU - Lau, Y. L. DA - Dec DO - 10.1203/01.Pdr.0000088067.04673.1b 10.1203/01.PDR.0000088067.04673.1B. Epub 2003 Aug 20. DP - Nlm ET - 2003/08/22 IS - 6 LA - eng PY - 2003 SN - 0031-3998 (Print) 0031-3998 SP - 919-25 ST - Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways T2 - Pediatr Res TI - Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways VL - 54 ID - 6462 ER - TY - JOUR AD - Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, United States Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, United States AU - Belinsky, M. G. AU - Rink, L. AU - Cai, K. Q. AU - Ochs, M. F. AU - Eisenberg, B. AU - Huang, M. AU - Von Mehren, M. AU - Godwin, A. K. DB - Scopus DO - 10.4161/cc.7.19.6760 IS - 19 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2008 SP - 2949-2955 ST - The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors T2 - Cell Cycle TI - The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-53649108514&doi=10.4161%2fcc.7.19.6760&partnerID=40&md5=6cda63addeb4fdd68479ed361f34c0f2 VL - 7 ID - 6463 ER - TY - JOUR AD - W. Zumkeller, Department of Pediatrics, Martin-Luther-Univ. Halle-Wittenberg, Children's University Hospital, Ernst-Grube-Str. 40, 06097 Halle Saale, Germany AU - Zumkeller, W. DB - Embase Medline DO - 10.1080/10428190290011958 IS - 3 LA - English M3 - Review N1 - L34232914 2002-03-28 PY - 2002 SN - 1042-8194 SP - 487-491 ST - The insulin-like growth factor system in hematopoietic cells T2 - Leukemia and Lymphoma TI - The insulin-like growth factor system in hematopoietic cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34232914&from=exporthttp://dx.doi.org/10.1080/10428190290011958 VL - 43 ID - 6464 ER - TY - JOUR AD - H. Liu, Department of Rheumatology, Shandong University Qilu Hospital, 107 Wenhua Xi Road, Jinan, Shandong Province, China AU - Chen, C. AU - Bai, X. AU - Bi, Y. AU - Liu, G. AU - Li, H. AU - Liu, Z. AU - Liu, H. C1 - ly 294002 pd 98059 DB - Embase Medline DO - 10.1179/1476830514Y.0000000147 IS - 2 LA - English M3 - Article N1 - L611287798 2016-07-25 2017-01-24 PY - 2017 SN - 1476-8305 1028-415X SP - 89-102 ST - Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro T2 - Nutritional Neuroscience TI - Insulin-like growth factor-1 attenuates apoptosis and protects neurochemical phenotypes of dorsal root ganglion neurons with paclitaxel-induced neurotoxicity in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611287798&from=exporthttp://dx.doi.org/10.1179/1476830514Y.0000000147 VL - 20 ID - 6465 ER - TY - JOUR AD - Department of Plastic and Reconstructive Surgery, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4, Sakamoto, Nagasaki 852-8523, Japan. AN - 12787120 AU - Daian, T. AU - Ohtsuru, A. AU - Rogounovitch, T. AU - Ishihara, H. AU - Hirano, A. AU - Akiyama-Uchida, Y. AU - Saenko, V. AU - Fujii, T. AU - Yamashita, S. DA - Jun DO - 10.1046/j.1523-1747.2003.12143.x 10.1046/j.1523-1747.2003.12143.x. DP - Nlm ET - 2003/06/06 IS - 6 LA - eng PY - 2003 SN - 0022-202X (Print) 0022-202x SP - 956-62 ST - Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts T2 - J Invest Dermatol TI - Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts VL - 120 ID - 6466 ER - TY - JOUR AD - Department of Neurosurgery, Wenzhou Medical College, 109 Xueyuan Street, Wenzhou 325000, China Department of Neurosurgery, Union Hospital, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China AU - Zhou, H. AU - Rao, J. AU - Lin, J. AU - Yin, B. AU - Sheng, H. AU - Lin, F. AU - Zhang, N. AU - Yang, L. DB - Scopus DO - 10.3892/or.2011.1233 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2011 SP - 1565-1571 ST - The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy T2 - Oncology Reports TI - The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954545017&doi=10.3892%2for.2011.1233&partnerID=40&md5=977f012f0a6d1506d6c32c38928c663c VL - 25 ID - 6467 ER - TY - JOUR AD - Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. mariachiara.pelleri2@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. allison.piovesan2@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. maria.caracausi2@unibo.it. Research Laboratory Stem Cells, U.O.C. Immunohematology-Transfusion Medicine and Laboratory of Hematology, Santo Spirito's Hospital, Via del Circuito, 65100, Pescara, Italy. annacberardi@yahoo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. lorenza.vitale@unibo.it. Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Via Belmeloro 8, 40126, Bologna, BO, Italy. pierluigi.strippoli@unibo.it. Interdepartmental Center for Cancer Research Giorgio Prodi (CIRC), S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, BO, Italy. pierluigi.strippoli@unibo.it. AN - 25476127 AU - Pelleri, M. C. AU - Piovesan, A. AU - Caracausi, M. AU - Berardi, A. C. AU - Vitale, L. AU - Strippoli, P. C2 - PMC4304173 DA - Dec 5 DO - 10.1186/s12920-014-0063-z 10.1186/s12920-014-0063-z. DP - Nlm ET - 2014/12/06 LA - eng PY - 2014 SN - 1755-8794 SP - 63 ST - Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS) T2 - BMC Med Genomics TI - Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS) VL - 7 ID - 6468 ER - TY - JOUR AD - P. Zavattari, Unit of Biology and Genetics, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy AU - Antonelli, M. AU - Fadda, A. AU - Loi, E. AU - Moi, L. AU - Zavattari, C. AU - Sulas, P. AU - Gentilini, D. AU - Cameli, C. AU - Bacchelli, E. AU - Badiali, M. AU - Arcella, A. AU - Morra, I. AU - Giangaspero, F. AU - Zavattari, P. DB - Embase DO - 10.18632/oncotarget.24480 IS - 17 LA - English M3 - Article N1 - L621000120 2018-03-08 2018-03-14 PY - 2018 SN - 1949-2553 SP - 13807-13821 ST - Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas T2 - Oncotarget TI - Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621000120&from=exporthttp://dx.doi.org/10.18632/oncotarget.24480 VL - 9 ID - 6469 ER - TY - JOUR AD - P. Chandra, Departments of Neurosurgery, AIIMS, New Delhi, India AU - Dixit, A. AU - Srivastava, A. AU - Sharma, D. AU - Tripathi, M. AU - Paul, D. AU - Lalwani, S. AU - Doddamani, R. AU - Sharma, M. AU - Banerjee, J. AU - Chandra, P. DB - Embase Medline DO - 10.4103/0028-3886.280649 IS - 2 LA - English M3 - Article N1 - L631872590 2020-06-02 2020-06-15 PY - 2020 SN - 1998-4022 0028-3886 SP - 307-313 ST - Integrated Genome-Wide DNA Methylation and RNAseq Analysis of Hippocampal Specimens Identifies Potential Candidate Genes and Aberrant Signalling Pathways in Patients with Hippocampal Sclerosis T2 - Neurology India TI - Integrated Genome-Wide DNA Methylation and RNAseq Analysis of Hippocampal Specimens Identifies Potential Candidate Genes and Aberrant Signalling Pathways in Patients with Hippocampal Sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631872590&from=exporthttp://dx.doi.org/10.4103/0028-3886.280649 VL - 68 ID - 6470 ER - TY - JOUR AD - M. Kool, Department of Human Genetics, Academic Medical Center, Amsterdam, Netherlands AU - Kool, M. AU - Koster, J. AU - Bunt, J. AU - Hasselt, N. E. AU - Lakeman, A. AU - van Sluis, P. AU - Troost, D. AU - Schouten-van Meeteren, N. AU - Caron, H. N. AU - Cloos, J. AU - Mršić, A. AU - Ylstra, B. AU - Grajkowska, W. AU - Hartmann, W. AU - Pietsch, T. AU - Ellison, D. AU - Clifford, S. C. AU - Versteeg, R. DB - Embase Medline DO - 10.1371/journal.pone.0003088 IS - 8 L1 - internal-pdf://1371499336/journal.pone.0003088.PDF LA - English M3 - Article N1 - L352410178 2008-10-09 PY - 2008 SN - 1932-6203 ST - Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features T2 - PLoS ONE TI - Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352410178&from=exporthttp://dx.doi.org/10.1371/journal.pone.0003088 VL - 3 ID - 6471 ER - TY - JOUR AD - Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science and. Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. Department of Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. Deparment of Pediatrics, Nakadori General Hospital, Akita, Japan; and. Department of Cellular Signaling, Graduate School of Medicine and. Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. AN - 29437595 AU - Murakami, N. AU - Okuno, Y. AU - Yoshida, K. AU - Shiraishi, Y. AU - Nagae, G. AU - Suzuki, K. AU - Narita, A. AU - Sakaguchi, H. AU - Kawashima, N. AU - Wang, X. AU - Xu, Y. AU - Chiba, K. AU - Tanaka, H. AU - Hama, A. AU - Sanada, M. AU - Ito, M. AU - Hirayama, M. AU - Watanabe, A. AU - Ueno, T. AU - Kojima, S. AU - Aburatani, H. AU - Mano, H. AU - Miyano, S. AU - Ogawa, S. AU - Takahashi, Y. AU - Muramatsu, H. DA - Apr 5 DO - 10.1182/blood-2017-07-798157 10.1182/blood-2017-07-798157. Epub 2018 Feb 2. DP - Nlm ET - 2018/02/14 IS - 14 LA - eng PY - 2018 SN - 0006-4971 SP - 1576-1586 ST - Integrated molecular profiling of juvenile myelomonocytic leukemia T2 - Blood TI - Integrated molecular profiling of juvenile myelomonocytic leukemia VL - 131 ID - 6472 ER - TY - JOUR AD - 1 Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. 2 Department of Pathology, Texas Children's Hospital, Houston, TX, USA. 3 Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. 4 Department of Pediatric Medicine, Texas Children's Hospital, Houston, TX, USA. 5 Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX, USA. AN - 26366474 AU - Ballester, L. Y. AU - Sarabia, S. F. AU - Sayeed, H. AU - Patel, N. AU - Baalwa, J. AU - Athanassaki, I. AU - Hernandez, J. A. AU - Fang, E. AU - Quintanilla, N. M. AU - Roy, A. AU - López-Terrada, D. H. DA - Mar-Apr DO - 10.2350/15-05-1638-oa.1 10.2350/15-05-1638-OA.1. Epub 2015 Sep 14. DP - Nlm ET - 2015/09/15 IS - 2 LA - eng PY - 2016 SN - 1093-5266 (Print) 1093-5266 SP - 94-100 ST - Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions T2 - Pediatr Dev Pathol TI - Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions VL - 19 ID - 6473 ER - TY - JOUR AD - J.T. Dudley, 1 Gustave L Levy Place, New York, NY, United States AU - Smith, M. R. AU - Burman, P. AU - Sadahiro, M. AU - Kidd, B. A. AU - Dudley, J. T. AU - Morishita, H. DB - Embase Medline DO - 10.1523/ENEURO.0240-16.2016 IS - 6 LA - English M3 - Article N1 - L614172087 2017-02-02 2017-02-07 PY - 2016 SN - 2373-2822 ST - Integrative analysis of disease signatures shows inflammation disrupts juvenile experience-dependent cortical plasticity T2 - eNeuro TI - Integrative analysis of disease signatures shows inflammation disrupts juvenile experience-dependent cortical plasticity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614172087&from=exporthttp://dx.doi.org/10.1523/ENEURO.0240-16.2016 VL - 3 ID - 6474 ER - TY - JOUR AD - J. Schmidt, Institute of Pathology, University Hospital Tübingen, Tübingen, Germany AU - Schmidt, J. AU - Ramis-Záldivar, J. AU - Nadeu, F. AU - Gonzalez-Farre, B. AU - Navarro, A. AU - Dojcinov, S. AU - Rosenwald, A. AU - Ott, G. AU - Campo, E. AU - Fend, F. AU - Egan, C. AU - Jaffe, E. AU - Salaverria, I. AU - Quintanilla-Martinez, L. DB - Embase DO - 10.1002/hon.2438 LA - English M3 - Conference Abstract N1 - L617732401 2017-08-15 PY - 2017 SN - 0278-0232 SP - 149-150 ST - Integrative mutational analysis of pediatric-type follicular lymphoma reveals TNFRSF14 and MAP2K1 as the most frequently mutated genes T2 - Hematological Oncology TI - Integrative mutational analysis of pediatric-type follicular lymphoma reveals TNFRSF14 and MAP2K1 as the most frequently mutated genes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617732401&from=exporthttp://dx.doi.org/10.1002/hon.2438 VL - 35 ID - 6475 ER - TY - JOUR AD - Dipartimento di Scienze Biomediche, Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Firenze, Italy Dipartimento di Scienze Chimiche, Università degli Studi di Napoli “Federico II”, Napoli, Italy Dipartimento di Scienze degli Alimenti e del Farmaco, Università di Parma, Parma, Italy AU - Bianchini, F. AU - De Santis, A. AU - Portioli, E. AU - Russo Krauss, I. AU - Battistini, L. AU - Curti, C. AU - Peppicelli, S. AU - Calorini, L. AU - D'Errico, G. AU - Zanardi, F. AU - Sartori, A. DB - Scopus DO - 10.1016/j.nano.2019.02.015 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 135-145 ST - Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools T2 - Nanomedicine: Nanotechnology, Biology, and Medicine TI - Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063633857&doi=10.1016%2fj.nano.2019.02.015&partnerID=40&md5=d5766bee94abbe00e5315fcc4ed0d753 VL - 18 ID - 6476 ER - TY - JOUR AD - D.L. Durden, Department of Pediatrics, University of California, Rady Children's Hospital, 3855 Health Sciences Drive #0819, San Diego, CA 92093-0819, United States AU - De, P. AU - Dey, N. AU - Terakedis, B. AU - Bergsagel, P. L. AU - Li, Z. H. AU - Mahadevan, D. AU - Garlich, J. R. AU - Trudel, S. AU - Makale, M. T. AU - Durden, D. L. C1 - sf 1126 velcade DB - Embase Medline DO - 10.1007/s00280-013-2078-0 IS - 4 LA - English M3 - Article N1 - L52412917 2013-01-30 2013-07-16 PY - 2013 SN - 0344-5704 1432-0843 SP - 867-881 ST - An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo T2 - Cancer Chemotherapy and Pharmacology TI - An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52412917&from=exporthttp://dx.doi.org/10.1007/s00280-013-2078-0 VL - 71 ID - 6477 ER - TY - JOUR AD - E. J. Lowe, Division of Pediatric Hematology-Oncology, Children's Hospital of the King's Daughters, 601 Children's Lane, Norfolk, VA 23507 AU - Lowe, E. J. AU - Sposto, R. AU - Perkins, S. L. AU - Gross, T. G. AU - Finlay, J. AU - Zwick, D. AU - Abromowitch, M. DB - Embase Medline DO - 10.1002/pbc.21817 IS - 3 LA - English M3 - Article N1 - L354496785 2009-05-08 PY - 2009 SN - 1545-5009 1545-5017 SP - 335-339 ST - Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941 T2 - Pediatric Blood and Cancer TI - Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354496785&from=exporthttp://dx.doi.org/10.1002/pbc.21817http://www3.interscience.wiley.com/cgi-bin/fulltext/121501532/PDFSTART VL - 52 ID - 6478 ER - TY - JOUR AD - Carcinogenesis and Developmental Therapeutics Program, College of Veterinary Medicine, University of Tennessee, Knoxville 37909-1071, USA. AN - 10771023 AU - Schuller, H. M. AU - Jull, B. A. AU - Sheppard, B. J. AU - Plummer, H. K. DA - Mar 30 DO - 10.1016/s0014-2999(00)00094-7 10.1016/s0014-2999(00)00094-7. DP - Nlm ET - 2000/04/20 IS - 1-3 LA - eng PY - 2000 SN - 0014-2999 (Print) 0014-2999 SP - 265-77 ST - Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders T2 - Eur J Pharmacol TI - Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders VL - 393 ID - 6479 ER - TY - JOUR AD - X. Lei, NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China AU - Xiao, X. AU - Qi, J. AU - Lei, X. AU - Wang, J. DB - Embase DO - 10.3389/fmicb.2019.00321 IS - FEB LA - English M3 - Review N1 - L627729215 2019-05-29 PY - 2019 SN - 1664-302X ST - Interactions between enteroviruses and the inflammasome: New insights into viral pathogenesis T2 - Frontiers in Microbiology TI - Interactions between enteroviruses and the inflammasome: New insights into viral pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627729215&from=exporthttp://dx.doi.org/10.3389/fmicb.2019.00321 VL - 10 ID - 6480 ER - TY - JOUR AD - Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China Cancer Center, First Hospital of Jilin University, Changchun, China Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, China Department of Medical Oncology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Military Command, Nanjing, China Department of Respiratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Respiratory Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, China Department of Oncology, First Affiliated Hospital of Soochow University, Soochow, China Department of Respiratory Medicine, Changhai Hospital Affiliated to Shanghai Second Military Medical University, Shanghai, China Department of Radiotherapy, Hangzhou First People's Hospital, Hangzhou, China Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China Department of Medical Oncology, PLA 81 Hospital, Nanjing, China Department of Medical Oncology, Wuxi Fourth People's Hospital, Wuxi, China AU - Jian, H. AU - Li, W. AU - Ma, Z. AU - Huang, J. AU - Feng, J. AU - Song, Y. AU - Gao, B. AU - Zhu, H. AU - Tao, M. AU - Bai, C. AU - Ma, S. AU - Pan, H. AU - Qin, S. AU - Hua, D. AU - Yu, Y. AU - Lu, S. C7 - 8483 DB - Scopus DO - 10.1038/s41598-017-08399-8 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 ST - Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status T2 - Scientific Reports TI - Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027518666&doi=10.1038%2fs41598-017-08399-8&partnerID=40&md5=d897102accfa7f31fb5c5cdf82443eeb VL - 7 ID - 6481 ER - TY - JOUR AD - Division of Endocrine and Minimally Invasive Surgery, Department of Surgery, New York Presbyterian Hospital-Weill Cornell Medical College, New York, USA. AN - 21879273 AU - Buitrago, D. AU - Keutgen, X. M. AU - Crowley, M. AU - Filicori, F. AU - Aldailami, H. AU - Hoda, R. AU - Liu, Y. F. AU - Hoda, R. S. AU - Scognamiglio, T. AU - Jin, M. AU - Fahey, T. J., 3rd AU - Zarnegar, R. DA - Mar DO - 10.1245/s10434-011-2029-0 10.1245/s10434-011-2029-0. Epub 2011 Aug 31. DP - Nlm ET - 2011/09/01 IS - 3 LA - eng PY - 2012 SN - 1068-9265 SP - 973-80 ST - Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma T2 - Ann Surg Oncol TI - Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma VL - 19 ID - 6482 ER - TY - JOUR AD - K. Steinbrink, Department of Dermatology, University Medical Center, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany AU - Bacher, N. AU - Raker, V. AU - Hofmann, C. AU - Graulich, E. AU - Schwenk, M. AU - Baumgrass, R. AU - Bopp, T. AU - Zechner, U. AU - Merten, L. AU - Becker, C. AU - Steinbrink, K. DB - Embase Medline DO - 10.1158/0008-5472.CAN-12-3788 IS - 18 LA - English M3 - Article N1 - L369916041 2013-10-08 2013-10-28 PY - 2013 SN - 0008-5472 1538-7445 SP - 5647-5656 ST - Interferon-a suppresses cAMP to disarm human regulatory T cells T2 - Cancer Research TI - Interferon-a suppresses cAMP to disarm human regulatory T cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369916041&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-12-3788http://cancerres.aacrjournals.org/content/73/18/5647.full.pdf+html VL - 73 ID - 6483 ER - TY - JOUR AD - C. Brehm, Clinic for Pediatric and Adolescent Medicine, University Hospital Frankfurt, Goethe University, Frankfurt/Main, Germany AU - Brehm, C. AU - Huenecke, S. AU - Esser, R. AU - Kloess, S. AU - Quaiser, A. AU - Betz, S. AU - Zimmermann, O. AU - Soerensen, J. AU - Passweg, J. R. AU - Klingebiel, T. AU - Schwabe, D. AU - Bader, P. AU - Koehl, U. C1 - cellcept(Hoffmann La Roche) C2 - Hoffmann La Roche DB - Embase Medline DO - 10.1007/s00262-014-1556-5 IS - 8 LA - English M3 - Article N1 - L53156079 2014-06-09 2014-09-06 PY - 2014 SN - 1432-0851 0340-7004 SP - 821-833 ST - Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: Possible consequences for immunotherapy T2 - Cancer Immunology, Immunotherapy TI - Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: Possible consequences for immunotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53156079&from=exporthttp://dx.doi.org/10.1007/s00262-014-1556-5 VL - 63 ID - 6484 ER - TY - JOUR AD - T.-Y. Chu, Department of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital, No. 707, Chung-Yang Rd., Sec. 3, Hualien, Taiwan AU - Ding, D. C. AU - Liu, H. W. AU - Chu, T. Y. DB - Embase DO - 10.7150/jca.16116 IS - 13 LA - English M3 - Article N1 - L613577040 2016-12-19 2016-12-21 PY - 2016 SN - 1837-9664 SP - 1815-1823 ST - Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3 T2 - Journal of Cancer TI - Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613577040&from=exporthttp://dx.doi.org/10.7150/jca.16116 VL - 7 ID - 6485 ER - TY - JOUR AD - Y.A. DeClerck, Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine, Los Angeles, CA 90027, United States AU - Ara, T. AU - DeClerck, Y. A. C1 - 531 201 actemra(Chugai) amg 162 bay 43 9006 cnto 328(Centocor) diaclone(Besancon,France) incb 20(Incyte,United States) nexavar nsc 74859 revlimid(Celgene,United States) s31 201 su 11248 C2 - Besancon(France) Celgene(United States) Centocor Chugai Genentech Hoffmann La Roche Incyte(United States) DB - Embase Medline DO - 10.1016/j.ejca.2010.02.026 IS - 7 LA - English M3 - Article N1 - L50844345 2010-04-20 2010-06-15 PY - 2010 SN - 0959-8049 SP - 1223-1231 ST - Interleukin-6 in bone metastasis and cancer progression T2 - European Journal of Cancer TI - Interleukin-6 in bone metastasis and cancer progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50844345&from=exporthttp://dx.doi.org/10.1016/j.ejca.2010.02.026 VL - 46 ID - 6486 ER - TY - JOUR AU - Shen, T. N. Y. AU - Kanazawa, S. AU - Kado, M. AU - Okada, K. AU - Luo, L. AU - Hayashi, A. AU - Mizuno, H. AU - Tanaka, R. C1 - sb 203580 DB - Embase Medline DO - 10.1371/journal.pone.0178232 IS - 5 LA - English M3 - Article N1 - L616317373 2017-05-30 2019-05-14 PY - 2017 SN - 1932-6203 ST - Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice T2 - PLoS ONE TI - Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616317373&from=exporthttp://dx.doi.org/10.1371/journal.pone.0178232 VL - 12 ID - 6487 ER - TY - JOUR AD - Y.-Y. Wu, Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan AU - Tsai, C. L. AU - Chiu, Y. M. AU - Lee, Y. J. AU - Hsieh, C. T. AU - Shieh, D. C. AU - Tsay, G. J. AU - Bau, D. T. AU - Wu, Y. Y. DB - Embase Medline DO - 10.1684/ecn.2018.0407 IS - 1 LA - English M3 - Article N1 - L622219698 2018-05-29 2018-09-28 PY - 2018 SN - 1952-4005 1148-5493 SP - 36-47 ST - Interleukin-32 plays an essential role in human calcified aortic valve cells T2 - European Cytokine Network TI - Interleukin-32 plays an essential role in human calcified aortic valve cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622219698&from=exporthttp://dx.doi.org/10.1684/ecn.2018.0407 VL - 29 ID - 6488 ER - TY - JOUR AN - 105803809. Language: English. Entry Date: 20080829. Revision Date: 20161115. Publication Type: journal article AU - Shah, N. P. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Réa, D. AU - Dorlhiac-Llacer, P. E. AU - Milone, J. H. AU - Vela-Ojeda, J. AU - Silver, R. T. AU - Khoury, H. J. AU - Charbonnier, A. AU - Khoroshko, N. AU - Paquette, R. L. AU - Deininger, M. AU - Collins, R. H. AU - Otero, I. AU - Hughes, T. AU - Bleickardt, E. AU - Strauss, L. AU - Francis, S. AU - Hochhaus, A. DB - ccm DO - 10.1200/JCO.2007.14.9260 DP - EBSCOhost IS - 19 N1 - clinical trial; research. Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Grant Information: CA180-034/CA/NCI NIH HHS/United States. NLM UID: 8309333. PMID: NLM18541900. PY - 2008 SN - 0732-183X SP - 3204-3212 ST - Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia T2 - Journal of Clinical Oncology TI - Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105803809&site=ehost-live&scope=site VL - 26 ID - 6489 ER - TY - JOUR AD - St. Jude Children's Research Hospital, University of Tennessee, TN, United States College of Medicine, Memphis, TN, United States Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Children's Hospital, Harvard Medical School, Boston, MA, United States College of Pharmacy, Memphis, TN, United States Department of Pediatrics, University of Milan-Bicocca, Ospedale San Gerardo, Monza, Italy AU - Pui, C. H. AU - Sallan, S. AU - Relling, M. V. AU - Masera, G. AU - Evans, W. E. DB - Scopus DO - 10.1038/sj.leu.2402111 IS - 5 M3 - Review N1 - Cited By :36 Export Date: 18 November 2020 PY - 2001 SP - 707-715 ST - International childhood Acute Lymphoblastic Leukemia wokshop: Sausalito, CA, 30 November-1 December 2000 T2 - Leukemia TI - International childhood Acute Lymphoblastic Leukemia wokshop: Sausalito, CA, 30 November-1 December 2000 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035001835&doi=10.1038%2fsj.leu.2402111&partnerID=40&md5=1b645958abbb605c9838711dbed94ce2 VL - 15 ID - 6490 ER - TY - JOUR AD - Department of Pathology, University of Kentucky, MS-155, 800 Rose Street, Lexington, KY 40536, USA. craig.horbinski@uky.edu AN - 22492957 AU - Horbinski, C. AU - Nikiforova, M. N. AU - Hagenkord, J. M. AU - Hamilton, R. L. AU - Pollack, I. F. C2 - PMC3367847 DA - Jun DO - 10.1093/neuonc/nos077 10.1093/neuonc/nos077. Epub 2012 Apr 5. DP - Nlm ET - 2012/04/12 IS - 6 LA - eng PY - 2012 SN - 1522-8517 (Print) 1522-8517 SP - 777-89 ST - Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas T2 - Neuro Oncol TI - Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas VL - 14 ID - 6491 ER - TY - JOUR AD - Graduate School of Medicine, Nippon Medical School, Tokyo, Japan. Electronic address: agemma@nms.ac.jp. National Cancer Center Hospital East, Kashiwa, Japan. St. Luke's International Hospital, Tokyo, Japan. Izumi Municipal Hospital, Osaka, Japan. Pfizer Japan Inc., Tokyo, Japan. Tokyo Medical University Hospital, Tokyo, Japan. AN - 30521972 AU - Gemma, A. AU - Kusumoto, M. AU - Kurihara, Y. AU - Masuda, N. AU - Banno, S. AU - Endo, Y. AU - Houzawa, H. AU - Ueno, N. AU - Ohki, E. AU - Yoshimura, A. DA - Apr DO - 10.1016/j.jtho.2018.11.022 10.1016/j.jtho.2018.11.022. Epub 2018 Dec 3. DP - Nlm ET - 2018/12/07 IS - 4 LA - eng PY - 2019 SN - 1556-0864 SP - 672-682 ST - Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib T2 - J Thorac Oncol TI - Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib VL - 14 ID - 6492 ER - TY - JOUR AD - Department of Hepatology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan AU - Kotani, K. AU - Enomoto, M. AU - Okada, M. AU - Yoshida, K. AU - Motoyama, H. AU - Fujii, H. AU - Hagihara, A. AU - Uchida-Kobayashi, S. AU - Morikawa, H. AU - Murakami, Y. AU - Tamori, A. AU - Kawada, N. DB - Scopus DO - 10.1007/s12328-019-00983-x IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 355-360 ST - Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma T2 - Clinical Journal of Gastroenterology TI - Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064741462&doi=10.1007%2fs12328-019-00983-x&partnerID=40&md5=4790f9995df3abd4b8ff576047cf8320 VL - 12 ID - 6493 ER - TY - JOUR AD - G. Lozano, Department of Genetics, The Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Valentin-Vega, Y. A. AU - Okano, H. AU - Lozano, G. DB - Embase Medline DO - 10.1038/cdd.2008.109 IS - 11 LA - English M3 - Article N1 - L50213954 2008-11-12 PY - 2008 SN - 1350-9047 1476-5403 SP - 1772-1781 ST - The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival T2 - Cell Death and Differentiation TI - The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50213954&from=exporthttp://dx.doi.org/10.1038/cdd.2008.109 VL - 15 ID - 6494 ER - TY - JOUR AD - Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Department of Dermatology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Department of Dermatology, Medical School, Instituto i+12, Universidad Complutense, Hospital Universitario 12 de Octubre, Madrid, Spain. Department of Pathology, Hospital Virgen Macarena, Sevilla, Spain. Department of Pathology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jrperalto@salud.madrid.org. AN - 26083553 AU - Riveiro-Falkenbach, E. AU - Villanueva, C. A. AU - Garrido, M. C. AU - Ruano, Y. AU - García-Martín, R. M. AU - Godoy, E. AU - Ortiz-Romero, P. L. AU - Ríos-Martín, J. J. AU - Santos-Briz, A. AU - Rodríguez-Peralto, J. L. DA - Dec DO - 10.1038/jid.2015.229 10.1038/jid.2015.229. Epub 2015 Jun 17. DP - Nlm ET - 2015/06/18 IS - 12 LA - eng PY - 2015 SN - 0022-202x SP - 3078-3085 ST - Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors T2 - J Invest Dermatol TI - Intra- and Inter-Tumoral Homogeneity of BRAF(V600E) Mutations in Melanoma Tumors VL - 135 ID - 6495 ER - TY - JOUR AD - Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Xin, N. AU - Fen, Z. AU - Li, C. AU - Yan, X. AU - Runming, J. C7 - 1072 DB - Scopus DO - 10.3389/fphar.2019.01072 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - Intracranial hemorrhage following oral low-dose methotrexate after multiple toxicities caused by high-dose methotrexate in childhood acute lymphoblastic leukemia T2 - Frontiers in Pharmacology TI - Intracranial hemorrhage following oral low-dose methotrexate after multiple toxicities caused by high-dose methotrexate in childhood acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072924578&doi=10.3389%2ffphar.2019.01072&partnerID=40&md5=6fdba687e373d3df8016c29cdb3c9fc4 VL - 10 ID - 6496 ER - TY - JOUR AD - Department of Plastic & Oral Surgery, Boston Children’s Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, United States Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Radiology, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Orthopedic Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, United States Department of Genetics, Harvard Medical School, Boston, United States AU - Goss, J. A. AU - Konczyk, D. J. AU - Smits, P. J. AU - Kozakewich, H. P. W. AU - Alomari, A. I. AU - Al-Ibraheemi, A. AU - Taghinia, A. H. AU - Dickie, B. H. AU - Adams, D. M. AU - Fishman, S. J. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. DB - Scopus DO - 10.1007/s10456-019-09678-w IS - 4 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 547-552 ST - Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations T2 - Angiogenesis TI - Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071748658&doi=10.1007%2fs10456-019-09678-w&partnerID=40&md5=1289d9c76fabfe4d387f764c0e9d2991 VL - 22 ID - 6497 ER - TY - JOUR AD - C. Klopsch, Reference and Translation Center for Cardiac Stem Cell Therapy, Rostock University, Medical Center, Rostock, Germany AU - Klopsch, C. AU - Skorska, A. AU - Ludwig, M. AU - Lemcke, H. AU - Maass, G. AU - Gaebel, R. AU - Beyer, M. AU - Lux, C. AU - Toelk, A. AU - Müller, K. AU - Maschmeier, C. AU - Rohde, S. AU - Mela, P. AU - Müller-Hilke, B. AU - Jockenhoevel, S. AU - Vollmar, B. AU - Jaster, R. AU - David, R. AU - Steinhoff, G. C1 - epoetin alfa(Ortho,Germany) erypo(Ortho,Germany) C2 - Ortho(Germany) DB - Embase Medline DO - 10.1242/dmm.033282 IS - 6 LA - English M3 - Article N1 - L622727960 2018-07-02 2018-12-27 PY - 2018 SN - 1754-8411 1754-8403 ST - Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart T2 - DMM Disease Models and Mechanisms TI - Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622727960&from=exporthttp://dx.doi.org/10.1242/dmm.033282 VL - 11 ID - 6498 ER - TY - JOUR AD - Department of Hematology/Oncology, Osaka Medical Center, Research Institute for Maternal and Child Health, 840 Murodo, Izumi City, Osaka, 594-1101, Japan AU - Mayumi, A. AU - Sawada, A. AU - Ioi, A. AU - Higuchi, K. AU - Shimizu, M. AU - Sato, M. AU - Yasui, M. AU - Inoue, M. DB - Scopus DO - 10.1097/MPH.0000000000000937 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - e129-e132 ST - Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse after Haploidentical Hematopoietic Stem Cell Transplantation T2 - Journal of Pediatric Hematology/Oncology TI - Intrathecal Infusion of Haploidentical Nondonor Lymphocytes for Central Nervous System Leukemic Relapse after Haploidentical Hematopoietic Stem Cell Transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044369088&doi=10.1097%2fMPH.0000000000000937&partnerID=40&md5=3f353393564f0565b07c1444a780f28c VL - 40 ID - 6499 ER - TY - JOUR AD - Department of Stem Cell Transplantation, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center Research Institute, Tampa, Florida, United States Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin, United States CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, California, United States Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio, United States Division of Hematology and Oncology, Emory University Hospital, Atlanta, Georgia, United States Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States Section of Hematology/Oncology, University of Chicago School of Medicine, Chicago, Illinois, United States Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, Minnesota, United States Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, Minnesota, United States Ottawa Hospital Blood and Marrow Transplant Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California, United States University Medical Center Utrecht, Utrecht, Netherlands Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom AU - Kebriaei, P. AU - Anasetti, C. AU - Zhang, M. J. AU - Wang, H. L. AU - Aldoss, I. AU - de Lima, M. AU - Khoury, H. J. AU - Sandmaier, B. M. AU - Horowitz, M. M. AU - Artz, A. AU - Bejanyan, N. AU - Ciurea, S. AU - Lazarus, H. M. AU - Gale, R. P. AU - Litzow, M. AU - Bredeson, C. AU - Seftel, M. D. AU - Pulsipher, M. A. AU - Boelens, J. J. AU - Alvarnas, J. AU - Champlin, R. AU - Forman, S. AU - Pullarkat, V. AU - Weisdorf, D. AU - Marks, D. I. AU - Hogan, W. AU - Battiwalla, M. AU - Copelan, E. AU - Hildebrandt, G. AU - Ganguly, S. AU - Majhail, N. AU - Woolfrey, A. AU - Nivison-Smith, I. AU - Hertzberg, M. AU - Diaz, M. A. AU - Jakubowski, A. AU - Ustun, C. AU - Yong, A. AU - Freytes, C. AU - DeFilipp, Z. AU - Inamoto, Y. AU - Cahn, J. Y. AU - Savani, B. AU - Yared, J. AU - Bajel, A. AU - Bacher, U. AU - Uy, G. AU - Rizzieri, D. AU - Wieduwilt, M. AU - Schultz, K. AU - Grunwald, M. AU - Kamble, R. AU - Qayed, M. AU - Brammer, J. AU - Ballen, K. AU - Khera, N. AU - Schouten, H. AU - Bierings, M. AU - Kanakry, C. AU - Wood, W. A. AU - Saad, A. AU - Savoie, L. AU - Hamilton, B. K. AU - Aljurf, M. AU - Vij, R. AU - Pawarode, A. AU - Olsson, R. AU - Wirk, B. M. AU - Beitinjaneh, A. AU - Seo, S. AU - Cerny, J. AU - Akpek, G. AU - Norkin, M. AU - Nishihori, T. AU - Lazaryan, A. AU - Sabloff, M. AU - Acute Leukemia Committee of the, Cibmtr DB - Scopus DO - 10.1016/j.bbmt.2017.11.025 IS - 4 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2018 SP - 726-733 ST - Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia T2 - Biology of Blood and Marrow Transplantation TI - Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041917243&doi=10.1016%2fj.bbmt.2017.11.025&partnerID=40&md5=4825d4fa62a20056770732632fcc00e5 VL - 24 ID - 6500 ER - TY - JOUR AD - The University of Toledo College of Medicine & Life Sciences, Toledo, OH 43606, USA ProMedica Health System, Toledo, OH 43606, USA West German Cancer Center, Deparment of Medical Oncology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany Centre Léon Bérard, Unicancer, LYRICAN and Université Claude Bernard Lyon 1, Lyon, France Leiden University Medical Center, Leiden, The Netherlands Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA University Hospitals Leuven, Department of General Medical Oncology, Leuven Cancer Institute, Leuven, Belgium Fox Chase Cancer Center, Philadelphia, PA 19111, USA Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University & Department of Medical Oncology Alfred Health, Melbourne, Australia Deciphera Pharmaceuticals, LLC, Waltham, MA 02451, USA Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA AN - 140274518. Language: English. Entry Date: 20200625. Revision Date: 20200806. Publication Type: journal article AU - Nemunaitis, John AU - Bauer, Sebastian AU - Blay, Jean-Yves AU - Choucair, Khalil AU - Gelderblom, Hans AU - George, Suzanne AU - Schöffski, Patrick AU - Mehren, Margaret von AU - Zalcberg, John AU - Achour, Haroun AU - Ruiz-Soto, Rodrigo AU - Heinrich, Michael C. DB - ccm DO - 10.2217/fon-2019-0633 DP - EBSCOhost IS - 1 N1 - clinical trial; research; randomized controlled trial. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Evidence-Based Practice. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins); Global Assessment of Functioning Scale (GAF). Grant Information: I01 BX000338/BX/BLRD VA/United States. NLM UID: 101256629. PMID: NLM31755321. PY - 2020 SN - 1479-6694 SP - 4251-4264 ST - Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib T2 - Future Oncology TI - Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=140274518&site=ehost-live&scope=site VL - 16 ID - 6501 ER - TY - JOUR AD - H.D. Davies, Department of Pediatrics, College of Medicine, University of Nebraska Medical Center, Omaha, NE, United States AU - Korir, M. L. AU - Manning, S. D. AU - Davies, H. D. DB - Embase Medline DO - 10.1128/CMR.00019-17 IS - 4 LA - English M3 - Review N1 - L617798022 2017-08-25 2017-08-29 PY - 2017 SN - 1098-6618 0893-8512 SP - 973-989 ST - Intrinsic maturational neonatal immune deficiencies and susceptibility to group B streptococcus infection T2 - Clinical Microbiology Reviews TI - Intrinsic maturational neonatal immune deficiencies and susceptibility to group B streptococcus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617798022&from=exporthttp://dx.doi.org/10.1128/CMR.00019-17 VL - 30 ID - 6502 ER - TY - JOUR AD - Department of Medicine, Division of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan AU - Sato, E. AU - Iriyama, N. AU - Tokuhira, M. AU - Takaku, T. AU - Ishikawa, M. AU - Nakazato, T. AU - Sugimoto, K. J. AU - Fujita, H. AU - Fujioka, I. AU - Asou, N. AU - Komatsu, N. AU - Kizaki, M. AU - Hatta, Y. AU - Kawaguchi, T. DB - Scopus DO - 10.1080/10428194.2017.1365858 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 1105-1112 ST - Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score T2 - Leukemia and Lymphoma TI - Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) score UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028574636&doi=10.1080%2f10428194.2017.1365858&partnerID=40&md5=fa8ade391ca83fed2d58867b4d61edbd VL - 59 ID - 6503 ER - TY - JOUR AD - K. Waters, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Waters, K. AU - Rangan, K. AU - Margol, A. AU - Robison, N. AU - Dhall, G. AU - Evans, A. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098190 2018-07-25 PY - 2018 SN - 1523-5866 SP - i152 ST - Introduction of skin care guidelines for children and teens taking molecularly targeted agents T2 - Neuro-Oncology TI - Introduction of skin care guidelines for children and teens taking molecularly targeted agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098190&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 6504 ER - TY - JOUR AD - M. Ruggieri, Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, AOU “Policlinico”, PO “G. Rodolico”, Via S. Sofia, 78, Catania, Italy AU - Ruggieri, M. AU - Polizzi, A. AU - Marceca, G. P. AU - Catanzaro, S. AU - Praticò, A. D. AU - Di Rocco, C. DB - Embase Medline DO - 10.1007/s00381-020-04758-5 LA - English M3 - Article in Press N1 - L2006718661 PY - 2020 SN - 1433-0350 0256-7040 ST - Introduction to phacomatoses (neurocutaneous disorders) in childhood T2 - Child's Nervous System TI - Introduction to phacomatoses (neurocutaneous disorders) in childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006718661&from=exporthttp://dx.doi.org/10.1007/s00381-020-04758-5 ID - 6505 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, University of Tennessee, College of Medicine, Memphis, TN 38105-2794, USA. AN - 10706887 AU - Ma, Z. AU - Cools, J. AU - Marynen, P. AU - Cui, X. AU - Siebert, R. AU - Gesk, S. AU - Schlegelberger, B. AU - Peeters, B. AU - De Wolf-Peeters, C. AU - Wlodarska, I. AU - Morris, S. W. DA - Mar 15 DP - Nlm ET - 2000/03/09 IS - 6 LA - eng N1 - Ma, Z Cools, J Marynen, P Cui, X Siebert, R Gesk, S Schlegelberger, B Peeters, B De Wolf-Peeters, C Wlodarska, I Morris, S W CA21765/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Blood. 2000 Mar 15;95(6):2144-9. PY - 2000 SN - 0006-4971 (Print) 0006-4971 SP - 2144-9 ST - Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis T2 - Blood TI - Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis VL - 95 ID - 6506 ER - TY - JOUR AD - L.M. Kuhn AU - Kuhn, L. M. AU - Schipp, C. AU - Hein, D. AU - Killing, B. AU - Qin, N. AU - Jepsen, V. H. AU - Ahlert, H. AU - Bartl, J. AU - Marquardt, V. AU - Pauck, D. AU - Völtzke, K. AU - Lim, J. AU - Leprivier, G. AU - Remke, M. AU - Bhatia, S. AU - Rosenbaum, T. AU - Borkhardt, A. AU - Fischer, U. DB - Embase DO - 10.1182/blood-2019-131406 LA - English M3 - Conference Abstract N1 - L630318720 2019-12-31 PY - 2019 SN - 1528-0020 ST - Investigation of new therapeutic compounds for juvenile myelomonocytic leukemia using induced pluripotent stem cells with stably activated ras pathway T2 - Blood TI - Investigation of new therapeutic compounds for juvenile myelomonocytic leukemia using induced pluripotent stem cells with stably activated ras pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630318720&from=exporthttp://dx.doi.org/10.1182/blood-2019-131406 VL - 134 ID - 6507 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. State Institution V. P. Komisarenko Institute of Endocrinology and Metabolism of AMS of Ukraine, Kyiv, Ukraine. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Columbia University Medical Center, New York, NY. AN - 29165687 AU - Efanov, A. A. AU - Brenner, A. V. AU - Bogdanova, T. I. AU - Kelly, L. M. AU - Liu, P. AU - Little, M. P. AU - Wald, A. I. AU - Hatch, M. AU - Zurnadzy, L. Y. AU - Nikiforova, M. N. AU - Drozdovitch, V. AU - Leeman-Neill, R. AU - Mabuchi, K. AU - Tronko, M. D. AU - Chanock, S. J. AU - Nikiforov, Y. E. C2 - PMC6059206 DA - Apr 1 DO - 10.1093/jnci/djx209 10.1093/jnci/djx209. DP - Nlm ET - 2017/11/23 IS - 4 LA - eng PY - 2018 SN - 0027-8874 (Print) 0027-8874 SP - 371-378 ST - Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer T2 - J Natl Cancer Inst TI - Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer VL - 110 ID - 6508 ER - TY - JOUR AD - Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Polish Mother's Memorial Hospital-Research Institute, Rzgowska Street No. 281/289, 93-338 Lodz, Poland. AN - 17693984 AU - Brzeziańska, E. AU - Pastuszak-Lewandoska, D. AU - Wojciechowska, K. AU - Migdalska-Sek, M. AU - Cyniak-Magierska, A. AU - Nawrot, E. AU - Lewiński, A. DA - Aug DP - Nlm ET - 2007/08/19 IS - 4 LA - eng N1 - Brzeziańska, Ewa Pastuszak-Lewandoska, Dorota Wojciechowska, Katarzyna Migdalska-Sek, Monika Cyniak-Magierska, Anna Nawrot, Ewa Lewiński, Andrzej Journal Article Sweden Neuro Endocrinol Lett. 2007 Aug;28(4):351-9. PY - 2007 SN - 0172-780X (Print) 0172-780x SP - 351-9 ST - Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population T2 - Neuro Endocrinol Lett TI - Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population VL - 28 ID - 6509 ER - TY - JOUR AD - Cellular and Molecular Neuroscience, National Brain Research Centre (NBRC), NH-8, Nainwal Road, Manesar, Gurgaon, Haryana 122051, India Sagol Department of Neurobiology and Ethology, University of Haifa, Haifa, Israel AU - Malik, S. AU - Saha, R. AU - Seth, P. DB - Scopus DO - 10.1007/s11481-014-9523-7 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2014 SP - 340-353 ST - Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure T2 - Journal of Neuroimmune Pharmacology TI - Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901259174&doi=10.1007%2fs11481-014-9523-7&partnerID=40&md5=e458b439b735988c707e728cdd28f47c VL - 9 ID - 6510 ER - TY - JOUR AD - K.S.J. Elenitoba-Johnson, Department of Pathology, University of Utah, Salt Lake City, UT 84132, United States AU - Elenitoba-Johnson, K. S. J. AU - Jenson, S. D. AU - Abbott, R. T. AU - Palais, R. A. AU - Bohling, S. D. AU - Lin, Z. AU - Tripp, S. AU - Shami, P. J. AU - Wang, L. Y. AU - Coupland, R. W. AU - Buckstein, R. AU - Perez-Ordonez, B. AU - Perkins, S. L. AU - Dube, I. D. AU - Lim, M. S. C1 - sb 203580 DB - Embase Medline DO - 10.1073/pnas.1137463100 IS - 12 LA - English M3 - Article N1 - L36706426 2003-07-01 PY - 2003 SN - 0027-8424 SP - 7259-7264 ST - Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36706426&from=exporthttp://dx.doi.org/10.1073/pnas.1137463100 VL - 100 ID - 6511 ER - TY - JOUR AD - Y. Zhu, Department of Neurosurgery, University of Duisburg-Essen, Hufelandstr.55, 45122 Essen, Germany AU - Zhu, Y. AU - Wloch, A. AU - Wu, Q. AU - Peters, C. AU - Pagenstecher, A. AU - Bertalanffy, H. AU - Sure, U. DB - Embase Medline DO - 10.1161/STROKEAHA.108.526376 IS - 3 LA - English M3 - Article N1 - L354355355 2009-04-10 PY - 2009 SN - 0039-2499 SP - 820-826 ST - Involvement of PTEN promoter methylation in cerebral cavernous malformations T2 - Stroke TI - Involvement of PTEN promoter methylation in cerebral cavernous malformations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354355355&from=exporthttp://dx.doi.org/10.1161/STROKEAHA.108.526376 VL - 40 ID - 6512 ER - TY - JOUR AD - N. Gross, Pediatric Oncology Research Unit, Department of Pediatrics, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland AU - Liberman, J. AU - Sartelet, H. AU - Flahaut, M. AU - Mühlethaler-Mottet, A. AU - Coulon, A. AU - Nyalendo, C. AU - Vassal, G. AU - Joseph, J. M. AU - Gross, N. DB - Embase Medline DO - 10.1371/journal.pone.0043665 IS - 8 L1 - internal-pdf://2554970779/journal.pone.0043665.PDF LA - English M3 - Article N1 - L365470319 2012-08-28 2012-09-07 PY - 2012 SN - 1932-6203 ST - Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma T2 - PLoS ONE TI - Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365470319&from=exporthttp://dx.doi.org/10.1371/journal.pone.0043665 VL - 7 ID - 6513 ER - TY - JOUR AD - A. Schiattarella, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, Naples, Italy AU - Riemma, G. AU - Laganà, A. S. AU - Schiattarella, A. AU - Garzon, S. AU - Cobellis, L. AU - Autiero, R. AU - Licciardi, F. AU - Della Corte, L. AU - La Verde, M. AU - De Franciscis, P. DB - Embase Medline DO - 10.3390/ijms21031114 IS - 3 LA - English M3 - Review N1 - L2003730714 2020-02-14 2020-02-19 PY - 2020 SN - 1422-0067 1661-6596 ST - Ion channels in the pathogenesis of endometriosis: A cutting-edge point of view T2 - International Journal of Molecular Sciences TI - Ion channels in the pathogenesis of endometriosis: A cutting-edge point of view UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003730714&from=exporthttp://dx.doi.org/10.3390/ijms21031114 VL - 21 ID - 6514 ER - TY - JOUR AD - Y. Kondo, Department of Neurosurgery, Unit BSRB1004, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Kanzawa, T. AU - Iwado, E. AU - Aoki, H. AU - Iwamaru, A. AU - Hollingsworth, E. F. AU - Sawaya, R. AU - Kondo, S. AU - Kondo, Y. C1 - sp 600125(Calbiochem,United States) C2 - Calbiochem(United States) DB - Embase Medline DO - 10.1038/sj.onc.1209414 IS - 26 LA - English M3 - Article N1 - L43980485 2006-07-19 PY - 2006 SN - 0950-9232 1476-5594 SP - 3638-3648 ST - Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway T2 - Oncogene TI - Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43980485&from=exporthttp://dx.doi.org/10.1038/sj.onc.1209414 VL - 25 ID - 6515 ER - TY - JOUR AD - Department of Molecular and Translational Medicine (DMMT), University of Brescia, Viale Europa 11, Brescia, 25123, Italy AU - Fanzani, A. AU - Poli, M. C7 - 1718 DB - Scopus DO - 10.3390/ijms18081718 IS - 8 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2017 ST - Iron, oxidative damage and ferroptosis in rhabdomyosarcoma T2 - International Journal of Molecular Sciences TI - Iron, oxidative damage and ferroptosis in rhabdomyosarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027053896&doi=10.3390%2fijms18081718&partnerID=40&md5=8de1afb652a4c8a32e493010b884845e VL - 18 ID - 6516 ER - TY - JOUR AD - Qatar Medical Genetics Center, Hamad General Hospital (HGH), Hamad Medical Corporation, Doha, Qatar National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation, Doha, Qatar Interim Translational Research Institute (iTRI), Hamad Medical Corporation, Doha, Qatar Faculty of Health and Social Care Sciences, Kingston University and St. George’s University of London, London, United Kingdom Academic Health System, Hamad Medical Corporation, Doha, Qatar Quality of Life Unit, Hamad Medical Corporation, Doha, Qatar Department of Psychology, Kingston University, London, United Kingdom Molecular Genetics Laboratory, Hamad Medical Corporation, Doha, Qatar Primary Health Care Center (PHCC), Hamad Medical Corporation, Doha, Qatar Medicines Management and Pharmacy Services, Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom Faculty of Medicines and Health, LICAMM, University of Leeds, Leeds, United Kingdom AU - Al-Dewik, N. I. AU - Morsi, H. M. AU - Samara, M. M. AU - Ghasoub, R. S. AU - Gnanam, C. C. AU - Bhaskaran, S. K. AU - Nashwan, A. J. AU - Al-Jurf, R. M. AU - Ismail, M. A. AU - Alsharshani, M. M. AU - Alsayab, A. A. AU - Ben-Omran, T. I. AU - Khatib, R. B. AU - Yassin, M. A. DB - Scopus DO - 10.4137/CMO.S32822 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2016 SP - 95-104 ST - Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar? T2 - Clinical Medicine Insights: Oncology TI - Is adherence to imatinib mesylate treatment among patients with chronic myeloid leukemia associated with better clinical outcomes in Qatar? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009433455&doi=10.4137%2fCMO.S32822&partnerID=40&md5=e6d17abc85ffc17700392b0d754aca1a VL - 10 ID - 6517 ER - TY - JOUR AD - Department of Paediatric Oncology and Haematology, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Cardiology, Aarhus University Hospital, Skejby, Denmark Department of Paediatrics, Aarhus University Hospital, Skejby, Denmark AU - Jarfelt, M. AU - Andersen, N. H. AU - Hasle, H. DB - Scopus DO - 10.1111/bjh.14374 IS - 4 M3 - Review N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 SP - 577-587 ST - Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? T2 - British Journal of Haematology TI - Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991486824&doi=10.1111%2fbjh.14374&partnerID=40&md5=31ded55a46faf4c8a2fc821574129e38 VL - 175 ID - 6518 ER - TY - JOUR AD - S.H. Adams, Arkansas Children’s Nutrition Center, 15 Children’s Way, 512-20B, Little Rock, AR, United States AU - Ono-Moore, K. D. AU - Blackburn, M. L. AU - Adams, S. H. DB - Embase Medline DO - 10.1152/ajpendo.00187.2018 IS - 5 LA - English M3 - Article N1 - L624975123 2018-11-21 2018-11-28 PY - 2018 SN - 1522-1555 0193-1849 SP - E780-E794 ST - Is palmitate truly proinflammatory? Experimental confounders and context-specificity T2 - American Journal of Physiology - Endocrinology and Metabolism TI - Is palmitate truly proinflammatory? Experimental confounders and context-specificity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624975123&from=exporthttp://dx.doi.org/10.1152/ajpendo.00187.2018 VL - 315 ID - 6519 ER - TY - JOUR AD - Clinical Research Division, Institut Gustave Roussy, Villejuif Cedex, France. gilles.vassal@igr.fr AN - 23329813 AU - Vassal, G. AU - Geoerger, B. AU - Morland, B. DA - Mar 15 DO - 10.1158/1078-0432.Ccr-12-2551 10.1158/1078-0432.CCR-12-2551. Epub 2013 Jan 17. DP - Nlm ET - 2013/01/19 IS - 6 LA - eng PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 1315-25 ST - Is the European pediatric medicine regulation working for children and adolescents with cancer? T2 - Clin Cancer Res TI - Is the European pediatric medicine regulation working for children and adolescents with cancer? VL - 19 ID - 6520 ER - TY - JOUR AD - Department of Paediatric Oncology, Royal Liverpool Children's NHS Trust, Liverpool, UK. AN - 17914741 AU - Rannan-Eliya, Y. F. AU - Pulford, K. AU - Johnson, R. AU - Peart, I. AU - Kokai, G. AU - Baillie, C. AU - Ait-Tahar, K. AU - Pizer, B. DA - Apr DO - 10.1002/pbc.21357 10.1002/pbc.21357. DP - Nlm ET - 2007/10/05 IS - 4 LA - eng PY - 2008 SN - 1545-5009 SP - 879-81 ST - Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration T2 - Pediatr Blood Cancer TI - Isolated cutaneous anaplastic large cell lymphoma progressing to severe systemic disease with myocardial involvement and central nervous system infiltration VL - 50 ID - 6521 ER - TY - JOUR AD - A. S. Y. Lau, Molecular Chinese Medicine Laboratory, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong AU - Or, T. C. T. AU - Yang, C. L. H. AU - Law, A. H. Y. AU - Li, J. C. B. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1016/j.neuropharm.2010.12.002 IS - 6 LA - English M3 - Article N1 - L51243361 2011-01-28 2011-03-24 PY - 2011 SN - 0028-3908 SP - 823-831 ST - Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia T2 - Neuropharmacology TI - Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51243361&from=exporthttp://dx.doi.org/10.1016/j.neuropharm.2010.12.002 VL - 60 ID - 6522 ER - TY - JOUR AD - C.C. McCuaig, CHU Sainte Justine Division of Dermatology in Pediatrics, University of Montreal, 3175 chemin Côte Sainte-Catherine, Montreal, QC, Canada AU - Caruana, M. AU - Hatami, A. AU - Marcoux, D. AU - Perreault, S. AU - McCuaig, C. C. DB - Embase DO - 10.1016/j.jdcr.2020.07.021 IS - 10 LA - English M3 - Article N1 - L2007877481 2020-09-25 2020-10-20 PY - 2020 SN - 2352-5126 SP - 1056-1058 ST - Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib T2 - JAAD Case Reports TI - Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007877481&from=exporthttp://dx.doi.org/10.1016/j.jdcr.2020.07.021 VL - 6 ID - 6523 ER - TY - JOUR AD - Imperial College, Hammersmith Campus, London, England W12 0NN. j.apperley@imperial.ac.uk. AN - 105251458. Language: English. Entry Date: 20100319. Revision Date: 20150711. Publication Type: Journal Article. Journal Subset: Biomedical AU - Apperley, J. DB - ccm DP - EBSCOhost IS - 10 N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101162515. PMID: NLM19930974. PY - 2009 SN - 1540-1405 SP - 1050-1058 ST - Issues of imatinib and pregnancy outcome T2 - Journal of the National Comprehensive Cancer Network TI - Issues of imatinib and pregnancy outcome UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105251458&site=ehost-live&scope=site VL - 7 ID - 6524 ER - TY - JOUR AD - EA2216 Immunology and Pathology and Institut Fédératif de Recherche 148, Université de Bretagne Occidentale, Brest, France. AN - 20516366 AU - Séïté, J. F. AU - Cornec, D. AU - Renaudineau, Y. AU - Youinou, P. AU - Mageed, R. A. AU - Hillion, S. DA - Sep 9 DO - 10.1182/blood-2009-12-261461 10.1182/blood-2009-12-261461. Epub 2010 Jun 1. DP - Nlm ET - 2010/06/03 IS - 10 LA - eng PY - 2010 SN - 0006-4971 SP - 1698-704 ST - IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes T2 - Blood TI - IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes VL - 116 ID - 6525 ER - TY - JOUR AD - C. Mambet, Stefan S Nicolau Institute of Virology, MyeloAL Program, Bucharest, Romania AU - Mambet, C. AU - Defour, J. P. AU - Babosova, O. AU - Leroy, E. AU - Necula, L. AU - Stanca, O. AU - Tatic, A. AU - Coriu, D. AU - Belickova, M. AU - Kralova, B. AU - Lanikova, L. AU - Saussoy, P. AU - Havelange, V. AU - Diaconu, C. C. AU - Divoky, V. AU - Constantinescu, S. N. DB - Embase DO - 10.1182/blood-2018-99-117019 LA - English M3 - Conference Abstract N1 - L626530538 2019-03-04 PY - 2018 SN - 0006-4971 ST - JAK2 R1063H variant enhances V617F constitutive signaling and favors development of essential thrombocythemia with increased hemoglobin and neutrophils T2 - Blood TI - JAK2 R1063H variant enhances V617F constitutive signaling and favors development of essential thrombocythemia with increased hemoglobin and neutrophils UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530538&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-117019 VL - 132 ID - 6526 ER - TY - JOUR AD - M. Tolomeo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, via del Vespro 129, Palermo, Italy AU - Tolomeo, M. AU - Grimaudo, S. DB - Embase Medline DO - 10.3390/ijms21124308 IS - 12 LA - English M3 - Review N1 - L2004569095 2020-07-24 2020-09-08 PY - 2020 SN - 1422-0067 1661-6596 SP - 1-18 ST - The “janus” role of C/EBPs family members in cancer progression T2 - International Journal of Molecular Sciences TI - The “janus” role of C/EBPs family members in cancer progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004569095&from=exporthttp://dx.doi.org/10.3390/ijms21124308 VL - 21 ID - 6527 ER - TY - JOUR AD - C.S. Moreno, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States AU - Li, Z. AU - Sun, C. AU - Tao, S. AU - Osunkoya, A. O. AU - Arnold, R. S. AU - Petros, J. A. AU - Zu, X. AU - Moreno, C. S. C2 - Cayman(United States) Selleck(United States) DB - Embase DO - 10.1016/j.tranon.2020.100751 IS - 4 LA - English M3 - Article N1 - L2005245595 2020-04-10 2020-04-14 PY - 2020 SN - 1936-5233 ST - The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression T2 - Translational Oncology TI - The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005245595&from=exporthttp://dx.doi.org/10.1016/j.tranon.2020.100751 VL - 13 ID - 6528 ER - TY - JOUR AD - Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. AN - 24469048 AU - Bunda, S. AU - Qin, K. AU - Kommaraju, K. AU - Heir, P. AU - Ohh, M. DA - Feb 5 DO - 10.1038/onc.2013.596 10.1038/onc.2013.596. Epub 2014 Jan 27. DP - Nlm ET - 2014/01/29 IS - 6 LA - eng PY - 2015 SN - 0950-9232 SP - 789-97 ST - Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway T2 - Oncogene TI - Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway VL - 34 ID - 6529 ER - TY - JOUR AD - C.M. Niemeyer, Div. of Pediatric Hematol./Oncology, Dept. of Pediat./Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Niemeyer, C. M. AU - Kratz, C. C1 - e 21r intron A(Schering Plough,United States) l 744832 r 115777 C2 - Schering Plough(United States) DB - Embase Medline DO - 10.1007/s11912-003-0013-y IS - 6 LA - English M3 - Review N1 - L38898823 2004-07-25 PY - 2003 SN - 1523-3790 SP - 510-515 ST - Juvenile myelomonocytic leukemia T2 - Current Oncology Reports TI - Juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38898823&from=exporthttp://dx.doi.org/10.1007/s11912-003-0013-y VL - 5 ID - 6530 ER - TY - JOUR AD - M. Proytcheva, Children's Memorial Hospital, Box 17, 2300 Children's Plaza, Chicago, IL 60614, United States AU - Proytcheva, M. DB - Embase Medline DO - 10.1053/j.semdp.2011.08.007 IS - 4 LA - English M3 - Article N1 - L363018157 2011-12-07 2011-12-22 PY - 2011 SN - 0740-2570 1930-1111 SP - 298-303 ST - Juvenile myelomonocytic leukemia T2 - Seminars in Diagnostic Pathology TI - Juvenile myelomonocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L363018157&from=exporthttp://dx.doi.org/10.1053/j.semdp.2011.08.007 VL - 28 ID - 6531 ER - TY - JOUR AD - B.R. Agarwal, Department of Pediatric Hematology and Oncology, B.J. Wadia Hospital for Children, Parel, Mumbai, India AU - Agarwal, B. R. DB - Embase DO - 10.1007/s12288-013-0303-y IS - 4 LA - English M3 - Conference Abstract N1 - L71223414 2013-11-15 PY - 2013 SN - 0971-4502 SP - 200-201 ST - Juvenile myelomonocytic leukemia (JMML) T2 - Indian Journal of Hematology and Blood Transfusion TI - Juvenile myelomonocytic leukemia (JMML) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71223414&from=exporthttp://dx.doi.org/10.1007/s12288-013-0303-y VL - 29 ID - 6532 ER - TY - JOUR AD - M.M. Ali, University of California San Francisco, San Francisco, CA, United States AU - Ali, M. M. AU - Gilliam, A. E. AU - Gilliam, A. C. AU - Rauen, K. A. DB - Embase DO - 10.231/JIM.0000000000000033 IS - 1 LA - English M3 - Conference Abstract N1 - L71391554 2014-04-04 PY - 2014 SN - 1081-5589 SP - 231 ST - Juvenile xanthogranuloma in Noonan syndrome T2 - Journal of Investigative Medicine TI - Juvenile xanthogranuloma in Noonan syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71391554&from=exporthttp://dx.doi.org/10.231/JIM.0000000000000033 VL - 62 ID - 6533 ER - TY - JOUR AD - Z.-F. Xiong, Division of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Li, Q. T. AU - Feng, Y. M. AU - Ke, Z. H. AU - Qiu, M. J. AU - He, X. X. AU - Wang, M. M. AU - Li, Y. N. AU - Xu, J. AU - Shi, L. L. AU - Xiong, Z. F. DB - Embase Medline DO - 10.1136/jim-2019-001073 IS - 1 LA - English M3 - Article N1 - L629015773 2019-08-28 2020-01-09 PY - 2020 SN - 1708-8267 1081-5589 SP - 68-74 ST - KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma T2 - Journal of Investigative Medicine TI - KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629015773&from=exporthttp://dx.doi.org/10.1136/jim-2019-001073 VL - 68 ID - 6534 ER - TY - JOUR AD - P. Bhatia, Pediatric Hematology-Oncology Unit, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Totadri, S. AU - Singh, M. AU - Trehan, A. AU - Varma, N. AU - Bhatia, P. DB - Embase DO - 10.1007/s12288-018-0997-y IS - 4 LA - English M3 - Review N1 - L623527756 2018-08-22 2018-10-25 PY - 2018 SN - 0974-0449 0971-4502 SP - 595-601 ST - Keeping PACE with Ph Positive to Ph-Like Detection in B-Lineage Acute Lymphoblastic Leukemia: A Practical and Cost Effective (PACE) Approach in a Resource Constrained Setting T2 - Indian Journal of Hematology and Blood Transfusion TI - Keeping PACE with Ph Positive to Ph-Like Detection in B-Lineage Acute Lymphoblastic Leukemia: A Practical and Cost Effective (PACE) Approach in a Resource Constrained Setting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623527756&from=exporthttp://dx.doi.org/10.1007/s12288-018-0997-y VL - 34 ID - 6535 ER - TY - JOUR AD - Department of Dermatology, University Hospital of Pontevedra, Pontevedra (Galicia), Spain Department of Dermatology, University Hospital La Paz, Madrid, Spain Department of Pathology, University Hospital La Paz, Madrid, Spain AU - Oro-Ayude, M. AU - Feito, M. AU - Quintana-Castanedo, L. AU - Beato-Merino, M. J. AU - De Lucas, R. DB - Scopus DO - 10.1111/pde.14267 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 968-969 ST - Keratosis pilaris-like eruption secondary to nilotinib in a child T2 - Pediatric Dermatology TI - Keratosis pilaris-like eruption secondary to nilotinib in a child UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087299326&doi=10.1111%2fpde.14267&partnerID=40&md5=9192768269aa05d5b55009ce9884fb2b VL - 37 ID - 6536 ER - TY - JOUR AD - Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy. AN - 25382612 AU - Antonelli, M. AU - Badiali, M. AU - Moi, L. AU - Buttarelli, F. R. AU - Baldi, C. AU - Massimino, M. AU - Sanson, M. AU - Giangaspero, F. DA - Apr DO - 10.1002/pbc.25272 10.1002/pbc.25272. Epub 2014 Nov 8. DP - Nlm ET - 2014/11/11 IS - 4 LA - eng PY - 2015 SN - 1545-5009 SP - 724-7 ST - KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis T2 - Pediatr Blood Cancer TI - KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis VL - 62 ID - 6537 ER - TY - JOUR AD - R. Riedel, University Hospital of Cologne, Lung Cancer Group Cologne, Department I of Internal Medicine, Cologne, Germany AU - Riedel, R. AU - Plenker, D. AU - Michels, S. AU - Nogova, L. AU - Abdulla, D. AU - Scheffler, M. AU - Fischer, R. AU - Brandes, V. AU - Heukamp, L. C. AU - Scheel, A. H. AU - Büttner, R. AU - Sos, M. L. AU - Wolf, J. DB - Embase DO - 10.1159/000479566 LA - English M3 - Conference Abstract N1 - L618607510 2017-10-11 PY - 2017 SN - 2296-5262 SP - 173 ST - KIF5B-MET fusion genes are novel targets in NSCLC and show sensitivity to MET inhibition with crizotinib T2 - Oncology Research and Treatment TI - KIF5B-MET fusion genes are novel targets in NSCLC and show sensitivity to MET inhibition with crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618607510&from=exporthttp://dx.doi.org/10.1159/000479566 VL - 40 ID - 6538 ER - TY - JOUR AD - M.B. Lodish, Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, 10 Center Drive, Bethesda, MD 20892, United States AU - Lodish, M. B. DB - Embase DO - 10.1210/jc.2012-4085 IS - 4 LA - English M3 - Review N1 - L368740088 2013-04-24 2013-05-09 PY - 2013 SN - 0021-972X 1945-7197 SP - 1333-1342 ST - Kinase inhibitors: Adverse effects related to the endocrine system T2 - Journal of Clinical Endocrinology and Metabolism TI - Kinase inhibitors: Adverse effects related to the endocrine system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368740088&from=exporthttp://dx.doi.org/10.1210/jc.2012-4085http://jcem.endojournals.org/content/98/4/1333.full.pdf+html VL - 98 ID - 6539 ER - TY - JOUR AD - MRC Human Genetics Unit and The University of Edinburgh Institute for Genetics and Molecular Medicine, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK. AN - 19376813 AU - Anastasaki, C. AU - Estep, A. L. AU - Marais, R. AU - Rauen, K. A. AU - Patton, E. E. C2 - PMC2701326 DA - Jul 15 DO - 10.1093/hmg/ddp186 10.1093/hmg/ddp186. Epub 2009 Apr 17. DP - Nlm ET - 2009/04/21 IS - 14 LA - eng PY - 2009 SN - 0964-6906 (Print) 0964-6906 SP - 2543-54 ST - Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors T2 - Hum Mol Genet TI - Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors VL - 18 ID - 6540 ER - TY - JOUR AD - Department of Hematology, BMT, Cairo University, Egypt Department of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Egypt Department of Hematology, Nasser Institute, Ministry of Health, Egypt Clinical Oncology Center, School of Medicine, Cairo University, Egypt AU - Mahmoud, H. K. AU - El Nahas, Y. AU - Moaty, M. A. AU - Fattah, R. A. AU - El Emary, M. AU - El Metnawy, W. DB - Scopus IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2009 SP - 223-228 ST - Kinetics of BCR-ABL transcripts in imatinib mesylate treated chronic phase CML (CPCML), a predictor of response and progression free survival T2 - International Journal of Biomedical Science TI - Kinetics of BCR-ABL transcripts in imatinib mesylate treated chronic phase CML (CPCML), a predictor of response and progression free survival UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953391705&partnerID=40&md5=9ece2093a613dfc46aab002cb89387df VL - 5 ID - 6541 ER - TY - JOUR AD - L. Mussolin, Clinica di Oncoematologia Pediatrica, Dipartimento di Pediatria, Università di Padova, Padua, Italy AU - Mussolin, L. AU - Bonvini, P. AU - Ait-Tahar, K. AU - Pillon, M. AU - Tridello, G. AU - Buffardi, S. AU - Lombardi, A. AU - Pulford, K. AU - Rosolen, A. DB - Embase Medline DO - 10.1038/leu.2008.184 IS - 2 LA - English M3 - Letter N1 - L50204107 2009-02-26 PY - 2009 SN - 1476-5551 0887-6924 SP - 400-402 ST - Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL T2 - Leukemia TI - Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50204107&from=exporthttp://dx.doi.org/10.1038/leu.2008.184 VL - 23 ID - 6542 ER - TY - JOUR AD - I. Andolfo, CEINGE, Biotecnologie Avanzate, Naples, Italy AU - Andolfo, I. AU - Lasorsa, V. A. AU - Manna, F. AU - Rosato, B. E. AU - Formicola, D. AU - Iolascon, A. AU - Capasso, M. DB - Embase Medline DO - 10.1111/jcmm.15297 IS - 11 LA - English M3 - Article N1 - L2004762958 2020-05-07 PY - 2020 SN - 1582-1838 SP - 6459-6471 ST - Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma T2 - Journal of Cellular and Molecular Medicine TI - Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004762958&from=exporthttp://dx.doi.org/10.1111/jcmm.15297 VL - 24 ID - 6543 ER - TY - JOUR AD - M.D. Ringel, Ohio State University, 445D McCampbell Hall, 1581 Dodd Drive, Columbus, OH 43210, United States AU - Stathatos, N. AU - Bourdeau, I. AU - Espinosa, A. V. AU - Saji, M. AU - Vasko, V. V. AU - Burman, K. D. AU - Stratakis, C. A. AU - Ringel, M. D. DB - Embase Medline DO - 10.1210/jc.2005-0963 IS - 9 LA - English M3 - Article N1 - L41262312 2005-09-29 PY - 2005 SN - 0021-972X SP - 5432-5440 ST - KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity T2 - Journal of Clinical Endocrinology and Metabolism TI - KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41262312&from=exporthttp://dx.doi.org/10.1210/jc.2005-0963http://jcem.endojournals.org/cgi/reprint/90/9/5432 VL - 90 ID - 6544 ER - TY - JOUR AD - Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. AN - 21569090 AU - Yun, J. AU - Lee, J. AU - Jang, J. AU - Lee, E. J. AU - Jang, K. T. AU - Kim, J. H. AU - Kim, K. M. DA - Jun DO - 10.1111/j.1600-0463.2011.02737.x 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24. DP - Nlm ET - 2011/05/17 IS - 6 LA - eng PY - 2011 SN - 0903-4641 SP - 330-5 ST - KIT amplification and gene mutations in acral/mucosal melanoma in Korea T2 - Apmis TI - KIT amplification and gene mutations in acral/mucosal melanoma in Korea VL - 119 ID - 6545 ER - TY - JOUR AD - M.-J. Zhu, Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Zhu, M. J. AU - Ou, W. B. AU - Fletcher, C. D. M. AU - Cohen, P. S. AU - Demetri, G. D. AU - Fletcher, J. A. DB - Embase Medline DO - 10.1038/sj.onc.1210464 IS - 44 LA - English M3 - Article N1 - L47494217 2007-09-27 PY - 2007 SN - 0950-9232 1476-5594 SP - 6386-6395 ST - KIT oncoprotein interactions in gastrointestinal stromal tumors: Therapeutic relevance T2 - Oncogene TI - KIT oncoprotein interactions in gastrointestinal stromal tumors: Therapeutic relevance UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47494217&from=exporthttp://dx.doi.org/10.1038/sj.onc.1210464 VL - 26 ID - 6546 ER - TY - JOUR AU - Liu, Y. AU - Zhang, R. X. AU - Yuan, W. AU - Chen, H. Q. AU - Tian, D. D. AU - Li, H. AU - Jiang, X. AU - Deng, Z. L. AU - Wang, Y. DB - Embase Medline DO - 10.1159/000487784 IS - 5 LA - English M3 - Article N1 - L620990894 2018-03-08 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1759-1771 ST - Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression T2 - Cellular Physiology and Biochemistry TI - Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620990894&from=exporthttp://dx.doi.org/10.1159/000487784 VL - 45 ID - 6547 ER - TY - JOUR AD - Department of Emergency Trauma Surgery, Jining No.1 People's Hospital, No.6 Jiankang Road, Jining,Shandong, 272011, China Second Department of Orthopedics, Hospital of Shandong University of Traditional Chinese Medicine, Jinan,Shandong, China Department of Cardiology, Weihai Hospital of Traditional Chinese Medicine, Weihai,Shandong, China AU - Xia, B. AU - Wang, L. AU - Feng, L. AU - Tian, B. AU - Tan, Y. AU - Du, B. DB - Scopus DO - 10.3727/096504018X15199511344806 IS - 1 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 89-98 ST - Knockdown of long noncoding RNA CAT104 inhibits the proliferation, migration, and invasion of human osteosarcoma cells by regulating microrna-381 T2 - Oncology Research TI - Knockdown of long noncoding RNA CAT104 inhibits the proliferation, migration, and invasion of human osteosarcoma cells by regulating microrna-381 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059374730&doi=10.3727%2f096504018X15199511344806&partnerID=40&md5=7eed68e3c9e1b4e3d8a17604a4437e9c VL - 27 ID - 6548 ER - TY - JOUR AD - Y. Li, Department of Radiology, China-Japan Union Hospital of Jilin University, No.126, Xiantai Street, Changchun, Jilin, China AU - Wang, Y. AU - Huang, H. AU - Li, Y. DB - Embase Medline DO - 10.1080/21691401.2019.1601099 IS - 1 LA - English M3 - Article N1 - L627279562 2019-05-14 PY - 2019 SN - 2169-141X 2169-1401 SP - 1458-1465 ST - Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP T2 - Artificial Cells, Nanomedicine and Biotechnology TI - Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627279562&from=exporthttp://dx.doi.org/10.1080/21691401.2019.1601099 VL - 47 ID - 6549 ER - TY - JOUR AD - X. Ying, Department of Gynecology, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China AU - Li, Y. AU - Kong, C. AU - Wu, C. AU - Wang, Y. AU - Xu, B. AU - Liang, S. AU - Ying, X. DB - Embase Medline DO - 10.1042/BSR20181794 IS - 7 LA - English M3 - Article N1 - L2002402929 2019-08-01 2019-08-06 PY - 2019 SN - 1573-4935 0144-8463 ST - Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11 T2 - Bioscience Reports TI - Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002402929&from=exporthttp://dx.doi.org/10.1042/BSR20181794 VL - 39 ID - 6550 ER - TY - JOUR AD - Y. Liu, Center for Perinatal Research, Columbus Children's Research Institute, 700 Children's Drive, Columbus, OH 43205, United States AU - Wang, X. AU - Meng, X. AU - Kuhlman, J. R. AU - Nelin, L. D. AU - Nicol, K. K. AU - English, B. K. AU - Liu, Y. DB - Embase Medline DO - 10.4049/jimmunol.178.8.5312 IS - 8 LA - English M3 - Article N1 - L46595317 2007-04-15 PY - 2007 SN - 0022-1767 SP - 5312-5320 ST - Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria T2 - Journal of Immunology TI - Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46595317&from=exporthttp://dx.doi.org/10.4049/jimmunol.178.8.5312 VL - 178 ID - 6551 ER - TY - JOUR AD - Department of Ophthalmology and Visual Science, Havener Eye Institute, The Ohio State University, Wexner Medical Center, 915 Olentangy River Rd, Ste 5000, Columbus, OH, 43212, USA. Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Wexner Medical Center, Columbus, OH, USA. Department of Ophthalmology and Visual Science, Havener Eye Institute, The Ohio State University, Wexner Medical Center, 915 Olentangy River Rd, Ste 5000, Columbus, OH, 43212, USA. colleen.cebulla@osumc.edu. AN - 31098752 AU - Kunkler, A. L. AU - Binkley, E. M. AU - Mantopoulos, D. AU - Hendershot, A. J. AU - Ohr, M. P. AU - Kendra, K. L. AU - Davidorf, F. H. AU - Cebulla, C. M. DA - Aug DO - 10.1007/s00417-019-04337-8 10.1007/s00417-019-04337-8. Epub 2019 May 16. DP - Nlm ET - 2019/05/18 IS - 8 LA - eng PY - 2019 SN - 0721-832x SP - 1771-1781 ST - Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics T2 - Graefes Arch Clin Exp Ophthalmol TI - Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics VL - 257 ID - 6552 ER - TY - JOUR AD - Arizona College of Osteopathic Medicine, Glendale, Arizona, USA. Departments of Pathology and Dermatology, Kaiser Permanente, Sunset Medical Center, Los Angeles, California, USA. AN - 32974961 AU - Jafri, Z. A. AU - Reddy, S. P. AU - Cassarino, D. S. DA - Sep 25 DO - 10.1111/cup.13883 10.1111/cup.13883. DP - Nlm ET - 2020/09/26 LA - eng PY - 2020 SN - 0303-6987 ST - KRAS 117N positive Rosai-Dorfman with atypical features T2 - J Cutan Pathol TI - KRAS 117N positive Rosai-Dorfman with atypical features ID - 6553 ER - TY - JOUR AD - C.C. Gomes, Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil AU - Coura, B. P. AU - Bernardes, V. F. AU - de Sousa, S. F. AU - França, J. A. AU - Pereira, N. B. AU - Pontes, H. A. R. AU - Batista, A. C. AU - da Cruz Perez, D. E. AU - Albuquerque Junior, R. L. C. AU - de Souza, L. B. AU - Martins, M. D. AU - Diniz, M. G. AU - Gomez, R. S. AU - Gomes, C. C. DB - Embase Medline DO - 10.1038/s41379-018-0194-4 IS - 6 LA - English M3 - Article N1 - L625984703 2019-01-22 2019-06-26 PY - 2019 SN - 1530-0285 0893-3952 SP - 799-806 ST - KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features T2 - Modern Pathology TI - KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625984703&from=exporthttp://dx.doi.org/10.1038/s41379-018-0194-4 VL - 32 ID - 6554 ER - TY - JOUR AD - Institut de Physiologie et Biologie Cellulaires, EA 3813, Université de Poitiers, Poitiers 86000, France. AN - 18287965 AU - Mok, E. AU - Constantin, B. AU - Favreau, F. AU - Neveux, N. AU - Magaud, C. AU - Delwail, A. AU - Hankard, R. DA - Mar DO - 10.1203/PDR.0b013e318163a259 10.1203/PDR.0b013e318163a259. DP - Nlm ET - 2008/02/22 IS - 3 LA - eng PY - 2008 SN - 0031-3998 (Print) 0031-3998 SP - 268-73 ST - l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice T2 - Pediatr Res TI - l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice VL - 63 ID - 6555 ER - TY - JOUR AD - Fight against Angiogenesis-Related Blindness (FARB) Laboratory, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea Tumor Microenvironment Research Center, Global Core Research Center, Seoul National University, Seoul, South Korea Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea Department of Biomolecular Science, University of Science and Technology, Daejeon, South Korea Department of Pathology, College of Medicine, Seoul National University, Seoul, South Korea Department of Chemistry, Dongguk University, Seoul, South Korea Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea AU - Jo, D. H. AU - Lee, K. AU - Kim, J. H. AU - Jun, H. O. AU - Kim, Y. AU - Cho, Y. L. AU - Yu, Y. S. AU - Min, J. K. AU - Kim, J. H. DB - Scopus DO - 10.18632/oncotarget.14487 IS - 9 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2017 SP - 15441-15452 ST - L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma T2 - Oncotarget TI - L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014066896&doi=10.18632%2foncotarget.14487&partnerID=40&md5=67258552108a4726e3294adf26381d56 VL - 8 ID - 6556 ER - TY - JOUR AD - Department of Cytogenetics, National Institute of Immunohaematology (ICMR), 13th Floor, New Multistoried Building, KEM Hospital Campus, Parel, Mumbai, 400012, India Department of Hematology, KEM Hospital, 10th Floor, New Multistoried Building, Parel, Mumbai, 400012, India AU - Dhangar, S. AU - Shanbhag, V. AU - Shanmukhaiah, C. AU - Vundinti, B. R. DB - Scopus DO - 10.1007/s11033-019-04950-0 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 4997-5003 ST - Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients T2 - Molecular Biology Reports TI - Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068822582&doi=10.1007%2fs11033-019-04950-0&partnerID=40&md5=2671567626e4e986718dca7ae97f0804 VL - 46 ID - 6557 ER - TY - JOUR AD - Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco2Department of Otolaryngology-Head and Neck Surgery, Northwestern University, Chicago, Illinois. AN - 24030686 AU - Gouveia, C. AU - Can, N. T. AU - Bostrom, A. AU - Grenert, J. P. AU - van Zante, A. AU - Orloff, L. A. DA - Nov DO - 10.1001/jamaoto.2013.4501 10.1001/jamaoto.2013.4501. DP - Nlm ET - 2013/09/14 IS - 11 LA - eng PY - 2013 SN - 2168-6181 SP - 1164-70 ST - Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience T2 - JAMA Otolaryngol Head Neck Surg TI - Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience VL - 139 ID - 6558 ER - TY - JOUR AD - Department of Cleft Lip and Palate, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China. AN - 21430505 AU - Wu, D. AU - Wang, M. AU - Wang, X. AU - Yin, N. AU - Song, T. AU - Li, H. AU - Yu, J. AU - Wang, D. M. AU - Zhao, Z. DA - Jun DO - 10.1097/DAD.0b013e3181fb5bc7 10.1097/DAD.0b013e3181fb5bc7. DP - Nlm ET - 2011/03/25 IS - 4 LA - eng PY - 2011 SN - 0193-1091 SP - 341-4 ST - Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population T2 - Am J Dermatopathol TI - Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population VL - 33 ID - 6559 ER - TY - JOUR AD - T. Visalli, Eisai Inc., Global Nonclinical Regulatory Affairs, 155 Tice Boulevard, Woodcliff Lake, NJ, United States AU - Visalli, T. AU - Bower, N. AU - Kokate, T. AU - Andrews, P. A. DB - Embase Medline DO - 10.1016/j.yrtph.2018.05.009 LA - English M3 - Review N1 - L2000787373 2018-05-29 2018-12-27 PY - 2018 SN - 1096-0295 0273-2300 SP - 167-177 ST - Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials T2 - Regulatory Toxicology and Pharmacology TI - Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000787373&from=exporthttp://dx.doi.org/10.1016/j.yrtph.2018.05.009 VL - 96 ID - 6560 ER - TY - JOUR AD - R. Buettner, Cologne Institute of Pathology, University Hospital Cologne, Kerpener Straße 62, Cologne, Germany AU - Gültekin, S. E. AU - Aziz, R. AU - Heydt, C. AU - Sengüven, B. AU - Zöller, J. AU - Safi, A. F. AU - Kreppel, M. AU - Buettner, R. DB - Embase Medline DO - 10.1007/s00428-018-2305-5 IS - 5 LA - English M3 - Article N1 - L621588408 2018-04-13 2018-06-05 PY - 2018 SN - 1432-2307 0945-6317 SP - 807-814 ST - The landscape of genetic alterations in ameloblastomas relates to clinical features T2 - Virchows Archiv TI - The landscape of genetic alterations in ameloblastomas relates to clinical features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621588408&from=exporthttp://dx.doi.org/10.1007/s00428-018-2305-5 VL - 472 ID - 6561 ER - TY - JOUR AD - C. Menicanti, IRCCS Cà Granda Foundation, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy AU - Menicanti, C. AU - Nuñez Hipólito, L. AU - Prieto Torres, L. AU - Alegría-Landa, V. AU - Requena, L. DB - Embase IS - 10 LA - English M3 - Conference Abstract N1 - L629610670 2019-10-22 PY - 2019 SN - 1533-0311 SP - e125 ST - Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome a non-previously described association T2 - American Journal of Dermatopathology TI - Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome a non-previously described association UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629610670&from=export VL - 41 ID - 6562 ER - TY - JOUR AD - K. Mohr, Department of Dermatology and Dermatopathology, University of Arkansas for Medical Sciences, Little Rock, AR, United States AU - Mohr, K. AU - Gardner, J. AU - Kincannon, J. DB - Embase DO - 10.1016/j.jaad.2019.06.845 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643217 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB231 ST - Langerhans cell histiocytosis in pediatric patient responsive to vemurafenib after refractory to initial therapy and significant morbidity to salvage therapy T2 - Journal of the American Academy of Dermatology TI - Langerhans cell histiocytosis in pediatric patient responsive to vemurafenib after refractory to initial therapy and significant morbidity to salvage therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643217&from=exporthttp://dx.doi.org/10.1016/j.jaad.2019.06.845 VL - 81 ID - 6563 ER - TY - JOUR AD - K. Ohno, Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan AU - Mishima, K. AU - Kitoh, H. AU - Ohkawara, B. AU - Okuno, T. AU - Ito, M. AU - Masuda, A. AU - Ishiguro, N. AU - Ohno, K. DB - Embase Medline DO - 10.1016/j.ebiom.2015.11.024 IS - 12 LA - English M3 - Article N1 - L608512927 2016-03-02 2016-03-07 PY - 2015 SN - 2352-3964 SP - 2046-2061 ST - Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis T2 - EBioMedicine TI - Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608512927&from=exporthttp://dx.doi.org/10.1016/j.ebiom.2015.11.024 VL - 2 ID - 6564 ER - TY - JOUR AD - Division of Clinical Pharmacology, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland Department of Clinical Pharmacology and Toxicology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Novartis Oncology Region Europe, Milan, Italy Laboratory of Clinical Pharmacology, Innovation and Development Unit, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Bordeaux, France AU - Gotta, V. AU - Bouchet, S. AU - Widmer, N. AU - Schuld, P. AU - Decosterd, L. A. AU - Buclin, T. AU - Mahon, F. X. AU - Csajka, C. AU - Molimard, M. DB - Scopus DO - 10.1016/j.leukres.2014.03.023 IS - 7 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2014 SP - 764-772 ST - Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions T2 - Leukemia Research TI - Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902110431&doi=10.1016%2fj.leukres.2014.03.023&partnerID=40&md5=109c870c237280e5bd1abe4821f628fe VL - 38 ID - 6565 ER - TY - GEN AD - S. Berger, Cancer Center Heilbronn-Franken, MOLIT Institute, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, Heilbronn, Germany AU - Berger, S. AU - Martens, U. M. AU - Bochum, S. C1 - loxo 101 C5 - 30069765 DB - Embase Medline DO - 10.1007/978-3-319-91442-8_10 J2 - Recent Results Cancer Res. LA - English M1 - (Berger S., stephanie.berger@slk-kliniken.de; Martens U.M., uwe.martens@slk-kliniken.de; Bochum S., sylvia.bochum@slk-kliniken.de) Cancer Center Heilbronn-Franken, MOLIT Institute, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, Heilbronn, Germany M3 - Chapter N1 - L623409430 2018-08-14 2018-08-21 PY - 2018 SN - 2197-6767 0080-0015 SP - 141-151 ST - Larotrectinib (LOXO-101) TI - Larotrectinib (LOXO-101) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623409430&from=exporthttp://dx.doi.org/10.1007/978-3-319-91442-8_10 VL - 211 ID - 6566 ER - TY - JOUR AD - Department of Pediatrics and Orthopedics, David Geffen School of Medicine, University of California, Los Angeles, CA, United States Department of Medical Oncology, St. Vincent’s University Hospital & University College Dublin, Dublin, Ireland AU - Federman, N. AU - McDermott, R. DB - Scopus DO - 10.1080/17512433.2019.1661775 IS - 10 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 931-939 ST - Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer T2 - Expert Review of Clinical Pharmacology TI - Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073313039&doi=10.1080%2f17512433.2019.1661775&partnerID=40&md5=60050b74925aeffd3fb7afc064e90799 VL - 12 ID - 6567 ER - TY - JOUR AD - Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, United States Department of Medicine, University of Minnesota, Minneapolis, MN, United States Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States Department of Medicine, City of Hope National Medical Center, Duarte, CA, United States Hematology-Oncology and Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, United States Department of Social Sciences and Pediatrics, City of Hope National Medical Center, Duarte, CA, United States Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States AU - Wu, J. AU - Chen, Y. AU - Hageman, L. AU - Francisco, L. AU - Ness, E. C. AU - Parman, M. AU - Kung, M. AU - Watson, J. A. AU - Weisdorf, D. J. AU - Snyder, D. S. AU - McGlave, P. B. AU - Forman, S. J. AU - Arora, M. AU - Armenian, S. H. AU - Bhatia, R. AU - Bhatia, S. DB - Scopus DO - 10.1002/cncr.32443 IS - 22 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 4033-4042 ST - Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report T2 - Cancer TI - Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070747925&doi=10.1002%2fcncr.32443&partnerID=40&md5=dd5e8824cf53a0b6fcf3c755560f809a VL - 125 ID - 6568 ER - TY - JOUR AD - Department of Hematology and Oncology, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa 920-8641, Japan Department of Internal Medicine, Toyama City Hospital, Toyama, Japan Department of Hematology and Immunology, Kanazawa Medical University, Kahoku, Japan Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan Department of Hematology, Tonami General Hospital, Tonami, Japan Department of Hematology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan AU - Takami, A. AU - Ohtake, S. AU - Morishita, E. AU - Terasaki, Y. AU - Fukushima, T. AU - Kurokawa, T. AU - Sugimori, N. AU - Matano, S. AU - Ohata, K. AU - Saito, C. AU - Yamaguchi, M. AU - Hosokawa, K. AU - Yamazaki, H. AU - Kondo, Y. AU - Nakao, S. DB - Scopus DO - 10.1007/s12185-012-1155-1 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2012 SP - 357-363 ST - Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia T2 - International Journal of Hematology TI - Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866994353&doi=10.1007%2fs12185-012-1155-1&partnerID=40&md5=ba4218fb8971c762577f1b0f01f99de3 VL - 96 ID - 6569 ER - TY - JOUR AD - F. Kuang, Institute of Neurosciences, Fourth Military Medical University, Xi'an, China AU - Liu, J. T. AU - Chen, B. Y. AU - Zhang, J. Q. AU - Kuang, F. AU - Chen, L. W. DB - Embase Medline DO - 10.1016/j.toxlet.2015.09.015 IS - 2 LA - English M3 - Article N1 - L606121862 2015-09-29 2015-10-02 PY - 2015 SN - 1879-3169 0378-4274 SP - 97-107 ST - Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades T2 - Toxicology Letters TI - Lead exposure induced microgliosis and astrogliosis in hippocampus of young mice potentially by triggering TLR4-MyD88-NFκB signaling cascades UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606121862&from=exporthttp://dx.doi.org/10.1016/j.toxlet.2015.09.015 VL - 239 ID - 6570 ER - TY - JOUR AD - E. Fox, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, 1-5750, 10 Center Dr, Bethesda, MD 20892, United States AU - Fox, E. AU - Citrin, D. AU - Balis, F. M. DB - Embase Medline DO - 10.1093/jnci/djp238 IS - 16 LA - English M3 - Editorial N1 - L355154126 2009-09-21 PY - 2009 SN - 0027-8874 1460-2105 SP - 1105-1107 ST - The legacy of cancer therapy in children T2 - Journal of the National Cancer Institute TI - The legacy of cancer therapy in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355154126&from=exporthttp://dx.doi.org/10.1093/jnci/djp238 VL - 101 ID - 6571 ER - TY - JOUR AD - E. Benelli, University of Trieste, Trieste, Italy AU - Benelli, E. AU - Bruno, I. AU - Belcaro, C. AU - Ventura, A. AU - Berti, I. DB - Embase Medline DO - 10.1186/s13052-015-0115-9 IS - 1 LA - English M3 - Review N1 - L602649239 2015-03-12 2015-03-17 PY - 2015 SN - 1824-7288 1720-8424 ST - Legius syndrome: Case report and review of literature T2 - Italian Journal of Pediatrics TI - Legius syndrome: Case report and review of literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602649239&from=exporthttp://dx.doi.org/10.1186/s13052-015-0115-9 VL - 41 ID - 6572 ER - TY - JOUR AD - C.A. Stratakis, Section on Endocrinology and Genetics, NICHD, NIH, 10 Center Dr., Bethesda, MD 20892, United States AU - Bauer, A. J. AU - Stratakis, C. A. DB - Embase Medline DO - 10.1136/jmg.2003.017806 IS - 11 LA - English M3 - Review N1 - L41598187 2005-11-24 PY - 2005 SN - 0022-2593 SP - 801-810 ST - The lentiginoses: Cutaneous markers of systemic disease and a window to new aspects of tumourigenesis T2 - Journal of Medical Genetics TI - The lentiginoses: Cutaneous markers of systemic disease and a window to new aspects of tumourigenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41598187&from=exporthttp://dx.doi.org/10.1136/jmg.2003.017806 VL - 42 ID - 6573 ER - TY - JOUR AD - Division of Gastroenterology, Department of Medicine, Kurume University, School of Medicine, Kurume, Fukuoka, 830-0011, Japan Department of Gastroenterology and Hepatology, Yokokura Hospital, Miyama, Fukuoka, 839-0295, Japan Department of Gastroenterology and Hepatology, Yanagawa Hospital, Yanagawa, Fukuoka, 832-0077, Japan Department OfGastroenterology and Hepatology, Iwamoto Internal Medical Clinic, Kitakyushu, Fukuoka, 802-0832, Japan Department of Gastroenterology and Hepatology, Omuta City Hospital, Omuta, Fukuoka, 836-8567, Japan AU - Shimose, S. AU - Kawaguchi, T. AU - Tanaka, M. AU - Iwamoto, H. AU - Miyazaki, K. AU - Moriyama, E. AU - Suzuki, H. AU - Niizeki, T. AU - Shirono, T. AU - Nakano, M. AU - Suga, H. AU - Yamaguchi, T. AU - Yokokura, Y. AU - Noguchi, K. AU - Koga, H. AU - Torimura, T. DB - Scopus DO - 10.3892/ol.2020.11758 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 2257-2265 ST - Lenvatinib prolongs the progression.free survival time of patients with intermediate.stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis T2 - Oncology Letters TI - Lenvatinib prolongs the progression.free survival time of patients with intermediate.stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090512273&doi=10.3892%2fol.2020.11758&partnerID=40&md5=6b1733af1d92510c9c3ae68d6cc5143c VL - 20 ID - 6574 ER - TY - JOUR AD - The University of Texas MD Anderson Cancer Center, Houston, TX, USA AN - 111878926. Language: English. Entry Date: 20160507. Revision Date: 20191111. Publication Type: journal article AU - Cabanillas, Maria E. AU - Habra, Mouhammed Amir DB - ccm DO - 10.1016/j.ctrv.2015.11.003 DP - EBSCOhost N1 - review. Journal Subset: Biomedical; Double Blind Peer Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 7502030. PMID: NLM26678514. PY - 2016 SN - 0305-7372 SP - 47-55 ST - Lenvatinib: Role in thyroid cancer and other solid tumors T2 - Cancer Treatment Reviews TI - Lenvatinib: Role in thyroid cancer and other solid tumors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111878926&site=ehost-live&scope=site VL - 42 ID - 6575 ER - TY - JOUR AD - S. Madhogaria, Birmingham Children's Hospital, Birmingham, United Kingdom AU - Madhogaria, S. AU - Sharif, S. AU - Moss, C. DB - Embase DO - 10.1111/bjd.12360 LA - English M3 - Conference Abstract N1 - L71125561 2013-08-07 PY - 2013 SN - 0007-0963 SP - 119 ST - LEOPARD syndrome or Noonan syndrome? A difficult distinction in early childhood T2 - British Journal of Dermatology TI - LEOPARD syndrome or Noonan syndrome? A difficult distinction in early childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71125561&from=exporthttp://dx.doi.org/10.1111/bjd.12360 VL - 169 ID - 6576 ER - TY - JOUR AD - John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom AU - Bhatnagar, N. AU - Qureshi, A. AU - Hall, G. DB - Scopus DO - 10.1016/j.paed.2017.08.007 IS - 11 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 489-494 ST - Leukaemias: a review T2 - Paediatrics and Child Health (United Kingdom) TI - Leukaemias: a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029494578&doi=10.1016%2fj.paed.2017.08.007&partnerID=40&md5=64ee4be0d174dfad85660cf18a5e78c9 VL - 27 ID - 6577 ER - TY - JOUR AD - Department of Pediatrics, Asahikawa Medical College, Asahikawa, Japan. AN - 17483702 AU - Makita, Y. AU - Narumi, Y. AU - Yoshida, M. AU - Niihori, T. AU - Kure, S. AU - Fujieda, K. AU - Matsubara, Y. AU - Aoki, Y. DA - May DO - 10.1097/MPH.0b013e3180547136 10.1097/MPH.0b013e3180547136. DP - Nlm ET - 2007/05/08 IS - 5 LA - eng PY - 2007 SN - 1077-4114 (Print) 1077-4114 SP - 287-90 ST - Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene T2 - J Pediatr Hematol Oncol TI - Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene VL - 29 ID - 6578 ER - TY - JOUR AD - V. Leventaki, Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, United States AU - Graetz, D. AU - Crews, K. R. AU - Azzato, E. M. AU - Singh, R. K. AU - Raimondi, S. AU - Mason, J. AU - Valentine, M. AU - Mullighan, C. G. AU - Holland, A. AU - Inaba, H. AU - Leventaki, V. DB - Embase Medline DO - 10.3324/haematol.2018.215103 IS - 5 LA - English M3 - Article N1 - L2002006557 2019-07-10 2019-07-15 PY - 2019 SN - 1592-8721 0390-6078 SP - e218-e221 ST - Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib T2 - Haematologica TI - Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002006557&from=exporthttp://dx.doi.org/10.3324/haematol.2018.215103 VL - 104 ID - 6579 ER - TY - JOUR AD - N. Kanda, School of Medicine, Department of Dermatology, Teikyo University, 11-1, Kaga-2, Itabashi-Ku, Tokyo 173-8605, Japan AU - Kanda, N. AU - Watanabe, S. DB - Embase Medline DO - 10.1111/j.1365-2222.2007.02743.x IS - 7 LA - English M3 - Article N1 - L46955520 2007-07-01 PY - 2007 SN - 0954-7894 1365-2222 SP - 1074-1082 ST - Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes T2 - Clinical and Experimental Allergy TI - Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46955520&from=exporthttp://dx.doi.org/10.1111/j.1365-2222.2007.02743.x VL - 37 ID - 6580 ER - TY - JOUR AD - S. Paruchuri, Department of Chemistry, University of Akron, KNCL 406, 185 E Mill street, Akron, OH, United States AU - Kondeti, V. AU - Al-Azzam, N. AU - Duah, E. AU - Thodeti, C. K. AU - Boyce, J. A. AU - Paruchuri, S. DB - Embase Medline DO - 10.1016/j.jaci.2015.06.030 IS - 1 LA - English M3 - Article N1 - L605510307 2015-08-11 2016-01-19 PY - 2016 SN - 1097-6825 0091-6749 SP - 289-298 ST - Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3 T2 - Journal of Allergy and Clinical Immunology TI - Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605510307&from=exporthttp://dx.doi.org/10.1016/j.jaci.2015.06.030 VL - 137 ID - 6581 ER - TY - JOUR AD - Cancer Epigenetics Laboratory and School of Cellular & Molecular Medicine, University of Bristol, Bristol, UK. Department of Cellular Pathology, Southmead Hospital, Bristol, UK. Colorectal Cancer Laboratory, School of Cellular & Molecular Medicine, University of Bristol, Bristol, UK. The Kids Research Institute, The Children's Hospital at Westmead, Westmead, New South Wales, Australia. Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK. AN - 26517508 AU - Vieira, G. C. AU - Chockalingam, S. AU - Melegh, Z. AU - Greenhough, A. AU - Malik, S. AU - Szemes, M. AU - Park, J. H. AU - Kaidi, A. AU - Zhou, L. AU - Catchpoole, D. AU - Morgan, R. AU - Bates, D. O. AU - Gabb, P. D. AU - Malik, K. C2 - PMC4741879 DA - Nov 24 DO - 10.18632/oncotarget.5548 10.18632/oncotarget.5548. DP - Nlm ET - 2015/10/31 IS - 37 LA - eng PY - 2015 SN - 1949-2553 SP - 40053-67 ST - LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma T2 - Oncotarget TI - LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma VL - 6 ID - 6582 ER - TY - JOUR AD - X. Wang, Department of Anesthesiology, Renji Hospital, Shanghai Jiaotong University School of Medicine, 1630 Dong Fang Road, Shanghai 200127, China AU - Su, D. AU - Gu, Y. AU - Wang, Z. AU - Wang, X. DB - Embase Medline DO - 10.1213/ANE.0b013e3181e9e897 IS - 3 LA - English M3 - Article N1 - L51021976 2010-08-13 2010-11-25 PY - 2010 SN - 0003-2999 SP - 768-774 ST - Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia T2 - Anesthesia and Analgesia TI - Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51021976&from=exporthttp://dx.doi.org/10.1213/ANE.0b013e3181e9e897 VL - 111 ID - 6583 ER - TY - JOUR AD - Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Institute of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China AU - Zhang, Y. AU - Yu, S. AU - Li, X. AU - Yang, B. AU - Wu, C. DB - Scopus DO - 10.1042/CS20160547 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 SP - 297-308 ST - The ligands of translocator protein inhibit human th1 responses and the rejection of murine skin allografts T2 - Clinical Science TI - The ligands of translocator protein inhibit human th1 responses and the rejection of murine skin allografts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014119202&doi=10.1042%2fCS20160547&partnerID=40&md5=f3662253288aaa14bd01f4b29d379482 VL - 131 ID - 6584 ER - TY - JOUR AD - Department of Oncology, University of Torino Medical School, Torino, Italy Investigative Clinical Oncology (INCO), Fondazione Del Piemonte per l'Oncologia, Candiolo Cancer Institute (IRCCs), Turin, Italy Laboratory of Cell Adhesion Dynamics, University of Torino School of Medicine, Fondazione Del Piemonte per l'Oncologia-Candiolo Cancer Institute (IRCCs), Candiolo, Italy AU - Aversa, C. AU - Leone, F. AU - Zucchini, G. AU - Serini, G. AU - Geuna, E. AU - Milani, A. AU - Valdembri, D. AU - Martinello, R. AU - Montemurro, F. DB - Scopus DO - 10.1586/14737140.2015.1042369 IS - 6 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 677-687 ST - Linifanib: Current status and future potential in cancer therapy T2 - Expert Review of Anticancer Therapy TI - Linifanib: Current status and future potential in cancer therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930451779&doi=10.1586%2f14737140.2015.1042369&partnerID=40&md5=fa9bcd7bb856544c1c230bf09090bc78 VL - 15 ID - 6585 ER - TY - JOUR AD - M.G. Bianchi, Department of Medicine and Surgery, University of Parma, Parma, Italy AU - Bianchi, M. G. AU - Allegri, M. AU - Chiu, M. AU - Costa, A. L. AU - Blosi, M. AU - Ortelli, S. AU - Bussolati, O. AU - Bergamaschi, E. DB - Embase DO - 10.3389/fimmu.2017.00866 IS - AUG LA - English M3 - Article N1 - L617629197 2017-08-11 2017-08-16 PY - 2017 SN - 1664-3224 ST - Lipopolysaccharide adsorbed to the bio-corona of TiO2 nanoparticles powerfully activates selected pro-inflammatory transduction pathways T2 - Frontiers in Immunology TI - Lipopolysaccharide adsorbed to the bio-corona of TiO2 nanoparticles powerfully activates selected pro-inflammatory transduction pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617629197&from=exporthttp://dx.doi.org/10.3389/fimmu.2017.00866 VL - 8 ID - 6586 ER - TY - JOUR AD - Department of Neonatology, University of Heidelberg, Medical School, Heidelberg, Germany. lutz.koch@med.uni-heidelberg.de AN - 20798552 AU - Koch, L. AU - Fritzsching, B. AU - Frommhold, D. AU - Poeschl, J. DO - 10.1159/000313967 10.1159/000313967. Epub 2010 Aug 27. DP - Nlm ET - 2010/08/28 IS - 2 LA - eng PY - 2011 SN - 1661-7800 SP - 140-5 ST - Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK T2 - Neonatology TI - Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK VL - 99 ID - 6587 ER - TY - JOUR AD - P.J. Gebicke-Haerter, Central Institute for Mental Health, Dept. of Psychopharmacology, J5, D-68159 Mannheim, Germany AU - Kitamura, Y. AU - Spleiss, O. AU - Li, H. AU - Taniguchi, T. AU - Kimura, H. AU - Nomura, Y. AU - Gebicke-Haerter, P. J. DB - Embase Medline DO - 10.1002/jnr.1107 IS - 6 LA - English M3 - Article N1 - L32520676 2001-06-28 PY - 2001 SN - 0360-4012 SP - 553-563 ST - Lipopolysaccharide-induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)-16 messenger RNAs in cultured rat microglia T2 - Journal of Neuroscience Research TI - Lipopolysaccharide-induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)-16 messenger RNAs in cultured rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32520676&from=exporthttp://dx.doi.org/10.1002/jnr.1107 VL - 64 ID - 6588 ER - TY - JOUR AN - 141262304. Language: English. Entry Date: 20200129. Revision Date: 20200131. Publication Type: Article DB - ccm DP - EBSCOhost IS - 6 N1 - abstract; research. Supplement Title: Dec2019/Jan2020. Journal Subset: Core Nursing; Editorial Board Reviewed; Expert Peer Reviewed; Nursing; Peer Reviewed; USA. NLM UID: 100972358. PY - 2019 SN - 1531-037X SP - 24-29 ST - LITSCAN FOR CASE MANAGERS T2 - Care Management TI - LITSCAN FOR CASE MANAGERS UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141262304&site=ehost-live&scope=site VL - 25 ID - 6589 ER - TY - JOUR AD - Department of Hematology, Shengjing Hospital, China Medical University, Shenyang, 110039, China Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, 110122, China Department of Urology, Shengjing Hospital, China Medical University, Shenyang, 110004, China Laboratory of Molecular Neuro-Oncology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, United States AU - Wang, H. AU - Wang, X. AU - Xin, N. AU - Qi, L. AU - Liao, A. AU - Yang, W. AU - Liu, Z. AU - Zhao, C. DB - Scopus DO - 10.1007/s11010-017-3032-y IS - 1-2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 25-32 ST - Live kinase B1 maintains CD34+CD38− AML cell proliferation and self-renewal T2 - Molecular and Cellular Biochemistry TI - Live kinase B1 maintains CD34+CD38− AML cell proliferation and self-renewal UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017273532&doi=10.1007%2fs11010-017-3032-y&partnerID=40&md5=1b2c906fbf56c03e5c4d818e00fc9084 VL - 434 ID - 6590 ER - TY - JOUR AD - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, 510060, China AU - Xiao, B. AU - Peng, J. AU - Tang, J. AU - Zhang, R. AU - Li, C. AU - Lin, J. AU - Ding, P. AU - Wan, D. AU - Pan, Z. AU - Wu, X. DB - Scopus DO - 10.2147/CMAR.S187061 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 6121-6127 ST - Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: A retrospective study from a single center T2 - Cancer Management and Research TI - Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: A retrospective study from a single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057615960&doi=10.2147%2fCMAR.S187061&partnerID=40&md5=94d86ee067acf417744795a02daac784 VL - 10 ID - 6591 ER - TY - JOUR AD - J. Lu, Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, China AU - Wu, D. M. AU - Wang, Y. J. AU - Han, X. R. AU - Wen, X. AU - Wang, S. AU - Shen, M. AU - Fan, S. H. AU - Zhuang, J. AU - Zhang, Z. F. AU - Shan, Q. AU - Li, M. Q. AU - Hu, B. AU - Sun, C. H. AU - Lu, J. AU - Zheng, Y. L. DB - Embase Medline DO - 10.1002/jcp.26329 IS - 9 LA - English M3 - Article N1 - L621386526 2018-03-28 2018-06-08 PY - 2018 SN - 1097-4652 0021-9541 SP - 6689-6704 ST - LncRNA LINC00880 promotes cell proliferation, migration, and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma T2 - Journal of Cellular Physiology TI - LncRNA LINC00880 promotes cell proliferation, migration, and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621386526&from=exporthttp://dx.doi.org/10.1002/jcp.26329 VL - 233 ID - 6592 ER - TY - JOUR AD - X. Yan, Department of Anesthesiology, Shenzhen Bao'an Maternity and Child Health Hospital, NO.56 Yulv Road, Bao'an District, Shenzhen, China AU - Chen, H. AU - Wang, X. AU - Yan, X. AU - Cheng, X. AU - He, X. AU - Zheng, W. DB - Embase Medline DO - 10.1016/j.intimp.2017.11.038 LA - English M3 - Article N1 - L619591841 2017-12-15 2018-08-24 PY - 2018 SN - 1878-1705 1567-5769 SP - 69-76 ST - LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB T2 - International Immunopharmacology TI - LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619591841&from=exporthttp://dx.doi.org/10.1016/j.intimp.2017.11.038 VL - 55 ID - 6593 ER - TY - JOUR AD - Department of Pediatric Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China AU - Pan, J. AU - Zhang, D. AU - Zhang, J. AU - Qin, P. AU - Wang, J. DB - Scopus DO - 10.1080/15384047.2018.1550568 IS - 5 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2019 SP - 653-665 ST - LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases T2 - Cancer Biology and Therapy TI - LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059081065&doi=10.1080%2f15384047.2018.1550568&partnerID=40&md5=54af07dedcb1a5d80bfce0d34ff96c3f VL - 20 ID - 6594 ER - TY - JOUR AD - C.-X. Dong, Department of Hemangioma and Vascular Malformation Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, NO. 7 Weiwu Road, Zhengzhou, China AU - Li, M. M. AU - Dong, C. X. AU - Sun, B. AU - Lei, H. Z. AU - Wang, Y. L. AU - Gong, Y. B. AU - Sun, L. L. AU - Sun, Z. W. DB - Embase Medline DO - 10.1016/j.lfs.2019.116946 LA - English M3 - Article N1 - L2003715473 2019-11-13 2019-11-18 PY - 2019 SN - 1879-0631 0024-3205 ST - LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway T2 - Life Sciences TI - LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003715473&from=exporthttp://dx.doi.org/10.1016/j.lfs.2019.116946 VL - 239 ID - 6595 ER - TY - JOUR AD - Saint-Antoine Research Center, INSERM UMRS_938, Paris, France; Sorbonne Université, Paris, France. Saint-Antoine Research Center, INSERM UMRS_938, Paris, France; Université Paris-Descartes, Paris, France; AP-HP, Hôpital Cochin, Department of Dermatology, Paris, France. Université Paris-Descartes, Paris, France; AP-HP, Hôpital Necker-Enfants-Malades, Department of Maxillofacial and Plastic Surgery, Paris, France. AN - 31059696 AU - Rouillé, T. AU - Aractingi, S. AU - Kadlub, N. AU - Fraitag, S. AU - How-Kit, A. AU - Daunay, A. AU - Hivelin, M. AU - Moguelet, P. AU - Picard, A. AU - Fontaine, R. H. AU - Guégan, S. DA - Sep DO - 10.1016/j.jid.2019.03.1156 10.1016/j.jid.2019.03.1156. Epub 2019 May 3. DP - Nlm ET - 2019/05/07 IS - 9 LA - eng PY - 2019 SN - 0022-202x SP - 2004-2015.e13 ST - Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi T2 - J Invest Dermatol TI - Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi VL - 139 ID - 6596 ER - TY - JOUR AD - G.-B. Sun, Endoscopy Center, Tianjin Fifth Central Hospital, Tianjin, China AU - Dou, G. X. AU - Zhang, J. N. AU - Wang, P. AU - Wa, J. L. AU - Sun, G. B. DB - Embase Medline DO - 10.12659/MSM.914248 LA - English M3 - Article N1 - L2001833947 2019-05-14 2019-09-04 PY - 2019 SN - 1643-3750 1234-1010 SP - 2141-2150 ST - Long intergenic non-protein-coding RNA 01138 accelerates tumor growth and invasion in gastric cancer by regulating miR-1273e T2 - Medical Science Monitor TI - Long intergenic non-protein-coding RNA 01138 accelerates tumor growth and invasion in gastric cancer by regulating miR-1273e UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001833947&from=exporthttp://dx.doi.org/10.12659/MSM.914248 VL - 25 ID - 6597 ER - TY - JOUR AD - R. Jiang, Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China AU - Zhao, J. AU - Zhang, C. AU - Gao, Z. AU - Wu, H. AU - Gu, R. AU - Jiang, R. DB - Embase Medline DO - 10.1002/jcb.26671 IS - 8 LA - English M3 - Article N1 - L622321872 2018-05-31 2018-07-09 PY - 2018 SN - 1097-4644 0730-2312 SP - 6461-6469 ST - Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21 T2 - Journal of Cellular Biochemistry TI - Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622321872&from=exporthttp://dx.doi.org/10.1002/jcb.26671 VL - 119 ID - 6598 ER - TY - JOUR AD - P.-Y. Li, Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Wang, M. R. AU - Fang, D. AU - Di, M. P. AU - Guan, J. L. AU - Wang, G. AU - Liu, L. AU - Sheng, J. Q. AU - Tian, D. A. AU - Li, P. Y. DB - Embase Medline DO - 10.7150/ijms.45256 IS - 9 LA - English M3 - Article N1 - L2004579292 2020-08-07 2020-09-07 PY - 2020 SN - 1449-1907 SP - 1224-1234 ST - Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway T2 - International Journal of Medical Sciences TI - Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004579292&from=exporthttp://dx.doi.org/10.7150/ijms.45256 VL - 17 ID - 6599 ER - TY - JOUR AD - Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China Department of Orthopaedic, First Affiliated Hospital, School of Medicine, Shihezi University, ShiHeZi, Xinjiang, China AU - Ruan, Z. AU - Ma, H. AU - Li, J. AU - Liu, H. AU - Jia, H. AU - Li, F. DB - Scopus DO - 10.1177/1535370218760774 IS - 7 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 595-600 ST - The long non-coding RNA NEAT1 contributes to extracellular matrix degradation in degenerative human nucleus pulposus cells T2 - Experimental Biology and Medicine TI - The long non-coding RNA NEAT1 contributes to extracellular matrix degradation in degenerative human nucleus pulposus cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045075322&doi=10.1177%2f1535370218760774&partnerID=40&md5=eb8d590c4465d746d890495c5e73b10d VL - 243 ID - 6600 ER - TY - JOUR AD - D. Deng, Department of Hematology, Kaifeng Children’s Hospital, Kaifeng, Henan, China AU - Deng, D. AU - Yang, S. AU - Wang, X. DB - Embase Medline DO - 10.1042/BSR20200723 IS - 5 LA - English M3 - Article N1 - L2006048610 2020-06-11 2020-06-16 PY - 2020 SN - 1573-4935 0144-8463 ST - Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells T2 - Bioscience Reports TI - Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006048610&from=exporthttp://dx.doi.org/10.1042/BSR20200723 VL - 40 ID - 6601 ER - TY - JOUR AD - C. Luo, Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Chongqing Medical University, Chongqing, China X. Wu, Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China AU - Li, T. AU - Liu, N. AU - Gao, Y. AU - Quan, Z. AU - Hao, Y. AU - Yu, C. AU - Li, L. AU - Yuan, M. AU - Niu, L. AU - Luo, C. AU - Wu, X. DB - Embase Medline DO - 10.1038/s41416-020-01091-1 LA - English M3 - Article in Press N1 - L2006887774 2020-10-13 PY - 2020 SN - 1532-1827 0007-0920 ST - Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM T2 - British Journal of Cancer TI - Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006887774&from=exporthttp://dx.doi.org/10.1038/s41416-020-01091-1 ID - 6602 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China AU - Li, Z. AU - Yang, L. AU - Liu, X. AU - Nie, Z. AU - Luo, J. DB - Scopus DO - 10.1016/j.biopha.2018.05.047 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2018 SP - 181-192 ST - Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21 T2 - Biomedicine and Pharmacotherapy TI - Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047065941&doi=10.1016%2fj.biopha.2018.05.047&partnerID=40&md5=df3cca7842a963315df99002d334930c VL - 104 ID - 6603 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Princess Margaret Hospital, Toronto, ON, Canada Seoul St. Mary's Hospital, Seoul, South Korea Department of Internal Medicine II, Hubertus Wald Tumor Center, University Cancer Center Hamburg, Hamburg, Germany Pfizer Inc, New York, NY, United States Pfizer Inc, Cambridge, MA, United States Pfizer Inc, Groton, CT, United States Universitätsklinikum RWTH Aachen, Aachen, Germany University of Milano-Bicocca, Monza, Italy AU - Cortes, J. E. AU - Khoury, H. J. AU - Kantarjian, H. M. AU - Lipton, J. H. AU - Kim, D. W. AU - Schafhausen, P. AU - Matczak, E. AU - Leip, E. AU - Noonan, K. AU - Brümmendorf, T. H. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1002/ajh.24536 IS - 12 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2016 SP - 1206-1214 ST - Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib T2 - American Journal of Hematology TI - Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84993972082&doi=10.1002%2fajh.24536&partnerID=40&md5=5c8af8002dcfdf8a22cd170e6da263d3 VL - 91 ID - 6604 ER - TY - JOUR AD - University of Milano Bicocca, San Gerardo Hospital, Monza, Italy. St Petersburg Medical University, St Petersburg, Russia. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong, China. Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada. Department of Medical Oncology, Sun-Yat Sen University Cancer Center, Guangdong, China. National Kyushu Cancer Center, Fukuoka, Japan. National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Highlands Oncology Group, Fayetteville, Arkansas. Cancer Institute of Greenville Health System, Greenville, South Carolina. Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Oregon Health & Science University, Portland, Oregon. National Cancer Center Hospital, Tokyo, Japan. Washington University School of Medicine, St. Louis, Missouri. National Taiwan University Hospital, Taipei, Taiwan. Pfizer Oncology, Milan, Italy. Pfizer Oncology, La Jolla, California. Seoul National University Hospital, Seoul, South Korea. AN - 29352732 AU - Gambacorti-Passerini, C. AU - Orlov, S. AU - Zhang, L. AU - Braiteh, F. AU - Huang, H. AU - Esaki, T. AU - Horibe, K. AU - Ahn, J. S. AU - Beck, J. T. AU - Edenfield, W. J. AU - Shi, Y. AU - Taylor, M. AU - Tamura, K. AU - Van Tine, B. A. AU - Wu, S. J. AU - Paolini, J. AU - Selaru, P. AU - Kim, T. M. C2 - PMC5947833 DA - May DO - 10.1002/ajh.25043 10.1002/ajh.25043. Epub 2018 Feb 8. DP - Nlm ET - 2018/01/21 IS - 5 LA - eng PY - 2018 SN - 0361-8609 (Print) 0361-8609 SP - 607-614 ST - Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study T2 - Am J Hematol TI - Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study VL - 93 ID - 6605 ER - TY - JOUR AD - Department of Internal Medicine, University of Milano-Bicocca, Monza, Italy Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Seoul St. Mary's Hospital, Seoul, South Korea Division of Hematology, Winship Cancer Institute of Emory University, Atlanta, GA, United States Hematology Research Center, Moscow, Russian Federation Clinic for Oncology, Hematology, and Stem Cell Transplantation, Universitätsklinikum Aachen, RWTH Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Pfizer, New York, NY, United States Pfizer Global Research and Development, Paris, France Pfizer, Cambridge, MA, United States AU - Gambacorti-Passerini, C. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Khoury, H. J. AU - Turkina, A. G. AU - Brümmendorf, T. H. AU - Matczak, E. AU - Bardy-Bouxin, N. AU - Shapiro, M. AU - Turnbull, K. AU - Leip, E. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.24034 IS - 9 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2015 SP - 755-768 ST - Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939565243&doi=10.1002%2fajh.24034&partnerID=40&md5=c6f1bc57ee47941fc925566d2d76f5a2 VL - 90 ID - 6606 ER - TY - JOUR AD - F. Farina, School of Medicine, Milano Bicocca University, Italy AU - Farina, F. AU - Ceccon, M. AU - Mori, S. AU - Verga, L. AU - Borin, L. M. AU - Mologni, L. AU - Fontana, D. AU - Geeta, G. AU - Piazza, R. AU - Gambacorti-Passerini, C. DB - Embase LA - English M3 - Conference Abstract N1 - L617378980 2017-07-24 PY - 2017 SN - 1592-8721 SP - 221-222 ST - Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: Clinical and biological correlates T2 - Haematologica TI - Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: Clinical and biological correlates UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378980&from=export VL - 102 ID - 6607 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States Winship Cancer Institute of Emory University, Atlanta, GA, United States Universitätsklinikum RWTH Aachen, Aachen, Germany Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Memorial Sloan Kettering Cancer Center, New York, NY, United States Pfizer Inc, New York, NY, United States Pfizer Inc, Groton, CT, United States Pfizer Inc, Cambridge, MA, United States Princess Margaret Cancer Center, Toronto, ON, Canada University of Milano-Bicocca, Monza, Italy AU - Cortes, J. E. AU - Jean Khoury, H. AU - Kantarjian, H. AU - Brümmendorf, T. H. AU - Mauro, M. J. AU - Matczak, E. AU - Pavlov, D. AU - Aguiar, J. M. AU - Fly, K. D. AU - Dimitrov, S. AU - Leip, E. AU - Shapiro, M. AU - Lipton, J. H. AU - Durand, J. B. AU - Gambacorti-Passerini, C. DB - Scopus DO - 10.1002/ajh.24360 IS - 6 M3 - Article N1 - Cited By :33 Export Date: 18 November 2020 PY - 2016 SP - 606-616 ST - Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib T2 - American Journal of Hematology TI - Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963900816&doi=10.1002%2fajh.24360&partnerID=40&md5=0252f17a95e9ee5437cb3f64ac0b3e21 VL - 91 ID - 6608 ER - TY - JOUR AD - Pediatric Hematology and Oncology, University Children's Hospital Carl Gustav Carus, Fetscherstrasse 74, 01307 Dresden, Germany Institute for Medical Informatics and Biometry, Medical Faculty Carl Gustav Carus, Dresden, Germany Experimental Center, Medical Faculty Carl Gustav Carus, Technical University, Dresden, Germany AU - Tauer, J. T. AU - Ulmer, A. AU - Glauche, I. AU - Jung, R. AU - Suttorp, M. DB - Scopus DO - 10.1055/s-0034-1372643 IS - 3 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 169-174 ST - Long-term imatinib treatment does not cause testicular toxicity in male adolescents with chronic myeloid leukemia and in a juvenile rat model T2 - Klinische Padiatrie TI - Long-term imatinib treatment does not cause testicular toxicity in male adolescents with chronic myeloid leukemia and in a juvenile rat model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900539712&doi=10.1055%2fs-0034-1372643&partnerID=40&md5=0364183c72fef4834788a40ca65098dc VL - 226 ID - 6609 ER - TY - JOUR AD - Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Medical Oncology, University of Texas, Southwestern Dallas, TX, United States Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Jain, P. AU - Kantarjian, H. AU - Alattar, M. L. AU - Jabbour, E. AU - Sasaki, K. AU - Gonzalez, G. N. AU - Dellasala, S. AU - Pierce, S. AU - Verstovsek, S. AU - Wierda, W. AU - Borthakur, G. AU - Ravandi, F. AU - O'Brien, S. AU - Cortes, J. DB - Scopus DO - 10.1016/S2352-3026(15)00021-6 IS - 3 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2015 SP - e118-e128 ST - Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: Retrospective analysis of patient data from five clinical trials T2 - The Lancet Haematology TI - Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: Retrospective analysis of patient data from five clinical trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940550022&doi=10.1016%2fS2352-3026%2815%2900021-6&partnerID=40&md5=757a7d5d39ccb7219fdcddfae0ba8ed9 VL - 2 ID - 6610 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 428, Houston, TX 77030, United States Department of Hematopathology, University of Texas, M. D. Anderson Cancer Center, Houston, TX, United States AU - Jabbour, E. AU - Jones, D. AU - Kantarjian, H. M. AU - O'Brien, S. AU - Tam, C. AU - Koller, C. AU - Burger, J. A. AU - Borthakur, G. AU - Wierda, W. G. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2009-01-197715 IS - 10 M3 - Article N1 - Cited By :96 Export Date: 18 November 2020 PY - 2009 SP - 2037-2043 ST - Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations T2 - Blood TI - Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349245253&doi=10.1182%2fblood-2009-01-197715&partnerID=40&md5=b61a92006467e262a2c95d3a15421aac VL - 114 ID - 6611 ER - TY - JOUR AD - Georgina V. Long, University of Sydney, and Royal North Shore Hospital; Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales; Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia; Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL; Jeffrey Infante, Tennessee Oncology; Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Adil Daud, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, University of Colorado, Denver, CO; Lynn Schuchter, University of Pennsylvania, Philadelphia, PA; William Sharfman, Sidney Kimmel Cancer Center, Baltimore, MD; Robert McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University, New Haven, CT; Suman Redhu, Eduard Gasal, and Bijoyesh Mookerjee, Novartis, East Hanover, NJ; Jeffrey Weber, New York University Langone Medical Center, New York, NY; and Keith T. Flaherty, Dana-Farber/Harvard Cancer Center, Boston, MA. AN - 28991513 AU - Long, G. V. AU - Eroglu, Z. AU - Infante, J. AU - Patel, S. AU - Daud, A. AU - Johnson, D. B. AU - Gonzalez, R. AU - Kefford, R. AU - Hamid, O. AU - Schuchter, L. AU - Cebon, J. AU - Sharfman, W. AU - McWilliams, R. AU - Sznol, M. AU - Redhu, S. AU - Gasal, E. AU - Mookerjee, B. AU - Weber, J. AU - Flaherty, K. T. DA - Mar 1 DO - 10.1200/jco.2017.74.1025 10.1200/JCO.2017.74.1025. Epub 2017 Oct 9. DP - Nlm ET - 2017/10/11 IS - 7 LA - eng PY - 2018 SN - 0732-183x SP - 667-673 ST - Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib T2 - J Clin Oncol TI - Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib VL - 36 ID - 6612 ER - TY - JOUR AD - MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China Molecular Diagnostic Laboratory, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China AU - Qu, S. Q. AU - Qin, T. J. AU - Xu, Z. F. AU - Zhang, Y. AU - Ai, X. F. AU - Li, B. AU - Zhang, H. L. AU - Fang, L. W. AU - Pan, L. J. Li-Juan AU - Hu, N. B. AU - Xiao, Z. J. DB - Scopus DO - 10.18632/oncotarget.8906 IS - 22 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 33229-33236 ST - Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: Experience of a single center in China T2 - Oncotarget TI - Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: Experience of a single center in China UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973569095&doi=10.18632%2foncotarget.8906&partnerID=40&md5=e4c9418b8795ce211c1c30f06f62ed99 VL - 7 ID - 6613 ER - TY - JOUR AD - Department of Leukemia, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Santos, F. P. S. AU - Alvarado, Y. AU - Kantarjian, H. AU - Verma, D. AU - O'Brien, S. AU - Mattiuzzi, G. AU - Ravandi, F. AU - Borthakur, G. AU - Cortes, J. DB - Scopus DO - 10.1002/cncr.25533 IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 982-991 ST - Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib T2 - Cancer TI - Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952009886&doi=10.1002%2fcncr.25533&partnerID=40&md5=9339bd778514e14a2d272ae9e0ee099d VL - 117 ID - 6614 ER - TY - JOUR AD - Haematology, Department of Cellular Biotechnologies and Haematology, ‘Sapienza’ University, Rome, Italy Haemato-Oncology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy Clinical Experimental Haematology Unit, Gaslini Research Institute of Genoa, Genoa, Italy Paediatric Haematology Unit, Pausilipon Hospital, Naples, Italy Department of Paediatrics, Paediatric Unit ‘F. Vecchio’, University of Bari, Bari, Italy Division of Haematology, ‘Bianchi-Melacrino-Morelli’ Hospital, Reggio Calabria, Italy Department of Paediatrics, Haemato-Oncology Unit, ‘Casa Sollievo della Sofferenza’ Hospital, San Giovanni Rotondo, Italy Paediatric Haemato-Oncology Unit, Sant'Anna Hospital, Ferrara, Italy Haemato-Oncology Unit, Azienda Ospedaliera ‘Pugliese-Ciaccio’, Catanzaro, Italy Department of Paediatrics, University of Milano-Bicocca, Monza, Italy Haemato-Oncology Unit, Department of Paediatrics, University of Bologna, Bologna, Italy Department of Paediatrics, University of Pavia, Pavia, Italy Paediatric Haematology-Oncology, IRCCS Ospedale Paediatrico Bambino Gesù, Rome, Italy Biostatistics Unit, GIMEMA Foundation, Rome, Italy Department of Clinical and Biological Sciences, University of Turin at Orbassano, Turin, Italy AU - Giona, F. AU - Putti, M. C. AU - Micalizzi, C. AU - Menna, G. AU - Moleti, M. L. AU - Santoro, N. AU - Iaria, G. AU - Ladogana, S. AU - Burnelli, R. AU - Consarino, C. AU - Varotto, S. AU - Tucci, F. AU - Messina, C. AU - Nanni, M. AU - Diverio, D. AU - Biondi, A. AU - Pession, A. AU - Locatelli, F. AU - Piciocchi, A. AU - Gottardi, E. AU - Saglio, G. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.13453 IS - 3 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 SP - 398-407 ST - Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience T2 - British Journal of Haematology TI - Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942103657&doi=10.1111%2fbjh.13453&partnerID=40&md5=014838c23996a3175fda6ebcbc47dbda VL - 170 ID - 6615 ER - TY - JOUR AD - L. Crinó, Medical Oncology Unit, Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (IRST)- IRCCS, Meldola, Italy AU - Crinó, L. AU - Ahn, M. J. AU - Han, J. Y. AU - Liu, X. AU - Ou, S. H. I. AU - Shaw, A. T. AU - Yang, P. C. AU - Shi, Y. K. AU - Lanzalone, S. AU - Polli, A. AU - Wilner, K. D. AU - Kim, D. W. DB - Embase DO - 10.1093/annonc/mdy292.020 LA - English M3 - Conference Abstract N1 - L628559028 2019-07-23 PY - 2018 SN - 1569-8041 SP - viii503-viii504 ST - Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) T2 - Annals of Oncology TI - Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628559028&from=exporthttp://dx.doi.org/10.1093/annonc/mdy292.020 VL - 29 ID - 6616 ER - TY - JOUR AD - Department of Medicine III, University of Aachen, Pauwelstraße 30, Aachen 52074, Germany AU - Roderburg, C. AU - Bubenzer, J. AU - Spannbauer, M. AU - do Nicole, O. AU - Mahnken, A. AU - Luedde, T. AU - Trautwein, C. AU - Tischendorf, J. J. W. DB - Scopus DO - 10.4254/wjh.v2.i6.239 IS - 6 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2010 SP - 239-242 ST - Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib T2 - World Journal of Hepatology TI - Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871747719&doi=10.4254%2fwjh.v2.i6.239&partnerID=40&md5=39db91604657caf7bb5d20b999f5fc43 VL - 2 ID - 6617 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea AU - Kim, J. H. AU - Ryu, M. H. AU - Yoo, C. AU - Chae, H. AU - Na, H. AU - Beck, M. AU - Kim, B. S. AU - Yoo, M. W. AU - Yook, J. H. AU - Kim, B. S. AU - Kim, K. H. AU - Kim, C. W. AU - Kang, Y. K. DB - Scopus DO - 10.1002/cam4.1994 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 1034-1043 ST - Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience T2 - Cancer Medicine TI - Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063410948&doi=10.1002%2fcam4.1994&partnerID=40&md5=96ed7fdc2e32299c13c04a7e3184e8bd VL - 8 ID - 6618 ER - TY - JOUR AD - Department of Human and Hereditary Pathology, Institute of Dermatology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Institute of Hematology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Department of Pediatrics, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy Department of Health Sciences, Section of Medical Statistics and Epidemiology, University of Pavia, Piazza C. Golgi 2, 27100 Pavia, Italy AU - Brazzelli, V. AU - Prestinari, F. AU - Barbagallo, T. AU - Rona, C. AU - Orlandi, E. AU - Passamonti, F. AU - Locatelli, F. AU - Zecca, M. AU - Villani, S. AU - Borroni, G. DB - Scopus DO - 10.1111/j.1468-3083.2006.01981.x IS - 3 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2007 SP - 384-387 ST - A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: A study of five patients T2 - Journal of the European Academy of Dermatology and Venereology TI - A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: A study of five patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847005917&doi=10.1111%2fj.1468-3083.2006.01981.x&partnerID=40&md5=03271a1ef24270714d5cb00ce101f133 VL - 21 ID - 6619 ER - TY - JOUR AD - Ontologie, Hämatologie und Palliativmedizin, Marienhospital, Stuttgart, Germany Department of Internal Medicine III, Marienhospital, Boeheimstr. 37, 70199 Stuttgart, Germany AU - Hass, H. G. AU - Denzlinger, C. DB - Scopus DO - 10.1055/s-2008-1027482 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2009 SP - 27-29 ST - Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva®) - A case report T2 - Zeitschrift fur Gastroenterologie TI - Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva®) - A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59849096953&doi=10.1055%2fs-2008-1027482&partnerID=40&md5=6de75643b37251b57f076ec579a2f38b VL - 47 ID - 6620 ER - TY - JOUR AD - Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Department of Surgery, Kochi Medical School, Kochi, Japan Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan AU - Kakoki, K. AU - Miyata, Y. AU - Mochizuki, Y. AU - Iwata, T. AU - Obatake, M. AU - Abe, K. AU - Nagayasu, T. AU - Sakai, H. DB - Scopus DO - 10.1016/j.clgc.2016.12.026 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2017 SP - e503-e506 ST - Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature T2 - Clinical Genitourinary Cancer TI - Long-term Treatment With Sequential Molecular Targeted Therapy for Xp11.2 Translocation Renal Cell Carcinoma: A Case Report and Review of the Literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012904204&doi=10.1016%2fj.clgc.2016.12.026&partnerID=40&md5=72b530566a1828de613f28d67c11c8bf VL - 15 ID - 6621 ER - TY - JOUR AD - Massachusetts General Hospital, Boston, MA, United States Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy Memorial Sloan Kettering Cancer Center, New York, NY, United States Gustave Roussy Cancer Campus, Villejuif, France Department of Cancer Medicine, Paris-Sud University, Orsay, France National University Cancer Institute, Singapore, Singapore Chris O'Brien Lifehouse, Camperdown, NSW, Australia National Taiwan University Hospital, Taipei, Taiwan Sarah Cannon Cancer Research Institute and Tennessee Oncology, PLLC, Nashville, TN, United States Pfizer Global Product Development-Oncology, Cambridge, MA, United States Pfizer Global Product Development-Oncology, La Jolla, CA, United States Pfizer Oncology, Groton, CT, United States Pfizer Global Product Development-Oncology, Milan, Italy University of California Irvine, Irvine, CA, United States AU - Shaw, A. T. AU - Solomon, B. J. AU - Chiari, R. AU - Riely, G. J. AU - Besse, B. AU - Soo, R. A. AU - Kao, S. AU - Lin, C. C. AU - Bauer, T. M. AU - Clancy, J. S. AU - Thurm, H. AU - Martini, J. F. AU - Peltz, G. AU - Abbattista, A. AU - Li, S. AU - Ou, S. H. I. DB - Scopus DO - 10.1016/S1470-2045(19)30655-2 IS - 12 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2019 SP - 1691-1701 ST - Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial T2 - The Lancet Oncology TI - Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075141426&doi=10.1016%2fS1470-2045%2819%2930655-2&partnerID=40&md5=85de2eb31eb7479e8444b84816f3561f VL - 20 ID - 6622 ER - TY - JOUR AD - Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand. dru@adis.com. AN - 30604291 AU - Syed, Y. Y. DA - Jan DO - 10.1007/s40265-018-1041-0 10.1007/s40265-018-1041-0. DP - Nlm ET - 2019/01/04 IS - 1 LA - eng PY - 2019 SN - 0012-6667 SP - 93-98 ST - Lorlatinib: First Global Approval T2 - Drugs TI - Lorlatinib: First Global Approval VL - 79 ID - 6623 ER - TY - JOUR AD - D.H. Teitelbaum, Section of Pediatric Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States AU - Feng, Y. AU - Tsai, Y. H. AU - Xiao, W. AU - Ralls, M. W. AU - Stoeck, A. AU - Wilson, C. L. AU - Raines, E. W. AU - Teitelbaum, D. H. AU - Dempsey, P. J. DB - Embase Medline DO - 10.1128/MCB.00143-15 IS - 21 LA - English M3 - Article N1 - L606538719 2015-10-28 2015-10-30 PY - 2015 SN - 1098-5549 0270-7306 SP - 3604-3621 ST - Loss of ADAM17-mediated tumor necrosis factor alpha signaling in intestinal cells attenuates mucosal atrophy in a mouse model of parenteral nutrition T2 - Molecular and Cellular Biology TI - Loss of ADAM17-mediated tumor necrosis factor alpha signaling in intestinal cells attenuates mucosal atrophy in a mouse model of parenteral nutrition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606538719&from=exporthttp://dx.doi.org/10.1128/MCB.00143-15 VL - 35 ID - 6624 ER - TY - JOUR AD - F.J. Cubero, Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany AU - Cubero, F. J. AU - Mohamed, M. R. AU - Woitok, M. M. AU - Zhao, G. AU - Hatting, M. AU - Nevzorova, Y. A. AU - Chen, C. AU - Haybaeck, J. AU - de Bruin, A. AU - Avila, M. A. AU - Boekschoten, M. V. AU - Davis, R. J. AU - Trautwein, C. DB - Embase DO - 10.1002/hep4.1495 IS - 6 LA - English M3 - Article N1 - L2004655408 2020-04-24 2020-06-12 PY - 2020 SN - 2471-254X SP - 834-851 ST - Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma T2 - Hepatology Communications TI - Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004655408&from=exporthttp://dx.doi.org/10.1002/hep4.1495 VL - 4 ID - 6625 ER - TY - JOUR AD - Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006; HistoPath Pathology, North Ryde, NSW, Australia 2113. Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia 2065; Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards NSW, Australia 2065; Sydney Medical School, University of Sydney, NSW, Australia 2006. Electronic address: affgill@med.usyd.edu.au. AN - 27184481 AU - Wang, J. AU - Andrici, J. AU - Sioson, L. AU - Clarkson, A. AU - Sheen, A. AU - Farzin, M. AU - Toon, C. W. AU - Turchini, J. AU - Gill, A. J. DA - Sep DO - 10.1016/j.humpath.2016.04.018 10.1016/j.humpath.2016.04.018. Epub 2016 May 14. DP - Nlm ET - 2016/05/18 LA - eng PY - 2016 SN - 0046-8177 SP - 83-90 ST - Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency T2 - Hum Pathol TI - Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency VL - 55 ID - 6626 ER - TY - JOUR AD - D.B. Solit, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States AU - Nissan, M. H. AU - Pratilas, C. A. AU - Jones, A. M. AU - Ramirez, R. AU - Won, H. AU - Liu, C. AU - Tiwari, S. AU - Kong, L. AU - Hanrahan, A. J. AU - Yao, Z. AU - Merghoub, T. AU - Ribas, A. AU - Chapman, P. B. AU - Yaeger, R. AU - Taylor, B. S. AU - Schultz, N. AU - Berger, M. F. AU - Rosen, N. AU - Solit, D. B. C1 - azd 6244 mek 162 pd 0325901 DB - Embase Medline DO - 10.1158/0008-5472.CAN-13-2625 IS - 8 LA - English M3 - Article N1 - L372973668 2014-05-09 2014-05-14 PY - 2014 SN - 1538-7445 0008-5472 SP - 2340-2350 ST - Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence T2 - Cancer Research TI - Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372973668&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-13-2625 VL - 74 ID - 6627 ER - TY - JOUR AD - S. Murase, Laboratory of Molecular Biology, National Institute of Neurological Disorder and Stroke, Bethesda, MD 20892, United States AU - Murase, S. AU - Kim, E. AU - Lin, L. AU - Hoffman, D. A. AU - McKay, R. D. DB - Embase Medline DO - 10.1523/JNEUROSCI.2940-12.2012 IS - 44 LA - English M3 - Article N1 - L365951217 2012-11-07 2012-11-13 PY - 2012 SN - 0270-6474 1529-2401 SP - 15511-15520 ST - Loss of signal transducer and activator of transcription 3 (STAT3) signaling during elevated activity causes vulnerability in hippocampal neurons T2 - Journal of Neuroscience TI - Loss of signal transducer and activator of transcription 3 (STAT3) signaling during elevated activity causes vulnerability in hippocampal neurons UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365951217&from=exporthttp://dx.doi.org/10.1523/JNEUROSCI.2940-12.2012http://www.jneurosci.org/content/32/44/15511.full.pdf+html VL - 32 ID - 6628 ER - TY - JOUR AD - Section of Endocrinology and Metabolism, University of Illinois College of Medicine, Chicago, Illinois 60612, USA. bcollins@uic.edu AN - 16487015 AU - Collins, B. J. AU - Schneider, A. B. AU - Prinz, R. A. AU - Xu, X. DA - Jan DO - 10.1089/thy.2006.16.61 10.1089/thy.2006.16.61. DP - Nlm ET - 2006/02/21 IS - 1 LA - eng PY - 2006 SN - 1050-7256 (Print) 1050-7256 SP - 61-6 ST - Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure T2 - Thyroid TI - Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure VL - 16 ID - 6629 ER - TY - JOUR AD - X.-C. Zhang, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China AU - Yin, K. AU - Feng, H. B. AU - Li, L. L. AU - Chen, Y. AU - Xie, Z. AU - Lv, Z. Y. AU - Guo, W. B. AU - Lu, D. X. AU - Yang, X. N. AU - Yan, W. Q. AU - Wu, Y. L. AU - Zhang, X. C. DB - Embase Medline DO - 10.1111/1759-7714.13271 IS - 2 LA - English M3 - Article N1 - L2003823817 2019-12-17 2020-02-24 PY - 2020 SN - 1759-7714 1759-7706 SP - 346-352 ST - Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma T2 - Thoracic Cancer TI - Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003823817&from=exporthttp://dx.doi.org/10.1111/1759-7714.13271 VL - 11 ID - 6630 ER - TY - JOUR AD - Divisions of Hospital Medicine Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, FL, Miami, United States AU - Florindez, J. AU - Trent, J. DB - Scopus DO - 10.1097/COC.0000000000000659 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 270-278 ST - Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients T2 - American journal of clinical oncology TI - Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082561193&doi=10.1097%2fCOC.0000000000000659&partnerID=40&md5=3c60f8cfaa50fb56dd556aa06ad6a686 VL - 43 ID - 6631 ER - TY - JOUR AD - S.M. Fransson, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden AU - Fransson, S. M. AU - Javanmardi, N. AU - Sjoberg, R. M. AU - Kogner, P. AU - Martinsson, T. DB - Embase DO - 10.1158/1538-7445.AM2017-4876 IS - 13 LA - English M3 - Conference Abstract N1 - L618567217 2017-10-10 PY - 2017 SN - 1538-7445 ST - Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment T2 - Cancer Research TI - Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618567217&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2017-4876 VL - 77 ID - 6632 ER - TY - JOUR AD - S. Hederova, Department of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava, Slovakia AU - Hederova, S. AU - Mocna, A. AU - Husakova, K. AU - Kaiserova, E. AU - Makohusova, M. AU - Jakešova, S. AU - Rychly, B. AU - Kolenova, A. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098250 2018-07-25 PY - 2018 SN - 1523-5866 SP - i107-i108 ST - Low grade glioma, 16 years single center experience T2 - Neuro-Oncology TI - Low grade glioma, 16 years single center experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098250&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 6633 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, University of Cincinnati, 231 Albert Sabin Way, P.O. Box 670529, Cincinnati, OH 45267 0529, USA. yuri.nikiforov@uc.edu AN - 15145515 AU - Nikiforova, M. N. AU - Ciampi, R. AU - Salvatore, G. AU - Santoro, M. AU - Gandhi, M. AU - Knauf, J. A. AU - Thomas, G. A. AU - Jeremiah, S. AU - Bogdanova, T. I. AU - Tronko, M. D. AU - Fagin, J. A. AU - Nikiforov, Y. E. DA - Jun 8 DO - 10.1016/j.canlet.2003.12.004 10.1016/j.canlet.2003.12.004. DP - Nlm ET - 2004/05/18 IS - 1 LA - eng PY - 2004 SN - 0304-3835 (Print) 0304-3835 SP - 1-6 ST - Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas T2 - Cancer Lett TI - Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas VL - 209 ID - 6634 ER - TY - JOUR AD - Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, NSW, Australia. james_indsto@wmi.usyd.edu.au AN - 17518771 AU - Indsto, J. O. AU - Kumar, S. AU - Wang, L. AU - Crotty, K. A. AU - Arbuckle, S. M. AU - Mann, G. J. DA - Jun DO - 10.1111/j.1600-0560.2006.00646.x 10.1111/j.1600-0560.2006.00646.x. DP - Nlm ET - 2007/05/24 IS - 6 LA - eng PY - 2007 SN - 0303-6987 (Print) 0303-6987 SP - 448-55 ST - Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions T2 - J Cutan Pathol TI - Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions VL - 34 ID - 6635 ER - TY - JOUR AD - Division of Metabolism, Chang Gung Memorial Hospital, Kaohsiung, Taiwan, ROC. AN - 15876154 AU - Liu, R. T. AU - Chou, F. F. AU - Wang, C. H. AU - Lin, C. L. AU - Chao, F. P. AU - Chung, J. C. AU - Huang, C. C. AU - Wang, P. W. AU - Cheng, J. T. DA - Apr DO - 10.1089/thy.2005.15.326 10.1089/thy.2005.15.326. DP - Nlm ET - 2005/05/07 IS - 4 LA - eng PY - 2005 SN - 1050-7256 (Print) 1050-7256 SP - 326-35 ST - Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese T2 - Thyroid TI - Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese VL - 15 ID - 6636 ER - TY - JOUR AD - Y. Zhang, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China AU - Gao, H. AU - Wang, F. AU - Lan, X. AU - Li, C. AU - Feng, J. AU - Bai, J. AU - Cao, L. AU - Gui, S. AU - Hong, L. AU - Zhang, Y. DB - Embase Medline DO - 10.1186/s12885-015-1267-0 IS - 1 LA - English M3 - Article N1 - L603887617 2015-04-30 2015-05-01 PY - 2015 SN - 1471-2407 ST - Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas T2 - BMC Cancer TI - Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603887617&from=exporthttp://dx.doi.org/10.1186/s12885-015-1267-0 VL - 15 ID - 6637 ER - TY - JOUR AD - Servicio de Hematología, Hospital Universitario 'Dr. José Eleuterio González', UANL, Mexico Departamento de Bioquímica y Medicina Molecular, UANL, Mexico AU - Gutierrez-Aguirre, C. H. AU - Garcia-Rodriguez, F. AU - Ortiz-Galvez, V. M. AU - Cantu-Rodriguez, O. G. AU - Salazar-Riojas, R. AU - Martinez-Gonzalez, O. L. AU - Gonzalez-Llano, O. AU - Jaime-Pérez, J. C. AU - Ortiz-Lopez, R. AU - Flores-Jimenez, J. A. AU - Alatorre-Ricardo, J. AU - Mancias-Guerra, C. AU - Gomez-Almaguer, D. DB - Scopus DO - 10.1179/1607845412Y.0000000069 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - 224-229 ST - Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia T2 - Hematology TI - Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880008373&doi=10.1179%2f1607845412Y.0000000069&partnerID=40&md5=6a0c61cb7035f7f8d024aad7d7b5e1e9 VL - 18 ID - 6638 ER - TY - JOUR AD - R. A. Gottlieb, Bioscience Center, San Diego State Univ., 5500 Campanile Dr., San Diego, CA 92182-4650 AU - Yuan, H. AU - Perry, C. N. AU - Huang, C. AU - Iwai-Kanai, E. AU - Carreira, R. S. AU - Glembotski, C. C. AU - Gottlieb, R. A. DB - Embase Medline DO - 10.1152/ajpheart.01051.2008 IS - 2 LA - English M3 - Article N1 - L354657598 2009-06-16 PY - 2009 SN - 0363-6135 1522-1539 SP - H470-H479 ST - LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection T2 - American Journal of Physiology - Heart and Circulatory Physiology TI - LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354657598&from=exporthttp://dx.doi.org/10.1152/ajpheart.01051.2008http://ajpheart.physiology.org/cgi/reprint/296/2/H470 VL - 296 ID - 6639 ER - TY - JOUR AD - Department of Otolaryngology Head and Neck Surgery, Guangxi Medical University, Nanning, Guangxi 530007, China Department of Otolaryngology Head and Neck Surgery, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi 530021, China AU - Ban, Z. AU - He, J. AU - Tang, Z. AU - Zhang, L. AU - Xu, Z. DB - Scopus DO - 10.3892/or.2019.7123 IS - 6 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 3270-3280 ST - LRG‑1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial‑mesenchymal transition by activating MAPK/p38 signaling T2 - Oncology Reports TI - LRG‑1 enhances the migration of thyroid carcinoma cells through promotion of the epithelial‑mesenchymal transition by activating MAPK/p38 signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064427361&doi=10.3892%2for.2019.7123&partnerID=40&md5=53ce0c2e38e0c2341c77b514dbf79264 VL - 41 ID - 6640 ER - TY - JOUR AD - R. Zhang, Department of Obstetrics and Gynecology, Fengxian Hospital, Southern Medical University, Shanghai, PR, China AU - Ren, Y. AU - Lu, H. AU - Zhao, D. AU - Ou, Y. AU - Yu, K. AU - Gu, J. AU - Wang, L. AU - Jiang, S. AU - Chen, M. AU - Wang, J. AU - Zhang, R. AU - Xu, C. DB - Embase IS - 6 LA - English M3 - Article N1 - L605711048 2015-08-26 2015-08-28 PY - 2015 SN - 1943-8141 SP - 1095-1105 ST - LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma T2 - American Journal of Translational Research TI - LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605711048&from=export VL - 7 ID - 6641 ER - TY - JOUR AD - C. Bellido, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, Avenida de Córdoba s/n, Madrid, Spain AU - Bellido, C. AU - Barbero, P. AU - Forcén, L. AU - Blanco, M. AU - Alonso-Riaño, M. AU - Galindo, A. DB - Embase Medline DO - 10.1080/14767058.2018.1461830 IS - 19 LA - English M3 - Article N1 - L621755815 2018-04-25 2019-07-19 PY - 2019 SN - 1476-4954 1476-7058 SP - 3300-3302 ST - Lung adenocarcinoma during pregnancy: clinical case and literature review T2 - Journal of Maternal-Fetal and Neonatal Medicine TI - Lung adenocarcinoma during pregnancy: clinical case and literature review UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621755815&from=exporthttp://dx.doi.org/10.1080/14767058.2018.1461830 VL - 32 ID - 6642 ER - TY - JOUR AD - G.D. Romano, Oncology Unit, Vito Fazzi Hospital, Italy AU - Romano, G. D. AU - Cocciolo, A. AU - Vasta, I. AU - Gnoni, A. AU - Licchetta, A. AU - Nuzzo, C. AU - Cairo, G. AU - Saracino, V. AU - Tornesello, A. DB - Embase DO - 10.1097/01.JTO.0000438438.14562.c8 LA - English M3 - Conference Abstract N1 - L71397894 2014-04-08 PY - 2013 SN - 1556-0864 SP - S1298-S1299 ST - Lung adenocarcinoma with EML4-ALK traslocation and ovarian teratoma in a 20-year-old woman. A case report T2 - Journal of Thoracic Oncology TI - Lung adenocarcinoma with EML4-ALK traslocation and ovarian teratoma in a 20-year-old woman. A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71397894&from=exporthttp://dx.doi.org/10.1097/01.JTO.0000438438.14562.c8 VL - 8 ID - 6643 ER - TY - JOUR AD - Pulmonology Department, Maltepe University Hospital, Istanbul, Turkey. nessariman@yahoo.com AN - 23254266 AU - Sarıman, N. AU - Levent, E. AU - Yener, N. A. AU - Orki, A. AU - Saygı, A. DA - Mar DO - 10.1016/j.lungcan.2012.11.014 10.1016/j.lungcan.2012.11.014. Epub 2012 Dec 14. DP - Nlm ET - 2012/12/21 IS - 3 LA - eng PY - 2013 SN - 0169-5002 SP - 321-3 ST - Lung cancer and pregnancy T2 - Lung Cancer TI - Lung cancer and pregnancy VL - 79 ID - 6644 ER - TY - JOUR AD - L. Zhang, Medical Oncoloyg Dept., Sun Yat-Sen University Cancer Center, Guangzhou, China AU - Zhang, L. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L615339319 2017-04-18 PY - 2017 SN - 1556-1380 SP - S113-S114 ST - Lung cancer in China: Challenges and perspectives T2 - Journal of Thoracic Oncology TI - Lung cancer in China: Challenges and perspectives UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615339319&from=export VL - 12 ID - 6645 ER - TY - JOUR AD - M.S. Herridge, Toronto General Hospital, EN10-212, 200 Elizabeth Street, Toronto, ON M5G 2N2, Canada AU - Flaherty, K. R. AU - Herridge, M. S. C1 - pf 02341066(Pfizer) vx 770 C2 - Pfizer DB - Embase Medline DO - 10.1513/pats.201108-044TT IS - 5 LA - English M3 - Review N1 - L362593100 2011-09-28 2011-09-30 PY - 2011 SN - 1546-3222 1943-5665 SP - 398-403 ST - Lung cancer, sleep apnea, interventional pulmonary/pleural disease, cystic fibrosis T2 - Proceedings of the American Thoracic Society TI - Lung cancer, sleep apnea, interventional pulmonary/pleural disease, cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362593100&from=exporthttp://dx.doi.org/10.1513/pats.201108-044TThttp://pats.atsjournals.org/cgi/reprint/8/5/398 VL - 8 ID - 6646 ER - TY - JOUR AD - A.M. Andruska, Pulmonary and Critical Care, Stanford University Hospital, Stanford, CA, United States AU - Andruska, A. M. AU - Shafiq, M. AU - Ohgami, R. AU - Guo, H. H. AU - Sung, A. W. DB - Embase IS - MeetingAbstracts LA - English M3 - Conference Abstract N1 - L622965439 2018-07-16 PY - 2018 SN - 1535-4970 ST - A lung cyst in a sea of histiocytes: Systemic langerhans cell histiocytosis diagnosed via EBUS T2 - American Journal of Respiratory and Critical Care Medicine TI - A lung cyst in a sea of histiocytes: Systemic langerhans cell histiocytosis diagnosed via EBUS UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622965439&from=export VL - 197 ID - 6647 ER - TY - JOUR AD - L. Ning, Department of Orthopaedics, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, 3 East Qingchun Road, Hangzhou, China AU - Ning, L. AU - Wan, S. AU - Jie, Z. AU - Xie, Z. AU - Li, X. AU - Pan, X. AU - Wan, X. AU - Chen, W. AU - Huang, H. AU - Wang, J. AU - Qin, A. AU - Fan, S. AU - Zhao, X. C1 - lycorine(Sigma Aldrich,United States) sb 203580(Selleck,United States) C2 - Selleck(United States) Sigma Aldrich(United States) DB - Embase Medline DO - 10.1097/BRS.0000000000003217 IS - 3 LA - English M3 - Article N1 - L629219707 2019-09-10 2020-01-31 PY - 2020 SN - 1528-1159 0362-2436 SP - E126-E139 ST - Lycorine Induces Apoptosis and G1 Phase Arrest through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo T2 - Spine TI - Lycorine Induces Apoptosis and G1 Phase Arrest through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629219707&from=exporthttp://dx.doi.org/10.1097/BRS.0000000000003217 VL - 45 ID - 6648 ER - TY - JOUR AD - Department of Surgery, University of Helsinki, Helsinki University Hospital, PO Box 340, Huch, 00029, Finland Department of Pathology, Haartman Institute and HUSLab, University of Helsinki, Helsinki University Hospital, Helsinki, Finland Department of Oncology, Helsinki University Hospital, Helsinki, Finland Research Programs Unit, Translational Cancer Biology, University of Helsinki, Finland AU - Siironen, P. AU - Hagström, J. AU - Mäenpää, H. O. AU - Louhimo, J. AU - Arola, J. AU - Haglund, C. DB - Scopus DO - 10.3109/0284186X.2015.1070963 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 357-364 ST - Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma T2 - Acta Oncologica TI - Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940728332&doi=10.3109%2f0284186X.2015.1070963&partnerID=40&md5=decee2d95f97f22ec18b975825f91432 VL - 55 ID - 6649 ER - TY - JOUR AD - Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Pathology, Penn State Hershey Medical Center, Hershey, PA, 17033 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Departments of Pathology, Massachusetts General Hospital, Boston, MA, 02114 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Medical Genetics, National Taiwan University Hospital, Taipei, 100, Taiwan. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287 USA. Electronic address: mlin36@jhmi.edu. AN - 25456393 AU - Chen, G. AU - Dudley, J. AU - Tseng, L. H. AU - Smith, K. AU - Gurda, G. T. AU - Gocke, C. D. AU - Eshleman, J. R. AU - Lin, M. T. DA - Jan DO - 10.1016/j.humpath.2014.09.014 10.1016/j.humpath.2014.09.014. Epub 2014 Oct 7. DP - Nlm ET - 2014/12/03 IS - 1 LA - eng PY - 2015 SN - 0046-8177 SP - 113-9 ST - Lymph node metastases of melanoma: challenges for BRAF mutation detection T2 - Hum Pathol TI - Lymph node metastases of melanoma: challenges for BRAF mutation detection VL - 46 ID - 6650 ER - TY - JOUR AD - Department of Molecular Oncology, John Wayne Cancer Institute at Saint Johns Hospital, Santa Monica, CA 90404, USA. AN - 17060774 AU - Kim, J. AU - Giuliano, A. E. AU - Turner, R. R. AU - Gaffney, R. E. AU - Umetani, N. AU - Kitago, M. AU - Elashoff, D. AU - Hoon, D. S. C2 - PMC1856588 DA - Nov DO - 10.1097/01.sla.0000224751.80858.13 10.1097/01.sla.0000224751.80858.13. DP - Nlm ET - 2006/10/25 IS - 5 LA - eng PY - 2006 SN - 0003-4932 (Print) 0003-4932 SP - 799-804 ST - Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma T2 - Ann Surg TI - Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma VL - 244 ID - 6651 ER - TY - JOUR AD - R.J. Brown, Diabetes, Endocrinology and Obesity Branch (DEOB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Building 10/CRC, MSC 1612, 10 Center Drive, Bethesda, MD, United States AU - Brown, R. J. AU - Chan, J. L. AU - Jaffe, E. S. AU - Cochran, E. AU - Depaoli, A. M. AU - Gautier, J. F. AU - Goujard, C. AU - Vigouroux, C. AU - Gorden, P. DB - Embase Medline DO - 10.3109/10428194.2015.1040015 IS - 1 LA - English M3 - Article N1 - L607757507 2016-01-26 2016-02-01 PY - 2016 SN - 1029-2403 1042-8194 SP - 45-50 ST - Lymphoma in acquired generalized lipodystrophy T2 - Leukemia and Lymphoma TI - Lymphoma in acquired generalized lipodystrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607757507&from=exporthttp://dx.doi.org/10.3109/10428194.2015.1040015 VL - 57 ID - 6652 ER - TY - JOUR AD - Institute of Hematology, University of Perugia, Perugia, Italy. AN - 10552961 AU - Falini, B. AU - Pulford, K. AU - Pucciarini, A. AU - Carbone, A. AU - De Wolf-Peeters, C. AU - Cordell, J. AU - Fizzotti, M. AU - Santucci, A. AU - Pelicci, P. G. AU - Pileri, S. AU - Campo, E. AU - Ott, G. AU - Delsol, G. AU - Mason, D. Y. DA - Nov 15 DP - Nlm ET - 1999/11/24 IS - 10 LA - eng N1 - Falini, B Pulford, K Pucciarini, A Carbone, A De Wolf-Peeters, C Cordell, J Fizzotti, M Santucci, A Pelicci, P G Pileri, S Campo, E Ott, G Delsol, G Mason, D Y Journal Article Research Support, Non-U.S. Gov't United States Blood. 1999 Nov 15;94(10):3509-15. PY - 1999 SN - 0006-4971 (Print) 0006-4971 SP - 3509-15 ST - Lymphomas expressing ALK fusion protein(s) other than NPM-ALK T2 - Blood TI - Lymphomas expressing ALK fusion protein(s) other than NPM-ALK VL - 94 ID - 6653 ER - TY - JOUR AD - C. McKay, Department of Dermatology, Sydney Children's Hospital, Sydney, NSW, Australia AU - McKay, C. AU - Nelson, A. AU - Sugo, E. AU - Cohn, R. AU - Wargon, O. DB - Embase DO - 10.1111/ajd.12064 IS - 4 LA - English M3 - Article N1 - L52608681 2013-06-04 2014-12-01 PY - 2014 SN - 1440-0960 0004-8380 SP - e60-e64 ST - Lymphomatoid papulosis with associated cerebellar lesion of similar histology and T-cell clonality T2 - Australasian Journal of Dermatology TI - Lymphomatoid papulosis with associated cerebellar lesion of similar histology and T-cell clonality UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52608681&from=exporthttp://dx.doi.org/10.1111/ajd.12064 VL - 55 ID - 6654 ER - TY - JOUR AD - W. P. Schiemann, Case Comprehensive Cancer Center, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, United States AU - Taylor, M. A. AU - Amin, J. D. AU - Kirschmann, D. A. AU - Schiemann, W. P. DB - Embase Medline DO - 10.1593/neo.101086 IS - 5 LA - English M3 - Article N1 - L361747176 2011-05-18 2011-05-30 PY - 2011 SN - 1522-8002 1476-5586 SP - 406-418 ST - Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells T2 - Neoplasia TI - Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361747176&from=exporthttp://dx.doi.org/10.1593/neo.101086http://www.neoplasia.com/pdf/manuscript/v13i05/neo101086.pdf VL - 13 ID - 6655 ER - TY - JOUR AD - P. Li, Department of Gastric Surgery, Fujian Medical University Union Hospital, No.29 Xinquan Road, Fuzhou Fujian Province, China AU - Xie, J. W. AU - Huang, X. B. AU - Chen, Q. Y. AU - Ma, Y. B. AU - Zhao, Y. J. AU - Liu, L. C. AU - Wang, J. B. AU - Lin, J. X. AU - Lu, J. AU - Cao, L. L. AU - Lin, M. AU - Tu, R. H. AU - Zheng, C. H. AU - Huang, C. M. AU - Li, P. DB - Embase Medline DO - 10.1186/s12943-020-01223-4 IS - 1 LA - English M3 - Article N1 - L632298346 2020-08-17 2020-09-04 PY - 2020 SN - 1476-4598 ST - m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling T2 - Molecular Cancer TI - m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632298346&from=exporthttp://dx.doi.org/10.1186/s12943-020-01223-4 VL - 19 ID - 6656 ER - TY - JOUR AD - N. Takeda, Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan AU - Abe, H. AU - Takeda, N. AU - Isagawa, T. AU - Semba, H. AU - Nishimura, S. AU - Morioka, M. S. AU - Nakagama, Y. AU - Sato, T. AU - Soma, K. AU - Koyama, K. AU - Wake, M. AU - Katoh, M. AU - Asagiri, M. AU - Neugent, M. L. AU - Kim, J. W. AU - Stockmann, C. AU - Yonezawa, T. AU - Inuzuka, R. AU - Hirota, Y. AU - Maemura, K. AU - Yamashita, T. AU - Otsu, K. AU - Manabe, I. AU - Nagai, R. AU - Komuro, I. DB - Embase Medline DO - 10.1038/s41467-019-10859-w IS - 1 LA - English M3 - Article N1 - L628280196 2019-07-03 2019-07-16 PY - 2019 SN - 2041-1723 ST - Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M T2 - Nature Communications TI - Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628280196&from=exporthttp://dx.doi.org/10.1038/s41467-019-10859-w VL - 10 ID - 6657 ER - TY - JOUR AD - B.N. Porto, Laboratory of Clinical and Experimental Immunology, Infant Center, School of Medicine, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil AU - de Souza, G. F. AU - Muraro, S. P. AU - Santos, L. D. AU - Monteiro, A. P. T. AU - da Silva, A. G. AU - de Souza, A. P. D. AU - Stein, R. T. AU - Bozza, P. T. AU - Porto, B. N. DB - Embase Medline DO - 10.1007/s00011-019-01233-z LA - English M3 - Article in Press N1 - L627211626 2019-04-19 PY - 2019 SN - 1420-908X 1023-3830 ST - Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages T2 - Inflammation Research TI - Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627211626&from=exporthttp://dx.doi.org/10.1007/s00011-019-01233-z ID - 6658 ER - TY - JOUR AD - A. Guo, Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Nantong, China AU - Zhang, Y. AU - Zhou, Y. AU - Chen, S. AU - Hu, Y. AU - Zhu, Z. AU - Wang, Y. AU - Du, N. AU - Song, T. AU - Yang, Y. AU - Guo, A. AU - Wang, Y. DB - Embase Medline DO - 10.1186/s12974-019-1468-6 IS - 1 LA - English M3 - Article N1 - L627186321 2019-05-14 PY - 2019 SN - 1742-2094 ST - Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury T2 - Journal of Neuroinflammation TI - Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627186321&from=exporthttp://dx.doi.org/10.1186/s12974-019-1468-6 VL - 16 ID - 6659 ER - TY - JOUR AD - Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India Department of Radiodiagnosis, Tata Memorial Hospital, Mumbai, Maharashtra, India AU - Pandey, A. V. AU - Phillip, D. S. AU - Noronha, V. AU - Joshi, A. AU - Janu, A. AU - Jambekar, N. AU - Kaushal, R. AU - Mahajan, A. AU - Prabhash, K. DB - Scopus DO - 10.4103/0971-5851.171544 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 238-242 ST - Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center T2 - Indian Journal of Medical and Paediatric Oncology TI - Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84953307055&doi=10.4103%2f0971-5851.171544&partnerID=40&md5=1c7364ae35c6772f8dc494f1bdc7a2b3 VL - 36 ID - 6660 ER - TY - JOUR AD - H. Hasle, Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark AU - Hasle, H. DB - Embase Medline DO - 10.1159/000243773 IS - SUPPL. 2 LA - English M3 - Conference Paper N1 - L358081722 2010-02-15 PY - 2009 SN - 0301-0163 SP - 8-14 ST - Malignant diseases in noonan syndrome and related disorders T2 - Hormone Research TI - Malignant diseases in noonan syndrome and related disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358081722&from=exporthttp://dx.doi.org/10.1159/000243773 VL - 72 ID - 6661 ER - TY - JOUR AD - A.Y. Bedikian, Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, United States AU - Kolandijan, N. A. AU - Wei, C. AU - Burke, A. AU - Bedikian, A. Y. DB - Embase Medline DO - 10.1097/MPH.0000000000000231 IS - 7 LA - English M3 - Article N1 - L600873988 2014-12-24 2015-01-05 PY - 2014 SN - 1536-3678 1077-4114 SP - 552-558 ST - Malignant melanoma in teenagers and young adults T2 - Journal of Pediatric Hematology/Oncology TI - Malignant melanoma in teenagers and young adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600873988&from=exporthttp://dx.doi.org/10.1097/MPH.0000000000000231 VL - 36 ID - 6662 ER - TY - JOUR AD - Department of Ophthalmology, Palmetto Health/University of South Carolina, Richland. Department of Ophthalmology, Palmetto Health/University of South Carolina, Richland. Electronic address: keckkt@gmail.com. Department of Otolaryngology, Palmetto Health/University of South Carolina, Richland. Department of Pathology, Palmetto Health/University of South Carolina, Richland. AN - 29126970 AU - Walters, A. R. AU - Keck, K. M. AU - Simmons, O. AU - Williams, S. G. AU - Cross, S. AU - Patel, R. M. DA - Dec DO - 10.1016/j.jaapos.2017.06.025 10.1016/j.jaapos.2017.06.025. Epub 2017 Nov 7. DP - Nlm ET - 2017/11/12 IS - 6 LA - eng PY - 2017 SN - 1091-8531 SP - 501-503 ST - Malignant melanoma presenting as amelanotic caruncular lesion in a child T2 - J aapos TI - Malignant melanoma presenting as amelanotic caruncular lesion in a child VL - 21 ID - 6663 ER - TY - JOUR AD - Department of Medicine, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, 91200 Jerusalem, Israel Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel AU - Szalat, A. AU - Fraenkel, M. AU - Doviner, V. AU - Salmon, A. AU - Gross, D. J. DB - Scopus DO - 10.1007/s12020-010-9422-5 IS - 2 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2011 SP - 160-166 ST - Malignant pheochromocytoma: Predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center T2 - Endocrine TI - Malignant pheochromocytoma: Predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953655714&doi=10.1007%2fs12020-010-9422-5&partnerID=40&md5=79802c835c14d53d75df50ec6fe30cad VL - 39 ID - 6664 ER - TY - JOUR AD - Y. Adachi, Department of Diagnostic Pathology, Toyooka Hospital, 1094 Tobera, Toyooka, Hyogo, Japan AU - Okumura, Y. AU - Adachi, Y. AU - Shirahase, T. AU - Nagashima, Y. AU - Tanaka, Y. AU - Taki, Y. AU - Watanabe, J. AU - Uegaki, M. AU - Sakatani, T. AU - Ikehara, S. DB - Embase DO - 10.3892/mco.2019.1848 IS - 1 LA - English M3 - Article N1 - L2002184730 2019-07-12 2019-07-17 PY - 2019 SN - 2049-9469 2049-9450 SP - 55-58 ST - Malignant rhabdoid tumour in an adult kidney: A case report T2 - Molecular and Clinical Oncology TI - Malignant rhabdoid tumour in an adult kidney: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002184730&from=exporthttp://dx.doi.org/10.3892/mco.2019.1848 VL - 11 ID - 6665 ER - TY - JOUR AD - M.R. Jeng, Department of Pediatrics, Hematology/Oncology/Stem Cell Transplantation, Stanford University School of Medicine, 1000Welch Road, Suite 300, Palo Alto, CA, United States AU - Jeng, M. R. AU - Fuh, B. AU - Blatt, J. AU - Gupta, A. AU - Merrow, A. C. AU - Hammill, A. AU - Adams, D. C1 - mekinist DB - Embase Medline DO - 10.1002/pbc.25067 IS - 11 LA - English M3 - Article N1 - L603768752 2015-04-20 2015-05-12 PY - 2014 SN - 1545-5017 1545-5009 SP - 2115-2117 ST - Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab T2 - Pediatric Blood and Cancer TI - Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603768752&from=exporthttp://dx.doi.org/10.1002/pbc.25067 VL - 61 ID - 6666 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, University Hospital of Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147 Essen, NW, Germany. AN - 23871289 AU - Reis, H. AU - Hager, T. AU - Wohlschlaeger, J. AU - Bauer, S. AU - Katenkamp, K. AU - Katenkamp, D. AU - Baba, H. A. DA - Oct DO - 10.1016/j.humpath.2013.04.018 10.1016/j.humpath.2013.04.018. Epub 2013 Jul 17. DP - Nlm ET - 2013/07/23 IS - 10 LA - eng PY - 2013 SN - 0046-8177 SP - 2266-74 ST - Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma T2 - Hum Pathol TI - Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma VL - 44 ID - 6667 ER - TY - JOUR AD - B. Liu, Department of General Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China AU - Hu, K. AU - Huang, P. AU - Luo, H. AU - Yao, Z. AU - Wang, Q. AU - Xiong, Z. AU - Lin, J. AU - Huang, H. AU - Xu, S. AU - Zhang, P. AU - Liu, B. DB - Embase DO - 10.1002/2211-5463.12254 IS - 8 LA - English M3 - Article N1 - L616991417 2017-07-03 2017-08-10 PY - 2017 SN - 2211-5463 SP - 1144-1153 ST - Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells T2 - FEBS Open Bio TI - Mammalian-enabled (MENA) protein enhances oncogenic potential and cancer stem cell-like phenotype in hepatocellular carcinoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616991417&from=exporthttp://dx.doi.org/10.1002/2211-5463.12254 VL - 7 ID - 6668 ER - TY - JOUR AD - J. Fuchs, Department of Pediatric Surgery and Pediatric Urology, Children´s Hospital, University of Tuebingen, Hoppe-Seyler-Str. 03, Tuebingen, Germany AU - Fuchs, J. AU - Warmann, S. W. AU - Urla, C. AU - Schäfer, J. F. AU - Schmidt, A. DB - Embase Medline DO - 10.1016/j.sempedsurg.2020.150941 IS - 4 LA - English M3 - Article N1 - L2007302842 2020-08-07 2020-10-07 PY - 2020 SN - 1532-9453 1055-8586 ST - Management of benign liver tumors T2 - Seminars in Pediatric Surgery TI - Management of benign liver tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007302842&from=exporthttp://dx.doi.org/10.1016/j.sempedsurg.2020.150941 VL - 29 ID - 6669 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, University Children's Hospital, Fetscherstr. 74, 01307 Dresden, Germany Department of Oncology, Hematology, And Cellular Therapy University Hospital, Poitiers, France AU - Suttorp, M. AU - Eckardt, L. AU - Tauer, J. T. AU - Millot, F. DB - Scopus DO - 10.1007/s11899-012-0113-6 IS - 2 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2012 SP - 116-124 ST - Management of chronic myeloid leukemia in childhood T2 - Current Hematologic Malignancy Reports TI - Management of chronic myeloid leukemia in childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860835140&doi=10.1007%2fs11899-012-0113-6&partnerID=40&md5=9f4aaef4e8397ca90d3e6ec0892beff8 VL - 7 ID - 6670 ER - TY - JOUR AD - Division of Hematology/Oncology, McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, ON, Canada Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Division of Pediatric Endocrinology and Metabolism, Emory University School of Medicine, Atlanta, GA, United States Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, United States Division of Hematology/Oncology, Golisano Children's Hospital, University of Rochester, Rochester, NY, United States Division of Hematology/Oncology, Ste Justine University Hospital Center, Montreal, QC, Canada Division of Hematology/Oncology/BMT, British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada Division of Hematology/Oncology, Children's Hospital of Wisconsin, Milwaukee, WI, United States Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States Nemours Center for Cancer and Blood Disorders, Nemours/Alfred I DuPont Hospital for Children, Wilmington, DE, United States Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada AU - Athale, U. AU - Hijiya, N. AU - Patterson, B. C. AU - Bergsagel, J. AU - Andolina, J. R. AU - Bittencourt, H. AU - Schultz, K. R. AU - Burke, M. J. AU - Redell, M. S. AU - Kolb, E. A. AU - Johnston, D. L. C7 - e27827 DB - Scopus DO - 10.1002/pbc.27827 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 ST - Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group T2 - Pediatric Blood and Cancer TI - Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067390025&doi=10.1002%2fpbc.27827&partnerID=40&md5=39f6d6856e105520c885fe6251a8c25b VL - 66 ID - 6671 ER - TY - JOUR AD - University Department of Surgery, St James Hospital and Trinity College, Dublin 8, Ireland AU - Butt, J. AU - Rowley, S. AU - Byrne, P. J. AU - Reynolds, J. V. DB - Scopus DO - 10.1007/s11845-007-0054-6 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2007 SP - 157-160 ST - Management of gastrointestinal stromal tumours: A single-centre experience T2 - Irish Journal of Medical Science TI - Management of gastrointestinal stromal tumours: A single-centre experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548488952&doi=10.1007%2fs11845-007-0054-6&partnerID=40&md5=7f1a95924734df58f30093fa91069371 VL - 176 ID - 6672 ER - TY - JOUR AD - University of Cincinnati. Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Harvard Medical School. Broad Institute of MIT and Harvard, Boston, Massachusetts. Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital. Division of Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta. Emory University School of Medicine, Atlanta, Georgia, USA. AN - 30531227 AU - de Blank, P. AU - Bandopadhayay, P. AU - Haas-Kogan, D. AU - Fouladi, M. AU - Fangusaro, J. C2 - PMC6664811 C6 - NIHMS1037092 DA - Feb DO - 10.1097/mop.0000000000000717 10.1097/MOP.0000000000000717. DP - Nlm ET - 2018/12/12 IS - 1 LA - eng PY - 2019 SN - 1040-8703 (Print) 1040-8703 SP - 21-27 ST - Management of pediatric low-grade glioma T2 - Curr Opin Pediatr TI - Management of pediatric low-grade glioma VL - 31 ID - 6673 ER - TY - JOUR AD - Department of Pediatric Hematology-Oncology, Lorestan University of Medical Sciences, Khoramabad, Iran Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Department of Pediatric Hematology-Oncology, Iran University of Medical Sciences, Tehran, Iran AU - Abdolkarimi, B. AU - Zareifar, S. AU - Karimi, M. AU - Salajegheh, P. DB - Scopus IS - 2 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 77-84 ST - Management of refractory/relapsed acute leukemia with heart limitation by anthracycline-free chemotherapy regimens in pediatric patients: New hypothesis and new approach T2 - Middle East Journal of Cancer TI - Management of refractory/relapsed acute leukemia with heart limitation by anthracycline-free chemotherapy regimens in pediatric patients: New hypothesis and new approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044354622&partnerID=40&md5=c9343e7919cd631d83005a55cb75f25c VL - 9 ID - 6674 ER - TY - JOUR AD - Texas Childrens Cancer Center, Baylor College of Medicine, Houston, TX, United States AU - Rabin, K. R. AU - Poplack, D. G. DB - Scopus IS - 4 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 ST - Management strategies in acute lymphoblastic leukemia T2 - Oncology TI - Management strategies in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956226779&partnerID=40&md5=579ebbf4bf92a2603d221e51b586b04d VL - 25 ID - 6675 ER - TY - JOUR AD - Paediatrics Department, Saint Mary Hospital, London, United Kingdom Department of Paediatric Haematology, Hopital Robert Debré, Paris, France M. Tettamanti Research Centre, Paediatrics Department, University of Milano-Bicocca, Monza, Italy Department of Paediatric Oncology, Beatrix Children's Hospital, Groningen, Netherlands Department of Paediatric Haematology-Oncology, CHR La Citadelle, Liège, Belgium Department of Paediatric Haematology and Oncology, University Hospital, Technical University Dresden, Dresden, Germany Department of Paediatric Oncology, CHU Poitiers, Poitiers, France AU - de la Fuente, J. AU - Baruchel, A. AU - Biondi, A. AU - de Bont, E. AU - Dresse, M. F. AU - Suttorp, M. AU - Millot, F. AU - International, B. F. M. Group Study Group Chronic Myeloid Leukaemia Committee DB - Scopus DO - 10.1111/bjh.12977 IS - 1 M3 - Article N1 - (iBFM) Cited By :54 Export Date: 18 November 2020 PY - 2014 SP - 33-47 ST - Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years T2 - British Journal of Haematology TI - Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84909980867&doi=10.1111%2fbjh.12977&partnerID=40&md5=3bc0b1f113e0b4bca043b87d79f7fa7d VL - 167 ID - 6676 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad Telangana, 500 082, India AU - Kumar, K. AU - Sadashivudu, G. AU - Krishnamani, K. AU - Linga, V. AU - Maddali, L. AU - Digumarti, R. DB - Scopus DO - 10.4103/0971-5851.195738 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 260-264 ST - Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world T2 - Indian Journal of Medical and Paediatric Oncology TI - Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007443216&doi=10.4103%2f0971-5851.195738&partnerID=40&md5=748b724e4ba0c09b2deaffd81f4983a2 VL - 37 ID - 6677 ER - TY - JOUR AD - Department of Biological Sciences and the Center for Gene Structure and Function, Hunter College of the City University of New York, Graduate Center of the City University of New York, New York, New York 10021, USA. AN - 14635193 AU - Nie, K. AU - Henderson, A. DA - Dec 15 DO - 10.1002/jcb.10704 DP - Nlm ET - 2003/11/25 IS - 6 LA - eng N1 - Nie, K Henderson, A PY - 2003 SN - 0730-2312 (Print) 0730-2312 SP - 1197-206 ST - MAP kinase activation in cells exposed to a 60 Hz electromagnetic field T2 - J Cell Biochem TI - MAP kinase activation in cells exposed to a 60 Hz electromagnetic field VL - 90 ID - 6678 ER - TY - JOUR AD - Y. Liu, Center for Perinatal Research The Abigail Wexner Research Institute at Nationwide Children's Hospital, 575 Children's Cross Road, Columbus, OH, United States AU - Kirk, S. G. AU - Samavati, L. AU - Liu, Y. DB - Embase Medline DO - 10.1016/j.lfs.2019.117157 LA - English M3 - Article N1 - L2004284242 2019-12-20 2019-12-31 PY - 2020 SN - 1879-0631 0024-3205 ST - MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response T2 - Life Sciences TI - MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004284242&from=exporthttp://dx.doi.org/10.1016/j.lfs.2019.117157 VL - 241 ID - 6679 ER - TY - JOUR AD - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. michal.grzmil@fmi.ch AN - 21406405 AU - Grzmil, M. AU - Morin, P., Jr. AU - Lino, M. M. AU - Merlo, A. AU - Frank, S. AU - Wang, Y. AU - Moncayo, G. AU - Hemmings, B. A. DA - Mar 15 DO - 10.1158/0008-5472.Can-10-3112 10.1158/0008-5472.CAN-10-3112. Epub 2011 Mar 14. DP - Nlm ET - 2011/03/17 IS - 6 LA - eng PY - 2011 SN - 0008-5472 SP - 2392-402 ST - MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma T2 - Cancer Res TI - MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma VL - 71 ID - 6680 ER - TY - JOUR AD - J.B. Kunz, Heidelberg University Children's Hospital, Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg, Germany AU - Cordas dos Santos, D. M. AU - Eilers, J. AU - Sosa Vizcaino, A. AU - Orlova, E. AU - Zimmermann, M. AU - Stanulla, M. AU - Schrappe, M. AU - Börner, K. AU - Grimm, D. AU - Muckenthaler, M. U. AU - Kulozik, A. E. AU - Kunz, J. B. DB - Embase Medline DO - 10.1186/s12885-018-4525-0 IS - 1 LA - English M3 - Article N1 - L622608485 2018-06-26 2019-02-14 PY - 2018 SN - 1471-2407 ST - MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-ΚB T2 - BMC Cancer TI - MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-ΚB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622608485&from=exporthttp://dx.doi.org/10.1186/s12885-018-4525-0 VL - 18 ID - 6681 ER - TY - JOUR AD - L. Gregory, Developmental Endocrinology Research Group, UCL, Insititute of Child Health, London, United Kingdom AU - Gregory, L. AU - Kypranou, N. AU - Besser, R. AU - Vignola, L. AU - Temple, K. AU - Davis, J. AU - Gevers, E. AU - Dattani, M. AU - Gaston-Massuet, C. DB - Embase DO - 10.1159/000449142 LA - English M3 - Conference Abstract N1 - L615915447 2017-05-09 PY - 2016 SN - 1663-2826 SP - 33-34 ST - The MAPK effector BRAF is essential for the integrity of hypothalamic-pituitary development and deregulation of this pathway causes congenital hypopituitarism T2 - Hormone Research in Paediatrics TI - The MAPK effector BRAF is essential for the integrity of hypothalamic-pituitary development and deregulation of this pathway causes congenital hypopituitarism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615915447&from=exporthttp://dx.doi.org/10.1159/000449142 VL - 86 ID - 6682 ER - TY - JOUR AD - S. Haston, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom AU - Haston, S. AU - Pozzi, S. AU - Carreno, G. AU - Manshaei, S. AU - Panousopoulos, L. AU - Gonzalez-Meljem, J. M. AU - Apps, J. R. AU - Virasami, A. AU - Thavaraj, S. AU - Gutteridge, A. AU - Forshew, T. AU - Marais, R. AU - Brandner, S. AU - Jacques, T. S. AU - Andoniadou, C. L. AU - Martinez-Barbera, J. P. DB - Embase Medline DO - 10.1242/dev.150490 IS - 12 LA - English M3 - Article N1 - L616963837 2017-06-29 2017-07-04 PY - 2017 SN - 1477-9129 0950-1991 SP - 2141-2152 ST - MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma T2 - Development (Cambridge) TI - MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616963837&from=exporthttp://dx.doi.org/10.1242/dev.150490 VL - 144 ID - 6683 ER - TY - JOUR AD - Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO; Department of Pediatrics, University of California School of Medicine, San Francisco, CA; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY; Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA; Division of Pediatric Hematology and Oncology, University of Utah, Salt Lake City, UT; Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN; and. Department of Microbiology, New York University Langone Medical Center, New York, NY. AN - 26324703 AU - Jones, C. L. AU - Gearheart, C. M. AU - Fosmire, S. AU - Delgado-Martin, C. AU - Evensen, N. A. AU - Bride, K. AU - Waanders, A. J. AU - Pais, F. AU - Wang, J. AU - Bhatla, T. AU - Bitterman, D. S. AU - de Rijk, S. R. AU - Bourgeois, W. AU - Dandekar, S. AU - Park, E. AU - Burleson, T. M. AU - Madhusoodhan, P. P. AU - Teachey, D. T. AU - Raetz, E. A. AU - Hermiston, M. L. AU - Müschen, M. AU - Loh, M. L. AU - Hunger, S. P. AU - Zhang, J. AU - Garabedian, M. J. AU - Porter, C. C. AU - Carroll, W. L. C2 - PMC4635116 DA - Nov 5 DO - 10.1182/blood-2015-04-639138 10.1182/blood-2015-04-639138. Epub 2015 Aug 31. DP - Nlm ET - 2015/09/02 IS - 19 LA - eng PY - 2015 SN - 0006-4971 (Print) 0006-4971 SP - 2202-12 ST - MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia T2 - Blood TI - MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia VL - 126 ID - 6684 ER - TY - JOUR AD - J.G. Rheinwald, BWH Dermatology, HIM 664, 77 Avenue Louis Pasteur, Boston, MA 02115, United States AU - Degen, M. AU - Natarajan, E. AU - Barron, P. AU - Widlund, H. R. AU - Rheinwald, J. G. DB - Embase Medline DO - 10.1016/j.ajpath.2012.02.028 IS - 6 LA - English M3 - Article N1 - L364909551 2012-06-07 2012-06-15 PY - 2012 SN - 0002-9440 1525-2191 SP - 2462-2478 ST - MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma T2 - American Journal of Pathology TI - MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364909551&from=exporthttp://dx.doi.org/10.1016/j.ajpath.2012.02.028 VL - 180 ID - 6685 ER - TY - JOUR AD - Department of Pediatrics, Pediatric Oncology Institute (Grupo de Apoio ao Adolescente e à Criança com Câncer), Federal University of São Paulo, São Paulo, SP 04023-062, Brazil. francine.tesser@yahoo.com.br AN - 22154052 AU - Tesser-Gamba, F. AU - Petrilli, A. S. AU - de Seixas Alves, M. T. AU - Filho, R. J. AU - Juliano, Y. AU - Toledo, S. R. DA - Jul DO - 10.1016/j.humpath.2011.08.003 10.1016/j.humpath.2011.08.003. Epub 2011 Dec 9. DP - Nlm ET - 2011/12/14 IS - 7 LA - eng PY - 2012 SN - 0046-8177 SP - 994-1002 ST - MAPK7 and MAP2K4 as prognostic markers in osteosarcoma T2 - Hum Pathol TI - MAPK7 and MAP2K4 as prognostic markers in osteosarcoma VL - 43 ID - 6686 ER - TY - JOUR AD - S.R.C. Toledo, Department of Pediatrics, Genetics Laboratory, Pediatric Oncology Institute (IOP/GRAACC), Federal University of São Paulo, São Paulo-SP, Brazil AU - Tesser-Gamba, F. AU - Lopes, L. J. D. S. AU - Petrilli, A. S. AU - Toledo, S. R. C. DB - Embase Medline DO - 10.1002/mc.22420 IS - 11 LA - English M3 - Article N1 - L607356012 2015-12-29 2016-10-14 PY - 2016 SN - 1098-2744 0899-1987 SP - 1700-1713 ST - MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma T2 - Molecular Carcinogenesis TI - MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607356012&from=exporthttp://dx.doi.org/10.1002/mc.22420 VL - 55 ID - 6687 ER - TY - JOUR AD - Department of Oncology, MS 260, Division of Neuro-Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Neurosurgery, LeBonheur Children's Hospital, Memphis, TN, USA. Department of Ophthalmology & Pediatrics, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, USA. Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA. Department of Oncology, MS 260, Division of Neuro-Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. ibrahim.qaddoumi@stjude.org. AN - 29392423 AU - Upadhyaya, S. A. AU - Robinson, G. W. AU - Harreld, J. H. AU - Klimo, P. D., Jr. AU - Hoehn, M. E. AU - Orr, B. A. AU - Qaddoumi, I. A. C2 - PMC5857244 C6 - NIHMS939364 DA - Apr DO - 10.1007/s00381-018-3739-4 10.1007/s00381-018-3739-4. Epub 2018 Feb 1. DP - Nlm ET - 2018/02/03 IS - 4 LA - eng PY - 2018 SN - 0256-7040 (Print) 0256-7040 SP - 605-610 ST - Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases T2 - Childs Nerv Syst TI - Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases VL - 34 ID - 6688 ER - TY - JOUR AD - Howard Hughes Medical Institute, Dept. of Biol./Ctr. for Cancer Res., Massachusetts Inst. of Technology, Cambridge, MA, United States Department of Pathology, Children's Hospital, Boston, MA, United States Department of Radiology, Children's Hosp./Harvard Med. Sch., Boston, MA, United States Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States Department of Neurology, Children's Hospital, Harvard Medical School, Boston, MA, United States Department of Pediatrics, Division of Hematology-Oncology, Univ. of TX Southwestern Med. Ctr., Dallas, TX 75019-9063, United States AU - McLaughlin, M. E. AU - Robson, C. D. AU - Kieran, M. W. AU - Jacks, T. AU - Pomeroy, S. L. AU - Cameron, S. DB - Scopus DO - 10.1097/00043426-200308000-00012 IS - 8 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2003 SP - 644-648 ST - Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation T2 - Journal of Pediatric Hematology/Oncology TI - Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): A case report and laboratory investigation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042570478&doi=10.1097%2f00043426-200308000-00012&partnerID=40&md5=32769c068441cd8967ebead8369351a4 VL - 25 ID - 6689 ER - TY - JOUR AD - Department of Hematology, First Affiliated Hospital of Anhui Medical University, Hefei, China Department of Oncology, First Affiliated Hospital of Anhui Medical University, Hefei, China AU - Ni, J. AU - Hong, J. AU - Zhang, Z. AU - Li, Q. AU - Xia, R. AU - Zeng, Q. AU - Sun, G. DB - Scopus DO - 10.1080/10428194.2019.1702186 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1195-1200 ST - Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia T2 - Leukemia and Lymphoma TI - Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076927453&doi=10.1080%2f10428194.2019.1702186&partnerID=40&md5=7b302e9057dc6bfc5c067644e596e609 VL - 61 ID - 6690 ER - TY - JOUR AD - D. W. Clapp, Cancer Research Institute, Bldg. R4, 1044 W Walnut St, Indianapolis, IN 46202, United States AU - Staser, K. AU - Yang, F. C. AU - Clapp, D. W. C1 - gleevec DB - Embase Medline DO - 10.1182/blood-2009-09-242875 IS - 2 LA - English M3 - Review N1 - L359513990 2010-09-21 2010-09-27 PY - 2010 SN - 0006-4971 1528-0020 SP - 157-164 ST - Mast cells and the neurofibroma microenvironment T2 - Blood TI - Mast cells and the neurofibroma microenvironment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359513990&from=exporthttp://dx.doi.org/10.1182/blood-2009-09-242875http://bloodjournal.hematologylibrary.org/cgi/reprint/116/2/157 VL - 116 ID - 6691 ER - TY - JOUR AD - Department of Pediatrics, Onze-Lieve-Vrouw Hospital, Aalst, Belgium Department of Dermatology and Venereology, University Medical Center, Sophia Children's Hospital, Rotterdam, Netherlands AU - Van Gysel, D. AU - Oranje, A. P. DB - Scopus IS - 2 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 101-104 ST - Mastocytosis T2 - European Journal of Pediatric Dermatology TI - Mastocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-51749122863&partnerID=40&md5=5130641e14d1236f2bfc3c7197224a59 VL - 18 ID - 6692 ER - TY - JOUR AD - Institute of Animal Nutrition, Northeast Agricultural University, Harbin, 150030, P. R. China. asshan@neau.edu.cn. AN - 31432838 AU - Meng, Q. AU - Sun, S. AU - Luo, Z. AU - Shi, B. AU - Shan, A. AU - Cheng, B. DA - Sep 1 DO - 10.1039/c9fo00637k 10.1039/c9fo00637k. Epub 2019 Aug 21. DP - Nlm ET - 2019/08/23 IS - 9 LA - eng PY - 2019 SN - 2042-6496 SP - 5626-5643 ST - Maternal dietary resveratrol alleviates weaning-associated diarrhea and intestinal inflammation in pig offspring by changing intestinal gene expression and microbiota T2 - Food Funct TI - Maternal dietary resveratrol alleviates weaning-associated diarrhea and intestinal inflammation in pig offspring by changing intestinal gene expression and microbiota VL - 10 ID - 6693 ER - TY - JOUR AD - Department of Occupational and Environmental Health, School of Public Heath, China Medical University, PR China. Department of Occupational and Environmental Health, School of Public Heath, China Medical University, PR China. Electronic address: Jchen@cmu.edu.cn. AN - 29635194 AU - Gu, W. AU - Wang, Y. AU - Qiu, Z. AU - Dong, J. AU - Wang, Y. AU - Chen, J. DA - Sep 1 DO - 10.1016/j.scitotenv.2018.03.329 10.1016/j.scitotenv.2018.03.329. Epub 2018 Apr 7. DP - Nlm ET - 2018/04/11 LA - eng PY - 2018 SN - 0048-9697 SP - 525-533 ST - Maternal exposure to nonylphenol during pregnancy and lactation induces microglial cell activation and pro-inflammatory cytokine production in offspring hippocampus T2 - Sci Total Environ TI - Maternal exposure to nonylphenol during pregnancy and lactation induces microglial cell activation and pro-inflammatory cytokine production in offspring hippocampus VL - 634 ID - 6694 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine and Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, and Howard Hughes Medical Institute, Portland, Oregon AU - Burwick, R. M. AU - Kuo, K. AU - Brewer, D. AU - Druker, B. J. DB - Scopus DO - 10.1097/AOG.0000000000001972 IS - 5 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2017 SP - 831-834 ST - Maternal, fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy T2 - Obstetrics and Gynecology TI - Maternal, fetal, and neonatal imatinib levels with treatment of chronic myeloid leukemia in pregnancy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017091406&doi=10.1097%2fAOG.0000000000001972&partnerID=40&md5=cb1be24ea1ddec331645678abbbd4abe VL - 129 ID - 6695 ER - TY - JOUR AD - M.S. Lim, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Stellar-Chance Laboratories, 422 Curie Blvd, Philadelphia, PA, United States AU - Pillai, V. AU - Tallarico, M. AU - Bishop, M. R. AU - Lim, M. S. DB - Embase Medline DO - 10.1111/bjh.14044 IS - 4 LA - English M3 - Review N1 - L609152692 2016-03-30 2016-06-16 PY - 2016 SN - 1365-2141 0007-1048 SP - 573-581 ST - Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents T2 - British Journal of Haematology TI - Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609152692&from=exporthttp://dx.doi.org/10.1111/bjh.14044 VL - 173 ID - 6696 ER - TY - JOUR AU - Hammami, M. B. AU - Alsabbagh, M. E. Y. Y. DB - Embase DO - 10.1016/S0016-5085(18)33982-9 IS - 6 LA - English M3 - Conference Abstract N1 - L2000864498 2019-08-01 PY - 2018 SN - 1528-0012 0016-5085 SP - S-1205 ST - MAVYRET-INDUCED ACUTE LIVER INJURY IN A NON-CIRRHOTIC, NONHBV INFECTED PATIENT: A CASE REPORT T2 - Gastroenterology TI - MAVYRET-INDUCED ACUTE LIVER INJURY IN A NON-CIRRHOTIC, NONHBV INFECTED PATIENT: A CASE REPORT UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000864498&from=exporthttp://dx.doi.org/10.1016/S0016-5085(18)33982-9 VL - 154 ID - 6697 ER - TY - JOUR AD - Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA. landim@mail.nih.gov AN - 16809487 AU - Landi, M. T. AU - Bauer, J. AU - Pfeiffer, R. M. AU - Elder, D. E. AU - Hulley, B. AU - Minghetti, P. AU - Calista, D. AU - Kanetsky, P. A. AU - Pinkel, D. AU - Bastian, B. C. DA - Jul 28 DO - 10.1126/science.1127515 10.1126/science.1127515. Epub 2006 Jun 29. DP - Nlm ET - 2006/07/01 IS - 5786 LA - eng PY - 2006 SN - 0036-8075 SP - 521-2 ST - MC1R germline variants confer risk for BRAF-mutant melanoma T2 - Science TI - MC1R germline variants confer risk for BRAF-mutant melanoma VL - 313 ID - 6698 ER - TY - JOUR AD - T. Imaizumi, Department of Vascular Biology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan AU - Imaizumi, T. AU - Murakami, K. AU - Ohta, K. AU - Seki, H. AU - Matsumiya, T. AU - Meng, P. AU - Hayakari, R. AU - Xing, F. AU - Aizawa-Yashiro, T. AU - Tatsuta, T. AU - Yoshida, H. AU - Kijima, H. DB - Embase Medline DO - 10.1016/j.neures.2013.05.002 IS - 4 LA - English M3 - Article N1 - L52615374 2013-06-06 2013-08-07 PY - 2013 SN - 0168-0102 1872-8111 SP - 195-206 ST - MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells T2 - Neuroscience Research TI - MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52615374&from=exporthttp://dx.doi.org/10.1016/j.neures.2013.05.002 VL - 76 ID - 6699 ER - TY - JOUR AD - V. Tisato, Department of Morphology, Surgery and Experimental Medicine and LTTA Centre, University of Ferrara, Via Fossato di Mortara 66, Ferrara, Italy AU - Tisato, V. AU - Voltan, R. AU - Gonelli, A. AU - Secchiero, P. AU - Zauli, G. C1 - abt 199 amg 232(Amgen) cgm 097(Novartis) ds 3032b(Daiichi Industry) hdm 201(Novartis) mi 77301(Labaz) mk 8242(Merck) rg 7112(Hoffmann La Roche) rg 7388 ro 5045337(Hoffmann La Roche) ro 5503781 sar 405838(Labaz) sch 900242(Merck) C2 - Amgen Daiichi Industry Hoffmann La Roche Labaz Merck Novartis DB - Embase Medline DO - 10.1186/s13045-017-0500-5 IS - 1 LA - English M3 - Review N1 - L617035749 2017-07-10 2017-07-11 PY - 2017 SN - 1756-8722 ST - MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer T2 - Journal of Hematology and Oncology TI - MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617035749&from=exporthttp://dx.doi.org/10.1186/s13045-017-0500-5 VL - 10 ID - 6700 ER - TY - JOUR AD - B. Will, Department of Medicine (Oncology) & Department of Cell Biology Director, Stem Cell Pharmacodynamics Laboratory, Albert Einstein College of Medicine, Jack & Pearl Resnick Campus, 1300 Morris Park Avenue, Chanin Building, Room 401, Bronx, NY, United States AU - Bussel, J. AU - Kulasekararaj, A. AU - Cooper, N. AU - Verma, A. AU - Steidl, U. AU - Semple, J. W. AU - Will, B. DB - Embase Medline DO - 10.1053/j.seminhematol.2019.09.001 IS - 4 LA - English M3 - Review N1 - L2003801391 2019-11-27 2019-12-18 PY - 2019 SN - 1532-8686 0037-1963 SP - 262-278 ST - Mechanisms and therapeutic prospects of thrombopoietin receptor agonists T2 - Seminars in Hematology TI - Mechanisms and therapeutic prospects of thrombopoietin receptor agonists UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003801391&from=exporthttp://dx.doi.org/10.1053/j.seminhematol.2019.09.001 VL - 56 ID - 6701 ER - TY - JOUR AD - Department of Human Genetics, Catholic University Leuven, Leuven, Belgium. AN - 19410195 AU - Brems, H. AU - Beert, E. AU - de Ravel, T. AU - Legius, E. DA - May DO - 10.1016/s1470-2045(09)70033-6 10.1016/S1470-2045(09)70033-6. DP - Nlm ET - 2009/05/05 IS - 5 LA - eng PY - 2009 SN - 1470-2045 SP - 508-15 ST - Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 T2 - Lancet Oncol TI - Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 VL - 10 ID - 6702 ER - TY - JOUR AD - B. Liu, Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, United States AU - Shi, Q. AU - Pei, F. AU - Silverman, G. A. AU - Pak, S. C. AU - Perlmutter, D. H. AU - Liu, B. AU - Bahar, I. DB - Embase Medline DO - 10.3390/ijms21082855 IS - 8 LA - English M3 - Article N1 - L2004241886 2020-05-08 2020-05-13 PY - 2020 SN - 1422-0067 1661-6596 ST - Mechanisms of action of autophagy modulators dissected by quantitative systems pharmacology analysis T2 - International Journal of Molecular Sciences TI - Mechanisms of action of autophagy modulators dissected by quantitative systems pharmacology analysis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004241886&from=exporthttp://dx.doi.org/10.3390/ijms21082855 VL - 21 ID - 6703 ER - TY - JOUR AD - G.M. Brodeur, Children's Hospital of Philadelphia, University of Pennsylvania, CTRB Rm. 3018, Civic Center Boulevard, Philadelphia, PA, United States AU - MacFarland, S. P. AU - Naraparaju, K. AU - Iyer, R. AU - Guan, P. AU - Kolla, V. AU - Hu, Y. AU - Tan, K. AU - Brodeur, G. M. C1 - rxdx 101(ignyta) C2 - ignyta DB - Embase Medline DO - 10.1158/1535-7163.MCT-18-1044 IS - 3 LA - English M3 - Article N1 - L2005693386 2020-05-04 2020-07-02 PY - 2020 SN - 1538-8514 1535-7163 SP - 920-926 ST - Mechanisms of entrectinib resistance in a neuroblastoma xenograft model T2 - Molecular Cancer Therapeutics TI - Mechanisms of entrectinib resistance in a neuroblastoma xenograft model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005693386&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-18-1044 VL - 19 ID - 6704 ER - TY - JOUR AD - T.J. Shackleford, Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, TX, United States AU - Shackleford, T. J. AU - Hariharan, S. AU - Phelps, D. AU - Bid, H. AU - Zhong, H. AU - Houghton, P. DB - Embase DO - 10.1158/1538-7445.AM2017-5825 IS - 13 LA - English M3 - Conference Abstract N1 - L618566399 2017-10-10 PY - 2017 SN - 1538-7445 ST - Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines T2 - Cancer Research TI - Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618566399&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2017-5825 VL - 77 ID - 6705 ER - TY - JOUR AD - B. B. Hasinoff, Apotex Centre, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada AU - Hasinoff, B. B. AU - Patel, D. C1 - cardioxane icrf 187 zinecard C2 - Adria(United States) LC(United States) DB - Embase Medline DO - 10.1007/s12012-009-9056-0 IS - 1 LA - English M3 - Article N1 - L50704754 2009-11-19 2010-05-10 PY - 2010 SN - 1530-7905 SP - 1-8 ST - Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib T2 - Cardiovascular Toxicology TI - Mechanisms of myocyte cytotoxicity induced by the multikinase inhibitor sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50704754&from=exporthttp://dx.doi.org/10.1007/s12012-009-9056-0 VL - 10 ID - 6706 ER - TY - JOUR AD - John D. Dingell VA Medical Center, Wayne State University, Detroit, MI, United States Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States Oncology Department, Wayne State University, Detroit, MI, United States Pathology Department, Wayne State University, Detroit, MI, United States Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia College of Pharmacy and Pharmaceutical Sciences, Florida A and M University, Tallahassee, FL, United States AU - Muthu, M. AU - Cheriyan, V. T. AU - Munie, S. AU - Levi, E. AU - Frank, J. AU - Ashour, A. E. AU - Singh, M. AU - Rishi, A. K. C7 - e102567 DB - Scopus DO - 10.1371/journal.pone.0102567 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2014 ST - Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics T2 - PLoS ONE TI - Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904463200&doi=10.1371%2fjournal.pone.0102567&partnerID=40&md5=30a562969f8ce269c06d8eee4247af1f VL - 9 ID - 6707 ER - TY - JOUR AD - W. Akik, Research Institute, McGill University Health Centre, Montreal, QC, Canada AU - Akik, W. AU - Dauletbaev, N. AU - Lands, L. C. DB - Embase IS - 9 LA - English M3 - Conference Abstract N1 - L630354941 2020-01-01 PY - 2019 SN - 1535-4970 ST - Mechanisms underlying corticosteroid insensitivity induction by interleukin-17A in bronchial epithelial cells T2 - American Journal of Respiratory and Critical Care Medicine TI - Mechanisms underlying corticosteroid insensitivity induction by interleukin-17A in bronchial epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630354941&from=export VL - 199 ID - 6708 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States School of Public Health, University of California, Berkeley, CA, United States National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Research Triangle Park, North Carolina, United States Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, United States School of Environmental Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand NIEHS, NIH, DHHS, Research Triangle ParkNC, United States AU - Bailey, K. A. AU - Smith, A. H. AU - Tokar, E. J. AU - Graziano, J. H. AU - Kim, K. W. AU - Navasumrit, P. AU - Ruchirawat, M. AU - Thiantanawat, A. AU - Suk, W. A. AU - Fry, R. C. DB - Scopus DO - 10.1289/ehp.1409360 IS - 2 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2016 SP - 170-175 ST - Mechanisms underlying latent disease risk associated with early-life arsenic exposure: Current research trends and scientific gaps T2 - Environmental Health Perspectives TI - Mechanisms underlying latent disease risk associated with early-life arsenic exposure: Current research trends and scientific gaps UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956617044&doi=10.1289%2fehp.1409360&partnerID=40&md5=3c1d0eb1e6ade4cd54149a373110840e VL - 124 ID - 6709 ER - TY - JOUR AD - J.D. Piganelli, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15213-3205, United States AU - Tse, H. M. AU - Milton, M. J. AU - Piganelli, J. D. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2003.10.029 IS - 2 LA - English M3 - Article N1 - L38117241 2004-02-17 PY - 2004 SN - 0891-5849 SP - 233-247 ST - Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation-reduction reactions in innate immunity T2 - Free Radical Biology and Medicine TI - Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation-reduction reactions in innate immunity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38117241&from=exporthttp://dx.doi.org/10.1016/j.freeradbiomed.2003.10.029 VL - 36 ID - 6710 ER - TY - JOUR AD - Clinical Trial Service Unit, Epidemiological Studies Unit, Radcliffe Infirmary, Oxford, United Kingdom Royal Free and University College, School of Medicine, Royal Free Campus, London, United Kingdom University College Hospital, National Health Service Trust, London, United Kingdom AU - Durrant, I. J. AU - Richards, S. M. AU - Prentice, H. G. AU - Goldstone, A. H. DB - Scopus DO - 10.1016/S0889-8588(05)70189-1 IS - 6 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2000 SP - 1327-1352 ST - The medical research council trials in adult acute lymphocytic leukemia T2 - Hematology/Oncology Clinics of North America TI - The medical research council trials in adult acute lymphocytic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033637014&doi=10.1016%2fS0889-8588%2805%2970189-1&partnerID=40&md5=8fff60ef9197f7fa6d7cd3b6a3a832b9 VL - 14 ID - 6711 ER - TY - JOUR AD - Department of Pharmacy, Foothills Medical Centre, Calgary, Canada Kristin.anderson2@albertahealthservices.ca Pharmacy Department, Tom Baker Cancer Centre, Calgary, Canada Division of Hematology and Hematologic Malignancies, Tom Baker Cancer Centre, Calgary, Canada AN - 103867187. Language: English. Entry Date: 20141230. Revision Date: 20200708. Publication Type: Journal Article AU - Anderson, Kristin R. AU - Chambers, Carole R. AU - Lam, Nadine AU - Yau, Patrick S. AU - Cusano, Frances AU - Savoie, M. Lynn AU - Sheikh, Naureen DB - ccm DO - 10.1177/1078155213520261 DP - EBSCOhost IS - 1 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. NLM UID: 9511372. PMID: NLM24503243. PY - 2015 SN - 1078-1552 SP - 19-25 ST - Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia T2 - Journal of Oncology Pharmacy Practice TI - Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103867187&site=ehost-live&scope=site VL - 21 ID - 6712 ER - TY - JOUR AD - Kaiser Permanente Research, Department of Research and Evaluation, 100 S Los Robles, 2nd Floor, Pasadena, CA, 91101 AN - 125074375. Language: English. Entry Date: 20180302. Revision Date: 20190516. Publication Type: journal article AU - Haque, Reina AU - Jiaxiao, Shi AU - Joanie, Chung AU - Xiaoqing, Xu AU - Avila, Chantal AU - Campbell, Christopher AU - Ahmed, Syed A. AU - Lei, Chen AU - Schottinger, Joanne E. AU - Shi, Jiaxiao AU - Chung, Joanie AU - Xu, Xiaoqing AU - Chen, Lei DB - ccm DO - 10.1016/j.japh.2017.01.004 DP - EBSCOhost IS - 3 N1 - research. Supplement Title: May2017:Supplement. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 101176252. PMID: NLM28259737. PY - 2017 SN - 1544-3191 SP - 303-310.e2 ST - Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO T2 - Journal of the American Pharmacists Association: JAPhA TI - Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125074375&site=ehost-live&scope=site VL - 57 ID - 6713 ER - TY - JOUR AD - Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. AN - 12709419 AU - Calabrese, C. AU - Frank, A. AU - Maclean, K. AU - Gilbertson, R. DA - Jul 4 DO - 10.1074/jbc.M211600200 DP - Nlm ET - 2003/04/24 IS - 27 LA - eng N1 - Calabrese, Christopher Frank, Adrian Maclean, Kirsteen Gilbertson, Richard PY - 2003 SN - 0021-9258 (Print) 0021-9258 SP - 24951-9 ST - Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM T2 - J Biol Chem TI - Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM VL - 278 ID - 6714 ER - TY - JOUR AD - J. Jóźwiak, Department of Histology and Embryology, Center for Biostructure Research, Medical University of Warsaw, 5 Chalubinskiego St., Warsaw, Poland AU - Borowska, A. AU - Jóźwiak, J. DB - Embase DO - 10.5114/aoms.2016.59939 IS - 3 LA - English M3 - Article N1 - L610734683 2016-06-15 2016-06-21 PY - 2016 SN - 1896-9151 1734-1922 SP - 659-666 ST - Medulloblastoma: Molecular pathways and histopathological classification T2 - Archives of Medical Science TI - Medulloblastoma: Molecular pathways and histopathological classification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610734683&from=exporthttp://dx.doi.org/10.5114/aoms.2016.59939 VL - 12 ID - 6715 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110 029, India AU - Sarkar, C. AU - Deb, P. AU - Sharma, M. C. DB - Embase Medline DO - 10.4103/0028-3886.24696 IS - 1 LA - English M3 - Review N1 - L43748718 2006-06-13 PY - 2006 SN - 0028-3886 SP - 16-23 ST - Medulloblastomas: New directions in risk stratification T2 - Neurology India TI - Medulloblastomas: New directions in risk stratification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43748718&from=exporthttp://dx.doi.org/10.4103/0028-3886.24696 VL - 54 ID - 6716 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus MC Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands. Netherlands Translational Research Center B.V., Oss, The Netherlands. The Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. AN - 27174491 AU - Canté-Barrett, K. AU - Spijkers-Hagelstein, J. A. AU - Buijs-Gladdines, J. G. AU - Uitdehaag, J. C. AU - Smits, W. K. AU - van der Zwet, J. AU - Buijsman, R. C. AU - Zaman, G. J. AU - Pieters, R. AU - Meijerink, J. P. C2 - PMC5240021 Center B.V. The remaining authors declare no conflict of interests. DA - Sep DO - 10.1038/leu.2016.83 10.1038/leu.2016.83. Epub 2016 Apr 22. DP - Nlm ET - 2016/05/14 IS - 9 LA - eng PY - 2016 SN - 0887-6924 (Print) 0887-6924 SP - 1832-43 ST - MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia T2 - Leukemia TI - MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia VL - 30 ID - 6717 ER - TY - JOUR AD - Paediatric Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Genetics and Genomic Medicine, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Paediatric Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK. Developmental Biology and Cancer Programme, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. AN - 28253523 AU - Kinsler, V. A. AU - O'Hare, P. AU - Jacques, T. AU - Hargrave, D. AU - Slater, O. C2 - PMC5396107 conflict of interest. DA - Apr 11 DO - 10.1038/bjc.2017.49 10.1038/bjc.2017.49. Epub 2017 Mar 2. DP - Nlm ET - 2017/03/03 IS - 8 LA - eng PY - 2017 SN - 0007-0920 (Print) 0007-0920 SP - 990-993 ST - MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children T2 - Br J Cancer TI - MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children VL - 116 ID - 6718 ER - TY - JOUR AD - Children’s Hospital Medical Center, Division of Experimental Hematology and Cancer Biology, 3333 Burnet Ave., M.L.C. 7013, Cincinnati, Ohio 45229, USA. AN - 23221341 AU - Jessen, W. J. AU - Miller, S. J. AU - Jousma, E. AU - Wu, J. AU - Rizvi, T. A. AU - Brundage, M. E. AU - Eaves, D. AU - Widemann, B. AU - Kim, M. O. AU - Dombi, E. AU - Sabo, J. AU - Hardiman Dudley, A. AU - Niwa-Kawakita, M. AU - Page, G. P. AU - Giovannini, M. AU - Aronow, B. J. AU - Cripe, T. P. AU - Ratner, N. C2 - PMC3533264 DA - Jan DO - 10.1172/jci60578 10.1172/JCI60578. Epub 2012 Dec 10. DP - Nlm ET - 2012/12/12 IS - 1 LA - eng PY - 2013 SN - 0021-9738 (Print) 0021-9738 SP - 340-7 ST - MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors T2 - J Clin Invest TI - MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors VL - 123 ID - 6719 ER - TY - JOUR AD - Unidad de Investigación, Hospital Universitario Reina Sofía, Córdoba, Spain. nuria.barbarroja.exts@juntadeandalucia.es AN - 18445086 AU - Barbarroja, N. AU - Siendones, E. AU - Torres, L. A. AU - Luque, M. J. AU - Martinez, J. M. AU - Dorado, G. AU - Velasco, F. AU - Torres, A. AU - López-Pedrera, C. DA - Jul DO - 10.1111/j.1365-2141.2008.07154.x 10.1111/j.1365-2141.2008.07154.x. Epub 2008 Apr 28. DP - Nlm ET - 2008/05/01 IS - 1 LA - eng PY - 2008 SN - 0007-1048 SP - 27-35 ST - MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia T2 - Br J Haematol TI - MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia VL - 142 ID - 6720 ER - TY - JOUR AD - Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA. yoheme@mail.nih.gov khanjav@mail.nih.gov. Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Oncogenomics Section, Genetics Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA. Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH, Bethesda, MD 20892, USA. Pathology/Histotechnology Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NIH, Frederick, MD 21702, USA. Laboratory Animal Sciences Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NIH, Frederick, MD 21701, USA. Collaborative Protein Technology Resource, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Systems Biology Center, National Heart Lung and Blood Institute, NIH, Bethesda, MD 20892, USA. AN - 29973406 AU - Yohe, M. E. AU - Gryder, B. E. AU - Shern, J. F. AU - Song, Y. K. AU - Chou, H. C. AU - Sindiri, S. AU - Mendoza, A. AU - Patidar, R. AU - Zhang, X. AU - Guha, R. AU - Butcher, D. AU - Isanogle, K. A. AU - Robinson, C. M. AU - Luo, X. AU - Chen, J. Q. AU - Walton, A. AU - Awasthi, P. AU - Edmondson, E. F. AU - Difilippantonio, S. AU - Wei, J. S. AU - Zhao, K. AU - Ferrer, M. AU - Thomas, C. J. AU - Khan, J. DA - Jul 4 DO - 10.1126/scitranslmed.aan4470 10.1126/scitranslmed.aan4470. DP - Nlm ET - 2018/07/06 IS - 448 LA - eng PY - 2018 SN - 1946-6234 ST - MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma T2 - Sci Transl Med TI - MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma VL - 10 ID - 6721 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. AN - 27588400 AU - Kerstjens, M. AU - Driessen, E. M. AU - Willekes, M. AU - Pinhanços, S. S. AU - Schneider, P. AU - Pieters, R. AU - Stam, R. W. C2 - PMC5362448 DA - Feb 28 DO - 10.18632/oncotarget.11730 10.18632/oncotarget.11730. DP - Nlm ET - 2016/09/03 IS - 9 LA - eng PY - 2017 SN - 1949-2553 SP - 14835-14846 ST - MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations T2 - Oncotarget TI - MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations VL - 8 ID - 6722 ER - TY - JOUR AD - B. S. Braun, Department of Pediatrics, University of California, San Francisco, CA 94158, United States AU - Lyubynska, N. AU - Gorman, M. F. AU - Lauchle, J. O. AU - Hong, W. X. AU - Akutagawa, J. K. AU - Shannon, K. AU - Braun, B. S. C1 - pd 0325901(Pfizer) C2 - Pfizer DB - Embase Medline DO - 10.1126/scitranslmed.3001069 IS - 76 LA - English M3 - Article N1 - L361532839 2011-04-07 2011-04-28 PY - 2011 SN - 1946-6234 1946-6242 ST - A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice T2 - Science Translational Medicine TI - A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361532839&from=exporthttp://dx.doi.org/10.1126/scitranslmed.3001069http://stm.sciencemag.org/content/3/76/76ra27.full.pdf VL - 3 ID - 6723 ER - TY - JOUR AD - Z. Wang, Department of Thoracic Medical Oncology, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China AU - Wang, Y. AU - Yan, P. AU - Liu, Z. AU - Yang, X. AU - Wang, Y. AU - Shen, Z. AU - Bai, H. AU - Wang, J. AU - Wang, Z. C1 - azd 6244(Selleck,United States) bez 235(Selleck,United States) C2 - Selleck(United States) DB - Embase DO - 10.1111/1759-7714.12325 IS - 3 LA - English M3 - Article N1 - L607391685 2015-12-30 2016-05-06 PY - 2016 SN - 1759-7714 1759-7706 SP - 279-287 ST - MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation T2 - Thoracic Cancer TI - MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607391685&from=exporthttp://dx.doi.org/10.1111/1759-7714.12325 VL - 7 ID - 6724 ER - TY - JOUR AD - M. Shatara, Children's Hospital of Michigan, Detroit, MI, United States AU - Shatara, M. AU - Knight, T. AU - Altinok, D. AU - Yankelevich, M. AU - Bhmabhani, K. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305696 2019-05-14 PY - 2019 SN - 1545-5017 SP - S112 ST - Mek inhibitor for pediatric low-grade gliomas (LGGS): A single-institution experience T2 - Pediatric Blood and Cancer TI - Mek inhibitor for pediatric low-grade gliomas (LGGS): A single-institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305696&from=exporthttp://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 6725 ER - TY - JOUR AD - C. Zhou, University of Oklahoma Health Sciences Center, College of Medicine AU - Zhou, C. AU - Davis, D. AU - Haskell, H. AU - Levin, J. DB - Embase DO - 10.1016/j.jaad.2019.06.357 IS - 4 LA - English M3 - Conference Abstract N1 - L2002643058 2019-08-23 PY - 2019 SN - 1097-6787 0190-9622 SP - AB92 ST - MEK inhibitor-induced chronic paronychia T2 - Journal of the American Academy of Dermatology TI - MEK inhibitor-induced chronic paronychia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002643058&from=exporthttp://dx.doi.org/10.1016/j.jaad.2019.06.357 VL - 81 ID - 6726 ER - TY - JOUR AD - T. Tajiri, Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, 465 Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan AU - Tanaka, T. AU - Higashi, M. AU - Kimura, K. AU - Wakao, J. AU - Fumino, S. AU - Iehara, T. AU - Hosoi, H. AU - Sakai, T. AU - Tajiri, T. C1 - ch 5126766(Chugai) trametinib(LC) C2 - Chugai LC DB - Embase Medline DO - 10.1016/j.jpedsurg.2016.09.043 IS - 12 LA - English M3 - Article N1 - L613524343 2016-12-08 2016-12-14 PY - 2016 SN - 1531-5037 0022-3468 SP - 2074-2079 ST - MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy T2 - Journal of Pediatric Surgery TI - MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613524343&from=exporthttp://dx.doi.org/10.1016/j.jpedsurg.2016.09.043 VL - 51 ID - 6727 ER - TY - JOUR AD - Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Division of Hematology-Oncology, Arthur and Sonia Labatt Brain Tumour Research Centre, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON M4N1X8, Canada. Department of Pathology and ARUP Laboratories, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA. Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Primary Children's Hospital/Intermountain Healthcare, Salt Lake City, UT 84113, USA. Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Department of Oncological Sciences and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: rodney.stewart@hci.utah.edu. AN - 27783941 AU - Modzelewska, K. AU - Boer, E. F. AU - Mosbruger, T. L. AU - Picard, D. AU - Anderson, D. AU - Miles, R. R. AU - Kroll, M. AU - Oslund, W. AU - Pysher, T. J. AU - Schiffman, J. D. AU - Jensen, R. AU - Jette, C. A. AU - Huang, A. AU - Stewart, R. A. DA - Oct 25 DO - 10.1016/j.celrep.2016.09.081 10.1016/j.celrep.2016.09.081. DP - Nlm ET - 2016/10/27 IS - 5 LA - eng PY - 2016 SP - 1255-1264 ST - MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells T2 - Cell Rep TI - MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells VL - 17 ID - 6728 ER - TY - JOUR AD - M. Kudek, Medical College of Wisconsin, Milwaukee, WI, United States AU - Kudek, M. AU - Knipstein, J. AU - Zimbric, K. AU - Schloemer, N. DB - Embase DO - 10.1002/pbc.27713 LA - English M3 - Conference Abstract N1 - L627305566 2019-05-14 PY - 2019 SN - 1545-5017 SP - S105-S106 ST - Mek-ing a plan to treat NF: Safe delivery of mek inhibitors for inoperable plexiform neurofibromas T2 - Pediatric Blood and Cancer TI - Mek-ing a plan to treat NF: Safe delivery of mek inhibitors for inoperable plexiform neurofibromas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627305566&from=exporthttp://dx.doi.org/10.1002/pbc.27713 VL - 66 ID - 6729 ER - TY - JOUR AD - A. Polak, Dept. of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland AU - Polak, A. AU - Kiliszek, P. AU - Sewastianik, T. AU - Szydlowski, M. AU - Jablonska, E. AU - Bialopiotrowicz, E. AU - Gorniak, P. AU - Markowicz, S. AU - Nowak, E. AU - Grygorowicz, M. A. AU - Nowis, D. AU - Golab, J. AU - Giebel, S. AU - Lech-Maranda, E. AU - Warzocha, K. AU - Juszczynski, P. DB - Embase IS - 23 LA - English M3 - Conference Abstract N1 - L72175607 2016-02-08 PY - 2015 SN - 0006-4971 SP - 4917 ST - MEK1 inhibitor selumetinib sensitizes precursor b-cell acute lymphoblastic leukemia cells (B-ALL) to dexamethasone through modulation of mTOR activity and stimulation of autophagy T2 - Blood TI - MEK1 inhibitor selumetinib sensitizes precursor b-cell acute lymphoblastic leukemia cells (B-ALL) to dexamethasone through modulation of mTOR activity and stimulation of autophagy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72175607&from=exporthttp://www.bloodjournal.org/content/126/23/4917 VL - 126 ID - 6730 ER - TY - JOUR AD - B. Gyorffy, MTA-TTK Lendület Cancer Biomarker Research Group, Budapest, Hungary AU - Pénzváltó, Z. AU - Lánczky, A. AU - Lénárt, J. AU - Meggyesházi, N. AU - Krenács, T. AU - Szoboszlai, N. AU - Denkert, C. AU - Pete, I. AU - Gyorffy, B. C1 - pd 0325901 DB - Embase Medline DO - 10.1186/1471-2407-14-837 IS - 1 LA - English M3 - Article N1 - L612234534 2016-09-28 2016-10-04 PY - 2014 SN - 1471-2407 ST - MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer T2 - BMC Cancer TI - MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612234534&from=exporthttp://dx.doi.org/10.1186/1471-2407-14-837 VL - 14 ID - 6731 ER - TY - JOUR AD - J. Charron, Centre de recherche sur le cancer, Université Laval, CRCHU de Québec, L'Hôtel-Dieu de Québec, Québec, Canada AU - Aoidi, R. AU - Houde, N. AU - Landry-Truchon, K. AU - Holter, M. AU - Jacquet, K. AU - Charron, L. AU - Krishnaswami, S. R. AU - Yu, B. D. AU - Rauen, K. A. AU - Bisson, N. AU - Newbern, J. AU - Charron, J. DB - Embase Medline DO - 10.1242/dmm.031278 IS - 3 LA - English M3 - Review N1 - L621593226 2018-04-13 2018-10-19 PY - 2018 SN - 1754-8411 1754-8403 ST - Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome T2 - DMM Disease Models and Mechanisms TI - Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621593226&from=exporthttp://dx.doi.org/10.1242/dmm.031278 VL - 11 ID - 6732 ER - TY - JOUR AD - L.D. Trucco, Cancer Research UK Manchester Institute, Manchester, United Kingdom AU - Trucco, L. D. AU - Mundra, P. A. AU - Garcia-Martinez, P. AU - Hogan, K. AU - Dhomen, N. AU - Pavet, V. AU - Marais, R. DB - Embase DO - 10.1158/1538-7445.SABCS18-4653 IS - 13 LA - English M3 - Conference Abstract N1 - L628906990 2019-08-20 PY - 2019 SN - 1538-7445 ST - Melanocyte specific deletion of Map3k1 reveals its role in BRAFV600E-driven melanoma T2 - Cancer Research TI - Melanocyte specific deletion of Map3k1 reveals its role in BRAFV600E-driven melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628906990&from=exporthttp://dx.doi.org/10.1158/1538-7445.SABCS18-4653 VL - 79 ID - 6733 ER - TY - JOUR AD - G.J. Walker, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, QLD, Australia AU - Tonks, I. D. AU - Mukhopadhyay, P. AU - Schroder, W. A. AU - Sorolla, A. AU - Mould, A. W. AU - Handoko, H. Y. AU - Ferguson, B. AU - Muller, H. K. AU - Keith, P. AU - Hayward, N. K. AU - Walker, G. J. AU - Kay, G. F. DB - Embase Medline DO - 10.1038/onc.2016.511 IS - 26 LA - English M3 - Article N1 - L614424160 2017-02-20 2017-07-12 PY - 2017 SN - 1476-5594 0950-9232 SP - 3789-3795 ST - Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation T2 - Oncogene TI - Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614424160&from=exporthttp://dx.doi.org/10.1038/onc.2016.511 VL - 36 ID - 6734 ER - TY - JOUR AD - Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. nmargaryan@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. agilgur@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. eseftor@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. chad-purnell@northwestern.edu. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. narva@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. argosain@luriechildrens.org. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. m-hendrix@northwestern.edu. Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. lstrizzi@luriechildrens.org. AN - 27011171 AU - Margaryan, N. V. AU - Gilgur, A. AU - Seftor, E. A. AU - Purnell, C. AU - Arva, N. C. AU - Gosain, A. K. AU - Hendrix, M. J. AU - Strizzi, L. C2 - PMC4813269 DA - Mar 22 DO - 10.3390/ijms17030418 10.3390/ijms17030418. DP - Nlm ET - 2016/03/25 IS - 3 LA - eng PY - 2016 SN - 1422-0067 SP - 418 ST - Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi T2 - Int J Mol Sci TI - Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi VL - 17 ID - 6735 ER - TY - JOUR AD - Departement of Biopathology, Centre Leon Bérard, Lyon. Department of Pathology, Centre Hospitalier Universitaire de Québec-Université Laval. Department of Molecular Biology and Medical Biochemistry, Faculté de médecine de l'Université Laval, Québec City, QC, Canada. Centre George François Leclerc, Dijon. Department of Histopathology, University Hospitals of Toulouse, Toulouse. Pathology Laboratory of Auxerre, Auxerre, France. AN - 29635259 AU - Perron, E. AU - Pissaloux, D. AU - Charon Barra, C. AU - Karanian, M. AU - Lamant, L. AU - Parfait, S. AU - Alberti, L. AU - de la Fouchardière, A. DA - May DO - 10.1097/pas.0000000000000973 10.1097/PAS.0000000000000973. DP - Nlm ET - 2018/04/11 IS - 5 LA - eng PY - 2018 SN - 0147-5185 SP - 595-603 ST - Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge T2 - Am J Surg Pathol TI - Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge VL - 42 ID - 6736 ER - TY - JOUR AD - A. de la Fouchardière, Department of Biopathology, Centre Léon Bérard, Lyon, France AU - Houlier, A. AU - Pissaloux, D. AU - Masse, I. AU - Tirode, F. AU - Karanian, M. AU - Pincus, L. B. AU - McCalmont, T. H. AU - LeBoit, P. E. AU - Bastian, B. C. AU - Yeh, I. AU - de la Fouchardière, A. DB - Embase Medline DO - 10.1038/s41379-019-0384-8 IS - 5 LA - English M3 - Article N1 - L2003633707 2019-11-22 PY - 2020 SN - 1530-0285 0893-3952 SP - 846-857 ST - Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations T2 - Modern Pathology TI - Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003633707&from=exporthttp://dx.doi.org/10.1038/s41379-019-0384-8 VL - 33 ID - 6737 ER - TY - JOUR AD - M. Sakaguchi, Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama-shi, Okayama, Japan AU - Chen, Y. AU - Sumardika, I. W. AU - Tomonobu, N. AU - Winarsa Ruma, I. M. AU - Kinoshita, R. AU - Kondo, E. AU - Inoue, Y. AU - Sato, H. AU - Yamauchi, A. AU - Murata, H. AU - Yamamoto, K. I. AU - Tomida, S. AU - Shien, K. AU - Yamamoto, H. AU - Soh, J. AU - Liu, M. AU - Futami, J. AU - Sasai, K. AU - Katayama, H. AU - Kubo, M. AU - Putranto, E. W. AU - Hibino, T. AU - Sun, B. AU - Nishibori, M. AU - Toyooka, S. AU - Sakaguchi, M. DB - Embase Medline DO - 10.1016/j.canlet.2019.03.023 LA - English M3 - Article N1 - L2001752201 2019-04-04 2019-04-09 PY - 2019 SN - 1872-7980 0304-3835 SP - 178-190 ST - Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion T2 - Cancer Letters TI - Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001752201&from=exporthttp://dx.doi.org/10.1016/j.canlet.2019.03.023 VL - 452 ID - 6738 ER - TY - JOUR AD - O.V. Volpert, Northwestern University Feinberg School of Medicine, Tarry Bldg, Ste 16-761, 303 East Chicago Ave., Chicago, IL, United States AU - Nwani, N. G. AU - Deguiz, M. L. AU - Jimenez, B. AU - Vinokour, E. AU - Dubrovskyi, O. AU - Ugolkov, A. AU - Mazar, A. P. AU - Volpert, O. V. DB - Embase Medline DO - 10.1158/0008-5472.CAN-15-2468 IS - 8 LA - English M3 - Article N1 - L610185621 2016-06-07 PY - 2016 SN - 1538-7445 0008-5472 SP - 2265-2276 ST - Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts T2 - Cancer Research TI - Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610185621&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-15-2468 VL - 76 ID - 6739 ER - TY - JOUR AU - Krengel, S. AU - Reyes-Múgica, M. DB - Embase Medline DO - 10.1111/bjd.15477 IS - 5 LA - English M3 - Note N1 - L616192162 2017-05-19 2017-06-01 PY - 2017 SN - 1365-2133 0007-0963 SP - 1114 ST - Melanoma risk in congenital melanocytic naevi T2 - British Journal of Dermatology TI - Melanoma risk in congenital melanocytic naevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616192162&from=exporthttp://dx.doi.org/10.1111/bjd.15477 VL - 176 ID - 6740 ER - TY - JOUR AD - Melanoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. The Institute of Cancer Research, Division of Radiotherapy and Imaging, 123 Old Brompton Road, London SW7 3RP, UK. The Institute of Cancer Research, Division of Clinical Studies, 123 Old Brompton Road, London SW7 3RP, UK. Department of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK. AN - 26484413 AU - Wilkins, A. AU - Furness, A. AU - Corbett, R. W. AU - Bloomfield, A. AU - Porta, N. AU - Morris, S. AU - Ali, Z. AU - Larkin, J. AU - Harrington, K. C2 - PMC4815790 DA - Nov 3 DO - 10.1038/bjc.2015.357 10.1038/bjc.2015.357. Epub 2015 Oct 20. DP - Nlm ET - 2015/10/21 IS - 9 LA - eng PY - 2015 SN - 0007-0920 (Print) 0007-0920 SP - 1275-81 ST - The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma T2 - Br J Cancer TI - The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma VL - 113 ID - 6741 ER - TY - JOUR AD - Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan. Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung, Taiwan. Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan. Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan. Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan. Department of Medical Education and Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Department of Cellular and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. AN - 29766567 AU - Lu, K. H. AU - Su, S. C. AU - Lin, C. W. AU - Hsieh, Y. H. AU - Lin, Y. C. AU - Chien, M. H. AU - Reiter, R. J. AU - Yang, S. F. DA - Oct DO - 10.1111/jpi.12507 10.1111/jpi.12507. Epub 2018 May 28. DP - Nlm ET - 2018/05/17 IS - 3 LA - eng PY - 2018 SN - 0742-3098 SP - e12507 ST - Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway T2 - J Pineal Res TI - Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway VL - 65 ID - 6742 ER - TY - JOUR AD - B. Vincent, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand AU - Shukla, M. AU - Htoo, H. H. AU - Wintachai, P. AU - Hernandez, J. F. AU - Dubois, C. AU - Postina, R. AU - Xu, H. AU - Checler, F. AU - Smith, D. R. AU - Govitrapong, P. AU - Vincent, B. DB - Embase Medline DO - 10.1111/jpi.12200 IS - 2 LA - English M3 - Article N1 - L602185400 2015-02-23 2015-02-25 PY - 2015 SN - 1600-079X 0742-3098 SP - 151-165 ST - Melatonin stimulates the nonamyloidogenic processing of βaPP through the positive transcriptional regulation of ADAM10 and ADAM17 T2 - Journal of Pineal Research TI - Melatonin stimulates the nonamyloidogenic processing of βaPP through the positive transcriptional regulation of ADAM10 and ADAM17 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602185400&from=exporthttp://dx.doi.org/10.1111/jpi.12200 VL - 58 ID - 6743 ER - TY - JOUR AD - A. Mathew, Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, S6-862, 55 Lake Avenue North, Worcester, MA 01655, United States AU - Friberg, H. AU - Burns, L. AU - Woda, M. AU - Kalayanarooj, S. AU - Endy, T. P. AU - Stephens, H. A. F. AU - Green, S. AU - Rothman, A. L. AU - Mathew, A. DB - Embase Medline DO - 10.1038/icb.2010.61 IS - 1 LA - English M3 - Article N1 - L50889876 2010-04-29 2011-02-01 PY - 2011 SN - 0818-9641 1440-1711 SP - 122-129 ST - Memory CD8 T cells from naturally acquired primary dengue virus infection are highly cross-reactive T2 - Immunology and Cell Biology TI - Memory CD8 T cells from naturally acquired primary dengue virus infection are highly cross-reactive UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50889876&from=exporthttp://dx.doi.org/10.1038/icb.2010.61 VL - 89 ID - 6744 ER - TY - JOUR AD - D. K. Graham, University of Colorado Denver School of Medicine, Department of Pediatrics, Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Linger, R. M. A. AU - DeRyckere, D. AU - Brandão, L. AU - Sawczyn, K. K. AU - Jacobsen, K. M. AU - Liang, X. AU - Keating, A. K. AU - Graham, D. K. DB - Embase Medline DO - 10.1182/blood-2009-03-209247 IS - 13 LA - English M3 - Article N1 - L355629953 2009-12-03 PY - 2009 SN - 0006-4971 1528-0020 SP - 2678-2687 ST - Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia T2 - Blood TI - Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355629953&from=exporthttp://dx.doi.org/10.1182/blood-2009-03-209247http://bloodjournal.hematologylibrary.org/cgi/reprint/114/13/2678 VL - 114 ID - 6745 ER - TY - JOUR AD - D.K. Graham, Department of Pediatrics, P18-4401, Mail Stop 8302, Aurora, CO, United States AU - Linger, R. M. A. AU - Lee-Sherick, A. B. AU - DeRyckere, D. AU - Cohen, R. A. AU - Jacobsen, K. M. AU - McGranahan, A. AU - Brandão, L. N. AU - Winges, A. AU - Sawczyn, K. K. AU - Liang, X. AU - Keating, A. K. AU - Tan, A. C. AU - Earp, H. S. AU - Graham, D. K. DB - Embase Medline DO - 10.1182/blood-2013-01-478156 IS - 9 LA - English M3 - Article N1 - L617279397 2017-07-18 2017-07-24 PY - 2013 SN - 1528-0020 0006-4971 SP - 1599-1609 ST - Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia T2 - Blood TI - Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617279397&from=exporthttp://dx.doi.org/10.1182/blood-2013-01-478156 VL - 122 ID - 6746 ER - TY - JOUR AD - Department of General Pediatrics, Acute Lymphoblastic Leukemia-Berlin-Frankfurt-Münster Study Group, and. Department of Children's Pathology, University Hospital Schleswig-Holstein, Kiel, Germany; and. II. Medical Clinic and Institute of Tumor Biology, University Hospital Eppendorf, Hamburg, Germany. AN - 25428221 AU - Krause, S. AU - Pfeiffer, C. AU - Strube, S. AU - Alsadeq, A. AU - Fedders, H. AU - Vokuhl, C. AU - Loges, S. AU - Waizenegger, J. AU - Ben-Batalla, I. AU - Cario, G. AU - Möricke, A. AU - Stanulla, M. AU - Schrappe, M. AU - Schewe, D. M. DA - Jan 29 DO - 10.1182/blood-2014-06-583062 10.1182/blood-2014-06-583062. Epub 2014 Nov 26. DP - Nlm ET - 2014/11/28 IS - 5 LA - eng PY - 2015 SN - 0006-4971 SP - 820-30 ST - Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) T2 - Blood TI - Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS) VL - 125 ID - 6747 ER - TY - JOUR AD - I. Murakami, Department of Pathology, Kochi Medical School, Kochi University, Kohasu, Okoh, Nankoku, Kochi, Japan AU - Murakami, I. AU - Wada, N. AU - Nakashima, J. AU - Iguchi, M. AU - Toi, M. AU - Hashida, Y. AU - Higuchi, T. AU - Daibata, M. AU - Matsushita, M. AU - Iwasaki, T. AU - Kuwamoto, S. AU - Horie, Y. AU - Nagata, K. AU - Hayashi, K. AU - Oka, T. AU - Yoshino, T. AU - Imamura, T. AU - Morimoto, A. AU - Imashuku, S. AU - Gogusev, J. AU - Jaubert, F. DB - Embase Medline DO - 10.1186/s12964-018-0261-y IS - 1 LA - English M3 - Review N1 - L623556902 2018-08-28 2018-08-30 PY - 2018 SN - 1478-811X ST - Merkel cell polyomavirus and Langerhans cell neoplasm T2 - Cell Communication and Signaling TI - Merkel cell polyomavirus and Langerhans cell neoplasm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623556902&from=exporthttp://dx.doi.org/10.1186/s12964-018-0261-y VL - 16 ID - 6748 ER - TY - JOUR AD - D.K. Graham, Department of Pediatrics, School of Medicine, University of Colorado, 12800 East 19th Avenue, Aurora, CO, 80045, United States AU - Schlegel, J. AU - Sambade, M. J. AU - Sather, S. AU - Moschos, S. J. AU - Tan, A. C. AU - Winges, A. AU - DeRyckere, D. AU - Carson, C. C. AU - Trembath, D. G. AU - Tentler, J. J. AU - Eckhardt, S. G. AU - Kuan, P. F. AU - Hamilton, R. L. AU - Duncan, L. M. AU - Miller, C. R. AU - Nikolaishvili-Feinberg, N. AU - Midkiff, B. R. AU - Liu, J. AU - Zhang, W. AU - Yang, C. AU - Wang, X. AU - Frye, S. V. AU - Earp, H. S. AU - Shields, J. M. AU - Graham, D. K. DB - Embase Medline DO - 10.1172/JCI67816 IS - 5 LA - English M3 - Article N1 - L368856944 2013-05-14 2013-05-16 PY - 2013 SN - 0021-9738 1558-8238 SP - 2257-2267 ST - MERTK receptor tyrosine kinase is a therapeutic target in melanoma T2 - Journal of Clinical Investigation TI - MERTK receptor tyrosine kinase is a therapeutic target in melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368856944&from=exporthttp://dx.doi.org/10.1172/JCI67816http://www.jci.org/articles/view/67816/pdf VL - 123 ID - 6749 ER - TY - JOUR AD - M.D. Siegelin, Columbia University Medical Center, 630 W, 168th Street, P&S 15th–415, New York, NY, United States AU - Zhang, Y. AU - Nguyen, T. T. T. AU - Shang, E. AU - Mela, A. AU - Humala, N. AU - Mahajan, A. AU - Zhao, J. AU - Shu, C. AU - Torrini, C. AU - Sanchez-Quintero, M. J. AU - Kleiner, G. AU - Bianchetti, E. AU - Westhoff, M. A. AU - Quinzii, C. M. AU - Karpel-Massler, G. AU - Bruce, J. N. AU - Canoll, P. AU - Siegelin, M. D. DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-1389 IS - 1 LA - English M3 - Article N1 - L2004593613 2020-01-16 2020-01-23 PY - 2020 SN - 1538-7445 0008-5472 SP - 30-43 ST - MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma T2 - Cancer Research TI - MET inhibition elicits PGC1α-dependent metabolic reprogramming in glioblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004593613&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-19-1389 VL - 80 ID - 6750 ER - TY - JOUR AD - J. Anderson, Unit of Molecular Haematology and Cancer Biology, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, United Kingdom AU - Rees, H. AU - Williamson, D. AU - Papanastasiou, A. AU - Jina, N. AU - Nabarro, S. AU - Shipley, J. AU - Anderson, J. DB - Embase Medline DO - 10.1080/08977190600759923 IS - 3 LA - English M3 - Article N1 - L44669350 2006-11-27 PY - 2006 SN - 0897-7194 1029-2292 SP - 197-208 ST - The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas T2 - Growth Factors TI - The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44669350&from=exporthttp://dx.doi.org/10.1080/08977190600759923 VL - 24 ID - 6751 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. AN - 27840956 AU - Otabe, O. AU - Kikuchi, K. AU - Tsuchiya, K. AU - Katsumi, Y. AU - Yagyu, S. AU - Miyachi, M. AU - Iehara, T. AU - Hosoi, H. DA - Jan DO - 10.3892/or.2016.5213 10.3892/or.2016.5213. Epub 2016 Nov 2. DP - Nlm ET - 2016/11/15 IS - 1 LA - eng PY - 2017 SN - 1021-335x SP - 98-104 ST - MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells T2 - Oncol Rep TI - MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells VL - 37 ID - 6752 ER - TY - JOUR AD - Institute of Drug Metabolism and Pharmacokinetics, Merck KGaA, Grafing, Germany (H.S., F.K., E.W.); Central Analytics, Bio NMR and NMR Spectroscopy (A.M.) and Department of Clinical Pharmacology (A.J.), Merck KGaA, Darmstadt, Germany holger.scheible@merckgroup.com. Institute of Drug Metabolism and Pharmacokinetics, Merck KGaA, Grafing, Germany (H.S., F.K., E.W.); Central Analytics, Bio NMR and NMR Spectroscopy (A.M.) and Department of Clinical Pharmacology (A.J.), Merck KGaA, Darmstadt, Germany. AN - 27934635 AU - Scheible, H. AU - Kraetzer, F. AU - Marx, A. AU - Johne, A. AU - Wimmer, E. DA - Feb DO - 10.1124/dmd.116.072934 10.1124/dmd.116.072934. Epub 2016 Dec 1. DP - Nlm ET - 2016/12/10 IS - 2 LA - eng PY - 2017 SN - 0090-9556 SP - 174-182 ST - Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors T2 - Drug Metab Dispos TI - Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phosphoethanolamine in Patients with Solid Tumors VL - 45 ID - 6753 ER - TY - JOUR AD - Department of Chemical Biology, Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. AN - 23085756 AU - Martino, J. J. AU - Wall, B. A. AU - Mastrantoni, E. AU - Wilimczyk, B. J. AU - La Cava, S. N. AU - Degenhardt, K. AU - White, E. AU - Chen, S. C2 - PMC3910169 C6 - NIHMS549991 DA - Sep 12 DO - 10.1038/onc.2012.471 10.1038/onc.2012.471. Epub 2012 Oct 22. DP - Nlm ET - 2012/10/23 IS - 37 LA - eng PY - 2013 SN - 0950-9232 (Print) 0950-9232 SP - 4366-76 ST - Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells T2 - Oncogene TI - Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells VL - 32 ID - 6754 ER - TY - JOUR AD - X. Feng, Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China AU - Tao, Y. F. AU - Xu, L. X. AU - Lu, J. AU - Cao, L. AU - Li, Z. H. AU - Hu, S. Y. AU - Wang, N. N. AU - Du, X. J. AU - Sun, L. C. AU - Zhao, W. L. AU - Xiao, P. F. AU - Fang, F. AU - Li, Y. H. AU - Li, G. AU - Zhao, H. AU - Li, Y. P. AU - Xu, Y. Y. AU - Ni, J. AU - Wang, J. AU - Feng, X. AU - Pan, J. DB - Embase Medline DO - 10.1186/1479-5876-12-182 IS - 1 LA - English M3 - Article N1 - L53214904 2014-07-01 2014-07-16 PY - 2014 SN - 1479-5876 ST - Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation T2 - Journal of Translational Medicine TI - Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53214904&from=exporthttp://dx.doi.org/10.1186/1479-5876-12-182 VL - 12 ID - 6755 ER - TY - JOUR AD - Y. Jiang, Department of Joint Surgery, Huadu District People's Hospital, Southern Medical University, Guangzhou, Guangdong, China AU - Su, Z. AU - Yang, B. AU - Zeng, Z. AU - Zhu, S. AU - Wang, C. AU - Lei, S. AU - Jiang, Y. AU - Lin, L. DB - Embase DO - 10.3892/ol.2020.11544 IS - 1 LA - English M3 - Article N1 - L2006061124 2020-06-09 2020-07-07 PY - 2020 SN - 1792-1082 1792-1074 SP - 99-112 ST - Metastasis-associated gene MAPK15 promotes the migration and invasion of osteosarcoma cells via the c-Jun/MMPs pathway T2 - Oncology Letters TI - Metastasis-associated gene MAPK15 promotes the migration and invasion of osteosarcoma cells via the c-Jun/MMPs pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006061124&from=exporthttp://dx.doi.org/10.3892/ol.2020.11544 VL - 20 ID - 6756 ER - TY - JOUR AD - Department of Internal Medicine, Florida Hospital Internal Medicine Residency, Orlando, FL, United States Department of Pathology, Florida Hospital, Orlando, FL, United States Department of Obstetrics and Gynecology, Florida Hospital, Orlando, FL, United States Florida Hospital Cancer Institute, Orlando, FL, United States AU - Yuan, C. AU - Ma, M. J. AU - Parker, J. V. AU - Mekhail, T. M. DB - Scopus DO - 10.12659/AJCR.903698 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 799-804 ST - Metastatic anaplastic lymphoma kinase-1 (ALK-1)-rearranged inflammatory myofibroblastic sarcoma to the brain with leptomeningeal involvement: Favorable response to serial ALK inhibitors: A case report T2 - American Journal of Case Reports TI - Metastatic anaplastic lymphoma kinase-1 (ALK-1)-rearranged inflammatory myofibroblastic sarcoma to the brain with leptomeningeal involvement: Favorable response to serial ALK inhibitors: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026432042&doi=10.12659%2fAJCR.903698&partnerID=40&md5=408e4c2067c373906b55255726fa2c41 VL - 18 ID - 6757 ER - TY - JOUR AD - Department of Pathology, University of Manitoba, Winnipeg, MB, Canada Pediatric Hematology-Oncology, Bone Marrow Transplant Unit, University of Manitoba, Winnipeg, MB, Canada AU - Shuying, Ji AU - Shash, Hwazen AU - Stefanovici, Camelia AU - Phillips, Susan AU - Cuvelier, Geoff DB - ccm DP - EBSCOhost N1 - Accession Number: 138682130. Language: English. Entry Date: In Process. Revision Date: 20190919. Publication Type: Article. Supplement Title: 2016 Supplement. PY - 2016 SN - 1918-915X SP - 8-9 ST - Metastatic inflammatory myofibroblastic tumour following allogeneic stem cell transplant with fatal pulmonary toxicity from Crizotinib T2 - Canadian Journal of Pathology TI - Metastatic inflammatory myofibroblastic tumour following allogeneic stem cell transplant with fatal pulmonary toxicity from Crizotinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138682130&site=ehost-live&scope=site VL - 8 ID - 6758 ER - TY - JOUR AD - C. Pföhler, Universitätsklinikum Des Saarlandes, Klinik für Dermatologie, Venerologie und Allergologie, Homburg/Saar, Germany AU - Pföhler, C. AU - Krecké, N. AU - Schneider, G. AU - Solomayer, E. F. AU - Bohle, R. M. AU - Vogt, T. DB - Embase DO - 10.1159/000444354 LA - English M3 - Conference Abstract N1 - L72212747 2016-03-21 PY - 2016 SN - 2296-5270 SP - 149 ST - Metastatic melanoma in pregnancy-a diagnostic and therapeutic challenge T2 - Oncology Research and Treatment TI - Metastatic melanoma in pregnancy-a diagnostic and therapeutic challenge UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72212747&from=exporthttp://dx.doi.org/10.1159/000444354 VL - 39 ID - 6759 ER - TY - JOUR AD - Department of Hematology, Second Hospital of Hebei Medical University, Key Laboratory of Hematology, 215 West Heping Road, Shijiazhuang, Hebei 050000, China Department of Hematology, Harrison International Peace Hospital, Hengshui, Hebei 053000, China AU - Li, Y. AU - Yang, L. AU - Pan, Y. AU - Yang, J. AU - Shang, Y. AU - Luo, J. DB - Scopus DO - 10.3892/or.2014.3098 IS - 5 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2014 SP - 2438-2446 ST - Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia T2 - Oncology Reports TI - Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898623920&doi=10.3892%2for.2014.3098&partnerID=40&md5=a1b7a72f6badae0243368fc9f3d094ea VL - 31 ID - 6760 ER - TY - JOUR AD - From the Departments of Biochemistry and Molecular Biology. From the Departments of Biochemistry and Molecular Biology, Dermatology, and Obstetrics and Gynecology and the Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland 21201 reckert@umaryland.edu. AN - 25851901 AU - Saha, K. AU - Eckert, R. L. C2 - PMC4505598 DA - May 22 DO - 10.1074/jbc.M115.642868 10.1074/jbc.M115.642868. Epub 2015 Apr 7. DP - Nlm ET - 2015/04/09 IS - 21 LA - eng PY - 2015 SN - 0021-9258 (Print) 0021-9258 SP - 13521-30 ST - Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression T2 - J Biol Chem TI - Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression VL - 290 ID - 6761 ER - TY - JOUR AD - L. F. Parada, Dept. of Developmental Biology, Kent Waldrep Foundation Ctr. for Basic Neuroscience Research on Nerve Growth and Regeneration, Univ. of Texas Southwestern Medical Ctr., Dallas, TX 75390-9133, United States AU - Lin, L. AU - Chen, J. AU - Richardson, J. A. AU - Parada, L. F. DB - Embase Medline DO - 10.1152/ajpgi.00007.2009 IS - 4 LA - English M3 - Article N1 - L355385680 2009-11-20 PY - 2009 SN - 0193-1857 1522-1547 SP - G751-G761 ST - Mice lacking neurofibromin develop gastric hyperplasia T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Mice lacking neurofibromin develop gastric hyperplasia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355385680&from=exporthttp://dx.doi.org/10.1152/ajpgi.00007.2009http://ajpgi.physiology.org/cgi/reprint/297/4/G751 VL - 297 ID - 6762 ER - TY - JOUR AD - CEINGE, Biotecnologie Avanzate, Via Gaetano Salvatore 486, 80145 Naple, Italy Department of Biochemistry, Medical Biotechnologies (DBBM), Federico II University of Naples, Naples, Italy Paediatric Neurosurgery, Ospedale Santobono-Pausilipon, Naples, Italy Haemato-Oncology Laboratory, Department of Paediatrics, University of Padova, Padua, Italy AU - Andolfo, I. AU - Liguori, L. AU - De Antonellis, P. AU - Cusanelli, E. AU - Marinaro, F. AU - Pistollato, F. AU - Garzia, L. AU - De Vita, G. AU - Petrosino, G. AU - Accordi, B. AU - Migliorati, R. AU - Basso, G. AU - Iolascon, A. AU - Cinalli, G. AU - Zollo, M. DB - Scopus DO - 10.1093/neuonc/nos002 IS - 5 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2012 SP - 596-612 ST - The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma T2 - Neuro-Oncology TI - The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860378895&doi=10.1093%2fneuonc%2fnos002&partnerID=40&md5=3d37d353e09907780cf66a7dd7c0ff37 VL - 14 ID - 6763 ER - TY - JOUR AD - Erasmus MC/Sophia Children's Hospital, Erasmus University Medical Center, Dept. of Pediatric Oncology and Hematology, Dr. Molewaterplein 60, 3015 GJ Rotterdam, Netherlands AU - den Boer, M. L. AU - Pieters, R. DB - Scopus DO - 10.2174/138945007780830755 IS - 6 M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2007 SP - 761-764 ST - Microarray-based identification of new targets for specific therapies in pediatric leukemia T2 - Current Drug Targets TI - Microarray-based identification of new targets for specific therapies in pediatric leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34447513733&doi=10.2174%2f138945007780830755&partnerID=40&md5=5b1aec8ac56c7a5819b82d5c0e6a1774 VL - 8 ID - 6764 ER - TY - JOUR AD - J. Ding, Shanghai Jiao Tong University School of Medicine, Department of Neurology and Institute of Neurology, Ruijin Hospital, 197 Ruijin Er Road, Shanghai, China AU - Yang, X. AU - Lou, Y. AU - Liu, G. AU - Wang, X. AU - Qian, Y. AU - Ding, J. AU - Chen, S. AU - Xiao, Q. DB - Embase Medline DO - 10.1186/s12974-017-0795-8 IS - 1 LA - English M3 - Article N1 - L614476641 2017-02-27 2017-03-22 PY - 2017 SN - 1742-2094 ST - Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process T2 - Journal of Neuroinflammation TI - Microglia P2Y6 receptor is related to Parkinson's disease through neuroinflammatory process UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614476641&from=exporthttp://dx.doi.org/10.1186/s12974-017-0795-8 VL - 14 ID - 6765 ER - TY - JOUR AD - G. Nuovo, GNOME Diagnostics, Powell, OH, United States AU - Tili, E. AU - Mezache, L. AU - Michaille, J. J. AU - Amann, V. AU - Williams, J. AU - Vandiver, P. AU - Quinonez, M. AU - Fadda, P. AU - Mikhail, A. AU - Nuovo, G. DB - Embase Medline DO - 10.1016/j.anndiagpath.2018.03.006 LA - English M3 - Article N1 - L2000609259 2018-04-13 2018-11-06 PY - 2018 SN - 1532-8198 1092-9134 SP - 103-109 ST - microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia T2 - Annals of Diagnostic Pathology TI - microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000609259&from=exporthttp://dx.doi.org/10.1016/j.anndiagpath.2018.03.006 VL - 34 ID - 6766 ER - TY - JOUR AD - Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. stefano.caramuta@ki.se AN - 20357817 AU - Caramuta, S. AU - Egyházi, S. AU - Rodolfo, M. AU - Witten, D. AU - Hansson, J. AU - Larsson, C. AU - Lui, W. O. DA - Aug DO - 10.1038/jid.2010.63 10.1038/jid.2010.63. Epub 2010 Apr 1. DP - Nlm ET - 2010/04/02 IS - 8 LA - eng PY - 2010 SN - 0022-202x SP - 2062-70 ST - MicroRNA expression profiles associated with mutational status and survival in malignant melanoma T2 - J Invest Dermatol TI - MicroRNA expression profiles associated with mutational status and survival in malignant melanoma VL - 130 ID - 6767 ER - TY - JOUR AD - R. Gruszka, Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Pomorska 251, Lodz, Poland AU - Gruszka, R. AU - Zakrzewski, K. AU - Liberski, P. P. AU - Zakrzewska, M. DB - Embase Medline DO - 10.5114/FN.2020.96734 IS - 2 LA - English M3 - Article N1 - L2007580907 2020-09-07 2020-09-09 PY - 2020 SN - 1509-572X 1641-4640 SP - 123-132 ST - MicroRNA interaction with MAPK and AKT pathways in paediatric brain tumours-Preliminary results and review of the literature T2 - Folia Neuropathologica TI - MicroRNA interaction with MAPK and AKT pathways in paediatric brain tumours-Preliminary results and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007580907&from=exporthttp://dx.doi.org/10.5114/FN.2020.96734 VL - 58 ID - 6768 ER - TY - JOUR AD - Department of Surgery, Section of Endocrine Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. AN - 21537871 AU - Yip, L. AU - Kelly, L. AU - Shuai, Y. AU - Armstrong, M. J. AU - Nikiforov, Y. E. AU - Carty, S. E. AU - Nikiforova, M. N. C2 - PMC4157306 C6 - NIHMS538551 DA - Jul DO - 10.1245/s10434-011-1733-0 10.1245/s10434-011-1733-0. Epub 2011 May 3. DP - Nlm ET - 2011/05/04 IS - 7 LA - eng PY - 2011 SN - 1068-9265 (Print) 1068-9265 SP - 2035-41 ST - MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma T2 - Ann Surg Oncol TI - MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma VL - 18 ID - 6769 ER - TY - JOUR AD - P. Fedatto, Ribeirão Preto Medicine School, University of São Paulo, Pediatrics, Ribeirão Preto, Brazil AU - Fedatto, P. AU - Marco Antonio, D. AU - Baroni, M. AU - Panepucci, R. AU - Goes, A. AU - Martinelli, C. AU - Antonini, S. AU - De Castro, M. AU - Tucci, S. AU - Neder, L. AU - Seidinger, A. AU - Matellaro, M. AU - Yunes, J. AU - Brandalise, S. AU - Tone, L. AU - Scrideli, C. A. DB - Embase DO - 10.1002/pbc.25715 LA - English M3 - Conference Abstract N1 - L613189598 2016-11-17 PY - 2015 SN - 1545-5017 SP - S161 ST - Microrna signatures in pediatric adrenocortical tumors: Identification of micrornas and predicted pathways involved in tumorigenesis and prognosis T2 - Pediatric Blood and Cancer TI - Microrna signatures in pediatric adrenocortical tumors: Identification of micrornas and predicted pathways involved in tumorigenesis and prognosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613189598&from=exporthttp://dx.doi.org/10.1002/pbc.25715 VL - 62 ID - 6770 ER - TY - JOUR AD - H. Zhang, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China AU - Zhao, Y. AU - Liu, X. L. AU - Huang, J. H. AU - Yin, A. J. AU - Zhang, H. DB - Embase Medline DO - 10.26355/eurrev_202005_21311 IS - 10 LA - English M3 - Review N1 - L2006023327 2020-06-05 2020-06-16 PY - 2020 SN - 2284-0729 1128-3602 SP - 5292-5302 ST - MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition T2 - European Review for Medical and Pharmacological Sciences TI - MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006023327&from=exporthttp://dx.doi.org/10.26355/eurrev_202005_21311 VL - 24 ID - 6771 ER - TY - JOUR AD - Y. Zhou, Department of Clinical Laboratory, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute and Hospital, Tianjin Medical University, Tianjin's Clinical Research Center for Cancer, Tianjin, China AU - Liu, X. AU - Zhang, L. AU - Tong, Y. AU - Yu, M. AU - Wang, M. AU - Dong, D. AU - Shao, J. AU - Zhang, F. AU - Niu, R. AU - Zhou, Y. DB - Embase Medline DO - 10.1016/j.lfs.2018.11.057 LA - English M3 - Article N1 - L2001353236 2018-12-10 2018-12-11 PY - 2019 SN - 1879-0631 0024-3205 SP - 57-69 ST - MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα T2 - Life Sciences TI - MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001353236&from=exporthttp://dx.doi.org/10.1016/j.lfs.2018.11.057 VL - 217 ID - 6772 ER - TY - JOUR AD - Department of Cancer Genetics, Royal College of Surgeons in Ireland, York House, York Street, Dublin 2, Ireland. AN - 21266077 AU - Tivnan, A. AU - Tracey, L. AU - Buckley, P. G. AU - Alcock, L. C. AU - Davidoff, A. M. AU - Stallings, R. L. C2 - PMC3038978 DA - Jan 25 DO - 10.1186/1471-2407-11-33 10.1186/1471-2407-11-33. DP - Nlm ET - 2011/01/27 LA - eng PY - 2011 SN - 1471-2407 SP - 33 ST - MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma T2 - BMC Cancer TI - MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma VL - 11 ID - 6773 ER - TY - JOUR AD - H. Wu, Department of Orthopedics, China–Japan Union Hospital of Jilin University, No. 126, Xiantai Street, Changchun, Jilin Province, China AU - Jiang, R. AU - Zhang, C. AU - Liu, G. AU - Gu, R. AU - Wu, H. DB - Embase Medline DO - 10.3727/096504017X14882829077237 IS - 8 LA - English M3 - Article N1 - L618512890 2017-10-05 2018-07-09 PY - 2017 SN - 1555-3906 0965-0407 SP - 1409-1419 ST - MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1 T2 - Oncology Research TI - MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618512890&from=exporthttp://dx.doi.org/10.3727/096504017X14882829077237 VL - 25 ID - 6774 ER - TY - JOUR AD - J. Wu, 23 Pingjiang Road, Hexi District, Tianjin, China AU - Wu, J. AU - Cui, H. AU - Zhu, Z. AU - Wang, L. DB - Embase Medline DO - 10.1016/j.bbrc.2016.08.085 IS - 3 LA - English M3 - Article N1 - L612905770 2016-11-07 2016-11-21 PY - 2016 SN - 1090-2104 0006-291X SP - 1158-1164 ST - MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5 T2 - Biochemical and Biophysical Research Communications TI - MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612905770&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2016.08.085 VL - 478 ID - 6775 ER - TY - JOUR AD - J. Shipley, Molecular Cytogenetics Team, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom AU - Missiaglia, E. AU - Shepherd, C. J. AU - Patel, S. AU - Thway, K. AU - Pierron, G. AU - Pritchard-Jones, K. AU - Renard, M. AU - Sciot, R. AU - Rao, P. AU - Oberlin, O. AU - Delattre, O. AU - Shipley, J. DB - Embase Medline DO - 10.1038/sj.bjc.6605684 IS - 12 LA - English M3 - Article N1 - L50926958 2010-05-27 2010-06-28 PY - 2010 SN - 0007-0920 1532-1827 SP - 1769-1777 ST - MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas T2 - British Journal of Cancer TI - MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50926958&from=exporthttp://dx.doi.org/10.1038/sj.bjc.6605684 VL - 102 ID - 6776 ER - TY - JOUR AD - Y. Zhuang, Department of Orthopedics, Affiliated Jiangyin Hospital, Southeast University Medical College, Wuxi, China AU - Tian, Z. G. AU - Zhuang, Y. AU - Jin, Z. AU - Zhou, F. AU - Zhu, L. F. AU - Shen, P. C. DB - Embase Medline IS - 17 LA - English M3 - Article N1 - L623984826 2018-10-02 2018-10-04 PY - 2018 SN - 2284-0729 1128-3602 SP - 5460-5470 ST - MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways T2 - European Review for Medical and Pharmacological Sciences TI - MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623984826&from=export VL - 22 ID - 6777 ER - TY - JOUR AD - Y.-Q. Zhang, Department of Neurosurgery, Yuquan Hospital, Tsinghua University, No. 5 Shijingshan Road, Shijingshan District, Beijing, China AU - Ma, X. L. AU - Shang, F. AU - Ni, W. AU - Zhu, J. AU - Luo, B. AU - Zhang, Y. Q. DB - Embase Medline DO - 10.1007/s00432-018-2745-y IS - 12 LA - English M3 - Article N1 - L623963235 2018-09-25 2018-12-20 PY - 2018 SN - 1432-1335 0171-5216 SP - 2351-2366 ST - MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1 T2 - Journal of Cancer Research and Clinical Oncology TI - MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623963235&from=exporthttp://dx.doi.org/10.1007/s00432-018-2745-y VL - 144 ID - 6778 ER - TY - JOUR AD - Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China. Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Department of Neurosurgery, People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou 450003, PR China; Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Electronic address: buxingyaozz@yeah.net. AN - 29908894 AU - Wang, B. Q. AU - Yang, B. AU - Yang, H. C. AU - Wang, J. Y. AU - Hu, S. AU - Gao, Y. S. AU - Bu, X. Y. DA - Sep DO - 10.1016/j.brainresbull.2018.06.005 10.1016/j.brainresbull.2018.06.005. Epub 2018 Jun 15. DP - Nlm ET - 2018/06/18 LA - eng PY - 2018 SN - 0361-9230 SP - 96-106 ST - MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway T2 - Brain Res Bull TI - MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway VL - 142 ID - 6779 ER - TY - JOUR AD - F. Liu, Medical College of Xiamen University, Department of Basic Medical Sciences, Medical College, Xiamen University, Fujian Sheng, China AU - Fan, C. AU - Lin, B. AU - Huang, Z. AU - Cui, D. AU - Zhu, M. AU - Ma, Z. AU - Zhang, Y. AU - Liu, F. AU - Liu, Y. DB - Embase IS - 41 LA - English M3 - Article N1 - L628343593 2019-07-05 2019-07-10 PY - 2019 SN - 1949-2553 SP - 4192-4204 ST - MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4 T2 - Oncotarget TI - MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628343593&from=export VL - 10 ID - 6780 ER - TY - JOUR AD - Department of Ophthalmology, The First People's Hospital of Shangqiu, Shangqiu, Henan 476100, P.R. China. Department of Pathology, Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China. AN - 30664191 AU - Guo, L. AU - Bai, Y. AU - Ji, S. AU - Ma, H. C2 - PMC6365030 DA - Mar DO - 10.3892/ijo.2019.4689 10.3892/ijo.2019.4689. Epub 2019 Jan 17. DP - Nlm ET - 2019/01/22 IS - 3 LA - eng PY - 2019 SN - 1019-6439 (Print) 1019-6439 SP - 807-820 ST - MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway T2 - Int J Oncol TI - MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway VL - 54 ID - 6781 ER - TY - JOUR AD - Z.-F. Zhang, department of Gynecology, Affiliated, Hangzhou Hospital of Nanjing Medical University, 369 Kunpeng Road, Hangzhou, Zhejiang, China R.-C. Chian, department of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University, 818 Tianyuan East Road, Jiangning, Nanjing, Jiangsu, China AU - Zhang, D. AU - Wang, L. AU - Guo, H. L. AU - Zhang, Z. W. AU - Wang, C. AU - Chian, R. C. AU - Zhang, Z. F. DB - Embase Medline DO - 10.3892/ijmm.2020.4749 IS - 6 LA - English M3 - Article N1 - L2008424808 2020-11-04 PY - 2020 SN - 1791-244X 1107-3756 SP - 2078-2088 ST - MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway T2 - International Journal of Molecular Medicine TI - MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008424808&from=exporthttp://dx.doi.org/10.3892/ijmm.2020.4749 VL - 46 ID - 6782 ER - TY - JOUR AU - Zhang, Q. AU - Xiao, Z. AU - He, F. AU - Zou, J. AU - Wu, S. AU - Liu, Z. DB - Embase Medline DO - 10.1159/000343750 IS - 2 LA - English M3 - Article N1 - L603917486 2015-04-27 2015-05-11 PY - 2013 SN - 1423-0100 0300-5526 SP - 104-113 ST - MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis T2 - Intervirology TI - MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603917486&from=exporthttp://dx.doi.org/10.1159/000343750 VL - 56 ID - 6783 ER - TY - JOUR AD - Division of Molecular Life Sciences, Tokai University School of Medicine, 143 Shimokasuya, Isehara Kanagawa 259-1193, Japan Institute of Cellular Medicine, University of Newcastle, Medical School Framlington Place, Newcastle upon Tyne NE2 4HH, United Kingdom Department of Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara Kanagawa 259-1193, Japan Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics Yata, 111, Mishima, Shizuoka 411-8540, Japan Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden Chikusaku, Nagoya 646-8681, Japan AU - Harkensee, C. AU - Oka, A. AU - Onizuka, M. AU - Middleton, P. G. AU - Inoko, H. AU - Nakaoka, H. AU - Gennery, A. R. AU - Ando, K. AU - Morishima, Y. DB - Scopus DO - 10.1007/s00251-013-0691-z IS - 6 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2013 SP - 417-427 ST - Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation T2 - Immunogenetics TI - Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878017009&doi=10.1007%2fs00251-013-0691-z&partnerID=40&md5=2eca51a123f26a787e6160202f7fb5e3 VL - 65 ID - 6784 ER - TY - JOUR AD - Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States Department of Pathology, Washington University School of Medicine, St. Louis, MO, United States AU - Guo, X. AU - Pan, Y. AU - Xiong, M. AU - Sanapala, S. AU - Anastasaki, C. AU - Cobb, O. AU - Dahiya, S. AU - Gutmann, D. H. C7 - 2177 DB - Scopus DO - 10.1038/s41467-020-15770-3 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 ST - Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth T2 - Nature Communications TI - Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084080912&doi=10.1038%2fs41467-020-15770-3&partnerID=40&md5=7ee0011b178457df7a07f3110dfdede9 VL - 11 ID - 6785 ER - TY - JOUR AD - Novartis Oncology, East Hanover, NJ, United States Novartis Pharmaceuticals Corporation, 180 Park Avenue, Florham Park, NJ 07932, United States Novartis Oncology, Basel, Switzerland ERT, East Bridgewater, NJ, United States Osborne Research Center, LLC, Little Rock, AR, United States AU - Del Corral, A. AU - Dutreix, C. AU - Huntsman-Labed, A. AU - Lorenzo, S. AU - Morganroth, J. AU - Harrell, R. AU - Wang, Y. DB - Scopus DO - 10.1007/s00280-012-1825-y IS - 5 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2012 SP - 1255-1263 ST - Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers T2 - Cancer Chemotherapy and Pharmacology TI - Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862270599&doi=10.1007%2fs00280-012-1825-y&partnerID=40&md5=63f19375e513216d5fdd84de03fedd89 VL - 69 ID - 6786 ER - TY - JOUR AD - R. Gruber, Department of Oral Biology, Medical University of Vienna, Austria, Sensengasse 2a, Vienna, Austria AU - Panahipour, L. AU - Kochergina, E. AU - Kreissl, A. AU - Haiden, N. AU - Gruber, R. DB - Embase DO - 10.1016/j.cytox.2019.100009 IS - 2 LA - English M3 - Article N1 - L2002307035 2019-07-19 2019-07-25 PY - 2019 SN - 2590-1532 ST - Milk modulates macrophage polarization in vitro T2 - Cytokine: X TI - Milk modulates macrophage polarization in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002307035&from=exporthttp://dx.doi.org/10.1016/j.cytox.2019.100009 VL - 1 ID - 6787 ER - TY - JOUR AD - Institute of Nutritional Sciences, Justus-Liebig-University Giessen, Giessen, Germany. Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany. AN - 30984764 AU - Kuntz, S. AU - Rudloff, S. AU - Kunz, C. C2 - PMC6447651 DO - 10.3389/fnut.2019.00031 10.3389/fnut.2019.00031. eCollection 2019. DP - Nlm ET - 2019/04/16 LA - eng PY - 2019 SN - 2296-861X (Print) 2296-861x SP - 31 ST - Milk Oligosaccharides From Different Cattle Breeds Influence Growth-Related Characteristics of Intestinal Cells T2 - Front Nutr TI - Milk Oligosaccharides From Different Cattle Breeds Influence Growth-Related Characteristics of Intestinal Cells VL - 6 ID - 6788 ER - TY - JOUR AU - Wang, M. AU - Li, Y. AU - Zhou, K. AU - Zhang, G. AU - Wang, Y. AU - Liu, T. AU - Zhang, Y. AU - Guo, A. AU - An, Y. DB - Embase Medline DO - 10.1159/000447796 IS - 3 LA - English M3 - Article N1 - L611674653 2016-08-19 2019-05-14 PY - 2016 SN - 1421-9778 1015-8987 SP - 860-870 ST - Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism T2 - Cellular Physiology and Biochemistry TI - Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611674653&from=exporthttp://dx.doi.org/10.1159/000447796 VL - 39 ID - 6789 ER - TY - JOUR AD - Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, South Korea AU - Yoon, J. H. AU - Min, G. J. AU - Park, S. S. AU - Jeon, Y. W. AU - Lee, S. E. AU - Cho, B. S. AU - Eom, K. S. AU - Kim, Y. J. AU - Kim, H. J. AU - Min, C. K. AU - Cho, S. G. AU - Kim, D. W. AU - Lee, J. W. AU - Lee, S. DB - Scopus DO - 10.1002/cncr.31874 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2019 SP - 873-883 ST - Minimal residual disease–based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia T2 - Cancer TI - Minimal residual disease–based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058036805&doi=10.1002%2fcncr.31874&partnerID=40&md5=9db3c44d2ede50810740e2c1cb2d94ca VL - 125 ID - 6790 ER - TY - JOUR AD - J. Jankovic, Parkinson's Disease Center, Department of Neurology, Baylor College of Medicine, 6550 Fannin St., Houston, TX 77030, United States AU - Thomas, M. AU - Le, W. D. AU - Jankovic, J. C1 - cep 1347 DB - Embase Medline DO - 10.1097/00002826-200301000-00005 IS - 1 LA - English M3 - Article N1 - L36184111 2003-02-26 PY - 2003 SN - 0362-5664 SP - 18-23 ST - Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease T2 - Clinical Neuropharmacology TI - Minocycline and other tetracycline derivatives: A neuroprotective strategy in Parkinson's disease and Huntington's disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36184111&from=exporthttp://dx.doi.org/10.1097/00002826-200301000-00005 VL - 26 ID - 6791 ER - TY - JOUR AD - J. Xu, Shaoxing Second Hospital, 123 Yanan Road, Shaoxing, Zhejiang, China AU - Zheng, G. AU - Qiu, G. AU - Ge, M. AU - Meng, J. AU - Zhang, G. AU - Wang, J. AU - Huang, R. AU - Shu, Q. AU - Xu, J. DB - Embase Medline DO - 10.1155/2020/4370983 LA - English M3 - Article N1 - L2004858916 2020-02-14 2020-02-20 PY - 2020 SN - 1466-1861 0962-9351 ST - MiR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory Function T2 - Mediators of Inflammation TI - MiR-10a in Peripheral Blood Mononuclear Cells Is a Biomarker for Sepsis and Has Anti-Inflammatory Function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004858916&from=exporthttp://dx.doi.org/10.1155/2020/4370983 VL - 2020 ID - 6792 ER - TY - JOUR AD - 1 Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, China . 2 Department of Gerontology, The First Affiliated Hospital of Sun Yat-sen University , Guangzhou, China . 3 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital of Sun Yat-sen University , Guangzhou, China . 4 Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center , Guangzhou, China . AN - 27717302 AU - Hong, S. AU - Yu, S. AU - Li, J. AU - Yin, Y. AU - Liu, Y. AU - Zhang, Q. AU - Guan, H. AU - Li, Y. AU - Xiao, H. DA - Dec DO - 10.1089/thy.2015.0578 10.1089/thy.2015.0578. Epub 2016 Nov 2. DP - Nlm ET - 2016/11/03 IS - 12 LA - eng PY - 2016 SN - 1050-7256 SP - 1733-1743 ST - MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway T2 - Thyroid TI - MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway VL - 26 ID - 6793 ER - TY - JOUR AD - M. Pigazzi, Laboratory of Hematology-Oncology, Department of Pediatries, University of Padova, Via Giustiniani 3, 35128 Padova, Italy AU - Pigazzi, M. AU - Manara, E. AU - Baron, E. AU - Basso, G. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-3404 IS - 6 L1 - internal-pdf://0337739299/2471.full.pdf LA - English M3 - Article N1 - L354656706 2009-06-10 PY - 2009 SN - 0008-5472 1538-7445 SP - 2471-2478 ST - MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia T2 - Cancer Research TI - MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354656706&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-08-3404 VL - 69 ID - 6794 ER - TY - JOUR AD - Y.-P. Zhang, Department of Prenatal Diagnosis Center, Maternal and Child Health Care Hospital of Shandong Province, Key Laboratory of Birth Regulation and Control Technology of National Health and Family Planning Commission of China, Key Laboratory for Improving Birth Outcome Technique of Shandong Province, Jinan, China AU - Du, S. Y. AU - Huang, X. X. AU - Li, N. M. AU - Lv, C. Y. AU - Lv, C. H. AU - Wei, M. L. AU - Gao, Z. AU - Zhang, Y. P. DB - Embase Medline DO - 10.26355/eurrev_202010_23388 IS - 20 LA - English M3 - Article N1 - L2008501552 2020-11-13 PY - 2020 SN - 2284-0729 1128-3602 SP - 10383-10390 ST - MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4 T2 - European Review for Medical and Pharmacological Sciences TI - MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008501552&from=exporthttp://dx.doi.org/10.26355/eurrev_202010_23388 VL - 24 ID - 6795 ER - TY - JOUR AD - H. Zhang, Department of Orthopedics, Affiliated Jiangyin Hospital, Medical College of Southeast University, No. 163, Shoushan Road, Jiangyin, Jiangsu, China AU - Xu, X. AU - Cao, F. AU - Zhang, H. DB - Embase IS - 2 LA - English M3 - Article N1 - L2003914076 2020-03-06 2020-03-10 PY - 2020 SN - 1940-5901 SP - 407-416 ST - MiR-133b in predicting prognosis for patients with osteosarcoma, and its effect on apoptosis of osteosarcoma cells T2 - International Journal of Clinical and Experimental Medicine TI - MiR-133b in predicting prognosis for patients with osteosarcoma, and its effect on apoptosis of osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003914076&from=export VL - 13 ID - 6796 ER - TY - JOUR AD - R. Xue, Neonatal Ward of Department of Pediatrics, Jining No. 1 People's Hospital, No. 6 Jiankang Road, Jining, China AU - Quan, B. AU - Zhang, H. AU - Xue, R. DB - Embase Medline DO - 10.1016/j.lfs.2018.11.056 LA - English M3 - Article N1 - L2001335552 2018-12-07 2018-12-12 PY - 2019 SN - 1879-0631 0024-3205 SP - 271-278 ST - miR-141 alleviates LPS-induced inflammation injury in WI-38 fibroblasts by up-regulation of NOX2 T2 - Life Sciences TI - miR-141 alleviates LPS-induced inflammation injury in WI-38 fibroblasts by up-regulation of NOX2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001335552&from=exporthttp://dx.doi.org/10.1016/j.lfs.2018.11.056 VL - 216 ID - 6797 ER - TY - JOUR AD - Division of Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University , Kaohsiung, Taiwan. AN - 20406109 AU - Chou, C. K. AU - Chen, R. F. AU - Chou, F. F. AU - Chang, H. W. AU - Chen, Y. J. AU - Lee, Y. F. AU - Yang, K. D. AU - Cheng, J. T. AU - Huang, C. C. AU - Liu, R. T. DA - May DO - 10.1089/thy.2009.0027 10.1089/thy.2009.0027. DP - Nlm ET - 2010/04/22 IS - 5 LA - eng PY - 2010 SN - 1050-7256 SP - 489-94 ST - miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation T2 - Thyroid TI - miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation VL - 20 ID - 6798 ER - TY - JOUR AU - Li, N. AU - Nan, C. C. AU - Zhong, X. Y. AU - Weng, J. Q. AU - Fan, H. D. AU - Sun, H. P. AU - Tang, S. AU - Shi, L. AU - Huang, S. X. DB - Embase Medline DO - 10.1159/000493411 IS - 4 LA - English M3 - Article N1 - L624040053 2018-10-01 2019-05-14 PY - 2018 SN - 1421-9778 1015-8987 SP - 1329-1341 ST - MiR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1 T2 - Cellular Physiology and Biochemistry TI - MiR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624040053&from=exporthttp://dx.doi.org/10.1159/000493411 VL - 49 ID - 6799 ER - TY - JOUR AD - Z. Wang, Pediatric Orthopedic Department, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, 1678 Dongfang Road, Pudong, Shanghai, China AU - Cai, H. AU - Miao, M. AU - Wang, Z. DB - Embase DO - 10.3892/ol.2018.8927 IS - 2 LA - English M3 - Article N1 - L622921393 2018-07-11 2018-07-17 PY - 2018 SN - 1792-1082 1792-1074 SP - 2620-2628 ST - Mir-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting cadm1 T2 - Oncology Letters TI - Mir-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting cadm1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622921393&from=exporthttp://dx.doi.org/10.3892/ol.2018.8927 VL - 16 ID - 6800 ER - TY - JOUR AD - G. Decorti, Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Trieste, Italy AU - Lucafò, M. AU - Sicari, D. AU - Chicco, A. AU - Curci, D. AU - Bellazzo, A. AU - Di Silvestre, A. AU - Pegolo, C. AU - Autry, R. AU - Cecchin, E. AU - De Iudicibus, S. AU - Collavin, L. AU - Evans, W. AU - Decorti, G. AU - Stocco, G. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1007/s00280-020-04122-z IS - 3 LA - English M3 - Article N1 - L2005814660 2020-08-13 PY - 2020 SN - 1432-0843 0344-5704 SP - 361-374 ST - miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway T2 - Cancer Chemotherapy and Pharmacology TI - miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005814660&from=exporthttp://dx.doi.org/10.1007/s00280-020-04122-z VL - 86 ID - 6801 ER - TY - JOUR AD - X.-X. He, Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Fan, Y. P. AU - Liao, J. Z. AU - Lu, Y. Q. AU - Tian, D. A. AU - Ye, F. AU - Zhao, P. X. AU - Xiang, G. Y. AU - Tang, W. X. AU - He, X. X. DB - Embase DO - 10.1016/j.omtn.2017.03.010 LA - English M3 - Article N1 - L616751658 2017-06-20 2017-06-28 PY - 2017 SN - 2162-2531 SP - 181-189 ST - MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma T2 - Molecular Therapy - Nucleic Acids TI - MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616751658&from=exporthttp://dx.doi.org/10.1016/j.omtn.2017.03.010 VL - 7 ID - 6802 ER - TY - JOUR AD - F. Wang, Department of Oncology, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan, Hubei, China AU - Fu, H. AU - Zhang, J. AU - Pan, T. AU - Ai, S. AU - Tang, L. AU - Wang, F. C2 - Selleck(United States) DB - Embase Medline DO - 10.3892/mmr.2018.8390 IS - 3 LA - English M3 - Article N1 - L620409122 2018-02-05 2018-02-06 PY - 2018 SN - 1791-3004 1791-2997 SP - 4581-4588 ST - MiR-378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c-RAF T2 - Molecular Medicine Reports TI - MiR-378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c-RAF UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620409122&from=exporthttp://dx.doi.org/10.3892/mmr.2018.8390 VL - 17 ID - 6803 ER - TY - JOUR AD - S. Wang, Department of Rheumatology and Immune Disease, The First People’s Hospital of Yunnan Province, Kunming, Yunnan, China AU - Liu, K. AU - He, B. AU - Xu, J. AU - Li, Y. AU - Guo, C. AU - Cai, Q. AU - Wang, S. DB - Embase Medline DO - 10.12659/MSM.913005 LA - English M3 - Article N1 - L2001617890 2019-04-04 2019-05-14 PY - 2019 SN - 1643-3750 1234-1010 SP - 1459-1468 ST - MiR-483-5p targets MKNK1 to suppress wilms’ tumor cell proliferation and apoptosis in vitro and in vivo T2 - Medical Science Monitor TI - MiR-483-5p targets MKNK1 to suppress wilms’ tumor cell proliferation and apoptosis in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001617890&from=exporthttp://dx.doi.org/10.12659/MSM.913005 VL - 25 ID - 6804 ER - TY - JOUR AD - F. Meggetto, Inserm, UMR1037 CRCT, Toulouse, France AU - Hoareau-Aveilla, C. AU - Quelen, C. AU - Congras, A. AU - Caillet, N. AU - Labourdette, D. AU - Dozier, C. AU - Brousset, P. AU - Lamant, L. AU - Meggetto, F. C1 - pd 0332991 C2 - Sigma Aldrich(France) Selleck Chemicals(United States) DB - Embase Medline DO - 10.3324/haematol.2018.195131 IS - 2 LA - English M3 - Article N1 - L2001600606 2019-04-01 2019-04-03 PY - 2019 SN - 1592-8721 0390-6078 SP - 347-359 ST - miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells T2 - Haematologica TI - miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001600606&from=exporthttp://dx.doi.org/10.3324/haematol.2018.195131 VL - 104 ID - 6805 ER - TY - JOUR AD - T. Lv, Department of Hand and Foot Microsurgery, Liaoyang Central Hospital, Liaoyang, Liaoning, China AU - Lv, T. AU - Liu, Y. AU - Li, Z. AU - Huang, R. AU - Zhang, Z. AU - Li, J. DB - Embase Medline DO - 10.3233/CBM-170906 IS - 3 LA - English M3 - Article N1 - L625493375 2018-12-21 2019-04-10 PY - 2018 SN - 1875-8592 1574-0153 SP - 315-322 ST - MiR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor T2 - Cancer Biomarkers TI - MiR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625493375&from=exporthttp://dx.doi.org/10.3233/CBM-170906 VL - 23 ID - 6806 ER - TY - JOUR AD - Z. Wang, Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China AU - Chen, Y. AU - Qin, C. AU - Cui, X. AU - Geng, W. AU - Xian, G. AU - Wang, Z. DB - Embase Medline DO - 10.1002/jcp.29506 IS - 7-8 LA - English M3 - Article N1 - L2004157603 2020-02-04 2020-05-01 PY - 2020 SN - 1097-4652 0021-9541 SP - 5711-5721 ST - miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2 T2 - Journal of Cellular Physiology TI - miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004157603&from=exporthttp://dx.doi.org/10.1002/jcp.29506 VL - 235 ID - 6807 ER - TY - JOUR AD - J. Luo, Department of Orthopedics, Henan Provincial People's Hospital, 7 Weiwu Road, Zhengzhou, Henan, China AU - Gao, S. AU - Wang, J. AU - Tian, S. AU - Luo, J. DB - Embase Medline DO - 10.3892/ijo.2019.4783 IS - 6 LA - English M3 - Article N1 - L2001865335 2019-05-14 PY - 2019 SN - 1791-2423 1019-6439 SP - 1921-1932 ST - MiR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16 T2 - International Journal of Oncology TI - MiR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001865335&from=exporthttp://dx.doi.org/10.3892/ijo.2019.4783 VL - 54 ID - 6808 ER - TY - JOUR AD - M.S. Brassesco, Departamento de Biologia, FFCLRP-USP, Av. Bandeirantes, 3900, Bairro Monte Alegre, Ribeirao Preto, SP, Brazil AU - Viera, G. M. AU - Salomao, K. B. AU - de Sousa, G. R. AU - Baroni, M. AU - Delsin, L. E. A. AU - Pezuk, J. A. AU - Brassesco, M. S. DB - Embase Medline DO - 10.1007/s12094-019-02104-z IS - 12 LA - English M3 - Review N1 - L2002703455 2019-09-10 PY - 2019 SN - 1699-3055 1699-048X SP - 1583-1623 ST - miRNA signatures in childhood sarcomas and their clinical implications T2 - Clinical and Translational Oncology TI - miRNA signatures in childhood sarcomas and their clinical implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002703455&from=exporthttp://dx.doi.org/10.1007/s12094-019-02104-z VL - 21 ID - 6809 ER - TY - JOUR AD - G. Gao, Department of Orthopedics, Guizhou Provincial People's Hospital, No. 83, East Zhongshan Road, Guiyang Guizhou, China AU - Gao, G. AU - Tian, Z. AU - Zhu, H. Y. AU - Ouyang, X. Y. DB - Embase DO - 10.1186/s12935-018-0696-7 IS - 1 LA - English M3 - Article N1 - L625468031 2018-12-25 2019-01-03 PY - 2018 SN - 1475-2867 ST - MiRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma T2 - Cancer Cell International TI - MiRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625468031&from=exporthttp://dx.doi.org/10.1186/s12935-018-0696-7 VL - 18 ID - 6810 ER - TY - JOUR AD - Department of Respiratory Medicine, Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, 210008, China Department of Pediatrics, Jiangsu Huai'an Maternity and Children's Hospital, Huai'an, Jiangsu, 223002, China AU - Zhou, Y. AU - Yang, Q. AU - Xu, H. AU - Zhang, J. AU - Deng, H. AU - Gao, H. AU - Yang, J. AU - Zhao, D. AU - Liu, F. C7 - e0148821 DB - Scopus DO - 10.1371/journal.pone.0148821 IS - 2 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2016 ST - MiRNA-221-3p enhances the secretion of interleukin-4 in mast cells through the phosphatase and tensin homolog/p38/nuclear factor-kappaB pathway T2 - PLoS ONE TI - MiRNA-221-3p enhances the secretion of interleukin-4 in mast cells through the phosphatase and tensin homolog/p38/nuclear factor-kappaB pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960540793&doi=10.1371%2fjournal.pone.0148821&partnerID=40&md5=c74284dd019c95fe3612c4fa48312f1d VL - 11 ID - 6811 ER - TY - JOUR AD - N. Kaparos, Pediatric Dermatology Unit, University Hospital CHUV, Lausanne, Switzerland AU - Kaparos, N. AU - Norrenberg, S. AU - Christen-Zaech, S. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779725 2017-10-23 PY - 2017 SN - 1525-1470 SP - S24 ST - Misdiagnosis of neurofibromatosis type 1 in patients with piebaldism T2 - Pediatric Dermatology TI - Misdiagnosis of neurofibromatosis type 1 in patients with piebaldism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779725&from=exporthttp://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 6812 ER - TY - JOUR AD - Department of Pediatrics, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States Midwest Research Institute, Kansas City, MO, United States Neonatology Research Laboratory, Children's Mercy Hospital, Pediatric Research Center, 2401 Gillham Rd., Kansas City, MO 64108, United States AU - Xu, D. AU - Guthrie, J. R. AU - Mabry, S. AU - Sack, T. M. AU - Truog, W. E. DB - Scopus DO - 10.1152/ajplung.00045.2006 IS - 5 M3 - Article N1 - Cited By :62 Export Date: 18 November 2020 PY - 2006 SP - L966-L975 ST - Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751082661&doi=10.1152%2fajplung.00045.2006&partnerID=40&md5=95c94e621a0d85e07580f825e97d0b7a VL - 291 ID - 6813 ER - TY - JOUR AD - S. Grazioli, Pediatric Intensive Care Unit, Department of Pediatrics, University Hospital of Geneva, University of Geneva, Geneva, Switzerland AU - Grazioli, S. AU - Pugin, J. DB - Embase DO - 10.3389/fimmu.2018.00832 IS - MAY LA - English M3 - Review N1 - L622020029 2018-05-16 2018-05-29 PY - 2018 SN - 1664-3224 ST - Mitochondrial damage-associated molecular patterns: From inflammatory signaling to human diseases T2 - Frontiers in Immunology TI - Mitochondrial damage-associated molecular patterns: From inflammatory signaling to human diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622020029&from=exporthttp://dx.doi.org/10.3389/fimmu.2018.00832 VL - 9 ID - 6814 ER - TY - JOUR AD - S. W. Sunnarborg, Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599, United States AU - Myers, T. J. AU - Brennaman, L. H. AU - Stevenson, M. AU - Higashiyama, S. AU - Russell, W. E. AU - Lee, D. C. AU - Sunnarborg, S. W. DB - Embase Medline DO - 10.1091/mbc.E08-12-1256 IS - 24 LA - English M3 - Article N1 - L358082990 2010-02-02 PY - 2009 SN - 1059-1524 SP - 5236-5249 ST - Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-α shedding T2 - Molecular Biology of the Cell TI - Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factor-α shedding UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358082990&from=exporthttp://dx.doi.org/10.1091/mbc.E08-12-1256http://www.molbiolcell.org/cgi/reprint/20/24/5236 VL - 20 ID - 6815 ER - TY - JOUR AD - Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy. Center for Life Nano Science at Sapienza, Italian Institute of Technology, 00161 Rome, Italy. Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy. Department of Biochemical Sciences 'A. Rossi Fanelli', Sapienza University of Rome, 00161 Rome, Italy. Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. AN - 30483764 AU - Antonucci, L. AU - Di Magno, L. AU - D'Amico, D. AU - Manni, S. AU - Serrao, S. M. AU - Di Pastena, F. AU - Bordone, R. AU - Yurtsever, Z. N. AU - Caimano, M. AU - Petroni, M. AU - Giorgi, A. AU - Schininà, M. E. AU - Yates Iii, J. R. AU - Di Marcotullio, L. AU - De Smaele, E. AU - Checquolo, S. AU - Capalbo, C. AU - Agostinelli, E. AU - Maroder, M. AU - Coni, S. AU - Canettieri, G. C2 - PMC6317670 DA - Feb DO - 10.3892/ijo.2018.4638 10.3892/ijo.2018.4638. Epub 2018 Nov 19. DP - Nlm ET - 2018/11/30 IS - 2 LA - eng PY - 2019 SN - 1019-6439 (Print) 1019-6439 SP - 505-514 ST - Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation T2 - Int J Oncol TI - Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation VL - 54 ID - 6816 ER - TY - JOUR AD - X.-P. Li, Department of Pediatrics, First Hospital of Jilin University, Changchun, Jilin Province, China AU - Gu, Y. AU - Ma, L. J. AU - Bai, X. X. AU - Jie, J. AU - Zhang, X. F. AU - Chen, D. AU - Li, X. P. DB - Embase DO - 10.4103/1673-5374.238621 IS - 10 LA - English M3 - Article N1 - L623688913 2018-09-04 2018-09-07 PY - 2018 SN - 1876-7958 1673-5374 SP - 1842-1850 ST - Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity T2 - Neural Regeneration Research TI - Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623688913&from=exporthttp://dx.doi.org/10.4103/1673-5374.238621 VL - 13 ID - 6817 ER - TY - JOUR AD - M.M. Talavera, Center for Perinatal Research, Research Institute at Nationwide Children's Hospital, Columbus, OH, United States AU - Talavera, M. M. AU - Kralik, N. AU - Jin, Y. AU - Chen, B. AU - Liu, Y. AU - Nelin, L. D. DB - Embase Medline DO - 10.1038/pr.2015.88 IS - 2 LA - English M3 - Article N1 - L605267937 2015-07-27 2015-07-28 PY - 2015 SN - 1530-0447 0031-3998 SP - 128-136 ST - Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells T2 - Pediatric Research TI - Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605267937&from=exporthttp://dx.doi.org/10.1038/pr.2015.88 VL - 78 ID - 6818 ER - TY - JOUR AD - Q.-Y. Wu, Heart Center, First Hospital of Tsinghua University, Beijing 100016, China AU - Zhang, H. S. AU - Wu, Q. Y. AU - Xu, M. AU - Zhou, Y. X. AU - Shui, C. X. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.2012.13.001 IS - 13 LA - English M3 - Article N1 - L365240035 2012-07-20 2012-08-06 PY - 2012 SN - 0366-6999 SP - 2243-2249 ST - Mitogen-activated protein kinase signal pathways play an important role in right ventricular hypertrophy of tetralogy of Fallot T2 - Chinese Medical Journal TI - Mitogen-activated protein kinase signal pathways play an important role in right ventricular hypertrophy of tetralogy of Fallot UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365240035&from=exporthttp://dx.doi.org/10.3760/cma.j.issn.0366-6999.2012.13.001http://www.cmj.org/Periodical/PdfList.asp?id=CMJLW201273383785202457 VL - 125 ID - 6819 ER - TY - JOUR AD - U.J.F. Tietge, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands AU - De Boer, J. F. AU - Dikkers, A. AU - Jurdzinski, A. AU - Felden, J. V. AU - Gaestel, M. AU - Bavendiek, U. AU - Tietge, U. J. F. DB - Embase Medline DO - 10.1371/journal.pone.0106300 IS - 9 LA - English M3 - Article N1 - L600046302 2014-10-01 2019-12-30 PY - 2014 SN - 1932-6203 ST - Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice T2 - PLoS ONE TI - Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600046302&from=exporthttp://dx.doi.org/10.1371/journal.pone.0106300 VL - 9 ID - 6820 ER - TY - JOUR AD - L. Xie, Department of Pharmacology, Institute of Natural Medicine, Anhui Medical University, Hefei, China AU - Xie, L. AU - Yang, Y. AU - Rui, W. J. AU - Jiang, J. M. AU - Hu, X. P. AU - Wu, C. DB - Embase DO - 10.1038/aps.2013.108 LA - English M3 - Conference Abstract N1 - L71285127 2014-01-15 PY - 2013 SN - 1671-4083 SP - 15 ST - Mitogen-activated protein kinases inhibitors exerts anti-fibrosis by mediating TGF-β/ Smad signaling in HepG2 cells and HSC cells T2 - Acta Pharmacologica Sinica TI - Mitogen-activated protein kinases inhibitors exerts anti-fibrosis by mediating TGF-β/ Smad signaling in HepG2 cells and HSC cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71285127&from=exporthttp://dx.doi.org/10.1038/aps.2013.108 VL - 34 ID - 6821 ER - TY - JOUR AD - Department of Immunochemistry, Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. AN - 22749438 AU - Sugiura, Y. AU - Hiramatsu, K. AU - Hamauzu, R. AU - Motoki, T. AU - Miyazaki, M. AU - Uto, H. AU - Tsubouchi, H. AU - Tanaka, S. AU - Gohda, E. DA - Oct DO - 10.1016/j.cyto.2012.06.007 10.1016/j.cyto.2012.06.007. Epub 2012 Jun 30. DP - Nlm ET - 2012/07/04 IS - 1 LA - eng PY - 2012 SN - 1043-4666 SP - 205-11 ST - Mitogen-activated protein kinases-dependent induction of hepatocyte growth factor production in human dermal fibroblasts by the antibiotic polymyxin B T2 - Cytokine TI - Mitogen-activated protein kinases-dependent induction of hepatocyte growth factor production in human dermal fibroblasts by the antibiotic polymyxin B VL - 60 ID - 6822 ER - TY - JOUR AD - R. Beroukhim, Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA, United States AU - Reitman, Z. J. AU - Paolella, B. R. AU - Bergthold, G. AU - Pelton, K. AU - Becker, S. AU - Jones, R. AU - Sinai, C. E. AU - Malkin, H. AU - Huang, Y. AU - Grimmet, L. AU - Herbert, Z. T. AU - Sun, Y. AU - Weatherbee, J. L. AU - Alberta, J. A. AU - Daley, J. F. AU - Rozenblatt-Rosen, O. AU - Condurat, A. L. AU - Qian, K. AU - Khadka, P. AU - Segal, R. A. AU - Haas-Kogan, D. AU - Filbin, M. G. AU - Suva, M. L. AU - Regev, A. AU - Stiles, C. D. AU - Kieran, M. W. AU - Goumnerova, L. AU - Ligon, K. L. AU - Shalek, A. K. AU - Bandopadhayay, P. AU - Beroukhim, R. DB - Embase Medline DO - 10.1038/s41467-019-11493-2 IS - 1 LA - English M3 - Article N1 - L2002505294 2019-08-26 2019-08-29 PY - 2019 SN - 2041-1723 ST - Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells T2 - Nature Communications TI - Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002505294&from=exporthttp://dx.doi.org/10.1038/s41467-019-11493-2 VL - 10 ID - 6823 ER - TY - JOUR AD - Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei 10002, Taiwan. Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7, Chung-Shan South Road, Taipei , 10002, Taiwan. AN - 30664316 AU - Huang, Y. L. AU - Chang, Y. L. AU - Chen, K. C. AU - Wu, C. T. DA - Feb DO - 10.1111/pin.12747 10.1111/pin.12747. Epub 2019 Jan 21. DP - Nlm ET - 2019/01/22 IS - 2 LA - eng PY - 2019 SN - 1320-5463 SP - 104-109 ST - Mixed squamous cell and glandular papilloma of the lung: A case report of a novel mutation in the BRAF gene and coexistent HPV infection, possible relationship to ciliated muconodular papillary tumor T2 - Pathol Int TI - Mixed squamous cell and glandular papilloma of the lung: A case report of a novel mutation in the BRAF gene and coexistent HPV infection, possible relationship to ciliated muconodular papillary tumor VL - 69 ID - 6824 ER - TY - JOUR AD - HRB Clinical Research Facilities, National University of Ireland Galway, Trinity College Dublin, Galway, Ireland Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States Chaim Sheba Medical Center, Tel-Hashomer, Israel Universitätsklinikum Jena, Jena, Germany Johann Wolfgang Goethe Universität, Frankfurt, Germany Division of Cellular Therapy, Duke University Hospital, Durham, NC, United States University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States Merck and Co., Inc., North Wales, PA, United States Hematology and Oncology Department, Charité, Berlin, Germany University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Giles, F. J. AU - Swords, R. T. AU - Nagler, A. AU - Hochhaus, A. AU - Ottmann, O. G. AU - Rizzieri, D. A. AU - Talpaz, M. AU - Clark, J. AU - Watson, P. AU - Xiao, A. AU - Zhao, B. AU - Bergstrom, D. AU - Le Coutre, P. D. AU - Freedman, S. J. AU - Cortes, J. E. DB - Scopus DO - 10.1038/leu.2012.186 IS - 1 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2013 SP - 113-117 ST - MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia T2 - Leukemia TI - MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873570889&doi=10.1038%2fleu.2012.186&partnerID=40&md5=d93afb3ea93951515cc5715a7cde9226 VL - 27 ID - 6825 ER - TY - JOUR AU - Tietz, S. M. AU - Hofmann, R. AU - Thomas, T. AU - Tackenberg, B. AU - Gaestel, M. AU - Berghoff, M. DB - Embase Medline DO - 10.1371/journal.pone.0100363 IS - 6 LA - English M3 - Article N1 - L373419024 2014-07-09 2014-07-14 PY - 2014 SN - 1932-6203 ST - MK2 and Fas receptor contribute to the severity of CNS demyelination T2 - PLoS ONE TI - MK2 and Fas receptor contribute to the severity of CNS demyelination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373419024&from=exporthttp://dx.doi.org/10.1371/journal.pone.0100363 VL - 9 ID - 6826 ER - TY - JOUR AD - S.E. Dunn, Department of Pediatrics, Child and Family Research Institute, University of British Columbia, 950 West 28th Ave, Vancouver, BC, V5Z 4H4, Canada AU - Astanehe, A. AU - Finkbeiner, M. R. AU - Krzywinski, M. AU - Fotovati, A. AU - Dhillon, J. AU - Berquin, I. M. AU - Mills, G. B. AU - Marra, M. A. AU - Dunn, S. E. C1 - herceptin DB - Embase Medline DO - 10.1038/onc.2011.617 IS - 41 LA - English M3 - Article N1 - L51815436 2012-01-18 2012-10-26 PY - 2012 SN - 0950-9232 1476-5594 SP - 4434-4446 ST - MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition T2 - Oncogene TI - MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51815436&from=exporthttp://dx.doi.org/10.1038/onc.2011.617 VL - 31 ID - 6827 ER - TY - JOUR AD - J.A. Hanna, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Hanna, J. A. AU - Langdon, C. G. AU - Garcia, M. R. AU - Finkelstein, D. AU - Rehg, J. E. AU - Hatley, M. E. DB - Embase DO - 10.1158/1538-7445.SABCS18-4631 IS - 13 LA - English M3 - Conference Abstract N1 - L628905989 2019-08-20 PY - 2019 SN - 1538-7445 ST - Modeling the vascular sarcoma spectrum with genetically engineered mice T2 - Cancer Research TI - Modeling the vascular sarcoma spectrum with genetically engineered mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628905989&from=exporthttp://dx.doi.org/10.1158/1538-7445.SABCS18-4631 VL - 79 ID - 6828 ER - TY - JOUR AD - M.H. Sohn, Department of Pediatrics, Yonsei University College of Medicine, 134 Sinchon-Dong, Seoul 120-752, South Korea AU - Lee, K. E. AU - Kim, K. W. AU - Hong, J. Y. AU - Kim, K. E. AU - Sohn, M. H. DB - Embase Medline DO - 10.1007/s10875-013-9909-y IS - 6 LA - English M3 - Article N1 - L52639299 2013-06-20 2013-08-03 PY - 2013 SN - 0271-9142 1573-2592 SP - 1117-1125 ST - Modulation of IL-8 boosted by mycoplasma pneumoniae lysate in human airway epithelial cells T2 - Journal of Clinical Immunology TI - Modulation of IL-8 boosted by mycoplasma pneumoniae lysate in human airway epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52639299&from=exporthttp://dx.doi.org/10.1007/s10875-013-9909-y VL - 33 ID - 6829 ER - TY - JOUR AD - N.B. Goren, CEFYBO-UBA-CONICET, Paraguay 2155, Piso 12, Buenos Aires 1121, Argentina AU - Hovsepian, E. AU - Mirkin, G. A. AU - Penas, F. AU - Manzano, A. AU - Bartrons, R. AU - Goren, N. B. DB - Embase Medline DO - 10.1016/j.ijpara.2010.12.002 IS - 5 LA - English M3 - Article N1 - L51262179 2011-03-23 2011-03-29 PY - 2011 SN - 0020-7519 SP - 553-562 ST - Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes T2 - International Journal for Parasitology TI - Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51262179&from=exporthttp://dx.doi.org/10.1016/j.ijpara.2010.12.002 VL - 41 ID - 6830 ER - TY - JOUR AD - I. Singh, Department of Pediatrics, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, United States AU - Paintlia, A. S. AU - Paintlia, M. K. AU - Singh, A. K. AU - Singh, I. DB - Embase Medline DO - 10.1002/glia.22537 IS - 9 LA - English M3 - Article N1 - L52681332 2013-07-17 2013-08-09 PY - 2013 SN - 0894-1491 1098-1136 SP - 1500-1517 ST - Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism T2 - GLIA TI - Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52681332&from=exporthttp://dx.doi.org/10.1002/glia.22537 VL - 61 ID - 6831 ER - TY - JOUR AD - V.I. Avramis, #57, 4650 Sunset Blvd., Los Angeles, CA 90027, United States AU - Avramis, V. I. C1 - gleevec glivec nsc 680410 sti 571 DB - Embase IS - 11 LA - English M3 - Review N1 - L38133151 2004-02-12 PY - 2003 SN - 0377-8282 SP - 1087-1102 ST - Modulation of signaling pathways by adaphostin (NSC-680410), an antileukemic tyrosine kinase inhibitor: The past, the present and recommendations for the future T2 - Drugs of the Future TI - Modulation of signaling pathways by adaphostin (NSC-680410), an antileukemic tyrosine kinase inhibitor: The past, the present and recommendations for the future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38133151&from=export VL - 28 ID - 6832 ER - TY - JOUR AD - A. Schindeler, Orthopaedic Research & Biotechnology Research Building, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, Australia AU - Bobyn, J. D. AU - Deo, N. AU - Little, D. G. AU - Schindeler, A. DB - Embase Medline DO - 10.1016/j.jos.2020.05.016 LA - English M3 - Article in Press N1 - L2007164129 2020-07-29 PY - 2020 SN - 1436-2023 0949-2658 ST - Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation T2 - Journal of Orthopaedic Science TI - Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine model of NF1 double inactivation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007164129&from=exporthttp://dx.doi.org/10.1016/j.jos.2020.05.016 ID - 6833 ER - TY - JOUR AU - Qian, J. AU - Chen, Q. AU - Yao, D. M. AU - Yang, L. AU - Yang, J. AU - Wen, X. M. AU - Zhang, Y. Y. AU - Chai, H. Y. AU - Ma, J. C. AU - Deng, Z. Q. AU - Lin, J. DB - Medline IS - 1 LA - English M3 - Article N1 - L609476640 2016-04-13 PY - 2015 SN - 1936-2625 SP - 127-136 ST - MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia T2 - International journal of clinical and experimental pathology TI - MOK overexpression is associated with promoter hypomethylation in patients with acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609476640&from=export VL - 8 ID - 6834 ER - TY - JOUR AD - Institut National de la Santé et de la Recherche Médicale (Inserm) U1053, Universitaire de Bordeaux, F-33076 Bordeaux, France. Service de Pathologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France. Service de Biologie des Tumeurs-Tumorothèque, Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut-Lévêque, F-33604 Pessac, France. Service de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, F-33000 Bordeaux, France. Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, CEP 20550-013 Rio de Janeiro, Brazil. Plateforme de Vectorologie, Unité Mixte de Services (UMS TBM-Core), Centre National de la Recherche Scientifique (CNRS)- Institut National de la Santé et de la Recherche Médicale (Inserm)-Universitaire de Bordeaux, F-33076 Bordeaux, France. Biothérapies des Maladies Génétiques et Cancers, Institut National de la Santé et de la Recherche Médicale (Inserm), U1035, Universitaire de Bordeaux, F-33076 Bordeaux, France. AN - 27626696 AU - Mélard, P. AU - Idrissi, Y. AU - Andrique, L. AU - Poglio, S. AU - Prochazkova-Carlotti, M. AU - Berhouet, S. AU - Boucher, C. AU - Laharanne, E. AU - Chevret, E. AU - Pham-Ledard, A. AU - De Souza Góes, A. C. AU - Guyonnet-Duperat, V. AU - Bibeyran, A. AU - Moreau-Gaudry, F. AU - Vergier, B. AU - Beylot-Barry, M. AU - Merlio, J. P. AU - Cappellen, D. C2 - PMC5356586 DA - Oct 18 DO - 10.18632/oncotarget.11930 10.18632/oncotarget.11930. DP - Nlm ET - 2016/09/15 IS - 42 LA - eng PY - 2016 SN - 1949-2553 SP - 68734-68748 ST - Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes T2 - Oncotarget TI - Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes VL - 7 ID - 6835 ER - TY - JOUR AD - Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. Present address: Research Department of Pathology, Cancer Institute, University College London, 72 Huntley St, Camden Town, London, WC1E 6DD, UK. Present address: Department of Neuropathology, St Jude Children's Research Hospital, Memphis, TN, 38105, USA. Present address: Inivata Limited, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Developmental Biology and Cancer Programme, UCL-Institute of Child Health, University College London, London, WC1N 1EH, UK. Department of Neurosurgery, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Department of Oncology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, WC1N 3JH, UK. t.jacques@ich.ucl.ac.uk. Developmental Biology and Cancer Programme, UCL-Institute of Child Health, University College London, London, WC1N 1EH, UK. t.jacques@ich.ucl.ac.uk. Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK. d.sheer@qmul.ac.uk. AN - 26682910 AU - Jones, T. A. AU - Jeyapalan, J. N. AU - Forshew, T. AU - Tatevossian, R. G. AU - Lawson, A. R. AU - Patel, S. N. AU - Doctor, G. T. AU - Mumin, M. A. AU - Picker, S. R. AU - Phipps, K. P. AU - Michalski, A. AU - Jacques, T. S. AU - Sheer, D. C2 - PMC4683939 DA - Dec 18 DO - 10.1186/s40478-015-0266-3 10.1186/s40478-015-0266-3. DP - Nlm ET - 2015/12/20 LA - eng PY - 2015 SN - 2051-5960 SP - 86 ST - Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways T2 - Acta Neuropathol Commun TI - Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways VL - 3 ID - 6836 ER - TY - JOUR AD - L. Altucci, Dipartimento di Patologia Generale, Seconda Università di Napoli, Via L. De Crecchio 7, Napoli, Italy AU - Bontempo, P. AU - Mita, L. AU - Doto, A. AU - Miceli, M. AU - Nebbioso, A. AU - Lepore, I. AU - Franci, G. L. AU - Menafra, R. AU - Carafa, V. AU - Conte, M. AU - De Bellis, F. AU - Manzo, F. AU - Di Cerbo, V. AU - Benedetti, R. AU - D'Amato, L. AU - Marino, M. AU - Bolli, A. AU - Del Pozzo, G. AU - Diano, N. AU - Portaccio, M. AU - Mita, G. D. AU - Vietri, M. T. AU - Cioffi, M. AU - Nola, E. AU - Dell'Aversana, C. AU - Sica, V. AU - Molinari, A. M. AU - Altucci, L. DB - Embase Medline DO - 10.1186/1479-5876-7-48 LA - English M3 - Article N1 - L355071327 2009-09-14 PY - 2009 SN - 1479-5876 ST - Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells T2 - Journal of Translational Medicine TI - Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355071327&from=exporthttp://dx.doi.org/10.1186/1479-5876-7-48 VL - 7 ID - 6837 ER - TY - JOUR AD - Y.J. Kang, Department of Medicine, Univ. of Louisville Sch. of Medicine, 511 S. Floyd St., MDR 530, Louisville, KY 40202, United States AU - Kang, Y. J. DB - Embase Medline DO - 10.1289/ehp.01109s127 IS - SUPPL. 1 LA - English M3 - Article N1 - L32303228 2001-05-01 PY - 2001 SN - 0091-6765 SP - 27-34 ST - Molecular and cellular mechanisms of cardiotoxicity T2 - Environmental Health Perspectives TI - Molecular and cellular mechanisms of cardiotoxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32303228&from=exporthttp://dx.doi.org/10.1289/ehp.01109s127 VL - 109 ID - 6838 ER - TY - JOUR AD - Department of Pediatrics, University of California San Francisco, San Francisco, CA, United States Department of Genetics, LSU Health Sciences Center, New Orleans, LA, United States McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MD, United States Center for Pediatric and Adolescent Medicine, Thibodaux, LA, United States GeneDx, Gaithersburg, MD, United States Pediatrics, LSUHSC and Children's Hospital, 200 Henry Clay, New Orleans, LA 70118, United States AU - Rauen, K. A. AU - Tidyman, W. E. AU - Estep, A. L. AU - Sampath, S. AU - Peltier, H. M. AU - Bale, S. J. AU - Lacassie, Y. DB - Scopus DO - 10.1002/ajmg.a.33342 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2010 SP - 807-814 ST - Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations T2 - American Journal of Medical Genetics, Part A TI - Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: Transmission through four generations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950409870&doi=10.1002%2fajmg.a.33342&partnerID=40&md5=f5bd091c1dcce4d96ddf65076dcfa429 VL - 152 ID - 6839 ER - TY - JOUR AD - Department of Immunology and Experimental Therapeutics, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Cancer Biology PhD Program, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, United States Department of Pathology, H. Lee Moffitt Cancer Center, Research Institute, Tampa, FL, United States Hematology Research Unit, Biomedicum Helsinki, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland AU - Powers, J. J. AU - Dubovsky, J. A. AU - Epling-Burnette, P. K. AU - Moscinski, L. AU - Zhang, L. AU - Mustjoki, S. AU - Sotomayor, E. M. AU - Pinilla-Ibarz, J. A. DB - Scopus DO - 10.3109/10428194.2010.550074 IS - 4 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2011 SP - 668-679 ST - A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors T2 - Leukemia and Lymphoma TI - A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953206281&doi=10.3109%2f10428194.2010.550074&partnerID=40&md5=3cc30a6ff1b56e99218dc8c79a5a1e62 VL - 52 ID - 6840 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. AN - 23730215 AU - Shi, B. AU - Vishwamitra, D. AU - Granda, J. G. AU - Whitton, T. AU - Shi, P. AU - Amin, H. M. C2 - PMC3664999 DA - Jun DO - 10.1593/neo.122012 10.1593/neo.122012. DP - Nlm ET - 2013/06/05 IS - 6 LA - eng PY - 2013 SN - 1522-8002 (Print) 1476-5586 SP - 669-83 ST - Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor T2 - Neoplasia TI - Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor VL - 15 ID - 6841 ER - TY - JOUR AD - T. Kamijo, Division of Biochemistry and Molecular Carcinogenesis, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba, Chiba 260-8717, Japan AU - Kamijo, T. AU - Nakagawara, A. DB - Embase Medline DO - 10.1007/s10147-012-0415-7 IS - 3 LA - English M3 - Review N1 - L52012382 2012-05-18 2012-07-12 PY - 2012 SN - 1341-9625 1437-7772 SP - 190-195 ST - Molecular and genetic bases of neuroblastoma T2 - International Journal of Clinical Oncology TI - Molecular and genetic bases of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52012382&from=exporthttp://dx.doi.org/10.1007/s10147-012-0415-7 VL - 17 ID - 6842 ER - TY - JOUR AD - Department of Molecular Medicine and Haematology, Faculty of Health Sciences, Wits Medical School, National Health Laboratory Services and University of the Witwatersrand, Parktown, Johannesburg 2195, South Africa National Cancer Registry and Research, NHLS/MRC Cancer Epidemiology Research Group, National Health Laboratory Services, Johannesburg, South Africa Department of Histopathology, Partner Drs Gritzman and Thatcher, The Wits University Donald Gordon Medical Centre, Johannesburg, South Africa Department of Anatomical Pathology, National Health Laboratory Service and University of Pretoria, Tshwane, South Africa Department of Anatomical Pathology, Faculty of Health Sciences, National Health Laboratory Service and University of the Free State, Bloemfontein, South Korea Department of Pathology, Edouard Herriot Hospital and University of Lyon, University Claude Bernard, Lyon, France Department of Medical Oncology, Center Leon Berard, University Claude Bernard, Lyon, France AU - Baker, G. AU - Babb, C. AU - Schnugh, D. AU - Nayler, S. AU - Louw, M. AU - Goedhals, J. AU - Bringuier, P. P. AU - Blay, J. Y. AU - Willem, P. DB - Scopus DO - 10.3892/ol.2012.1013 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2012 SP - 155-160 ST - Molecular characterisation of gastrointestinal stromal tumours in a South African population T2 - Oncology Letters TI - Molecular characterisation of gastrointestinal stromal tumours in a South African population UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869030780&doi=10.3892%2fol.2012.1013&partnerID=40&md5=c0171d660180bfe5be04f5eea5e4a9cc VL - 5 ID - 6843 ER - TY - JOUR AD - Institut National de la Santé et de la Recherche Médicale, UMR 664, Lyon F-69372, France. AN - 19208736 AU - Durand, S. AU - Ferraro-Peyret, C. AU - Joufre, M. AU - Chave, A. AU - Borson-Chazot, F. AU - Selmi-Ruby, S. AU - Rousset, B. DA - Jun DO - 10.1677/erc-08-0081 10.1677/ERC-08-0081. Epub 2009 Feb 10. DP - Nlm ET - 2009/02/12 IS - 2 LA - eng PY - 2009 SN - 1351-0088 (Print) 1351-0088 SP - 467-81 ST - Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features T2 - Endocr Relat Cancer TI - Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features VL - 16 ID - 6844 ER - TY - JOUR AD - K.C. Moon, Department of Pathology and Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, 103 Daehak-ro Jongno-gu, Seoul, South Korea AU - Park, J. H. AU - Lee, C. AU - Chang, M. S. AU - Kim, K. AU - Choi, S. AU - Lee, H. AU - Lee, H. S. AU - Moon, K. C. DB - Embase DO - 10.1016/j.tranon.2018.05.010 IS - 4 LA - English M3 - Article N1 - L2000863275 2018-06-21 2018-06-26 PY - 2018 SN - 1936-5233 SP - 962-970 ST - Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma T2 - Translational Oncology TI - Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000863275&from=exporthttp://dx.doi.org/10.1016/j.tranon.2018.05.010 VL - 11 ID - 6845 ER - TY - JOUR AD - Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Pathological Anatomy, University of Pisa, Pisa, Italy. AN - 24913568 AU - Proietti, A. AU - Borrelli, N. AU - Giannini, R. AU - Romani, R. AU - Di Coscio, G. AU - Quilici, F. AU - Rago, T. AU - Miccoli, P. AU - Vitti, P. AU - Basolo, F. DA - Oct DO - 10.1002/cncy.21454 10.1002/cncy.21454. Epub 2014 Jun 9. DP - Nlm ET - 2014/06/11 IS - 10 LA - eng PY - 2014 SN - 1934-662x SP - 751-9 ST - Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas T2 - Cancer Cytopathol TI - Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas VL - 122 ID - 6846 ER - TY - JOUR AD - Department of Surgical and Molecular Pathology, National Institute of Oncology, Budapest, Hungary. vereczkey.ildiko@oncol.hu AN - 21136228 AU - Vereczkey, I. AU - Serester, O. AU - Dobos, J. AU - Gallai, M. AU - Szakács, O. AU - Szentirmay, Z. AU - Tóth, E. DA - Sep DO - 10.1007/s12253-010-9345-8 10.1007/s12253-010-9345-8. Epub 2010 Dec 7. DP - Nlm ET - 2010/12/08 IS - 3 LA - eng PY - 2011 SN - 1219-4956 SP - 551-9 ST - Molecular characterization of 103 ovarian serous and mucinous tumors T2 - Pathol Oncol Res TI - Molecular characterization of 103 ovarian serous and mucinous tumors VL - 17 ID - 6847 ER - TY - JOUR AD - Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China Department of Respiratory Disease, Xinqiao Hospital, Third Military Medical University, Chongqing, China Department of Respiratory Medicine, Southwest Hospital, Third Military Medical University, Chongqing, China Department of Respiratory, Zhongda Hospital, Southeast University, Nanjing, China Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, China Department of Respiratory Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, China Divsion of Respiratory Diseases, Department of Internal Medicine, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institutes of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China Department of Respiratory Medicine, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China Department of Pulmonary Medicine, He'nan Provincial People's Hospital, Zhengzhou, China Department of Pulmonary Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou, China Department of Pulmonary Medicine, The Second Hospital of Dalian Medical University, Dalian, China GloriousMed Technology Co.,Ltd., Shanghai, China Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China AU - Song, P. AU - Cui, X. AU - Bai, L. AU - Zhou, X. AU - Zhu, X. AU - Zhang, J. AU - Jin, F. AU - Zhao, J. AU - Zhou, C. AU - Zhou, Y. AU - Zhang, X. AU - Wang, K. AU - Wang, Q. AU - Yu, Y. AU - Zhang, X. AU - Bai, C. AU - Zhang, L. DB - Scopus DO - 10.1111/1759-7714.13078 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 1303-1309 ST - Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients T2 - Thoracic Cancer TI - Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065131627&doi=10.1111%2f1759-7714.13078&partnerID=40&md5=49d21ad82a9e885efba3198c0df8e860 VL - 10 ID - 6848 ER - TY - JOUR AD - R.J. Leeman-Neill, VC14-236, Columbia University Medical Center, New York, NY, United States AU - Leeman-Neill, R. J. AU - Raciti, P. M. AU - Hsiao, S. J. AU - Vundavalli, M. AU - Alobeid, B. AU - Mansukhani, M. M. AU - Bhagat, G. DB - Embase LA - English M3 - Conference Abstract N1 - L620386166 2018-02-01 PY - 2017 SN - 1528-0020 ST - Molecular characterization of post-transplant plasmablastic lymphomas implicates RAS, TP53, and notch mutations and MYC deregulation in disease pathogenesis T2 - Blood TI - Molecular characterization of post-transplant plasmablastic lymphomas implicates RAS, TP53, and notch mutations and MYC deregulation in disease pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620386166&from=export VL - 130 ID - 6849 ER - TY - JOUR AD - Clinical Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, USA. AN - 16287957 AU - Sweet, K. AU - Willis, J. AU - Zhou, X. P. AU - Gallione, C. AU - Sawada, T. AU - Alhopuro, P. AU - Khoo, S. K. AU - Patocs, A. AU - Martin, C. AU - Bridgeman, S. AU - Heinz, J. AU - Pilarski, R. AU - Lehtonen, R. AU - Prior, T. W. AU - Frebourg, T. AU - Teh, B. T. AU - Marchuk, D. A. AU - Aaltonen, L. A. AU - Eng, C. DA - Nov 16 DO - 10.1001/jama.294.19.2465 10.1001/jama.294.19.2465. DP - Nlm ET - 2005/11/17 IS - 19 LA - eng PY - 2005 SN - 0098-7484 SP - 2465-73 ST - Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis T2 - Jama TI - Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis VL - 294 ID - 6850 ER - TY - JOUR AD - S. Krishnakumar, Department of Ocular pathology, Vision Research Foundation, Sankara Nethralaya, 41, College Road, Chennai, 600006, India AU - Venkatesan, N. AU - Krishnakumar, S. AU - Deepa, P. R. AU - Deepa, M. AU - Khetan, V. AU - Ashwin Reddy, M. DB - Embase Medline LA - English M3 - Article N1 - L365863419 2012-10-24 2012-11-02 PY - 2012 SN - 1090-0535 SP - 2420-2437 ST - Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells T2 - Molecular Vision TI - Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365863419&from=exporthttp://www.molvis.org/molvis/v18/a255 VL - 18 ID - 6851 ER - TY - JOUR AD - W.C. Chan, Center for Research in Lymphoma and Leukemia, Department of Pathology and Microbiology, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, United States AU - Deffenbacher, K. E. AU - Iqbal, J. AU - Sanger, W. AU - Shen, Y. AU - Lachel, C. AU - Liu, Z. AU - Liu, Y. AU - Lim, M. S. AU - Perkins, S. L. AU - Fu, K. AU - Smith, L. AU - Lynch, J. AU - Staudt, L. M. AU - Rimsza, L. M. AU - Jaffe, E. AU - Rosenwald, A. AU - Ott, G. K. AU - Delabie, J. AU - Campo, E. AU - Gascoyne, R. D. AU - Cairo, M. S. AU - Weisenburger, D. D. AU - Greiner, T. C. AU - Gross, T. G. AU - Chan, W. C. DB - Embase Medline DO - 10.1182/blood-2011-05-349662 IS - 16 LA - English M3 - Article N1 - L364702337 2012-05-07 2012-05-09 PY - 2012 SN - 0006-4971 1528-0020 SP - 3757-3766 ST - Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling T2 - Blood TI - Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364702337&from=exporthttp://dx.doi.org/10.1182/blood-2011-05-349662http://bloodjournal.hematologylibrary.org/content/119/16/3757.full.pdf+html VL - 119 ID - 6852 ER - TY - JOUR AD - Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States Department of Orthopedics, Imam Khomeini University Hospital, Tehran University of Medical Sciences, Tehran, Iran Howard Hughes Medical Institute, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States Dept. of Medical and Molecular Genetics, 975 West Walnut St., IB130, Indianapolis, IN 46202, United States AU - Garringer, H. J. AU - Malekpour, M. AU - Esteghamat, F. AU - Mortazavi, S. M. J. AU - Davis, S. I. AU - Farrow, E. G. AU - Yu, X. AU - Arking, D. E. AU - Dietz, H. C. AU - White, K. E. DB - Scopus DO - 10.1152/ajpendo.90456.2008 IS - 4 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2008 SP - E929-E937 ST - Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis T2 - American Journal of Physiology - Endocrinology and Metabolism TI - Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-56049106116&doi=10.1152%2fajpendo.90456.2008&partnerID=40&md5=80f4a69f98acd959771e93b7821803ad VL - 295 ID - 6853 ER - TY - JOUR AD - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children's Hospital, Harvard Medical School, 1 Blackfan Circle, Boston, MA 02115, United States AU - Armstrong, S. A. AU - Look, A. T. DB - Scopus DO - 10.1200/JCO.2005.05.047 IS - 26 M3 - Review N1 - Cited By :259 Export Date: 18 November 2020 PY - 2005 SP - 6306-6315 ST - Molecular genetics of acute lymphoblastic leukemia T2 - Journal of Clinical Oncology TI - Molecular genetics of acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-27244440324&doi=10.1200%2fJCO.2005.05.047&partnerID=40&md5=438ebc99b37ca6d69be193a6e8730863 VL - 23 ID - 6854 ER - TY - JOUR AD - Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: Andrew.colebatch@health.nsw.gov.au. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Queensland Institute of Medical Research, Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia; School of Cancer Medicine and Molecular Cancer Prevention Program, La Trobe University, Bundoora, Victoria, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Department of Melanoma and Surgical Oncology, Discipline of Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia. Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. AN - 30772300 AU - Colebatch, A. J. AU - Ferguson, P. AU - Newell, F. AU - Kazakoff, S. H. AU - Witkowski, T. AU - Dobrovic, A. AU - Johansson, P. A. AU - Saw, R. P. M. AU - Stretch, J. R. AU - McArthur, G. A. AU - Long, G. V. AU - Thompson, J. F. AU - Pearson, J. V. AU - Mann, G. J. AU - Hayward, N. K. AU - Waddell, N. AU - Scolyer, R. A. AU - Wilmott, J. S. DA - Aug DO - 10.1016/j.jid.2018.12.033 10.1016/j.jid.2018.12.033. Epub 2019 Feb 14. DP - Nlm ET - 2019/02/18 IS - 8 LA - eng PY - 2019 SN - 0022-202x SP - 1762-1768 ST - Molecular Genomic Profiling of Melanocytic Nevi T2 - J Invest Dermatol TI - Molecular Genomic Profiling of Melanocytic Nevi VL - 139 ID - 6855 ER - TY - JOUR AD - S.H. Swerdlow, Division of Hematopathology, Hill Building, Room 359, 3477 Euler Way, Pittsburgh, PA, United States AU - Barasch, N. J. K. AU - Liu, Y. C. AU - Ho, J. AU - Bailey, N. AU - Aggarwal, N. AU - Cook, J. R. AU - Swerdlow, S. H. DB - Embase Medline DO - 10.1016/j.humpath.2020.09.014 LA - English M3 - Article N1 - L2008478727 2020-11-10 PY - 2020 SN - 1532-8392 0046-8177 SP - 93-105 ST - The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma T2 - Human Pathology TI - The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008478727&from=exporthttp://dx.doi.org/10.1016/j.humpath.2020.09.014 VL - 106 ID - 6856 ER - TY - JOUR AD - K. Ichimura, Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan AU - Ichimura, K. AU - Nishikawa, R. AU - Matsutani, M. DB - Embase Medline DO - 10.1093/neuonc/nos204 IS - SUPPL.4 LA - English M3 - Article N1 - L365938486 2012-11-06 2012-11-08 PY - 2012 SN - 1522-8517 1523-5866 SP - iv90-iv99 ST - Molecular markers in pediatric neuro-oncology T2 - Neuro-Oncology TI - Molecular markers in pediatric neuro-oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365938486&from=exporthttp://dx.doi.org/10.1093/neuonc/nos204 VL - 14 ID - 6857 ER - TY - JOUR AD - N. Maulik, Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut Health Center, Farmington, CT 06032, United States AU - Selvaraju, V. AU - Parinandi, N. L. AU - Adluri, R. S. AU - Goldman, J. W. AU - Hussain, N. AU - Sanchez, J. A. AU - Maulik, N. C1 - fg 2216 gsk 360a(Glaxo SmithKline) tm 6008 tm 6089 C2 - FibroGen(United States) Glaxo SmithKline(United States) DB - Embase Medline DO - 10.1089/ars.2013.5186 IS - 16 LA - English M3 - Review N1 - L373064556 2014-05-22 2014-05-29 PY - 2014 SN - 1557-7716 1523-0864 SP - 2631-2665 ST - Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of hif-prolyl 4-hydroxylases for treatment of ischemic diseases T2 - Antioxidants and Redox Signaling TI - Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of hif-prolyl 4-hydroxylases for treatment of ischemic diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373064556&from=exporthttp://dx.doi.org/10.1089/ars.2013.5186 VL - 20 ID - 6858 ER - TY - JOUR AD - Department of Hematology, University Hospital, Uppsala, Sweden Department of Genetics and Pathology, University Hospital, Uppsala, Sweden Hematology Research Unit, Biomedicum Helsinki, Helsinki, Finland Division of Hematology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Medicine, HUCH, Helsinki, Finland Clinical Genetics Unit, Department of Molecular Medicine and Surgery and Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden AU - Olsson-Strömberg, U. AU - Hermansson, M. AU - Lundán, T. AU - Ohm, A. C. AU - Engdahl, I. AU - Höglund, M. AU - Simonsson, B. AU - Porkka, K. AU - Barbany, G. DB - Scopus DO - 10.1111/j.1600-0609.2010.01506.x IS - 5 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2010 SP - 399-404 ST - Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib T2 - European Journal of Haematology TI - Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958574010&doi=10.1111%2fj.1600-0609.2010.01506.x&partnerID=40&md5=e09b8eb3454c8bf9ebb2831c0bcb0f50 VL - 85 ID - 6859 ER - TY - JOUR AD - FUNDALEU, Centro de Internación e Investigación Clínica Angélica Ocampo, Buenos Aires, Argentina Hospital General de Agudos J.M. Ramos Mejia, Buenos Aires, Argentina Instituto Privado de Hematología, Entre Ríos, Argentina Hospital Privado de Córdoba, Córdoba, Argentina AU - Pavlovsky, C. AU - Giere, I. AU - Moiraghi, B. AU - Pavlovsky, M. A. AU - Aranguren, P. N. AU - García, J. AU - Fernandez, I. AU - Bengió, R. AU - Milone, J. AU - Labanca, V. AU - Uriarte, R. AU - Lombardi, V. AU - Reinoso, F. G. AU - Magarios, A. E. AU - Martinez, L. AU - Murro, H. AU - Lastiri, F. AU - Pavlovsky, S. DB - Scopus DO - 10.1016/j.clml.2011.03.016 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2011 SP - 280-285 ST - Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: Does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053355373&doi=10.1016%2fj.clml.2011.03.016&partnerID=40&md5=16df6faa326f78ba0716ff422e22c6db VL - 11 ID - 6860 ER - TY - JOUR AD - E.E.W. Cohen, Department of Medicine, Section of Hematology/Oncology, University of Chicago, 900 East 57th Street, Chicago, IL, 60637, United States AU - Young, N. R. AU - Liu, J. AU - Pierce, C. AU - Wei, T. F. AU - Grushko, T. AU - Olopade, O. I. AU - Liu, W. AU - Shen, C. AU - Seiwert, T. Y. AU - Cohen, E. E. W. C1 - zd 1839(Astra Zeneca,United Kingdom) C2 - Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1016/j.molonc.2012.11.001 IS - 3 LA - English M3 - Article N1 - L52327277 2012-11-30 2013-06-05 PY - 2013 SN - 1878-0261 1574-7891 SP - 359-368 ST - Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition T2 - Molecular Oncology TI - Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52327277&from=exporthttp://dx.doi.org/10.1016/j.molonc.2012.11.001 VL - 7 ID - 6861 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas. fjanku@mdanderson.org diamone1@mskcc.org. Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York. fjanku@mdanderson.org diamone1@mskcc.org. Center for Personalized Cancer Therapy, Division of Blood and Marrow Transplantation, Division of Hematology/Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. AN - 31015311 AU - Janku, F. AU - Diamond, E. L. AU - Goodman, A. M. AU - Raghavan, V. K. AU - Barnes, T. G. AU - Kato, S. AU - Abdel-Wahab, O. AU - Durham, B. H. AU - Meric-Bernstam, F. AU - Kurzrock, R. C2 - PMC6548628 C6 - NIHMS1526992 BioMed Valley Discoveries, Plexxikon, Deciphera, Piqur, Symphogen, Bayer, FujiFilm Corporation and Upsher-Smith Laboratories; is on the Scientific Advisory Boards of IFM Therapeutics, Synlogic, Guardant Health and Deciphera; is a paid consultant for Trovagene and Immunomet; and has ownership interests in Trovagene. Dr. Razelle Kurzrock receives research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, and Guardant; consultant fees from Sequenom, LOXO, Actuate Therapeutics, and Genentech; and speaker fees from Roche. Dr. Kurzrock also has an ownership interest in CureMatch, Inc. DA - Jun DO - 10.1158/1535-7163.Mct-18-1244 10.1158/1535-7163.MCT-18-1244. Epub 2019 Apr 23. DP - Nlm ET - 2019/04/25 IS - 6 LA - eng PY - 2019 SN - 1535-7163 (Print) 1535-7163 SP - 1149-1157 ST - Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis T2 - Mol Cancer Ther TI - Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis VL - 18 ID - 6862 ER - TY - JOUR AD - A. Idbaih, Sorbonne Université, Inserm, CNRS, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France AU - Boisseau, W. AU - Euskirchen, P. AU - Mokhtari, K. AU - Dehais, C. AU - Touat, M. AU - Hoang-Xuan, K. AU - Sanson, M. AU - Capelle, L. AU - Nouet, A. AU - Karachi, C. AU - Bielle, F. AU - Guégan, J. AU - Marie, Y. AU - Martin-Duverneuil, N. AU - Taillandier, L. AU - Rousseau, A. AU - Delattre, J. Y. AU - Idbaih, A. C1 - campto CCNU vp16 DB - Embase Medline DO - 10.1634/theoncologist.2019-0223 IS - 12 LA - English M3 - Article N1 - L628861617 2019-08-14 2019-12-20 PY - 2019 SN - 1549-490X 1083-7159 SP - 1584-1592 ST - Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations T2 - Oncologist TI - Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628861617&from=exporthttp://dx.doi.org/10.1634/theoncologist.2019-0223 VL - 24 ID - 6863 ER - TY - JOUR AD - Hereditary Endocrine Cancer Research Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain Research Institute, Santa Creu and Sant Pau Hospital, Barcelona, Spain Biochemistry and Molecular Biology Department, Autonomous University of Barcelona (UAB), Barcelona, Spain Pathology Service, Santa Creu and Sant Pau Hospital, Barcelona, Spain Endocrinology Unit, Hospital of Sabadell, Spain Department of Pathology and Molecular Genetics, Arnau de Vilanova Hospital (IRBLLEIDA), Lleida, Spain Pathology Service, Hospital of Sabadell, Spain Bioinformatics Department, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Spain Functional Genomics Node INB, Spain Department of Endocrinology and Nutrition, Santa Creu and Sant Pau Hospital, Barcelona, Spain ISCIII CIBER-BBN, Spain Department of Endocrinology, Arnau de Vilanova Hospital (IRBLLEIDA), Lleida, Spain Spanish NationalCancer Centre, Melchor Fernández Almagro 3, E-28029 Madrid, Spain Department of Endocrinology, Arnau de Vilanova Hospital, Av. Alcalde Rovira Roure 80, E-25198 Lleida, Spain AU - Montero-Conde, C. AU - Martín-Campos, J. M. AU - Lerma, E. AU - Gimenez, G. AU - Martínez-Guitarte, J. L. AU - Combalía, N. AU - Montaner, D. AU - Matías-Guiu, X. AU - Dopazo, J. AU - De Leiva, A. AU - Robledo, M. AU - Mauricio, D. DB - Scopus DO - 10.1038/sj.onc.1210792 IS - 11 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 2008 SP - 1554-1561 ST - Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information T2 - Oncogene TI - Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449117749&doi=10.1038%2fsj.onc.1210792&partnerID=40&md5=7a2447f2e11af6425e53a9e1ad36b464 VL - 27 ID - 6864 ER - TY - JOUR AU - Pavkovic, M. AU - Angelkovic, R. AU - Popova-Simjanovska, M. AU - Genadieva-Stavric, S. AU - Cevreska, L. AU - Stojanovic, A. DB - Scopus DO - 10.1515/prilozi-2015-0065 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 179-186 ST - Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre Experience T2 - Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) TI - Molecular Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib - Single Centre Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984848175&doi=10.1515%2fprilozi-2015-0065&partnerID=40&md5=55781e4a7325a9edd73ddbf36067319a VL - 36 ID - 6865 ER - TY - JOUR AD - T. Gupta, Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, India AU - Gupta, T. AU - Shirsat, N. AU - Jalali, R. DB - Embase Medline DO - 10.2174/1573396311666150702104030 IS - 2 LA - English M3 - Article N1 - L605196750 2015-07-22 2016-05-05 PY - 2015 SN - 1875-6336 1573-3963 SP - 106-119 ST - Molecular subgrouping of medulloblastoma: Impact upon research and clinical practice T2 - Current Pediatric Reviews TI - Molecular subgrouping of medulloblastoma: Impact upon research and clinical practice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605196750&from=exporthttp://dx.doi.org/10.2174/1573396311666150702104030 VL - 11 ID - 6866 ER - TY - JOUR AD - A. Guerreiro Stücklin, PLGG Taskforce The Hospital for Sick Children, Toronto, ON, Canada AU - Guerreiro Stücklin, A. AU - Ryall, S. AU - Fukuoka, K. AU - Zapotocky, M. AU - Lassaletta, A. AU - Arnoldo, A. AU - Zhong, Y. AU - Kowalski, P. AU - Li, C. AU - Grotzer, M. AU - Taylor, M. AU - Tabori, U. AU - Hawkins, C. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239699 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii224 ST - Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life T2 - Neuro-Oncology TI - Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239699&from=exporthttp://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 6867 ER - TY - JOUR AD - A.-L. Cheng, National Taiwan University Hospital, Taipei, Taiwan AU - Cheng, A. L. DB - Embase DO - 10.1007/s12072-010-9241-z IS - 1 LA - English M3 - Conference Abstract N1 - L70368944 2011-03-30 PY - 2011 SN - 1936-0533 SP - 28 ST - Molecular targeted therapy for advanced hepatocellular carcinoma: Sorafenib and beyond T2 - Hepatology International TI - Molecular targeted therapy for advanced hepatocellular carcinoma: Sorafenib and beyond UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70368944&from=exporthttp://dx.doi.org/10.1007/s12072-010-9241-z VL - 5 ID - 6868 ER - TY - JOUR AD - T. Kawaguchi, Department of Neurosurgery, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8507, Japan AU - Kawaguchi, T. AU - Yoshikawa, K. AU - Kawamoto, K. AU - Yoshimura, K. AU - Oshige, H. AU - Asai, A. C2 - biogate(Japan) DB - Embase Medline IS - 6 LA - English M3 - Article N1 - L373341782 2014-07-01 2014-07-02 PY - 2014 SN - 1791-2423 1019-6439 SP - 1879-1885 ST - Molecular targeting of neuroblastoma with a novel p16INK4a transporter system T2 - International Journal of Oncology TI - Molecular targeting of neuroblastoma with a novel p16INK4a transporter system UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373341782&from=export VL - 44 ID - 6869 ER - TY - JOUR AD - D.L. Stirewalt, Fred Hutchinson Cancer Res. Center, 1100 Fairview Avenue, North Seattle, WA 98109, United States AU - Stirewalt, D. L. AU - Meshinchi, S. AU - Radich, J. P. C1 - cep 5214(Cephalon,United States) gleevec pkc 412(Novartis,United States) sti 571 su 5416 su 6668 C2 - Cephalon(United States) Novartis(United States) DB - Embase Medline DO - 10.1016/S0268-960X(02)00057-7 IS - 1 LA - English M3 - Article N1 - L36176208 2003-02-20 PY - 2003 SN - 0268-960X SP - 15-23 ST - Molecular targets in acute myelogenous leukemia T2 - Blood Reviews TI - Molecular targets in acute myelogenous leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36176208&from=exporthttp://dx.doi.org/10.1016/S0268-960X(02)00057-7 VL - 17 ID - 6870 ER - TY - JOUR AD - 1 Division of Oncology, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania. 2 Asuragen, Inc. , Austin, Texas. 3 Division of Anatomic Pathology, Department of Pathology. 4 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania. 5 Department of Biostatistics and Epidemiology, University of Pennsylvania , Philadelphia, Pennsylvania. 6 Division of Pediatric Otolaryngology, Department of Pediatric Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 7 Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 8 Division of General Surgery, Department of Pediatric Surgery, University of Pennsylvania , Philadelphia, Pennsylvania. 9 Division of Endocrinology and Diabetes, Department of Pediatrics, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania. AN - 29108474 AU - Mostoufi-Moab, S. AU - Labourier, E. AU - Sullivan, L. AU - LiVolsi, V. AU - Li, Y. AU - Xiao, R. AU - Beaudenon-Huibregtse, S. AU - Kazahaya, K. AU - Adzick, N. S. AU - Baloch, Z. AU - Bauer, A. J. C2 - PMC5770125 DA - Jan DO - 10.1089/thy.2017.0059 10.1089/thy.2017.0059. Epub 2017 Dec 11. DP - Nlm ET - 2017/11/08 IS - 1 LA - eng PY - 2018 SN - 1050-7256 (Print) 1050-7256 SP - 60-67 ST - Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions T2 - Thyroid TI - Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions VL - 28 ID - 6871 ER - TY - JOUR AD - J. P. P. Meijerink, Erasmus MC, Sophia Children's Hospital, Department of Paediatric Oncology/Haematology, Dr Molewaterplein 60, 3000 CB Rotterdam, Netherlands AU - Van Vlierberghe, P. AU - Pieters, R. AU - Beverloo, H. B. AU - Meijerink, J. P. P. DB - Embase Medline DO - 10.1111/j.1365-2141.2008.07314.x IS - 2 LA - English M3 - Review N1 - L352431827 2008-10-29 PY - 2008 SN - 0007-1048 1365-2141 SP - 153-168 ST - Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352431827&from=exporthttp://dx.doi.org/10.1111/j.1365-2141.2008.07314.x VL - 143 ID - 6872 ER - TY - JOUR AD - S. Ahuja, Icahn School of Medicine, Mount Sinai Hospital AU - Ahuja, S. AU - Bryce, C. DB - Embase DO - 10.1093/jnen/nlaa036 IS - 6 LA - English M3 - Conference Abstract N1 - L632059648 2020-07-24 PY - 2020 SN - 1554-6578 SP - 673 ST - Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) with distinct clinical and molecular features in a cerebellar tonsils T2 - Journal of Neuropathology and Experimental Neurology TI - Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) with distinct clinical and molecular features in a cerebellar tonsils UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632059648&from=exporthttp://dx.doi.org/10.1093/jnen/nlaa036 VL - 79 ID - 6873 ER - TY - JOUR AD - K.E. Warren, National Cancer Institute, Neuro-Oncology Branch, 9030 Old Georgetown Road, Bethesda, MD 20892-8200, United States AU - Warren, K. E. C1 - gleevec(Novartis,United States) gw 572016 iressa osi 774(Osi,United States) r 115777 sch 66336 sti 571(Novartis,United States) su 101 tarceva(Osi,United States) zarnestra zd 1839 C2 - Novartis(United States) Osi(United States) DB - Embase Medline DO - 10.1007/s11060-005-6765-5 IS - 3 LA - English M3 - Review N1 - L43019489 2006-01-10 PY - 2005 SN - 0167-594X 1573-7373 SP - 335-343 ST - Molecularly targeted therapy for pediatric brain tumors T2 - Journal of Neuro-Oncology TI - Molecularly targeted therapy for pediatric brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43019489&from=exporthttp://dx.doi.org/10.1007/s11060-005-6765-5 VL - 75 ID - 6874 ER - TY - JOUR AD - Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China AU - Tan, Y. AU - Liu, Z. AU - Wang, W. AU - Zhu, G. AU - Guo, J. AU - Chen, X. AU - Zheng, C. AU - Xu, Z. AU - Chang, J. AU - Ren, F. AU - Wang, H. DB - Scopus DO - 10.1016/j.leukres.2018.04.013 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 89-93 ST - Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia T2 - Leukemia Research TI - Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046161901&doi=10.1016%2fj.leukres.2018.04.013&partnerID=40&md5=dbd67d55b70a4c2d04ee9f66831d1e8b VL - 69 ID - 6875 ER - TY - JOUR AD - Armed Forces Medical College, Pune, 411040, India Army Hospital (R and R), Delhi Cantt, 110010, India Maulana Azad Medical College, New Delhi, 110002, India PGIMER, Chandigarh, India AFMS, O/o DGAFMS, Ministry of Defence, New Delhi, India Dept of Community Medicine, Army College of Medical Sciences, New Delhi, 11001, India AU - Nair, V. AU - Sharma, A. AU - Kotwal, J. AU - Bhikshapathy, M. AU - Mishra, D. K. AU - Das, S. AU - Sharma, S. AU - Kapoor, R. AU - Singh, J. AU - Nair, V. AU - Uday, Y. AU - Kotwal, A. AU - Kotwal, A. DB - Scopus DO - 10.1016/j.mjafi.2014.07.005 IS - 4 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2014 SP - 315-320 ST - Monitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP) T2 - Medical Journal Armed Forces India TI - Monitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908505977&doi=10.1016%2fj.mjafi.2014.07.005&partnerID=40&md5=a9a5b6cb90d4058bc6b174174fc7b51d VL - 70 ID - 6876 ER - TY - JOUR AD - R. Becher, Department of Air Pollution and Noise, Division of Environmental Medicine, Norwegian Institute of Public Health, PO Box 4404, Nydalen, N-0403 Oslo, Norway AU - Rakkestad, K. E. AU - Holme, J. A. AU - Paulsen, R. E. AU - Schwarze, P. E. AU - Becher, R. DB - Embase Medline DO - 10.3109/08958370903019885 IS - 2 LA - English M3 - Article N1 - L358196991 2010-03-01 PY - 2010 SN - 0895-8378 1091-7691 SP - 140-150 ST - Mono(2-ethylhexyl) phthalate induces both pro- and anti-inflammatory responses in rat alveolar macrophages through crosstalk between p38, the lipoxygenase pathway and PPARα T2 - Inhalation Toxicology TI - Mono(2-ethylhexyl) phthalate induces both pro- and anti-inflammatory responses in rat alveolar macrophages through crosstalk between p38, the lipoxygenase pathway and PPARα UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358196991&from=exporthttp://dx.doi.org/10.3109/08958370903019885 VL - 22 ID - 6877 ER - TY - JOUR AD - Department of Pathology, University of Leuven, Belgium. AN - 9250148 AU - Pittaluga, S. AU - Wlodarska, I. AU - Pulford, K. AU - Campo, E. AU - Morris, S. W. AU - Van den Berghe, H. AU - De Wolf-Peeters, C. C2 - PMC1858018 DA - Aug DP - Nlm ET - 1997/08/01 IS - 2 LA - eng N1 - 1525-2191 Pittaluga, S Wlodarska, I Pulford, K Campo, E Morris, S W Van den Berghe, H De Wolf-Peeters, C CA01702/CA/NCI NIH HHS/United States CA69129/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Am J Pathol. 1997 Aug;151(2):343-51. PY - 1997 SN - 0002-9440 (Print) 0002-9440 SP - 343-51 ST - The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements T2 - Am J Pathol TI - The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements VL - 151 ID - 6878 ER - TY - JOUR AD - Department of Pathology, Brigham and Women(tm)s Hospital, Harvard Medical School, Boston, MA, United States Department of Pathology, Medical University of Graz, Graz, Austria Department of Pathology, Oregon Health and Science University, Portland, OR, United States Department of Pathology, Brigham and Womenh(tm)s Hospital, 75 Francis Street, Boston, MA 02115, United States AU - Liegl, B. AU - Hornick, J. L. AU - Corless, C. L. AU - Fletcher, C. D. M. DB - Scopus DO - 10.1097/PAS.0b013e318186b158 IS - 3 M3 - Article N1 - Cited By :196 Export Date: 18 November 2020 PY - 2009 SP - 437-446 ST - Monoclonal antibody DOG1.1 Shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes T2 - American Journal of Surgical Pathology TI - Monoclonal antibody DOG1.1 Shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-62849083680&doi=10.1097%2fPAS.0b013e318186b158&partnerID=40&md5=1a155a9e3f58df9b63d802edd286b127 VL - 33 ID - 6879 ER - TY - JOUR AD - L. Ou, College of Pharmacy, Shaanxi University of Chinese Medicine, Century Avenue, Xianyang, Shaanxi Province, China AU - Ou, L. AU - Gao, F. AU - Li, M. AU - Wei, P. DB - Embase IS - 2 LA - English M3 - Article N1 - L2003914077 2020-03-06 2020-03-10 PY - 2020 SN - 1940-5901 SP - 417-428 ST - Monotropein accelerates chondrocyte progression in osteoarthritis by alleviating TNF-α induced inflammatiothrough regulation of MAPK/NF-κB signaling pathway T2 - International Journal of Clinical and Experimental Medicine TI - Monotropein accelerates chondrocyte progression in osteoarthritis by alleviating TNF-α induced inflammatiothrough regulation of MAPK/NF-κB signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003914077&from=export VL - 13 ID - 6880 ER - TY - JOUR AD - D. Zhang AU - Zhang, D. AU - Kongkarnka, S. AU - Komissarova, E. V. AU - Del Portillo, A. AU - Neto, A. G. AU - Sepulveda, J. AU - Sepulveda, A. DB - Embase DO - 10.1038/labinvest.2016.168 LA - English M3 - Conference Abstract N1 - L615116464 2017-04-06 PY - 2017 SN - 1530-0307 SP - 209A ST - Morphological and molecular features of gastric glomus tumors T2 - Laboratory Investigation TI - Morphological and molecular features of gastric glomus tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615116464&from=exporthttp://dx.doi.org/10.1038/labinvest.2016.168 VL - 97 ID - 6881 ER - TY - JOUR AD - Department of Pediatric Laboratory Medicine, Hospital for Sick Children and University of Toronto, Ontario, Canada. AN - 11178628 AU - Sherman, C. G. AU - Zielenska, M. AU - Lorenzana, A. N. AU - Pulford, K. A. AU - Mason, D. Y. AU - Hutchison, R. E. AU - Thorner, P. S. DA - Mar-Apr DO - 10.1007/s100240010139 10.1007/s100240010139. DP - Nlm ET - 2001/02/15 IS - 2 LA - eng PY - 2001 SN - 1093-5266 (Print) 1093-5266 SP - 129-37 ST - Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation T2 - Pediatr Dev Pathol TI - Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation VL - 4 ID - 6882 ER - TY - JOUR AD - F. Altmüller, Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany AU - Altmüller, F. AU - Schanze, D. AU - Schanze, I. AU - Fejtova, A. AU - Zenker, M. DB - Embase DO - 10.1007/s11825-013-0376-x IS - 1 LA - English M3 - Conference Abstract N1 - L71009549 2013-03-14 PY - 2013 SN - 0936-5931 SP - 96 ST - Morphological characterization of murine neurons exhibiting hyperactivation of the Ras-MAPK signaling pathway T2 - Medizinische Genetik TI - Morphological characterization of murine neurons exhibiting hyperactivation of the Ras-MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71009549&from=exporthttp://dx.doi.org/10.1007/s11825-013-0376-x VL - 25 ID - 6883 ER - TY - JOUR AD - M. O'Driscoll, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom AU - Bennett, J. T. AU - Tan, T. Y. AU - Alcantara, D. AU - Tétrault, M. AU - Timms, A. E. AU - Jensen, D. AU - Collins, S. AU - Nowaczyk, M. J. M. AU - Lindhurst, M. J. AU - Christensen, K. M. AU - Braddock, S. R. AU - Brandling-Bennett, H. AU - Hennekam, R. C. M. AU - Chung, B. AU - Lehman, A. AU - Su, J. AU - Ng, S. AU - Amor, D. J. AU - Majewski, J. AU - Biesecker, L. G. AU - Boycott, K. M. AU - Dobyns, W. B. AU - O'Driscoll, M. AU - Moog, U. AU - McDonell, L. M. DB - Embase Medline DO - 10.1016/j.ajhg.2016.02.006 IS - 3 LA - English M3 - Article N1 - L608903995 2016-03-16 2016-03-24 PY - 2016 SN - 1537-6605 0002-9297 SP - 579-587 ST - Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis T2 - American Journal of Human Genetics TI - Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608903995&from=exporthttp://dx.doi.org/10.1016/j.ajhg.2016.02.006 VL - 98 ID - 6884 ER - TY - JOUR AD - Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine University Dusseldorf, Düsseldorf, Germany AU - Bhatia, S. AU - Daschkey, S. AU - Lang, F. AU - Borkhardt, A. AU - Hauer, J. DB - Scopus DO - 10.1080/17460441.2016.1229297 IS - 11 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 1081-1091 ST - Mouse models for pre-clinical drug testing in leukemia T2 - Expert Opinion on Drug Discovery TI - Mouse models for pre-clinical drug testing in leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991000775&doi=10.1080%2f17460441.2016.1229297&partnerID=40&md5=094f289de247ed5f14e2b85feb8b4f86 VL - 11 ID - 6885 ER - TY - JOUR AD - C. Fan, Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH, United States AU - Fan, C. AU - Zhao, C. AU - Zhang, F. AU - Cai, X. AU - Xu, L. AU - Lin, S. AU - Chen, X. AU - Guo, F. AU - Lu, R. Q. AU - Tian, W. AU - Zheng, Y. DB - Embase LA - English M3 - Conference Abstract N1 - L620385264 2018-02-01 PY - 2017 SN - 1528-0020 ST - Mtor restricts chromatin access and genomic activity to maintain hematopoietic stem cell quiescence and engraftment T2 - Blood TI - Mtor restricts chromatin access and genomic activity to maintain hematopoietic stem cell quiescence and engraftment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385264&from=export VL - 130 ID - 6886 ER - TY - JOUR AD - L. Li, Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, No. 71 Hedi Road, Nanning, Guangxi, China AU - Chen, J. AU - Wang, Q. AU - Yin, F. Q. AU - Zhang, W. AU - Yan, L. H. AU - Li, L. DB - Embase IS - 9 LA - English M3 - Article N1 - L606475192 2015-10-22 2015-10-27 PY - 2015 SN - 1943-8141 SP - 1510-1527 ST - MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy T2 - American Journal of Translational Research TI - MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606475192&from=export VL - 7 ID - 6887 ER - TY - JOUR AD - P. Zhang, Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China AU - Wang, Y. AU - Dai, X. AU - Liu, Y. AU - Li, J. AU - Liu, Z. AU - Yin, P. AU - Chen, J. AU - Wang, Y. AU - Wang, N. AU - Zhang, P. DB - Embase Medline DO - 10.1016/j.yjmcc.2016.10.012 LA - English M3 - Article N1 - L613221947 2016-11-28 2016-12-23 PY - 2016 SN - 1095-8584 0022-2828 SP - 1-10 ST - MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells T2 - Journal of Molecular and Cellular Cardiology TI - MTUS1 silencing promotes E-selectin production through p38 MAPK-dependent CREB ubiquitination in endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613221947&from=exporthttp://dx.doi.org/10.1016/j.yjmcc.2016.10.012 VL - 101 ID - 6888 ER - TY - JOUR AD - 1 Institute of Pathology, Lille University Hospital , Lille, France . AN - 25012490 AU - Renaud, F. AU - Gnemmi, V. AU - Devos, P. AU - Aubert, S. AU - Crépin, M. AU - Coppin, L. AU - Ramdane, N. AU - Bouchindhomme, B. AU - d'Herbomez, M. AU - Van Seuningen, I. AU - Do Cao, C. AU - Pattou, F. AU - Carnaille, B. AU - Pigny, P. AU - Wémeau, J. L. AU - Leteurtre, E. DA - Sep DO - 10.1089/thy.2013.0594 10.1089/thy.2013.0594. Epub 2014 Aug 1. DP - Nlm ET - 2014/07/12 IS - 9 LA - eng PY - 2014 SN - 1050-7256 SP - 1375-84 ST - MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse T2 - Thyroid TI - MUC1 expression in papillary thyroid carcinoma is associated with BRAF mutation and lymph node metastasis; the latter is the most important risk factor of relapse VL - 24 ID - 6889 ER - TY - JOUR AD - A.L. Feldman, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States AU - Sciallis, A. P. AU - Law, M. E. AU - Inwards, D. J. AU - McClure, R. F. AU - MacOn, W. R. AU - Kurtin, P. J. AU - Dogan, A. AU - Feldman, A. L. DB - Embase Medline DO - 10.1038/modpathol.2012.38 IS - 7 LA - English M3 - Article N1 - L51893168 2012-03-07 2012-07-15 PY - 2012 SN - 0893-3952 1530-0285 SP - 983-992 ST - Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders T2 - Modern Pathology TI - Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51893168&from=exporthttp://dx.doi.org/10.1038/modpathol.2012.38 VL - 25 ID - 6890 ER - TY - JOUR AD - Liver Research Unit, 'Bambino Gesù' Children's Hospital, IRCCS, Rome 00165, Italy Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong Department of Oncohematology, 'Bambino Gesù' Children's Hospital, IRCCS, Rome 00165, Italy AU - Alisi, A. AU - Cho, W. C. AU - Locatelli, F. AU - Fruci, D. DB - Scopus DO - 10.3390/ijms141224706 IS - 12 M3 - Review N1 - Cited By :55 Export Date: 18 November 2020 PY - 2013 SP - 24706-24725 ST - Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma T2 - International Journal of Molecular Sciences TI - Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890953102&doi=10.3390%2fijms141224706&partnerID=40&md5=8830a1d7644a82b3bc760f4c863c2d89 VL - 14 ID - 6891 ER - TY - JOUR AD - Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. AN - 25651238 AU - Carrera, C. AU - Puig-Butillè, J. A. AU - Tell-Marti, G. AU - García, A. AU - Badenas, C. AU - Alós, L. AU - Puig, S. AU - Malvehy, J. DA - May DO - 10.1001/jamadermatol.2014.4115 10.1001/jamadermatol.2014.4115. DP - Nlm ET - 2015/02/05 IS - 5 LA - eng PY - 2015 SN - 2168-6068 SP - 544-8 ST - Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma T2 - JAMA Dermatol TI - Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma VL - 151 ID - 6892 ER - TY - JOUR AD - K. Kosaki, Center for Medical Genetics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan AU - Takenouchi, T. AU - Shimizu, A. AU - Torii, C. AU - Kosaki, R. AU - Takahashi, T. AU - Saya, H. AU - Kosaki, K. DB - Embase Medline DO - 10.1002/ajmg.a.36288 IS - 2 LA - English M3 - Article N1 - L52907314 2013-12-11 2014-02-13 PY - 2014 SN - 1552-4825 1552-4833 SP - 392-396 ST - Multiple café au lait spots in familial patients with MAP2K2 mutation T2 - American Journal of Medical Genetics, Part A TI - Multiple café au lait spots in familial patients with MAP2K2 mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52907314&from=exporthttp://dx.doi.org/10.1002/ajmg.a.36288 VL - 164 ID - 6893 ER - TY - JOUR AD - B. Yuan, Laboratory of Pharmacology, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama, Japan AU - Yuan, B. AU - Shimada, R. AU - Xu, K. AU - Han, L. AU - Si, N. AU - Zhao, H. AU - Bian, B. AU - Hayashi, H. AU - Okazaki, M. AU - Takagi, N. C2 - Baoji Herbest(China) DB - Embase Medline DO - 10.1016/j.cbi.2019.108849 LA - English M3 - Article N1 - L2003366816 2019-10-18 2019-11-21 PY - 2019 SN - 1872-7786 0009-2797 ST - Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87 T2 - Chemico-Biological Interactions TI - Multiple cytotoxic effects of gamabufotalin against human glioblastoma cell line U-87 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003366816&from=exporthttp://dx.doi.org/10.1016/j.cbi.2019.108849 VL - 314 ID - 6894 ER - TY - JOUR AD - Y. Capri, Dpt of Genetic CHU Robert Debre, Paris, France AU - Capri, Y. AU - Bourdeaut, F. AU - Dorfmuller, G. AU - El Maleh, M. AU - Vera, L. AU - Bourrat, E. AU - Cave, H. AU - Verloes, A. DB - Embase DO - 10.1038/s41431-018-0248-6 LA - English M3 - Conference Abstract N1 - L629480527 2019-10-08 PY - 2019 SN - 1476-5438 SP - 971 ST - Multiple glioma in Noonan syndrome: Report on a RAF1 mutated patient T2 - European Journal of Human Genetics TI - Multiple glioma in Noonan syndrome: Report on a RAF1 mutated patient UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629480527&from=exporthttp://dx.doi.org/10.1038/s41431-018-0248-6 VL - 26 ID - 6895 ER - TY - JOUR AD - Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030, United States Division of Pediatrics, Children's Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Nilsson, M. B. AU - Zage, P. E. AU - Zeng, L. AU - Xu, L. AU - Cascone, T. AU - Wu, H. K. AU - Saigal, B. AU - Zweidler-Mckay, P. A. AU - Heymach, J. V. DB - Scopus DO - 10.1038/onc.2010.60 IS - 20 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2010 SP - 2938-2949 ST - Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: Implications for antiangiogenic mechanisms of multikinase inhibitors T2 - Oncogene TI - Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: Implications for antiangiogenic mechanisms of multikinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952671059&doi=10.1038%2fonc.2010.60&partnerID=40&md5=5ceaa123b7165990ac64dd8a6cdcfcd0 VL - 29 ID - 6896 ER - TY - JOUR AD - Department of Surgical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, 380 004, India AU - Tadaiya, M. V. K. AU - Tankshali, R. DB - Scopus DO - 10.4103/ijmpo.ijmpo_73_18 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 89-92 ST - Multiple small bowel perforations in a patient of chronic myeloid leukemia on imatinib T2 - Indian Journal of Medical and Paediatric Oncology TI - Multiple small bowel perforations in a patient of chronic myeloid leukemia on imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085148436&doi=10.4103%2fijmpo.ijmpo_73_18&partnerID=40&md5=062869cf9ada0d50cccf426b874d0427 VL - 41 ID - 6897 ER - TY - JOUR AD - Department of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan. nozomim@gunma-u.ac.jp. Department of Human Pathology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma, 371-8511, Japan. Department of Pathology, Brain Research Institute, Niigata University, Niigata, Niigata, Japan. Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Miyagi, Japan. Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Niigata, Japan. Department of Neurosurgery, Nishi-Niigata Chuo National Hospital, Niigata, Niigata, Japan. Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan. Department of Epileptology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Aichi, Japan. Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan. Department of Neurosurgery, Kumamoto University Hospital, Kumamoto, Kumamoto, Japan. Department of Pathology, Hidaka Hospital, Takasaki, Gunma, Japan. Department of Diagnostic Pathology, Gunma University Hospital, Maebashi, Gunma, Japan. AN - 30825062 AU - Matsumura, N. AU - Nobusawa, S. AU - Ito, J. AU - Kakita, A. AU - Suzuki, H. AU - Fujii, Y. AU - Fukuda, M. AU - Iwasaki, M. AU - Nakasato, N. AU - Tominaga, T. AU - Natsume, A. AU - Mikami, Y. AU - Shinojima, N. AU - Yamazaki, T. AU - Nakazato, Y. AU - Hirato, J. AU - Yokoo, H. DA - May DO - 10.1007/s11060-019-03138-7 10.1007/s11060-019-03138-7. Epub 2019 Mar 1. DP - Nlm ET - 2019/03/03 IS - 1 LA - eng PY - 2019 SN - 0167-594x SP - 27-33 ST - Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors T2 - J Neurooncol TI - Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors VL - 143 ID - 6898 ER - TY - JOUR AD - Medical and Scientific Affairs, Roche Molecular Systems, Inc, 4300 Hacienda Dr, Pleasanton, CA 94588, USA. AN - 22332713 AU - Anderson, S. AU - Bloom, K. J. AU - Vallera, D. U. AU - Rueschoff, J. AU - Meldrum, C. AU - Schilling, R. AU - Kovach, B. AU - Lee, J. R. AU - Ochoa, P. AU - Langland, R. AU - Halait, H. AU - Lawrence, H. J. AU - Dugan, M. C. DA - Nov DO - 10.5858/arpa.2011-0505-OA 10.5858/arpa.2011-0505-OA. Epub 2012 Feb 14. DP - Nlm ET - 2012/02/16 IS - 11 LA - eng PY - 2012 SN - 0003-9985 SP - 1385-91 ST - Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma T2 - Arch Pathol Lab Med TI - Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma VL - 136 ID - 6899 ER - TY - JOUR AD - H.B. Kim, Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States AU - Lee, E. AU - Hodgkinson, N. AU - Fawaz, R. AU - Vakili, K. AU - Kim, H. B. C1 - fk 506 DB - Embase Medline DO - 10.1111/petr.12904 IS - 5 LA - English M3 - Article N1 - L615408716 2017-04-20 2017-07-20 PY - 2017 SN - 1399-3046 1397-3142 ST - Multivisceral transplantation for abdominal tumors in children: A single center experience and review of the literature T2 - Pediatric Transplantation TI - Multivisceral transplantation for abdominal tumors in children: A single center experience and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615408716&from=exporthttp://dx.doi.org/10.1111/petr.12904 VL - 21 ID - 6900 ER - TY - JOUR AD - Department of Clinical Hematology, King Georges Medical University, Lucknow, UP, India AU - Tripathi, A. K. AU - Verma, S. P. AU - Kumar, N. DB - Scopus DO - 10.1007/s12288-016-0755-y IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 316-320 ST - Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response T2 - Indian Journal of Hematology and Blood Transfusion TI - Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85000868520&doi=10.1007%2fs12288-016-0755-y&partnerID=40&md5=ca906047bcef1d068bd33ba9f06601c8 VL - 33 ID - 6901 ER - TY - JOUR AD - Laboratoire de Biologie des Cancers, Equipe Micro-organismes et Facteurs Oncogènes, Faculté de Médecine et de Pharmacie, Fez, Morocco. AN - 21161938 AU - Bennani, B. AU - Gilles, S. AU - Fina, F. AU - Nanni, I. AU - Ibrahimi, S. A. AU - Riffi, A. A. AU - Nejjari, C. AU - Benajeh, D. A. AU - El Abkari, M. AU - Martin, P. M. AU - Ouafik, L. DA - Oct-Dec DP - Nlm ET - 2010/12/17 IS - 4 LA - eng N1 - 1724-6008 Bennani, Bahia Gilles, Sophie Fina, Frederic Nanni, Isabelle Ibrahimi, Sidi Adil Riffi, Afaf Amarti Nejjari, Chakib Benajeh, Dafr-Allah El Abkari, Mohammed Martin, Pierre-Marie Ouafik, L'Houcine Journal Article United States Int J Biol Markers. 2010 Oct-Dec;25(4):179-84. PY - 2010 SN - 0393-6155 SP - 179-84 ST - Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer T2 - Int J Biol Markers TI - Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer VL - 25 ID - 6902 ER - TY - JOUR AD - Section for Pathology, The Gade Institute, University of Bergen, Haukeland University Hospital, Bergen, Norway. lars.akslen@gades.uib.no AN - 18227705 AU - Akslen, L. A. AU - Puntervoll, H. AU - Bachmann, I. M. AU - Straume, O. AU - Vuhahula, E. AU - Kumar, R. AU - Molven, A. DA - Feb DO - 10.1097/CMR.0b013e3282f32517 10.1097/CMR.0b013e3282f32517. DP - Nlm ET - 2008/01/30 IS - 1 LA - eng PY - 2008 SN - 0960-8931 (Print) 0960-8931 SP - 29-35 ST - Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma T2 - Melanoma Res TI - Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma VL - 18 ID - 6903 ER - TY - JOUR AD - Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. AN - 17661820 AU - Lee, S. T. AU - Ki, C. S. AU - Lee, H. J. DA - Aug DO - 10.1111/j.1399-0004.2007.00839.x 10.1111/j.1399-0004.2007.00839.x. DP - Nlm ET - 2007/07/31 IS - 2 LA - eng PY - 2007 SN - 0009-9163 (Print) 0009-9163 SP - 150-5 ST - Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome T2 - Clin Genet TI - Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome VL - 72 ID - 6904 ER - TY - JOUR AD - Department of Neuropathology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany. AN - 15517309 AU - Knobbe, C. B. AU - Reifenberger, J. AU - Reifenberger, G. DA - Dec DO - 10.1007/s00401-004-0929-9 10.1007/s00401-004-0929-9. Epub 2004 Oct 28. DP - Nlm ET - 2004/11/02 IS - 6 LA - eng PY - 2004 SN - 0001-6322 (Print) 0001-6322 SP - 467-70 ST - Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas T2 - Acta Neuropathol TI - Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas VL - 108 ID - 6905 ER - TY - JOUR AD - From the Department of Pathology, MD Anderson Cancer Center, Houston, Texas (Dr Gertz); the Division of Molecular Genomic Pathology, University of Pittsburgh, Pennsylvania (Dr Nikiforov); the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison (Drs Lloyd and Rehrauer); and the School of Public Health, Louisiana State University, New Orleans (Dr McDaniel). Dr Gertz is now located at the Department of Pathology, OhioHealth Riverside Methodist Hospital, Columbus, Ohio. AN - 26910217 AU - Gertz, R. J. AU - Nikiforov, Y. AU - Rehrauer, W. AU - McDaniel, L. AU - Lloyd, R. V. DA - Feb DO - 10.5858/arpa.2014-0612-OA 10.5858/arpa.2014-0612-OA. DP - Nlm ET - 2016/02/26 IS - 2 LA - eng PY - 2016 SN - 0003-9985 SP - 134-9 ST - Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population T2 - Arch Pathol Lab Med TI - Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population VL - 140 ID - 6906 ER - TY - JOUR AD - J. A. E. Irving, Northern Institute for Cancer Research, Paul O'Gorman Building, Framlington Place, Newcastle upon Tyne, Tyne and Wear, United Kingdom AU - Case, M. AU - Matheson, E. AU - Minto, L. AU - Hassan, R. AU - Harrison, C. J. AU - Bown, N. AU - Bailey, S. AU - Vormoor, J. AU - Hall, A. G. AU - Irving, J. A. E. DB - Embase Medline DO - 10.1158/0008-5472.CAN-08-0101 IS - 16 L1 - internal-pdf://2439701652/6803.full.pdf LA - English M3 - Article N1 - L352481122 2008-11-04 PY - 2008 SN - 0008-5472 SP - 6803-6809 ST - Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia T2 - Cancer Research TI - Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352481122&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-08-0101 VL - 68 ID - 6907 ER - TY - JOUR AD - Department of Laboratory Diagnostics, Division of Molecular Diagnostics, University Hospital Center Zagrab, Croatia. AN - 22489692 AU - Rako, I. AU - Jakic-Razumovic, J. AU - Katalinic, D. AU - Sertic, J. AU - Plestina, S. DO - 10.4149/neo_2012_049 10.4149/neo_2012_049. DP - Nlm ET - 2012/04/12 IS - 4 LA - eng PY - 2012 SN - 0028-2685 (Print) 0028-2685 SP - 376-83 ST - Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients T2 - Neoplasma TI - Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients VL - 59 ID - 6908 ER - TY - JOUR AD - Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Electronic address: marie.frugier-regairaz@ens-cachan.fr. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France; Sainte Justine University Hospital Center, University of Montréal, Montréal, Québec, Canada. Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. Histocytopathology Unit, Laboratory of Translational Research, Gustave Roussy, Villejuif, France. Research on Cell Growth, Tissue Repair and Regeneration (CRRET), Centre National de la Recherche Scientifique, University Paris-Est Créteil, Créteil, France. Department of Pathology, Bicêtre Hospital, Le Kremlin-Bicêtre, France. Department of Pediatrics, Shiga University of Medical Science, Otsu, Shiga, Japan. Histocytopathology Unit, Laboratory of Translational Research, Gustave Roussy, Villejuif, France; Department of Pathology and Biobank, Gustave Roussy, Villejuif, France. Department of Pediatrics, Gustave Roussy, Villejuif, France. Laboratory for Vectorology and Anticancer Therapeutics, Gustave Roussy, Paris-Sud University, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8203, Villejuif, France. Electronic address: gilles.vassal@gustaveroussy.fr. AN - 26687816 AU - Regairaz, M. AU - Munier, F. AU - Sartelet, H. AU - Castaing, M. AU - Marty, V. AU - Renauleaud, C. AU - Doux, C. AU - Delbé, J. AU - Courty, J. AU - Fabre, M. AU - Ohta, S. AU - Vielh, P. AU - Michiels, S. AU - Valteau-Couanet, D. AU - Vassal, G. DA - Feb DO - 10.1016/j.ajpath.2015.10.016 10.1016/j.ajpath.2015.10.016. Epub 2015 Dec 12. DP - Nlm ET - 2015/12/22 IS - 2 LA - eng PY - 2016 SN - 0002-9440 SP - 435-45 ST - Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma T2 - Am J Pathol TI - Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma VL - 186 ID - 6909 ER - TY - JOUR AD - N.E. Sharpless, The Lineberger Comprehensive Cancer Center, University of North Carolina School Medicine, Chapel Hill, NC, United States AU - Burd, C. E. AU - Liu, W. AU - Huynh, M. V. AU - Waqas, M. A. AU - Gillahan, J. E. AU - Clark, K. S. AU - Fu, K. AU - Martin, B. L. AU - Jeck, W. R. AU - Souroullas, G. P. AU - Darr, D. B. AU - Zedek, D. C. AU - Miley, M. J. AU - Baguley, B. C. AU - Campbell, S. L. AU - Sharpless, N. E. DB - Embase Medline DO - 10.1158/2159-8290.CD-14-0729 IS - 12 LA - English M3 - Article N1 - L600713749 2014-12-17 PY - 2014 SN - 2159-8290 2159-8274 SP - 1418-1429 ST - Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma T2 - Cancer Discovery TI - Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600713749&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-14-0729 VL - 4 ID - 6910 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. tasians@email.chop.edu. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. tasians@email.chop.edu. Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Department of Pediatrics, Division of Hematology and Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Division of Hematology-Oncology, San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, University of California, San Francisco, CA, USA. Department of Hematology, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. AN - 29884903 AU - Tasian, S. K. AU - Casas, J. A. AU - Posocco, D. AU - Gandre-Babbe, S. AU - Gagne, A. L. AU - Liang, G. AU - Loh, M. L. AU - Weiss, M. J. AU - French, D. L. AU - Chou, S. T. C2 - PMC6286697 C6 - NIHMS969005 to this work. DA - Jan DO - 10.1038/s41375-018-0169-y 10.1038/s41375-018-0169-y. Epub 2018 Jun 8. DP - Nlm ET - 2018/06/10 IS - 1 LA - eng PY - 2019 SN - 0887-6924 (Print) 0887-6924 SP - 181-190 ST - Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells T2 - Leukemia TI - Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells VL - 33 ID - 6911 ER - TY - JOUR AD - Department of Biological Sciences, Institute of Cell Biology and Biosystem Technology, Rostock, Germany. thilo.papp@biologie.uni-rostock.de AN - 16179867 AU - Papp, T. AU - Schipper, H. AU - Kumar, K. AU - Schiffmann, D. AU - Zimmermann, R. DA - Oct DO - 10.1097/00008390-200510000-00008 10.1097/00008390-200510000-00008. DP - Nlm ET - 2005/09/24 IS - 5 LA - eng PY - 2005 SN - 0960-8931 (Print) 0960-8931 SP - 401-7 ST - Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi T2 - Melanoma Res TI - Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi VL - 15 ID - 6912 ER - TY - JOUR AD - M. He, Department of Pharmacology and Molecular Therapeutics, Nanchang University School of Pharmaceutical Science, Bayi Avenue, Nanchang, Jiangxi, China AU - Zou, Y. AU - Liu, F. Y. AU - Wu, J. AU - Wan, L. AU - Fang, S. F. AU - Zhang, Z. Y. AU - Luo, Y. AU - Chen, M. H. AU - Huang, M. Z. AU - He, M. AU - Huang, O. P. DB - Embase DO - 10.3892/ol.2017.6435 IS - 2 LA - English M3 - Article N1 - L617154196 2017-07-10 2017-07-17 PY - 2017 SN - 1792-1082 1792-1074 SP - 2427-2431 ST - Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 han Chinese patients with cervical carcinoma T2 - Oncology Letters TI - Mutational analysis of the RAS/RAF/MEK/ERK signaling pathway in 260 han Chinese patients with cervical carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617154196&from=exporthttp://dx.doi.org/10.3892/ol.2017.6435 VL - 14 ID - 6913 ER - TY - JOUR AD - N. Barasch, University of Pittsburgh Medical Center, Pittsburgh, PA, United States AU - Barasch, N. AU - Liu, Y. C. AU - Bailey, N. AU - Ho, J. AU - Swerdlow, S. H. DB - Embase DO - 10.1038/labinvest.2018.13 LA - English M3 - Conference Abstract N1 - L621623777 2018-04-16 PY - 2018 SN - 1530-0307 SP - 498 ST - Mutational and immunophenotypic landscape of primary cutaneous follicle center lymphoma T2 - Laboratory Investigation TI - Mutational and immunophenotypic landscape of primary cutaneous follicle center lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621623777&from=exporthttp://dx.doi.org/10.1038/labinvest.2018.13 VL - 98 ID - 6914 ER - TY - JOUR AD - J. Hellmuth, Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, United States AU - Hellmuth, J. AU - Louissaint, A. AU - Szczepanowski, M. AU - Häbe, S. AU - Pastore, A. AU - Staiger, A. M. AU - Hartmann, S. AU - Kridel, R. AU - Ducar, M. D. AU - Koch, P. AU - Dreyling, M. AU - Hansmann, M. L. AU - Ott, G. AU - Rosenwald, A. AU - Gascoyne, R. D. AU - Weinstock, D. M. AU - Hiddemann, W. AU - Klapper, W. AU - Weigert, O. DB - Embase LA - English M3 - Conference Abstract N1 - L620385702 2018-02-01 PY - 2017 SN - 1528-0020 ST - The mutational landscape and immune microenvironment of primary intestinal follicular lymphoma (PIFL) T2 - Blood TI - The mutational landscape and immune microenvironment of primary intestinal follicular lymphoma (PIFL) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385702&from=export VL - 130 ID - 6915 ER - TY - JOUR AD - R. Rabadan, Department of Biomedical Informatics, Columbia University, New York, NY, United States AU - Da Silva Almeida, A. C. AU - Abate, F. AU - Khiabanian, H. AU - Martinez-Escala, E. AU - Guitart, J. AU - Tensen, C. P. AU - Vermeer, M. H. AU - Rabadan, R. AU - Ferrando, A. AU - Palomero, T. DB - Embase Medline DO - 10.1038/ng.3442 IS - 12 LA - English M3 - Article N1 - L606884099 2015-11-18 2015-12-14 PY - 2015 SN - 1546-1718 1061-4036 SP - 1465-1470 ST - The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome T2 - Nature Genetics TI - The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606884099&from=exporthttp://dx.doi.org/10.1038/ng.3442 VL - 47 ID - 6916 ER - TY - JOUR AD - Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. AN - 22471241 AU - Jung, C. K. AU - Im, S. Y. AU - Kang, Y. J. AU - Lee, H. AU - Jung, E. S. AU - Kang, C. S. AU - Bae, J. S. AU - Choi, Y. J. DA - Aug DO - 10.1089/thy.2011.0123 10.1089/thy.2011.0123. Epub 2012 Apr 3. DP - Nlm ET - 2012/04/05 IS - 8 LA - eng PY - 2012 SN - 1050-7256 SP - 791-7 ST - Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma T2 - Thyroid TI - Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma VL - 22 ID - 6917 ER - TY - JOUR AD - A. Agarwal, Department of Endocrine Surgery, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India AU - George, N. AU - Agarwal, A. AU - Kumari, N. AU - Agarwal, S. AU - Krisnani, N. AU - Gupta, S. DB - Embase DO - 10.4103/ijem.IJEM_441_17 IS - 4 LA - English M3 - Article N1 - L624425790 2018-10-23 2018-10-26 PY - 2018 SN - 2230-9500 2230-8210 SP - 505-510 ST - Mutational profile of papillary thyroid carcinoma in an endemic goiter region of North India T2 - Indian Journal of Endocrinology and Metabolism TI - Mutational profile of papillary thyroid carcinoma in an endemic goiter region of North India UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624425790&from=exporthttp://dx.doi.org/10.4103/ijem.IJEM_441_17 VL - 22 ID - 6918 ER - TY - JOUR AD - 1 Integrated Biostatistics and Bioinformatics Programme, Duke-NUS Medical School, Singapore. 2 Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore. 3 Centre for Computational Biology, Duke-NUS Medical School, Singapore. 4 Lymphoma Genomic Translational Research Laboratory, National Cancer Centre Singapore, Singapore. 5 Department of Oral and Maxillofacial Surgery, National Dental Centre Singapore, Singapore. 6 Division of Surgical Oncology, National Cancer Centre Singapore, Singapore. 7 Cancer Science Institute of Singapore, National University of Singapore, Singapore. 8 Institute of Molecular and Cell Biology, Singapore. 9 Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore. 10 SingHealth/Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore. AN - 30917298 AU - Guan, P. AU - Wong, S. F. AU - Lim, J. Q. AU - Ng, C. C. Y. AU - Soong, P. L. AU - Sim, C. Q. X. AU - Ong, C. K. AU - Rajasegaran, V. AU - Myint, S. S. AU - Lee, J. Y. AU - Tan, H. K. AU - Iyer, N. G. AU - Soo, K. C. AU - Teh, B. T. AU - Tay, A. B. G. DA - Jun DO - 10.1177/0022034519837248 10.1177/0022034519837248. Epub 2019 Mar 27. DP - Nlm ET - 2019/03/28 IS - 6 LA - eng PY - 2019 SN - 0022-0345 SP - 652-658 ST - Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking T2 - J Dent Res TI - Mutational Signatures in Mandibular Ameloblastoma Correlate with Smoking VL - 98 ID - 6919 ER - TY - JOUR AD - Division of Oncology, The Children's Hospital of Philadelphia; Philadelphia, PA, USA. vincent.dam@jefferson.edu AN - 16822308 AU - Dam, V. AU - Morgan, B. T. AU - Mazanek, P. AU - Hogarty, M. D. C2 - PMC1533846 DA - Jul 5 DO - 10.1186/1471-2407-6-177 10.1186/1471-2407-6-177. DP - Nlm ET - 2006/07/11 LA - eng PY - 2006 SN - 1471-2407 SP - 177 ST - Mutations in PIK3CA are infrequent in neuroblastoma T2 - BMC Cancer TI - Mutations in PIK3CA are infrequent in neuroblastoma VL - 6 ID - 6920 ER - TY - JOUR AD - Department of Hematology, Tongji Hospital of Huazhong University of Science and Technology, 1905 Jiefang Avenue, Wuhan, Hubei, 430030, China Department of Hematology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, 471000, China AU - Liu, J. AU - Yang, H. AU - Xu, X. AU - Yi, S. AU - Meng, L. DB - Scopus DO - 10.3892/ol.2020.11650 IS - 2 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1071-1076 ST - Mutations in the bcr-abl1 kinase domain in patients with chronic myeloid leukaemia treated with tkis or at diagnosis T2 - Oncology Letters TI - Mutations in the bcr-abl1 kinase domain in patients with chronic myeloid leukaemia treated with tkis or at diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087212700&doi=10.3892%2fol.2020.11650&partnerID=40&md5=1a0849e086bf7feab3530ceb76944dbb VL - 20 ID - 6921 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Department of Pediatrics, Uji Takeda Hospital, Kyoto, Japan. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Electronic address: iehara@koto.kpu-m.ac.jp. Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan. AN - 30904164 AU - Nakagawa, N. AU - Kikuchi, K. AU - Yagyu, S. AU - Miyachi, M. AU - Iehara, T. AU - Tajiri, T. AU - Sakai, T. AU - Hosoi, H. DA - May 7 DO - 10.1016/j.bbrc.2019.03.038 10.1016/j.bbrc.2019.03.038. Epub 2019 Mar 21. DP - Nlm ET - 2019/03/25 IS - 3 LA - eng PY - 2019 SN - 0006-291x SP - 524-530 ST - Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma T2 - Biochem Biophys Res Commun TI - Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma VL - 512 ID - 6922 ER - TY - JOUR AD - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona. Anaxomics Biotech, Barcelona. Hematology Department. Hematopathology Unit, Hospital Clinic, Barcelona. Hematology Department, University Hospital- IBSAL, and Institute of Molecular and Cellular Biology of Cancer, University of Salamanca, CIBERONC. Hematology Department, Hospital Clínico Universitario, Valencia. Hematology Department, Hospital Universitario Central de Asturias, Oviedo. Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, CIBERONC, Spain. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Barcelona dcolomer@clinic.cat. AN - 30262568 AU - Giménez, N. AU - Martínez-Trillos, A. AU - Montraveta, A. AU - Lopez-Guerra, M. AU - Rosich, L. AU - Nadeu, F. AU - Valero, J. G. AU - Aymerich, M. AU - Magnano, L. AU - Rozman, M. AU - Matutes, E. AU - Delgado, J. AU - Baumann, T. AU - Gine, E. AU - González, M. AU - Alcoceba, M. AU - Terol, M. J. AU - Navarro, B. AU - Colado, E. AU - Payer, A. R. AU - Puente, X. S. AU - López-Otín, C. AU - Lopez-Guillermo, A. AU - Campo, E. AU - Colomer, D. AU - Villamor, N. C2 - PMC6395334 DA - Mar DO - 10.3324/haematol.2018.196931 10.3324/haematol.2018.196931. Epub 2018 Sep 27. DP - Nlm ET - 2018/09/29 IS - 3 LA - eng PY - 2019 SN - 0390-6078 (Print) 0390-6078 SP - 576-586 ST - Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia T2 - Haematologica TI - Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia VL - 104 ID - 6923 ER - TY - JOUR AD - Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, CH-8091 Zurich, Switzerland AU - Bode, B. AU - Frigerio, S. AU - Behnke, S. AU - Senn, B. AU - Odermatt, B. AU - Zimmermann, D. R. AU - Moch, H. DB - Scopus DO - 10.1038/modpathol.3800560 IS - 4 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2006 SP - 541-547 ST - Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma T2 - Modern Pathology TI - Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645301012&doi=10.1038%2fmodpathol.3800560&partnerID=40&md5=3d4e129b75a3764a32cb67fa6527f3c6 VL - 19 ID - 6924 ER - TY - JOUR AD - Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, Tübingen University Hospital, Tübingen, Germany. Hematopathology Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi Sunyer, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain. Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD. Department of Cellular Pathology, Barts and The London National Health Service Trust, London, United Kingdom. Pathology Department, Instituto Portugues de Oncología, Lisbon, Portugal. Department of Histopathology, Guy's and St Thomas' Hospitals, London, United Kingdom. Department of Pathology, All Wales Lymphoma Panel, University Hospital of Wales, Cardiff, United Kingdom. Institute of Pathology, University of Würzburg, Würzburg, Germany. Comprehensive Cancer Center Mainfranken, Würzburg, Germany. Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany; and. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. AN - 28533310 AU - Schmidt, J. AU - Ramis-Zaldivar, J. E. AU - Nadeu, F. AU - Gonzalez-Farre, B. AU - Navarro, A. AU - Egan, C. AU - Montes-Mojarro, I. A. AU - Marafioti, T. AU - Cabeçadas, J. AU - van der Walt, J. AU - Dojcinov, S. AU - Rosenwald, A. AU - Ott, G. AU - Bonzheim, I. AU - Fend, F. AU - Campo, E. AU - Jaffe, E. S. AU - Salaverria, I. AU - Quintanilla-Martinez, L. C2 - PMC5520474 DA - Jul 20 DO - 10.1182/blood-2017-03-776278 10.1182/blood-2017-03-776278. Epub 2017 May 22. DP - Nlm ET - 2017/05/24 IS - 3 LA - eng PY - 2017 SN - 0006-4971 (Print) 0006-4971 SP - 323-327 ST - Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation T2 - Blood TI - Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation VL - 130 ID - 6925 ER - TY - JOUR AD - Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA. AN - 26915300 AU - Kamionek, M. AU - Ahmadi Moghaddam, P. AU - Sakhdari, A. AU - Kovach, A. E. AU - Welch, M. AU - Meng, X. AU - Dresser, K. AU - Tomaszewicz, K. AU - Cosar, E. F. AU - Mark, E. J. AU - Fraire, A. E. AU - Hutchinson, L. DA - Sep DO - 10.1111/his.12955 10.1111/his.12955. Epub 2016 Apr 29. DP - Nlm ET - 2016/02/27 IS - 3 LA - eng PY - 2016 SN - 0309-0167 SP - 499-509 ST - Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease T2 - Histopathology TI - Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease VL - 69 ID - 6926 ER - TY - JOUR AD - J. Wang, Department of Cardiology, Affiliated Hospital of Jining Medical University, No. 89 Guhuai Road, Jining City, Shandong Province, China AU - Huang, C. AU - Zhang, Y. AU - Qi, H. AU - Xu, X. AU - Yang, L. AU - Wang, J. DB - Embase Medline DO - 10.1042/BSR20194472 IS - 6 LA - English M3 - Article N1 - L2007257487 2020-10-13 PY - 2020 SN - 1573-4935 0144-8463 ST - Myc is involved in Genistein protecting against LPS-induced myocarditis in vitro through mediating MAPK/JNK signaling pathway T2 - Bioscience Reports TI - Myc is involved in Genistein protecting against LPS-induced myocarditis in vitro through mediating MAPK/JNK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007257487&from=exporthttp://dx.doi.org/10.1042/BSR20194472 VL - 40 ID - 6927 ER - TY - JOUR AD - E.M. Frohman, Department of Neurology, University of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235, United States AU - Frohman, E. M. AU - Brannon, K. AU - Racke, M. K. AU - Hawker, K. DB - Embase Medline DO - 10.1097/00002826-200403000-00006 IS - 2 LA - English M3 - Review N1 - L38569179 2004-05-27 PY - 2004 SN - 0362-5664 SP - 80-83 ST - Mycophenolate Mofetil in Multiple Sclerosis T2 - Clinical Neuropharmacology TI - Mycophenolate Mofetil in Multiple Sclerosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38569179&from=exporthttp://dx.doi.org/10.1097/00002826-200403000-00006 VL - 27 ID - 6928 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Nursing, National Tainan Institute of Nursing, Tainan, Taiwan. Department of Pathology and Laboratory Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, and National Defense Medical Center, Taipei, Taiwan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, School of Medicine, Taipei Medical University and National Taiwan University, Taipei, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw. AN - 30348505 AU - Wang, R. C. AU - Sakata, S. AU - Chen, B. J. AU - Chang, S. T. AU - Hsieh, P. P. AU - Yang, C. S. AU - Baba, S. AU - Takeuchi, K. AU - Chuang, S. S. DA - Dec DO - 10.1016/j.pathol.2018.08.008 10.1016/j.pathol.2018.08.008. Epub 2018 Oct 20. DP - Nlm ET - 2018/10/24 IS - 7 LA - eng PY - 2018 SN - 0031-3025 SP - 718-724 ST - Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression T2 - Pathology TI - Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression VL - 50 ID - 6929 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, H.C. Andersen Children's Hospital, Odense University Hospital, Odense, Denmark Department of Pathology, Odense University Hospital, Odense, Denmark AU - Rathe, M. AU - Kristensen, T. K. AU - Møller, M. B. AU - Carlsen, N. L. T. DB - Scopus DO - 10.1002/pbc.22655 IS - 4 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2010 SP - 730-732 ST - Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate T2 - Pediatric Blood and Cancer TI - Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957056628&doi=10.1002%2fpbc.22655&partnerID=40&md5=f63b5054f4ec62183514739dd99049de VL - 55 ID - 6930 ER - TY - JOUR AD - K.-I. Lin, Department of Obstetrics and Gynecology, Chang Bing Show Chwan Memorial Hospital, No. 6 Lugong Road, Lugang Town, Changhua County, Taiwan AU - Yue, C. H. AU - Liu, J. Y. AU - Chi, C. S. AU - Hu, C. W. AU - Tan, K. T. AU - Huang, F. M. AU - Pan, Y. R. AU - Lin, K. I. AU - Lee, C. J. DB - Embase Medline DO - 10.21873/anticanres.13574 IS - 8 LA - English M3 - Article N1 - L2002603589 2019-08-21 2019-08-26 PY - 2019 SN - 1791-7530 0250-7005 SP - 4149-4164 ST - Myeloid Zinc Finger 1 (MZF1) maintains the mesenchymal phenotype by down-regulating IGF1R/p38 MAPK/ERα signaling pathway in high-level MZF1-expressing TNBC cells T2 - Anticancer Research TI - Myeloid Zinc Finger 1 (MZF1) maintains the mesenchymal phenotype by down-regulating IGF1R/p38 MAPK/ERα signaling pathway in high-level MZF1-expressing TNBC cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002603589&from=exporthttp://dx.doi.org/10.21873/anticanres.13574 VL - 39 ID - 6931 ER - TY - JOUR AD - M. U. Sani, Cardiology Unit, Department of Medicine, Aminu Kano Teaching Hospital, P.M.B 3452, Kano, Nigeria AU - Sani, M. U. DB - Embase Medline DO - 10.1007/s00508-008-0935-3 IS - 3-4 LA - English M3 - Review N1 - L351361645 2008-03-25 PY - 2008 SN - 0043-5325 SP - 77-87 ST - Myocardial disease in human immunodeficiency virus (HIV) infection: A review T2 - Wiener Klinische Wochenschrift TI - Myocardial disease in human immunodeficiency virus (HIV) infection: A review UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351361645&from=exporthttp://dx.doi.org/10.1007/s00508-008-0935-3 VL - 120 ID - 6932 ER - TY - JOUR AD - R. Di Nicolantonio, Department of Physiology, University of Melbourne, Melbourne, VIC 3010, Australia AU - Dwyer, J. P. AU - Ritchie, M. W. AU - Smyth, G. K. AU - Harrap, S. B. AU - Delbridge, L. M. D. AU - Domenighetti, A. A. AU - Nicolantonio, R. DB - Embase Medline DO - 10.1291/hypres.31.941 IS - 5 LA - English M3 - Article N1 - L351895039 2008-07-09 PY - 2008 SN - 0916-9636 1348-4214 SP - 941-955 ST - Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension T2 - Hypertension Research TI - Myocardial gene expression associated with genetic cardiac hypertrophy in the absence of hypertension UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351895039&from=exporthttp://dx.doi.org/10.1291/hypres.31.941 VL - 31 ID - 6933 ER - TY - JOUR AD - H.S. Bernstein, University of California, Box 1346, 513 Parnassus Avenue, San Francisco, CA 941431346, United States AU - Yeghiazarians, Y. AU - Gaur, M. AU - Zhang, Y. AU - Sievers, R. E. AU - Ritner, C. AU - Prasad, M. AU - Boyle, A. AU - Bernstein, H. S. DB - Embase Medline DO - 10.3109/14653249.2011.623690 IS - 2 LA - English M3 - Article N1 - L364100177 2012-01-25 2012-01-27 PY - 2012 SN - 1465-3249 1477-2566 SP - 223-231 ST - Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition T2 - Cytotherapy TI - Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364100177&from=exporthttp://dx.doi.org/10.3109/14653249.2011.623690 VL - 14 ID - 6934 ER - TY - JOUR AD - Y.-H. Lee, Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan AU - Lee, Y. H. AU - Su, S. B. AU - Huang, C. C. AU - Sheu, H. M. AU - Tsai, J. C. AU - Lin, C. H. AU - Wang, Y. J. AU - Wang, B. J. C2 - Merck Chemical Company(Germany) DB - Embase Medline DO - 10.1371/journal.pone.0108317 IS - 9 LA - English M3 - Article N1 - L600067438 2014-10-09 2014-10-11 PY - 2014 SN - 1932-6203 ST - N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression T2 - PLoS ONE TI - N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600067438&from=exporthttp://dx.doi.org/10.1371/journal.pone.0108317 VL - 9 ID - 6935 ER - TY - JOUR AD - S. Liu, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Huang, X. AU - Ye, Q. AU - Chen, M. AU - Li, A. AU - Mi, W. AU - Fang, Y. AU - Zaytseva, Y. Y. AU - O’Connor, K. L. AU - Vander Kooi, C. W. AU - Liu, S. AU - She, Q. B. DB - Embase Medline DO - 10.1038/s41467-019-11580-4 IS - 1 LA - English M3 - Article N1 - L2002547532 2019-08-27 2019-09-02 PY - 2019 SN - 2041-1723 ST - N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals T2 - Nature Communications TI - N-glycosylation-defective splice variants of neuropilin-1 promote metastasis by activating endosomal signals UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002547532&from=exporthttp://dx.doi.org/10.1038/s41467-019-11580-4 VL - 10 ID - 6936 ER - TY - JOUR AD - Department of Orthopedic, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China. Department of Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210009, P.R. China. AN - 29545891 AU - Bian, J. AU - Cao, D. AU - Shen, J. AU - Jiang, B. AU - Chen, D. AU - Bian, L. C2 - PMC5840919 DA - Apr DO - 10.3892/etm.2018.5842 10.3892/etm.2018.5842. Epub 2018 Feb 7. DP - Nlm ET - 2018/03/17 IS - 4 LA - eng PY - 2018 SN - 1792-0981 (Print) 1792-0981 SP - 3617-3622 ST - N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway T2 - Exp Ther Med TI - N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway VL - 15 ID - 6937 ER - TY - JOUR AD - Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan. AN - 10646854 AU - Misawa, A. AU - Hosoi, H. AU - Arimoto, A. AU - Shikata, T. AU - Akioka, S. AU - Matsumura, T. AU - Houghton, P. J. AU - Sawada, T. DA - Jan 1 DP - Nlm ET - 2000/01/26 IS - 1 LA - eng N1 - Misawa, A Hosoi, H Arimoto, A Shikata, T Akioka, S Matsumura, T Houghton, P J Sawada, T CA23099/CA/NCI NIH HHS/United States Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United States Cancer Res. 2000 Jan 1;60(1):64-9. PY - 2000 SN - 0008-5472 (Print) 0008-5472 SP - 64-9 ST - N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells T2 - Cancer Res TI - N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells VL - 60 ID - 6938 ER - TY - JOUR AD - Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany. Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. NCT Trial Center, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany. Division of Pediatric Neuro-oncology, DKFZ, German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. Division of Applied Bioinformatics, DKFZ, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. Dktk. Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany. National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany. Clinical Cooperation Unit Radiation Oncology, DKFZ, Heidelberg, Germany. Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany. DKFZ, Heidelberg, Germany. Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany. Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany. Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology, DKTK. Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKTK, DKFZ, Heidelberg, Germany. Department of Neurology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. AN - 30277538 AU - Wick, W. AU - Dettmer, S. AU - Berberich, A. AU - Kessler, T. AU - Karapanagiotou-Schenkel, I. AU - Wick, A. AU - Winkler, F. AU - Pfaff, E. AU - Brors, B. AU - Debus, J. AU - Unterberg, A. AU - Bendszus, M. AU - Herold-Mende, C. AU - Eisenmenger, A. AU - von Deimling, A. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Sahm, F. AU - Platten, M. C2 - PMC6303534 DA - Jan 1 DO - 10.1093/neuonc/noy161 10.1093/neuonc/noy161. DP - Nlm ET - 2018/10/03 IS - 1 LA - eng PY - 2019 SN - 1522-8517 (Print) 1522-8517 SP - 95-105 ST - N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma T2 - Neuro Oncol TI - N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma VL - 21 ID - 6939 ER - TY - JOUR AD - I. Szanto, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland AU - Carnesecchi, S. AU - Rougemont, A. L. AU - Doroshow, J. H. AU - Nagy, M. AU - Mouche, S. AU - Gumy-Pause, F. AU - Szanto, I. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2015.02.027 LA - English M3 - Article N1 - L603983267 2015-05-01 2015-05-22 PY - 2015 SN - 1873-4596 0891-5849 SP - 22-29 ST - The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines T2 - Free Radical Biology and Medicine TI - The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603983267&from=exporthttp://dx.doi.org/10.1016/j.freeradbiomed.2015.02.027 VL - 84 ID - 6940 ER - TY - JOUR AD - J.A. McGrath, Dermatology Research Laboratories, Floor 9 Tower Wing, Guy's Hospital, Great Maze Pond, London, United Kingdom AU - Aslam, A. AU - Salam, A. AU - Griffiths, C. E. M. AU - McGrath, J. A. DB - Embase Medline DO - 10.1111/ced.12209 IS - 1 LA - English M3 - Article N1 - L607371914 2019-08-27 PY - 2014 SN - 1365-2230 0307-6938 SP - 1-6 ST - Naevus sebaceus: A mosaic RASopathy T2 - Clinical and Experimental Dermatology TI - Naevus sebaceus: A mosaic RASopathy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607371914&from=exporthttp://dx.doi.org/10.1111/ced.12209 VL - 39 ID - 6941 ER - TY - JOUR AD - N. Kanazawa, Department of Dermatology, Wakayama Medical University, Wakayama 641-0012, Japan AU - Kanazawa, N. DB - Embase Medline DO - 10.2332/allergolint.11-RAI-0416 IS - 2 L1 - internal-pdf://4120871629/61_11-OA-0385.pdf LA - English M3 - Article N1 - L365065764 2012-06-29 2012-07-05 PY - 2012 SN - 1323-8930 1440-1592 SP - 197-206 ST - Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy T2 - Allergology International TI - Nakajo-Nishimura syndrome: An autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365065764&from=exporthttp://dx.doi.org/10.2332/allergolint.11-RAI-0416 VL - 61 ID - 6942 ER - TY - JOUR AD - Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, 110002, India AU - Agrwal, S. AU - Sahi, P. K. DB - Scopus DO - 10.1007/s13312-020-1855-1 IS - 6 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 561-564 ST - National Comprehensive Cancer Network Guidelines for Pediatric Acute Lymphoblastic Leukemia T2 - Indian Pediatrics TI - National Comprehensive Cancer Network Guidelines for Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086752444&doi=10.1007%2fs13312-020-1855-1&partnerID=40&md5=a5e7b83dea6b90ac62c1445c1dcc7296 VL - 57 ID - 6943 ER - TY - JOUR AD - Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Ayuttaya Hospital, Ayuttaya, Thailand Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkoknoi Bangkok 10700, Thailand AU - Auewarakul, C. U. AU - Huang, S. AU - Yimyam, M. AU - Boonmoh, S. DB - Scopus DO - 10.1159/000093641 IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2006 SP - 114-119 ST - Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants T2 - Acta Haematologica TI - Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747439438&doi=10.1159%2f000093641&partnerID=40&md5=b8f892e968224ec651a7567b2fef7a2e VL - 116 ID - 6944 ER - TY - JOUR AD - Department of Dermatology, University of Michigan Health System, Ann Arbor, MI, United States Department of Pathology, University of Michigan Health System, Ann Arbor, MI, United States Department of Biostatistics, University of Michigan Health System, Ann Arbor, MI, United States University of Michigan Medical School, Ann Arbor, MI, United States Department of Otolaryngology - Head and Neck Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgery, University of Michigan Health System, Ann Arbor, MI, United States Department of Surgery, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, Lebanon, NH, United States AU - Durham, A. B. AU - Schwartz, J. L. AU - Lowe, L. AU - Zhao, L. AU - Johnson, A. G. AU - Harms, K. L. AU - Bichakjian, C. K. AU - Orsini, A. P. AU - McLean, S. A. AU - Bradford, C. R. AU - Cohen, M. S. AU - Johnson, T. M. AU - Sabel, M. S. AU - Wong, S. L. DB - Scopus DO - 10.1002/jso.24765 IS - 8 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 1185-1192 ST - The natural history of thin melanoma and the utility of sentinel lymph node biopsy T2 - Journal of Surgical Oncology TI - The natural history of thin melanoma and the utility of sentinel lymph node biopsy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024831137&doi=10.1002%2fjso.24765&partnerID=40&md5=574ac83a11f34c02b4812af0e1098cbc VL - 116 ID - 6945 ER - TY - JOUR AD - St. Jude Children's Research Hospital, University of Tennessee, Health Science Center, United States Robert H. Lurie Comprehensive Cancer Center, Northwestern University, United States Memorial Sloan Kettering Cancer Center, United States Siteman Cancer Center, Barnes-Jewish Hospital, Washington University, School of Medicine, United States Ohio State University, Comprehensive Cancer Center, James Cancer Hospital, Solove Research Institute, United States AU - Pallera, A. AU - Altman, J. K. AU - Berman, E. AU - Abboud, C. N. AU - Bhatnagar, B. AU - Curtin, P. AU - DeAngelo, D. J. AU - Gotlib, J. AU - Tanner Hagelstrom, R. AU - Hobbs, G. AU - Jagasia, M. AU - Kantarjian, H. M. AU - Kropf, P. AU - Metheny, L. AU - Moore, J. O. AU - Ontiveros, E. AU - Purev, E. AU - Quiery, A. AU - Reddy, V. V. B. AU - Rose, M. G. AU - Shah, N. P. AU - Douglas Smith, B. AU - Snyder, D. S. AU - Sweet, K. L. AU - Tibes, R. AU - Yang, D. T. AU - Gregory, K. AU - Sundar, H. AU - Deininger, M. AU - Radich, J. P. DB - Scopus DO - 10.6004/jnccn.2016.0162 IS - 12 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2016 SP - 1505-1512 ST - NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85005990816&doi=10.6004%2fjnccn.2016.0162&partnerID=40&md5=88441b7830bf32ed85fd0fa28106e385 VL - 14 ID - 6946 ER - TY - JOUR AU - Demetri, G. D. AU - Von Mehren, M. AU - Antonescu, C. R. AU - DeMatteo, R. P. AU - Ganjoo, K. N. AU - Maki, R. G. AU - Pisters, P. W. T. AU - Raut, C. P. AU - Riedel, R. F. AU - Schuetze, S. AU - Sundar, H. M. AU - Trent, J. C. AU - Wayne, J. D. DB - Scopus DO - 10.6004/jnccn.2010.0116 IS - SUPPL. 2 M3 - Review N1 - Cited By :616 Export Date: 18 November 2020 PY - 2010 SP - S1-S40 ST - NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors T2 - JNCCN Journal of the National Comprehensive Cancer Network TI - NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77951875556&doi=10.6004%2fjnccn.2010.0116&partnerID=40&md5=e48c7455fe79e9f49f6489adf5580e98 VL - 8 ID - 6947 ER - TY - JOUR DB - Embase IS - 1 LA - English M3 - Conference Review N1 - L630753127 2020-02-04 PY - 2018 SN - 1098-4275 ST - NCE Abstracts 2017 T2 - Pediatrics TI - NCE Abstracts 2017 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630753127&from=export VL - 142 ID - 6948 ER - TY - JOUR AD - Z. Eroglu AU - Eroglu, Z. AU - Tawbi, H. A. H. AU - Hu, J. AU - Guan, M. AU - Frankel, P. H. AU - Ruel, N. AU - Wilczynski, S. AU - Christensen, S. AU - Gandara, D. R. AU - Chow, W. A. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523586 2014-07-16 PY - 2014 SN - 0732-183X ST - NCI #8412: A randomized phase II trial of AZD6244 alone and AZD6244 plus temsirolimus for soft-tissue sarcomas T2 - Journal of Clinical Oncology TI - NCI #8412: A randomized phase II trial of AZD6244 alone and AZD6244 plus temsirolimus for soft-tissue sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523586&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10526?sid=bd57f2ae-089e-41c9-9100-7badef5fe01c VL - 32 ID - 6949 ER - TY - JOUR AD - Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical University of Graz, Auenbruggerplatz 30, 8036 Graz, Austria Department of Surgery, Reconstructive Surgery, Medical University of Graz, Austria Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Austria AU - Hanzer, M. AU - Nebl, A. AU - Spendel, S. AU - Pilhatsch, A. AU - Urban, C. AU - Benesch, M. DB - Scopus DO - 10.1055/s-0030-1249093 IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2010 SP - 184-186 ST - Necrosisof a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh T2 - Klinische Padiatrie TI - Necrosisof a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953143593&doi=10.1055%2fs-0030-1249093&partnerID=40&md5=62dadf703e44489704e1beae0697cba8 VL - 222 ID - 6950 ER - TY - JOUR AD - Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. The Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Departments of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33101, United States; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, United States. Electronic address: jbarredo@miami.edu. AN - 27626202 AU - Leclerc, G. M. AU - Zheng, S. AU - Leclerc, G. J. AU - DeSalvo, J. AU - Swords, R. T. AU - Barredo, J. C. DA - Nov DO - 10.1016/j.leukres.2016.09.007 10.1016/j.leukres.2016.09.007. Epub 2016 Sep 5. DP - Nlm ET - 2016/10/27 LA - eng PY - 2016 SN - 0145-2126 SP - 1-10 ST - The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia T2 - Leuk Res TI - The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia VL - 50 ID - 6951 ER - TY - JOUR AD - Section of Adult hematology and hematopoietic Stem Cell Transplant, Oncology Centre and Department of research Administration, King Fahad Specialist hospital, Dammam 31444, Saudi Arabia Section of Adult hematology and hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist hospital and research Centre, Riyadh 11211, Saudi Arabia AU - Al-Anazi, K. A. AU - Chaudhri, N. AU - Al-Mohareb, F. I. AU - Al-Zahrani, H. A. AU - Al-Omar, H. M. AU - Al-Shanqeeti, A. AU - Sahovic, E. AU - Al Sharif, F. Z. AU - Mohamed, S. Y. AU - Rasheed, W. AU - Beihani, A. AU - Hejazi, A. AU - Zaidi, Z. AU - Morshid, M. AU - Seth, P. AU - El-Tayeb, K. I. AU - Nassar, A. AU - Bakr, M. AU - Jafar, S. A. AU - Othman, I. A. AU - Abdulwahab, A. AU - Al-Sultan, O. AU - Aljurf, M. D. DB - Scopus DO - 10.4137/CMT.S5784 M3 - Article N1 - Export Date: 18 November 2020 PY - 2010 SP - 877-888 ST - The negative impact of imatinib mesylate therapy prior to allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia T2 - Clinical Medicine Insights: Therapeutics TI - The negative impact of imatinib mesylate therapy prior to allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650751012&doi=10.4137%2fCMT.S5784&partnerID=40&md5=a91ec98d2a642bd2391eca0c7c92b304 VL - 2 ID - 6952 ER - TY - JOUR AD - Y. Nagumo, Department of Urology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan AU - Nagumo, Y. AU - Maejima, A. AU - Toyoshima, Y. AU - Komiyama, M. AU - Yonemori, K. AU - Yoshida, A. AU - Fujimoto, H. DB - Embase DO - 10.1016/j.ijscr.2018.04.027 LA - English M3 - Article N1 - L2000752002 2018-05-18 2018-06-04 PY - 2018 SN - 2210-2612 SP - 1-4 ST - Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report T2 - International Journal of Surgery Case Reports TI - Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000752002&from=exporthttp://dx.doi.org/10.1016/j.ijscr.2018.04.027 VL - 48 ID - 6953 ER - TY - JOUR AD - Department of Surgery, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Pathology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Radiology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden Department of Oncology, Lundberg Lab. for Cancer Research, Sahlgrenska University Hospital, S-417 45 Göteborg, Sweden AU - Bümming, P. AU - Andersson, J. AU - Meis-Kindblom, J. M. AU - Klingenstierna, H. AU - Engström, K. AU - Stierner, U. AU - Wängberg, B. AU - Jansson, S. AU - Ahlman, H. AU - Kindblom, L. G. AU - Nilsson, B. DB - Scopus DO - 10.1038/sj.bjc.6600965 IS - 3 M3 - Article N1 - Cited By :132 Export Date: 18 November 2020 PY - 2003 SP - 460-464 ST - Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients T2 - British Journal of Cancer TI - Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: A centre-based study of 17 patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042978501&doi=10.1038%2fsj.bjc.6600965&partnerID=40&md5=4b9a9b8da913aea595776fa8192cc391 VL - 89 ID - 6954 ER - TY - JOUR AD - Division of Nephrology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia USA Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia USA AN - 104061069. Language: English. Entry Date: 20140402. Revision Date: 20200708. Publication Type: Journal Article AU - Ruebner, Rebecca AU - Copelovitch, Lawrence AU - Evageliou, Nicholas AU - Denburg, Michelle AU - Belasco, Jean AU - Kaplan, Bernard DB - ccm DO - 10.1007/s00467-013-2696-0 DP - EBSCOhost IS - 5 N1 - case study; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Special Interest: Pediatric Care. NLM UID: 8708728. PMID: NLM24310825. PY - 2014 SN - 0931-041X SP - 863-869 ST - Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature T2 - Pediatric Nephrology TI - Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104061069&site=ehost-live&scope=site VL - 29 ID - 6955 ER - TY - JOUR AD - Medical Oncology Clinic, Jules Bordet Institute, Université Libre de Bruxelles, Boulevard de Waterloo 121, Brussels, B-1000, Belgium Division of Medical Oncology, Hospital Universitario la Princesa, Madrid, Spain Division of Breast Oncology, Saitama Cancer Center, Ina, Japan Dnepropetrovsk State Medical Academy, Dnepropetrovsk, Ukraine Tata Memorial Centre, Parel, India University of the Witwatersrand Department of Medical Oncology, Wits Donald Gordon Medical Centre, Johannesburg, South Africa National University Cancer Institute, Singapore, Singapore Central India Cancer Research Institute, Nagpur, India Asan Medical Center, University of Ulsan, Seoul, South Korea Centre Léon Bérard, Lyon, France B. P. Poddar Hospital and Medical Research Ltd, Kolkata, India Institute Rotary Cancer Hospital, AIIMS, New Delhi, India Washington University School of Medicine, St Louis, MO, United States Puma Biotechnology Inc, Los Angeles, CA, United States Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, United States AU - Awada, A. AU - Colomer, R. AU - Inoue, K. AU - Bondarenko, I. AU - Badwe, R. A. AU - Demetriou, G. AU - Lee, S. C. AU - Mehta, A. O. AU - Kim, S. B. AU - Bachelot, T. AU - Goswami, C. AU - Deo, S. AU - Bose, R. AU - Wong, A. AU - Xu, F. AU - Yao, B. AU - Bryce, R. AU - Carey, L. A. DB - Scopus DO - 10.1001/jamaoncol.2016.0237 IS - 12 M3 - Article N1 - Cited By :99 Export Date: 18 November 2020 PY - 2016 SP - 1557-1564 ST - Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer the NEfERT-T randomized clinical trial T2 - JAMA Oncology TI - Neratinib plus paclitaxel vs trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer the NEfERT-T randomized clinical trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013219022&doi=10.1001%2fjamaoncol.2016.0237&partnerID=40&md5=86eea349025f30292d39cef1b92a37f4 VL - 2 ID - 6956 ER - TY - JOUR AD - Department of Cardiology, Boston Children's Hospital, Boston, MA 02115, United States Department of Pediatrics, University of Pittsburgh, Richard King Mellon Institute for Pediatric Research, Division of Pediatric Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, United States Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, United States Department of Pediatrics, Harvard Medical School, Boston, MA 02115, United States Pre-clinical MRI Core, Beth Israel Deaconess Medical Center, Boston, MA 02115, United States Department of Developmental Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15224, United States Rangos Research Center Animal Imaging Core, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, United States McGowan Institute for Regenerative Medicine, Pittsburgh, PA 15219, United States Interdisciplinary Biomedical Graduate Program, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, United States PAREXEL Informatics, Billerica, MA 01821, United States AU - Ganapathy, B. AU - Nandhagopal, N. AU - Polizzotti, B. D. AU - Bennett, D. AU - Asan, A. AU - Wu, Y. AU - Kühn, B. C7 - e0155456 DB - Scopus DO - 10.1371/journal.pone.0155456 IS - 5 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2016 ST - Neuregulin-1 administration protocols sufficient for stimulating cardiac regeneration in young mice do not induce somatic, organ, or neoplastic growth T2 - PLoS ONE TI - Neuregulin-1 administration protocols sufficient for stimulating cardiac regeneration in young mice do not induce somatic, organ, or neoplastic growth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84970028928&doi=10.1371%2fjournal.pone.0155456&partnerID=40&md5=965313b6b1f5fb03e95eda573ccc48d3 VL - 11 ID - 6957 ER - TY - JOUR AD - E. Vreugdenhil, Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University Medical Center, PO Box 9502, 2300 RA Leiden, Netherlands AU - Verissimo, C. S. AU - Molenaar, J. J. AU - Fitzsimons, C. P. AU - Vreugdenhil, E. C1 - cep 701 imc a12 mln8237 pf 02341066 DB - Embase Medline DO - 10.1530/ERC-11-0251 IS - 6 LA - English M3 - Review N1 - L364102828 2012-01-25 2012-01-27 PY - 2011 SN - 1351-0088 1479-6821 SP - R213-R231 ST - Neuroblastoma therapy: What is in the pipeline? T2 - Endocrine-Related Cancer TI - Neuroblastoma therapy: What is in the pipeline? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364102828&from=exporthttp://dx.doi.org/10.1530/ERC-11-0251http://erc.endocrinology-journals.org/content/18/6/R213.full.pdf+html VL - 18 ID - 6958 ER - TY - JOUR AD - R. Vadde, Department of Biotechnology & Bioinformatics, Yogi Vemana University, Kadapa, Andhra Pradesh, India AU - Mallepalli, S. AU - Gupta, M. K. AU - Vadde, R. DB - Embase Medline DO - 10.2174/1389200221666191226102231 IS - 13 LA - English M3 - Review N1 - L2003853638 2020-03-24 2020-04-29 PY - 2019 SN - 1875-5453 1389-2002 SP - 1014-1022 ST - Neuroblastoma: An updated review on biology and treatment T2 - Current Drug Metabolism TI - Neuroblastoma: An updated review on biology and treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003853638&from=exporthttp://dx.doi.org/10.2174/1389200221666191226102231 VL - 20 ID - 6959 ER - TY - JOUR AD - V.P. Tolbert, Department of Pediatrics, UCSF Helen Diller Family Comprehensive Cancer Center, and UCSF Benioff Children’s Hospital, University of California, San Francisco, CA, United States AU - Tolbert, V. P. AU - Matthay, K. K. DB - Embase Medline DO - 10.1007/s00441-018-2821-2 IS - 2 LA - English M3 - Review N1 - L621402077 2018-03-30 2018-05-16 PY - 2018 SN - 1432-0878 0302-766X SP - 195-209 ST - Neuroblastoma: clinical and biological approach to risk stratification and treatment T2 - Cell and Tissue Research TI - Neuroblastoma: clinical and biological approach to risk stratification and treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621402077&from=exporthttp://dx.doi.org/10.1007/s00441-018-2821-2 VL - 372 ID - 6960 ER - TY - JOUR AD - University Hospital of Wales, Department of Neurosurgery, Cardiff University, Heath Park, Cardiff, CF14 4XW, UK. Sharouffh@cardiff.ac.uk. University Hospital of Wales, Department of Neurosurgery, Cardiff University, Heath Park, Cardiff, CF14 4XW, UK. University Hospital of Wales, Cardiff, UK. AN - 29948137 AU - Sharouf, F. AU - Zaben, M. AU - Lammie, A. AU - Leach, P. AU - Bhatti, M. I. C2 - PMC6060827 DA - Aug DO - 10.1007/s00381-018-3851-5 10.1007/s00381-018-3851-5. Epub 2018 Jun 12. DP - Nlm ET - 2018/06/28 IS - 8 LA - eng PY - 2018 SN - 0256-7040 (Print) 0256-7040 SP - 1471-1477 ST - Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update T2 - Childs Nerv Syst TI - Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update VL - 34 ID - 6961 ER - TY - JOUR AD - K. Kadomatsu, Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan AU - Lu, F. AU - Kishida, S. AU - Mu, P. AU - Huang, P. AU - Cao, D. AU - Tsubota, S. AU - Kadomatsu, K. DB - Embase Medline DO - 10.1111/cas.12628 IS - 4 LA - English M3 - Article N1 - L602970192 2015-03-19 2015-05-11 PY - 2015 SN - 1349-7006 1347-9032 SP - 390-396 ST - NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK T2 - Cancer Science TI - NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602970192&from=exporthttp://dx.doi.org/10.1111/cas.12628 VL - 106 ID - 6962 ER - TY - JOUR AD - Y. Adachi, Department of Diagnostic Pathology, Toyooka Hospital, 1094 Tobera, Toyooka, Hyogo, Japan AU - Miyoshi, K. AU - Adachi, Y. AU - Nakaji, H. AU - Okamura, A. AU - Sakai, Y. AU - Hirano, R. AU - Yahata, S. AU - Li, M. AU - Ikehara, S. DB - Embase DO - 10.3892/mco.2017.1308 IS - 2 LA - English M3 - Article N1 - L617153298 2017-07-10 2017-07-12 PY - 2017 SN - 2049-9469 2049-9450 SP - 188-192 ST - Neuroendocrine carcinoma of the lung expressing anaplastic lymphoma kinase on high-sensitivity immunohistochemistry: A case report T2 - Molecular and Clinical Oncology TI - Neuroendocrine carcinoma of the lung expressing anaplastic lymphoma kinase on high-sensitivity immunohistochemistry: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617153298&from=exporthttp://dx.doi.org/10.3892/mco.2017.1308 VL - 7 ID - 6963 ER - TY - JOUR AD - M. Hemenway, Children's Hospital Colorado, Univ of Colorado, Aurora, CO, United States AU - Hemenway, M. AU - Waters, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098299 2018-07-25 PY - 2018 SN - 1523-5866 SP - i154 ST - Neurofibromatosis therapeutics: Pearls to treat the complex child T2 - Neuro-Oncology TI - Neurofibromatosis therapeutics: Pearls to treat the complex child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098299&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 6964 ER - TY - JOUR AD - Departments of Dermatology and Genetics, University of Alabama at Birmingham, Birmingham, AL, United States AU - Boyd, K. P. AU - Korf, B. R. AU - Theos, A. DB - Scopus DO - 10.1016/j.jaad.2008.12.051 IS - 1 M3 - Review N1 - Cited By :246 Export Date: 18 November 2020 PY - 2009 SP - 1-14 ST - Neurofibromatosis type 1 T2 - Journal of the American Academy of Dermatology TI - Neurofibromatosis type 1 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66949142979&doi=10.1016%2fj.jaad.2008.12.051&partnerID=40&md5=97f8dc4c7adf7f02ccc9f323150ffc56 VL - 61 ID - 6965 ER - TY - JOUR AD - T. Rosenbaum, Klinikum Duisburg, Klinik für Kinder- U. Jugendmedizin, Zu den Rehwiesen 9, Duisburg, Germany AU - Rosenbaum, T. AU - Wimmer, K. DB - Embase Medline DO - 10.1055/s-0034-1382021 IS - 6-7 LA - English M3 - Review N1 - L53263891 2014-08-01 2015-10-09 PY - 2014 SN - 1439-3824 0300-8630 SP - 309-315 ST - Neurofibromatosis type 1 (NF1) and Associated Tumors T2 - Klinische Padiatrie TI - Neurofibromatosis type 1 (NF1) and Associated Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53263891&from=exporthttp://dx.doi.org/10.1055/s-0034-1382021 VL - 226 ID - 6966 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics Maternal and Child Health, University of Genova and Policlinico San Martino, Genova, Italy AU - Demichelis, C. AU - Lapucci, C. AU - Grisanti, S. AU - Genova, C. AU - Grossi, F. AU - Tanda, E. AU - Queirolo, P. AU - Benedetti, L. AU - Schenone, A. AU - Grandis, M. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622822418 2018-07-06 PY - 2018 SN - 2532-1900 SP - 67-68 ST - Neuromuscular complications following target therapy in cancer patients T2 - Acta Myologica TI - Neuromuscular complications following target therapy in cancer patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622822418&from=export VL - 37 ID - 6967 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Policlinico San Martino, Genova, Italy AU - Demichelis, C. AU - Lapucci, C. AU - Zuppa, A. AU - Grisanti, S. AU - Genova, C. AU - Queirolo, P. AU - Schenone, A. AU - Grandis, M. AU - Benedetti, L. DB - Embase DO - 10.1111/jns.12312 LA - English M3 - Conference Abstract N1 - L627391002 2019-05-14 PY - 2019 SN - 1529-8027 SP - S18 ST - Neuromuscular complications following targeted therapy in cancer patients T2 - Journal of the Peripheral Nervous System TI - Neuromuscular complications following targeted therapy in cancer patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627391002&from=exporthttp://dx.doi.org/10.1111/jns.12312 VL - 24 ID - 6968 ER - TY - JOUR AD - C. Demichelis, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy AU - Demichelis, C. AU - Balestra, A. AU - Lapucci, C. AU - Zuppa, A. AU - Grisanti, S. G. AU - Prada, V. AU - Pesce, G. AU - Grasso, I. AU - Queirolo, P. AU - Schenone, A. AU - Benedetti, L. AU - Grandis, M. DB - Embase Medline DO - 10.1007/s10072-020-04604-1 LA - English M3 - Article in Press N1 - L2005828894 2020-08-17 PY - 2020 SN - 1590-3478 1590-1874 ST - Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature T2 - Neurological Sciences TI - Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005828894&from=exporthttp://dx.doi.org/10.1007/s10072-020-04604-1 ID - 6969 ER - TY - JOUR AD - Department of Physiology and Biophysics, Georgetown University, Washington, DC 20057, USA. AN - 20676138 AU - Lu, C. AU - Everhart, L. AU - Tilan, J. AU - Kuo, L. AU - Sun, C. C. AU - Munivenkatappa, R. B. AU - Jönsson-Rylander, A. C. AU - Sun, J. AU - Kuan-Celarier, A. AU - Li, L. AU - Abe, K. AU - Zukowska, Z. AU - Toretsky, J. A. AU - Kitlinska, J. C2 - PMC2955165 C6 - NIHMS215233 DA - Oct 14 DO - 10.1038/onc.2010.301 10.1038/onc.2010.301. Epub 2010 Aug 2. DP - Nlm ET - 2010/08/03 IS - 41 LA - eng PY - 2010 SN - 0950-9232 (Print) 0950-9232 SP - 5630-42 ST - Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy T2 - Oncogene TI - Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy VL - 29 ID - 6970 ER - TY - JOUR AD - Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Georgetown University, Washington, DC, USA. McGovern Institute, Massachusetts Institute of Technology, Boston, MA, USA. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Georgetown University, Washington, DC, USA. 1] Department of Nursing, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA [2] Department of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA. Department of Pathology and Neuropathology, Medical University of Gdańsk, Gdańsk, Poland. Department of Human Science, School of Nursing and Health Studies, Georgetown University, Washington, DC, USA. AN - 25132261 AU - Czarnecka, M. AU - Trinh, E. AU - Lu, C. AU - Kuan-Celarier, A. AU - Galli, S. AU - Hong, S. H. AU - Tilan, J. U. AU - Talisman, N. AU - Izycka-Swieszewska, E. AU - Tsuei, J. AU - Yang, C. AU - Martin, S. AU - Horton, M. AU - Christian, D. AU - Everhart, L. AU - Maheswaran, I. AU - Kitlinska, J. C2 - PMC4333135 C6 - NIHMS607462 DA - Jun 11 DO - 10.1038/onc.2014.253 10.1038/onc.2014.253. Epub 2014 Aug 18. DP - Nlm ET - 2014/08/19 IS - 24 LA - eng PY - 2015 SN - 0950-9232 (Print) 0950-9232 SP - 3131-43 ST - Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance T2 - Oncogene TI - Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance VL - 34 ID - 6971 ER - TY - JOUR AD - K. Zheng, Department of Neurosurgery, The First Affiliated Hospital of Wen Zhou Medical College, Wenzhou, Zhejiang, China AU - Chen, S. Y. AU - Zheng, K. AU - Wang, Z. Q. C2 - Sigma Aldrich(United States) DB - Embase DO - 10.4314/tjpr.v15i2.4 IS - 2 LA - English M3 - Article N1 - L608769110 2016-03-09 2016-03-14 PY - 2016 SN - 1596-9827 1596-5996 SP - 241-251 ST - Neuroprotective effects of ellagic acid on neonatal hypoxic brain injury via inhibition of inflammatory mediators and down-regulation of JNK/p38 MAPK activation T2 - Tropical Journal of Pharmaceutical Research TI - Neuroprotective effects of ellagic acid on neonatal hypoxic brain injury via inhibition of inflammatory mediators and down-regulation of JNK/p38 MAPK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608769110&from=exporthttp://dx.doi.org/10.4314/tjpr.v15i2.4 VL - 15 ID - 6972 ER - TY - JOUR AD - R.J. Packer, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, United States AU - Wells, E. M. AU - Nageswara Rao, A. A. AU - Scafidi, J. AU - Packer, R. J. C1 - avastin(Genentech) azd2281(Astra Zeneca) cci 779(Pfizer) depakote(Abbott,United States) gleevac(Novartis,United States) iressa(Astra Zeneca,United States) krx 0401(Keryx,United States) rapamycin(Pfizer) revlimid(Celgene,United States) semagacestat(Lilly,United States) sutent(Pfizer,United States) tarceva(Genentech,United States) tykerb(Glaxo SmithKline,United States) vismodegib(Hoffmann La Roche,Switzerland) vorinostat(Patheon,United States) zarnestra(Johnson and Johnson,United States) C2 - Abbott(United States) Astra Zeneca(United States) Celgene(United States) Genentech(United States) Glaxo SmithKline(United States) Hoffmann La Roche(Switzerland) Johnson and Johnson(United States) Keryx(United States) Lilly(United States) Novartis(United States) Patheon(United States) Pfizer(United States) DB - Embase Medline DO - 10.1016/j.pediatrneurol.2012.02.006 IS - 4 LA - English M3 - Review N1 - L364594189 2012-04-17 2012-04-20 PY - 2012 SN - 0887-8994 1873-5150 SP - 212-221 ST - Neurotoxicity of biologically targeted agents in pediatric cancer trials T2 - Pediatric Neurology TI - Neurotoxicity of biologically targeted agents in pediatric cancer trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364594189&from=exporthttp://dx.doi.org/10.1016/j.pediatrneurol.2012.02.006 VL - 46 ID - 6973 ER - TY - JOUR AD - A.T.S. Wyse, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600-Anexo, CEP, Porto Alegre, RS, Brazil AU - Pierozan, P. AU - Biasibetti, H. AU - Schmitz, F. AU - Ávila, H. AU - Fernandes, C. G. AU - Pessoa-Pureur, R. AU - Wyse, A. T. S. DB - Embase Medline DO - 10.1007/s12035-016-0101-2 IS - 8 LA - English M3 - Article N1 - L612356929 2016-10-03 2018-08-10 PY - 2017 SN - 1559-1182 0893-7648 SP - 5752-5767 ST - Neurotoxicity of Methylmercury in Isolated Astrocytes and Neurons: the Cytoskeleton as a Main Target T2 - Molecular Neurobiology TI - Neurotoxicity of Methylmercury in Isolated Astrocytes and Neurons: the Cytoskeleton as a Main Target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612356929&from=exporthttp://dx.doi.org/10.1007/s12035-016-0101-2 VL - 54 ID - 6974 ER - TY - JOUR AD - Department of Pediatric Hematology, Oncology and Endocrinology, University Hospital of Essen, Essen, Germany Department of Ophthalmology, University Hospital of Essen, Essen, Germany Department of Human Genetics, University Hospital of Essen, Essen, Germany University Hospital of Essen, Department of Pediatric Hematology, Oncology and Endocrinology, Hufelandstrasse 55, 45122 Essen, Germany AU - Stephan, H. AU - Zakrzewski, J. L. AU - Bölöni, R. AU - Grasemann, C. AU - Lohmann, D. R. AU - Eggert, A. DB - Scopus DO - 10.1002/pbc.21369 IS - 2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2008 SP - 218-222 ST - Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines T2 - Pediatric Blood and Cancer TI - Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37549026852&doi=10.1002%2fpbc.21369&partnerID=40&md5=ca2a42891b253404dff442a9c924c940 VL - 50 ID - 6975 ER - TY - JOUR AD - Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea. AN - 19816090 AU - Kim, J. H. AU - Kim, J. H. AU - Kim, D. H. AU - Cho, C. S. AU - Jun, H. O. AU - Yu, Y. S. AU - Kim, K. W. DO - 10.1159/000243766 10.1159/000243766. Epub 2009 Oct 7. DP - Nlm ET - 2009/10/10 IS - 5-6 LA - eng PY - 2009 SN - 1010-4283 SP - 233-41 ST - Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation T2 - Tumour Biol TI - Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation VL - 30 ID - 6976 ER - TY - JOUR AD - K.C. Kim, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, United States AU - Kuwahara, I. AU - Lillehoj, E. P. AU - Lu, W. AU - Singh, I. S. AU - Isohama, Y. AU - Miyata, T. AU - Kim, K. C. DB - Embase Medline DO - 10.1152/ajplung.00471.2005 IS - 3 LA - English M3 - Article N1 - L44343717 2006-09-18 PY - 2006 SN - 1040-0605 1522-1504 SP - L407-L416 ST - Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR transactivation in a lung epithelial cell line T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR transactivation in a lung epithelial cell line UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44343717&from=exporthttp://dx.doi.org/10.1152/ajplung.00471.2005http://ajplung.physiology.org/cgi/reprint/291/3/L407 VL - 291 ID - 6977 ER - TY - JOUR AD - B. Amulic, Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Chariteplatz 1, Berlin, Germany AU - Harbort, C. J. AU - Soeiro-Pereira, P. V. AU - Von Bernuth, H. AU - Kaindl, A. M. AU - Costa-Carvalho, B. T. AU - Condino-Neto, A. AU - Reichenbach, J. AU - Roesler, J. AU - Zychlinsky, A. AU - Amulic, B. DB - Embase Medline DO - 10.1182/blood-2015-05-645424 IS - 26 LA - English M3 - Article N1 - L607776617 2016-01-27 2016-02-02 PY - 2015 SN - 1528-0020 0006-4971 SP - 2842-2851 ST - Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis T2 - Blood TI - Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607776617&from=exporthttp://dx.doi.org/10.1182/blood-2015-05-645424 VL - 126 ID - 6978 ER - TY - JOUR AD - Department of Pathology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (D.B., C.M.S., M.R.M.); Department of Plastic Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (L.J.G.); Department of Radiology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (A.P.); Division of Plastic and Reconstructive Surgery, NorthShore University HealthSystem, Northbrook, Illinois (B.S.B., D.J., V.R.); Division of Molecular Genomic Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (M.N.); Department of Pediatrics and Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (Y.K.); Department of Pediatrics, Weill Cornell Medical College, New York, New York (Y.K.). AN - 26354928 AU - Basu, D. AU - Salgado, C. M. AU - Bauer, B. S. AU - Johnson, D. AU - Rundell, V. AU - Nikiforova, M. AU - Khakoo, Y. AU - Gunwaldt, L. J. AU - Panigrahy, A. AU - Reyes-Múgica, M. C2 - PMC4799680 DA - Apr DO - 10.1093/neuonc/nov184 10.1093/neuonc/nov184. Epub 2015 Sep 9. DP - Nlm ET - 2015/09/12 IS - 4 LA - eng PY - 2016 SN - 1522-8517 (Print) 1522-8517 SP - 528-37 ST - Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway T2 - Neuro Oncol TI - Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway VL - 18 ID - 6979 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ 07601, USA Division of Pediatric Hematology/Oncology, NYU Winthrop Hospital, Mineola, NY 11501, USA AU - Jing, Chen AU - Glasser, Chana L. DB - ccm DO - 10.3390/children7020012 DP - EBSCOhost IS - 2 N1 - Accession Number: 142484061. Language: English. Entry Date: In Process. Revision Date: 20200403. Publication Type: Article. PY - 2020 SN - 2227-9067 SP - 1-15 ST - New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) T2 - Children TI - New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=142484061&site=ehost-live&scope=site VL - 7 ID - 6980 ER - TY - JOUR AD - Department of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada. AN - 28174704 AU - Coulombe, G. AU - Rivard, N. C2 - PMC4980741 DA - Jan DO - 10.1016/j.jcmgh.2015.11.001 10.1016/j.jcmgh.2015.11.001. eCollection 2016 Jan. DP - Nlm ET - 2015/11/14 IS - 1 LA - eng PY - 2016 SN - 2352-345X (Print) 2352-345x SP - 11-21 ST - New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract T2 - Cell Mol Gastroenterol Hepatol TI - New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract VL - 2 ID - 6981 ER - TY - JOUR AD - Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States Clinical Pharmacology and Therapeutics, ARC 916, 3615 Civic Center Blvd., Philadelphia, PA 19104, United States AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1097/00130404-200507000-00008 IS - 4 M3 - Review N1 - Cited By :18 Export Date: 18 November 2020 PY - 2005 SP - 324-330 ST - New approaches to drug development in pediatric oncology T2 - Cancer Journal TI - New approaches to drug development in pediatric oncology UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-32944471321&doi=10.1097%2f00130404-200507000-00008&partnerID=40&md5=42f31a5f2f82107ca741b915f20437f3 VL - 11 ID - 6982 ER - TY - JOUR AD - Department of Genetics, University of Alabama at Birmingham, 1720 Second Ave S, Kaul 230, Birmingham, AL 35294, United States Laboratory for Molecular Medicine, Partners Healthcare Center for Personalized Genetic Medicine, Cambridge, MA, United States AU - Korf, B. R. AU - Rehm, H. L. DB - Scopus DO - 10.1001/jama.2013.3239 IS - 14 M3 - Review N1 - Cited By :86 Export Date: 18 November 2020 PY - 2013 SP - 1511-1521 ST - New approaches to molecular diagnosis T2 - JAMA - Journal of the American Medical Association TI - New approaches to molecular diagnosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84875932002&doi=10.1001%2fjama.2013.3239&partnerID=40&md5=ee49e239b79bfd3abebc751702a46b4a VL - 309 ID - 6983 ER - TY - JOUR AD - Renato Bassan, Ospedale dell'Angelo, Mestre-Venezia AN - 133447938. Language: English. Entry Date: 20200528. Revision Date: 20181222. Publication Type: journal article. Journal Subset: Biomedical AU - Bassan, Renato AU - Bourquin, Jean-Pierre AU - DeAngelo, Daniel J. AU - Chiaretti, Sabina DB - ccm DO - 10.1200/JCO.2017.77.3648 DP - EBSCOhost IS - 35 N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 8309333. PMID: NLM30240326. PY - 2018 SN - 0732-183X SP - 3504-3519 ST - New Approaches to the Management of Adult Acute Lymphoblastic Leukemia T2 - Journal of Clinical Oncology TI - New Approaches to the Management of Adult Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133447938&site=ehost-live&scope=site VL - 36 ID - 6984 ER - TY - JOUR AD - Division of Hematology/Oncology, University of California, San Diego, CA, United States Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California, San Diego, CA, United States AU - Schwartz, M. AU - Wieduwilt, M. J. DB - Scopus DO - 10.1053/j.seminhematol.2020.09.001 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - New approaches to the treatment of older adults with acute lymphoblastic leukemia T2 - Seminars in Hematology TI - New approaches to the treatment of older adults with acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091711352&doi=10.1053%2fj.seminhematol.2020.09.001&partnerID=40&md5=f4254a9b1cb877531113eaaa445e4358 ID - 6985 ER - TY - JOUR AD - G. Vassal, Division of Clinical Research, Institut Gustave Roussy, Paris-Sud University, 94805 Villejuif, France AU - Vassal, G. AU - Zwaan, C. M. AU - Ashley, D. AU - Le Deley, M. C. AU - Hargrave, D. AU - Blanc, P. AU - Adamson, P. C. C1 - r 1507 DB - Embase Medline DO - 10.1016/S1470-2045(13)70013-5 IS - 3 LA - English M3 - Review N1 - L52453670 2013-02-23 2013-04-15 PY - 2013 SN - 1470-2045 1474-5488 SP - e117-e124 ST - New drugs for children and adolescents with cancer: The need for novel development pathways T2 - The Lancet Oncology TI - New drugs for children and adolescents with cancer: The need for novel development pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52453670&from=exporthttp://dx.doi.org/10.1016/S1470-2045(13)70013-5 VL - 14 ID - 6986 ER - TY - JOUR AU - Tomić, T. T. AU - Olausson, J. AU - Wilzén, A. AU - Sabel, M. AU - Truvé, K. AU - Sjögren, H. AU - Dósa, S. AU - Tisell, M. AU - Lannering, B. AU - Enlund, F. AU - Martinsson, T. AU - Åman, P. AU - Abel, F. DB - Embase Medline DO - 10.1371/journal.pone.0175638 IS - 4 LA - English M3 - Article N1 - L615757421 2017-05-08 2017-05-12 PY - 2017 SN - 1932-6203 ST - A new fusion mediating MAPK pathway activation in pilocytic astrocytoma T2 - PLoS ONE TI - A new fusion mediating MAPK pathway activation in pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615757421&from=exporthttp://dx.doi.org/10.1371/journal.pone.0175638 VL - 12 ID - 6987 ER - TY - JOUR AD - Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Department of Next Generation Hematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan Department of Clinical Laboratory, Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan AU - Kitamura, H. AU - Tabe, Y. AU - Ai, T. AU - Tsuchiya, K. AU - Yuri, M. AU - Misawa, S. AU - Horii, T. AU - Kawaguchi, A. AU - Ohsaka, A. AU - Kimura, S. C7 - e0207170 DB - Scopus DO - 10.1371/journal.pone.0207170 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 ST - A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib T2 - PLoS ONE TI - A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062606205&doi=10.1371%2fjournal.pone.0207170&partnerID=40&md5=f06f11bda04531ee392882cd565c2bd8 VL - 14 ID - 6988 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI, United States Gastrointestinal, University of Michigan, Ann Arbor, MI, United States AU - Speck, O. AU - Greenson, J. K. DB - Scopus DO - 10.1016/j.mpdhp.2014.03.012 IS - 6 M3 - Review N1 - Export Date: 18 November 2020 PY - 2014 SP - 222-227 ST - New issues in gastrointestinal stromal tumors of the stomach T2 - Diagnostic Histopathology TI - New issues in gastrointestinal stromal tumors of the stomach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901695266&doi=10.1016%2fj.mpdhp.2014.03.012&partnerID=40&md5=af553b1bdb9b19a4d55a5c77138887f0 VL - 20 ID - 6989 ER - TY - JOUR AD - Department of Hematology/Oncology, 'L and A Seràgnoli S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy Molecular Biology Unit, Institute of Hematology and Medical Oncology 'Sergnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy Department of Clinical and Biological Science, University of Turin at Orbassano, Turin, Italy CEINGE Biotecnologie Avanzate, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy AU - Martinelli, G. AU - Iacobucci, I. AU - Soverini, S. AU - Piccaluga, P. P. AU - Cilloni, D. AU - Pane, F. DB - Scopus DO - 10.1586/ehm.09.16 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2009 SP - 297-303 ST - New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia T2 - Expert Review of Hematology TI - New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953418690&doi=10.1586%2fehm.09.16&partnerID=40&md5=fdf55d263cf6b2153501c91fc5ba9b74 VL - 2 ID - 6990 ER - TY - JOUR AD - D.A. Largaespada, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States AU - Williams, K. B. AU - Largaespada, D. A. C1 - pd 0325901 plx 3397 DB - Embase Medline DO - 10.3390/genes11050477 IS - 5 LA - English M3 - Review N1 - L2004246218 2020-05-06 2020-05-15 PY - 2020 SN - 2073-4425 ST - New model systems and the development of targeted therapies for the treatment of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors T2 - Genes TI - New model systems and the development of targeted therapies for the treatment of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004246218&from=exporthttp://dx.doi.org/10.3390/genes11050477 VL - 11 ID - 6991 ER - TY - JOUR AD - M. Chuma, Department of Gastroenterology and Hepatology, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Japan AU - Chuma, M. AU - Terashita, K. AU - Sakamoto, N. DB - Embase DO - 10.1111/hepr.12459 IS - 10 LA - English M3 - Review N1 - L602428028 2015-02-26 2015-11-09 PY - 2015 SN - 1872-034X 1386-6346 SP - E1-E11 ST - New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions T2 - Hepatology Research TI - New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602428028&from=exporthttp://dx.doi.org/10.1111/hepr.12459 VL - 45 ID - 6992 ER - TY - JOUR AD - Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil AU - Mascarenhas, C. C. AU - Cunha, A. F. AU - Miranda, E. C. AU - Zulli, R. AU - Silveira, R. A. AU - Costa, F. F. AU - Pagnano, K. B. AU - De Souza, C. A. DB - Scopus DO - 10.1080/10428190902930496 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2009 SP - 1148-1154 ST - New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors T2 - Leukemia and Lymphoma TI - New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68449086340&doi=10.1080%2f10428190902930496&partnerID=40&md5=4564ab8c3359382f8ea1d84544ef2e2b VL - 50 ID - 6993 ER - TY - JOUR AD - St Jude Children's Research Hospital, Department of Pathology, Mail Stop 342, 262 Danny Thomas Place, Memphis, TN 38105, United States AU - Mullighan, C. G. DB - Scopus DO - 10.1158/1078-0432.CCR-10-1203 IS - 3 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2011 SP - 396-400 ST - New strategies in acute lymphoblastic leukemia: Translating advances in genomics into clinical practice T2 - Clinical Cancer Research TI - New strategies in acute lymphoblastic leukemia: Translating advances in genomics into clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79551699535&doi=10.1158%2f1078-0432.CCR-10-1203&partnerID=40&md5=0d10d2556c34a2cd333e4d1e33c1a170 VL - 17 ID - 6994 ER - TY - JOUR AD - K. Dunleavy, National Cancer Institute, Building 10, 10 Center Drive, Bethesda, MD 20892-1868, United States AU - Dunleavy, K. AU - Piekarz, R. L. AU - Zain, J. AU - Janik, J. E. AU - Wilson, W. H. AU - O'Connor, O. A. AU - Bates, S. E. C1 - campath fk 228 MDX 060 ontak pxd 101 sgn 30 sgn 35 DB - Embase Medline DO - 10.1158/1078-0432.CCR-09-1995 IS - 23 LA - English M3 - Review N1 - L360186126 2010-12-28 2011-01-06 PY - 2010 SN - 1078-0432 1557-3265 SP - 5608-5617 ST - New strategies in peripheral T-cell lymphoma: Understanding tumor biology and developing novel therapies T2 - Clinical Cancer Research TI - New strategies in peripheral T-cell lymphoma: Understanding tumor biology and developing novel therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360186126&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-09-1995http://clincancerres.aacrjournals.org/content/16/23/5608.full.pdf+html VL - 16 ID - 6995 ER - TY - JOUR AD - Department of Pathology, CHU Purpan, Toulouse, France. AN - 9057627 AU - Delsol, G. AU - Lamant, L. AU - Mariamé, B. AU - Pulford, K. AU - Dastugue, N. AU - Brousset, P. AU - Rigal-Huguet, F. AU - al Saati, T. AU - Cerretti, D. P. AU - Morris, S. W. AU - Mason, D. Y. DA - Mar 1 DP - Nlm ET - 1997/03/01 IS - 5 LA - eng N1 - Delsol, G Lamant, L Mariamé, B Pulford, K Dastugue, N Brousset, P Rigal-Huguet, F al Saati, T Cerretti, D P Morris, S W Mason, D Y PY - 1997 SN - 0006-4971 (Print) 0006-4971 SP - 1483-90 ST - A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation T2 - Blood TI - A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation VL - 89 ID - 6996 ER - TY - JOUR AD - C. Rossig, Department of Pediatric Hematology and Oncology, University Children's Hospital M̈unster, Building A1, Albert-Schweitzer Campus 1, 48149 M̈unster, Germany AU - Rossig, C. AU - Juergens, H. AU - Berdel, W. E. C1 - herceptin iressa tarceva tykerb tyverb DB - Embase Medline DO - 10.3109/08880018.2011.613094 IS - 7 LA - English M3 - Review N1 - L362607494 2011-09-29 2011-10-05 PY - 2011 SN - 0888-0018 1521-0669 SP - 539-555 ST - New targets and targeted drugs for the treatment of cancer: An outlook to pediatric oncology T2 - Pediatric Hematology and Oncology TI - New targets and targeted drugs for the treatment of cancer: An outlook to pediatric oncology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362607494&from=exporthttp://dx.doi.org/10.3109/08880018.2011.613094 VL - 28 ID - 6997 ER - TY - JOUR AD - C. Tregnago AU - Tregnago, C. AU - Zampini, M. AU - Bisio, V. AU - Buldini, B. AU - Indraccolo, S. AU - Basso, G. AU - Locatelli, F. AU - Pigazzi, M. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614225306 2017-02-01 PY - 2016 SN - 1528-0020 ST - New therapeutic opportunities for pediatric patients with T(6;11)-rearranged acute myeloid leukemia T2 - Blood TI - New therapeutic opportunities for pediatric patients with T(6;11)-rearranged acute myeloid leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614225306&from=export VL - 128 ID - 6998 ER - TY - JOUR AD - Department of Oncology, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, United States University of Tennessee Health Science Center, Memphis, TN 38163, United States AU - Pui, C. H. AU - Jeha, S. DB - Scopus DO - 10.1038/nrd2240 IS - 2 M3 - Review N1 - Cited By :170 Export Date: 18 November 2020 PY - 2007 SP - 149-165 ST - New therapeutic strategies for the treatment of acute lymphoblastic leukaemia T2 - Nature Reviews Drug Discovery TI - New therapeutic strategies for the treatment of acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947588149&doi=10.1038%2fnrd2240&partnerID=40&md5=e055f42a3c6bffff97f24cb910bc7470 VL - 6 ID - 6999 ER - TY - JOUR AD - M.S. Cairo, Department of Pediatrics, Medicine and Pathology, Morgan Stanley Children's Hospital of New York, Presbyterian, NY, United States AU - Cairo, M. S. DB - Embase IS - 5 L1 - internal-pdf://0555996658/519-Article Text-1980-1-10-20090610.pdf LA - English M3 - Conference Abstract N1 - L70007658 2009-11-27 PY - 2009 SN - 1970-7339 SP - 79-80 ST - New therapeutic targets in childhood and adolescent NHL T2 - Haematologica Meeting Reports TI - New therapeutic targets in childhood and adolescent NHL UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70007658&from=export VL - 3 ID - 7000 ER - TY - JOUR AD - Y. Tsukamoto, Department of Pathology, Takarazuka City Hospital, Takarazuka, Japan AU - Masuda, Y. AU - Tsukamoto, Y. AU - Zenitani, M. AU - Oda, Y. AU - Kinoshita, I. AU - Kohashi, K. AU - Takemoto, J. AU - Hirota, S. AU - Shibata, A. AU - Koda, T. AU - Takeshima, Y. DB - Embase Medline DO - 10.1002/pbc.27902 IS - 10 LA - English M3 - Letter N1 - L628356142 2019-07-08 2019-09-03 PY - 2019 SN - 1545-5017 1545-5009 ST - A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion T2 - Pediatric Blood and Cancer TI - A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628356142&from=exporthttp://dx.doi.org/10.1002/pbc.27902 VL - 66 ID - 7001 ER - TY - JOUR AD - J.C.D. Dental College, Sirsa, India Department of Neonatology, Fernandez Hospital, Hyderabad, AP, 500029, India Department of Pediatrics, S.P. Medical College, Bikaner, India AU - Jain, N. AU - Sharma, D. AU - Agrawal, R. AU - Jain, A. DB - Scopus DO - 10.1159/000381806 IS - 3 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2015 SP - 291-293 ST - A newborn with teratogenic effect of imatinib mesylate: A very rare case report T2 - Medical Principles and Practice TI - A newborn with teratogenic effect of imatinib mesylate: A very rare case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929943564&doi=10.1159%2f000381806&partnerID=40&md5=214bb52ddf68f032b25845756f1d1b04 VL - 24 ID - 7002 ER - TY - JOUR AD - J.K.C. Chan, Department of Pathology, Queen Elizabeth Hospital, Gascoigne Road, Kowloon, Hong Kong AU - Chan, J. K. C. DB - Embase Medline DO - 10.1177/1066896913507601 IS - 6 LA - English M3 - Review N1 - L370294276 2013-11-27 2013-11-29 PY - 2013 SN - 1066-8969 1940-2465 SP - 553-572 ST - Newly available antibodies with practical applications in surgical pathology T2 - International Journal of Surgical Pathology TI - Newly available antibodies with practical applications in surgical pathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370294276&from=exporthttp://dx.doi.org/10.1177/1066896913507601 VL - 21 ID - 7003 ER - TY - JOUR AD - Department of Pediatrics, Section of Pediatric Hematology-Oncology, Baylor College of Medicine, Houston, TX, United States Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States AU - Heikamp, E. B. AU - Pui, C. H. DB - Scopus DO - 10.1016/j.jpeds.2018.07.039 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 14-24.e2 ST - Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia T2 - Journal of Pediatrics TI - Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053036994&doi=10.1016%2fj.jpeds.2018.07.039&partnerID=40&md5=2b7502149e1aea8b1b6b3fd867d674dc VL - 203 ID - 7004 ER - TY - JOUR AD - Department of Surgery, St Jude Children's Research Hospital, Mail Stop 133, 262 Danny Thomas Place, Memphis, TN 38105, United States Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, United States Department of Hematology, University College London, London, United Kingdom AU - Tracey, L. AU - Streck, C. J. AU - Du, Z. AU - Williams, R. F. AU - Pfeffer, L. M. AU - Nathwani, A. C. AU - Davidoff, A. M. DB - Scopus DO - 10.1038/leu.2010.2 IS - 4 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2010 SP - 806-812 ST - NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia T2 - Leukemia TI - NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950930700&doi=10.1038%2fleu.2010.2&partnerID=40&md5=50582c8716e244d537d8141d7ef5b4bc VL - 24 ID - 7005 ER - TY - JOUR AD - J.A. Epstein, 954 BRB II, 421 Curie Blvd, Philadelphia, PA 19104, United States AU - Xu, J. AU - Ismat, F. A. AU - Wang, T. AU - Yang, J. AU - Epstein, J. A. DB - Embase Medline DO - 10.1161/CIRCULATIONAHA.107.707752 IS - 19 LA - English M3 - Article N1 - L350060352 2007-11-28 PY - 2007 SN - 0009-7322 SP - 2148-2156 ST - NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response T2 - Circulation TI - NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350060352&from=exporthttp://dx.doi.org/10.1161/CIRCULATIONAHA.107.707752 VL - 116 ID - 7006 ER - TY - JOUR AD - Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. AN - 9607929 AU - Zhang, Y. Y. AU - Vik, T. A. AU - Ryder, J. W. AU - Srour, E. F. AU - Jacks, T. AU - Shannon, K. AU - Clapp, D. W. C2 - PMC2212307 DA - Jun 1 DO - 10.1084/jem.187.11.1893 10.1084/jem.187.11.1893. DP - Nlm ET - 1998/06/10 IS - 11 LA - eng PY - 1998 SN - 0022-1007 (Print) 0022-1007 SP - 1893-902 ST - Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines T2 - J Exp Med TI - Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines VL - 187 ID - 7007 ER - TY - JOUR AD - B. Weiss, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Weiss, B. AU - Plotkin, S. AU - Widemann, B. AU - Tonsgard, J. AU - Blakeley, J. AU - Allen, J. AU - Schorry, E. AU - Korf, B. AU - Rosser, T. AU - Goldman, S. AU - Vinks, A. AU - Cutter, G. AU - Dombi, E. AU - Ratner, N. AU - Packer, R. AU - Fisher, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098342 2018-07-25 PY - 2018 SN - 1523-5866 SP - i143 ST - NF106: Phase 2 trial of the MEK inhibitor PD-0325901 in adolescents and adults with nf1-related plexiform neurofibromas: An NF clinical trials consortium study T2 - Neuro-Oncology TI - NF106: Phase 2 trial of the MEK inhibitor PD-0325901 in adolescents and adults with nf1-related plexiform neurofibromas: An NF clinical trials consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098342&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7008 ER - TY - JOUR AD - N. Silverberg, Chief, Pediatric Dermatology, Department of Dermatology, Mt. Sinai, St. Luke's-Roosevelt Hospital Center, New York, NY, United States AU - Tuchman, M. AU - Silverberg, J. I. AU - Jacob, S. E. AU - Silverberg, N. DB - Embase Medline DO - 10.1016/j.clindermatol.2014.12.008 IS - 3 LA - English M3 - Article N1 - L607805602 2016-02-01 2016-02-02 PY - 2015 SN - 1879-1131 0738-081X SP - 320-326 ST - Nickel contact dermatitis in children T2 - Clinics in Dermatology TI - Nickel contact dermatitis in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607805602&from=exporthttp://dx.doi.org/10.1016/j.clindermatol.2014.12.008 VL - 33 ID - 7009 ER - TY - JOUR AD - C. Y. Chen, Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline Ave., Boston, MA 02215, United States AU - Nishioka, T. AU - Guo, J. AU - Yamamoto, D. AU - Chen, L. AU - Huppi, P. AU - Chen, C. Y. DB - Embase Medline DO - 10.1002/jcb.22392 IS - 1 LA - English M3 - Article N1 - L358085624 2010-01-28 PY - 2010 SN - 0730-2312 1097-4644 SP - 152-161 ST - Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation T2 - Journal of Cellular Biochemistry TI - Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358085624&from=exporthttp://dx.doi.org/10.1002/jcb.22392http://www3.interscience.wiley.com/cgi-bin/fulltext/122682680/PDFSTART VL - 109 ID - 7010 ER - TY - JOUR AD - South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, SA Pathology, Adelaide, SA, Australia Hospital Erasto Gaertner – Liga Paranaense Combate ao Câncer, Curitiba, Brazil Hospital São Rafael-Monte Tabor & Hospital Universitario Professor Edgard Santos-Universidade Federal da Bahia, Salvador, Brazil Hospital Ampang, Selangor, Malaysia National Cancer Institute, Cairo University, Cairo, Egypt School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia FUNDALEU, Hospitalization and Clinical Research Centre, Buenos Aires, Argentina University of the Free State, Bloemfontein, South Africa Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taoyuan City, Taiwan FGB Haematology Research Centre Health Ministry Research Facility, Moscow, Russian Federation Hospital de Especialidades, CMN Siglo XXI, Mexico City, Mexico Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Novartis Healthcare Pvt. Ltd., Hyderabad, India Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada AU - Hughes, T. P. AU - Munhoz, E. AU - Aurelio Salvino, M. AU - Ong, T. C. AU - Elhaddad, A. AU - Shortt, J. AU - Quach, H. AU - Pavlovsky, C. AU - Louw, V. J. AU - Shih, L. Y. AU - Turkina, A. G. AU - Meillon, L. AU - Jin, Y. AU - Acharya, S. AU - Dalal, D. AU - Lipton, J. H. DB - Scopus DO - 10.1111/bjh.14829 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2017 SP - 219-228 ST - Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd T2 - British Journal of Haematology TI - Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023209621&doi=10.1111%2fbjh.14829&partnerID=40&md5=2db3b51ac8db0ddb377ca6a184458c22 VL - 179 ID - 7011 ER - TY - JOUR AD - Department of Haematology, Toulouse University Cancer Institute, Toulouse, France Laboratory of Haematology, University Hospital Saint-Louis AP-HP and EA3518, University Paris Diderot, Paris, France Department of Oncology and Haematology, Saint Vincent de Paul Hospital, Lille, France Novartis Pharma S.A.S., Rueil-Malmaison, France Department of Haematology, University Hospital Centre, Reunion Island, Saint-Pierre, France Department of Clinical Haematology and Cell Therapy, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France Department of Medical Oncology, Institut Bergonié, Bordeaux, France AU - Huguet, F. AU - Cayuela, J. M. AU - Cambier, N. AU - Carpentier, N. AU - Tindel, M. AU - Violet, I. AU - Zunic, P. AU - Lascaux, A. AU - Etienne, G. AU - On behalf of Adhe, R. M. C. Investigators DB - Scopus DO - 10.1111/bjh.16145 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 615-626 ST - Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice T2 - British Journal of Haematology TI - Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070720553&doi=10.1111%2fbjh.16145&partnerID=40&md5=fa2c9909ba95ac18f8e9b1d0014f3ada VL - 187 ID - 7012 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States J.W. Goethe Universität, Frankfurt, Germany Moffitt Cancer Center, Tampa, FL, United States Novartis Pharmaceuticals, East Hanover, NJ, United States Quest Diagnostics, San Juan Capistrano, CA, United States Fakultät fur Klinische Medizin Mannheim, Universität Heidelberg, Mannheim, Germany Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Leukemia, University of Texas M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, United States AU - Kantarjian, H. AU - Giles, F. AU - Wunderle, L. AU - Bhalla, K. AU - O'Brien, S. AU - Wassmann, B. AU - Tanaka, C. AU - Manley, P. AU - Rae, P. AU - Mietlowski, W. AU - Bochinski, K. AU - Hochhaus, A. AU - Griffin, J. D. AU - Hoelzer, D. AU - Albitar, M. AU - Dugan, M. AU - Cortes, J. AU - Alland, L. AU - Ottmann, O. G. DB - Scopus DO - 10.1056/NEJMoa055104 IS - 24 M3 - Article N1 - Cited By :1068 Export Date: 18 November 2020 PY - 2006 SP - 2542-2551 ST - Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL T2 - New England Journal of Medicine TI - Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745086350&doi=10.1056%2fNEJMoa055104&partnerID=40&md5=af92db40c295ac2500677aa18b6f969d VL - 354 ID - 7013 ER - TY - JOUR AD - HRB Clinical Research Facilities, National University of Ireland Galway, Trinity College, Dublin, Ireland Department of Hematology and Oncology, Charité-Humboldt-Universität, Campus Virchow Klinikum, Berlin, Germany H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, United States University of Chicago, Chicago, IL, United States Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-Universität, Düsseldorf, Germany Department of Medicine, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany Department of Hematology and Oncology, Universitätsklinikum Jena, Jena, Germany Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States Department of Cellular Biotechnologies and Hematology, University at Orbassano, Turin, Italy Institute of Medical and Veterinary Science, Adelaide, SA, Australia Department of Hematology/Oncology L and A Seragnoli, University of Bologna, Bologna, Italy Seoul St Mary's Hospital, Seoul, South Korea Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Giles, F. J. AU - Le Coutre, P. D. AU - Pinilla-Ibarz, J. AU - Larson, R. A. AU - Gattermann, N. AU - Ottmann, O. G. AU - Hochhaus, A. AU - Radich, J. P. AU - Saglio, G. AU - Hughes, T. P. AU - Martinelli, G. AU - Kim, D. W. AU - Novick, S. AU - Gillis, K. AU - Fan, X. AU - Cortes, J. AU - Baccarani, M. AU - Kantarjian, H. M. DB - Scopus DO - 10.1038/leu.2012.181 IS - 1 M3 - Article N1 - Cited By :147 Export Date: 18 November 2020 PY - 2013 SP - 107-112 ST - Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study T2 - Leukemia TI - Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873568081&doi=10.1038%2fleu.2012.181&partnerID=40&md5=5c564bc24c02a05821c766d910910c8f VL - 27 ID - 7014 ER - TY - JOUR AD - Pediatric Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milano, Italy University of Bonn, Childreǹs Medical Hospital, Department of Paediatric Haematology/Oncology, Bonn, Germany AU - Massimino, M. AU - Bode, U. AU - Biassoni, V. AU - Fleischhack, G. DB - Scopus DO - 10.1517/14712598.2011.546341 IS - 2 M3 - Article N1 - Cited By :54 Export Date: 18 November 2020 PY - 2011 SP - 247-256 ST - Nimotuzumab for pediatric diffuse intrinsic pontine gliomas T2 - Expert Opinion on Biological Therapy TI - Nimotuzumab for pediatric diffuse intrinsic pontine gliomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651369365&doi=10.1517%2f14712598.2011.546341&partnerID=40&md5=a2f17ad9ca6ca844be7f1933cbac44bb VL - 11 ID - 7015 ER - TY - JOUR AD - Hospital for Sick Children, Division for Haematology/Oncology, 555 University Ave, Toronto, ON M5G 1X8, Canada AU - Lam, C. AU - Bouffet, E. AU - Bartels, U. DB - Scopus DO - 10.2217/fon.09.119 IS - 9 M3 - Review N1 - Cited By :17 Export Date: 18 November 2020 PY - 2009 SP - 1349-1361 ST - Nimotuzumab in pediatric glioma T2 - Future Oncology TI - Nimotuzumab in pediatric glioma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74949130000&doi=10.2217%2ffon.09.119&partnerID=40&md5=486ad82828a6a0c49fd996c4c963dcab VL - 5 ID - 7016 ER - TY - JOUR AD - Department of Laboratory Medicine and Clinical Immunology of Developmental Age, Medical University of Warsaw, Zwirki i Wigury 63a Street, Warsaw, 02-091, Poland Postgraduate School of Molecular Medicine, Medical University of Warsaw, Zwirki i Wigury 61 Street, Warsaw, 02-091, Poland The Finsen Laboratory, Faculty of Health Sciences, Rigshospitalet, University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Faculty of Health Sciences, Danish Stem Cell Centre (DanStem), University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Department of Biology, The Bioinformatics Centre, University of Copenhagen, Ole Maaloesvej 5, Copenhagen, 2200, Denmark Department of Histology and Embryology, Medical University of Warsaw, Chalubinskiego 5 Street, Warsaw, 02-004, Poland Department of Immunology, The Children’s Memorial Health Institute, Aleja Dzieci Polskich 20, Warsaw, 04-730, Poland Department of Immunology, Medical University of Warsaw, Jana Nielubowicza 5 Street, Warsaw, 02-097, Poland Department of Laboratory Diagnostics, Medical University of Warsaw, Banacha 1a Street, Warsaw, 02-097, Poland AU - Manda-Handzlik, A. AU - Bystrzycka, W. AU - Cieloch, A. AU - Glodkowska-Mrowka, E. AU - Jankowska-Steifer, E. AU - Heropolitanska-Pliszka, E. AU - Skrobot, A. AU - Muchowicz, A. AU - Ciepiela, O. AU - Wachowska, M. AU - Demkow, U. DB - Scopus DO - 10.1007/s00018-019-03331-x IS - 15 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 3059-3075 ST - Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps T2 - Cellular and Molecular Life Sciences TI - Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074327911&doi=10.1007%2fs00018-019-03331-x&partnerID=40&md5=0efd315e4a517048a8c88fc70df6bf78 VL - 77 ID - 7017 ER - TY - JOUR AN - CN-01909643 AU - Euctr, F. R. PY - 2018 ST - Nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma in patients with progressive disease or in patients in complete remission after relapse T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2018-001447-31-FR TI - Nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma in patients with progressive disease or in patients in complete remission after relapse UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01909643/full ID - 7018 ER - TY - JOUR AD - The authors' affiliations are listed in the Appendix. AN - 25399552 AU - Robert, C. AU - Long, G. V. AU - Brady, B. AU - Dutriaux, C. AU - Maio, M. AU - Mortier, L. AU - Hassel, J. C. AU - Rutkowski, P. AU - McNeil, C. AU - Kalinka-Warzocha, E. AU - Savage, K. J. AU - Hernberg, M. M. AU - Lebbé, C. AU - Charles, J. AU - Mihalcioiu, C. AU - Chiarion-Sileni, V. AU - Mauch, C. AU - Cognetti, F. AU - Arance, A. AU - Schmidt, H. AU - Schadendorf, D. AU - Gogas, H. AU - Lundgren-Eriksson, L. AU - Horak, C. AU - Sharkey, B. AU - Waxman, I. M. AU - Atkinson, V. AU - Ascierto, P. A. DA - Jan 22 DO - 10.1056/NEJMoa1412082 10.1056/NEJMoa1412082. Epub 2014 Nov 16. DP - Nlm ET - 2014/11/18 IS - 4 LA - eng PY - 2015 SN - 0028-4793 SP - 320-30 ST - Nivolumab in previously untreated melanoma without BRAF mutation T2 - N Engl J Med TI - Nivolumab in previously untreated melanoma without BRAF mutation VL - 372 ID - 7019 ER - TY - JOUR AD - K. Dunleavy, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States AU - Lai, C. AU - Dunleavy, K. DB - Embase Medline DO - 10.1016/j.beha.2013.04.004 IS - 1 LA - English M3 - Review N1 - L52596740 2013-05-27 2013-06-28 PY - 2013 SN - 1521-6926 1532-1924 SP - 33-41 ST - NK/T-cell lymphomas in children T2 - Best Practice and Research: Clinical Haematology TI - NK/T-cell lymphomas in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52596740&from=exporthttp://dx.doi.org/10.1016/j.beha.2013.04.004 VL - 26 ID - 7020 ER - TY - JOUR AD - B. Lerman, Brookfield, WI, United States AU - Lerman, B. AU - Verbsky, J. AU - Routes, J. AU - Bausch-Jurken, M. DB - Embase IS - 5 LA - English M3 - Conference Abstract N1 - L619349013 2017-11-27 PY - 2017 SN - 1534-4436 SP - S77 ST - NOD2 compound heterozygous mutations in a patient with severe crohn's disease T2 - Annals of Allergy, Asthma and Immunology TI - NOD2 compound heterozygous mutations in a patient with severe crohn's disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619349013&from=export VL - 119 ID - 7021 ER - TY - JOUR AD - J. Xie, Departments of Pediatrics, Biochemistry and Molecular Biology, Pharmacology and Toxicology, The Wells Center for Pediatrics Research, 1044 W, Walnut Street, Indianapolis, IN, United States AU - Gu, D. AU - Xie, J. DB - Embase DO - 10.3390/cancers7030857 IS - 3 LA - English M3 - Review N1 - L605879006 2015-09-14 2015-09-17 PY - 2015 SN - 2072-6694 SP - 1684-1698 ST - Non-canonical Hh signaling in cancer—Current understanding and future directions T2 - Cancers TI - Non-canonical Hh signaling in cancer—Current understanding and future directions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605879006&from=exporthttp://dx.doi.org/10.3390/cancers7030857 VL - 7 ID - 7022 ER - TY - GEN AD - J. Hochberg, Departments of Pediatrics, New York Medical College, Valhalla, NY, United States AU - Hochberg, J. AU - El-Mallawany, N. K. AU - Brugieres, L. AU - McMillan, A. AU - Cairo, M. S. DB - Embase DO - 10.1007/978-3-319-33679-4_4 J2 - Pediatr. Oncol. LA - English M1 - (Hochberg J., jessica_hochberg@nymc.edu; El-Mallawany N.K., nader_kim@nymc.edu; Cairo M.S., mitchell_cairo@nymc.edu) Departments of Pediatrics, New York Medical College, Valhalla, NY, United States M3 - Chapter N1 - L618183517 2017-09-19 2017-09-20 PY - 2017 SN - 2191-0812 1613-5318 SP - 69-117 ST - Non-Hodgkin Lymphoma TI - Non-Hodgkin Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618183517&from=exporthttp://dx.doi.org/10.1007/978-3-319-33679-4_4 ID - 7023 ER - TY - JOUR AD - Véronique Minard-Colin, Laurence Brugières, Anne Auperin, Marie-Cécile Le Deley, and Catherine Patte, Institut Gustave Roussy, Villejuif; Martine Raphael, Centre National de la Recherche Scientifique UMR 8126, Université Paris Sud; Elizabeth Macintyre, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, and Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris; Laurence Lamant, Institut Universitaire du Cancer Toulouse Oncopole and Université Paul-Sabatier, Toulouse, France; Alfred Reiter, Wilhelm Woessmann, and Christine Damm-Welk, Justus-Liebig-University Giessen, Giessen; Birgit Burkhardt, Children University Hospital, Münster; Martin Zimmerman, Medizinische Hochschule, Hannover; Wolfram Klapper, Christian-Albrechts-University Kiel, Kiel, Germany; Mitchell S. Cairo, New York Medical College, Valhalla, NY; Thomas G. Gross, National Cancer Institute, Bethesda, MD; John T. Sandlund, St Jude Children's Research Hospital and University of Tennessee Health Science Center, College of Medicine, Memphis, TN; Sherrie L. Perkins, University of Utah Health Sciences, Salt Lake City, UT; Denise Williams, Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom; Marta Pillon and Angelo Rosolen, University of Padova, Padova; Lara Mussolin, Istituto di Ricerca Pediatrico-Fondazione Cittàdella Speranza and University of Padua, Padua, Italy; Keizo Horibe, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; and Hélène A. Poirel, Center for Human Genetics, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Belgium, Brussels. Véronique Minard-Colin, Laurence Brugières, Anne Auperin, Marie-Cécile Le Deley, and Catherine Patte, Institut Gustave Roussy, Villejuif; Martine Raphael, Centre National de la Recherche Scientifique UMR 8126, Université Paris Sud; Elizabeth Macintyre, Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, and Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris; Laurence Lamant, Institut Universitaire du Cancer Toulouse Oncopole and Université Paul-Sabatier, Toulouse, France; Alfred Reiter, Wilhelm Woessmann, and Christine Damm-Welk, Justus-Liebig-University Giessen, Giessen; Birgit Burkhardt, Children University Hospital, Münster; Martin Zimmerman, Medizinische Hochschule, Hannover; Wolfram Klapper, Christian-Albrechts-University Kiel, Kiel, Germany; Mitchell S. Cairo, New York Medical College, Valhalla, NY; Thomas G. Gross, National Cancer Institute, Bethesda, MD; John T. Sandlund, St Jude Children's Research Hospital and University of Tennessee Health Science Center, College of Medicine, Memphis, TN; Sherrie L. Perkins, University of Utah Health Sciences, Salt Lake City, UT; Denise Williams, Cambridge University Hospitals Foundation Trust, Cambridge, United Kingdom; Marta Pillon and Angelo Rosolen, University of Padova, Padova; Lara Mussolin, Istituto di Ricerca Pediatrico-Fondazione Cittàdella Speranza and University of Padua, Padua, Italy; Keizo Horibe, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; and Hélène A. Poirel, Center for Human Genetics, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Belgium, Brussels. catherine.patte@gustaveroussy.fr. AN - 26304908 AU - Minard-Colin, V. AU - Brugières, L. AU - Reiter, A. AU - Cairo, M. S. AU - Gross, T. G. AU - Woessmann, W. AU - Burkhardt, B. AU - Sandlund, J. T. AU - Williams, D. AU - Pillon, M. AU - Horibe, K. AU - Auperin, A. AU - Le Deley, M. C. AU - Zimmerman, M. AU - Perkins, S. L. AU - Raphael, M. AU - Lamant, L. AU - Klapper, W. AU - Mussolin, L. AU - Poirel, H. A. AU - Macintyre, E. AU - Damm-Welk, C. AU - Rosolen, A. AU - Patte, C. C2 - PMC4979194 online at www.jco.org. Author contributions are found at the end of this article. DA - Sep 20 DO - 10.1200/jco.2014.59.5827 10.1200/JCO.2014.59.5827. Epub 2015 Aug 24. DP - Nlm ET - 2015/08/26 IS - 27 LA - eng PY - 2015 SN - 0732-183X (Print) 0732-183x SP - 2963-74 ST - Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead T2 - J Clin Oncol TI - Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead VL - 33 ID - 7024 ER - TY - JOUR AD - Division of Experimental Medicine, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. Department of Experimental Pathology, Immunology and Microbiology, American University Of Beirut, Beirut, Lebanon. Departments of Pediatrics and Human Genetics, McGill University and McGill University Health Centre, Montreal, Quebec, Canada. Division of Theoretical Bioinformatics, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Division of Pediatric Neurooncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany. Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany. McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada. Department of Neurosurgery, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary. Department of Neurosurgery, Montreal Children's Hospital and McGill University Health Centre, Montreal, Canada. Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom. Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Division of Pediatric Hematology-Oncology and The Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada. Department of Pathology, Montreal Children's Hospital and McGill University Health Centre, Montreal, Canada. Institute of Neuropathology, University Hospital Münster, Münster, Germany. AN - 26378811 AU - Fontebasso, A. M. AU - Shirinian, M. AU - Khuong-Quang, D. A. AU - Bechet, D. AU - Gayden, T. AU - Kool, M. AU - De Jay, N. AU - Jacob, K. AU - Gerges, N. AU - Hutter, B. AU - Şeker-Cin, H. AU - Witt, H. AU - Montpetit, A. AU - Brunet, S. AU - Lepage, P. AU - Bourret, G. AU - Klekner, A. AU - Bognár, L. AU - Hauser, P. AU - Garami, M. AU - Farmer, J. P. AU - Montes, J. L. AU - Atkinson, J. AU - Lambert, S. AU - Kwan, T. AU - Korshunov, A. AU - Tabori, U. AU - Collins, V. P. AU - Albrecht, S. AU - Faury, D. AU - Pfister, S. M. AU - Paulus, W. AU - Hasselblatt, M. AU - Jones, D. T. AU - Jabado, N. C2 - PMC4741644 DA - Oct 13 DO - 10.18632/oncotarget.5571 10.18632/oncotarget.5571. DP - Nlm ET - 2015/09/18 IS - 31 LA - eng PY - 2015 SN - 1949-2553 SP - 31844-56 ST - Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age T2 - Oncotarget TI - Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age VL - 6 ID - 7025 ER - TY - JOUR AD - N. Ali, Department of Cardiology, Royal Children's Hospital, Flemington Road, Parkville, VIC 3052, Australia AU - Ali, N. AU - Konstantinov, I. AU - Heath, J. A. AU - Bhagwat, K. AU - Cheung, M. DB - Embase Medline DO - 10.1007/s00246-012-0230-y IS - 5 LA - English M3 - Article N1 - L51859468 2012-02-21 2012-07-31 PY - 2012 SN - 0172-0643 1432-1971 SP - 843-845 ST - Nonbacterial thrombotic endocarditis in a child with non-hodgkin's lymphoma T2 - Pediatric Cardiology TI - Nonbacterial thrombotic endocarditis in a child with non-hodgkin's lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51859468&from=exporthttp://dx.doi.org/10.1007/s00246-012-0230-y VL - 33 ID - 7026 ER - TY - JOUR AD - B. Lecka-Czernik, Department of Orthopaedic Surgery, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States B. Lecka-Czernik, Department of Physiology and Pharmacology, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States B. Lecka-Czernik, Center for Diabetes and Endocrine Research, University of Toledo, College of Medicine and Life Sciences, Toledo, OH, United States AU - Chougule, A. AU - Kolli, V. AU - Baroi, S. AU - Ebraheim, N. AU - Czernik, P. J. AU - Loh, Y. P. AU - Lecka-Czernik, B. DB - Embase DO - 10.1002/jbm4.10392 IS - 9 LA - English M3 - Article N1 - L2005838951 2020-08-17 2020-09-28 PY - 2020 SN - 2473-4039 ST - Nonenzymatic and Trophic Activities of Carboxypeptidase E Regulate Bone Mass and Bioenergetics of Skeletal Stem Cells in Mice T2 - JBMR Plus TI - Nonenzymatic and Trophic Activities of Carboxypeptidase E Regulate Bone Mass and Bioenergetics of Skeletal Stem Cells in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005838951&from=exporthttp://dx.doi.org/10.1002/jbm4.10392 VL - 4 ID - 7027 ER - TY - JOUR AD - Department of Hematology/Oncology, Cook Children's Medical Center, 1500 Cooper Street, Fort Worth, TX 76104, United States Medical Science Liaison-Hematology, Celgene Corporation, Dallas, TX, United States Office of the Chief Quality Officer, Baylor Scott and White Health, Dallas, TX, United States AU - Heym, K. M. AU - Gressett Ussery, S. M. AU - Trinkman, H. AU - Philpot, L. M. DB - Scopus DO - 10.1097/MPH.0000000000000277 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - e111-e113 ST - Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: A predominance of musculoskeletal pain T2 - Journal of Pediatric Hematology/Oncology TI - Nonhematologic toxicity of imatinib mesylate in pediatric patients with chronic myelogenous leukemia: A predominance of musculoskeletal pain UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924175013&doi=10.1097%2fMPH.0000000000000277&partnerID=40&md5=ae1efa635249000acf6a176585540047 VL - 37 ID - 7028 ER - TY - JOUR AD - Unidade de Endocrinologia do Desenvolvimento, Laboratorio de Hormonios e Genetica Molecular LIM/42, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. alexj@usp.br AN - 19258709 AU - Jorge, A. A. AU - Malaquias, A. C. AU - Arnhold, I. J. AU - Mendonca, B. B. DO - 10.1159/000201106 10.1159/000201106. Epub 2009 Mar 4. DP - Nlm ET - 2009/03/05 IS - 4 LA - eng PY - 2009 SN - 0301-0163 SP - 185-93 ST - Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway T2 - Horm Res TI - Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway VL - 71 ID - 7029 ER - TY - JOUR AD - B.D. Gelb, Department of Pediatrics, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States AU - Gelb, B. D. AU - Tartaglia, M. DB - Embase Medline DO - 10.1093/hmg/ddl197 IS - SUPPL. 2 LA - English M3 - Article N1 - L44446797 2006-10-11 PY - 2006 SN - 0964-6906 1460-2083 SP - R220-R226 ST - Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction T2 - Human Molecular Genetics TI - Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44446797&from=exporthttp://dx.doi.org/10.1093/hmg/ddl197 VL - 15 ID - 7030 ER - TY - JOUR AD - B. McDonald, Department of Dermatology, Watford General Hospital, West Hertfordshire Hospitals NHS Trust, Watford, United Kingdom AU - McDonald, B. AU - Amieva, M. AU - Kelsell, D. P. AU - O'Toole, E. A. AU - Burkett-Wright, E. AU - Kerr, B. AU - Batta, K. DB - Embase DO - 10.1111/bjd.14580 LA - English M3 - Conference Abstract N1 - L613932448 2017-01-04 PY - 2016 SN - 1365-2133 SP - 163 ST - Noonan syndrome with multiple lentigines identified by next-generation sequencing T2 - British Journal of Dermatology TI - Noonan syndrome with multiple lentigines identified by next-generation sequencing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613932448&from=exporthttp://dx.doi.org/10.1111/bjd.14580 VL - 175 ID - 7031 ER - TY - JOUR AD - M. Abbaszadegan, Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran AU - Tafazoli, A. AU - Eshraghi, P. AU - Koleti, Z. K. AU - Abbaszadegan, M. DB - Embase DO - 10.5114/aoms.2017.64720 IS - 1 LA - English M3 - Review N1 - L613935415 2017-01-06 2017-02-02 PY - 2017 SN - 1896-9151 1734-1922 SP - 215-222 ST - Noonan syndrome-a new survey T2 - Archives of Medical Science TI - Noonan syndrome-a new survey UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613935415&from=exporthttp://dx.doi.org/10.5114/aoms.2017.64720 VL - 13 ID - 7032 ER - TY - JOUR AD - E.A. Croonen, Department of Pediatrics, Radboud University Nijmegen Medical Centre, PO Box 9101, Nijmegen, Netherlands AU - Croonen, E. A. AU - Nillesen, W. AU - Schrander, C. AU - Jongmans, M. AU - Scheffer, H. AU - Noordam, C. AU - Draaisma, J. M. T. AU - Van Der Burgt, I. AU - Yntema, H. G. DB - Embase DO - 10.1159/000350686 IS - 5 LA - English M3 - Article N1 - L603918074 2015-04-27 2015-05-11 PY - 2013 SN - 1661-8777 1661-8769 SP - 227-234 ST - Noonan syndrome: Comparing mutation-positive with mutation-negative dutch patients T2 - Molecular Syndromology TI - Noonan syndrome: Comparing mutation-positive with mutation-negative dutch patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603918074&from=exporthttp://dx.doi.org/10.1159/000350686 VL - 4 ID - 7033 ER - TY - JOUR AD - T. Rohrer, Department of Pediatrics and Neonatology, Saarland University Hospital, Kirrberger Strasse 1, Geb. 9, DE-66421 Homburg/Saar, Germany AU - Rohrer, T. DB - Embase Medline DO - 10.1159/000243772 IS - SUPPL. 2 LA - English M3 - Conference Paper N1 - L358081721 2010-02-15 PY - 2009 SN - 0301-0163 SP - 3-7 ST - Noonan syndrome: Introduction and basic clinical features T2 - Hormone Research TI - Noonan syndrome: Introduction and basic clinical features UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358081721&from=exporthttp://dx.doi.org/10.1159/000243772 VL - 72 ID - 7034 ER - TY - JOUR AD - Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan. AN - 19765597 AU - Chen, Y. J. AU - Tsai, Y. M. AU - Kuo, C. D. AU - Ku, K. L. AU - Shie, H. S. AU - Liao, H. F. DA - Oct 21 DO - 10.1016/j.lfs.2009.09.003 10.1016/j.lfs.2009.09.003. Epub 2009 Sep 16. DP - Nlm ET - 2009/09/22 IS - 17-18 LA - eng PY - 2009 SN - 0024-3205 SP - 642-51 ST - Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect T2 - Life Sci TI - Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect VL - 85 ID - 7035 ER - TY - JOUR AD - Z. Song, Pain Research Center, Department of Anesthesiology, University of Cincinnati, Cincinnati, OH, United States AU - Ding, Z. AU - Xu, W. AU - Zhang, J. AU - Zou, W. AU - Guo, Q. AU - Huang, C. AU - Liu, C. AU - Zhong, T. AU - Zhang, J. M. AU - Song, Z. DB - Embase Medline DO - 10.1002/ijc.30438 IS - 2 LA - English M3 - Article N1 - L612734338 2016-10-19 2016-12-16 PY - 2017 SN - 1097-0215 0020-7136 SP - 411-422 ST - Normalizing GDNF expression in the spinal cord alleviates cutaneous hyperalgesia but not ongoing pain in a rat model of bone cancer pain T2 - International Journal of Cancer TI - Normalizing GDNF expression in the spinal cord alleviates cutaneous hyperalgesia but not ongoing pain in a rat model of bone cancer pain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612734338&from=exporthttp://dx.doi.org/10.1002/ijc.30438 VL - 140 ID - 7036 ER - TY - JOUR AU - Palacios, G. AU - Shaw, T. I. AU - Li, Y. AU - Singh, R. K. AU - Valentine, M. AU - Sandlund, J. T. AU - Lim, M. S. AU - Mullighan, C. G. AU - Leventaki, V. DB - Embase DO - 10.1038/leu.2016.331 IS - 3 LA - English M3 - Letter N1 - L613994768 2017-01-11 2017-03-14 PY - 2017 SN - 1476-5551 0887-6924 SP - 743-747 ST - Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex T2 - Leukemia TI - Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613994768&from=exporthttp://dx.doi.org/10.1038/leu.2016.331 VL - 31 ID - 7037 ER - TY - JOUR AD - Department of Hematology, Institute of Hematology and Transfusion Medicine, Indiry Gandhi 14 str, 02-776 Warsaw, Poland Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland AU - Lech-Maranda, E. AU - Mlynarski, W. DB - Scopus DO - 10.2174/156800912800673275 IS - 5 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2012 SP - 505-521 ST - Novel and emerging drugs for acute lymphoblastic leukemia T2 - Current Cancer Drug Targets TI - Novel and emerging drugs for acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861730938&doi=10.2174%2f156800912800673275&partnerID=40&md5=fd9ea0c7420140f6ddfa9a82e35af8c7 VL - 12 ID - 7038 ER - TY - JOUR AD - B.K.W. Cheung, Cytokine Biology Group, Department of Paediatrics and, Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Ksong Special Administrative Region, Pokfulam, China AU - Cheung, B. K. W. AU - Yim, H. C. H. AU - Lee, N. C. M. AU - Lau, A. S. Y. DB - Embase Medline DO - 10.1186/1471-2172-10-64 LA - English M3 - Article N1 - L358128738 2010-02-23 PY - 2009 SN - 1471-2172 ST - A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1 T2 - BMC Immunology TI - A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358128738&from=exporthttp://dx.doi.org/10.1186/1471-2172-10-64 VL - 10 ID - 7039 ER - TY - JOUR AD - G. Koltsida, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Koltsida, G. AU - Piccione, J. AU - Tapia, I. AU - Phinizy, P. DB - Embase DO - 10.1164/ajrccm-conference.2017.B67. LA - English M3 - Conference Abstract N1 - L617707886 2017-08-15 PY - 2017 SN - 1535-4970 ST - Novel approach to inflammatory myofibroblastic bronchial tumor: a case report T2 - American Journal of Respiratory and Critical Care Medicine TI - Novel approach to inflammatory myofibroblastic bronchial tumor: a case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617707886&from=exporthttp://dx.doi.org/10.1164/ajrccm-conference.2017.B67. VL - 195 ID - 7040 ER - TY - JOUR AD - H. Cin, Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany AU - Cin, H. AU - Meyer, C. AU - Herr, R. AU - Janzarik, W. G. AU - Lambert, S. AU - Jones, D. T. W. AU - Jacob, K. AU - Witt, H. AU - Remke, M. AU - Bender, S. AU - Scheurlen, W. AU - Witt, O. AU - Omran, H. AU - Jabado, N. AU - Peter Collins, V. AU - Brummer, T. AU - Marschalek, R. AU - Lichter, P. AU - Korshunov, A. AU - Pfister, S. M. DB - Embase DO - 10.1093/neuonc/nor018 LA - English M3 - Conference Abstract N1 - L70462918 2011-07-16 PY - 2011 SN - 1522-8517 SP - i2 ST - A novel BRAF fusion gene resulting from 7Q34 deletion constitutes an alternative mechanism of mitogen-activated protein kinase pathway activation in pilocytic astrocytoma T2 - Neuro-Oncology TI - A novel BRAF fusion gene resulting from 7Q34 deletion constitutes an alternative mechanism of mitogen-activated protein kinase pathway activation in pilocytic astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70462918&from=exporthttp://dx.doi.org/10.1093/neuonc/nor018 VL - 13 ID - 7041 ER - TY - JOUR AD - L. Pulakat AU - Pulakat, L. AU - Belenchia, A. M. AU - Toedebusch, R. G. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L622546233 2018-06-18 PY - 2018 SN - 1530-6860 ST - The novel cardio-oncology drug, NP-6A4, regulates the growth of multiple breast cancer cell lines through distinct cell-specific mechanisms T2 - FASEB Journal TI - The novel cardio-oncology drug, NP-6A4, regulates the growth of multiple breast cancer cell lines through distinct cell-specific mechanisms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622546233&from=export VL - 32 ID - 7042 ER - TY - JOUR AD - A.R. Oseghale, Vascular Biology Center, Augusta University, Augusta, GA, United States AU - Oseghale, A. R. AU - Johnson, M. M. AU - Zhu, X. AU - Nudelman, A. AU - Rephaeli, A. AU - Pace, B. S. DB - Embase LA - English M3 - Conference Abstract N1 - L620385380 2018-02-01 PY - 2017 SN - 1528-0020 ST - Novel conjugates of butyrate and δ-aminolevulinate increase γ-globin gene expression and fetal hemoglobin synthesis in erythroid progenitors T2 - Blood TI - Novel conjugates of butyrate and δ-aminolevulinate increase γ-globin gene expression and fetal hemoglobin synthesis in erythroid progenitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620385380&from=export VL - 130 ID - 7043 ER - TY - JOUR AD - T.K. Olsen, Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Norway AU - Olsen, T. K. AU - Panagopoulos, I. AU - Gorunova, L. AU - Micci, F. AU - Andersen, K. AU - Kilen Andersen, H. AU - Meling, T. R. AU - Due-Tønnessen, B. AU - Scheie, D. AU - Heim, S. AU - Brandal, P. DB - Embase Medline DO - 10.1002/gcc.22392 IS - 12 LA - English M3 - Article N1 - L611452772 2016-08-05 2016-11-30 PY - 2016 SN - 1098-2264 1045-2257 SP - 944-953 ST - Novel fusion genes and chimeric transcripts in ependymal tumors T2 - Genes Chromosomes and Cancer TI - Novel fusion genes and chimeric transcripts in ependymal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611452772&from=exporthttp://dx.doi.org/10.1002/gcc.22392 VL - 55 ID - 7044 ER - TY - JOUR AD - Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, PO Box 49534, Montebello, Nydalen, Oslo, 0424, Norway Section for Applied Informatics, Institute for Cancer Genetics and Informatics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Genomics Core Facility, Department of Core Facilities, Oslo University Hospital, Oslo, Norway Department of Pediatrics, Division of Child and Adolescent Health, University Hospital of North-Norway, Tromsø, 9038, Norway Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Science, Arctic University of Norway-UiT, Tromsø, 9037, Norway Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway AU - Panagopoulos, I. AU - Brunetti, M. AU - Stoltenberg, M. AU - Strandabø, Rø A. U. AU - Staurseth, J. AU - Andersen, K. AU - Kostolomov, I. AU - Hveem, T. S. AU - Lorenz, S. AU - Nystad, T. A. AU - Flægstad, T. AU - Micci, F. AU - Heim, S. C7 - 12 DB - Scopus DO - 10.1186/s40164-019-0136-y IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 ST - Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype T2 - Experimental Hematology and Oncology TI - Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066954234&doi=10.1186%2fs40164-019-0136-y&partnerID=40&md5=fb4508ef8ee2887e75d0136b4d0205d2 VL - 8 ID - 7045 ER - TY - JOUR AD - Department of Immunology, Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, Netherlands AU - Staal, F. J. T. AU - Van Dongen, J. J. M. AU - Langerak, A. W. DB - Scopus DO - 10.1007/s11899-007-0024-0 IS - 3 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2007 SP - 176-182 ST - Novel insights into the development of T-cell acute lymphoblastic leukemia T2 - Current Hematologic Malignancy Reports TI - Novel insights into the development of T-cell acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547766674&doi=10.1007%2fs11899-007-0024-0&partnerID=40&md5=5fc17b55e4d02758f25da1bee45a1f6c VL - 2 ID - 7046 ER - TY - JOUR AD - Department of Cell Biology, Lerner Research Institute Cleveland Clinic College of Medicine of CWRU, 9500 Euclid Avenue, Cleveland, OH 44195, United States Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic, Cleveland, OH, United States Department of Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, United States AU - Feldstein, A. E. DB - Scopus DO - 10.1055/s-0030-1267539 IS - 4 M3 - Review N1 - Cited By :89 Export Date: 18 November 2020 PY - 2010 SP - 391-401 ST - Novel insights into the pathophysiology of nonalcoholic fatty liver disease T2 - Seminars in Liver Disease TI - Novel insights into the pathophysiology of nonalcoholic fatty liver disease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958183243&doi=10.1055%2fs-0030-1267539&partnerID=40&md5=4b39787a2ad19f1c55c749ba5a6b5a43 VL - 30 ID - 7047 ER - TY - JOUR AD - Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA. AN - 24832869 AU - Scorsone, K. AU - Zhang, L. AU - Woodfield, S. E. AU - Hicks, J. AU - Zage, P. E. DA - Oct DO - 10.1007/s10637-014-0107-4 10.1007/s10637-014-0107-4. Epub 2014 May 16. DP - Nlm ET - 2014/05/17 IS - 5 LA - eng PY - 2014 SN - 0167-6997 SP - 815-24 ST - The novel kinase inhibitor EMD1214063 is effective against neuroblastoma T2 - Invest New Drugs TI - The novel kinase inhibitor EMD1214063 is effective against neuroblastoma VL - 32 ID - 7048 ER - TY - JOUR AD - Department of Pathology, Stanford University Medical Center, Stanford, CA, United States Applied Genomics Inc., Burlingame, CA, United States Department of Pathology, OHSU Cancer Institute, Oregon Health and Science University, Portland, OR, United States Departments of Anatomic Pathology and Molecular Genetics, Lerner Research Institute, Taussig Cancer Center, Cleveland, OH, United States Department of Pathology, University of British Columbia, Vancouver, BC, Canada Department of Pathology, L-235, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States AU - Espinosa, I. AU - Lee, C. H. AU - Kim, M. K. AU - Rouse, B. T. AU - Subramanian, S. AU - Montgomery, K. AU - Varma, S. AU - Corless, C. L. AU - Heinrich, M. C. AU - Smith, K. S. AU - Wang, Z. AU - Rubin, B. AU - Nielsen, T. O. AU - Seitz, R. S. AU - Ross, D. T. AU - West, R. B. AU - Cleary, M. L. AU - Van De Rijn, M. DB - Scopus DO - 10.1097/PAS.0b013e3181238cec IS - 2 M3 - Article N1 - Cited By :315 Export Date: 18 November 2020 PY - 2008 SP - 210-218 ST - A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors T2 - American Journal of Surgical Pathology TI - A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38649098794&doi=10.1097%2fPAS.0b013e3181238cec&partnerID=40&md5=c49c9f51218265a62a35398c9587a638 VL - 32 ID - 7049 ER - TY - JOUR AD - I. Somekh, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany AU - Somekh, I. AU - Marquardt, B. AU - Liu, Y. AU - Rohlfs, M. AU - Frizinsky, S. AU - Unal, E. AU - Kotlarz, D. AU - Somech, R. AU - Klein, C. DB - Embase LA - English M3 - Conference Abstract N1 - L620384866 2018-02-01 PY - 2017 SN - 1528-0020 ST - Novel mutations in RASGRP1 are associated with immune dysregulation and predispose to EBV-induced lymphoma T2 - Blood TI - Novel mutations in RASGRP1 are associated with immune dysregulation and predispose to EBV-induced lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620384866&from=export VL - 130 ID - 7050 ER - TY - JOUR AD - R. Somech, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center; Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, 52621, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel AU - Somekh, I. AU - Marquardt, B. AU - Liu, Y. AU - Rohlfs, M. AU - Hollizeck, S. AU - Karakukcu, M. AU - Unal, E. AU - Yilmaz, E. AU - Patiroglu, T. AU - Cansever, M. AU - Frizinsky, S. AU - Vishnvenska-Dai, V. AU - Rechavi, E. AU - Stauber, T. AU - Simon, A. J. AU - Lev, A. AU - Klein, C. AU - Kotlarz, D. AU - Somech, R. DB - Embase Medline DO - 10.1007/s10875-018-0533-8 IS - 6 LA - English M3 - Article N1 - L623185246 2018-07-30 2018-09-25 PY - 2018 SN - 1573-2592 0271-9142 SP - 699-710 ST - Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma T2 - Journal of Clinical Immunology TI - Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623185246&from=exporthttp://dx.doi.org/10.1007/s10875-018-0533-8 VL - 38 ID - 7051 ER - TY - JOUR AD - M. Kurpisz, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland AU - Malcher, A. AU - Jedrzejczak, P. AU - Stokowy, T. AU - Monem, S. AU - Nowicka-Bauer, K. AU - Zimna, A. AU - Czyzyk, A. AU - Maciejewska-Jeske, M. AU - Meczekalski, B. AU - Bednarek-Rajewska, K. AU - Wozniak, A. AU - Rozwadowska, N. AU - Kurpisz, M. DB - Embase Medline DO - 10.3390/ijms20215418 IS - 21 LA - English M3 - Article N1 - L2002894737 2019-11-07 2019-12-16 PY - 2019 SN - 1422-0067 1661-6596 ST - Novel mutations segregating with complete androgen insensitivity syndrome and their molecular characteristics T2 - International Journal of Molecular Sciences TI - Novel mutations segregating with complete androgen insensitivity syndrome and their molecular characteristics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002894737&from=exporthttp://dx.doi.org/10.3390/ijms20215418 VL - 20 ID - 7052 ER - TY - JOUR AD - Y. Nakano, National Cancer Center Research Institute, Division of Brain Tumor Translational Research, Tokyo, Japan AU - Nakano, Y. AU - Tomiyama, A. AU - Yamasaki, K. AU - Fukuoka, K. AU - Fukushima, H. AU - Inoue, T. AU - Kohno, T. AU - Yoshida, A. AU - Matsusaka, Y. AU - Hara, J. AU - Sakamoto, H. AU - Ichimura, K. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619369640 2017-11-28 PY - 2017 SN - 1545-5017 SP - S54-S55 ST - Novel oncogenic klc1-ros1 fusion in pediatric low grade glioma T2 - Pediatric Blood and Cancer TI - Novel oncogenic klc1-ros1 fusion in pediatric low grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619369640&from=exporthttp://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 7053 ER - TY - JOUR AD - J. Bleloch, University of Cape Town, Cape Town, South Africa AU - Bleloch, J. AU - Ballim, R. AU - Blanckenberg, A. AU - Mapolie, S. AU - Kimani, S. AU - Prince, S. DB - Embase DO - 10.1158/1538-7445.NEWFRONT17-B38 IS - 22 LA - English M3 - Conference Abstract N1 - L619752347 2017-12-20 PY - 2017 SN - 1538-7445 ST - A novel palladacycle complex with anti-cancer activity against breast cancer and melanomas also exhibits potent cytotoxicity in a range of sarcomas T2 - Cancer Research TI - A novel palladacycle complex with anti-cancer activity against breast cancer and melanomas also exhibits potent cytotoxicity in a range of sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619752347&from=exporthttp://dx.doi.org/10.1158/1538-7445.NEWFRONT17-B38 VL - 77 ID - 7054 ER - TY - JOUR AD - S. Igawa, Department of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, Japan AU - Igawa, S. AU - Honma, M. AU - Minami-Hori, M. AU - Tsuchida, E. AU - Iizuka, H. AU - Ishida-Yamamoto, A. DB - Embase Medline DO - 10.1111/1346-8138.13153 IS - 1 LA - English M3 - Letter N1 - L607258737 2015-12-22 2016-04-19 PY - 2016 SN - 1346-8138 0385-2407 SP - 103-104 ST - Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi T2 - Journal of Dermatology TI - Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607258737&from=exporthttp://dx.doi.org/10.1111/1346-8138.13153 VL - 43 ID - 7055 ER - TY - JOUR AD - S.D. Held, University of Texas, Health Science Center at San Antonio, San Antonio, TX, United States AU - Held, S. D. AU - Kinney, M. C. AU - Medina, E. A. AU - Higgins, R. A. DB - Embase DO - 10.1038/labinvest.2012.38 LA - English M3 - Conference Abstract N1 - L70662882 2012-02-13 PY - 2012 SN - 0023-6837 SP - 339A ST - Novel recurrent gains and deletions in adults with anaplastic large cell lymphoma T2 - Laboratory Investigation TI - Novel recurrent gains and deletions in adults with anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70662882&from=exporthttp://dx.doi.org/10.1038/labinvest.2012.38 VL - 92 ID - 7056 ER - TY - JOUR AD - I. Singh, Div. of Developmental Neurogenetics, Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, United States AU - Pannu, R. AU - Won, J. S. AU - Khan, M. AU - Singh, A. K. AU - Singh, I. DB - Embase Medline DO - 10.1523/JNEUROSCI.1271-04.2004 IS - 26 LA - English M3 - Article N1 - L38859392 2004-07-29 PY - 2004 SN - 0270-6474 SP - 5942-5954 ST - A novel role of lactosylceramide in the regulation of lipopolysaccharide/ interferon-γ-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases T2 - Journal of Neuroscience TI - A novel role of lactosylceramide in the regulation of lipopolysaccharide/ interferon-γ-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38859392&from=exporthttp://dx.doi.org/10.1523/JNEUROSCI.1271-04.2004 VL - 24 ID - 7057 ER - TY - JOUR AD - UOC Oncologia Pediatrica, Fondazione Policlinico Universitario 'A Gemelli', Rome, Italy Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesu, Rome, Italy Department of Oncology and Molecular Medicine, Istituto Superiore di Sanita, Rome, Italy Mendel Institute, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy Institute of Neurology, Catholic University, Rome, Italy UOC Neurologia, Fondazione Policlinico Universitario a Gemelli, Rome, Italy Institute of Pathology, Catholic University, Rome, Italy Institute of Neurosurgery, Catholic University, Rome, Italy Department of Pediatrics, Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States AU - Servidei, T. AU - Meco, D. AU - Muto, V. AU - Bruselles, A. AU - Ciolfi, A. AU - Trivieri, N. AU - Lucchini, M. AU - Morosetti, R. AU - Mirabella, M. AU - Martini, M. AU - Caldarelli, M. AU - Lasorella, A. AU - Tartaglia, M. AU - Riccardi, R. DB - Scopus DO - 10.1158/0008-5472.CAN-17-0790 IS - 21 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 5860-5872 ST - Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens T2 - Cancer Research TI - Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035031657&doi=10.1158%2f0008-5472.CAN-17-0790&partnerID=40&md5=24c1baf92cb86ad03b1942aa170e4501 VL - 77 ID - 7058 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. From the Department of Pathology, UT Health-Department of Pathology and Laboratory medicine, Houston, Texas, United States of America. Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Pediatric Hematology/Oncology/BMT, Levine Children's Hospital/Levine Cancer Institute, Charlotte, North Carolina, United States of America. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Center for Personalized Cancer Therapy and Division of Hematology & Oncology, University of California San Diego - Moores Cancer Center, La Jolla, California, United States of America. AN - 25119929 AU - Jiang, Y. AU - Subbiah, V. AU - Janku, F. AU - Ludwig, J. A. AU - Naing, A. AU - Benjamin, R. S. AU - Brown, R. E. AU - Anderson, P. AU - Kurzrock, R. C2 - PMC4131855 DO - 10.1371/journal.pone.0093676 DP - Nlm ET - 2014/08/15 IS - 8 LA - eng N1 - 1932-6203 Jiang, Yunyun Subbiah, Vivek Janku, Filip Ludwig, Joseph A Naing, Aung Benjamin, Robert S Brown, Robert E Anderson, Pete Kurzrock, Razelle PY - 2014 SN - 1932-6203 SP - e93676 ST - Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors T2 - PLoS One TI - Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors VL - 9 ID - 7059 ER - TY - JOUR AD - V. Subbiah, Phase 1 Program, UT MD AndersonCancer Center, Houston, United States AU - Subbiah, V. AU - Jiang, Y. AU - Janku, F. AU - Ludwig, J. A. AU - Naing, A. AU - Benjamin, R. S. AU - Brown, R. E. AU - Anderson, P. M. AU - Kurzrock, R. DB - Embase DO - 10.1002/pbc.25314 LA - English M3 - Conference Abstract N1 - L71655960 2014-10-31 PY - 2014 SN - 1545-5009 SP - S235 ST - Novel secondary somatic mutations in ewing's sarcoma and desmoplastic small round cell tumors in children, adolescents and young adults T2 - Pediatric Blood and Cancer TI - Novel secondary somatic mutations in ewing's sarcoma and desmoplastic small round cell tumors in children, adolescents and young adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71655960&from=exporthttp://dx.doi.org/10.1002/pbc.25314http://onlinelibrary.wiley.com/doi/10.1002/pbc.25314/pdf VL - 61 ID - 7060 ER - TY - JOUR AD - C. Reimann, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany AU - Reimann, C. AU - Arola, M. AU - Bierings, M. AU - Karow, A. AU - van den Heuvel-Eibrink, M. M. AU - Hasle, H. AU - Niemeyer, C. M. AU - Kratz, C. P. DB - Embase Medline DO - 10.1038/sj.leu.2404303 IS - 9 LA - English M3 - Letter N1 - L44264116 2006-09-07 PY - 2006 SN - 1476-5551 0887-6924 SP - 1637-1638 ST - A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia [11] T2 - Leukemia TI - A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia [11] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44264116&from=exporthttp://dx.doi.org/10.1038/sj.leu.2404303 VL - 20 ID - 7061 ER - TY - JOUR AD - Departments of Oncology and Pediatrics, School of Medicine, Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231, United States Division of Pediatric Hematology/Oncology, University of Colorado, Childrens Hospital, Aurora, CO, United States Division of Hematology/Oncology, University of Cincinnati, Cincinnati Childrens Hospital, Cincinnati, OH, United States Department of Pediatrics, Cancer Institute, New York University, New York, NY, United States Division of Pediatric Oncology, Group Cheirs Office, Childrens Oncology Group, Washington, DC, United States AU - Brown, P. AU - Hunger, S. P. AU - Smith, F. O. AU - Carroll, W. L. AU - Reaman, G. H. DB - Scopus DO - 10.1586/ehm.09.1 IS - 2 M3 - Review N1 - Cited By :27 Export Date: 18 November 2020 PY - 2009 SP - 145-158 ST - Novel targeted drug therapies for the treatment of childhood acute leukemia T2 - Expert Review of Hematology TI - Novel targeted drug therapies for the treatment of childhood acute leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953384502&doi=10.1586%2fehm.09.1&partnerID=40&md5=68b3396b2a938e6059e9d916c20e532b VL - 2 ID - 7062 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, University at Buffalo, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Department of Paediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France. AN - 30701541 AU - Barth, M. J. AU - Minard-Colin, V. DA - Jun DO - 10.1111/bjh.15783 10.1111/bjh.15783. Epub 2019 Jan 30. DP - Nlm ET - 2019/02/01 IS - 6 LA - eng PY - 2019 SN - 0007-1048 SP - 1111-1124 ST - Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma T2 - Br J Haematol TI - Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma VL - 185 ID - 7063 ER - TY - JOUR AD - J.T. Leonard AU - Leonard, J. T. AU - Chang, B. H. AU - Tyner, J. W. AU - Hayes-Lattin, B. AU - Loriaux, M. M. AU - Druker, B. J. AU - Borate, U. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614247113 2017-02-03 PY - 2016 SN - 1528-0020 ST - Novel targets identified by in vitro screening of patient samples with adult acute lymphoblastic leukemia T2 - Blood TI - Novel targets identified by in vitro screening of patient samples with adult acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614247113&from=export VL - 128 ID - 7064 ER - TY - JOUR AD - M.R. Litzow, Division of Hematology, Mayo Clinic, 200 First Street, South West, Rochester, MN 55905, United States AU - Litzow, M. R. C1 - cat 3888 cat 8015 cci 779 dt 2219 ly 231514 rad 001 DB - Embase Medline DO - 10.1016/j.hoc.2011.09.019 IS - 6 LA - English M3 - Review N1 - L362941069 2011-11-23 2011-11-25 PY - 2011 SN - 0889-8588 1558-1977 SP - 1303-1317 ST - Novel Therapeutic Approaches for Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Novel Therapeutic Approaches for Acute Lymphoblastic Leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362941069&from=exporthttp://dx.doi.org/10.1016/j.hoc.2011.09.019 VL - 25 ID - 7065 ER - TY - JOUR AD - K. Watanabe, Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Japan AU - Watanabe, K. AU - Takita, J. DB - Embase DO - 10.1002/pbc.27514 LA - English M3 - Conference Abstract N1 - L625308364 2018-12-06 PY - 2018 SN - 1545-5017 SP - S13 ST - Novel therapeutic approaches to high-risk neuroblastoma targeting cancer metabolism T2 - Pediatric Blood and Cancer TI - Novel therapeutic approaches to high-risk neuroblastoma targeting cancer metabolism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625308364&from=exporthttp://dx.doi.org/10.1002/pbc.27514 VL - 65 ID - 7066 ER - TY - JOUR AD - Department of Orthopaedics Surgery, University of Melbourne, St. Vincent's Health, Melbourne, VIC, Australia Bone and Soft Tissue Sarcoma Service, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan Department of Orthopaedics Surgery, University of Melbourne, St. Vincent's Health, P.O. Box 2900, Melbourne, VIC 3065, Australia AU - Akiyama, T. AU - Dass, C. R. AU - Choong, P. F. M. DB - Scopus DO - 10.1158/1535-7163.MCT-08-0530 IS - 11 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2008 SP - 3461-3469 ST - Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway T2 - Molecular Cancer Therapeutics TI - Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-56249123993&doi=10.1158%2f1535-7163.MCT-08-0530&partnerID=40&md5=c57cea1a7682a54cafe82512895e3ffb VL - 7 ID - 7067 ER - TY - JOUR AD - Department of Leukemia, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Fullmer, A. AU - O'Brien, S. AU - Kantarjian, H. AU - Jabbour, E. DB - Scopus DO - 10.1007/s11899-009-0021-6 IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2009 SP - 148-156 ST - Novel therapies for relapsed acute lymphoblastic leukemia T2 - Current Hematologic Malignancy Reports TI - Novel therapies for relapsed acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650227612&doi=10.1007%2fs11899-009-0021-6&partnerID=40&md5=b7c55fa1ca82bfe775edcdef71c61fcc VL - 4 ID - 7068 ER - TY - JOUR AD - S. Albani, University of California, Department of Pediatrics, 9500 Gilman Drive, La Jolla, CA 92093, United States AU - Tremouler, A. H. AU - Albani, S. C1 - incb 3284 medi 522 mln 1202 tgn 1412 tmi 005 tmi 2 C2 - Amgen Vertex DB - Embase Medline DO - 10.1517/13543784.15.11.1427 IS - 11 LA - English M3 - Review N1 - L44615290 2006-11-15 PY - 2006 SN - 1354-3784 SP - 1427-1441 ST - Novel therapies for rheumatoid arthritis T2 - Expert Opinion on Investigational Drugs TI - Novel therapies for rheumatoid arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44615290&from=exporthttp://dx.doi.org/10.1517/13543784.15.11.1427 VL - 15 ID - 7069 ER - TY - JOUR AU - Hazar, V. DB - Embase DO - 10.1016/S0145-2126(19)30236-X LA - English M3 - Conference Abstract N1 - L2004021042 2019-12-03 PY - 2019 SN - 1873-5835 0145-2126 SP - S17-S18 ST - Novel therapy for relapsed childhood acute lymphoblastic leukemia T2 - Leukemia Research TI - Novel therapy for relapsed childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004021042&from=exporthttp://dx.doi.org/10.1016/S0145-2126(19)30236-X VL - 85 ID - 7070 ER - TY - JOUR AD - Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Blood and Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Jabbour, E. AU - Cortes, J. AU - Kantarjian, H. AU - Giralt, S. AU - Andersson, B. S. AU - Giles, F. AU - Shpall, E. AU - Kebriaei, P. AU - Champlin, R. AU - De Lima, M. DB - Scopus DO - 10.1002/cncr.22778 IS - 2 M3 - Article N1 - Cited By :50 Export Date: 18 November 2020 PY - 2007 SP - 340-344 ST - Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity T2 - Cancer TI - Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: No evidence for increased transplant-related toxicity UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547178987&doi=10.1002%2fcncr.22778&partnerID=40&md5=39d1b4b47d07da817b3c9f4a2cb98fa1 VL - 110 ID - 7071 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. AN - 18615679 AU - Agaram, N. P. AU - Wong, G. C. AU - Guo, T. AU - Maki, R. G. AU - Singer, S. AU - Dematteo, R. P. AU - Besmer, P. AU - Antonescu, C. R. C2 - PMC2902874 C6 - NIHMS216366 DA - Oct DO - 10.1002/gcc.20589 10.1002/gcc.20589. DP - Nlm ET - 2008/07/11 IS - 10 LA - eng PY - 2008 SN - 1045-2257 (Print) 1045-2257 SP - 853-9 ST - Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors T2 - Genes Chromosomes Cancer TI - Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors VL - 47 ID - 7072 ER - TY - JOUR AU - Kohn, L. AU - Ahn, T. AU - Cerrone, D. AU - Butte, M. DB - Embase DO - 10.1016/j.anai.2020.08.311 IS - 5 LA - English M3 - Conference Abstract N1 - L2008361758 2020-10-26 PY - 2020 SN - 1534-4436 1081-1206 SP - S94 ST - NOVEL VARIATION IN RASGRP1 CAUSES NEWBORN T CELL LYMPHOPENIA T2 - Annals of Allergy, Asthma and Immunology TI - NOVEL VARIATION IN RASGRP1 CAUSES NEWBORN T CELL LYMPHOPENIA UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2008361758&from=exporthttp://dx.doi.org/10.1016/j.anai.2020.08.311 VL - 125 ID - 7073 ER - TY - JOUR AU - Pomari, E. AU - Basso, G. AU - Bresolin, S. AU - Pillon, M. AU - Carraro, E. AU - D'Amore, E. S. AU - Viola, G. AU - Frasson, C. AU - Basso, K. AU - Bonvini, P. AU - Mussolin, L. DB - Embase Medline DO - 10.1038/leu.2016.292 IS - 2 LA - English M3 - Letter N1 - L613339624 2016-11-28 2017-02-15 PY - 2017 SN - 1476-5551 0887-6924 SP - 498-501 ST - NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma T2 - Leukemia TI - NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613339624&from=exporthttp://dx.doi.org/10.1038/leu.2016.292 VL - 31 ID - 7074 ER - TY - JOUR AD - Department of Pathology, University of Michigan, Ann Arbor, MI, USA. AN - 22179823 AU - McDonnell, S. R. AU - Hwang, S. R. AU - Basrur, V. AU - Conlon, K. P. AU - Fermin, D. AU - Wey, E. AU - Murga-Zamalloa, C. AU - Zeng, Z. AU - Zu, Y. AU - Elenitoba-Johnson, K. S. AU - Lim, M. S. C2 - PMC4244868 C6 - NIHMS643434 DA - Aug 9 DO - 10.1038/onc.2011.542 10.1038/onc.2011.542. Epub 2011 Dec 19. DP - Nlm ET - 2011/12/20 IS - 32 LA - eng PY - 2012 SN - 0950-9232 (Print) 0950-9232 SP - 3733-40 ST - NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis T2 - Oncogene TI - NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis VL - 31 ID - 7075 ER - TY - JOUR AD - Department of Internal Medicine I, University of Saarland, Homburg/Saar, Germany. AN - 9209648 AU - Trümper, L. AU - Daus, H. AU - Merz, H. AU - von Bonin, F. AU - Loftin, U. AU - Cochlovius, C. AU - Möller, P. AU - Feller, A. C. AU - Pfreundschuh, M. DP - Nlm ET - 1997/01/01 LA - eng N1 - Trümper, L Daus, H Merz, H von Bonin, F Loftin, U Cochlovius, C Möller, P Feller, A C Pfreundschuh, M Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't England Ann Oncol. 1997;8 Suppl 2:83-7. PY - 1997 SN - 0923-7534 (Print) 0923-7534 SP - 83-7 ST - NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis T2 - Ann Oncol TI - NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis VL - 8 Suppl 2 ID - 7076 ER - TY - JOUR AN - 10450759 AU - Hernández, F. AU - López, O. AU - Estivill, C. AU - Baiget, M. AU - Pujol, R. M. AU - Bordes, R. AU - Nomdedéu, J. F. DA - Aug DO - 10.1038/sj.leu.2401475 10.1038/sj.leu.2401475. DP - Nlm ET - 1999/08/18 IS - 8 LA - eng PY - 1999 SN - 0887-6924 (Print) 0887-6924 SP - 1291-2 ST - NPM/ALK rearrangements in indolent cutaneous lesions T2 - Leukemia TI - NPM/ALK rearrangements in indolent cutaneous lesions VL - 13 ID - 7077 ER - TY - JOUR AD - Inserm, U1078, Brest, F-29200, France. arnaud.uguen@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. arnaud.uguen@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. arnaud.uguen@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. matthieu.talagas@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. matthieu.talagas@chu-brest.fr. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. matthieu.talagas@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. sebastian.costa@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. laura.samaison@gmail.com. Université Européenne de Bretagne, Rennes, France. laura.samaison@gmail.com. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. laura.samaison@gmail.com. CHRU Brest, Laboratoire de Génétique Moléculaire et d'Histocompatibilité, Brest, F-29220, France. laure.paule@chu-brest.fr. Inserm, CIC1412, Brest, F-29200, France. zarrin.alavi@chu-brest.fr. Inserm, U1078, Brest, F-29200, France. marc.debraekeleer@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. marc.debraekeleer@chu-brest.fr. CHRU Brest, Laboratoire de Cytogénétique et Biologie de la Reproduction, Brest, F-29220, France. marc.debraekeleer@chu-brest.fr. Inserm, U1078, Brest, F-29200, France. cedric.lemarechal@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. cedric.lemarechal@chu-brest.fr. CHRU Brest, Laboratoire de Génétique Moléculaire et d'Histocompatibilité, Brest, F-29220, France. cedric.lemarechal@chu-brest.fr. Department of Molecular Genetics and Histocompatibily, University Hospital Morvan, 2, Avenue Foch 29609, Brest, France. cedric.lemarechal@chu-brest.fr. CHRU Brest, Service d'anatomie et cytologie pathologiques, Brest, F-29220, France. pascale.marcorelles@chu-brest.fr. Université Européenne de Bretagne, Rennes, France. pascale.marcorelles@chu-brest.fr. Faculté de Médecine et des Sciences de la Santé Université de Brest, EA4685, Brest, F-29200, France. pascale.marcorelles@chu-brest.fr. Department of Pathology, University Hospital Morvan, 2, Avenue Foch 29609, Brest, France. pascale.marcorelles@chu-brest.fr. AN - 26204954 AU - Uguen, A. AU - Talagas, M. AU - Costa, S. AU - Samaison, L. AU - Paule, L. AU - Alavi, Z. AU - De Braekeleer, M. AU - Le Marechal, C. AU - Marcorelles, P. C2 - PMC4513673 DA - Jul 25 DO - 10.1186/s13000-015-0359-0 10.1186/s13000-015-0359-0. DP - Nlm ET - 2015/07/25 LA - eng PY - 2015 SN - 1746-1596 SP - 121 ST - NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas T2 - Diagn Pathol TI - NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas VL - 10 ID - 7078 ER - TY - JOUR AD - Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université Pierre et Marie Curie-Paris VI, Paris, France. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Medical Oncology, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Maxillofacial and Plastic Surgery, Hôpital Necker, APHP, Paris, France. Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH, Paris, France. Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Pathology, Hôpital Trousseau, APHP, Paris, France. Laboratory for Functional Genomics, Fondation Jean Dausset-CEPH, Paris, France; Laboratory for Epigenetics and Environment, Centre National de Génotypage, CEA-Institut de Génomique, Evry, France. Laboratory of Pharmacology-Genetics, Hôpital Saint-Louis, APHP, Paris, France. Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université René Descartes-Paris V, Paris, France; Department of Dermatology, Hôpital Cochin, APHP, Paris, France. Saint Antoine Research Center, U938, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Université Pierre et Marie Curie-Paris VI, Paris, France; Department of Dermatology, Hôpital Tenon, APHP, Paris, France. Electronic address: sarah.guegan@tnn.aphp.fr. AN - 24129063 AU - Charbel, C. AU - Fontaine, R. H. AU - Malouf, G. G. AU - Picard, A. AU - Kadlub, N. AU - El-Murr, N. AU - How-Kit, A. AU - Su, X. AU - Coulomb-L'Hermine, A. AU - Tost, J. AU - Mourah, S. AU - Aractingi, S. AU - Guégan, S. DA - Apr DO - 10.1038/jid.2013.429 10.1038/jid.2013.429. Epub 2013 Oct 15. DP - Nlm ET - 2013/10/17 IS - 4 LA - eng PY - 2014 SN - 0022-202x SP - 1067-1074 ST - NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi T2 - J Invest Dermatol TI - NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi VL - 134 ID - 7079 ER - TY - JOUR AD - Department of Pharmacy, International University of Health, Welfare Ichikawa Hospital, 6-1-14 Kounodai, Ichikawa-shi, Chiba, 272-0827, Japan Department of Pharmacy, Institute of Medical Science, University of Tokyo Department of Pharmacotherapy, Meiji Pharmaceutical University Department of Medicinal Therapy Research, Meiji Pharmaceutical University Department of Pharmacotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo Department of Respiratory Surgery, International University of Health, Welfare Ichikawa Hospital, Chiba, Japan AU - Iimura, Y. AU - Shimomura, H. AU - Yasu, T. AU - Imanaka, K. AU - Ogawa, R. AU - Ito, A. AU - Suzuki, K. AU - Yamaguchi, G. AU - Kawasaki, N. AU - Konaka, C. DB - Scopus DO - 10.5414/CP203323 IS - 11 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 551-554 ST - NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients T2 - International Journal of Clinical Pharmacology and Therapeutics TI - NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055613356&doi=10.5414%2fCP203323&partnerID=40&md5=fe50c231f647a4bb66b92763873201c3 VL - 56 ID - 7080 ER - TY - JOUR AD - Department of Pathology, Yale School of Medicine, New Haven, Connecticut. Anatomic Pathology, Bellaria Hospital, University of Bologna School of Medicine, Bologna, Italy. Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Department of Surgery, Yale School of Medicine, New Haven, Connecticut. AN - 26784937 AU - Prasad, M. L. AU - Vyas, M. AU - Horne, M. J. AU - Virk, R. K. AU - Morotti, R. AU - Liu, Z. AU - Tallini, G. AU - Nikiforova, M. N. AU - Christison-Lagay, E. R. AU - Udelsman, R. AU - Dinauer, C. A. AU - Nikiforov, Y. E. DA - Apr 1 DO - 10.1002/cncr.29887 10.1002/cncr.29887. Epub 2016 Jan 19. DP - Nlm ET - 2016/01/20 IS - 7 LA - eng PY - 2016 SN - 0008-543x SP - 1097-107 ST - NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States T2 - Cancer TI - NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States VL - 122 ID - 7081 ER - TY - JOUR AD - A. Drilon, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Cocco, E. AU - Scaltriti, M. AU - Drilon, A. DB - Embase Medline DO - 10.1038/s41571-018-0113-0 IS - 12 LA - English M3 - Review N1 - L624458460 2018-10-25 2019-06-07 PY - 2018 SN - 1759-4782 1759-4774 SP - 731-747 ST - NTRK fusion-positive cancers and TRK inhibitor therapy T2 - Nature Reviews Clinical Oncology TI - NTRK fusion-positive cancers and TRK inhibitor therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624458460&from=exporthttp://dx.doi.org/10.1038/s41571-018-0113-0 VL - 15 ID - 7082 ER - TY - JOUR AD - L. Bertero, Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy AU - Gambella, A. AU - Senetta, R. AU - Collemi, G. AU - Vallero, S. G. AU - Monticelli, M. AU - Cofano, F. AU - Zeppa, P. AU - Garbossa, D. AU - Pellerino, A. AU - Rudà, R. AU - Soffietti, R. AU - Fagioli, F. AU - Papotti, M. AU - Cassoni, P. AU - Bertero, L. DB - Embase Medline DO - 10.3390/ijms21030753 IS - 3 LA - English M3 - Review N1 - L2003652036 2020-02-03 2020-02-06 PY - 2020 SN - 1422-0067 1661-6596 ST - NTRK fusions in central nervous system tumors: A rare, but worthy target T2 - International Journal of Molecular Sciences TI - NTRK fusions in central nervous system tumors: A rare, but worthy target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003652036&from=exporthttp://dx.doi.org/10.3390/ijms21030753 VL - 21 ID - 7083 ER - TY - JOUR AD - Institute of Pathology and Molecular Diagnostics, University Clinic Augsburg, Germany II. Medical Clinic, University Clinic Augsburg, Germany AU - Märkl, B. AU - Hirschbühl, K. AU - Dhillon, C. C7 - 152572 DB - Scopus DO - 10.1016/j.prp.2019.152572 IS - 10 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 ST - NTRK-Fusions – A new kid on the block T2 - Pathology Research and Practice TI - NTRK-Fusions – A new kid on the block UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072351002&doi=10.1016%2fj.prp.2019.152572&partnerID=40&md5=f0d4fef0ad2ec373d577de1a4df71fd4 VL - 215 ID - 7084 ER - TY - JOUR AD - 1 Prince Henry's Institute of Medical Research , Clayton, Australia . AN - 24559275 AU - Mond, M. AU - Alexiadis, M. AU - Eriksson, N. AU - Davis, M. J. AU - Muscat, G. E. AU - Fuller, P. J. AU - Gilfillan, C. DA - Jun DO - 10.1089/thy.2013.0509 10.1089/thy.2013.0509. Epub 2014 May 19. DP - Nlm ET - 2014/02/25 IS - 6 LA - eng PY - 2014 SN - 1050-7256 SP - 1000-11 ST - Nuclear receptor expression in human differentiated thyroid tumors T2 - Thyroid TI - Nuclear receptor expression in human differentiated thyroid tumors VL - 24 ID - 7085 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and. Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA. AN - 27879258 AU - Werner, M. T. AU - Zhao, C. AU - Zhang, Q. AU - Wasik, M. A. DA - Feb 16 DO - 10.1182/blood-2016-05-717793 10.1182/blood-2016-05-717793. Epub 2016 Nov 22. DP - Nlm ET - 2016/11/24 IS - 7 LA - eng PY - 2017 SN - 0006-4971 SP - 823-831 ST - Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target T2 - Blood TI - Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target VL - 129 ID - 7086 ER - TY - JOUR AD - R.W. Wong, WPI Nano Life Science Institute (WPI-nanolsi) & Unit Leader in Cell-Bionomics Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan AU - Dewi, F. R. P. AU - Jiapaer, S. AU - Kobayashi, A. AU - Hazawa, M. AU - Ikliptikawati, D. K. AU - Hartono AU - Sabit, H. AU - Nakada, M. AU - Wong, R. W. DB - Embase Medline DO - 10.1080/15548627.2020.1741318 LA - English M3 - Article in Press N1 - L2004499374 2020-04-07 PY - 2020 SN - 1554-8635 1554-8627 ST - Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma T2 - Autophagy TI - Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004499374&from=exporthttp://dx.doi.org/10.1080/15548627.2020.1741318 ID - 7087 ER - TY - JOUR AU - Li, Z. F. AU - Xu, W. W. AU - Li, J. D. AU - Tao, F. L. AU - Chen, J. X. AU - Xu, J. H. DB - Medline DO - 10.1177/0036850419891046 LA - English M3 - Article in Press N1 - L630034592 2019-12-11 PY - 2019 SN - 2047-7163 SP - 36850419891046 ST - Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis T2 - Science progress TI - Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630034592&from=exporthttp://dx.doi.org/10.1177/0036850419891046 ID - 7088 ER - TY - JOUR AD - Department of Hematology and Oncology, The First Affiliated Hospital of the People's Liberation Army General Hospital, Beijing 100048, China AU - Zhou, M. H. AU - Yang, Q. M. DB - Scopus DO - 10.3892/ol.2014.2263 IS - 3 M3 - Review N1 - Cited By :19 Export Date: 18 November 2020 PY - 2014 SP - 959-962 ST - NUP214 fusion genes in acute leukemia (Review) T2 - Oncology Letters TI - NUP214 fusion genes in acute leukemia (Review) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904267839&doi=10.3892%2fol.2014.2263&partnerID=40&md5=454ef586e4110c9b45e691e1f3ab622a VL - 8 ID - 7089 ER - TY - JOUR AD - Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Medizinische Klinik III, Hindenburgdamm 30, 12200 Berlin, Germany AU - Burmeister, T. AU - Gökbuget, N. AU - Reinhardt, R. AU - Rieder, H. AU - Hoelzer, D. AU - Schwartz, S. DB - Scopus DO - 10.1182/blood-2006-04-014514 IS - 10 M3 - Article N1 - Cited By :36 Export Date: 18 November 2020 PY - 2006 SP - 3556-3559 ST - NUP214-ABL1 in adult T-ALL: The GMALL study group experience T2 - Blood TI - NUP214-ABL1 in adult T-ALL: The GMALL study group experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751173419&doi=10.1182%2fblood-2006-04-014514&partnerID=40&md5=e34fcaaad368beecd90d80d85dc5fce8 VL - 108 ID - 7090 ER - TY - JOUR AD - J.D. Trobe, University of Michigan, 1000 Wall Street, Ann Arbor, MI, United States AU - Tuohy, M. AU - Robertson, P. L. AU - Rivas-Rodriguez, F. AU - Trobe, J. D. DB - Embase Medline DO - 10.3928/01913913-20190801-01 IS - 1 LA - English M3 - Article N1 - L2005919656 2020-06-02 2020-06-15 PY - 2019 SN - 1938-2405 0191-3913 SP - E79-E83 ST - Nystagmus in the diagnosis of Russell diencephalic syndrome T2 - Journal of Pediatric Ophthalmology and Strabismus TI - Nystagmus in the diagnosis of Russell diencephalic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005919656&from=exporthttp://dx.doi.org/10.3928/01913913-20190801-01 VL - 56 ID - 7091 ER - TY - JOUR AD - Arkansas Children's Nutrition Center, 15 Children's Way, Little Rock, AK 72202, United States Department of Animal Science and Reproductive and Developmental Sciences Program, Michigan State University, East Lansing, MI 48824, United States Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AK 72205, United States Arkansas Fertility and Gynecology Clinic, Little Rock, AK 72205, United States AU - Ruebel, M. L. AU - Cotter, M. AU - Sims, C. R. AU - Moutos, D. M. AU - Badger, T. M. AU - Cleves, M. A. AU - Shankar, K. AU - Andres, A. DB - Scopus DO - 10.1210/jc.2016-3524 IS - 6 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2017 SP - 2029-2038 ST - Obesity modulates inflammation and lipidmetabolism oocyte gene expression: A single-cell transcriptome perspective T2 - Journal of Clinical Endocrinology and Metabolism TI - Obesity modulates inflammation and lipidmetabolism oocyte gene expression: A single-cell transcriptome perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020476087&doi=10.1210%2fjc.2016-3524&partnerID=40&md5=78dd1ccfd5f40f57d2e6a753a0bf0e09 VL - 102 ID - 7092 ER - TY - JOUR AD - Pediatric Oncology Experimental Therapeutics Investigators Consortium (POETIC) Laboratory for Pre-Clinical and Drug Discovery Studies, University of Calgary, Calgary, AB, Canada. AN - 23176524 AU - Jayanthan, A. AU - Cooper, T. M. AU - Hoeksema, K. A. AU - Lotfi, S. AU - Woldum, E. AU - Lewis, V. A. AU - Narendran, A. DA - Jul DO - 10.3109/10428194.2012.752079 10.3109/10428194.2012.752079. Epub 2012 Dec 29. DP - Nlm ET - 2012/11/28 IS - 7 LA - eng PY - 2013 SN - 1026-8022 SP - 1505-16 ST - Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells T2 - Leuk Lymphoma TI - Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells VL - 54 ID - 7093 ER - TY - JOUR AD - Department of Pediatric Oncology, Léon Bérard Cancer Center, 28, rue Laennec, 69008 Lyon, France Université Claude Bernard Lyon 1, Lyon, France Hôpital Mère-enfant, 7 quai Moncousu, Nantes, France CHU Hautepierre, 1 avenue Molière, Strasbourg, France Institut Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, France Centre Oscar Lambret, 3 rue Frédéric Combemale, Lille, France Institut Curie, 26 rue d'Ulm, Paris, France Centre Jean Perrin, 58 Rue Montalembert, Clermont-Ferrand, France CHU La Timone, 264 rue Saint-Pierre, Marseille, France Centre Antoine Lacassagne, 33 Avenue Valombrose, Nice, France CHU Jean Minjoz, 2 Bd Fleming, Besançon, France CHU Bretonneau, 2 Bd Tonnellé, Tours, France CHU Raymond Poincaré, 104 Bd Raymond Poincaré, Garches, France AN - 110830257. Language: English. Entry Date: 20180801. Revision Date: 20201026. Publication Type: journal article AU - Penel-Page, Mathilde AU - Ray-Coquard, Isabelle AU - Larcade, Julie AU - Girodet, Magali AU - Bouclier, Laure AU - Rogasik, Muriel AU - Corradini, Nadège AU - Entz-Werle, Natacha AU - Brugieres, Laurence AU - Domont, Julien AU - Lervat, Cyril AU - Piperno-Neumann, Sophie AU - Pacquement, Helène AU - Bay, Jacques-Olivier AU - Gentet, Jean-Claude AU - Thyss, Antoine AU - Chaigneau, Loic AU - Narciso, Bérangère AU - Cornille, Helène AU - Blay, Jean-Yves DB - ccm DO - 10.1186/s12885-015-1894-5 DP - EBSCOhost N1 - research; tables/charts. Journal Subset: Biomedical; Europe; UK & Ireland. NLM UID: 100967800. PMID: NLM26541413. PY - 2015 SN - 1471-2407 SP - 1-9 ST - Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes) T2 - BMC Cancer TI - Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110830257&site=ehost-live&scope=site VL - 15 ID - 7094 ER - TY - JOUR AD - Centre Léon Bérard, 28 rue Laennec 69 373, LYON CEDEX, 08, France Université Claude Bernard Lyon 1, Lyon, France Institut Gustave Roussy, Villejuif, France Centre Oscar Lambret, Lille, France Institut Claudius Regaud, Toulouse, France Centre Jean Perrin, Clermont-Ferrand, France CHU Estaing, Clermont-Ferrand, France Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, France Institut régional du Cancer, Montpellier, France CHU La Timone, Marseille, France Institut Curie, Paris, France Centre René Gauducheau, Nantes, France Centre Antoine Lacassagne, Nice, France CHU Jean Minjoz, Besançon, France Institut Paoli-Calmettes, Marseille, France AU - Eberst, L. AU - Cropet, C. AU - Le Cesne, A. AU - Pautier, P. AU - Penel, N. AU - Adenis, A. AU - Chevreau, C. AU - Bay, J. O. AU - Collard, O. AU - Cupissol, D. AU - Duffaud, F. AU - Gentet, J. C. AU - Piperno-Neumann, S. AU - Marec-Berard, P. AU - Bompas, E. AU - Thyss, A. AU - Chaigneau, L. AU - Cassier, P. AU - Bertucci, F. AU - Blay, J. Y. AU - Ray-Coquard, I. C7 - 870 DB - Scopus DO - 10.1186/1471-2407-14-870 IS - 1 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 ST - The off-label use of targeted therapies in sarcomas: The OUTC'S program T2 - BMC Cancer TI - The off-label use of targeted therapies in sarcomas: The OUTC'S program UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924345871&doi=10.1186%2f1471-2407-14-870&partnerID=40&md5=31c8ae026784a9ddee461d2fa8d13b17 VL - 14 ID - 7095 ER - TY - JOUR AD - P. Bandopadhayay, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Department of Pediatric Neuro-Oncology, 450 Brookline Ave, Boston, MA, United States AU - Clymer, J. AU - Bandopadhayay, P. DB - Embase Medline DO - 10.1093/neuonc/noy188 IS - 2 LA - English M3 - Editorial N1 - L626566412 2019-03-06 2019-03-07 PY - 2019 SN - 1523-5866 1522-8517 SP - 143-145 ST - Old meet new-the path to combination treatments in pediatric low-grade gliomas T2 - Neuro-Oncology TI - Old meet new-the path to combination treatments in pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626566412&from=exporthttp://dx.doi.org/10.1093/neuonc/noy188 VL - 21 ID - 7096 ER - TY - JOUR AD - Laboratory of Bone and Metabolic Biochemistry, Faculty of Medicine, Université Libre de Bruxelles, Unité Mixte de Recherche en Santé Unité 1166, 808 Route de Lennik, Brussels, B-1070, Belgium Institute of Life Sciences, Université Catholique de Louvain, Louvain-la-Neuve, 1348, Belgium Department of Rheumatology and Physical Medicine, Erasme Hospital, Brussels, B-1070, Belgium AU - Gillet, C. AU - Spruyt, D. AU - Rigutto, S. AU - Dalla Valle, A. AU - Berlier, J. AU - Louis, C. AU - Debier, C. AU - Gaspard, N. AU - Malaisse, W. J. AU - Gangji, V. AU - Rasschaert, J. DB - Scopus DO - 10.1210/en.2015-1303 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2015 SP - 4081-4093 ST - Oleate abrogates palmitate-induced lipotoxicity and proinflammatory response in human bone marrow-derived mesenchymal stem cells and osteoblastic cells T2 - Endocrinology TI - Oleate abrogates palmitate-induced lipotoxicity and proinflammatory response in human bone marrow-derived mesenchymal stem cells and osteoblastic cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946029992&doi=10.1210%2fen.2015-1303&partnerID=40&md5=179a452d9da6482b385338bd0d5280ec VL - 156 ID - 7097 ER - TY - JOUR AD - Department of Biochemistry and Molecular Biology, The Aging and Apoptosis Research Center, Seoul National University College of Medicine, Seoul 110-799, South Korea Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science, Incheon 406-840, South Korea AU - Ryu, S. J. AU - An, H. J. AU - Oh, Y. S. AU - Choi, H. R. AU - Ha, M. K. AU - Park, S. C. DB - Scopus DO - 10.1038/cdd.2008.96 IS - 11 M3 - Article N1 - Cited By :43 Export Date: 18 November 2020 PY - 2008 SP - 1673-1680 ST - On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis T2 - Cell Death and Differentiation TI - On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54049117149&doi=10.1038%2fcdd.2008.96&partnerID=40&md5=2110b24e4749d0381e274882bcc6dfc8 VL - 15 ID - 7098 ER - TY - JOUR AD - J.R. Walter, Prentice Women's Hospital, 250 E Superior, Suite 03-2303, Chicago, IL, United States AU - Walter, J. R. AU - Xu, S. AU - Paller, A. S. AU - Choi, J. N. AU - Woodruff, T. K. DB - Embase Medline DO - 10.1016/j.jaad.2016.04.031 IS - 3 LA - English M3 - Article N1 - L617755213 2017-08-17 2017-08-21 PY - 2016 SN - 1097-6787 0190-9622 SP - 528-534 ST - Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies T2 - Journal of the American Academy of Dermatology TI - Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617755213&from=exporthttp://dx.doi.org/10.1016/j.jaad.2016.04.031 VL - 75 ID - 7099 ER - TY - JOUR AD - D.M. Lopategui, University of Miami Miller School of Medicine, Miami, FL, United States AU - Lopategui, D. M. AU - Yechieli, R. AU - Ramasamy, R. DB - Embase DO - 10.21037/tau.2017.07.03 IS - 5 LA - English M3 - Review N1 - L618986267 2017-11-01 2017-11-06 PY - 2017 SN - 2223-4691 2223-4683 SP - 951-958 ST - Oncofertility in sarcoma patients T2 - Translational Andrology and Urology TI - Oncofertility in sarcoma patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618986267&from=exporthttp://dx.doi.org/10.21037/tau.2017.07.03 VL - 6 ID - 7100 ER - TY - JOUR AD - Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. AN - 22142829 AU - Shukla, N. AU - Ameur, N. AU - Yilmaz, I. AU - Nafa, K. AU - Lau, C. Y. AU - Marchetti, A. AU - Borsu, L. AU - Barr, F. G. AU - Ladanyi, M. C2 - PMC3271129 C6 - NIHMS342183 DA - Feb 1 DO - 10.1158/1078-0432.Ccr-11-2056 10.1158/1078-0432.CCR-11-2056. Epub 2011 Dec 5. DP - Nlm ET - 2011/12/07 IS - 3 LA - eng PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 748-57 ST - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways T2 - Clin Cancer Res TI - Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways VL - 18 ID - 7101 ER - TY - JOUR AD - L.C. Krab, Department of Neuroscience, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands AU - Krab, L. C. AU - Goorden, S. M. I. AU - Elgersma, Y. DB - Embase Medline DO - 10.1016/j.tig.2008.07.005 IS - 10 LA - English M3 - Review N1 - L50260643 2008-11-05 PY - 2008 SN - 0168-9525 SP - 498-510 ST - Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases T2 - Trends in Genetics TI - Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50260643&from=exporthttp://dx.doi.org/10.1016/j.tig.2008.07.005 VL - 24 ID - 7102 ER - TY - JOUR AD - Department of Pathology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea. AN - 21940108 AU - Kwon, M. J. AU - Choi, Y. L. AU - Sung, K. W. AU - Kang, S. Y. AU - Park, S. M. AU - Choi, S. Y. AU - Kim, J. S. AU - Suh, Y. L. DA - Oct 15 DO - 10.1016/j.prp.2011.07.011 10.1016/j.prp.2011.07.011. Epub 2011 Sep 21. DP - Nlm ET - 2011/09/24 IS - 10 LA - eng PY - 2011 SN - 0344-0338 SP - 634-9 ST - Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors T2 - Pathol Res Pract TI - Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors VL - 207 ID - 7103 ER - TY - JOUR AD - C. Sarkar, Department of Pathology, All India Institute of Medical Sciences, New Delhi, India AU - Kumar, A. AU - Pathak, P. AU - Purkait, S. AU - Faruq, M. AU - Jha, P. AU - Mallick, S. AU - Suri, V. AU - Sharma, M. C. AU - Suri, A. AU - Sarkar, C. DB - Embase Medline DO - 10.1016/j.cancergen.2015.01.009 IS - 3 LA - English M3 - Article N1 - L603090008 2015-03-24 2015-04-28 PY - 2015 SN - 2210-7770 2210-7762 SP - 91-95 ST - Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas T2 - Cancer Genetics TI - Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603090008&from=exporthttp://dx.doi.org/10.1016/j.cancergen.2015.01.009 VL - 208 ID - 7104 ER - TY - JOUR AD - R. Zeiser, Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany AU - Hamarsheh, S. AU - Osswald, L. AU - Saller, B. S. AU - Unger, S. AU - De Feo, D. AU - Vinnakota, J. M. AU - Konantz, M. AU - Uhl, F. M. AU - Becker, H. AU - Lübbert, M. AU - Shoumariyeh, K. AU - Schürch, C. AU - Andrieux, G. AU - Venhoff, N. AU - Schmitt-Graeff, A. AU - Duquesne, S. AU - Pfeifer, D. AU - Cooper, M. A. AU - Lengerke, C. AU - Boerries, M. AU - Duyster, J. AU - Niemeyer, C. M. AU - Erlacher, M. AU - Blazar, B. R. AU - Becher, B. AU - Groß, O. AU - Brummer, T. AU - Zeiser, R. DB - Embase Medline DO - 10.1038/s41467-020-15497-1 IS - 1 LA - English M3 - Article N1 - L2004628006 2020-05-22 2020-05-26 PY - 2020 SN - 2041-1723 ST - Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation T2 - Nature Communications TI - Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004628006&from=exporthttp://dx.doi.org/10.1038/s41467-020-15497-1 VL - 11 ID - 7105 ER - TY - JOUR AD - M. Santoro, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, via S Pansini 5, 80131 Naples, Italy AU - Santoro, M. AU - Carlomagno, F. DB - Embase Medline DO - 10.1172/JCI72725 IS - 11 LA - English M3 - Article N1 - L370245421 2013-11-20 PY - 2013 SN - 0021-9738 1558-8238 SP - 4566-4568 ST - Oncogenic rearrangements driving ionizing radiation-associated human cancer T2 - Journal of Clinical Investigation TI - Oncogenic rearrangements driving ionizing radiation-associated human cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370245421&from=exporthttp://dx.doi.org/10.1172/JCI72725http://www.jci.org/articles/view/72725/pdf VL - 123 ID - 7106 ER - TY - JOUR AD - A. Tomiyama, Div. Brain. Tumor. Transl. Res., Natl. Can. Ctr. Res. Inst., Japan AU - Tomiyama, A. AU - Nakano, Y. AU - Yamasaki, K. AU - Fukushima, H. AU - Inoue, T. AU - Kohno, T. AU - Yoshida, A. AU - Fukuoka, K. AU - Matsusaka, Y. AU - Hara, J. AU - Sakamoto, H. AU - Mori, K. AU - Ichimura, K. DB - Embase LA - English M3 - Conference Abstract N1 - L621976582 2018-05-08 PY - 2018 SN - 1349-7006 ST - The oncogenic role of a novel KLC1-ROS1 fusion gene identified in a pediatric low-grade glioma T2 - Cancer Science TI - The oncogenic role of a novel KLC1-ROS1 fusion gene identified in a pediatric low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621976582&from=export VL - 109 ID - 7107 ER - TY - JOUR AD - H.-S. Lee, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec. 2, Cheng-Gong Road, Taipei 114, Taiwan AU - Cheng, M. F. AU - Lee, C. H. AU - Huang, G. S. AU - Wu, H. W. AU - Chiang, P. C. AU - Sheu, L. F. AU - Lee, H. S. C2 - Sigma(United States) DB - Embase IS - 1 LA - English M3 - Article N1 - L354272949 2009-03-18 PY - 2009 SN - 1011-4564 SP - 13-18 ST - Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells T2 - Journal of Medical Sciences TI - Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354272949&from=export VL - 29 ID - 7108 ER - TY - JOUR AD - Hematology, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy Hematology, Sant’Eugenio Hospital, Roma, Italy Gynecology and Obstetrics, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy AU - Sgherza, N. AU - Abruzzese, E. AU - Perla, G. AU - Minervini, M. M. AU - Chiello, V. AU - Sciannamè, N. AU - Cascavilla, N. DB - Scopus DO - 10.2147/TCRM.S137103 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 751-755 ST - Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: Case report and revision of literature T2 - Therapeutics and Clinical Risk Management TI - Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: Case report and revision of literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021664467&doi=10.2147%2fTCRM.S137103&partnerID=40&md5=aa9a2b3c156ae01136460d85d984922c VL - 13 ID - 7109 ER - TY - JOUR AD - Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM) and 3rd Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany Department of Neurosurgery, Klinikum Idar-Oberstein, Idar-Oberstein, Germany Department of Neurosurgery, Charité University Hospital, Humboldt University Berlin, Berlin, Germany Department of Neuroradiology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany Department of Neurosurgery, Ruhr-University Bochum, Bochum, Germany Department of Internal Medicine II, University Hospital Jena, Jena, Germany University Medical Center Freiburg, Freiburg, Germany AN - 141102990. Language: English. Entry Date: 20200111. Revision Date: 20201104. Publication Type: Article AU - Sautter, Lisa AU - Hofheinz, Ralf AU - Tuettenberg, Jochen AU - Grimm, Mario AU - Vajkoczy, Peter AU - Groden, Christoph AU - Schmieder, Kirsten AU - Hochhaus, Andreas AU - Wenz, Frederik AU - Giordano, Frank A DB - ccm DO - 10.1159/000502483 DP - EBSCOhost IS - 1 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe. Instrumentation: Eastern Cooperative Oncology Group (ECOG) Performance Status Scale. NLM UID: 0135054. PY - 2020 SN - 0030-2414 SP - 16-22 ST - Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma T2 - Oncology TI - Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141102990&site=ehost-live&scope=site VL - 98 ID - 7110 ER - TY - JOUR AD - V. Moreno AU - Moreno, V. AU - Min Kim, T. AU - Young Rha, S. AU - Longo, F. AU - Sathornsumetee, S. AU - Zhang, S. AU - Hirschberg, Y. AU - Pramanik, B. AU - Wamil, B. D. AU - Kiss, I. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3520 IS - 15 LA - English M3 - Conference Abstract N1 - L632807446 2020-09-15 PY - 2020 SN - 1527-7755 ST - An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies (ASCEND-10) T2 - Journal of Clinical Oncology TI - An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies (ASCEND-10) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632807446&from=exporthttp://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3520 VL - 38 ID - 7111 ER - TY - JOUR AD - H.-J. Jang, College of Korean Medicine and College of Pharmacy, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, South Korea AU - An, E. J. AU - Kim, Y. AU - Lee, S. H. AU - Choi, S. H. AU - Chung, W. S. AU - Jang, H. J. C2 - ChemFaces(China) DB - Embase Medline DO - 10.1016/j.bbrc.2019.10.190 IS - 1 LA - English M3 - Article N1 - L2003779876 2019-11-28 PY - 2020 SN - 1090-2104 0006-291X SP - 40-46 ST - Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell T2 - Biochemical and Biophysical Research Communications TI - Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003779876&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2019.10.190 VL - 522 ID - 7112 ER - TY - JOUR AD - S. Nair, Department of Pediatric Hematology Oncology, University of Florida, 1600 SW Archer Road, Gainesville, FL, United States AU - Nair, S. AU - Fort, J. A. AU - Yachnis, A. T. AU - Williams, C. A. DB - Embase Medline DO - 10.1002/pbc.25382 IS - 6 LA - English M3 - Article N1 - L601630714 2015-01-30 2015-05-06 PY - 2015 SN - 1545-5017 1545-5009 SP - 1084-1086 ST - Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome T2 - Pediatric Blood and Cancer TI - Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601630714&from=exporthttp://dx.doi.org/10.1002/pbc.25382 VL - 62 ID - 7113 ER - TY - JOUR AD - M. Cassina, Clinical Genetics Unit, Department of Women’s and Children’s Health, University of Padova, Padova, Italy AU - Cassina, M. AU - Frizziero, L. AU - Opocher, E. AU - Parrozzani, R. AU - Sorrentino, U. AU - Viscardi, E. AU - Miglionico, G. AU - Midena, E. AU - Clementi, M. AU - Trevisson, E. C1 - azd 6244 DB - Embase DO - 10.3390/cancers11111790 IS - 11 LA - English M3 - Review N1 - L2003245104 2019-11-22 2019-11-28 PY - 2019 SN - 2072-6694 ST - Optic pathway glioma in type 1 neurofibromatosis: Review of its pathogenesis, diagnostic assessment, and treatment recommendations T2 - Cancers TI - Optic pathway glioma in type 1 neurofibromatosis: Review of its pathogenesis, diagnostic assessment, and treatment recommendations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003245104&from=exporthttp://dx.doi.org/10.3390/cancers11111790 VL - 11 ID - 7114 ER - TY - JOUR AD - Pediatric Oncology Research Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark AU - Rank, C. U. AU - Schmiegelow, K. DB - Scopus DO - 10.1053/j.seminhematol.2020.08.001 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020 T2 - Seminars in Hematology TI - Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091018632&doi=10.1053%2fj.seminhematol.2020.08.001&partnerID=40&md5=10b203fc58065f3a86c210ab129c663a ID - 7115 ER - TY - JOUR AD - Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui Japan AN - 113528458. Language: English. Entry Date: 20170731. Revision Date: 20170731. Publication Type: Article AU - Tanizawa, Akihiko DB - ccm DO - 10.1111/ped.12876 DP - EBSCOhost IS - 3 N1 - review; tables/charts. Journal Subset: Asia; Biomedical; Peer Reviewed. NLM UID: 100886002. PY - 2016 SN - 1328-8067 SP - 171-179 ST - Optimal management for pediatric chronic myeloid leukemia T2 - Pediatrics International TI - Optimal management for pediatric chronic myeloid leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=113528458&site=ehost-live&scope=site VL - 58 ID - 7116 ER - TY - JOUR AD - Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, United States Department of Haematology, Hammersmith Hospital, Imperial College, London, United Kingdom Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, United States AU - Mughal, T. AU - Goldman, J. M. DB - Scopus DO - 10.3816/CLM.2007.s.008 IS - SUPPL. 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2007 SP - S95-S101 ST - Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007 T2 - Clinical Lymphoma and Myeloma TI - Optimal management of patients with newly diagnosed chronic phase chronic myeloid leukemia in 2007 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249694651&doi=10.3816%2fCLM.2007.s.008&partnerID=40&md5=01230e96c7d441476770aac0d638b00b VL - 7 ID - 7117 ER - TY - JOUR AD - D.H. Gutmann, Washington University School of Medicine, Department of Neurology, Washington University Neurofibromatosis Center, 660 South Euclid Avenue, St. Louis, MO 63110, United States AU - Gutmann, D. H. AU - Blakeley, J. O. AU - Korf, B. R. AU - Packer, R. J. C1 - azd 6244 plx 3397 ptc 299 rad 001 sarc 016 DB - Embase Medline DO - 10.1517/13543784.2013.772979 IS - 4 LA - English M3 - Review N1 - L368551011 2013-03-27 2013-04-04 PY - 2013 SN - 1354-3784 1744-7658 SP - 443-462 ST - Optimizing biologically targeted clinical trials for neurofibromatosis T2 - Expert Opinion on Investigational Drugs TI - Optimizing biologically targeted clinical trials for neurofibromatosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368551011&from=exporthttp://dx.doi.org/10.1517/13543784.2013.772979 VL - 22 ID - 7118 ER - TY - JOUR AD - Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands Department of Pharmacy, Leiden University Medical Center, Leiden, Netherlands The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom AU - Lankheet, N. A. G. AU - Desar, I. M. E. AU - Mulder, S. F. AU - Burger, D. M. AU - Kweekel, D. M. AU - van Herpen, C. M. L. AU - van der Graaf, W. T. A. AU - van Erp, N. P. DB - Scopus DO - 10.1111/bcp.13327 IS - 10 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2017 SP - 2195-2204 ST - Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib T2 - British Journal of Clinical Pharmacology TI - Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021786134&doi=10.1111%2fbcp.13327&partnerID=40&md5=fc7bd4ed134812600602b377dab04287 VL - 83 ID - 7119 ER - TY - JOUR AD - Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Memorial Sloan-Kettering Cancer Center, Howard Bldg., Box 437, 1275 York Ave, New York, NY 10021, United States AU - Miller, V. A. DB - Scopus DO - 10.1016/j.jpeds.2006.04.047 IS - SUPPL. 1 M3 - Article N1 - Cited By :64 Export Date: 18 November 2020 PY - 2006 SP - S25-S31 ST - Optimizing therapy in previously treated non-small cell lung cancer T2 - Seminars in Oncology TI - Optimizing therapy in previously treated non-small cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745633826&doi=10.1016%2fj.jpeds.2006.04.047&partnerID=40&md5=2cca856e81b1f0edf5f8b162711f39a0 VL - 33 ID - 7120 ER - TY - JOUR AD - Division of Oral Medicine, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Department of Biostatistics and Computational Biology, 450 Brookline Avenue, Dana-Farber Cancer Institute, Boston, MA 02215, USA Department of Medical Oncology, Rhode Island Hospital Comprehensive Cancer Center, 1454 South County Trail, Suite 2100, East Greenwich, RI 02818, USA Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA Department of Medicine, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA AN - 110512235. Language: English. Entry Date: 20161120. Revision Date: 20180718. Publication Type: journal article AU - Yuan, Anna AU - Kurtz, Sharyn L. AU - Barysauskas, Constance M. AU - Pilotte, Amy P. AU - Wagner, Andrew J. AU - Treister, Nathaniel S. DB - ccm DO - 10.1016/j.oraloncology.2015.09.003 DP - EBSCOhost IS - 11 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9709118. PMID: NLM26403941. PY - 2015 SN - 1368-8375 SP - 1026-1033 ST - Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors T2 - Oral Oncology TI - Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110512235&site=ehost-live&scope=site VL - 51 ID - 7121 ER - TY - JOUR AD - B. Scholtz, Genomic Medicine and Bioinformatic Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary AU - Horváth, J. AU - Szabó, A. AU - Tar, I. AU - Dezső, B. AU - Kiss, C. AU - Márton, I. AU - Scholtz, B. DB - Embase Medline DO - 10.1007/s12253-017-0296-1 IS - 4 LA - English M3 - Article N1 - L618172318 2017-09-12 2018-11-21 PY - 2018 SN - 1532-2807 1219-4956 SP - 833-842 ST - Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer T2 - Pathology and Oncology Research TI - Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618172318&from=exporthttp://dx.doi.org/10.1007/s12253-017-0296-1 VL - 24 ID - 7122 ER - TY - JOUR AN - CN-01501791 AU - Nct PY - 2010 ST - Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: a Randomized and Prospective Study T2 - https://clinicaltrials.gov/show/NCT01238471 TI - Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: a Randomized and Prospective Study UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01501791/full ID - 7123 ER - TY - JOUR AD - J. Hong, UMDNJ New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, United States AU - Hong, J. AU - Bielory, L. C1 - grazax(Alk Abello,Denmark) oralair(Stallergenes,France) C2 - Alk Abello(Denmark) Stallergenes(France) DB - Embase Medline DO - 10.1586/eci.11.36 IS - 4 LA - English M3 - Article N1 - L362235584 2011-08-05 2011-08-09 PY - 2011 SN - 1744-666X 1744-8409 SP - 437-444 ST - Oralair®: Sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis T2 - Expert Review of Clinical Immunology TI - Oralair®: Sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362235584&from=exporthttp://dx.doi.org/10.1586/eci.11.36 VL - 7 ID - 7124 ER - TY - JOUR AD - Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA. erik_sampson@urmc.rochester.edu AN - 21308771 AU - Sampson, E. R. AU - Martin, B. A. AU - Morris, A. E. AU - Xie, C. AU - Schwarz, E. M. AU - O'Keefe, R. J. AU - Rosier, R. N. DA - Jun DO - 10.1002/jbmr.336 10.1002/jbmr.336. DP - Nlm ET - 2011/02/11 IS - 6 LA - eng PY - 2011 SN - 0884-0431 SP - 1283-94 ST - The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model T2 - J Bone Miner Res TI - The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model VL - 26 ID - 7125 ER - TY - JOUR AD - Department of Developmental Neurobiology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, United States Department of Chemical Biology and Therapeutics, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, United States Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, United States Department of Computational Biology and Bioinformatics, St Jude Children's Research Hospital, Memphis, TN, United States Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States Department of Biological Sciences, University of Memphis, Memphis, TN, United States AU - Eden, C. J. AU - Ju, B. AU - Murugesan, M. AU - Phoenix, T. N. AU - Nimmervoll, B. AU - Tong, Y. AU - Ellison, D. W. AU - Finkelstein, D. AU - Wright, K. AU - Boulos, N. AU - Dapper, J. AU - Thiruvenkatam, R. AU - Lessman, C. A. AU - Taylor, M. R. AU - Gilbertson, R. J. DB - Scopus DO - 10.1038/onc.2014.107 IS - 13 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2015 SP - 1736-1742 ST - Orthotopic models of pediatric brain tumors in zebrafish T2 - Oncogene TI - Orthotopic models of pediatric brain tumors in zebrafish UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898520210&doi=10.1038%2fonc.2014.107&partnerID=40&md5=48b94c64e792b20145ddbcf80ed25464 VL - 34 ID - 7126 ER - TY - JOUR AD - C.-H. Tang, Department of Pharmacology, College of Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, Taiwan AU - Fong, Y. C. AU - Maa, M. C. AU - Tsai, F. J. AU - Chen, W. C. AU - Lin, J. G. AU - Jeng, L. B. AU - Yang, R. S. AU - Fu, W. M. AU - Tang, C. H. DB - Embase Medline DO - 10.1359/jbmr.080206 IS - 6 LA - English M3 - Article N1 - L351768814 2008-06-19 PY - 2008 SN - 0884-0431 SP - 961-970 ST - Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells T2 - Journal of Bone and Mineral Research TI - Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351768814&from=exporthttp://dx.doi.org/10.1359/jbmr.080206 VL - 23 ID - 7127 ER - TY - GEN AD - P.B. Gahan, Department of Anatomy and Human Sciences, King’s College London, London Bridge, London, United Kingdom AU - Hui, L. AU - Maron, J. L. AU - Gahan, P. B. DB - Embase DO - 10.1007/978-94-017-9168-7_11 J2 - Adv. Predictive Prev. Personalised Med. LA - English M1 - (Hui L.) Department of Perinatal Medicine, Mercy Hospital for Women, Heidelberg, VIC, Australia M3 - Article N1 - L601380382 2015-02-02 2015-07-27 PY - 2015 SN - 2211-3509 2211-3495 SP - 295-323 ST - Other body fluids as non-invasive sources of cell-free DNA/RNA TI - Other body fluids as non-invasive sources of cell-free DNA/RNA UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601380382&from=exporthttp://dx.doi.org/10.1007/978-94-017-9168-7_11 VL - 5 ID - 7128 ER - TY - JOUR AD - UMR 911, INSERM, Marseille, France; Medecine School, Aix-Marseille University, Marseille, France. AN - 23278243 AU - Colin, C. AU - Padovani, L. AU - Chappé, C. AU - Mercurio, S. AU - Scavarda, D. AU - Loundou, A. AU - Frassineti, F. AU - André, N. AU - Bouvier, C. AU - Korshunov, A. AU - Lena, G. AU - Figarella-Branger, D. DA - Oct DO - 10.1111/nan.12013 10.1111/nan.12013. DP - Nlm ET - 2013/01/03 IS - 6 LA - eng PY - 2013 SN - 0305-1846 SP - 693-705 ST - Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution T2 - Neuropathol Appl Neurobiol TI - Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution VL - 39 ID - 7129 ER - TY - JOUR AN - 104489052. Language: English. Entry Date: 20130726. Revision Date: 20200708. Publication Type: journal article AU - Rutkowski, Piotr AU - Bylina, Elbieta AU - Klimczak, Anna AU - Switaj, Tomasz AU - Falkowski, Slawomir AU - Kroc, Jacek AU - Lugowska, Iwona AU - Brzeskwiniewicz, Magdalena AU - Melerowicz, Wojciech AU - Osuch, Czeslaw AU - Mierzejewska, Ewa AU - Wasielewski, Kacper AU - Wozniak, Agnieszka AU - Grzesiakowska, Urszula AU - Nowecki, Zbigniew I. AU - Siedlecki, Janusz A. AU - Limon, Janusz AU - Bylina, Elżbieta AU - Falkowski, Sławomir AU - Osuch, Czesław DB - ccm DO - 10.1186/1471-2407-12-107 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Oncologic Care. NLM UID: 100967800. PMID: NLM22439647. PY - 2012 SN - 1471-2407 SP - 107-107 ST - The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study T2 - BMC Cancer TI - The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104489052&site=ehost-live&scope=site VL - 12 ID - 7130 ER - TY - JOUR AD - Kaposi Mór Teaching Hospital, Kaposvár, Hungary Tawam Hospital, AlAin-United Arab Emirates Pécs University, Faculty of General Medicine, Department of Pathology, Pécs-Hungary AN - 111644894. Language: English. Entry Date: 20160928. Revision Date: 20180925. Publication Type: journal article AU - Alizadeh, Hussain AU - Jaafar, Hassan AU - Kajtár, Béla DB - ccm DO - 10.5144/0256-4947.2015.468 DP - EBSCOhost IS - 6 N1 - case study. Journal Subset: Biomedical; Middle East; Peer Reviewed. NLM UID: 8507355. PMID: NLM26657232. PY - 2015 SN - 0256-4947 SP - 468-471 ST - Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports T2 - Annals of Saudi Medicine TI - Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111644894&site=ehost-live&scope=site VL - 35 ID - 7131 ER - TY - JOUR AD - C. Lai AU - Lai, C. AU - Pittaluga, S. AU - Shovlin, M. AU - Steinberg, S. M. AU - Roschewski, M. J. AU - Jaffe, E. S. AU - Wilson, W. H. AU - Dunleavy, K. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72014953 2015-09-28 PY - 2015 SN - 0732-183X ST - The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH T2 - Journal of Clinical Oncology TI - The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72014953&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/8564?sid=15159491-756d-4d64-8132-ddcf7b94d26f VL - 33 ID - 7132 ER - TY - JOUR AD - Department for Stem Cell Transplantation, University Cancer Center Hamburg (UCCH), Martinistr. 52, 20246 Hamburg, Germany Department of Hematology and Immunology, Obafemi Awolowo University (OAU), Ile-Ife, Nigeria Department of Oncology and Hematology, University Cancer Center Hamburg (UCCH), Hamburg, Germany Department for Oncology and Haematology, University Hospital, Medical Faculty Halle, Halle, Germany Department of Pediatric Hematology and Oncology, University of Hamburg, Hamburg, Germany MLL Munich Leukemia Laboratory, Munich, Germany AU - Oyekunle, A. AU - Zander, A. R. AU - Binder, M. AU - Ayuk, F. AU - Zabelina, T. AU - Christopeit, M. AU - Stübig, T. AU - Alchalby, H. AU - Schafhausen, P. AU - Lellek, H. AU - Wolschke, C. AU - Müller, I. AU - Bacher, U. AU - Kröger, N. DB - Scopus DO - 10.1007/s00277-012-1650-8 IS - 4 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2013 SP - 487-496 ST - Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy T2 - Annals of Hematology TI - Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877028031&doi=10.1007%2fs00277-012-1650-8&partnerID=40&md5=9a94687de5c051cb88b7e541a856e63e VL - 92 ID - 7133 ER - TY - JOUR AD - Department of Internal Medicine/Oncology, College of Medicine, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Al-Khobar, Eastern Province, Saudi Arabia AU - Al-Amri, A. M. DB - Scopus DO - 10.1016/j.clml.2018.01.002 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 199-203 ST - Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041577947&doi=10.1016%2fj.clml.2018.01.002&partnerID=40&md5=339cc8d33af93d05f71936ef50f0f668 VL - 18 ID - 7134 ER - TY - JOUR AD - S. Bakhshi, Department of Medical Oncology, Dr B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India AU - Patel, A. AU - Sharma, M. C. AU - Bakhshi, S. DB - Embase Medline DO - 10.1007/s12098-017-2585-9 IS - 9 LA - English M3 - Article N1 - L620625746 2018-02-15 2018-11-16 PY - 2018 SN - 0973-7693 0019-5456 SP - 782-784 ST - Outcome of Early Stage Pediatric Non-Lymphoblastic Non-Hodgkin Lymphoma T2 - Indian Journal of Pediatrics TI - Outcome of Early Stage Pediatric Non-Lymphoblastic Non-Hodgkin Lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620625746&from=exporthttp://dx.doi.org/10.1007/s12098-017-2585-9 VL - 85 ID - 7135 ER - TY - JOUR AD - M. Alzahrani AU - Alzahrani, M. AU - Savage, K. J. AU - Toze, C. L. AU - Sehn, L. H. AU - Broady, R. AU - Mourad, Y. A. AU - Barnett, M. J. AU - Forrest, D. L. AU - Gerrie, A. S. AU - Hogge, D. E. AU - Nantel, S. H. AU - Narayanan, S. AU - Nevill, T. J. AU - Power, M. M. AU - Sanford, D. AU - Scott, D. W. AU - Sutherland, H. J. AU - Villa, D. AU - O'Leary, H. AU - Connors, J. M. AU - Song, K. W. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614265721 2017-02-06 PY - 2016 SN - 1528-0020 ST - Outcome of patients with peripheral T-cell lymphoma undergoing allogeneic stem cell in British Columbia T2 - Blood TI - Outcome of patients with peripheral T-cell lymphoma undergoing allogeneic stem cell in British Columbia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614265721&from=export VL - 128 ID - 7136 ER - TY - JOUR AD - Royal Marsden NHS Foundation Trust, Sarcoma Unit, Royal Marsden Hospital, Fulham Rd, London, SW3 6JJ, United Kingdom Centre Leon Berard, University Claude Bernard, Lyon, France Erasmus Medical Centre, Rotterdam, Netherlands EORTC Headquarters, Brussels, Belgium Institut Gustave Roussy, Villejuif, France Military Hospital-State Health Centre, Budapest, Hungary University Hospitals Leuven-KU Leuven, Leuven, Belgium Sarcoma Oncology Centre, Santa Monica, United States Institut Jules Bordet, Brussels, Belgium Institut Curie, Paris, France Novartis Pharma AG, Basel, Switzerland Institute of Cancer Research, London, United Kingdom AU - Benson, C. AU - Ray-Coquard, I. AU - Sleijfer, S. AU - Litière, S. AU - Blay, J. Y. AU - Le Cesne, A. AU - Papai, Z. AU - Judson, I. AU - Schöffski, P. AU - Chawla, S. AU - Gil, T. AU - Piperno-Neumann, S. AU - Marréaud, S. AU - Dewji, M. R. AU - Van Der Graaf, W. T. A. DB - Scopus DO - 10.1016/j.ygyno.2016.03.024 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2016 SP - 89-94 ST - Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European -rganisation for Research and Truatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072 T2 - Gynecologic Oncology TI - Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European -rganisation for Research and Truatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964647495&doi=10.1016%2fj.ygyno.2016.03.024&partnerID=40&md5=c08bf84d65966cd46cafbc494545d526 VL - 142 ID - 7137 ER - TY - JOUR AD - Department of Pediatrics-Hematology, Oncology and Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States Division of Hematology Oncology and Blood and Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, United States Bone Marrow and Stem Cell Transplantation, Icahn School of Medicine at Mount Sinai, New York, NY, United States Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden Froedtert Memorial Lutheran Hospital, Milwaukee, WI, United States Cumming School of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Centre Hamburg, Hamburg, Germany Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA, United States Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX, United States Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, United States Department of Hematology/Oncology, All Children's Hospital, St. Petersburg, FL, United States Cancer Research Foundation of New York, Bronx, NY, United States Department of Blood and Marrow Transplantation, Mayo Clinic, Rochester, MN, United States Pediatric Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom Division of Hematology Oncology and Transplantation, University of Minneapolis, Minneapolis, MN, United States Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, United States Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden AU - Chaudhury, S. AU - Sparapani, R. AU - Hu, Z. H. AU - Nishihori, T. AU - Abdel-Azim, H. AU - Malone, A. AU - Olsson, R. AU - Hamadani, M. AU - Daly, A. AU - Bacher, U. AU - Wirk, B. M. AU - Kamble, R. T. AU - Gale, R. P. AU - Wood, W. A. AU - Hale, G. AU - Wiernik, P. H. AU - Hashmi, S. K. AU - Marks, D. AU - Ustun, C. AU - Munker, R. AU - Savani, B. N. AU - Alyea, E. AU - Popat, U. AU - Sobecks, R. AU - Kalaycio, M. AU - Maziarz, R. AU - Hijiya, N. AU - Saber, W. DB - Scopus DO - 10.1016/j.bbmt.2016.02.015 IS - 6 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2016 SP - 1056-1064 ST - Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis T2 - Biology of Blood and Marrow Transplantation TI - Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963595294&doi=10.1016%2fj.bbmt.2016.02.015&partnerID=40&md5=d6c33585e9b4211365a2fbccdebb6f3e VL - 22 ID - 7138 ER - TY - JOUR AD - Pediatric Hematology/Oncology, National Cancer Institute, Cairo University, Cairo, Egypt Pediatric Hematology/Oncology, Children Cancer Hospital Egypt, Cairo, Egypt Clinical Pathology, Children Cancer Hospital Egypt, Cairo, Egypt Research Department, Children Cancer Hospital Egypt, Cairo, Egypt AU - Hafez, H. A. AU - Abdallah, A. AU - Hammad, M. AU - Hamdy, N. AU - Yassin, D. AU - Salem, S. AU - Hassanain, O. AU - Elhalaby, L. AU - Elhaddad, A. C7 - e13664 DB - Scopus DO - 10.1111/petr.13664 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience T2 - Pediatric Transplantation TI - Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079431955&doi=10.1111%2fpetr.13664&partnerID=40&md5=3af3db2f68f31657e601ac033bf2d316 VL - 24 ID - 7139 ER - TY - JOUR AU - Nobre, L. AU - Zapotocky, M. AU - Ramaswamy, V. AU - Ryall, S. AU - Bennett, J. AU - Alderete, D. AU - Guill, J. B. AU - Baroni, L. AU - Bartels, U. AU - Bavle, A. AU - Bornhorst, M. AU - Boue, D. R. AU - Canete, A. AU - Chintagumpala, M. AU - Coven, S. L. AU - Cruz, O. AU - Dahiya, S. AU - Dirks, P. AU - Dunkel, I. J. AU - Eisenstat, D. AU - Conter, C. F. AU - Finch, E. AU - Finlay, J. L. AU - Frappaz, D. AU - Garre, M. L. AU - Gauvain, K. AU - Bechensteen, A. G. AU - Hansford, J. R. AU - Harting, I. AU - Hauser, P. AU - Hazrati, L. N. AU - Huang, A. AU - Injac, S. G. AU - Iurilli, V. AU - Karajannis, M. AU - Kaur, G. AU - Kyncl, M. AU - Krskova, L. AU - Laperriere, N. AU - Larouche, V. AU - Lassaletta, A. AU - Leary, S. AU - Lin, F. AU - Mascelli, S. AU - McKeown, T. AU - Milde, T. AU - la Madrid, A. M. AU - Morana, G. AU - Morse, H. AU - Mushtaq, N. AU - Osorio, D. S. AU - Packer, R. AU - Pavelka, Z. AU - Quiroga-Cantero, E. AU - Rutka, J. AU - Sabel, M. AU - Salgado, D. AU - Solano, P. AU - Sterba, J. AU - Su, J. AU - Sumerauer, D. AU - Taylor, M. D. AU - Toledano, H. AU - Tsang, D. S. AU - Fernandes, M. V. AU - van Landeghem, F. AU - van Tilburg, C. M. AU - Wilson, B. AU - Witt, O. AU - Zamecnik, J. AU - Bouffet, E. AU - Hawkins, C. AU - Tabori, U. DB - Embase DO - 10.1200/PO.19.00298 LA - English M3 - Conference Paper N1 - L2006710049 2020-07-06 PY - 2019 SN - 2473-4284 SP - 561-571 ST - Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition T2 - JCO Precision Oncology TI - Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006710049&from=exporthttp://dx.doi.org/10.1200/PO.19.00298 VL - 3 ID - 7140 ER - TY - JOUR AD - Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada Division of Haematology/Oncology, McMaster University, Hamilton, ON, Canada Division of Hematology/Oncology, University of Ottawa, Ottawa, ON, Canada Centre for Health Services Research, University of Queensland, Brisbane, QLD, Australia Division of Haematology/Oncology, Kingston General Hospital, Kingston, ON, Canada Division of Haematology/Oncology, Western University, London, ON, Canada AU - Egan, G. AU - Athale, U. AU - Johnston, D. AU - Pole, J. D. AU - Silva, M. AU - Zorzi, A. AU - Alexander, S. C7 - e28491 DB - Scopus DO - 10.1002/pbc.28491 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Outcomes of children with chronic myeloid leukemia: A population-based cohort study T2 - Pediatric Blood and Cancer TI - Outcomes of children with chronic myeloid leukemia: A population-based cohort study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087169364&doi=10.1002%2fpbc.28491&partnerID=40&md5=b97b0eb980d9652a307bc21b71e673fa VL - 67 ID - 7141 ER - TY - JOUR AD - Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey Department of Medical Genetics, School of Medicine, Mehmet Ali Aydinlar Acibadem University, Istanbul, Turkey AU - Soysal, T. AU - Eskazan, A. E. AU - Serin, I. AU - Sadri, S. AU - Keskin, D. AU - Ozgur Yurttas, N. AU - Berk, S. AU - Erdogan Ozunal, I. AU - Salihoglu, A. AU - Ar, M. C. AU - Ongoren, S. AU - Baslar, Z. AU - Ozbek, U. AU - Aydin, Y. DB - Scopus DO - 10.1016/j.clml.2019.03.028 IS - 7 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - e377-e384 ST - The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations T2 - Clinical Lymphoma, Myeloma and Leukemia TI - The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065290051&doi=10.1016%2fj.clml.2019.03.028&partnerID=40&md5=44685e4a6a2d9c5b5527660590cb1086 VL - 19 ID - 7142 ER - TY - JOUR AD - Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United States AU - Nagle, S. J. AU - Woo, K. AU - Schuster, S. J. AU - Nasta, S. D. AU - Stadtmauer, E. AU - Mick, R. AU - Svoboda, J. DB - Scopus DO - 10.1002/ajh.23524 IS - 10 M3 - Article N1 - Cited By :72 Export Date: 18 November 2020 PY - 2013 SP - 890-894 ST - Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era T2 - American Journal of Hematology TI - Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884708515&doi=10.1002%2fajh.23524&partnerID=40&md5=fcfa49a41dff079884f90d71cb298916 VL - 88 ID - 7143 ER - TY - JOUR AD - Centre for Biotechnology, Anna University, Chennai, 600025, India Department of Genetics, University of Leicester, Leicester, LE1 7RH, United Kingdom AU - Shankar, B. AU - Krishnan, S. AU - Malladi, V. AU - Balakrishnan, A. AU - Williams, P. H. DB - Scopus DO - 10.1016/j.ijmm.2008.07.005 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2009 SP - 121-132 ST - Outer membrane proteins of wild-type and intimin-deficient enteropathogenic Escherichia coli induce Hep-2 cell death through intrinsic and extrinsic pathways of apoptosis T2 - International Journal of Medical Microbiology TI - Outer membrane proteins of wild-type and intimin-deficient enteropathogenic Escherichia coli induce Hep-2 cell death through intrinsic and extrinsic pathways of apoptosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-58649085440&doi=10.1016%2fj.ijmm.2008.07.005&partnerID=40&md5=58adfc02ea3e63ac9a5aa3a6100668c7 VL - 299 ID - 7144 ER - TY - JOUR AD - Department of Medical Biology, Medical Faculty, Uludag University, Bursa, Turkey. btunca@uludag.edu.tr AN - 23322277 AU - Tunca, B. AU - Tezcan, G. AU - Cecener, G. AU - Egeli, U. AU - Zorluoglu, A. AU - Yilmazlar, T. AU - Ak, S. AU - Yerci, O. AU - Ozturk, E. AU - Umut, G. AU - Evrensel, T. DA - Apr DO - 10.1007/s00432-013-1372-x 10.1007/s00432-013-1372-x. Epub 2013 Jan 16. DP - Nlm ET - 2013/01/17 IS - 4 LA - eng PY - 2013 SN - 0171-5216 SP - 691-702 ST - Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients T2 - J Cancer Res Clin Oncol TI - Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients VL - 139 ID - 7145 ER - TY - JOUR AD - Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA. Martin.Belinsky@fccc.edu AN - 23109135 AU - Belinsky, M. G. AU - Rink, L. AU - Flieder, D. B. AU - Jahromi, M. S. AU - Schiffman, J. D. AU - Godwin, A. K. AU - Mehren, Mv C2 - PMC3564228 C6 - NIHMS430867 DA - Feb DO - 10.1002/gcc.22023 10.1002/gcc.22023. Epub 2012 Oct 29. DP - Nlm ET - 2012/10/31 IS - 2 LA - eng PY - 2013 SN - 1045-2257 (Print) 1045-2257 SP - 214-24 ST - Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors T2 - Genes Chromosomes Cancer TI - Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors VL - 52 ID - 7146 ER - TY - JOUR AD - L. Li, Department of Endocrinology, Second Affiliated Hospital, Chongqing Medical University, 400010 Chongqing, China AU - Yang, M. AU - Dai, J. AU - Jia, Y. AU - Suo, L. AU - Li, S. AU - Guo, Y. AU - Liu, H. AU - Li, L. AU - Yang, G. DB - Embase Medline DO - 10.1111/febs.12853 IS - 14 LA - English M3 - Article N1 - L53199381 2014-06-26 2014-08-06 PY - 2014 SN - 1742-4658 1742-464X SP - 3193-3205 ST - Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB T2 - FEBS Journal TI - Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53199381&from=exporthttp://dx.doi.org/10.1111/febs.12853 VL - 281 ID - 7147 ER - TY - JOUR AD - Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College, No. 2 Fuxue Lane, Wenzhou, Zhejiang, China. AN - 22855362 AU - Zhou, Y. L. AU - Liu, C. AU - Dai, X. X. AU - Zhang, X. H. AU - Wang, O. C. DA - Dec DO - 10.1007/s12032-012-0315-8 10.1007/s12032-012-0315-8. Epub 2012 Aug 2. DP - Nlm ET - 2012/08/03 IS - 5 LA - eng PY - 2012 SN - 1357-0560 SP - 3360-6 ST - Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas T2 - Med Oncol TI - Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas VL - 29 ID - 7148 ER - TY - JOUR AD - P. Ding, Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China AU - Xue, L. P. AU - Lu, B. AU - Gao, B. B. AU - Shi, Y. Y. AU - Xu, J. Q. AU - Yang, R. AU - Xu, B. AU - Ding, P. DB - Embase Medline DO - 10.12659/MSM.916024 LA - English M3 - Article N1 - L2004761102 2020-02-05 2020-02-10 PY - 2019 SN - 1643-3750 1234-1010 SP - 8422-8429 ST - Overexpression of tripartite motif-containing 48 (TRIM48) inhibits growth of human glioblastoma cells by suppressing extracellular signal regulated kinase 1/2 (ERK1/2) pathway T2 - Medical Science Monitor TI - Overexpression of tripartite motif-containing 48 (TRIM48) inhibits growth of human glioblastoma cells by suppressing extracellular signal regulated kinase 1/2 (ERK1/2) pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004761102&from=exporthttp://dx.doi.org/10.12659/MSM.916024 VL - 25 ID - 7149 ER - TY - JOUR AD - Department of Pediatrics, University of Colorado School of Medicine/Anschutz Medical Campus, Aurora, CO, United States Children's Hospital Colorado, Aurora, CO, United States University of Colorado Cancer Center, Aurora, CO, United States Developmental Therapeutics Program, Aurora, CO, United States Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA, United States AU - Faulk, K. AU - Gore, L. AU - Cooper, T. DB - Scopus DO - 10.1007/s40272-014-0067-3 IS - 3 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2014 SP - 213-227 ST - Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia T2 - Pediatric Drugs TI - Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902378710&doi=10.1007%2fs40272-014-0067-3&partnerID=40&md5=8078013588557e901d3399de87876397 VL - 16 ID - 7150 ER - TY - JOUR AD - M. Xu, College of Food Science and Engineering, Jiangxi Agricultural University, 1101 Zhimin Avenue, Nanchang, China AU - Zhu, G. AU - Luo, J. AU - Du, H. AU - Jiang, Y. AU - Tu, Y. AU - Yao, Y. AU - Xu, M. DB - Embase Medline DO - 10.1016/j.ijbiomac.2018.08.058 LA - English M3 - Article N1 - L2001026816 2018-08-21 2019-01-11 PY - 2018 SN - 1879-0003 0141-8130 SP - 1-9 ST - Ovotransferrin enhances intestinal immune response in cyclophosphamide-induced immunosuppressed mice T2 - International Journal of Biological Macromolecules TI - Ovotransferrin enhances intestinal immune response in cyclophosphamide-induced immunosuppressed mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001026816&from=exporthttp://dx.doi.org/10.1016/j.ijbiomac.2018.08.058 VL - 120 ID - 7151 ER - TY - JOUR AD - UCL Cancer Institute, University College London, Gower Street, London, WC1E 6BT, United Kingdom Royal Free Hospital, London, United Kingdom AU - Goldstein, R. AU - Yu, D. AU - Gillmore, R. AU - Thirlwell, C. AU - O'Donoghue, P. AU - Mayer, A. AU - Meyer, T. DB - Scopus DO - 10.2217/FON.14.108 IS - 13 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 2007-2014 ST - Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: Case report and single-center retrospective review T2 - Future Oncology TI - Oxaliplatin/5-fluorouracil in advanced hepatocellular carcinoma: Case report and single-center retrospective review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911164273&doi=10.2217%2fFON.14.108&partnerID=40&md5=68f6a84f6ae643f61b06edc731c4b965 VL - 10 ID - 7152 ER - TY - JOUR AD - B. L. Upham, 243 Food Safety and Toxicology Center, Michigan State University, East Lansing, MI 48824, United States AU - Upham, B. L. AU - Trosko, J. E. DB - Embase Medline DO - 10.1089/ars.2008.2146 IS - 2 LA - English M3 - Review N1 - L354018066 2009-01-30 PY - 2009 SN - 1523-0864 SP - 297-307 ST - Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression T2 - Antioxidants and Redox Signaling TI - Oxidative-dependent integration of signal transduction with intercellular gap junctional communication in the control of gene expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354018066&from=exporthttp://dx.doi.org/10.1089/ars.2008.2146 VL - 11 ID - 7153 ER - TY - JOUR AU - Guo, R. AU - Preeshagul, I. AU - Schoenfeld, A. AU - McCarthy, C. AU - Makhnin, A. AU - Plodkowski, A. AU - Ginsberg, M. AU - Davare, M. AU - Delasos, L. AU - Somwar, R. AU - Arcila, M. AU - Riely, G. AU - Rekhtman, N. AU - Ladanyi, M. AU - Kris, M. AU - Drilon, A. DB - Embase DO - 10.1016/j.jtho.2019.08.1201 IS - 10 LA - English M3 - Conference Abstract N1 - L2003405563 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S574-S575 ST - P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma T2 - Journal of Thoracic Oncology TI - P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003405563&from=exporthttp://dx.doi.org/10.1016/j.jtho.2019.08.1201 VL - 14 ID - 7154 ER - TY - JOUR AU - Chen, H. AU - Ling, T. AU - Huang, Y. AU - Chen, J. AU - Su, S. DB - Embase DO - 10.1016/j.jtho.2019.08.1487 IS - 10 LA - English M3 - Conference Abstract N1 - L2003407279 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S699 ST - P2.03-40 Particle Matters Induce Carcinogenic Phenotype and Gene Expression Changes in Murine Pulmonary Progenitor Cells T2 - Journal of Thoracic Oncology TI - P2.03-40 Particle Matters Induce Carcinogenic Phenotype and Gene Expression Changes in Murine Pulmonary Progenitor Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003407279&from=exporthttp://dx.doi.org/10.1016/j.jtho.2019.08.1487 VL - 14 ID - 7155 ER - TY - JOUR AD - J.-W. Zeng, Department of Physiology, Zunyi Medical College, No. 6 West Xuefu Road, Xinpu District, Zunyi, Guizhou, China AU - Liu, P. W. AU - Yue, M. X. AU - Zhou, R. AU - Niu, J. AU - Huang, D. J. AU - Xu, T. AU - Luo, P. AU - Liu, X. H. AU - Zeng, J. W. DB - Embase DO - 10.2147/JPR.S137131 LA - English M3 - Article N1 - L617515852 2017-08-04 2017-08-07 PY - 2017 SN - 1178-7090 SP - 1755-1767 ST - P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia T2 - Journal of Pain Research TI - P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617515852&from=exporthttp://dx.doi.org/10.2147/JPR.S137131 VL - 10 ID - 7156 ER - TY - JOUR AD - S. Liang, Department of Physiology, Basic Medical School of Nanchang University, Nanchang, Jiangxi, China AU - Yi, Z. AU - Xie, L. AU - Zhou, C. AU - Yuan, H. AU - Ouyang, S. AU - Fang, Z. AU - Zhao, S. AU - Jia, T. AU - Zou, L. AU - Wang, S. AU - Xue, Y. AU - Wu, B. AU - Gao, Y. AU - Li, G. AU - Liu, S. AU - Xu, H. AU - Xu, C. AU - Zhang, C. AU - Liang, S. DB - Embase Medline DO - 10.1007/s11302-017-9594-z IS - 1 LA - English M3 - Article N1 - L619347888 2017-11-27 2018-04-03 PY - 2018 SN - 1573-9546 1573-9538 SP - 47-58 ST - P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2′,3′-dideoxycytidine T2 - Purinergic Signalling TI - P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2′,3′-dideoxycytidine UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619347888&from=exporthttp://dx.doi.org/10.1007/s11302-017-9594-z VL - 14 ID - 7157 ER - TY - JOUR AD - X. P. Wan, Department of Obstetrics and Gynaecology, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, China AU - Lu, W. AU - Xia, Y. H. AU - Qu, J. J. AU - He, Y. Y. AU - Li, B. L. AU - Lu, C. AU - Luo, X. AU - Wan, X. P. DB - Embase Medline DO - 10.4149/neo_2013_064 IS - 5 LA - English M3 - Article N1 - L372233209 2014-02-06 2020-06-05 PY - 2013 SN - 1338-4317 0028-2685 SP - 493-503 ST - p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion T2 - Neoplasma TI - p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372233209&from=exporthttp://dx.doi.org/10.4149/neo_2013_064 VL - 60 ID - 7158 ER - TY - JOUR AD - W.-H. Li, Department of Skin Biology and Pharmacology, The Johnson & Johnson Skin Research Center, Johnson & Johnson Consumer and Personal Products Worldwide, Division of Johnson and Johnson Consumer Companies, Inc., 199 Grandview Road, Skillman, NJ, United States AU - Li, W. H. AU - Zhang, L. AU - Lyte, P. AU - Rodriguez, K. AU - Cavender, D. AU - Southall, M. D. C1 - sb 203580 scio 469(Scios,United States) DB - Embase DO - 10.1007/s13555-015-0072-7 IS - 1 LA - English M3 - Article N1 - L603280858 2015-04-02 2015-04-10 PY - 2015 SN - 2190-9172 2193-8210 SP - 53-66 ST - p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro T2 - Dermatology and Therapy TI - p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603280858&from=exporthttp://dx.doi.org/10.1007/s13555-015-0072-7 VL - 5 ID - 7159 ER - TY - JOUR AD - Institute for Biomechanics, ETH Zurich, Zurich, Switzerland Fukushima Medical University, Fukushima, Japan Biostatistics, Research Office, Paracelsus Medical University, Salzburg, Austria Department of Ophthalmology and Optometry, Paracelsus Medical University, Salzburg, Austria Neuro and Spine Center, Hirslanden Klinik St. Anna, Lucerne, Switzerland Prodorso, Zurich, Switzerland Academic Teaching Hospital, Spine Research Institute, Paracelsus Medical University, Salzburg, Austria Spine Center, Schön Klinic Munich Harlaching, Munich, Germany Department of Health Sciences, University of Potsdam, Potsdam, Germany AU - Krupkova, O. AU - Sadowska, A. AU - Kameda, T. AU - Hitzl, W. AU - Hausmann, O. N. AU - Klasen, J. AU - Wuertz-Kozak, K. C7 - 1706 DB - Scopus DO - 10.3389/fimmu.2018.01706 IS - AUG M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 ST - p38 MAPK facilitates crosstalk between endoplasmic reticulum stress and IL-6 release in the intervertebral disc T2 - Frontiers in Immunology TI - p38 MAPK facilitates crosstalk between endoplasmic reticulum stress and IL-6 release in the intervertebral disc UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051627378&doi=10.3389%2ffimmu.2018.01706&partnerID=40&md5=8f704b619ccdb2d6ac74f27bf1ae236c VL - 9 ID - 7160 ER - TY - JOUR AD - Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku. Kyoto, Japan AU - Marumo, S. AU - Hoshino, Y. AU - Kiyokawa, H. AU - Tanabe, N. AU - Sato, A. AU - Ogawa, E. AU - Muro, S. AU - Hirai, T. AU - Mishima, M. C7 - 79 DB - Scopus DO - 10.1186/1471-2466-14-79 IS - 1 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2014 ST - P38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice T2 - BMC Pulmonary Medicine TI - P38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900846903&doi=10.1186%2f1471-2466-14-79&partnerID=40&md5=38ccab33324f5c382b8adff786ed2581 VL - 14 ID - 7161 ER - TY - JOUR AD - M.D. Johnson, Department of Pathology, Division of Neuropathology, University of Rochester Medical Center, Box 626, 601 Elmwood Avenue, Rochester, NY, United States AU - Johnson, M. D. AU - Reeder, J. E. AU - O'Connell, M. DB - Embase Medline DO - 10.1016/j.jocn.2015.12.031 LA - English M3 - Article N1 - L609403380 2016-04-06 2016-07-08 PY - 2016 SN - 1532-2653 0967-5868 SP - 110-114 ST - P38MAPK activation and DUSP10 expression in meningiomas T2 - Journal of Clinical Neuroscience TI - P38MAPK activation and DUSP10 expression in meningiomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609403380&from=exporthttp://dx.doi.org/10.1016/j.jocn.2015.12.031 VL - 30 ID - 7162 ER - TY - JOUR AD - Department of Experimental Medicine, University of Genoa, Genoa, Italy. AN - 23579276 AU - Marengo, B. AU - De Ciucis, C. G. AU - Ricciarelli, R. AU - Furfaro, A. L. AU - Colla, R. AU - Canepa, E. AU - Traverso, N. AU - Marinari, U. M. AU - Pronzato, M. A. AU - Domenicotti, C. C2 - PMC3641341 DA - Apr 11 DO - 10.1038/cddis.2013.118 10.1038/cddis.2013.118. DP - Nlm ET - 2013/04/13 IS - 4 LA - eng PY - 2013 SP - e589 ST - p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment T2 - Cell Death Dis TI - p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment VL - 4 ID - 7163 ER - TY - JOUR AD - R. Kapur, Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, United States AU - Hu, P. AU - Nebreda, A. R. AU - Hanenberg, H. AU - Kinnebrew, G. H. AU - Ivan, M. AU - Yoder, M. C. AU - Filippi, M. D. AU - Broxmeyer, H. E. AU - Kapur, R. C1 - sp 600125 DB - Embase Medline DO - 10.1038/s41467-018-05955-2 IS - 1 LA - English M3 - Article N1 - L623695254 2018-09-10 2018-09-11 PY - 2018 SN - 2041-1723 ST - P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim T2 - Nature Communications TI - P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of Bim UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623695254&from=exporthttp://dx.doi.org/10.1038/s41467-018-05955-2 VL - 9 ID - 7164 ER - TY - JOUR AD - Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. AN - 12713619 AU - Yamamoto, H. AU - Oda, Y. AU - Saito, T. AU - Sakamoto, A. AU - Miyajima, K. AU - Tamiya, S. AU - Tsuneyoshi, M. DA - May DO - 10.1046/j.1365-2559.2003.01611.x 10.1046/j.1365-2559.2003.01611.x. DP - Nlm ET - 2003/04/26 IS - 5 LA - eng PY - 2003 SN - 0309-0167 (Print) 0309-0167 SP - 431-9 ST - p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours T2 - Histopathology TI - p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours VL - 42 ID - 7165 ER - TY - JOUR AD - Department of Medical Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110 029, India AU - Pushpam, D. AU - Bakhshi, S. DB - Scopus DO - 10.4103/ijmr.IJMR_331_19 IS - 5 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 600-609 ST - Paediatric chronic myeloid leukaemia: Is it really a different disease? T2 - Indian Journal of Medical Research TI - Paediatric chronic myeloid leukaemia: Is it really a different disease? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071039498&doi=10.4103%2fijmr.IJMR_331_19&partnerID=40&md5=a7a9a81858a62bba18f3425ddf71e0d9 VL - 149 ID - 7166 ER - TY - JOUR AD - S.Y. Ha, Department of Paediatrics and Adolescent Medicine, Hong Kong Children’s Hospital, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong AU - Ha, S. Y. AU - Cheuk, D. K. L. DB - Embase IS - 4 LA - English M3 - Article N1 - L2002854098 2019-11-15 2019-11-20 PY - 2019 SN - 2309-5393 1013-9923 SP - 216-226 ST - Paediatric haematology and oncology in Hong Kong: A quarter century of progress T2 - Hong Kong Journal of Paediatrics TI - Paediatric haematology and oncology in Hong Kong: A quarter century of progress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002854098&from=export VL - 24 ID - 7167 ER - TY - JOUR AD - D. Hargrave, Paediatric Oncology Unit, Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom AU - Hargrave, D. C1 - avastin azd 6244 iressa tarceva DB - Embase Medline DO - 10.1080/02688690903158809 IS - 4 LA - English M3 - Review N1 - L355108910 2009-10-12 PY - 2009 SN - 0268-8697 1360-046X SP - 351-363 ST - Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy T2 - British Journal of Neurosurgery TI - Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355108910&from=exporthttp://dx.doi.org/10.1080/02688690903158809 VL - 23 ID - 7168 ER - TY - JOUR AD - W. Klapper, Department of Pathology, Haematopathology Section, University-Hospital Schleswig-Holstein, University of Kiel, Michaelisstrasse 11, Kiel, Germany AU - Shiramizu, B. AU - Mussolin, L. AU - Woessmann, W. AU - Klapper, W. DB - Embase Medline DO - 10.1111/bjh.14009 IS - 4 LA - English M3 - Review N1 - L609267452 2016-04-01 2016-06-16 PY - 2016 SN - 1365-2141 0007-1048 SP - 617-624 ST - Paediatric non-Hodgkin lymphoma - perspectives in translational biology T2 - British Journal of Haematology TI - Paediatric non-Hodgkin lymphoma - perspectives in translational biology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609267452&from=exporthttp://dx.doi.org/10.1111/bjh.14009 VL - 173 ID - 7169 ER - TY - JOUR AD - ACCELERATE/ITCC, European Union Princess Máxima Center, Utrecht, Erasmus MC, Rotterdam, Netherlands ITCC, European Union Nemours/Alfred I. duPont Hospital for Children, United States European Medicines Agency, Amsterdam, Netherlands Fred Hutchinson Cancer Research Center, Leukaemia Lymphoma Society, Target Paediatric AML, United States AbbVie, United States Royal Marsden Hospital, The Institute of Cancer Research, United Kingdom Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, United States National Institutes of Health, National Cancer Institute, United States Seattle Children's Hospital, United States Sanofi US, Emeritus Professor of Paediatrics & Pharmacology, Perelman School of Medicine, University of Pennsylvania, United States Pfizer, United States Celgene, United States Servier, United States Jazz Pharmaceuticals, Ireland Novartis Pharma, Switzerland Astellas Pharma Global Development, Inc., United States Takeda Pharmaceuticals, United States Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Sanofi Genzyme, United States Department of Paediatrics, Aarhus University Hospital, Denmark KickCancer, Belgium BMS, United States Martin Luther University Halle-Wittenberg, Germany Helsinn Healthcare, Switzerland FORMA Therapeutics, United States Queensland Children's Hospital, Brisbane, Australia Amgen, United States Janssen Research & Development, United States University Hospital Essen, Germany Zoé4life, Switzerland CCI, European Union Roche/Genentech, Switzerland Agios Pharmaceuticals, United States Universitair Ziekenhuis Antwerpen, FAMHP, Belgium Food and Drug Administration, United States Gustave Roussy Cancer Centre, France AU - Pearson, A. D. J. AU - Zwaan, C. M. AU - Kolb, E. A. AU - Karres, D. AU - Guillot, J. AU - Kim, S. Y. AU - Marshall, L. AU - Tasian, S. K. AU - Smith, M. AU - Cooper, T. AU - Adamson, P. C. AU - Barry, E. AU - Benettaib, B. AU - Binlich, F. AU - Borgman, A. AU - Brivio, E. AU - Capdeville, R. AU - Delgado, D. AU - Faller, D. V. AU - Fogelstrand, L. AU - Fraenkel, P. G. AU - Hasle, H. AU - Heenen, D. AU - Kaspers, G. AU - Kieran, M. AU - Klusmann, J. H. AU - Lesa, G. AU - Ligas, F. AU - Mappa, S. AU - Mohamed, H. AU - Moore, A. AU - Morris, J. AU - Nottage, K. AU - Reinhardt, D. AU - Scobie, N. AU - Simko, S. AU - Winkler, T. AU - Norga, K. AU - Reaman, G. AU - Vassal, G. DB - Scopus DO - 10.1016/j.ejca.2020.04.038 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 116-129 ST - Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration T2 - European Journal of Cancer TI - Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087974955&doi=10.1016%2fj.ejca.2020.04.038&partnerID=40&md5=400596b1d7351b95399744446034cb5d VL - 136 ID - 7170 ER - TY - JOUR AD - Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. AN - 20398663 AU - Munitz, A. AU - Cole, E. T. AU - Beichler, A. AU - Groschwitz, K. AU - Ahrens, R. AU - Steinbrecher, K. AU - Willson, T. AU - Han, X. AU - Denson, L. AU - Rothenberg, M. E. AU - Hogan, S. P. C2 - PMC3423916 C6 - NIHMS197647 DA - Aug DO - 10.1053/j.gastro.2010.04.006 10.1053/j.gastro.2010.04.006. Epub 2010 Apr 14. DP - Nlm ET - 2010/04/20 IS - 2 LA - eng PY - 2010 SN - 0016-5085 (Print) 0016-5085 SP - 530-41 ST - Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis T2 - Gastroenterology TI - Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis VL - 139 ID - 7171 ER - TY - JOUR AD - D. W. Clapp, Indiana University School of Medicine, Cancer Research Institute, 1044 W Walnut Street, R4 402, Indianapolis, IN 46202 AU - McDaniel, A. S. AU - Allen, J. D. AU - Park, S. J. AU - Jaffer, Z. M. AU - Michels, E. G. AU - Burgin, S. J. AU - Chen, S. AU - Bessler, W. K. AU - Hofmann, C. AU - Ingram, D. A. AU - Chernoff, J. AU - Clapp, D. W. DB - Embase Medline DO - 10.1182/blood-2008-04-155085 IS - 12 LA - English M3 - Article N1 - L354286425 2009-04-01 PY - 2008 SN - 0006-4971 1528-0020 SP - 4646-4654 ST - Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/ mast cells T2 - Blood TI - Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/ mast cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354286425&from=exporthttp://dx.doi.org/10.1182/blood-2008-04-155085http://bloodjournal.hematologylibrary.org/cgi/reprint/112/12/4646 VL - 112 ID - 7172 ER - TY - JOUR AD - R.C. Bunn, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, United States AU - Bunn, R. C. AU - Cockrell, G. E. AU - Ou, Y. AU - Thrailkill, K. M. AU - Lumpkin Jr, C. K. AU - Fowlkes, J. L. DB - Embase Medline DO - 10.1186/1475-2840-9-73 LA - English M3 - Article N1 - L51142967 2010-11-11 2010-12-02 PY - 2010 SN - 1475-2840 ST - Palmitate and insulin synergistically induce IL-6 expression in human monocytes T2 - Cardiovascular Diabetology TI - Palmitate and insulin synergistically induce IL-6 expression in human monocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51142967&from=exporthttp://dx.doi.org/10.1186/1475-2840-9-73http://www.cardiab.com/content/9/1/73 VL - 9 ID - 7173 ER - TY - JOUR AN - CN-01988728 AU - Couch, D. G. AU - Cook, H. AU - Ortori, C. AU - Barrett, D. AU - Lund, J. N. AU - O'Sullivan, S. E. DO - 10.1093/ibd/izz017 IS - 6 M3 - Journal Article; Randomized Controlled Trial PY - 2019 SP - 1006‐1018 ST - Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial T2 - Inflammatory bowel diseases TI - Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01988728/full VL - 25 ID - 7174 ER - TY - JOUR AD - Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Universitat de Barcelona, 170 Villarroel street, Barcelona, 08036, Spain BCLC Group, Pathology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C/Villarroel 170, Escala 3 Planta 1, Barcelona, 08036, Spain BCLC Group, Radiology Department, Hospital Clinic of Barcelona, Biomedical Research Center Network for Liver and Digestive Diseases (CIBERehd), University of Barcelona, C/Villarroel 170, Escala 3 Planta 1, Barcelona, 08036, Spain AU - Diáz-González, Á AU - Belmonte, E. AU - Sapena, V. AU - Sanduzzi-Zamparelli, M. AU - Darnell, A. AU - Diáz, A. AU - Gomes Da Fonseca, L. AU - Llarch, N. AU - Iserte, G. AU - Ayuso, C. AU - Forner, A. AU - Bruix, J. AU - Rimola, J. AU - Reig, M. DB - Scopus DO - 10.1097/MCG.0000000000001366 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Pancreatic Insufficiency in Patients under Sorafenib Treatment for Hepatocellular Carcinoma T2 - Journal of Clinical Gastroenterology TI - Pancreatic Insufficiency in Patients under Sorafenib Treatment for Hepatocellular Carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086773844&doi=10.1097%2fMCG.0000000000001366&partnerID=40&md5=16748abb30b0e985fa2a4995f3857063 ID - 7175 ER - TY - JOUR AD - H. Koga, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Japan AU - Ikezono, Y. AU - Koga, H. AU - Akiba, J. AU - Abe, M. AU - Yoshida, T. AU - Wada, F. AU - Nakamura, T. AU - Iwamoto, H. AU - Masuda, A. AU - Sakaue, T. AU - Yano, H. AU - Tsuruta, O. AU - Torimura, T. DB - Embase Medline DO - 10.1158/1541-7786.MCR-16-0285 IS - 6 LA - English M3 - Article N1 - L616742605 2017-06-15 2017-06-20 PY - 2017 SN - 1557-3125 1541-7786 SP - 744-752 ST - Pancreatic neuroendocrine tumors and EMT behavior are driven by the CSC marker DCLK1 T2 - Molecular Cancer Research TI - Pancreatic neuroendocrine tumors and EMT behavior are driven by the CSC marker DCLK1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616742605&from=exporthttp://dx.doi.org/10.1158/1541-7786.MCR-16-0285 VL - 15 ID - 7176 ER - TY - JOUR AD - Endocrinology Division, Department of Internal and Specialistic Medicine, University of Catania Medical School, Garibaldi-Nesima Hospital, Catania, Italy. gabriellapellegriti@hotmail.com AN - 19893009 AU - Pellegriti, G. AU - De Vathaire, F. AU - Scollo, C. AU - Attard, M. AU - Giordano, C. AU - Arena, S. AU - Dardanoni, G. AU - Frasca, F. AU - Malandrino, P. AU - Vermiglio, F. AU - Previtera, D. M. AU - D'Azzò, G. AU - Trimarchi, F. AU - Vigneri, R. DA - Nov 18 DO - 10.1093/jnci/djp354 10.1093/jnci/djp354. Epub 2009 Nov 5. DP - Nlm ET - 2009/11/07 IS - 22 LA - eng PY - 2009 SN - 0027-8874 SP - 1575-83 ST - Papillary thyroid cancer incidence in the volcanic area of Sicily T2 - J Natl Cancer Inst TI - Papillary thyroid cancer incidence in the volcanic area of Sicily VL - 101 ID - 7177 ER - TY - JOUR AD - Z. Gil, Department of Otolaryngology, Head and Neck Surgery, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel AU - Gil, Z. AU - Cavel, O. AU - Kelly, K. AU - Brader, P. AU - Rein, A. AU - Gao, S. P. AU - Carlson, D. L. AU - Shah, J. P. AU - Fong, Y. AU - Wong, R. J. DB - Embase Medline DO - 10.1093/jnci/djp456 IS - 2 LA - English M3 - Article N1 - L358181550 2010-02-04 2019-09-12 PY - 2010 SN - 1460-2105 0027-8874 SP - 107-118 ST - Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves T2 - Journal of the National Cancer Institute TI - Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358181550&from=exporthttp://dx.doi.org/10.1093/jnci/djp456 VL - 102 ID - 7178 ER - TY - JOUR AD - Director, Florida Craniofacial Institute, Tampa, FL, United States Previous Fellow, Florida Craniofacial Institute, Tampa, FL, United States Pediatric Hematology Oncology, St Joseph's Children's Hospital, Tampa, FL, United States AU - Ricalde, P. AU - Ahson, I. AU - Schaefer, S. T. DB - Scopus DO - 10.1016/j.joms.2019.02.021 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 1278.e1-1278.e7 ST - A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib T2 - Journal of Oral and Maxillofacial Surgery TI - A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065603239&doi=10.1016%2fj.joms.2019.02.021&partnerID=40&md5=c06e5c5e7915e8772443dc8a72facee3 VL - 77 ID - 7179 ER - TY - JOUR AD - K. Vakili, Department of Surgery, Pediatric Transplant Center, Boston Children's Hospital, Boston, MA, United States AU - Vakili, K. AU - Kim, H. B. DB - Embase Medline DO - 10.1111/ajt.12623 IS - 3 LA - English M3 - Article N1 - L52971816 2014-01-27 2014-03-11 PY - 2014 SN - 1600-6135 1600-6143 SP - 720-723 ST - Partial esophageal transplantation is possible as part of a multivisceral graft T2 - American Journal of Transplantation TI - Partial esophageal transplantation is possible as part of a multivisceral graft UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52971816&from=exporthttp://dx.doi.org/10.1111/ajt.12623 VL - 14 ID - 7180 ER - TY - JOUR AD - Department of Internal Medicine, Patan Hospital, Lalitpur, Nepal Department of Emergency Medicine, Patan Hospital, Lalitpur, Nepal Nick Simon Institute, Lalitpur, Nepal Division of Hematology of the Department of Internal Medicine, Department of Oncology, Mayo Clinic, Rochester, MN, United States AU - Kayastha, G. K. AU - Gurung, P. AU - Acharya, P. K. AU - Paudyal, B. P. AU - Hayes, B. AU - Zimmerman, M. AU - Karki, A. AU - Mansfield, A. S. C7 - 8 DB - Scopus DO - 10.1186/1471-2326-10-8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2010 ST - Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor T2 - BMC Blood Disorders TI - Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649750354&doi=10.1186%2f1471-2326-10-8&partnerID=40&md5=044f3bb735e3f0989f494b3cca1dcd6f VL - 10 ID - 7181 ER - TY - JOUR AD - Research, Department of Veterans Affairs Medical Center, St. Louis, MO, United States Department of Obstetrics and Gynecology, Washington University School of Medicine in St. LouisMO 63110, United States AU - Esakky, P. AU - Moley, K. H. DB - Scopus DO - 10.1016/j.mce.2016.07.015 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 85-93 ST - Paternal smoking and germ cell death: A mechanistic link to the effects of cigarette smoke on spermatogenesis and possible long-term sequelae in offspring T2 - Molecular and Cellular Endocrinology TI - Paternal smoking and germ cell death: A mechanistic link to the effects of cigarette smoke on spermatogenesis and possible long-term sequelae in offspring UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978811066&doi=10.1016%2fj.mce.2016.07.015&partnerID=40&md5=5eec1e0b36bcad9f05f75ecf0ca02e19 VL - 435 ID - 7182 ER - TY - JOUR AD - DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig. AN - 10994999 AU - Drexler, H. G. AU - Gignac, S. M. AU - von Wasielewski, R. AU - Werner, M. AU - Dirks, W. G. DA - Sep DO - 10.1038/sj.leu.2401878 10.1038/sj.leu.2401878. DP - Nlm ET - 2000/09/20 IS - 9 LA - eng PY - 2000 SN - 0887-6924 (Print) 0887-6924 SP - 1533-59 ST - Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas T2 - Leukemia TI - Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas VL - 14 ID - 7183 ER - TY - JOUR AD - H.B. Gaspar, Molecular Immunology Unit, Institute of Child Health, University College London, 30 Guildford Street, London WC1N 1EH, United Kingdom AU - Gilmour, K. C. AU - Gaspar, H. B. C1 - cymevene(Hoffmann La Roche,Switzerland) endoxana(Baxter,United States) foscavir(Astra Zeneca,United Kingdom) myleran(Glaxo SmithKline,United Kingdom) vepesid(Bristol Myers Squibb,United States) C2 - Astra Zeneca(United Kingdom) Baxter(United States) Bristol Myers Squibb(United States) Glaxo SmithKline(United Kingdom) Hoffmann La Roche(Switzerland) DB - Embase Medline DO - 10.1586/14737159.3.5.549 IS - 5 LA - English M3 - Review N1 - L37101871 2003-10-05 PY - 2003 SN - 1473-7159 SP - 549-561 ST - Pathogenesis and diagnosis of X-linked lymphoproliferative disease T2 - Expert Review of Molecular Diagnostics TI - Pathogenesis and diagnosis of X-linked lymphoproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37101871&from=exporthttp://dx.doi.org/10.1586/14737159.3.5.549 VL - 3 ID - 7184 ER - TY - JOUR AU - Aftab, S. AU - Dattani, M. T. DB - Medline DO - 10.17458/per.vol16.2019.ad.pathogenesisrasopathies LA - English M3 - Article N1 - L627933403 2019-06-11 2019-06-14 PY - 2019 SN - 1565-4753 SP - 447-458 ST - Pathogenesis of Growth Failure in Rasopathies T2 - Pediatric endocrinology reviews : PER TI - Pathogenesis of Growth Failure in Rasopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627933403&from=exporthttp://dx.doi.org/10.17458/per.vol16.2019.ad.pathogenesisrasopathies VL - 16 ID - 7185 ER - TY - JOUR AD - Laboratoire de Biologie et Pharmacologie Appliquée, CNRS UMR 8113, Ecole Normale Supérieure de Cachan, 61, Ave du Président Wilson, 94235 Cachan Cedex, France Department of Internal Medicine i, Division of Hematology and Hemostaseology, Medical University of Vienna and Ludwig Boltzmann Cluster Oncology Vienna Austria, Waehringer Guertel 18-20, A-1090 Vienna, Austria AU - Arock, M. AU - Valent, P. DB - Scopus DO - 10.1586/ehm.10.42 IS - 4 M3 - Review N1 - Cited By :94 Export Date: 18 November 2020 PY - 2010 SP - 497-516 ST - Pathogenesis, classification and treatment of mastocytosis: State of the art in 2010 and future perspectives T2 - Expert Review of Hematology TI - Pathogenesis, classification and treatment of mastocytosis: State of the art in 2010 and future perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955642537&doi=10.1586%2fehm.10.42&partnerID=40&md5=7e8a636ac2f5a3e946fb2e0c3ae7bea0 VL - 3 ID - 7186 ER - TY - JOUR AD - Departments of Computational Biology. Oncology. Pathology, St. Jude Children's Research Hospital, Memphis, TN. Departments of Pathology and Translational Research, Institut Curie, Paris, France. AN - 31498175 AU - Newman, S. AU - Pappo, A. AU - Raimondi, S. AU - Zhang, J. AU - Barnhill, R. AU - Bahrami, A. DA - Dec DO - 10.1097/pas.0000000000001362 10.1097/PAS.0000000000001362. DP - Nlm ET - 2019/09/10 IS - 12 LA - eng PY - 2019 SN - 0147-5185 SP - 1631-1637 ST - Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort T2 - Am J Surg Pathol TI - Pathologic Characteristics of Spitz Melanoma With MAP3K8 Fusion or Truncation in a Pediatric Cohort VL - 43 ID - 7187 ER - TY - GEN AU - Rodriguez, F. J. AU - Lim, K. S. AU - Bowers, D. AU - Eberhart, C. G. C1 - nexavar rapamune tarceva C5 - 23121055 DB - Embase Medline DO - 10.1146/annurev-pathol-020712-164009 J2 - Annu. Rev. Pathol. Mech. Dis. LA - English M1 - (Rodriguez F.J.; Lim K.S.; Eberhart C.G., ceberha@jhmi.edu) Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States M3 - Review N1 - L369002373 2013-06-05 2013-06-10 PY - 2013 SN - 1553-4014 1553-4006 SP - 361-379 ST - Pathological and molecular advances in pediatric low-grade astrocytoma TI - Pathological and molecular advances in pediatric low-grade astrocytoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369002373&from=exporthttp://dx.doi.org/10.1146/annurev-pathol-020712-164009 VL - 8 ID - 7188 ER - TY - JOUR AD - J. Lu, Department of Orthopaedics, The Central Hospital of Yongzhou, Yongzhou, China AU - Tang, H. AU - Tang, Z. AU - Jiang, Y. AU - Wei, W. AU - Lu, J. DB - Embase Medline DO - 10.1111/ajco.13165 IS - 4 LA - English M3 - Review N1 - L627827523 2019-05-30 2019-07-24 PY - 2019 SN - 1743-7563 1743-7555 SP - 218-224 ST - Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma T2 - Asia-Pacific Journal of Clinical Oncology TI - Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627827523&from=exporthttp://dx.doi.org/10.1111/ajco.13165 VL - 15 ID - 7189 ER - TY - JOUR AD - Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, USA. AU - Miettinen, M. AU - Majidi, M. AU - Lasota, J. DB - Scopus DO - 10.1016/s0959-8049(02)80602-5 M3 - Review N1 - Cited By :402 Export Date: 18 November 2020 PY - 2002 SP - S39-51 ST - Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review T2 - European journal of cancer (Oxford, England : 1990) TI - Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036769966&doi=10.1016%2fs0959-8049%2802%2980602-5&partnerID=40&md5=fa23d2cdd779168654a6a51adbfa25fe VL - 38 Suppl 5 ID - 7190 ER - TY - JOUR AD - Laboratório de Microbiologia Experimental, Instituto Nacional de Ciência e Tecnologia Translacional em Medicina, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, SC, Brazil Núcleo de Excelência em Neurociências Aplicadas de Santa Catarina (NENASC), Unidade Acadêmica de Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, SC, Brazil Center for Experimental Models in Psychiatry, Department of Psychiatry and Behavioral Sciences, Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil AU - Barichello, T. AU - Fagundes, G. D. AU - Generoso, J. S. AU - Elias, S. G. AU - Simões, L. R. AU - Teixeira, A. L. DB - Scopus DO - 10.1099/jmm.0.059840-0 IS - PART 12 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2013 SP - 1781-1789 ST - Pathophysiology of neonatal acute bacterial meningitis T2 - Journal of Medical Microbiology TI - Pathophysiology of neonatal acute bacterial meningitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887902364&doi=10.1099%2fjmm.0.059840-0&partnerID=40&md5=8742b24abdbc891be82159e96072b7c3 VL - 62 ID - 7191 ER - TY - JOUR AD - S.F. Ahmed, Bone and Endocrine Research Group, Department of Child Health, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, United Kingdom AU - MacRae, V. E. AU - Farquharson, C. AU - Ahmed, S. F. DB - Embase Medline DO - 10.1093/rheumatology/kei091 IS - 1 LA - English M3 - Review N1 - L43033868 2006-01-16 PY - 2006 SN - 1462-0324 1462-0332 SP - 11-19 ST - The pathophysiology of the growth plate in juvenile idiopathic arthritis T2 - Rheumatology TI - The pathophysiology of the growth plate in juvenile idiopathic arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43033868&from=exporthttp://dx.doi.org/10.1093/rheumatology/kei091 VL - 45 ID - 7192 ER - TY - JOUR AD - R.O. Dillman, AIVITA Biomedical, Inc., Irvine, CA, United States AU - Dillman, R. O. AU - Cornforth, A. N. AU - McClay, E. F. AU - Depriest, C. DB - Embase DO - 10.2217/mmt-2018-0010 IS - 2 LA - English M3 - Article N1 - L628983296 2019-08-27 2019-09-02 PY - 2019 SN - 2045-0893 2045-0885 ST - Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma T2 - Melanoma Management TI - Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628983296&from=exporthttp://dx.doi.org/10.2217/mmt-2018-0010 VL - 6 ID - 7193 ER - TY - JOUR DB - Scopus DO - 10.1016/j.bbmt.2014.09.012 IS - 1 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 184-189 ST - Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation T2 - Biology of Blood and Marrow Transplantation TI - Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927127674&doi=10.1016%2fj.bbmt.2014.09.012&partnerID=40&md5=41db58e65d6c8f4a22296197d13bf715 VL - 21 ID - 7194 ER - TY - JOUR AD - Peking University People’s Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Beijing, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom AU - Jiang, Q. AU - Yu, L. AU - Gale, R. P. DB - Scopus DO - 10.1007/s00432-018-2594-8 IS - 4 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2018 SP - 735-741 ST - Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia T2 - Journal of Cancer Research and Clinical Oncology TI - Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041100387&doi=10.1007%2fs00432-018-2594-8&partnerID=40&md5=d48b9375ca90f9967e35456867092d23 VL - 144 ID - 7195 ER - TY - JOUR AD - Bone Marrow Transplantation Unit, Hospital Israelita Albert Einstein (HIAE) and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Estadual de Campinas (Unicamp), Campinas and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Instituto de Tratamento do Câncer Infantil (ITACI), Instituto da Criança (ICR), Hospital de Clínicas da Universidade de São Paulo (HC-USP) and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Federal do Paraná (UFP), Paraná and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Centro de Tratamento Oncológico (Centron), São Paulo and Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil Universidade Federal do Rio de Janeiro (UFRJ), and Head of the Hematology Service, Hospital Universitário Clementino Fraga Filho (HUCCFF), Universidade Federal do Rio de Janeiro (UFRJ), Brasileira de Linfoma e Leucemia (ABRALE), Rio de Janeiro, São Paulo, Brazil Associação Brasileira de Linfoma e Leucemia (ABRALE), São Paulo, Brazil AU - Hamerschlak, N. AU - de Souza, C. AU - Cornacchioni, A. L. AU - Pasquini, R. AU - Tabak, D. AU - Spector, N. AU - Steagall, M. DB - Scopus DO - 10.1590/1516-3180.2014.0001306 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 471-479 ST - Percepções dos pacientes sobre diagnóstico e tratamento da leucemia mieloide crônica: Estudo transversal entre pacientes brasileiros T2 - Sao Paulo Medical Journal TI - Patients’ perceptions about diagnosis and treatment of chronic myeloid leukemia: A cross-sectional study among Brazilian patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954349301&doi=10.1590%2f1516-3180.2014.0001306&partnerID=40&md5=0b4c1d12069c6fec67486667760383c4 VL - 133 ID - 7196 ER - TY - JOUR AD - N. Azarpira, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran AU - Azarpira, N. AU - Safaie, A. AU - Monabati, A. AU - Hosseinzadeh, M. AU - Noori, S. AU - Moini, M. AU - Rahimi, A. AU - Heidari, T. AU - Rahsaz, M. DB - Embase DO - 10.22037/ghfbb.v0i0.1022 IS - 4 LA - English M3 - Article N1 - L619908851 2017-12-27 PY - 2017 SN - 2008-4234 2008-2258 SP - 332-336 ST - PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; A case report T2 - Gastroenterology and Hepatology from Bed to Bench TI - PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619908851&from=exporthttp://dx.doi.org/10.22037/ghfbb.v0i0.1022 VL - 10 ID - 7197 ER - TY - JOUR AD - Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto Japan AN - 124587041. Language: English. Entry Date: 20170822. Revision Date: 20190513. Publication Type: Article AU - Umeda, Katsutsugu AU - Kato, Itaru AU - Saida, Satoshi AU - Okamoto, Takeshi AU - Adachi, Souchi DB - ccm DO - 10.1111/ped.13307 DP - EBSCOhost IS - 8 N1 - case study; diagnostic images; tables/charts. Journal Subset: Asia; Biomedical; Peer Reviewed. NLM UID: 100886002. PY - 2017 SN - 1328-8067 SP - 937-938 ST - Pazopanib for second recurrence of osteosarcoma in pediatric patients T2 - Pediatrics International TI - Pazopanib for second recurrence of osteosarcoma in pediatric patients UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=124587041&site=ehost-live&scope=site VL - 59 ID - 7198 ER - TY - GEN AD - Department of Chemotherapy, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Department of Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Orthopedic Surgery, Orthopedic Oncologic Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway AU - Longhi, Alessandra AU - Paioli, Anna AU - Palmerini, Emanuela AU - Cesari, Marilena AU - Abate, Massimo E. AU - Setola, Elisabetta AU - Spinnato, Paolo AU - Donati, Davide AU - Hompland, Ivar AU - Boye, Kjetil CY - Philadelphia, Pennsylvania DB - ccm DO - 10.1080/0284186X.2018.1503714 DP - EBSCOhost J2 - Acta Oncologica N1 - Accession Number: 134747712. Language: English. Entry Date: 20190219. Revision Date: 20200624. Publication Type: Letter to the Editor; case study; diagnostic images; letter; research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. NLM UID: 8709065. PB - Taylor & Francis Ltd PY - 2019 SN - 0284-186X SP - 124-128 ST - Pazopanib in relapsed osteosarcoma patients: report on 15 cases TI - Pazopanib in relapsed osteosarcoma patients: report on 15 cases UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134747712&site=ehost-live&scope=site VL - 58 ID - 7199 ER - TY - JOUR AD - Department of Oncology, Aarhus University Hospital, Aarhus, Denmark AU - Aggerholm-Pedersen, N. AU - Rossen, P. AU - Rose, H. AU - Safwat, A. DB - Scopus DO - 10.1016/j.tranon.2019.12.001 IS - 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 295-299 ST - Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience T2 - Translational Oncology TI - Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076851219&doi=10.1016%2fj.tranon.2019.12.001&partnerID=40&md5=6a233f179be9fd2de995d96ce8194f8f VL - 13 ID - 7200 ER - TY - JOUR AD - Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul Korea Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-gu, Seoul, 05505, Korea AN - 117066168. Language: English. Entry Date: 20180723. Revision Date: 20180725. Publication Type: journal article AU - Kim, Jwa AU - Park, Inkeun AU - Lee, Jae AU - Kim, Jwa Hoon AU - Lee, Jae Lyun DB - ccm DO - 10.1007/s00280-016-3093-8 DP - EBSCOhost IS - 2 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. NLM UID: 7806519. PMID: NLM27324136. PY - 2016 SN - 0344-5704 SP - 325-332 ST - Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features T2 - Cancer Chemotherapy & Pharmacology TI - Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=117066168&site=ehost-live&scope=site VL - 78 ID - 7201 ER - TY - JOUR AD - Sarcoma Unit, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London, SW3 6JJ, United Kingdom Department of Oncology, Cambridge University Hospitals, NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom Institute of Cancer Research, Sutton, United Kingdom AU - Szucs, Z. AU - Messiou, C. AU - Wong, H. H. AU - Hatcher, H. AU - Miah, A. AU - Zaidi, S. AU - Van Der Graaf, W. T. A. AU - Judson, I. AU - Jones, R. L. AU - Benson, C. DB - Scopus DO - 10.1097/CAD.0000000000000474 IS - 4 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2017 SP - 421-426 ST - Pazopanib, a promising option for the treatment of aggressive fibromatosis T2 - Anti-Cancer Drugs TI - Pazopanib, a promising option for the treatment of aggressive fibromatosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009774549&doi=10.1097%2fCAD.0000000000000474&partnerID=40&md5=9329b598aded3010878e6c48edb8fb64 VL - 28 ID - 7202 ER - TY - JOUR AD - M. Beidas, Microbiology, Kuwait University, Kuwait, Kuwait AU - Beidas, M. AU - Chehadeh, W. DB - Embase DO - 10.1093/ofid/ofx163.728 LA - English M3 - Conference Abstract N1 - L628004453 2019-06-13 PY - 2017 SN - 2328-8957 SP - S312 ST - Pcr array profiling of antiviral genes in human embryonic kidney cells expressing human coronavirus Oc43 structural and accessory proteins T2 - Open Forum Infectious Diseases TI - Pcr array profiling of antiviral genes in human embryonic kidney cells expressing human coronavirus Oc43 structural and accessory proteins UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628004453&from=exporthttp://dx.doi.org/10.1093/ofid/ofx163.728 VL - 4 ID - 7203 ER - TY - JOUR AD - N. Oishi, Mayo Clinic, Rochester, MN, United States AU - Oishi, N. AU - Boddicker, R. L. AU - Ansell, S. M. AU - Dasari, S. AU - Rech, K. AU - Feldman, A. DB - Embase DO - 10.1038/labinvest.2018.13 LA - English M3 - Conference Abstract N1 - L621622891 2018-04-16 PY - 2018 SN - 1530-0307 SP - 542-543 ST - PD-l1 expression correlates with genetic subtype and predicts outcome in anaplastic large cell lymphoma T2 - Laboratory Investigation TI - PD-l1 expression correlates with genetic subtype and predicts outcome in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621622891&from=exporthttp://dx.doi.org/10.1038/labinvest.2018.13 VL - 98 ID - 7204 ER - TY - JOUR AD - L. Hou, Beijing Institute of Biotechnology, Beijing, China AU - Zhang, Z. AU - Wang, B. AU - Wu, S. AU - Wen, Y. AU - Wang, X. AU - Song, X. AU - Zhang, J. AU - Hou, L. AU - Chen, W. C1 - pd169316 DB - Embase Medline DO - 10.1016/j.virol.2017.05.012 LA - English M3 - Article N1 - L616314341 2017-05-29 2017-06-02 PY - 2017 SN - 1096-0341 0042-6822 SP - 150-158 ST - PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71 T2 - Virology TI - PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616314341&from=exporthttp://dx.doi.org/10.1016/j.virol.2017.05.012 VL - 508 ID - 7205 ER - TY - JOUR AD - S. Penco, Department of Laboratory Medicine, Medical Genetics Unit - Niguarda Ca' Granda Hospital, Milan, Italy AU - Sole Cigoli, M. AU - Avemaria, F. AU - De Benedetti, S. AU - Gesu, G. P. AU - Giordano Accorsi, L. AU - Parmigiani, S. AU - Franca Corona, M. AU - Capra, V. AU - Mosca, A. AU - Giovannini, S. AU - Notturno, F. AU - Ciccocioppo, F. AU - Volpi, L. AU - Estienne, M. AU - De Michele, G. AU - Antenora, A. AU - Bilo, L. AU - Tavoni, A. AU - Zamponi, N. AU - Alfei, E. AU - Baranello, G. AU - Riva, D. AU - Penco, S. DB - Embase Medline DO - 10.1371/journal.pone.0110438 IS - 10 LA - English M3 - Article N1 - L600310275 2014-11-13 2014-11-19 PY - 2014 SN - 1932-6203 ST - PDCD10 gene mutations in multiple cerebral cavernous malformations T2 - PLoS ONE TI - PDCD10 gene mutations in multiple cerebral cavernous malformations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600310275&from=exporthttp://dx.doi.org/10.1371/journal.pone.0110438 VL - 9 ID - 7206 ER - TY - JOUR AD - Department of Internal Medicine and Medical Specialties, University of Rome "Sapienza", 00161, Rome, Italy. Department of Health Sciences, University of Catanzaro "Magna Graecia", Campus "S. Venuta", Viale Europa, 88100, Catanzaro, Italy. Institute of Medical Genetics, University Hospital "S. Maria della Misericordia", 33100, Udine, Italy. Department of Surgical Sciences, University of Rome "Sapienza", 00161, Rome, Italy. Department of Radiological, Oncological and Pathological Sciences, University of Rome "Sapienza", 00161, Rome, Italy. Department of Health Sciences, University of Catanzaro "Magna Graecia", Campus "S. Venuta", Viale Europa, 88100, Catanzaro, Italy. d.russo@unicz.it. AN - 25837309 AU - Sponziello, M. AU - Verrienti, A. AU - Rosignolo, F. AU - De Rose, R. F. AU - Pecce, V. AU - Maggisano, V. AU - Durante, C. AU - Bulotta, S. AU - Damante, G. AU - Giacomelli, L. AU - Di Gioia, C. R. AU - Filetti, S. AU - Russo, D. AU - Celano, M. DA - Nov DO - 10.1007/s12020-015-0586-x 10.1007/s12020-015-0586-x. Epub 2015 Apr 3. DP - Nlm ET - 2015/04/04 IS - 2 LA - eng PY - 2015 SN - 1355-008x SP - 434-41 ST - PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells T2 - Endocrine TI - PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells VL - 50 ID - 7207 ER - TY - JOUR AD - Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria. AN - 23064464 AU - Laimer, D. AU - Dolznig, H. AU - Kollmann, K. AU - Vesely, P. W. AU - Schlederer, M. AU - Merkel, O. AU - Schiefer, A. I. AU - Hassler, M. R. AU - Heider, S. AU - Amenitsch, L. AU - Thallinger, C. AU - Staber, P. B. AU - Simonitsch-Klupp, I. AU - Artaker, M. AU - Lagger, S. AU - Turner, S. D. AU - Pileri, S. AU - Piccaluga, P. P. AU - Valent, P. AU - Messana, K. AU - Landra, I. AU - Weichhart, T. AU - Knapp, S. AU - Shehata, M. AU - Todaro, M. AU - Sexl, V. AU - Höfler, G. AU - Piva, R. AU - Medico, E. AU - Ruggeri, B. A. AU - Cheng, M. AU - Eferl, R. AU - Egger, G. AU - Penninger, J. M. AU - Jaeger, U. AU - Moriggl, R. AU - Inghirami, G. AU - Kenner, L. DA - Nov DO - 10.1038/nm.2966 10.1038/nm.2966. Epub 2012 Oct 14. DP - Nlm ET - 2012/10/16 IS - 11 LA - eng PY - 2012 SN - 1078-8956 SP - 1699-704 ST - PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas T2 - Nat Med TI - PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas VL - 18 ID - 7208 ER - TY - JOUR AD - J.J. Yang, Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, United States AU - Zhang, Y. AU - Gao, Y. AU - Zhang, H. AU - Zhang, J. AU - He, F. AU - Hnízda, A. AU - Qian, M. AU - Liu, X. AU - Gocho, Y. AU - Pui, C. H. AU - Cheng, T. AU - Wang, Q. AU - Yang, J. J. AU - Zhu, X. AU - Liu, X. DB - Embase Medline DO - 10.1182/blood-2017-11-817510 IS - 20 LA - English M3 - Article N1 - L622326440 2018-06-05 2018-06-07 PY - 2018 SN - 1528-0020 0006-4971 SP - 2256-2261 ST - PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia T2 - Blood TI - PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622326440&from=exporthttp://dx.doi.org/10.1182/blood-2017-11-817510 VL - 131 ID - 7209 ER - TY - JOUR AD - Rady Children's Hospital San Diego and the University of California, San Diego, California 92123, USA. AN - 21255872 AU - Tom, W. L. AU - Hsu, J. W. AU - Eichenfield, L. F. AU - Friedlander, S. F. DA - Mar DO - 10.1016/j.jaad.2009.12.063 10.1016/j.jaad.2009.12.063. Epub 2011 Jan 20. DP - Nlm ET - 2011/01/25 IS - 3 LA - eng PY - 2011 SN - 0190-9622 SP - 559-72 ST - Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children T2 - J Am Acad Dermatol TI - Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children VL - 64 ID - 7210 ER - TY - JOUR AD - Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands Pediatric Oncology/Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam (CNZ), Netherlands Pediatric Oncology/Hematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands AU - Kaspers, G. J. L. AU - Zwaan, C. N. DB - Scopus DO - 10.3324/haematol.11203 IS - 11 M3 - Review N1 - Cited By :125 Export Date: 18 November 2020 PY - 2007 SP - 1519-1532 ST - Pediatric acute myeloid leukemia: Towards high-quality cure of all patients T2 - Haematologica TI - Pediatric acute myeloid leukemia: Towards high-quality cure of all patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-36349018880&doi=10.3324%2fhaematol.11203&partnerID=40&md5=9d7e117ec457b397adea27498d0ac6d8 VL - 92 ID - 7211 ER - TY - JOUR AD - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. AN - 15166029 AU - Brown, P. AU - Meshinchi, S. AU - Levis, M. AU - Alonzo, T. A. AU - Gerbing, R. AU - Lange, B. AU - Arceci, R. AU - Small, D. DA - Sep 15 DO - 10.1182/blood-2004-03-1034 10.1182/blood-2004-03-1034. Epub 2004 May 27. DP - Nlm ET - 2004/05/29 IS - 6 LA - eng PY - 2004 SN - 0006-4971 (Print) 0006-4971 SP - 1841-9 ST - Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition T2 - Blood TI - Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition VL - 104 ID - 7212 ER - TY - JOUR AD - Pediatric Oncology Branch National Cancer Institute National Institutes of Health, Bethesda, Maryland 20892, USA. kimsuyou@mail.nih.gov AN - 20485167 AU - Kim, S. Y. AU - Janeway, K. AU - Pappo, A. C2 - PMC2949288 C6 - NIHMS237419 DA - Jul DO - 10.1097/CCO.0b013e32833aaae7 10.1097/CCO.0b013e32833aaae7. DP - Nlm ET - 2010/05/21 IS - 4 LA - eng PY - 2010 SN - 1040-8746 (Print) 1040-8746 SP - 347-50 ST - Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches T2 - Curr Opin Oncol TI - Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches VL - 22 ID - 7213 ER - TY - JOUR AU - Segal, D. AU - Karajannis, M. A. DB - Embase Medline DO - 10.1016/j.cppeds.2016.04.004 IS - 7 LA - English M3 - Article N1 - L610620216 2016-06-10 2016-07-01 PY - 2016 SN - 1538-3199 1538-5442 SP - 242-250 ST - Pediatric Brain Tumors: An Update T2 - Current Problems in Pediatric and Adolescent Health Care TI - Pediatric Brain Tumors: An Update UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610620216&from=exporthttp://dx.doi.org/10.1016/j.cppeds.2016.04.004 VL - 46 ID - 7214 ER - TY - JOUR AN - 104974399. Language: English. Entry Date: 20110218. Revision Date: 20200708. Publication Type: Journal Article AU - MacDonald, Tamara DB - ccm DO - 10.3821/1913-701X-143.5.240 DP - EBSCOhost IS - 5 N1 - pictorial. Journal Subset: Biomedical; Canada; Peer Reviewed. NLM UID: 101257110. PY - 2010 SN - 1715-1635 SP - 240-247 ST - Pediatric cancer: a comprehensive review. Part II: chemotherapy, monoclonal antibodies and tyrosine kinase inhibitors T2 - Canadian Pharmacists Journal TI - Pediatric cancer: a comprehensive review. Part II: chemotherapy, monoclonal antibodies and tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104974399&site=ehost-live&scope=site VL - 143 ID - 7215 ER - TY - JOUR AD - C.H. Dunphy, Department of Pathology and Laboratory Medicine, CB# 7525, UNC, Chapel Hill, NC 27599-7525, United States AU - Dunphy, C. H. AU - DeMello, D. E. AU - Gale, G. B. C1 - adriamycin DB - Embase Medline IS - 12 LA - English M3 - Review N1 - L44906967 2007-01-11 PY - 2006 SN - 0003-9985 SP - 1859-1864 ST - Pediatric CD56+ anaplastic large cell lymphoma: A review of the literature T2 - Archives of Pathology and Laboratory Medicine TI - Pediatric CD56+ anaplastic large cell lymphoma: A review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L44906967&from=export VL - 130 ID - 7216 ER - TY - JOUR AD - Division of Hematology/Oncology/Stem Cell Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Pediatrics, Northwestern University Feinberg, School of Medicine, Chicago, IL, United States Michael Cuccione Childhood Cancer Research Program, BC Children's Hospital, Child and Family Research Institute, Vancouver, BC, Canada Division of Pediatric Oncology and Hematology, Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany Centre d'Investigation Clinique 1402, INSERM, University Hospital Poitiers, Poitiers, France Division of Pediatric Hematology and Oncology, University Children's Hospital, Dresden, Germany AU - Hijiya, N. AU - Schultz, K. R. AU - Metzler, M. AU - Millot, F. AU - Suttorp, M. DB - Scopus DO - 10.1182/blood-2015-06-648667 IS - 4 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2016 SP - 392-399 ST - Pediatric chronic myeloid leukemia is a unique disease that requires a different approach T2 - Blood TI - Pediatric chronic myeloid leukemia is a unique disease that requires a different approach UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958225376&doi=10.1182%2fblood-2015-06-648667&partnerID=40&md5=e50316650e109c4c35d45303facd4535 VL - 127 ID - 7217 ER - TY - JOUR AD - Department of Medicine, Boston Children's Hospital, Boston, MA, United States Nemours Center for Cancer and Blood Disorders, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, United States Department of Pathology and Laboratory Medicine, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, United States Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Department of Medicine, Division of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Lewen, M. AU - Gresh, R. AU - Queenan, M. AU - Paessler, M. AU - Pillai, V. AU - Hexner, E. AU - Frank, D. AU - Bagg, A. AU - Aplenc, R. AU - Caywood, E. AU - Wertheim, G. C7 - 14 DB - Scopus DO - 10.1186/s40364-016-0069-0 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2016 ST - Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report T2 - Biomarker Research TI - Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056447718&doi=10.1186%2fs40364-016-0069-0&partnerID=40&md5=ab9f0aed5f0eb89521f7ac2c64e3b855 VL - 4 ID - 7218 ER - TY - JOUR AD - Speciality Medical Officer, Department of Pathology, Melaka Manipal Medical College, Manipal campus, Manipal Academy of Higher Education, Karnataka, India Assistant Professor, Department of Pathology, Melaka Manipal Medical College, Manipal campus, Manipal Academy of Higher Education, Karnataka, India Junior Resident, Dept. of Pathology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India Associate Professor, Dept. of Pathology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India AN - 144463835. Language: English. Entry Date: 20200720. Revision Date: 20200720. Publication Type: Article AU - Shanthakumari, B. R. AU - Singh, Varun Kumar AU - Ramakrishnan, Karthik AU - Belurkar, Sushma DB - ccm DP - EBSCOhost IS - 4 N1 - case study; pictorial. Journal Subset: Allied Health; Asia. PY - 2019 SN - 0972-5997 SP - 1-3 ST - Pediatric Chronic Myeloid Leukemia: Case Report of a Disease with a Unique Biology T2 - Online Journal of Health & Allied Sciences TI - Pediatric Chronic Myeloid Leukemia: Case Report of a Disease with a Unique Biology UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144463835&site=ehost-live&scope=site VL - 18 ID - 7219 ER - TY - JOUR AD - Pediatric Oncology Unit, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom AU - Hargrave, D. R. AU - Zacharoulis, S. DB - Scopus DO - 10.1586/14737175.7.8.1029 IS - 8 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2007 SP - 1029-1042 ST - Pediatric CNS tumors: Current treatment and future directions T2 - Expert Review of Neurotherapeutics TI - Pediatric CNS tumors: Current treatment and future directions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548014961&doi=10.1586%2f14737175.7.8.1029&partnerID=40&md5=c73ed1b2eee2c191eb71e0676dd2153d VL - 7 ID - 7220 ER - TY - JOUR AD - L. Gore, Pediatrics Mail Stop 8302, Aurora, CO 80045, United States AU - Macy, M. E. AU - Sawczyn, K. K. AU - Garrington, T. P. AU - Graham, D. K. AU - Gore, L. C1 - bms 354825 cep 701 ps 341 sti 571 DB - Embase Medline DO - 10.1007/s11912-008-0073-0 IS - 6 LA - English M3 - Review N1 - L354099820 2009-02-17 PY - 2008 SN - 1523-3790 SP - 477-490 ST - Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials T2 - Current Oncology Reports TI - Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354099820&from=exporthttp://dx.doi.org/10.1007/s11912-008-0073-0 VL - 10 ID - 7221 ER - TY - JOUR AD - D. Cao, Department of Radiology, The First hospital of Jilin University, XinMin Street 71, Chang Chun, China AU - Liu, L. AU - Kong, X. AU - Lu, X. AU - Cao, D. DB - Embase DO - 10.4081/cp.2016.853 IS - 4 LA - English M3 - Review N1 - L614248946 2017-02-07 2017-02-28 PY - 2016 SN - 2039-7283 2039-7275 SP - 113-116 ST - Pediatric endobronchial inflammatory myofibroblastic tumor: A case report and review of the literature T2 - Clinics and Practice TI - Pediatric endobronchial inflammatory myofibroblastic tumor: A case report and review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614248946&from=exporthttp://dx.doi.org/10.4081/cp.2016.853 VL - 6 ID - 7222 ER - TY - JOUR AD - Department of Radiology, Miller School of Medicine, University of Miami, Coral Gables, FL, United States Department of Surgery, Miller School of Medicine, University of Miami, Coral Gables, FL 33146, United States AU - Quiroz, H. J. AU - Willobee, B. A. AU - Sussman, M. S. AU - Fox, B. R. AU - Thorson, C. M. AU - Sola, J. E. AU - Perez, E. A. C7 - 54 DB - Scopus DO - 10.21037/tgh.2018.07.08 IS - August M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 ST - Pediatric gastrointestinal stromal tumors—a review of diagnostic modalities T2 - Translational Gastroenterology and Hepatology TI - Pediatric gastrointestinal stromal tumors—a review of diagnostic modalities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051752995&doi=10.21037%2ftgh.2018.07.08&partnerID=40&md5=28da4b66df6e272c7e84fab89c58c88b VL - 3 ID - 7223 ER - TY - JOUR AD - Department of Pediatrics, Hematology/Oncology, Wake Forest University, School of Medicine, Winston-Salem, NC, United States Department of Pediatrics, Hematology/Oncology, Wake Forest University, Health Sciences Building, Medical Center Blvd, Winston-Salem, NC 27157, United States AU - Castellino, S. M. AU - McLean, T. W. DB - Scopus DO - 10.1097/CCO.0b013e3280ad43ce IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2007 SP - 248-253 ST - Pediatric genitourinary tumors T2 - Current Opinion in Oncology TI - Pediatric genitourinary tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247161829&doi=10.1097%2fCCO.0b013e3280ad43ce&partnerID=40&md5=374fd0c835c75eb3590767f4ad6fd21c VL - 19 ID - 7224 ER - TY - JOUR AN - 27061517 AU - Printz, C. DA - Apr 15 DO - 10.1002/cncr.29999 10.1002/cncr.29999. DP - Nlm ET - 2016/04/12 IS - 8 LA - eng PY - 2016 SN - 0008-543x SP - 1148 ST - Pediatric gliomas with CRAF fusions may require combination treatment T2 - Cancer TI - Pediatric gliomas with CRAF fusions may require combination treatment VL - 122 ID - 7225 ER - TY - JOUR AD - Department of Pediatrics, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, China AU - Jin, M. AU - Xu, S. AU - An, Q. DB - Scopus DO - 10.3892/ol.2017.6106 IS - 1 M3 - Review N1 - Export Date: 18 November 2020 PY - 2017 SP - 10-14 ST - Pediatric haematopoiesis and related malignancies (Review) T2 - Oncology Letters TI - Pediatric haematopoiesis and related malignancies (Review) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020222334&doi=10.3892%2fol.2017.6106&partnerID=40&md5=26caef9c17b5815d8d91f2642801ec3c VL - 14 ID - 7226 ER - TY - JOUR AD - Department of Medicine, Children's Hospital Boston, MA, USA. katherine.janeway@childrens.harvard.edu AN - 17909012 AU - Janeway, K. A. AU - Liegl, B. AU - Harlow, A. AU - Le, C. AU - Perez-Atayde, A. AU - Kozakewich, H. AU - Corless, C. L. AU - Heinrich, M. C. AU - Fletcher, J. A. DA - Oct 1 DO - 10.1158/0008-5472.Can-07-1938 10.1158/0008-5472.CAN-07-1938. DP - Nlm ET - 2007/10/03 IS - 19 LA - eng PY - 2007 SN - 0008-5472 (Print) 0008-5472 SP - 9084-8 ST - Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors T2 - Cancer Res TI - Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors VL - 67 ID - 7227 ER - TY - JOUR AD - M.J. Fisher, Division of Oncology, Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, United States AU - Sievert, A. J. AU - Fisher, M. J. DB - Embase Medline DO - 10.1177/0883073809342005 IS - 11 LA - English M3 - Conference Paper N1 - L355575986 2009-12-11 PY - 2009 SN - 0883-0738 1708-8283 SP - 1397-1408 ST - Pediatric low-grade gliomas T2 - Journal of Child Neurology TI - Pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355575986&from=exporthttp://dx.doi.org/10.1177/0883073809342005 VL - 24 ID - 7228 ER - TY - JOUR AD - M.W. Kieran, Dana-Farber Cancer Institute and Boston Children's Hospital 450 Brookline Avenue, Boston, MA 02215, United States AU - Bergthold, G. AU - Bandopadhayay, P. AU - Bi, W. L. AU - Ramkissoon, L. AU - Stiles, C. AU - Segal, R. A. AU - Beroukhim, R. AU - Ligon, K. L. AU - Grill, J. AU - Kieran, M. W. C1 - vp 16 DB - Embase Medline DO - 10.1016/j.bbcan.2014.02.004 IS - 2 LA - English M3 - Article N1 - L372623831 2014-03-25 2020-10-08 PY - 2014 SN - 1879-2561 0304-419X SP - 294-307 ST - Pediatric low-grade gliomas: How modern biology reshapes the clinical field T2 - Biochimica et Biophysica Acta - Reviews on Cancer TI - Pediatric low-grade gliomas: How modern biology reshapes the clinical field UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372623831&from=exporthttp://dx.doi.org/10.1016/j.bbcan.2014.02.004 VL - 1845 ID - 7229 ER - TY - JOUR AD - J.H. Aldrink, Division of Pediatric Surgery, Department of Surgery, Nationwide Childrens Hospital, The Ohio State University College of Medicine, Nationwide Childrens Dr, FB Suite 6B.1, Columbus, Ohio, United States AU - Tracy, E. T. AU - Aldrink, J. H. DB - Embase Medline DO - 10.1053/j.sempedsurg.2016.09.010 IS - 5 LA - English M3 - Article N1 - L613650817 2016-12-16 2017-01-12 PY - 2016 SN - 1532-9453 1055-8586 SP - 290-298 ST - Pediatric melanoma T2 - Seminars in Pediatric Surgery TI - Pediatric melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613650817&from=exporthttp://dx.doi.org/10.1053/j.sempedsurg.2016.09.010 VL - 25 ID - 7230 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Niemeyer, C. M. AU - Kratz, C. P. AU - Hasle, H. DB - Scopus DO - 10.1007/s11864-005-0004-3 IS - 3 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2005 SP - 209-214 ST - Pediatric myelodysplastic syndromes T2 - Current Treatment Options in Oncology TI - Pediatric myelodysplastic syndromes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21744441996&doi=10.1007%2fs11864-005-0004-3&partnerID=40&md5=15224ad7e6f628114f9fbdd8f539b30b VL - 6 ID - 7231 ER - TY - JOUR AD - Department of Pediatric Oncology, Adolescents and Young Adults, Institut Curie, 26 rue d'Ulm, Paris, 75005, France Department of Translational Research, Institut Curie, Paris, France Department of Radiology, Institut Curie, Paris, France Department of Pathology, Institut Curie, Paris, France Department of Pediatric Surgery, Necker Enfants-Malades Hospital, Assistance Publique, Paris, France Department of Somatic Genetics, Institut Curie, Paris, France Department of Pediatrics, University of Paris-Descartes, Sorbonne Paris Cité, Paris, France Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France INSERM U830 Research Center, Institut Curie, Paris, France AU - Jiménez, I. AU - Brisse, H. J. AU - Fréneaux, P. AU - Sarnacki, S. AU - Michon, J. AU - Orbach, D. AU - Pierron, G. AU - Clément, N. AU - Doz, F. AU - Escudier, B. AU - Schleiermacher, G. DB - Scopus DO - 10.1097/MPH.0000000000000774 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - e279-e284 ST - Pediatric Patient with Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature T2 - Journal of Pediatric Hematology/Oncology TI - Pediatric Patient with Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016171171&doi=10.1097%2fMPH.0000000000000774&partnerID=40&md5=2abefef3495c813e8066b3eace9b0a8e VL - 39 ID - 7232 ER - TY - JOUR AD - S. Rangaraju, Ignyta, Inc, San Diego, CA, United States AU - Rangaraju, S. AU - Li, G. AU - Christiansen, J. AU - Hornby, Z. AU - Multani, P. AU - Esquibel, V. AU - Maneval, E. C. DB - Embase DO - 10.1093/neuonc/nox083 LA - English M3 - Conference Abstract N1 - L620678279 2018-02-19 PY - 2017 SN - 1523-5866 SP - iv53 ST - Pediatric phase 1/1B study of entrectinib in patients with primary brain tumors, neuroblastoma, and ntrk, ros1, or alk fusions T2 - Neuro-Oncology TI - Pediatric phase 1/1B study of entrectinib in patients with primary brain tumors, neuroblastoma, and ntrk, ros1, or alk fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620678279&from=exporthttp://dx.doi.org/10.1093/neuonc/nox083 VL - 19 ID - 7233 ER - TY - JOUR AU - Aplenc, R. AU - Blaney, S. M. AU - Strauss, L. C. AU - Balis, F. M. AU - Shusterman, S. AU - Ingle, A. M. AU - Agrawal, S. AU - Sun, J. AU - Wright, J. J. AU - Adamson, P. C. DB - Scopus DO - 10.1200/JCO.2010.30.7231 IS - 7 M3 - Article N1 - Cited By :75 Export Date: 18 November 2020 PY - 2011 SP - 839-844 ST - Pediatric phase I trial and pharmacokinetic study of dasatinib: A report from the children's oncology group phase I consortium T2 - Journal of Clinical Oncology TI - Pediatric phase I trial and pharmacokinetic study of dasatinib: A report from the children's oncology group phase I consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952319155&doi=10.1200%2fJCO.2010.30.7231&partnerID=40&md5=a165c96eaa0b981bbca31ff8a1381cb3 VL - 29 ID - 7234 ER - TY - JOUR AD - C.P. Reynolds, Texas Tech University Health Sciences Center, Lubbock, TX, United States AU - Reynolds, C. P. AU - Kang, M. H. AU - Carol, H. AU - Lock, R. B. AU - Gorlick, R. AU - Kolb, E. A. AU - Alexander, D. AU - Kurmasheva, R. T. AU - Keir, S. T. AU - Maris, J. M. AU - Wu, J. AU - Houghton, P. J. AU - Smith, M. A. DB - Embase DO - 10.1158/1535-7163.TARG-11-C106 IS - 11 LA - English M3 - Conference Abstract N1 - L70609702 2011-12-20 PY - 2011 SN - 1535-7163 ST - Pediatric Preclinical Testing Program (PPTP) Stage 1 evaluation of the PI3K inhibitor XL147 (SAR245408) T2 - Molecular Cancer Therapeutics TI - Pediatric Preclinical Testing Program (PPTP) Stage 1 evaluation of the PI3K inhibitor XL147 (SAR245408) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70609702&from=exporthttp://dx.doi.org/10.1158/1535-7163.TARG-11-C106http://mct.aacrjournals.org/search?tocsectionid=Pharmacokinetics+and+Pharmacodynamics%3A+Poster+Presentations+-+Proffered+Abstracts&displaysectionid=Pharmacokinetics+and+Pharmacodynamics%3A+Poster+Presentations+-+Proffered+Abstracts&volume=10&issue=Supplement+1&hits=10&flag=MTG_ABSTRACT_ARTICLE&submit=Submit VL - 10 ID - 7235 ER - TY - JOUR AD - A.W. Baqir, SUNY Downstate, United States AU - Baqir, A. W. AU - Gupta, R. AU - Dresner, L. AU - Zuretti, A. DB - Embase DO - 10.1093/ajcp/aqy090 LA - English M3 - Conference Abstract N1 - L629440950 2019-10-02 PY - 2018 SN - 1943-7722 SP - S21 ST - A pediatric primary anaplastic large cell lymphoma of the breast: Unusual presentation in an unexpected clinical setting T2 - American Journal of Clinical Pathology TI - A pediatric primary anaplastic large cell lymphoma of the breast: Unusual presentation in an unexpected clinical setting UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629440950&from=exporthttp://dx.doi.org/10.1093/ajcp/aqy090 VL - 150 ID - 7236 ER - TY - JOUR AD - Department of Medicine, University of Chicago Medical Center, Chicago, IL, United States AU - Stock, W. DB - Scopus IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2009 SP - 244-246 ST - Pediatric regimens for adult acute lymphoblastic leukemia T2 - Clinical Advances in Hematology and Oncology TI - Pediatric regimens for adult acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-66449131835&partnerID=40&md5=fbaec450eeb7a4d58a453cff857c20c0 VL - 7 ID - 7237 ER - TY - JOUR AD - Children's Mercy Hospitals and Clinics, 2401 Gillham Road Kansas City USA Alberta Children's Hospital, Calgary Canada AN - 104279147. Language: English. Entry Date: 20130426. Revision Date: 20200708. Publication Type: Journal Article AU - August, Keith AU - Narendran, Aru AU - Neville, Kathleen DB - ccm DO - 10.1007/s40265-013-0026-2 DP - EBSCOhost IS - 5 N1 - review; tables/charts. Journal Subset: Australia & New Zealand; Biomedical; Peer Reviewed. Special Interest: Oncologic Care; Pediatric Care. NLM UID: 7600076. PMID: NLM23568274. PY - 2013 SN - 0012-6667 SP - 439-461 ST - Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions T2 - Drugs TI - Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104279147&site=ehost-live&scope=site VL - 73 ID - 7238 ER - TY - JOUR AD - N. Federman, Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States AU - Anderson, J. L. AU - Denny, C. T. AU - Tap, W. D. AU - Federman, N. C1 - amg 655 arq 197 cp 751871 g 3139 gleevec imc 3g3 imc a 12 imc c 225 mln 8237 pci 24781 pf 02341066 r 1507 rad 001 sb 939 DB - Embase Medline DO - 10.1038/pr.2012.54 IS - 2 LA - English M3 - Review N1 - L365329139 2012-08-03 2012-08-13 PY - 2012 SN - 0031-3998 1530-0447 SP - 112-121 ST - Pediatric sarcomas: Translating molecular pathogenesis of disease to novel therapeutic possibilities T2 - Pediatric Research TI - Pediatric sarcomas: Translating molecular pathogenesis of disease to novel therapeutic possibilities UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365329139&from=exporthttp://dx.doi.org/10.1038/pr.2012.54 VL - 72 ID - 7239 ER - TY - JOUR AD - A. Louissaint, Massachusetts General Hospital, Department of Pathology, 55 Fruit St, Warren 2, Boston, MA, United States AU - Louissaint, A. AU - Schafernak, K. T. AU - Geyer, J. T. AU - Kovach, A. E. AU - Ghandi, M. AU - Gratzinger, D. AU - Roth, C. G. AU - Paxton, C. N. AU - Kim, S. AU - Namgyal, C. AU - Morin, R. AU - Morgan, E. A. AU - Neuberg, D. S. AU - South, S. T. AU - Harris, M. H. AU - Hasserjian, R. P. AU - Hochberg, E. P. AU - Garraway, L. A. AU - Harris, N. L. AU - Weinstock, D. M. DB - Embase Medline DO - 10.1182/blood-2015-12-682591 IS - 8 LA - English M3 - Article N1 - L611891113 2016-09-07 2016-09-16 PY - 2016 SN - 1528-0020 0006-4971 SP - 1093-1100 ST - Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations T2 - Blood TI - Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611891113&from=exporthttp://dx.doi.org/10.1182/blood-2015-12-682591 VL - 128 ID - 7240 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, United States Harvard Medical School, United States Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute, Boston, MA, United States Department of Pathology, United States Division of Hematology and Oncology, Portland VA Medical Center, United States Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States AU - Rege, T. A. AU - Wagner, A. J. AU - Corless, C. L. AU - Heinrich, M. C. AU - Hornick, J. L. DB - Scopus DO - 10.1097/PAS.0b013e31820e5f7d IS - 4 M3 - Article N1 - Cited By :82 Export Date: 18 November 2020 PY - 2011 SP - 495-504 ST - "Pediatric-type" gastrointestinal stromal tumors in adults: Distinctive histology predicts genotype and clinical behavior T2 - American Journal of Surgical Pathology TI - "Pediatric-type" gastrointestinal stromal tumors in adults: Distinctive histology predicts genotype and clinical behavior UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953183996&doi=10.1097%2fPAS.0b013e31820e5f7d&partnerID=40&md5=9d314af3efcb6f58746ac523aee09799 VL - 35 ID - 7241 ER - TY - JOUR AD - Paediatric Surgery, Great Ormond Street Hospital, London, United Kingdom Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Fegan 3, Boston, Massachusetts 02445, United States AU - Mullassery, D. AU - Weldon, C. B. DB - Scopus DO - 10.1053/j.sempedsurg.2016.09.004 IS - 5 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 305-310 ST - Pediatric/“Wildtype” gastrointestinal stromal tumors T2 - Seminars in Pediatric Surgery TI - Pediatric/“Wildtype” gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002979737&doi=10.1053%2fj.sempedsurg.2016.09.004&partnerID=40&md5=2faadd309465983106b158bcfdff45dc VL - 25 ID - 7242 ER - TY - JOUR AD - University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: aribas@mednet.ucla.edu. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. University of Zürich, Zürich, Switzerland. University Hospital Essen, Essen, Germany. The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Gustave Roussy and Paris-Sud University, Villejuif, France. Dana-Farber Cancer Institute, Boston, MA, USA. Sheba Medical Center, Tel Hashomer, Israel. New York University Cancer Institute, New York, NY, USA. University of Colorado Denver, Aurora, CO, USA. University of Arizona Cancer Center, Tucson, AZ, USA. Netherlands Cancer Institute, Amsterdam, Netherlands. Beverly Hills Cancer Center, Beverly Hills, CA, USA. Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. Duke Cancer Institute, Durham, NC, USA. Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. University Medical Center, Mainz, Germany. Universitätsklinikum Tübingen, Tübingen, Germany. Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. University of North Carolina, Chapel Hill, NC, USA. University of Pittsburgh, Pittsburgh, PA, USA. Memorial Sloan Kettering Cancer Center, New York, NY, USA. Merck & Co, Kenilworth, NJ, USA. University of California, San Francisco, San Francisco, CA, USA. AN - 26115796 AU - Ribas, A. AU - Puzanov, I. AU - Dummer, R. AU - Schadendorf, D. AU - Hamid, O. AU - Robert, C. AU - Hodi, F. S. AU - Schachter, J. AU - Pavlick, A. C. AU - Lewis, K. D. AU - Cranmer, L. D. AU - Blank, C. U. AU - O'Day, S. J. AU - Ascierto, P. A. AU - Salama, A. K. AU - Margolin, K. A. AU - Loquai, C. AU - Eigentler, T. K. AU - Gangadhar, T. C. AU - Carlino, M. S. AU - Agarwala, S. S. AU - Moschos, S. J. AU - Sosman, J. A. AU - Goldinger, S. M. AU - Shapira-Frommer, R. AU - Gonzalez, R. AU - Kirkwood, J. M. AU - Wolchok, J. D. AU - Eggermont, A. AU - Li, X. N. AU - Zhou, W. AU - Zernhelt, A. M. AU - Lis, J. AU - Ebbinghaus, S. AU - Kang, S. P. AU - Daud, A. DA - Aug DO - 10.1016/s1470-2045(15)00083-2 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. DP - Nlm ET - 2015/06/28 IS - 8 LA - eng PY - 2015 SN - 1470-2045 SP - 908-18 ST - Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial T2 - Lancet Oncol TI - Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial VL - 16 ID - 7243 ER - TY - JOUR AD - E.M. Speer, Department of Pediatrics, Stony Brook University, School of Medicine, Stony Brook, NY, United States AU - Speer, E. M. AU - Dowling, D. J. AU - Ozog, L. S. AU - Xu, J. AU - Yang, J. AU - Kennady, G. AU - Levy, O. DB - Embase Medline DO - 10.1038/pr.2017.6 IS - 5 LA - English M3 - Article N1 - L617159861 2017-07-10 2017-07-13 PY - 2017 SN - 1530-0447 0031-3998 SP - 806-816 ST - Pentoxifylline inhibits TLR- A nd inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns T2 - Pediatric Research TI - Pentoxifylline inhibits TLR- A nd inflammasome-mediated in vitro inflammatory cytokine production in human blood with greater efficacy and potency in newborns UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617159861&from=exporthttp://dx.doi.org/10.1038/pr.2017.6 VL - 81 ID - 7244 ER - TY - JOUR AD - Department of Pediatrics, Division of Neonatology, Stony Brook University School of Medicine, Stony Brook, NY, United States Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, United States Precision Vaccine Program, Boston Children’s Hospital, Boston, MA, United States AU - Speer, E. M. AU - Dowling, D. J. AU - Xu, J. AU - Ozog, L. S. AU - Mathew, J. A. AU - Chander, A. AU - Yin, D. AU - Levy, O. C7 - e0196352 DB - Scopus DO - 10.1371/journal.pone.0196352 IS - 5 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 ST - Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro T2 - PLoS ONE TI - Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046364989&doi=10.1371%2fjournal.pone.0196352&partnerID=40&md5=318800f9b20a3e075462c4cb89cfd43a VL - 13 ID - 7245 ER - TY - JOUR AD - Department of Biological Sciences, CIRPeB and IBB CNR, University of Naples "Federico II," Napoli, Italy. AN - 22654515 AU - Cantisani, M. AU - Vitiello, M. AU - Falanga, A. AU - Finamore, E. AU - Galdiero, M. AU - Galdiero, S. C2 - PMC3363952 DO - 10.2147/ijn.S30467 10.2147/IJN.S30467. Epub 2012 May 11. DP - Nlm ET - 2012/06/02 LA - eng PY - 2012 SN - 1176-9114 (Print) 1176-9114 SP - 2361-71 ST - Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity T2 - Int J Nanomedicine TI - Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity VL - 7 ID - 7246 ER - TY - JOUR AD - X. Zhang, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China AU - Ma, Z. AU - Liu, X. AU - Li, F. AU - Wang, Y. AU - Xu, Y. AU - Zhang, M. AU - Zhang, X. AU - Ying, X. AU - Zhang, X. DB - Embase Medline DO - 10.18632/oncotarget.11684 IS - 41 LA - English M3 - Article N1 - L613013865 2016-11-08 2016-11-30 PY - 2016 SN - 1949-2553 SP - 66558-66568 ST - Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/ mTOR signaling T2 - Oncotarget TI - Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/ mTOR signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613013865&from=exporthttp://dx.doi.org/10.18632/oncotarget.11684 VL - 7 ID - 7247 ER - TY - JOUR AD - Department of Radiology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-ku, Saitama, Saitama Prefecture, 330-8777, Japan Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan Department of Radiology, Keio University, School of Medicine, Tokyo, Japan AU - Hosokawa, T. AU - Hara, T. AU - Arakawa, Y. AU - Oguma, E. AU - Yamada, Y. DB - Scopus DO - 10.1097/MPH.0000000000001595 IS - 8 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - e822-e825 ST - Periosteal Reaction Possibly Induced by Pazopanib: A Case Report and Literature Review T2 - Journal of Pediatric Hematology/Oncology TI - Periosteal Reaction Possibly Induced by Pazopanib: A Case Report and Literature Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089906421&doi=10.1097%2fMPH.0000000000001595&partnerID=40&md5=882325a05ca5ba48868b8900855f875b VL - 42 ID - 7248 ER - TY - JOUR AD - S. Hausmann, Department of General Surgery, Technische Universität München, Munich, Germany AU - Hausmann, S. AU - Regel, I. AU - Mazur, P. AU - Federlein, A. AU - Wagner, N. AU - Steiger, K. AU - Michalski, C. AU - Erkan, M. AU - Friess, H. AU - Kleeff, J. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L71952079 2015-07-27 PY - 2015 SN - 1424-3903 SP - S33 ST - Periostin promotes pancreatic carcinogenesis and metastatic spread T2 - Pancreatology TI - Periostin promotes pancreatic carcinogenesis and metastatic spread UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71952079&from=export VL - 15 ID - 7249 ER - TY - JOUR AD - Department of Hematology and Medial Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road NE, Atlanta, GA 30322, United States Department of Pathology and Laboratory Medicine, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States Department of Biostatistics and Bioinformatics, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States AU - Lima, L. AU - Bernal-Mizrachi, L. AU - Saxe, D. AU - Mann, K. P. AU - Tighiouart, M. AU - Arellano, M. AU - Heffner, L. AU - McLemore, M. AU - Langston, A. AU - Winton, E. AU - Khoury, H. J. DB - Scopus DO - 10.1002/cncr.25678 IS - 6 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2011 SP - 1245-1252 ST - Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond T2 - Cancer TI - Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952375521&doi=10.1002%2fcncr.25678&partnerID=40&md5=4d82c6a4f751d32dfdf013bc4603942b VL - 117 ID - 7250 ER - TY - JOUR AD - D.A. Stevenson, University of Utah, Division of Medical Genetics, 2C412 SOM, Salt Lake City, UT 84132, United States AU - Stevenson, D. A. AU - Allen, S. AU - Tidyman, W. E. AU - Carey, J. C. AU - Viskochil, D. H. AU - Stevens, A. AU - Hanson, H. AU - Sheng, X. AU - Thompson, B. A. AU - J. Okumura, M. AU - Reinker, K. AU - Johnson, B. AU - Rauen, K. A. DB - Embase Medline DO - 10.1002/mus.23324 IS - 3 LA - English M3 - Article N1 - L365498347 2012-08-31 2012-09-05 PY - 2012 SN - 0148-639X 1097-4598 SP - 394-399 ST - Peripheral muscle weakness in RASopathies T2 - Muscle and Nerve TI - Peripheral muscle weakness in RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365498347&from=exporthttp://dx.doi.org/10.1002/mus.23324 VL - 46 ID - 7251 ER - TY - JOUR AD - Second Department of Medicine, Bogenhausen Acad. Teaching Hospital, Munich, Germany Department of Pathology, Bogenhausen Acad. Teaching Hospital, Munich, Germany Department of Pathology, Heinrich-Heine-University, Düsseldorf, Germany Department of Pathology, Technical University of Munich, Munich, Germany Third Department of Medicine, Technical University of Munich, Munich, Germany Department of Surgery, Technical University of Munich, Munich, Germany Second Department of Medicine, Bogenhausen Acad. Teaching Hospital, Englschalkinger Strasse 77, 81925 Munich, Germany AU - Czekalla, R. AU - Fuchs, M. AU - Stölzle, A. AU - Nerlich, A. AU - Poremba, C. AU - Schaefer, K. L. AU - Weirich, G. AU - Höfler, H. AU - Schneller, F. AU - Peschel, C. AU - Siewert, J. R. AU - Schepp, W. DB - Scopus DO - 10.1097/00042737-200412000-00026 IS - 12 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2004 SP - 1391-1400 ST - Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: A case report T2 - European Journal of Gastroenterology and Hepatology TI - Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-10344225694&doi=10.1097%2f00042737-200412000-00026&partnerID=40&md5=10512ec9bf324aaa52d0d44f640aa60c VL - 16 ID - 7252 ER - TY - JOUR AU - Nikila, R. AU - Shivani, P. AU - Kesavan, M. R. AU - Venkateswaran, V. S. AU - Indira, J. AU - Balasubramaniam, R. AU - Lakshman, V. AU - Ramya, U. AU - Revathi, R. DB - Embase DO - 10.1016/j.phoj.2019.08.081 IS - 2 LA - English M3 - Conference Abstract N1 - L2002713669 2019-09-05 PY - 2019 SN - 2468-1245 SP - S29 ST - Peripheral T cell lymphoma (PTCL) in children and adolescents – a single centre experience T2 - Pediatric Hematology Oncology Journal TI - Peripheral T cell lymphoma (PTCL) in children and adolescents – a single centre experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002713669&from=exporthttp://dx.doi.org/10.1016/j.phoj.2019.08.081 VL - 4 ID - 7253 ER - TY - JOUR AD - S. White, University of Illinois, College of Medicine at Peoria, Peoria, IL, United States AU - White, S. AU - Bach, S. AU - Chiang, J. AU - Lin, J. AU - Lucas, J. AU - Qaddoumi, I. AU - Aprahamian, C. AU - O'Suoji, C. AU - Libes, J. DB - Embase DO - 10.1002/pbc.27057 LA - English M3 - Conference Abstract N1 - L621728784 2018-04-24 PY - 2018 SN - 1545-5017 SP - S70 ST - Peritoneal dissemination of braf fusion positive high grade neuroepithelial tumors in a child with a ventriculo-peritoneal shunt placed for a braf-fusion positive low grade glioma T2 - Pediatric Blood and Cancer TI - Peritoneal dissemination of braf fusion positive high grade neuroepithelial tumors in a child with a ventriculo-peritoneal shunt placed for a braf-fusion positive low grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621728784&from=exporthttp://dx.doi.org/10.1002/pbc.27057 VL - 65 ID - 7254 ER - TY - JOUR AD - M.-S. Lee, Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taiwan AU - Huang, H. P. AU - Chang, M. H. AU - Chen, Y. T. AU - Hsu, H. Y. AU - Chiang, C. L. AU - Cheng, T. S. AU - Wu, Y. M. AU - Wu, M. Z. AU - Hsu, Y. C. AU - Shen, C. C. AU - Lee, C. N. AU - Chuang, Y. H. AU - Hong, C. L. AU - Jeng, Y. M. AU - Chen, P. H. AU - Chen, H. L. AU - Lee, M. S. DB - Embase Medline DO - 10.1002/hep.24657 IS - 1 LA - English M3 - Article N1 - L51723667 2011-11-22 2012-01-03 PY - 2012 SN - 0270-9139 1527-3350 SP - 161-172 ST - Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation T2 - Hepatology TI - Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51723667&from=exporthttp://dx.doi.org/10.1002/hep.24657 VL - 55 ID - 7255 ER - TY - JOUR AD - J. Lin, Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children’s Hospital, Department of Pediatrics, The Ohio State University, 700 Children’s Drive, Columbus, OH, United States AU - Wu, X. AU - Xiao, H. AU - Wang, R. AU - Liu, L. AU - Li, C. AU - Lin, J. C1 - azd6244(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.2174/1568009615666150916093110 IS - 7 LA - English M3 - Article N1 - L612155724 2016-09-19 2016-09-22 PY - 2016 SN - 1873-5576 1568-0096 SP - 631-638 ST - Persistent GP130/STAT3 signaling contributes to the resistance of doxorubicin, cisplatin, and MEK inhibitor in human rhabdomyosarcoma cells T2 - Current Cancer Drug Targets TI - Persistent GP130/STAT3 signaling contributes to the resistance of doxorubicin, cisplatin, and MEK inhibitor in human rhabdomyosarcoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612155724&from=exporthttp://dx.doi.org/10.2174/1568009615666150916093110 VL - 16 ID - 7256 ER - TY - JOUR AD - Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom AU - Balfour-Lynn, I. M. DB - Scopus DO - 10.1016/j.prrv.2014.04.003 IS - S1 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2014 SP - 2-5 ST - Personalised medicine in cystic fibrosis is unaffordable T2 - Paediatric Respiratory Reviews TI - Personalised medicine in cystic fibrosis is unaffordable UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901639121&doi=10.1016%2fj.prrv.2014.04.003&partnerID=40&md5=68810dad80d8535ae1e3a028eb850e83 VL - 15 ID - 7257 ER - TY - GEN AD - H. Hazin, New York Methodist Hospital, Brooklyn, NY, United States AU - Hazin, H. AU - Dosik, D. DB - Embase DO - 10.1007/978-3-319-12166-6_6 J2 - Adv. Predictive Prev. Personalised Med. LA - English M1 - (Hazin H., heshamhazin@yahoo.com; Dosik D., ddosik@aol.com) New York Methodist Hospital, Brooklyn, NY, United States M3 - Article N1 - L602792711 2015-03-18 2015-07-22 PY - 2015 SN - 2211-3509 2211-3495 SP - 53-60 ST - Personalized chemotherapy for hepatocellular carcinoma TI - Personalized chemotherapy for hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602792711&from=exporthttp://dx.doi.org/10.1007/978-3-319-12166-6_6 VL - 8 ID - 7258 ER - TY - JOUR AD - F.S. Ong, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States AU - Ong, F. S. AU - Das, K. AU - Wang, J. AU - Vakil, H. AU - Kuo, J. Z. AU - Blackwell, W. L. B. AU - Lim, S. W. AU - Goodarzi, M. O. AU - Bernstein, K. E. AU - Rotter, J. I. AU - Grody, W. W. DB - Embase Medline DO - 10.1586/erm.12.59 IS - 6 LA - English M3 - Review N1 - L365379001 2012-08-14 2012-08-21 PY - 2012 SN - 1473-7159 1744-8352 SP - 593-602 ST - Personalized medicine and pharmacogenetic biomarkers: Progress in molecular oncology testing T2 - Expert Review of Molecular Diagnostics TI - Personalized medicine and pharmacogenetic biomarkers: Progress in molecular oncology testing UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365379001&from=exporthttp://dx.doi.org/10.1586/erm.12.59 VL - 12 ID - 7259 ER - TY - JOUR AD - University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, RES 435B, Fort Worth, TX 76107, United States Department of Pharmacy, Memorial Regional Hospital, 3501 Johnson Street, Hollywood, FL 33021, United States AU - Monestime, S. AU - Lazaridis, D. DB - Scopus DO - 10.1007/s40268-020-00314-3 IS - 3 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 SP - 189-195 ST - Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor T2 - Drugs in R and D TI - Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087503907&doi=10.1007%2fs40268-020-00314-3&partnerID=40&md5=e43e935212411feff88b8c6dd3345dc5 VL - 20 ID - 7260 ER - TY - JOUR AD - M. Prieto-Barrios, Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain AU - Prieto-Barrios, M. AU - Llamas-Martin, R. AU - Velasco-Tamariz, V. AU - Calleja-Algarra, A. AU - Ruano, Y. AU - Ortiz-Romero, P. L. AU - Rodriguez-Peralto, J. L. DB - Embase Medline DO - 10.1111/bjd.16435 IS - 5 LA - English M3 - Article N1 - L622065395 2018-05-14 2019-11-20 PY - 2018 SN - 1365-2133 0007-0963 SP - 1163-1167 ST - Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma T2 - British Journal of Dermatology TI - Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622065395&from=exporthttp://dx.doi.org/10.1111/bjd.16435 VL - 179 ID - 7261 ER - TY - JOUR AD - S. Palencia Pérez, Hospital Universitario 12 De Octubre, Dermatology, Madrid, Spain AU - Palencia Pérez, S. AU - Prieto Barrios, M. AU - Llamas Martin, R. AU - Velasco Tamariz, V. AU - Calleja Algarra, A. AU - Aragón De Miguel, R. AU - Ruano, Y. AU - Postigo Llorente, C. AU - Rodríguez Peralto, J. L. AU - Ortiz Romero, P. L. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618778899 2017-10-23 PY - 2017 SN - 1525-1470 SP - S26 ST - Phacomatosis pigmentokeratotica: A case report of hras mosaicism T2 - Pediatric Dermatology TI - Phacomatosis pigmentokeratotica: A case report of hras mosaicism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618778899&from=exporthttp://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 7262 ER - TY - JOUR AD - M. Prieto Barrios, Dermatology, Hospital Universitario 12 De Octubre, Madrid, Spain AU - Prieto Barrios, M. AU - Llamas Martin, R. AU - Palencia Pérez, S. AU - Velasco Tamariz, V. AU - Yolanda, R. AU - Aragón De Miguel, R. AU - Calleja Algarra, A. AU - Gil De La Cruz, E. AU - Ortiz Romero, P. AU - Rodriguez Peralto, J. DB - Embase DO - 10.1016/j.jid.2017.07.214 IS - 10 LA - English M3 - Conference Abstract N1 - L618276579 2017-09-19 PY - 2017 SN - 1523-1747 SP - S229 ST - Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better understand cancer T2 - Journal of Investigative Dermatology TI - Phacomatosis Pigmentokeratotica: Mosaic RASopathies as a key to better understand cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618276579&from=exporthttp://dx.doi.org/10.1016/j.jid.2017.07.214 VL - 137 ID - 7263 ER - TY - JOUR AD - E. Degui, Pharmacy, IUCT Oncopole Toulouse, Toulouse, France AU - Degui, E. AU - Vinson, C. AU - Pelagatti, V. C. AU - Canonge, J. M. AU - Puisset, F. DB - Embase DO - 10.1007/s11096-016-0347-9 IS - 5 LA - English M3 - Conference Abstract N1 - L612648476 2016-10-17 PY - 2016 SN - 2210-7711 SP - 1338 ST - Pharmacist counselling for outpatient treated by oral chemotherapy T2 - International Journal of Clinical Pharmacy TI - Pharmacist counselling for outpatient treated by oral chemotherapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612648476&from=exporthttp://dx.doi.org/10.1007/s11096-016-0347-9 VL - 38 ID - 7264 ER - TY - JOUR AD - Vanderbilt-Ingram Cancer Center, 777 Preston Research Building, Nashville, TN 37232-6307, USA. jeff.sosman@vanderbilt.edu AN - 23569304 AU - Trunzer, K. AU - Pavlick, A. C. AU - Schuchter, L. AU - Gonzalez, R. AU - McArthur, G. A. AU - Hutson, T. E. AU - Moschos, S. J. AU - Flaherty, K. T. AU - Kim, K. B. AU - Weber, J. S. AU - Hersey, P. AU - Long, G. V. AU - Lawrence, D. AU - Ott, P. A. AU - Amaravadi, R. K. AU - Lewis, K. D. AU - Puzanov, I. AU - Lo, R. S. AU - Koehler, A. AU - Kockx, M. AU - Spleiss, O. AU - Schell-Steven, A. AU - Gilbert, H. N. AU - Cockey, L. AU - Bollag, G. AU - Lee, R. J. AU - Joe, A. K. AU - Sosman, J. A. AU - Ribas, A. DA - May 10 DO - 10.1200/jco.2012.44.7888 10.1200/JCO.2012.44.7888. Epub 2013 Apr 8. DP - Nlm ET - 2013/04/10 IS - 14 LA - eng PY - 2013 SN - 0732-183x SP - 1767-74 ST - Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma T2 - J Clin Oncol TI - Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma VL - 31 ID - 7265 ER - TY - JOUR AD - Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, United States AU - Mei, L. AU - Ontiveros, E. P. AU - Griffiths, E. A. AU - Thompson, J. E. AU - Wang, E. S. AU - Wetzler, M. DB - Scopus DO - 10.1016/j.blre.2015.01.001 IS - 4 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2015 SP - 243-249 ST - Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy T2 - Blood Reviews TI - Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937163670&doi=10.1016%2fj.blre.2015.01.001&partnerID=40&md5=008864be70b08417389479b2638ad097 VL - 29 ID - 7266 ER - TY - JOUR AD - AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom Department of Medical Oncology, Cancer Research Campaign, Christie Hospital NHS Trust, Manchester, United Kingdom AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom AU - Swaisland, H. C. AU - Ranson, M. AU - Smith, R. P. AU - Leadbetter, J. AU - Laight, A. AU - McKillop, D. AU - Wild, M. J. DB - Scopus DO - 10.2165/00003088-200544100-00005 IS - 10 M3 - Article N1 - Cited By :115 Export Date: 18 November 2020 PY - 2005 SP - 1067-1081 ST - Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol T2 - Clinical Pharmacokinetics TI - Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-25144436285&doi=10.2165%2f00003088-200544100-00005&partnerID=40&md5=56535905a413c8e55767e421d842718d VL - 44 ID - 7267 ER - TY - JOUR AD - BCLC group. Liver Unit, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd, University of Barcelona, Barcelona, Spain Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, Hospital Clínic de Barcelona. IDIBAPS. CIBERehd, University of Barcelona, Barcelona, Spain Medical Statistics Core Facility, IDIBAPS. Hospital Clínic de Barcelona. Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain BCLC group. Radiology department, Hospital Clínic de Barcelona. IDIBAPS, University of Barcelona, Barcelona, Spain AU - Díaz-González, Á AU - Sapena, V. AU - Boix, L. AU - Brunet, M. AU - Torres, F. AU - Llarch, N. AU - Samper, E. AU - Millán, O. AU - Corominas, J. AU - Iserte, G. AU - Sanduzzi-Zamparelli, M. AU - da Fonseca, L. G. AU - Darnell, A. AU - Belmonte, E. AU - Forner, A. AU - Ayuso, C. AU - Bruix, J. AU - Reig, M. DB - Scopus DO - 10.1111/liv.14587 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 2476-2488 ST - Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials T2 - Liver International TI - Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088370181&doi=10.1111%2fliv.14587&partnerID=40&md5=cd5c6a5b70b41b2dbafc71f996d43491 VL - 40 ID - 7268 ER - TY - JOUR AD - Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Pharmaceutical Services, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States Department of Pharmaceutical Sciences, University of Tennessee, Memphis, TN, United States AU - Christiansen, S. R. AU - Broniscer, A. AU - Panetta, J. C. AU - Stewart, C. F. DB - Scopus DO - 10.1592/phco.29.7.858 IS - 7 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2009 SP - 858-866 ST - Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: Case report and review of the literature T2 - Pharmacotherapy TI - Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: Case report and review of the literature UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650786282&doi=10.1592%2fphco.29.7.858&partnerID=40&md5=fd2a4b3f69a989fc3b4989a8c3c5fc28 VL - 29 ID - 7269 ER - TY - JOUR AD - Department of Clinical Pharmacology, Akros Pharma, Inc., Princeton, NJ, United States Chaikin Associates LLC, Sarasota, FL, United States DaVita Clinical Research, Minneapolis, MN, United States AU - Pai, S. M. AU - Chaikin, P. AU - Berg, J. K. DB - Scopus DO - 10.1002/jcph.1430 IS - 10 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 1379-1383 ST - Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance Hemodialysis T2 - Journal of Clinical Pharmacology TI - Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance Hemodialysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065748574&doi=10.1002%2fjcph.1430&partnerID=40&md5=67ecfdff3373012cc96c14c7ddb9139d VL - 59 ID - 7270 ER - TY - JOUR AD - Sun Yat‐sen University Cancer Center, Guangzhou, China Fudan University Shanghai Cancer Center, Shanghai, China China Development Unit, AstraZeneca, Zhangjiang Hi‐Tech Park, Shanghai, China AstraZeneca, Macclesfield, United Kingdom AN - 128708760. Language: English. Entry Date: 20180412. Revision Date: 20201026. Publication Type: Article AU - Zhao, Hongyun AU - Cao, Junning AU - Chang, Jianhua AU - Zhang, Zhenxian AU - Yang, Li AU - Wang, Jia AU - Cantarini, Mireille AU - Zhang, Li DB - ccm DO - 10.1002/jcph.1042 DP - EBSCOhost IS - 4 N1 - clinical trial; research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 0366372. PY - 2018 SN - 0091-2700 SP - 504-513 ST - Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study T2 - Journal of Clinical Pharmacology TI - Pharmacokinetics of Osimertinib in Chinese Patients With Advanced NSCLC: A Phase 1 Study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128708760&site=ehost-live&scope=site VL - 58 ID - 7271 ER - TY - JOUR AD - APEX GmbH, Munich, Germany AstraZeneca, Alderley Park, Macclesfield SK10 4TG, Cheshire, Germany AU - Weil, A. AU - Martin, P. AU - Smith, R. AU - Oliver, S. AU - Langmuir, P. AU - Read, J. AU - Molz, K. H. DB - Scopus DO - 10.2165/11534330-000000000-00000 IS - 9 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2010 SP - 607-618 ST - Pharmacokinetics of vandetanib in subjects with renal or hepatic impairment T2 - Clinical Pharmacokinetics TI - Pharmacokinetics of vandetanib in subjects with renal or hepatic impairment UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955454200&doi=10.2165%2f11534330-000000000-00000&partnerID=40&md5=84e15ad2cc8fdd762fc48d733c347bbf VL - 49 ID - 7272 ER - TY - JOUR AD - N. F. Schor, Department of Pediatrics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, United States AU - Ganeshan, V. R. AU - Schor, N. F. C1 - abt 751 DB - Embase Medline DO - 10.2165/11591630-000000000-00000 IS - 4 LA - English M3 - Review N1 - L362016658 2011-07-04 PY - 2011 SN - 1174-5878 1179-2019 SP - 245-255 ST - Pharmacologic management of high-risk neuroblastoma in children T2 - Pediatric Drugs TI - Pharmacologic management of high-risk neuroblastoma in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362016658&from=exporthttp://dx.doi.org/10.2165/11591630-000000000-00000 VL - 13 ID - 7273 ER - TY - JOUR AD - Roche Pharmaceuticals, 3431 Hillview Avenue, Palo Alto, CA 94304, USA, United States AU - Srinivasan, D. AU - Kosaka, A. H. AU - Daniels, D. V. AU - Ford, A. P. D. W. AU - Bhattacharya, A. DB - Scopus DO - 10.1016/j.ejphar.2004.10.004 IS - 3 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2004 SP - 155-167 ST - Pharmacological and functional characterization of bradykinin B 2 receptor in human prostate T2 - European Journal of Pharmacology TI - Pharmacological and functional characterization of bradykinin B 2 receptor in human prostate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8444231324&doi=10.1016%2fj.ejphar.2004.10.004&partnerID=40&md5=0567206e9f1427d3adb1655bc89afe6d VL - 504 ID - 7274 ER - TY - JOUR AD - M.W. Konstan, Department of Pediatrics, Case Western Reserve Univ. Sch. Med., Rainbow Babies and Children's Hosp., 11100 Euclid Avenue, Cleveland, OH 44106, United States AU - Konstan, M. W. AU - Davis, P. B. DB - Embase Medline DO - 10.1016/S0169-409X(02)00146-1 IS - 11 LA - English M3 - Review N1 - L35375768 2002-12-11 PY - 2002 SN - 0169-409X SP - 1409-1423 ST - Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis T2 - Advanced Drug Delivery Reviews TI - Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35375768&from=exporthttp://dx.doi.org/10.1016/S0169-409X(02)00146-1 VL - 54 ID - 7275 ER - TY - JOUR AD - R. Ruggieri, Center of Oncology and Cell Biology, Feinstein Institute, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, United States AU - Markowitz, D. AU - Powell, C. AU - Tran, N. L. AU - Berens, M. E. AU - Ryken, T. C. AU - Vanan, M. AU - Rosen, L. AU - He, M. AU - Sun, S. AU - Symons, M. AU - Al-Abed, Y. AU - Ruggieri, R. C1 - m 443 DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0849 IS - 8 LA - English M3 - Article N1 - L611997026 2016-09-13 2016-10-04 PY - 2016 SN - 1538-8514 1535-7163 SP - 1799-1808 ST - Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma T2 - Molecular Cancer Therapeutics TI - Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611997026&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-15-0849 VL - 15 ID - 7276 ER - TY - JOUR AD - R. Béliveau, Laboratoire d'Oncologie Moléculaire, Université du Québec à Montréal, C.P. 8888, Succ. Centre-ville, Montréal, QC, H3C 3P8, Canada AU - Annabi, B. AU - Vaillancourt-Jean, E. AU - Weil, A. G. AU - Béliveau, R. DB - Embase DO - 10.2147/OTT.S14503 LA - English M3 - Article N1 - L365235894 2012-07-20 2012-08-02 PY - 2010 SN - 1178-6930 SP - 219-226 ST - Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells T2 - OncoTargets and Therapy TI - Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365235894&from=exporthttp://dx.doi.org/10.2147/OTT.S14503http://www.dovepress.com/oncotargets-and-therapy-journal VL - 3 ID - 7277 ER - TY - JOUR AD - Pediatric Hematology and Oncology, University Hospital ‘Carl Gustav Carus’, Dresden, Germany I. Medical Clinic, University Hospital ‘Carl Gustav Carus’, Dresden, Germany Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany Pediatric Oncology Unit, CIC 802 INSERM, University Hospital, Poitiers, France AU - Suttorp, M. AU - Bornhäuser, M. AU - Metzler, M. AU - Millot, F. AU - Schleyer, E. DB - Scopus DO - 10.1080/17512433.2018.1398644 IS - 3 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 219-231 ST - Pharmacology and pharmacokinetics of imatinib in pediatric patients T2 - Expert Review of Clinical Pharmacology TI - Pharmacology and pharmacokinetics of imatinib in pediatric patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042332935&doi=10.1080%2f17512433.2018.1398644&partnerID=40&md5=17b497c372243d58f8e748dd93e05b1a VL - 11 ID - 7278 ER - TY - JOUR AD - M. R. Litzow, Department of Hematology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States AU - Litzow, M. R. C1 - bcx 1777 campath 1h DB - Embase Medline DO - 10.2165/11588950-000000000-00000 IS - 4 LA - English M3 - Review N1 - L361425437 2011-03-21 2011-03-28 PY - 2011 SN - 0012-6667 1179-1950 SP - 415-442 ST - Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults T2 - Drugs TI - Pharmacotherapeutic advances in the treatment of acute lymphoblastic leukaemia in adults UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361425437&from=exporthttp://dx.doi.org/10.2165/11588950-000000000-00000 VL - 71 ID - 7279 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, Justus-Liebig University of Giessen, Feulgenstraße 12, Giessen, 35392, Germany Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany Clinical Cooperation Unit Pediatric Oncology, German Cancer Research center (DKFZ), Heidelberg, Germany Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Halle, Germany AU - Mauz-Körholz, C. AU - Ströter, N. AU - Baumann, J. AU - Botzen, A. AU - Körholz, K. AU - Körholz, D. DB - Scopus DO - 10.1007/s40272-017-0265-x IS - 1 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 43-57 ST - Pharmacotherapeutic Management of Pediatric Lymphoma T2 - Pediatric Drugs TI - Pharmacotherapeutic Management of Pediatric Lymphoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033459854&doi=10.1007%2fs40272-017-0265-x&partnerID=40&md5=c6a265c8927e46b97ebedcc419719365 VL - 20 ID - 7280 ER - TY - JOUR AD - M. L. Bernstein, IWK Health Center, Hematology-Oncology, 5850/5980 University Avenue, Halifax, NS B3K 6R8, Canada AU - George, R. E. AU - Diller, L. AU - Bernstein, M. L. C1 - 17 AAG cep 701 g 3139 imc a 12 pf 2341066 ps 341 DB - Embase Medline DO - 10.1517/14656566.2010.482100 IS - 9 LA - English M3 - Review N1 - L358877723 2010-06-02 2010-06-10 PY - 2010 SN - 1465-6566 SP - 1467-1478 ST - Pharmacotherapy of neuroblastoma T2 - Expert Opinion on Pharmacotherapy TI - Pharmacotherapy of neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358877723&from=exporthttp://dx.doi.org/10.1517/14656566.2010.482100 VL - 11 ID - 7281 ER - TY - JOUR AD - V. Subbiah, Department of Pediatrics, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States AU - Subbiah, V. AU - Kurzrock, R. C1 - amg 479(Amgen,United States) azd 2171(Astra Zeneca,United States) cp 751871 imc a12 jnj 26854165 pf 02341066(Pfizer,United States) r 1507 rg 7112(Hoffmann La Roche,United States) sb 715992 su11248 C2 - Amgen(United States) Astra Zeneca(United States) Hoffmann La Roche(United States) Pfizer(United States) DB - Embase Medline DO - 10.1097/CCO.0b013e3283477a94 IS - 4 LA - English M3 - Review N1 - L51386460 2011-04-28 2011-06-23 PY - 2011 SN - 1040-8746 1531-703X SP - 352-360 ST - Phase 1 clinical trials for sarcomas: The cutting edge T2 - Current Opinion in Oncology TI - Phase 1 clinical trials for sarcomas: The cutting edge UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51386460&from=exporthttp://dx.doi.org/10.1097/CCO.0b013e3283477a94 VL - 23 ID - 7282 ER - TY - JOUR AD - A. Banerjee AU - Banerjee, A. AU - Jakacki, R. AU - Onar-Thomas, A. AU - Wu, S. AU - Nicolaides, T. AU - Turner, D. AU - Richardson, S. AU - Young-Poussaint, T. AU - Phillips, J. J. AU - Prados, M. AU - Packer, R. AU - Qaddoumi, I. A. AU - Gururangan, S. AU - Goldman, S. AU - Pollack, I. AU - Doyle, L. A. AU - Stewart, C. F. AU - Boyett, J. M. AU - Fouladi, M. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523493 2014-07-16 PY - 2014 SN - 0732-183X ST - A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report T2 - Journal of Clinical Oncology TI - A phase 1 study of AZD6244 in children with recurrent or refractory low-grade gliomas: A Pediatric Brain Tumor Consortium report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523493&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10065?sid=cd52d472-81c9-4f24-82f7-5862d43dd32e VL - 32 ID - 7283 ER - TY - JOUR AD - M. Fischer, University Children's Hospital of Cologne, Pediatric Oncology, Cologne, Germany AU - Fischer, M. AU - Wulff, B. AU - Baruchel, S. AU - Berlanga, P. AU - Trahair, T. AU - Mechinaud, F. AU - Schulte, J. AU - Modak, S. AU - Merks, J. H. AU - Zwaan, C. M. AU - Marshall, L. V. AU - Casanova, M. AU - Branle, F. AU - Malet, I. AU - Emeremni, A. C. AU - Geoerger, B. DB - Embase LA - English M3 - Conference Abstract N1 - L615060003 2017-04-04 PY - 2016 SN - 1879-0852 SP - S49-S50 ST - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population T2 - European Journal of Cancer TI - Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615060003&from=export VL - 69 ID - 7284 ER - TY - JOUR AD - A. Vijay Desai AU - Vijay Desai, A. AU - Brodeur, G. M. AU - Foster, J. AU - Berg, S. L. AU - Basu, E. M. AU - Shusterman, S. AU - Sabnis, A. J. AU - Macy, M. AU - Yoon, J. AU - Gauvain, K. AU - Esquibel, V. AU - Maneval, E. C. AU - Multani, P. S. AU - Fox, E. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10536 IS - 15 LA - English M3 - Conference Abstract N1 - L625975930 2019-01-22 PY - 2018 SN - 1527-7755 ST - Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors T2 - Journal of Clinical Oncology TI - Phase 1 study of entrectinib (RXDX-101), a TRK, ROS1, and ALK inhibitor, in children, adolescents, and young adults with recurrent or refractory solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625975930&from=exporthttp://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10536 VL - 36 ID - 7285 ER - TY - JOUR AD - Leukemia Department, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States Charite Universitatsmedizin, Campus Virchow Klinkum, Berlin, Germany Malignant Hematology Deparment, H. Lee Moffitt Cancer Center, Tampa, FL, United States Bone Marrow Transplantation and Cord Blood Bank Div., Chaim Sheba Medical Center, Tel Hashomer, Israel Medical Clinic III, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Division of Hematology, Respiratory Medication and Oncology, Saga University, Saga, Japan Medical Clinic II, Johann Wolfgang Goethe University, Frankfurt, Germany AU - Kantarjian, H. AU - Le Coutre, P. AU - Cortes, J. AU - Pinilla-Ibarz, J. AU - Nagler, A. AU - Hochhaus, A. AU - Kimura, S. AU - Ottmann, O. DB - Scopus DO - 10.1002/cncr.25079 IS - 11 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2010 SP - 2665-2672 ST - Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in philadelphia chromosome-positive leukemias after imatinib resistance or intolerance T2 - Cancer TI - Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in philadelphia chromosome-positive leukemias after imatinib resistance or intolerance UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952840150&doi=10.1002%2fcncr.25079&partnerID=40&md5=c29984f77a3df3fae7179112a63db617 VL - 116 ID - 7286 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio, TX, 78229, USA. Amita.Patnaik@start.stoh.com. South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio, TX, 78229, USA. Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA. GlaxoSmithKline, Research Triangle Park, NC, 27709, USA. Quinitles, 4820 Emperor Boulevard, Durham, NC, 27703, USA. MedImmune, 1 Medimmune Way, Gaithersburg, MD, 20878, USA. GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA, 19426, USA. Teva Pharmaceuticals Industries, Ltd., 1090 Horsham Road, North Wales, PA, 19454, USA. GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA, USA. AN - 27392790 AU - Patnaik, A. AU - Tolcher, A. AU - Papadopoulos, K. P. AU - Beeram, M. AU - Rasco, D. AU - Werner, T. L. AU - Bauman, J. W. AU - Scheuber, A. AU - Cox, D. S. AU - Patel, B. R. AU - Zhou, Y. AU - Hamid, M. AU - Schramek, D. AU - Sharma, S. DA - Sep DO - 10.1007/s00280-016-3090-y 10.1007/s00280-016-3090-y. Epub 2016 Jul 8. DP - Nlm ET - 2016/07/10 IS - 3 LA - eng PY - 2016 SN - 0344-5704 SP - 491-500 ST - Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours T2 - Cancer Chemother Pharmacol TI - Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours VL - 78 ID - 7287 ER - TY - JOUR AD - B. Geoerger AU - Geoerger, B. AU - Moertel, C. L. AU - Whitlock, J. AU - McCowage, G. B. AU - Kieran, M. W. AU - Broniscer, A. AU - Hargrave, D. R. AU - Hingorani, P. AU - Kilburn, L. B. AU - Mueller, S. AU - Tseng, L. AU - Nebot, N. AU - Dasgupta, K. AU - Russo, M. W. AU - Fox, E. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10537 IS - 15 LA - English M3 - Conference Abstract N1 - L625975949 2019-01-22 PY - 2018 SN - 1527-7755 ST - Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN) T2 - Journal of Clinical Oncology TI - Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625975949&from=exporthttp://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10537 VL - 36 ID - 7288 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennesssee. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 29512900 AU - Broniscer, A. AU - Jia, S. AU - Mandrell, B. AU - Hamideh, D. AU - Huang, J. AU - Onar-Thomas, A. AU - Gajjar, A. AU - Raimondi, S. C. AU - Tatevossian, R. G. AU - Stewart, C. F. C2 - PMC5980705 C6 - NIHMS942124 DA - Jul DO - 10.1002/pbc.27035 10.1002/pbc.27035. Epub 2018 Mar 7. DP - Nlm ET - 2018/03/08 IS - 7 LA - eng PY - 2018 SN - 1545-5009 (Print) 1545-5009 SP - e27035 ST - Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma T2 - Pediatr Blood Cancer TI - Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma VL - 65 ID - 7289 ER - TY - JOUR AD - G.W. Robinson AU - Robinson, G. W. AU - Gajjar, A. J. AU - Gauvain, K. M. AU - Basu, E. M. AU - Macy, M. E. AU - Maese, L. D. AU - Sabnis, A. J. AU - Foster, J. H. AU - Shusterman, S. AU - Yoon, J. AU - Weiss, B. D. AU - Abdelbaki, M. AU - Farid-Kapadia, M. AU - Meneses-Lorente, G. AU - Cardenas, A. AU - Hutchinson, K. AU - Bergthold, G. AU - Maneval, E. C. AU - Fox, E. AU - Desai, A. V. DB - Embase DO - 10.1200/JCO.2019.37.15_suppl.10009 LA - English M3 - Conference Abstract N1 - L629361175 2019-09-24 PY - 2019 SN - 1527-7755 ST - Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors T2 - Journal of Clinical Oncology TI - Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629361175&from=exporthttp://dx.doi.org/10.1200/JCO.2019.37.15_suppl.10009 VL - 37 ID - 7290 ER - TY - JOUR AD - Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel AU - Shimoni, A. AU - Volchek, Y. AU - Koren-Michowitz, M. AU - Varda-Bloom, N. AU - Somech, R. AU - Shem-Tov, N. AU - Yerushalmi, R. AU - Nagler, A. DB - Scopus DO - 10.1002/cncr.29141 IS - 6 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2015 SP - 863-871 ST - Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Cancer TI - Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924108845&doi=10.1002%2fcncr.29141&partnerID=40&md5=44561bb1cdce26b8485ed88928a9a50e VL - 121 ID - 7291 ER - TY - JOUR AD - Department of Medicine Division of Oncology, University of Washington, Seattle, WA, United States Clinical Research Division Fred Hutchinson Cancer Research Center, Seattle, WA, United States Seattle Cancer Care Alliance, Seattle, WA, United States AU - Bezerra, E. D. AU - Flowers, M. E. AU - Onstad, L. E. AU - Chielens, D. AU - Radich, J. AU - Higano, C. S. DB - Scopus DO - 10.1080/10428194.2019.1605508 IS - 11 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 2754-2761 ST - A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation T2 - Leukemia and Lymphoma TI - A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064818998&doi=10.1080%2f10428194.2019.1605508&partnerID=40&md5=a5e4dbd8bf0803a8092acf19021a3bb3 VL - 60 ID - 7292 ER - TY - JOUR AD - Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation Department of Pediatrics, Pediatric Hematology Oncology Unit, University of Milano Bicocca, Monza e Brianza per il Bambino e la sua Mamma Foundation, Azienda Socio Sanitaria Territoriale Monza, Monza, Italy Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan IRCCS Hematology Unit, Istituto Giannina Gaslini, Genoa, Italy Division of Hematology/Oncology, Kanagawa Children’s Medical Center, Yokohama, Japan Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children’s Hospital, Seoul, South Korea Department of Pediatrics, Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Nationwide Children’s Hospital, Ohio State University, Columbus, OH, United States Department of Pediatrics, Hematology/Oncology Unit, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey Department of Pediatric Oncology, Hospital Niño Jesus, Madrid, Spain Centre Hospitalier Universitaire (CHU) Bordeaux, Oncologie Hématologie Pédiatrique, Université de Bordeaux, Unité INSERM U1218, Bordeaux, France Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Pediatric Oncology/Hematology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, Netherlands Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands Innovative Therapies for Children with Cancer Consortium, Utrecht, Netherlands Unité d’Onco-Hématologie Pédiatrique, Clinical Investigation Center 1402 INSERM, CHU de Poitiers, Poitiers, France Novartis Pharma AG, Basel, Switzerland Clinical Development and Analytics Pharmacokinetics Sciences, and Trial Management, Novartis Pharma AG, Basel, Switzerland Trial Management, Novartis Pharma AG, Basel, Switzerland Department of Pediatrics, Hematology and Oncology Division, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Pediatrics, Columbia University Medical Center, 161 Fort Washington Ave, New York, NY 10032, United States AU - Hijiya, N. AU - Maschan, A. AU - Rizzari, C. AU - Shimada, H. AU - Dufour, C. AU - Goto, H. AU - Kang, H. J. AU - Guinipero, T. AU - Karakas, Z. AU - Bautista, F. AU - Ducassou, S. AU - Yoo, K. H. AU - Zwaan, C. M. AU - Millot, F. AU - Aimone, P. AU - Allepuz, A. AU - Quenet, S. AU - Hourcade-Potelleret, F. AU - Hertle, S. AU - Sosothikul, D. DB - Scopus DO - 10.1182/blood.2019000069 IS - 23 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 2036-2045 ST - Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia T2 - Blood TI - Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076196337&doi=10.1182%2fblood.2019000069&partnerID=40&md5=c1d0e0ed45d3dab8ba640249fd4e1710 VL - 134 ID - 7293 ER - TY - JOUR AD - Division of Child Neurology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada. s.perreault@umontreal.ca. Division of Hemato-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada. Department of Pathology, Hospital for Sick Children, Toronto, ON, Canada. CHU Sainte-Justine Research Center, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Pathology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Radiology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Department of Pharmacology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Neuropsychology, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec City, QC, Canada. Division of Neurology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Departments of Oncology and Pediatrics, Alberta Children's Hospital, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada. Division of Child Neurology and Oncology, BC Children's Hospital, University of British Columbia, BC, Vancouver, British Columbia, Canada. Division of Hemato-Oncology, Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada. Division of Hemato-Oncology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. AN - 31881853 AU - Perreault, S. AU - Larouche, V. AU - Tabori, U. AU - Hawkin, C. AU - Lippé, S. AU - Ellezam, B. AU - Décarie, J. C. AU - Théoret, Y. AU - Métras, MÉ AU - Sultan, S. AU - Cantin, É AU - Routhier, MÈ AU - Caru, M. AU - Legault, G. AU - Bouffet, É AU - Lafay-Cousin, L. AU - Hukin, J. AU - Erker, C. AU - Jabado, N. C2 - PMC6935133 DA - Dec 27 DO - 10.1186/s12885-019-6442-2 10.1186/s12885-019-6442-2. DP - Nlm ET - 2019/12/29 IS - 1 LA - eng PY - 2019 SN - 1471-2407 SP - 1250 ST - A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01 T2 - BMC Cancer TI - A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01 VL - 19 ID - 7294 ER - TY - JOUR AD - I. Kiss, Clinic of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic AU - Kiss, I. AU - Rodón, J. AU - Grande Pulido, E. AU - Rha, S. Y. AU - Sathornsumetee, S. AU - Hess, G. AU - Eigendorff, E. AU - Cesic, D. AU - Sutradhar, S. AU - Pramanik, B. AU - Kim, T. M. DB - Embase DO - 10.1093/annonc/mdw368.53 LA - English M3 - Conference Abstract N1 - L613911745 2017-01-03 PY - 2016 SN - 1569-8041 ST - Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 T2 - Annals of Oncology TI - Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613911745&from=exporthttp://dx.doi.org/10.1093/annonc/mdw368.53 VL - 27 ID - 7295 ER - TY - JOUR AD - State Key Laboratory of Experimental Hematology, Department of Clinical Hematology, Institute of Hematology, Tianjin, China Shanghai Institute of Hematology, Shanghai Ruijin Hospital, Shanghai, China Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Orbassano, Italy Department of Hematology, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang Province, China Institute of Hematology, Wuhan Union Hospital, Tongji Medical College, Wuhan Hubei, China Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou Guangdong, China Department of Hematology, Jiangsu Province People's Hospital, Nan-Jing, China Department of Hematology, Nanfang Hospital, Guangzhou Southern Medical University, Guangzhou Guangdong, China Department of Hematology, West China Hospital of Sichuan University, Chengdu Sichuan, China Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China Department of Hematology, Changhai Hospital, Second Military Medical University, Shanghai, China Department of Hematology, Qilu Hospital, Shandong University, Jinan, China Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States Beijing Novartis Pharma Company, Limited, Beijing, China Department of Hematology-Oncology, University of Bologna, Bologna, Italy Peking University People's Hospital, Institute of Hematology, Peking University Institute of Hematology, 11 Xizhimen South Street, Beijing, 100044, China AU - Wang, J. AU - Shen, Z. X. AU - Saglio, G. AU - Jin, J. AU - Huang, H. AU - Hu, Y. AU - Du, X. AU - Li, J. AU - Meng, F. AU - Zhu, H. AU - Hu, J. AU - Wang, J. AU - Hou, M. AU - Hertle, S. AU - Menssen, H. D. AU - Ortmann, C. E. AU - Tribouley, C. AU - Yuan, Y. AU - Baccarani, M. AU - Huang, X. DB - Scopus DO - 10.1182/blood-2014-09-601674 IS - 18 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2015 SP - 2771-2778 ST - Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina T2 - Blood TI - Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929494071&doi=10.1182%2fblood-2014-09-601674&partnerID=40&md5=e1f3a7ed847f93a6cd49294e16a29674 VL - 125 ID - 7296 ER - TY - JOUR AD - G. Garcia-Manero AU - Garcia-Manero, G. AU - Navada, S. C. AU - Fenaux, P. AU - Zbyszewski, P. S. AU - Adesanya, A. R. AU - Azarnia, N. AU - Fruchtman, S. M. AU - Silverman, L. R. DB - Embase DO - 10.1182/blood-2019-132149 LA - English M3 - Conference Abstract N1 - L630315301 2019-12-31 PY - 2019 SN - 1528-0020 ST - Phase 3, multi-center, international, randomized, double-blind placebo controlled study of oral rigosertib + injectable azacitidine (AZA) versus injectable azacitidine in treatment-naive patients with higher-risk myelodysplastic syndrome (HR-MDS) T2 - Blood TI - Phase 3, multi-center, international, randomized, double-blind placebo controlled study of oral rigosertib + injectable azacitidine (AZA) versus injectable azacitidine in treatment-naive patients with higher-risk myelodysplastic syndrome (HR-MDS) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630315301&from=exporthttp://dx.doi.org/10.1182/blood-2019-132149 VL - 134 ID - 7297 ER - TY - JOUR AD - Department of Hematology-Oncology, Mail Stop 260, St. Jude Children's Research Hospital, 332 N Lauderdale, Memphis, TN 38105-2794, United States AU - Daw, N. C. AU - Furman, W. L. AU - Stewart, C. F. AU - Iacono, L. C. AU - Krailo, M. AU - Bernstein, M. L. AU - Dancey, J. E. AU - Speights, R. A. AU - Blaney, S. M. AU - Croop, J. M. AU - Reaman, G. H. AU - Adamson, P. C. DB - Scopus DO - 10.1200/JCO.2005.11.429 IS - 25 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2005 SP - 6172-6180 ST - Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study T2 - Journal of Clinical Oncology TI - Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: A children's oncology group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-24944519394&doi=10.1200%2fJCO.2005.11.429&partnerID=40&md5=9da75bb6cb022e4446a64540636b4d84 VL - 23 ID - 7298 ER - TY - JOUR AD - Harvard Medical School, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. birgit.geoerger@gustaveroussy.fr. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, New York. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. UCL Great Ormond Street Institute of Child Health, Pediatric Oncology Unit, London, United Kingdom. Phoenix Children's Hospital, Center for Cancer and Blood Disorders, Phoenix, Arizona. Institut Curie, PSL Research University, Oncology Center SIREDO, Paris, France. CHU de Toulouse - Pôle Pédiatrique, Toulouse, France. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Cancer and Blood Disorder Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Children's Hospital of Orange County, Orange, California. The Hospital for Sick Children, University of Toronto, Department of Pediatrics, Toronto, Ontario. Paediatric Drug Development, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, and The Institute of Cancer Research, Sutton, United Kingdom. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. Novartis Pharma AG, Basel, Switzerland. AN - 31506385 AU - Kieran, M. W. AU - Geoerger, B. AU - Dunkel, I. J. AU - Broniscer, A. AU - Hargrave, D. AU - Hingorani, P. AU - Aerts, I. AU - Bertozzi, A. I. AU - Cohen, K. J. AU - Hummel, T. R. AU - Shen, V. AU - Bouffet, E. AU - Pratilas, C. A. AU - Pearson, A. D. J. AU - Tseng, L. AU - Nebot, N. AU - Green, S. AU - Russo, M. W. AU - Whitlock, J. A. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-17-3572 10.1158/1078-0432.CCR-17-3572. Epub 2019 Sep 10. DP - Nlm ET - 2019/09/12 IS - 24 LA - eng PY - 2019 SN - 1078-0432 (Print) 1078-0432 SP - 7294-7302 ST - A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors T2 - Clin Cancer Res TI - A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors VL - 25 ID - 7299 ER - TY - JOUR AD - Department of Pediatrics, UCSF, School of Medicine, 505, Parnassus Avenue, M646, San Francisco, CA 94143-0106, United States Department of Pediatrics, Children's Hospital Boston, Harvard Medical School, Boston, MA, United States Children's Oncology Group Operations Center, Arcadia, CA, United States Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Pharmacology, Mayo College of Medicine, Rochester, MN, United States Department of Hematology/ Oncology, Hospital for Sick Children, Toronto, ON, Canada Department of Pediatrics, Morgan Stanley Children's Hospital, Columbia University School of Medicine, New York, NY, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Department of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States AU - DuBois, S. G. AU - Shusterman, S. AU - Ingle, A. M. AU - Ahern, C. H. AU - Reid, J. M. AU - Wu, B. AU - Baruchel, S. AU - Glade-Bender, J. AU - Ivy, P. AU - Grier, H. E. AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1158/1078-0432.CCR-11-0237 IS - 15 M3 - Article N1 - Cited By :82 Export Date: 18 November 2020 PY - 2011 SP - 5113-5122 ST - Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: A children's oncology group study T2 - Clinical Cancer Research TI - Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: A children's oncology group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960983264&doi=10.1158%2f1078-0432.CCR-11-0237&partnerID=40&md5=ed265068a4313b85a531fde27ae055e4 VL - 17 ID - 7300 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426, United States Department of Clinical Pharmacology, Pfizer Global Research and Development, Paris, France AU - Abbas, R. AU - Hug, B. A. AU - Leister, C. AU - Gaaloul, M. E. AU - Chalon, S. AU - Sonnichsen, D. DB - Scopus DO - 10.1007/s00280-011-1688-7 IS - 1 M3 - Article N1 - Cited By :63 Export Date: 18 November 2020 PY - 2012 SP - 221-227 ST - A phase i ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects T2 - Cancer Chemotherapy and Pharmacology TI - A phase i ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856689752&doi=10.1007%2fs00280-011-1688-7&partnerID=40&md5=073fe157eca40b17a58cd594f35330ae VL - 69 ID - 7301 ER - TY - JOUR AD - Department of Internal Medicine and Medical Oncology, West German Cancer Center, University Medical School of Essen, Essen; Department of Hematology and Medical Oncology, University of Bochum, Herne; Bayer Healthcare, Pharma Research Center, Wuppertal, Germany; Bayer Pharmaceuticals Corporation, West Haven, CT; and Jules Bordet Institute, Brussels, Belgium AU - Strumberg, D. AU - Richly, H. AU - Hilger, R. A. AU - Schleucher, N. AU - Korfee, S. AU - Tewes, M. AU - Faghih, M. AU - Brendel, E. AU - Voliotis, D. AU - Haase, C. G. AU - Schwartz, B. AU - Awada, A. AU - Voigtmann, R. AU - Scheulen, M. E. AU - Seeber, S. DB - Scopus DO - 10.1200/JCO.2005.06.124 IS - 5 M3 - Article N1 - Cited By :751 Export Date: 18 November 2020 PY - 2005 SP - 965-972 ST - Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors T2 - Journal of Clinical Oncology TI - Phase I clinical and pharmacokinetic study of the novel raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-20044382799&doi=10.1200%2fJCO.2005.06.124&partnerID=40&md5=b4a31f14eb97ed8f5473f87da33caf26 VL - 23 ID - 7302 ER - TY - JOUR AD - Centro de Oncologia e Hematologia Do Hospital Israelita Albert Einstein, São Paulo, Brazil Department of Investigational Cancer Therapeutics (Phase i Clinical Trials Program), University of Texas MD Anderson Cancer Center, Unit 455, 1400 Holcombe Boulevard, Houston, TX 77030, United States Sarah Cannon Research Institute at HealthONE, Denver, CO, United States Department of Medicine, University of California, San Diego, San Diego, CA, United States AU - Rodrigues, H. V. AU - Ke, D. AU - Lim, J. AU - Stephen, B. AU - Bellido, J. AU - Janku, F. AU - Zinner, R. AU - Tsimberidou, A. AU - Hong, D. AU - Piha-Paul, S. AU - Fu, S. AU - Naing, A. AU - Subbiah, V. AU - Karp, D. AU - Falchook, G. AU - Kurzrock, R. AU - Wheler, J. DB - Scopus DO - 10.1007/s10637-015-0238-2 IS - 3 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2015 SP - 700-709 ST - Phase i combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy T2 - Investigational New Drugs TI - Phase i combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937758561&doi=10.1007%2fs10637-015-0238-2&partnerID=40&md5=9f54315058a922351e430a4e43d20ca7 VL - 33 ID - 7303 ER - TY - JOUR AD - Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, Netherlands Department of Medical Oncology, University Hospital, Groningen, Netherlands Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, United States Boehringer Ingelheim BV, Alkmaar, Netherlands Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany Department of Medical Oncology, Erasmus University Medical Center, PO Box 2040, Rotterdam, 3000 CA, Netherlands AU - Eskens, F. A. L. M. AU - Mom, C. H. AU - Planting, A. S. T. AU - Gietema, J. A. AU - Amelsberg, A. AU - Huisman, H. AU - Van Doorn, L. AU - Burger, H. AU - Stopfer, P. AU - Verweij, J. AU - De Vries, E. G. E. DB - Scopus DO - 10.1038/sj.bjc.6604108 IS - 1 M3 - Article N1 - Cited By :199 Export Date: 18 November 2020 PY - 2008 SP - 80-85 ST - A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours T2 - British Journal of Cancer TI - A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049038935&doi=10.1038%2fsj.bjc.6604108&partnerID=40&md5=8279dde1914d53375f689b726335cd60 VL - 98 ID - 7304 ER - TY - JOUR AU - Eskens, F. A. L. M. AU - Steeghs, N. AU - Verweij, J. AU - Bloem, J. L. AU - Christensen, O. AU - Van Doorn, L. AU - Ouwerkerk, J. AU - De Jonge, M. J. A. AU - Nortier, J. W. R. AU - Kraetzschmar, J. AU - Rajagopalan, P. AU - Gelderblom, H. DB - Scopus DO - 10.1200/JCO.2008.18.8193 IS - 25 M3 - Article N1 - Cited By :42 Export Date: 18 November 2020 PY - 2009 SP - 4169-4176 ST - Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor β, and c-Kit, in patients with advanced or metastatic solid tumors T2 - Journal of Clinical Oncology TI - Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor β, and c-Kit, in patients with advanced or metastatic solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70249129087&doi=10.1200%2fJCO.2008.18.8193&partnerID=40&md5=5c59e240efef6b5483e464325ef70267 VL - 27 ID - 7305 ER - TY - JOUR AD - N. Robison, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Robison, N. AU - Pauly, J. AU - Malvar, J. AU - Filbin, M. AU - De Mola, R. L. AU - Dorris, K. AU - Bendel, A. AU - Bowers, D. AU - Bornhorst, M. AU - Gauvain, K. AU - Leary, S. AU - MacDonald, T. AU - Gardner, S. AU - Reddy, A. AU - Diaz, P. AU - Tan, Y. J. AU - Sinai, C. AU - Davidson, T. AU - Ullrich, N. AU - Margol, A. AU - Dhall, G. AU - Borchert, M. AU - Ligon, K. AU - Sposto, R. AU - Kieran, M. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619948205 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi189 ST - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS-RAF pathway-activated tumors: Initial report T2 - Neuro-Oncology TI - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS-RAF pathway-activated tumors: Initial report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619948205&from=exporthttp://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 7306 ER - TY - JOUR AD - N. Robison, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Robison, N. AU - Pauly, J. AU - Malvar, J. AU - Gruber-Filbin, M. AU - De Mola, R. L. AU - Dorris, K. AU - Bendel, A. AU - Bowers, D. AU - Bornhorst, M. AU - Gauvain, K. AU - Leary, S. AU - Diaz, P. AU - Tan, Y. J. AU - Margol, A. AU - Dhall, G. AU - Rosser, T. AU - Bandopadhayay, P. AU - Davidson, T. AU - Ullrich, N. AU - Borchert, M. AU - Nelson, M. AU - Sinai, C. AU - Ligon, K. AU - Sposto, R. AU - Kieran, M. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098662 2018-07-25 PY - 2018 SN - 1523-5866 SP - i114 ST - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS/RAF pathway-activated tumors T2 - Neuro-Oncology TI - A phase I dose escalation trial of the MEK1/2 inhibitor MEK162 (binimetinib) in children with lowgrade gliomas and other RAS/RAF pathway-activated tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098662&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7307 ER - TY - JOUR AD - M.R. Khawaja AU - Khawaja, M. R. AU - Khatua, S. AU - Karp, D. AU - Janku, F. AU - Hong, D. AU - Munoz, J. AU - Tsimberidou, A. AU - Zaky, W. AU - Sherman, S. I. AU - Hwu, P. AU - Meric-Bernstam, F. AU - Subbiah, V. DB - Embase DO - 10.1158/1538-7445.AM2016-CT052 IS - 14 LA - English M3 - Conference Abstract N1 - L613610120 2016-12-19 PY - 2016 SN - 1538-7445 ST - A phase I dose escalation trial of vemurafenib in combination with the mTOR inhibitor everolimus for melanoma and non-melanoma cancers with a BRAF aberration T2 - Cancer Research TI - A phase I dose escalation trial of vemurafenib in combination with the mTOR inhibitor everolimus for melanoma and non-melanoma cancers with a BRAF aberration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613610120&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2016-CT052 VL - 76 ID - 7308 ER - TY - JOUR AD - F. Janku AU - Janku, F. AU - Elez, E. AU - Iyer, G. AU - Yamamoto, N. AU - Tan, D. S. W. AU - Stathis, A. AU - Stammberger, U. Z. M. AU - Evans, H. AU - Seroutou, A. AU - Mais, A. AU - Schuler, M. H. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3640 IS - 15 LA - English M3 - Conference Abstract N1 - L632809472 2020-09-15 PY - 2020 SN - 1527-7755 ST - Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations T2 - Journal of Clinical Oncology TI - Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632809472&from=exporthttp://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3640 VL - 38 ID - 7309 ER - TY - JOUR AD - J.M. Hubbard, NCCTG Division of Medical Oncology, Mayo Clinic, Rochester, MN, United States AU - Hubbard, J. M. AU - Alberts, S. R. AU - Loui, W. S. AU - Mahoney, M. R. AU - Roberts, L. R. AU - Smyrk, T. C. AU - Gatalica, Z. AU - Kumar, S. AU - Dakhil, S. R. AU - Flynn, P. J. AU - Lafky, J. M. AU - Bury, M. J. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70710020 2012-04-10 PY - 2011 SN - 0732-183X ST - Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745 T2 - Journal of Clinical Oncology TI - Phase I evaluation of sorafenib (SOR) and bevacizumab (BEV) as first-line therapy in hepatocellular cancer (HCC): North Central Cancer Treatment Group trial N0745 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70710020&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/29/15-suppl/4116?sid=4d50f7b6-eb01-440e-95dc-2c30a26d3d85 VL - 29 ID - 7310 ER - TY - JOUR AD - M.G. Fakih, Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States AU - Fakih, M. G. AU - Trump, D. L. AU - Muindi, J. R. AU - Black, J. D. AU - Bernardi, R. J. AU - Creaven, P. J. AU - Schwartz, J. AU - Brattain, M. G. AU - Hutson, A. AU - French, R. AU - Johnson, C. S. C1 - calcijex(Abbott,United States) iressa(Astra Zeneca,United Kingdom) C2 - Abbott(United States) Astra Zeneca(United Kingdom) DB - Embase Medline DO - 10.1158/1078-0432.CCR-06-1165 IS - 4 LA - English M3 - Article N1 - L46424063 2007-04-11 PY - 2007 SN - 1078-0432 SP - 1216-1223 ST - A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors T2 - Clinical Cancer Research TI - A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46424063&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-06-1165 VL - 13 ID - 7311 ER - TY - JOUR AD - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China Shanghai Allist Pharmaceuticals, Shanghai, China AU - Zhang, J. AU - Cao, J. AU - Li, J. AU - Zhang, Y. AU - Chen, Z. AU - Peng, W. AU - Sun, S. AU - Zhao, N. AU - Wang, J. AU - Zhong, D. AU - Zhang, X. AU - Zhang, J. C7 - 22 DB - Scopus DO - 10.1186/1756-8722-7-22 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2014 ST - A phase i study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors T2 - Journal of Hematology and Oncology TI - A phase i study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907444509&doi=10.1186%2f1756-8722-7-22&partnerID=40&md5=7eb29c29dabe80f666c0694c402d4946 VL - 7 ID - 7312 ER - TY - JOUR AD - B. Geoerger AU - Geoerger, B. AU - Schulte, J. AU - Zwaan, C. M. AU - Casanova, M. AU - Fischer, M. AU - Moreno, L. AU - Trahair, T. AU - Jimenez, I. AU - Kang, H. J. AU - Pappo, A. S. AU - Schafer, E. AU - Weiss, B. D. AU - Healy, M. E. AU - Li, K. AU - Lin, T. AU - Boral, A. AU - Pearson, A. D. J. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015800 2015-09-28 PY - 2015 SN - 0732-183X ST - Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results T2 - Journal of Clinical Oncology TI - Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015800&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10005?sid=1399ec67-05e7-4f7d-9c85-3f508502267a VL - 33 ID - 7313 ER - TY - JOUR AD - T. Yau, Queen Mary Hospital, Hong Kong, Hong Kong AU - Yau, T. AU - Chen, P. J. AU - Curtis, C. M. AU - Murphy, P. S. AU - Suttle, A. B. AU - Arumugham, T. AU - Hodge, J. P. AU - Dar, M. M. AU - Poon, R. T. DB - Embase DO - 10.1002/hep.23307 LA - English M3 - Conference Abstract N1 - L70075182 2010-03-12 PY - 2009 SN - 0270-9139 SP - 1124A-1125A ST - Phase i study of pazopanib (PAZ) in hepatocellular carcinoma (HCC): Determination of MTD and evaluation of clinical activity, pharmacokinetics (PK), and pharmacodynamic (PD) changes in dynamic contrast enhanced MRI (DCE-MRI) T2 - Hepatology TI - Phase i study of pazopanib (PAZ) in hepatocellular carcinoma (HCC): Determination of MTD and evaluation of clinical activity, pharmacokinetics (PK), and pharmacodynamic (PD) changes in dynamic contrast enhanced MRI (DCE-MRI) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70075182&from=exporthttp://dx.doi.org/10.1002/hep.23307 VL - 50 ID - 7314 ER - TY - JOUR AD - C.C. Yau AU - Yau, C. C. AU - Chen, P. J. AU - Curtis, C. M. AU - Murphy, P. S. AU - Suttle, A. B. AU - Arumugham, T. AU - Hodge, J. P. AU - Dar, M. M. AU - Poon, R. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L70240943 2010-08-18 PY - 2009 SN - 0732-183X SP - 3561 ST - A phase I study of pazopanib in patients with advanced hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - A phase I study of pazopanib in patients with advanced hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70240943&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/27/15S/3561 VL - 27 ID - 7315 ER - TY - JOUR AD - Pediatric Neuro-Oncology Program, Dana-Farber Cancer Institute, Boston, MA, United States Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, United States Operations and Biostatistics Center, St. Jude Children's Research Hospital, Memphis, TN, United States Department of Radiology, Children's Hospital Boston, Boston, MA, United States Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, PA, United States Department of Neurology, Children's National Medical Center, Washington, DC, United States Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States Department of Pediatrics, Children's Hospital, Regional Medical Center, Seattle, WA, United States Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, United States Hematology/Oncology Division, Children's Memorial Hospital, Memphis, TN, United States Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN, United States Division of Hematology/Oncology, Children's National Medical Center, Washington, DC, United States Pediatric Neuro-Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, United States AU - Kieran, M. W. AU - Supko, J. G. AU - Wallace, D. AU - Fruscio, R. AU - Poussaint, T. Y. AU - Phillips, P. AU - Pollack, I. AU - Packer, R. AU - Boyett, J. M. AU - Blaney, S. AU - Banerjee, A. AU - Geyer, R. AU - Friedman, H. AU - Goldman, S. AU - Kun, L. E. AU - MacDonald, T. DB - Scopus DO - 10.1002/pbc.21873 IS - 2 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2009 SP - 169-176 ST - Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors T2 - Pediatric Blood and Cancer TI - Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-59449108256&doi=10.1002%2fpbc.21873&partnerID=40&md5=0ae459236a31016f60ff6cd4968e972c VL - 52 ID - 7316 ER - TY - JOUR AD -, , , , , , , , , , , , and , The University of Texas MD Anderson Cancer Center, Houston, TX; and , Sarah Cannon Research Institute at HealthONE, Denver, CO. AN - 32913986 AU - Subbiah, V. AU - Sen, S. AU - Hess, K. R. AU - Janku, F. AU - Hong, D. S. AU - Khatua, S. AU - Karp, D. D. AU - Munoz, J. AU - Falchook, G. S. AU - Groisberg, R. AU - Tsimberidou, A. M. AU - Sherman, S. I. AU - Hwu, P. AU - Meric-Bernstam, F. C2 - PMC7446411 interpretation of the data; the writing of the article; and the decision to submit the article for publication.The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center. Vivek SubbiahConsulting or Advisory Role: MedImmune Research Funding: Novartis (Inst), GlaxoSmithKline (Inst), NanoCarrier (Inst), Northwest Biotherapeutics (Inst), Genentech (Inst), Berg Pharma (Inst), Bayer (Inst), Incyte (Inst), Fujifilm (Inst), PharmaMar (Inst), D3 Oncology Solutions (Inst), Pfizer (Inst), Amgen (Inst), AbbVie (Inst), Multivir (Inst), Blueprint Medicines (Inst), Loxo (Inst), Vegenics (Inst), Takeda (Inst), Alfasigma (Inst), Agensys (Inst), Idera (Inst), Boston Biomedical (Inst) Travel, Accommodations, Expenses: PharmaMar, BayerShiraj SenNo relationship to discloseKenneth R. HessNo relationship to discloseFilip JankuStock and Other Ownership Interests: Trovagene Consulting or Advisory Role: Deciphera, Trovagene, Novartis, Sequenom, Foundation Medicine, Guardant Health, Immunome Research Funding: Novartis, BioMed Valley Discoveries, Roche, Agios, Astellas Pharma, Deciphera, Symphony Evolution, Plexxikon, Piqur, Fujifilm Other Relationship: Bio-RadDavid S. HongStock and Other Ownership Interests: MolecularMatch, Oncorena Honoraria: Adaptimmune, Baxter, Merrimack, Bayer Consulting or Advisory Role: Baxter, Bayer, Guidepoint Global, Janssen Speakers' Bureau: Genentech, Janssen Oncology Research Funding: Novartis, Genentech, Eisai, AstraZeneca, Pfizer, miRNA Therapeutics, Amgen, Daiichi Sankyo, Merck, Mirati Therapeutics, Eli Lilly, Adaptimmune, AbbVie, Bayer, Bristol-Myers Squibb, Genmab, Ignyta, Infinity Pharmaceuticals, Kite Pharma, Kyowa Hakko Kirin, Loxo, MedImmune, Molecular Templates, Takeda Travel, Accommodations, Expenses: Loxo, miRNA Therapeutics Other Relationship: Oncorena, EisaiSoumen KhatuaNo relationship to discloseDaniel D. KarpConsulting or Advisory Role: Black Beret Life Sciences Research Funding: Phosplatin Therapeutics Travel, Accommodations, Expenses: Phosplatin TherapeuticsJavier MunozConsulting or Advisory Role: Kite Pharma, Pfizer, Pharmacyclics, Bayer, Alexion Pharmaceuticals, Bristol-Myers Squibb, Janssen, Seattle Genetics, Gilead Sciences, Kyowa Hakko Kirin Speakers' Bureau: Kite PharmaGerald S. FalchookEmployment: Sarah Cannon Research Institute, HealthONE Research Funding: Millennium, EMD Serono, Celgene, MedImmune, Genmab, Vegenics, Novartis, AstraZeneca, Incyte, ARMO BioSciences, Kolltan Pharmaceuticals, 3-V Biosciences, AbbVie, Aileron Therapeutics, DelMar Pharmaceuticals, eFFECTOR Therapeutics, Strategia Therapeutics, Fujifilm, Hutchison MediPharma, Regeneron, Biothera, Curegenix, Curis, Eli Lilly, Jounce Therapeutics, OncoMed, Precision Oncology, Syndax, Taiho Pharmaceutical, Tesaro, Takeda, BeiGene, Ignyta, Merck, Rgenix, Tarveda Therapeutics, Tocagen Patents, Royalties, Other Intellectual Property: Handbook of Targeted Cancer Therapy Travel, Accommodations, Expenses: Millennium, Sarah Cannon Research Institute, EMD Serono, Bristol-Myers SquibbRoman GroisbergNo relationship to discloseApostolia M. TsimberidouConsulting or Advisory Role: Roche Research Funding: EMD Serono (Inst), Baxter (Inst), Foundation Medicine (Inst), Onyx (Inst), Bayer (Inst), Boston Biomedical (Inst), Placon (Inst), IMMATICS (Inst), Karus Therapeutics (Inst), Stem Cells (Inst), OBI Pharma (Inst)Steven I. ShermanHonoraria: Genzyme, Eisai Consulting or Advisory Role: Eisai, Exelixis, Veracyte, Novo Nordisk, Bristol-Myers Squibb, Loxo, Genzyme, Ignyta, Novartis Research Funding: Genzyme Travel, Accommodations, Expenses: Eisai, Veracyte, IgnytaPatrick HwuStock and Other Ownership Interests: Immatics Consulting or Advisory Role: Dragonfly Therapeutics, GlaxoS ithKline, Immatics, Sanofi Research Funding: Genentech (Inst)Funda Meric-BernstamHonoraria: Sumitomo Group, Dialectica Consulting or Advisory Role: Genentech, Inflection Biosciences, Pieris Pharmaceuticals, Clearlight Diagnostics, Darwin Health, Samsung Bioepis, Spectrum Pharmaceuticals Research Funding: Novartis, AstraZeneca, Taiho Pharmaceutical, Genentech, Calithera Biosciences, Debiopharm Group, Bayer, Aileron Therapeutics, PUMA Biotechnology, CytomX Therapeutics, Jounce Therapeutics, Zymeworks, Curis, Pfizer, eFFECTOR Therapeutics, AbbVie DO - 10.1200/po.18.00189 10.1200/PO.18.00189. eCollection 2018. DP - Nlm ET - 2018/09/13 LA - eng PY - 2018 SN - 2473-4284 ST - Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies T2 - JCO Precis Oncol TI - Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated Malignancies VL - 2 ID - 7317 ER - TY - JOUR AD - D.S. Hong, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Kato, S. AU - Jardim, D. L. AU - Johnson, F. M. AU - Subbiah, V. AU - Piha-Paul, S. AU - Tsimberidou, A. M. AU - Falchook, G. S. AU - Karp, D. AU - Zinner, R. AU - Wheler, J. AU - Janku, F. AU - Fu, S. AU - Lim, J. A. AU - Bean, S. AU - Nguyen, L. AU - Urban, S. AU - Browne, E. AU - Meric-Bernstam, F. AU - Hong, D. S. DB - Embase Medline DO - 10.1007/s10637-017-0513-5 IS - 3 LA - English M3 - Article N1 - L618837426 2017-10-25 2018-05-29 PY - 2018 SN - 1573-0646 0167-6997 SP - 416-423 ST - Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer T2 - Investigational New Drugs TI - Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618837426&from=exporthttp://dx.doi.org/10.1007/s10637-017-0513-5 VL - 36 ID - 7318 ER - TY - JOUR AD - Princess Margaret Hospital, Toronto, ON M5G 2M9, Canada National Cancer Institute, Bethesda, MD 20852-7426, United States Juravinski Cancer Centre, 699 Concession Street, Hamilton, ON L8V 5C2, Canada AU - Sahebjam, S. AU - Bedard, P. L. AU - Castonguay, V. AU - Chen, Z. AU - Reedijk, M. AU - Liu, G. AU - Cohen, B. AU - Zhang, W. J. AU - Clarke, B. AU - Zhang, T. AU - Kamel-Reid, S. AU - Chen, H. AU - Ivy, S. P. AU - Razak, A. R. A. AU - Oza, A. M. AU - Chen, E. X. AU - Hirte, H. W. AU - McGarrity, A. AU - Wang, L. AU - Siu, L. L. AU - Hotte, S. J. DB - Scopus DO - 10.1038/bjc.2013.380 IS - 4 M3 - Article N1 - Cited By :50 Export Date: 18 November 2020 PY - 2013 SP - 943-949 ST - A phase i study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) T2 - British Journal of Cancer TI - A phase i study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883185608&doi=10.1038%2fbjc.2013.380&partnerID=40&md5=44b113a8488fcc554f76602dd68b1767 VL - 109 ID - 7319 ER - TY - JOUR AD - B.C. Widemann AU - Widemann, B. C. AU - Marcus, L. J. AU - Fisher, M. J. AU - Weiss, B. D. AU - Kim, A. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Martin, S. AU - Gillespie, A. AU - Doyle, A. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71523507 2014-07-16 PY - 2014 SN - 0732-183X ST - Phase I study of the MEK1/2 inhibitor selumetinib (AZD6244) hydrogen sulfate in children and young adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) T2 - Journal of Clinical Oncology TI - Phase I study of the MEK1/2 inhibitor selumetinib (AZD6244) hydrogen sulfate in children and young adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71523507&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/10018?sid=cd52d472-81c9-4f24-82f7-5862d43dd32e VL - 32 ID - 7320 ER - TY - JOUR AD - Fox Chase Cancer Center, Philadelphia, PA; Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH; Dana-Farber Cancer Center, Boston, MA; and Pfizer Oncology, New London, CT AU - Lewis, N. L. AU - Lewis, L. D. AU - Eder, J. P. AU - Reddy, N. J. AU - Guo, F. AU - Pierce, K. J. AU - Olszanski, A. J. AU - Cohen, R. B. DB - Scopus DO - 10.1200/JCO.2009.21.8487 IS - 31 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2009 SP - 5262-5269 ST - Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers T2 - Journal of Clinical Oncology TI - Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449707509&doi=10.1200%2fJCO.2009.21.8487&partnerID=40&md5=5f9d3861b649196e31b683b5baba3602 VL - 27 ID - 7321 ER - TY - JOUR AD - E. Wang AU - Wang, E. AU - Kim, D. W. AU - Mahipal, A. AU - Chen, D. T. AU - Cao, B. AU - Masawi, F. AU - Kim, R. D. DB - Embase LA - English M3 - Conference Abstract N1 - L627163334 2019-04-16 PY - 2019 SN - 1527-7755 ST - Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC) T2 - Journal of Clinical Oncology TI - Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627163334&from=export VL - 37 ID - 7322 ER - TY - JOUR AD - University of California San Francisco, San Francisco, California; Boston Children's Hospital, Boston, Massachusetts; Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; St Jude Children's Research Hospital, Memphis, Tennessee; Lurie Children's Hospital, Chicago, Illinois; Children's National Medical Center, Washington, DC; Duke University Medical Center, Durham, North Carolina; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. AN - 28339824 AU - Banerjee, A. AU - Jakacki, R. I. AU - Onar-Thomas, A. AU - Wu, S. AU - Nicolaides, T. AU - Young Poussaint, T. AU - Fangusaro, J. AU - Phillips, J. AU - Perry, A. AU - Turner, D. AU - Prados, M. AU - Packer, R. J. AU - Qaddoumi, I. AU - Gururangan, S. AU - Pollack, I. F. AU - Goldman, S. AU - Doyle, L. A. AU - Stewart, C. F. AU - Boyett, J. M. AU - Kun, L. E. AU - Fouladi, M. C2 - PMC5570236 DA - Aug 1 DO - 10.1093/neuonc/now282 10.1093/neuonc/now282. DP - Nlm ET - 2017/03/25 IS - 8 LA - eng PY - 2017 SN - 1522-8517 (Print) 1522-8517 SP - 1135-1144 ST - A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study T2 - Neuro Oncol TI - A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study VL - 19 ID - 7323 ER - TY - JOUR AD - Royal Marsden Hospital, Institute of Cancer Research, Sutton, United Kingdom Institut Gustave Roussy, Université Paris XI, Villejuif, France Institut Curie, INSERM U900, Paris, France AU - Postel-Vinay, S. AU - Gomez-Roca, C. AU - Molife, L. R. AU - Anghan, B. AU - Levy, A. AU - Judson, I. AU - De Bono, J. AU - Soria, J. C. AU - Kaye, S. AU - Paoletti, X. DB - Scopus DO - 10.1200/JCO.2010.31.9236 IS - 13 M3 - Article N1 - Cited By :93 Export Date: 18 November 2020 PY - 2011 SP - 1728-1735 ST - Phase I trials of molecularly targeted agents: Should we pay more attention to late toxicities? T2 - Journal of Clinical Oncology TI - Phase I trials of molecularly targeted agents: Should we pay more attention to late toxicities? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955617684&doi=10.1200%2fJCO.2010.31.9236&partnerID=40&md5=7dbfc309c0161887d4f210aa911b71ce VL - 29 ID - 7324 ER - TY - JOUR AD - Mayo Clinic, 13400 E. Shea Blvd., Scottsdale, AZ 85259, United States Astex Pharmaceuticals Inc., 4140 Dublin Blvd., Ste. 200, Dublin, CA 94568, United States South Texas Accelerated Research Therapeutics (START), 4383 Medical Drive, San Antonio TX 78229, United States AU - Tibes, R. AU - Fine, G. AU - Choy, G. AU - Redkar, S. AU - Taverna, P. AU - Oganesian, A. AU - Sahai, A. AU - Azab, M. AU - Tolcher, A. W. DB - Scopus DO - 10.1007/s00280-012-2019-3 IS - 2 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2013 SP - 463-471 ST - A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors T2 - Cancer Chemotherapy and Pharmacology TI - A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874118848&doi=10.1007%2fs00280-012-2019-3&partnerID=40&md5=28257ccb718a34b12524dc95f3447b74 VL - 71 ID - 7325 ER - TY - JOUR AD - Department of Pediatrics, Nagoya Medical Center, Nagoya 460-0001, Japan.masahiro.sekimizu@nnh.go.jp. AN - 30140094 AU - Sekimizu, M. AU - Osumi, T. AU - Fukano, R. AU - Koga, Y. AU - Kada, A. AU - Saito, A. M. AU - Mori, T. DA - Aug DO - 10.18926/amo/56184 10.18926/AMO/56184. DP - Nlm ET - 2018/08/25 IS - 4 LA - eng PY - 2018 SN - 0386-300X (Print) 0386-300x SP - 431-436 ST - A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial T2 - Acta Med Okayama TI - A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial VL - 72 ID - 7326 ER - TY - JOUR AD - Department of Gastroenterology, University of Tokyo, Tokyo, Japan Department of Clinical Drug Evaluation, Graduate School of Medicine, University of Tokyo, Tokyo, Japan Department of Hepatology, Kyoundo Hospital, Tokyo, Japan Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan Division of Medical Oncology, Yokohama Rosai Hospital, Yokohama, Japan Department of Gastroenterology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan AU - Kanai, F. AU - Yoshida, H. AU - Tateishi, R. AU - Sato, S. AU - Kawabe, T. AU - Obi, S. AU - Kondo, Y. AU - Taniguchi, M. AU - Tagawa, K. AU - Ikeda, M. AU - Morizane, C. AU - Okusaka, T. AU - Arioka, H. AU - Shiina, S. AU - Omata, M. DB - Scopus DO - 10.1007/s00280-010-1320-2 IS - 2 M3 - Article N1 - Cited By :61 Export Date: 18 November 2020 PY - 2011 SP - 315-324 ST - A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma T2 - Cancer Chemotherapy and Pharmacology TI - A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953803472&doi=10.1007%2fs00280-010-1320-2&partnerID=40&md5=20f37afada5bc645c4a3abc1021e9732 VL - 67 ID - 7327 ER - TY - JOUR AD - University of Colorado, Denver, Colorado. AN - 30042150 AU - Krishnamurthy, A. AU - Dasari, A. AU - Noonan, A. M. AU - Mehnert, J. M. AU - Lockhart, A. C. AU - Leong, S. AU - Capasso, A. AU - Stein, M. N. AU - Sanoff, H. K. AU - Lee, J. J. AU - Hansen, A. AU - Malhotra, U. AU - Rippke, S. AU - Gustafson, D. L. AU - Pitts, T. M. AU - Ellison, K. AU - Davis, S. L. AU - Messersmith, W. A. AU - Eckhardt, S. G. AU - Lieu, C. H. C2 - PMC6139073 C6 - NIHMS1500544 Bayer AG and Merck & Co, Inc., Mark N. Stein: Merck Sharpe & Dohme Corp. DA - Sep 15 DO - 10.1158/0008-5472.Can-18-0316 10.1158/0008-5472.CAN-18-0316. Epub 2018 Jul 24. DP - Nlm ET - 2018/07/26 IS - 18 LA - eng PY - 2018 SN - 0008-5472 (Print) 0008-5472 SP - 5398-5407 ST - Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer T2 - Cancer Res TI - Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer VL - 78 ID - 7328 ER - TY - JOUR AD - Department of Medical Oncology, National Cancer Centre Singapore, Singapore. Department of Haematology-Oncology, National University Health System, Singapore. Divisions of Clinical Trials and Epidemiological Sciences. Oncologic Imaging, National Cancer Centre Singapore, Singapore. Cancer Science Institute of Singapore, National University of Singapore, Singapore. SingHealth Duke-NUS Radiological Sciences Academic Clinical Program, Singapore. Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research, National Cancer Centre Singapore, Singapore. Department of Pathology, Singapore General Hospital, Singapore, Singapore. Department of Medical Oncology, National Cancer Centre Singapore, Singapore choo.su.pin@singhealth.com.sg. AN - 27681866 AU - Tai, W. M. AU - Yong, W. P. AU - Lim, C. AU - Low, L. S. AU - Tham, C. K. AU - Koh, T. S. AU - Ng, Q. S. AU - Wang, W. W. AU - Wang, L. Z. AU - Hartano, S. AU - Thng, C. H. AU - Huynh, H. AU - Lim, K. T. AU - Toh, H. C. AU - Goh, B. C. AU - Choo, S. P. DA - Dec DO - 10.1093/annonc/mdw415 10.1093/annonc/mdw415. Epub 2016 Sep 28. DP - Nlm ET - 2016/09/30 IS - 12 LA - eng PY - 2016 SN - 0923-7534 SP - 2210-2215 ST - A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) T2 - Ann Oncol TI - A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) VL - 27 ID - 7329 ER - TY - JOUR AD - South Texas Accelerated Research Therapeutics LLC, San Antonio. Electronic address: atolcher@start.stoh.com. Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. South Texas Accelerated Research Therapeutics LLC, San Antonio. GlaxoSmithKline, Collegeville. Pharmaceutical Companies of Johnson and Johnson, Greater Philadelphia Area. Novartis, East Hanover, USA. AN - 25344362 AU - Tolcher, A. W. AU - Bendell, J. C. AU - Papadopoulos, K. P. AU - Burris, H. A., 3rd AU - Patnaik, A. AU - Jones, S. F. AU - Rasco, D. AU - Cox, D. S. AU - Durante, M. AU - Bellew, K. M. AU - Park, J. AU - Le, N. T. AU - Infante, J. R. DA - Jan DO - 10.1093/annonc/mdu482 10.1093/annonc/mdu482. Epub 2014 Oct 24. DP - Nlm ET - 2014/10/26 IS - 1 LA - eng PY - 2015 SN - 0923-7534 SP - 58-64 ST - A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors T2 - Ann Oncol TI - A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors VL - 26 ID - 7330 ER - TY - JOUR AD - Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, 1760 Haygood Drive NE, Atlanta, GA 30322, United States Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, United States Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, United States Department of Hematology/Oncology, Seattle Children's Hospital, Seattle, WA 98145, United States Pediatric Oncology, Clinical Care Center, Baylor College of Medicine, Houston, TX 77030, United States Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States AU - Wetmore, C. AU - Daryani, V. M. AU - Billups, C. A. AU - Boyett, J. M. AU - Leary, S. AU - Tanos, R. AU - Goldsmith, K. C. AU - Stewart, C. F. AU - Blaney, S. M. AU - Gajjar, A. DB - Scopus DO - 10.1002/cam4.713 IS - 7 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2016 SP - 1416-1424 ST - Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021 T2 - Cancer Medicine TI - Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006184468&doi=10.1002%2fcam4.713&partnerID=40&md5=7d4f626f2e7a36b64075c953ae6a5b4c VL - 5 ID - 7331 ER - TY - JOUR AD - J.R. Fangusaro AU - Fangusaro, J. R. AU - Onar-Thomas, A. AU - Young-Poussaint, T. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. I. AU - Banerjee, A. AU - Packer, R. AU - Kilburn, L. B. AU - Pollack, I. AU - Jakacki, R. AU - Qaddoumi, I. A. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. A. AU - Kreissman, S. G. AU - Doyle, L. A. AU - Smith, M. A. AU - Dunkel, I. J. AU - Fouladi, M. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L617388927 2017-07-25 PY - 2017 SN - 0732-183X ST - A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study T2 - Journal of Clinical Oncology TI - A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617388927&from=export VL - 35 ID - 7332 ER - TY - JOUR AD - J. Fangusaro, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, United States AU - Fangusaro, J. AU - Onar-Thomas, A. AU - Poussaint, T. Y. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. AU - Banerjee, A. AU - Packer, R. J. AU - Kilburn, L. B. AU - Goldman, S. AU - Pollack, I. F. AU - Jakacki, R. I. AU - Qaddoumi, I. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. AU - Kreissman, S. G. AU - Stewart, C. F. AU - Jones, D. T. W. AU - Pfster, S. M. AU - Vezina, G. AU - Stern, J. S. AU - Panigrahy, A. AU - Jones, B. V. AU - Patay, Z. AU - Tamrazi, B. AU - Jones, J. Y. AU - Haque, S. S. AU - Enterline, D. S. AU - Cha, S. AU - Fisher, M. J. AU - Doyle, A. AU - Smith, M. AU - Fouladi, M. AU - Dunkel, I. J. DB - Embase DO - 10.1093/neuonc/noz036.145 LA - English M3 - Conference Abstract N1 - L628912312 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA98-AA99 ST - A phase ii prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (PLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B T2 - Neuro-Oncology TI - A phase ii prospective trial of selumetinib in children with recurrent/progressive pediatric low-grade glioma (PLGG) with a focus upon optic pathway/hypothalamic tumors and visual acuity outcomes: A pediatric brain tumor consortium (PBTC) study, PBTC-029B UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628912312&from=exporthttp://dx.doi.org/10.1093/neuonc/noz036.145 VL - 21 ID - 7333 ER - TY - JOUR AD - J.M. Llovet, Icahn School of Medicine at Mount Sinai, New York, NY, United States AU - Llovet, J. M. AU - Merle, P. AU - Weiss, K. H. AU - Yau, T. AU - Ross, P. AU - Mazzaferro, V. AU - Blanc, J. F. AU - Ma, Y. T. AU - Yen, C. J. AU - Kocsis, J. AU - Choo, S. P. AU - Sukeepaisarnjaroen, W. AU - Gérolami, R. AU - Dufour, J. F. AU - Gane, E. J. AU - Ryoo, B. Y. AU - Peck-Radosavljevic, M. AU - Dao, T. AU - Yeo, W. AU - Lamlertthon, W. AU - Thongsawat, S. AU - Teufel, M. AU - Krissel, H. AU - Lim, H. Y. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612594775 2016-11-11 PY - 2016 SN - 0270-9139 SP - 621A ST - Phase II studies with refametinib or refametinib plus sorafenib in patients with mutant RAS hepatocellular carcinoma (HCC) T2 - Hepatology TI - Phase II studies with refametinib or refametinib plus sorafenib in patients with mutant RAS hepatocellular carcinoma (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612594775&from=export VL - 64 ID - 7334 ER - TY - JOUR AD - UNC Chapel Hill, Chapel Hill, NC; Vanderbilt-Ingram Cancer Center Comprehensive Cancer Center, Nashville, TN; Emory University, Atlanta, GA; The Ohio State University, Columbus, OH; Moffitt Cancer Center, Tampa, FL; VCU Massey Cancer Center, Richmond, VA AN - 120350922. Language: English. Entry Date: In Process. Revision Date: 20161223. Publication Type: journal article. Supplement Title: 5/21/2009 Supplement Part 1 of 2. Journal Subset: Biomedical AU - O'Neil, B. H. AU - Williams-Goff, L. W. AU - Kauh, J. AU - Bekaii-Saab, T. AU - Strosberg, J. R. AU - Lee, R. AU - Deal, A. M. AU - Sullivan, D. AU - Sebti, S. M. DB - ccm DP - EBSCOhost N1 - Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 8309333. PMID: NLM27962385. PY - 2009 SN - 0732-183X SP - e15574-e15574 ST - A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120350922&site=ehost-live&scope=site VL - 27 ID - 7335 ER - TY - JOUR AD - Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, TX, United States AU - Kadia, T. M. AU - Kantarjian, H. M. AU - Thomas, D. A. AU - O'Brien, S. AU - Estrov, Z. AU - Ravandi, F. AU - Jabbour, E. AU - Pemmaraju, N. AU - Daver, N. AU - Wang, X. AU - Jain, P. AU - Pierce, S. AU - Brandt, M. AU - Garcia-Manero, G. AU - Cortes, J. AU - Borthakur, G. DB - Scopus DO - 10.1002/ajh.23886 IS - 2 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2015 SP - 120-124 ST - Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia T2 - American Journal of Hematology TI - Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921405793&doi=10.1002%2fajh.23886&partnerID=40&md5=ebd8355d4c13061c0409980afac9e7b5 VL - 90 ID - 7336 ER - TY - JOUR AD - Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni, 56, Rozzano, Milano, 20089, Italy Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy Istituto Superiore di Sanità, Roma, Italy San Raffaele Institute, Sulmona, Italy Human Tumors Immunobiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Hematology and BMT Unit, University of Brescia, Brescia, Italy Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Division of Hematology, S. Croce and Carle Hospital, Cuneo, Italy Hematology and BMT Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Biostatistic Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy Hematology, University of Milano, Milano, Italy AU - Guidetti, A. AU - Carlo-Stella, C. AU - Locatelli, S. L. AU - Malorni, W. AU - Mortarini, R. AU - Viviani, S. AU - Russo, D. AU - Marchianò, A. AU - Sorasio, R. AU - Dodero, A. AU - Farina, L. AU - Giordano, L. AU - Di Nicola, M. AU - Anichini, A. AU - Corradini, P. AU - Gianni, A. M. DB - Scopus DO - 10.1158/1078-0432.CCR-14-0770 IS - 22 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2014 SP - 5641-5651 ST - Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases T2 - Clinical Cancer Research TI - Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918509201&doi=10.1158%2f1078-0432.CCR-14-0770&partnerID=40&md5=1c3af8c9c1b2c9269d9438bf205df7e7 VL - 20 ID - 7337 ER - TY - JOUR AD - NYU Comprehensive Neurofibromatosis Center, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (M.A.K., G.L., A.M., J.C.A.); Division of Oncology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (M.J.F., A.J.S.); Department of Radiology, NYU Langone Medical Center, New York, New York (S.S.M., M.C.B.); The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (K.J.C.); Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Langone Medical Center, New York, New York (J.H.W., D.H.H.); Division of Biostatistics, Department of Population Health and The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (J.D.G., T.H.); Department of Neurosurgery, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (A.C.R); Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); German Cancer Research Center and University Hospital, Heidelberg, Germany (D.T.W.J., A.K., S.M.P.); Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland (C.G.E.); Division of Neuropathology, Department of Pathology, Department of Neurosurgery and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (D.Z.). AN - 24803676 AU - Karajannis, M. A. AU - Legault, G. AU - Fisher, M. J. AU - Milla, S. S. AU - Cohen, K. J. AU - Wisoff, J. H. AU - Harter, D. H. AU - Goldberg, J. D. AU - Hochman, T. AU - Merkelson, A. AU - Bloom, M. C. AU - Sievert, A. J. AU - Resnick, A. C. AU - Dhall, G. AU - Jones, D. T. AU - Korshunov, A. AU - Pfister, S. M. AU - Eberhart, C. G. AU - Zagzag, D. AU - Allen, J. C. C2 - PMC4165419 DA - Oct DO - 10.1093/neuonc/nou059 10.1093/neuonc/nou059. Epub 2014 May 6. DP - Nlm ET - 2014/05/08 IS - 10 LA - eng PY - 2014 SN - 1522-8517 (Print) 1522-8517 SP - 1408-16 ST - Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas T2 - Neuro Oncol TI - Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas VL - 16 ID - 7338 ER - TY - JOUR AD - M.A. Karajannis, NYU Langone Medical Center, New York, NY, United States AU - Karajannis, M. A. AU - Fisher, M. J. AU - Milla, S. S. AU - Cohen, K. J. AU - Legault, G. AU - Wisoff, J. H. AU - Harter, D. H. AU - Hartnett, E. AU - Merkelson, A. AU - Bloom, M. C. AU - Dhall, G. AU - Jones, D. AU - Korshunov, A. AU - Pfister, S. AU - Eberhart, C. G. AU - Zagzag, D. AU - Allen, J. C. DB - Embase DO - 10.1093/neuonc/nos232 LA - English M3 - Conference Abstract N1 - L70929624 2012-11-29 PY - 2012 SN - 1522-8517 SP - vi101 ST - Phase II study of sorafenib in children with recurrent/progressive low-grade astrocytomas T2 - Neuro-Oncology TI - Phase II study of sorafenib in children with recurrent/progressive low-grade astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70929624&from=exporthttp://dx.doi.org/10.1093/neuonc/nos232 VL - 14 ID - 7339 ER - TY - JOUR AD - G.K. Abou-Alfa, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10022, United States AU - Abou-Alfa, G. K. AU - Schwartz, L. AU - Ricci, S. AU - Amadori, D. AU - Santoro, A. AU - Figer, A. AU - De Greve, J. AU - Douillard, J. Y. AU - Lathia, C. AU - Schwartz, B. AU - Taylor, I. AU - Moscovici, M. AU - Saltz, L. B. DB - Embase Medline DO - 10.1200/JCO.2005.01.3441 IS - 26 LA - English M3 - Article N1 - L46630787 2006-09-10 PY - 2006 SN - 0732-183X SP - 4293-4300 ST - Phase II study of sorafenib in patients with advanced hepatocellular carcinoma T2 - Journal of Clinical Oncology TI - Phase II study of sorafenib in patients with advanced hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46630787&from=exporthttp://dx.doi.org/10.1200/JCO.2005.01.3441 VL - 24 ID - 7340 ER - TY - JOUR AU - Maki, R. G. AU - D'Adamo, D. R. AU - Keohan, M. L. AU - Saulle, M. AU - Schuetze, S. M. AU - Undevia, S. D. AU - Livingston, M. B. AU - Cooney, M. M. AU - Hensley, M. L. AU - Mita, M. M. AU - Takimoto, C. H. AU - Kraft, A. S. AU - Elias, A. D. AU - Brockstein, B. AU - Blachère, N. E. AU - Edgar, M. A. AU - Schwartz, L. H. AU - Qin, L. X. AU - Antonescu, C. R. AU - Schwartz, G. K. DB - Scopus DO - 10.1200/JCO.2008.20.4495 IS - 19 M3 - Article N1 - Cited By :393 Export Date: 18 November 2020 PY - 2009 SP - 3133-3140 ST - Phase II study of sorafenib in patients with metastatic or recurrent sarcomas T2 - Journal of Clinical Oncology TI - Phase II study of sorafenib in patients with metastatic or recurrent sarcomas UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650293850&doi=10.1200%2fJCO.2008.20.4495&partnerID=40&md5=2b3dd93930d251c46b8f735e8f26c85f VL - 27 ID - 7341 ER - TY - JOUR AD - Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Medical Oncology, University of Milano, Milano, Italy Istituto Superiore di Sanità, Roma, Italy Istituto San Raffaele Sulmona, Sulmona, Italy Centre of Integrated Metabolomics, Roma, Italy Human Tumours Immunobiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Haematology and BMT Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy Haematology and Molecular Biotechnology Centre, University of Torino, Torino, Italy Haematology, University of Milano, Milano, Italy AU - Guidetti, A. AU - Carlo-Stella, C. AU - Locatelli, S. L. AU - Malorni, W. AU - Pierdominici, M. AU - Barbati, C. AU - Mortarini, R. AU - Devizzi, L. AU - Matteucci, P. AU - Marchianò, A. AU - Lanocita, R. AU - Farina, L. AU - Dodero, A. AU - Tarella, C. AU - Di Nicola, M. AU - Corradini, P. AU - Anichini, A. AU - Gianni, A. M. DB - Scopus DO - 10.1111/j.1365-2141.2012.09139.x IS - 1 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2012 SP - 108-119 ST - Phase II study of sorafenib in patients with relapsed or refractory lymphoma T2 - British Journal of Haematology TI - Phase II study of sorafenib in patients with relapsed or refractory lymphoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862256588&doi=10.1111%2fj.1365-2141.2012.09139.x&partnerID=40&md5=1ee8104e2fee77aca97d55a7fdfd6199 VL - 158 ID - 7342 ER - TY - JOUR AD - PLA Cancer Center, Nanjing Bayi Hospital, Nanjing, 210002, China Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, China Division of Medical Oncology, National Cancer Center Singapore, Singapore Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Medical Oncology, Sir Run Shaw Hospital, Zhejiang University, Hangzhou, China Department of Surgery, Queen Mary Hospital, University of Hong Kong, Hong Kong Nanfang Hospital, Guangzhou Southern Medical University, Guangzhou, China Sun Yat-Sen University Cancer Center, Guangzhou, China Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China Department of Gastrointestinal Oncology, 307 Hospital of People’s Liberation Army, Beijing, China Department of Internal Medicine, National Cheng Kung University Hospital, Tainan City, Taiwan Department of Oncology, National Taiwan University Hospital, Taipei City, Taiwan Translational Clinical Oncology, Novartis Institutes for BioMedical Research, East Hanover, NJ, United States AU - Qin, S. AU - Chan, S. L. AU - Sukeepaisarnjaroen, W. AU - Han, G. AU - Choo, S. P. AU - Sriuranpong, V. AU - Pan, H. AU - Yau, T. AU - Guo, Y. AU - Chen, M. AU - Ren, Z. AU - Xu, J. AU - Yen, C. J. AU - Lin, Z. Z. AU - Manenti, L. AU - Gu, Y. AU - Sun, Y. AU - Tiedt, R. AU - Hao, L. AU - Song, W. AU - Tanwandee, T. DB - Scopus DO - 10.1177/1758835919889001 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2019 ST - A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma T2 - Therapeutic Advances in Medical Oncology TI - A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076565560&doi=10.1177%2f1758835919889001&partnerID=40&md5=0dc5aeb27bbe0cae43b92c9a0f0d4c28 VL - 11 ID - 7343 ER - TY - JOUR AD - University of North Carolina, 170 Manning Drive, Chapel Hill, NC 27599-730, USA. Bert_oneil@med.unc.edu AN - 21519015 AU - O'Neil, B. H. AU - Goff, L. W. AU - Kauh, J. S. AU - Strosberg, J. R. AU - Bekaii-Saab, T. S. AU - Lee, R. M. AU - Kazi, A. AU - Moore, D. T. AU - Learoyd, M. AU - Lush, R. M. AU - Sebti, S. M. AU - Sullivan, D. M. C2 - PMC3107750 found at the end of this article. DA - Jun 10 DO - 10.1200/jco.2010.33.9432 10.1200/JCO.2010.33.9432. Epub 2011 Apr 25. DP - Nlm ET - 2011/04/27 IS - 17 LA - eng PY - 2011 SN - 0732-183X (Print) 0732-183x SP - 2350-6 ST - Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma T2 - J Clin Oncol TI - Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma VL - 29 ID - 7344 ER - TY - JOUR AD - M. Sekimizu, Department of Pediatrics, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan AU - Sekimizu, M. AU - Fukano, R. AU - Choi, I. AU - Kada, A. AU - Saito, A. AU - Asada, R. AU - Mori, T. AU - Nagai, H. DB - Embase DO - 10.1182/blood-2018-99-112708 LA - English M3 - Conference Abstract N1 - L626530588 2019-03-04 PY - 2018 SN - 0006-4971 ST - Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma T2 - Blood TI - Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530588&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-112708 VL - 132 ID - 7345 ER - TY - JOUR AD - Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Solid Tumor Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Radiation Oncology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States Neurosurgery, Geisinger Health System, Danville, PA, United States Quantitative Health Services, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, United States AU - Peereboom, D. M. AU - Shepard, D. R. AU - Ahluwalia, M. S. AU - Brewer, C. J. AU - Agarwal, N. AU - Stevens, G. H. J. AU - Suh, J. H. AU - Toms, S. A. AU - Vogelbaum, M. A. AU - Weil, R. J. AU - Elson, P. AU - Barnett, G. H. DB - Scopus DO - 10.1007/s11060-009-0067-2 IS - 1 M3 - Article N1 - Cited By :134 Export Date: 18 November 2020 PY - 2010 SP - 93-99 ST - Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme T2 - Journal of Neuro-Oncology TI - Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953617053&doi=10.1007%2fs11060-009-0067-2&partnerID=40&md5=1914513201a76241fd3c5b902b8ebab1 VL - 98 ID - 7346 ER - TY - JOUR AD - H.Y. Lim AU - Lim, H. Y. AU - Yen, C. J. AU - Tak, W. Y. AU - Heo, J. AU - Choi, H. J. AU - Lin, C. Y. AU - Yoon, J. H. AU - Hsu, C. AU - Rau, K. M. AU - Ping Poon, R. T. AU - Yeo, W. AU - Park, J. W. AU - Tay, M. H. AU - Hsieh, W. S. AU - Kappeler, C. AU - Rajagopalan, P. AU - Krissel, H. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L71003872 2013-03-08 PY - 2012 SN - 0732-183X ST - A phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC) T2 - Journal of Clinical Oncology TI - A phase II trial of MEK inhibitor BAY 86-9766 in combination with sorafenib as first-line systemic treatment for patients with unresectable hepatocellular carcinoma (HCC) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71003872&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/30/15_suppl/4103?sid=3beffa44-7c95-44cc-99bb-073fc0df7598 VL - 30 ID - 7347 ER - TY - JOUR AD - Medical Oncology Unit, Institute for Cancer Research and Treatment, Candiolo, Italy Chemotherapy Unit, Department of Musculoskeletal Oncology, Istituti Ortopedici Rizzoli, Bologna, Italy Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Department of Pediatric Oncology, Ospedale Infantile Regina Margherita, Torino, Italy 5th Department of Orthopedics, Istituti Ortopedici Rizzoli and University of Bologna, Bologna, Italy Laboratory of Experimental Oncology, Istituti Ortopedici Rizzoli, Bologna, Italy AU - Grignani, G. AU - Palmerini, E. AU - Dileo, P. AU - Asaftei, S. D. AU - D'Ambrosio, L. AU - Pignochino, Y. AU - Mercuri, M. AU - Picci, P. AU - Fagioli, F. AU - Casali, P. G. AU - Ferrari, S. AU - Aglietta, M. DB - Scopus DO - 10.1093/annonc/mdr151 IS - 2 M3 - Article N1 - Cited By :182 Export Date: 18 November 2020 PY - 2012 SP - 508-516 ST - A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study T2 - Annals of Oncology TI - A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: An Italian sarcoma group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856343533&doi=10.1093%2fannonc%2fmdr151&partnerID=40&md5=ab920d0cf6d3f4210afaf2b6cdf07db6 VL - 23 ID - 7348 ER - TY - JOUR AD - I.H. El Dika AU - El Dika, I. H. AU - Capanu, M. AU - Chou, J. F. AU - Harding, J. J. AU - Hrabovsky, A. D. AU - Do, R. K. G. AU - Shia, J. AU - Germino, J. AU - O'Reilly, E. M. AU - Abou-Alfa, G. K. DB - Embase DO - 10.1200/JCO.2018.36.15-suppl.4080 IS - 15 LA - English M3 - Conference Abstract N1 - L625973745 2019-02-26 PY - 2018 SN - 1527-7755 ST - Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S) T2 - Journal of Clinical Oncology TI - Phase II trial of sorafenib plus doxorubicin (SD) in patients (Pts) with advanced hepatocellular carcinoma (HCC) after progression of disease (PD) on sorafenib (S) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625973745&from=exporthttp://dx.doi.org/10.1200/JCO.2018.36.15-suppl.4080 VL - 36 ID - 7349 ER - TY - JOUR AD - G.H.O. Coyne AU - Coyne, G. H. O. AU - Gross, A. M. AU - Dombi, E. AU - Tibery, C. AU - Carbonell, A. AU - Takebe, N. AU - Derdak, J. AU - Pichard, D. AU - Srivastava, A. K. AU - Herrick, W. AU - Parchment, R. E. AU - Martin, S. AU - Wolters, P. AU - Whitcomb, P. AU - Rubinstein, L. AU - Doroshow, J. H. AU - Chen, A. P. AU - Widemann, B. C. DB - Embase DO - 10.1200/JCO.2020.38.15_suppl.3612 IS - 15 LA - English M3 - Conference Abstract N1 - L632807206 2020-09-15 PY - 2020 SN - 1527-7755 ST - Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) T2 - Journal of Clinical Oncology TI - Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632807206&from=exporthttp://dx.doi.org/10.1200/JCO.2020.38.15_suppl.3612 VL - 38 ID - 7350 ER - TY - JOUR AD - D. Bradford AU - Bradford, D. AU - Whitcomb, P. AU - Dombi, E. AU - Chen, A. P. AU - Baldwin, A. AU - Wolters, P. AU - Martin, S. AU - Glod, J. AU - Derdak, J. AU - Coyne, G. H. O. AU - Cowen, E. W. AU - Holmblad, M. AU - Trepel, J. AU - Wood, B. J. AU - Paul, S. M. AU - Clapp, W. AU - Johnson, G. L. AU - Rubinstein, L. AU - Doyle, L. A. AU - Widemann, B. C. DB - Embase LA - English M3 - Conference Abstract N1 - L611756106 2016-08-25 PY - 2016 SN - 1527-7755 ST - Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) T2 - Journal of Clinical Oncology TI - Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611756106&from=export VL - 34 ID - 7351 ER - TY - JOUR AD - Departments of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Molecular Imaging, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Pharmacological Research Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Pathology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China Departments of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China AU - Liao, Z. AU - Li, F. AU - Zhang, C. AU - Zhu, L. AU - Shi, Y. AU - Zhao, G. AU - Bai, X. AU - Hassan, S. AU - Liu, X. AU - Li, T. AU - Xing, P. AU - Zhao, J. AU - Zhang, J. AU - Xing, R. AU - Teng, S. AU - Yang, Y. AU - Chen, K. AU - Yang, J. C7 - 24 DB - Scopus DO - 10.1038/s12276-019-0221-7 IS - 3 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2019 ST - Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety T2 - Experimental and Molecular Medicine TI - Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062397370&doi=10.1038%2fs12276-019-0221-7&partnerID=40&md5=080f4f49db230de13f15ca83c739c9d3 VL - 51 ID - 7352 ER - TY - JOUR AD - Alvaro Lassaletta, Cynthia E. Hawkins, Rahul Krishnatry, Matthew Mistry, Anthony Arnoldo, Vijay Ramaswamy, Annie Huang, Ute Bartels, Uri Tabori, and Eric Bouffet, The Hospital for Sick Children, Toronto; Katrin Scheinemann, McMaster Children's Hospital; Shayna M. Zelcer, Children's Hospital of Western Ontario, London; Gregory Russell Pond, Ontario Clinical Oncology Group, McMaster University, Hamilton; Daniel Keene and Donna L. Johnston, Children's Hospital of Eastern Ontario, Ottawa, Ontario; Juliette Hukin and Ken Poskitt, British Columbia Children's Hospital, Vancouver, British Columbia; Beverley A. Wilson, University of Alberta Hospital; Lucie Lafay-Cousin, Alberta Children's Hospital, Calgary; David D. Eisenstat, Stollery Children's Hospital, Edmonton; Alberta; Nada Jabado, McGill University; Anne Sophie Carret, Hospital Sainte Justine, Montreal; Valerie Larouche, Centre Hospitalier Universitaire de Québec, Québec, Québec; and David D. Eisenstat, Cancer Care Manitoba, Winnipeg, Manitoba, Canada. AN - 27573663 AU - Lassaletta, A. AU - Scheinemann, K. AU - Zelcer, S. M. AU - Hukin, J. AU - Wilson, B. A. AU - Jabado, N. AU - Carret, A. S. AU - Lafay-Cousin, L. AU - Larouche, V. AU - Hawkins, C. E. AU - Pond, G. R. AU - Poskitt, K. AU - Keene, D. AU - Johnston, D. L. AU - Eisenstat, D. D. AU - Krishnatry, R. AU - Mistry, M. AU - Arnoldo, A. AU - Ramaswamy, V. AU - Huang, A. AU - Bartels, U. AU - Tabori, U. AU - Bouffet, E. DA - Oct 10 DO - 10.1200/jco.2016.68.1585 10.1200/JCO.2016.68.1585. DP - Nlm ET - 2016/08/31 IS - 29 LA - eng PY - 2016 SN - 0732-183x SP - 3537-3543 ST - Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study T2 - J Clin Oncol TI - Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study VL - 34 ID - 7353 ER - TY - JOUR AD - HELIOS Klinikum Bad Saarow, Sarkomzentrum Berlin-Brandenburg, Bad Saarow, Germany Léon Bérar Comprehensive Cancer Centre, Université Claude Bernard Lyon I, Lyon, France Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands Department of Internal Medicine III, University Hospitals Grosshadern, Ludwig Maximilians University Munich, Munich, Germany Center for Sarcoma and Bone Oncology, Ludwig Center at Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, Boston, United States Institut Bergonié, Bordeaux, France Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia Novartis Pharmaceuticals Corporation, Florham Park, United States Novartis Pharma AG, Basel, Switzerland Department of Soft Tissue/Bone Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland AU - Reichardt, P. AU - Blay, J. Y. AU - Gelderblom, H. AU - Schlemmer, M. AU - Demetri, G. D. AU - Bui-nguyen, B. AU - McArthur, G. A. AU - Yazji, S. AU - Hsu, Y. AU - Galetic, I. AU - Rutkowski, P. C7 - mdr598 DB - Scopus DO - 10.1093/annonc/mdr598 IS - 7 M3 - Article N1 - Cited By :81 Export Date: 18 November 2020 PY - 2012 SP - 1680-1687 ST - Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib T2 - Annals of Oncology TI - Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864293774&doi=10.1093%2fannonc%2fmdr598&partnerID=40&md5=51bdef44d34c960c43b81d4543ad71b4 VL - 23 ID - 7354 ER - TY - JOUR AU - Cortes, J. E. AU - Baccarani, M. AU - Guilhot, F. AU - Druker, B. J. AU - Branford, S. AU - Kim, D. W. AU - Pane, F. AU - Pasquini, R. AU - Goldberg, S. L. AU - Kalaycio, M. AU - Moiraghi, B. AU - Rowe, J. M. AU - Tothova, E. AU - De Souza, C. AU - Rudoltz, M. AU - Yu, R. AU - Krahnke, T. AU - Kantarjian, H. M. AU - Radich, J. P. AU - Hughes, T. P. DB - Scopus DO - 10.1200/JCO.2009.25.3724 IS - 3 M3 - Article N1 - Cited By :213 Export Date: 18 November 2020 PY - 2010 SP - 424-430 ST - Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine kinase inhibitor optimization and selectivity study T2 - Journal of Clinical Oncology TI - Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine kinase inhibitor optimization and selectivity study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-75749105885&doi=10.1200%2fJCO.2009.25.3724&partnerID=40&md5=bdf7bc53c27e59304e9ee9fad042a323 VL - 28 ID - 7355 ER - TY - JOUR AD - Y. Wu, State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Cardiovascular Institute, Center of Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, North Lishi Road, Xicheng District, No. 167, Beijing, China AU - Gao, H. AU - Wu, D. AU - Zhang, E. AU - Liang, T. AU - Meng, X. AU - Chen, L. AU - Wu, Y. DB - Embase IS - 2 LA - English M3 - Article N1 - L2001628640 2019-04-03 2019-04-08 PY - 2019 SN - 1943-8141 SP - 911-930 ST - Phasic change and apoptosis regulation of jak2/stat3 pathway in a type 2 diabetic rat model T2 - American Journal of Translational Research TI - Phasic change and apoptosis regulation of jak2/stat3 pathway in a type 2 diabetic rat model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001628640&from=export VL - 11 ID - 7356 ER - TY - JOUR AD - Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4006, Australia. c.rosty@uq.edu.au AN - 22510757 AU - Rosty, C. AU - Buchanan, D. D. AU - Walsh, M. D. AU - Pearson, S. A. AU - Pavluk, E. AU - Walters, R. J. AU - Clendenning, M. AU - Spring, K. J. AU - Jenkins, M. A. AU - Win, A. K. AU - Hopper, J. L. AU - Sweet, K. AU - Frankel, W. L. AU - Aronson, M. AU - Gallinger, S. AU - Goldblatt, J. AU - Woodall, S. AU - Arnold, J. AU - Walker, N. I. AU - Jass, J. R. AU - Parry, S. AU - Young, J. P. C2 - PMC3354022 C6 - NIHMS361343 respect to this work. DA - Jun DO - 10.1097/PAS.0b013e31824e133f 10.1097/PAS.0b013e31824e133f. DP - Nlm ET - 2012/04/19 IS - 6 LA - eng PY - 2012 SN - 0147-5185 (Print) 0147-5185 SP - 876-82 ST - Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics T2 - Am J Surg Pathol TI - Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics VL - 36 ID - 7357 ER - TY - JOUR AD - S. Nakamura, Dept. of Pathol./Molec. Diagnostics, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-Ku, Nagoya 464-8681, Japan AU - Ichimura, K. AU - Kagami, Y. AU - Suzuki, R. AU - Kojima, M. AU - Yoshino, T. AU - Ohshima, K. AU - Koike, K. AU - Kondo, E. AU - Taji, H. AU - Ogura, M. AU - Morishima, Y. AU - Akagi, T. AU - Takahashi, T. AU - Nakamura, S. DB - Embase Medline DO - 10.1046/j.1440-1827.2003.01479.x IS - 6 LA - English M3 - Article N1 - L36859624 2003-07-30 PY - 2003 SN - 1320-5463 SP - 333-344 ST - Phenotypic analysis of peripheral T/NK cell lymphoma: Study of 408 Japanese cases with special reference to their anatomical sites T2 - Pathology International TI - Phenotypic analysis of peripheral T/NK cell lymphoma: Study of 408 Japanese cases with special reference to their anatomical sites UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36859624&from=exporthttp://dx.doi.org/10.1046/j.1440-1827.2003.01479.x VL - 53 ID - 7358 ER - TY - JOUR AD - T.H. Tran, Division of Pediatric Hematology-Oncology, CHU Sainte-Justine, 3175 Cote Sainte-Catherine, Local A-435, Montreal, QC, Canada AU - Khan, M. AU - Siddiqi, R. AU - Tran, T. H. C1 - azd 2014 nvp bbt 594 DB - Embase Medline DO - 10.1053/j.seminhematol.2018.05.001 IS - 4 LA - English M3 - Review N1 - L2000884840 2018-06-29 2018-12-06 PY - 2018 SN - 1532-8686 0037-1963 SP - 235-241 ST - Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options T2 - Seminars in Hematology TI - Philadelphia chromosome-like acute lymphoblastic leukemia: A review of the genetic basis, clinical features, and therapeutic options UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000884840&from=exporthttp://dx.doi.org/10.1053/j.seminhematol.2018.05.001 VL - 55 ID - 7359 ER - TY - JOUR AD - Department of Leukemia, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, United States Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, United States AU - Ravandi, F. AU - Kebriaei, P. DB - Scopus DO - 10.1016/j.hoc.2009.07.007 IS - 5 M3 - Review N1 - Cited By :42 Export Date: 18 November 2020 PY - 2009 SP - 1043-1063 ST - Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349754444&doi=10.1016%2fj.hoc.2009.07.007&partnerID=40&md5=6554eb9c8494cbb177a32903c52fc146 VL - 23 ID - 7360 ER - TY - JOUR AD - Division of Pedatric Hematology, Oncology, Blood and Marrow Transplantation, British Columbia Childrens Hospital, University of British Columbia, Vancouver, BC, V6H 3V4, Canada Division of Hematology/Oncology/Transplantation, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, WI, United States AU - Schultz, K. R. AU - Prestidge, T. AU - Camitta, B. DB - Scopus DO - 10.1586/ehm.10.60 IS - 6 M3 - Review N1 - Cited By :11 Export Date: 18 November 2020 PY - 2010 SP - 731-742 ST - Philadelphia chromosome-positive acute lymphoblastic leukemia in children: New and emerging treatment options T2 - Expert Review of Hematology TI - Philadelphia chromosome-positive acute lymphoblastic leukemia in children: New and emerging treatment options UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649505429&doi=10.1586%2fehm.10.60&partnerID=40&md5=afdfde40e8855872d31914f9dfde803a VL - 3 ID - 7361 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Comenius University Medical School, University Children's Hospital, Limbova 1, Bratislava, 833 40, Slovakia Pediatric Hematology/Oncology/BMT, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO, United States Department of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States AU - Kolenova, A. AU - Maloney, K. W. AU - Hunger, S. P. DB - Scopus DO - 10.1097/MPH.0000000000000582 IS - 6 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2016 SP - e193-e195 ST - Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast crisis T2 - Journal of Pediatric Hematology/Oncology TI - Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast crisis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966430675&doi=10.1097%2fMPH.0000000000000582&partnerID=40&md5=36179a3e30c3c3dcb7c7f8c20918813f VL - 38 ID - 7362 ER - TY - JOUR AD - S. Hashioka, Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan AU - Hashioka, S. AU - Han, Y. H. AU - Fujii, S. AU - Kato, T. AU - Monji, A. AU - Utsumi, H. AU - Sawada, M. AU - Nakanishi, H. AU - Kanba, S. DB - Embase Medline DO - 10.1016/j.freeradbiomed.2006.12.003 IS - 7 LA - English M3 - Article N1 - L46356888 2007-04-12 PY - 2007 SN - 0891-5849 SP - 945-954 ST - Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation T2 - Free Radical Biology and Medicine TI - Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46356888&from=exporthttp://dx.doi.org/10.1016/j.freeradbiomed.2006.12.003 VL - 42 ID - 7363 ER - TY - JOUR AD - E.D. Fleuren, Institute of Cancer Research, London, United Kingdom AU - Fleuren, E. D. AU - Vlenterie, M. AU - Van Der Graaf, W. AU - Hillebrandt-Roeffen, M. AU - Cebeci, S. AU - Van De Ven, A. AU - Flucke, U. AU - Wu, J. AU - Versleijen-Jonkers, Y. AU - Daly, R. DB - Embase DO - 10.1158/1538-7445.AM2017-5837 IS - 13 LA - English M3 - Conference Abstract N1 - L618566796 2017-10-10 PY - 2017 SN - 1538-7445 ST - Phosphoproteomic landscape of sarcoma: Novel subgroups and actionable targets T2 - Cancer Research TI - Phosphoproteomic landscape of sarcoma: Novel subgroups and actionable targets UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618566796&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2017-5837 VL - 77 ID - 7364 ER - TY - JOUR AD - Cell Biology Program, The Hospital for Sick Children, TMDT East Tower #12-314, 101 College St., Toronto, Ontario, M5G 1L7; Canada. dkaplan@sickkids.ca. AN - 23701117 AU - Vojvodic, M. AU - Hansford, L. M. AU - Morozova, O. AU - Blakely, K. M. AU - Taylor, P. AU - Fathers, K. E. AU - Moffat, J. AU - Marra, M. AU - Smith, K. M. AU - Moran, M. F. AU - Kaplan, D. R. DA - Dec DO - 10.2174/15701638113109990001 10.2174/15701638113109990001. DP - Nlm ET - 2013/05/25 IS - 4 LA - eng PY - 2013 SN - 1570-1638 SP - 283-304 ST - A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines T2 - Curr Drug Discov Technol TI - A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines VL - 10 ID - 7365 ER - TY - JOUR AD - Department of Pediatric Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Division of Pediatric Oncology, Shanghai Institute of Pediatric Research, Shanghai, China. AN - 27732954 AU - Chen, K. AU - Lv, F. AU - Xu, G. AU - Zhang, M. AU - Wu, Y. AU - Wu, Z. C2 - PMC5342791 DA - Nov 15 DO - 10.18632/oncotarget.12513 10.18632/oncotarget.12513. DP - Nlm ET - 2016/10/13 IS - 46 LA - eng PY - 2016 SN - 1949-2553 SP - 75968-75980 ST - Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma T2 - Oncotarget TI - Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma VL - 7 ID - 7366 ER - TY - JOUR AD - Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea Department of Dermatology, Seoul Medical Center, Seoul, South Korea Department of Biochemistry, Ajou University School of Medicine, Suwon, South Korea Department of Biomedical Sciences, Graduate School, Ajou University, Suwon, South Korea Ellead Skin & Bio Research, Ellead Co., Ltd., Osong Research Center, Cheongju-si, South Korea AU - Kim, S. K. AU - Oh, S. J. AU - Park, S. Y. AU - Kim, W. J. AU - Kim, Y. S. AU - Kim, Y. C. DB - Scopus DO - 10.1111/pcmr.12658 IS - 2 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2018 SP - 277-286 ST - Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts T2 - Pigment Cell and Melanoma Research TI - Photodynamic therapy inhibits melanogenesis through paracrine effects by keratinocytes and fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041824693&doi=10.1111%2fpcmr.12658&partnerID=40&md5=42b8088fa79eb45d42495b3dd10ac799 VL - 31 ID - 7367 ER - TY - JOUR AD - Y. Ohmichi, Department of Anatomy, Aichi Medical University, 1-1 Yazakokarimta, Nagakute, Aichi, Japan AU - Ohmichi, Y. AU - Ohmichi, M. AU - Tashima, R. AU - Osuka, K. AU - Fukushige, K. AU - Kanikowska, D. AU - Fukazawa, Y. AU - Yawo, H. AU - Tsuda, M. AU - Naito, M. AU - Nakano, T. DB - Embase Medline DO - 10.1097/j.pain.0000000000001867 IS - 8 LA - English M3 - Article N1 - L632859884 2020-09-22 2020-09-24 PY - 2020 SN - 1872-6623 0304-3959 SP - 1808-1823 ST - Physical disuse contributes to widespread chronic mechanical hyperalgesia, tactile allodynia, and cold allodynia through neurogenic inflammation and spino-parabrachio-amygdaloid pathway activation T2 - Pain TI - Physical disuse contributes to widespread chronic mechanical hyperalgesia, tactile allodynia, and cold allodynia through neurogenic inflammation and spino-parabrachio-amygdaloid pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632859884&from=exporthttp://dx.doi.org/10.1097/j.pain.0000000000001867 VL - 161 ID - 7368 ER - TY - JOUR AD - The Hebrew University of Jerusalem, Facul. Agri. Food/Envtl. Qlty. Sci., P.O. Box 12, Rehovot 76100, Israel AU - Stark, A. AU - Madar, Z. DB - Scopus DO - 10.1515/JPEM.2002.15.5.561 IS - 5 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2002 SP - 561-572 ST - Phytoestrogens: A review of recent findings T2 - Journal of Pediatric Endocrinology and Metabolism TI - Phytoestrogens: A review of recent findings UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036013248&doi=10.1515%2fJPEM.2002.15.5.561&partnerID=40&md5=daf0450e84ec08e7622898437893ddeb VL - 15 ID - 7369 ER - TY - JOUR AD - R.J. Chan, Indiana University School of Medicine, Department of Pediatrics, Herman B Wells Center for Pediatric Research, United States AU - Goodwin, C. B. AU - Li, X. J. AU - Mali, R. S. AU - Chan, G. AU - Kang, M. AU - Liu, Z. AU - Vanhaesebroeck, B. AU - Neel, B. G. AU - Loh, M. L. AU - Lannutti, B. J. AU - Kapur, R. AU - Chan, R. J. C1 - gs 1101(Gilead) pd 0325901(Selleck) C2 - Gilead Selleck DB - Embase Medline DO - 10.1182/blood-2013-10-535104 IS - 18 LA - English M3 - Article N1 - L373379872 2014-07-04 2014-07-08 PY - 2014 SN - 1528-0020 0006-4971 SP - 2838-2842 ST - PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML T2 - Blood TI - PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373379872&from=exporthttp://dx.doi.org/10.1182/blood-2013-10-535104 VL - 123 ID - 7370 ER - TY - JOUR AD - Dermatology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 160 East 53rd Street, New York, NY 10022, United States Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Balagula, Y. AU - Pulitzer, M. P. AU - Maki, R. G. AU - Myskowski, P. L. DB - Scopus IS - 9 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2011 SP - 1062-1066 ST - Pigmentary changes in a patient treated with imatinib T2 - Journal of Drugs in Dermatology TI - Pigmentary changes in a patient treated with imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053330202&partnerID=40&md5=ad3e302b9005ebe434f06e9c14e8b77a VL - 10 ID - 7371 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. AN - 21829508 AU - Janku, F. AU - Lee, J. J. AU - Tsimberidou, A. M. AU - Hong, D. S. AU - Naing, A. AU - Falchook, G. S. AU - Fu, S. AU - Luthra, R. AU - Garrido-Laguna, I. AU - Kurzrock, R. C2 - PMC3146490 DO - 10.1371/journal.pone.0022769 10.1371/journal.pone.0022769. Epub 2011 Jul 29. DP - Nlm ET - 2011/08/11 IS - 7 LA - eng PY - 2011 SN - 1932-6203 SP - e22769 ST - PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers T2 - PLoS One TI - PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers VL - 6 ID - 7372 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. fjanku@mdanderson.org AN - 23248156 AU - Janku, F. AU - Wheler, J. J. AU - Naing, A. AU - Stepanek, V. M. AU - Falchook, G. S. AU - Fu, S. AU - Garrido-Laguna, I. AU - Tsimberidou, A. M. AU - Piha-Paul, S. A. AU - Moulder, S. L. AU - Lee, J. J. AU - Luthra, R. AU - Hong, D. S. AU - Kurzrock, R. C2 - PMC3681495 support from GlaxoSmithKline, Novartis, Merck, and Bayer. DA - Dec DO - 10.18632/oncotarget.716 10.18632/oncotarget.716. DP - Nlm ET - 2012/12/19 IS - 12 LA - eng PY - 2012 SN - 1949-2553 SP - 1566-75 ST - PIK3CA mutations in advanced cancers: characteristics and outcomes T2 - Oncotarget TI - PIK3CA mutations in advanced cancers: characteristics and outcomes VL - 3 ID - 7373 ER - TY - JOUR AD - Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., FC8.2057, Box 0455, Houston, TX 77030, USA. AN - 21216929 AU - Janku, F. AU - Tsimberidou, A. M. AU - Garrido-Laguna, I. AU - Wang, X. AU - Luthra, R. AU - Hong, D. S. AU - Naing, A. AU - Falchook, G. S. AU - Moroney, J. W. AU - Piha-Paul, S. A. AU - Wheler, J. J. AU - Moulder, S. L. AU - Fu, S. AU - Kurzrock, R. C2 - PMC3072168 C6 - NIHMS263540 the subject of this manuscript. DA - Mar DO - 10.1158/1535-7163.Mct-10-0994 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. DP - Nlm ET - 2011/01/11 IS - 3 LA - eng PY - 2011 SN - 1535-7163 (Print) 1535-7163 SP - 558-65 ST - PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors T2 - Mol Cancer Ther TI - PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors VL - 10 ID - 7374 ER - TY - JOUR AD - A.C.D.M. Malinverni, Department of Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil A.C.D.M. Malinverni, Laboratory of Molecular and Experimental Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil AU - Salles, D. AU - Laviola, G. AU - Malinverni, A. C. D. M. AU - Stávale, J. N. DB - Embase Medline DO - 10.1177/0883073820937225 IS - 12 LA - English M3 - Review N1 - L2005644270 2020-07-29 PY - 2020 SN - 1708-8283 0883-0738 SP - 852-858 ST - Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics T2 - Journal of Child Neurology TI - Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005644270&from=exporthttp://dx.doi.org/10.1177/0883073820937225 VL - 35 ID - 7375 ER - TY - JOUR AD - Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Department of Pediatric Oncology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Division of Neurosurgery, Department of Surgical Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Department of Radiation Oncology, Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. sridhep@gmail.com. Department of Pathology (& Division of Molecular Pathology), Tata Memorial Hospital and ACTREC, Tata Memorial Centre, Homi Baba National Institute, Mumbai, 400012, India. sridhep@gmail.com. AN - 31321520 AU - Kurani, H. AU - Gurav, M. AU - Shetty, O. AU - Chinnaswamy, G. AU - Moiyadi, A. AU - Gupta, T. AU - Jalali, R. AU - Epari, S. DA - Sep DO - 10.1007/s00381-019-04282-1 10.1007/s00381-019-04282-1. Epub 2019 Jul 18. DP - Nlm ET - 2019/07/20 IS - 9 LA - eng PY - 2019 SN - 0256-7040 SP - 1525-1536 ST - Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups T2 - Childs Nerv Syst TI - Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups VL - 35 ID - 7376 ER - TY - JOUR AD - Al-Karama Teaching Hospital, Al-Kut, Baghdad, Iraq AU - Al-Husseinawi, E. K. DB - Scopus DO - 10.1097/MPH.0000000000000091 IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2014 SP - e207-e211 ST - A pilot study for the detection of FLT3-ITD mutation frequency in 25 Iraqi patients with acute lymphoid leukemia in 2 Iraqi hospitals T2 - Journal of Pediatric Hematology/Oncology TI - A pilot study for the detection of FLT3-ITD mutation frequency in 25 Iraqi patients with acute lymphoid leukemia in 2 Iraqi hospitals UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899981378&doi=10.1097%2fMPH.0000000000000091&partnerID=40&md5=f628b4fd1a4e356bbcbf27bb95864550 VL - 36 ID - 7377 ER - TY - JOUR AD - Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Cell and Gene Therapy, Novartis, Cambridge, Massachusetts. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. sar@mail.nih.gov. AN - 28093487 AU - Deniger, D. C. AU - Kwong, M. L. AU - Pasetto, A. AU - Dudley, M. E. AU - Wunderlich, J. R. AU - Langhan, M. M. AU - Lee, C. R. AU - Rosenberg, S. A. C2 - PMC5245178 C6 - NIHMS827134 DA - Jan 15 DO - 10.1158/1078-0432.Ccr-16-0906 10.1158/1078-0432.CCR-16-0906. Epub 2016 Oct 7. DP - Nlm ET - 2017/01/18 IS - 2 LA - eng PY - 2017 SN - 1078-0432 (Print) 1078-0432 SP - 351-362 ST - A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma T2 - Clin Cancer Res TI - A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma VL - 23 ID - 7378 ER - TY - JOUR AD - Department of Experimental Medicine, University of L'Aquila, Via Vetoio, Coppito II, 67100 L'Aquila, Italy. AN - 12186945 AU - Mauro, A. AU - Ciccarelli, C. AU - De Cesaris, P. AU - Scoglio, A. AU - Bouché, M. AU - Molinaro, M. AU - Aquino, A. AU - Zani, B. M. DA - Sep 15 DO - 10.1242/jcs.00037 10.1242/jcs.00037. DP - Nlm ET - 2002/08/21 IS - Pt 18 LA - eng PY - 2002 SN - 0021-9533 (Print) 0021-9533 SP - 3587-99 ST - PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells T2 - J Cell Sci TI - PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells VL - 115 ID - 7379 ER - TY - JOUR AD - S. Gong, Guangzhou Medical University, Digestive Department, Guangzhou Women and Children's Medical Center, No.9 Jinsui Road, Guangzhou, Guangdong, China AU - Cheng, Y. AU - Zhu, Y. AU - Xu, J. AU - Yang, M. AU - Chen, P. AU - Xu, W. AU - Zhao, J. AU - Geng, L. AU - Gong, S. DB - Embase Medline DO - 10.1186/s12943-017-0747-z IS - 1 LA - English M3 - Article N1 - L620329101 2018-01-31 2018-02-05 PY - 2018 SN - 1476-4598 ST - PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway T2 - Molecular Cancer TI - PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620329101&from=exporthttp://dx.doi.org/10.1186/s12943-017-0747-z VL - 17 ID - 7380 ER - TY - JOUR AU - Doebele, R. DB - Embase DO - 10.1016/j.jtho.2019.08.051 IS - 10 LA - English M3 - Conference Abstract N1 - L2003405943 2019-10-23 PY - 2019 SN - 1556-1380 1556-0864 SP - S2 ST - PL01.01 Tumor-Agnostic Biologically Driven Treatments: An Endless Dream? T2 - Journal of Thoracic Oncology TI - PL01.01 Tumor-Agnostic Biologically Driven Treatments: An Endless Dream? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003405943&from=exporthttp://dx.doi.org/10.1016/j.jtho.2019.08.051 VL - 14 ID - 7381 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing People's Republic of China Collaborative Innovation Center of Hematology, Soochow University, Suzhou People's Republic of China AN - 139646169. Language: English. Entry Date: 20191119. Revision Date: 20191119. Publication Type: Article AU - Dou, Xuelin AU - Qin, Yazhen AU - Huang, Xiaojun AU - Jiang, Qian DB - ccm DO - 10.1634/theoncologist.2019-0109 DP - EBSCOhost IS - 11 N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9607837. PY - 2019 SN - 1083-7159 SP - e1141-e1147 ST - Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy T2 - Oncologist TI - Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139646169&site=ehost-live&scope=site VL - 24 ID - 7382 ER - TY - JOUR AD - CIC 802 INSERM, CHU de Poitiers, Poitiers, France Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia Leukemia Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States Istituto di Ematologia L. e A. Seràgnoli, University of Bologna, Bologna, Italy Novartis Pharma AG, Basel, Switzerland Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States Clinical Pharmacology Oncology, Novartis Pharmaceuticals Corporation, Florham Park, NJ, United States AU - Guilhot, F. AU - Hughes, T. P. AU - Cortes, J. AU - Druker, B. J. AU - Baccarani, M. AU - Gathmann, I. AU - Hayes, M. AU - Granvil, C. AU - Wang, Y. DB - Scopus DO - 10.3324/haematol.2011.045666 IS - 5 M3 - Article N1 - Cited By :59 Export Date: 18 November 2020 PY - 2012 SP - 731-738 ST - Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor OPtimization and Selectivity trial T2 - Haematologica TI - Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor OPtimization and Selectivity trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860549849&doi=10.3324%2fhaematol.2011.045666&partnerID=40&md5=11a8656677b758a8025e497188c3b55e VL - 97 ID - 7383 ER - TY - JOUR AD - Orthopedic Surgery Service, Memorial Sloan-Kettering Cancer Center, Weil Medical College of Cornell University, New York, New York, USA. AN - 18338812 AU - Kubo, T. AU - Piperdi, S. AU - Rosenblum, J. AU - Antonescu, C. R. AU - Chen, W. AU - Kim, H. S. AU - Huvos, A. G. AU - Sowers, R. AU - Meyers, P. A. AU - Healey, J. H. AU - Gorlick, R. DA - May 15 DO - 10.1002/cncr.23437 10.1002/cncr.23437. DP - Nlm ET - 2008/03/15 IS - 10 LA - eng PY - 2008 SN - 0008-543X (Print) 0008-543x SP - 2119-29 ST - Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma T2 - Cancer TI - Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma VL - 112 ID - 7384 ER - TY - JOUR AD - L.B. Rapkin, Department of Pediatric Hematology/Oncology, Emory University School of Medicine, Children's Healthcare of Atlanta, Aflac Cancer & Blood Disorders Center, Atlanta, GA, United States AU - Carden, M. A. AU - Smith, S. AU - Meany, H. AU - Yin, H. AU - Alazraki, A. AU - Rapkin, L. B. DB - Embase DO - 10.1002/pbc.26402 IS - 7 LA - English M3 - Article N1 - L613956573 2017-01-09 2017-05-31 PY - 2017 SN - 1545-5017 1545-5009 ST - Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases T2 - Pediatric Blood and Cancer TI - Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613956573&from=exporthttp://dx.doi.org/10.1002/pbc.26402 VL - 64 ID - 7385 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA. Pediatric Neurosurgery, Children's Hospital of Michigan, Detroit, Michigan, USA. Department of Radiology, Children's Hospital of Michigan, Detroit, Michigan, USA. Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA, yankelevic@gmail.com. Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA, yankelevic@gmail.com. AN - 31661699 AU - Gorsi, H. AU - Marupudi, N. I. AU - Sood, S. AU - Altinok, D. AU - Yankelevich, M. DO - 10.1159/000503639 10.1159/000503639. Epub 2019 Oct 29. DP - Nlm ET - 2019/10/30 IS - 1 LA - eng PY - 2020 SN - 1016-2291 SP - 51-53 ST - Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib T2 - Pediatr Neurosurg TI - Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib VL - 55 ID - 7386 ER - TY - JOUR AD - L. Kilburn, Children's National Health System, Washington, DC, United States AU - Kilburn, L. AU - Kuhn, J. AU - Nazemi, K. AU - Molinaro, A. AU - Liang, W. AU - Banerjee, A. AU - Hwang, E. AU - Crawford, J. AU - Nicolaides, T. AU - Packer, R. AU - Nazarian, J. AU - Gupta, N. AU - Resnick, A. C. AU - Byron, S. AU - Berens, M. AU - Prados, M. AU - Mueller, S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098402 2018-07-25 PY - 2018 SN - 1523-5866 SP - i64 ST - PNOC-003: Precision medicine trial for children with diffuses intrinsic pontine glioma: Preliminary experience with multi-agent personalized therapy recommendations T2 - Neuro-Oncology TI - PNOC-003: Precision medicine trial for children with diffuses intrinsic pontine glioma: Preliminary experience with multi-agent personalized therapy recommendations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098402&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7387 ER - TY - JOUR AD - V. Ganapathy, Dept. of Biochemistry/Molec. Biol., Medical College of Georgia, Augusta, GA 30912-2100, United States AU - Kekuda, R. AU - Leibach, F. H. AU - Furesz, T. C. AU - Smith, C. H. AU - Ganapathy, V. DB - Embase Medline IS - 3 LA - English M3 - Article N1 - L30136598 2000-03-20 PY - 2000 SN - 0022-3565 SP - 1032-1041 ST - Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta T2 - Journal of Pharmacology and Experimental Therapeutics TI - Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta UR - https://www.embase.com/search/results?subaction=viewrecord&id=L30136598&from=export VL - 292 ID - 7388 ER - TY - JOUR AD - A. K. Bauer, Department of Environmental and Occupational Health, University of Colorado Anschutz Medical Center, Aurora, CO, United States AU - Osgood, R. S. AU - Upham, B. L. AU - Hill Iii, T. AU - Helms, K. L. AU - Velmurugan, K. AU - Babica, P. AU - Bauer, A. K. C1 - sb202190 sb203580 u0126 DB - Embase Medline DO - 10.1371/journal.pone.0065150 IS - 6 L1 - internal-pdf://1346811305/journal.pone.0065150.PDF LA - English M3 - Article N1 - L369060150 2013-06-13 2013-06-27 PY - 2013 SN - 1932-6203 ST - Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure T2 - PLoS ONE TI - Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369060150&from=exporthttp://dx.doi.org/10.1371/journal.pone.0065150 VL - 8 ID - 7389 ER - TY - JOUR AD - B.L. Upham, Dept. of Pediatrics/Human Devt., Michigan State University, B240 Life Sciences, East Lansing, MI 48824, United States AU - Rummel, A. M. AU - Trosko, J. E. AU - Wilson, M. R. AU - Upham, B. L. DB - Embase Medline DO - 10.1093/toxsci/49.2.232 IS - 2 LA - English M3 - Article N1 - L29300409 1999-07-12 PY - 1999 SN - 1096-6080 SP - 232-240 ST - Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity T2 - Toxicological Sciences TI - Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L29300409&from=exporthttp://dx.doi.org/10.1093/toxsci/49.2.232 VL - 49 ID - 7390 ER - TY - JOUR AD - Department of Pharmacology, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy Institute of Hematology and Medical Oncology 'Landa Seràgnoli', Sant'Orsola-Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy Department of Public Health, Epidemiological Service, Local Health Authority of Bologna, Via del Seminario, 1, 40068 San Lazzaro di Savena (BO), Italy Faculty of Statistics, University of Bologna, Via Belle Arti 41, Bologna I-40126, Italy Faculty of Education, Free University of Bolzano, Italy Adult Mesenchymal Tumour Medical Oncology Unit, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy AU - Angelini, S. AU - Pantaleo, M. A. AU - Ravegnini, G. AU - Zenesini, C. AU - Cavrini, G. AU - Nannini, M. AU - Fumagalli, E. AU - Palassini, E. AU - Saponara, M. AU - Di Battista, M. AU - Casali, P. G. AU - Hrelia, P. AU - Cantelli-Forti, G. AU - Biasco, G. DB - Scopus DO - 10.1016/j.phrs.2012.10.015 IS - 1 M3 - Article N1 - Cited By :52 Export Date: 18 November 2020 PY - 2013 SP - 1-6 ST - Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy T2 - Pharmacological Research TI - Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872339745&doi=10.1016%2fj.phrs.2012.10.015&partnerID=40&md5=129ac8d60b79f4983fbcdfc36d4d8680 VL - 68 ID - 7391 ER - TY - JOUR AD - Hematology Department, Centre Léon Bérard, Lyon, France INSERM U1170, Normal and Pathologic Hematopoiesis, Institut Gustave Roussy, Créteil, France Hematology Department, Hôpital Saint Louis, Paris, France Hematology Department, Centre Hospitalier Universitaire du Bocage, Dijon, France Hematology Department, Institut Paoli Calmettes, Marseilles, France Hematology Department, Hôpital A. Mignot, Le Chesnay, University Paris Saclay EA4340, Fontenay aux Roses, France Hematology Department, Hôpital Claude Huriez, Lille, France Hematology Department, Hôpital Pontchaillou, Rennes, France Hematology Department, Hotel Dieu, Nantes, France Hematology Department, Institut Universitaire du Cancer, Toulouse, France Hematology Department, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Hematology Department, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France Hematology Department, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France Hematology Department, Hôpital Civil, Strasbourg, France Incyte Biosciences France, Boulogne-Billancourt, France Hematology Department, Hôpital Henri Mondor, Créteil, France Hematology Department, Institut Bergonié, Bordeaux, France INSERM U1052, CRCL, Lyon, France French Group of CML (Fi-LMC), Institut Bergonié, Bordeaux, France AU - Heiblig, M. AU - Rea, D. AU - Chrétien, M. L. AU - Charbonnier, A. AU - Rousselot, P. AU - Coiteux, V. AU - Escoffre-Barbe, M. AU - Dubruille, V. AU - Huguet, F. AU - Cayssials, E. AU - Hermet, E. AU - Guerci-Bresler, A. AU - Amé, S. AU - Sackmann-Sala, L. AU - Roy, L. AU - Sobh, M. AU - Morisset, S. AU - Etienne, G. AU - Nicolini, F. E. DB - Scopus DO - 10.1016/j.exphem.2018.08.006 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 41-48 ST - Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study T2 - Experimental Hematology TI - Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053878617&doi=10.1016%2fj.exphem.2018.08.006&partnerID=40&md5=524426ab32c80885f3c537805aa38b37 VL - 67 ID - 7392 ER - TY - JOUR AD - Inserm CIC 1402, University Hospital, Poitiers, France Medical Faculty, Pediatric Hemato-oncology, Technical University, Dresden, Germany Department of Pediatric Oncology/Hematology, Princess Maxima Center, Utrecht, Netherlands Department of Pediatric Hematology Oncology and Transplantation, Wroclaw Medical University, Wroclaw, Poland Department of Pediatric Hematology-oncology, University Hospital, Lille, France Department of Pediatric Hematology-oncology, University Hospital, Bordeaux, France Department of Pediatric Hematology, Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon, France Department of Pediatric Hematology, Robert Debré Hospital, Paris, France AN - 144991000. Language: English. Entry Date: 20200902. Revision Date: 20200902. Publication Type: Article AU - Millot, Frédéric AU - Suttorp, Meinolf AU - Versluys, Anne B. AU - Kalwak, Krzysztof AU - Nelken, Brigitte AU - Ducassou, Stephane AU - Bertrand, Yves AU - Baruchel, André DB - ccm DO - 10.1016/j.ejca.2020.05.020 DP - EBSCOhost N1 - research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 9005373. PY - 2020 SN - 0959-8049 SP - 107-112 ST - Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia study T2 - European Journal of Cancer TI - Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144991000&site=ehost-live&scope=site VL - 136 ID - 7393 ER - TY - JOUR AD - Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada AU - Poch Martell, M. AU - Sibai, H. AU - Deotare, U. AU - Lipton, J. H. DB - Scopus DO - 10.1080/17474086.2016.1232163 IS - 10 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2016 SP - 923-932 ST - Ponatinib in the therapy of chronic myeloid leukemia T2 - Expert Review of Hematology TI - Ponatinib in the therapy of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989323320&doi=10.1080%2f17474086.2016.1232163&partnerID=40&md5=4aa3fba64494e84c26db8ca961028cda VL - 9 ID - 7394 ER - TY - JOUR AD - Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada Duke-NUS Medical School, Singapore General Hospital, Singapore Brabois Hospital, Vandoeuvre-lès-Nancy, France Institute of Hematology, University of Bologna, Bologna, Italy North Shore Hospital, Westlake, Auckland, New Zealand Department of Oncology, Jewish General Hospital, McGill University, Montréal, QC, Canada Département d'Hématologie, Institut Bergonié, Bordeaux, France Haematology Department, Centre Hospitalier Lyon Sud, Pierre Bénite, France Department of Hematology, Oncology and Tumor Immunology, Charité–Universitätsmedizin Berlin, Berlin, Germany Department of Haematology, Royal Liverpool University Hospital, Liverpool, Merseyside, UK Department of Oncology–Pathology, Karolinska Institute and University Hospital, Stockholm, Sweden Rocky Mountain Cancer Centers, Boulder, CO, USA Fred Hutchinson Cancer Research Center, Seattle, WA, USA ARIAD Pharmaceuticals, Inc, Cambridge, MA, USA Department of Hematology and Oncology, University of Bologna, Bologna, Italy The University of Texas MD Anderson Cancer Center, Houston, TX, USA INSERM Clinical Investigation Center 1402, Centre Hospitalier et Universitaire de Poitiers, Poitiers, France AN - 114878963. Corporate Author: EPIC investigators. Language: English. Entry Date: 20180304. Revision Date: 20190516. Publication Type: journal article AU - Lipton, Jeffrey H. AU - Chuah, Charles AU - Guerci-Bresler, Agnès AU - Rosti, Gianantonio AU - Simpson, David AU - Assouline, Sarit AU - Etienne, Gabriel AU - Nicolini, Franck E. AU - le Coutre, Philipp AU - Clark, Richard E. AU - Stenke, Leif AU - Andorsky, David AU - Oehler, Vivian AU - Lustgarten, Stephanie AU - Rivera, Victor M. AU - Clackson, Timothy AU - Haluska, Frank G. AU - Baccarani, Michele AU - Cortes, Jorge E. AU - Guilhot, François DB - ccm DO - 10.1016/S1470-2045(16)00080-2 DP - EBSCOhost IS - 5 N1 - research; randomized controlled trial. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Special Interest: Evidence-Based Practice. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 100957246. PMID: NLM27083332. PY - 2016 SN - 1470-2045 SP - 612-621 ST - Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial T2 - Lancet Oncology TI - Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114878963&site=ehost-live&scope=site VL - 17 ID - 7395 ER - TY - JOUR AD - University Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong Department of Pathology, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong AU - Au, W. Y. AU - Chan, E. C. AU - Lie, A. K. W. AU - Liang, R. AU - Leung, A. Y. H. AU - Ma, S. K. AU - Kwong, Y. L. DB - Scopus DO - 10.1007/s00277-003-0676-3 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2003 SP - 410-415 ST - Poor engraftment after allogeneic bone marrow transplantation: Role of chimerism analysis in treatment and outcome T2 - Annals of Hematology TI - Poor engraftment after allogeneic bone marrow transplantation: Role of chimerism analysis in treatment and outcome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042634274&doi=10.1007%2fs00277-003-0676-3&partnerID=40&md5=961d5df5334bbf7a7ddcf565bc250728 VL - 82 ID - 7396 ER - TY - JOUR AD - Department of Medical Oncology, Radiology, Nuclear Medicine and Pathology, Tata Memorial Hospital, Dr. E Borges Road, Parel, Mumbai, Maharashtra, 400 012, India AU - Ramaswamy, A. AU - Joshi, A. AU - Noronha, V. AU - Patil, V. AU - Sahu, A. AU - Manickam, D. AU - Kothari, R. AU - Sable, N. AU - Agrawal, A. AU - Menon, S. AU - Prabhash, K. DB - Scopus DO - 10.4103/ijmpo.ijmpo_154_16 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2017 SP - 311-315 ST - Poor risk advanced renal cell carcinoma: Outcomes from a registry in a tertiary cancer center T2 - Indian Journal of Medical and Paediatric Oncology TI - Poor risk advanced renal cell carcinoma: Outcomes from a registry in a tertiary cancer center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048143670&doi=10.4103%2fijmpo.ijmpo_154_16&partnerID=40&md5=c0ceb83c1f2e9523d84b0a14eb4f7d3a VL - 38 ID - 7397 ER - TY - JOUR AD - Department of Clinical Pharmacology, Pfizer Inc., San Diego, CA, United States Department of Clinical Pharmacology, Pfizer Inc., 10578 Science Center Drive, CB10, San Diego, CA 92121, United States AU - Houk, B. E. AU - Bello, C. L. AU - Kang, D. AU - Amantea, M. DB - Scopus DO - 10.1158/1078-0432.CCR-08-1893 IS - 7 M3 - Article N1 - Cited By :177 Export Date: 18 November 2020 PY - 2009 SP - 2497-2506 ST - A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients T2 - Clinical Cancer Research TI - A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-65249087328&doi=10.1158%2f1078-0432.CCR-08-1893&partnerID=40&md5=54e56e6941be9f33f003a47ec0779802 VL - 15 ID - 7398 ER - TY - JOUR AD - Children's Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104, United States Texas Children's Cancer Center/Baylor College of Medicine, Houston, TX, United States IWK Health Centre, Halifax, NS, United States British Columbia Children's Hospital, Vancouver, BC, United States Hôpital Sainte-Justine, Montreal, QC, United States Adjunct Faculty, University of Pennsylvania, Philadelphia, PA, United States AU - Menon-Andersen, D. AU - Mondick, J. T. AU - Jayaraman, B. AU - Thompson, P. A. AU - Blaney, S. M. AU - Bernstein, M. AU - Bond, M. AU - Champagne, M. AU - Fossler, M. J. AU - Barrett, J. S. DB - Scopus DO - 10.1007/s00280-008-0730-x IS - 2 M3 - Article N1 - Cited By :48 Export Date: 18 November 2020 PY - 2009 SP - 229-238 ST - Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults T2 - Cancer Chemotherapy and Pharmacology TI - Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-57249088703&doi=10.1007%2fs00280-008-0730-x&partnerID=40&md5=7af0963b03559a1038acffea96599ff0 VL - 63 ID - 7399 ER - TY - JOUR AD - Haematology Department, Royal Liverpool University Hospital, Liverpool, United Kingdom Haematology Department, Warrington Hospital, Lovely Lane, Warrington, United Kingdom Haematology Department, Countess of Chester Hospital, Liverpool Road, Chester, United Kingdom Haematology Department, Southport District General Hospital, Town Lane, Kew, Southport, United Kingdom Department of Haematology, Arrowe Park Hospital, Upton, Wirral, United Kingdom Haematology Department, University Hospital Aintree, Liverpool, United Kingdom Haematology Department, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, United Kingdom Alaw Unit, Ysbyty Gwynedd Hospital, Bangor, United Kingdom AU - Francis, S. AU - Lucas, C. AU - Lane, S. AU - Wang, L. AU - Watmough, S. AU - Knight, K. AU - Bell, J. AU - Kaleel-Rahman, M. AU - Lee, E. AU - O'Brien, D. AU - Butt, N. M. AU - Sadik, W. AU - De Soysa, L. AU - Seale, J. R. C. AU - Salim, R. AU - Clark, R. E. DB - Scopus DO - 10.1016/j.leukres.2013.04.003 IS - 7 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2013 SP - 752-758 ST - A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia T2 - Leukemia Research TI - A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878490313&doi=10.1016%2fj.leukres.2013.04.003&partnerID=40&md5=6a03c92388100c57ff53dea129c2fe29 VL - 37 ID - 7400 ER - TY - JOUR AD - Pharmacy Department, Hospital de Pediatría Dr. Prof. Juan P. Garrahan, Buenos Aires, Argentina Pharmacy Department, Hospital Interzonal Especializado Materno Infantil “Victorio Tetamanti”, Mar del Plata, Argentina Pharmacy Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Madrid, Spain AU - González, J. AU - Quiroga, M. AU - Escudero-Vilaplana, V. AU - Collado-Borrell, R. AU - Herranz-Alonso, A. AU - Sanjurjo Sáez, M. DB - Scopus DO - 10.1080/14740338.2018.1477937 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 553-572 ST - Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities T2 - Expert Opinion on Drug Safety TI - Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047481669&doi=10.1080%2f14740338.2018.1477937&partnerID=40&md5=490db6fafb63b5145a84b796acea124b VL - 17 ID - 7401 ER - TY - JOUR AD - Dept. of Paediatr. Haematol./Oncol., VU University Medical Center, Amsterdam, Netherlands Dept. of Paediatr. Haematol./Oncol., VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, Netherlands AU - Zwaan, Ch M. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1111/j.1365-2141.2004.05167.x IS - 3 M3 - Review N1 - Cited By :23 Export Date: 18 November 2020 PY - 2004 SP - 264-279 ST - Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia T2 - British Journal of Haematology TI - Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8344272920&doi=10.1111%2fj.1365-2141.2004.05167.x&partnerID=40&md5=6c9fee7904121031393a378dc6babe96 VL - 127 ID - 7402 ER - TY - JOUR AD - L.-P. Yang, Peking University Eye Center, Peking University Third Hospital, 49 North Garden Road, Beijing 100083, China AU - Yang, L. P. AU - Zhu, X. A. AU - Tso, M. O. M. DB - Embase Medline L1 - internal-pdf://1411154259/v13a232-yang.pdf LA - English M3 - Article N1 - L350031852 2007-12-21 PY - 2007 SN - 1090-0535 SP - 2048-2057 ST - A possible mechanism of microglia-photoreceptor crosstalk T2 - Molecular Vision TI - A possible mechanism of microglia-photoreceptor crosstalk UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350031852&from=export VL - 13 ID - 7403 ER - TY - JOUR AD - Second Division, Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashi-ku, Hamamatsu 431-3192, Japan. AN - 20501680 AU - Iino, K. AU - Oki, Y. AU - Yamashita, M. AU - Matsushita, F. AU - Hayashi, C. AU - Yogo, K. AU - Nishizawa, S. AU - Yamada, S. AU - Maekawa, M. AU - Sasano, H. AU - Nakamura, H. DA - Aug DO - 10.1210/jc.2009-2716 10.1210/jc.2009-2716. Epub 2010 May 25. DP - Nlm ET - 2010/05/27 IS - 8 LA - eng PY - 2010 SN - 0021-972x SP - 4003-11 ST - Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenoma T2 - J Clin Endocrinol Metab TI - Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenoma VL - 95 ID - 7404 ER - TY - JOUR AD - Histopathology Department, School of Medicine, Trinity College Dublin, Dublin, Ireland National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland Computational Biology, Systems Biology/Immunology, Animal and Grassland Research and Innovation Centre, Teagasc, Dunsany, County Meath, Ireland Centre for Cancer Research, National Cancer Institute, Bethesda, MD, United States Department of Pediatric Hematology-Oncology, Dana Farber Cancer Institute and Children's Hospital, Boston, MA, United States Institute of Pathology, University of Cologne Medical Centre, Cologne, Germany Department of Pathology, Stanford University Medical Centre, Stanford, CA, United States Department of Human Genetics, Catholic University Leuven and University Hospitals, Leuven, Belgium AU - Kelly, L. AU - Bryan, K. AU - Kim, S. Y. AU - Janeway, K. A. AU - Killian, J. K. AU - Schildhaus, H. U. AU - Miettinen, M. AU - Helman, L. AU - Meltzer, P. S. AU - van de Rijn, M. AU - Debiec-Rychter, M. AU - O'Sullivan, M. C7 - e64102 DB - Scopus DO - 10.1371/journal.pone.0064102 IS - 5 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2013 ST - Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST] T2 - PLoS ONE TI - Post-Transcriptional Dysregulation by miRNAs Is Implicated in the Pathogenesis of Gastrointestinal Stromal Tumor [GIST] UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878144906&doi=10.1371%2fjournal.pone.0064102&partnerID=40&md5=a0c0ce70018df59784398c7e6bb180c5 VL - 8 ID - 7405 ER - TY - JOUR AD - W.L. Miller, University of California, San Francisco, United States AU - Miller, W. L. AU - Tee, M. K. C1 - sb 202190 sb 203580 DB - Embase Medline DO - 10.1016/j.mce.2014.09.010 LA - English M3 - Review N1 - L604021341 2015-05-08 2015-05-11 PY - 2015 SN - 1872-8057 0303-7207 SP - 99-106 ST - The post-translational regulation of 17,20 lyase activity T2 - Molecular and Cellular Endocrinology TI - The post-translational regulation of 17,20 lyase activity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604021341&from=exporthttp://dx.doi.org/10.1016/j.mce.2014.09.010 VL - 408 ID - 7406 ER - TY - JOUR AD - Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California, Davis, California; AN - 24163071 AU - den Hartigh, L. J. AU - Altman, R. AU - Norman, J. E. AU - Rutledge, J. C. C2 - PMC3920150 DA - Jan 1 DO - 10.1152/ajpheart.00137.2013 10.1152/ajpheart.00137.2013. Epub 2013 Oct 25. DP - Nlm ET - 2013/10/29 IS - 1 LA - eng PY - 2014 SN - 0363-6135 (Print) 0363-6135 SP - H109-20 ST - Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB T2 - Am J Physiol Heart Circ Physiol TI - Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB VL - 306 ID - 7407 ER - TY - JOUR AD - Department of Dermatology, University of Regensburg, Regensburg, Germany. AN - 22683711 AU - Groesser, L. AU - Herschberger, E. AU - Ruetten, A. AU - Ruivenkamp, C. AU - Lopriore, E. AU - Zutt, M. AU - Langmann, T. AU - Singer, S. AU - Klingseisen, L. AU - Schneider-Brachert, W. AU - Toll, A. AU - Real, F. X. AU - Landthaler, M. AU - Hafner, C. DA - Jun 10 DO - 10.1038/ng.2316 10.1038/ng.2316. DP - Nlm ET - 2012/06/12 IS - 7 LA - eng PY - 2012 SN - 1061-4036 SP - 783-7 ST - Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome T2 - Nat Genet TI - Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome VL - 44 ID - 7408 ER - TY - JOUR AD - Department of Vascular Biology, Boston Children's Hospital, Boston, Massachusetts, USA. Paul.Beaudry@CalgaryHealthRegion.ca AN - 18245671 AU - Beaudry, P. AU - Nilsson, M. AU - Rioth, M. AU - Prox, D. AU - Poon, D. AU - Xu, L. AU - Zweidler-Mckay, P. AU - Ryan, A. AU - Folkman, J. AU - Ryeom, S. AU - Heymach, J. DA - Feb DO - 10.1158/1535-7163.Mct-07-0568 10.1158/1535-7163.MCT-07-0568. Epub 2008 Feb 1. DP - Nlm ET - 2008/02/05 IS - 2 LA - eng PY - 2008 SN - 1535-7163 (Print) 1535-7163 SP - 418-24 ST - Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium T2 - Mol Cancer Ther TI - Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium VL - 7 ID - 7409 ER - TY - JOUR AD - M. Pereira, Department of Medicine Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, United States AU - Cheng, Y. AU - Pereira, M. AU - Raukar, N. AU - Reagan, J. L. AU - Queseneberry, M. AU - Goldberg, L. AU - Borgovan, T. AU - LaFrance, W. C. AU - Dooner, M. AU - Deregibus, M. AU - Camussi, G. AU - Ramratnam, B. AU - Quesenberry, P. DB - Embase Medline DO - 10.1002/jcp.28139 IS - 8 LA - English M3 - Article N1 - L625983492 2019-01-22 2019-05-14 PY - 2019 SN - 1097-4652 0021-9541 SP - 14377-14388 ST - Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles T2 - Journal of Cellular Physiology TI - Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625983492&from=exporthttp://dx.doi.org/10.1002/jcp.28139 VL - 234 ID - 7410 ER - TY - JOUR AD - S.H. Ghaffari, Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran, Iran AU - Zekri, A. AU - Mesbahi, Y. AU - Boustanipour, E. AU - Sadr, Z. AU - Ghaffari, S. H. C1 - azd 1152 DB - Embase Medline DO - 10.1007/s12031-018-1118-y IS - 4 LA - English M3 - Article N1 - L623276979 2018-08-03 2018-11-21 PY - 2018 SN - 1559-1166 0895-8696 SP - 444-455 ST - The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA) T2 - Journal of Molecular Neuroscience TI - The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623276979&from=exporthttp://dx.doi.org/10.1007/s12031-018-1118-y VL - 65 ID - 7411 ER - TY - JOUR AD - L. Dalle Carbonare, Department of Medicine, University of Verona, Verona, Italy AU - Deiana, M. AU - Dalle Carbonare, L. AU - Serena, M. AU - Cheri, S. AU - Mutascio, S. AU - Gandini, A. AU - Innamorati, G. AU - Lorenzi, P. AU - Cumerlato, M. AU - Bertacco, J. AU - Antoniazzi, F. AU - Romanelli, M. G. AU - Mottes, M. AU - Zipeto, D. AU - Valenti, M. T. DB - Embase Medline DO - 10.3390/cells9030751 IS - 3 LA - English M3 - Article N1 - L2004079346 2020-04-10 2020-04-20 PY - 2020 SN - 2073-4409 ST - A potential role of RUNX2-RUNT domain in modulating the expression of genes involved in bone metastases: An in vitro study with melanoma cells T2 - Cells TI - A potential role of RUNX2-RUNT domain in modulating the expression of genes involved in bone metastases: An in vitro study with melanoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004079346&from=exporthttp://dx.doi.org/10.3390/cells9030751 VL - 9 ID - 7412 ER - TY - JOUR AD - Q. Xu, Department of Gynecology, Obstetrics and Gynecology, Hospital Affiliated to Nanjing Medical University, 123 Mochou Rd, Nanjing, China AU - Ma, H. AU - Shi, X. AU - Fu, Z. AU - Wu, X. AU - Huangfu, Y. AU - Xu, P. AU - Zeng, X. AU - Xu, J. AU - Ruan, H. AU - Xu, Q. DB - Embase DO - 10.21037/tcr.2018.10.16 IS - 6 LA - English M3 - Article N1 - L625775697 2019-01-11 PY - 2018 SN - 2219-6803 2218-676X SP - 1376-1383 ST - Potential roles of microRNA in levonorgestrel-treated uterine leiomyoma cells T2 - Translational Cancer Research TI - Potential roles of microRNA in levonorgestrel-treated uterine leiomyoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625775697&from=exporthttp://dx.doi.org/10.21037/tcr.2018.10.16 VL - 7 ID - 7413 ER - TY - JOUR AD - M.S. Lim, Department of Pathology, University of Michigan, 1301 Catherine St, 5242 Medical Science I, SPC 0602, Ann Arbor, MI 48109, United States AU - Lowe, E. J. AU - Lim, M. S. C1 - af 802(Chugai) C2 - Amgen Ariad Astellas Bristol Myers Squibb Chugai Glaxo SmithKline nerviano medical science Novartis Pfizer Xcovery DB - Embase Medline DO - 10.1007/s40272-013-0027-3 IS - 3 LA - English M3 - Article N1 - L369074142 2013-06-17 2013-06-19 PY - 2013 SN - 1174-5878 1179-2019 SP - 163-169 ST - Potential therapies for anaplastic lymphoma kinase-driven tumors in children: Progress to date T2 - Pediatric Drugs TI - Potential therapies for anaplastic lymphoma kinase-driven tumors in children: Progress to date UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369074142&from=exporthttp://dx.doi.org/10.1007/s40272-013-0027-3 VL - 15 ID - 7414 ER - TY - JOUR AD - Y. Mareeva, 1 Samory Mashela Str, Moscow, Russian Federation AU - Zhukov, N. AU - Mareeva, Y. AU - Konovalov, D. AU - Druy, A. AU - Grachev, N. AU - Litvinov, D. DB - Embase DO - 10.1200/PO.19.00282 LA - English M3 - Article N1 - L2006156800 2020-06-30 2020-07-03 PY - 2019 SN - 2473-4284 ST - Potentially curative targeted therapy for undifferentiated high-grade sarcoma developing after malignant transformation of a BRAF V600E-mutated ameloblastic fibroma T2 - JCO Precision Oncology TI - Potentially curative targeted therapy for undifferentiated high-grade sarcoma developing after malignant transformation of a BRAF V600E-mutated ameloblastic fibroma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006156800&from=exporthttp://dx.doi.org/10.1200/PO.19.00282 VL - 3 ID - 7415 ER - TY - JOUR AD - H.-K. Yi, Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Chonbuk National University, 634-18, Deokjin-dong, Deokjin-gu, Jeonju, Jeonbuk, South Korea AU - Kim, J. S. AU - Lee, Y. H. AU - Chang, Y. U. AU - Yi, H. K. DB - Embase Medline DO - 10.1007/s13105-016-0523-3 IS - 1 LA - English M3 - Article N1 - L612666915 2016-10-18 2017-03-22 PY - 2017 SN - 1877-8755 1138-7548 SP - 49-57 ST - PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells T2 - Journal of Physiology and Biochemistry TI - PPARγ regulates inflammatory reaction by inhibiting the MAPK/NF-κB pathway in C2C12 skeletal muscle cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612666915&from=exporthttp://dx.doi.org/10.1007/s13105-016-0523-3 VL - 73 ID - 7416 ER - TY - JOUR AD - Department of Hepato-Gastroenterology, University Hospital F. Mitterrand, Dijon, France Department of Hepato-Gastroenterology, University Hospital Trousseau, Tours, France Department of Hepato-Gastroenterology, Robert Debré Hospital, Reims, France Fédération Française de Cancérologie Digestive (FFCD), Dijon, France Department of Hepato-Gastroenterology, Saint-Jean Hospital, Perpignan, France Department of Hepato-Gastroenterology, University Hospital Charles Nicolle, Rouen, France Department of Hepato-Gastroenterology, University Hospital Nord, Amiens, France Department of Hepato-Gastroenterology, University Hospital Côte de Nacre, Caen, France Department of Hepato-Gastroenterology, University Hospital Dupuytren, Limoges, France Department of Hepato-Gastroenterology, Les Oudairies Hospital, La Roche-sur-Yon, France Department of Medical Oncology, Auxerre Hospital, Auxerre, France Department of Hepato-Gastroenterology, University Hospital Haut-Lévêque, Pessac, France Department of Medical Oncology, Centre Catherine de Sienne, Nantes, France INSERM U954, University of Lorraine and University Hospital of Nancy, Vandoeuvre-les-Nancy, France Department of Oncology and Hepato-Gastroenterology, University Hospital La Timone, Marseille, France Department of Hepato-Gastroenterology, La Source Hospital, Orléans, France Department of Hepato-Gastroenterology, Louise Michel Hospital, Evry, France INSERM U1231, University of Bourgogne - Franche-Comté, Faculté de Médecine, Dijon, France Department of Hepato-Gastroenterology, University Hospital of Saint-Etienne – Hôpital Nord, Saint-Priest-en-Jarez, France AU - Jouve, J. L. AU - Lecomte, T. AU - Bouché, O. AU - Barbier, E. AU - Khemissa Akouz, F. AU - Riachi, G. AU - Nguyen Khac, E. AU - Ollivier-Hourmand, I. AU - Debette-Gratien, M. AU - Faroux, R. AU - Villing, A. L. AU - Vergniol, J. AU - Ramee, J. F. AU - Bronowicki, J. P. AU - Seitz, J. F. AU - Legoux, J. L. AU - Denis, J. AU - Manfredi, S. AU - Phelip, J. M. DB - Scopus DO - 10.1016/j.jhep.2019.04.021 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2019 SP - 516-522 ST - Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma T2 - Journal of Hepatology TI - Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068447598&doi=10.1016%2fj.jhep.2019.04.021&partnerID=40&md5=15430b972d5b898451948edd3ad5be72 VL - 71 ID - 7417 ER - TY - JOUR AD - Lymphoma and Genomics Research Program, IOR Institute of Oncology Research, Bellinzona, Switzerland; AN - 24004669 AU - Boi, M. AU - Rinaldi, A. AU - Kwee, I. AU - Bonetti, P. AU - Todaro, M. AU - Tabbò, F. AU - Piva, R. AU - Rancoita, P. M. AU - Matolcsy, A. AU - Timar, B. AU - Tousseyn, T. AU - Rodríguez-Pinilla, S. M. AU - Piris, M. A. AU - Beà, S. AU - Campo, E. AU - Bhagat, G. AU - Swerdlow, S. H. AU - Rosenwald, A. AU - Ponzoni, M. AU - Young, K. H. AU - Piccaluga, P. P. AU - Dummer, R. AU - Pileri, S. AU - Zucca, E. AU - Inghirami, G. AU - Bertoni, F. DA - Oct 10 DO - 10.1182/blood-2013-04-497933 10.1182/blood-2013-04-497933. Epub 2013 Sep 4. DP - Nlm ET - 2013/09/06 IS - 15 LA - eng PY - 2013 SN - 0006-4971 SP - 2683-93 ST - PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma T2 - Blood TI - PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma VL - 122 ID - 7418 ER - TY - JOUR AD - Division of Hematology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Hematology, Singapore General Hospital, Level 3, Academia, 20 College Road, Singapore, 169856, Singapore Department of Hematology-Oncology, National University Cancer Institute, Singapore AU - Ma, L. AU - Hao, S. AU - Diong, C. AU - Goh, Y. T. AU - Gopalakrishnan, S. AU - Ho, A. AU - Hwang, W. AU - Koh, L. P. AU - Koh, M. AU - Lim, Z. Y. AU - Loh, Y. AU - Poon, M. AU - Tan, L. K. AU - Tan, P. AU - Linn, Y. C. DB - Scopus DO - 10.3109/10428194.2014.956318 IS - 5 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2015 SP - 1362-1369 ST - Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: An analysis of Southeast Asian patients T2 - Leukemia and Lymphoma TI - Pre-transplant achievement of negativity in minimal residual disease and French-American-British L1 morphology predict superior outcome after allogeneic transplant for Philadelphia chromosome positive acute lymphoblastic leukemia: An analysis of Southeast Asian patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84932094704&doi=10.3109%2f10428194.2014.956318&partnerID=40&md5=b388631b12298b1f9196dd370a8e5325 VL - 56 ID - 7419 ER - TY - JOUR AD - C. Fan, Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai, China AU - Fan, C. AU - Cai, X. AU - Zhang, F. AU - Hochstetler, C. AU - Chen, X. AU - Guo, F. AU - Tian, W. AU - Zheng, Y. DB - Embase DO - 10.1182/blood-2018-99-115225 LA - English M3 - Conference Abstract N1 - L626588687 2019-03-08 PY - 2018 SN - 0006-4971 ST - Precision assessment of on-and off-target effects of mtor kinase inhibitors in a mouse model T2 - Blood TI - Precision assessment of on-and off-target effects of mtor kinase inhibitors in a mouse model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626588687&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-115225 VL - 132 ID - 7420 ER - TY - JOUR AD - Clinical and Translational Oncology Group, Clínica del Country, Calle 116 No. 9-72, c. 318, Bogotá, Colombia Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCaN), México city, Mexico Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia Thoracic Oncology Program, Memorial Cancer Institute (MCI), Florida International University (FIU), Miami, FL, United States Thoracic Medical Oncology and Early Clinical Trials Unit, University of Maryland, Baltimore, MD, United States Global Clinical Development, Merck KGaA, Darmstadt, Germany Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Catalunya, Spain Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Catalunya, Spain AU - Cardona, A. F. AU - Arrieta, O. AU - Ruiz-Patiño, A. AU - Sotelo, C. AU - Zamudio-Molano, N. AU - Zatarain-Barrón, Z. L. AU - Ricaurte, L. AU - Raez, L. AU - Álvarez, M. P. P. AU - Barrón, F. AU - Rojas, L. AU - Rolfo, C. AU - Karachaliou, N. AU - Molina-Vila, M. A. AU - Rosell, R. DB - Scopus DO - 10.1177/1753466620938553 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries T2 - Therapeutic Advances in Respiratory Disease TI - Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087711760&doi=10.1177%2f1753466620938553&partnerID=40&md5=448bf48411c49086f9230b613ee1e135 VL - 14 ID - 7421 ER - TY - JOUR AD - Departments of Oncology and Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105, United States AU - Pui, C. H. DB - Scopus DO - 10.1007/s11684-020-0759-8 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Precision medicine in acute lymphoblastic leukemia T2 - Frontiers of Medicine TI - Precision medicine in acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092742355&doi=10.1007%2fs11684-020-0759-8&partnerID=40&md5=da76e8a77251846621bcf906fbc763e5 ID - 7422 ER - TY - JOUR AD - I. Modlin, Department of Gastrointestinal Surgery, School of Medicine, Yale University, Connecticut, United States AU - Alvarez, M. J. AU - Subramaniam, P. S. AU - Tang, L. H. AU - Grunn, A. AU - Aburi, M. AU - Rieckhof, G. AU - Komissarova, E. V. AU - Hagan, E. A. AU - Bodei, L. AU - Clemons, P. A. AU - Dela Cruz, F. S. AU - Dhall, D. AU - Diolaiti, D. AU - Fraker, D. A. AU - Ghavami, A. AU - Kaemmerer, D. AU - Karan, C. AU - Kidd, M. AU - Kim, K. M. AU - Kim, H. C. AU - Kunju, L. P. AU - Langel, Ü AU - Li, Z. AU - Lee, J. AU - Li, H. AU - Livolsi, V. AU - Pfragner, R. AU - Rainey, A. R. AU - Realubit, R. B. AU - Remotti, H. AU - Regberg, J. AU - Roses, R. AU - Rustgi, A. AU - Sepulveda, A. R. AU - Serra, S. AU - Shi, C. AU - Yuan, X. AU - Barberis, M. AU - Bergamaschi, R. AU - Chinnaiyan, A. M. AU - Detre, T. AU - Ezzat, S. AU - Frilling, A. AU - Hommann, M. AU - Jaeger, D. AU - Kim, M. K. AU - Knudsen, B. S. AU - Kung, A. L. AU - Leahy, E. AU - Metz, D. C. AU - Milsom, J. W. AU - Park, Y. S. AU - Reidy-Lagunes, D. AU - Schreiber, S. AU - Washington, K. AU - Wiedenmann, B. AU - Modlin, I. AU - Califano, A. C1 - arq 197 azd 8055 cd 437 fk 866 i bet 151 ly 2183240 mk 2206 ms 27 275 pdx 101 pha 665752 su 11274 y 27632 DB - Embase Medline DO - 10.1038/s41588-018-0138-4 IS - 7 LA - English M3 - Article N1 - L622636890 2018-06-25 2018-07-17 PY - 2018 SN - 1546-1718 1061-4036 SP - 979-989 ST - A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors T2 - Nature Genetics TI - A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622636890&from=exporthttp://dx.doi.org/10.1038/s41588-018-0138-4 VL - 50 ID - 7423 ER - TY - JOUR AD - N. Ratner, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, Cincinnati, OH, United States AU - Jousma, E. AU - Rizvi, T. A. AU - Wu, J. AU - Janhofer, D. AU - Dombi, E. AU - Dunn, R. S. AU - Kim, M. O. AU - Masters, A. R. AU - Jones, D. R. AU - Cripe, T. P. AU - Ratner, N. C1 - pd 0325901(Pfizer,United States) C2 - Pfizer(United States) DB - Embase Medline DO - 10.1002/pbc.25546 IS - 10 LA - English M3 - Article N1 - L603967621 2015-04-28 2015-08-28 PY - 2015 SN - 1545-5017 1545-5009 SP - 1709-1716 ST - Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1 T2 - Pediatric Blood and Cancer TI - Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603967621&from=exporthttp://dx.doi.org/10.1002/pbc.25546 VL - 62 ID - 7424 ER - TY - JOUR AD - M. Meel, VU University Medical Center, Amsterdam, Netherlands AU - Meel, M. AU - Navarro, M. G. AU - De Gooijer, M. AU - Waranecki, P. AU - Petersen, N. AU - Van Vuurden, D. AU - Kaspers, G. AU - Hulleman, E. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098455 2018-07-25 PY - 2018 SN - 1523-5866 SP - i31 ST - Preclinical efficacy of combined inhibition of MEK and MELK in atypical teratoid/rhabdoid tumors T2 - Neuro-Oncology TI - Preclinical efficacy of combined inhibition of MEK and MELK in atypical teratoid/rhabdoid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098455&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7425 ER - TY - JOUR AD - M.H. Meel, VU University Medical Center, Amsterdam, Netherlands AU - Meel, M. H. AU - Guillén-Navarro, M. AU - De Gooijer, M. C. AU - Waranecki, P. AU - De Winter, M. P. AU - Van Vuurden, D. G. AU - Kaspers, G. J. L. AU - Hulleman, E. DB - Embase DO - 10.1093/neuonc/nox083 LA - English M3 - Conference Abstract N1 - L620678189 2018-02-19 PY - 2017 SN - 1523-5866 SP - iv2 ST - Preclinical efficacy of radiation-free treatment of atypical teratoid/rhabdoid tumors by combined mek and melk inhibition T2 - Neuro-Oncology TI - Preclinical efficacy of radiation-free treatment of atypical teratoid/rhabdoid tumors by combined mek and melk inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620678189&from=exporthttp://dx.doi.org/10.1093/neuonc/nox083 VL - 19 ID - 7426 ER - TY - JOUR AD - School of Women's and Infants' Health, King Edward Memorial Hospital, University of Western Australia, 374 Bagot Road, Perth, WA 6008, Australia Women and Infants Research Foundation of Western Australia, King Edward Memorial Hospital, Perth, WA, Australia Department of Pathology, Sidra Medical and Research Center, Doha, Qatar AU - Ireland, D. J. AU - Nathan, E. A. AU - Li, S. AU - Charles, A. K. AU - Stinson, L. F. AU - Kemp, M. W. AU - Newnham, J. P. AU - Keelan, J. A. DB - Scopus DO - 10.1177/1753425916672313 IS - 1 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 20-33 ST - Preclinical evaluation of drugs to block inflammation-driven preterm birth T2 - Innate Immunity TI - Preclinical evaluation of drugs to block inflammation-driven preterm birth UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006743981&doi=10.1177%2f1753425916672313&partnerID=40&md5=bea6f2f40942de55b2a4f5af2b1506c6 VL - 23 ID - 7427 ER - TY - JOUR AD - Pediatric Hematology and Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Pediatric Hematology/Oncology/BMT, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, United States AU - Teachey, D. T. AU - Hunger, S. P. DB - Scopus DO - 10.1111/bjh.12442 IS - 5 M3 - Review N1 - Cited By :53 Export Date: 18 November 2020 PY - 2013 SP - 606-620 ST - Predicting relapse risk in childhood acute lymphoblastic leukaemia T2 - British Journal of Haematology TI - Predicting relapse risk in childhood acute lymphoblastic leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881669095&doi=10.1111%2fbjh.12442&partnerID=40&md5=720cd31f17afa5610178ac199b7a5e00 VL - 162 ID - 7428 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, California AN - 128331326. Language: English. Entry Date: 20190825. Revision Date: 20190830. Publication Type: journal article. Journal Subset: Biomedical AU - Sasaki, Koji AU - Kantarjian, Hagop AU - O'Brien, Susan AU - Ravandi, Farhad AU - Konopleva, Marina AU - Borthakur, Gautam AU - Garcia‐Manero, Guillermo AU - Wierda, William AU - Daver, Naval AU - Ferrajoli, Alessandra AU - Takahashi, Koichi AU - Jain, Preetesh AU - Rios, Mary Beth AU - Pierce, Sherry AU - Jabbour, Elias AU - Cortes, Jorge E. AU - O'Brien, Susan AU - Garcia-Manero, Guillermo DB - ccm DO - 10.1002/cncr.31187 DP - EBSCOhost IS - 6 N1 - Peer Reviewed; USA. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins). Grant Information: P01 CA049639/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM29266206. PY - 2018 SN - 0008-543X SP - 1160-1168 ST - Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase T2 - Cancer (0008543X) TI - Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=128331326&site=ehost-live&scope=site VL - 124 ID - 7429 ER - TY - JOUR AD - Departments of1Neurosurgery. 2Radiology, and. 3Pathology, Huashan Hospital, Fudan University; and. 4State Key Laboratory of Medical Neurobiology, School of Basic Medical Sciences and Institutes of Brain Science, Fudan University, Shanghai, China. AN - 28984520 AU - Yue, Q. AU - Yu, Y. AU - Shi, Z. AU - Wang, Y. AU - Zhu, W. AU - Du, Z. AU - Yao, Z. AU - Chen, L. AU - Mao, Y. DA - Jul DO - 10.3171/2017.4.Jns163113 10.3171/2017.4.JNS163113. Epub 2017 Oct 6. DP - Nlm ET - 2017/10/07 IS - 1 LA - eng PY - 2018 SN - 0022-3085 SP - 27-34 ST - Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features T2 - J Neurosurg TI - Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features VL - 129 ID - 7430 ER - TY - JOUR AD - Laboratoire d'Hématologie, AP-HP Necker, 149-161 rue de Sèvres, 75743 Paris Cedex 15, France INSERM EMI02.10, AP-HP Necker, Paris, France Service d'Hématologie Adultes, AP-HP Necker, Paris, France Service de Néphrologie, Laboratoire de Biostatistiques, Centre Hospitalier Lyon-Sud, Lyon, France Laboratoire d'Hématologie, AP-HP La Pitié-Salpétrière, Paris, France Service d'Oncologie et Hématologie, Hôpital d'Amiens, Paris, France Service d'Hématologie, AP-HP La Pitié-Salpétrière, Paris, France AU - Asnafi, V. AU - Rubio, M. T. AU - Delabesse, E. AU - Villar, E. AU - Davi, F. AU - Damaj, G. AU - Hirsch, I. AU - Dhédin, N. AU - Vernant, J. P. AU - Varet, B. AU - Buzyn, A. AU - Macintyre, E. DB - Scopus DO - 10.1038/sj.leu.2404170 IS - 5 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2006 SP - 793-799 ST - Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia T2 - Leukemia TI - Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646127175&doi=10.1038%2fsj.leu.2404170&partnerID=40&md5=35cf7090ddd4e2f2f646670c24166c1b VL - 20 ID - 7431 ER - TY - JOUR AD - Medical Oncology Department, Centre Leon Berard, University Lyon I, Lyon, France. Electronic address: christelle.delafouchardiere@lyon.unicancer.fr. Pathology Department, Hospital Lyon-Sud, University Lyon I, Pierre-Bénite, France. Epidemiology, Pharmacology and Clinical Investigations, Mother Child Hospital, Bron; University Lyon I, Lyon, France. Biochemistry and Molecular Biology Department, Hospital Lyon-Sud, University Lyon I, Lyon, Pierre-Bénite, France. Department of General and Endocrine Surgery, University Hospital Lyon-Sud, Lyon, France. Department of Nuclear Medicine Centre Leon Berard, University Lyon I, Lyon, France. Endocrinology Department-INSERM, UMR 1052, University Lyon I, Lyon, France. Department of Nuclear Medicine, Hospital Louis Pradel, University Lyon I, Bron, France. AN - 29413688 AU - de la Fouchardière, C. AU - Decaussin-Petrucci, M. AU - Berthiller, J. AU - Descotes, F. AU - Lopez, J. AU - Lifante, J. C. AU - Peix, J. L. AU - Giraudet, A. L. AU - Delahaye, A. AU - Masson, S. AU - Bournaud-Salinas, C. AU - Borson Chazot, F. DA - Mar DO - 10.1016/j.ejca.2017.12.027 10.1016/j.ejca.2017.12.027. Epub 2018 Feb 3. DP - Nlm ET - 2018/02/08 LA - eng PY - 2018 SN - 0959-8049 SP - 40-47 ST - Predictive factors of outcome in poorly differentiated thyroid carcinomas T2 - Eur J Cancer TI - Predictive factors of outcome in poorly differentiated thyroid carcinomas VL - 92 ID - 7432 ER - TY - JOUR AD - Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. AN - 23051629 AU - Karram, S. AU - Novy, M. AU - Saroufim, M. AU - Loya, A. AU - Taraif, S. AU - Houreih, M. A. AU - Rauscher, B. AU - Habib, R. H. AU - Oberkanins, C. AU - Khalifeh, I. DA - Jun DO - 10.1097/DAD.0b013e31826db181 10.1097/DAD.0b013e31826db181. DP - Nlm ET - 2012/10/12 IS - 4 LA - eng PY - 2013 SN - 0193-1091 SP - 412-8 ST - Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure T2 - Am J Dermatopathol TI - Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure VL - 35 ID - 7433 ER - TY - JOUR AD - Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States Facultad de Medicina, Universidad Juárez del Estado de Durango, Gómez Palacio, Durango 34000, Mexico AU - Bailey, K. A. AU - Laine, J. AU - Rager, J. E. AU - Sebastian, E. AU - Olshan, A. AU - Smeester, L. AU - Drobná, Z. AU - Stýblo, M. AU - Rubio-Andrade, M. AU - García-Vargas, G. AU - Fry, R. C. C7 - kfu053 DB - Scopus DO - 10.1093/toxsci/kfu053 IS - 2 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2014 SP - 328-337 ST - Prenatal arsenic exposure and shifts in the newborn proteome: Interindividual differences in tumor necrosis factor (TNF)-responsive signaling T2 - Toxicological Sciences TI - Prenatal arsenic exposure and shifts in the newborn proteome: Interindividual differences in tumor necrosis factor (TNF)-responsive signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899981472&doi=10.1093%2ftoxsci%2fkfu053&partnerID=40&md5=822aed0bfbac3c77fb48162914d1491c VL - 139 ID - 7434 ER - TY - JOUR AD - S.K. Banu, Department of Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A and M University, College Station, TX, United States AU - Sivakumar, K. K. AU - Stanley, J. A. AU - Arosh, J. A. AU - Pepling, M. E. AU - Burghardt, R. C. AU - Banu, S. K. DB - Embase Medline DO - 10.1016/j.ydbio.2014.02.003 IS - 1 LA - English M3 - Article N1 - L600267460 2014-11-04 2014-11-06 PY - 2014 SN - 1095-564X 0012-1606 SP - 22-34 ST - Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring T2 - Developmental Biology TI - Prenatal exposure to chromium induces early reproductive senescence by increasing germ cell apoptosis and advancing germ cell cyst breakdown in the F1 offspring UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600267460&from=exporthttp://dx.doi.org/10.1016/j.ydbio.2014.02.003 VL - 388 ID - 7435 ER - TY - JOUR AD - Division of Endocrinology, Department of Pediatrics, Children's Hospital of, Pittsburgh of UPMC, Pittsburgh, PA, United States. Electronic address: melissa.buryk@chp.edu. AN - 23993207 AU - Buryk, M. A. AU - Monaco, S. E. AU - Witchel, S. F. AU - Mehta, D. K. AU - Gurtunca, N. AU - Nikiforov, Y. E. AU - Simons, J. P. DA - Oct DO - 10.1016/j.ijporl.2013.07.029 10.1016/j.ijporl.2013.07.029. Epub 2013 Aug 9. DP - Nlm ET - 2013/09/03 IS - 10 LA - eng PY - 2013 SN - 0165-5876 SP - 1697-700 ST - Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules T2 - Int J Pediatr Otorhinolaryngol TI - Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules VL - 77 ID - 7436 ER - TY - JOUR AD - T. Chen, National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang, China AU - Tian, P. AU - Wang, Y. AU - Liu, H. AU - Yang, Y. AU - Wu, X. AU - Wei, H. AU - Chen, T. DB - Embase Medline DO - 10.3389/fcimb.2019.00275 LA - English M3 - Article N1 - L629221916 2019-09-20 2019-10-03 PY - 2019 SN - 2235-2988 ST - Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus T2 - Frontiers in Cellular and Infection Microbiology TI - Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629221916&from=exporthttp://dx.doi.org/10.3389/fcimb.2019.00275 VL - 9 ID - 7437 ER - TY - JOUR AD - T.L. Ng, University of Colorado, Division of Medical Oncology, 12801 E 17th Ave, 8122, 8th Floor, Aurora, CO, United States AU - Ng, T. L. AU - Yu, H. AU - Smith, D. E. AU - Boyle, T. A. AU - York, E. R. AU - Leedy, S. AU - Gao, D. AU - Aisner, D. L. AU - Van Bokhoven, A. AU - Heasley, L. E. AU - Hirsch, F. R. AU - Camidge, D. R. DB - Embase Medline DO - 10.1016/j.cllc.2018.09.001 IS - 1 LA - English M3 - Article N1 - L2001157576 2018-10-15 2019-01-03 Introduction: Preclinically, high epidermal growth factor receptor 1 (FGFR1) messenger RNA (FGFR1-MRNA) and FGFR1 amplification (FGFR1-AMP) predicted sensitivity to fibroblast growth factor receptor inhibitors in non–small-cell lung cancer and small-cell lung cancer cell lines. KRAS mutations did not preclude sensitivity. Patients and Methods: Metastatic EGFR- and ALK-negative lung cancers were screened for FGFR1-MRNA by in-situ hybridization (ISH) and FGFR1-AMP by silver in-situ hybridization (SISH). Patients with positive findings were offered ponatinib, a multi–kinase inhibitor of FGFR1-4. Differences in overall survival (OS) between cohorts were assessed by the log-rank test. Association of FGFR1 positivity with clinicopathologic features were assessed by Fisher exact test and Kruskal-Wallis rank sum test. Results: A total of 171 cases were prescreened: 9 (7.3%) of 123 SISH+; 53 (42.1%) of 126 ISH+; and 6 cases concordantly positive for SISH and ISH. SISH+ cases had fewer coincident KRAS mutations (P =.03) than SISH− cases, and ISH+ cases had worse OS (P =.020) than ISH− cases. Data distributions suggested a distinct higher positivity cut point for FGFR1 ISH (≥ 20%), occurring in 29 (23%) of 126 cases, was associated with small-cell lung cancer histology (P =.022), soft tissue metastases (P =.050) and shorter OS (P =.031). Four patients received ponatinib on study: All ISH+ by the initial cut point, 2 of 4 by higher cut point, 1 of 4 SISH+. Tolerability was poor. The best response for the 2 higher ISH cases was stable disease and progressive disease for the 2 lower ISH cases. Conclusion: Elevated FGFR1-MRNA is more common than FGFR1-AMP and associated with worse OS. Higher FGFR1 mRNA expression may be associated with a specific phenotype and is worthy of further exploration. Ponatinib's poor tolerance suggests further fibroblast growth factor receptor exploration in ISH+ cases should utilize more selective FGFR1 inhibitors. PY - 2019 SN - 1938-0690 1525-7304 SP - e39-e51 ST - Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib T2 - Clinical Lung Cancer TI - Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001157576&from=exporthttp://dx.doi.org/10.1016/j.cllc.2018.09.001 VL - 20 ID - 7438 ER - TY - JOUR AD - J.F. Val-Bernal, Departamento de Anatomía Patológica, Hospital Universitario Marqués de Valdecilla, Avda. Valdecilla 1, ES-39008 Santander, Spain AU - González-vela, M. C. AU - Val-bernal, J. F. AU - Arce, F. P. AU - Gómez-Roman, J. AU - González-López, M. A. AU - Fernández-Llaca, J. H. DB - Embase Medline DO - 10.1111/j.1468-3083.2006.01876.x IS - 3 LA - English M3 - Letter N1 - L46243339 2007-03-08 PY - 2007 SN - 0926-9959 1468-3083 SP - 399-401 ST - Presence of human herpesvirus-8 in inflammatory myofibroblastic tumor of the skin [6] T2 - Journal of the European Academy of Dermatology and Venereology TI - Presence of human herpesvirus-8 in inflammatory myofibroblastic tumor of the skin [6] UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46243339&from=exporthttp://dx.doi.org/10.1111/j.1468-3083.2006.01876.x VL - 21 ID - 7439 ER - TY - JOUR AD - Department of Surgery, St James s Hospital, James s St, Dublin 8, Ireland AU - Mongan, A. M. AU - Malik, V. AU - Rowley, S. AU - Claxton, Z. AU - Muldoon, C. AU - O'Toole, D. AU - Ravi, N. AU - Reynolds, J. V. DB - Scopus IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 ST - Presentation and management of gastrointestinal stromal tumours T2 - Irish Medical Journal TI - Presentation and management of gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878977227&partnerID=40&md5=c0b8dc6fb3e8b10a319f68704c874147 VL - 106 ID - 7440 ER - TY - JOUR AD - Department of Pathology and Microbiology, The Aga Khan University, Medical Centre, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan. AN - 15648604 AU - Noorali, S. AU - Pervez, S. AU - Yaqoob, N. AU - Moatter, T. AU - Nasir, M. I. AU - Haroon, S. AU - Hodges, E. AU - Smith, J. L. DO - 10.1016/j.prp.2004.08.004 10.1016/j.prp.2004.08.004. DP - Nlm ET - 2005/01/15 IS - 10 LA - eng PY - 2004 SN - 0344-0338 (Print) 0344-0338 SP - 669-79 ST - Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients T2 - Pathol Res Pract TI - Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients VL - 200 ID - 7441 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera-Università di Padova, Via Giustiniani 3, Padova 35128, Italy AU - Mussolin, L. AU - Pillon, M. AU - d'Amore, E. S. AU - Santoro, N. AU - Lombardi, A. AU - Fagioli, F. AU - Zanesco, L. AU - Rosolen, A. DB - Embase Medline DO - 10.1038/sj.leu.2403888 IS - 9 LA - English M3 - Article N1 - L43090410 2006-02-20 PY - 2005 SN - 1476-5551 0887-6924 SP - 1643-1647 ST - Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma T2 - Leukemia TI - Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43090410&from=exporthttp://dx.doi.org/10.1038/sj.leu.2403888 VL - 19 ID - 7442 ER - TY - JOUR AD - Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany Center for Internal Medicine, Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany St. Johannes Hospital, Department of Medicine, Duisburg, Germany Department of Hematology and Oncology, University of Münster, Münster, Germany Department of Hematology and Oncology, Eberhardt-Karls University, Tübingen, Germany Center for Internal Medicine, Department of Hematology and Oncology, University of Essen, Essen, Germany AU - Pfeifer, H. AU - Lange, T. AU - Wystub, S. AU - Wassmann, B. AU - Maier, J. AU - Binckebanck, A. AU - Giagounidis, A. AU - Stelljes, M. AU - Schmalzing, M. AU - Dührsen, U. AU - Wunderle, L. AU - Serve, H. AU - Brück, P. AU - Schmidt, A. AU - Hoelzer, D. AU - Ottmann, O. G. DB - Scopus DO - 10.1038/leu.2012.5 IS - 7 M3 - Article N1 - Cited By :46 Export Date: 18 November 2020 PY - 2012 SP - 1475-1481 ST - Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia T2 - Leukemia TI - Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863782824&doi=10.1038%2fleu.2012.5&partnerID=40&md5=e0edb643f543132734316c4df02895fe VL - 26 ID - 7443 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China Collaborative Innovation Centre of Haematology, Soochow University, Suzhou, China Peking-Tsinghua Centre for Life Sciences, Beijing, China AU - Qin, Y. Z. AU - Jiang, Q. AU - Jiang, H. AU - Lai, Y. Y. AU - Shi, H. X. AU - Chen, W. M. AU - Yu, L. AU - Huang, X. J. DB - Scopus DO - 10.1111/bjh.15453 IS - 5 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 693-700 ST - Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre T2 - British Journal of Haematology TI - Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050613726&doi=10.1111%2fbjh.15453&partnerID=40&md5=12579701ea7b516ca7161b847d379564 VL - 182 ID - 7444 ER - TY - JOUR AD - G.S. Smelick, Clinical Pharmacology, Genentech Research and Early Development, 1 DNA Way, South San Francisco, CA 94080, United States AU - Smelick, G. S. AU - Heffron, T. P. AU - Chu, L. AU - Dean, B. AU - West, D. A. AU - Duvall, S. L. AU - Lum, B. L. AU - Budha, N. AU - Holden, S. N. AU - Benet, L. Z. AU - Frymoyer, A. AU - Dresser, M. J. AU - Ware, J. A. DB - Embase Medline DO - 10.1021/mp400403s IS - 11 LA - English M3 - Article N1 - L370224875 2013-11-20 PY - 2013 SN - 1543-8384 1543-8392 SP - 4055-4062 ST - Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development T2 - Molecular Pharmaceutics TI - Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370224875&from=exporthttp://dx.doi.org/10.1021/mp400403s VL - 10 ID - 7445 ER - TY - JOUR AD - Department of Medicine, University of Padua, Padua, Italy; Istituto Oncologico Veneto, Padua, Italy. Department of Medicine, University of Padua, Padua, Italy. Istituto Oncologico Veneto, Padua, Italy. Unit of Dermatology, University of Padua, Padua, Italy. Unit of Plastic and Reconstructive Surgery, University of Padua, Padua, Italy. Department of Medicine, University of Padua, Padua, Italy; Veneto Tumor Registry, Veneto Region, Padua, Italy. Department of Dermatology, Medical University Graz, Graz, Austria. Department of Medicine, University of Padua, Padua, Italy. Electronic address: matteo.fassan@unipd.it. AN - 29920315 AU - Saraggi, D. AU - Salmaso, R. AU - Zamuner, C. AU - Munari, G. AU - Lanza, C. AU - Alaibac, M. S. AU - Bassetto, F. AU - Rugge, M. AU - Montesco, M. C. AU - Cerroni, L. AU - Fassan, M. DA - Oct DO - 10.1016/j.jaad.2018.06.018 10.1016/j.jaad.2018.06.018. Epub 2018 Jun 18. DP - Nlm ET - 2018/06/20 IS - 4 LA - eng PY - 2018 SN - 0190-9622 SP - 728-735 ST - Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions T2 - J Am Acad Dermatol TI - Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions VL - 79 ID - 7446 ER - TY - JOUR AD - Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan. Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Surgery, National Taiwan University Hospital, Hsin-Chu Branch, Hisn-Chu, Taiwan. Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: chiayu@ntu.edu.tw. AN - 25767048 AU - Sheen, Y. S. AU - Liao, Y. H. AU - Liau, J. Y. AU - Lin, M. H. AU - Hsieh, Y. C. AU - Jee, S. H. AU - Chu, C. Y. DA - Feb DO - 10.1016/j.jfma.2015.02.001 10.1016/j.jfma.2015.02.001. Epub 2015 Mar 10. DP - Nlm ET - 2015/03/15 IS - 2 LA - eng PY - 2016 SN - 0929-6646 (Print) 0929-6646 SP - 121-7 ST - Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan T2 - J Formos Med Assoc TI - Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan VL - 115 ID - 7447 ER - TY - JOUR AD - Division of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. christoph.schmid@usz.ch. Division of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. Competence Centre for Systems Physiology and Metabolic Diseases, Swiss Federal Institute of Technology (ETH) Zurich, 8093, Zurich, Switzerland. AN - 28316059 AU - Schmid, C. AU - Ghirlanda, C. AU - Niessen, M. C2 - PMC5532423 DA - Aug DO - 10.1007/s11010-017-2996-y 10.1007/s11010-017-2996-y. Epub 2017 Mar 18. DP - Nlm ET - 2017/03/21 IS - 1-2 LA - eng PY - 2017 SN - 0300-8177 (Print) 0300-8177 SP - 41-54 ST - Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase T2 - Mol Cell Biochem TI - Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase VL - 432 ID - 7448 ER - TY - JOUR AD - Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India AU - Mishra, K. AU - Jandial, A. AU - Singh, V. AU - Radotra, B. AU - Malhotra, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_234_18 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 418-420 ST - Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions T2 - Indian Journal of Medical and Paediatric Oncology TI - Priapism in chronic myeloid leukemia: Meeting at the crossroads and heading in different directions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088495194&doi=10.4103%2fijmpo.ijmpo_234_18&partnerID=40&md5=006381fba332ab7187ca50918f536f8f VL - 41 ID - 7449 ER - TY - JOUR AD - Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan Department of Clinical Sciences and Community Health; Università degli Studi di Milano, Milan, Italy AN - 132770711. Language: English. Entry Date: 20191130. Revision Date: 20200311. Publication Type: journal article. Journal Subset: Biomedical AU - Colombo, Carla AU - De Leo, Simone AU - Di Stefano, Marta AU - Vannucchi, Guia AU - Persani, Luca AU - Fugazzola, Laura DB - ccm DO - 10.1210/jc.2018-01836 DP - EBSCOhost N1 - USA. Instrumentation: Impact of Events Scale (IES); Personality Assessment Inventory (PAI). NLM UID: 0375362. PMID: NLM30383218. PY - 2018 SN - 0021-972X SP - N.PAG-N.PAG ST - Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy T2 - Journal of Clinical Endocrinology & Metabolism TI - Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132770711&site=ehost-live&scope=site ID - 7450 ER - TY - JOUR AD - K.T.E. Chang, Departments of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore AU - Hue, S. S. S. AU - Iyer, P. AU - Toh, L. H. W. AU - Jain, S. AU - Tan, E. E. K. AU - Sittampalam, K. AU - Lian, D. W. Q. AU - Chang, K. T. E. DB - Embase Medline DO - 10.1097/MPH.0000000000000839 IS - 2 LA - English M3 - Article N1 - L621403368 2018-03-30 2018-04-11 PY - 2018 SN - 1536-3678 1077-4114 SP - e103-e107 ST - Primary Bone Anaplastic Large Cell Lymphoma Masquerading as Ewing Sarcoma: Diagnosis by Anchored Multiplex PCR T2 - Journal of Pediatric Hematology/Oncology TI - Primary Bone Anaplastic Large Cell Lymphoma Masquerading as Ewing Sarcoma: Diagnosis by Anchored Multiplex PCR UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621403368&from=exporthttp://dx.doi.org/10.1097/MPH.0000000000000839 VL - 40 ID - 7451 ER - TY - CASE A2 - Houcine, Yoldez A4 - Charfi, Lamia AB - The article presents a case study of a 16-year-old girl presented with erythematous and infiltrative changes which appeared one month ago in the left breast. Topics include reports that physical examination showed an increase in the volume of the left breast with diffuse thickening, induration, and variable edema, but no mass was palpated. AD - Pathology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia Medical Oncology Department, Faculty of Medicine of Tunis, Salah Azaiez Institute, El Manar University, Tunis, Tunisia DB - ccm DO - 10.1111/tbj.13949 DP - EBSCOhost J2 - Breast Journal KW - Breast Neoplasms -- Diagnosis -- In Adolescence Anaplastic Lymphoma Kinase -- In Adolescence Breast Examination Breast Neoplasms -- Surgery Lymph Node Excision Adolescence Female Breast -- Ultrasonography Biopsy Immunohistochemistry Paraffin Embedding Polymerase Chain Reaction N1 - Accession Number: 146733960. Language: English. Entry Date: 20201107. Revision Date: 20201107. Publication Type: Case Study; case study; pictorial. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Peer Reviewed; USA. NLM UID: 9505539. NV - Malden, Massachusetts PB - Wiley-Blackwell PY - 2020 SP - 2068-2069 ST - Primary breast Anaplasic Lymphoma Kinase‐positive anaplastic lymphoma in an adolescent TI - Primary breast Anaplasic Lymphoma Kinase‐positive anaplastic lymphoma in an adolescent UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146733960&site=ehost-live&scope=site VL - 26 ID - 7452 ER - TY - JOUR AD - D. Yim, Seoul National University, College of Medicine/Hospital, Seoul, South Korea AU - Yim, D. AU - Song, S. G. AU - Kim, S. AU - Park, S. Y. AU - Kim, T. M. AU - Park, S. H. AU - Jeon, Y. K. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631879679 2020-06-02 PY - 2020 SN - 1530-0285 SP - 1412 ST - Primary cns lymphoma of peripheral t-cell lineage: Clinicopathological analysis of 10 cases from a single institute T2 - Modern Pathology TI - Primary cns lymphoma of peripheral t-cell lineage: Clinicopathological analysis of 10 cases from a single institute UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631879679&from=export VL - 33 ID - 7453 ER - TY - JOUR AD - Department of Pathology, Chinese PLA General Hospital, Beijing, China. shihuaiyin@sina.com AN - 20350216 AU - Shi, H. AU - Li, Y. AU - Wei, L. AU - Sun, L. DA - Apr DO - 10.3109/00313021003631312 10.3109/00313021003631312. DP - Nlm ET - 2010/03/31 IS - 3 LA - eng PY - 2010 SN - 0031-3025 SP - 235-41 ST - Primary colorectal inflammatory myofibroblastic tumour: a clinicopathological and immunohistochemical study of seven cases T2 - Pathology TI - Primary colorectal inflammatory myofibroblastic tumour: a clinicopathological and immunohistochemical study of seven cases VL - 42 ID - 7454 ER - TY - JOUR AD - D. Vincent, Department of Paediatric Neurology, Cork University Hospital, United Kingdom AU - Vincent, D. AU - O'Connor, G. AU - McSweeney, N. DB - Embase DO - 10.1111/dmcn.13347 LA - English M3 - Conference Abstract N1 - L614879055 2017-03-22 PY - 2017 SN - 1469-8749 SP - 104-105 ST - Primary congenital glaucoma as a neonatal presentation of neurofibromatosis 1: A case report T2 - Developmental Medicine and Child Neurology TI - Primary congenital glaucoma as a neonatal presentation of neurofibromatosis 1: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614879055&from=exporthttp://dx.doi.org/10.1111/dmcn.13347 VL - 59 ID - 7455 ER - TY - JOUR AD - M. E. Kadin, Roger Williams Medical Center, Elmhurst Bldg., 50 Maude street, Providence, RI AU - Kadin, M. E. AU - Pinkus, J. L. AU - Pinkus, G. S. AU - Duran, I. H. AU - Fuller, C. E. AU - Onciu, M. AU - Kawaguchi, H. AU - Morris, S. W. DB - Embase Medline DO - 10.1097/PAS.0b013e3181648d6d IS - 9 LA - English M3 - Article N1 - L354635349 2009-06-05 PY - 2008 SN - 0147-5185 1532-0979 SP - 1421-1426 ST - Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative T2 - American Journal of Surgical Pathology TI - Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354635349&from=exporthttp://dx.doi.org/10.1097/PAS.0b013e3181648d6d VL - 32 ID - 7456 ER - TY - JOUR AD - S. Küpeli, Department of Pediatric Oncology, Institute of Oncology, Hacettepe University, 06100 Ankara, Turkey AU - Daar, G. AU - Küpeli, S. AU - Yalçin, B. AU - Kesik, V. AU - Orhan, D. AU - Büyükpamukçu, M. DB - Embase Medline DO - 10.3109/08880018.2010.493575 IS - 7 LA - English M3 - Article N1 - L359672096 2010-10-07 2010-10-13 PY - 2010 SN - 0888-0018 1521-0669 SP - 558-563 ST - Primary cutaneous anaplastic large cell lymphoma T2 - Pediatric Hematology and Oncology TI - Primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359672096&from=exporthttp://dx.doi.org/10.3109/08880018.2010.493575 VL - 27 ID - 7457 ER - TY - JOUR AD - M.-C. Liu, Department of Pediatrics, Chi-Mei Foundation Hospital, Liouying, No.201, Taikang Village, Liouying Township, Tainan 736, Taiwan AU - Hung, T. Y. AU - Lin, Y. C. AU - Sun, H. L. AU - Liu, M. C. DB - Embase Medline DO - 10.1007/s00431-006-0409-4 IS - 1 LA - English M3 - Article N1 - L350159812 2007-12-04 PY - 2008 SN - 0340-6199 SP - 111-113 ST - Primary cutaneous anaplastic large cell lymphoma in a young child T2 - European Journal of Pediatrics TI - Primary cutaneous anaplastic large cell lymphoma in a young child UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350159812&from=exporthttp://dx.doi.org/10.1007/s00431-006-0409-4 VL - 167 ID - 7458 ER - TY - JOUR AD - Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. City of Hope Comprehensive Cancer Center, Duarte, CA, USA. City of Hope Comprehensive Cancer Center, Duarte, CA, USA lxue@coh.org. AN - 25633507 AU - Xue, D. AU - Li, X. AU - Ren, Y. AU - Liu, Q. AU - Yen, Y. AU - Xue, L. DA - Jun DO - 10.1177/1066896915568993 10.1177/1066896915568993. Epub 2015 Jan 29. DP - Nlm ET - 2015/01/31 IS - 4 LA - eng PY - 2015 SN - 1066-8969 SP - 333-5 ST - Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule T2 - Int J Surg Pathol TI - Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule VL - 23 ID - 7459 ER - TY - JOUR AD - Department of Pathology, Chi-Mei Medical Center, Liouying, Taiwan. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Department of Pathology, Kaohsiung Medical University Hospital and School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Pathology, Taipei Medical University, Taipei, Taiwan; Department of Pathology, National Taiwan University, Taipei, Taiwan. Electronic address: cmh5301@mail.chimei.org.tw. AN - 28693749 AU - Lee, Y. Y. AU - Takata, K. AU - Wang, R. C. AU - Yang, S. F. AU - Chuang, S. S. DA - Aug DO - 10.1016/j.pathol.2017.05.007 10.1016/j.pathol.2017.05.007. Epub 2017 Jul 8. DP - Nlm ET - 2017/07/12 IS - 5 LA - eng PY - 2017 SN - 0031-3025 SP - 479-485 ST - Primary gastrointestinal anaplastic large cell lymphoma T2 - Pathology TI - Primary gastrointestinal anaplastic large cell lymphoma VL - 49 ID - 7460 ER - TY - JOUR AD - N. Pflederer, Creighton University, Omaha, NE, United States AU - Pflederer, N. AU - Gross, J. AU - Bridge, J. AU - Nguyen, C. AU - Ruma, T. DB - Embase DO - 10.1093/neuonc/noy148 LA - English M3 - Conference Abstract N1 - L628635129 2019-07-26 PY - 2018 SN - 1523-5866 SP - vi241 ST - Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: A rare entity T2 - Neuro-Oncology TI - Primary intra-axial central nervous system inflammatory myofibroblastic tumor, ALK negative: A rare entity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628635129&from=exporthttp://dx.doi.org/10.1093/neuonc/noy148 VL - 20 ID - 7461 ER - TY - JOUR AD - CHU Clermont-Ferrand, Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, Hôtel-Dieu, France. AN - 19131793 AU - Merlin, E. AU - Chabrier, S. AU - Verkarre, V. AU - Cramer, E. AU - Delabesse, E. AU - Stéphan, J. L. DA - Dec DO - 10.1097/MPH.0b013e31818a959a 10.1097/MPH.0b013e31818a959a. DP - Nlm ET - 2009/01/10 IS - 12 LA - eng PY - 2008 SN - 1077-4114 SP - 963-7 ST - Primary leptomeningeal ALK+ lymphoma in a 13-year-old child T2 - J Pediatr Hematol Oncol TI - Primary leptomeningeal ALK+ lymphoma in a 13-year-old child VL - 30 ID - 7462 ER - TY - JOUR AU - Huo, Z. AU - Wu, H. AU - Li, J. AU - Li, S. AU - Wu, S. AU - Liu, Y. AU - Luo, Y. AU - Cao, J. AU - Zeng, X. AU - Liang, Z. DB - Embase DO - 10.1371/journal.pone.0143169 IS - 11 LA - English M3 - Article N1 - L608007724 2016-02-09 2016-02-11 PY - 2015 SN - 1932-6203 ST - Primary pulmonary mucoepidermoid carcinoma: Histopathological and moleculargenetic studies of 26 cases T2 - PLoS ONE TI - Primary pulmonary mucoepidermoid carcinoma: Histopathological and moleculargenetic studies of 26 cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608007724&from=exporthttp://dx.doi.org/10.1371/journal.pone.0143169 VL - 10 ID - 7463 ER - TY - JOUR AD - *Department of Pathology, King Fahd University Hospital, University of Dammam, Dammam, Kingdom of Saudi Arabia; and †Department of Pathology, King Khalid University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia. AN - 24752216 AU - A, A. LSayyah AU - AlHumidi, A. DA - Jan DO - 10.1097/dad.0000000000000063 10.1097/DAD.0000000000000063. DP - Nlm ET - 2014/04/23 IS - 1 LA - eng PY - 2015 SN - 0193-1091 SP - e12-4 ST - A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case T2 - Am J Dermatopathol TI - A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case VL - 37 ID - 7464 ER - TY - JOUR AD - S. Sacchi, Dipartimento di Scienze Mediche, 5 piano Policlinico, 4100 Modena, Italy AU - Fiorani, C. AU - Vinci, G. AU - Sacchi, S. AU - Bonaccorsi, G. AU - Artusi, T. DB - Embase Medline DO - 10.3816/CLM.2001.n.009 IS - 1 LA - English M3 - Article N1 - L32677847 2001-08-06 PY - 2001 SN - 1526-9655 SP - 29-37 ST - Primary systemic anaplastic large-cell lymphoma (CD30+): Advances in biology and current therapeutic approaches T2 - Clinical Lymphoma TI - Primary systemic anaplastic large-cell lymphoma (CD30+): Advances in biology and current therapeutic approaches UR - https://www.embase.com/search/results?subaction=viewrecord&id=L32677847&from=exporthttp://dx.doi.org/10.3816/CLM.2001.n.009 VL - 2 ID - 7465 ER - TY - JOUR AD - Y. P. Han, Department of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China AU - Shi, H. AU - Han, Y. P. AU - He, M. X. AU - Huang, L. AU - Bai, C. AU - Li, Q. AU - Ma, D. DB - Embase Medline DO - 10.3760/cma.j.issn.0366-6999.20130695 IS - 4 LA - English M3 - Note N1 - L372411222 2014-02-27 2014-03-07 PY - 2014 SN - 0366-6999 SP - 794-795 ST - Primary tracheobronchial anaplastic large cell lymphoma in an 8-year-old child presenting with asthma-like symptoms T2 - Chinese Medical Journal TI - Primary tracheobronchial anaplastic large cell lymphoma in an 8-year-old child presenting with asthma-like symptoms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372411222&from=exporthttp://dx.doi.org/10.3760/cma.j.issn.0366-6999.20130695http://www.cmj.org/ch/reader/create_pdf.aspx?file_no=20130695&year_id=2014&quarter_id=4&falg=1 VL - 127 ID - 7466 ER - TY - JOUR AD - P.A.J. Henricks, Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, Utrecht, CG, Netherlands AU - Li, M. AU - van Esch, B. C. A. M. AU - Wagenaar, G. T. M. AU - Garssen, J. AU - Folkerts, G. AU - Henricks, P. A. J. DB - Embase Medline DO - 10.1016/j.ejphar.2018.05.003 LA - English M3 - Article N1 - L2000764967 2018-05-30 2018-10-23 PY - 2018 SN - 1879-0712 0014-2999 SP - 52-59 ST - Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells T2 - European Journal of Pharmacology TI - Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000764967&from=exporthttp://dx.doi.org/10.1016/j.ejphar.2018.05.003 VL - 831 ID - 7467 ER - TY - JOUR AD - Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China ; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Department of Orthopedics, General Hospital of Tianjin Medical University, Tianjin, People's Republic of China. Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA. Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center and Sino-US Joint Laboratory for Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA ; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center and Sino-US Joint Laboratory for Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China. Department of Biochemistry, Medical Center, Rush University, Chicago, IL, USA. Department of Colorectal Surgery, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China. Research Center for Bioengineering and Sensing Technology, University of Science and Technology Beijing, Beijing, People's Republic of China. Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City, UT, USA. Department of General Surgery, The First People's Hospital of Shunde affiliated to Southern Medical University, Foshan, Guangdong, People's Republic of China. Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China. AN - 25792811 AU - Niu, N. K. AU - Wang, Z. L. AU - Pan, S. T. AU - Ding, H. Q. AU - Au, G. H. AU - He, Z. X. AU - Zhou, Z. W. AU - Xiao, G. AU - Yang, Y. X. AU - Zhang, X. AU - Yang, T. AU - Chen, X. W. AU - Qiu, J. X. AU - Zhou, S. F. C2 - PMC4362906 DO - 10.2147/dddt.S74197 10.2147/DDDT.S74197. eCollection 2015. DP - Nlm ET - 2015/03/21 LA - eng PY - 2015 SN - 1177-8881 SP - 1555-84 ST - Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway T2 - Drug Des Devel Ther TI - Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway VL - 9 ID - 7468 ER - TY - JOUR AD - F. Batteux, Immunology Department, Cochin Hospital, Paris Descartes University, Paris, France AU - Batteux, F. DB - Embase DO - 10.5301/je.5000214 LA - English M3 - Conference Abstract N1 - L618421485 2017-09-27 PY - 2015 SN - 2284-0273 SP - S10-S11 ST - Pro-inflammatory signals and endometriosis pathogenesis: Clinical applications T2 - Journal of Endometriosis and Pelvic Pain Disorders TI - Pro-inflammatory signals and endometriosis pathogenesis: Clinical applications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618421485&from=exporthttp://dx.doi.org/10.5301/je.5000214 VL - 7 ID - 7469 ER - TY - JOUR AD - B. Dong, Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China J. Kong, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China AU - Ma, H. AU - Dong, X. F. AU - Cao, X. R. AU - Hei, N. H. AU - Li, J. L. AU - Wang, Y. L. AU - Kong, J. AU - Dong, B. C1 - pd 98059 DB - Embase Medline DO - 10.1089/hum.2019.124 IS - 11-12 LA - English M3 - Article N1 - L632617196 2020-08-24 2020-10-23 PY - 2020 SN - 1557-7422 1043-0342 SP - 639-650 ST - Pro-Renin Receptor Overexpression Promotes Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice T2 - Human Gene Therapy TI - Pro-Renin Receptor Overexpression Promotes Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632617196&from=exporthttp://dx.doi.org/10.1089/hum.2019.124 VL - 31 ID - 7470 ER - TY - JOUR AD - D.B. Polk, Department of Pediatrics, Vanderbilt University, Nashville, TN, United States AU - Polk, D. B. DB - Embase IS - 1-2 LA - English M3 - Conference Paper N1 - L39287200 2004-10-17 PY - 2004 SN - 0392-6699 SP - 29-34 ST - Probiotic initiation of intestinal epithelial cell survival response T2 - EOS Rivista di Immunologia ed Immunofarmacologia TI - Probiotic initiation of intestinal epithelial cell survival response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39287200&from=export VL - 24 ID - 7471 ER - TY - JOUR AD - J. Versalovic, Department of Pathology, Texas Children's Hospital, 6621 Fannin St., Houston, TX 77030, United States AU - Lin, Y. P. AU - Thibodeaux, C. H. AU - Peña, J. A. AU - Ferry, G. D. AU - Versalovic, J. DB - Embase Medline DO - 10.1002/ibd.20448 IS - 8 LA - English M3 - Article N1 - L352180720 2008-09-03 PY - 2008 SN - 1078-0998 1536-4844 SP - 1068-1083 ST - Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun T2 - Inflammatory Bowel Diseases TI - Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352180720&from=exporthttp://dx.doi.org/10.1002/ibd.20448 VL - 14 ID - 7472 ER - TY - JOUR AD - L. Schoyer, RASopathies Network, Altadena, CA, United States AU - Rauen, K. A. AU - Schoyer, L. AU - Schill, L. AU - Stronach, B. AU - Albeck, J. AU - Andresen, B. S. AU - Cavé, H. AU - Ellis, M. AU - Fruchtman, S. M. AU - Gelb, B. D. AU - Gibson, C. C. AU - Gripp, K. AU - Hefner, E. AU - Huang, W. Y. C. AU - Itkin, M. AU - Kerr, B. AU - Linardic, C. M. AU - McMahon, M. AU - Oberlander, B. AU - Perlstein, E. AU - Ratner, N. AU - Rogers, L. AU - Schenck, A. AU - Shankar, S. AU - Shvartsman, S. AU - Stevenson, D. A. AU - Stites, E. C. AU - Stork, P. J. S. AU - Sun, C. AU - Therrien, M. AU - Ullian, E. M. AU - Widemann, B. C. AU - Yeh, E. AU - Zampino, G. AU - Zenker, M. AU - Timmer, W. AU - McCormick, F. DB - Embase Medline DO - 10.1002/ajmg.a.40632 IS - 12 LA - English M3 - Conference Paper N1 - L624319363 2018-10-17 2019-11-05 PY - 2018 SN - 1552-4833 1552-4825 SP - 2924-2929 ST - Proceedings of the fifth international RASopathies symposium: When development and cancer intersect T2 - American Journal of Medical Genetics, Part A TI - Proceedings of the fifth international RASopathies symposium: When development and cancer intersect UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624319363&from=exporthttp://dx.doi.org/10.1002/ajmg.a.40632 VL - 176 ID - 7473 ER - TY - JOUR AD - I. Hide, Department of Pharmacology, Grad. School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan AU - Suzuki, T. AU - Hide, I. AU - Ido, K. AU - Kohsaka, S. AU - Inoue, K. AU - Nakata, Y. DB - Embase Medline DO - 10.1523/JNEUROSCI.3792-03.2004 IS - 1 LA - English M3 - Article N1 - L38181664 2004-02-26 PY - 2004 SN - 0270-6474 SP - 1-7 ST - Production and Release of Neuroprotective Tumor Necrosis Factor by P2X 7 Receptor-Activated Microglia T2 - Journal of Neuroscience TI - Production and Release of Neuroprotective Tumor Necrosis Factor by P2X 7 Receptor-Activated Microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38181664&from=exporthttp://dx.doi.org/10.1523/JNEUROSCI.3792-03.2004 VL - 24 ID - 7474 ER - TY - JOUR AD - Department of Pathology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Chennai, Tamil Nadu, 600 116, India Department of Pediatric Hematology Oncology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra University, Chennai, Tamil Nadu, India AU - Bernard, C. AU - Suman, F. R. AU - Rashmika, R. AU - Latha, M. S. AU - Scott, J. X. AU - Rajesh, V. DB - Scopus DO - 10.4103/ijmpo.ijmpo_234_17 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - S77-S81 ST - Profile of pediatric chronic myeloid leukemia in the era of imatinib: A study from South India T2 - Indian Journal of Medical and Paediatric Oncology TI - Profile of pediatric chronic myeloid leukemia in the era of imatinib: A study from South India UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070757605&doi=10.4103%2fijmpo.ijmpo_234_17&partnerID=40&md5=ed33d82c8ce16d974be3fdc18d480aa7 VL - 40 ID - 7475 ER - TY - JOUR AD - Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. AN - 19924296 AU - MacConaill, L. E. AU - Campbell, C. D. AU - Kehoe, S. M. AU - Bass, A. J. AU - Hatton, C. AU - Niu, L. AU - Davis, M. AU - Yao, K. AU - Hanna, M. AU - Mondal, C. AU - Luongo, L. AU - Emery, C. M. AU - Baker, A. C. AU - Philips, J. AU - Goff, D. J. AU - Fiorentino, M. AU - Rubin, M. A. AU - Polyak, K. AU - Chan, J. AU - Wang, Y. AU - Fletcher, J. A. AU - Santagata, S. AU - Corso, G. AU - Roviello, F. AU - Shivdasani, R. AU - Kieran, M. W. AU - Ligon, K. L. AU - Stiles, C. D. AU - Hahn, W. C. AU - Meyerson, M. L. AU - Garraway, L. A. C2 - PMC2774511 consultant for and/or receives sponsored research from Novartis, Inc. None of these relationships constitute a conflict of interest for this work. This does not alter his adherence to all PLoS ONE policies on data sharing and materials. DA - Nov 18 DO - 10.1371/journal.pone.0007887 10.1371/journal.pone.0007887. DP - Nlm ET - 2009/11/20 IS - 11 LA - eng PY - 2009 SN - 1932-6203 SP - e7887 ST - Profiling critical cancer gene mutations in clinical tumor samples T2 - PLoS One TI - Profiling critical cancer gene mutations in clinical tumor samples VL - 4 ID - 7476 ER - TY - JOUR AD - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States Weill Cornell Medical College, New York, NY, United States Columbia University College of Physicians and Surgeons, New York, NY, United States AU - Kuk, D. AU - Shoushtari, A. N. AU - Barker, C. A. AU - Panageas, K. S. AU - Munhoz, R. R. AU - Momtaz, P. AU - Ariyan, C. E. AU - Brady, M. S. AU - Coit, D. G. AU - Bogatch, K. AU - Callahan, M. K. AU - Wolchok, J. D. AU - Carvajal, R. D. AU - Postow, M. A. DB - Scopus DO - 10.1634/theoncologist.2015-0522 IS - 7 M3 - Article N1 - Cited By :60 Export Date: 18 November 2020 PY - 2016 SP - 848-854 ST - Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis T2 - Oncologist TI - Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978473836&doi=10.1634%2ftheoncologist.2015-0522&partnerID=40&md5=d84f912d3931d5a2b301e8258d5b2674 VL - 21 ID - 7477 ER - TY - JOUR AD - Department of Pediatric Hematology and Oncology, Teaching Hospital Motol, Charles University, Prague, Czech Republic Institute of Clinical Biochemistry and Laboratory Diagnostics, General Faculty Hospital, Charles University, Prague, Czech Republic Institute of Hematology and Blood Transfusion, Prague, Czech Republic Czech Stem Cell Donor Registry, Prague, Czech Republic Czech National Marrow Donors Registry, Prague, Czech Republic AU - Krol, L. AU - Formankova, R. AU - Keslova, P. AU - Vavra, V. AU - Zemanova, Z. AU - Michalova, K. AU - Dobrovolna, M. AU - Moravcova, J. AU - Kobylka, P. AU - Ivaskova, E. AU - Navratilova, J. AU - Stary, J. AU - Sedlacek, P. DB - Scopus IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2008 SP - 101-106 ST - Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic T2 - Neoplasma TI - Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-48549106575&partnerID=40&md5=5b0d07b65460822183409c0fe5cfb29e VL - 55 ID - 7478 ER - TY - JOUR AD - Service d'Oncologie Médicale, Centre Eugene Marquis, Rennes, France. Brittany Melanoma Network, GRoupe Ouest Mélanome (GROUM), Rennes, France. Gene Expression and Oncogenesis Team, Institut de Génétique et Developement de Rennes, CNRS UMR6290, Rennes, France. CHU Pontchaillou, Université Européenne de Bretagne, Rennes, France. CHU Pontchaillou, Service de Génétique Moléculaire et Génomique des Cancers, Rennes, France. SFR Biosit UMS CNRS 3480/US INSERM 018, Rennes, France. Service d'Anatomopathologie, CHU Pontchaillou, Rennes, France. Laboratoire d'Anatomopathologie Atalante, Rennes, France. Centre d'Investigations Cliniques et Unité de Pharmacologie et de Pharmaco-épidémiologie, Rennes, France. CHU Pontchaillou, Service de Dermatologie, Rennes, France. AN - 25623140 AU - Pracht, M. AU - Mogha, A. AU - Lespagnol, A. AU - Fautrel, A. AU - Mouchet, N. AU - Le Gall, F. AU - Paumier, V. AU - Lefeuvre-Plesse, C. AU - Rioux-Leclerc, N. AU - Mosser, J. AU - Oger, E. AU - Adamski, H. AU - Galibert, M. D. AU - Lesimple, T. DA - Aug DO - 10.1111/jdv.12910 10.1111/jdv.12910. Epub 2015 Jan 26. DP - Nlm ET - 2015/01/28 IS - 8 LA - eng PY - 2015 SN - 0926-9959 SP - 1530-8 ST - Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma T2 - J Eur Acad Dermatol Venereol TI - Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma VL - 29 ID - 7479 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan Faculty of Medicine, Department of Gastroenterology and Hepatology, Kindai University, Osaka, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Atsukawa, M. AU - Hirooka, M. AU - Tsuji, K. AU - Ishikawa, T. AU - Takaguchi, K. AU - Kariyama, K. AU - Itobayashi, E. AU - Tajiri, K. AU - Shimada, N. AU - Shibata, H. AU - Ochi, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Nagano, T. AU - Itokawa, N. AU - Hayama, K. AU - Imai, M. AU - Joko, K. AU - Koizumi, Y. AU - Hiasa, Y. AU - Michitaka, K. AU - Kudo, M. AU - the Real-life Practice Experts for Hcc Study Group, H. C. C. Group DB - Scopus DO - 10.1002/cam4.2241 IS - 8 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :41 Export Date: 18 November 2020 PY - 2019 SP - 3719-3728 ST - Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions—Multicenter analysis T2 - Cancer Medicine TI - Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions—Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069483972&doi=10.1002%2fcam4.2241&partnerID=40&md5=0ee6a371d70be5db38c9da3b2055d16e VL - 8 ID - 7480 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Pediatrics, The Catholic University of Korea, College of Medicine, Seoul, South Korea AU - Lee, J. W. AU - Cho, B. DB - Scopus DO - 10.3345/kjp.2017.60.5.129 IS - 5 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2017 SP - 129-137 ST - Prognostic factors and treatment of pediatric acute lymphoblastic leukemia T2 - Korean Journal of Pediatrics TI - Prognostic factors and treatment of pediatric acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019563402&doi=10.3345%2fkjp.2017.60.5.129&partnerID=40&md5=81825768da0cb8fbbf59b65aaac21f8b VL - 60 ID - 7481 ER - TY - JOUR AD - Department of Hematology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea Cancer Research Institute, The Catholic University of Korea, Seoul, South Korea AU - Lee, S. E. AU - Choi, S. Y. AU - Kim, S. H. AU - Jang, E. J. AU - Bang, J. H. AU - Byeun, J. Y. AU - Park, J. E. AU - Jeon, H. R. AU - Oh, Y. J. AU - Yahng, S. A. AU - Cho, B. S. AU - Eom, K. S. AU - Kim, Y. J. AU - Lee, S. AU - Min, C. K. AU - Kim, H. J. AU - Lee, J. W. AU - Min, W. S. AU - Park, C. W. AU - Kim, D. W. DB - Scopus DO - 10.1179/1607845413Y.0000000100 IS - 2 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 SP - 63-72 ST - Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors T2 - Hematology TI - Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896039551&doi=10.1179%2f1607845413Y.0000000100&partnerID=40&md5=34e73cbb25ac517e930b244fb141a691 VL - 19 ID - 7482 ER - TY - JOUR AD - Department of Surgery, Royal Marsden, Fulham Road, London SW3 6JJ, United Kingdom Sarcoma Unit, Royal Marsden, Fulham Road, London SW3 6JJ, United Kingdom AU - Cananzi, F. C. M. AU - Lorenzi, B. AU - Belgaumkar, A. AU - Benson, C. AU - Judson, I. AU - Mudan, S. DB - Scopus DO - 10.1007/s00423-014-1160-3 IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2014 SP - 323-332 ST - Prognostic factors for primary gastrointestinal stromal tumours: Are they the same in the multidisciplinary treatment era? T2 - Langenbeck's Archives of Surgery TI - Prognostic factors for primary gastrointestinal stromal tumours: Are they the same in the multidisciplinary treatment era? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898839615&doi=10.1007%2fs00423-014-1160-3&partnerID=40&md5=7bc7eb7f1b8f8526c6694df0f7c5927e VL - 399 ID - 7483 ER - TY - JOUR AD - W. Woessmann, Dept. of Paediatric Haematology and Oncology, NHL-BFM Study Centre, Justus-Liebig-University, Feulgenstrasse 12, Giessen, Germany AU - Damm-Welk, C. AU - Pillon, M. AU - Woessmann, W. AU - Mussolin, L. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L604838437 2015-06-22 2015-06-26 PY - 2015 SN - 1945-0524 1945-0516 SP - 205-216 ST - Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK T2 - Frontiers in Bioscience - Scholar TI - Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604838437&from=export VL - 7S ID - 7484 ER - TY - JOUR AD - Hematology Unit, Mansoura University Oncology Center, Mansoura University, Mansoura, Egypt Hematology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt Physiology, Zoology Department, Faculty of Science, Damietta University, Damietta, Egypt AU - Aref, S. AU - Azmy, E. AU - El-Bakry, K. AU - Ibrahim, L. AU - Mabed, M. DB - Scopus DO - 10.1080/10245332.2017.1404276 IS - 5 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 263-270 ST - Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients T2 - Hematology TI - Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034669629&doi=10.1080%2f10245332.2017.1404276&partnerID=40&md5=359a36c9bd30703d931f26f1d73d6c5a VL - 23 ID - 7485 ER - TY - JOUR AD - Y. Iijima-Yamashita, Department of Clinical Trials and Research, Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi, Japan AU - Iijima-Yamashita, Y. AU - Mori, T. AU - Nakazawa, A. AU - Fukano, R. AU - Takimoto, T. AU - Tsurusawa, M. AU - Kobayashi, R. AU - Horibe, K. DB - Embase Medline DO - 10.1007/s12185-017-2338-6 IS - 2 LA - English M3 - Article N1 - L618784855 2017-10-23 2018-06-08 PY - 2018 SN - 1865-3774 0925-5710 SP - 244-250 ST - Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma T2 - International Journal of Hematology TI - Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618784855&from=exporthttp://dx.doi.org/10.1007/s12185-017-2338-6 VL - 107 ID - 7486 ER - TY - JOUR AD - Department of Immunology and Molecular Medicine, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Advanced Centre for Human Genetics, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India AU - Azad, N. A. AU - Shah, Z. A. AU - Pandith, A. A. AU - Khan, M. S. AU - Rasool, R. AU - Rasool, J. AU - Aziz, S. A. DB - Scopus DO - 10.22034/APJCP.2018.19.6.1479 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 1479-1485 ST - Prognostic implication of BCR-ABL fusion transcript variants in Chronic myeloid leukemia (CML) treated with Imatinib. A first of its kind study on CML patients of Kashmir T2 - Asian Pacific Journal of Cancer Prevention TI - Prognostic implication of BCR-ABL fusion transcript variants in Chronic myeloid leukemia (CML) treated with Imatinib. A first of its kind study on CML patients of Kashmir UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048978199&doi=10.22034%2fAPJCP.2018.19.6.1479&partnerID=40&md5=45033950a6e48582b06910679858bdb3 VL - 19 ID - 7487 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, St. Anna Children's Hospital, Vienna, Austria Children's Cancer Research Institute (CCRI), St. Anna Kinderkrebsforschung, Vienna, Austria Department of Human Molecular Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany Department of Paediatric Haematology and Oncology, Children's University Hospital, University Hospital Schleswig-Holstein, Kiel, Germany AU - Attarbaschi, A. AU - Pisecker, M. AU - Inthal, A. AU - Mann, G. AU - Janousek, D. AU - Dworzak, M. AU - Pötschger, U. AU - Ullmann, R. AU - Schrappe, M. AU - Gadner, H. AU - Haas, O. A. AU - Panzer-Grümayer, R. AU - Strehl, S. DB - Scopus DO - 10.1111/j.1365-2141.2009.07944.x IS - 2 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2010 SP - 293-300 ST - Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements T2 - British Journal of Haematology TI - Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-72649097977&doi=10.1111%2fj.1365-2141.2009.07944.x&partnerID=40&md5=4cbba85b4d5c73b934186b810628fd4c VL - 148 ID - 7488 ER - TY - JOUR AD - Oncosurgery, Geneva UniversityHospital, Geneva, Switzerland. arnaud.roth@sim.hcuge.ch AN - 20008640 AU - Roth, A. D. AU - Tejpar, S. AU - Delorenzi, M. AU - Yan, P. AU - Fiocca, R. AU - Klingbiel, D. AU - Dietrich, D. AU - Biesmans, B. AU - Bodoky, G. AU - Barone, C. AU - Aranda, E. AU - Nordlinger, B. AU - Cisar, L. AU - Labianca, R. AU - Cunningham, D. AU - Van Cutsem, E. AU - Bosman, F. DA - Jan 20 DO - 10.1200/jco.2009.23.3452 10.1200/JCO.2009.23.3452. Epub 2009 Dec 14. DP - Nlm ET - 2009/12/17 IS - 3 LA - eng PY - 2010 SN - 0732-183x SP - 466-74 ST - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial T2 - J Clin Oncol TI - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial VL - 28 ID - 7489 ER - TY - JOUR AD - Department of Hematology, Kuwait Cancer Control Center, Shuwaikh city, Kuwait Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Alhuraiji, A. AU - Kantarjian, H. AU - Boddu, P. AU - Ravandi, F. AU - Borthakur, G. AU - DiNardo, C. AU - Daver, N. AU - Kadia, T. AU - Pemmaraju, N. AU - Pierce, S. AU - Garcia-Manero, G. AU - Wierda, W. AU - Verstovsek, S. AU - Jabbour, E. AU - Cortes, J. DB - Scopus DO - 10.1002/ajh.24943 IS - 1 M3 - Article N1 - Cited By :20 Export Date: 18 November 2020 PY - 2018 SP - 84-90 ST - Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033486402&doi=10.1002%2fajh.24943&partnerID=40&md5=0dc4f5659b62be5df0785b49fdf5d6d8 VL - 93 ID - 7490 ER - TY - JOUR AD - Departments of Anatomic Pathology and Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan. AN - 23209032 AU - Endo, M. AU - Yamamoto, H. AU - Setsu, N. AU - Kohashi, K. AU - Takahashi, Y. AU - Ishii, T. AU - Iida, K. AU - Matsumoto, Y. AU - Hakozaki, M. AU - Aoki, M. AU - Iwasaki, H. AU - Dobashi, Y. AU - Nishiyama, K. AU - Iwamoto, Y. AU - Oda, Y. DA - Jan 15 DO - 10.1158/1078-0432.Ccr-12-1067 10.1158/1078-0432.CCR-12-1067. Epub 2012 Dec 3. DP - Nlm ET - 2012/12/05 IS - 2 LA - eng PY - 2013 SN - 1078-0432 (Print) 1078-0432 SP - 450-61 ST - Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors T2 - Clin Cancer Res TI - Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors VL - 19 ID - 7491 ER - TY - JOUR AD - Department of Pathology, The University of Texas Medical Center Health Sciences Center, Houston, Texas, USA Department of Pathology, The University of Texas Medical Center Health Sciences Center, Houston, Texas. AN - 104672894. Language: English. Entry Date: 20111028. Revision Date: 20170817. Publication Type: journal article. Journal Subset: Biomedical AU - Jaso, J. AU - Thomas, D. A. AU - Cunningham, K. AU - Jorgensen, J. L. AU - Kantarjian, H. M. AU - Medeiros, L. J. AU - Wang, S. A. AU - Jaso, Jesse AU - Thomas, Deborah A. AU - Cunningham, Krista AU - Jorgensen, Jeffrey L. AU - Kantarjian, Hagop M. AU - Medeiros, L. Jeffrey AU - Wang, Sa A. DB - ccm DO - 10.1002/cncr.25978 DP - EBSCOhost IS - 17 N1 - Peer Reviewed; USA. Special Interest: Oncologic Care. Grant Information: P30 CA016672/CA/NCI NIH HHS/United States. NLM UID: 0374236. PMID: NLM21365622. PY - 2011 SN - 0008-543X SP - 4009-4017 ST - Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors T2 - Cancer (0008543X) TI - Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104672894&site=ehost-live&scope=site VL - 117 ID - 7492 ER - TY - JOUR AD - Department of Pathology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. AN - 17464320 AU - Li, C. AU - Takino, H. AU - Eimoto, T. AU - Ishida, T. AU - Inagaki, A. AU - Ueda, R. AU - Suzuki, R. AU - Yoshino, T. AU - Nakagawa, A. AU - Nakamura, S. AU - Inagaki, H. DA - Jun DO - 10.1038/modpathol.3800781 10.1038/modpathol.3800781. Epub 2007 Apr 20. DP - Nlm ET - 2007/04/28 IS - 6 LA - eng PY - 2007 SN - 0893-3952 (Print) 0893-3952 SP - 648-55 ST - Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma T2 - Mod Pathol TI - Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma VL - 20 ID - 7493 ER - TY - JOUR AD - Z. Li, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China AU - Wan, X. AU - Liu, R. AU - Li, Z. DB - Embase Medline DO - 10.1155/2017/5356737 LA - English M3 - Article N1 - L619904580 2017-12-29 2018-08-17 PY - 2017 SN - 2314-6141 2314-6133 ST - The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma T2 - BioMed Research International TI - The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619904580&from=exporthttp://dx.doi.org/10.1155/2017/5356737 VL - 2017 ID - 7494 ER - TY - JOUR AD - Department of Laboratory Medicine, Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China AU - Zhang, X. AU - Liu, R. AU - Huang, B. AU - Zhang, X. AU - Yu, W. AU - Bao, C. AU - Li, J. AU - Sun, C. DB - Scopus DO - 10.3892/ol.2016.4942 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2016 SP - 2976-2981 ST - Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia T2 - Oncology Letters TI - Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983412049&doi=10.3892%2fol.2016.4942&partnerID=40&md5=cdcffb871c9770752fc1858f0f3ad8ef VL - 12 ID - 7495 ER - TY - JOUR AD - L. Hendriks, Pulmonary Diseases, Maastricht University Medical Center+, Netherlands AU - Hendriks, L. AU - Mellema, W. W. AU - Smit, E. F. AU - Troost, E. AU - Dingemans, A. M. DB - Embase DO - 10.1097/01.JTO.0000438438.14562.c8 LA - English M3 - Conference Abstract N1 - L71397919 2014-04-08 PY - 2013 SN - 1556-0864 SP - S1312-S1313 ST - Progression of radiation induced esophageal stenosis in a non-small cell lung cancer (NSCLC) patient treated with sorafenib T2 - Journal of Thoracic Oncology TI - Progression of radiation induced esophageal stenosis in a non-small cell lung cancer (NSCLC) patient treated with sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71397919&from=exporthttp://dx.doi.org/10.1097/01.JTO.0000438438.14562.c8 VL - 8 ID - 7496 ER - TY - JOUR AD - Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, China AU - Ma, F. C. AU - Yu, Q. AU - Zeng, Z. M. AU - He, R. Q. AU - Mo, C. H. AU - Zhong, J. C. AU - Ma, J. AU - Feng, Z. B. AU - Chen, G. AU - Hu, X. H. DB - Scopus DO - 10.2147/OTT.S146051 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2017 SP - 5237-5242 ST - Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: A case report T2 - OncoTargets and Therapy TI - Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034067380&doi=10.2147%2fOTT.S146051&partnerID=40&md5=2879793651f3ca81d1a724df890a0765 VL - 10 ID - 7497 ER - TY - JOUR AD - E.M. Kwon, Dermatology, Medical College of Wisconsin, Milwaukee, WI, United States AU - Kwon, E. M. AU - Rosen, A. H. AU - Paller, A. S. AU - Siegel, D. H. DB - Embase DO - 10.1038/jid.2012.84 LA - English M3 - Conference Abstract N1 - L70730959 2012-05-07 PY - 2012 SN - 0022-202X SP - S67 ST - Progressive ectodermal phenotype of costello syndrome T2 - Journal of Investigative Dermatology TI - Progressive ectodermal phenotype of costello syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70730959&from=exporthttp://dx.doi.org/10.1038/jid.2012.84 VL - 132 ID - 7498 ER - TY - JOUR AD - M.L. Galluzzo, Pathology Department, Hospital Nacional de Pediatría Garrahan, Buenos Aires, Argentina AU - Galluzzo, M. L. AU - Roibón, N. G. AU - Felizzia, G. AU - La Rosa, C. S. AU - Buján, M. M. AU - Braier, J. AU - Durham, B. H. AU - Abdel-Wahab, O. AU - Diamond, E. L. DB - Embase DO - 10.1002/pbc.27548 LA - English M3 - Conference Abstract N1 - L625283699 2018-12-05 PY - 2019 SN - 1545-5017 ST - Progressive nodular histiocytosis. Report of a pediatric case T2 - Pediatric Blood and Cancer TI - Progressive nodular histiocytosis. Report of a pediatric case UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625283699&from=exporthttp://dx.doi.org/10.1002/pbc.27548 VL - 66 ID - 7499 ER - TY - JOUR AD - Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore. Electron Microscopy Laboratory, Life Sciences Institute, National University of Singapore, Singapore. Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Centre for Biomedical & Life Sciences, Singapore Polytechnic, Singapore. AN - 29324904 AU - Too, I. H. K. AU - Bonne, I. AU - Tan, E. L. AU - Chu, J. J. H. AU - Alonso, S. C2 - PMC5764453 DA - Jan DO - 10.1371/journal.ppat.1006778 10.1371/journal.ppat.1006778. eCollection 2018 Jan. DP - Nlm ET - 2018/01/13 IS - 1 LA - eng PY - 2018 SN - 1553-7366 (Print) 1553-7366 SP - e1006778 ST - Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis T2 - PLoS Pathog TI - Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis VL - 14 ID - 7500 ER - TY - JOUR AD - Pituitary Center, Cedars-Sinai Medical Center, 8700 Beverly Blvd., B-131, Los Angeles, CA 90048, United States Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, United States Division of Hematology and Oncology, Department of Medicine, CSMC, Los Angeles, CA, United States Biostatistics and Bioinformatics Research Center, Samuel Oschin Comprehensive Cancer Institute, CSMC, Los Angeles, CA, United States AU - Cooper, O. AU - Mamelak, A. AU - Bannykh, S. AU - Carmichael, J. AU - Bonert, V. AU - Lim, S. AU - Cook-Wiens, G. AU - Ben-Shlomo, A. DB - Scopus DO - 10.1007/s12020-013-0093-x IS - 2 M3 - Article N1 - Cited By :37 Export Date: 18 November 2020 PY - 2014 SP - 318-327 ST - Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors T2 - Endocrine TI - Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902304359&doi=10.1007%2fs12020-013-0093-x&partnerID=40&md5=1095f6d44edc957baad8c70b71ad0a40 VL - 46 ID - 7501 ER - TY - JOUR AD - V.S. Budhram-Mahadeo, Cardiovascular Division, King's College London, Department of Cardiology, The Rayne Institute, St Thomas's Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom AU - Ounzain, S. AU - Bowen, S. AU - Patel, C. AU - Fujita, R. AU - Heads, R. J. AU - Budhram-Mahadeo, V. S. DB - Embase Medline DO - 10.1186/bcr2809 IS - 1 LA - English M3 - Article N1 - L51237515 2011-01-21 2011-08-30 PY - 2011 SN - 1465-5411 1465-542X ST - Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway T2 - Breast Cancer Research TI - Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51237515&from=exporthttp://dx.doi.org/10.1186/bcr2809http://breast-cancer-research.com/content/13/1/R5 VL - 13 ID - 7502 ER - TY - JOUR AD - Department of Pediatrics, UCSF Helen Diller Family Comprehensive Cancer Center, and UCSF Benioff Children's Hospital, UCSF Medical Center, University of California, San Francisco, CA 94143-0106, USA. matthayk@peds.ucsf.edu AN - 22589483 AU - Matthay, K. K. AU - George, R. E. AU - Yu, A. L. C2 - PMC3382042 C6 - NIHMS366101 DA - May 15 DO - 10.1158/1078-0432.Ccr-11-1939 10.1158/1078-0432.CCR-11-1939. DP - Nlm ET - 2012/05/17 IS - 10 LA - eng PY - 2012 SN - 1078-0432 (Print) 1078-0432 SP - 2740-53 ST - Promising therapeutic targets in neuroblastoma T2 - Clin Cancer Res TI - Promising therapeutic targets in neuroblastoma VL - 18 ID - 7503 ER - TY - JOUR AD - H. Okada, Department of Gastroenterology, Kanazawa University, Ishikawa, Japan AU - Okada, H. AU - Honda, M. AU - S. Campbell, J. AU - Takabatake, R. AU - Takegoshi, K. AU - Yamashita, T. AU - Shirasaki, T. AU - Tanaka, T. AU - Kaneko, S. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L612595199 2016-11-11 PY - 2016 SN - 0270-9139 SP - 244A ST - Promoted liver fibrosis and malignant phenotype in HCV/PDGF-C transgenic mice are accompanied by abnormal expression of the glycolysis-related gene pyruvate kinase M T2 - Hepatology TI - Promoted liver fibrosis and malignant phenotype in HCV/PDGF-C transgenic mice are accompanied by abnormal expression of the glycolysis-related gene pyruvate kinase M UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612595199&from=export VL - 64 ID - 7504 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Takahashi, K. AU - Kantarjian, H. M. AU - Yang, Y. AU - Sasaki, K. AU - Jain, P. AU - DellaSala, S. AU - Ravandi, F. AU - Kadia, T. AU - Pemmaraju, N. AU - Daver, N. AU - Borthakur, G. AU - Garcia-Manero, G. AU - Jabbour, E. AU - Cortes, J. E. DB - Scopus DO - 10.1002/cncr.30197 IS - 21 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 3336-3343 ST - A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase T2 - Cancer TI - A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991584284&doi=10.1002%2fcncr.30197&partnerID=40&md5=3af7e1e28c3cbe78abed7a45b625d09e VL - 122 ID - 7505 ER - TY - JOUR AD - Department of Pediatrics, Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Chuo-ku, Niigata City, Niigata 951-8566, Japan Department of Pediatrics, Niigata University Graduate School of Medicine, Niigata, Japan AU - Watanabe, A. AU - Chansu, S. AU - Ogawa, A. AU - Asami, K. AU - Imamura, M. DB - Scopus DO - 10.1111/ped.12019 IS - 3 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2013 SP - e56-e58 ST - Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Pediatrics International TI - Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879361000&doi=10.1111%2fped.12019&partnerID=40&md5=7bed62b52cd34b782fd196586355c450 VL - 55 ID - 7506 ER - TY - JOUR AD - Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China AU - Wu, X. AU - Liu, Q. DB - Scopus DO - 10.1053/j.seminhematol.2019.04.001 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 209-214 ST - Prophylaxis and treatment of relapse after haploidentical stem cell transplantation: What is known vs unknown? T2 - Seminars in Hematology TI - Prophylaxis and treatment of relapse after haploidentical stem cell transplantation: What is known vs unknown? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065531587&doi=10.1053%2fj.seminhematol.2019.04.001&partnerID=40&md5=b8019051350fa5a4f83dde2527943103 VL - 56 ID - 7507 ER - TY - JOUR AD - Department of Orthopedic, Children’s Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China AU - Zhou, P. AU - Liu, H. AU - Wu, Y. AU - Chen, D. DB - Scopus DO - 10.12659/MSM.908592 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2018 SP - 4379-4385 ST - Propofol promotes ankle fracture healing in children by inhibiting inflammatory response T2 - Medical Science Monitor TI - Propofol promotes ankle fracture healing in children by inhibiting inflammatory response UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049695626&doi=10.12659%2fMSM.908592&partnerID=40&md5=9bca95bc24fb27eebc974d59a7e5dad9 VL - 24 ID - 7508 ER - TY - JOUR AD - Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany InfectoPharm Arzneimittel und Consilium GmbH, Von-Humboldt-Straße 1, D-64646 Heppenheim, Germany Department of Paediatric Dermatology, Catholic Children's Hospital Wilhelmstift, Liliencronstraße 130, D-22149 Hamburg, Germany AU - Storch, C. H. AU - Hoeger, P. H. DB - Scopus DO - 10.1111/j.1365-2133.2010.09848.x IS - 2 M3 - Review N1 - Cited By :359 Export Date: 18 November 2020 PY - 2010 SP - 269-274 ST - Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action T2 - British Journal of Dermatology TI - Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954867089&doi=10.1111%2fj.1365-2133.2010.09848.x&partnerID=40&md5=88fac99ffc0dc96a9768029431ee8ed6 VL - 163 ID - 7509 ER - TY - JOUR AD - Y.-F. Zhao, Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, Hubei 430079, China AU - Zou, H. X. AU - Jia, J. AU - Zhang, W. F. AU - Sun, Z. J. AU - Zhao, Y. F. DB - Embase Medline DO - 10.1016/j.carpath.2012.10.001 IS - 3 LA - English M3 - Article N1 - L52299755 2012-11-15 2013-05-24 PY - 2013 SN - 1054-8807 1879-1336 SP - 203-210 ST - Propranolol inhibits endothelial progenitor cell homing: A possible treatment mechanism of infantile hemangioma T2 - Cardiovascular Pathology TI - Propranolol inhibits endothelial progenitor cell homing: A possible treatment mechanism of infantile hemangioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52299755&from=exporthttp://dx.doi.org/10.1016/j.carpath.2012.10.001 VL - 22 ID - 7510 ER - TY - JOUR AD - Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA Department of Pathology and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York, USA Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, New York, USA. Department of Surgery, Columbia University College of Physicians and Surgeons, New York, New York, USA jw92@cumc.columbia.edu. AN - 26574555 AU - Munabi, N. C. AU - England, R. W. AU - Edwards, A. K. AU - Kitajewski, A. A. AU - Tan, Q. K. AU - Weinstein, A. AU - Kung, J. E. AU - Wilcox, M. AU - Kitajewski, J. K. AU - Shawber, C. J. AU - Wu, J. K. C2 - PMC4704871 DA - Jan DO - 10.5966/sctm.2015-0076 10.5966/sctm.2015-0076. Epub 2015 Nov 16. DP - Nlm ET - 2015/11/18 IS - 1 LA - eng PY - 2016 SN - 2157-6564 (Print) 2157-6564 SP - 45-55 ST - Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation T2 - Stem Cells Transl Med TI - Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation VL - 5 ID - 7511 ER - TY - JOUR AD - Department of Hematology and Oncology, Iwate Medical University, Morioka, Japan Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan Department of Hematology, Iwate Prefectural Chubu Hospital, Kitakami, Japan Department of Hematology, Osaki Citizen Hospital, Osaki, Japan Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan Department of Hematology, Morioka Red Cross Hospital, Morioka, Japan Department of Internal Medicine, Omagari Kosei Medical Center, Omagari, Japan Department of Hematology, National Hospital Organization, Sendai Medical Center, Sendai, Japan Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology (DNHMED), Yamagata University Faculty of Medicine, Yamagata, Japan Department of Hematology, Yamagata City Hospital Saiseikan, Yamagata, Japan Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Interfaculty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan Tokai Central Hospital, Kakamigahara, Japan AU - Murai, K. AU - Akagi, T. AU - Shimosegawa, K. AU - Sugawara, T. AU - Ishizawa, K. AU - Ito, S. AU - Murai, K. AU - Motegi, M. AU - Yokoyama, H. AU - Noji, H. AU - Tajima, K. AU - Kimura, J. AU - Chou, T. AU - Ogawa, K. AU - Harigae, H. AU - Kubo, K. AU - Oba, K. AU - Sakamoto, J. AU - Ishida, Y. DB - Scopus DO - 10.1111/ejh.12536 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2015 SP - 558-565 ST - A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria T2 - European Journal of Haematology TI - A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955261006&doi=10.1111%2fejh.12536&partnerID=40&md5=5489d95e786ab5dc6a09f5a9cccbf251 VL - 95 ID - 7512 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Zulbaran-Rojas, A. AU - Lin, H. K. AU - Shi, Q. AU - Williams, L. A. AU - George, B. AU - Garcia-Manero, G. AU - Jabbour, E. AU - O’Brien, S. AU - Ravandi, F. AU - Wierda, W. AU - Estrov, Z. AU - Borthakur, G. AU - Kadia, T. AU - Cleeland, C. AU - Cortes, J. E. AU - Kantarjian, H. DB - Scopus DO - 10.1002/cam4.1808 IS - 11 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2018 SP - 5457-5469 ST - A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors T2 - Cancer Medicine TI - A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054924309&doi=10.1002%2fcam4.1808&partnerID=40&md5=fe4aed5a3e08b114b4f47b8fa890df18 VL - 7 ID - 7513 ER - TY - JOUR AD - R.N. DuBois, Vanderbilt-Ingram Cancer Center, Preston Research Building, 2300 Pierce Avenue, Nashville, TN 37232-6838, United States AU - Wang, D. AU - Buchanan, F. G. AU - Wang, H. AU - Dey, S. K. AU - DuBois, R. N. DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-3671 IS - 5 LA - English M3 - Article N1 - L40478610 2005-05-01 PY - 2005 SN - 0008-5472 SP - 1822-1829 ST - Prostaglandin E2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade T2 - Cancer Research TI - Prostaglandin E2 enhances intestinal adenoma growth via activation of the ras-mitogen-activated protein kinase cascade UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40478610&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-04-3671 VL - 65 ID - 7514 ER - TY - JOUR AD - Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, College of Stomatology, Chongqing Medical University, Chongqing, China. Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, College of Stomatology, Chongqing Medical University. Department of Preventive Dentistry, College of Stomatology, Chongqing Medical University. Department of Orthodontics, College of Stomatology, Chongqing Medical University. Key Laboratory of Clinical Laboratory Science, Ministry of Education, College of Laboratory Medicine, Chongqing Medical University. AN - 27982724 AU - Jiang, L. AU - Song, J. AU - Hu, X. AU - Zhang, H. AU - Huang, E. AU - Zhang, Y. AU - Deng, F. AU - Wu, X. DA - May DO - 10.1902/jop.2016.160396 10.1902/jop.2016.160396. Epub 2016 Dec 16. DP - Nlm ET - 2016/12/17 IS - 5 LA - eng PY - 2017 SN - 0022-3492 SP - 473-483 ST - The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats T2 - J Periodontol TI - The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats VL - 88 ID - 7515 ER - TY - JOUR AD - State Key Laboratory of Animal Nutrition, China Agricultural University, Beijing, China. Beijing Key Laboratory of Bio-feed Additives, China Agricultural University, Beijing, China. National Feed Engineering Technology Research Center, Beijing, China. Department of Animal Sciences, South Dakota State University, Brookings, SD, United States. Swine Nutrition and Production, West Central Research and Outreach Center, University of Minnesota, Morris, MN, United States. AN - 30057893 AU - Yu, H. AU - Ding, X. AU - Shang, L. AU - Zeng, X. AU - Liu, H. AU - Li, N. AU - Huang, S. AU - Wang, Y. AU - Wang, G. AU - Cai, S. AU - Chen, M. AU - Levesque, C. L. AU - Johnston, L. J. AU - Qiao, S. C2 - PMC6053529 DO - 10.3389/fcimb.2018.00242 10.3389/fcimb.2018.00242. eCollection 2018. DP - Nlm ET - 2018/07/31 LA - eng PY - 2018 SN - 2235-2988 SP - 242 ST - Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells T2 - Front Cell Infect Microbiol TI - Protective Ability of Biogenic Antimicrobial Peptide Microcin J25 Against Enterotoxigenic Escherichia Coli-Induced Intestinal Epithelial Dysfunction and Inflammatory Responses IPEC-J2 Cells VL - 8 ID - 7516 ER - TY - JOUR AD - Y. Qin, General Hospital of Jinan Iron and Steel Group Co., Ltd., Shandong, China AU - Wang, J. AU - Qin, Y. AU - Mi, X. DB - Embase Medline DO - 10.1016/j.biopha.2016.02.037 LA - English M3 - Article N1 - L608799483 2016-03-11 2016-03-22 PY - 2016 SN - 1950-6007 0753-3322 SP - 176-187 ST - The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-κB signaling pathways T2 - Biomedicine and Pharmacotherapy TI - The protective effects of bone marrow-derived mesenchymal stem cell (BMSC) on LPS-induced acute lung injury via TLR3-mediated IFNs, MAPK and NF-κB signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608799483&from=exporthttp://dx.doi.org/10.1016/j.biopha.2016.02.037 VL - 79 ID - 7517 ER - TY - JOUR AD - C. Li, Department of Pediatric Surgery, Maternal and Child Health Care, Hospital of Qujing, 371 Liaokuo South Road, Qujing, Yunnan, China AU - Yu, X. AU - Li, C. DB - Embase Medline DO - 10.3892/mmr.2019.10113 IS - 5 LA - English M3 - Article N1 - L2001807120 2019-04-17 2019-08-22 PY - 2019 SN - 1791-3004 1791-2997 SP - 4507-4513 ST - Protective effects of propofol on experimental neonatal acute lung injury T2 - Molecular Medicine Reports TI - Protective effects of propofol on experimental neonatal acute lung injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001807120&from=exporthttp://dx.doi.org/10.3892/mmr.2019.10113 VL - 49 ID - 7518 ER - TY - JOUR AD - Z. Liu, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China AU - Ji, J. AU - Liu, Z. AU - Hong, X. AU - Liu, Z. AU - Gao, J. AU - Liu, J. DB - Embase Medline DO - 10.1186/s12872-020-01529-7 IS - 1 LA - English M3 - Article N1 - L631834312 2020-06-02 2020-07-01 PY - 2020 SN - 1471-2261 ST - Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts T2 - BMC Cardiovascular Disorders TI - Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631834312&from=exporthttp://dx.doi.org/10.1186/s12872-020-01529-7 VL - 20 ID - 7519 ER - TY - JOUR AD - C. Zhang, Department of Pediatrics, Jining No.1 People's Hospital, Jining, China AU - Meng, J. AU - Chen, Y. AU - Zhang, C. DB - Embase Medline DO - 10.1002/jcb.28755 IS - 9 LA - English M3 - Article N1 - L627469652 2019-05-14 2019-08-01 PY - 2019 SN - 1097-4644 0730-2312 SP - 14928-14935 ST - Protective impacts of long noncoding RNA taurine-upregulated 1 against lipopolysaccharide-evoked injury in MRC-5 cells through inhibition of microRNA-127 T2 - Journal of Cellular Biochemistry TI - Protective impacts of long noncoding RNA taurine-upregulated 1 against lipopolysaccharide-evoked injury in MRC-5 cells through inhibition of microRNA-127 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627469652&from=exporthttp://dx.doi.org/10.1002/jcb.28755 VL - 120 ID - 7520 ER - TY - JOUR AD - Viral Disease Division, Animal and Plant Quarantine Agency , Anyang-Si, Gyeonggi-Do , Republic of Korea. AN - 23952478 AU - Lee, J. AU - Shin, Y. K. AU - Song, J. Y. AU - Lee, K. W. DA - Jan DO - 10.3109/09553002.2013.835502 10.3109/09553002.2013.835502. Epub 2013 Sep 13. DP - Nlm ET - 2013/08/21 IS - 1 LA - eng PY - 2014 SN - 0955-3002 SP - 20-8 ST - Protective mechanism of morin against ultraviolet B-induced cellular senescence in human keratinocyte stem cells T2 - Int J Radiat Biol TI - Protective mechanism of morin against ultraviolet B-induced cellular senescence in human keratinocyte stem cells VL - 90 ID - 7521 ER - TY - JOUR AD - E. Gitto, Neonatal Intensive Care Unit, Department of Pediatrics, University of Messina, Via Consolare Valeria, 98125 Messina, Italy AU - Gitto, E. AU - Marseglia, L. AU - Manti, S. AU - D'Angelo, G. AU - Barberi, I. AU - Salpietro, C. AU - Reiter, R. J. DB - Embase DO - 10.1155/2013/980374 LA - English M3 - Review N1 - L370449339 2013-12-18 2013-12-23 PY - 2013 SN - 1942-0994 1942-0900 ST - Protective role of melatonin in neonatal diseases T2 - Oxidative Medicine and Cellular Longevity TI - Protective role of melatonin in neonatal diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370449339&from=exporthttp://dx.doi.org/10.1155/2013/980374 ID - 7522 ER - TY - JOUR AD - Laboratory for Molecular Carcinogenesis, MGC-Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL, Leiden, Netherlands. AN - 11152962 AU - Vertegaal, A. C. AU - Kuiperij, H. B. AU - Yamaoka, S. AU - Courtois, G. AU - van der Eb, A. J. AU - Zantema, A. DA - Dec DO - 10.1016/s0898-6568(00)00133-9 10.1016/s0898-6568(00)00133-9. DP - Nlm ET - 2001/01/12 IS - 11-12 LA - eng PY - 2000 SN - 0898-6568 (Print) 0898-6568 SP - 759-68 ST - Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells T2 - Cell Signal TI - Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells VL - 12 ID - 7523 ER - TY - JOUR AD - F.M. Uckun, Children's Hospital Los Angeles, Children's Center for Cancer and Blood Diseases, Los Angeles, CA 90027, United States AU - D'Cruz, O. J. AU - Uckun, F. M. C2 - Ariad Novartis DB - Embase Medline DO - 10.1517/14656566.2013.780031 IS - 6 LA - English M3 - Review N1 - L368551088 2013-03-27 2013-04-03 PY - 2013 SN - 1465-6566 1744-7666 SP - 707-721 ST - Protein kinase inhibitors against malignant lymphoma T2 - Expert Opinion on Pharmacotherapy TI - Protein kinase inhibitors against malignant lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368551088&from=exporthttp://dx.doi.org/10.1517/14656566.2013.780031 VL - 14 ID - 7524 ER - TY - JOUR AD - M. Steinhoff, Department of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48149 Münster, Germany AU - Rattenholl, A. AU - Seeliger, S. AU - Buddenkotte, J. AU - Schön, M. AU - Schön, M. P. AU - Ständer, S. AU - Vergnolle, N. AU - Steinhoff, M. C1 - pd 153035 C2 - Sigma(Germany) DB - Embase Medline DO - 10.1038/sj.jid.5700847 IS - 9 LA - English M3 - Article N1 - L47258489 2007-09-01 PY - 2007 SN - 0022-202X 1523-1747 SP - 2245-2252 ST - Proteinase-activated receptor-2 (PAR2): A tumor suppressor in skin carcinogenesis T2 - Journal of Investigative Dermatology TI - Proteinase-activated receptor-2 (PAR2): A tumor suppressor in skin carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47258489&from=exporthttp://dx.doi.org/10.1038/sj.jid.5700847 VL - 127 ID - 7525 ER - TY - JOUR AU - Delve, E. AU - Di Scipio, M. AU - Kandel, R. DB - Embase DO - 10.1016/j.joca.2020.02.170 LA - English M3 - Conference Abstract N1 - L2005478841 2020-04-10 PY - 2020 SN - 1522-9653 1063-4584 SP - S106 ST - Proteoglycan 4 expression by superficial zone chondrocytes is regulated in part by JNK and P38 in vitro T2 - Osteoarthritis and Cartilage TI - Proteoglycan 4 expression by superficial zone chondrocytes is regulated in part by JNK and P38 in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005478841&from=exporthttp://dx.doi.org/10.1016/j.joca.2020.02.170 VL - 28 ID - 7526 ER - TY - JOUR AD - Department of Dermatology, Seoul National University Hospital, Seoul, South Korea Center for Skin Cancer and Adverse Skin Reaction to Chemotherapeutics, Seoul National University Cancer Hospital, Seoul, South Korea Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea AU - Cho, S. I. AU - Lee, J. AU - Lim, J. AU - Park, J. S. AU - Kim, M. AU - Kim, T. Y. AU - Kim, T. M. AU - Lee, K. H. AU - Keam, B. AU - Han, S. W. AU - Jo, S. J. DB - Scopus DO - 10.2340/00015555-3129 IS - 4 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 435-441 ST - Pruritus in patients under targeted anticancer therapy: A multidimensional analysis using the 5-D itch scale T2 - Acta Dermato-Venereologica TI - Pruritus in patients under targeted anticancer therapy: A multidimensional analysis using the 5-D itch scale UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064109738&doi=10.2340%2f00015555-3129&partnerID=40&md5=9f241b6376438ae0f74a561523abad38 VL - 99 ID - 7527 ER - TY - JOUR AD - K.C. Kim, University of Arizona College of Medicine, 1656 E Mabel St, MRB-419, Tucson, AZ, United States AU - Kato, K. AU - Hanss, A. D. AU - Zemskova, M. A. AU - Morgan, N. E. AU - Kim, M. AU - Knox, K. S. AU - Lin, Y. AU - Lillehoj, E. P. AU - Kim, K. C. DB - Embase Medline DO - 10.1016/j.bbrc.2017.08.056 IS - 2 LA - English M3 - Article N1 - L617974839 2017-08-29 2017-09-13 PY - 2017 SN - 1090-2104 0006-291X SP - 231-235 ST - Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway T2 - Biochemical and Biophysical Research Communications TI - Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617974839&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2017.08.056 VL - 492 ID - 7528 ER - TY - JOUR AD - Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China AU - Alshorafa, A. K. H. AU - Guo, Q. AU - Zeng, F. AU - Chen, M. AU - Yin, R. AU - Tan, G. AU - Tang, Z. DB - Scopus DO - 10.1620/tiem.228.325 IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2012 SP - 325-332 ST - Psoriasis is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory molecule T2 - Tohoku Journal of Experimental Medicine TI - Psoriasis is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory molecule UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869021999&doi=10.1620%2ftiem.228.325&partnerID=40&md5=8ee66269e36c7c0bcdd944f5aad104ea VL - 228 ID - 7529 ER - TY - JOUR AD - Department of Hematology, Xiang Ya Hospital, Central South University, Changsha, Hunan, China Department of Hematology, West China Hospital, Si Chuan University, Chengdu, Sichuan, China AU - Huang, F. F. AU - Zhang, L. AU - Wu, D. S. AU - Yuan, X. Y. AU - Chen, F. P. AU - Zeng, H. AU - Yu, Y. H. AU - Zhao, X. L. C7 - e88298 DB - Scopus DO - 10.1371/journal.pone.0088298 IS - 3 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2014 ST - PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia T2 - PLoS ONE TI - PTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897406427&doi=10.1371%2fjournal.pone.0088298&partnerID=40&md5=3fbc437f682668f36461155a87f4ed86 VL - 9 ID - 7530 ER - TY - JOUR AD - B.A. Croker, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, United States AU - Speir, M. AU - Nowell, C. J. AU - Chen, A. A. AU - O’Donnell, J. A. AU - Shamie, I. S. AU - Lakin, P. R. AU - D’Cruz, A. A. AU - Braun, R. O. AU - Babon, J. J. AU - Lewis, R. S. AU - Bliss-Moreau, M. AU - Shlomovitz, I. AU - Wang, S. AU - Cengia, L. H. AU - Stoica, A. I. AU - Hakem, R. AU - Kelliher, M. A. AU - O’Reilly, L. A. AU - Patsiouras, H. AU - Lawlor, K. E. AU - Weller, E. AU - Lewis, N. E. AU - Roberts, A. W. AU - Gerlic, M. AU - Croker, B. A. DB - Embase Medline DO - 10.1038/s41590-019-0550-7 IS - 1 LA - English M3 - Article N1 - L2003855269 2019-12-23 2020-01-31 PY - 2020 SN - 1529-2916 1529-2908 SP - 54-64 ST - Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation T2 - Nature Immunology TI - Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003855269&from=exporthttp://dx.doi.org/10.1038/s41590-019-0550-7 VL - 21 ID - 7531 ER - TY - JOUR AD - S. Ašikovali, Ege University, Faculty of Medicine, Department of Medical Genetics, Izmir, Turkey AU - Ašikovali, S. AU - Aykut, A. AU - Durmaz, A. AU - Onay, H. AU - Hazan, F. AU - Özen, S. AU - Atik, T. AU - Kara, C. AU - Mihçi, E. AU - Gökšen, D. DB - Embase LA - English M3 - Conference Abstract N1 - L619523526 2017-12-08 PY - 2017 SN - 1308-5735 SP - 25 ST - PTPN11, SOS1, and BRAF gene mutation spectrum in RASopathies in molecular diagnosis T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - PTPN11, SOS1, and BRAF gene mutation spectrum in RASopathies in molecular diagnosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619523526&from=export VL - 9 ID - 7532 ER - TY - JOUR AD - J. Chen, Department of Breast Surgery, Nantong Maternity and Child Health Care Hospital Affiliated to Nantong University, 399 Century Avenue, Nantong, Jiangsu, China AU - Li, Z. AU - Xu, W. AU - Ren, X. AU - Xu, J. AU - Chen, J. C2 - National Institutes for Food and Drug Control(China) DB - Embase Medline DO - 10.3892/mmr.2018.9682 IS - 1 LA - English M3 - Article N1 - L625809177 2019-01-11 2019-01-16 PY - 2019 SN - 1791-3004 1791-2997 SP - 205-212 ST - Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer T2 - Molecular Medicine Reports TI - Puerarin promotes DUSP1 expression by regulating miR-133a-3p in breast cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625809177&from=exporthttp://dx.doi.org/10.3892/mmr.2018.9682 VL - 19 ID - 7533 ER - TY - JOUR AN - 108185958. Language: English. Entry Date: 20120727. Revision Date: 20200706. Publication Type: Journal Article AU - Montani, D. AU - Bergot, E. AU - Günther, S. AU - Savale, L. AU - Bergeron, A. AU - Bourdin, A. AU - Bouvaist, H. AU - Canuet, M. AU - Pison, C. AU - Macro, M. AU - Poubeau, P. AU - Girerd, B. AU - Natali, D. AU - Guignabert, C. AU - Perros, F. AU - O'Callaghan, D. S. AU - Jaïs, X. AU - Tubert-Bitter, P. AU - Zalcman, G. AU - Sitbon, O. DB - ccm DO - 10.1161/circulationaha.111.079921 DP - EBSCOhost IS - 17 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 0147763. PMID: NLM22451584. PY - 2012 SN - 0009-7322 SP - 2128-2137 ST - Pulmonary arterial hypertension in patients treated by dasatinib T2 - Circulation TI - Pulmonary arterial hypertension in patients treated by dasatinib UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108185958&site=ehost-live&scope=site VL - 125 ID - 7534 ER - TY - JOUR AD - I.P. Giles, Centre for Rheumatology, Division of Medicine, University College London (UCL), Rayne Institute, Room 411, 5 University Street, London, United Kingdom AU - Poulton, K. AU - Ripoll, V. M. AU - Pericleous, C. AU - Meroni, P. L. AU - Gerosa, M. AU - Ioannou, Y. AU - Rahman, A. AU - Giles, I. P. DB - Embase Medline DO - 10.1111/aji.12341 IS - 5 LA - English M3 - Article N1 - L601029451 2014-12-30 2015-04-28 PY - 2015 SN - 1600-0897 1046-7408 SP - 390-401 ST - Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion T2 - American Journal of Reproductive Immunology TI - Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601029451&from=exporthttp://dx.doi.org/10.1111/aji.12341 VL - 73 ID - 7535 ER - TY - JOUR AD - Department of Medicine, Center for Patient Care and Outcomes Research, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, United States Department of Medicine, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226, United States AU - Flynn, K. E. AU - Atallah, E. DB - Scopus DO - 10.1007/s11899-016-0306-5 IS - 2 M3 - Review N1 - Cited By :19 Export Date: 18 November 2020 PY - 2016 SP - 80-85 ST - Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia T2 - Current Hematologic Malignancy Reports TI - Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958241812&doi=10.1007%2fs11899-016-0306-5&partnerID=40&md5=1be78e2e5ea07b341a2d78a50c1e2513 VL - 11 ID - 7536 ER - TY - JOUR AD - Mental Health and Behavioral Sciences, James A. Haley Veterans' Hospital, Tampa, FL, USA. AN - 104242885. Language: English. Entry Date: 20130927. Revision Date: 20200708. Publication Type: journal article AU - Phillips, Kristin M. AU - Pinilla-Ibarz, Javier AU - Sotomayor, Eduardo AU - Lee, Morgan R. AU - Jim, Heather S. L. AU - Small, Brent J. AU - Sokol, Lubomir AU - Lancet, Jeffrey AU - Tinsley, Sara AU - Sweet, Kendra AU - Komrokji, Rami AU - Jacobsen, Paul B. DB - ccm DO - 10.1007/s00520-012-1630-5 DP - EBSCOhost IS - 4 N1 - research. Journal Subset: Biomedical; Continental Europe; Double Blind Peer Reviewed; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. Special Interest: Oncologic Care. NLM UID: 9302957. PMID: NLM23179489. PY - 2013 SN - 0941-4355 SP - 1097-1103 ST - Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison T2 - Supportive Care in Cancer TI - Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104242885&site=ehost-live&scope=site VL - 21 ID - 7537 ER - TY - JOUR AD - W. Woessmann, NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany AU - Damm-Welk, C. AU - Kutscher, N. AU - Zimmermann, M. AU - Attarbaschi, A. AU - Schieferstein, J. AU - Knörr, F. AU - Oschlies, I. AU - Klapper, W. AU - Woessmann, W. DB - Embase Medline DO - 10.3324/haematol.2019.232314 IS - 8 LA - English M3 - Article N1 - L2007360970 2020-08-18 PY - 2020 SN - 1592-8721 0390-6078 SP - 2141-2149 ST - Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma T2 - Haematologica TI - Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007360970&from=exporthttp://dx.doi.org/10.3324/haematol.2019.232314 VL - 105 ID - 7538 ER - TY - JOUR AD - M. Yao, Department of Anesthesiology and Pain Research center, The Affiliated Hospital of Jiaxing University, Jiaxing, China AU - Wang, T. AU - Shen, H. AU - Deng, H. AU - Pan, H. AU - He, Q. AU - Ni, H. AU - Tao, J. AU - Liu, S. AU - Xu, L. AU - Yao, M. DB - Embase Medline DO - 10.1016/j.jprot.2020.103879 LA - English M3 - Article N1 - L2006893913 2020-07-09 2020-07-14 PY - 2020 SN - 1876-7737 1874-3919 ST - Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster T2 - Journal of Proteomics TI - Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006893913&from=exporthttp://dx.doi.org/10.1016/j.jprot.2020.103879 VL - 225 ID - 7539 ER - TY - JOUR AD - Department of Paediatric Haematology and Oncology, AP-HM, La Timone Children's Hospital, Marseille 13005, France. Department of Paediatric Neurology, AP-HM, La Timone Children's Hospital, Marseille 13005, France. Centre d'Essais Précoce en Cancérologie de Marseille, AP-HM, La Timone Children's Hospital, Marseille 13005, France. AN - 30174724 AU - Papalia, H. AU - Audic, F. AU - Rivière, G. R. AU - Verschuur, A. AU - André, N. C2 - PMC6113984 DO - 10.3332/ecancer.2018.862 10.3332/ecancer.2018.862. eCollection 2018. DP - Nlm ET - 2018/09/04 LA - eng PY - 2018 SN - 1754-6605 (Print) 1754-6605 SP - 862 ST - Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas T2 - Ecancermedicalscience TI - Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas VL - 12 ID - 7540 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. AN - 25585684 AU - Leng, R. AU - Liao, G. AU - Wang, H. AU - Kuang, J. AU - Tang, L. DA - Feb DO - 10.1007/s12032-014-0329-5 10.1007/s12032-014-0329-5. Epub 2015 Jan 14. DP - Nlm ET - 2015/01/15 IS - 2 LA - eng PY - 2015 SN - 1357-0560 SP - 329 ST - Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome T2 - Med Oncol TI - Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome VL - 32 ID - 7541 ER - TY - JOUR AD - P. Fang, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, United States AU - Fang, P. AU - Jiang, W. AU - Allen, P. AU - Glitza, I. AU - Guha, N. AU - Hwu, P. AU - Ghia, A. AU - Phan, J. AU - Mahajan, A. AU - Tawbi, H. AU - Li, J. DB - Embase Medline DO - 10.1007/s11060-017-2470-4 IS - 3 LA - English M3 - Article N1 - L616187158 2017-05-19 2017-08-14 PY - 2017 SN - 1573-7373 0167-594X SP - 595-602 ST - Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma T2 - Journal of Neuro-Oncology TI - Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616187158&from=exporthttp://dx.doi.org/10.1007/s11060-017-2470-4 VL - 133 ID - 7542 ER - TY - JOUR AD - C. Posch, Rudolfstiftung Hospital, Dermatology, Vienna, Austria AU - Posch, C. AU - Steffal, C. AU - Haider, A. AU - Flechl, B. AU - Kann, T. AU - Weihsengruber, F. AU - Schratter-Sehn, A. U. DB - Embase DO - 10.1097/CMR.0000000000000285 LA - English M3 - Conference Abstract N1 - L612247953 2016-09-26 PY - 2016 SN - 1473-5636 SP - e46 ST - Radiation therapy in melanoma patients with poor clinical characteristics-a collaborative experience with 107 patients T2 - Melanoma Research TI - Radiation therapy in melanoma patients with poor clinical characteristics-a collaborative experience with 107 patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612247953&from=exporthttp://dx.doi.org/10.1097/CMR.0000000000000285 VL - 26 ID - 7543 ER - TY - JOUR AD - J. Gao, Department of Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, 1 Jianshe East Rd, Henan, China AU - Tan, H. AU - Wang, B. AU - Xiao, H. AU - Lian, Y. AU - Gao, J. C1 - magnevist(Schering,Germany) ultravist(Schering) C2 - Schering Schering(Germany) DB - Embase Medline DO - 10.1097/RCT.0000000000000444 IS - 1 LA - English M3 - Article N1 - L610529405 2016-06-03 2017-01-31 PY - 2017 SN - 1532-3145 0363-8715 SP - 90-97 ST - Radiologic and clinicopathologic findings of inflammatory myofibroblastic tumor T2 - Journal of Computer Assisted Tomography TI - Radiologic and clinicopathologic findings of inflammatory myofibroblastic tumor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610529405&from=exporthttp://dx.doi.org/10.1097/RCT.0000000000000444 VL - 41 ID - 7544 ER - TY - JOUR AD - Department of Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, University of Hull, Hull, United Kingdom Department of Oncology, Castle Hill Hospital, Hull and East Yorkshire Hospitals Trust, Hull, United Kingdom AU - Sathyapalan, T. AU - Dixit, S. DB - Scopus DO - 10.1586/era.12.27 IS - 5 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 669-683 ST - Radiotherapy-induced hypopituitarism: A review T2 - Expert Review of Anticancer Therapy TI - Radiotherapy-induced hypopituitarism: A review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861308420&doi=10.1586%2fera.12.27&partnerID=40&md5=17ad2d787b94b1899a14d579ee10a2c6 VL - 12 ID - 7545 ER - TY - JOUR AD - T. Forshew, Queen Mary University of London, Centre for Neuroscience and Trauma, Barts and the London School of Medicine and Dentistry, London El 2AT, United Kingdom AU - Lawson, A. R. J. AU - Tatevossian, R. G. AU - Phipps, K. P. AU - Picker, S. R. AU - Michalski, A. AU - Sheer, D. AU - Jacques, T. S. AU - Forshew, T. DB - Embase Medline DO - 10.1007/s00401-010-0693-y IS - 2 LA - English M3 - Note N1 - L50904185 2010-05-19 2010-12-02 PY - 2010 SN - 0001-6322 SP - 271-273 ST - RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort T2 - Acta Neuropathologica TI - RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50904185&from=exporthttp://dx.doi.org/10.1007/s00401-010-0693-y VL - 120 ID - 7546 ER - TY - JOUR AD - N. Rosen, Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, United States AU - Joseph, E. W. AU - Pratilas, C. A. AU - Poulikakos, P. I. AU - Tadi, M. AU - Wang, W. AU - Taylor, B. S. AU - Halilovic, E. AU - Persaud, Y. AU - Xing, F. AU - Viale, A. AU - Tsai, J. AU - Chapman, P. B. AU - Bollag, G. AU - Solit, D. B. AU - Rosen, N. C1 - pd 0325901 plx 4032 DB - Embase Medline DO - 10.1073/pnas.1008990107 IS - 33 L1 - internal-pdf://2624151020/14903.full.pdf LA - English M3 - Article N1 - L359663606 2010-10-05 2010-10-12 PY - 2010 SN - 0027-8424 1091-6490 SP - 14903-14908 ST - The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner T2 - Proceedings of the National Academy of Sciences of the United States of America TI - The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359663606&from=exporthttp://dx.doi.org/10.1073/pnas.1008990107 VL - 107 ID - 7547 ER - TY - JOUR AD - M. Merad, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States AU - Hogstad, B. AU - Berres, M. L. AU - Chakraborty, R. AU - Tang, J. AU - Bigenwald, C. AU - Serasinghe, M. AU - Lim, K. P. H. AU - Lin, H. AU - Man, T. K. AU - Remark, R. AU - Baxter, S. AU - Kana, V. AU - Jordan, S. AU - Karoulia, Z. AU - Kwan, W. H. AU - Leboeuf, M. AU - Brandt, E. AU - Salmon, H. AU - McClain, K. AU - Poulikakos, P. AU - Chipuk, J. AU - Mulder, W. J. M. AU - Allen, C. E. AU - Merad, M. C1 - abt 263 gsk 1120212 DB - Embase Medline DO - 10.1084/jem.20161881 IS - 1 LA - English M3 - Article N1 - L620086797 2018-01-11 2018-01-12 PY - 2018 SN - 1540-9538 0022-1007 SP - 319-336 ST - RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions T2 - Journal of Experimental Medicine TI - RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620086797&from=exporthttp://dx.doi.org/10.1084/jem.20161881 VL - 215 ID - 7548 ER - TY - JOUR AD - Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea. Department of Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. Electronic address: ejseo@amc.seoul.kr. AN - 24613277 AU - Lim, J. H. AU - Jang, S. AU - Park, C. J. AU - Cho, Y. U. AU - Lee, J. H. AU - Lee, K. H. AU - Lee, J. O. AU - Shin, J. Y. AU - Kim, J. I. AU - Huh, J. AU - Seo, E. J. DA - Jan-Feb DO - 10.1016/j.cancergen.2013.12.003 10.1016/j.cancergen.2013.12.003. Epub 2014 Jan 21. DP - Nlm ET - 2014/03/13 IS - 1-2 LA - eng PY - 2014 SN - 2210-7762 (Print) SP - 40-5 ST - RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia T2 - Cancer Genet TI - RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia VL - 207 ID - 7549 ER - TY - JOUR AD - Department of Hematology, Oncology of the University Hospitals, Frankfurt, Germany Department of Hematology, Oncology of the University Hospitals, Tübingen, Germany Department of Hematology, Oncology of the University Hospitals, Heidelberg, Germany Department of Hematology, Oncology of the University Hospitals, Dresden, Germany Department of Hematology, Hemostasis, Oncology, Stem Cell Transplantation, Hannover Medical School, Hannover, Germany Department of Bone Marrow Transplantation, Westdeutsches Tumorzentrum, Universitätsklinikum Essen, Essen, Germany Department of Hematology, Oncology of the University Hospitals, Leipzig, Germany Department of Hematology, Oncology of the University Hospitals, Berlin, Germany Department of Hematology, Oncology of the University Hospitals, Münster, Germany Department of Bone Marrow Transplantation, Medizinische Klinik 5 des Klinikum Nürnberg Nord, Nürnberg, Germany Deutsche Klinik für Diagnostik, Wiesbaden, Germany Evangelisches Krankenhaus Hamm, Germany Department of Hematology and Oncology, Universitätsklinikum des Saarlandes, Homburg Saar, Germany Medizinische Klinik und Poliklinik, Uni-Klinikum Campus Kiel II, Kiel, Germany Sektion Stammzell und Immuntherapie im Dr Mildred-Scheel-Haus, Klinik für Innere Medizin i, Uni-Klinikum Campus Kiel, Kiel, Germany AU - Pfeifer, H. AU - Wassmann, B. AU - Bethge, W. AU - Dengler, J. AU - Bornhäuser, M. AU - Stadler, M. AU - Beelen, D. AU - Vucinic, V. AU - Burmeister, T. AU - Stelljes, M. AU - Faul, C. AU - Dreger, P. AU - Kiani, A. AU - Schäfer-Eckart, K. AU - Schwerdtfeger, R. AU - Lange, E. AU - Kubuschok, B. AU - Horst, H. A. AU - Gramatzki, M. AU - Brück, P. AU - Serve, H. AU - Hoelzer, D. AU - Gökbuget, N. AU - Ottmann, O. G. DB - Scopus DO - 10.1038/leu.2012.352 IS - 6 M3 - Article N1 - Cited By :127 Export Date: 18 November 2020 PY - 2013 SP - 1254-1262 ST - Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia T2 - Leukemia TI - Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878915659&doi=10.1038%2fleu.2012.352&partnerID=40&md5=7468369177a154a45532d4fb66547038 VL - 27 ID - 7550 ER - TY - JOUR AD - Medical Oncology Service, Hospital Universitario Central de Asturias, C/Celestino Villamil s/n, 33006 Oviedo, Spain Department of Medical Oncology, Hospital Juan Canalejo, A Coruña, Spain Department of Medical Oncology, Hospital de Cabueñes, Gijón, Spain Department of Medical Oncology, Hospital de León, León, Spain Department of Medical Oncology, University Clinic of Navarra, Pamplona, Spain Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain Department of Medical Oncology, Hospital General Yagüe, Burgos, Spain AstraZeneca, Madrid, Spain AU - Viéitez, J. M. AU - Valladares, M. AU - Peláez, I. AU - De Sande González, L. AU - García-Foncillas, J. AU - García-López, J. L. AU - García-Girón, C. AU - Reboredo, M. AU - Bovio, H. AU - Lacave, A. J. DB - Scopus DO - 10.1007/s10637-010-9400-z IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 1038-1044 ST - A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143) T2 - Investigational New Drugs TI - A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856077157&doi=10.1007%2fs10637-010-9400-z&partnerID=40&md5=2de8936789b3b6df9a80ab902f6866b3 VL - 29 ID - 7551 ER - TY - JOUR AD - Department of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, 1090, Belgium Department of Medical and Radiation Oncology, AZ Sint-Lucas Gent, Ghent, Belgium Department of Medical Oncology, CHU Liège, Liège, Belgium Department of Medical Oncology, GHDC, Charleroi, Belgium Department of Medical Oncology, ZNA Middelheim, Antwerp, Belgium Department of Neurosurgery, CHU Charleroi, Charleroi, Belgium Department of Pathology, Hopital Erasme Université Libre de Bruxelles, Brussels, Belgium Department of Psychiatry, CHU Brugmann, Brussels, Belgium Departments of Pathology and Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium AU - Duerinck, J. AU - Du Four, S. AU - Bouttens, F. AU - Andre, C. AU - Verschaeve, V. AU - Van Fraeyenhove, F. AU - Chaskis, C. AU - D’Haene, N. AU - Le Mercier, M. AU - Rogiers, A. AU - Michotte, A. AU - Salmon, I. AU - Neyns, B. DB - Scopus DO - 10.1007/s11060-017-2629-z IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 115-125 ST - Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma T2 - Journal of Neuro-Oncology TI - Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030699211&doi=10.1007%2fs11060-017-2629-z&partnerID=40&md5=8af11decc7b5546debb909873cb0f86d VL - 136 ID - 7552 ER - TY - JOUR AD - Division of Hematology, Department of Medical Specialties, University Hospital and University of Geneva, Geneva, Switzerland Swiss Group for Clinical Cancer Research, Bern, Switzerland Division of Hematology, Hospices Civils de Lyon, Switzerland Division of Hematology, Hôpital Saint-Louis, University Paris Diderot, Paris, France Division of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Division of Hematology, Institut Universitaire de Cancérologie, Toulouse, France Division of Hematology, Hôpital Haut-Levêque, Pessac, France Division of Hematology, Hôpital Mignot, Versailles, France Division of Hematology, Centre Henri Becquerel, Rouen, France Division of Hematology, Hôpital Pontchailloux, Rennes, France Division of Hematology, Hôpital Henri Mondor, University Paris Est Créteil, Créteil, France Division of Hematology, Hôpital Claude Huriez, Lille, France Division of Hematology, Institut de Cancérologie Lucien-Neuwirth, Saint-Priest-en-Jarez, France Division of Hematology, Hôpital de la Timone, Marseille, France Group for Research on Adult Acute Lymphoblastic Leukemia, Lyon, France Division of Biostatistics, Hôpital Saint-Louis, University Paris Diderot, Paris, France Division of Hematology, Centre Hospitalier Universitaire d'Angers And, INSERM U892, Angers, France AU - Chalandon, Y. AU - Thomas, X. AU - Hayette, S. AU - Cayuela, J. M. AU - Abbal, C. AU - Huguet, F. AU - Raffoux, E. AU - Leguay, T. AU - Rousselot, P. AU - Lepretre, S. AU - Escoffre-Barbe, M. AU - Maury, S. AU - Berthon, C. AU - Tavernier, E. AU - Lambert, J. F. AU - Lafage-Pochitaloff, M. AU - Lhéritier, V. AU - Chevret, S. AU - Ifrah, N. AU - Dombret, H. AU - Group for Research on Adult Acute Lymphoblastic, Leukemia DB - Scopus DO - 10.1182/blood-2015-02-627935 IS - 24 M3 - Article N1 - (GRAALL) Cited By :156 Export Date: 18 November 2020 PY - 2015 SP - 3711-3719 ST - Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia T2 - Blood TI - Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930352842&doi=10.1182%2fblood-2015-02-627935&partnerID=40&md5=103006e9194489b16225131e7c565436 VL - 125 ID - 7553 ER - TY - JOUR AD - Division of Pathogenic Biochemistry, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan 21st Century COE Program, University of Toyama, Toyama 930-0194, Japan Department of Microbiology, SORST, Kinki University School of Medicine, Osaka 589-8511, Japan AU - Nakamura, E. S. AU - Koizumi, K. AU - Kobayashi, M. AU - Saitoh, Y. AU - Arita, Y. AU - Nakayama, T. AU - Sakurai, H. AU - Yoshie, O. AU - Saiki, I. DB - Scopus DO - 10.1007/s10585-006-9006-1 IS - 1 M3 - Article N1 - Cited By :78 Export Date: 18 November 2020 PY - 2006 SP - 9-18 ST - RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 T2 - Clinical and Experimental Metastasis TI - RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750073849&doi=10.1007%2fs10585-006-9006-1&partnerID=40&md5=1f4b1d0409d6b19c0e8c60220eb0a6ed VL - 23 ID - 7554 ER - TY - JOUR AD - Dept. of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Japan Division of Haematology, Respiratory Medicine, and Oncology, Faculty of Medicine, Saga University, Saga 849-8501, Japan Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine, Japan Department of Haematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan Division of Haematology and Oncology, Narita Red Cross Hospital, Japan Division of Oncology and Haematology, National Cancer Centre Hospital East, Japan Department of Oncology and Haematology, The Jikei University Kashiwa Hospital, Japan Department of Haematology, Japanese Red Cross Medical Centre, Japan Department of Haematology, Johann Wolfgang Goethe-Universitat, Frankfurt, Germany Department of Haematology, Centre for Cancer Biology SA Pathology, Adelaide, Australia AU - Tanaka, R. AU - Kimura, S. AU - Ashihara, E. AU - Yoshimura, M. AU - Takahashi, N. AU - Wakita, H. AU - Itoh, K. AU - Nishiwaki, K. AU - Suzuki, K. AU - Nagao, R. AU - Yao, H. AU - Hayashi, Y. AU - Satake, S. AU - Hirai, H. AU - Sawada, K. I. AU - Ottmann, O. G. AU - Melo, J. V. AU - Maekawa, T. DB - Scopus DO - 10.1016/j.canlet.2011.08.009 IS - 2 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2011 SP - 228-234 ST - Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients T2 - Cancer Letters TI - Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053987395&doi=10.1016%2fj.canlet.2011.08.009&partnerID=40&md5=250b53a533a4e44d987fae9b435e5b8d VL - 312 ID - 7555 ER - TY - JOUR AD - Department of Medicine, Division of Medical Oncology, Washington University School of Medicine Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Division of Neuropathology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri AN - 29295876 AU - Johanns, T. M. AU - Ferguson, C. J. AU - Grierson, P. M. AU - Dahiya, S. AU - Ansstas, G. DA - Jan DO - 10.6004/jnccn.2017.7032 10.6004/jnccn.2017.7032. DP - Nlm ET - 2018/01/04 IS - 1 LA - eng PY - 2018 SN - 1540-1405 SP - 4-10 ST - Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma T2 - J Natl Compr Canc Netw TI - Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF-Mutated High-Grade Glioma VL - 16 ID - 7556 ER - TY - JOUR AD - Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan. AN - 23792105 AU - Chang, Y. S. AU - Lin, I. L. AU - Yeh, K. T. AU - Chang, J. G. DA - Oct DO - 10.1016/j.clinbiochem.2013.06.005 10.1016/j.clinbiochem.2013.06.005. Epub 2013 Jun 20. DP - Nlm ET - 2013/06/25 IS - 15 LA - eng PY - 2013 SN - 0009-9120 SP - 1572-7 ST - Rapid detection of K-, N-, H-RAS, and BRAF hotspot mutations in thyroid cancer using the multiplex primer extension T2 - Clin Biochem TI - Rapid detection of K-, N-, H-RAS, and BRAF hotspot mutations in thyroid cancer using the multiplex primer extension VL - 46 ID - 7557 ER - TY - JOUR AD - Université de Lorraine, CNRS UMR7039 CRAN, Institut de Cancérologie de Lorraine, Service de Biopathologie, Vandoeuvre-lès- Nancy, France. Université de Lorraine, CNRS UMR7039 CRAN, Centre Hospitalier Régional Universitaire (CHRU), Hôpital d'enfants, Service d'Oncologie Pédiatrique, Vandoeuvre-lès-Nancy, France. Service d'Oncologie Pédiatrique, Institut Curie, Paris, France. Service de Neuropathologie, Centre Hospitalier St Anne, Paris, France. Université de Lorraine, INSERM UMRS954 NGERE, Service d'Anatomie Pathologique, CHRU Nancy, Vandoeuvre-lès- Nancy, France. AN - 31642744 AU - Merlin, M. S. AU - Gilson, P. AU - Rouyer, M. AU - Chastagner, P. AU - Doz, F. AU - Varlet, P. AU - Leroux, A. AU - Gauchotte, G. AU - Merlin, J. L. DA - Feb DO - 10.1080/08880018.2019.1679304 10.1080/08880018.2019.1679304. Epub 2019 Oct 23. DP - Nlm ET - 2019/10/24 IS - 1 LA - eng PY - 2020 SN - 0888-0018 SP - 29-40 ST - Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas T2 - Pediatr Hematol Oncol TI - Rapid fully-automated assay for routine molecular diagnosis of BRAF mutations for personalized therapy of low grade gliomas VL - 37 ID - 7558 ER - TY - JOUR AD - Haematology, Department of Cellular Biotechnologies and Haematology, “Sapienza” University, Rome, Italy GIMEMA Data Centre, GIMEMA Foundation, Rome, Italy Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, United States Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, United States Institute of Haematology, Centro Ricerche Onco-Ematologiche (CREO), University of Perugia, Perugia, Italy Department of Paediatric Haematology/Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Institute of Haematology and Blood Transfusion, Prague, Czech Republic Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Molecular Medicine, “Sapienza” University, Rome, Italy AU - Chiaretti, S. AU - Messina, M. AU - Grammatico, S. AU - Piciocchi, A. AU - Fedullo, A. L. AU - Di Giacomo, F. AU - Peragine, N. AU - Gianfelici, V. AU - Lauretti, A. AU - Bareja, R. AU - Martelli, M. P. AU - Vignetti, M. AU - Apicella, V. AU - Vitale, A. AU - Li, L. S. AU - Salek, C. AU - Elemento, O. AU - Inghirami, G. AU - Weinstock, D. M. AU - Guarini, A. AU - Foà, R. DB - Scopus DO - 10.1111/bjh.15251 IS - 5 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2018 SP - 642-652 ST - Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications T2 - British Journal of Haematology TI - Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047562389&doi=10.1111%2fbjh.15251&partnerID=40&md5=2e07e4618ec43f14acfd1930ae19bbeb VL - 181 ID - 7559 ER - TY - JOUR AD - National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China Sano Suzhou Precision Medicine Co., Ltd, Suzhou, China Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States AU - Dai, H. P. AU - Yin, J. AU - Li, Z. AU - Yang, C. X. AU - Cao, T. AU - Chen, P. AU - Zong, Y. H. AU - Zhu, M. Q. AU - Zhu, X. M. AU - Xiao, S. AU - Wu, D. P. AU - Tang, X. W. C7 - 359 DB - Scopus DO - 10.3389/fonc.2020.00359 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion T2 - Frontiers in Oncology TI - Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083055764&doi=10.3389%2ffonc.2020.00359&partnerID=40&md5=078cbc4d4df57455cf8832cb185b1429 VL - 10 ID - 7560 ER - TY - JOUR AD - N. Maximova, Bone Marrow Transplant Unit, Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy AU - Maximova, N. AU - Maestro, A. AU - Zanon, D. AU - Marcuzzi, A. DB - Embase Medline DO - 10.1136/jitc-2019-000388 IS - 1 LA - English M3 - Article N1 - L630969054 2020-04-13 2020-04-29 PY - 2020 SN - 2051-1426 ST - Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration T2 - Journal for ImmunoTherapy of Cancer TI - Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630969054&from=exporthttp://dx.doi.org/10.1136/jitc-2019-000388 VL - 8 ID - 7561 ER - TY - JOUR AD - K. Gomes, Centre for Children's Cancer and Blood Disorders, Sydney Children's Hospital, Randwick, Sydney, NSW, Australia AU - Gomes, K. AU - Sugo, E. AU - Barbaric, D. AU - Trahair, T. DB - Embase DO - 10.1111/ajco.12030 LA - English M3 - Conference Abstract N1 - L70911116 2012-11-06 PY - 2012 SN - 1743-7555 SP - 300 ST - Rapid regression of life threatening alk positive epithelioid inflammatory myofibroblastic sarcoma following single agent crizotinib therapy T2 - Asia-Pacific Journal of Clinical Oncology TI - Rapid regression of life threatening alk positive epithelioid inflammatory myofibroblastic sarcoma following single agent crizotinib therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70911116&from=exporthttp://dx.doi.org/10.1111/ajco.12030 VL - 8 ID - 7562 ER - TY - JOUR AD - A. Suleymanova, National Research Center of Pediatric Hematology, Oncology and Immunology Named after Dmitry Rogachev, Clinical Oncology, Moscow, Russian Federation AU - Suleymanova, A. AU - Imyanitov, E. AU - Roschin, V. AU - Shamanskaya, T. AU - Olshanskaya, Y. AU - Kazakova, A. AU - Mitiushkina, N. AU - Preobrazhenskaya, E. AU - Kachanov, D. AU - Varfolomeeva, S. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624180027 2018-10-11 PY - 2018 SN - 1545-5017 SP - S388 ST - Rapid response to crizotinib in 3-year-old boy with ros1-rearranged inflammatory myofibroblastic tumor of the stomach T2 - Pediatric Blood and Cancer TI - Rapid response to crizotinib in 3-year-old boy with ros1-rearranged inflammatory myofibroblastic tumor of the stomach UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624180027&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 7563 ER - TY - JOUR AD - M. Pawar, Department of Dermatology, Dr. Vasantrao Pawar Medical College, Hospital and Research Center, Nashik, Maharashtra, India AU - Shah, M. AU - Pawar, M. AU - Zawar, V. DB - Embase Medline DO - 10.15570/actaapa.2018.7 IS - 1 LA - English M3 - Article N1 - L621565699 2018-04-11 2018-10-11 PY - 2018 SN - 1581-2979 1318-4458 SP - 33-34 ST - A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma T2 - Acta Dermatovenerologica Alpina, Pannonica et Adriatica TI - A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621565699&from=exporthttp://dx.doi.org/10.15570/actaapa.2018.7 VL - 27 ID - 7564 ER - TY - JOUR AD - M.A. Davare, Division of Pediatric Hematology/Oncology, Department of Pediatrics, Pape Pediatric Research Institute, Oregon Health and Sciences University, Portland, OR, United States AU - Davare, M. A. AU - Henderson, J. J. AU - Agarwal, A. AU - Wagner, J. P. AU - Iyer, S. R. AU - Shah, N. AU - Woltjer, R. AU - Somwar, R. AU - Gilheeney, S. W. AU - DeCarvalo, A. AU - Mikkelson, T. AU - Van Meir, E. G. AU - Ladanyi, M. AU - Druker, B. J. C1 - pf 06463922 rxdx 101 xl 184 xl 880 DB - Embase Medline DO - 10.1158/1078-0432.CCR-18-1052 IS - 24 LA - English M3 - Article N1 - L625427861 2018-12-20 2018-12-27 PY - 2018 SN - 1557-3265 1078-0432 SP - 6471-6482 ST - Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma T2 - Clinical Cancer Research TI - Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625427861&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-18-1052 VL - 24 ID - 7565 ER - TY - JOUR AD - Department of Pathology, Kasturba Medical College, Mangalore, Manipal University, Manipal, India. AN - 26458652 AU - Sridevi, H. B. AU - Shanthala, P. R. AU - Raghuveer, C. V. AU - Prabhu, A. K. AU - Akbar, J. K. AU - Shivaprasad, G. S. AU - Suresh, P. K. AU - Navani, S. DA - Jul-Sep DO - 10.4103/0973-1482.139338 10.4103/0973-1482.139338. DP - Nlm ET - 2015/10/16 IS - 3 LA - eng PY - 2015 SN - 1998-4138 SP - 656 ST - A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult T2 - J Cancer Res Ther TI - A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult VL - 11 ID - 7566 ER - TY - JOUR AD - G. Haebich, Princess of Wales Hospital, Bridgend, United Kingdom AU - Haebich, G. AU - Pilz, D. AU - Li, V. DB - Embase DO - 10.1111/bjd.17890 LA - English M3 - Conference Abstract N1 - L628868442 2019-08-14 PY - 2019 SN - 1365-2133 SP - 82 ST - A rare case of mutation-positive cardiofaciocutaneous syndrome with associated multiple epidermoid cysts T2 - British Journal of Dermatology TI - A rare case of mutation-positive cardiofaciocutaneous syndrome with associated multiple epidermoid cysts UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628868442&from=exporthttp://dx.doi.org/10.1111/bjd.17890 VL - 181 ID - 7567 ER - TY - JOUR AD - Department of Pathology & Immunology, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX, United States Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX, United States AU - Huho, A. N. AU - Issaq, N. AU - Iacobas, I. AU - Elghetany, T. M. AU - López-Terrada, D. AU - Fisher, K. E. AU - Punia, J. N. DB - Scopus DO - 10.1177/1093526617698601 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 100-104 ST - A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis T2 - Pediatric and Developmental Pathology TI - A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041574454&doi=10.1177%2f1093526617698601&partnerID=40&md5=814ad2c31295631b26f28481b5ee4cf4 VL - 21 ID - 7568 ER - TY - JOUR AD - Department of Hematology, Ankara University School of Medicine, Ankara, Turkey AU - Atilla, E. AU - Topcuoglu, P. AU - Ataca, P. AU - Pekcan, G. AU - Bozdag, S. C. AU - Yuksel, M. K. AU - Ozcan, M. AU - Gurman, G. AU - Toprak, S. K. DB - Scopus DO - 10.1111/ctr.12741 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2016 SP - 669-672 ST - A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis T2 - Clinical Transplantation TI - A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010670346&doi=10.1111%2fctr.12741&partnerID=40&md5=7ac51b5f39fa71e74f9d962e6f0d659f VL - 30 ID - 7569 ER - TY - JOUR AD - Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais-UFMG, Belo Horizonte, MG, Brazil International Center for Research - CIPE, A. C. Camargo Cancer Center, São Paulo, SP, Brazil Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia – UnB, Brasilia, DF, Brazil Clinical Genetics Department and Institute of Regional Health, University of Southern Denmark, Odense, Denmark Urology Department, Faculty of Medicine, UNESP, Botucatu, SP, Brazil Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Geras-UFMG, Belo Horizonte, MG, Brazil AU - Diniz, M. G. AU - Duarte, A. P. AU - Villacis, R. A. AU - Guimarães, B. V. A. AU - Duarte, L. C. P. AU - Rogatto, S. R. AU - Gomez, R. S. AU - Gomes, C. C. DB - Scopus DO - 10.1111/jop.12505 IS - 5 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 371-376 ST - Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis T2 - Journal of Oral Pathology and Medicine TI - Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991660125&doi=10.1111%2fjop.12505&partnerID=40&md5=cc67bdc0da656ed5115f2e07718c8ab2 VL - 46 ID - 7570 ER - TY - JOUR AD - M. Minkov, Dept. Pediatrics, Neonatology and Adolescent Medicine, Juchgasse 25, Vienna, Austria AU - Minkov, M. DB - Embase IS - 4 LA - English M3 - Review N1 - L2001650688 2019-04-09 2019-04-11 PY - 2018 SN - 2008-4595 SP - 101-107 ST - The “rare” or “non-lch” histiocytic disorders in childhood: A brief overview T2 - Iranian Journal of Blood and Cancer TI - The “rare” or “non-lch” histiocytic disorders in childhood: A brief overview UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001650688&from=export VL - 10 ID - 7571 ER - TY - JOUR AD - I. Brcic, Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, Graz, Austria AU - Szurian, K. AU - Till, H. AU - Amerstorfer, E. AU - Hinteregger, N. AU - Mischinger, H. J. AU - Liegl-Atzwanger, B. AU - Brcic, I. DB - Embase Medline DO - 10.3748/wjg.v23.i31.5817 IS - 31 LA - English M3 - Article N1 - L617954728 2017-08-29 2018-05-28 PY - 2017 SN - 2219-2840 1007-9327 SP - 5817-5822 ST - Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases T2 - World Journal of Gastroenterology TI - Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617954728&from=exporthttp://dx.doi.org/10.3748/wjg.v23.i31.5817 VL - 23 ID - 7572 ER - TY - JOUR AD - C.M. Niemeyer, Department of Pediatric Hematology and Oncology, Universitätsklinikum Freiburg, Germany AU - Niemeyer, C. M. DB - Embase Medline DO - 10.3324/haematol.2014.114595 IS - 11 LA - English M3 - Review N1 - L600330070 2014-11-11 2014-11-19 PY - 2014 SN - 1592-8721 0390-6078 SP - 1653-1662 ST - RAS diseases in children T2 - Haematologica TI - RAS diseases in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600330070&from=exporthttp://dx.doi.org/10.3324/haematol.2014.114595 VL - 99 ID - 7573 ER - TY - JOUR AD - I.S. Jerchel AU - Jerchel, I. S. AU - Hoogkamer, A. Q. AU - Ariës, I. M. AU - Steeghs, E. M. P. AU - Boer, J. M. AU - Besselink, N. J. M. AU - Boeree, A. AU - Van De Ven, C. AU - De Groot-Kruseman, H. A. AU - De Haas, V. AU - Horstmann, M. A. AU - Escherich, G. AU - Stam, R. W. AU - Zwaan, C. M. AU - Cuppen, E. AU - Koudijs, M. J. AU - Pieters, R. AU - Den Boer, M. L. DB - Embase IS - 22 LA - English M3 - Conference Abstract N1 - L614246633 2017-02-03 PY - 2016 SN - 1528-0020 ST - RAS pathway mutations as predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia T2 - Blood TI - RAS pathway mutations as predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614246633&from=export VL - 128 ID - 7574 ER - TY - JOUR AD - C. Yu, Prenatal Diagnosis Center, Hubei Maternal and Child Hospital, 745 Wuluo Road, Wuhan, Hubei, China AU - Huang, Z. AU - Wang, R. AU - Wei, G. AU - Jiang, R. AU - Zheng, Y. AU - Tian, Y. AU - Chen, B. AU - Ye, C. AU - Xue, M. AU - Yu, C. DB - Embase DO - 10.3892/ol.2017.6648 IS - 3 LA - English M3 - Article N1 - L617554952 2017-08-02 2017-08-04 PY - 2017 SN - 1792-1082 1792-1074 SP - 3839-3845 ST - RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α T2 - Oncology Letters TI - RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617554952&from=exporthttp://dx.doi.org/10.3892/ol.2017.6648 VL - 14 ID - 7575 ER - TY - JOUR AD - B. Kerr, University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom AU - Burkitt Wright, E. M. M. AU - Kerr, B. DB - Embase Medline DO - 10.1136/adc.2009.160069 IS - 9 LA - English M3 - Review N1 - L359374104 2010-08-26 2010-09-02 PY - 2010 SN - 0003-9888 1468-2044 SP - 724-730 ST - RAS-MAPK pathway disorders: Important causes of congenital heart disease, feeding difficulties, developmental delay and short stature T2 - Archives of Disease in Childhood TI - RAS-MAPK pathway disorders: Important causes of congenital heart disease, feeding difficulties, developmental delay and short stature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359374104&from=exporthttp://dx.doi.org/10.1136/adc.2009.160069http://adc.bmj.com/content/95/9/724.full.pdf VL - 95 ID - 7576 ER - TY - JOUR AD - T. Shinjyo, Department of Endocrinoiogy and Metabolism, Department of Internal Medicine, University of Ryukyus, Nakagami-Nishihara, Okinawa 903-0215, Japan AU - Shinjyo, T. AU - Kurosawa, H. AU - Miyagi, J. I. AU - Ohama, K. AU - Masuda, M. AU - Nagasaki, A. AU - Matsui, H. AU - Inaba, T. AU - Furukawa, Y. AU - Takasu, N. DB - Embase Medline DO - 10.1620/tjem.216.25 IS - 1 LA - English M3 - Article N1 - L352525891 2008-10-31 PY - 2008 SN - 0040-8727 1349-3329 SP - 25-34 ST - Ras-mediated up-regulation of survivin expression in cytokine-dependent murine pro-B lymphocytic cells T2 - Tohoku Journal of Experimental Medicine TI - Ras-mediated up-regulation of survivin expression in cytokine-dependent murine pro-B lymphocytic cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352525891&from=exporthttp://dx.doi.org/10.1620/tjem.216.25http://www.jstage.jst.go.jp/article/tjem/216/1/25/_pdf VL - 216 ID - 7577 ER - TY - JOUR AD - H. Chen, Department of Gastroenterology, Zhongda Hospital, Southeast University, Nanjing, 210009 Jiangsu, China AU - Chen, H. AU - Cheng, Z. Y. AU - Pan, Y. AU - Wang, Z. AU - Liu, Y. AU - Zhang, J. Q. DB - Embase Medline DO - 10.1007/s13577-014-0090-2 IS - 3 LA - English M3 - Article N1 - L53008625 2014-02-24 2014-07-25 PY - 2014 SN - 1749-0774 0914-7470 SP - 103-110 ST - RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway T2 - Human Cell TI - RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53008625&from=exporthttp://dx.doi.org/10.1007/s13577-014-0090-2 VL - 27 ID - 7578 ER - TY - GEN AD - K.A. Rauen, Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, United States AU - Rauen, K. A. C5 - 23875798 DB - Embase Medline DO - 10.1146/annurev-genom-091212-153523 J2 - Annu. Rev. Genomics Hum. Genet. LA - English M1 - (Rauen K.A., rauenk@peds.ucsf.edu) Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, United States M3 - Review N1 - L369839424 2013-09-26 2013-09-30 PY - 2013 SN - 1527-8204 1545-293X SP - 355-369 ST - The RASopathies TI - The RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369839424&from=exporthttp://dx.doi.org/10.1146/annurev-genom-091212-153523 VL - 14 ID - 7579 ER - TY - JOUR AN - 24156711 AU - Cizmarova, M. AU - Kostalova, L. AU - Pribilincova, Z. AU - Lasabova, Z. AU - Hlavata, A. AU - Kovacs, L. AU - Ilencikova, D. DA - Oct DO - 10.4149/endo_2013_04_217 10.4149/endo_2013_04_217. DP - Nlm ET - 2013/10/26 IS - 4 LA - eng PY - 2013 SN - 1210-0668 (Print) 1210-0668 SP - 217-22 ST - Rasopathies - dysmorphic syndromes with short stature and risk of malignancy T2 - Endocr Regul TI - Rasopathies - dysmorphic syndromes with short stature and risk of malignancy VL - 47 ID - 7580 ER - TY - JOUR AD - N. Bezniakow AU - Bezniakow, N. AU - Gos, M. AU - Obersztyn, E. DB - Medline IS - 3 LA - English M3 - Review N1 - L373970811 2014-10-17 PY - 2014 SN - 1428-345X SP - 285-296 ST - The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes T2 - Developmental period medicine TI - The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373970811&from=export VL - 18 ID - 7581 ER - TY - JOUR AD - Pediatrics Department, Miguel Servet Children's Hospital, Isabel la Católica Avenue 1-3, 50009, Zaragoza, Spain. irenebaquedano.l@gmail.com. Clinical Genetics and Assisted Reproduction, Clinical Biochemistry Department, Miguel Servet Hospital, Padre Arrupe Street, 50009, Zaragoza, Spain. Neonatology Department, Miguel Servet Children's Hospital, Isabel la Católica Avenue 1-3, 50009, Zaragoza, Spain. AN - 30953504 AU - Baquedano Lobera, I. AU - Izquierdo Álvarez, S. AU - Oliván Del Cacho, M. J. C2 - PMC6449997 DA - Apr 5 DO - 10.1186/s12887-019-1463-1 10.1186/s12887-019-1463-1. DP - Nlm ET - 2019/04/07 IS - 1 LA - eng PY - 2019 SN - 1471-2431 SP - 92 ST - Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient T2 - BMC Pediatr TI - Rasopathies case report: concurrence of two pathogenic variations de novo in NF1 and KRAS genes in a patient VL - 19 ID - 7582 ER - TY - JOUR AD - W.E. Tidyman, Department of Pediatrics, Division of Medical Genetics, University of California, San Francisco, CA 94115, United States AU - Tidyman, W. E. AU - Rauen, K. A. DB - Embase Medline DO - 10.1016/j.gde.2009.04.001 IS - 3 LA - English M3 - Review N1 - L355090784 2009-09-14 PY - 2009 SN - 0959-437X SP - 230-236 ST - The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation T2 - Current Opinion in Genetics and Development TI - The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355090784&from=exporthttp://dx.doi.org/10.1016/j.gde.2009.04.001 VL - 19 ID - 7583 ER - TY - JOUR AD - K.W. Gripp, Department of Medical Genetics, Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE, United States AU - Gripp, K. W. DB - Embase DO - 10.1007/s11825-011-0264-1 IS - 1 LA - English M3 - Conference Abstract N1 - L70406898 2011-05-10 PY - 2011 SN - 0936-5931 SP - 65 ST - The rasopathies: Distinct disorders related by dysregulation of the Ras/MAPK signalling pathway T2 - Medizinische Genetik TI - The rasopathies: Distinct disorders related by dysregulation of the Ras/MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70406898&from=exporthttp://dx.doi.org/10.1007/s11825-011-0264-1 VL - 23 ID - 7584 ER - TY - JOUR AD - V. Keshari, Kushabhau Thakrey District Hospital, India AU - Keshari, V. AU - Tripathi, G. AU - Keshari, V. AU - Singh, J. DB - Embase DO - 10.1016/j.phoj.2018.11.032 IS - 3 LA - English M3 - Conference Abstract N1 - L2001337399 2018-12-06 PY - 2018 SN - 2468-1245 SP - S12 ST - RASopathies: Link Between Birth Defects and Cancer in children T2 - Pediatric Hematology Oncology Journal TI - RASopathies: Link Between Birth Defects and Cancer in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001337399&from=exporthttp://dx.doi.org/10.1016/j.phoj.2018.11.032 VL - 3 ID - 7585 ER - TY - JOUR AD - M. Llano, Centro Médico de los Andes, Colombia AU - Llano, M. DB - Embase LA - English M3 - Conference Abstract N1 - L70931677 2012-12-07 PY - 2012 SN - 1663-2818 SP - 32 ST - Rasopathies: Molecular entities with pediatric endocrine outcome? T2 - Hormone Research in Paediatrics TI - Rasopathies: Molecular entities with pediatric endocrine outcome? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70931677&from=export VL - 78 ID - 7586 ER - TY - JOUR AD - S.Y. Shvartsman, Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United States AU - Jindal, G. A. AU - Goyal, Y. AU - Burdine, R. D. AU - Rauen, K. A. AU - Shvartsman, S. Y. DB - Embase Medline DO - 10.1242/dmm.020339 IS - 8 LA - English M3 - Review N1 - L605690182 2015-08-25 2015-08-27 PY - 2015 SN - 1754-8411 1754-8403 SP - 769-782 ST - RASopathies: Unraveling mechanisms with animal models T2 - DMM Disease Models and Mechanisms TI - RASopathies: Unraveling mechanisms with animal models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605690182&from=exporthttp://dx.doi.org/10.1242/dmm.020339 VL - 8 ID - 7587 ER - TY - JOUR AD - J.A. Fahrner, McKusick-Nathans Institute of Genetic Medicine, 600 N. Wolfe St., Blalock 1008, Baltimore, MD 21287, United States AU - Fahrner, J. A. AU - Frazier, A. AU - Bachir, S. AU - Walsh, M. F. AU - Applegate, C. D. AU - Thompson, R. AU - Halushka, M. K. AU - Murphy, A. M. AU - Gunay-Aygun, M. DB - Embase Medline DO - 10.1002/ajmg.a.35363 IS - 6 LA - English M3 - Article N1 - L52013244 2012-05-18 2012-05-31 PY - 2012 SN - 1552-4825 1552-4833 SP - 1414-1421 ST - A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1 T2 - American Journal of Medical Genetics, Part A TI - A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52013244&from=exporthttp://dx.doi.org/10.1002/ajmg.a.35363 VL - 158 A ID - 7588 ER - TY - JOUR AD - F. Guo, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, Cincinnati, OH, United States AU - Nguyen, P. AU - Chakrabarti, J. AU - Li, Y. AU - Kalim, K. W. AU - Zhang, M. AU - Zhang, L. AU - Zheng, Y. AU - Guo, F. C1 - casin(Cayman) C2 - Cayman Selleck Sigma Aldrich DB - Embase DO - 10.3389/fonc.2019.00958 LA - English M3 - Article N1 - L629580519 2019-10-25 2019-12-18 PY - 2019 SN - 2234-943X ST - Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma T2 - Frontiers in Oncology TI - Rational Targeting of Cdc42 Overcomes Drug Resistance of Multiple Myeloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629580519&from=exporthttp://dx.doi.org/10.3389/fonc.2019.00958 VL - 9 ID - 7589 ER - TY - JOUR AD - P.K. Mangat, American Society of Clinical Oncology, 2318 Mill Rd, Alexandria, VA, United States AU - Mangat, P. K. AU - Halabi, S. AU - Bruinooge, S. S. AU - Garrett-Mayer, E. AU - Alva, A. AU - Janeway, K. A. AU - Stella, P. J. AU - Voest, E. AU - Yost, K. J. AU - Perlmutter, J. AU - Pinto, N. AU - Kim, E. S. AU - Schilsky, R. L. DB - Embase DO - 10.1200/PO.18.00122 IS - 2 LA - English M3 - Article N1 - L626826794 2019-03-27 2019-03-29 PY - 2018 SN - 2473-4284 ST - Rationale and design of the targeted agent and profiling utilization registry study T2 - JCO Precision Oncology TI - Rationale and design of the targeted agent and profiling utilization registry study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626826794&from=exporthttp://dx.doi.org/10.1200/PO.18.00122 ID - 7590 ER - TY - JOUR AD - Y.-J. Yang, College of Animal Medicine, Jilin University, No. 5333 Xi'an Road, Changchun, China AU - Lei, Q. Q. AU - Hu, G. Q. AU - Chen, W. AU - Yu, S. X. AU - Qi, S. AU - Du, C. T. AU - Gu, J. M. AU - Lin, T. J. AU - Yang, Y. J. DB - Embase Medline DO - 10.1016/j.molimm.2016.07.009 LA - English M3 - Article N1 - L611294203 2016-07-26 2016-08-05 PY - 2016 SN - 1872-9142 0161-5890 SP - 26-33 ST - RCAN1 deficiency protects against Salmonella intestinal infection by modulating JNK activation T2 - Molecular Immunology TI - RCAN1 deficiency protects against Salmonella intestinal infection by modulating JNK activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611294203&from=exporthttp://dx.doi.org/10.1016/j.molimm.2016.07.009 VL - 77 ID - 7591 ER - TY - JOUR AD - Children's Hospital of Nanjing Medical University Jiangsu China. Department of Musculoskeletal Tumor Shanghai Cancer Center Fudan University Shanghai China. AN - 30868057 AU - Xie, G. AU - Wu, H. AU - Cai, W. AU - Chen, M. AU - Huang, W. AU - Yan, W. AU - Chang, Y. C2 - PMC6396142 DA - Mar DO - 10.1002/2211-5463.12586 10.1002/2211-5463.12586. eCollection 2019 Mar. DP - Nlm ET - 2019/03/15 IS - 3 LA - eng PY - 2019 SN - 2211-5463 (Print) 2211-5463 SP - 490-497 ST - RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway T2 - FEBS Open Bio TI - RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway VL - 9 ID - 7592 ER - TY - JOUR AD - P. A. Jänne, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, HIM 223, Boston,MA 02215, United States AU - Ercan, D. AU - Xu, C. AU - Yanagita, M. AU - Monast, C. S. AU - Pratilas, C. A. AU - Montero, J. AU - Butaney, M. AU - Shimamura, T. AU - Sholl, L. AU - Ivanova, E. V. AU - Tadi, M. AU - Rogers, A. AU - Repellin, C. AU - Capelletti, M. AU - Maertens, O. AU - Goetz, E. M. AU - Letai, A. AU - Garraway, L. A. AU - Lazzara, M. J. AU - Rosen, N. AU - Gray, N. S. AU - Wong, K. K. AU - Jänne, P. A. C1 - ci 1040(Selleck) gsk 1120212(Haoyuan Chemexpress) mk 2206(Selleck) C2 - Haoyuan Chemexpress Selleck DB - Embase Medline DO - 0.1158/2159-8290.CD-12-0103 IS - 10 LA - English M3 - Article N1 - L365940012 2012-11-06 2012-11-12 PY - 2012 SN - 2159-8274 2159-8290 SP - 934-947 ST - Reactivation of ERK signaling causes resistance to EGFR Kinase inhibitors T2 - Cancer Discovery TI - Reactivation of ERK signaling causes resistance to EGFR Kinase inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365940012&from=exporthttp://dx.doi.org/0.1158/2159-8290.CD-12-0103http://cancerdiscovery.aacrjournals.org/content/2/10/934.full.pdf+html VL - 2 ID - 7593 ER - TY - JOUR AD - School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, South Korea Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea AU - Kim, S. AU - Kim, Y. E. AU - Hong, S. AU - Kim, K. T. AU - Sung, D. K. AU - Lee, Y. AU - Park, W. S. AU - Chang, Y. S. AU - Song, M. R. DB - Scopus DO - 10.1002/glia.23712 IS - 1 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2020 SP - 178-192 ST - Reactive microglia and astrocytes in neonatal intraventricular hemorrhage model are blocked by mesenchymal stem cells T2 - GLIA TI - Reactive microglia and astrocytes in neonatal intraventricular hemorrhage model are blocked by mesenchymal stem cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071277310&doi=10.1002%2fglia.23712&partnerID=40&md5=47e847acb68884838c1557be4ea7d3f6 VL - 68 ID - 7594 ER - TY - JOUR AD - N. Asher, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel G. Markel, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel G. Markel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel G. Markel, The Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel AU - Asher, N. AU - Ben-Betzalel, G. AU - Lev-Ari, S. AU - Shapira-Frommer, R. AU - Steinberg-Silman, Y. AU - Gochman, N. AU - Schachter, J. AU - Meirson, T. AU - Markel, G. DB - Embase DO - 10.3390/cancers12082329 IS - 8 LA - English M3 - Article N1 - L2004935923 2020-08-26 2020-10-05 PY - 2020 SN - 2072-6694 SP - 1-18 ST - Real world outcomes of ipilimumab and nivolumab in patients with metastatic melanoma T2 - Cancers TI - Real world outcomes of ipilimumab and nivolumab in patients with metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004935923&from=exporthttp://dx.doi.org/10.3390/cancers12082329 VL - 12 ID - 7595 ER - TY - JOUR AD - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea AU - Oh, C. R. AU - Hong, J. Y. AU - Kim, J. H. AU - Lee, J. S. AU - Kim, H. S. AU - Kim, T. W. AU - Ahn, J. H. AU - Kim, J. E. DB - Scopus DO - 10.1007/s11523-020-00731-z IS - 4 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 485-493 ST - Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study T2 - Targeted Oncology TI - Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087312051&doi=10.1007%2fs11523-020-00731-z&partnerID=40&md5=74600f86f204f08d1c13c72f148b7603 VL - 15 ID - 7596 ER - TY - JOUR AD - J.-Y. Lee, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea AU - Kim, S. H. AU - Suh, Y. AU - Ah, Y. M. AU - Jun, K. AU - Lee, J. Y. DB - Embase Medline DO - 10.1007/s00520-019-05204-2 IS - 8 LA - English M3 - Article N1 - L2003816692 2019-12-13 PY - 2020 SN - 1433-7339 0941-4355 SP - 3617-3626 ST - Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study T2 - Supportive Care in Cancer TI - Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003816692&from=exporthttp://dx.doi.org/10.1007/s00520-019-05204-2 VL - 28 ID - 7597 ER - TY - JOUR AU - Saunders, I. M. AU - Goodman, A. M. AU - Kurzrock, R. DB - Medline DO - 10.1634/theoncologist.2019-0606 IS - 2 LA - English M3 - Article N1 - L630890069 2020-02-17 PY - 2020 SN - 1549-490X SP - e386-e390 ST - Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease T2 - The oncologist TI - Real-World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim-Chester Disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630890069&from=exporthttp://dx.doi.org/10.1634/theoncologist.2019-0606 VL - 25 ID - 7598 ER - TY - JOUR AD - J.L. Espirito, The US Oncology Network/McKesson Specialty Health, The Woodlands, TX, United States AU - Reynolds, C. AU - Masters, E. T. AU - Black-Shinn, J. AU - Boyd, M. AU - Mardekian, J. AU - Espirito, J. L. AU - Chioda, M. DB - Embase DO - 10.3390/jcm7060129 IS - 6 LA - English M3 - Article N1 - L622336783 2018-06-07 2018-06-12 PY - 2018 SN - 2077-0383 ST - Real-world use and outcomes of ALK-positive crizotinib-treated metastatic NSCLC in us community oncology practices: A retrospective observational study T2 - Journal of Clinical Medicine TI - Real-world use and outcomes of ALK-positive crizotinib-treated metastatic NSCLC in us community oncology practices: A retrospective observational study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622336783&from=exporthttp://dx.doi.org/10.3390/jcm7060129 VL - 7 ID - 7599 ER - TY - JOUR AD - Department of Radiobiology/Molecular Epidemiology, Radiation Effects Research Foundation, Minami-ku, Hiroshima, Japan. AN - 23050789 AU - Hamatani, K. AU - Mukai, M. AU - Takahashi, K. AU - Hayashi, Y. AU - Nakachi, K. AU - Kusunoki, Y. C2 - PMC3487115 DA - Nov DO - 10.1089/thy.2011.0511 10.1089/thy.2011.0511. Epub 2012 Oct 10. DP - Nlm ET - 2012/10/12 IS - 11 LA - eng PY - 2012 SN - 1050-7256 (Print) 1050-7256 SP - 1153-9 ST - Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors T2 - Thyroid TI - Rearranged anaplastic lymphoma kinase (ALK) gene in adult-onset papillary thyroid cancer amongst atomic bomb survivors VL - 22 ID - 7600 ER - TY - JOUR AD - Department of Dermatology, Complejo Hospitalario de Navarra, Navarra, Spain. Department of Dermatology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. AN - 31705590 AU - Martínez-de-Espronceda, I. AU - Bernabeu-Wittel, J. AU - Azcona, M. AU - Monserrat, M. T. DA - Jan DO - 10.1111/dth.13164 10.1111/dth.13164. Epub 2019 Nov 15. DP - Nlm ET - 2019/11/11 IS - 1 LA - eng PY - 2020 SN - 1396-0296 SP - e13164 ST - Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient T2 - Dermatol Ther TI - Recalcitrant trametinib-induced paronychia treated successfully with topical timolol in a pediatric patient VL - 33 ID - 7601 ER - TY - JOUR AD - Department of Hematology, Affiliated Hospital of Zunyi Medical College, Guizhou 563003, China AU - Du, X. L. AU - Chen, Q. C1 - abt 737 ha 14 1 ps 341 velcade DB - Embase Medline DO - 10.1159/000345260 IS - 4 LA - English M3 - Review N1 - L52382715 2013-01-10 2013-05-31 PY - 2013 SN - 0001-5792 1421-9662 SP - 207-214 ST - Recent advancements of bortezomib in acute lymphocytic leukemia treatment T2 - Acta Haematologica TI - Recent advancements of bortezomib in acute lymphocytic leukemia treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52382715&from=exporthttp://dx.doi.org/10.1159/000345260 VL - 129 ID - 7602 ER - TY - JOUR AD - N.J. Hewitt, SWS, Wingertstrasse 25, 64390 Erzhausen, Germany AU - Godoy, P. AU - Hewitt, N. J. AU - Albrecht, U. AU - Andersen, M. E. AU - Ansari, N. AU - Bhattacharya, S. AU - Bode, J. G. AU - Bolleyn, J. AU - Borner, C. AU - Böttger, J. AU - Braeuning, A. AU - Budinsky, R. A. AU - Burkhardt, B. AU - Cameron, N. R. AU - Camussi, G. AU - Cho, C. S. AU - Choi, Y. J. AU - Craig Rowlands, J. AU - Dahmen, U. AU - Damm, G. AU - Dirsch, O. AU - Donato, M. T. AU - Dong, J. AU - Dooley, S. AU - Drasdo, D. AU - Eakins, R. AU - Ferreira, K. S. AU - Fonsato, V. AU - Fraczek, J. AU - Gebhardt, R. AU - Gibson, A. AU - Glanemann, M. AU - Goldring, C. E. P. AU - Gómez-Lechón, M. J. AU - Groothuis, G. M. M. AU - Gustavsson, L. AU - Guyot, C. AU - Hallifax, D. AU - Hammad, S. AU - Hayward, A. AU - Häussinger, D. AU - Hellerbrand, C. AU - Hewitt, P. AU - Hoehme, S. AU - Holzhütter, H. G. AU - Houston, J. B. AU - Hrach, J. AU - Ito, K. AU - Jaeschke, H. AU - Keitel, V. AU - Kelm, J. M. AU - Kevin Park, B. AU - Kordes, C. AU - Kullak-Ublick, G. A. AU - Lecluyse, E. L. AU - Lu, P. AU - Luebke-Wheeler, J. AU - Lutz, A. AU - Maltman, D. J. AU - Matz-Soja, M. AU - McMullen, P. AU - Merfort, I. AU - Messner, S. AU - Meyer, C. AU - Mwinyi, J. AU - Naisbitt, D. J. AU - Nussler, A. K. AU - Olinga, P. AU - Pampaloni, F. AU - Pi, J. AU - Pluta, L. AU - Przyborski, S. A. AU - Ramachandran, A. AU - Rogiers, V. AU - Rowe, C. AU - Schelcher, C. AU - Schmich, K. AU - Schwarz, M. AU - Singh, B. AU - Stelzer, E. H. K. AU - Stieger, B. AU - Stöber, R. AU - Sugiyama, Y. AU - Tetta, C. AU - Thasler, W. E. AU - Vanhaecke, T. AU - Vinken, M. AU - Weiss, T. S. AU - Widera, A. AU - Woods, C. G. AU - Xu, J. J. AU - Yarborough, K. M. AU - Hengstler, J. G. DB - Embase Medline DO - 10.1007/s00204-013-1078-5 IS - 8 LA - English M3 - Review N1 - L52745520 2013-08-29 2013-09-27 PY - 2013 SN - 0340-5761 1432-0738 SP - 1315-1530 ST - Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME T2 - Archives of Toxicology TI - Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52745520&from=exporthttp://dx.doi.org/10.1007/s00204-013-1078-5 VL - 87 ID - 7603 ER - TY - JOUR AD - Parker Hughes Cancer Center, Hughes Institute, 2665 Long Lake Road, St Paul Minnesota 55113, United States AU - Sudbeck, E. A. AU - Uckun, F. M. DB - Scopus IS - 10 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 1999 SP - 1026-1030 ST - Recent advances in JAK3 kinase inhibitors T2 - IDrugs TI - Recent advances in JAK3 kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032853338&partnerID=40&md5=37c5a19ef3021a21f85bfc7f0d476f9f VL - 2 ID - 7604 ER - TY - JOUR AD - Department of Medicine, University of Western Ontario, London, ON N6A 5A5, Canada Division of General Internal Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, AB T6G 2R1, Canada Division of Gastroenterology, University of British Columbia, Vancouver, BC V6T 2B5, Canada AU - Thomson, A. B. R. AU - Chopra, A. AU - Clandinin, M. T. AU - Freeman, H. DB - Scopus DO - 10.3748/wjg.v18.i26.3336 IS - 26 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2012 SP - 3336-3352 ST - Recent advances in small bowel diseases: Part I T2 - World Journal of Gastroenterology TI - Recent advances in small bowel diseases: Part I UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863902263&doi=10.3748%2fwjg.v18.i26.3336&partnerID=40&md5=f7dff67e62457df8af37ac885fa4e8f4 VL - 18 ID - 7605 ER - TY - JOUR AD - K.A. Hodby, Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, United Kingdom AU - Hodby, K. A. AU - Marks, D. I. DB - Embase Medline DO - 10.1007/s11864-020-0712-8 IS - 3 LA - English M3 - Article N1 - L2004316868 2020-03-02 2020-03-04 PY - 2020 SN - 1534-6277 1527-2729 ST - Recent Advances in the Management of Acute Lymphoblastic Leukaemia T2 - Current Treatment Options in Oncology TI - Recent Advances in the Management of Acute Lymphoblastic Leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004316868&from=exporthttp://dx.doi.org/10.1007/s11864-020-0712-8 VL - 21 ID - 7606 ER - TY - JOUR AD - R.M. Beattie, Department of Nutrition, Paediatric Medical Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, United Kingdom AU - Bremner, A. R. AU - Beattie, R. M. C1 - cdp 571 DB - Embase Medline DO - 10.1517/14656566.8.15.2553 IS - 15 LA - English M3 - Review N1 - L350031293 2007-11-22 PY - 2007 SN - 1465-6566 SP - 2553-2568 ST - Recent advances in the medical therapy of Crohn's disease in childhood T2 - Expert Opinion on Pharmacotherapy TI - Recent advances in the medical therapy of Crohn's disease in childhood UR - https://www.embase.com/search/results?subaction=viewrecord&id=L350031293&from=exporthttp://dx.doi.org/10.1517/14656566.8.15.2553 VL - 8 ID - 7607 ER - TY - JOUR AD - M.L. Loh, Health Sciences East 302, 513 Parnassus Ave, San Francisco, CA 94143-0519, United States AU - Loh, M. L. C1 - azd 6244 bay 43 9006 ci 1040 incb 018424(Incyte) incb 018424(Novartis) r 115777 C2 - Incyte Novartis DB - Embase Medline DO - 10.1111/j.1365-2141.2010.08525.x IS - 6 LA - English M3 - Article N1 - L361328443 2011-03-07 PY - 2011 SN - 0007-1048 1365-2141 SP - 677-687 ST - Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia T2 - British Journal of Haematology TI - Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361328443&from=exporthttp://dx.doi.org/10.1111/j.1365-2141.2010.08525.x VL - 152 ID - 7608 ER - TY - JOUR AD - R.P. Erickson, Department of Pediatrics, University of Arizona, Tucson, AZ, United States AU - Erickson, R. P. DB - Embase DO - 10.1016/j.gde.2014.06.001 LA - English M3 - Review N1 - L600110730 2014-10-21 2014-10-24 PY - 2014 SN - 1879-0380 0959-437X SP - 73-78 ST - Recent advances in the study of somatic mosaicism and diseases other than cancer T2 - Current Opinion in Genetics and Development TI - Recent advances in the study of somatic mosaicism and diseases other than cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600110730&from=exporthttp://dx.doi.org/10.1016/j.gde.2014.06.001 VL - 26 ID - 7609 ER - TY - JOUR AD - Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: frodrig4@jhmi.edu. Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Cellular and Tissue Biology, National Autonomous University of Mexico (UNAM), Mexico City, Mexico. Division of Molecular Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. AN - 27444975 AU - Rodriguez, F. J. AU - Vizcaino, M. A. AU - Lin, M. T. C2 - PMC5397677 DA - Sep DO - 10.1016/j.jmoldx.2016.05.005 10.1016/j.jmoldx.2016.05.005. DP - Nlm ET - 2016/07/23 IS - 5 LA - eng PY - 2016 SN - 1525-1578 (Print) 1525-1578 SP - 620-634 ST - Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults T2 - J Mol Diagn TI - Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults VL - 18 ID - 7610 ER - TY - JOUR AD - F. Liu, Department of Pediatric Surgery, Xuzhou Children’s Hospital, 18 Sudibei Road, Xuzhou, Jiangsu, China AU - Li, Z. AU - Yin, Y. AU - Liu, F. DB - Embase DO - 10.3892/ol.2017.6243 IS - 1 LA - English M3 - Article N1 - L616650170 2017-06-12 2017-06-15 PY - 2017 SN - 1792-1082 1792-1074 SP - 497-500 ST - Recent developments in predictive biomarkers of pediatric glioma (Review) T2 - Oncology Letters TI - Recent developments in predictive biomarkers of pediatric glioma (Review) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616650170&from=exporthttp://dx.doi.org/10.3892/ol.2017.6243 VL - 14 ID - 7611 ER - TY - JOUR AD - Y. Shi, Department of Pediatric Surgery, Xuzhou Children's Hospital, Xuzhou Medical University, 18 Sudibei Road, Xuzhou, Jiangsu, China AU - Li, Z. AU - Sun, Q. AU - Shi, Y. DB - Embase Medline DO - 10.23736/S0026-4946.17.04823-X IS - 2 LA - English M3 - Review N1 - L2006737238 2020-07-24 2020-08-26 PY - 2020 SN - 1827-1715 0026-4946 SP - 116-122 ST - Recent perspectives of molecular aberrations in pediatric high-grade glioma T2 - Minerva Pediatrica TI - Recent perspectives of molecular aberrations in pediatric high-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006737238&from=exporthttp://dx.doi.org/10.23736/S0026-4946.17.04823-X VL - 72 ID - 7612 ER - TY - JOUR AD - Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China Department of Ophthalmology, Second Hospital of Jilin University, Changchun, China AU - Zhang, Q. AU - Jin, Y. AU - Zhao, C. F. AU - Wang, W. J. AU - Liu, G. Y. C7 - gmr.15027817 DB - Scopus DO - 10.4238/gmr.15027817 IS - 2 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 ST - Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro T2 - Genetics and Molecular Research TI - Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975217561&doi=10.4238%2fgmr.15027817&partnerID=40&md5=3645adf8e8f76176afa945841317e5af VL - 15 ID - 7613 ER - TY - GEN AD - D. L. Stirewalt, Clinical Research Division, From Fred Hutchinson Cancer Research Center, Seattle, WA, United States AU - Stirewalt, D. L. AU - Meshinchi, S. C1 - amn 107 bms 354825 cep 5214(Cephalon) cep 701(Cephalon) ct 53518(Millennium) gleevec mln 518 pkc 412(Novartis) su 11248(Sugen) su 5614(Sugen) C2 - Cephalon Millennium Novartis Sugen C5 - 20306247 DB - Embase Medline DO - 10.1007/978-0-387-69259-3_6 J2 - Cancer Treat. Res. LA - English M1 - (Stirewalt D.L., dstirewa@fhcrc.org) Clinical Research Division, From Fred Hutchinson Cancer Research Center, Seattle, WA, United States M3 - Review N1 - L359445729 2010-09-08 2010-10-04 PY - 2010 SN - 0927-3042 9780387692579 SP - 85-108 ST - Receptor tyrosine kinase alterations in AML - Biology and therapy TI - Receptor tyrosine kinase alterations in AML - Biology and therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359445729&from=exporthttp://dx.doi.org/10.1007/978-0-387-69259-3_6 VL - 145 ID - 7614 ER - TY - JOUR AD - J. Potratz, Department of Pediatric Hematology and Oncology, University Hospital Münster, Albert-Schweitzer-Campus 1, Münster, Germany AU - Berning, P. AU - Hennemann, C. AU - Tulotta, C. AU - Schaefer, C. AU - Lechtape, B. AU - Hotfilder, M. AU - El Gourari, Y. AU - Jürgens, H. AU - Snaar-Jagalska, E. AU - Hempel, G. AU - Dirksen, U. AU - Potratz, J. C1 - bms 777607 DB - Embase DO - 10.3390/cancers12040904 IS - 4 LA - English M3 - Article N1 - L2004152861 2020-04-30 2020-05-08 PY - 2020 SN - 2072-6694 ST - The receptor tyrosine kinase RON and its isoforms as therapeutic targets in ewing sarcoma T2 - Cancers TI - The receptor tyrosine kinase RON and its isoforms as therapeutic targets in ewing sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004152861&from=exporthttp://dx.doi.org/10.3390/cancers12040904 VL - 12 ID - 7615 ER - TY - JOUR AD - Ottawa Regional Cancer Centre, Department of Biochemistry, University of Ottawa, Ottawa, Ont., Canada W. Alton Jones Cell Science Center, 10 Old Barn Road, Lake Placid, NY 12946, United States Ottawa Regional Cancer Centre, 501 Smyth Rd., Ottawa, Ont. K1H 8L6, Canada AU - Bennett, S. A. L. AU - Birnboim, H. C. DB - Scopus DO - 10.1002/(SICI)1098-2744(199712)20:4<366::AID-MC6>3.0.CO;2-H IS - 4 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 1997 SP - 366-375 ST - Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor T2 - Molecular Carcinogenesis TI - Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031416120&doi=10.1002%2f%28SICI%291098-2744%28199712%2920%3a4%3c366%3a%3aAID-MC6%3e3.0.CO%3b2-H&partnerID=40&md5=a968e083fe83bd439cecd80152389e08 VL - 20 ID - 7616 ER - TY - JOUR AD - Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996, USA. hmsch@utk.edu AN - 12494489 AU - Schuller, H. M. AU - Plummer, H. K., 3rd AU - Jull, B. A. DA - Jan DO - 10.1002/ar.a.10019 10.1002/ar.a.10019. DP - Nlm ET - 2002/12/21 IS - 1 LA - eng PY - 2003 SN - 1552-4884 (Print) 1552-4884 SP - 51-8 ST - Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells T2 - Anat Rec A Discov Mol Cell Evol Biol TI - Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells VL - 270 ID - 7617 ER - TY - JOUR AD - Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, VIC, Australia Department of Medicine, University of Melbourne, Western Hospital, Footscray, VIC, Australia Department of Pathology, Peter MacCallum Institute, East Melbourne, VIC, Australia Laboratoire de Signalisation Cellulaire Normale et Tumorale, Faculté de Pharmacie, Montpellier, France AU - Tebbutt, N. C. AU - Giraud, A. S. AU - Inglese, M. AU - Jenkins, B. AU - Waring, P. AU - Clay, F. J. AU - Malki, S. AU - Alderman, B. M. AU - Grail, D. AU - Hollande, F. AU - Heath, J. K. AU - Ernst, M. DB - Scopus DO - 10.1038/nm763 IS - 10 M3 - Article N1 - Cited By :368 Export Date: 18 November 2020 PY - 2002 SP - 1089-1097 ST - Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice T2 - Nature Medicine TI - Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036796060&doi=10.1038%2fnm763&partnerID=40&md5=56560725b1b86619c872d226524f0909 VL - 8 ID - 7618 ER - TY - JOUR AD - Division of Pediatric Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, United States Division of Pediatric Hematology Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States Department of Child Health, The Ron Matricaria Institute of Molecular Medicine at Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix, AZ, United States Pediatric Hematology, Oncology & Stem Cell Transplantation, Department of Pediatrics, Children's Hospital, Technical University of Dresden, Dresden, Germany AU - Samis, J. AU - Lee, P. AU - Zimmerman, D. AU - Arceci, R. J. AU - Suttorp, M. AU - Hijiya, N. DB - Scopus DO - 10.1002/pbc.26028 IS - 8 M3 - Review N1 - Cited By :24 Export Date: 18 November 2020 PY - 2016 SP - 1332-1338 ST - Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia T2 - Pediatric Blood and Cancer TI - Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976474984&doi=10.1002%2fpbc.26028&partnerID=40&md5=1ad94d5ee6fb5ffdb6f288eb4948333d VL - 63 ID - 7619 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child and Family Research Institute, University of British Columbia, Room 317, 950 West 28th Avenue, Vancouver, BC, Canada AU - Chang, H. M. AU - Cheng, J. C. AU - Fang, L. AU - Qiu, X. AU - Klausen, C. AU - Taylor, E. L. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1210/jc.2014-2496 IS - 3 LA - English M3 - Article N1 - L603095114 2015-03-24 2015-03-26 PY - 2015 SN - 1945-7197 0021-972X SP - E365-E374 ST - Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells T2 - Journal of Clinical Endocrinology and Metabolism TI - Recombinant BMP4 and BMP7 downregulate pentraxin 3 in human granulosa cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603095114&from=exporthttp://dx.doi.org/10.1210/jc.2014-2496 VL - 100 ID - 7620 ER - TY - JOUR AD - Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic Clinical Laboratories Department, AL-Assad Hospital, Damascus University, Damascus, Syrian Arab Republic AU - Kelani, R. AU - Monem, F. DB - Scopus DO - 10.1111/ijlh.12394 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2015 SP - 723-728 ST - Reconsideration of BCR-ABL protein flow cytometric immunobead assay: How potent to diagnose and monitor chronic myeloid leukemia? T2 - International Journal of Laboratory Hematology TI - Reconsideration of BCR-ABL protein flow cytometric immunobead assay: How potent to diagnose and monitor chronic myeloid leukemia? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941745747&doi=10.1111%2fijlh.12394&partnerID=40&md5=2daacc81d6a14e7d0d4d886439971ace VL - 37 ID - 7621 ER - TY - JOUR AD - M.A. Karajannis, Department of Pediatrics, NYU Langone Medical Center, Hassenfeld Children's Center for Cancer and Blood Disorders, 160 East 32nd Street, New York, NY, United States AU - Legault, G. AU - Kieran, M. W. AU - Scott, R. M. AU - Chordas, C. AU - Milla, S. S. AU - Karajannis, M. A. DB - Embase Medline DO - 10.1097/MPH.0000000000000094 IS - 8 LA - English M3 - Article N1 - L600874059 2014-12-24 2015-01-07 PY - 2014 SN - 1536-3678 1077-4114 SP - e533-e535 ST - Recurrent ascites in a patient with low-grade astrocytoma and ventriculo-peritoneal shunt treated with the multikinase inhibitor sorafenib T2 - Journal of Pediatric Hematology/Oncology TI - Recurrent ascites in a patient with low-grade astrocytoma and ventriculo-peritoneal shunt treated with the multikinase inhibitor sorafenib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600874059&from=exporthttp://dx.doi.org/10.1097/MPH.0000000000000094 VL - 36 ID - 7622 ER - TY - JOUR AD - Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. AN - 23890088 AU - Botton, T. AU - Yeh, I. AU - Nelson, T. AU - Vemula, S. S. AU - Sparatta, A. AU - Garrido, M. C. AU - Allegra, M. AU - Rocchi, S. AU - Bahadoran, P. AU - McCalmont, T. H. AU - LeBoit, P. E. AU - Burton, E. A. AU - Bollag, G. AU - Ballotti, R. AU - Bastian, B. C. C2 - PMC3808507 C6 - NIHMS512581 DA - Nov DO - 10.1111/pcmr.12148 10.1111/pcmr.12148. Epub 2013 Aug 19. DP - Nlm ET - 2013/07/31 IS - 6 LA - eng PY - 2013 SN - 1755-1471 (Print) 1755-1471 SP - 845-51 ST - Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy T2 - Pigment Cell Melanoma Res TI - Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy VL - 26 ID - 7623 ER - TY - JOUR AD - H.-G. Liu, Department of Pathology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Dongcheng District, Beijing 100730, China AU - He, C. Y. AU - Dong, G. H. AU - Liu, H. G. DB - Embase Medline DO - 10.1186/1477-7819-12-54 IS - 1 LA - English M3 - Article N1 - L372938988 2014-05-05 2014-05-09 PY - 2014 SN - 1477-7819 ST - Recurrent laryngeal inflammatory myofibroblastic tumor with positive anaplastic lymphoma kinase mimicking recurrent respiratory papillomatosis: A case report T2 - World Journal of Surgical Oncology TI - Recurrent laryngeal inflammatory myofibroblastic tumor with positive anaplastic lymphoma kinase mimicking recurrent respiratory papillomatosis: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372938988&from=exporthttp://dx.doi.org/10.1186/1477-7819-12-54 VL - 12 ID - 7624 ER - TY - JOUR AD - S.M. Pfister, Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany AU - Bender, S. AU - Gronych, J. AU - Warnatz, H. J. AU - Hutter, B. AU - Gröbner, S. AU - Ryzhova, M. AU - Pfaff, E. AU - Hovestadt, V. AU - Weinberg, F. AU - Halbach, S. AU - Kool, M. AU - Northcott, P. A. AU - Sturm, D. AU - Bjerke, L. AU - Zichner, T. AU - Stütz, A. M. AU - Schramm, K. AU - Huang, B. AU - Buchhalter, I. AU - Heinold, M. AU - Risch, T. AU - Worst, B. C. AU - Van Tilburg, C. M. AU - Weber, U. D. AU - Zapatka, M. AU - Raeder, B. AU - Milford, D. AU - Heiland, S. AU - Von Kalle, C. AU - Previti, C. AU - Lawerenz, C. AU - Kulozik, A. E. AU - Unterberg, A. AU - Witt, O. AU - Von Deimling, A. AU - Capper, D. AU - Truffaux, N. AU - Grill, J. AU - Jabado, N. AU - Sehested, A. M. AU - Sumerauer, D. AU - Brahim, D. H. B. AU - Trabelsi, S. AU - Ng, H. K. AU - Zagzag, D. AU - Allen, J. C. AU - Karajannis, M. A. AU - Gottardo, N. G. AU - Jones, C. AU - Korbel, J. O. AU - Schmidt, S. AU - Wolf, S. AU - Reifenberger, G. AU - Felsberg, J. AU - Brors, B. AU - Herold-Mende, C. AU - Lehrach, H. AU - Brummer, T. AU - Korshunov, A. AU - Eils, R. AU - Yaspo, M. L. AU - Pfister, S. M. AU - Lichter, P. AU - Jones, D. T. W. DB - Embase Medline DO - 10.1038/nm.4204 IS - 11 LA - English M3 - Article N1 - L612827553 2016-10-25 2019-10-31 PY - 2016 SN - 1546-170X 1078-8956 SP - 1314-1320 ST - Recurrent MET fusion genes represent a drug target in pediatric glioblastoma T2 - Nature Medicine TI - Recurrent MET fusion genes represent a drug target in pediatric glioblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612827553&from=exporthttp://dx.doi.org/10.1038/nm.4204 VL - 22 ID - 7625 ER - TY - JOUR AD - N.R. Bhat, Department of Neurology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, United States AU - Pawate, S. AU - Shen, Q. AU - Fan, F. AU - Bhat, N. R. DB - Embase Medline DO - 10.1002/jnr.20180 IS - 4 LA - English M3 - Article N1 - L39007006 2004-08-29 PY - 2004 SN - 0360-4012 SP - 540-551 ST - Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ T2 - Journal of Neuroscience Research TI - Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39007006&from=exporthttp://dx.doi.org/10.1002/jnr.20180 VL - 77 ID - 7626 ER - TY - JOUR AD - M. Torres, M.S.57, 4650 Sunset Blvd., Los Angeles, CA 90027, United States AU - Torres, M. AU - Forman, H. J. DB - Embase Medline DO - 10.1002/biof.5520170128 IS - 1-4 LA - English M3 - Conference Paper N1 - L37267162 2003-10-29 PY - 2003 SN - 0951-6433 SP - 287-296 ST - Redox signaling and the MAP kinase pathways T2 - BioFactors TI - Redox signaling and the MAP kinase pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37267162&from=exporthttp://dx.doi.org/10.1002/biof.5520170128 VL - 17 ID - 7627 ER - TY - JOUR AU - Sun, Y. AU - Chen, C. AU - Zhang, P. AU - Xie, H. AU - Hou, L. AU - Hui, Z. AU - Xu, Y. AU - Du, Q. AU - Zhou, X. AU - Su, B. AU - Gao, W. DB - Medline DO - 10.1038/srep06527 LA - English M3 - Article N1 - L606788527 2015-11-12 PY - 2014 SN - 2045-2322 SP - 6527 ST - Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway T2 - Scientific reports TI - Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606788527&from=exporthttp://dx.doi.org/10.1038/srep06527 VL - 4 ID - 7628 ER - TY - JOUR AD - Instituto de Matemática e Computação, Universidade Federal de Itajubá, Brazil Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Germany National Center for Tumor Diseases (NCT), Partner Site, Dresden, Germany AU - Fassoni, A. C. AU - Baldow, C. AU - Roeder, I. AU - Glauche, I. DB - Scopus DO - 10.3324/haematol.2018.194522 IS - 11 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2018 SP - 1825-1834 ST - Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: A simulation study based on phase III trial data T2 - Haematologica TI - Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: A simulation study based on phase III trial data UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055844213&doi=10.3324%2fhaematol.2018.194522&partnerID=40&md5=4046c648e903a80c490f6eb98e7a659f VL - 103 ID - 7629 ER - TY - JOUR AD - Department of Nuclear Medicine, Virgen de las Nieves University Hospital, Granada, Spain. marisacgarre@gmail.com AN - 22504197 AU - Cañadas-Garre, M. AU - Becerra-Massare, P. AU - López de la Torre-Casares, M. AU - Villar-del Moral, J. AU - Céspedes-Mas, S. AU - Vílchez-Joya, R. AU - Muros-de Fuentes, T. AU - García-Calvente, C. AU - Piédrola-Maroto, G. AU - López-Nevot, M. A. AU - Montes-Ramírez, R. AU - Llamas-Elvira, J. M. DA - May DO - 10.1097/SLA.0b013e31824e8d70 10.1097/SLA.0b013e31824e8d70. DP - Nlm ET - 2012/04/17 IS - 5 LA - eng PY - 2012 SN - 0003-4932 SP - 986-92 ST - Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients T2 - Ann Surg TI - Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients VL - 255 ID - 7630 ER - TY - JOUR AD - Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-Osaka 577-8502, Japan. AN - 22326785 AU - Tsubaki, M. AU - Satou, T. AU - Itoh, T. AU - Imano, M. AU - Ogaki, M. AU - Yanae, M. AU - Nishida, S. DA - Mar 15 DO - 10.1016/j.taap.2012.01.024 10.1016/j.taap.2012.01.024. Epub 2012 Feb 3. DP - Nlm ET - 2012/02/14 IS - 3 LA - eng PY - 2012 SN - 0041-008x SP - 402-10 ST - Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway T2 - Toxicol Appl Pharmacol TI - Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway VL - 259 ID - 7631 ER - TY - JOUR AD - X. Shi, Department of Pediatrics, Women and Infants Hospital of Zhengzhou, 41 Jinshui Road, Zhengzhou, Henan, China AU - Ren, H. AU - Shi, X. AU - Li, Y. DB - Embase DO - 10.3892/etm.2016.3776 IS - 5 LA - English M3 - Article N1 - L612826432 2016-10-25 2016-10-28 PY - 2016 SN - 1792-1015 1792-0981 SP - 3425-3432 ST - Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas T2 - Experimental and Therapeutic Medicine TI - Reduction of p38 mitogen-activated protein kinase and cyclooxygenase-2 signaling by isoflurane inhibits proliferation and apoptosis evasion in human papillomavirus-infected laryngeal papillomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612826432&from=exporthttp://dx.doi.org/10.3892/etm.2016.3776 VL - 12 ID - 7632 ER - TY - JOUR AD - Department of Pathology, Yale University, New Haven, Connecticut 06520, USA. AN - 21568726 AU - Adeniran, A. J. AU - Theoharis, C. AU - Hui, P. AU - Prasad, M. L. AU - Hammers, L. AU - Carling, T. AU - Udelsman, R. AU - Chhieng, D. C. DA - Jul DO - 10.1089/thy.2011.0021 10.1089/thy.2011.0021. Epub 2011 May 13. DP - Nlm ET - 2011/05/17 IS - 7 LA - eng PY - 2011 SN - 1050-7256 SP - 717-23 ST - Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study T2 - Thyroid TI - Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study VL - 21 ID - 7633 ER - TY - JOUR AD - Université Paris-Sud 11, Vectorology and Anticancer Therapeutics, UMR 8203, Villejuif, France. CNRS, Vectorology and Anticancer Therapeutics, UMR 8203, Orsay, France. Gustave Roussy, Vectorology and Anticancer Therapeutics, UMR 8203, Villejuif, France. University Children's Hospital, Department of Pediatric Hematology and Oncology, Münster, Germany. PFEP (Plateforme d'évaluation préclinique), Gustave Roussy, Villejuif, France. Tribvn, Châtillon, France. Pathology Laboratory, Gustave Roussy, Villejuif, France. Department of Neuropathology, Sainte-Anne's Hospital, Paris, France. Paris Descartes University, Paris, France. Bayer Pharma Aktiengesellschaft, Berlin, Germany. AN - 26599335 AU - Daudigeos-Dubus, E. AU - Le Dret, L. AU - Lanvers-Kaminsky, C. AU - Bawa, O. AU - Opolon, P. AU - Vievard, A. AU - Villa, I. AU - Pagès, M. AU - Bosq, J. AU - Vassal, G. AU - Zopf, D. AU - Geoerger, B. C2 - PMC4658168 supported by Bayer Pharma Aktiengesellschaft. Co-author Dieter Zopf is employed by Bayer Pharma Aktiengesellschaft. Co-author Albane Vievard is employed by Tribvn. There are no patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials as detailed online in the guide for authors. All other authors have no conflict to interest to declare. DO - 10.1371/journal.pone.0142612 10.1371/journal.pone.0142612. eCollection 2015. DP - Nlm ET - 2015/11/26 IS - 11 LA - eng PY - 2015 SN - 1932-6203 SP - e0142612 ST - Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models T2 - PLoS One TI - Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models VL - 10 ID - 7634 ER - TY - JOUR AD - E. Scoditti, Institute of Clinical Physiology-CNR, Lecce, Italy AU - Scoditti, E. AU - Massaro, M. AU - Carluccio, M. A. AU - Pellegrino, M. AU - Calabriso, N. AU - Wabitsch, M. AU - Storelli, C. AU - De Caterina, R. DB - Embase DO - 10.1093/cvr/cvu098.164 LA - English M3 - Conference Abstract N1 - L71588679 2014-08-23 PY - 2014 SN - 0008-6363 SP - S136 ST - Regulation of adiponectin expression by selective molecular components of mediterranean diets in human adipocytes T2 - Cardiovascular Research TI - Regulation of adiponectin expression by selective molecular components of mediterranean diets in human adipocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71588679&from=exporthttp://dx.doi.org/10.1093/cvr/cvu098.164 VL - 103 ID - 7635 ER - TY - JOUR AD - S. Krueger, Institute of Pathology, Otto-von-Guericke University, Leipziger Strasse 44, D-39120 Magdeburg, Germany AU - Krueger, S. AU - Kuester, D. AU - Bernhardt, A. AU - Wex, T. AU - Roessner, A. DB - Embase Medline DO - 10.1002/path.2485 IS - 4 LA - English M3 - Article N1 - L354450659 2009-05-05 PY - 2009 SN - 0022-3417 1096-9896 SP - 581-588 ST - Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages T2 - Journal of Pathology TI - Regulation of cathepsin X overexpression in H. pylori-infected gastric epithelial cells and macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354450659&from=exporthttp://dx.doi.org/10.1002/path.2485http://www3.interscience.wiley.com/cgi-bin/fulltext/121506167/PDFSTART VL - 217 ID - 7636 ER - TY - JOUR AD - Service de Neuropédiatrie and INSERM CRI 97-01, Hôpital Robert-Debré, Paris, France. AN - 9603224 AU - Gressens, P. AU - Marret, S. AU - Martin, J. L. AU - Laquerrière, A. AU - Lombet, A. AU - Evrard, P. DA - Jun DO - 10.1046/j.1471-4159.1998.70062574.x 10.1046/j.1471-4159.1998.70062574.x. DP - Nlm ET - 1998/05/29 IS - 6 LA - eng PY - 1998 SN - 0022-3042 (Print) 0022-3042 SP - 2574-84 ST - Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies T2 - J Neurochem TI - Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies VL - 70 ID - 7637 ER - TY - JOUR AD - Department of Medical Sciences, Indiana Univ. School of Medicine, Jordan Hall 105, Bloomington, IN 47405-4401, United States Department of Dermatology, Indiana Univ. School of Medicine, Indianapolis, IN 46202, United States The Ohio State University, Department of Veterinary Biosciences, Columbus, OH 43210, United States Dept. of Biochemistry/Molec. Biology, Indianapolis School of Medicine, Indianapolis, IN 46202, United States Dept. of Pathology/Laboratory Med., Indianapolis School of Medicine, Indianapolis, IN 46202, United States AU - Cho, Y. M. AU - Lewis, D. A. AU - Koltz, P. F. AU - Richard, V. AU - Gocken, T. A. AU - Rosol, T. J. AU - Konger, R. L. AU - Spandau, D. F. AU - Foley, J. DB - Scopus DO - 10.1677/joe.0.1810179 IS - 1 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2004 SP - 179-190 ST - Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes T2 - Journal of Endocrinology TI - Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2342647462&doi=10.1677%2fjoe.0.1810179&partnerID=40&md5=b0e587b55cac9afd2d93044e4b29b2bf VL - 181 ID - 7638 ER - TY - JOUR AD - Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, United States Department of Ophthalmology, Kyung Hee University Hospital, Gangdong, Seoul, South Korea AU - Kang, M. H. AU - Oh, D. J. AU - Kang, J. AU - Rhee, D. J. DB - Scopus DO - 10.1167/iovs.12-11474 IS - 4 M3 - Article N1 - Cited By :24 Export Date: 18 November 2020 PY - 2013 SP - 2523-2532 ST - Regulation of SPARC by transforming growth factor β2 in human trabecular meshwork T2 - Investigative Ophthalmology and Visual Science TI - Regulation of SPARC by transforming growth factor β2 in human trabecular meshwork UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876119431&doi=10.1167%2fiovs.12-11474&partnerID=40&md5=38947a4e84efb2d68bb8a756a75635cb VL - 54 ID - 7639 ER - TY - JOUR AD - H. Tsujimoto, Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan AU - Tomiyasu, H. AU - Watanabe, M. AU - Sugita, K. AU - Goto-Koshino, Y. AU - Fujino, Y. AU - Ohno, K. AU - Sugano, S. AU - Tsujimoto, H. DB - Embase Medline IS - 12 LA - English M3 - Article N1 - L372018523 2014-01-08 2014-01-10 PY - 2013 SN - 0250-7005 SP - 5317-5324 ST - Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines T2 - Anticancer Research TI - Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372018523&from=exporthttp://ar.iiarjournals.org/content/33/12/5317.full.pdf+html VL - 33 ID - 7640 ER - TY - JOUR AD - V.E. Torres, Div. of Nephrology, Mayo Clinic, 200 First St. SW, Rochester, MN, United States AU - Ye, H. AU - Wang, X. AU - Constans, M. M. AU - Sussman, C. R. AU - Chebib, F. T. AU - Irazabal, M. V. AU - Young, W. F. AU - Harris, P. C. AU - Kirschner, L. S. AU - Torres, V. E. DB - Embase Medline DO - 10.1152/ajprenal.00119.2017 IS - 3 LA - English M3 - Article N1 - L618213922 2017-09-13 2017-09-18 PY - 2017 SN - 1522-1466 0363-6127 SP - F677-F686 ST - The regulatory 1α subunit of protein kinase a modulates renal cystogenesis T2 - American Journal of Physiology - Renal Physiology TI - The regulatory 1α subunit of protein kinase a modulates renal cystogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618213922&from=exporthttp://dx.doi.org/10.1152/ajprenal.00119.2017 VL - 313 ID - 7641 ER - TY - JOUR AD - AMEOS Reha Klinikum Ratzeburg, Röpersberg 47, Ratzeburg, 23909, Germany Klinik Reinhardshöhe, Bad Wildungen, Germany Facharztpraxis für Innere Medizin, Bad Bocklet, Germany MediClin Klinik Reichshof, Reichshof-Eckenhagen, Germany Strandklinik Boltenhagen, Boltenhagen, Germany AU - Schmielau, J. AU - Rick, O. AU - Reuss-Borst, M. AU - Kalusche-Bontemps, E. M. AU - Steimann, M. DB - Scopus DO - 10.1159/000485187 IS - 12 M3 - Review N1 - Cited By :12 Export Date: 18 November 2020 PY - 2017 SP - 764-771 ST - Rehabilitation of Cancer Survivors with Long-Term Toxicities T2 - Oncology Research and Treatment TI - Rehabilitation of Cancer Survivors with Long-Term Toxicities UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85036606633&doi=10.1159%2f000485187&partnerID=40&md5=6ed26604bf4bf2ae74fb01ef3dc8d66c VL - 40 ID - 7642 ER - TY - JOUR AD - Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. ICGEX Platform, Institut Curie, Paris, France. 1] ICGEX Platform, Institut Curie, Paris, France. [2] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. Unité de Génétique Somatique, Institut Curie, Paris, France. Centre Léon-Bérard, Laboratoire de Recherche Translationnelle Lyon, Lyon, France. Département de Pédiatrie, Institut Curie, Paris, France. Princess Margaret Cancer Centre, University Health Network; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA. Department of Biostatistics, University of Florida, Children's Oncology Group (COG), Gainesville, Florida, USA. 1] The Ohio State University College of Medicine, Columbus, Ohio, USA. [2] Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA. 1] Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA. [2] Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA. [3] Keck School of Medicine, University of Southern California, Los Angeles, California, USA. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA. Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA. Translational Cancer Therapeutics Laboratory, Cancer Research UK, London, UK. 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. 1] Department of Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. [2] German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. [3] Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany. [4] Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany. Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA. 1] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. [2] Département de Pédiatrie, Institut Curie, Paris, France. [3] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France. AN - 26121087 AU - Eleveld, T. F. AU - Oldridge, D. A. AU - Bernard, V. AU - Koster, J. AU - Colmet Daage, L. AU - Diskin, S. J. AU - Schild, L. AU - Bentahar, N. B. AU - Bellini, A. AU - Chicard, M. AU - Lapouble, E. AU - Combaret, V. AU - Legoix-Né, P. AU - Michon, J. AU - Pugh, T. J. AU - Hart, L. S. AU - Rader, J. AU - Attiyeh, E. F. AU - Wei, J. S. AU - Zhang, S. AU - Naranjo, A. AU - Gastier-Foster, J. M. AU - Hogarty, M. D. AU - Asgharzadeh, S. AU - Smith, M. A. AU - Guidry Auvil, J. M. AU - Watkins, T. B. AU - Zwijnenburg, D. A. AU - Ebus, M. E. AU - van Sluis, P. AU - Hakkert, A. AU - van Wezel, E. AU - van der Schoot, C. E. AU - Westerhout, E. M. AU - Schulte, J. H. AU - Tytgat, G. A. AU - Dolman, M. E. AU - Janoueix-Lerosey, I. AU - Gerhard, D. S. AU - Caron, H. N. AU - Delattre, O. AU - Khan, J. AU - Versteeg, R. AU - Schleiermacher, G. AU - Molenaar, J. J. AU - Maris, J. M. C2 - PMC4775079 C6 - NIHMS757254 DA - Aug DO - 10.1038/ng.3333 10.1038/ng.3333. Epub 2015 Jun 29. DP - Nlm ET - 2015/06/30 IS - 8 LA - eng PY - 2015 SN - 1061-4036 (Print) 1061-4036 SP - 864-71 ST - Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations T2 - Nat Genet TI - Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations VL - 47 ID - 7643 ER - TY - JOUR AD - Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Fondazione MBBM/ S.Gerardo Hospital, Monza, Italy St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria CLIP, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University, University Hospital Motol, Prague, Czech Republic Molecular Diagnostics, Children’s Cancer Institute, University of NSW, Sydney, NSW, Australia Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Sackler Faculty of Medicine, Tel Aviv University, Israel Pediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany Department of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS), Childrens' Hospital Bambino Gesù, Sapienza, University of Rome, Rome, Italy IIGM Torino and Pediatric Hemato-Oncology, SDB Departiment, University of Padova, Padova, Italy Department of Human Genetics, Medical School Hannover, Hannover, Germany Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia Women’s and Children’s Hospital, SA Pathology, University of Adelaide, Adelaide, Australia Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany University Children’s Hospital Zurich, Zurich, Switzerland Pediatric Hematology-Oncology Department, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel AU - Cario, G. AU - Leoni, V. AU - Conter, V. AU - Attarbaschi, A. AU - Zaliova, M. AU - Sramkova, L. AU - Cazzaniga, G. AU - Fazio, G. AU - Sutton, R. AU - Elitzur, S. AU - Izraeli, S. AU - Lauten, M. AU - Locatelli, F. AU - Basso, G. AU - Buldini, B. AU - Bergmann, A. K. AU - Lentes, J. AU - Steinemann, D. AU - Göhring, G. AU - Schlegelberger, B. AU - Haas, O. A. AU - Schewe, D. AU - Buchmann, S. AU - Moericke, A. AU - White, D. AU - Revesz, T. AU - Stanulla, M. AU - Mann, G. AU - Bodmer, N. AU - Arad-Cohen, N. AU - Zuna, J. AU - Valsecchi, M. G. AU - Zimmermann, M. AU - Schrappe, M. AU - Biondi, A. DB - Scopus DO - 10.3324/haematol.2019.231720 IS - 7 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 1887-1894 ST - Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols T2 - Haematologica TI - Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084210841&doi=10.3324%2fhaematol.2019.231720&partnerID=40&md5=ef079e8c7ed84160f1d645d20b3826f7 VL - 105 ID - 7644 ER - TY - JOUR AD - S. Barbarot, Dermatology Department, CHU Hôtel Dieu, 1 place Alexis Ricordeau, 44093, Nantes Cedex, France AU - Miquel, J. AU - Vourc'H-Jourdain, M. AU - Thomas, C. AU - Cassagnau, E. AU - Stalder, J. F. AU - Barbarot, S. DB - Embase Medline DO - 10.1111/ced.12101 IS - 7 LA - English M3 - Article N1 - L369929738 2013-10-10 2013-10-11 PY - 2013 SN - 0307-6938 1365-2230 SP - 741-744 ST - Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant T2 - Clinical and Experimental Dermatology TI - Relapsing lymphomatoid papulosis after allogenic bone-marrow transplant UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369929738&from=exporthttp://dx.doi.org/10.1111/ced.12101 VL - 38 ID - 7645 ER - TY - JOUR AD - M.-L. Jullie, St John's Institute of Dermatopathology and Dermatology, London, United Kingdom AU - Jullie, M. L. AU - Garcia-Herrera, A. AU - Calonje, E. AU - Child, F. AU - Ortonne, N. AU - Carp, L. AU - Coppen, M. DB - Embase DO - 10.1111/bjd.13796 LA - English M3 - Conference Abstract N1 - L71969638 2015-08-08 PY - 2015 SN - 0007-0963 SP - 126 ST - The relationship between CD30+ intravascular T-cell lymphoproliferations and reactive processes T2 - British Journal of Dermatology TI - The relationship between CD30+ intravascular T-cell lymphoproliferations and reactive processes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71969638&from=exporthttp://dx.doi.org/10.1111/bjd.13796 VL - 173 ID - 7646 ER - TY - JOUR AD - Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, PR China. AN - 19082454 AU - Hu, K. AU - Gan, Y. H. AU - Li, S. L. AU - Gao, Y. AU - Wu, D. C. AU - Wang, C. Y. AU - Yu, G. Y. DA - Jan DP - Nlm ET - 2008/12/17 IS - 1 LA - eng N1 - Hu, Kai Gan, Ye-Hua Li, Sheng-Lin Gao, Yan Wu, Deng-Cheng Wang, Cun-Yu Yu, Guang-Yan Journal Article Research Support, Non-U.S. Gov't Greece Oncol Rep. 2009 Jan;21(1):137-43. PY - 2009 SN - 1021-335X (Print) 1021-335x SP - 137-43 ST - Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma T2 - Oncol Rep TI - Relationship of activated extracellular signal-regulated kinase 1/2 with lung metastasis in salivary adenoid cystic carcinoma VL - 21 ID - 7647 ER - TY - JOUR AD - Department of Pathology, Gülhane Military Medical Academy and School of Medicine, Ankara, Turkey. bkurt@gata.edu.tr AN - 22767446 AU - Kurt, B. AU - Yalçın, S. AU - Alagöz, E. AU - Karslıoğlu, Y. AU - Yigit, N. AU - Günal, A. AU - Deveci, M. S. DA - Sep DO - 10.1007/s12022-012-9218-7 10.1007/s12022-012-9218-7. DP - Nlm ET - 2012/07/07 IS - 3 LA - eng PY - 2012 SN - 1046-3976 SP - 135-40 ST - The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas T2 - Endocr Pathol TI - The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas VL - 23 ID - 7648 ER - TY - JOUR AD - GlaxoSmithKline, Collegeville, PA, USA. Sarah Cannon Research Institute, Nashville, TN, USA. Pinnacle Oncology Hematology, Scottsdale, AZ, USA. AN - 27136909 AU - Cox, D. S. AU - Allred, A. AU - Zhou, Y. AU - Infante, J. R. AU - Gordon, M. S. AU - Bendell, J. AU - Jones, S. AU - Burris, H., 3rd AU - Orford, K. DA - Jul DO - 10.1002/cpdd.152 10.1002/cpdd.152. Epub 2014 Oct 27. DP - Nlm ET - 2016/05/04 IS - 4 LA - eng PY - 2015 SN - 2160-763x SP - 287-94 ST - Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors T2 - Clin Pharmacol Drug Dev TI - Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors VL - 4 ID - 7649 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan AU - Sasaki, K. AU - Strom, S. S. AU - O'Brien, S. AU - Jabbour, E. AU - Ravandi, F. AU - Konopleva, M. AU - Borthakur, G. AU - Pemmaraju, N. AU - Daver, N. AU - Jain, P. AU - Pierce, S. AU - Kantarjian, H. AU - Cortes, J. E. DB - Scopus DO - 10.1016/S2352-3026(15)00048-4 IS - 5 M3 - Article N1 - Cited By :112 Export Date: 18 November 2020 PY - 2015 SP - e186-e193 ST - Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials T2 - The Lancet Haematology TI - Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029353793&doi=10.1016%2fS2352-3026%2815%2900048-4&partnerID=40&md5=9aba92d53a23f6f6f177f23884afd6b7 VL - 2 ID - 7650 ER - TY - JOUR AD - Division of Pediatric Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey AU - Aksu, T. AU - Ünal, Ş AU - Gümrük, F. DB - Scopus DO - 10.24953/turkjped.2020.03.016 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 479-481 ST - The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia T2 - Turkish Journal of Pediatrics TI - The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086719637&doi=10.24953%2fturkjped.2020.03.016&partnerID=40&md5=25d84900d78bbcbd06b12ad2df83c678 VL - 62 ID - 7651 ER - TY - JOUR AD - S.-J. Kim, Seoul National University Hospital, Seoul, South Korea AU - Kim, S. J. AU - Kim, D. W. AU - Kim, T. M. AU - Lee, S. H. AU - Heo, D. S. AU - Bang, Y. J. DB - Embase Medline DO - 10.1200/JCO.2011.39.9766 IS - 16 LA - English M3 - Article N1 - L365265679 2012-07-25 2012-07-31 PY - 2012 SN - 0732-183X 1527-7755 SP - e147-e150 ST - Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer T2 - Journal of Clinical Oncology TI - Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365265679&from=exporthttp://dx.doi.org/10.1200/JCO.2011.39.9766http://jco.ascopubs.org/content/30/16/e147.full.pdf+html VL - 30 ID - 7652 ER - TY - JOUR AD - Ashirwad Haematology Centre, Ghamat Lodge, 804/A, Dr. B. Ambedkar Road, Mumbai - 400 014, Maharashtra, India AU - Agarwal, M. B. AU - Agarwal, U. AU - Rathi, S. AU - Masurkar, S. AU - Zaveri, B. DB - Scopus DO - 10.4103/0971-5851.123741 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 199-203 ST - Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009 T2 - Indian Journal of Medical and Paediatric Oncology TI - Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891845037&doi=10.4103%2f0971-5851.123741&partnerID=40&md5=b548787d576b9747d924624266f3fcfa VL - 34 ID - 7653 ER - TY - JOUR AD - C. Miller, Department of Neurosurgery, University of Minnesota, 420 Delaware St. SE, MMC 96, Rm. D429, Mayo Building, Minneapolis, MN, United States AU - Miller, C. AU - Guillaume, D. AU - Dusenbery, K. AU - Clark, H. B. AU - Moertel, C. C1 - mekinist(Glaxo SmithKline) C2 - Glaxo SmithKline DB - Embase Medline DO - 10.3171/2016.9.PEDS16328 IS - 3 LA - English M3 - Article N1 - L616482184 2017-06-01 2017-06-06 PY - 2017 SN - 1933-0715 1933-0707 SP - 319-324 ST - Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: Documentation of volumetric response T2 - Journal of Neurosurgery: Pediatrics TI - Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: Documentation of volumetric response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616482184&from=exporthttp://dx.doi.org/10.3171/2016.9.PEDS16328 VL - 19 ID - 7654 ER - TY - JOUR AD - V. Vasko, Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4712, United States AU - Kushchayeva, Y. AU - Jensen, K. AU - Burman, K. D. AU - Vasko, V. C1 - viracept DB - Embase Medline DO - 10.1530/ERC-13-0473 IS - 3 LA - English M3 - Review N1 - L373428067 2014-07-10 2014-07-18 PY - 2014 SN - 1479-6821 1351-0088 SP - R183-R194 ST - Repositioning therapy for thyroid cancer: New insights on established medications T2 - Endocrine-Related Cancer TI - Repositioning therapy for thyroid cancer: New insights on established medications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373428067&from=exporthttp://dx.doi.org/10.1530/ERC-13-0473 VL - 21 ID - 7655 ER - TY - JOUR AD - Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. Mucosal Immunobiology and Vaccine Center (MIVAC), Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, SE-405 30, Gothenburg, Sweden. Turning Point Therapeutics, Inc. 10628 Science Center Drive, Suite 200, San Diego, California, 92121, United States. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. ruth.palmer@gu.se. Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden. bengt.hallberg@gu.se. AN - 31852910 AU - Cervantes-Madrid, D. AU - Szydzik, J. AU - Lind, D. E. AU - Borenäs, M. AU - Bemark, M. AU - Cui, J. AU - Palmer, R. H. AU - Hallberg, B. C2 - PMC6920469 Therapeutics. All other authors declare no potential conflict of interest. DA - Dec 18 DO - 10.1038/s41598-019-55060-7 10.1038/s41598-019-55060-7. DP - Nlm ET - 2019/12/20 IS - 1 LA - eng PY - 2019 SN - 2045-2322 SP - 19353 ST - Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells T2 - Sci Rep TI - Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells VL - 9 ID - 7656 ER - TY - JOUR AD - National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, United States AU - Lundberg, L. AU - Brahms, A. AU - Hooper, I. AU - Carey, B. AU - Lin, S. C. AU - Dahal, B. AU - Narayanan, A. AU - Kehn-Hall, K. DB - Scopus DO - 10.1016/j.antiviral.2018.07.005 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 57-67 ST - Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses T2 - Antiviral Research TI - Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049512324&doi=10.1016%2fj.antiviral.2018.07.005&partnerID=40&md5=b1e189fba014d86537b9208b22060541 VL - 157 ID - 7657 ER - TY - JOUR AD - J. Luo, Department of Hematology, The Second Hospital of Hebei Medical University, Key Laboratory of Hematology, Shijiazhuang, Hebei, China AU - Zhang, X. AU - Yang, L. AU - Liu, X. AU - Nie, Z. AU - Wang, X. AU - Pan, Y. AU - Luo, J. C1 - lbh 589(Selleck,United States) C2 - Selleck(United States) DB - Embase Medline DO - 10.1111/bjh.14739 IS - 5 LA - English M3 - Article N1 - L616106621 2017-05-16 2017-08-30 PY - 2017 SN - 1365-2141 0007-1048 SP - 728-738 ST - Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia T2 - British Journal of Haematology TI - Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616106621&from=exporthttp://dx.doi.org/10.1111/bjh.14739 VL - 178 ID - 7658 ER - TY - JOUR AN - CN-01894510 AU - Isrctn PY - 2017 ST - A research study to compare treatment with dabrafenib and trametinib, either taken continuously every day, or intermittently (with planned treatment breaks in each cycle), in patients with metastatic Melanoma T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN18183156 TI - A research study to compare treatment with dabrafenib and trametinib, either taken continuously every day, or intermittently (with planned treatment breaks in each cycle), in patients with metastatic Melanoma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01894510/full ID - 7659 ER - TY - JOUR AD - C.E. McCoach, Division of Medical Oncology, UCSF Helen Diller Comprehensive Cancer Center, 1600 Divisadero St, MS 1770, San Francisco, CA, United States AU - McCoach, C. E. AU - Le, A. T. AU - Gowan, K. AU - Jones, K. AU - Schubert, L. AU - Doak, A. AU - Estrada-Bernal, A. AU - Davies, K. D. AU - Merrick, D. T. AU - Bunn, P. A. AU - Purcell, W. T. AU - Dziadziuszko, R. AU - Varella-Garcia, M. AU - Aisner, D. L. AU - Camidge, D. R. AU - Doebele, R. C. DB - Embase Medline DO - 10.1158/1078-0432.CCR-17-2452 IS - 14 LA - English M3 - Article N1 - L623054788 2018-07-25 PY - 2018 SN - 1557-3265 1078-0432 SP - 3334-3347 ST - Resistance mechanisms to targeted therapies in ROS1þ and ALKþ non–small cell lung cancer T2 - Clinical Cancer Research TI - Resistance mechanisms to targeted therapies in ROS1þ and ALKþ non–small cell lung cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623054788&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-17-2452 VL - 24 ID - 7660 ER - TY - JOUR AD - Leukemia Service, Department of Medicine, United States Cytogenetics Laboratory, United States Department of Pathology, New York University Langone Medical Center, United States Human Oncology and Pathogenesis Program, United States Adult Bone Marrow Transplant Service, all Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY, United States NeoGenomic Laboratories, Irvine, CA, United States AU - Berman, E. AU - Jhanwar, S. AU - Hedvat, C. AU - Arcila, M. E. AU - Wahab, O. A. AU - Levine, R. AU - Maloy, M. AU - Ma, W. AU - Albitar, M. DB - Scopus DO - 10.1016/j.leukres.2016.08.006 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2016 SP - 108-112 ST - Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL135INS T2 - Leukemia Research TI - Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL135INS UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988499747&doi=10.1016%2fj.leukres.2016.08.006&partnerID=40&md5=0d1263982d88e09ba4fbb516ffe30c25 VL - 49 ID - 7661 ER - TY - JOUR AD - E. Cocco, Memorial Sloan Kettering Cancer Center, New York, NY, United States AU - Cocco, E. AU - Kulick, A. AU - Misale, S. AU - Yaeger, R. AU - Razavi, P. AU - Won, H. H. AU - Ptashkin, R. AU - Hechtman, J. F. AU - Toska, E. AU - Cownie, J. AU - Somwar, R. AU - Shifman, S. AU - Mattar, M. AU - Selçuklu, S. D. AU - Samoila, A. AU - Guzman, S. AU - Tuch, B. B. AU - Ebata, K. AU - De Stanchina, E. AU - Nagy, R. J. AU - Lanman, R. B. AU - Berger, M. F. AU - Ladanyi, M. AU - Hyman, D. M. AU - Drilon, A. AU - Scaltriti, M. AU - Schram, A. M. DB - Embase DO - 10.1158/1538-7445.SABCS18-LB-118 IS - 13 LA - English M3 - Conference Abstract N1 - L628709858 2019-08-01 PY - 2019 SN - 1538-7445 ST - Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation T2 - Cancer Research TI - Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628709858&from=exporthttp://dx.doi.org/10.1158/1538-7445.SABCS18-LB-118 VL - 79 ID - 7662 ER - TY - JOUR AD - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Weill Cornell Medical College, New York, NY, USA. Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Loxo Oncology, South San Francisco, CA, USA. Department of Medical Affairs, Guardant Health Inc., Redwood City, CA, USA. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. drilona@mskcc.org. Weill Cornell Medical College, New York, NY, USA. drilona@mskcc.org. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scaltrim@mskcc.org. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. scaltrim@mskcc.org. AN - 31406350 AU - Cocco, E. AU - Schram, A. M. AU - Kulick, A. AU - Misale, S. AU - Won, H. H. AU - Yaeger, R. AU - Razavi, P. AU - Ptashkin, R. AU - Hechtman, J. F. AU - Toska, E. AU - Cownie, J. AU - Somwar, R. AU - Shifman, S. AU - Mattar, M. AU - Selçuklu, S. D. AU - Samoila, A. AU - Guzman, S. AU - Tuch, B. B. AU - Ebata, K. AU - de Stanchina, E. AU - Nagy, R. J. AU - Lanman, R. B. AU - Houck-Loomis, B. AU - Patel, J. A. AU - Berger, M. F. AU - Ladanyi, M. AU - Hyman, D. M. AU - Drilon, A. AU - Scaltriti, M. C2 - PMC6736691 C6 - NIHMS1533563 DA - Sep DO - 10.1038/s41591-019-0542-z 10.1038/s41591-019-0542-z. Epub 2019 Aug 12. DP - Nlm ET - 2019/08/14 IS - 9 LA - eng PY - 2019 SN - 1078-8956 (Print) 1078-8956 SP - 1422-1427 ST - Resistance to TRK inhibition mediated by convergent MAPK pathway activation T2 - Nat Med TI - Resistance to TRK inhibition mediated by convergent MAPK pathway activation VL - 25 ID - 7663 ER - TY - JOUR AD - H.-C. Kuo, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan AU - Hsieh, Y. Y. AU - Shen, C. H. AU - Huang, W. S. AU - Chin, C. C. AU - Kuo, Y. H. AU - Hsieh, M. C. AU - Yu, H. R. AU - Chang, T. S. AU - Lin, T. H. AU - Chiu, Y. W. AU - Chen, C. N. AU - Kuo, H. C. AU - Tung, S. Y. DB - Embase DO - 10.1186/1423-0127-21-59 IS - 1 LA - English M3 - Article N1 - L602967815 2015-03-24 2015-03-30 PY - 2015 SN - 1423-0127 1021-7770 ST - Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells T2 - Journal of Biomedical Science TI - Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602967815&from=exporthttp://dx.doi.org/10.1186/1423-0127-21-59 VL - 21 ID - 7664 ER - TY - JOUR AD - S.T. Ngu, Alan Lyell Centre for Dermatology, Queen Elizabeth University Hospital, Glasgow, United Kingdom AU - Ngu, S. T. AU - French, P. AU - Jury, C. AU - Bilsland, D. AU - Hague, R. DB - Embase DO - 10.1111/bjd.15428 LA - English M3 - Conference Abstract N1 - L617313393 2017-07-18 PY - 2017 SN - 1365-2133 SP - 22 ST - Resolution of primary cutaneous anaplastic large cell lymphoma with rapamycin T2 - British Journal of Dermatology TI - Resolution of primary cutaneous anaplastic large cell lymphoma with rapamycin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617313393&from=exporthttp://dx.doi.org/10.1111/bjd.15428 VL - 177 ID - 7665 ER - TY - JOUR AD - Department of Medicine, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, TX 77555-1060, United States Division of Endocrinology, MRB 8.138, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1060, United States AU - Choudhary, S. AU - Boldogh, S. AU - Garofalo, R. AU - Jamaluddin, M. AU - Brasier, A. R. DB - Scopus DO - 10.1128/JVI.79.14.8948-8959.2005 IS - 14 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2005 SP - 8948-8959 ST - Respiratory syncytial virus influences NF-κB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-κB2 T2 - Journal of Virology TI - Respiratory syncytial virus influences NF-κB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-κB2 UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-21644463312&doi=10.1128%2fJVI.79.14.8948-8959.2005&partnerID=40&md5=6d43d9c125911e58f442033be5809425 VL - 79 ID - 7666 ER - TY - JOUR AD - Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Internal Medicine, Ohio State University, Columbus, OH 43210, United States Department of Veterinary Biosciences, Ohio State University, Columbus, OH 43210, United States Institute of Behavioral Medicine Research, Ohio State University, Columbus, OH 43210, United States Booz Allen Hamilton, 4001 Fairfax Drive, Arlington, VA 22203, United States Lake Erie College of Osteopathic Medicine, 5000 Lakewood Ranch Boulevard, Bradenton, FL 34211, United States AU - Hinzey, A. AU - Alexander, J. AU - Corry, J. AU - Adams, K. M. AU - Claggett, A. M. AU - Traylor, Z. P. AU - Davis, I. C. AU - Marketon, J. I. W. DB - Scopus DO - 10.1210/en.2010-0774 IS - 2 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2011 SP - 483-494 ST - Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation T2 - Endocrinology TI - Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951635405&doi=10.1210%2fen.2010-0774&partnerID=40&md5=60c6b155e67c43d00bbe2c38de830e6e VL - 152 ID - 7667 ER - TY - JOUR AD - J. O. Lauchle, Department of Pediatrics, University of California, San Francisco, CA 94143, United States AU - Lauchle, J. O. AU - Kim, D. AU - Le, D. T. AU - Akagi, K. AU - Crone, M. AU - Krisman, K. AU - Warner, K. AU - Bonifas, J. M. AU - Li, Q. AU - Coakley, K. M. AU - Diaz-Flores, E. AU - Gorman, M. AU - Przybranowski, S. AU - Tran, M. AU - Kogan, S. C. AU - Roose, J. P. AU - Copeland, N. G. AU - Jenkins, N. A. AU - Parada, L. AU - Wolff, L. AU - Sebolt-Leopold, J. AU - Shannon, K. C1 - ci 1040(Pfizer) pd 0325901(Pfizer) sb 202190(Calbiochem) C2 - Calbiochem Pfizer DB - Embase Medline DO - 10.1038/nature08279 IS - 7262 LA - English M3 - Article N1 - L50629907 2009-10-02 PY - 2009 SN - 0028-0836 1476-4687 SP - 411-414 ST - Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras T2 - Nature TI - Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50629907&from=exporthttp://dx.doi.org/10.1038/nature08279 VL - 461 ID - 7668 ER - TY - JOUR AD - Division of Medical Oncology, Department of Internal Medicine, University of Michigan Medical Center, Comprehensive Cancer Center, Ann Arbor, MI, United States Department of Orthopedic Surgery, University of Michigan Medical Center, Comprehensive Cancer Center, Ann Arbor, MI, United States Division of Hematology, University of Michigan, 7216 CCGC, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0948, United States AU - Mace, J. AU - Sybil Biermann, J. AU - Sondak, V. AU - McGinn, C. AU - Hayes, C. AU - Thomas, D. AU - Baker, L. DB - Scopus DO - 10.1002/cncr.11029 IS - 11 M3 - Article N1 - Cited By :155 Export Date: 18 November 2020 PY - 2002 SP - 2373-2379 ST - Response of extraabdominal desmoid tumors to therapy with imatinib mesylate T2 - Cancer TI - Response of extraabdominal desmoid tumors to therapy with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036890418&doi=10.1002%2fcncr.11029&partnerID=40&md5=8695cf0eaa4ab0d14a5c6caf8b76f0a7 VL - 95 ID - 7669 ER - TY - JOUR AD - J.M. Olson, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, Seattle, WA 98109, United States AU - Spiller, S. E. AU - Ditzler, S. H. AU - Pullar, B. J. AU - Olson, J. M. C2 - Aton(United States) Sigma DB - Embase Medline DO - 10.1007/s11060-007-9505-1 IS - 2 LA - English M3 - Article N1 - L50007232 2008-04-15 PY - 2008 SN - 0167-594X 1573-7373 SP - 133-141 ST - Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA) T2 - Journal of Neuro-Oncology TI - Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50007232&from=exporthttp://dx.doi.org/10.1007/s11060-007-9505-1 VL - 87 ID - 7670 ER - TY - JOUR AD - Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia. Electronic address: adithya.balasubramanian@austin.org.au. Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia. Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia; La Trobe University School of Cancer Medicine, 145 Studley Road Heidelberg, Victoria 3084, Australia; Department of Medicine, University of Melbourne, 145 Studley Road Heidelberg, Victoria 3084, Australia. Department of Radiology, Austin Health, 145 Studley Road Heidelberg, Victoria 3084, Australia; University of Melbourne, Parkville, Victoria 3010, Australia. AN - 33070910 AU - Balasubramanian, A. AU - Gunjur, A. AU - Gan, H. K. AU - Perchyonok, Y. AU - Cher, L. M. DA - Sep DO - 10.1016/j.jocn.2020.07.028 10.1016/j.jocn.2020.07.028. Epub 2020 Aug 26. DP - Nlm ET - 2020/10/20 LA - eng PY - 2020 SN - 0967-5868 SP - 269-271 ST - Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma T2 - J Clin Neurosci TI - Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma VL - 79 ID - 7671 ER - TY - JOUR AD - Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Cancer Center, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, 6701 Fannin Street, Suite 1510.23, Houston, TX 77030, United States Department of Pediatrics, Division of Endocrinology, Alberta Children's Hospital, Calgary, AB, Canada Department of Pediatrics, Division of Hematology/Oncology, Loma Linda University, San Bernardino, CA, United States Department of Pathology and Immunology, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States Michael E. DeBakey Department of Surgery, Division of Pediatric Surgery, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States Department of Radiology, Texas Children's Hospital, Houston, TX, United States Department of Pediatrics, Division of Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States AU - Mahajan, P. AU - Dawrant, J. AU - Kheradpour, A. AU - Quintanilla, N. M. AU - Lopez, M. E. AU - Orth, R. C. AU - Athanassaki, I. AU - Venkatramani, R. DB - Scopus DO - 10.1089/thy.2018.0064 IS - 11 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2018 SP - 1450-1454 ST - Response to lenvatinib in children with papillary thyroid carcinoma T2 - Thyroid TI - Response to lenvatinib in children with papillary thyroid carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056307571&doi=10.1089%2fthy.2018.0064&partnerID=40&md5=5b4f72c8fb03b6cea0d322e41d0ab957 VL - 28 ID - 7672 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Yale University School of Medicine, New Haven, Connecticut. Department of Radiation Oncology, Yale University School of Medicine, New Haven, Connecticut. Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. Department of Neurosurgery, Yale University School of Medicine. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. AN - 29380516 AU - Marks, A. M. AU - Bindra, R. S. AU - DiLuna, M. L. AU - Huttner, A. AU - Jairam, V. AU - Kahle, K. T. AU - Kieran, M. W. DA - May DO - 10.1002/pbc.26969 10.1002/pbc.26969. Epub 2018 Jan 30. DP - Nlm ET - 2018/01/31 IS - 5 LA - eng PY - 2018 SN - 1545-5009 SP - e26969 ST - Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib T2 - Pediatr Blood Cancer TI - Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib VL - 65 ID - 7673 ER - TY - JOUR AD - Department of Haematology, Belfast City Hospital, Belfast, United Kingdom Department of Haematology, Altnagelvin Hospital, Derry, United Kingdom Centre for Medical Education, Queen’s University Belfast, Belfast, United Kingdom AU - McMullan, R. R. AU - McConville, C. AU - McMullin, M. F. DB - Scopus IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 105-110 ST - Response to therapy, treatment intolerance and tyrosine Kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid Leukaemia patients T2 - Ulster Medical Journal TI - Response to therapy, treatment intolerance and tyrosine Kinase inhibitor cessation eligibility in a real-world cohort of chronic myeloid Leukaemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065657881&partnerID=40&md5=dc0b9eaf5a5d26002fbfe85b4c96598d VL - 88 ID - 7674 ER - TY - JOUR AD - Hopp Children's Cancer Center (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany. Institute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Würzburg, Germany. Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. Department of Pediatric Oncology/Hematology, Charité Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin and Berlin Institute of Health, Berlin, Germany. Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Department of Neuropathology, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet Zu Berlin, and Berlin Institute of Health, Charité-Universitaetsmedizin Berlin, Berlin, Germany. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Berlin, Berlin, Germany. Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany. Hopp Children's Cancer Center (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. t.milde@kitz-heidelberg.de. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. t.milde@kitz-heidelberg.de. KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany. t.milde@kitz-heidelberg.de. AN - 33026636 AU - Selt, F. AU - van Tilburg, C. M. AU - Bison, B. AU - Sievers, P. AU - Harting, I. AU - Ecker, J. AU - Pajtler, K. W. AU - Sahm, F. AU - Bahr, A. AU - Simon, M. AU - Jones, D. T. W. AU - Well, L. AU - Mautner, V. F. AU - Capper, D. AU - Hernáiz Driever, P. AU - Gnekow, A. AU - Pfister, S. M. AU - Witt, O. AU - Milde, T. C2 - PMC7609413 DA - Sep DO - 10.1007/s11060-020-03640-3 DP - Nlm ET - 2020/10/08 IS - 3 LA - eng N1 - 1573-7373 Selt, Florian Orcid: 0000-0001-9717-6712 van Tilburg, Cornelis M Bison, Brigitte Sievers, Philipp Harting, Inga Ecker, Jonas Pajtler, Kristian W Sahm, Felix Bahr, Annabelle Simon, Michèle Jones, David T W Well, Lennart Mautner, Victor-Felix Capper, David Hernáiz Driever, Pablo Gnekow, Astrid Pfister, Stefan M Witt, Olaf Milde, Till PY - 2020 SN - 0167-594X (Print) 0167-594x SP - 499-510 ST - Response to trametinib treatment in progressive pediatric low-grade glioma patients T2 - J Neurooncol TI - Response to trametinib treatment in progressive pediatric low-grade glioma patients VL - 149 ID - 7675 ER - TY - JOUR AD - S.-X. Lin, Department of Pathology, Sun Yat-Sen University, Cancer Center, Guangzhou, China AU - Huang, J. L. AU - Zeng, J. AU - Wang, F. AU - Huang, Q. T. AU - Lu, J. B. AU - Li, X. M. AU - Chen, W. Q. AU - Zhu, C. M. AU - Jin, J. T. AU - Lin, S. X. DB - Embase Medline DO - 10.2217/pme-2016-0080 IS - 2 LA - English M3 - Article N1 - L614330059 2017-02-10 2018-09-14 PY - 2017 SN - 1744-828X 1741-0541 SP - 99-107 ST - Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions T2 - Personalized Medicine TI - Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614330059&from=exporthttp://dx.doi.org/10.2217/pme-2016-0080 VL - 14 ID - 7676 ER - TY - JOUR AD - Jiangsu Institute of Haematology, Key Laboratory of Thrombosis and Haemostasis, Ministry of Health, First Affiliated Hospital of Soochow University, Suzhou, China Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China Nanjing Medical University, Affiliated Wuxi Second Hospital, Department of Haematology, Zhongshan Road 68, Wuxi, 214002, China Jiangsu Institute of Haematology, First Affiliated Hospital of Soochow University, Shizi Street 188, Suzhou, 215006, China AU - Tan, J. AU - Xue, M. AU - Pan, J. AU - Cen, J. AU - Qi, X. AU - Liu, P. AU - Zhao, X. AU - Wu, P. AU - Wang, Q. AU - Liu, D. AU - Liu, Y. AU - Chen, S. AU - Wang, Z. DB - Scopus DO - 10.1159/000495335 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 79-86 ST - Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients T2 - Acta Haematologica TI - Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065909166&doi=10.1159%2f000495335&partnerID=40&md5=c27249b0d0a6918760c81eb9d22c4fcf VL - 142 ID - 7677 ER - TY - JOUR AD - Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria. Electronic address: guido.gualdoni@meduniwien.ac.at. AN - 24035785 AU - Gualdoni, G. A. AU - Kovarik, J. J. AU - Hofer, J. AU - Dose, F. AU - Pignitter, M. AU - Doberer, D. AU - Steinberger, P. AU - Somoza, V. AU - Wolzt, M. AU - Zlabinger, G. J. DA - Jan DO - 10.1016/j.bbagen.2013.09.009 10.1016/j.bbagen.2013.09.009. Epub 2013 Sep 12. DP - Nlm ET - 2013/09/17 IS - 1 LA - eng PY - 2014 SN - 0006-3002 (Print) 0006-3002 SP - 95-105 ST - Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation T2 - Biochim Biophys Acta TI - Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation VL - 1840 ID - 7678 ER - TY - JOUR AD - A. Quincozes-Santos, Department of Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil AU - Bobermin, L. D. AU - Quincozes-Santos, A. AU - Guerra, M. C. AU - Leite, M. C. AU - Souza, D. O. AU - Gonçalves, C. A. AU - Gottfried, C. C2 - Sigma(United States) DB - Embase Medline DO - 10.1371/journal.pone.0052164 IS - 12 L1 - internal-pdf://1884167637/journal.pone.0052164.PDF LA - English M3 - Article N1 - L366301817 2012-12-27 2013-01-09 PY - 2012 SN - 1932-6203 ST - Resveratrol Prevents Ammonia Toxicity in Astroglial Cells T2 - PLoS ONE TI - Resveratrol Prevents Ammonia Toxicity in Astroglial Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L366301817&from=exporthttp://dx.doi.org/10.1371/journal.pone.0052164 VL - 7 ID - 7679 ER - TY - JOUR AD - J. Zhang, Department of Orthodontics, School of Stomatology, Shandong University, 44-1 Wenhua Xi road, Jinan, Shandong, China AU - Yuan, J. AU - Wang, X. AU - Ma, D. AU - Gao, H. AU - Zheng, D. AU - Zhang, J. C1 - pd 98059 DB - Embase Medline DO - 10.3892/mmr.2020.11021 IS - 5 LA - English M3 - Article N1 - L2005368189 2020-04-07 PY - 2020 SN - 1791-3004 1791-2997 SP - 2085-2094 ST - Resveratrol rescues TNF-α-induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway T2 - Molecular Medicine Reports TI - Resveratrol rescues TNF-α-induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005368189&from=exporthttp://dx.doi.org/10.3892/mmr.2020.11021 VL - 21 ID - 7680 ER - TY - JOUR AD - B. Salehian, City of Hope, Department of Diabetes, Endocrine and Metabolism, CA, United States AU - Salehian, B. AU - Samoa, R. DB - Embase Medline DO - 10.4274/Jcrpe.870 IS - SUPPL.1 LA - English M3 - Review N1 - L368446540 2013-03-11 2013-03-26 PY - 2013 SN - 1308-5727 1308-5735 SP - 70-78 ST - RET gene abnormalities and thyroid disease: Who should be screened and when T2 - JCRPE Journal of Clinical Research in Pediatric Endocrinology TI - RET gene abnormalities and thyroid disease: Who should be screened and when UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368446540&from=exporthttp://dx.doi.org/10.4274/Jcrpe.870http://www.jcrpe.org/sayilar/44/buyuk/70-78.pdf VL - 5 ID - 7681 ER - TY - JOUR AD - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. AN - 23436219 AU - Leeman-Neill, R. J. AU - Brenner, A. V. AU - Little, M. P. AU - Bogdanova, T. I. AU - Hatch, M. AU - Zurnadzy, L. Y. AU - Mabuchi, K. AU - Tronko, M. D. AU - Nikiforov, Y. E. C2 - PMC3648615 C6 - NIHMS416400 DA - May 15 DO - 10.1002/cncr.27893 10.1002/cncr.27893. Epub 2013 Feb 21. DP - Nlm ET - 2013/02/26 IS - 10 LA - eng PY - 2013 SN - 0008-543X (Print) 0008-543x SP - 1792-9 ST - RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics T2 - Cancer TI - RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics VL - 119 ID - 7682 ER - TY - JOUR AD - G. I. Liou, Department of Ophthalmology, Medical College of Georgia, Augusta, GA, United States AU - Ibrahim, A. S. AU - El-Remessy, A. B. AU - Matragoon, S. AU - Zhang, W. AU - Patel, Y. AU - Khan, S. AU - Al-Gayyar, M. M. AU - El-Shishtawy, M. M. AU - Liou, G. I. DB - Embase Medline DO - 10.2337/db10-1160 IS - 4 LA - English M3 - Article N1 - L361526539 2011-04-06 2011-04-12 PY - 2011 SN - 0012-1797 1939-327X SP - 1122-1133 ST - Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes T2 - Diabetes TI - Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361526539&from=exporthttp://dx.doi.org/10.2337/db10-1160http://diabetes.diabetesjournals.org/content/60/4/1122.full.pdf+html VL - 60 ID - 7683 ER - TY - JOUR AD - K. Ishii, First Department of Internal Medicine, Division of Hematology and Oncology, Kansai Medical University, Osaka, Japan AU - Nakaya, A. AU - Ishii, K. AU - Fujita, S. AU - Satake, A. AU - Nakanishi, T. AU - Azuma, Y. AU - Tsubokura, Y. AU - Saito, R. AU - Konishi, A. AU - Hotta, M. AU - Yoshimura, H. AU - Ito, T. AU - Nomura, S. DB - Embase LA - English M3 - Conference Abstract N1 - L629911914 2019-11-26 PY - 2019 SN - 2572-9241 SP - 933 ST - Retrospective analysis of adolescent and young adult (AYA) with lymphoma in Japan T2 - HemaSphere TI - Retrospective analysis of adolescent and young adult (AYA) with lymphoma in Japan UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629911914&from=export VL - 3 ID - 7684 ER - TY - JOUR AD - S. Janssens, University Hospital Leuven, Dermatologie, Leuven, Belgium AU - Janssens, S. AU - Morren, M. A. AU - Renard, M. AU - Hauben, E. AU - DeHaes, P. AU - Busschots, A. DB - Embase DO - 10.1111/pde.13268 LA - English M3 - Conference Abstract N1 - L618779330 2017-10-23 PY - 2017 SN - 1525-1470 SP - S42 ST - A retrospective cohort study of cutaneous lymphoma diagnosed in children in the University Hospital in Leuven T2 - Pediatric Dermatology TI - A retrospective cohort study of cutaneous lymphoma diagnosed in children in the University Hospital in Leuven UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618779330&from=exporthttp://dx.doi.org/10.1111/pde.13268 VL - 34 ID - 7685 ER - TY - JOUR AD - Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark. Research Center, Danish Cancer Society, Copenhagen, Denmark. Research Unit, Section of General Practice, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark. Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. Division of Pathology, Department of Molecular and Clinical Medicine, Royal Liverpool University Hospital, Liverpool, England. Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark4Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark. AN - 26425792 AU - Larsen, A. C. AU - Dahmcke, C. M. AU - Dahl, C. AU - Siersma, V. D. AU - Toft, P. B. AU - Coupland, S. E. AU - Prause, J. U. AU - Guldberg, P. AU - Heegaard, S. DA - Nov DO - 10.1001/jamaophthalmol.2015.3200 10.1001/jamaophthalmol.2015.3200. DP - Nlm ET - 2015/10/02 IS - 11 LA - eng PY - 2015 SN - 2168-6165 SP - 1295-303 ST - A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations T2 - JAMA Ophthalmol TI - A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations VL - 133 ID - 7686 ER - TY - JOUR AD - Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province 450008, China Department of Medical Oncology, The Affiliated People’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450003, China Department of Orthopedics, the People’s Hospital of Jiyuan, Jiyuan, Henan Province 459000, China Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province 450008, China AU - Tian, Z. AU - Liu, H. AU - Zhang, F. AU - Li, L. AU - Du, X. AU - Li, C. AU - Yang, J. AU - Wang, J. DB - Scopus DO - 10.1007/s10637-020-00912-7 IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 1559-1569 ST - Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma T2 - Investigational New Drugs TI - Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087841867&doi=10.1007%2fs10637-020-00912-7&partnerID=40&md5=f4dd324779ddb38e13314ac35d4db40d VL - 38 ID - 7687 ER - TY - JOUR AU - Department of, Medical AU - Pediatric Oncology, The Gujarat Cancer AU - Research Institute, Ahmedabad Gujarat India DB - Scopus IS - 23 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 15-20 ST - A Retrospective Study of Clinical Profile and Long Term Outcome to Imatinib Mesylate Alone in Childhood Chronic Myeloid Leukemia in Chronic Phase T2 - The Gulf journal of oncology TI - A Retrospective Study of Clinical Profile and Long Term Outcome to Imatinib Mesylate Alone in Childhood Chronic Myeloid Leukemia in Chronic Phase UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061116921&partnerID=40&md5=dd2ff5073763525c4e64d8bd6208111b VL - 1 ID - 7688 ER - TY - JOUR AD - Pharmacy Department, University Hospital Hematological Malignancies Registry, Burgundy University Hematology Department, University Hospital AN - 109815057. Language: English. Entry Date: 20150728. Revision Date: 20200708. Publication Type: Journal Article AU - Lang, A. S. AU - Mounier, M. AU - Roques, M. AU - Chretien, M. L. AU - Boulin, M. DB - ccm DO - 10.1111/jcpt.12273 DP - EBSCOhost IS - 4 N1 - research; tables/charts. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. NLM UID: 8704308. PMID: NLM25865674. PY - 2015 SN - 0269-4727 SP - 391-397 ST - A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years T2 - Journal of Clinical Pharmacy & Therapeutics TI - A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109815057&site=ehost-live&scope=site VL - 40 ID - 7689 ER - TY - JOUR AD - M. Pinter, Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria AU - Pinter, M. AU - Peck-Radosavljevic, M. C1 - fgf 401 DB - Embase Medline DO - 10.1111/apt.14913 IS - 6 LA - English M3 - Review N1 - L623244376 2018-08-01 2018-08-30 PY - 2018 SN - 1365-2036 0269-2813 SP - 598-609 ST - Review article: systemic treatment of hepatocellular carcinoma T2 - Alimentary Pharmacology and Therapeutics TI - Review article: systemic treatment of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623244376&from=exporthttp://dx.doi.org/10.1111/apt.14913 VL - 48 ID - 7690 ER - TY - JOUR AD - P. Ashwood, Div. Rheumatol., Allerg./Clin. I., Department of Internal Medicine, University of California, One Shield's Avenue, Davis, CA 95616, United States AU - Ashwood, P. AU - Van De Water, J. DB - Embase Medline DO - 10.1080/10446670410001722096 IS - 2 LA - English M3 - Review N1 - L38955074 2004-08-10 PY - 2004 SN - 1740-2522 SP - 165-174 ST - A review of autism and the immune response T2 - Clinical and Developmental Immunology TI - A review of autism and the immune response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38955074&from=exporthttp://dx.doi.org/10.1080/10446670410001722096 VL - 11 ID - 7691 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO 64108, United States AU - Fulbright, J. M. C7 - 942090 DB - Scopus DO - 10.4061/2011/942090 IS - 1 M3 - Review N1 - Cited By :41 Export Date: 18 November 2020 PY - 2011 ST - Review of cardiotoxicity in pediatric cancer patients: During and after therapy T2 - Cardiology Research and Practice TI - Review of cardiotoxicity in pediatric cancer patients: During and after therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052679204&doi=10.4061%2f2011%2f942090&partnerID=40&md5=2aa3cd40a55d2961c60504004600bf54 VL - 1 ID - 7692 ER - TY - JOUR AU - Cao, H. AU - Alrejaye, N. AU - Klein, O. D. AU - Goodwin, A. F. AU - Oberoi, S. DB - Medline DO - 10.1111/ocr.12144 LA - English M3 - Review N1 - L622854899 2018-07-06 PY - 2017 SN - 1601-6343 SP - 32-38 ST - A review of craniofacial and dental findings of the RASopathies T2 - Orthodontics & craniofacial research TI - A review of craniofacial and dental findings of the RASopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622854899&from=exporthttp://dx.doi.org/10.1111/ocr.12144 VL - 20 ID - 7693 ER - TY - JOUR AD - Department of Dermatology, St. Luke's-Roosevelt Hospital Center., United States AU - Scheinfeld, N. DB - Scopus IS - 3 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2007 SP - 352-355 ST - A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine T2 - Journal of drugs in dermatology : JDD TI - A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247197662&partnerID=40&md5=d74d3fca6f20554f5bbec8f740a04cbc VL - 6 ID - 7694 ER - TY - JOUR AD - Northwestern University, Department of Dermatology, Chicago, IL, United States AU - Tan, A. U. AU - Schlosser, B. J. AU - Paller, A. S. DB - Scopus DO - 10.1016/j.ijwd.2017.10.006 IS - 2 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2018 SP - 56-71 ST - A review of diagnosis and treatment of acne in adult female patients T2 - International Journal of Women's Dermatology TI - A review of diagnosis and treatment of acne in adult female patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038860277&doi=10.1016%2fj.ijwd.2017.10.006&partnerID=40&md5=240752adebd156d7f7cc656ae864b228 VL - 4 ID - 7695 ER - TY - JOUR AD - C. Willis, Royal Hospital for Children, Paediatric Oncology, Glasgow, United Kingdom AU - Willis, C. AU - Murphy, D. AU - Ronghe, M. AU - McIntosh, D. AU - Sastry, J. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179038 2018-10-11 PY - 2018 SN - 1545-5017 SP - S421 ST - A review of outcomes for paediatric patients with solid tumours treated with targeted therapies in the west of scotland T2 - Pediatric Blood and Cancer TI - A review of outcomes for paediatric patients with solid tumours treated with targeted therapies in the west of scotland UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179038&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 7696 ER - TY - JOUR AD - M. Good, Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, MO, United States AU - Nolan, L. S. AU - Parks, O. B. AU - Good, M. DB - Embase Medline DO - 10.3390/nu12010014 IS - 1 LA - English M3 - Review N1 - L2003390609 2020-01-06 2020-01-08 PY - 2020 SN - 2072-6643 ST - A review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis T2 - Nutrients TI - A review of the immunomodulating components of maternal breast milk and protection against necrotizing enterocolitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003390609&from=exporthttp://dx.doi.org/10.3390/nu12010014 VL - 12 ID - 7697 ER - TY - JOUR AD - Robinson Institute, Department of Paediatrics and Reproductive Health, Faculty of Health Sciences, University of Adelaide, Frome Road, Adelaide, SA 5005, Australia AU - Clifton, V. L. DB - Scopus DO - 10.1016/j.placenta.2009.11.010 IS - SUPPL. M3 - Article N1 - Cited By :420 Export Date: 18 November 2020 PY - 2010 SP - S33-S39 ST - Review: Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival T2 - Placenta TI - Review: Sex and the Human Placenta: Mediating Differential Strategies of Fetal Growth and Survival UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77049105365&doi=10.1016%2fj.placenta.2009.11.010&partnerID=40&md5=aedbe66df2fc9a303c431f596ad627e6 VL - 31 ID - 7698 ER - TY - JOUR AD - F. Bautista, INSERM U1018, CESP, Univ. Paris-Sud, Univ. Paris-Saclay, Villejuif, France AU - Bautista, F. AU - Moreno, L. AU - Marshall, L. AU - Pearson, A. D. J. AU - Geoerger, B. AU - Paoletti, X. C1 - lde 225 ldk 378 lee 011 DB - Embase Medline DO - 10.1016/j.ejca.2017.09.015 LA - English M3 - Article N1 - L618790053 2017-10-26 2017-10-31 PY - 2017 SN - 1879-0852 0959-8049 SP - 275-284 ST - Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium T2 - European Journal of Cancer TI - Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618790053&from=exporthttp://dx.doi.org/10.1016/j.ejca.2017.09.015 VL - 86 ID - 7699 ER - TY - JOUR AD - Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of Utah, Salt Lake City, UT, United States Department of Pathology, Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE, United States Department of Orthopedics, Huntsman Cancer Institute Sarcoma Service, University of Utah, Salt Lake City, UT, United States Department of Laboratory Medicine, Columbus Children's Hospital, Columbus, OH, United States Children's Cancer Research Institute, University of Texas Health Science Center, 8403 Floyd Curl Drive, San Antonio, TX 78229-3900, United States AU - Blandford, M. C. AU - Barr, F. G. AU - Lynch, J. C. AU - Randall, R. L. AU - Qualman, S. J. AU - Keller, C. DB - Scopus DO - 10.1002/pbc.20466 IS - 3 M3 - Article N1 - Cited By :43 Export Date: 18 November 2020 PY - 2006 SP - 329-338 ST - Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group T2 - Pediatric Blood and Cancer TI - Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: A report from the children's oncology group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-32044469857&doi=10.1002%2fpbc.20466&partnerID=40&md5=498c5ff39f6487ced4606bf053808d0d VL - 46 ID - 7700 ER - TY - JOUR AD - Z. Wang, State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital, Changle West Road #169, Xi'an 710032, China AU - Fan, L. AU - Li, P. AU - Yin, Z. AU - Fu, G. AU - Liao, D. J. AU - Liu, Y. AU - Zhu, J. AU - Zhang, Y. AU - Wang, L. AU - Yan, Q. AU - Guo, Y. AU - Shao, C. AU - Huang, G. AU - Wang, Z. DB - Embase Medline DO - 10.1038/bjc.2013.463 IS - 5 LA - English M3 - Article N1 - L52728569 2013-08-16 2013-09-18 PY - 2013 SN - 0007-0920 1532-1827 SP - 1137-1146 ST - Ribosomal s6 protein kinase 4: A prognostic factor for renal cell carcinoma T2 - British Journal of Cancer TI - Ribosomal s6 protein kinase 4: A prognostic factor for renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52728569&from=exporthttp://dx.doi.org/10.1038/bjc.2013.463 VL - 109 ID - 7701 ER - TY - JOUR AD - Pediatric Oncology Branch, National Cancer Institute. Molecular Oncology Section, Pediatric Oncology Branch, CCR, NCI, NIH. Laboratory of Cellular and Molecular Biolgoy, National Cancer Institute. Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH. Division of Preclinical Innovation, NCATS, NIH. Frederick National Laboratory for Cancer Research, National Cancer Institute. Laboratory of Animal Science Program, Leidos Biomedical Research Inc.,Frederick National Laboratory for Cancer Research. Collaborative Protein Technology Resource, Laboratory of Cell Biology, NCI, NIH. Laboratory of Biochemistry and Molecular Biology, National Cancer Institute. Medical Oncology Branch, National Institutes of Health. National Center for Advancing Translational Sciences, National Institutes of Health. Limb / ppb, nichd / nih. Laboratory of Cell and Developmental Signaling, National Cancer Institute. Pediatric Oncology Branch, National Cancer Institute yoheme@mail.nih.gov. AN - 33158997 AU - Kowalczyk, J. T. AU - Wan, X. AU - Hernandez, E. R. AU - Luo, R. AU - Lyons, G. C. AU - Wilson, K. M. AU - Gallardo, D. C. AU - Isanogle, K. A. AU - Robinson, C. M. AU - Mendoza, A. AU - Heske, C. M. AU - Chen, J. Q. AU - Luo, X. AU - Kelly, A. E. AU - Difilippantonio, S. AU - Robey, R. W. AU - Thomas, C. J. AU - Sackett, D. L. AU - Morrison, D. K. AU - Randazzo, P. A. AU - Miller Jenkins, L. M. AU - Yohe, M. E. DA - Nov 6 DO - 10.1158/1535-7163.Mct-20-0525 10.1158/1535-7163.MCT-20-0525. DP - Nlm ET - 2020/11/08 LA - eng PY - 2020 SN - 1535-7163 ST - Rigosertib induces mitotic arrest and apoptosis in RAS-driven rhabdomyosarcoma and neuroblastoma T2 - Mol Cancer Ther TI - Rigosertib induces mitotic arrest and apoptosis in RAS-driven rhabdomyosarcoma and neuroblastoma ID - 7702 ER - TY - JOUR AD - R.S. Geha, Div. of Immunology, 1 Blackfan Circle, Boston, MA 02115, United States AU - Vivarelli, M. S. AU - McDonald, D. AU - Miller, M. AU - Cusson, N. AU - Kelliher, M. AU - Geha, R. S. DB - Embase Medline DO - 10.1084/jem.20040446 IS - 3 LA - English M3 - Article N1 - L39031258 2004-08-23 PY - 2004 SN - 0022-1007 SP - 399-404 ST - RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation T2 - Journal of Experimental Medicine TI - RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39031258&from=exporthttp://dx.doi.org/10.1084/jem.20040446 VL - 200 ID - 7703 ER - TY - JOUR AD - Department of Medicine, Centre Léon Bérard, Lyon, France Headquarters, Unicancer, Paris, France LYRICAN, Lyon, France Faculte Lyon Est, Université Claude Bernard, Lyon, France Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain Department of Medicine, Portland VA Health Care System, Portland, OR, United States OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States Department of Epidemiology and Preventative Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia Department of Medical Oncology, West German Cancer Center, University of Duisburg-Essen, Essen, Germany German Consortium for Translational Cancer Research (DKTK), Partner Site Essen, Germany Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands Leuven Cancer Institute and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United States Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Weill Cornell Medicine, New York, NY, United States Department of Oncology, Helios Klinikum Berlin-Buch, Berlin, Germany Deciphera Pharmaceuticals, Waltham, MA, United States Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States AU - Blay, J. Y. AU - Serrano, C. AU - Heinrich, M. C. AU - Zalcberg, J. AU - Bauer, S. AU - Gelderblom, H. AU - Schöffski, P. AU - Jones, R. L. AU - Attia, S. AU - D'Amato, G. AU - Chi, P. AU - Reichardt, P. AU - Meade, J. AU - Shi, K. AU - Ruiz-Soto, R. AU - George, S. AU - von Mehren, M. DB - Scopus DO - 10.1016/S1470-2045(20)30168-6 IS - 7 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2020 SP - 923-934 ST - Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial T2 - The Lancet Oncology TI - Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086649923&doi=10.1016%2fS1470-2045%2820%2930168-6&partnerID=40&md5=5a5064c6246fc952dbd010121f7f9e7b VL - 21 ID - 7704 ER - TY - JOUR AD - Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan AN - 108214646. Language: English. Entry Date: 20120518. Revision Date: 20170411. Publication Type: journal article AU - Minami-Shimmyo, Y. AU - Ohe, Y. AU - Yamamoto, S. AU - Sumi, M. AU - Nokihara, H. AU - Horinouchi, H. AU - Yamamoto, N. AU - Sekine, I. AU - Kubota, K. AU - Tamura, T. AU - Minami-Shimmyo, Yuko AU - Ohe, Yuichiro AU - Yamamoto, Seiichiro AU - Sumi, Minako AU - Nokihara, Hiroshi AU - Horinouchi, Hidehito AU - Yamamoto, Noboru AU - Sekine, Ikuo AU - Kubota, Kaoru AU - Tamura, Tomohide DB - ccm DO - 10.1097/JTO.0b013e31823c4c07 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA. Special Interest: Oncologic Care. NLM UID: 101274235. PMID: NLM22134071. PY - 2012 SN - 1556-0864 SP - 177-182 ST - Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer T2 - Journal of Thoracic Oncology TI - Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108214646&site=ehost-live&scope=site VL - 7 ID - 7705 ER - TY - JOUR AD - Laboratory of Intracellular Signaling in Health and Disease, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russian Federation Biological Faculty, Lomonosov Moscow State University, Moscow, 119234, Russian Federation AU - Gorbacheva, A. M. AU - Korneev, K. V. AU - Kuprash, D. V. AU - Mitkin, N. A. C7 - 2911 DB - Scopus DO - 10.3390/ijms19102911 IS - 10 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 ST - The risk G allele of the single-nucleotide polymorphism rs928413 creates a CREB1-binding site that activates IL33 promoter in lung epithelial cells T2 - International Journal of Molecular Sciences TI - The risk G allele of the single-nucleotide polymorphism rs928413 creates a CREB1-binding site that activates IL33 promoter in lung epithelial cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054130043&doi=10.3390%2fijms19102911&partnerID=40&md5=66cfa9e6112f6a502bb1d33c2c1aef77 VL - 19 ID - 7706 ER - TY - JOUR AD - Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom Center for Primary Health Care Research, Lund University, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, United States Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Japan Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Finland Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom AU - Chattopadhyay, S. AU - Zheng, G. AU - Sud, A. AU - Yu, H. AU - Sundquist, K. AU - Sundquist, J. AU - Försti, A. AU - Hemminki, A. AU - Houlston, R. AU - Hemminki, K. DB - Scopus DO - 10.1016/S2352-3026(18)30108-X IS - 8 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - e368-e377 ST - Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden T2 - The Lancet Haematology TI - Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050728636&doi=10.1016%2fS2352-3026%2818%2930108-X&partnerID=40&md5=194eecb2ac6e74169aca380460b2d52f VL - 5 ID - 7707 ER - TY - JOUR AD - Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States Leukemia/Lymphoma Developmental Therapeutics, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States Hematological Malignancies Program, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Jeha, S. AU - Pui, C. H. DB - Scopus DO - 10.1016/j.hoc.2009.07.009 IS - 5 M3 - Review N1 - Cited By :26 Export Date: 18 November 2020 PY - 2009 SP - 973-990 ST - Risk-adapted Treatment of Pediatric Acute Lymphoblastic Leukemia T2 - Hematology/Oncology Clinics of North America TI - Risk-adapted Treatment of Pediatric Acute Lymphoblastic Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349756898&doi=10.1016%2fj.hoc.2009.07.009&partnerID=40&md5=9fc4038049542cc65c186170187a0b99 VL - 23 ID - 7708 ER - TY - JOUR AD - J. Golay, Lab. Cell. Gene Ther. G. L., Presidio Matteo Rota, Ospedali Riuniti Bergamo, via Garibaldi 11-13, 24128 Bergamo, Italy AU - Cittera, E. AU - Onofri, C. AU - D'Apolito, M. AU - Cartron, G. AU - Cazzaniga, G. AU - Zelante, L. AU - Paolucci, P. AU - Biondi, A. AU - Introna, M. AU - Golay, J. DB - Embase Medline DO - 10.1007/s00262-004-0599-4 IS - 3 LA - English M3 - Article N1 - L40174245 2005-02-11 PY - 2005 SN - 0340-7004 SP - 273-286 ST - Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines T2 - Cancer Immunology, Immunotherapy TI - Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40174245&from=exporthttp://dx.doi.org/10.1007/s00262-004-0599-4 VL - 54 ID - 7709 ER - TY - JOUR AD - M.B. Yaffe, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States AU - Dreaden, E. C. AU - Kong, Y. W. AU - Quadir, M. A. AU - Correa, S. AU - Suárez-López, L. AU - Barberio, A. E. AU - Hwang, M. K. AU - Shi, A. C. AU - Oberlton, B. AU - Gallagher, P. N. AU - Shopsowitz, K. E. AU - Elias, K. M. AU - Yaffe, M. B. AU - Hammond, P. T. C2 - LC Sigma Aldrich DB - Embase DO - 10.1002/btm2.10086 IS - 1 LA - English M3 - Article N1 - L623769866 2018-09-11 2018-09-13 PY - 2018 SN - 2380-6761 SP - 26-36 ST - RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors T2 - Bioengineering and Translational Medicine TI - RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623769866&from=exporthttp://dx.doi.org/10.1002/btm2.10086 VL - 3 ID - 7710 ER - TY - JOUR AD - Z. Xia, College of Veterinary Medicine, China Agricultural University, Beijing, China AU - Liu, Y. AU - Jia, Y. AU - Liu, C. AU - Ding, L. AU - Xia, Z. C2 - Beijing Shine Biology(China) DB - Embase Medline DO - 10.1186/s12864-018-5261-1 IS - 1 LA - English M3 - Article N1 - L625171786 2018-12-12 2020-07-28 PY - 2018 SN - 1471-2164 ST - RNA-Seq transcriptome analysis of breast muscle in Pekin ducks supplemented with the dietary probiotic Clostridium butyricum T2 - BMC Genomics TI - RNA-Seq transcriptome analysis of breast muscle in Pekin ducks supplemented with the dietary probiotic Clostridium butyricum UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625171786&from=exporthttp://dx.doi.org/10.1186/s12864-018-5261-1 VL - 19 ID - 7711 ER - TY - JOUR AD - Department of Orthopaedics, Second Affiliated Hospital, Shandong University, 247 Beiyuan Da Street, Jinan 250033, PR China. AN - 22179790 AU - Si, H. AU - Peng, C. AU - Li, J. AU - Wang, X. AU - Zhai, L. AU - Li, X. AU - Li, J. C2 - PMC3584577 DA - Apr DO - 10.3892/ijo.2011.1303 10.3892/ijo.2011.1303. Epub 2011 Dec 15. DP - Nlm ET - 2011/12/20 IS - 4 LA - eng PY - 2012 SN - 1019-6439 (Print) 1019-6439 SP - 1291-7 ST - RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro T2 - Int J Oncol TI - RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro VL - 40 ID - 7712 ER - TY - JOUR AD - L. Bian, Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China AU - Wang, B. AU - Cui, Z. AU - Zhong, Z. AU - Sun, Y. AU - Yang, G. Y. AU - Sun, Q. AU - Bian, L. DB - Embase Medline DO - 10.1002/mc.22467 IS - 12 LA - English M3 - Article N1 - L608140507 2016-02-11 2016-12-06 PY - 2016 SN - 1098-2744 0899-1987 SP - 2268-2277 ST - The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges T2 - Molecular Carcinogenesis TI - The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608140507&from=exporthttp://dx.doi.org/10.1002/mc.22467 VL - 55 ID - 7713 ER - TY - JOUR AD - Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Department of Preventive Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Division of Pathology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Centre for Oral Cancer Prevention Awareness and Research, Sree Balaji Dental College and Hospital, Bharat University, Chennai, Tamil Nadu, India. Division of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Division of Preventive Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. AN - 29199726 AU - Krishnamurthy, A. AU - Ramshankar, V. AU - Murherkar, K. AU - Vidyarani, S. AU - Raghunandhan, G. C. AU - Das, A. AU - Desai, P. B. AU - Albert, K. DA - Jan-Mar DO - 10.4103/ijc.IJC_182_17 10.4103/ijc.IJC_182_17. DP - Nlm ET - 2017/12/05 IS - 1 LA - eng PY - 2017 SN - 0019-509x SP - 372-378 ST - Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature T2 - Indian J Cancer TI - Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature VL - 54 ID - 7714 ER - TY - JOUR AD - J.C.B. Li, Immunology Research Laboratory, Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, HKG, China AU - Ling, W. L. AU - Wang, L. J. AU - Pong, J. C. H. AU - Lau, A. S. Y. AU - Li, J. C. B. DB - Embase Medline DO - 10.1111/imm.12140 IS - 3 LA - English M3 - Article N1 - L369949507 2013-10-10 2013-10-15 PY - 2013 SN - 0019-2805 1365-2567 SP - 323-334 ST - A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages T2 - Immunology TI - A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369949507&from=exporthttp://dx.doi.org/10.1111/imm.12140 VL - 140 ID - 7715 ER - TY - JOUR AD - J.M. Low, Dept. of Molec. Microbiol./Immunol., Division of Rheumatology, Saint Louis Univ. School of Medicine, Saint Louis, MO, United States AU - Low, J. M. AU - Moore, T. L. DB - Embase Medline DO - 10.2174/1381612053381936 IS - 5 LA - English M3 - Review N1 - L40277873 2005-03-09 PY - 2005 SN - 1381-6128 SP - 655-670 ST - A role for the complement system in rheumatoid arthritis T2 - Current Pharmaceutical Design TI - A role for the complement system in rheumatoid arthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40277873&from=exporthttp://dx.doi.org/10.2174/1381612053381936 VL - 11 ID - 7716 ER - TY - JOUR AD - Institution of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road 1277 Jianghan District, Wuhan, Hubei Province, China Institution of Hematology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China AU - Li, X. AU - Cai, S. AU - Zhong, Z. AU - Wang, H. AU - Wang, L. AU - You, Y. AU - Zhang, M. C7 - e19256 DB - Scopus DO - 10.1097/MD.0000000000019256 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 ST - Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report T2 - Medicine (United States) TI - Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080068200&doi=10.1097%2fMD.0000000000019256&partnerID=40&md5=d72652f97dd6dc0de852707fc86c7aa9 VL - 99 ID - 7717 ER - TY - JOUR AD - Surgical Clinic II, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy. Division of General Surgery, Department of Medical and Surgical Sciences, Hospital of Cattinara, University of Trieste, Trieste, Italy. Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto-IRCCS, Padova, Italy. Endocrinology Unit, Department of Medicine, University of Padova, Padova, Italy. Department of Imaging, Nuclear Medicine, PET/CT Centre, Radiology, Neuroradiology, Medical Physics, Santa Maria della Misericordia Hospital, Rovigo, Italy. Electronic address: domenico.rubello@libero.it. AN - 24721322 AU - Pelizzo, M. R. AU - Dobrinja, C. AU - Casal Ide, E. AU - Zane, M. AU - Lora, O. AU - Toniato, A. AU - Mian, C. AU - Barollo, S. AU - Izuzquiza, M. AU - Guerrini, J. AU - De Manzini, N. AU - Merante Boschin, I. AU - Rubello, D. DA - May DO - 10.1016/j.biopha.2014.03.008 10.1016/j.biopha.2014.03.008. Epub 2014 Mar 18. DP - Nlm ET - 2014/04/12 IS - 4 LA - eng PY - 2014 SN - 0753-3322 SP - 413-7 ST - The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma T2 - Biomed Pharmacother TI - The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma VL - 68 ID - 7718 ER - TY - JOUR AD - S. Karnam, Shiley Eye Institute, University of California San Diego, San Diego, CA, United States AU - Karnam, S. AU - Chavali, V. R. M. AU - Reddy, G. B. AU - Ayyagari, R. DB - Embase IS - 12 LA - English M3 - Conference Abstract N1 - L616081777 2017-05-16 PY - 2016 SN - 0146-0404 SP - 3181 ST - Role of complement-1q tumor necrosis factor related protein 5 (CTRP5/C1QTNF5) in late-onset retinal degeneration (L-ORD) pathology T2 - Investigative Ophthalmology and Visual Science TI - Role of complement-1q tumor necrosis factor related protein 5 (CTRP5/C1QTNF5) in late-onset retinal degeneration (L-ORD) pathology UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616081777&from=export VL - 57 ID - 7719 ER - TY - JOUR AD - D.M. Schewe, Department of Pediatrics, Christian-Albrechts University Kiel, University Medical Center Schleswig-Holstein, Kiel, Germany AU - Fedders, H. AU - Alsadeq, A. AU - Schmäh, J. AU - Vogiatzi, F. AU - Zimmermann, M. AU - Möricke, A. AU - Lenk, L. AU - zur Stadt, U. AU - Horstmann, M. A. AU - Pieters, R. AU - Schrappe, M. AU - Stanulla, M. AU - Cario, G. AU - Schewe, D. M. DB - Embase Medline DO - 10.3324/haematol.2017.169870 IS - 11 LA - English M3 - Letter N1 - L619078294 2017-11-08 2018-10-25 PY - 2017 SN - 1592-8721 0390-6078 SP - e438-e442 ST - The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia T2 - Haematologica TI - The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619078294&from=exporthttp://dx.doi.org/10.3324/haematol.2017.169870 VL - 102 ID - 7720 ER - TY - JOUR AD - Roswell Park Cancer Institute, Buffalo, NY, United States Medical College of Wisconsin, Milwaukee, WI, United States NIH, NCI, CCR, Genetics Branch, Bethesda, MD, United States Kimmel Comprehensive Cancer Center, Baltimore, MD, United States Children's Oncology Group, Arcadia, CA, United States Childrens's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, United States Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States Cincinnati Children's Hospital, Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, United States Blue Shield of California, San Francisco, CA, United States AU - Oliansky, D. M. AU - Rizzo, J. D. AU - Aplan, P. D. AU - Arceci, R. J. AU - Leone, L. AU - Ravindranath, Y. AU - Sanders, J. E. AU - Smith Iii, F. O. AU - Wilmot, F. AU - McCarthy Jr, P. L. AU - Hahn, T. DB - Scopus DO - 10.1016/j.bbmt.2006.10.024 IS - 1 M3 - Review N1 - Cited By :61 Export Date: 18 November 2020 PY - 2007 SP - 1-25 ST - The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review T2 - Biology of Blood and Marrow Transplantation TI - The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846057947&doi=10.1016%2fj.bbmt.2006.10.024&partnerID=40&md5=8bdc68d7d222414ecc38abdf11b3cf96 VL - 13 ID - 7721 ER - TY - JOUR AD - D.G. Gilliland, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, United States AU - Gilliland, D. G. AU - Griffin, J. D. C1 - ag 1295 ag 1296 cep 701(Cephalon,United States) ct 53518(Millennium,United States) pkc 412(Novartis,United States) sti 571 su 11248(Sugen) su 5416(Sugen) su 5614(Sugen) C2 - Cephalon(United States) Millennium(United States) Novartis(United States) Sugen DB - Embase Medline DO - 10.1097/00062752-200207000-00003 IS - 4 LA - English M3 - Review N1 - L34596870 2002-06-17 PY - 2002 SN - 1065-6251 SP - 274-281 ST - Role of FLT3 in leukemia T2 - Current Opinion in Hematology TI - Role of FLT3 in leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34596870&from=exporthttp://dx.doi.org/10.1097/00062752-200207000-00003 VL - 9 ID - 7722 ER - TY - JOUR AD - University of Tromsø, Molecular Inflammation Research Group, Department of Medical Biology, Faculty of Health Sciences, Tromsø, Norway Karolinska Institutet, Childhood Cancer Research Unit, Department of Women's and Children's Health, Stockholm, Sweden University of Tromsø, Endocrinology Research Group, Department of Clinical Medicine, Faculty of Health Sciences, Tromsø, Norway University of Tromsø, Department of Medical Biology, Faculty of Health Sciences, Tromsø, Norway University Hospital of North Norway, Department of Laboratory Medicine, Tromsø, Norway AU - Snapkov, I. AU - Öqvist, C. O. AU - Figenschau, Y. AU - Kogner, P. AU - Johnsen, J. I. AU - Sveinbjørnsson, B. C7 - 490 DB - Scopus DO - 10.1186/s12885-016-2545-1 IS - 1 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2016 ST - The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis T2 - BMC Cancer TI - The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978646011&doi=10.1186%2fs12885-016-2545-1&partnerID=40&md5=5ab8671594df2ff9bbbb1365dae91ec7 VL - 16 ID - 7723 ER - TY - JOUR AD - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY, United States AU - Antonescu, C. R. DB - Scopus DO - 10.1111/j.1365-2559.2005.02285.x IS - 1 M3 - Review N1 - Cited By :107 Export Date: 18 November 2020 PY - 2006 SP - 13-21 ST - The role of genetic testing in soft tissue sarcoma T2 - Histopathology TI - The role of genetic testing in soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645083214&doi=10.1111%2fj.1365-2559.2005.02285.x&partnerID=40&md5=beeb2f6569c19426e1eb35fe257d73d8 VL - 48 ID - 7724 ER - TY - JOUR AD - S. Loges, Department of Hematology and Oncology, Institute of Tumor Biology, University Comprehensive Cancer Center Hamburg, Martinistrasse 52, Hamburg, Germany AU - Waizenegger, J. S. AU - Ben-Batalla, I. AU - Weinhold, N. AU - Meissner, T. AU - Wroblewski, M. AU - Janning, M. AU - Riecken, K. AU - Binder, M. AU - Atanackovic, D. AU - Taipaleenmaeki, H. AU - Schewe, D. AU - Sawall, S. AU - Gensch, V. AU - Cubas-Cordova, M. AU - Seckinger, A. AU - Fiedler, W. AU - Hesse, E. AU - Kröger, N. AU - Fehse, B. AU - Hose, D. AU - Klein, B. AU - Raab, M. S. AU - Pantel, K. AU - Bokemeyer, C. AU - Loges, S. DB - Embase Medline DO - 10.1038/leu.2014.236 IS - 3 LA - English M3 - Article N1 - L602900796 2015-03-17 2020-09-01 PY - 2015 SN - 1476-5551 0887-6924 SP - 696-704 ST - Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma T2 - Leukemia TI - Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602900796&from=exporthttp://dx.doi.org/10.1038/leu.2014.236 VL - 29 ID - 7725 ER - TY - JOUR AD - Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, United States Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, CRC 1w-3750, Bethesda, MD 20892, United States AU - Kim, S. Y. AU - Toretsky, J. A. AU - Scher, D. AU - Helman, L. J. DB - Scopus DO - 10.1634/theoncologist.2008-0189 IS - 1 M3 - Article N1 - Cited By :74 Export Date: 18 November 2020 PY - 2009 SP - 83-91 ST - The role of IGF-1R in pediatric malignancies T2 - Oncologist TI - The role of IGF-1R in pediatric malignancies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-61449097712&doi=10.1634%2ftheoncologist.2008-0189&partnerID=40&md5=f5a9968c15964206ba865e61394911af VL - 14 ID - 7726 ER - TY - JOUR AD - Division of Surgical Oncology, Oregon Health and Science University, OHSU-Knight Cancer Institute, 3181 S.W. Sam Jackson Park Rd., Portland, OR 97239, United States AU - Vetto, J. T. DB - Scopus DO - 10.2147/ott.s4740 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2009 SP - 151-159 ST - Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs) T2 - OncoTargets and Therapy TI - Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953446464&doi=10.2147%2fott.s4740&partnerID=40&md5=8bf5f8ce932d6b6af19579f75cfff0e6 VL - 2 ID - 7727 ER - TY - JOUR AD - Y. Yamaoka, Vet. Affairs Medical Center (111D), 2002 Holcombe Boulevard, Houston, TX 77030, United States AU - Yamaoka, Y. AU - Kudo, T. AU - Lu, H. AU - Casola, A. AU - Brasier, A. R. AU - Graham, D. Y. DB - Embase Medline DO - 10.1053/j.gastro.2003.12.048 IS - 4 LA - English M3 - Article N1 - L38451175 2004-05-06 PY - 2004 SN - 0016-5085 SP - 1030-1043 ST - Role of Interferon-Stimulated Responsive Element-like Element in Interleukin-8 Promoter in Helicobacter pylori Infection T2 - Gastroenterology TI - Role of Interferon-Stimulated Responsive Element-like Element in Interleukin-8 Promoter in Helicobacter pylori Infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38451175&from=exporthttp://dx.doi.org/10.1053/j.gastro.2003.12.048 VL - 126 ID - 7728 ER - TY - JOUR AD - R. Kapur, Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 W Walnut Street, Indianapolis, IN 46202, United States AU - Ma, P. AU - Mali, R. S. AU - Martin, H. AU - Ramdas, B. AU - Sims, E. AU - Kapur, R. DB - Embase Medline DO - 10.1038/leu.2012.22 IS - 7 LA - English M3 - Article N1 - L51841038 2012-02-03 2012-07-25 PY - 2012 SN - 1476-5551 0887-6924 SP - 1499-1506 ST - Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease T2 - Leukemia TI - Role of intracellular tyrosines in activating KIT-induced myeloproliferative disease UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51841038&from=exporthttp://dx.doi.org/10.1038/leu.2012.22 VL - 26 ID - 7729 ER - TY - JOUR AD - R.K. Gutti, Stem Cells and Haematological Disorders Laboratory, Department of Biochemistry, School of Life Sciences, University of Hyderabad, (PO) Gachibowli, Hyderabad, Telangana, India AU - Undi, R. B. AU - Gutti, U. AU - Gutti, R. K. DB - Embase Medline DO - 10.1016/j.biocel.2016.08.009 LA - English M3 - Article N1 - L611639834 2016-08-19 2016-08-23 PY - 2016 SN - 1878-5875 1357-2725 SP - 61-68 ST - Role of let-7b/Fzd4 axis in mitochondrial biogenesis through wnt signaling: In neonatal and adult megakaryocytes T2 - International Journal of Biochemistry and Cell Biology TI - Role of let-7b/Fzd4 axis in mitochondrial biogenesis through wnt signaling: In neonatal and adult megakaryocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611639834&from=exporthttp://dx.doi.org/10.1016/j.biocel.2016.08.009 VL - 79 ID - 7730 ER - TY - JOUR AD - U488 Inserm, 80 rue du Gi Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France Neurology Unit, Dept. of Clin. Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, United Kingdom AU - Zrouri, H. AU - Le Goascogne, C. AU - Li, W. W. AU - Pierre, M. AU - Courtin, F. DB - Scopus DO - 10.1111/j.1460-9568.2004.03641.x IS - 7 M3 - Article N1 - Cited By :28 Export Date: 18 November 2020 PY - 2004 SP - 1811-1818 ST - The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve T2 - European Journal of Neuroscience TI - The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-8144231119&doi=10.1111%2fj.1460-9568.2004.03641.x&partnerID=40&md5=8a62a64f5fc8eb7ac6e6540ee4f736fd VL - 20 ID - 7731 ER - TY - JOUR AD - Department of Medical Oncology, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, 500 082, India AU - Chaitanya, P. AU - Kumar, K. AU - Stalin, B. AU - Sadashivudu, G. AU - Srinivas, M. DB - Scopus DO - 10.4103/ijmpo.ijmpo_115_17 IS - 3 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 328-333 ST - The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years T2 - Indian Journal of Medical and Paediatric Oncology TI - The role of mutation testing in patients with chronic myeloid leukemia in chronic phase after imatinib failure and their outcomes after treatment modification: Single-institutional experience over 13 years UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048121611&doi=10.4103%2fijmpo.ijmpo_115_17&partnerID=40&md5=60e33ed5db395c66cc6a12cc4ec05132 VL - 38 ID - 7732 ER - TY - JOUR AD - R. Franca, Institute for Maternal and Child Health (I.R.C.C.S.) Burlo Garofolo, UO Pediatric Hemato-Oncology, Trieste, Italy AU - Franca, R. AU - Stocco, G. AU - Favretto, D. AU - Giurici, N. AU - Decorti, G. AU - Rabusin, M. DB - Embase Medline DO - 10.3390/ijms160818601 IS - 8 LA - English M3 - Review N1 - L605602344 2015-08-21 2015-08-25 PY - 2015 SN - 1422-0067 1661-6596 SP - 18601-18627 ST - Role of pharmacogenetics in hematopoietic stem cell transplantation outcome in children T2 - International Journal of Molecular Sciences TI - Role of pharmacogenetics in hematopoietic stem cell transplantation outcome in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605602344&from=exporthttp://dx.doi.org/10.3390/ijms160818601 VL - 16 ID - 7733 ER - TY - JOUR AD - C. Lechler, II. Medizinische Klinik und Poliklinik, Klinikum Rechts der Isar, TU München, Munich, Germany AU - Lechler, C. AU - Roesner, T. AU - Kohnke-Ertel, B. AU - Saur, D. AU - Sage, J. AU - Schmid, R. M. AU - Ehmer, U. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L621223532 2018-03-19 PY - 2017 SN - 1600-0641 SP - S225-S226 ST - Role of RAS-dependent signaling pathways in hepatic carcinogenesis T2 - Journal of Hepatology TI - Role of RAS-dependent signaling pathways in hepatic carcinogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621223532&from=export VL - 66 ID - 7734 ER - TY - JOUR AD - Hematology Branch, NHLBI, NIH, Building 10, Room 7C103, 9000 Rockville Pike, Bethesda, MD 20892, United States AU - Barrett, A. J. AU - Ito, S. DB - Scopus DO - 10.1182/blood-2014-10-567784 IS - 21 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2015 SP - 3230-3235 ST - The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century T2 - Blood TI - The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929999516&doi=10.1182%2fblood-2014-10-567784&partnerID=40&md5=862ab9e94724f0611f80d4842931a2e3 VL - 125 ID - 7735 ER - TY - JOUR AD - L.-J. Gao, Clinical Laboratory, Nanjing Maternity and Child Health Care Hospital Tianfei Alley, Nanjing Mochou Road, 210004, Nanjing, China AU - Liu, Z. AU - Su, Y. J. AU - Gu, P. Q. AU - Ji, Z. Y. AU - Wang, X. G. AU - Gao, L. J. DB - Embase Medline DO - 10.1159/000343308 IS - 5 LA - English M3 - Article N1 - L52253610 2012-10-16 2019-05-14 PY - 2012 SN - 1421-9778 1015-8987 SP - 1181-1190 ST - The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma T2 - Cellular Physiology and Biochemistry TI - The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52253610&from=exporthttp://dx.doi.org/10.1159/000343308 VL - 30 ID - 7736 ER - TY - JOUR AD - University Hospital Munich-Grosshadern, Department of Medicine II, Ludwig-Maximilians-University Munich, Marchioninistr 15, D-81377 Munich, Germany AU - Dambacher, J. AU - Beigel, F. AU - Zitzmann, K. AU - De Toni, E. N. AU - Göke, B. AU - Diepolder, H. M. AU - Auernhammer, C. J. AU - Brand, S. DB - Scopus DO - 10.1136/gut.2007.130112 IS - 9 M3 - Article N1 - Cited By :148 Export Date: 18 November 2020 PY - 2009 SP - 1207-1217 ST - The role of the novel Th17 cytokine IL-26 in intestinal inflammation T2 - Gut TI - The role of the novel Th17 cytokine IL-26 in intestinal inflammation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68849124464&doi=10.1136%2fgut.2007.130112&partnerID=40&md5=1f790e44a90685bf4aa2d3b7b3492c2d VL - 58 ID - 7737 ER - TY - JOUR AD - Y. Yuhas, Laboratory of Infectious Diseases, Felsenstein Medical Research Center, Beilinson Campus, Petach Tikva 49100, Israel AU - Yuhas, Y. AU - Berent, E. AU - Cohen, R. AU - Ashkenazi, S. DB - Embase Medline DO - 10.1128/AAC.00961-08 IS - 4 L1 - internal-pdf://2717557498/Antimicrobial Agents and Chemotherapy-2009-Yuh.pdf LA - English M3 - Article N1 - L354592520 2009-06-22 PY - 2009 SN - 0066-4804 1098-6596 SP - 1539-1545 ST - Roles of NF-KB activation and peroxisome proliferator-activated teceptor famma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells T2 - Antimicrobial Agents and Chemotherapy TI - Roles of NF-KB activation and peroxisome proliferator-activated teceptor famma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354592520&from=exporthttp://dx.doi.org/10.1128/AAC.00961-08 VL - 53 ID - 7738 ER - TY - JOUR AD - M. S. Cairo, Department of Pediatrics, Professor of Pediatrics, Medicine, Pathology, Microbiology & Immunology and Cell Biology & Anatomy, Maria Fareri Children Hospital at Westchester Medical Center, New York Medical College, 40 Sunshine Cottage Rd., Skyline Office 1N-D12, Valhalla, NY, United States AU - Chu, Y. AU - Yahr, A. AU - Huang, B. AU - Ayello, J. AU - Barth, M. AU - S. Cairo, M. C1 - romidepsin(Celgene,United States) C2 - Celgene(United States) DB - Embase DO - 10.1080/2162402X.2017.1341031 IS - 9 LA - English M3 - Article N1 - L618078120 2017-09-06 2017-09-21 PY - 2017 SN - 2162-402X 2162-4011 ST - Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice T2 - OncoImmunology TI - Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618078120&from=exporthttp://dx.doi.org/10.1080/2162402X.2017.1341031 VL - 6 ID - 7739 ER - TY - JOUR AD - K. Prabhash, Department of Medical Oncology, TMH, Mumbai, India AU - Joshi, A. AU - Pande, N. AU - Noronha, V. AU - Patil, V. AU - Kumar, R. AU - Chougule, A. AU - Trivedi, V. AU - Janu, A. AU - Mahajan, A. AU - Prabhash, K. DB - Embase DO - 10.3332/ecancer.2019.900 LA - English M3 - Article N1 - L2002842544 2019-09-20 2019-09-25 PY - 2019 SN - 1754-6605 ST - ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes T2 - ecancermedicalscience TI - ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002842544&from=exporthttp://dx.doi.org/10.3332/ecancer.2019.900 VL - 13 ID - 7740 ER - TY - JOUR AD - Early Drug Development and Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States Department of Medicine, Weill Cornell Medical College, New York, NY, United States Department of Pediatrics, Oregon Health & Science University, Portland, OR, United States AU - Drilon, A. AU - Jenkins, C. AU - Iyer, S. AU - Schoenfeld, A. AU - Keddy, C. AU - Davare, M. A. DB - Scopus DO - 10.1038/s41571-020-0408-9 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - ROS1-dependent cancers — biology, diagnostics and therapeutics T2 - Nature Reviews Clinical Oncology TI - ROS1-dependent cancers — biology, diagnostics and therapeutics UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089025894&doi=10.1038%2fs41571-020-0408-9&partnerID=40&md5=48169b53fe4ea380670b0bb085f2e16c ID - 7741 ER - TY - JOUR AD - Institute of Hematology L. and A. Seràgnoli, Department of Experimental Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Chair of Hematology Sapienza University, Rome, Italy Chair of Hematology, Careggi Hospital, University of Florence, Florence, Italy Hematology Unit, A. Businco Hospital, Cagliari, Italy IRCCS AOU San Martino-IST, Hematology and Bone Marrow Transplantation Unit, Genova, Italy Chair of Hematology, Department of Clinical and Biological Sciences, S. Luigi Gonzaga University Hospital, University of Torino, Orbassano, Italy Hematology Unit, Bianchi-Melacrino-Morelli Hospital, Reggio Calabria, Italy Hematology Unit S. Eugenio Hospital, Rome, Italy Chair of Hematology, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy Chair of Hematology, Ferrarotto Hospital, University of Catania, Catania, Italy Chair of Hematology, Department of Biochemistry and Medical Biotechnologies, Federico II University, Naples, Italy Hematology Unit, Spedali Civili Hospital, Brescia, Italy Chair of Hematology, S.Maria alle Scotte Hospital, Siena, Italy Chair of Hematology, S. AnnaHospital, University of Ferrara, Ferrara, Italy Chair of Hematology, University of Udine, Udine, Italy Chair of Hematology, A. Avogadro University of Eastern Piedmont, Novara, Italy Hematology Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, S.Giovanni Rotondo, Italy Chair of Hematology, University of Messina, Messina, Italy Hematology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy Department of Hematology and Oncology L. and A. Seràgnoli, University of Bologna, Bologna, Italy AU - Gugliotta, G. AU - Castagnetti, F. AU - Breccia, M. AU - Gozzini, A. AU - Usala, E. AU - Carella, A. M. AU - Rege-Cambrin, G. AU - Martino, B. AU - Abruzzese, E. AU - Albano, F. AU - Stagno, F. AU - Luciano, L. AU - D'Adda, M. AU - Bocchia, M. AU - Cavazzini, F. AU - Tiribelli, M. AU - Lunghi, M. AU - Pia Falcone, A. AU - Musolino, C. AU - Levato, L. AU - Venturi, C. AU - Soverini, S. AU - Cavo, M. AU - Alimena, G. AU - Pane, F. AU - Martinelli, G. AU - Saglio, G. AU - Rosti, G. AU - Baccarani, M. DB - Scopus DO - 10.1002/ajh.24362 IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2016 SP - 617-622 ST - Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia T2 - American Journal of Hematology TI - Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84967225610&doi=10.1002%2fajh.24362&partnerID=40&md5=f35baa74d23e7e0f6d879db5427c70df VL - 91 ID - 7742 ER - TY - JOUR AD - C. Konialis, Department of Molecular Genetics, InterGenetics - Diagnostic Genetic Center, Vas. Sofias 120, Athens 11526, Greece AU - Konialis, C. AU - Savola, S. AU - Karapanou, S. AU - Markaki, A. AU - Bela, M. K. AU - Polychronopoulou, S. AU - Ampatzidou, M. AU - Michael, V. V. AU - Vinious, N. A. AU - Variant, E. AU - Koumarianou, A. AU - Zoi, K. AU - Hagnefelt, B. AU - Schouten, J. P. AU - Pángalos, C. DB - Embase Medline DO - 10.1179/1607845413Y.0000000112 IS - 4 LA - English M3 - Article N1 - L373181493 2014-06-06 2014-06-11 PY - 2014 SN - 1607-8454 1024-5332 SP - 217-224 ST - Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics T2 - Hematology TI - Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373181493&from=exporthttp://dx.doi.org/10.1179/1607845413Y.0000000112 VL - 19 ID - 7743 ER - TY - JOUR AD - W. Pao, Division of Hematology-Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, United States AU - Lovly, C. M. AU - Dahlman, K. B. AU - Fohn, L. E. AU - Su, Z. AU - Dias-Santagata, D. AU - Hicks, D. J. AU - Hucks, D. AU - Berry, E. AU - Terry, C. AU - Duke, M. AU - Su, Y. AU - Sobolik-Delmaire, T. AU - Richmond, A. AU - Kelley, M. C. AU - Vnencak-Jones, C. L. AU - Iafrate, A. J. AU - Sosman, J. AU - Pao, W. DB - Embase Medline DO - 10.1371/journal.pone.0035309 IS - 4 L1 - internal-pdf://3620197421/journal.pone.0035309.PDF LA - English M3 - Article N1 - L364661823 2012-05-07 PY - 2012 SN - 1932-6203 ST - Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials T2 - PLoS ONE TI - Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364661823&from=exporthttp://dx.doi.org/10.1371/journal.pone.0035309 VL - 7 ID - 7744 ER - TY - JOUR AD - Department of Research, Australasian College of Cutaneous Oncology, Docklands, VIC, Australia DermOne Dermatology Centre, Department of Dermatology, Irving, TX, United States Maffra Medical Group, Maffra, Australia Department of Pathology, Australasian College of Cutaneous Oncology, Docklands, VIC, Australia Baker IDI Heart and Diabetes Institute, Department of Research, Melbourne, VIC, Australia AU - Dixon, A. AU - Steinman, H. AU - Anderson, S. AU - Nirenberg, A. AU - Dixon, J. DB - Scopus DO - 10.1111/bjd.14769 IS - 6 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2016 SP - 1340-1341 ST - Routine usage of sentinel node biopsy in melanoma management must cease T2 - British Journal of Dermatology TI - Routine usage of sentinel node biopsy in melanoma management must cease UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006401771&doi=10.1111%2fbjd.14769&partnerID=40&md5=3a5fe19dc5a75281933ff2aa3f206583 VL - 175 ID - 7745 ER - TY - JOUR AD - A. Areskeviciute, University of Copenhagen, Faculty of Science, Copenhagen, Denmark AU - Areskeviciute, A. AU - Sandager, C. N. AU - Skov, S. AU - Broholm, H. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L71992354 2015-09-08 PY - 2014 SN - 0722-5091 SP - 203 ST - RSK activity in pediatric tumors: Investigation of the MAP kinase pathway with special emphasis on RSK T2 - Clinical Neuropathology TI - RSK activity in pediatric tumors: Investigation of the MAP kinase pathway with special emphasis on RSK UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71992354&from=exporthttp://www.dustri.com/nc/journals-in-english/mag/clinical-neuropathology/vol/volume-33/issue/mayjune-7.html VL - 33 ID - 7746 ER - TY - JOUR AD - Department of Hematology and Oncology, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina Department of Genetics, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina Department of Immunology, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina AU - Alonso, C. N. AU - Gallego, M. S. AU - Rossi, J. G. AU - Medina, A. AU - Rubio, P. L. AU - Bernasconi, A. R. AU - Zubizarreta, P. A. AU - Felice, M. S. DB - Scopus DO - 10.1016/j.leukres.2011.12.003 IS - 6 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 704-708 ST - RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina T2 - Leukemia Research TI - RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859835234&doi=10.1016%2fj.leukres.2011.12.003&partnerID=40&md5=13f3a33c8a609b646ce5f15cbc84e18f VL - 36 ID - 7747 ER - TY - JOUR AD - Molecular Oncology Laboratory, Institute of Comparative Medicine, University of Glasgow, Bearsden Road, Bearsden, Glasgow G61 1QH, United Kingdom Lincoln's Inn Fields Laboratories, London Research Institute, London, United Kingdom Heinrich-Pette-Institute for Experimental Virology and Immunology, Hamburg, Germany AU - Wolyniec, K. AU - Wotton, S. AU - Kilbey, A. AU - Jenkins, A. AU - Terry, A. AU - Peters, G. AU - Stocking, C. AU - Cameron, E. AU - Neil, J. C. DB - Scopus DO - 10.1038/onc.2009.101 IS - 27 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2009 SP - 2502-2512 ST - RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress T2 - Oncogene TI - RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650432153&doi=10.1038%2fonc.2009.101&partnerID=40&md5=b1b896c46dd827f653fa29200c31300a VL - 28 ID - 7748 ER - TY - JOUR AD - Children's Healthcare of Atlanta, United States AU - Bunting, S. T. AU - Lew, G. DB - Scopus DO - 10.1182/blood-2014-01-547513 IS - 16 M3 - Article N1 - Export Date: 18 November 2020 PY - 2014 SP - 2448 ST - "Russell-like" bodies in Philadelphia chromosome-positive B-lymphoblastic leukemia T2 - Blood TI - "Russell-like" bodies in Philadelphia chromosome-positive B-lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899063302&doi=10.1182%2fblood-2014-01-547513&partnerID=40&md5=39b76d565a6aa29d95ca92812d45e285 VL - 123 ID - 7749 ER - TY - JOUR AD - W. Deng, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China AU - Li, A. AU - Shi, D. AU - Xu, B. AU - Wang, J. AU - Tang, Y. L. AU - Xiao, W. AU - Shen, G. AU - Deng, W. AU - Zhao, C. DB - Embase Medline DO - 10.1002/mc.22563 IS - 3 LA - English M3 - Article N1 - L612488325 2016-10-10 2017-03-14 PY - 2017 SN - 1098-2744 0899-1987 SP - 972-984 ST - S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway T2 - Molecular Carcinogenesis TI - S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612488325&from=exporthttp://dx.doi.org/10.1002/mc.22563 VL - 56 ID - 7750 ER - TY - JOUR AD - Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: mosse@chop.edu. AN - 23598171 AU - Mossé, Y. P. AU - Lim, M. S. AU - Voss, S. D. AU - Wilner, K. AU - Ruffner, K. AU - Laliberte, J. AU - Rolland, D. AU - Balis, F. M. AU - Maris, J. M. AU - Weigel, B. J. AU - Ingle, A. M. AU - Ahern, C. AU - Adamson, P. C. AU - Blaney, S. M. C2 - PMC3730818 C6 - NIHMS476957 company. The other authors declare that they have no conflicts of interest. DA - May DO - 10.1016/s1470-2045(13)70095-0 10.1016/S1470-2045(13)70095-0. Epub 2013 Apr 16. DP - Nlm ET - 2013/04/20 IS - 6 LA - eng PY - 2013 SN - 1470-2045 (Print) 1470-2045 SP - 472-80 ST - Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study T2 - Lancet Oncol TI - Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study VL - 14 ID - 7751 ER - TY - JOUR AD - Department of Pediatric Hematology/Oncology, Center for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. University Cancer Center (UCT), University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. German Cancer Consortium (DKTK), site Frankfurt/Mainz, Germany, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, 69120 Heidelberg, Germany. German Cancer Consortium (DKTK)-German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Institute of Pathology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany. AN - 32224911 AU - Beck, O. AU - Paret, C. AU - Russo, A. AU - Burhenne, J. AU - Fresnais, M. AU - Steimel, K. AU - Seidmann, L. AU - Wagner, D. C. AU - Vewinger, N. AU - Lehmann, N. AU - Sprang, M. AU - Backes, N. AU - Roth, L. AU - Neu, M. A. AU - Wingerter, A. AU - Henninger, N. AU - Malki, K. E. AU - Otto, H. AU - Alt, F. AU - Desuki, A. AU - Kindler, T. AU - Faber, J. C2 - PMC7225940 DA - Mar 26 DO - 10.3390/cancers12040793 10.3390/cancers12040793. DP - Nlm ET - 2020/04/01 IS - 4 LA - eng PY - 2020 SN - 2072-6694 (Print) 2072-6694 ST - Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma T2 - Cancers (Basel) TI - Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma VL - 12 ID - 7752 ER - TY - JOUR AD - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. drilona@mskcc.org. Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milan, Italy. Chao Family Comprehensive Cancer Center, University of California, Irvine, California. Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, Florida. Samsung Medical Center, Seoul, Korea. Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. Massachusetts General Hospital, Boston, Massachusetts. The University of Texas MD Anderson Cancer Center, Houston, Texas. Georgetown Lombardi Comprehensive Cancer Center, Washington, DC. University of Colorado Cancer Center, Aurora, Colorado. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Nerviano Medical Sciences s.r.l, Milan, Italy. Ignyta, Inc., San Diego, California. AN - 28183697 AU - Drilon, A. AU - Siena, S. AU - Ou, S. I. AU - Patel, M. AU - Ahn, M. J. AU - Lee, J. AU - Bauer, T. M. AU - Farago, A. F. AU - Wheler, J. J. AU - Liu, S. V. AU - Doebele, R. AU - Giannetta, L. AU - Cerea, G. AU - Marrapese, G. AU - Schirru, M. AU - Amatu, A. AU - Bencardino, K. AU - Palmeri, L. AU - Sartore-Bianchi, A. AU - Vanzulli, A. AU - Cresta, S. AU - Damian, S. AU - Duca, M. AU - Ardini, E. AU - Li, G. AU - Christiansen, J. AU - Kowalski, K. AU - Johnson, A. D. AU - Patel, R. AU - Luo, D. AU - Chow-Maneval, E. AU - Hornby, Z. AU - Multani, P. S. AU - Shaw, A. T. AU - De Braud, F. G. C2 - PMC5380583 C6 - NIHMS848554 AbbVie, Intervention Insights, Merrimack Pharmaceuticals, Pharmamar SA, and Takeda. JW is currently employed by Novartis. RD has research agreements with Ignyta and Loxo and intellectual property royalties and/or licensing fees from Abbott Molecular and Ariad Pharmaceuticals. SS is an advisory board member of Amgen, Bayer, Eli Lilly, Merck, Novartis, Roche, and Sanofi. GL, JC, KK, AJ, RP, DL, ECM, ZH, and PM are employees of Ignyta. EA is an employee of Nerviano Medical Sciences. DA - Apr DO - 10.1158/2159-8290.Cd-16-1237 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9. DP - Nlm ET - 2017/02/12 IS - 4 LA - eng PY - 2017 SN - 2159-8274 (Print) 2159-8274 SP - 400-409 ST - Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) T2 - Cancer Discov TI - Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) VL - 7 ID - 7753 ER - TY - JOUR AD - B. Neven, Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris, France AU - Pincez, T. AU - Bruneau, J. AU - Berteloot, L. AU - Piekarski, E. AU - Thomas, C. AU - Marçais, A. AU - Trinquand, A. AU - Castelle, M. AU - Garcelon, N. AU - Plantaz, D. AU - Cheminant, M. AU - Moshous, D. AU - Molina, T. J. AU - Hermine, O. AU - Macintyre, E. AU - Fischer, A. AU - Blanche, S. AU - Suarez, F. AU - Neven, B. DB - Embase Medline DO - 10.3324/haematol.2019.230276 IS - 9 LA - English M3 - Letter N1 - L2007704596 2020-10-07 2020-10-22 PY - 2020 SN - 1592-8721 0390-6078 SP - E461-E464 ST - Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies T2 - Haematologica TI - Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007704596&from=exporthttp://dx.doi.org/10.3324/haematol.2019.230276 VL - 105 ID - 7754 ER - TY - JOUR AD - Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, China AU - Wang, H. Y. AU - Chu, J. F. AU - Zhang, P. AU - Wang, J. Q. AU - Yan, Z. AU - Yao, S. N. AU - Yao, Z. H. AU - Liu, Y. Y. DB - Scopus DO - 10.2147/OTT.S235349 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2020 SP - 1561-1568 ST - Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma T2 - OncoTargets and Therapy TI - Safety and efficacy of chemotherapy combined with anlotinib plus anlotinib maintenance in Chinese patients with advanced/metastatic soft tissue sarcoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079846649&doi=10.2147%2fOTT.S235349&partnerID=40&md5=3c2b50804c55aa89c863cad701c3572f VL - 13 ID - 7755 ER - TY - JOUR AD - Department of Orthopedics, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province 450008, China Department of Orthopedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China Department of Orthopedics, the Affiliated People’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450003, China Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province 450008, China AU - Tian, Z. AU - Wang, X. AU - Liu, Z. AU - Wang, J. AU - Yao, W. AU - Zhao, Y. AU - Gao, S. AU - Zhang, P. AU - Ge, H. DB - Scopus DO - 10.2147/CMAR.S207150 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 5293-5300 ST - Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: An observational study from multiple institutions T2 - Cancer Management and Research TI - Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: An observational study from multiple institutions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068013542&doi=10.2147%2fCMAR.S207150&partnerID=40&md5=637798f43d223cbb380569990c580fb5 VL - 11 ID - 7756 ER - TY - JOUR AD - Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Matsuyama, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan AU - Tada, T. AU - Kumada, T. AU - Hiraoka, A. AU - Michitaka, K. AU - Atsukawa, M. AU - Hirooka, M. AU - Tsuji, K. AU - Ishikawa, T. AU - Takaguchi, K. AU - Kariyama, K. AU - Itobayashi, E. AU - Tajiri, K. AU - Shimada, N. AU - Shibata, H. AU - Ochi, H. AU - Toyoda, H. AU - Nouso, K. AU - Tsutsui, A. AU - Nagano, T. AU - Itokawa, N. AU - Hayama, K. AU - Imai, M. AU - Joko, K. AU - Koizumi, Y. AU - Hiasa, Y. DB - Scopus DO - 10.1111/hepr.13427 IS - 1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2020 SP - 75-83 ST - Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching T2 - Hepatology Research TI - Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076343239&doi=10.1111%2fhepr.13427&partnerID=40&md5=3c98d11fc35abca7a9879ca8549c501a VL - 50 ID - 7757 ER - TY - JOUR AD - Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center Hospital, Yokohama, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan Department of Gastroenterology, Shonan Fujisawa General Hospital, Fujisawa, Japan Department of Gastroenterology, Kanagawa Prefectural Ashigarakami Hospital, Kanagawa, Japan Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan Department of Gastroenterology, Yokohama City University Hospital, Yokohama, Japan Department of Gastroenterology, Shonan Kamakura General Hospital, Kamakura, Japan Gastroenterology Division, Hadano Red Cross Hospital, Hadano, Japan AU - Ogushi, K. AU - Chuma, M. AU - Uojima, H. AU - Hidaka, H. AU - Numata, K. AU - Kobayashi, S. AU - Hirose, S. AU - Hattori, N. AU - Fujikawa, T. AU - Nakazawa, T. AU - Wada, N. AU - Iwasaki, S. AU - Fukushima, T. AU - Sano, Y. AU - Ueno, M. AU - Kawano, K. AU - Tsuruya, K. AU - Shomura, M. AU - Watanabe, T. AU - Matsunaga, K. AU - Kunishi, Y. AU - Saigusa, Y. AU - Irie, K. AU - Iwabuchi, S. AU - Kako, M. AU - Morimoto, M. AU - Kagawa, T. AU - Tanaka, K. AU - Maeda, S. DB - Scopus DO - 10.2147/CEG.S256691 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 385-396 ST - Safety and efficacy of lenvatinib treatment in child–pugh a and b patients with unresectable hepatocellular carcinoma in clinical practice: a multicenter analysis T2 - Clinical and Experimental Gastroenterology TI - Safety and efficacy of lenvatinib treatment in child–pugh a and b patients with unresectable hepatocellular carcinoma in clinical practice: a multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091910417&doi=10.2147%2fCEG.S256691&partnerID=40&md5=b852839033b04856b49e52f5b0183a7f VL - 13 ID - 7758 ER - TY - JOUR AD - University of Milano-Bicocca, Monza, Italy University of Texas MD Anderson Cancer Center, Houston, TX, United States Princess Margaret Cancer Centre, Toronto, ON, Canada Seoul St. Mary’s Hospital, South Korea Department of Internal Medicine II, Hubertus Wald Tumor Center, University Cancer Center Hamburg, Germany Pfizer Inc., Collegeville, PA, United States Pfizer Global Research and Development, Paris, France Pfizer Inc., Cambridge, MA, United States Pfizer Inc., Groton, CT, United States Universitätsklinikum RWTH Aachen, Germany Winship Cancer Institute of Emory University, Atlanta, GA, United States AU - Gambacorti-Passerini, C. AU - Cortes, J. E. AU - Lipton, J. H. AU - Kantarjian, H. M. AU - Kim, D. W. AU - Schafhausen, P. AU - Crescenzo, R. AU - Bardy-Bouxin, N. AU - Shapiro, M. AU - Noonan, K. AU - Leip, E. AU - Deannuntis, L. AU - Brümmendorf, T. H. AU - Jean Khoury, H. DB - Scopus DO - 10.3324/haematol.2017.171249 IS - 8 M3 - Article N1 - Cited By :14 Export Date: 18 November 2020 PY - 2018 SP - 1298-1307 ST - Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: Final results of a phase I/II study T2 - Haematologica TI - Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: Final results of a phase I/II study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051142821&doi=10.3324%2fhaematol.2017.171249&partnerID=40&md5=f7856d58ded073defb07d1ab92048328 VL - 103 ID - 7759 ER - TY - JOUR AD - A. Bavle, Jimmy Everest Section of Pediatric Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States AU - Bavle, A. AU - Choudhry, F. AU - Gavula, T. AU - Shah, R. AU - Ruiz-Elizalde, A. AU - Taylor, A. AU - Gross, N. AU - Peterson, J. E. AU - Fung, K. M. AU - McNall-Knapp, R. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098386 2018-07-25 PY - 2018 SN - 1523-5866 SP - i144 ST - Safety and efficacy of trametinib in the management of children with rasopathies T2 - Neuro-Oncology TI - Safety and efficacy of trametinib in the management of children with rasopathies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098386&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7760 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy M. Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warsaw, Poland Davidoff Cancer Center, Tel-Aviv University, Petah Tikva, Israel William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom Leiden University Medical Center, Leiden, Netherlands Thyroid Unit, University of Siena, Siena, Italy Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy M. Sklodowska-Curie Memorial Institute Cancer Center, Gliwice Branch, Gliwice, Poland Sanofi Genzyme, Cambridge, MA, United States AU - Hu, M. I. AU - Elisei, R. AU - Dedecjus, M. AU - Popovtzer, A. AU - Druce, M. AU - Kapiteijn, E. AU - Pacini, F. AU - Locati, L. AU - Krajewska, J. AU - Weiss, R. AU - Gagel, R. F. DB - Scopus DO - 10.1530/ERC-18-0258 IS - 2 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2019 SP - 241-250 ST - Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer T2 - Endocrine-Related Cancer TI - Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058745190&doi=10.1530%2fERC-18-0258&partnerID=40&md5=0ec40273d805dabb3c0eab0113b7af25 VL - 26 ID - 7761 ER - TY - JOUR AD - Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Department of Experimental Medicine, “Sapienza”, University of Rome, Roma, Italy Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy AU - Fallahi, P. AU - Ferrari, S. M. AU - Baldini, E. AU - Biricotti, M. AU - Ulisse, S. AU - Materazzi, G. AU - Miccoli, P. AU - Antonelli, A. DB - Scopus DO - 10.1080/14737140.2016.1238764 IS - 11 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2016 SP - 1109-1118 ST - The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer T2 - Expert Review of Anticancer Therapy TI - The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989220549&doi=10.1080%2f14737140.2016.1238764&partnerID=40&md5=405c073d9434488249fe43dd9ba045f2 VL - 16 ID - 7762 ER - TY - JOUR AD - E.G. Greengard AU - Greengard, E. G. AU - Mosse, Y. P. AU - Liu, X. AU - Ahern, C. H. AU - Minard, C. AU - Blaney, S. AU - Fox, E. AU - Weigel, B. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015853 2015-09-28 PY - 2015 SN - 0732-183X ST - Safety and tolerability of crizotinib in combination with chemotherapy for relapsed or refractory solid tumors or anaplastic large cell lymphoma: A children's oncology group phase I consortium study T2 - Journal of Clinical Oncology TI - Safety and tolerability of crizotinib in combination with chemotherapy for relapsed or refractory solid tumors or anaplastic large cell lymphoma: A children's oncology group phase I consortium study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015853&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10058?sid=a1f9e3a2-0a0d-494c-896f-69f5cc91b53c VL - 33 ID - 7763 ER - TY - JOUR AD - Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. emilyg@umn.edu. St Jude Children's Research Hospital, Memphis, TN, USA. Children's Oncology Group, Monrovia, CA, USA. Baylor College of Medicine, Houston, TX, USA. Mayo Clinic, Rochester, MN, USA. Dana Farber Cancer Institute, Boston, MA, USA. Pfizer, Inc, Bentonville, AR, USA. Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. AN - 33095287 AU - Greengard, E. AU - Mosse, Y. P. AU - Liu, X. AU - Minard, C. G. AU - Reid, J. M. AU - Voss, S. AU - Wilner, K. AU - Fox, E. AU - Balis, F. AU - Blaney, S. M. AU - Adamson, P. C. AU - Weigel, B. J. DA - Dec DO - 10.1007/s00280-020-04171-4 10.1007/s00280-020-04171-4. Epub 2020 Oct 23. DP - Nlm ET - 2020/10/24 IS - 6 LA - eng PY - 2020 SN - 0344-5704 SP - 829-840 ST - Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212) T2 - Cancer Chemother Pharmacol TI - Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212) VL - 86 ID - 7764 ER - TY - JOUR AD - Clinical Pharmacology, Hoffman-La Roche, Nutley, New Jersey 07110, USA. lucy.lee@roche.com AN - 19934286 AU - Lee, L. AU - Niu, H. AU - Rueger, R. AU - Igawa, Y. AU - Deutsch, J. AU - Ishii, N. AU - Mu, S. AU - Sakamoto, Y. AU - Busse-Reid, R. AU - Gimmi, C. AU - Goelzer, P. AU - De Schepper, S. AU - Yoshimura, Y. AU - Barrett, J. AU - Ishikawa, Y. AU - Weissgerber, G. AU - Peck, R. DA - Dec 1 DO - 10.1158/1078-0432.Ccr-09-1696 10.1158/1078-0432.CCR-09-1696. Epub 2009 Nov 24. DP - Nlm ET - 2009/11/26 IS - 23 LA - eng PY - 2009 SN - 1078-0432 (Print) 1078-0432 SP - 7368-74 ST - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker T2 - Clin Cancer Res TI - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarker VL - 15 ID - 7765 ER - TY - JOUR AD - Department of Clinical Pharmacology, Hoffman-La Roche, Inc, 340 Kingsland Street, Nutley, NJ 07110, United States Department of Oncology Discovery, Nutley, NJ, United States Department of Drug Metabolism and Pharmacokinetics, Nutley, NJ, United States Department of Biomarkers and Experimental Medicine, Nutley, NJ, United States Department of Clinical Drug Safety, Nutley, NJ, United States Department of Biostatistics, Nutley, NJ, United States Department of Clinical Development, Hoffmann-La Roche, Nutley, NJ, United States Molecular Laboratories, HistoGeneX, Lindendreef, Belgium Institute of Translational and Experimental Medicine, Strasbourg, France AU - Lee, L. AU - Niu, H. AU - Goelzer, P. AU - Rueger, R. AU - Deutsch, J. AU - Busse-Reid, R. AU - Deschepper, S. AU - Blotner, S. AU - Barrett, J. AU - Weissgerber, G. AU - Peck, R. DB - Scopus DO - 10.1177/0091270010361254 IS - 12 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2010 SP - 1397-1405 ST - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: Assessment of target suppression T2 - Journal of Clinical Pharmacology TI - The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: Assessment of target suppression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-78649790745&doi=10.1177%2f0091270010361254&partnerID=40&md5=64e65070d8bf56834915e9e641aac519 VL - 50 ID - 7766 ER - TY - JOUR AD - C. Kiss, University of Debrecen, Department of Pediatrics, Debrecen, Hungary AU - Kiss, C. AU - Horváth, J. AU - Lábiscsák, P. AU - Tar, I. AU - Szabó, A. AU - Csósz, É AU - Scholtz, B. AU - Márton, I. J. DB - Embase DO - 10.1002/eji.201670200 LA - English M3 - Conference Abstract N1 - L611906093 2016-09-05 PY - 2016 SN - 1521-4141 SP - 373 ST - Salivary expression of dysregulated immune/inflammatory genes provides a useful set of biomarkers in detection of oral cavity squamous cell carcinoma T2 - European Journal of Immunology TI - Salivary expression of dysregulated immune/inflammatory genes provides a useful set of biomarkers in detection of oral cavity squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611906093&from=exporthttp://dx.doi.org/10.1002/eji.201670200 VL - 46 ID - 7767 ER - TY - JOUR AD - Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan Department of Pediatrics, Kansai Medical University Hirakata Hospital, Osaka, Japan Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan Department of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Mito, Japan Department of Hematology and Oncology, Miyagi Children's Hospital, Miyagi, Japan Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan Department of Pediatric Hematology and Oncology, Okayama University Hospital, Okayama, Japan Human Health Sciences, Kyoto University, Kyoto, Japan Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan AU - Kodama, Y. AU - Manabe, A. AU - Kawasaki, H. AU - Kato, I. AU - Kato, K. AU - Sato, A. AU - Matsumoto, K. AU - Kato, M. AU - Hiramatsu, H. AU - Sano, H. AU - Kaneko, T. AU - Oda, M. AU - Saito, A. M. AU - Adachi, S. AU - Horibe, K. AU - Mizutani, S. AU - Ishii, E. AU - Shimada, H. C7 - e26423 DB - Scopus DO - 10.1002/pbc.26423 IS - 8 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2017 ST - Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Pediatric Blood and Cancer TI - Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020670584&doi=10.1002%2fpbc.26423&partnerID=40&md5=5ee766c0de9c490bf497d7185fe98aba VL - 64 ID - 7768 ER - TY - JOUR AD - Department of Neurology and Neurological Surgery, University of Washington, Seattle, WA 98109, USA. chambemc@u.washington.edu AN - 23756728 AU - Chamberlain, M. C. DA - Sep DO - 10.1007/s11060-013-1176-5 10.1007/s11060-013-1176-5. Epub 2013 Jun 12. DP - Nlm ET - 2013/06/13 IS - 2 LA - eng PY - 2013 SN - 0167-594x SP - 237-40 ST - Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series T2 - J Neurooncol TI - Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series VL - 114 ID - 7769 ER - TY - JOUR AD - Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. teicherba@mail.nih.gov. Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland. Molecular Pharmacology Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland. AN - 26351324 AU - Teicher, B. A. AU - Polley, E. AU - Kunkel, M. AU - Evans, D. AU - Silvers, T. AU - Delosh, R. AU - Laudeman, J. AU - Ogle, C. AU - Reinhart, R. AU - Selby, M. AU - Connelly, J. AU - Harris, E. AU - Monks, A. AU - Morris, J. C2 - PMC4636476 C6 - NIHMS718413 to report. DA - Nov DO - 10.1158/1535-7163.Mct-15-0074 10.1158/1535-7163.MCT-15-0074. Epub 2015 Sep 8. DP - Nlm ET - 2015/09/10 IS - 11 LA - eng PY - 2015 SN - 1535-7163 (Print) 1535-7163 SP - 2452-62 ST - Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression T2 - Mol Cancer Ther TI - Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression VL - 14 ID - 7770 ER - TY - JOUR AD - Department of Neurology, Johns Hopkins University School of Medicine, MD 21205, USA. AN - 16230398 AU - Li, Y. AU - Lal, B. AU - Kwon, S. AU - Fan, X. AU - Saldanha, U. AU - Reznik, T. E. AU - Kuchner, E. B. AU - Eberhart, C. AU - Laterra, J. AU - Abounader, R. DA - Oct 15 DO - 10.1158/0008-5472.Can-05-1946 DP - Nlm ET - 2005/10/19 IS - 20 LA - eng N1 - Li, Yunqing Lal, Bachchu Kwon, Sherwin Fan, Xing Saldanha, Usha Reznik, Thomas E Kuchner, Eric B Eberhart, Charles Laterra, John Abounader, Roger PY - 2005 SN - 0008-5472 (Print) 0008-5472 SP - 9355-62 ST - The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy T2 - Cancer Res TI - The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy VL - 65 ID - 7771 ER - TY - JOUR AD - Unidad de Dermatología, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria La Fe, Valencia, Spain Grupo de Investigación en Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Valencia, Spain Grupo de Investigación Clínica y Traslacional del Cáncer, Hospital Universitario y Politécnico La Fe, Valencia, Spain Grupo de Investigación de Dermatología y Regeneración Tisular, Hospital Universitario y Politécnico La Fe, Valencia, Spain AU - Molés-Poveda, P. AU - Montesinos, P. AU - Sanz-Caballer, J. AU - de Unamuno, B. AU - Piñana, J. L. AU - Sahuquillo, A. AU - Botella-Estrada, R. DB - Scopus DO - 10.1016/j.ad.2017.11.003 IS - 3 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 SP - 241-247 ST - Tratamiento de la enfermedad de injerto contra huésped crónica esclerodermiforme con imatinib: una perspectiva dermatológica T2 - Actas Dermo-Sifiliograficas TI - Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044610449&doi=10.1016%2fj.ad.2017.11.003&partnerID=40&md5=31a286ae9129aec84a507d34e0a54f7f VL - 109 ID - 7772 ER - TY - JOUR AD - S. Ubol, Department of Microbiology, Faculty of Science, Mahidol University, 272 Rama VI Rd., Ratchatewee, Bangkok 10400, Thailand AU - Ubol, S. AU - Kasisith, J. AU - Pitidhammabhorn, D. AU - Tepsumethanol, V. DB - Embase Medline DO - 10.1111/j.1348-0421.2005.tb03746.x IS - 5 LA - English M3 - Article N1 - L40806067 2005-06-26 PY - 2005 SN - 0385-5600 SP - 423-431 ST - Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain T2 - Microbiology and Immunology TI - Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40806067&from=exporthttp://dx.doi.org/10.1111/j.1348-0421.2005.tb03746.x VL - 49 ID - 7773 ER - TY - JOUR AD - N. Lavoine, Gustave-Roussy, Villejuif, France AU - Lavoine, N. AU - Le Deley, M. C. AU - Woessmann, W. AU - Pillon, M. AU - Williams, D. AU - Horibe, K. AU - Wrobel, G. AU - Attarbaschi, A. AU - Bezhuisen, A. AU - Uyttebroeck, A. AU - Mellgren, K. AU - Brugières, L. DB - Embase DO - 10.1111/bjh.13753 LA - English M3 - Conference Abstract N1 - L72231395 2016-04-13 PY - 2015 SN - 0007-1048 SP - 55 ST - Second and subsequent relapses of ALCL: EICNHL experience T2 - British Journal of Haematology TI - Second and subsequent relapses of ALCL: EICNHL experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72231395&from=exporthttp://dx.doi.org/10.1111/bjh.13753 VL - 171 ID - 7774 ER - TY - JOUR AD - Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden Department of Haematology, Karolinska University Hospital, Stockholm, Sweden Department of Medicine, Karolinska Institutet, Stockholm, Sweden Department of Medical Science and Division of Haematology, University Hospital, Uppsala, Sweden Regional Cancer Centre, Uppsala-Örebro, Sweden Department of Haematology, University Hospital, Linköping, Sweden Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Haematology, University Hospital, Umeå, Sweden Department of Haematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden AU - Gunnarsson, N. AU - Stenke, L. AU - Höglund, M. AU - Sandin, F. AU - Björkholm, M. AU - Dreimane, A. AU - Lambe, M. AU - Markevärn, B. AU - Olsson-Strömberg, U. AU - Richter, J. AU - Wadenvik, H. AU - Wallvik, J. AU - Själander, A. DB - Scopus DO - 10.1111/bjh.13346 IS - 5 M3 - Article N1 - Cited By :35 Export Date: 18 November 2020 PY - 2015 SP - 683-688 ST - Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era T2 - British Journal of Haematology TI - Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929234796&doi=10.1111%2fbjh.13346&partnerID=40&md5=bb7706fad0b4bde892742c9339e83582 VL - 169 ID - 7775 ER - TY - JOUR AD - H. Zhang, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Shi, Y. AU - Yu, Y. AU - Wang, Z. AU - Wang, H. AU - Bieerkehazhi, S. AU - Zhao, Y. AU - Suzuk, L. AU - Zhang, H. C1 - ps 1145 C2 - LC(United States) Sigma Aldrich DB - Embase Medline DO - 10.18632/oncotarget.12048 IS - 45 LA - English M3 - Article N1 - L613339240 2016-11-28 2016-12-20 PY - 2016 SN - 1949-2553 SP - 73697-73710 ST - Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells T2 - Oncotarget TI - Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613339240&from=exporthttp://dx.doi.org/10.18632/oncotarget.12048 VL - 7 ID - 7776 ER - TY - JOUR AD - Department of Cellular Biotechnologies and Hematology, La Sapienza University, Rome, Italy Institute of Hematology and Medical Oncology Lorenzo and Ariosto Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy AU - Breccia, M. AU - Palandri, F. AU - Iori, A. P. AU - Colaci, E. AU - Latagliata, R. AU - Castagnetti, F. AU - Torelli, G. F. AU - Usai, S. AU - Valle, V. AU - Martinelli, G. AU - Rosti, G. AU - Foà, R. AU - Baccarani, M. AU - Alimena, G. DB - Scopus DO - 10.1016/j.leukres.2009.04.036 IS - 2 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2010 SP - 143-147 ST - Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib T2 - Leukemia Research TI - Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74849117346&doi=10.1016%2fj.leukres.2009.04.036&partnerID=40&md5=69702b194d33bc2eb4565e85b3a5777e VL - 34 ID - 7777 ER - TY - JOUR AD - Division of Haematology and Internal Medicine, Department of Clinical and Biological Science, University of Turin, Turin, Italy Bome Marrow Unit, Molinette Hospital, Turin, Italy AU - Fava, C. AU - Rege-Cambrin, G. AU - Busca, A. AU - Gottardi, E. AU - Daraio, F. AU - Saglio, G. DB - Scopus DO - 10.1016/j.clml.2013.05.017 IS - SUPPL. 2 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2013 SP - S272-S275 ST - Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Second-generation tyrosine kinase inhibitors can induce complete molecular response in Ph-positive acute lymphoblastic leukemia after allogeneic stem cell transplant UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84889058902&doi=10.1016%2fj.clml.2013.05.017&partnerID=40&md5=f4c3b823412842e0bf0fd97a275f60c7 VL - 13 ID - 7778 ER - TY - JOUR AD - Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pediatrics, Weill Cornell Medical College, New York, New York. Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Division of Pediatric Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. cpratil1@jhmi.edu. AN - 29880583 AU - Wang, J. AU - Yao, Z. AU - Jonsson, P. AU - Allen, A. N. AU - Qin, A. C. R. AU - Uddin, S. AU - Dunkel, I. J. AU - Petriccione, M. AU - Manova, K. AU - Haque, S. AU - Rosenblum, M. K. AU - Pisapia, D. J. AU - Rosen, N. AU - Taylor, B. S. AU - Pratilas, C. A. C2 - PMC6125191 C6 - NIHMS978289 advisory board of and has ownership interests in BeiGene and Kura. Neal Rosen is also on the scientific advisory board of Chugai and Astra-Zeneca. Ira J. Dunkel is a consultant to Apexigen, Bayer, Bristol-Myers Squibb, Celgene, Eisai, Ipsen and Pfizer. DA - Sep DO - 10.1158/2159-8290.Cd-17-1263 10.1158/2159-8290.CD-17-1263. Epub 2018 Jun 7. DP - Nlm ET - 2018/06/09 IS - 9 LA - eng PY - 2018 SN - 2159-8274 (Print) 2159-8274 SP - 1130-1141 ST - A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF(V600E)-Mutant Brain Tumor T2 - Cancer Discov TI - A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF(V600E)-Mutant Brain Tumor VL - 8 ID - 7779 ER - TY - JOUR AD - Department of Hematology and Cellular Therapy Unit, Hôpital Emile Muller, Mulhouse, France Centre de Competences on Thrombotic Microangiopathies, Region Alsace, France Laboratory of Hematology, Hôpital Emile Muller, Mulhouse, France Central Pharmacy, Hôpital Emile Muller, Mulhouse, France Department of Internal Medicine, Hôpital Emile Muller, Mulhouse, France Department of Cardiology, Hôpital Emile Muller, Mulhouse, France Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Antoine Béclère, Université Paris, Clamart, France Department of Nephrology, Hôpital Emile Muller, Mulhouse, France AN - 115469173. Language: English. Entry Date: 20161207. Revision Date: 20190712. Publication Type: Article AU - Ojeda-Uribe, Mario AU - Merieau, Sylvain AU - Guillon, Marie AU - Aujoulat, Olivier AU - Hinschberger, Olivier AU - Eisenmann, Jean-Claude AU - Kenizou, David AU - Debliquis, Agathe AU - Veyradier, Agnès AU - Chantrel, François DB - ccm DO - 10.1177/1078155214568580 DP - EBSCOhost IS - 2 N1 - case study; research; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 9511372. PY - 2016 SN - 1078-1552 SP - 361-370 ST - Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate T2 - Journal of Oncology Pharmacy Practice TI - Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=115469173&site=ehost-live&scope=site VL - 22 ID - 7780 ER - TY - JOUR AD - Biomedical Research Institute, Department of Biological Sciences, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, United Kingdom Division of Clinical Science, Warwick Medical School, University of Warwick, Coventry, United Kingdom Medical School, University of Leeds, Leeds, United Kingdom AU - Chen, J. AU - Tan, B. AU - Karteris, E. AU - Zervou, S. AU - Digby, J. AU - Hillhouse, E. W. AU - Vatish, M. AU - Randeva, H. S. DB - Scopus DO - 10.1007/s00125-006-0194-7 IS - 6 M3 - Article N1 - Cited By :175 Export Date: 18 November 2020 PY - 2006 SP - 1292-1302 ST - Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines T2 - Diabetologia TI - Secretion of adiponectin by human placenta: Differential modulation of adiponectin and its receptors by cytokines UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646494846&doi=10.1007%2fs00125-006-0194-7&partnerID=40&md5=4fb40d0faaf5c97e33ab937b94ec607f VL - 49 ID - 7781 ER - TY - JOUR AD - Laboratory of Pharmaceutical Nanomaterials Science, Department of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa, 3200003, Israel Institut de Recerca Sant Joan de Deu, Barcelona, Spain Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, 08950, Spain AU - Zaritski, A. AU - Castillo-Ecija, H. AU - Kumarasamy, M. AU - Peled, E. AU - Sverdlov Arzi, R. AU - Carcaboso, Á M. AU - Sosnik, A. DB - Scopus DO - 10.1021/acsami.9b12682 IS - 42 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 38483-38496 ST - Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression T2 - ACS Applied Materials and Interfaces TI - Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073143274&doi=10.1021%2facsami.9b12682&partnerID=40&md5=d834618160a4d31d332c7f9b95903371 VL - 11 ID - 7782 ER - TY - JOUR AD - J.W. Horton, Dept. of Surgery, Univ. of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9160, United States AU - Horton, J. W. AU - Tan, J. AU - White, D. J. AU - Maass, D. L. AU - Thomas, J. A. DB - Embase Medline DO - 10.1152/ajpheart.00390.2004 IS - 5 56-5 LA - English M3 - Article N1 - L39430765 2004-11-16 PY - 2004 SN - 0363-6135 SP - H2241-H2251 ST - Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury T2 - American Journal of Physiology - Heart and Circulatory Physiology TI - Selective decontamination of the digestive tract attenuated the myocardial inflammation and dysfunction that occur with burn injury UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39430765&from=exporthttp://dx.doi.org/10.1152/ajpheart.00390.2004 VL - 287 ID - 7783 ER - TY - JOUR AD - Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA. ofer.levy@childrens.harvard.edu AN - 15383597 AU - Levy, O. AU - Zarember, K. A. AU - Roy, R. M. AU - Cywes, C. AU - Godowski, P. J. AU - Wessels, M. R. DA - Oct 1 DO - 10.4049/jimmunol.173.7.4627 10.4049/jimmunol.173.7.4627. DP - Nlm ET - 2004/09/24 IS - 7 LA - eng PY - 2004 SN - 0022-1767 (Print) 0022-1767 SP - 4627-34 ST - Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848 T2 - J Immunol TI - Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848 VL - 173 ID - 7784 ER - TY - JOUR AD - A.R. Kahn, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States AU - Kahn, A. R. AU - Hartwell, K. A. AU - Miller, P. G. AU - Ebert, B. L. AU - Golub, T. R. AU - Moore, M. A. S. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70770278 2012-06-19 PY - 2011 SN - 0006-4971 ST - Selective targeting of leukemic over normal stem cells by the serotonin receptor antagonist SB-216641 T2 - Blood TI - Selective targeting of leukemic over normal stem cells by the serotonin receptor antagonist SB-216641 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70770278&from=exporthttp://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/1884?maxtoshow=&hits=60&RESULTFORMAT=&searchid=1&FIRSTINDEX=3000&displaysectionid=Poster+Sessions&fdate=1/1/2011&tdate=12/31/2011&resourcetype=HWCIT VL - 118 ID - 7785 ER - TY - JOUR AD - A.J. De Bold, Cardiovasc. Endocrinology Laboratory, Dept. of Cell. and Molec. Medicine, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ont. K1Y 4W7, Canada AU - Ma, K. K. AU - Ogawa, T. AU - De Bold, A. J. DB - Embase Medline DO - 10.1016/j.yjmcc.2004.01.001 IS - 4 LA - English M3 - Article N1 - L38469941 2004-04-26 PY - 2004 SN - 0022-2828 SP - 505-513 ST - Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase T2 - Journal of Molecular and Cellular Cardiology TI - Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38469941&from=exporthttp://dx.doi.org/10.1016/j.yjmcc.2004.01.001 VL - 36 ID - 7786 ER - TY - JOUR AD - James Graham Brown Cancer Center, University of Louisville, KY 40202, USA. AN - 19588509 AU - Wysoczynski, M. AU - Shin, D. M. AU - Kucia, M. AU - Ratajczak, M. Z. C2 - PMC4021846 C6 - NIHMS578205 DA - Jan 15 DO - 10.1002/ijc.24732 10.1002/ijc.24732. DP - Nlm ET - 2009/07/10 IS - 2 LA - eng PY - 2010 SN - 0020-7136 (Print) 0020-7136 SP - 371-81 ST - Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications T2 - Int J Cancer TI - Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications VL - 126 ID - 7787 ER - TY - JOUR AD - T.J. Triche, Dept. of Pathol. and Lab. Medicine, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard, Los Angeles, CA 90027, United States AU - Zhang, J. AU - Hu, S. AU - Schofield, D. E. AU - Sorensen, P. H. B. AU - Triche, T. J. DB - Embase Medline DO - 10.1158/0008-5472.CAN-03-2594 IS - 17 LA - English M3 - Article N1 - L39129400 2004-09-19 PY - 2004 SN - 0008-5472 SP - 6026-6034 ST - Selective usage of D-type cyclins by Ewing's tumors and rhabdomyosarcomas T2 - Cancer Research TI - Selective usage of D-type cyclins by Ewing's tumors and rhabdomyosarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39129400&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-03-2594 VL - 64 ID - 7788 ER - TY - JOUR AD - Y. Zhang, The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue, Box 171, New York, NY, United States AU - Zhang, Y. AU - Brownstein, A. J. AU - Buonora, M. AU - Niikura, K. AU - Ho, A. AU - Correa da Rosa, J. AU - Kreek, M. J. AU - Ott, J. DB - Embase DO - 10.1016/j.neuroscience.2014.11.013 LA - English M3 - Article N1 - L601084542 2015-01-12 PY - 2015 SN - 1873-7544 0306-4522 SP - 34-46 ST - Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice T2 - Neuroscience TI - Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L601084542&from=exporthttp://dx.doi.org/10.1016/j.neuroscience.2014.11.013 VL - 285 ID - 7789 ER - TY - JOUR AD - Assistant Clinical Professor of Medicine, University of California, San Francisco Associate Clinical Professor, School of Pharmacy, University of California, San Francisco AN - 144418659. Language: English. Entry Date: 20200715. Revision Date: 20201026. Publication Type: Article. Journal Subset: Biomedical AU - Elliott, William AU - Chan, James DB - ccm DP - EBSCOhost IS - 12 N1 - USA. NLM UID: 8003602. PY - 2020 SN - 0195-315X SP - 10-11 ST - Selpercatinib Capsules (Retevmo) T2 - Internal Medicine Alert TI - Selpercatinib Capsules (Retevmo) UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144418659&site=ehost-live&scope=site VL - 42 ID - 7790 ER - TY - JOUR AN - CN-01895662 AU - Isrctn PY - 2018 ST - SeluDex: an international trial of selumetinib in combination with dexamethasone for the treatment of acute lymphoblastic leukaemia T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN92323261 TI - SeluDex: an international trial of selumetinib in combination with dexamethasone for the treatment of acute lymphoblastic leukaemia UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01895662/full ID - 7791 ER - TY - JOUR AD - M.J. Fisher, Children's Hospital of Philadelphia, Philadelphia, PA, United States AU - Fisher, M. J. AU - Marcus, L. AU - Weiss, B. AU - Kim, A. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Martin, S. AU - Gillespie, A. AU - Doyle, A. AU - Widemann, B. C. DB - Embase DO - 10.1093/neuonc/nou081 LA - English M3 - Conference Abstract N1 - L71506038 2014-06-26 PY - 2014 SN - 1522-8517 SP - i129 ST - Selumetinib (AZD6244) hydrogen sulfate, a MEK1/2 inhibitor, in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNS): A phase i study T2 - Neuro-Oncology TI - Selumetinib (AZD6244) hydrogen sulfate, a MEK1/2 inhibitor, in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNS): A phase i study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71506038&from=exporthttp://dx.doi.org/10.1093/neuonc/nou081 VL - 16 ID - 7792 ER - TY - JOUR AN - 28089105 AU - Burki, T. K. DA - Feb DO - 10.1016/s1470-2045(17)30009-8 10.1016/S1470-2045(17)30009-8. Epub 2017 Jan 7. DP - Nlm ET - 2017/01/17 IS - 2 LA - eng PY - 2017 SN - 1470-2045 SP - e69 ST - Selumetinib for children with plexiform neurofibromas T2 - Lancet Oncol TI - Selumetinib for children with plexiform neurofibromas VL - 18 ID - 7793 ER - TY - JOUR AD - H. Nzwalo, Department of Biomedical Sciences and Medicine, Universidade do Algarve, Faro, Portugal AU - Espírito Santo, V. AU - Passos, J. AU - Nzwalo, H. AU - Carvalho, I. AU - Santos, F. AU - Martins, C. AU - Salgado, L. AU - Silva, C. AU - Vinhais, S. AU - Vilares, M. AU - Salgado, D. AU - Nunes, S. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1007/s11060-020-03443-6 IS - 2 LA - English M3 - Article N1 - L2004386158 2020-03-16 2020-04-23 PY - 2020 SN - 1573-7373 0167-594X SP - 459-463 ST - Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience T2 - Journal of Neuro-Oncology TI - Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004386158&from=exporthttp://dx.doi.org/10.1007/s11060-020-03443-6 VL - 147 ID - 7794 ER - TY - JOUR AD - From the Pediatric Oncology Branch (A.M.G., P.L.W., E.D., P.W., S.M., M.C.R., D.C.P., A.C., J.T., O.K., J.G., B.C.W.) and the Clinical Pharmacology Program (C.J.P., W.D.F.), Center for Cancer Research, National Cancer Institute, and the Rehabilitation Medicine Department, Clinical Center (S.M.P), National Institutes of Health, Bethesda, the Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick (A.B., K.H.), the Cancer Therapy Evaluation Program (M.S., L.A.D.) and the Biostatistics and Data Management Section, Center for Cancer Research (S.M.S., D.J.V.), National Cancer Institute, National Institutes of Health, Shady Grove, and Johns Hopkins University School of Medicine, Baltimore (J.O.B.) - all in Maryland; Children's Hospital of Philadelphia, Philadelphia (M.J.F., A.C.S.); Cincinnati Children's Hospital, Cincinnati (B.W.); Children's National Hospital, Washington, DC (A.K., M.B.); and Indiana University School of Medicine, Indianapolis (D.W.C., C.Z.). AN - 32187457 AU - Gross, A. M. AU - Wolters, P. L. AU - Dombi, E. AU - Baldwin, A. AU - Whitcomb, P. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Bornhorst, M. AU - Shah, A. C. AU - Martin, S. AU - Roderick, M. C. AU - Pichard, D. C. AU - Carbonell, A. AU - Paul, S. M. AU - Therrien, J. AU - Kapustina, O. AU - Heisey, K. AU - Clapp, D. W. AU - Zhang, C. AU - Peer, C. J. AU - Figg, W. D. AU - Smith, M. AU - Glod, J. AU - Blakeley, J. O. AU - Steinberg, S. M. AU - Venzon, D. J. AU - Doyle, L. A. AU - Widemann, B. C. C2 - PMC7305659 C6 - NIHMS1590456 DA - Apr 9 DO - 10.1056/NEJMoa1912735 10.1056/NEJMoa1912735. Epub 2020 Mar 18. DP - Nlm ET - 2020/03/19 IS - 15 LA - eng PY - 2020 SN - 0028-4793 (Print) 0028-4793 SP - 1430-1442 ST - Selumetinib in Children with Inoperable Plexiform Neurofibromas T2 - N Engl J Med TI - Selumetinib in Children with Inoperable Plexiform Neurofibromas VL - 382 ID - 7795 ER - TY - JOUR AD - R.D. Carvajal, Division of Hematology/ Oncology, Columbia University, Medical Center, New York, NY, United States AU - Carvajal, R. D. AU - Piperno-Neumann, S. AU - Kapiteijn, E. AU - Chapman, P. B. AU - Frank, S. AU - Joshua, A. M. AU - Piulats, J. M. AU - Wolter, P. AU - Cocquyt, V. AU - Chmielowski, B. AU - Evans, T. R. J. AU - Gastaud, L. AU - Linette, G. AU - Berking, C. AU - Schachter, J. AU - Rodrigues, M. J. AU - Shoushtari, A. N. AU - Clemett, D. AU - Ghiorghiu, D. AU - Mariani, G. AU - Spratt, S. AU - Lovick, S. AU - Barker, P. AU - Kilgour, E. AU - Lai, Z. AU - Schwartz, G. K. AU - Nathan, P. C1 - arry 142886 azd 6244 DB - Embase Medline DO - 10.1200/JCO.2017.74.1090 IS - 12 LA - English M3 - Conference Paper N1 - L621718128 2018-04-26 2019-08-27 PY - 2018 SN - 1527-7755 0732-183X SP - 1232-1239 ST - Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) T2 - Journal of Clinical Oncology TI - Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621718128&from=exporthttp://dx.doi.org/10.1200/JCO.2017.74.1090 VL - 36 ID - 7796 ER - TY - JOUR AD - Department of Hematology, Oncology, and Stem Cell Transplantation, Children's Healthcare of Atlanta and Emory University, Atlanta, GA, USA. Electronic address: jfangus@emory.edu. Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Radiology, Boston Children's Hospital, Boston, MA, USA. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Center for Cancer and Blood Disorders, University of California, San Francisco, San Francisco, CA, USA. Department of Neurology, Children's National Medical Center, Washington, DC, USA. Department of Haematology and Oncology, Children's National Medical Center, Washington, DC, USA. Department of Haematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA. Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Hematology and Oncology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Neurology, Stanford University Medical Center, Palo Alto, CA, USA. Department of Hematology and Oncology, Children's Hospital Los Angeles, Los Angeles, CA, USA. Department of Hematology and Oncology, Texas Children's Hospital, Houston, TX, USA. Department of Hematology and Oncology, Duke University School of Medicine, Durham, NC, USA. Department of Pharmaceutical Science, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Pediatric Glioma Research Group, Hopp Children's Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Pediatric Neuro-Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ) and German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Radiology, Children's National Medical Center, Washington, DC, USA. Department of Radiology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA. Department of Radiology, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, TN, USA. Department of Radiology, Children's Hospital Los Angeles, Los Angeles, CA, USA. Department of Radiology, Nationwide Children's Hospital, Columbus, OH, USA. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Radiology, Duke University School of Medicine, Durham, NC, USA. Department of Radiology, University of California, San Francisco, San Francisco, CA, USA. Department of Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. Investigational Drug Branch, National Cancer Institute and Cancer Therapy Evaluation Program, Bethesda, MD, USA. Clinical Investigation Branch, National Cancer Institute and Cancer Therapy Evaluation Program, Bethesda, MD, USA. Department of Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Department of Haematology and Oncology, Cincinnati Children's Hospital, Cincinnati, OH, USA. AN - 31151904 AU - Fangusaro, J. AU - Onar-Thomas, A. AU - Young Poussaint, T. AU - Wu, S. AU - Ligon, A. H. AU - Lindeman, N. AU - Banerjee, A. AU - Packer, R. J. AU - Kilburn, L. B. AU - Goldman, S. AU - Pollack, I. F. AU - Qaddoumi, I. AU - Jakacki, R. I. AU - Fisher, P. G. AU - Dhall, G. AU - Baxter, P. AU - Kreissman, S. G. AU - Stewart, C. F. AU - Jones, D. T. W. AU - Pfister, S. M. AU - Vezina, G. AU - Stern, J. S. AU - Panigrahy, A. AU - Patay, Z. AU - Tamrazi, B. AU - Jones, J. Y. AU - Haque, S. S. AU - Enterline, D. S. AU - Cha, S. AU - Fisher, M. J. AU - Doyle, L. A. AU - Smith, M. AU - Dunkel, I. J. AU - Fouladi, M. C2 - PMC6628202 C6 - NIHMS1035573 AstraZeneca and was an employee of AstraZeneca from 9/2014–5/2017. RJP serves on a selumetinib plexiform neurofibroma Advisory Committee for AstraZeneca. MJF acted as an unpaid consultant for AstraZeneca and received travel reimbursement to participate in an Advisory Board meeting. All other authors declare no competing interests. DA - Jul DO - 10.1016/s1470-2045(19)30277-3 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. DP - Nlm ET - 2019/06/04 IS - 7 LA - eng PY - 2019 SN - 1470-2045 (Print) 1470-2045 SP - 1011-1022 ST - Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial T2 - Lancet Oncol TI - Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial VL - 20 ID - 7797 ER - TY - JOUR AD - Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy. francescobaldo11@yahoo.it. Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, 34127, Trieste, Italy. Pharmacy and Clinical Pharmacology Unit, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. Department of Radiology, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. Department of Radiology, Institute for Maternal and Child Health, IRCCS Giannina Gaslini, Via Gerolamo Gaslini 5, 16147, Genova, Italy. Department of Pediatrics, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34137, Trieste, Italy. AN - 32533336 AU - Baldo, F. AU - Grasso, A. G. AU - Cortellazzo Wiel, L. AU - Maestro, A. AU - Trojniak, M. P. AU - Murru, F. M. AU - Basso, L. AU - Magnolato, A. AU - Bruno, I. AU - Barbi, E. DA - Aug DO - 10.1007/s40272-020-00399-y 10.1007/s40272-020-00399-y. DP - Nlm ET - 2020/06/14 IS - 4 LA - eng PY - 2020 SN - 1174-5878 SP - 417-423 ST - Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects T2 - Paediatr Drugs TI - Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects VL - 22 ID - 7798 ER - TY - JOUR AN - 144768968. Language: English. Entry Date: 20200730. Revision Date: 20200803. Publication Type: Article DB - ccm DO - 10.1093/ajhp/zxaa165 DP - EBSCOhost IS - 15 N1 - practice guidelines. Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA. NLM UID: 9503023. PY - 2020 SN - 1079-2082 SP - 1180-1182 ST - Selumetinib Sulfate T2 - American Journal of Health-System Pharmacy TI - Selumetinib Sulfate UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144768968&site=ehost-live&scope=site VL - 77 ID - 7799 ER - TY - JOUR AD - A. Markham, Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, New Zealand AU - Markham, A. AU - Keam, S. J. DB - Embase Medline DO - 10.1007/s40265-020-01331-x IS - 9 LA - English M3 - Article N1 - L2005165467 2020-06-30 2020-07-03 PY - 2020 SN - 1179-1950 0012-6667 SP - 931-937 ST - Selumetinib: First Approval T2 - Drugs TI - Selumetinib: First Approval UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005165467&from=exporthttp://dx.doi.org/10.1007/s40265-020-01331-x VL - 80 ID - 7800 ER - TY - JOUR AD - aInstitute of Molecular Biology and Biophysics bBioLink Ltd, Novosibirsk cN.N.Blokhin Russian Cancer Research Center, Moscow, Russia dBioron GmbH, Ludwigshafen eInstitute of Pathology fDepartment of Dermatology, University Hospital Erlangen, Erlangen, Germany. AN - 24922189 AU - Pisareva, E. AU - Gutkina, N. AU - Kovalenko, S. AU - Kuehnapfel, S. AU - Hartmann, A. AU - Heinzerling, L. AU - Schneider-Stock, R. AU - Lyubchenko, L. AU - Shamanin, V. A. DA - Aug DO - 10.1097/cmr.0000000000000090 10.1097/CMR.0000000000000090. DP - Nlm ET - 2014/06/13 IS - 4 LA - eng PY - 2014 SN - 0960-8931 SP - 322-31 ST - Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma T2 - Melanoma Res TI - Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma VL - 24 ID - 7801 ER - TY - JOUR AD - Department of Neuropathology, University of Bonn, Germany. AN - 21817898 AU - Setty, P. AU - Gessi, M. AU - Waha, A. AU - Hammes, J. AU - El-Maarri, O. AU - Pietsch, T. AU - Waha, A. DA - Sep DO - 10.1097/PDM.0b013e3182143817 10.1097/PDM.0b013e3182143817. DP - Nlm ET - 2011/08/06 IS - 3 LA - eng PY - 2011 SN - 1052-9551 SP - 148-57 ST - Sensitive determination of BRAF copy number in clinical samples by pyrosequencing T2 - Diagn Mol Pathol TI - Sensitive determination of BRAF copy number in clinical samples by pyrosequencing VL - 20 ID - 7802 ER - TY - JOUR AD - N. Andersson, Children's Hospital, University of Helsinki and Helsinki University Central Hospital, PO Box 20, 00014, Helsinki, Finland AU - Andersson, N. AU - Anttonen, M. AU - Färkkilä, A. AU - Pihlajoki, M. AU - Butzow, R. AU - Unkila-Kallio, L. AU - Heikinheimo, M. C2 - Selleck(United States) DB - Embase Medline DO - 10.1530/JME-13-0286 IS - 2 LA - English M3 - Article N1 - L372670254 2014-04-01 2014-04-02 PY - 2014 SN - 0952-5041 1479-6813 SP - 223-234 ST - Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition T2 - Journal of Molecular Endocrinology TI - Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372670254&from=exporthttp://dx.doi.org/10.1530/JME-13-0286http://jme.endocrinology-journals.org/content/52/2/223.full.pdf VL - 52 ID - 7803 ER - TY - JOUR AD - Department of Hematology and Oncology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Hämatologie und Onkologie, III. Medizinische Klinik, Wissenschaftliches Labor, Universitätsklinikum Mannheim GmbH, Pettenkoferstraße 22, Mannheim, 68169, Germany AU - Spiess, B. AU - Kleiner, H. AU - Flach, J. AU - Fabarius, A. AU - Saussele, S. AU - Hofmann, W. K. AU - Seifarth, W. DB - Scopus DO - 10.1007/s00277-020-04007-4 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 991-1006 ST - Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients T2 - Annals of Hematology TI - Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083058819&doi=10.1007%2fs00277-020-04007-4&partnerID=40&md5=ea7b49126d90354f5822075de0d80540 VL - 99 ID - 7804 ER - TY - JOUR AD - The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, DC; Center for Neuroscience and Behavior, Children's National Health System, Washington, DC. Electronic address: averyr@email.chop.edu. The Gilbert Family Neurofibromatosis Institute, Children's National Health System, Washington, DC. Division of Oncology, Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC; The Brain Tumor Institute, Children's National Health System, Washington, DC. AN - 27108842 AU - Avery, R. A. AU - Trimboli-Heidler, C. AU - Kilburn, L. B. C2 - PMC4912405 C6 - NIHMS780872 DA - Jun DO - 10.1016/j.jaapos.2016.01.012 10.1016/j.jaapos.2016.01.012. Epub 2016 Apr 21. DP - Nlm ET - 2016/04/26 IS - 3 LA - eng PY - 2016 SN - 1091-8531 (Print) 1091-8531 SP - 268-71 ST - Separation of outer retinal layers secondary to selumetinib T2 - J aapos TI - Separation of outer retinal layers secondary to selumetinib VL - 20 ID - 7805 ER - TY - JOUR AD - Department of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi, Japan Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya Japan Department of Pediatrics, Iwate Prefectural Chubu Hospital, Iwate, Japan Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan Department of Pediatrics, Keio University School of Medicine, Tokyo Japan Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya Japan Department of Pediatrics, Soma General Hospital, Fukushima, Japan Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo Japan Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital, Hiroshima Japan Department of Pediatrics, Japan Community Healthcare Organization Tokuyama Central Hospital, Tokuyama Japan Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki Japan Department of Pediatrics, St. Luke's International Hospital, Tokyo Japan Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo Japan Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto Japan Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan AN - 132481169. Language: English. Entry Date: 20190519. Revision Date: 20201026. Publication Type: journal article AU - Kurosawa, Hidemitsu AU - Tanizawa, Akihiko AU - Muramatsu, Hideki AU - Tono, Chikako AU - Watanabe, Akihiro AU - Shima, Haruko AU - Ito, Masaki AU - Yuza, Yuki AU - Hamamoto, Kazuko AU - Hotta, Noriko AU - Okada, Masahiko AU - Saito, Akiko Moriya AU - Manabe, Atsushi AU - Mizutani, Shuki AU - Adachi, Souichi AU - Horibe, Keizo AU - Ishii, Eiichi AU - Shimada, Hiroyuki DB - ccm DO - 10.1002/pbc.27368 DP - EBSCOhost IS - 12 N1 - research; tables/charts. Journal Subset: Biomedical; Peer Reviewed; USA. NLM UID: 101186624. PMID: NLM30084127. PY - 2018 SN - 1545-5009 SP - N.PAG-N.PAG ST - Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group T2 - Pediatric Blood & Cancer TI - Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=132481169&site=ehost-live&scope=site VL - 65 ID - 7806 ER - TY - JOUR AD - Department of Dermatology, University Hospital Würzburg, Würzburg, Germany Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany Translational Skin Cancer Research, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Essen, Germany Department of Dermatology, University Duisburg-Essen, Essen, Germany Department of Dermatology, Medical University of Graz, Graz, Austria AU - Willmes, C. AU - Kumar, R. AU - Becker, J. C. AU - Fried, I. AU - Rachakonda, P. S. AU - Poppe, L. M. AU - Hesbacher, S. AU - Schadendorf, D. AU - Sucker, A. AU - Schrama, D. AU - Ugurel, S. DB - Scopus DO - 10.18632/oncotarget.6956 IS - 9 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 10117-10132 ST - SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma T2 - Oncotarget TI - SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961588345&doi=10.18632%2foncotarget.6956&partnerID=40&md5=e2de23f45f2761fa90e76cf121310aba VL - 7 ID - 7807 ER - TY - JOUR AD - Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 101-0062, Japan Forsyth Institute, Boston, MA, United States Department of Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, United States 21st Century Center of Excellence Program, Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone, Tokyo, Japan Core to Core Program, JSPS, Tokyo Medical and Dental University, Tokyo, Japan Hard Tissue Genome Research Center, Tokyo Medical and Dental University, Tokyo, Japan Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 3-10 Kanda-Surugadai, 2-chome, Chiyoda-ku, Tokyo 101-0062, Japan AU - Hayashi, C. AU - Rittling, S. AU - Hayata, T. AU - Amagasa, T. AU - Denhardt, D. AU - Ezura, Y. AU - Nakashima, K. AU - Noda, M. DB - Scopus DO - 10.1002/jcb.21298 IS - 4 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2007 SP - 979-986 ST - Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration T2 - Journal of Cellular Biochemistry TI - Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34447265320&doi=10.1002%2fjcb.21298&partnerID=40&md5=9fe4047e7860391bfb0780a902d1f8c2 VL - 101 ID - 7808 ER - TY - JOUR AD - Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan Department of Hematology, Sapporo City General Hospital, Sapporo, Japan Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan Department of Hematology, Asahikawa Medical University, Asahikawa, Japan Department of Hematology/Oncology, Asahikawa Kosei Hospital, Asahikawa, Japan Faculty of Medicine and Graduate School of Medicine, Department of Hematology, Hokkaido University, Sapporo, Japan Department of Hematology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan Department of Hematology, Aiiku Hospital, Sapporo, Japan Department of Hematology, Tenshi Hospital, Sapporo, Japan Department of Hematology, Sapporo Medical University, Sapporo, Japan Department of Hematology, Steel Memorial Muroran Hospital, Muroran, Japan Department of Hematology, Tonan Hospital, Sapporo, Japan Department of Pediatrics, Sapporo Medical University, Sapporo, Japan Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan Department of Pediatrics, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan Department of Hematology/Oncology for Children and Adolescent, Sapporo Hokuyu Hospital, Sapporo, Japan Department of Hematology and Oncology, NTT East Japan Sapporo Hospital, Sapporo, Japan Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan Department of Hematology, Higashisapporo Hospital, Sapporo, Japan Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan Department of Hematology, Obihiro Kosei HospitalObihiro, Japan Palliative Care Center, Sapporo Kosei Hospital, Sapporo, Japan Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan AU - Ota, S. AU - Matsukawa, T. AU - Yamamoto, S. AU - Ito, S. AU - Shindo, M. AU - Sato, K. AU - Kondo, T. AU - Kohda, K. AU - Sakai, H. AU - Mori, A. AU - Takahashi, T. AU - Ikeda, H. AU - Kuroda, H. AU - Haseyama, Y. AU - Yamamoto, M. AU - Sarashina, T. AU - Yoshida, M. AU - Kobayashi, R. AU - Nishio, M. AU - Ishihara, T. AU - Hirayama, Y. AU - Kakinoki, Y. AU - Kobayashi, H. AU - Fukuhara, T. AU - Imamura, M. AU - Kurosawa, M. DB - Scopus DO - 10.1111/ejh.13081 IS - 1 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 95-105 ST - Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemia T2 - European Journal of Haematology TI - Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047499349&doi=10.1111%2fejh.13081&partnerID=40&md5=46100baf99299974eae95de73f057e84 VL - 101 ID - 7809 ER - TY - JOUR AD - S.L. Kleina, W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States AU - Kleina, S. L. AU - Marriott, I. AU - Fish, E. N. DB - Embase Medline DO - 10.1093/trstmh/tru167 IS - 1 LA - English M3 - Article N1 - L604282631 2015-05-13 2015-05-26 PY - 2014 SN - 1878-3503 0035-9203 SP - 9-15 ST - Sex-based differences in immune function and responses to vaccination T2 - Transactions of the Royal Society of Tropical Medicine and Hygiene TI - Sex-based differences in immune function and responses to vaccination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604282631&from=exporthttp://dx.doi.org/10.1093/trstmh/tru167 VL - 109 ID - 7810 ER - TY - JOUR AD - Department of Mathematics and Statistics, California State University, 1250 Bellflower Boulevard, Long Beach, CA 90840-1001, United States Department of Computer Science, University of California, Santa Cruz, CA 95064, United States Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, FDA, Jefferson, AR 72079, United States Graduate Institute of Biostatistics, Biostatistics Center, China Medical University, Taichung, Taiwan AU - Moon, H. AU - Lopez, K. L. AU - Lin, G. I. AU - Chen, J. J. DB - Scopus DO - 10.1155/2013/393020 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2013 SP - 661-667 ST - Sex-specific genomic biomarkers for individualized treatment of life-threatening diseases T2 - Disease Markers TI - Sex-specific genomic biomarkers for individualized treatment of life-threatening diseases UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888862868&doi=10.1155%2f2013%2f393020&partnerID=40&md5=d796cc1b1bcffb65485dfb93d15bf556 VL - 35 ID - 7811 ER - TY - JOUR AD - Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden Division of Laboratory Medicine, Department of Clinical Genetics and Pathology, Lund, Sweden Department of Hematology, Skåne University Hospital, Lund, Sweden Department of Pediatrics, Linköping University Hospital, Linköping, Sweden Department of Pediatrics, Skåne University Hospital, Lund, Sweden AU - Biloglav, A. AU - Olsson-Arvidsson, L. AU - Theander, J. AU - Behrendtz, M. AU - Castor, A. AU - Johansson, B. DB - Scopus DO - 10.1002/gcc.22852 IS - 9 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 540-543 ST - SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias T2 - Genes Chromosomes and Cancer TI - SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084229626&doi=10.1002%2fgcc.22852&partnerID=40&md5=4b48cfc1340e659e4155b928b66aeafd VL - 59 ID - 7812 ER - TY - JOUR AN - 23883275 AU - Kang, S. Y. AU - Ahn, S. AU - Lee, S. M. AU - Jeong, J. Y. AU - Sung, J. Y. AU - Oh, Y. L. AU - Kim, K. M. C2 - PMC3751688 DA - Jul 24 DO - 10.1186/1746-1596-8-121 10.1186/1746-1596-8-121. DP - Nlm ET - 2013/07/26 LA - eng PY - 2013 SN - 1746-1596 SP - 121 ST - Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas T2 - Diagn Pathol TI - Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas VL - 8 ID - 7813 ER - TY - JOUR AD - INSERM UMR1037, Cancer Research Center of Toulouse, Pavillon Lefebvre, BP3028, Toulouse, France Laboratoire d'Hématologie, CHU Toulouse, Hô Pital Purpan, Toulouse, France Service d'Hématologie, CHU de Toulouse, Hô Pital Purpan, place du Dr Baylac, Toulouse Cedex 31059, France Université Toulouse III Paul Sabatier, Toulouse, France CNRS UMR5237, Université de Montpellier, CRBM, Montpellier, France AU - Fialin, C. AU - Larrue, C. AU - Vergez, F. AU - Sarry, J. E. AU - Bertoli, S. AU - Mansat-De Mas, V. AU - Demur, C. AU - Delabesse, E. AU - Payrastre, B. AU - Manenti, S. AU - Roche, S. AU - Récher, C. DB - Scopus DO - 10.1038/leu.2012.240 IS - 2 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 SP - 325-335 ST - The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors T2 - Leukemia TI - The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873568032&doi=10.1038%2fleu.2012.240&partnerID=40&md5=43fb2823b747988d9a9fab5b5aaa2af9 VL - 27 ID - 7814 ER - TY - JOUR AD - C.-E. Zhang, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Lab of Respiratory Disease, Affiliated Cancer Hospital of Guangzhou Medical University, Guangdong, China AU - Chen, H. AU - Liang, L. AU - Xu, H. AU - Xu, J. AU - Yao, L. AU - Li, Y. AU - Tan, Y. AU - Li, X. AU - Huang, Q. AU - Yang, Z. AU - Wu, J. AU - Chen, J. AU - Huang, H. AU - Wang, X. AU - Zhang, C. E. AU - Liu, J. C1 - bilirubin(Sigma Aldrich,United States) C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.3233/JAD-190945 IS - 1 LA - English M3 - Article N1 - L630705745 2020-01-31 2020-02-05 PY - 2020 SN - 1875-8908 1387-2877 SP - 277-295 ST - Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life T2 - Journal of Alzheimer's Disease TI - Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630705745&from=exporthttp://dx.doi.org/10.3233/JAD-190945 VL - 73 ID - 7815 ER - TY - JOUR AD - Department of Experimental Medicine, Second University of Naples, 80138 Naples, Italy. Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, 80138 Naples, Italy. Department of Veterinary Medicine and Animal Reproduction, Federico II University, 80138 Naples, Italy. Unit of General and Geriatric Surgery, School of Medicine, Second University of Naples, 80137 Naples, Italy. AN - 25197428 AU - Monda, M. AU - Messina, G. AU - Scognamiglio, I. AU - Lombardi, A. AU - Martin, G. A. AU - Sperlongano, P. AU - Porcelli, M. AU - Caraglia, M. AU - Stiuso, P. C2 - PMC4147268 DO - 10.1155/2014/131024 10.1155/2014/131024. Epub 2014 Aug 13. DP - Nlm ET - 2014/09/10 LA - eng PY - 2014 SN - 1942-0900 (Print) 1942-0994 SP - 131024 ST - Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress T2 - Oxid Med Cell Longev TI - Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress VL - 2014 ID - 7816 ER - TY - JOUR AD - Biomaterials and Tissue Engineering Research Unit, School of AMME, The University of Sydney, Sydney, Australia. AN - 22296271 AU - Lu, Z. AU - Wang, G. AU - Dunstan, C. R. AU - Zreiqat, H. DA - Sep 1 DO - 10.1089/scd.2011.0589 10.1089/scd.2011.0589. Epub 2012 Mar 6. DP - Nlm ET - 2012/02/03 IS - 13 LA - eng PY - 2012 SN - 1547-3287 SP - 2420-9 ST - Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation T2 - Stem Cells Dev TI - Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation VL - 21 ID - 7817 ER - TY - JOUR AD - Y. Komatsu, Department of Pediatrics, University of Texas, Medical School at Houston, 6431 Fannin St, Houston, TX, United States AU - Kamiya, N. AU - Shen, J. AU - Noda, K. AU - Kitami, M. AU - Feng, G. S. AU - Chen, D. AU - Komatsu, Y. DB - Embase Medline DO - 10.1002/jbmr.2541 IS - 11 LA - English M3 - Article N1 - L606575279 2015-10-29 2015-10-30 PY - 2015 SN - 1523-4681 0884-0431 SP - 2028-2032 ST - SHP2-Deficiency in Chondrocytes Deforms Orofacial Cartilage and Ciliogenesis in Mice T2 - Journal of Bone and Mineral Research TI - SHP2-Deficiency in Chondrocytes Deforms Orofacial Cartilage and Ciliogenesis in Mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606575279&from=exporthttp://dx.doi.org/10.1002/jbmr.2541 VL - 30 ID - 7818 ER - TY - JOUR AD - N. Ratner, Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, 3333 Burnet Avenue, M.L.C. 7013, Cincinnati, OH, United States AU - Patel, A. V. AU - Chaney, K. E. AU - Choi, K. AU - Largaespada, D. A. AU - Kumar, A. R. AU - Ratner, N. DB - Embase Medline DO - 10.1016/j.ebiom.2016.06.007 LA - English M3 - Article N1 - L612824826 2016-10-25 2016-10-28 PY - 2016 SN - 2352-3964 SP - 110-119 ST - An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors T2 - EBioMedicine TI - An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612824826&from=exporthttp://dx.doi.org/10.1016/j.ebiom.2016.06.007 VL - 9 ID - 7819 ER - TY - JOUR AD - Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA 52242. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093. Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan. Division of Medical Microbiology, Lund University, SE-223 62 Lund, Sweden. Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, Department of Pediatrics, Department of Pathology, Department of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093 a1varki@ucsd.edu vnizet@ucsd.edu. AN - 24799499 AU - Ali, S. R. AU - Fong, J. J. AU - Carlin, A. F. AU - Busch, T. D. AU - Linden, R. AU - Angata, T. AU - Areschoug, T. AU - Parast, M. AU - Varki, N. AU - Murray, J. AU - Nizet, V. AU - Varki, A. C2 - PMC4042635 DA - Jun 2 DO - 10.1084/jem.20131853 10.1084/jem.20131853. Epub 2014 May 5. DP - Nlm ET - 2014/05/07 IS - 6 LA - eng PY - 2014 SN - 0022-1007 (Print) 0022-1007 SP - 1231-42 ST - Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus T2 - J Exp Med TI - Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus VL - 211 ID - 7820 ER - TY - JOUR AD - R.-M. Jin, Pediatric Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China AU - Xu, J. W. AU - Jin, R. M. AU - Li, E. Q. AU - Wang, Y. R. AU - Bai, Y. DB - Embase Medline DO - 10.1007/s12519-009-0028-z IS - 2 LA - English M3 - Article N1 - L354947028 2009-08-18 PY - 2009 SN - 1708-8569 SP - 140-145 ST - Signal pathways in ouabain-induced proliferation of leukemia cells T2 - World Journal of Pediatrics TI - Signal pathways in ouabain-induced proliferation of leukemia cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354947028&from=exporthttp://dx.doi.org/10.1007/s12519-009-0028-z VL - 5 ID - 7821 ER - TY - JOUR AD - Department of Pediatric Dentistry, Institute of Odontology, Karolinska Institutet, Box 4064, SE-141 04 Huddinge, Sweden AU - Yucel-Lindberg, T. AU - Olsson, T. AU - Kawakami, T. DB - Scopus DO - 10.1016/j.cellsig.2006.04.003 IS - 12 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2006 SP - 2131-2142 ST - Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts T2 - Cellular Signalling TI - Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750344327&doi=10.1016%2fj.cellsig.2006.04.003&partnerID=40&md5=b1d3f863f2d7aa0f1ec3304e892593a2 VL - 18 ID - 7822 ER - TY - JOUR AD - D. P. M. Hughes, Department of Pediatrics Research, Children's Cancer Hospital, University of Texas M. D. Anderson Cancer Center, Box 0853, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Richards, K. N. AU - Zweidler-McKay, P. A. AU - Van Roy, N. AU - Speleman, F. AU - Trevino, J. AU - Zage, P. E. AU - Hughes, D. P. M. C1 - ci 1033(Pfizer,United States) C2 - Osi(United States) Pfizer(United States) DB - Embase Medline DO - 10.1002/cncr.25073 IS - 13 LA - English M3 - Article N1 - L359118913 2010-07-13 2010-07-19 PY - 2010 SN - 0008-543X 1097-0142 SP - 3233-3243 ST - Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo T2 - Cancer TI - Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359118913&from=exporthttp://dx.doi.org/10.1002/cncr.25073http://www3.interscience.wiley.com/cgi-bin/fulltext/123359347/PDFSTART VL - 116 ID - 7823 ER - TY - JOUR AD - Department of Dental Medicine, Division of Pediatric Dentistry, Karolinska Institutet, 141 04 Huddinge, Sweden Science for Life Laboratory, Division of Gene Technology, School of Biotechnology, Royal Institute of Technology, Solna, Sweden Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden Department of Dental Medicine, Division of Cariology, Karolinska Institutet, 141 04 Huddinge, Sweden AU - Davanian, H. AU - Båge, T. AU - Lindberg, J. AU - Lundeberg, J. AU - Q. Concha, H. AU - Sällberg Chen, M. AU - Yucel-Lindberg, T. DB - Scopus DO - 10.1016/j.cyto.2011.12.008 IS - 3 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2012 SP - 406-416 ST - Signaling pathways involved in the regulation of TNFα-induced toll-like receptor 2 expression in human gingival fibroblasts T2 - Cytokine TI - Signaling pathways involved in the regulation of TNFα-induced toll-like receptor 2 expression in human gingival fibroblasts UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856370445&doi=10.1016%2fj.cyto.2011.12.008&partnerID=40&md5=06bc312e068f6e7200c1d26e6cf23306 VL - 57 ID - 7824 ER - TY - JOUR AN - 22092579 AU - Passeron, T. AU - Lacour, J. P. AU - Allegra, M. AU - Ségalen, C. AU - Deville, A. AU - Thyss, A. AU - Giacchero, D. AU - Ortonne, J. P. AU - Bertolotto, C. AU - Ballotti, R. AU - Bahadoran, P. DA - Dec DO - 10.1111/j.1600-0625.2011.01385.x 10.1111/j.1600-0625.2011.01385.x. DP - Nlm ET - 2011/11/19 IS - 12 LA - eng PY - 2011 SN - 0906-6705 SP - 1030-2 ST - Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? T2 - Exp Dermatol TI - Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy? VL - 20 ID - 7825 ER - TY - JOUR AD - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Falchi, L. AU - Kantarjian, H. M. AU - Wang, X. AU - Verma, D. AU - Quintás-Cardama, A. AU - O'Brien, S. AU - Jabbour, E. J. AU - Ravandi-Kashani, F. AU - Borthakur, G. AU - Garcia-Manero, G. AU - Verstovsek, S. AU - Burger, J. A. AU - Luthra, R. AU - Cortes, J. E. DB - Scopus DO - 10.1002/ajh.23560 IS - 12 M3 - Article N1 - Cited By :45 Export Date: 18 November 2020 PY - 2013 SP - 1024-1029 ST - Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors T2 - American Journal of Hematology TI - Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888066021&doi=10.1002%2fajh.23560&partnerID=40&md5=ae38bca514920b81ea6523fd426de7f6 VL - 88 ID - 7826 ER - TY - JOUR AD - X. Shi, Shanghai, China AU - Shi, X. AU - Liu, A. AU - Wang, K. AU - Zhang, B. AU - Wang, J. DB - Embase IS - 3 LA - English M3 - Conference Abstract N1 - L631879552 2020-06-02 PY - 2020 SN - 1530-0285 SP - 80-83 ST - Significance of NGS in diagnosis and therapy guidance of bone and soft tissue sarcomas T2 - Modern Pathology TI - Significance of NGS in diagnosis and therapy guidance of bone and soft tissue sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631879552&from=export VL - 33 ID - 7827 ER - TY - JOUR AD - Y. Chu, New York Medical College, Valhalla, NY, United States AU - Chu, Y. AU - Su, N. K. AU - Rosenblum, J. AU - Wong, H. C. AU - Lee, D. A. AU - Cairo, M. S. DB - Embase DO - 10.1186/s40425-017-0288-4 LA - English M3 - Conference Abstract N1 - L619372141 2017-11-28 PY - 2017 SN - 2051-1426 ST - Significant enhancement of expanded natural killer cells against GD2 pediatric solid tumors (ST) in combination with ALT-803 (IL-15 superagonist) and dinutuximab T2 - Journal for ImmunoTherapy of Cancer TI - Significant enhancement of expanded natural killer cells against GD2 pediatric solid tumors (ST) in combination with ALT-803 (IL-15 superagonist) and dinutuximab UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619372141&from=exporthttp://dx.doi.org/10.1186/s40425-017-0288-4 VL - 5 ID - 7828 ER - TY - JOUR AD - B.H. Chang, OHSU, Portland, OR, United States AU - Chang, B. H. AU - Leonard, J. AU - Wolf, J. AU - Degnin, M. AU - Lenz, K. AU - Wilmot, B. AU - Mullighan, C. G. AU - Loh, M. L. AU - Hunger, S. P. AU - Tyner, J. W. AU - Druker, B. J. DB - Embase DO - 10.1182/blood-2018-99-115706 LA - English M3 - Conference Abstract N1 - L626588637 2019-03-08 PY - 2018 SN - 0006-4971 ST - Significant in vivo sensitivity to aurora kinase inhibition in TCF3-HLF rearranged acute lymphoblastic leukemia T2 - Blood TI - Significant in vivo sensitivity to aurora kinase inhibition in TCF3-HLF rearranged acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626588637&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-115706 VL - 132 ID - 7829 ER - TY - JOUR AD - X. Shi, Department of Orthopedic Trauma and Hand and Foot Surgery, Jinan Central Hospital Affiliated to Shandong University, No. 105, Jiefang Road, Jinan City, Shandong Province, China AU - Liu, B. AU - Zhao, H. AU - Zhang, L. AU - Shi, X. DB - Embase Medline DO - 10.1186/s12885-019-6335-4 IS - 1 LA - English M3 - Article N1 - L629849750 2019-11-22 2019-11-26 PY - 2019 SN - 1471-2407 ST - Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway T2 - BMC Cancer TI - Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629849750&from=exporthttp://dx.doi.org/10.1186/s12885-019-6335-4 VL - 19 ID - 7830 ER - TY - JOUR AD - Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances, Guangzhou, China Department of Biochemistry and Molecular Biology, School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou, China Department of clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China AU - Wang, W. Z. AU - Pu, Q. H. AU - Lin, X. H. AU - Liu, M. Y. AU - Wu, L. R. AU - Wu, Q. Q. AU - Chen, Y. H. AU - Liao, F. F. AU - Zhu, J. Y. AU - Jin, X. B. DB - Scopus DO - 10.1016/j.leukres.2015.07.008 IS - 10 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2015 SP - 1117-1124 ST - Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway T2 - Leukemia Research TI - Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941316648&doi=10.1016%2fj.leukres.2015.07.008&partnerID=40&md5=ecbf06834a0700219cf2c68a8a81d391 VL - 39 ID - 7831 ER - TY - JOUR AD - Department of Biochemistry, Virginia Commonwealth University, Richmond, VA 23298, USA. stgrant@hsc.vcu.edu AN - 17584030 AU - Grant, S. AU - Dent, P. DA - Jun DO - 10.2174/138945007780830764 DP - Nlm ET - 2007/06/23 IS - 6 LA - eng N1 - 1873-5592 Grant, Steven Dent, Paul PY - 2007 SN - 1389-4501 SP - 751-9 ST - Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias T2 - Curr Drug Targets TI - Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias VL - 8 ID - 7832 ER - TY - JOUR AD - Department of Medical Oncology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. AN - 23867124 AU - van Gaal, J. C. AU - Roeffen, M. H. AU - Flucke, U. E. AU - van der Laak, J. A. AU - van der Heijden, G. AU - de Bont, E. S. AU - Suurmeijer, A. J. AU - Versleijen-Jonkers, Y. M. AU - van der Graaf, W. T. DA - Nov DO - 10.1016/j.ejca.2013.06.022 10.1016/j.ejca.2013.06.022. Epub 2013 Jul 15. DP - Nlm ET - 2013/07/23 IS - 16 LA - eng PY - 2013 SN - 0959-8049 SP - 3462-70 ST - Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice T2 - Eur J Cancer TI - Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice VL - 49 ID - 7833 ER - TY - JOUR AD - D.L. Durden, Department of Pediatrics, Moores Cancer Center, University of California, 3855 Health Sciences Drive, San Diego, CA, United States AU - Singh, A. R. AU - Joshi, S. AU - Burgoyne, A. M. AU - Sicklick, J. K. AU - Ikeda, S. AU - Kono, Y. AU - Garlich, J. R. AU - Morales, G. A. AU - Durden, D. L. C1 - ly 294002 sf 1126 DB - Embase Medline DO - 10.1158/1535-7163.MCT-15-0976 IS - 11 LA - English M3 - Article N1 - L613162498 2016-11-22 2016-12-08 PY - 2016 SN - 1538-8514 1535-7163 SP - 2553-2562 ST - Single agent and synergistic activity of the "first-in-class" dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma T2 - Molecular Cancer Therapeutics TI - Single agent and synergistic activity of the "first-in-class" dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613162498&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-15-0976 VL - 15 ID - 7834 ER - TY - JOUR AD - Z. Reitman, Dana-Farber Cancer Institute, Boston, MA, United States AU - Reitman, Z. AU - Paolella, B. AU - Bergthold, G. AU - Pelton, K. AU - Becker, S. AU - Jones, R. AU - Sinai, C. AU - Malkin, H. AU - Huang, Y. AU - Grimmet, L. AU - Herbert, Z. AU - Sun, Y. AU - Weatherbee, J. AU - Qian, K. AU - Condurat, A. L. AU - Alberta, J. AU - Daley, J. AU - Rozenblatt-Rozen, O. AU - Segal, R. AU - Haas-Kogan, D. AU - Filbin, M. AU - Suva, M. AU - Regev, A. AU - Stiles, C. AU - Kieran, M. AU - Goumnerova, L. AU - Ligon, K. AU - Shalek, A. AU - Beroukhim, R. AU - Bandopadhayay, P. DB - Embase DO - 10.1093/neuonc/noz036.148 LA - English M3 - Conference Abstract N1 - L628912489 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA99 ST - Single cell RNA sequencing reveals mitogenic and progenitor gene programs in braf-rearranged pilocytic astrocytomas T2 - Neuro-Oncology TI - Single cell RNA sequencing reveals mitogenic and progenitor gene programs in braf-rearranged pilocytic astrocytomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628912489&from=exporthttp://dx.doi.org/10.1093/neuonc/noz036.148 VL - 21 ID - 7835 ER - TY - JOUR AD - T. Loka, Haematology/Oncology Clinical Trials Research Office, Level 1, Barclay House, 37 Queens Square, London, United Kingdom AU - Loka, T. AU - O'Hare, P. AU - Mahon, C. DB - Embase DO - 10.1136/archdischild-2017-084620.68 LA - English M3 - Conference Abstract N1 - L620926116 2018-03-06 PY - 2017 SN - 1468-2044 ST - Single centre experience of cutaneous toxicity associated with braf and mek inhibitor treatment in children T2 - Archives of Disease in Childhood TI - Single centre experience of cutaneous toxicity associated with braf and mek inhibitor treatment in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620926116&from=exporthttp://dx.doi.org/10.1136/archdischild-2017-084620.68 VL - 102 ID - 7836 ER - TY - JOUR AD - N. Singh AU - Singh, N. AU - Frey, N. V. AU - Engels, B. AU - Barrett, D. M. AU - Shestova, O. AU - Ravikumar, P. AU - Shyu, A. AU - Highfill, S. AU - Zhao, L. AU - Peng, L. AU - Granda, B. AU - Ramones, M. AU - Lu, X. M. AU - Christian, D. A. AU - Perazzelli, J. AU - Lacey, S. F. AU - Roy, N. AU - Burkhardt, J. K. AU - Colomb, F. AU - Abdel-Mohsen, M. AU - Young, R. M. AU - Brogdon, J. AU - Grupp, S. AU - June, C. H. AU - Maude, S. L. AU - Gill, S. I. AU - Ruella, M. DB - Embase DO - 10.1182/blood-2019-131024 LA - English M3 - Conference Abstract N1 - L630320423 2019-12-31 PY - 2019 SN - 1528-0020 ST - Single chain variable fragment linker length regulates CAR biology and T cell efficacy T2 - Blood TI - Single chain variable fragment linker length regulates CAR biology and T cell efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630320423&from=exporthttp://dx.doi.org/10.1182/blood-2019-131024 VL - 134 ID - 7837 ER - TY - JOUR AD - Department of Oncology, S.K. Compreh. Cancer Ctr. J. Hopkins, CRB, 1650 Orleans St, Baltimore, MD 21231, United States AU - Smith, B. D. AU - Levis, M. AU - Beran, M. AU - Giles, F. AU - Kantarjian, H. AU - Berg, K. AU - Murphy, K. M. AU - Dauses, T. AU - Allebach, J. AU - Small, D. DB - Scopus DO - 10.1182/blood-2003-11-3775 IS - 10 M3 - Article N1 - Cited By :500 Export Date: 18 November 2020 PY - 2004 SP - 3669-3676 ST - Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia T2 - Blood TI - Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842420032&doi=10.1182%2fblood-2003-11-3775&partnerID=40&md5=4c124567a2eda30bbc00d8d11224ffa8 VL - 103 ID - 7838 ER - TY - JOUR AD - AstraZeneca Pharmaceuticals, Macclesfield, United Kingdom Queen Elizabeth University Hospital, Birmingham, United Kingdom Christie Hospital, Manchester, United Kingdom University of Berne, Berne, Switzerland Clinical Pharmacology Unit, Aster, Paris, France AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom AU - Swaisland, H. C. AU - Smith, R. P. AU - Laight, A. AU - Kerr, D. J. AU - Ranson, M. AU - Wilder-Smith, C. H. AU - Duvauchelle, T. DB - Scopus DO - 10.2165/00003088-200544110-00004 IS - 11 M3 - Article N1 - Cited By :111 Export Date: 18 November 2020 PY - 2005 SP - 1165-1177 ST - Single-dose clinical pharmacokinetic studies of gefitinib T2 - Clinical Pharmacokinetics TI - Single-dose clinical pharmacokinetic studies of gefitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-26944478585&doi=10.2165%2f00003088-200544110-00004&partnerID=40&md5=4a745dd5f3da4d970467f0428555bd00 VL - 44 ID - 7839 ER - TY - JOUR AD - Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment of Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100000, China AU - Jiang, Y. AU - Jiao, Y. AU - Wang, Z. AU - Li, T. AU - Liu, Y. AU - Li, Y. AU - Zhao, X. AU - Wang, D. C7 - A1945 DB - Scopus DO - 10.3390/ijms18091945 IS - 9 M3 - Review N1 - Cited By :13 Export Date: 18 November 2020 PY - 2017 ST - Sinomenine hydrochloride inhibits human glioblastoma cell growth through reactive oxygen species generation and autophagy-lysosome pathway activation: An in vitro and in vivo study T2 - International Journal of Molecular Sciences TI - Sinomenine hydrochloride inhibits human glioblastoma cell growth through reactive oxygen species generation and autophagy-lysosome pathway activation: An in vitro and in vivo study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029371078&doi=10.3390%2fijms18091945&partnerID=40&md5=f897cd3969f6fbd294ba3707970951a7 VL - 18 ID - 7840 ER - TY - JOUR AD - L. Zhao, Department of Dermatology, Jining No. 1 People's Hospital, Jining, Shandong, China AU - Liu, S. AU - Man, Y. AU - Zhao, L. DB - Embase Medline DO - 10.1016/j.biopha.2018.02.086 LA - English M3 - Article N1 - L620915284 2018-03-07 2018-09-18 PY - 2018 SN - 1950-6007 0753-3322 SP - 422-429 ST - Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells T2 - Biomedicine and Pharmacotherapy TI - Sinomenine inhibits lipopolysaccharide-induced inflammatory injury by regulation of miR-101/MKP-1/JNK pathway in keratinocyte cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620915284&from=exporthttp://dx.doi.org/10.1016/j.biopha.2018.02.086 VL - 101 ID - 7841 ER - TY - JOUR AD - K.W. Gripp, Al duPont Hospital for Children, Wilmington, DE, United States AU - Gripp, K. W. AU - Schill, L. AU - Schoyer, L. AU - Stronach, B. AU - Bennett, A. M. AU - Blaser, S. AU - Brown, A. AU - Burdine, R. AU - Burkitt-Wright, E. AU - Castel, P. AU - Darilek, S. AU - Dias, A. AU - Dyer, T. AU - Ellis, M. AU - Erickson, G. AU - Gelb, B. D. AU - Green, T. AU - Gross, A. AU - Ho, A. AU - Holder, J. L. AU - Inoue, S. I. AU - Jelin, A. C. AU - Kennedy, A. AU - Klein, R. AU - Kontaridis, M. I. AU - Magoulas, P. AU - McConnell, D. B. AU - McCormick, F. AU - Neel, B. G. AU - Prada, C. E. AU - Rauen, K. A. AU - Roberts, A. AU - Rodriguez-Viciana, P. AU - Rosen, N. AU - Rumbaugh, G. AU - Sablina, A. AU - Solman, M. AU - Tartaglia, M. AU - Thomas, A. AU - Timmer, W. C. AU - Venkatachalam, K. AU - Walsh, K. S. AU - Wolters, P. L. AU - Yi, J. S. AU - Zenker, M. AU - Ratner, N. C1 - bi 1701963 bi 2852 bi 3406 ci 1040 ly 294002 shp 099 DB - Embase Medline DO - 10.1002/ajmg.a.61434 IS - 3 LA - English M3 - Conference Paper N1 - L2003888070 2019-12-30 2020-03-04 PY - 2020 SN - 1552-4833 1552-4825 SP - 597-606 ST - The sixth international RASopathies symposium: Precision medicine—From promise to practice T2 - American Journal of Medical Genetics, Part A TI - The sixth international RASopathies symposium: Precision medicine—From promise to practice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003888070&from=exporthttp://dx.doi.org/10.1002/ajmg.a.61434 VL - 182 ID - 7842 ER - TY - JOUR AD - J.S. Hwang, Department of Genetic Engineering & Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, South Korea AU - Joo, Y. A. AU - Chung, H. AU - Yoon, S. AU - Park, J. I. AU - Lee, J. E. AU - Myung, C. H. AU - Hwang, J. S. C2 - Greenpharma(France) DB - Embase DO - 10.4062/biomolther.2016.011 IS - 5 LA - English M3 - Article N1 - L612291406 2016-09-27 2016-10-03 PY - 2016 SN - 2005-4483 1976-9148 SP - 529-535 ST - Skin barrier recovery by protease-activated receptor-2 antagonist lobaric acid T2 - Biomolecules and Therapeutics TI - Skin barrier recovery by protease-activated receptor-2 antagonist lobaric acid UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612291406&from=exporthttp://dx.doi.org/10.4062/biomolther.2016.011 VL - 24 ID - 7843 ER - TY - JOUR AD - Z. Yao, Department of Dermatology, Xinhua Hospital, Jiaotong University School of Medicine, Shanghai, China AU - Yu, X. AU - Zhang, J. AU - Xu, K. AU - Li, M. AU - Yao, Z. DB - Embase Medline DO - 10.1111/ced.13146 IS - 5 LA - English M3 - Article N1 - L616502133 2017-06-05 2017-06-26 PY - 2017 SN - 1365-2230 0307-6938 SP - 539-542 ST - Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma T2 - Clinical and Experimental Dermatology TI - Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616502133&from=exporthttp://dx.doi.org/10.1111/ced.13146 VL - 42 ID - 7844 ER - TY - JOUR AD - Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan. Department of Dermatology, Kyoto University Hospital, Kyoto, Japan. AN - 29498772 AU - Sugimoto, A. AU - Kataoka, T. R. AU - Ueshima, C. AU - Takei, Y. AU - Kitamura, K. AU - Hirata, M. AU - Nomura, T. AU - Haga, H. DA - Jun DO - 10.1111/exd.13523 10.1111/exd.13523. DP - Nlm ET - 2018/03/03 IS - 6 LA - eng PY - 2018 SN - 0906-6705 SP - 641-646 ST - SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis T2 - Exp Dermatol TI - SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis VL - 27 ID - 7845 ER - TY - JOUR AD - Q. Zeng, Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, China AU - Liu, N. N. AU - Xi, Y. AU - Callaghan, M. U. AU - Fribley, A. AU - Moore-Smith, L. AU - Zimmerman, J. W. AU - Pasche, B. AU - Zeng, Q. AU - Li, Y. L. DB - Embase Medline DO - 10.1007/s13277-013-1088-1 IS - 1 LA - English M3 - Article N1 - L52745477 2013-08-29 2014-03-10 PY - 2014 SN - 1010-4283 1423-0380 SP - 641-650 ST - SMAD4 is a potential prognostic marker in human breast carcinomas T2 - Tumor Biology TI - SMAD4 is a potential prognostic marker in human breast carcinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52745477&from=exporthttp://dx.doi.org/10.1007/s13277-013-1088-1 VL - 35 ID - 7846 ER - TY - JOUR AD - A.B.R. Thomson, University of Alberta, College Plaza, 205, 8215-112 Street, Edmonton, Alta. T6G 2C8, Canada AU - Thomson, A. B. R. AU - Drozdowski, L. AU - Iordache, C. AU - Thomson, B. K. A. AU - Vermeire, S. AU - Clandinin, M. T. AU - Wild, G. DB - Embase Medline DO - 10.1023/A:1024724109128 IS - 8 LA - English M3 - Review N1 - L36936694 2003-08-13 PY - 2003 SN - 0163-2116 SP - 1565-1581 ST - Small bowel review: Normal physiology, part 2 T2 - Digestive Diseases and Sciences TI - Small bowel review: Normal physiology, part 2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L36936694&from=exporthttp://dx.doi.org/10.1023/A:1024724109128 VL - 48 ID - 7847 ER - TY - JOUR AD - Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung University. Department of Nursing, Chang Gung University and Memorial Hospital. Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taoyuan, Taiwan. AN - 29952979 AU - Jaing, T. H. AU - Chang, T. Y. AU - Chen, S. H. AU - Wen, Y. C. AU - Chuang, W. Y. AU - Yang, C. P. C2 - PMC6039684 DA - Jun DO - 10.1097/md.0000000000011222 10.1097/MD.0000000000011222. DP - Nlm ET - 2018/06/29 IS - 26 LA - eng PY - 2018 SN - 0025-7974 (Print) 0025-7974 SP - e11222 ST - Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation: A case report T2 - Medicine (Baltimore) TI - Small cell variant of ALK-positive anaplastic large cell lymphoma with primary subcutaneous presentation: A case report VL - 97 ID - 7848 ER - TY - JOUR AD - M.S. Sidik, Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia AU - Shiran, M. S. AU - Tan, G. C. AU - Sabariah, A. R. AU - Chye, P. C. AU - Pathmanathan, R. DB - Embase Medline IS - 2 LA - English M3 - Article N1 - L352582367 2008-11-07 PY - 2008 SN - 0300-5283 SP - 150-151 ST - Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99 T2 - Medical Journal of Malaysia TI - Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352582367&from=export VL - 63 ID - 7849 ER - TY - JOUR AD - Texas Children's Cancer Center, Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States Division of Pediatric Surgery, Texas Children's Hospital Department of Surgery, Michael E. DeBakey Department of Surgery, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, United States Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, United States Department of Cardiothoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China AU - Li, H. AU - Yu, Y. AU - Zhao, Y. AU - Wu, D. AU - Yu, X. AU - Lu, J. AU - Chen, Z. AU - Zhang, H. AU - Hu, Y. AU - Zhai, Y. AU - Su, J. AU - Aheman, A. AU - De las Casas, A. AU - Jin, J. AU - Xu, X. AU - Shi, Z. AU - Woodfield, S. E. AU - Vasudevan, S. A. AU - Agarwal, S. AU - Yan, Y. AU - Yang, J. AU - Foster, J. H. DB - Scopus DO - 10.1016/j.canlet.2019.05.011 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2019 SP - 129-141 ST - Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling T2 - Cancer Letters TI - Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065832592&doi=10.1016%2fj.canlet.2019.05.011&partnerID=40&md5=5ec9498a3dfddfcbf5e7276068a6d27b VL - 457 ID - 7850 ER - TY - JOUR AD - Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Nuclear Dynamics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. School of Physiology and Pharmacology, University of Bristol, Bristol, UK. Centre for Molecular Processing and School of Biosciences, University of Kent, Canterbury, UK. Institut für Medizinische Virologie, Klinikum der Goethe-Universität, Frankfurt am Main, Germany. Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Electronic address: K.T.A.Malik@bristol.ac.uk. AN - 28602975 AU - Kollareddy, M. AU - Sherrard, A. AU - Park, J. H. AU - Szemes, M. AU - Gallacher, K. AU - Melegh, Z. AU - Oltean, S. AU - Michaelis, M. AU - Cinatl, J., Jr. AU - Kaidi, A. AU - Malik, K. C2 - PMC5542135 DA - Sep 10 DO - 10.1016/j.canlet.2017.05.027 10.1016/j.canlet.2017.05.027. Epub 2017 Jun 7. DP - Nlm ET - 2017/06/13 LA - eng PY - 2017 SN - 0304-3835 (Print) 0304-3835 SP - 74-85 ST - The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis T2 - Cancer Lett TI - The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis VL - 403 ID - 7851 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstr. 1, 79106 Freiburg, Germany University of Paris-Sud, UPRES EA3535 Pharmacology and New Treatments in Cancer, Institut Gustave Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif Cedex, France Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, 79106 Freiburg, Germany UPRES EA 3535 Pharmacology and New Treatments in Cancer, Faculty of Medicine, University Paris-Sud AU - Rössler, J. AU - Geoerger, B. AU - Taylor, M. AU - Vassal, G. DB - Scopus DO - 10.2174/156800908783497113 IS - 1 M3 - Review N1 - Cited By :15 Export Date: 18 November 2020 PY - 2008 SP - 76-85 ST - Small molecule tyrosine kinase inhibitors: Potential role in pediatric malignant solid tumors T2 - Current Cancer Drug Targets TI - Small molecule tyrosine kinase inhibitors: Potential role in pediatric malignant solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-39049098974&doi=10.2174%2f156800908783497113&partnerID=40&md5=4ae433bc462a8c5d7eb0fc561ff90370 VL - 8 ID - 7852 ER - TY - JOUR AD - Q. Chang, Department of Pathology, Peking University School of Basic Medical Science, Peking University Third Hospital, Peking Univeristy Health Science Center, Beijing, China AU - Li, Y. X. AU - Yu, Z. W. AU - Jiang, T. AU - Shao, L. W. AU - Liu, Y. AU - Li, N. AU - Wu, Y. F. AU - Zheng, C. AU - Wu, X. Y. AU - Zhang, M. AU - Zheng, D. F. AU - Qi, X. L. AU - Ding, M. AU - Zhang, J. AU - Chang, Q. DB - Embase Medline DO - 10.1111/cas.13515 IS - 4 LA - English M3 - Article N1 - L620773368 2018-02-26 2018-04-19 PY - 2018 SN - 1349-7006 1347-9032 SP - 1263-1275 ST - SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis T2 - Cancer Science TI - SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620773368&from=exporthttp://dx.doi.org/10.1111/cas.13515 VL - 109 ID - 7853 ER - TY - JOUR AD - Hematology, Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX Onkologikum, Frankfurt am Museumsufer, Frankfurt, Germany AN - 129330876. Language: English. Entry Date: 20190529. Revision Date: 20200528. Publication Type: journal article AU - Chiaretti, Sabina AU - Jabbour, Elias AU - Hoelzer, Dieter DB - ccm DO - 10.1016/j.clml.2018.03.014 DP - EBSCOhost IS - 5 N1 - review; tables/charts. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM29653823. PY - 2018 SN - 2152-2650 SP - 301-310 ST - "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL T2 - Clinical Lymphoma, Myeloma & Leukemia TI - "Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions"-Treatment of ALL UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=129330876&site=ehost-live&scope=site VL - 18 ID - 7854 ER - TY - GEN AD - A. Ferrari, Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian, 1, Milano, Italy AU - Ferrari, A. AU - Patel, S. R. AU - Wunder, J. AU - Albritton, K. H. DB - Embase DO - 10.1007/978-3-319-33679-4_15 J2 - Pediatr. Oncol. LA - English M1 - (Ferrari A., andrea.ferrari@istitutotumori.mi.it) Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian, 1, Milano, Italy M3 - Chapter N1 - L618183531 2017-09-19 PY - 2017 SN - 2191-0812 1613-5318 SP - 383-416 ST - Soft Tissue Sarcoma TI - Soft Tissue Sarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618183531&from=exporthttp://dx.doi.org/10.1007/978-3-319-33679-4_15 ID - 7855 ER - TY - JOUR AD - Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX AN - 137747932. Language: English. Entry Date: 20200808. Revision Date: 20200810. Publication Type: journal article AU - Paul, Shilpa AU - Rausch, Caitlin R. AU - Welch, Mary Alma AU - Kantarjian, Hagop M. AU - Jabbour, Elias J. DB - ccm DO - 10.1016/j.clml.2019.06.011 DP - EBSCOhost IS - 8 N1 - review. Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA. NLM UID: 101525386. PMID: NLM31307896. PY - 2019 SN - 2152-2650 SP - 471-479 ST - SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia T2 - Clinical Lymphoma, Myeloma & Leukemia TI - SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137747932&site=ehost-live&scope=site VL - 19 ID - 7856 ER - TY - JOUR AD - From the Department of Genetic Medicine and Development, University of Geneva Medical School (S.I.N., X.B., S.E.A.), Service of Genetic Medicine, University Hospitals of Geneva (S.I.N., S.E.A.), and iGE3, Institute of Genetics and Genomics of Geneva (S.E.A.) - all in Geneva; the Department of Fundamental Neurobiology, Krembil Research Institute (S.V., M.T., I.R.), Toronto General Hospital Research Institute (E.B., N.K., P.V.D., J.E.F.), the Department of Pathology (T.-R.K.), the Division of Neurosurgery, Department of Surgery (V.M.P., T.K., H.A.-B., T.T., T.V., G.Z., M.T., I.R.), and the Joint Division of Medical Imaging, Department of Medical Imaging (V.M.P., T.K.), Toronto Western Hospital, University Health Network, the Department of Laboratory Medicine and Pathobiology, University of Toronto (E.B., N.K., P.V.D., T.-R.K., J.E.F.), and the Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research (E.B., N.K., P.V.D., J.E.F.) - all in Toronto; the Department of Molecular Medicine, AIV Institute, University of Eastern Finland (S.J., B.R.J., S.S., S.Y.-H., J.F.), and the Hemorrhagic Brain Pathology Research Group, Department of Neurosurgery and NeuroCenter (S.J., B.R.J., S.S., T.R., J.F.), and the Department of Pathology (T.R.), Kuopio University Hospital - all in Kuopio, Finland; and the Cardiovascular Research Institute and the Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston (A.M.H., J.D.W.). AN - 29298116 AU - Nikolaev, S. I. AU - Vetiska, S. AU - Bonilla, X. AU - Boudreau, E. AU - Jauhiainen, S. AU - Rezai Jahromi, B. AU - Khyzha, N. AU - DiStefano, P. V. AU - Suutarinen, S. AU - Kiehl, T. R. AU - Mendes Pereira, V. AU - Herman, A. M. AU - Krings, T. AU - Andrade-Barazarte, H. AU - Tung, T. AU - Valiante, T. AU - Zadeh, G. AU - Tymianski, M. AU - Rauramaa, T. AU - Ylä-Herttuala, S. AU - Wythe, J. D. AU - Antonarakis, S. E. AU - Frösen, J. AU - Fish, J. E. AU - Radovanovic, I. DA - Jan 18 DO - 10.1056/NEJMoa1709449 10.1056/NEJMoa1709449. Epub 2018 Jan 3. DP - Nlm ET - 2018/01/04 IS - 3 LA - eng PY - 2018 SN - 0028-4793 SP - 250-261 ST - Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain T2 - N Engl J Med TI - Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain VL - 378 ID - 7857 ER - TY - JOUR AD - H. Kang, Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States AU - Kang, H. AU - Jha, S. AU - Deng, Z. AU - Fratzl-Zelman, N. AU - Cabral, W. AU - Ivovic, A. AU - Meylan, F. AU - Hanson, E. AU - Lange, E. AU - Katz, J. AU - Roschger, P. AU - Klaushofer, K. AU - Cowen, E. AU - Siegel, R. AU - Bhattacharyya, T. AU - Marini, J. DB - Embase DO - 10.1007/s00223-018-0418-0 IS - 1 LA - English M3 - Conference Abstract N1 - L622359931 2018-06-04 PY - 2018 SN - 1432-0827 SP - S151 ST - Somatic activating mutations in MAP2K1 cause melorheostosis T2 - Calcified Tissue International TI - Somatic activating mutations in MAP2K1 cause melorheostosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622359931&from=exporthttp://dx.doi.org/10.1007/s00223-018-0418-0 VL - 102 ID - 7858 ER - TY - JOUR AD - Department of Pediatrics, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Dermatology, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Pathology, Tohoku University School of Medicine, Sendai, Miyagi, Japan. Department of Neurosurgery, Tohoku University School of Medicine, Sendai, Miyagi, Japan. AN - 26360803 AU - Watanabe, Y. AU - Shido, K. AU - Niihori, T. AU - Niizuma, H. AU - Katata, Y. AU - Iizuka, C. AU - Oba, D. AU - Moriya, K. AU - Saito-Nanjo, Y. AU - Onuma, M. AU - Rikiishi, T. AU - Sasahara, Y. AU - Watanabe, M. AU - Aiba, S. AU - Saito, R. AU - Sonoda, Y. AU - Tominaga, T. AU - Aoki, Y. AU - Kure, S. DA - Jan DO - 10.1002/ajmg.a.37376 10.1002/ajmg.a.37376. Epub 2015 Sep 11. DP - Nlm ET - 2015/09/12 IS - 1 LA - eng PY - 2016 SN - 1552-4825 SP - 189-94 ST - Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities T2 - Am J Med Genet A TI - Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities VL - 170a ID - 7859 ER - TY - JOUR AD - R.I. Gafni, National Institute of Dental and Craniofacial Research, National Institutes of Health, United States AU - Gafni, R. I. AU - Zhadina, M. AU - Streit, J. AU - Collins, M. T. AU - Flippo, C. L. AU - Gottschalk, M. AU - Patel, D. AU - Nilubol, N. DB - Embase LA - English M3 - Conference Abstract N1 - L631807840 2020-05-26 PY - 2019 SN - 1523-4681 SP - 305 ST - Somatic HRAS variant in a parathyroid adenoma, squamous cell carcinoma, and endomyocardial membrane expands the phenotype of the cutaneous skeletal hypophosphatemia syndrome (CSHS) T2 - Journal of Bone and Mineral Research TI - Somatic HRAS variant in a parathyroid adenoma, squamous cell carcinoma, and endomyocardial membrane expands the phenotype of the cutaneous skeletal hypophosphatemia syndrome (CSHS) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631807840&from=export VL - 34 ID - 7860 ER - TY - JOUR AD - A.K. Greene, Department of Plastic & Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States AU - Couto, J. A. AU - Huang, A. Y. AU - Konczyk, D. J. AU - Goss, J. A. AU - Fishman, S. J. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. DB - Embase Medline DO - 10.1016/j.ajhg.2017.01.018 IS - 3 LA - English M3 - Article N1 - L614441974 2017-02-21 2017-03-14 PY - 2017 SN - 1537-6605 0002-9297 SP - 546-554 ST - Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation T2 - American Journal of Human Genetics TI - Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614441974&from=exporthttp://dx.doi.org/10.1016/j.ajhg.2017.01.018 VL - 100 ID - 7861 ER - TY - JOUR AD - Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA. Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA; Department of Orthopaedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115, USA. Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Vascular Anomalies Center, Boston Children's Hospital, Boston, MA 02115, USA. Electronic address: arin.greene@childrens.harvard.edu. AN - 25728774 AU - Couto, J. A. AU - Vivero, M. P. AU - Kozakewich, H. P. AU - Taghinia, A. H. AU - Mulliken, J. B. AU - Warman, M. L. AU - Greene, A. K. C2 - PMC4375628 DA - Mar 5 DO - 10.1016/j.ajhg.2015.01.007 10.1016/j.ajhg.2015.01.007. Epub 2015 Feb 26. DP - Nlm ET - 2015/03/03 IS - 3 LA - eng PY - 2015 SN - 0002-9297 (Print) 0002-9297 SP - 480-6 ST - A somatic MAP3K3 mutation is associated with verrucous venous malformation T2 - Am J Hum Genet TI - A somatic MAP3K3 mutation is associated with verrucous venous malformation VL - 96 ID - 7862 ER - TY - JOUR AD - Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, China. AN - 22430133 AU - Xu, J. AU - He, J. AU - Yang, H. AU - Luo, X. AU - Liang, Z. AU - Chen, J. AU - Cai, Z. AU - Xu, J. AU - Ren-Heidenreich, L. DO - 10.3233/cbm-2012-0233 10.3233/CBM-2012-0233. DP - Nlm ET - 2011/01/01 IS - 2 LA - eng PY - 2011 SN - 1574-0153 SP - 63-9 ST - Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer T2 - Cancer Biomark TI - Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer VL - 10 ID - 7863 ER - TY - JOUR AD - C. Wang, Dept. of Gastroenterology, West China Hospital, Sichuan Univ., Guo Xue St. 37, Chengdu, China AU - Li, X. AU - Cai, L. AU - Xu, H. AU - Geng, C. AU - Lu, J. AU - Tao, L. AU - Sun, D. AU - Ghishan, F. K. AU - Wang, C. C1 - l 817818 DB - Embase Medline DO - 10.1152/ajpgi.00239.2016 IS - 5 LA - English M3 - Article N1 - L613150549 2016-11-22 2016-12-08 PY - 2016 SN - 1522-1547 0193-1857 SP - G954-G963 ST - Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613150549&from=exporthttp://dx.doi.org/10.1152/ajpgi.00239.2016 VL - 311 ID - 7864 ER - TY - JOUR AD - M. Reig, Hospital Clinic, BCLC Group, Liver Unit, Barcelona, Spain AU - Reig, M. AU - Forner, A. AU - Rimola, J. AU - De Lope, C. R. AU - Ayuso, C. AU - Llovet, J. M. AU - Bruix, J. DB - Embase LA - English M3 - Conference Abstract N1 - L70134075 2010-05-19 PY - 2009 SN - 0168-8278 SP - S298 ST - Sorafenib for the treatment of advanced hepatocellular carcinoma. Feasibility and safety outside research trials T2 - Journal of Hepatology TI - Sorafenib for the treatment of advanced hepatocellular carcinoma. Feasibility and safety outside research trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70134075&from=export VL - 50 ID - 7865 ER - TY - JOUR AD - Medical Oncology Division, Versilia Hospital, via Aurelia 335, 55041 Lido di Camaiore (LU), Italy Cardiology Division, Ospedale San Sebastiano, via Circondaria 1, 42015 Correggio (RE), Italy AU - Valsuani, C. AU - Siclari, O. AU - Camerini, A. AU - Canale, M. L. AU - Rondini, M. AU - Donati, S. AU - Puccinelli, P. AU - Tartarelli, G. AU - Puccetti, C. AU - Amoroso, D. C7 - 9133 DB - Scopus DO - 10.1186/1757-1626-2-9133 IS - 12 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2009 ST - Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: A case report T2 - Cases Journal TI - Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953409338&doi=10.1186%2f1757-1626-2-9133&partnerID=40&md5=523826b77597d299afc6ecbde589ef00 VL - 2 ID - 7866 ER - TY - JOUR AD - Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan. AN - 27508178 AU - Hsu, C. H. AU - Shen, Y. C. AU - Shao, Y. Y. AU - Hsu, C. AU - Cheng, A. L. C2 - PMC4918267 DO - 10.2147/jhc.S45040 10.2147/JHC.S45040. eCollection 2014. DP - Nlm ET - 2014/01/01 LA - eng PY - 2014 SN - 2253-5969 (Print) 2253-5969 SP - 85-99 ST - Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives T2 - J Hepatocell Carcinoma TI - Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives VL - 1 ID - 7867 ER - TY - JOUR AD - M.G. Raga, Medical Oncology Department, Sagunto Hospital, Avenida Ramón y Cajal, s/n, Sagunto, Valencia, Spain AU - Raga, M. G. AU - González-Cruz, V. I. AU - Aguilera, M. J. S. C1 - bay43 9006(Bayer) nexavar(Onyx) C2 - Bayer Onyx DB - Embase IS - 1 LA - English M3 - Article N1 - L619466685 2017-12-05 2017-12-12 PY - 2017 SN - 1885-740X SP - 20-26 ST - Sorafenib in advanced hepatocellular carcinoma: Therapeutic approach and future research T2 - Cancer and Chemotherapy Reviews TI - Sorafenib in advanced hepatocellular carcinoma: Therapeutic approach and future research UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619466685&from=export VL - 12 ID - 7868 ER - TY - JOUR AD - The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom The Institute of Cancer Research, Division of Clinical Studies and Cancer Therapeutics, Sutton, Surrey, United Kingdom AU - Pearson, H. AU - Marshall, L. V. AU - Carceller, F. DB - Scopus DO - 10.1080/08880018.2020.1740844 IS - 5 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 412-423 ST - Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective T2 - Pediatric Hematology and Oncology TI - Sorafenib in pediatric hepatocellular carcinoma from a clinician perspective UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082187940&doi=10.1080%2f08880018.2020.1740844&partnerID=40&md5=ba212e945af10a7ebef0c6073d2f5816 VL - 37 ID - 7869 ER - TY - JOUR AD - A. Santoro, Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Via Manzoni 56, 20089 Rozzano, Milan, Italy AU - Rimassa, L. AU - Santoro, A. C1 - nexavar(Bayer) C2 - Bayer Onyx DB - Embase Medline DO - 10.1586/ERA.09.41 IS - 6 LA - English M3 - Article N1 - L355146727 2009-10-07 PY - 2009 SN - 1473-7140 1744-8328 SP - 739-745 ST - Sorafenib therapy in advanced hepatocellular carcinoma: The SHARP trial T2 - Expert Review of Anticancer Therapy TI - Sorafenib therapy in advanced hepatocellular carcinoma: The SHARP trial UR - https://www.embase.com/search/results?subaction=viewrecord&id=L355146727&from=exporthttp://dx.doi.org/10.1586/ERA.09.41http://www.expert-reviews.com/doi/pdf/10.1586/era.09.41 VL - 9 ID - 7870 ER - TY - JOUR AD - Oncological Endocrinology Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, Via Genova 3, Turin, 10126, Italy Unit of Clinical Epidemiology, AOU Città della Salute e della Scienza di Torino, CPO-Piemonte and University of Turin, Turin, Italy AU - Gallo, M. AU - Michelon, F. AU - Castiglione, A. AU - Felicetti, F. AU - Viansone, A. A. AU - Nervo, A. AU - Zichi, C. AU - Ciccone, G. AU - Piovesan, A. AU - Arvat, E. DB - Scopus DO - 10.1007/s12020-014-0481-x IS - 3 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2015 SP - 726-734 ST - Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center T2 - Endocrine TI - Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937970280&doi=10.1007%2fs12020-014-0481-x&partnerID=40&md5=96d674aebffd5d99e26baca525259cbb VL - 49 ID - 7871 ER - TY - JOUR AD - Department of Medical Oncology, Kantonsspital St Gallen, St Gallen, Switzerland Department of Hepatology, University Hospital Bern, Bern, Switzerland Department of Medical Oncology, St László Teaching Hospital, Budapest, Hungary SAKK Coordinating Center, Berne, Switzerland Quality of life Office, International Breast Cancer Study Group, Bern, Switzerland Department of Medical Oncology, University Hospital Zurich, Zürich, Switzerland Department of Medical Oncology, Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland Department of Medical Oncology, University Hospital of Geneva, Geneva, Switzerland Department of Medical Oncology, University Hospital Bern, Bern, Switzerland Department of Medical Oncology, University Hospital Lausanne, Lausanne, Switzerland Department of Medical Oncology, Hôpital du Valais (RSV)-CHCVs, Lausanne, Switzerland Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria Department of Medical Oncology, Spital STS AG, Bern, Switzerland Claraspital Basel, Switzerland Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland AU - Koeberle, D. AU - Dufour, J. F. AU - Demeter, G. AU - Li, Q. AU - Ribi, K. AU - Samaras, P. AU - Saletti, P. AU - Roth, A. D. AU - Horber, D. AU - Buehlmann, M. AU - Wagner, A. D. AU - Montemurro, M. AU - Lakatos, G. AU - Feilchenfeldt, J. AU - Peck-Radosavljevic, M. AU - Rauch, D. AU - Tschanz, B. AU - Bodoky, G. AU - for the Swiss Group for Clinical Cancer, Research C7 - 10.1093/annonc/mdw052 DB - Scopus DO - 10.1093/annonc/mdw054 IS - 5 M3 - Article N1 - (SAKK) Cited By :43 Export Date: 18 November 2020 PY - 2016 SP - 856-861 ST - Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) T2 - Annals of Oncology TI - Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964786369&doi=10.1093%2fannonc%2fmdw054&partnerID=40&md5=264ca8e291582ff8445bc39e86b7bb08 VL - 27 ID - 7872 ER - TY - JOUR AD - Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States AU - Iyer, R. AU - Fetterly, G. AU - Lugade, A. AU - Thanavala, Y. DB - Scopus DO - 10.1517/14656566.2010.496453 IS - 11 M3 - Review N1 - Cited By :100 Export Date: 18 November 2020 PY - 2010 SP - 1943-1955 ST - Sorafenib: A clinical and pharmacologic review T2 - Expert Opinion on Pharmacotherapy TI - Sorafenib: A clinical and pharmacologic review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954781214&doi=10.1517%2f14656566.2010.496453&partnerID=40&md5=23b07dcfc29eabd74e7c3b7e45b053ea VL - 11 ID - 7873 ER - TY - SER AB - Sorafenib (BAY 43-9006, Nexavar®) is an oral multiple tyrosine kinase inhibitor. Main targets are receptor tyrosine kinase pathways frequently deregulated in cancer such as the Raf–Ras pathway, vascular endothelial growth factor (VEGF) pathway, and FMS-like tyrosine kinase 3 (FLT3). Sorafenib was approved by the FDA in fast track for advanced renal cell cancer and hepatocellular cancer and shows good clinical activity in thyroid cancer. Multiple clinical trials are undertaken to further investigate the role of sorafenib alone or in combination for the treatment of various tumor entities. © Springer-Verlag Berlin Heidelberg 2014. AD - Department Innere Medizin, Klinik für Innere Medizin I, Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation, Hugstetter Str. 55, Freiburg, 79102, Germany AU - Hasskarl, J. DB - Scopus DO - 10.1007/978-3-642-54490-3_8 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2014 SP - 145-164 ST - Sorafenib: Targeting multiple tyrosine kinases in cancer T2 - Recent Results in Cancer Research TI - Sorafenib: Targeting multiple tyrosine kinases in cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906923306&doi=10.1007%2f978-3-642-54490-3_8&partnerID=40&md5=186beb0a9fcdd0a830ce7472b1ab175f VL - 201 ID - 7874 ER - TY - JOUR AD - M. Mus̈chen, Deptartment of Laboratory Medicine, University of California, San Francisco, 521 Parnassus Ave, San Francisco, CA 94143, United States AU - Ramezani-Rad, P. AU - Geng, H. AU - Hurtz, C. AU - Chan, L. N. AU - Chen, Z. AU - Jumaa, H. AU - Melnick, A. AU - Paietta, E. AU - Carroll, W. L. AU - Willman, C. L. AU - Lefebvre, V. AU - Mus̈chen, M. DB - Embase Medline DO - 10.1182/blood-2012-05-428938 IS - 1 LA - English M3 - Article N1 - L368072153 2013-01-16 2013-01-22 PY - 2013 SN - 0006-4971 1528-0020 SP - 148-155 ST - SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia T2 - Blood TI - SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368072153&from=exporthttp://dx.doi.org/10.1182/blood-2012-05-428938http://bloodjournal.hematologylibrary.org/content/121/1/148.full.pdf+html VL - 121 ID - 7875 ER - TY - JOUR AD - E. Santamaría, Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Irunlarrea, Pamplona, Spain AU - González-Morales, A. AU - Zabaleta, A. AU - Guruceaga, E. AU - Alonso, M. M. AU - García-Moure, M. AU - Fernández-Irigoyen, J. AU - Santamaría, E. C1 - dnx 2401 DB - Embase DO - 10.18632/oncotarget.25774 IS - 57 LA - English M3 - Article N1 - L623245969 2018-08-01 2018-08-03 PY - 2018 SN - 1949-2553 SP - 31045-31065 ST - Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection T2 - Oncotarget TI - Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623245969&from=exporthttp://dx.doi.org/10.18632/oncotarget.25774 VL - 9 ID - 7876 ER - TY - JOUR AD - K. Huang, Department of Gastrointestinal Surgery, Jiangxi Provincial Cancer Hospital, No. 519, Beijing East Road, Nanchang, Jiangxi, China AU - Zhang, S. AU - Xiao, J. AU - Chai, Y. AU - Hong, Z. AU - Liu, Z. AU - Yuan, R. AU - Luo, Z. AU - Zhou, X. AU - Iii, D. E. L. P. AU - Huang, K. DB - Embase Medline DO - 10.1007/s10620-017-4884-4 IS - 2 LA - English M3 - Article N1 - L619860729 2017-12-25 2018-05-29 PY - 2018 SN - 1573-2568 0163-2116 SP - 395-402 ST - Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer T2 - Digestive Diseases and Sciences TI - Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619860729&from=exporthttp://dx.doi.org/10.1007/s10620-017-4884-4 VL - 63 ID - 7877 ER - TY - JOUR AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, SINH-Changzheng Hospital Joint Center for Translational Medicine, Institutes for Translational Medicine (CAS-SMMU), Changzheng Hospital, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai, 200031, China Department of General Surgery, PLA General Hospital, Beijing, China Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Nanjing, China AU - Zeng, C. AU - Zhu, L. AU - Jia, X. AU - Pang, Y. AU - Li, Z. AU - Lu, X. AU - Xie, F. AU - Duan, L. AU - Wang, Y. DB - Scopus DO - 10.1007/s10120-020-01069-1 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 837-847 ST - Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors T2 - Gastric Cancer TI - Spectrum of activity of dasatinib against mutant KIT kinases associated with drug-sensitive and drug-resistant gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083459214&doi=10.1007%2fs10120-020-01069-1&partnerID=40&md5=e67565adae9dfc3f0392b982ca2ed3d0 VL - 23 ID - 7878 ER - TY - JOUR AD - University of Chicago Medical Center, Department of Pathology, 5841 S. Maryland Avenue, Chicago, IL 60637, United States AU - Pytel, P. DB - Scopus DO - 10.1586/14737140.7.12.S51 IS - 12 SUPPL. M3 - Review N1 - Cited By :9 Export Date: 18 November 2020 PY - 2007 SP - S51-S60 ST - Spectrum of pediatric gliomas: Implications for the development of future therapies T2 - Expert Review of Anticancer Therapy TI - Spectrum of pediatric gliomas: Implications for the development of future therapies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38049110869&doi=10.1586%2f14737140.7.12.S51&partnerID=40&md5=bec62c1ed4bf432ff8bc67330d3b3c35 VL - 7 ID - 7879 ER - TY - JOUR AD - H. Yu, Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, United States AU - Hsu, L. C. AU - Reddy, S. V. AU - Yilmaz, Ö AU - Yu, H. DB - Embase DO - 10.3390/cells8010017 IS - 1 LA - English M3 - Article N1 - L2001542516 2019-02-28 2019-03-01 PY - 2019 SN - 2073-4409 ST - Sphingosine-1-phosphate receptor 2 controls podosome components induced by RANKL affecting osteoclastogenesis and bone resorption T2 - Cells TI - Sphingosine-1-phosphate receptor 2 controls podosome components induced by RANKL affecting osteoclastogenesis and bone resorption UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001542516&from=exporthttp://dx.doi.org/10.3390/cells8010017 VL - 8 ID - 7880 ER - TY - JOUR AD - Renal Division, Department of Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, St. James' Hospital Campus, Dublin, Ireland Irish Centre for Vascular Biology, Trinity College Dublin, Dublin, Ireland Peking-Tsinghua Center for Life Sciences, Beijing, China AU - Wang, L. Y. AU - Sun, X. J. AU - Wang, C. AU - Chen, S. F. AU - Li, Z. Y. AU - Chen, M. AU - Little, M. A. AU - Zhao, M. H. DB - Scopus DO - 10.1042/CS20200497 IS - 12 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 1475-1489 ST - Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner T2 - Clinical Science TI - Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087110575&doi=10.1042%2fCS20200497&partnerID=40&md5=3e48c86fbe1f844caba47f438a4cea4f VL - 134 ID - 7881 ER - TY - JOUR AD - I. Yeh, Departments of Pathology and Dermatology, University of California San Francisco, San Francisco, CA, United States AU - Raghavan, S. S. AU - Peternel, S. AU - Mully, T. W. AU - North, J. P. AU - Pincus, L. B. AU - LeBoit, P. E. AU - McCalmont, T. H. AU - Bastian, B. C. AU - Yeh, I. DB - Embase Medline DO - 10.1038/s41379-019-0445-z IS - 6 LA - English M3 - Article N1 - L2004009773 2020-01-13 2020-07-02 PY - 2020 SN - 1530-0285 0893-3952 SP - 1122-1134 ST - Spitz melanoma is a distinct subset of spitzoid melanoma T2 - Modern Pathology TI - Spitz melanoma is a distinct subset of spitzoid melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004009773&from=exporthttp://dx.doi.org/10.1038/s41379-019-0445-z VL - 33 ID - 7882 ER - TY - JOUR AD - J.P.-Y. Ting, Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, United States AU - Callaway, J. B. AU - Smith, S. A. AU - McKinnon, K. P. AU - De Silva, A. M. AU - Crowe, J. E. AU - Ting, J. P. Y. DB - Embase Medline DO - 10.1074/jbc.M115.664136 IS - 28 LA - English M3 - Article N1 - L605761484 2015-09-03 2015-09-08 PY - 2015 SN - 1083-351X 0021-9258 SP - 17306-17320 ST - Spleen tyrosine kinase (Syk) mediates IL-1β induction by primary human monocytes during antibody-enhanced dengue virus infection T2 - Journal of Biological Chemistry TI - Spleen tyrosine kinase (Syk) mediates IL-1β induction by primary human monocytes during antibody-enhanced dengue virus infection UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605761484&from=exporthttp://dx.doi.org/10.1074/jbc.M115.664136 VL - 290 ID - 7883 ER - TY - JOUR AD - D. Orbach, SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France AU - Orbach, D. AU - Sparber-Sauer, M. AU - Laetsch, T. W. AU - Minard-Colin, V. AU - Bielack, S. S. AU - Casanova, M. AU - Corradini, N. AU - Koscielniak, E. AU - Scheer, M. AU - Hettmer, S. AU - Bisogno, G. AU - Hawkins, D. S. AU - Ferrari, A. DB - Embase Medline DO - 10.1016/j.ejca.2020.06.028 LA - English M3 - Article N1 - L2007396828 2020-08-13 2020-08-21 PY - 2020 SN - 1879-0852 0959-8049 SP - 183-192 ST - Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies T2 - European Journal of Cancer TI - Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007396828&from=exporthttp://dx.doi.org/10.1016/j.ejca.2020.06.028 VL - 137 ID - 7884 ER - TY - JOUR AD - E. Pasmant, UMR745 INSERM, Université Paris Descartes, Faculté des Sciences Pharmaceutiques et Biologiques, 4 avenue de l'Observatoire, 75006, Paris, France AU - Pasmant, E. AU - Sabbagh, A. AU - Hanna, N. AU - Masliah-Planchon, J. AU - Jolly, E. AU - Goussard, P. AU - Ballerini, P. AU - Cartault, F. AU - Barbarot, S. AU - Landman-Parker, J. AU - Soufir, N. AU - Parfait, B. AU - Vidaud, M. AU - Wolkenstein, P. AU - Vidaud, D. AU - France, R. N. F. DB - Embase Medline DO - 10.1136/jmg.2008.065243 IS - 7 L1 - internal-pdf://1389867269/425.full.pdf LA - English M3 - Article N1 - L354913312 2009-08-18 PY - 2009 SN - 0022-2593 1468-6244 SP - 425-430 ST - SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype T2 - Journal of Medical Genetics TI - SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354913312&from=exporthttp://dx.doi.org/10.1136/jmg.2008.065243 VL - 46 ID - 7885 ER - TY - JOUR AD - Department of Medicine, Kurume University School of Medicine, Research Center for Innovative Cancer Therapy, Kurume, Japan Department of Pathology, Kurume University School of Medicine, Research Center for Innovative Cancer Therapy, Kurume, Japan Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Maidashi, Higashi-ku, Fukuoka, Japan Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan AU - Yoshida, T. AU - Hisamoto, T. AU - Akiba, J. AU - Koga, H. AU - Nakamura, K. AU - Tokunaga, Y. AU - Hanada, S. AU - Kumemura, H. AU - Maeyama, M. AU - Harada, M. AU - Ogata, H. AU - Yano, H. AU - Kojiro, M. AU - Ueno, T. AU - Yoshimura, A. AU - Sata, M. DB - Scopus DO - 10.1038/sj.onc.1209635 IS - 45 M3 - Article N1 - Cited By :121 Export Date: 18 November 2020 PY - 2006 SP - 6056-6066 ST - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors T2 - Oncogene TI - Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749836283&doi=10.1038%2fsj.onc.1209635&partnerID=40&md5=e25f2ccae397d427ce9f51470f49afcd VL - 25 ID - 7886 ER - TY - JOUR AD - A. Gross, National Institutes of Health, Bethesda, MD, United States AU - Gross, A. AU - Wolters, P. AU - Baldwin, A. AU - Dombi, E. AU - Fisher, M. J. AU - Weiss, B. AU - Kim, A. AU - Blakeley, J. AU - Whitcomb, P. AU - Holmblad, M. AU - Maritin, S. AU - Roderick, M. C. AU - Paul, S. M. AU - Therrien, J. AU - Heisey, K. AU - Doyle, A. AU - Smith, M. AU - Glod, J. AU - Steinberg, S. AU - Widemann, B. C. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098363 2018-07-25 PY - 2018 SN - 1523-5866 SP - i143-i144 ST - Sprint: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) T2 - Neuro-Oncology TI - Sprint: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098363&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7887 ER - TY - JOUR AD - P.C.K. Leung, Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Room 317, 950 west 28th Ave, Vancouver, BC, Canada AU - So, W. K. AU - Cheng, J. C. AU - Liu, Y. AU - Xu, C. AU - Zhao, J. AU - Chang, V. T. W. AU - Leung, P. C. K. DB - Embase Medline DO - 10.1007/s13277-016-4790-y IS - 7 LA - English M3 - Article N1 - L607781462 2016-01-26 2016-09-07 PY - 2016 SN - 1423-0380 1010-4283 SP - 9197-9207 ST - Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells T2 - Tumor Biology TI - Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607781462&from=exporthttp://dx.doi.org/10.1007/s13277-016-4790-y VL - 37 ID - 7888 ER - TY - JOUR AD - P. Zhang, Longgang E.N.T. Hospital, Shenzhen Key Laboratory of E.N.T., Institute of E.N.T., Shenzhen, Guangdong, China AU - Liu, X. Y. AU - Zheng, C. B. AU - Wang, T. AU - Xu, J. AU - Zhang, M. AU - Gou, L. S. AU - Jin, L. AU - Qi, X. AU - Zeng, X. AU - Li, H. AU - Qiu, S. AU - Zhang, P. DB - Embase Medline DO - 10.1042/CS20190865 IS - 2 LA - English M3 - Article N1 - L630852136 2020-02-13 2020-02-19 PY - 2020 SN - 1470-8736 0143-5221 SP - 155-167 ST - SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer T2 - Clinical Science TI - SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630852136&from=exporthttp://dx.doi.org/10.1042/CS20190865 VL - 134 ID - 7889 ER - TY - JOUR AD - Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. Oncology Research Center of Mercogliano (CROM), Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale", IRCCS, Naples, Italy. Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Pharmacy Department, University of Genoa, Genoa, Italy. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia PA, USA. AN - 25762618 AU - Casini, N. AU - Forte, I. M. AU - Mastrogiovanni, G. AU - Pentimalli, F. AU - Angelucci, A. AU - Festuccia, C. AU - Tomei, V. AU - Ceccherini, E. AU - Di Marzo, D. AU - Schenone, S. AU - Botta, M. AU - Giordano, A. AU - Indovina, P. C2 - PMC4494948 DA - May 20 DO - 10.18632/oncotarget.3043 10.18632/oncotarget.3043. DP - Nlm ET - 2015/03/13 IS - 14 LA - eng PY - 2015 SN - 1949-2553 SP - 12421-35 ST - SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation T2 - Oncotarget TI - SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation VL - 6 ID - 7890 ER - TY - JOUR AD - Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. pindovina@inwind.it. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. pindovina@inwind.it. Department of Medicine, Surgery and Neuroscience, University of Siena and Istituto Toscano Tumori (ITT), Siena, Italy. Oncology Research Center of Mercogliano (CROM), Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy. AORN Dei Colli Monaldi UOC, Oncology, Naples, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. Pharmacy Department, University of Genoa, Genoa, Italy. Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania. giordano@temple.edu. AN - 27037775 AU - Indovina, P. AU - Casini, N. AU - Forte, I. M. AU - Garofano, T. AU - Cesari, D. AU - Iannuzzi, C. A. AU - Del Porro, L. AU - Pentimalli, F. AU - Napoliello, L. AU - Boffo, S. AU - Schenone, S. AU - Botta, M. AU - Giordano, A. DA - Jan DO - 10.1002/jcp.25397 10.1002/jcp.25397. Epub 2016 Apr 19. DP - Nlm ET - 2016/04/03 IS - 1 LA - eng PY - 2017 SN - 0021-9541 SP - 129-35 ST - SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration T2 - J Cell Physiol TI - SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration VL - 232 ID - 7891 ER - TY - JOUR AD - Department of Neurosurgery, Osaka University Medical School, Suita, Japan Department of Neurosurgery, Spine and Spinal Cord Center, Yukioka Hospital, Osaka, Japan Department of Neurosurgery, Kobe Univ. Grad. School of Medicine, Kobe, Japan Department of Neurosurgery, Spine and Spinal Cord Center, Yukioka Hospital, 2-2-3 Ukita, Kita-ku Osaka City, Osaka 530-0021, Japan AU - Akiyama, C. AU - Yuguchi, T. AU - Nishio, M. AU - Tomishima, T. AU - Fujinaka, T. AU - Taniguchi, M. AU - Nakajima, Y. AU - Kohmura, E. AU - Yoshimine, T. DB - Scopus DO - 10.1089/0897715041526230 IS - 7 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2004 SP - 923-931 ST - Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats T2 - Journal of Neurotrauma TI - Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-3242892545&doi=10.1089%2f0897715041526230&partnerID=40&md5=f1de46279999ea7c3ecef624c7ad0a3b VL - 21 ID - 7892 ER - TY - JOUR AD - A.-G. Shen, Jiangsu Province Key Lab. of Neuroregeneration, Nantong University, Nantong, 226001, China AU - Sun, L. L. AU - Cheng, C. AU - Liu, H. O. AU - Shen, C. C. AU - Xiao, F. AU - Qin, J. AU - Yang, J. L. AU - Shen, A. G. C1 - go 6983(Sigma) C2 - Sigma DB - Embase Medline DO - 10.1007/s12031-007-0003-x IS - 1 LA - English M3 - Article N1 - L47450552 2007-05-01 PY - 2007 SN - 0895-8696 SP - 16-24 ST - Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-α biosynthesis in rat astrocytes T2 - Journal of Molecular Neuroscience TI - Src suppressed C kinase substrate regulates the lipopolysaccharide-induced TNF-α biosynthesis in rat astrocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47450552&from=exporthttp://dx.doi.org/10.1007/s12031-007-0003-x VL - 32 ID - 7893 ER - TY - JOUR AD - Samsung Genome Institute, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul, 135-710, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea Department of Internal Medicine, Eulji University School of Medicine, Eulji General Hospital, Seoul, South Korea Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea AU - Park, G. AU - Kim, T. H. AU - Lee, H. O. AU - Lim, J. A. AU - Won, J. K. AU - Min, H. S. AU - Lee, K. E. AU - Park, D. J. AU - Park, Y. J. AU - Park, W. Y. DB - Scopus DO - 10.1530/ERC-14-0467 IS - 1 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2015 SP - 55-63 ST - Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer T2 - Endocrine-Related Cancer TI - Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923637478&doi=10.1530%2fERC-14-0467&partnerID=40&md5=b1f353e9b0808ce197f54921914562ca VL - 22 ID - 7894 ER - TY - JOUR AD - E. Lazzari, Department of Pathology, San Bortolo Hospital, UO Anatomia Patologica, Viale F. Rodolfi 37, Vicenza, Italy AU - D'Amore, E. S. G. AU - Visco, C. AU - Menin, A. AU - Famengo, B. AU - Bonvini, P. AU - Lazzari, E. DB - Medline DO - 10.1097/PAS.0b013e318287791f IS - 5 LA - English M3 - Article N1 - L368789094 2013-06-07 PY - 2013 SN - 0147-5185 1532-0979 SP - 780-786 ST - STAT3 pathway is activated in ALK-positive large b-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target T2 - American Journal of Surgical Pathology TI - STAT3 pathway is activated in ALK-positive large b-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368789094&from=exporthttp://dx.doi.org/10.1097/PAS.0b013e318287791f VL - 37 ID - 7895 ER - TY - JOUR AD - Department of Pediatric Intensive Care, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands. AN - 22506067 AU - de Jong, P. R. AU - Schadenberg, A. W. AU - van den Broek, T. AU - Beekman, J. M. AU - van Wijk, F. AU - Coffer, P. J. AU - Prakken, B. J. AU - Jansen, N. J. C2 - PMC3323636 DO - 10.1371/journal.pone.0035070 10.1371/journal.pone.0035070. Epub 2012 Apr 10. DP - Nlm ET - 2012/04/17 IS - 4 LA - eng PY - 2012 SN - 1932-6203 SP - e35070 ST - STAT3 regulates monocyte TNF-alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass T2 - PLoS One TI - STAT3 regulates monocyte TNF-alpha production in systemic inflammation caused by cardiac surgery with cardiopulmonary bypass VL - 7 ID - 7896 ER - TY - JOUR AD - Pediatric Hospital, University of Tübingen, Germany University Hospital for Children and Adolescents, Goethe University, Frankfurt, Germany AU - Niethammer, D. AU - Bader, P. AU - Handgretinger, R. AU - Klingebiel, T. DB - Scopus DO - 10.1055/s-0033-1337970 IS - SUPPL1 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2013 SP - S94-S98 ST - Stem cell transplantation T2 - Klinische Padiatrie TI - Stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878099045&doi=10.1055%2fs-0033-1337970&partnerID=40&md5=aa7d4e4213264d71a42f31d2bde9fba7 VL - 225 ID - 7897 ER - TY - JOUR AD - Dept. Haematology/Bone Marrow Trans., University College London Hospital, London, United Kingdom Dept. Haematology/Bone Marrow Trans., Medical Centre, Rambam, Haifa, Israel AU - Avivi, I. AU - Rowe, J. M. AU - Goldstone, A. H. DB - Scopus DO - 10.1053/beha.2003.0232 IS - 4 M3 - Review N1 - Cited By :14 Export Date: 18 November 2020 PY - 2002 SP - 653-674 ST - Stem cell transplantation in adult ALL patients T2 - Best Practice and Research: Clinical Haematology TI - Stem cell transplantation in adult ALL patients UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036950005&doi=10.1053%2fbeha.2003.0232&partnerID=40&md5=59ff2ce0edf6cae8496ab0387ccf81a8 VL - 15 ID - 7898 ER - TY - JOUR AD - Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre León Bérard, Cancer Research Center of Lyon, Equipe Labelliseé Ligue Contre le Cancer, Lyon, France LabEx DEVweCAN, Université de Lyon, Lyon, France Université Aix Marseille, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Molecular Oncology, Equipe Labelliseé Ligue Contre le Cancer, Marseille, France Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France Centre León Bérard, Lyon, France Fondation Synergie Lyon Cancer, Centre León Bérard, Lyon, France ProfileXpert, Bron, France Université Paris-Sud, CNRS-UMR 8200, Unit of Genetic Stability and Oncogenesis, Equipe Labelliseé Ligue Contre le Cancer, Institut de Cancérologie Gustave Roussy, Villejuif, France Clinique Phenicia, Marseille, France Université de Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Department of Pathology, Jean Perrin Cancer Center, ERTICa Research Group, University of Auvergne, Clermont-Ferrand, France Department of Pathology, University of Melbourne, Parkville, VIC, Australia AU - Morel, A. P. AU - Ginestier, C. AU - Pommier, R. M. AU - Cabaud, O. AU - Ruiz, E. AU - Wicinski, J. AU - Devouassoux-Shisheboran, M. AU - Combaret, V. AU - Finetti, P. AU - Chassot, C. AU - Pinatel, C. AU - Fauvet, F. AU - Saintigny, P. AU - Thomas, E. AU - Moyret-Lalle, C. AU - Lachuer, J. AU - Despras, E. AU - Jauffret, J. L. AU - Bertucci, F. AU - Guitton, J. AU - Wierinckx, A. AU - Wang, Q. AU - Radosevic-Robin, N. AU - Penault-Llorca, F. AU - Cox, D. G. AU - Hollande, F. AU - Ansieau, S. AU - Caramel, J. AU - Birnbaum, D. AU - Vigneron, A. M. AU - Tissier, A. AU - Charafe-Jauffret, E. AU - Puisieux, A. DB - Scopus DO - 10.1038/nm.4323 IS - 5 M3 - Article N1 - Cited By :55 Export Date: 18 November 2020 PY - 2017 SP - 568-578 ST - A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability T2 - Nature Medicine TI - A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017248475&doi=10.1038%2fnm.4323&partnerID=40&md5=5c1d833f200484fdb9b1fe02beb70d8f VL - 23 ID - 7899 ER - TY - JOUR AD - K.S. Keene, University of Alabama at Birmingham, Birmingham, AL, United States AU - Keene, K. S. AU - Dubay, D. AU - McGuire, B. AU - Desmond, R. AU - Jacob, R. AU - Dobelbower, M. C. AU - Eckhoff, D. AU - Posey, J. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L71624110 2014-09-30 PY - 2014 SN - 0360-3016 SP - S369 ST - Stereotactic body radiation therapy followed by sorafenib improves survival without increasing toxicity T2 - International Journal of Radiation Oncology Biology Physics TI - Stereotactic body radiation therapy followed by sorafenib improves survival without increasing toxicity UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71624110&from=export VL - 90 ID - 7900 ER - TY - JOUR AD - R. Bale, Department of Radiology, Interventional Oncology-Microinvasive Therapy (SIP), Medical University of Innsbruck, Innsbruck, Austria AU - Hetzer, B. AU - Vogel, G. F. AU - Entenmann, A. AU - Heil, M. AU - Schullian, P. AU - Putzer, D. AU - Meister, B. AU - Crazzolara, R. AU - Kropshofer, G. AU - Salvador, C. AU - Straub, S. AU - Karall, D. AU - Niederwanger, C. AU - Cortina, G. AU - Janecke, A. AU - Freund-Unsinn, K. AU - Maurer, K. AU - Schweigmann, G. AU - Oberhuber, G. AU - Renz, O. AU - Schneeberger, S. AU - Müller, T. AU - Bale, R. DB - Embase Medline DO - 10.1080/02656736.2020.1822549 IS - 1 LA - English M3 - Article N1 - L2006760386 2020-09-28 2020-10-20 PY - 2020 SN - 1464-5157 0265-6736 SP - 1074-1081 ST - Stereotactic radiofrequency ablation of a variety of liver masses in children T2 - International Journal of Hyperthermia TI - Stereotactic radiofrequency ablation of a variety of liver masses in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006760386&from=exporthttp://dx.doi.org/10.1080/02656736.2020.1822549 VL - 37 ID - 7901 ER - TY - JOUR AD - Comprehensive Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong, China. AN - 25643922 AU - Zhu, L. AU - Dissanayaka, W. L. AU - Green, D. W. AU - Zhang, C. C2 - PMC6495676 DA - Apr DO - 10.1111/cpr.12172 10.1111/cpr.12172. Epub 2015 Feb 3. DP - Nlm ET - 2015/02/04 IS - 2 LA - eng PY - 2015 SN - 0960-7722 (Print) 0960-7722 SP - 231-8 ST - Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells T2 - Cell Prolif TI - Stimulation of EphB2/ephrin-B1 signalling by tumour necrosis factor alpha in human dental pulp stem cells VL - 48 ID - 7902 ER - TY - JOUR AD - C. Boura, Université de Lorraine, CNRS, CRAN, Nancy, France AU - Gong, C. AU - Valduga, J. AU - Chateau, A. AU - Richard, M. AU - Pellegrin-Moïse, N. AU - Barberi-Heyob, M. AU - Chastagner, P. AU - Boura, C. C1 - mr 438 DB - Embase DO - 10.18632/oncotarget.24521 IS - 20 LA - English M3 - Article N1 - L621297233 2018-03-22 2018-04-03 PY - 2018 SN - 1949-2553 SP - 15312-15325 ST - Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1 T2 - Oncotarget TI - Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621297233&from=exporthttp://dx.doi.org/10.18632/oncotarget.24521 VL - 9 ID - 7903 ER - TY - JOUR AD - Department of Hematology and Oncology, Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, INSERM U1173, Centre Hospitalier de Versailles, Le Chesnay, France AU - Rousselot, P. DB - Scopus DO - 10.1080/10428194.2018.1459611 IS - 12 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2018 SP - 2782-2791 ST - The story of tyrosine kinase inhibitors discontinuation in clinical practice T2 - Leukemia and Lymphoma TI - The story of tyrosine kinase inhibitors discontinuation in clinical practice UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048831867&doi=10.1080%2f10428194.2018.1459611&partnerID=40&md5=2aeecc58f958fadc19b14728629cceee VL - 59 ID - 7904 ER - TY - GEN AD - B.J. Weigel, Pediatric Hematology/Oncology, The University of Minnesota Masonic Children’s Hospital/Masonic Cancer Center, Minneapolis, MN, United States AU - Greengard, E. G. AU - Weigel, B. J. C1 - mk 1775 DB - Embase DO - 10.1007/978-3-030-51160-9_11 J2 - Pediatr. Oncol. LA - English M1 - (Greengard E.G., emilyg@umn.edu; Weigel B.J., weige007@umn.edu) Pediatric Hematology/Oncology, The University of Minnesota Masonic Children’s Hospital/Masonic Cancer Center, Minneapolis, MN, United States M3 - Chapter N1 - L633030313 2020-10-12 2020-11-05 PY - 2021 SN - 2191-0812 1613-5318 SP - 149-164 ST - Strategies for new agent development in pediatric sarcomas TI - Strategies for new agent development in pediatric sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633030313&from=exporthttp://dx.doi.org/10.1007/978-3-030-51160-9_11 ID - 7905 ER - TY - JOUR AD - Department of Experimental Medicine, II University of Naples, Via De Crecchio 7, 80138 Naples, Italy. AN - 16584185 AU - Galdiero, S. AU - Vitiello, M. AU - Amodeo, P. AU - D'Isanto, M. AU - Cantisani, M. AU - Pedone, C. AU - Galdiero, M. DA - Apr 11 DO - 10.1021/bi052262p 10.1021/bi052262p. DP - Nlm ET - 2006/04/06 IS - 14 LA - eng PY - 2006 SN - 0006-2960 (Print) 0006-2960 SP - 4491-501 ST - Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae T2 - Biochemistry TI - Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae VL - 45 ID - 7906 ER - TY - JOUR AD - B.L. Upham, Michigan State University, National Food Safety and Toxicology Center, East Lansing, MI 48824, United States AU - Upham, B. L. AU - Park, J. S. AU - Babica, P. AU - Sovadinova, I. AU - Rummel, A. M. AU - Trosko, J. E. AU - Hirose, A. AU - Hasegawa, R. AU - Kanno, J. AU - Sai, K. DB - Embase Medline DO - 10.1289/ehp.11728 IS - 4 L1 - internal-pdf://0195740084/11728.pdf.txt LA - English M3 - Article N1 - L354438396 2009-04-20 PY - 2009 SN - 0091-6765 1552-9924 SP - 545-551 ST - Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems T2 - Environmental Health Perspectives TI - Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354438396&from=exporthttp://dx.doi.org/10.1289/ehp.11728 VL - 117 ID - 7907 ER - TY - JOUR AD - Department of Neurosurgery, Universitatsklinikum Essen, Germany Institute of Neuropathology, University Hospital Essen, Essen, Germany Department of Neurosurgery, KRH Hospital Nordstadt, Hannover, Germany AU - Pierscianek, D. AU - Wolf, S. AU - Keyvani, K. AU - El Hindy, N. AU - Stein, K. P. AU - Sandalcioglu, I. E. AU - Sure, U. AU - Mueller, O. AU - Zhu, Y. DB - Scopus DO - 10.1111/neup.12316 IS - 1 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2017 SP - 3-11 ST - Study of angiogenic signaling pathways in hemangioblastoma T2 - Neuropathology TI - Study of angiogenic signaling pathways in hemangioblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978224560&doi=10.1111%2fneup.12316&partnerID=40&md5=1f201e0a9c7f1a01baaafbe4e11e328e VL - 37 ID - 7908 ER - TY - JOUR AD - Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States Developmental Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA, United States Children’s Oncology Group, Monrovia, CA, United States Dan L, Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, United States Department of Oncology Research, Mayo Clinic, Rochester, MN, United States Department of Pediatrics, Masonic Children’s Hospital, University of Minnesota Medical Center, Minneapolis, MN, United States AU - Geller, J. I. AU - Fox, E. AU - Turpin, B. K. AU - Goldstein, S. L. AU - Liu, X. AU - Minard, C. G. AU - Kudgus, R. A. AU - Reid, J. M. AU - Berg, S. L. AU - Weigel, B. J. DB - Scopus DO - 10.1002/cncr.31725 IS - 23 M3 - Article N1 - Cited By :8 Export Date: 18 November 2020 PY - 2018 SP - 4548-4555 ST - A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315) T2 - Cancer TI - A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056097679&doi=10.1002%2fcncr.31725&partnerID=40&md5=01b7f11453fcf3dbe1ee55bbac61ba78 VL - 124 ID - 7909 ER - TY - JOUR AN - CN-02009912 AU - Nct PY - 2019 ST - A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma T2 - https://clinicaltrials.gov/show/NCT04166409 TI - A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02009912/full ID - 7910 ER - TY - JOUR AN - CN-02181751 AU - Nct PY - 2020 ST - A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma T2 - https://clinicaltrials.gov/show/NCT04576117 TI - A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02181751/full ID - 7911 ER - TY - JOUR AU - Oschlies, I. AU - Simonitsch-Klupp, I. AU - Maldyk, J. AU - Konovalov, D. AU - Abramov, D. AU - Myakova, N. AU - Lisfeld, J. AU - Attarbaschi, A. AU - Kontny, U. AU - Woessmann, W. AU - Klapper, W. DB - Embase Medline DO - 10.1111/bjd.13440 IS - 3 LA - English M3 - Letter N1 - L602100198 2015-02-13 2015-03-31 PY - 2015 SN - 1365-2133 0007-0963 SP - 793-797 ST - Subcutaneous panniculitis-like T-cell lymphoma in children: A detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome T2 - British Journal of Dermatology TI - Subcutaneous panniculitis-like T-cell lymphoma in children: A detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602100198&from=exporthttp://dx.doi.org/10.1111/bjd.13440 VL - 172 ID - 7912 ER - TY - JOUR AD - F. Le Loarer, Department of Pathology, Institut Bergonié, Bordeaux, France AU - Le Loarer, F. AU - Cleven, A. H. G. AU - Bouvier, C. AU - Castex, M. P. AU - Romagosa, C. AU - Moreau, A. AU - Salas, S. AU - Bonhomme, B. AU - Gomez-Brouchet, A. AU - Laurent, C. AU - Le Guellec, S. AU - Audard, V. AU - Giraud, A. AU - Ramos-Oliver, I. AU - Cleton-Jansen, A. M. AU - Savci-Heijink, D. C. AU - Kroon, H. M. AU - Baud, J. AU - Pissaloux, D. AU - Pierron, G. AU - Sherwood, A. AU - Coindre, J. M. AU - Bovée, J. V. M. G. AU - Larousserie, F. AU - Tirode, F. DB - Embase Medline DO - 10.1038/s41379-019-0323-8 IS - 3 LA - English M3 - Article N1 - L2002408720 2019-08-14 2020-03-19 PY - 2020 SN - 1530-0285 0893-3952 SP - 404-419 ST - A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation T2 - Modern Pathology TI - A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002408720&from=exporthttp://dx.doi.org/10.1038/s41379-019-0323-8 VL - 33 ID - 7913 ER - TY - JOUR AD - N. Cobanoglu, Near East University, Department of Paediatric Pulmonology, Nicosia, Cyprus AU - Cobanoglu, N. DB - Embase Medline DO - 10.2174/1871523011202030210 IS - 3 LA - English M3 - Review N1 - L368919626 2013-05-22 2013-05-30 PY - 2012 SN - 1871-5230 1875-614X SP - 210-216 ST - Success of inhaled corticosteroids in the treatment of non-asthmatic respiratory diseases T2 - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry TI - Success of inhaled corticosteroids in the treatment of non-asthmatic respiratory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368919626&from=exporthttp://dx.doi.org/10.2174/1871523011202030210 VL - 11 ID - 7914 ER - TY - JOUR AD - Department of Clinical and Experimental Medicine, University of Catania, Center of Experimental Oncology and Hematology, Building 8D/2 - Via Santa Sofia, 78, Catania, 95123, Italy Center of Experimental Oncology and Hematology, A.O.U. Policlinico-Vittorio Emanuele, Catania, Italy Division of Hematology, University of Messina, Messina, Italy Division of Hematology and Bone Marrow Transplant, A.O.U. Policlinico-Vittorio Emanuele, Catania, Italy Department of Surgery, Medical and Surgical Specialities, University of Catania, Catania, Italy AU - Stella, S. AU - Tirró, E. AU - Massimino, M. AU - Vitale, S. R. AU - Russo, S. AU - Pennisi, M. S. AU - Puma, A. AU - Romano, C. AU - Di Gregorio, S. AU - Innao, V. AU - Stagno, F. AU - Di Raimondo, F. AU - Musolino, C. AU - Manzella, L. DB - Scopus DO - 10.21873/invivo.11641 IS - 5 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2019 SP - 1593-1598 ST - Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib T2 - In Vivo TI - Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071739559&doi=10.21873%2finvivo.11641&partnerID=40&md5=57b9d8e1a172310b8dff2f655cf5ec6b VL - 33 ID - 7915 ER - TY - JOUR AD - Haematology Department, Amiri Hospital, Kuwait City, Kuwait Leukemia Center, Sabah Hospital, Shuwaikh, Kuwait Shuwaikh Residential Center, Kuwait City, Kuwait AU - Al-Jafar, H. A. AU - Al-Mulla, A. AU - Aldallal, S. AU - Buhamad, J. H. AU - Askar, H. DB - Scopus DO - 10.1159/000380905 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2015 SP - 122-127 ST - Successful nilotinib treatment in a child with chronic myeloid leukemia T2 - Case Reports in Oncology TI - Successful nilotinib treatment in a child with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929575858&doi=10.1159%2f000380905&partnerID=40&md5=0f6b2f30eba1ab2c2373f5cadd93bde8 VL - 8 ID - 7916 ER - TY - JOUR AD - Department of Pediatric Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary Department of Hematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary AU - Kassa, C. AU - Reményi, P. AU - Sinkó, J. AU - Kállay, K. AU - Kertész, G. AU - Kriván, G. C7 - e13302 DB - Scopus DO - 10.1111/petr.13302 IS - 8 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2018 ST - Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder T2 - Pediatric Transplantation TI - Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055277134&doi=10.1111%2fpetr.13302&partnerID=40&md5=9afb22c1d25b2294ac120826d35540a7 VL - 22 ID - 7917 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, Fukushima Medical University, Fukushima, 960-1295, Japan Fukushima Medical Center for Children and Women, Fukushima Medical University, Fukushima, 960-1295, Japan AU - Furukawa, Y. AU - Takahashi, T. AU - Suganuma, R. AU - Ohara, M. AU - Ota, K. AU - Kyozuka, H. AU - Yamaguchi, A. AU - Soeda, S. AU - Watanabe, T. AU - Komiya, H. AU - Mizunuma, H. AU - Fujimori, K. C7 - e2020005 DB - Scopus DO - 10.4084/MJHID.2020.005 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 ST - Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: Case report and literature review T2 - Mediterranean Journal of Hematology and Infectious Diseases TI - Successful planned pregnancy through vitrified-warmed embryo transfer in a woman with chronic myeloid leukemia: Case report and literature review UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077906144&doi=10.4084%2fMJHID.2020.005&partnerID=40&md5=0759d611f34a85b206960aac2bcab0e0 VL - 11 ID - 7918 ER - TY - JOUR AD - Service d'Oncologie Hématologique et de Thérapie Cellulaire, Centre Hospitalier Universitaire de Poitiers, 2 rue de la Milétrie, 86 021 Poitiers, France Centre d'Investigation Clinique INSERM 802, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Service d'Hématologie et Oncologie Biologique, Centre Hospitalier Universitaire de Poitiers, Poitiers, France Service d'Hématologie, Centre Hospitalier Universitaire de Nantes, Nantes, France AU - Millot, F. AU - Cividin, M. AU - Brizard, F. AU - Chomel, J. C. AU - Méchinaud, F. AU - Guilhot, F. DB - Scopus DO - 10.1002/pbc.21938 IS - 7 M3 - Article N1 - Cited By :15 Export Date: 18 November 2020 PY - 2009 SP - 891-892 ST - Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia T2 - Pediatric Blood and Cancer TI - Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650478307&doi=10.1002%2fpbc.21938&partnerID=40&md5=23a7cc09a1286e87dad644a85fe0a284 VL - 52 ID - 7919 ER - TY - JOUR AD - A. Arakawa, Department of Pediatric Oncology, National Cancer Center Hospital, Japan AU - Arakawa, A. AU - Yonemori, K. AU - Kumamoto, T. AU - Aoki, Y. AU - Sonoda, T. AU - Sugiyama, M. AU - Ishimaru, S. AU - Shirakawa, N. AU - Umeda, K. AU - Okajima, H. AU - Adachi, S. AU - Ogawa, C. DB - Embase DO - 10.1002/pbc.26872 LA - English M3 - Conference Abstract N1 - L619370093 2017-11-28 PY - 2017 SN - 1545-5017 SP - S40 ST - Successful treatment of a highly aggressive abdominal cavity ALK-rearranged inflammatory myofibroblastic tumor with alectinib: A case report T2 - Pediatric Blood and Cancer TI - Successful treatment of a highly aggressive abdominal cavity ALK-rearranged inflammatory myofibroblastic tumor with alectinib: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619370093&from=exporthttp://dx.doi.org/10.1002/pbc.26872 VL - 64 ID - 7920 ER - TY - JOUR AD - L.S. Sender, Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California-Irvine, 101 The City Drive South, Building 23, 4th Floor, Orange, CA, United States AU - McEachron, T. A. AU - Kirov, I. AU - Wungwattana, M. AU - Cortes, D. AU - Zabokrtsky, K. B. AU - Sassoon, A. AU - Craig, D. AU - Carpten, J. D. AU - Sender, L. S. DB - Embase Medline DO - 10.1002/pbc.25854 IS - 4 LA - English M3 - Article N1 - L607580000 2016-01-12 2016-03-22 PY - 2016 SN - 1545-5017 1545-5009 SP - 727-730 ST - Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation T2 - Pediatric Blood and Cancer TI - Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607580000&from=exporthttp://dx.doi.org/10.1002/pbc.25854 VL - 63 ID - 7921 ER - TY - JOUR AD - J. Andrew Livingston, Department of Sarcoma Medical Oncology, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 0450, Houston, TX, United States AU - Dupuis, M. AU - Shen, Y. AU - Curcio, C. AU - Meis, J. M. AU - Wang, W. L. AU - Amini, B. AU - Rhines, L. AU - Reuther, J. AU - Roy, A. AU - Fisher, K. E. AU - Conley, A. P. AU - Andrew Livingston, J. DB - Embase DO - 10.1186/s13569-020-00136-6 IS - 1 LA - English M3 - Article N1 - L632556946 2020-08-26 2020-10-01 PY - 2020 SN - 2045-3329 ST - Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor T2 - Clinical Sarcoma Research TI - Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor UR - https://www.embase.com/search/results?subaction=viewrecord&id=L632556946&from=exporthttp://dx.doi.org/10.1186/s13569-020-00136-6 VL - 10 ID - 7922 ER - TY - JOUR AD - M. Manalang, Children's Mercy Hospital, Kansas City, MO, United States AU - Manalang, M. AU - Mitchell, G. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687886 2017-08-11 PY - 2017 SN - 1545-5017 SP - S87-S88 ST - Successful use of crizotinib in treatment of a pulmonary inflammatory myofibroblastic tumor without any ALK rearrangement or other known genetic target, case report T2 - Pediatric Blood and Cancer TI - Successful use of crizotinib in treatment of a pulmonary inflammatory myofibroblastic tumor without any ALK rearrangement or other known genetic target, case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687886&from=exporthttp://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 7923 ER - TY - JOUR AD - Department of Haematology, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom Glasgow Area Medicines Evaluation Unit, Royal Infirmary, Glasgow, United Kingdom Scotland Leukaemia Registry, Public Health Sciences, University of Edinburgh, Edinburgh, United Kingdom University of Glasgow, Academic Transfusion Medicine Unit, Royal Infirmary, Glasgow, United Kingdom AU - Shepherd, P. AU - Dhanapala, C. AU - Maguire, C. AU - White, J. AU - Drummond, M. AU - Holyoake, T. AU - Johnson, P. R. E. DB - Scopus DO - 10.1258/RSMSMJ.53.3.8 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2008 SP - 8-12 ST - Successful use of national cancer registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia T2 - Scottish Medical Journal TI - Successful use of national cancer registry data to monitor the effective use of imatinib for treating chronic myeloid leukaemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-54049145126&doi=10.1258%2fRSMSMJ.53.3.8&partnerID=40&md5=13742dc2f35178d21bfec1f54c714856 VL - 53 ID - 7924 ER - TY - JOUR AD - Department of Gastroenterology, First Affiliated Hospital, Zhejiang University, No. 79 Qing Chun Road, Hangzhou, Zhejiang Province, 310003, China AU - Wang, Y. M. AU - Gu, M. L. AU - Ji, F. DB - Scopus DO - 10.3748/wjg.v21.i8.2303 IS - 8 M3 - Review N1 - Cited By :20 Export Date: 18 November 2020 PY - 2015 SP - 2303-2314 ST - Succinate dehydrogenase-deficient gastrointestinal stromal tumors T2 - World Journal of Gastroenterology TI - Succinate dehydrogenase-deficient gastrointestinal stromal tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923827409&doi=10.3748%2fwjg.v21.i8.2303&partnerID=40&md5=fdbf1cf78eadc820cb01c8f08d2f7410 VL - 21 ID - 7925 ER - TY - JOUR AD - L.-O. Brandenburg, Department of Anatomy and Cell Biology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany AU - Brandenburg, L. O. AU - Kipp, M. AU - Lucius, R. AU - Pufe, T. AU - Wruck, C. J. C2 - Sigma Aldrich(United States) DB - Embase Medline DO - 10.1007/s00011-009-0116-5 IS - 6 LA - English M3 - Article N1 - L50708965 2009-11-20 2010-07-22 PY - 2010 SN - 1023-3830 1420-908X SP - 443-450 ST - Sulforaphane suppresses LPS-induced inflammation in primary rat microglia T2 - Inflammation Research TI - Sulforaphane suppresses LPS-induced inflammation in primary rat microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50708965&from=exporthttp://dx.doi.org/10.1007/s00011-009-0116-5 VL - 59 ID - 7926 ER - TY - JOUR AD - Dept. Life Sciences, University of Siena, Via. A. Moro 2, Siena 53100, Italy. AN - 23965518 AU - Monti, M. AU - Terzuoli, E. AU - Ziche, M. AU - Morbidelli, L. DA - Oct DO - 10.1016/j.phrs.2013.08.003 10.1016/j.phrs.2013.08.003. Epub 2013 Aug 18. DP - Nlm ET - 2013/08/24 LA - eng PY - 2013 SN - 1043-6618 SP - 171-81 ST - The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis T2 - Pharmacol Res TI - The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis VL - 76 ID - 7927 ER - TY - JOUR AD - A. Decherney, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States AU - Zolton, J. R. AU - Decherney, A. DB - Embase Medline DO - 10.1097/GRF.0000000000000310 IS - 3 LA - English M3 - Article N1 - L617534864 2017-08-01 2017-08-03 PY - 2017 SN - 1532-5520 0009-9201 SP - 539-542 ST - Summary of Future Developments T2 - Clinical Obstetrics and Gynecology TI - Summary of Future Developments UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617534864&from=exporthttp://dx.doi.org/10.1097/GRF.0000000000000310 VL - 60 ID - 7928 ER - TY - JOUR AD - H.M. Amin, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, United States AU - Vishwamitra, D. AU - Curry, C. V. AU - Shi, P. AU - Alkan, S. AU - Amin, H. M. DB - Embase Medline DO - 10.1016/j.neo.2015.09.005 IS - 9 LA - English M3 - Article N1 - L607172451 2015-12-15 PY - 2015 SN - 1476-5586 1522-8002 SP - 742-754 ST - SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein TI - SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein UR - https://www.embase.com/search/results?subaction=viewrecord&id=L607172451&from=exporthttp://dx.doi.org/10.1016/j.neo.2015.09.005 VL - 17 ID - 7929 ER - TY - JOUR AD - Department of Medical Oncology, Sichuan Cancer Hospital, No.55 South Renmin Road, Chengdu, Sichuan 610041, China AU - Chen, J. AU - Zhou, C. AU - Long, Y. AU - Yin, X. DB - Scopus DO - 10.1007/s13277-014-2608-3 IS - 1 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2014 SP - 183-191 ST - Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study T2 - Tumor Biology TI - Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922220283&doi=10.1007%2fs13277-014-2608-3&partnerID=40&md5=ee944876184c4e7698cc75284af0b225 VL - 36 ID - 7930 ER - TY - JOUR AD - Strelitz Diabetes Center and Neuroendocrine Unit, Department of Internal Medicine, Eastern Virginia Medical School, PA-C, 855 W Brambleton Ave, Norfolk, VA 23510, United States AU - Bourcier, M. E. AU - Vinik, A. I. DB - Scopus DO - 10.1097/MPA.0b013e31825c53fa IS - 2 M3 - Article N1 - Cited By :18 Export Date: 18 November 2020 PY - 2013 SP - 348-352 ST - Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma) T2 - Pancreas TI - Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874058676&doi=10.1097%2fMPA.0b013e31825c53fa&partnerID=40&md5=166daa5f7e8e564fe07bde07782d258a VL - 42 ID - 7931 ER - TY - JOUR AD - Gustave Roussy Cancer Campus, Villejuif, France Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France CLCC Oscar-Lambret, Lille, France CHRU de Tours-Hospital Bretonneau, Tours, France Aix Marseille Univ.-Assistance Publique Hôpitaux de Marseille, Marseille, France Centre de Lutte Contre le Cancer François Baclesse, Caen, France University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France AU - Remon, J. AU - Girard, N. AU - Mazieres, J. AU - Dansin, E. AU - Pichon, E. AU - Grellier, L. AU - Dubos, C. AU - Lindsay, C. R. AU - Besse, B. DB - Scopus DO - 10.1016/j.lungcan.2016.04.024 M3 - Article N1 - Cited By :23 Export Date: 18 November 2020 PY - 2016 SP - 99-104 ST - Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network T2 - Lung Cancer TI - Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966661202&doi=10.1016%2fj.lungcan.2016.04.024&partnerID=40&md5=dc4d91b9a1d56e125870e3f57404ea90 VL - 97 ID - 7932 ER - TY - JOUR AD - Y. Gao, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China AU - Gao, Y. AU - Qian, H. AU - Tang, X. AU - Du, X. AU - Wang, G. AU - Zhang, H. AU - Ye, F. AU - Liu, T. DB - Embase Medline DO - 10.2147/IJN.S200480 LA - English M3 - Article N1 - L2001899887 2019-05-20 2019-05-22 PY - 2019 SN - 1178-2013 1176-9114 SP - 2719-2731 ST - Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth T2 - International Journal of Nanomedicine TI - Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001899887&from=exporthttp://dx.doi.org/10.2147/IJN.S200480 VL - 14 ID - 7933 ER - TY - JOUR AD - Y. Ma, Deparatment of Neonatology, The Affiliated Children Hospital of Xi'an Jiaotong University, Xi'an, China AU - Liu, H. AU - Lin, Z. AU - Ma, Y. DB - Embase Medline DO - 10.1016/j.biopha.2020.109943 LA - English M3 - Article N1 - L2005028410 2020-02-27 2020-03-04 PY - 2020 SN - 1950-6007 0753-3322 ST - Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation T2 - Biomedicine and Pharmacotherapy TI - Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005028410&from=exporthttp://dx.doi.org/10.1016/j.biopha.2020.109943 VL - 125 ID - 7934 ER - TY - JOUR AD - Department of Clinical Laboratory, Zhumadian Central Hospital, Zhumadian, 463100, China. Electronic address: guo_dfang3@163.com. Department of Clinical Laboratory, Zhumadian Central Hospital, Zhumadian, 463100, China. Deparment of Hematopathology, Zhumadian Central Hospital, Zhumadian, 463100, China. Deparment of Infectious Diseases, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, 471000, China. AN - 31521893 AU - Guo, D. AU - Zhang, A. AU - Huang, J. AU - Suo, M. AU - Zhong, Y. AU - Liang, Y. DA - Nov DO - 10.1016/j.biopha.2019.109399 10.1016/j.biopha.2019.109399. Epub 2019 Sep 12. DP - Nlm ET - 2019/09/16 LA - eng PY - 2019 SN - 0753-3322 SP - 109399 ST - Suppression of HSP70 inhibits the development of acute lymphoblastic leukemia via TAK1/Egr-1 T2 - Biomed Pharmacother TI - Suppression of HSP70 inhibits the development of acute lymphoblastic leukemia via TAK1/Egr-1 VL - 119 ID - 7935 ER - TY - JOUR AD - Department of Pediatrics, Faculty of Pediatrics, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. AN - 17617806 AU - Hung, C. H. AU - Suen, J. L. AU - Hua, Y. M. AU - Chiang, W. AU - Chang, H. C. AU - Chen, C. N. AU - Jong, Y. J. DA - Aug DO - 10.1111/j.1399-3038.2007.00535.x 10.1111/j.1399-3038.2007.00535.x. DP - Nlm ET - 2007/07/10 IS - 5 LA - eng PY - 2007 SN - 0905-6157 (Print) 0905-6157 SP - 378-84 ST - Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes T2 - Pediatr Allergy Immunol TI - Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes VL - 18 ID - 7936 ER - TY - JOUR AD - College of Medicine, University of Tennessee Health Science Center. Department of Neurosurgery, Le Bonheur Children's Hospital. Division of Neurosurgery, St. Jude Children's Research Hospital. Semmes-Murphey Neurologic & Spine Institute; and. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. AN - 28686121 AU - Lee, R. P. AU - Foster, K. A. AU - Lillard, J. C. AU - Klimo, P., Jr. AU - Ellison, D. W. AU - Orr, B. AU - Boop, F. A. C2 - PMC5839469 C6 - NIHMS1500030 DA - Sep DO - 10.3171/2017.4.Peds16668 10.3171/2017.4.PEDS16668. Epub 2017 Jul 7. DP - Nlm ET - 2017/07/08 IS - 3 LA - eng PY - 2017 SN - 1933-0707 (Print) 1933-0707 SP - 247-255 ST - Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors T2 - J Neurosurg Pediatr TI - Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors VL - 20 ID - 7937 ER - TY - JOUR AD - Boston Children's Hospital, Boston, MA, United States Harvard Medical School, Boston, MA, United States Dana-Farber/Boston Children's Cancer, Blood Disorders Center, Boston, MA, United States Brigham and Women's Hospital, Boston, MA, United States Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States Fox Chase Cancer Center, Philadelphia, PA, United States St Jude Children's Research Hospital, Memphis, TN, United States Huntsman Cancer Institute, Salt Lake City, UT, United States Sylvester Comprehensive Cancer Center, Miami, FL, United States Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States National Cancer Institute, Bethesda, MD, United States Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, United States Department of Surgery, 300 Longwood Ave, Fegan 3, Boston, MA 02115, United States AU - Weldon, C. B. AU - Madenci, A. L. AU - Boikos, S. A. AU - Janeway, K. A. AU - George, S. AU - Von Mehren, M. AU - Pappo, A. S. AU - Schiffman, J. D. AU - Wright, J. AU - Trent, J. C. AU - Pacak, K. AU - Stratakis, C. A. AU - Helman, L. J. AU - Quaglia, M. P. L. DB - Scopus DO - 10.1200/JCO.2016.68.6733 IS - 5 M3 - Article N1 - Cited By :26 Export Date: 18 November 2020 PY - 2017 SP - 523-528 ST - Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic T2 - Journal of Clinical Oncology TI - Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012866987&doi=10.1200%2fJCO.2016.68.6733&partnerID=40&md5=0caebae2c2a21c9bfac18fd53c200376 VL - 35 ID - 7938 ER - TY - JOUR AD - Department of Dermatology and Allergology, University Hospital of RWTH Aachen, Aachen, Germany Department of Medical Engineering and Technomathematics, FH Aachen University of Applied Sciences, Campus Jülich, Germany AU - Balakirski, G. AU - Kotliar, K. AU - Pauly, K. J. AU - Krings, L. K. AU - Rübben, A. AU - Baron, J. M. AU - Schmitt, L. DB - Scopus DO - 10.1097/DSS.0000000000001615 IS - 12 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 1525-1536 ST - Surgical site infections after dermatologic surgery in immunocompromised patients: A single-center experience T2 - Dermatologic Surgery TI - Surgical site infections after dermatologic surgery in immunocompromised patients: A single-center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057204219&doi=10.1097%2fDSS.0000000000001615&partnerID=40&md5=b938c7430bf8eb3e29b1396a35f8fe1e VL - 44 ID - 7939 ER - TY - JOUR AD - Valley Radiotherapy Associates, 1500 Rosecrans Avenue, Manhattan Beach, CA, 90266, USA. tinadasgupta2006@gmail.com. Department of Laboratory Medicine, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Radiation Oncology, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Pediatrics, University of California, San Francisco, San Francisco, CA, 94143, USA. Department of Neurology, University of California, San Francisco (UCSF), San Francisco, CA, 94143, USA. Department of Radiotherapy, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. AN - 26384810 AU - Dasgupta, T. AU - Olow, A. K. AU - Yang, X. AU - Hashizume, R. AU - Nicolaides, T. P. AU - Tom, M. AU - Aoki, Y. AU - Berger, M. S. AU - Weiss, W. A. AU - Stalpers, L. J. AU - Prados, M. AU - James, C. D. AU - Mueller, S. AU - Haas-Kogan, D. A. C2 - PMC4907264 C6 - NIHMS792232 DA - Feb DO - 10.1007/s11060-015-1939-2 10.1007/s11060-015-1939-2. Epub 2015 Sep 18. DP - Nlm ET - 2015/09/20 IS - 3 LA - eng PY - 2016 SN - 0167-594X (Print) 0167-594x SP - 385-93 ST - Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma T2 - J Neurooncol TI - Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma VL - 126 ID - 7940 ER - TY - JOUR AD - Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 2100 Webster Street, Suite 326, San Francisco, CA, 94115, USA. Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 2100 Webster Street, Suite 326, San Francisco, CA, 94115, USA. KimKB@sutterhealth.org. AN - 29703161 AU - Vosoughi, E. AU - Lee, J. M. AU - Miller, J. R. AU - Nosrati, M. AU - Minor, D. R. AU - Abendroth, R. AU - Lee, J. W. AU - Andrews, B. T. AU - Leng, L. Z. AU - Wu, M. AU - Leong, S. P. AU - Kashani-Sabet, M. AU - Kim, K. B. C2 - PMC5924486 DA - Apr 27 DO - 10.1186/s12885-018-4374-x 10.1186/s12885-018-4374-x. DP - Nlm ET - 2018/04/29 IS - 1 LA - eng PY - 2018 SN - 1471-2407 SP - 490 ST - Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies T2 - BMC Cancer TI - Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies VL - 18 ID - 7941 ER - TY - JOUR AD - Life Raft Group, 155 Route 46 West, Suite 202, Wayne, NJ 07470, United States LPC, 2004 MacGregor Park Circle, Ft Myers, FL 33908-5419, United States Department of Biostatistics and Medical Informatics, University of Wisconsin, School of Medicine and Public Health, 600 Highland Ave, Madison, WI 53792-4675, United States AU - Call, J. AU - Walentas, C. D. AU - Eickhoff, J. C. AU - Scherzer, N. C7 - 90 DB - Scopus DO - 10.1186/1471-2407-12-90 M3 - Article N1 - Cited By :30 Export Date: 18 November 2020 PY - 2012 ST - Survival of gastrointestinal stromal tumor patients in the imatinib era: Life raft group observational registry T2 - BMC Cancer TI - Survival of gastrointestinal stromal tumor patients in the imatinib era: Life raft group observational registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858304485&doi=10.1186%2f1471-2407-12-90&partnerID=40&md5=c97bcbf996d4e18b933ca2bab3e968a7 VL - 12 ID - 7942 ER - TY - JOUR AD - Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. Department of Medical Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia. Department of Medicine, Institute Gustave Roussy, Villejuif, France. Medical Oncology and Haematology, Cabrini Health, Melbourne, Victoria, Australia. Dermatology Service, University Hospital of Bordeaux, Bordeaux, France. UOC Oncological Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Clinique de Dermatologie, Unité d'Onco-Dermatologie, Institut National de la Santé et de la Recherche Médicale (INSERM) U1189, Centre Hospitalier Régional Universitaire de Lille, Lille, France. Department of Dermatology, University Hospital Heidelberg and National Center for Tumor Diseases, Heidelberg, Germany. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland. Chris O'Brien Lifehouse, Melanoma Institute Australia, Camperdown, New South Wales. Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. Assistance Publique-Hôpitaux de Paris Dermatology and Centre d'Investigation Clinique, University Paris Diderot INSERM U976, Saint Louis Hospital, Paris, France. Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France. Dermatology Department, Grenoble Alpes University Hospital, Grenoble, France. Department of Oncology, McGill University, Montreal, Quebec, Canada. Melanoma Cancer Unit, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. Department of Dermatology, University Hospital Cologne, Cologne, Germany. Division of Oncology, Regina Elena Institute, Rome, Italy. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. Hospital Clinic and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Center for Cancer Immune Therapy, Herlev Hospital, Herlev, Denmark. Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Department of Dermatology, University Hospital Essen, Essen, Germany. German Cancer Consortium, Heidelberg, Germany. First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. Global Biometric Sciences, Bristol-Myers Squibb, Princeton, New Jersey. Oncology Clinical Development, Bristol-Myers Squibb, Princeton, New Jersey. Princess Alexandra Hospital, University of Queensland, Woolloongabba, Queensland, Australia. Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia. AN - 30422243 AU - Ascierto, P. A. AU - Long, G. V. AU - Robert, C. AU - Brady, B. AU - Dutriaux, C. AU - Di Giacomo, A. M. AU - Mortier, L. AU - Hassel, J. C. AU - Rutkowski, P. AU - McNeil, C. AU - Kalinka-Warzocha, E. AU - Savage, K. J. AU - Hernberg, M. M. AU - Lebbé, C. AU - Charles, J. AU - Mihalcioiu, C. AU - Chiarion-Sileni, V. AU - Mauch, C. AU - Cognetti, F. AU - Ny, L. AU - Arance, A. AU - Svane, I. M. AU - Schadendorf, D. AU - Gogas, H. AU - Saci, A. AU - Jiang, J. AU - Rizzo, J. AU - Atkinson, V. C2 - PMC6439558 role with Bristol-Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Amgen, Array, Merck, Pierre-Fabre, Incyte, Genmab, Newlink Genetics, MedImmune, Syndax, and AstraZeneca and reported receiving institutional research funding from Bristol-Myers Squibb, Roche-Genentech, and Array. Dr Long reported receiving honoraria from Merck MSD, Roche, and Bristol-Myers Squibb and reported having a paid consulting role with Merck MSD, Roche, Bristol-Myers Squibb, Amgen, Novartis, and Pierre-Fabre. Dr Robert reported having a paid consulting role with Bristol-Myers Squibb, Merck, Roche, and Amgen and reported receiving honoraria from Bristol-Myers Squibb, Merck, GlaxoSmithKline, Roche, Novartis, and Amgen. Dr Brady reported being paid to participate in speakers’ bureaus for Bristol-Myers Squibb and Merck; reported having a paid consulting role with Merck and Novartis; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb. Dr Di Giacomo reported receiving honoraria from Bristol-Myers Squibb, Roche, and Merck Sharp & Dohme and reported being a consultant for Incyte, Pierre-Fabre, and GlaxoSmithKline. Dr Mortier reported receiving clinical trials funding from Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp & Dohme, and Roche and reported participating on an advisory board for Bristol-Myers Squibb. Dr Hassel reported having a paid consulting role with Merck and Amgen and reported receiving honoraria from Bristol-Myers Squibb, Merck, Novartis, Roche, and Pfizer. Dr Rutkowski reported receiving honoraria from Bristol-Myers Squibb, Roche, Novartis, Merck Sharp & Dohme, and GlaxoSmithKline; reported having a paid consulting role with Bristol-Myers Squibb, Roche, Merck Sharp & Dohme, and Amgen; reported being paid to participate in speakers’ bureaus for Novartis and Merck Sharp & Dohme; reported receiving institutional research funding from Bristol-Myers Squibb; and reported having travel or other expenses paid or reimbursed by Novartis. Dr McNeil and members of her department reported having travel or other expenses paid or reimbursed by Merck Sharp & Dohme and Bristol-Myers Squibb; reported participating on advisory boards for Bristol-Myers Squibb and Merck Sharp & Dohme; and reported receiving research funding from Merck Sharp & Dohme for her institution. Dr Kalinka-Warzocha reported receiving payments for trial procedures according to study protocol from Bristol-Myers Squibb; reported receiving honoraria from Bristol-Myers Squibb, Roche, Novartis, Merck Sharp & Dohme, and AstraZeneca; and reported having a paid consultant role with Bristol-Myers Squibb, Merck Sharp & Dohme, and AstraZeneca. Dr Savage reported receiving honoraria from Seattle Genetics, Bristol-Myers Squibb, Celgene, and Takeda; reported having a paid consulting role with Seattle Genetics, Merck, and Bristol-Myers Squibb; reported being paid to participate in a speakers’ bureau for Seattle Genetics; and reported receiving research funding from Roche. Dr Lebbé reported participating on advisory boards for Bristol-Myers Squibb, Merck Sharp & Dohme, Roche, GlaxoSmithKline, and Novartis and reported receiving travel expenses from Bristol-Myers Squibb and Merck Sharp & Dohme. Dr Mihalcioiu reporting having a paid consulting role with Bristol-Myers Squibb, Novartis, and Merck and reported having an issued US patent on circulatory cells. Dr Chiarion-Sileni reported having a paid consulting role with Bristol-Myers Squibb, Roche, GlaxoSmithKline, and Merck Sharp & Dohme; reported being paid to participate in a speakers’ bureau for Bristol-Myers Squibb, Roche, and GlaxoSmithKline; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb, Roche, GlaxoSmithKline, and Merck Sharp & Dohme. Dr Cognetti reported participating on an advisory board for Astellas Oncology. Dr Ny reported receiving clinical institutional funding from Merck Sharpe & Dohme and Syndax; reported receiving payment for participating in advisory boards with Bristol-Myers Squibb and Novartis; and reported having a co sulting role with Bristol-Myers Squibb and AstraZeneca. Dr Arance reported having a paid consulting role with GlaxoSmithKline and Roche; reported being paid to participate in speakers’ bureaus for GlaxoSmithKline, Roche, and Bristol-Myers Squibb; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb. Dr Svane reported receiving honoraria from Bristol-Myers Squibb, Merck, and Roche; reported receiving clinical research funding from Bristol-Myers Squibb, Novartis, and Roche; and reported receiving payment for participation in scientific advisory boards from Bristol-Myers Squibb, GlaxoSmithKline, and Roche. Dr Schadendorf reported receiving honoraria from Merck Sharp & Dohme, Roche, Amgen, Novartis, and Bristol-Myers Squibb; reported having paid consulting roles and being a member of speakers’ bureaus with Merck Sharp & Dohme, Roche, Amgen, Novartis, Bristol-Myers Squibb, Pierre-Fabre, and Merck-Serono; reported having a paid consultant role with Incyte; and reported receiving research funding from Merck Sharp & Dohme and Bristol-Myers Squibb. Dr Gogas reported receiving personal fees from GlaxoSmithKline, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, and Amgen. Drs Saci, Jiang, and Rizzo reported being employed by Bristol-Myers Squibb. Dr Atkinson reported receiving honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; reported having a paid consulting role with Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; reported being paid to participate in speakers’ bureaus for Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis; and reported having travel or other expenses paid or reimbursed by Bristol-Myers Squibb, Merck Sharp & Dohme, and Novartis. No other disclosures were reported. DA - Feb 1 DO - 10.1001/jamaoncol.2018.4514 10.1001/jamaoncol.2018.4514. DP - Nlm ET - 2018/11/14 IS - 2 LA - eng PY - 2019 SN - 2374-2437 (Print) 2374-2437 SP - 187-194 ST - Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial T2 - JAMA Oncol TI - Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial VL - 5 ID - 7943 ER - TY - JOUR AD - Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, 75 Mikras Asias Str, Athens, 11527, Greece Department of Pediatric Hematology-Oncology, “Pan & Agl. Kyriakou” Children's Hospital, Thivon and Papadiamantopoulou Str, Athens, 11527, Greece National Cancer Registry of Ukraine, National Institute of Cancer, Lomonosova str, 33/43, Kyiv, 03022, Ukraine Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Childhood Cancer Subregistry of Belarus, Lesnoe-2, Minsk Region, 223040, Belarus Bulgarian National Cancer Registry, National Oncology Hospital, 6, Plovdivsko Pole Street, Sofia, 1756, Bulgaria Institute of Public Health of Serbia, Dr Subotica 5, Belgrade, 11000, Serbia Izmir Cancer Registry, Izmir Hub, Izmir & Hacettepe University Institute of Public Health, Zubeyde Hanim Caddesi No:100, Karsiyaka, Izmir, 35067, Turkey North Region Cancer Registry of Portugal (RORENO), Portuguese Oncology Institute of Porto, Rua António Bernardino da Almeida, Porto, 4200-072, Portugal Croatian National Cancer Registry, Croatian Institute of Public Health, Rockefellerova 7, Zagreb, 10000, Croatia Cancer Registry of Republic of Slovenia, Institute of Oncology, Zaloška cesta 2, Ljubljana, SI-1000, Slovenia Central Region Cancer Registry of Portugal (ROR-Centro), Portuguese Oncology Institute of Coimbra, Av. Bissaya Barreto 98, Coimbra, 3000-075, Portugal Cyprus Cancer Registry-Health Monitoring Unit, Ministry of Health, 1 Prodromou Str & 17 Chilonos Str, Nicosia, 1448, Cyprus Malta National Cancer Registry, Department of Health Information and Research, 95, Guardamangia Hill, GuardamangiaMSD08, Malta Regional Cancer Registry of Iasio, National Institute of Public Health, 14 Victor Babes Street 700465, Iasi, Romania Regional Cancer Registry of Cluj, Oncological Institute ‘‘Ion Chiricuta”, Republicii Str no. 34-36, Cluj Napoca, 400015, Romania Department of Pediatric Haematology-Oncology, “Aghia Sophia” Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece Department of Pediatric Hematology-Oncology, University of Crete, University Hospital of Heraklion, Arsinois 23, Heraklion Crete, 71303, Greece Haematology-Oncology Unit, First Department of Pediatrics, Athens University Medical School, “Aghia Sophia” Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece 2nd Department of Pediatrics, Aristotelion University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece Department of Pediatric Hematology and Oncology, Hippokration Hospital, Konstantinoupoleos Str 49, Thessaloniki, 54642, Greece Stem Cell Transplantion Unit, Aghia Sophia Children's Hospital, Thivon and Livadias, Goudi, Athens, 115 27, Greece Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, 20230-130, Brazil Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, United States Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Kirkeveien 166, Frederik Holsts hus, Oslo, 0450, Norway AU - Karalexi, M. A. AU - Baka, M. AU - Ryzhov, A. AU - Zborovskaya, A. AU - Dimitrova, N. AU - Zivkovic, S. AU - Eser, S. AU - Antunes, L. AU - Sekerija, M. AU - Zagar, T. AU - Bastos, J. AU - Demetriou, A. AU - Agius, D. AU - Florea, M. AU - Coza, D. AU - Polychronopoulou, S. AU - Stiakaki, E. AU - Moschovi, M. AU - Hatzipantelis, E. AU - Kourti, M. AU - Graphakos, S. AU - Pombo-de-Oliveira, M. S. AU - Adami, H. O. AU - Petridou, E. T. DB - Scopus DO - 10.1016/j.ejca.2016.08.011 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 183-190 ST - Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America T2 - European Journal of Cancer TI - Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988664480&doi=10.1016%2fj.ejca.2016.08.011&partnerID=40&md5=4ddcdaa51ef3c9c2601b745bc6bf1b81 VL - 67 ID - 7944 ER - TY - JOUR AD - Department of Transplantation, Medical College, Jagiellonian University, ul. Wielicka 265, 30-663 Krakow, Poland University Childrens Hospital, Department of Oncology and Hematology, Wielicka 265, 30-663 Krakow, Poland AU - Skoczen, S. AU - Surmiak, M. AU - Strojny, W. DB - Scopus DO - 10.1517/14740330903410213 IS - 1 M3 - Review N1 - Cited By :2 Export Date: 18 November 2020 PY - 2010 SP - 65-77 ST - Survivors of acute lymphoblastic leukemia and body mass changes T2 - Expert Opinion on Drug Safety TI - Survivors of acute lymphoblastic leukemia and body mass changes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-74349086889&doi=10.1517%2f14740330903410213&partnerID=40&md5=8b801fbb32bebf2be82809dc9b30c7d0 VL - 9 ID - 7945 ER - TY - JOUR AU - Greene, M. AU - Kobierska, M. AU - Kent, P. M. AU - Piasecki, P. DB - Scopus DO - 10.1016/j.currproblcancer.2013.07.011 IS - 4 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2013 SP - 236-243 ST - Survivorship in young patients with bone cancer T2 - Current Problems in Cancer TI - Survivorship in young patients with bone cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887545130&doi=10.1016%2fj.currproblcancer.2013.07.011&partnerID=40&md5=15f54c734c5eeae6293e96624b54d2a5 VL - 37 ID - 7946 ER - TY - JOUR AD - Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA. AN - 23221337 AU - Chang, T. AU - Krisman, K. AU - Theobald, E. H. AU - Xu, J. AU - Akutagawa, J. AU - Lauchle, J. O. AU - Kogan, S. AU - Braun, B. S. AU - Shannon, K. C2 - PMC3533281 DA - Jan DO - 10.1172/jci63193 10.1172/JCI63193. Epub 2012 Dec 10. DP - Nlm ET - 2012/12/12 IS - 1 LA - eng PY - 2013 SN - 0021-9738 (Print) 0021-9738 SP - 335-9 ST - Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice T2 - J Clin Invest TI - Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice VL - 123 ID - 7947 ER - TY - JOUR AD - MD Anderson Cancer Center, University of Texas, Houston, TX, United States AU - Triche, L. AU - Yarbrough, A. AU - Roth, M. AU - Ying, A. AU - Wells, R. DB - Scopus DO - 10.1080/08880018.2020.1751755 IS - 5 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - 375-379 ST - Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story T2 - Pediatric Hematology and Oncology TI - Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation & the effects on growth in a child with chronic myeloid leukemia: not always a short story UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85084253202&doi=10.1080%2f08880018.2020.1751755&partnerID=40&md5=90ef390e1404b6a514427b6e5af7a4be VL - 37 ID - 7948 ER - TY - JOUR AD - K. Harmoney, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States AU - Harmoney, K. AU - Modi, A. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617687854 2017-08-11 PY - 2017 SN - 1545-5017 SP - S75 ST - Sustained remission in a patient with malignant histiocytosis using targeted therapy against BRAF-V600E mutation T2 - Pediatric Blood and Cancer TI - Sustained remission in a patient with malignant histiocytosis using targeted therapy against BRAF-V600E mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617687854&from=exporthttp://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 7949 ER - TY - JOUR AD - S. Toll, Children's Hospital Los Angeles, Los Angeles, CA, United States AU - Toll, S. AU - Cotter, J. AU - Judkins, A. AU - Tamrazi, B. AU - Biegel, J. AU - Patel, P. AU - Tran, H. N. AU - Cooper, R. AU - Margol, A. S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098295 2018-07-25 PY - 2018 SN - 1523-5866 SP - i98 ST - Sustained response of three pediatric BRAFV600E mutated high-grade gliomas with BRAF and MEK inhibitor therapy T2 - Neuro-Oncology TI - Sustained response of three pediatric BRAFV600E mutated high-grade gliomas with BRAF and MEK inhibitor therapy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098295&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 7950 ER - TY - JOUR AD - S.I. Labidi-Galy, Department of Oncology, Hôpitaux Universitaires de Genève, Rue Gabrielle Perret-Gentil 4, Geneva, Switzerland AU - Terzic, J. AU - Seipel, A. AU - Dubuisson, J. AU - Tille, J. C. AU - Tsantoulis, P. AU - Addeo, A. AU - Labidi-Galy, S. I. DB - Embase DO - 10.1016/j.gore.2020.100600 LA - English M3 - Article N1 - L2006786369 2020-07-06 2020-07-08 PY - 2020 SN - 2352-5789 ST - Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation T2 - Gynecologic Oncology Reports TI - Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006786369&from=exporthttp://dx.doi.org/10.1016/j.gore.2020.100600 VL - 33 ID - 7951 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology. Division of Radiology. Division of Pathology. Division of Neurosurgery, King Hussein Cancer Center, Amman, Jordan. Division of Hematology/Oncology. Division of Pathology, The Hospital for Sick Children, Toronto, ON, Canada. AN - 29200156 AU - Amayiri, N. AU - Swaidan, M. AU - Al-Hussaini, M. AU - Halalsheh, H. AU - Al-Nassan, A. AU - Musharbash, A. AU - Tabori, U. AU - Hawkins, C. AU - Bouffet, E. DA - Aug DO - 10.1097/mph.0000000000001032 10.1097/MPH.0000000000001032. DP - Nlm ET - 2017/12/05 IS - 6 LA - eng PY - 2018 SN - 1077-4114 SP - 478-482 ST - Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma T2 - J Pediatr Hematol Oncol TI - Sustained Response to Targeted Therapy in a Patient With Disseminated Anaplastic Pleomorphic Xanthoastrocytoma VL - 40 ID - 7952 ER - TY - JOUR AD - Dept. of Urology, Rechts der Isar Medical Center, Technical University of Munich, Ismaninger Str. 22, Munich, 81675, Germany Dept. of Urology, Eberhard Karls University Tübingen, Hoppe-Seyler-Str.3, Tübingen, 72076, Germany Dept. of Urology, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Münster, 48149, Germany Dept. of Urology, Universitätsklinikum Jena, Lessingstr. 1, Jena, 07743, Germany Dept. of Urology, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Str., Greifswald, 17475, Germany Medical Oncology, Onkologie Leer–Emden–Papenburg, Annenestr. 11, Leer, 26789, Germany Dept. of Urology, Universitätsklinikum Freiburg, Hugstetter Str. 55, Freiburg, 79106, Germany Dept. of Urology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany Dept. of Urology, Universitätsklinikum Dresden, Fetscherstr. 74, Dresden, 01307, Germany Dept. of Urology, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, Ulm, 89081, Germany Dept. of Oncology, Elisabeth Tweesteden Ziekenhuis, Dr. Deelenlaan 5, Tilburg, AD 5042, Netherlands Dept. of Oncology, Kaiser-Franz-Josef-Spital and Department of Urology, Medical University of Vienna, Kundratstr. 3, Vienna, 1100, Austria Dept. of Oncology, Spaarne Ziekenhuis, Spaarnepoort 1, Hoofddorp, TM 2134, Netherlands Dept. of Urology, Städtisches Krankenhaus Kiel, Chemnitzstr. 33, Kiel, 24116, Germany IOMEDICO AG, Hanferstr. 28, Freiburg, 79108, Germany Center for Oncology, II. Medical Clinic and Polyclinic, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany AUO Study Group, Germany AU - Retz, M. AU - Bedke, J. AU - Bögemann, M. AU - Grimm, M. O. AU - Zimmermann, U. AU - Müller, L. AU - Leiber, C. AU - Teber, D. AU - Wirth, M. AU - Bolenz, C. AU - van Alphen, R. AU - De Santis, M. AU - Beeker, A. AU - Lehmann, J. AU - Indorf, M. AU - Frank, M. AU - Bokemeyer, C. AU - Gschwend, J. E. DB - Scopus DO - 10.1016/j.ejca.2018.11.001 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2019 SP - 37-45 ST - SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) T2 - European Journal of Cancer TI - SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057599396&doi=10.1016%2fj.ejca.2018.11.001&partnerID=40&md5=ff84878f426fd48fa9a02a9c6913f619 VL - 107 ID - 7953 ER - TY - JOUR AD - Registro Español de Investigación y Tratamiento de Leucemia Mieloide Crnica (RELMC), Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Virgen de la Salud, Toledo, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Valle de Hebrón, Barcelona, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Miguel Servet, Zaragoza, Spain Servicio de Hematología y Hemoterapia, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario La Paz, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Puerta de Hierro, Majadahonda, Spain Servicio de Hematología y Hemoterapia, Hospital General Universitario Gregorio Marañón, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Severo Ochoa, Leganés, Spain Servicio de Hematología y Hemoterapia, Hospital Lozano Blesa, Zaragoza, Spain Servicio de Hematología y Hemoterapia, Hospital Clínico Universitario de Valladolid, Valladolid, Spain Servicio de Hematología y Hemoterapia, Hospital General de Ciudad Real, Ciudad Real, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Infanta Leonor, Madrid, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain Servicio de Hematología y Hemoterapia, Hospital Universitario de la Princesa, Madrid, Spain AU - Casado, L. F. AU - García-Gutiérrez, J. V. AU - Massagué, I. AU - Giraldo, P. AU - Pérez-Encinas, M. AU - de Paz, R. AU - Martínez-López, J. AU - Bautista, G. AU - Osorio, S. AU - Requena, M. J. AU - Palomera, L. AU - Peñarrubia, M. J. AU - Calle, C. AU - Hernández-Rivas, J. A. AU - Burgaleta, C. AU - Maestro, B. AU - García-Ormeña, N. AU - Steegmann, J. L. DB - Scopus DO - 10.1002/cam4.440 IS - 7 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 995-1002 ST - Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months T2 - Cancer Medicine TI - Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006200849&doi=10.1002%2fcam4.440&partnerID=40&md5=1c4b2fbe6952860975e6fcde00d255c2 VL - 4 ID - 7954 ER - TY - JOUR AD - Molecular Inflammation Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens veg 18, Tromsø, 9019, Norway Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Tomtebodav 18A, Stockholm, 17177, Sweden IRCM, Inserm U1194, Université Montpellier, ICM, Institut régional du Cancer Montpellier, Campus Val d'Aurelle, 208 Rue des Apothicaires, Montpellier Cedex 5, 34298, France Department of Clinical Pathology, University Hospital of Northern Norway, Sykehusveien 38, Tromsø, 9019, Norway AU - Tümmler, C. AU - Dumitriu, G. AU - Wickström, M. AU - Coopman, P. AU - Valkov, A. AU - Kogner, P. AU - Johnsen, J. I. AU - Moens, U. AU - Sveinbjörnsson, B. C7 - 202 DB - Scopus DO - 10.3390/cancers11020202 IS - 2 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 ST - SYK inhibition potentiates the effect of chemotherapeutic drugs on neuroblastoma cells in vitro T2 - Cancers TI - SYK inhibition potentiates the effect of chemotherapeutic drugs on neuroblastoma cells in vitro UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062395353&doi=10.3390%2fcancers11020202&partnerID=40&md5=867b12f7f0beff30cfbe6ad783602d41 VL - 11 ID - 7955 ER - TY - JOUR AD - Department of Psycho-oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India Department of Medical Oncology, Cancer Institute (WIA), 36, Sardar Patel Road, Chennai, Tamil Nadu, 600 036, India AU - Unnikrishnan, R. AU - Veeraiah, S. AU - Ganesan, P. DB - Scopus DO - 10.4103/ijmpo.ijmpo_160_16 IS - 2 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 165-168 ST - Symptom burden and quality of life issues among patients of chronic myeloid leukemia on long-term imatinib therapy T2 - Indian Journal of Medical and Paediatric Oncology TI - Symptom burden and quality of life issues among patients of chronic myeloid leukemia on long-term imatinib therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027878771&doi=10.4103%2fijmpo.ijmpo_160_16&partnerID=40&md5=04f8b45ac16954895117bea2f0dc0110 VL - 38 ID - 7956 ER - TY - JOUR AD - Gonda Department of Cell and Molecular Biology, House Ear Institute, University of Southern California, Los Angeles, CA 90057, USA. AN - 14993593 AU - Watanabe, T. AU - Jono, H. AU - Han, J. AU - Lim, D. J. AU - Li, J. D. C2 - PMC373502 DA - Mar 9 DO - 10.1073/pnas.0400557101 10.1073/pnas.0400557101. Epub 2004 Mar 1. DP - Nlm ET - 2004/03/03 IS - 10 LA - eng PY - 2004 SN - 0027-8424 (Print) 0027-8424 SP - 3563-8 ST - Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha T2 - Proc Natl Acad Sci U S A TI - Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha VL - 101 ID - 7957 ER - TY - JOUR AD - M. Hiwatari, University of Tokyo, Cell Therapy and Transplantation Medicine, Tokyo, Japan AU - Hiwatari, M. AU - Watanabe, K. AU - Kimura, S. AU - Takita, J. DB - Embase DO - 10.1002/pbc.27455 LA - English M3 - Conference Abstract N1 - L624179926 2018-10-11 PY - 2018 SN - 1545-5017 SP - S252 ST - Synergistic activity of ALK and STAT3 inhibitors for the treatment of ALK mutated neuroblastoma cells T2 - Pediatric Blood and Cancer TI - Synergistic activity of ALK and STAT3 inhibitors for the treatment of ALK mutated neuroblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624179926&from=exporthttp://dx.doi.org/10.1002/pbc.27455 VL - 65 ID - 7958 ER - TY - JOUR AD - S. Shalapour, Department of Pediatric Oncology/Hematology, Division of General Pediatrics, Charité-Universitätsmedizin Berlin, Berlin 13353, Germany AU - Bastian, L. AU - Hof, J. AU - Pfau, M. AU - Fichtner, I. AU - Eckert, C. AU - Henze, G. AU - Prada, J. AU - Von Stackelberg, A. AU - Seeger, K. AU - Shalapour, S. C2 - Janssen Cilag Klinke Sigma Aldrich DB - Embase Medline DO - 10.1158/1078-0432.CCR-12-1511 IS - 6 LA - English M3 - Article N1 - L368552622 2013-03-27 2013-04-12 PY - 2013 SN - 1078-0432 1557-3265 SP - 1445-1457 ST - Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB T2 - Clinical Cancer Research TI - Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368552622&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-12-1511http://clincancerres.aacrjournals.org/content/19/6/1445.full.pdf+html VL - 19 ID - 7959 ER - TY - JOUR AD - J.R. Stehn, University of New South Wales, Sydney, Australia AU - Stehn, J. R. AU - Chen, D. AU - Currier, M. A. AU - Eaves, D. AU - Desouza, M. AU - Moosavian, M. AU - Cripe, T. P. AU - Gunning, P. W. DB - Embase DO - 10.1158/1538-7445.PEDCAN-B50 IS - 20 LA - English M3 - Conference Abstract N1 - L71713790 2014-12-15 PY - 2014 SN - 0008-5472 ST - Synergistic anti-neuroblastoma efficacy using combinatorial cytoskeletal inhibitors T2 - Cancer Research TI - Synergistic anti-neuroblastoma efficacy using combinatorial cytoskeletal inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713790&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCAN-B50http://cancerres.aacrjournals.org/content/74/20_Supplement/B50.abstract?sid=897a1880-199a-4e71-ac50-5b103da1a6ee VL - 74 ID - 7960 ER - TY - JOUR AD - Instituto Universitario de Oncología del Principado de Asturias (IUOPA), c/Julian Claveria, Oviedo, Spain. AN - 20025643 AU - Casado-Zapico, S. AU - Rodriguez-Blanco, J. AU - García-Santos, G. AU - Martín, V. AU - Sánchez-Sánchez, A. M. AU - Antolín, I. AU - Rodriguez, C. DA - Jan DO - 10.1111/j.1600-079X.2009.00727.x 10.1111/j.1600-079X.2009.00727.x. DP - Nlm ET - 2009/12/23 IS - 1 LA - eng PY - 2010 SN - 0742-3098 SP - 72-80 ST - Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway T2 - J Pineal Res TI - Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway VL - 48 ID - 7961 ER - TY - JOUR AD - V.E. Palau, Division of Hematology-Oncology, Department of Internal Medicine, James H. Quillen College of Medicine, Johnson City, TN, United States AU - Rogers, M. AU - Kalra, S. AU - Moukharskaya, J. AU - Chakraborty, K. AU - Niyazi, M. AU - Krishnan, K. AU - Lightner, J. AU - Brannon, M. AU - Stone, W. L. AU - Palau, V. E. C2 - Sigma(United States) DB - Embase Medline IS - 4 LA - English M3 - Article N1 - L604019439 2015-05-01 2015-05-18 PY - 2015 SN - 0250-7005 SP - 1851-1860 ST - Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate T2 - Anticancer Research TI - Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604019439&from=export VL - 35 ID - 7962 ER - TY - JOUR AD - Y. Yu, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China AU - Liu, J. AU - Qu, J. AU - Zhou, W. AU - Huang, Y. AU - Jia, L. AU - Huang, X. AU - Qian, Z. AU - Xia, J. AU - Yu, Y. DB - Embase Medline DO - 10.1016/j.ejmech.2018.05.015 LA - English M3 - Article N1 - L2000807242 2018-06-05 2020-10-07 PY - 2018 SN - 1768-3254 0223-5234 SP - 354-366 ST - Syntenin-targeted peptide blocker inhibits progression of cancer cells T2 - European Journal of Medicinal Chemistry TI - Syntenin-targeted peptide blocker inhibits progression of cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000807242&from=exporthttp://dx.doi.org/10.1016/j.ejmech.2018.05.015 VL - 154 ID - 7963 ER - TY - JOUR AU - Basavarajappa, H. D. AU - Lee, B. AU - Fei, X. AU - Lim, D. AU - Callaghan, B. AU - Mund, J. A. AU - Case, J. AU - Rajashekhar, G. AU - Seo, S. Y. AU - Corson, T. W. C1 - sh 11052 DB - Embase Medline DO - 10.1371/journal.pone.0095694 IS - 4 LA - English M3 - Article N1 - L372991230 2014-05-12 2014-05-21 PY - 2014 SN - 1932-6203 ST - Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth T2 - PLoS ONE TI - Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372991230&from=exporthttp://dx.doi.org/10.1371/journal.pone.0095694 VL - 9 ID - 7964 ER - TY - JOUR AD - H.R. Madala, Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, United States AU - Madala, H. R. AU - Punganuru, S. R. AU - Kalkunte, S. DB - Embase IS - 1 LA - English M3 - Conference Abstract N1 - L616904789 2017-06-28 PY - 2017 SN - 1530-6860 ST - Synthesis of a novel non-diuretic, brain-penetrating, ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models T2 - FASEB Journal TI - Synthesis of a novel non-diuretic, brain-penetrating, ethacrynic acid analog and demonstration of its potent efficacy in orthotopic glioblastoma (GBM) models UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616904789&from=export VL - 31 ID - 7965 ER - TY - JOUR AD - Key Laboratory of Organ Regeneration and Transplantation, Ministry of Education, Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, 1163 Xinmin Street, Changchun, 130021, China Department of Neurology, Neuroscience Center, First Hospital of Jilin University, Jilin University, Changchun, China Nursing Department, Second Hospital, Jilin University, Changchun, China AU - Pan, P. AU - Wang, L. AU - Wang, Y. AU - Shen, L. AU - Zheng, P. AU - Bi, C. AU - Zhang, A. AU - Lv, Y. AU - Xue, Z. AU - Sun, M. AU - Sun, C. AU - Li, J. AU - Jin, L. AU - Yao, Y. DB - Scopus DO - 10.1159/000501537 IS - 3 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 204-216 ST - Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia T2 - Acta Haematologica TI - Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072191395&doi=10.1159%2f000501537&partnerID=40&md5=539fcd44df95b7b22d6e57d069d02d2b VL - 143 ID - 7966 ER - TY - JOUR AD - F Hoffmann-La Roche Ltd., Global Access, 4070 Basel, Switzerland Mtech Access Ltd., 30 Murdock Road, Bicester, OX26 4PP, UK Roche Products Ltd., Health Economics and Strategic Pricing, Welwyn Garden City, AL7 1TW, UK AN - 141291180. Language: English. Entry Date: 20201014. Revision Date: 20201014. Publication Type: journal article AU - Chu, Paula AU - Batson, Sarah AU - Hodgson, Matthew AU - Mitchell, Catherine R. AU - Steenrod, Anna DB - ccm DO - 10.2217/fon-2019-0534 DP - EBSCOhost IS - 4 N1 - meta analysis; research. Journal Subset: Biomedical; Europe; UK & Ireland. Special Interest: Evidence-Based Practice. Instrumentation: Clinical Decision Making in Nursing Scale (CDMNS) (Jenkins); Longitudinal Interval Follow-Up Evaluation (LIFE); Ferrans and Powers Quality of Life Index. NLM UID: 101256629. PMID: NLM31942815. PY - 2020 SN - 1479-6694 SP - 61-74 ST - Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy T2 - Future Oncology TI - Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141291180&site=ehost-live&scope=site VL - 16 ID - 7967 ER - TY - JOUR AD - K.S. Kwatra, Department of Pathology, Christian Medical College and Hospital, Ludhiana, Punjab, India AU - Kwatra, K. S. AU - Paul, P. A. M. AU - Calton, N. AU - John, J. M. AU - Cotelingam, J. D. C1 - adriamycin DB - Embase DO - 10.4103/2278-330X.214575 IS - 3 LA - English M3 - Article N1 - L618346073 2017-09-25 2017-09-27 PY - 2017 SN - 2278-4306 2278-330X SP - 129-131 ST - Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile T2 - South Asian Journal of Cancer TI - Systemic and primary cutaneous anaplastic large cell lymphoma: Clinical features, morphological spectrum, and immunohistochemical profile UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618346073&from=exporthttp://dx.doi.org/10.4103/2278-330X.214575 VL - 6 ID - 7968 ER - TY - JOUR AD - P. Kadam, St Vincent's Centre for Applied Medical Research, Darlinghurst, NSW, Australia AU - Kadam, P. DB - Embase DO - 10.1111/ajd.12652 LA - English M3 - Conference Abstract N1 - L615732058 2017-05-03 PY - 2017 SN - 1440-0960 SP - 64-65 ST - Systemic cutaneous anaplastic large t-cell lymphoma T2 - Australasian Journal of Dermatology TI - Systemic cutaneous anaplastic large t-cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615732058&from=exporthttp://dx.doi.org/10.1111/ajd.12652 VL - 58 ID - 7969 ER - TY - JOUR AD - Zhejiang University Division of Neurobiology and Physiology, Department of Basic Medical Sciences, Institute of Neuroscience, School of Medicine, Key Lab. of Medical Neurobiology Ministry of Health, Zhejiang Province Key Laboratory of Neurobiology, Hangzhou, 310058, China Third Military Medical University, Department of Pathophysiology and High Altitude Physiology, College of High Altitude Military Medicine, Chongqing, 400038, China University of Birmingham, School of Clinical and Experimental Medicine, Birmingham, B15 2TT, United Kingdom AU - Song, T. T. AU - Bi, Y. H. AU - Gao, Y. Q. AU - Huang, R. AU - Hao, K. AU - Xu, G. AU - Tang, J. W. AU - Ma, Z. Q. AU - Kong, F. P. AU - Coote, J. H. AU - Chen, X. Q. AU - Du, J. Z. C7 - 63 DB - Scopus DO - 10.1186/s12974-016-0528-4 IS - 1 M3 - Article N1 - Cited By :51 Export Date: 18 November 2020 PY - 2016 ST - Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia T2 - Journal of Neuroinflammation TI - Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960414098&doi=10.1186%2fs12974-016-0528-4&partnerID=40&md5=13d97b920c1ec1aa0d259f15acbcf723 VL - 13 ID - 7970 ER - TY - JOUR AD - M.-A. Wörns, Department of Internal Medicine i, University Medical Center, Johannes Gutenberg University, Langenbeckstrasse 1, DE-55131 Mainz, Germany AU - Wörns, M. A. C1 - abt 869 arq 197 azd 6244 bay 73 4506 calgb 80802 imc 1121b imc a 12 lbh 589 pxd 101 DB - Embase Medline DO - 10.1159/000347202 IS - 1 LA - English M3 - Article N1 - L369214430 2013-07-09 2013-07-11 PY - 2013 SN - 0257-2753 1421-9875 SP - 104-111 ST - Systemic therapy and synergies by combination T2 - Digestive Diseases TI - Systemic therapy and synergies by combination UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369214430&from=exporthttp://dx.doi.org/10.1159/000347202 VL - 31 ID - 7971 ER - TY - JOUR AD - Institute for Digestive Heath and Liver Disease, Mercy Medical Center, Baltimore, MD, United States University of Maryland School of Medicine, 655 W Baltimore S, Baltimore, MD 21201, United States AU - Doycheva, I. AU - Thuluvath, P. J. DB - Scopus DO - 10.1016/j.jceh.2019.07.012 IS - 5 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 588-596 ST - Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field T2 - Journal of Clinical and Experimental Hepatology TI - Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071333373&doi=10.1016%2fj.jceh.2019.07.012&partnerID=40&md5=f94cd8d0a9a9038f75f88e3e00610dfb VL - 9 ID - 7972 ER - TY - JOUR AD - V. Chung, Department of Medical Oncology and Therapeutics Research, City of Hope, 1500 East Duarte Road, Duarte, CA, United States AU - Chung, V. C1 - g 202 nexavar xl 184 DB - Embase Medline DO - 10.1016/j.soc.2014.09.009 IS - 1 LA - English M3 - Review N1 - L600155486 2014-10-21 2015-02-24 PY - 2015 SN - 1558-5042 1055-3207 SP - 187-198 ST - Systemic therapy for hepatocellular Carcinoma and cholangiocarcinoma T2 - Surgical Oncology Clinics of North America TI - Systemic therapy for hepatocellular Carcinoma and cholangiocarcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600155486&from=exporthttp://dx.doi.org/10.1016/j.soc.2014.09.009 VL - 24 ID - 7973 ER - TY - JOUR AD - M. Strazzabosco, Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, 333 Cedar Street/1080 LMP, PO Box 208019, New Haven, CT 06520-8019, United States AU - Wrzesinski, S. H. AU - Taddei, T. H. AU - Strazzabosco, M. C1 - abt 869 azd 2171 gw 786034 ptk 787 zk 222584 DB - Embase Medline DO - 10.1016/j.cld.2011.03.002 IS - 2 LA - English M3 - Review N1 - L361974952 2011-06-27 2011-07-01 PY - 2011 SN - 1089-3261 1557-8224 SP - 423-441 ST - Systemic Therapy in Hepatocellular Carcinoma T2 - Clinics in Liver Disease TI - Systemic Therapy in Hepatocellular Carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361974952&from=exporthttp://dx.doi.org/10.1016/j.cld.2011.03.002 VL - 15 ID - 7974 ER - TY - JOUR AD - Northwestern Medicine Developmental Therapeutics Institute (NMDTI), Chicago, IL, United States Division of Hematology and Oncology, Robert H. Lurie Medical Research Center, 303 East Superior, Chicago, IL 60611, United States Division of Hepatology and Gastroenterology, Northwestern University, 676 North St Clair, 19th Floor, Chicago, IL 60611, United States AU - Kalyan, A. AU - Nimeiri, H. AU - Kulik, L. DB - Scopus DO - 10.1016/j.cld.2015.01.009 IS - 2 M3 - Review N1 - Cited By :17 Export Date: 18 November 2020 PY - 2015 SP - 421-432 ST - Systemic Therapy of Hepatocellular Carcinoma: Current and Promising T2 - Clinics in Liver Disease TI - Systemic Therapy of Hepatocellular Carcinoma: Current and Promising UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928824816&doi=10.1016%2fj.cld.2015.01.009&partnerID=40&md5=7a5840dbb584f708a619e7b65dc2916c VL - 19 ID - 7975 ER - TY - JOUR AD - J. Bruix, Barcelona Clinic Liver Cancer (BCLC) Group, Hospital Clínic Barcelona, University of Barcelona, C/Villarroel 170, Barcelona, Spain AU - Reig, M. AU - Gazzola, A. AU - Di Donato, R. AU - Bruix, J. DB - Embase Medline DO - 10.1016/j.bpg.2014.08.003 IS - 5 LA - English M3 - Review N1 - L603882459 2015-04-24 2020-10-08 PY - 2014 SN - 1532-1916 1521-6918 SP - 921-935 ST - Systemic treatment T2 - Best Practice and Research: Clinical Gastroenterology TI - Systemic treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603882459&from=exporthttp://dx.doi.org/10.1016/j.bpg.2014.08.003 VL - 28 ID - 7976 ER - TY - JOUR AD - S. Cabezas-Camarero, Department of Medical Oncology, Hospital Universitario Clinico San Carlos, Madrid, Spain AU - Cabezas-Camarero, S. AU - Luna-Barrera, A. M. AU - Pérez-Segura, P. DB - Embase IS - 2 LA - English M3 - Article N1 - L613012663 2016-11-08 2016-11-21 PY - 2016 SN - 1885-740X SP - 55-65 ST - Systemic treatment of low-grade gliomas T2 - Cancer and Chemotherapy Reviews TI - Systemic treatment of low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613012663&from=export VL - 11 ID - 7977 ER - TY - JOUR AD - Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom School of Medicine, Taylor's University, Subang Jaya, Malaysia University of Colorado School of Medicine, Denver, CO, United States Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, United States AU - Sawangjit, R. AU - Dilokthornsakul, P. AU - Lloyd-Lavery, A. AU - Lai, N. M. AU - Dellavalle, R. AU - Chaiyakunapruk, N. C7 - Cd013206 DB - Scopus DO - 10.1002/14651858.CD013206.pub2 IS - 9 M3 - Review N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 ST - Systemic treatments for eczema: a network meta-analysis T2 - Cochrane Database of Systematic Reviews TI - Systemic treatments for eczema: a network meta-analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071450014&doi=10.1002%2f14651858.CD013206.pub2&partnerID=40&md5=ca714ad052325eff801f658953fafcf9 VL - 2020 ID - 7978 ER - TY - JOUR AD - M. Kawahara, Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan AU - Sogo, T. AU - Kawahara, M. AU - Ueda, H. AU - Otsu, M. AU - Onodera, M. AU - Nakauchi, H. AU - Nagamune, T. DB - Embase Medline DO - 10.1016/j.cyto.2008.12.020 IS - 1 LA - English M3 - Article N1 - L50425734 2009-04-10 PY - 2009 SN - 1043-4666 SP - 127-136 ST - T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera T2 - Cytokine TI - T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera UR - https://www.embase.com/search/results?subaction=viewrecord&id=L50425734&from=exporthttp://dx.doi.org/10.1016/j.cyto.2008.12.020 VL - 46 ID - 7979 ER - TY - JOUR AD - E.A. Raetz, Department of Pediatrics, Huntsman Cancer Institute, University of Utah, 100 N. Mario Capecchi Dr, Salt Lake City, UT, United States AU - Raetz, E. A. AU - Teachey, D. T. DB - Embase Medline DO - 10.1182/asheducation-2016.1.580 IS - 1 LA - English M3 - Article N1 - L616751173 2017-09-06 2017-09-13 PY - 2016 SN - 1520-4383 1520-4391 SP - 580-588 ST - T-cell acute lymphoblastic leukemia TI - T-cell acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616751173&from=exporthttp://dx.doi.org/10.1182/asheducation-2016.1.580 VL - 2016 ID - 7980 ER - TY - JOUR AD - L. Rifas, Department of Pediatrics, Washington University School of Medicine, Campus Box 8208, 660 South Euclid Avenue, St. Louis, MO 63110, United States AU - Rifas, L. DB - Embase Medline DO - 10.1002/jcb.20933 IS - 4 LA - English M3 - Article N1 - L43993389 2006-07-24 PY - 2006 SN - 0730-2312 1097-4644 SP - 706-714 ST - T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization T2 - Journal of Cellular Biochemistry TI - T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43993389&from=exporthttp://dx.doi.org/10.1002/jcb.20933 VL - 98 ID - 7981 ER - TY - JOUR AD - Department of Pediatric Oncology, Fukushima Medical University Hospital, Fukushima, Japan Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan AU - Sano, H. AU - Mochizuki, K. AU - Akaihata, M. AU - Kobayashi, S. AU - Ohto, H. AU - Kikuta, A. C7 - e26242 DB - Scopus DO - 10.1002/pbc.26242 IS - 3 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 ST - T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy T2 - Pediatric Blood and Cancer TI - T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84999806623&doi=10.1002%2fpbc.26242&partnerID=40&md5=c355b763abf8d4aa3ac59587fea1b7f2 VL - 64 ID - 7982 ER - TY - JOUR AD - M. Pigazzi, University of Padova-Città della Speranza, Padova, Italy AU - Pigazzi, M. AU - Manara, E. AU - Baron, E. AU - Beghin, A. AU - Tregnago, C. AU - Basso, G. DB - Embase LA - English M3 - Conference Abstract N1 - L71698418 2014-12-09 PY - 2011 SN - 0390-6078 SP - 250 ST - T(6;11)(Q27;Q23)MLL/AF6 enhances RAS pathway weakening af6 function in myeloid cells T2 - Haematologica TI - T(6;11)(Q27;Q23)MLL/AF6 enhances RAS pathway weakening af6 function in myeloid cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71698418&from=exporthttp://www.haematologica.org/content/96/supplement_2/1.full-text.pdf+html VL - 96 ID - 7983 ER - TY - JOUR AD - Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, 500 034, India Department of Laboratory Medicine, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India Department of Radiodiagnosis, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India AU - Jaiswal, R. AU - Pinninti, R. AU - Krishna, M. M. AU - Santa, A. AU - Boyella, P. K. AU - Nambaru, L. AU - Murthy, S. S. AU - Chowdary, K. V. AU - Rajappa, S. DB - Scopus DO - 10.4103/ijmpo.ijmpo_215_18 IS - 1 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 73-78 ST - T790M mutation and clinical outcomes with osimertinib in patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer T2 - Indian Journal of Medical and Paediatric Oncology TI - T790M mutation and clinical outcomes with osimertinib in patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064870891&doi=10.4103%2fijmpo.ijmpo_215_18&partnerID=40&md5=2999786270999641e22717c5f65e33bd VL - 40 ID - 7984 ER - TY - JOUR AD - Wilmer Eye Institute, Department of Otolaryngology/Head and Neck Surgery, Division of Head and Neck Cancer Research, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. AN - 16123397 AU - Goldenberg-Cohen, N. AU - Cohen, Y. AU - Rosenbaum, E. AU - Herscovici, Z. AU - Chowers, I. AU - Weinberger, D. AU - Pe'er, J. AU - Sidransky, D. DA - Sep DO - 10.1167/iovs.04-1449 10.1167/iovs.04-1449. DP - Nlm ET - 2005/08/27 IS - 9 LA - eng PY - 2005 SN - 0146-0404 (Print) 0146-0404 SP - 3027-30 ST - T1799A BRAF mutations in conjunctival melanocytic lesions T2 - Invest Ophthalmol Vis Sci TI - T1799A BRAF mutations in conjunctival melanocytic lesions VL - 46 ID - 7985 ER - TY - JOUR AD - Division of Infection & Immunity, FBLS, University of Glasgow, Glasgow, UK. AN - 18985043 AU - Janssen, C. S. AU - Sibbett, R. AU - Henriquez, F. L. AU - McKay, I. C. AU - Kemp, E. G. AU - Roberts, F. C2 - PMC2584949 DA - Nov 18 DO - 10.1038/sj.bjc.6604731 10.1038/sj.bjc.6604731. Epub 2008 Nov 4. DP - Nlm ET - 2008/11/06 IS - 10 LA - eng PY - 2008 SN - 0007-0920 (Print) 0007-0920 SP - 1673-7 ST - The T1799A point mutation is present in posterior uveal melanoma T2 - Br J Cancer TI - The T1799A point mutation is present in posterior uveal melanoma VL - 99 ID - 7986 ER - TY - JOUR AD - Paediatric Solid Tumour Biology and Therapeutics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Paediatric Solid Tumour Biology and Therapeutics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom. Louis.Chesler@icr.ac.uk. AN - 26122839 AU - Tucker, E. R. AU - Danielson, L. S. AU - Innocenti, P. AU - Chesler, L. C2 - PMC4539575 C6 - EMS62962 DA - Jul 15 DO - 10.1158/0008-5472.Can-14-3817 10.1158/0008-5472.CAN-14-3817. Epub 2015 Jun 29. DP - Nlm ET - 2015/07/01 IS - 14 LA - eng PY - 2015 SN - 0008-5472 (Print) 0008-5472 SP - 2770-4 ST - Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic T2 - Cancer Res TI - Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic VL - 75 ID - 7987 ER - TY - JOUR AD - C.-H. Kuo, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100 Tzyou First Road, Kaohsiung, Taiwan AU - Chang, K. T. AU - Lin, H. Y. H. AU - Kuo, C. H. AU - Hung, C. H. DB - Embase DO - 10.1016/j.jmii.2014.07.006 IS - 3 LA - English M3 - Article N1 - L612825168 2016-10-25 2016-11-21 PY - 2016 SN - 1995-9133 1684-1182 SP - 409-416 ST - Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes T2 - Journal of Microbiology, Immunology and Infection TI - Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612825168&from=exporthttp://dx.doi.org/10.1016/j.jmii.2014.07.006 VL - 49 ID - 7988 ER - TY - JOUR AD - Department of Medical Genetics, Ajou University School of Medicine, Suwon, Republic of Korea. Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea. Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea. AN - 25109740 AU - Park, G. H. AU - Lee, S. J. AU - Yim, H. AU - Han, J. H. AU - Kim, H. J. AU - Sohn, Y. B. AU - Ko, J. M. AU - Jeong, S. Y. C2 - PMC4148385 DA - Oct DO - 10.3892/or.2014.3379 10.3892/or.2014.3379. Epub 2014 Aug 4. DP - Nlm ET - 2014/08/12 IS - 4 LA - eng PY - 2014 SN - 1021-335X (Print) 1021-335x SP - 1347-54 ST - TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions T2 - Oncol Rep TI - TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions VL - 32 ID - 7989 ER - TY - JOUR AD - S.L. George, Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom AU - George, S. L. AU - Izquierdo, E. AU - Campbell, J. AU - Koutroumanidou, E. AU - Proszek, P. AU - Jamal, S. AU - Hughes, D. AU - Yuan, L. AU - Marshall, L. V. AU - Carceller, F. AU - Chisholm, J. C. AU - Vaidya, S. AU - Mandeville, H. AU - Angelini, P. AU - Wasti, A. AU - Bexelius, T. AU - Thway, K. AU - Gatz, S. A. AU - Clarke, M. AU - Al-Lazikani, B. AU - Barone, G. AU - Anderson, J. AU - Tweddle, D. A. AU - Gonzalez, D. AU - Walker, B. A. AU - Barton, J. AU - Depani, S. AU - Eze, J. AU - Ahmed, S. W. AU - Moreno, L. AU - Pearson, A. AU - Shipley, J. AU - Jones, C. AU - Hargrave, D. AU - Jacques, T. S. AU - Hubank, M. AU - Chesler, L. DB - Embase Medline DO - 10.1016/j.ejca.2019.07.027 LA - English M3 - Article N1 - L2003393367 2019-10-23 2019-11-07 PY - 2019 SN - 1879-0852 0959-8049 SP - 224-235 ST - A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations T2 - European Journal of Cancer TI - A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003393367&from=exporthttp://dx.doi.org/10.1016/j.ejca.2019.07.027 VL - 121 ID - 7990 ER - TY - JOUR AD - D. K. Graham, University of Colorado, Denver School of Medicine, Department of Pediatrics, 12800 E. 19th Avenue, Aurora, CO 80045, United States AU - Linger, R. M. A. AU - Keating, A. K. AU - Earp, H. S. AU - Graham, D. K. C1 - bms 777607(Bristol Myers Squibb) gsk 1363089(Glaxo SmithKline) mp 470(Supergen) pf 2341066(Pfizer) pf 5208763(Pfizer) r 428(Rigel) ski 606(Wyeth) C2 - Bristol Myers Squibb Glaxo SmithKline Pfizer Rigel Supergen Wyeth DB - Embase Medline DO - 10.1517/14728222.2010.515980 IS - 10 LA - English M3 - Review N1 - L359632597 2010-10-04 2010-10-08 PY - 2010 SN - 1472-8222 SP - 1073-1090 ST - Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors T2 - Expert Opinion on Therapeutic Targets TI - Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359632597&from=exporthttp://dx.doi.org/10.1517/14728222.2010.515980 VL - 14 ID - 7991 ER - TY - JOUR AD - K. Harmoney, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States AU - Harmoney, K. AU - Al-Huniti, A. AU - Clepp, J. AU - Modi, A. AU - Sato, M. DB - Embase DO - 10.1002/pbc.26591 LA - English M3 - Conference Abstract N1 - L617688057 2017-08-11 PY - 2017 SN - 1545-5017 SP - S91-S92 ST - A tale of two cases - BRAF-V600E targeted therapy in Iowa T2 - Pediatric Blood and Cancer TI - A tale of two cases - BRAF-V600E targeted therapy in Iowa UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617688057&from=exporthttp://dx.doi.org/10.1002/pbc.26591 VL - 64 ID - 7992 ER - TY - JOUR AD - D. K. Graham, Department of Pediatrics, University of Colorado Denver School of Medicine, Pediatrics Mail Stop 8302, PO Box 6511, Aurora, CO 80045, United States AU - Brandão, L. AU - Migdall-Wilson, J. AU - Eisenman, K. AU - Graham, D. K. C1 - bms 777607(Bristol Myers Squibb) gsk 1363089(Glaxo SmithKline) mp 470(Supergen) pf 2341066(Pfizer) C2 - Bristol Myers Squibb Glaxo SmithKline Pfizer Supergen DB - Embase Medline DO - 10.1615/CritRevOncog.v16.i1-2.60 IS - 1-2 LA - English M3 - Review N1 - L363072194 2011-12-19 2011-12-21 PY - 2011 SN - 0893-9675 SP - 47-63 ST - TAM receptors in leukemia: Expression, signaling, and therapeutic implications T2 - Critical Reviews in Oncogenesis TI - TAM receptors in leukemia: Expression, signaling, and therapeutic implications UR - https://www.embase.com/search/results?subaction=viewrecord&id=L363072194&from=exporthttp://dx.doi.org/10.1615/CritRevOncog.v16.i1-2.60http://www.dl.begellhouse.com/download/article/305b0e1923e5c7e0/CRO-11-105%20revised%202.pdf VL - 16 ID - 7993 ER - TY - JOUR AD - B.K. Petroff, Diagnostic Companion Animal and Population Health Laboratory, Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, United States AU - Piasecka-Srader, J. AU - Blanco, F. F. AU - Delman, D. H. AU - Dixon, D. A. AU - Geiser, J. L. AU - Ciereszko, R. E. AU - Petroff, B. K. DB - Embase Medline DO - 10.1095/biolreprod.114.126136 IS - 5 LA - English M3 - Article N1 - L605213755 2015-07-21 2015-07-23 PY - 2015 SN - 1529-7268 0006-3363 ST - Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries T2 - Biology of Reproduction TI - Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605213755&from=exporthttp://dx.doi.org/10.1095/biolreprod.114.126136 VL - 92 ID - 7994 ER - TY - JOUR AD - A.S. Levy, Montefiore Medical Center, Bronx, NY, United States AU - Levy, A. S. AU - Roth, M. AU - Patterson, N. AU - Scott, E. AU - Quispe-Tintaya, W. AU - Ewart, M. R. AU - Maslov, A. AU - Golden, A. AU - Montagna, C. DB - Embase DO - 10.1158/1557-3265.PMSCLINGEN15-15 IS - 1 LA - English M3 - Conference Abstract N1 - L624072536 2018-10-02 PY - 2016 SN - 1557-3265 ST - Target next sequencing profiling of pediatric solid tumors: Potential use for the identification of actionable mutations T2 - Clinical Cancer Research TI - Target next sequencing profiling of pediatric solid tumors: Potential use for the identification of actionable mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L624072536&from=exporthttp://dx.doi.org/10.1158/1557-3265.PMSCLINGEN15-15 VL - 22 ID - 7995 ER - TY - JOUR AD - Department of Paediatrics, Institut Gustave Roussy, University Paris-XI, 39 Rue Camille Desmoulins, 94805 Villejuif, France Children's Hospital, Steelhouse Lane, B4 6NH Birmingham, United Kingdom Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif; University Paris-XI, 39 Rue Camille Desmoulins, France Paediatrics, Institut Curie, 26 Rue d'Ulm, 75248 Paris cedex 05, France CHU Cochin Port Royal, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France CHU Fondation Lenval, 57 Avenue de la Californie, 06000 Nice, France Centre Oscar Lambret, 3 Rue Frederic Combemale, BP 307, 59020 Lille, France Centre Léon Bérard, 28 Rue Laennec, 69373 Lyon, France EA3035 Institut Claudius-Regaud, 31052 Toulouse, France UMR8121, Vectorology and Gene Transfer, Institut Gustave Roussy, 39 Rue Camille Desmoulins, Villejuif, France University College Hospital, 235 Euston Road, NW1 2BU London, United Kingdom CHU Nantes, 50 Route St Sebastien sur Loire, 44093 Nantes, France Pathology Departments, Institut Gustave Roussy, 39 Rue Camille Desmoulins, Villejuif, France Department of Pathology, Centre Ambroise Pare, 9 Avenue Charles de Gaulle, 92104 Boulogne, France Novartis Pharma AG, Lichtstrasse 35, Basel, CH-4002, Switzerland AU - Geoerger, B. AU - Morland, B. AU - Ndiaye, A. AU - Doz, F. AU - Kalifa, G. AU - Geoffray, A. AU - Pichon, F. AU - Frappaz, D. AU - Chatelut, E. AU - Opolon, P. AU - Hain, S. AU - Boderet, F. AU - Bosq, J. AU - Emile, J. F. AU - Deley, M. C. L. AU - Capdeville, R. AU - Vassal, G. DB - Scopus DO - 10.1016/j.ejca.2009.03.007 IS - 13 M3 - Article N1 - Cited By :38 Export Date: 18 November 2020 PY - 2009 SP - 2342-2351 ST - Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium T2 - European Journal of Cancer TI - Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949170337&doi=10.1016%2fj.ejca.2009.03.007&partnerID=40&md5=8e0e2a2035f989783d5462ec9c332bab VL - 45 ID - 7996 ER - TY - JOUR AD - L. Moreno, Royal Marsden NHS Foundation Trust, Children and Young People's Unit, Sutton, Surrey, United Kingdom AU - Hirsch, S. AU - Marshall, L. V. AU - Carceller Lechon, F. AU - Pearson, A. D. J. AU - Moreno, L. DB - Embase Medline DO - 10.1517/17460441.2015.1025745 IS - 5 LA - English M3 - Review N1 - L604003033 2015-04-30 2015-05-18 PY - 2015 SN - 1746-045X 1746-0441 SP - 483-495 ST - Targeted approaches to childhood cancer: Progress in drug discovery and development T2 - Expert Opinion on Drug Discovery TI - Targeted approaches to childhood cancer: Progress in drug discovery and development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604003033&from=exporthttp://dx.doi.org/10.1517/17460441.2015.1025745 VL - 10 ID - 7997 ER - TY - JOUR AD - A.K. Olow, University of California, San Francisco, CA, United States AU - Olow, A. K. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Meyerowitz, J. AU - Weiss, W. AU - Resnick, A. C. AU - Waanders, A. J. AU - Berger, M. S. AU - Gupta, N. AU - James, C. D. AU - Haas-Kogan, D. A. DB - Embase DO - 10.1093/neuonc/nov061.153 LA - English M3 - Conference Abstract N1 - L72189181 2016-02-19 PY - 2015 SN - 1522-8517 SP - iii38 ST - Targeted combinatorial approach for treatment of pediatric low grade gliomas in the context of BRAFV600E and KIAA1549:BRAF mutations T2 - Neuro-Oncology TI - Targeted combinatorial approach for treatment of pediatric low grade gliomas in the context of BRAFV600E and KIAA1549:BRAF mutations UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72189181&from=exporthttp://dx.doi.org/10.1093/neuonc/nov061.153 VL - 17 ID - 7998 ER - TY - JOUR AD - J. Xia, Department of Chemistry, Chinese University of Hong Kong, Shatin, Hong Kong AU - Yu, Y. AU - Nie, Y. AU - Feng, Q. AU - Qu, J. AU - Wang, R. AU - Bian, L. AU - Xia, J. DB - Embase Medline DO - 10.1021/acs.molpharmaceut.6b00952 IS - 5 LA - English M3 - Article N1 - L615770242 2017-05-08 2017-05-11 PY - 2017 SN - 1543-8392 1543-8384 SP - 1548-1557 ST - Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells T2 - Molecular Pharmaceutics TI - Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615770242&from=exporthttp://dx.doi.org/10.1021/acs.molpharmaceut.6b00952 VL - 14 ID - 7999 ER - TY - JOUR AD - Texas Scottish Rite Hospital for Children, 2222 Welborn Street, Dallas, TX 75219, United States Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States Department of Pathology, Division of Biological Sciences, University of California San Diego, San Diego, CA, United States Department of Biochemistry, Rush University Medical Center, Chicago, IL, United States Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States AU - Kim, H. K. W. AU - Feng, G. S. AU - Chen, D. AU - King, P. D. AU - Kamiya, N. DB - Scopus DO - 10.1002/jbmr.2062 IS - 3 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2014 SP - 761-769 ST - Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions T2 - Journal of Bone and Mineral Research TI - Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888875580&doi=10.1002%2fjbmr.2062&partnerID=40&md5=44254d2bc5e53f9008e980a3c87107bc VL - 29 ID - 8000 ER - TY - JOUR AD - J.A. Lake, Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, United States AU - Lake, J. A. AU - Donson, A. M. AU - Prince, E. AU - Davies, K. D. AU - Nellan, A. AU - Green, A. L. AU - Mulcahy Levy, J. AU - Dorris, K. AU - Vibhakar, R. AU - Hankinson, T. C. AU - Foreman, N. K. AU - Ewalt, M. D. AU - Kleinschmidt-DeMasters, B. K. AU - Hoffman, L. M. AU - Gilani, A. DB - Embase Medline DO - 10.1002/pbc.28028 IS - 1 LA - English M3 - Article N1 - L2003447825 2019-10-31 PY - 2020 SN - 1545-5017 1545-5009 ST - Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors T2 - Pediatric Blood and Cancer TI - Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003447825&from=exporthttp://dx.doi.org/10.1002/pbc.28028 VL - 67 ID - 8001 ER - TY - JOUR AD - POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. asingh@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. asingh@ucalgary.ca. POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. ruan@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. ruan@ucalgary.ca. Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. trippet1@MSKCC.org. POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada. a.narendran@ucalgary.ca. Division of Pediatric Oncology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. a.narendran@ucalgary.ca. AN - 26384788 AU - Singh, A. AU - Ruan, Y. AU - Tippett, T. AU - Narendran, A. C2 - PMC4575431 DA - Sep 18 DO - 10.1186/s13046-015-0222-x 10.1186/s13046-015-0222-x. DP - Nlm ET - 2015/09/20 IS - 1 LA - eng PY - 2015 SN - 0392-9078 (Print) 0392-9078 SP - 104 ST - Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells T2 - J Exp Clin Cancer Res TI - Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells VL - 34 ID - 8002 ER - TY - JOUR AD - Department of Pathology, University of Texas Southwestern Medical Center Department of Pathology and Laboratory Medicine, Children's Health Department of Pediatrics, University of Texas Southwestern Medical Center Department of Pediatrics, Children's Health Department of Radiology, University of Texas Southwestern Medical Center Department of Radiology, Children's Health Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas AN - 28784858 AU - Drobysheva, A. AU - Klesse, L. J. AU - Bowers, D. C. AU - Rajaram, V. AU - Rakheja, D. AU - Timmons, C. F. AU - Wang, J. AU - Koral, K. AU - Gargan, L. AU - Ramos, E. AU - Park, J. Y. DA - Aug DO - 10.6004/jnccn.2017.0139 10.6004/jnccn.2017.0139. DP - Nlm ET - 2017/08/09 IS - 8 LA - eng PY - 2017 SN - 1540-1405 SP - 978-982 ST - Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas T2 - J Natl Compr Canc Netw TI - Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas VL - 15 ID - 8003 ER - TY - JOUR AD - V. Subbiah, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Subbiah, V. AU - Naing, A. AU - Brown, R. E. AU - Chen, H. AU - Doyle, L. AU - LoRusso, P. AU - Benjamin, R. AU - Anderson, P. AU - Kurzrock, R. C1 - imc a12(Imclone,United States) r 1507(Hoffmann La Roche,United States) sch 717454(Schering,United States) C2 - Hoffmann La Roche(United States) Imclone(United States) Schering(United States) DB - Embase Medline DO - 10.1371/journal.pone.0018424 IS - 4 L1 - internal-pdf://1823089412/journal.pone.0018424.PDF LA - English M3 - Article N1 - L361565151 2011-04-14 2011-04-18 PY - 2011 SN - 1932-6203 ST - Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures T2 - PLoS ONE TI - Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures UR - https://www.embase.com/search/results?subaction=viewrecord&id=L361565151&from=exporthttp://dx.doi.org/10.1371/journal.pone.0018424 VL - 6 ID - 8004 ER - TY - JOUR AD - M.J. Kwon, Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, 22, Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea AU - Park, H. Y. AU - Kwon, M. J. AU - Kang, H. S. AU - Kim, Y. J. AU - Kim, N. Y. AU - Kim, M. J. AU - Min, K. W. AU - Choi, K. C. AU - Nam, E. S. AU - Cho, S. J. AU - Park, H. R. AU - Min, S. K. AU - Seo, J. AU - Choe, J. Y. AU - Lee, H. K. DB - Embase Medline DO - 10.1016/j.humpath.2019.02.007 LA - English M3 - Article N1 - L2001796467 2019-04-16 2019-04-18 PY - 2019 SN - 1532-8392 0046-8177 SP - 83-94 ST - Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets T2 - Human Pathology TI - Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001796467&from=exporthttp://dx.doi.org/10.1016/j.humpath.2019.02.007 VL - 87 ID - 8005 ER - TY - JOUR AD - C. Lechler, Department of Medicine II, Klinikum rechts Der Isar, Technische Universitat Munchen, Munich, Germany AU - Lechler, C. AU - Dong, S. AU - Rosner, T. AU - Manmadhan, S. AU - Kohnke-Ertel, B. AU - Steiger, K. AU - Schmid, R. M. AU - Ehmer, U. AU - Sage, J. DB - Embase DO - 10.1055/s-0038-1677213 IS - 1 LA - English M3 - Conference Abstract N1 - L627523866 2019-05-14 PY - 2019 SN - 1439-7803 SP - e63 ST - A targeted screen to identify relevant oncogenes in RAS activated liver cancer T2 - Zeitschrift fur Gastroenterologie TI - A targeted screen to identify relevant oncogenes in RAS activated liver cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627523866&from=exporthttp://dx.doi.org/10.1055/s-0038-1677213 VL - 57 ID - 8006 ER - TY - JOUR AD - E. Lowe, Children's Hospital of The King's Daughters, Norfolk, VA, United States AU - Lowe, E. DB - Embase DO - 10.1111/bjh.13753 LA - English M3 - Conference Abstract N1 - L72231328 2016-04-13 PY - 2015 SN - 0007-1048 SP - 19-20 ST - Targeted therapeutic approaches in anaplastic large cell lymphoma T2 - British Journal of Haematology TI - Targeted therapeutic approaches in anaplastic large cell lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72231328&from=exporthttp://dx.doi.org/10.1111/bjh.13753 VL - 171 ID - 8007 ER - TY - JOUR AD - A.C. Xavier, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Children’s Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL, United States AU - Sorge, C. E. AU - McDaniel, J. K. AU - Xavier, A. C. C1 - pxd 101 DB - Embase DO - 10.3390/ph9020028 IS - 2 LA - English M3 - Review N1 - L610612294 2016-06-14 2016-06-20 PY - 2016 SN - 1424-8247 ST - Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: Present and future T2 - Pharmaceuticals TI - Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: Present and future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610612294&from=exporthttp://dx.doi.org/10.3390/ph9020028 VL - 9 ID - 8008 ER - TY - JOUR AD - K.D. Burman, Division of Endocrinology, Department of 41 Medicine, MedStar Washington Hospital Center, 110 Irving Street Northwest, Washington, DC, United States AU - Bikas, A. AU - Vachhani, S. AU - Jensen, K. AU - Vasko, V. AU - Burman, K. D. DB - Embase DO - 10.1080/17512433.2016.1204230 IS - 10 LA - English M3 - Review N1 - L612316838 2016-09-28 2016-11-02 PY - 2016 SN - 1751-2441 1751-2433 SP - 1299-1313 ST - Targeted therapies in thyroid cancer: an extensive review of the literature T2 - Expert Review of Clinical Pharmacology TI - Targeted therapies in thyroid cancer: an extensive review of the literature UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612316838&from=exporthttp://dx.doi.org/10.1080/17512433.2016.1204230 VL - 9 ID - 8009 ER - TY - JOUR AD - Murdoch Children's Research Institute, Royal Children's Hospital, Parkville Australia Department of Paediatrics, University of Melbourne, Parkville Australia School of BioSciences, University of Melbourne, Parkville Australia Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville Australia Children's Cancer Centre, Royal Children's Hospital, Parkville Australia Walter and Eliza Hall Institute, Parkville Australia Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville Australia Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia Department of Paediatrics, University of Melbourne, Parkville, Australia Children's Cancer Centre, Royal Children's Hospital, Parkville, Australia AN - 138225095. Language: English. Entry Date: 20200131. Revision Date: 20200930. Publication Type: journal article AU - Brown, Lauren M. AU - Bartolo, Ray C. AU - Davidson, Nadia M. AU - Schmidt, Breon AU - Brooks, Ian AU - Challis, Jackie AU - Petrovic, Vida AU - Khuong‐Quang, Dong‐Anh AU - Mechinaud, Francoise AU - Khaw, Seong L. AU - Majewski, Ian J. AU - Oshlack, Alicia AU - Ekert, Paul G. AU - Khuong-Quang, Dong-Anh DB - ccm DO - 10.1002/pbc.27897 DP - EBSCOhost IS - 10 N1 - research. Journal Subset: Biomedical; Peer Reviewed; USA. Grant Information: //Felton Bequest/. NLM UID: 101186624. PMID: NLM31250523. PY - 2019 SN - 1545-5009 SP - N.PAG-N.PAG ST - Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia T2 - Pediatric Blood & Cancer TI - Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138225095&site=ehost-live&scope=site VL - 66 ID - 8010 ER - TY - JOUR AD - University of California, San Francisco, San Francisco, CA 94158, USA. AN - 22038996 AU - Nicolaides, T. P. AU - Li, H. AU - Solomon, D. A. AU - Hariono, S. AU - Hashizume, R. AU - Barkovich, K. AU - Baker, S. J. AU - Paugh, B. S. AU - Jones, C. AU - Forshew, T. AU - Hindley, G. F. AU - Hodgson, J. G. AU - Kim, J. S. AU - Rowitch, D. H. AU - Weiss, W. A. AU - Waldman, T. A. AU - James, C. D. C2 - PMC3638050 C6 - NIHMS334979 constituting conflicts) at the time of submission. DA - Dec 15 DO - 10.1158/1078-0432.Ccr-11-1456 10.1158/1078-0432.CCR-11-1456. Epub 2011 Oct 28. DP - Nlm ET - 2011/11/01 IS - 24 LA - eng PY - 2011 SN - 1078-0432 (Print) 1078-0432 SP - 7595-604 ST - Targeted therapy for BRAFV600E malignant astrocytoma T2 - Clin Cancer Res TI - Targeted therapy for BRAFV600E malignant astrocytoma VL - 17 ID - 8011 ER - TY - JOUR AD - P.G. Gibson, John Hunter Hospital, Newcastle, NSW, Australia AU - Gibson, P. G. AU - Peters, M. J. AU - Wainwright, C. E. DB - Embase Medline DO - 10.5694/mja16.00731 IS - 3 LA - English M3 - Review N1 - L620162556 2018-01-22 2018-01-25 PY - 2017 SN - 1326-5377 0025-729X SP - 136-140 ST - Targeted therapy for chronic respiratory disease: A new paradigm T2 - Medical Journal of Australia TI - Targeted therapy for chronic respiratory disease: A new paradigm UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620162556&from=exporthttp://dx.doi.org/10.5694/mja16.00731 VL - 206 ID - 8012 ER - TY - JOUR AD - German Cancer Consortium (DKTK), Germany. AN - 24166094 AU - Schulte, J. H. AU - Schulte, S. AU - Heukamp, L. C. AU - Astrahantseff, K. AU - Stephan, H. AU - Fischer, M. AU - Schramm, A. AU - Eggert, A. DA - Nov DO - 10.1055/s-0033-1357132 10.1055/s-0033-1357132. Epub 2013 Oct 28. DP - Nlm ET - 2013/10/30 IS - 6 LA - eng PY - 2013 SN - 0300-8630 SP - 303-8 ST - Targeted Therapy for Neuroblastoma: ALK Inhibitors T2 - Klin Padiatr TI - Targeted Therapy for Neuroblastoma: ALK Inhibitors VL - 225 ID - 8013 ER - TY - JOUR AD - E. Bouffet, Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada AU - Kilday, J. P. AU - Bartels, U. K. AU - Bouffet, E. C1 - azd 6244 mk 2206 DB - Embase Medline DO - 10.1007/s11910-014-0441-0 IS - 4 LA - English M3 - Review N1 - L53040742 2014-03-13 2019-12-20 PY - 2014 SN - 1534-6293 1528-4042 ST - Targeted therapy in pediatric low-grade glioma T2 - Current Neurology and Neuroscience Reports TI - Targeted therapy in pediatric low-grade glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L53040742&from=exporthttp://dx.doi.org/10.1007/s11910-014-0441-0 VL - 14 ID - 8014 ER - TY - JOUR AD - K. Katsibardi, Aghia Sophia Children's Hospital, Paediatric Haematology Oncology, Athens, Greece AU - Katsibardi, K. AU - Tourkantoni, N. AU - Roka, K. AU - Avgerinou, G. AU - Filippidou, M. AU - Tsipou, H. AU - Kattamis, A. DB - Embase DO - 10.1002/pbc.26233 LA - English M3 - Conference Abstract N1 - L612593203 2016-11-11 PY - 2016 SN - 1545-5017 SP - S180-S181 ST - Targeted therapy with brentuximab vedotin as a bridge to bone marrow transplantation in children with relapsed anaplastic lymphoma T2 - Pediatric Blood and Cancer TI - Targeted therapy with brentuximab vedotin as a bridge to bone marrow transplantation in children with relapsed anaplastic lymphoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612593203&from=exporthttp://dx.doi.org/10.1002/pbc.26233 VL - 63 ID - 8015 ER - TY - JOUR AD - Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Computational Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. phil.potter@stjude.org. AN - 29855693 AU - Wierdl, M. AU - Tsurkan, L. AU - Chi, L. AU - Hatfield, M. J. AU - Tollemar, V. AU - Bradley, C. AU - Chen, X. AU - Qu, C. AU - Potter, P. M. C2 - PMC6054567 C6 - NIHMS971365 DA - Aug DO - 10.1007/s00280-018-3615-7 10.1007/s00280-018-3615-7. Epub 2018 May 31. DP - Nlm ET - 2018/06/02 IS - 2 LA - eng PY - 2018 SN - 0344-5704 (Print) 0344-5704 SP - 251-263 ST - Targeting ALK in pediatric RMS does not induce antitumor activity in vivo T2 - Cancer Chemother Pharmacol TI - Targeting ALK in pediatric RMS does not induce antitumor activity in vivo VL - 82 ID - 8016 ER - TY - JOUR AD - Yael P. Mossé, Megan S. Lim, Delphine Rolland, Elizabeth Fox, and Peter Adamson, University of Pennsylvania, Philadelphia, PA; Stephan D. Voss, Harvard Medical School, Boston, MA; Charles G. Minard and Susan M. Blaney, Baylor College of Medicine, Houston, TX; Keith Wilner, Pfizer Oncology, La Jolla, CA; and Brenda J. Weigel, University of Minnesota Cancer Center, Minneapolis, MN. AN - 28787259 AU - Mossé, Y. P. AU - Voss, S. D. AU - Lim, M. S. AU - Rolland, D. AU - Minard, C. G. AU - Fox, E. AU - Adamson, P. AU - Wilner, K. AU - Blaney, S. M. AU - Weigel, B. J. C2 - PMC5617123 DA - Oct 1 DO - 10.1200/jco.2017.73.4830 10.1200/JCO.2017.73.4830. Epub 2017 Aug 8. DP - Nlm ET - 2017/08/09 IS - 28 LA - eng PY - 2017 SN - 0732-183X (Print) 0732-183x SP - 3215-3221 ST - Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study T2 - J Clin Oncol TI - Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study VL - 35 ID - 8017 ER - TY - JOUR AD - R. Salgia, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637, United States AU - La Madrid, A. M. AU - Campbell, N. AU - Smith, S. AU - Cohn, S. L. AU - Salgia, R. C1 - 17 AAG ap 26113 asp 3026(Astellas) cep 28122(Cephalon) ch 5424802(Chugai) crl 151104a ipi 204 ldk 378 pf 03446962 sta 9090 tae 684 C2 - Astellas Cephalon Chugai DB - Embase Medline DO - 10.1007/s11523-012-0227-8 IS - 3 LA - English M3 - Review N1 - L52205203 2012-09-15 2019-07-22 PY - 2012 SN - 1776-260X 1776-2596 SP - 199-210 ST - Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma T2 - Targeted Oncology TI - Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52205203&from=exporthttp://dx.doi.org/10.1007/s11523-012-0227-8 VL - 7 ID - 8018 ER - TY - JOUR AD - B. Hallberg, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden AU - Umapathy, G. AU - Mendoza-Garcia, P. AU - Hallberg, B. AU - Palmer, R. H. C1 - nvp tae 684 DB - Embase Medline DO - 10.1111/apm.12940 IS - 5 LA - English M3 - Review N1 - L627061362 2019-04-09 2019-06-17 PY - 2019 SN - 1600-0463 0903-4641 SP - 288-302 ST - Targeting anaplastic lymphoma kinase in neuroblastoma T2 - APMIS TI - Targeting anaplastic lymphoma kinase in neuroblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L627061362&from=exporthttp://dx.doi.org/10.1111/apm.12940 VL - 127 ID - 8019 ER - TY - JOUR AD - Inserm, UMR1037 CRCT, F-31000 Toulouse, France. Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France. CNRS, ERL5294 CRCT, F-31000 Toulouse, France. Phenotyping Service, INSERM-US006 ANEXPLO/CREFRE, Toulouse, France. Université Toulouse III - Paul Sabatier, Toulouse, France. INSERM/UPS - US006/CREFRE, Service d'Histopathologie, CHU Purpan, Toulouse, France. INSERM UMRS 1185, Faculté de Médecine Paris Sud, Le Kremlin-Bicêtre, France. Department of Pathology, IUCT, Toulouse, France. European Research Initiative on ALK-related malignancies (ERIA). Institut Necker Enfants-Malades, INSERM U1151-CNRS UMR 8253, Paris, France. AN - 26338968 AU - Mitou, G. AU - Frentzel, J. AU - Desquesnes, A. AU - Le Gonidec, S. AU - AlSaati, T. AU - Beau, I. AU - Lamant, L. AU - Meggetto, F. AU - Espinos, E. AU - Codogno, P. AU - Brousset, P. AU - Giuriato, S. C2 - PMC4745787 DA - Oct 6 DO - 10.18632/oncotarget.4999 10.18632/oncotarget.4999. DP - Nlm ET - 2015/09/05 IS - 30 LA - eng PY - 2015 SN - 1949-2553 SP - 30149-64 ST - Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma T2 - Oncotarget TI - Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma VL - 6 ID - 8020 ER - TY - JOUR AD - From the Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA. AN - 24857135 AU - Kieran, M. W. DO - 10.14694/EdBook_AM.2014.34.e436 10.14694/EdBook_AM.2014.34.e436. DP - Nlm ET - 2014/05/27 LA - eng PY - 2014 SN - 1548-8748 SP - e436-40 ST - Targeting BRAF in pediatric brain tumors T2 - Am Soc Clin Oncol Educ Book TI - Targeting BRAF in pediatric brain tumors ID - 8021 ER - TY - JOUR AD - A. Sukhanova, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, United States AU - Sukhanova, A. AU - Gorin, A. AU - Serebriiskii, I. G. AU - Gabitova, L. AU - Zheng, H. AU - Restifo, D. AU - Egleston, B. L. AU - Cunningham, D. AU - Bagnyukova, T. AU - Liu, H. AU - Nikonova, A. AU - Adams, G. P. AU - Zhou, Y. AU - Yang, D. H. AU - Mehra, R. AU - Burtness, B. AU - Cai, K. Q. AU - Klein-Szanto, A. AU - Kratz, L. E. AU - Kelley, R. I. AU - Weiner, L. M. AU - Herman, G. E. AU - Golemis, E. A. AU - Astsaturov, I. C1 - cpt 11 ly 294022 u 0126 C2 - Fox DB - Embase Medline DO - 10.1158/2159-8290.CD-12-0031 IS - 1 LA - English M3 - Article N1 - L368187371 2013-02-01 2013-02-07 PY - 2013 SN - 2159-8274 2159-8290 SP - 96-112 ST - Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation T2 - Cancer Discovery TI - Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368187371&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-12-0031http://cancerdiscovery.aacrjournals.org/content/3/1/96.full.pdf+html VL - 3 ID - 8022 ER - TY - JOUR AD - Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China. Basic Medical School, Wuhan University, Wuhan, China. Institute of Model Animal of Wuhan University, Wuhan, China. Medical Research Institute, School of Medicine, Wuhan University, Wuhan, China. College of Life Sciences, Wuhan University, Wuhan, China. Division of Cardiothoracic and Vascular Surgery, Heart-Lung Transplantation Center, Sino-Swiss Heart-Lung Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Biomedical Engineering Department, Huazhong University of Science and Technology, Wuhan, China. AN - 28218919 AU - Wang, P. X. AU - Ji, Y. X. AU - Zhang, X. J. AU - Zhao, L. P. AU - Yan, Z. Z. AU - Zhang, P. AU - Shen, L. J. AU - Yang, X. AU - Fang, J. AU - Tian, S. AU - Zhu, X. Y. AU - Gong, J. AU - Zhang, X. AU - Wei, Q. F. AU - Wang, Y. AU - Li, J. AU - Wan, L. AU - Xie, Q. AU - She, Z. G. AU - Wang, Z. AU - Huang, Z. AU - Li, H. DA - Apr DO - 10.1038/nm.4290 10.1038/nm.4290. Epub 2017 Feb 20. DP - Nlm ET - 2017/02/22 IS - 4 LA - eng PY - 2017 SN - 1078-8956 SP - 439-449 ST - Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates T2 - Nat Med TI - Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates VL - 23 ID - 8023 ER - TY - JOUR AD - Department of Pediatrics, University of California San Diego (UCSD), Rady Children's Hospital, San Diego, CA, United States Department of Internal Medicine III, University Hospital, RWTH-Aachen, Germany Yale University, West Haven Veterans Medical Center, New Haven, CT, United States AU - Wree, A. AU - Mehal, W. Z. AU - Feldstein, A. E. DB - Scopus DO - 10.1055/s-0035-1571272 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2016 SP - 27-36 ST - Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis T2 - Seminars in Liver Disease TI - Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958178106&doi=10.1055%2fs-0035-1571272&partnerID=40&md5=57287355ddd4e536f6180de1fefe2d68 VL - 36 ID - 8024 ER - TY - JOUR AD - L. Gore, Children's Hospital Colorado, 13123 East 16th Av., Aurora, CO 80045, United States AU - Gore, L. AU - DeGregori, J. AU - Porter, C. C. DB - Embase Medline DO - 10.1016/S1470-2045(12)70530-2 IS - 2 LA - English M3 - Review N1 - L368229223 2013-02-07 2013-02-20 PY - 2013 SN - 1470-2045 1474-5488 SP - e70-e78 ST - Targeting developmental pathways in children with cancer: What price success? T2 - The Lancet Oncology TI - Targeting developmental pathways in children with cancer: What price success? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368229223&from=exporthttp://dx.doi.org/10.1016/S1470-2045(12)70530-2 VL - 14 ID - 8025 ER - TY - JOUR AD - Department of Molecular Biology and Genetics, Gebze Technical University, Kocaeli, Turkey Department of Molecular Biology and Genetics, Istanbul Medeniyet University, Istanbul, Turkey AU - Sagir, F. AU - Demiroglu-Zergeroglu, A. DB - Scopus DO - 10.1515/tjb-2017-0276 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 62-69 ST - Targeting epidermal growth factor receptor pathway with irreversible tyrosine kinase inhibitor T2 - Turkish Journal of Biochemistry TI - Targeting epidermal growth factor receptor pathway with irreversible tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065657486&doi=10.1515%2ftjb-2017-0276&partnerID=40&md5=448599b1095ae993b24a0c65896a088a VL - 44 ID - 8026 ER - TY - JOUR AD - N. Alijaj, University Children's Hospital Zurich, Zurich, Switzerland AU - Alijaj, N. AU - Moutel, S. AU - Gray, M. AU - Roveri, M. AU - Manzella, G. AU - Wachtel, M. AU - Perez, F. AU - Schafer, B. AU - Bernasconi, M. DB - Embase DO - 10.1158/1538-7445.SABCS18-3116 IS - 13 LA - English M3 - Conference Abstract N1 - L628907233 2019-08-20 PY - 2019 SN - 1538-7445 ST - Targeting fibroblast growth factor receptors in rhabdomyosarcoma T2 - Cancer Research TI - Targeting fibroblast growth factor receptors in rhabdomyosarcoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628907233&from=exporthttp://dx.doi.org/10.1158/1538-7445.SABCS18-3116 VL - 79 ID - 8027 ER - TY - JOUR AD - A. Walker, Pediatric Oncology Branch, CCR, NCI, NIH, Bethesda, MD, United States AU - Walker, A. AU - Lopomo, P. AU - Babbitt, W. AU - Vigny, M. AU - Mackall, C. AU - Orentas, R. DB - Embase LA - English M3 - Conference Abstract N1 - L72035916 2015-10-17 PY - 2014 SN - 2051-1426 ST - Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246) T2 - Journal for ImmunoTherapy of Cancer TI - Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72035916&from=export VL - 2 ID - 8028 ER - TY - JOUR AD - K.M. Shannon AU - Shannon, K. M. DB - Embase DO - 10.1158/1538-7445.PEDCA15-IA20 IS - 5 LA - English M3 - Conference Abstract N1 - L613568437 2016-12-13 PY - 2016 SN - 1538-7445 ST - Targeting hyperactive Ras signaling in acute leukemia T2 - Cancer Research TI - Targeting hyperactive Ras signaling in acute leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613568437&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCA15-IA20 VL - 76 ID - 8029 ER - TY - JOUR AD - Division of Hematology-Medical Oncology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. AN - 12512384 AU - Beeram, M. AU - Patnaik, A. DA - Oct DO - 10.1016/s0889-8588(02)00054-0 10.1016/s0889-8588(02)00054-0. DP - Nlm ET - 2003/01/07 IS - 5 LA - eng PY - 2002 SN - 0889-8588 (Print) 0889-8588 SP - 1089-100 ST - Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics T2 - Hematol Oncol Clin North Am TI - Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics VL - 16 ID - 8030 ER - TY - JOUR AD - Clinical Medicine, Guizhou Medical University, Guiyang, 550004, China Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China Department of Hematology, Guizhou Provincial Laboratory of Hematopoietic Stem Cell Transplantation Center, Guiyang, 550004, China Department of Pharmacy, The Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang, 550004, China Department of Hematology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China AU - Lin, X. AU - Zou, X. AU - Wang, Z. AU - Fang, Q. AU - Chen, S. AU - Huang, J. AU - Zhe, N. AU - Yu, M. AU - Zhang, Y. AU - Wang, J. DB - Scopus DO - 10.18632/oncotarget.10725 IS - 33 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - 53679-53701 ST - Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL T2 - Oncotarget TI - Targeting of Heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84982267351&doi=10.18632%2foncotarget.10725&partnerID=40&md5=1e1a24de2a56038127301396cc717bce VL - 7 ID - 8031 ER - TY - JOUR AD - Department of Paediatrics, Section of Haematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver School of Medicine, Aurora, CO, United States AU - Lee-Sherick, A. B. AU - Linger, R. M. A. AU - Gore, L. AU - Keating, A. K. AU - Graham, D. K. DB - Scopus DO - 10.1111/j.1365-2141.2010.08282.x IS - 4 M3 - Review N1 - Cited By :34 Export Date: 18 November 2020 PY - 2010 SP - 295-311 ST - Targeting paediatric acute lymphoblastic leukaemia: Novel therapies currently in development T2 - British Journal of Haematology TI - Targeting paediatric acute lymphoblastic leukaemia: Novel therapies currently in development UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958542555&doi=10.1111%2fj.1365-2141.2010.08282.x&partnerID=40&md5=737c5e583e732e48b0464183965b6765 VL - 151 ID - 8032 ER - TY - JOUR AD - A.K. Olow AU - Olow, A. K. AU - Mueller, S. AU - Yang, X. AU - Hashizume, R. AU - Weiss, W. AU - Resnick, A. C. AU - Sievert, A. J. AU - Berger, M. S. AU - Gupta, N. AU - James, D. C. AU - Haas-Kogan, D. A. DB - Embase DO - 10.1158/1538-8514.PI3K14-B42 IS - 7 LA - English M3 - Conference Abstract N1 - L616800969 2017-06-20 PY - 2015 SN - 1538-8514 ST - Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas T2 - Molecular Cancer Therapeutics TI - Targeting PI3K in personalized treatment of BRAF-mutated pediatric low-grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L616800969&from=exporthttp://dx.doi.org/10.1158/1538-8514.PI3K14-B42 VL - 14 ID - 8033 ER - TY - JOUR AD - X. Wang, Shanghai Institute of Materia Medica, Shanghai, China AU - Wang, X. AU - Li, B. S. AU - Ding, L. X. AU - Liang, C. AU - Ding, J. AU - Meng, L. H. DB - Embase DO - 10.1158/1538-7445.AM2013-3262 IS - 8 LA - English M3 - Conference Abstract N1 - L71344046 2014-03-01 PY - 2013 SN - 0008-5472 ST - Targeting PI3K-coupled MEK/ERK pathway for therapy in pediatric B-cell acute lymphocytic leukemia T2 - Cancer Research TI - Targeting PI3K-coupled MEK/ERK pathway for therapy in pediatric B-cell acute lymphocytic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71344046&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2013-3262 VL - 73 ID - 8034 ER - TY - JOUR AD - M. Snurdel, Massachusetts General Hospital, Boston, MA, United States AU - Snurdel, M. AU - Batista, A. AU - Kirkpatrick, N. AU - Almodovar, C. AU - Riedemann, L. AU - Peterson, T. AU - Ferrara, N. AU - Klagsbrun, M. AU - Duda, D. G. AU - Fukumura, D. AU - Xu, L. AU - Carmeliet, P. AU - Jain, R. DB - Embase DO - 10.1158/1538-7445.PEDCAN-IA17 IS - 20 LA - English M3 - Conference Abstract N1 - L71713818 2014-12-15 PY - 2014 SN - 0008-5472 ST - Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma T2 - Cancer Research TI - Targeting placental growth factor/ neuropilin-1 pathway inhibits growth and spread of medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713818&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCAN-IA17http://cancerres.aacrjournals.org/content/74/20_Supplement/IA17.abstract?sid=d535fed3-6e06-482c-974a-5f845d36f4b3 VL - 74 ID - 8035 ER - TY - JOUR AD - South-American Office for Anticancer Drug Development (SOAD), Comprehensive Cancer Center, Lutheran University of Brazil, Canoas, RS, Brazil South-American Office for Anticancer Drug Development (SOAD), Comprehensive Cancer Center, Lutheran University of Brazil, Rua Miguel Tostes 101, 92420-280 Canoas, RS, Brazil AU - Da Rocha, A. B. AU - Mans, D. R. A. AU - Regner, A. AU - Schwartsmann, G. DB - Scopus DO - 10.1634/theoncologist.7-1-17 IS - 1 M3 - Review N1 - Cited By :129 Export Date: 18 November 2020 PY - 2002 SP - 17-33 ST - Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? T2 - Oncologist TI - Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036177115&doi=10.1634%2ftheoncologist.7-1-17&partnerID=40&md5=10b96fd23c0256e2dc85f2e0bb8cd5dd VL - 7 ID - 8036 ER - TY - JOUR AD - L.-S. Chang, Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's HospitalandTheOhioStateUniversityCollegeofMedicine, 700Children'sDrive, Columbus, OH, United States AU - Chang, L. S. AU - Oblinger, J. L. AU - Burns, S. S. AU - Huang, J. AU - Anderson, L. W. AU - Hollingshead, M. G. AU - Shen, R. AU - Pan, L. AU - Agarwal, G. AU - Ren, Y. AU - Roberts, R. D. AU - O'Keefe, B. R. AU - Douglas Kinghorn, A. AU - Collins, J. M. DB - Embase Medline DO - 10.1158/1535-7163.MCT-19-0809 IS - 3 LA - English M3 - Article N1 - L2005693370 2020-05-04 2020-07-07 PY - 2020 SN - 1538-8514 1535-7163 SP - 731-741 ST - Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas T2 - Molecular Cancer Therapeutics TI - Targeting protein translation by rocaglamide and didesmethylrocaglamide to treat MPNST and other sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005693370&from=exporthttp://dx.doi.org/10.1158/1535-7163.MCT-19-0809 VL - 19 ID - 8037 ER - TY - JOUR AD - Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Germany. AN - 17584027 AU - Flotho, C. AU - Kratz, C. AU - Niemeyer, C. M. DA - Jun DO - 10.2174/138945007780830773 10.2174/138945007780830773. DP - Nlm ET - 2007/06/23 IS - 6 LA - eng PY - 2007 SN - 1389-4501 SP - 715-25 ST - Targeting RAS signaling pathways in juvenile myelomonocytic leukemia T2 - Curr Drug Targets TI - Targeting RAS signaling pathways in juvenile myelomonocytic leukemia VL - 8 ID - 8038 ER - TY - JOUR AD - Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. Department of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China. Eaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear and Harvard Medical School, Boston, MA 02114. Molecular Pathology Division, Massachusetts General Hospital, Boston, MA 02114. Division of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. Department of Neurology, Massachusetts General Hospital, Boston, MA 02114. Cancer Center, Massachusetts General Hospital, Boston, MA 02114. Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; jain@steele.mgh.harvard.edu lei@steele.mgh.harvard.edu. AN - 29440379 AU - Zhao, Y. AU - Liu, P. AU - Zhang, N. AU - Chen, J. AU - Landegger, L. D. AU - Wu, L. AU - Zhao, F. AU - Zhao, Y. AU - Zhang, Y. AU - Zhang, J. AU - Fujita, T. AU - Stemmer-Rachamimov, A. AU - Ferraro, G. B. AU - Liu, H. AU - Muzikansky, A. AU - Plotkin, S. R. AU - Stankovic, K. M. AU - Jain, R. K. AU - Xu, L. C2 - PMC5834719 DA - Feb 27 DO - 10.1073/pnas.1719966115 10.1073/pnas.1719966115. Epub 2018 Feb 9. DP - Nlm ET - 2018/02/15 IS - 9 LA - eng PY - 2018 SN - 0027-8424 (Print) 0027-8424 SP - E2077-e2084 ST - Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models T2 - Proc Natl Acad Sci U S A TI - Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models VL - 115 ID - 8039 ER - TY - JOUR AD - S.H. Chu, Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States AU - Chu, S. H. AU - Song, E. J. AU - Chabon, J. AU - Minehart, J. AU - Feng, Z. AU - Ross, K. AU - Koche, R. AU - Krivtsov, A. V. AU - Armstrong, S. DB - Embase LA - English M3 - Conference Abstract N1 - L620386002 2018-02-01 PY - 2017 SN - 1528-0020 ST - Targeting the DNA damage response pathway in MLL-rearranged B-acute lymphoblastic leukemias T2 - Blood TI - Targeting the DNA damage response pathway in MLL-rearranged B-acute lymphoblastic leukemias UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620386002&from=export VL - 130 ID - 8040 ER - TY - JOUR AD - M.-E. Halatsch, Department of Neurosurgery, University of Ulm, School of Medicine, Steinhövelstrasse 9, D-89075 Ulm, Germany AU - Merkur, N. AU - Westhoff, M. A. AU - Karpel-Massler, G. AU - Halatsch, M. E. DB - Embase DO - 10.2174/157436212799278034 IS - 1 LA - English M3 - Article N1 - L364958642 2012-06-19 2012-06-20 PY - 2012 SN - 1574-3624 SP - 3-13 ST - Targeting the epidermal growth factor receptor in glioblastoma treatment T2 - Current Signal Transduction Therapy TI - Targeting the epidermal growth factor receptor in glioblastoma treatment UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364958642&from=exporthttp://dx.doi.org/10.2174/157436212799278034 VL - 7 ID - 8041 ER - TY - JOUR AD - D. B. Solit, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States AU - Pratilas, C. A. AU - Solit, D. B. C1 - azd 6244(Astra Zeneca) ci 1040(Pfizer) exelixis nexavar pd 0325901(Pfizer) raf 265(Novartis) C2 - Astra Zeneca Hoffmann La Roche Novartis Pfizer Plexxikon DB - Embase Medline DO - 10.1158/1078-0432.CCR-09-3064 IS - 13 LA - English M3 - Review N1 - L359110829 2010-07-12 2010-07-19 PY - 2010 SN - 1078-0432 1557-3265 SP - 3329-3334 ST - Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response T2 - Clinical Cancer Research TI - Targeting the mitogen-activated protein kinase pathway: Physiological feedback and drug response UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359110829&from=exporthttp://dx.doi.org/10.1158/1078-0432.CCR-09-3064http://clincancerres.aacrjournals.org/content/16/13/3329.full.pdf+html VL - 16 ID - 8042 ER - TY - JOUR AD - L.M. Wagner, Division of Pediatric Hematology/ Oncology, Office C-453, 800 Rose Street, Lexington, KY, United States AU - Wagner, L. M. AU - Adams, V. R. DB - Embase DO - 10.2147/OTT.S124008 LA - English M3 - Review N1 - L615381317 2017-04-24 2017-05-02 PY - 2017 SN - 1178-6930 SP - 2097-2106 ST - Targeting the PD-1 pathway in pediatric solid tumors and brain tumors T2 - OncoTargets and Therapy TI - Targeting the PD-1 pathway in pediatric solid tumors and brain tumors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615381317&from=exporthttp://dx.doi.org/10.2147/OTT.S124008 VL - 10 ID - 8043 ER - TY - JOUR AD - Brody School of Medicine at East Carolina University, Department of Microbiology & Immunology, Greenville, NC 27834, USA. AN - 17465719 AU - Lambert, P. J. AU - Shahrier, A. Z. AU - Whitman, A. G. AU - Dyson, O. F. AU - Reber, A. J. AU - McCubrey, J. A. AU - Akula, S. M. DA - May DO - 10.1517/14728222.11.5.589 10.1517/14728222.11.5.589. DP - Nlm ET - 2007/05/01 IS - 5 LA - eng PY - 2007 SN - 1472-8222 SP - 589-99 ST - Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis T2 - Expert Opin Ther Targets TI - Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis VL - 11 ID - 8044 ER - TY - JOUR AD - Wayne State University School of Medicine, Detroit, MI, United States Cancer Biology Graduate Program, Wayne State University School of Medicine, Detroit, MI, United States Department of Oncology, Wayne State University School of Medicine, Detroit, MI, United States Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, United States Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI, United States AU - Caldwell, J. T. AU - Edwards, H. AU - Buck, S. A. AU - Ge, Y. AU - Taub, J. W. DB - Scopus DO - 10.1002/pbc.25081 IS - 10 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 1767-1773 ST - Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia T2 - Pediatric Blood and Cancer TI - Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908500934&doi=10.1002%2fpbc.25081&partnerID=40&md5=0cf83b1a88243656073118cb84164f57 VL - 61 ID - 8045 ER - TY - JOUR AD - Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, United States Texas Children's Cancer Center, Section on Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States AU - Hsu, D. AU - Shohet, J. M. AU - Kim, E. S. DB - Scopus DO - 10.2174/22115528112019990004 IS - 1 M3 - Review N1 - Export Date: 18 November 2020 PY - 2013 SP - 30-39 ST - Targeting vascular endothelial growth factor in neuroblastoma T2 - Current Angiogenesis TI - Targeting vascular endothelial growth factor in neuroblastoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952995753&doi=10.2174%2f22115528112019990004&partnerID=40&md5=ec5ed1974c115e6f1931c0d625b49e86 VL - 2 ID - 8046 ER - TY - JOUR AD - A. Scott, School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia AU - Scott, A. AU - Harris, A. AU - Thornton, A. AU - Van Der Westhuizen, A. AU - Gillespie, R. DB - Embase DO - 10.1111/ajd.12652 LA - English M3 - Conference Abstract N1 - L615732001 2017-05-03 PY - 2017 SN - 1440-0960 SP - 79 ST - A tattoo pigment reaction in a patient with metastatic melanoma treated with dabrafenib and trametinib T2 - Australasian Journal of Dermatology TI - A tattoo pigment reaction in a patient with metastatic melanoma treated with dabrafenib and trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L615732001&from=exporthttp://dx.doi.org/10.1111/ajd.12652 VL - 58 ID - 8047 ER - TY - JOUR AD - Department of Pediatric Internal Medicine, Cangzhou Central Hospital, Xihuan Middle Street, Yunhe District, Cangzhou city, Hebei Province 061000, China. Electronic address: ZhaoQiuJu_zqj083@163.com. The Orthopedics Department, Cangzhou People's Hospital, No. 7 Qingchi Road, Xinhua District, Cangzhou city, Heibei Province 061500, China. Department of Pediatric Internal Medicine, Cangzhou Central Hospital, Xihuan Middle Street, Yunhe District, Cangzhou city, Hebei Province 061000, China. AN - 30551418 AU - Zhao, Q. AU - Zhao, S. AU - Li, J. AU - Zhang, H. AU - Qian, C. AU - Wang, H. AU - Liu, J. AU - Zhao, Y. DA - Jan DO - 10.1016/j.biopha.2018.10.046 10.1016/j.biopha.2018.10.046. Epub 2018 Nov 16. DP - Nlm ET - 2018/12/16 LA - eng PY - 2019 SN - 0753-3322 SP - 1640-1649 ST - TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway T2 - Biomed Pharmacother TI - TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway VL - 109 ID - 8048 ER - TY - JOUR AD - M. Nishitani, University of Chicago Medical Center, Chicago, IL, United States AU - Nishitani, M. AU - Dolan, P. AU - Gundeti, M. AU - Tonsgard, J. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.464 IS - 1 LA - English M3 - Conference Abstract N1 - L630752940 2020-02-04 PY - 2018 SN - 1098-4275 ST - Teen with neurofibromatosis type 1 presents with large scrotal mass and large tumor burden T2 - Pediatrics TI - Teen with neurofibromatosis type 1 presents with large scrotal mass and large tumor burden UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752940&from=exporthttp://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.464 VL - 142 ID - 8049 ER - TY - JOUR AD - Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States Department of Pathology, Botucatu Medical School, UNESP-Univ. Estadual Paulista, Botucatu, Sao Paulo, Brazil Department of Epidemiology and Biostatistics, Texas A and M University System Health Science Center, College Station, Texas, United States Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, North Carolina, United States AU - Polettini, J. AU - Behnia, F. AU - Taylor, B. D. AU - Saade, G. R. AU - Taylor, R. N. AU - Menon, R. C7 - e0137188 DB - Scopus DO - 10.1371/journal.pone.0137188 IS - 9 M3 - Article N1 - Cited By :57 Export Date: 18 November 2020 PY - 2015 ST - Telomere fragment induced amnion cell senescence: A contributor to parturition? T2 - PLoS ONE TI - Telomere fragment induced amnion cell senescence: A contributor to parturition? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946934889&doi=10.1371%2fjournal.pone.0137188&partnerID=40&md5=d277c2ba69c2bdb03e5c44c21ca9806a VL - 10 ID - 8050 ER - TY - JOUR AD - G. Raverot, Groupement Hospitalier Est, Fédération d'Endocrinologie, Hospices Civils de Lyon, Bron, France AU - Lasolle, H. AU - Cortet, C. AU - Castinetti, F. AU - Cloix, L. AU - Caron, P. AU - Delemer, B. AU - Desailloud, R. AU - Jublanc, C. AU - Lebrun-Frenay, C. AU - Sadoul, J. L. AU - Taillandier, L. AU - Batisse-Lignier, M. AU - Bonnet, F. AU - Bourcigaux, N. AU - Bresson, D. AU - Chabre, O. AU - Chanson, P. AU - Garcia, C. AU - Haissaguerre, M. AU - Reznik, Y. AU - Borot, S. AU - Villa, C. AU - Vasiljevic, A. AU - Gaillard, S. AU - Jouanneau, E. AU - Assié, G. AU - Raverot, G. C1 - adriblastine DB - Embase Medline DO - 10.1530/EJE-16-0979 IS - 6 LA - English M3 - Article N1 - L618093973 2017-09-06 2017-09-13 PY - 2017 SN - 1479-683X 0804-4643 SP - 769-777 ST - Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas T2 - European Journal of Endocrinology TI - Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618093973&from=exporthttp://dx.doi.org/10.1530/EJE-16-0979 VL - 176 ID - 8051 ER - TY - JOUR AD - S.R. Rheingold AU - Rheingold, S. R. AU - Whitlock, J. AU - Tasian, S. K. AU - Teachey, D. T. AU - Borowitz, M. J. AU - Liu, X. AU - Ahern, C. H. AU - Minard, C. AU - Fox, E. AU - Weigel, B. AU - Blaney, S. DB - Embase IS - 15 LA - English M3 - Conference Abstract N1 - L72015824 2015-09-28 PY - 2015 SN - 0732-183X ST - Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A children's oncology group study T2 - Journal of Clinical Oncology TI - Temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukemia (ALL): A children's oncology group study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72015824&from=exporthttp://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10029?sid=a1f9e3a2-0a0d-494c-896f-69f5cc91b53c VL - 33 ID - 8052 ER - TY - JOUR AD - F. Boulad, 1275 York Ave, NY 10065, United States AU - Giulino-Roth, L. AU - Ricafort, R. AU - Kernan, N. A. AU - Small, T. N. AU - Trippett, T. M. AU - Steinherz, P. G. AU - Prockop, S. E. AU - Scaradavou, A. AU - Chiu, M. AU - O'Reilly, R. J. AU - Boulad, F. C1 - vp 16 DB - Embase Medline DO - 10.1002/pbc.24722 IS - 12 LA - English M3 - Article N1 - L52759058 2013-09-06 2013-10-29 PY - 2013 SN - 1545-5009 1545-5017 SP - 2018-2024 ST - Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation T2 - Pediatric Blood and Cancer TI - Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52759058&from=exporthttp://dx.doi.org/10.1002/pbc.24722 VL - 60 ID - 8053 ER - TY - JOUR AD - a Nuffield Department of Orthopaedics; Rheumatology and Musculoskeletal Sciences ; Kennedy Institute of Rheumatology; University of Oxford ; Oxford , UK. AN - 25482829 AU - Giblin, S. P. AU - Midwood, K. S. C2 - PMC4422809 DO - 10.4161/19336918.2014.987587 10.4161/19336918.2014.987587. DP - Nlm ET - 2014/12/09 IS - 1-2 LA - eng PY - 2015 SN - 1933-6918 (Print) 1933-6918 SP - 48-82 ST - Tenascin-C: Form versus function T2 - Cell Adh Migr TI - Tenascin-C: Form versus function VL - 9 ID - 8054 ER - TY - JOUR AD - 1Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. 2Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 3Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. 4Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 5Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. 6Department of Internal Medicine, Kuma Hospital, Kobe, Japan. 7Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan. 8Department of Surgery, Kuma Hospital, Kobe, Japan. 9Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. AN - 31286848 AU - Tanaka, A. AU - Matsuse, M. AU - Saenko, V. AU - Nakao, T. AU - Yamanouchi, K. AU - Sakimura, C. AU - Yano, H. AU - Nishihara, E. AU - Hirokawa, M. AU - Suzuki, K. AU - Miyauchi, A. AU - Eguchi, S. AU - Yoshiura, K. I. AU - Yamashita, S. AU - Nagayasu, T. AU - Mitsutake, N. DA - Aug DO - 10.1089/thy.2018.0695 10.1089/thy.2018.0695. Epub 2019 Aug 5. DP - Nlm ET - 2019/07/10 IS - 8 LA - eng PY - 2019 SN - 1050-7256 SP - 1105-1114 ST - TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas T2 - Thyroid TI - TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas VL - 29 ID - 8055 ER - TY - JOUR AD - L. Gabler, Department of Medicine I, Institute of Cancer Research, Medical University, Vienna, Austria AU - Gabler, L. AU - Gojo, J. AU - Lötsch, D. AU - Kirchhofer, D. AU - Van Schoonhoven, S. AU - Stojanovic, M. AU - Schmidt, H. M. AU - Ensle, D. AU - Czech, T. AU - Haberler, C. AU - Slavc, I. AU - Spiegl-Kreinecker, S. AU - Berger, W. DB - Embase DO - 10.1093/neuonc/noy139 LA - English M3 - Conference Abstract N1 - L628239666 2019-06-28 PY - 2018 SN - 1523-5866 SP - iii290 ST - TERT promoter mutation-driven TERT activation is mediated by ETS1 in BRAF V600E mutated glioma T2 - Neuro-Oncology TI - TERT promoter mutation-driven TERT activation is mediated by ETS1 in BRAF V600E mutated glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628239666&from=exporthttp://dx.doi.org/10.1093/neuonc/noy139 VL - 20 ID - 8056 ER - TY - JOUR AD - Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, PO-Box 2040, 3000 CA, Rotterdam, The Netherlands. AN - 25035100 AU - Dubbink, H. J. AU - Bakels, H. AU - Post, E. AU - Zwarthoff, E. C. AU - Verdijk, R. M. DA - Nov DO - 10.1007/s11060-014-1553-8 10.1007/s11060-014-1553-8. Epub 2014 Jul 18. DP - Nlm ET - 2014/07/19 IS - 2 LA - eng PY - 2014 SN - 0167-594x SP - 267-72 ST - TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors T2 - J Neurooncol TI - TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors VL - 120 ID - 8057 ER - TY - JOUR AD - Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, USA. Département de BioPathologie, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH-8091 Zurich, Switzerland. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, USA. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. AN - 26061100 AU - Lee, S. AU - Barnhill, R. L. AU - Dummer, R. AU - Dalton, J. AU - Wu, J. AU - Pappo, A. AU - Bahrami, A. C2 - PMC4462090 DA - Jun 10 DO - 10.1038/srep11200 10.1038/srep11200. DP - Nlm ET - 2015/06/11 LA - eng PY - 2015 SN - 2045-2322 SP - 11200 ST - TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms T2 - Sci Rep TI - TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms VL - 5 ID - 8058 ER - TY - JOUR AD - Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Electronic address: revita@naver.com. Department of Pathology, Gang Nam Severance Hospital, Yonsei University, Seoul 135-720, South Korea. Electronic address: soonwonh@yuhs.ac. AN - 24745617 AU - Kim, Y. H. AU - Choi, S. E. AU - Yoon, S. O. AU - Hong, S. W. DA - Jul DO - 10.1016/j.humpath.2014.02.025 10.1016/j.humpath.2014.02.025. Epub 2014 Mar 14. DP - Nlm ET - 2014/04/22 IS - 7 LA - eng PY - 2014 SN - 0046-8177 SP - 1483-8 ST - A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma T2 - Hum Pathol TI - A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma VL - 45 ID - 8059 ER - TY - JOUR AD - Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, 63000, France UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France Department of Laboratories, Seattle Children's Hospital, University of Washington Medical Center, Seattle, WA, United States Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States AU - Penault-Llorca, F. AU - Rudzinski, E. R. AU - Sepulveda, A. R. DB - Scopus DO - 10.1136/jclinpath-2018-205679 IS - 7 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2019 SP - 460-467 ST - Testing algorithm for identification of patients with TRK fusion cancer T2 - Journal of Clinical Pathology TI - Testing algorithm for identification of patients with TRK fusion cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065572475&doi=10.1136%2fjclinpath-2018-205679&partnerID=40&md5=b6a140852ae144f378ffc20bcaedcd13 VL - 72 ID - 8060 ER - TY - JOUR AD - H. Li, Cardiovascular Research Institute, Wuhan University, JieFang Road 238, Wuhan 430060, China AU - Shen, D. F. AU - Tang, Q. Z. AU - Yan, L. AU - Zhang, Y. AU - Zhu, L. H. AU - Wang, L. AU - Liu, C. AU - Bian, Z. Y. AU - Li, H. DB - Embase Medline DO - 10.1111/j.1476-5381.2009.00605.x IS - 4 LA - English M3 - Article N1 - L358350124 2010-03-03 2010-03-11 PY - 2010 SN - 0007-1188 1476-5381 SP - 970-981 ST - Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling T2 - British Journal of Pharmacology TI - Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358350124&from=exporthttp://dx.doi.org/10.1111/j.1476-5381.2009.00605.x VL - 159 ID - 8061 ER - TY - JOUR AD - S. Berdnikovs, Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, 240 East Huron Avenue, Chicago, IL, United States AU - Abdala-Valencia, H. AU - Bryce, P. J. AU - Schleimer, R. P. AU - Wechsler, J. B. AU - Loffredo, L. F. AU - Cook-Mills, J. M. AU - Hsu, C. L. AU - Berdnikovs, S. DB - Embase Medline DO - 10.4049/jimmunol.1302874 IS - 4 LA - English M3 - Article N1 - L605595609 2015-08-18 2015-08-20 PY - 2015 SN - 1550-6606 0022-1767 SP - 1377-1387 ST - Tetraspanin CD151 is a negative regulator of FcεRI-mediated mast cell activation T2 - Journal of Immunology TI - Tetraspanin CD151 is a negative regulator of FcεRI-mediated mast cell activation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605595609&from=exporthttp://dx.doi.org/10.4049/jimmunol.1302874 VL - 195 ID - 8062 ER - TY - JOUR AD - Clinical Oncology Research Institute, N. N. Blokhin Russian Cancer Research Center of Russian Academy of Medical Sciences, Moscow, Russia. Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, Russia. Institute of Molecular Biology and Biophysics, Novosibirsk, Russia. AN - 26600396 AU - Lyubchenko, L. AU - Emelyanova, M. AU - Shamanin, V. AU - Demidov, L. AU - Zasedatelev, A. AU - Nasedkina, T. DO - 10.3233/cbm-150551 10.3233/CBM-150551. DP - Nlm ET - 2015/11/26 IS - 1 LA - eng PY - 2016 SN - 1574-0153 SP - 153-60 ST - The \textit{BRAF} V600E mutation in single- institution study of Russian melanoma patients T2 - Cancer Biomark TI - The \textit{BRAF} V600E mutation in single- institution study of Russian melanoma patients VL - 16 ID - 8063 ER - TY - JOUR AD - D. Tang, Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA, United States AU - Yang, M. AU - Li, C. AU - Zhu, S. AU - Cao, L. AU - Kroemer, G. AU - Zeh, H. AU - Tang, D. AU - Kang, R. C2 - Selleck(United States) Sigma(United States) DB - Embase DO - 10.1080/2162402X.2018.1431086 IS - 6 LA - English M3 - Article N1 - L620741404 2018-02-22 2018-06-26 PY - 2018 SN - 2162-402X 2162-4011 ST - TFAM is a novel mediator of immunogenic cancer cell death T2 - OncoImmunology TI - TFAM is a novel mediator of immunogenic cancer cell death UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620741404&from=exporthttp://dx.doi.org/10.1080/2162402X.2018.1431086 VL - 7 ID - 8064 ER - TY - JOUR AD - P.S. Thorner, Division of Pathology, Hospital for Sick Children, Toronto, Canada AU - Thorner, P. S. AU - Shago, M. AU - Marrano, P. AU - Shaikh, F. AU - Somers, G. R. DB - Embase Medline DO - 10.1016/j.prp.2016.07.004 IS - 10 LA - English M3 - Article N1 - L611342082 2016-07-27 2016-12-02 PY - 2016 SN - 1618-0631 0344-0338 SP - 937-942 ST - TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation T2 - Pathology Research and Practice TI - TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L611342082&from=exporthttp://dx.doi.org/10.1016/j.prp.2016.07.004 VL - 212 ID - 8065 ER - TY - JOUR AD - Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; Department of Surgery, Department of Laboratory Medicine and Pathobiology, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. Institute of Neuropathology, University Hospital Zürich, Schmelzbergstrasse 12, CH-8091 Zürich, Switzerland. The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada; Department of Surgery, Department of Laboratory Medicine and Pathobiology, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. Paediatric Leukaemia Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland; Department of Oncology, University Children's Hospital Zürich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland. Paediatric Neuro-Oncology Research Group, Department of Oncology, Children's Research Center, University Children's Hospital Zürich, August-Forel Strasse 1, CH-8008 Zürich, Switzerland. Electronic address: martin.baumgartner@kispi.uzh.ch. AN - 29949765 AU - Santhana Kumar, K. AU - Neve, A. AU - Guerreiro Stucklin, A. S. AU - Kuzan-Fischer, C. M. AU - Rushing, E. J. AU - Taylor, M. D. AU - Tripolitsioti, D. AU - Behrmann, L. AU - Kirschenbaum, D. AU - Grotzer, M. A. AU - Baumgartner, M. DA - Jun 26 DO - 10.1016/j.celrep.2018.05.083 10.1016/j.celrep.2018.05.083. DP - Nlm ET - 2018/06/28 IS - 13 LA - eng PY - 2018 SP - 3798-3812.e8 ST - TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma T2 - Cell Rep TI - TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma VL - 23 ID - 8066 ER - TY - JOUR AD - V. Keitel, Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf, Germany AU - Reich, M. AU - Deutschmann, K. AU - Sommerfeld, A. AU - Klindt, C. AU - Kluge, S. AU - Kubitz, R. AU - Ullmer, C. AU - Knoefel, W. T. AU - Herebian, D. AU - Mayatepek, E. AU - Häussinger, D. AU - Keitel, V. DB - Embase DO - 10.1136/gutjnl-2015-309458 IS - 3 LA - English M3 - Article N1 - L608884254 2016-03-21 2016-03-24 PY - 2016 SN - 1468-3288 0017-5749 SP - 487-501 ST - TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro T2 - Gut TI - TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L608884254&from=exporthttp://dx.doi.org/10.1136/gutjnl-2015-309458 VL - 65 ID - 8067 ER - TY - JOUR AD - R.D. Britt, Center for Perinatal Research, The Research Inst. at Nationwide Children’s Hospital, 575 Children’s Crossroad, Columbus, OH, United States AU - Britt, R. D. AU - Thompson, M. A. AU - Sasse, S. AU - Pabelick, C. M. AU - Gerber, A. N. AU - Prakash, Y. S. DB - Embase Medline DO - 10.1152/ajplung.00547.2017 IS - 1 LA - English M3 - Article N1 - L625901290 2019-01-17 2019-01-23 PY - 2019 SN - 1522-1504 1040-0605 SP - L71-L81 ST - Th1 cytokines tnf-α and ifn-γ promote corticosteroid resistance in developing human airway smooth muscle T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Th1 cytokines tnf-α and ifn-γ promote corticosteroid resistance in developing human airway smooth muscle UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625901290&from=exporthttp://dx.doi.org/10.1152/ajplung.00547.2017 VL - 316 ID - 8068 ER - TY - JOUR AD - Centro de Hematología y Medicina Interna, Clinica Ruiz, Puebla, Mexico Laboratorios Clínicos de Puebla, Clinica Ruiz, Puebla, Mexico Departamento de Hematología, Hospital Universitario, Monterrey, Mexico Department of Hematology, MD Anderson Cancer Center, Houston, TX, United States AU - Ruiz-Argüelles, G. J. AU - Tarin-Arzaga, L. C. AU - Gonzalez-Carrillo, M. L. AU - Gutierrez-Riveroll, K. I. AU - Rangel-Malo, R. AU - Gutiérrez-Aguirre, C. H. AU - Cantú-Rodríguez, O. G. AU - Gómez-Almaguer, D. AU - Giralt, S. DB - Scopus DO - 10.1038/bmt.2008.90 IS - 1 M3 - Article N1 - Cited By :47 Export Date: 18 November 2020 PY - 2008 SP - 23-28 ST - Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? T2 - Bone Marrow Transplantation TI - Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-47549110816&doi=10.1038%2fbmt.2008.90&partnerID=40&md5=154e12a2af810efd8d660bf60cf018c4 VL - 42 ID - 8069 ER - TY - JOUR AD - S. Hong, Department of Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Dongguk University, Dongguk-ro 27, Ilsandong-gu, Goyang-si, Gyeonggi-do, South Korea AU - Yang, J. AU - Min, S. AU - Hong, S. DB - Embase DO - 10.1155/2017/5469125 LA - English M3 - Article N1 - L614478692 2017-02-28 2017-03-28 PY - 2017 SN - 1741-4288 1741-427X ST - Therapeutic effects of fermented flax seed oil on NC/Nga mice with atopic dermatitis-like skin lesions T2 - Evidence-based Complementary and Alternative Medicine TI - Therapeutic effects of fermented flax seed oil on NC/Nga mice with atopic dermatitis-like skin lesions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614478692&from=exporthttp://dx.doi.org/10.1155/2017/5469125 VL - 2017 ID - 8070 ER - TY - JOUR AD - S.S. Roy, UTHSCSA, San Antonio, TX, United States AU - Roy, S. S. AU - Shackleford, T. AU - Houghton, P. DB - Embase DO - 10.1158/1538-7445.AM2017-1431 IS - 13 LA - English M3 - Conference Abstract N1 - L618565149 2017-10-10 PY - 2017 SN - 1538-7445 ST - Therapeutic exploitation of mutant BRAF in childhood glioma T2 - Cancer Research TI - Therapeutic exploitation of mutant BRAF in childhood glioma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L618565149&from=exporthttp://dx.doi.org/10.1158/1538-7445.AM2017-1431 VL - 77 ID - 8071 ER - TY - JOUR AD - Department of Neurosurgery, Third Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530031, China Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States AU - Ma, H. AU - Sinha, B. AU - Pandya, R. S. AU - Lin, N. AU - Popp, A. J. AU - Li, J. AU - Yao, J. AU - Wang, X. DB - Scopus DO - 10.2174/156652412803833517 IS - 10 M3 - Review N1 - Cited By :29 Export Date: 18 November 2020 PY - 2012 SP - 1282-1296 ST - Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury T2 - Current Molecular Medicine TI - Therapeutic hypothermia as a neuroprotective strategy in neonatal hypoxic-ischemic brain injury and traumatic brain injury UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870202240&doi=10.2174%2f156652412803833517&partnerID=40&md5=fb3c6ef1cc35d4a08eb63327fc36a717 VL - 12 ID - 8072 ER - TY - JOUR AD - Y. Zeng, Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China AU - Wu, Y. AU - Lu, X. AU - Shen, B. AU - Zeng, Y. DB - Embase Medline DO - 10.2174/1566523219666190716092203 IS - 4 LA - English M3 - Article N1 - L2003254318 2019-11-29 2019-12-04 PY - 2019 SN - 1875-5631 1566-5232 SP - 255-263 ST - The therapeutic potential and role of miRNA, IncRNA, and circRNA in osteoarthritis T2 - Current Gene Therapy TI - The therapeutic potential and role of miRNA, IncRNA, and circRNA in osteoarthritis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003254318&from=exporthttp://dx.doi.org/10.2174/1566523219666190716092203 VL - 19 ID - 8073 ER - TY - JOUR AD - C.C. Wang, Department of Obstetrics and Gynaecology, Faculty of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, Hong Kong C.C. Wang, Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong SAR, Hong Kong AU - Man, G. C. W. AU - Wang, J. AU - Song, Y. AU - Wong, J. H. AU - Zhao, Y. AU - Lau, T. S. AU - Leung, K. T. AU - Chan, T. H. AU - Wang, H. AU - Kwong, J. AU - Ng, T. B. AU - Wang, C. C. DB - Embase Medline DO - 10.1186/s12885-020-07455-3 IS - 1 LA - English M3 - Article N1 - L633028090 2020-10-19 PY - 2020 SN - 1471-2407 ST - Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer T2 - BMC Cancer TI - Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633028090&from=exporthttp://dx.doi.org/10.1186/s12885-020-07455-3 VL - 20 ID - 8074 ER - TY - JOUR AD - Department of Immunology, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States Department of Biochemistry, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States Department of Hematology, Parker Hughes Institute, Parker Hughes Cancer Center, 2720 Patton Rd., St. Paul, MN 55113, United States AU - Cetkovic-Cvrlje, M. AU - Tibbles, H. E. DB - Scopus DO - 10.2174/1381612043384529 IS - 15 M3 - Review N1 - Cited By :25 Export Date: 18 November 2020 PY - 2004 SP - 1767-1784 ST - Therapeutic potential of Janus kinase 3 (JAK3) inhibitors T2 - Current Pharmaceutical Design TI - Therapeutic potential of Janus kinase 3 (JAK3) inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442464602&doi=10.2174%2f1381612043384529&partnerID=40&md5=d93b5bc5e9727a6db42ebb4b0fe0df5a VL - 10 ID - 8075 ER - TY - JOUR AD - Gastroenterology Center, Ehime Prefectural Central Hospital, Ehime, Japan Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Gifu, Japan Department of Gastroenterology, Okayama City Hospital, Okayama, Japan Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan Department of Gastroenterology, Asahi General Hospital, Asahi, Japan Division of Gastroenterology and Hepatology, Ootakanomori Hospital, Kashiwa, Japan Department of Gastroenterology, Toyama University Hospital, Toyama, Japan Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan Department of Gastroenterology, Saiseikai Niigata Daini Hospital, Niigata, Japan Hepato-biliary Center, Matsuyama Red Cross Hospital, Matsuyama, Japan Department of Gastroenterology and Metabology, Ehime University Graduate School of MedicineEhime, Japan Department of Gastroenterology, Tokushima Prefectural Central Hospital, Tokushima, Japan AU - Hiraoka, A. AU - Kumada, T. AU - Kariyama, K. AU - Takaguchi, K. AU - Itobayashi, E. AU - Shimada, N. AU - Tajiri, K. AU - Tsuji, K. AU - Ishikawa, T. AU - Ochi, H. AU - Hirooka, M. AU - Tsutsui, A. AU - Shibata, H. AU - Tada, T. AU - Toyoda, H. AU - Nouso, K. AU - Joko, K. AU - Hiasa, Y. AU - Michitaka, K. AU - On behalf of the Real-life Practice Experts for, H. C. C. Study Group AU - the, H. C. C. Group DB - Scopus DO - 10.1111/hepr.13243 IS - 1 M3 - Article N1 - (RELPEC) (hepatocellular carcinoma experts from 48 clinics in Japan) Cited By :41 Export Date: 18 November 2020 PY - 2019 SP - 111-117 ST - Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis T2 - Hepatology Research TI - Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054634693&doi=10.1111%2fhepr.13243&partnerID=40&md5=111e2c750cae283fcc95921b3e94ba72 VL - 49 ID - 8076 ER - TY - JOUR AD - D.B. Solit, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, United States AU - Pratilas, C. A. AU - Solit, D. B. C1 - arry 142886(Array Biopharma) azd 6244(Astra Zeneca) bay 439006(Bayer) bay 439006(Onyx) chir 265(Chiron) chir 265(Novartis) ci 1040(Pfizer) cnf 2024(Biogen) exel 2819(Exelixis) letx(Van Andel Research Institute) nexavar(Bayer) nexavar(Onyx) pd 0325901(Pfizer) pd 184352(Pfizer) plx 4032(Plexxikon) raf 265(Chiron) raf 265(Novartis) sb 590885(Glaxo SmithKline) snx 5542(Serenex) ver 49009(Vernalis) xl 281(Exelixis) C2 - Array Biopharma Astra Zeneca Bayer Biogen Chiron Exelixis Glaxo SmithKline Infinity Kosan Novartis Onyx Pfizer Plexxikon Serenex Van Andel Research Institute Vernalis DB - Embase Medline DO - 10.2174/157488707780599393 IS - 2 LA - English M3 - Review N1 - L46773880 2007-05-01 PY - 2007 SN - 1574-8871 SP - 121-134 ST - Therapeutic strategies for targeting BRAF in human cancer T2 - Reviews on Recent Clinical Trials TI - Therapeutic strategies for targeting BRAF in human cancer UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46773880&from=exporthttp://dx.doi.org/10.2174/157488707780599393http://www.ingentaconnect.com/content/ben/rrct/2007/00000002/00000002/art00006 VL - 2 ID - 8077 ER - TY - JOUR AD - M. Wang, Department of Haematology, Cambridge University Hospitals, Cambridge, United Kingdom AU - Wang, M. AU - Eskiocak, U. AU - Agathokleous, M. AU - Yuan, S. AU - Crawley, C. AU - Morrison, S. J. DB - Embase IS - 23 LA - English M3 - Conference Abstract N1 - L72171810 2016-02-08 PY - 2015 SN - 0006-4971 SP - 1264 ST - Therapeutic synergy from combined inhibition of the SERCA channel and MAPK signaling pathway in MAPK-dependent leukemia T2 - Blood TI - Therapeutic synergy from combined inhibition of the SERCA channel and MAPK signaling pathway in MAPK-dependent leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72171810&from=exporthttp://www.bloodjournal.org/content/126/23/1264 VL - 126 ID - 8078 ER - TY - JOUR AD - A. Alhammer, Newcastle University, Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom AU - Alhammer, A. AU - Case, M. AU - Matheson, E. AU - Blair, H. AU - Vormoor, J. AU - Irving, J. DB - Embase LA - English M3 - Conference Abstract N1 - L617378538 2017-07-24 PY - 2017 SN - 1592-8721 SP - 195 ST - Therapeutic targeting of pre-B cell receptor signalling in childhood acute lymphoblastic leukemia T2 - Haematologica TI - Therapeutic targeting of pre-B cell receptor signalling in childhood acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617378538&from=export VL - 102 ID - 8079 ER - TY - JOUR AD - Sanford Children's Health Research Center, Department of Pediatrics, University of South Dakota School of Medicine, Vermillion, United States Biomedical Engineering Department, University of South Dakota, Vermillion, United States BioSNTR, Brookings, United States AU - Messerli, S. M. AU - Hoffman, M. M. AU - Gnimpieba, E. Z. AU - Bhardwaj, R. D. DB - Scopus DO - 10.1158/1541-7786.MCR-16-0432 IS - 8 M3 - Article N1 - Cited By :11 Export Date: 18 November 2020 PY - 2017 SP - 973-983 ST - Therapeutic targeting of PTK7 is cytotoxic in atypical teratoid rhabdoid tumors T2 - Molecular Cancer Research TI - Therapeutic targeting of PTK7 is cytotoxic in atypical teratoid rhabdoid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026643566&doi=10.1158%2f1541-7786.MCR-16-0432&partnerID=40&md5=df48110d76ff30d328f4610507717cc0 VL - 15 ID - 8080 ER - TY - JOUR AD - P.K. Wlodarski, Medical University of Warsaw, Center for Biostructure Research, Department of Histology and Embryology, Warsaw, Poland AU - Wlodarski, P. K. AU - Jozwiak, J. C1 - amd 3100 cur 61414 gant 58 gant 61 hhantag 691 DB - Embase Medline DO - 10.1517/14728222.12.4.449 IS - 4 LA - English M3 - Review N1 - L351546371 2008-05-01 PY - 2008 SN - 1472-8222 SP - 449-461 ST - Therapeutic targets for medulloblastoma T2 - Expert Opinion on Therapeutic Targets TI - Therapeutic targets for medulloblastoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351546371&from=exporthttp://dx.doi.org/10.1517/14728222.12.4.449 VL - 12 ID - 8081 ER - TY - JOUR AD - G.M. Brodeur, Children's Hospital of Philadelphias, Division of Oncology, 3501 Civic Center Blvd., Philadelphia, PA 19104-4302, United States AU - Brodeur, G. M. AU - Iyer, R. AU - Croucher, J. L. AU - Zhuang, T. AU - Higashi, M. AU - Kolla, V. DB - Embase Medline DO - 10.1517/14728222.2014.867946 IS - 3 LA - English M3 - Review N1 - L372394899 2014-02-26 2014-03-03 PY - 2014 SN - 1472-8222 1744-7631 SP - 277-292 ST - Therapeutic targets for neuroblastomas T2 - Expert Opinion on Therapeutic Targets TI - Therapeutic targets for neuroblastomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372394899&from=exporthttp://dx.doi.org/10.1517/14728222.2014.867946 VL - 18 ID - 8082 ER - TY - JOUR AD - Department of Pediatrics, Division of Pediatric Hematology/Oncology, NYU Langone Medical Center, 522 First Avenue, New York, NY 10016, United States Department of Pediatrics, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, United States University of Philadelphia, Perelman School of Medicine, Philadelphia, PA, United States AU - Carroll, W. L. AU - Hunger, S. P. DB - Scopus DO - 10.1097/MOP.0000000000000293 IS - 1 M3 - Review N1 - Cited By :10 Export Date: 18 November 2020 PY - 2016 SP - 12-18 ST - Therapies on the horizon for childhood acute lymphoblastic leukemia T2 - Current Opinion in Pediatrics TI - Therapies on the horizon for childhood acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954026407&doi=10.1097%2fMOP.0000000000000293&partnerID=40&md5=d932d29505e5bbb9b199fd43546af73a VL - 28 ID - 8083 ER - TY - JOUR AD - S.A. Stewart, Washington University in St. Louis School of Medicine, BJC-IH ICCE Institute (Rm 7610), 660 South Euclid, Box 8228, St. Louis, MO, United States AU - Yao, Z. AU - Murali, B. AU - Ren, Q. AU - Luo, X. AU - Faget, D. V. AU - Cole, T. AU - Ricci, B. AU - Thotala, D. AU - Monahan, J. AU - Van Deursen, J. M. AU - Baker, D. AU - Faccio, R. AU - Schwarz, J. K. AU - Stewart, S. A. C1 - ati 450(Aclaris Therapeutics) cdd 111(Aclaris Therapeutics) C2 - Aclaris Therapeutics DB - Embase Medline DO - 10.1158/0008-5472.CAN-19-2348 IS - 5 LA - English M3 - Article N1 - L2005424132 2020-04-07 2020-04-14 PY - 2020 SN - 1538-7445 0008-5472 SP - 1171-1182 ST - Therapy-induced senescence drives bone loss T2 - Cancer Research TI - Therapy-induced senescence drives bone loss UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005424132&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-19-2348 VL - 80 ID - 8084 ER - TY - JOUR AD - Department of Neurosurgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. Department of Neurosurgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. mkanamori@med.tohoku.ac.jp. Department of Pediatrics, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan. Department of Pathology and Laboratory Medicine, National Hospital Organization Sendai Medical Center, Sendai, Japan. Department of Pathology, Tohoku University Hospital, Sendai, Miyagi, Japan. AN - 29666969 AU - Kajitani, T. AU - Kanamori, M. AU - Saito, R. AU - Watanabe, Y. AU - Suzuki, H. AU - Watanabe, M. AU - Kure, S. AU - Tominaga, T. DA - Apr DO - 10.1007/s10014-018-0316-1 10.1007/s10014-018-0316-1. Epub 2018 Apr 17. DP - Nlm ET - 2018/04/19 IS - 2 LA - eng PY - 2018 SN - 1433-7398 SP - 114-122 ST - Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia T2 - Brain Tumor Pathol TI - Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia VL - 35 ID - 8085 ER - TY - JOUR AD - C.V. Mahuad, Service of Hematology, Department of Internal Medicine, Hospital Alemán, Pueyrredón 1640, 1118 – CABA, Buenos Aires, Argentina AU - Mahuad, C. V. AU - Repáraz, M. Á V. AU - Zerga, M. E. AU - Aizpurua, M. F. AU - Casali, C. AU - Garate, G. DB - Embase DO - 10.4081/rt.2016.6266 IS - 2 LA - English M3 - Article N1 - L610956143 2016-07-05 2016-07-11 PY - 2016 SN - 2036-3613 2036-3605 SP - 88-89 ST - Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib T2 - Rare Tumors TI - Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L610956143&from=exporthttp://dx.doi.org/10.4081/rt.2016.6266 VL - 8 ID - 8086 ER - TY - JOUR AD - W.S. Park, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea AU - Sung, D. K. AU - Chang, Y. S. AU - Sung, S. I. AU - Ahn, S. Y. AU - Park, W. S. DB - Embase DO - 10.3390/jcm8040533 IS - 4 LA - English M3 - Article N1 - L2002182741 2019-08-20 2019-08-22 PY - 2019 SN - 2077-0383 ST - Thrombin preconditioning of extracellular vesicles derived from mesenchymal stem cells accelerates cutaneous wound healing by boosting their biogenesis and enriching cargo content T2 - Journal of Clinical Medicine TI - Thrombin preconditioning of extracellular vesicles derived from mesenchymal stem cells accelerates cutaneous wound healing by boosting their biogenesis and enriching cargo content UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002182741&from=exporthttp://dx.doi.org/10.3390/jcm8040533 VL - 8 ID - 8087 ER - TY - JOUR AD - S.C. Land, Tayside Inst. of Child Health, Ninewells Hosp. and Medical School, Univ. of Dundee, Dundee, DD1 9SY, United Kingdom AU - Land, S. C. AU - Darakhshan, F. DB - Embase Medline IS - 3 30-3 LA - English M3 - Article N1 - L38233617 2004-03-05 PY - 2004 SN - 1040-0605 SP - L473-L487 ST - Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants T2 - American Journal of Physiology - Lung Cellular and Molecular Physiology TI - Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants UR - https://www.embase.com/search/results?subaction=viewrecord&id=L38233617&from=export VL - 286 ID - 8088 ER - TY - JOUR AD - Department of Endocrinology and Diabetes, Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC 3052, Australia Khoo Teck Puat-National University Children’s Medical Institute, National University Hospital, Singapore, 119074, Singapore Department of Endocrinology, Royal Children’s Hospital, Flemington Rd, Parkville, VIC 3052, Australia AU - Ho, W. L. C. AU - Zacharin, M. R. DB - Scopus DO - 10.1007/s00431-016-2692-z IS - 5 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2016 SP - 677-683 ST - Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure T2 - European Journal of Pediatrics TI - Thyroid carcinoma in children, adolescents and adults, both spontaneous and after childhood radiation exposure UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955243651&doi=10.1007%2fs00431-016-2692-z&partnerID=40&md5=afd907f9e4068b0e8726a7faceeb9eff VL - 175 ID - 8089 ER - TY - JOUR AD - Department of Endocrine Neoplasia and Hormonal Disorders, Department of Pediatrics-Patient Care, University of Texas MD Anderson Cancer Center, Unit 1461, PO Box 301402, Houston, TX 77230, United States AU - Waguespack, S. G. DB - Scopus DO - 10.1159/000495040 IS - 2 M3 - Review N1 - Cited By :5 Export Date: 18 November 2020 PY - 2019 SP - 104-117 ST - Thyroid Sequelae of Pediatric Cancer Therapy T2 - Hormone Research in Paediatrics TI - Thyroid Sequelae of Pediatric Cancer Therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058817712&doi=10.1159%2f000495040&partnerID=40&md5=c217cd155cecddf02498ebe9d62dcac2 VL - 91 ID - 8090 ER - TY - JOUR AD - Department of Pathology, Virginia Mason Medical Center, Seattle, WA, USA. AN - 18587320 AU - Assaad, A. AU - Voeghtly, L. AU - Hunt, J. L. DA - Sep DO - 10.1038/modpathol.2008.122 10.1038/modpathol.2008.122. Epub 2008 Jun 27. DP - Nlm ET - 2008/07/01 IS - 9 LA - eng PY - 2008 SN - 0893-3952 SP - 1176-82 ST - Thyroidectomies from patients with history of therapeutic radiation during childhood and adolescence have a unique mutational profile T2 - Mod Pathol TI - Thyroidectomies from patients with history of therapeutic radiation during childhood and adolescence have a unique mutational profile VL - 21 ID - 8091 ER - TY - JOUR AD - B. Shivanna, Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States AU - Menon, R. T. AU - Shrestha, A. K. AU - Barrios, R. AU - Reynolds, C. AU - Shivanna, B. DB - Embase Medline DO - 10.3390/ijms21072408 IS - 7 LA - English M3 - Article N1 - L2004197024 2020-04-29 2020-05-15 PY - 2020 SN - 1422-0067 1661-6596 ST - Tie-2 cre-mediated deficiency of extracellular signal-regulated kinase 2 potentiates experimental bronchopulmonary dysplasia-associated pulmonary hypertension in neonatal mice T2 - International Journal of Molecular Sciences TI - Tie-2 cre-mediated deficiency of extracellular signal-regulated kinase 2 potentiates experimental bronchopulmonary dysplasia-associated pulmonary hypertension in neonatal mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004197024&from=exporthttp://dx.doi.org/10.3390/ijms21072408 VL - 21 ID - 8092 ER - TY - JOUR AD - Department of Medical Sciences, University of Milan and Endocrine Unit, Fondazione Policlinico IRCCS, Milan. AN - 20447069 AU - Muzza, M. AU - Degl'Innocenti, D. AU - Colombo, C. AU - Perrino, M. AU - Ravasi, E. AU - Rossi, S. AU - Cirello, V. AU - Beck-Peccoz, P. AU - Borrello, M. G. AU - Fugazzola, L. DA - May DO - 10.1111/j.1365-2265.2009.03699.x 10.1111/j.1365-2265.2009.03699.x. DP - Nlm ET - 2010/05/08 IS - 5 LA - eng PY - 2010 SN - 0300-0664 SP - 702-8 ST - The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies T2 - Clin Endocrinol (Oxf) TI - The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies VL - 72 ID - 8093 ER - TY - JOUR AD - H. S. Bernstein, University of California, Box 1346, 513 Parnassus Avenue, San Francisco, CA 941431346, United States AU - Gaur, M. AU - Ritner, C. AU - Sievers, R. AU - Pedersen, A. AU - Prasad, M. AU - Bernstein, H. S. AU - Yeghiazarians, Y. DB - Embase Medline DO - 10.3109/14653249.2010.491821 IS - 6 LA - English M3 - Article N1 - L359686167 2010-10-11 2010-10-28 PY - 2010 SN - 1465-3249 1477-2566 SP - 807-817 ST - Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes T2 - Cytotherapy TI - Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359686167&from=exporthttp://dx.doi.org/10.3109/14653249.2010.491821 VL - 12 ID - 8094 ER - TY - JOUR AD - Y. Luan, Central Research Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, China AU - Zhang, Z. AU - Sun, C. AU - Wang, J. AU - Jiang, W. AU - Xin, Q. AU - Luan, Y. DB - Embase Medline DO - 10.1111/jcmm.13843 IS - 11 LA - English M3 - Article N1 - L623776231 2018-09-11 2018-11-02 PY - 2018 SN - 1582-1838 SP - 5759-5763 ST - Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia T2 - Journal of Cellular and Molecular Medicine TI - Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623776231&from=exporthttp://dx.doi.org/10.1111/jcmm.13843 VL - 22 ID - 8095 ER - TY - JOUR AD - Department of Pediatrics, Klinik und Poliklinik für Kinder- und Jugendmedizin, University Hospital Carl Gustav Caruso, Fetscherstraße 74, 1307 Dresden, Germany Medical Faculty Carl Gustav Caruso, Institute for Medical Informatics and Biometry, Dresden, Germany Medical Faculty Carl Gustav Caruso Experimental Center, Dresden, Germany AU - Ulmer, A. AU - Tabea Tauer, J. AU - Glauche, I. AU - Jung, R. AU - Suttorp, M. DB - Scopus DO - 10.1055/s-0033-1343483 IS - 3 M3 - Article N1 - Cited By :19 Export Date: 18 November 2020 PY - 2013 SP - 120-126 ST - TK inhibitor treatment disrupts growth hormone axis: Clinical observations in children with CML and experimental data from a Juvenile Animal Model T2 - Klinische Padiatrie TI - TK inhibitor treatment disrupts growth hormone axis: Clinical observations in children with CML and experimental data from a Juvenile Animal Model UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878387514&doi=10.1055%2fs-0033-1343483&partnerID=40&md5=4f0358dd9197b3af61bf005f8573b69e VL - 225 ID - 8096 ER - TY - JOUR AD - P.N. Cunningham, Section of Nephrology, Department of Medicine, University of Chicago, 5841 S. Maryland Ave, MC 5100, Chicago, IL, United States AU - Xu, C. AU - Wu, X. AU - Hack, B. K. AU - Bao, L. AU - Cunningham, P. N. DB - Embase DO - 10.14814/phy2.12636 IS - 12 LA - English M3 - Article N1 - L613726644 2016-12-23 2016-12-28 PY - 2015 SN - 2051-817X ST - TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism T2 - Physiological Reports TI - TNF causes changes in glomerular endothelial permeability and morphology through a Rho and myosin light chain kinase-dependent mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613726644&from=exporthttp://dx.doi.org/10.14814/phy2.12636 VL - 3 ID - 8097 ER - TY - JOUR AD - M. Mempel, Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU München, Biedersteiner Str. 29, D-80802 München, Germany AU - Claßen, A. AU - Kalali, B. N. AU - Schnopp, C. AU - Andres, C. AU - Aguilar-Pimentel, J. A. AU - Ring, J. AU - Ollert, M. AU - Mempel, M. DB - Embase Medline DO - 10.1111/j.1600-0625.2010.01174.x IS - 1 LA - English M3 - Article N1 - L360167305 2010-12-23 2011-01-04 PY - 2011 SN - 0906-6705 1600-0625 SP - 48-52 ST - TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP 1, and downstream gene transcription T2 - Experimental Dermatology TI - TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP 1, and downstream gene transcription UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360167305&from=exporthttp://dx.doi.org/10.1111/j.1600-0625.2010.01174.x VL - 20 ID - 8098 ER - TY - JOUR AD - D. B. Polk, Departments of Pediatrics and Biochemistry and Molecular Biology, The Saban Research Institute of Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, 4650 Sunset Blvd., Mailstop 126, Los Angeles, CA 37232-0696, United States AU - Hobbs, S. S. AU - Goettel, J. A. AU - Liang, D. AU - Yan, F. AU - Edelblum, K. L. AU - Frey, M. R. AU - Mullane, M. T. AU - Polk, D. B. DB - Embase Medline DO - 10.1152/ajpgi.00383.2010 IS - 2 L1 - internal-pdf://2735703404/ajpgi.00383.2010.pdf LA - English M3 - Article N1 - L362255411 2011-08-09 2011-08-11 PY - 2011 SN - 0193-1857 1522-1547 SP - G220-G229 ST - TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362255411&from=exporthttp://dx.doi.org/10.1152/ajpgi.00383.2010 VL - 301 ID - 8099 ER - TY - JOUR AD - K.M. Sakamoto, Department of Pediatrics, Stanford University School of Medicine, CCSR 1215C, 269 Campus Dr, Stanford, CA, United States AU - Bibikova, E. AU - Youn, M. Y. AU - Danilova, N. AU - Ono-Uruga, Y. AU - Konto-Ghiorghi, Y. AU - Ochoa, R. AU - Narla, A. AU - Glader, B. AU - Lin, S. AU - Sakamoto, K. M. DB - Embase Medline DO - 10.1182/blood-2014-06-584656 IS - 25 LA - English M3 - Article N1 - L600898379 2014-12-30 2015-01-12 PY - 2014 SN - 1528-0020 0006-4971 SP - 3791-3798 ST - TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors T2 - Blood TI - TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600898379&from=exporthttp://dx.doi.org/10.1182/blood-2014-06-584656 VL - 124 ID - 8100 ER - TY - JOUR AD - D. Y. M. Leung, Department of Pediatrics, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, United States AU - Kim, B. E. AU - Howell, M. D. AU - Guttman, E. AU - Gilleaudeau, P. M. AU - Cardinale, I. R. AU - Boguniewicz, M. AU - Krueger, J. G. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1038/jid.2011.24 IS - 6 LA - English M3 - Article N1 - L51293568 2011-05-24 2019-07-16 PY - 2011 SN - 1523-1747 0022-202X SP - 1272-1279 ST - TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-α antagonists to improve skin barrier T2 - Journal of Investigative Dermatology TI - TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: Role for TNF-α antagonists to improve skin barrier UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51293568&from=exporthttp://dx.doi.org/10.1038/jid.2011.24 VL - 131 ID - 8101 ER - TY - JOUR AD - C.J. Xian, Department of Orthopaedic Surgery, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia AU - Zhou, F. H. AU - Foster, B. K. AU - Zhou, X. F. AU - Cowin, A. J. AU - Xian, C. J. C1 - etanercept(Wyeth,Australia) sb 239063 C2 - Wyeth(Australia) DB - Embase Medline DO - 10.1359/jbmr.060410 IS - 7 LA - English M3 - Article N1 - L43962836 2006-07-18 PY - 2006 SN - 0884-0431 SP - 1075-1088 ST - TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats T2 - Journal of Bone and Mineral Research TI - TNF-α mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43962836&from=exporthttp://dx.doi.org/10.1359/jbmr.060410 VL - 21 ID - 8102 ER - TY - JOUR AD - R.H. Scott, Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD Scotland, United Kingdom AU - Pollock, J. AU - McFarlane, S. M. AU - Connell, M. C. AU - Zehavi, U. AU - Vandenabeele, P. AU - MacEwan, D. J. AU - Scott, R. H. DB - Embase Medline DO - 10.1016/S0028-3908(01)00163-0 IS - 1 LA - English M3 - Article N1 - L34062825 2002-01-30 PY - 2002 SN - 0028-3908 SP - 93-106 ST - TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones T2 - Neuropharmacology TI - TNF-α receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones UR - https://www.embase.com/search/results?subaction=viewrecord&id=L34062825&from=exporthttp://dx.doi.org/10.1016/S0028-3908(01)00163-0 VL - 42 ID - 8103 ER - TY - JOUR AD - I.L.M.H. Aye, Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado, Anschutz Medical Campus, Mail Code 7836, 12700 East 19th Avenue, Aurora, CO, United States AU - Aye, I. L. M. H. AU - Jansson, T. AU - Powell, T. L. DB - Embase DO - 10.14814/phy2.12594 IS - 10 LA - English M3 - Article N1 - L613727853 2016-12-23 2017-01-09 PY - 2015 SN - 2051-817X ST - TNF-α stimulates system a amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling T2 - Physiological Reports TI - TNF-α stimulates system a amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613727853&from=exporthttp://dx.doi.org/10.14814/phy2.12594 VL - 3 ID - 8104 ER - TY - JOUR AD - Department of Prosthodontics, Qingdao Stomatological Hospital, Qingdao, China Department of Periodontology, Qingdao Stomatological Hospital, Qingdao, China Department of Stomatology, Longkou Hospital of Traditional Chinese Medicine, Yantai, China Department of Oral and Maxillofacial Surgery, Yantai Affiliated Hospital of Binzhou Medical University, No 717, Jinbu Street, Muping District, Yantai, 264100, China AU - Cui, Y. M. AU - Han, X. H. AU - Lin, Y. Y. AU - Lv, W. W. AU - Wang, Y. L. DB - Scopus DO - 10.1691/ph.2017.7450 IS - 6 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2017 SP - 329-333 ST - TNF-α was involved in calcium hydroxide-promoted osteogenic differentiation of human DPSCs through NF-κB/p38MAPK/Wnt pathway T2 - Pharmazie TI - TNF-α was involved in calcium hydroxide-promoted osteogenic differentiation of human DPSCs through NF-κB/p38MAPK/Wnt pathway UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020253751&doi=10.1691%2fph.2017.7450&partnerID=40&md5=93aa2f5f82d53a4ab4fdd4b26c807e0b VL - 72 ID - 8105 ER - TY - JOUR AD - Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, The Netherlands. Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands. Newcastle University, Northern Institute for Cancer Research, Wolfson Childhood Cancer Research Centre, Newcastle upon Tyne, United Kingdom. Departamento de Medicina Interna, Universidade Federal do Parana, Hospital de Clinicas de Curitiba, Curitiba, Brazil. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Hans.Koenen@radboudumc.nl. AN - 29248493 AU - Urbano, P. C. M. AU - Aguirre-Gamboa, R. AU - Ashikov, A. AU - van Heeswijk, B. AU - Krippner-Heidenreich, A. AU - Tijssen, H. AU - Li, Y. AU - Azevedo, V. F. AU - Smits, L. J. T. AU - Hoentjen, F. AU - Joosten, I. AU - Koenen, Hjpm DA - Aug DO - 10.1016/j.jaci.2017.11.024 10.1016/j.jaci.2017.11.024. Epub 2017 Dec 14. DP - Nlm ET - 2017/12/19 IS - 2 LA - eng PY - 2018 SN - 0091-6749 SP - 517-529 ST - TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression T2 - J Allergy Clin Immunol TI - TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression VL - 142 ID - 8106 ER - TY - JOUR AD - Department of Laboratory Medicine, Laboratory of Medical Immunology (LMI), Radboud University Medical Center, Nijmegen, Netherlands Department of Neurology, Radboud University Medical Center, Nijmegen, Netherlands Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, Netherlands Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands Newcastle University, Northern Institute for Cancer Research, Wolfson Childhood Cancer Research Centre, Newcastle upon Tyne, United Kingdom Departamento de Medicina Interna, Universidade Federal do Parana, Hospital de Clinicas de Curitiba, Curitiba, Brazil AU - Urbano, P. C. M. AU - Aguirre-Gamboa, R. AU - Ashikov, A. AU - van Heeswijk, B. AU - Krippner-Heidenreich, A. AU - Tijssen, H. AU - Li, Y. AU - Azevedo, V. F. AU - Smits, L. J. T. AU - Hoentjen, F. AU - Joosten, I. AU - Koenen, H. J. P. M. DB - Scopus DO - 10.1016/j.jaci.2017.11.024 IS - 2 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2018 SP - 517-529 ST - TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression T2 - Journal of Allergy and Clinical Immunology TI - TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041092351&doi=10.1016%2fj.jaci.2017.11.024&partnerID=40&md5=6d6c5561082425c81adf67b3a307a5ca VL - 142 ID - 8107 ER - TY - JOUR AD - D. Palmieri, Laboratory of Clinical and Experimental Vascular Biology, DISC, University of Genoa, IRCCS San Martino-IST, Largo Rosanna Benzi 8, 16132 Genoa, Italy AU - Palmieri, D. AU - Capponi, S. AU - Geroldi, A. AU - Mura, M. AU - Mandich, P. AU - Palombo, D. DB - Embase Medline DO - 10.1016/j.bbrc.2013.11.092 IS - 1 LA - English M3 - Article N1 - L52901511 2013-12-11 2014-01-02 PY - 2014 SN - 0006-291X 1090-2104 SP - 246-251 ST - TNFα induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149 T2 - Biochemical and Biophysical Research Communications TI - TNFα induces the expression of genes associated with endothelial dysfunction through p38MAPK-mediated down-regulation of miR-149 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52901511&from=exporthttp://dx.doi.org/10.1016/j.bbrc.2013.11.092 VL - 443 ID - 8108 ER - TY - JOUR AD - T. Miyamoto, Department of Orthopedic Surgery, Keio University School of Medicine, 35 Shinano-machi, Tokyo 160-8582, Japan AU - Mori, T. AU - Sato, Y. AU - Miyamoto, K. AU - Kobayashi, T. AU - Shimizu, T. AU - Kanagawa, H. AU - Katsuyama, E. AU - Fujie, A. AU - Hao, W. AU - Tando, T. AU - Iwasaki, R. AU - Kawana, H. AU - Morioka, H. AU - Matsumoto, M. AU - Saya, H. AU - Toyama, Y. AU - Miyamoto, T. DB - Embase Medline DO - 10.1038/onc.2013.545 IS - 33 LA - English M3 - Article N1 - L52919830 2013-12-19 2014-09-04 PY - 2014 SN - 1476-5594 0950-9232 SP - 4236-4241 ST - TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state T2 - Oncogene TI - TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52919830&from=exporthttp://dx.doi.org/10.1038/onc.2013.545 VL - 33 ID - 8109 ER - TY - JOUR AD - C. Horbinski, Department of Pathology, University of Kentucky, MS-155, 800 Rose St, Lexington, KY 40536, United States AU - Horbinski, C. C1 - azd 6244 plx 4032 DB - Embase Medline DO - 10.1097/NEN.0b013e318279f3db IS - 1 LA - English M3 - Review N1 - L52353587 2012-12-18 2013-01-22 PY - 2013 SN - 0022-3069 1554-6578 SP - 2-7 ST - To BRAF or not to BRAF: Is that even a question anymore? T2 - Journal of Neuropathology and Experimental Neurology TI - To BRAF or not to BRAF: Is that even a question anymore? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52353587&from=exporthttp://dx.doi.org/10.1097/NEN.0b013e318279f3db VL - 72 ID - 8110 ER - TY - JOUR AD - K. Krishnan, Department of Internal Medicine, JamesH. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States AU - Shin-Kang, S. AU - Ramsauer, V. P. AU - Lightner, J. AU - Chakraborty, K. AU - Stone, W. AU - Campbell, S. AU - Reddy, S. A. G. AU - Krishnan, K. C2 - Cayman(United States) Tama(Japan) DB - Embase Medline DO - 10.1016/j.freeradbiomed.2011.06.008 IS - 6 LA - English M3 - Article N1 - L51515938 2011-07-13 2011-08-26 PY - 2011 SN - 0891-5849 1873-4596 SP - 1164-1174 ST - Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway T2 - Free Radical Biology and Medicine TI - Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51515938&from=exporthttp://dx.doi.org/10.1016/j.freeradbiomed.2011.06.008 VL - 51 ID - 8111 ER - TY - JOUR AD - Department of Pediatrics, UCSF School of Medicine, 505 Parnassus Avenue, M646, San Francisco, CA 94143-0106, United States Department of Pediatrics, Children's Hospital Boston, Harvard Medical School, Boston, MA, United States Department of Pharmacology, Mayo College of Medicine, Rochester, MN, United States Children's Oncology Group Operations Center, Arcadia, CA, United States Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States Department of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada Department of Pediatrics, Morgan Stanley Children's Hospital, Columbia University School of Medicine, New York, NY, United States Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States Department of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, United States Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, United States AU - DuBois, S. G. AU - Shusterman, S. AU - Reid, J. M. AU - Ingle, A. M. AU - Ahern, C. H. AU - Baruchel, S. AU - Glade-Bender, J. AU - Ivy, P. AU - Adamson, P. C. AU - Blaney, S. M. DB - Scopus DO - 10.1007/s00280-011-1798-2 IS - 4 M3 - Article N1 - Cited By :25 Export Date: 18 November 2020 PY - 2012 SP - 1021-1027 ST - Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: A Children's Oncology Group study T2 - Cancer Chemotherapy and Pharmacology TI - Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: A Children's Oncology Group study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859801305&doi=10.1007%2fs00280-011-1798-2&partnerID=40&md5=611c66adb10f4ccd8bf02fc8fa311ed8 VL - 69 ID - 8112 ER - TY - JOUR AD - Department of Dermatology, Southwest Hospital, Third Military Medical University, Chongqing, China. Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China. Department of Dermatology and Allergy, Technische Universita et Muenchen, Munich, Germany. AN - 25912722 AU - Song, Z. AU - Deng, X. AU - Chen, W. AU - Xu, J. AU - Chen, S. AU - Zhong, H. AU - Hao, F. DA - Nov DO - 10.1111/jdv.13172 10.1111/jdv.13172. Epub 2015 Apr 24. DP - Nlm ET - 2015/04/29 IS - 11 LA - eng PY - 2015 SN - 0926-9959 SP - 2169-76 ST - Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis T2 - J Eur Acad Dermatol Venereol TI - Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis VL - 29 ID - 8113 ER - TY - JOUR AD - P.-H. Lee, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan AU - Hsiao, C. C. AU - Chen, P. H. AU - Cheng, C. I. AU - Tsai, M. S. AU - Chang, C. Y. AU - Lu, S. C. AU - Hsieh, M. C. AU - Lin, Y. C. AU - Lee, P. H. AU - Kao, Y. H. DB - Embase Medline DO - 10.1016/j.canlet.2015.08.004 IS - 1 LA - English M3 - Article N1 - L605755127 2015-08-28 2015-09-03 PY - 2015 SN - 1872-7980 0304-3835 SP - 144-152 ST - Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells T2 - Cancer Letters TI - Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605755127&from=exporthttp://dx.doi.org/10.1016/j.canlet.2015.08.004 VL - 368 ID - 8114 ER - TY - JOUR AD - S.P. Singh, Division of Hematology & Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States AU - Bose, C. AU - Singh, S. P. AU - Igid, H. AU - Green, W. C. AU - Singhal, S. S. AU - Lee, J. AU - Palade, P. T. AU - Rajan, A. AU - Ball, S. AU - Tonk, V. AU - Hindle, A. AU - Tarbox, M. AU - Awasthi, S. C1 - azd 2461(Techne,United States) C2 - Sigma(United States) Techne(United States) DB - Embase DO - 10.3390/cancers11101556 IS - 10 LA - English M3 - Article N1 - L2002796111 2019-10-29 2019-11-05 PY - 2019 SN - 2072-6694 ST - Topical 2′-hydroxyflavanone for cutaneous melanoma T2 - Cancers TI - Topical 2′-hydroxyflavanone for cutaneous melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002796111&from=exporthttp://dx.doi.org/10.3390/cancers11101556 VL - 11 ID - 8115 ER - TY - JOUR AD - Y.S. Choi, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States AU - Choi, Y. S. AU - Dobry, A. S. AU - Hawryluk, E. B. AU - Zakka, L. R. AU - Mihm, M. C. AU - Fisher, D. E. DB - Embase DO - 10.1111/pcmr.12747 IS - 1 LA - English M3 - Conference Abstract N1 - L628190744 2019-06-25 PY - 2019 SN - 1755-148X SP - 176 ST - Topical hapten-based immunotherapy and MEK-targeted local therapy regress congenital melanocytic nevi in NRASQ61R-driven preclinical models of human giant congenital nevi T2 - Pigment Cell and Melanoma Research TI - Topical hapten-based immunotherapy and MEK-targeted local therapy regress congenital melanocytic nevi in NRASQ61R-driven preclinical models of human giant congenital nevi UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628190744&from=exporthttp://dx.doi.org/10.1111/pcmr.12747 VL - 32 ID - 8116 ER - TY - JOUR AD - G. Sun, Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China AU - Luo, Y. AU - Dong, X. AU - Yu, Y. AU - Sun, G. AU - Sun, X. DB - Embase Medline DO - 10.1016/j.jep.2015.01.017 LA - English M3 - Article N1 - L602260866 2015-02-26 2015-03-03 PY - 2015 SN - 1872-7573 0378-8741 SP - 241-250 ST - Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice T2 - Journal of Ethnopharmacology TI - Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602260866&from=exporthttp://dx.doi.org/10.1016/j.jep.2015.01.017 VL - 163 ID - 8117 ER - TY - JOUR AD - Neonatal Intensive Care Unit, Department of Health Promotion, Mother-Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University Hospital "P. Giaccone", Via Alfonso Giordano n. 3, 90127, Palermo, Italy Pediatric Surgery Unit, Department of Health Promotion, Mother-Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University Hospital "P. Giaccone", Via Alfonso Giordano n. 3, 90127, Palermo, Italy AN - 145947953. Language: English. Entry Date: 20201009. Revision Date: 20201009. Publication Type: Article AU - Schierz, Ingrid Anne Mandy AU - Cimador, Marcello AU - Giuffrè, Mario AU - Aiello, Claudia Maria AU - Antona, Vincenzo AU - Corsello, Giovanni AU - Piro, Ettore DB - ccm DO - 10.1186/s13052-020-00901-9 DP - EBSCOhost IS - 1 N1 - case study; diagnostic images; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed. NLM UID: 101510759. PY - 2020 SN - 1720-8424 SP - N.PAG-N.PAG ST - Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report T2 - Italian Journal of Pediatrics TI - Total colonic aganglionosis and cleft palate in a newborn with Janus-cysteine 618 mutation of RET proto-oncogene: a case report UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145947953&site=ehost-live&scope=site VL - 46 ID - 8118 ER - TY - JOUR AD - Pediatric Drug Development Unit, Children and Young People's Unit, Royal Marsden NHS Foundation Trust, Sutton, SM2 5PT, United Kingdom Pediatric Drug Development Team, Divisions of Cancer Therapeutics and Clinical Studies, Institute of Cancer Research, Sutton, United Kingdom Pediatric Oncology Department, Great Ormond Street Hospital, London, United Kingdom Institute of Child Health, University College London, London, United Kingdom AU - Morgenstern, D. A. AU - Hargrave, D. AU - Marshall, L. V. AU - Gatz, S. A. AU - Barone, G. AU - Crowe, T. AU - Pritchard-Jones, K. AU - Zacharoulis, S. AU - Lancaster, D. L. AU - Vaidya, S. J. AU - Chisholm, J. C. AU - Pearson, A. D. J. AU - Moreno, L. DB - Scopus DO - 10.1097/MPH.0000000000000003 IS - 3 M3 - Article N1 - Cited By :17 Export Date: 18 November 2020 PY - 2014 SP - 218-223 ST - Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: The Royal Marsden experience T2 - Journal of Pediatric Hematology/Oncology TI - Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: The Royal Marsden experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897476173&doi=10.1097%2fMPH.0000000000000003&partnerID=40&md5=bd6a043070e48d5d303da01cfba2524c VL - 36 ID - 8119 ER - TY - JOUR AD - E.J. Lowe, Children's Hospital of The King's Daughters, Norfolk, VA, United States AU - Lowe, E. J. AU - Reilly, A. AU - Bollard, C. M. AU - Barkauskas, D. A. AU - Buxton, A. B. AU - Hall, D. AU - Saguilig, L. AU - Sandlund, J. T. DB - Embase DO - 10.1182/blood-2018-99-118450 LA - English M3 - Conference Abstract N1 - L626530846 2019-03-04 PY - 2018 SN - 0006-4971 ST - Toxicity profile of brentuximab vedotin in combination with chemotherapy for newly diagnosed patients with ALK+ ALCL: A children's oncology group study ANHL12P1 T2 - Blood TI - Toxicity profile of brentuximab vedotin in combination with chemotherapy for newly diagnosed patients with ALK+ ALCL: A children's oncology group study ANHL12P1 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626530846&from=exporthttp://dx.doi.org/10.1182/blood-2018-99-118450 VL - 132 ID - 8120 ER - TY - JOUR AD - Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil Hematologia, Centro de Pesquisas Oncológicas (CEPON), Florianópolis, Brazil Hematologia, Hospital de Clínicas da Universidade Federal do Paraná (UFPR), Curitiba, Brazil AU - Silva, W. F. D. AU - Massaut, I. H. B. AU - Bendlin, R. M. AU - Rosa, L. I. AU - Velloso, E. D. R. P. AU - Rego, E. M. AU - Rocha, V. DB - Scopus DO - 10.1016/j.clml.2020.04.001 IS - 8 M3 - Article N1 - Export Date: 18 November 2020 PY - 2020 SP - e523-e528 ST - Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study T2 - Clinical Lymphoma, Myeloma and Leukemia TI - Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085100506&doi=10.1016%2fj.clml.2020.04.001&partnerID=40&md5=7315d98727550456c6ba9f35f2d15a37 VL - 20 ID - 8121 ER - TY - JOUR AD - J.W. Tyner, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Mailcode KR-HEM, Portland, OR, United States AU - Nechiporuk, T. AU - Kurtz, S. E. AU - Nikolova, O. AU - Liu, T. AU - Jones, C. L. AU - D’alessandro, A. AU - Culp-Hill, R. AU - D’almeida, A. AU - Joshi, S. K. AU - Rosenberg, M. AU - Tognon, C. E. AU - Danilov, A. V. AU - Druker, B. J. AU - Chang, B. H. AU - McWeeney, S. K. AU - Tyner, J. W. DB - Embase Medline DO - 10.1158/2159-8290.CD-19-0125 IS - 7 LA - English M3 - Article N1 - L2002229750 2019-08-06 2019-08-08 PY - 2019 SN - 2159-8290 2159-8274 SP - 910-925 ST - The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells T2 - Cancer Discovery TI - The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002229750&from=exporthttp://dx.doi.org/10.1158/2159-8290.CD-19-0125 VL - 9 ID - 8122 ER - TY - JOUR AD - Laboratorio de Genética Hematológica, IMEX, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina Servicio de Hematología, Hospital Ramos Mejía, Buenos Aires, Argentina Departamento de Hemato-oncología, Academia Nacional de Medicina, Buenos Aires, Argentina FUNDALEU, Buenos Aires, Argentina AU - Weich, N. AU - Ferri, C. AU - Moiraghi, B. AU - Bengió, R. AU - Giere, I. AU - Pavlovsky, C. AU - Larripa, I. AU - Fundia, A. DB - Scopus DO - 10.1016/j.bcmd.2016.05.007 M3 - Article N1 - Cited By :4 Export Date: 18 November 2020 PY - 2016 SP - 129-133 ST - TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome T2 - Blood Cells, Molecules, and Diseases TI - TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969951872&doi=10.1016%2fj.bcmd.2016.05.007&partnerID=40&md5=4b61450aeb97afc884376f533175b10c VL - 59 ID - 8123 ER - TY - JOUR AD - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. AN - 10934142 AU - Lawrence, B. AU - Perez-Atayde, A. AU - Hibbard, M. K. AU - Rubin, B. P. AU - Dal Cin, P. AU - Pinkus, J. L. AU - Pinkus, G. S. AU - Xiao, S. AU - Yi, E. S. AU - Fletcher, C. D. AU - Fletcher, J. A. C2 - PMC1850130 DA - Aug DO - 10.1016/s0002-9440(10)64550-6 10.1016/S0002-9440(10)64550-6. DP - Nlm ET - 2000/08/10 IS - 2 LA - eng PY - 2000 SN - 0002-9440 (Print) 0002-9440 SP - 377-84 ST - TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors T2 - Am J Pathol TI - TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors VL - 157 ID - 8124 ER - TY - JOUR AD - D.H. Teitelbaum, Department of Surgery, Section of Pediatric Surgery, University of Michigan, Mott Children's Hospital, 1540 E Hospital Dr.,SPC 4211, Ann Arbor, United States AU - Freeman, J. J. AU - Feng, Y. AU - Demehri, F. R. AU - Dempsey, P. J. AU - Teitelbaum, D. H. DB - Embase Medline DO - 10.1096/fj.14-269480 IS - 7 LA - English M3 - Article N1 - L605761059 2015-09-03 2015-09-08 PY - 2015 SN - 1530-6860 0892-6638 SP - 2943-2958 ST - TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways T2 - FASEB Journal TI - TPN-associated intestinal epithelial cell atrophy is modulated by TLR4/EGF signaling pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605761059&from=exporthttp://dx.doi.org/10.1096/fj.14-269480 VL - 29 ID - 8125 ER - TY - JOUR AD - University of Rochester Medical Center, Rochester, NY, United States Westchester Medical Center, New York Medical College, Valhalla, NY, United States AU - Schwartz, R. G. AU - Jain, D. AU - Storozynsky, E. DB - Scopus DO - 10.1007/s12350-013-9707-1 IS - 3 M3 - Review N1 - Cited By :63 Export Date: 18 November 2020 PY - 2013 SP - 443-464 ST - Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively T2 - Journal of Nuclear Cardiology TI - Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878013653&doi=10.1007%2fs12350-013-9707-1&partnerID=40&md5=fc2e5d2500270797a5d4869c321ae000 VL - 20 ID - 8126 ER - TY - JOUR AD - Dept of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy. secchier@mail.umbi.umd.edu AN - 12969966 AU - Secchiero, P. AU - Melloni, E. AU - Heikinheimo, M. AU - Mannisto, S. AU - Di Pietro, R. AU - Iacone, A. AU - Zauli, G. DA - Jan 15 DO - 10.1182/blood-2003-06-2137 10.1182/blood-2003-06-2137. Epub 2003 Sep 11. DP - Nlm ET - 2003/09/13 IS - 2 LA - eng PY - 2004 SN - 0006-4971 (Print) 0006-4971 SP - 517-22 ST - TRAIL regulates normal erythroid maturation through an ERK-dependent pathway T2 - Blood TI - TRAIL regulates normal erythroid maturation through an ERK-dependent pathway VL - 103 ID - 8127 ER - TY - JOUR AD - M. Kondyli, Division of Hematology/Oncology, CHU Sainte-Justine, Montreal, QC, Canada AU - Kondyli, M. AU - Ellezam, B. AU - Saint-Martin, C. AU - Farmer, J. P. AU - Crevier, L. AU - Perreault, S. AU - Jabado, N. DB - Embase DO - 10.1093/neuonc/nox168 LA - English M3 - Conference Abstract N1 - L619947817 2017-12-29 PY - 2017 SN - 1523-5866 SP - vi185-vi186 ST - Trametinib and dabrafenib for refractory/ inoperable pediatric low grade gliomas T2 - Neuro-Oncology TI - Trametinib and dabrafenib for refractory/ inoperable pediatric low grade gliomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619947817&from=exporthttp://dx.doi.org/10.1093/neuonc/nox168 VL - 19 ID - 8128 ER - TY - JOUR AD - Division of Hemato-Oncology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada. Department of Radiology, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Department of Pathology, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Hematology-Oncology Research Center, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Hemato-Oncology, Department of Pediatrics, McGill University Health Center, Montreal Children's Hospital, Montreal, QC, Canada. Division of Neurosurgery, Department of Surgery, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada. Division of Neurosurgery, Department of Surgery, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada. Division of Neurosurgery, Department of Pediatric Surgery, McGill University Health Center, Montreal, QC, Canada. Division of Child Neurology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, 3175 Chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada. s.perreault@umontreal.ca. AN - 30097824 AU - Kondyli, M. AU - Larouche, V. AU - Saint-Martin, C. AU - Ellezam, B. AU - Pouliot, L. AU - Sinnett, D. AU - Legault, G. AU - Crevier, L. AU - Weil, A. AU - Farmer, J. P. AU - Jabado, N. AU - Perreault, S. DA - Nov DO - 10.1007/s11060-018-2971-9 10.1007/s11060-018-2971-9. Epub 2018 Aug 10. DP - Nlm ET - 2018/08/12 IS - 2 LA - eng PY - 2018 SN - 0167-594x SP - 435-444 ST - Trametinib for progressive pediatric low-grade gliomas T2 - J Neurooncol TI - Trametinib for progressive pediatric low-grade gliomas VL - 140 ID - 8129 ER - TY - JOUR AD - N. Manoharan, Dana Farber Cancer Institute/Boston Children's Cancer and Blood Disorder Center, Boston, MA, United States AU - Manoharan, N. AU - Choi, J. AU - Chordas, C. AU - Zimmerman, M. A. AU - Scully, J. AU - Clymer, J. AU - Ullrich, N. J. AU - Filbin, M. AU - Bandopadhayay, P. AU - Chi, S. AU - Yeo, K. K. DB - Embase DO - 10.1093/neuonc/noz036.155 LA - English M3 - Conference Abstract N1 - L628910984 2019-08-20 PY - 2019 SN - 1523-5866 SP - AA101 ST - Trametinib for the treatment of recurrent/progressive pediatric low grade glioma: A single institution experience T2 - Neuro-Oncology TI - Trametinib for the treatment of recurrent/progressive pediatric low grade glioma: A single institution experience UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628910984&from=exporthttp://dx.doi.org/10.1093/neuonc/noz036.155 VL - 21 ID - 8130 ER - TY - JOUR AD - Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, MA, 02215-5450, USA. Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. Department of Radiology, Boston Children's Hospital, Boston, USA. Department of Neurology, Boston Children's Hospital, Boston, USA. Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, MA, 02215-5450, USA. keek_yeo@dfci.harvard.edu. AN - 32780261 AU - Manoharan, N. AU - Choi, J. AU - Chordas, C. AU - Zimmerman, M. A. AU - Scully, J. AU - Clymer, J. AU - Filbin, M. AU - Ullrich, N. J. AU - Bandopadhayay, P. AU - Chi, S. N. AU - Yeo, K. K. DA - Sep DO - 10.1007/s11060-020-03592-8 10.1007/s11060-020-03592-8. Epub 2020 Aug 11. DP - Nlm ET - 2020/08/12 IS - 2 LA - eng PY - 2020 SN - 0167-594x SP - 253-262 ST - Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma T2 - J Neurooncol TI - Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma VL - 149 ID - 8131 ER - TY - JOUR AD - G.B. McCowage AU - McCowage, G. B. AU - Mueller, S. AU - Pratilas, C. A. AU - Hargrave, D. R. AU - Moertel, C. L. AU - Whitlock, J. AU - Fox, E. AU - Hingorani, P. AU - Russo, M. W. AU - Dasgupta, K. AU - Tseng, L. AU - Mookerjee, B. AU - Geoerger, B. DB - Embase DO - 10.1200/JCO.2018.36.15_suppl.10504 IS - 15 LA - English M3 - Conference Abstract N1 - L625973254 2019-01-22 PY - 2018 SN - 1527-7755 ST - Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study T2 - Journal of Clinical Oncology TI - Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)-associated plexiform neurofibroma: A phase I/IIa study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L625973254&from=exporthttp://dx.doi.org/10.1200/JCO.2018.36.15_suppl.10504 VL - 36 ID - 8132 ER - TY - JOUR AD - J.A. Suárez, Hospital Sant Joan de Déu-Barcelona, Department of Pharmacy, Barcelona, Spain AU - Escoda, A. C. AU - Genestar, J. L. V. AU - Salvador, H. H. AU - Busquets, F. B. AU - Suárez, J. A. AU - Celma, M. S. DB - Embase DO - 10.1136/ejhpharm-2017-000640.289 LA - English M3 - Conference Abstract N1 - L617772590 2017-08-18 PY - 2017 SN - 2047-9964 SP - A131-A132 ST - Trametinib safety and acceptability in paediatric oncology patients: Experience based on a case series T2 - European Journal of Hospital Pharmacy TI - Trametinib safety and acceptability in paediatric oncology patients: Experience based on a case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617772590&from=exporthttp://dx.doi.org/10.1136/ejhpharm-2017-000640.289 VL - 24 ID - 8133 ER - TY - JOUR AD - E. Bouffet, University of Toronto Hospital for Sick Children, Toronto, ON, Canada AU - Bouffet, E. AU - Kieran, M. AU - Hargrave, D. AU - Roberts, S. AU - Aerts, I. AU - Broniscer, A. AU - Geoerger, B. AU - Dasgupta, K. AU - Tseng, L. AU - Russo, M. AU - Mookerjee, B. AU - Moertel, C. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098705 2018-07-25 PY - 2018 SN - 1523-5866 SP - i114 ST - Trametinib therapy in pediatric patients with low-grade gliomas (LGG) with BRAF gene fusion; A disease-specific cohort in the first pediatric testing of trametinib T2 - Neuro-Oncology TI - Trametinib therapy in pediatric patients with low-grade gliomas (LGG) with BRAF gene fusion; A disease-specific cohort in the first pediatric testing of trametinib UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098705&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 8134 ER - TY - JOUR AD - Division of Haematology/Oncology. Division of Endocrinology, The Hospital for Sick Children. Divison of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. AN - 30676433 AU - Egan, G. AU - Hamilton, J. AU - McKeown, T. AU - Bouffet, E. AU - Tabori, U. AU - Dirks, P. AU - Bartels, U. DA - May DO - 10.1097/mph.0000000000001427 10.1097/MPH.0000000000001427. DP - Nlm ET - 2019/01/25 IS - 4 LA - eng PY - 2020 SN - 1077-4114 SP - e248-e250 ST - Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings? T2 - J Pediatr Hematol Oncol TI - Trametinib Toxicities in Patients With Low-grade Gliomas and Diabetes Insipidus: Related Findings? VL - 42 ID - 8135 ER - TY - JOUR AD - Brain Tumor Center, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center. Department of Pediatrics, University of Cincinnati College of Medicine. Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. AN - 32520842 AU - Lazow, M. A. AU - Lawson, S. A. AU - Salloum, R. AU - Hummel, T. R. AU - Pillay Smiley, N. AU - DeWire-Schottmiller, M. D. AU - Fouladi, M. AU - de Blank, P. DA - Jun 9 DO - 10.1097/mph.0000000000001859 10.1097/MPH.0000000000001859. DP - Nlm ET - 2020/06/11 LA - eng PY - 2020 SN - 1077-4114 ST - Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor T2 - J Pediatr Hematol Oncol TI - Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor ID - 8136 ER - TY - JOUR AD - Department of Neurosciences, University of California and Rady Children's Hospital. Department of Pediatrics, Division of Hematology-Oncology, University of California San Diego and Rady Children's Hospital, San Diego, CA. AN - 32398601 AU - Paul, M. R. AU - Pehlivan, K. C. AU - Milburn, M. AU - Yeh-Nayre, L. AU - Elster, J. AU - Crawford, J. R. DA - Nov DO - 10.1097/mph.0000000000001819 10.1097/MPH.0000000000001819. DP - Nlm ET - 2020/05/14 IS - 8 LA - eng PY - 2020 SN - 1077-4114 SP - e730-e737 ST - Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience T2 - J Pediatr Hematol Oncol TI - Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience VL - 42 ID - 8137 ER - TY - JOUR AD - *Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY Divisions of †Cardiology ‡Hematology-Oncology, All Children's Hospital, St Petersburg, FL. AN - 26181424 AU - Modak, S. AU - Asante-Korang, A. AU - Steinherz, L. J. AU - Grana, N. DA - Aug DO - 10.1097/mph.0000000000000364 10.1097/MPH.0000000000000364. DP - Nlm ET - 2015/07/17 IS - 6 LA - eng PY - 2015 SN - 1077-4114 SP - e381-3 ST - Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma T2 - J Pediatr Hematol Oncol TI - Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma VL - 37 ID - 8138 ER - TY - JOUR AD - I. Lugowska, Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgen Street 5, Warsaw, Poland AU - Lugowska, I. AU - Koseła-Paterczyk, H. AU - Kozak, K. AU - Rutkowski, P. C1 - gsk 1120212 DB - Embase DO - 10.2147/OTT.S72951 LA - English M3 - Review N1 - L605766983 2015-09-02 2015-09-03 PY - 2015 SN - 1178-6930 SP - 2251-2259 ST - Trametinib: A MEK inhibitor for management of metastatic melanoma T2 - OncoTargets and Therapy TI - Trametinib: A MEK inhibitor for management of metastatic melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605766983&from=exporthttp://dx.doi.org/10.2147/OTT.S72951 VL - 8 ID - 8139 ER - TY - JOUR AD - Adis R & D Insight, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754, Auckland, New Zealand. dru@adis.com AN - 23846731 AU - Wright, C. J. AU - McCormack, P. L. DA - Jul DO - 10.1007/s40265-013-0096-1 10.1007/s40265-013-0096-1. DP - Nlm ET - 2013/07/13 IS - 11 LA - eng PY - 2013 SN - 0012-6667 SP - 1245-54 ST - Trametinib: first global approval T2 - Drugs TI - Trametinib: first global approval VL - 73 ID - 8140 ER - TY - JOUR AD - Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China AU - Huang, Q. AU - Yang, Y. AU - Li, X. AU - Huang, S. DB - Scopus DO - 10.1007/s13277-011-0222-1 IS - 6 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2011 SP - 1191-1197 ST - Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells T2 - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine TI - Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879789506&doi=10.1007%2fs13277-011-0222-1&partnerID=40&md5=098e25d14163ca7a7c05d681b5c8c586 VL - 32 ID - 8141 ER - TY - JOUR AD - A.R. Anvikar, Epidemiology and Clinical Research Division, ICMR-National Institute of Malaria Research, New Delhi, India AU - Ahmed, M. Z. AU - Bhardwaj, N. AU - Sharma, S. AU - Pande, V. AU - Anvikar, A. R. DB - Embase Medline DO - 10.3390/biom9100600 IS - 10 LA - English M3 - Article N1 - L2002777393 2019-10-23 2019-12-16 PY - 2019 SN - 2218-273X ST - Transcriptional modulation of the host immunity mediated by cytokines and transcriptional factors in plasmodium falciparum-infected patients of north-east India T2 - Biomolecules TI - Transcriptional modulation of the host immunity mediated by cytokines and transcriptional factors in plasmodium falciparum-infected patients of north-east India UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2002777393&from=exporthttp://dx.doi.org/10.3390/biom9100600 VL - 9 ID - 8142 ER - TY - JOUR AD - H. Azevedo, Department of Pediatrics, Faculdade de Medicina da Universidade de Sao Paulo (FMUSP), São Paulo, SP, Brazil AU - Azevedo, H. AU - Fujita, A. AU - Bando, S. Y. AU - Iamashita, P. AU - Moreira-Filho, C. A. DB - Embase Medline DO - 10.1371/journal.pone.0110934 IS - 11 LA - English M3 - Article N1 - L600373044 2014-11-20 2014-11-24 PY - 2014 SN - 1932-6203 ST - Transcriptional network analysis reveals that AT1 and AT2 Angiotensin II receptors are both involved in the regulation of genes essential for glioma progression T2 - PLoS ONE TI - Transcriptional network analysis reveals that AT1 and AT2 Angiotensin II receptors are both involved in the regulation of genes essential for glioma progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600373044&from=exporthttp://dx.doi.org/10.1371/journal.pone.0110934 VL - 9 ID - 8143 ER - TY - JOUR AD - J. R. Dry, 33G83 Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom AU - Dry, J. R. AU - Pavey, S. AU - Pratilas, C. A. AU - Harbron, C. AU - Runswick, S. AU - Hodgson, D. AU - Chresta, C. AU - McCormack, R. AU - Byrne, N. AU - Cockerill, M. AU - Graham, A. AU - Beran, G. AU - Cassidy, A. AU - Haggerty, C. AU - Brown, H. AU - Ellison, G. AU - Dering, J. AU - Taylor, B. S. AU - Stark, M. AU - Bonazzi, V. AU - Ravishankar, S. AU - Packer, L. AU - Xing, F. AU - Solit, D. B. AU - Finn, R. S. AU - Rosen, N. AU - Hayward, N. K. AU - French, T. AU - Smith, P. D. C1 - azd 6244 DB - Embase Medline DO - 10.1158/0008-5472.CAN-09-1577 IS - 6 L1 - internal-pdf://1335939811/2264.full.pdf LA - English M3 - Article N1 - L358549108 2010-04-08 2010-04-28 PY - 2010 SN - 0008-5472 1538-7445 SP - 2264-2273 ST - Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244) T2 - Cancer Research TI - Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244) UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358549108&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-09-1577 VL - 70 ID - 8144 ER - TY - JOUR AD - K.P.H. Lim, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Missouri City, TX, United States AU - Lim, K. P. H. AU - Milne, P. AU - Poidinger, M. AU - Lin, H. AU - Duan, K. AU - Merad, M. AU - Newell, E. AU - Chakraborty, R. AU - Eckstein, O. S. AU - Zinn, D. AU - Abhyankar, H. AU - McClain, K. L. AU - Man, C. T. K. AU - Ginhoux, F. AU - Collin, M. P. AU - Allen, C. E. DB - Embase LA - English M3 - Conference Abstract N1 - L620334685 2018-01-30 PY - 2017 SN - 1528-0020 ST - Transcriptional profiles, lineage tracing with BRAF-V600E and HLA-DQB2 expression support a model of blood CD1c+ cells as precursors to LCH Lesion CD207+ Cells T2 - Blood TI - Transcriptional profiles, lineage tracing with BRAF-V600E and HLA-DQB2 expression support a model of blood CD1c+ cells as precursors to LCH Lesion CD207+ Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620334685&from=export VL - 130 ID - 8145 ER - TY - JOUR AD - School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, Jiangsu, China School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang, Jiangsu, China Institute of Environmental Health and Ecological Security, Jiangsu University, Zhenjiang, Jiangsu, China AU - Ding, Y. AU - Gao, K. AU - Liu, Y. AU - Mao, G. AU - Chen, K. AU - Qiu, X. AU - Zhao, T. AU - Yang, L. AU - Feng, W. AU - Wu, X. DB - Scopus DO - 10.1007/s00204-019-02590-8 IS - 11 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2019 SP - 3183-3206 ST - Transcriptome analysis revealed the mechanism of the metabolic toxicity and susceptibility of di-(2-ethylhexyl)phthalate on adolescent male ICR mice with type 2 diabetes mellitus T2 - Archives of Toxicology TI - Transcriptome analysis revealed the mechanism of the metabolic toxicity and susceptibility of di-(2-ethylhexyl)phthalate on adolescent male ICR mice with type 2 diabetes mellitus UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074229900&doi=10.1007%2fs00204-019-02590-8&partnerID=40&md5=f18206e4a5f09ed7cf61090372123d2e VL - 93 ID - 8146 ER - TY - JOUR AD - S. Burdach, Department of Pediatrics and Children's Cancer Research Center, Kinderklinik München Schwabing, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Munich, Germany AU - Weidenbusch, B. AU - Richter, G. H. S. AU - Kesper, M. S. AU - Guggemoos, M. AU - Gall, K. AU - Prexler, C. AU - Kazantsev, I. AU - Sipol, A. AU - Lindner, L. AU - Nathrath, M. AU - Witt, O. AU - Specht, K. AU - Beitinger, F. AU - Knebel, C. AU - Hosie, S. AU - von Eisenhardt-Rothe, R. AU - Weichert, W. AU - Teichert-von Luettichau, I. AU - Burdach, S. DB - Embase DO - 10.18632/oncotarget.25087 IS - 29 LA - English M3 - Article N1 - L621732356 2018-04-24 2018-05-03 PY - 2018 SN - 1949-2553 SP - 20747-20760 ST - Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy T2 - Oncotarget TI - Transcriptome based individualized therapy of refractory pediatric sarcomas: Feasibility, tolerability and efficacy UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621732356&from=exporthttp://dx.doi.org/10.18632/oncotarget.25087 VL - 9 ID - 8147 ER - TY - JOUR AD - Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, United Kingdom. AN - 20416888 AU - Ghorbel, M. T. AU - Cherif, M. AU - Jenkins, E. AU - Mokhtari, A. AU - Kenny, D. AU - Angelini, G. D. AU - Caputo, M. C2 - PMC2951593 C6 - UKMS32141 DA - Aug DO - 10.1016/j.jtcvs.2009.12.055 10.1016/j.jtcvs.2009.12.055. Epub 2010 Apr 22. DP - Nlm ET - 2010/04/27 IS - 2 LA - eng PY - 2010 SN - 0022-5223 (Print) 0022-5223 SP - 337-345.e26 ST - Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression T2 - J Thorac Cardiovasc Surg TI - Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression VL - 140 ID - 8148 ER - TY - JOUR AD - Department of Pathology and Cytology, Karolinska Institute and Hospital, Stockholm, Sweden. AN - 7579458 AU - Elmberger, P. G. AU - Lozano, M. D. AU - Weisenburger, D. D. AU - Sanger, W. AU - Chan, W. C. DA - Nov 1 DP - Nlm ET - 1995/11/01 IS - 9 LA - eng N1 - Elmberger, P G Lozano, M D Weisenburger, D D Sanger, W Chan, W C CA36727/CA/NCI NIH HHS/United States Journal Article Research Support, U.S. Gov't, P.H.S. United States Blood. 1995 Nov 1;86(9):3517-21. PY - 1995 SN - 0006-4971 (Print) 0006-4971 SP - 3517-21 ST - Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions T2 - Blood TI - Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions VL - 86 ID - 8149 ER - TY - JOUR AD - A. Leonardi, via Giustiniani 2, 35128 Padova, Italy AU - Leonardi, A. AU - Di Stefano, A. AU - Motterle, L. AU - Zavan, B. AU - Abatangelo, G. AU - Brun, P. DB - Embase Medline DO - 10.1111/j.1365-2222.2010.03626.x IS - 1 LA - English M3 - Article N1 - L360135433 2010-12-20 2010-12-23 PY - 2011 SN - 0954-7894 1365-2222 SP - 52-60 ST - Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis T2 - Clinical and Experimental Allergy TI - Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L360135433&from=exporthttp://dx.doi.org/10.1111/j.1365-2222.2010.03626.x VL - 41 ID - 8150 ER - TY - JOUR AD - Department of Pediatrics and Child Neurology, Oita University Faculty of Medicine, Oita, Japan. AN - 23950000 AU - Sekiguchi, K. AU - Maeda, T. AU - Suenobu, S. AU - Kunisaki, N. AU - Shimizu, M. AU - Kiyota, K. AU - Handa, Y. S. AU - Akiyoshi, K. AU - Korematsu, S. AU - Aoki, Y. AU - Matsubara, Y. AU - Izumi, T. DA - Oct DO - 10.1002/ajmg.a.36107 10.1002/ajmg.a.36107. Epub 2013 Aug 15. DP - Nlm ET - 2013/08/21 IS - 10 LA - eng PY - 2013 SN - 1552-4825 SP - 2600-3 ST - A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation T2 - Am J Med Genet A TI - A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation VL - 161a ID - 8151 ER - TY - JOUR AD - Fred Hutchinson Cancer Research Center, The University of Washington, Seattle, WA, United States Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States AU - Carpenter, P. A. AU - Meshinchi, S. AU - Davies, S. M. DB - Scopus DO - 10.1016/j.bbmt.2011.10.035 IS - 1 SUPPL. M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2012 SP - S33-S39 ST - Transplantation for AML in Children T2 - Biology of Blood and Marrow Transplantation TI - Transplantation for AML in Children UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855379199&doi=10.1016%2fj.bbmt.2011.10.035&partnerID=40&md5=71a07c1d78bf10aa42d3328b0af01ef8 VL - 18 ID - 8152 ER - TY - JOUR AD - G. Fond, Service Universitaire de Psychiatrie Adulte (Pr JP. Boulenger), Hôpital la Colombiere, CHU Montpellier, 39, avenue Charles Flahault 34295, Montpellier cedex 05, France AU - Fond, G. AU - MacGregor, A. AU - Attal, J. AU - Larue, A. AU - Brittner, M. AU - Ducasse, D. AU - Capdevielle, D. DB - Embase Medline DO - 10.1111/j.1440-1819.2012.02359.x IS - 5 LA - English M3 - Review N1 - L365337124 2012-08-07 2012-08-09 PY - 2012 SN - 1323-1316 1440-1819 SP - 375-382 ST - Treating patients with schizophrenia deficit with erythropoietin? T2 - Psychiatry and Clinical Neurosciences TI - Treating patients with schizophrenia deficit with erythropoietin? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L365337124&from=exporthttp://dx.doi.org/10.1111/j.1440-1819.2012.02359.x VL - 66 ID - 8153 ER - TY - JOUR AD - Patan Academy of Health Science, Kathmandu, Nepal Patan Hospital, Kathmandu, Nepal National Health Service Blood and Transplant and Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom Oxford University Clinical Research Unit-Nepal, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States Department of Oncology, Mayo Clinic, Rochester, MN, United States AU - Kayastha, G. K. AU - Ranjitkar, N. AU - Gurung, R. AU - Raj K, K. C. AU - Karki, S. AU - Shrestha, R. AU - Thapa, R. K. AU - Rajbhandari, P. AU - Poudyal, B. AU - Acharya, P. AU - Roberts, D. J. AU - Hayes, B. AU - Zimmerman, M. AU - Basnyat, B. AU - Mansfield, A. DB - Scopus DO - 10.1111/bjh.14645 IS - 6 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2017 SP - 991-999 ST - Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal T2 - British Journal of Haematology TI - Treating Philadelphia chromosome/BCR-ABL1 positive patients with Glivec (Imatinib mesylate): 10 years’ experience at Patan Hospital, Nepal UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016558897&doi=10.1111%2fbjh.14645&partnerID=40&md5=02c88988da7658edc4936c7db444823d VL - 177 ID - 8154 ER - TY - JOUR AD - Institute for Medical Information Sciences, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Marchioninistrasse 15, München, 81377, Germany University of Bologna, Bologna, Italy Institute of Hematology 'L and A Seragnoli, Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy Division of Hematology, AOU Policlinico-OVE, University of Catania, Catania, Italy Servicio de Hematologiá, Hospital Virgen de la Salud, Toledo, Spain Federal State-Funded Institution, National Research Center for Hematology', Ministry of Healthcare of Russian Federation, Moscow, Russian Federation Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Haematology, VU University Medical Center, Amsterdam, Netherlands St Petersburg State Medical University, St Petersburg, Russian Federation University of Uppsala, Uppsala, Sweden Department Hemato-oncology, University Hospital Olomouc, Olomouc, Czech Republic Department of Hematology, University Hospital, Bratislava, Slovakia Katedra i Klinika Hematologii UJCM, Kraków, Poland Royal Liverpool University, Liverpool, United Kingdom Clinic of Hematology CCS, Faculty of Medicine, University of Belgrade, Belgrade, Serbia Department of Hematology and Transplantation, Medical University of Gdansk, Gdansk, Poland Vilnius University, Hospital Santariskiu Klinikos, Vilnius, Lithuania Munich Cancer Registry, Ludwig-Maximilians-Universitaet, Munich, Germany Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia INSERM CIC, CHU Poitiers, Poitiers, France Riga East Clinical University, Riga, Latvia Department of Hematology, University Clinical Centre, Ljubljana, Slovenia Klinikum Wells-Grieskirchen Wells, Austria Helsinki University Central Hospital, Hematology Research Unit, Biomedicum Helsinki, Helsinki, Finland Tartu University Hospital, Tartu, Estonia Karaiskakio Foundation, Nicosia, Cyprus Department of Oncology and Hematology, St Orsola University Hospital, Bologna, Italy III. Medizinische Klinik, University of Heidelberg at Mannheim, Mannheim, Germany Abteilung Hämatologie Onkologie, Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany AU - Hoffmann, V. S. AU - Baccarani, M. AU - Hasford, J. AU - Castagnetti, F. AU - Di Raimondo, F. AU - Casado, L. F. AU - Turkina, A. AU - Zackova, D. AU - Ossenkoppele, G. AU - Zaritskey, A. AU - Höglund, M. AU - Simonsson, B. AU - Indrak, K. AU - Sninska, Z. AU - Sacha, T. AU - Clark, R. AU - Bogdanovic, A. AU - Hellmann, A. AU - Griskevicius, L. AU - Schubert-Fritschle, G. AU - Sertic, D. AU - Guilhot, J. AU - Lejniece, S. AU - Zupan, I. AU - Burgstaller, S. AU - Koskenvesa, P. AU - Everaus, H. AU - Costeas, P. AU - Lindoerfer, D. AU - Rosti, G. AU - Saussele, S. AU - Hochhaus, A. AU - Hehlmann, R. DB - Scopus DO - 10.1038/leu.2016.246 IS - 3 M3 - Article N1 - Cited By :41 Export Date: 18 November 2020 PY - 2017 SP - 593-601 ST - Treatment and outcome of 2904 CML patients from the EUTOS population-based registry T2 - Leukemia TI - Treatment and outcome of 2904 CML patients from the EUTOS population-based registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988566338&doi=10.1038%2fleu.2016.246&partnerID=40&md5=8548882baf9d0bd4b6b2e26388f02164 VL - 31 ID - 8155 ER - TY - JOUR AD - Department of Woman’s and Child’s Health, University of Padua, Via Giustiniani 3, Padua, 35128, Italy AU - Zulian, F. AU - Tirelli, F. C7 - 45 DB - Scopus DO - 10.1007/s11926-020-00910-x IS - 8 M3 - Review N1 - Export Date: 18 November 2020 PY - 2020 ST - Treatment in Juvenile Scleroderma T2 - Current Rheumatology Reports TI - Treatment in Juvenile Scleroderma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086847271&doi=10.1007%2fs11926-020-00910-x&partnerID=40&md5=8a9b7c5c5ca6bd77a3193323096f7a9d VL - 22 ID - 8156 ER - TY - JOUR AD - Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States Department of Haematology, University College Hospital Galway (UCHG), Galway, Ireland Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio, CTRC Institute for Drug Development, San Antonio, TX, United States Division of Hematology and Medical Oncology, University of Texas Health Science Center at San Antonio, CTRC Institute for Drug Development, 7979 Wurzbach Road, San Antonio, TX 78229, United States AU - Apostolidou, E. AU - Swords, R. AU - Alvarado, Y. AU - Giles, F. J. DB - Scopus DO - 10.2165/00003495-200767150-00004 IS - 15 M3 - Review N1 - Cited By :44 Export Date: 18 November 2020 PY - 2007 SP - 2153-2171 ST - Treatment of acute lymphoblastic leukaemia: A new era T2 - Drugs TI - Treatment of acute lymphoblastic leukaemia: A new era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-35048824745&doi=10.2165%2f00003495-200767150-00004&partnerID=40&md5=7bc90eaf48eafb6e483f3557bb15c22f VL - 67 ID - 8157 ER - TY - JOUR AD - Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada AU - Brandwein, J. M. DB - Scopus DO - 10.1007/s11912-011-0185-9 IS - 5 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2011 SP - 371-378 ST - Treatment of acute lymphoblastic leukemia in adolescents and young adults T2 - Current Oncology Reports TI - Treatment of acute lymphoblastic leukemia in adolescents and young adults UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80755139631&doi=10.1007%2fs11912-011-0185-9&partnerID=40&md5=bc874370b101d5ebf40e87a2f4e6a526 VL - 13 ID - 8158 ER - TY - JOUR AD - E. Derenzini, Institute of Hematology and Medical Oncology L.A. Seragnoli, Department of Experimental, Diagnostic and Specialty Medicine- DIMES, University of Bologna, Bologna, Italy AU - Derenzini, E. AU - Zinzani, P. L. DB - Embase LA - English M3 - Conference Abstract N1 - L72081192 2015-11-27 PY - 2015 SN - 0390-6078 SP - 200-202 ST - Treatment of adult langerhans cell histiocytosis T2 - Haematologica TI - Treatment of adult langerhans cell histiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L72081192&from=exporthttp://www.haematologica.org/content/100/supplement_3/1.full-text.pdf+html VL - 100 ID - 8159 ER - TY - JOUR AD - J.B. Aragon-Ching, Division of Hematology and Oncology, Department of Medicine, George Washington University Medical Center, 2150 Pennsylvania Avenue, NW, Washington, DC 20037, United States AU - Aragon-Ching, J. B. AU - Maki, R. G. C1 - et 743 yondelis DB - Embase Medline DO - 10.3109/07357907.2012.658936 IS - 4 LA - English M3 - Article N1 - L364675375 2012-05-07 PY - 2012 SN - 0735-7907 1532-4192 SP - 300-308 ST - Treatment of adult soft tissue sarcoma: Old concepts, new insights, and potential for drug discovery T2 - Cancer Investigation TI - Treatment of adult soft tissue sarcoma: Old concepts, new insights, and potential for drug discovery UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364675375&from=exporthttp://dx.doi.org/10.3109/07357907.2012.658936 VL - 30 ID - 8160 ER - TY - JOUR AD - Department of Pediatric Oncology/Hematology, VU University Medical Center, De Boelelaan 1117, NL-1080 HV Amsterdam, Netherlands Department of Pediatrics, Division of Oncology-Hematology, VU University Medical Center, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands AU - ter Bals, E. AU - Kaspers, G. J. L. DB - Scopus DO - 10.1586/14737140.5.5.917 IS - 5 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2005 SP - 917-929 ST - Treatment of childhood acute myeloid leukemia T2 - Expert Review of Anticancer Therapy TI - Treatment of childhood acute myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744598066&doi=10.1586%2f14737140.5.5.917&partnerID=40&md5=c7bae89f438dd895cebdc15ba9b0ef08 VL - 5 ID - 8161 ER - TY - JOUR AD - M.A. Pulsipher, Division of Hematology, Univ. of Utah School of Medicine, Primary Children's Medical Center, 50 North Medical Drive, Salt Lake City, UT 84132, United States AU - Pulsipher, M. A. C1 - gleevec sti 571 DB - Embase Medline DO - 10.1002/pbc.20062 IS - 5 LA - English M3 - Review N1 - L39313948 2004-10-21 PY - 2004 SN - 1545-5009 SP - 523-533 ST - Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? T2 - Pediatric Blood and Cancer TI - Treatment of CML in pediatric patients: Should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L39313948&from=exporthttp://dx.doi.org/10.1002/pbc.20062 VL - 43 ID - 8162 ER - TY - JOUR AD - Department of Hemato-Oncology, University Hospital, Olomouc, Czech Republic Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic Department of Hemato-Oncology, University Hospital, Plzeň, Czech Republic Department of Hematology and Blood Transfusion, University Hospital, Bratislava, Slovakia 2nd Department of Internal Medicine, Division of Hematology, University Hospital, Hradec Králové, Czech Republic Department of Internal Medicine, National Oncology Institute, Bratislava, Slovakia Department of Hematology and Blood Transfusion, University Hospital, Martin, Slovakia Department of Hematology, FD Roosevelt University Hospital, Banská Bystrica, Slovakia Department of Internal Medicine, Division of Hematology, General University Hospital, Prague, Czech Republic Department of Hematology, University Hospital, Královské Vinohrady, Prague, Czech Republic Department of Hematology and Hemato-Oncology, L Pasteur University Hospital, Košice, Slovakia AU - Faber, E. AU - Mužík, J. AU - Koza, V. AU - Demečková, E. AU - Voglová, J. AU - Demitrovičová, L. AU - Chudej, J. AU - Markuljak, I. AU - Cmunt, E. AU - Kozák, T. AU - Tóthová, E. AU - Jarošová, M. AU - Dušek, L. AU - Indrák, K. DB - Scopus DO - 10.1111/j.1600-0609.2011.01637.x IS - 2 M3 - Article N1 - Cited By :31 Export Date: 18 November 2020 PY - 2011 SP - 157-168 ST - Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry T2 - European Journal of Haematology TI - Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960408943&doi=10.1111%2fj.1600-0609.2011.01637.x&partnerID=40&md5=e987b2405fa172f1d3cb414305c6c8ba VL - 87 ID - 8163 ER - TY - JOUR AD - Merck Pharmaceuticals, North Wales, PA, United States Division of Pediatric Hematology/Oncology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States Division of Pediatric Hematology/Oncology, Department of Oncology, Essentia Health Duluth Clinic, Duluth, MN, United States Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States AU - Bidadi, B. AU - Watson, A. AU - Weigel, B. AU - Oliveira, A. AU - Kirkham, J. AU - Arndt, C. C7 - e28288 DB - Scopus DO - 10.1002/pbc.28288 IS - 6 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 ST - Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report T2 - Pediatric Blood and Cancer TI - Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083663846&doi=10.1002%2fpbc.28288&partnerID=40&md5=a837b790d9c673fa14834f59df7c942c VL - 67 ID - 8164 ER - TY - JOUR AD - J.L. Finlay, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States AU - Finlay, J. L. AU - Zacharoulis, S. C1 - gw 572016 iressa osi 774 r 115777 sch 66336 tarceva zd 1839 DB - Embase Medline DO - 10.1007/s11060-005-6747-7 IS - 3 LA - English M3 - Review N1 - L43023756 2006-01-18 PY - 2005 SN - 0167-594X 1573-7373 SP - 253-266 ST - The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical - and futuristic - perspective T2 - Journal of Neuro-Oncology TI - The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical - and futuristic - perspective UR - https://www.embase.com/search/results?subaction=viewrecord&id=L43023756&from=exporthttp://dx.doi.org/10.1007/s11060-005-6747-7 VL - 75 ID - 8165 ER - TY - JOUR AD - S. Weitzman, Division of Haematology/Oncology, Department of Pediatrics, Hospital for Sick Children, 555 University Ave, Toronto, ON, Canada AU - Abla, O. AU - Weitzman, S. DB - Embase Medline DO - 10.1182/asheducation-2015.1.565 IS - 1 LA - English M3 - Article N1 - L614261626 2017-02-06 2017-02-09 PY - 2015 SN - 1520-4383 1520-4391 SP - 565-570 ST - Treatment of Langerhans cell histiocytosis: Role of BRAF/MAPK inhibition TI - Treatment of Langerhans cell histiocytosis: Role of BRAF/MAPK inhibition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614261626&from=exporthttp://dx.doi.org/10.1182/asheducation-2015.1.565 VL - 2015 ID - 8166 ER - TY - JOUR AD - R.J. Antaya, Department of Dermatology, Yale University School of Medicine, New Haven, CT, United States R.J. Antaya, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States AU - Sun, Q. AU - Antaya, R. J. DB - Embase Medline DO - 10.1111/pde.14276 IS - 5 LA - English M3 - Article N1 - L2005520939 2020-07-17 PY - 2020 SN - 1525-1470 0736-8046 SP - 970-971 ST - Treatment of MEK inhibitor-induced paronychia with doxycycline T2 - Pediatric Dermatology TI - Treatment of MEK inhibitor-induced paronychia with doxycycline UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005520939&from=exporthttp://dx.doi.org/10.1111/pde.14276 VL - 37 ID - 8167 ER - TY - JOUR AD - Division of Hematology and Oncology, 1956 The Vanderbilt Clinic, 22nd Avenue, Nashville, TN 37232-5536, United States AU - Johnson, D. H. AU - Sandler, A. DB - Scopus IS - 1 M3 - Review N1 - Cited By :1 Export Date: 18 November 2020 PY - 2001 SP - 133-164 ST - Treatment of metastatic non-small-cell lung cancer T2 - Chest Surgery Clinics of North America TI - Treatment of metastatic non-small-cell lung cancer UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035099625&partnerID=40&md5=f626fe7c069ce2cd8327224d0d8975e5 VL - 11 ID - 8168 ER - TY - JOUR AD - Division of Pediatric Hematology-Oncology, Rady Children's Hospital-San Diego, University of California, 3020 Children's Way, MC 5035, San Diego, CA 92123, United States Division of Pediatric Hematology-Oncology, St Joseph's Children's Hospital, Paterson, NJ, United States Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, NY, United States AU - Kuo, D. J. AU - Menell, J. S. AU - Bender, J. L. G. DB - Scopus DO - 10.1097/MPH.0000000000000571 IS - 5 M3 - Review N1 - Cited By :6 Export Date: 18 November 2020 PY - 2016 SP - e169-e172 ST - Treatment of metastatic, refractory alveolar soft part sarcoma: Case reports and literature review of treatment options in the era of targeted therapy T2 - Journal of Pediatric Hematology/Oncology TI - Treatment of metastatic, refractory alveolar soft part sarcoma: Case reports and literature review of treatment options in the era of targeted therapy UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84966293296&doi=10.1097%2fMPH.0000000000000571&partnerID=40&md5=b77996d72636de5b3e4d2a65bc43e947 VL - 38 ID - 8169 ER - TY - JOUR AD - University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Subbiah, V. AU - Slopis, J. AU - Hong, D. S. AU - Ketonen, L. M. AU - Hamilton, J. AU - McCutcheon, I. E. AU - Kurzrock, R. DB - Scopus DO - 10.1200/JCO.2011.38.2614 IS - 5 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2012 SP - e64-e68 ST - Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: From bench to bedside T2 - Journal of Clinical Oncology TI - Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: From bench to bedside UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856873458&doi=10.1200%2fJCO.2011.38.2614&partnerID=40&md5=de18c10a62e2ae1c86e5f34376d99a79 VL - 30 ID - 8170 ER - TY - JOUR AD - Department of Pediatrics, Catholic University of Korea Colledge of Medicine, Seoul, South Korea AU - Lee, J. W. AU - Chung, N. G. DB - Scopus DO - 10.3345/kjp.2011.54.3.110 IS - 3 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2011 SP - 110-115 ST - The treatment of pediatric chronic myelogenous leukemia in the imatinib era T2 - Korean Journal of Pediatrics TI - The treatment of pediatric chronic myelogenous leukemia in the imatinib era UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958069450&doi=10.3345%2fkjp.2011.54.3.110&partnerID=40&md5=290f69840b3a5cdb0d4f4898d62fa5db VL - 54 ID - 8171 ER - TY - JOUR AD - Division of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Carl Gustav Carus, Dresden, Germany. AU - Suttorp, M. AU - Millot, F. DB - Scopus DO - 10.1182/asheducation-2010.1.368 M3 - Review N1 - Cited By :71 Export Date: 18 November 2020 PY - 2010 SP - 368-376 ST - Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955040838&doi=10.1182%2fasheducation-2010.1.368&partnerID=40&md5=8a617123d89a737b9bb704a573faf749 VL - 2010 ID - 8172 ER - TY - JOUR AD - R. Kobayashi, Department of Pediatrics, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishiku Sapporo, Hokkaido, Japan AU - Kobayashi, R. AU - Sunami, S. AU - Mitsui, T. AU - Nakazawa, A. AU - Koga, Y. AU - Mori, T. AU - Tanaka, F. AU - Ueyama, J. I. AU - Osumi, T. AU - Fukano, R. AU - Ohki, K. AU - Sekimizu, M. AU - Mori, T. DB - Embase Medline DO - 10.1111/ped.12725 IS - 4 LA - English M3 - Review N1 - L605838752 2015-09-04 2015-09-08 PY - 2015 SN - 1442-200X 1328-8067 SP - 523-534 ST - Treatment of pediatric lymphoma in Japan: Current status and plans for the future T2 - Pediatrics International TI - Treatment of pediatric lymphoma in Japan: Current status and plans for the future UR - https://www.embase.com/search/results?subaction=viewrecord&id=L605838752&from=exporthttp://dx.doi.org/10.1111/ped.12725 VL - 57 ID - 8173 ER - TY - JOUR AD - Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada AU - Thyagu, S. AU - Minden, M. D. AU - Gupta, V. AU - Yee, K. W. AU - Schimmer, A. D. AU - Schuh, A. C. AU - Lipton, J. H. AU - Messner, H. A. AU - Xu, W. AU - Brandwein, J. M. DB - Scopus DO - 10.1111/j.1365-2141.2012.09182.x IS - 4 M3 - Article N1 - Cited By :16 Export Date: 18 November 2020 PY - 2012 SP - 506-514 ST - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol T2 - British Journal of Haematology TI - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864297804&doi=10.1111%2fj.1365-2141.2012.09182.x&partnerID=40&md5=0d6e7f6c026df0a0bb37d6ee534fd9ba VL - 158 ID - 8174 ER - TY - JOUR AD - Bone Marrow Transplantation Unit, Hospital Italiano de la Plata, La Plata, Argentina AU - Milone, J. H. AU - Enrico, A. DB - Scopus DO - 10.3109/10428190903370395 IS - SUPPL. 2 M3 - Review N1 - Cited By :7 Export Date: 18 November 2020 PY - 2009 SP - 9-15 ST - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia T2 - Leukemia and Lymphoma TI - Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73849107115&doi=10.3109%2f10428190903370395&partnerID=40&md5=c2e03e6bf15c44af445027f3b1afa2e9 VL - 50 ID - 8175 ER - TY - JOUR AD - Box 428, University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States AU - Kantarjian, H. M. AU - O'Brien, S. AU - Cortes, J. E. AU - Smith, T. L. AU - Rios, M. B. AU - Shan, J. AU - Yang, Y. AU - Giles, F. J. AU - Thomas, D. A. AU - Faderl, S. AU - Garcia-Manero, G. AU - Jeha, S. AU - Wierda, W. AU - Issa, J. P. J. AU - Kornblau, S. M. AU - Keating, M. AU - Resta, D. AU - Capdeville, R. AU - Talpaz, M. DB - Scopus IS - 7 M3 - Article N1 - Cited By :98 Export Date: 18 November 2020 PY - 2002 SP - 2167-2176 ST - Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate T2 - Clinical Cancer Research TI - Treatment of Philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035992318&partnerID=40&md5=68571b6b8a7ff866151d1e7e3261a26a VL - 8 ID - 8176 ER - TY - JOUR AD - Emory University Winship Cancer Institute, Atlanta, GA, United States AU - Arellano, M. L. AU - Langston, A. AU - Winton, E. AU - Flowers, C. R. AU - Waller, E. K. DB - Scopus DO - 10.1016/j.bbmt.2006.09.005 IS - 1 M3 - Article N1 - Cited By :73 Export Date: 18 November 2020 PY - 2007 SP - 116-123 ST - Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience T2 - Biology of Blood and Marrow Transplantation TI - Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center Experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846007694&doi=10.1016%2fj.bbmt.2006.09.005&partnerID=40&md5=baba69a87815ecc6e8d67f7b5fdbc643 VL - 13 ID - 8177 ER - TY - JOUR AD - Parker Hughes Cancer Center, Hughes Institute, St. Paul, MN 55113, United States Biotherapy Program, Univ. of MN Academic Health Center, Minneapolis, MN 55455, United States Kenneth Norris Cancer Center, University of Southern California, Los Angeles, CA 90033, United States Univ. of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States Cedar Sinai Medical Center, Los Angeles, CA 90048, United States University of Wisconsin, Milwaukee, WI 53226, United States Hughes Institute, 2665 Long Lake Road, St. Paul, MN 55113, United States AU - Uckun, F. M. AU - Messinger, Y. AU - Chen, C. L. AU - O'Neill, K. AU - Myers, D. E. AU - Goldman, F. AU - Hurvitz, C. AU - Casper, J. T. AU - Levine, A. DB - Scopus IS - 12 M3 - Article N1 - Cited By :67 Export Date: 18 November 2020 PY - 1999 SP - 3906-3913 ST - Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor T2 - Clinical Cancer Research TI - Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033387144&partnerID=40&md5=d57c0ce876c60a31fcdbe09b88ed25c7 VL - 5 ID - 8178 ER - TY - JOUR AD - Oncology Department, Addenbrooke's Hospital, Cambridge, United Kingdom Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom Sarcoma Unit, Royal Marsden Hospital, Sutton, London, United Kingdom Pediatric Oncology Department, Box 181, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom AU - Murray, M. AU - Hatcher, H. AU - Jessop, F. AU - Williams, D. AU - Carroll, N. AU - Bulusu, R. AU - Judson, I. DB - Scopus DO - 10.1002/pbc.21312 IS - 2 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2008 SP - 386-388 ST - Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib T2 - Pediatric Blood and Cancer TI - Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-37549052917&doi=10.1002%2fpbc.21312&partnerID=40&md5=7ed5fbef7cf12daed3e10f89ad5a997d VL - 50 ID - 8179 ER - TY - JOUR AD - E.E. Lepik, Clinical Hematologist, Oncology Department, Raisa Gorbacheva Memorial Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University, L. Tolstoy St. 6-8, St. Petersburg, Russian Federation AU - Lepik, E. E. AU - Kozlov, A. V. AU - Borzenkova, E. S. AU - Zalyalov, Y. R. AU - Lepik, K. V. AU - Kondakova, E. V. AU - Baykov, V. V. AU - Moiseev, I. S. AU - Schneider, T. V. AU - Mikhaylova, N. B. AU - Afanasyev, B. V. DB - Embase DO - 10.18620/ctt-1866-8836-2020-9-1-28-37 IS - 1 LA - English M3 - Article N1 - L2004467246 2020-07-13 PY - 2020 SN - 1866-8836 1867-416X SP - 28-37 ST - Treatment options for T-cell lymphomas: A single-center study T2 - Cellular Therapy and Transplantation TI - Treatment options for T-cell lymphomas: A single-center study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004467246&from=exporthttp://dx.doi.org/10.18620/ctt-1866-8836-2020-9-1-28-37 VL - 9 ID - 8180 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, Warsaw, 02-781, Poland Early Phase Clinical Trial Unit, Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, Warsaw, 02-781, Poland Department of Oncology, Iagiellonian University, Cracow, Poland Department of General Surgery, Iagiellonian University, Cracow, Poland AU - Rutkowski, P. AU - Bylina, E. AU - Lugowska, I. AU - Teterycz, P. AU - Klimczak, A. AU - Streb, J. AU - Czarnecka, A. M. AU - Osuch, C. DB - Scopus DO - 10.1016/j.jgo.2018.03.009 IS - 5 M3 - Article N1 - Cited By :2 Export Date: 18 November 2020 PY - 2018 SP - 520-525 ST - Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST) T2 - Journal of Geriatric Oncology TI - Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044366163&doi=10.1016%2fj.jgo.2018.03.009&partnerID=40&md5=c3ce8b3e2b04d37e6b75d1aabf3e3442 VL - 9 ID - 8181 ER - TY - JOUR AD - Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK; Unit of Bone and Soft Tissue Oncology, Tel-Aviv Sourasky Medical Center and Tel-Aviv University Sackler School of Medicine, Tel-Aviv, Israel; Divisione Oncologia Medica, Candiolo Cancer Institute – FPO I.R.C.C.S., Candiolo, Italy; Hadassah-Hebrew University Medical Center, Jerusalem, Israel; United BioSource (Germany) GmbH, Loerrach, Germany; United BioSource Corporation, Quebec, Canada; bluebird bio, London, UK; Bristol-Myers Squibb, Uxbridge, UK; Novartis Oncology, East Hanover, NJ, USA; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy AN - 126327981. Language: English. Entry Date: 20171128. Revision Date: 20201026. Publication Type: Article AU - Gelderblom, Hans AU - Judson, Ian R. AU - Benson, Charlotte AU - Merimsky, Ofer AU - Grignani, Giovanni AU - Katz, Daniela AU - Freivogel, Klaus W. AU - Stein, Dara AU - Jobanputra, Minesh AU - Mungul, Arron AU - Manson, Stephanie C. AU - Sanfilippo, Roberta DB - ccm DO - 10.1080/0284186X.2017.1332779 DP - EBSCOhost IS - 12 N1 - research; tables/charts. Journal Subset: Biomedical; Continental Europe; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed. NLM UID: 8709065. PY - 2017 SN - 0284-186X SP - 1769-1775 ST - Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study T2 - Acta Oncologica TI - Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126327981&site=ehost-live&scope=site VL - 56 ID - 8182 ER - TY - JOUR AD - Universidade de Campinas (Unicamp), Centro de Hematologia e Hemoterapia, Campinas, SP, Brazil AU - Ribeiro, B. F. AU - Miranda, E. C. M. AU - de Albuquerque, D. M. AU - Delamain, M. T. AU - Oliveira-Duarte, G. AU - Almeida, M. H. AU - Vergilio, B. AU - da Silveira, R. A. AU - Oliveira-Duarte, V. AU - Lorand-Metze, I. AU - de Souza, C. A. AU - Pagnano, K. B. B. DB - Scopus DO - 10.6061/clinics/2015(08)04 IS - 8 M3 - Article N1 - Cited By :9 Export Date: 18 November 2020 PY - 2015 SP - 550-555 ST - Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors -a single center experience T2 - Clinics TI - Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors -a single center experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938792608&doi=10.6061%2fclinics%2f2015%2808%2904&partnerID=40&md5=93919942245f72d1ab3bafb4beb4d1e4 VL - 70 ID - 8183 ER - TY - JOUR AD - Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy Washington Hospital Center, WA, D.C. 20010 AU - Biondi, B. AU - Wartofsky, L. DB - Scopus DO - 10.1210/er.2013-1083 IS - 3 M3 - Review N1 - Cited By :106 Export Date: 18 November 2020 PY - 2014 SP - 433-512 ST - Treatment with thyroid hormone T2 - Endocrine Reviews TI - Treatment with thyroid hormone UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901484766&doi=10.1210%2fer.2013-1083&partnerID=40&md5=e46061b7aa0a1da567d790f07034dd8f VL - 35 ID - 8184 ER - TY - JOUR AD - Department of Hematology Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8603, Japan Department of Hematology, National Hospital Organization Disaster Medical Center, Tachikawa, Japan Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan Interfactulty Initiative in Information Studies, The University of Tokyo, Tokyo, Japan Department of Hematology, Ome Municipal General Hospital, Tokyo, Japan Department of Hematology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Division of Hematology and Oncology, Japanese Red Cross Society, Narita Red Cross Hospital, Narita, Japan Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan Hematology Division, Showa General Hospital, Tokyo, Japan Division of Hematology and Oncology, Gunma Prefectural Cancer Center, Ohta, Japan Department of Hematology, National Hospital Organization, Mito Medical Center, Higashiibarakigun, Ibaraki, Japan Department of Hematology, Tokyo Medical University, Tokyo, Japan Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan Tokai Central Hospital, Kakamigahara, Japan Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan AU - Yamaguchi, H. AU - Takezako, N. AU - Ohashi, K. AU - Oba, K. AU - Kumagai, T. AU - Kozai, Y. AU - Wakita, H. AU - Yamamoto, K. AU - Fujita, A. AU - Igarashi, T. AU - Yoshida, C. AU - Ohyashiki, K. AU - Okamoto, S. AU - Sakamoto, J. AU - Sakamaki, H. AU - Inokuchi, K. DB - Scopus DO - 10.1007/s12185-019-02801-z IS - 3 M3 - Article N1 - Cited By :3 Export Date: 18 November 2020 PY - 2020 SP - 401-408 ST - Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group T2 - International Journal of Hematology TI - Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077208389&doi=10.1007%2fs12185-019-02801-z&partnerID=40&md5=daab5920b2b89b6a2031e6ab4f1b6d10 VL - 111 ID - 8185 ER - TY - JOUR AD - CML Advocates Network, Bern, Switzerland Israeli CML Patients Organization, Netanya, Israel Quality Health Ltd, Derbyshire, United Kingdom Leukaemia Care, Worcester, United Kingdom Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy LyLe Patientforeningenen for Lymfekræft Leukæmi og MDS, Sealand Region, Denmark Association des malades atteints de leucémies AMAL, Marrakech, Morocco LMC France, Marseille, France LeukaNET e.V, Riemerling, Germany AU - Sharf, G. AU - Marin, C. AU - Bradley, J. A. AU - Pemberton-Whiteley, Z. AU - Bombaci, F. AU - Christensen, R. I. O. AU - Gouimi, B. AU - Deekes, N. B. AU - Daban, M. AU - Geissler, J. DB - Scopus DO - 10.1038/s41375-020-0867-0 IS - 8 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2020 SP - 2102-2112 ST - Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs T2 - Leukemia TI - Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085365110&doi=10.1038%2fs41375-020-0867-0&partnerID=40&md5=5df7429b944b4048a108897db2bf330f VL - 34 ID - 8186 ER - TY - JOUR AD - Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, NICHD, NIH, Building 10, CRC, Room 1-3330, 10 Center Dr., MSC1103, Bethesda, MD 20892, USA Section on Endocrinology & Genetics, Program on Developmental Endocrinology & Genetics, NICHD, NIH, Building 10, CRC, Room 1-3330, 10 Center Dr., MSC1103, Bethesda, MD 20892, USA. stratakc@mail.nih.gov AN - 105368757. Language: English. Entry Date: 20090724. Revision Date: 20200313. Publication Type: journal article AU - Stratakis, C. A. AU - Carney, J. A. AU - Stratakis, C. A. AU - Carney, J. A. DB - ccm DO - 10.1111/j.1365-2796.2009.02110.x DP - EBSCOhost IS - 1 N1 - review. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Grant Information: Z01 HD000642/ImNIH/Intramural NIH HHS/United States. NLM UID: 8904841. PMID: NLM19522824. PY - 2009 SN - 0954-6820 SP - 43-52 ST - The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications T2 - Journal of Internal Medicine TI - The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105368757&site=ehost-live&scope=site VL - 266 ID - 8187 ER - TY - JOUR AN - CN-02067629 AU - Euctr, G. B. PY - 2017 ST - A trial to compare giving chemotherapy intermittently to chemotherapy administered continuously to patients with inoperable or metastatic melanoma T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2016-005228-27-GB TI - A trial to compare giving chemotherapy intermittently to chemotherapy administered continuously to patients with inoperable or metastatic melanoma UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-02067629/full ID - 8188 ER - TY - JOUR AN - CN-01875554 AU - Ntr PY - 2014 ST - Trial with melanoma patients who are treated with dabrafenib and trametinib to make the tumor smaller, so it can be surgically removed T2 - http://www.who.int/trialsearch/Trial2.aspx?TrialID=NTR4654 TI - Trial with melanoma patients who are treated with dabrafenib and trametinib to make the tumor smaller, so it can be surgically removed UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01875554/full ID - 8189 ER - TY - JOUR AD - S.-F. Yang, Institute of Medicine Chung Shan Medical University, Taichung, Taiwan AU - Chang, P. Y. AU - Hsieh, M. J. AU - Hsieh, Y. S. AU - Chen, P. N. AU - Yang, J. S. AU - Lo, F. C. AU - Yang, S. F. AU - Lu, K. H. DB - Embase Medline DO - 10.1002/tox.22380 IS - 8 LA - English M3 - Article N1 - L613545147 2016-12-09 2017-07-24 PY - 2017 SN - 1522-7278 1520-4081 SP - 2032-2040 ST - Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways T2 - Environmental Toxicology TI - Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613545147&from=exporthttp://dx.doi.org/10.1002/tox.22380 VL - 32 ID - 8190 ER - TY - JOUR AD - X. Chen, Department of Pharmacology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China AU - Wang, P. AU - Zhang, P. AU - Huang, J. AU - Li, M. AU - Chen, X. DB - Embase Medline DO - 10.1016/j.neuro.2013.03.007 LA - English M3 - Article N1 - L368884007 2013-05-16 2013-06-06 PY - 2013 SN - 0161-813X 1872-9711 SP - 51-62 ST - Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function T2 - NeuroToxicology TI - Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368884007&from=exporthttp://dx.doi.org/10.1016/j.neuro.2013.03.007 VL - 37 ID - 8191 ER - TY - JOUR AD - K. Shi, Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, China AU - Wu, C. AU - Shang, X. Q. AU - You, Z. P. AU - Jin, Q. F. AU - Zhang, Y. L. AU - Zhou, Y. AU - Zhang, Y. Z. AU - Shi, K. DB - Embase Medline DO - 10.1167/IOVS.61.10.2 IS - 10 LA - English M3 - Article N1 - L2007671884 2020-10-12 PY - 2020 SN - 1552-5783 0146-0404 ST - TRIM59 promotes retinoblastoma progression by activating the p38–MAPK signaling pathway T2 - Investigative Ophthalmology and Visual Science TI - TRIM59 promotes retinoblastoma progression by activating the p38–MAPK signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007671884&from=exporthttp://dx.doi.org/10.1167/IOVS.61.10.2 VL - 61 ID - 8192 ER - TY - JOUR AU - Wu, Y. T. AU - Ma, S. Y. AU - Sun, W. Q. AU - Shen, W. W. AU - Zhu, H. T. AU - Zhang, Q. AU - Chen, H. F. DB - Medline DO - 10.1210/clinem/dgaa804 LA - English M3 - Article in Press N1 - L633342970 2020-11-11 PY - 2020 SN - 1945-7197 ST - TRIM65 promotes invasion of endometrial stromal cells by activating ERK1/2/C-myc signaling via ubiquitination of DUSP6 T2 - The Journal of clinical endocrinology and metabolism TI - TRIM65 promotes invasion of endometrial stromal cells by activating ERK1/2/C-myc signaling via ubiquitination of DUSP6 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L633342970&from=exporthttp://dx.doi.org/10.1210/clinem/dgaa804 ID - 8193 ER - TY - JOUR AD - H. Tang, School of Public Health, Dongguan Key Laboratory of Environmental Medicine, Guangdong Medical University, China AU - Liu, X. AU - Zhao, X. AU - Wang, Y. AU - Hong, J. AU - Shi, M. AU - Pfaff, D. AU - Guo, L. AU - Tang, H. DB - Embase Medline DO - 10.1016/j.chemosphere.2020.126470 LA - English M3 - Article N1 - L2005460176 2020-04-20 2020-07-13 Concerns have been raised over the neurotoxicity of triphenyl phosphate (TPP), but there have been few studies of the neurotoxic effects of TPP on mammals and the underlying mechanisms. In this study, weaned male mice (C57/BL6) were used and exposed to 0, 50, or 150 mg/kg TPP daily by oral gavage for 30 days. The blood brain barrier (BBB) permeability of TPP and its metabolite diphenyl phosphate (DPP) in the brain, and TPP induced metabolomic and transcriptomic changes of the brain were investigated. The results showed that TPP and DPP can cross the BBB of mice. Histopathological examination of the brain revealed abnormalities in the hippocampus, cortex and thalamus, and mice treated with high doses showed a potential inflammation in the thalamus and hippocampus. Untargeted metabolomic results revealed that the changed level of glutamic acid, N-acetyl CoA metabolites, and organic acid in the brain of treated mice, suggest that amino acid and lipid metabolism was interfered. RNA-seq data indicated that neuronal transcription processes and cell apoptosis pathway (forkhead box (FOXO), and mitogen-activated protein kinase (MAPK) signaling pathways) were significantly affected by TPP exposure. RT-PCR showed proinflammation cytokine tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6)) levels were increased, while antioxidant genes including nuclear factor-E2-related factor 2 (Nrf2), heme oxygenase1 (HO-1) and superoxide dismutase (SOD1) decreased. These results suggest that TPP could cause a degree of neurotoxicity by inducing neuroinflammation and neuronal apoptosis, which are related to oxidative stress. The potential implications for neurophysiology and behavioral regulation cannot be ignored. PY - 2020 SN - 1879-1298 0045-6535 ST - Triphenyl phosphate permeates the blood brain barrier and induces neurotoxicity in mouse brain T2 - Chemosphere TI - Triphenyl phosphate permeates the blood brain barrier and induces neurotoxicity in mouse brain UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005460176&from=exporthttp://dx.doi.org/10.1016/j.chemosphere.2020.126470 VL - 252 ID - 8194 ER - TY - JOUR AD - Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. China. Outpatient Department, Qingdao No. 1 Sanitarium, Qingdao, Shandong, P.R. China. Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. China. AN - 29426375 AU - Jiang, J. AU - Song, X. AU - Yang, J. AU - Lei, K. AU - Ni, Y. AU - Zhou, F. AU - Sun, L. DA - Sep 14 DO - 10.3727/096504018x15179661552702 10.3727/096504018X15179661552702. Epub 2018 Feb 9. DP - Nlm ET - 2018/02/11 IS - 8 LA - eng PY - 2018 SN - 0965-0407 SP - 1235-1243 ST - Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a T2 - Oncol Res TI - Triptolide Inhibits Proliferation and Migration of Human Neuroblastoma SH-SY5Y Cells by Upregulating MicroRNA-181a VL - 26 ID - 8195 ER - TY - JOUR AD - W. Liu, Institute of Radiation Medicine, Shandong Academy of Medical Science, 18877 Jingshi Road, Jinan, Shandong, China AU - Zhao, L. AU - Jiang, B. AU - Wang, D. AU - Liu, W. AU - Zhang, H. AU - Liu, W. AU - Qiu, Z. DB - Embase DO - 10.3892/etm.2016.3164 IS - 5 LA - English M3 - Article N1 - L609235546 2016-04-13 PY - 2016 SN - 1792-1015 1792-0981 SP - 2005-2010 ST - Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression T2 - Experimental and Therapeutic Medicine TI - Triptolide reduces the viability of osteosarcoma cells by reducing MKP-1 and Hsp70 expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L609235546&from=exporthttp://dx.doi.org/10.3892/etm.2016.3164 VL - 11 ID - 8196 ER - TY - JOUR AD - Memorial Sloan Kettering Cancer Center, New York. Weill Cornell Medical College, New York, USA. AN - 31738426 AU - Drilon, A. C2 - PMC6859818 DA - Nov 1 DO - 10.1093/annonc/mdz282 10.1093/annonc/mdz282. DP - Nlm ET - 2019/11/19 IS - Suppl_8 LA - eng PY - 2019 SN - 0923-7534 (Print) 0923-7534 SP - viii23-viii30 ST - TRK inhibitors in TRK fusion-positive cancers T2 - Ann Oncol TI - TRK inhibitors in TRK fusion-positive cancers VL - 30 ID - 8197 ER - TY - JOUR AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Department of Hematology, Affiliated Hospital of the University of Nantong, Jiangsu, China. Department of Pathology and Immunology, Baylor College of Medicine & Texas Children's Hospital, Houston, TX, USA. Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. AN - 28557340 AU - Shi, W. AU - George, S. K. AU - George, B. AU - Curry, C. V. AU - Murzabdillaeva, A. AU - Alkan, S. AU - Amin, H. M. C2 - PMC5579389 DA - Sep DO - 10.1002/1878-0261.12088 10.1002/1878-0261.12088. Epub 2017 Jun 18. DP - Nlm ET - 2017/05/31 IS - 9 LA - eng PY - 2017 SN - 1574-7891 (Print) 1574-7891 SP - 1189-1207 ST - TrkA is a binding partner of NPM-ALK that promotes the survival of ALK(+) T-cell lymphoma T2 - Mol Oncol TI - TrkA is a binding partner of NPM-ALK that promotes the survival of ALK(+) T-cell lymphoma VL - 11 ID - 8198 ER - TY - JOUR AD - J. Milstrokoszewska, Department of Cell Biology, Cancer Centre and Institute of Oncology, Roentgena str. 5, 02-781 Warsaw, Poland AU - Milstrokoszewska, J. AU - Przybyszewska, M. AU - Gos, M. AU - Swoboda, P. AU - Trembacz, H. DB - Embase Medline DO - 10.1111/cpr.12015 IS - 2 LA - English M3 - Article N1 - L368577250 2013-04-02 2013-04-05 PY - 2013 SN - 0960-7722 1365-2184 SP - 146-152 ST - TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions T2 - Cell Proliferation TI - TrkB expression level correlates with metastatic properties of L1 mouse sarcoma cells cultured in non-adhesive conditions UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368577250&from=exporthttp://dx.doi.org/10.1111/cpr.12015 VL - 46 ID - 8199 ER - TY - JOUR AD - Oncology Research, The Children's Hospital of Philadelphia, CTRB Rm. 3018, 3501 Civic Center Blvd., Philadelphia, PA, 19104-4302, USA. AN - 103874181. Language: English. Entry Date: 20150320. Revision Date: 20200708. Publication Type: journal article AU - Croucher, Jamie L. AU - Iyer, Radhika AU - Li, Nanxin AU - Molteni, Valentina AU - Loren, Jon AU - Gordon, W. Perry AU - Tuntland, Tove AU - Liu, Bo AU - Brodeur, Garrett M. DB - ccm DO - 10.1007/s00280-014-2627-1 DP - EBSCOhost IS - 1 N1 - research. Journal Subset: Biomedical; Continental Europe; Europe; Peer Reviewed. Special Interest: Oncologic Care. Grant Information: CA-094194/CA/NCI NIH HHS/United States. NLM UID: 7806519. PMID: NLM25394774. PY - 2015 SN - 0344-5704 SP - 131-141 ST - TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts T2 - Cancer Chemotherapy & Pharmacology TI - TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103874181&site=ehost-live&scope=site VL - 75 ID - 8200 ER - TY - JOUR AD - E.P. Rahrmann, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States AU - Rahrmann, E. P. AU - Moriarity, B. S. AU - Otto, G. M. AU - Watson, A. L. AU - Choi, K. AU - Collins, M. H. AU - Wallace, M. AU - Webber, B. R. AU - Forster, C. L. AU - Rizzardi, A. E. AU - Schmechel, S. C. AU - Ratner, N. AU - Largaespada, D. A. DB - Embase Medline DO - 10.1016/j.ajpath.2014.04.006 IS - 7 LA - English M3 - Article N1 - L373373122 2014-07-03 2014-07-14 PY - 2014 SN - 1525-2191 0002-9440 SP - 2082-2098 ST - Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis T2 - American Journal of Pathology TI - Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L373373122&from=exporthttp://dx.doi.org/10.1016/j.ajpath.2014.04.006 VL - 184 ID - 8201 ER - TY - JOUR AD - W. Zhang, Department of Pharmacology, School of Medicine, Nantong University, 19 Qixiu Road, Nantong 226001, Jiangsu, China AU - Huang, C. AU - Wang, Y. AU - Wang, J. AU - Yao, W. AU - Chen, X. AU - Zhang, W. DB - Embase Medline DO - 10.1186/1742-2094-10-129 LA - English M3 - Article N1 - L52828633 2013-10-28 2020-07-28 PY - 2013 SN - 1742-2094 ST - TSG (2,3,4', 5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia T2 - Journal of Neuroinflammation TI - TSG (2,3,4', 5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52828633&from=exporthttp://dx.doi.org/10.1186/1742-2094-10-129 VL - 10 ID - 8202 ER - TY - JOUR AD - B.M. Seo, Department of Oral and Maxillofacial Surgery, Seoul National University, 101 DaeHak-ro Jongno-gu, Seoul, South Korea AU - Um, S. AU - Kim, H. Y. AU - Lee, J. H. AU - Song, I. S. AU - Seo, B. M. DB - Embase Medline DO - 10.1007/s00441-017-2581-4 IS - 3 LA - English M3 - Article N1 - L614614355 2017-03-06 2017-06-01 PY - 2017 SN - 1432-0878 0302-766X SP - 551-561 ST - TSG-6 secreted by mesenchymal stem cells suppresses immune reactions influenced by BMP-2 through p38 and MEK mitogen-activated protein kinase pathway T2 - Cell and Tissue Research TI - TSG-6 secreted by mesenchymal stem cells suppresses immune reactions influenced by BMP-2 through p38 and MEK mitogen-activated protein kinase pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614614355&from=exporthttp://dx.doi.org/10.1007/s00441-017-2581-4 VL - 368 ID - 8203 ER - TY - JOUR AD - J.J. Bissler, Department of Pediatrics, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, TN, United States AU - Bissler, J. J. AU - Zadjali, F. AU - Bridges, D. AU - Astrinidis, A. AU - Barone, S. AU - Yao, Y. AU - Redd, J. R. AU - Siroky, B. J. AU - Wang, Y. AU - Finley, J. T. AU - Rusiniak, M. E. AU - Baumann, H. AU - Zahedi, K. AU - Gross, K. W. AU - Soleimani, M. DB - Embase Medline DO - 10.14814/phy2.13983 IS - 2 LA - English M3 - Article N1 - L626169781 2019-02-05 2019-02-06 PY - 2019 SN - 2051-817X ST - Tuberous sclerosis complex exhibits a new renal cystogenic mechanism T2 - Physiological Reports TI - Tuberous sclerosis complex exhibits a new renal cystogenic mechanism UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626169781&from=exporthttp://dx.doi.org/10.14814/phy2.13983 VL - 7 ID - 8204 ER - TY - JOUR AD - B. Homey, Department of Dermatology, Heinrich Heine University, Moorenstrasse 5, D-40225 Düsseldorf, Germany AU - Pivarcsi, A. AU - Müller, A. AU - Hippe, A. AU - Rieker, J. AU - Van Lierop, A. AU - Steinhoff, M. AU - Seeliger, S. AU - Kubitza, R. AU - Pippirs, U. AU - Meller, S. AU - Gerber, P. A. AU - Liersch, R. AU - Buenemann, E. AU - Sonkoly, E. AU - Wiesner, U. AU - Hoffmann, T. K. AU - Schneider, L. AU - Piekorz, R. AU - Enderlein, E. AU - Reifenberger, J. AU - Rohr, U. P. AU - Haas, R. AU - Boukamp, P. AU - Haase, I. AU - Nürnberg, B. AU - Ruzicka, T. AU - Zlotnik, A. AU - Homey, B. DB - Embase Medline DO - 10.1073/pnas.0705673104 IS - 48 L1 - internal-pdf://2349174261/19055.full.pdf LA - English M3 - Article N1 - L351024692 2008-01-23 PY - 2007 SN - 0027-8424 1091-6490 SP - 19055-19060 ST - Tumor immune escape by the loss of homeostatic chemokine expression T2 - Proceedings of the National Academy of Sciences of the United States of America TI - Tumor immune escape by the loss of homeostatic chemokine expression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L351024692&from=exporthttp://dx.doi.org/10.1073/pnas.0705673104 VL - 104 ID - 8205 ER - TY - JOUR AD - Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States Developmental Biology, Sloan-Kettering Institute, New York, NY, United States Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, United States AU - DeMatteo, R. P. AU - Gold, J. S. AU - Saran, L. AU - Gönen, M. AU - Kui, H. L. AU - Maki, R. G. AU - Singer, S. AU - Besmer, P. AU - Brennan, M. F. AU - Antonescu, C. R. DB - Scopus DO - 10.1002/cncr.23199 IS - 3 M3 - Article N1 - Cited By :354 Export Date: 18 November 2020 PY - 2008 SP - 608-615 ST - Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) T2 - Cancer TI - Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38749149936&doi=10.1002%2fcncr.23199&partnerID=40&md5=4cba9f63165c2e6d62ab89aa86bdce55 VL - 112 ID - 8206 ER - TY - JOUR AD - A. Forschner, Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Liebermeisterstr. 25, Tuebingen, Germany AU - Forschner, A. AU - Battke, F. AU - Hadaschik, D. AU - Schulze, M. AU - Weißgraeber, S. AU - Han, C. T. AU - Kopp, M. AU - Frick, M. AU - Klumpp, B. AU - Tietze, N. AU - Amaral, T. AU - Martus, P. AU - Sinnberg, T. AU - Eigentler, T. AU - Keim, U. AU - Garbe, C. AU - Döcker, D. AU - Biskup, S. DB - Embase Medline DO - 10.1186/s40425-019-0659-0 IS - 1 LA - English M3 - Article N1 - L628486221 2019-07-19 2019-07-24 PY - 2019 SN - 2051-1426 ST - Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - Results of a prospective biomarker study T2 - Journal for ImmunoTherapy of Cancer TI - Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - Results of a prospective biomarker study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628486221&from=exporthttp://dx.doi.org/10.1186/s40425-019-0659-0 VL - 7 ID - 8207 ER - TY - JOUR AD - T. Kielian, University of Arkansas for Medical Sciences, Department of Neurobiology and Developmental Sciences, 4301 W. Markham Street, Slot 846, Little Rock, AR 72205, United States AU - Syed, M. Md AU - Phulwani, N. K. AU - Kielian, T. DB - Embase Medline DO - 10.1111/j.1471-4159.2007.04838.x IS - 4 LA - English M3 - Article N1 - L47631804 2007-11-01 PY - 2007 SN - 0022-3042 1471-4159 SP - 1461-1471 ST - Tumor necrosis factor-alpha (TNF-α) regulates Toll-like receptor 2 (TLR2) expression in microglia T2 - Journal of Neurochemistry TI - Tumor necrosis factor-alpha (TNF-α) regulates Toll-like receptor 2 (TLR2) expression in microglia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47631804&from=exporthttp://dx.doi.org/10.1111/j.1471-4159.2007.04838.x VL - 103 ID - 8208 ER - TY - JOUR AD - Departments of Surgery, University of Texas Medical Branch, Galveston, Texas, USA. AN - 20716917 AU - Baregamian, N. AU - Song, J. AU - Bailey, C. E. AU - Papaconstantinou, J. AU - Evers, B. M. AU - Chung, D. H. C2 - PMC2835918 DA - Nov-Dec DO - 10.4161/oxim.2.5.9541 10.4161/oxim.2.5.9541. DP - Nlm ET - 2010/08/19 IS - 5 LA - eng PY - 2009 SN - 1942-0900 (Print) 1942-0994 SP - 297-306 ST - Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis T2 - Oxid Med Cell Longev TI - Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis VL - 2 ID - 8209 ER - TY - JOUR AD - F. K. Ghishan, Dept. of Pediatrics, Steele Children's Research Ctr., Univ. of Arizona Health Sciences Ctr., 1501 N. Campbell Ave., Tucson, AZ 85724, United States AU - Chen, H. AU - Xu, H. AU - Dong, J. AU - Li, J. AU - Ghishan, F. K. DB - Embase Medline DO - 10.1152/ajpgi.90722.2008 IS - 4 LA - English M3 - Article N1 - L354862521 2009-08-03 PY - 2009 SN - 0193-1857 1522-1547 SP - G775-G781 ST - Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis T2 - American Journal of Physiology - Gastrointestinal and Liver Physiology TI - Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354862521&from=exporthttp://dx.doi.org/10.1152/ajpgi.90722.2008http://ajpgi.physiology.org/cgi/reprint/296/4/G775 VL - 296 ID - 8210 ER - TY - JOUR AD - C.-H. Hung, Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan AU - Lin, Y. C. AU - Lin, Y. C. AU - Huang, M. Y. AU - Kuo, P. L. AU - Wu, C. C. AU - Lee, M. S. AU - Hsieh, C. C. AU - Kuo, H. F. AU - Kuo, C. H. AU - Tsai, W. C. AU - Hung, C. H. C1 - enbrel(Immunex,United States) humira(AbbVie,United States) C2 - AbbVie(United States) Immunex(United States) DB - Embase Medline DO - 10.1016/j.molimm.2017.01.009 LA - English M3 - Article N1 - L614115945 2017-01-25 2017-01-30 PY - 2017 SN - 1872-9142 0161-5890 SP - 82-91 ST - Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification T2 - Molecular Immunology TI - Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614115945&from=exporthttp://dx.doi.org/10.1016/j.molimm.2017.01.009 VL - 83 ID - 8211 ER - TY - JOUR AD - J. Zhao, Department of Orthopedics, Southern Medical University, Jinling Hospital, 305 Zhongshan East Road, Nanjing, Jiangsu, China AU - Zhang, Z. AU - Fang, Y. AU - Wang, Q. AU - Sun, Y. AU - Xiong, C. AU - Cao, L. AU - Wang, B. AU - Bao, N. AU - Zhao, J. DB - Embase Medline DO - 10.3892/mmr.2015.3529 IS - 1 LA - English M3 - Article N1 - L603645562 2015-04-16 2015-04-23 PY - 2015 SN - 1791-3004 1791-2997 SP - 1499-1505 ST - Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway T2 - Molecular Medicine Reports TI - Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L603645562&from=exporthttp://dx.doi.org/10.3892/mmr.2015.3529 VL - 12 ID - 8212 ER - TY - JOUR AD - M.I. Lewis, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048, United States AU - Lewis, M. I. AU - Da, X. AU - Li, H. AU - Fournier, M. DB - Embase Medline DO - 10.1152/japplphysiol.00238.2005 IS - 5 LA - English M3 - Article N1 - L41547159 2005-11-22 PY - 2005 SN - 8750-7587 SP - 1649-1657 ST - Tumor necrosis factor-α and malnutrition-induced inhibition of diaphragm fiber growth in young rats T2 - Journal of Applied Physiology TI - Tumor necrosis factor-α and malnutrition-induced inhibition of diaphragm fiber growth in young rats UR - https://www.embase.com/search/results?subaction=viewrecord&id=L41547159&from=exporthttp://dx.doi.org/10.1152/japplphysiol.00238.2005 VL - 99 ID - 8213 ER - TY - JOUR AD - E.R. Maher, Section of Medical and Molecular Genetics, Institute of Biomedical Research, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom AU - Morris, M. R. AU - Gentle, D. AU - Abdulrahman, M. AU - Maina, E. N. AU - Gupta, K. AU - Banks, R. E. AU - Wiesener, M. S. AU - Kishida, T. AU - Yao, M. AU - Teh, B. AU - Lauf, F. AU - Maher, E. R. C1 - gf 109203x(Calbiochem) pd 98059(Calbiochem,United States) u 0126(Promega) u 73122(Calbiochem) C2 - Calbiochem(United States) Promega DB - Embase Medline DO - 10.1158/0008-5472.CAN-04-3371 IS - 11 LA - English M3 - Article N1 - L40740795 2005-06-26 PY - 2005 SN - 0008-5472 SP - 4598-4606 ST - Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma T2 - Cancer Research TI - Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40740795&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-04-3371 VL - 65 ID - 8214 ER - TY - JOUR AD - R. Chakravarty, ICMR Virus Unit, Kolkata, ID and BG Hospital Campus, 57, Dr. S C Banerjee Road, Beliaghata, Kolkata West Bengal, India AU - Bandopadhyay, M. AU - Banerjee, A. AU - Sarkar, N. AU - Panigrahi, R. AU - Datta, S. AU - Pal, A. AU - Singh, S. P. AU - Biswas, A. AU - Chakrabarti, S. AU - Chakravarty, R. DB - Embase Medline DO - 10.1186/1471-2407-14-721 IS - 1 LA - English M3 - Article N1 - L600442534 2014-11-20 2014-11-25 PY - 2014 SN - 1471-2407 ST - Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by Hepatitis B virus X protein in malignant hepatocytes T2 - BMC Cancer TI - Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by Hepatitis B virus X protein in malignant hepatocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L600442534&from=exporthttp://dx.doi.org/10.1186/1471-2407-14-721 VL - 14 ID - 8215 ER - TY - JOUR AD - J.R. Apps, Developmental Biology and Cancer Programme, Birth Defects Research Centre, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom AU - Apps, J. R. AU - Carreno, G. AU - Gonzalez-Meljem, J. M. AU - Haston, S. AU - Guiho, R. AU - Cooper, J. E. AU - Manshaei, S. AU - Jani, N. AU - Hölsken, A. AU - Pettorini, B. AU - Beynon, R. J. AU - Simpson, D. M. AU - Fraser, H. C. AU - Hong, Y. AU - Hallang, S. AU - Stone, T. J. AU - Virasami, A. AU - Donson, A. M. AU - Jones, D. AU - Aquilina, K. AU - Spoudeas, H. AU - Joshi, A. R. AU - Grundy, R. AU - Storer, L. C. D. AU - Korbonits, M. AU - Hilton, D. A. AU - Tossell, K. AU - Thavaraj, S. AU - Ungless, M. A. AU - Gil, J. AU - Buslei, R. AU - Hankinson, T. AU - Hargrave, D. AU - Goding, C. AU - Andoniadou, C. L. AU - Brogan, P. AU - Jacques, T. S. AU - Williams, H. J. AU - Martinez-Barbera, J. P. DB - Embase Medline DO - 10.1007/s00401-018-1830-2 IS - 5 LA - English M3 - Article N1 - L621250923 2018-03-20 2018-04-30 PY - 2018 SN - 1432-0533 0001-6322 SP - 757-777 ST - Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target T2 - Acta Neuropathologica TI - Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621250923&from=exporthttp://dx.doi.org/10.1007/s00401-018-1830-2 VL - 135 ID - 8216 ER - TY - JOUR AD - V.-M. Kähäri, Department of Dermatology, University of Turku and Turku University Hospital, Hämeentie 11 TE6, Turku, Finland AU - Riihilä, P. AU - Viiklepp, K. AU - Nissinen, L. AU - Farshchian, M. AU - Kallajoki, M. AU - Kivisaari, A. AU - Meri, S. AU - Peltonen, J. AU - Peltonen, S. AU - Kähäri, V. M. DB - Embase Medline DO - 10.1111/bjd.18095 IS - 3 LA - English M3 - Article N1 - L628856681 2019-08-14 2020-03-12 PY - 2020 SN - 1365-2133 0007-0963 SP - 658-670 ST - Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma T2 - British Journal of Dermatology TI - Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L628856681&from=exporthttp://dx.doi.org/10.1111/bjd.18095 VL - 182 ID - 8217 ER - TY - JOUR AU - Graff, Z. AU - Mendoza, G. AU - Barche, A. AU - Turner, C. DB - Embase Medline DO - 10.1542/pir.2016-0034 IS - 9 LA - English M3 - Article N1 - L612036359 2016-09-13 2016-09-28 PY - 2016 SN - 1526-3347 0191-9601 SP - 399-401 ST - Two black eschars in a 6-year-old girl T2 - Pediatrics in Review TI - Two black eschars in a 6-year-old girl UR - https://www.embase.com/search/results?subaction=viewrecord&id=L612036359&from=exporthttp://dx.doi.org/10.1542/pir.2016-0034 VL - 37 ID - 8218 ER - TY - JOUR AD - E. Mayson, Haematology Department, Wollongong Hospital, Crown Street, Wollongong, NSW 2500, Australia AU - Mayson, E. AU - Saverimuttu, J. AU - Warburton, P. DB - Embase Medline DO - 10.1111/imj.12347 IS - 2 LA - English M3 - Article N1 - L372383321 2014-02-26 2014-02-28 PY - 2014 SN - 1444-0903 1445-5994 SP - 198-201 ST - Two-faced haemophagocytic lymphohistiocytosis: Comparative review of two cases of adult haemophagocytic lymphohistiocytosis T2 - Internal Medicine Journal TI - Two-faced haemophagocytic lymphohistiocytosis: Comparative review of two cases of adult haemophagocytic lymphohistiocytosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L372383321&from=exporthttp://dx.doi.org/10.1111/imj.12347 VL - 44 ID - 8219 ER - TY - JOUR AD - Y. Li, Department of Orthopedic Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China AU - Peng, Y. AU - Wu, S. AU - Li, Y. AU - Crane, J. L. C1 - l 235 DB - Embase Medline DO - 10.7150/thno.34126 IS - 1 LA - English M3 - Review N1 - L630442940 2020-01-22 2020-01-31 PY - 2020 SN - 1838-7640 SP - 426-436 ST - Type H blood vessels in bone modeling and remodeling T2 - Theranostics TI - Type H blood vessels in bone modeling and remodeling UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630442940&from=exporthttp://dx.doi.org/10.7150/thno.34126 VL - 10 ID - 8220 ER - TY - JOUR AD - B.-L. Chiang, Department of Pediatrics, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan AU - Chiang, B. L. AU - Lee, J. H. AU - Wang, L. C. AU - Yu, H. H. AU - Lin, Y. T. AU - Yang, Y. H. DB - Embase Medline DO - 10.1155/2010/567351 LA - English M3 - Review N1 - L359312695 2010-08-17 2010-08-20 PY - 2010 SN - 0962-9351 1466-1861 ST - Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma T2 - Mediators of Inflammation TI - Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359312695&from=exporthttp://dx.doi.org/10.1155/2010/567351 VL - 2010 ID - 8221 ER - TY - JOUR AD - K.D. Wright, Dana-Farber Cancer Institute, Boston, MA, United States AU - Wright, K. D. AU - Zimmerman, M. A. AU - Fine, E. AU - Aspri, T. AU - Kieran, M. W. AU - Chi, S. DB - Embase DO - 10.1093/neuonc/noy059 LA - English M3 - Conference Abstract N1 - L623098411 2018-07-25 PY - 2018 SN - 1523-5866 SP - i110 ST - Type II BRAF inhibitor TAK-580 shows promise for upcoming clinal trial as evidenced by single patient IND study T2 - Neuro-Oncology TI - Type II BRAF inhibitor TAK-580 shows promise for upcoming clinal trial as evidenced by single patient IND study UR - https://www.embase.com/search/results?subaction=viewrecord&id=L623098411&from=exporthttp://dx.doi.org/10.1093/neuonc/noy059 VL - 20 ID - 8222 ER - TY - JOUR AD - P. Schöffski, Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Laboratory of Experimental Oncology, KU Leuven, Herestraat 49, Leuven, Belgium AU - Schöffski, P. AU - Wozniak, A. AU - Leahy, M. G. AU - Aamdal, S. AU - Rutkowski, P. AU - Bauer, S. AU - Richter, S. AU - Grünwald, V. AU - Debiec-Rychter, M. AU - Sciot, R. AU - Geoerger, B. AU - Marréaud, S. AU - Collette, S. AU - Nzokirantevye, A. AU - Strauss, S. J. DB - Embase Medline DO - 10.1016/j.ejca.2018.02.011 LA - English M3 - Article N1 - L2000558478 2018-03-26 2018-04-03 PY - 2018 SN - 1879-0852 0959-8049 SP - 156-167 ST - The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ T2 - European Journal of Cancer TI - The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’ UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2000558478&from=exporthttp://dx.doi.org/10.1016/j.ejca.2018.02.011 VL - 94 ID - 8223 ER - TY - JOUR AD - Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, United States Department of Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, TX, United States AU - Chamoun, K. AU - Kantarjian, H. AU - Atallah, R. AU - Gonzalez, G. N. AU - Issa, G. C. AU - Rios, M. B. AU - Garcia-Manero, G. AU - Borthakur, G. AU - Ravandi, F. AU - Jain, N. AU - Daver, N. AU - Konopleva, M. AU - Dinardo, C. D. AU - Kadia, T. AU - Pemmaraju, N. AU - Jabbour, E. AU - Cortes, J. C7 - 1 DB - Scopus DO - 10.1186/s13045-018-0686-1 IS - 1 M3 - Article N1 - Cited By :12 Export Date: 18 November 2020 PY - 2019 ST - Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: A single-institution experience T2 - Journal of Hematology and Oncology TI - Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: A single-institution experience UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059493271&doi=10.1186%2fs13045-018-0686-1&partnerID=40&md5=b7c4efe7e810d6f0496f8cc244c4c87a VL - 12 ID - 8224 ER - TY - JOUR AU - Furman, W. L. AU - Navid, F. AU - Daw, N. C. AU - Beth McCarville, M. AU - McGregor, L. M. AU - Spunt, S. L. AU - Rodriguez-Galindo, C. AU - Panetta, J. C. AU - Crews, K. R. AU - Wu, J. AU - Gajjar, A. J. AU - Houghton, P. J. AU - Santana, V. M. AU - Stewart, C. F. DB - Scopus DO - 10.1200/JCO.2008.19.6642 IS - 27 M3 - Article N1 - Cited By :40 Export Date: 18 November 2020 PY - 2009 SP - 4599-4604 ST - Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors T2 - Journal of Clinical Oncology TI - Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-76749168084&doi=10.1200%2fJCO.2008.19.6642&partnerID=40&md5=c1e885886b0fd768ddd3841b03cc88f4 VL - 27 ID - 8225 ER - TY - JOUR AD - S.R. Wilson, Department of Paediatric Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom AU - Wilson, S. R. AU - Weston, V. J. AU - Stankovic, T. AU - Kearns, P. R. DB - Embase IS - 21 LA - English M3 - Conference Abstract N1 - L70769243 2012-06-19 PY - 2011 SN - 0006-4971 ST - Tyrosine kinase inhibitor screen identifies the multikinase inhibitor, foretinib, as a sensitisor of treatment-resistant B-precursor ALL to core chemotherapeutic agents T2 - Blood TI - Tyrosine kinase inhibitor screen identifies the multikinase inhibitor, foretinib, as a sensitisor of treatment-resistant B-precursor ALL to core chemotherapeutic agents UR - https://www.embase.com/search/results?subaction=viewrecord&id=L70769243&from=exporthttp://abstracts.hematologylibrary.org/cgi/content/abstract/118/21/1509?maxtoshow=&hits=60&RESULTFORMAT=&searchid=1&FIRSTINDEX=2040&displaysectionid=Poster+Sessions&fdate=1/1/2011&tdate=12/31/2011&resourcetype=HWCIT VL - 118 ID - 8226 ER - TY - JOUR AD - Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong AU - Au, W. Y. AU - Lie, A. K. W. AU - Ma, S. K. AU - Wan, T. S. AU - Liang, R. AU - Chan, E. C. AU - Kwong, Y. L. DB - Scopus DO - 10.1038/sj.bmt.1703678 IS - 7 M3 - Article N1 - Cited By :7 Export Date: 18 November 2020 PY - 2002 SP - 453-457 ST - Tyrosine kinase inhibitor sti571 in the treatment of philadelphia chromosome-positive leukemia failing myeloablative stem cell transplantation T2 - Bone Marrow Transplantation TI - Tyrosine kinase inhibitor sti571 in the treatment of philadelphia chromosome-positive leukemia failing myeloablative stem cell transplantation UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036775905&doi=10.1038%2fsj.bmt.1703678&partnerID=40&md5=4d5b4d659f677f99500eb278d08227e6 VL - 30 ID - 8227 ER - TY - JOUR AD - Children's Hospital Colorado and Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, United States AU - Hunger, S. P. DB - Scopus DO - 10.1182/asheducation-2011.1.361 M3 - Review N1 - Cited By :33 Export Date: 18 November 2020 PY - 2011 SP - 361-365 ST - Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia T2 - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program TI - Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859377971&doi=10.1182%2fasheducation-2011.1.361&partnerID=40&md5=5af35e7a8b615d4c22db1f46b95020ff VL - 2011 ID - 8228 ER - TY - JOUR AD - Institute of Hematology and Medical Oncology, L. and A. Seràgnoli S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy Institute of Hematology and Medical Oncology, L. and A. Seràgnoli S. Orsola Malpighi Hospital, University of Bologna, Via Massarenti, 9-40, 138 Bologna, Italy AU - Piccaluga, P. P. AU - Paolini, S. AU - Martinelli, G. DB - Scopus DO - 10.1002/cncr.22881 IS - 6 M3 - Review N1 - Cited By :63 Export Date: 18 November 2020 PY - 2007 SP - 1178-1186 ST - Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia T2 - Cancer TI - Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548744667&doi=10.1002%2fcncr.22881&partnerID=40&md5=0761c917c8b07ec31955b43c94632ceb VL - 110 ID - 8229 ER - TY - JOUR AD - Université Pierre et Marie Curie, Paris, France INSERM-UMRs 938, Paris, France Service d’Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France CHRU Hôtel-Dieu, Nantes, France University Hospital Leuven, Leuven, Belgium Hôpital Saint Louis, Paris, France Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy Helsinki University Central Hospital, Finland University of Freiburg Medical Center, Germany Lund University Hospital, Sweden University Hospital Hamburg-Eppendorf, Hamburg, Germany AU - Brissot, E. AU - Labopin, M. AU - Beckers, M. M. AU - Socié, G. AU - Rambaldi, A. AU - Volin, L. AU - Finke, J. AU - Lenhoff, S. AU - Kröger, N. AU - Ossenkoppele, G. J. AU - Craddock, C. F. AU - Yakoub-Agha, I. AU - Gürman, G. AU - Russell, N. H. AU - Aljurf, M. AU - Potter, M. N. AU - Nagler, A. AU - Ottmann, O. AU - Cornelissen, J. J. AU - Esteve, J. AU - Mohty, M. DB - Scopus DO - 10.3324/haematol.2014.116954 IS - 3 M3 - Article N1 - Cited By :66 Export Date: 18 November 2020 PY - 2015 SP - 392-399 ST - Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with philadelphia chromosome positive acute lymphoblastic leukemia T2 - Haematologica TI - Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with philadelphia chromosome positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924737371&doi=10.3324%2fhaematol.2014.116954&partnerID=40&md5=3ddfdae987b135819469fbb400de9c27 VL - 100 ID - 8230 ER - TY - JOUR AD - Paediatric Haematology-Oncology Department and ‘Tettamanti’ Research Centre, Milano-Bicocca University, ‘Fondazione MBBM’ San Gerardo Hospital, Monza, Italy AU - Leoni, V. AU - Biondi, A. DB - Scopus DO - 10.3324/haematol.2015.124016 IS - 3 M3 - Article N1 - Cited By :22 Export Date: 18 November 2020 PY - 2015 SP - 295 ST - Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia T2 - Haematologica TI - Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924664857&doi=10.3324%2fhaematol.2015.124016&partnerID=40&md5=ba63bb0590b3b5e4aa2d76cf15bcfa64 VL - 100 ID - 8231 ER - TY - JOUR AD - Division of Clinical Pharmacology and Therapeutics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, United States Division of Clinical Pharmacology and Therapeutics, Children's Hospital of Philadelphia, Abramson Research Center 916, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, United States AU - Skolnik, J. M. AU - Adamson, P. C. DB - Scopus DO - 10.1080/07357900701513074 IS - 7 M3 - Review N1 - Cited By :4 Export Date: 18 November 2020 PY - 2007 SP - 606-612 ST - Tyrosine kinase inhibitors in pediatric malignancies T2 - Cancer Investigation TI - Tyrosine kinase inhibitors in pediatric malignancies UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-36248955657&doi=10.1080%2f07357900701513074&partnerID=40&md5=503d4ebce886bf92ae125543526fa554 VL - 25 ID - 8232 ER - TY - JOUR AN - CN-01393704 AU - Hazarika, M. AU - Chuk, M. K. AU - Theoret, M. R. AU - Mushti, S. AU - He, K. AU - Weis, S. L. AU - Putman, A. H. AU - Helms, W. S. AU - Cao, X. AU - Li, H. AU - et al. DO - 10.1158/1078-0432.CCR-16-0712 IS - 14 M3 - Journal Article; Randomized Controlled Trial PY - 2017 SP - 3484‐3488 ST - U.S. FDA Approval Summary: nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab T2 - Clinical cancer research TI - U.S. FDA Approval Summary: nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01393704/full VL - 23 ID - 8233 ER - TY - JOUR AD - L. Jiang, Department of Neurosurgery, Children’s Hospital of Chongqing Medical University, No 136 Zhongshan 2nd Road, YuZhong District, Chongqing, China AU - Zhou, Y. AU - Liang, P. AU - Ji, W. AU - Yu, Z. AU - Chen, H. AU - Jiang, L. DB - Embase DO - 10.2147/OTT.S176582 LA - English M3 - Article N1 - L2001574921 2019-03-22 2019-03-26 PY - 2019 SN - 1178-6930 SP - 1825-1839 ST - Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway T2 - OncoTargets and Therapy TI - Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2001574921&from=exporthttp://dx.doi.org/10.2147/OTT.S176582 VL - 12 ID - 8234 ER - TY - JOUR AD - Z. Chen, Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China J. Wang, Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, China AU - Miao, R. AU - Lu, Y. AU - He, X. AU - Liu, X. AU - Chen, Z. AU - Wang, J. DB - Embase Medline DO - 10.1111/jcmm.15724 IS - 18 LA - English M3 - Article N1 - L2005862705 2020-08-19 PY - 2020 SN - 1582-1838 SP - 10946-10957 ST - Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway T2 - Journal of Cellular and Molecular Medicine TI - Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2005862705&from=exporthttp://dx.doi.org/10.1111/jcmm.15724 VL - 24 ID - 8235 ER - TY - JOUR AD - D.K. Graham, University of Colorado, Anschutz Medical Campus, Building RC1-N, 12800 E. 19th Ave, Aurora, CO 80045, United States AU - Christoph, S. AU - DeRyckere, D. AU - Schlegel, J. AU - Frazer, J. K. AU - Batchelor, L. A. AU - Trakhimets, A. Y. AU - Sather, S. AU - Hunter, D. M. AU - Cummings, C. T. AU - Liu, J. AU - Yang, C. AU - Kireev, D. AU - Simpson, C. AU - Norris-Drouin, J. AU - Hull-Ryde, E. A. AU - Janzen, W. P. AU - Johnson, G. L. AU - Wang, X. AU - Frye, S. V. AU - Earp Iii, H. S. AU - Graham, D. K. DB - Embase Medline DO - 10.1158/1535-7163 IS - 11 LA - English M3 - Article N1 - L370245471 2013-11-21 PY - 2013 SN - 1535-7163 1538-8514 SP - 2367-2377 ST - UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo T2 - Molecular Cancer Therapeutics TI - UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo UR - https://www.embase.com/search/results?subaction=viewrecord&id=L370245471&from=exporthttp://dx.doi.org/10.1158/1535-7163http://mct.aacrjournals.org/content/12/11/2367.full.pdf+html VL - 12 ID - 8236 ER - TY - JOUR AD - C.P. Kratz, Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany AU - Kratz, C. P. AU - Niemeyer, C. M. AU - Zenker, M. DB - Embase Medline DO - 10.1007/s00109-006-0135-4 IS - 3 LA - English M3 - Review N1 - L46295245 2007-03-15 PY - 2007 SN - 0946-2716 SP - 223-231 ST - An unexpected new role of mutant Ras: Perturbation of human embryonic development T2 - Journal of Molecular Medicine TI - An unexpected new role of mutant Ras: Perturbation of human embryonic development UR - https://www.embase.com/search/results?subaction=viewrecord&id=L46295245&from=exporthttp://dx.doi.org/10.1007/s00109-006-0135-4 VL - 85 ID - 8237 ER - TY - JOUR AD - Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan Division of Hematology, Jichi Medical University, Tochigi, Japan AU - Sakurai, M. AU - Mori, T. AU - Karigane, D. AU - Tozawa, K. AU - Matsuki, E. AU - Shimizu, T. AU - Yokoyama, K. AU - Nakajima, H. AU - Kanda, Y. AU - Okamoto, S. DB - Scopus DO - 10.1007/s12185-015-1840-y IS - 3 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2015 SP - 342-348 ST - Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors T2 - International Journal of Hematology TI - Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941259031&doi=10.1007%2fs12185-015-1840-y&partnerID=40&md5=983c1af3f271286a9fe4effe7d551c5a VL - 102 ID - 8238 ER - TY - JOUR AD - Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan Department of Allergy and Immunology, National Research Institute for Child Health and Development, Setagaya-ku, Tokyo, Japan Department of Anatomy, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan Department of Laboratory Medicine, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan Center for Cooperative Research in Advanced Science and Technology, Nagoya University, Japan AU - Sugiura, K. AU - Muro, Y. AU - Futamura, K. AU - Matsumoto, K. AU - Hashimoto, N. AU - Nishizawa, Y. AU - Nagasaka, T. AU - Saito, H. AU - Tomita, Y. AU - Usukura, J. DB - Scopus DO - 10.1038/jid.2009.51 IS - 9 M3 - Article N1 - Cited By :53 Export Date: 18 November 2020 PY - 2009 SP - 2126-2135 ST - The unfolded protein response is activated in differentiating epidermal keratinocytes T2 - Journal of Investigative Dermatology TI - The unfolded protein response is activated in differentiating epidermal keratinocytes UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940363675&doi=10.1038%2fjid.2009.51&partnerID=40&md5=431e43e6323ad63b5920aab591c64b9e VL - 129 ID - 8239 ER - TY - JOUR AD - J.M. Kirkwood, Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, 5150 Centre Avenue, Pittsburgh, PA, United States AU - Davar, D. AU - Lin, Y. AU - Kirkwood, J. M. C1 - mekinist(Glaxo SmithKline) tafinlar(Glaxo SmithKline) zelboraf(Genentech) C2 - Genentech Glaxo SmithKline DB - Embase Medline DO - 10.1038/jid.2014.467 IS - 3 LA - English M3 - Review N1 - L602188562 2015-02-19 2015-02-24 PY - 2015 SN - 1523-1747 0022-202X SP - 659-662 ST - Unfolding the mutational landscape of human melanoma T2 - Journal of Investigative Dermatology TI - Unfolding the mutational landscape of human melanoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602188562&from=exporthttp://dx.doi.org/10.1038/jid.2014.467 VL - 135 ID - 8240 ER - TY - JOUR AD - Division of Hepatology, Department of Internal Medicine, Dankook University College of Medicine, 16-5 Anseo-dong, Cheonan 330-715, Chungnam, South Korea Department of Internal Medicine, Hallym University Sacred Heart Hospital, 896 Pyeongchon-dong, Anyang 431-070, Gyeonggi-do, South Korea AU - Kang, H. Y. AU - Moon, S. H. AU - Song, I. H. C7 - 72 DB - Scopus DO - 10.1186/1752-1947-8-72 IS - 1 M3 - Article N1 - Cited By :5 Export Date: 18 November 2020 PY - 2014 ST - A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: A case report T2 - Journal of Medical Case Reports TI - A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: A case report UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895927542&doi=10.1186%2f1752-1947-8-72&partnerID=40&md5=8d1b9e79b49f2d09cfda76a56ea39b6d VL - 8 ID - 8241 ER - TY - JOUR AD - A. Ferrante, Department of Immunopathology, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia AU - Moghaddami, N. AU - Costabile, M. AU - Grover, P. K. AU - Jersmann, H. P. A. AU - Huang, Z. H. AU - Hii, C. S. T. AU - Ferrante, A. DB - Embase Medline DO - 10.4049/jimmunol.171.5.2616 IS - 5 LA - English M3 - Article N1 - L37025574 2003-09-09 PY - 2003 SN - 0022-1767 SP - 2616-2624 ST - Unique effect of arachidonic acid on human neutrophil TNF receptor expression: Up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2 T2 - Journal of Immunology TI - Unique effect of arachidonic acid on human neutrophil TNF receptor expression: Up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2 UR - https://www.embase.com/search/results?subaction=viewrecord&id=L37025574&from=exporthttp://dx.doi.org/10.4049/jimmunol.171.5.2616 VL - 171 ID - 8242 ER - TY - JOUR AD - W. Jeong AU - Jeong, W. AU - Doroshow, J. H. AU - Kummar, S. C1 - bosulif(Pfizer) caprelsa(Astra Zeneca) erivedge(Genentech) gleevec(Novartis) iclusig(Ariad) inlyta(Pfizer) iressa(Astra Zeneca) jakafi(Incyte) nexavar(Bayer) nexavar(Onyx) sprycel(Bristol Myers Squibb) stivarga(Bayer) sutent(Pfizer) tarceva(Osi) tasigna(Novartis) tykerb(Glaxo SmithKline) votrient(Glaxo SmithKline) xalkori(Pfizer) C2 - Ariad Astra Zeneca Bayer Bristol Myers Squibb Genentech Glaxo SmithKline Incyte Novartis Onyx Osi Pfizer DB - Embase Medline DO - 10.1016/j.currproblcancer.2013.06.001 IS - 3 LA - English M3 - Article N1 - L369851237 2013-09-27 2013-10-01 PY - 2013 SN - 0147-0272 1535-6345 SP - 110-144 ST - United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies T2 - Current Problems in Cancer TI - United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies UR - https://www.embase.com/search/results?subaction=viewrecord&id=L369851237&from=exporthttp://dx.doi.org/10.1016/j.currproblcancer.2013.06.001 VL - 37 ID - 8243 ER - TY - JOUR AD - Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint Antoine, Paris, 75012, France Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy ALWP office, Hôpital Saint-Antoine, Paris, France Department of Hematology II, Ospedale San Martino, Genova, Italy Università cattolica del Sacro Cuore, Roma, Italy Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy Hematology Department, Anadolu Medical Center Hospital, Kocaeli, Turkey Bone Marrow Transplantation Center, First Affiliated Hospital, School of Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Hematology and Transplantology, Ratsa Gorbacheva Memorial Children’s Institute, Saint Petersburg State Medical Pavlov University, St. Petersburg, Russian Federation Stem Cell Transplant Unit, Department of Hematology, Tor Vergata “University Hospital”, Rome, Italy Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Munich, Germany Department of Hematology and Trasfusional Medicine, Lund University, Ospedale Civile, Pescara, Sweden Department of Bone Marrow Transplantation and Onco-Hematology, Comprehensive Cancer Center M. Sklodowska-Curie Memorial Institute, Gliwice Branch, Gliwice, Poland Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel AU - Santoro, N. AU - Ruggeri, A. AU - Labopin, M. AU - Bacigalupo, A. AU - Ciceri, F. AU - Gülbaş, Z. AU - Huang, H. AU - Afanasyev, B. AU - Arcese, W. AU - Wu, D. AU - Koc, Y. AU - Tischer, J. AU - Santarone, S. AU - Giebel, S. AU - Mohty, M. AU - Nagler, A. C7 - 113 DB - Scopus DO - 10.1186/s13045-017-0480-5 IS - 1 M3 - Article N1 - Cited By :32 Export Date: 18 November 2020 PY - 2017 ST - Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT T2 - Journal of Hematology and Oncology TI - Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019733626&doi=10.1186%2fs13045-017-0480-5&partnerID=40&md5=06ceb113ec2279264313ad750a081bf0 VL - 10 ID - 8244 ER - TY - JOUR AD - Department of Cell Metabolism, National Institute of Haematology and Immunology, Budapest, Hungary. AN - 11583024 AU - Kolonics, A. AU - Apáti, A. AU - Nahajevszky, S. AU - Gáti, R. AU - Brózik, A. AU - Magócsi, M. DO - 10.1163/15685590152492936 10.1163/15685590152492936. DP - Nlm ET - 2001/10/05 IS - 2 LA - eng PY - 2001 SN - 0017-6559 (Print) 0017-6559 SP - 125-38 ST - Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia T2 - Haematologia (Budap) TI - Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia VL - 31 ID - 8245 ER - TY - JOUR AD - S. Cesaro, Clinic of Pediatric Hematology Oncology, Department of Pediatrics, University of Padova, Via Giustiniani 3, 35128, Padova, Italy AU - Cesaro, S. AU - Pillon, M. AU - Visintin, G. AU - Putti, M. C. AU - Gazzola, M. V. AU - D'Amore, E. AU - Scarzello, G. AU - Zanesco, L. AU - Messina, C. AU - Rosolen, A. DB - Embase Medline DO - 10.1111/j.1600-0609.2005.00422.x IS - 1 LA - English M3 - Article N1 - L40873957 2005-07-06 PY - 2005 SN - 0902-4441 SP - 22-26 ST - Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: A single center case series T2 - European Journal of Haematology TI - Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: A single center case series UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40873957&from=exporthttp://dx.doi.org/10.1111/j.1600-0609.2005.00422.x VL - 75 ID - 8246 ER - TY - JOUR AD - S.P. Hunger, UCHSC Campus Box C229, 4200 East Ninth Ave, Denver, CO 80262, United States AU - Meech, S. J. AU - McGavran, L. AU - Odom, L. F. AU - Liang, X. AU - Maltesen, L. AU - Gump, J. AU - Wei, Q. AU - Carlsen, S. AU - Hunger, S. P. DB - Embase Medline DO - 10.1182/blood.V98.4.1209 IS - 4 LA - English M3 - Article N1 - L35119686 2002-10-22 PY - 2001 SN - 0006-4971 SP - 1209-1216 ST - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4 - Anaplastic lymphoma kinase gene fusion T2 - Blood TI - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4 - Anaplastic lymphoma kinase gene fusion UR - https://www.embase.com/search/results?subaction=viewrecord&id=L35119686&from=exporthttp://dx.doi.org/10.1182/blood.V98.4.1209 VL - 98 ID - 8247 ER - TY - JOUR AD - Section of Pediatric Hematology/Oncology, Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO 80262, USA. AN - 11493472 AU - Meech, S. J. AU - McGavran, L. AU - Odom, L. F. AU - Liang, X. AU - Meltesen, L. AU - Gump, J. AU - Wei, Q. AU - Carlsen, S. AU - Hunger, S. P. DA - Aug 15 DO - 10.1182/blood.v98.4.1209 DP - Nlm ET - 2001/08/09 IS - 4 LA - eng N1 - Meech, S J McGavran, L Odom, L F Liang, X Meltesen, L Gump, J Wei, Q Carlsen, S Hunger, S P PY - 2001 SN - 0006-4971 (Print) 0006-4971 SP - 1209-16 ST - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion T2 - Blood TI - Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion VL - 98 ID - 8248 ER - TY - JOUR AD - J. Chen, Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China AU - Wang, X. AU - Wang, X. AU - Li, W. AU - Zhang, Q. AU - Chen, J. AU - Chen, T. DB - Embase DO - 10.3389/fonc.2019.01105 IS - OCT LA - English M3 - Article N1 - L629729295 2019-11-12 2019-11-14 PY - 2019 SN - 2234-943X ST - Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma T2 - Frontiers in Oncology TI - Up-regulation of hsa_circ_0000517 predicts adverse prognosis of hepatocellular carcinoma UR - https://www.embase.com/search/results?subaction=viewrecord&id=L629729295&from=exporthttp://dx.doi.org/10.3389/fonc.2019.01105 VL - 9 ID - 8249 ER - TY - JOUR AD - A. Komatsuda, 3rd Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita City, Akita 010-8543, Japan AU - Okuyama, S. AU - Komatsuda, A. AU - Wakui, H. AU - Aiba, N. AU - Fujishima, N. AU - Iwamoto, K. AU - Ohtani, H. AU - Sawada, K. I. DB - Embase Medline DO - 10.1093/ndt/gfh673 IS - 3 LA - English M3 - Article N1 - L40378422 2005-04-03 PY - 2005 SN - 0931-0509 SP - 539-544 ST - Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome T2 - Nephrology Dialysis Transplantation TI - Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome UR - https://www.embase.com/search/results?subaction=viewrecord&id=L40378422&from=exporthttp://dx.doi.org/10.1093/ndt/gfh673 VL - 20 ID - 8250 ER - TY - JOUR AD - F. Blasi, IFOM, Fondazione Istituto FIRC di Oncologia Moleculare, via Adamello 16, 20139 Milano, Italy AU - d'Alessio, S. AU - Gerasi, L. AU - Blasi, F. DB - Embase Medline DO - 10.1242/jcs.037549 IS - 23 L1 - internal-pdf://2994426238/3922.full.pdf LA - English M3 - Article N1 - L354136850 2009-02-16 PY - 2008 SN - 0021-9533 SP - 3922-3932 ST - uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro T2 - Journal of Cell Science TI - uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro UR - https://www.embase.com/search/results?subaction=viewrecord&id=L354136850&from=exporthttp://dx.doi.org/10.1242/jcs.037549 VL - 121 ID - 8251 ER - TY - JOUR AD - Institute of Pathology, University of Basel, Schönbeinstrasse 40, CH-4003 Basel, Switzerland Institute of Pathology, University of Basel, Basel, Switzerland AU - Tornillo, L. AU - Terracciano, L. M. DB - Scopus DO - 10.1136/jcp.2005.031112 IS - 6 M3 - Review N1 - Cited By :89 Export Date: 18 November 2020 PY - 2006 SP - 557-563 ST - An update on molecular genetics of gastrointestinal stromal tumours T2 - Journal of Clinical Pathology TI - An update on molecular genetics of gastrointestinal stromal tumours UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745099617&doi=10.1136%2fjcp.2005.031112&partnerID=40&md5=cec025cae020bd3a05086c080a72d2fb VL - 59 ID - 8252 ER - TY - JOUR AD - Department of Oncology, Hematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN, United States AU - Pui, C. H. DB - Scopus IS - 12 M3 - Article N1 - Cited By :1 Export Date: 18 November 2020 PY - 2006 SP - 884-886 ST - Update on pediatric ALL T2 - Clinical Advances in Hematology and Oncology TI - Update on pediatric ALL UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846426451&partnerID=40&md5=f479ff2e11e9c26d36bc8136506df48f VL - 4 ID - 8253 ER - TY - JOUR AD - S. Bringhen, University of Torino, Division of Hematology, Myeloma Unit, AOU S Giovanni Battista, Torino, Italy AU - Guglielmelli, T. AU - Bringhen, S. AU - Palumbo, A. DB - Embase Medline DO - 10.1517/14712598.2012.657623 IS - 3 LA - English M3 - Article N1 - L364300414 2012-02-29 PY - 2012 SN - 1471-2598 SP - 353-361 ST - Update on the use of defibrotide T2 - Expert Opinion on Biological Therapy TI - Update on the use of defibrotide UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364300414&from=exporthttp://dx.doi.org/10.1517/14712598.2012.657623 VL - 12 ID - 8254 ER - TY - JOUR AD - Division of Medical Oncology, University of Colorado, Denver, Colorado. Medical University of Gdańsk, Gdańsk, Poland. Lausanne University Hospital, Lausanne, Switzerland. State Key Laboratory of South China, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. F. Hoffmann-La Roche Ltd, Basel, Switzerland. University of Michigan, Ann Arbor, Michigan. University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada. Royal North Shore Hospital, Sydney University, Sydney, Australia. European Institute of Oncology, Scientific Institute for Research and Healthcare, Milan, Italy. Severence Hospital, Seoul, Republic of Korea. Sun Yet-sen University Cancer Center, Guangdong, People's Republic of China. Grenoble University Hospital Center, La Tronche, France. Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address: Ashaw1@partners.org. AN - 30902613 AU - Camidge, D. R. AU - Dziadziuszko, R. AU - Peters, S. AU - Mok, T. AU - Noe, J. AU - Nowicka, M. AU - Gadgeel, S. M. AU - Cheema, P. AU - Pavlakis, N. AU - de Marinis, F. AU - Cho, B. C. AU - Zhang, L. AU - Moro-Sibilot, D. AU - Liu, T. AU - Bordogna, W. AU - Balas, B. AU - Müller, B. AU - Shaw, A. T. DA - Jul DO - 10.1016/j.jtho.2019.03.007 10.1016/j.jtho.2019.03.007. Epub 2019 Mar 20. DP - Nlm ET - 2019/03/25 IS - 7 LA - eng PY - 2019 SN - 1556-0864 SP - 1233-1243 ST - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study T2 - J Thorac Oncol TI - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study VL - 14 ID - 8255 ER - TY - JOUR AN - CN-01937246 AU - Camidge, D. R. AU - Dziadziuszko, R. AU - Peters, S. AU - Mok, T. AU - Noe, J. AU - Nowicka, M. AU - Gadgeel, S. M. AU - Cheema, P. AU - Pavlakis, N. AU - de Marinis, F. AU - et al. DO - 10.1016/j.jtho.2019.03.007 IS - 7 M3 - Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non‐U.S. Gov't PY - 2019 SP - 1233‐1243 ST - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study T2 - Journal of thoracic oncology TI - Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study UR - https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01937246/full VL - 14 ID - 8256 ER - TY - JOUR AD - BCLC Group, Liver Unit, University of Barcelona, Catalonia, Spain Division of Liver Diseases, RM Transplantation Institute, Mount Sinai School of Medicine, Madison Ave. 1425, New York, NY 10029, United States AU - Llovet, J. M. DB - Scopus DO - 10.1007/s00535-005-1566-3 IS - 3 M3 - Review N1 - Cited By :425 Export Date: 18 November 2020 PY - 2005 SP - 225-235 ST - Updated treatment approach to hepatocellular carcinoma T2 - Journal of Gastroenterology TI - Updated treatment approach to hepatocellular carcinoma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-18144411666&doi=10.1007%2fs00535-005-1566-3&partnerID=40&md5=86210985c670d04478a3947ed934e1b2 VL - 40 ID - 8257 ER - TY - JOUR AD - C.H. June, Abraham Cancer Center, Perelman School of Medicine, Philadelphia, PA, United States AU - June, C. H. DB - Embase DO - 10.1007/s00277-014-2297-4 IS - 1 LA - English M3 - Conference Abstract N1 - L71868763 2015-05-07 PY - 2015 SN - 0939-5555 SP - S14-S16 ST - Updates on cars for leukemia and beyond T2 - Annals of Hematology TI - Updates on cars for leukemia and beyond UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71868763&from=exporthttp://dx.doi.org/10.1007/s00277-014-2297-4 VL - 94 ID - 8258 ER - TY - JOUR AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, P.R. China. AN - 25369801 AU - Zhang, Z. AU - Nie, F. AU - Chen, X. AU - Qin, Z. AU - Kang, C. AU - Chen, B. AU - Ma, J. AU - Pan, B. AU - Ma, Y. C2 - PMC4262479 DA - Feb DO - 10.3892/mmr.2014.2827 10.3892/mmr.2014.2827. Epub 2014 Oct 31. DP - Nlm ET - 2014/11/06 IS - 2 LA - eng PY - 2015 SN - 1791-2997 (Print) 1791-2997 SP - 857-64 ST - Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1 T2 - Mol Med Rep TI - Upregulated periostin promotes angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as well as the upregulated expression of VEGF and angiopoietin‑1 VL - 11 ID - 8259 ER - TY - JOUR AD - T. Srivastava, Section of Nephrology, Children’s Mercy Hospital, University of Missouri, Kansas City, MO, United States AU - Srivastava, T. AU - Joshi, T. AU - Jiang, Y. AU - Heruth, D. P. AU - Rezaiekhaligh, M. H. AU - Novak, J. AU - Staggs, V. S. AU - Alon, U. S. AU - Garola, R. E. AU - El-Meanawy, A. AU - McCarthy, E. T. AU - Zhou, J. AU - Boinpelly, V. C. AU - Sharma, R. AU - Savin, V. J. AU - Sharma, M. DB - Embase Medline DO - 10.1152/ajprenal.00183.2020 IS - 2 LA - English M3 - Article N1 - L2007611645 2020-10-12 2020-11-12 PY - 2020 SN - 1522-1466 0363-6127 SP - F312-F322 ST - Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes T2 - American Journal of Physiology - Renal Physiology TI - Upregulated proteoglycan-related signaling pathways in fluid flow shear stress-treated podocytes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007611645&from=exporthttp://dx.doi.org/10.1152/ajprenal.00183.2020 VL - 319 ID - 8260 ER - TY - JOUR AD - Y. Fan, Department of Traditional Chinese Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China AU - Yang, T. AU - Wang, S. AU - Yang, X. AU - Zheng, Q. AU - Wang, L. AU - Li, Q. AU - Wei, M. AU - Du, Z. AU - Fan, Y. DB - Embase DO - 10.3389/fnins.2017.00011 IS - JAN LA - English M3 - Article N1 - L614312738 2017-02-14 2017-02-28 PY - 2017 SN - 1662-453X 1662-4548 ST - Upregulation of Bcl-2 and its promoter signals in CD4+ T cells during neuromyelitis optica remission T2 - Frontiers in Neuroscience TI - Upregulation of Bcl-2 and its promoter signals in CD4+ T cells during neuromyelitis optica remission UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614312738&from=exporthttp://dx.doi.org/10.3389/fnins.2017.00011 VL - 11 ID - 8261 ER - TY - JOUR AD - Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, Germany. Kids Cancer Center, Sydneys Children's Hospital, Children's Cancer Institute, Lowy Cancer Centre, University of New South Wales, Sydney, Australia. Unité Inserm U830, Centre de Recherche, Institut Curie, Paris, France. Biotherapy Unit, IRCCS AOU San Martino-IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Oncology Discovery Research and Early Development, Johnson & Johnson, Beerse, Belgium. AN - 25805801 AU - Lambertz, I. AU - Kumps, C. AU - Claeys, S. AU - Lindner, S. AU - Beckers, A. AU - Janssens, E. AU - Carter, D. R. AU - Cazes, A. AU - Cheung, B. B. AU - De Mariano, M. AU - De Bondt, A. AU - De Brouwer, S. AU - Delattre, O. AU - Gibbons, J. AU - Janoueix-Lerosey, I. AU - Laureys, G. AU - Liang, C. AU - Marchall, G. M. AU - Porcu, M. AU - Takita, J. AU - Trujillo, D. C. AU - Van Den Wyngaert, I. AU - Van Roy, N. AU - Van Goethem, A. AU - Van Maerken, T. AU - Zabrocki, P. AU - Cools, J. AU - Schulte, J. H. AU - Vialard, J. AU - Speleman, F. AU - De Preter, K. DA - Jul 15 DO - 10.1158/1078-0432.Ccr-14-2024 10.1158/1078-0432.CCR-14-2024. Epub 2015 Mar 24. DP - Nlm ET - 2015/03/26 IS - 14 LA - eng PY - 2015 SN - 1078-0432 (Print) 1078-0432 SP - 3327-39 ST - Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment T2 - Clin Cancer Res TI - Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment VL - 21 ID - 8262 ER - TY - JOUR AD - S. Surendran, Department of Pediatrics, University of Texas Health Science Center, Houston, TX 77030, United States AU - Surendran, S. DB - Embase Medline DO - 10.1007/s11033-007-9167-2 IS - 1 LA - English M3 - Article N1 - L352727305 2008-12-22 PY - 2009 SN - 0301-4851 1573-4978 SP - 201-206 ST - Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility T2 - Molecular Biology Reports TI - Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility UR - https://www.embase.com/search/results?subaction=viewrecord&id=L352727305&from=exporthttp://dx.doi.org/10.1007/s11033-007-9167-2 VL - 36 ID - 8263 ER - TY - JOUR AU - Moore, C. AU - Palau, V. E. AU - Mahboob, R. AU - Lightner, J. AU - Stone, W. AU - Krishnan, K. DB - Medline DO - 10.1186/s12885-020-06947-6 IS - 1 LA - English M3 - Article N1 - L631779994 2020-05-25 PY - 2020 SN - 1471-2407 SP - 428 ST - Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells T2 - BMC cancer TI - Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L631779994&from=exporthttp://dx.doi.org/10.1186/s12885-020-06947-6 VL - 20 ID - 8264 ER - TY - JOUR AD - A. Xuan, Institute of Neuroscience, Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Key Lab. of Neurogenetics and Channelopathies of Guangdong Prov. and the Min. of Education of China, Guangzhou, China AU - Gong, Z. AU - Huang, J. AU - Xu, B. AU - Ou, Z. AU - Zhang, L. AU - Lin, X. AU - Ye, X. AU - Kong, X. AU - Long, D. AU - Sun, X. AU - He, X. AU - Xu, L. AU - Li, Q. AU - Xuan, A. C2 - Standard Laboratories(China) DB - Embase Medline DO - 10.1186/s12974-019-1450-3 IS - 1 LA - English M3 - Article N1 - L626758927 2019-03-22 2019-08-02 PY - 2019 SN - 1742-2094 ST - Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice T2 - Journal of Neuroinflammation TI - Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626758927&from=exporthttp://dx.doi.org/10.1186/s12974-019-1450-3 VL - 16 ID - 8265 ER - TY - JOUR AD - Department of Surgical Oncology, Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, United States Division of Medical Oncology, University of British Columbia, Vancouver, Canada Department of Medical Oncology, Sarcoma Program, Fox Chase Cancer Center, Philadelphia, PA, United States Division of Oncology, Medical Oncology Section, Washington University, St Louis, WA, United States Novartis Pharmaceuticals Corp., East Hanover, United States Department of Medical Oncology, Sarcoma Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, United States AU - Pisters, P. W. T. AU - Blanke, C. D. AU - von Mehren, M. AU - Picus, J. AU - Sirulnik, A. AU - Stealey, E. AU - Trent, J. C. DB - Scopus DO - 10.1093/annonc/mdq773 IS - 11 M3 - Article N1 - Cited By :29 Export Date: 18 November 2020 PY - 2011 SP - 2523-2529 ST - A USA registry of gastrointestinal stromal tumor patients: Changes in practice over time and differences between community and academic practices T2 - Annals of Oncology TI - A USA registry of gastrointestinal stromal tumor patients: Changes in practice over time and differences between community and academic practices UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80355143677&doi=10.1093%2fannonc%2fmdq773&partnerID=40&md5=4c7a116d953aeecd90393b6d20d34f88 VL - 22 ID - 8266 ER - TY - JOUR AD - Department of Pathology, Texas Children's Hospital, Houston, TX, USA. Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA. Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA. Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX, USA. AN - 28219109 AU - Ballester, L. Y. AU - Cantu, M. D. AU - Lim, K. P. H. AU - Sarabia, S. F. AU - Ferguson, L. S. AU - Renee Webb, C. AU - Allen, C. E. AU - McClain, K. L. AU - Mohila, C. A. AU - Punia, J. N. AU - Roy, A. AU - López-Terrada, D. H. AU - John Hicks, M. AU - Fisher, K. E. C2 - PMC6886693 C6 - NIHMS1060374 DA - Feb DO - 10.1002/hon.2388 10.1002/hon.2388. Epub 2017 Feb 20. DP - Nlm ET - 2017/02/22 IS - 1 LA - eng PY - 2018 SN - 0278-0232 (Print) 0278-0232 SP - 307-315 ST - The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis T2 - Hematol Oncol TI - The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis VL - 36 ID - 8267 ER - TY - JOUR AD - D.M. Duarte, INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P., National Authority of Medicines and Health Products, I.P., Parque Saúde de Lisboa, Av. do Brasil, 53, Lisboa, Portugal AU - Duarte, D. M. C1 - abt 263 afinitor apn 311 avastin busilvex caprelsa cometriq dacogen evoltra glivec iclusig mekinist mepact mozobil nexavar siklos stivarga tafinlar tasigna temodal tepadina votrient votubia xaluprine xgeva zaltrap DB - Embase Medline DO - 10.1016/j.reprotox.2015.05.005 LA - English M3 - Article N1 - L604484699 2015-05-28 2015-08-06 PY - 2015 SN - 1873-1708 0890-6238 SP - 97-104 ST - Use of juvenile animal studies to support oncology medicine development in children T2 - Reproductive Toxicology TI - Use of juvenile animal studies to support oncology medicine development in children UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604484699&from=exporthttp://dx.doi.org/10.1016/j.reprotox.2015.05.005 VL - 56 ID - 8268 ER - TY - JOUR AD - University of Texas Southwestern, Dallas, Texas, USA. Massachusetts General Hospital, Boston, Massachusetts, USA. Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Children's Tumor Foundation, New York, New York, USA. Keck School of Medicine of USC, Children's Hospital of Los Angeles, Los Angeles, California, USA. Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio. Boston Children's Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA. University of Utah, Salt Lake City, Utah, USA. NYU Langone Health, New York, New York, USA. AN - 32272491 AU - Klesse, L. J. AU - Jordan, J. T. AU - Radtke, H. B. AU - Rosser, T. AU - Schorry, E. AU - Ullrich, N. AU - Viskochil, D. AU - Knight, P. AU - Plotkin, S. R. AU - Yohay, K. C2 - PMC7356675 DA - Jul DO - 10.1634/theoncologist.2020-0069 10.1634/theoncologist.2020-0069. Epub 2020 Apr 22. DP - Nlm ET - 2020/04/10 IS - 7 LA - eng PY - 2020 SN - 1083-7159 (Print) 1083-7159 SP - e1109-e1116 ST - The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities T2 - Oncologist TI - The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities VL - 25 ID - 8269 ER - TY - JOUR AD - A. Rosolen, Clinica di Oncoematologia Pediatrica and Fondazione Città della Speranza, Azienda Ospedaliera-Università di Padova, Associazione Italiana Emato-Oncologia Pediatrica, via Giustiniani 3, Padova 35128, Italy AU - Mussolin, L. AU - Damm-Welk, C. AU - Pillon, M. AU - Zimmermann, M. AU - Franceschetto, G. AU - Pulford, K. AU - Reiter, A. AU - Rosolen, A. AU - Woessmann, W. DB - Embase Medline DO - 10.1038/leu.2012.205 IS - 2 LA - English M3 - Article N1 - L52171483 2012-08-23 2013-02-27 PY - 2013 SN - 0887-6924 1476-5551 SP - 416-422 ST - Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis T2 - Leukemia TI - Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L52171483&from=exporthttp://dx.doi.org/10.1038/leu.2012.205 VL - 27 ID - 8270 ER - TY - JOUR AD - Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Box 428, 1515 Holcombe Blvd, Houston, TX 77030, United States AU - Garg, R. J. AU - Kantarjian, H. AU - O'Brien, S. AU - Quintás-Cardama, A. AU - Faderl, S. AU - Estrov, Z. AU - Cortes, J. DB - Scopus DO - 10.1182/blood-2009-05-221531 IS - 20 M3 - Article N1 - Cited By :95 Export Date: 18 November 2020 PY - 2009 SP - 4361-4368 ST - The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: Long-term follow-up T2 - Blood TI - The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: Long-term follow-up UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-73349100015&doi=10.1182%2fblood-2009-05-221531&partnerID=40&md5=46bd8eb4b1727bbc9a3128fac9327ae8 VL - 114 ID - 8271 ER - TY - JOUR AD - N. Garnier, Institute of Pediatric Hematology and Oncology, IHOP, Centre Léon Bérard, 1 Place Joseph Renaut, Lyon Cedex 08, France AU - Garnier, N. AU - Bertrand, A. AU - Libbrecht, C. AU - Corradini, N. AU - Pacquement, H. AU - Gentet, J. C. AU - Lervat, C. AU - Girodet, M. AU - Bouclier, L. AU - Ray-Coquard, I. AU - Marec-Berard, P. C1 - vp 16 DB - Embase DO - 10.1055/s-0036-1597609 IS - 3 LA - English M3 - Article N1 - L613925055 2017-01-04 2017-02-07 PY - 2016 SN - 1879-5404 1879-5390 SP - 136-145 ST - Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes T2 - Journal of Pediatric Biochemistry TI - Use of Off-Label Targeted Therapies in Refractory Sarcomas: Analysis of Pediatric Data from the French Registry Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613925055&from=exporthttp://dx.doi.org/10.1055/s-0036-1597609 VL - 6 ID - 8272 ER - TY - JOUR AD - T.G. Muñoz, Microenvironment and Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain AU - Muñoz, T. G. AU - Di Giannatale, A. AU - Savini, C. AU - Garcia-Silva, S. AU - Benito-Martin, A. AU - Merino, C. AU - Peinado, H. DB - Embase DO - 10.1080/20013078.2018.1461450 LA - English M3 - Conference Abstract N1 - L622571939 2018-06-19 PY - 2018 SN - 2001-3078 SP - 232-233 ST - Use of tumour-secreted exosomes to define new biomarkers and targets to prevent malignant peripheral nerve-sheath tumour progression T2 - Journal of Extracellular Vesicles TI - Use of tumour-secreted exosomes to define new biomarkers and targets to prevent malignant peripheral nerve-sheath tumour progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622571939&from=exporthttp://dx.doi.org/10.1080/20013078.2018.1461450 VL - 7 ID - 8273 ER - TY - JOUR AD - D.Y.M. Leung, National Jewish Health, 1400 Jackson St, K926i, Denver, CO 80206, United States AU - Goleva, E. AU - Jackson, L. P. AU - Gleason, M. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1016/j.jaci.2011.12.001 IS - 3 LA - English M3 - Article N1 - L51804475 2012-01-12 2012-03-14 PY - 2012 SN - 0091-6749 1097-6825 SP - 687-693.e1 ST - Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients T2 - Journal of Allergy and Clinical Immunology TI - Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51804475&from=exporthttp://dx.doi.org/10.1016/j.jaci.2011.12.001 VL - 129 ID - 8274 ER - TY - JOUR AD - a Department of Pediatrics ; University of Colorado Denver ; Aurora , CO USA. AN - 25484091 AU - Mulcahy Levy, J. M. AU - Foreman, N. K. AU - Thorburn, A. C2 - PMC4502777 DO - 10.4161/auto.36138 10.4161/auto.36138. DP - Nlm ET - 2014/12/09 IS - 11 LA - eng PY - 2014 SN - 1554-8627 (Print) 1554-8627 SP - 2077-8 ST - Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors T2 - Autophagy TI - Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors VL - 10 ID - 8275 ER - TY - JOUR AD - J. Wu, Cincinnati Children's Hospital, Medical Center, Cincinnati, OH, United States AU - Wu, J. AU - Jousma, E. AU - Rizvi, T. AU - Dunn, R. S. AU - Jones, D. R. AU - Cripe, T. P. AU - Kim, M. O. AU - Marcus, L. AU - Dombi, E. AU - Baldwin, A. AU - Long, L. M. AU - Andrea, G. AU - Whitcomb, P. AU - Peron, S. M. AU - Widemann, B. AU - Janhofer, D. AU - Ratner, N. DB - Embase DO - 10.1158/1538-7445.PEDCAN-A2 IS - 20 LA - English M3 - Conference Abstract N1 - L71713688 2014-12-15 PY - 2014 SN - 0008-5472 ST - Using plexiform neurofibroma preclinical therapeutics to help guide clinical trials T2 - Cancer Research TI - Using plexiform neurofibroma preclinical therapeutics to help guide clinical trials UR - https://www.embase.com/search/results?subaction=viewrecord&id=L71713688&from=exporthttp://dx.doi.org/10.1158/1538-7445.PEDCAN-A2http://cancerres.aacrjournals.org/content/74/20_Supplement/A2.abstract?sid=0e6b4920-7f0c-4a79-bb1d-794f181c13b2 VL - 74 ID - 8276 ER - TY - JOUR AD - M.L.C. Policarpio-Nicolas, Cleveland Clinic, 9500 Euclid Avenue, Mail Code L25, Main Campus, Cleveland, OH, United States AU - Zarei, S. AU - Abdul-Karim, F. W. AU - Chase, D. M. AU - Astbury, C. AU - Policarpio-Nicolas, M. L. C. DB - Embase Medline DO - 10.1097/PGP.0000000000000588 IS - 2 LA - English M3 - Article N1 - L626348481 2019-02-18 PY - 2020 SN - 1538-7151 0277-1691 SP - 152-156 ST - Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: A case report T2 - International Journal of Gynecological Pathology TI - Uterine inflammatory myofibroblastic tumor showing an atypical ALK signal pattern by FISH and DES-ALK fusion by RNA sequencing: A case report UR - https://www.embase.com/search/results?subaction=viewrecord&id=L626348481&from=exporthttp://dx.doi.org/10.1097/PGP.0000000000000588 VL - 39 ID - 8277 ER - TY - JOUR AD - Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of General Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Otorhinolaryngology-Head and Neck Surgery, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Pathology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Nuclear Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Radiation Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea. Department of Radiology, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, South Korea. Department of Surgery (Busan Cancer Center), Pusan National University Hospital, Pusan National University College of Medicine, Busan, South Korea. AN - 30118506 AU - Kim, D. S. AU - Kim, D. W. AU - Heo, Y. J. AU - Baek, J. W. AU - Lee, Y. J. AU - Choo, H. J. AU - Park, Y. M. AU - Park, H. K. AU - Ha, T. K. AU - Kim, D. H. AU - Jung, S. J. AU - Park, J. S. AU - Ahn, K. J. AU - Baek, H. J. AU - Kang, T. C2 - PMC6097667 DO - 10.1371/journal.pone.0202687 10.1371/journal.pone.0202687. eCollection 2018. DP - Nlm ET - 2018/08/18 IS - 8 LA - eng PY - 2018 SN - 1932-6203 SP - e0202687 ST - Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules T2 - PLoS One TI - Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules VL - 13 ID - 8278 ER - TY - JOUR AD - S.I. Bannykh, Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA, United States AU - Bannykh, S. I. AU - Mirocha, J. AU - Nuno, M. AU - Lopategui, J. AU - Kandala, G. DB - Embase Medline DO - 10.5414/NP300753 IS - 6 LA - English M3 - Article N1 - L604744029 2015-06-10 2015-06-18 PY - 2014 SN - 0722-5091 SP - 388-398 ST - V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior T2 - Clinical Neuropathology TI - V600E BRAF mutation in pilocytic astrocytoma is associated with a more diffuse growth pattern but does not confer a more aggressive clinical behavior UR - https://www.embase.com/search/results?subaction=viewrecord&id=L604744029&from=exporthttp://dx.doi.org/10.5414/NP300753 VL - 33 ID - 8279 ER - TY - JOUR AD - Department of Biology, College of Education for pure Sciences, Kerbala University, Kerbala, Iraq AU - Al-Mafragy, H. S. AU - Al-Awade, H. A. R. DB - Scopus DO - 10.25258/ijpqa.10.1.16 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2019 SP - 100-107 ST - Validations of prognostic scoring systems in Iraqi patients with chronic myeloid leukemia in single center T2 - International Journal of Pharmaceutical Quality Assurance TI - Validations of prognostic scoring systems in Iraqi patients with chronic myeloid leukemia in single center UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069862739&doi=10.25258%2fijpqa.10.1.16&partnerID=40&md5=705d6ed5149a601723eade5d42157ec3 VL - 10 ID - 8280 ER - TY - JOUR AD - Institut Gustave Roussy, Université Paris-Sud, Villejuif, France AN - 104501546. Language: English. Entry Date: 20121116. Revision Date: 20200708. Publication Type: journal article AU - Leboulleux, S. AU - Bastholt, L. AU - Krause, T. AU - de la Fouchardiere, C. AU - Tennvall, J. AU - Awada, A. AU - Gómez, J. M. AU - Bonichon, F. AU - Leenhardt, L. AU - Soufflet, C. AU - Licour, M. AU - Schlumberger, M. J. AU - Leboulleux, Sophie AU - Bastholt, Lars AU - Krause, Thomas AU - de la Fouchardiere, Christelle AU - Tennvall, Jan AU - Awada, Ahmad AU - Gómez, José Manuel AU - Bonichon, Françoise DB - ccm DO - 10.1016/S1470-2045(12)70335-2 DP - EBSCOhost IS - 9 N1 - research; randomized controlled trial. Commentary: Bible KC, Bible Keith C. Treating advanced radioresistant differentiated thyroid cancer. (LANCET ONCOL) Sep2012; 13 (9): 854-855. Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland. Special Interest: Oncologic Care. NLM UID: 100957246. PMID: NLM22898678. PY - 2012 SN - 1470-2045 SP - 897-905 ST - Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial T2 - Lancet Oncology TI - Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial UR - http://proxy.lib.umich.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104501546&site=ehost-live&scope=site VL - 13 ID - 8281 ER - TY - JOUR AD - M. Herbrink, Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, BK Amsterdam, Netherlands AU - Herbrink, M. AU - Nuijen, B. AU - Schellens, J. H. M. AU - Beijnen, J. H. C1 - bosulif caprelsa cometriq giotrif gleevec glivec iclusig inlyta iressa jakavi nexavar sprycel stivarga sutent tafinlar tarceva tasigna tyverb votrient xalkori zelboraf DB - Embase Medline DO - 10.1016/j.ctrv.2015.03.005 IS - 5 LA - English M3 - Review N1 - L606966338 2015-11-24 2015-11-30 PY - 2015 SN - 1532-1967 0305-7372 SP - 412-422 ST - Variability in bioavailability of small molecular tyrosine kinase inhibitors T2 - Cancer Treatment Reviews TI - Variability in bioavailability of small molecular tyrosine kinase inhibitors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L606966338&from=exporthttp://dx.doi.org/10.1016/j.ctrv.2015.03.005 VL - 41 ID - 8282 ER - TY - JOUR AD - E.A. Simons, Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, MS 8117, 12801 E 17th Avenue, Aurora, CO, United States AU - Simons, E. A. AU - Smith, D. E. AU - Gao, D. AU - Camidge, D. R. DB - Embase Medline DO - 10.1016/j.jtho.2020.04.020 IS - 9 LA - English M3 - Conference Paper N1 - L2006039396 2020-06-05 2020-10-05 PY - 2020 SN - 1556-1380 1556-0864 SP - 1425-1433 ST - Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences T2 - Journal of Thoracic Oncology TI - Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006039396&from=exporthttp://dx.doi.org/10.1016/j.jtho.2020.04.020 VL - 15 ID - 8283 ER - TY - JOUR AD - Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. AN - 16116481 AU - Gee, M. F. AU - Tsuchida, R. AU - Eichler-Jonsson, C. AU - Das, B. AU - Baruchel, S. AU - Malkin, D. DA - Dec 1 DO - 10.1038/sj.onc.1208939 10.1038/sj.onc.1208939. DP - Nlm ET - 2005/08/24 IS - 54 LA - eng PY - 2005 SN - 0950-9232 (Print) 0950-9232 SP - 8025-37 ST - Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid T2 - Oncogene TI - Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid VL - 24 ID - 8284 ER - TY - JOUR AD - E. S. Kleinerman, Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States AU - Yu, L. AU - Su, B. AU - Hollomon, M. AU - Deng, Y. AU - Facchinetti, V. AU - Kleinerman, E. S. DB - Embase Medline DO - 10.1158/0008-5472.CAN-09-2795 IS - 4 L1 - internal-pdf://2866829876/1334.full.pdf LA - English M3 - Article N1 - L358308285 2010-02-24 2010-03-02 PY - 2010 SN - 0008-5472 1538-7445 SP - 1334-1343 ST - Vasculogenesis driven by bone marrow-derived cells is essential for growth of ewing's sarcomas T2 - Cancer Research TI - Vasculogenesis driven by bone marrow-derived cells is essential for growth of ewing's sarcomas UR - https://www.embase.com/search/results?subaction=viewrecord&id=L358308285&from=exporthttp://dx.doi.org/10.1158/0008-5472.CAN-09-2795 VL - 70 ID - 8285 ER - TY - JOUR AD - Departments of *Pathology ∥Urology ¶Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD †Department of Pathology, University of South Carolina School of Medicine-Greenville, Greenville, SC ‡Department of Pathology, Brigham and Women's Hospital, Boston, MA §Departments of Pathology/Microbiology, Pediatrics and Orthopedic Surgery, University of Nebraska Medical Center, Omaha, NE. AN - 24698962 AU - Smith, N. E. AU - Deyrup, A. T. AU - Mariño-Enriquez, A. AU - Fletcher, J. A. AU - Bridge, J. A. AU - Illei, P. B. AU - Netto, G. J. AU - Argani, P. C2 - PMC4352307 C6 - NIHMS664075 DA - Jun DO - 10.1097/pas.0000000000000179 10.1097/PAS.0000000000000179. DP - Nlm ET - 2014/04/05 IS - 6 LA - eng PY - 2014 SN - 0147-5185 (Print) 0147-5185 SP - 858-63 ST - VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? T2 - Am J Surg Pathol TI - VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? VL - 38 ID - 8286 ER - TY - JOUR AD - B. Wang, Monash University, Centre of Cardiovascular Research and Education in Therapeutics, SPHPM Melbourne, Australia AU - Wang, B. AU - Xu, T. T. AU - Cai, Y. AU - Huang, L. AU - Ma, Y. Y. AU - Vinh, N. AU - Min, S. D. AU - Wang, K. X. AU - Scammells, P. AU - Ju, S. H. DB - Embase DO - 10.1093/eurheartj/ehx502.P5274 LA - English M3 - Conference Abstract N1 - L621237161 2018-03-20 PY - 2017 SN - 1522-9645 SP - 1105 ST - VCP979, a novel p38MAPK inhibitor, attenuates inflammatory response and improve cardiac function post-myocardial infarction T2 - European Heart Journal TI - VCP979, a novel p38MAPK inhibitor, attenuates inflammatory response and improve cardiac function post-myocardial infarction UR - https://www.embase.com/search/results?subaction=viewrecord&id=L621237161&from=exporthttp://dx.doi.org/10.1093/eurheartj/ehx502.P5274 VL - 38 ID - 8287 ER - TY - JOUR AD - Hematology Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Laboratory Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Hematology Department, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. Urology surgery Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, Hunan, China. Molecular Biology Research Center, School of Life Science, Central South University, Changsha, 410078, China. Hematology Department, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. xychenfp@qq.com. AN - 29051621 AU - Peng, M. AU - Li, Y. AU - Zhang, J. AU - Wu, Y. AU - Yang, X. AU - Lei, Y. AU - Ye, M. AU - Liu, J. AU - Han, X. AU - Kuang, Y. AU - Zhao, X. AU - Chen, F. C2 - PMC5648841 DA - Oct 19 DO - 10.1038/s41598-017-14099-0 10.1038/s41598-017-14099-0. DP - Nlm ET - 2017/10/21 IS - 1 LA - eng PY - 2017 SN - 2045-2322 SP - 13571 ST - Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation T2 - Sci Rep TI - Vector-independent transmembrane transport of oligodeoxyribonucleotides involves p38 mitogen activated protein kinase phosphorylation VL - 7 ID - 8288 ER - TY - JOUR AD - Department of Orthopedics, Tongji Hospital of Tongji University, Shanghai, 200065, China, meijiong005@sina.com. AN - 24375110 AU - Mei, J. AU - Zhu, X. AU - Wang, Z. AU - Wang, Z. DA - May DO - 10.1007/s12013-013-9781-7 10.1007/s12013-013-9781-7. DP - Nlm ET - 2014/01/01 IS - 1 LA - eng PY - 2014 SN - 1085-9195 SP - 151-6 ST - VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment T2 - Cell Biochem Biophys TI - VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment VL - 69 ID - 8289 ER - TY - JOUR AD - Trousseau Hospital, Paris, France. Centre Hospitalier Universitaire R.-Poincaré, Garches, France. Centre Hospitalier Universitaire de Grenoble, Grenoble, France. Cambridge University Hospitals, Cambridge, United Kingdom. Medical University of Vienna, Vienna, Austria. Azienda Ospedaliero-Universitaria A. Meyer, Florence, Italy. Centre Hospitalier du Nord, Zgharta, Lebanon. Rafic Hariri University Hospital, Beirut, Lebanon. Newcastle University, Newcastle upon Tyne, United Kingdom. Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France. Université Paris-Saclay, Boulogne-Billancourt, France. Hôpital Sainte Marguerite, Marseille, France. Centre Hospitalier Universitaire Félix-Guyon (Saint-Denis), La Réunion, France. Comenius University Children's Hospital Limbova 1, Bratislava, Slovakia. Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Centre Hospitalier Universitaire de Rouen, Rouen, France. Centre Hospitalier Universitaire de Toulouse, Toulouse, France. Centre Hospitalier Universitaire d'Amiens, Amiens, France. Universitätsklinikum Frankfurt, Frankfurt am Main, Germany. Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium. University Hospital, Minsk, Belarus. Universitätsklinikum Münster Klinik für Kinder- und Jugendmedizin-Pädiatrische Hämatologie und Onkologie, Münster, Germany. Centre Hospitalier Universitaire de Poitiers, Poitiers, France. Centre Hospitalier Universitaire de Lille, Lille, France. Hôpital Mustapha, Mustapha, Algeria. Charité-University Medicine Berlin, Berlin, Germany. University Hospital Motol, Prague, Czech Republic. Hôpitaux Universitaires de Genève, Geneva, Switzerland. Schneider Children's Medical Center, Petah Tikva, Israel. The Edmond and Lily Safra Children's Hospital, Tel-Hahsomer, Israel. Dmitriy Rogachev National Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia. Centre Hospitalier Universitaire La Pitié-Salpêtrière-Charles Foix, Paris, France. Great Ormond Street Hospital, London, United Kingdom. Université Paris Sorbonne Cité, Paris, France. AN - 31513482 AU - Donadieu, J. AU - Larabi, I. A. AU - Tardieu, M. AU - Visser, J. AU - Hutter, C. AU - Sieni, E. AU - Kabbara, N. AU - Barkaoui, M. AU - Miron, J. AU - Chalard, F. AU - Milne, P. AU - Haroche, J. AU - Cohen, F. AU - Hélias-Rodzewicz, Z. AU - Simon, N. AU - Jehanne, M. AU - Kolenova, A. AU - Pagnier, A. AU - Aladjidi, N. AU - Schneider, P. AU - Plat, G. AU - Lutun, A. AU - Sonntagbauer, A. AU - Lehrnbecher, T. AU - Ferster, A. AU - Efremova, V. AU - Ahlmann, M. AU - Blanc, L. AU - Nicholson, J. AU - Lambilliote, A. AU - Boudiaf, H. AU - Lissat, A. AU - Svojgr, K. AU - Bernard, F. AU - Elitzur, S. AU - Golan, M. AU - Evseev, D. AU - Maschan, M. AU - Idbaih, A. AU - Slater, O. AU - Minkov, M. AU - Taly, V. AU - Collin, M. AU - Alvarez, J. C. AU - Emile, J. F. AU - Héritier, S. C2 - PMC6823889 DA - Nov 1 DO - 10.1200/jco.19.00456 10.1200/JCO.19.00456. Epub 2019 Sep 12. DP - Nlm ET - 2019/09/13 IS - 31 LA - eng PY - 2019 SN - 0732-183X (Print) 0732-183x SP - 2857-2865 ST - Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study T2 - J Clin Oncol TI - Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study VL - 37 ID - 8290 ER - TY - JOUR AD - Pediatric and Adolescent Oncology Department, Gustave Roussy, Villejuif, France. AN - 24375920 AU - Bautista, F. AU - Paci, A. AU - Minard-Colin, V. AU - Dufour, C. AU - Grill, J. AU - Lacroix, L. AU - Varlet, P. AU - Valteau-Couanet, D. AU - Geoerger, B. DA - Jun DO - 10.1002/pbc.24891 10.1002/pbc.24891. Epub 2013 Dec 3. DP - Nlm ET - 2014/01/01 IS - 6 LA - eng PY - 2014 SN - 1545-5009 SP - 1101-3 ST - Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas T2 - Pediatr Blood Cancer TI - Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas VL - 61 ID - 8291 ER - TY - JOUR AD - Columbia University College of Physicians and Surgeons, New York, New York. AN - 24602192 AU - West, E. S. AU - Williams, V. L. AU - Morelli, J. G. DA - Jan-Feb DO - 10.1111/pde.12316 10.1111/pde.12316. Epub 2014 Mar 6. DP - Nlm ET - 2014/03/08 IS - 1 LA - eng PY - 2015 SN - 0736-8046 SP - 153-4 ST - Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma T2 - Pediatr Dermatol TI - Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma VL - 32 ID - 8292 ER - TY - JOUR AD - J.-D. Li, Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, 100 Piedmont Avenue, Atlanta, GA, United States AU - Komatsu, K. AU - Nam, D. H. AU - Lee, J. Y. AU - Yoneda, G. AU - Yan, C. AU - Li, J. D. C1 - pd 98059(Enzo Life Sciences) C2 - Enzo Life Sciences Tocris DB - Embase Medline DO - 10.4049/jimmunol.1901299 IS - 4 LA - English M3 - Article N1 - L2004868454 2020-02-14 2020-02-24 PY - 2020 SN - 1550-6606 0022-1767 SP - 933-942 ST - Vinpocetine suppresses streptococcus pneumoniae-induced inflammation via inhibition of ERK1 by CYLD T2 - Journal of Immunology TI - Vinpocetine suppresses streptococcus pneumoniae-induced inflammation via inhibition of ERK1 by CYLD UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2004868454&from=exporthttp://dx.doi.org/10.4049/jimmunol.1901299 VL - 204 ID - 8293 ER - TY - JOUR AD - Université de Poitiers, Équipe Récepteurs, Régulations et Cellules Tumorales (2RCT), Pôle Biologie Santé, Bât. B36/B37, UFR Sciences Fondamentales et Appliquées, 1 rue Georges Bonnet TSA, 51106 86073 Poitiers Cedex 9, France. Université de Rouen, INSERM U982, Equipe Neuropeptides, survie neuronale et plasticité cellulaire, IRIB, UFR Sciences et Techniques, Place E. Blondel, 76821 Mont-Saint-Aignan, France. INRS, Institut Armand-Frappier, 531 boul. des Prairies, Laval, QC H7V 1B7, Canada. Université de la Réunion, Stemcis c/o CYROI, 2, rue Maxime Rivière, 97490 Sainte Clotilde, France. Université de Poitiers, Équipe Récepteurs, Régulations et Cellules Tumorales (2RCT), Pôle Biologie Santé, Bât. B36/B37, UFR Sciences Fondamentales et Appliquées, 1 rue Georges Bonnet TSA, 51106 86073 Poitiers Cedex 9, France. Electronic address: corinne.chadeneau@univ-poitiers.fr. AN - 26826611 AU - de Boisvilliers, M. AU - Perrin, F. AU - Hebache, S. AU - Balandre, A. C. AU - Bensalma, S. AU - Garnier, A. AU - Vaudry, D. AU - Fournier, A. AU - Festy, F. AU - Muller, J. M. AU - Chadéneau, C. DA - Apr DO - 10.1016/j.peptides.2016.01.014 10.1016/j.peptides.2016.01.014. Epub 2016 Jan 27. DP - Nlm ET - 2016/01/31 LA - eng PY - 2016 SN - 0196-9781 SP - 30-41 ST - VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells T2 - Peptides TI - VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells VL - 78 ID - 8294 ER - TY - JOUR AD - APHP, Groupe Henri Mondor Albert Chenevier, Liver Unit, Henri Mondor Hospital, Créteil, France APHP, Groupe Henri Mondor Albert Chenevier, Department of Radiology, Henri Mondor Hospital, Créteil, France APHP, Groupe Hôpital Européen Georges Pompidou, Department of Clinical Research, Paris, France INSERM, UMRS 1138, Department of Research of Les Cordeliers, Team 22, Paris, France University Paris 5 René Descartes, Paris, France Department of Statistics, George Mason University, Fairfax, VA, United States APHP, Groupe Henri Mondor Albert Chenevier, Department of Hepatobiliary Surgery, Henri Mondor Hospital, Créteil, France University Paris Est Créteil, Créteil, France INSERM U955, Team 18, Créteil, France Université Paris 13, Sorbonne Paris Cité, UFR SMBH, Bobigny, F-93000, France APHP, Hôpitaux Universitaires Paris, France Seine Saint-Denis, Site Jean Verdier, Pôle d'Activité Cancérologique Spécialisée, Service d'Hépatologie, Bondy, F-93143, France INSERM, UMR-1162, Génomique fonctionnelle des Tumeurs solides, IUH, Paris, F-75010, France CHU de Grenoble, Pôle DIGI-DUNE, Service d'Hépatologie et de Gastroentérologie, Grenoble, F-38000, France INSERM U823, Institut Albert Bonniot, équipe 8, Grenoble, F-38000, France AU - Nault, J. C. AU - Pigneur, F. AU - Nelson, A. C. AU - Costentin, C. AU - Tselikas, L. AU - Katsahian, S. AU - Diao, G. AU - Laurent, A. AU - Mallat, A. AU - Duvoux, C. AU - Luciani, A. AU - Decaens, T. DB - Scopus DO - 10.1016/j.dld.2015.07.001 IS - 10 M3 - Article N1 - Cited By :27 Export Date: 18 November 2020 PY - 2015 SP - 869-876 ST - Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors T2 - Digestive and Liver Disease TI - Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942199209&doi=10.1016%2fj.dld.2015.07.001&partnerID=40&md5=7268ba67bfab5109d4c5d77d3de8975d VL - 47 ID - 8295 ER - TY - JOUR AD - L. Ma, School of Laboratory Medicine and Biotechnology, Institute of Molecular Immunology, Southern Medical University, Guangzhou, China AU - He, W. AU - Hu, S. AU - Du, X. AU - Wen, Q. AU - Zhong, X. P. AU - Zhou, X. AU - Zhou, C. AU - Xiong, W. AU - Gao, Y. AU - Zhang, S. AU - Wang, R. AU - Yang, J. AU - Ma, L. DB - Embase DO - 10.3389/fimmu.2018.00365 IS - FEB LA - English M3 - Article N1 - L620841695 2018-03-05 2018-03-08 PY - 2018 SN - 1664-3224 ST - Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis T2 - Frontiers in Immunology TI - Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620841695&from=exporthttp://dx.doi.org/10.3389/fimmu.2018.00365 VL - 9 ID - 8296 ER - TY - JOUR AD - Tecnologico de Monterrey School of Medicine, Monterrey, Nuevo León, Mexico AU - Rodríguez-Romo, L. DB - Scopus DO - 10.1016/j.jpeds.2015.12.051 M3 - Article N1 - Export Date: 18 November 2020 PY - 2016 SP - 121 ST - Vitamin B12 studies in myelogenous leukemia of childhood T2 - Journal of Pediatrics TI - Vitamin B12 studies in myelogenous leukemia of childhood UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969749845&doi=10.1016%2fj.jpeds.2015.12.051&partnerID=40&md5=da2fb693322045c71334a4a3248ac341 VL - 173 ID - 8297 ER - TY - JOUR AD - Y.S. Prakash, Mayo Clinic, 4-184W Jos SMH, 200 First St SW, Rochester, MN, United States AU - Britt, R. D. AU - Faksh, A. AU - Vogel, E. R. AU - Thompson, M. A. AU - Chu, V. AU - Pandya, H. C. AU - Amrani, Y. AU - Martin, R. J. AU - Pabelick, C. M. AU - Prakash, Y. S. DB - Embase Medline DO - 10.1002/jcp.24814 IS - 6 LA - English M3 - Article N1 - L602495402 2015-03-02 2015-03-05 PY - 2015 SN - 1097-4652 0021-9541 SP - 1189-1198 ST - Vitamin D Attenuates Cytokine-Induced Remodeling in Human Fetal Airway Smooth Muscle Cells T2 - Journal of Cellular Physiology TI - Vitamin D Attenuates Cytokine-Induced Remodeling in Human Fetal Airway Smooth Muscle Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L602495402&from=exporthttp://dx.doi.org/10.1002/jcp.24814 VL - 230 ID - 8298 ER - TY - JOUR AD - D.Y.M. Leung, Division of Pediatric Allergy and Immunology, National Jewish Health, 1400 Jackson Street, K926i, Denver, CO 80206, United States AU - Searing, D. A. AU - Leung, D. Y. M. DB - Embase Medline DO - 10.1016/j.iac.2010.05.005 IS - 3 LA - English M3 - Review N1 - L359338254 2010-08-19 2010-09-13 PY - 2010 SN - 0889-8561 SP - 397-409 ST - Vitamin D in atopic dermatitis, asthma and allergic diseases T2 - Immunology and Allergy Clinics of North America TI - Vitamin D in atopic dermatitis, asthma and allergic diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L359338254&from=exporthttp://dx.doi.org/10.1016/j.iac.2010.05.005 VL - 30 ID - 8299 ER - TY - JOUR AD - L. Zhang, Department of Nursing, First People's Hospital of Foshan, 81 North Lingnan Avenue, Chancheng, Foshan, Guangdong, China AU - Lyu, C. AU - Jiang, S. AU - Kong, M. AU - Chen, X. AU - Zhang, L. C2 - Merck AG Sigma Aldrich DB - Embase Medline DO - 10.3892/mmr.2020.11286 IS - 3 LA - English M3 - Article N1 - L2007066653 2020-10-13 2020-11-13 PY - 2020 SN - 1791-3004 1791-2997 SP - 2107-2114 ST - Vitamin D protects against necrotising enterocolitis in newborn mice by activating the ERK signalling pathway T2 - Molecular Medicine Reports TI - Vitamin D protects against necrotising enterocolitis in newborn mice by activating the ERK signalling pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007066653&from=exporthttp://dx.doi.org/10.3892/mmr.2020.11286 VL - 22 ID - 8300 ER - TY - JOUR AD - J.T. Seykora, Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States AU - Lee, V. AU - Gober, M. D. AU - Bashir, H. AU - O'Day, C. AU - Blair, I. A. AU - Mesaros, C. AU - Weng, L. AU - Huang, A. AU - Chen, A. AU - Tang, R. AU - Anagnos, V. AU - Li, J. AU - Roling, S. AU - Sagaityte, E. AU - Wang, A. AU - Lin, C. AU - Yeh, C. AU - Atillasoy, C. AU - Marshall, C. AU - Dentchev, T. AU - Ridky, T. AU - Seykora, J. T. DB - Embase Medline DO - 10.1111/exd.14038 IS - 1 LA - English M3 - Article N1 - L2003531501 2019-11-14 PY - 2020 SN - 1600-0625 0906-6705 SP - 29-38 ST - Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress T2 - Experimental Dermatology TI - Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2003531501&from=exporthttp://dx.doi.org/10.1111/exd.14038 VL - 29 ID - 8301 ER - TY - JOUR AD - Nemours Center for Cancer and Blood Disorders, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, United States of America. Department of Pediatrics, Division of Hematology and Oncology, Children's Healthcare of Mississippi, University of Mississippi Medical Center, Jackson, MS, United States of America. AN - 26571493 AU - Sampson, V. B. AU - Vetter, N. S. AU - Kamara, D. F. AU - Collier, A. B. AU - Gresh, R. C. AU - Kolb, E. A. C2 - PMC4646493 DO - 10.1371/journal.pone.0142704 10.1371/journal.pone.0142704. eCollection 2015. DP - Nlm ET - 2015/11/17 IS - 11 LA - eng PY - 2015 SN - 1932-6203 SP - e0142704 ST - Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways T2 - PLoS One TI - Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways VL - 10 ID - 8302 ER - TY - JOUR AD - M. Athar, Department of Dermatology, University of Alabama at Birmingham, 1530 3rd Avenue South, VH 509, Birmingham, AL 35294-0019, United States AU - Kurundkar, D. AU - Srivastava, R. K. AU - Chaudhary, S. C. AU - Ballestas, M. E. AU - Kopelovich, L. AU - Elmets, C. A. AU - Athar, M. DB - Embase Medline DO - 10.1016/j.taap.2012.11.002 IS - 2 LA - English M3 - Article N1 - L368019476 2013-01-09 2013-01-11 PY - 2013 SN - 0041-008X 1096-0333 SP - 233-244 ST - Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model T2 - Toxicology and Applied Pharmacology TI - Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368019476&from=exporthttp://dx.doi.org/10.1016/j.taap.2012.11.002 VL - 266 ID - 8303 ER - TY - JOUR AD - Department of Obstetrics and Gynecology, NYU Langone Medical Center, 550 First Avenue, New York, NY 10016, United States Departments of Gynecologic and Oncology, New York, United States Departments of Pathology, New York, United States Departments of Pediatric Hematology-Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, New York, United States AU - Conroy, E. M. AU - Frimer, M. AU - Karabakhtsian, R. G. AU - Gorlick, R. AU - Goldberg, G. L. DB - Scopus DO - 10.1097/MPH.0000000000000261 IS - 1 M3 - Article N1 - Export Date: 18 November 2020 PY - 2015 SP - 63-67 ST - Vulvar fibromatosis: A clinical enigma T2 - Journal of Pediatric Hematology/Oncology TI - Vulvar fibromatosis: A clinical enigma UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920595635&doi=10.1097%2fMPH.0000000000000261&partnerID=40&md5=9e63726d8c1ede1d00623b95bf7c54aa VL - 37 ID - 8304 ER - TY - JOUR AD - C.-F. Lin, Department of Cosmetic Science, Chang Gung University of Science and Technology, No. 261, Wenhua 1st Rd., Guishan Dist., Taoyuan City, Taiwan AU - Liou, C. J. AU - Huang, Y. L. AU - Huang, W. C. AU - Yeh, K. W. AU - Huang, T. Y. AU - Lin, C. F. DB - Embase Medline DO - 10.1016/j.jep.2017.01.043 LA - English M3 - Article N1 - L614254497 2017-02-20 2017-02-24 PY - 2017 SN - 1872-7573 0378-8741 SP - 30-38 ST - Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways T2 - Journal of Ethnopharmacology TI - Water extract of Helminthostachys zeylanica attenuates LPS-induced acute lung injury in mice by modulating NF-κB and MAPK pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614254497&from=exporthttp://dx.doi.org/10.1016/j.jep.2017.01.043 VL - 199 ID - 8305 ER - TY - JOUR AD - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of General Surgery, Jagiellonian University, Kopernika 40, 31-501 Cracow, Poland Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Radiology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland Department of Biochemistry and Molecular Biology, Institute of Rheumatology, Spartanska 1, 02-637 Warsaw, Poland Laboratory of Experimental Oncology, Catholic University of Leuven, Herestraat 49, Post 815, 3000 Louvain, Belgium Department of Biology and Genetics, Medical University of Gdansk, Debinki 1, 80-211 Gdańsk, Poland Center for Human Genetics, Catholic University of Leuven, Herestraat 49, Post 815, 3000 Louvain, Belgium Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland AU - Rutkowski, P. AU - Andrzejuk, J. AU - Bylina, E. AU - Osuch, C. AU - Świtaj, T. AU - Jerzak Vel Dobosz, A. AU - Grzesiakowska, U. AU - Jurkowska, M. AU - Wozniak, A. AU - Limon, J. AU - Dȩbiec-Rychter, M. AU - Siedlecki, J. A. C7 - 765 DB - Scopus DO - 10.1007/s12032-013-0765-7 IS - 4 M3 - Article N1 - Cited By :13 Export Date: 18 November 2020 PY - 2013 ST - What are the current outcomes of advanced gastrointestinal stromal tumors: Who are the long-term survivors treated initially with imatinib? T2 - Medical Oncology TI - What are the current outcomes of advanced gastrointestinal stromal tumors: Who are the long-term survivors treated initially with imatinib? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84887030495&doi=10.1007%2fs12032-013-0765-7&partnerID=40&md5=767adddacfaee66c5fc4eae3467c4bd0 VL - 30 ID - 8306 ER - TY - JOUR AD - Department of Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53792, United States AU - Durrani, S. R. AU - Viswanathan, R. K. AU - Busse, W. W. DB - Scopus DO - 10.1016/j.jaci.2011.06.002 IS - 3 M3 - Review N1 - Cited By :126 Export Date: 18 November 2020 PY - 2011 SP - 439-448 ST - What effect does asthma treatment have on airway remodeling? Current perspectives T2 - Journal of Allergy and Clinical Immunology TI - What effect does asthma treatment have on airway remodeling? Current perspectives UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052267387&doi=10.1016%2fj.jaci.2011.06.002&partnerID=40&md5=88b0edd2425fd0f97e9797ec05fd9b9d VL - 128 ID - 8307 ER - TY - JOUR AD - C. Chiaverini, Centre de référence des maladies rares de la peau et des muqueuses d'origine génétique, service de dermatologie, hôpital Archet 2, CHU de Nice, France AU - Chiaverini, C. DB - Embase Medline DO - 10.1016/S0151-9638(17)31063-3 LA - English French M3 - Article N1 - L619813455 2017-12-22 2018-08-17 PY - 2017 SN - 0151-9638 SP - IVS29-IVS39 ST - What's new in pediatric dermatology? T2 - Annales de Dermatologie et de Venereologie TI - What's new in pediatric dermatology? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L619813455&from=exporthttp://dx.doi.org/10.1016/S0151-9638(17)31063-3 VL - 144 ID - 8308 ER - TY - JOUR AD - H.B. Pride, Department of Dermatology, Geisinger Medical Center, 115 Woodbine Ln, Danville, PA 17822-5206, United States AU - Pride, H. B. AU - Tollefson, M. AU - Silverman, R. DB - Embase Medline DO - 10.1016/j.jaad.2013.03.001 IS - 6 LA - English M3 - Review N1 - L368923702 2013-05-23 2013-05-29 PY - 2013 SN - 0190-9622 1097-6787 SP - 885.e1-885.e12 ST - What's new in pediatric dermatology?: Part I. Diagnosis and pathogenesis T2 - Journal of the American Academy of Dermatology TI - What's new in pediatric dermatology?: Part I. Diagnosis and pathogenesis UR - https://www.embase.com/search/results?subaction=viewrecord&id=L368923702&from=exporthttp://dx.doi.org/10.1016/j.jaad.2013.03.001 VL - 68 ID - 8309 ER - TY - JOUR AD - E. Legius, Department of Human Genetics, Catholic University of Leuven, Herestraat 49, 3000 Leuven, Belgium AU - Denayer, E. AU - Legius, E. DB - Embase Medline DO - 10.1007/s00431-007-0535-7 IS - 11 LA - English M3 - Review N1 - L47476634 2007-11-01 PY - 2007 SN - 0340-6199 SP - 1091-1098 ST - What's new in the neuro-cardio-facial-cutaneous syndromes? T2 - European Journal of Pediatrics TI - What's new in the neuro-cardio-facial-cutaneous syndromes? UR - https://www.embase.com/search/results?subaction=viewrecord&id=L47476634&from=exporthttp://dx.doi.org/10.1007/s00431-007-0535-7 VL - 166 ID - 8310 ER - TY - JOUR AD - Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China Peking-Tsinghua Center for Life Sciences, Beijing 100871, China AU - Qin, Y. Z. AU - Jiang, Q. AU - Jiang, H. AU - Li, J. L. AU - Li, L. D. AU - Zhu, H. H. AU - Lai, Y. Y. AU - Lu, X. J. AU - Liu, Y. R. AU - Jiang, B. AU - Huang, X. J. DB - Scopus DO - 10.1016/j.leukres.2013.06.003 IS - 9 M3 - Article N1 - Cited By :10 Export Date: 18 November 2020 PY - 2013 SP - 1035-1040 ST - Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABLIS or log reduction from the baseline level? T2 - Leukemia Research TI - Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABLIS or log reduction from the baseline level? UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880963686&doi=10.1016%2fj.leukres.2013.06.003&partnerID=40&md5=986c5ec831fb646feef26a7dc43e69ac VL - 37 ID - 8311 ER - TY - JOUR AD - E. Sabattini, Unit of Haemolymphopathology, Department of Hematology and Oncology, S. Orsola University Hospital, Bologna, Italy AU - Sabattini, E. AU - Agostinelli, C. AU - Bacci, F. AU - Sagramoso, C. DB - Embase LA - English M3 - Conference Abstract N1 - L620886556 2018-03-02 PY - 2017 SN - 1592-8721 SP - 212 ST - WHO 2016: What changes for lymphoid neoplasms T2 - Haematologica TI - WHO 2016: What changes for lymphoid neoplasms UR - https://www.embase.com/search/results?subaction=viewrecord&id=L620886556&from=export VL - 102 ID - 8312 ER - TY - JOUR AD - Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Sydney Medical School, The University of Sydney, Sydney, Australia. Charles Perkins Centre, The University of Sydney, Sydney, Australia. QIMR Berghofer Medical Research Institute, Brisbane, Australia. Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia. Royal Prince Alfred Hospital, Camperdown, Australia. The University of the Highlands and Islands, Inverness, United Kingdom. Royal North Shore Hospital, New South Wales, Australia. Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, Camperdown, Australia. Macquarie University, North Ryde, Australia. Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia. AN - 30178487 AU - Wilmott, J. S. AU - Johansson, P. A. AU - Newell, F. AU - Waddell, N. AU - Ferguson, P. AU - Quek, C. AU - Patch, A. M. AU - Nones, K. AU - Shang, P. AU - Pritchard, A. L. AU - Kazakoff, S. AU - Holmes, O. AU - Leonard, C. AU - Wood, S. AU - Xu, Q. AU - Saw, R. P. M. AU - Spillane, A. J. AU - Stretch, J. R. AU - Shannon, K. F. AU - Kefford, R. F. AU - Menzies, A. M. AU - Long, G. V. AU - Thompson, J. F. AU - Pearson, J. V. AU - Mann, G. J. AU - Hayward, N. K. AU - Scolyer, R. A. DA - Mar 1 DO - 10.1002/ijc.31791 10.1002/ijc.31791. Epub 2018 Nov 21. DP - Nlm ET - 2018/09/05 IS - 5 LA - eng PY - 2019 SN - 0020-7136 SP - 1049-1060 ST - Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility T2 - Int J Cancer TI - Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility VL - 144 ID - 8313 ER - TY - JOUR AD - Translational Genomics Research Institute, 445 N. Fifth St, Phoenix, AZ, 85004, USA, mdemeure@tgen.org. AN - 24633422 AU - Demeure, M. J. AU - Aziz, M. AU - Rosenberg, R. AU - Gurley, S. D. AU - Bussey, K. J. AU - Carpten, J. D. DA - Jun DO - 10.1007/s00268-014-2485-3 10.1007/s00268-014-2485-3. DP - Nlm ET - 2014/03/19 IS - 6 LA - eng PY - 2014 SN - 0364-2313 SP - 1296-305 ST - Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target T2 - World J Surg TI - Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target VL - 38 ID - 8314 ER - TY - JOUR AD - Endocrine and Sarcoma Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, P9:03, Stockholm, 171 76, Sweden Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden AU - Åhlén, J. AU - Karlsson, F. AU - Wejde, J. AU - Nilsson, I. L. AU - Larsson, C. AU - Bränström, R. DB - Scopus DO - 10.1007/s00268-018-4498-9 IS - 8 M3 - Article N1 - Cited By :6 Export Date: 18 November 2020 PY - 2018 SP - 2512-2521 ST - Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs) T2 - World Journal of Surgery TI - Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs) UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041908122&doi=10.1007%2fs00268-018-4498-9&partnerID=40&md5=54a2d69da1212b29205a7157b218aa5e VL - 42 ID - 8315 ER - TY - JOUR AD - E. Cordes, Western Michigan University School of Medicine, Kalamazoo, MI, United States AU - Cordes, E. AU - Barr, J. DB - Embase DO - 10.1542/peds.142.1_MeetingAbstract.705 IS - 1 LA - English M3 - Conference Abstract N1 - L630752688 2020-02-04 PY - 2018 SN - 1098-4275 ST - Widening the differential: An adult case of hemophagocytic lymphohistiocytosis disguised as a fever of unknown origin T2 - Pediatrics TI - Widening the differential: An adult case of hemophagocytic lymphohistiocytosis disguised as a fever of unknown origin UR - https://www.embase.com/search/results?subaction=viewrecord&id=L630752688&from=exporthttp://dx.doi.org/10.1542/peds.142.1_MeetingAbstract.705 VL - 142 ID - 8316 ER - TY - JOUR AD - G. Kaur, Medical Biotechnology Laboratory, Department of Biotechnology, Guru Nanak Dev University, Amritsar, Punjab, India AU - Gupta, M. AU - Kaur, G. DB - Embase Medline DO - 10.1007/s12017-018-8497-7 IS - 3 LA - English M3 - Article N1 - L622411330 2018-06-06 PY - 2018 SN - 1559-1174 1535-1084 SP - 343-362 ST - Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation T2 - NeuroMolecular Medicine TI - Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation UR - https://www.embase.com/search/results?subaction=viewrecord&id=L622411330&from=exporthttp://dx.doi.org/10.1007/s12017-018-8497-7 VL - 20 ID - 8317 ER - TY - JOUR AD - Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, China AU - Jin, Z. AU - Zhao, C. AU - Han, X. AU - Han, Y. C7 - 480 DB - Scopus DO - 10.1186/1471-2407-12-480 M3 - Article N1 - Cited By :34 Export Date: 18 November 2020 PY - 2012 ST - Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression T2 - BMC Cancer TI - Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870656223&doi=10.1186%2f1471-2407-12-480&partnerID=40&md5=4eb7d4d0719e924e8ba83460b95d7783 VL - 12 ID - 8318 ER - TY - JOUR AD - D. J. Hackam, Division of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, United States AU - Lin, J. AU - Hackam, D. J. DB - Embase Medline DO - 10.1242/dmm.007252 IS - 4 LA - English M3 - Note N1 - L362029265 2011-07-05 2011-07-07 PY - 2011 SN - 1754-8403 1754-8411 SP - 447-456 ST - Worms, flies and four-legged friends: The applicability of biological models to the understanding of intestinal inflammatory diseases T2 - DMM Disease Models and Mechanisms TI - Worms, flies and four-legged friends: The applicability of biological models to the understanding of intestinal inflammatory diseases UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362029265&from=exporthttp://dx.doi.org/10.1242/dmm.007252http://dmm.biologists.org/content/4/4/447.full.pdf+html VL - 4 ID - 8319 ER - TY - JOUR AD - Department of Urology, Austin Health, Heidelberg, VIC, Australia Cancer Surgery, Peter MacCallum Cancer Center, Melbourne, VIC, Australia Department of Pathology, Tissue Path, Mount Waverley, VIC, Australia YURO, Young Urology Researchers Organisation, Melbourne, VIC, Australia AU - Pascoe, C. AU - Christidis, D. AU - Clouston, D. AU - Lawrentschuk, N. C7 - bcr-2017-223423 DB - Scopus DO - 10.1136/bcr-2017-223423 M3 - Article N1 - Export Date: 18 November 2020 PY - 2018 ST - Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: First reported case of yet another mask T2 - BMJ Case Reports TI - Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: First reported case of yet another mask UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045904872&doi=10.1136%2fbcr-2017-223423&partnerID=40&md5=4b7cdba0d43aeb5cbafc5e4ebb419859 VL - 2018 ID - 8320 ER - TY - JOUR AD - Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, 226-3, Chile Laboratory for Diagnostic Genome Analysis, Department of Clinical Genetics, Leiden University Medical Center, ZA Leiden, 2333, Netherlands Department of Genetics, Erasmus MC, CE Rotterdam, 3015, Netherlands Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Pediatrics Division, Faculty of Medicine, Pontificia Universidad Catolica de Chile Santiago, Santiago, 340, Chile Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States Institute of Human Development, University of Manchester and Manchester Academic Health Sciences Centre, Manchester, M13 9PL, United Kingdom Department of Pediatrics, Leiden University Medical Center, ZA Leiden, 2333, Netherlands AU - De Bruin, C. AU - Mericq, V. AU - Andrew, S. F. AU - Van Duyvenvoorde, H. A. AU - Verkaik, N. S. AU - Losekoot, M. AU - Porollo, A. AU - Garcia, H. AU - Kuang, Y. AU - Hanson, D. AU - Clayton, P. AU - Van Gent, D. C. AU - Wit, J. M. AU - Hwa, V. AU - Dauber, A. DB - Scopus DO - 10.1210/jc.2015-1098 IS - 5 M3 - Article N1 - Cited By :33 Export Date: 18 November 2020 PY - 2015 SP - E789-E798 ST - An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome T2 - Journal of Clinical Endocrinology and Metabolism TI - An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929359433&doi=10.1210%2fjc.2015-1098&partnerID=40&md5=e5884a550ed85cb0cd8384ab8a57385a VL - 100 ID - 8321 ER - TY - JOUR AD - K.R. Schultz, 4480 Oak Street, B315, Vancouver, BC, Canada AU - Kariminia, A. AU - Ivison, S. M. AU - Leung, V. M. AU - Sung, S. AU - Couto, N. AU - Rozmus, J. AU - Rolf, N. AU - Narendran, A. AU - Dunn, S. E. AU - Reid, G. S. D. AU - Schultz, K. R. DB - Embase DO - 10.3892/ol.2016.5437 IS - 1 LA - English M3 - Article N1 - L613676017 2016-12-19 2017-01-03 PY - 2017 SN - 1792-1082 1792-1074 SP - 497-505 ST - Y-box-binding protein 1 contributes to IL-7-Mediated survival signaling in B-cell precursor acute lymphoblastic leukemia T2 - Oncology Letters TI - Y-box-binding protein 1 contributes to IL-7-Mediated survival signaling in B-cell precursor acute lymphoblastic leukemia UR - https://www.embase.com/search/results?subaction=viewrecord&id=L613676017&from=exporthttp://dx.doi.org/10.3892/ol.2016.5437 VL - 13 ID - 8322 ER - TY - JOUR AD - Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, 11 Xizhimen South Street, Beijing, 100044, China Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China New Sunshine Charity Foundation, Beijing, China Division of Experimental Medicine, Department of Medicine, Haematology Research Centre, Imperial College London, London, United Kingdom AU - Jiang, Q. AU - Liu, Z. C. AU - Zhang, S. X. AU - Gale, R. P. DB - Scopus DO - 10.1007/s00432-016-2159-7 IS - 7 M3 - Article N1 - Cited By :21 Export Date: 18 November 2020 PY - 2016 SP - 1539-1547 ST - Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia T2 - Journal of Cancer Research and Clinical Oncology TI - Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia UR - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963747511&doi=10.1007%2fs00432-016-2159-7&partnerID=40&md5=361d97fb01ffe63e99cf262572aceaf1 VL - 142 ID - 8323 ER - TY - JOUR AU - Olmo, I. G. AU - Carvalho, T. G. AU - Costa, V. V. AU - Alves-Silva, J. AU - Ferrari, C. Z. AU - Izidoro-Toledo, T. C. AU - da Silva, J. F. AU - Teixeira, A. L. AU - Souza, D. G. AU - Marques, J. T. AU - Teixeira, M. M. AU - Vieira, L. B. AU - Ribeiro, F. M. DB - Embase DO - 10.3389/fimmu.2017.01016 IS - AUG LA - English M3 - Article N1 - L617949510 2017-08-30 2017-09-04 PY - 2017 SN - 1664-3224 ST - Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors T2 - Frontiers in Immunology TI - Zika virus promotes neuronal cell death in a non-cell autonomous manner by triggering the release of neurotoxic factors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L617949510&from=exporthttp://dx.doi.org/10.3389/fimmu.2017.01016 VL - 8 ID - 8324 ER - TY - JOUR AD - Y. Wang, Cardiovascular Center & Geriatric Medicine, The First Hospital of Jilin University, Changchun, Jilin, China AU - Wang, S. AU - Wang, B. AU - Wang, Y. AU - Tong, Q. AU - Liu, Q. AU - Sun, J. AU - Zheng, Y. AU - Cai, L. DB - Embase Medline DO - 10.3390/ijms18030580 IS - 3 LA - English M3 - Article N1 - L614688608 2017-03-15 2017-03-20 PY - 2017 SN - 1422-0067 1661-6596 ST - Zinc prevents the development of diabetic cardiomyopathy in db/db mice T2 - International Journal of Molecular Sciences TI - Zinc prevents the development of diabetic cardiomyopathy in db/db mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614688608&from=exporthttp://dx.doi.org/10.3390/ijms18030580 VL - 18 ID - 8325 ER - TY - JOUR AD - Y. Zheng, Cardiovascular Center, The First Hospital of Jilin University, Changchun, Jilin, China AU - Wang, S. AU - Gu, J. AU - Xu, Z. AU - Zhang, Z. AU - Bai, T. AU - Xu, J. AU - Cai, J. AU - Barnes, G. AU - Liu, Q. J. AU - Freedman, J. H. AU - Wang, Y. AU - Liu, Q. AU - Zheng, Y. AU - Cai, L. DB - Embase Medline DO - 10.1111/jcmm.13050 IS - 6 LA - English M3 - Article N1 - L614478198 2017-02-22 2017-05-31 PY - 2017 SN - 1582-1838 SP - 1182-1192 ST - Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway T2 - Journal of Cellular and Molecular Medicine TI - Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L614478198&from=exporthttp://dx.doi.org/10.1111/jcmm.13050 VL - 21 ID - 8326 ER - TY - JOUR AD - N. Galeotti, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology, University of Florence, Viale G. Pieraccini 6, Florence, Italy AU - Borgonetti, V. AU - Governa, P. AU - Biagi, M. AU - Pellati, F. AU - Galeotti, N. C2 - Extrasynthese(France) Indena(Italy) Sigma Aldrich(Italy) DB - Embase Medline DO - 10.1016/j.phymed.2020.153307 LA - English M3 - Article N1 - L2007546953 2020-08-26 2020-10-22 PY - 2020 SN - 1618-095X 0944-7113 ST - Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice T2 - Phytomedicine TI - Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007546953&from=exporthttp://dx.doi.org/10.1016/j.phymed.2020.153307 VL - 78 ID - 8327 ER - TY - JOUR AD - C.-C. Li, Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan AU - Wang, S. C. AU - Sun, H. L. AU - Hsu, Y. H. AU - Liu, S. H. AU - Lii, C. K. AU - Tsai, C. H. AU - Liu, K. L. AU - Huang, C. S. AU - Li, C. C. DB - Embase Medline DO - 10.1016/j.bcp.2020.114152 LA - English M3 - Article N1 - L2007135341 2020-07-29 2020-09-03 PY - 2020 SN - 1873-2968 0006-2952 ST - α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition T2 - Biochemical Pharmacology TI - α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2007135341&from=exporthttp://dx.doi.org/10.1016/j.bcp.2020.114152 VL - 180 ID - 8328 ER - TY - JOUR AD - H. Wang AU - Yu, X. AU - Jia, B. AU - Wang, F. AU - Lv, X. AU - Peng, X. AU - Wang, Y. AU - Li, H. AU - Wang, Y. AU - Lu, D. AU - Wang, H. DB - Medline DO - 10.1111/jcmm.12184 IS - 2 LA - English M3 - Article N1 - L1052909406 2014-07-08 PY - 2014 SN - 1582-1838 SP - 263-273 ST - α1 adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway T2 - Journal of Cellular and Molecular Medicine TI - α1 adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway UR - https://www.embase.com/search/results?subaction=viewrecord&id=L1052909406&from=exporthttp://dx.doi.org/10.1111/jcmm.12184 VL - 18 ID - 8329 ER - TY - JOUR AD - X. Lu, Department of Geriatrics, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210011, China AU - Yuan, Q. AU - Yang, H. AU - Cheng, C. AU - Li, C. AU - Wu, X. AU - Huan, W. AU - Sun, H. AU - Zhou, Z. AU - Wang, Y. AU - Zhao, Y. AU - Lu, X. AU - Shen, A. DB - Embase Medline DO - 10.1007/s11010-012-1254-6 IS - 1-2 LA - English M3 - Article N1 - L51876293 2012-02-27 2012-05-08 PY - 2012 SN - 0300-8177 1573-4919 SP - 149-158 ST - β-1,4-Galactosyltransferase i involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways T2 - Molecular and Cellular Biochemistry TI - β-1,4-Galactosyltransferase i involved in Schwann cells proliferation and apoptosis induced by tumor necrosis factor-alpha via the activation of MAP kinases signal pathways UR - https://www.embase.com/search/results?subaction=viewrecord&id=L51876293&from=exporthttp://dx.doi.org/10.1007/s11010-012-1254-6 VL - 365 ID - 8330 ER - TY - JOUR AD - J. Romero, Laboratorio de Apoyo A la Investigación, Hospital Universitario Fundación Alcorcón, Alcorcón, 28922 Madrid, Spain AU - Benito, C. AU - Tolõn, R. M. AU - Castillo, A. I. AU - Ruiz-Valdepeñas, L. AU - Martínez-Orgado, J. A. AU - Fernández-Sánchez, F. J. AU - Vázquez, C. AU - Cravatt, B. F. AU - Romero, J. DB - Embase Medline DO - 10.1111/j.1476-5381.2012.01889.x IS - 4 LA - English M3 - Article N1 - L364856389 2012-05-30 2012-06-06 PY - 2012 SN - 0007-1188 1476-5381 SP - 1474-1489 ST - β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors T2 - British Journal of Pharmacology TI - β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors UR - https://www.embase.com/search/results?subaction=viewrecord&id=L364856389&from=exporthttp://dx.doi.org/10.1111/j.1476-5381.2012.01889.x VL - 166 ID - 8331 ER - TY - JOUR AD - L. Zou, Center for Clinical Molecular Medicine, Children's Hospital, Chongqing Medical University, Chongqing 400014, China AU - Zhang, P. AU - He, X. AU - Tan, J. AU - Zhou, X. AU - Zou, L. DB - Embase Medline DO - 10.3892/or.2011.1417 IS - 6 LA - English M3 - Article N1 - L362696756 2011-10-13 2011-10-21 PY - 2011 SN - 1021-335X 1791-2431 SP - 1471-1477 ST - β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression T2 - Oncology Reports TI - β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression UR - https://www.embase.com/search/results?subaction=viewrecord&id=L362696756&from=exporthttp://dx.doi.org/10.3892/or.2011.1417http://www.spandidos-publications.com/serveFile/or_26_6_1471_PDF.pdf?type=article&article_id=or_26_6_1471&item=PDF VL - 26 ID - 8332 ER - TY - JOUR AD - J. Wu, NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China AU - Sun, Y. AU - Sun, Y. AU - Sun, Y. AU - Gao, L. AU - Gao, L. AU - Gao, L. AU - Hou, W. AU - Hou, W. AU - Hou, W. AU - Wu, J. AU - Wu, J. AU - Wu, J. DB - Embase Medline DO - 10.1155/2020/7532306 LA - English M3 - Article N1 - L2006163155 2020-07-06 2020-07-14 PY - 2020 SN - 2314-6141 2314-6133 ST - β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κ B Pathways in LPS-Exposed BV2 Cells T2 - BioMed Research International TI - β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κ B Pathways in LPS-Exposed BV2 Cells UR - https://www.embase.com/search/results?subaction=viewrecord&id=L2006163155&from=exporthttp://dx.doi.org/10.1155/2020/7532306 VL - 2020 ID - 8333 ER -